PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Goldschmidt, P; Degorge, S; Merabet, L; Chaumeil, C				Goldschmidt, Pablo; Degorge, Sandrine; Merabet, Lilia; Chaumeil, Christine			Enzymatic Treatment of Specimens before DNA Extraction Directly Influences Molecular Detection of Infectious Agents	PLOS ONE			English	Article							REAL-TIME PCR; POLYMERASE-CHAIN-REACTION; RAPID DIAGNOSIS; BLOOD; ENDOPHTHALMITIS; CULTURE; AMPLIFICATION; MICROBIOLOGY; ACANTHAMOEBA; INHIBITOR	Introduction: Biological samples, pharmaceuticals or food contain proteins, lipids, polymers, ammoniums and macromolecules that alter the detection of infectious agents by DNA amplification techniques (PCR). Moreover the targeted DNA has to be released from the complex cell walls and the compact nucleoprotein matrixes and cleared from potential inhibitors. The goal of the present work was to assess the efficiency of enzymatic pretreatments on infectious agents to make DNA available for further extraction and amplification. Methods: Staphylococcus epidermidis, Streptococcus mitis, Propionibacterium acnes, Escherichia coli, Pseudomonas aeruginosa, Candida albicans, Aspergillus niger and Fusarium solani were mixed with an internal control virus and treated with: 1) proteinase K; 2) lyticase and 3) lyticase followed by proteinase K. DNAs was manually extracted using the QIAmp DNA Mini kit or the MagNA Pure Compact automate. DNA extraction yields and the inhibitors were assessed with a phocid Herpesvirus. Bacterial detection was performed using TaqMan real-time PCR and yeasts and filamentous Fungi with HRM (real-time PCR followed by high-resolution melting analysis). Results: Viral DNA was released, extracted and detected using manual and automatic methods without pre enzymatic treatments. Either the manual or the automatic DNA extraction systems did not meet the sensitivity expectations if enzymatic treatments were not performed before: lyticase for Fungi and Proteinase K for Bacteria. The addition of lyticase and proteinase K did not improve results. For Fungi the detection after lyticase was higher than for Proteinase K, for which melting analysis did not allow fungal specification. Discussion: Columns and magnetic beads allowed collecting DNA and separate PCR inhibitors. Detection rates cannot be related to DNA-avidity of beads or to elution but to the lack of proteolysis.	[Goldschmidt, Pablo; Degorge, Sandrine; Merabet, Lilia; Chaumeil, Christine] Lab Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France	CHNO des Quinze-Vingts; UDICE-French Research Universities; Sorbonne Universite	Goldschmidt, P (corresponding author), Lab Ctr Hosp Natl Ophtalmol Quinze Vingts, Paris, France.	pablogol@aol.com						Allan EK, 2005, BRIT J HAEMATOL, V128, P578, DOI 10.1111/j.1365-2141.2004.05333.x; Allen SD, 1985, ANAEROBIC BACTERIA M; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ascioglu S, 2002, CLIN INFECT DIS, V34, P7, DOI 10.1086/323335; Benz MS, 2004, AM J OPHTHALMOL, V137, P38, DOI 10.1016/S0002-9394(03)00896-1; BETZEL C, 1993, J BIOL CHEM, V268, P15854; BOOM R, 1990, J CLIN MICROBIOL, V28, P495, DOI 10.1128/JCM.28.3.495-503.1990; Bretagne S, 2005, FEMS IMMUNOL MED MIC, V45, P361, DOI 10.1016/j.femsim.2005.05.012; Dauphin LA, 2011, DIAGN MICR INFEC DIS, V70, P299, DOI 10.1016/j.diagmicrobio.2011.02.010; Fairfax MR, 2013, CLIN LAB MED, V33, P787, DOI 10.1016/j.cll.2013.08.003; Fredricks DN, 1998, J CLIN MICROBIOL, V36, P2810, DOI 10.1128/JCM.36.10.2810-2816.1998; Freise J, 2001, ANN RHEUM DIS, V60, P140, DOI 10.1136/ard.60.2.140; Gauduchon V, 2003, J CLIN MICROBIOL, V41, P763, DOI 10.1128/JCM.41.2.763-766.2003; Goldschmidt P, 2008, BRIT J OPHTHALMOL, V92, P112, DOI 10.1136/bjo.2007.125898; Goldschmidt P, 2006, BRIT J OPHTHALMOL, V90, P1425, DOI 10.1136/bjo.2006.096420; Goldschmidt P, 2006, BRIT J OPHTHALMOL, V90, P1354, DOI 10.1136/bjo.2006.098830; Goldschmidt P, 2011, PATHOL BIOL, V59, P248, DOI 10.1016/j.patbio.2009.10.008; Goldschmidt P, 2009, BRIT J OPHTHALMOL, V93, P258, DOI 10.1136/bjo.2008.146639; Goldschmidt P, 2009, BRIT J OPHTHALMOL, V93, P1089, DOI 10.1136/bjo.2008.152181; Goldschmidt P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037660; Goldschmidt P, 2012, OPHTHALMOLOGY, V119, P945, DOI 10.1016/j.ophtha.2011.10.038; GREISEN K, 1994, J CLIN MICROBIOL, V32, P335, DOI 10.1128/JCM.32.2.335-351.1994; Heckenberg Sebastiaan G B, 2014, Handb Clin Neurol, V121, P1361, DOI 10.1016/B978-0-7020-4088-7.00093-6; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Henning L, 1999, ACTA TROP, V72, P149, DOI 10.1016/S0001-706X(98)00090-4; Holt J., 1994, BERGEYS MANUAL DETER; Horvath LL, 2004, J CLIN MICROBIOL, V42, P115, DOI 10.1128/JCM.42.1.115-118.2004; Jeddi F, 2013, PARASITE, V20, DOI 10.1051/parasite/2013051; Loeffler J, 2000, DIAGN MICR INFEC DIS, V38, P207, DOI 10.1016/S0732-8893(00)00201-7; Loffler J, 1997, J CLIN MICROBIOL, V35, P3311; Marr KA, 2002, CLIN INFECT DIS, V34, P909, DOI 10.1086/339202; Martin C, 2000, J CLIN MICROBIOL, V38, P3735, DOI 10.1128/JCM.38.10.3735-3742.2000; Metwally L, 2008, J MED MICROBIOL, V57, P296, DOI 10.1099/jmm.0.47617-0; Millar BC, 2001, J MICROBIOL METH, V47, P255, DOI 10.1016/S0167-7012(01)00334-7; Mohammadi T, 2005, TRANSFUSION, V45, P731, DOI 10.1111/j.1537-2995.2005.04258.x; Molteni CG, 2013, INT J IMMUNOPATH PH, V26, P779, DOI 10.1177/039463201302600324; Ng JQ, 2005, OPHTHALMOLOGY, V112, P1199, DOI 10.1016/j.ophtha.2005.01.050; Obara H, 2011, J INFECT CHEMOTHER, V17, P327, DOI 10.1007/s10156-010-0168-z; Ostrosky-Zeichner L, 2003, ANTIMICROB AGENTS CH, V47, P3149, DOI 10.1128/AAC.47.10.3149-3154.2003; Podnecky NL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058032; Poppert S, 2005, J CLIN MICROBIOL, V43, P3390, DOI 10.1128/JCM.43.7.3390-3397.2005; Rabodonirina M, 1999, J CLIN MICROBIOL, V37, P127, DOI 10.1128/JCM.37.1.127-131.1999; Radomski N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078749; Ratanarat R, 2007, BLOOD PURIFICAT, V25, P106, DOI 10.1159/000096406; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Ririe KM, 1997, ANAL BIOCHEM, V245, P154, DOI 10.1006/abio.1996.9916; SCOTT JH, 1980, J BACTERIOL, V142, P414, DOI 10.1128/JB.142.2.414-423.1980; Seal D, 2008, J CATARACT REFR SURG, V34, P1439, DOI 10.1016/j.jcrs.2008.05.043; Seitzman GD, 2006, AM J OPHTHALMOL, V141, P756, DOI 10.1016/j.ajo.2005.10.056; Surinder K, 2007, Indian J Med Microbiol, V25, P395; van Doornum GJJ, 2003, J CLIN MICROBIOL, V41, P576, DOI 10.1128/JCM.41.2.576-580.2003; Welinder-Olsson C, 2007, CLIN MICROBIOL INFEC, V13, P879, DOI 10.1111/j.1469-0691.2007.01756.x; White PL, 2003, J MED MICROBIOL, V52, P229, DOI 10.1099/jmm.0.05049-0	53	20	20	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e94886	10.1371/journal.pone.0094886	http://dx.doi.org/10.1371/journal.pone.0094886			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936792	gold, Green Submitted, Green Published			2022-12-27	WOS:000338503400003
J	Kim, TN; Park, MS; Kim, YJ; Lee, EJ; Kim, MK; Kim, JM; Ko, KS; Rhee, BD; Won, JC				Kim, Tae Nyun; Park, Man Sik; Kim, You Jeong; Lee, Eun Ju; Kim, Mi-Kyung; Kim, Jung Min; Ko, Kyung Soo; Rhee, Byoung Doo; Won, Jong Chul			Association of Low Muscle Mass and Combined Low Muscle Mass and Visceral Obesity with Low Cardiorespiratory Fitness	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; KOREAN SARCOPENIC OBESITY; ALL-CAUSE MORTALITY; METABOLIC SYNDROME; INSULIN-RESISTANCE; SKELETAL-MUSCLE; POSTMENOPAUSAL WOMEN; PHYSICAL-ACTIVITY; OLDER-ADULTS; INFLAMMATION	Objective: Previous studies have shown that low cardiorespiratory fitness (CRF), visceral obesity and low muscle mass may share pathophysiological mechanisms, such as insulin resistance and chronic inflammation. In this study, we investigated whether low CRF is associated with low muscle mass, visceral obesity, and visceral obesity combined with low muscle mass. Research Design and Methods: The associations between CRF and low muscle mass and combined low muscle mass and visceral obesity were examined in 298 apparently healthy adults aged 20-70 years. Low muscle mass was defined using a skeletal muscle mass index (SMI) that was calculated using dual energy X-ray absorptiometry. Visceral obesity was defined as a visceral fat area (VFA) exceeding 100 cm(2) in women and 130 cm(2) in men. We classified the participants into 4 low muscle mass/visceral obesity groups according to SMI and VFA. CRF was measured using a cycle ergometer test. Results: CRF level correlated positively with SMI and negatively with VFA. Individuals with low muscle mass had lower CRF values than those without low muscle mass. After adjustment for age, sex, lifestyle factors, and markers for insulin resistance and inflammation, participants in the lowest quartile of CRF had an odds ratio (OR) for low muscle mass of 4.98 compared with those in the highest quartile (95% confidence interval (CI) = 1.19-12.99; P for trend = 0.001) and an OR for combined low muscle mass and visceral obesity of 31.46 (95% CI = 4.31-229.68; P for trend = 0.001). Conclusions: Individuals with lower CRF exhibited increased risk of low muscle mass and combined low muscle mass and visceral obesity. These results suggest that low CRF may be a potential indicator for low muscle mass and combined low muscle mass and visceral obesity in Korean adults.	[Kim, Tae Nyun; Kim, You Jeong; Lee, Eun Ju; Kim, Mi-Kyung; Kim, Jung Min; Ko, Kyung Soo; Rhee, Byoung Doo; Won, Jong Chul] Inje Univ, Coll Med, Dept Internal Med, Pusan, South Korea; [Kim, Tae Nyun; Kim, Jung Min; Ko, Kyung Soo; Rhee, Byoung Doo; Won, Jong Chul] Inje Univ, Cardiovasc & Metab Dis Ctr, Div Endocrinol & Metab, Pusan, South Korea; [Park, Man Sik] Sungshin Womens Univ, Coll Nat Sci, Dept Stat, Seoul, South Korea	Inje University; Inje University; Sungshin Women's University	Won, JC (corresponding author), Inje Univ, Coll Med, Dept Internal Med, Pusan, South Korea.	drwonjc@gmail.com	Kim, Tae Nyun/AAV-5521-2020	Kim, Mi-kyung/0000-0003-1111-9122; Kim, Tae Nyun/0000-0001-6568-2469; Won, Jong Chul/0000-0002-2219-4083; Kim, Jung Min/0000-0002-1848-3747	Korea Ministry of Health Welfare; Korean Diabetes Association; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0020224]; Inje University [20140036]	Korea Ministry of Health Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); Korean Diabetes Association; Priority Research Centers Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology(National Research Foundation of Korea); Inje University	This study was supported by the Health Promotion Funds from the Korea Ministry of Health & Welfare, Korean Diabetes Association, 2009, and Priority Research Centers Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0020224). This work was also supported by a grant from Research year of Inje University in 2014 (20140036). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arsenault BJ, 2007, ARCH INTERN MED, V167, P1518, DOI 10.1001/archinte.167.14.1518; Beyer I, 2012, CURR OPIN CLIN NUTR, V15, P12, DOI 10.1097/MCO.0b013e32834dd297; BIOLO G, 1995, J CLIN INVEST, V95, P811, DOI 10.1172/JCI117731; BLAIR SN, 1995, JAMA-J AM MED ASSOC, V273, P1093, DOI 10.1001/jama.273.14.1093; BLAIR SN, 1989, JAMA-J AM MED ASSOC, V262, P2395, DOI 10.1001/jama.262.17.2395; Blood I, 2005, CARDIOL REV, V13, P322; Carroll S, 2004, SPORTS MED, V34, P371, DOI 10.2165/00007256-200434060-00004; Cesari M, 2005, AM J CLIN NUTR, V82, P428, DOI 10.1093/ajcn/82.2.428; Church TS, 2007, JAMA-J AM MED ASSOC, V297, P2081, DOI 10.1001/jama.297.19.2081; Davidson LE, 2009, ARCH INTERN MED, V169, P122, DOI 10.1001/archinternmed.2008.558; de Oliveira RJ, 2009, J SPORT SCI MED, V8, P337; FLEG JL, 1988, J APPL PHYSIOL, V65, P1147, DOI 10.1152/jappl.1988.65.3.1147; FLETCHER GF, 1992, CIRCULATION, V86, P340, DOI 10.1161/01.CIR.86.1.340; Gerson LS, 2006, MED SCI SPORT EXER, V38, P1709, DOI 10.1249/01.mss.0000228365.31821.22; Janssen I, 2002, J AM GERIATR SOC, V50, P889, DOI 10.1046/j.1532-5415.2002.50216.x; Janssen I, 2007, DIABETES CARE, V30, P2143, DOI 10.2337/dc07-0734; Kim TN, 2009, INT J OBESITY, V33, P885, DOI 10.1038/ijo.2009.130; Kim TN, 2010, DIABETES CARE, V33, P1497, DOI 10.2337/dc09-2310; Kim TN, DIABETES RES CLIN PR, V101, P210; Kullo IJ, 2002, AM J CARDIOL, V90, P795, DOI 10.1016/S0002-9149(02)02617-6; Lee ES, 2005, OBES RES, V13, P320, DOI 10.1038/oby.2005.43; Lim S, 2010, DIABETES CARE, V33, P1652, DOI 10.2337/dc10-0107; Liu CJ, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002759.pub2; Messier V, 2008, METABOLISM, V57, P1293, DOI 10.1016/j.metabol.2008.04.026; Proctor DN, 1997, J APPL PHYSIOL, V82, P1411, DOI 10.1152/jappl.1997.82.5.1411; Ryu M, AGE AGEING, V42, P734; Schrager MA, 2007, J APPL PHYSIOL, V102, P919, DOI 10.1152/japplphysiol.00627.2006; Srikanthan P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010805; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Sui XM, 2007, JAMA-J AM MED ASSOC, V298, P2507, DOI 10.1001/jama.298.21.2507; Utzschneider KM, 2006, J CLIN ENDOCR METAB, V91, P4753, DOI 10.1210/jc.2006-0587; WHO/IASO/IOTF, 2000, ASIA PACIFIC PERSPEC; Zamboni M, 2008, NUTR METAB CARDIOVAS, V18, P388, DOI 10.1016/j.numecd.2007.10.002	33	32	33	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100118	10.1371/journal.pone.0100118	http://dx.doi.org/10.1371/journal.pone.0100118			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937121	gold, Green Published, Green Submitted			2022-12-27	WOS:000338503400078
J	Kraft, P; Drechsler, C; Gunreben, I; Nieswandt, B; Stoll, G; Heuschmann, PU; Kleinschnitz, C				Kraft, Peter; Drechsler, Christiane; Gunreben, Ignaz; Nieswandt, Bernhard; Stoll, Guido; Heuschmann, Peter Ulrich; Kleinschnitz, Christoph			Von Willebrand Factor Regulation in Patients with Acute and Chronic Cerebrovascular Disease: A Pilot, Case-Control Study	PLOS ONE			English	Article							NONVALVULAR ATRIAL-FIBRILLATION; FACTOR LEVELS INCREASE; ABO BLOOD-GROUP; ISCHEMIC-STROKE; ENDOTHELIAL DYSFUNCTION; THROMBUS FORMATION; SYSTEMIC INFLAMMATION; MYOCARDIAL-INFARCTION; PLATELET ACTIVATION; FACTOR-VIII	Background and Purpose: In animal models, von Willebrand factor (VWF) is involved in thrombus formation and propagation of ischemic stroke. However, the pathophysiological relevance of this molecule in humans, and its potential use as a biomarker for the risk and severity of ischemic stroke remains unclear. This study had two aims: to identify predictors of altered VWF levels and to examine whether VWF levels differ between acute cerebrovascular events and chronic cerebrovascular disease (CCD). Methods: A case-control study was undertaken between 2010 and 2013 at our University clinic. In total, 116 patients with acute ischemic stroke (AIS) or transitory ischemic attack (TIA), 117 patients with CCD, and 104 healthy volunteers (HV) were included. Blood was taken at days 0, 1, and 3 in patients with AIS or TIA, and once in CCD patients and HV. VWF serum levels were measured and correlated with demographic and clinical parameters by multivariate linear regression and ANOVA. Results: Patients with CCD (158 +/- 46%) had significantly higher VWF levels than HV (113 +/- 36%, P<0.001), but lower levels than AIS/TIA patients (200 +/- 95%, P<0.001). Age, sex, and stroke severity influenced VWF levels (P<0.05). Conclusions: VWF levels differed across disease subtypes and patient characteristics. Our study confirms increased VWF levels as a risk factor for cerebrovascular disease and, moreover, suggests that it may represent a potential biomarker for stroke severity, warranting further investigation.	[Kraft, Peter; Gunreben, Ignaz; Stoll, Guido; Kleinschnitz, Christoph] Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany; [Drechsler, Christiane] Univ Hosp Wurzburg, Dept Internal Med, Wurzburg, Germany; [Heuschmann, Peter Ulrich] Univ Hosp Wurzburg, Clin Trial Ctr, Wurzburg, Germany; [Kraft, Peter; Heuschmann, Peter Ulrich] Univ Wurzburg, Comprehens Heart Failure Ctr, Inst Clin Epidemiol & Biometry, D-97070 Wurzburg, Germany; [Nieswandt, Bernhard] Univ Wurzburg, Rudolf Virchow Ctr Expt Biomed, D-97070 Wurzburg, Germany	University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg; University of Wurzburg	Kleinschnitz, C (corresponding author), Univ Hosp Wurzburg, Dept Neurol, Wurzburg, Germany.	christoph.kleinschnitz@uni-wuerzburg.de		Kleinschnitz, Christoph/0000-0002-1650-8875	German Research Foundation (Deutsche Forschungsgemeinschaft) [Sonderforschungsbereich 688]; German Ministry for Research and Education (Bundesministerium fur Bildung und Forschung, Comprehensive Heart Failure Center, Wurzburg, Germany)	German Research Foundation (Deutsche Forschungsgemeinschaft)(German Research Foundation (DFG)); German Ministry for Research and Education (Bundesministerium fur Bildung und Forschung, Comprehensive Heart Failure Center, Wurzburg, Germany)	This publication was funded by the German Research Foundation (Deutsche Forschungsgemeinschaft, Sonderforschungsbereich 688) and the German Ministry for Research and Education (Bundesministerium fur Bildung und Forschung, Comprehensive Heart Failure Center, Wurzburg, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Bongers TN, 2006, STROKE, V37, P2672, DOI 10.1161/01.STR.0000244767.39962.f7; Caponnetto P, 2011, EUR J CLIN INVEST, V41, P616, DOI 10.1111/j.1365-2362.2010.02449.x; Catto AJ, 1997, THROMB HAEMOSTASIS, V77, P1104; Claus RA, 2010, CURR MOL MED, V10, P236, DOI 10.2174/156652410790963367; Conway DSG, 2003, CIRCULATION, V107, P3141, DOI 10.1161/01.CIR.0000077912.12202.FC; De Meyer SF, 2012, STROKE, V43, P599, DOI 10.1161/STROKEAHA.111.628867; Della-Morte D, 2012, J NEUROL SCI, V323, P93, DOI 10.1016/j.jns.2012.08.020; Dmitrieva NI, 2014, P NATL ACAD SCI USA, V111, P6485, DOI 10.1073/pnas.1404809111; Faille D, 2014, EUR J NEUROL, V21, P643, DOI 10.1111/ene.12369; Folsom AR, 1999, CIRCULATION, V100, P736, DOI 10.1161/01.CIR.100.7.736; Gauberti M, 2014, J THROMB HAEMOST, V12, P409, DOI 10.1111/jth.12487; GILL JC, 1987, BLOOD, V69, P1691; GRANGER CV, 1979, ARCH PHYS MED REHAB, V60, P14; Hanson E, 2011, J THROMB HAEMOST, V9, P275, DOI 10.1111/j.1538-7836.2010.04134.x; Jenkins PV, 2006, TRANSFUSION, V46, P1836, DOI 10.1111/j.1537-2995.2006.00975.x; Johnsen JM, 2013, BLOOD, V122, P590, DOI 10.1182/blood-2013-02-485094; Kleinschnitz C, 2007, CIRCULATION, V115, P2323, DOI 10.1161/CIRCULATIONAHA.107.691279; Kleinschnitz C, 2009, BLOOD, V113, P3600, DOI 10.1182/blood-2008-09-180695; Kraft P, 2012, J CEREBR BLOOD F MET, V32, P1831, DOI 10.1038/jcbfm.2012.108; Le Behot A, 2014, BLOOD IN PRESS; Lip GYH, 2002, BLOOD COAGUL FIBRIN, V13, P339, DOI 10.1097/00001721-200206000-00010; Momi S, 2013, BLOOD, V121, P5088, DOI 10.1182/blood-2012-11-464545; Muir KW, 1996, STROKE, V27, P1817, DOI 10.1161/01.STR.27.10.1817; Nieswandt B, 2011, J PHYSIOL-LONDON, V589, P4115, DOI 10.1113/jphysiol.2011.212886; Nilsson TK, 2002, J CARDIOVASC RISK, V9, P215, DOI 10.1097/00043798-200208000-00006; Noto ATW, 2006, THROMB HAEMOSTASIS, V96, P53, DOI 10.1160/TH05-11-0772; Pinto A, 2009, CLIN SCI, V116, P781, DOI 10.1042/CS20080372; Roldan V, 2005, THROMB RES, V116, P321, DOI 10.1016/j.thromres.2005.01.005; Soares AL, 2011, BLOOD COAGUL FIBRIN, V22, P600, DOI 10.1097/MBC.0b013e32834b2fe1; Stegner D, 2011, J MOL MED, V89, P109, DOI 10.1007/s00109-010-0691-5; Stoll G, 2008, BLOOD, V112, P3555, DOI 10.1182/blood-2008-04-144758; Stoll G, 2010, ANN NY ACAD SCI, V1207, P149, DOI 10.1111/j.1749-6632.2010.05730.x; Suadicani P, 2002, J CARDIOVASC RISK, V9, P191, DOI 10.1097/00043798-200208000-00003; Tzoulaki I, 2007, CIRCULATION, V115, P2119, DOI 10.1161/CIRCULATIONAHA.106.635029; Vischer UM, 2006, J THROMB HAEMOST, V4, P1186, DOI 10.1111/j.1538-7836.2006.01949.x; von Beckerath N, 2004, BLOOD COAGUL FIBRIN, V15, P61, DOI 10.1097/00001721-200401000-00010; Westein E, 2013, P NATL ACAD SCI USA, V110, P1357, DOI 10.1073/pnas.1209905110; Wieberdink RG, 2010, STROKE, V41, P2151, DOI 10.1161/STROKEAHA.110.586289; Wu DM, 2002, BLOOD, V99, P3623, DOI 10.1182/blood.V99.10.3623; Xia ZY, 2011, VASA, V40, P199, DOI 10.1024/0301-1526/a000094	42	20	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99851	10.1371/journal.pone.0099851	http://dx.doi.org/10.1371/journal.pone.0099851			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937073	Green Published, gold			2022-12-27	WOS:000338503400044
J	Hilu, KW; Black, CM; Oza, D				Hilu, Khidir W.; Black, Chelsea M.; Oza, Dipan			Impact of Gene Molecular Evolution on Phylogenetic Reconstruction: A Case Study in the Rosids (Superorder Rosanae, Angiosperms)	PLOS ONE			English	Article							NUCLEOTIDE SUBSTITUTION; SEQUENCE DATA; MATK; INFORMATIVENESS; UTILITY; SIGNAL; DNA; CHARACTER; MODELS; RBCL	Rate of substitution of genomic regions is among the most debated intrinsic features that impact phylogenetic informativeness. However, this variable is also coupled with rates of nonsynonymous substitutions that underscore the nature and degree of selection on the selected genes. To empirically address these variables, we constructed four completely overlapping data sets of plastid matK, atpB, rbcL, and mitochondrial matR genes and used the rosid lineage (angiosperms) as a working platform. The genes differ in combinations of overall rates of nucleotide and amino acid substitutions. Tree robustness, homoplasy, accuracy in contrast to a reference tree, and phylogenetic informativeness are evaluated. The rapidly evolving/unconstrained matK faired best, whereas remaining genes varied in degrees of contribution to rosid phylogenetics across the lineage's 108 million years evolutionary history. Phylogenetic accuracy was low with the slowly evolving/unconstrained matR despite least amount of homoplasy. Third codon positions contributed the highest amount of parsimony informative sites, resolution and informativeness, but magnitude varied with gene mode of evolution. These findings are in clear contrast with the views that rapidly evolving regions and the 3rd codon position have inevitable negative impact on phylogenetic reconstruction at deep historic level due to accumulation of multiple hits and subsequent elevation in homoplasy and saturation. Relaxed evolutionary constraint in rapidly evolving genes distributes substitutions across codon positions, an evolutionary mode expected to reduce the frequency of multiple hits. These findings should be tested at deeper evolutionary histories.	[Hilu, Khidir W.; Black, Chelsea M.; Oza, Dipan] Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University	Hilu, KW (corresponding author), Virginia Tech, Dept Biol Sci, Blacksburg, VA 24061 USA.	hilukw@vt.edu			National Science Foundation, USA, Assembling Tree of Life [EF-043105, REU-4776833]	National Science Foundation, USA, Assembling Tree of Life	This work was supported by grant from the National Science Foundation, USA, Assembling Tree of Life (grant numbers EF-043105 and REU-4776833) to KH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barthet MM, 2008, J MOL EVOL, V66, P85, DOI 10.1007/s00239-007-9060-6; Bjorklund M, 1999, CLADISTICS, V15, P191, DOI 10.1111/j.1096-0031.1999.tb00261.x; Blouin MS, 1998, MOL BIOL EVOL, V15, P1719, DOI 10.1093/oxfordjournals.molbev.a025898; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Brockington SF, 2009, INT J PLANT SCI, V170, P627, DOI 10.1086/597785; BROWN WM, 1982, J MOL EVOL, V18, P225, DOI 10.1007/BF01734101; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Campbell DL, 2000, MOL BIOL EVOL, V17, P684, DOI 10.1093/oxfordjournals.molbev.a026347; Cantino PD, 2007, TAXON, V56, P822, DOI 10.2307/25065865; Collins TM, 2005, SYST BIOL, V54, P493, DOI 10.1080/10635150590947339; Crawley SS, 2012, J SYST EVOL, V50, P387, DOI 10.1111/j.1759-6831.2012.00197.x; Criscuolo A, 2009, J MOL EVOL, V68, P377, DOI 10.1007/s00239-009-9212-y; Dornburg A, 2012, MOL BIOL EVOL, V29, P721, DOI 10.1093/molbev/msr228; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; EDWARDS SV, 1991, P ROY SOC B-BIOL SCI, V243, P99, DOI 10.1098/rspb.1991.0017; FARRIS JS, 1989, CLADISTICS, V5, P417, DOI 10.1111/j.1096-0031.1989.tb00573.x; FELSENSTEIN J, 1978, SYST ZOOL, V27, P401, DOI 10.2307/2412923; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fong JJ, 2011, MOL PHYLOGENET EVOL, V61, P300, DOI 10.1016/j.ympev.2011.06.016; Goldman N, 1998, P ROY SOC B-BIOL SCI, V265, P1779, DOI 10.1098/rspb.1998.0502; Goremykin VV, 2003, MOL BIOL EVOL, V20, P1499, DOI 10.1093/molbev/msg159; Graham SW, 2000, AM J BOT, V87, P1712, DOI 10.2307/2656749; GRAYBEAL A, 1994, SYST BIOL, V43, P174, DOI 10.2307/2413460; HASEBE M, 1994, P NATL ACAD SCI USA, V91, P5730, DOI 10.1073/pnas.91.12.5730; Hastad O, 1998, MOL BIOL EVOL, V15, P1381, DOI 10.1093/oxfordjournals.molbev.a025866; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; HILLIS DM, 1987, ANNU REV ECOL SYST, V18, P23, DOI 10.1146/annurev.es.18.110187.000323; Hilu KW, 2008, MOL PHYLOGENET EVOL, V48, P1120, DOI 10.1016/j.ympev.2008.05.021; Hilu KW, 2003, AM J BOT, V90, P1758, DOI 10.3732/ajb.90.12.1758; Hilu KW, 1997, AM J BOT, V84, P830, DOI 10.2307/2445819; Kallersjo M, 1999, CLADISTICS, V15, P91; Kallersjo M, 1998, PLANT SYSTEMATICS EV; Klopfstein S, 2010, SYST BIOL, V59, P226, DOI 10.1093/sysbio/syp105; KLUGE AG, 1969, SYST ZOOL, V18, P1, DOI 10.2307/2412407; Korber B, 2000, COMPUTATIONAL EVOLUT, P52; Lewis LA, 1997, MOL PHYLOGENET EVOL, V7, P377, DOI 10.1006/mpev.1996.0395; LI WH, 1991, FUNDAMENTALS MOL EVO; Lopez-Giraldez F, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-152; Magallon S, 2002, AM J BOT, V89, P1991, DOI 10.3732/ajb.89.12.1991; Magallon S, 2013, AM J BOT, V100, P556, DOI 10.3732/ajb.1200416; Milinkovitch MC, 1996, GENETICS, V144, P1817; Moeller AH, 2011, MOL PHYLOGENET EVOL, V60, P271, DOI 10.1016/j.ympev.2011.04.023; Moore MJ, 2010, P NATL ACAD SCI; Mossel E, 2004, MATH BIOSCI, V187, P189, DOI 10.1016/j.mbs.2003.10.004; MRibu HK, 1996, GENET RESOUR CROP EV, V43, P203, DOI 10.1007/BF00123272; Muller KF, 2006, MOL PHYLOGENET EVOL, V41, P99, DOI 10.1016/j.ympev.2006.06.017; Mueller RL, 2006, SYST BIOL, V55, P289, DOI 10.1080/10635150500541672; Muller J, 2003, PLANT MOL BIOL REP, V21, P5; Muller K, 2004, MOL PHYLOGENET EVOL, V31, P780, DOI 10.1016/j.ympev.2003.12.006; NAYLOR GJP, 1995, NATURE, V373, P565, DOI 10.1038/373565b0; Nixon KC, 1999, CLADISTICS, V15, P407, DOI 10.1111/j.1096-0031.1999.tb00277.x; Olmstead R. G., 1998, MOL SYSTEMATICS PLAN, P164; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Qiu YL, 2010, J SYST EVOL, V48, P391, DOI 10.1111/j.1759-6831.2010.00097.x; Raja HA, 2011, MYCOKEYS, P63, DOI 10.3897/mycokeys.1.1966; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Schoch CL, 2009, SYST BIOL, V58, P224, DOI 10.1093/sysbio/syp020; Sennblad B, 2000, SYST BIOL, V49, P101, DOI 10.1080/10635150050207410; Shen XX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039256; Shpak M, 2000, MOL PHYLOGENET EVOL, V17, P231, DOI 10.1006/mpev.2000.0846; Simmons MP, 2006, SYST BIOL, V55, P245, DOI 10.1080/10635150500481473; Simmons MP, 2004, CLADISTICS, V20, P191, DOI 10.1111/j.1096-0031.2004.00014.x; Simmons MP, 2002, MOL PHYLOGENET EVOL, V24, P78, DOI 10.1016/S1055-7903(02)00202-6; Sogin ML, 1991, CURR OPIN GENET DEV, V1, P457, DOI 10.1016/S0959-437X(05)80192-3; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Steel M, 2000, MOL BIOL EVOL, V17, P839, DOI 10.1093/oxfordjournals.molbev.a026364; Steel Mike, 2005, P163; Swofford David L., 1996, P407; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Townsend JP, 2008, J MOL EVOL, V67, P437, DOI 10.1007/s00239-008-9142-0; Townsend JP, 2007, SYSTEMATIC BIOL, V56, P222, DOI 10.1080/10635150701311362; Townsend JP, 2012, SYST BIOL, V61, P835, DOI 10.1093/sysbio/sys036; Townsend JP, 2011, SYST BIOL, V60, P358, DOI 10.1093/sysbio/syq097; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wenzel JW, 1999, CLADISTICS, V15, P51, DOI 10.1006/clad.1999.0084; WOESSNER JP, 1986, GENE, V44, P17; Worberg A, 2007, ORG DIVERS EVOL, V7, P55, DOI 10.1016/j.ode.2006.08.001; Yang ZH, 1996, J MOL EVOL, V42, P587, DOI 10.1007/BF02352289; Yang ZH, 1998, SYST BIOL, V47, P125, DOI 10.1080/106351598261067; Yoder AD, 1996, MOL BIOL EVOL, V13, P1339, DOI 10.1093/oxfordjournals.molbev.a025580; Young ND, 2000, MOL BIOL EVOL, V17, P1933, DOI 10.1093/oxfordjournals.molbev.a026295; Zhu XY, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-217	84	17	17	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99725	10.1371/journal.pone.0099725	http://dx.doi.org/10.1371/journal.pone.0099725			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932884	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600060
J	Paccosi, S; Musilli, C; Caporale, R; Gelli, AMG; Guasti, D; Clemente, AM; Torcia, MG; Filippelli, A; Romagnoli, P; Parenti, A				Paccosi, Sara; Musilli, Claudia; Caporale, Roberto; Gelli, Anna Maria Grazia; Guasti, Daniele; Clemente, Ann Maria; Torcia, Maria Gabriella; Filippelli, Amelia; Romagnoli, Paolo; Parenti, Astrid			Stimulatory Interactions between Human Coronary Smooth Muscle Cells and Dendritic Cells	PLOS ONE			English	Article							INTERCELLULAR-ADHESION MOLECULE-1; NEOINTIMA FORMATION; VASCULAR INJURY; INFLAMMATION; ATHEROSCLEROSIS; EXPRESSION; MIGRATION; MECHANISMS; MATURATION; LEUKOCYTES	Despite inflammatory and immune mechanisms participating to atherogenesis and dendritic cells (DCs) driving immune and non-immune tissue injury response, the interactions between DCs and vascular smooth muscle cells (VSMCs) possibly relevant to vascular pathology including atherogenesis are still unclear. To address this issue, immature DCs (iDCs) generated from CD14(+) cells isolated from healthy donors were matured either with cytokines (mDCs), or co-cultured (ccDCs) with human coronary artery VSMCs (CASMCs) using transwell chambers. Co-culture induced DC immunophenotypical and functional maturation similar to cytokines, as demonstrated by flow cytometry and mixed lymphocyte reaction. In turn, factors from mDCs and ccDCs induced CASMC migration. MCP-1 and TNF alpha, secreted from DCs, and IL-6 and MCP-1, secreted from CASMCs, were primarily involved. mDCs adhesion to CASMCs was enhanced by CASMC pre-treatment with IFN gamma and TNF alpha ICAM-1 and VCAM-1 were involved, since the expression of specific mRNAs for these molecules increased and adhesion was inhibited by neutralizing antibodies to the counter-receptors CD11c and CD18. Adhesion was also inhibited by CASMC pre-treatment with the HMG-CoA-reductase inhibitor atorvastatin and the PPAR gamma agonist rosiglitazone, which suggests a further mechanism for the anti-inflammatory action of these drugs. Adhesion of DCs to VSMCs was shown also in vivo in rat carotid 7 to 21 days after crush and incision injury. The findings indicate that DCs and VSMCs can interact with reciprocal stimulation, possibly leading to perpetuate inflammation and vascular wall remodelling, and that the interaction is enhanced by a cytokine-rich inflammatory environment and down-regulated by HMGCoA-reductase inhibitors and PPAR gamma agonists.	[Paccosi, Sara; Musilli, Claudia; Parenti, Astrid] Univ Florence, Dept Hlth Sci, Clin Pharmacol & Oncol Unit, Florence, Italy; [Caporale, Roberto; Gelli, Anna Maria Grazia] Azienda Osped Univ Careggi, Cent Lab, Florence, Italy; [Guasti, Daniele; Romagnoli, Paolo] Univ Florence, Dept Expt & Clin Med, Florence, Italy; [Clemente, Ann Maria; Torcia, Maria Gabriella] Univ Florence, Dept Expt & Clin Biomed Sci, Florence, Italy; [Filippelli, Amelia] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy	University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Florence; University of Florence; University of Salerno	Parenti, A (corresponding author), Univ Florence, Dept Hlth Sci, Clin Pharmacol & Oncol Unit, Florence, Italy.	astrid.parenti@unifi.it	Romagnoli, Paolo/AAJ-9636-2020; Filippelli, Amelia/AAC-5321-2022; Torcia, Maria Gabriella G/K-1840-2018; Paccosi, Sara/K-5292-2016	Torcia, Maria Gabriella G/0000-0003-4740-4646; DANIELE, GUASTI/0000-0002-2856-6829; ROMAGNOLI, Paolo/0000-0002-9614-7247; Parenti, Astrid/0000-0002-7980-6853; Filippelli, Amelia/0000-0002-8235-9118; Paccosi, Sara/0000-0001-5062-4127	Italian Ministry of University and Scientific and Technological Research [2007LTAJMA_002, 2007LTAJMA_003]; University of Florence; Foemina Foundation	Italian Ministry of University and Scientific and Technological Research(Ministry of Education, Universities and Research (MIUR)); University of Florence; Foemina Foundation	This work was supported by the Italian Ministry of University and Scientific and Technological Research (www.istruzione.it) grants 2007LTAJMA_002 and 2007LTAJMA_003 to AP and PR), the University of Florence (www.unifi.it), Foemina Foundation (www.fondazionefoemina.it/it/home). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Babelova A, 2013, CURR OPIN PHARMACOL, V13, P260, DOI 10.1016/j.coph.2013.01.004; Bacci S, 2008, THROMB RES, V122, P657, DOI 10.1016/j.thromres.2008.04.013; Barlic J, 2007, J LEUKOCYTE BIOL, V82, P226, DOI 10.1189/jlb.1206761; Bauriedel G, 2003, J AM COLL CARDIOL, V42, P930, DOI 10.1016/S0735-1097(03)00828-3; Bellik L, 2006, CLIN IMMUNOL, V121, P74, DOI 10.1016/j.clim.2006.06.011; Bellosta S, 1998, ATHEROSCLEROSIS, V137, pS101, DOI 10.1016/S0021-9150(97)00319-5; Bobryshev YV, 1998, CARDIOVASC RES, V37, P799, DOI 10.1016/S0008-6363(97)00229-0; BRAUN M, 1995, J MOL CELL CARDIOL, V27, P2571, DOI 10.1006/jmcc.1995.0044; Ceriello A, 2008, DIABETES-METAB RES, V24, P14, DOI 10.1002/dmrr.790; Choi JH, 2011, IMMUNITY, V35, P819, DOI 10.1016/j.immuni.2011.09.014; COUFFINHAL T, 1994, CIRC RES, V74, P225, DOI 10.1161/01.RES.74.2.225; Doran AC, 2008, ARTERIOSCL THROM VAS, V28, P812, DOI 10.1161/ATVBAHA.107.159327; Feng WG, 2010, HYPERTENSION, V55, P1381, DOI 10.1161/HYPERTENSIONAHA.110.150995; Fiorina P, 2008, TRANSPLANTATION, V85, P1030, DOI 10.1097/TP.0b013e31816843a0; Forte A, 2001, J CELL PHYSIOL, V186, P307, DOI 10.1002/1097-4652(200002)186:2<307::AID-JCP1029>3.0.CO;2-I; Fotis L, 2012, IN VIVO, V26, P243; Gerlini G, 2008, J IMMUNOL, V181, P2999, DOI 10.4049/jimmunol.181.5.2999; Gouwy M, 2014, IMMUNOBIOLOGY, V219, P218, DOI 10.1016/j.imbio.2013.10.004; Hirase T, 2012, AM J PHYSIOL-HEART C, V302, pH499, DOI 10.1152/ajpheart.00325.2011; Jimenez F, 2010, J IMMUNOL, V184, P5571, DOI 10.4049/jimmunol.0803494; Jin CZ, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/357060; Jongstra-Bilen J, 2006, J EXP MED, V203, P2073, DOI 10.1084/jem.20060245; Lee AW, 2002, VACCINE, V20, pA8, DOI 10.1016/S0264-410X(02)00382-1; Lee SJ, 2007, J LEUKOCYTE BIOL, V82, P436, DOI 10.1189/jlb.1206739; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Liu PY, 2009, CIRCULATION, V119, P131, DOI 10.1161/CIRCULATIONAHA.108.813311; Luo YK, 2004, J CARDIOVASC PHARM, V44, P381, DOI 10.1097/01.fjc.0000138164.88740.f8; Maddaluno M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047464; Madhur MS, 2011, ARTERIOSCL THROM VAS, V31, P1565, DOI 10.1161/ATVBAHA.111.227629; Meng L, 2010, AM J PHYSIOL-HEART C, V298, pH736, DOI 10.1152/ajpheart.00935.2009; Moretta L, 2003, VACCINE, V21, pS38, DOI 10.1016/S0264-410X(03)00197-X; Musilli C, 2011, MOL IMMUNOL, V49, P234, DOI 10.1016/j.molimm.2011.08.019; Niessner A, 2010, CLIN IMMUNOL, V134, P25, DOI 10.1016/j.clim.2009.05.006; Parenti A, 2004, AM J PHYSIOL-HEART C, V286, pH1978, DOI 10.1152/ajpheart.00414.2003; Pieri L, 2008, HISTOL HISTOPATHOL, V23, P19, DOI 10.14670/HH-23.19; Raines EW, 2005, J LIPID RES, V46, P1081, DOI 10.1194/jlr.R500004-JLR200; Rinaldi B, 2006, BRIT J PHARMACOL, V147, P175, DOI 10.1038/sj.bjp.0706472; Rinaldi B, 2009, SHOCK, V32, P638, DOI 10.1097/SHK.0b013e3181a5a377; Scimone ML, 2005, IMMUNOLOGY, V114, P375, DOI 10.1111/j.1365-2567.2005.02104.x; Simon DI, 2012, CIRC J, V76, P1811, DOI 10.1253/circj.CJ-12-0801; Wang CY, 2008, TRENDS MOL MED, V14, P37, DOI 10.1016/j.molmed.2007.11.004; WANG XK, 1995, ATHEROSCLEROSIS, V115, P89, DOI 10.1016/0021-9150(94)05503-B; Wei-Guo Z, 2009, CELL IMMUNOL, V254, P110, DOI 10.1016/j.cellimm.2008.08.001; Weis M, 2002, ARTERIOSCL THROM VAS, V22, P1817, DOI 10.1161/01.ATV.0000036418.04998.D5; Weyand CM, 2008, CURR OPIN LIPIDOL, V19, P469, DOI 10.1097/MOL.0b013e32830bfdc2; Wick G, 1997, FASEB J, V11, P1199, DOI 10.1096/fasebj.11.13.9367355; Yilmaz A, 2004, ATHEROSCLEROSIS, V176, P101, DOI 10.1016/j.atherosclerosis.2004.04.027; Yilmaz A, 2006, J LEUKOCYTE BIOL, V79, P529, DOI 10.1189/jlb.0205064	48	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99652	10.1371/journal.pone.0099652	http://dx.doi.org/10.1371/journal.pone.0099652			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932497	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600053
J	Wang, SQ; Liu, Y; Ma, LY; Liu, HB; Tang, Y; Wu, LP; Wang, Z; Li, YY; Wu, RL; Pang, XM				Wang, Siqi; Liu, Ying; Ma, Liying; Liu, Huabo; Tang, Yan; Wu, Liping; Wang, Zhe; Li, Yingyue; Wu, Rongling; Pang, Xiaoming			Isolation and Characterization of Microsatellite Markers and Analysis of Genetic Diversity in Chinese Jujube (Ziziphus jujuba Mill.)	PLOS ONE			English	Article							SEQUENCE REPEAT MARKERS; SSR MARKERS; LINKAGE MAP; CONSTRUCTION; L.	Chinese jujube (Ziziphus jujuba Mill, 2n = 2x = 24, Rhamnaceae) is an economically important Chinese native species. It has high nutritional value, and its medicinal properties have led to extensive use in traditional oriental medicine. The characterization of genotypes using molecular markers is important for genetic studies and plant breeding. However, few simple sequence repeat (SSR) markers are available for this species. In this study, 1,488 unique SSR clones were isolated from Z. jujuba 'Dongzao' using enriched genomic libraries coupled with a three-primer colony PCR screening strategy, yielding a high enrichment rate of 73.3%. Finally, 1,188 (80.87%) primer pairs were amplified successfully in the size expected for 'Dongzao'. A total of 350 primer pairs were further selected and evaluated for their ability to detect polymorphisms across a panel of six diverse cultivars; among these, 301 primer pairs detected polymorphisms, and the polymorphism information content (PIC) value across all loci ranged from 0.15 to 0.82, with an average of 0.52. An analysis of 76 major cultivars employed in Chinese jujube production using 31 primer pairs revealed comparatively high genetic diversity among these cultivars. Within-population differences among individuals accounted for 98.2% of the observed genetic variation. Neighbor-joining clustering divided the cultivars into three main groups, none of which correspond to major geographic regions, suggesting that the genetics and geographical origin of modern Chinese jujube cultivars might not be linked. The current work firstly reports the large-scale development of Chinese jujube SSR markers. The development of these markers and their polymorphic information represent a significant improvement in the available Chinese jujube genomic resources and will facilitate both genetic and breeding applications, further accelerating the development of new cultivars.	[Wang, Siqi; Liu, Ying; Ma, Liying; Liu, Huabo; Tang, Yan; Wu, Liping; Wang, Zhe; Li, Yingyue; Wu, Rongling; Pang, Xiaoming] Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Natl Engn Lab Tree Breeding, Ctr Computat Biol,Coll Biol Sci & Biotechnol,Mini, Beijing, Peoples R China	Beijing Forestry University	Pang, XM (corresponding author), Beijing Forestry Univ, Key Lab Genet & Breeding Forest Trees & Ornamenta, Natl Engn Lab Tree Breeding, Ctr Computat Biol,Coll Biol Sci & Biotechnol,Mini, Beijing, Peoples R China.	xmpang@bjfu.edu.cn			State Forestry Administration of China [201004017]; National Natural Science Foundation of China [31372019]; Ministry of Science and Technology of China [2013BAD14B0302]; Ministry of Education of China [JD2010-5]; Thousand-person Plan Award	State Forestry Administration of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Education of China(Ministry of Education, China); Thousand-person Plan Award(Chinese Academy of Sciences)	Support for this work came from the following: 1.Special Fund for Forestry-Scientific Research in the Public Welfare (201004017) from the State Forestry Administration of China (www.forestry.gov.cn) to XP; 2.Grant 31372019 from the National Natural Science Foundation of China (http://www.nsfc.gov.cn/) to XP; 3.Projects in the National Science & Technology Pillar Program (2013BAD14B0302) from the Ministry of Science and Technology of China (www.most.gov.cn/) to XP; 4.the Fundamental Research Funds for the Central Universities (JD2010-5) from the Ministry of Education of China (www.moe.gov.cn) to XP; and 5.the Thousand-person Plan Award from http://www.1000plan.org/to RW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos W, 2007, MOL ECOL NOTES, V7, P10, DOI 10.1111/j.1471-8286.2006.01560.x; Appleby Nikki, 2009, V513, P19, DOI 10.1007/978-1-59745-427-8_2; Ashworth VETM, 2003, J HERED, V94, P407, DOI 10.1093/jhered/esg076; Bai RX, 2008, THESIS HEBEI AGR U; Barthe S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040699; BOTSTEIN D, 1980, AM J HUM GENET, V32, P314; Butler JM, 2006, J FORENSIC SCI, V51, P253, DOI 10.1111/j.1556-4029.2006.00046.x; Cai HW, 2005, THEOR APPL GENET, V112, P158, DOI 10.1007/s00122-005-0118-9; Cai HW, 2003, THEOR APPL GENET, V107, P1337, DOI 10.1007/s00122-003-1386-x; Cipriani G, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-127; CYONG JC, 1980, PHYTOCHEMISTRY, V19, P2747, DOI 10.1016/S0031-9422(00)83955-2; Danin-Poleg Y, 2001, THEOR APPL GENET, V102, P61, DOI 10.1007/s001220051618; Dirlewanger E, 2002, THEOR APPL GENET, V105, P127, DOI 10.1007/s00122-002-0867-7; El-Kassaby YA, 2007, BREEDING BREEDING AP, P43; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Federici CT, 1998, THEOR APPL GENET, V96, P812, DOI 10.1007/s001220050807; Fisher PJ, 1998, THEOR APPL GENET, V96, P969, DOI 10.1007/s001220050828; Gai H.M., 2011, MOL PLANT BREEDING, V9, P1359; Hendre PS, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-51; Hirata M, 2006, THEOR APPL GENET, V113, P270, DOI 10.1007/s00122-006-0292-4; Jena SN, 2012, THEOR APPL GENET, V124, P565, DOI 10.1007/s00122-011-1729-y; Li JW, 2007, FOOD CHEM, V103, P454, DOI 10.1016/j.foodchem.2006.08.016; Li ML, 2009, MOL BREEDING, V24, P41, DOI 10.1007/s11032-009-9270-2; Liu J, 2014, SCI HORTIC-AMSTERDAM, V165, P99, DOI 10.1016/j.scienta.2013.10.033; Liu MJ, 2009, ACTA HORTIC, V840, P25; Liu M.J., 2009, GERMPLASM RESOURCES; Lu JinYing, 2005, Acta Horticulturae Sinica, V32, P680; Ma QH, 2011, SCI HORTIC-AMSTERDAM, V129, P597, DOI 10.1016/j.scienta.2011.04.032; Mahajan R. T., 2009, Pharmacognosy Reviews, V3, P320; Mammadov JA, 2010, THEOR APPL GENET, V121, P577, DOI 10.1007/s00122-010-1331-8; Mir RR, 2009, CROP SCI, V49, P1687, DOI 10.2135/cropsci2008.10.0599; MURRAY MG, 1980, NUCLEIC ACIDS RES, V8, P4321, DOI 10.1093/nar/8.19.4321; Nunome T, 2006, PLANT MOL BIOL REP, V24, P305, DOI 10.1007/BF02913457; Nunome T, 2009, THEOR APPL GENET, V119, P1143, DOI 10.1007/s00122-009-1116-0; Pang Xiao-Ming, 2003, Acta Genetica Sinica, V30, P81; Park S.D.E., 2001, TRYPANOTOLERANCE W A; Peng JianYing, 2000, Acta Horticulturae Sinica, V27, P171; Perumal R, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-77; Rahimmalek M, 2011, GENES GENOM, V33, P475, DOI 10.1007/s13258-011-0045-x; Rallo P, 2000, THEOR APPL GENET, V101, P984, DOI 10.1007/s001220051571; Richards CM, 2009, TREE GENET GENOMES, V5, P339, DOI 10.1007/s11295-008-0190-9; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sethy NK, 2006, THEOR APPL GENET, V112, P1416, DOI 10.1007/s00122-006-0243-0; Shen LY, 2005, THESIS HEBEI AGR U; SMITH JSC, 1992, ADV AGRON, V47, P85, DOI 10.1016/S0065-2113(08)60489-7; Stagel A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-357; State Forestry Administration, 2011, CHIN FOR STAT YB; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang S, 2002, THEOR APPL GENET, V105, P1124, DOI 10.1007/s00122-002-0989-y; Tsukazaki H, 2007, EUPHYTICA, V157, P83, DOI 10.1007/s10681-007-9398-2; Varshney RK, 2005, TRENDS BIOTECHNOL, V23, P48, DOI 10.1016/j.tibtech.2004.11.005; Vosman Ben, 1998, P382; Wang XW, 2007, MOL ECOL NOTES, V7, P558, DOI 10.1111/j.1471-8286.2006.01655.x; Wang YW, 2011, THEOR APPL GENET, V122, P677, DOI 10.1007/s00122-010-1477-4; Wang YL, 2001, EC FOREST RES, V9, P59; Wu YQ, 2007, GENOME, V50, P84, DOI 10.1139/G06-133; Yu KF, 1999, GENOME, V42, P27, DOI 10.1139/gen-42-1-27; Yuan SX, 2013, EUPHYTICA, V189, P393, DOI 10.1007/s10681-012-0788-8; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x; Zhang JJ, 2012, PLANT CELL REP, V31, P299, DOI 10.1007/s00299-011-1164-1; Zhang YL, 2005, CHINESE J CLIN REHAB, V9, P247; Zhang ZhiShan, 2010, China Fruits, P5	62	35	45	0	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99842	10.1371/journal.pone.0099842	http://dx.doi.org/10.1371/journal.pone.0099842			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932973	Green Submitted, gold, Green Published			2022-12-27	WOS:000337738600070
J	Werth, S; Scheidegger, C				Werth, Silke; Scheidegger, Christoph			Gene Flow within and between Catchments in the Threatened Riparian Plant Myricaria germanica	PLOS ONE			English	Article							DISTANCE SEED DISPERSAL; MAXIMUM-LIKELIHOOD-ESTIMATION; POPULATION-STRUCTURE; SPARGANIUM-EMERSUM; SCALE PATTERNS; RIVER SYSTEMS; DIVERSITY; METAPOPULATION; LAXIFLORA; WIND	One of the major distinctions of riparian habitats is their linearity. In linear habitats, gene flow is predicted to follow a one-dimensional stepping stone model, characterized by bidirectional gene flow between neighboring populations. Here, we studied the genetic structure of Myricaria germanica, a threatened riparian shrub which is capable of both wind and water dispersal. Our data led us to reject the 'one catchment - one gene pool' hypothesis as we found support for two gene pools, rather than four as expected in a study area including four catchments. This result also implies that in the history of the studied populations, dispersal across catchments has occurred. Two contemporary catchment-crossing migration events were detected, albeit between spatially proximate catchments. Allelic richness and inbreeding coefficients differed substantially between gene pools. There was significant isolation by distance, and our data confirmed the one-dimensional stepping-stone model of gene flow. Contemporary migration was bidirectional within the studied catchments, implying that dispersal vectors other than water are important for M. germanica.	[Werth, Silke; Scheidegger, Christoph] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Werth, Silke] Univ Iceland, Dept Life & Environm Sci, Reykjavik, Iceland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Iceland	Werth, S (corresponding author), Swiss Fed Res Inst WSL, Birmensdorf, Switzerland.	silke@hi.is	Werth, Silke/I-4757-2012; Werth, Silke/AAB-7138-2020; Scheidegger, Christoph/C-6547-2011	Werth, Silke/0000-0002-4981-7850; Scheidegger, Christoph/0000-0003-3713-5331	Federal Office of the Environment, FOEN [07.0071.PJ/G473-0382]; European Commission [302589]	Federal Office of the Environment, FOEN; European Commission(European CommissionEuropean Commission Joint Research Centre)	This study was funded by the Federal Office of the Environment, FOEN as part of the project "Integrated Rivermanagement'' (07.0071.PJ/G473-0382). SW received funding in form of a Marie Curie IEF ('Lichenomics', grant number 302589), a program funded under the Seventh Framework Programme (FP7) of the European Commission. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alp M., 2011, EAU ENERGIE AIR, V3, P216; ANDERSEN M, 1991, AM NAT, V137, P476, DOI 10.1086/285178; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; Beerli Peter, 2009, V17, P42; Bullock JM, 2006, PLANT ECOL, V186, P217, DOI 10.1007/s11258-006-9124-5; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; BUSCH DE, 1995, ECOL MONOGR, V65, P347, DOI 10.2307/2937064; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Chen FQ, 2007, PLANT ECOL, V191, P67, DOI 10.1007/s11258-006-9214-4; DeWoody J, 2004, CONSERV GENET, V5, P603, DOI 10.1007/s10592-004-1985-3; Dyer RJ, 2004, MOL ECOL, V13, P1713, DOI 10.1111/j.1365-294X.2004.02177.x; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Ellenberg H., 1963, VEGETATION MITTELEUR; ENDRESS P K, 1975, Vierteljahrsschrift der Naturforschenden Gesellschaft in Zuerich, V120, P1; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Frisendahl A., 1921, ACTA FLORA SUECIAE, V1, P265; Goldstein DB, 1997, J HERED, V88, P335, DOI 10.1093/oxfordjournals.jhered.a023114; He TH, 2004, MOL ECOL, V13, P1099, DOI 10.1111/j.1365-294X.2004.02120.x; Honnay O, 2009, J ECOL, V97, P131, DOI 10.1111/j.1365-2745.2008.01452.x; Honnay O, 2010, J BIOGEOGR, V37, P1730, DOI 10.1111/j.1365-2699.2010.02331.x; Hu LJ, 2010, CONSERV GENET, V11, P77, DOI 10.1007/s10592-009-0004-0; Hulten E., 1986, ATLAS N EUROPEAN VAS, V1-3; Imbert E, 2003, J ECOL, V91, P447, DOI 10.1046/j.1365-2745.2003.00772.x; Jacquemyn H, 2010, BIOL INVASIONS, V12, P553, DOI 10.1007/s10530-009-9461-0; Jakalaniemi A, 2006, CONSERV BIOL, V20, P844, DOI 10.1111/j.1523-1739.2006.00348.x; Jansson R, 2000, ECOL APPL, V10, P203; Jansson R, 2005, J ECOL, V93, P1094, DOI 10.1111/j.1365-2745.2005.01057.x; Jansson R, 2000, ECOLOGY, V81, P899, DOI 10.1890/0012-9658(2000)081[0899:FORFIR]2.0.CO;2; Jarne P, 1996, TRENDS ECOL EVOL, V11, P424, DOI 10.1016/0169-5347(96)10049-5; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kondo T, 2009, AM J BOT, V96, P1532, DOI 10.3732/ajb.0800273; Liu YF, 2006, AM J BOT, V93, P206, DOI 10.3732/ajb.93.2.206; Liu YF, 2009, MOL ECOL, V18, P2700, DOI 10.1111/j.1365-294X.2009.04214.x; MANTEL N, 1967, CANCER RES, V27, P209; Markwith SH, 2007, AM J BOT, V94, P151, DOI 10.3732/ajb.94.2.151; Merritt DM, 2010, ECOL MONOGR, V80, P609, DOI 10.1890/09-1533.1; Mitsui Y, 2010, AM J BOT, V97, P101, DOI 10.3732/ajb.0800220; Moor M., 1958, Mitteilungen der Schweizerischen Anstalt fur das forstliche Versuchswesen, V34, P221; Muller N., 2001, STUDIES VEGETATION A, P127; Nei M., 1987, MOL EVOLUTIONARY GEN; Nichols J., 2001, DISPERSAL; Nilsson C, 2010, BIOL REV, V85, P837, DOI 10.1111/j.1469-185X.2010.00129.x; Oksanen J., 2010, VEGAN PACKAGE; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Pfenninger M, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-135; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Pollux BJA, 2009, AQUAT BOT, V90, P199, DOI 10.1016/j.aquabot.2008.07.002; Pollux BJA, 2009, FRESHWATER BIOL, V54, P64, DOI 10.1111/j.1365-2427.2008.02100.x; Prentis PJ, 2008, FRESHWATER BIOL, V53, P973, DOI 10.1111/j.1365-2427.2008.01953.x; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; Ronce Ophelie, 2001, Trends in Ecology and Evolution, V16, P663, DOI 10.1016/S0169-5347(01)02348-5; Sakamoto Y., 1986, AKAIKE INFORM CRITER; Schmidt K, 2000, AM J BOT, V87, P678, DOI 10.2307/2656854; Schweingruber Fritz H., 2007, Bauhinia, P5; Silvertown J., 2001, INTRO PLANT POPULATI; SLATKIN M, 1993, EVOLUTION, V47, P264, DOI 10.1111/j.1558-5646.1993.tb01215.x; Smulders MJM, 2008, FOREST ECOL MANAG, V255, P1388, DOI 10.1016/j.foreco.2007.10.063; Sork VL, 2010, MOL ECOL, V19, P3806, DOI 10.1111/j.1365-294X.2010.04726.x; Tackenberg O, 2003, ECOL MONOGR, V73, P173, DOI 10.1890/0012-9615(2003)073[0173:MLDOPD]2.0.CO;2; Tackenberg O, 2003, ECOL MONOGR, V73, P191, DOI 10.1890/0012-9615(2003)073[0191:AOWDPI]2.0.CO;2; Tero N, 2003, MOL ECOL, V12, P2073, DOI 10.1046/j.1365-294X.2003.01898.x; Tikka PM, 2001, LANDSCAPE ECOL, V16, P659, DOI 10.1023/A:1013120529382; Tockner K, 2002, ENVIRON CONSERV, V29, P308, DOI 10.1017/S037689290200022X; Van Looy K, 2009, BIOL CONSERV, V142, P870, DOI 10.1016/j.biocon.2008.12.006; Werth S, 2011, CONSERV GENET RESOUR, V3, P445, DOI 10.1007/s12686-010-9376-1; WRIGHT S, 1950, NATURE, V166, P247, DOI 10.1038/166247a0; Wright S, 1943, GENETICS, V28, P114	75	16	17	1	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99400	10.1371/journal.pone.0099400	http://dx.doi.org/10.1371/journal.pone.0099400			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932520	Green Submitted, gold, Green Published			2022-12-27	WOS:000337738600032
J	Yin, JD; Yang, JW; Guo, QY				Yin, Jiandong; Yang, Jiawen; Guo, Qiyong			Evaluating the Feasibility of an Agglomerative Hierarchy Clustering Algorithm for the Automatic Detection of the Arterial Input Function Using DSC-MRI	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; SINGULAR-VALUE DECOMPOSITION; SUSCEPTIBILITY CONTRAST MRI; PERFUSION MRI; BOLUS TRACKING; QUANTIFICATION; DECONVOLUTION; VOLUME; HEMODYNAMICS; SELECTION	During dynamic susceptibility contrast-magnetic resonance imaging (DSC-MRI), it has been demonstrated that the arterial input function (AIF) can be obtained using fuzzy c-means (FCM) and k-means clustering methods. However, due to the dependence on the initial centers of clusters, both clustering methods have poor reproducibility between the calculation and recalculation steps. To address this problem, the present study developed an alternative clustering technique based on the agglomerative hierarchy (AH) method for AIF determination. The performance of AH method was evaluated using simulated data and clinical data based on comparisons with the two previously demonstrated clustering-based methods in terms of the detection accuracy, calculation reproducibility, and computational complexity. The statistical analysis demonstrated that, at the cost of a significantly longer execution time, AH method obtained AIFs more in line with the expected AIF, and it was perfectly reproducible at different time points. In our opinion, the disadvantage of AH method in terms of the execution time can be alleviated by introducing a professional high-performance workstation. The findings of this study support the feasibility of using AH clustering method for detecting the AIF automatically.	[Yin, Jiandong; Yang, Jiawen; Guo, Qiyong] China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Liaoning, Peoples R China	China Medical University	Guo, QY (corresponding author), China Med Univ, Shengjing Hosp, Dept Radiol, Shenyang, Liaoning, Peoples R China.	guoqy@sj-hospital.org			provincial government fund-Science and Technique Foundation of Liaoning [2011402016]	provincial government fund-Science and Technique Foundation of Liaoning	This study was supported by the provincial government fund-Science and Technique Foundation of Liaoning (No. 2011402016). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bleeker EJW, 2011, MAGN RESON MED, V65, P448, DOI 10.1002/mrm.22599; Bleeker EJW, 2009, J CEREBR BLOOD F MET, V29, P840, DOI 10.1038/jcbfm.2008.155; Bleeker Egbert JW, 2012, IMAGING MED, V2, P41; Calamante F, 2013, PROG NUCL MAG RES SP, V74, P1, DOI 10.1016/j.pnmrs.2013.04.002; Carroll TJ, 2003, RADIOLOGY, V227, P593, DOI 10.1148/radiol.2272020092; Conturo TE, 2005, J MAGN RESON IMAGING, V22, P697, DOI 10.1002/jmri.20457; Donahue MJ, 2012, STROKE, V43, P903, DOI 10.1161/STROKEAHA.111.635995; Enmi J, 2012, PHYS MED BIOL, V57, P7873, DOI 10.1088/0031-9155/57/23/7873; Essig M, 2013, AM J ROENTGENOL, V200, P24, DOI 10.2214/AJR.12.9543; Freire L, 2002, IEEE T MED IMAGING, V21, P470, DOI 10.1109/TMI.2002.1009383; Freire L, 2001, NEUROIMAGE, V14, P709, DOI 10.1006/nimg.2001.0869; Gruner R, 2006, MAGN RESON MED, V55, P805, DOI 10.1002/mrm.20850; Guzman-de-Villoria JA, 2012, RADIOLOGIA-MADRID, V54, P208, DOI 10.1016/j.rx.2011.06.003; Ibaraki M, 2005, J CEREBR BLOOD F MET, V25, P378, DOI 10.1038/sj.jcbfm.9600037; Kellner E, 2013, MAGN RESON MED, V69, P771, DOI 10.1002/mrm.24319; Kim J, 2010, COMPUT METH PROG BIO, V98, P204, DOI 10.1016/j.cmpb.2009.12.005; Kjolby BF, 2009, MAGN RESON MED, V61, P1300, DOI 10.1002/mrm.21849; Knutsson L, 2010, MAGN RESON IMAGING, V28, P1, DOI 10.1016/j.mri.2009.06.006; Kong YY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092069; McGehee BE, 2012, J MAGN RESON IMAGING, V36, P1257, DOI 10.1002/jmri.23645; Mehndiratta A, 2013, NEUROIMAGE, V64, P560, DOI 10.1016/j.neuroimage.2012.08.083; Mlynash M, 2005, AM J NEURORADIOL, V26, P1479; Mouannes-Srour JJ, 2012, MAGN RESON MED, V68, P495, DOI 10.1002/mrm.23257; Mouridsen K, 2006, MAGN RESON MED, V55, P524, DOI 10.1002/mrm.20759; Murase K, 2001, PHYS MED BIOL, V46, P3147, DOI 10.1088/0031-9155/46/12/306; Murase K, 2001, J MAGN RESON IMAGING, V13, P797, DOI 10.1002/jmri.1111; Ostergaard L, 1996, MAGN RESON MED, V36, P715, DOI 10.1002/mrm.1910360510; Ostergaard Leif, 2004, Top Magn Reson Imaging, V15, P3; Peruzzo D, 2011, COMPUT METH PROG BIO, V104, pE148, DOI 10.1016/j.cmpb.2011.02.012; REMPP KA, 1994, RADIOLOGY, V193, P637, DOI 10.1148/radiology.193.3.7972800; Shi L, 2013, J MAGN RESON IMAGING; Shin WY, 2007, MAGN RESON MED, V58, P1232, DOI 10.1002/mrm.21420; Smith AM, 2000, J MAGN RESON IMAGING, V12, P400, DOI 10.1002/1522-2586(200009)12:3<400::AID-JMRI5>3.0.CO;2-C; Thomsen H, 2012, ACTA RADIOL, V53, P95, DOI 10.1258/ar.2011.110242; Vonken EPA, 1999, MAGN RESON MED, V41, P343, DOI 10.1002/(SICI)1522-2594(199902)41:2<343::AID-MRM19>3.0.CO;2-T; Willats L, 2013, NMR BIOMED, V26, P913, DOI 10.1002/nbm.2833; Willats L, 2011, J CEREBR BLOOD F MET, V31, P2189, DOI 10.1038/jcbfm.2011.78; Wirestam R, 2000, MAGNET RESON MED, V43, P691, DOI 10.1002/(SICI)1522-2594(200005)43:5<691::AID-MRM11>3.0.CO;2-B; Wu O, 2003, MAGNET RESON MED, V50, P164, DOI 10.1002/mrm.10522	39	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100308	10.1371/journal.pone.0100308	http://dx.doi.org/10.1371/journal.pone.0100308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932638	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600109
J	Buchner, DL; Brenner, JL; Kabakyenga, J; Teddy, K; Maling, S; Barigye, C; Nettel-Aguirre, A; Singhal, N				Buchner, Denise L.; Brenner, Jennifer L.; Kabakyenga, Jerome; Teddy, Kyomuhangi; Maling, Samuel; Barigye, Celestine; Nettel-Aguirre, Alberto; Singhal, Nalini			Stakeholders' Perceptions of Integrated Community Case Management by Community Health Workers: A Post-Intervention Qualitative Study	PLOS ONE			English	Article							CARE-SEEKING; CHILDREN; ACCESS; PNEUMONIA	Background: Integrated community case management (iCCM) involves delivery of simple medicines to children with pneumonia, diarrhea and/or malaria by community health workers (CHWs). Between 2010 and 2012, an iCCM intervention trial was implemented by Healthy Child Uganda. This study used qualitative tools to assess whether project stakeholders perceived that iCCM improved access to care for children under five years of age. Methods: The intervention involved training and equipping 196 CHWs in 98 study villages in one sub-county in Uganda in iCCM. During the eight-month intervention, CHWs assessed sick children, provided antimalarials (coartem) for fever, antibiotics (amoxicillin) for cough and fast breathing, oral rehydration salts/zinc for diarrhea, and referred very sick children to health facilities. In order to examine community perceptions and acceptability of iCCM, post-intervention focus groups and key respondent interviews involving caregivers, health workers, CHWs and local leaders were carried out by experienced facilitators using semi-structured interview guides. Data were analyzed using thematic analysis techniques. Results: Respondents reported increased access to health care for children as a result of iCCM. Access was reportedly closer to home, available more hours in a day, and the availability of CHWs was perceived as more reliable. CHW care was reported to be trustworthy and caring. Families reported saving money especially due to reduced transportation costs, and less time away from home. Respondents also perceived better health outcomes. Linkages between health facilities and communities were reportedly improved by the iCCM intervention due to the presence of trained CHWs in the community. Conclusions: iCCM delivered by CHWs may improve access to health care and is acceptable to families. Policymakers should continue to seek opportunities to implement and support iCCM, particularly in remote communities where there are health worker shortages.	[Buchner, Denise L.; Brenner, Jennifer L.] Univ Calgary, Fac Med, Calgary, AB, Canada; [Kabakyenga, Jerome; Maling, Samuel; Nettel-Aguirre, Alberto; Singhal, Nalini] Mbrara Univ Sci & Technol, Fac Med, Mbrara Dist, Mbrara, Uganda; [Teddy, Kyomuhangi] Hlth Child Uganda, Mbrara Dist, Mbrara, Uganda; [Barigye, Celestine] Govt Uganda, Minist Hlth, Kampala, Uganda	University of Calgary	Buchner, DL (corresponding author), Univ Calgary, Fac Med, Calgary, AB, Canada.	dlbuchne@ucalgary.ca	Nettel-Aguirre, Alberto/ABB-9412-2021	Nettel-Aguirre, Alberto/0000-0001-6604-0652	Global Health Research Initiative [105957-001]; Canadian Institutes of Health Research; Canadian International Development Agency; International Development Research Centre; International Development Research Centre (IDRC), Ottawa, Canada; Government of Canada provided through the Canadian International Development Agency (CIDA)	Global Health Research Initiative; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canadian International Development Agency; International Development Research Centre; International Development Research Centre (IDRC), Ottawa, Canada; Government of Canada provided through the Canadian International Development Agency (CIDA)	This work (grant number 105957-001) was carried out with support from the Global Health Research Initiative (http://www.idrc.ca/EN/Programs/Global_Health_Policy/Global_Health_Research_Initiative/Pages/default.aspx), a research funding partnership composed of the Canadian Institutes of Health Research, the Canadian International Development Agency, and the International Development Research Centre. This work was carried out with the aid of a grant from the International Development Research Centre (IDRC), Ottawa, Canada, and with the financial support of the Government of Canada provided through the Canadian International Development Agency (CIDA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bazeley P., 2013, QUALITATIVE DATA ANA, V2nd; Brenner J, THERE IS NO IN PRESS; Brenner JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027997; Buchner D, 2012, FINAL METHODS RESULT; Buchner D, 2011, STORIES ENDINGS ILLN; Callaghan-Koru JA, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-55; Ettarh R, 2011, HEALTH PLACE, V17, P320, DOI 10.1016/j.healthplace.2010.11.009; Guenther T, 2012, AM J TROP MED HYG, V87, P77, DOI 10.4269/ajtmh.2012.11-0747; Guest G, 2012, APPL THEMATIC ANAL, DOI 10.4135/9781483384436; Healthy Child Uganda, 2009, CAN VILL HLTH VOL TR; Jacobs B, 2012, HEALTH POLICY PLANN, V27, P288, DOI 10.1093/heapol/czr038; Kallander K, 2008, B WORLD HEALTH ORGAN, V86, P332, DOI 10.2471/BLT.07.049353; Kallander K, 2006, T ROY SOC TROP MED H, V100, P956, DOI 10.1016/j.trstmh.2005.11.004; Khanal S, 2011, J HLTH POPULATION NU, V29; Kizito J, 2012, MALARIA J, V11, DOI [10.1186/PREACCEPT-2317562776368437, 10.1186/1475-2875-11-55]; Masanja H, 2005, IMPACT INTEGRATED MA; Ministry of Health (MOH), 2010, INT COMM CAS MAN CHI; Nabudere H, 2011, INT J TECHNOL ASSESS, V27, P173, DOI 10.1017/S0266462311000055; Nanyonjo A, 2012, AM J TROP MED HYG, V87, P97, DOI 10.4269/ajtmh.2012.11-0763; Rand, 2001, MILL RAND DIG 100 00; Rutherford ME, 2010, TROP MED INT HEALTH, V15, P508, DOI 10.1111/j.1365-3156.2010.02497.x; Sasaki S, 2010, TROP MED INT HEALTH, V15, P312, DOI 10.1111/j.1365-3156.2009.02460.x; UNICEF, 2010, UG STAT; UNICEF WHO, 2012, WHO UNICEF JOINT STA	24	16	16	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98610	10.1371/journal.pone.0098610	http://dx.doi.org/10.1371/journal.pone.0098610			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927074	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100019
J	Hwang, SH; Park, SH; Choi, J; Lee, DC; Oh, JH; Kim, SW; Kim, JB				Hwang, Se Hwan; Park, Sun Hwa; Choi, Jin; Lee, Dong Chang; Oh, Jeong Hoon; Kim, Sung Won; Kim, Jin Bae			Characteristics of Mesenchymal Stem Cells Originating from the Bilateral Inferior Turbinate in Humans with Nasal Septal Deviation	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; DIFFERENTIATION; HISTOPATHOLOGY	Background and objectives: Nasal septal deviation (NSD) is often associated with overgrowth of the unilateral inferior turbinate. In vivo and in vitro studies indicate that human mesenchymal stem cells (MSCs) are able to differentiate into multiple cell types, including osteoblasts. We tested the hypothesis that turbinate size affects human turbinate-derived MSC (hTMSCs) quantity, proliferation, and differentiation into osteogenic lineages, and that hypertrophic turbinates may predispose to NSD on the contralateral side. Subjects and Methods: The hypertrophic and contralateral inferior turbinate tissues used in our study were obtained and cultured from the tissue discarded from 10 patients who underwent septoplasty and partial turbinectomy. After isolating the hTMSCs from both turbinates, the cells were enumerated using an automated cell counter. The expression of surface markers for MSCs over four passages was assessed by fluorescent-activated cell sorting analysis (FACS), and cell proliferation was assessed using a cell counting kit (CCK)-8 according to turbinate size. In addition, osteogenic differentiation of hTMSCs was identified using alkaline phosphatase (ALP) and alizarin red S staining, after which osteoblastic gene expression was evaluated. Results: There was no significant difference in the number of hTMSCs. FACS analysis revealed that the hTMSCs were negative for CD14, CD19, CD34, and HLA-DR, and positive for CD29, CD73, and CD90, representing a characteristic MSC phenotype, with no significant difference between the two groups. The cellular proliferation and osteogenic differentiation potential of the hTMSCs were also not significantly different between the two groups. Conclusions: We conclude that turbinate size does not affect the characterization, proliferation, and osteogenic differentiation potential of hTMSCs in vitro test, and therefore should not affect the clinical decision of whether to use autologous or allogenic hTMSCs. However, more experiments are required to definitively state the relationship of hTMSCs with turbinate size or the process NSD in humans.	[Hwang, Se Hwan; Park, Sun Hwa; Choi, Jin; Lee, Dong Chang; Oh, Jeong Hoon; Kim, Sung Won] Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea; [Kim, Jin Bae] Hallym Univ, Kangnam Sacred Heart Hosp, Dept Internal Med, Div Gastroenterol, Chunchon, South Korea	Catholic University of Korea; Hallym University	Kim, SW (corresponding author), Catholic Univ Korea, Coll Med, Dept Otolaryngol Head & Neck Surg, Seoul, South Korea.	kswent@catholic.ac.kr; jbkim87@hallym.or.kr		Hwang, Se Hwan/0000-0002-2838-7820	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2010-0011249]; Research Fund of Seoul St. Mary's Hospital; Catholic University of Korea, Catholic Institute of Cell Therapy; Otorhinolaryngology Alumni Fund of the Catholic University of Korea made in the program; Research Fund for the Colleague of Catholic University Medical College; Catholic Medical Center Research Foundation made in the program	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; Research Fund of Seoul St. Mary's Hospital; Catholic University of Korea, Catholic Institute of Cell Therapy; Otorhinolaryngology Alumni Fund of the Catholic University of Korea made in the program; Research Fund for the Colleague of Catholic University Medical College; Catholic Medical Center Research Foundation made in the program	This research was supported by a Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0011249), Research Fund of Seoul St. Mary's Hospital, The Catholic University of Korea, Catholic Institute of Cell Therapy in 2013, the Otorhinolaryngology Alumni Fund of the Catholic University of Korea made in the program year of 2013, the 2012 Research Fund for the Colleague of Catholic University Medical College, and the Catholic Medical Center Research Foundation made in the program year of 2013. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek Wook-Young, 2011, Front Biosci (Schol Ed), V3, P126, DOI 10.2741/s138; Berger G, 2006, ARCH OTOLARYNGOL, V132, P588, DOI 10.1001/archotol.132.6.588; Berger G, 2000, LARYNGOSCOPE, V110, P2100, DOI 10.1097/00005537-200012000-00024; Chen D, 2004, GROWTH FACTORS, V22, P233, DOI 10.1080/08977190412331279890; Meirelles LDS, 2006, J CELL SCI, V119, P2204, DOI 10.1242/jcs.02932; Egeli E, 2004, LARYNGOSCOPE, V114, P113, DOI 10.1097/00005537-200401000-00020; GRAY LP, 1978, ANN OTO RHINOL LARYN, V87, P3, DOI 10.1177/00034894780873S201; Huang ZN, 2007, TISSUE ENG, V13, P2311, DOI 10.1089/ten.2006.0423; Hwang SH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074330; Hwang SH, 2011, TISSUE ENG REGEN MED, V8, P544; Hwang SH, 2011, TISSUE ENG REGEN MED, V8, P536; Jun BC, 2009, EUR ARCH OTO-RHINO-L, V266, P975, DOI 10.1007/s00405-008-0855-x; Kim SW, 2009, INT J ORAL MAX IMPL, V24, P991; Kim SW, 2008, OTOLARYNG HEAD NECK, V139, P143, DOI 10.1016/j.otohns.2008.04.015; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Marom R, 2005, J CELL PHYSIOL, V202, P41, DOI 10.1002/jcp.20109; Min Yang-Gi, 1995, Rhinology (Utrecht), V33, P61; Musina RA, 2005, B EXP BIOL MED+, V139, P504, DOI 10.1007/s10517-005-0331-1; Sakou T, 1998, BONE, V22, P591, DOI 10.1016/S8756-3282(98)00053-2; Stolzing A, 2008, MECH AGEING DEV, V129, P163, DOI 10.1016/j.mad.2007.12.002; Troken A, 2007, P I MECH ENG H, V221, P429, DOI 10.1243/09544119JEIM288; Willatt D, 2009, RHINOLOGY, V47, P227, DOI [10.4193/Rhin09.017, 10.4193/Rhin.09.017]; Yamaguchi A, 2000, ENDOCR REV, V21, P393, DOI 10.1210/er.21.4.393; Zhou S, 2008, AGING CELL, V7, P335, DOI 10.1111/j.1474-9726.2008.00377.x; Zielnik-Jurkiewicz B, 2006, INT J PEDIATR OTORHI, V70, P731, DOI 10.1016/j.ijporl.2004.09.014	25	18	20	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100219	10.1371/journal.pone.0100219	http://dx.doi.org/10.1371/journal.pone.0100219			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926874	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100122
J	Francis, VA; Abera, AB; Matjila, M; Millar, RP; Katz, AA				Francis, Victor A.; Abera, Aron B.; Matjila, Mushi; Millar, Robert P.; Katz, Arieh A.			Kisspeptin Regulation of Genes Involved in Cell Invasion and Angiogenesis in First Trimester Human Trophoblast Cells	PLOS ONE			English	Article							EXPRESSION; METASTASIS; MIGRATION; PREECLAMPSIA; PLACENTA; RECEPTOR; KISS-1; METALLOPROTEINASES; INHIBITOR; PREGNANCY	The precise regulation of extravillous trophoblast invasion of the uterine wall is a key process in successful pregnancies. Kisspeptin (KP) has been shown to inhibit cancer cell metastasis and placental trophoblast cell migration. In this study primary cultures of first trimester human trophoblast cells have been utilized in order to study the regulation of invasion and angiogenesis-related genes by KP. Trophoblast cells were isolated from first trimester placenta and their identity was confirmed by immunostaining for cytokeratin-7. Real-time quantitative RT-PCR demonstrated that primary trophoblast cells express higher levels of GPR54 (KP receptor) and KP mRNA than the trophoblast cell line HTR8Svneo. Furthermore, trophoblast cells also expressed higher GPR54 and KP protein levels. Treating primary trophoblast cells with KP induced ERK1/2 phosphorylation, while co-treating the cells with a KP antagonist almost completely blocked the activation of ERK1/2 and demonstrated that KP through its cognate GPR54 receptor can activate ERK1/2 in trophoblast cells. KP reduced the migratory capability of trophoblast cells in a scratch-migration assay. Real-time quantitative RT-PCR demonstrated that KP treatment reduced the expression of matrix metalloproteinase 1, 2, 3, 7, 9, 10, 14 and VEGF-A, and increased the expression of tissue inhibitors of metalloproteinases 1 and 3. These results suggest that KP can inhibit first trimester trophoblast cells invasion via inhibition of cell migration and down regulation of the metalloproteinase system and VEGF-A.	[Francis, Victor A.; Abera, Aron B.; Matjila, Mushi; Millar, Robert P.; Katz, Arieh A.] Univ Cape Town, Fac Hlth Sci, MRC UCT Receptor Biol Unit, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Francis, Victor A.; Abera, Aron B.; Matjila, Mushi; Millar, Robert P.; Katz, Arieh A.] Univ Cape Town, Fac Hlth Sci, Div Med Biochem, ZA-7925 Cape Town, South Africa; [Matjila, Mushi] Univ Cape Town, Fac Hlth Sci, Groote Schuur Hosp, Dept Obstet & Gynaecol, ZA-7925 Cape Town, South Africa; [Millar, Robert P.] Univ Pretoria, Mammal Res Inst, ZA-0002 Pretoria, South Africa; [Millar, Robert P.] Univ Edinburgh, Ctr Integrated Physiol, Edinburgh, Midlothian, Scotland	University of Cape Town; University of Cape Town; University of Cape Town; University of Pretoria; University of Edinburgh	Katz, AA (corresponding author), Univ Cape Town, Fac Hlth Sci, MRC UCT Receptor Biol Unit, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa.	arieh.katz@uct.ac.za		Millar, Robert P/0000-0003-3606-2708	South African MRC; University of Cape Town	South African MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Cape Town	This work was supported by research grants from the South African MRC and the University of Cape Town to AAK and RPM. VAF is a Claude Leon Foundation postdoctoral fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Burton GJ, 2009, REPRODUCTION, V138, P895, DOI 10.1530/REP-09-0092; Cartwright JE, 2012, J ENDOCRINOL, V214, P79, DOI 10.1530/JOE-12-0091; Cohen M, 2006, PLACENTA, V27, P783, DOI 10.1016/j.placenta.2005.08.006; d'Anglemont de Tassigny X, 2007, P NATL ACAD SCI USA, V104, P10714, DOI 10.1073/pnas.0704114104; Galaup A, 2006, P NATL ACAD SCI USA, V103, P18721, DOI 10.1073/pnas.0609025103; GRAHAM CH, 1993, EXP CELL RES, V206, P204, DOI 10.1006/excr.1993.1139; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Horikoshi Y, 2003, J CLIN ENDOCR METAB, V88, P914, DOI 10.1210/jc.2002-021235; IRVING JA, 1995, EXP CELL RES, V217, P419, DOI 10.1006/excr.1995.1105; Janneau JL, 2002, J CLIN ENDOCR METAB, V87, P5336, DOI 10.1210/jc.2002-021093; Karmakar S, 2002, AM J REPROD IMMUNOL, V48, P210, DOI 10.1034/j.1600-0897.2002.01151.x; KHONG TY, 1986, BRIT J OBSTET GYNAEC, V93, P1049, DOI 10.1111/j.1471-0528.1986.tb07830.x; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Lee JH, 1996, JNCI-J NATL CANCER I, V88, P1731, DOI 10.1093/jnci/88.23.1731; Lian IA, 2010, PLACENTA, V31, P615, DOI 10.1016/j.placenta.2010.04.003; Luo JY, 2011, J HUAZHONG U SCI-MED, V31, P241, DOI 10.1007/s11596-011-0260-3; Messager S, 2005, P NATL ACAD SCI USA, V102, P1761, DOI 10.1073/pnas.0409330102; Nagase H, 2006, CARDIOVASC RES, V69, P562, DOI 10.1016/j.cardiores.2005.12.002; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Park DW, 2012, AM J REPROD IMMUNOL, V67, P132, DOI 10.1111/j.1600-0897.2011.01073.x; PIJNENBORG R, 1983, PLACENTA, V4, P397, DOI 10.1016/S0143-4004(83)80043-5; Reister F, 2006, J PERINAT MED, V34, P272, DOI 10.1515/JPM.2006.052; Roseweir AK, 2012, PLACENTA, V33, P408, DOI 10.1016/j.placenta.2012.02.001; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; Sonderegger S, 2010, ENDOCRINOLOGY, V151, P211, DOI 10.1210/en.2009-0557; Stafford LJ, 2002, CANCER RES, V62, P5399; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Tapia A, 2008, HUM REPROD, V23, P1724, DOI 10.1093/humrep/den121; Tseng JJ, 2006, PLACENTA, V27, P70, DOI 10.1016/j.placenta.2004.12.011; Wu SH, 2014, PATHOL RES PRACT, V210, P47, DOI 10.1016/j.prp.2013.09.017; Wu X, 2005, J IMMUNOL, V175, P61, DOI 10.4049/jimmunol.175.1.61; ZHOU Y, 1993, J CLIN INVEST, V91, P950, DOI 10.1172/JCI116316	36	41	44	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99680	10.1371/journal.pone.0099680	http://dx.doi.org/10.1371/journal.pone.0099680			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923321	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300085
J	Helyar, SJ; Lloyd, HA; de Bruyn, M; Leake, J; Bennett, N; Carvalho, GR				Helyar, Sarah J.; Lloyd, Hywel ap D.; de Bruyn, Mark; Leake, Jonathan; Bennett, Niall; Carvalho, Gary R.			Fish Product Mislabelling: Failings of Traceability in the Production Chain and Implications for Illegal, Unreported and Unregulated (IUU) Fishing	PLOS ONE			English	Article							BIOGEOGRAPHIC ORIGINS; BARCODING REVEALS; DNA; IDENTIFICATION; SUBSTITUTION; FISHERIES; TAXONOMY; TOOLS	Increasing consumer demand for seafood, combined with concern over the health of our oceans, has led to many initiatives aimed at tackling destructive fishing practices and promoting the sustainability of fisheries. An important global threat to sustainable fisheries is Illegal, Unreported and Unregulated (IUU) fishing, and there is now an increased emphasis on the use of trade measures to prevent IUU-sourced fish and fish products from entering the international market. Initiatives encompass new legislation in the European Union requiring the inclusion of species names on catch labels throughout the distribution chain. Such certification measures do not, however, guarantee accuracy of species designation. Using two DNA-based methods to compare species descriptions with molecular ID, we examined 386 samples of white fish, or products labelled as primarily containing white fish, from major UK supermarket chains. Species specific real-time PCR probes were used for cod (Gadus morhua) and haddock (Melanogrammus aeglefinus) to provide a highly sensitive and species-specific test for the major species of white fish sold in the UK. Additionally, fish-specific primers were used to sequence the forensically validated barcoding gene, mitochondrial cytochrome oxidase I (COI). Overall levels of congruence between product label and genetic species identification were high, with 94.34% of samples correctly labelled, though a significant proportion in terms of potential volume, were mislabelled. Substitution was usually for a cheaper alternative and, in one case, extended to a tropical species. To our knowledge, this is the first published study encompassing a large-scale assessment of UK retailers, and if representative, indicates a potentially significant incidence of incorrect product designation.	[Helyar, Sarah J.; Lloyd, Hywel ap D.; de Bruyn, Mark; Carvalho, Gary R.] Bangor Univ, Mol Ecol & Fisheries Genet Lab, Bangor, Gwynedd, Wales; [Leake, Jonathan] Sunday Times, London, England; [Bennett, Niall] Greenpeace UK, London, England	Bangor University	Helyar, SJ (corresponding author), Matis, Food Safety Environm & Genet, Reykjavik, Iceland.	sarah.helyar@matis.is	de Bruyn, Mark/C-5568-2008; Helyar, Sarah/C-4988-2013	de Bruyn, Mark/0000-0003-1528-9604; Helyar, Sarah/0000-0002-1600-997X	Greenpeace; Sunday Times	Greenpeace; Sunday Times	This study was jointly funded by Greenpeace and The Sunday Times. The funder Greenpeace provided support in the form of salary for author NB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funder The Sunday Times provided support in the form of salary for author JL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agnew DJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004570; [Anonymous], 2000, OFFICIAL J EUROPEA L, VL17, P22; Ardura A, 2010, FOOD RES INT, V43, P1549, DOI 10.1016/j.foodres.2010.03.016; Armani A, 2011, FOOD CONTROL, V22, P888, DOI 10.1016/j.foodcont.2010.11.020; Barbuto M, 2010, FOOD RES INT, V43, P376, DOI 10.1016/j.foodres.2009.10.009; Butterworth DS, 2005, B MAR SCI, V76, P287; Byrkjedal I, 2008, J FISH BIOL, V73, P1183, DOI 10.1111/j.1095-8649.2008.01958.x; Carr SM, 1999, CAN J ZOOL, V77, P19, DOI 10.1139/cjz-77-1-19; Carr SM, 2008, MITOCHONDR DNA, V19, P490, DOI 10.1080/19401730802570942; Cawthorn DM, 2012, FOOD RES INT, V46, P30, DOI 10.1016/j.foodres.2011.11.011; Coulson MW, 2006, GENOME, V49, P1115, DOI 10.1139/G06-083; Crego-Prieto Victor, 2010, P315; Dawnay N, 2007, FORENSIC SCI INT, V173, P1, DOI 10.1016/j.forsciint.2006.09.013; EC (European Commission), 2001, OFFICIAL J EUROPEA L, V278, P6; FAO, 1990, FAO FISH SYN S125, V10; FAO, 2009, GUID EC FISH FISH PR; *FAO, 2012, SPEC FACT SHEET; FAO, 2012, STAT WORLDS FISH AQ; FAO, 2011, STAT WORLDS FISH AQ; FAO (Food and Agriculture Organization), 2001, INT PLAN ACT PREV DE; Ferrantelli V, 2012, FOOD ADDIT CONTAM A, V29, P1046, DOI 10.1080/19440049.2012.675595; Filonzi L, 2010, FOOD RES INT, V43, P1383, DOI 10.1016/j.foodres.2010.04.016; FishPop Trace Consortium, 2012, Nature Communications, V3, P1, DOI 10.1038/ncomms1845; Food and Agriculture Organization (FAO), 2004, FISH AQ COUNTR PROF; Glover KA, 2012, FISH FISH, V13, P313, DOI 10.1111/j.1467-2979.2011.00447.x; Glover KA, 2010, AQUACULT ENV INTERAC, V1, P1, DOI 10.3354/aei00002; Gold JR, 2011, BIOL J LINN SOC, V102, P915, DOI 10.1111/j.1095-8312.2011.01621.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HIGGINS DG, 1988, GENE, V73, P237, DOI 10.1016/0378-1119(88)90330-7; Huxley-Jones E, 2012, CONSERV BIOL, V26, P367, DOI 10.1111/j.1523-1739.2011.01813.x; Iglesias SP, 2010, AQUAT CONSERV, V20, P319, DOI 10.1002/aqc.1083; Johnsen E, 2012, AFR J MAR SCI, V34, P43, DOI 10.2989/1814232X.2012.673274; Logan CA, 2008, BIOL CONSERV, V141, P1591, DOI 10.1016/j.biocon.2008.04.007; Marko PB, 2004, NATURE, V430, P309, DOI 10.1038/430309b; Miller DD, 2010, FRONT ECOL ENVIRON, V8, P517, DOI 10.1890/090212; MRAG, 2008, GLOB EXT ILL FISH; Ogden R, 2008, FISH FISH, V9, P462, DOI 10.1111/j.1467-2979.2008.00305.x; Pauly D, 2002, NATURE, V418, P689, DOI 10.1038/nature01017; Pepe T, 2007, J AGR FOOD CHEM, V55, P3681, DOI 10.1021/jf063321o; Potts T, 2011, 270211 SAMS; Rademeyer RA, 2008, AFR J MAR SCI, V30, P263, DOI 10.2989/AJMS.2008.30.2.7.557; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Stokstad E, 2010, SCIENCE, V330, P1468, DOI 10.1126/science.330.6010.1468; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Taylor MI, 2002, MOL ECOL NOTES, V2, P599, DOI 10.1046/j.1471-8286.2002.00269.x; Ursvik A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-86; von der Heyden S, 2010, ICES J MAR SCI, V67, P176, DOI 10.1093/icesjms/fsp222; Ward RD, 2005, PHILOS T R SOC B, V360, P1847, DOI 10.1098/rstb.2005.1716; Ward RD, 2007, MOL ECOL NOTES, V7, P899, DOI 10.1111/j.1471-8286.2007.01886.x; Wong EHK, 2008, FOOD RES INT, V41, P828, DOI 10.1016/j.foodres.2008.07.005; WSSD, 2002, ACONF19920 WSSD	51	103	108	3	122	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98691	10.1371/journal.pone.0098691	http://dx.doi.org/10.1371/journal.pone.0098691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921655	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300012
J	Schluter, EW; Mitz, AR; Cheer, JF; Averbeck, BB				Schluter, Erik W.; Mitz, Andrew R.; Cheer, Joseph F.; Averbeck, Bruno B.			Real-Time Dopamine Measurement in Awake Monkeys	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; PREMOTOR CORTEX; REWARD; RELEASE; VOLTAMMETRY; NEURONS; STIMULATION; PREDICTION; STRIATUM; DELIVERY	Fast-scan cyclic voltammetry (FSCV) is often used to measure real-time dopamine (DA) concentrations in awake, behaving rodents. Extending this technique to work in monkeys would provide a platform for advanced behavioral studies and a primate model for preclinical research. The present study demonstrates the feasibility of DA recordings in two awake monkeys (Macaca mulatta) using a mixture of techniques adapted from rodent, primate and brain slice work. We developed a long carbon fiber electrode to operate in the larger primate brain. This electrode was lowered into the striatum each day using a recording chamber and a detachable micromanipulator system. A manipulator also moved one or more tungsten stimulating electrodes into either the nearby striatum or the ventral tegmental area/substantia nigra pars compacta (VTA/SNc). We developed an electrical stimulation controller to reduce artifacts during electrical stimulation. We also introduce a stimulation-based methodology for estimating distances between electrodes in the brain. Dopamine responses within the striatum were evoked by either stimulation of the striatum near the FSCV electrode, or stimulation within the VTA/SNc. Unexpected juice rewards also evoked dopamine responses in the ventral striatum. Thus, we demonstrate that robust dopamine responses can be recorded from awake, behaving primates with FSCV. In addition, we describe how a stimulation technique borrowed from the neuroprosthetics field can activate the distributed monkey midbrain dopamine system in a way that mimics rodent VTA stimulation.	[Schluter, Erik W.; Mitz, Andrew R.; Averbeck, Bruno B.] NIMH, Neuropsychol Lab, Div Intramural Res, NIH, Bethesda, MD 20892 USA; [Cheer, Joseph F.] Univ Maryland, Sch Med, Dept Anat & Neurobiol, Baltimore, MD 21201 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); University System of Maryland; University of Maryland Baltimore	Averbeck, BB (corresponding author), NIMH, Neuropsychol Lab, Div Intramural Res, NIH, Bldg 9, Bethesda, MD 20892 USA.	bruno.averbeck@nih.gov	Cheer, Joseph F/J-6102-2014	Cheer, Joseph F/0000-0001-5086-7559; , Andrew/0000-0002-8045-0970	US National Institute of Mental Health; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002928] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the Intramural Research Program of the US National Institute of Mental Health (http://www.nimh.nih.gov). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apawu AK, 2013, ACS CHEM NEUROSCI, V4, P895, DOI 10.1021/cn4000742; Ariansen JL, 2012, FRONT BEHAV NEUROSCI, V6, DOI 10.3389/fnbeh.2012.00036; Brown HD, 2011, EUR J NEUROSCI, V34, P1997, DOI 10.1111/j.1460-9568.2011.07914.x; Cheer JF, 2007, NEURON, V54, P237, DOI 10.1016/j.neuron.2007.03.021; Clark JJ, 2010, NAT METHODS, V7, P126, DOI [10.1038/NMETH.1412, 10.1038/nmeth.1412]; Dahlstroem A., 1964, ACTA PHYSL SCAND S, V232, P231; DOMESICK VB, 1988, ANN NY ACAD SCI, V537, P10, DOI 10.1111/j.1749-6632.1988.tb42094.x; Fuxe K, 2010, PROG NEUROBIOL, V90, P82, DOI 10.1016/j.pneurobio.2009.10.012; Garris PA, 1997, J NEUROCHEM, V68, P152; GHOSH S, 1988, J PHYSIOL-LONDON, V400, P617, DOI 10.1113/jphysiol.1988.sp017139; GIBSON AR, 1985, J PHYSIOL-LONDON, V358, P527, DOI 10.1113/jphysiol.1985.sp015565; Giompres P, 2005, CEREBELLUM, V4, P105, DOI 10.1080/14734220510007851; Glimcher PW, 2011, P NATL ACAD SCI USA, V108, P15647, DOI 10.1073/pnas.1014269108; GODSCHALK M, 1995, NEUROSCI RES, V23, P269, DOI 10.1016/0168-0102(95)00950-7; Haber SN, 2000, J NEUROSCI, V20, P2369; Hashemi P, 2009, ANAL CHEM, V81, P9462, DOI 10.1021/ac9018846; Heien MLAV, 2003, ANALYST, V128, P1413, DOI 10.1039/b307024g; Heien MLAV, 2004, ANAL CHEM, V76, P5697, DOI 10.1021/ac0491509; IKAI Y, 1992, NEUROSCIENCE, V51, P719, DOI 10.1016/0306-4522(92)90310-X; Iravani MM, 1996, NEUROSCIENCE, V70, P1025, DOI 10.1016/0306-4522(95)00396-7; JONES SR, 1994, J NEUROSCI METH, V52, P1, DOI 10.1016/0165-0270(94)90048-5; KAWAGOE KT, 1994, TALANTA, V41, P865, DOI 10.1016/0039-9140(94)E0064-X; Kishida KT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023291; Kume-Kick J, 1998, J NEUROSCI METH, V84, P55, DOI 10.1016/S0165-0270(98)00087-9; Lee KH, 2011, IEEE ENG MED BIO, P677, DOI 10.1109/IEMBS.2011.6090152; McIntyre CC, 2001, ANN BIOMED ENG, V29, P227, DOI 10.1114/1.1352640; MITZ AR, 1987, J NEUROSCI, V7, P1010; Mitz AR, 2005, J NEUROSCI METH, V148, P19, DOI 10.1016/j.jneumeth.2005.07.012; MITZ AR, 1991, J NEUROSCI, V11, P1855; OLDS ME, 1981, ANNU REV PSYCHOL, V32, P523, DOI 10.1146/annurev.ps.32.020181.002515; Panin F, 2012, J PHARMACOL TOX MET, V65, P83, DOI 10.1016/j.vascn.2012.01.003; RANCK JB, 1975, BRAIN RES, V98, P417, DOI 10.1016/0006-8993(75)90364-9; Roberts JG, 2010, LANGMUIR, V26, P9116, DOI 10.1021/la9048924; Robinson DL, 2003, CLIN CHEM, V49, P1763, DOI 10.1373/49.10.1763; Robinson DL, 2007, FRONT NEUROENG, V1, P17; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Saleem KS, 2012, COMBINED MRI HISTOLO; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Shon YM, 2010, NEUROSCI LETT, V475, P136, DOI 10.1016/j.neulet.2010.03.060; Silva L, 2012, ANAL METHODS-UK, V4, P2300, DOI 10.1039/c2ay25076d; STAMFORD JA, 1986, J NEUROSCI METH, V17, P1, DOI 10.1016/0165-0270(86)90031-2; Swiergiel AH, 1997, J NEUROSCI METH, V73, P29, DOI 10.1016/S0165-0270(96)02207-8; Thompson JL, 2012, MOL PSYCHIAT; Van Gompel JJ, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.5.FOCUS10110; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; Wise RA, 2005, J COMP NEUROL, V493, P115, DOI 10.1002/cne.20689; Wise SP, 1998, EXP BRAIN RES, V121, P285, DOI 10.1007/s002210050462; Zen JM, 2004, ANAL CHEM, V76, P4251, DOI 10.1021/ac0495135; Zhang TC, 2010, J NEURAL ENG, V7, DOI 10.1088/1741-2560/7/6/066009	50	25	24	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98692	10.1371/journal.pone.0098692	http://dx.doi.org/10.1371/journal.pone.0098692			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921937	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300013
J	Neuman, M; Kawachi, I; Gortmaker, S; Subramanian, SV				Neuman, Melissa; Kawachi, Ichiro; Gortmaker, Steven; Subramanian, S. V.			National Economic Development and Disparities in Body Mass Index: A Cross-Sectional Study of Data from 38 Countries	PLOS ONE			English	Article							MIDDLE-INCOME COUNTRIES; NUTRITION TRANSITION; SOCIOECONOMIC-STATUS; NORMAL-WEIGHT; OBESITY; OVERWEIGHT; HEALTH; TRENDS; WOMEN; WORLD	Background: Increases in body mass index (BMI) and the prevalence of overweight in low- and middle income countries (LMICs) are often ascribed to changes in global trade patterns or increases in national income. These changes are likely to affect populations within LMICs differently based on their place of residence or socioeconomic status (SES). Objective: Using nationally representative survey data from 38 countries and national economic indicators from the World Bank and other international organizations, we estimated ecological and multilevel models to assess the association between national levels of gross domestic product (GDP), foreign direct investment (FDI), and mean tariffs and BMI. Design: We used linear regression to estimate the ecological association between average annual change in economic indicators and BMI, and multilevel linear or ordered multinomial models to estimate associations between national economic indicators and individual BMI or over- and underweight. We also included cross-level interaction terms to highlight differences in the association of BMI with national economic indicators by type of residence or socioeconomic status (SES). Results: There was a positive but non-significant association of GDP and mean BMI. This positive association of GDP and BMI was greater among rural residents and the poor. There were no significant ecological associations between measures of trade openness and mean BMI, but FDI was positively associated with BMI among the poorest respondents and in rural areas and tariff levels were negatively associated with BMI among poor and rural respondents. Conclusion: Measures of national income and trade openness have different associations with the BMI across populations within developing countries. These divergent findings underscore the complexity of the effects of development on health and the importance of considering how the health effects of "globalizing" economic and cultural trends are modified by individual-level wealth and residence.	[Neuman, Melissa; Kawachi, Ichiro; Gortmaker, Steven; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Neuman, M (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA.	m.neuman@ucl.ac.uk		Neuman, Melissa/0000-0002-8870-6504	National Institutes of Health Career Development Award [NHLBI K25 HL081275]; Robert Wood Johnson Investigator Award in Health Policy Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K25HL081275] Funding Source: NIH RePORTER	National Institutes of Health Career Development Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert Wood Johnson Investigator Award in Health Policy Research; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S V Subramanian is supported by the National Institutes of Health Career Development Award (NHLBI K25 HL081275) and the Robert Wood Johnson Investigator Award in Health Policy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitsi-Selmi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039507; [Anonymous], SAMPL MAN; [Anonymous], 2008, DEMOGRAPHIC HLTH RES; [Anonymous], MEASURING INTERPRETI; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; Basu S, 2013, AM J PUBLIC HEALTH, V103, P2071, DOI 10.2105/AJPH.2012.300974; Case A, 2009, ECON HUM BIOL, V7, P271, DOI 10.1016/j.ehb.2009.07.002; Dearth-Wesley T, 2008, EUR J CLIN NUTR, V62, P1302, DOI 10.1038/sj.ejcn.1602853; Dickson G., 2005, International Journal of Sport Management and Marketing, V1, P169, DOI 10.1504/IJSMM.2005.007128; Drewnowski A, 1997, NUTR REV, V55, P31, DOI 10.1111/j.1753-4887.1997.tb01593.x; Egger G, 2012, ECON HUM BIOL, V10, P147, DOI 10.1016/j.ehb.2012.01.002; Ezzati M, 2005, PLOS MED, V2, P404, DOI 10.1371/journal.pmed.0020133; FAO, 2004, C DAT QUAL INT ORG W; Fernald LC, 2004, JAMA-J AM MED ASSOC, V291, P2544, DOI 10.1001/jama.291.21.2544; Fezeu L, 2006, INT J EPIDEMIOL, V35, P105, DOI 10.1093/ije/dyi214; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Fleischer NL, 2012, AM J EPIDEMIOL, V175, P167, DOI 10.1093/aje/kwr314; Freedman DM, 2006, INT J OBESITY, V30, P822, DOI 10.1038/sj.ijo.0803193; Goldstein H, 2011, MULTILEVEL STAT MODE, Vxxi; Gupta MA, 2001, J PSYCHOSOM RES, V50, P193, DOI 10.1016/S0022-3999(00)00221-X; GWATKIN DR, 2000, SOCIOECONOMIC DIFFER; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hawkes C, 2008, OBES REV, V9, P151, DOI 10.1111/j.1467-789X.2007.00458.x; Hawkes C, 2005, PUBLIC HEALTH NUTR, V8, P357, DOI 10.1079/PHN2004706; Hawkes C, 2006, GLOBALIZATION HEALTH, V2, DOI 10.1186/1744-8603-2-4; Heston Alan, 2011, PENN WORLD TABLE VER; Holdsworth M, 2004, INT J OBESITY, V28, P1561, DOI 10.1038/sj.ijo.0802739; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hu FB, 2008, OBESITY EPIDEMIOLOGY; Jacoby E, 2003, PREV MED, V37, P396, DOI 10.1016/S0091-7435(03)00159-2; Jones-Smith JC, 2010, SOC SCI MED, V71, P1436, DOI 10.1016/j.socscimed.2010.07.027; Kelly T, 2008, INT J OBESITY, V32, P1431, DOI 10.1038/ijo.2008.102; Kennedy G., 2004, FAO Food and Nutrition Paper, P1; Loureiro ML, 2005, AM J AGR ECON, V87, P1147, DOI 10.1111/j.1467-8276.2005.00800.x; MANSON JE, 1995, NEW ENGL J MED, V333, P677, DOI 10.1056/NEJM199509143331101; Marcuse P, 2000, GLOBALIZING CITIES N, Vxviii; MEASURE DHS, 2010, DEM HLTH SURV; MEASURE DHS, 2011, LIST DHS FIN REP; Monteiro C, 2004, INT J OBESITY, V28, P1181, DOI 10.1038/sj.ijo.0802716; Monteiro CA, 2000, EUR J CLIN NUTR, V54, P342, DOI 10.1038/sj.ejcn.1600960; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Nandi A, 2011, J EPIDEMIOL COMMUN H, V65, pA347, DOI 10.1136/jech.2011.142976l.85; Nandi A, AM J CLIN NUTR; Nandi A, 2014, AM J PUBLIC HEALTH, V104, pE162, DOI 10.2105/AJPH.2013.301392; Neuman M, 2013, AM J CLIN NUTR, V97, P428, DOI 10.3945/ajcn.112.045997; Neuman M, 2011, AM J CLIN NUTR, V94, P1348, DOI 10.3945/ajcn.111.018127; ORC Macro, 2006, DEM HLTH SURV INT MA; Peytremann-Bridevaux I, 2007, PREV MED, V44, P442, DOI 10.1016/j.ypmed.2006.11.011; Popkin BM, 1998, PUBLIC HEALTH NUTR, V1, P5, DOI 10.1079/PHN19980004; Popkin BM, 2006, FOOD POLICY, V31, P554, DOI 10.1016/j.foodpol.2006.02.008; Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Prentice AM, 2006, INT J EPIDEMIOL, V35, P93, DOI 10.1093/ije/dyi272; Pullum TW, 2008, ASSESSMENT QUALITY D; Rasbash J., 2012, MLWIN VERSION 2 25; Rutstein S.O., 2004, DHS COMP REPORTS; Rutstein SO, 2003, GUIDE DHS STAT; Sahr R, 2006, CONSUMER PRICE INDEX; Sassen Saskia., 1992, POLIT SCI QUART, V107, P370; Sassen Saskia., 2019, CITIES WORLD EC, V5th ed; Siervo M, 2006, Eat Weight Disord, V11, P100; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Sobal J, 2001, INT TXB OBESITY; StataCorp, STAT STAT SOFTW REL; Stiglitz JE, 2003, GLOBALIZATION ITS DI, Vxxii; Stuckler D, 2012, PLOS MED, V9, DOI [10.1371/journal.pmed.1001235, 10.1371/journal.pmed.1001242]; Subramanian SV, 2006, AM J CLIN NUTR, V84, P633, DOI 10.1093/ajcn/84.3.633; Subramanian SV, 2011, LANCET, V377, P1915, DOI 10.1016/S0140-6736(11)60803-9; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; Swinburn BA, 2011, LANCET, V378, P804, DOI 10.1016/S0140-6736(11)60813-1; Tiberti L, 2007, GLOBALISATION HLTH I; UNCTAD, 2012, INW OUTW FOR DIR INV; UNCTAD, 2004, WORLD INV DIR; United Nations Population Division, 2002, WORLD URB PROSP 2001; United Nations Statistics Division, 2011, POP DENS URB; Vaessen M, 1996, POTENTIAL DEMOGRAPHI; Vaessen M, 2005, DEMOGRAPHIC HLTH SUR; Vlahov D, 2002, J URBAN HEALTH, V79, pS1, DOI 10.1093/jurban/79.suppl_1.S1; Wang H, 2007, INT J OBESITY, V31, P272, DOI 10.1038/sj.ijo.0803416; Wells JCK, 2012, SOC SCI MED, V75, P482, DOI 10.1016/j.socscimed.2012.03.029; Willett W., 1998, NUTR EPIDEMIOLOGY, pxiv; WILLETT WC, 1995, JAMA-J AM MED ASSOC, V273, P461, DOI 10.1001/jama.273.6.461; Wirth M., 2006, MONITORING HLTH EQUI; World Bank, 2012, WORLD INT TRAD SOL	84	13	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99327	10.1371/journal.pone.0099327	http://dx.doi.org/10.1371/journal.pone.0099327			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24919199	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000338631000076
J	Podgorski, T; Lusseau, D; Scandura, M; Sonnichsen, L; Jedrzejewska, B				Podgorski, Tomasz; Lusseau, David; Scandura, Massimo; Sonnichsen, Leif; Jedrzejewska, Bogumila			Long-Lasting, Kin-Directed Female Interactions in a Spatially Structured Wild Boar Social Network	PLOS ONE			English	Article							SUS-SCROFA; GENETIC RELATEDNESS; POPULATION-STRUCTURE; LITTER SIZE; SPACE USE; BEHAVIOR; PATTERNS; KINSHIP; ASSOCIATIONS; PERFORMANCE	Individuals can increase inclusive fitness benefits through a complex network of social interactions directed towards kin. Preferential relationships with relatives lead to the emergence of kin structures in the social system. Cohesive social groups of related individuals and female philopatry of wild boar create conditions for cooperation through kin selection and make the species a good biological model for studying kin structures. Yet, the role of kinship in shaping the social structure of wild boar populations is still poorly understood. In the present study, we investigated spatio-temporal patterns of associations and the social network structure of the wild boar Sus scrofa population in Bialowiezia National Park, Poland, which offered a unique opportunity to understand wild boar social interactions away from anthropogenic factors. We used a combination of telemetry data and genetic information to examine the impact of kinship on network cohesion and the strength of social bonds. Relatedness and spatial proximity between individuals were positively related to the strength of social bond. Consequently, the social network was spatially and genetically structured with well-defined and cohesive social units. However, spatial proximity between individuals could not entirely explain the association patterns and network structure. Genuine, kin-targeted, and temporarily stable relationships of females extended beyond spatial proximity between individuals while males interactions were short-lived and not shaped by relatedness. The findings of this study confirm the matrilineal nature of wild boar social structure and show how social preferences of individuals translate into an emergent socio-genetic population structure.	[Podgorski, Tomasz; Sonnichsen, Leif; Jedrzejewska, Bogumila] Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland; [Lusseau, David] Univ Aberdeen, Inst Biol & Environm Sci, Aberdeen, Scotland; [Scandura, Massimo] Univ Sassari, Dept Sci Nat & Environm Resources, I-07100 Sassari, Italy	Polish Academy of Sciences; Mammal Research Institute of the Polish Academy of Sciences; University of Aberdeen; University of Sassari	Podgorski, T (corresponding author), Polish Acad Sci, Mammal Res Inst, Bialowieza, Poland.	t_podgorski@ibs.bialowieza.pl	Lusseau, David/AAV-9295-2021; Podgórski, Tomasz/B-4869-2015; Lusseau, David/A-8501-2012	Lusseau, David/0000-0003-1245-3747; Podgórski, Tomasz/0000-0001-6858-7838; Scandura, Massimo/0000-0003-2754-6866	Ministry of Science and Higher Education [NN304 253935]; Mammal Research Institute PAS; BIOCONSUS project (Research Potential in Conservation and Sustainable Management of Biodiversity) [245737]	Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland); Mammal Research Institute PAS; BIOCONSUS project (Research Potential in Conservation and Sustainable Management of Biodiversity)	The study was funded by the Ministry of Science and Higher Education (grant number NN304 253935), the budget of the Mammal Research Institute PAS, and BIOCONSUS project (Research Potential in Conservation and Sustainable Management of Biodiversity, 7th Framework Programme contract no. 245737, FP7/2009-2014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], [No title captured]; Armitage KB, 2000, P NATL ACAD SCI USA, V97, P12149, DOI 10.1073/pnas.200196097; BOITANI L, 1994, J MAMMAL, V75, P600, DOI 10.2307/1382507; Borgatti S.P., 2002, NETDRAW GRAPH VISUAL; CAIRNS SJ, 1987, ANIM BEHAV, V35, P1454, DOI 10.1016/S0003-3472(87)80018-0; Campbell RA, 2008, BIOL LETTERS, V4, P139, DOI 10.1098/rsbl.2007.0487; Carter KD, 2013, ANIM BEHAV, V85, P385, DOI 10.1016/j.anbehav.2012.11.011; Clayton L, 1999, J MAMMAL, V80, P1147, DOI 10.2307/1383165; Clutton-Brock T, 2009, NATURE, V462, P51, DOI 10.1038/nature08366; CROOK JH, 1976, ANIM BEHAV, V24, P261, DOI 10.1016/S0003-3472(76)80035-8; Csillery K, 2006, GENETICS, V173, P2091, DOI 10.1534/genetics.106.057331; DARDAILLON M, 1988, Z SAUGETIERKD, V53, P22; DELCROIX I, 1990, J REPROD FERTIL, V89, P613, DOI 10.1530/jrf.0.0890613; Edwards GR, 1996, APPL ANIM BEHAV SCI, V50, P147, DOI 10.1016/0168-1591(96)01077-5; Ferriere R, 1996, AM NAT, V147, P692, DOI 10.1086/285875; Fieberg J, 2005, J WILDLIFE MANAGE, V69, P1346, DOI 10.2193/0022-541X(2005)69[1346:QHOTIO]2.0.CO;2; Fowler AC, 2005, ANIM BEHAV, V69, P973, DOI 10.1016/j.anbehav.2004.07.014; Frere CH, 2010, ANIM BEHAV, V80, P481, DOI 10.1016/j.anbehav.2010.06.007; Gabor TM, 1999, J ZOOL, V247, P311, DOI 10.1111/j.1469-7998.1999.tb00994.x; Garroway CJ, 2013, BEHAV ECOL SOCIOBIOL, V67, P113, DOI 10.1007/s00265-012-1431-3; Geisser H, 2005, J ZOOL, V267, P89, DOI 10.1017/S095283690500734X; Gero S, 2008, BEHAV ECOL SOCIOBIOL, V63, P143, DOI 10.1007/s00265-008-0645-x; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Greenberg CH, 2000, FOREST ECOL MANAG, V132, P199, DOI 10.1016/S0378-1127(99)00226-1; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; HARRIS S, 1990, MAMMAL REV, V20, P97, DOI 10.1111/j.1365-2907.1990.tb00106.x; Hirsch BT, 2013, ANIM BEHAV, V85, P463, DOI 10.1016/j.anbehav.2012.12.011; Iacolina L, 2009, J MAMMAL, V90, P666, DOI 10.1644/08-MAMM-A-074R1.1; Jedrzejewska B, 1997, ACTA THERIOL, V42, P399; Jedrzejewski W, 2004, WILDLIFE SOC B, V32, P1305, DOI 10.2193/0091-7648(2004)032[1305:FTFMDF]2.0.CO;2; Kaminski G, 2005, CAN J ZOOL, V83, P474, DOI 10.1139/Z05-019; Krause J, 2007, BEHAV ECOL SOCIOBIOL, V62, P15, DOI 10.1007/s00265-007-0445-8; Kreeger T. J., 1997, HDB WILDLIFE CHEM IM; LALAND KN, 1990, ANIM LEARN BEHAV, V18, P246, DOI 10.3758/BF03205282; Lambin X, 1998, J ANIM ECOL, V67, P1, DOI 10.1046/j.1365-2656.1998.00181.x; LENTH RV, 1981, TECHNOMETRICS, V23, P149, DOI 10.2307/1268030; Lusseau D, 2006, J ANIM ECOL, V75, P14, DOI 10.1111/j.1365-2656.2005.01013.x; Lusseau D, 2008, ANIM BEHAV, V75, P1809, DOI 10.1016/j.anbehav.2007.10.029; Maher CR, 2009, BEHAV ECOL SOCIOBIOL, V63, P857, DOI 10.1007/s00265-009-0726-5; Manly BFJ, 1997, RANDOMIZATION BOOTST; MATSCHKE GH, 1967, J WILDLIFE MANAGE, V31, P109, DOI 10.2307/3798365; Midford PE, 2000, ANIM BEHAV, V59, P1199, DOI 10.1006/anbe.1999.1419; Moyer MA, 2006, J MAMMAL, V87, P255, DOI 10.1644/05-MAMM-A-192R1.1; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066133; PACKER C, 1995, AM NAT, V145, P833, DOI 10.1086/285771; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pomeroy PP, 2001, P ROY SOC B-BIOL SCI, V268, P711, DOI 10.1098/rspb.2000.1422; Poteaux C, 2009, J ZOOL, V278, P116, DOI 10.1111/j.1469-7998.2009.00553.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Scandura M, 2008, MOL ECOL, V17, P1745, DOI 10.1111/j.1365-294X.2008.03703.x; Scandura M, 2011, HEREDITY, V106, P1012, DOI 10.1038/hdy.2010.155; Servanty S, 2007, BEHAV ECOL, V18, P427, DOI 10.1093/beheco/arl099; Silk JB, 2007, PHILOS T R SOC B, V362, P539, DOI 10.1098/rstb.2006.1994; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; SOMERS MJ, 1995, ACTA THERIOL, V40, P257, DOI 10.4098/AT.arch.95-25; SPITZ F, 1992, ONGULES / UNGULATES 91, P385; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Truve J, 2003, WILDLIFE BIOL, V9, P51, DOI 10.2981/wlb.2003.056; Van Horn RC, 2008, ANIM BEHAV, V75, P1173, DOI 10.1016/j.anbehav.2007.08.027; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vernesi C, 2003, MOL ECOL, V12, P585, DOI 10.1046/j.1365-294X.2003.01763.x; Wang CL, 2012, GENETICS, V192, P651, DOI 10.1534/genetics.112.139519; West SA, 2007, CURR BIOL, V17, pR661, DOI 10.1016/j.cub.2007.06.004; Wey T, 2008, ANIM BEHAV, V75, P333, DOI 10.1016/j.anbehav.2007.06.020; White AM, 2010, BEHAVIOUR, V147, P1, DOI 10.1163/000579509X12459309054841; White AM, 2009, ANIM BEHAV, V77, P87, DOI 10.1016/j.anbehav.2008.08.030; Whitehead H, 1997, ANIM BEHAV, V53, P1053, DOI 10.1006/anbe.1996.0358; WHITEHEAD H, 1995, BEHAV ECOL, V6, P199, DOI 10.1093/beheco/6.2.199; Whitehead H, 1999, ADV STUD BEHAV, V28, P33, DOI 10.1016/S0065-3454(08)60215-6; Whitehead H, 2008, ANAL ANIMAL SOC QUAN, DOI 10.7208/chicago/9780226895246.001.0001; Whitehead H, 2009, BEHAV ECOL SOCIOBIOL, V63, P765, DOI 10.1007/s00265-008-0697-y; Williams CT, 2013, BEHAV ECOL SOCIOBIOL, V67, P757, DOI 10.1007/s00265-013-1499-4; Wimmer B, 2002, BEHAV ECOL SOCIOBIOL, V52, P166, DOI 10.1007/s00265-002-0497-8; Wiszniewski J, 2010, ANIM BEHAV, V80, P895, DOI 10.1016/j.anbehav.2010.08.013; Wolf JBW, 2008, P ROY SOC B-BIOL SCI, V275, P2063, DOI 10.1098/rspb.2008.0356; Wolf JBW, 2007, ANIM BEHAV, V74, P1293, DOI 10.1016/j.anbehav.2007.02.024; Zeyl E, 2009, MOL ECOL, V18, P735, DOI 10.1111/j.1365-294X.2008.04049.x	81	52	52	0	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99875	10.1371/journal.pone.0099875	http://dx.doi.org/10.1371/journal.pone.0099875			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919178	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000124
J	Chen, C; Han, S; Meng, LX; Li, ZH; Zhang, X; Wu, AH				Chen, Chen; Han, Sheng; Meng, Lingxuan; Li, Zhonghua; Zhang, Xue; Wu, Anhua			TERT Promoter Mutations Lead to High Transcriptional Activity under Hypoxia and Temozolomide Treatment and Predict Poor Prognosis in Gliomas	PLOS ONE			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMA; CLINICAL-IMPLICATIONS; METHYLATION STATUS; TELOMERASE; CANCER; HTERT; CELLS; EXPRESSION; CHEMOSENSITIVITY; RADIOTHERAPY	Objective: This study explored the effects of telomerase reverse transcriptase (TERT) promoter mutations on transcriptional activity of the TERT gene under hypoxic and temozolomide (TMZ) treatment conditions, and investigated the status and prognostic value of these mutations in gliomas. Methods: The effect of TERT promoter mutations on the transcriptional activity of the TERT gene under hypoxic and TMZ treatment conditions was investigated in glioma cells using the luciferase assay. TERT promoter mutations were detected in 101 glioma samples (grades I-IV) and 49 other brain tumors by sequencing. TERT mRNA expression in gliomas was examined by real-time PCR. Hazard ratios from survival analysis of glioma patients were determined relative to the presence of TERT promoter mutations. Results: Mutations in the TERT promoter enhanced gene transcription even under hypoxic and TMZ treatment conditions, inducing upregulation of TERT mRNA expression. Mutations were detected in gliomas, but not in meningiomas, pituitary adenomas, cavernomas, intracranial metastases, normal brain tissues, or peripheral blood of glioma patients. Patients with TERT promoter mutations had lower survival rates, even after adjusting for other known or potential risk factors, and the incidence of mutation was correlated with patient age. Conclusion: TERT promoter mutations were specific to gliomas. TERT promoter mutations maintained its ability of inducing high transcriptional activity even under hypoxic and TMZ treatment conditions, and the presence of mutations was associated with poor prognosis in glioma patients. These findings demonstrate that TERT promoter mutations are novel prognostic markers for gliomas that can inform prospective therapeutic strategies.	[Chen, Chen; Zhang, Xue; Wu, Anhua] China Med Univ, Res Ctr Med Genom, Key Lab Med Cell Biol, Minist Educ,Coll Basic Med Sci, Shenyang, Liaoning, Peoples R China; [Han, Sheng; Meng, Lingxuan; Li, Zhonghua; Wu, Anhua] China Med Univ, Affiliated Hosp 1, Dept Neurosurg, Shenyang, Liaoning, Peoples R China; [Zhang, Xue] Peking Union Med Univ, Dept Med Genet, Beijing, Peoples R China	China Medical University; China Medical University; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Wu, AH (corresponding author), China Med Univ, Res Ctr Med Genom, Key Lab Med Cell Biol, Minist Educ,Coll Basic Med Sci, Shenyang, Liaoning, Peoples R China.	wuanhua1@yahoo.com	li, zh/HII-5698-2022		Pacific Northwest Udall Center (PANUC; RC); National Institute on Aging [FH: R37 AG006457]; National Multiple Sclerosis Society (Horak) [MB0011]; Oregon Clinical and Translational Research Institute (OCTRI); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1 RR024140]; NIH Roadmap for Medical Research; NATIONAL INSTITUTE ON AGING [R37AG006457] Funding Source: NIH RePORTER	Pacific Northwest Udall Center (PANUC; RC); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Multiple Sclerosis Society (Horak); Oregon Clinical and Translational Research Institute (OCTRI); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by pilot awards from the Pacific Northwest Udall Center (PANUC; RC), a MERIT award from the National Institute on Aging (FH: R37 AG006457), and a postdoctoral Mentored Research Award from the National Multiple Sclerosis Society (Horak #MB0011). Additional support was provided from the Oregon Clinical and Translational Research Institute (OCTRI), grant number UL1 RR024140 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beier D, 2008, CANCER RES, V68, P5706, DOI 10.1158/0008-5472.CAN-07-6878; Brandes AA, 2008, J CLIN ONCOL, V26, P2192, DOI 10.1200/JCO.2007.14.8163; Brandes AA, 2012, NAT REV NEUROL, V8, P664, DOI 10.1038/nrneurol.2012.220; Brandes AA, 2010, NEURO-ONCOLOGY, V12, P283, DOI 10.1093/neuonc/nop050; Chen LC, 2012, NEURO-ONCOLOGY, V14, P1026, DOI 10.1093/neuonc/nos122; Clarke JL, 2009, J CLIN ONCOL, V27, P3861, DOI 10.1200/JCO.2008.20.7944; Counter CM, 1998, ONCOGENE, V16, P1217, DOI 10.1038/sj.onc.1201882; Galceran J, 2000, DEVELOPMENT, V127, P469; Guo XL, 2008, CANCER BIOL THER, V7, P1555, DOI 10.4161/cbt.7.10.6539; Han S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076717; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Killela PJ, 2013, P NATL ACAD SCI USA, V110, P6021, DOI 10.1073/pnas.1303607110; Kinde I, 2013, CANCER RES, V73, P7162, DOI 10.1158/0008-5472.CAN-13-2498; Kohler BA, 2011, JNCI-J NATL CANCER I, V103, P714, DOI 10.1093/jnci/djr077; Nagalski A, 2013, BRAIN STRUCT FUNCT, V218, P1531, DOI 10.1007/s00429-012-0474-6; Nishi H, 2004, MOL CELL BIOL, V24, P6076, DOI 10.1128/MCB.24.13.6076-6083.2004; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Rivera AL, 2010, NEURO-ONCOLOGY, V12, P116, DOI 10.1093/neuonc/nop020; Shay JW, 2001, HUM MOL GENET, V10, P677, DOI 10.1093/hmg/10.7.677; Spiegl-Kreinecker S, 2010, NEURO-ONCOLOGY, V12, P28, DOI 10.1093/neuonc/nop003; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Svensson KJ, 2008, CANCER RES, V68, P9291, DOI 10.1158/0008-5472.CAN-08-2340; Swanson KR, 2011, CANCER RES, V71, P7366, DOI 10.1158/0008-5472.CAN-11-1399; Tang K, 2012, MED ONCOL, V29, P1292, DOI 10.1007/s12032-011-9901-4; Tchirkov A, 2003, BRIT J CANCER, V88, P516, DOI 10.1038/sj.bjc.6600754; Ueda Y, 2011, J PEDIATR SURG, V46, P2221, DOI 10.1016/j.jpedsurg.2011.09.003; Varea O, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005153; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Wang L, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-33; Werner C, 2011, ATHEROSCLEROSIS, V216, P23, DOI 10.1016/j.atherosclerosis.2011.02.011; Zhang Y, 2012, J BIOL CHEM, V287, P32494, DOI 10.1074/jbc.M112.368282	32	33	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100297	10.1371/journal.pone.0100297	http://dx.doi.org/10.1371/journal.pone.0100297			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937153	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400102
J	Demarchi, B; O'Connor, S; Ponzoni, AD; Ponzoni, RDR; Sheridan, A; Penkman, K; Hancock, Y; Wilson, J				Demarchi, Beatrice; O'Connor, Sonia; Ponzoni, Andre de Lima; Ponzoni, Raquel de Almeida Rocha; Sheridan, Alison; Penkman, Kirsty; Hancock, Y.; Wilson, Julie			An Integrated Approach to the Taxonomic Identification of Prehistoric Shell Ornaments	PLOS ONE			English	Article							AMINO-ACID; MOLLUSK EXPLOITATION; QUATERNARY; BEADS; RACEMIZATION; BEHAVIOR; AMINOSTRATIGRAPHY; AURIGNACIAN; ECONOMIES; FRACTION	Shell beads appear to have been one of the earliest examples of personal adornments. Marine shells identified far from the shore evidence long-distance transport and imply networks of exchange and negotiation. However, worked beads lose taxonomic clues to identification, and this may be compounded by taphonomic alteration. Consequently, the significance of this key early artefact may be underestimated. We report the use of bulk amino acid composition of the stable intracrystalline proteins preserved in shell biominerals and the application of pattern recognition methods to a large dataset (777 samples) to demonstrate that taxonomic identification can be achieved at genus level. Amino acid analyses are fast (< 2 hours per sample) and micro-destructive (sample size <2 mg). Their integration with non-destructive techniques provides a valuable and affordable tool, which can be used by archaeologists and museum curators to gain insight into early exploitation of natural resources by humans. Here we combine amino acid analyses, macro-and microstructural observations (by light microscopy and scanning electron microscopy) and Raman spectroscopy to try to identify the raw material used for beads discovered at the Early Bronze Age site of Great Cornard (UK). Our results show that at least two shell taxa were used and we hypothesise that these were sourced locally.	[Demarchi, Beatrice] Univ York, Dept Archaeol, BioArCh, York YO10 5DD, N Yorkshire, England; [O'Connor, Sonia] Univ Bradford, Sch Life Sci, Bradford BD7 1DP, W Yorkshire, England; [Ponzoni, Andre de Lima; Ponzoni, Raquel de Almeida Rocha; Hancock, Y.] Univ York, Dept Phys, York YO10 5DD, N Yorkshire, England; [Sheridan, Alison] Natl Museums Scotland, Edinburgh, Midlothian, Scotland; [Penkman, Kirsty] Univ York, Dept Chem, BioArCh, York YO10 5DD, N Yorkshire, England; [Wilson, Julie] Univ York, Dept Math, York YO10 5DD, N Yorkshire, England; [Wilson, Julie] Univ York, Dept Chem, York YO10 5DD, N Yorkshire, England; [Hancock, Y.; Wilson, Julie] Univ York, York Ctr Complex Syst Anal YCCSA, York YO10 5DD, N Yorkshire, England	University of York - UK; University of Bradford; University of York - UK; University of York - UK; University of York - UK; University of York - UK; University of York - UK	Demarchi, B (corresponding author), Univ York, Dept Archaeol, BioArCh, York YO10 5DD, N Yorkshire, England.	beatrice.demarchi@york.ac.uk; julie.wilson@york.ac.uk	Demarchi, Beatrice/P-5107-2019; de Almeida Rocha Ponzoni, Raquel/ABA-8167-2021; Rocha, Raquel/HDN-5721-2022; Penkman, Kirsty E/D-1952-2012; Demarchi, Beatrice/Y-5308-2019	de Almeida Rocha Ponzoni, Raquel/0000-0002-5752-5006; Penkman, Kirsty E/0000-0002-6226-9799; Demarchi, Beatrice/0000-0002-8398-4409	EU [PERG07-GA-2010-268429]; Heritage programme [AH/H032150/1]; AHRC/EPSRC Science; Arts and Humanities Research Council [AH/H032150/1] Funding Source: researchfish; AHRC [AH/H032150/1] Funding Source: UKRI	EU(European Commission); Heritage programme; AHRC/EPSRC Science(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)Engineering & Physical Sciences Research Council (EPSRC)); Arts and Humanities Research Council(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC)); AHRC(UK Research & Innovation (UKRI)Arts & Humanities Research Council (AHRC))	BD was funded by EU FP7 Re(In)tegration grant PERG07-GA-2010-268429 (project: mAARiTIME). URL:ec.europa.eu/research/fp7.2.SOC was jointly funded by the AHRC/EPSRC Science and Heritage programme, Award AH/H032150/1 (Project: Cultural Objects Worked in Skeletal Hard Tissues). URLs:www.ahrc.ac.uk, www.epsrc.ac.uk, www.heritagescience.ac.uk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELSON PH, 1957, ANN NY ACAD SCI, V69, P276, DOI 10.1111/j.1749-6632.1957.tb49663.x; ANDREWS JT, 1985, GEOL J, V20, P1; AnimalBase project Group, 2005, ANIMALBASE; BADA JL, 1978, EARTH PLANET SC LETT, V41, P67, DOI 10.1016/0012-821X(78)90042-0; BAILEY GN, 1975, J ARCHAEOL SCI, V2, P45, DOI 10.1016/0305-4403(75)90045-X; Bajnoczi B, 2013, J ARCHAEOL SCI, V40, P874, DOI 10.1016/j.jas.2012.09.022; Balme J, 2006, ANTIQUITY, V80, P799, DOI 10.1017/S0003598X00094436; Bar-Yosef O, 1998, EVOL ANTHROPOL, V6, P159, DOI 10.1002/(SICI)1520-6505(1998)6:5<159::AID-EVAN4>3.0.CO;2-7; Belcher AM, 1996, NATURE, V381, P56, DOI 10.1038/381056a0; Carter J.G., 1989, SKELETAL BIOMINERALI; Cartwright Caroline, 2003, Environmental Archaeology, V8, P85; Colonese AC, 2011, QUATERN INT, V239, P86, DOI 10.1016/j.quaint.2010.09.001; Cuenca-Solana D, 2013, CURR ANTHROPOL, V54, P370, DOI 10.1086/670325; d'Errico F, 2005, J HUM EVOL, V48, P3, DOI 10.1016/j.jhevol.2004.09.002; Debruyne S, 2014, ENV ARCHAEO IN PRESS; Debruyne S, 2010, ANATOL STUD, V60, P149, DOI 10.1017/S0066154600001071; DEGENS ET, 1967, COMP BIOCHEM PHYSIOL, V20, P553, DOI 10.1016/0010-406X(67)90269-1; Demarchi B, 2013, QUAT GEOCHRONOL, V16, P144, DOI 10.1016/j.quageo.2012.03.016; Demarchi B, 2011, QUATERN INT, V239, P114, DOI 10.1016/j.quaint.2010.05.029; Dimitrijevic V., 2006, DOCUMENTA PRAEHISTOR, VXXXIII, P237, DOI DOI 10.4312/DP.33.21; Eerkens JW, 2007, ACS SYM SER, V968, P167, DOI 10.1021/bk-2007-0968.ch009; ERLANDSON JM, 1988, AM ANTIQUITY, V53, P102, DOI 10.2307/281156; GOODFRIEND GA, 1991, GEOCHIM COSMOCHIM AC, V55, P293, DOI 10.1016/0016-7037(91)90418-5; Hare E., 1969, ORGANIC GEOCHEMISTRY, P438, DOI 10.1007/978-3- 642- 87734- 6_22; HAUGEN JE, 1989, J FORAMIN RES, V19, P38, DOI 10.2113/gsjfr.19.1.38; Hutterer R, 2014, QUATERN INT, V320, P83, DOI 10.1016/j.quaint.2013.12.006; Ifantidis F., 2011, SPONDYLUS PREHISTORY; KAUFMAN DS, 1992, GEOCHIM COSMOCHIM AC, V56, P2445, DOI 10.1016/0016-7037(92)90201-S; Kaufman DS, 1998, QUATERNARY SCI REV, V17, P987, DOI 10.1016/S0277-3791(97)00086-3; Kohonen T., 1992, P INT JOINT C NEUR N, VI, P725; Kuhn SL, 2001, P NATL ACAD SCI USA, V98, P7641, DOI 10.1073/pnas.121590798; Lajoie K.R., 1980, P305; Maier E, 2010, PALAEOGEOGR PALAEOCL, V291, P228, DOI 10.1016/j.palaeo.2010.02.032; Mann K, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-28; Mannino AM, 2002, WORLD ARCHAEOL, V33, P452; Marie B, 2012, P NATL ACAD SCI USA, V109, P20986, DOI 10.1073/pnas.1210552109; Marin F., 2013, RECENTS ADV PEARL RE, V149; Mayer DEBY, 2009, J HUM EVOL, V56, P307, DOI 10.1016/j.jhevol.2008.10.005; Mayer DEB, 1997, J ARCHAEOL SCI, V24, P97; Miller G.H., 1980, P415; Miller G.H., 1989, Quaternary International, V1, P111, DOI 10.1016/1040-6182(89)90011-6; MILLER GH, 1979, NATURE, V281, P539, DOI 10.1038/281539a0; Mitchell PJ., 1996, AFR ARCHAEOL REV, V13, P35, DOI DOI 10.1007/BF01956132; O'Connor S, UNUSUAL FIND S UNPUB; OBIS, 2014, DAT OC BIOG INF SYST; Oliva M, 2010, TECHNOLOGY PRODUCTIO, V66, P146; PARMALEE PW, 1974, AM ANTIQUITY, V39, P421, DOI 10.2307/279431; Penkman KEH, 2007, QUATERNARY SCI REV, V26, P2958, DOI 10.1016/j.quascirev.2007.06.034; Penkman KEH, 2008, QUAT GEOCHRONOL, V3, P2, DOI 10.1016/j.quageo.2007.07.001; Penkman KEH, 2013, QUATERNARY SCI REV, V61, P111, DOI 10.1016/j.quascirev.2012.10.046; Penkman KEH, 2011, NATURE, V476, P446, DOI 10.1038/nature10305; Richter KK, 2011, J ARCHAEOL SCI, V38, P1502, DOI 10.1016/j.jas.2011.02.014; Seferiades M, 2009, LOST WORLD OLD EUROP, P180; Stiner Mary C., 2014, Biology Theory, V9, P51, DOI 10.1007/s13752-013-0157-4; Stiner MC, 1999, ANTIQUITY, V73, P735, DOI 10.1017/S0003598X00065492; Sykes GA, 1995, ORG GEOCHEM, V23, P1059, DOI 10.1016/0146-6380(95)00086-0; Trubitt MBD, 2003, J ARCHAEOL RES, V11, P243, DOI 10.1023/A:1025028814962; Vanhaeren M, 2004, J ARCHAEOL SCI, V31, P1481, DOI 10.1016/j.jas.2004.03.011; Vanhaeren M, 2006, J ARCHAEOL SCI, V33, P1105, DOI 10.1016/j.jas.2005.11.017; Vermeij G.J., 1995, NATURAL HIST SHELLS, VVolume 15; Wehmiller J.F., 1980, P341; WEHMILLER JF, 1977, EARTH PLANET SC LETT, V37, P184, DOI 10.1016/0012-821X(77)90163-7; Wehmiller JF, 2013, QUAT GEOCHRONOL, V16, P3, DOI 10.1016/j.quageo.2012.05.008; WEINER S, 1984, PHILOS T ROY SOC B, V304, P425, DOI 10.1098/rstb.1984.0036; WoRMS Editorial Board, 2014, WORLD REGISTER MARIN	65	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99839	10.1371/journal.pone.0099839	http://dx.doi.org/10.1371/journal.pone.0099839			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AK5YM	24936797	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000338503400042
J	Foulds, WL; Lucas, MC				Foulds, William L.; Lucas, Martyn C.			Paradoxical Exploitation of Protected Fishes As Bait for Anglers: Evaluating the Lamprey Bait Market in Europe and Developing Sustainable and Ethical Solutions	PLOS ONE			English	Article							FRESH-WATER FISHES; RIVER LAMPREY; STAKEHOLDER ATTITUDES; PETROMYZON-MARINUS; CONSERVATION; MANAGEMENT; IMPACT; TRADE; EEL; ANGUILLA	A reoccurring conservation problem is the resolution of consumptive use of threatened wildlife and is especially difficult to defend when it occurs for recreational practices. We explored the commercial capture and supply of threatened European river lamprey (Lampetra fluviatilis) to anglers, to determine the extent of exploitation and seek opportunities for improved conservation. The trade began in 1995 from England, but by 2012 involved sale of lamprey from England, The Netherlands and Estonia, including from protected populations. Lamprey are sold frozen for the capture of predatory fish, mostly in freshwater. In the year 2011/2012 9 tonnes (. 90,000 lampreys) of river lamprey were supplied, almost exclusively to British anglers. Although annual catches in the main English lamprey fishery (River Ouse) have varied widely since 1995, catch per unit effort did not decline between 2000 and 2012. Conservation actions since 2011 have included a cap on fishing licenses, catch quotas and restricted fishing seasons. Now, 86% of lamprey bait is imported to Britain. Most bait sellers interviewed would not stock lamprey if they knew they were from threatened populations; many felt their trade would not be impacted if lamprey were not stocked. This facilitates opportunities to enter into dialogue with anglers over alternative baits to threatened lamprey. The study emphasises the need to inform stakeholders about conservation species subjected to market-driven exploitation.	[Foulds, William L.; Lucas, Martyn C.] Univ Durham, Sch Biol & Biomed Sci, Durham, England	Durham University	Foulds, WL (corresponding author), Univ Durham, Sch Biol & Biomed Sci, Durham, England.	will_foulds@hotmail.com			Durham University	Durham University	Mr. William Foulds was supported by a Grevillea Trust scholarship from Durham University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aas Oystein, 2000, North American Journal of Fisheries Management, V20, P940, DOI 10.1577/1548-8675(2000)020&lt;0940:ARTPHR&gt;2.0.CO;2; Allan JD, 2005, BIOSCIENCE, V55, P1041, DOI 10.1641/0006-3568(2005)055[1041:OOIW]2.0.CO;2; Andrade NO, 2007, HYDROBIOLOGIA, V582, P121, DOI 10.1007/s10750-006-0540-2; Arlinghaus R, 2008, N AM J FISH MANAGE, V28, P123, DOI 10.1577/M06-263.1; Arlinghaus R, 2002, FISH FISH, V3, P261, DOI 10.1046/j.1467-2979.2002.00102.x; Bark A, 2007, ICES J MAR SCI, V64, P1368, DOI 10.1093/icesjms/fsm117; Beaulaton L, 2008, FISH RES, V92, P90, DOI 10.1016/j.fishres.2008.01.001; BIERNACKI P, 1981, SOCIOL METHOD RES, V10, P141, DOI 10.1177/004912418101000205; Birzaks J, 2011, SCI J RIGA TECHNICAL, V7, P32; Bourque L.B., 2003, CONDUCT TELEPHONE SU; Chan KMA, 2007, CONSERV BIOL, V21, P59, DOI 10.1111/j.1523-1739.2006.00570.x; Close DA, 2002, FISHERIES, V27, P19, DOI 10.1577/1548-8446(2002)027<0019:TEACIO>2.0.CO;2; Cowx IG, 2010, J FISH BIOL, V76, P2194, DOI 10.1111/j.1095-8649.2010.02686.x; CRYER M, 1987, BIOL CONSERV, V42, P83, DOI 10.1016/0006-3207(87)90016-4; Danylchuk AJ, 2011, CONSERV BIOL, V25, P458, DOI 10.1111/j.1523-1739.2010.01631.x; de Nie H., 2003, Nederlandsche Commissie voor Internationale Natuurbescherming Mededelingen, V38, P159; Dekker W, 2003, FISHERIES MANAG ECOL, V10, P365, DOI 10.1111/j.1365-2400.2003.00352.x; Dorow M, 2010, FISHERIES MANAG ECOL, V17, P106, DOI 10.1111/j.1365-2400.2009.00674.x; Dorow M, 2009, BIOL CONSERV, V142, P2973, DOI 10.1016/j.biocon.2009.07.029; Dotinga H, 2009, UTRECHT LAW REV, V5, P21, DOI 10.18352/ulr.93; FAO Fisheries Department, 2010, STAT WORLD FISH AQ 2; Freyhof J, 2010, IUCN 2012 IUCN RED L; Freyhof J., 2008, IUCN 2012 IUCN RED L; Freyhof J, 2011, IUCN 2012 IUCN RED L; Gaudron SM, 2006, J FISH BIOL, V68, P640, DOI 10.1111/j.0022-1112.2006.00937.x; Gelcich S, 2005, CONSERV BIOL, V19, P865, DOI 10.1111/j.1523-1739.2005.00534.x; Gonzalez JA, 2003, BIOL CONSERV, V114, P437, DOI 10.1016/S0006-3207(03)00071-5; Gozlan RE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053200; Grabowski JH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010188; Granek EF, 2008, CONSERV BIOL, V22, P1125, DOI 10.1111/j.1523-1739.2008.00977.x; Gratwicke B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002544; Hardisty MW, 1986, FRESHWATER FISHES 1, V1, P249; Janson HM, 2007, CO4807 IMARES; Kelly F.L., 2001, BIOL ENVIRON, V101B, P165; Lanzing W.J.R., 1959, STUDIES RIVER LAMPRE; Likert R., 1932, ARCH PSYCHOL, V140, P1, DOI DOI 10.1111/J.1540-5834.2010.00585.X; MAITLAND P, 1997, FRESHWATER FORUM, V6, P57; Marshall G, 2005, RADIOGRAPHY, V11, P131, DOI [10.1016/j.radi.2004.09.002, 10.1016/j.radi.2004.09.001]; Marshall K, 2007, BIODIVERS CONSERV, V16, P3129, DOI 10.1007/s10531-007-9167-5; Masters JEG, 2006, AQUAT CONSERV, V16, P77, DOI 10.1002/aqc.686; Mateus Catarina S., 2012, Endangered Species Research, V16, P183, DOI 10.3354/esr00405; Mintzer VJ, 2013, BIOL CONSERV, V158, P280, DOI 10.1016/j.biocon.2012.10.006; Peterson MN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044616; Phelps NBD, 2013, DIS AQUAT ORGAN, V102, P211, DOI 10.3354/dao02549; Raghavan R, 2013, BIOL CONSERV, V164, P158, DOI 10.1016/j.biocon.2013.04.019; Renaud CB, 1997, J APPL ICHTHYOL, V13, P143, DOI 10.1111/j.1439-0426.1997.tb00114.x; Reynolds John D., 2002, P319; Richards SA, 2008, J APPL ECOL, V45, P218, DOI 10.1111/j.1365-2664.2007.01377.x; Saat T., 2002, P34; Schlaepfer MA, 2005, BIOSCIENCE, V55, P256, DOI 10.1641/0006-3568(2005)055[0256:CIETIO]2.0.CO;2; Sjoberg K., 2011, J N STUD, V5, P51; Spice EK, 2012, MOL ECOL, V21, P2916, DOI 10.1111/j.1365-294X.2012.05585.x; Stankey GH, 2006, CONSERV BIOL, V20, P29; Thiel Ralf, 2009, Endangered Species Research, V8, P233, DOI 10.3354/esr00222; Thorbjarnarson J, 1999, CONSERV BIOL, V13, P465, DOI 10.1046/j.1523-1739.1999.00011.x; Tourangeau R, 2007, PSYCHOL BULL, V133, P859, DOI 10.1037/0033-2909.133.5.859; Tsounis G, 2010, OCEANOGR MAR BIOL, V48, P161, DOI 10.1201/EBK1439821169-c3; VALTONEN T, 1980, CAN J FISH AQUAT SCI, V37, P1967, DOI 10.1139/f80-237; White PCL, 2005, J APPL ECOL, V42, P421, DOI 10.1111/j.1365-2664.2005.01032.x; WITKOWSKI A, 1992, NETH J ZOOL, V42, P243, DOI 10.1163/156854291X00315; Worthington T, 2010, FISHERIES MANAG ECOL, V17, P465, DOI 10.1111/j.1365-2400.2010.00745.x	61	9	9	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99617	10.1371/journal.pone.0099617	http://dx.doi.org/10.1371/journal.pone.0099617			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936643	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000338503400026
J	Ma, WP; Gu, S; Wang, Y; Zhang, XJ; Wang, AR; Zhao, NQ; Song, YY				Ma, Wei-ping; Gu, Shuo; Wang, Yi; Zhang, Xian-jing; Wang, Ai-rong; Zhao, Nai-qing; Song, Yan-yan			The Use of Mixed Generalized Additive Modeling to Assess the Effect of Temperature on the Usage of Emergency Electrocardiography Examination among the Elderly in Shanghai	PLOS ONE			English	Article							ACUTE MYOCARDIAL-INFARCTION; DAILY WEATHER CONDITIONS; HOSPITAL ADMISSIONS; HEART-DISEASE	Background: Acute coronary artery diseases have been observed to be associated with some meteorological variables. But few of the previous studies considered autocorrelated outcomes. Electrocardiography is a widely used tool in the initial diagnosis of acute cardiovascular events, and emergency electrocardiography counts were shown to be highly correlated with acute myocardial infarction in our pilot study, hence a good index of prediction for acute cardiovascular events morbidity among the elderly. To indirectly assess the impact of temperature on the number of acute cardiovascular events, we studied the association between temperature and emergency electrocardiography counts while considering autocorrelated nature of the response variables. Methods: We collected daily emergency electrocardiography counts for elderly females and males in Shanghai from 2007 to middle 2012, and studied temperature and other effects on these data using Mixed Generalized Additive Modelling methods. Delayed temperature effect distribution was described as the weighted average of the temperatures within 3 days before the counts was recorded. Autoregressive random effects were used in the model to describe the autocorrelation of the response variables. Main Results: Temperature effect was observed to be piecewise linearly associated with the logarithm of emergency electrocardiography counts. The optimal weights of the delayed temperature effect distribution were obtained from the model estimation. The weights of lag-1 were the maximums, significantly greater than the weights of lag-2 and lag-3 for both females and males. The model showed good fit with R-2 values of 0.860 for females and 0.856 for males. Conclusion: From the mixed generalized additive model, we infer that during cold and mild days, the number of emergency electrocardiography counts increase as temperature effect decreases, while during hot days, counts increase as temperature effect increases. Similar properties could be inferred for the occurrence of cardiovascular events.	[Ma, Wei-ping; Zhao, Nai-qing] Fudan Univ, Sch Publ Hlth, Dept Biostat & Social Med, Shanghai 200433, Peoples R China; [Gu, Shuo] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Shanghai 200030, Peoples R China; [Wang, Yi] Fudan Univ, Childrens Hosp, Shanghai 200433, Peoples R China; [Zhang, Xian-jing; Wang, Ai-rong] Shang Hai Med Insurance Adm, Shanghai, Peoples R China; [Song, Yan-yan] Shanghai Jiao Tong Univ, Sch Med, Dept Biostat, Shanghai 200030, Peoples R China	Fudan University; Shanghai Jiao Tong University; Fudan University; Shanghai Jiao Tong University	Zhao, NQ (corresponding author), Fudan Univ, Sch Publ Hlth, Dept Biostat & Social Med, Shanghai 200433, Peoples R China.	nqzhao@fudan.edu.cn; yanyansong@sjtu.edu.cn		Gu, shuo/0000-0001-5225-6874	National Natural Science Foundation of China [81273187]; Ministry of Science and Technology of the People's Republic of China [2012ZX09303-013-014]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Science and Technology of the People's Republic of China(Ministry of Science and Technology, China)	This research was supported by National Natural Science Foundation of China (Grant 81273187) and Ministry of Science and Technology of the People's Republic of China (Major Grant 2012ZX09303-013-014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barnett AG, 2005, J EPIDEMIOL COMMUN H, V59, P551, DOI 10.1136/jech.2004.028514; Benjamin MA, 2003, J AM STAT ASSOC, V98, P214, DOI 10.1198/016214503388619238; Bhaskaran K, 2009, HEART, V95, P1760, DOI 10.1136/hrt.2009.175000; COLLINS KJ, 1986, AGE AGEING, V15, P212, DOI 10.1093/ageing/15.4.212; Danet S, 1999, CIRCULATION, V100, pE11, DOI 10.1161/01.CIR.100.1.e1; De Lorenzo F, 1999, QJM-INT J MED, V92, P747, DOI 10.1093/qjmed/92.12.747; ENQUSELASSIE F, 1993, INT J EPIDEMIOL, V22, P632, DOI 10.1093/ije/22.4.632; Gerber Y, 2006, J AM COLL CARDIOL, V48, P287, DOI 10.1016/j.jacc.2006.02.065; Hastie TJ., 1990, GEN ADDITIVE MODELS, Vvol. 43, DOI DOI 10.1201/9780203753781; Hopstock LA, 2012, J EPIDEMIOL COMMUN H, V66, P815, DOI 10.1136/jech.2010.131458; Lin S, 2009, EPIDEMIOLOGY, V20, P738, DOI 10.1097/EDE.0b013e3181ad5522; MARCHANT B, 1993, BRIT HEART J, V69, P385; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Morris F, 2002, BRIT MED J, V324, P831, DOI 10.1136/bmj.324.7341.831; PAN WH, 1995, LANCET, V345, P353, DOI 10.1016/S0140-6736(95)90341-0; Pell JP, 1999, QJM-INT J MED, V92, P689, DOI 10.1093/qjmed/92.12.689; Ren CZ, 2006, ENVIRON HEALTH PERSP, V114, P1690, DOI 10.1289/ehp.9266; Schwartz J, 2004, EPIDEMIOLOGY, V15, P755, DOI 10.1097/01.ede.0000134875.15919.0f; Wolf K, 2009, CIRCULATION, V120, P735, DOI 10.1161/CIRCULATIONAHA.108.815860; Yang L, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-165	20	4	4	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100284	10.1371/journal.pone.0100284	http://dx.doi.org/10.1371/journal.pone.0100284			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936868	gold, Green Published, Green Submitted			2022-12-27	WOS:000338503400100
J	Popovic, N; Caballero-Bleda, M; Popovic, M				Popovic, Natalija; Caballero-Bleda, Maria; Popovic, Miroljub			Post-Training Scopolamine Treatment Induced Maladaptive Behavior in Open Field Habituation Task in Rats	PLOS ONE			English	Article							EXPLORATORY ACTIVITY; MEMORY; ACETYLCHOLINE; MICE; CONSOLIDATION; NOVELTY; ACQUISITION; AVOIDANCE; DRUGS	The effects of scopolamine on memory consolidation are controversial and depend on several factors (i.e. site of administration, time of administration and testing, dose, cognitive task, experimental protocol, specie, strain, etc.). Generally, the range dose of systemic administered scopolamine, used in memory consolidation studies, has varied from 0.05 to 50 mg/kg. However, according to the literature, the most frequently used doses of scopolamine efficient on memory consolidation, are 1 and 30 mg/kg, low and high doses, respectively. In open field habituation studies only lower doses of scopolamine were used to test memory consolidation. Therefore, in the present study we compared the effects of low (1 mg/kg) and high (30 mg/kg) scopolamine dose, on the open field habituation task, in male Wistar rats. Scopolamine was administered immediately after the acquisition task and animals were retested 48 h later on. On the retested day, the ambulation and rearing in the open field decreased in the same manner in all tested groups. In saline- and 1 mg/kg scopolamine-treated animals, the time spent in grooming significantly decreased in the habituation task, while the same parameter significantly increased in animals treated with 30 mg/kg of scopolamine. The defecation rate significantly decreased (control group), maintained (1 mg/kg of scopolamine treated animals) or significantly increased (30 mg/kg of scopolamine treated group) on retention test. In conclusion, the present data suggest that post-training scopolamine administration does not affect locomotion neither exploration in the habituation to a novel environment, but increases defecation and grooming, two behaviours associated with fearful and stressful situations.	[Popovic, Natalija; Caballero-Bleda, Maria; Popovic, Miroljub] Univ Murcia, Fac Med, Dept Human Anat & Psychobiol, Murcia, Spain; [Popovic, Natalija; Caballero-Bleda, Maria; Popovic, Miroljub] Univ Murcia, Res Inst Aging, Murcia, Spain	University of Murcia; University of Murcia	Popovic, M (corresponding author), Univ Murcia, Fac Med, Dept Human Anat & Psychobiol, Murcia, Spain.	miroljub@um.es	Bleda, Maria Caballero/L-5394-2014; Popovic, Natalija/L-5377-2014; Popovic, Miroljub/L-5320-2014	Bleda, Maria Caballero/0000-0002-9900-9819; Popovic, Natalija/0000-0003-2930-4035; Popovic, Miroljub/0000-0002-1326-3876	Consejeria de Sanidad, Region de Murcia, Spain	Consejeria de Sanidad, Region de Murcia, Spain	Funding for this study was provided by the Consejeria de Sanidad, Region de Murcia, Spain (MCB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anagnostaras SG, 1999, NEUROPSYCHOPHARMACOL, V21, P731, DOI 10.1016/S0893-133X(99)00083-4; Blake MG, 2011, PHYSIOL BEHAV, V102, P332, DOI 10.1016/j.physbeh.2010.11.026; Brodkin J, 1999, BEHAV PHARMACOL, V10, P445, DOI 10.1097/00008877-199909000-00002; CANDLAND DK, 1969, ANN NY ACAD SCI, V159, P831, DOI 10.1111/j.1749-6632.1969.tb12982.x; CERBONE A, 1994, NEUROSCI BIOBEHAV R, V18, P497, DOI 10.1016/0149-7634(94)90004-3; DUNN AJ, 1979, SCIENCE, V203, P281, DOI 10.1126/science.216073; Giovannini MG, 2001, NEUROSCIENCE, V106, P43, DOI 10.1016/S0306-4522(01)00266-4; Hall CS, 1934, J COMP PSYCHOL, V18, P385, DOI 10.1037/h0071444; Hasselmo ME, 1999, TRENDS COGN SCI, V3, P351, DOI 10.1016/S1364-6613(99)01365-0; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; Miranda MI, 2009, BEHAV BRAIN RES, V202, P19, DOI 10.1016/j.bbr.2009.03.008; Klinkenberg I, 2010, NEUROSCI BIOBEHAV R, V34, P1307, DOI 10.1016/j.neubiorev.2010.04.001; Kucuk A, 2008, BEHAV BRAIN RES, V195, P147, DOI 10.1016/j.bbr.2008.05.023; Larauche M, 2009, J PHYSIOL PHARMACOL, V60, P33; Leussis MP, 2006, NEUROSCI BIOBEHAV R, V30, P1045, DOI 10.1016/j.neubiorev.2006.03.006; Micheau J, 2011, BEHAV BRAIN RES, V221, P424, DOI 10.1016/j.bbr.2010.11.052; Molinengo L, 1999, PHARMACOL BIOCHEM BE, V63, P221, DOI 10.1016/S0091-3057(98)00229-9; PAN SY, 1995, ACTA PHARM SINIC, V16, P125; Pepeu G, 2010, CHEM-BIOL INTERACT, V187, P403, DOI 10.1016/j.cbi.2009.11.018; PLATEL A, 1982, PSYCHOPHARMACOLOGY, V78, P346, DOI 10.1007/BF00433739; RUSH DK, 1988, BEHAV NEURAL BIOL, V50, P255, DOI 10.1016/S0163-1047(88)90938-7; Schildein S, 2000, NEUROBIOL LEARN MEM, V73, P21, DOI 10.1006/nlme.1999.3915; Thiel CM, 1998, NEUROSCIENCE, V85, P1253, DOI 10.1016/S0306-4522(98)00030-X; UKAI M, 1994, GEN PHARMACOL, V25, P433, DOI 10.1016/0306-3623(94)90193-7; UKAI M, 1994, GEN PHARMACOL, V25, P179, DOI 10.1016/0306-3623(94)90030-2; Zhou W, 2009, NUTR NEUROSCI, V12, P57, DOI 10.1179/147683009X388832	26	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100348	10.1371/journal.pone.0100348	http://dx.doi.org/10.1371/journal.pone.0100348			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936785	gold, Green Published, Green Submitted			2022-12-27	WOS:000338503400107
J	Shindo, A; Tanemura, H; Yata, K; Hamada, K; Shibata, M; Umeda, Y; Asakura, F; Toma, N; Sakaida, H; Fujisawa, T; Taki, W; Tomimoto, H				Shindo, Akihiro; Tanemura, Hiroshi; Yata, Kenichiro; Hamada, Kazuhide; Shibata, Masunari; Umeda, Yasuyuki; Asakura, Fumio; Toma, Naoki; Sakaida, Hiroshi; Fujisawa, Takao; Taki, Waro; Tomimoto, Hidekazu			Inflammatory Biomarkers in Atherosclerosis: Pentraxin 3 Can Become a Novel Marker of Plaque Vulnerability	PLOS ONE			English	Article							C-REACTIVE PROTEIN; INTERCELLULAR-ADHESION MOLECULE-1; ACUTE CORONARY SYNDROMES; INTIMA-MEDIA THICKNESS; SOLUBLE E-SELECTIN; ISCHEMIC-STROKE; HIGH-RISK; CAROTID ATHEROSCLEROSIS; EXPRESSION; LESIONS	Inflammation is crucially involved in the development of carotid plaques. We examined the relationship between plaque vulnerability and inflammatory biomarkers using intraoperative blood and tissue specimens. We examined 58 patients with carotid stenosis. Following carotid plaque magnetic resonance imaging, 41 patients underwent carotid artery stenting (CAS) and 17 underwent carotid endarterectomy (CEA). Blood samples were obtained from the femoral artery (systemic) and common carotid artery immediately before and after CAS (local). Seventeen resected CEA tissue samples were embedded in paraffin, and histopathological and immunohistochemical analyses for IL-6, IL-10, E-selectin, adiponectin, and pentraxin 3 (PTX3) were performed. Serum levels of IL-6, IL-1 beta, IL-10, TNF alpha, E-selectin, VCAM-1, adiponectin, hs-CRP, and PTX3 were measured by multiplex bead array system and ELISA. CAS-treated patients were classified as stable plaques (n = 21) and vulnerable plaques (n = 20). The vulnerable group showed upregulation of the proinflammatory cytokines (IL-6 and TNF alpha), endothelial activation markers (E-selectin and VCAM-1), and inflammation markers (hs-CRP and PTX3) and downregulation of the anti-inflammatory markers (adiponectin and IL-10). PTX3 levels in both systemic and intracarotid samples before and after CAS were higher in the vulnerable group than in the stable group. Immunohistochemical analysis demonstrated that IL-6 was localized to inflammatory cells in the vulnerable plaques, and PTX3 was observed in the endothelial and perivascular cells. Our findings reveal that carotid plaque vulnerability is modulated by the upregulation and downregulation of proinflammatory and anti-inflammatory factors, respectively. PTX3 may thus be a potential predictive marker of plaque vulnerability.	[Shindo, Akihiro; Yata, Kenichiro; Shibata, Masunari; Tomimoto, Hidekazu] Mie Univ, Dept Neurol, Grad Sch Med, Tsu, Mie 514, Japan; [Tanemura, Hiroshi; Hamada, Kazuhide; Umeda, Yasuyuki; Asakura, Fumio; Toma, Naoki; Sakaida, Hiroshi; Taki, Waro] Mie Univ, Dept Neurosurg, Grad Sch Med, Tsu, Mie 514, Japan; [Fujisawa, Takao] Mie Natl Hosp, Inst Clin Res, Tsu, Mie, Japan	Mie University; Mie University	Shindo, A (corresponding author), Mie Univ, Dept Neurol, Grad Sch Med, 2-174 Edobasih, Tsu, Mie 514, Japan.	a-shindo@clin.medic.mie-u.ac.jp			Ministry of Health Labour and Welfare, Japan	Ministry of Health Labour and Welfare, Japan(Ministry of Health, Labour and Welfare, Japan)	This work was supported by a grant-in-aid for Comprehensive Research on Aging and Health (HT) from the Ministry of Health Labour and Welfare, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe Y, 2010, J CEREBR BLOOD F MET, V30, P857, DOI 10.1038/jcbfm.2009.250; Blann AD, 1996, CORONARY ARTERY DIS, V7, P143, DOI 10.1097/00019501-199602000-00008; Bonacina F, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/725102; Cai JM, 2002, CIRCULATION, V106, P1368, DOI 10.1161/01.CIR.0000028591.44554.F9; Cao JJ, 2003, CIRCULATION, V108, P166, DOI 10.1161/01.CIR.0000079160.07364.6A; Crouse JR, 2006, J LIPID RES, V47, P1677, DOI 10.1194/jlr.R600012-JLR200; Davies MJ, 1996, CIRCULATION, V94, P2013, DOI 10.1161/01.CIR.94.8.2013; Davignon J, 2004, CIRCULATION, V109, P27, DOI 10.1161/01.CIR.0000131515.03336.f8; DEVRIES JE, 1995, ANN MED, V27, P537, DOI 10.3109/07853899509002465; El-Mesallamy HO, 2011, MINERVA ENDOCRINOL, V36, P163; FALK E, 1995, CIRCULATION, V92, P657, DOI 10.1161/01.CIR.92.3.657; Folco EJ, 2009, J BIOL CHEM, V284, P25569, DOI 10.1074/jbc.M109.019786; Gardener H, 2012, STROKE, V43, P1123, DOI 10.1161/STROKEAHA.111.641761; Garlanda C, 2005, ANNU REV IMMUNOL, V23, P337, DOI 10.1146/annurev.immunol.23.021704.115756; Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2; Hermus L, 2011, CLIN BIOCHEM, V44, P1292, DOI 10.1016/j.clinbiochem.2011.08.1141; Kumada M, 2004, CIRCULATION, V109, P2046, DOI 10.1161/01.CIR.0000127953.98131.ED; Libby P, 2002, SCI AM, V286, P47; LIBBY P, 1995, CIRCULATION, V91, P2844, DOI 10.1161/01.CIR.91.11.2844; Matsuura Y, 2012, J ATHEROSCLER THROMB, V19, P837, DOI 10.5551/jat.12526; MORENO PR, 1994, CIRCULATION, V90, P775, DOI 10.1161/01.CIR.90.2.775; Norata GD, 2010, TRENDS CARDIOVAS MED, V20, P35, DOI 10.1016/j.tcm.2010.03.005; O'Farrell AM, 1998, EMBO J, V17, P1006, DOI 10.1093/emboj/17.4.1006; OBrien KD, 1996, CIRCULATION, V93, P672, DOI 10.1161/01.CIR.93.4.672; Profumo E, 2007, ATHEROSCLEROSIS, V191, P340, DOI 10.1016/j.atherosclerosis.2006.03.030; Ridker PM, 2000, NEW ENGL J MED, V342, P836, DOI 10.1056/NEJM200003233421202; Rolph MS, 2002, ARTERIOSCL THROM VAS, V22, pE10, DOI 10.1161/01.ATV.0000015595.95497.2F; Ross R, 1999, NEW ENGL J MED, V340, P115, DOI 10.1056/NEJM199901143400207; Ryu WS, 2012, ATHEROSCLEROSIS, V220, P581, DOI 10.1016/j.atherosclerosis.2011.11.036; Saam T, 2007, RADIOLOGY, V244, P64, DOI 10.1148/radiol.2441051769; Sakurai S, 2009, J ATHEROSCLER THROMB, V16, P339, DOI 10.5551/jat.No182; Savchenko AS, 2008, J PATHOL, V215, P48, DOI 10.1002/path.2314; Shenhar-Tsarfaty S, 2010, INT J STROKE, V5, P16, DOI 10.1111/j.1747-4949.2009.00396.x; Singh U, 2006, ARTERIOSCL THROM VAS, V26, P2469, DOI 10.1161/01.ATV.0000241572.05292.fb; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; Tanemura H, 2013, STROKE, V44, P105, DOI 10.1161/STROKEAHA.112.663138; TAYLOR DW, 1991, NEW ENGL J MED, V325, P445; Wang JYJ, 2006, CEREBROVASC DIS, V21, P67, DOI 10.1159/000090005; Wozniak SE, 2009, DIGEST DIS SCI, V54, P1847, DOI 10.1007/s10620-008-0585-3; Yadav JS, 2004, NEW ENGL J MED, V351, P1493, DOI 10.1056/NEJMoa040127; Yuan C, 2008, J NUCL CARDIOL, V15, P266, DOI 10.1016/j.nuclcard.2008.02.001	41	61	70	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100045	10.1371/journal.pone.0100045	http://dx.doi.org/10.1371/journal.pone.0100045			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936646	gold, Green Published, Green Submitted			2022-12-27	WOS:000338503400066
J	Tie, RX; Zhang, TS; Fu, HR; Wang, LM; Wang, YB; He, Y; Wang, BS; Zhu, N; Fu, S; Lai, XY; Shi, JM; Huang, H				Tie, Ruxiu; Zhang, Tiansong; Fu, Huarui; Wang, Limengmeng; Wang, Yebo; He, Ying; Wang, Binsheng; Zhu, Ni; Fu, Shan; Lai, Xiaoyu; Shi, Jimin; Huang, He			Association between DNMT3A Mutations and Prognosis of Adults with De Novo Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis	PLOS ONE			English	Article							MICRORNA-EXPRESSION SIGNATURES; ACUTE MYELOGENOUS LEUKEMIA; PUBLICATION BIAS; POOR-PROGNOSIS; OLDER PATIENTS; FUNNEL PLOTS; GENE; IMPACT; CANCER; AML	Background: DNA methyltransferase 3A (DNMT3A) mutations were considered to be independently associated with unfavorable prognosis in adults with de novo acute myeloid leukemia (AML), however, there are still debates on this topic. Here, we aim to further investigate the association between DNMT3A mutations and prognosis of patients with AML. Methods: Eligible studies were identified from several data bases including PubMed, Embase, Web of Science, ClinicalTrials and the Cochrane Library (up to June 2013). The primary endpoint was overall survival (OS), while relapse-free survival (RFS) and event-free survival (EFS) were chosen as secondary endpoints. If possible, we would pool estimate effects (hazard ratio [HR] with 95% confidence interval[CI]) of outcomes in random and fixed effects models respectively. Results: That twelve cohort studies with 6377 patients exploring the potential significance of DNMT3A mutations on prognosis were included. Patients with DNMT3A mutations had slightly shorter OS (HR = 1.60; 95% CI, 1.31-1.95; P < 0.001), as compared to wild-type carriers. Among the patients younger than 60 years of age, DNMT3A mutations predicted a worse OS (HR = 1.84; 95% CI, 1.36-2.50; P < 0.001). In addition, mutant DNMT3A predicted inferior OS (HR = 2.30; 95% CI, 1.78-2.97; P = 0.862) in patients with unfavorable genotype abnormalities. Similar results were also found in some other subgroups. However, no significant prognostic value was found on OS (HR = 1.40; 95% CI, 0.98-1.99; P = 0.798) in the favorable genotype subgroup. Similar results were found on RFS and EFS under different conditions. Conclusions: DNMT3A mutations have slightly but significantly poor prognostic impact on OS, RFS and EFS of adults with de novo AML in total population and some specific subgroups.	[Tie, Ruxiu; Fu, Huarui; Wang, Limengmeng; Wang, Yebo; He, Ying; Wang, Binsheng; Zhu, Ni; Fu, Shan; Lai, Xiaoyu; Shi, Jimin; Huang, He] Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Zhejiang, Peoples R China; [Zhang, Tiansong] Jingan Dist Cent Hosp, Dept TCM, Shanghai, Peoples R China	Zhejiang University	Huang, H (corresponding author), Zhejiang Univ, Sch Med, Affiliated Hosp 1, Bone Marrow Transplantat Ctr, Hangzhou, Zhejiang, Peoples R China.	hehuang.zju@gmail.com	Wang, Limengmeng/U-9989-2019		National Natural Science Foundation of China [81170526]; National Natural Science Foundation for Distinguished Young Scholars of China [81100364]; Zhejiang Province Natural Science Major Foundation [Z2100097]; Zhejiang Province Natural Science Foundation [Y2110152]; Public Welfare Research Subproject from National Ministry of Health [201202017]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation for Distinguished Young Scholars of China(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); Zhejiang Province Natural Science Major Foundation; Zhejiang Province Natural Science Foundation(Natural Science Foundation of Zhejiang Province); Public Welfare Research Subproject from National Ministry of Health	The research article was supported by the National Natural Science Foundation of China (No: 81170526), the National Natural Science Foundation for Distinguished Young Scholars of China (No: 81100364), the Zhejiang Province Natural Science Major Foundation (No: Z2100097), the Zhejiang Province Natural Science Foundation (No: Y2110152) and the Public Welfare Research Subproject from National Ministry of Health (No: 201202017). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abba K, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008122.pub2; Abdel-Wahab O, 2012, HEMATOLOGY, V17, pS39, DOI 10.1179/102453312X13336169155411; Becker H, 2010, BLOOD, V116, P255; Becker H, 2010, J CLIN ONCOL, V28, P596, DOI 10.1200/JCO.2009.25.1496; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Byrd JC, 2002, BLOOD, V100, P4325, DOI 10.1182/blood-2002-03-0772; Cheson BD, 2003, J CLIN ONCOL, V21, P4642, DOI 10.1200/JCO.2003.04.036; Delhommeau F, 2009, NEW ENGL J MED, V360, P2289, DOI 10.1056/NEJMoa0810069; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dohner H, 2010, BLOOD, V115, P453, DOI 10.1182/blood-2009-07-235358; Duval S, 2000, BIOMETRICS, V56, P455, DOI 10.1111/j.0006-341X.2000.00455.x; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Gaidzik VI, 2013, BLOOD, V121, P4769, DOI 10.1182/blood-2012-10-461624; Grimwade D, 1998, BLOOD, V92, P2322, DOI 10.1182/blood.V92.7.2322; Grimwade D, 2010, BLOOD, V116, P354, DOI 10.1182/blood-2009-11-254441; Hou HA, 2012, BLOOD, V119, P559, DOI 10.1182/blood-2011-07-369934; Ley TJ, 2010, NEW ENGL J MED, V363, P2424, DOI 10.1056/NEJMoa1005143; Marcucci G, 2008, J CLIN ONCOL, V26, P5078, DOI 10.1200/JCO.2008.17.5554; Marcucci G, 2012, J CLIN ONCOL, V30, P742, DOI 10.1200/JCO.2011.39.2092; Marcucci G, 2010, J CLIN ONCOL, V28, P2348, DOI 10.1200/JCO.2009.27.3730; Mardis ER, 2009, NEW ENGL J MED, V361, P1058, DOI 10.1056/NEJMoa0903840; Markova J, 2012, EUR J HAEMATOL, V88, P128, DOI 10.1111/j.1600-0609.2011.01716.x; Moreno SG, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2981; Ostronoff F, 2013, LEUKEMIA, V27, P238, DOI 10.1038/leu.2012.168; Palmer TM, 2008, STATA J, V8, P242, DOI 10.1177/1536867X0800800206; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Patel JP, 2012, NEW ENGL J MED, V366, P1079, DOI 10.1056/NEJMoa1112304; Peters JL, 2008, J CLIN EPIDEMIOL, V61, P991, DOI 10.1016/j.jclinepi.2007.11.010; Renneville A, 2012, LEUKEMIA, V26, P1247, DOI 10.1038/leu.2011.382; Ribeiro AFT, 2012, BLOOD, V119, P5824, DOI 10.1182/blood-2011-07-367961; Sattar N, 2010, LANCET, V375, P735, DOI 10.1016/S0140-6736(09)61965-6; Shen Y, 2011, BLOOD, V118, P5593, DOI 10.1182/blood-2011-03-343988; Shivarov V, 2013, LEUKEMIA RES, V37, P1445, DOI 10.1016/j.leukres.2013.07.032; Slovak ML, 2000, BLOOD, V96, P4075, DOI 10.1182/blood.V96.13.4075; Taskesen E, 2011, BLOOD, V117, P2469, DOI 10.1182/blood-2010-09-307280; Thiede C, 2002, BLOOD, V99, P4326, DOI 10.1182/blood.V99.12.4326; Thol F, 2011, J CLIN ONCOL, V29, P2889, DOI 10.1200/JCO.2011.35.4894; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Wells GA, 2014, NEWCASTLE OTTAWA SCA, DOI DOI 10.2307/632432; Whitman SP, 2010, BLOOD, V116, P3622, DOI 10.1182/blood-2010-05-283648; Xu Y, 2012, BLOOD, P120; Yamashita Y, 2010, ONCOGENE, V29, P3723, DOI 10.1038/onc.2010.117; Yan XJ, 2011, NAT GENET, V43, P309, DOI 10.1038/ng.788	44	34	34	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e93353	10.1371/journal.pone.0093353	http://dx.doi.org/10.1371/journal.pone.0093353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936645	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400002
J	Mathieu, NG; Gentaz, E; Harquel, S; Vercueil, L; Chauvin, A; Bonnet, S; Campagne, A				Mathieu, Nicolas Gilles; Gentaz, Edouard; Harquel, Sylvain; Vercueil, Laurent; Chauvin, Alan; Bonnet, Stephane; Campagne, Aurelie			Brain Processing of Emotional Scenes in Aging: Effect of Arousal and Affective Context	PLOS ONE			English	Article							AGE-RELATED DIFFERENCES; NEGATIVITY BIAS; OLDER-ADULTS; ATTENTION; MEMORY; YOUNGER; INFORMATION; MODULATION; COGNITION; PICTURES	Research on emotion showed an increase, with age, in prevalence of positive information relative to negative ones. This effect is called positivity effect. From the cerebral analysis of the Late Positive Potential (LPP), sensitive to attention, our study investigated to which extent the arousal level of negative scenes is differently processed between young and older adults and, to which extent the arousal level of negative scenes, depending on its value, may contextually modulate the cerebral processing of positive (and neutral) scenes and favor the observation of a positivity effect with age. With this aim, two negative scene groups characterized by two distinct arousal levels (high and low) were displayed into two separate experimental blocks in which were included positive and neutral pictures. The two blocks only differed by their negative pictures across participants, as to create two negative global contexts for the processing of the positive and neutral pictures. The results show that the relative processing of different arousal levels of negative stimuli, reflected by LPP, appears similar between the two age groups. However, a lower activity for negative stimuli is observed with the older group for both tested arousal levels. The processing of positive information seems to be preserved with age and is also not contextually impacted by negative stimuli in both younger and older adults. For neutral stimuli, a significantly reduced activity is observed for older adults in the contextual block of low-arousal negative stimuli. Globally, our study reveals that the positivity effect is mainly due to a modulation, with age, in processing of negative stimuli, regardless of their arousal level. It also suggests that processing of neutral stimuli may be modulated with age, depending on negative context in which they are presented to. These age-related effects could contribute to justify the differences in emotional preference with age.	[Mathieu, Nicolas Gilles; Gentaz, Edouard; Harquel, Sylvain; Chauvin, Alan; Bonnet, Stephane; Campagne, Aurelie] Univ Grenoble Alpes, Lab Psychol & Neurocognit LPNC, Grenoble, France; [Mathieu, Nicolas Gilles; Gentaz, Edouard; Harquel, Sylvain; Chauvin, Alan; Campagne, Aurelie] CNRS, LPNC, Grenoble, France; [Gentaz, Edouard] Univ Geneva, Fac Psychol & Sci Educ, CH-1211 Geneva 4, Switzerland; [Harquel, Sylvain] Univ Grenoble Alpes, IRMaGe, Grenoble, France; [Harquel, Sylvain] CNRS, UMR3552, Grenoble, France; [Harquel, Sylvain] INSERM, US17, Grenoble, France; [Harquel, Sylvain] CHU Grenoble, IRMaGe, F-38043 Grenoble, France; [Vercueil, Laurent] Univ Grenoble Alpes, CHU Grenoble, SEFSN, Grenoble, France; [Vercueil, Laurent] Univ Grenoble Alpes, GIN, Grenoble, France; [Vercueil, Laurent] INSERM, GIN, Grenoble, France; [Vercueil, Laurent] CHU Grenoble, GIN, F-38043 Grenoble, France; [Bonnet, Stephane] Univ Grenoble Alpes, Leti, Grenoble, France; [Bonnet, Stephane] Commissariat Energie Atom & Energies Alternat, Leti, Grenoble, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); University of Geneva; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); CEA; Centre National de la Recherche Scientifique (CNRS); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CEA	Mathieu, NG (corresponding author), Univ Grenoble Alpes, Lab Psychol & Neurocognit LPNC, Grenoble, France.	nicolas.mathieu@gmail.com; campagne.aurelie@upmf-grenoble.fr	Chauvin, Alan/AAJ-8531-2020; Chauvin, Alan/D-2731-2012; VERCUEIL, Laurent/AAN-2941-2021	Chauvin, Alan/0000-0002-6498-2766; Chauvin, Alan/0000-0002-6498-2766; VERCUEIL, Laurent/0000-0003-3323-0091	MINATEC IDEAs Laboratory, CEA-Leti MINATEC; French program "Investissement d'Avenir" run by the 'Agence Nationale pour la Recherche' [ANR-11-INBS-0006]	MINATEC IDEAs Laboratory, CEA-Leti MINATEC; French program "Investissement d'Avenir" run by the 'Agence Nationale pour la Recherche'(French National Research Agency (ANR))	This study was funded by MINATEC IDEAs Laboratory, CEA-Leti MINATEC and, partly, by the French program "Investissement d'Avenir" run by the 'Agence Nationale pour la Recherche'; grant 'Infrastructure d'avenir en Biologie Sante - ANR-11-INBS-0006. The funders had no role in study design, data collection and analysis, or decision to publish, or preparation of the manuscript.	BARGH JA, 1992, J PERS SOC PSYCHOL, V62, P893, DOI 10.1037/0022-3514.62.6.893; Bradley MA, 2003, BEHAV NEUROSCI, V117, P369, DOI 10.1037/0735-7044.117.2.369; Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; Briggs KE, 2008, BIOL PSYCHOL, V78, P29, DOI 10.1016/j.biopsycho.2007.12.007; BRUCE V, 1986, Q J EXP PSYCHOL-A, V38, P125, DOI 10.1080/14640748608401588; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Cacioppo JT., 2011, SOCIAL NEUROSCIENCE, P249, DOI [DOI 10.1093/ACPROF:OSO/9780195316872.003.0017, 10.1093/acprof:oso/9780195316872.003.0017]; Carstensen LL, 2003, MOTIV EMOTION, V27, P103, DOI 10.1023/A:1024569803230; Carstensen LL, 1999, AM PSYCHOL, V54, P165, DOI 10.1037/0003-066X.54.3.165; Charles ST, 2001, J PERS SOC PSYCHOL, V80, P136, DOI 10.1037//0022-3514.80.1.136; Charles ST, 2003, J EXP PSYCHOL GEN, V132, P310, DOI 10.1037/0096-3445.132.2.310; Charles ST, 2010, PSYCHOL BULL, V136, P1068, DOI 10.1037/a0021232; Cunningham J, 2007, EVID BASED MIDWIFERY; De Cesarei A, 2011, PSYCHOPHYSIOLOGY, V48, P1397, DOI 10.1111/j.1469-8986.2011.01204.x; Dolan RJ, 2002, SCIENCE, V298, P1191, DOI 10.1126/science.1076358; Erdfelder E, 1996, BEHAV RES METH INS C, V28, P1, DOI 10.3758/BF03203630; Ferrari V, 2008, J COGNITIVE NEUROSCI, V20, P1753, DOI 10.1162/jocn.2008.20121; Ferrari V, 2011, PSYCHOPHYSIOLOGY, V48, P515, DOI 10.1111/j.1469-8986.2010.01083.x; Gruhn D, 2008, BEHAV RES METHODS, V40, P512, DOI 10.3758/BRM.40.2.512; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Isaacowitz DM, 2008, PSYCHOL SCI, V19, P848, DOI 10.1111/j.1467-9280.2008.02167.x; Isaacowitz DM, 2009, PSYCHOL AGING, V24, P989, DOI 10.1037/a0017706; Isaacowitz DM, 2006, PSYCHOL AGING, V21, P40, DOI 10.1037/0882-7974.21.1.40; Ito TA, 2005, COGNITION EMOTION, V19, P1, DOI 10.1080/02699930441000120; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Keil A, 2009, PSYCHOL AGING, V24, P668, DOI 10.1037/a0016969; Kensinger EA, 2008, J GERONTOL B-PSYCHOL, V63, pP13, DOI 10.1093/geronb/63.1.P13; Kisley MA, 2007, PSYCHOL SCI, V18, P838, DOI 10.1111/j.1467-9280.2007.01988.x; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; Knight M, 2007, EMOTION, V7, P705, DOI 10.1037/1528-3542.7.4.705; Labouvie-Vief G, 2003, CURR DIR PSYCHOL SCI, V12, P201, DOI 10.1046/j.0963-7214.2003.01262.x; Langeslag SJE, 2010, J PSYCHOPHYSIOL, V24, P186, DOI 10.1027/0269-8803/a000009; Langeslag SJE, 2009, EMOTION, V9, P369, DOI 10.1037/a0015356; Langeslag SJE, 2008, INT J PSYCHOPHYSIOL, V70, P105, DOI 10.1016/j.ijpsycho.2008.07.022; Leclerc CM, 2008, PSYCHOL AGING, V23, P209, DOI 10.1037/0882-7974.23.1.209; Leclerc CM, 2011, DEV NEUROPSYCHOL, V36, P519, DOI 10.1080/87565641.2010.549864; LEDOUX JE, 1995, ANNU REV PSYCHOL, V46, P209, DOI 10.1146/annurev.ps.46.020195.001233; Madden DJ, 2004, CEREB CORTEX, V14, P143, DOI 10.1093/cercor/bhg113; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mather M, 2004, PSYCHOL SCI, V15, P259, DOI 10.1111/j.0956-7976.2004.00662.x; Mather M, 2006, J GERONTOL B-PSYCHOL, V61, pP54, DOI 10.1093/geronb/61.1.P54; Mather M, 2005, J EXP PSYCHOL GEN, V134, P38, DOI 10.1037/0096-3445.134.1.38; Mather M, 2003, PSYCHOL SCI, V12, P761, DOI [10.1023/B:TRAG.0000005082.29212.cf, DOI 10.1023/B:TRAG.0000005082.29212.CF]; Mikels JA, 2005, PSYCHOL AGING, V20, P542, DOI 10.1037/0882-7974.20.4.542; Mroczek DK, 1998, J PERS SOC PSYCHOL, V75, P1333, DOI 10.1037/0022-3514.75.5.1333; Murphy NA, 2008, PSYCHOL AGING, V23, P263, DOI 10.1037/0882-7974.23.2.263; Nashiro K, 2012, GERONTOLOGY, V58, P156, DOI 10.1159/000328465; Olofsson JK, 2008, BIOL PSYCHOL, V77, P247, DOI 10.1016/j.biopsycho.2007.11.006; Oostenveld R, 2001, CLIN NEUROPHYSIOL, V112, P713, DOI 10.1016/S1388-2457(00)00527-7; Perrien J, 1997, ADV CONSUM RES, V24, P267; Reed AE, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00339; Rosler A, 2005, J NEUROL SCI, V229, P109, DOI 10.1016/j.jns.2004.11.007; Rozin P, 2001, PERS SOC PSYCHOL REV, V5, P296, DOI 10.1207/S15327957PSPR0504_2; Salthouse TA, 1996, PSYCHOL REV, V103, P403, DOI 10.1037/0033-295X.103.3.403; Samanez-Larkin G. R., 2011, OXFORD HDB SOCIAL NE, P507, DOI DOI 10.1093/OXFORDHB/9780195342161.013.0034; Samanez-Larkin GR, 2011, ANN NY ACAD SCI, V1235, pV, DOI 10.1111/j.1749-6632.2011.06252.x; Scheibe S, 2010, J GERONTOL B-PSYCHOL, V65, P135, DOI 10.1093/geronb/gbp132; Schupp HT, 2006, PROG BRAIN RES, V156, P31, DOI 10.1016/S0079-6123(06)56002-9; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Smith NK, 2006, J PERS SOC PSYCHOL, V90, P210, DOI 10.1037/0022-3514.90.2.210; St Jacques PL, 2009, PSYCHOL SCI, V20, P74, DOI 10.1111/j.1467-9280.2008.02258.x; Streubel B, 2011, PSYCHOL AGING, V26, P966, DOI 10.1037/a0023424; System IAPS, 1997, INT AFFECTIVE PICTUR; Wieser MJ, 2006, BRAIN RES, V1096, P138, DOI 10.1016/j.brainres.2006.04.028; Williams LM, 2006, J NEUROSCI, V26, P6422, DOI 10.1523/JNEUROSCI.0022-06.2006; Wood S, 2006, PSYCHOL AGING, V21, P815, DOI 10.1037/0882-7974.21.4.815; Zhang Q, 2012, BRAIN RES, V1474, P60, DOI 10.1016/j.brainres.2012.07.023	68	15	16	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99523	10.1371/journal.pone.0099523	http://dx.doi.org/10.1371/journal.pone.0099523			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ5PV	24932857	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600038
J	Lim, HC; Adie, S; Naylor, JM; Harris, IA				Lim, Hyeung C.; Adie, Sam; Naylor, Justine M.; Harris, Ian A.			Randomised Trial Support for Orthopaedic Surgical Procedures	PLOS ONE			English	Article							EVIDENCE-BASED MEDICINE; EMPIRICAL-EVIDENCE; PEDIATRIC-SURGERY; QUALITY; INTERVENTIONS; JOURNALS; BIAS; OUTCOMES; IMPACT	We investigated the proportion of orthopaedic procedures supported by evidence from randomised controlled trials comparing operative procedures to a non-operative alternative. Orthopaedic procedures conducted in 2009, 2010 and 2011 across three metropolitan teaching hospitals were identified, grouped and ranked according to frequency. Searches of the Cochrane Central Register of Controlled Trials (CENTRAL), the Cochrane Database of Systematic Reviews (CDSR) and the Database of Abstracts of Reviews of Effects (DARE) were performed to identify RCTs evaluating the most commonly performed orthopaedic procedures. Included studies were categorised as "supportive'' or "not supportive'' of operative treatment. A risk of bias analysis was conducted for included studies using the Cochrane Collaboration's Risk of Bias tool. A total of 9,392 orthopaedic procedures were performed across the index period. 94.6% (8886 procedures) of the total volume, representing the 32 most common operative procedure categories, were used for this analysis. Of the 83 included RCTs, 22.9% (19/83) were classified as supportive of operative intervention. 36.9% (3279/8886) of the total volume of procedures performed were supported by at least one RCT showing surgery to be superior to a non-operative alternative. 19.6% (1743/8886) of the total volume of procedures performed were supported by at least one low risk of bias RCT showing surgery to be superior to a non-operative alternative. The level of RCT support for common orthopaedic procedures compares unfavourably with other fields of medicine.	[Lim, Hyeung C.; Adie, Sam; Naylor, Justine M.; Harris, Ian A.] Ingham Inst Appl Med Res, Whitlam Orthopaed Res Ctr, Liverpool, Australia; [Adie, Sam; Naylor, Justine M.; Harris, Ian A.] Univ New S Wales, Liverpool Hosp, South Western Sydney Clin Sch, Liverpool, Australia; [Naylor, Justine M.; Harris, Ian A.] Liverpool Hosp, South Western Sydney Local Hlth Dist, Liverpool, Australia	Ingham Institute for Applied Medical Research; Liverpool Hospital; University of New South Wales Sydney; Liverpool Hospital	Lim, HC (corresponding author), Ingham Inst Appl Med Res, Whitlam Orthopaed Res Ctr, Liverpool, Australia.	chadhclim@gmail.com	Naylor, Justine/R-8459-2019	Naylor, Justine/0000-0002-9147-1312; Adie, Sam/0000-0003-0780-4338				[Anonymous], 1995, JAMA-J AM MED ASSOC, V273, P1421; Avery KN, 2013, LANCET, V381, P27, DOI 10.1016/S0140-6736(13)60015-X; Baraldini V, 1998, PEDIATR SURG INT, V13, P331, DOI 10.1007/s003830050332; Concato J, 2000, NEW ENGL J MED, V342, P1887, DOI 10.1056/NEJM200006223422507; Cook Jonathan A, 2004, Clin Trials, V1, P421, DOI 10.1191/1740774504cn042oa; Cook JA, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-9; Crowther H, 2011, J EVAL CLIN PRACT, V17, P868, DOI 10.1111/j.1365-2753.2011.01723.x; Dickersin K, 2002, EVAL HEALTH PROF, V25, P38, DOI 10.1177/0163278702025001004; ELLIS J, 1995, LANCET, V346, P407, DOI 10.1016/S0140-6736(95)92781-6; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Ghosh A K, 2007, J Assoc Physicians India, V55, P787; Hamilton D, 2012, POSTGRAD MED J, V88, P627, DOI 10.1136/postgradmedj-2011-130715; Hardin WD, 1999, J PEDIATR SURG, V34, P908, DOI 10.1016/S0022-3468(99)90396-2; Higgins JPT, 2009, COCHRANE HDB SYSTEMA; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Horton R, 1996, LANCET, V347, P984, DOI 10.1016/S0140-6736(96)90137-3; Howes N, 1997, BRIT J SURG, V84, P1220; Katz P, 1999, SCAPELS EDGE CULTURE; Kenny SE, 1997, ARCH DIS CHILD, V76, P50, DOI 10.1136/adc.76.1.50; Kiter E, 2003, ARCH ORTHOP TRAUM SU, V123, P82, DOI 10.1007/s00402-003-0501-4; Kjaergard LL, 2001, ANN INTERN MED, V135, P982, DOI 10.7326/0003-4819-135-11-200112040-00010; Ko CY, 2002, DIS COLON RECTUM, V45, P443, DOI 10.1007/s10350-004-6217-x; Lochner HV, 2001, J BONE JOINT SURG AM, V83A, P1650, DOI 10.2106/00004623-200111000-00005; Mann M, 2008, ANN SURG, V247, P217, DOI 10.1097/SLA.0b013e3181568e26; MCARDLE CS, 1991, BRIT MED J, V302, P1501, DOI 10.1136/bmj.302.6791.1501; McCulloch P, 2002, BRIT MED J, V324, P1448, DOI 10.1136/bmj.324.7351.1448; Michaud G, 1998, ARCH INTERN MED, V158, P1665, DOI 10.1001/archinte.158.15.1665; Obremskey WT, 2005, J BONE JOINT SURG AM, V87A, P2632, DOI 10.2106/JBJS.E.00370; Pildal J, 2007, INT J EPIDEMIOL, V36, P847, DOI 10.1093/ije/dym087; Sackett DL, 1996, BRIT MED J, V312, P71, DOI 10.1136/bmj.312.7023.71; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Schulz KF, 2002, LANCET, V359, P515, DOI 10.1016/S0140-6736(02)07683-3; SOLOMON MJ, 1993, DIS COLON RECTUM, V36, P43, DOI 10.1007/BF02050300; STIRRAT GM, 1992, ANN ROY COLL SURG, V74, P80; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD	35	20	21	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e96745	10.1371/journal.pone.0096745	http://dx.doi.org/10.1371/journal.pone.0096745			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927114	Green Submitted, gold, Green Published			2022-12-27	WOS:000338278100004
J	Wang, ND; Rizvydeen, S; Vahedi, M; Gonzalez, DMV; Allred, AL; Perry, DW; Mirabito, PM; Kirk, KE				Wang, Nengding; Rizvydeen, Saajidha; Vahedi, Mithaq; Gonzalez, Daysi M. Vargas; Allred, Amanda L.; Perry, Dustin W.; Mirabito, Peter M.; Kirk, Karen E.			Novel Telomere-Anchored PCR Approach for Studying Sexual Stage Telomeres in Aspergillus nidulans	PLOS ONE			English	Article							CHROMOSOME ENDS; MEIOTIC SPINDLE; LENGTH; LOOPS; ORGANIZATION; NUCLEOTIDES; GENERATION; SEQUENCE; COMPLEX; ORYZAE	Telomere length varies between germline and somatic cells of the same organism, leading to the hypothesis that telomeres are lengthened during meiosis. However, little is known about the meiotic telomere length in many organisms. In the filamentous fungus Aspergillus nidulans, the telomere lengths in hyphae and asexual spores are invariant. No study using existing techniques has determined the telomere length of the sexual ascospores due to the relatively low abundance of pure meiotic cells in A. nidulans and the small quantity of DNA present. To address this, we developed a simple and sensitive PCR strategy to measure the telomere length of A. nidulans meiotic cells. This novel technique, termed "telomere-anchored PCR,'' measures the length of the telomere on chromosome II-L using a small fraction of the DNA required for the traditional terminal restriction fragment (TRF) Southern analysis. Using this approach, we determined that the A. nidulans ascospore telomere length is virtually identical to telomeres of other cell types from this organism, approximately 110 bp, indicating that a surprisingly strict telomere length regulation exists in the major cell types of A. nidulans. When the hyphal telomeres were measured in a telomerase reverse transcriptase (TERT) knockout strain, small decreases in length were readily detected. Thus, this technique can detect telomeres in relatively rare cell types and is particularly sensitive in measuring exceptionally short telomeres. This rapid and inexpensive telomere-anchored PCR method potentially can be utilized in other filamentous fungi and types of organisms.	[Wang, Nengding; Rizvydeen, Saajidha; Vahedi, Mithaq; Gonzalez, Daysi M. Vargas; Allred, Amanda L.; Kirk, Karen E.] Lake Forest Coll, Dept Biol, Lake Forest, IL 60045 USA; [Perry, Dustin W.; Mirabito, Peter M.] Univ Kentucky, Dept Biol, Lexington, KY USA	University of Kentucky	Kirk, KE (corresponding author), Lake Forest Coll, Dept Biol, Lake Forest, IL 60045 USA.	kirk@lakeforest.edu			National Science Foundation [MCB 0950957]; Direct For Biological Sciences [0950957] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by a grant from the National Science Foundation (nsf.gov) MCB 0950957 to Karen E. Kirk. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aubert G, 2008, PHYSIOL REV, V88, P557, DOI 10.1152/physrev.00026.2007; Baird DM, 2005, EXP GERONTOL, V40, P363, DOI 10.1016/j.exger.2005.02.008; Baird DM, 2003, NAT GENET, V33, P203, DOI 10.1038/ng1084; BARRATT RW, 1965, GENETICS, V52, P233; Baumann P, 2010, FEBS LETT, V584, P3779, DOI 10.1016/j.febslet.2010.05.024; Bekaert S, 2004, DEV BIOL, V274, P15, DOI 10.1016/j.ydbio.2004.06.023; Bhattacharyya A, 1997, NUCLEIC ACIDS RES, V25, P1426, DOI 10.1093/nar/25.7.1426; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Cesare AJ, 2008, MOL CELL BIOL, V28, P20, DOI 10.1128/MCB.01122-07; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; DELANGE T, 1990, MOL CELL BIOL, V10, P518, DOI 10.1128/MCB.10.2.518; Ferreira MG, 2004, MOL CELL, V13, P7, DOI 10.1016/S1097-2765(03)00531-8; Forstemann K, 2000, NUCLEIC ACIDS RES, V28, P2690, DOI 10.1093/nar/28.14.2690; Friedman KL, 2003, MOL BIOL CELL, V14, P1, DOI 10.1091/mbc.E02-06-0327; Griffith JD, 1999, CELL, V97, P503, DOI 10.1016/S0092-8674(00)80760-6; Heacock M, 2004, EMBO J, V23, P2304, DOI 10.1038/sj.emboj.7600236; Jacob NK, 2003, MOL CELL, V11, P1021, DOI 10.1016/S1097-2765(03)00131-X; Jain D, 2010, ANNU REV GENET, V44, P243, DOI 10.1146/annurev-genet-102108-134841; Keefe DL, 2006, CURR OPIN OBSTET GYN, V18, P280, DOI 10.1097/01.gco.0000193019.05686.49; KIRK KE, 1995, GENE DEV, V9, P59, DOI 10.1101/gad.9.1.59; Kuprys PV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058661; Kusumoto KI, 2003, APPL MICROBIOL BIOT, V61, P247, DOI 10.1007/s00253-002-1193-3; Lin KW, 2005, J CELL MOL MED, V9, P977, DOI 10.1111/j.1582-4934.2005.tb00395.x; Maniatis T., 1982, MOL CLONING; Murti KG, 1999, P NATL ACAD SCI USA, V96, P14436, DOI 10.1073/pnas.96.25.14436; Nayak T, 2006, GENETICS, V172, P1557, DOI 10.1534/genetics.105.052563; Osmani AH, 2006, NAT PROTOC, V1, P2517, DOI 10.1038/nprot.2006.406; Pitt CW, 2004, J CELL SCI, V117, P199, DOI 10.1242/jcs.00844; Qi XD, 2013, NUCLEIC ACIDS RES, V41, P450, DOI 10.1093/nar/gks980; Rehmeyer C, 2006, NUCLEIC ACIDS RES, V34, P4685, DOI 10.1093/nar/gkl588; Saint-Andre CD, 2008, BIOCHIMIE, V90, P181, DOI 10.1016/j.biochi.2007.08.0; Sanchez-Alonso P, 2008, FUNGAL GENET BIOL, V45, pS54, DOI 10.1016/j.fgb.2008.04.009; Schaetzlein S, 2004, P NATL ACAD SCI USA, V101, P8034, DOI 10.1073/pnas.0402400101; Sfeir AJ, 2005, CELL CYCLE, V4, P1467, DOI 10.4161/cc.4.11.2161; Sfeir AJ, 2005, MOL CELL, V18, P131, DOI 10.1016/j.molcel.2005.02.035; Siderakis M, 2007, CHROMOSOME RES, V15, P667, DOI 10.1007/s10577-007-1149-7; Todd RB, 2007, NAT PROTOC, V2, P811, DOI 10.1038/nprot.2007.112; Tomita K, 2007, CELL, V130, P113, DOI 10.1016/j.cell.2007.05.024; Tomita K, 2013, EMBO REP, V14, P252, DOI 10.1038/embor.2012.218; Wei C, 2003, CELL MOL LIFE SCI, V60, P2283, DOI 10.1007/s00018-003-3244-z; Wu C, 2009, GENETICS, V181, P1129, DOI 10.1534/genetics.107.084392; Yang L, 2004, EUKARYOT CELL, V3, P1359, DOI 10.1128/EC.3.5.1359-1362.2004	42	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99491	10.1371/journal.pone.0099491	http://dx.doi.org/10.1371/journal.pone.0099491			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927411	gold, Green Published			2022-12-27	WOS:000338278100046
J	Fu, WJ; Zhang, X; Zhang, XY; Zhang, P; Gao, JP; Dong, J; Chen, GF; Xu, AX; Ma, X; Li, HZ; Shi, LX				Fu, Weijun; Zhang, Xu; Zhang, Xiaoyi; Zhang, Peng; Gao, Jiangping; Dong, Jun; Chen, Guangfu; Xu, Axiang; Ma, Xin; Li, Hongzhao; Shi, Lixin			Pure Laparoscopic and Robot-Assisted Laparoscopic Reconstructive Surgery in Congenital Megaureter: A Single Institution Experience	PLOS ONE			English	Article							PRIMARY OBSTRUCTIVE MEGAURETER; URETERAL REIMPLANTATION; URETERONEOCYSTOSTOMY; ADULTS; HITCH	To report our experience of pure laparoscopic and robot-assisted laparoscopic reconstructive surgery in congenital megaureter, seven patients (one bilateral) with symptomatic congenital megaureter underwent pure laparoscopic or robot-assisted laparoscopic surgery. The megaureter was exposed at the level of the blood vessel and was isolated to the bladder narrow area. Extreme ureter trim and submucosal tunnel encapsulation or papillary implantations and anti-reflux ureter bladder anastomosis were performed intraperitoneally by pure laparoscopic or robot-assisted laparoscopic surgery. The clinical data of seven patients after operation were analyzed, including the operation time, intraoperative complications, intraoperative bleeding volumes, postoperative complications, postoperative hospitalization time and pathological results. All of the patients were followed. The operation was successfully performed in seven patients. The mean operation times for pure laparoscopic surgery and robotic-assistant laparoscopic surgery were 175 (range: 150-220) and 187 (range: 170-205) min, respectively, and the mean operative blood loss volumes were 20 (range: 10-30) and 28.75 (range: 15-20) ml, respectively. There were no intraoperative complications. The postoperative drainage time was 5 (range: 4-6) and 5.75 (range: 5-6) d, respectively, and the indwelling catheter time was 6.33 (range: 4-8) d and 7 (range: 7-7) d, respectively. The postoperative hospitalization time was 7.67 (range: 7-8) d and 8 (range: 7-10) d, respectively. There was no obvious pain, no secondary bleeding and no urine leakage after the operation. Postoperative pathology reports revealed chronic urothelial mucosa inflammation. The follow-up results confirmed that all patients were relieved of their symptoms. Both pure laparoscopic and robot-assisted laparoscopic surgery using different anti-reflux ureter bladder anastomoses are safe and effective approaches in the minimally invasive treatment of congenital megaureter.	[Fu, Weijun; Zhang, Xu; Zhang, Peng; Gao, Jiangping; Dong, Jun; Chen, Guangfu; Xu, Axiang; Ma, Xin; Li, Hongzhao; Shi, Lixin] Peoples Liberat Army Gen Hosp, Sch Med, Dept Urol, Beijing, Peoples R China; [Zhang, Xiaoyi] PLA, Artillery Gen Hosp 2, Dept Urol, Beijing, Peoples R China	Chinese People's Liberation Army General Hospital	Fu, WJ (corresponding author), Peoples Liberat Army Gen Hosp, Sch Med, Dept Urol, Beijing, Peoples R China.	fuweijun68@hotmail.com; xuzhang@foxmail.com			National High Technology Research and Development Program ("863" Program) of China [2012AA021100]	National High Technology Research and Development Program ("863" Program) of China(National High Technology Research and Development Program of China)	This work was supported by the National High Technology Research and Development Program ("863" Program) of China (NO. 2012AA021100). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham GP, 2012, J ENDOUROL, V26, P1187, DOI 10.1089/end.2012.0039; ALSHUKRI S, 1983, BRIT J UROL, V55, P477, DOI 10.1111/j.1464-410X.1983.tb03352.x; Bapat S, 2000, J ENDOUROL, V14, P263, DOI 10.1089/end.2000.14.263; Biyani CS, 2001, J ENDOUROL, V15, P797, DOI 10.1089/089277901753205771; Chung H, 2006, J ENDOUROL, V20, P632, DOI 10.1089/end.2006.20.632; Dorairajan L. N., 1999, International Urology and Nephrology, V31, P633, DOI 10.1023/A:1007104404287; Hemal AK, 2003, UROLOGY, V61, P703, DOI 10.1016/S0090-4295(02)02590-6; Hemal AK, 2009, J ENDOUROL, V23, P2041, DOI 10.1089/end.2009.0103; Mufarrij PW, 2008, J UROLOGY, V180, P1391, DOI 10.1016/j.juro.2008.06.024; Patil NN, 2008, UROLOGY, V72, P47, DOI 10.1016/j.urology.2007.12.097; Schimpf MO, 2009, JSLS-J SOC LAPAROEND, V13, P44; Shokeir AA, 2000, BJU INT, V86, P861, DOI 10.1046/j.1464-410x.2000.00922.x; Tatlisen A, 2005, J UROLOGY, V173, P877, DOI 10.1097/01.ju.0000152533.93716.3c; Thiel DD, 2008, J ENDOUROL, V22, P2667, DOI 10.1089/end.2008.9692	14	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99777	10.1371/journal.pone.0099777	http://dx.doi.org/10.1371/journal.pone.0099777			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924420	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300093
J	Gu, JN; Bakke, AM; Valen, EC; Lein, I; Krogdahl, A				Gu, Jinni; Bakke, Anne Marie; Valen, Elin C.; Lein, Ingrid; Krogdahl, Ashild			Bt-maize (MON810) and Non-GM Soybean Meal in Diets for Atlantic Salmon (Salmo salar L.) Juveniles - Impact on Survival, Growth Performance, Development, Digestive Function, and Transcriptional Expression of Intestinal Immune and Stress Responses	PLOS ONE			English	Article							GENETICALLY-MODIFIED MAIZE; THURINGIENSIS INSECTICIDAL TOXIN; MEDIUM-CHAIN TRIGLYCERIDES; 90-DAY SAFETY ASSURANCE; ZEBRAFISH DANIO-RERIO; RATS FED GRAIN; BACILLUS-THURINGIENSIS; GENE-EXPRESSION; TRANSGENIC EXPRESSION; INDUCED ENTERITIS	Responses in Atlantic salmon (Salmo salar L.) juveniles (fry) fed diets containing genetically modified maize (Bt-maize, MON810) expressing Cry1Ab protein from first-feeding were investigated during a 99-day feeding trial. Four experimental diets were made; each diet contained, similar to 20% maize, either Bt-maize or its near-isogenic maternal line (non-GM maize). One pair was fishmeal-based while the other pair included standard (extracted) soybean meal (SBM; 16.7% inclusion level), with the intention of investigating responses to the maize varieties in healthy fish as well as in immunologically challenged fish with SBM-induced distal intestinal inflammation, respectively. Three replicate tanks of fry (0.17 +/- 0.01 g; initial mean weight +/- SEM) were fed one of the four diets and samples were taken on days 15, 36, 48 and 99. Survival, growth performance, whole body composition, digestive function, morphology of intestine, liver and skeleton, and mRNA expression of some immune and stress response parameters in the distal intestine were evaluated. After 99 days of feeding, survival was enhanced and the intended SBM-induced inflammatory response in the distal intestine of the two groups of SBM-fed fish was absent, indicating that the juvenile salmon were tolerant to SBM. Mortality, growth performance and body composition were similar in fish fed the two maize varieties. The Bt-maize fed fish, however, displayed minor but significantly decreased digestive enzyme activities of leucine aminopeptidase and maltase, as well as decreased concentration of gut bile salts, but significantly increased amylase activity at some sampling points. Histomorphological, radiographic and mRNA expression evaluations did not reveal any biologically relevant effects of Bt-maize in the gastrointestinal tract, liver or skeleton. The results suggest that the Cry1Ab protein or other compositional differences in GM Bt-maize may cause minor alterations in intestinal responses in juvenile salmon, but without affecting overall survival, growth performance, development or health.	[Gu, Jinni; Bakke, Anne Marie; Valen, Elin C.; Krogdahl, Ashild] Norwegian Univ Life Sci NMBU, NMBU Sch Vet Med, Dept Basic Sci & Aquat Med, Oslo, Norway; [Lein, Ingrid] Nofima AS, Sunndalsora, Norway	Norwegian University of Life Sciences; Nofima	Bakke, AM (corresponding author), Norwegian Univ Life Sci NMBU, NMBU Sch Vet Med, Dept Basic Sci & Aquat Med, Oslo, Norway.	annemarie.bakke@nmbu.no			European Union Seventh Framework Programme grant "Biomarkers for post market monitoring of short and long-term effects of genetically modified organisms on animal and human health'' (GMSAFOOD) [211820]; Research Council of Norway's Centre of Excellence (CoE) "Aquaculture Protein Centre'' (APC) [145949/120]	European Union Seventh Framework Programme grant "Biomarkers for post market monitoring of short and long-term effects of genetically modified organisms on animal and human health'' (GMSAFOOD); Research Council of Norway's Centre of Excellence (CoE) "Aquaculture Protein Centre'' (APC)	The study was financed by a European Union Seventh Framework Programme grant "Biomarkers for post market monitoring of short and long-term effects of genetically modified organisms on animal and human health'' (GMSAFOOD, grant no. 211820) and the Research Council of Norway's Centre of Excellence (CoE) "Aquaculture Protein Centre'' (APC, grant no. 145949/120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baeverfjord G, 1996, J FISH DIS, V19, P375, DOI 10.1111/j.1365-2761.1996.tb00376.x; Bakke-McKellep AM, 2008, RES VET SCI, V84, P395, DOI 10.1016/j.rvsc.2007.06.008; Bakke-McKellep AM, 2007, J FISH DIS, V30, P13, DOI 10.1111/j.1365-2761.2007.00769.x; Bakke-McKellep AM, 2007, J FISH DIS, V30, P65, DOI 10.1111/j.1365-2761.2007.00782.x; Bakke-McKellep AM, 2000, J FISH DIS, V23, P115, DOI 10.1046/j.1365-2761.2000.00218.x; Brake DG, 2004, J AGR FOOD CHEM, V52, P2097, DOI 10.1021/jf0347362; Bravo A, 2007, TOXICON, V49, P423, DOI 10.1016/j.toxicon.2006.11.022; Burton SL, 1999, J MOL BIOL, V287, P1011, DOI 10.1006/jmbi.1999.2649; Buzoianu SG, 2013, J ANIM SCI, V91, P318, DOI 10.2527/jas.2012-5360; Campbell PM, 2011, J AGR FOOD CHEM, V59, P6047, DOI 10.1021/jf200456j; Chen W, 2011, AQUACULTURE, V318, P95, DOI 10.1016/j.aquaculture.2011.04.050; Chikwati EM, 2012, BRIT J NUTR, V107, P1570, DOI 10.1017/S0007114511004892; Chowdhury EH, 2003, VET HUM TOXICOL, V45, P95; Chowdhury EH, 2003, J ANIM SCI, V81, P2546; Finamore A, 2008, J AGR FOOD CHEM, V56, P11533, DOI 10.1021/jf802059w; Francis G, 2002, AQUACULTURE, V203, P311, DOI 10.1016/S0044-8486(01)00628-7; Francis G, 2001, COMP BIOCHEM PHYS C, V129, P105, DOI 10.1016/S1532-0456(01)00189-2; Froystad-Saugen MK, 2009, AQUACULT NUTR, V15, P104, DOI 10.1111/j.1365-2095.2008.00572.x; Gu JN, 2013, BRIT J NUTR, V109, P1408, DOI 10.1017/S000711451200325X; Guerrero GG, 2007, MOL IMMUNOL, V44, P1209, DOI 10.1016/j.molimm.2006.06.007; Guimaraes V, 2010, J AGR FOOD CHEM, V58, P3222, DOI 10.1021/jf903189j; Hammond B, 2006, FOOD CHEM TOXICOL, V44, P147, DOI 10.1016/j.fct.2005.06.008; Hammond BG, 2006, FOOD CHEM TOXICOL, V44, P1092, DOI 10.1016/j.fct.2006.01.003; Hemre GI, 2007, AQUACULT NUTR, V13, P186, DOI 10.1111/j.1365-2095.2007.00465.x; KAKADE ML, 1973, J NUTR, V103, P1772, DOI 10.1093/jn/103.12.1772; KNOWLES BH, 1994, ADV INSECT PHYSIOL, V24, P275, DOI 10.1016/S0065-2806(08)60085-5; KNOWLES BH, 1984, FEBS LETT, V168, P197, DOI 10.1016/0014-5793(84)80245-8; Kortner TM, 2011, AQUACULTURE, V318, P355, DOI 10.1016/j.aquaculture.2011.05.038; Krogdahl A, 2000, AQUACULT NUTR, V6, P77; Krogdahl A, 2003, AQUACULT NUTR, V9, P361, DOI 10.1046/j.1365-2095.2003.00264.x; Krogdahl A, 2005, COMP BIOCHEM PHYS A, V141, P450, DOI 10.1016/j.cbpb.2005.06.002; Krogdahl A, 2005, AQUACULT NUTR, V11, P103, DOI 10.1111/j.1365-2095.2004.00327.x; Lilleeng E, 2007, COMP BIOCHEM PHYS A, V147, P25, DOI 10.1016/j.cbpa.2006.10.043; Linderoth A, 2006, BRIT J NUTR, V95, P105, DOI 10.1079/BJN20051612; Marjara IS, 2012, CYTOKINE, V60, P186, DOI 10.1016/j.cyto.2012.05.027; Marzo F, 2011, J ANIM PHYSIOL AN N, V95, P591, DOI 10.1111/j.1439-0396.2010.01088.x; Meissle M, 2011, PEST MANAG SCI, V67, P1049, DOI 10.1002/ps.2221; Moreno-Fierros L, 2000, MICROBES INFECT, V2, P885, DOI 10.1016/S1286-4579(00)00398-1; Muller PY, 2002, BIOTECHNIQUES, V32, P1372; Nordrum S, 2000, AQUACULTURE, V186, P341, DOI 10.1016/S0044-8486(99)00385-3; Nordrum S, 2003, AQUACULT NUTR, V9, P263, DOI 10.1046/j.1365-2095.2003.00252.x; NRC, 1993, NUTR REQ FISH, DOI [10.17226/2115, DOI 10.17226/2115]; OLLI JJ, 1994, ACTA AGR SCAND A-AN, V44, P50, DOI 10.1080/09064709409410181; Penn MH, 2011, AQUACULTURE, V310, P267, DOI 10.1016/j.aquaculture.2010.10.040; Peres A, 1996, FISH PHYSIOL BIOCHEM, V15, P237, DOI 10.1007/BF01875574; Prescott VE, 2006, PHARMACOL THERAPEUT, V111, P374, DOI 10.1016/j.pharmthera.2005.10.005; Prescott VE, 2005, J AGR FOOD CHEM, V53, P9023, DOI 10.1021/jf050594v; Sagstad A, 2008, AQUACULT NUTR, V14, DOI 10.1111/j.1365-2095.2008.00630.x; Sagstad A, 2007, J FISH DIS, V30, P201, DOI 10.1111/j.1365-2761.2007.00808.x; Sanden M, 2006, AQUACULT NUTR, V12, P1, DOI 10.1111/j.1365-2095.2006.00367.x; Sanden M, 2005, J FISH DIS, V28, P317, DOI 10.1111/j.1365-2761.2005.00618.x; Sanden M, 2013, BRIT J NUTR, V110, P2222, DOI 10.1017/S0007114513001748; Saraswathy N, 2004, ELECTRON J BIOTECHN, V7, P178; Schroder M, 2007, FOOD CHEM TOXICOL, V45, P339, DOI 10.1016/j.fct.2006.09.001; Shimada N, 2006, APPL ENTOMOL ZOOL, V41, P295, DOI 10.1303/aez.2006.295; Sissener NH, 2011, BRIT J NUTR, V106, P42, DOI 10.1017/S0007114510005726; Sissener NH, 2010, BRIT J NUTR, V103, P3, DOI 10.1017/S0007114509991401; Sullivan M, 2007, J FISH DIS, V30, P759, DOI 10.1111/j.1365-2761.2007.00890.x; van Haver E, 2008, FOOD CHEM TOXICOL, V46, pS2, DOI 10.1016/j.fct.2008.02.008; Vazquez-Padron RI, 2000, BRAZ J MED BIOL RES, V33, P147, DOI 10.1590/S0100-879X2000000200002; Vazquez-Padron RI, 1999, LIFE SCI, V64, P1897, DOI 10.1016/S0024-3205(99)00136-8; Vazquez-Padron RI, 2000, BIOCHEM BIOPH RES CO, V271, P54, DOI 10.1006/bbrc.2000.2584; Walsh MC, 2012, BRIT J NUTR, V107, P364, DOI 10.1017/S0007114511003011; Walsh MC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027177; Zhang X, 2005, CELL DEATH DIFFER, V12, P1407, DOI 10.1038/sj.cdd.4401675	65	15	20	0	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99932	10.1371/journal.pone.0099932	http://dx.doi.org/10.1371/journal.pone.0099932			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923786	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300108
J	Hiroshima, Y; Maawy, A; Zhang, Y; Sato, S; Murakami, T; Yamamoto, M; Uehara, F; Miwa, S; Yano, S; Momiyama, M; Chishima, T; Tanaka, K; Bouvet, M; Endo, I; Hoffman, RM				Hiroshima, Yukihiko; Maawy, Ali; Zhang, Yong; Sato, Sho; Murakami, Takashi; Yamamoto, Mako; Uehara, Fuminari; Miwa, Shinji; Yano, Shuya; Momiyama, Masashi; Chishima, Takashi; Tanaka, Kuniya; Bouvet, Michael; Endo, Itaru; Hoffman, Robert M.			Fluorescence-Guided Surgery in Combination with UVC Irradiation Cures Metastatic Human Pancreatic Cancer in Orthotopic Mouse Models	PLOS ONE			English	Article							INCREASES SURVIVAL; COMPLETE RESECTION; STOMACH-CANCER; NUDE-MICE; LIVE MICE; TUMOR; CARCINOMA; ANTIBODY; PROTEIN; GFP	The aim of this study is to determine if ultraviolet light (UVC) irradiation in combination with fluorescence-guided surgery (FGS) can eradicate metastatic human pancreatic cancer in orthotopic nude-mouse models. Two weeks after orthotopic implantation of human MiaPaCa-2 pancreatic cancer cells, expressing green fluorescent protein (GFP), in nude mice, bright-light surgery (BLS) was performed on all tumor-bearing mice (n = 24). After BLS, mice were randomized into 3 treatment groups; BLS-only (n = 8) or FGS (n = 8) or FGS-UVC (n = 8). The residual tumors were resected using a hand-held portable imaging system under fluorescence navigation in mice treated with FGS and FGS-UVC. The surgical resection bed was irradiated with 2700 J/m(2) UVC (254 nm) in the mice treated with FGS-UVC. The average residual tumor area after FGS (n = 16) was significantly smaller than after BLS only (n = 24) (0.135 +/- 0.137 mm(2) and 3.338 +/- 2.929 mm(2), respectively; p = 0.007). The BLS treated mice had significantly reduced survival compared to FGS-and FGS-UVC-treated mice for both relapse-free survival (RFS) (p<0.001 and p<0.001, respectively) and overall survival (OS) (p<0.001 and p<0.001, respectively). FGS-UVC-treated mice had increased RFS and OS compared to FGS-only treated mice (p = 0.008 and p = 0.025, respectively); with RFS lasting at least 150 days indicating the animals were cured. The results of the present study suggest that UVC irradiation in combination with FGS has clinical potential to increase survival.	[Hiroshima, Yukihiko; Zhang, Yong; Yamamoto, Mako; Uehara, Fuminari; Miwa, Shinji; Yano, Shuya; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA 92111 USA; [Hiroshima, Yukihiko; Maawy, Ali; Yamamoto, Mako; Uehara, Fuminari; Miwa, Shinji; Yano, Shuya; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Hiroshima, Yukihiko; Sato, Sho; Murakami, Takashi; Momiyama, Masashi; Chishima, Takashi; Tanaka, Kuniya; Endo, Itaru] Yokohama City Univ, Grad Sch Med, Yokohama, Kanagawa 232, Japan	Anti Cancer Inc; University of California System; University of California San Diego; Yokohama City University	Hoffman, RM (corresponding author), AntiCancer Inc, San Diego, CA 92111 USA.	all@anticancer.com	Miwa, Shinji/AAI-9309-2020; Yano, Shuya/AAL-8028-2020	Miwa, Shinji/0000-0002-5962-8287; Murakami, Takashi/0000-0002-9429-5705; UEHARA, FUMINARI/0000-0001-6567-2113	National Cancer Institute [CA CA132971, CA142669]; Japanese Ministry of Education, Culture, Sports, Science and Technology [23592018, 24592009]; NATIONAL CANCER INSTITUTE [R01CA132971, R01CA142669] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [24592009] Funding Source: KAKEN	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported in part by National Cancer Institute grant CA CA132971 and CA142669, and Grants-in-Aid from the Japanese Ministry of Education, Culture, Sports, Science and Technology for Fundamental Research(C) (#23592018 to I.E and #24592009 to K.T). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	An ZL, 1999, CLIN EXP METASTAS, V17, P265, DOI 10.1023/A:1006654600095; Bouvet M, 2002, CANCER RES, V62, P1534; Bouvet M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003375; Cao HST, 2012, HEPATO-GASTROENTEROL, V59, P1994, DOI 10.5754/hge11836; Cao HST, 2010, MOL CANCER THER, V9, P2068, DOI 10.1158/1535-7163.MCT-10-0201; FU XY, 1991, INT J CANCER, V49, P938, DOI 10.1002/ijc.2910490623; FU XY, 1992, P NATL ACAD SCI USA, V89, P5645, DOI 10.1073/pnas.89.12.5645; FURUKAWA T, 1993, INT J CANCER, V53, P608, DOI 10.1002/ijc.2910530414; FURUKAWA T, 1993, CANCER RES, V53, P1204; FURUKAWA T, 1993, CANCER RES, V53, P3070; Hiroshima Y, 2014, J SURG RES, V187, P510, DOI 10.1016/j.jss.2013.11.1083; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Kato K, 2009, PANCREAS, V38, P605, DOI 10.1097/MPA.0b013e3181a4891d; Katz MH, 2003, J SURG RES, V113, P151, DOI 10.1016/S0022-4804(03)00234-8; Kaushal S, 2008, J GASTROINTEST SURG, V12, P1938, DOI 10.1007/s11605-008-0581-0; Kimura H, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3526356; Kimura H, 2010, J CELL BIOCHEM, V110, P1439, DOI 10.1002/jcb.22693; Kishimoto H, 2011, CELL CYCLE, V10, P2737, DOI 10.4161/cc.10.16.16756; Kishimoto H, 2009, MOL CANCER THER, V8, P3001, DOI 10.1158/1535-7163.MCT-09-0556; Kishimoto H, 2009, P NATL ACAD SCI USA, V106, P14514, DOI 10.1073/pnas.0906388106; KUO TH, 1993, ANTICANCER RES, V13, P627; McElroy M, 2008, WORLD J SURG, V32, P1057, DOI 10.1007/s00268-007-9452-1; Metildi CA, 2014, ANN SURG ONCOL, V21, P1405, DOI 10.1245/s10434-014-3495-y; Metildi CA, 2013, J SURG RES, V179, P87, DOI 10.1016/j.jss.2012.08.052; Metildi CA, 2012, J AM COLL SURGEONS, V215, P126, DOI 10.1016/j.jamcollsurg.2012.02.021; Metildi CA, 2012, J AM COLL SURGEONS, V214, P997, DOI 10.1016/j.jamcollsurg.2012.02.009; Miwa S, 2013, J CELL BIOCHEM, V114, P2493, DOI 10.1002/jcb.24599; Momiyama M, 2013, J CELL BIOCHEM, V114, P428, DOI 10.1002/jcb.24381; Momiyama M, 2012, ANTICANCER RES, V32, P4327; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; THEODORESCU D, 1990, P NATL ACAD SCI USA, V87, P9047, DOI 10.1073/pnas.87.22.9047; Tsai MH, 2010, ANTICANCER RES, V30, P3291; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927	36	27	27	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99977	10.1371/journal.pone.0099977	http://dx.doi.org/10.1371/journal.pone.0099977			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924955	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300116
J	Kaplan, RA; Enticott, PG; Hohwy, J; Castle, DJ; Rossell, SL				Kaplan, Ryan A.; Enticott, Peter G.; Hohwy, Jakob; Castle, David J.; Rossell, Susan L.			Is Body Dysmorphic Disorder Associated with Abnormal Bodily Self-Awareness? A Study Using the Rubber Hand Illusion	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; SCHIZOPHRENIA; EXPERIENCE; OWNERSHIP; IMAGE; PROPRIOCEPTION; INFORMATION; VALIDATION; BRAIN; MODEL	Evidence from past research suggests that behaviours and characteristics related to body dissatisfaction may be associated with greater instability of perceptual body image, possibly due to problems in the integration of body-related multisensory information. We investigated whether people with body dysmorphic disorder (BDD), a condition characterised by body image disturbances, demonstrated enhanced susceptibility to the rubber hand illusion (RHI), which arises as a result of multisensory integration processes when a rubber hand and the participant's hidden real hand are stimulated in synchrony. Overall, differences in RHI experience between the BDD group and healthy and schizophrenia control groups (n = 17 in each) were not significant. RHI strength, however, was positively associated with body dissatisfaction and related tendencies. For the healthy control group, proprioceptive drift towards the rubber hand was observed following synchronous but not asynchronous stimulation, a typical pattern when inducing the RHI. Similar drifts in proprioceptive awareness occurred for the BDD group irrespective of whether stimulation was synchronous or not. These results are discussed in terms of possible abnormalities in visual processing and multisensory integration among people with BDD.	[Kaplan, Ryan A.] Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia; [Kaplan, Ryan A.; Enticott, Peter G.; Rossell, Susan L.] Monash Univ, Monash Alfred Psychiat Res Ctr, Alfred & Cent Clin Sch, Melbourne, Vic 3004, Australia; [Rossell, Susan L.] Swinburne Univ Technol, Brain & Psychol Sci Res Ctr, Melbourne, Vic, Australia; [Castle, David J.; Rossell, Susan L.] St Vincents Hosp, Dept Psychiat, Melbourne, Vic, Australia; [Castle, David J.; Rossell, Susan L.] Univ Melbourne, Melbourne, Vic, Australia; [Hohwy, Jakob] Monash Univ, Sch Philosoph Hist & Int Studies, Melbourne, Vic 3004, Australia; [Enticott, Peter G.] Deakin Univ, Sch Psychol, Cognit Neurosci Unit, Burwood, Australia	Monash University; Monash University; Swinburne University of Technology; St Vincent's Hospital Melbourne; University of Melbourne; Monash University; Deakin University	Kaplan, RA (corresponding author), Monash Univ, Sch Psychol & Psychiat, Melbourne, Vic 3004, Australia.	ryan.a.kaplan@gmail.com	Enticott, Peter/L-4361-2019; Enticott, Peter/G-6923-2017	Enticott, Peter/0000-0002-6638-951X; Hohwy, Jakob/0000-0003-3906-3060; Rossell, Susan/0000-0002-7415-8252	School of Psychology and Psychiatry, Monash University; Australian Postgraduate Award	School of Psychology and Psychiatry, Monash University(Monash University); Australian Postgraduate Award(Australian Government)	This research was funded by the School of Psychology and Psychiatry, Monash University. RAK was supported by an Australian Postgraduate Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; Andreasen N. C., 1984, SCALE ASSESSMENT POS; ARCHER RP, 1985, J SOC CLIN PSYCHOL, V3, P170, DOI 10.1521/jscp.1985.3.2.170; Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Brown TA, 1997, BEHAV RES THER, V35, P79, DOI 10.1016/S0005-7967(96)00068-X; Buckley PF, 2009, SCHIZOPHRENIA BULL, V35, P383, DOI 10.1093/schbul/sbn135; Carruthers G, 2013, J CONSCIOUSNESS STUD, V20, P33; Castle DJ, 2006, PSYCHIAT CLIN N AM, V29, P521, DOI 10.1016/j.psc.2006.02.001; CHAPMAN LJ, 1978, J ABNORM PSYCHOL, V87, P399, DOI 10.1037/0021-843X.87.4.399; Cutting J., 1990, RIGHT CEREBRAL HEMIS; Ehrsson H.H., 2012, NEW HDB MULTISENSORY, P775, DOI DOI 10.1126/SCIENCE.1097011; Ehrsson HH, 2008, BRAIN, V131, P3443, DOI 10.1093/brain/awn297; Ehrsson HH, 2005, J NEUROSCI, V25, P10564, DOI 10.1523/JNEUROSCI.0800-05.2005; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; ERWIN BJ, 1979, J ABNORM PSYCHOL, V88, P234, DOI 10.1037/0021-843X.88.3.234; Eshkevari E, 2012, PSYCHOL MED, V42, P819, DOI 10.1017/S0033291711002091; Ferri F, 2014, SCHIZOPHR RES, V152, P51, DOI 10.1016/j.schres.2013.06.026; Feusner JD, 2011, PSYCHOL MED, V41, P2385, DOI 10.1017/S0033291711000572; Feusner JD, 2007, ARCH GEN PSYCHIAT, V64, P1417, DOI 10.1001/archpsyc.64.12.1417; Feusner JD, 2010, ARCH GEN PSYCHIAT, V67, P197, DOI 10.1001/archgenpsychiatry.2009.190; Freire A, 2000, PERCEPTION, V29, P159, DOI 10.1068/p3012; Garner D.M, 2004, EATING DISORDER INVE; Germine L, 2013, PSYCHIAT RES, V207, P45, DOI 10.1016/j.psychres.2012.11.022; Graziano MSA, 2000, SCIENCE, V290, P1782, DOI 10.1126/science.290.5497.1782; Graziano MSA, 2004, SYSTEM MULTIMODAL AR, P51; Holdnack H. A., 2001, WECHSLER TEST ADULT; Holle H, 2011, COGN NEUROSCI-UK, V2, P171, DOI 10.1080/17588928.2011.603828; Holmes N.P., 2012, SEEING PERCEIVING, V25, P52; Kalckert A, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00040; Kaplan RA, 2013, COGNITIVE NEUROPSYCH, P1; Labuschagne I, 2010, AUST NZ J PSYCHIAT, V44, P706, DOI 10.3109/00048671003671007; Lewis E, 2010, PHENOMENOL COGN SCI, V9, P317, DOI 10.1007/s11097-010-9154-2; Lloyd DM, 2003, NAT NEUROSCI, V6, P17, DOI 10.1038/nn991; Lopez C, 2010, CONSCIOUS COGN, V19, P33, DOI 10.1016/j.concog.2009.12.003; Lovibond SH, 1995, MANUAL DEPRESSION AN, V2nd; Makin TR, 2008, BEHAV BRAIN RES, V191, P1, DOI 10.1016/j.bbr.2008.02.041; Mancuso SG, 2010, AUST NZ J PSYCHIAT, V44, P535, DOI 10.3109/00048671003596055; Mancuso SG, 2010, COMPR PSYCHIAT, V51, P177, DOI 10.1016/j.comppsych.2009.05.001; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Morgan HL, 2011, BIOL PSYCHIAT, V69, P35, DOI 10.1016/j.biopsych.2010.07.032; Moseley GL, 2012, NEUROSCI BIOBEHAV R, V36, P34, DOI 10.1016/j.neubiorev.2011.03.013; Mussap AJ, 2006, J HEALTH PSYCHOL, V11, P627, DOI 10.1177/1359105306065022; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Paton B, 2012, J AUTISM DEV DISORD, V42, P1870, DOI 10.1007/s10803-011-1430-7; Peled A, 2003, SCHIZOPHR RES, V64, P157, DOI 10.1016/S0920-9964(03)00057-4; Peled A, 2000, BIOL PSYCHIAT, V48, P1105, DOI 10.1016/S0006-3223(00)00947-1; PHILLIPS KA, 1993, AM J PSYCHIAT, V150, P302; Phillips KA, 2006, J PSYCHIAT RES, V40, P95, DOI 10.1016/j.jpsychires.2005.08.005; Phillips KA, 2005, PSYCHOSOMATICS, V46, P317, DOI 10.1176/appi.psy.46.4.317; Phillips KA, 1997, PSYCHOPHARMACOL BULL, V33, P17; Phillips KA., 2009, UNDERSTANDING BODY D; Pinninti NR, 2003, EUR PSYCHIAT, V18, P361, DOI 10.1016/j.eurpsy.2003.03.004; Pinto Anthony, 2005, Body Image, V2, P401, DOI 10.1016/j.bodyim.2005.10.003; RADO S, 1953, AM J PSYCHIAT, V110, P406, DOI 10.1176/ajp.110.6.406; RAULIN ML, 1984, J CLIN PSYCHOL, V40, P780, DOI 10.1002/1097-4679(198405)40:3<780::AID-JCLP2270400324>3.0.CO;2-M; Raulin ML, 1978, SOMATIC SYMPTOMS SCA; Reese HE, 2011, BEHAV THER, V42, P387, DOI 10.1016/j.beth.2010.10.001; RITZLER B, 1974, J ABNORM PSYCHOL, V83, P106, DOI 10.1037/h0036477; RITZLER BA, 1977, J ABNORM PSYCHOL, V86, P501, DOI 10.1037/0021-843X.86.5.501; Rizzolatti G, 1997, SCIENCE, V277, P190, DOI 10.1126/science.277.5323.190; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; ROSENBAUM GERALD, 1965, J ABNORM PSYCHOL, V70, P446, DOI 10.1037/h0022779; Sass LA, 2003, SCHIZOPHRENIA BULL, V29, P427, DOI 10.1093/oxfordjournals.schbul.a007017; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Slater M, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.006.2008; Suzuki K, 2013, NEUROPSYCHOLOGIA, V51, P2909, DOI 10.1016/j.neuropsychologia.2013.08.014; Thakkar KN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027089; THERON WH, 1991, PERCEPT MOTOR SKILL, V73, P979, DOI 10.2466/PMS.73.7.979-983; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2011, P ROYAL SOC B; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P703, DOI 10.1016/j.neuropsychologia.2009.09.034; WALKER E, 1982, BIOL PSYCHIAT, V17, P381; Yaryura-Tobias Jose A, 2002, CNS Spectr, V7, P432	74	31	31	3	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99981	10.1371/journal.pone.0099981	http://dx.doi.org/10.1371/journal.pone.0099981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24925079	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300117
J	Kizuka, T; Akasaka, M; Kadoya, T; Takamura, N				Kizuka, Toshikazu; Akasaka, Munemitsu; Kadoya, Taku; Takamura, Noriko			Visibility from Roads Predict the Distribution of Invasive Fishes in Agricultural Ponds	PLOS ONE			English	Article							LARGEMOUTH BASS; BIOLOGICAL INVASIONS; BLUEGILL SUNFISH; SPATIAL-ANALYSIS; WATER-QUALITY; LAND-USE; HABITAT; BIODIVERSITY; LANDSCAPE; DISPERSAL	Propagule pressure and habitat characteristics are important factors used to predict the distribution of invasive alien species. For species exhibiting strong propagule pressure because of human-mediated introduction of species, indicators of introduction potential must represent the behavioral characteristics of humans. This study examined 64 agricultural ponds to assess the visibility of ponds from surrounding roads and its value as a surrogate of propagule pressure to explain the presence and absence of two invasive fish species. A three-dimensional viewshed analysis using a geographic information system quantified the visual exposure of respective ponds to humans. Binary classification trees were developed as a function of their visibility from roads, as well as five environmental factors: river density, connectivity with upstream dam reservoirs, pond area, chlorophyll a concentration, and pond drainage. Traditional indicators of human-mediated introduction (road density and proportion of urban land-use area) were alternatively included for comparison instead of visual exposure. The presence of Bluegill (Lepomis macrochirus) was predicted by the ponds' higher visibility from roads and pond connection with upstream dam reservoirs. Results suggest that fish stocking into ponds and their dispersal from upstream sources facilitated species establishment. Largemouth bass (Micropterus salmoides) distribution was constrained by chlorophyll a concentration, suggesting their lower adaptability to various environments than that of Bluegill. Based on misclassifications from classification trees for Bluegill, pond visual exposure to roads showed greater predictive capability than traditional indicators of human-mediated introduction. Pond visibility is an effective predictor of invasive species distribution. Its wider use might improve management and mitigate further invasion. The visual exposure of recipient ecosystems to humans is important for many invasive species that spread with frequent instances of human-mediated introduction.	[Kizuka, Toshikazu; Akasaka, Munemitsu; Kadoya, Taku; Takamura, Noriko] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Akasaka, Munemitsu] Tokyo Univ Agr & Technol, Fac Agr, Fuchu, Tokyo 183, Japan	National Institute for Environmental Studies - Japan; Tokyo University of Agriculture & Technology	Kizuka, T (corresponding author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan.	t.kizuka1981@gmail.com	Akasaka, Munemitsu/G-1172-2013	Akasaka, Munemitsu/0000-0002-0143-0841	Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan	Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan	The present study was supported by the Environment Research and Technology Development Fund (S9) of the Ministry of the Environment, Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaboshi T, 1996, BLACK BASS; Akasaka M, 2011, OIKOS, V120, P38, DOI 10.1111/j.1600-0706.2010.18497.x; Akasaka M, 2010, FRESHWATER BIOL, V55, P909, DOI 10.1111/j.1365-2427.2009.02334.x; Alonso JC, 2012, BEHAV ECOL, V23, P491, DOI 10.1093/beheco/arr215; [Anonymous], 2009, JPN J LIMNOL; Bonvechio KI, 2006, N AM J FISH MANAGE, V26, P124, DOI 10.1577/M04-191.1; Borgatti SP, 2006, SOC NETWORKS, V28, P466, DOI 10.1016/j.socnet.2005.11.005; Bourg NA, 2005, ECOLOGY, V86, P2793, DOI 10.1890/04-1666; Breiman L., 2017, CLASSIFICATION REGRE; Buchan LAJ, 1999, ECOL APPL, V9, P254, DOI 10.2307/2641184; Chipps SR, 2004, OECOLOGIA, V138, P32, DOI 10.1007/s00442-003-1396-z; Chytry M, 2008, ECOLOGY, V89, P1541, DOI 10.1890/07-0682.1; Compton TJ, 2012, FRESHWATER BIOL, V57, P938, DOI 10.1111/j.1365-2427.2012.02754.x; De Montis A, 2012, LANDSCAPE URBAN PLAN, V105, P315, DOI 10.1016/j.landurbplan.2012.01.005; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; Drake DAR, 2010, ECOL APPL, V20, P2286, DOI 10.1890/09-2005.1; Ervin S, 2003, ENVIRON PLANN B, V30, P757, DOI 10.1068/b2968; Essl F, 2012, BIOL INVASIONS, V14, P1331, DOI 10.1007/s10530-011-0156-y; Fisher P, 1997, J ARCHAEOL SCI, V24, P581, DOI 10.1006/jasc.1996.0142; Freund JG, 2005, J FRESHWATER ECOL, V20, P735, DOI 10.1080/02705060.2005.9664797; Fukushima M, 1999, FRESHWATER BIOL, V42, P719, DOI 10.1046/j.1365-2427.1999.00507.x; Gido KB, 2004, BIOL CONSERV, V118, P121, DOI 10.1016/j.biocon.2003.07.015; Giorgis MA, 2011, BIOL INVASIONS, V13, P1423, DOI 10.1007/s10530-010-9900-y; GROSS MR, 1980, P NATL ACAD SCI-BIOL, V77, P6937, DOI 10.1073/pnas.77.11.6937; Hasler CT, 2009, PHYSIOL BIOCHEM ZOOL, V82, P143, DOI 10.1086/591806; Irwin ER, 2002, AM FISH S S, V31, P61; Ishii Y., 2003, JAPANESE J CONSERVAT, V8, P25; Jackson ZJ, 2010, LAKE RESERV MANAGE, V26, P14, DOI 10.1080/07438140903500586; Japan Dam Foundation, 2007, DAM YB 2007; Johnson PTJ, 2008, FRONT ECOL ENVIRON, V6, P359, DOI 10.1890/070156; Kadoya T, 2011, ECOL INDIC, V11, P1396, DOI 10.1016/j.ecolind.2011.03.001; Kaufman SD, 2009, CAN J FISH AQUAT SCI, V66, P212, DOI 10.1139/F08-205; Kawamura K, 2006, MOL ECOL, V15, P613, DOI 10.1111/j.1365-294X.2006.02823.x; Knutson MG, 2004, ECOL APPL, V14, P669, DOI 10.1890/02-5305; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Kondo T, 2003, DIVERS DISTRIB, V5, P223; Land Improvement and Consolidation Division Hyogo Prefecture Government, 1990, LAND IMPR HIST HYOG; Lockwood JL, 2007, INVASION ECOLOGY; Lorini ML, 2011, NAT CONSERVACAO, V9, P129, DOI 10.4322/natcon.2011.019; MacIsaac Hugh J., 2007, V2, P347; Mack RN, 2000, ECOL APPL, V10, P689, DOI 10.1890/1051-0761(2000)010[0689:BICEGC]2.0.CO;2; Maezono Y, 2005, ECOL APPL, V15, P638, DOI 10.1890/02-5386; Marini L, 2012, GLOBAL ECOL BIOGEOGR, V21, P534, DOI 10.1111/j.1466-8238.2011.00702.x; Maruyama T, 1987, INTRO PROCESS FOREIG; Maruyama T, 2002, BLACK BASS ITS BIOL, P99; McKinney CL, 2001, BIOL CONSERV, V100, P243, DOI 10.1016/S0006-3207(01)00027-1; Miyata Hiroshi, 2007, Ecology and Civil Engineering, V10, P117, DOI 10.3825/ece.10.117; Moyle PB, 2006, BIOSCIENCE, V56, P515, DOI 10.1641/0006-3568(2006)56[515:PISFFI]2.0.CO;2; National Federation of Inlandwater Fisheries Cooperatices, 1992, REV EX LARG BASS MIC; Niggemann M, 2009, ECOL MODEL, V220, P1339, DOI 10.1016/j.ecolmodel.2009.02.018; OECD, 1982, EUTR WAT MON ASS CON; Oertli B, 2005, AQUAT CONSERV, V15, P535, DOI 10.1002/aqc.752; Pollnac F, 2012, BIOL INVASIONS, V14, P1753, DOI 10.1007/s10530-012-0188-y; R Core Team, 2021, R LANGUAGE ENV STAT; Senou H., 2008, ALIEN FISHES JAPAN; Senou H, 2002, BLACK BASS BIOL ECOS, P47; Sevenant M, 2007, LANDSCAPE URBAN PLAN, V80, P362, DOI 10.1016/j.landurbplan.2006.09.004; Sharma GP, 2009, ENVIRON MONIT ASSESS, V157, P191, DOI 10.1007/s10661-008-0527-8; Shoup DE, 2009, T AM FISH SOC, V138, P1018, DOI 10.1577/T09-015.1; Takamura K, 2007, ECOL RES, V22, P940, DOI 10.1007/s11284-007-0415-7; Takamura N., 2012, BIODIVERSITY OBSERVA, P133; Therneau T. M., 1997, INTRO RECURSIVE PART; Tricarico E, 2012, FISHERIES MANAG ECOL, V19, P133, DOI 10.1111/j.1365-2400.2011.00834.x; Uchida K., 2003, IRRIGATION PONDS JAP; UN CBD, 2010, COP 10 DEC X 2 STRAT; Vander Zanden MJ, 2008, CAN J FISH AQUAT SCI, V65, P1512, DOI 10.1139/F08-099; Welch EB, 2011, LAKE RESERV MANAGE, V27, P271, DOI 10.1080/07438141.2011.607553; Williams P, 2004, BIOL CONSERV, V115, P329, DOI 10.1016/S0006-3207(03)00153-8; Yonekura R, 2004, ICHTHYOL RES, V51, P176, DOI 10.1007/s10228-003-0200-8; Yonekura R, 2002, ECOL RES, V17, P49, DOI 10.1046/j.1440-1703.2002.00462.x	70	11	11	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99709	10.1371/journal.pone.0099709	http://dx.doi.org/10.1371/journal.pone.0099709			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923423	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300086
J	Li, M; Wang, K; Wang, X; Yang, PF				Li, Ming; Wang, Kun; Wang, Xin; Yang, Pingfang			Morphological and Proteomic Analysis Reveal the Role of Pistil under Pollination in Liriodendron chinense (Hemsl.) Sarg.	PLOS ONE			English	Article							PROTEIN-DISULFIDE-ISOMERASE; EMBRYO DEVELOPMENT; SEED-SET; IDENTIFICATION; GENES; HYDROLYSIS; ANNOTATION; DATABASES; BLAST2GO; POPLAR	Pollination is an important physiological process during which interaction between pollen and pistil occurs. This interaction could determine whether or not fertilization will occur and hence the ratio of plant seed setting. Liriodendron chinense (Hemsl.) Sarg. (L. chinense) exhibits a distinct phenomenon where seed setting ratio is not more than 10% in natural environment. To explore the origin of this phenomenon, we conducted a comparative morphological and proteomic analysis on L. chinense pistils upon pollination. The morphological analysis showed that pollen grows well in vitro, but much slower on pistil or nutrient medium containing pistil extract. Proteomic analysis showed that 493 proteins had changed the expression after pollination. Among them, 468 and 51 proteins were identified by isobaric tags for relative and absolute quantitation and two-dimensional gel electrophoresis respectively, and 26 proteins were common in the two methods. After proteins functional categorization, 66 differentially expressed proteins that are involved in reproduction process were found. Further analysis showed that among the reproductive process related proteins, protein disulfide-isomerase A6 and four embryo-defective proteins showed closer relations with the low seed setting phenomenon. The results indicated that the element from pistil might be the main reason leading to low seed setting in L. chinense, which will provide new insights in the mechanisms underlying L. chinense reproduction process.	[Li, Ming; Wang, Kun; Wang, Xin; Yang, Pingfang] Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China; [Li, Ming; Wang, Xin] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Botanical Garden, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Yang, PF (corresponding author), Chinese Acad Sci, Wuhan Bot Garden, Key Lab Plant Germplasm Enhancement & Special Agr, Wuhan, Peoples R China.	yangpf@wbgcas.cn		Li, Ming/0000-0002-2679-6137	100 talents program of Chinese Academy of Sciences; National Natural Science Foundation of China [31300516]	100 talents program of Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the 100 talents program of Chinese Academy of Sciences and the National Natural Science Foundation of China (No. 31300516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlin A, 2006, BIOTECHNOL BIOENG, V93, P880, DOI 10.1002/bit.20783; Bryant N, 2011, PLANT PHYSIOL, V155, P1678, DOI 10.1104/pp.110.168120; CELEN I, 2008, HOLZFORSCHUNG, V62, P189, DOI DOI 10.1515/HF.2008.048; Chi F, 2010, PROTEOMICS, V10, P1861, DOI 10.1002/pmic.200900694; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa Ana, 2008, Int J Plant Genomics, V2008, P619832, DOI 10.1155/2008/619832; Devic M, 2008, CR BIOL, V331, P726, DOI 10.1016/j.crvi.2008.07.014; Ducret A, 1998, PROTEIN SCI, V7, P706, DOI 10.1002/pro.5560070320; Fan Ru-Wen, 1992, Acta Botanica Sinica, V34, P437; Fan RuWen, 1996, Journal of Nanjing Forestry University, V20, P1; Gotz S, 2011, BIOINFORMATICS, V27, P919, DOI 10.1093/bioinformatics/btr059; Gotz S, 2008, NUCLEIC ACIDS RES, V36, P3420, DOI 10.1093/nar/gkn176; Gruber CW, 2007, J BIOL CHEM, V282, P20435, DOI 10.1074/jbc.M700018200; Gruber CW, 2006, TRENDS BIOCHEM SCI, V31, P455, DOI 10.1016/j.tibs.2006.06.001; Hao Ri-Ming, 1995, Journal of Plant Resources and Environment, V4, P1; Hernandez R., 1997, STRENGTH STIFFNESS R, VVolume 554; Hiscock SJ, 2008, NEW PHYTOL, V179, P286, DOI 10.1111/j.1469-8137.2008.02457.x; Hoagland D.R., 1950, WATER CULTURE METHOD, V347, P29; Huang JQ, 1998, J ZHEJIANG FORESTRY, V15, P267; Huang SQ, 1999, ACTA BOT SIN, V41, P241; Huang SQ, 1998, ACTA BOT SIN, V40, P22; Huang SQ, 2002, BOT J LINN SOC, V140, P31, DOI 10.1046/j.1095-8339.2002.00080.x; Hunt D., 1998, MAGNOLIAS THEIR ALLI; Kanungo T, 2002, IEEE T PATTERN ANAL, V24, P881, DOI 10.1109/TPAMI.2002.1017616; Kim KD, 2005, ENVIRON MANAGE, V36, P1, DOI 10.1007/s00267-004-1089-3; Kim YJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044493; Kudi AC, 1999, J ETHNOPHARMACOL, V67, P225, DOI 10.1016/S0378-8741(98)00214-1; Li M, 2012, SEX PLANT REPROD, V25, P281, DOI 10.1007/s00497-012-0197-0; Makarov A, 2006, ANAL CHEM, V78, P2113, DOI 10.1021/ac0518811; Meinke D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007386; Moody RC, 1993, YELLOW POPLAR GLULAM; Moon MK, 2007, ARCH PHARM RES, V30, P299, DOI 10.1007/BF02977609; Mooney BP, 2004, PHYTOCHEMISTRY, V65, P1733, DOI 10.1016/j.phytochem.2004.04.011; Muralla R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028398; Pagnussat GC, 2005, DEVELOPMENT, V132, P603, DOI 10.1242/dev.01595; PARKS CR, 1990, J HERED, V81, P317, DOI 10.1093/oxfordjournals.jhered.a110996; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Qin Y, 2011, PLANT J, V68, P800, DOI 10.1111/j.1365-313X.2011.04729.x; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; Wang HZ, 2008, PLANT CELL, V20, P3300, DOI 10.1105/tpc.108.062919; Wang S, 1992, RED LIST ENDANGERED; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017; Williams RS, 2004, FOREST PROD J, V54, P96; Xiang Q, 2004, APPL BIOCHEM BIOTECH, V113, P1127, DOI 10.1385/ABAB:115:1-3:1127; Yang PF, 2007, PROTEOMICS, V7, P3358, DOI 10.1002/pmic.200700207; Zhou J., 1999, CHINESE B BOT, V16, P75; Zhou J, 1994, SCI SILVAE SIN, V30, P405	47	9	10	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99970	10.1371/journal.pone.0099970	http://dx.doi.org/10.1371/journal.pone.0099970			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924488	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300113
J	Menezes-Souza, D; Mendes, TAD; Nagem, RAP; Santos, TTD; Silva, ALT; Santoro, MM; de Carvalho, SFG; Coelho, EAF; Bartholomeu, DC; Fujiwara, RT				Menezes-Souza, Daniel; de Oliveira Mendes, Tiago Antonio; Pinto Nagem, Ronaldo Alves; de Oliveira Santos, Thais Teodoro; Teixeira Silva, Ana Luiza; Santoro, Marcelo Matos; Guimaraes de Carvalho, Silvio Fernando; Ferraz Coelho, Eduardo Antonio; Bartholomeu, Daniella Castanheira; Fujiwara, Ricardo Toshio			Mapping B-Cell Epitopes for the Peroxidoxin of Leishmania (Viannia) braziliensis and Its Potential for the Clinical Diagnosis of Tegumentary and Visceral Leishmaniasis	PLOS ONE			English	Article							IMMUNOSORBENT-ASSAY ELISA; CUTANEOUS LEISHMANIASIS; ANTIBODIES; VACCINE; IDENTIFICATION; SERODIAGNOSIS; ANTIGEN; PEROXIREDOXINS; PROMASTIGOTE; METASTASIS	The search toward the establishment of novel serological tests for the diagnosis of leishmaniasis and proper differential diagnosis may represent one alternative to the invasive parasitological methods currently used to identify infected individuals. In the present work, we investigated the potential use of recombinant peroxidoxin (rPeroxidoxin) of Leishmania (Viannia) braziliensis as a potential antigen for the immunodiagnosis of human tegumentary (TL) and visceral leishmaniasis (VL) and canine visceral leishmaniasis (CVL). Linear B-cell epitope mapping was performed to identify polymorphic epitopes when comparing orthologous sequences present in Trypanosoma cruzi, the agent for Chagas disease (CD), and the Homo sapiens and Canis familiaris hosts. The serological assay (ELISA) demonstrated that TL, VL and CVL individuals showed high levels of antibodies against rPeroxidoxin, allowing identification of infected ones with considerable sensitivity and great ability to discriminate (specificity) between non-infected and CD individuals (98.46% and 100%; 98.18% and 95.71%; 95.79% and 100%, respectively). An rPeroxidoxin ELISA also showed a greater ability to discriminate between vaccinated and infected animals, which is an important requirement for the public campaign control of CVL. A depletion ELISA assay using soluble peptides of this B-cell epitope confirmed the recognition of these sites only by Leishmania-infected individuals. Moreover, this work identifies two antigenic polymorphic linear B-cell epitopes of L. braziliensis. Specific recognition of TL and VL patients was confirmed by significantly decreased IgG reactivity against rPeroxidoxin after depletion of peptide-1-and peptide-2-specific antibodies (peptide 1: reduced by 32%, 42% and 5% for CL, ML and VL, respectively; peptide-2: reduced by 24%, 22% and 13% for CL, ML and VL, respectively) and only peptide-2 for CVL (reduced 9%). Overall, rPeroxidoxin may be a potential antigen for the immunodiagnosis of TL, VL or CVL, as it has a higher agreement with parasitological assays and is better than other reference tests that use soluble Leishmania antigens for diagnosing CVL in Brazil (EIE-LVC, Bio-manguinhos, FIOCRUZ).	[Menezes-Souza, Daniel; de Oliveira Mendes, Tiago Antonio; de Oliveira Santos, Thais Teodoro; Teixeira Silva, Ana Luiza; Bartholomeu, Daniella Castanheira; Fujiwara, Ricardo Toshio] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil; [Pinto Nagem, Ronaldo Alves; Santoro, Marcelo Matos] Univ Fed Minas Gerais, Dept Bioquim & Imunol, Belo Horizonte, MG, Brazil; [Guimaraes de Carvalho, Silvio Fernando] Univ Estadual Montes Claros, Ctr Ciencias Biol & Saude, Montes Claros, Brazil; [Ferraz Coelho, Eduardo Antonio] Univ Fed Minas Gerais, Fac Med, Programa Posgrad Ciencias Saude Infectol & Med Tr, Belo Horizonte, MG, Brazil; [Ferraz Coelho, Eduardo Antonio] Univ Fed Minas Gerais, COLTEC, Dept Patol Clin, Belo Horizonte, MG, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Estadual de Montes Claros; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais	Fujiwara, RT (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Parasitol, Belo Horizonte, MG, Brazil.	fujiwara@icb.ufmg.br	Mendes, Tiago/AAG-1709-2021; Bartholomeu, Daniella C./J-4714-2015; Nagem, Ronaldo A P/K-3995-2012; Fujiwara, Ricardo Toshio/J-7579-2012; COELHO, EA/V-7926-2017; Menezes-Souza, Daniel DMS/N-7389-2014	Mendes, Tiago/0000-0002-5569-4893; Bartholomeu, Daniella C./0000-0003-0974-7357; Fujiwara, Ricardo Toshio/0000-0002-4713-575X; COELHO, EA/0000-0002-6681-9014; Teixeira Silva, Ana Luiza/0000-0002-1152-9255	FAPEMIG; CNPq; CAPES; Pro-Reitoria de Pesquisa of UFMG	FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Pro-Reitoria de Pesquisa of UFMG	Funding provided by FAPEMIG, CNPq, CAPES and Pro-Reitoria de Pesquisa of UFMG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acestor N, 2006, J INFECT DIS, V194, P1160, DOI 10.1086/507646; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Pereira VRA, 2012, DIAGN MICR INFEC DIS, V74, P292, DOI 10.1016/j.diagmicrobio.2012.06.025; Alves Waneska Alexandre, 2004, Cad. Saúde Pública, V20, P259, DOI 10.1590/S0102-311X2004000100043; ANTHONY RL, 1980, AM J TROP MED HYG, V29, P190, DOI 10.4269/ajtmh.1980.29.190; Aslett M, 2010, NUCLEIC ACIDS RES, V38, pD457, DOI 10.1093/nar/gkp851; BADARO R, 1986, AM J TROP MED HYG, V35, P72, DOI 10.4269/ajtmh.1986.35.72; Barbosa-de-Deus R, 2002, CLIN DIAGN LAB IMMUN, V9, P1361, DOI 10.1128/CDLI.9.6.1361-1366.2002; BARRAL A, 1987, Memorias do Instituto Oswaldo Cruz, V82, P579, DOI 10.1590/S0074-02761987000400018; Basu A, 2012, PROTEIN J, V31, P93, DOI [10.1007/s10930-011-9377-2, 10.1107/S174430911105038X]; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Braga M D, 1998, Rev Soc Bras Med Trop, V31, P419, DOI 10.1590/S0037-86821998000500001; Brito MEF, 2000, CLIN DIAGN LAB IMMUN, V7, P318, DOI 10.1128/CDLI.7.2.318-321.2000; Bueno LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021289; Carneiro FRG, 2006, BIOCHEM BIOPH RES CO, V343, P260, DOI 10.1016/j.bbrc.2006.02.140; Coelho EAF, 2009, CLIN VACCINE IMMUNOL, V16, P1774, DOI 10.1128/CVI.00295-09; Coelho VTS, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001430; Costa MM, 2011, J PROTEOME RES, V10, P2172, DOI 10.1021/pr101286y; Mendes TAD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002524; DEBRUIJN MHL, 1992, ACTA TROP, V52, P45, DOI 10.1016/0001-706X(92)90006-J; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; EVANS TG, 1990, AM J TROP MED HYG, V42, P118, DOI 10.4269/ajtmh.1990.42.118; Ferreira Maíra Peres, 2006, Rev. Inst. Med. trop. S. Paulo, V48, P215, DOI 10.1590/S0036-46652006000400008; FLEISS JL, 1972, ARCH GEN PSYCHIAT, V26, P168; Giunchetti RC, 2008, RES VET SCI, V85, P106, DOI 10.1016/j.rvsc.2007.09.008; Giunchetti RC, 2007, VACCINE, V25, P7674, DOI 10.1016/j.vaccine.2007.08.009; Gretes MC, 2012, ANTIOXID REDOX SIGN, V17, P608, DOI 10.1089/ars.2011.4404; Ikonomopoulos J, 2003, VET PARASITOL, V113, P99, DOI 10.1016/S0304-4017(03)00061-X; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Larsen Jens Erik Pontoppidan, 2006, Immunome Res, V2, P2, DOI 10.1186/1745-7580-2-2; Linnet K, 2012, CLIN CHEM, V58, P1292, DOI 10.1373/clinchem.2012.182543; Mabey D, 2004, NAT REV MICROBIOL, V2, P231, DOI 10.1038/nrmicro841; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; MAYRINK W, 1979, T ROY SOC TROP MED H, V73, P385, DOI 10.1016/0035-9203(79)90159-7; Mayrink W, 1996, MEM I OSWALDO CRUZ, V91, P695, DOI 10.1590/S0074-02761996000600006; Ndao Momar, 2009, Interdiscip Perspect Infect Dis, V2009, P278246, DOI 10.1155/2009/278246; ParanhosSilva M, 1996, AM J TROP MED HYG, V55, P39, DOI 10.4269/ajtmh.1996.55.39; Porrozzi R, 2007, CLIN VACCINE IMMUNOL, V14, P544, DOI 10.1128/CVI.00420-06; Rhee SG, 2005, FREE RADICAL BIO MED, V38, P1543, DOI 10.1016/j.freeradbiomed.2005.02.026; ROFFI J, 1980, AM J TROP MED HYG, V29, P183, DOI 10.4269/ajtmh.1980.29.183; Santarem N, 2005, IMMUNOL LETT, V101, P18, DOI 10.1016/j.imlet.2005.04.006; Santarem N, 2010, J CLIN MICROBIOL, V48, P1866, DOI 10.1128/JCM.02402-09; Souza AP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066110; Todoli F, 2009, VET PARASITOL, V164, P154, DOI 10.1016/j.vetpar.2009.05.032; Vega-Lopez F, 2003, CURR OPIN INFECT DIS, V16, P97, DOI 10.1097/00001432-200304000-00006; Vexenat Ana De Cassia, 1996, Revista do Instituto de Medicina Tropical de Sao Paulo, V38, P177, DOI 10.1590/S0036-46651996000300003; Walker J, 2006, MOL BIOCHEM PARASIT, V145, P254, DOI 10.1016/j.molbiopara.2005.10.008; Wellings DA, 1997, METHOD ENZYMOL, V289, P44	48	30	30	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99216	10.1371/journal.pone.0099216	http://dx.doi.org/10.1371/journal.pone.0099216			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921246	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300046
J	Park, K; Song, B; Kim, J; Hong, I; Song, S; Lee, J; Park, S; Kim, J; An, B; Lee, HW; Lee, S; Kim, H; Lee, JC; Lee, S; Choi, S				Park, Kyungjoon; Song, Beomjong; Kim, Jeongyeon; Hong, Ingie; Song, Sangho; Lee, Junuk; Park, Sungmo; Kim, Jihye; An, Bobae; Lee, Hyun Woo; Lee, Seungbok; Kim, Hyun; Lee, Justin C.; Lee, Sukwon; Choi, Sukwoo			ABA Renewal Involves Enhancements in Both GluA2-Lacking AMPA Receptor Activity and GluA1 Phosphorylation in the Lateral Amygdala	PLOS ONE			English	Article							CALCIUM-PERMEABLE AMPA; LONG-TERM POTENTIATION; HIPPOCAMPAL INACTIVATION; GLUTAMATE RECEPTORS; CONTEXTUAL CONTROL; FEAR MEMORY; EXTINCTION; RAT; MEDIATE; RECTIFICATION	Fear renewal, the context-specific relapse of fear following fear extinction, is a leading animal model of post-traumatic stress disorders (PTSD) and fear-related disorders. Although fear extinction can diminish fear responses, this effect is restricted to the context where the extinction is carried out, and the extinguished fear strongly relapses when assessed in the original acquisition context (ABA renewal) or in a context distinct from the conditioning and extinction contexts (ABC renewal). We have previously identified Ser831 phosphorylation of GluA1 subunit in the lateral amygdala (LA) as a key molecular mechanism for ABC renewal. However, molecular mechanisms underlying ABA renewal remain to be elucidated. Here, we found that both the excitatory synaptic efficacy and GluA2-lacking AMPAR activity at thalamic input synapses onto the LA (T-LA synapses) were enhanced upon ABA renewal. GluA2-lacking AMPAR activity was also increased during low-threshold potentiation, a potential cellular substrate of renewal, at T-LA synapses. The microinjection of 1-naphtylacetyl-spermine (NASPM), a selective blocker of GluA2-lacking AMPARs, into the LA attenuated ABA renewal, suggesting a critical role of GluA2-lacking AMPARs in ABA renewal. We also found that Ser831 phosphorylation of GluA1 in the LA was increased upon ABA renewal. We developed a short peptide mimicking the Ser831-containing C-tail region of GluA1, which can be phosphorylated upon renewal (GluA1(S)); thus, the phosphorylated GluA1(S) may compete with Ser831-phosphorylated GluA1. This GluA1(S) peptide blocked the low-threshold potentiation when dialyzed into a recorded neuron. The microinjection of a cell-permeable form of GluA1(S) peptide into the LA attenuated ABA renewal. In support of the GluA1(S) experiments, a GluA1(D) peptide (in which the serine at 831 is replaced with a phosphomimetic amino acid, aspartate) attenuated ABA renewal when microinjected into the LA. These findings suggest that enhancements in both the GluA2-lacking AMPAR activity and GluA1 phosphorylation at Ser831 are required for ABA renewal.	[Park, Kyungjoon; Song, Beomjong; Hong, Ingie; Lee, Junuk; Park, Sungmo; Kim, Jihye; An, Bobae; Lee, Sukwon; Choi, Sukwoo] Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea; [Kim, Jeongyeon; Song, Sangho; Lee, Justin C.] Korea Inst Sci & Technol, Ctr Neural Sci, Seoul, South Korea; [Kim, Jeongyeon; Song, Sangho; Lee, Justin C.] Korea Inst Sci & Technol, Ctr Connect, Seoul, South Korea; [Lee, Hyun Woo; Kim, Hyun] Korea Univ, Coll Med, Dept Anat, Seoul 136705, South Korea; [Lee, Hyun Woo; Kim, Hyun] Korea Univ, Coll Med, Brain Korea Biomed Sci Program 21, Seoul 136705, South Korea; [Lee, Seungbok] Seoul Natl Univ, Dent Res Inst, Dept Cell & Dev Biol, Seoul, South Korea	Seoul National University (SNU); Korea Institute of Science & Technology (KIST); Korea Institute of Science & Technology (KIST); Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine); Seoul National University (SNU)	Lee, S (corresponding author), Seoul Natl Univ, Coll Nat Sci, Sch Biol Sci, Seoul 151742, South Korea.	sukwon2@snu.ac.kr; sukwoo12@snu.ac.k	Lee, Seungbok/AAS-1529-2021; Park, Kyungjoon/AAL-8086-2020	Lee, Seungbok/0000-0002-6620-6269; Park, Kyungjoon/0000-0002-7518-636X; Song, Beomjong/0000-0001-8820-7310; Kim, Hyun/0000-0002-7210-5798; Lee, Sukwon/0000-0001-7654-5769; Lee, C Justin/0000-0002-3555-0980; Lee, Junuk/0000-0002-3596-2651; Hong, Ingie/0000-0002-7246-9233	National Research Foundation (NRF) of Korea [NRF-2011-0012876]; Korean Ministry of Science and Technology; NRF of Korea grant - Korea government the Ministry of Education, Science and Technology (MEST) [2011-0018209]; Original Technology ResearchProgram for Brain Science through the NRF of Korea - MEST [2011-0019226]; Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI); Ministry of Health AMP; Welfare, Republic of Korea [HI12C1492]; Brain Korea 21 Research Fellowships from the Korean Ministry of Education	National Research Foundation (NRF) of Korea(National Research Foundation of Korea); Korean Ministry of Science and Technology(Ministry of Science & Technology (MOST), Republic of Korea); NRF of Korea grant - Korea government the Ministry of Education, Science and Technology (MEST)(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); Original Technology ResearchProgram for Brain Science through the NRF of Korea - MEST(National Research Foundation of KoreaMinistry of Education, Science & Technology (MEST), Republic of Korea); Korea Health Technology RAMP;D Project through the Korea Health Industry Development Institute (KHIDI)(Korea Health Industry Development Institute (KHIDI)); Ministry of Health AMP; Welfare, Republic of Korea; Brain Korea 21 Research Fellowships from the Korean Ministry of Education(Ministry of Education (MOE), Republic of Korea)	This work was supported by the National Research Foundation (NRF) of Korea Grant NRF-2011-0012876, funded by the Korean Ministry of Science and Technology (SL), by the NRF of Korea grant funded by the Korea government the Ministry of Education, Science and Technology (MEST) (No. 2011-0018209) (SC), by the Original Technology ResearchProgram for Brain Science through the NRF of Korea funded by MEST (No. 2011-0019226) (SC), and by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI12C1492). KP, BS, JK, IH and JL were supported by Brain Korea 21 Research Fellowships from the Korean Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham WC, 1996, TRENDS NEUROSCI, V19, P126, DOI 10.1016/S0166-2236(96)80018-X; Bouton ME, 2004, LEARN MEMORY, V11, P485, DOI 10.1101/lm.78804; BOWIE D, 1995, NEURON, V15, P453, DOI 10.1016/0896-6273(95)90049-7; Chung HJ, 2000, J NEUROSCI, V20, P7258; Clem RL, 2010, SCIENCE, V330, P1108, DOI 10.1126/science.1195298; Cole S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058701; Cole S, 2011, LEARN MEMORY, V18, P88, DOI 10.1101/lm.2049511; Conrad KL, 2008, NATURE, V454, P118, DOI 10.1038/nature06995; Corcoran KA, 2004, LEARN MEMORY, V11, P598, DOI 10.1101/lm.78704; Corcoran KA, 2001, J NEUROSCI, V21, P1720, DOI 10.1523/JNEUROSCI.21-05-01720.2001; Derkach VA, 2007, NAT REV NEUROSCI, V8, P101, DOI 10.1038/nrn2055; Dunah AW, 2001, J NEUROSCI, V21, P5546, DOI 10.1523/JNEUROSCI.21-15-05546.2001; Ehlers A, 2002, BEHAV RES THER, V40, P995, DOI 10.1016/S0005-7967(01)00077-8; Fonteyne R, 2011, EXP PSYCHOL, V58, P278, DOI 10.1027/1618-3169/a000094; Frohardt RJ, 2000, BEHAV NEUROSCI, V114, P227, DOI 10.1037/0735-7044.114.2.227; Guire ES, 2008, J NEUROSCI, V28, P6000, DOI 10.1523/JNEUROSCI.0384-08.2008; Harris JA, 2000, J EXP PSYCHOL-ANIM B, V26, P174, DOI 10.1037//0097-7403.26.2.174; Havermans RC, 2005, LEARN MOTIV, V36, P1, DOI 10.1016/j.lmot.2004.09.002; Hermans D, 2006, BIOL PSYCHIAT, V60, P361, DOI 10.1016/j.biopsych.2005.10.006; Herry C, 2008, NATURE, V454, P600, DOI 10.1038/nature07166; Hong I, 2013, P NATL ACAD SCI USA, V110, P8218, DOI 10.1073/pnas.1305235110; KAMBOJ SK, 1995, J PHYSIOL-LONDON, V486, P297, DOI 10.1113/jphysiol.1995.sp020812; Kessels HW, 2009, NAT NEUROSCI, V12, P888, DOI 10.1038/nn.2340; Kim J, 2007, P NATL ACAD SCI USA, V104, P20955, DOI 10.1073/pnas.0710548105; Kim J, 2007, BIOCHEM BIOPH RES CO, V355, P188, DOI 10.1016/j.bbrc.2007.01.125; Knapska E, 2009, LEARN MEMORY, V16, P486, DOI 10.1101/lm.1463909; KOH DS, 1995, J PHYSIOL-LONDON, V486, P305, DOI 10.1113/jphysiol.1995.sp020813; Kristensen AS, 2011, NAT NEUROSCI, V14, P727, DOI 10.1038/nn.2804; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lee S, 2013, NAT NEUROSCI, V16, P1436, DOI 10.1038/nn.3491; Mahanty NK, 1998, NATURE, V394, P683, DOI 10.1038/29312; MALINOW R, 1990, NATURE, V346, P177, DOI 10.1038/346177a0; Mao SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059580; Maren S, 2004, NAT REV NEUROSCI, V5, P844, DOI 10.1038/nrn1535; McKernan MG, 1997, NATURE, V390, P607, DOI 10.1038/37605; Myers KM, 2007, MOL PSYCHIATR, V12, P120, DOI 10.1038/sj.mp.4001939; Nader K, 2001, LEARN MEMORY, V8, P156, DOI 10.1101/lm.38101; Neumann DL, 2006, LEARN MOTIV, V37, P149, DOI 10.1016/j.lmot.2005.06.004; Noh KM, 2005, P NATL ACAD SCI USA, V102, P12230, DOI 10.1073/pnas.0505408102; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Rogan MT, 1997, NATURE, V390, P604, DOI 10.1038/37601; Sapolsky RM, 2001, HIPPOCAMPUS, V11, P90, DOI 10.1002/hipo.1026; Sotres-Bayon F, 2012, NEURON, V76, P804, DOI 10.1016/j.neuron.2012.09.028; Thomas BL, 2003, LEARN MOTIV, V34, P410, DOI 10.1016/S0023-9690(03)00037-7; Toth K, 1998, NAT NEUROSCI, V1, P572, DOI 10.1038/2807; Ungor M, 2008, LEARNING MOTIVATION; Vervliet B, 2013, ANNU REV CLIN PSYCHO, V9, P215, DOI 10.1146/annurev-clinpsy-050212-185542; Wilensky AE, 1999, J NEUROSCI, V19, DOI 10.1523/JNEUROSCI.19-24-j0006.1999; WILSON A, 1995, BEHAV NEUROSCI, V109, P828, DOI 10.1037/0735-7044.109.5.828	50	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e100108	10.1371/journal.pone.0100108	http://dx.doi.org/10.1371/journal.pone.0100108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925360	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300121
J	Takase, K; Kikuchi, K; Tsuneoka, Y; Oda, S; Kuroda, M; Funato, H				Takase, Kenkichi; Kikuchi, Kenichi; Tsuneoka, Yousuke; Oda, Satoko; Kuroda, Masaru; Funato, Hiromasa			Meta-Analysis of Melanin-Concentrating Hormone Signaling-Deficient Mice on Behavioral and Metabolic Phenotypes	PLOS ONE			English	Article							DIET-INDUCED OBESITY; FEEDING-BEHAVIOR; BODY-WEIGHT; RECEPTOR ANTAGONIST; MCH1 RECEPTOR; RAT-BRAIN; NEURONS; OREXIN; IDENTIFICATION; ABLATION	The demand for meta-analyses in basic biomedical research has been increasing because the phenotyping of genetically modified mice does not always produce consistent results. Melanin-concentrating hormone (MCH) has been reported to be involved in a variety of behaviors that include feeding, body-weight regulation, anxiety, sleep, and reward behavior. However, the reported behavioral and metabolic characteristics of MCH signaling-deficient mice, such as MCH-deficient mice and MCH receptor 1 (MCHR1)-deficient mice, are not consistent with each other. In the present study, we performed a meta-analysis of the published data related to MCH-deficient and MCHR1-deficient mice to obtain robust conclusions about the role of MCH signaling. Overall, the meta-analysis revealed that the deletion of MCH signaling enhanced wakefulness, locomotor activity, aggression, and male sexual behavior and that MCH signaling deficiency suppressed non-REM sleep, anxiety, responses to novelty, startle responses, and conditioned place preferences. In contrast to the acute orexigenic effect of MCH, MCH signaling deficiency significantly increased food intake. Overall, the meta-analysis also revealed that the deletion of MCH signaling suppressed the body weight, fat mass, and plasma leptin, while MCH signaling deficiency increased the body temperature, oxygen consumption, heart rate, and mean arterial pressure. The lean phenotype of the MCH signaling-deficient mice was also confirmed in separate meta-analyses that were specific to sex and background strain (i.e., C57BL/6 and 129Sv). MCH signaling deficiency caused a weak anxiolytic effect as assessed with the elevated plus maze and the open field test but also caused a weak anxiogenic effect as assessed with the emergence test. MCH signaling-deficient mice also exhibited increased plasma corticosterone under non-stressed conditions, which suggests enhanced activity of the hypothalamic-pituitary-adrenal axis. To the best of our knowledge, the present work is the first study to systematically compare the effects of MCH signaling on behavioral and metabolic phenotypes.	[Takase, Kenkichi; Tsuneoka, Yousuke; Oda, Satoko; Kuroda, Masaru; Funato, Hiromasa] Toho Univ, Sch Med, Dept Anat, Tokyo, Japan; [Kikuchi, Kenichi] Toho Univ, Fac Sci, Dept Informat Sci, Chiba 2748510, Japan; [Funato, Hiromasa] Univ Tsukuba, Int Inst Integrat Sleep Med, Ibaraki, Japan	Toho University; Toho University; University of Tsukuba	Funato, H (corresponding author), Toho Univ, Sch Med, Dept Anat, Tokyo, Japan.	hiromasa.funato@med.toho-u.ac.jp	Satoko, Oda/J-8508-2016	Funato, Hiromasa/0000-0002-2787-9700	JSPS KAKENHI [25126725, 25460317]; MEXT KAKENHI [25460318]; Nestle Nutrition Council Japan; JSPSKAKENHI [24780292]; Toho University School of Medicine [21-3]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Nestle Nutrition Council Japan(Nestle SA); JSPSKAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Toho University School of Medicine(Toho University)	This work was supported by JSPS KAKENHI Grant Number 25126725 to HF, MEXT KAKENHI Grant Number 25460318 to HF, the Research Grant from Nestle Nutrition Council Japan to HF, JSPS KAKENHI Grant Number 25460317 to KT, JSPSKAKENHI Grant Number 24780292 to YT, and the Research Grant from Toho University School of Medicine (No. 21-3) to HF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamantidis A, 2005, EUR J NEUROSCI, V21, P2837, DOI 10.1111/j.1460-9568.2005.04100.x; Adams AC, 2011, BEHAV BRAIN RES, V224, P195, DOI 10.1016/j.bbr.2011.05.039; Ahnaou A, 2011, BEHAV BRAIN RES, V218, P42, DOI 10.1016/j.bbr.2010.11.019; Alon T, 2006, J NEUROSCI, V26, P389, DOI 10.1523/JNEUROSCI.1203-05.2006; An SZ, 2001, P NATL ACAD SCI USA, V98, P7576, DOI 10.1073/pnas.131200698; ANAND BK, 1951, YALE J BIOL MED, V24, P123; Anderson DJ, 2012, BIOL PSYCHIAT, V71, P1081, DOI 10.1016/j.biopsych.2011.11.012; Astrand A, 2004, AM J PHYSIOL-REG I, V287, pR749, DOI 10.1152/ajpregu.00134.2004; Borenstein M, 2010, RES SYNTH METHODS, V1, P97, DOI 10.1002/jrsm.12; Borowsky B, 2002, NAT MED, V8, P825, DOI 10.1038/nm741; Brown SDM, 2012, MAMM GENOME, V23, P632, DOI 10.1007/s00335-012-9427-x; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Carter ME, 2010, NAT NEUROSCI, V13, P1526, DOI 10.1038/nn.2682; Chen YY, 2002, ENDOCRINOLOGY, V143, P2469, DOI 10.1210/en.143.7.2469; Crabbe JC, 1999, SCIENCE, V284, P1670, DOI 10.1126/science.284.5420.1670; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Duncan EA, 2007, ALCOHOL CLIN EXP RES, V31, P1325, DOI 10.1111/j.1530-0277.2007.00427.x; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Funato H, 2009, CELL METAB, V9, P64, DOI 10.1016/j.cmet.2008.10.010; Gehlert DR, 2009, J PHARMACOL EXP THER, V329, P429, DOI 10.1124/jpet.108.143362; Georgescu D, 2005, J NEUROSCI, V25, P2933, DOI 10.1523/JNEUROSCI.1714-04.2005; Glier MB, 2010, PEPTIDES, V31, P123, DOI 10.1016/j.peptides.2009.10.018; Gomori A, 2003, AM J PHYSIOL-ENDOC M, V284, pE583, DOI 10.1152/ajpendo.00350.2002; Hassani OK, 2009, P NATL ACAD SCI USA, V106, P2418, DOI 10.1073/pnas.0811400106; Hill J, 2001, J BIOL CHEM, V276, P20125, DOI 10.1074/jbc.M102068200; Jego S, 2013, NAT NEUROSCI, V16, P1637, DOI 10.1038/nn.3522; KAWAUCHI H, 1983, NATURE, V305, P321, DOI 10.1038/305321a0; Kerman IA, 2007, J COMP NEUROL, V505, P586, DOI 10.1002/cne.21511; Kokkotou E, 2005, AM J PHYSIOL-REG I, V289, pR117, DOI 10.1152/ajpregu.00861.2004; Lalonde R, 2007, BEHAV BRAIN RES, V178, P293, DOI 10.1016/j.bbr.2007.01.006; Lin DY, 2011, NATURE, V470, P221, DOI 10.1038/nature09736; Lipsey M. W., 2000, PRACTICAL METAANALAY; Ludwig DS, 2001, J CLIN INVEST, V107, P379, DOI 10.1172/JCI10660; Marsh DJ, 2002, P NATL ACAD SCI USA, V99, P3240, DOI 10.1073/pnas.052706899; Monti JM, 2013, SLEEP MED REV, V17, P293, DOI 10.1016/j.smrv.2012.10.002; Moore NA, 2014, NEUROBIOL DIS, V61, P47, DOI 10.1016/j.nbd.2013.07.009; Nakamura K, 2011, AM J PHYSIOL-REG I, V301, pR1207, DOI 10.1152/ajpregu.00109.2011; Nelson RJ, 2007, NAT REV NEUROSCI, V8, P536, DOI 10.1038/nrn2174; Pissios P, 2006, ENDOCR REV, V27, P606, DOI 10.1210/er.2006-0021; Qu DQ, 1996, NATURE, V380, P243, DOI 10.1038/380243a0; Rosenthal R, 2001, ANNU REV PSYCHOL, V52, P59, DOI 10.1146/annurev.psych.52.1.59; Rossi M, 1997, ENDOCRINOLOGY, V138, P351, DOI 10.1210/en.138.1.351; Roy M, 2006, NEUROPSYCHOPHARMACOL, V31, P112, DOI 10.1038/sj.npp.1300805; Roy M, 2007, BIOL PSYCHIAT, V61, P174, DOI 10.1016/j.biopsych.2006.03.076; Sailer AW, 2001, P NATL ACAD SCI USA, V98, P7564, DOI 10.1073/pnas.121170598; Saito Y, 2001, J COMP NEUROL, V435, P26, DOI 10.1002/cne.1191; Saito Y, 1999, NATURE, V400, P265, DOI 10.1038/22321; Sakurai T, 1998, CELL, V92, P573, DOI 10.1016/S0092-8674(00)80949-6; Shearman LP, 2003, EUR J PHARMACOL, V475, P37, DOI 10.1016/S0014-2999(03)02146-0; Sherwood A, 2012, EUR J NEUROSCI, V36, P3126, DOI 10.1111/j.1460-9568.2012.08207.x; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; SKOFITSCH G, 1985, BRAIN RES BULL, V15, P635, DOI 10.1016/0361-9230(85)90213-8; Smith DG, 2006, NEUROPSYCHOPHARMACOL, V31, P1135, DOI 10.1038/sj.npp.1300913; Smith DG, 2005, J NEUROSCI, V25, P914, DOI 10.1523/JNEUROSCI.4079-04.2005; Tabakoff B, 2013, PHARMACOL BIOCHEM BE, V113, P20, DOI 10.1016/j.pbb.2013.10.009; Takekawa S, 2002, EUR J PHARMACOL, V438, P129, DOI 10.1016/S0014-2999(02)01314-6; Tyhon A, 2006, BEHAV BRAIN RES, V173, P94, DOI 10.1016/j.bbr.2006.06.007; Tyhon A, 2008, EUR J PHARMACOL, V599, P72, DOI 10.1016/j.ejphar.2008.09.027; Whiddon BB, 2013, J NEUROSCI, V33, P2009, DOI 10.1523/JNEUROSCI.3921-12.2013; Willie JT, 2008, NEUROSCIENCE, V156, P819, DOI 10.1016/j.neuroscience.2008.08.048; Yamanaka A, 1999, BRAIN RES, V849, P248, DOI 10.1016/S0006-8993(99)01905-8; Zhou D, 2005, REGUL PEPTIDES, V124, P53, DOI 10.1016/j.regpep.2004.06.026	63	17	17	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99961	10.1371/journal.pone.0099961	http://dx.doi.org/10.1371/journal.pone.0099961			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924345	Green Submitted, Green Published, gold			2022-12-27	WOS:000338701300111
J	Yang, H; Shao, ML; Chen, LM; Chen, QS; Yu, LC; Cai, LQ; Lin, ZZ; Zhang, C; Lu, XM				Yang, Hong; Shao, Minglong; Chen, Liangmiao; Chen, Qingshou; Yu, Lechu; Cai, Lingqiao; Lin, Zhenzhen; Zhang, Chi; Lu, Xuemian			Screening Strategies for Thyroid Disorders in the First and Second Trimester of Pregnancy in China	PLOS ONE			English	Article							SUBCLINICAL HYPOTHYROIDISM; WOMEN; DYSFUNCTION; UNIVERSAL; DISEASE; RISK; COMPLICATIONS; MANAGEMENT; DEFICIENCY; OUTCOMES	Background: Thyroid dysfunction during pregnancy is associated with multiple adverse outcomes, but whether all women should be screened for thyroid disorders during pregnancy remains controversial. Objective: To evaluate the effectiveness of the targeted high risk case-finding approach for identifying women with thyroid dysfunction during the first and second trimesters of pregnancy. Methods: Levels of thyroid stimulating hormone (TSH), free thyroxine (FT4), and thyroid peroxidase antibodies (TPOAb) were measured in 3882 Chinese women during the first and second trimester of pregnancy. All tested women were divided into the high risk or non-high risk groups, based on their history, findings from physical examination, or other clinical features suggestive of a thyroid disorder. Diagnosis of thyroid disorders was made according to the standard trimester-specific reference intervals. The prevalence of thyroid disorders in each group was determined, and the feasibility of a screening approach focusing exclusively on high risk women was evaluated to estimate the ability of finding women with thyroid dysfunction. Results: The prevalence of overt hypothyroidism or hyperthyroidism in the high risk group was higher than in the non-high risk group during the first trimester (0.8% vs 0, chi(2) = 7.10, p = 0.008; 1.6% vs 0.2%, chi(2) = 7.02, p = 0.008, respectively). The prevalence of hypothyroxinemia or TPOAb positivity was significantly higher in the high risk group than in the non-high risk group during the second trimester (1.3% vs 0.5%, chi(2) = 4.49, p = 0.034; 11.6% vs 8.4%, chi(2) = 6.396, p = 0.011, respectively). The total prevalence of hypothyroidism or hyperthyroidism and the prevalence of subclinical hypothyroidism or hyperthyroidism were not statistically different between the high risk and non-high risk groups, for either the first or second trimester. Conclusion: The high risk screening strategy failed to detect the majority of pregnant women with thyroid disorders. Therefore, we recommend universal screening of sTSH, FT4, and TPOAb during the first trimester and second trimester of pregnancy.	[Yang, Hong; Chen, Liangmiao; Chen, Qingshou; Yu, Lechu; Cai, Lingqiao; Lin, Zhenzhen; Lu, Xuemian] Wenzhou Med Univ, Dept Endocrinol, Hosp 3, Ruian, Zhejiang, Peoples R China; [Yang, Hong; Chen, Liangmiao; Chen, Qingshou; Yu, Lechu; Cai, Lingqiao; Lin, Zhenzhen; Lu, Xuemian] Wenzhou Med Univ, Ruian Ctr, Hosp 3, Chinese Amer Res Inst Diabet Complicat, Ruian, Zhejiang, Peoples R China; [Shao, Minglong; Zhang, Chi] Wenzhou Med Univ, Key Lab Biotechnol Pharmaceut Engn, Sch Pharmaceut Sci, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Zhejiang, Peoples R China	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University	Zhang, C (corresponding author), Wenzhou Med Univ, Key Lab Biotechnol Pharmaceut Engn, Sch Pharmaceut Sci, Chinese Amer Res Inst Diabet Complicat, Wenzhou, Zhejiang, Peoples R China.	zhangchi515@126.com; lu89118@medmail.com.cn	Cai, Lu/AAG-9920-2019	Liangmiao, Chen/0000-0002-6687-5825	Medical Science Research Foundation of Zhejiang Province [2009A198]; Science and technology project of Ruian city [20093092]; Ruian Science and Technology Plan [201002051]; Young Scientist Award from National Science Foundation of China [81000294]; National Science Foundation of China [81370917]; Research Development Fund of Wenzhou Medical University [QTJ13005]	Medical Science Research Foundation of Zhejiang Province; Science and technology project of Ruian city; Ruian Science and Technology Plan; Young Scientist Award from National Science Foundation of China; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Development Fund of Wenzhou Medical University	This study was supported in part by a project from Medical Science Research Foundation of Zhejiang Province (2009A198, to XL), and the third batch of Science and technology project of Ruian city (20093092, to XL), a project funding was further supported by Ruian Science and Technology Plan (201002051, to HY), a Young Scientist Award from National Science Foundation of China (81000294, to CZ), a National Science Foundation of China (81370917, to CZ) and the Research Development Fund of Wenzhou Medical University (QTJ13005, to CZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan WC, 2000, J MED SCREEN, V7, P127, DOI 10.1136/jms.7.3.127; [Anonymous], 2003, THYROID, V13, P3; Casey BM, 2005, OBSTET GYNECOL, V105, P239, DOI 10.1097/01.AOG.0000152345.99421.22; Casey BM, 2006, OBSTET GYNECOL, V108, P1283, DOI 10.1097/01.AOG.0000244103.91597.c5; De Groot L, 2012, J CLIN ENDOCR METAB, V97, P2543, DOI 10.1210/jc.2011-2803; De Vivo A, 2010, THYROID, V20, P633, DOI 10.1089/thy.2009.0323; Dosiou C, 2012, J CLIN ENDOCR METAB, V97, P1536, DOI 10.1210/jc.2011-2884; Endocrine Society, 2007, Thyroid, V17, P1159; GLINOER D, 1994, J CLIN ENDOCR METAB, V79, P197, DOI 10.1210/jcem.79.1.8027226; Haddow JE, 1999, NEW ENGL J MED, V341, P549, DOI 10.1056/NEJM199908193410801; Hirsch D, 2013, EUR J ENDOCRINOL, V169, P313, DOI 10.1530/EJE-13-0228; Julvez J, 2013, EPIDEMIOLOGY, V24, P150, DOI 10.1097/EDE.0b013e318276ccd3; Lazarus JH, 2012, NEW ENGL J MED, V366, P493, DOI 10.1056/NEJMoa1106104; Mannisto T, 2013, J CLIN ENDOCR METAB, V98, P2725, DOI 10.1210/jc.2012-4233; Mannisto T, 2010, J CLIN ENDOCR METAB, V95, P1084, DOI 10.1210/jc.2009-1904; Negro R, 2006, J CLIN ENDOCR METAB, V91, P2587, DOI 10.1210/jc.2005-1603; Negro R, 2010, J CLIN ENDOCR METAB, V95, P1699, DOI 10.1210/jc.2009-2009; Papendieck P, 2009, J PEDIATR ENDOCR MET, V22, P547; Pop VJ, 2003, CLIN ENDOCRINOL, V59, P282, DOI 10.1046/j.1365-2265.2003.01822.x; Potlukova E, 2012, J CLIN ENDOCR METAB, V97, P1945, DOI 10.1210/jc.2011-3275; Prummel MF, 2004, EUR J ENDOCRINOL, V150, P751, DOI 10.1530/eje.0.1500751; Sheffield JS, 2004, AM J OBSTET GYNECOL, V190, P211, DOI 10.1016/S0002-9378(03)00944-X; Stagnaro-Green A, 2011, THYROID, V21, P1081, DOI 10.1089/thy.2011.0087; Su PY, 2011, J CLIN ENDOCR METAB, V96, P3234, DOI 10.1210/jc.2011-0274; Thung SF, 2009, AM J OBSTET GYNECOL, V200, pe261; Vaidya B, 2007, J CLIN ENDOCR METAB, V92, P203, DOI 10.1210/jc.2006-1748; Wang WW, 2011, EUR J ENDOCRINOL, V164, P263, DOI 10.1530/EJE-10-0660	27	16	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99611	10.1371/journal.pone.0099611	http://dx.doi.org/10.1371/journal.pone.0099611			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925135	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300081
J	Wang, XH; Li, QL; Hu, QS; Suntharalingam, P; From, AHL; Zhang, JY				Wang, Xiaohong; Li, Qinglu; Hu, Qingsong; Suntharalingam, Piradeep; From, Arthur H. L.; Zhang, Jianyi			Intra-Myocardial Injection of Both Growth Factors and Heart Derived Sca-1(+)/CD31(-) Cells Attenuates Post-MI LV Remodeling More Than Does Cell Transplantation Alone: Neither Intervention Enhances Functionally Significant Cardiomyocyte Regeneration	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; INFARCTED MYOCARDIUM; VENTRICULAR-FUNCTION; ISCHEMIC-HEART; AKT; PROTECTION; APOPTOSIS; THERAPY; MULTIPOTENT; ACTIVATION	Insulin-like growth factor 1 (IGF-1) and hepatocyte growth factor (HGF) are two potent cell survival and regenerative factors in response to myocardial injury (MI). We hypothesized that simultaneous delivery of IGF+HGF combined with Sca-1(+)/CD31(-) cells would improve the outcome of transplantation therapy in response to the altered hostile microenvironment post MI. One million adenovirus nuclear LacZ-labeled Sca-1(+)/CD31(-) cells were injected into the peri-infarction area after left anterior descending coronary artery (LAD) ligation in mice. Recombinant mouse IGF-1+HGF was added to the cell suspension prior to the injection. The left ventricular (LV) function was assessed by echocardiography 4 weeks after the transplantation. The cell engraftment, differentiation and cardiomyocyte regeneration were evaluated by histological analysis. Sca-1(+)/CD31(-) cells formed viable grafts and improved LV ejection fraction (EF) (Control, 54.5+/-2.4; MI, 17.6+/-2 3.1; Cell, 28.2+/-4.2, n = 9, P<0.01). IGF+HGF significantly enhanced the benefits of cell transplantation as evidenced by increased EF (38.8+/-2.2; n = 9, P<0.01) and attenuated adverse structural remodeling. Furthermore, IGF+HGF supplementation increased the cell engraftment rate, promoted the transplanted cell survival, enhanced angiogenesis, and minimally stimulated endogenous cardiomyocyte regeneration in vivo. The in vitro experiments showed that IGF+HGF treatment stimulated Sca-1(+)/CD31(-) cell proliferation and inhibited serum free medium induced apoptosis. Supperarray profiling of Sca-1(+)/CD31(-) cells revealed that Sca-1(+)/CD31(-) cells highly expressed various trophic factor mRNAs and IGF+HGF treatment altered the mRNAs expression patterns of these cells. These data indicate that IGF-1+HGF could serve as an adjuvant to cell transplantation for myocardial repair by stimulating donor cell and endogenous cardiac stem cell survival, regeneration and promoting angiogenesis.	[Wang, Xiaohong; Li, Qinglu; Hu, Qingsong; Suntharalingam, Piradeep; From, Arthur H. L.; Zhang, Jianyi] Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Wang, XH (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Cardiovasc, Minneapolis, MN 55455 USA.	wangx270@umn.edu; zhang047@umn.edu	Zhang, Jianyi/N-1949-2018; wang, xiao/HGB-7081-2022	Zhang, Jianyi/0000-0002-3955-6554; wang, xiao/0000-0002-4088-3341	American Heart Association; Lillehei Institute; National Institutes of Health [NCRR P41 RR008079]; Department of Medicine (Cardiology Division) of the University of Minnesota;  [HL 67828];  [0750160Z]; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR008079] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015894] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Lillehei Institute; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Medicine (Cardiology Division) of the University of Minnesota; ; ; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was supported by an American Heart Association Grant-in Aid (X.W #0750160Z) and the Lillehei Institute and the Department of Medicine (Cardiology Division) of the University of Minnesota (X.W. and J.Z.), and HL 67828 (J.Z.) and support to the Center for Magnetic Resonance Research of the University of Minnesota by National Institutes of Health grant NCRR P41 RR008079 (to Kamil Ugurbil, PhD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akasaka Y, 2006, MODERN PATHOL, V19, P588, DOI 10.1038/modpathol.3800568; Anversa P, 2005, BASIC RES CARDIOL, V100, P482, DOI 10.1007/s00395-005-0554-3; Bialik S, 1997, J CLIN INVEST, V100, P1363, DOI 10.1172/JCI119656; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; Davis ME, 2006, P NATL ACAD SCI USA, V103, P8155, DOI 10.1073/pnas.0602877103; Devin JK, 2008, CURR OPIN INVEST DR, V9, P983; Donath S, 2006, CIRCULATION, V113, P1203, DOI 10.1161/CIRCULATIONAHA.105.576785; Giordano FJ, 2001, P NATL ACAD SCI USA, V98, P5780, DOI 10.1073/pnas.091415198; Gnecchi M, 2005, NAT MED, V11, P367, DOI 10.1038/nm0405-367; Gnecchi M, 2008, CIRC RES, V103, P1204, DOI 10.1161/CIRCRESAHA.108.176826; Gnecchi M, 2006, FASEB J, V20, P661, DOI 10.1096/fj.05-5211com; Gnecchi M, 2009, STEM CELLS, V27, P971, DOI 10.1002/stem.12; Guarita-Souza LC, 2006, CIRCULATION, V114, pI120, DOI 10.1161/CIRCULATIONAHA.105.000646; Jayasankar V, 2003, CIRCULATION, V108, P230, DOI 10.1161/01.cir.0000087444.53354.66; Kajstura J, 2005, CIRC RES, V96, P127, DOI 10.1161/01.RES.0000151843.79801.60; Li Z, 2007, CIRCULATION, V116, pI46, DOI 10.1161/CIRCULATIONAHA.106.680561; Linke A, 2005, P NATL ACAD SCI USA, V102, P8966, DOI 10.1073/pnas.0502678102; Mangi AA, 2003, NAT MED, V9, P1195, DOI 10.1038/nm912; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miyagawa S, 2002, CIRCULATION, V105, P2556, DOI 10.1161/01.CIR.0000016722.37138.F2; Miyahara Y, 2006, NAT MED, V12, P459, DOI 10.1038/nm1391; Nakamura T, 2000, J CLIN INVEST, V106, P1511, DOI 10.1172/JCI10226; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Penn MS, 2008, CIRC RES, V102, P1471, DOI 10.1161/CIRCRESAHA.108.175174; Rappolee DA, 1996, CIRC RES, V78, P1028, DOI 10.1161/01.RES.78.6.1028; Rota M, 2008, CIRC RES, V103, P107, DOI 10.1161/CIRCRESAHA.108.178525; Tang XL, 2010, CIRCULATION, V121, P293, DOI 10.1161/CIRCULATIONAHA.109.871905; Tang YL, 2007, BIOCHEM BIOPH RES CO, V359, P877, DOI 10.1016/j.bbrc.2007.05.216; Ueda H, 2001, CARDIOVASC RES, V51, P41, DOI 10.1016/S0008-6363(01)00272-3; Urbanek K, 2005, CIRC RES, V97, P663, DOI 10.1161/01.RES.0000183733.53101.11; van der Bogt KEA, 2008, CIRCULATION, V118, pS121, DOI 10.1161/CIRCULATIONAHA.107.759480; Wang XH, 2006, STEM CELLS, V24, P1779, DOI 10.1634/stemcells.2005-0386; Wang XH, 2009, CIRCULATION, V120, pS790; Weber KT, 1997, CIRCULATION, V96, P2488; Whelan RS, 2010, ANNU REV PHYSIOL, V72, P19, DOI 10.1146/annurev.physiol.010908.163111; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730	36	12	14	3	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e95247	10.1371/journal.pone.0095247	http://dx.doi.org/10.1371/journal.pone.0095247			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919180	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000004
J	Giacomazzi, J; Graudenz, MS; Osorio, CABT; Koehler-Santos, P; Palmero, EI; Zagonel-Oliveira, M; Michelli, RAD; Neto, CS; Fernandes, GC; Achatz, MIWS; Martel-Planche, G; Soares, FA; Caleffi, M; Goldim, JR; Hainaut, P; Camey, SA; Ashton-Prolla, P				Giacomazzi, Juliana; Graudenz, Marcia S.; Osorio, Cynthia A. B. T.; Koehler-Santos, Patricia; Palmero, Edenir I.; Zagonel-Oliveira, Marcelo; Michelli, Rodrigo A. D.; Neto, Cristovam Scapulatempo; Fernandes, Gabriela C.; Achatz, Maria Isabel W. S.; Martel-Planche, Ghyslaine; Soares, Fernando A.; Caleffi, Maira; Goldim, Jose Roberto; Hainaut, Pierre; Camey, Suzi A.; Ashton-Prolla, Patricia			Prevalence of the TP53 p.R337H Mutation in Breast Cancer Patients in Brazil	PLOS ONE			English	Article							LI-FRAUMENI; SCREENING-PROGRAM; R337H MUTATION; POPULATION; FAMILIES; PH	Germline TP53 mutations predispose individuals to multiple cancers and are associated with Li-Fraumeni/Li-Fraumeni-Like Syndromes (LFS/LFL). The founder mutation TP53 p.R337H is detected in 0.3% of the general population in southern Brazil. This mutation is associated with an increased risk of childhood adrenal cortical carcinoma (ACC) but is also common in Brazilian LFS/LFL families. Breast Cancer (BC) is one of the most common cancers diagnosed in TP53 mutation carriers. We have assessed the prevalence of p.R337H in two groups: (1) 59 BC affected women with a familial history (FH) suggestive of hereditary cancer syndrome but no LFS/LFL features; (2) 815 BC affected women unselected for cancer FH, diagnosed with BC at or before age 45 or at age 55 or older. Among group 1 and group 2 patients, 2/59 (3.4%, CI95%: 0.4%-11.7%) and 70/815 (8.6%, CI95%: 6.8%-10.7%), respectively, were p.R337H carriers in the germline. The prevalence of p.R337H was higher in women diagnosed with BC at or before age 45 (12.1%, CI95%: 9.1%-15.8%) than at age 55 or older (5.1%, CI95%: 3.2%-7.7%), p<0.001). The Brazilian founder p.R337H haplotype was detected in all carriers analysed. These results suggest that inheritance of p.R337H may significantly contribute to the high incidence of BC in Brazil, in addition to its recently demonstrated impact on the risk of childhood ACC.	[Giacomazzi, Juliana; Ashton-Prolla, Patricia] Hosp Clin Porto Alegre HCPA, Expt Res Ctr, Genom Med Lab, Porto Alegre, RS, Brazil; [Giacomazzi, Juliana; Graudenz, Marcia S.; Ashton-Prolla, Patricia] Univ Fed Rio Grande Sul UFRGS, Postgrad Program Med Med Sci, Porto Alegre, RS, Brazil; [Graudenz, Marcia S.] HCPA, Pathol Serv, Porto Alegre, RS, Brazil; [Graudenz, Marcia S.] Inst Patol, Porto Alegre, RS, Brazil; [Osorio, Cynthia A. B. T.; Soares, Fernando A.] Hosp Canc AC Camargo HCACC, Pathol Serv, Sao Paulo, Brazil; [Koehler-Santos, Patricia] HCPA, Expt Res Ctr, Prot & Mol Anal Lab, Porto Alegre, RS, Brazil; [Palmero, Edenir I.; Michelli, Rodrigo A. D.; Neto, Cristovam Scapulatempo; Fernandes, Gabriela C.] Hosp Canc Barretos, Mol Oncol Res Ctr, Sao Paulo, Brazil; [Zagonel-Oliveira, Marcelo; Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, Natl Inst Populat Med Genet INAGEMP, Porto Alegre, RS, Brazil; [Achatz, Maria Isabel W. S.] HCACC, Oncogenet Dept, Sao Paulo, Brazil; [Martel-Planche, Ghyslaine; Hainaut, Pierre] Int Agcy Res Canc IARC, Lyon, Rhone, France; [Caleffi, Maira] Hosp Moinhos Vento, Porto Alegre, RS, Brazil; [Goldim, Jose Roberto] HCPA, Bioeth Res Lab, Porto Alegre, RS, Brazil; [Hainaut, Pierre] Int Prevent Res Inst, Lyon, Rhone, France; [Camey, Suzi A.] Univ Fed Rio Grande do Sul, Inst Math, Dept Stat, Porto Alegre, RS, Brazil; [Ashton-Prolla, Patricia] Univ Fed Rio Grande do Sul, Postgrad Program Genet & Mol Biol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; A.C.Camargo Cancer Center; Hospital de Cancer de Barretos; Universidade Federal do Rio Grande do Sul; A.C.Camargo Cancer Center; World Health Organization; International Agency for Research on Cancer (IARC); Universidade Federal do Rio Grande do Sul; Universidade Federal do Rio Grande do Sul	Giacomazzi, J (corresponding author), Hosp Clin Porto Alegre HCPA, Expt Res Ctr, Genom Med Lab, Porto Alegre, RS, Brazil.	jugiacomazzi@gmail.com	Hainaut, Pierre/B-6018-2012; Osório, Cynthia/AAI-7427-2020; Camey, Suzi A/H-2346-2012; Palmero, Edenir/F-4341-2015; Achatz, Maria Isabel/C-5751-2013; Fernandes, Gabriela/GRJ-1743-2022; Ashton-Prolla, Patricia/T-3515-2019; Camey, Suzi Alves/Y-2756-2019; Ashton-Prolla, Patricia/H-2927-2012; de Toledo Osório, Cynthia Bueno/J-9282-2015; GRAUDENZ, MARCIA S/Q-4174-2017; Goldim, Jose R/G-2726-2012; Giacomazzi, Juliana/F-6629-2015	Hainaut, Pierre/0000-0002-1303-1610; Camey, Suzi A/0000-0002-5564-081X; Palmero, Edenir/0000-0003-1904-2158; Achatz, Maria Isabel/0000-0001-6894-1219; Camey, Suzi Alves/0000-0002-5564-081X; de Toledo Osório, Cynthia Bueno/0000-0002-7675-9780; Scapulatempo-Neto, Cristovam/0000-0002-8920-6579; Soares, Fernando Augusto/0000-0003-1647-7842; Goldim, Jose Roberto/0000-0003-2127-6594; Giacomazzi, Juliana/0000-0001-5811-5140; Zagonel de Oliveira, Marcelo/0000-0003-4006-4052; Caleffi, Maira/0000-0002-9494-9457; Soares, Fernando/0000-0002-1212-9093	GlaxoSmithKline Oncology (Ethnic Research Initiative), U.K.; CNPq, Brazil [307779 2009-2]; FAPERGS-PPSUS [09/0103-0]; FAPERGS PRONEX [10/0051-9]; Fundo de Incentivo a Pesquisa e Eventos, Hospital de Clinicas de Porto Alegre (GPPG), Brazil [08080]; CAPES; CNPQ (Brazil)	GlaxoSmithKline Oncology (Ethnic Research Initiative), U.K.; CNPq, Brazil(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERGS-PPSUS; FAPERGS PRONEX(Fundacao de Amparo a Ciencia e Tecnologia do Estado do Rio Grande do Sul (FAPERGS)); Fundo de Incentivo a Pesquisa e Eventos, Hospital de Clinicas de Porto Alegre (GPPG), Brazil; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPQ (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The study was supported in part by grants from GlaxoSmithKline Oncology (Ethnic Research Initiative Grant Award 2009), U.K.; CNPq to PA-P (grant 307779 2009-2), Brazil; FAPERGS-PPSUS (grant # 09/0103-0), FAPERGS PRONEX (grant #10/0051-9) and Fundo de Incentivo a Pesquisa e Eventos, Hospital de Clinicas de Porto Alegre (GPPG # 08080), Brazil. The work of JG was supported by fellowships from CAPES and CNPQ (Brazil). The authors certify that none of the funders had a role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Assumpcao JG, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-357; BORRESEN AL, 1992, CANCER RES, V52, P3234; Custodio G, 2013, J CLIN ONCOL, V31, P2619, DOI 10.1200/JCO.2012.46.3711; da Silva EM, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-449; DiGiammarino EL, 2002, NAT STRUCT BIOL, V9, P12, DOI 10.1038/nsb730; Garritano S, 2010, HUM MUTAT, V31, P143, DOI 10.1002/humu.21151; Giacomazzi J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-187; Ginsburg OM, 2009, FAM CANCER, V8, P563, DOI 10.1007/s10689-009-9287-z; Gomes MCB, 2012, HERED CANCER CLIN PR, V10, DOI 10.1186/1897-4287-10-3; Gonzalez KD, 2009, J CLIN ONCOL, V27, P1250, DOI 10.1200/JCO.2008.16.6959; Hafsi H, 2011, ANTIOXID REDOX SIGN, V15, P1655, DOI 10.1089/ars.2010.3771; Haikel RL, 2012, BMC WOMENS HEALTH, V12, DOI 10.1186/1472-6874-12-32; Lalloo F, 2006, EUR J CANCER, V42, P1143, DOI 10.1016/j.ejca.2005.11.032; Latronico AC, 2001, J CLIN ENDOCR METAB, V86, P4970, DOI 10.1210/jc.86.10.4970; Lee DSC, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3172; MALKIN D, 1990, SCIENCE, V250, P1233, DOI 10.1126/science.1978757; McCuaig JM, 2012, FAM CANCER, V11, P607, DOI 10.1007/s10689-012-9557-z; Meijers-Heijboer H, 2003, AM J HUM GENET, V72, P1308, DOI 10.1086/375121; Mouchawar J, 2010, CANCER RES, V70, P4795, DOI 10.1158/0008-5472.CAN-09-0851; Offit K, 1996, J CLIN ONCOL, V14, P1730, DOI 10.1200/JCO.1996.14.5.1730; Olivier M, 2003, CANCER RES, V63, P6643; Palmero EI, 2008, CANCER LETT, V261, P21, DOI 10.1016/j.canlet.2007.10.044; Ribeiro RC, 2001, P NATL ACAD SCI USA, V98, P9330, DOI 10.1073/pnas.161479898; Seidinger AL, 2011, CANCER-AM CANCER SOC, V117, P2228, DOI 10.1002/cncr.25826; SIDRANSKY D, 1992, CANCER RES, V52, P2984; Tinat J, 2009, J CLIN ONCOL, V27, pE108, DOI 10.1200/JCO.2009.22.7967; Achatz MIW, 2007, CANCER LETT, V245, P96, DOI 10.1016/j.canlet.2005.12.039; Walsh T, 2011, P NATL ACAD SCI USA, V108, P18032, DOI 10.1073/pnas.1115052108; Webb BA, 2011, NAT REV CANCER, V11, P671, DOI 10.1038/nrc3110	29	43	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99893	10.1371/journal.pone.0099893	http://dx.doi.org/10.1371/journal.pone.0099893			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936644	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400050
J	Pabayo, R; Janosz, M; Bisset, S; Kawachi, I				Pabayo, Roman; Janosz, Michel; Bisset, Sherri; Kawachi, Ichiro			School Social Fragmentation, Economic Deprivation and Social Cohesion and Adolescent Physical Inactivity: A Longitudinal Study	PLOS ONE			English	Article							HEALTH; FAMILY; YOUTH; INTERVENTIONS; CONNECTEDNESS; OPPORTUNITIES; INDIVIDUALS; STUDENTS; CLIMATE; CHILD	Objectives: To examine the independent influence of school economic deprivation, social fragmentation, and social cohesion on the likelihood of participating in no physical activity among students. Methods: Data are from a large-scale longitudinal study of schools based in disadvantaged communities in Quebec, Canada. Questionnaires were administered every year between 2002 and 2008 among n = 14,924 students aged 12 to 18 from a sample of 70 schools. Cross-sectional and longitudinal analyses were conducted. Multilevel modeling was utilized to account for the clustering of students within schools. Schools were categorized as being low, moderate or high economic deprivation, social fragmentation and social cohesion. Those who indicated that they do no participate in any physical activity during the week were identified as being physically inactive. Results: In baseline multilevel cross-sectional analyses, adolescents attending schools in the highest (compared to the lowest) levels of socioeconomic deprivation and social fragmentation were more likely to be physically inactive (OR = 1.33, 95% CI = 1.03, 1.72; and OR = 1.24, 95% CI = 0.98, 1.56, respectively). Conversely, students attending schools with the highest cohesion were less likely to be physically inactive (OR = 0.78, 95% CI = 0.61, 0.99). In longitudinal analysis, physically active students who attended schools with the highest social fragmentation were more likely to become physically inactive over two years (OR = 1.65, 95% CI = 1.09, 2.51). Conclusion: The school socioeconomic environment appears to be an important contextual influence on participation in no physical activity among adolescents. Following adolescents beyond two years is necessary to determine if these environments have a lasting effect on physical activity behavior.	[Pabayo, Roman; Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Janosz, Michel] Univ Montreal, Ecole Psychoeduc, Montreal, PQ, Canada; [Janosz, Michel] Univ Montreal, SERG, Montreal, PQ, Canada; [Janosz, Michel] Univ Montreal Publ Hlth Res Inst IRSPUM, Montreal, PQ, Canada; [Bisset, Sherri] Univ Laval, Inst Univ Cardiol & Pneumol Quebec CRIUCPQ, Ctr Rech, Quebec City, PQ, Canada	Harvard University; Harvard T.H. Chan School of Public Health; Universite de Montreal; Universite de Montreal; Universite de Montreal; Laval University	Pabayo, R (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, 665 Huntington Ave, Boston, MA 02115 USA.	rpabayo@hsph.harvard.edu	P, Roman/AAO-3485-2020	P, Roman/0000-0003-4018-4898	Canadian Institutes of Health	Canadian Institutes of Health(Canadian Institutes of Health Research (CIHR))	RP is funded by a Canadian Institutes of Health Postdoctoral Fellowship Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2007, CAN J PUBLIC HEALTH, V98, P97, DOI 10.1007/BF03404317; Barnett TA, 2009, INT J PUBLIC HEALTH, V54, P150, DOI 10.1007/s00038-009-7110-0; Birnbaum AS, 2005, AM J HEALTH BEHAV, V29, P250, DOI 10.5993/AJHB.29.3.6; Bonell CP, 2010, J ADOLESCENT HEALTH, V47, P555, DOI 10.1016/j.jadohealth.2010.04.011; Bourhis RY, 2012, DECLINE ENGLISH SCH; Colley Rachel C, 2011, Health Rep, V22, P15; Congdon P, 2004, INT J EPIDEMIOL, V33, P741, DOI 10.1093/ije/dyh173; Cradock AL, 2009, SOC SCI MED, V68, P427, DOI 10.1016/j.socscimed.2008.10.028; Diez-Roux AV, 2000, ANNU REV PUBL HEALTH, V21, P171, DOI 10.1146/annurev.publhealth.21.1.171; Eaton Danice K., 2012, Morbidity and Mortality Weekly Report, V61, P1; Evenson KR, 2007, AM J HEALTH BEHAV, V31, P86, DOI 10.5993/AJHB.31.1.9; Fagg J, 2008, SOC SCI MED, V66, P242, DOI 10.1016/j.socscimed.2007.07.032; Fagg J, 2006, SOC SCI MED, V63, P636, DOI 10.1016/j.socscimed.2006.02.012; Faulkner GEJ, 2009, J SCHOOL HEALTH, V79, P312, DOI 10.1111/j.1746-1561.2009.00415.x; Freudenberg Nicholas, 2007, Prev Chronic Dis, V4, pA107; Fuller D, 2011, J SCHOOL HEALTH, V81, P449, DOI 10.1111/j.1746-1561.2011.00613.x; Haug E, 2010, HEALTH EDUC RES, V25, P248, DOI 10.1093/her/cyn050; Hoy WK, 1996, J EDUC ADMIN, V34, P41, DOI DOI 10.1108/09578239610107156; Ivory VC, 2011, SOC SCI MED, V72, P1993, DOI 10.1016/j.socscimed.2011.04.015; Janosz M., 1998, REV CANADIENNE PSYCH, V27, P285; Janosz M., 2007, RAPPORT VALIDATION Q; Kahn JA, 2008, J ADOLESCENT HEALTH, V42, P369, DOI 10.1016/j.jadohealth.2007.11.143; Kawachi I., 2008, SOCIAL CAPITAL HLTH, P1, DOI DOI 10.1007/978-0-387-71311-3_1; Keresztes N, 2008, J R SOC PROMO HEALTH, V128, P21, DOI 10.1177/1466424007085228; Kirby J, 2011, J PHYS ACT HEALTH, V8, P785, DOI 10.1123/jpah.8.6.785; Lamarre P, 2012, ENGLISH ED QUEBEC IS, P175; Lasheras L, 2001, PREV MED, V32, P455, DOI 10.1006/pmed.2001.0843; Libbey HP, 2004, J SCHOOL HEALTH, V74, P274, DOI 10.1111/j.1746-1561.2004.tb08284.x; Ma X, 2000, EVALUATION REV, V24, P435, DOI 10.1177/0193841X0002400501; Ma X, 2007, SCH EFF SCH IMPROV, V18, P209, DOI 10.1080/09243450600909183; Markham WA, 2003, SOC SCI MED, V56, P1209, DOI 10.1016/S0277-9536(02)00120-X; MCGINNIS JM, 1991, J SCHOOL HEALTH, V61, P292, DOI 10.1111/j.1746-1561.1991.tb07408.x; Mckenzie TL, 2004, MED SCI SPORT EXER, V36, P1382, DOI 10.1249/01.MSS.0000135792.20358.4D; Millstein RA, 2011, PEDIATR EXERC SCI, V23, P487, DOI 10.1123/pes.23.4.487; Molnar BE, 2004, AM J HEALTH PROMOT, V18, P378, DOI 10.4278/0890-1171-18.5.378; Morton KL, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-48; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926; Pabayo R, 2014, AM J PUBLI IN PRESS; Pabayo R, 2006, HEALTH EDUC BEHAV, V33, P690, DOI 10.1177/1090198105285327; Pabayo Roman, 2012, Am J Public Health, V102, pe30, DOI 10.2105/AJPH.2012.300868; Pabayo R, 2011, SOC SCI MED, V72, P430, DOI 10.1016/j.socscimed.2010.09.039; Reid Robert J, 2006, J Prim Prev, V27, P281, DOI 10.1007/s10935-006-0035-y; Sallis JF, 2003, AM J PREV MED, V24, P209, DOI 10.1016/S0749-3797(02)00646-3; Sallis JF, 2001, AM J PUBLIC HEALTH, V91, P618, DOI 10.2105/AJPH.91.4.618; Sellstrom E, 2006, SCAND J PUBLIC HEALT, V34, P544, DOI 10.1080/14034940600551251; Smith B, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-593; Snijders T. A. B., 2011, MULTILEVEL ANAL INTR; Story M, 1999, Adolesc Med, V10, P109; Story M, 1999, ADOLESCENT MED, V10, pvi; Tremblay MS, 2011, APPL PHYSIOL NUTR ME, V36, P36, DOI [10.1139/H11-009, 10.1139/H11-010]; van Sluijs EMF, 2011, BRIT J SPORT MED, V45, P914, DOI 10.1136/bjsports-2011-090187; Waters SK, 2009, J SCHOOL HEALTH, V79, P516, DOI 10.1111/j.1746-1561.2009.00443.x; Zammit S, 2010, ARCH GEN PSYCHIAT, V67, P914, DOI 10.1001/archgenpsychiatry.2010.101	53	16	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99154	10.1371/journal.pone.0099154	http://dx.doi.org/10.1371/journal.pone.0099154			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ5PV	24932679	Green Submitted, gold, Green Published			2022-12-27	WOS:000337738600023
J	Thomsen, EK; Strode, C; Hemmings, K; Hughes, AJ; Chanda, E; Musapa, M; Kamuliwo, M; Phiri, FN; Muzia, L; Chanda, J; Kandyata, A; Chirwa, B; Poer, K; Hemingway, J; Wondji, CS; Ranson, H; Coleman, M				Thomsen, Edward K.; Strode, Clare; Hemmings, Kay; Hughes, Angela J.; Chanda, Emmanuel; Musapa, Mulenga; Kamuliwo, Mulakwa; Phiri, Faustina N.; Muzia, Lucy; Chanda, Javan; Kandyata, Alister; Chirwa, Brian; Poer, Kathleen; Hemingway, Janet; Wondji, Charles S.; Ranson, Hilary; Coleman, Michael			Underpinning Sustainable Vector Control through Informed Insecticide Resistance Management	PLOS ONE			English	Article							ANOPHELES-FUNESTUS DIPTERA; MALARIA CONTROL; PYRETHROID RESISTANCE; TREATED NETS; GAMBIAE-S.S.; IDENTIFICATION; IMPACT; POPULATIONS; EXPRESSION; ARABIENSIS	Background: There has been rapid scale-up of malaria vector control in the last ten years. Both of the primary control strategies, long-lasting pyrethroid treated nets and indoor residual spraying, rely on the use of a limited number of insecticides. Insecticide resistance, as measured by bioassay, has rapidly increased in prevalence and has come to the forefront as an issue that needs to be addressed to maintain the sustainability of malaria control and the drive to elimination. Zambia's programme reported high levels of resistance to the insecticides it used in 2010, and, as a result, increased its investment in resistance monitoring to support informed resistance management decisions. Methodology/Principal Findings: A country-wide survey on insecticide resistance in Zambian malaria vectors was performed using WHO bioassays to detect resistant phenotypes. Molecular techniques were used to detect target-site mutations and microarray to detect metabolic resistance mechanisms. Anopheles gambiae s.s. was resistant to pyrethroids, DDT and carbamates, with potential organophosphate resistance in one population. The resistant phenotypes were conferred by both target-site and metabolic mechanisms. Anopheles funestus s.s. was largely resistant to pyrethroids and carbamates, with potential resistance to DDT in two locations. The resistant phenotypes were conferred by elevated levels of cytochrome p450s. Conclusions/Significance: Currently, the Zambia National Malaria Control Centre is using these results to inform their vector control strategy. The methods employed here can serve as a template to all malaria-endemic countries striving to create a sustainable insecticide resistance management plan.	[Thomsen, Edward K.; Strode, Clare; Hemmings, Kay; Hughes, Angela J.; Hemingway, Janet; Wondji, Charles S.; Ranson, Hilary; Coleman, Michael] Univ Liverpool, Liverpool Sch Trop Med, Vector Biol Dept, Liverpool L3 5QA, Merseyside, England; [Chanda, Emmanuel; Kamuliwo, Mulakwa; Phiri, Faustina N.; Chanda, Javan; Kandyata, Alister] Natl Malaria Control Ctr, Lusaka, Zambia; [Musapa, Mulenga; Muzia, Lucy; Chirwa, Brian; Poer, Kathleen] Abt Associates Inc, Zambia Integrated Syst Strengthening Program, Lusaka, Zambia	Liverpool School of Tropical Medicine; University of Liverpool; ABT Associates	Thomsen, EK (corresponding author), Univ Liverpool, Liverpool Sch Trop Med, Vector Biol Dept, Liverpool L3 5QA, Merseyside, England.	ethomsen@liv.ac.uk	Wondji, Charles/AAG-1510-2020; Thomsen, Edward/AAH-3299-2020	Thomsen, Edward/0000-0003-1136-6430; Strode, Clare/0000-0003-2833-8073; Hemingway, Janet/0000-0002-3200-7173; Coleman, Michael/0000-0003-4186-3526; Ranson, Hilary/0000-0003-2332-8247; Wondji, Charles S./0000-0003-0791-3673	Presidents Malaria Initiative via the Zambia Integrated Systems Strengthening Program; Innovative Vector Control Consortium	Presidents Malaria Initiative via the Zambia Integrated Systems Strengthening Program; Innovative Vector Control Consortium	This work was funded through the Presidents Malaria Initiative via the Zambia Integrated Systems Strengthening Program and the Innovative Vector Control Consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abilio AP, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-110; Aikpon R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-192; Amenya DA, 2008, INSECT MOL BIOL, V17, P19, DOI 10.1111/j.1365-2583.2008.00776.x; [Anonymous], PRES MAL IN MAL OP P; [Anonymous], ZAMB 2010 CENS POP H; [Anonymous], NAT MAL CONTR PROGR; [Anonymous], 2005, GLOB STRAT PLAN ROLL; [Anonymous], 1925, J ECON ENTOMOL; [Anonymous], EXTENSIVE ACE2 DUPLI; [Anonymous], ANOPHELINAE AFRICA S; [Anonymous], 1968, ANOPHELINAE AFR S SA; Asidi A, 2012, EMERG INFECT DIS, V18, P1101, DOI 10.3201/eid1807.120218; Bass C, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-111; Bass C, 2010, PESTIC BIOCHEM PHYS, V96, P80, DOI 10.1016/j.pestbp.2009.09.004; Bass C, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-177; Brooke BD, 2001, B ENTOMOL RES, V91, P265, DOI 10.1079/BER2001108; Casimiro S, 2006, J MED ENTOMOL, V43, P267, DOI 10.1603/0022-2585(2006)043[0267:IRIAFD]2.0.CO;2; Casimiro S, 2006, J MED ENTOMOL, V43, P276, DOI 10.1603/0022-2585(2006)043[0276:IRIAAA]2.0.CO;2; Chanda E, 2013, J MED ENTOMOL, V50, P1275, DOI 10.1603/ME13041; Chanda E, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-10; Chanda E, 2012, MALARIA J, V11, DOI 10.1186/1475-2875-11-437; Chanda E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024336; Chiu TL, 2008, P NATL ACAD SCI USA, V105, P8855, DOI 10.1073/pnas.0709249105; Chizema-Kawesha E, 2010, AM J TROP MED HYG, V83, P480, DOI 10.4269/ajtmh.2010.10-0035; Christian RN, 2011, PESTIC BIOCHEM PHYS, V99, P140, DOI 10.1016/j.pestbp.2010.11.010; Coleman M, 2006, J MED ENTOMOL, V43, P663, DOI 10.1093/jmedent/43.4.663; Ding YC, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-35; Djogbenou L, 2011, MED VET ENTOMOL, V25, P256, DOI 10.1111/j.1365-2915.2010.00925.x; Eisen L, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001016; Favia G, 1997, INSECT MOL BIOL, V6, P377, DOI 10.1046/j.1365-2583.1997.00189.x; Feachem RGA, 2010, LANCET, V376, P1566, DOI 10.1016/S0140-6736(10)61270-6; Fornadel CM, 2008, AM J TROP MED HYG, V79, P876, DOI 10.4269/ajtmh.2008.79.876; Hargreaves K, 2000, MED VET ENTOMOL, V14, P181, DOI 10.1046/j.1365-2915.2000.00234.x; Hemingway J, 2013, P NATL ACAD SCI USA, V110, P9397, DOI 10.1073/pnas.1307656110; Kelly-Hope L, 2008, LANCET INFECT DIS, V8, P387, DOI 10.1016/S1473-3099(08)70045-8; Koekemoer LL, 1999, J MED ENTOMOL, V36, P125, DOI 10.1093/jmedent/36.2.125; Kwiatkowska RM, 2013, GENE, V519, P98, DOI 10.1016/j.gene.2013.01.036; Maharaj R, 2005, SAMJ S AFR MED J, V95, P871; Masaninga Freddie, 2013, Asian Pacific Journal of Tropical Biomedicine, V3, P89, DOI 10.1016/S2221-1691(13)60030-1; Mathias DK, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-10; Mitchell SN, 2012, P NATL ACAD SCI USA, V109, P6147, DOI 10.1073/pnas.1203452109; Muller P, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000286; Muller P, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-36; Murray CJL, 2012, LANCET, V379, P413, DOI 10.1016/S0140-6736(12)60034-8; N'Guessan R, 2003, MED VET ENTOMOL, V17, P19, DOI 10.1046/j.1365-2915.2003.00406.x; N'Guessan R, 2007, EMERG INFECT DIS, V13, P199, DOI 10.3201/eid1302.060631; Oduola AO, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-116; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ramphul U, 2009, T ROY SOC TROP MED H, V103, P1121, DOI 10.1016/j.trstmh.2009.02.014; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Riveron JM, 2013, P NATL ACAD SCI USA, V110, P252, DOI 10.1073/pnas.1216705110; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Sharp B, 2002, TROP MED INT HEALTH, V7, P732, DOI 10.1046/j.1365-3156.2002.00928.x; Trape JF, 2011, LANCET INFECT DIS, V11, P925, DOI 10.1016/S1473-3099(11)70194-3; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2013, TEST PROC INREMO; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774; Wondji CS, 2012, P NATL ACAD SCI USA, V109, P19063, DOI 10.1073/pnas.1217229109; Wondji CS, 2009, GENOME RES, V19, P452, DOI 10.1101/gr.087916.108; Zaim M, 2002, TRENDS PARASITOL, V18, P161, DOI 10.1016/S1471-4922(01)02220-6; Zambian Ministry of Health, 2012, ZAMB NAT MAL IND SUR	61	41	41	0	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99822	10.1371/journal.pone.0099822	http://dx.doi.org/10.1371/journal.pone.0099822			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932861	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000337738600069
J	An, J; Shen, XF; Ma, QB; Yang, CY; Liu, SM; Chen, Y				An, Jing; Shen, Xuefeng; Ma, Qibin; Yang, Cunyi; Liu, Simin; Chen, Yong			Transcriptome Profiling to Discover Putative Genes Associated with Paraquat Resistance in Goosegrass (Eleusine indica L.)	PLOS ONE			English	Article							SUPPLEMENT TREMBL; SEQUENCE DATABASE; POLYAMINES; TRANSLOCATION; TRANSPORTER; TOLERANCE; TOXICITY; PROTEIN; GENERATION; MECHANISM	Background: Goosegrass (Eleusine indica L.), a serious annual weed in the world, has evolved resistance to several herbicides including paraquat, a non-selective herbicide. The mechanism of paraquat resistance in weeds is only partially understood. To further study the molecular mechanism underlying paraquat resistance in goosegrass, we performed transcriptome analysis of susceptible and resistant biotypes of goosegrass with or without paraquat treatment. Results: The RNA-seq libraries generated 194,716,560 valid reads with an average length of 91.29 bp. De novo assembly analysis produced 158,461 transcripts with an average length of 1153.74 bp and 100,742 unigenes with an average length of 712.79 bp. Among these, 25,926 unigenes were assigned to 65 GO terms that contained three main categories. A total of 13,809 unigenes with 1,208 enzyme commission numbers were assigned to 314 predicted KEGG metabolic pathways, and 12,719 unigenes were categorized into 25 KOG classifications. Furthermore, our results revealed that 53 genes related to reactive oxygen species scavenging, 10 genes related to polyamines and 18 genes related to transport were differentially expressed in paraquat treatment experiments. The genes related to polyamines and transport are likely potential candidate genes that could be further investigated to confirm their roles in paraquat resistance of goosegrass. Conclusion: This is the first large-scale transcriptome sequencing of E. indica using the Illumina platform. Potential genes involved in paraquat resistance were identified from the assembled sequences. The transcriptome data may serve as a reference for further analysis of gene expression and functional genomics studies, and will facilitate the study of paraquat resistance at the molecular level in goosegrass.	[An, Jing; Shen, Xuefeng; Liu, Simin; Chen, Yong] South China Agr Univ, Coll Agr, Weed Res Lab, Guangzhou, Guangdong, Peoples R China; [Ma, Qibin; Yang, Cunyi] South China Agr Univ, Coll Agr, State Key Lab Conservat & Utilizat Subtrop Agrobi, Guangzhou, Guangdong, Peoples R China	South China Agricultural University; South China Agricultural University	Chen, Y (corresponding author), South China Agr Univ, Coll Agr, Weed Res Lab, Guangzhou, Guangdong, Peoples R China.	chenyong@scau.edu.cn	ma, qibin/HDO-2133-2022	An, Jing/0000-0001-5279-2845	National Natural Science Foundation of China [31272054]; Special Fund for Agro-scientific Research in the Public Interest [201303031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Agro-scientific Research in the Public Interest	This work was supported by the National Natural Science Foundation of China (No. 31272054) and Special Fund for Agro-scientific Research in the Public Interest (No. 201303031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Baerson SR, 2002, PLANT PHYSIOL, V129, P1265, DOI 10.1104/pp.001560; Bairoch A, 2000, NUCLEIC ACIDS RES, V28, P45, DOI 10.1093/nar/28.1.45; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benavides MP, 2000, PLANT GROWTH REGUL, V31, P215, DOI 10.1023/A:1006316926002; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Bromilow RH, 2004, PEST MANAG SCI, V60, P340, DOI 10.1002/ps.823; CARROLL EW, 1988, PLANT PHYSIOL, V87, P651, DOI 10.1104/pp.87.3.651; Chang CJ, 1997, PLANT GROWTH REGUL, V22, P163, DOI 10.1023/A:1005890312557; Chattopadhyay MK, 2003, P NATL ACAD SCI USA, V100, P2261, DOI 10.1073/pnas.2627990100; Chuah TS, 2013, S AFR J BOT, V84, P128, DOI 10.1016/j.sajb.2012.11.003; Dang ZH, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-29; DITOMASO JM, 1993, PLANT PHYSIOL, V102, P467, DOI 10.1104/pp.102.2.467; Dori-Bachash M, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001106; FOYER CH, 1994, PLANT CELL ENVIRON, V17, P507, DOI 10.1111/j.1365-3040.1994.tb00146.x; Fujita M, 2012, P NATL ACAD SCI USA, V109, P6343, DOI 10.1073/pnas.1121406109; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Haas BJ, 2013, NAT PROTOC, V8, P1494, DOI 10.1038/nprot.2013.084; HART JJ, 1992, PLANT PHYSIOL, V99, P1400, DOI 10.1104/pp.99.4.1400; HART JJ, 1993, PLANT PHYSIOL, V103, P963, DOI 10.1104/pp.103.3.963; HART JJ, 1994, WEED SCI, V42, P277, DOI 10.1017/S0043174500080395; Holm L, 1977, WORLDS WORST WEEDS D, P47; Jori B, 2007, PESTIC BIOCHEM PHYS, V88, P57, DOI 10.1016/j.pestbp.2006.08.013; Jung IL, 2003, CELL BIOL TOXICOL, V19, P29, DOI 10.1023/A:1022065614490; Kashiwagi K, 1997, J BIOL CHEM, V272, P6318, DOI 10.1074/jbc.272.10.6318; Kim HS, 2006, J PLANT BIOL, V49, P237, DOI 10.1007/BF03030539; Koschnick TJ, 2006, WEED SCI, V54, P615, DOI 10.1614/WS-06-002R.1; Kusano T, 2008, PLANTA, V228, P367, DOI 10.1007/s00425-008-0772-7; LEACH GE, 1995, PESTIC BIOCHEM PHYS, V51, P129, DOI 10.1006/pest.1995.1013; Lee J, 2013, PLANTA, V237, P823, DOI 10.1007/s00425-012-1797-5; Lee LJ, 2000, PEST MANAG SCI, V56, P336, DOI 10.1002/(SICI)1526-4998(200004)56:4<336::AID-PS123>3.3.CO;2-#; Marchler-Bauer Aron, 2011, Nucleic Acids Res, V39, pD225, DOI 10.1093/nar/gkq1189; Mardis ER, 2008, TRENDS GENET, V24, P133, DOI 10.1016/j.tig.2007.12.007; MUDGE LC, 1984, WEED SCI, V32, P591, DOI 10.1017/S0043174500059610; Nefedova LN, 2003, RUSS J GENET+, V39, P264, DOI 10.1023/A:1023256608389; POWLES SB, 1987, AUST J PLANT PHYSIOL, V14, P81, DOI 10.1071/PP9870081; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Schuster SC, 2008, NAT METHODS, V5, P16, DOI [10.1038/nmeth1156, 10.1038/NMETH1156]; Seng CT, 2010, WEED BIOL MANAG, V10, P229, DOI 10.1111/j.1445-6664.2010.00388.x; SHAALTIEL Y, 1986, PESTIC BIOCHEM PHYS, V26, P22, DOI 10.1016/0048-3575(86)90058-1; Soar CJ, 2004, PESTIC BIOCHEM PHYS, V80, P94, DOI 10.1016/j.pestbp.2004.07.002; Soar CJ, 2003, PESTIC BIOCHEM PHYS, V76, P91, DOI 10.1016/S0048-3575(03)00069-5; Su YH, 2004, PLANT PHYSIOL, V136, P3104, DOI 10.1104/pp.104.045278; Summers L.A., 1980, BIPYRIDINIUM HERBICI; Szigeti Zoltan, 2005, Acta Biologica Szegediensis, V49, P177; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Xi J, 2012, PLANT J, V69, P782, DOI 10.1111/j.1365-313X.2011.04830.x; Yang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069168; Ye B, 2000, PLANTA, V211, P50, DOI 10.1007/s004250000257; YERUSHALMI H, 1995, J BIOL CHEM, V270, P6856, DOI 10.1074/jbc.270.12.6856; Yu Q, 2004, FUNCT PLANT BIOL, V31, P247, DOI 10.1071/FP03234; Yu Q, 2010, PESTIC BIOCHEM PHYS, V98, P104, DOI 10.1016/j.pestbp.2010.05.007; Zhou YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-266	53	43	50	3	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99940	10.1371/journal.pone.0099940	http://dx.doi.org/10.1371/journal.pone.0099940			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927422	Green Submitted, gold, Green Published			2022-12-27	WOS:000338278100095
J	Chakraborty, S; Adhikary, A; Mazumdar, M; Mukherjee, S; Bhattacharjee, P; Guha, D; Choudhuri, T; Chattopadhyay, S; Sa, G; Sen, A; Das, T				Chakraborty, Samik; Adhikary, Arghya; Mazumdar, Minakshi; Mukherjee, Shravanti; Bhattacharjee, Pushpak; Guha, Deblina; Choudhuri, Tathagata; Chattopadhyay, Samit; Sa, Gaurisankar; Sen, Aparna; Das, Tanya			Capsaicin-Induced Activation of p53-SMAR1 Auto-Regulatory Loop Down-Regulates VEGF in Non-Small Cell Lung Cancer to Restrain Angiogenesis	PLOS ONE			English	Article							MALIGNANT-MELANOMA-CELLS; RECEPTOR-BETA LOCUS; SWISS ALBINO MICE; BREAST-CANCER; COLORECTAL-CANCER; CARCINOMA CELLS; CYCLE ARREST; P53; APOPTOSIS; HYPOXIA	Lung cancer is the leading cause of cancer-related deaths worldwide. Despite decades of research, the treatment options for lung cancer patients remain inadequate, either to offer a cure or even a substantial survival advantage owing to its intrinsic resistance to chemotherapy. Our results propose the effectiveness of capsaicin in down-regulating VEGF expression in non-small cell lung carcinoma (NSCLC) cells in hypoxic environment. Capsaicin-treatment re-activated p53-SMAR1 positive feedback loop in these cells to persuade p53-mediated HIF-1 alpha degradation and SMAR1-induced repression of Cox-2 expression that restrained HIF-1 alpha nuclear localization. Such signal-modulations consequently down regulated VEGF expression to thwart endothelial cell migration and network formation, pre-requisites of angiogenesis in tumor micro-environment. The above results advocate the candidature of capsaicin in exclusively targeting angiogenesis by down-regulating VEGF in tumor cells to achieve more efficient and cogent therapy of resistant NSCLC.	[Chakraborty, Samik; Adhikary, Arghya; Mazumdar, Minakshi; Mukherjee, Shravanti; Bhattacharjee, Pushpak; Guha, Deblina; Sa, Gaurisankar; Das, Tanya] Bose Inst, Div Mol Med, Kolkata, W Bengal, India; [Choudhuri, Tathagata] Viswa Bharati, Dept Biotechnol, Santini Ketan, W Bengal, India; [Chattopadhyay, Samit] Pune Univ, Natl Ctr Cell Sci, Pune, Maharashtra, India; [Sen, Aparna] Lady Brabourne Coll, Dept Microbiol, Kolkata, W Bengal, India	Department of Science & Technology (India); Bose Institute; Visva Bharati University; Department of Biotechnology (DBT) India; National Centre for Cell Science, Pune (NCCS); Savitribai Phule Pune University	Das, T (corresponding author), Bose Inst, Div Mol Med, Kolkata, W Bengal, India.	tanya@jcbose.ac.in	Bhattacharjee, Pushpak/AFV-4590-2022; Choudhuri, Tathagata/F-8139-2011; Chakraborty, Samik/Q-1779-2018	Chakraborty, Samik/0000-0002-5232-0474	University Grants Commission [UGC 2-8/2002]; Department of Science and Technology [DST R/3393/06]; Department of Biotechnology-DBT-RA; Council of Scientific and Industrial Research [CSIR 09/015(0386)/2010 EMR-1]	University Grants Commission(University Grants Commission, India); Department of Science and Technology(Department of Science & Technology (India)); Department of Biotechnology-DBT-RA; Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	SC- University Grants Commission- UGC 2-8/2002(SA I)(SA-I) dated 06.11.2008. AA- Department of Science and Technology- DST R/3393/06 dated 16.10.2006. MM- Department of Biotechnology-DBT-RA dated 05.06.2009. SM- Council of Scientific and Industrial Research- CSIR 09/015(0386)/2010 EMR-1 dated 22.02.2010. PB- Department of Biotechnology-DBT-RA dated 01.06.2010. DG- University Grants Commission- UGC 2-8/2002(SA I) dated 21.04.2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikary A, 2010, FEBS LETT, V584, P7, DOI 10.1016/j.febslet.2009.10.081; Amantini C, 2009, CARCINOGENESIS, V30, P1320, DOI 10.1093/carcin/bgp138; Anandakumar P, 2008, PHYTOTHER RES, V22, P529, DOI 10.1002/ptr.2393; Anandakumar P, 2013, INT IMMUNOPHARMACOL, V17, P254, DOI 10.1016/j.intimp.2013.05.015; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Blagosklonny MV, 1998, J BIOL CHEM, V273, P11995, DOI 10.1074/jbc.273.20.11995; Blagosklonny MV, 2004, CANCER CELL, V5, P13, DOI 10.1016/S1535-6108(03)00336-2; Bottaro DP, 2003, NATURE, V423, P593, DOI 10.1038/423593a; Brown KC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010243; Chakraborty S, 2014, FEBS LETT, V588, P549, DOI 10.1016/j.febslet.2013.11.040; Chattopadhyay S, 2000, GENOMICS, V68, P93, DOI 10.1006/geno.2000.6279; Chen D, 2012, INT J UROL, V19, P662, DOI 10.1111/j.1442-2042.2012.02981.x; Chou CC, 2009, ONCOL REP, V21, P665, DOI 10.3892/or_00000269; de Moraes E, 2007, INT J CANCER, V121, P929, DOI 10.1002/ijc.22899; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 1995, NEW ENGL J MED, V333, P1757, DOI 10.1056/NEJM199512283332608; Gallo O, 2003, AM J PATHOL, V163, P723, DOI 10.1016/S0002-9440(10)63699-1; Hossain DMS, 2013, IMMUNITY, V39, P1057, DOI 10.1016/j.immuni.2013.11.005; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Jalota A, 2005, J BIOL CHEM, V280, P16019, DOI 10.1074/jbc.M413200200; Jung MY, 2001, CANC LETT, V165, P39; Kaul-Ghanekar R, 2005, J BIOL CHEM, V280, P9450, DOI 10.1074/jbc.M412206200; Liu XH, 2002, J BIOL CHEM, V277, P50081, DOI 10.1074/jbc.M201095200; Malonia SK, 2011, BBA-REV CANCER, V1815, P1, DOI 10.1016/j.bbcan.2010.08.003; Mayer RJ, 2004, NEW ENGL J MED, V350, P2406, DOI 10.1056/NEJMe048098; Mazumdar M, 2013, APOPTOSIS, V18, P589, DOI 10.1007/s10495-013-0803-0; Min JK, 2004, CANCER RES, V64, P644, DOI 10.1158/0008-5472.CAN-03-3250; Oyagbemi AA, 2010, INDIAN J CANCER, V47, P53, DOI 10.4103/0019-509X.58860; Papadimitriou A, 2007, CELL PHYSIOL BIOCHEM, V20, P607, DOI 10.1159/000107544; Patel PS, 2002, J INTERF CYTOK RES, V22, P427, DOI 10.1089/10799900252952217; Patel PS, 2002, J CANCER RES CLIN, V128, P461, DOI 10.1007/s00432-002-0368-8; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ravi R, 2000, GENE DEV, V14, P34; Saha B, 2012, ONCOGENE, V31, P173, DOI 10.1038/onc.2011.234; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Sen GS, 2011, J BIOL CHEM, V286, P42232, DOI 10.1074/jbc.M111.262295; Shin DH, 2008, EXP MOL MED, V40, P486, DOI 10.3858/emm.2008.40.5.486; Singh K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000660; Sinha S, 2010, EMBO J, V29, P830, DOI 10.1038/emboj.2009.395; Teel RW, 1999, IN VIVO, V13, P231; Thoennissen NH, 2010, ONCOGENE, V29, P285, DOI 10.1038/onc.2009.335; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Zaidi SK, 2005, EMBO REP, V6, P128, DOI 10.1038/sj.embor.7400337; Zhang J, 2003, LEUKEMIA RES, V27, P275, DOI 10.1016/S0145-2126(02)00164-9	44	50	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99743	10.1371/journal.pone.0099743	http://dx.doi.org/10.1371/journal.pone.0099743			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926985	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100074
J	Park, S; Han, JM; Cheon, J; Hwang, JI; Seong, JY				Park, Sumi; Han, Ji Man; Cheon, Jun; Hwang, Jong-Ik; Seong, Jae Young			Apoptotic Death of Prostate Cancer Cells by a Gonadotropin-Releasing Hormone-II Antagonist	PLOS ONE			English	Article							GNRH-II; LUTEINIZING-HORMONE; MITOCHONDRIAL HOMEOSTASIS; GROWTH-FACTOR; RECEPTOR; AUTOPHAGY; PITUITARY; (GNRH)-I; PATHWAY; KINASE	Gonadotropin-releasing hormone-I (GnRH-I) has attracted strong attention as a hormonal therapeutic tool, particularly for androgen-dependent prostate cancer patients. However, the androgen-independency of the cancer in advanced stages has spurred researchers to look for new medical treatments. In previous reports, we developed the GnRH-II antagonist Trp-1 to inhibit proliferation and stimulate the autophagic death of various prostate cancer cells, including androgen-independent cells. We further screened many GnRH-II antagonists to identify molecules with higher efficiency. Here, we investigated the effect of SN09-2 on the growth of PC3 prostate cancer cells. SN09-2 reduced the growth of prostate cancer cells but had no effect on cells derived from other tissues. Compared with Trp-1, SN09-2 conspicuously inhibited prostate cancer cell growth, even at low concentrations. SN09-2-induced PC3 cell growth inhibition was associated with decreased membrane potential in mitochondria where the antagonist was accumulated, and increased mitochondrial and cytosolic reactive oxygen species. SN09-2 induced lactate dehydrogenase release into the media and annexin V-staining on the PC3 cell surface, suggesting that the antagonist stimulated prostate cancer cell death by activating apoptotic signaling pathways. Furthermore, cytochrome c release from mitochondria to the cytosol and caspase-3 activation occurred in a concentration-and time-dependent manner. SN09-2 also inhibited the growth of PC3 cells xenotransplanted into nude mice. These results demonstrate that SN09-2 directly induces mitochondrial dysfunction and the consequent ROS generation, leading to not only growth inhibition but also apoptosis of prostate cancer cells.	[Park, Sumi; Han, Ji Man; Hwang, Jong-Ik; Seong, Jae Young] Korea Univ, Grad Sch Med, Seoul, South Korea; [Cheon, Jun] Korea Univ, Sch Med, Dept Urol, Seoul, South Korea	Korea University; Korea University Medicine (KU Medicine); Korea University; Korea University Medicine (KU Medicine)	Hwang, JI (corresponding author), Korea Univ, Grad Sch Med, Seoul, South Korea.	hjibio@korea.ac.kr; jyseong@korea.ac.kr	Seong, Jae Young/A-5794-2012	Seong, Jae Young/0000-0002-3312-6924; Hwang, Jong-Ik/0000-0002-0729-1782	Basic Research Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2013R1A2A2A01068295]; National R&D Program for Cancer Control, Ministry of Health Welfare [0520270-1]; Medical Research Council [MR/K000608/1] Funding Source: researchfish	Basic Research Program of the National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; National R&D Program for Cancer Control, Ministry of Health Welfare(Ministry of Health & Welfare (MOHW), Republic of Korea); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by grants from the Basic Research Program (2013R1A2A2A01068295) of the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning and the National R&D Program for Cancer Control, Ministry of Health & Welfare (0520270-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Kheir W, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026112; Baade PD, 2009, MOL NUTR FOOD RES, V53, P171, DOI 10.1002/mnfr.200700511; Blank M, 2007, CELL CYCLE, V6, P686, DOI 10.4161/cc.6.6.3990; Bolla M, 1997, NEW ENGL J MED, V337, P295, DOI 10.1056/NEJM199707313370502; Burbulla LF, 2010, HUM MOL GENET, V19, P4437, DOI 10.1093/hmg/ddq370; Chalah A, 2008, ADV EXP MED BIOL, V615, P25, DOI 10.1007/978-1-4020-6554-5_3; Chen A, 2002, NAT MED, V8, P1421, DOI 10.1038/nm801; Chen YQ, 2007, J CELL SCI, V120, P4155, DOI 10.1242/jcs.011163; Comaru-Schally AM, 1998, J CLIN ENDOCR METAB, V83, P3826, DOI 10.1210/jc.83.11.3826; Cook T, 2000, Oncologist, V5, P162, DOI 10.1634/theoncologist.5-2-162; Davidson JS, 1997, BIOCHEMISTRY-US, V36, P12881, DOI 10.1021/bi971377t; Densmore VS, 2003, J CLIN ENDOCR METAB, V88, P2126, DOI 10.1210/jc.2002-021359; Deocaris CC, 2006, CELL STRESS CHAPERON, V11, P116, DOI 10.1379/CSC-144R.1; EISENBERGER MA, 1986, J CLIN ONCOL, V4, P414, DOI 10.1200/JCO.1986.4.3.414; Faurholm B, 2001, GENOMICS, V78, P15, DOI 10.1006/geno.2001.6650; Gault PM, 2003, J NEUROENDOCRINOL, V15, P831, DOI 10.1046/j.1365-2826.2003.01065.x; Grosse R, 2000, J BIOL CHEM, V275, P9193, DOI 10.1074/jbc.275.13.9193; Grundker C, 2004, EUR J ENDOCRINOL, V151, P141, DOI 10.1530/eje.0.1510141; Herman-Antosiewicz A, 2006, CANCER RES, V66, P5828, DOI 10.1158/0008-5472.CAN-06-0139; Illing N, 1999, P NATL ACAD SCI USA, V96, P2526, DOI 10.1073/pnas.96.5.2526; Kang BH, 2007, CELL, V131, P257, DOI 10.1016/j.cell.2007.08.028; Kang SK, 2001, ENDOCRINOLOGY, V142, P182, DOI 10.1210/en.142.1.182; Kim DK, 2009, CANCER RES, V69, P923, DOI 10.1158/0008-5472.CAN-08-2115; Kim KY, 2006, ENDOCR-RELAT CANCER, V13, P211, DOI 10.1677/erc.1.01033; Klionsky DJ, 2000, SCIENCE, V290, P1717, DOI 10.1126/science.290.5497.1717; Kraus S, 2004, CANCER RES, V64, P5736, DOI 10.1158/0008-5472.CAN-04-1156; Leung PCK, 2003, MOL CELL ENDOCRINOL, V202, P145, DOI 10.1016/S0303-7207(03)00076-5; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Maiti K, 2005, J CLIN ENDOCR METAB, V90, P4287, DOI 10.1210/jc.2004-1894; Marelli MM, 1999, ENDOCRINOLOGY, V140, P329; Maudsley S, 2004, CANCER RES, V64, P7533, DOI 10.1158/0008-5472.CAN-04-1360; Millar R, 2001, P NATL ACAD SCI USA, V98, P9636, DOI 10.1073/pnas.141048498; Millar RP, 2004, ENDOCR REV, V25, P235, DOI 10.1210/er.2003-0002; Moretti RM, 1996, J CLIN ENDOCR METAB, V81, P3930, DOI 10.1210/jc.81.11.3930; Morgan K, 2003, ENDOCRINOLOGY, V144, P423, DOI 10.1210/en.2002-220622; Navarro D, 2002, J STEROID BIOCHEM, V81, P191, DOI 10.1016/S0960-0760(02)00064-X; Okada Y, 2003, BIOL REPROD, V69, P1356, DOI 10.1095/biolreprod.103.016162; Patel AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041394; Sealfon SC, 1997, ENDOCR REV, V18, P180, DOI 10.1210/er.18.2.180; SHERWOOD NM, 1993, ENDOCR REV, V14, P241, DOI 10.1210/er.14.2.241; Siegel R, 2011, CA-CANCER J CLIN, V61, P212, DOI 10.3322/caac.20121; Sviridonov L, 2013, MOL CELL ENDOCRINOL, V369, P107, DOI 10.1016/j.mce.2013.01.010; Szabadkai G, 2006, J CELL BIOL, V175, P901, DOI 10.1083/jcb.200608073; Tiwary BK, 2013, NEUROENDOCRINOLOGY, V97, P242, DOI 10.1159/000342694; Wang L, 2001, P NATL ACAD SCI USA, V98, P361, DOI 10.1073/pnas.011508498; White RB, 1998, P NATL ACAD SCI USA, V95, P305, DOI 10.1073/pnas.95.1.305; Wu HM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-300	47	6	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99723	10.1371/journal.pone.0099723	http://dx.doi.org/10.1371/journal.pone.0099723			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926857	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100073
J	Wang, GS; Yu, ZG; Zhen, Y; Mi, TZ; Shi, Y; Wang, JY; Wang, MX; Sun, S				Wang, Guoshan; Yu, Zhigang; Zhen, Yu; Mi, Tiezhu; Shi, Yan; Wang, Jianyan; Wang, Minxiao; Sun, Song			Molecular Characterisation, Evolution and Expression of Hypoxia-Inducible Factor in Aurelia sp.1	PLOS ONE			English	Article							FACTOR-I; STRIATED-MUSCLE; GENOME; HIF; TRANSCRIPTION; REPRODUCTION; JELLYFISH; CNIDARIA; REVEALS; HISTORY	The maintenance of physiological oxygen homeostasis is mediated by hypoxia-inducible factor (HIF), a key transcriptional factor of the PHD-HIF system in all metazoans. However, the molecular evolutionary origin of this central physiological regulatory system is not well characterized. As the earliest eumetazoans, Cnidarians can be served as an interesting model for exploring the HIF system from an evolutionary perspective. We identified the complete cDNA sequence of HIF-1 alpha (ASHIF) from the Aurelia sp.1, and the predicted HIF-1 alpha protein (pASHIF) was comprised of 674 amino acids originating from 2,025 bp nucleotides. A Pairwise comparison revealed that pASHIF not only possessed conserved basic helix-loop-helix (bHLH) and Per-Arnt-Sim (PAS) domains but also contained the oxygen dependent degradation (ODD) and the C-terminal transactivation domains (C-TAD), the key domains for hypoxia regulation. As indicated by sequence analysis, the ASHIF gene contains 8 exons interrupted by 7 introns. Western blot analysis indicated that pASHIF that existed in the polyps and medusa of Aurelia. sp.1 was more stable for a hypoxic response than normoxia.	[Wang, Guoshan; Wang, Jianyan] Ocean Univ China, Coll Marine Life Sci, Qingdao, Shandong, Peoples R China; [Yu, Zhigang] Minist Educ, Key Lab Marine Chem Theory & Engn, Qingdao, Shandong, Peoples R China; [Yu, Zhigang] Ocean Univ China, Coll Chem & Chem Engn, Qingdao, Shandong, Peoples R China; [Zhen, Yu; Mi, Tiezhu] Minist Educ, Key Lab Marine Environm & Ecol, Qingdao, Shandong, Peoples R China; [Zhen, Yu; Mi, Tiezhu; Shi, Yan] Ocean Univ China, Coll Environm Sci & Engn, Qingdao, Shandong, Peoples R China; [Wang, Minxiao; Sun, Song] Chinese Acad Sci, Inst Oceanol, Key Lab Marine Ecol & Environm Sci, Qingdao, Shandong, Peoples R China	Ocean University of China; Ocean University of China; Ocean University of China; Chinese Academy of Sciences; Institute of Oceanology, CAS	Zhen, Y (corresponding author), Minist Educ, Key Lab Marine Environm & Ecol, Qingdao, Shandong, Peoples R China.	zhenyu@ouc.edu.cn	ZHEN, YU/E-3247-2014	ZHEN, YU/0000-0003-1097-8179; Minxiao, Wang/0000-0002-6567-3295	National Basic Research Program of China (973 Program) [2011CB403602]; National Natural Science Foundation of China [41221004, 41076085]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Basic Research Program of China (973 Program) (2011CB403602), and by the National Natural Science Foundation of China (41221004 and 41076085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Collins AG, 2002, J EVOLUTION BIOL, V15, P418, DOI 10.1046/j.1420-9101.2002.00403.x; Crews ST, 1998, GENE DEV, V12, P607, DOI 10.1101/gad.12.5.607; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Erwin DH, 2011, SCIENCE, V334, P1091, DOI 10.1126/science.1206375; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; Hughes BT, 2008, EMBO J, V27, P1491, DOI 10.1038/emboj.2008.83; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Lee C, 2003, J BIOL CHEM, V278, P7558, DOI 10.1074/jbc.M210385200; Loenarz C, 2011, EMBO REP, V12, P63, DOI 10.1038/embor.2010.170; Lucas CH, 2001, HYDROBIOLOGIA, V451, P229, DOI 10.1023/A:1011836326717; Mahon PC, 2001, GENE DEV, V15, P2675, DOI 10.1101/gad.924501; Martindale MQ, 2004, DEVELOPMENT, V131, P2463, DOI 10.1242/dev.01119; Muller P, 2003, DEV BIOL, V255, P216, DOI 10.1016/S0012-1606(02)00091-X; Purcell JE, 2001, COAST EST S, V58, P77; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Ruas JL, 2002, J BIOL CHEM, V277, P38723, DOI 10.1074/jbc.M205051200; Rytkonen KT, 2011, MOL BIOL EVOL, V28, P1913, DOI 10.1093/molbev/msr012; Rytkonen KT, 2011, EMBO REP, V12, P3, DOI 10.1038/embor.2010.192; Rytkonen KT, 2010, MOL EVOLUTION METAZO; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Seipel K, 2005, DEV BIOL, V282, P14, DOI 10.1016/j.ydbio.2005.03.032; SEMENZA GL, 1992, MOL CELL BIOL, V12, P5447, DOI 10.1128/MCB.12.12.5447; Semenza GL, 2012, CELL, V148, P399, DOI 10.1016/j.cell.2012.01.021; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; Tu Q, 2012, GENOME RES, V22, P2079, DOI 10.1101/gr.139170.112; [Вагелли А.А. Vagelli Alejandro A.], 2007, [Зоология беспозвоночных, Invertebrate Zoology, Zoologiya bespozvonochnykh], V4, P111; WANG GL, 1993, P NATL ACAD SCI USA, V90, P4304, DOI 10.1073/pnas.90.9.4304; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510	31	7	8	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100057	10.1371/journal.pone.0100057	http://dx.doi.org/10.1371/journal.pone.0100057			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926666	Green Submitted, Green Published, gold			2022-12-27	WOS:000338278100112
J	Zhang, B; Chen, X; Xu, TY; Zhang, ZG; Li, X; Han, L; Xu, ZY				Zhang, Ben; Chen, Xiang; Xu, Tong-yi; Zhang, Zhi-gang; Li, Xin; Han, Lin; Xu, Zhi-yun			Transcatheter Pulmonary Valve Replacement by Hybrid Approach Using a Novel Polymeric Prosthetic Heart Valve: Proof of Concept in Sheep	PLOS ONE			English	Article							IMPLANTATION; POSITION; CONDUIT; EXPERIENCE; LEAFLET; PATCH	Background: Since 2000, transcatheter pulmonary valve replacement has steadily advanced. However, the available prosthetic valves are restricted to bioprosthesis which have defects like poor durability. Polymeric heart valve is thought as a promising alternative to bioprosthesis. In this study, we introduced a novel polymeric transcatheter pulmonary valve and evaluated its feasibility and safety in sheep by a hybrid approach. Methods: We designed a novel polymeric trileaflet transcatheter pulmonary valve with a balloon-expandable stent, and the valve leaflets were made of 0.1-mm expanded polytetrafluoroethylene (ePTFE) coated with phosphorylcholine. We chose glutaraldehyde-treated bovine pericardium valves as control. Pulmonary valve stents were implanted in situ by a hybrid transapical approach in 10 healthy sheep (8 for polymeric valve and 2 for bovine pericardium valve), weighing an average of 22.5 +/- 2.0 kg. Angiography and cardiac catheter examination were performed after implantation to assess immediate valvular functionality. After 4-week follow-up, angiography, echocardiography, computed tomography, and cardiac catheter examination were used to assess early valvular function. One randomly selected sheep with polymeric valve was euthanized and the explanted valved stent was analyzed macroscopically and microscopically. Findings: Implantation was successful in 9 sheep. Angiography at implantation showed all 9 prosthetic valves demonstrated orthotopic position and normal functionality. All 9 sheep survived at 4-week follow-up. Four-week follow-up revealed no evidence of valve stent dislocation or deformation and normal valvular and cardiac functionality. The cardiac catheter examination showed the peak-peak transvalvular pressure gradient of the polymeric valves was 11.9 +/- 5.0 mmHg, while that of two bovine pericardium valves were 11 and 17 mmHg. Gross morphology demonstrated good opening and closure characteristics. No thrombus or calcification was seen macroscopically. Conclusions: This design of the novel ePTFE transcatheter pulmonary valve is safe and effective to deploy in sheep by hybrid approach, and the early valvular functionality is good.	[Zhang, Ben; Xu, Tong-yi; Li, Xin; Han, Lin; Xu, Zhi-yun] Second Mil Med Univ, Changhai Hosp, Dept Cardiothorac Surg, Shanghai, Peoples R China; [Zhang, Ben] Guangzhou Mil Reg, Guangzhou Gen Hosp, Ctr Cardiovasc Surg, Guangzhou, Guangdong, Peoples R China; [Chen, Xiang; Zhang, Zhi-gang] Second Mil Med Univ, Changhai Hosp, Dept Cardiol, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Xu, ZY (corresponding author), Second Mil Med Univ, Changhai Hosp, Dept Cardiothorac Surg, Shanghai, Peoples R China.	zhiyunxu168@gmail.com						Ando M, 2009, J THORAC CARDIOV SUR, V137, P124, DOI 10.1016/j.jtcvs.2008.08.060; Attmann T, 2006, ANN THORAC SURG, V82, P708, DOI 10.1016/j.athoracsur.2006.01.096; Bonhoeffer P, 2000, LANCET, V356, P1403, DOI 10.1016/S0140-6736(00)02844-0; Bonhoeffer P, 2000, CIRCULATION, V102, P813, DOI 10.1161/01.CIR.102.7.813; Campbell E J, 1994, ASAIO J, V40, pM853, DOI 10.1097/00002480-199407000-00118; Chen CY, 1998, J SURG RES, V77, P119, DOI 10.1006/jsre.1998.5399; Claiborne TE, 2012, EXPERT REV MED DEVIC, V9, P577, DOI [10.1586/ERD.12.51, 10.1586/erd.12.51]; Claiborne TE, 2009, INT J ARTIF ORGANS, V32, P262, DOI 10.1177/039139880903200503; Coats L, 2007, HEART, V93, P639, DOI 10.1136/hrt.2005.074799; Dahe GJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025236; Duraiswamy N, 2009, J BIOMATER APPL, V23, P367, DOI 10.1177/0885328208093854; Ghanbari H, 2009, TRENDS BIOTECHNOL, V27, P359, DOI 10.1016/j.tibtech.2009.03.002; Gil-Jaurena JM, 2010, REV ESP CARDIOL, V63, P1438, DOI 10.1016/S0300-8932(10)70270-0; Ito T, 2010, ANN THORAC SURG, V89, P1620, DOI 10.1016/j.athoracsur.2009.11.064; Kenny D, 2011, J AM COLL CARDIOL, V58, P2248, DOI 10.1016/j.jacc.2011.07.040; Kiefer P, 2011, ANN THORAC SURG, V92, P155, DOI 10.1016/j.athoracsur.2011.03.020; Lee C, 2013, EUR J CARDIO-THORAC, V43, P468, DOI 10.1093/ejcts/ezs381; Lee YS, 2012, KOREAN CIRC J, V42, P652, DOI 10.4070/kcj.2012.42.10.652; Lurz P, 2008, CIRCULATION, V117, P1964, DOI 10.1161/CIRCULATIONAHA.107.735779; Lurz P, 2011, J AM COLL CARDIOL, V57, P724, DOI 10.1016/j.jacc.2010.07.056; McElhinney DB, 2010, CIRCULATION, V122, P507, DOI 10.1161/CIRCULATIONAHA.109.921692; Metzner A, 2010, J THORAC CARDIOV SUR, V139, P748, DOI 10.1016/j.jtcvs.2009.08.013; NISTAL F, 1990, J THORAC CARDIOV SUR, V99, P1074; Quintessenza JA, 2010, WORLD J PEDIATR CONG, V1, P20, DOI 10.1177/2150135110361509; Sachweh JS, 2006, ASAIO J, V52, P575, DOI 10.1097/01.mat.0000237695.87457.2a; Tzamtzis S, 2010, CARDIOLOGY, V115, P292; Zegdi R, 2011, EUR J CARDIO-THORAC, V40, P257, DOI 10.1016/j.ejcts.2010.11.010; Zong GJ, 2009, J THORAC CARDIOV SUR, V137, P1363, DOI 10.1016/j.jtcvs.2008.12.025	28	11	11	3	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100065	10.1371/journal.pone.0100065	http://dx.doi.org/10.1371/journal.pone.0100065			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926892	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100114
J	Sadakata, T; Kakegawa, W; Shinoda, Y; Hosono, M; Katoh-Semba, R; Sekine, Y; Sato, Y; Saruta, C; Ishizaki, Y; Yuzaki, M; Kojima, M; Furuichi, T				Sadakata, Tetsushi; Kakegawa, Wataru; Shinoda, Yo; Hosono, Mayu; Katoh-Semba, Ritsuko; Sekine, Yukiko; Sato, Yumi; Saruta, Chihiro; Ishizaki, Yasuki; Yuzaki, Michisuke; Kojima, Masami; Furuichi, Teiichi			Axonal Localization of Ca2+- Dependent Activator Protein for Secretion 2 Is Critical for Subcellular Locality of Brain-Derived Neurotrophic Factor and Neurotrophin-3 Release Affecting Proper Development of Postnatal Mouse Cerebellum	PLOS ONE			English	Article							CORE VESICLE TRAFFICKING; AUTISTIC-LIKE PHENOTYPES; DIFFERENTIAL REGULATION; CADPS2-KNOCKOUT MICE; SYNAPTIC PLASTICITY; CADPS2; BDNF; CALCIUM; CAPS1; EXOCYTOSIS	Ca2+-dependent activator protein for secretion 2 (CAPS2) is a protein that is essential for enhanced release of brain-derived neurotrophic factor (BDNF) and neurotrophin-3 (NT-3) from cerebellar granule cells. We previously identified dex3, a rare alternative splice variant of CAPS2, which is overrepresented in patients with autism and is missing an exon 3 critical for axonal localization. We recently reported that a mouse model CAPS2(Delta ex3/Delta ex3) expressing dex3 showed autistic-like behavioral phenotypes including impaired social interaction and cognition and increased anxiety in an unfamiliar environment. Here, we verified impairment in axonal, but not somato-dendritic, localization of dex3 protein in cerebellar granule cells and demonstrated cellular and physiological phenotypes in postnatal cerebellum of CAPS2(Delta ex3/Delta ex3) mice. Interestingly, both BDNF and NT-3 were markedly reduced in axons of cerebellar granule cells, resulting in a significant decrease in their release. As a result, dex3 mice showed developmental deficits in dendritic arborization of Purkinje cells, vermian lobulation and fissurization, and granule cell precursor proliferation. Paired-pulse facilitation at parallel fiber-Purkinje cell synapses was also impaired. Together, our results indicate that CAPS2 plays an important role in subcellular locality (axonal vs. somato-dendritic) of enhanced BDNF and NT-3 release, which is indispensable for proper development of postnatal cerebellum.	[Sadakata, Tetsushi; Hosono, Mayu] Gunma Univ, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma, Japan; [Sadakata, Tetsushi; Shinoda, Yo; Kojima, Masami; Furuichi, Teiichi] JST CREST, Kawaguchi, Saitama, Japan; [Kakegawa, Wataru; Yuzaki, Michisuke] Keio Univ, Sch Med, Dept Physiol, Tokyo 160, Japan; [Shinoda, Yo; Katoh-Semba, Ritsuko; Sekine, Yukiko; Sato, Yumi; Saruta, Chihiro; Furuichi, Teiichi] Tokyo Univ Sci, Dept Appl Biol Sci, Noda, Chiba 278, Japan; [Ishizaki, Yasuki] Gunma Univ, Grad Sch Med, Dept Mol & Cellular Neurobiol, Maebashi, Gunma, Japan; [Kojima, Masami] Natl Inst Adv Ind Sci & Technol, Hlth Res Inst, Biointerface Res Grp, Ikeda, Osaka, Japan	Gunma University; Japan Science & Technology Agency (JST); Keio University; Tokyo University of Science; Gunma University; National Institute of Advanced Industrial Science & Technology (AIST)	Sadakata, T (corresponding author), Gunma Univ, Adv Sci Res Leaders Dev Unit, Maebashi, Gunma, Japan.	sadakata-1024@umin.ac.jp; tfuruichi@rs.tus.ac.jp	Ishizaki, Yasuki/AAB-1209-2020; Sadakata, Tetsushi/W-9324-2018; Kakegawa, Wataru/G-5569-2016; Shinoda, Yo/H-3091-2019; Yuzaki, Michisuke/K-5328-2013; Furuichi, Teiichi/B-5086-2014	Sadakata, Tetsushi/0000-0003-0276-4162; Shinoda, Yo/0000-0003-3253-2194; Yuzaki, Michisuke/0000-0002-5750-3544; Furuichi, Teiichi/0000-0002-9676-1888	Japan Foundation for Neuroscience and Mental Health; Uehara Memorial Foundation; Takeda Science Foundation; Nakajima Foundation; Yamada Science Foundation; Mother and Child Health Foundation; NOVARTIS Foundation for the Promotion of Science; Inamori Foundation; Scientific Research on Innovative Areas "Foundation of Synapse and Neurocircuit Pathology''; Japan Science and Technology Agency; Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) [25110707]; Japan Society for the Promotion of Science (JSPS) [25430061]; Institute of Physical and Chemical Research (RIKEN); Program to Disseminate Tenure Tracking System of MEXT; Grants-in-Aid for Scientific Research [25110707, 25430061, 26250024] Funding Source: KAKEN	Japan Foundation for Neuroscience and Mental Health(Japan Foundation for Neuroscience and Mental Health); Uehara Memorial Foundation(Uehara Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Nakajima Foundation; Yamada Science Foundation; Mother and Child Health Foundation(Mother and Child Health Foundation); NOVARTIS Foundation for the Promotion of Science; Inamori Foundation; Scientific Research on Innovative Areas "Foundation of Synapse and Neurocircuit Pathology''(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Institute of Physical and Chemical Research (RIKEN); Program to Disseminate Tenure Tracking System of MEXT; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by Grants-in-Aid for Scientific Research from the Japan Foundation for Neuroscience and Mental Health, the Uehara Memorial Foundation, the Takeda Science Foundation, the Nakajima Foundation, the Yamada Science Foundation, the Mother and Child Health Foundation, the NOVARTIS Foundation for the Promotion of Science, the Inamori Foundation, Scientific Research on Innovative Areas "Foundation of Synapse and Neurocircuit Pathology'', the Japan Science and Technology Agency, the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT; grant number 25110707), the Japan Society for the Promotion of Science (JSPS; grant numbers 25430061), the Institute of Physical and Chemical Research (RIKEN), and the Program to Disseminate Tenure Tracking System of MEXT granted to Gunma University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amir RE, 1999, NAT GENET, V23, P185, DOI 10.1038/13810; Atluri PP, 1998, J NEUROSCI, V18, P8214; Bangash MA, 2011, CELL, V145, P758, DOI 10.1016/j.cell.2011.03.052; Bates B, 1999, NAT NEUROSCI, V2, P115, DOI 10.1038/5669; Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400; Binda AV, 2005, BIOCHEM PHARMACOL, V69, P1451, DOI 10.1016/j.bcp.2005.02.015; Bonora E, 2014, EMBO MOL MED; Carter AR, 2002, J NEUROSCI, V22, P1316, DOI 10.1523/JNEUROSCI.22-04-01316.2002; Chang QA, 2006, NEURON, V49, P341, DOI 10.1016/j.neuron.2005.12.027; Christian SL, 2008, BIOL PSYCHIAT, V63, P1111, DOI 10.1016/j.biopsych.2008.01.009; Cisternas FA, 2003, GENOMICS, V81, P279, DOI 10.1016/S0888-7543(02)00040-X; COURCHESNE E, 1988, NEW ENGL J MED, V318, P1349, DOI 10.1056/NEJM198805263182102; Eran A, 2009, J CLIN INVEST, V119, P679, DOI 10.1172/JCI38620; Grishanin RN, 2004, NEURON, V43, P551, DOI 10.1016/j.neuron.2004.07.028; Ito M, 2001, PHYSIOL REV, V81, P1143, DOI 10.1152/physrev.2001.81.3.1143; Kakegawa W, 2008, J NEUROSCI, V28, P1460, DOI 10.1523/JNEUROSCI.2553-07.2008; Katoh-Semba R, 2000, J NEUROCHEM, V74, P1923, DOI 10.1046/j.1471-4159.2000.0741923.x; KatohSemba R, 1996, J NEUROCHEM, V66, P330; Lu B, 2003, LEARN MEMORY, V10, P86, DOI 10.1101/lm.54603; Moretti P, 2006, J NEUROSCI, V26, P319, DOI 10.1523/JNEUROSCI.2623-05.2006; Okamoto N, 2011, AM J MED GENET A, V155A, P1568, DOI 10.1002/ajmg.a.34028; Palferman S, 2001, HUM MOL GENET, V10, P973; Pierce K, 2001, BIOL PSYCHIAT, V49, P655, DOI 10.1016/S0006-3223(00)01008-8; Sadakata T, 2007, J CLIN INVEST, V117, P931, DOI 10.1172/JCI29031; Sadakata T, 2007, J NEUROSCI, V27, P2472, DOI 10.1523/JNEUROSCI.2279-06.2007; Sadakata T, 2013, J NEUROSCI, V33, P17326, DOI 10.1523/JNEUROSCI.2777-13.2013; Sadakata T, 2012, P NATL ACAD SCI USA, V109, P21104, DOI 10.1073/pnas.1210055109; Sadakata T, 2010, J BIOL CHEM, V285, P38710, DOI 10.1074/jbc.M110.137414; Sadakata T, 2009, CEREBELLUM, V8, P312, DOI 10.1007/s12311-009-0097-5; Schwartz PM, 1997, NEURON, V19, P269, DOI 10.1016/S0896-6273(00)80938-1; Shinoda Y, 2011, P NATL ACAD SCI USA, V108, P373, DOI 10.1073/pnas.1012220108; Speidel D, 2005, NEURON, V46, P75, DOI 10.1016/j.neuron.2005.02.019; Szatmari P, 2007, NAT GENET, V39, P319, DOI 10.1038/ng1985; Tandon A, 1998, NEURON, V21, P147, DOI 10.1016/S0896-6273(00)80522-X; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110	36	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99524	10.1371/journal.pone.0099524	http://dx.doi.org/10.1371/journal.pone.0099524			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923991	Green Submitted, gold, Green Published			2022-12-27	WOS:000338701300071
J	Watari, K; Shibata, T; Kawahara, A; Sata, K; Nabeshima, H; Shinoda, A; Abe, H; Azuma, K; Murakami, Y; Izumi, H; Takahashi, T; Kage, M; Kuwano, M; Ono, M				Watari, Kosuke; Shibata, Tomohiro; Kawahara, Akihiko; Sata, Ken-ichi; Nabeshima, Hiroshi; Shinoda, Ai; Abe, Hideyuki; Azuma, Koichi; Murakami, Yuichi; Izumi, Hiroto; Takahashi, Takashi; Kage, Masayoshi; Kuwano, Michihiko; Ono, Mayumi			Tumor-Derived Interleukin-1 Promotes Lymphangiogenesis and Lymph Node Metastasis through M2-Type Macrophages	PLOS ONE			English	Article							GROWTH-FACTOR-C; CELL-LINE NCI-H460-LNM35; NF-KAPPA-B; CANCER-CELLS; LUNG-CANCER; INFLAMMATORY STIMULI; EMERGING MECHANISMS; VEGF-C; ANGIOGENESIS; ACTIVATION	Tumors formed by a highly metastatic human lung cancer cell line are characterized by activated signaling via vascular endothelial growth factor (VEGF)-C through its receptor (VEGFR-3) and aggressive lymph node metastasis. In this study, we examined how these highly metastatic cancers acquired aggressive lymph node metastasis. Compared with their lower metastatic counterparts, the highly metastatic tumors formed by this cell line expressed higher amounts of interleukin (IL)-1 alpha, with similarly augmented expression of IL-1 alpha and IL-1 beta by tumor stromal cells and of VEGF-A and VEGF-C by tumor-associated macrophages. These tumor-associated macrophages were mainly of the M2 type. Administration of a macrophage-targeting drug suppressed the production of these potent angiogenic and lymphangiogenic factors, resulting in decreased tumor growth, angiogenesis, lymphangiogenesis, and lymph node metastasis. In Matrigel plug assays, the highly metastatic cells formed tumors that were extensively infiltrated by M2-type macrophages and exhibited enhanced angiogenesis and lymphangiogenesis. All of these responses were suppressed by the IL-1 receptor (IL-1R) antagonist anakinra. Thus, the IL-1 alpha-driven inflammatory activation of angiogenesis and lymphangiogenesis seems to provide a highly metastatic tumor microenvironment favorable for lymph node metastasis through cross-talk with macrophages. Accordingly, the IL-1R/M2-type macrophage axis may be a good therapeutic target for patients with this form of lung cancer.	[Watari, Kosuke; Shibata, Tomohiro; Sata, Ken-ichi; Nabeshima, Hiroshi; Shinoda, Ai; Murakami, Yuichi; Ono, Mayumi] Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Oncol, Fukuoka 812, Japan; [Kawahara, Akihiko; Abe, Hideyuki; Kage, Masayoshi] Kurume Univ Hosp, Dept Diagnost Pathol, Kurume, Fukuoka, Japan; [Azuma, Koichi] Kurume Univ, Sch Med, Dept Internal Med, Div Respirol Neurol & Rheumatol, Kurume, Fukuoka 830, Japan; [Murakami, Yuichi] St Marys Hosp, Kurume, Fukuoka, Japan; [Izumi, Hiroto] Univ Occupat & Environm Hlth, Dept Occupat Pneumol, Inst Ind Ecol Sci, Kitakyushu, Fukuoka 807, Japan; [Takahashi, Takashi] Nagoya Univ, Grad Sch Med, Div Mol Carcinogenesis, Ctr Neurol Dis & Canc, Nagoya, Aichi 4648601, Japan; [Kuwano, Michihiko] Kyushu Univ, Grad Sch Pharmaceut Sci, Lab Mol Canc Biol, Fukuoka 812, Japan	Kyushu University; Kurume University; Kurume University; University of Occupational & Environmental Health - Japan; Nagoya University; Kyushu University	Ono, M (corresponding author), Kyushu Univ, Grad Sch Pharmaceut Sci, Dept Pharmaceut Oncol, Fukuoka 812, Japan.	mono@phar.kyushu-u.ac.jp	Takahashi, Takashi/I-7262-2014	Takahashi, Takashi/0000-0003-0615-7001; Watari, Kosuke/0000-0003-0260-2323	JSPS KAKENHI [23112515, 23300350]; Grants-in-Aid for Scientific Research [221S0001, 23300350] Funding Source: KAKEN	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was supported by JSPS KAKENHI Grant Numbers 23112515, 23300350 (to MO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achen MG, 2005, CANCER CELL, V7, P121, DOI 10.1016/j.ccr.2005.01.017; Apte RN, 2008, IMMUNOL REV, V222, P222, DOI 10.1111/j.1600-065X.2008.00615.x; Apte RN, 2006, CANCER METAST REV, V25, P387, DOI 10.1007/s10555-006-9004-4; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Cao YH, 2005, NAT REV CANCER, V5, P735, DOI 10.1038/nrc1693; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Cursiefen C, 2004, J CLIN INVEST, V113, P1040, DOI 10.1172/JCI200420465; Enholm B, 1997, ONCOGENE, V14, P2475, DOI 10.1038/sj.onc.1201090; Fujiwara T, 2011, AM J PATHOL, V179, P1157, DOI 10.1016/j.ajpath.2011.05.034; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Hanahan D, 1996, CELL, V86, P353, DOI 10.1016/S0092-8674(00)80108-7; He YL, 2005, CANCER RES, V65, P4739, DOI 10.1158/0008-5472.CAN-04-4576; He YL, 2002, J NATL CANCER I, V94, P819, DOI 10.1093/jnci/94.11.819; Heckman CA, 2008, CANCER RES, V68, P4754, DOI 10.1158/0008-5472.CAN-07-5809; Hiraoka K, 2008, CANCER SCI, V99, P1595, DOI 10.1111/j.1349-7006.2008.00880.x; Holopainen T, 2012, J NATL CANCER I, V104, P461, DOI 10.1093/jnci/djs009; Kajita T, 2001, BRIT J CANCER, V85, P255, DOI 10.1054/bjoc.2001.1882; Kimura YN, 2007, CANCER SCI, V98, P2009, DOI 10.1111/j.1349-7006.2007.00633.x; Koukourakis MI, 1998, BRIT J CANCER, V77, P1696, DOI 10.1038/bjc.1998.280; Kozaki K, 2000, CANCER RES, V60, P2535; Kozaki K, 2001, ONCOGENE, V20, P4228, DOI 10.1038/sj.onc.1204561; Kuwano T, 2004, FASEB J, V18, P300, DOI 10.1096/fj.03-0473com; Ling JH, 2012, CANCER CELL, V21, P105, DOI 10.1016/j.ccr.2011.12.006; Mandriota SJ, 2001, EMBO J, V20, P672, DOI 10.1093/emboj/20.4.672; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Murakami Y, 2013, J BIOL CHEM, V288, P25025, DOI 10.1074/jbc.M113.472068; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Ono M, 2008, CANCER SCI, V99, P1501, DOI 10.1111/j.1349-7006.2008.00853.x; Orlandini M, 2001, J BIOL CHEM, V276, P6576, DOI 10.1074/jbc.M009573200; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Ristimaki A, 1998, J BIOL CHEM, V273, P8413, DOI 10.1074/jbc.273.14.8413; Sica A, 2007, J CLIN INVEST, V117, P1155, DOI 10.1172/JCI31422; Skobe M, 2001, NAT MED, V7, P192, DOI 10.1038/84643; Torisu H, 2000, INT J CANCER, V85, P182, DOI 10.1002/(SICI)1097-0215(20000115)85:2<182::AID-IJC6>3.3.CO;2-D; Tsai PW, 2003, J BIOL CHEM, V278, P5750, DOI 10.1074/jbc.M204863200; Voronov E, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00177; Watari K, 2008, BIOCHEM BIOPH RES CO, V377, P826, DOI 10.1016/j.bbrc.2008.10.077	41	49	52	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99568	10.1371/journal.pone.0099568	http://dx.doi.org/10.1371/journal.pone.0099568			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924428	gold, Green Published, Green Submitted			2022-12-27	WOS:000338701300074
J	Zhang, YF; Lu, J; Yu, FF; Gao, HF; Zhou, YH				Zhang, Yu-Fei; Lu, Jian; Yu, Fei-Fei; Gao, Hong-Fang; Zhou, Yu-Hao			Polyunsaturated Fatty Acid Intake and Risk of Lung Cancer: A Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							DIETARY-FAT; TREND ESTIMATION; SMOKING; CHOLESTEROL; HABITS; COHORT; JAPAN; FOODS	Background: Studies have reported inconsistent results for the existence of an association between polyunsaturated fatty acid (PUFA) intake and risk of lung cancer. The purpose of this study is to summarize the evidence regarding this relationship using a dose response meta-analytic approach. Methodology and Principal Findings: We searched the PubMed, EmBase, and Cochrane Library electronic databases for related articles published through July 2013. Only prospective studies that reported effect estimates with 95% confidence intervals (CIs) of lung cancer incidence for greater than 2 categories of PUFA intake were included. We did random-effects meta-analyses of study-specific incremental estimates to determine the risk of lung cancer associated with a 5 g per day increase in PUFA intake. Overall, we included 8 prospective cohort studies reporting data on 1,268,442 individuals. High PUFA intake had little or no effect on lung cancer risk (risk ratio [RR], 0.91; 95% CI, 0.78-1.06; P = 0.230). Furthermore, the dose-response meta-analysis also suggested that a 5 g per day increase in PUFA has no significant effect on the risk of lung cancer (RR, 0.98; 95% CI: 0.96-1.01; P = 0.142). Finally, the findings of dose response curve suggested that PUFA intake of up to 15 g/d seemed to increase the risk of lung cancer. Furthermore, PUFA intake greater than 15 g/d was associated with a small beneficial effect and borderline statistical significance. Subgroup analyses for 5 g per day increment in PUFA indicated that the protective effect of PUFA was more evident in women (RR, 0.94; 95% CI, 0.87-1.01; P = 0.095) than in men (RR, 1.00; 95% CI, 0.98-1.02; P = 0.784). Conclusion/Significance: Our study indicated that PUFA intake had little or no effect on lung cancer risk. PUFA intake might play an important role in lung cancer prevention in women.	[Zhang, Yu-Fei; Gao, Hong-Fang] Shanghai Seventh Peoples Hosp, Dept Oncol, Shanghai, Peoples R China; [Lu, Jian; Yu, Fei-Fei] Second Mil Med Univ, Dept Hlth Stat, Shanghai, Peoples R China; [Zhou, Yu-Hao] Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China	Naval Medical University	Zhou, YH (corresponding author), Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China.	zhou_ly@126.com	Zhang, yufei/HHC-7375-2022		Key disciplines group construction project of Pudong Health Bureau of Shanghai [PWZxkq2011-01]; Shanghai key speciality of traditional Chinese medicine [ZYXK2012010]; Talents Training Program of Shanghai Seventh People's Hospital [XX2012-023]	Key disciplines group construction project of Pudong Health Bureau of Shanghai; Shanghai key speciality of traditional Chinese medicine; Talents Training Program of Shanghai Seventh People's Hospital	This study was funded by Key disciplines group construction project of Pudong Health Bureau of Shanghai (PWZxkq2011-01), Shanghai key speciality of traditional Chinese medicine (ZYXK2012010), and Talents Training Program of Shanghai Seventh People's Hospital (XX2012-023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; Avula C. P. R., 2000, Recent Research Developments in Lipids, V4, P303; Bandera EV, 1997, CANCER CAUSE CONTROL, V8, P828, DOI 10.1023/A:1018456127018; BARONZIO G, 1994, ANTICANCER RES, V14, P1145; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Daniel CR, 2011, CANCER PREV RES, V4, P1903, DOI 10.1158/1940-6207.CAPR-11-0241; Darby S, 2001, BRIT J CANCER, V84, P728, DOI 10.1054/bjoc.2000.1668; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; DeStefani E, 1997, CANCER CAUSE CONTROL, V8, P913, DOI 10.1023/A:1018424614723; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; GOODMAN MT, 1988, AM J EPIDEMIOL, V128, P1241, DOI 10.1093/oxfordjournals.aje.a115078; GOODMAN MT, 1992, EPIDEMIOLOGY, V3, P288, DOI 10.1097/00001648-199207000-00004; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; KNEKT P, 1991, NUTR CANCER, V16, P267, DOI 10.1080/01635589109514165; KOO LC, 1988, NUTR CANCER, V11, P155, DOI 10.1080/01635588809513983; Laake I, 2013, INT J CANCER, V132, P1389, DOI 10.1002/ijc.27737; Linseisen J, 2011, CANCER CAUSE CONTROL, V22, P909, DOI 10.1007/s10552-011-9764-1; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Ozasa K, 2001, JPN J CANCER RES, V92, P1259, DOI 10.1111/j.1349-7006.2001.tb02148.x; PIERCE RJ, 1989, NUTR CANCER, V12, P237, DOI 10.1080/01635588909514023; PORTER NA, 1995, LIPIDS, V30, P277, DOI 10.1007/BF02536034; SANKARANARAYANAN R, 1994, INT J CANCER, V58, P644, DOI 10.1002/ijc.2910580505; SWANSON CA, 1992, INT J CANCER, V50, P876, DOI 10.1002/ijc.2910500609; Takezaki T, 2003, NUTR CANCER, V45, P160, DOI 10.1207/S15327914NC4502_04; Takezaki T, 2011, BRIT J CANCER, V84, P1199; Troyer D, 1996, NUTR RES, V16, P1959, DOI 10.1016/S0271-5317(96)00219-9; Veierod MB, 1997, EUR J CANCER PREV, V6, P540, DOI 10.1097/00008469-199712000-00009; Wakai K, 1999, LUNG CANCER, V25, P147, DOI 10.1016/S0169-5002(99)00051-3; Wells G.A., 2000, VIS COMMUN Q; Wingo PA, 2003, CANCER-AM CANCER SOC, V97, P3133, DOI 10.1002/cncr.11380; WYNDER EL, 1987, J NATL CANCER I, V79, P631	36	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99637	10.1371/journal.pone.0099637	http://dx.doi.org/10.1371/journal.pone.0099637			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925369	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300083
J	Walton, AH; Muenzer, JT; Rasche, D; Boomer, JS; Sato, B; Brownstein, BH; Pachot, A; Brooks, TL; Deych, E; Shannon, WD; Green, JM; Storch, GA; Hotchkiss, RS				Walton, Andrew H.; Muenzer, Jared T.; Rasche, David; Boomer, Jonathan S.; Sato, Bryan; Brownstein, Bernard H.; Pachot, Alexandre; Brooks, Terrence L.; Deych, Elena; Shannon, William D.; Green, Jonathan M.; Storch, Gregory A.; Hotchkiss, Richard S.			Reactivation of Multiple Viruses in Patients with Sepsis	PLOS ONE			English	Article							HERPES-SIMPLEX-VIRUS; CRITICALLY-ILL PATIENTS; EPSTEIN-BARR-VIRUS; STEM-CELL TRANSPLANTATION; TIME PCR ASSAY; CYTOMEGALOVIRUS REACTIVATION; TT VIRUS; IMMUNOCOMPETENT HOSTS; SURROGATE MARKER; HCMV INFECTION	A current controversy is whether patients with sepsis progress to an immunosuppressed state. We hypothesized that reactivation of latent viruses occurred with prolonged sepsis thereby providing evidence of clinically-relevant immunosuppression and potentially providing a means to serially-monitor patients' immune status. Secondly, if viral loads are markedly elevated, they may contribute to morbidity and mortality. This study determined if reactivation of herpesviruses, polyomaviruses, and the anellovirus TTV occurred in sepsis and correlated with severity. Serial whole blood and plasma samples from 560 critically-ill septic, 161 critically-ill non-septic, and 164 healthy age-matched patients were analyzed by quantitative-polymerase-chain-reaction for cytomegalovirus (CMV), Epstein-Barr (EBV), herpes-simplex (HSV), human herpes virus-6 (HHV-6), and TTV. Polyomaviruses BK and JC were quantitated in urine. Detectable virus was analyzed with respect to secondary fungal and opportunistic bacterial infections, ICU duration, severity of illness, and survival. Patients with protracted sepsis had markedly increased frequency of detectable virus. Cumulative viral DNA detection rates in blood were: CMV (24.2%), EBV (53.2%), HSV (14.1%), HHV-6 (10.4%), and TTV (77.5%). 42.7% of septic patients had presence of two or more viruses. The 50% detection rate for herpesviruses was 5-8 days after sepsis onset. A small subgroup of septic patients had markedly elevated viral loads (>10(4)-10(6) DNA copies/ml blood) for CMV, EBV, and HSV. Excluding TTV, DNAemia was uncommon in critically-ill non-septic patients and in age-matched healthy controls. Compared to septic patients without DNAemia, septic patients with viremia had increased fungal and opportunistic bacterial infections. Patients with detectable CMV in plasma had higher 90-day mortality compared to CMV-negative patients; p, 0.05. Reactivation of latent viruses is common with prolonged sepsis, with frequencies similar to those occurring in transplant patients on immunosuppressive therapy and consistent with development of an immunosuppressive state. Whether reactivated latent viruses contribute to morbidity and mortality in sepsis remains unknown.	[Walton, Andrew H.; Rasche, David; Brownstein, Bernard H.; Hotchkiss, Richard S.] Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA; [Muenzer, Jared T.; Storch, Gregory A.] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Boomer, Jonathan S.; Brooks, Terrence L.; Deych, Elena; Shannon, William D.; Green, Jonathan M.] Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA; [Sato, Bryan] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA; [Pachot, Alexandre] BioMerieux Inc, Med Diagnost Discovery Dept, Marcy Letoile, France	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL); bioMerieux	Hotchkiss, RS (corresponding author), Washington Univ, Sch Med, Dept Anesthesiol, St Louis, MO 63110 USA.	hotch@wustl.edu		Walton, Andrew/0000-0003-2805-6666; Green, Jonathan/0000-0002-7449-4387	National Institutes of Health [GM 441181, GM 55194, GM09839, AI101530, HL 104985]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL104985] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI101530] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055194, R01GM098391] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work received financial support from the following National Institutes of Health grants: GM 441181, GM 55194, GM09839, AI101530, and HL 104985. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angus DC, 2013, NEW ENGL J MED, V369, P840, DOI [10.1056/NEJMc1312359, 10.1056/NEJMra1208623]; Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853; Babel N, 2011, NAT REV NEPHROL, V7, P399, DOI 10.1038/nrneph.2011.59; Bakker NA, 2007, TRANSPLANTATION, V83, P433, DOI 10.1097/01.tp.0000252784.60159.96; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Beland K, 2013, J INFECT DIS; Beland K, 2014, J INFECT DIS, V209, P247, DOI 10.1093/infdis/jit423; Berrington WR, 2009, CLIN INFECT DIS, V49, P1295, DOI 10.1086/606053; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Boothpur R, 2010, J CLIN VIROL, V47, P306, DOI 10.1016/j.jcv.2009.12.006; Brennan DC, 2005, AM J TRANSPLANT, V5, P582, DOI 10.1111/j.1600-6143.2005.00742.x; Bruynseels P, 2003, LANCET, V362, P1536, DOI 10.1016/S0140-6736(03)14740-X; Chen YP, 2009, NEW ENGL J MED, V361, P1067, DOI 10.1056/NEJMoa0904267; Cheng XXS, 2011, J AM SOC NEPHROL, V22, P825, DOI 10.1681/ASN.2010080877; Chiche L, 2011, CURR OPIN INFECT DIS, V24, P152, DOI 10.1097/QCO.0b013e328343b6e4; Cohen J, 2012, LANCET INFECT DIS, V12, P503, DOI 10.1016/S1473-3099(12)70136-6; Cook CH, 2003, CRIT CARE MED, V31, P1923, DOI 10.1097/01.CCM.0000070222.11325.C4; Cook CH, 2011, ANTIVIR RES, V90, P151, DOI 10.1016/j.antiviral.2011.03.179; De Vlaminck I, 2013, CELL, V155, P1178, DOI 10.1016/j.cell.2013.10.034; De Vlieger G, 2012, CRIT CARE MED, V40, P36, DOI 10.1097/CCM.0b013e31822b50ae; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Dockrell DH, 2003, J MED MICROBIOL, V52, P5, DOI 10.1099/jmm.0.05074-0; Dolgin E, 2012, NAT MED, V18, P1000, DOI 10.1038/nm0712-1000; Espy MJ, 2000, J CLIN MICROBIOL, V38, P795, DOI 10.1128/JCM.38.2.795-799.2000; Focosi D, 2010, J CLIN VIROL, V47, P189, DOI 10.1016/j.jcv.2009.11.027; Gartner B, 2010, J CLIN VIROL, V48, P82, DOI 10.1016/j.jcv.2010.03.016; Hall MW, 2011, INTENS CARE MED, V37, P525, DOI 10.1007/s00134-010-2088-x; Hamprecht K, 1998, J CLIN VIROL, V11, P125, DOI 10.1016/S1386-6532(98)00046-4; Heininger A, 2001, CRIT CARE MED, V29, P541, DOI 10.1097/00003246-200103000-00012; Heininger A, 2011, CRIT CARE, V15, DOI 10.1186/cc10069; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 1999, CRIT CARE MED, V27, P1230, DOI 10.1097/00003246-199907000-00002; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Humar A, 2006, AM J TRANSPLANT, V6, P262, DOI 10.1111/j.1600-6143.2005.01207.x; Humar A, 2006, TRANSPLANTATION, V82, pS9, DOI 10.1097/01.tp.0000230432.39447.8b; Juvonen E, 2007, HAEMATOLOGICA, V92, P819, DOI 10.3324/haematol.10751; Kalil AC, 2011, CRIT CARE, V15, DOI 10.1186/cc10093; Kalil AC, 2009, CRIT CARE MED, V37, P2350, DOI 10.1097/CCM.0b013e3181a3aa43; Kutza AST, 1998, CLIN INFECT DIS, V26, P1076, DOI 10.1086/520307; Lee YJ, 2013, BIOL BLOOD MARROW TR, V19, P387, DOI 10.1016/j.bbmt.2012.10.014; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Linssen CFM, 2008, INTENS CARE MED, V34, P2202, DOI 10.1007/s00134-008-1231-4; Luyt CE, 2007, AM J RESP CRIT CARE, V175, P935, DOI 10.1164/rccm.200609-1322OC; Maggi F, 2003, J VIROL, V77, P2418, DOI 10.1128/JVI.77.4.2418-2425.2003; Meisel C, 2009, AM J RESP CRIT CARE, V180, P640, DOI 10.1164/rccm.200903-0363OC; Micek ST, 2010, ANTIMICROB AGENTS CH, V54, P1742, DOI 10.1128/AAC.01365-09; Munford RS, 2001, AM J RESP CRIT CARE, V163, P316, DOI 10.1164/ajrccm.163.2.2007102; Otto GP, 2011, CRIT CARE, V15, DOI 10.1186/cc10332; Pollock JL, 1997, VIROLOGY, V227, P168, DOI 10.1006/viro.1996.8303; Prosch S, 2000, VIROLOGY, V272, P357, DOI 10.1006/viro.2000.0367; Razonable RR, 2013, AM J TRANSPLANT, V13, P67, DOI 10.1111/ajt.12008; Razonable RR, 2002, J INFECT DIS, V185, P110, DOI 10.1086/324772; Sanchez JL, 2002, J CLIN MICROBIOL, V40, P2381, DOI 10.1128/JCM.40.7.2381-2386.2002; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Shibayama T, 2001, AIDS, V15, P563, DOI 10.1097/00002030-200103300-00004; Touinssi M, 2001, J CLIN VIROL, V21, P135, DOI 10.1016/S1386-6532(01)00157-3; Venet F, 2013, CURR OPIN IMMUNOL; Venet F, 2009, INTENS CARE MED, V35, P678, DOI 10.1007/s00134-008-1337-8; Vincent JL, 2013, LANCET, V381, P774, DOI 10.1016/S0140-6736(12)61815-7; Wada K, 2007, J CLIN MICROBIOL, V45, P1426, DOI 10.1128/JCM.01515-06; Wandinger KP, 2000, NEUROLOGY, V55, P178, DOI 10.1212/WNL.55.2.178; Wherry EJ, 2006, VIROLOGY, V353, P366, DOI 10.1016/j.virol.2006.06.017; Xiao WZ, 2011, J EXP MED, V208, P2581, DOI 10.1084/jem.20111354; Xu FJ, 2006, JAMA-J AM MED ASSOC, V296, P964, DOI 10.1001/jama.296.8.964	66	222	230	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98819	10.1371/journal.pone.0098819	http://dx.doi.org/10.1371/journal.pone.0098819			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919177	Green Published, gold			2022-12-27	WOS:000338631000028
J	Rees, JR; Zens, MS; Gui, J; Celaya, MO; Riddle, BL; Karagas, MR				Rees, Judy R.; Zens, M. Scot; Gui, Jiang; Celaya, Maria O.; Riddle, Bruce L.; Karagas, Margaret R.			Non Melanoma Skin Cancer and Subsequent Cancer Risk	PLOS ONE			English	Article							BASAL-CELL CARCINOMA; 2ND PRIMARY CANCERS; CUTANEOUS MALIGNANT-MELANOMA; IN-SITU; PROSPECTIVE COHORT; GENE VARIANTS; UNITED-STATES; NONMELANOMA; DIAGNOSIS; ASSOCIATION	Introduction: Several studies have shown an increased risk of cancer after non melanoma skin cancers (NMSC) but the individual risk factors underlying this risk have not been elucidated, especially in relation to sun exposure and skin sensitivity to sunlight. Purpose: The aim of this study was to examine the individual risk factors associated with the development of subsequent cancers after non melanoma skin cancer. Methods: Participants in the population-based New Hampshire Skin Cancer Study provided detailed risk factor data, and subsequent cancers were identified via linkage with the state cancer registry. Deaths were identified via state and national death records. A Cox proportional hazard model was used to estimate risk of subsequent malignancies in NMSC patients versus controls and to assess the potential confounding effects of multiple risk factors on this risk. Results: Among 3584 participants, risk of a subsequent cancer (other than NMSC) was higher after basal cell carcinoma (BCC) (adjusted HR 1.40 [95% CI 1.15, 1.71]) than squamous cell carcinoma (SCC) (adjusted HR 1.18 [95% CI 0.95, 1.46]) compared to controls (adjusted for age, sex and current cigarette smoking). After SCC, risk was higher among those diagnosed before age 60 (HR 1.96 [95% CI 1.24, 3.12]). An over 3-fold risk of melanoma after SCC (HR 3.62; 95% CI 1.85, 7.11) and BCC (HR 3.28; 95% CI 1.66, 6.51) was observed, even after further adjustment for sun exposure-related factors and family history of skin cancer. In men, prostate cancer incidence was higher after BCC compared to controls (HR 1.64; 95% CI 1.10, 2.46). Conclusions: Our population-based study indicates an increased cancer risk after NMSC that cannot be fully explained by known cancer risk factors.	[Rees, Judy R.; Zens, M. Scot; Gui, Jiang; Celaya, Maria O.; Riddle, Bruce L.; Karagas, Margaret R.] Geisel Sch Med Dartmouth, Dept Community & Family Med, Biostat & Epidemiol Sect, Lebanon, NH 03756 USA; [Rees, Judy R.; Celaya, Maria O.; Riddle, Bruce L.] New Hampshire State Canc Registry, Hanover, NH USA	Dartmouth College	Rees, JR (corresponding author), Geisel Sch Med Dartmouth, Dept Community & Family Med, Biostat & Epidemiol Sect, Lebanon, NH 03756 USA.	judy.rees@dartmouth.edu			American Cancer Society [RSGHP-08-004-01-CPHPS]; National Cancer Institute, National Institutes of Health [CA057494]; Centers for Disease Control and Prevention [UA/DP003930-01]; NATIONAL CANCER INSTITUTE [R01CA057494, P30CA023108] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This project was supported by a Research Scholars Grant of the American Cancer Society RSGHP-08-004-01-CPHPS; by Grant CA057494 of the National Cancer Institute, National Institutes of Health, and in part by the Centers for Disease Control and Prevention's National Program of Cancer Registries, cooperative agreement UA/DP003930-01 awarded to the New Hampshire Department of Health and Human Services, Division of Public Health Services, Bureau of Public Health Statistics and Informatics, Office of Health Statistics and Data Management. Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the Centers for Disease Control and Prevention or NH Department of Health and Human Services. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Athas WF, 2003, CANCER EPIDEM BIOMAR, V12, P1105; Bergmann MM, 1998, AM J EPIDEMIOL, V147, P556; Bower CPR, 2000, J AM ACAD DERMATOL, V42, P988, DOI 10.1016/S0190-9622(00)90291-3; Brewster AM, 2004, CANCER EPIDEM BIOMAR, V13, P1271; Chen J, 2008, JNCI-J NATL CANCER I, V100, P1215, DOI 10.1093/jnci/djn260; Cho EY, 2005, CANCER EPIDEM BIOMAR, V14, P1241, DOI 10.1158/1055-9965.EPI-04-0632; COLDITZ GA, 1986, AM J EPIDEMIOL, V123, P894, DOI 10.1093/oxfordjournals.aje.a114319; Crocetti E, 2004, EUR J CANCER PREV, V13, P33, DOI 10.1097/00008469-200402000-00006; Efird JT, 2002, ANN EPIDEMIOL, V12, P469, DOI 10.1016/S1047-2797(01)00276-9; Friedman GD, 2000, CANCER CAUSE CONTROL, V11, P891, DOI 10.1023/A:1026591016153; Frisch M, 1996, ANN INTERN MED, V125, P815, DOI 10.7326/0003-4819-125-10-199611150-00005; FRISCH M, 1995, AM J EPIDEMIOL, V141, P916, DOI 10.1093/oxfordjournals.aje.a117358; GREENLAND S, 1989, AM J PUBLIC HEALTH, V79, P340, DOI 10.2105/AJPH.79.3.340; Havener LE, 2004, STANDARDS CANC REGIS; Hemminki K, 2000, ARCH DERMATOL, V136, P647, DOI 10.1001/archderm.136.5.647; Hemminki K, 2000, EPIDEMIOLOGY, V11, P309, DOI 10.1097/00001648-200005000-00014; Hemminki K, 2003, CANCER-AM CANCER SOC, V97, P2432, DOI 10.1002/cncr.11372; Hsu LI, 2013, AM J EPIDEMIOL, V177, P202, DOI 10.1093/aje/kws369; Jorgensen TJ, 2012, CANCER EPIDEMIOL, V36, pE288, DOI 10.1016/j.canep.2012.05.001; Jung GW, 2014, BRIT J DERMATOL, V170, P136, DOI 10.1111/bjd.12694; KALDOR J, 1993, INT J CANCER, V53, P886, DOI 10.1002/ijc.2910530603; Karagas MR, 1998, CANCER EPIDEM BIOMAR, V7, P157; Karagas MR, 1999, INT J CANCER, V81, P555, DOI 10.1002/(SICI)1097-0215(19990517)81:4<555::AID-IJC9>3.0.CO;2-R; Levi F, 1996, BRIT J CANCER, V74, P1847, DOI 10.1038/bjc.1996.642; Levi F, 1997, AM J EPIDEMIOL, V146, P734; LINDELOF B, 1991, J AM ACAD DERMATOL, V25, P245, DOI 10.1016/0190-9622(91)70189-9; Maitra SK, 2005, BRIT J CANCER, V92, P570, DOI 10.1038/sj.bjc.6602306; Milan T, 2000, INT J CANCER, V87, P283, DOI 10.1002/1097-0215(20000715)87:2<283::AID-IJC21>3.0.CO;2-I; Nugent Z, 2005, CANCER EPIDEM BIOMAR, V14, P2584, DOI 10.1158/1055-9965.EPI-05-0379; Ong ELH, 2014, CANCER EPIDEM BIOMAR, V23, P490, DOI 10.1158/1055-9965.EPI-13-0902; Robinson SN, 2013, J INVEST DERMATOL, V133, P1950, DOI 10.1038/jid.2013.33; Roh MR, 2012, J DERMATOL, V39, P541, DOI 10.1111/j.1346-8138.2011.01495.x; Rosenberg CA, 2004, CANCER, V100, P130, DOI 10.1002/cncr.11874; Ruczinski I, 2012, CARCINOGENESIS, V33, P1692, DOI 10.1093/carcin/bgs170; Song FJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001433; TEPPO L, 1985, J NATL CANCER I, V75, P207; Thompson CA, 2013, EUR J EPIDEMIOL, V28, P557, DOI 10.1007/s10654-013-9812-0; Thornton M, 2011, STANDARDS CANC REGIS; Troyanova P, 2002, NEOPLASMA, V49, P81; U. S. Cancer Statistics Working Group, 2010, US CANC STAT 1999 20; Walls AC, 2013, AM J EPIDEMIOL, V177, P997, DOI 10.1093/aje/kws335; Wassberg C, 1996, BRIT J CANCER, V73, P255, DOI 10.1038/bjc.1996.45; Wassberg C, 1999, INT J CANCER, V80, P511, DOI 10.1002/(SICI)1097-0215(19990209)80:4<511::AID-IJC5>3.3.CO;2-G; WEINSTOCK MA, 1993, ARCH DERMATOL, V129, P1286, DOI 10.1001/archderm.129.10.1286; Wheless L, 2010, CANCER EPIDEM BIOMAR, V19, P1686, DOI 10.1158/1055-9965.EPI-10-0243	45	52	53	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99674	10.1371/journal.pone.0099674	http://dx.doi.org/10.1371/journal.pone.0099674			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937304	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400031
J	Zeisset, I; Beebee, TJC				Zeisset, Inga; Beebee, Trevor J. C.			Drift Rather than Selection Dominates MHC Class II Allelic Diversity Patterns at the Biogeographical Range Scale in Natterjack Toads Bufo calamita	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; BATRACHOCHYTRIUM-DENDROBATIDIS; MOLECULAR CHARACTERIZATION; POPULATION-STRUCTURE; BETA-CHAIN; AMPHIBIAN CHYTRIDIOMYCOSIS; MICROSATELLITE LOCI; NATURAL-SELECTION; GENETIC-VARIATION; COMMON FROG	Study of major histocompatibility complex (MHC) loci has gained great popularity in recent years, partly due to their function in protecting vertebrates from infections. This is of particular interest in amphibians on account of major threats many species face from emergent diseases such as chytridiomycosis. In this study we compare levels of diversity in an expressed MHC class II locus with neutral genetic diversity at microsatellite loci in natterjack toad (Bufo (Epidalea) calamita) populations across the whole of the species' biogeographical range. Variation at both classes of loci was high in the glacial refugium areas (REF) and much lower in postglacial expansion areas (PGE), especially in range edge populations. Although there was clear evidence that the MHC locus was influenced by positive selection in the past, congruence with the neutral markers suggested that historical demographic events were the main force shaping MHC variation in the PGE area. Both neutral and adaptive genetic variation declined with distance from glacial refugia. Nevertheless, there were also some indications from differential isolation by distance and allele abundance patterns that weak effects of selection have been superimposed on the main drift effect in the PGE zone.	[Zeisset, Inga] Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England; [Zeisset, Inga; Beebee, Trevor J. C.] Univ Sussex, Sch Life Sci, Brighton, E Sussex, England	University of Brighton; University of Sussex	Zeisset, I (corresponding author), Univ Brighton, Sch Pharm & Biomol Sci, Brighton, E Sussex, England.	i.zeisset@brighton.ac.uk		Zeisset, Inga/0000-0002-4474-1527	Leverhulme trust [F/00230/AH]	Leverhulme trust(Leverhulme Trust)	This research was funded by the Leverhulme trust (http://www.leverhulme.ac.uk). Grant number: F/00230/AH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andre C, 2011, HEREDITY, V106, P270, DOI 10.1038/hdy.2010.71; Antao T, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-323; Babik W, 2009, MOL ECOL, V18, P769, DOI 10.1111/j.1365-294X.2008.04057.x; Babik W, 2008, MOL ECOL, V17, P2339, DOI 10.1111/j.1365-294X.2008.03757.x; Babik W, 2010, MOL ECOL RESOUR, V10, P237, DOI 10.1111/j.1755-0998.2009.02788.x; Beaumont MA, 1996, P ROY SOC B-BIOL SCI, V263, P1619, DOI 10.1098/rspb.1996.0237; Beebee TJC, 2005, BIOL CONSERV, V125, P271, DOI 10.1016/j.biocon.2005.04.009; Beebee TJC, 2000, BIOL J LINN SOC, V69, P367, DOI 10.1111/j.1095-8312.2000.tb01211.x; Bonneaud C, 2006, EVOLUTION, V60, P383, DOI 10.1111/j.0014-3820.2006.tb01114.x; Bos DH, 2005, IMMUNOGENETICS, V57, P775, DOI 10.1007/s00251-005-0038-5; Brookfield JFY, 1996, MOL ECOL, V5, P453, DOI 10.1046/j.1365-294X.1996.00098.x; BROWN JH, 1993, NATURE, V364, P33, DOI 10.1038/364033a0; Bryant D, 2004, MOL BIOL EVOL, V21, P255, DOI 10.1093/molbev/msh018; Campos JL, 2006, CONSERV GENET, V7, P515, DOI 10.1007/s10592-005-9063-z; Cheng YY, 2012, IMMUNOGENETICS, V64, P525, DOI 10.1007/s00251-012-0614-4; de Bellocq JG, 2008, J EVOLUTION BIOL, V21, P1144, DOI 10.1111/j.1420-9101.2008.01538.x; Delport W, 2010, BIOINFORMATICS, V26, P2455, DOI 10.1093/bioinformatics/btq429; Dionne M, 2007, EVOLUTION, V61, P2154, DOI 10.1111/j.1558-5646.2007.00178.x; Eimes JA, 2011, J EVOLUTION BIOL, V24, P1847, DOI 10.1111/j.1420-9101.2011.02311.x; ELLEGREN H, 1993, P NATL ACAD SCI USA, V90, P8150, DOI 10.1073/pnas.90.17.8150; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Felsenstein J., 1993, PHYLIP PHYLOGENY INF; Fisher MC, 2009, ANNU REV MICROBIOL, V63, P291, DOI 10.1146/annurev.micro.091208.073435; Froeschke G, 2005, MOL BIOL EVOL, V22, P1254, DOI 10.1093/molbev/msi112; Frost DR, 2006, B AM MUS NAT HIST, P8, DOI 10.1206/0003-0090(2006)297[0001:TATOL]2.0.CO;2; Gahl MK, 2012, CONSERV BIOL, V26, P135, DOI 10.1111/j.1523-1739.2011.01801.x; Garrigan D, 2003, EVOLUTION, V57, P1707; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Graybeal A, 1997, ZOOL J LINN SOC-LOND, V119, P297, DOI 10.1111/j.1096-3642.1997.tb00139.x; Guernier V, 2004, PLOS BIOL, V2, P740, DOI 10.1371/journal.pbio.0020141; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hauswaldt JS, 2007, IMMUNOGENETICS, V59, P479, DOI 10.1007/s00251-007-0210-1; Hedrick PW, 2001, TRENDS ECOL EVOL, V16, P629, DOI 10.1016/S0169-5347(01)02282-0; HEDRICK PW, 1994, AM NAT, V143, P945, DOI 10.1086/285643; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hidalgo-Vila J, 2012, DIS AQUAT ORGAN, V98, P113, DOI 10.3354/dao02419; Houlahan JE, 2000, NATURE, V404, P752, DOI 10.1038/35008052; Hughes AL, 1998, ANNU REV GENET, V32, P415, DOI 10.1146/annurev.genet.32.1.415; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; JUKES T H, 1969, P21; Kiemnec-Tyburczy KM, 2010, IMMUNOGENETICS, V62, P741, DOI 10.1007/s00251-010-0476-6; Kiemnec-Tyburczy KM, 2012, CONSERV GENET, V5, P109; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Klein J, 1998, SCAND J IMMUNOL, V47, P199; KOBARI F, 1995, IMMUNOGENETICS, V42, P376, DOI 10.1007/BF00179399; Kobari F., 1995, Zoological Science (Tokyo), V12, P38; Pond SLK, 2006, MOL BIOL EVOL, V23, P1891, DOI 10.1093/molbev/msl051; Landry C, 2001, MOL ECOL, V10, P2525, DOI 10.1046/j.1365-294X.2001.01383.x; Langefors A, 2001, P ROY SOC B-BIOL SCI, V268, P479, DOI 10.1098/rspb.2000.1378; Laurens V, 2001, EUR J IMMUNOL, V31, P506, DOI 10.1002/1521-4141(200102)31:2<506::AID-IMMU506>3.0.CO;2-P; Lillie M, 2012, J HERED, V103, P467, DOI 10.1093/jhered/ess012; Male PJG, 2012, BIOL J LINN SOC, V105, P881, DOI 10.1111/j.1095-8312.2011.01799.x; Marsden CD, 2012, MOL ECOL, V21, P1379, DOI 10.1111/j.1365-294X.2012.05477.x; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; May S, 2009, CONSERV GENET RESOUR, V1, P415, DOI 10.1007/s12686-009-9096-6; Meyer-Lucht Y, 2005, MOL ECOL, V14, P2233, DOI 10.1111/j.1365-294X.2005.02557.x; Meyer-Lucht Y, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-39; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; NEI M, 1986, MOL BIOL EVOL, V3, P418; Nei M., 2000, MOL EVOLUTION PHYLOG; Ohashi J, 2006, TISSUE ANTIGENS, V68, P427, DOI 10.1111/j.1399-0039.2006.00688.x; Ohta Y, 2006, J IMMUNOL, V176, P3674, DOI 10.4049/jimmunol.176.6.3674; Oliver MK, 2012, MOL BIOL EVOL, V29, P1713, DOI 10.1093/molbev/mss063; Oliver MK, 2009, MOL ECOL, V18, P80, DOI 10.1111/j.1365-294X.2008.04015.x; Osborne AJ, 2013, HEREDITY, V111, P44, DOI 10.1038/hdy.2013.18; Padidam M, 1999, VIROLOGY, V265, P218, DOI 10.1006/viro.1999.0056; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Piertney SB, 2006, HEREDITY, V96, P7, DOI 10.1038/sj.hdy.6800724; Ploshnitsa AI, 2012, ECOL EVOL, V2, P165, DOI 10.1002/ece3.42; Posada D, 2002, MOL BIOL EVOL, V19, P708, DOI 10.1093/oxfordjournals.molbev.a004129; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Richmond JQ, 2009, BIOSCIENCE, V59, P311, DOI 10.1525/bio.2009.59.4.9; Rowe G, 2006, MOL PHYLOGENET EVOL, V39, P335, DOI 10.1016/j.ympev.2005.08.021; Sato A, 2011, MOL BIOL EVOL, V28, P1943, DOI 10.1093/molbev/msr015; SATO K, 1993, J IMMUNOL, V150, P2831; Savage AE, 2011, P NATL ACAD SCI USA, V108, P16705, DOI 10.1073/pnas.1106893108; Schad J, 2011, HEREDITY, V107, P115, DOI 10.1038/hdy.2010.173; Searle CL, 2011, CONSERV BIOL, V25, P965, DOI 10.1111/j.1523-1739.2011.01708.x; Shafer ABA, 2012, J HERED, V103, P371, DOI 10.1093/jhered/esr138; Simkova A, 2006, EVOL ECOL, V20, P465, DOI 10.1007/s10682-006-0014-z; SMITH JM, 1992, J MOL EVOL, V34, P126; Sommer Simone, 2005, Frontiers in Zoology, V2, P1, DOI 10.1186/1742-9994-2-16; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Sunnucks P, 2000, MOL ECOL, V9, P1699, DOI 10.1046/j.1365-294x.2000.01084.x; Sutton JT, 2011, MOL ECOL, V20, P4408, DOI 10.1111/j.1365-294X.2011.05292.x; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Taylor SS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036748; Tong Joo Chuan, 2006, Immunome Res, V2, P1, DOI 10.1186/1745-7580-2-1; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walker SF, 2010, ECOL LETT, V13, P372, DOI 10.1111/j.1461-0248.2009.01434.x; Wegner KM, 2003, J EVOLUTION BIOL, V16, P224, DOI 10.1046/j.1420-9101.2003.00519.x; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whittaker JC, 2003, GENETICS, V164, P781; Zeisset I, 2008, HEREDITY, V101, P109, DOI 10.1038/hdy.2008.30; Zeisset I, 2013, ANIM CONSERV, V16, P359, DOI 10.1111/acv.12003; Zeisset I, 2010, HEREDITY, V104, P423, DOI 10.1038/hdy.2009.157; Zeisset I, 2009, MOL ECOL RESOUR, V9, P738, DOI 10.1111/j.1755-0998.2009.02535.x; Zeisset I, 2013, CONSERV GENET RESOUR, V5, P211, DOI 10.1007/s12686-012-9770-y; ZUCKERKANDL EMILE, 1965, P97	104	21	21	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100176	10.1371/journal.pone.0100176	http://dx.doi.org/10.1371/journal.pone.0100176			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937211	gold, Green Submitted, Green Published			2022-12-27	WOS:000338503400086
J	Bulf, H; Cassia, VM; de Hevia, MD				Bulf, Hermann; Cassia, Viola Macchi; de Hevia, Maria Dolores			Are Numbers, Size and Brightness Equally Efficient in Orienting Visual Attention? Evidence from an Eye-Tracking Study	PLOS ONE			English	Article							MENTAL REPRESENTATION; HUMAN INFANTS; MAGNITUDE; SPACE; PERCEPTION; LUMINANCE; NEGLECT; PARITY; CORTEX; COMMON	A number of studies have shown strong relations between numbers and oriented spatial codes. For example, perceiving numbers causes spatial shifts of attention depending upon numbers' magnitude, in a way suggestive of a spatially oriented, mental representation of numbers. Here, we investigated whether this phenomenon extends to non-symbolic numbers, as well as to the processing of the continuous dimensions of size and brightness, exploring whether different quantitative dimensions are equally mapped onto space. After a numerical (symbolic Arabic digits or non-symbolic arrays of dots; Experiment 1) or a non-numerical cue (shapes of different size or brightness level; Experiment 2) was presented, participants' saccadic response to a target that could appear either on the left or the right side of the screen was registered using an automated eye-tracker system. Experiment 1 showed that, both in the case of Arabic digits and dot arrays, right targets were detected faster when preceded by large numbers, and left targets were detected faster when preceded by small numbers. Participants in Experiment 2 were faster at detecting right targets when cued by large-sized shapes and left targets when cued by small-sized shapes, whereas brightness cues did not modulate the detection of peripheral targets. These findings indicate that looking at a symbolic or a non-symbolic number induces attentional shifts to a peripheral region of space that is congruent with the numbers' relative position on a mental number line, and that a similar shift in visual attention is induced by looking at shapes of different size. More specifically, results suggest that, while the dimensions of number and size spontaneously map onto an oriented space, the dimension of brightness seems to be independent at a certain level of magnitude elaboration from the dimensions of spatial extent and number, indicating that not all continuous dimensions are equally mapped onto space.	[Bulf, Hermann; Cassia, Viola Macchi] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [de Hevia, Maria Dolores] Univ Paris 05, Lab Psychol Percept, CNRS, UMR 8242, Paris, France; [de Hevia, Maria Dolores] INSERM, U992, NeuroSpin, Cognit Neuroimaging Unit, Gif Sur Yvette, France	University of Milano-Bicocca; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Paris Cite; CEA; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay	Bulf, H (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	hermann.bulf@unimib.it	Macchi Cassia, Viola/HCI-2058-2022	macchi cassia, viola/0000-0002-9983-8254	University of Milano-Bicocca	University of Milano-Bicocca	This research was supported by a grant from the University of Milano-Bicocca to the last author, MDdH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berch DB, 1999, J EXP CHILD PSYCHOL, V74, P286, DOI 10.1006/jecp.1999.2518; Bueti D, 2009, PHILOS T R SOC B, V364, P1831, DOI 10.1098/rstb.2009.0028; Bulf H, 2013, DEV PSYCHOL, V49, P1909, DOI 10.1037/a0031310; Bulf H, 2009, PERCEPTION, V38, P1313, DOI 10.1068/p6272; de Hevia MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096412; de Hevia MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081241; de Hevia MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035530; de Hevia MD, 2010, PSYCHOL SCI, V21, P653, DOI 10.1177/0956797610366091; de Hevia MD, 2009, COGNITION, V110, P198, DOI 10.1016/j.cognition.2008.11.003; de Hevia MD, 2006, EXP BRAIN RES, V168, P254, DOI 10.1007/s00221-005-0084-0; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; DEHAENE S, 1993, J EXP PSYCHOL GEN, V122, P371, DOI 10.1037/0278-7393.21.2.314; DEHAENE S, 1992, COGNITION, V44, P1, DOI 10.1016/0010-0277(92)90049-N; Dehaene S, 2008, SCIENCE, V320, P1217, DOI 10.1126/science.1156540; Fias W, 2001, PSYCHOL RES-PSYCH FO, V65, P250, DOI 10.1007/s004260100065; Fias W., 2005, HDB MATH COGNITION, P43; Fias W., 1996, MATH COGNITION, V2, P95, DOI [DOI 10.1080/135467996387552, 10.1080/135467996387552]; Fischer MH, 2004, EXP PSYCHOL, V51, P91, DOI 10.1027/1618-3169.51.2.91; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Fischer MH, 2003, VIS COGN, V10, P493, DOI 10.1080/13506280244000186; Gebuis T, 2011, ATTEN PERCEPT PSYCHO, V73, P259, DOI 10.3758/s13414-010-0002-9; Kadosh RC, 2008, CEREB CORTEX, V18, P337, DOI 10.1093/cercor/bhm058; Knops A, 2009, SCIENCE, V324, P1583, DOI 10.1126/science.1171599; Loetscher T, 2007, EXP BRAIN RES, V180, P655, DOI 10.1007/s00221-007-0889-0; Loetscher T, 2010, CURR BIOL, V20, pR264, DOI 10.1016/j.cub.2010.01.015; Lourenco SF, 2010, PSYCHOL SCI, V21, P873, DOI 10.1177/0956797610370158; Opfer JE, 2010, DEVELOPMENTAL SCI, V13, P761, DOI 10.1111/j.1467-7687.2009.00934.x; Piazza M, 2004, NEURON, V44, P547, DOI 10.1016/j.neuron.2004.10.014; Piazza M, 2007, NEURON, V53, P293, DOI 10.1016/j.neuron.2006.11.022; Pinel P, 2004, NEURON, V41, P983, DOI 10.1016/S0896-6273(04)00107-2; Ren P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023553; Rugani R, 2010, BIOL LETTERS, V6, P290, DOI 10.1098/rsbl.2009.0960; Shaki S, 2009, PSYCHON B REV, V16, P328, DOI 10.3758/PBR.16.2.328; van Galen MS, 2008, J EXP CHILD PSYCHOL, V101, P99, DOI 10.1016/j.jecp.2008.05.001; Viarouge A, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00484; Vuilleumier P, 2004, CORTEX, V40, P399, DOI 10.1016/S0010-9452(08)70134-5; Walsh V, 2003, TRENDS COGN SCI, V7, P483, DOI 10.1016/j.tics.2003.09.002; Zorzi M, 2002, NATURE, V417, P138, DOI 10.1038/417138a	38	25	25	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99499	10.1371/journal.pone.0099499	http://dx.doi.org/10.1371/journal.pone.0099499			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932753	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600037
J	Goncalves, MD; Delattre, C; Balestrino, D; Charbonnel, N; Elboutachfaiti, R; Wadouachi, A; Badel, S; Bernardi, T; Michaud, P; Forestier, C				Goncalves, Marina Dos Santos; Delattre, Cedric; Balestrino, Damien; Charbonnel, Nicolas; Elboutachfaiti, Redouan; Wadouachi, Anne; Badel, Stephanie; Bernardi, Thierry; Michaud, Philippe; Forestier, Christiane			Anti-Biofilm Activity: A Function of Klebsiella pneumoniae Capsular Polysaccharide	PLOS ONE			English	Article							PSEUDOMONAS-AERUGINOSA; EXOPOLYSACCHARIDES; INHIBITION; EXPRESSION; BACTERIA	Competition and cooperation phenomena occur within highly interactive biofilm communities and several non-biocides molecules produced by microorganisms have been described as impairing biofilm formation. In this study, we investigated the anti-biofilm capacities of an ubiquitous and biofilm producing bacterium, Klebsiella pneumoniae. Cell-free supernatant from K. pneumoniae planktonic cultures showed anti-biofilm effects on most Gram positive bacteria tested but also encompassed some Gram negative bacilli. The anti-biofilm non-bactericidal activity was further investigated on Staphylococcus epidermidis, by determining the biofilm biomass, microscopic observations and agglutination measurement through a magnetic bead-mediated agglutination test. Cell-free extracts from K. pneumoniae biofilm (supernatant and acellular matrix) also showed an influence, although to a lesser extend. Chemical analyses indicated that the active molecule was a high molecular weight polysaccharide composed of five monosaccharides: galactose, glucose, rhamnose, glucuronic acid and glucosamine and the main following sugar linkage residues [-> 2)-alpha-L-Rhap-(1 ->]; [-> 4)-alpha-L-Rhap-(1 ->]; [alpha-D-Galp-(1 ->]; [-> 2,3)-alpha-D-Galp-(1 ->]; [-> 3)-beta-D-Galp-(1 ->] and, [-> 4)-beta-D-GlcAp-(1 ->]. Characterization of this molecule indicated that this component was more likely capsular polysaccharide (CPS) and precoating of abiotic surfaces with CPS extracts from different serotypes impaired the bacteria-surface interactions. Thus the CPS of Klebsiella would exhibit a pleiotropic activity during biofilm formation, both stimulating the initial adhesion and maturation steps as previously described, but also repelling potential competitors.	[Goncalves, Marina Dos Santos; Balestrino, Damien; Charbonnel, Nicolas; Forestier, Christiane] Univ Auvergne, Lab Microorganismes Genome Environm LMGE, Clermont Univ, CNRS,UMR 6023, Clermont Ferrand, France; [Delattre, Cedric; Michaud, Philippe] Univ Blaise Pascal, Clermont Univ, Inst Pascal, CNRS,Polytech Clermont Ferrand,UMR 6602, Aubiere, France; [Elboutachfaiti, Redouan] Univ Picardie, IUT Amiens GB, EA BioPI Biol Plantes & Innovat 3900, Amiens, France; [Wadouachi, Anne] Univ Picardie, Inst Chim Picardie, Lab Glucides, FRE CNRS 3517,FR 3085, Amiens, France; [Badel, Stephanie; Bernardi, Thierry] BioFilm Control, Biopole Clermont Limagne, St Beauzire, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); Universite Clermont Auvergne (UCA); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Universite Clermont Auvergne (UCA); Picardie Universites; Universite de Picardie Jules Verne (UPJV); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Picardie Universites; Universite de Picardie Jules Verne (UPJV)	Forestier, C (corresponding author), Univ Auvergne, Lab Microorganismes Genome Environm LMGE, Clermont Univ, CNRS,UMR 6023, Clermont Ferrand, France.	christiane.forestier@udamail.fr	Michaud, Philippe/U-1844-2019; Michaud, Philippe/U-1042-2019	Michaud, Philippe/0000-0002-6677-4549; BALESTRINO, Damien/0000-0001-5378-0379; Delattre, cedric/0000-0003-3605-1929; Badel-Berchoux, stephanie/0000-0002-7212-8199	Region Auvergn-FEDER	Region Auvergn-FEDER(Region Auvergne-Rhone-AlpesRegion Bourgogne-Franche-ComteRegion Hauts-de-FranceRegion Nouvelle-Aquitaine)	This work was partially supported by a fellowship from the Region Auvergn-FEDER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Other source of funding was non-specific and internal to our organization.	Augustine N, 2010, ARCH MICROBIOL, V192, P1019, DOI 10.1007/s00203-010-0633-1; Balestrino D, 2005, J BACTERIOL, V187, P2870, DOI 10.1128/JB.187.8.2870-2880.2005; Balestrino D, 2008, ENVIRON MICROBIOL, V10, P685, DOI 10.1111/j.1462-2920.2007.01491.x; Bazaka K, 2011, ADV EXP MED BIOL, V715, P213, DOI 10.1007/978-94-007-0940-9_13; Bendaoud M, 2011, J BACTERIOL, V193, P3879, DOI 10.1128/JB.00311-11; Chavant P, 2007, J MICROBIOL METH, V68, P605, DOI 10.1016/j.mimet.2006.11.010; Chou HC, 2004, INFECT IMMUN, V72, P3783, DOI 10.1128/IAI.72.7.3783-3792.2004; Coghlan A, 1996, NEW SCI, V2045, P34; Cugini C, 2007, MOL MICROBIOL, V65, P896, DOI 10.1111/j.1365-2958.2007.05840.x; Davey ME, 2000, MICROBIOL MOL BIOL R, V64, P847, DOI 10.1128/MMBR.64.4.847-867.2000; De Araujo C, 2010, RES MICROBIOL, V161, P595, DOI 10.1016/j.resmic.2010.05.014; DOMENICO P, 1989, J MICROBIOL METH, V9, P211, DOI 10.1016/0167-7012(89)90038-9; Donlan RM, 2002, EMERG INFECT DIS, V8, P881, DOI 10.3201/eid0809.020063; Donlan RM, 2002, CLIN MICROBIOL REV, V15, P167, DOI 10.1128/CMR.15.2.167-193.2002; DUBOIS M, 1956, ANAL CHEM, V28, P350, DOI 10.1021/ac60111a017; Evrard B, 2010, INFECT IMMUN, V78, P210, DOI 10.1128/IAI.00864-09; Favre-Bonte S., 1998, Journal of Antimicrobial Chemotherapy, V41, P51, DOI 10.1093/jac/41.suppl_2.51; Hennequin C, 2007, RES MICROBIOL, V158, P339, DOI 10.1016/j.resmic.2007.02.005; Hibbing ME, 2010, NAT REV MICROBIOL, V8, P15, DOI 10.1038/nrmicro2259; Jiang P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018514; Kachlany SC, 2001, ENVIRON MICROBIOL, V3, P774, DOI 10.1046/j.1462-2920.2001.00248.x; Kanmani P, 2011, BIORESOURCE TECHNOL, V102, P4827, DOI 10.1016/j.biortech.2010.12.118; Kaplan JB, 2003, J BACTERIOL, V185, P4693, DOI 10.1128/JB.185.16.4693-4698.2003; Karwacki MT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063844; Kim Y, 2009, BIOCHEM BIOPH RES CO, V379, P324, DOI 10.1016/j.bbrc.2008.12.053; Kubler-Kielb J, 2013, CARBOHYD RES, V369, P6, DOI 10.1016/j.carres.2012.12.018; McAlester G, 2008, J MED MICROBIOL, V57, P563, DOI 10.1099/jmm.0.47705-0; Moons P, 2009, CRIT REV MICROBIOL, V35, P157, DOI 10.1080/10408410902809431; Murray EGD, 1926, J PATHOL BACTERIOL, V29, P407, DOI 10.1002/path.1700290409; Nielsen AT, 2000, ENVIRON MICROBIOL, V2, P59, DOI 10.1046/j.1462-2920.2000.00084.x; Pihl M, 2010, FEMS IMMUNOL MED MIC, V59, P439, DOI 10.1111/j.1574-695X.2010.00697.x; Qin ZQ, 2009, MICROBIOL-SGM, V155, P2148, DOI 10.1099/mic.0.028001-0; Rendueles O, 2013, ENVIRON MICROBIOL, V15, P334, DOI 10.1111/j.1462-2920.2012.02810.x; Rendueles O, 2012, FEMS MICROBIOL REV, V36, P972, DOI 10.1111/j.1574-6976.2012.00328.x; Rendueles O, 2011, MBIO, V2, DOI 10.1128/mBio.00043-11; ROSENBERG M, 1980, FEMS MICROBIOL LETT, V9, P29, DOI 10.1111/j.1574-6968.1980.tb05599.x; Sayem S M Abu, 2011, Microb Cell Fact, V10, P74, DOI 10.1186/1475-2859-10-74; Schembri MA, 2005, INFECT IMMUN, V73, P4626, DOI 10.1128/IAI.73.8.4626-4633.2005; Schembri MA, 2004, J BACTERIOL, V186, P1249, DOI 10.1128/JB.186.5.1249-1257.2004; Schollmeyer M, 2012, INT J BIOL MACROMOL, V50, P518, DOI 10.1016/j.ijbiomac.2012.01.003; Stenutz R, 1997, CARBOHYD RES, V302, P79, DOI 10.1016/S0008-6215(97)00106-7; Sugimoto S, 2013, J BACTERIOL, V195, P1645, DOI 10.1128/JB.01672-12; Travier L, 2013, ANTIMICROB AGENTS CH, V57, P3960, DOI 10.1128/AAC.02606-12; Valle J, 2003, MOL MICROBIOL, V48, P1075, DOI 10.1046/j.1365-2958.2003.03493.x; Valle J, 2006, P NATL ACAD SCI USA, V103, P12558, DOI 10.1073/pnas.0605399103; Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004; Whiteley M, 2001, NATURE, V413, P860, DOI 10.1038/35101627; Whitfield C, 1999, MOL MICROBIOL, V31, P1307, DOI 10.1046/j.1365-2958.1999.01276.x; Zhao K, 2013, NATURE, V497, P388, DOI 10.1038/nature12155	49	37	38	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99995	10.1371/journal.pone.0099995	http://dx.doi.org/10.1371/journal.pone.0099995			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932475	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600084
J	Das, NS; Usman, J; Choudhury, D; Abu Osman, NA				Das, Nabangshu S.; Usman, Juliana; Choudhury, Dipankar; Abu Osman, Noor Azuan			Nature and Pattern of Cricket Injuries: The Asian Cricket Council Under-19, Elite Cup, 2013	PLOS ONE			English	Article							INTERVENTION; PERIOD	Cricket has over the years gained much popularity in Asia, thus the number of cricket players has also grown in tandem. However, cricket players are not as fortunate as other athletes as they do not always have a standard cricket infrastructure to practice; therefore, the injury prevalence is expected to be high. Unfortunately, very few studies have been conducted to investigate the nature and pattern of cricket injuries prevalent to cricketers in this region. Therefore, a prospective cohort injury surveillance study was conducted during the Asian Cricket Council (ACC) Under-19 Elite Cup held in June 2013 in order to gather more data on the type of injuries sustained by cricket players. Overall, 31 injuries occurred to 28 players throughout the tournament, of which 7 injuries happened during practice sessions. The overall injury incidence rate (IIR) was 292.0 per 10,000 player hours (95% CI 176.9-407.1) and 10.4 per 10,000 balls faced and 2.6 per 1000 overs bowled delivered during batting and bowling, respectively. Injuries to the lower limb (IIR: 146; 95% CI 1.8-98.2) were the most frequent, followed by injuries to the upper limb (97.3; 95% CI 30.2-164.5) and to the trunk and back (IIR: 36.5; 95% CI 0.0-77.7). Sprain/strains (IIR 109.5; 95% CI 38.4-180.7) to muscle/tendon and joint/ligament were the most commonly reported nature of injury. This is the first study investigating injury incidence among the players of the ACC. It provides an overview of injuries sustained by elite players' under-19 years of age from 10 Asian countries. The overall IIR is similar to earlier studies conducted in well-established cricket playing nations.	[Das, Nabangshu S.; Usman, Juliana; Abu Osman, Noor Azuan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Usman, Juliana; Abu Osman, Noor Azuan] Univ Malaya, Ctr Appl Biomech, Kuala Lumpur, Malaysia; [Choudhury, Dipankar] Brno Univ Technol, Fac Mech Engn, CS-61090 Brno, Czech Republic; [Choudhury, Dipankar] Brno Univ Technol, CEITEC Cent European Inst Technol, CS-61090 Brno, Czech Republic	Universiti Malaya; Universiti Malaya; Brno University of Technology; Brno University of Technology	Usman, J (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.	juliana_78@um.edu.my	USMAN, JULIANA/B-8725-2010; ABU OSMAN, NOOR AZUAN/B-9265-2010	USMAN, JULIANA/0000-0001-8983-0892; ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421	High Impact Research Grant [UM.C/HIR/MOHE/ENG/10]; Bantuan Kecil Penyelidikan (BKP) fund from the University of Malaya [BK024-2012]	High Impact Research Grant; Bantuan Kecil Penyelidikan (BKP) fund from the University of Malaya	These works are supported by the High Impact Research Grant UM.C/HIR/MOHE/ENG/10 and by Bantuan Kecil Penyelidikan (BKP) fund BK024-2012 from the University of Malaya. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dennis R, 2005, BRIT J SPORT MED, V39, P834; Dennis RJ, 2008, BRIT J SPORT MED, V42, P477, DOI 10.1136/bjsm.2008.046698; Dhillon MS, 2012, SPORTS MED ARTHROSC, V4, P1; Elliot B, 1995, SPORTS EXERC INJ, V1, P201; Elliott BC, 2007, MED SCI SPORTS EXERC, V34, P1714; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Finch CF, 2010, J SCI MED SPORT, V13, P489, DOI 10.1016/j.jsams.2009.10.489; Frost WL, 2014, BRIT J SPORT MED, V48, P1002, DOI 10.1136/bjsports-2012-091337; Mansingh A, 2006, BRIT J SPORT MED, V40, P119, DOI 10.1136/bjsm.2005.019414; Orchard J, 2005, J SCI MED SPORT, V8, P1, DOI 10.1016/S1440-2440(05)80019-2; Orchard J, 2010, OPEN ACCESS J SPORTS, V1, P63; Orchard JW, 2006, J SCI MED SPORT, V9, P459, DOI 10.1016/j.jsams.2006.05.001; Ranson C, 2011, BRIT J SPORT MED, V47, P637; Ranson C, 2009, SPORT BIOMECH, V8, P261, DOI 10.1080/14763140903469908; Stretch RA, 2003, BRIT J SPORT MED, V37, P250, DOI 10.1136/bjsm.37.3.250; Stretch RA., 2011, S AFR J SPORTS MED, V23, P45; Twomey DM, 2012, J SCI MED SPORT, V15, P110, DOI 10.1016/j.jsams.2011.08.005; Wallis R, 2002, J SPORT SCI, V20, P495, DOI 10.1080/02640410252925161	18	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100028	10.1371/journal.pone.0100028	http://dx.doi.org/10.1371/journal.pone.0100028			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927127	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100108
J	Drouet, V; Ruiz, M; Zala, D; Feyeux, M; Auregan, G; Cambon, K; Troquier, L; Carpentier, J; Aubert, S; Merienne, N; Bourgois-Rocha, F; Hassig, R; Rey, M; Dufour, N; Saudou, F; Perrier, AL; Hantraye, P; Deglon, N				Drouet, Valerie; Ruiz, Marta; Zala, Diana; Feyeux, Maxime; Auregan, Gwennaelle; Cambon, Karine; Troquier, Laetitia; Carpentier, Johann; Aubert, Sophie; Merienne, Nicolas; Bourgois-Rocha, Fany; Hassig, Raymonde; Rey, Maria; Dufour, Noelle; Saudou, Frederic; Perrier, Anselme L.; Hantraye, Philippe; Deglon, Nicole			Allele-Specific Silencing of Mutant Huntingtin in Rodent Brain and Human Stem Cells	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; RNA INTERFERENCE; LENTIVIRAL VECTOR; GENE-THERAPY; NEUROLOGICAL DISORDERS; POLYGLUTAMINE REPEAT; PARKINSONS-DISEASE; MOUSE MODEL; EXPRESSION; DERIVATION	Huntington's disease (HD) is an autosomal dominant neurodegenerative disorder resulting from polyglutamine expansion in the huntingtin (HTT) protein and for which there is no cure. Although suppression of both wild type and mutant HTT expression by RNA interference is a promising therapeutic strategy, a selective silencing of mutant HTT represents the safest approach preserving WT HTT expression and functions. We developed small hairpin RNAs (shRNAs) targeting single nucleotide polymorphisms (SNP) present in the HTT gene to selectively target the disease HTT isoform. Most of these shRNAs silenced, efficiently and selectively, mutant HTT in vitro. Lentiviral-mediated infection with the shRNAs led to selective degradation of mutant HTT mRNA and prevented the apparition of neuropathology in HD rat's striatum expressing mutant HTT containing the various SNPs. In transgenic BACHD mice, the mutant HTT allele was also silenced by this approach, further demonstrating the potential for allele-specific silencing. Finally, the allele-specific silencing of mutant HTT in human embryonic stem cells was accompanied by functional recovery of the vesicular transport of BDNF along microtubules. These findings provide evidence of the therapeutic potential of allele-specific RNA interference for HD.	[Drouet, Valerie; Ruiz, Marta; Auregan, Gwennaelle; Cambon, Karine; Carpentier, Johann; Hassig, Raymonde; Dufour, Noelle; Hantraye, Philippe; Deglon, Nicole] CEA, Inst Biomed Imaging I2BM, Fontenay Aux Roses, France; [Drouet, Valerie; Ruiz, Marta; Auregan, Gwennaelle; Cambon, Karine; Carpentier, Johann; Hassig, Raymonde; Dufour, Noelle; Hantraye, Philippe; Deglon, Nicole] CEA, Mol Imaging Res Ctr MIRCen, Fontenay Aux Roses, France; [Drouet, Valerie; Ruiz, Marta; Auregan, Gwennaelle; Cambon, Karine; Carpentier, Johann; Hassig, Raymonde; Dufour, Noelle; Hantraye, Philippe; Deglon, Nicole] CNRS, URA2210, Fontenay Aux Roses, France; [Zala, Diana; Saudou, Frederic] Inst Curie, F-91405 Orsay, France; [Zala, Diana; Saudou, Frederic] CNRS, UMR3306, F-91405 Orsay, France; [Zala, Diana; Saudou, Frederic] Univ Paris 11, INSERM, U1005, F-91405 Orsay, France; [Feyeux, Maxime; Bourgois-Rocha, Fany; Perrier, Anselme L.] AFM, INSERM, U861, Evry, France; [Feyeux, Maxime; Bourgois-Rocha, Fany; Perrier, Anselme L.] AFM, I STEM, UEVE U861, Evry, France; [Aubert, Sophie] AFM, I STEM, CECS, Evry, France; [Troquier, Laetitia; Merienne, Nicolas; Rey, Maria; Deglon, Nicole] Lausanne Univ Hosp CHUV, Dept Clin Neurosci DNC, Lausanne, Switzerland	CEA; CEA; UDICE-French Research Universities; Universite Paris Saclay; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Deglon, N (corresponding author), CEA, Inst Biomed Imaging I2BM, Fontenay Aux Roses, France.	nicole.deglon@chuv.ch	SAUDOU, Frédéric/L-3454-2014; Deglon, Nicole/A-2265-2012; ZALA, Diana/L-4651-2017; Zala, Diana/R-8196-2019; Perrier, Anselme L/B-2272-2019; Perrier, Anselme/E-3764-2010	SAUDOU, Frédéric/0000-0001-6107-1046; Deglon, Nicole/0000-0003-4475-9476; ZALA, Diana/0000-0002-0052-8011; Zala, Diana/0000-0002-0052-8011; Perrier, Anselme L/0000-0001-7915-1968; Cambon, Karine/0000-0001-9263-4366; Merienne, Nicolas/0000-0002-4934-7211; Gorrichon, Kevin/0000-0002-8974-3286; Troquier, Laetitia/0000-0003-1046-6325; Drouet, Valerie/0000-0001-9958-8470	Agence Nationale de la Recherche [ANR-2006-MRAR-043-01]; FP6-NeuroNe [LSHM-CT-2004-512039]; FP6-Clinigene [LSH-2004-1.2.4-3]; Atomic Energy Commission; FP6 STEM-HD; DIM-STEM POLE Region Ile-de-France fellowship; Swiss National Science Foundation	Agence Nationale de la Recherche(French National Research Agency (ANR)); FP6-NeuroNe(European Commission); FP6-Clinigene; Atomic Energy Commission(French Atomic Energy Commission); FP6 STEM-HD; DIM-STEM POLE Region Ile-de-France fellowship(Region Ile-de-France); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Agence Nationale de la Recherche [ANR-2006-MRAR-043-01], FP6-NeuroNe [LSHM-CT-2004-512039], FP6-Clinigene [LSH-2004-1.2.4-3], the Atomic Energy Commission, FP6 STEM-HD, DIM-STEM POLE Region Ile-de-France fellowship to [F.B-R] and the Swiss National Science Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003341; Boudreau RL, 2009, MOL THER, V17, P1053, DOI 10.1038/mt.2009.17; Bowers WJ, 2011, HUM MOL GENET, V20, pR28, DOI 10.1093/hmg/ddr110; Bowles KR, 2012, BRAIN RES BULL, V88, P276, DOI 10.1016/j.brainresbull.2011.07.021; Bradley CK, 2011, STEM CELLS DEV, V20, P495, DOI 10.1089/scd.2010.0120; Carroll JB, 2011, MOL THER, V19, P2178, DOI 10.1038/mt.2011.201; Cartier N, 2009, SCIENCE, V326, P818, DOI 10.1126/science.1171242; Davidson BL, 2012, CELL, V150, P873, DOI 10.1016/j.cell.2012.08.008; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; de Almeida LP, 2002, J NEUROSCI, V22, P3473; Deglon N, 2000, HUM GENE THER, V11, P179, DOI 10.1089/10430340050016256; DiFiglia M, 1997, SCIENCE, V277, P1990, DOI 10.1126/science.277.5334.1990; Drouet V, 2009, ANN NEUROL, V65, P276, DOI 10.1002/ana.21569; Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107; Feyeux M, 2012, HUM MOL GENET, V21, P3883, DOI 10.1093/hmg/dds216; Fiszer A, 2011, NUCLEIC ACIDS RES, V39, P5578, DOI 10.1093/nar/gkr156; Gauthier LR, 2004, CELL, V118, P127, DOI 10.1016/j.cell.2004.06.018; Gray M, 2008, J NEUROSCI, V28, P6182, DOI 10.1523/JNEUROSCI.0857-08.2008; Hottinger AF, 2000, J NEUROSCI, V20, P5587, DOI 10.1523/JNEUROSCI.20-15-05587.2000; Hu JX, 2010, CHEM BIOL, V17, P1183, DOI 10.1016/j.chembiol.2010.10.013; Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831; Kordasiewicz HB, 2012, NEURON, V74, P1031, DOI 10.1016/j.neuron.2012.05.009; Lee JM, 2012, AM J HUM GENET, V90, P434, DOI 10.1016/j.ajhg.2012.01.005; Lombardi MS, 2009, EXP NEUROL, V217, P312, DOI 10.1016/j.expneurol.2009.03.004; Lundberg C, 2008, CURR GENE THER, V8, P461, DOI 10.2174/156652308786847996; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Mandel RJ, 2006, MOL THER, V13, P463, DOI 10.1016/j.ymthe.2005.11.009; Mateizel I, 2006, HUM REPROD, V21, P503, DOI 10.1093/humrep/dei345; Menalled Liliana B, 2005, NeuroRx, V2, P465, DOI 10.1602/neurorx.2.3.465; Miller VM, 2003, P NATL ACAD SCI USA, V100, P7195, DOI 10.1073/pnas.1231012100; Mingozzi F, 2011, NAT REV GENET, V12, P341, DOI 10.1038/nrg2988; Naldini L, 1996, SCIENCE, V272, P263, DOI 10.1126/science.272.5259.263; Ostergaard ME, 2013, NUCLEIC ACIDS RES, V41, P9634, DOI 10.1093/nar/gkt725; Palfi S, 2014, LANCET, V383, P1138, DOI 10.1016/S0140-6736(13)61939-X; Pfister EL, 2009, CURR BIOL, V19, P774, DOI 10.1016/j.cub.2009.03.030; Pouladi MA, 2012, HUM MOL GENET, V21, P2219, DOI 10.1093/hmg/dds037; Slow EJ, 2003, HUM MOL GENET, V12, P1555, DOI 10.1093/hmg/ddg169; Southwell AL, 2013, HUM MOL GENET, V22, P18, DOI 10.1093/hmg/dds397; Taymans JM, 2007, HUM GENE THER, V18, P195, DOI 10.1089/hum.2006.178; Tropel P, 2010, IN VITRO CELL DEV-AN, V46, P376, DOI 10.1007/s11626-010-9300-8; van Bilsen PHJ, 2008, HUM GENE THER, V19, P710, DOI 10.1089/hum.2007.116; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Warby SC, 2011, EUR J HUM GENET, V19, P561, DOI 10.1038/ejhg.2010.229; Warby SC, 2009, AM J HUM GENET, V84, P351, DOI 10.1016/j.ajhg.2009.02.003; Wei N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049309; Wu LG, 2008, CURR BIOL, V18, P1327, DOI 10.1016/j.cub.2008.07.072; Yu DB, 2012, CELL, V150, P895, DOI 10.1016/j.cell.2012.08.002; Zala D, 2008, HUM MOL GENET, V17, P3837, DOI 10.1093/hmg/ddn281; Zhang Y, 2011, GENE THER, V18, P1139, DOI 10.1038/gt.2011.170	49	38	40	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99341	10.1371/journal.pone.0099341	http://dx.doi.org/10.1371/journal.pone.0099341			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926995	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100035
J	Miranda, JJ; Lopez-Rivera, LA; Quistberg, DA; Rosales-Mayor, E; Gianella, C; Paca-Palao, A; Luna, D; Huicho, L				Jaime Miranda, J.; Lopez-Rivera, Luis A.; Alex Quistberg, D.; Rosales-Mayor, Edmundo; Gianella, Camila; Paca-Palao, Ada; Luna, Diego; Huicho, Luis		PIAT Working Grp	Epidemiology of Road Traffic Incidents in Peru 1973-2008: Incidence, Mortality, and Fatality	PLOS ONE			English	Article							HEALTH-STATISTICS; POLICY; INJURIES; CRASHES; TRENDS	Background: The epidemiological profile and trends of road traffic injuries (RTIs) in Peru have not been well-defined, though this is a necessary step to address this significant public health problem in Peru. The objective of this study was to determine trends of incidence, mortality, and fatality of RTIs in Peru during 1973-2008, as well as their relationship to population trends such as economic growth. Methods and Findings: Secondary aggregated databases were used to estimate incidence, mortality and fatality rate ratios (IRRs) of RTIs. These estimates were standardized to age groups and sex of the 2008 Peruvian population. Negative binomial regression and cubic spline curves were used for multivariable analysis. During the 35-year period there were 952,668 road traffic victims, injured or killed. The adjusted yearly incidence of RTIs increased by 3.59 (95% CI 2.43-5.31) on average. We did not observe any significant trends in the yearly mortality rate. The total adjusted yearly fatality rate decreased by 0.26 (95% CI 0.15-0.43), while among adults the fatality rate increased by 1.25 (95% CI 1.09-1.43). Models fitted with splines suggest that the incidence follows a bimodal curve and closely followed trends in the gross domestic product (GDP) per capita Conclusions: The significant increasing incidence of RTIs in Peru affirms their growing threat to public health. A substantial improvement of information systems for RTIs is needed to create a more accurate epidemiologic profile of RTIs in Peru. This approach can be of use in other similar low and middle-income settings to inform about the local challenges posed by RTIs.	[Jaime Miranda, J.; Lopez-Rivera, Luis A.; Rosales-Mayor, Edmundo; Gianella, Camila; Paca-Palao, Ada; Luna, Diego; Huicho, Luis] Salud Sin Limites Peru, Programa Invest Accidentes Transito, Lima, Peru; [Jaime Miranda, J.; Rosales-Mayor, Edmundo; Huicho, Luis] Univ Peruana Cayetano Heredia, CRONICAS, Ctr Excellence Chron Dis, Lima, Peru; [Jaime Miranda, J.; Huicho, Luis] Univ Peruana Cayetano Heredia, Sch Med, Lima, Peru; [Jaime Miranda, J.; Gianella, Camila] Asociac Civil Educ Derechos Humanos Con Aplica Sa, EDHUCASALUD, Lima, Peru; [Lopez-Rivera, Luis A.] Minist Trabajo & Promoc Empleo, Programa Nacl Empleo Juvenil Jovenes Obra, Lima, Peru; [Alex Quistberg, D.] Univ Washington, Sch Med, Dept Pediat, Seattle, WA 98195 USA; [Alex Quistberg, D.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Rosales-Mayor, Edmundo] Clin Anglo Amer, Ctr Trastornos Resp Suen CENTRES, Lima, Peru; [Rosales-Mayor, Edmundo] GIS, Lima, Peru; [Rosales-Mayor, Edmundo] Hosp Clin Barcelona, Barcelona, Spain; [Luna, Diego] Univ Pacifico, Dept Ciencias Soci & Polit, Lima, Peru; [Luna, Diego] Asociac Civil Gobierno Coherente, Lima, Peru; [Huicho, Luis] Inst Nacl Salud Nino, Dept Pediat, Lima, Peru; [Huicho, Luis] Univ Nacl Mayor San Marcos, Sch Med, Lima 14, Peru	Universidad Peruana Cayetano Heredia; Universidad Peruana Cayetano Heredia; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Barcelona; Hospital Clinic de Barcelona; Universidad del Pacifico Peru; Universidad Nacional Mayor de San Marcos	Miranda, JJ (corresponding author), Salud Sin Limites Peru, Programa Invest Accidentes Transito, Lima, Peru.	jaime.miranda@upch.pe	Quistberg, D Alex/P-3538-2019; Rosales-Mayor, Edmundo/E-6728-2019; Huicho, Luis/AAD-7353-2019; Rosales-Mayor, Edmundo/F-9689-2016	Quistberg, D Alex/0000-0001-9730-2686; Rosales-Mayor, Edmundo/0000-0001-9493-1241; Rosales-Mayor, Edmundo/0000-0001-9493-1241; Huicho, Luis/0000-0002-5272-5885; Miranda, J. Jaime/0000-0002-4738-5468; Gianella Malca, Camila/0000-0002-2656-0589	Instituto Nacional Salud de Peru as part of the Programa de Investigacion en Accidentes de Transito (PIAT - Road Traffic Incident Investigation Program); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health [5T32HD057822]; National Heart, Lung, and Blood Institute Global Health Initiative [268200900033C-1-0-1]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057822] Funding Source: NIH RePORTER	Instituto Nacional Salud de Peru as part of the Programa de Investigacion en Accidentes de Transito (PIAT - Road Traffic Incident Investigation Program); Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Heart, Lung, and Blood Institute Global Health Initiative; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was funded by the Instituto Nacional Salud de Peru as part of the Programa de Investigacion en Accidentes de Transito (PIAT - Road Traffic Incident Investigation Program) completed by Salud Sin Limites Peru. Dr. Quistberg is currently supported by The Eunice Kennedy Shriver National Institute of Child Health and Human Development of the National Institutes of Health under award number 5T32HD057822. Dr. Miranda and the CRONICAS Center of Excellence in Chronic Diseases are supported by the National Heart, Lung, and Blood Institute Global Health Initiative under the contract Global Health Activities in Developing Countries to Combat Non-Communicable Chronic Diseases under award number 268200900033C-1-0-1. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AbouZahr C, 2007, LANCET, V369, P1039, DOI 10.1016/S0140-6736(07)60463-2; [Anonymous], VIOL SEG PUBL COMP S; [Anonymous], STAT ANN OUTP NEG BI; [Anonymous], EST ACC NIV NAC 1973; [Anonymous], BANC CENTR RES PER C; Bambarem Alatrista Celso, 2004, Rev Med Hered, V15, P30; Boerma JT, 2007, LANCET, V369, P779, DOI 10.1016/S0140-6736(07)60364-X; Cameron A., 1998, ECONOMETRIC SOC MONO; Chen HY, 2010, TRAFFIC INJ PREV, V11, P8, DOI 10.1080/15389580903434207; Cole TJ, 2009, STAT MED, V28, P880, DOI 10.1002/sim.3504; Davies AR, 2007, EUR HEART J, V28, P2142, DOI 10.1093/eurheartj/ehm272; Direccion Tecnica Demografica Instituto Nacional de Estadistica e Informatica, 2001, PER POBL TOT 1950 20; Direccion Tecnica Demografica Instituto Nacional de Estadistica e Informatica, 2002, I NAC EST INF B ESP; Donroe J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003166; Grundy C, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4469; Huicho L, 2009, ESTUDIO CAP NIVEL SE; Institute for Health Metrics and Evaluation, 2013, GLOB BURD DIS PROF P; Instituto Nacional de Estadistica e Informatica, 2009, SIST CONS DAT 11 CEN; Instituto Nacional de Estadistica e Informatica, 2008, PER COMP EST; Instituto Nacional de Estadistica e Informatica, 2007, 11 CENS POBL 6 VIV; Instituto Nacional de Salud, 2007, PRIOR INV SAL PER AN; Jacobs G., 2000, 445 TRL; Kopits E, 2005, ACCIDENT ANAL PREV, V37, P169, DOI 10.1016/j.aap.2004.04.006; Kuha J, 2004, SOCIOL METHOD RES, V33, P188, DOI 10.1177/0049124103262065; Law T H, 2005, Int J Inj Contr Saf Promot, V12, P9; Medina YR, 2011, REV PANAM SALUD PUBL, V29, P191; Miranda J. Jaime, 2010, Rev. perú. med. exp. salud publica, V27, P273, DOI 10.1590/s1726-46342010000200018; Miranda J. Jaime, 2010, Rev. perú. med. exp. salud publica, V27, P179, DOI 10.1590/s1726-46342010000200004; Mohan D, 2002, INT J EPIDEMIOL, V31, P527, DOI 10.1093/ije/31.3.527; Murray CJL, 2007, LANCET, V369, P862, DOI 10.1016/S0140-6736(07)60415-2; National Cancer Institute, SEER STAT TUT CALC A; Patton GC, 2009, LANCET, V374, P881, DOI 10.1016/S0140-6736(09)60741-8; Planzer R, 2005, SEGURIDAD VIAL REGIO; Puig Xavi, 2005, Gac Sanit, V19, P481, DOI 10.1016/S0213-9111(05)71401-1; Quistberg DA, 2013, INJURY PREVENTION; Rahimi-Movaghar V, 2009, INT J INJ CONTROL SA, V16, P179, DOI 10.1080/17457300903024277; Rosales-Mayor E, 2011, CAD SAUDE PUBLICA, V27, P1837, DOI 10.1590/S0102-311X2011000900017; Scuffham PA, 2002, ACCIDENT ANAL PREV, V34, P673, DOI 10.1016/S0001-4575(01)00067-7; Secretaria Tecnica del Consejo de Transporte de Lima y Callao, 2009, VULN PEAT VIAL AR ME; Secretaria Tecnica del Consejo de Transporte de Lima y Callao, 2008, REL PUNT NEGR ACC TR; Sharma BR, 2008, PUBLIC HEALTH, V122, P1399, DOI 10.1016/j.puhe.2008.06.009; Stuckler D, 2009, LANCET, V374, P315, DOI 10.1016/S0140-6736(09)61124-7; Suriyawongpaisal Paibul, 2003, Inj Control Saf Promot, V10, P95, DOI 10.1076/icsp.10.1.95.14110; Vasquez Cordano A, 2008, ENSAYOS ROL INFRAEST; Walker N, 2007, LANCET, V369, P956, DOI 10.1016/S0140-6736(07)60454-1; World Health Organization, 2004, WORLD REPORT ROAD TR; World Health Organization, 2006, ROAD TRAFF INJ PREV; World Health Organization, 2009, GLOB STAT REP ROAD S	48	9	9	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99662	10.1371/journal.pone.0099662	http://dx.doi.org/10.1371/journal.pone.0099662			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2VQ	24927195	Green Published, gold			2022-12-27	WOS:000338278100061
J	Liu, Y; Lv, QJ; Gao, J; Long, L; Duan, ZJ; Liang, H; Shen, T; Lu, FM				Liu, Yuan; Lv, Quanjun; Gao, Jian; Long, Lu; Duan, Zhaojun; Liang, Hua; Shen, Tao; Lu, Fengmin			Coinfection with HIV-1 Alleviates Iron Accumulation in Patients with Chronic Hepatitis C Virus Infection	PLOS ONE			English	Article							CHRONIC VIRAL-HEPATITIS; HEPCIDIN; THERAPY; DISEASE; FERROPORTIN; METABOLISM; MECHANISMS; LIVER; HCV	Most chronically-infected hepatitis C virus (HCV) patients have increased levels of iron in the liver. Iron overload reduces sustained responses to antiviral therapy, leading to more rapid progression to liver cirrhosis and the development of hepatocellular carcinoma. However, it is still unclear how HIV-1 infection affects iron status in patients chronically infected with HCV. The present study recruited 227 patients from a village in central China. These patients were either monoinfected with HCV (n = 129) or coinfected with HCV/HIV-1 (n = 98). Healthy controls (n = 84) were also recruited from the same village. Indicators of iron status, such as serum levels of iron, ferritin, and transferrin, total iron-binding capacity (TIBC), transferrin saturation (Tfs), and hepcidin, were analyzed and compared across the three groups. The results showed that serum levels of iron (p = 0.001) and ferritin (p = 0.009) and the Tfs (p = 0.002) were significantly higher in HCV-monoinfected patients than in the healthy controls; however, there were no differences in iron levels and Tfs between HCV/HIV-1 coinfected patients and healthy controls. Additionally, although serum hepcidin levels in HCV-monoinfected and HCV/HIV-1-coinfected patients were lower (p<0.001) than those in health controls, the levels in coinfected patients were higher (p = 0.025) than those in HCV-monoinfected patients. Serum iron and ferritin levels in HCV-monoinfected patients were positively correlated with serum ALT/AST. Serum transferrin levels were negatively correlated with ALT/AST levels. The levels of iron in the serum of coinfected patients with a CD4+T-cell count <500/mu l were lower than those in patients with a CD4+T-cell count >= 500/mu l, whereas serum hepcidin levels showed the opposite trend. Taken together, these results suggest that coinfection with HIV-1 alleviates iron accumulation caused by chronic HCV infection. Our study indicated that determining the status of serum iron and other iron-associated parameters will be helpful to understand the complexity of alternations in iron distribution in HCV/HIV-1-coinfected patients.	[Liu, Yuan; Gao, Jian; Long, Lu; Duan, Zhaojun; Shen, Tao; Lu, Fengmin] Peking Univ, Dept Microbiol, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Liu, Yuan; Gao, Jian; Long, Lu; Duan, Zhaojun; Shen, Tao; Lu, Fengmin] Peking Univ, Ctr Infect Dis, Hlth Sci Ctr, Beijing 100871, Peoples R China; [Liu, Yuan; Lv, Quanjun] Zhengzhou Univ, Coll Publ Hlth, Dept Nutr & Food Hyg, Zhengzhou, Henan, Peoples R China; [Liang, Hua] Chinese Ctr Dis Control & Prevent, State Key Lab Infect Dis Prevent & Control, Natl Ctr AIDS STD Control & Prevent, Collaborat Innovat Ctr Diag & Treatment Infect Di, Beijing, Peoples R China	Peking University; Peking University; Zhengzhou University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention; Collaborative Innovation Center for Diagnosis & Treatment of Infectious Diseases	Shen, T (corresponding author), Peking Univ, Dept Microbiol, Hlth Sci Ctr, Beijing 100871, Peoples R China.	taoshen@hsc.pku.edu.cn		Shen, Tao/0000-0002-1365-9862; Lu, fengmin/0000-0002-1832-3209	National Natural Science of China [81271826]; National Science Foundation of Beijing [7122108]; National S&T Major Project for Infectious Diseases [2012ZX10002003, 2012ZX10002005]	National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Science Foundation of Beijing; National S&T Major Project for Infectious Diseases	This work was supported by grants from the National Natural Science of China (81271826), the National Science Foundation of Beijing (7122108) and the National S&T Major Project for Infectious Diseases (2012ZX10002003 and 2012ZX10002005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bonkovsky H L, 2000, Clin Liver Dis, V4, P409, DOI 10.1016/S1089-3261(05)70116-1; Bonkovsky HL, 2002, AM J GASTROENTEROL, V97, P1; Bonkovsky HL, 1997, HEPATOLOGY, V25, P759, DOI 10.1002/hep.510250345; Bonkovsky HL, 2000, CLIN LIVER DIS, V4, pvi; Cohen LA, 2010, BLOOD, V116, P1574, DOI 10.1182/blood-2009-11-253815; Dallalio G, 2006, BLOOD, V107, P2702, DOI 10.1182/blood-2005-07-2854; de Monye C, 1999, AIDS, V13, P375, DOI 10.1097/00002030-199902250-00010; Drakesmith H, 2008, NAT REV MICROBIOL, V6, P541, DOI 10.1038/nrmicro1930; Drakesmith H, 2012, SCIENCE, V338, P768, DOI 10.1126/science.1224577; Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014; Fillebeen C, 2005, J BIOL CHEM, V280, P9049, DOI 10.1074/jbc.M412687200; Fujita N, 2007, J GASTROEN HEPATOL, V22, P1886, DOI 10.1111/j.1440-1746.2006.04759.x; Fujita N, 2007, MOL MED, V13, P97, DOI 10.2119/2006-00057.Fujita; Galli A, 2005, HEPATOLOGY, V41, P1074, DOI 10.1002/hep.20683; Ganz T, 2011, BLOOD, V117, P4425, DOI 10.1182/blood-2011-01-258467; Girelli D, 2009, J HEPATOL, V51, P845, DOI 10.1016/j.jhep.2009.06.027; Gordeuk VR, 2001, J CLIN VIROL, V20, P111, DOI 10.1016/S1386-6532(00)00134-7; Jaeschke H, 2002, TOXICOL SCI, V65, P166, DOI 10.1093/toxsci/65.2.166; Kagu M B, 2007, Afr J Med Med Sci, V36, P125; McDermid JM, 2007, JAIDS-J ACQ IMM DEF, V46, P498, DOI 10.1097/QAI.0b013e31815b2d4b; Mcnabb J, 2001, CLIN INFECT DIS, V33, P413, DOI 10.1086/321872; Mueller S, 2010, J HEPATOL, V53, P990, DOI 10.1016/j.jhep.2010.08.003; Nelson James E, 2012, Curr Gastroenterol Rep, V14, P8, DOI 10.1007/s11894-011-0234-4; Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742; OLYNYK JK, 1995, GASTROENTEROLOGY, V108, P1104, DOI 10.1016/0016-5085(95)90209-0; P Kosaralaksa TB, 2011, 6 IAS C HIV PATH TRE; Pietrangelo A, 2007, HEPATOLOGY, V46, P1291, DOI 10.1002/hep.21886; Shepard CW, 2005, LANCET INFECT DIS, V5, P558, DOI 10.1016/S1473-3099(05)70216-4; Stebbing J, 2004, NEW ENGL J MED, V350, P1872, DOI 10.1056/NEJMra032395; Ufearo H, 2010, CLIN CHIM ACTA, V411, P653, DOI 10.1016/j.cca.2010.01.028; Valenti L, 2007, HAEMATOLOGICA, V92, P1037, DOI 10.3324/haematol.11281; Venturini D, 2010, DIGEST DIS SCI, V55, P1120, DOI 10.1007/s10620-009-0833-1; Wisaksana R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079904; Wisaksana R, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-213; Xu M, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-104	35	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98039	10.1371/journal.pone.0098039	http://dx.doi.org/10.1371/journal.pone.0098039			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927015	gold, Green Submitted, Green Published			2022-12-27	WOS:000338278100011
J	Lund, CA; Moller, AM; Wetterslev, J; Lundstrom, LH				Lund, Caterina A.; Moller, Ann M.; Wetterslev, Jorn; Lundstrom, Lars H.			Organizational Factors and Long-Term Mortality after Hip Fracture Surgery. A Cohort Study of 6143 Consecutive Patients Undergoing Hip Fracture Surgery	PLOS ONE			English	Article							RISK-FACTORS; FEMORAL FRACTURES; SURGICAL FIXATION; ELDERLY-PATIENTS; DELAY; MORBIDITY; TIME; OPERATION; STAY; ASSOCIATION	Objective: In hospital and health care organizational factors may be changed to reduce postoperative mortality. The aim of this study is to evaluate a possible association between mortality and 'length of hospital stay', 'priority of surgery', 'time of surgery', or 'surgical delay' in hip fracture surgery. Design: Observational cohort study. Setting: Prospectively and consecutively reported data from the Danish Anaesthesia Database were linked to The Danish National Registry of Patients and The Civil Registration System. Records on vital status, admittance, discharges, codes of diagnosis, anaesthetic and surgical procedures were retrieved. Participants: 6143 patients aged more than 65 years undergoing hip fracture surgery. Main Outcome Measures: All-cause mortality. Results: The one year mortality was 30% (28-31%, 95% Confidence interval (CI)). In a multivariate model 'length of hospital stay' less than 10 days and more than 20 days are associated with mortality with hazard ratios of 1.34 (1.20-1.53 CI, p<0.001) and 1.27 (1.06-1.51 CI, p<0.001), respectively. 'Priority of surgery' categorized as 'non-scheduled' is associated with mortality with a hazard ratio of 1.31 (1.13-1.50 CI, p<0.001). Surgical delay and time of surgery are not significantly associated with mortality. Conclusion: Non-scheduled surgery and length of hospital stay were associated with increased mortality. Confounding by indication may bias observational studies evaluating early and late discharge as well as priority; therefore cluster randomized clinical trials comparing different clinical set ups may be warranted evaluating health care organizational factors.	[Lund, Caterina A.; Moller, Ann M.] Herlev Univ Hosp, Dept Anaesthesia & Intens Care, DK-2730 Herlev, Denmark; [Wetterslev, Jorn; Lundstrom, Lars H.] Copenhagen Univ Hosp, Rigshosp, Ctr Clin Intervent Res, Copenhagen Trial Unit, Copenhagen, Denmark; [Lundstrom, Lars H.] Hillerod Univ Hosp, Nordsjaellands Hosp, Dept Anaesthesia, Hillerod, Denmark	University of Copenhagen; Herlev & Gentofte Hospital; Rigshospitalet; University of Copenhagen; University of Copenhagen	Moller, AM (corresponding author), Herlev Univ Hosp, Dept Anaesthesia & Intens Care, DK-2730 Herlev, Denmark.	ann.moeller@regionh.dk	Wetterslev, Jørn/ABF-1251-2020; Moller, Ann Merete/AAO-6020-2021	Wetterslev, Jørn/0000-0001-7778-1771; Lundstrom, Lars/0000-0002-2179-1433				Bergeron E, 2006, J TRAUMA, V60, P753, DOI 10.1097/01.ta.0000214649.53190.2a; Bjorgul K, 2010, J ARTHROPLASTY, V25, P134, DOI 10.1016/j.arth.2010.04.010; Bosma E, 2010, J BONE JOINT SURG BR, V92B, P110, DOI 10.1302/0301-620X.92B1.22671; Bottle A, 2006, BMJ-BRIT MED J, V332, P947, DOI 10.1136/bmj.38790.468519.55; BREDAHL C, 1992, INJURY, V23, P83, DOI 10.1016/0020-1383(92)90037-S; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Clague JE, 2002, INJURY, V33, P1, DOI 10.1016/S0020-1383(01)00142-5; Deeks J J, 2003, Health Technol Assess, V7, piii; Dorotka R, 2003, J BONE JOINT SURG BR, V85B, P1107, DOI 10.1302/0301-620X.85B8.14282; Egerod I, 2010, DAN MED BULL, V57; EISKJAER S, 1991, CLIN ORTHOP RELAT R, P295; Franzo A, 2005, EUR J EPIDEMIOL, V20, P985, DOI 10.1007/s10654-005-4280-9; Gdalevich M, 2004, ARCH ORTHOP TRAUM SU, V124, P334, DOI 10.1007/s00402-004-0662-9; Grimes JP, 2002, AM J MED, V112, P702, DOI 10.1016/S0002-9343(02)01119-1; Hahn Seokyung, 2005, BMC Med Res Methodol, V5, P10, DOI 10.1186/1471-2288-5-10; Holt G, 2008, J BONE JOINT SURG BR, V90B, P1357, DOI 10.1302/0301-620X.90B10.21328; Holvik K, 2010, J AGING HEALTH, V22, P1114, DOI 10.1177/0898264310378040; Kehlet H, 2003, LANCET, V362, P1921, DOI 10.1016/S0140-6736(03)14966-5; Kehlet H, 2002, AM J SURG, V183, P630, DOI 10.1016/S0002-9610(02)00866-8; KENZORA JE, 1984, CLIN ORTHOP RELAT R, P45; KEYS A, 1972, J CHRON DIS, V25, P329, DOI 10.1016/0021-9681(72)90027-6; Lefaivre KA, 2009, J BONE JOINT SURG BR, V91B, P922, DOI 10.1302/0301-620X.91B7.22446; Leung F, 2010, OSTEOPOROSIS INT, V21, pS529, DOI 10.1007/s00198-010-1391-2; Majumdar SR, 2006, MED CARE, V44, P552, DOI 10.1097/01.mlr.0000215812.13720.2e; Moran CG, 2005, J BONE JOINT SURG AM, V87A, P483, DOI 10.2106/JBJS.D.01796; Orosz GM, 2004, JAMA-J AM MED ASSOC, V291, P1738, DOI 10.1001/jama.291.14.1738; OWENS WD, 1978, ANESTHESIOLOGY, V49, P239, DOI 10.1097/00000542-197810000-00003; PARKER MJ, 1992, J BONE JOINT SURG BR, V74, P203, DOI 10.1302/0301-620X.74B2.1544952; Radcliff TA, 2008, J BONE JOINT SURG AM, V90A, P34, DOI 10.2106/JBJS.G.00065; Rae HC, 2007, ANZ J SURG, V77, P889, DOI 10.1111/j.1445-2197.2007.04267.x; ROGERS FB, 1995, J TRAUMA, V39, P261, DOI 10.1097/00005373-199508000-00012; Rubin DB, 2004, MULTIPLE IMPUTATION; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Siegmeth AW, 2005, J BONE JOINT SURG BR, V87B, P1123, DOI 10.1302/0301-620X.87B8; Simunovic N, 2010, CAN MED ASSOC J, V182, P1609, DOI 10.1503/cmaj.092220; Sund R, 2005, QUAL SAF HEALTH CARE, V14, P371, DOI 10.1136/qshc.2004.012831; Vidal EIO, 2009, OSTEOPOROSIS INT, V20, P723, DOI 10.1007/s00198-008-0757-1; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI 10.2471/BLT.07.045120; Weller I, 2005, J BONE JOINT SURG BR, V87B, P361, DOI 10.1302/0301-620X.87B3.15300; Zuckerman JD, 1996, NEW ENGL J MED, V334, P1519, DOI 10.1056/NEJM199606063342307	41	42	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99308	10.1371/journal.pone.0099308	http://dx.doi.org/10.1371/journal.pone.0099308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926876	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100034
J	Schult, J; von Stulpnagel, R; Steffens, MC				Schult, Janette; von Stuelpnagel, Rul; Steffens, Melanie C.			Enactment versus Observation: Item-Specific and Relational Processing in Goal-Directed Action Sequences (and Lists of Single Actions)	PLOS ONE			English	Article							FREE-RECALL; ORDER INFORMATION; PERFORMED TASKS; ACTION EVENTS; MEMORY; INTEGRATION; SUBJECT; RETRIEVAL; ADULTS; ORGANIZATION	What are the memory-related consequences of learning actions (such as "apply the patch'') by enactment during study, as compared to action observation? Theories converge in postulating that enactment encoding increases item-specific processing, but not the processing of relational information. Typically, in the laboratory enactment encoding is studied for lists of unrelated single actions in which one action execution has no overarching purpose or relation with other actions. In contrast, real-life actions are usually carried out with the intention to achieve such a purpose. When actions are embedded in action sequences, relational information provides efficient retrieval cues. We contrasted memory for single actions with memory for action sequences in three experiments. We found more reliance on relational processing for action-sequences than single actions. To what degree can this relational information be used after enactment versus after the observation of an actor? We found indicators of superior relational processing after observation than enactment in ordered pair recall (Experiment 1A) and in emerging subjective organization of repeated recall protocols (recall runs 2-3, Experiment 2). An indicator of superior item-specific processing after enactment compared to observation was recognition (Experiment 1B, Experiment 2). Similar net recall suggests that observation can be as good a learning strategy as enactment. We discuss possible reasons why these findings only partly converge with previous research and theorizing.	[Schult, Janette] Univ Jena, Inst Psychol, Jena, Germany; [von Stuelpnagel, Rul] Univ Freiburg, Inst Informat & Gesell, D-79106 Freiburg, Germany; [Steffens, Melanie C.] Univ Koblenz Landau, Fachbereich Psychol, Landau, Germany	Friedrich Schiller University of Jena; University of Freiburg; University of Koblenz & Landau	Steffens, MC (corresponding author), Univ Koblenz Landau, Fachbereich Psychol, Landau, Germany.	steffens@uni-landau.de			Deutsche Forschungsgemeinschaft (German Science Foundation) [938/7-1, 938/7-2]	Deutsche Forschungsgemeinschaft (German Science Foundation)(German Research Foundation (DFG))	The research was supported by a grant from the Deutsche Forschungsgemeinschaft to the senior author (German Science Foundation, Ste 938/7-1,-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURNS DJ, 1993, J EXP PSYCHOL LEARN, V19, P163, DOI 10.1037/0278-7393.19.1.163; COHEN J, 1993, BEHAV RES METH INSTR, V25, P257, DOI 10.3758/BF03204507; Cohen J.E., 1988, STAT POWER ANAL BEHA; COHEN RL, 1983, MEM COGNITION, V11, P575, DOI 10.3758/BF03198282; COHEN RL, 1983, INTELLIGENCE, V7, P287, DOI 10.1016/0160-2896(83)90019-3; COHEN RL, 1987, MEM COGNITION, V15, P109, DOI 10.3758/BF03197022; COHEN RL, 1981, SCAND J PSYCHOL, V22, P267, DOI 10.1111/j.1467-9450.1981.tb00402.x; COHEN RL, 1989, PSYCHOL RES-PSYCH FO, V51, P176, DOI 10.1007/BF00309145; ENGELKAMP J, 1980, Z EXP ANGEW PSYCHOL, V27, P511; Engelkamp J, 2005, MEM COGNITION, V33, P371, DOI 10.3758/BF03193055; Engelkamp J, 1997, ACTA PSYCHOL, V96, P43, DOI 10.1016/S0001-6918(97)00005-X; Engelkamp J, 2000, J EXP PSYCHOL LEARN, V26, P671, DOI 10.1037/0278-7393.26.3.671; Engelkamp J, 2004, PSYCHOL RES-PSYCH FO, V69, P1, DOI 10.1007/s00426-003-0160-7; Engelkamp J, 2003, PSYCHOL RES-PSYCH FO, V67, P280, DOI 10.1007/s00426-002-0118-1; Engelkamp J, 2003, Q J EXP PSYCHOL-A, V56, P829, DOI 10.1080/02724980244000648; Engelkamp J, 2002, PSYCHOL RES-PSYCH FO, V66, P91, DOI 10.1007/s00426-001-0082-1; ENGELKAMP J, 1991, PSYCHOL RES-PSYCH FO, V53, P175, DOI 10.1007/BF00941384; Engelkamp J., 1998, MEMORY ACTIONS; Engelkamp J., 1983, SPRACHE KOGNIT, V2, P117; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Feyereisen P, 2009, MEMORY, V17, P374, DOI 10.1080/09658210902731851; Foley MA, 2001, MEMORY ACTION DISTIN; GLOVER JA, 1987, J EDUC PSYCHOL, V79, P445, DOI 10.1037/0022-0663.79.4.445; Gold DA, 2009, PSYCHOL RES-PSYCH FO, V73, P336, DOI 10.1007/s00426-008-0148-4; Golly-Haring C, 2003, J EXP PSYCHOL LEARN, V29, P965, DOI 10.1037/0278-7393.29.5.965; Hornstein SL, 2004, PSYCHON B REV, V11, P367, DOI 10.3758/BF03196584; KLEIN SB, 1989, J EXP PSYCHOL LEARN, V15, P1192, DOI 10.1037/0278-7393.15.6.1192; Knopf M, 2005, SCAND J PSYCHOL, V46, P11, DOI 10.1111/j.1467-9450.2005.00430.x; Knopf M, 1995, MEMORY PERFORMANCE AND COMPETENCIES, P127; KORIAT A, 1991, PSYCHOL RES-PSYCH FO, V53, P260, DOI 10.1007/BF00941396; KormiNouri R, 1995, EUR J COGN PSYCHOL, V7, P337, DOI 10.1080/09541449508403103; LICHTENSTEIN EH, 1980, COGNITIVE PSYCHOL, V12, P412, DOI 10.1016/0010-0285(80)90015-8; Manzi A, 2008, MEMORY, V16, P595, DOI 10.1080/09658210802070749; McDaniel MA, 1998, J EXP PSYCHOL LEARN, V24, P173, DOI 10.1037/0278-7393.24.1.173; Mulligan NW, 2003, MEM COGNITION, V31, P412, DOI 10.3758/BF03194399; Nadar MS, 2008, CLIN REHABIL, V22, P847, DOI 10.1177/0269215508091874; PAYNE DG, 1987, PSYCHOL BULL, V101, P5, DOI 10.1037/0033-2909.101.1.5; Prinz W, 1998, PSYCHOL RUNDSCH, V49, P10; RATNER HH, 1988, DEV PSYCHOL, V24, P664, DOI 10.1037/0012-1649.24.5.664; Ratner HH, 2001, J EXP CHILD PSYCHOL, V79, P162, DOI 10.1006/jecp.2000.2585; RATNER HH, 1991, PSYCHOL RES-PSYCH FO, V53, P195, DOI 10.1007/BF00941387; ROENKER DL, 1971, PSYCHOL BULL, V76, P45, DOI 10.1037/h0031355; Schult JC, 2011, MEM COGNITION, V39, P1487, DOI 10.3758/s13421-011-0110-3; SNODGRASS JG, 1988, J EXP PSYCHOL GEN, V117, P34, DOI 10.1037/0096-3445.117.1.34; Steffens MC, 2006, Q J EXP PSYCHOL, V59, P557, DOI 10.1080/02724980443000764; Steffens MC, 2007, MEM COGNITION, V35, P1841, DOI 10.3758/BF03192919; Steffens MC, 2007, PSYCHON B REV, V14, P1194, DOI 10.3758/BF03193112; Steffens MC, 2009, EUR J COGN PSYCHOL, V21, P61, DOI 10.1080/09541440701868668; TULVING E, 1962, PSYCHOL REV, V69, P344, DOI 10.1037/h0043150; Von Essen JD, 2005, SCAND J PSYCHOL, V46, P315, DOI 10.1111/j.1467-9450.2005.00461.x	50	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99985	10.1371/journal.pone.0099985	http://dx.doi.org/10.1371/journal.pone.0099985			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2VQ	24927279	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100102
J	Lazado, CC; Kumaratunga, HPS; Nagasawa, K; Babiak, I; Giannetto, A; Fernandes, JMO				Lazado, Carlo C.; Kumaratunga, Hiruni P. S.; Nagasawa, Kazue; Babiak, Igor; Giannetto, Alessia; Fernandes, Jorge M. O.			Daily Rhythmicity of Clock Gene Transcripts in Atlantic Cod Fast Skeletal Muscle	PLOS ONE			English	Article							BASS DICENTRARCHUS-LABRAX; TELEOST FISH GENOMES; GADUS-MORHUA L.; CIRCADIAN CLOCKS; CONTINUOUS LIGHT; TISSUE DISTRIBUTION; SOLEA-SENEGALENSIS; MOLECULAR-CLONING; PINEAL-GLAND; REV-ERB	The classical notion of a centralized clock that governs circadian rhythmicity has been challenged with the discovery of peripheral oscillators that enable organisms to cope with daily changes in their environment. The present study aimed to identify the molecular clock components in Atlantic cod (Gadus morhua) and to investigate their daily gene expression in fast skeletal muscle. Atlantic cod clock genes were closely related to their orthologs in teleosts and tetrapods. Synteny was conserved to varying degrees in the majority of the 18 clock genes examined. In particular, aryl hydrocarbon receptor nuclear translocator-like 2 (arntl2), RAR-related orphan receptor A (rora) and timeless (tim) displayed high degrees of conservation. Expression profiling during the early ontogenesis revealed that some transcripts were maternally transferred, namely arntl2, cryptochrome 1b and 2 (cry1b and cry2), and period 2a and 2b (per2a and per2b). Most clock genes were ubiquitously expressed in various tissues, suggesting the possible existence of multiple peripheral clock systems in Atlantic cod. In particular, they were all detected in fast skeletal muscle, with the exception of neuronal PAS (Per-Arnt-Single-minded) domain-containing protein (npas1) and rora. Rhythmicity analysis revealed 8 clock genes with daily rhythmic expression, namely arntl2, circadian locomotor output cycles kaput (clock), npas2, cry2, cry3 per2a, nuclear receptor subfamily 1, group D, member 1 (nr1d1), and nr1d2a. Transcript levels of the myogenic genes myogenic factor 5 (myf5) and muscleblind-like 1 (mbnl1) strongly correlated with clock gene expression. This is the first study to unravel the molecular components of peripheral clocks in Atlantic cod. Taken together, our data suggest that the putative clock system in fast skeletal muscle of Atlantic cod has regulatory implications on muscle physiology, particularly in the expression of genes related to myogenesis.	[Lazado, Carlo C.; Kumaratunga, Hiruni P. S.; Nagasawa, Kazue; Babiak, Igor; Giannetto, Alessia; Fernandes, Jorge M. O.] Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway; [Giannetto, Alessia] Univ Messina, Dept Biol & Environm Sci, Messina, Italy	Nord University; University of Messina	Fernandes, JMO (corresponding author), Univ Nordland, Fac Biosci & Aquaculture, Bodo, Norway.	jorge.fernandes@uin.no	Fernandes, Jorge MO/A-3526-2013; Giannetto, Alessia/AAA-6735-2019; Fernandes, Jorge/AAC-4632-2022; Lazado, Carlo C./H-7444-2019; Nagasawa, Kazue/ABH-6117-2020	Fernandes, Jorge MO/0000-0002-2550-1640; Giannetto, Alessia/0000-0002-5853-2881; Fernandes, Jorge/0000-0002-2550-1640; Nagasawa, Kazue/0000-0003-2819-3302; Babiak, Igor/0000-0002-1462-2690	Research Council of Norway [190350/S40]	Research Council of Norway(Research Council of Norway)	This research was supported by grant 190350/S40 from the Research Council of Norway (http://www.forskningsradet.no/en) to JMOF. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral IPG, 2012, AM J PHYSIOL-REG I, V302, pR193, DOI 10.1152/ajpregu.00367.2011; Andrews JL, 2010, P NATL ACAD SCI USA, V107, P19090, DOI 10.1073/pnas.1014523107; Sanchez JA, 2010, CHRONOBIOL INT, V27, P19, DOI 10.3109/07420520903398633; Bayarri MJ, 2002, J PINEAL RES, V32, P34, DOI 10.1034/j.1600-079x.2002.10806.x; Bowden TJ, 2007, FISH SHELLFISH IMMUN, V22, P695, DOI 10.1016/j.fsi.2006.08.016; Busza A, 2004, SCIENCE, V304, P1503, DOI 10.1126/science.1096973; Campos C, 2010, J EXP BIOL, V213, P200, DOI 10.1242/jeb.033126; Campos C, 2012, GENE, V500, P93, DOI 10.1016/j.gene.2012.03.041; Cavallari N, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001142; Cermakian N, 2000, P NATL ACAD SCI USA, V97, P4339, DOI 10.1073/pnas.97.8.4339; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; Cuesta IH, 2014, CHRONOBIOL INT, V31, P468, DOI 10.3109/07420528.2013.856316; Dardente H, 2007, CHRONOBIOL INT, V24, P195, DOI 10.1080/07420520701283693; Dekens MPS, 2008, EMBO J, V27, P2757, DOI 10.1038/emboj.2008.183; del Pozo A, 2012, COMP BIOCHEM PHYS A, V163, P364, DOI 10.1016/j.cbpa.2012.07.004; Esteban MA, 2006, J PINEAL RES, V41, P261, DOI 10.1111/j.1600-079X.2006.00362.x; Falcon J, 1999, PROG NEUROBIOL, V58, P121, DOI 10.1016/S0301-0082(98)00078-1; Fernandes JMO, 2008, COMP BIOCHEM PHYS B, V150, P23, DOI 10.1016/j.cbpb.2008.01.003; Giannetto A, 2014, DEV COMP IMMUNOL, V44, P30, DOI 10.1016/j.dci.2013.11.011; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Huang TS, 2010, CHRONOBIOL INT, V27, P1715, DOI 10.3109/07420528.2010.521272; Hughes AL, 2005, P NATL ACAD SCI USA, V102, P8791, DOI 10.1073/pnas.0503922102; Hughes AL, 2002, TRENDS GENET, V18, P433, DOI 10.1016/S0168-9525(02)02755-5; Kobayashi K, 1998, NUCLEIC ACIDS RES, V26, P5086, DOI 10.1093/nar/26.22.5086; Lee C, 1999, MOL CELL BIOL, V19, P5316; Lefta M, 2011, CURR TOP DEV BIOL, V96, P231, DOI 10.1016/B978-0-12-385940-2.00009-7; Patino MAL, 2011, CHRONOBIOL INT, V28, P381, DOI 10.3109/07420528.2011.566398; Lopez-Olmeda JF, 2010, CHRONOBIOL INT, V27, P1380, DOI 10.3109/07420528.2010.501926; Lowrey PL, 2004, ANNU REV GENOM HUM G, V5, P407, DOI 10.1146/annurev.genom.5.061903.175925; Martin-Robles AJ, 2012, J COMP PHYSIOL B, V182, P673, DOI 10.1007/s00360-012-0653-z; McCarthy JJ, 2007, PHYSIOL GENOMICS, V31, P86, DOI 10.1152/physiolgenomics.00066.2007; Migaud H, 2010, J FISH BIOL, V76, P27, DOI 10.1111/j.1095-8649.2009.02500.x; Nagasawa K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036908; OHTA T, 1990, THEOR POPUL BIOL, V37, P213, DOI 10.1016/0040-5809(90)90036-U; Ptitsyn AA, 2006, PLOS COMPUT BIOL, V2, P126, DOI 10.1371/journal.pcbi.0020016; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Richards J, 2012, FASEB J, V26, P3602, DOI 10.1096/fj.12-203554; Ruangsri J, 2012, FISH SHELLFISH IMMUN, V32, P396, DOI 10.1016/j.fsi.2011.11.022; Sharma VK, 2003, CHRONOBIOL INT, V20, P901, DOI 10.1081/CBI-120026099; Takahata S, 1998, BIOCHEM BIOPH RES CO, V248, P789, DOI 10.1006/bbrc.1998.9012; Taranger GL, 2006, ICES J MAR SCI, V63, P365, DOI 10.1016/j.icesjms.2005.10.014; Vatine G, 2011, FEBS LETT, V585, P1485, DOI 10.1016/j.febslet.2011.04.007; Velarde E, 2009, J BIOL RHYTHM, V24, P104, DOI 10.1177/0748730408329901; Wang H, 2008, J MOL EVOL, V67, P29, DOI 10.1007/s00239-008-9121-5; Wang H, 2008, MAR GENOM, V1, P69, DOI 10.1016/j.margen.2008.06.003; Weger BD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017080; Weger M, 2013, DEV BIOL, V380, P259, DOI 10.1016/j.ydbio.2013.04.035; Whitmore D, 2000, NATURE, V404, P87, DOI 10.1038/35003589; Woods IG, 2005, GENOME RES, V15, P1307, DOI 10.1101/gr.4134305	51	46	47	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99172	10.1371/journal.pone.0099172	http://dx.doi.org/10.1371/journal.pone.0099172			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921252	Green Submitted, gold, Green Published			2022-12-27	WOS:000338701300039
J	Bonnett, LJ; Marson, AG; Johnson, A; Kim, L; Sander, JW; Lawn, N; Beghi, E; Leone, M; Smith, CT				Bonnett, Laura Jayne; Marson, Anthony G.; Johnson, Anthony; Kim, Lois; Sander, Josemir W.; Lawn, Nicholas; Beghi, Ettore; Leone, Maurizio; Smith, Catrin Tudur			External Validation of a Prognostic Model for Seizure Recurrence Following a First Unprovoked Seizure and Implications for Driving	PLOS ONE			English	Article							TONIC-CLONIC SEIZURE; EARLY EPILEPSY; SINGLE SEIZURES; RISK; TRIAL; SURVIVAL	Objective: In the United Kingdom and other European Union countries guidelines for driving following a first unprovoked seizure require the risk of another seizure in the next year to be less than 20%. Using data from one clinical trial, we previously developed a prognostic model to inform driving guidelines. The objective of this work is to externally validate our published model and demonstrate its generalisability. Methods: A cohort of 620 people with a first unprovoked seizure was used to develop the original model which included variables for aetiology, first degree relative with epilepsy, seizures only while asleep, electroencephalogram, computed tomography or magnetic resonance scan result, and treatment policy. The validation cohorts consisted of 274 (United Kingdom), 305 (Italy), and 847 (Australia) people. The model was evaluated using discrimination and calibration methods. A covariate, missing from the Italian dataset, was handled via five imputation methods. Following external validation, the model was fitted to a pooled population comprising all validation datasets and the development dataset. The model was stratified by dataset. Results: The model generalised relatively well. All methods of imputation performed fairly similarly. At six months, the risk of a seizure recurrence following a first ever seizure, based on the pooled datasets, is 15% (95% CI: (12% to 18%)) for patients who are treated immediately and 18% (95% CI: (15 to 21%)) otherwise. Individuals can be reliably stratified into risk groups according to the clinical factors included in the model. Significance: Our prognostic model, used to inform driving regulations, has been validated and consequently has been proven as a valuable tool for predicting risk of seizure recurrence following a first seizure in people with various combinations of risk factors. Additionally, there is evidence to support one worldwide overall prognostic model for risk of second seizure following a first.	[Bonnett, Laura Jayne; Smith, Catrin Tudur] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Marson, Anthony G.] Univ Liverpool, Dept Mol & Clin Pharmacol, Liverpool L69 3BX, Merseyside, England; [Johnson, Anthony] Cambridge Inst Publ Hlth, MRC, Biostat Unit, Cambridge, England; [Kim, Lois] London Sch Hyg & Trop Med, Dept Med Stat, London WC1, England; [Sander, Josemir W.] Univ Coll London Hosp, Natl Inst Hlth Res, Biomed Res Ctr, London, England; [Lawn, Nicholas] Royal Perth Hosp, Western Australian Comprehens Epilepsy Ctr, Perth, WA 6001, Australia; [Lawn, Nicholas] Fremantle Hosp, Perth, WA, Australia; [Beghi, Ettore] Ist Ric Farmacol Mario Negri, Dept Neurosci, Milan, Italy; [Leone, Maurizio] Osped Maggiore La Carita, Neurol Clin, Novara, Italy; [Johnson, Anthony] MRC, Clin Trials Unit, London, England; [Sander, Josemir W.] UCL, Inst Neurol, London, England; [Sander, Josemir W.] Epilepsy Soc, Gerrards Cross, Bucks, England	University of Liverpool; University of Liverpool; MRC Biostatistics Unit; University of Cambridge; University of London; London School of Hygiene & Tropical Medicine; University College London Hospitals NHS Foundation Trust; University of London; University College London; Royal Perth Hospital; Istituto di Ricerche Farmacologiche Mario Negri IRCCS; Medical Research Council Clinical Trials Unit; University of London; University College London	Bonnett, LJ (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England.	L.J.Bonnett@liv.ac.uk	Bonnett, Laura/A-2159-2015; Leone, Maurizio A./J-4130-2016; Sander, Josemir W/C-1576-2008; Marson, Anthony/AAW-9776-2020; Beghi, Ettore/AAA-7426-2020	Bonnett, Laura/0000-0002-6981-9212; Leone, Maurizio A./0000-0002-6339-5738; Sander, Josemir W/0000-0001-6041-9661; Marson, Anthony/0000-0002-6861-8806; Beghi, Ettore/0000-0003-2542-0469; Tudur Smith, Catrin/0000-0003-3051-1445; Kim, Lois/0000-0002-4552-3820	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme [RP-PG-0606-1062]; Medical Research Council [MC_EX_G0800814] Funding Source: researchfish; MRC [MC_EX_G0800814] Funding Source: UKRI	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme(National Institute for Health Research (NIHR)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This paper presents independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme [http://www.ccf.nihr.ac.uk/PGfAR/Pages/Home.aspx Grant Reference Number RP-PG-0606-1062]. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR or the Department of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b605; [Austroads Ltd National Transport commission Australia], 2012, ASS FITN DRIV; Bonnett LJ, 2010, BRIT MED J, V341, DOI 10.1136/bmj.c6477; Bonnett LJ, 2012, PROGNOSTIC FACTORS E; Brown JWL, 2011, EPILEPSIA, V52, P401, DOI 10.1111/j.1528-1167.2010.02924.x; Collett, 2003, MODELLING SURVIVAL D; Cox D. R., 1984, ANAL SURVIVAL DATA; COX DR, 1957, J AM STAT ASSOC, V52, P543, DOI 10.2307/2281704; Davis FG, 1999, CANCER, V85, P485, DOI 10.1002/(SICI)1097-0142(19990115)85:2<485::AID-CNCR29>3.3.CO;2-C; Driver and Vehicle Licensing Agency (DVLA), 2010, GLANC GUID CURR MED; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HART YM, 1989, NEUROEPIDEMIOLOGY, V8, P221; Kho LK, 2006, NEUROLOGY, V67, P1047, DOI 10.1212/01.wnl.0000237555.12146.66; Kim LG, 2006, LANCET NEUROL, V5, P317, DOI 10.1016/S1474-4422(06)70383-0; Leone MA, 2006, NEUROLOGY, V67, P2227, DOI 10.1212/01.wnl.0000249309.80510.63; Lin CL, 2003, SURG NEUROL, V60, P402, DOI 10.1016/S0090-3019(03)00322-7; Little R. J. A., 1987, STAT ANAL MISSING DA; Marson A, 2005, LANCET, V365, P2007, DOI 10.1016/S0140-6736(05)66694-9; Musicco M, 1997, NEUROLOGY, V49, P991, DOI 10.1212/WNL.49.4.991; MUSICCO M, 1993, NEUROLOGY, V43, P478; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Steyerberg E., 2009, CLIN PREDICTION MODE; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223	23	13	14	1	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99063	10.1371/journal.pone.0099063	http://dx.doi.org/10.1371/journal.pone.0099063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919184	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000338631000046
J	Tully, MA; Panter, J; Ogilvie, D				Tully, Mark A.; Panter, Jenna; Ogilvie, David			Individual Characteristics Associated with Mismatches between Self-Reported and Accelerometer-Measured Physical Activity	PLOS ONE			English	Article							HEALTH; CAMBRIDGE; ADULTS; MONITORS; TIME	Background: Accurate assessment tools are required for the surveillance of physical activity (PA) levels and the assessment of the effect of interventions. In addition, increasing awareness of PA is often used as the first step in pragmatic behavioural interventions, as discrepancies between the amount of activity an individual perceives they do and the amount actually undertaken may act as a barrier to change. Previous research has demonstrated differences in the amount of activity individuals report doing, compared to their level of physical activity when measured with an accelerometer. Understanding the characteristics of those whose PA level is ranked differently when measured with either self-report or accelerometry is important as it may inform the choice of instrument for future research. The aim of this project was to determine which individual characteristics are associated with differences between self-reported and accelerometer measured physical activity. Methods: Participant data from the 2009 wave of the Commuting and Health in Cambridge study were used. Quartiles of self-reported and accelerometer-measured PA were derived by ranking each measure from lowest to highest. These quartiles were compared to determine whether individuals' physical activity was ranked higher by either method. Multinomial logistic regression models were used to investigate the individual characteristics associated with different categories of mismatch. Results: Data from 486 participants (70% female) were included in the analysis. In adjusted analyses, the physical activity of overweight or obese individuals was significantly more likely to be ranked higher by self-report than by accelerometer than that of normal-weight individuals (OR = 2.07, 95%CI = 1.28-3.34), particularly among women (OR = 3.97, 95%CI = 2.11-7.47). Conclusions: There was a greater likelihood of mismatch between self-reported and accelerometer measured physical activity levels in overweight or obese adults. Future studies in overweight or obese adults should consider employing both methods of measurement.	[Tully, Mark A.] Royal Victoria Hosp, Inst Clin Sci B, Ctr Publ Hlth, UKCRC Ctr Excellence Publ Hlth NI, Belfast BT12 6BA, Antrim, North Ireland; [Panter, Jenna; Ogilvie, David] Univ Cambridge, Sch Clin Med, MRC, Epidemiol Unit, Cambridge, England; [Panter, Jenna; Ogilvie, David] Univ Cambridge, Sch Clin Med, Cambridge Biomed Campus, UKCRC Ctr Diet & Act Res CEDAR, Cambridge, England	University of Cambridge; University of Cambridge	Tully, MA (corresponding author), Royal Victoria Hosp, Inst Clin Sci B, Ctr Publ Hlth, UKCRC Ctr Excellence Publ Hlth NI, Belfast BT12 6BA, Antrim, North Ireland.	m.tully@qub.ac.uk	Tully, Mark/AAB-2939-2019	Tully, Mark/0000-0001-9710-4014; Ogilvie, David/0000-0002-0270-4672	Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust, under the UK Clinical Research Collaboration; National Institute for Health Research Public Health Research programme [09/3001/06]; Department for Employment and Learning, Northern Ireland; Medical Research Council [MC_UU_12015/6]; NIHR post-doctoral fellowship; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MR/K023187/1, MR/K023241/1, MC_UP_1001/1] Funding Source: researchfish; National Institute for Health Research [PDF-2012-05-157, 09/3001/06] Funding Source: researchfish; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UP_1001/1, MR/K023187/1, MC_UU_12015/6, MR/K023241/1] Funding Source: UKRI	Centre for Diet and Activity Research (CEDAR); UKCRC Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust, under the UK Clinical Research Collaboration(Wellcome Trust); National Institute for Health Research Public Health Research programme; Department for Employment and Learning, Northern Ireland; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIHR post-doctoral fellowship; Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The Commuting and Health in Cambridge study was developed by David Ogilvie, Simon Griffin, Andy Jones and Roger Mackett and initially funded under the auspices of the Centre for Diet and Activity Research (CEDAR), a UKCRC Public Health Research Centre of Excellence. Funding from the British Heart Foundation, Economic and Social Research Council, Medical Research Council, National Institute for Health Research and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The study is now funded by the National Institute for Health Research Public Health Research programme (project number 09/3001/06: see http://www.phr.nihr.ac.uk/funded_projects). Mark Tully's contribution to this study was funded by the Department for Employment and Learning, Northern Ireland, and is gratefully acknowledged. David Ogilvie supported by the Medical Research Council [Unit Programme number MC_UU_12015/6]. Jenna Panter is supported by an NIHR post-doctoral fellowship. The views and opinions expressed herein are those of the authors and do not necessarily reflect those of the NIHR PHR programme or the Department of Health. The funders had no role in study design, data collection and analysis, the decision to publish, or the preparation of the manuscript.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Bauman Adrian, 2006, Promot Educ, V13, P92, DOI 10.1177/10253823060130020103; Beran Tanya N, 2010, BMC Res Notes, V3, P267, DOI 10.1186/1756-0500-3-267; Besson H, 2010, AM J CLIN NUTR, V91, P106, DOI 10.3945/ajcn.2009.28432; Butte NF, 2012, MED SCI SPORT EXER, V44, pS5, DOI 10.1249/MSS.0b013e3182399c0e; Evenson KR, 2009, RES Q EXERCISE SPORT, V80, P355, DOI 10.1080/02701367.2009.10599570; Hallal PC, 2012, J PHYS ACT HEALTH, V9, pS88, DOI 10.1123/jpah.9.s1.s88; Hansen BH, 2013, J SPORTS SCI, V00, P1; Haskell WL, 2012, J PHYS ACT HEALTH, V9, pS5, DOI 10.1123/jpah.9.s1.s5; Hosmer D, 1989, MODEL BUILDING STRAT; Kaminsky LA, 2012, PHYSIOL MEAS, V33, P1869, DOI 10.1088/0967-3334/33/11/1869; Lechner L, 2006, HEALTH PROMOT INT, V21, P104, DOI 10.1093/heapro/dal011; Marcus BH, 2008, MOTIVATING PEOPLE BE; National Health Service, 2006, GEN PRACT PHYS ACT Q; Ogilvie D, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-703; Panter J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042202; Panter J, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-124; Prince SA, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-56; Shephard RJ, 2003, BRIT J SPORT MED, V37, P197, DOI 10.1136/bjsm.37.3.197; Tucker JM, 2011, AM J PREV MED, V40, P454, DOI 10.1016/j.amepre.2010.12.016; Van Sluijs EM, 2007, INT J BEHAV NUTR PHY, V9, P1; VanderWeele TJ, 2012, AM J EPIDEMIOL, V176, P608, DOI 10.1093/aje/kws213; Walsh MC, 2004, AM J CLIN NUTR, V79, P1013; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Watkinson C, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-68; Welk GJ, 2004, MED SCI SPORT EXER, V36, P1637, DOI 10.1249/01.MSS.0000074670.03001.98; Westerterp KR, 2009, EUR J APPL PHYSIOL, V105, P823, DOI 10.1007/s00421-009-1000-2; WHO, 2009, GLOB HLTH RISKS PROG; Yang L, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-841; Yang L, 2012, PREV MED, V55, P453, DOI 10.1016/j.ypmed.2012.08.019	30	29	30	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99636	10.1371/journal.pone.0099636	http://dx.doi.org/10.1371/journal.pone.0099636			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919185	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000100
J	Brolin, EB; Jernberg, T; Brismar, TB; Daniel, M; Henareh, L; Ripsweden, J; Tornvall, P; Cederlund, K				Brolin, Elin B.; Jernberg, Tomas; Brismar, Torkel B.; Daniel, Maria; Henareh, Loghman; Ripsweden, Jonaz; Tornvall, Per; Cederlund, Kerstin			Coronary Plaque Burden, as Determined by Cardiac Computed Tomography, in Patients with Myocardial Infarction and Angiographically Normal Coronary Arteries Compared to Healthy Volunteers: A Prospective Multicenter Observational Study	PLOS ONE			English	Article							RISK STRATIFICATION; MAGNETIC-RESONANCE; DISEASE; CT; ATHEROSCLEROSIS; QUANTIFICATION; PROGNOSIS; OUTCOMES; WOMEN	Objectives: Patients presenting with acute myocardial infarction and angiographically normal coronary arteries (MINCA) represent a diagnostic and a therapeutic challenge. Cardiac computed tomography (CT) allows detection of coronary artery disease (CAD) even in the absence of significant stenosis. We aimed to investigate whether patients suffering from MINCA had a greater coronary plaque burden, as determined by cardiac CT, than a matched group of healthy volunteers. Methods: Consecutive patients, aged 45 to 70, with MINCA were enrolled in the Stockholm metropolitan area. Patients with myocarditis were excluded using cardiovascular magnetic resonance imaging. Remaining patients underwent cardiac CT, as did a reference group of healthy volunteers matched by age and gender, with no known cardiovascular disease. Plaque burden was evaluated semi-quantitatively on a per patient and a per segment level. Results: Despite a higher prevalence of smoking and hypertension, patients with MINCA did not have more CAD than healthy volunteers. Among 57 MINCA patients and 58 volunteers no signs of CAD were found in 24 (42%) and 25 (43%) respectively. On a per segment level, MINCA patients had less segments with stenosis >= 20% (2% vs. 5%, p<0.01), as well as a smaller proportion of large (2% vs. 4%, p<0.05) and mixed type plaques (1% vs. 4%, p<0.01). The median coronary calcium score did not differ between MINCA patients and healthy volunteers (6 vs. 8, ns). Conclusions: MINCA patients with no or minimal angiographic stenosis do not have more coronary atherosclerosis than healthy volunteers, and a large proportion of these patients do not have any signs of CAD, as determined by cardiac CT. The MINCA patient group is probably heterogeneous, with a variety of different underlying mechanisms. Non-obstructive CAD is most likely not the most prevalent cause of myocardial infarction in this patient group.	[Brolin, Elin B.; Brismar, Torkel B.; Ripsweden, Jonaz; Cederlund, Kerstin] Karolinska Univ Hosp Huddinge, Dept Radiol, Stockholm, Sweden; [Brolin, Elin B.; Brismar, Torkel B.; Ripsweden, Jonaz; Cederlund, Kerstin] Karolinska Inst, Div Med Imaging & Technol, Dept Clin Sci Intervent & Technol, Stockholm, Sweden; [Jernberg, Tomas; Henareh, Loghman] Karolinska Univ Hosp Huddinge, Cardiol Sect, Dept Med, Stockholm, Sweden; [Jernberg, Tomas; Daniel, Maria; Henareh, Loghman] Karolinska Inst, Stockholm, Sweden; [Daniel, Maria] Karolinska Univ Hosp Solna, Dept Med, Cardiol Unit, Stockholm, Sweden; [Tornvall, Per] Karolinska Inst, Inst Clin Sci & Educ Sodersjukhuset, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet	Brolin, EB (corresponding author), Karolinska Univ Hosp Huddinge, Dept Radiol, Stockholm, Sweden.	elin.bacsovics.brolin@ki.se	Brismar, Torkel B/H-2872-2019	Brismar, Torkel B/0000-0002-3409-1938; Ripsweden, Jonaz/0000-0003-2118-5414; Jernberg, Tomas/0000-0003-1695-379X	Swedish Heart-Lung Foundation; Stockholm County Council; Karolinska Institutet	Swedish Heart-Lung Foundation(Swedish Heart-Lung Foundation); Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet)	This work was supported by the Swedish Heart-Lung Foundation (www.hjart-lungfonden.se) and by the regional agreement on medical training and clinical research (ALF) between Stockholm County Council and Karolinska Institutet. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGATSTON AS, 1990, J AM COLL CARDIOL, V15, P827, DOI 10.1016/0735-1097(90)90282-T; Agewall S, 2012, ANGIOLOGY, V63, P500, DOI 10.1177/0003319711429560; Aldrovandi A, 2012, CIRCULATION, V126, P3000, DOI 10.1161/CIRCULATIONAHA.112.117598; Aldrovandi A, 2008, CIRC-CARDIOVASC IMAG, V1, P205, DOI 10.1161/CIRCIMAGING.108.786962; Austen W G, 1975, Circulation, V51, P5; Budoff MJ, 2005, J AM COLL CARDIOL, V46, P383, DOI [10.1016/j.jacc.2005.04.033, 10.1161/CIRCULATIONAHA.105.168237]; Bugiardini R, 2006, ARCH INTERN MED, V166, P1391, DOI 10.1001/archinte.166.13.1391; Caussin C, 2003, AM J CARDIOL, V92, P849, DOI 10.1016/S0002-9149(03)00899-3; Chokshi NP, 2010, CLIN CARDIOL, V33, P495, DOI 10.1002/clc.20794; Collste O, 2013, J INTERN MED, V273, P189, DOI 10.1111/j.1365-2796.2012.02567.x; Gehrie ER, 2009, AM HEART J, V158, P688, DOI 10.1016/j.ahj.2009.08.004; Hadarnitzky M, 2010, AM J CARDIOL, V105, P1746, DOI 10.1016/j.amjcard.2010.01.354; Hwang Y, 2010, CLIN RADIOL, V65, P601, DOI 10.1016/j.crad.2010.04.009; Kardasz I, 2007, J INTERN MED, V261, P330, DOI 10.1111/j.1365-2796.2007.01788.x; Laissy JP, 2005, RADIOLOGY, V237, P75, DOI 10.1148/radiol.2371041322; Larsen AI, 2005, AM J CARDIOL, V95, P261, DOI 10.1016/j.amjcard.2004.09.014; Larsen AI, 2013, AM J CARDIOL, V111, P643, DOI 10.1016/j.amjcard.2012.11.011; Leber AW, 2004, J AM COLL CARDIOL, V43, P1241, DOI 10.1016/j.jacc.2003.10.059; Maurovich-Horvat P, 2009, J CARDIOVASC COMP S3, V3, pS91; Mowatt G, 2008, HEART, V94, P1386, DOI 10.1136/hrt.2008.145292; Neefjes LA, 2011, HEART, V97, P1151, DOI 10.1136/hrt.2010.220699; Ong P, 2008, J AM COLL CARDIOL, V52, P523, DOI 10.1016/j.jacc.2008.04.050; Papadopoulou SL, 2011, ATHEROSCLEROSIS, V219, P163, DOI 10.1016/j.atherosclerosis.2011.07.005; Pflederer T, 2010, ATHEROSCLEROSIS, V211, P437, DOI 10.1016/j.atherosclerosis.2010.02.001; Prasad A, 2008, AM HEART J, V155, P408, DOI 10.1016/j.ahj.2007.11.008; Pundziute G, 2008, EUR HEART J, V29, P2373, DOI 10.1093/eurheartj/ehn356; Reynolds HR, 2011, CIRCULATION, V124, P1414, DOI 10.1161/CIRCULATIONAHA.111.026542; Stensaeth KH, 2011, INT J CARDIOVAS IMAG, V27, P355, DOI 10.1007/s10554-010-9671-7; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Virmani R, 2006, J AM COLL CARDIOL, V47, pC13, DOI 10.1016/j.jacc.2005.10.065; Voros S, 2011, JACC-CARDIOVASC IMAG, V4, P537, DOI 10.1016/j.jcmg.2011.03.006; Wittstein IS, 2005, NEW ENGL J MED, V352, P539, DOI 10.1056/NEJMoa043046	32	10	10	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99783	10.1371/journal.pone.0099783	http://dx.doi.org/10.1371/journal.pone.0099783			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937192	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400038
J	Geml, J; Gravendeel, B; van der Gaag, KJ; Neilen, M; Lammers, Y; Raes, N; Semenova, TA; de Knijff, P; Noordeloos, ME				Geml, Jozsef; Gravendeel, Barbara; van der Gaag, Kristiaan J.; Neilen, Manon; Lammers, Youri; Raes, Niels; Semenova, Tatiana A.; de Knijff, Peter; Noordeloos, Machiel E.			The Contribution of DNA Metabarcoding to Fungal Conservation: Diversity Assessment, Habitat Partitioning and Mapping Red-Listed Fungi in Protected Coastal Salix repens Communities in the Netherlands	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; BIODIVERSITY ASSESSMENT; ECTOMYCORRHIZAL FUNGI; SEASONAL DYNAMICS; RARE BIOSPHERE; PH GRADIENT; SOIL; FOREST; BACTERIAL; BOREAL	Western European coastal sand dunes are highly important for nature conservation. Communities of the creeping willow (Salix repens) represent one of the most characteristic and diverse vegetation types in the dunes. We report here the results of the first kingdom-wide fungal diversity assessment in S. repens coastal dune vegetation. We carried out massively parallel pyrosequencing of ITS rDNA from soil samples taken at ten sites in an extended area of joined nature reserves located along the North Sea coast of the Netherlands, representing habitats with varying soil pH and moisture levels. Fungal communities in Salix repens beds are highly diverse and we detected 1211 non-singleton fungal 97% sequence similarity OTUs after analyzing 688,434 ITS2 rDNA sequences. Our comparison along a north-south transect indicated strong correlation between soil pH and fungal community composition. The total fungal richness and the number OTUs of most fungal taxonomic groups negatively correlated with higher soil pH, with some exceptions. With regard to ecological groups, dark-septate endophytic fungi were more diverse in acidic soils, ectomycorrhizal fungi were represented by more OTUs in calcareous sites, while detected arbuscular mycorrhizal genera fungi showed opposing trends regarding pH. Furthermore, we detected numerous red listed species in our samples often from previously unknown locations, indicating that some of the fungal species currently considered rare may be more abundant in Dutch S. repens communities than previously thought.	[Geml, Jozsef; Gravendeel, Barbara; Neilen, Manon; Lammers, Youri; Raes, Niels; Semenova, Tatiana A.; Noordeloos, Machiel E.] Naturalis Biodivers Ctr, Leiden, Netherlands; [Geml, Jozsef; Gravendeel, Barbara; Semenova, Tatiana A.] Leiden Univ, Fac Sci, Leiden, Netherlands; [Gravendeel, Barbara] Univ Appl Sci Leiden, Leiden, Netherlands; [van der Gaag, Kristiaan J.; de Knijff, Peter] Leiden Univ, Med Ctr, Forens Lab DNA Res, Leiden, Netherlands	Naturalis Biodiversity Center; Leiden University; Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Geml, J (corresponding author), Naturalis Biodivers Ctr, Leiden, Netherlands.	Jozsef.Geml@naturalis.nl	Geml, Jozsef/AAW-9993-2020; de Knijff, Peter/Y-2519-2018; Geml, Jozsef/C-2223-2018; Raes, Niels/A-9645-2011	de Knijff, Peter/0000-0002-0899-771X; Geml, Jozsef/0000-0001-8745-0423; Raes, Niels/0000-0002-4329-4892; Neilen, Manon/0000-0001-6261-5199; van der Gaag, Kristiaan/0000-0001-7976-1977; Gravendeel, Barbara/0000-0002-6508-0895	Naturalis Biodiversity Center; Kits van Waveren Postdoctoral Fellowship	Naturalis Biodiversity Center; Kits van Waveren Postdoctoral Fellowship	This research was sponsored by a Next-Generation Sequencing grant from the Naturalis Biodiversity Center to JG and MEN and by the Kits van Waveren Postdoctoral Fellowship to JG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, NEW PHYTOL, V186, P281, DOI 10.1111/j.1469-8137.2009.03160.x; Acosta-Martinez V, 2008, SOIL BIOL BIOCHEM, V40, P2762, DOI 10.1016/j.soilbio.2008.07.022; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Arnold AE, 2007, ECOLOGY, V88, P541, DOI 10.1890/05-1459; Arnolds E, 2008, BASISRAPPORT; Arnolds E, 1995, OVERZICHT PADDENSTOE; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; Bakker TWM, 1987, DUIN, V10, P34; Bidartondo MI, 2004, P ROY SOC B-BIOL SCI, V271, P1799, DOI 10.1098/rspb.2004.2807; Bjorbaekmo MFM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-244; Blaalid R, 2012, MOL ECOL, V21, P1897, DOI 10.1111/j.1365-294X.2011.05214.x; Blackwell M, 2011, AM J BOT, V98, P426, DOI 10.3732/ajb.1000298; Brown AC, 2002, ENVIRON CONSERV, V29, P62, DOI 10.1017/S037689290200005X; Brown SP, 2013, FEMS MICROBIOL ECOL, V86, P557, DOI 10.1111/1574-6941.12181; Coughlan AP, 2000, CAN J FOREST RES, V30, P1543, DOI 10.1139/cjfr-30-10-1543; De Roman M, 2005, MYCOL RES, V109, P1063, DOI 10.1017/S0953756205003564; Delforge P, 2007, GUIDE ORCHIDEES FRAN; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Feola S, 2011, BIODIVERS CONSERV, V20, P1457, DOI 10.1007/s10531-011-0037-9; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Gardes M, 1996, CAN J BOT, V74, P1572, DOI 10.1139/b96-190; Geml J, 2014, MOL ECOL, V23, P2452, DOI 10.1111/mec.12765; Geml J, 2012, J BIOGEOGR, V39, P74, DOI 10.1111/j.1365-2699.2011.02588.x; Geml J, 2010, NEW PHYTOL, V187, P494, DOI 10.1111/j.1469-8137.2010.03283.x; Geml J, 2009, MOL ECOL, V18, P2213, DOI 10.1111/j.1365-294X.2009.04192.x; Gihring TM, 2012, ENVIRON MICROBIOL, V14, P285, DOI 10.1111/j.1462-2920.2011.02550.x; HARLEY J L, 1987, New Phytologist, V105, P1, DOI 10.1111/j.1469-8137.1987.tb00674.x; HAWKSWORTH DL, 1991, MYCOL RES, V95, P641, DOI 10.1016/S0953-7562(09)80810-1; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Higgins KL, 2007, MOL PHYLOGENET EVOL, V42, P543, DOI 10.1016/j.ympev.2006.07.012; Jalink LM, 2001, BR MYCOL SY, V22, P89, DOI 10.1017/CBO9780511565168.007; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; Kauserud H, 2012, MYCORRHIZA, V22, P309, DOI 10.1007/s00572-011-0403-1; Koljalg U, 2000, MOL ECOL, V9, P1985, DOI 10.1046/j.1365-294X.2000.01105.x; Koljalg U, 2013, MOL ECOL, V22, P5271, DOI 10.1111/mec.12481; Kuiper M, 2009, HOLLANDS DUINEN, V54, P16; Kunin V, 2010, ENVIRON MICROBIOL, V12, P118, DOI 10.1111/j.1462-2920.2009.02051.x; Lauber CL, 2008, SOIL BIOL BIOCHEM, V40, P2407, DOI 10.1016/j.soilbio.2008.05.021; Lodge J, 2004, BIODIVERSITY FUNGI I, P128, DOI DOI 10.1016/B978-012509551-8/50011-8; McCune B., 2002, ANAL ECOLOGICAL COMM; Molina R., 1992, Mycorrhizal functioning: an integrative plant-fungal process., P357; Nauta MM, 2001, BR MYCOL SY, V22, P242, DOI 10.1017/CBO9780511565168.022; Nauta MM, 1995, ATLAS NEDERLANDSE PA; Nevarez L, 2009, INT J FOOD MICROBIOL, V130, P166, DOI 10.1016/j.ijfoodmicro.2009.01.013; Nguyen HDT, 2008, PERSOONIA, V21, P57, DOI 10.3767/003158508X361334; Nilsson RH, 2011, NEW PHYTOL, V191, P314, DOI 10.1111/j.1469-8137.2011.03755.x; Nilsson RH, 2011, TOAINFOJ, V5, P81, DOI DOI 10.2174/1874136301005010081; O'Brien HE, 2005, APPL ENVIRON MICROB, V71, P5544, DOI 10.1128/AEM.71.9.5544-5550.2005; Perini Claudia, 2008, Coolia, V51, P181; Porter TM, 2008, MOL ECOL, V17, P3037, DOI 10.1111/j.1365-294X.2008.03813.x; PORTER WM, 1987, J APPL ECOL, V24, P659, DOI 10.2307/2403900; Postma JWM, 2007, SOIL BIOL BIOCHEM, V39, P400, DOI 10.1016/j.soilbio.2006.08.007; Reeder J, 2009, NAT METHODS, V6, P636, DOI 10.1038/nmeth0909-636; Rogers PC, 2009, J VEG SCI, V20, P498, DOI 10.1111/j.1654-1103.2009.01064.x; Rousk J, 2008, FEMS MICROBIOL ECOL, V63, P350, DOI 10.1111/j.1574-6941.2008.00440.x; Rousk J, 2010, ISME J, V4, P1340, DOI 10.1038/ismej.2010.58; Salman A, 1991, SANDDUNE INVENTORY E, P28; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmit JP, 2007, BIODIVERS CONSERV, V16, P99, DOI 10.1007/s10531-006-9129-3; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tamm H, 2010, MYCOL PROG, V9, P509, DOI 10.1007/s11557-010-0659-4; Taylor DL, 2008, NEW PHYTOL, V177, P1020, DOI 10.1111/j.1469-8137.2007.02320.x; Taylor DL, 2010, CAN J FOREST RES, V40, P1288, DOI 10.1139/X10-081; Taylor DL, 1997, P NATL ACAD SCI USA, V94, P4510, DOI 10.1073/pnas.94.9.4510; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; van der Heijden EW, 2001, MYCORRHIZA, V10, P185, DOI 10.1007/s005720000077; van der Heijden EW, 1999, CAN J BOT, V77, P1821, DOI 10.1139/cjb-77-12-1821; van der Maarel E, 2003, PHYTOCOENOLOGIA, V33, P187, DOI 10.1127/0340-269X/2003/0033-0187; Van der Meulen F, 1996, NATURE CONSERVATION; Van Zadelhoff FJ, 1981, NEDERLANDSE KUSTDUIN; Vare H., 1992, Mycorrhiza, V1, P93, DOI 10.1007/BF00203256; Watling R, 2005, MYCOL RES, V109, P1418, DOI 10.1017/S0953756205004004; Weiss M, 2004, MYCOL RES, V108, P1003, DOI 10.1017/S0953756204000772; WHEELER KA, 1991, INT J FOOD MICROBIOL, V12, P141, DOI 10.1016/0168-1605(91)90063-U	77	50	58	2	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99852	10.1371/journal.pone.0099852	http://dx.doi.org/10.1371/journal.pone.0099852			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937200	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400045
J	Oberfeld, D; Stahn, P; Kuta, M				Oberfeld, Daniel; Stahn, Patricia; Kuta, Martha			Why Do Forward Maskers Affect Auditory Intensity Discrimination? Evidence from "Molecular Psychophysics"	PLOS ONE			English	Article							SELECTIVE ATTENTION; LOUDNESS ENHANCEMENT; COCHLEAR SENSITIVITY; PRIOR STIMULATION; RESPONSES; MASKING; TIME; CORTEX; RECOVERY; NEURONS	Nonsimultaneous maskers can strongly impair performance in an auditory intensity discrimination task. Using methods of molecular psychophysics, we quantified the extent to which (1) a masker-induced impairment of the representation of target intensity (i.e., increase in internal noise) and (2) a systematic influence of the masker intensities on the decision variable contribute to these effects. In a two-interval intensity discrimination procedure, targets were presented in quiet, and combined with forward maskers. The lateralization of the maskers relative to the targets was varied via the interaural time difference. Intensity difference limens (DLs) were strongly elevated under forward masking but less with contralateral than with ipsilateral maskers. For most listeners and conditions, perceptual weights measuring the relation between the target and masker levels and the response in the intensity discrimination task were positive and significant. Higher perceptual weights assigned to the maskers corresponded to stronger elevations of the intensity DL. The maskers caused only a weak increase in internal noise, unrelated to target level and masker lateralization. The results indicate that the effects of forward masking on intensity discrimination are determined by an inclusion of the masker intensities in the decision variable, compatible with the hypothesis that the impairment in performance is to a large part caused by difficulties in directing selective attention to the targets. The effects of masker lateralization are evidence for top-down influences, and the observed positive signs of the masker weights suggest that the relevant mechanisms are located at higher processing stages rather than in the auditory periphery.	[Oberfeld, Daniel; Stahn, Patricia; Kuta, Martha] Johannes Gutenberg Univ Mainz, Sect Expt Psychol, Dept Psychol, D-55122 Mainz, Germany	Johannes Gutenberg University of Mainz	Oberfeld, D (corresponding author), Johannes Gutenberg Univ Mainz, Sect Expt Psychol, Dept Psychol, D-55122 Mainz, Germany.	oberfeld@uni-mainz.de	Oberfeld, Daniel/A-7997-2008	Oberfeld, Daniel/0000-0002-6710-3309	Deutsche Forschungsgemeinschaft [OB 346/4-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by a grant from Deutsche Forschungsgemeinschaft (www.dfg.de) to Daniel Oberfeld (OB 346/4-1). No additional external funding was received. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBAS PJ, 1981, J ACOUST SOC AM, V69, P492, DOI 10.1121/1.385477; AHUMADA A, 1971, J ACOUST SOC AM, V49, P1751, DOI 10.1121/1.1912577; Ahumada AJ, 2002, J VISION, V2, P121, DOI 10.1167/2.1.8; Alves-Pinto A, 2010, JARO-J ASSOC RES OTO, V11, P477, DOI 10.1007/s10162-010-0215-6; [Anonymous], 1970, 318 IEC; Avissar M, 2007, J NEUROSCI, V27, P6461, DOI 10.1523/JNEUROSCI.5239-06.2007; Baures R, 2014, ACCIDENT ANAL PREV, V65, P72, DOI 10.1016/j.aap.2013.12.013; BEKESY GEORG v., 1947, ACTA OTO LARYNGOL [STOCKHOLM], V35, P411, DOI 10.3109/00016484709123756; BERG BG, 1989, J ACOUST SOC AM, V86, P1743, DOI 10.1121/1.398605; Best V, 2008, P NATL ACAD SCI USA, V105, P13174, DOI 10.1073/pnas.0803718105; Bregman AS, 1990, AUDITORY SCENE ANAL; Brosch M, 2000, CEREB CORTEX, V10, P1155, DOI 10.1093/cercor/10.12.1155; Brosch M, 1999, J NEUROPHYSIOL, V82, P1542, DOI 10.1152/jn.1999.82.3.1542; Brosch M, 2008, EXP BRAIN RES, V184, P349, DOI 10.1007/s00221-007-1109-7; Burton P, 1998, STAT MED, V17, P1261, DOI 10.1002/(SICI)1097-0258(19980615)17:11<1261::AID-SIM846>3.0.CO;2-Z; CARLYON RP, 1993, J ACOUST SOC AM, V93, P2886, DOI 10.1121/1.405808; Cohen J.E., 1988, STAT POWER ANAL BEHA; CRAMER H., 1946, Mathematical methods of statistics.; Delano PH, 2007, J NEUROSCI, V27, P4146, DOI 10.1523/JNEUROSCI.3702-06.2007; Deutsch D., 1999, PSYCHOL MUSIC, P299, DOI [10.1016/B978-012213564-4/50010-X, DOI 10.1016/B978-012213564-4/50010-X]; DURLACH NI, 1969, J ACOUST SOC AM, V46, P372, DOI 10.1121/1.1911699; Edwards LJ, 2008, STAT MED, V27, P6137, DOI 10.1002/sim.3429; ELMASIAN R, 1980, J ACOUST SOC AM, V67, P601, DOI 10.1121/1.383937; Fouladi RT, 2004, COMMUN STAT-SIMUL C, V33, P807, DOI 10.1081/SAC-200033260; Fritz JB, 2007, CURR OPIN NEUROBIOL, V17, P437, DOI 10.1016/j.conb.2007.07.011; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Gould M, 2013, J EXP PSYCHOL-APPL, V19, P171, DOI 10.1037/a0033286; GREEN DM, 1964, PSYCHOL REV, V71, P392, DOI 10.1037/h0044520; Griffiths TD, 2004, NAT REV NEUROSCI, V5, P887, DOI 10.1038/nrn1538; HARRIS DM, 1979, J NEUROPHYSIOL, V42, P1083, DOI 10.1152/jn.1979.42.4.1083; Hartmann W. M., 2005, SIGNALS SOUND SENSAT; HEDGES LV, 1985, STAT METHODS METAANA, DOI [10.1016/C2009-0-03396-0, DOI 10.1016/C2009-0-03396-0]; Hesketh B, 2002, ECOL PSYCHOL, V14, P111, DOI 10.1207/S15326969ECO1403_1; Jepsen ML, 2008, J ACOUST SOC AM, V124, P422, DOI 10.1121/1.2924135; Kahneman D., 1981, PERCEPTUAL ORG, P181; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Keselman HJ, 2002, MULTIVAR BEHAV RES, V37, P331, DOI 10.1207/S15327906MBR3703_2; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; LOVELESS N, 1989, ELECTROEN CLIN NEURO, V74, P217, DOI 10.1016/0013-4694(89)90008-4; Lovie P., 1986, NEW DEV STAT PSYCHOL, P45; LYON DR, 1995, ACTA PSYCHOL, V89, P239, DOI 10.1016/0001-6918(95)98945-Z; Malania M, 2007, J VISION, V7, DOI 10.1167/7.2.1; Manassi M, 2012, J VISION, V12, DOI 10.1167/12.10.13; MCGILL WJ, 1968, J ACOUST SOC AM, V44, P576, DOI 10.1121/1.1911123; MCKENNA TM, 1989, BRAIN RES, V481, P142, DOI 10.1016/0006-8993(89)90494-0; Moore BCJ, 2012, PHILOS T R SOC B, V367, P919, DOI 10.1098/rstb.2011.0355; Nandy AS, 2007, J VISION, V7, DOI 10.1167/7.2.5; Nunez Angel, 2007, Adv Anat Embryol Cell Biol, V187, P1; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Oberfeld D, 2008, J EXP PSYCHOL HUMAN, V34, P605, DOI 10.1037/0096-1523.34.3.605; Oberfeld D, 2008, J ACOUST SOC AM, V123, P1571, DOI 10.1121/1.2837284; Oberfeld D, 2007, J ACOUST SOC AM, V121, P2137, DOI 10.1121/1.2710433; Oberfeld D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079830; Oberfeld D, 2012, HEARING RES, V294, P1, DOI 10.1016/j.heares.2012.09.004; Oberfeld D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048054; Oberfeld D, 2011, ATTEN PERCEPT PSYCHO, V73, P189, DOI 10.3758/s13414-010-0011-8; Oberfeld D, 2010, NEUROPHYSIOLOGICAL BASES OF AUDITORY PERCEPTION, P99, DOI 10.1007/978-1-4419-5686-6_10; Oberfeld D, 2009, J ACOUST SOC AM, V125, P294, DOI 10.1121/1.3021296; Plack CJ, 2006, J NEUROSCI, V26, P8767, DOI 10.1523/JNEUROSCI.1134-06.2006; PLACK CJ, 1995, J ACOUST SOC AM, V97, P1141, DOI 10.1121/1.412227; Plack CJ, 1998, J ACOUST SOC AM, V103, P1598, DOI 10.1121/1.421294; PLACK CJ, 1992, J ACOUST SOC AM, V92, P3097, DOI 10.1121/1.404205; PLOMP R, 1964, J ACOUST SOC AM, V36, P277, DOI 10.1121/1.1918946; RELKIN EM, 1991, HEARING RES, V55, P215, DOI 10.1016/0378-5955(91)90106-J; Rinne T, 2008, J NEUROPHYSIOL, V100, P3323, DOI 10.1152/jn.90607.2008; Rupp A, 2000, NEUROREPORT, V11, P3731, DOI 10.1097/00001756-200011270-00028; Sayim B, 2010, PSYCHOL SCI, V21, P641, DOI 10.1177/0956797610368811; Schaalje GB, 2002, J AGRIC BIOL ENVIR S, V7, P512, DOI 10.1198/108571102726; Schlauch RS, 1997, J ACOUST SOC AM, V102, P461, DOI 10.1121/1.419610; Schreiner CE, 1997, ACTA OTO-LARYNGOL, P54; SHAW B K, 1991, Ecological Psychology, V3, P253, DOI 10.1207/s15326969eco0303_4; SHORE SE, 1995, HEARING RES, V82, P31, DOI 10.1016/0378-5955(94)00160-R; Skene SS, 2010, STAT MED, V29, P2825, DOI 10.1002/sim.4073; SMITH RL, 1977, J NEUROPHYSIOL, V40, P1098, DOI 10.1152/jn.1977.40.5.1098; Srinivasan S, 2012, NEUROSCIENCE, V223, P325, DOI 10.1016/j.neuroscience.2012.07.062; Suga N, 2000, P NATL ACAD SCI USA, V97, P11807, DOI 10.1073/pnas.97.22.11807; SWETS JA, 1959, J ACOUST SOC AM, V31, P514, DOI 10.1121/1.1907745; von Kriegstein K, 2008, CURR BIOL, V18, P1855, DOI 10.1016/j.cub.2008.10.052; Wang J, 2014, NEUROSCIENCE, V256, P309, DOI 10.1016/j.neuroscience.2013.10.042; Winkowski DE, 2006, NATURE, V439, P336, DOI 10.1038/nature04411; Wolfinger RD, 1996, J AGR BIOL ENVIR ST, V1, P205, DOI [10.2307/1400366, DOI 10.2307/1400366]; ZENG FG, 1992, J ACOUST SOC AM, V92, P782, DOI 10.1121/1.403947; ZENG FG, 1991, HEARING RES, V55, P223, DOI 10.1016/0378-5955(91)90107-K; Zhang PXY, 2006, J ACOUST SOC AM, V120, P3471, DOI 10.1121/1.2372456	84	8	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99745	10.1371/journal.pone.0099745	http://dx.doi.org/10.1371/journal.pone.0099745			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937050	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400037
J	Tsunoda, T; Kachi, N; Suzuki, JI				Tsunoda, Tomonori; Kachi, Naoki; Suzuki, Jun-Ichirou			Availability and Temporal Heterogeneity of Water Supply Affect the Vertical Distribution and Mortality of a Belowground Herbivore and Consequently Plant Growth	PLOS ONE			English	Article							SOIL-MOISTURE; RESPONSES; GRASSLAND; TEMPERATURE; PERSPECTIVE; SUCCESSION; COLEOPTERA; SURVIVAL; EXTREMES; DEPEND	We examined how the volume and temporal heterogeneity of water supply changed the vertical distribution and mortality of a belowground herbivore, and consequently affected plant biomass. Plantago lanceolata (Plantaginaceae) seedlings were grown at one per pot under different combinations of water volume (large or small volume) and heterogeneity (homogeneous water conditions, watered every day; heterogeneous conditions, watered every 4 days) in the presence or absence of a larva of the belowground herbivorous insect, Anomala cuprea (Coleoptera: Scarabaeidae). The larva was confined in different vertical distributions to top feeding zone (top treatment), middle feeding zone (middle treatment), or bottom feeding zone (bottom treatment); alternatively no larva was introduced (control treatment) or larval movement was not confined (free treatment). Three-way interaction between water volume, heterogeneity, and the herbivore significantly affected plant biomass. With a large water volume, plant biomass was lower in free treatment than in control treatment regardless of heterogeneity. Plant biomass in free treatment was as low as in top treatment. With a small water volume and in free treatment, plant biomass was low (similar to that under top treatment) under homogeneous water conditions but high under heterogeneous ones (similar to that under middle or bottom treatment). Therefore, there was little effect of belowground herbivory on plant growth under heterogeneous water conditions. In other watering regimes, herbivores would be distributed in the shallow soil and reduced root biomass. Herbivore mortality was high with homogeneous application of a large volume or heterogeneous application of a small water volume. Under the large water volume, plant biomass was high in pots in which the herbivore had died. Thus, the combinations of water volume and heterogeneity affected plant growth via the change of a belowground herbivore.	[Tsunoda, Tomonori; Kachi, Naoki; Suzuki, Jun-Ichirou] Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan	Tokyo Metropolitan University	Tsunoda, T (corresponding author), Tokyo Metropolitan Univ, Dept Biol Sci, Hachioji, Tokyo, Japan.	ttsunoda@tmu.ac.jp	Tsunoda, Tomonori/AAH-8628-2020	Tsunoda, Tomonori/0000-0002-1163-2893	Japan Society for the Promotion of Science [11J06132]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was supported partly by the Japan Society for the Promotion of Science (11J06132 to TT). The funder had no role in study design, data collection and analysis, decision to publish, or preparation to the manuscript. No additional external funding received for this study.	Bardgett R. D., 2005, The biology of soil: a community and ecosystem approach; Bardgett R.D., 2010, AUSTRAL ECOL, V37, P26; Barnett K, 2013, ADV INSECT PHYSIOL, V45, P1, DOI 10.1016/B978-0-12-417165-7.00001-5; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Briones MJI, 1997, APPL SOIL ECOL, V6, P117; Brown V.K., 1990, Advances in Ecological Research, V20, P1, DOI 10.1016/S0065-2504(08)60052-5; BROWN VK, 1992, VEGETATIO, V101, P3, DOI 10.1007/BF00031910; Campbell RE, 1937, ECOLOGY, V18, P479, DOI 10.2307/1930574; Crawley M.J., 2007, R BOOK; DAVIDSON RL, 1969, B ENTOMOL RES, V58, P559, DOI 10.1017/S0007485300057291; De Deyn GB, 2003, NATURE, V422, P711, DOI 10.1038/nature01548; Easterling DR, 2000, SCIENCE, V289, P2068, DOI 10.1126/science.289.5487.2068; Erb M, 2013, J EXP BOT, V64, P1295, DOI 10.1093/jxb/ert007; GODFREY L D, 1985, Journal of Agricultural Entomology, V2, P370; Hagiwara Y, 2008, BOTANY, V86, P1111, DOI 10.1139/B08-064; Hagiwara Y, 2010, ANN BOT-LONDON, V106, P173, DOI 10.1093/aob/mcq096; Heisler-White JL, 2008, OECOLOGIA, V158, P129, DOI 10.1007/s00442-008-1116-9; James SE, 2003, J ECOL, V91, P234, DOI 10.1046/j.1365-2745.2003.00758.x; JONES OT, 1979, ECOL ENTOMOL, V4, P327, DOI 10.1111/j.1365-2311.1979.tb00592.x; Knapp AK, 2008, BIOSCIENCE, V58, P811, DOI 10.1641/B580908; Ladd TL, 1979, J ECON ENTOMOL, V32, P341; LAFRANCE J, 1968, CAN ENTOMOL, V100, P801, DOI 10.4039/Ent100801-8; Maestre FT, 2007, ECOLOGY, V88, P501, DOI 10.1890/06-0421; MORAN NA, 1988, ECOLOGY, V69, P1214, DOI 10.2307/1941276; Novoplansky A, 2001, J VEG SCI, V12, P199, DOI 10.2307/3236604; Okuno T, 1978, DIS PESTS FLOWERS VE; R Development Core Team, 2012, R LANG ENV STAT COMP; RAMSELL J, 1993, J ECOL, V81, P777, DOI 10.2307/2261675; REGNIERE J, 1981, ENVIRON ENTOMOL, V10, P654, DOI 10.1093/ee/10.5.654; Reyer CPO, 2013, GLOBAL CHANGE BIOL, V19, P75, DOI 10.1111/gcb.12023; Riis L, 1998, ENVIRON ENTOMOL, V27, P1182, DOI 10.1093/ee/27.5.1182; Sakai K., 2007, ATLAS JAPANESE SCARA, V2; Smith MD, 2011, J ECOL, V99, P656, DOI 10.1111/j.1365-2745.2011.01798.x; Staley JT, 2008, ROOT FEEDERS: AN ECOSYSTEM PERSPECTIVE, P192, DOI 10.1079/9781845934613.0192; Staley JT, 2007, EUR J SOIL BIOL, V43, P189, DOI 10.1016/j.ejsobi.2007.02.010; Stein C, 2010, ECOLOGY, V91, P1639, DOI 10.1890/09-0600.1; Tsunoda T, 2014, ECOL RES, V29, P351, DOI 10.1007/s11284-014-1133-6; van der Putten WH, 2009, OECOLOGIA, V161, P1, DOI 10.1007/s00442-009-1351-8; Villani M.G., 1988, Bulletin of the Entomological Society of America, V34, P132; VILLANI MG, 1990, ANNU REV ENTOMOL, V35, P249, DOI 10.1146/annurev.en.35.010190.001341; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875	41	13	13	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100437	10.1371/journal.pone.0100437	http://dx.doi.org/10.1371/journal.pone.0100437			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937126	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400110
J	Wang, B; Wang, B; Liu, PX; Li, T; Si, W; Xiu, JS; Liu, HG				Wang, Bin; Wang, Bin; Liu, Peixin; Li, Tao; Si, Wei; Xiu, Jinsheng; Liu, Henggui			Package of NDV-Pseudotyped HIV-Luc Virus and Its Application in the Neutralization Assay for NDV Infection	PLOS ONE			English	Article							NEWCASTLE-DISEASE VIRUS; HEMAGGLUTINATION INHIBITION TEST; OSTRICHES STRUTHIO-CAMELUS; LINKED-IMMUNOSORBENT-ASSAY; RECOMBINANT FOWLPOX VIRUS; NEURAMINIDASE HN PROTEIN; MONOCLONAL-ANTIBODIES; FUSION PROTEIN; ENVELOPE GLYCOPROTEINS; PARAMYXOVIRUS FUSION	Newcastle disease virus (NDV) is a member of the Paramyxovirinae subfamily and can infect most species of birds. It has been a great threat for the poultry industry all around the world. In this report, we successfully produced infectious pseudotyped pNL4-3-Luc-R-E- (HIV-Luc) viruses with the HN and F envelope proteins of NDV. Further investigation revealed the cytoplasmic domains of HN and F, especially HN, plays a significant role in the infection efficiency of these pseudotyped HIV-Luc viruses. Replacement of, or direct fusion to the cytoplasmic domain of the HN protein by that of vesicular stomatitis virus G (VSV-G) could greatly enhance or destroy the infective potential of HN and F-pseudotyped (NDV-pseudotyped) HIV-Luc virus. We further established a novel neutralization assay to evaluate neutralizing antibodies against NDV with the NDV-pseudotyped HIV-Luc viruses. Comparative neutralization data indicate that the results determined by using the NDV-pseudotyped HIV-Luc viruses are as reliable as those by the conventional virus-neutralization assay (VN test) with native NDV. Moreover, the results show that the novel neutralization assay is more sensitive than the VN test.	[Wang, Bin; Wang, Bin; Liu, Peixin; Li, Tao; Si, Wei; Liu, Henggui] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China; [Wang, Bin; Li, Tao; Xiu, Jinsheng] Fujian Agr & Forestry Univ, Coll Anim Sci, Fuzhou, Peoples R China	Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Fujian Agriculture & Forestry University	Liu, HG (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin, Peoples R China.	lhg@hvri.ac.cn			Fundamental Research Funds for Central Public Welfare Research Institutes [0302013006]; State Key Laboratory of Veterinary Biotechnology Research Fund [SKLVBP201217]	Fundamental Research Funds for Central Public Welfare Research Institutes; State Key Laboratory of Veterinary Biotechnology Research Fund	This work was supported by grants from the Fundamental Research Funds for Central Public Welfare Research Institutes (0302013006) and State Key Laboratory of Veterinary Biotechnology Research Fund (SKLVBP201217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLAN WH, 1974, VET REC, V95, P120, DOI 10.1136/vr.95.6.120; Arita M, 2011, CLIN VACCINE IMMUNOL, V18, P1889, DOI 10.1128/CVI.05225-11; BOURSNELL MEG, 1990, VIROLOGY, V178, P297, DOI 10.1016/0042-6822(90)90408-J; Cadman HF, 1997, AVIAN PATHOL, V26, P357, DOI 10.1080/03079459708419218; Chan SY, 2001, CELL, V106, P117, DOI 10.1016/S0092-8674(01)00418-4; Chang A, 2012, VIRUSES-BASEL, V4, P613, DOI 10.3390/v4040613; Chazal N, 2001, J VIROL, V75, P4014, DOI 10.1128/JVI.75.8.4014-4018.2001; Chen WW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076965; Choudhry V, 2007, VIROLOGY, V363, P79, DOI 10.1016/j.virol.2007.01.015; CHOWERS MY, 1994, J VIROL, V68, P2906, DOI 10.1128/JVI.68.5.2906-2914.1994; Cosson P, 1996, EMBO J, V15, P5783, DOI 10.1002/j.1460-2075.1996.tb00964.x; Crennell S, 2000, NAT STRUCT BIOL, V7, P1068; Czifra G, 1996, AVIAN PATHOL, V25, P691, DOI 10.1080/03079459608419175; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Dowd KA, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002111; Du L, 2010, BIOCH BIOPHYSICAL RE; FREED EO, 1995, J BIOL CHEM, V270, P23883, DOI 10.1074/jbc.270.41.23883; Funke S, 2008, MOL THER, V16, P1427, DOI 10.1038/mt.2008.128; HE JL, 1995, J VIROL, V69, P4587, DOI 10.1128/JVI.69.7.4587-4592.1995; IORIO RM, 1989, VIRUS RES, V13, P245, DOI 10.1016/0168-1702(89)90019-1; IORIO RM, 1984, J IMMUNOL, V133, P2215; IORIO RM, 1991, J VIROL, V65, P4999, DOI 10.1128/JVI.65.9.4999-5006.1991; IORIO RM, 1983, J VIROL, V48, P440, DOI 10.1128/JVI.48.2.440-450.1983; Jain S, 2007, J VIROL, V81, P2328, DOI 10.1128/JVI.01940-06; Jin J, 2013, J VIROL METHODS, V187, P362, DOI 10.1016/j.jviromet.2012.11.014; KALETA EF, 1979, COMP IMMUNOL MICROB, V2, P485, DOI 10.1016/0147-9571(79)90090-0; Kang YB, 2002, J VIROL, V76, P9378, DOI 10.1128/JVI.76.18.9378-9388.2002; Kang YX, 2012, J BIOL CHEM, V287, P16499, DOI 10.1074/jbc.M112.354084; Khan AR, 2012, POULTRY SCI, V91, P1598, DOI 10.3382/ps.2011-02042; Kishishita N, 2013, J CLIN MICROBIOLOGY; Kobayashi M, 2003, J VIROL, V77, P2607, DOI 10.1128/JVI.77.4.2607-2614.2003; Krishnamurthy S, 1998, J GEN VIROL, V79, P2419, DOI 10.1099/0022-1317-79-10-2419; Kumar S, 2011, J VIROL, V85, P6521, DOI 10.1128/JVI.00367-11; Lagging LM, 1998, J VIROL, V72, P3539, DOI 10.1128/JVI.72.5.3539-3546.1998; Lotery AJ, 2002, HUM GENE THER, V13, P689, DOI 10.1089/104303402317322258; Lu XF, 2012, ANTIMICROB AGENTS CH, V56, P341, DOI 10.1128/AAC.05537-11; McGinnes LW, 2010, J VIROL, V84, P4513, DOI 10.1128/JVI.01931-09; Mirza AM, 2013, J VIROL, V87, P8813, DOI 10.1128/JVI.01066-13; Molesti Eleonora, 2012, J Mol Genet Med, V7, P315; MORGAN RW, 1992, AVIAN DIS, V36, P858, DOI 10.2307/1591544; Morrison TG, 2003, BBA-BIOMEMBRANES, V1614, P73, DOI 10.1016/S0005-2736(03)00164-0; Nefkens I, 2007, J CLIN VIROL, V39, P27, DOI 10.1016/j.jcv.2007.02.005; Nie JH, 2012, J VIROL METHODS, V185, P267, DOI 10.1016/j.jviromet.2012.07.011; Palomares K, 2013, J VIROL, V87, P2094, DOI 10.1128/JVI.02032-12; Porotto M, 2003, J VIROL, V77, P3647, DOI 10.1128/JVI.77.6.3647-3654.2003; Porotto M, 2012, J VIROL, V86, P5730, DOI 10.1128/JVI.06793-11; REED L. J., 1938, AMER JOUR HYG, V27, P493; Reynolds DL, 2000, AVIAN DIS, V44, P138, DOI 10.2307/1592517; Sanders DA, 2002, CURR OPIN BIOTECH, V13, P437, DOI 10.1016/S0958-1669(02)00374-9; Scott Simon, 2012, J Mol Genet Med, V6, P304; Simmons G, 2004, P NATL ACAD SCI USA, V101, P4240, DOI 10.1073/pnas.0306446101; STEWARD M, 1993, J GEN VIROL, V74, P2539, DOI 10.1099/0022-1317-74-12-2539; Sun HL, 2008, AVIAN DIS, V52, P111, DOI 10.1637/7998-041807-Reg; Tang DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043596; TAYLOR J, 1990, J VIROL, V64, P1441, DOI 10.1128/JVI.64.4.1441-1450.1990; Wambura PN, 2011, TROP ANIM HEALTH PRO, V43, P99, DOI 10.1007/s11250-010-9659-2; Williams R, 1997, AVIAN DIS, V41, P864, DOI 10.2307/1592340; Xu H, 1997, J IMMUNOL METHODS, V208, P61, DOI 10.1016/S0022-1759(97)00128-2; YERAMIAN P, 1985, CR ACAD SCI III-VIE, V300, P255; YU XF, 1992, J VIROL, V66, P4966, DOI 10.1128/JVI.66.8.4966-4971.1992; Zhang MY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044241	61	8	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99905	10.1371/journal.pone.0099905	http://dx.doi.org/10.1371/journal.pone.0099905			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937158	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400054
J	Zhang, JB; Pan, ZX; Moloney, S; Sheppard, A				Zhang, Jinbi; Pan, Zengxiang; Moloney, Stephanie; Sheppard, Allan			RNA-Seq Analysis Implicates Detoxification Pathways in Ovine Mycotoxin Resistance	PLOS ONE			English	Article							GENE-EXPRESSION; OXIDATIVE STRESS; FACIAL ECZEMA; LIVER; SPORIDESMIN; ENZYMES; IDENTIFICATION; ANNOTATION; MECHANISMS; TOXICITY	Mycotoxin induced hepatoxocity has been linked to oxidative stress, resulting from either an increase in levels of reactive oxygen species (ROS) above normal levels and/or the suppression of antioxidant protective pathways. However, few detailed molecular studies of mycotoxicoses in animals have been carried out. This study use current RNA-seq based approaches to investigate the effects of mycotoxin exposure in a ruminant model. Having first assembled a de novo reference transcriptome, we use RNA-Seq technology to define in vivo hepatic gene expression changes resulting from mycotoxin exposure in relationship to pathological effect. As expected, characteristic oxidative stress related gene expression is markedly different in animals exhibiting poorer outcomes. However, expression of multiple genes critical for detoxification, particularly members of the cytochrome P450 gene family, was significantly higher in animals exhibiting mycotoxin tolerance ('resistance'). Further, we present novel evidence for the amplification of Wnt signalling pathway activity in 'resistant' animals, resulting from the marked suppression of multiple key Wnt inhibitor genes. Notably, 'resistance' may be determined primarily by the ability of an individual to detoxify secondary metabolites generated by the metabolism of mycotoxins and the potentiation of Wnt signalling may be pivotal to achieving a favourable outcome upon challenge.	[Zhang, Jinbi; Pan, Zengxiang; Moloney, Stephanie; Sheppard, Allan] Univ Auckland, Liggins Inst, Auckland 1, New Zealand	University of Auckland	Zhang, JB (corresponding author), Univ Auckland, Liggins Inst, Auckland 1, New Zealand.	jinbi.zhang@auckland.ac.nz	Zhang, Jinbi/CAG-1983-2022	zhang, jinbi/0000-0002-9492-3425	Epigenomics Based Prognostics Program - Ministry of Business, Industry and Employment (MBIE) of the New Zealand Government; High Efficiency Sensor Program - Ministry of Business, Industry and Employment (MBIE) of the New Zealand Government; China Scholarship Council; Developmental Epigenetics Lab, Liggins institute, University of Auckland	Epigenomics Based Prognostics Program - Ministry of Business, Industry and Employment (MBIE) of the New Zealand Government; High Efficiency Sensor Program - Ministry of Business, Industry and Employment (MBIE) of the New Zealand Government; China Scholarship Council(China Scholarship Council); Developmental Epigenetics Lab, Liggins institute, University of Auckland	This work was supported in part by the Epigenomics Based Prognostics Program (AS is the PI) and the High Efficiency Sensor Program (AS is a co-PI) both funded by the Ministry of Business, Industry and Employment (MBIE) of the New Zealand Government. JZ acknowledges scholarship support from the China Scholarship Council. The authors would like to further acknowledge the support of the Developmental Epigenetics Lab, Liggins institute, University of Auckland. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bindea G, 2009, BIOINFORMATICS, V25, P1091, DOI 10.1093/bioinformatics/btp101; Braeuning A, 2009, DRUG METAB DISPOS, V37, P1138, DOI 10.1124/dmd.108.026179; Chesire DR, 2004, CANCER RES, V64, P2523, DOI 10.1158/0008-5472.CAN-03-3309; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cruciat C-M, 2013, COLD SPRING HARBOR P, V5; Djordjevic J, 2010, PHYSIOL RES, V59, P729, DOI 10.33549/physiolres.931862; El Golli-Bennour E, 2011, TOXICOLOGY, V287, P1, DOI 10.1016/j.tox.2011.06.002; Fairclough RJ, 1978, STUDIES SPORIDESMIN, P65; Fink-Gremmels J, 2007, ANIM FEED SCI TECH, V137, P326, DOI 10.1016/j.anifeedsci.2007.06.008; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Gardiner DM, 2005, MICROBIOL-SGM, V151, P1021, DOI 10.1099/mic.0.27847-0; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hailfinger S, 2006, HEPATOLOGY, V43, P407, DOI 10.1002/hep.21082; Huwig A, 2001, TOXICOL LETT, V122, P179, DOI 10.1016/S0378-4274(01)00360-5; Ingelman-Sundberg M, 2005, PHARMACOGENOMICS J, V5, P6, DOI 10.1038/sj.tpj.6500285; Ingelman-Sundberg M, 2004, N-S ARCH PHARMACOL, V369, P89, DOI 10.1007/s00210-003-0819-z; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Kawano Y, 2003, J CELL SCI, V116, P2627, DOI 10.1242/jcs.00623; Lade AG, 2011, DEV DYNAM, V240, P486, DOI 10.1002/dvdy.22522; Li D, 2012, MOL PHARMACOL, V81, P86, DOI 10.1124/mol.111.074393; Li RQ, 2009, BIOINFORMATICS, V25, P1966, DOI 10.1093/bioinformatics/btp336; Li SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036592; Ma S, 2012, GASTROENTEROLOGY, V143, P675, DOI 10.1053/j.gastro.2012.06.007; Morgavi DP, 2007, ANIM FEED SCI TECH, V137, P201, DOI 10.1016/j.anifeedsci.2007.06.002; Morris CA, 2004, NEW ZEAL VET J, V52, P205, DOI 10.1080/00480169.2004.36431; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; MORTIMER PH, 1968, J COMP PATHOL, V78, P505, DOI 10.1016/0021-9975(68)90050-9; MUNDAY R, 1989, FREE RADICAL BIO MED, V7, P659, DOI 10.1016/0891-5849(89)90147-0; Munday R, 1997, NEW ZEAL VET J, V45, P93, DOI 10.1080/00480169.1997.36002; Omiecinski CJ, 2011, TOXICOL SCI, V120, pS49, DOI 10.1093/toxsci/kfq338; Pamplona R, 2011, AM J PHYSIOL-REG I, V301, pR843, DOI 10.1152/ajpregu.00034.2011; Paterson RRM, 2010, FOOD RES INT, V43, P1902, DOI 10.1016/j.foodres.2009.07.010; Peltonen J, 2013, J BIOCH MOL TOXICOLO; Pertea G, 2003, BIOINFORMATICS, V19, P651, DOI 10.1093/bioinformatics/btg034; Pestka JJ, 2007, ANIM FEED SCI TECH, V137, P283, DOI 10.1016/j.anifeedsci.2007.06.006; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rustemeyer SM, 2011, J ANIM SCI, V89, P916, DOI 10.2527/jas.2010-3473; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sekine S, 2006, HEPATOLOGY, V43, P817, DOI 10.1002/hep.21131; SMITH BL, 1980, NEW ZEAL VET J, V28, P35, DOI 10.1080/00480169.1980.34686; Stahl S, 2005, HEPATOLOGY, V42, P353, DOI 10.1002/hep.20768; Swales K, 2004, MOL ENDOCRINOL, V18, P1589, DOI 10.1210/me.2003-0397; Tan XP, 2006, GASTROENTEROLOGY, V131, P1561, DOI 10.1053/j.gastro.2006.08.042; TOWERS NR, 1978, NEW ZEAL VET J, V26, P109, DOI 10.1080/00480169.1978.34508; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Voss KA, 2007, ANIM FEED SCI TECH, V137, P299, DOI 10.1016/j.anifeedsci.2007.06.007; Wild CP, 2010, CARCINOGENESIS, V31, P71, DOI 10.1093/carcin/bgp264; Wu F, 2011, WORLD MYCOTOXIN J, V4, P79, DOI 10.3920/WMJ2010.1246; Zaki M.M., 2012, J TOXICOL ENV HLTH, V4, P13, DOI DOI 10.5897/JTEHS11.072; Zhang CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089817; Zhang CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072686; Zhang YH, 2012, GENOMICS, V100, P35, DOI 10.1016/j.ygeno.2012.05.002; Zhu JH, 2011, BIOCHEM BIOPH RES CO, V404, P559, DOI 10.1016/j.bbrc.2010.12.025	54	7	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99975	10.1371/journal.pone.0099975	http://dx.doi.org/10.1371/journal.pone.0099975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936865	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400060
J	Asner, SA; Science, ME; Tran, D; Smieja, M; Merglen, A; Mertz, D				Asner, Sandra A.; Science, Michelle E.; Dat Tran; Smieja, Marek; Merglen, Arnaud; Mertz, Dominik			Clinical Disease Severity of Respiratory Viral Co-Infection versus Single Viral Infection: A Systematic Review and Meta-Analysis	PLOS ONE			English	Review							COMMUNITY-ACQUIRED PNEUMONIA; HUMAN METAPNEUMOVIRUS; HOSPITALIZED INFANTS; TRACT INFECTIONS; SYNCYTIAL VIRUS; CHILDREN; MULTIPLE	Background: Results from cohort studies evaluating the severity of respiratory viral co-infections are conflicting. We conducted a systematic review and meta-analysis to assess the clinical severity of viral co-infections as compared to single viral respiratory infections. Methods: We searched electronic databases and other sources for studies published up to January 28, 2013. We included observational studies on inpatients with respiratory illnesses comparing the clinical severity of viral co-infections to single viral infections as detected by molecular assays. The primary outcome reflecting clinical disease severity was length of hospital stay (LOS). A random-effects model was used to conduct the meta-analyses. Results: Twenty-one studies involving 4,280 patients were included. The overall quality of evidence applying the GRADE approach ranged from moderate for oxygen requirements to low for all other outcomes. No significant differences in length of hospital stay (LOS) (mean difference (MD) -0.20 days, 95% CI -0.94, 0.53, p = 0.59), or mortality (RR 2.44, 95% CI 0.86, 6.91, p = 0.09) were documented in subjects with viral co-infections compared to those with a single viral infection. There was no evidence for differences in effects across age subgroups in post hoc analyses with the exception of the higher mortality in preschool children (RR 9.82, 95% CI 3.09, 31.20, p<0.001) with viral co-infection as compared to other age groups (I 2 for subgroup analysis 64%, p = 0.04). Conclusions: No differences in clinical disease severity between viral co-infections and single respiratory infections were documented. The suggested increased risk of mortality observed amongst children with viral co-infections requires further investigation.	[Asner, Sandra A.; Science, Michelle E.; Dat Tran] Univ Toronto, Hosp Sick Children, Dept Paediat, Div Infect Dis, Toronto, ON M5G 1X8, Canada; [Smieja, Marek; Mertz, Dominik] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Smieja, Marek; Mertz, Dominik] McMaster Univ, Dept Med, Hamilton, ON, Canada; [Smieja, Marek] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Merglen, Arnaud] Univ Toronto, Hosp Sick Children, Div Paediat Med, Toronto, ON M5G 1X8, Canada; [Merglen, Arnaud] Univ Toronto, Hosp Sick Children, Paediat Outcomes Res Team, Toronto, ON M5G 1X8, Canada; [Merglen, Arnaud] Univ Hosp Geneva, Div Gen Paediat, Geneva, Switzerland; [Merglen, Arnaud] Univ Geneva, Fac Med, Geneva, Switzerland; [Asner, Sandra A.] Univ Lausanne Hosp, Dept Paediat, Paediat Infect Dis Unit, Lausanne, Switzerland; [Asner, Sandra A.] Univ Lausanne Hosp, Div Infect Dis, Dept Med, Lausanne, Switzerland; [Smieja, Marek; Mertz, Dominik] Hamilton Hlth Sci, Hamilton, ON, Canada; [Smieja, Marek; Mertz, Dominik] McMaster Univ, Michael G DeGroote Inst Infect Dis Res, Hamilton, ON, Canada	University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); McMaster University; McMaster University; McMaster University; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Geneva; University of Geneva; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); McMaster University; McMaster University	Mertz, D (corresponding author), McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada.	mertzd@mcmaster.ca			Hamilton Health Sciences Foundation; Swiss National Science Foundation [PBGEP3-139828]; Canadian Institutes of Health Research (CIHR)	Hamilton Health Sciences Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR))	DM is a recipient of a Research Early Career Award from Hamilton Health Sciences Foundation (Jack Hirsh Fellowship). AM is a recipient of a Swiss National Science Foundation postdoctoral fellowship (PBGEP3-139828). Dr. Marek Smieja is a recipient of a Canadian Institutes of Health Research (CIHR) New Investigator Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, NEWCASTLEOTTAWA SCAL; Aramburo A, 2011, PEDIATR CRIT CARE ME, V12, pE160, DOI 10.1097/PCC.0b013e3181f36e86; Blyth CC, 2013, INFLUENZA OTHER RESP, V7, P168, DOI 10.1111/j.1750-2659.2012.00360.x; Brozek J, 2008, GRADEPRO VERSION 3 2; Calvo C, 2008, J CLIN VIROL, V42, P268, DOI 10.1016/j.jcv.2008.03.012; Camargo C, 2012, BRAZ J INFECT DIS, V16, P180, DOI [10.1016/S1413-8670(12)70302-1, 10.1590/S1413-86702012000200013]; Canducci F, 2008, J MED VIROL, V80, P716, DOI 10.1002/jmv.21108; Cheuk DKL, 2007, PEDIATR INFECT DIS J, V26, P995, DOI 10.1097/INF.0b013e3181586b63; Choi SH, 2012, AM J RESP CRIT CARE, V186, P325, DOI 10.1164/rccm.201112-2240OC; Cilla G, 2008, J MED VIROL, V80, P1843, DOI 10.1002/jmv.21271; DaPalma T, 2010, VIRUS RES, V149, P1, DOI 10.1016/j.virusres.2010.01.002; De Paulis M, 2011, J PEDIAT-BRAZIL, V87, P307, DOI [10.2223/JPED.2100, 10.1590/S0021-75572011000400006]; Drews AL, 1997, CLIN INFECT DIS, V25, P1421, DOI 10.1086/516137; Esper FP, 2011, J INFECTION, V63, P260, DOI 10.1016/j.jinf.2011.04.004; Franz A, 2010, J CLIN VIROL, V48, P239, DOI 10.1016/j.jcv.2010.05.007; Garcia-Garcia ML, 2010, PEDIATR PULM, V45, P585, DOI 10.1002/ppul.21225; Garcia-Garcia ML, 2006, ARCH DIS CHILD, V91, P290, DOI 10.1136/adc.2005.082388; Gerna G, 2008, J CLIN VIROL, V41, P49, DOI 10.1016/j.jcv.2007.10.018; Goka E, 2012, INFLUENZA OTHER RESP; Guerrier G, 2013, PEDIATR INFECT DIS J, V32, pE8, DOI 10.1097/INF.0b013e31826fd40d; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1294, DOI 10.1016/j.jclinepi.2011.03.017; Henssge U, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021430; Horn SD, 2002, J PEDIATR-US, V141, P496, DOI 10.1067/mpd.2002.126925; Hozo Stela Pudar, 2005, BMC Med Res Methodol, V5, P13, DOI 10.1186/1471-2288-5-13; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Manager R, 2011, REVM VERS 5 1; Marcos MA, 2011, EUR RESPIR J, V38, P739, DOI 10.1183/09031936.00168610; Marguet C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004596; Martin ET, 2012, INFLUENZA OTHER RESP, V6, P71, DOI 10.1111/j.1750-2659.2011.00265.x; Metersky ML, 2012, INT J INFECT DIS, V16, pE321, DOI 10.1016/j.ijid.2012.01.003; Moher D, 2009, J CLIN EPIDEMIOL, V62, P1006, DOI 10.1016/j.jclinepi.2009.06.005; Nascimento MS, 2010, CLINICS, V65, P1133, DOI 10.1590/S1807-59322010001100014; Nascimento-Carvalho CM, 2011, INFLUENZA OTHER RESP, V5, P285, DOI 10.1111/j.1750-2659.2011.00206.x; Prill MM, 2012, PEDIATR INFECT DIS J, V31, P235, DOI 10.1097/INF.0b013e31823e07fe; Rhedin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051491; Simunovic N, 2010, CAN MED ASSOC J, V182, P1609, DOI 10.1503/cmaj.092220; Sun X, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c117; Tran D, 2013, J PEDIAT RIO J	39	90	101	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99392	10.1371/journal.pone.0099392	http://dx.doi.org/10.1371/journal.pone.0099392			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932493	gold, Green Published, Green Submitted			2022-12-27	WOS:000337738600030
J	Wurth, JJ; Blumenthal, NR; Shastri, VP				Wurth, Jonathan J.; Blumenthal, Nils R.; Shastri, V. Prasad			Hydrophilization of Poly(Caprolactone) Copolymers through Introduction of Oligo(Ethylene Glycol) Moieties	PLOS ONE			English	Article							TISSUE ENGINEERING APPLICATIONS; RING-OPENING POLYMERIZATION; EPSILON-CAPROLACTONE; DRUG-DELIVERY; BIODEGRADABLE POLYMERS; POLY(ETHYLENE GLYCOL); BLOCK-COPOLYMERS; CONTACT-ANGLE; POLYESTERS; BIOMATERIALS	In this study, a new family of poly(e-caprolactone) (PCL) copolymers that bear oligo(ethylene glycol) (OEG) moieties is described. The synthesis of three different oligo(ethylene glycol) functionalized epoxide monomers derived from 2-methyl-4-pentenoic acid, and their copolymerization with epsilon-caprolactone (CL) to poly(CL-co-OEG-MPO) copolymers is presented. The statistical copolymerization initiated with SnOct(2)/BnOH yielded the copolymers with varying OEG content and composition. The linear relationship between feed ratio and incorporation of the OEG co-monomer enables control over backbone functional group density. The introduction of OEG moieties influenced both the thermal and the hydrophilic characteristics of the copolymers. Both increasing OEG length and backbone content resulted in a decrease in static water contact angle. The introduction of OEG side chains in the PCL copolymers had no adverse influence on MC-3TE3-E1 cell interaction. However, changes to cell form factor (W) were observed. While unmodified PCL promoted elongated (anisotropic) morphologies (Phi=0.094), PCL copolymer with tri-ethylene glycol side chains at or above seven percent backbone incorporation induced more isotropic cell morphologies (Phi=0.184) similar to those observed on glass controls (Phi=0.151).	[Wurth, Jonathan J.; Blumenthal, Nils R.; Shastri, V. Prasad] Univ Freiburg, Inst Macromol Chem, Freiburg, Germany; [Wurth, Jonathan J.; Blumenthal, Nils R.; Shastri, V. Prasad] Univ Freiburg, BIOSS Ctr Biol Signaling Studies, D-79106 Freiburg, Germany	University of Freiburg; University of Freiburg	Shastri, VP (corresponding author), Univ Freiburg, Inst Macromol Chem, Freiburg, Germany.	prasad.shastri@gmail.com			Excellence Initiative of the German Federal and State Governments BIOSS [EXC 294]	Excellence Initiative of the German Federal and State Governments BIOSS	This study was supported by the Excellence Initiative of the German Federal and State Governments (EXC 294) BIOSS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albertsson AC, 2003, BIOMACROMOLECULES, V4, P1466, DOI 10.1021/bm034247a; Bhadra D, 2002, PHARMAZIE, V57, P5; Brostow W, 2008, MATER LETT, V62, P3152, DOI 10.1016/j.matlet.2008.02.008; Cho KY, 2006, POLYM BULL, V57, P849, DOI 10.1007/s00289-006-0658-4; Dash TK, 2012, J CONTROL RELEASE, V158, P15, DOI 10.1016/j.jconrel.2011.09.064; Deng XM, 1997, J POLYM SCI POL CHEM, V35, P703, DOI 10.1002/(SICI)1099-0518(199703)35:4<703::AID-POLA13>3.0.CO;2-R; Dubois P, 1996, MACROMOLECULES, V29, P1965, DOI 10.1021/ma951738h; GOOD RJ, 1992, J ADHES SCI TECHNOL, V6, P1269, DOI 10.1163/156856192X00629; Gottlieb HE, 1997, J ORG CHEM, V62, P7512, DOI 10.1021/jo971176v; Heiny M, 2014, ELSEVIER SCI; Ikada Y, 2000, MACROMOL RAPID COMM, V21, P117, DOI 10.1002/(SICI)1521-3927(20000201)21:3<117::AID-MARC117>3.3.CO;2-O; Jagur-Grodzinski J, 2003, E-POLYMERS, V012, P25; Knop K, 2010, ANGEW CHEM INT EDIT, V49, P6288, DOI 10.1002/anie.200902672; Kweon H, 2003, BIOMATERIALS, V24, P801, DOI 10.1016/S0142-9612(02)00370-8; Labet M, 2009, CHEM SOC REV, V38, P3484, DOI 10.1039/b820162p; Lam CNC, 2002, ADV COLLOID INTERFAC, V96, P169, DOI 10.1016/S0001-8686(01)00080-X; Mark James E., 2009, POLYM DATA HDB, P1264; Middleton JC, 2000, BIOMATERIALS, V21, P2335, DOI 10.1016/S0142-9612(00)00101-0; Nair LS, 2007, PROG POLYM SCI, V32, P762, DOI 10.1016/j.progpolymsci.2007.05.017; Oh SH, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/1/014101; Patel A, 2013, BIOMATERIALS, V34, P3970, DOI 10.1016/j.biomaterials.2013.01.045; Piao LH, 2003, POLYMER, V44, P2025, DOI 10.1016/S0032-3861(03)00087-9; Rieger J, 2004, MACROMOLECULES, V37, P9738, DOI 10.1021/ma048768h; Sabir MI, 2009, J MATER SCI, V44, P5713, DOI 10.1007/s10853-009-3770-7; Schmidmaier G, 2001, J BIOMED MATER RES, V58, P449; Shastri V. P., 2004, US Pat., Patent No. [6,730,772, 6730772, 6,730,772 B2]; Sinha VR, 2004, INT J PHARMACEUT, V278, P1, DOI 10.1016/j.ijpharm.2004.01.044; Stevens MP., 1990, POLYM CHEM-UK; Thire RMSM, 2007, MACROMOL SYMP, V258, P38, DOI 10.1002/masy.200751205; Tokiwa Y, 2007, J POLYM ENVIRON, V15, P259, DOI 10.1007/s10924-007-0066-3; Veronese FM, 2005, DRUG DISCOV TODAY, V10, P1451, DOI 10.1016/S1359-6446(05)03575-0; Vert M, 2005, BIOMACROMOLECULES, V6, P538, DOI 10.1021/bm0494702; Wei XW, 2009, INT J PHARMACEUT, V381, P1, DOI 10.1016/j.ijpharm.2009.07.033; Wurth JJ, 2013, J POLYM SCI POL CHEM, V51, P3375, DOI 10.1002/pola.26734	34	14	14	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99157	10.1371/journal.pone.0099157	http://dx.doi.org/10.1371/journal.pone.0099157			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932726	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600024
J	Jang, JY; Kim, SJ; Cho, EK; Jeong, SW; Park, EJ; Lee, WC; Lee, SH; Kim, SG; Kim, YS; Kim, HS; Kim, BS; Lin, WY; Chung, RT				Jang, Jae Young; Kim, Seong-Jun; Cho, Eun Kyung; Jeong, Soung Won; Park, Eui Ju; Lee, Woong Cheul; Lee, Sae Hwan; Kim, Sang Gyune; Kim, Young Seok; Kim, Hong Soo; Kim, Boo Sung; Lin, Wenyu; Chung, Raymond T.			TRAIL Enhances Apoptosis of Human Hepatocellular Carcinoma Cells Sensitized by Hepatitis C Virus Infection: Therapeutic Implications	PLOS ONE			English	Article							VIRAL-HEPATITIS; DEATH RECEPTORS; LIVER-INJURY; POLY(ADP-RIBOSE) POLYMERASE; HUMAN HEPATOCYTES; LIGAND; ACTIVATION; CLEAVAGE; MITOCHONDRIA; MODULATION	Hepatitis C virus (HCV) infection causes chronic liver diseases leading to hepatocellular carcinoma (HCC) and liver failure. We have previously shown that HCV sensitizes hepatocytes to mitochondrial apoptosis via the TRAIL death receptors DR4 and DR5. Although TRAIL and its receptors are selective targets for cancer therapy, their potential against HCC with chronic HCV infection has not been explored yet. Here we show that HCV induces DR4/DR5-dependent activation of caspase-8 leading to elevation of apoptotic signaling in infected cells and also present TRAIL effect in HCV-induced apoptotic signaling. HCV induced proteolytic cleavage of caspase-9 by stimulating DR4 and DR5, resulting in subsequent cleavage of caspase-3. Further, HCV-induced proteolytic cleavage in caspase-8, caspase-9, and caspase-3 was enhanced in the presence of recombinant TRAIL. HCV-induced cleavage in caspase-9 and increase in caspase-3/7 activity was completely suppressed by silencing of either DR4 or DR5. Perturbing DR4/DR5-caspase-8 signaling complex by silencing DR4 and DR5 or by chemical inhibitor specific to caspase-8 led to decrease of HCV-induced cleavage of poly(ADP-ribose) polymerase (PARP), a substrate for caspase-3 during apoptosis, indicating the functional role of caspase-8 in HCV-induced apoptotic signaling network. Furthermore, TRAIL enhanced PARP cleavage in apoptotic response induced by HCV infection, indicating the effect of TRAIL for the induction of selective apoptosis of HCC cells infected with HCV. Given the importance of apoptosis in HCC development, our data suggest that HCV-induced DR4 and DR5 may be considered as an attractive target for TRAIL therapy against HCC with chronic HCV infection.	[Jang, Jae Young; Cho, Eun Kyung; Jeong, Soung Won; Park, Eui Ju; Lee, Woong Cheul; Kim, Boo Sung] Soonchunhyang Univ, Inst Digest Res, Ctr Digest Dis, Dept Internal Med,Coll Med, Seoul, South Korea; [Lee, Sae Hwan; Kim, Hong Soo] Soonchunhyang Univ, Dept Internal Med, Coll Med, Cheonan, South Korea; [Kim, Sang Gyune; Kim, Young Seok] Soonchunhyang Univ, Dept Internal Med, Coll Med, Puchon, South Korea; [Kim, Seong-Jun] Univ Calif San Diego, Dept Med, Div Infect Dis, La Jolla, CA 92093 USA; [Lin, Wenyu; Chung, Raymond T.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Dept Med, Boston, MA 02138 USA	Soonchunhyang University; Soonchunhyang University; Soonchunhyang University; University of California System; University of California San Diego; Harvard University; Harvard Medical School; Massachusetts General Hospital	Chung, RT (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Gastrointestinal Unit,Dept Med, Boston, MA 02138 USA.	rtchung@partners.org	Kim, Sang gyune/AAI-5704-2020	Kim, Sang gyune/0000-0001-8694-777X	National Research Foundation of Korea (NRF) Grant - Korean Government (MOE) [NRF-2011-0010229]; NIH [AI069939]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098079] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) Grant - Korean Government (MOE); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Research Foundation of Korea (NRF) Grant funded by the Korean Government (MOE) (No. Grant Number: NRF-2011-0010229) and NIH AI069939 (R.T.C.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alter MJ, 2006, J HEPATOL, V44, pS6, DOI 10.1016/j.jhep.2005.11.004; Ashkenazi A, 1998, SCIENCE, V281, P1305, DOI 10.1126/science.281.5381.1305; Bantel H, 2003, CELL DEATH DIFFER, V10, pS48, DOI 10.1038/sj.cdd.4401119; Bantel H, 2001, HEPATOLOGY, V34, P758, DOI 10.1053/jhep.2001.28229; Calabrese F, 2000, HEPATOLOGY, V31, P1153, DOI 10.1053/he.2000.7123; Canbay A, 2004, HEPATOLOGY, V39, P273, DOI 10.1002/hep.20051; Deng L, 2008, J VIROL, V82, P10375, DOI 10.1128/JVI.00395-08; Deng ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037700; GONZALEZAMARO R, 1994, J EXP MED, V179, P841, DOI 10.1084/jem.179.3.841; Gores GJ, 2001, HEPATOLOGY, V34, P3, DOI 10.1053/jhep.2001.25173; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Harnois DM, 2012, MAYO CLIN PROC, V87, P7, DOI 10.1016/j.mayocp.2011.11.004; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; Iio S, 1998, J HEPATOL, V29, P517, DOI 10.1016/S0168-8278(98)80145-1; Jang JY, 2011, J HEPATOL, V54, P612, DOI 10.1016/j.jhep.2010.07.042; Jang Jae Young, 2010, Korean J Hepatol, V16, P263, DOI 10.3350/kjhep.2010.16.3.263; Kanzler S, 2000, SEMIN CANCER BIOL, V10, P173, DOI 10.1006/scbi.2000.0318; KAUFMANN SH, 1993, CANCER RES, V53, P3976; Kumar S, 2007, CELL DEATH DIFFER, V14, P32, DOI 10.1038/sj.cdd.4402060; Lan L, 2008, J IMMUNOL, V181, P4926, DOI 10.4049/jimmunol.181.7.4926; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lawrence D, 2001, NAT MED, V7, P383, DOI 10.1038/86397; Levrero M, 2006, ONCOGENE, V25, P3834, DOI 10.1038/sj.onc.1209562; Li HL, 1998, CELL, V94, P491, DOI 10.1016/S0092-8674(00)81590-1; Luo X, 1998, CELL, V94, P481, DOI 10.1016/S0092-8674(00)81589-5; Malhi H, 2008, GASTROENTEROLOGY, V134, P1641, DOI 10.1053/j.gastro.2008.03.002; Masuoka HC, 2009, CLIN LIVER DIS, V13, P467, DOI 10.1016/j.cld.2009.05.010; Mundt B, 2005, GUT, V54, P1590, DOI 10.1136/gut.2004.056929; Mundt B, 2002, FASEB J, V16, P94, DOI 10.1096/fj.02-0537fje; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pianko S, 2001, J VIRAL HEPATITIS, V8, P406, DOI 10.1046/j.1365-2893.2001.00316.x; Rust C, 2000, AM J MED, V108, P567, DOI 10.1016/S0002-9343(00)00370-3; Saitou Y, 2005, HUM PATHOL, V36, P1066, DOI 10.1016/j.humpath.2005.07.019; Schuchmann M, 2001, EUR J GASTROEN HEPAT, V13, P785, DOI 10.1097/00042737-200107000-00005; Schulze-Osthoff K, 1998, EUR J BIOCHEM, V254, P439, DOI 10.1046/j.1432-1327.1998.2540439.x; Sedger LM, 1999, J IMMUNOL, V163, P920; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; Song JJ, 2008, CELL SIGNAL, V20, P892, DOI 10.1016/j.cellsig.2008.01.001; Sprick MR, 2000, IMMUNITY, V12, P599, DOI 10.1016/S1074-7613(00)80211-3; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Thornberry NA, 1998, CHEM BIOL, V5, pR97, DOI 10.1016/S1074-5521(98)90615-9; Volkmann X, 2007, HEPATOLOGY, V46, P1498, DOI 10.1002/hep.21846; Walczak H, 1999, NAT MED, V5, P157, DOI 10.1038/5517; Wiezorek J, 2010, CLIN CANCER RES, V16, P1701, DOI 10.1158/1078-0432.CCR-09-1692; Zhu HZ, 2007, GASTROENTEROLOGY, V133, P1649, DOI 10.1053/j.gastro.2007.09.017	45	9	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98171	10.1371/journal.pone.0098171	http://dx.doi.org/10.1371/journal.pone.0098171			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927176	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100013
J	Moran-Luis, M; Fameli, A; Blanco-Fontao, B; Fernandez-Gil, A; Rodriguez-Munoz, R; Quevedo, M; Mirol, P; Banuelos, MJ				Moran-Luis, Maria; Fameli, Alberto; Blanco-Fontao, Beatriz; Fernandez-Gil, Alberto; Rodriguez-Munoz, Rolando; Quevedo, Mario; Mirol, Patricia; Banuelos, Maria-Jose			Demographic Status and Genetic Tagging of Endangered Capercaillie in NW Spain	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; TETRAO-UROGALLUS-CANTABRICUS; MARK-RECAPTURE; INDIVIDUAL IDENTIFICATION; HABITAT SELECTION; MATING SYSTEM; CONSERVATION; PROGRAM; ADULT; CONSEQUENCES	Counting rare and elusive animals and evaluating their demographic status, are fundamental yet challenging aspects of population ecology and conservation biology. We set out to estimate population size (N-c), genetic effective population size (N-e (gen)), sex ratio, and movements based on genetic tagging for the threatened Cantabrian capercaillie. We used 9 microsatellite loci to genotype 134 droppings collected at 34 display areas during the breeding season. Using genetic capture-mark-recapture, we estimated 93 individuals (N-c, 95% CI: 70-116) in an area of about 500 km(2), with sex ratio biased towards males (1: 1.6). Estimated N-e gen (35.5) was 38% of N-c, notably higher than the published average in wild populations. This capercaillie population is small and well within concern in terms of population viability. By genetic tagging, we detected mostly short movements; just a few males were recaptured between contiguous display areas. Non-invasive surveys of endangered populations have a great potential, yet adequate sample size and location are key to obtain reliable information on conservation status.	[Moran-Luis, Maria; Quevedo, Mario; Banuelos, Maria-Jose] Univ Oviedo, Res Unit Biodivers UO PA CSIC, Mieres, Spain; [Moran-Luis, Maria; Blanco-Fontao, Beatriz; Quevedo, Mario; Banuelos, Maria-Jose] Univ Oviedo, Dept Biol Organisms & Syst, Ecol Unit, Oviedo, Spain; [Fameli, Alberto; Mirol, Patricia] Argentinian Museum Nat Sci Bernardino Rivadavia, Grp Biodivers & Conservat Genet GECOBI, Buenos Aires, DF, Argentina; [Fernandez-Gil, Alberto] CSIC, Donana Biol Stn, Dept Conservat Biol, E-41080 Seville, Spain; [Rodriguez-Munoz, Rolando] Univ Exeter, Sch Biosci, Ctr Ecol & Conservat, Penryn, England	University of Oviedo; University of Oviedo; Museo Argentino de Ciencias Naturales Bernardino Rivadavia (MACN); Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); University of Exeter	Banuelos, MJ (corresponding author), Univ Oviedo, Res Unit Biodivers UO PA CSIC, Mieres, Spain.	mariajo.banuelos@gmail.com	Quevedo, Mario/I-2493-2015; Moran-Luis, Maria/ABA-1134-2021; /H-9916-2015	Quevedo, Mario/0000-0002-6067-3237; Fameli, Alberto/0000-0001-6566-405X; Blanco Fontao, Beatriz/0000-0002-5492-2399; Moran-Luis, Maria/0000-0002-6449-2388; /0000-0002-8221-0487	 [IB08-158];  [CGL2010-15990]	; 	This study is a contribution to grants IB08-158 (FICYT,www.ficyt.es) to MJ Banuelos and CGL2010-15990 (MICINN,www.idi.mineco.gob.es) to M. J. Banuelos and M. Quevedo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banks SC, 2003, ANIM CONSERV, V6, P101, DOI 10.1017/S1367943003003135; Caizergues A, 2001, MOL ECOL NOTES, V1, P36, DOI 10.1046/j.1471-8278.2000.00015.x; Caro T, 2007, TRENDS ECOL EVOL, V22, P394, DOI 10.1016/j.tree.2007.06.003; CAUGHLEY G, 1994, J ANIM ECOL, V63, P215, DOI 10.2307/5542; Charlesworth B, 2009, NAT REV GENET, V10, P195, DOI 10.1038/nrg2526; Chenuil A, 2000, FRESHWATER BIOL, V43, P121, DOI 10.1046/j.1365-2427.2000.00531.x; Creel S, 2003, MOL ECOL, V12, P2003, DOI 10.1046/j.1365-294X.2003.01868.x; Donald PF, 2007, IBIS, V149, P671, DOI 10.1111/j.1474-919X.2007.00724.x; Efford MG, 2011, ECOLOGY, V92, P2202, DOI 10.1890/11-0332.1; Eggert LS, 2003, MOL ECOL, V12, P1389, DOI 10.1046/j.1365-294X.2003.01822.x; Ellis JS, 2011, GENETICA, V139, P353, DOI 10.1007/s10709-011-9554-4; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; FRANKHAM R, 1995, GENET RES, V66, P95, DOI 10.1017/S0016672300034455; Frankham R., 2010, INTRO CONSERVATION G, DOI DOI 10.1017/CBO9780511809002; Frankham R, 2014, BIOL CONSERV, V170, P56, DOI 10.1016/j.biocon.2013.12.036; Frantz AC, 2003, MOL ECOL, V12, P1649, DOI 10.1046/j.1365-294X.2003.01848.x; Garcia D, 2005, FOREST ECOL MANAG, V208, P29, DOI 10.1016/j.foreco.2004.10.071; Gonzalez MA, 2012, IBIS, V154, P260, DOI 10.1111/j.1474-919X.2012.01217.x; Guschanski K, 2009, BIOL CONSERV, V142, P290, DOI 10.1016/j.biocon.2008.10.024; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hoglund J, 2009, EVOLUTIONARY CONSERVATION GENETICS, P1; Hoglund J., 1995, LEKS, DOI DOI 10.1515/9781400864157; Jacob G, 2010, CONSERV GENET, V11, P33, DOI 10.1007/s10592-008-9794-8; Katzner TE, 2011, ANIM CONSERV, V14, P328, DOI 10.1111/j.1469-1795.2011.00444.x; Lee AM, 2011, AM NAT, V177, P301, DOI 10.1086/658344; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; Margalida A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026784; Martin J, 2007, CONSERV BIOL, V21, P472, DOI 10.1111/j.1523-1739.2006.00613.x; Martinez AM, 1993, THESIS U LEON; McKelvey KS, 2005, MOL ECOL NOTES, V5, P716, DOI 10.1111/j.1471-8286.2005.01038.x; Miller CR, 2005, MOL ECOL, V14, P1991, DOI 10.1111/j.1365-294X.2005.02577.x; Miller CR, 2002, GENETICS, V160, P357; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Moran P, 2006, ECOL FRESHW FISH, V15, P597, DOI 10.1111/j.1600-0633.2006.00201.x; Neel MC, 2013, HEREDITY, V111, P189, DOI 10.1038/hdy.2013.37; NUNNEY L, 1993, EVOLUTION, V47, P1329, DOI 10.1111/j.1558-5646.1993.tb02158.x; Palsboll PJ, 1997, NATURE, V388, P767, DOI 10.1038/42005; Palsboll PJ, 1999, BIOL J LINN SOC, V68, P3, DOI 10.1111/j.1095-8312.1999.tb01155.x; Palstra FP, 2012, ECOL EVOL, V2, P2357, DOI 10.1002/ece3.329; Peakall R, 2006, J ZOOL, V268, P207, DOI 10.1111/j.1469-7998.2005.00011.x; Perez T, 2011, CONSERV GENET RESOUR, V3, P483, DOI 10.1007/s12686-011-9385-8; Petit E, 2006, CONSERV BIOL, V20, P1062, DOI 10.1111/j.1523-1739.2006.00417.x; PICOZZI N, 1992, J APPL ECOL, V29, P751, DOI 10.2307/2404485; Piertney SB, 2001, MOL ECOL NOTES, V1, P303, DOI 10.1046/j.1471-8278.2001.00118.x; Pollo CJ, 2005, BIRD CONSERV INT, V15, P397, DOI 10.1017/S0959270905000626; Puechmaille SJ, 2007, J APPL ECOL, V44, P843, DOI 10.1111/j.1365-2664.2007.01321.x; Quevedo M, 2006, BIOL CONSERV, V127, P190, DOI 10.1016/j.biocon.2005.07.019; Quevedo M, 2006, WILDLIFE BIOL, V12, P267, DOI 10.2981/0909-6396(2006)12[267:HSBCCT]2.0.CO;2; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rodriguez-Munoz R, 2007, CONSERV GENET, V8, P659, DOI 10.1007/s10592-006-9212-z; Rudnick JA, 2005, MOL ECOL, V14, P2959, DOI 10.1111/j.1365-294X.2005.02641.x; Segelbacher G, 2000, MOL ECOL, V9, P1934, DOI 10.1046/j.1365-294x.2000.0090111934.x; Segelbacher G, 2003, MOL ECOL, V12, P1773, DOI 10.1046/j.1365-294X.2003.01873.x; Smith DA, 2006, MOL ECOL, V15, P387, DOI 10.1111/j.1365-294X.2005.02841.x; Solberg KH, 2006, BIOL CONSERV, V128, P158, DOI 10.1016/j.biocon.2005.09.025; Stephens PA, 1999, TRENDS ECOL EVOL, V14, P401, DOI 10.1016/S0169-5347(99)01684-5; Storch I, 2006, J ORNITHOL, V147, P653, DOI 10.1007/s10336-006-0101-5; Storch I, 1997, WILDLIFE BIOL, V3, P149, DOI 10.2981/wlb.1997.019; Storz JF, 2001, EVOLUTION, V55, P1224; Taberlet P, 1999, BIOL J LINN SOC, V68, P41, DOI 10.1111/j.1095-8312.1999.tb01157.x; Taberlet P, 1996, NUCLEIC ACIDS RES, V24, P3189, DOI 10.1093/nar/24.16.3189; Tallmon DA, 2008, MOL ECOL RESOUR, V8, P299, DOI 10.1111/j.1471-8286.2007.01997.x; Thompson WL, 2004, SAMPLING RARE ELUSIV; Traill LW, 2007, BIOL CONSERV, V139, P159, DOI 10.1016/j.biocon.2007.06.011; Valiere N, 2002, MOL ECOL NOTES, V2, P377, DOI 10.1046/j.1471-8286.2002.00228.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Vazquez JF, 2012, J WILDLIFE MANAGE, V76, P957, DOI 10.1002/jwmg.346; Vucetich JA, 1997, EVOLUTION, V51, P2017, DOI 10.1111/j.1558-5646.1997.tb05123.x; Waits LP, 2001, MOL ECOL, V10, P249, DOI 10.1046/j.1365-294X.2001.01185.x; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Waples RS, 2008, MOL ECOL RESOUR, V8, P753, DOI 10.1111/j.1755-0998.2007.02061.x; Waples RS, 2010, EVOL APPL, V3, P244, DOI 10.1111/j.1752-4571.2009.00104.x; Waples RS, 2005, MOL ECOL, V14, P3335, DOI 10.1111/j.1365-294X.2005.02673.x; Watson A., 2008, GROUSE NATURAL HIST; WEGGE P, 1987, AUK, V104, P481, DOI 10.2307/4087547; WEGGE P, 1986, BEHAV ECOL SOCIOBIOL, V19, P401, DOI 10.1007/BF00300542; Zhan XJ, 2006, CURR BIOL, V16, pR451, DOI 10.1016/j.cub.2006.05.042	77	15	16	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99799	10.1371/journal.pone.0099799	http://dx.doi.org/10.1371/journal.pone.0099799			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926790	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100081
J	Riahi, Z; Bonnet, C; Zainine, R; Louha, M; Bouyacoub, Y; Laroussi, N; Chargui, M; Kefi, R; Jonard, L; Dorboz, I; Hardelin, JP; Salah, SB; Levilliers, J; Weil, D; McElreavey, K; Boespflug, OT; Besbes, G; Abdelhak, S; Petit, C				Riahi, Zied; Bonnet, Crystel; Zainine, Rim; Louha, Malek; Bouyacoub, Yosra; Laroussi, Nadia; Chargui, Mariem; Kefi, Rym; Jonard, Laurence; Dorboz, Imen; Hardelin, Jean-Pierre; Salah, Sihem Belhaj; Levilliers, Jacqueline; Weil, Dominique; McElreavey, Kenneth; Boespflug, Odile Tanguy; Besbes, Ghazi; Abdelhak, Sonia; Petit, Christine			Whole Exome Sequencing Identifies New Causative Mutations in Tunisian Families with Non-Syndromic Deafness	PLOS ONE			English	Article							NONSYNDROMIC HEARING-LOSS; PROFOUND DEAFNESS; GENE; ASSOCIATION; DOMINANT; HUMANS; DEFECT; CELLS; DFNB3	Identification of the causative mutations in patients affected by autosomal recessive non syndromic deafness (DFNB forms), is demanding due to genetic heterogeneity. After the exclusion of GJB2 mutations and other mutations previously reported in Tunisian deaf patients, we performed whole exome sequencing in patients affected with severe to profound deafness, from four unrelated consanguineous Tunisian families. Four biallelic non previously reported mutations were identified in three different genes: a nonsense mutation, c.208C>T (p.R70X), in LRTOMT, a missense mutation, c.5417T>C (p.L1806P), in MYO15A and two splice site mutations, c.7395+3G>A, and c.2260+2T>A, in MYO15A and TMC1 respectively. We thereby provide evidence that whole exome sequencing is a powerful, cost-effective screening tool to identify mutations causing recessive deafness in consanguineous families.	[Riahi, Zied; Bouyacoub, Yosra; Laroussi, Nadia; Chargui, Mariem; Kefi, Rym; Abdelhak, Sonia] Inst Pasteur Tunis, Lab Genom Biomed & Oncogenet, Tunis, Tunisia; [Riahi, Zied; Laroussi, Nadia; Abdelhak, Sonia] Univ Tunis El Manar, Fac Sci Tunis, Tunis, Tunisia; [Bonnet, Crystel; Petit, Christine] INSERM, UMRS 1120, Inst Vis, Paris, France; [Zainine, Rim; Salah, Sihem Belhaj; Besbes, Ghazi] CHU La Rabta, Serv ORL & Chirurg Maxillofaciale, Tunis, Tunisia; [Louha, Malek; Jonard, Laurence] Hop Trousseau, APHP, Ctr Reference Surdites Genet, F-75571 Paris, France; [Dorboz, Imen] INSERM, U931, Clermont Ferrand, France; [Hardelin, Jean-Pierre; Levilliers, Jacqueline; Weil, Dominique; Petit, Christine] Inst Pasteur Paris, Unite Genet & Physiol Audit, Paris, France; [McElreavey, Kenneth] Inst Pasteur Paris, Unite Genet Dev Humain, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Tunis-El-Manar; Faculte des Sciences de Tunis (FST); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite de Bordeaux; Universite de Tunis-El-Manar; Hopital La Rabta; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Ambroise-Pare - APHP; Hopital Universitaire Armand-Trousseau - APHP; UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Abdelhak, S (corresponding author), Inst Pasteur Tunis, Lab Genom Biomed & Oncogenet, Tunis, Tunisia.	sonia.abdelhak@pasteur.rns.tn	Bonnet, Crystel/AAN-5950-2021; Abdelhak, Sonia/L-2831-2013	Bonnet, Crystel/0000-0002-1916-9119; BOUYACOUB, Yosra/0000-0003-2423-199X; Jonard, Laurence/0000-0003-0369-0505; Abdelhak, Sonia/0000-0001-8466-5525; Petit, Christine/0000-0002-9069-002X	Tunisian Ministry of Public Health; Ministry of Higher Education and Scientific Research [LR11IPT05]; E.C. [295097]; BNP Paribas foundation	Tunisian Ministry of Public Health; Ministry of Higher Education and Scientific Research(Ministry of Higher Education & Scientific Research (MHESR)); E.C.(European CommissionEuropean Commission Joint Research Centre); BNP Paribas foundation	This work was supported by the Tunisian Ministry of Public Health, the Ministry of Higher Education and Scientific Research (LR11IPT05) and by the E.C. Grant agreement No 295097 for FP7 project GM-NCD-Inco and BNP Paribas foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed ZM, 2008, NAT GENET, V40, P1335, DOI 10.1038/ng.245; Belguith H, 2009, GENET TEST MOL BIOMA, V13, P147, DOI 10.1089/gtmb.2008.0077; Belyantseva IA, 2005, NAT CELL BIOL, V7, P148, DOI 10.1038/ncb1219; Ben Said M, 2010, GENET TEST MOL BIOMA, V14, P307, DOI 10.1089/gtmb.2009.0174; Bonnet C, 2013, GENE, V527, P537, DOI 10.1016/j.gene.2013.06.044; Charif M, 2012, MOL BIOL REP, V39, P11011, DOI 10.1007/s11033-012-2003-3; Delmaghani S, 2012, HUM MOL GENET, V21, P3835, DOI 10.1093/hmg/dds212; Denoyelle F, 1999, LANCET, V353, P1298, DOI 10.1016/S0140-6736(98)11071-1; Diaz-Horta O, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050628; Du X, 2008, P NATL ACAD SCI USA, V105, P14609, DOI 10.1073/pnas.0807219105; Ishida S, 2013, NAT GENET, V45, P552, DOI 10.1038/ng.2601; Kawashima Y, 2011, J CLIN INVEST, V121, P4796, DOI 10.1172/JCI60405; Kitajiri SI, 2007, CLIN GENET, V72, P546, DOI 10.1111/j.1399-0004.2007.00895.x; Liburd N, 2001, HUM GENET, V109, P535, DOI 10.1007/s004390100604; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Riahi Z, 2013, INT J PEDIATR OTORHI, V77, P1485, DOI 10.1016/j.ijporl.2013.06.015; Riahi Z, 2013, INT J PEDIATR OTORHI, V77, P1481, DOI 10.1016/j.ijporl.2013.06.013; Riahi Z, 2013, GENE, V525, P1, DOI 10.1016/j.gene.2013.04.078; Romdhane L, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-52; Sirmaci A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032000; Sirmaci A, 2009, INT J PEDIATR OTORHI, V73, P699, DOI 10.1016/j.ijporl.2009.01.005; Wang AH, 1998, SCIENCE, V280, P1447, DOI 10.1126/science.280.5368.1447; Woo HM, 2013, BMC MED GENET, V14, DOI 10.1186/1471-2350-14-72; Yan D, 2013, GENET TEST MOL BIOMA, V17, P581, DOI 10.1089/gtmb.2012.0464; Yano T, 2013, J CLIN CASE REPORTS	25	20	24	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99797	10.1371/journal.pone.0099797	http://dx.doi.org/10.1371/journal.pone.0099797			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926664	Green Submitted, Green Published, gold			2022-12-27	WOS:000338278100080
J	Wang, W; Ding, JH; Li, Y; Wang, CF; Zhou, LP; Zhu, H; Peng, WJ				Wang, Wei; Ding, Jianhui; Li, Yuan; Wang, Chaofu; Zhou, Liangping; Zhu, Hui; Peng, Weijun			Magnetic Resonance Imaging and Computed Tomography Characteristics of Renal Cell Carcinoma Associated with Xp11.2 Translocation/TFE3 Gene Fusion	PLOS ONE			English	Article							MULTIPHASIC MULTIDETECTOR CT; OF-THE-LITERATURE; PATHOLOGICAL CORRELATION; HELICAL CT; ADULTS; NEOPLASMS; FEATURES; MASSES; DIFFERENTIATION; CLASSIFICATION	Purpose: To characterize Xp11.2 translocation renal cell carcinoma (RCC) using magnetic resonance imaging (MRI) and computed tomography (CT). Methods: This study retrospectively collected the MRI and CT data of twelve patients with Xp11.2 translocation RCC confirmed by pathology. Nine cases underwent dynamic contrast-enhanced MRI (DCE-MRI) and 6 cases underwent CT, of which 3 cases underwent MRI and CT simultaneously. The MRI and CT findings were analyzed in regard to tumor position, size, hemorrhagic, cystic or necrotic components, calcification, tumor density, signal intensity and enhancement features. Results: The age of the 12 patients ranged from 13 to 46 years (mean age: 23 years). T2WI revealed heterogeneous intensity, hyper-intensity, and slight hypo-intensity in 6 cases, 2 cases, and 1 case, respectively. On DCE-MR images, mild, moderate, and marked rim enhancement of the tumor in the corticomedullary phase (CMP) were observed in 1, 6, and 2 cases, respectively. The tumor parenchyma showed iso-attenuation (n = 4) or slight hyper-attenuation (n = 1) compared to the normal renal cortex on non-contrast CT images. Imaging findings were suggestive of hemorrhage (n = 4) or necrosis (n = 8) in the tumors, and there was evidence of calcification in 8 cases by CT (n = 3) and pathology (n = 8). On dynamic contrast-enhanced CT images, 3 cases and 1 case manifested moderate and strong CMP enhancement, respectively. Nine tumors by MRI and 4 tumors by CT showed prolonged enhancement. Three neoplasms presented at stage I, 2 at stage II, 3 at stage III, and 4 at stage IV according the 2010 AJCC staging criteria. Conclusions: XP11.2 translocation RCC should be considered when a child or young adult patient presents with a renal tumor with heterogeneous features such as hemorrhage, necrosis, cystic changes, and calcification on CT and MRI and/or is accompanied by metastatic evidence.	[Wang, Wei; Ding, Jianhui; Zhou, Liangping; Zhu, Hui; Peng, Weijun] Fudan Univ, Shanghai Canc Ctr, Dept Radiol, Shanghai 200433, Peoples R China; [Wang, Wei; Ding, Jianhui; Li, Yuan; Wang, Chaofu; Zhou, Liangping; Zhu, Hui; Peng, Weijun] Fudan Univ, Shanghai Med Coll, Dept Oncol, Shanghai 200433, Peoples R China; [Li, Yuan; Wang, Chaofu] Fudan Univ, Shanghai Canc Ctr, Dept Pathol, Shanghai 200433, Peoples R China	Fudan University; Fudan University; Fudan University	Peng, WJ (corresponding author), Fudan Univ, Shanghai Canc Ctr, Dept Radiol, Shanghai 200433, Peoples R China.	pengweijun601@163.com	Wang, Chao/GXF-8353-2022	Li, Yuan/0000-0001-5651-819X				Altinok G, 2005, PEDIATR DEVEL PATHOL, V8, P168, DOI 10.1007/s10024-004-9106-3; Amin MB, 2008, AM J SURG PATHOL, V32, P1822, DOI 10.1097/PAS.0b013e3181831e68; Aoyagi T, 2011, UROL INT, V86, P487, DOI 10.1159/000323866; Argani P, 2005, AM J SURG PATHOL, V29, P230, DOI 10.1097/01.pas.0000146007.54092.37; Argani P, 2005, CLIN LAB MED, V25, P363, DOI 10.1016/j.cll.2005.01.008; Argani P, 2003, ADV ANAT PATHOL, V10, P243, DOI 10.1097/00125480-200309000-00001; Argani P, 2003, ONCOGENE, V22, P5374, DOI 10.1038/sj.onc.1206686; Argani P, 2003, AM J SURG PATHOL, V27, P750, DOI 10.1097/00000478-200306000-00005; Argani P, 2001, AM J PATHOL, V159, P179, DOI 10.1016/S0002-9440(10)61684-7; Argani P, 2007, AM J SURG PATHOL, V31, P1149, DOI 10.1097/PAS.0b013e318031ffff; Argani P, 2006, AM J CLIN PATHOL, V126, P332, DOI 10.1309/EAEJTJGD5J4JB4F; Armah HB, 2008, PATHOLOGY, V40, P306, DOI 10.1080/00313020701816373; Armah HB, 2009, DIAGN PATHOL, V4, DOI 10.1186/1746-1596-4-15; Camparo P, 2008, AM J SURG PATHOL, V32, P656, DOI 10.1097/PAS.0b013e3181609914; Dang TT, 2012, J COMPUT ASSIST TOMO, V36, P669, DOI 10.1097/RCT.0b013e3182680182; Delahunt B, 2001, HUM PATHOL, V32, P590, DOI 10.1053/hupa.2001.24984; Edge SB, 2010, ANN SURG ONCOL, V17, P1471, DOI 10.1245/s10434-010-0985-4; Vera-Badillo FE, 2012, INT J UROL, V19, P894, DOI 10.1111/j.1442-2042.2012.03079.x; Eren S, 2006, EUR J RADIOL, V59, P93, DOI 10.1016/j.ejrad.2006.01.003; Fujimoto H, 1999, JPN J CLIN ONCOL, V29, P198, DOI 10.1093/jjco/29.4.198; Herts BR, 2002, AM J ROENTGENOL, V178, P367, DOI 10.2214/ajr.178.2.1780367; Kato H, 2011, J MAGN RESON IMAGING, V33, P217, DOI 10.1002/jmri.22392; Kim JK, 2004, RADIOLOGY, V230, P677, DOI 10.1148/radiol.2303030003; Kondo T, 2004, INT J UROL, V11, P817, DOI 10.1111/j.1442-2042.2004.00907.x; Koo HJ, 2013, ACTA RADIOL, V54, P827, DOI 10.1177/0284185113484019; Lopez-Beltran A, 2006, EUR UROL, V49, P798, DOI 10.1016/j.eururo.2005.11.035; Meyer PN, 2007, AM J CLIN PATHOL, V128, P70, DOI 10.1309/LR5G1VMXPY3G0CUK; Pedrosa I, 2008, RADIOGRAPHICS, V28, P985, DOI 10.1148/rg.284065018; Pedrosa I, 2008, EUR RADIOL, V18, P365, DOI 10.1007/s00330-007-0757-0; Rao Q, 2011, INT J SURG PATHOL, V19, P170, DOI 10.1177/1066896909354337; Rini BI, 2009, J CLIN ONCOL, V27, P4462, DOI 10.1200/JCO.2008.21.7034; Salles Paulo G. O., 2005, Int. braz j urol., V31, P251, DOI 10.1590/S1677-55382005000300009; Sasaguri K, 2010, JPN J RADIOL, V28, P453, DOI 10.1007/s11604-010-0450-0; Sasiwimonphan K, 2012, RADIOLOGY, V263, P160, DOI 10.1148/radiol.12111205; Sauk SC, 2011, RADIOLOGY, V261, P854, DOI 10.1148/radiol.11101508; Silverman SG, 2007, RADIOGRAPHICS, V27, P1131, DOI 10.1148/rg.274065147; STUDER UE, 1990, J UROLOGY, V144, P243, DOI 10.1016/S0022-5347(17)39422-3; SUSSMAN SK, 1990, RADIOLOGY, V177, P495, DOI 10.1148/radiology.177.2.2217790; Suzigan S, 2007, INT J SURG PATHOL, V15, P199, DOI 10.1177/1066896906295891; Winarti NW, 2008, INT J SURG PATHOL, V16, P66, DOI 10.1177/1066896907304994; Wu A, 2008, HISTOPATHOLOGY, V53, P533, DOI 10.1111/j.1365-2559.2008.03151.x; Yoshimitsu Kengo, 2004, Radiat Med, V22, P371; Young JR, 2013, RADIOLOGY, V267, P444, DOI 10.1148/radiol.13112617; Zhu QQ, 2013, ACTA RADIOL, V54, P355, DOI 10.1258/ar.2012.120255	44	24	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99990	10.1371/journal.pone.0099990	http://dx.doi.org/10.1371/journal.pone.0099990			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926688	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100104
J	Wu, CS; Lee, TY; Chou, RH; Yen, CJ; Huang, WC; Wu, CY; Yu, YL				Wu, Chen-Shiou; Lee, Teng-Yu; Chou, Ruey-Hwang; Yen, Chia-Jui; Huang, Wei-Chien; Wu, Chung-Yi; Yu, Yung-Luen			Development of a Highly Sensitive Glycan Microarray for Quantifying AFP-L3 for Early Prediction of Hepatitis B Virus-Related Hepatocellular Carcinoma	PLOS ONE			English	Article							SERUM ALPHA-FETOPROTEIN; AGGLUTININ-REACTIVE FRACTION; DES-GAMMA-CARBOXYPROTHROMBIN; D-GLUCOSAMINIDE ALPHA; CARBOXY PROTHROMBIN; CDNA CLONING; DIAGNOSIS; CIRRHOSIS; CANCER; IMMUNOTHERAPY	The alpha-fetoprotein fraction L3 (AFP-L3), which is synthesized by malignant cells and incorporates a fucosylated oligosaccharide, has been investigated as a diagnostic and prognostic marker for hepatocellular carcinoma (HCC). Quantification of AFP-L3 by conventional enzyme-linked immunosorbent assay (ELISA) has not always produced reliable results for serum samples with low AFP, and thus we evaluated the clinical utility of quantifying AFP-L3 using a new and highly sensitive glycan microarray assay. Sera from 9 patients with chronic hepatitis B and 32 patients with hepatitis B virus (HBV)-related HCC were tested for AFP-L3 level using the glycan microarray. Additionally, we compared receiver operator characteristic curves for the ELISA and glycan microarray methods for determination of the AFP-L3: AFP-L1 ratio in patient samples. This ratio was calculated for 8 HCC patients who underwent transarterial embolization therapy pre- or post-treatment with AFP-L3. Glycan microarrays showed that the AFP-L3 ratio of HBV-related HCC patients was significantly higher than that measured for chronic hepatitis B patients. Overall parameters for estimating AFP-L3% in HCC samples were as follows: sensitivity, 53.13%; specificity, 88.89%; and area under the curve, 0.75. The elevated AFP-L3% in the 8 patients with HBV-related HCC was strongly associated with HCC progression. Following one month of transarterial embolization therapy, the relative mean AFP-L3% decreased significantly. In addition, we compared Fut8 gene expression between paired tumor and non-tumor tissues from 24 patients with HBV-related HCC. The Fut8 mRNA expression was significantly increased in tumorous tissues in these patients than that in non-tumor tissue controls. Higher expression of Fut8 mRNA in tumorous tissues in these patients was associated with poor differentiation than well and moderate differentiation. Our results describe a new glycan microarray for the sensitive and rapid quantification of fucosylated AFP; this method is potentially applicable to screening changes in AFP-L3 level for assessment of HCC progression.	[Wu, Chen-Shiou; Chou, Ruey-Hwang; Huang, Wei-Chien; Wu, Chung-Yi; Yu, Yung-Luen] China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan; [Lee, Teng-Yu] China Med Univ, Grad Inst Clin Med Sci, Taichung, Taiwan; [Chou, Ruey-Hwang; Huang, Wei-Chien; Yu, Yung-Luen] China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Chou, Ruey-Hwang; Huang, Wei-Chien; Yu, Yung-Luen] China Med Univ, Ctr Mol Med, Taichung, Taiwan; [Wu, Chen-Shiou; Wu, Chung-Yi] Acad Sinica, Genom Res Ctr, Taipei 115, Taiwan; [Lee, Teng-Yu] Chung Shan Med Univ, Dept Med, Taichung, Taiwan; [Lee, Teng-Yu] Taichung Vet Gen Hosp, Div Gastroenterol, Taichung, Taiwan; [Chou, Ruey-Hwang; Huang, Wei-Chien; Yu, Yung-Luen] Asia Univ, Dept Biotechnol, Taichung, Taiwan; [Yen, Chia-Jui] Natl Cheng Kung Univ, Grad Inst Clin Med, Tainan 70101, Taiwan; [Yen, Chia-Jui] Natl Cheng Kung Univ Hosp, Dept Internal Med, Div Hematol Oncol, Tainan 70428, Taiwan	China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; Academia Sinica - Taiwan; Chung Shan Medical University; Taichung Veterans General Hospital; Asia University Taiwan; National Cheng Kung University; National Cheng Kung University; National Cheng Kung University Hospital	Yu, YL (corresponding author), China Med Univ, PhD Program Canc Biol & Drug Discovery, Taichung, Taiwan.	ylyu@mail.cmu.edu.tw	Huang, Wei-Chien/H-3126-2019; Chou, Ruey-Hwang/K-8541-2013; Wu, Chung-Yi/K-8334-2018	Huang, Wei-Chien/0000-0001-6467-8716; Chou, Ruey-Hwang/0000-0002-2297-2180; Wu, Chen-Shiou/0000-0003-0791-1483	 [NSC101-2321-B-039-004];  [NHRI-EX102-10245BI]	; 	This work was supported by the following grants: NSC101-2321-B-039-004; and NHRI-EX102-10245BI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyagi Y, 2002, HEPATOL RES, V23, P287, DOI 10.1016/S1386-6346(01)00184-X; Beale G, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-200; Carr BI, 2007, DIGEST DIS SCI, V52, P776, DOI 10.1007/s10620-006-9541-2; Cheng Hau-Tsai, 2007, J Chin Med Assoc, V70, P310, DOI 10.1016/S1726-4901(08)70011-X; Chu KC, 2012, FUTURE MED CHEM, V4, P1767, DOI [10.4155/fmc.12.102, 10.4155/FMC.12.102]; Durazo FA, 2008, J GASTROEN HEPATOL, V23, P1541, DOI 10.1111/j.1440-1746.2008.05395.x; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Gomaa AI, 2009, WORLD J GASTROENTERO, V15, P1301, DOI 10.3748/wjg.15.1301; Huang CY, 2006, P NATL ACAD SCI USA, V103, P15, DOI 10.1073/pnas.0509693102; IKEDA K, 1993, HEPATOLOGY, V17, P1003, DOI 10.1016/0270-9139(93)90114-3; KINOSHITA N, 1989, CLIN CHIM ACTA, V179, P143, DOI 10.1016/0009-8981(89)90160-5; KUROMATSU R, 1993, LIVER, V13, P177; LIAW YF, 1988, HEPATOLOGY, V8, P493, DOI 10.1002/hep.1840080310; LIAW YF, 1986, GASTROENTEROLOGY, V90, P263, DOI 10.1016/0016-5085(86)90919-4; Liu Y, 2013, J ALLERGY CLIN IMMUN, V131, P213, DOI 10.1016/j.jaci.2012.10.018; Llovet JM, 2012, J HEPATOL, V56, P908, DOI 10.1016/j.jhep.2011.12.001; Marrero JA, 2009, GASTROENTEROLOGY, V137, P110, DOI 10.1053/j.gastro.2009.04.005; Nakamura K, 1998, ANAL CHEM, V70, P954, DOI 10.1021/ac9711495; OKA H, 1994, HEPATOLOGY, V19, P61, DOI 10.1016/0270-9139(94)90053-1; Park S, 2013, CHEM SOC REV, V42, P4310, DOI 10.1039/c2cs35401b; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sterling RK, 2009, CLIN GASTROENTEROL H, V7, P104, DOI 10.1016/j.cgh.2008.08.041; Stravitz RT, 2008, AM J MED, V121, P119, DOI 10.1016/j.amjmed.2007.09.020; TAKAYASU K, 1995, AM J ROENTGENOL, V164, P885, DOI 10.2214/ajr.164.4.7726041; TAKAYASU K, 1990, AM J ROENTGENOL, V155, P49, DOI 10.2214/ajr.155.1.1693808; TAKETA K, 1993, CANCER RES, V53, P5419; TATSUTA M, 1986, ONCOLOGY, V43, P306, DOI 10.1159/000226388; Tseng SY, 2008, CHEM-ASIAN J, V3, P1395, DOI 10.1002/asia.200800154; Uozumi N, 1996, J BIOL CHEM, V271, P27810, DOI 10.1074/jbc.271.44.27810; Uozumi N, 1996, J BIOCHEM, V120, P385; Wang YA, 2012, FISH SHELLFISH IMMUN, V33, P213, DOI 10.1016/j.fsi.2012.04.011; Wu CS, 2014, INT J CANCER, V134, P1638, DOI 10.1002/ijc.28501; Wu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039466; Wu CY, 2009, ORG BIOMOL CHEM, V7, P2247, DOI 10.1039/b902510n; Yanagidani S, 1997, J BIOCHEM-TOKYO, V121, P626; Yiang GT, 2009, J BIOMED SCI, V16, DOI 10.1186/1423-0127-16-47; Yu YL, 2012, J CELL PHYSIOL, V227, P213, DOI 10.1002/jcp.22719; Yu YL, 2010, INT J ONCOL, V36, P365, DOI 10.3892/ijo_00000508; Zhang JF, 2012, J ATHEROSCLER THROMB, V19, P213, DOI 10.5551/jat.11148	39	21	24	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99959	10.1371/journal.pone.0099959	http://dx.doi.org/10.1371/journal.pone.0099959			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927126	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100100
J	Yokobe, J; Kitahara, M; Matsushima, M; Uezono, S				Yokobe, Junya; Kitahara, Masaki; Matsushima, Masato; Uezono, Shoichi			Preference for Different Anchor Descriptors on Visual Analogue Scales among Japanese Patients with Chronic Pain	PLOS ONE			English	Article							NUMERICAL RATING-SCALES; PSYCHOMETRIC PROPERTIES; COGNITIVE IMPAIRMENT; DEPRESSION SCALE; HOSPITAL ANXIETY; OLDER-ADULTS; CANCER PAIN; INTENSITY; VALIDITY; YOUNGER	Context: Although many previous studies have examined the preference of patients for different pain measurement scales, preference for anchor descriptors has not been thoroughly discussed. Objectives: To examine (1) the preferred end-phrases used in the VAS as anchor labels for Japanese patients with chronic pain, and (2) whether the preference differs according to factors such as age, sex, educational level, duration of pain, and pain intensity. Methods: We performed an observational study in patients suffering from non-cancer chronic pain for more than 3 months at a pain center in Japan. The patients were asked to rate their pain intensity using four types of VAS that used the following different anchor descriptors: "worst pain'' ("Worst''), "worst pain bearable'' ("Bearable''), "worst pain imaginable'' ("Imaginable''), and "worst pain you have ever experienced'' ("Experienced''). They were also asked to rank the four scales according to ease of responding, and asked which descriptor best reflected their perceived pain. Results: In total, 183 patients participated in the study. They consisted of 119 (65.0%) women and 64 (35.0%) men aged 18-84 years with the mean age of 56.9 years. "Experienced'' was most preferred (69.8%), followed by "Bearable'' (66.3%), "Worst'' (48.8%), and "Imaginable'' (16.9%). Factors such as age, sex, educational background, duration of pain, and pain intensity did not significantly affect the results. In 83.1% of patients, the preferred descriptor corresponded to the descriptor that best reflected patients' perceived pain. Conclusion: The frequently used expression "worst pain imaginable'' is considered to be difficult to understand for most patients. Widely preferred descriptors, such as "worst pain you have ever experienced'' and "worst pain bearable'', should be used when evaluating perceived pain. The preference of anchor descriptors was not significantly affected by the factors such as age, sex, educational level, duration of pain, and pain intensity.	[Yokobe, Junya; Kitahara, Masaki; Uezono, Shoichi] Jikei Univ, Sch Med, Dept Anesthesiol, Minato Ku, Tokyo, Japan; [Matsushima, Masato] Jikei Univ, Sch Med, Div Clin Epidemiol, Minato Ku, Tokyo, Japan	Jikei University; Jikei University	Yokobe, J (corresponding author), Jikei Univ, Sch Med, Dept Anesthesiol, Minato Ku, Tokyo, Japan.	yokobejunya@gmail.com						Berthier F, 1998, AM J EMERG MED, V16, P132, DOI 10.1016/S0735-6757(98)90029-8; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bolton JE, 1998, J MANIP PHYSIOL THER, V21, P1; Brunelli C, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-42; CARLSSON AM, 1983, PAIN, V16, P87, DOI 10.1016/0304-3959(83)90088-X; Clark P, 2003, J RHEUMATOL, V30, P1584; Closs SJ, 2004, J PAIN SYMPTOM MANAG, V27, P196, DOI 10.1016/j.jpainsymman.2003.12.010; DOWNIE WW, 1978, ANN RHEUM DIS, V37, P378, DOI 10.1136/ard.37.4.378; Fanurik D, 1998, Clin Nurs Res, V7, P103, DOI 10.1177/105477389800700202; Fanurik D, 1998, CLIN NURS RES, V7, P120; Flaherty S A, 1996, AANA J, V64, P133; Gabre Pia, 2002, Spec Care Dentist, V22, P174, DOI 10.1111/j.1754-4505.2002.tb00267.x; Gagliese L, 2005, PAIN, V117, P412, DOI 10.1016/j.pain.2005.07.004; Grotle M, 2004, SPINE, V29, pE492, DOI 10.1097/01.brs.0000143664.02702.0b; Herr K A, 1993, Appl Nurs Res, V6, P39; Herr KA, 2004, CLIN J PAIN, V20, P207, DOI 10.1097/00002508-200407000-00002; Hjermstad MJ, 2011, J PAIN SYMPTOM MANAG, V41, P1073, DOI 10.1016/j.jpainsymman.2010.08.016; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; KREMER E, 1981, PAIN, V10, P241, DOI 10.1016/0304-3959(81)90199-8; LANGLEY GB, 1985, RHEUMATOL INT, V5, P145, DOI 10.1007/BF00541514; Larroy C, 2002, BEHAV MED, V27, P179, DOI 10.1080/08964280209596043; Loder E, 2012, CEPHALALGIA, V32, P179, DOI 10.1177/0333102411434812; Marquie L., 2008, ACUTE PAIN, V10, P31, DOI DOI 10.1016/J.ACPAIN.2008.01.003; McQuay HJ, 2006, TXB PAIN, V5, P415; Melzack R, 2006, WALL MELZACKS TXB PA, P291; Merskey H., 1994, CLASSIFICATION CHRON, P207, DOI DOI 10.1002/ANA.20394; Paice JA, 1997, CANCER NURS, V20, P88, DOI 10.1097/00002820-199704000-00002; Peters ML, 2007, PAIN MED, V8, P601, DOI 10.1111/j.1526-4637.2007.00311.x; PRICE DD, 1994, PAIN, V56, P217, DOI 10.1016/0304-3959(94)90097-3; Radbruch L, 2000, PALLIATIVE MED, V14, P266, DOI 10.1191/026921600672986600; Rahim-Williams B, 2012, PAIN MED, V13, P522, DOI 10.1111/j.1526-4637.2012.01336.x; Rodriguez CS, 2004, CANCER NURS, V27, P425; SEYMOUR RA, 1982, EUR J CLIN PHARMACOL, V23, P441, DOI 10.1007/BF00605995; Skovlund E, 2005, CLIN J PAIN, V21, P292, DOI 10.1097/01.ajp.0000110636.14355.3e; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Williams ACD, 2000, PAIN, V85, P457, DOI 10.1016/S0304-3959(99)00299-7; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	37	8	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99891	10.1371/journal.pone.0099891	http://dx.doi.org/10.1371/journal.pone.0099891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2VQ	24927424	Green Submitted, gold, Green Published			2022-12-27	WOS:000338278100087
J	Yu, XL; Yu, YX; Zeng, Q				Yu, Xinliang; Yu, Yixiong; Zeng, Qun			Support Vector Machine Classification of Streptavidin-Binding Aptamers	PLOS ONE			English	Article							SELECTION; SELEX; DESCRIPTORS; QSAR	Background: Synthesizing and characterizing aptamers with high affinity and specificity have been extensively carried out for analytical and biomedical applications. Few publications can be found that describe structure-activity relationships (SARs) of candidate aptamer sequences. Methodology: This paper reports pattern recognition with support vector machine (SVM) classification techniques for the identification of streptavidin-binding aptamers as "low'' or "high'' affinity aptamers. The SVM parameters C and gamma were optimized using genetic algorithms. Four descriptors, the topological descriptor PW4 (path/walk 4 - Randic shape index), the connectivity index X3A (average connectivity index chi-3), the topological charge index JGI2 (mean topological charge index of order 2), and the free energy E of the secondary structure, were used to describe the structures of candidate aptamer sequences from SELEX selection (Schutze et al. (2011) PLoS ONE (12): e29604). Conclusions: The predicted fractions of winning streptavidin-binding aptamers for ten rounds of SELEX conform to the aptamer evolutionary principles of SELEX-based screening. The feasibility of applying pattern recognition based on SVM and genetic algorithms for streptavidin-binding aptamers has been demonstrated.	[Yu, Xinliang] Hunan Inst Engn, Coll Chem & Chem Engn, Xiangtan, Hunan, Peoples R China; [Yu, Xinliang] Hunan Univ, Coll Chem & Chem Engn, State Key Lab Chemo Biosensing & Chemometr, Changsha 410082, Hunan, Peoples R China; [Yu, Yixiong] Lushan Int Expt Sch, Changsha, Hunan, Peoples R China; [Zeng, Qun] Xiangtan Cent Hosp, Dept Neurol Surg, Xiangtan, Hunan, Peoples R China	Hunan Institute of Engineering; Hunan University	Yu, XL (corresponding author), Hunan Inst Engn, Coll Chem & Chem Engn, Xiangtan, Hunan, Peoples R China.	yxliang5602@sina.com.cn			Hunan Provincial Natural Science Foundation of China [12JJ6011]	Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province)	This work was supported by the Hunan Provincial Natural Science Foundation of China (Contract No. 12JJ6011). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afantitis A, 2010, MOL DIVERS, V14, P225, DOI 10.1007/s11030-009-9163-7; Bing T, 2010, BIOORGAN MED CHEM, V18, P1798, DOI 10.1016/j.bmc.2010.01.054; Birzele F, 2006, BIOINFORMATICS, V22, P2628, DOI 10.1093/bioinformatics/btl453; Bunka DHJ, 2006, NAT REV MICROBIOL, V4, P588, DOI 10.1038/nrmicro1458; Cambridge Soft Inc, 2008, CHEMBIOOFFICE ULTR 1; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Djordjevic M, 2006, PHYS BIOL, V3, P13, DOI 10.1088/1478-3975/3/1/002; Djordjevic M, 2007, BIOMOL ENG, V24, P179, DOI 10.1016/j.bioeng.2007.03.001; GALVEZ J, 1994, J CHEM INF COMP SCI, V34, P520, DOI 10.1021/ci00019a008; Hwang DW, 2010, J NUCL MED, V51, P98, DOI 10.2967/jnumed.109.069880; Karelson M, 1996, CHEM REV, V96, P1027, DOI 10.1021/cr950202r; Levine HA, 2007, COMPUT BIOL CHEM, V31, P11, DOI 10.1016/j.compbiolchem.2006.10.002; Li S, 2007, SAR QSAR ENVIRON RES, V18, P423, DOI 10.1080/10629360701428474; Mandloi M, 2000, J CHEM INF COMP SCI, V40, P57, DOI 10.1021/ci980139h; Nikolaus N, 2014, SENSORS-BASEL, V14, P3737, DOI 10.3390/s140203737; Petrova T, 2011, J NANOPART RES, V13, P3235, DOI 10.1007/s11051-011-0238-x; Plewczynski D, 2006, J MOL MODEL, V12, P453, DOI 10.1007/s00894-005-0070-2; Randic M, 2001, J CHEM INF COMP SCI, V41, P607, DOI 10.1021/ci0001031; Reuter JS, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-129; Schutze T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029604; Shangguan DH, 2008, ANAL CHEM, V80, P721, DOI 10.1021/ac701962v; Talete SRL, 2006, DRAGON WIDOWS SOFTWA; Tan WH, 2013, CHEM REV, V113, P2842, DOI 10.1021/cr300468w; Turabekova MA, 2004, MOLECULES, V9, P1194, DOI 10.3390/91201194; Vant-Hull B, 1998, J MOL BIOL, V278, P579, DOI 10.1006/jmbi.1998.1727; Wang B, 2009, QSAR COMB SCI, V28, P561, DOI 10.1002/qsar.200860065; Wilson DS, 1999, ANNU REV BIOCHEM, V68, P611, DOI 10.1146/annurev.biochem.68.1.611; Yomogida K, 2012, CYTOKINE, V58, P431, DOI 10.1016/j.cyto.2012.02.007; Yu XL, 2013, IND ENG CHEM RES, V52, P11182, DOI 10.1021/ie400001u	29	6	6	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99964	10.1371/journal.pone.0099964	http://dx.doi.org/10.1371/journal.pone.0099964			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927174	Green Submitted, gold, Green Published			2022-12-27	WOS:000338278100101
J	Tao, DD; Deng, R; Jiang, Y; Galvin, JJ; Fu, QJ; Chen, B				Tao, Duoduo; Deng, Rui; Jiang, Ye; Galvin, John J., III; Fu, Qian-Jie; Chen, Bing			Contribution of Auditory Working Memory to Speech Understanding in Mandarin-Speaking Cochlear Implant Users	PLOS ONE			English	Article							SHORT-TERM-MEMORY; OF-THE-LITERATURE; CLINICAL EFFECTIVENESS; NORMAL-HEARING; DEAF-CHILDREN; DIGIT SPAN; LANGUAGE; RECOGNITION; PERFORMANCE; VOCABULARY	Purpose: To investigate how auditory working memory relates to speech perception performance by Mandarin-speaking cochlear implant (CI) users. Method: Auditory working memory and speech perception was measured in Mandarin-speaking CI and normal-hearing (NH) participants. Working memory capacity was measured using forward digit span and backward digit span; working memory efficiency was measured using articulation rate. Speech perception was assessed with: (a) word-in-sentence recognition in quiet, (b) word-in-sentence recognition in speech-shaped steady noise at +5 dB signal-to-noise ratio, (c) Chinese disyllable recognition in quiet, (d) Chinese lexical tone recognition in quiet. Self-reported school rank was also collected regarding performance in schoolwork. Results: There was large inter-subject variability in auditory working memory and speech performance for CI participants. Working memory and speech performance were significantly poorer for CI than for NH participants. All three working memory measures were strongly correlated with each other for both CI and NH participants. Partial correlation analyses were performed on the CI data while controlling for demographic variables. Working memory efficiency was significantly correlated only with sentence recognition in quiet when working memory capacity was partialled out. Working memory capacity was correlated with disyllable recognition and school rank when efficiency was partialled out. There was no correlation between working memory and lexical tone recognition in the present CI participants. Conclusions: Mandarin-speaking CI users experience significant deficits in auditory working memory and speech performance compared with NH listeners. The present data suggest that auditory working memory may contribute to CI users' difficulties in speech understanding. The present pattern of results with Mandarin-speaking CI users is consistent with previous auditory working memory studies with English-speaking CI users, suggesting that the lexical importance of voice pitch cues (albeit poorly coded by the CI) did not influence the relationship between working memory and speech perception.	[Tao, Duoduo; Deng, Rui; Jiang, Ye; Fu, Qian-Jie; Chen, Bing] Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Otol & Skull Base Surg, Shanghai 200433, Peoples R China; [Tao, Duoduo; Galvin, John J., III; Fu, Qian-Jie] House Res Inst, Div Commun & Auditory Neurosci, Los Angeles, CA USA; [Galvin, John J., III; Fu, Qian-Jie] Univ Calif Los Angeles, David Geffen Sch Med, Dept Head & Neck Surg, Los Angeles, CA 90095 USA	Fudan University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Chen, B (corresponding author), Fudan Univ, Eye Ear Nose & Throat Hosp, Dept Otol & Skull Base Surg, Shanghai 200433, Peoples R China.	entdtao@gmail.com			Special Fund for Projects of Ministry of Health of China [201202005]; National Nature Science Foundation of China [81371087]; Shanghai Science and Technology Commission Medical Guide Project [134119a1800]; National Institutes of Health (NIH) [R01-DC004993]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004993] Funding Source: NIH RePORTER	Special Fund for Projects of Ministry of Health of China; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Science and Technology Commission Medical Guide Project; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was funded in part by the Special Fund for Projects of Ministry of Health of China (#201202005), the National Nature Science Foundation of China (#81371087), Shanghai Science and Technology Commission Medical Guide Project (#134119a1800), and by National Institutes of Health (NIH) grant R01-DC004993. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams AM, 2000, INT J LANG COMM DIS, V35, P95; Alloway TP, 2006, CHILD DEV, V77, P1698, DOI 10.1111/j.1467-8624.2006.00968.x; Alloway TP, 2009, CHILD DEV, V80, P606, DOI 10.1111/j.1467-8624.2009.01282.x; Andersson U, 2008, BRIT J EDUC PSYCHOL, V78, P181, DOI 10.1348/000709907X209854; Baddeley A, 1998, PSYCHOL REV, V105, P158, DOI 10.1037/0033-295X.105.1.158; Baddeley A, 2003, J COMMUN DISORD, V36, P189, DOI 10.1016/S0021-9924(03)00019-4; Baddeley A, 2010, CURR BIOL, V20, pR136, DOI 10.1016/j.cub.2009.12.014; Berrettini S, 2011, ACTA OTORHINOLARYNGO, V31, P299; Bodmer D, 2007, LARYNGOSCOPE, V117, P1408, DOI 10.1097/MLG.0b013e318068b57e; Bruce I A, 2011, Cochlear Implants Int, V12 Suppl 1, pS82, DOI 10.1179/146701011X13001035752886; Bull R, 2001, DEV NEUROPSYCHOL, V19, P273, DOI 10.1207/S15326942DN1903_3; Burkholder R, 2004, INT CONGR SER, V1273, P312, DOI 10.1016/j.ics.2004.08.030; Caplan D, 2013, PSYCHON B REV, V20, P243, DOI 10.3758/s13423-012-0369-9; Cleary M, 2000, VOLTA REV, V102, P259; Cowan N, 1998, J EXP PSYCHOL GEN, V127, P141, DOI 10.1037/0096-3445.127.2.141; Diller Gottfried, 2010, Cochlear Implants Int, V11 Suppl 1, P286, DOI 10.1179/146701010X12671177989273; Forli F, 2011, ACTA OTORHINOLARYNGO, V31, P281; Friesen LM, 2001, J ACOUST SOC AM, V110, P1150, DOI 10.1121/1.1381538; Fu QJ, 2011, J ACOUST SOC AM, V129, pEL267, DOI 10.1121/1.3590739; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 1997, DEV PSYCHOL, V33, P966, DOI 10.1037/0012-1649.33.6.966; Geers AE, 2013, OTOL NEUROTOL, V34, P396, DOI 10.1097/MAO.0b013e318277a0cb; Gupta P, 1997, BRAIN LANG, V59, P267, DOI 10.1006/brln.1997.1819; Harris MS, 2013, EAR HEARING, V34, P179, DOI 10.1097/AUD.0b013e318269ce50; Kronenberger WG, 2012, J SPEECH LANG HEAR R; Kronenberger WG, 2013, J SPEECH LANG HEAR R, V56, P805, DOI 10.1044/1092-4388(2012/11-0356); Lee CY, 2010, J ACOUST SOC AM, V127, P481, DOI 10.1121/1.3266683; Lenarz M, 2012, LARYNGOSCOPE, V122, P1361, DOI 10.1002/lary.23232; MCGARR NS, 1983, J SPEECH HEAR RES, V26, P451, DOI 10.1044/jshr.2603.451; Niparko JK, 2003, MENT RETARD DEV D R, V9, P267, DOI 10.1002/mrdd.10089; Nittrouer S, 2013, INT J PEDIATR OTORHI, V77, P1886, DOI 10.1016/j.ijporl.2013.09.001; Oba SI, 2013, J REHABIL RES DEV, V50, P99, DOI 10.1682/JRRD.2011.12.0229; Pickering SJ, 2001, MEMORY, V9, P423, DOI 10.1080/09658210143000182; Pisoni David B, 2011, Ear Hear, V32, p60S, DOI 10.1097/AUD.0b013e3181ffd58e; Pisoni DB, 2000, EAR HEARING, V21, P70, DOI 10.1097/00003446-200002000-00010; Pisoni DB, 2003, EAR HEARING, V24, p106S, DOI 10.1097/01.AUD.0000051692.05140.8E; Pisoni DB, 2000, ANN OTO RHINOL LARYN, V109, P92, DOI 10.1177/0003489400109S1240; Santarelli R, 2008, AUDIOL NEURO-OTOL, V13, P257, DOI 10.1159/000115435; Semenov YR, 2012, OTOLARYNG CLIN N AM, V45, P959, DOI 10.1016/j.otc.2012.06.003; Smyth MM, 1996, BRIT J PSYCHOL, V87, P179, DOI 10.1111/j.2044-8295.1996.tb02584.x; Stiles DJ, 2012, J SPEECH LANG HEAR R, V55, P154, DOI 10.1044/1092-4388(2011/11-0021); Wang RH, 1993, STANDARD CHINESE DAT; Watson DR, 2007, AUDIOL NEURO-OTOL, V12, P65, DOI 10.1159/000097793; Zhu MM, 2012, ACTA OTO-LARYNGOL, V132, P855, DOI 10.3109/00016489.2011.653668	44	21	21	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99096	10.1371/journal.pone.0099096	http://dx.doi.org/10.1371/journal.pone.0099096			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24921934	gold, Green Published, Green Submitted			2022-12-27	WOS:000338701300027
J	Hendrickx, A; Pierrot, N; Tasiaux, B; Schakman, O; Kienlen-Campard, P; De Smet, C; Octave, JN				Hendrickx, Aurelie; Pierrot, Nathalie; Tasiaux, Bernadette; Schakman, Olivier; Kienlen-Campard, Pascal; De Smet, Charles; Octave, Jean-Noel			Epigenetic Regulations of Immediate Early Genes Expression Involved in Memory Formation by the Amyloid Precursor Protein of Alzheimer Disease	PLOS ONE			English	Article							MEDIAL PREFRONTAL CORTEX; LONG-TERM POTENTIATION; SYNAPTIC PLASTICITY; HISTONE ACETYLATION; MICE LACKING; C-FOS; TRANSCRIPTION FACTORS; NERVOUS-SYSTEM; SPATIAL MEMORY; INTRACELLULAR DOMAIN	We previously demonstrated that APP epigenetically regulates Egr1 expression both in cultured neurons and in vivo. Since Egr1 is an immediate early gene involved in memory formation, we wondered whether other early genes involved in memory were regulated by APP and we studied molecular mechanisms involved. By comparing prefrontal (PF) cortex from wild type (APP+/+) and APP knockout mice (APP-/-), we observed that APP down regulates expression of four immediate early genes, Egr1, c-Fos, Bdnf and Arc. Down regulation of Egr1, c-Fos and Bdnf transcription resulted from a decreased enrichment of acetylated histone H4 on the corresponding gene promoter. Further characterization of H4 acetylation at Egr1 and c-Fos promoters revealed increased acetylation of H4K5 and H4K12 residues in APP-/- mice. Whereas APP affected Egr1 promoter activity by reducing access of the CREB transcription factor, its effect on c-Fos appeared to depend on increased recruitment of HDAC2 histone deacetylase to the gene promoter. The physiological relevance of the epigenetic regulation of Egr1 and c-Fos gene transcription by APP was further analyzed following exposure of mice to novelty. Although transcription of Egr1 and c-Fos was increased following exposure of APP+/+ mice to novelty, such an induction was not possible in APP2/2 mice with a high basal level of expression of these immediate early genes. Altogether, these results demonstrate that APP-mediated regulation of c-Fos and Egr1 by different epigenetic mechanisms is needed for their induction during exposure to novelty.	[Hendrickx, Aurelie; Pierrot, Nathalie; Tasiaux, Bernadette; Schakman, Olivier; Kienlen-Campard, Pascal; Octave, Jean-Noel] Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium; [De Smet, Charles] Catholic Univ Louvain, de Duve Inst, B-1200 Brussels, Belgium	Universite Catholique Louvain; Universite Catholique Louvain	Octave, JN (corresponding author), Catholic Univ Louvain, Inst Neurosci IoNS, B-1200 Brussels, Belgium.	jean-noel.octave@uclouvain.be		Kienlen-Campard, Pascal/0000-0003-1086-2942	FRIA of the Belgian Fonds pour la Recherche Scientifique (FNRS-FRS); Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy; Belgian Fonds de la Recherche Scientifique Medicale; Fondation pour la Recherche sur la Maladie d'Alzheimer (SAOFRA); Programme d'excellence Marshall Diane convention	FRIA of the Belgian Fonds pour la Recherche Scientifique (FNRS-FRS)(Fonds de la Recherche Scientifique - FNRS); Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy(Belgian Federal Science Policy Office); Belgian Fonds de la Recherche Scientifique Medicale(Fonds de la Recherche Scientifique - FNRS); Fondation pour la Recherche sur la Maladie d'Alzheimer (SAOFRA); Programme d'excellence Marshall Diane convention	This work was supported by FRIA funding of the Belgian Fonds pour la Recherche Scientifique (FNRS-FRS), by Interuniversity Attraction Poles Programme-Belgian State-Belgian Science Policy, The Belgian Fonds de la Recherche Scientifique Medicale, the Fondation pour la Recherche sur la Maladie d'Alzheimer (SAOFRA) and the Programme d'excellence Marshall Diane convention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Aydin D, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-160; Baek SH, 2002, CELL, V110, P55, DOI 10.1016/S0092-8674(02)00809-7; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Belyaev ND, 2009, EMBO REP, V10, P94, DOI 10.1038/embor.2008.222; Bertaina-Anglade V, 2000, EUR J NEUROSCI, V12, P3803, DOI 10.1046/j.1460-9568.2000.00258.x; Bousiges O, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057816; Bousiges O, 2010, NEUROPSYCHOPHARMACOL, V35, P2521, DOI 10.1038/npp.2010.117; Bozon B, 2002, HIPPOCAMPUS, V12, P570, DOI 10.1002/hipo.10100; Cao XW, 2001, SCIENCE, V293, P115, DOI 10.1126/science.1058783; Cortes-Mendoza J, 2013, INT J DEV NEUROSCI, V31, P359, DOI 10.1016/j.ijdevneu.2013.04.003; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; DeVito LM, 2010, LEARN MEMORY, V17, P161, DOI 10.1101/lm.1685710; Dias R, 2002, BEHAV NEUROSCI, V116, P498, DOI 10.1037//0735-7044.116.3.498; Dickey CA, 2004, J NEUROCHEM, V88, P434, DOI 10.1046/j.1471-4159.2003.02185.x; Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631; Fleischmann A, 2003, J NEUROSCI, V23, P9116; Francis YI, 2009, J ALZHEIMERS DIS, V18, P131, DOI 10.3233/JAD-2009-1134; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guzowski JF, 2002, HIPPOCAMPUS, V12, P86, DOI 10.1002/hipo.10010; Hall J, 2000, NAT NEUROSCI, V3, P533, DOI 10.1038/75698; Hebert SS, 2006, EMBO REP, V7, P739, DOI 10.1038/sj.embor.7400704; Hendrickx A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074305; Herdegen T, 1998, BRAIN RES REV, V28, P370, DOI 10.1016/S0165-0173(98)00018-6; HUNT SP, 1987, NATURE, V328, P632, DOI 10.1038/328632a0; Jones MW, 2001, NAT NEUROSCI, V4, P289, DOI 10.1038/85138; Kim HS, 2003, FASEB J, V17, P1951, DOI 10.1096/fj.03-0106fje; Koppel I, 2013, NEUROPHARMACOLOGY, V75, P106, DOI 10.1016/j.neuropharm.2013.07.015; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kovacs KJ, 2008, J NEUROENDOCRINOL, V20, P665, DOI 10.1111/j.1365-2826.2008.01734.x; Kuo MH, 1998, BIOESSAYS, V20, P615, DOI 10.1002/(SICI)1521-1878(199808)20:8<615::AID-BIES4>3.0.CO;2-H; Levenson JM, 2004, J BIOL CHEM, V279, P40545, DOI 10.1074/jbc.M402229200; Lonze BE, 2002, NEURON, V35, P605, DOI 10.1016/S0896-6273(02)00828-0; Lubin FD, 2011, NEUROSCIENTIST, V17, P616, DOI 10.1177/1073858411386967; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Pardossi-Piquard R, 2005, NEURON, V46, P541, DOI 10.1016/j.neuron.2005.04.008; Peixoto L, 2013, NEUROPSYCHOPHARMACOL, V38, P62, DOI 10.1038/npp.2012.86; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Pruunsild P, 2007, GENOMICS, V90, P397, DOI 10.1016/j.ygeno.2007.05.004; Renaudineau S, 2009, P NATL ACAD SCI USA, V106, P11771, DOI 10.1073/pnas.0900484106; Reul JMHM, 2014, FRONT PSYCHIATRY, V5, DOI [10.3389/fpsyt.2014.00005, 10.3389/fpsyt.2004.0005]; Riccio A, 2010, NAT NEUROSCI, V13, P1330, DOI 10.1038/nn.2671; Rinaldi A, 2010, NEUROBIOL LEARN MEM, V94, P373, DOI 10.1016/j.nlm.2010.08.004; Rowe A, 2008, NEOPLASIA, V10, P1421, DOI 10.1593/neo.08850; RUSAK B, 1990, SCIENCE, V248, P1237, DOI 10.1126/science.2112267; Russell DL, 2003, MOL ENDOCRINOL, V17, P520, DOI 10.1210/me.2002-0066; Ryan KA, 2005, J CELL BIOL, V171, P327, DOI 10.1083/jcb.200505078; SASSONECORSI P, 1988, GENE DEV, V2, P1529, DOI 10.1101/gad.2.12a.1529; Seabrook GR, 1999, NEUROPHARMACOLOGY, V38, P349, DOI 10.1016/S0028-3908(98)00204-4; Shepherd JD, 2011, NAT NEUROSCI, V14, P279, DOI 10.1038/nn.2708; Steward O, 1998, NEURON, V21, P741, DOI 10.1016/S0896-6273(00)80591-7; Taylor CJ, 2008, NEUROBIOL DIS, V31, P250, DOI 10.1016/j.nbd.2008.04.011; Vazdarjanova A, 2006, J COMP NEUROL, V498, P317, DOI 10.1002/cne.21003; Veyrac A, 2013, P NATL ACAD SCI USA, V110, P7062, DOI 10.1073/pnas.1220558110; Yochiy A, 2012, BEHAV NEUROSCI, V126, P826, DOI 10.1037/a0030721	56	46	48	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99467	10.1371/journal.pone.0099467	http://dx.doi.org/10.1371/journal.pone.0099467			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919190	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000088
J	Labrecque, MP; Takhar, MK; Jagdeo, JM; Tam, KJ; Chiu, C; Wang, TY; Prefontaine, GG; Cox, ME; Beischlag, TV				Labrecque, Mark P.; Takhar, Mandeep K.; Jagdeo, Julienne M.; Tam, Kevin J.; Chiu, Christina; Wang, Te-Yu; Prefontaine, Gratien G.; Cox, Michael E.; Beischlag, Timothy V.			A TRIP230-Retinoblastoma Protein Complex Regulates Hypoxia-Inducible Factor-1 alpha-Mediated Transcription and Cancer Cell Invasion	PLOS ONE			English	Article							ARYL-HYDROCARBON RECEPTOR; NUCLEAR TRANSLOCATOR ARNT; THYROID-HORMONE RECEPTOR; BREAST-CANCER; RETINOBLASTOMA PROTEIN; EXPRESSION; GENE; FAMILY; RECRUITMENT; CARCINOMA	Localized hypoxia in solid tumors activates transcriptional programs that promote the metastatic transformation of cells. Like hypoxia-inducible hyper-vascularization, loss of the retinoblastoma protein (Rb) is a trait common to advanced stages of tumor progression in many metastatic cancers. However, no link between the role of Rb and hypoxia-driven metastatic processes has been established. We demonstrated that Rb is a key mediator of the hypoxic response mediated by HIF1 alpha/beta, the master regulator of the hypoxia response, and its essential co-activator, the thyroid hormone receptor/retinoblastomainteracting protein (TRIP230). Furthermore, loss of Rb unmasks the full co-activation potential of TRIP230. Using small inhibitory RNA approaches in vivo, we established that Rb attenuates the normal physiological response to hypoxia by HIF1 alpha. Notably, loss of Rb results in hypoxia-dependent biochemical changes that promote acquisition of an invasive phenotype in MCF7 breast cancer cells. In addition, Rb is present in HIF1 alpha-ARNT/HIF1b transcriptional complexes associated with TRIP230 as determined by co-immuno-precipitation, GST-pull-down and ChIP assays. These results demonstrate that Rb is a negative modulator of hypoxia-regulated transcription by virtue of its direct effects on the HIF1 complex. This work represents the first link between the functional ablation of Rb in tumor cells and HIF1 alpha-dependent transcriptional activation and invasion.	[Labrecque, Mark P.; Takhar, Mandeep K.; Jagdeo, Julienne M.; Tam, Kevin J.; Chiu, Christina; Wang, Te-Yu; Prefontaine, Gratien G.; Beischlag, Timothy V.] Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada; [Cox, Michael E.] Univ British Columbia, Vancouver Prostate Ctr, Dept Urol Sci, Vancouver, BC V5Z 1M9, Canada	Simon Fraser University; University of British Columbia	Beischlag, TV (corresponding author), Simon Fraser Univ, Fac Hlth Sci, Burnaby, BC V5A 1S6, Canada.	tvb@sfu.ca	Labrecque, Mark/GPP-4575-2022	Labrecque, Mark/0000-0001-7887-7599	Canadian Breast Cancer Foundation BC/Yukon; Natural Sciences and Engineering Research Council of Canada [RGPIN 356355]	Canadian Breast Cancer Foundation BC/Yukon; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by operating grants from the Canadian Breast Cancer Foundation BC/Yukon (http://www.cbcf.org/bc/Pages/default.aspx) and the Natural Sciences and Engineering Research Council, RGPIN 356355 (http://www.nserc-crsng.gc.ca/index_eng.asp) of Canada to TVB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Bachelder RE, 2002, CANCER RES, V62, P7203; Beischlag TV, 2005, J BIOL CHEM, V280, P21607, DOI 10.1074/jbc.C500090200; Beischlag TV, 2004, J BIOL CHEM, V279, P54620, DOI 10.1074/jbc.M410456200; Beischlag TV, 2002, MOL CELL BIOL, V22, P4319, DOI 10.1128/MCB.22.12.4319-4333.2002; BOOKSTEIN R, 1990, P NATL ACAD SCI USA, V87, P7762, DOI 10.1073/pnas.87.19.7762; Brat DJ, 2002, ADV ANAT PATHOL, V9, P24, DOI 10.1097/00125480-200201000-00004; Chang KH, 1997, P NATL ACAD SCI USA, V94, P9040, DOI 10.1073/pnas.94.17.9040; Chen YH, 2006, J BIOL CHEM, V281, P12242, DOI 10.1074/jbc.M512537200; Chen YM, 1999, P NATL ACAD SCI USA, V96, P4443, DOI 10.1073/pnas.96.8.4443; Dick FA, 2013, NAT REV MOL CELL BIO, V14, P297, DOI 10.1038/nrm3567; Du W, 2006, ONCOGENE, V25, P5190, DOI 10.1038/sj.onc.1209651; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; Eisinger-Mathason TSK, 2010, CANCER CELL, V18, P3, DOI 10.1016/j.ccr.2010.06.007; Elferink CJ, 2001, MOL PHARMACOL, V59, P664, DOI 10.1124/mol.59.4.664; FRIEND SH, 1986, NATURE, V323, P643, DOI 10.1038/323643a0; Gilkes DM, 2013, CANCER RES, V73, P3285, DOI 10.1158/0008-5472.CAN-12-3963; Gilkes DM, 2013, MOL CANCER RES, V11, P456, DOI 10.1158/1541-7786.MCR-12-0629; Gilkes DM, 2013, J BIOL CHEM, V288, P10819, DOI 10.1074/jbc.M112.442939; Gordan JD, 2008, CANCER CELL, V14, P435, DOI 10.1016/j.ccr.2008.10.016; Grandinetti KB, 2008, CELL CYCLE, V7, P1550, DOI 10.4161/cc.7.11.6052; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Hirota K, 2006, CRIT REV ONCOL HEMAT, V59, P15, DOI 10.1016/j.critrevonc.2005.12.003; Honey K, 2009, J CLIN INVEST, V119, P1400, DOI 10.1172/JCI39834; Imai T, 2003, AM J PATHOL, V163, P1437, DOI 10.1016/S0002-9440(10)63501-8; Jeon HW, 2010, MOL CANCER THER, V9, P1361, DOI 10.1158/1535-7163.MCT-09-0717; Jung SY, 2005, MOL ENDOCRINOL, V19, P2451, DOI 10.1210/me.2004-0476; Kato H, 2004, J BIOL CHEM, V279, P41966, DOI 10.1074/jbc.M406320200; Labrecque MP, 2013, CURR MOL MED, V13, P1047; Labrecque MP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029545; Lai A, 2001, MOL CELL BIOL, V21, P2918, DOI 10.1128/MCB.21.8.2918-2932.2001; Laj A, 1999, MOL CELL BIOL, V19, P6632; LANGER R, 1980, P NATL ACAD SCI-BIOL, V77, P4331, DOI 10.1073/pnas.77.7.4331; Lee JH, 2009, MOL CANCER RES, V7, P1663, DOI 10.1158/1541-7786.MCR-09-0191; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; NISHIKAWA R, 1995, CANCER RES, V55, P1941; Partch CL, 2009, J BIOL CHEM, V284, P15184, DOI 10.1074/jbc.M808479200; Prefontaine GG, 1998, MOL CELL BIOL, V18, P3416, DOI 10.1128/MCB.18.6.3416; Qi JF, 2010, CANCER CELL, V18, P23, DOI 10.1016/j.ccr.2010.05.024; Qian DZ, 2006, CANCER RES, V66, P8814, DOI 10.1158/0008-5472.CAN-05-4598; Rubin SM, 2013, TRENDS BIOCHEM SCI, V38, P12, DOI 10.1016/j.tibs.2012.10.007; Scambia G, 2006, ONCOGENE, V25, P5302, DOI 10.1038/sj.onc.1209620; SCHMIDT EE, 1994, CANCER RES, V54, P6321; Sharma A, 2010, J CLIN INVEST, V120, P4478, DOI 10.1172/JCI44239; Simin K, 2004, PLOS BIOL, V2, P194, DOI 10.1371/journal.pbio.0020022; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Staller P, 2003, NATURE, V425, P307, DOI 10.1038/nature01874; Sun XQ, 2010, CANCER METAST REV, V29, P709, DOI 10.1007/s10555-010-9256-x; Traina TA, 2009, ONCOLOGY-NY, V23, P327; Tricoli JV, 1996, GENE CHROMOSOME CANC, V15, P108, DOI 10.1002/(SICI)1098-2264(199602)15:2<108::AID-GCC5>3.0.CO;2-7; Wang F, 2004, J BIOL CHEM, V279, P46733, DOI 10.1074/jbc.M409002200; Yokota J, 2003, CLIN EXP METASTAS, V20, P189, DOI 10.1023/A:1022978932215; Zia MK, 2007, INT J MOL MED, V20, P605	53	8	8	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99214	10.1371/journal.pone.0099214	http://dx.doi.org/10.1371/journal.pone.0099214			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919196	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000058
J	Hu, M; Liang, HL				Hu, Meng; Liang, Hualou			Search for Information-Bearing Components in Neural Data	PLOS ONE			English	Article							EMPIRICAL MODE DECOMPOSITION; NOISE	Multivariate empirical mode decomposition (MEMD) is an important extension of EMD, suitable for processing multichannel data. It can adaptively decompose multivariate data into a set of intrinsic mode functions (IMFs) that are matched both in number and in frequency scale. This method is thus holds great potential for the analysis of multi-channel neural recordings as it is capable of ensuring all the intrinsic oscillatory modes are aligned not only across channels, but also across trials. Given a plethora of IMFs derived by MEMD, a question of significant interest is how to identify which IMFs contain information, and which IMFs are noise. Existing methods that exploit the dyadic filter bank structure of white noise decomposition are insufficient since the IMFs do not always adhere to the presumed dyadic relationship. Here we propose a statistical procedure to identify information-bearing IMFs, which is built upon MEMD that allows adding noise as separate channels to serve as a reference to facilitate IMF identification. In this procedure, Wasserstein distance is used to measure the similarity between the reference IMF and that from data. Simulations are performed to validate the method. Local field potentials from cortex of monkeys while performing visual tasks are used for demonstration.	[Hu, Meng; Liang, Hualou] Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA	Drexel University	Liang, HL (corresponding author), Drexel Univ, Sch Biomed Engn Sci & Hlth Syst, Philadelphia, PA 19104 USA.	hualou.liang@drexel.edu						Bin Altaf MU, 2007, INT CONF ACOUST SPEE, P1009; Chen M, 2007, P IEEE WORKSH MACH L, P223; Cichocki A., 2012, ADAPTIVE BLIND SIGNA, DOI DOI 10.1002/0470845899; Dudley R. M., 2002, REAL ANAL PROBABILIT, V74; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Flandrin P, 2004, IEEE SIGNAL PROC LET, V11, P112, DOI 10.1109/LSP.2003.821662; Flandrin P, 2005, INTERD MATH SCI, V5, P57; Gibbs AL, 2002, INT STAT REV, V70, P419, DOI 10.2307/1403865; Hu M, 2011, COGN NEURODYNAMICS, V5, P277, DOI 10.1007/s11571-011-9159-8; Huang NE, 1998, P ROY SOC A-MATH PHY, V454, P903, DOI 10.1098/rspa.1998.0193; Liang H, 2000, MED BIOL ENG COMPUT, V38, P35, DOI 10.1007/BF02344686; Liang HL, 2005, BIOL CYBERN, V92, P380, DOI 10.1007/s00422-005-0566-y; MANDELBROT BB, 1968, SIAM REV, V10, P422, DOI 10.1137/1010093; Nalatore H, 2009, J NEUROSCI METH, V179, P131, DOI 10.1016/j.jneumeth.2009.01.013; Ni K, 2009, INT J COMPUT VISION, V84, P97, DOI 10.1007/s11263-009-0234-0; Rehman N, 2010, P ROY SOC A-MATH PHY, V466, P1291, DOI 10.1098/rspa.2009.0502; Rehman NU, 2013, ADV DATA SCI ADAPT, V5, DOI 10.1142/S1793536913500076; Rehman NU, 2011, IEEE T SIGNAL PROCES, V59, P2421, DOI 10.1109/TSP.2011.2106779; Rehman NU, 2009, INT CONF ACOUST SPEE, P3449, DOI 10.1109/ICASSP.2009.4960367; Rilling G, 2007, IEEE SIGNAL PROC LET, V14, P936, DOI 10.1109/LSP.2007.904710; Rubner Y, 2000, INT J COMPUT VISION, V40, P99, DOI 10.1023/A:1026543900054; Sweeney-Reed CM, 2007, J COMPUT NEUROSCI, V23, P79, DOI 10.1007/s10827-007-0020-3; Tanaka T, 2007, IEEE SIGNAL PROC LET, V14, P101, DOI 10.1109/LSP.2006.882107; ur Rehman N, 2010, IEEE T SIGNAL PROCES, V58, P1059, DOI 10.1109/TSP.2009.2033730; WIESENFELD K, 1995, NATURE, V373, P33, DOI 10.1038/373033a0; Wilke M, 2006, P NATL ACAD SCI USA, V103, P17507, DOI 10.1073/pnas.0604673103; Wu ZH, 2004, P ROY SOC A-MATH PHY, V460, P1597, DOI 10.1098/rspa.2003.1221; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P339, DOI 10.1142/S1793536909000187; Wu ZH, 2009, ADV DATA SCI ADAPT, V1, P1, DOI 10.1142/S1793536909000047	29	12	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99793	10.1371/journal.pone.0099793	http://dx.doi.org/10.1371/journal.pone.0099793			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932596	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600065
J	Lopez-Sanchez, LM; Jimenez, C; Valverde, A; Hernandez, V; Penarando, J; Martinez, A; Lopez-Pedrera, C; Munoz-Castaneda, JR; De la Haba-Rodriguez, JR; Aranda, E; Rodriguez-Ariza, A				Lopez-Sanchez, Laura M.; Jimenez, Carla; Valverde, Araceli; Hernandez, Vanessa; Penarando, Jon; Martinez, Antonio; Lopez-Pedrera, Chary; Munoz-Castaneda, Juan R.; De la Haba-Rodriguez, Juan R.; Aranda, Enrique; Rodriguez-Ariza, Antonio			CoCl2, a Mimic of Hypoxia, Induces Formation of Polyploid Giant Cells with Stem Characteristics in Colon Cancer	PLOS ONE			English	Article							SELF-RENEWAL; OXYGEN; CYCLE; MAINTENANCE; HIF-1-ALPHA; SENESCENCE; CHALLENGES; RESISTANCE; EXPANSION; DIVISION	The induction of polyploidy is considered the reproductive end of cells, but there is evidence that polyploid giant cancer cells (PGCCs) contribute to cell repopulation during tumor relapse. However, the role of these cells in the development, progression and response to therapy in colon cancer remains undefined. Therefore, the main objective of this study was to investigate the generation of PGCCs in colon cancer cells and identify mechanisms of formation. Treatment of HCT-116 and Caco-2 colon cancer cells with the hypoxia mimic CoCl2 induced the formation of cells with larger cell and nuclear size (PGCCs), while the cells with normal morphology were selectively eliminated. Cytometric analysis showed that CoCl2 treatment induced G2 cell cycle arrest and the generation of a polyploid cell subpopulation with increased cellular DNA content. Polyploidy of hypoxia-induced PGCCs was confirmed by FISH analysis. Furthermore, CoCl2 treatment effectively induced the stabilization of HIF-1 alpha, the differential expression of a truncated form of p53 (p47) and decreased levels of cyclin D1, indicating molecular mechanisms associated with cell cycle arrest at G2. Generation of PGCCs also contributed to expansion of a cell subpopulation with cancer stem cells (CSCs) characteristics, as indicated by colonosphere formation assays, and enhanced chemoresistance to 5-fluorouracil and oxaliplatin. In conclusion, the pharmacological induction of hypoxia in colon cancer cells causes the formation of PGCCs, the expansion of a cell subpopulation with CSC characteristics and chemoresistance. The molecular mechanisms involved, including the stabilization of HIF-1 alpha, the involvement of p53/p47 isoform and cell cycle arrest at G2, suggest novel targets to prevent tumor relapse and treatment failure in colon cancer.	[Lopez-Sanchez, Laura M.; Jimenez, Carla; Valverde, Araceli; Hernandez, Vanessa; Penarando, Jon; Martinez, Antonio; De la Haba-Rodriguez, Juan R.; Aranda, Enrique; Rodriguez-Ariza, Antonio] Univ Cordoba, Reina Sofia Hosp, Dept Oncol, Maimonides Inst Biomed Res IMIBIC, Cordoba, Spain; [Lopez-Sanchez, Laura M.; Jimenez, Carla; Valverde, Araceli; Hernandez, Vanessa; Penarando, Jon; Martinez, Antonio; De la Haba-Rodriguez, Juan R.; Aranda, Enrique; Rodriguez-Ariza, Antonio] Inst Salud Carlos III, Spanish Canc Network RTICC, Madrid, Spain; [Lopez-Pedrera, Chary; Munoz-Castaneda, Juan R.] Univ Cordoba, Reina Sofia Hosp, Res Unit, Maimonides Inst Biomed Res IMIBIC, Cordoba, Spain	Universidad de Cordoba; Instituto de Salud Carlos III; Universidad de Cordoba	Rodriguez-Ariza, A (corresponding author), Univ Cordoba, Reina Sofia Hosp, Dept Oncol, Maimonides Inst Biomed Res IMIBIC, Cordoba, Spain.	antonio.rodriguez.exts@juntadeandalucia.es	Peñarando, Jon/AAB-2890-2021; Lopez-Pedrera, Chary/M-4603-2015; Rodriguez-Ariza, Antonio/U-4854-2017; López-Sánchez, Laura María/E-3260-2018; Aranda, Enrique/AAA-4147-2019; Muñoz-Castañeda, Juan R./AFQ-3443-2022	Lopez-Pedrera, Chary/0000-0003-2067-4603; Rodriguez-Ariza, Antonio/0000-0001-5304-5745; López-Sánchez, Laura María/0000-0002-0763-1804; Haba Rodriguez, Juan Rafael de la/0000-0001-5111-1702; Munoz-Castaneda, Juan R/0000-0002-9341-0724	Programa de Promocion de la Investigacion en Salud del Ministerio de Economia y Competitividad, Instituto de Salud Carlos III [PI10/00428, PI13/00553]	Programa de Promocion de la Investigacion en Salud del Ministerio de Economia y Competitividad, Instituto de Salud Carlos III	Supported by grants to A.R.-A. from Programa de Promocion de la Investigacion en Salud del Ministerio de Economia y Competitividad, Instituto de Salud Carlos III (PI10/00428 and PI13/00553) (http://www.isciii.es/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccelli I, 2012, J CELL BIOL, V198, P281, DOI 10.1083/jcb.201202014; Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Bertout JA, 2008, NAT REV CANCER, V8, P967, DOI 10.1038/nrc2540; Bourougaa K, 2010, MOL CELL, V38, P78, DOI 10.1016/j.molcel.2010.01.041; Brenner H, 2012, INT J CANCER, V131, P1649, DOI 10.1002/ijc.26192; Chaffer CL, 2013, CELL, V154, P61, DOI 10.1016/j.cell.2013.06.005; Conley SJ, 2012, P NATL ACAD SCI USA, V109, P2784, DOI 10.1073/pnas.1018866109; Erenpreisa J, 2007, CELL BIOL INT, V31, P1507, DOI 10.1016/j.cellbi.2007.08.013; Erenpreisa J, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-92; Ferlay J, 2013, EUR J CANCER, V49, P1374, DOI 10.1016/j.ejca.2012.12.027; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Fox DT, 2013, DEVELOPMENT, V140, P3, DOI 10.1242/dev.080531; Gilbertson RJ, 2007, NAT REV CANCER, V7, P733, DOI 10.1038/nrc2246; Hashimoto O, 2011, PATHOBIOLOGY, V78, P181, DOI 10.1159/000325538; Ho VT, 1996, BIOCHEM BIOPH RES CO, V223, P175, DOI 10.1006/bbrc.1996.0865; Kanwar SS, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-212; KASTAN MB, 1991, CANCER RES, V51, P6304; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Konopleva MY, 2011, J CLIN ONCOL, V29, P591, DOI 10.1200/JCO.2010.31.0904; Koumenis C, 2006, CURR MOL MED, V6, P55, DOI 10.2174/156652406775574604; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Lu J, 2013, CANCER CELL, V23, P171, DOI 10.1016/j.ccr.2012.12.021; Marusyk A, 2012, NAT REV CANCER, V12, P323, DOI 10.1038/nrc3261; Medema JP, 2013, NAT CELL BIOL, V15, P338, DOI 10.1038/ncb2717; Merlos-Suarez A, 2011, CELL STEM CELL, V8, P511, DOI 10.1016/j.stem.2011.02.020; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Puig PE, 2008, CELL BIOL INT, V32, P1031, DOI 10.1016/j.cellbi.2008.04.021; Rajaraman R, 2006, CANCER CELL INT, V6, DOI 10.1186/1475-2867-6-25; Ravizza R, 2009, EUR J CANCER, V45, P890, DOI 10.1016/j.ejca.2008.12.021; Roberts DL, 2009, BRIT J CANCER, V101, P1290, DOI 10.1038/sj.bjc.6605311; Sandau KB, 2001, BLOOD, V97, P1009, DOI 10.1182/blood.V97.4.1009; Soeda A, 2009, ONCOGENE, V28, P3949, DOI 10.1038/onc.2009.252; Stacey DW, 2003, CURR OPIN CELL BIOL, V15, P158, DOI 10.1016/S0955-0674(03)00008-5; Sundaram M, 2004, CANCER BIOL THER, V3, P207, DOI 10.4161/cbt.3.2.663; Thiery JP, 2013, CANCER CELL, V23, P272, DOI 10.1016/j.ccr.2013.03.004; Vermeulen L, 2012, LANCET ONCOL, V13, pE83, DOI 10.1016/S1470-2045(11)70257-1; Visvader JE, 2012, CELL STEM CELL, V10, P717, DOI 10.1016/j.stem.2012.05.007; Walmsley SR, 2008, AM J RESP CELL MOL, V38, P251, DOI 10.1165/rcmb.2007-0331TR; Wheatley D, 2008, CELL BIOL INT, V32, P1029, DOI 10.1016/j.cellbi.2008.06.001; Yeung TM, 2011, P NATL ACAD SCI USA, V108, P4382, DOI 10.1073/pnas.1014519107; Zhang HJ, 2012, BLOOD, V119, P2595, DOI 10.1182/blood-2011-10-387381; Zhang S, 2013, ONCOGENE	42	84	85	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99143	10.1371/journal.pone.0099143	http://dx.doi.org/10.1371/journal.pone.0099143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932611	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600022
J	Tasca, G; Monforte, M; Iannaccone, E; Laschena, F; Ottaviani, P; Leoncini, E; Boccia, S; Galluzzi, G; Pelliccioni, M; Masciullo, M; Frusciante, R; Mercuri, E; Ricci, E				Tasca, Giorgio; Monforte, Mauro; Iannaccone, Elisabetta; Laschena, Francesco; Ottaviani, Pierfrancesco; Leoncini, Emanuele; Boccia, Stefania; Galluzzi, Giuliana; Pelliccioni, Marco; Masciullo, Marcella; Frusciante, Roberto; Mercuri, Eugenio; Ricci, Enzo			Upper Girdle Imaging in Facioscapulohumeral Muscular Dystrophy	PLOS ONE			English	Article							ONSET POMPE DISEASE; BODY MUSCLE MRI; MOLECULAR DIAGNOSIS; INVOLVEMENT; PHENOTYPE; CARRIERS	Background: In Facioscapulohumeral muscular dystrophy (FSHD), the upper girdle is early involved and often difficult to assess only relying on physical examination. Our aim was to evaluate the pattern and degree of involvement of upper girdle muscles in FSHD compared with other muscle diseases with scapular girdle impairment. Methods: We propose an MRI protocol evaluating neck and upper girdle muscles. One hundred-eight consecutive symptomatic FSHD patients and 45 patients affected by muscular dystrophies and myopathies with prominent upper girdle involvement underwent this protocol. Acquired scans were retrospectively analyzed. Results: The trapezius (100% of the patients) and serratus anterior (85% of the patients) were the most and earliest affected muscles in FSHD, followed by the latissimus dorsi and pectoralis major, whilst spinati and subscapularis (involved in less than 4% of the patients) were consistently spared even in late disease stages. Asymmetry and hyperintensities on short-tau inversion recovery (STIR) sequences were common features, and STIR hyperintensities could also be found in muscles not showing signs of fatty replacement. The overall involvement appears to be disease-specific in FSHD as it significantly differed from that encountered in the other myopathies. Conclusions: The detailed knowledge of single muscle involvement provides useful information for correctly evaluating patients' motor function and to set a baseline for natural history studies. Upper girdle imaging can also be used as an additional tool helpful in supporting the diagnosis of FSHD in unclear situations, and may contribute with hints on the currently largely unknown molecular pathogenesis of this disease.	[Tasca, Giorgio] Don Carlo Gnocchi Onlus Fdn, Milan, Italy; [Monforte, Mauro; Iannaccone, Elisabetta; Ricci, Enzo] Univ Cattolica Sacro Cuore, Sch Med, Inst Neurol, I-00168 Rome, Italy; [Laschena, Francesco; Ottaviani, Pierfrancesco] IRCCS, Ist Dermopat Immacolata, Dept Radiol, Rome, Italy; [Leoncini, Emanuele; Boccia, Stefania] Univ Cattolica Sacro Cuore, Sch Med, Dept Publ Hlth, Inst Hyg, I-00168 Rome, Italy; [Galluzzi, Giuliana] CNR, Cellular Biol & Neurobiol Inst, Rome, Italy; [Pelliccioni, Marco] Unione Italiana Lotta Distrofia Muscolare UILDM R, Rome, Italy; [Masciullo, Marcella] IRCCS Santa Lucia Fdn, Rome, Italy; [Frusciante, Roberto] Univ Cattolica Sacro Cuore, Sch Med, Columbus Hosp, Neurophysiopathol Unit, I-00168 Rome, Italy; [Mercuri, Eugenio] Univ Cattolica Sacro Cuore, Sch Med, Pediat Neurol Unit, I-00168 Rome, Italy	IRCCS Fondazione Don Carlo Gnocchi Onlus; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; IRCCS Istituto Dermopatico dell'Immacolata (IDI); Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Consiglio Nazionale delle Ricerche (CNR); IRCCS Santa Lucia; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Ricci, E (corresponding author), Univ Cattolica Sacro Cuore, Sch Med, Inst Neurol, I-00168 Rome, Italy.	ericci@rm.unicatt.it	Monforte, Mauro/AAS-7120-2021; Tasca, Giorgio/J-5153-2018; Monforte, Mauro/J-2918-2018; Boccia, Stefania/AFN-1666-2022; Masciullo, Marcella/J-9144-2016; Ricci, Enzo/AAC-4448-2020; Boccia, Stefania/AAB-9533-2022; , emanuele/A-5466-2010; Mercuri, Eugenio/G-1351-2015	Monforte, Mauro/0000-0002-4327-6969; Tasca, Giorgio/0000-0003-0849-9144; Monforte, Mauro/0000-0002-4327-6969; Boccia, Stefania/0000-0002-1864-749X; Masciullo, Marcella/0000-0003-1368-7692; Boccia, Stefania/0000-0002-1864-749X; , emanuele/0000-0002-7669-8535; Mercuri, Eugenio/0000-0002-9851-5365; RICCI, Enzo/0000-0003-3092-3597	Don Carlo Gnocchi Onlus Foundation (Ricerca Corrente); Telethon Foundation [GUP11009M]	Don Carlo Gnocchi Onlus Foundation (Ricerca Corrente); Telethon Foundation(Fondazione Telethon)	This study was supported in part by fundings from Don Carlo Gnocchi Onlus Foundation (Ricerca Corrente 2012) to GT and Telethon Foundation (Grant GUP11009M) to ER. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alejaldre A, 2012, NEUROMUSCULAR DISORD, V22, pS148, DOI 10.1016/j.nmd.2012.05.011; BROUWER OF, 1992, BRAIN, V115, P1587, DOI 10.1093/brain/115.5.1587; Carlier RY, 2011, NEUROMUSCULAR DISORD, V21, P791, DOI 10.1016/j.nmd.2011.06.748; Cartier PG, 2012, NEUROMUSCULAR DISORD, V22, pS41, DOI 10.1016/j.nmd.2012.08.001; Esposito A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059308; Felice KJ, 1997, MUSCLE NERVE, V20, P1194, DOI 10.1002/(SICI)1097-4598(199709)20:9<1194::AID-MUS19>3.0.CO;2-T; Friedman SD, 2014, MUSCLE NERVE, V49, P257, DOI 10.1002/mus.23911; Friedman SD, 2012, MUSCLE NERVE, V45, P500, DOI 10.1002/mus.22342; Frisullo G, 2011, J CLIN IMMUNOL, V31, P155, DOI 10.1007/s10875-010-9474-6; Geng LN, 2012, DEV CELL, V22, P38, DOI 10.1016/j.devcel.2011.11.013; Janssen BH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085416; Jarraya M, 2012, NEUROMUSCULAR DISORD, V22, pS137, DOI 10.1016/j.nmd.2012.06.347; Kan HE, 2009, NEUROMUSCULAR DISORD, V19, P357, DOI 10.1016/j.nmd.2009.02.009; Kesper K, 2009, ACTA NEUROL SCAND, V120, P111, DOI 10.1111/j.1600-0404.2008.01129.x; Landouzy L, 1885, REV MED, V5, P81; Leidenroth A, 2012, EUR J HUM GENET, V20, P999, DOI 10.1038/ejhg.2012.42; Lemmers Richard J L F, 2012, Neuromuscul Disord, V22, P463, DOI 10.1016/j.nmd.2011.09.004; Lemmers RJLF, 2010, SCIENCE, V329, P1650, DOI 10.1126/science.1189044; Martin RM, 2008, CURR REV MUSCULOSKE, V1, P1, DOI 10.1007/s12178-007-9000-5; Mercuri E, 2007, J MAGN RESON IMAGING, V25, P433, DOI 10.1002/jmri.20804; Monforte M, 2013, NEUROLOGY, V81, pE95, DOI 10.1212/WNL.0b013e3182a4a4e6; Olsen DB, 2006, J NEUROL, V253, P1437, DOI 10.1007/s00415-006-0230-z; Padberg G.W.A.M., 1982, THESIS; Padberg GW, 2009, CURR OPIN NEUROL, V22, P539, DOI 10.1097/WCO.0b013e328330a572; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Sacconi S, 2012, J MED GENET, V49, P41, DOI 10.1136/jmedgenet-2011-100101; Sarkozy A, 2012, NEUROMUSCULAR DISORD, V22, pS122, DOI 10.1016/j.nmd.2012.05.012; Sarparanta J, 2012, NAT GENET, V44, P450, DOI 10.1038/ng.1103; Scionti I, 2012, AM J HUM GENET, V90, P628, DOI 10.1016/j.ajhg.2012.02.019; Tasca G, 2012, EUR J NEUROL, V19, P1256, DOI 10.1111/j.1468-1331.2012.03753.x; Tasca G, 2011, NEUROMUSCULAR DISORD, V21, P671, DOI 10.1016/j.nmd.2011.06.860; Tasca G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038779; Tawil R, 2014, NEUROMUSCULAR DISORD, V24, P79, DOI 10.1016/j.nmd.2013.07.009; Tonini MMO, 2004, NEUROMUSCULAR DISORD, V14, P33, DOI 10.1016/j.nmd.2003.07.001; Wang CH, 2012, NEUROMUSCULAR DISORD, V22, P331, DOI 10.1016/j.nmd.2011.10.018; Wattjes MP, 2010, EUR RADIOL, V20, P2447, DOI 10.1007/s00330-010-1799-2; Zatz M, 1998, AM J MED GENET, V77, P155, DOI 10.1002/(SICI)1096-8628(19980501)77:2<155::AID-AJMG9>3.3.CO;2-G	37	62	62	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100292	10.1371/journal.pone.0100292	http://dx.doi.org/10.1371/journal.pone.0100292			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932477	gold, Green Published, Green Submitted			2022-12-27	WOS:000337738600106
J	Barbosa, RPA; Salgado, APC; Garcia, CC; Galvao, B; Goncalves, APD; Lima, BHF; Lopes, GAO; Rachid, MA; Peixoto, ACC; de Oliveira, DB; Ataide, MA; Zirke, CA; Cotrim, TM; Costa, EA; Almeida, GMD; Russo, RC; Gazzinelli, RT; Machado, ADV				Alves Barbosa, Rafael Polidoro; Carneiro Salgado, Ana Paula; Garcia, Cristiana Couto; Galvao Filho, Bruno; de Faria Goncalves, Ana Paula; Freire Lima, Braulio Henrique; Oliveira Lopes, Gabriel Augusto; Rachid, Milene Alvarenga; Cardoso Peixoto, Andiara Cristina; de Oliveira, Danilo Bretas; Ataide, Marco Antonio; Zirke, Carla Aparecida; Cotrim, Tatiane Marques; Costa, Erica Azevedo; de Freitas Almeida, Gabriel Magno; Russo, Remo Castro; Gazzinelli, Ricardo Tostes; Vieira Machado, Alexandre de Magalhaes			Protective Immunity and Safety of a Genetically Modified Influenza Virus Vaccine	PLOS ONE			English	Article							T-CELL RESPONSES; A VIRUS; VIRAL VECTORS; LUNG INJURY; PATHOGENESIS; NEUTROPHILS; INTERFERON; MACROPHAGES; INFECTIONS; INDUCTION	Recombinant influenza viruses are promising viral platforms to be used as antigen delivery vectors. To this aim, one of the most promising approaches consists of generating recombinant viruses harboring partially truncated neuraminidase (NA) segments. To date, all studies have pointed to safety and usefulness of this viral platform. However, some aspects of the inflammatory and immune responses triggered by those recombinant viruses and their safety to immunocompromised hosts remained to be elucidated. In the present study, we generated a recombinant influenza virus harboring a truncated NA segment (vNA-Delta) and evaluated the innate and inflammatory responses and the safety of this recombinant virus in wild type or knock-out (KO) mice with impaired innate (Myd88 -/-) or acquired (RAG -/-) immune responses. Infection using truncated neuraminidase influenza virus was harmless regarding lung and systemic inflammatory response in wild type mice and was highly attenuated in KO mice. We also demonstrated that vNA-Delta infection does not induce unbalanced cytokine production that strongly contributes to lung damage in infected mice. In addition, the recombinant influenza virus was able to trigger both local and systemic virus-specific humoral and CD8+ T cellular immune responses which protected immunized mice against the challenge with a lethal dose of homologous A/PR8/34 influenza virus. Taken together, our findings suggest and reinforce the safety of using NA deleted influenza viruses as antigen delivery vectors against human or veterinary pathogens.	[Alves Barbosa, Rafael Polidoro; Carneiro Salgado, Ana Paula; Galvao Filho, Bruno; de Faria Goncalves, Ana Paula; Zirke, Carla Aparecida; Cotrim, Tatiane Marques; Costa, Erica Azevedo; Gazzinelli, Ricardo Tostes; Vieira Machado, Alexandre de Magalhaes] Fiocruz MS, Lab Imunopatol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [Alves Barbosa, Rafael Polidoro; Ataide, Marco Antonio; Gazzinelli, Ricardo Tostes] Univ Fed Minas Gerais, Lab Imunoparasitol, Dept Bioquim & Imunol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Garcia, Cristiana Couto; Freire Lima, Braulio Henrique; Oliveira Lopes, Gabriel Augusto; Cardoso Peixoto, Andiara Cristina; Russo, Remo Castro] Univ Fed Minas Gerais, Lab Imunofarmacol, Dept Bioquim & Imunol, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Garcia, Cristiana Couto; Freire Lima, Braulio Henrique; Oliveira Lopes, Gabriel Augusto; Cardoso Peixoto, Andiara Cristina; Russo, Remo Castro] Univ Fed Minas Gerais, Lab Imunol & Mecan Pulm, Dept Fisiol & Biofis, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [Rachid, Milene Alvarenga] Univ Fed Minas Gerais, Dept Patol Geral, Inst Ciencias Biol, Belo Horizonte, MG, Brazil; [de Oliveira, Danilo Bretas; de Freitas Almeida, Gabriel Magno] Univ Fed Minas Gerais, Dept Microbiol, Inst Ciencias Biol, Lab Virus, Belo Horizonte, MG, Brazil; [Gazzinelli, Ricardo Tostes] Univ Massachusetts, Dept Med, Sch Med, Div Infect Dis & Immunol, Worcester, MA USA	Fundacao Oswaldo Cruz; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of Massachusetts System; University of Massachusetts Worcester	Machado, ADV (corresponding author), Fiocruz MS, Lab Imunopatol, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil.	amarok@cpqrr.fiocruz.br	Garcia, Cristiana Couto/AAE-4290-2022; Garcia, Cristiana C/G-9509-2013; Polidoro, Rafael Barbosa/A-6385-2016; Machado, Alexandre M Vieira/G-2468-2012; Russo, Remo Castro/O-8980-2019; Russo, Remo Castro/F-9048-2010; Rachid, Milene Alvarenga/C-3530-2017; Almeida, Gabriel MF/I-8910-2012; Ataide, Marco/Y-4219-2019; oliveira, danilo/AAX-5520-2021	Garcia, Cristiana Couto/0000-0002-4400-9141; Garcia, Cristiana C/0000-0002-4400-9141; Polidoro, Rafael Barbosa/0000-0003-2982-0072; Machado, Alexandre M Vieira/0000-0003-1506-4093; Russo, Remo Castro/0000-0002-1715-3834; Russo, Remo Castro/0000-0002-1715-3834; Rachid, Milene Alvarenga/0000-0002-3142-6552; Almeida, Gabriel MF/0000-0003-2317-5092; oliveira, danilo/0000-0002-3566-2878; Gazzinelli, Ricardo/0000-0003-2427-7699; Ataide, Marco/0000-0003-4014-0326	FIOCRUZ/PDTIS-Vacinas; National Institute for Vaccine Development and Technology (CNPq/FAPEMIG) [015/2008]; CNPq/MAPA/SDA [064/2008]; Universal FAPEMIG	FIOCRUZ/PDTIS-Vacinas; National Institute for Vaccine Development and Technology (CNPq/FAPEMIG); CNPq/MAPA/SDA(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Universal FAPEMIG(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG))	This work was supported by grants from FIOCRUZ/PDTIS-Vacinas, and National Institute for Vaccine Development and Technology (CNPq/FAPEMIG No 015/2008), CNPq/MAPA/SDA No 064/2008, and Universal FAPEMIG. CNPq provided fellowships to RPAB, APCS, CCG, BHFL, GAOL, MAR, ACCP, DBO, MAA, CAZ, TMC, EAC, RCR, RTG and AMVM. CAPES provided fellowship to GMFA. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaike T, 1996, P NATL ACAD SCI USA, V93, P2448, DOI 10.1073/pnas.93.6.2448; Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Barbosa RPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061795; Askovich PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074863; Beck CR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029249; Cox RJ, 2004, SCAND J IMMUNOL, V59, P1, DOI 10.1111/j.0300-9475.2004.01382.x; Crompton T, 2007, NAT REV IMMUNOL, V7, P726, DOI 10.1038/nri2151; de Goede AL, 2009, VACCINE, V27, P5735, DOI 10.1016/j.vaccine.2009.07.032; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; de Oliveira DB, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/275617; de Wit E, 2004, VIRUS RES, V103, P155, DOI 10.1016/j.virusres.2004.02.028; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Fujii Y, 2003, P NATL ACAD SCI USA, V100, P2002, DOI 10.1073/pnas.0437772100; Fukuyama S, 2011, CURR OPIN IMMUNOL, V23, P481, DOI 10.1016/j.coi.2011.07.016; Garcia CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064443; Garcia CC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001171; Garcia-Sastre A, 2011, VIRUS RES, V162, P12, DOI 10.1016/j.virusres.2011.10.017; Hamada H, 2013, J IMMUNOL, V190, P296, DOI 10.4049/jimmunol.1200571; Hashimoto Y, 2007, J IMMUNOL, V178, P2448, DOI 10.4049/jimmunol.178.4.2448; Horvat JC, 2007, AM J RESP CRIT CARE, V176, P556, DOI 10.1164/rccm.200607-1005OC; Hufford MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046581; Jewell NA, 2010, J VIROL, V84, P11515, DOI 10.1128/JVI.01703-09; Julkunen I, 2000, VACCINE, V19, pS32, DOI 10.1016/S0264-410X(00)00275-9; Kuiken T, 2012, CURR OPIN VIROL, V2, P276, DOI 10.1016/j.coviro.2012.02.013; Kunisaki KM, 2009, LANCET INFECT DIS, V9, P493, DOI 10.1016/S1473-3099(09)70175-6; Laidlaw BJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003207; Lau YF, 2010, VIROLOGY, V406, P80, DOI 10.1016/j.virol.2010.07.008; Li JW, 2013, BIOENGINEERED, V4, P9, DOI 10.4161/bioe.21950; Machado AV, 2010, VACCINE, V28, P3247, DOI 10.1016/j.vaccine.2010.02.003; Machado AV, 2006, VIROLOGY, V345, P73, DOI 10.1016/j.virol.2005.09.050; Machado AV, 2003, VIROLOGY, V313, P235, DOI 10.1016/S0042-6822(03)00289-7; Maines TR, 2012, J INFECT DIS, V205, P474, DOI 10.1093/infdis/jir768; Marsh GA, 2007, J VIROL, V81, P9727, DOI 10.1128/JVI.01144-07; Martina BEE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018995; Narasaraju T, 2010, AM J RESP CELL MOL, V42, P732, DOI 10.1165/rcmb.2008-0423OC; Narasaraju T, 2011, AM J PATHOL, V179, P199, DOI 10.1016/j.ajpath.2011.03.013; PALESE P., 2007, FIELDS VIROLOGY, V2, P1647, DOI DOI 10.1371/JOURNAL.PPAT.1003019; Peiris JSM, 2009, TRENDS IMMUNOL, V30, P574, DOI 10.1016/j.it.2009.09.004; Perrone LA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000115; Robert-Guroff M, 2007, CURR OPIN BIOTECH, V18, P546, DOI 10.1016/j.copbio.2007.10.010; Rocha CD, 2004, INT MICROBIOL, V7, P83; Rollier CS, 2011, CURR OPIN IMMUNOL, V23, P377, DOI 10.1016/j.coi.2011.03.006; Russo RC, 2011, AM J RESP CELL MOL, V45, P72, DOI 10.1165/rcmb.2009-0406OC; Russo RC, 2011, J LEUKOCYTE BIOL, V89, P269, DOI 10.1189/jlb.0610346; Shen Z, 2013, CLIN MICROBIOL INFEC; Shinya K, 2004, J VIROL, V78, P3083, DOI 10.1128/JVI.78.6.3083-3088.2004; Small JC, 2011, CURR OPIN VIROL, V1, P241, DOI 10.1016/j.coviro.2011.07.009; Sugamata R, 2012, MICROBIOL IMMUNOL, V56, P171, DOI 10.1111/j.1348-0421.2011.00424.x; Suliman HB, 2001, AM J PHYSIOL-LUNG C, V280, pL69, DOI 10.1152/ajplung.2001.280.1.L69; Teijaro JR, 2011, CELL, V146, P980, DOI 10.1016/j.cell.2011.08.015; Tumpey TM, 2005, J VIROL, V79, P14933, DOI 10.1128/JVI.79.23.14933-14944.2005; Walsh KB, 2011, P NATL ACAD SCI USA, V108, P12018, DOI 10.1073/pnas.1107024108; Wang ZF, 2014, P NATL ACAD SCI USA, V111, P769, DOI 10.1073/pnas.1321748111	53	8	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98685	10.1371/journal.pone.0098685	http://dx.doi.org/10.1371/journal.pone.0098685			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927156	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100020
J	Badejo, AC; Chung, WH; Kim, NS; Chai, JC; Lee, YS; Jung, KH; Kim, HJ; Chai, YG				Badejo, Abimbola Comfort; Chung, Won Hyong; Kim, Nam Shin; Chai, Jin Choul; Lee, Young Seek; Jung, Kyoung Hwa; Kim, Hyo Joon; Chai, Young Gyu			Energy Metabolism in Mycobacterium gilvum PYR-GCK: Insights from Transcript Expression Analyses Following Two States of Induction	PLOS ONE			English	Article							RNA-SEQ; DEGRADATION; BIODEGRADATION; RESPIRATION; STARVATION; PATHWAYS; REVEALS; CARBON; GENE	Mycobacterium gilvum PYR-GCK, a pyrene degrading bacterium, has been the subject of functional studies aimed at elucidating mechanisms related to its outstanding pollutant bioremediation/biodegradation activities. Several studies have investigated energy production and conservation in Mycobacterium, however, they all focused on the pathogenic strains using their various hosts as induction sources. To gain greater insight into Mycobacterium energy metabolism, mRNA expression studies focused on respiratory functions were performed under two different conditions using the toxic pollutant pyrene as a test substrate and glucose as a control substrate. This was done using two transcriptomic techniques: global transcriptomic RNA-sequencing and quantitative Real-Time PCR. Growth in the presence of pyrene resulted in upregulated expression of genes associated with limited oxygen or anaerobiosis in M. gilvum PYR-GCK. Upregulated genes included succinate dehydrogenases, nitrite reductase and various electron donors including formate dehydrogenases, fumarate reductases and NADH dehydrogenases. Oxidative phosphorylation genes (with respiratory chain complexes I, III - V) were expressed at low levels compared to the genes coding for the second molecular complex in the bacterial respiratory chain (fumarate reductase); which is highly functional during microaerophilic or anaerobic bacterial growth. This study reveals a molecular adaptation to a hypoxic mode of respiration during aerobic pyrene degradation. This is likely the result of a cellular oxygen shortage resulting from exhaustion of the oxygenase enzymes required for these degradation activities in M. gilvum PYR-GCK.	[Badejo, Abimbola Comfort; Chai, Jin Choul; Lee, Young Seek; Jung, Kyoung Hwa; Kim, Hyo Joon; Chai, Young Gyu] Hanyang Univ, Dept Mol & Life Sci, Ansan, South Korea; [Chung, Won Hyong] Korea Res Inst Biosci & Biotechnol, Korean Bioinformat Ctr, Taejon, South Korea; [Kim, Nam Shin; Chai, Young Gyu] Hanyang Univ, Dept Nanobiotechnol, Seoul 133791, South Korea	Hanyang University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Hanyang University	Kim, HJ (corresponding author), Hanyang Univ, Dept Mol & Life Sci, Ansan, South Korea.	kimhj104@hanyang.ac.kr; ygchai@hanyang.ac.kr	Kim, Namshin/Q-6491-2017	Kim, Namshin/0000-0001-6361-274X	Hanyang University [HY-2013-P]	Hanyang University	The research was funded by Hanyang University under the contract number HY-2013-P; www.hanyang.ac.kr. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badejo AC, 2013, BIODEGRADATION, V24, P741, DOI 10.1007/s10532-013-9622-9; Badejo AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058066; Berney M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008614; Betts JC, 2002, MOL MICROBIOL, V43, P717, DOI 10.1046/j.1365-2958.2002.02779.x; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; DeanRoss D, 1996, APPL MICROBIOL BIOT, V46, P307, DOI 10.1007/s002530050822; Diaz MP, 2000, MAR BIOTECHNOL, V2, P522, DOI 10.1007/s101260000037; ELMANSI EMT, 1989, J GEN MICROBIOL, V135, P2875; FERRY JG, 1976, ARCH MICROBIOL, V107, P33, DOI 10.1007/BF00427864; Frezza C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024411; FRITZSCHE C, 1994, APPL ENVIRON MICROB, V60, P1687, DOI 10.1128/AEM.60.5.1687-1689.1994; Fuchs G, 2011, NAT REV MICROBIOL, V9, P803, DOI 10.1038/nrmicro2652; JARLIER V, 1994, FEMS MICROBIOL LETT, V123, P11, DOI 10.1111/j.1574-6968.1994.tb07194.x; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Jormakka M, 2003, CURR OPIN STRUC BIOL, V13, P418, DOI 10.1016/S0959-440X(03)00098-8; Kim SJ, 2007, J BACTERIOL, V189, P464, DOI 10.1128/JB.01310-06; Kim YH, 2006, PROTEOMICS, V6, P1301, DOI 10.1002/pmic.200500329; KROGER A, 1992, ARCH MICROBIOL, V158, P311, DOI 10.1007/BF00245358; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Metcalf L., 1991, WASTEWATER ENG TREAT; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Noor E, 2010, MOL CELL, V39, P809, DOI 10.1016/j.molcel.2010.08.031; Omura S, 2001, P NATL ACAD SCI USA, V98, P60, DOI 10.1073/pnas.011524698; Ortega-Calvo JJ, 2010, APPL ENVIRON MICROB, V76, P4430, DOI 10.1128/AEM.00461-10; Richardson DJ, 2000, MICROBIOL-SGM, V146, P551, DOI 10.1099/00221287-146-3-551; Rozen S, 2000, Methods Mol Biol, V132, P365; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Tang YJ, 2009, BIOTECHNOL LETT, V31, P1233, DOI 10.1007/s10529-009-9991-7; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Widdel F, 2001, CURR OPIN BIOTECH, V12, P259, DOI 10.1016/S0958-1669(00)00209-3	31	2	2	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99464	10.1371/journal.pone.0099464	http://dx.doi.org/10.1371/journal.pone.0099464			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927157	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100044
J	Gu, YL; Shen, XH; Zhou, DJ; Wang, ZD; Zhang, N; Shan, ZY; Jin, LH; Lei, L				Gu, Yanli; Shen, Xinghui; Zhou, Dongjie; Wang, Zhendong; Zhang, Na; Shan, Zhiyan; Jin, Lianhong; Lei, Lei			Selection and Expression Profiles of Reference Genes in Mouse Preimplantation Embryos of Different Ploidies at Various Developmental Stages	PLOS ONE			English	Article							REAL-TIME PCR; TETRAPLOID EMBRYOS; HOUSEKEEPING GENES; NORMALIZATION; OPTIMIZATION; MODEL; VITRO	Real-time reverse transcription quantitative polymerase chain reaction (qPCR) has become the most frequently used system for studies of gene expression. Manystudies have provided reliable evidence that the transcription levels of reference genes are not constant at different developmental stages and in different experimental conditions. However, suitable reference genes which are stably expressed in polyploid preimplantation embryos of different developmental stages have not yet been identified. Therefore, it is critical to verify candidate reference genes to analyze gene expression accurately in both diploid and polyploid embryos. We examined the expression levels of 12 candidate reference genes in preimplantation embryos of four different ploidies at six developmental stages. Stability analysis of the reference genes was performed by four independent software programs, and the stability of three genes was evaluated by comparison with the Oct4 expression level during preimplantation development in diploid embryos. The expression levels of most genes in the polyploid embryos were higher than that in the diploid embryos, but the increasing degree were disproportionate with the ploidies. There were no significant difference in reference gene expressions among embryos of different ploidies when they reached the morula stage, and the expression level remained flat until the blastocyst stage. Ubc, Ppia, and Pgk1 were the three most stable reference genes in diploid and polyploid embryos.	[Gu, Yanli; Shen, Xinghui; Zhou, Dongjie; Wang, Zhendong; Zhang, Na; Shan, Zhiyan; Jin, Lianhong; Lei, Lei] Harbin Med Univ, Dept Histol & Embryol, Harbin, Heilongjiang Pr, Peoples R China	Harbin Medical University	Jin, LH (corresponding author), Harbin Med Univ, Dept Histol & Embryol, Harbin, Heilongjiang Pr, Peoples R China.	wstjlh@126.com; leiys2002@yahoo.com	Shen, Xinghui/ABF-9560-2021		China National Science Fund [31271590]; China Postdoctoral Science Foundation Special Funded Project [201104421]	China National Science Fund; China Postdoctoral Science Foundation Special Funded Project	The work was supported by China National Science Fund (31271590) and China Postdoctoral Science Foundation Special Funded Project (201104421). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; BilodeauGoeseels S, 1997, MOL REPROD DEV, V47, P413, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;413::AID-MRD7&gt;3.0.CO;2-N; Chang Z, 2010, ANAL BIOCHEM, V406, P214, DOI 10.1016/j.ab.2010.07.021; EGLITIS MA, 1981, J EMBRYOL EXP MORPH, V66, P91; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Huggett J, 2005, GENES IMMUN, V6, P279, DOI 10.1038/sj.gene.6364190; Jeong YJ, 2005, MOL REPROD DEV, V71, P284, DOI 10.1002/mrd.20269; Kawaguchi J, 2009, J REPROD DEVELOP, V55, P670, DOI 10.1262/jrd.09-127A; Lei L, 2009, ZYGOTE, V17, P125, DOI 10.1017/S0967199409005206; Llobat L, 2012, REPROD DOMEST ANIM, V47, P629, DOI 10.1111/j.1439-0531.2011.01934.x; Lossos IS, 2003, LEUKEMIA, V17, P789, DOI 10.1038/sj.leu.2402880; Luchsinger C, 2013, ZYGOTE, V26, P1; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Mamo S, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-14; Marum L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035113; Miura C, 2012, GENE, V510, P107, DOI 10.1016/j.gene.2012.09.001; Paris DBBP, 2011, REPROD FERT DEVELOP, V23, P353, DOI 10.1071/RD10039; Park MR, 2012, J REPROD DEVELOP, V58, P344, DOI 10.1262/jrd.11-110M; Park MR, 2011, DEV DYNAM, V240, P1660, DOI 10.1002/dvdy.22653; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Robert C, 2002, BIOL REPROD, V67, P1465, DOI 10.1095/biolreprod.102.006320; Saigusa S, 2013, J CANCER RES CLIN, V139, P131, DOI 10.1007/s00432-012-1308-x; Shen B, 2011, EXP THER MED, V2, P1151, DOI 10.3892/etm.2011.331; Silver N, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-33; Suzuki T, 2000, BIOTECHNIQUES, V29, P332, DOI 10.2144/00292rv02; Tachaudomdach C, 2012, EXP THER MED, V3, P713, DOI 10.3892/etm.2012.473; Thellin O, 1999, J BIOTECHNOL, V75, P291, DOI 10.1016/S0168-1656(99)00163-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wen DH, 2003, ACAD J GUANGZHOU MED, V31, P65; Yuasa K, 2012, FEBS LETT, V586, P3464, DOI 10.1016/j.febslet.2012.07.074; Zhang QJ, 2003, BIRTH DEFECTS RES A, V67, P533, DOI 10.1002/bdra.10075	31	7	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98956	10.1371/journal.pone.0098956	http://dx.doi.org/10.1371/journal.pone.0098956			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927500	Green Submitted, Green Published, gold			2022-12-27	WOS:000338278100023
J	Kumar, N; Palmer, GR; Shah, V; Walker, VK				Kumar, Niraj; Palmer, Gerald R.; Shah, Vishal; Walker, Virginia K.			The Effect of Silver Nanoparticles on Seasonal Change in Arctic Tundra Bacterial and Fungal Assemblages	PLOS ONE			English	Article							SOIL BACTERIAL; MICROBIAL COMMUNITY; ANTIFUNGAL ACTIVITY; ETHIDIUM MONOAZIDE; ESCHERICHIA-COLI; EXPOSURE; IMPACT; GROWTH; ACCUMULATION; POPULATIONS	The impact of silver nanoparticles (NPs) and microparticles (MPs) on bacterial and fungal assemblages was studied in soils collected from a low arctic site. Two different concentrations (0.066% and 6.6%) of Ag NPs and Ag MPs were tested in microcosms that were exposed to temperatures mimicking a winter to summer transition. Toxicity was monitored by differential respiration, phospholipid fatty acid analysis, polymerase chain reaction-denaturing gradient gel electrophoresis and DNA sequencing. Notwithstanding the effect of Ag MPs, nanosilver had an obvious, additional impact on the microbial community, underscoring the importance of particle size in toxicity. This impact was evidenced by levels of differential respiration in 0.066% Ag NP-treated soil that were only half that of control soils, a decrease in signature bacterial fatty acids, and changes in both richness and evenness in bacterial and fungal DNA sequence assemblages. Prominent after Ag NP-treatment were Hypocreales fungi, which increased to 70%, from only 1% of fungal sequences under control conditions. Genera within this Order known for their antioxidant properties (Cordyceps/Isaria) dominated the fungal assemblage after NP addition. In contrast, sequences attributed to the nitrogen-fixing Rhizobiales bacteria appeared vulnerable to Ag NP-mediated toxicity. This combination of physiological, biochemical and molecular studies clearly demonstrate that Ag NPs can severely disrupt the natural seasonal progression of tundra assemblages.	[Kumar, Niraj; Palmer, Gerald R.; Walker, Virginia K.] Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada; [Shah, Vishal] Dowling Coll, Dept Biol, Oakdale, NY USA; [Walker, Virginia K.] Queens Univ, Sch Environm Studies, Kingston, ON, Canada	Queens University - Canada; Queens University - Canada	Walker, VK (corresponding author), Queens Univ, Dept Biol, Kingston, ON K7L 3N6, Canada.	walkervk@queensu.ca			NSERC (Canada); Queen's University Chair; National Science Foundation [0966741]	NSERC (Canada)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Queen's University Chair; National Science Foundation(National Science Foundation (NSF))	This work was supported by NSERC (Canada) and a Queen's University Chair to VW. VS was supported by a National Science Foundation grant, #0966741. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn Mi Young, 2008, International Journal of Industrial Entomology, V17, P197; Bailey MT, 2010, INFECT IMMUN, V78, P1509, DOI 10.1128/IAI.00862-09; Bansal V, 2011, AUST J CHEM, V64, P279, DOI 10.1071/CH10343; Bartelt-Ryser J, 2005, PERSPECT PLANT ECOL, V7, P27, DOI 10.1016/j.ppees.2004.11.002; Blaser SA, 2008, SCI TOTAL ENVIRON, V390, P396, DOI 10.1016/j.scitotenv.2007.10.010; Burleson DJ, 2004, J ENVIRON SCI HEAL A, V39, P2707, DOI [10.1081/LESA-200027029, 10.1081/ESE-200027029]; Chu HY, 2011, SOIL SCI SOC AM J, V75, P1756, DOI 10.2136/sssaj2011.0057; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; Dasari TP, 2010, SCI TOTAL ENVIRON, V408, P5817, DOI 10.1016/j.scitotenv.2010.08.030; Dowd SE, 2008, BMC MICROBIOL, V8, DOI [10.1186/1471-2180-8-125, 10.1186/1471-2180-8-43]; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Eckhardt S, 2007, ATMOS CHEM PHYS, V7, P4527, DOI 10.5194/acp-7-4527-2007; Eckhardt S, 2013, CHEM REV, V113, P4708, DOI 10.1021/cr300288v; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Gottschalk F, 2009, ENVIRON SCI TECHNOL, V43, P9216, DOI 10.1021/es9015553; Han DW, 2005, WORLD J MICROB BIOT, V21, P921, DOI 10.1007/s11274-004-6721-0; Han X, 2014, SCI TOTAL ENVIRON, V487, P822, DOI 10.1016/j.scitotenv.2013.12.129; Hornung C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055045; Hume ME, 2012, FOODBORNE PATHOG DIS, V9, P853, DOI 10.1089/fpd.2011.1093; Hung H, 2010, SCI TOTAL ENVIRON, V408, P2854, DOI 10.1016/j.scitotenv.2009.10.044; Hyung H, 2007, ENVIRON SCI TECHNOL, V41, P179, DOI 10.1021/es061817g; Ishak HD, 2011, MICROB ECOL, V61, P821, DOI 10.1007/s00248-010-9793-4; Jiang YH, 2005, J FOOD BIOCHEM, V29, P323, DOI 10.1111/j.1745-4514.2005.00040.x; Kim JS, 2007, NANOMED-NANOTECHNOL, V3, P95, DOI 10.1016/j.nano.2006.12.001; Klaus T, 1999, P NATL ACAD SCI USA, V96, P13611, DOI 10.1073/pnas.96.24.13611; Koukol O, 2011, FUNGAL DIVERS, V49, P75, DOI 10.1007/s13225-011-0092-2; Kumar Niraj, 2013, Biology (Basel), V2, P356, DOI 10.3390/biology2010356; Kumar N, 2012, ENVIRON TOXICOL CHEM, V31, P131, DOI 10.1002/etc.721; Kumar N, 2011, J HAZARD MATER, V190, P816, DOI 10.1016/j.jhazmat.2011.04.005; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Lipson DA, 2004, APPL ENVIRON MICROB, V70, P2867, DOI 10.1128/AEM.70.5.2867-2879.2004; MacCormack TJ, 2008, J IND ECOL, V12, P286, DOI 10.1111/j.1530-9290.2008.00041.x; Marambio-Jones C, 2010, J NANOPART RES, V12, P1531, DOI 10.1007/s11051-010-9900-y; McMahon SK, 2011, SOIL BIOL BIOCHEM, V43, P287, DOI 10.1016/j.soilbio.2010.10.013; McMahon SK, 2009, ENV MICROBIOL REP, V1, P162, DOI 10.1111/j.1758-2229.2009.00025.x; Mishra VK, 2009, DIG J NANOMATER BIOS, V4, P587; Moller A, 2011, ENVIRON POLLUT, V159, P1577, DOI 10.1016/j.envpol.2011.02.054; Monteiro DR, 2012, LETT APPL MICROBIOL, V54, P383, DOI 10.1111/j.1472-765X.2012.03219.x; Mueller NC, 2008, ENVIRON SCI TECHNOL, V42, P4447, DOI 10.1021/es7029637; Nasrollahi A, 2011, INT J NANO DIMENS, V1, P233, DOI 10.7508/ijnd.2010.03.007; Nel AE, 2009, NAT MATER, V8, P543, DOI [10.1038/NMAT2442, 10.1038/nmat2442]; Nevin KP, 2000, APPL ENVIRON MICROB, V66, P2248, DOI 10.1128/AEM.66.5.2248-2251.2000; Nobrega S, 2007, ECOSYSTEMS, V10, P419, DOI 10.1007/s10021-007-9033-z; Nogva HK, 2003, BIOTECHNIQUES, V34, P804, DOI 10.2144/03344rr02; Ovreas L, 1997, APPL ENVIRON MICROB, V63, P3367; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Ramanathan R, 2011, LANGMUIR, V27, P714, DOI 10.1021/la1036162; Rudi K, 2005, APPL ENVIRON MICROB, V71, P1018, DOI 10.1128/AEM.71.2.1018-1024.2005; Sasser M, 1990, 101 MIDI; Schadt CW, 2003, SCIENCE, V301, P1359, DOI 10.1126/science.1086940; Shah V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026263; Shah V, 2010, J HAZARD MATER, V178, P1141, DOI 10.1016/j.jhazmat.2010.01.141; Shah V, 2009, WATER AIR SOIL POLL, V197, P143, DOI 10.1007/s11270-008-9797-6; SHAVER GR, 1980, ECOLOGY, V61, P662, DOI 10.2307/1937432; Shi W, 2002, APPL ENVIRON MICROB, V68, P3859, DOI 10.1128/AEM.68.8.3859-3866.2002; Sigler WV, 2002, APPL SOIL ECOL, V21, P107, DOI 10.1016/S0929-1393(02)00088-4; Silver S, 2003, FEMS MICROBIOL REV, V27, P341, DOI 10.1016/S0168-6445(03)00047-0; Sinha R, 2011, BIORESOURCE TECHNOL, V102, P1516, DOI 10.1016/j.biortech.2010.07.117; SLAWSON RM, 1992, ARCH MICROBIOL, V158, P398; Soenen SJ, 2011, NANO TODAY, V6, P446, DOI 10.1016/j.nantod.2011.08.001; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; SUUTARI M, 1994, CRIT REV MICROBIOL, V20, P285, DOI 10.3109/10408419409113560; Throback IN, 2007, FEMS MICROBIOL LETT, V270, P189, DOI 10.1111/j.1574-6968.2007.00632.x; Vainio EJ, 2000, MYCOL RES, V104, P927, DOI 10.1017/S0953756200002471; WONG JWC, 1995, ENVIRON TECHNOL, V16, P527, DOI 10.1080/09593331608616294; Yamaguchi Y, 2000, PHYTOTHER RES, V14, P647, DOI 10.1002/1099-1573(200012)14:8&lt;647::AID-PTR670&gt;3.0.CO;2-W; Zhao GJ, 1998, BIOMETALS, V11, P27, DOI 10.1023/A:1009253223055	67	32	36	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99953	10.1371/journal.pone.0099953	http://dx.doi.org/10.1371/journal.pone.0099953			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926877	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100098
J	Lei, T; Wang, H; Liu, J; Nan, HZ; Liu, Q				Lei, Tao; Wang, Hui; Liu, Jing; Nan, Huizhu; Liu, Qun			ROP18 Is a Key Factor Responsible for Virulence Difference between Toxoplasma gondii and Neospora caninum	PLOS ONE			English	Article							HOST-CELL INVASION; IMMUNE MAPPED PROTEIN-1; PARASITOPHOROUS VACUOLE; RHOPTRY PROTEIN; APICOMPLEXAN; IDENTIFICATION; MACROPHAGES; EXPRESSION; RESISTANCE; PARASITES	Toxoplasma gondii (T. gondii) and Neospora caninum (N. caninum) are both obligate intracellular protozoan parasites and share many common morphological and biological features. Despite these similarities the two parasites differ dramatically in virulence in mice, but the factors involved in virulence differences between the two parasites remain unknown. A secreted serine-threonine kinase called rhoptry protein 18 (ROP18) was identified to play a crucial role on virulence differences among different T. gondii clonal lineages. Intriguingly, we found that ROP18 in Nc1 strain of N. caninum (NcROP18) is a pseudogene due to several interrupting stop codons in the sequence in our previous studies. We assume that the difference of ROP18 leads to virulence difference between T. gondii and N. caninum. We constructed a transgenic N. caninum Nc1 stain by transfecting the TgROP18 from the T. gondii RH strain. Phenotype and virulence assays showed that the expression of TgROP18 in N. caninum did not affect the motility and cell invasion, but resulted in a significant increase in intracellular parasite proliferation and virulence in mice. Immunity-Related GTPase (IRG) phosphorylation assay showed that the transgenic parasite Nc1-TgROP18 was able to phosphorylate IRGs as T. gondii did. The present study indicated that the ROP18 plays a crucial role in virulence of the closely related parasites T. gondii and N. caninum and it is indeed a key factor responsible for the virulence difference between T. gondii and N. caninum.	[Liu, Qun] China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100094, Peoples R China; China Agr Univ, Natl Anim Protozoa Lab, Coll Vet Med, Beijing 100094, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs; China Agricultural University	Liu, Q (corresponding author), China Agr Univ, Key Lab Anim Epidemiol & Zoonosis, Minist Agr, Beijing 100094, Peoples R China.	qunliu@cau.edu.cn			Natural Science Foundation of Beijing [6131001]; Natural Science Foundation of China [31302075]; National Special Research Programs for Non-Profit Trades (Agriculture) [200903036]; Modern Agro-industry Technology Research System	Natural Science Foundation of Beijing(Beijing Natural Science Foundation); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Special Research Programs for Non-Profit Trades (Agriculture); Modern Agro-industry Technology Research System	This study was supported by Natural Science Foundation of Beijing (6131001), the Natural Science Foundation of China (31302075), the National Special Research Programs for Non-Profit Trades (Agriculture) (200903036) and the earmarked fund for Modern Agro-industry Technology Research System. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beckers CJM, 1997, MOL BIOCHEM PARASIT, V89, P209, DOI 10.1016/S0166-6851(97)00120-5; Behnke MS, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002992; Bradley PJ, 2005, J BIOL CHEM, V280, P34245, DOI 10.1074/jbc.M504158200; Cui X, 2012, PARASITOLOGY, V139, P998, DOI 10.1017/S0031182012000285; Cui X, 2012, VACCINE, V30, P2282, DOI 10.1016/j.vaccine.2012.01.073; Daher W, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001132; Dubey JP, 2002, INT J PARASITOL, V32, P929, DOI 10.1016/S0020-7519(02)00094-2; DUBEY JP, 1988, J AM VET MED ASSOC, V192, P1269; El Hajj H, 2007, PLOS PATHOG, V3, P200, DOI 10.1371/journal.ppat.0030014; Fentress SJ, 2011, BIOESSAYS, V33, P693, DOI 10.1002/bies.201100054; Fentress SJ, 2010, CELL HOST MICROBE, V8, P484, DOI 10.1016/j.chom.2010.11.005; Gaskell EA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004801; Grigg ME, 2001, SCIENCE, V294, P161, DOI 10.1126/science.1061888; Hakansson S, 2001, EMBO J, V20, P3132, DOI 10.1093/emboj/20.12.3132; Howe DK, 1999, INT J PARASITOL, V29, P1489, DOI 10.1016/S0020-7519(99)00099-5; Howe DK, 1996, INFECT IMMUN, V64, P5193, DOI 10.1128/IAI.64.12.5193-5198.1996; Howe DK, 1997, MOL BIOCHEM PARASIT, V86, P29, DOI 10.1016/S0166-6851(96)02838-1; Kaufmann H, 1996, MOL CELL PROBE, V10, P289, DOI 10.1006/mcpr.1996.0038; Khaminets A, 2010, CELL MICROBIOL, V12, P939, DOI 10.1111/j.1462-5822.2010.01443.x; Kim K, 2004, INT J PARASITOL, V34, P423, DOI 10.1016/j.ijpara.2003.12.009; Ling YM, 2006, J EXP MED, V203, P2063, DOI 10.1084/jem.20061318; Martens S, 2005, PLOS PATHOG, V1, P187, DOI 10.1371/journal.ppat.0010024; Meissner M, 2002, SCIENCE, V298, P837, DOI 10.1126/science.1074553; Nishikawa Y, 2003, INT J PARASITOL, V33, P1525, DOI 10.1016/S0020-7519(03)00204-2; Ong YC, 2010, J BIOL CHEM, V285, P28731, DOI 10.1074/jbc.M110.112359; Plattner F, 2008, CELL HOST MICROBE, V3, P77, DOI 10.1016/j.chom.2008.01.001; Reese ML, 2011, P NATL ACAD SCI USA, V108, P9625, DOI 10.1073/pnas.1015980108; Reid AJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002567; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Saeij JPJ, 2005, TRENDS PARASITOL, V21, P476, DOI 10.1016/j.pt.2005.08.001; Santos JM, 2011, SCIENCE, V331, P473, DOI 10.1126/science.1199284; Sheiner L, 2010, MOL MICROBIOL, V77, P912, DOI 10.1111/j.1365-2958.2010.07255.x; Shenoy AR, 2007, IMMUNOBIOLOGY, V212, P771, DOI 10.1016/j.imbio.2007.09.018; Sibley LD, 2004, SCIENCE, V304, P248, DOI 10.1126/science.1094717; SIBLEY LD, 1992, NATURE, V359, P82, DOI 10.1038/359082a0; SIBLEY LD, 1994, P NATL ACAD SCI USA, V91, P5508, DOI 10.1073/pnas.91.12.5508; Steinfeldt T, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000576; Su C, 2003, SCIENCE, V299, P414, DOI 10.1126/science.1078035; Taylor GA, 2007, MICROBES INFECT, V9, P1644, DOI 10.1016/j.micinf.2007.09.004; Taylor S, 2006, SCIENCE, V314, P1776, DOI 10.1126/science.1133643; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053483; Yamamoto M, 2009, J EXP MED, V206, P2747, DOI 10.1084/jem.20091703; Zhang GH, 2010, VACCINE, V28, P7243, DOI 10.1016/j.vaccine.2010.08.096; Zhang HS, 2007, MOL BIOCHEM PARASIT, V151, P205, DOI 10.1016/j.molbiopara.2006.11.005; Zhao Y, 2009, J IMMUNOL, V182, P3775, DOI 10.4049/jimmunol.0804190	45	26	30	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99744	10.1371/journal.pone.0099744	http://dx.doi.org/10.1371/journal.pone.0099744			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927100	Green Submitted, Green Published, gold			2022-12-27	WOS:000338278100075
J	Menafra, R; Brinkman, AB; Matarese, F; Franci, G; Bartels, SJJ; Nguyen, L; Shimbo, T; Wade, PA; Hubner, NC; Stunnenberg, HG				Menafra, Roberta; Brinkman, Arie B.; Matarese, Filomena; Franci, Gianluigi; Bartels, Stefanie J. J.; Luan Nguyen; Shimbo, Takashi; Wade, Paul A.; Hubner, Nina C.; Stunnenberg, Hendrik G.			Genome-Wide Binding of MBD2 Reveals Strong Preference for Highly Methylated Loci	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; HUMAN X-CHROMOSOME; DNA METHYLATION; BREAST-CANCER; CPG ISLANDS; XIST GENE; CHROMATIN; TRANSCRIPTION; CELLS; IDENTIFICATION	MBD2 is a subunit of the NuRD complex that is postulated to mediate gene repression via recruitment of the complex to methylated DNA. In this study we adopted an MBD2 tagging-approach to study its genome wide binding characteristics. We show that in vivo MBD2 is mainly recruited to CpG island promoters that are highly methylated. Interestingly, MBD2 binds around 1 kb downstream of the transcription start site of a subset of similar to 400 CpG island promoters that are characterized by the presence of active histone marks, RNA polymerase II (Pol2) and low to medium gene expression levels and H3K36me3 deposition. These tagged-MBD2 binding sites in MCF-7 show increased methylation in a cohort of primary breast cancers but not in normal breast samples, suggesting a putative role for MBD2 in breast cancer.	[Menafra, Roberta; Brinkman, Arie B.; Matarese, Filomena; Franci, Gianluigi; Bartels, Stefanie J. J.; Luan Nguyen; Hubner, Nina C.; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands; [Shimbo, Takashi; Wade, Paul A.] NIEHS, Mol Carcinogenesis Lab, Res Triangle Pk, NC 27709 USA	Radboud University Nijmegen; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Stunnenberg, HG (corresponding author), Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.	H.Stunnenberg@ncmls.ru.nl	Franci, Gianluigi/AAC-6841-2022; Hubner, Nina C/C-4298-2008; Stunnenberg, Hendrik G./D-6875-2012; Wade, Paul A/D-2374-2019; Nguyen, Luan/GYA-2927-2022; Brinkman, Arie/V-1533-2018	Hubner, Nina C/0000-0002-7864-2877; Stunnenberg, Hendrik G./0000-0002-0066-1576; Wade, Paul A/0000-0002-6042-357X; Brinkman, Arie/0000-0002-9875-1835; Franci, Gianluigi/0000-0003-3321-4331	Dutch Cancer Foundation (KWF) grant KUN [20135833]; ATLAS; EC-FP7 project BLUEPRINT [282510]; SYSCOL (EU FP7); Intramural Research Program of the National Institute of Environmental Health Sciences, NIH [ZO1ES101965]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [Z01ES101965, ZIAES101965] Funding Source: NIH RePORTER	Dutch Cancer Foundation (KWF) grant KUN; ATLAS; EC-FP7 project BLUEPRINT; SYSCOL (EU FP7); Intramural Research Program of the National Institute of Environmental Health Sciences, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the Dutch Cancer Foundation (KWF) grant KUN 20135833, by ATLAS, by the EC-FP7 project BLUEPRINT (n degrees 282510) and by SYSCOL (EU FP7). This work was also supported, in part, by the Intramural Research Program of the National Institute of Environmental Health Sciences, NIH (Project number ZO1ES101965 to PAW). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARIEL M, 1995, NAT GENET, V9, P312, DOI 10.1038/ng0395-312; Ball MP, 2009, NAT BIOTECHNOL, V27, P361, DOI 10.1038/nbt.1533; Barr H, 2007, MOL CELL BIOL, V27, P3750, DOI 10.1128/MCB.02204-06; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; BIRD AP, 1986, NATURE, V321, P209, DOI 10.1038/321209a0; Brinkman AB, 2006, EMBO REP, V7, P628, DOI 10.1038/sj.embor.7400686; Costessi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042822; Costessi A, 2011, EMBO J, V30, P3786, DOI 10.1038/emboj.2011.262; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Deaton AM, 2011, GENE DEV, V25, P1010, DOI 10.1101/gad.2037511; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Fournier A, 2012, BRIEF FUNCT GENOMICS, V11, P251, DOI 10.1093/bfgp/elr040; Gunther K, 2013, NUCLEIC ACIDS RES, V41, P3010, DOI 10.1093/nar/gkt035; Habibi E, 2013, CELL STEM CELL, V13, P360, DOI 10.1016/j.stem.2013.06.002; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Hon GC, 2012, GENOME RES, V22, P246, DOI 10.1101/gr.125872.111; Hubner NC, 2011, METHODS, V53, P453, DOI 10.1016/j.ymeth.2010.12.016; Hubner NC, 2010, J CELL BIOL, V189, P739, DOI 10.1083/jcb.200911091; Jones PA, 2002, NAT REV GENET, V3, P415, DOI 10.1038/nrg816; Jonkers I, 2014, ELIFE, V3, DOI 10.7554/eLife.02407; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Komarnitsky P, 2000, GENE DEV, V14, P2452, DOI 10.1101/gad.824700; Laget S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011982; Le Guezennec X, 2006, MOL CELL BIOL, V26, P843, DOI 10.1128/MCB.26.3.843-851.2006; Martin V, 2008, PATHOBIOLOGY, V75, P281, DOI 10.1159/000151708; Mohn F, 2008, MOL CELL, V30, P755, DOI 10.1016/j.molcel.2008.05.007; Ovaska K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003100; Robertson KD, 2000, CARCINOGENESIS, V21, P461, DOI 10.1093/carcin/21.3.461; Ruike Y, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-137; Shimbo T, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004028; Smits AH, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks941; Stefanska B, 2013, CARCINOGENESIS, V34, P2738, DOI 10.1093/carcin/bgt273; Tian B, 2012, METHODS MOL BIOL, V809, P105, DOI 10.1007/978-1-61779-376-9_7; Vakoc CR, 2005, MOL CELL, V19, P381, DOI 10.1016/j.molcel.2005.06.011; Veloso A, 2014, GENOME RES; WOLF SF, 1984, P NATL ACAD SCI-BIOL, V81, P2806, DOI 10.1073/pnas.81.9.2806; Wutz A, 1997, NATURE, V389, P745, DOI 10.1038/39631; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhu D, 2011, CANCER RES, V71, P5859, DOI 10.1158/0008-5472.CAN-11-1157	42	29	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99603	10.1371/journal.pone.0099603	http://dx.doi.org/10.1371/journal.pone.0099603			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927503	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100055
J	Mizukami, Y; Abe, T; Shibata, H; Makimura, Y; Fujishiro, S; Yanase, K; Hishikawa, S; Kobayashi, E; Hanazono, Y				Mizukami, Yoshihisa; Abe, Tomoyuki; Shibata, Hiroaki; Makimura, Yukitoshi; Fujishiro, Shuh-hei; Yanase, Kimihide; Hishikawa, Shuji; Kobayashi, Eiji; Hanazono, Yutaka			MHC-Matched Induced Pluripotent Stem Cells Can Attenuate Cellular and Humoral Immune Responses but Are Still Susceptible to Innate Immunity in Pigs	PLOS ONE			English	Article							SLA CLASS-I; MINIATURE SWINE; NEURAL CELLS; TRANSPLANTATION; COMPLEMENT; ENGRAFTMENT; BANKING; ANEMIA; CD47; SELF	Recent studies have revealed negligible immunogenicity of induced pluripotent stem (iPS) cells in syngeneic mice and in autologous monkeys. Therefore, human iPS cells would not elicit immune responses in the autologous setting. However, given that human leukocyte antigen (HLA)-matched allogeneic iPS cells would likely be used for medical applications, a more faithful model system is needed to reflect HLA-matched allogeneic settings. Here we examined whether iPS cells induce immune responses in the swine leukocyte antigen (SLA)-matched setting. iPS cells were generated from the SLA-defined C1 strain of Clawn miniature swine, which were confirmed to develop teratomas in mice, and transplanted into the testes (n = 4) and ovary (n = 1) of C1 pigs. No teratomas were found in pigs on 47 to 125 days after transplantation. A Mixed lymphocyte reaction revealed that T-cell responses to the transplanted MHC-matched (C1) iPS cells were significantly lower compared to allogeneic cells. The humoral immune responses were also attenuated in the C1-to-C1 setting. More importantly, even MHC-matched iPS cells were susceptible to innate immunity, NK cells and serum complement. iPS cells lacked the expression of SLA class I and sialic acids. The in vitro cytotoxic assay showed that C1 iPS cells were targeted by NK cells and serum complement of C1. In vivo, the C1 iPS cells developed larger teratomas in NK-deficient NOG (T-B-NK-) mice (n = 10) than in NK-competent NOD/SCID (T-B-NK+) mice (n = 8) (p<0.01). In addition, C1 iPS cell failed to form teratomas after incubation with the porcine complement-active serum. Taken together, MHC-matched iPS cells can attenuate cellular and humoral immune responses, but still susceptible to innate immunity in pigs.	[Mizukami, Yoshihisa; Abe, Tomoyuki; Fujishiro, Shuh-hei; Yanase, Kimihide; Hanazono, Yutaka] Jichi Med Univ, Ctr Mol Med, Div Regenerat Med, Shimotsuke, Tochigi, Japan; [Abe, Tomoyuki; Makimura, Yukitoshi; Hishikawa, Shuji; Kobayashi, Eiji; Hanazono, Yutaka] Jichi Med Univ, Ctr Dev Adv Med Technol, Shimotsuke, Tochigi, Japan; [Shibata, Hiroaki] Natl Inst Biomed Innovat, Tsukuba Primate Res Ctr, Ibaraki, Japan; [Hanazono, Yutaka] Japan Sci & Technol Agcy, CREST, Tokyo, Japan	Jichi Medical University; Jichi Medical University; National Institute of Health Sciences - Japan; Japan Science & Technology Agency (JST)	Hanazono, Y (corresponding author), Jichi Med Univ, Ctr Mol Med, Div Regenerat Med, Shimotsuke, Tochigi, Japan.	hanazono@jichi.ac.jp			Japan Science and Technology Agency Research Center Network for Realization of Regenerative Medicine; KAKENHI from Ministry of Health, Labour and Welfare of Japan; Jichi Medical University Graduate Student Start-Up Grant	Japan Science and Technology Agency Research Center Network for Realization of Regenerative Medicine; KAKENHI from Ministry of Health, Labour and Welfare of Japan; Jichi Medical University Graduate Student Start-Up Grant	This study was in part supported by Japan Science and Technology Agency Research Center Network for Realization of Regenerative Medicine to YH, by KAKENHI from Ministry of Health, Labour and Welfare of Japan to YH, and by Jichi Medical University Graduate Student Start-Up Grant for Young Investigators to Y Mizukami. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alipio Z, 2010, P NATL ACAD SCI USA, V107, P13426, DOI 10.1073/pnas.1007884107; Ando A, 2005, XENOTRANSPLANTATION, V12, P121, DOI 10.1111/j.1399-3089.2005.00204.x; Ando A, 2003, IMMUNOGENETICS, V55, P583, DOI 10.1007/s00251-003-0619-0; Araki R, 2013, NATURE, V494, P100, DOI 10.1038/nature11807; Bollen P, 1997, PHARMACOL TOXICOL, V80, P3, DOI 10.1111/j.1600-0773.1997.tb01980.x; Dhodapkar KM, 2010, P NATL ACAD SCI USA, V107, P8718, DOI 10.1073/pnas.0915086107; Dressel R, 2010, FASEB J, V24, P2164, DOI 10.1096/fj.09-134957; Dressel R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002622; Emborg ME, 2013, CELL REP, V3, P646, DOI 10.1016/j.celrep.2013.02.016; Fujishiro S, 2013, STEM CELLS DEV, V22, P473, DOI 10.1089/scd.2012.0173; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Hanekamp JS, 2009, TRANSPLANTATION, V88, P30, DOI 10.1097/TP.0b013e3181a9ed5b; Hanna J, 2007, SCIENCE, V318, P1920, DOI 10.1126/science.1152092; Hayashi K, 2012, SCIENCE, V338, P971, DOI 10.1126/science.1226889; Ide K, 2007, P NATL ACAD SCI USA, V104, P5062, DOI 10.1073/pnas.0609661104; Jaiswal S, 2009, CELL, V138, P271, DOI 10.1016/j.cell.2009.05.046; Kaneko S, 2013, CELL STEM CELL, V12, P385, DOI 10.1016/j.stem.2013.03.008; KAZATCHKINE MD, 1979, J IMMUNOL, V122, P75; Kim D, 2012, LEUKEMIA, V26, P2538, DOI 10.1038/leu.2012.141; Kishi Y, 2008, CELL TRANSPLANT, V17, P1095, DOI 10.3727/096368908786991560; Koch CA, 2006, J IMMUNOL, V177, P4803, DOI 10.4049/jimmunol.177.7.4803; Kurre P, 2003, J PEDIAT HEMATOL ONC, V25, P581, DOI 10.1097/00043426-200307000-00019; Li Y, 2012, BLOOD, V120, P3436, DOI 10.1182/blood-2012-03-420612; Mezrich JD, 2003, TRANSPLANTATION, V75, P904, DOI 10.1097/01.TP.0000054839.43852.BF; Morizane A, 2013, STEM CELL REP, V1, P283, DOI 10.1016/j.stemcr.2013.08.007; NAKANISHI Y, 1991, Japanese Journal of Swine Science, V28, P211; Nakatsuji N, 2008, NAT BIOTECHNOL, V26, P739, DOI 10.1038/nbt0708-739; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Oldenborg PA, 2000, SCIENCE, V288, P2051, DOI 10.1126/science.288.5473.2051; Raulet DH, 2006, SEMIN IMMUNOL, V18, P145, DOI 10.1016/j.smim.2006.03.003; SACHS DH, 1994, PATHOL BIOL, V42, P217; SACHS DH, 1976, TRANSPLANTATION, V22, P559, DOI 10.1097/00007890-197612000-00004; Shook DR, 2013, BIOL BLOOD MARROW TR, V19, P291, DOI 10.1016/j.bbmt.2012.10.001; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Taylor CJ, 2012, CELL STEM CELL, V11, P147, DOI 10.1016/j.stem.2012.07.014; Yamaguchi T, 2013, STEM CELLS DEV, V22, DOI 10.1089/scd.2012.0339; Yanagimachi MD, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059243; Zimmermann A, 2012, STEM CELLS DEV, V21, P2364, DOI 10.1089/scd.2012.0088	39	26	26	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98319	10.1371/journal.pone.0098319	http://dx.doi.org/10.1371/journal.pone.0098319			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927426	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100015
J	Chawes, BL; Bonnelykke, K; Jensen, PF; Schoos, AMM; Heickendorff, L; Bisgaard, H				Chawes, Bo L.; Bonnelykke, Klaus; Jensen, Pia F.; Schoos, Ann-Marie M.; Heickendorff, Lene; Bisgaard, Hans			Cord Blood 25(OH)-Vitamin D Deficiency and Childhood Asthma, Allergy and Eczema: The COPSAC(2000) Birth Cohort Study	PLOS ONE			English	Article							VITAMIN-D DEFICIENCY; BACTERIAL-COLONIZATION; NONALLERGIC RHINITIS; YOUNG-CHILDREN; RISK; INFANTS; PREGNANCY; WHEEZE; FOOD; SENSITIZATION	Background: Epidemiological studies have suggested an association between maternal vitamin D dietary intake during pregnancy and risk of asthma and allergy in the offspring. However, prospective clinical studies on vitamin D measured in cord blood and development of clinical end-points are sparse. Objective: To investigate the interdependence of cord blood 25-hydroxyvitamin D (25(OH)-Vitamin D) level and investigator-diagnosed asthma-and allergy-related conditions during preschool-age. Methods: Cord blood 25(OH)-Vitamin D level was measured in 257 children from the Copenhagen Prospective Studies on Asthma in Childhood (COPSAC(2000)) at-risk mother-child cohort. Troublesome lung symptoms (TROLS), asthma, respiratory infections, allergic rhinitis, and eczema, at age 0-7 yrs were diagnosed exclusively by the COPSAC pediatricians strictly adhering to predefined algorithms. Objective assessments of lung function and sensitization were performed repeatedly from birth. Results: After adjusting for season of birth, deficient cord blood 25(OH)-Vitamin D level (<50 nmol/L) was associated with a 2.7-fold increased risk of recurrent TROLS (HR = 2.65; 95% CI = 1.02-6.86), but showed no association with respiratory infections or asthma. We saw no association between cord blood 25(OH)-Vitamin D level and lung function, sensitization, rhinitis or eczema. The effects were unaffected from adjusting for multiple lifestyle factors. Conclusion: Cord blood 25(OH)-Vitamin D deficiency associated with increased risk of recurrent TROLS till age 7 years. Randomized controlled trials of vitamin D supplementation during pregnancy are needed to prove causality.	[Chawes, Bo L.; Bonnelykke, Klaus; Jensen, Pia F.; Schoos, Ann-Marie M.; Bisgaard, Hans] Univ Copenhagen, Danish Pediat Asthma Ctr, Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, Gentofte, Denmark; [Heickendorff, Lene] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus, Denmark	University of Copenhagen; Aarhus University	Bisgaard, H (corresponding author), Univ Copenhagen, Danish Pediat Asthma Ctr, Copenhagen Univ Hosp, Copenhagen Prospect Studies Asthma Childhood, Gentofte, Denmark.	bisgaard@copsac.com	Schoos, Ann-Marie Malby/AAO-7677-2020; Bisgaard, Hans/N-4761-2016	Schoos, Ann-Marie Malby/0000-0002-5827-0885; Bisgaard, Hans/0000-0003-4131-7592; Bonnelykke, Klaus/0000-0003-2003-1018; Chawes, Bo/0000-0001-6846-6243	private and public research funds; Lundbeck Foundation; Danish Strategic Research Council; Pharmacy Foundation of 1991; Augustinus Foundation; Danish Medical Research Council; Lundbeck Foundation [R16-2007-1694] Funding Source: researchfish	private and public research funds; Lundbeck Foundation(Lundbeckfonden); Danish Strategic Research Council(Danske Strategiske Forskningsrad (DSF)); Pharmacy Foundation of 1991; Augustinus Foundation; Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Lundbeck Foundation(Lundbeckfonden)	COPSAC is funded by private and public research funds listed on www.copsac.com. The Lundbeck Foundation; The Danish Strategic Research Council; the Pharmacy Foundation of 1991; Augustinus Foundation; the Danish Medical Research Council and The Danish Pediatric Asthma Centre provided the core support for COPSAC research center. No pharmaceutical company was involved in the study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baiz N., 2013, J ALLERGY CLIN IMMUN; Ballardini N, 2006, ALLERGY, V61, P337, DOI 10.1111/j.1398-9995.2005.00936.x; Bisgaard H, 2004, ANN ALLERG ASTHMA IM, V93, P381, DOI 10.1016/S1081-1206(10)61398-1; Bisgaard H, 2006, NEW ENGL J MED, V354, P1998, DOI 10.1056/NEJMoa054692; Bisgaard H, 2011, J ALLERGY CLIN IMMUN; Bisgaard H, 2012, AM J RESP CRIT CARE; Bisgaard H, 2008, PLOS MED, V5, DOI 10.1371/journal.pmed.0050131; Bisgaard H, 2007, NEW ENGL J MED, V357, P1487, DOI 10.1056/NEJMoa052632; Bisgaard H, 2009, AM J RESP CRIT CARE, V179, P179, DOI 10.1164/rccm.200809-1436OC; BraunFahrlander C, 1997, PEDIATR ALLERGY IMMU, V8, P75, DOI 10.1111/j.1399-3038.1997.tb00147.x; Camargo CA, 2007, AM J CLIN NUTR, V85, P788, DOI 10.1093/ajcn/85.3.788; Camargo CA, 2011, PEDIATRICS, V127, pE180, DOI 10.1542/peds.2010-0442; Chawes BLK, 2009, ALLERGY, V64, P1547, DOI 10.1111/j.1398-9995.2009.02085.x; Chawes BLK, 2012, J ALLERGY CLIN IMMUN, V130, P354, DOI 10.1016/j.jaci.2012.04.045; Chawes BLK, 2010, AM J RESP CRIT CARE, V182, P138, DOI 10.1164/rccm.200909-1377OC; Chawes BLK, 2010, J ALLERGY CLIN IMMUN, V126, P567, DOI 10.1016/j.jaci.2010.06.026; Chawes BLK, 2010, CHEST, V137, P1332, DOI 10.1378/chest.09-2601; Devereux G, 2007, AM J CLIN NUTR, V85, P853, DOI 10.1093/ajcn/85.3.853; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Halkjaer LB, 2006, ARCH DERMATOL, V142, P561, DOI 10.1001/archderm.142.5.561; Hojskov CS, 2010, CLIN CHIM ACTA, V411, P114, DOI 10.1016/j.cca.2009.10.010; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Hollams EM, 2012, CURR OPIN ALLERGY CL, V12, P228, DOI 10.1097/ACI.0b013e3283534a32; Jones AP, 2012, PEDIATRICS, V130, pE1128, DOI 10.1542/peds.2012-1172; Litonjua AA, 2007, J ALLERGY CLIN IMMUN, V120, P1031, DOI 10.1016/j.jaci.2007.08.028; Litonjua AA, 2009, CURR OPIN ALLERGY CL, V9, P202, DOI 10.1097/ACI.0b013e32832b36cd; Liu X, 2013, PEDIATR RES, V74, P321, DOI 10.1038/pr.2013.110; Loland L, 2006, CHEST, V129, P669, DOI 10.1378/chest.129.3.669; Loland L, 2008, CHEST, V133, P115, DOI 10.1378/chest.07-1328; Maunsell Z, 2005, CLIN CHEM, V51, P1683, DOI 10.1373/clinchem.2005.052936; Miyake Y, 2010, EUR RESPIR J, V35, P1228, DOI 10.1183/09031936.00100609; Morales E, 2012, EPIDEMIOLOGY, V23, P64, DOI 10.1097/EDE.0b013e31823a44d3; Sichert-Hellert W, 2006, J NUTR, V136, P1329, DOI 10.1093/jn/136.5.1329; Sorensen M, 2007, BIOMARKERS, V12, P38, DOI 10.1080/13547500600943148; Vissing NH, 2013, AM J RESP CRIT CARE, V188, P1246, DOI 10.1164/rccm.201302-0215OC; Wickman M, 2003, PEDIATR ALLERGY IMMU, V14, P441, DOI 10.1046/j.0905-6157.2003.00079.x; Wjst M, 2006, PEDIAT ALLERG IMM-UK, V17, P477, DOI 10.1111/j.1399-3038.2006.00456.x; Yim S, 2007, J CYST FIBROS, V6, P403, DOI 10.1016/j.jcf.2007.03.003; Zosky GR, 2011, AM J RESP CRIT CARE, V183, P1336, DOI 10.1164/rccm.201010-1596OC	39	77	81	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99856	10.1371/journal.pone.0099856	http://dx.doi.org/10.1371/journal.pone.0099856			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925304	Green Submitted, Green Published, gold			2022-12-27	WOS:000338701300101
J	Li, CC; Hou, YC; Yeh, CL; Yeh, SL				Li, Cheng-Chung; Hou, Yu-Chen; Yeh, Chiu-Li; Yeh, Sung-Ling			RETRACTED: Effects of Eicosapentaenoic Acid and Docosahexaenoic Acid on Prostate Cancer Cell Migration and Invasion Induced by Tumor-Associated Macrophages (Retracted article. See vol. 12, e0173325, 2017)	PLOS ONE			English	Article; Retracted Publication							ACTIVATED-RECEPTOR-GAMMA; NF-KAPPA-B; N-3 FATTY-ACIDS; BREAST-CANCER; PPAR-GAMMA; MATRIX METALLOPROTEINASES; IN-VIVO; MACROPHAGES; EXPRESSION; PATHWAY	Eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) are the major n-3 polyunsaturated fatty acids (PUFAs) in fish oil that decrease the risk of prostate cancer. Tumor-associated macrophages (TAMs) are the main leukocytes of intratumoral infiltration, and increased TAMs correlates with poor prostate cancer prognosis. However, the mechanism of n-3 PUFAs on prostate cancer cell progression induced by TAMs is not well understood. In this study, we investigated the effects of EPA and DHA on modulating of migration and invasion of prostate cancer cells induced by TAMs-like M2-type macrophages. PC-3 prostate cancer cells were pretreated with EPA, DHA, or the peroxisome proliferator-activated receptor (PPAR)-gamma antagonist, GW9662, before exposure to conditioned medium (CM). CM was derived from M2-polarized THP-1 macrophages. The migratory and invasive abilities of PC-3 cells were evaluated using a coculture system of M2-type macrophages and PC-3 cells. EPA/DHA administration decreased migration and invasion of PC-3 cells. The PPAR-gamma DNA-binding activity and cytosolic inhibitory factor kappa B alpha (I kappa B alpha) protein expression increased while the nuclear factor (NF)-kappa B p65 transcriptional activity and nuclear NF-kappa B p65 protein level decreased in PC-3 cells incubated with CM in the presence of EPA/DHA. Further, EPA/DHA downregulated mRNA expressions of matrix metalloproteinase-9, cyclooxygenase-2, vascular endothelial growth factor, and macrophage colony-stimulating factor. Pretreatment with GW9662 abolished the favorable effects of EPA/DHA on PC-3 cells. These results indicate that EPA/DHA administration reduced migration, invasion and macrophage chemotaxis of PC-3 cells induced by TAM-like M2-type macrophages, which may partly be explained by activation of PPAR-gamma and decreased NF-kappa B p65 transcriptional activity.	[Li, Cheng-Chung; Yeh, Sung-Ling] Taipei Med Univ, Sch Nutr & Hlth Sci, Coll Publ Hlth & Nutr, Taipei, Taiwan; [Hou, Yu-Chen] Natl Taiwan Univ, Dept Surg, Taipei 10764, Taiwan; [Yeh, Chiu-Li] Chinese Culture Univ, Dept Nutr & Hlth Sci, Taipei, Taiwan	Taipei Medical University; National Taiwan University; Chinese Culture University	Yeh, SL (corresponding author), Taipei Med Univ, Sch Nutr & Hlth Sci, Coll Publ Hlth & Nutr, Taipei, Taiwan.	sangling@tmu.edu.tw			National Science Council Taipei, Taiwan [NSC 100-2320-B-038-009]	National Science Council Taipei, Taiwan(Ministry of Science and Technology, Taiwan)	This study was supported by the National Science Council grant NSC 100-2320-B-038-009 Taipei, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allavena P, 2008, CRIT REV ONCOL HEMAT, V66, P1, DOI 10.1016/j.critrevonc.2007.07.004; Allred CD, 2008, J NUTR, V138, P250, DOI 10.1093/jn/138.2.250; Annicotte JS, 2006, MOL CELL BIOL, V26, P7561, DOI 10.1128/MCB.00605-06; Augustsson K, 2003, CANCER EPIDEM BIOMAR, V12, P64; Bocci G, 2004, CANCER RES, V64, P6616, DOI 10.1158/0008-5472.CAN-04-0401; Chen Pin-Shern, 2011, PLoS One, V6, pe20164, DOI 10.1371/journal.pone.0020164; Colombo MP, 2005, CANCER RES, V65, P9113, DOI 10.1158/0008-5472.CAN-05-2714; DeCicco KL, 2004, CARCINOGENESIS, V25, P1805, DOI 10.1093/carcin/bgh210; DeNardo DG, 2009, CANCER CELL, V16, P91, DOI 10.1016/j.ccr.2009.06.018; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Edwards IJ, 2008, J BIOL CHEM, V283, P18441, DOI 10.1074/jbc.M802107200; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Greenhough A, 2009, CARCINOGENESIS, V30, P377, DOI 10.1093/carcin/bgp014; Guyton K, 2003, SHOCK, V20, P56, DOI 10.1097/01.shk.0000070903.21762.f8; Hagemann T, 2005, J IMMUNOL, V175, P1197, DOI 10.4049/jimmunol.175.2.1197; Hebert JR, 1998, JNCI-J NATL CANCER I, V90, P1637, DOI 10.1093/jnci/90.21.1637; Hotchkiss KA, 2003, CANCER RES, V63, P527; Huang FR, 2011, BRIT J NUTR, V105, P348, DOI 10.1017/S0007114510003703; Huang SY, 2001, ONCOGENE, V20, P4188, DOI 10.1038/sj.onc.1204535; Ide H, 2002, P NATL ACAD SCI USA, V99, P14404, DOI 10.1073/pnas.222537099; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Jinga DC, 2006, J CELL MOL MED, V10, P499, DOI 10.1111/j.1582-4934.2006.tb00415.x; Kaikkonen S, 2013, MOL ENDOCRINOL, V27, P212, DOI 10.1210/me.2012-1313; Kim HK, 2006, J NUTR, V136, P2965, DOI 10.1093/jn/136.12.2965; Kobayashi M, 1999, JPN J CANCER RES, V90, P914, DOI 10.1111/j.1349-7006.1999.tb00835.x; Kobayashi N, 2006, CLIN CANCER RES, V12, P4662, DOI 10.1158/1078-0432.CCR-06-0459; Lehrer S, 2004, TECHNOL CANCER RES T, V3, P411, DOI 10.1177/153303460400300501; Li M, 2000, MOL CELL BIOL, V20, P4699, DOI 10.1128/MCB.20.13.4699-4707.2000; Li QT, 2002, NAT REV IMMUNOL, V2, P725, DOI 10.1038/nri910; Lichtinghagen R, 2002, EUR UROL, V42, P398, DOI 10.1016/S0302-2838(02)00324-X; Lin EY, 2007, CANCER RES, V67, P5064, DOI 10.1158/0008-5472.CAN-07-0912; Lin EY, 2001, J EXP MED, V193, P727, DOI 10.1084/jem.193.6.727; Lissbrant IF, 2000, INT J ONCOL, V17, P445; Loberg RD, 2007, NEOPLASIA, V9, P556, DOI 10.1593/neo.07307; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Mizutani K, 2009, NEOPLASIA, V11, P1235, DOI 10.1593/neo.09988; Mueller E, 2000, P NATL ACAD SCI USA, V97, P10990, DOI 10.1073/pnas.180329197; Nagata Daisuke, 2008, Cancer Detect Prev, V32, P259, DOI 10.1016/j.cdp.2008.05.008; Niederberger E, 2008, FASEB J, V22, P3432, DOI 10.1096/fj.08-109355; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Park BH, 2011, J BIOL CHEM, V286, P20087, DOI 10.1074/jbc.M110.191718; Philibert A, 2006, AM J CLIN NUTR, V84, P1299, DOI 10.1093/ajcn/84.6.1299; Pollard AJ, 2004, CELL MICROBIOL, V6, P638, DOI 10.1111/j.1462-5822.2004.00388.x; Pollard JW, 2009, NAT REV IMMUNOL, V9, P259, DOI 10.1038/nri2528; Pruthi RS, 2003, J UROLOGY, V169, P2352, DOI 10.1097/01.ju.0000047364.56051.74; Rosen ED, 2001, J BIOL CHEM, V276, P37731, DOI 10.1074/jbc.R100034200; Sakurai H, 1999, J BIOL CHEM, V274, P30353, DOI 10.1074/jbc.274.43.30353; Shen D, 2007, POSTGRAD MED J, V83, P414, DOI 10.1136/pmj.2006.052761; Sica A, 2006, EUR J CANCER, V42, P717, DOI 10.1016/j.ejca.2006.01.003; Solinas G, 2009, J LEUKOCYTE BIOL, V86, P1065, DOI 10.1189/jlb.0609385; Sroka IC, 2011, MOL CANCER RES, V9, P1319, DOI 10.1158/1541-7786.MCR-11-0080; Stewart DA, 2012, MOL CANCER RES, V10, P727, DOI 10.1158/1541-7786.MCR-11-0604; Sun H, 2008, CANCER RES, V68, P2912, DOI 10.1158/0008-5472.CAN-07-2305; Tjiu JW, 2009, J INVEST DERMATOL, V129, P1016, DOI 10.1038/jid.2008.310; Visse R, 2003, CIRC RES, V92, P827, DOI 10.1161/01.RES.0000070112.80711.3D; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Yang YJ, 1999, CLIN BIOCHEM, V32, P405, DOI 10.1016/S0009-9120(99)00036-3; Zerbini LF, 2003, CANCER RES, V63, P2206	58	22	22	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99630	10.1371/journal.pone.0099630	http://dx.doi.org/10.1371/journal.pone.0099630			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925287	gold, Green Published			2022-12-27	WOS:000338701300082
J	Li, XT; De Beuckelaer, A; Guo, JH; Ma, FL; Xu, M; Liu, J				Li, Xueting; De Beuckelaer, Alain; Guo, Jiahui; Ma, Feilong; Xu, Miao; Liu, Jia			The Gray Matter Volume of the Amygdala Is Correlated with the Perception of Melodic Intervals: A Voxel-Based Morphometry Study	PLOS ONE			English	Article							MAJOR DEPRESSIVE DISORDER; EMOTION RECOGNITION; CORTICAL THICKNESS; CONGENITAL AMUSIA; STRESS REDUCTION; BIPOLAR DISORDER; AUDITORY-CORTEX; FUNCTIONAL MRI; MUSIC; DAMAGE	Music is not simply a series of organized pitches, rhythms, and timbres, it is capable of evoking emotions. In the present study, voxel-based morphometry (VBM) was employed to explore the neural basis that may link music to emotion. To do this, we identified the neuroanatomical correlates of the ability to extract pitch interval size in a music segment (i.e., interval perception) in a large population of healthy young adults (N = 264). Behaviorally, we found that interval perception was correlated with daily emotional experiences, indicating the intrinsic link between music and emotion. Neurally, and as expected, we found that interval perception was positively correlated with the gray matter volume (GMV) of the bilateral temporal cortex. More important, a larger GMV of the bilateral amygdala was associated with better interval perception, suggesting that the amygdala, which is the neural substrate of emotional processing, is also involved in music processing. In sum, our study provides one of first neuroanatomical evidence on the association between the amygdala and music, which contributes to our understanding of exactly how music evokes emotional responses.	[Li, Xueting] Renmin Univ China, Dept Psychol, Beijing, Peoples R China; [De Beuckelaer, Alain] Univ Ghent, Dept Personnel Management & Work & Org Psychol, B-9000 Ghent, Belgium; [De Beuckelaer, Alain] Radboud Univ Nijmegen, Inst Management Res, NL-6525 ED Nijmegen, Netherlands; [Guo, Jiahui; Ma, Feilong; Xu, Miao; Liu, Jia] Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China; [Liu, Jia] Beijing Normal Univ, Ctr Collaborat & Innovat Brain & Learning Sci, Beijing 100875, Peoples R China	Renmin University of China; Ghent University; Radboud University Nijmegen; Beijing Normal University; Beijing Normal University	Liu, J (corresponding author), Beijing Normal Univ, Sch Psychol, Beijing 100875, Peoples R China.	liujia@bnu.edu.cn		Liu, Jia/0000-0003-0383-0934; Jiahui, Guo/0000-0002-1528-9025	National Social Science Foundation of China [11ZD187]; National Natural Science Foundation of China [91132703]	National Social Science Foundation of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study is funded by the National Social Science Foundation of China (11&ZD187) and the National Natural Science Foundation of China (91132703). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adolphs R, 2004, J COGNITIVE NEUROSCI, V16, P453, DOI 10.1162/089892904322926782; Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291; Adolphs R, 2008, CURR OPIN NEUROBIOL, V18, P166, DOI 10.1016/j.conb.2008.06.006; Albouy P, 2013, BRAIN, V136, P1639, DOI 10.1093/brain/awt082; Altshuler LL, 1998, ARCH GEN PSYCHIAT, V55, P663, DOI 10.1001/archpsyc.55.7.663; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Ball T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000307; Bermudez P, 2009, CEREB CORTEX, V19, P1583, DOI 10.1093/cercor/bhn196; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bora E, 2012, J AFFECT DISORDERS, V138, P9, DOI 10.1016/j.jad.2011.03.049; Broks P, 1998, NEUROPSYCHOLOGIA, V36, P59, DOI 10.1016/S0028-3932(97)00105-X; Brown S, 2007, BRAIN COGNITION, V63, P59, DOI 10.1016/j.bandc.2006.08.006; Button KS, 2013, NAT REV NEUROSCI, V14, P365, DOI 10.1038/nrn3475; Caetano SC, 2004, PSYCHIAT RES-NEUROIM, V132, P141, DOI 10.1016/j.psychresns.2004.08.002; CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0; Calder AJ, 1996, COGNITIVE NEUROPSYCH, V13, P699, DOI 10.1080/026432996381890; Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812; Doeller CF, 2003, NEUROIMAGE, V20, P1270, DOI 10.1016/S1053-8119(03)00389-6; Driessen M, 2000, ARCH GEN PSYCHIAT, V57, P1115, DOI 10.1001/archpsyc.57.12.1115; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Ferguson YL, 2013, J POSIT PSYCHOL, V8, P23, DOI 10.1080/17439760.2012.747000; Foster NEV, 2010, NEUROIMAGE, V53, P26, DOI 10.1016/j.neuroimage.2010.06.042; Foster NEV, 2010, CEREB CORTEX, V20, P1350, DOI 10.1093/cercor/bhp199; Gaser C, 2003, J NEUROSCI, V23, P9240; Gianaros PJ, 2008, J NEUROSCI, V28, P990, DOI 10.1523/JNEUROSCI.3606-07.2008; Good CD, 2001, NEUROIMAGE, V14, P685, DOI 10.1006/nimg.2001.0857; Gosselin N, 2005, BRAIN, V128, P628, DOI 10.1093/brain/awh420; Gosselin N, 2007, NEUROPSYCHOLOGIA, V45, P236, DOI 10.1016/j.neuropsychologia.2006.07.012; Griffiths TD, 2004, J NEUROL NEUROSUR PS, V75, P344; Hamilton JP, 2008, MOL PSYCHIATR, V13, P993, DOI 10.1038/mp.2008.57; Holzel BK, 2010, SOC COGN AFFECT NEUR, V5, P11, DOI 10.1093/scan/nsp034; Hyde KL, 2007, J NEUROSCI, V27, P13028, DOI 10.1523/JNEUROSCI.3039-07.2007; Ising H, 2004, Noise Health, V6, P5; Klein ME, 2011, NEUROPSYCHOLOGIA, V49, P878, DOI 10.1016/j.neuropsychologia.2011.01.008; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2013, NEUROIMAGE, V81, P49, DOI 10.1016/j.neuroimage.2013.05.008; Koelsch S, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00110; Koelsch S, 2008, NEUROREPORT, V19, P1815, DOI 10.1097/WNR.0b013e32831a8722; Lamont A, 2011, MUSIC SCI, V15, P229, DOI 10.1177/1029864911403368; LeDoux J, 2007, CURR BIOL, V17, pR868, DOI 10.1016/j.cub.2007.08.005; Leonard, 1956, EMOTION MEANING MUSI; Lerner Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006230; Mitterschiffthaler MT, 2007, HUM BRAIN MAPP, V28, P1150, DOI 10.1002/hbm.20337; Nacewicz BM, 2006, ARCH GEN PSYCHIAT, V63, P1417, DOI 10.1001/archpsyc.63.12.1417; Nilsson U, 2005, EUR J ANAESTH, V22, P96, DOI 10.1017/S0265021505000189; Patterson RD, 2010, SPRINGER HANDB AUDIT, V36, P13, DOI 10.1007/978-1-4419-6114-3_2; Peretz I, 2003, ANN NY ACAD SCI, V999, P58, DOI 10.1196/annals.1284.006; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Raven J.C., 1998, ADV PROGR MATRICES; Rogers MA, 2009, PSYCHIAT RES-NEUROIM, V174, P210, DOI 10.1016/j.pscychresns.2009.06.001; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Savitz J, 2010, NEUROIMAGE, V49, P2966, DOI 10.1016/j.neuroimage.2009.11.025; Schmahl CG, 2003, PSYCHIAT RES-NEUROIM, V122, P193, DOI 10.1016/S0925-4927(03)00023-4; Schneider P, 2002, NAT NEUROSCI, V5, P688, DOI 10.1038/nn871; Schwenzer M, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-26; Sendelbach SE, 2006, J CARDIOVASC NURS, V21, P194, DOI 10.1097/00005082-200605000-00007; Sheline YI, 1998, NEUROREPORT, V9, P2023, DOI 10.1097/00001756-199806220-00021; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Strakowski SM, 1999, ARCH GEN PSYCHIAT, V56, P254, DOI 10.1001/archpsyc.56.3.254; Tottenham N, 2010, DEVELOPMENTAL SCI, V13, P46, DOI 10.1111/j.1467-7687.2009.00852.x; Wang SM, 2002, ANESTH ANALG, V94, P1489, DOI 10.1097/00000539-200206000-00021; Wehrum S, 2011, BRAIN RES, V1402, P80, DOI 10.1016/j.brainres.2011.05.057; White JK, 2004, PERS INDIV DIFFER, V37, P1519, DOI 10.1016/j.paid.2004.02.019	65	4	4	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99889	10.1371/journal.pone.0099889	http://dx.doi.org/10.1371/journal.pone.0099889			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923421	Green Published, gold			2022-12-27	WOS:000338701300105
J	Shapovalov, MV; Wang, Q; Xu, QF; Andrake, M; Dunbrack, RL				Shapovalov, Maxim V.; Wang, Qiang; Xu, Qifang; Andrake, Mark; Dunbrack, Roland L., Jr.			BioAssemblyModeler (BAM): User-Friendly Homology Modeling of Protein Homo- and Heterooligomers	PLOS ONE			English	Article							PREDICTION; DATABASE; PISCES; SERVER	Many if not most proteins function in oligomeric assemblies of one or more protein sequences. The Protein Data Bank provides coordinates for biological assemblies for each entry, at least 60% of which are dimers or larger assemblies. BioAssemblyModeler (BAM) is a graphical user interface to the basic steps in homology modeling of protein homooligomers and heterooligomers from the biological assemblies provided in the PDB. BAM takes as input up to six different protein sequences and begins by assigning Pfam domains to the target sequences. The program utilizes a complete assignment of Pfam domains to sequences in the PDB, PDBfam (http://dunbrack2.fccc.edu/protcid/pdbfam), to obtain templates that contain any or all of the domains assigned to the target sequence(s). The contents of the biological assemblies of potential templates are provided, and alignments of the target sequences to the templates are produced with a profile-profile alignment algorithm. BAM provides for visual examination and mouse-editing of the alignments supported by target and template secondary structure information and a 3D viewer of the template biological assembly. Side-chain coordinates for a model of the biological assembly are built with the program SCWRL4. A built-in protocol navigation system guides the user through all stages of homology modeling from input sequences to a three-dimensional model of the target complex.	[Shapovalov, Maxim V.; Wang, Qiang; Xu, Qifang; Andrake, Mark; Dunbrack, Roland L., Jr.] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA	Fox Chase Cancer Center	Dunbrack, RL (corresponding author), Fox Chase Canc Ctr, Inst Canc Res, 7701 Burholme Ave, Philadelphia, PA 19111 USA.	Roland.Dunbrack@fccc.edu	Dunbrack, Roland/ABG-7141-2020	Dunbrack, Roland/0000-0001-7674-6667	National Institutes of Health [R01 GM084453]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084453] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by National Institutes of Health grant R01 GM084453. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Fukuhara N, 2008, NUCLEIC ACIDS RES, V36, pW185, DOI 10.1093/nar/gkn218; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Hamp T, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002623; Kittichotirat W, 2009, NUCLEIC ACIDS RES, V37, pW519, DOI 10.1093/nar/gkp306; Koh GCKW, 2012, J PROTEOME RES, V11, P2014, DOI 10.1021/pr201211w; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Krivov GG, 2009, PROTEINS, V77, P778, DOI 10.1002/prot.22488; Kundrotas PJ, 2012, P NATL ACAD SCI USA, V109, P9438, DOI 10.1073/pnas.1200678109; Li CQ, 2010, MOL CELL BIOL, V30, P116, DOI 10.1128/MCB.01876-08; Magrane M, 2011, DATABASE-OXFORD, DOI 10.1093/database/bar009; Mosca R, 2013, NAT METHODS, V10, P47, DOI [10.1038/NMETH.2289, 10.1038/nmeth.2289]; Mukherjee S, 2011, STRUCTURE, V19, P955, DOI 10.1016/j.str.2011.04.006; Nickel J, 2009, CYTOKINE GROWTH F R, V20, P367, DOI 10.1016/j.cytogfr.2009.10.022; Roberts JL, 2012, P NATL ACAD SCI USA, V109, P10456, DOI 10.1073/pnas.1202249109; Sayers EW, 2019, NUCLEIC ACIDS RES, V47, pD23, DOI [10.1093/nar/gkr1184, 10.1093/nar/gks1189, 10.1093/nar/gky1069]; Shapovalov MV, 2011, STRUCTURE, V19, P844, DOI 10.1016/j.str.2011.03.019; Soding J, 2011, CURR OPIN STRUC BIOL, V21, P404, DOI 10.1016/j.sbi.2011.03.005; TRAUT TW, 1994, CRIT REV BIOCHEM MOL, V29, P125, DOI 10.3109/10409239409086799; Wang GL, 2005, NUCLEIC ACIDS RES, V33, pW94, DOI 10.1093/nar/gki402; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Wang GL, 2004, PROTEIN SCI, V13, P1612, DOI 10.1110/ps.03601504; Wei Q, 2013, PROTEINS, V81, P199, DOI 10.1002/prot.24176; Wei QO, 2010, PROTEINS, V78, P2058, DOI 10.1002/prot.22722; Xu QF, 2008, J MOL BIOL, V381, P487, DOI 10.1016/j.jmb.2008.06.002; Xu QF, 2006, BIOINFORMATICS, V22, P2876, DOI 10.1093/bioinformatics/btl490; Xu QF, 2012, BIOINFORMATICS, V28, P2763, DOI 10.1093/bioinformatics/bts533; Xu QF, 2011, NUCLEIC ACIDS RES, V39, pD761, DOI 10.1093/nar/gkq1059; Ye YZ, 2003, BIOINFORMATICS, V19, pII246, DOI 10.1093/bioinformatics/btg1086	29	15	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98309	10.1371/journal.pone.0098309	http://dx.doi.org/10.1371/journal.pone.0098309			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922057	Green Submitted, Green Published, gold			2022-12-27	WOS:000338701300007
J	Zenzeri, J; De Santis, D; Morasso, P				Zenzeri, Jacopo; De Santis, Dalia; Morasso, Pietro			Strategy Switching in the Stabilization of Unstable Dynamics	PLOS ONE			English	Article							MULTIJOINT ARM; MOTOR MEMORY; BODY SCHEMA; INVERTED PENDULUM; ANKLE STIFFNESS; SYSTEM; INSTABILITY; ADAPTATION; STABILITY; MOVEMENTS	In order to understand mechanisms of strategy switching in the stabilization of unstable dynamics, this work investigates how human subjects learn to become skilled users of an underactuated bimanual tool in an unstable environment. The tool, which consists of a mass and two hand-held non-linear springs, is affected by a saddle-like force-field. The non-linearity of the springs allows the users to determine size and orientation of the tool stiffness ellipse, by using different patterns of bimanual coordination: minimal stiffness occurs when the two spring terminals are aligned and stiffness size grows by stretching them apart. Tool parameters were set such that minimal stiffness is insufficient to provide stable equilibrium whereas asymptotic stability can be achieved with sufficient stretching, although at the expense of greater effort. As a consequence, tool users have two possible strategies for stabilizing the mass in different regions of the workspace: 1) high stiffness feedforward strategy, aiming at asymptotic stability and 2) low stiffness positional feedback strategy aiming at bounded stability. The tool was simulated by a bimanual haptic robot with direct torque control of the motors. In a previous study we analyzed the behavior of naive users and we found that they spontaneously clustered into two groups of approximately equal size. In this study we trained subjects to become expert users of both strategies in a discrete reaching task. Then we tested generalization capabilities and mechanism of strategy-switching by means of stabilization tasks which consist of tracking moving targets in the workspace. The uniqueness of the experimental setup is that it addresses the general problem of strategy-switching in an unstable environment, suggesting that complex behaviors cannot be explained in terms of a global optimization criterion but rather require the ability to switch between different sub-optimal mechanisms.	[Zenzeri, Jacopo; De Santis, Dalia; Morasso, Pietro] Ist Italiano Tecnol, Robot Brain & Cognit Sci Dept, Genoa, Italy	Istituto Italiano di Tecnologia - IIT	Zenzeri, J (corresponding author), Ist Italiano Tecnol, Robot Brain & Cognit Sci Dept, Genoa, Italy.	jacopo.zenzeri@iit.it	Zenzeri, Jacopo/X-5206-2019	Zenzeri, Jacopo/0000-0001-5536-1960	RBCS Dept. of the Istituto Italiano di Tecnologia; ACIRAS (Ausili CIbernetici Riabilitativi per la diagnosi e la valutazione quantitativa della disabilita motoria dell'Arto Superiore nei bambini e negli adulti) Project; Regione Liguria; DARWIN EU Project [FP7-270138]	RBCS Dept. of the Istituto Italiano di Tecnologia; ACIRAS (Ausili CIbernetici Riabilitativi per la diagnosi e la valutazione quantitativa della disabilita motoria dell'Arto Superiore nei bambini e negli adulti) Project; Regione Liguria(Regione Liguria); DARWIN EU Project	This research was supported by the RBCS Dept. of the Istituto Italiano di Tecnologia, ACIRAS (Ausili CIbernetici Riabilitativi per la diagnosi e la valutazione quantitativa della disabilita motoria dell'Arto Superiore nei bambini e negli adulti) Project, Regione Liguria, and DARWIN EU Project (Grant No: FP7-270138). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; Berniker M, 2014, J NEUROPHYSIOL, V111, P1165, DOI 10.1152/jn.00493.2013; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; BrashersKrug T, 1996, NATURE, V382, P252, DOI 10.1038/382252a0; Burdet E, 2001, NATURE, V414, P446, DOI 10.1038/35106566; Caithness G, 2004, J NEUROSCI, V24, P8662, DOI 10.1523/JNEUROSCI.2214-04.2004; Casadio M, 2005, GAIT POSTURE, V21, P410, DOI 10.1016/j.gaitpost.2004.05.005; Casadio Maura, 2006, Technol Health Care, V14, P123; Conditt MA, 1997, J NEUROPHYSIOL, V78, P554, DOI 10.1152/jn.1997.78.1.554; De Santis D, 2013, ADV INTELL SYST, V196, P109; Franklin DW, 2007, J NEUROSCI, V27, P7705, DOI 10.1523/JNEUROSCI.0968-07.2007; Franklin DW, 2003, EXP BRAIN RES, V151, P145, DOI 10.1007/s00221-003-1443-3; Gandolfo F, 1996, P NATL ACAD SCI USA, V93, P3843, DOI 10.1073/pnas.93.9.3843; Ganesh G, 2010, J NEUROPHYSIOL, V104, P382, DOI 10.1152/jn.01058.2009; Gomi H, 1998, J NEUROSCI, V18, P8965; Gomi H, 1997, BIOL CYBERN, V76, P163, DOI 10.1007/s004220050329; Hamilton AFD, 2004, EXP BRAIN RES, V157, P417, DOI 10.1007/s00221-004-1856-7; Harris CM, 1998, NATURE, V394, P780, DOI 10.1038/29528; HOGAN N, 1984, IEEE T AUTOMAT CONTR, V29, P681, DOI 10.1109/TAC.1984.1103644; Howard IS, 2010, J NEUROPHYSIOL, V104, P2082, DOI 10.1152/jn.00299.2010; Iriki A, 1996, NEUROREPORT, V7, P2325; Karniel A, 2002, EXP BRAIN RES, V143, P520, DOI 10.1007/s00221-002-1054-4; Lakie M, 2003, J PHYSIOL-LONDON, V551, P357, DOI 10.1113/jphysiol.2002.036939; Loram ID, 2007, J PHYSIOL-LONDON, V584, P661, DOI 10.1113/jphysiol.2007.140046; Loram ID, 2011, J PHYSIOL-LONDON, V589, P307, DOI 10.1113/jphysiol.2010.194712; Loram ID, 2002, J PHYSIOL-LONDON, V545, P1041, DOI 10.1113/jphysiol.2002.025049; Malfait N, 2002, J NEUROSCI, V22, P9656; Malfait N, 2005, J NEUROPHYSIOL, V93, P3327, DOI 10.1152/jn.00883.2004; Maravita A, 2004, TRENDS COGN SCI, V8, P79, DOI 10.1016/j.tics.2003.12.008; Mattar AAG, 2007, J NEUROPHYSIOL, V97, P220, DOI 10.1152/jn.00736.2006; McIntyre J, 1996, EXP BRAIN RES, V110, P248; Milner TE, 1998, IEEE T BIO-MED ENG, V45, P1363, DOI 10.1109/10.725333; Milton J, 2009, PHILOS T R SOC A, V367, P1181, DOI 10.1098/rsta.2008.0257; Mohan V, 2011, FRONTIERS NEUROROBOT, V5, P1, DOI DOI 10.3389/FNB0T.2011.00004); Morasso P., 2013, INT J MACH CONSCIOUS, V05, P75, DOI [10.1142/S1793843013400064, DOI 10.1142/S1793843013400064]; Perreault EJ, 2004, EXP BRAIN RES, V157, P507, DOI 10.1007/s00221-004-1864-7; Saha DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030301; Selen LPJ, 2009, J NEUROSCI, V29, P12606, DOI 10.1523/JNEUROSCI.2826-09.2009; SHADMEHR R, 1994, J NEUROSCI, V14, P3208; Shadmehr R, 1997, J NEUROSCI, V17, P409, DOI 10.1523/JNEUROSCI.17-01-00409.1997; Shadmehr R, 2000, J NEUROSCI, V20, P7807; Visalberghi E, 1998, BEHAV PROCESS, V42, P189, DOI 10.1016/S0376-6357(97)00076-4; VISALBERGHI E, 1993, TOOLS, LANGUAGE AND COGNITION IN HUMAN EVOLUTION, P138; Visalberghi Elisabetta, 1996, P57; Weir AAS, 2002, SCIENCE, V297, P981, DOI 10.1126/science.1073433; Zenzeri J, 2011, IEEE ENG MED BIO, P3115, DOI 10.1109/IEMBS.2011.6090850	46	27	27	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99087	10.1371/journal.pone.0099087	http://dx.doi.org/10.1371/journal.pone.0099087			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921254	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300025
J	Giachin, G; Narkiewicz, J; Scaini, D; Ngoc, AT; Margon, A; Sequi, P; Leita, L; Legname, G				Giachin, Gabriele; Narkiewicz, Joanna; Scaini, Denis; Ai Tran Ngoc; Margon, Alja; Sequi, Paolo; Leita, Liviana; Legname, Giuseppe			Prion Protein Interaction with Soil Humic Substances: Environmental Implications	PLOS ONE			English	Article							INSECTICIDAL CRY1AB PROTEIN; FULVIC-ACID; ORGANIC-MATTER; HURNIC ACID; ADSORPTION; TRANSMISSION; FATE; AFM; FRACTIONATION; AGGREGATION	Transmissible spongiform encephalopathies (TSE) are fatal neurodegenerative disorders caused by prions. Animal TSE include scrapie in sheep and goats, and chronic wasting disease (CWD) in cervids. Effective management of scrapie in many parts of the world, and of CWD in North American deer population is complicated by the persistence of prions in the environment. After shedding from diseased animals, prions persist in soil, withstanding biotic and abiotic degradation. As soil is a complex, multi-component system of both mineral and organic components, it is important to understand which soil compounds may interact with prions and thus contribute to disease transmission. Several studies have investigated the role of different soil minerals in prion adsorption and infectivity; we focused our attention on the interaction of soil organic components, the humic substances (HS), with recombinant prion protein (recPrP) material. We evaluated the kinetics of recPrP adsorption, providing a structural and biochemical characterization of chemical adducts using different experimental approaches. Here we show that HS act as potent anti-prion agents in prion infected neuronal cells and in the amyloid seeding assays: HS adsorb both recPrP and prions, thus sequestering them from the prion replication process. We interpreted our findings as highly relevant from an environmental point of view, as the adsorption of prions in HS may affect their availability and consequently hinder the environmental transmission of prion diseases in ruminants.	[Giachin, Gabriele; Narkiewicz, Joanna; Ai Tran Ngoc; Legname, Giuseppe] SISSA, Dept Neurosci, Lab Prion Biol, Trieste, Italy; [Scaini, Denis] Univ Trieste, Dept Life Sci, Trieste, Italy; [Margon, Alja; Sequi, Paolo; Leita, Liviana] Consiglio Ric & Sperimentaz Agr CRA, Gorizia, Italy	International School for Advanced Studies (SISSA); University of Trieste; Consiglio per la Ricerca in Agricoltura e L'analisi Dell'economia Agraria (CREA)	Leita, L (corresponding author), Consiglio Ric & Sperimentaz Agr CRA, Gorizia, Italy.	liviana.leita@entecra.it; giuseppe.legname@sissa.it	Giachin, Gabriele/AAE-2348-2020; Legname, Giuseppe/C-1723-2012; Scaini, Denis/HGU-4752-2022	Giachin, Gabriele/0000-0001-7550-0307; Legname, Giuseppe/0000-0003-0716-4393; Scaini, Denis/0000-0001-8398-8074	Italian Ministry of Agricultural, Food and Forestry Policies "Strategie di abbattimento della trasmissibilita delle Scrapie SCRASU" (Scrapie transmissibility reduction strategies)	Italian Ministry of Agricultural, Food and Forestry Policies "Strategie di abbattimento della trasmissibilita delle Scrapie SCRASU" (Scrapie transmissibility reduction strategies)	Italian Ministry of Agricultural, Food and Forestry Policies "Strategie di abbattimento della trasmissibilita delle Scrapie SCRASU" (Scrapie transmissibility reduction strategies) to GL and LL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEYER WN, 1994, J WILDLIFE MANAGE, V58, P375, DOI 10.2307/3809405; Chen CL, 2007, COLLOID SURFACE A, V302, P121, DOI 10.1016/j.colsurfa.2007.02.014; Cheng S, 2008, J MICROSC-OXFORD, V231, P384, DOI 10.1111/j.1365-2818.2008.02051.x; Colby DW, 2007, P NATL ACAD SCI USA, V104, P20914, DOI 10.1073/pnas.0710152105; Cornejo A, 2011, J ALZHEIMERS DIS, V27, P143, DOI 10.3233/JAD-2011-110623; Corsaro A, 2010, J BIOL REG HOMEOS AG, V24, P27; Ge XP, 2006, SCI CHINA SER B, V49, P256, DOI 10.1007/s11426-006-0256-1; Genovesi S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001069; Georgsson G, 2006, J GEN VIROL, V87, P3737, DOI 10.1099/vir.0.82011-0; Gough KC, 2010, PRION, V4, P275, DOI 10.4161/pri.4.4.13678; GREIG J. R., 1940, VET JOUR, V96, P203; Hoang NAT, 2010, NANOSCALE, V2, P2724, DOI 10.1039/c0nr00551g; Ilc G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011715; Imran M, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-493; Jacobson KH, 2013, ENVIRON SCI TECHNOL, V47, P6925, DOI 10.1021/es3045899; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Leita L, 2006, SOIL BIOL BIOCHEM, V38, P1638, DOI 10.1016/j.soilbio.2005.11.018; Li Y, 2013, ENVIRON SCI TECHNOL, V47, P5050, DOI 10.1021/es3053027; Liu AG, 2000, COLLOID SURFACE A, V174, P245, DOI 10.1016/S0927-7757(00)00535-5; Liu ZG, 2011, MICROSC MICROANAL, V17, P1015, DOI 10.1017/S1431927611012177; Miller MW, 2003, NATURE, V425, P35, DOI 10.1038/425035a; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Moudjou M, 2001, J GEN VIROL, V82, P2017, DOI 10.1099/0022-1317-82-8-2017; Namjesnik-Dejanovic K, 2001, GEOCHIM COSMOCHIM AC, V65, P1047, DOI 10.1016/S0016-7037(00)00542-1; Nebbioso A, 2012, ANAL CHIM ACTA, V720, P77, DOI 10.1016/j.aca.2012.01.027; Nebbioso A, 2011, BIOMACROMOLECULES, V12, P1187, DOI 10.1021/bm101488e; Nichols TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062455; Piccolo A., 2000, ADV ENVIRON RES, V3, P508; Polano M, 2008, BIOCHEM BIOPH RES CO, V367, P323, DOI 10.1016/j.bbrc.2007.12.143; Polano M, 2009, J MOL BIOL, V393, P1033, DOI 10.1016/j.jmb.2009.08.056; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Race BL, 2007, EMERG INFECT DIS, V13, P824, DOI 10.3201/eid1306.070186; Rao MA, 2007, SOIL BIOL BIOCHEM, V39, P493, DOI 10.1016/j.soilbio.2006.08.020; Russo F, 2010, OPEN MAGNETIC RESONA, V3, P84; Sander M, 2012, ENVIRON SCI TECHNOL, V46, P9923, DOI 10.1021/es3022478; Saunders SE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044051; Saunders SE, 2011, J VIROL, V85, P5476, DOI 10.1128/JVI.00282-11; Saunders SE, 2009, ENVIRON SCI TECHNOL, V43, P7728, DOI 10.1021/es901385t; Smith CB, 2014, SOIL BIOL BIOCHEM, V68, P309, DOI 10.1016/j.soilbio.2013.10.005; Smith CB, 2011, J ENVIRON QUAL, V40, P449, DOI 10.2134/jeq2010.0412; Stevenson F.J., 1994, HUMUS CHEM GENESIS C; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Surewicz WK, 2011, TOP CURR CHEM, V305, P135, DOI 10.1007/128_2011_165; Sutton R, 2005, ENVIRON SCI TECHNOL, V39, P9009, DOI 10.1021/es050778q; Tan WF, 2008, GEOCHIM COSMOCHIM AC, V72, P2090, DOI 10.1016/j.gca.2008.02.009; Terry LA, 2003, VET REC, V152, P387, DOI 10.1136/vr.152.13.387; Tomaszewski JE, 2012, ENVIRON SCI TECHNOL, V46, P9932, DOI 10.1021/es302248u; Tomaszewski JE, 2011, ENVIRON SCI TECHNOL, V45, P6003, DOI 10.1021/es200663h; Vilette D, 2008, VET RES, V39, DOI 10.1051/vetres:2007049; Walter WD, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1203; Weissmann C, 2001, PHILOS T R SOC B, V356, P177, DOI 10.1098/rstb.2000.0763; Wyckoff AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058630; Zahn R, 1997, FEBS LETT, V417, P400, DOI 10.1016/S0014-5793(97)01330-6	55	14	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100016	10.1371/journal.pone.0100016	http://dx.doi.org/10.1371/journal.pone.0100016			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937266	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400063
J	Gupta, PSP; Folger, JK; Rajput, SK; Lv, LH; Yao, JB; Ireland, JJ; Smith, GW				Gupta, P. S. P.; Folger, Joseph K.; Rajput, Sandeep K.; Lv, Lihua; Yao, Jianbo; Ireland, James J.; Smith, George W.			Regulation and Regulatory Role of WNT Signaling in Potentiating FSH Action during Bovine Dominant Follicle Selection	PLOS ONE			English	Article							CELL ESTRADIOL PRODUCTION; GRANULOSA-CELLS; STIMULATING-HORMONE; TRANSCRIPT CARTPT; ESTROUS-CYCLE; BETA-CATENIN; COCAINE; EXPRESSION; CATTLE; DEGRADATION	Follicular development occurs in wave like patterns in monotocous species such as cattle and humans and is regulated by a complex interaction of gonadotropins with local intrafollicular regulatory molecules. To further elucidate potential mechanisms controlling dominant follicle selection, granulosa cell RNA harvested from F1 (largest) and F2 (second largest) follicles isolated at predeviation (PD) and onset of diameter deviation (OD) stages of the first follicular wave was subjected to preliminary RNA transcriptome analysis. Expression of numerous WNT system components was observed. Hence experiments were performed to test the hypothesis that WNT signaling modulates FSH action on granulosa cells during follicular waves. Abundance of mRNA for WNT pathway members was evaluated in granulosa cells harvested from follicles at emergence (EM), PD, OD and early dominance (ED) stages of the first follicular wave. In F1 follicles, abundance of CTNNB1 and DVL1 mRNAs was higher and AXIN2 mRNA was lower at ED versus EM stages and DVL1 and FZD6 mRNAs were higher and AXIN2 mRNA was lower in F1 versus F2 follicle at the ED stage. Bovine granulosa cells were treated in vitro with increasing doses of the WNT inhibitor IWR-1+/- maximal stimulatory dose of FSH. IWR-1 treatment blocked the FSH-induced increase in granulosa cell numbers and reduced the FSH-induced increase in estradiol. Granulosa cells were also cultured in the presence or absence of FSH +/- IWR-1 and hormonal regulation of mRNA for WNT pathway members and known FSH targets determined. FSH treatment increased CYP19A1, CCND2, CTNNB1, AXIN2 and FZD6 mRNAs and the stimulatory effect on CYP19A1 mRNA was reduced by IWR-1. In contrast, FSH reduced CARTPT mRNA and IWR-1 partially reversed the inhibitory effect of FSH. Results support temporal and hormonal regulation and a potential role for WNT signaling in potentiating FSH action during dominant follicle selection.	[Gupta, P. S. P.; Folger, Joseph K.; Rajput, Sandeep K.; Smith, George W.] Michigan State Univ, Lab Mammalian Reprod Biol & Genom, E Lansing, MI 48824 USA; [Gupta, P. S. P.; Folger, Joseph K.; Rajput, Sandeep K.; Ireland, James J.; Smith, George W.] Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA; [Lv, Lihua; Smith, George W.] Shanxi Agr Univ, Coll Anim Sci & Technol, Taigu, Shanxi, Peoples R China; [Yao, Jianbo] W Virginia Univ, Div Anim & Nutr Sci, Lab Anim Biotechnol & Genom, Morgantown, WV 26506 USA	Michigan State University; Michigan State University; Shanxi Agricultural University; West Virginia University	Smith, GW (corresponding author), Michigan State Univ, Lab Mammalian Reprod Biol & Genom, E Lansing, MI 48824 USA.	smithge7@msu.edu	Rajput, Sandeep K/F-8857-2015	Rajput, Sandeep K/0000-0001-6450-7773	Department of Biotechnology, Government of India CREST award; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture [2009-65203-05700]; Chinese National Natural Science Fund [31172211]; Michigan State University Reproductive and Developmental Sciences Program; Michigan AgBioResearch	Department of Biotechnology, Government of India CREST award; Agriculture and Food Research Initiative Competitive Grant from the USDA National Institute of Food and Agriculture; Chinese National Natural Science Fund(National Natural Science Foundation of China (NSFC)); Michigan State University Reproductive and Developmental Sciences Program; Michigan AgBioResearch	P.S.P. Gupta was supported at Michigan State University by a Department of Biotechnology, Government of India CREST award. This project was supported by Agriculture and Food Research Initiative Competitive Grant no. 2009-65203-05700 from the USDA National Institute of Food and Agriculture to G. W. S., Chinese National Natural Science Fund Grant no. 31172211 to L. Lv, and funding from the Michigan State University Reproductive and Developmental Sciences Program and Michigan AgBioResearch. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beg MA, 2006, REPRODUCTION, V132, P365, DOI 10.1530/rep.1.01233; Boyer A, 2010, TRENDS ENDOCRIN MET, V21, P25, DOI 10.1016/j.tem.2009.08.005; Castanon BI, 2012, J ANIM SCI, V90, P3789, DOI 10.2527/jas.2011-4696; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Fan HY, 2010, MOL ENDOCRINOL, V24, P1529, DOI 10.1210/me.2010-0141; Folger JK, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111609; Fortune JE, 2001, BIOL REPROD, V65, P648, DOI 10.1095/biolreprod65.3.648; Gifford JAH, 2009, BIOL REPROD, V80, P1282, DOI 10.1095/biolreprod.108.072280; GREENWALD GS, 1994, PHYSL REPRODUCTION, V2, P629, DOI DOI 10.1039/C7RA00224F; Gutierrez CG, 1997, BIOL REPROD, V56, P608, DOI 10.1095/biolreprod56.3.608; Han YY, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.105106; Hunzicker-Dunn M, 2006, CELL SIGNAL, V18, P1351, DOI 10.1016/j.cellsig.2006.02.011; IRELAND JJ, 1983, ENDOCRINOLOGY, V112, P150, DOI 10.1210/endo-112-1-150; Ireland JJ, 2000, J DAIRY SCI, V83, P1648, DOI 10.3168/jds.S0022-0302(00)75033-8; Kolben T, 2012, BIOL CHEM, V393, P1433, DOI 10.1515/hsz-2012-0186; Lapointe Evelyne, 2011, Front Biosci (Schol Ed), V3, P276, DOI 10.2741/s151; Lu JM, 2009, BIOORG MED CHEM LETT, V19, P3825, DOI 10.1016/j.bmcl.2009.04.040; Luo WX, 2006, BIOL REPROD, V75, P217, DOI 10.1095/biolreprod.105.047407; Lv LH, 2009, BIOL REPROD, V81, P580, DOI 10.1095/biolreprod.109.077586; SAS Institute Inc, 2009, SAS ONL DOC 9 2; Scheetz D, 2012, REPROD FERT DEVELOP, V24, P327, DOI 10.1071/RD11020; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Selvaraju S, 2013, DOMEST ANIM ENDOCRIN, V44, P115, DOI 10.1016/j.domaniend.2012.10.002; Sen A, 2008, MOL ENDOCRINOL, V22, P2655, DOI 10.1210/me.2008-0077; Sen A, 2007, ENDOCRINOLOGY, V148, P4400, DOI 10.1210/en.2007-0332; Smith GW, 2010, SOC REPROD FERTIL, V67, P105; Stapp AD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086432; SUNDERLAND SJ, 1994, J REPROD FERTIL, V101, P547, DOI 10.1530/jrf.0.1010547; Wang HX, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.109801; XU ZZ, 1995, BIOL REPROD, V53, P951, DOI 10.1095/biolreprod53.4.951	30	28	30	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100201	10.1371/journal.pone.0100201	http://dx.doi.org/10.1371/journal.pone.0100201			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936794	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400091
J	Brouwer-Visser, J; Lee, J; McCullagh, K; Cossio, MJ; Wang, YH; Huang, GS				Brouwer-Visser, Jurriaan; Lee, Jiyeon; McCullagh, KellyAnne; Cossio, Maria J.; Wang, Yanhua; Huang, Gloria S.			Insulin-Like Growth Factor 2 Silencing Restores Taxol Sensitivity in Drug Resistant Ovarian Cancer	PLOS ONE			English	Article							IGF-II; CELLS; EFFICACY	Drug resistance is an obstacle to the effective treatment of ovarian cancer. We and others have shown that the insulin-like growth factor (IGF) signaling pathway is a novel potential target to overcome drug resistance. The purpose of this study was to validate IGF2 as a potential therapeutic target in drug resistant ovarian cancer and to determine the efficacy of targeting IGF2 in vivo. An analysis of The Cancer Genome Atlas (TCGA) data in the serous ovarian cancer cohort showed that high IGF2 mRNA expression is significantly associated with shortened interval to disease progression and death, clinical indicators of drug resistance. In a genetically diverse panel of ovarian cancer cell lines, the IGF2 mRNA levels measured in cell lines resistant to various microtubule-stabilizing agents including Taxol were found to be significantly elevated compared to the drug sensitive cell lines. The effect of IGF2 knockdown on Taxol resistance was investigated in vitro and in vivo. Transient IGF2 knockdown significantly sensitized drug resistant cells to Taxol treatment. A Taxol-resistant ovarian cancer xenograft model, developed from HEY-T30 cells, exhibited extreme drug resistance, wherein the maximal tolerated dose of Taxol did not delay tumor growth in mice. Blocking the IGF1R (a transmembrane receptor that transmits signals from IGF1 and IGF2) using a monoclonal antibody did not alter the response to Taxol. However, stable IGF2 knockdown using short-hairpin RNA in HEY-T30 effectively restored Taxol sensitivity. These findings validate IGF2 as a potential therapeutic target in drug resistant ovarian cancer and show that directly targeting IGF2 may be a preferable strategy compared with targeting IGF1R alone.	[Brouwer-Visser, Jurriaan; Lee, Jiyeon; McCullagh, KellyAnne; Cossio, Maria J.; Huang, Gloria S.] Albert Einstein Coll Med, Div Gynecol Oncol, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA; [Brouwer-Visser, Jurriaan; Lee, Jiyeon; McCullagh, KellyAnne; Cossio, Maria J.; Wang, Yanhua; Huang, Gloria S.] Montefiore Med Ctr, Bronx, NY 10467 USA; [Wang, Yanhua] Albert Einstein Coll Med, Dept Pathol, Bronx, NY 10467 USA; [Huang, Gloria S.] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA; [Huang, Gloria S.] Albert Einstein Coll Med, Albert Einstein Canc Ctr, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Montefiore Medical Center; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Huang, GS (corresponding author), Albert Einstein Coll Med, Div Gynecol Oncol, Dept Obstet & Gynecol & Womens Hlth, Bronx, NY 10467 USA.	ghuang@montefiore.org	Huang, Gloria/N-6129-2017	Huang, Gloria/0000-0002-0001-888X	National Cancer Institute-National Institute of Child Health and Human Development [K12 HD00849]; American Congress of Obstetricians and Gynecologists through the Reproductive Scientist Development Program award; National Cancer Institute Cancer Center Support grant [P30CA013330]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD000849] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA013330] Funding Source: NIH RePORTER	National Cancer Institute-National Institute of Child Health and Human Development; American Congress of Obstetricians and Gynecologists through the Reproductive Scientist Development Program award; National Cancer Institute Cancer Center Support grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Grant support was provided by the the National Cancer Institute-National Institute of Child Health and Human Development (K12 HD00849) and the American Congress of Obstetricians and Gynecologists through the Reproductive Scientist Development Program award to GSH. The authors acknowledge the use of the Albert Einstein Cancer Center Shared Resources (Flow Cytometry Core, Histology and Comparative Pathology Core), supported by the National Cancer Institute Cancer Center Support grant P30CA013330. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit D, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-134; BAKER J, 1993, CELL, V75, P73, DOI 10.1016/0092-8674(93)90680-O; Ballester M, 2004, BIOTECHNIQUES, V37, P610, DOI 10.2144/04374ST06; Beauchamp MC, 2010, J ONCOL, V2010, DOI 10.1155/2010/257058; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; BUICK RN, 1985, CANCER RES, V45, P3668; Duan Z, 2004, MOL CANC THER; Duguay SJ, 1998, J BIOL CHEM, V273, P18443, DOI 10.1074/jbc.273.29.18443; Eckstein N, 2009, CANCER RES, V69, P2996, DOI 10.1158/0008-5472.CAN-08-3153; EVA A, 1982, NATURE, V295, P116, DOI 10.1038/295116a0; Gallagher EJ, 2011, ENDOCRINOLOGY, V152, P2546, DOI 10.1210/en.2011-0231; Garcia-Echeverria C, 2004, CANCER CELL, V5, P231, DOI 10.1016/S1535-6108(04)00051-0; Garofalo C, 2011, ONCOGENE, V30, P2730, DOI 10.1038/onc.2010.640; Gotlieb WH, 2006, GYNECOL ONCOL, V100, P389, DOI 10.1016/j.ygyno.2005.09.048; Greenall SA, 2013, J BIOL CHEM, V288, P59, DOI 10.1074/jbc.M112.432013; HAMILTON TC, 1984, SEMIN ONCOL, V11, P285; He LF, 2001, MOL CANCER THER, V1, P3; Hope-Roberts M, 2011, BIOTECH HISTOCHEM, V86, P255, DOI 10.3109/10520291003723426; Huang GS, 2010, CLIN CANCER RES, V16, P2999, DOI 10.1158/1078-0432.CCR-09-3233; Huang GS, 2006, CLIN CANCER RES, V12, P298, DOI 10.1158/1078-0432.CCR-05-0229; LEE AV, 1994, MOL CELL ENDOCRINOL, V99, P211, DOI 10.1016/0303-7207(94)90010-8; Marcelletti JF, 2009, LEUKEMIA RES, V33, P769, DOI 10.1016/j.leukres.2008.09.020; Ogawa T, 2010, EUR ARCH OTO-RHINO-L, V267, P1599, DOI 10.1007/s00405-010-1257-4; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Ratajczak MZ, 2013, LEUKEMIA, V27, P773, DOI 10.1038/leu.2012.322; Shahabi S, 2010, GYNECOL ONCOL, V119, P345, DOI 10.1016/j.ygyno.2010.07.005; Sherman-Baust CA, 2011, J OVARIAN RES, V4, DOI 10.1186/1757-2215-4-21; Stordal B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040717; Tazearslan C, 2011, AGING CELL, V10, P551, DOI 10.1111/j.1474-9726.2011.00697.x; Torres K, 1998, CANCER RES, V58, P3620; Ulanet DB, 2010, P NATL ACAD SCI USA, V107, P10791, DOI 10.1073/pnas.0914076107; Vaughan S, 2011, NAT REV CANCER, V11, P719, DOI 10.1038/nrc3144; Wu JD, 2005, CLIN CANCER RES, V11, P3065, DOI 10.1158/1078-0432.CCR-04-1586	33	33	34	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100165	10.1371/journal.pone.0100165	http://dx.doi.org/10.1371/journal.pone.0100165			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932685	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600099
J	Chang, A; Chen, CC; Li, HH; Li, CSR				Chang, Andrew; Chen, Chien-Chung; Li, Hsin-Hung; Li, Chiang-Shan R.			Event-Related Potentials for Post-Error and Post-Conflict Slowing	PLOS ONE			English	Article							STOP-SIGNAL TASK; ANTERIOR CINGULATE CORTEX; FALSE DISCOVERY RATE; COGNITIVE CONTROL; RESPONSE-INHIBITION; BRAIN POTENTIALS; CONTROL MECHANISMS; ANTISACCADE TASK; ADJUSTMENTS; NEGATIVITY	In a reaction time task, people typically slow down following an error or conflict, each called post-error slowing (PES) and post-conflict slowing (PCS). Despite many studies of the cognitive mechanisms, the neural responses of PES and PCS continue to be debated. In this study, we combined high-density array EEG and a stop-signal task to examine event-related potentials of PES and PCS in sixteen young adult participants. The results showed that the amplitude of N2 is greater during PES but not PCS. In contrast, the peak latency of N2 is longer for PCS but not PES. Furthermore, error-positivity (Pe) but not error-related negativity (ERN) was greater in the stop error trials preceding PES than non-PES trials, suggesting that PES is related to participants' awareness of the error. Together, these findings extend earlier work of cognitive control by specifying the neural correlates of PES and PCS in the stop signal task.	[Chang, Andrew; Chen, Chien-Chung; Li, Hsin-Hung] Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan; [Chen, Chien-Chung] Natl Taiwan Univ, Ctr Neurobiol & Cognit Sci, Taipei 10764, Taiwan; [Li, Chiang-Shan R.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA; [Li, Chiang-Shan R.] Yale Univ, Dept Neurobiol, New Haven, CT USA; [Li, Chiang-Shan R.] Yale Univ, Interdept Neurosci Program, New Haven, CT USA	National Taiwan University; National Taiwan University; Yale University; Yale University; Yale University	Chen, CC (corresponding author), Natl Taiwan Univ, Dept Psychol, Taipei 10764, Taiwan.	c3chen@ntu.edu.tw	Chang, Andrew/J-7372-2019; Li, Chiang-Shan Ray/J-2813-2016	Chang, Andrew/0000-0001-6745-4435; Li, Chiang-Shan Ray/0000-0002-9393-1212; Li, Hsin-Hung/0000-0003-3245-2071; Chen, Chien-Chung/0000-0002-3848-0180	Taiwan MOE [101R892101]; NIH [5K02DA026990]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA021449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [K02DA026990] Funding Source: NIH RePORTER	Taiwan MOE; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Taiwan MOE 101R892101 to CCC and NIH 5K02DA026990 to C-SRL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benjamini Y, 2001, ANN STAT, V29, P1165; Beste C, 2009, NEUROSCIENCE, V159, P143, DOI 10.1016/j.neuroscience.2008.12.030; Beyer F, 2012, NEUROPSYCHOLOGIA, V50, P3304, DOI 10.1016/j.neuropsychologia.2012.10.007; Botvinick MM, 2004, TRENDS COGN SCI, V8, P539, DOI 10.1016/j.tics.2004.10.003; Botvinick MM, 2001, PSYCHOL REV, V108, P624, DOI 10.1037//0033-295X.108.3.624; Danielmeier C, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00233; de Bruijn ERA, 2004, PSYCHOPHARMACOLOGY, V177, P151, DOI 10.1007/s00213-004-1915-6; Debener S, 2005, J NEUROSCI, V25, P11730, DOI 10.1523/JNEUROSCI.3286-05.2005; Donkers FCL, 2004, BRAIN COGNITION, V56, P165, DOI 10.1016/j.bandc.2004.04.005; Egner T, 2008, TRENDS COGN SCI, V12, P374, DOI 10.1016/j.tics.2008.07.001; Egner T, 2007, NEUROIMAGE, V35, P940, DOI 10.1016/j.neuroimage.2006.11.061; Endrass T, 2007, EUR J NEUROSCI, V26, P1714, DOI 10.1111/j.1460-9568.2007.05785.x; Falkenstein M, 2000, BIOL PSYCHOL, V51, P87, DOI 10.1016/S0301-0511(99)00031-9; Farr OM, 2012, NEUROIMAGE, V63, P1070, DOI 10.1016/j.neuroimage.2012.07.049; Folstein JR, 2008, PSYCHOPHYSIOLOGY, V45, P152, DOI 10.1111/j.1469-8986.2007.00602.x; Gehring WJ, 2001, J NEUROSCI, V21, P9430, DOI 10.1523/JNEUROSCI.21-23-09430.2001; GEHRING WJ, 1993, PSYCHOL SCI, V4, P385, DOI 10.1111/j.1467-9280.1993.tb00586.x; Genovese CR, 2002, NEUROIMAGE, V15, P870, DOI 10.1006/nimg.2001.1037; Gentsch A, 2009, NEUROIMAGE, V47, P2023, DOI 10.1016/j.neuroimage.2009.05.064; Hajcak G, 2003, PSYCHOPHYSIOLOGY, V40, P895, DOI 10.1111/1469-8986.00107; Hendrick OM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013155; Hewig J, 2011, PSYCHOPHYSIOLOGY, V48, P1390, DOI 10.1111/j.1469-8986.2011.01209.x; Hu S, 2012, HUM BRAIN MAPP, V33, P2785, DOI 10.1002/hbm.21399; Hu S, 2012, FRONT AGING NEUROSCI, V4, DOI 10.3389/fnagi.2012.00004; Ide JS, 2013, J NEUROSCI, V33, P2039, DOI 10.1523/JNEUROSCI.2201-12.2013; Ide JS, 2011, NEUROIMAGE, V54, P455, DOI 10.1016/j.neuroimage.2010.07.042; Kerns JG, 2004, SCIENCE, V303, P1023, DOI 10.1126/science.1089910; Kopp B, 1996, PSYCHOPHYSIOLOGY, V33, P282, DOI 10.1111/j.1469-8986.1996.tb00425.x; Larson MJ, 2012, NEUROPSYCHOLOGIA, V50, P426, DOI 10.1016/j.neuropsychologia.2011.12.021; Larson MJ, 2011, COGN AFFECT BEHAV NE, V11, P159, DOI 10.3758/s13415-010-0018-6; LEVITT H, 1971, J ACOUST SOC AM, V49, P467, DOI 10.1121/1.1912375; Li CSR, 2008, NEUROSCIENCE, V155, P1142, DOI 10.1016/j.neuroscience.2008.06.062; Li CSR, 2008, J COGNITIVE NEUROSCI, V20, P1021, DOI 10.1162/jocn.2008.20071; Li CSR, 2006, DRUG ALCOHOL DEPEN, V85, P205, DOI 10.1016/j.drugalcdep.2006.04.008; Li CSR, 2009, CEREB CORTEX, V19, P839, DOI 10.1093/cercor/bhn132; Li CSR, 2006, J NEUROSCI, V26, P186, DOI 10.1523/JNEUROSCI.3741-05.2006; Li CSR, 2005, EXP BRAIN RES, V167, P305, DOI 10.1007/s00221-005-0110-2; Liotti M, 2000, NEUROPSYCHOLOGIA, V38, P701, DOI 10.1016/S0028-3932(99)00106-2; Luce R.D., 1991, RESPONSE TIMES THEIR; Manuel AL, 2012, J COGNITIVE NEUROSCI, V24, P1331, DOI 10.1162/jocn_a_00150; Mathalon DH, 2002, J ABNORM PSYCHOL, V111, P22, DOI 10.1037//0021-843X.111.1.22; Nieuwenhuis S, 2001, PSYCHOPHYSIOLOGY, V38, P752, DOI 10.1017/S0048577201001111; Nieuwenhuis S, 2003, COGN AFFECT BEHAV NE, V3, P17, DOI 10.3758/CABN.3.1.17; Nunez Castellar E, 2010, COGN AFFECT BEHAV NE, V10, P270, DOI DOI 10.3758/CABN.10.2.270; Penny W.D., 2004, HUMAN BRAIN FUNCTION, P843; PERRIN F, 1989, ELECTROEN CLIN NEURO, V72, P184, DOI 10.1016/0013-4694(89)90180-6; Riba J, 2005, COGNITIVE BRAIN RES, V25, P554, DOI 10.1016/j.cogbrainres.2005.08.009; Riba J, 2005, J NEUROSCI, V25, P4370, DOI 10.1523/JNEUROSCI.4437-04.2005; Steinhauser M, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00240; Steinhauser M, 2010, J NEUROSCI, V30, P15643, DOI 10.1523/JNEUROSCI.1899-10.2010; Strozyk JV, 2012, BRAIN RES, V1460, P41, DOI 10.1016/j.brainres.2012.04.028; Tieges Z, 2004, COGNITIVE BRAIN RES, V21, P87, DOI 10.1016/j.cogbrainres.2004.06.001; Upton DJ, 2010, EXP BRAIN RES, V206, P351, DOI 10.1007/s00221-010-2369-1; Verbruggen F, 2009, NEUROSCI BIOBEHAV R, V33, P647, DOI 10.1016/j.neubiorev.2008.08.014; Wessel JR, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00088; Wessel JR, 2011, NEUROIMAGE, V54, P2105, DOI 10.1016/j.neuroimage.2010.10.033; West R, 2008, CEREB CORTEX, V18, P1112, DOI 10.1093/cercor/bhm142; Yeung N, 2006, PSYCHOL SCI, V17, P164, DOI 10.1111/j.1467-9280.2006.01680.x; Yeung N, 2004, PSYCHOL REV, V111, P931, DOI 10.1037/0033-295x.111.4.931; Zhang S, 2012, HUM BRAIN MAPP, V33, P89, DOI 10.1002/hbm.21197; Zirnheld PJ, 2004, J COGNITIVE NEUROSCI, V16, P1098, DOI 10.1162/0898929041502779	61	29	29	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99909	10.1371/journal.pone.0099909	http://dx.doi.org/10.1371/journal.pone.0099909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ5PV	24932780	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600079
J	Li, Q; Fan, CM; Zhang, XM; Wang, X; Wu, FQ; Hu, RB; Fu, YF				Li, Qing; Fan, Chengming; Zhang, Xiaomei; Wang, Xu; Wu, Faqiang; Hu, Ruibo; Fu, Yongfu			Identification of a Soybean MOTHER OF FT AND TFL1 Homolog Involved in Regulation of Seed Germination	PLOS ONE			English	Article							PEBP GENE FAMILY; ARABIDOPSIS; ENCODES; BIOSYNTHESIS; EXPRESSION; DORMANCY; TIME; FT; 8'-HYDROXYLASES; NORMALIZATION	Seed germination is an important event in the life cycle of seed plants, and is controlled by complex and coordinated genetic networks. Many genes involved in the regulation of this process have been identified in different plant species so far. Recent studies in both Arabidopsis and wheat have uncovered a new role of MOTHER OF FT AND TFL1 (MFT) in seed germination. Here, we reported a homolog of MFT in soybean (GmMFT) which strongly expressed in seeds. Detailed expression analysis showed that the mRNA level of GmMFT increased with seed development but declined during seed germination. The transcription of GmMFT also responded to exogenous application of ABA and GA3. Ectopic expression of GmMFT CDS in Arabidopsis moderately inhibited seed germination. All these evidences suggest that GmMFT may be a negative regulator of seed germination.	[Li, Qing; Fan, Chengming; Zhang, Xiaomei; Wang, Xu; Wu, Faqiang; Fu, Yongfu] Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resource & Genet Improve, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China; [Li, Qing; Fan, Chengming] Chinese Acad Sci, Inst Genet & Dev Biol, Beijing, Peoples R China; [Hu, Ruibo] Chinese Acad Sci, Qingdao Inst Bioenergy & Bioproc Technol, Shandong Prov Key Lab Energy Genet, CAS Key Lab Biofuels, Qingdao, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Crop Sciences, CAAS; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; Qingdao Institute of Bioenergy & Bioprocess Technology, CAS	Fu, YF (corresponding author), Chinese Acad Agr Sci, Inst Crop Sci, Natl Key Facil Crop Gene Resource & Genet Improve, MOA Key Lab Soybean Biol Beijing, Beijing 100193, Peoples R China.	fufu19cn@163.com	Hu, Ruibo/P-3471-2018	Hu, Ruibo/0000-0001-6299-5320; Li, Qing/0000-0001-7010-7776; Fan, Chengming/0000-0002-1352-8301	973 Program [2010CB125906]; 863 program [2013AA102602]; Transgenic program [2011ZX08009-001, 2011ZX08004-005]; National Natural Science Founds [31000681]	973 Program(National Basic Research Program of China); 863 program(National High Technology Research and Development Program of China); Transgenic program; National Natural Science Founds	This work was partly supported by 973 Program (2010CB125906), 863 program (2013AA102602), Transgenic program (2011ZX08009-001 and 2011ZX08004-005), and the National Natural Science Founds (31000681). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JH, 2006, EMBO J, V25, P605, DOI 10.1038/sj.emboj.7600950; Cao DN, 2005, PLANTA, V223, P105, DOI 10.1007/s00425-005-0057-3; Chardon F, 2005, J MOL EVOL, V61, P579, DOI 10.1007/s00239-004-0179-4; CHIANG HH, 1995, PLANT CELL, V7, P195, DOI 10.1105/tpc.7.2.195; Danilevskaya ON, 2008, PLANT PHYSIOL, V146, P250, DOI 10.1104/pp.107.109538; Finkelstein RR, 2000, PLANT CELL, V12, P599, DOI 10.1105/tpc.12.4.599; GIRAUDAT J, 1992, PLANT CELL, V4, P1251, DOI 10.1105/tpc.4.10.1251; Gonzalez-Guzman M, 2004, PLANT PHYSIOL, V135, P325, DOI 10.1104/pp.103.036590; Gonzalez-Guzman M, 2002, PLANT CELL, V14, P1833, DOI 10.1105/tpc.002477; Graeber K, 2011, PLANT CELL, V23, P2045, DOI 10.1105/tpc.111.084103; Hanzawa Y, 2005, P NATL ACAD SCI USA, V102, P7748, DOI 10.1073/pnas.0500932102; Hedman H, 2009, PLANT MOL BIOL, V70, P359, DOI 10.1007/s11103-009-9478-x; Holdsworth MJ, 2008, NEW PHYTOL, V179, P33, DOI 10.1111/j.1469-8137.2008.02437.x; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Ikeda A, 2001, PLANT CELL, V13, P999, DOI 10.1105/tpc.13.5.999; Kanai M, 2010, PLANT J, V62, P936, DOI 10.1111/j.1365-313X.2010.04205.x; Kardailsky I, 1999, SCIENCE, V286, P1962, DOI 10.1126/science.286.5446.1962; Karlgren A, 2011, PLANT PHYSIOL, V156, P1967, DOI 10.1104/pp.111.176206; Kobayashi Y, 1999, SCIENCE, V286, P1960, DOI 10.1126/science.286.5446.1960; Kong FJ, 2010, PLANT PHYSIOL, V154, P1220, DOI 10.1104/pp.110.160796; Kushiro T, 2004, EMBO J, V23, P1647, DOI 10.1038/sj.emboj.7600121; Lee SC, 2002, GENE DEV, V16, P646, DOI 10.1101/gad.969002; Lefebvre V, 2006, PLANT J, V45, P309, DOI 10.1111/j.1365-313X.2005.02622.x; LeonKloosterziel KM, 1996, PLANT J, V10, P655, DOI 10.1046/j.1365-313X.1996.10040655.x; Li Q, 2012, PLANT CELL REP, V31, P1789, DOI 10.1007/s00299-012-1282-4; Mitchum MG, 2006, PLANT J, V45, P804, DOI 10.1111/j.1365-313X.2005.02642.x; Nakamura S, 2011, PLANT CELL, V23, P3215, DOI 10.1105/tpc.111.088492; Oh E, 2007, PLANT CELL, V19, P1192, DOI 10.1105/tpc.107.050153; Okamoto M, 2006, PLANT PHYSIOL, V141, P97, DOI 10.1104/pp.106.079475; Peng JR, 1997, GENE DEV, V11, P3194, DOI 10.1101/gad.11.23.3194; Peng JR, 1999, NATURE, V400, P256, DOI 10.1038/22307; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Pin PA, 2010, SCIENCE, V330, P1397, DOI 10.1126/science.1197004; Piskurewicz U, 2008, PLANT CELL, V20, P2729, DOI 10.1105/tpc.108.061515; Seo M, 2004, PLANT CELL PHYSIOL, V45, P1694, DOI 10.1093/pcp/pch198; Silverstone AL, 1998, PLANT CELL, V10, P155, DOI 10.1105/tpc.10.2.155; Sun TP, 2004, ANNU REV PLANT BIOL, V55, P197, DOI 10.1146/annurev.arplant.55.031903.141753; Tian ZX, 2010, P NATL ACAD SCI USA, V107, P8563, DOI 10.1073/pnas.1000088107; Tyler L, 2004, PLANT PHYSIOL, V135, P1008, DOI 10.1104/pp.104.039578; Vaistij FE, 2013, P NATL ACAD SCI USA, V110, P10866, DOI 10.1073/pnas.1301647110; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Weitbrecht K, 2011, J EXP BOT, V62, P3289, DOI 10.1093/jxb/err030; Xi WY, 2010, PLANT CELL, V22, P1733, DOI 10.1105/tpc.109.073072; Xiao CW, 2009, PLANT MOL BIOL, V71, P39, DOI 10.1007/s11103-009-9507-9; XU YL, 1995, P NATL ACAD SCI USA, V92, P6640, DOI 10.1073/pnas.92.14.6640; Yamauchi Y, 2004, PLANT CELL, V16, P367, DOI 10.1105/tpc.018143; Yamauchi Y, 2007, PLANT CELL PHYSIOL, V48, P555, DOI 10.1093/pcp/pcm023; Yoo SY, 2004, MOL CELLS, V17, P95	48	33	42	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99642	10.1371/journal.pone.0099642	http://dx.doi.org/10.1371/journal.pone.0099642			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932489	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600052
J	van Kleef, E; Gasparrini, A; Guy, R; Cookson, B; Hope, R; Jit, M; Robotham, JV; Deeny, SR; Edmunds, WJ				van Kleef, Esther; Gasparrini, Antonio; Guy, Rebecca; Cookson, Barry; Hope, Russell; Jit, Mark; Robotham, Julie V.; Deeny, Sarah R.; Edmunds, W. John			Nosocomial Transmission of C. difficile in English Hospitals from Patients with Symptomatic Infection	PLOS ONE			English	Article							TIME-SERIES ANALYSIS; CLOSTRIDIUM-DIFFICILE; RISK-FACTORS; EPIDEMIOLOGY; SURVEILLANCE; ACQUISITION; DIARRHEA; DISEASES; BURDEN	Background: Recent evidence suggests that less than one-quarter of patients with symptomatic nosocomial Clostridium difficile infections (CDI) are linked to other in-patients. However, this evidence was limited to one geographic area. We aimed to investigate the level of symptomatic CDI transmission in hospitals located across England from 2008 to 2012. Methods: A generalized additive mixed-effects Poisson model was fitted to English hospital-surveillance data. After adjusting for seasonal fluctuations and between-hospital variation in reported CDI over time, possible clustering (transmission between symptomatic in-patients) of CDI cases was identified. We hypothesised that a temporal proximity would be reflected in the degree of correlation between in-hospital CDI cases per week. This correlation was modelled through a latent autoregressive structure of order 1 (AR(1)). Findings: Forty-six hospitals (33 general, seven specialist, and six teaching hospitals) located in all English regions met our criteria. In total, 12,717 CDI cases were identified; seventy-five per cent of these occurred >48 hours after admission. There were slight increases in reports during winter months. We found a low, but statistically significant, correlation between successive weekly CDI case incidences (phi = 0.029, 95% CI: 0.009-0.049). This correlation was five times stronger in a subgroup analysis restricted to teaching hospitals (phi = 0.104, 95% CI: 0.048-0.159). Conclusions: The results suggest that symptomatic patient-to-patient transmission has been a source of CDI-acquisition in English hospitals in recent years, and that this might be a more important transmission route in teaching hospitals. Nonetheless, the weak correlation indicates that, in line with recent evidence, symptomatic cases might not be the primary source of nosocomial CDI in England.	[van Kleef, Esther; Gasparrini, Antonio; Jit, Mark; Edmunds, W. John] London Sch Hyg & Trop Med, London WC1, England; [van Kleef, Esther; Guy, Rebecca; Hope, Russell; Jit, Mark; Robotham, Julie V.; Deeny, Sarah R.] Publ Hlth England, London, England; [Cookson, Barry] UCL, London, England	University of London; London School of Hygiene & Tropical Medicine; Public Health England; University of London; University College London	van Kleef, E (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	esther.vankleef@lshtm.ac.uk	Hope, Russell/CAF-3297-2022; Jit, Mark/HDM-7797-2022; Gasparrini, Antonio/F-7627-2012	Hope, Russell/0000-0003-2838-6833; Gasparrini, Antonio/0000-0002-2271-3568; Deeny, Sarah/0000-0001-5994-1583; Robotham, Julie/0000-0003-2515-4084; Jit, Mark/0000-0001-6658-8255; Guy, Rebecca/0000-0001-5500-5691; van Kleef, Esther/0000-0002-3312-7185	Healthcare Infection Society; MRC [G1002296] Funding Source: UKRI; Medical Research Council [G1002296] Funding Source: researchfish	Healthcare Infection Society; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Healthcare Infection Society which has been granted to EvK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Archibald LK, 2004, J INFECT DIS, V189, P1585, DOI 10.1086/383045; Bootsma MCJ, 2007, AM J EPIDEMIOL, V166, P841, DOI 10.1093/aje/kwm149; Bosker, 2012, MULTILEVEL ANAL INTR; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; Department of Health, 2012, UPD GUID DIAGN REP C; Didelot X, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-12-r118; Dubberke ER, 2012, CLIN INFECT DIS, V55, pS88, DOI 10.1093/cid/cis335; Eyre DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078445; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Fekety R, 1997, CLIN INFECT DIS, V24, P324, DOI 10.1093/clinids/24.3.324; Forrester ML, 2007, BIOSTATISTICS, V8, P383, DOI 10.1093/biostatistics/kxl017; Ghantoji SS, 2010, J HOSP INFECT, V74, P309, DOI 10.1016/j.jhin.2009.10.016; Gilca R, 2012, ANTIMICROB AGENTS CH, V56, P639, DOI 10.1128/AAC.05411-11; Goldenberg SD, 2011, J HOSP INFECT, V79, P4, DOI 10.1016/j.jhin.2011.03.030; Goldstein Harvey, 2010, MULTILEVEL STAT MODE; Gould LH, 2010, CLIN INFECT DIS, V51, P577, DOI 10.1086/655692; Guerrero DM, 2013, J HOSP INFECT, V85, P155, DOI 10.1016/j.jhin.2013.07.002; Hsu J, 2010, AM J GASTROENTEROL, V105, P2327, DOI 10.1038/ajg.2010.254; Intelligence dr F, 2013, HOSP GUID; KAATZ GW, 1988, AM J EPIDEMIOL, V127, P1289, DOI 10.1093/oxfordjournals.aje.a114921; Kamboj M, 2011, CLIN INFECT DIS, V53, P1003, DOI 10.1093/cid/cir643; Khanna S, 2012, AM J GASTROENTEROL, V107, P89, DOI 10.1038/ajg.2011.398; KIM KH, 1981, J INFECT DIS, V143, P42, DOI 10.1093/infdis/143.1.42; Lewis SJ, 1997, SCAND J GASTROENTERO, V32, P920, DOI 10.3109/00365529709011203; McBryde ES, 2007, J R SOC INTERFACE, V4, P745, DOI 10.1098/rsif.2007.0224; MCFARLAND L, 1989, NEW ENGL J MED, V321, P190; Pinheiro J, 2001, MIXED EFFECTS MODELS; Polgreen PM, 2010, INFECT CONT HOSP EP, V31, P382, DOI 10.1086/651095; Public Health England (former Health Protection Agency), 2012, MAND SURV CLOSTR DIF; Public Health England (former Health Protection Agency), 2012, ENGL NAT POINT PREV; Ricciardi R, 2012, J HOSP INFECT, V80, P156, DOI 10.1016/j.jhin.2011.11.002; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; SODERLUND N, 1995, J PUBLIC HEALTH MED, V17, P25; Starr JM, 2003, AGE AGEING, V32, P657, DOI 10.1093/ageing/afg112; Thomas C, 2003, J ANTIMICROB CHEMOTH, V51, P1339, DOI 10.1093/jac/dkg254; Vernaz N, 2009, J ANTIMICROB CHEMOTH, V63, P1272, DOI 10.1093/jac/dkp128; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127; Walker AS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001172; Wilcox MH, 2012, CLIN INFECT DIS, V55, P1056, DOI 10.1093/cid/cis614; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279	41	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99860	10.1371/journal.pone.0099860	http://dx.doi.org/10.1371/journal.pone.0099860			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932484	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000337738600074
J	Duff, P; Bingham, B; Simo, A; Jury, D; Reading, C; Shannon, K				Duff, Putu; Bingham, Brittany; Simo, Annick; Jury, Delores; Reading, Charlotte; Shannon, Kate			The 'Stolen Generations' of Mothers and Daughters: Child Apprehension and Enhanced HIV Vulnerabilities for Sex Workers of Aboriginal Ancestry	PLOS ONE			English	Article							FOSTER-CARE; WOMEN; HEALTH; PREVALENCE; DISORDERS; MINORITY; SERVICES; VIOLENCE; CANADA; RISK	Objectives: The number of children in care of the state continues to grow in BC, Canada with a historical legacy of child apprehension among criminalized and marginalized populations, particularly women of Aboriginal ancestry and sex workers. However, there is a paucity of research investigating child apprehension experiences among marginalized mothers. The objective of the current analysis is to examine the prevalence and correlates of child apprehensions among female sex workers in Vancouver, Canada. Methods: Analyses were drawn from the AESHA (An Evaluation of Sex Workers Health Access, 2010-present), a prospective cohort of street and off-street SWs, through outreach and semi-annual visits to the research office. Bivariate and multivariate logistic regression were used to examine correlates of child apprehension. Results: Of a total of 510 SWs, 350 women who had given birth to at least one child were included in the analyses (median age = 37 yrs: IQR: 31-44 yrs). The prevalence of child apprehension among mothers was 38.3%, with 37.4% reporting having been apprehended themselves by child welfare services. In multivariable analysis, servicing clients in outdoor public spaces (versus formal sex work establishments or informal indoor settings) (adjusted odds ratio, (aOR) = 2.73; 95% CI 1.27-5.90), history of injecting drugs (aOR = 2.53; 95% CI 1.42-4.49), Aboriginal ancestry (aOR = 1.66; 95% CI 1.01-2.74) were associated with increased odds of child apprehension. Discussion/Conclusions: Child apprehension rates are high, particularly among the most marginalized sex workers, including sex workers who use drugs and sex workers of Aboriginal ancestry. Structural reforms to child protection are urgently needed, that support family-based care address the historical legacy of colonization affecting Aboriginal peoples.	[Duff, Putu; Bingham, Brittany; Simo, Annick; Shannon, Kate] British Columbia Ctr Excellence HIV AIDS, Gender & Sexual Hlth Initiat, Vancouver, BC, Canada; [Duff, Putu; Shannon, Kate] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada; [Bingham, Brittany] Simon Fraser Univ, Fac Hlth Sci, Vancouver, BC, Canada; [Jury, Delores] Sex Workers United Violence SWUAV, Vancouver, BC, Canada; [Reading, Charlotte] Univ Victoria, Sch Publ Hlth & Social Policy, Victoria, BC, Canada; [Shannon, Kate] Univ British Columbia, Dept Med, Vancouver, BC, Canada	B.C. Centre for Excellence in HIV/AIDS; University of British Columbia; Simon Fraser University; University of Victoria; University of British Columbia	Shannon, K (corresponding author), British Columbia Ctr Excellence HIV AIDS, Gender & Sexual Hlth Initiat, Vancouver, BC, Canada.	gshi@cfenet.ubc.ca	DSILVA, BROOKE/HCI-4879-2022		US National Institutes of Health [R01DA028648]; Canadian Institutes of Health Research [HHP-98835]; PHIRNET (Population Health Interventions Network), an initiative of the Canadian Institutes for Health Research (CIHR); NATIONAL INSTITUTE ON DRUG ABUSE [R01DA028648] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); PHIRNET (Population Health Interventions Network), an initiative of the Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This research was supported by operating grants from the US National Institutes of Health (R01DA028648) and Canadian Institutes of Health Research (HHP-98835). PD is supported by PHIRNET (Population Health Interventions Network), an initiative of the Canadian Institutes for Health Research (CIHR) KS is supported by US National Institutes of Health (R01DA028648). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartlett JG, 2007, SOC SCI MED, V65, P2371, DOI 10.1016/j.socscimed.2007.06.011; Bennett D., 2008, BROKEN PROMISES PARE; Benoit C, 2003, SOC SCI MED, V56, P821, DOI 10.1016/S0277-9536(02)00081-3; Benoit C., 2001, DISPELLING MYTHS UND, P134; Bingham B, 2014, CULT HEALTH SEX, V16, P440, DOI 10.1080/13691058.2014.888480; Blackstock C, 2004, VIOLENCE AGAINST WOM, V10, P901, DOI 10.1177/1077801204266312; Bodor R, 2011, PERSPECTIVES HOUSING; Boyd S, 2004, WITCHES CRACK MOMS; Castellano Marlene Brand, 2008, TRUTH RECONCILIATION; Dalla RL, 2010, APPL DEV SCI, P37; Euser S, 2013, CHILD MALTREAT; Farley LJ, 2005, TRANSCULT PSYCHIATRY, V42, P242; Fournier S., 1997, STOLEN OUR EMBRACE A; Guerin B, 2010, PIMATISIWIN J ABORIG, V8; Jeal N, 2008, SEX TRANSM INFECT, V84, P381, DOI 10.1136/sti.2008.030841; Jonson-Reid M, 2000, CHILD ABUSE NEGLECT, V24, P505, DOI 10.1016/S0145-2134(00)00107-1; Lavergne C, 2008, CHILD WELFARE, V87, P59; Lazarus L, 2011, SOC SCI MED, V73, P1600, DOI 10.1016/j.socscimed.2011.09.015; McClelland GT, 2008, J RES NURS, V13, P437, DOI 10.1177/1744987108095409; McMillen JC, 2005, J AM ACAD CHILD PSY, V44, P88, DOI 10.1097/01.chi.0000145806.24274.d2; Mill JE, 1997, WESTERN J NURS RES, V19, P466, DOI 10.1177/019394599701900404; Ministry of Children and Family Development, 2006, NOV 2006 REP CHILDR; Ministry of Children and Family Development, 2008, MAN AB CHILD PROT SE; Ministry of Children and Family Development, 2009, AB CHILDR CAR; National Centre for Youth Law, 2006, BROK PROM CAL IN UN; National Collaborating Centre for Aboriginal Health, 2005, CHILD WELF SERV CAN; Pilowsky DJ, 2006, J ADOLESCENT HEALTH, V38, P351, DOI 10.1016/j.jadohealth.2005.06.014; Poole N, 2000, EVALUATION REPORT SH; Shannon K, 2008, INT J DRUG POLICY, V19, P140, DOI 10.1016/j.drugpo.2007.11.024; Shannon Kate, 2007, Harm Reduct J, V4, P20, DOI 10.1186/1477-7517-4-20; Shannon K, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2939; Sharpe TT, 2001, QUAL HEALTH RES, V11, P612, DOI 10.1177/104973201129119334; Sloss CM., 2004, J ASS RES MOTHERING, V6; Smith D, 2005, CAN J NURS RES, V37, P38; Smithgall C., 2005, BEHAV PROBLEMS ED DI; Stueve A, 2001, AM J PUBLIC HEALTH, V91, P922, DOI 10.2105/AJPH.91.6.922; Trocme N, 2004, PATHWAYS OVERREPRESE; Varcoe C, 2008, J ABORIG HEAL, P42; Zlotnick C, 2012, AM J PUBLIC HEALTH, V102, P534, DOI 10.2105/AJPH.2011.300285	39	19	19	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99664	10.1371/journal.pone.0099664	http://dx.doi.org/10.1371/journal.pone.0099664			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2VQ	24927324	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100062
J	Himes, BE; Jiang, XF; Wagner, P; Hu, RX; Wang, QY; Klanderman, B; Whitaker, RM; Duan, QL; Lasky-Su, J; Nikolos, C; Jester, W; Johnson, M; Panettieri, RA; Tantisira, KG; Weiss, ST; Lu, Q				Himes, Blanca E.; Jiang, Xiaofeng; Wagner, Peter; Hu, Ruoxi; Wang, Qiyu; Klanderman, Barbara; Whitaker, Reid M.; Duan, Qingling; Lasky-Su, Jessica; Nikolos, Christina; Jester, William; Johnson, Martin; Panettieri, Reynold A., Jr.; Tantisira, Kelan G.; Weiss, Scott T.; Lu, Quan			RNA-Seq Transcriptome Profiling Identifies CRISPLD2 as a Glucocorticoid Responsive Gene that Modulates Cytokine Function in Airway Smooth Muscle Cells	PLOS ONE			English	Article							CHILDHOOD ASTHMA RESEARCH; C/EBP-BETA; DRUG-THERAPY; EXPRESSION; INFLAMMATION; ASSOCIATION; MECHANISMS; STEROIDS; RECEPTOR; AUGMENT	Asthma is a chronic inflammatory respiratory disease that affects over 300 million people worldwide. Glucocorticoids are a mainstay therapy for asthma because they exert anti-inflammatory effects in multiple lung tissues, including the airway smooth muscle (ASM). However, the mechanism by which glucocorticoids suppress inflammation in ASM remains poorly understood. Using RNA-Seq, a high-throughput sequencing method, we characterized transcriptomic changes in four primary human ASM cell lines that were treated with dexamethasone-a potent synthetic glucocorticoid (1 mu M for 18 hours). Based on a Benjamini-Hochberg corrected p-value < 0.05, we identified 316 differentially expressed genes, including both well known (DUSP1, KLF15, PER1, TSC22D3) and less investigated (C7, CCDC69, CRISPLD2) glucocorticoid-responsive genes. CRISPLD2, which encodes a secreted protein previously implicated in lung development and endotoxin regulation, was found to have SNPs that were moderately associated with inhaled corticosteroid resistance and bronchodilator response among asthma patients in two previously conducted genome-wide association studies. Quantitative RT-PCR and Western blotting showed that dexamethasone treatment significantly increased CRISPLD2 mRNA and protein expression in ASM cells. CRISPLD2 expression was also induced by the inflammatory cytokine IL1 beta, and small interfering RNA-mediated knockdown of CRISPLD2 further increased IL1 beta-induced expression of IL6 and IL8. Our findings offer a comprehensive view of the effect of a glucocorticoid on the ASM transcriptome and identify CRISPLD2 as an asthma pharmacogenetics candidate gene that regulates anti-inflammatory effects of glucocorticoids in the ASM.	[Himes, Blanca E.; Whitaker, Reid M.; Duan, Qingling; Lasky-Su, Jessica; Tantisira, Kelan G.; Weiss, Scott T.] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA; [Himes, Blanca E.; Whitaker, Reid M.; Duan, Qingling; Lasky-Su, Jessica; Tantisira, Kelan G.; Weiss, Scott T.] Harvard Univ, Sch Med, Boston, MA USA; [Himes, Blanca E.; Klanderman, Barbara; Weiss, Scott T.] Partners HealthCare Personalized Med, Boston, MA USA; [Himes, Blanca E.] Childrens Hosp Informat Program, Boston, MA USA; [Jiang, Xiaofeng; Wagner, Peter; Hu, Ruoxi; Wang, Qiyu; Lu, Quan] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Program Mol & Integrat Physiol Sci, Boston, MA 02115 USA; [Jiang, Xiaofeng; Wagner, Peter; Hu, Ruoxi; Wang, Qiyu; Lu, Quan] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Nikolos, Christina; Jester, William; Johnson, Martin; Panettieri, Reynold A., Jr.] Univ Penn, Pulm Allergy & Crit Care Div, Philadelphia, PA 19104 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Partners Healthcare System; Harvard University; Boston Children's Hospital; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard T.H. Chan School of Public Health; University of Pennsylvania	Himes, BE (corresponding author), Brigham & Womens Hosp, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA.	blanca.himes@channing.harvard.edu; qlu@hsph.harvard.edu	panettieri, reynold/AAG-9485-2019	Jester Jr., William/0000-0002-2872-6095; Lasky-Su, Jessica/0000-0001-6236-4705	National Institutes of Health (NIH) [U01 HL65899]; NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance [R01 HL097796, R01 HL114769, P30 ES013508]; NIH [K99 HL105663, T32 HL007118]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL097796, R01HL114769, T32HL007118, R00HL105663, U01HL065899, P01HL114471] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding was provided by National Institutes of Health (NIH) U01 HL65899, an NIH Pharmacogenomics Research Network (PGRN) - RIKEN Center for Genomic Medicine (CGM) Global Alliance, R01 HL097796, R01 HL114769, and P30 ES013508. BEH was funded by NIH K99 HL105663. XJ was supported by NIH training grant T32 HL007118. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akinbami LJ, 2012, TRENDS ASTHMA PREVAL, P2001; AKIRA S, 1990, EMBO J, V9, P1897, DOI 10.1002/j.1460-2075.1990.tb08316.x; [Anonymous], QUALITY CONTROL TOOL; Barnett DW, 2011, BIOINFORMATICS, V27, P1691, DOI 10.1093/bioinformatics/btr174; Berg T, 2005, BIOCHEM BIOPH RES CO, V334, P638, DOI 10.1016/j.bbrc.2005.06.146; Berg T, 2002, BIOCHEM BIOPH RES CO, V293, P907, DOI 10.1016/S0006-291X(02)00319-4; Burioka N, 2007, J PHARMACOL SCI, V103, P144, DOI 10.1254/jphs.FMJ06003X4; Cherniack R, 1999, CONTROL CLIN TRIALS, V20, P91; Chiquet BT, 2007, HUM MOL GENET, V16, P2241, DOI 10.1093/hmg/ddm176; Cooper PR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010235; Denlinger LC, 2007, J ALLERGY CLIN IMMUN, V119, P3, DOI 10.1016/j.jaci.2006.10.015; Doni A, 2008, J BIOL CHEM, V283, P29983, DOI 10.1074/jbc.M805631200; Doreswamy V, 2011, CLIN EXP ALLERGY, V41, P9, DOI 10.1111/j.1365-2222.2010.03628.x; Eddleston J, 2007, J ALLERGY CLIN IMMUN, V119, P115, DOI 10.1016/j.jaci.2006.08.027; Fanta CH, 2009, NEW ENGL J MED, V360, P1002, DOI 10.1056/NEJMra0804579; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Global Initiative for Asthma (GINA), 2012, GLOB STR ASTHM MAN P; Guilbert TW, 2004, CONTROL CLIN TRIALS, V25, P286, DOI 10.1016/j.cct.2004.03.002; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; HARGREAVE FE, 1981, J ALLERGY CLIN IMMUN, V68, P347, DOI 10.1016/0091-6749(81)90132-9; Himes BE, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002824; HOCHBERG Y, 1990, STAT MED, V9, P811, DOI 10.1002/sim.4780090710; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaur M, 2008, MOL PHARMACOL, V73, P203, DOI 10.1124/mol.107.040121; Kelly MM, 2012, BRIT J PHARMACOL, V165, P1737, DOI 10.1111/j.1476-5381.2011.01620.x; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Lakser OJ, 2008, EUR RESPIR J, V32, P1224, DOI 10.1183/09031936.00092908; LAMAS AM, 1991, J IMMUNOL, V147, P254; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Lu NZ, 2006, TRENDS CELL BIOL, V16, P301, DOI 10.1016/j.tcb.2006.04.005; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Masuno K, 2011, AM J RESP CELL MOL, V45, P642, DOI 10.1165/rcmb.2010-0369OC; McMaster A, 2007, EXP PHYSIOL, V92, P299, DOI 10.1113/expphysiol.2006.036194; Misior AM, 2009, AM J RESP CELL MOL, V41, P24, DOI 10.1165/rcmb.2008-0266OC; Moodley T, 2013, MOL PHARMACOL, V83, P894, DOI 10.1124/mol.112.083493; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; NELSON HS, 1995, NEW ENGL J MED, V333, P499, DOI 10.1056/NEJM199508243330807; Oyewumi L, 2003, AM J RESP CELL MOL, V28, P232, DOI 10.1165/rcmb.4877; PANETTIERI RA, 1989, AM J PHYSIOL, V256, pC329, DOI 10.1152/ajpcell.1989.256.2.C329; Panettieri RA, 2008, AM J RESP CRIT CARE, V177, P248, DOI 10.1164/rccm.200708-1217PP; Patel GP, 2012, AM J RESP CRIT CARE, V185, P133, DOI 10.1164/rccm.201011-1897CI; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Peters SP, 2007, NEW ENGL J MED, V356, P2027; Pratt WB, 2006, HANDB EXP PHARM, V172, P111; Pruim RJ, 2010, BIOINFORMATICS, V26, P2336, DOI 10.1093/bioinformatics/btq419; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Reddy TE, 2009, GENOME RES, V19, P2163, DOI 10.1101/gr.097022.109; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rincon M, 2012, INT J BIOL SCI, V8, P1281, DOI 10.7150/ijbs.4874; Roos AB, 2012, BIOCHEM BIOPH RES CO, V423, P134, DOI 10.1016/j.bbrc.2012.05.096; Schacke H, 2002, PHARMACOL THERAPEUT, V96, P23, DOI 10.1016/S0163-7258(02)00297-8; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shipp LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013754; Shore SA, 2003, RESP PHYSIOL NEUROBI, V137, P179, DOI 10.1016/S1569-9048(03)00146-0; Slats AM, 2006, CHEST, V130, P58, DOI 10.1378/chest.130.1.58; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Trapnell C, 2013, NAT BIOTECHNOL, V31, P46, DOI 10.1038/nbt.2450; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trifilieff A, 2000, AM J PHYSIOL-LUNG C, V279, pL1120, DOI 10.1152/ajplung.2000.279.6.L1120; WALLEN N, 1991, J IMMUNOL, V147, P3490; Wang J, 2012, GENOME RES, V22, P1798, DOI 10.1101/gr.139105.112; Wang T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065743; Wang ZQ, 2009, J IMMUNOL, V183, P6646, DOI 10.4049/jimmunol.0802348; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Yang HM, 2005, J CELL PHYSIOL, V204, P219, DOI 10.1002/jcp.20278; Yick CY, 2013, AM J RESP CRIT CARE, V187, P1076, DOI 10.1164/rccm.201210-1886OC	68	86	89	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99625	10.1371/journal.pone.0099625	http://dx.doi.org/10.1371/journal.pone.0099625			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926665	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100056
J	Montero-Marin, J; Demarzo, MMP; Stapinski, L; Gili, M; Garcia-Campayo, J				Montero-Marin, Jesus; Piva Demarzo, Marcelo Marcos; Stapinski, Lexine; Gili, Margarita; Garcia-Campayo, Javier			Perceived Stress Latent Factors and the Burnout Subtypes: A Structural Model in Dental Students	PLOS ONE			English	Article							ULCERATIVE-COLITIS; QUESTIONNAIRE; VALIDATION; DEFINITION; VERSION; SIZE	Background: Students of health-professions suffer high levels of stress and burnout. The aim of the present study was to evaluate the relationship between perceived stress latent factors ('tenseness' and 'frustration') and the features ('overload', 'lack of development' and 'neglect') of the three burnout subtypes ('frenetic', 'under-challenged' and 'worn-out', respectively), in a sample of Spanish dental students. Methods: The study employed a cross-sectional design. A sample of Spanish dental students (n = 314) completed the 'Perceived Stress Questionnaire' and the 'Burnout Clinical Subtype Questionnaire Student Survey'. The associations among variables were observed by means of structural equation modelling using the unweighted least squares method from polychoric correlations. Results: Strong associations among perceived stress factors and the burnout characteristics were observed, although a distinct pattern of relations was observed for each burnout subtype. The 'overload' was moderately and positively associated with both 'tenseness' (0.45), and 'frustration' (0.38) dimensions of perceived stress; the 'lack of development' was positively associated with the 'frustration' dimension (0.72), but negatively associated with 'tenseness' (-0.69); the 'neglect' showed a weaker positive associated with 'frustration' (0.41), and a small negative association with 'tenseness' (-0.20). The model was a very good fit to the data (GFI = 0.96; RSMR = 0.07; AGFI = 0.96; NFI = 0.95; RFI = 0.95). Conclusions: The stress factors of 'frustration' and 'tenseness' seems to be related in a distinct way to the burnout subtypes in Spanish dental students. This finding suggests that intervention programs specifically tailored to these subtypes may be a promising future direction.	[Montero-Marin, Jesus] Fac Hlth & Sport Sci, Huesca, Spain; [Piva Demarzo, Marcelo Marcos] Univ Fed Sao Paulo UNIFESP, Dept Prevent Med, Sao Paulo, Brazil; [Stapinski, Lexine] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Stapinski, Lexine] Univ New S Wales, Ctr Res Excellence Mental Hlth & Sustance Use, Sidney, BC, Canada; [Gili, Margarita] Univ Balearic Isl, Inst Univ Invest Ciencies Salut IUNICS, Mallorca, Spain; [Garcia-Campayo, Javier] Univ Zaragoza, Miguel Servet Univ Hosp, Zaragoza, Spain; [Montero-Marin, Jesus; Garcia-Campayo, Javier] Primary Care Prevent & Hlth Promot Res Network Re, Zaragoza, Spain	Universidade Federal de Sao Paulo (UNIFESP); University of Bristol; Universitat de les Illes Balears; Miguel Servet University Hospital; University of Zaragoza	Montero-Marin, J (corresponding author), Fac Hlth & Sport Sci, Huesca, Spain.	jmontero@unizar.es	Demarzo, Marcelo/A-7021-2010; Gili, Margalida/H-7680-2013; Montero-Marin, Jesus/ABG-8919-2020	Demarzo, Marcelo/0000-0002-7447-1839; Gili, Margalida/0000-0002-0535-6773; Montero-Marin, Jesus/0000-0001-5677-1662; Garcia-Campayo, Javier/0000-0002-3797-4218; Stapinski, Lexine/0000-0002-3656-4655	Research Network on Preventative Activities and Health Promotion, Aragon Health Sciences Institute, Faculty of Health and Sports (University of Zaragoza) [RD06/0018/0017]; Faculty of Medicine and Dentistry (University of Santiago de Compostela)	Research Network on Preventative Activities and Health Promotion, Aragon Health Sciences Institute, Faculty of Health and Sports (University of Zaragoza); Faculty of Medicine and Dentistry (University of Santiago de Compostela)	This study was supported by the Research Network on Preventative Activities and Health Promotion (RD06/0018/0017), Aragon Health Sciences Institute, Faculty of Health and Sports (University of Zaragoza) and Faculty of Medicine and Dentistry (University of Santiago de Compostela). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alzahem AM, 2011, EUR J DENT EDUC, V15, P8, DOI 10.1111/j.1600-0579.2010.00640.x; [Anonymous], 1998, THE; Bandura A, 2001, ANNU REV PSYCHOL, V52, P1, DOI 10.1146/annurev.psych.52.1.1; BOLLEN KA, 1986, PSYCHOMETRIKA, V51, P375, DOI 10.1007/BF02294061; Briggs NE, 2003, MULTIVAR BEHAV RES, V38, P25, DOI 10.1207/S15327906MBR3801_2; BROWNE MW, 1992, MULTIVAR BEHAV RES, V27, P269, DOI 10.1207/s15327906mbr2702_13; Bruhlmann T, 2013, SCHMERZ, V27, P521, DOI 10.1007/s00482-013-1312-3; Bruhlmann T, 2012, SCHMERZ, V27, P533; Buunk BP., 1999, EUR REV SOC PSYCHOL, V10, P259, DOI [DOI 10.1080/14792779943000080, 10.1080/14792779943000080]; Byrne B., 2009, STRUCTURAL EQUATION, V2nd ed.; Campos Juliana Alvares Duarte Bonini, 2012, Rev. bras. epidemiol., V15, P155, DOI 10.1590/S1415-790X2012000100014; Dahlin M, 2007, MED TEACH, V29, P43, DOI 10.1080/01421590601175309; Farber BA, 2000, J CLIN PSYCHOL, V56, P675, DOI 10.1002/(SICI)1097-4679(200005)56:5<675::AID-JCLP8>3.0.CO;2-D; Fliege H, 2005, PSYCHOSOM MED, V67, P78, DOI 10.1097/01.psy.0000151491.80178.78; Gabbe Steven G, 2008, Acad Med, V83, P476, DOI 10.1097/ACM.0b013e31816bdb96; Gorter RC, 2007, INT DENT J, V57, P279; Grau A, 2009, REV ESP SALUD PUBLIC, V83, P215, DOI 10.1590/S1135-57272009000200006; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; King G, 2003, INT STUDIES PERSPECT, V4, P100, DOI DOI 10.1111/1528-3577.04105; KNOL DL, 1991, MULTIVAR BEHAV RES, V26, P457, DOI 10.1207/s15327906mbr2603_5; Lazarus R.S., 1984, EMOTION ADAPTATION; Lee CT, 2012, MULTIVAR BEHAV RES, V47, P314, DOI 10.1080/00273171.2012.658340; Levenstein S, 2000, AM J GASTROENTEROL, V95, P1213, DOI 10.1111/j.1572-0241.2000.02012.x; LEVENSTEIN S, 1993, J PSYCHOSOM RES, V37, P19, DOI 10.1016/0022-3999(93)90120-5; LEVENSTEIN S, 1994, AM J GASTROENTEROL, V89, P1219; MacCallum RC, 2000, ANNU REV PSYCHOL, V51, P201, DOI 10.1146/annurev.psych.51.1.201; MARDIA KV, 1974, SANKHYA SER B, V36, P115; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; Maslach C., 1996, MASLACH BURNOUT INVE; Mazurkiewicz R, 2012, PSYCHOL HEALTH MED, V17, P188, DOI 10.1080/13548506.2011.597770; Montero-Marin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089090; Montero-Marin J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087071; Montero-Marin J, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-922; Montero-Marin Jesus, 2011, BMC Med Educ, V11, P103, DOI 10.1186/1472-6920-11-103; Montero-Marin J, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-74; Montero-Marin J, 2011, BMC MED EDUC, V11, DOI [10.1186/1472-6920-11-103, 10.1186/1471-244X-11-49]; Montero-Marin J, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-302; Montero-Marin Jesus, 2009, J Occup Med Toxicol, V4, P31, DOI 10.1186/1745-6673-4-31; MUTHEN B, 1992, BRIT J MATH STAT PSY, V45, P19, DOI 10.1111/j.2044-8317.1992.tb00975.x; PARRY CDH, 1991, APPL PSYCH MEAS, V15, P35, DOI 10.1177/014662169101500105; Pohlmann K, 2005, Eur J Dent Educ, V9, P78, DOI 10.1111/j.1600-0579.2004.00359.x; Rajab L D, 2001, J Dent Educ, V65, P232; Rodr?guez G., 2000, ANALISIS FACTORIAL; Ruotsalainen J, 2008, SCAND J WORK ENV HEA, V34, P169, DOI 10.5271/sjweh.1240; Russett B, 2003, INT STUDIES PERSPECT, V4, P88; Sanz-Carrillo C, 2002, J PSYCHOSOM RES, V52, P167, DOI 10.1016/S0022-3999(01)00275-6; Shah M, 2010, BMC MED EDUC, V10, DOI 10.1186/1472-6920-10-2; Smout M, 2012, AUST FAM PHYSICIAN, V41, P672; Varela J., 2006, MODELIZACION ESTRUCT; Watson R, 2008, INT J NURS STUD, V45, P1534, DOI 10.1016/j.ijnurstu.2007.11.003; Wilf H.S, 1977, STAT METHODS DIGITAL	51	17	18	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99765	10.1371/journal.pone.0099765	http://dx.doi.org/10.1371/journal.pone.0099765			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2VQ	24927260	gold, Green Published			2022-12-27	WOS:000338278100077
J	Pierce, AA; de Roode, JC; Altizer, S; Bartel, RA				Pierce, Amanda A.; de Roode, Jacobus C.; Altizer, Sonia; Bartel, Rebecca A.			Extreme Heterogeneity in Parasitism Despite Low Population Genetic Structure among Monarch Butterflies Inhabiting the Hawaiian Islands	PLOS ONE			English	Article							DANAUS-PLEXIPPUS L; OPHRYOCYSTIS-ELEKTROSCIRRHA; PROTOZOAN PARASITE; INFECTIOUS-DISEASE; HOST-RESISTANCE; DYNAMICS; MIGRATION; PATHOGEN; DIFFERENTIATION; LEPIDOPTERA	Host movement and spatial structure can strongly influence the ecology and evolution of infectious diseases, with limited host movement potentially leading to high spatial heterogeneity in infection. Monarch butterflies (Danaus plexippus) are best known for undertaking a spectacular long-distance migration in eastern North America; however, they also form non-migratory populations that breed year-round in milder climates such as Hawaii and other tropical locations. Prior work showed an inverse relationship between monarch migratory propensity and the prevalence of the protozoan parasite, Ophryocystis elektroscirrha. Here, we sampled monarchs from replicate sites within each of four Hawaiian Islands to ask whether these populations show consistently high prevalence of the protozoan parasite as seen for monarchs from several other non-migratory populations. Counter to our predictions, we observed striking spatial heterogeneity in parasite prevalence, with infection rates per site ranging from 4-85%. We next used microsatellite markers to ask whether the observed variation in infection might be explained by limited host movement and spatial sub-structuring among sites. Our results showed that monarchs across the Hawaiian Islands form one admixed population, supporting high gene flow among sites. Moreover, measures of individual-level genetic diversity did not predict host infection status, as might be expected if more inbred hosts harbored higher parasite loads. These results suggest that other factors such as landscape-level environmental variation or colonization-extinction processes might instead cause the extreme heterogeneity in monarch butterfly infection observed here.	[Pierce, Amanda A.; de Roode, Jacobus C.] Emory Univ, Dept Biol, Atlanta, GA 30322 USA; [Altizer, Sonia; Bartel, Rebecca A.] Univ Georgia, Odum Sch Ecol, Athens, GA 30602 USA; [Bartel, Rebecca A.] US Fish & Wildlife Serv, Red Wolf Recovery Program, Manteo, NC USA	Emory University; University System of Georgia; University of Georgia; United States Department of the Interior; US Fish & Wildlife Service	Pierce, AA (corresponding author), Emory Univ, Dept Biol, Atlanta, GA 30322 USA.	amanda.pierce@emory.edu		Pierce, Amanda/0000-0001-9507-0009	National Science Foundation [DEB-0643831, DEB-1019746]; Ruth L. Kirschstein National Research Service Award through the National Institutes of Health (NIH); NIH training grant [5T32AI055404-10]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI055404] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Ruth L. Kirschstein National Research Service Award through the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH training grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Funding for this project was provided by the National Science Foundation (grant DEB-0643831 to S.A., grant DEB-1019746 to J.D.R.), a Ruth L. Kirschstein National Research Service Award through the National Institutes of Health (NIH) to R.A.B., and the NIH training grant 5T32AI055404-10 (L. Real, PI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo-Whitehouse K, 2009, P R SOC B, V276, P3523, DOI 10.1098/rspb.2009.1001; Ackery PR, 1984, MILKWEED BUTTERFLIES; Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Almberg ES, 2010, ECOL APPL, V20, P2058, DOI 10.1890/09-1225.1; Altizer S, 2013, MONARCHS CH IN PRESS; Altizer SM, 2004, MONARCH BUTTERFLY BIOLOGY AND CONSERVATION, P203; Altizer SM, 1999, J INVERTEBR PATHOL, V74, P76, DOI 10.1006/jipa.1999.4853; Altizer SM, 2000, ECOL ENTOMOL, V25, P125, DOI 10.1046/j.1365-2311.2000.00246.x; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Altizer S, 2010, EVOLUTION, V64, P1018, DOI 10.1111/j.1558-5646.2010.00946.x; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bartel RA, 2011, ECOLOGY, V92, P342, DOI 10.1890/10-0489.1; Best A, 2011, P ROY SOC B-BIOL SCI, V278, P2216, DOI 10.1098/rspb.2010.1978; Bradley CA, 2005, ECOL LETT, V8, P290, DOI 10.1111/j.1461-0248.2005.00722.x; BROWER LP, 1991, AM ZOOL, V31, P265; Carlsson-Graner U, 2006, OIKOS, V112, P174, DOI 10.1111/j.0030-1299.2006.13292.x; Carlsson-Graner U, 2002, OIKOS, V97, P97, DOI 10.1034/j.1600-0706.2002.970110.x; Cockrell B.J., 1993, Natural History Museum of Los Angeles County Science Series, P233; Coltman DW, 1999, EVOLUTION, V53, P1259, DOI [10.2307/2640828, 10.1111/j.1558-5646.1999.tb04538.x]; Cronin JT, 2009, ECOLOGY, V90, P196, DOI 10.1890/08-0208.1; de Roode JC, 2007, PARASITOLOGY, V134, P657, DOI 10.1017/S0031182006002009; de Roode JC, 2009, OECOLOGIA, V161, P67, DOI 10.1007/s00442-009-1361-6; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; FOLSTAD I, 1991, CAN J ZOOL, V69, P2423, DOI 10.1139/z91-340; Gog J, 2002, P ROY SOC B-BIOL SCI, V269, P671, DOI 10.1098/rspb.2001.1667; HANSKI I, 1991, BIOL J LINN SOC, V42, P3, DOI 10.1111/j.1095-8312.1991.tb00548.x; HASSELL MP, 1991, NATURE, V353, P255, DOI 10.1038/353255a0; Hess G, 1996, ECOLOGY, V77, P1617, DOI 10.2307/2265556; Hess G.R., 2002, P102; Hood G.M., 2010, POPTOOLS VERSION 3 2; Johnson TL, 2011, J WILDLIFE MANAGE, V75, P357, DOI 10.1002/jwmg.40; Leong KLH, 1997, J INVERTEBR PATHOL, V69, P79, DOI 10.1006/jipa.1996.4634; Leong KLH, 1997, PAN-PAC ENTOMOL, V73, P49; Lindsey E, 2009, EVOL ECOL, V23, P607, DOI 10.1007/s10682-008-9258-0; Lyons JI, 2012, MOL ECOL, V21, P3433, DOI 10.1111/j.1365-294X.2012.05613.x; McCallum H, 2002, P ROY SOC B-BIOL SCI, V269, P2041, DOI 10.1098/rspb.2002.2079; MCLAUGHLIN RE, 1970, J PROTOZOOL, V17, P300, DOI 10.1111/j.1550-7408.1970.tb02375.x; Oksanen J., 2016, R PACKAG; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Pritchard JK, 2000, GENETICS, V155, P945; Ravensdale M, 2011, MOL PLANT PATHOL, V12, P93, DOI 10.1111/j.1364-3703.2010.00657.x; Real LA, 2005, DIS ECOLOGY COMMUNIT, P168; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Riley S, 2007, SCIENCE, V316, P1298, DOI 10.1126/science.1134695; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Shephard JM, 2002, BIOL J LINN SOC, V75, P437, DOI 10.1046/j.1095-8312.2002.00034.x; SLATKIN M, 1995, GENETICS, V139, P457; Smith DL, 2002, P NATL ACAD SCI USA, V99, P3668, DOI [10.1073/pnas.042400799, 10.1073/pnas.132272199]; Smith EM, 2012, LIVEST SCI, V143, P293, DOI 10.1016/j.livsci.2011.10.009; Szpiech Z, 2008, BIOINFORMATICS, V24, P1367, DOI DOI 10.1093/BIOINFORMATICS/BTN478); Thrall PH, 1997, J ECOL, V85, P743, DOI 10.2307/2960598; THRALL PH, 1995, CAN J BOT, V73, pS1249, DOI 10.1139/b95-385; URQUHART FA, 1978, CAN J ZOOL, V56, P1759, DOI 10.1139/z78-240; Vane-Wright R.I., 1993, Natural History Museum of Los Angeles County Science Series, P179; Whitehorn PR, 2011, P ROY SOC B-BIOL SCI, V278, P1195, DOI 10.1098/rspb.2010.1550; ZALUCKI MP, 1982, BEHAVIOUR, V80, P174, DOI 10.1163/156853982X00346; Zalucki MP, 2004, BIOL J LINN SOC, V82, P111, DOI 10.1111/j.1095-8312.2004.00322.x	57	10	10	1	95	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100061	10.1371/journal.pone.0100061	http://dx.doi.org/10.1371/journal.pone.0100061			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926796	Green Submitted, Green Published, gold			2022-12-27	WOS:000338278100113
J	Yan, F; Wang, Q; Xu, C; Cao, MF; Zhou, XM; Wang, TT; Yu, CX; Jing, F; Chen, WB; Gao, L; Zhao, JJ				Yan, Fang; Wang, Qi; Xu, Chao; Cao, Mingfeng; Zhou, Xiaoming; Wang, Tingting; Yu, Chunxiao; Jing, Fei; Chen, Wenbin; Gao, Ling; Zhao, Jiajun			Peroxisome Proliferator-Activated Receptor alpha Activation Induces Hepatic Steatosis, Suggesting an Adverse Effect	PLOS ONE			English	Article							FATTY LIVER-DISEASE; TYPE-2 DIABETES-MELLITUS; PPAR-ALPHA; NONALCOHOLIC STEATOHEPATITIS; LIPID-METABOLISM; MICE; FENOFIBRATE; EXPRESSION; ACID; RAT	Non-alcoholic fatty liver disease (NAFLD) is characterized by hepatic triglyceride accumulation, ranging from steatosis to steatohepatitis and cirrhosis. NAFLD is a risk factor for cardiovascular diseases and is associated with metabolic syndrome. Antihyperlipidemic drugs are recommended as part of the treatment for NAFLD patients. Although fibrates activate peroxisome proliferator-activated receptor alpha (PPAR alpha), leading to the reduction of serum triglyceride levels, the effects of these drugs on NAFLD remain controversial. Clinical studies have reported that PPAR alpha activation does not improve hepatic steatosis. In the present study, we focused on exploring the effect and mechanism of PPAR alpha activation on hepatic triglyceride accumulation and hepatic steatosis. Male C57BL/6J mice, Ppar alpha-null mice and HepG2 cells were treated with fenofibrate, one of the most commonly used fibrate drugs. Both low and high doses of fenofibrate were administered. Hepatic steatosis was detected through oil red O staining and electron microscopy. Notably, in fenofibrate-treated mice, the serum triglyceride levels were reduced and the hepatic triglyceride content was increased in a dose-dependent manner. Oil red O staining of liver sections demonstrated that fenofibrate-fed mice accumulated abundant neutral lipids. Fenofibrate also increased the intracellular triglyceride content in HepG2 cells. The expression of sterol regulatory element-binding protein 1c (SREBP-1c) and the key genes associated with lipogenesis were increased in fenofibrate-treated mouse livers and HepG2 cells in a dose-dependent manner. However, the effect was strongly impaired in Ppar alpha-null mice treated with fenofibrate. Fenofibrate treatment induced mature SREBP-1c expression via the direct binding of PPAR alpha to the DR1 motif of the SREBP-1c gene. Taken together, these findings indicate the molecular mechanism by which PPAR alpha activation increases liver triglyceride accumulation and suggest an adverse effect of fibrates on the pathogenesis of hepatic steatosis.	[Yan, Fang; Xu, Chao; Cao, Mingfeng; Yu, Chunxiao; Jing, Fei; Zhao, Jiajun] Shandong Univ, Shandong Prov Hosp, Dept Endocrinol & Metab, Jinan 250100, Shandong, Peoples R China; [Wang, Qi; Zhou, Xiaoming; Chen, Wenbin; Gao, Ling] Shandong Univ, Shandong Prov Hosp, Ctr Sci, Jinan 250100, Shandong, Peoples R China; [Yan, Fang; Xu, Chao; Wang, Tingting; Yu, Chunxiao; Jing, Fei; Gao, Ling; Zhao, Jiajun] Shandong Acad Clin Med, Inst Endocrinol, Jinan, Shandong, Peoples R China; [Wang, Qi] Shandong Univ, Inst Pharmacol, Jinan 250100, Shandong, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Gao, L (corresponding author), Shandong Univ, Shandong Prov Hosp, Ctr Sci, Jinan 250100, Shandong, Peoples R China.	gaoling1@medmail.com.cn; jjzhao@medmail.com.cn	wang, tingting/AAK-2640-2020; Zhao, Jiajun/W-2963-2018; wang, qi/ABE-3782-2020	Zhao, Jiajun/0000-0003-3267-9292; 	National Basic Research Program [2012CB524900]; National Natural Science Foundation [30971409, 30901461, 81230018, 81170794, 81270869, 81370891]; Natural Science Foundation [ZR2009CZ009]; Shandong Province	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Shandong Province	This work was supported by grants from the National Basic Research Program (2012CB524900), the National Natural Science Foundation (30971409, 30901461, 81230018, 81170794, 81270869 and 81370891), the Natural Science Foundation (ZR2009CZ009), an international cooperation grant (2011) of Shandong Province and the Jinan self-renovation plan for colleges, universities and scientific research institutes (2012) of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins JC, 1997, DRUGS, V54, P615, DOI 10.2165/00003495-199754040-00007; Aguilera-Mendez A, 2013, MINI-REV MED CHEM, V13, P1691; Bajaj M, 2007, DIABETOLOGIA, V50, P1723, DOI 10.1007/s00125-007-0698-9; Chen Q, 2007, NAT PROTOC, V2, P1197, DOI 10.1038/nprot.2007.118; Cong WN, 2008, LIFE SCI, V82, P983, DOI 10.1016/j.lfs.2008.01.022; Damiano F, 2012, INT J BIOCHEM CELL B, V44, P659, DOI 10.1016/j.biocel.2012.01.003; de Alwis NMW, 2008, J HEPATOL, V48, pS104, DOI 10.1016/j.jhep.2008.01.009; Delayre-Orthez C, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-91; Dowman JK, 2010, QJM-INT J MED, V103, P71, DOI 10.1093/qjmed/hcp158; Elijah IE, 2012, BURNS, V38, P481, DOI 10.1016/j.burns.2011.12.004; Fatani S, 2011, INT J GEN MED, V4, P211, DOI 10.2147/IJGM.S17376; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Fernandez-Alvarez A, 2011, J BIOL CHEM, V286, P21466, DOI 10.1074/jbc.M110.209973; Fernandez-Miranda C, 2008, DIGEST LIVER DIS, V40, P200, DOI 10.1016/j.dld.2007.10.002; Ferreira AVM, 2006, METABOLISM, V55, P731, DOI 10.1016/j.metabol.2006.01.020; Gao MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065641; Gibbons GF, 2002, ADV ENZYME REGUL, V42, P227, DOI 10.1016/S0065-2571(01)00033-4; Hamaguchi M, 2007, WORLD J GASTROENTERO, V13, P1579, DOI 10.3748/wjg.v13.i10.1579; Karahashi M, 2013, J PHARMACOL SCI, V123, P356, DOI 10.1254/jphs.13149FP; Keating GM, 2011, AM J CARDIOVASC DRUG, V11, P227, DOI 10.2165/11207690-000000000-00000; KIM JB, 1995, MOL CELL BIOL, V15, P2582; Knight BL, 2005, BIOCHEM J, V389, P413, DOI 10.1042/BJ20041896; Kostapanos MS, 2013, WORLD J HEPATOL, V5, P470, DOI 10.4254/wjh.v5.i9.470; Laurin J, 1996, HEPATOLOGY, V23, P1464; Le Jossic-Corcos C, 2004, BBA-MOL CELL BIOL L, V1683, P49, DOI 10.1016/j.bbalip.2004.04.004; LEE SST, 1995, MOL CELL BIOL, V15, P3012; Luo ZD, 2012, CELL RES, V22, P551, DOI 10.1038/cr.2011.205; Martin PD, 2003, CLIN THER, V25, P459, DOI 10.1016/S0149-2918(03)80089-9; Nakajima T, 2010, REDOX REP, V15, P123, DOI 10.1179/174329210X12650506623807; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; Oosterveer MH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006066; Pan SY, 2013, J PHARMACOL SCI, V123, P110, DOI 10.1254/jphs.13087FP; Pan SY, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-120; Panadero M. I., 2009, Endocrine Metabolic & Immune Disorders-Drug Targets, V9, P219; Pang SS, 2010, DIABETES, V59, P3041, DOI 10.2337/db10-0418; Patel DD, 2001, J LIPID RES, V42, P328; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schoonjans K, 1996, BBA-LIPID LIPID MET, V1302, P93, DOI 10.1016/0005-2760(96)00066-5; Seo YS, 2008, J GASTROEN HEPATOL, V23, P102, DOI 10.1111/j.1440-1746.2006.04819.x; Shiri-Sverdlov R, 2006, J HEPATOL, V44, P732, DOI 10.1016/j.jhep.2005.10.033; Valasek MA, 2007, J LIPID RES, V48, P2725, DOI 10.1194/jlr.M700345-JLR200; Vecera R, 2011, BIOPHARM DRUG DISPOS, V32, P482, DOI 10.1002/bdd.774; Xue ZH, 2007, CLIN EXP PHARMACOL P, V34, P27, DOI 10.1111/j.1440-1681.2007.04547.x; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Zhang XQ, 2010, HEPATOLOGY, V51, P1190, DOI 10.1002/hep.23486	45	52	52	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99245	10.1371/journal.pone.0099245	http://dx.doi.org/10.1371/journal.pone.0099245			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926685	Green Submitted, gold, Green Published			2022-12-27	WOS:000338278100032
J	Li, Y; Liu, HZ; Li, J; Zhang, Q; Gong, SS; He, D				Li, Yi; Liu, Huizhan; Li, Jun; Zhang, Qian; Gong, Shusheng; He, David			Morphology and Ciliary Motion of Mucosa in the Eustachian Tube of Neonatal and Adult Gerbils	PLOS ONE			English	Article							MIDDLE-EAR MUCOSA; BEAT FREQUENCY; COCHLEA; NASAL	The Eustachian tube is a small canal that connects the tympanic cavity with the nasal part of the pharynx. The epithelial lining of the Eustachian tube contains a ciliated columnar epithelium at the tympanic cavity and a pseudostratified, ciliated columnar epithelium with goblet cells near the pharynx. The tube serves to equalize air pressure across the eardrum and drains mucus away from the middle ear into the nasopharynx. Blockage of the Eustachian tube is the most common cause of all forms of otitis media, which is common in children. In the present study, we examined the epithelial lining of the Eustachian tube in neonatal and adult gerbils, with a focus on the morphological and functional development of ciliated cells in the mucosa. The length of the tube is similar to 8.8 mm in adult gerbils. Scanning electron microscopy showed that the mucosal member near the pharyngeal side contains a higher density of ciliated cells and goblet cells than that near the tympanic side. The cilia beat frequency is 11 Hz. During development, the length of the Eustachian tube increased significantly between postnatal day 1 (P1) and P18. Scanning electron microscopy showed that the mucosa contained a high density of ciliated cells with a few goblet cells at P1. The density of ciliated cells decreased while the density of goblet cells increased during development. At P18, the mucosa appeared to be adult-like. Interestingly, the ciliary beat frequency measured from ciliated cells at P1 was not statistically different from that measured from adult animals. Our study suggests that the Eustachian tube undergoes significant anatomical and histological changes between P1 and P18. The tube is morphologically and functionally mature at P18, when the auditory function (sensitivity and frequency selectivity) is mature in this species.	[Li, Yi; Gong, Shusheng] Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China; [Li, Yi; Liu, Huizhan; Li, Jun; Zhang, Qian; He, David] Creighton Univ, Sch Med, Dept Biomed Sci, Omaha, NE 68178 USA; [Li, Jun] Fudan Univ, Dept Otolaryngol, Hosp Zhongshan Qingpu, Shanghai 200433, Peoples R China	Capital Medical University; Creighton University; Fudan University	Gong, SS (corresponding author), Capital Med Univ, Beijing Tongren Hosp, Dept Otolaryngol Head & Neck Surg, Beijing, Peoples R China.	gongss@ccmu.edu.cn; hed@creighton.edu	Zhang, Qian/P-7110-2015	Li (li yi), Yi/0000-0002-9986-6546; He (he zhi zhou), Zhi-Zhou/0000-0001-8383-9634	National Institutes of Health [R01 DC004696]; Major State Basic Research Development Program of China (973 Program) [2011CB504503]; Medical Rising Star Cultivation Program of Shanghai Qingpu Health Bureau grant [WY2011-14]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004696] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Major State Basic Research Development Program of China (973 Program)(National Basic Research Program of China); Medical Rising Star Cultivation Program of Shanghai Qingpu Health Bureau grant; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work has been supported by the National Institutes of Health grant R01 DC004696 to DH, and by the Major State Basic Research Development Program of China (973 Program) (No. 2011CB504503) to SHG. JL has been supported by the Medical Rising Star Cultivation Program of Shanghai Qingpu Health Bureau grant WY2011-14. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBIIN N, 1986, ANN OTO RHINOL LARYN, V95, P2, DOI 10.1177/00034894860950S501; [Anonymous], 2005, EUSTACHIAN TUBE STRU; Chilvers MA, 2000, THORAX, V55, P314, DOI 10.1136/thorax.55.4.314; CLARYMEINESZ CF, 1992, BIOL CELL, V76, P335, DOI 10.1016/0248-4900(92)90436-5; COHEN YE, 1992, HEARING RES, V62, P187, DOI 10.1016/0378-5955(92)90185-P; Cunsolo E, 2010, Int J Immunopathol Pharmacol, V23, P4; DANIEL HJ, 1982, ANN OTO RHINOL LARYN, V91, P82, DOI 10.1177/000348948209100118; Dimova S, 2005, J PHARM PHARMACOL, V57, P521, DOI 10.1211/0022357055777; Gurr A, 2009, EUR ARCH OTO-RHINO-L, V266, P1865, DOI 10.1007/s00405-009-0984-x; HARADA Y, 1977, ACTA OTO-LARYNGOL, V83, P284, DOI 10.3109/00016487709128847; HONJO I, 1985, AM J OTOLARYNG, V6, P241, DOI 10.1016/S0196-0709(85)80095-8; HUANGFU M, 1983, J MORPHOL, V176, P249, DOI 10.1002/jmor.1051760302; Jia SP, 2011, AM J RESP CELL MOL, V45, P1084, DOI 10.1165/rcmb.2010-0268OC; Jia SP, 2005, NAT NEUROSCI, V8, P1028, DOI 10.1038/nn1509; Kim W, 2011, HEALTHC INFORM RES, V17, P111, DOI 10.4258/hir.2011.17.2.111; Lim D J, 1967, Acta Otolaryngol, V63, P425, DOI 10.3109/00016486709128777; LIM DJ, 1985, ACTA OTO-LARYNGOL, P1; LIM DJ, 1976, ANN OTO RHINOL LARYN, V85, P36, DOI 10.1177/00034894760850S209; MAEDA S, 1976, ANN OTO RHINOL LARYN, V85, P1; MCGUIRT JP, 1995, HEARING RES, V84, P52, DOI 10.1016/0378-5955(95)00015-V; Morris LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039004; OHASHI Y, 1985, ANN OTO RHINOL LARYN, V94, P419; Oldenburg AL, 2012, BIOMED OPT EXPRESS, V3, P1978, DOI 10.1364/BOE.3.001978; Overstreet EH, 2003, AUDIOL NEURO-OTOL, V8, P19, DOI 10.1159/000067892; PARK K, 1992, Yonsei Medical Journal, V33, P64; ROTH Y, 1984, J LARYNGOL OTOL, V98, P853, DOI 10.1017/S0022215100147620; Salathe M, 2007, ANNU REV PHYSIOL, V69, P401, DOI 10.1146/annurev.physiol.69.040705.141253; Sutto Z, 2004, J PHYSIOL-LONDON, V560, P519, DOI 10.1113/jphysiol.2004.068171; WAKE M, 1992, CLIN OTOLARYNGOL, V17, P155, DOI 10.1111/j.1365-2273.1992.tb01064.x; WATANUKI K, 1975, ARCH OTO-RHINO-LARYN, V211, P65, DOI 10.1007/BF00467292; WOOLF NK, 1988, HEARING RES, V35, P131, DOI 10.1016/0378-5955(88)90112-8; WOOLF NK, 1984, HEARING RES, V13, P277, DOI 10.1016/0378-5955(84)90081-9	32	5	5	2	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99840	10.1371/journal.pone.0099840	http://dx.doi.org/10.1371/journal.pone.0099840			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925141	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300100
J	Nolen, BM; Breen, EC; Bream, JH; Jenkins, FJ; Kingsley, LA; Rinaldo, CR; Lokshin, AE				Nolen, Brian M.; Breen, Elizabeth Crabb; Bream, Jay H.; Jenkins, Frank J.; Kingsley, Lawrence A.; Rinaldo, Charles R.; Lokshin, Anna E.			Circulating Mediators of Inflammation and Immune Activation in AIDS-Related Non-Hodgkin Lymphoma	PLOS ONE			English	Article							B-CELL LYMPHOMA; ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ACTIVE ANTIRETROVIRAL THERAPY; SERUM-LEVELS; INTERFERON-ALPHA; INFECTED PATIENTS; IN-VITRO; PATHOGENESIS; ERA; COHORT	Background: Non-Hodgkin lymphoma (NHL) is the most common AIDS-related malignancy in developed countries. An elevated risk of developing NHL persists among HIV-infected individuals in comparison to the general population despite the advent of effective antiretroviral therapy. The mechanisms underlying the development of AIDS-related NHL (A-NHL) are not fully understood, but likely involve persistent B-cell activation and inflammation. Methods: This was a nested case-control study within the ongoing prospective Multicenter AIDS Cohort Study (MACS). Cases included 47 HIV-positive male subjects diagnosed with high-grade B-cell NHL. Controls were matched to each case from among participating HIV-positive males who did not develop any malignancy. Matching criteria included time HIV+ or since AIDS diagnosis, age, race and CD4+ cell count. Sera were tested for 161 serum biomarkers using multiplexed bead-based immunoassays. Results: A subset of 17 biomarkers, including cytokines, chemokines, acute phase proteins, tissue remodeling agents and bone metabolic mediators was identified to be significantly altered in A-NHL cases in comparison to controls. Many of the biomarkers included in this subset were positively correlated with HIV viral load. A pathway analysis of our results revealed an extensive network of interactions between current and previously identified biomarkers. Conclusions: These findings support the current hypothesis that A-NHL develops in the context of persistent immune stimulation and inflammation. Further analysis of the biomarkers identified in this report should enhance our ability to diagnose, monitor and treat this disease.	[Nolen, Brian M.; Jenkins, Frank J.; Lokshin, Anna E.] Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15232 USA; [Breen, Elizabeth Crabb] Univ Calif Los Angeles, David Geffen Sch Med, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90095 USA; [Breen, Elizabeth Crabb] Univ Calif Los Angeles, UCLA AIDS Inst, Los Angeles, CA USA; [Bream, Jay H.] Johns Hopkins Univ, Johns Hopkins Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD USA; [Jenkins, Frank J.; Rinaldo, Charles R.; Lokshin, Anna E.] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA USA; [Kingsley, Lawrence A.] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA; [Lokshin, Anna E.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Lokshin, Anna E.] Univ Pittsburgh, Sch Med, Dept Ob Gyn, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Lokshin, AE (corresponding author), Univ Pittsburgh, Inst Canc, Pittsburgh, PA 15232 USA.	lokshina@pitt.edu		Kingsley, Lawrence/0000-0002-7000-8556; Bream, Jay/0000-0002-9149-7643	National Institute of Allergy and Infectious Diseases (NIAID); National Cancer Institute (NCI); National Heart, Lung, and Blood Institute (NHLBI); National Institute on Deafness and Communication Disorders (NIDCD); JHU CTSA [UL1-TR000424]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000424] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI035040, UM1AI035043, U01AI035042, U01AI035041, U01AI035039, U01AI035043] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Deafness and Communication Disorders (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); JHU CTSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Data in this manuscript were collected by the Multicenter AIDS Cohort Study (MACS) with centers (Principal Investigators) at: Johns Hopkins University Bloomberg School of Public Health (Joseph Margolick), U01-AI35042; Northwestern University (Steven Wolinsky), U01-AI35039; University of California, Los Angeles (Roger Detels), U01-AI35040; University of Pittsburgh (Charles Rinaldo), U01-AI35041; the Center for Analysis and Management of MACS, Johns Hopkins University Bloomberg School of Public Health (Lisa Jacobson), UM1-AI35043. The MACS is funded primarily by the National Institute of Allergy and Infectious Diseases (NIAID), with additional co-funding from the National Cancer Institute (NCI). Targeted supplemental funding for specific projects was also provided by the National Heart, Lung, and Blood Institute (NHLBI), and the National Institute on Deafness and Communication Disorders (NIDCD). MACS data collection is also supported by UL1-TR000424 (JHU CTSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansell SM, 2012, AM J HEMATOL, V87, P865, DOI 10.1002/ajh.23259; Bassig BA, 2012, ENVIRON MOL MUTAGEN, V53, P145, DOI 10.1002/em.21675; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERAL V, 1991, LANCET, V337, P805, DOI 10.1016/0140-6736(91)92513-2; Beral V, 1991, CANC SURV PLAINVIEW, P1; Bonnet F, 2006, CLIN INFECT DIS, V42, P411, DOI 10.1086/499054; Bonnet F, 2004, CANCER-AM CANCER SOC, V101, P317, DOI 10.1002/cncr.20354; Bower M, 2001, HIV Med, V2, P141, DOI 10.1046/j.1468-1293.2001.00061.x; Bozkurt C, 2008, PEDIATR HEMAT ONCOL, V25, P621, DOI 10.1080/08880010802313657; Breen EC, 2006, TUMOR BIOL, V27, P187, DOI 10.1159/000093022; Breen EC, 2005, AIDS, V19, P1711, DOI 10.1097/01.aids.0000184924.04983.7c; Breen EC, 2003, CLIN IMMUNOL, V109, P119, DOI 10.1016/S1521-6616(03)00214-6; Breen EC, 2011, CANCER EPIDEM BIOMAR, V20, P1303, DOI 10.1158/1055-9965.EPI-11-0037; Carbone A, 2002, HUM PATHOL, V33, P392, DOI 10.1053/hupa.2002.124723; Citak EC, 2008, PEDIATR HEMAT ONCOL, V25, P55, DOI 10.1080/08880010701826866; Corcione A, 2004, CLIN CANCER RES, V10, P964, DOI 10.1158/1078-0432.CCR-1182-3; Cote TR, 1996, J NATL CANCER I, V88, P675, DOI 10.1093/jnci/88.10.675; Cunto-Amesty G, 2000, BLOOD, V95, P1393, DOI 10.1182/blood.V95.4.1393.004k49_1393_1399; Dolganiuc A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044915; Ellis M, 2006, CLIN IMMUNOL, V120, P129, DOI 10.1016/j.clim.2006.03.003; Epeldegui M, 2006, CURR OPIN ONCOL, V18, P444, DOI 10.1097/01.cco.0000239882.23839.e5; Gaidano G, 1998, AM J PATHOL, V152, P623; Grulich A E, 2000, AIDS Read, V10, P341; Grulich AE, 2000, AIDS, V14, P133, DOI 10.1097/00002030-200001280-00008; Grulich AE, 2001, AIDS, V15, P629, DOI 10.1097/00002030-200103300-00013; Harrington WJ, 1996, LANCET, V348, P833; Hensbergen PJ, 2005, J IMMUNOTHER, V28, P343, DOI 10.1097/01.cji.0000165355.26795.27; Hottinger AF, 2011, ANN NEUROL, V70, P163, DOI 10.1002/ana.22360; Hussain SK, 2013, CANCER EPIDEM BIOMAR, V22, P295, DOI 10.1158/1055-9965.EPI-12-1122; KASLOW RA, 1987, AM J EPIDEMIOL, V126, P310, DOI 10.1093/aje/126.2.310; Killebrew D, 2004, CURR HIV RES, V2, P215, DOI 10.2174/1570162043351237; Kirk O, 2001, BLOOD, V98, P3406, DOI 10.1182/blood.V98.12.3406; Knowles DM, 2003, HEMATOL ONCOL CLIN N, V17, P785, DOI 10.1016/S0889-8588(03)00050-9; Lee RK, 1999, CANCER RES, V59, P5514; Marquart HV, 1997, SCAND J IMMUNOL, V46, P246, DOI 10.1046/j.1365-3083.1997.d01-122.x; Matthews GV, 2000, BLOOD, V96, P2730; Ouedraogo DE, 2013, J CLIN IMMUNOL, V33, P22, DOI 10.1007/s10875-012-9766-0; Pages F, 2005, BLOOD, V105, P1632, DOI 10.1182/blood-2004-08-3196; Panel on Antiretroviral Guidelines for Adults and Adolescents, 2008, GUIDELINES USE ANTIR; Polesel J, 2008, AIDS, V22, P301, DOI 10.1097/QAD.0b013e3282f2705d; Purdue MP, 2009, BLOOD, V114, P2730, DOI 10.1182/blood-2009-04-217521; Rabkin CS, 2001, EUR J CANCER, V37, P1316, DOI 10.1016/S0959-8049(01)00104-6; Schroeder JR, 1999, CANCER EPIDEM BIOMAR, V8, P979; Seaberg EC, 2010, CANCER-AM CANCER SOC, V116, P5507, DOI 10.1002/cncr.25530; Tarantul VZ, 2000, AIDS RES HUM RETROV, V16, P173, DOI 10.1089/088922200309511; Tian RR, 2012, ANTIVIR RES, V95, P57, DOI 10.1016/j.antiviral.2012.04.011; Toomey NL, 2001, ONCOGENE, V20, P7029, DOI 10.1038/sj.onc.1204895; Vendrame E, 2014, CANCER EPIDEM BIOMAR, V23, P343, DOI 10.1158/1055-9965.EPI-13-0714; Wang XB, 2007, J IMMUNOL, V179, P2880, DOI 10.4049/jimmunol.179.5.2880; Widney DP, 2010, AIDS RES TREAT, V2010, DOI 10.1155/2010/164586; Wong HL, 2010, AIDS, V24, P1025, DOI 10.1097/QAD.0b013e328332d5b1; Xia T, 2008, CANCER RES, V68, P1436, DOI 10.1158/0008-5472.CAN-07-5126; Yurkovetsky Z, 2010, J CLIN ONCOL, V28, P2159, DOI 10.1200/JCO.2008.19.2484	53	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99144	10.1371/journal.pone.0099144	http://dx.doi.org/10.1371/journal.pone.0099144			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922518	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000338701300037
J	Schlumpf, YR; Reinders, AATS; Nijenhuis, ERS; Luechinger, R; van Osch, MJP; Jancke, L				Schlumpf, Yolanda R.; Reinders, Antje A. T. S.; Nijenhuis, Ellert R. S.; Luechinger, Roger; van Osch, Matthias J. P.; Jaencke, Lutz			Dissociative Part-Dependent Resting-State Activity in Dissociative Identity Disorder: A Controlled fMRI Perfusion Study	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; CEREBRAL-BLOOD-FLOW; MULTIPLE-PERSONALITY; DEFAULT-MODE; FUNCTIONAL CONNECTIVITY; EMISSION-TOMOGRAPHY; TRAUMATIC MEMORIES; PREFRONTAL CORTEX; FANTASY PRONENESS; BRAIN ACTIVATION	Background: In accordance with the Theory of Structural Dissociation of the Personality (TSDP), studies of dissociative identity disorder (DID) have documented that two prototypical dissociative subsystems of the personality, the "Emotional Part'' (EP) and the "Apparently Normal Part'' (ANP), have different biopsychosocial reactions to supraliminal and subliminal trauma-related cues and that these reactions cannot be mimicked by fantasy prone healthy controls nor by actors. Methods: Arterial spin labeling perfusion MRI was used to test the hypotheses that ANP and EP in DID have different perfusion patterns in response to rest instructions, and that perfusion is different in actors who were instructed to simulate ANP and EP. In a follow-up study, regional cerebral blood flow of DID patients was compared with the activation pattern of healthy non-simulating controls. Results: Compared to EP, ANP showed elevated perfusion in bilateral thalamus. Compared to ANP, EP had increased perfusion in the dorsomedial prefrontal cortex, primary somatosensory cortex, and motor-related areas. Perfusion patterns for simulated ANP and EP were different. Fitting their reported role-play strategies, the actors activated brain structures involved in visual mental imagery and empathizing feelings. The follow-up study demonstrated elevated perfusion in the left temporal lobe in DID patients, whereas non-simulating healthy controls had increased activity in areas which mediate the mental construction of past and future episodic events. Conclusion: DID involves dissociative part-dependent resting-state differences. Compared to ANP, EP activated brain structures involved in self-referencing and sensorimotor actions more. Actors had different perfusion patterns compared to genuine ANP and EP. Comparisons of neural activity for individuals with DID and non-DID simulating controls suggest that the resting-state features of ANP and EP in DID are not due to imagination. The findings are consistent with TSDP and inconsistent with the idea that DID is caused by suggestion, fantasy proneness, and role-playing.	[Schlumpf, Yolanda R.; Jaencke, Lutz] Univ Zurich, Div Neuropsychol, Inst Psychol, Zurich, Switzerland; [Reinders, Antje A. T. S.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurosci, NL-9713 AV Groningen, Netherlands; [Reinders, Antje A. T. S.] Univ Groningen, Univ Med Ctr Groningen, BCN Neuroimaging Ctr, Groningen, Netherlands; [Reinders, Antje A. T. S.] Kings Coll London, Dept Psychosis Studies, Inst Psychiat, London WC2R 2LS, England; [Nijenhuis, Ellert R. S.] Top Referent Trauma Ctr Mental Hlth Care Drenthe, Assen, Netherlands; [Luechinger, Roger] Univ Zurich, Inst Biomed Engn, Zurich, Switzerland; [Luechinger, Roger] ETH, Zurich, Switzerland; [van Osch, Matthias J. P.] Leiden Univ, Dept Radiol, Med Ctr, CJ Gorter Ctr High Field MRI, Leiden, Netherlands; [Jaencke, Lutz] Univ Zurich, Int Normal Aging & Plast Imaging Ctr, Zurich, Switzerland	University of Zurich; University of Groningen; University of Groningen; University of London; King's College London; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Zurich	Schlumpf, YR (corresponding author), Univ Zurich, Div Neuropsychol, Inst Psychol, Zurich, Switzerland.	y.schlumpf@psychologie.uzh.ch	Luechinger, Roger/AAD-5192-2019; Van Osch, Matthias/AAV-3876-2021; Jancke, Lutz/D-2910-2013	Luechinger, Roger/0000-0002-7365-0421; Van Osch, Matthias/0000-0001-7034-8959; Jancke, Lutz/0000-0003-2110-9067; Nijenhuis, Ellert/0000-0003-4710-474X; Schlumpf, Yolanda/0000-0002-5754-2113	Forschungskredit of the University of Zurich; Netherlands Organization for Scientific Research, NWO-VENI [451-07-009]	Forschungskredit of the University of Zurich; Netherlands Organization for Scientific Research, NWO-VENI(Netherlands Organization for Scientific Research (NWO))	This research was supported by the Forschungskredit of the University of Zurich (www. researchers.uzh.ch/promotion/forschungskredit.html). A. A. T. Simone Reinders is supported by the Netherlands Organization for Scientific Research (www.nwo.nl), NWO-VENI grant no. 451-07-009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addis DR, 2008, HIPPOCAMPUS, V18, P227, DOI 10.1002/hipo.20405; Addis DR, 2007, NEUROPSYCHOLOGIA, V45, P1363, DOI 10.1016/j.neuropsychologia.2006.10.016; AHERN GL, 1993, ARCH NEUROL-CHICAGO, V50, P1020, DOI 10.1001/archneur.1993.00540100017009; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andrews-Hanna JR, 2010, J NEUROPHYSIOL, V104, P322, DOI 10.1152/jn.00830.2009; Barnes A, 1997, DIALOGUE-CAN PHILOS, V36, P705, DOI 10.1017/S0012217300017613; BENSON DF, 1986, ARCH NEUROL-CHICAGO, V43, P471, DOI 10.1001/archneur.1986.00520050051021; Blakemore SJ, 2001, NAT REV NEUROSCI, V2, P561, DOI 10.1038/35086023; Bob P, 2003, INT J NEUROSCI, V113, P903, DOI 10.1080/00207450390220376; Bonne O, 2003, BIOL PSYCHIAT, V54, P1077, DOI 10.1016/S0006-3223(03)00525-0; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Burgess PW, 2001, NEUROPSYCHOLOGIA, V39, P545, DOI 10.1016/S0028-3932(00)00149-4; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Craig AD, 2003, ANNU REV NEUROSCI, V26, P1, DOI 10.1146/annurev.neuro.26.041002.131022; Dalenberg CJ, 2012, PSYCHOL BULL, V138, P550, DOI 10.1037/a0027447; Damasio A.R., 2005, DESCARTES ERROR EMOT; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Davidson RJ, 2004, BIOL PSYCHOL, V67, P219, DOI 10.1016/j.biopsycho.2004.03.008; Decety J, 2008, DEV PSYCHOPATHOL, V20, P1053, DOI 10.1017/S0954579408000503; Decety J, 2008, NEUROPSYCHOLOGIA, V46, P2607, DOI 10.1016/j.neuropsychologia.2008.05.026; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DETRE JA, 1994, NMR BIOMED, V7, P75, DOI 10.1002/nbm.1940070112; Detre JA, 2012, J MAGN RESON IMAGING, V35, P1026, DOI 10.1002/jmri.23581; Diseth TH, 2006, DEV PSYCHOPATHOL, V18, P233, DOI 10.1017/So954579406060135; Dutra L, 2009, J NERV MENT DIS, V197, P383, DOI 10.1097/NMD.0b013e3181a653b7; Ehlers A, 1996, DTSCH POSTTRAUMATIC; Eisenberg N., 1987, EMPATHY ITS DEV; Etkin A, 2011, TRENDS COGN SCI, V15, P85, DOI 10.1016/j.tics.2010.11.004; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2005, HUM BRAIN MAPP, V26, P15, DOI 10.1002/hbm.20113; Gallese V, 1998, TRENDS COGN SCI, V2, P493, DOI 10.1016/S1364-6613(98)01262-5; Gast U., 2000, STRUKTURIERTE KLIN I; Gevers S, 2011, J CEREBR BLOOD F MET, V31, P1706, DOI 10.1038/jcbfm.2011.10; Giesbrecht T, 2008, PSYCHOL BULL, V134, P617, DOI 10.1037/0033-2909.134.5.617; Greicius MD, 2004, J COGNITIVE NEUROSCI, V16, P1484, DOI 10.1162/0898929042568532; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2009, PHILOS T R SOC B, V364, P1263, DOI 10.1098/rstb.2008.0296; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Hautzinger M, 2006, BDI 2 BECK DEPRESSIO; Hein G, 2008, CURR OPIN NEUROBIOL, V18, P153, DOI 10.1016/j.conb.2008.07.012; Hermans EJ, 2006, PSYCHIAT RES, V141, P233, DOI 10.1016/j.psychres.2005.03.007; HUGHES JR, 1990, CLIN ELECTROENCEPHAL, V21, P200, DOI 10.1177/155005949002100409; Hynes CA, 2006, NEUROPSYCHOLOGIA, V44, P374, DOI 10.1016/j.neuropsychologia.2005.06.011; Jackson PL, 2005, NEUROIMAGE, V24, P771, DOI 10.1016/j.neuroimage.2004.09.006; Kawasaki H, 2001, NAT NEUROSCI, V4, P15, DOI 10.1038/82850; Kim SJ, 2007, ACTA PSYCHIAT SCAND, V116, P145, DOI 10.1111/j.1600-0447.2006.00952.x; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; KOSSLYN SM, 1993, J COGNITIVE NEUROSCI, V5, P263, DOI 10.1162/jocn.1993.5.3.263; Kosslyn SM, 2001, NAT REV NEUROSCI, V2, P635, DOI 10.1038/35090055; Krystal John H., 1995, P239; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Lanius RA, 2011, ACTA PSYCHIAT SCAND, V124, P331, DOI 10.1111/j.1600-0447.2011.01755.x; Lanius RA, 2002, BIOL PSYCHIAT, V52, P305, DOI 10.1016/S0006-3223(02)01367-7; Lanius RA, 2005, BIOL PSYCHIAT, V57, P873, DOI 10.1016/j.biopsych.2005.01.011; Lanius RA, 2003, BIOL PSYCHIAT, V53, P204, DOI 10.1016/S0006-3223(02)01466-X; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; Lanius RA, 2010, AM J PSYCHIAT, V167, P640, DOI 10.1176/appi.ajp.2009.09081168; Lilienfeld SO, 1999, PSYCHOL BULL, V125, P507, DOI 10.1037/0033-2909.125.5.507; Lucey JV, 1997, BRIT J PSYCHIAT, V171, P346, DOI 10.1192/bjp.171.4.346; LYNN SJ, 1988, AM PSYCHOL, V43, P35, DOI 10.1037/0003-066X.43.1.35; Lynn SJ, 2012, CURR DIR PSYCHOL SCI, V21, P48, DOI 10.1177/0963721411429457; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; MATHEW RJ, 1985, KIDNEY INT, V28, P64, DOI 10.1038/ki.1985.119; Mazoyer B, 2001, BRAIN RES BULL, V54, P287, DOI 10.1016/S0361-9230(00)00437-8; Merckelbach H, 2000, PERS INDIV DIFFER, V29, P1133, DOI 10.1016/S0191-8869(99)00260-3; Merckelbach H, 2005, COMPR PSYCHIAT, V46, P181, DOI 10.1016/j.comppsych.2004.08.001; Merckelbach H, 2002, CLIN PSYCHOL REV, V22, P481, DOI 10.1016/S0272-7358(01)00115-5; Merckelbach H, 2001, BEHAV RES THER, V39, P245, DOI 10.1016/S0005-7967(99)00181-3; MERSKEY H, 1992, BRIT J PSYCHIAT, V160, P327, DOI 10.1192/bjp.160.3.327; MESULAM MM, 1981, ARCH NEUROL-CHICAGO, V38, P176, DOI 10.1001/archneur.1981.00510030070010; Mirzaei S, 2001, NEUROPSYCHOBIOLOGY, V43, P260, DOI 10.1159/000054900; Nijenhuis E. R. S., 2002, BIOL PSYCHIAT, V2, P1079, DOI [DOI 10.1002/0470854871.CHXXI, DOI 10.1002/0470854871.chxxi]; Nijenhuis ERS, 2011, DISSOCIATION AND THE DISSOCIATIVE DISORDERS: DSM-V AND BEYOND, P337; Nijenhuis ERS, 1999, AUST NZ J PSYCHIAT, V33, P511, DOI 10.1080/j.1440-1614.1999.00601.x; Nijenhuis ERS, PSICHIATRA IN PRESS; Nijenhuis ERS, 2012, TRAUMA DISSOCIATION, P111; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; Ogawa JR, 1997, DEV PSYCHOPATHOL, V9, P855, DOI 10.1017/S0954579497001478; Okuda J, 2003, NEUROIMAGE, V19, P1369, DOI 10.1016/S1053-8119(03)00179-4; Okuda J, 1998, NEUROSCI LETT, V253, P127, DOI 10.1016/S0304-3940(98)00628-4; Piper A, 2004, CAN J PSYCHIAT, V49, P592, DOI 10.1177/070674370404900904; Price CJ, 1997, NEUROIMAGE, V5, P261, DOI 10.1006/nimg.1997.0269; Price CJ, 1997, HUM BRAIN MAPP, V5, P264, DOI 10.1002/(SICI)1097-0193(1997)5:4<264::AID-HBM11>3.0.CO;2-E; Putnam F. W., 1997, DISSOCIATION CHILDRE; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380; Reinders AATS, 2006, BIOL PSYCHIAT, V60, P730, DOI 10.1016/j.biopsych.2005.12.019; Reinders AATS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039279; Reinders AATS, 2003, NEUROIMAGE, V20, P2119, DOI 10.1016/j.neuroimage.2003.08.021; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Sachinvala N, 2000, MIL MED, V165, P473, DOI 10.1093/milmed/165.6.473; Sar V., 2001, J TRAUMA DISSOCIATIO, V2, P5, DOI [10.1300/J229v02n02_02, DOI 10.1300/J229V02N02_02]; Sar V, 2013, J NERV MENT DIS, V201, P439, DOI 10.1097/NMD.0b013e31828e112b; SAXE GN, 1992, J NERV MENT DIS, V180, P662, DOI 10.1097/00005053-199210000-00009; Schacter DL, 2007, PHILOS T R SOC B, V362, P773, DOI 10.1098/rstb.2007.2087; SCHENK L, 1981, AM J PSYCHIAT, V138, P1311; Schlumpf YR, 2013, NEUROIMAGE-CLIN, V3, P54, DOI 10.1016/j.nicl.2013.07.002; Semiz UB, 2000, KLIN PSIKOFARMKOLOJI, V10, P176; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Shulman GL, 1997, J COGNITIVE NEUROSCI, V9, P648, DOI 10.1162/jocn.1997.9.5.648; Simeon D, 2000, AM J PSYCHIAT, V157, P1782, DOI 10.1176/appi.ajp.157.11.1782; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; SPANOS NP, 1994, PSYCHOL BULL, V116, P143, DOI 10.1037/0033-2909.116.1.143; Steele Kathy, 2005, J Trauma Dissociation, V6, P11, DOI 10.1300/J229v06n03_02; Steinberg M, 1993, STRUCTURED CLIN INTE; Szpunar KK, 2007, P NATL ACAD SCI USA, V104, P642, DOI 10.1073/pnas.0610082104; Tian LX, 2007, NEUROIMAGE, V36, P684, DOI 10.1016/j.neuroimage.2007.03.044; Tsai GE, 1999, HARVARD REV PSYCHIAT, V7, P119, DOI 10.1093/hrp/7.2.119; van der Hart O, 2006, HAUNTED SELF STRUCTU; van der Hart Onno, 2005, J Trauma Dissociation, V6, P55, DOI 10.1300/J229v06n01_04; van Osch MJP, 2009, MAGN RESON MED, V62, P165, DOI 10.1002/mrm.22002; VANDERKOLK BA, 1995, J TRAUMA STRESS, V8, P505, DOI 10.1002/jts.2490080402; Vogt BA, 2005, NAT REV NEUROSCI, V6, P533, DOI 10.1038/nrn1704; Wastling SJ, 2009, P INT SOC MAG RESON, V17; Yin Y, 2011, NEUROSCI LETT, V498, P185, DOI 10.1016/j.neulet.2011.02.069	122	46	46	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98795	10.1371/journal.pone.0098795	http://dx.doi.org/10.1371/journal.pone.0098795			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922512	Green Published, gold, Green Accepted			2022-12-27	WOS:000338701300016
J	Meester, I; Rosas-Taraco, AG; Salinas-Carmona, MC				Meester, Irene; Geovanni Rosas-Taraco, Adrian; Cesar Salinas-Carmona, Mario			Nocardia brasiliensis Induces Formation of Foamy Macrophages and Dendritic Cells In Vitro and In Vivo	PLOS ONE			English	Article							PPAR-GAMMA; LIPID-METABOLISM; TUBERCULOSIS; EXPRESSION; ACTINOMYCETOMA; INFLAMMATION; ACTIVATION; GRANULOMAS; INFECTION; PROTEIN	Foamy cells have been described in various infectious diseases, for example in actinomycetoma induced by Nocardia brasiliensis. These cells are generally considered to be macrophages, although they present dendritic cell (DC)-specific surface markers. In this study, we determined and confirmed the lineage of possible precursors of foamy cells in vitro and in vivo using an experimental actinomycetoma model in BALB/c mice. Bone marrow-derived macrophages (BMDM) or DC (BMDC) were infected in vitro with N. brasiliensis or labeled with carboxyfluorescein diacetate succinimidyl ester (CFSE). Both, macrophages and DC, differentiated into foamy cells after in vitro infection. CFSE-labeled BMDM or BMDC were tested for phagocytosis and CD11c/CD11b receptors markers expression before being transferred into the actinomycetoma lesion site of infected mice. In vivo studies showed that BMDM and BMDC were traced at the site where foamy cells are present in the experimental actinomycetoma. Interestingly, many of the transferred BMDM and BMDC were stained with the lipid-droplet fluorophore Nile Red. In conclusion, macrophages and DC cells can be differentiated into foamy cells in vitro and in vivo during N. brasiliensis infection.	[Meester, Irene; Geovanni Rosas-Taraco, Adrian; Cesar Salinas-Carmona, Mario] Univ Autonoma Nuevo Leon, Fac Med, Dept Immunol, San Nicolas De Los Garza, Nuevo Leon, Mexico	Universidad Autonoma de Nuevo Leon	Salinas-Carmona, MC (corresponding author), Univ Autonoma Nuevo Leon, Fac Med, Dept Immunol, San Nicolas De Los Garza, Nuevo Leon, Mexico.	mario.salinas@uanl.mx	meester, irene/AAG-9879-2020; Salinas-Carmona, Mario C/Y-2456-2019	meester, irene/0000-0002-0609-3207; Salinas-Carmona, Mario C/0000-0002-4239-7363	CONACYT Mexico [99149]; CONACYT [229067]	CONACYT Mexico(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This study was supported by a grant to AGRT from CONACYT Mexico (99149). IM is grateful for the CONACYT study grant 229067. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida PE, 2009, J IMMUNOL, V183, P1337, DOI 10.4049/jimmunol.0900365; Ammon C, 2000, IMMUNOLOGY, V100, P364, DOI 10.1046/j.1365-2567.2000.00056.x; AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013; Chawla A, 2001, NAT MED, V7, P48, DOI 10.1038/83336; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Daniel J, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002093; Elamin AA, 2012, J PATHOG, V2012, DOI 10.1155/2012/361374; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Guth AM, 2009, AM J PHYSIOL-LUNG C, V296, pL936, DOI 10.1152/ajplung.90625.2008; Hunter RL, 2006, ANN CLIN LAB SCI, V36, P371; INABA K, 1995, CELL IMMUNOL, V163, P148, DOI 10.1006/cimm.1995.1109; Kim MJ, 2010, EMBO MOL MED, V2, P258, DOI 10.1002/emmm.201000079; Kouoh F, 2000, APMIS, V108, P417, DOI 10.1034/j.1600-0463.2000.d01-77.x; Kruger T, 2004, J AM SOC NEPHROL, V15, P613, DOI 10.1097/01.ASN.0000114553.36258.91; KURUP IG, 1982, J BIOSCIENCES, V4, P307, DOI 10.1007/BF02702743; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Liu WW, 2014, INFLAMM RES, V63, P33, DOI 10.1007/s00011-013-0667-3; Mahajan S, 2012, J IMMUNOL, V188, P5593, DOI 10.4049/jimmunol.1103038; Martin P, 2000, BLOOD, V96, P2511, DOI 10.1182/blood.V96.7.2511.h8002511_2511_2519; Mattos KA, 2011, J IMMUNOL, V187, P2548, DOI 10.4049/jimmunol.1101344; Mattos KA, 2010, J LEUKOCYTE BIOL, V87, P371, DOI 10.1189/jlb.0609433; McLauchlan J, 2009, BBA-MOL CELL BIOL L, V1791, P552, DOI 10.1016/j.bbalip.2008.12.012; Meester I, 2013, PATHOG DIS, V67, P214, DOI 10.1111/2049-632X.12036; Mei CL, 2009, CELL BIOL INT, V33, P301, DOI 10.1016/j.cellbi.2008.12.002; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Moreno JM, 2002, IMMUNOLOGY, V106, P257, DOI 10.1046/j.1365-2567.2002.01403.x; Noverr MC, 2001, INFECT IMMUN, V69, P2957, DOI 10.1128/IAI.69.5.2957-2963.2001; O'Neill HC, 2004, J LEUKOCYTE BIOL, V75, P600, DOI 10.1189/jlb.0903446; Ordway D, 2005, J IMMUNOL, V175, P3873, DOI 10.4049/jimmunol.175.6.3873; Paulson KE, 2010, CIRC RES, V106, P383, DOI 10.1161/CIRCRESAHA.109.210781; Peyron P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000204; Rosas-Taraco AG, 2012, INFECT IMMUN, V80, P2493, DOI 10.1128/IAI.06307-11; Saka HA, 2012, ANN REV CELL DEV BIO; Salinas-Carmona MC, 1999, INFECT IMMUN, V67, P2428, DOI 10.1128/IAI.67.5.2428-2432.1999; Salinas-Carmona MC, 2000, MICROBES INFECT, V2, P1373, DOI 10.1016/S1286-4579(00)01291-0; Salinas-Carmona MC, 2012, A VANLEEUWENHOEK; Samsa MM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000632; Serbina NV, 2003, IMMUNITY, V19, P59, DOI 10.1016/S1074-7613(03)00171-7; Sonda S, 2001, J BIOL CHEM, V276, P34434, DOI 10.1074/jbc.M105025200; Tanigawa K, 2009, CLIN EXP IMMUNOL, V156, P495, DOI 10.1111/j.1365-2249.2009.03930.x; TOMIDA M, 1984, J BIOL CHEM, V259, P978; Trevino-Villarreal JH, 2012, INFECT IMMUN; Vera-Cabrera L, 2012, J BACTERIOL, V194, P2761, DOI 10.1128/JB.00210-12; Welsh O V-CL, 2007, ACTINOMICETOMA, P159; Yao J, 2014, IMMUNOL	45	5	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100064	10.1371/journal.pone.0100064	http://dx.doi.org/10.1371/journal.pone.0100064			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936860	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000338503400068
J	Randall, PA; Lee, CA; Nunes, EJ; Yohn, SE; Nowak, V; Khan, B; Shah, P; Pandit, S; Vemuri, VK; Makriyannis, A; Baqi, Y; Muller, CE; Correa, M; Salamone, JD				Randall, Patrick A.; Lee, Christie A.; Nunes, Eric J.; Yohn, Samantha E.; Nowak, Victoria; Khan, Bilal; Shah, Priya; Pandit, Saagar; Vemuri, V. Kiran; Makriyannis, Alex; Baqi, Younis; Mueller, Christa E.; Correa, Merce; Salamone, John D.			The VMAT-2 Inhibitor Tetrabenazine Affects Effort-Related Decision Making in a Progressive Ratio/Chow Feeding Choice Task: Reversal with Antidepressant Drugs	PLOS ONE			English	Article							NUCLEUS-ACCUMBENS DOPAMINE; MAJOR DEPRESSIVE DISORDER; CATECHOL-O-METHYLTRANSFERASE; ALTER RESPONSE ALLOCATION; A(2A) RECEPTOR ANTAGONISM; FOOD-SEEKING BEHAVIOR; ADENOSINE A(2A); PARKINSONS-DISEASE; NEGATIVE SYMPTOMS; MOVEMENT-DISORDERS	Behavioral activation is a fundamental feature of motivation, and organisms frequently make effort-related decisions based upon evaluations of reinforcement value and response costs. Furthermore, people with major depression and other disorders often show anergia, psychomotor retardation, fatigue, and alterations in effort-related decision making. Tasks measuring effort-based decision making can be used as animal models of the motivational symptoms of depression, and the present studies characterized the effort-related effects of the vesicular monoamine transport (VMAT-2) inhibitor tetrabenazine. Tetrabenazine induces depressive symptoms in humans, and also preferentially depletes dopamine (DA). Rats were assessed using a concurrent progressive ratio (PROG)/chow feeding task, in which they can either lever press on a PROG schedule for preferred high-carbohydrate food, or approach and consume a less-preferred lab chow that is freely available in the chamber. Previous work has shown that the DA antagonist haloperidol reduced PROG work output on this task, but did not reduce chow intake, effects that differed substantially from those of reinforcer devaluation or appetite suppressant drugs. The present work demonstrated that tetrabenazine produced an effort-related shift in responding on the PROG/chow procedure, reducing lever presses, highest ratio achieved and time spent responding, but not reducing chow intake. Similar effects were produced by administration of the subtype selective DA antagonists ecopipam (D1) and eticlopride (D2), but not by the cannabinoid CB1 receptor neutral antagonist and putative appetite suppressant AM 4413, which suppressed both lever pressing and chow intake. The adenosine A(2A) antagonist MSX-3, the antidepressant and catecholamine uptake inhibitor bupropion, and the MAO-B inhibitor deprenyl, all reversed the impairments induced by tetrabenazine. This work demonstrates the potential utility of the PROG/chow procedure as a rodent model of the effort-related deficits observed in depressed patients.	[Randall, Patrick A.; Lee, Christie A.; Nunes, Eric J.; Yohn, Samantha E.; Nowak, Victoria; Khan, Bilal; Shah, Priya; Pandit, Saagar; Correa, Merce; Salamone, John D.] Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA; [Vemuri, V. Kiran; Makriyannis, Alex] Northeastern Univ, Ctr Drug Discovery, Boston, MA 02115 USA; [Baqi, Younis; Mueller, Christa E.] Univ Bonn, Inst Pharmazeut, Pharma Zentrum Bonn, Bonn, Germany; [Baqi, Younis] Sultan Qaboos Univ, Fac Sci, Dept Chem, Muscat, Oman; [Correa, Merce] Univ Jaume 1, Area Psicobiol, Castellon de La Plana, Spain	University of Connecticut; Northeastern University; University of Bonn; Sultan Qaboos University; Universitat Jaume I	Salamone, JD (corresponding author), Univ Connecticut, Dept Psychol, Storrs, CT 06269 USA.	john.salamone@uconn.edu	Müller, Christa Elisabeth/C-7748-2014; Salamone, John/H-8165-2015; Baqi, Younis/I-8240-2016; CORREA, MERCE/G-6125-2011; Baqi, Younis/R-8364-2019	Müller, Christa Elisabeth/0000-0002-0013-6624; Salamone, John/0000-0001-6435-9635; Baqi, Younis/0000-0002-9659-8419; CORREA, MERCE/0000-0002-9868-3131; Baqi, Younis/0000-0002-9659-8419; Randall, Christie/0000-0003-4401-6525	National Institute of Mental Health [MH094966]; Fundacio Bancaixa/U. Jaume I. [P1.1B2010-43]; NATIONAL INSTITUTE OF MENTAL HEALTH [R03MH094966] Funding Source: NIH RePORTER	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Fundacio Bancaixa/U. Jaume I.; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant to J.S. from the National Institute of Mental Health (MH094966), and to M.C. from Fundacio Bancaixa/U. Jaume I. (P1.1B2010-43). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aberg E, 2011, J AFFECT DISORDERS, V129, P158, DOI 10.1016/j.jad.2010.08.009; Bardgett ME, 2009, BEHAV NEUROSCI, V123, P242, DOI 10.1037/a0014625; Beeler JA, 2012, EUR J NEUROSCI, V35, P146, DOI 10.1111/j.1460-9568.2011.07916.x; Berridge KC, 2003, TRENDS NEUROSCI, V26, P507, DOI 10.1016/S0166-2236(03)00233-9; Botvinick MM, 2009, COGN AFFECT BEHAV NE, V9, P16, DOI 10.3758/CABN.9.1.16; BROWN AS, 1993, J NEURAL TRANSM-GEN, V91, P75, DOI 10.1007/BF01245227; Brown RG, 2000, TRENDS NEUROSCI, V23, P412, DOI 10.1016/S0166-2236(00)01626-X; Cagniard B, 2006, NEUROPSYCHOPHARMACOL, V31, P1362, DOI 10.1038/sj.npp.1300966; Cousins MS, 1996, BEHAV BRAIN RES, V74, P189, DOI 10.1016/0166-4328(95)00151-4; Croxson PL, 2009, J NEUROSCI, V29, P4531, DOI 10.1523/JNEUROSCI.4515-08.2009; Cuthbert BN, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-126; Dantzer R, 2012, NAT REV CLIN ONCOL, V9, P414, DOI 10.1038/nrclinonc.2012.88; Demyttenaere K, 2005, INT J NEUROPSYCHOPH, V8, P93, DOI 10.1017/S1461145704004729; Farrar AM, 2008, NEUROSCIENCE, V152, P321, DOI 10.1016/j.neuroscience.2007.12.034; Farrar AM, 2010, NEUROSCIENCE, V166, P1056, DOI 10.1016/j.neuroscience.2009.12.056; Farrar AM, 2007, PSYCHOPHARMACOLOGY, V191, P579, DOI 10.1007/s00213-006-0554-5; Fava M, 1999, J CLIN PSYCHOPHARM, V19, P329, DOI 10.1097/00004714-199908000-00008; Fava M, 2014, DEPRESS ANXIETY, V31, P250, DOI 10.1002/da.22199; Fervaha G, 2013, NEUROSCI BIOBEHAV R, V37, P2649, DOI 10.1016/j.neubiorev.2013.09.001; Floresco SB, 2008, NEUROPSYCHOPHARMACOL, V33, P1966, DOI 10.1038/sj.npp.1301565; Floresco SB, 2007, CEREB CORTEX, V17, P251, DOI 10.1093/cercor/bhj143; Font L, 2008, PSYCHOPHARMACOLOGY, V199, P515, DOI 10.1007/s00213-008-1174-z; Frank S, 2010, NEUROPSYCH DIS TREAT, V6, P657, DOI 10.2147/NDT.S6430; Frank S, 2009, BMC NEUROL, V9, DOI 10.1186/1471-2377-9-62; Fung VSC, 2009, MOVEMENT DISORD, V24, P25, DOI 10.1002/mds.21878; Gold JM, 2013, BIOL PSYCHIAT, V74, P130, DOI 10.1016/j.biopsych.2012.12.022; Guay DRP, 2010, AM J GERIATR PHARMAC, V8, P331, DOI 10.1016/j.amjopharm.2010.08.006; Hanff TC, 2010, ISR J PSYCHIATR REL, V47, P64; Hauber W, 2009, CEREB CORTEX, V19, P2240, DOI 10.1093/cercor/bhn241; Hodgson RA, 2009, J PHARMACOL EXP THER, V330, P294, DOI 10.1124/jpet.108.149617; Jang S, 2013, J AFFECT DISORDERS, V151, P854, DOI 10.1016/j.jad.2013.07.023; KAROUM F, 1994, J NEUROCHEM, V63, P972, DOI 10.1046/j.1471-4159.1994.63030972.x; KENT TA, 1986, BIOL PSYCHIAT, V21, P483, DOI 10.1016/0006-3223(86)90190-3; Keppel G, 1991, DESIGN ANAL RES HDB; Kurniawan IT, 2010, J NEUROPHYSIOL, V104, P313, DOI 10.1152/jn.00027.2010; Mai B, 2012, COGN AFFECT BEHAV NE, V12, P74, DOI 10.3758/s13415-011-0068-4; Markou A, 2013, NEUROSCI BIOBEHAV R, V37, P2149, DOI 10.1016/j.neubiorev.2013.08.007; MARTIN P, 1987, PROG NEURO-PSYCHOPH, V11, P1, DOI 10.1016/0278-5846(87)90026-1; Matsumoto M, 2003, NEUROPSYCHOPHARMACOL, V28, P1521, DOI 10.1038/sj.npp.1300218; McGinty VB, 2013, NEURON, V78, P910, DOI 10.1016/j.neuron.2013.04.010; Milea D, 2010, CLIN THER, V32, P2057, DOI 10.1016/j.clinthera.2010.11.011; Miller AH, 2009, BRAIN BEHAV IMMUN, V23, P149, DOI 10.1016/j.bbi.2008.08.006; Mingote S, 2008, J NEUROSCI, V28, P9037, DOI 10.1523/JNEUROSCI.1525-08.2008; MOREAU JL, 1994, BEHAV PHARMACOL, V5, P344, DOI 10.1097/00008877-199406000-00012; Mott AM, 2009, PSYCHOPHARMACOLOGY, V204, P103, DOI 10.1007/s00213-008-1441-z; Muller T, 2009, PATIENT PREFER ADHER, V3, P51; Nicola SM, 2010, J NEUROSCI, V30, P16585, DOI 10.1523/JNEUROSCI.3958-10.2010; Nowend KL, 2001, PHARMACOL BIOCHEM BE, V69, P373, DOI 10.1016/S0091-3057(01)00524-X; Nunes EJ, 2010, NEUROSCIENCE, V170, P268, DOI 10.1016/j.neuroscience.2010.05.068; Nunes EJ, 2014, PSYCHOPHARMACOLOGY, V231, P727, DOI 10.1007/s00213-013-3285-4; Nunes EJ, 2013, J NEUROSCI, V33, P19120, DOI 10.1523/JNEUROSCI.2730-13.2013; Nunes EJ, 2013, NEUROSCI BIOBEHAV R, V37, P2015, DOI 10.1016/j.neubiorev.2013.04.002; Pae CU, 2007, MED HYPOTHESES, V69, P132, DOI 10.1016/j.mehy.2006.11.009; Papakostas GI, 2008, J CLIN PSYCHIAT, V69, P1287, DOI 10.4088/JCP.v69n0812; Pardo M, 2012, NEUROPHARMACOLOGY, V62, P2068, DOI 10.1016/j.neuropharm.2011.12.033; Pereira M, 2011, PSYCHOPHARMACOLOGY, V213, P69, DOI 10.1007/s00213-010-2015-4; PETTIBONE DJ, 1984, EUR J PHARMACOL, V102, P425, DOI 10.1016/0014-2999(84)90562-4; PRESKORN SH, 1984, PSYCHOPHARMACOLOGY, V84, P196, DOI 10.1007/BF00427445; Randall PA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047934; Randall PA, 2011, PSYCHOPHARMACOLOGY, V216, P173, DOI 10.1007/s00213-011-2198-3; Riederer Peter, 2011, Exp Neurobiol, V20, P1, DOI 10.5607/en.2011.20.1.1; Robbins TW, 2007, PSYCHOPHARMACOLOGY, V191, P433, DOI 10.1007/s00213-006-0528-7; Rogers MA, 2000, J CLIN EXP NEUROPSYC, V22, P232, DOI 10.1076/1380-3395(200004)22:2;1-1;FT232; Salamone JD, 2007, PSYCHOPHARMACOLOGY, V191, P461, DOI 10.1007/s00213-006-0668-9; SALAMONE JD, 1991, PSYCHOPHARMACOLOGY, V104, P515, DOI 10.1007/BF02245659; Salamone JD, 2002, BEHAV BRAIN RES, V137, P3, DOI 10.1016/S0166-4328(02)00282-6; Salamone JD, 2002, PSYCHOPHARMACOLOGY, V160, P371, DOI 10.1007/s00213-001-0994-x; Salamone JD, 1997, NEUROSCI BIOBEHAV R, V21, P341, DOI 10.1016/S0149-7634(96)00017-6; SALAMONE JD, 1994, BEHAV BRAIN RES, V65, P221, DOI 10.1016/0166-4328(94)90108-2; Salamone JD, 2006, CURR PSYCHIATRY REV, V2, P267, DOI 10.2174/157340006776875914; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; Salamone JD, 2009, BEHAV BRAIN RES, V201, P216, DOI 10.1016/j.bbr.2009.02.021; Santerre JL, 2012, PHARMACOL BIOCHEM BE, V102, P477, DOI 10.1016/j.pbb.2012.06.009; Schulz D, 2010, NEUROBIOL LEARN MEM, V93, P291, DOI 10.1016/j.nlm.2009.11.003; Sclar D. A., 2013, PRIM CARE COMPANION, V15; Shafiei N, 2012, NEUROPSYCHOPHARMACOL, V37, P2194, DOI 10.1038/npp.2012.69; Shore DM, 2011, MOVEMENT DISORD, V26, P1887, DOI 10.1002/mds.23736; SHULMAN R, 1978, BRIT J PSYCHIAT, V132, P133, DOI 10.1192/bjp.132.2.133; Sink KS, 2008, PSYCHOPHARMACOLOGY, V196, P565, DOI 10.1007/s00213-007-0988-4; Stahl SM, 2002, J CLIN PSYCHIAT, V63, P7, DOI 10.4088/JCP.v63n0102; TANRA AJ, 1995, PROG NEURO-PSYCHOPH, V19, P963, DOI 10.1016/0278-5846(95)00124-E; Treadway MT, 2012, J ABNORM PSYCHOL, V121, P553, DOI 10.1037/a0028813; Treadway MT, 2012, J NEUROSCI, V32, P6170, DOI 10.1523/JNEUROSCI.6459-11.2012; Treadway MT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006598; Trifilieff P, 2013, MOL PSYCHIATR, V18, P1025, DOI 10.1038/mp.2013.57; Walton ME, 2003, J NEUROSCI, V23, P6475; Wang JL, 2010, NUCL MED BIOL, V37, P479, DOI 10.1016/j.nucmedbio.2010.01.006; Wardle MC, 2011, J NEUROSCI, V31, P16597, DOI 10.1523/JNEUROSCI.4387-11.2011; Winograd-Gurvich C, 2006, BRAIN RES BULL, V70, P312, DOI 10.1016/j.brainresbull.2006.06.007; Worden LT, 2009, PSYCHOPHARMACOLOGY, V203, P489, DOI 10.1007/s00213-008-1396-0; Yamada K, 2013, PHARMACOL BIOCHEM BE, V114, P23, DOI 10.1016/j.pbb.2013.10.022; Yavich L, 2007, J NEUROSCI, V27, P10196, DOI 10.1523/JNEUROSCI.0665-07.2007	92	63	64	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99320	10.1371/journal.pone.0099320	http://dx.doi.org/10.1371/journal.pone.0099320			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5YM	24937131	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400014
J	De Beeck, MO; Lievens, B; Busschaert, P; Declerck, S; Vangronsveld, J; Colpaert, JV				De Beeck, Michiel Op; Lievens, Bart; Busschaert, Pieter; Declerck, Stephan; Vangronsveld, Jaco; Colpaert, Jan V.			Comparison and Validation of Some ITS Primer Pairs Useful for Fungal Metabarcoding Studies	PLOS ONE			English	Article							INTERNAL TRANSCRIBED SPACER; MICROBIAL DIVERSITY; DNA; COMMUNITIES; REGION; ITS2; IDENTIFICATION; REVEAL; RDNA; BIAS	Current metabarcoding studies aiming to characterize microbial communities generally rely on the amplification and sequencing of relatively short DNA regions. For fungi, the internal transcribed spacer (ITS) region in the ribosomal RNA (rRNA) operon has been accepted as the formal fungal barcode. Despite an increasing number of fungal metabarcoding studies, the amplification efficiency of primers is generally not tested prior to their application in metabarcoding studies. Some of the challenges that metabarcoding primers should overcome efficiently are the amplification of target DNA strands in samples rich in non-target DNA and environmental pollutants, such as humic acids, that may have been co-extracted with DNA. In the current study, three selected primer pairs were tested for their suitability as fungal metabarcoding primers. The selected primer pairs include two primer pairs that have been frequently used in fungal metabarcoding studies (ITS1F/ITS2 and ITS3/ITS4) and a primer pair (ITS86F/ITS4) that has been shown to efficiently amplify the ITS2 region of a broad range of fungal taxa in environmental soil samples. The selected primer pairs were evaluated in a 454 amplicon pyrosequencing experiment, real-time PCR (qPCR) experiments and in silico analyses. Results indicate that experimental evaluation of primers provides valuable information that could aid in the selection of suitable primers for fungal metabarcoding studies. Furthermore, we show that the ITS86F/ITS4 primer pair outperforms other primer pairs tested in terms of in silico primer efficiency, PCR efficiency, coverage, number of reads and number of species-level operational taxonomic units (OTUs) obtained. These traits push the ITS86F/ITS4 primer pair forward as highly suitable for studying fungal diversity and community structures using DNA metabarcoding.	[De Beeck, Michiel Op; Vangronsveld, Jaco; Colpaert, Jan V.] Hasselt Univ, Ctr Environm Sci, Hasselt, Limburg, Belgium; [Lievens, Bart; Busschaert, Pieter] Katholieke Univ Leuven, Dept Microbial & Mol Syst M2S, Antwerp, Belgium; [Declerck, Stephan] Catholic Univ Louvain, Earth & Life Inst, Louvain, Walloon Brabant, Belgium	Hasselt University; KU Leuven; Universite Catholique Louvain	Colpaert, JV (corresponding author), Hasselt Univ, Ctr Environm Sci, Hasselt, Limburg, Belgium.	jan.colpaert@uhasselt.be	Vangronsveld, Jaco/ABE-5907-2020; Lievens, Bart/B-3339-2019	Vangronsveld, Jaco/0000-0003-4423-8363; Colpaert, Jan V/0000-0003-1610-1861	Research Foundation Flanders (FWO)	Research Foundation Flanders (FWO)(FWO)	The study was made possible by funding of the Research Foundation Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abarenkov K, 2010, EVOL BIOINFORM, V6, P189, DOI 10.4137/EBO.S6271; Amend AS, 2010, MOL ECOL, V19, P5555, DOI 10.1111/j.1365-294X.2010.04898.x; Ashkannejhad S, 2006, NEW PHYTOL, V169, P345, DOI 10.1111/j.1469-8137.2005.01593.x; Bazzicalupo AL, 2013, FUNGAL ECOL, V6, P102, DOI 10.1016/j.funeco.2012.09.003; Begerow D, 2010, APPL MICROBIOL BIOT, V87, P99, DOI 10.1007/s00253-010-2585-4; Bellemain E, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-189; Blaalid R, 2013, MOL ECOL RESOUR, V13, P218, DOI 10.1111/1755-0998.12065; Buee M, 2009, NEW PHYTOL, V184, P449, DOI 10.1111/j.1469-8137.2009.03003.x; Carlsen T, 2012, FUNGAL ECOL, V5, P747, DOI 10.1016/j.funeco.2012.06.003; Davey ML, 2007, MYCOL RES, V111, P106, DOI 10.1016/j.mycres.2006.10.004; EGGER KN, 1995, CAN J BOT, V73, pS1415, DOI 10.1139/b95-405; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Feinstein LM, 2009, APPL ENVIRON MICROB, V75, P5428, DOI 10.1128/AEM.00120-09; GARDES M, 1993, MOL ECOL, V2, P113, DOI 10.1111/j.1365-294X.1993.tb00005.x; Ghannoum MA, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000713; Haas BJ, 2011, GENOME RES, V21, P494, DOI 10.1101/gr.112730.110; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hibbett David S., 2011, Fungal Biology Reviews, V25, P38, DOI 10.1016/j.fbr.2011.01.001; Hugenholtz P, 1996, TRENDS BIOTECHNOL, V14, P190, DOI 10.1016/0167-7799(96)10025-1; Ihrmark K, 2012, FEMS MICROBIOL ECOL, V82, P666, DOI 10.1111/j.1574-6941.2012.01437.x; Jumpponen A, 2009, NEW PHYTOL, V184, P438, DOI 10.1111/j.1469-8137.2009.02990.x; Jumpponen A, 2007, MICROB ECOL, V53, P233, DOI 10.1007/s00248-004-0006-x; Jumpponen A, 2010, MOL ECOL, V19, P41, DOI 10.1111/j.1365-294X.2009.04483.x; Juste A, 2008, FOOD MICROBIOL, V25, P745, DOI 10.1016/j.fm.2008.04.009; Kennedy S, 2011, PCR TROUBLESHOOTING AND OPTIMIZATION: THE ESSENTIAL GUIDE, P1; Koljalg U, 2005, NEW PHYTOL, V166, P1063, DOI 10.1111/j.1469-8137.2005.01376.x; Kosch TA, 2013, MOL ECOL RESOUR, V13, P230, DOI 10.1111/1755-0998.12041; Lefever S, 2013, CLIN CHEM, V59, P1470, DOI 10.1373/clinchem.2013.203653; Lindahl BD, 2013, NEW PHYTOL, V199, P288, DOI 10.1111/nph.12243; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Martin KJ, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-28; Monard C, 2013, FEMS MICROBIOL ECOL, V84, P165, DOI 10.1111/1574-6941.12046; Munzenberger B, 2012, MYCOL PROG, V11, P817, DOI 10.1007/s11557-011-0797-3; Nakamura Y, 2013, NUCLEIC ACIDS RES, V41, pD21, DOI 10.1093/nar/gks1084; Nilsson RH, 2009, FEMS MICROBIOL LETT, V296, P97, DOI 10.1111/j.1574-6968.2009.01618.x; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Porter TM, 2011, NEW PHYTOL, V192, P775, DOI 10.1111/j.1469-8137.2011.03838.x; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schoch CL, 2012, P NATL ACAD SCI USA, V109, P6241, DOI 10.1073/pnas.1117018109; Seifert KA, 2009, MOL ECOL RESOUR, V9, P83, DOI 10.1111/j.1755-0998.2009.02635.x; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; STAHL DA, 1984, SCIENCE, V224, P409, DOI 10.1126/science.224.4647.409; Taberlet P, 2012, MOL ECOL, V21, P2045, DOI 10.1111/j.1365-294X.2012.05470.x; Tedersoo L, 2010, NEW PHYTOL, V188, P291, DOI 10.1111/j.1469-8137.2010.03373.x; Toju H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040863; Turenne CY, 1999, J CLIN MICROBIOL, V37, P1846, DOI 10.1128/JCM.37.6.1846-1851.1999; Vancov T, 2009, FEMS MICROBIOL LETT, V296, P91, DOI 10.1111/j.1574-6968.2009.01621.x; Walters WA, 2011, BIOINFORMATICS, V27, P1159, DOI 10.1093/bioinformatics/btr087; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315	49	168	190	17	183	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e97629	10.1371/journal.pone.0097629	http://dx.doi.org/10.1371/journal.pone.0097629			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933453	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600004
J	Link, A; Balaguer, F; Nagasaka, T; Boland, CR; Goel, A				Link, Alexander; Balaguer, Francesc; Nagasaka, Takeshi; Boland, C. Richard; Goel, Ajay			MicroRNA miR-J1-5p as a potential Biomarker for JC Virus Infection in the Gastrointestinal Tract	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; T-ANTIGEN EXPRESSION; HUMAN POLYOMAVIRUSES; COLORECTAL CANCERS; COLON-CANCER; HUMAN BRAIN; BK VIRUS; PROTEINS; CELLS; DNA	Introduction: JC virus (JCV), a human polyomavirus that causes progressive multifocal leukoencephalopathy (PML), has been linked to colorectal cancer (CRC). However, determination of JCV infection and its role in carcinogenesis has been challenging, highlighting the need for better diagnostic strategies for this virus. JCV-specific microRNAs (miRNAs) were identified and shown to negatively regulate oncogenic JCV T-Ag. Herein, we determined the pattern of JCV miRNA expression in clinical specimens from healthy subjects and CRC patients. Material and Methods: JCV miRNA expression was validated in CRC cell lines transfected with the JCV T-Ag. Results were confirmed using CRC tissues that were expressed T-Ag. Expression of JCV-specific miR-J1-5p was measured in fresh stool samples from healthy volunteers, and samples from fecal occult blood test kits from healthy subject, and patients with colorectal neoplasms. Results: JCV miR-J1-5p was detected in JCV-transfected, but not vector-transfected, CRC cells, and was stable between cell passages. MiR-J1-5p was present in all six JCV T-Ag+ CRC samples. Surprisingly, JCV miRNA was detectable in all normal tissues, but the expression was much lower in CRC tissues. Similarly, miR-J1-5p expression was present in all fecal samples, but expression was lower in CRCs compared to controls or adenoma patients. Conclusion: JC virus-specific miR-J1-5p miRNA is a potential biomarker for viral infection, and the lower expression in patients with colonic neoplasia highlights its biological role regulating oncogenic T-Ag expression in CRC. Impact: JCV-specific miRNA is a candidate for the development of a non-invasive screening test, as well as therapeutic intervention for JCV-associated diseases.	[Link, Alexander; Balaguer, Francesc; Boland, C. Richard; Goel, Ajay] Baylor Univ, Med Ctr, Baylor Res Inst, Gastrointestinal Canc Res Lab,Div Gastroenterol, Dallas, TX 75246 USA; [Link, Alexander] Otto Von Guericke Univ, Dept Gastroenterol Hepatol & Infect Dis, Magdeburg, Germany; [Balaguer, Francesc] Univ Barcelona, CIBEREHD, Hosp Clin, Dept Gastroenterol, E-08007 Barcelona, Spain; [Nagasaka, Takeshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Gastroenterol Surg & Surg Oncol, Okayama 7008530, Japan	Baylor Scott & White Health; Baylor University; Baylor University Medical Center; Otto von Guericke University; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; University of Barcelona; Hospital Clinic de Barcelona; Okayama University	Goel, A (corresponding author), Baylor Univ, Med Ctr, Baylor Res Inst, Gastrointestinal Canc Res Lab,Div Gastroenterol, Dallas, TX 75246 USA.	ajay.goel@baylorhealth.edu	Balaguer, Francesc/GPX-7801-2022; BALAGUER, FRANCESC/G-2389-2016	Nagasaka, Takeshi/0000-0002-4236-350X; Balaguer, Francesc/0000-0002-0206-0539; Link, Alexander/0000-0002-9514-4562; Goel, Ajay/0000-0003-1396-6341	National Cancer Institute, National Institutes of Health [R01 CA098572]; Baylor Research Institute; NATIONAL CANCER INSTITUTE [R01CA098572] Funding Source: NIH RePORTER	National Cancer Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Baylor Research Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The present work was supported by grant R01 CA098572 from the National Cancer Institute, National Institutes of Health, and funds from the Baylor Research Institute. The funding was provided to CRB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Balaguer F, 2010, CANCER RES, V70, P6609, DOI 10.1158/0008-5472.CAN-10-0622; Bauman Y, 2011, CELL HOST MICROBE, V9, P93, DOI 10.1016/j.chom.2011.01.008; Boland CR, 2005, GUT, V54, P1321, DOI 10.1136/gut.2004.060079; BOLLAG B, 1992, VIRUS RES, V25, P223, DOI 10.1016/0168-1702(92)90136-W; Bollag B, 2006, J NEUROVIROL, V12, P428, DOI 10.1080/13550280601009553; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cullen BR, 2006, NAT GENET, V38, pS25, DOI 10.1038/ng1793; Del VL, 2002, J NEUROVIROL S2, V8, P138, DOI [10.1080/13550280290101111, DOI 10.1080/13550280290101111]; Enam S, 2002, CANCER RES, V62, P7093; FRISQUE RJ, 1980, J VIROL, V35, P265, DOI 10.1128/JVI.35.1.265-269.1980; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; Gan DD, 2001, ONCOGENE, V20, P4864, DOI 10.1038/sj.onc.1204670; Gee GV, 2010, BRIT J CANCER, V103, P885, DOI 10.1038/sj.bjc.6605848; Goel A, 2006, GASTROENTEROLOGY, V130, P1950, DOI 10.1053/j.gastro.2006.02.061; Jiang MX, 2009, VIROLOGY, V384, P266, DOI 10.1016/j.virol.2008.09.027; Jung WT, 2008, CANCER-AM CANCER SOC, V112, P1028, DOI 10.1002/cncr.23266; Kean JM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000363; Khalili K, 2007, NEUROLOGY, V68, P985, DOI 10.1212/01.wnl.0000257832.38943.2b; Knowles WA, 2006, ADV EXP MED BIOL, V577, P19; Laghi L, 1999, P NATL ACAD SCI USA, V96, P7484, DOI 10.1073/pnas.96.13.7484; Link A, 2010, CANCER EPIDEM BIOMAR, V19, P1766, DOI 10.1158/1055-9965.EPI-10-0027; Link A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008146; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MAJOR EO, 1992, CLIN MICROBIOL REV, V5, P49, DOI 10.1128/CMR.5.1.49-73.1992; McQuaig SM, 2009, APPL ENVIRON MICROB, V75, P3379, DOI 10.1128/AEM.02302-08; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; PADGETT BL, 1971, LANCET, V1, P1257; PADGETT BL, 1977, CANCER RES, V37, P718; Raj GV, 1996, ONCOGENE, V12, P1279; Ricciardiello L, 2000, GASTROENTEROLOGY, V119, P1228, DOI 10.1053/gast.2000.19269; Ricciardiello L, 2003, CANCER RES, V63, P7256; Seo GJ, 2008, J VIROL, V82, P9823, DOI 10.1128/JVI.01144-08; Stolt A, 2003, J GEN VIROL, V84, P1499, DOI 10.1099/vir.0.18842-0	34	20	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100036	10.1371/journal.pone.0100036	http://dx.doi.org/10.1371/journal.pone.0100036			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932487	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600085
J	Russo, T; D'Andrea, L; Parisi, A; Cataudella, S				Russo, Tommaso; D'Andrea, Lorenzo; Parisi, Antonio; Cataudella, Stefano			VMSbase: An R-Package for VMS and Logbook Data Management and Analysis in Fisheries Ecology	PLOS ONE			English	Article							VESSEL MONITORING-SYSTEM; SMALL-SCALE FISHERIES; CATCH; INDICATORS; VALIDATION; PROGRESS; MODEL	VMSbase is an R package devised to manage, process and visualize information about fishing vessels activity (provided by the vessel monitoring system - VMS) and catches/landings (as reported in the logbooks). VMSbase is primarily conceived to be user-friendly; to this end, a suite of state-of-the-art analyses is accessible via a graphical interface. In addition, the package uses a database platform allowing large datasets to be stored, managed and processed vey efficiently. Methodologies include data cleaning, that is removal of redundant or evidently erroneous records, and data enhancing, that is interpolation and merging with external data sources. In particular, VMSbase is able to estimate sea bottom depth for single VMS pings using an on-line connection to the National Oceanic and Atmospheric Administration (NOAA) database. It also allows VMS pings to be assigned to whatever geographic partitioning has been selected by users. Standard analyses comprise: 1) metier identification (using a modified CLARA clustering approach on Logbook data or Artificial Neural Networks on VMS data); 2) linkage between VMS and Logbook records, with the former organized into fishing trips; 3) discrimination between steaming and fishing points; 4) computation of spatial effort with respect to user-selected grids; 5) calculation of standard fishing effort indicators within Data Collection Framework; 6) a variety of mapping tools, including an interface for Google viewer; 7) estimation of trawled area. Here we report a sample workflow for the accessory sample datasets (available with the package) in order to explore the potentialities of VMSbase. In addition, the results of some performance tests on two large datasets (1610 5 and 1610 6 VMS signals, respectively) are reported to inform about the time required for the analyses. The results, although merely illustrative, indicate that VMSbase can represent a step forward in extracting and enhancing information from VMS/logbook data for fisheries studies.	[Russo, Tommaso; D'Andrea, Lorenzo; Cataudella, Stefano] Univ Roma Tor Vergata, Dept Biol, Lab Expt Ecol & Aquaculture, I-00173 Rome, Italy; [Parisi, Antonio] Univ Roma Tor Vergata, Fac Econ, Dept Econ & Finance, Rome, Italy	University of Rome Tor Vergata; University of Rome Tor Vergata	Russo, T (corresponding author), Univ Roma Tor Vergata, Dept Biol, Lab Expt Ecol & Aquaculture, Via Ric Sci Snc, I-00173 Rome, Italy.	Tommaso.Russo@Uniroma2.it	Russo, Tommaso/C-6157-2014	Russo, Tommaso/0000-0003-4047-959X; D'Andrea, Lorenzo/0000-0002-3795-3601				Acom ICM, 2011, ICES WKCPUEFFORT REP, P5; [Anonymous], 2013, MAPTOOLS TOOLS READI; Bezdek J.C., 1981, PATTERN RECOGN, DOI 10.1007/978-1-4757-0450-1; Bourgon R, 2013, INTERVALS TOOLS WORK, P1; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brownrigg R., 2013, MAPDATA EXTRA MAP DA; Campbell M, 2013, SCI AM, V308, P6; Castro J, 2010, FISH RES, V102, P184, DOI 10.1016/j.fishres.2009.11.011; Chang SK, 2014, MAR POLICY, V43, P338, DOI 10.1016/j.marpol.2013.07.003; Chang SK, 2011, MAR POLICY, V35, P116, DOI 10.1016/j.marpol.2010.08.009; Coll M, 2013, REV FISH BIOL FISH; Fmay MP, 2013, INTERVALS WEIGHTED L; Fock HO, 2011, MAR POLICY, V35, P181, DOI 10.1016/j.marpol.2010.09.003; Furrer R, 2013, FIELDS TOOLS SPATIAL; Garcia-Rodriguez M, 2006, FISH RES, V77, P226, DOI 10.1016/j.fishres.2005.09.002; Gerritsen H, 2011, ICES J MAR SCI, V68, P245, DOI 10.1093/icesjms/fsq137; Gerritsen HD, 2013, ICES J MAR SCI, V70, P523, DOI 10.1093/icesjms/fst017; Goslee S., 2013, ECODIST DISSIMILARIT; Grothendieck G., 2012, SQLDF PERFORM SQL SE; Hintzen NT, 2012, FISH RES, V115, P31, DOI 10.1016/j.fishres.2011.11.007; Ihaka R, 2010, R LESSONS LEARNED DI; James D., 2013, CHRON CHRONOLOGICAL; Kahle D, 2013, GGMAP PACKAGE SPATIA; Kidd S., 2011, ECOSYSTEM APPROACH M; Komsta L., 2011, OUTLIERS TESTS OUTLI; Lambert GI, 2012, ICES J MAR SCI, V69, P682, DOI 10.1093/icesjms/fss018; Lawrence M, 2011, CAIRODEVICE CAIRO BA; Legendre P., 2012, NUMERICAL ECOLOGY; Lemon JB, 2013, PLOTRIX VARIOUS PLOT; Maechler M., 2013, CLUSTER CLUSTER ANAL; Maechler M, 2013, DOSEGLJIVONA; Marchal P, 2008, ICES J MAR SCI, V65, P674, DOI 10.1093/icesjms/fsn044; Minka T.P., 2013, MAPS DRAW GEOGRAPHIC; Miyamoto S, 2008, STUD FUZZ SOFT COMP, V229, P1; Pante E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073051; Pebesma E., 2013, SP CLASSES METHODS S; Pelletier D, 2000, CAN J FISH AQUAT SCI, V57, P51, DOI 10.1139/cjfas-57-1-51; Piet GJ, 2007, ICES J MAR SCI, V64, P110, DOI 10.1093/icesjms/fsl006; R Core Team, 2021, R LANGUAGE ENV STAT; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Russo T, 2013, ECOL INDIC, V26, P141, DOI 10.1016/j.ecolind.2012.11.002; Russo T, 2010, J APPL ICHTHYOL, V26, P360, DOI 10.1111/j.1439-0426.2010.01435.x; Russo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086646; Russo T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086222; Russo T, 2011, FISH RES, V111, P53, DOI 10.1016/j.fishres.2011.06.011; Russo T, 2011, FISH RES, V108, P184, DOI 10.1016/j.fishres.2010.12.020; Russo T, 2009, ICES J MAR SCI, V66, P1718, DOI 10.1093/icesjms/fsp204; Russo T, 2009, J THEOR BIOL, V258, P521, DOI 10.1016/j.jtbi.2009.01.033; Scarcella G, 2014, J SEA RES, V89, P12, DOI 10.1016/j.seares.2014.02.002; Schnute J.T., 2013, USERS GUIDE R PACKAG; Schnute JT, 2007, 2549 FISH AQ SCI; Sharples J, 2013, PROG OCEANOGR, V117, P130, DOI 10.1016/j.pocean.2013.06.014; Tsontos V.M., 2000, Oceanography, V13, P25; Tzanatos E, 2005, FISH RES, V73, P147, DOI 10.1016/j.fishres.2004.12.006; Verzani J, 2012, GWIDGETS GWIDGETS AP; Verzani J, 2012, EXAMPLES GWIDGETS AB, P1; Walker E, 2010, ECOL MODEL, V221, P2008, DOI 10.1016/j.ecolmodel.2010.05.007	57	55	56	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100195	10.1371/journal.pone.0100195	http://dx.doi.org/10.1371/journal.pone.0100195			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932915	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600102
J	Yu, XF; Grace, M; Zou, YC; Yu, XF; Lu, XG; Wang, GP				Yu, Xiaofei; Grace, Michael; Zou, Yuanchun; Yu, Xuefeng; Lu, Xianguo; Wang, Guoping			Surface Sediments in the Marsh-Sandy Land Transitional Area: Sandification in the Western Songnen Plain, China	PLOS ONE			English	Article							NORTHEAST CHINA; USE/COVER CHANGES; DESERT; WETLANDS; DESERTIFICATION; HISTORY; FORMS; DUST; ZONE	The development of sandification process was studied, by monitoring the changes of sediment characteristics, at marsh-sandy land intersections in China's Songnen region. A series of sediment collection plates were deployed in the region; after one year, sediments in these plates were analyzed for changes of mass and chemical characteristics. The sediment flux and the sand content of the sediments decreased with the increasing longitudinal distance between the sampling site and the centre line of a sand dune. The mean sediment flux was 29 +/- 14 kg m(-2) yr(-1) and 0.6 +/- 0.3 kg m(-2) yr(-1) in the sandy land and marsh, respectively. Strong, positive correlations were found between the concentrations of organic matter, total nitrogen, P, Fe, Ti, V and Zr, all of which were also negatively correlated with the sand content. The concentrations of organic matter, total nitrogen, P, Fe, Ti, V and Zr in the marsh sediment samples were all significantly greater than the corresponding concentrations of the sandy land (p<0.001). Sand content and Ti, V and Zr concentrations all proved to be valid indicators of sandification intensity, and they showed that the marsh could be divided into three distinct zones. Sand expansion extended about 88 m into the marsh. The mean sand content in the sediments of the sandy land was 91% and then 64% in the marsh, which in turn was higher than that of marshes outside the influence of sandification, suggesting that the marsh in the marsh-sandy land transitional area has already undergone extensive sandification in the past. The study results provide information on the wetland's function of indicating and buffering the sandification process.	[Yu, Xiaofei; Zou, Yuanchun; Lu, Xianguo; Wang, Guoping] Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Peoples R China; [Grace, Michael] Monash Univ, Water Studies Ctr, Clayton, Vic, Australia; [Grace, Michael] Monash Univ, Sch Chem, Clayton, Vic, Australia; [Yu, Xuefeng] Chinese Acad Sci, Inst Earth Environm, State Key Lab Loess & Quaternary Geol, Xian, Peoples R China	Chinese Academy of Sciences; Northeast Institute of Geography & Agroecology, CAS; Monash University; Monash University; Chinese Academy of Sciences; Institute of Earth Environment, CAS	Wang, GP (corresponding author), Chinese Acad Sci, Northeast Inst Geog & Agroecol, Key Lab Wetland Ecol & Environm, Changchun, Peoples R China.	wangguoping@iga.ac.cn	Yu, Xuefeng/I-8594-2014; Grace, Mike/AAE-3073-2022; Zou, Yuanchun/B-6666-2008; YU, Xuefeng/B-9332-2009; Grace, Mike/AAE-3376-2021; Wang, Guoping/A-8140-2008	Zou, Yuanchun/0000-0003-1520-9678; Grace, Mike/0000-0002-0982-8133; Wang, Guoping/0000-0002-8350-812X; lu, xian guo/0000-0001-7638-2787; Yu, Xiaofei/0000-0001-6623-0165	National Basic Research Program [2012CB956100]; National Natural Science Foundation of China [41101195]; Science Foundation of State Key Laboratory of Loess and Quaternary Geology [SKLLQG0910]	National Basic Research Program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Foundation of State Key Laboratory of Loess and Quaternary Geology	The National Basic Research Program (No. 2012CB956100), the National Natural Science Foundation of China (No. 41101195) and the Science Foundation of State Key Laboratory of Loess and Quaternary Geology (No. SKLLQG0910) supplied the financial supports of this paper. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WETLAND ECOLOGY PRIN; AZMON E, 1994, SCI TOTAL ENVIRON, V149, P155, DOI 10.1016/0048-9697(94)90176-7; Bao S.D., 2000, AGROCHEMICAL ANAL SO, V3rd ed.; Bian JM, 2008, ENVIRON GEOL, V55, P1421, DOI 10.1007/s00254-007-1092-0; Bian JM, 2003, AREAL RES DEV, V22, P68; Chen B, 2009, J ENVIRON SCI-CHINA, V21, P1363, DOI 10.1016/S1001-0742(08)62427-4; CHESHIRE MV, 1977, GEOCHIM COSMOCHIM AC, V41, P1131, DOI 10.1016/0016-7037(77)90108-9; de Groot AV, 2011, MAR GEOL, V282, P240, DOI 10.1016/j.margeo.2011.03.002; Ding Z.J., 1999, SCI CHINA SER D, V29, P82; Guan QY, 2010, GEOSCI J, V14, P155, DOI 10.1007/s12303-010-0015-3; Kim JG, 2002, CATENA, V48, P267, DOI 10.1016/S0341-8162(02)00031-0; Kokfelt U, 2010, J PALEOLIMNOL, V44, P327, DOI 10.1007/s10933-010-9406-8; [李鱼 Li Yu], 2005, [水土保持通报, Bulletin of Soil and Water Conservation], V25, P83; Liu DW, 2009, CHINESE GEOGR SCI, V19, P299, DOI 10.1007/s11769-009-0299-2; Liu YS, 2005, ENVIRON MANAGE, V36, P691, DOI 10.1007/s00267-004-0285-5; Lombardo U, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072746; Maher BA, 2009, GEOLOGY, V37, P279, DOI 10.1130/G25293A.1; Pan MH, 2011, HDB SOIL SCI PROPERT, P20; Pigati JS, 2012, P NATL ACAD SCI USA, V109, P7208, DOI 10.1073/pnas.1200296109; Prospero JM, 2002, REV GEOPHYS, V40, DOI 10.1029/2000RG000095; Qiu S. W, 2007, HIST EVOLUTION NATUR, P86; Soons MB, 2006, APPL VEG SCI, V9, P271, DOI 10.1658/1402-2001(2006)9[271:WDIFWK]2.0.CO;2; Tang HP, 2003, ACTA BOT SIN, V45, P1166; Tweel AW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050528; Wang GP, 2004, WETLANDS, V24, P608, DOI 10.1672/0277-5212(2004)024[0608:HVOHMW]2.0.CO;2; Wang GP, 2008, GEODERMA, V145, P50, DOI 10.1016/j.geoderma.2008.02.004; Wen BL, 2012, CHINESE GEOGR SCI, V22, P167, DOI 10.1007/s11769-012-0519-z; White BL, 2008, WATER RESOUR RES, V44, DOI 10.1029/2006WR005651; Zha Y, 1997, J ARID ENVIRON, V37, P419, DOI 10.1006/jare.1997.0290; Zhai ZL, 2006, THESIS GRADUATE U CH; Zhou WJ, 2002, HOLOCENE, V12, P107, DOI 10.1191/0959683602hl525rr	31	10	12	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99715	10.1371/journal.pone.0099715	http://dx.doi.org/10.1371/journal.pone.0099715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932717	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600058
J	Arbuckle, BS; Kansa, SW; Kansa, E; Orton, D; Cakirlar, C; Gourichon, L; Atici, L; Galik, A; Marciniak, A; Mulville, J; Buitenhuis, H; Carruthers, D; De Cupere, B; Demirergi, A; Frame, S; Helmer, D; Martin, L; Peters, J; Pollath, N; Pawlowska, K; Russell, N; Twiss, K; Wurtenberger, D				Arbuckle, Benjamin S.; Kansa, Sarah Whitcher; Kansa, Eric; Orton, David; Cakirlar, Canan; Gourichon, Lionel; Atici, Levent; Galik, Alfred; Marciniak, Arkadiusz; Mulville, Jacqui; Buitenhuis, Hijlke; Carruthers, Denise; De Cupere, Bea; Demirergi, Arzu; Frame, Sheelagh; Helmer, Daniel; Martin, Louise; Peters, Joris; Poellath, Nadja; Pawlowska, Kamilla; Russell, Nerissa; Twiss, Katheryn; Wuertenberger, Doris			Data Sharing Reveals Complexity in the Westward Spread of Domestic Animals across Neolithic Turkey	PLOS ONE			English	Article							PIG DOMESTICATION; ULUCAK HOYUK; ANCIENT DNA; NEAR-EAST; CATTLE; ANATOLIA; MANAGEMENT; ORIGINS; EUROPE; SHEEP	This study presents the results of a major data integration project bringing together primary archaeozoological data for over 200,000 faunal specimens excavated from seventeen sites in Turkey spanning the Epipaleolithic through Chalcolithic periods, c. 18,000-4,000 cal BC, in order to document the initial westward spread of domestic livestock across Neolithic central and western Turkey. From these shared datasets we demonstrate that the westward expansion of Neolithic subsistence technologies combined multiple routes and pulses but did not involve a set 'package' comprising all four livestock species including sheep, goat, cattle and pig. Instead, Neolithic animal economies in the study regions are shown to be more diverse than deduced previously using quantitatively more limited datasets. Moreover, during the transition to agro-pastoral economies interactions between domestic stock and local wild fauna continued. Through publication of datasets with Open Context (opencontext. org), this project emphasizes the benefits of data sharing and web-based dissemination of large primary data sets for exploring major questions in archaeology (Alternative Language Abstract S1).	[Arbuckle, Benjamin S.] Univ N Carolina, Dept Anthropol, Chapel Hill, NC 27599 USA; [Kansa, Sarah Whitcher; Kansa, Eric] Alexandria Arch Inst, San Francisco, CA USA; [Kansa, Eric] Univ Calif Berkeley, D Lab, Berkeley, CA 94720 USA; [Orton, David; Martin, Louise] UCL, Inst Archaeol, London, England; [Cakirlar, Canan; Buitenhuis, Hijlke] Univ Groningen, Inst Archaeol, Groningen, Netherlands; [Gourichon, Lionel] Univ Nice Sophia Antipolis, F-06189 Nice, France; [Atici, Levent] Univ Nevada, Dept Anthropol, Las Vegas, NV 89154 USA; [Galik, Alfred] Univ Vet Med, Inst Anat Histol & Embryol, Vienna, Austria; [Marciniak, Arkadiusz] Adam Mickiewicz Univ, Inst Prehist, Poznan, Poland; [Mulville, Jacqui] Cardiff Univ, Sch Hist Archaeol & Relig, Cardiff CF10 3AX, S Glam, Wales; [Carruthers, Denise] Univ Liverpool, Liverpool L69 3BX, Merseyside, England; [De Cupere, Bea] Royal Belgian Inst Nat Sci, Brussels, Belgium; [Demirergi, Arzu] SUNY Stony Brook, Dept Anthropol, Stony Brook, NY 11794 USA; [Peters, Joris] Univ Munich, Dept Vet Sci, Inst Palaeoanat Domesticat Hist Vet Med, Munich, Germany; [Pawlowska, Kamilla] Adam Mickiewicz Univ, Inst Geol, Poznan, Poland; [Russell, Nerissa] Cornell Univ, Dept Anthropol, Ithaca, NY USA; [Wuertenberger, Doris] Univ Vienna, Inst Prehist & Hist Archaeol, Vienna, Austria; [Poellath, Nadja] Bavarian State Collect Anthropol & Palaeoanat, Munich, Germany	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Berkeley; University of London; University College London; University of Groningen; UDICE-French Research Universities; Universite Cote d'Azur; Nevada System of Higher Education (NSHE); University of Nevada Las Vegas; University of Veterinary Medicine Vienna; Adam Mickiewicz University; Cardiff University; University of Liverpool; Royal Belgian Institute of Natural Sciences; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Munich; Adam Mickiewicz University; Cornell University; University of Vienna	Arbuckle, BS (corresponding author), Univ N Carolina, Dept Anthropol, Chapel Hill, NC 27599 USA.	bsarbu@email.unc.edu	Russell, Nerissa/A-7815-2009; Mulville, Jacqueline/AAC-6106-2020; Gourichon, Lionel/E-8924-2016; Pöllath, Nadja/HII-5219-2022; Pawłowska, Kamilla/AAR-9415-2020; Marciniak, Arkadiusz/AAJ-3328-2020; De Cupere, Bea/B-6043-2014; Orton, David/G-7482-2015	Russell, Nerissa/0000-0001-7623-1364; Gourichon, Lionel/0000-0002-5160-5902; Pawłowska, Kamilla/0000-0002-4103-4501; Mulville, Jacqueline/0000-0002-9392-3693; Kansa, Eric/0000-0001-5620-4764; Cakirlar, Canan/0000-0002-7994-0091; Galik, Alfred/0000-0002-7070-1035; Peters, Joris/0000-0003-0894-2628; Kansa, Sarah Whitcher/0000-0001-7920-5321; Orton, David/0000-0003-4069-8004; De Cupere, Bea/0000-0001-7559-8965; Twiss, Katheryn/0000-0002-7609-853X	Alexandria Archive Institute; National Endowment for the Humanities [HK-50037-12]; Baylor University; Institute of Aegean Prehistory; Belgian Science Policy [IUAP VII/09]; American Research Institute in Turkey; National Geographic Society; National Science Foundation [BCS-0530699, BCS-0647131]; European Research Council [ERC-263339]; Austrian Science Fund [FWF P19859-G02, Y 528-G19]; German Research Foundation [DFG 424/9-1,2, 424/10,1-2]; Adam Mickiewicz University in Poznan; University of Gdansk; Polish National Science Foundation	Alexandria Archive Institute; National Endowment for the Humanities; Baylor University; Institute of Aegean Prehistory; Belgian Science Policy(Belgian Federal Science Policy Office); American Research Institute in Turkey; National Geographic Society(National Geographic Society); National Science Foundation(National Science Foundation (NSF)); European Research Council(European Research Council (ERC)European Commission); Austrian Science Fund(Austrian Science Fund (FWF)); German Research Foundation(German Research Foundation (DFG)); Adam Mickiewicz University in Poznan; University of Gdansk; Polish National Science Foundation(Foundation for Polish Science)	This project was supported by the Alexandria Archive Institute through a 2012 Computable Data Challenge grant from the Encyclopedia of Life (http://eol.org/info/323) (to SWK, EK, BSA), with additional funding from the National Endowment for the Humanities (http://www.neh.gov/) (award #HK-50037-12)(EK, SWK) and Baylor University (http://www.baylor.edu/)(BSA). Financial support for the archaeological and zooarchaeological work described in this project was provided by the Institute of Aegean Prehistory(http://www.aegeanprehistory.net/)(CC), Belgian Science Policy (http://www.belspo.be/belspo/index_en.stm)(IUAP VII/09)(BDC), the American Research Institute in Turkey (http://ccat.sas.upenn.edu/ARIT/index.html)(BSA), National Geographic Society (http://www.nationalgeographic.com/)(BSA), National Science Foundation (http://www.nsf.gov/)(BCS-0530699 [BSA]; BCS-0647131[KT]), European Research Council (http://erc.europa.eu/)(ERC-263339)(AG), Austrian Science Fund (http://www.fwf.ac.at/en/)(FWF P19859-G02 and Y 528-G19)(AG), German Research Foundation (http://www.dfg.de/en/)(DFG 424/9-1,2 and 424/10,1-2)(JP, NP), Adam Mickiewicz University in Poznan (http://amu.edu.pl/)(AM), University of Gdansk (http://ug.edu.pl/)(AM), and the Polish National Science Foundation (http://www.fnp.org.pl/en/)(AM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	akirlar C., 2013, ENV ARCHAEOLOGY SUBS, P59; Arbuckle B. S., 2008, ARCHAEOZOOLOGY SW AS, V2, P345; Arbuckle BS, 2008, J FIELD ARCHAEOL, V33, P219, DOI 10.1179/009346908791071277; Arbuckle BS, 2013, LEVANT, V45, P219, DOI 10.1179/0075891413Z.00000000026; Arbuckle BS, 2013, J ARCHAEOL SCI, V40, P1805, DOI 10.1016/j.jas.2012.12.008; Arbuckle BS, 2009, ANTIQUITY, V83, P669, DOI 10.1017/S0003598X00098902; Arbuckle BS, 2013, KOSK YOYUK FAUNAL DA; Arbuckle BS, 2013, ERBABA HOYUK SUBERDE; Arbuckle BS, 2014, EOL COMPUTATIONAL DA; Atici AL, 2013, ZOOARCHEOLOGY KARAIN; Baird D., 2012, COMPANION ARCHAEOLOG, P431; Bokonyi Sandor, 1969, DOMEST EXPLOIT PLANT, P607; Brami M, 2011, PRAEHIST Z, V86, P165, DOI 10.1515/PZ.2011.011; BUDJA M., 1999, DOCUMENTA PRAEHISTOR, V26, P119; Buitenhuis H., 1998, MAN ANIMAL WORLD, P122; Buitenhuis H, 2013, ILIPINAR ZOOARCHAEOL; Cakirlar C, 2013, ULUCAK HOYUK MAIN ZO; Cakirlar C, 2012, ANATOL STUD, V62, P1, DOI 10.1017/S0066154612000014; Cakirlar C, 2012, ANTHROPOZOOLOGICA, V47, P77, DOI 10.5252/az2012n2a6; CANEVA I., 1999, NEOLITHIC TURKEY CRA, P105; Carruthers D, 2013, PINARBASI EOL COMPUT; CHILDE VG, 1936, MAN MAKES HIMSELF; Cilingiroglu A., 2012, NEOLITHIC TURKEY NEW, P139; Cilingiroglu C., 2011, BEGINNINGS NEW RES A, P67; Cilingiroglu C, 2009, ALTAN CILINGIROGLUNA, P203; Cilingiroglu C, 2005, DOCUMENTA PRAEHISTOR, V32, P1, DOI DOI 10.4312/DP.32.1; Conolly J, 2012, HOLOCENE, V22, P997, DOI 10.1177/0959683612437871; Conolly J, 2011, J ARCHAEOL SCI, V38, P538, DOI 10.1016/j.jas.2010.10.008; Davis S., 1982, PALEORIENT, V8, P5; De Cupere B., 2008, ARCHAEOZOOLOGY NEAR, V2, P367; Degerbol M, 1970, URUS PRIMIGENIUS BOJ, V17; Derin Z., 2006, TURKIYEDE NEOLITIK D, P377; Driesch A. von den, 1976, PEABODY MUSEUM B, V1; During Bleda S., 2011, PREHISTORY ASIA MINO; Duru G., 2005, ANATOLIA ANTIQUA, V13, P15, DOI [10.3406/anata.2005.1034, DOI 10.3406/ANATA.2005.1034]; Duru R, 2008, MONOGRAPH SERIES, V4; Duru R, 1994, RESULTS EXCAVATIONS; Duru R, 1999, NEOLITHIC TURKEY CRA, P165; Ekdal E, 2012, GEOCHRONOMETRIA, V39, P268, DOI 10.2478/s13386-012-0013-5; Evershed RP, 2008, NATURE, V455, P528, DOI 10.1038/nature07180; FLANNERY KV, 1973, ANNU REV ANTHROPOL, V2, P271, DOI 10.1146/annurev.an.02.100173.001415; Forenbaher S, 2013, EUR J ARCHAEOL, V16, P589, DOI 10.1179/1461957113Y.0000000038; Galik A., 2013, BARCIN HOYUK ZOOARCH; Galik A, 2013, CUKURICI HOYUK ZOOAR; Gerard F., 2002, NEOLITHIC CENTRAL AN, P105; Gerritsen FA., 2013, ANATOLICA, V39, P53, DOI [10.2143/ANA.39.0.2990784, DOI 10.2143/ANA.39.0.2990784]; Gourichon L, 2013, FAUNAL DATA NEOLITHI; Helbak H., 1970, EXCAVATIONS HACILAR, P189; Helmer Daniel, 2005, P86; Hongo H., 2004, T RKIYE BILIMLER AKA, V7, P107, DOI [10.22520/tubaar.2004.0009, DOI 10.22520/TUBAAR.2004.0009]; Hongo Hitomi, 2000, ARCHAEOZOOLOGY NEAR, P121; Horejs B, 2008, AEGEAN BALKAN PREHIS; Horejs B, 2011, PRAEHIST Z, V86, P31, DOI 10.1515/PZ.2011.003; ?ilingiroglu ?., 2013, DOCUMENTA PRAEHISTOR, V40, P21, DOI [DOI 10.4312/DP.40.3, 10.4312/dp.40.3]; KANSA EC, 2014, INT J DIGITAL CURATI, V0009; Kansa E, 2012, WORLD ARCHAEOL, V44, P498, DOI 10.1080/00438243.2012.737575; Kansa EC, 2013, J EAST MEDITERR ARCH, V1, P88; Kansa SW, 2013, DOMUZTEPE EOL COMPUT; Karul N, 2011, ANATOLICA, V37, P1; Kintigh KW, 2014, AM ANTIQUITY, V79, P5, DOI 10.1073/pnas.1324000111; Krause-Kyora B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3348; Larson G, 2007, P NATL ACAD SCI USA, V104, P15276, DOI 10.1073/pnas.0703411104; Lichter Clemens, 2011, BEGINNINGS NEW RES A, P35; Marciniak A, 2013, CATALHOYUK AREA TP M; Meadow R.H, 1989, WALKING LARDER PATTE, P80; Meadow RH., 1999, HISTORICI ANIMALIUM, P285; NODDLE B, 1974, J ARCHAEOL SCI, V1, P195, DOI 10.1016/0305-4403(74)90042-9; Ottoni C, 2013, MOL BIOL EVOL, V30, P824, DOI 10.1093/molbev/mss261; Ozbasaran M., 2011, OXFORD HDB ANCIENT A, P99; Ozdogan M., 2006, AEGEAN MARMARA BLACK, P21; Ozdogan M, 2005, DID FARMING REACH EU, V2, P13; Ozdogan M, 2011, CURR ANTHROPOL, V52, pS415, DOI 10.1086/658895; Payne S., 1973, ANATOL STUD, V23, P281, DOI [10.2307/3642547, DOI 10.2307/3642547]; Perles C., 2001, EARLY NEOLITHIC GREE, DOI 10.1017/CBO9780511612855; Peters J, NEOLITHIC T IN PRESS; Peters Joris, 2005, P96; Peters J, 2013, PUBL INST ARCHAEOL, V59, P83; Pinhasi R, 2004, CURR ANTHROPOL, V45, pS59, DOI 10.1086/422085; PRICE EO, 1984, Q REV BIOL, V59, P1, DOI 10.1086/413673; Reingruber A, 2011, DOC PRAEHIST, V38, P291, DOI 10.4312/dp.38.23; Renfrew Cohn, 2002, EXAMINING FARMING LA; Roodenberg J, 1995, ILIPINAR EXCAVATIONS; Rowley-Conwy P, 2012, J WORLD PREHIST, V25, P1, DOI 10.1007/s10963-012-9055-0; Russell N, 2005, CURR ANTHROPOL, V46, pS101, DOI 10.1086/497664; Russell N, 2013, HUMANS LANDSCAPES CA, P213; Russell N, 2013, CATALHOYUK MAIN ZOOA; Schoop U., 2005, BYZAS 2 DID FARM REA, P179; Silver I. A., 1963, P250; Thissen L, 2010, LEIDEN J POTTERY STU, V26, P157; Thissen L., 2002, NEOLITHIC CENTRAL AN, P13; Turan N, 1990, TURKIYENIN AV VE YAB; Uerpmann H.-P., 1979, PROBLEME NEOLITHISIE; Uerpmann M., 1994, QALAAT AL BAHRAIN TH, V30(1), P417; van Zeist W, 1991, LATE Q VEGETATION NE; Vigne Jean-Denis, 2007, Anthropozoologica, V42, P9; Vigne JD, 2012, P NATL ACAD SCI USA, V109, P8445, DOI 10.1073/pnas.1201693109; Vigne JD, 2011, CURR ANTHROPOL, V52, pS255, DOI 10.1086/659306; Vigne JD, 2011, CR BIOL, V334, P171, DOI 10.1016/j.crvi.2010.12.009; Vigne JD, 2009, P NATL ACAD SCI USA, V106, P16135, DOI 10.1073/pnas.0905015106; Watson J.P.N., 1978, P97; Weninger B, 2006, QUATERNARY RES, V66, P401, DOI 10.1016/j.yqres.2006.06.009; Whittle A., 2002, ANTAEUS, V25, P63; Willcox G, 2012, ANTIQUITY, V86, P99, DOI 10.1017/S0003598X00062487; zbal H, 2012, ARKEOMETRI SONUCLARI, V28, P15; zdogan M, 1998, ANATOLICA, V24, P209; Zeder M.A., 2008, MOM EDITION, P243; Zeder MA, 2000, SCIENCE, V287, P2254, DOI 10.1126/science.287.5461.2254; Zeder Melinda A., 2006, P87; Zeder MA, 2008, P NATL ACAD SCI USA, V105, P11597, DOI 10.1073/pnas.0801317105; Zeder MA, 2012, BIODIVERSITY IN AGRICULTURE: DOMESTICATION, EVOLUTION, AND SUSTAINABILITY, P227; Zeder MA, 2011, CURR ANTHROPOL, V52, pS221, DOI 10.1086/659307	111	88	90	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99845	10.1371/journal.pone.0099845	http://dx.doi.org/10.1371/journal.pone.0099845			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	AK2VQ	24927173	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100085
J	Jiwaji, M; Sandison, ME; Reboud, J; Stevenson, R; Daly, R; Barkess, G; Faulds, K; Kolch, W; Graham, D; Girolami, MA; Cooper, JM; Pitt, AR				Jiwaji, Meesbah; Sandison, Mairi E.; Reboud, Julien; Stevenson, Ross; Daly, Ronan; Barkess, Grainne; Faulds, Karen; Kolch, Walter; Graham, Duncan; Girolami, Mark A.; Cooper, Jonathan M.; Pitt, Andrew R.			Quantification of Functionalised Gold Nanoparticle-Targeted Knockdown of Gene Expression in HeLa Cells	PLOS ONE			English	Article							SIZE-DEPENDENT ENDOCYTOSIS; METAL-RESPONSIVE ELEMENTS; DRUG-DELIVERY; METALLOTHIONEIN; THERAPY; VECTORS; RNAI; TRANSFECTION; BIOLOGY	Introduction: Gene therapy continues to grow as an important area of research, primarily because of its potential in the treatment of disease. One significant area where there is a need for better understanding is in improving the efficiency of oligonucleotide delivery to the cell and indeed, following delivery, the characterization of the effects on the cell. Methods: In this report, we compare different transfection reagents as delivery vehicles for gold nanoparticles functionalized with DNA oligonucleotides, and quantify their relative transfection efficiencies. The inhibitory properties of small interfering RNA (siRNA), single-stranded RNA (ssRNA) and single-stranded DNA (ssDNA) sequences targeted to human metallothionein hMT-IIa are also quantified in HeLa cells. Techniques used in this study include fluorescence and confocal microscopy, qPCR and Western analysis. Findings: We show that the use of transfection reagents does significantly increase nanoparticle transfection efficiencies. Furthermore, siRNA, ssRNA and ssDNA sequences all have comparable inhibitory properties to ssDNA sequences immobilized onto gold nanoparticles. We also show that functionalized gold nanoparticles can co-localize with autophagosomes and illustrate other factors that can affect data collection and interpretation when performing studies with functionalized nanoparticles. Conclusions: The desired outcome for biological knockdown studies is the efficient reduction of a specific target; which we demonstrate by using ssDNA inhibitory sequences targeted to human metallothionein IIa gene transcripts that result in the knockdown of both the mRNA transcript and the target protein.	[Jiwaji, Meesbah; Sandison, Mairi E.; Kolch, Walter; Pitt, Andrew R.] Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Sandison, Mairi E.; Reboud, Julien; Cooper, Jonathan M.] Univ Glasgow, Sch Engn, Div Biomed Engn, Glasgow, Lanark, Scotland; [Stevenson, Ross; Faulds, Karen; Graham, Duncan] Univ Strathclyde, Dept Pure & Appl Chem, Ctr Mol Nanometrol, Glasgow, Lanark, Scotland; [Daly, Ronan; Girolami, Mark A.] Univ Glasgow, Sch Comp Sci, Glasgow, Lanark, Scotland; [Barkess, Grainne] Univ Glasgow, Coll Med Vet & Life Sci, Inst Canc Sci, Glasgow, Lanark, Scotland; [Kolch, Walter] Syst Biol Ireland, Dublin, Ireland; [Kolch, Walter] Univ Coll Dublin, Conway Inst, Dublin 2, Ireland; [Girolami, Mark A.] UCL, Dept Stat Sci, London, England; [Jiwaji, Meesbah; Pitt, Andrew R.] Aston Univ, Sch Life & Hlth Sci, Birmingham B4 7ET, W Midlands, England	University of Glasgow; University of Glasgow; University of Strathclyde; University of Glasgow; University of Glasgow; University College Dublin; University of London; University College London; Aston University	Pitt, AR (corresponding author), Univ Glasgow, Coll Med Vet & Life Sci, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland.	a.r.pitt@aston.ac.uk	Reboud, Julien/F-1565-2014; Kolch, Walter/ABF-2102-2021; Cooper, Jonathan/E-9000-2010; Admin, SBI/HGB-2738-2022; Cooper, Jonathan/GLS-9195-2022; Graham, Duncan/C-8440-2011; Jiwaji, Meesbah/D-9509-2014	Reboud, Julien/0000-0002-6879-8405; Cooper, Jonathan/0000-0002-2358-1050; Cooper, Jonathan/0000-0002-2358-1050; Sandison, Mairi/0000-0003-1021-1461; Pitt, Andrew R/0000-0003-3619-6503; Graham, Duncan/0000-0002-6079-2105; Jiwaji, Meesbah/0000-0003-3557-4541; Barkess, Grainne/0000-0003-1742-921X; Kolch, Walter/0000-0001-5777-5016; Girolami, Mark/0000-0003-3008-253X; Daly, Ronan/0000-0002-1275-6820; Faulds, Karen/0000-0002-5567-7399	Engineering and Physical Sciences Research Council (EPSRC) Basic Technology Research Grant [EP/E032745/1]; Science Foundation Ireland [06/CE/B1129]; EPSRC [EP/E032745/2, EP/E032745/1] Funding Source: UKRI; Engineering and Physical Sciences Research Council [EP/E032745/1, EP/E032745/2] Funding Source: researchfish	Engineering and Physical Sciences Research Council (EPSRC) Basic Technology Research Grant(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Science Foundation Ireland(Science Foundation IrelandEuropean Commission); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Engineering and Physical Sciences Research Council (EPSRC) Basic Technology Research Grant [grant number EP/E032745/1]. WK was also supported by Science Foundation Ireland [grant number 06/CE/B1129]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agbasi-Porter C, 2006, BIOCONJUGATE CHEM, V17, P1178, DOI 10.1021/bc060100f; Bonetta L, 2004, NAT METHODS, V1, P79, DOI 10.1038/nmeth1004-79; Bonnemann H, 2001, EUR J INORG CHEM, P2455; BRUST M, 1995, J CHEM SOC CHEM COMM, P1655, DOI 10.1039/c39950001655; Chen PC, 2008, NANOTECHNOL SCI APPL, V1, P45; Cheon J, 2008, ACCOUNTS CHEM RES, V41, P1630, DOI 10.1021/ar800045c; Connor EE, 2005, SMALL, V1, P325, DOI 10.1002/smll.200400093; Daniel MC, 2004, CHEM REV, V104, P293, DOI 10.1021/cr030698+; Ghosh PS, 2008, ACS NANO, V2, P2213, DOI 10.1021/nn800507t; Green JJ, 2008, ACCOUNTS CHEM RES, V41, P749, DOI 10.1021/ar7002336; Gu YJ, 2009, TOXICOL APPL PHARM, V237, P196, DOI 10.1016/j.taap.2009.03.009; Guo X, 2003, ACCOUNTS CHEM RES, V36, P335, DOI 10.1021/ar9703241; Hacein-Bey-Abina S, 2003, NEW ENGL J MED, V348, P255, DOI 10.1056/NEJM200301163480314; Haes AJ, 2005, J PHYS CHEM B, V109, P11158, DOI 10.1021/jp051178g; Haes AJ, 2004, NANO LETT, V4, P1029, DOI 10.1021/nl049670j; Jiwaji M, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-103; Kagi J H, 1987, Experientia Suppl, V52, P25; KARIN M, 1987, MOL CELL BIOL, V7, P606, DOI 10.1128/MCB.7.2.606; KARIN M, 1984, CELL, V36, P371, DOI 10.1016/0092-8674(84)90230-7; Kay MA, 2001, NAT MED, V7, P33, DOI 10.1038/83324; KERSHAW WC, 1992, TOXICOL APPL PHARM, V112, P24, DOI 10.1016/0041-008X(92)90275-W; Kim DH, 2008, BIOTECHNIQUES, V44, P613, DOI 10.2144/000112792; Kim EY, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl147; Kim JH, 2010, CHEM COMMUN, V46, P4151, DOI 10.1039/c0cc00103a; Kocbek P, 2007, J CONTROL RELEASE, V120, P18, DOI 10.1016/j.jconrel.2007.03.012; Koizumi S, 1999, EUR J BIOCHEM, V259, P635, DOI 10.1046/j.1432-1327.1999.00069.x; Krizkova S, 2009, BRATISL MED J, V110, P93; LEYSHONSORLAND K, 1993, CANCER RES, V53, P4874; Masters JR, 2002, NAT REV CANCER, V2, P315, DOI 10.1038/nrc775; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; McCormick F, 2001, NAT REV CANCER, V1, P130, DOI 10.1038/35101008; McKenzie F, 2009, CHEM COMMUN, P2872, DOI 10.1039/b823057a; Mintzer MA, 2009, CHEM REV, V109, P259, DOI 10.1021/cr800409e; Murphy CJ, 2008, ACCOUNTS CHEM RES, V41, P1721, DOI 10.1021/ar800035u; Nordberg M, 1998, TALANTA, V46, P243, DOI 10.1016/S0039-9140(97)00345-7; Opalinska JB, 2002, NAT REV DRUG DISCOV, V1, P503, DOI 10.1038/nrd837; Paddison PJ, 2002, P NATL ACAD SCI USA, V99, P1443, DOI 10.1073/pnas.032652399; Patra HK, 2007, NANOMED-NANOTECHNOL, V3, P111, DOI 10.1016/j.nano.2007.03.005; Plummer M., 2003, P 3 INT WORKSH DISTR; Plummer M, 2006, R NEWS, V6, P11; Prato M, 2008, ACCOUNTS CHEM RES, V41, P60, DOI 10.1021/ar700089b; Raper SE, 2003, MOL GENET METAB, V80, P148, DOI 10.1016/j.ymgme.2003.08.016; Rosi NL, 2006, SCIENCE, V312, P1027, DOI 10.1126/science.1125559; Sandhu KK, 2002, BIOCONJUGATE CHEM, V13, P3, DOI 10.1021/bc015545c; Skroch P, 1993, Prog Clin Biol Res, V380, P113; Slowing II, 2008, ADV DRUG DELIVER REV, V60, P1278, DOI 10.1016/j.addr.2008.03.012; Soppimath KS, 2001, J CONTROL RELEASE, V70, P1, DOI 10.1016/S0168-3659(00)00339-4; Taylor U, 2010, CYTOM PART A, V77A, P439, DOI 10.1002/cyto.a.20846; Tekade RK, 2009, CHEM REV, V109, P49, DOI 10.1021/cr068212n; Templeton AC, 2000, ACCOUNTS CHEM RES, V33, P27, DOI 10.1021/ar9602664; Trewyn BG, 2007, ACCOUNTS CHEM RES, V40, P846, DOI 10.1021/ar600032u; Tsai CY, 2004, NANO LETT, V4, P1209, DOI 10.1021/nl0495231; TURKEVICH J, 1951, DISCUSS FARADAY SOC, P55, DOI 10.1039/df9511100055; Ulman A, 1996, CHEM REV, V96, P1533, DOI 10.1021/cr9502357; Van de Broek B, 2011, ACS NANO, V5, P4319, DOI 10.1021/nn1023363; Verma IM, 1997, NATURE, V389, P239, DOI 10.1038/38410; Vijayakumar S, 2012, J NANOMATER, V2012, DOI 10.1155/2012/734398; Wang SH, 2010, J NANOBIOTECHNOL, V8, DOI 10.1186/1477-3155-8-33; Watson P, 2005, ADV DRUG DELIVER REV, V57, P43, DOI 10.1016/j.addr.2004.05.003; Weare WW, 2000, J AM CHEM SOC, V122, P12890, DOI 10.1021/ja002673n; Wrzesien J, 2012, TETRAHEDRON, V68, P1230, DOI 10.1016/j.tet.2011.11.053; Zhang SL, 2009, ADV MATER, V21, P419, DOI 10.1002/adma.200801393	62	8	8	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99458	10.1371/journal.pone.0099458	http://dx.doi.org/10.1371/journal.pone.0099458			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926959	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100042
J	Koid, AE; Liu, ZF; Terrado, R; Jones, AC; Caron, DA; Heidelberg, KB				Koid, Amy E.; Liu, Zhenfeng; Terrado, Ramon; Jones, Adriane C.; Caron, David A.; Heidelberg, Karla B.			Comparative Transcriptome Analysis of Four Prymnesiophyte Algae	PLOS ONE			English	Article							POLYKETIDE SYNTHASES; ORGANIC NITROGEN; PROTISTS; GROWTH; GENES; CHRYSOCHROMULINA; PHYTOPLANKTON; EVOLUTION; GENOMES; MARINE	Genomic studies of bacteria, archaea and viruses have provided insights into the microbial world by unveiling potential functional capabilities and molecular pathways. However, the rate of discovery has been slower among microbial eukaryotes, whose genomes are larger and more complex. Transcriptomic approaches provide a cost-effective alternative for examining genetic potential and physiological responses of microbial eukaryotes to environmental stimuli. In this study, we generated and compared the transcriptomes of four globally-distributed, bloom-forming prymnesiophyte algae: Prymnesium parvum, Chrysochromulina brevifilum, Chrysochromulina ericina and Phaeocystis antarctica. Our results revealed that the four transcriptomes possess a set of core genes that are similar in number and shared across all four organisms. The functional classifications of these core genes using the euKaryotic Orthologous Genes (KOG) database were also similar among the four study organisms. More broadly, when the frequencies of different cellular and physiological functions were compared with other protists, the species clustered by both phylogeny and nutritional modes. Thus, these clustering patterns provide insight into genomic factors relating to both evolutionary relationships as well as trophic ecology. This paper provides a novel comparative analysis of the transcriptomes of ecologically important and closely related prymnesiophyte protists and advances an emerging field of study that uses transcriptomics to reveal ecology and function in protists.	[Koid, Amy E.; Liu, Zhenfeng; Terrado, Ramon; Jones, Adriane C.; Caron, David A.; Heidelberg, Karla B.] Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA	University of Southern California	Heidelberg, KB (corresponding author), Univ So Calif, Dept Biol Sci, Los Angeles, CA 90089 USA.	kheidelb@usc.edu	Liu, Zhenfeng/B-8252-2015; Heidelberg, Karla B./L-2096-2017	Heidelberg, Karla B./0000-0002-2645-8269; Liu, Zhenfeng/0000-0001-5892-6429	Gordon and Betty Moore Foundation [3299, 2637]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation)	This research was funded in part by the Gordon and Betty Moore Foundation through Grant #3299 to D. A. Caron and K. B. Heidelberg. The sequencing was funded by the Gordon and Betty Moore Foundation through Grant #2637 to the National Center for Genome Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Anantharaman V, 2007, ANNU REV MICROBIOL, V61, P453, DOI 10.1146/annurev.micro.61.080706.093309; Bachmann BO, 2009, METHOD ENZYMOL, V458, P181, DOI 10.1016/S0076-6879(09)04808-3; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bayer T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035269; Bender SJ, 2014, FRONT MAR SCI, V1, DOI 10.3389/fmars.2014.00003; Berg GM, 1997, MAR BIOL, V129, P377, DOI 10.1007/s002270050178; Bertrand EM, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00375; Bielewicz S, 2011, ISME J, V5, P1559, DOI 10.1038/ismej.2011.23; Caron DA, 2009, ISME J, V3, P4, DOI 10.1038/ismej.2008.101; Carvalho WF, 2010, HARMFUL ALGAE, V9, P105, DOI 10.1016/j.hal.2009.08.007; CHAVEZ FP, 1990, DEEP-SEA RES, V37, P1733, DOI 10.1016/0198-0149(90)90074-6; Chen F, 2006, NUCLEIC ACIDS RES, V34, pD363, DOI 10.1093/nar/gkj123; Chevreux B, 2004, GENOME RES, V14, P1147, DOI 10.1101/gr.1917404; Croft MT, 2006, EUKARYOT CELL, V5, P1175, DOI 10.1128/EC.00097-06; Cuvelier ML, 2010, P NATL ACAD SCI USA, V107, P14679, DOI 10.1073/pnas.1001665107; DiTullio GR, 2000, NATURE, V404, P595, DOI 10.1038/35007061; DROOP MR, 1954, NATURE, V174, P520, DOI 10.1038/174520b0; Edvardsen B, 2006, ECOL STU AN, V189, P67, DOI 10.1007/978-3-540-32210-8_6; Entcheva P, 2002, APPL ENVIRON MICROB, V68, P2843, DOI 10.1128/AEM.68.6.2843-2848.2002; Gobler CJ, 2001, MAR ECOL PROG SER, V209, P19, DOI 10.3354/meps209019; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; GREEN JC, 1991, SYST ASSOC SPEC VOL, V45, P401; Grigoriev IV, 2012, NUCLEIC ACIDS RES, V40, pD26, DOI 10.1093/nar/gkr947; GUIRY MD, 2007, ALGAEBASE VERSION 4; Haft DH, 2001, NUCLEIC ACIDS RES, V29, P41, DOI 10.1093/nar/29.1.41; HANSEN PJ, 1995, PHYCOLOGIA, V34, P409, DOI 10.2216/i0031-8884-34-5-409.1; Hansen PJ, 2002, MAR BIOL, V141, P975, DOI 10.1007/s00227-002-0879-5; Hartmann M, 2012, P NATL ACAD SCI USA, V109, P5756, DOI 10.1073/pnas.1118179109; Helliwell KE, 2011, MOL BIOL EVOL, V28, P2921, DOI 10.1093/molbev/msr124; Huang XQ, 1999, GENOME RES, V9, P868, DOI 10.1101/gr.9.9.868; Igarashi T, 1999, J AM CHEM SOC, V121, P8499, DOI 10.1021/ja991740e; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jeong Hae Jin, 2010, Ocean Science Journal, V45, P65, DOI 10.1007/s12601-010-0007-2; John U, 2008, PROTIST, V159, P21, DOI 10.1016/j.protis.2007.08.001; John U, 2010, EUR J PHYCOL, V45, P215, DOI 10.1080/09670261003746193; Jones AC, 2013, ENVIRON MICROBIOL, V15, P2557, DOI 10.1111/1462-2920.12151; JONES HLJ, 1993, J MAR BIOL ASSOC UK, V73, P283, DOI 10.1017/S0025315400032859; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; Kong WD, 2012, APPL ENVIRON MICROB, V78, P4358, DOI 10.1128/AEM.00029-12; Koonin EV, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r7; La Claire JW, 2006, MAR BIOTECHNOL, V8, P534, DOI 10.1007/s10126-005-5182-2; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Li RQ, 2008, BIOINFORMATICS, V24, P713, DOI 10.1093/bioinformatics/btn025; Li WZ, 2006, BIOINFORMATICS, V22, P1658, DOI 10.1093/bioinformatics/btl158; Liu H, 2009, P NATL ACAD SCI USA, V106, P12803, DOI 10.1073/pnas.0905841106; Lottaz C, 2003, BIOINFORMATICS, V19, pII103, DOI 10.1093/bioinformatics/btg1067; Lowe CD, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-519; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Manning SR, 2013, ANAL BIOCHEM, V442, P189, DOI 10.1016/j.ab.2013.07.034; Manning SR, 2010, MAR DRUGS, V8, P678, DOI 10.3390/md8030678; MCLAUGHLIN JJA, 1958, J PROTOZOOL, V5, P75, DOI 10.1111/j.1550-7408.1958.tb02529.x; Moestrup O, 1994, HAPTOPHYTE ALGAE, P265; Monroe EA, 2008, PROTIST, V159, P471, DOI 10.1016/j.protis.2008.02.004; Moorthi S, 2009, AQUAT MICROB ECOL, V54, P269, DOI 10.3354/ame01276; NYGAARD K, 1993, LIMNOL OCEANOGR, V38, P273, DOI 10.4319/lo.1993.38.2.0273; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Perez R, 2008, MAR DRUGS, V6, P164, DOI 10.3390/md20080009; Provasoli L, 1974, ALGAL PHYSL BIOCH, P741; R Core Team, 2012, R LANG ENV STAT COMP; RAHAT M, 1963, J GEN MICROBIOL, V31, P203, DOI 10.1099/00221287-31-2-203; Raymond JA, 2009, J PHYCOL, V45, P130, DOI 10.1111/j.1529-8817.2008.00623.x; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Salcedo T, 2012, MOL BIOL EVOL, V29, P1503, DOI 10.1093/molbev/mss007; Sanders RW, 2011, J EUKARYOT MICROBIOL, V58, P181, DOI 10.1111/j.1550-7408.2011.00543.x; SANDERS RW, 1991, J PROTOZOOL, V38, P76, DOI 10.1111/j.1550-7408.1991.tb04805.x; Simpson JT, 2012, GENOME RES, V22, P549, DOI 10.1101/gr.126953.111; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; SMITH WO, 1991, NATURE, V352, P514, DOI 10.1038/352514a0; Sun SL, 2011, NUCLEIC ACIDS RES, V39, pD546, DOI 10.1093/nar/gkq1102; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tang YZ, 2010, P NATL ACAD SCI USA, V107, P20756, DOI 10.1073/pnas.1009566107; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; Thomsen HA, 1994, HAPTOPHYTE ALGAE, P187; Tillmann U, 1999, J SEA RES, V42, P255, DOI 10.1016/S1385-1101(99)00029-5; Unrein F, 2007, LIMNOL OCEANOGR, V52, P456, DOI 10.4319/lo.2007.52.1.0456; Unrein F, 2014, ISME J, V8, P164, DOI 10.1038/ismej.2013.132; Van Dolah FM, 2009, HARMFUL ALGAE, V8, P562, DOI 10.1016/j.hal.2008.11.004; Worden AZ, 2009, SCIENCE, V324, P268, DOI 10.1126/science.1167222; Xu L, 2006, MOL BIOL EVOL, V23, P1107, DOI 10.1093/molbev/msk019; Zhang ZM, 2003, BIOINFORMATICS, V19, P307, DOI 10.1093/bioinformatics/19.2.307; Zubkov MV, 2008, NATURE, V455, P224, DOI 10.1038/nature07236	83	20	23	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e97801	10.1371/journal.pone.0097801	http://dx.doi.org/10.1371/journal.pone.0097801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926657	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100008
J	Wang, JH; Ni, ZH; Duan, ZP; Wang, GQ; Li, F				Wang, Jihan; Ni, Zhaohui; Duan, Zipeng; Wang, Guoqing; Li, Fan			Altered Expression of Hypoxia-Inducible Factor-1 alpha (HIF-1 alpha) and Its Regulatory Genes in Gastric Cancer Tissues	PLOS ONE			English	Article							NF-KAPPA-B; PROMOTER POLYMORPHISMS; INFLAMMATION; TUMORS; RISK	Tissue hypoxia induces reprogramming of cell metabolism and may result in normal cell transformation and cancer progression. Hypoxia-inducible factor 1-alpha (HIF-1 alpha), the key transcription factor, plays an important role in gastric cancer development and progression. This study aimed to investigate the underlying regulatory signaling pathway in gastric cancer using gastric cancer tissue specimens. The integration of gene expression profile and transcriptional regulatory element database (TRED) was pursued to identify HIF-1 alpha <-> NF kappa B1 -> BRCA1 -> STAT3 <- STAT1 gene pathways and their regulated genes. The data showed that there were 82 differentially expressed genes that could be regulated by these five transcription factors in gastric cancer tissues and these genes formed 95 regulation modes, among which seven genes (MMP1, TIMP1, TLR2, FCGR3A, IRF1, FAS, and TFF3) were hub molecules that are regulated at least by two of these five transcription factors simultaneously and were associated with hypoxia, inflammation, and immune disorder. Real-Time PCR and western blot showed increasing of HIF-1 alpha in mRNA and protein levels as well as TIMP1, TFF3 in mRNA levels in gastric cancer tissues. The data are the first study to demonstrate HIF-1 alpha-regulated transcription factors and their corresponding network genes in gastric cancer. Further study with a larger sample size and more functional experiments is needed to confirm these data and then translate into clinical biomarker discovery and treatment strategy for gastric cancer.	[Wang, Jihan; Ni, Zhaohui; Duan, Zipeng; Wang, Guoqing; Li, Fan] Jilin Univ, Coll Basic Med Sci, Jilin Key Lab Biomed Mat, Dept Pathogenobiol, Changchun 130023, Peoples R China; [Wang, Guoqing; Li, Fan] Jilin Univ, Minist Educ, Key Lab Bion Engn, Changchun 130023, Peoples R China	Jilin University; Jilin University	Wang, GQ (corresponding author), Jilin Univ, Coll Basic Med Sci, Jilin Key Lab Biomed Mat, Dept Pathogenobiol, Changchun 130023, Peoples R China.	qing8110@gmail.com; lifan@jlu.edu.cn			National Natural Science Foundation of China [81320108025, 81271897]; Specialized Research Fund for the Doctoral Program of Higher Education of China [20110061120093]; China Postdoctoral Science Foundation [20110491311, 2012T50285]; Foundation of Jilin Provincial Health Department [2011Z049]; Foundation of Jilin Province Science and Technology Department [20130522013JH, 20140414048GH]; Norman Bethune Program of Jilin University [2012219]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education of China(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Foundation of Jilin Provincial Health Department; Foundation of Jilin Province Science and Technology Department; Norman Bethune Program of Jilin University	This work was supported in part by grants from National Natural Science Foundation of China (#81320108025 and #81271897), Specialized Research Fund for the Doctoral Program of Higher Education of China (#20110061120093), China Postdoctoral Science Foundation (#20110491311 and #2012T50285), Foundation of Jilin Provincial Health Department (#2011Z049), Foundation of Jilin Province Science and Technology Department (#20130522013JH and #20140414048GH) and the Norman Bethune Program of Jilin University (#2012219). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao W, 2010, ARCH BIOCHEM BIOPHYS, V499, P49, DOI 10.1016/j.abb.2010.05.009; Baus-Loncar M, 2005, CELL MOL LIFE SCI, V62, P2921, DOI 10.1007/s00018-005-5480-x; Bournazou Eirini, 2013, JAKSTAT, V2, pe23828, DOI 10.4161/jkst.23828; Bruick RK, 2003, GENE DEV, V17, P2614, DOI 10.1101/gad.1145503; Burchard PR, 2013, CANCER GENET-NY, V206, P130, DOI 10.1016/j.cancergen.2013.03.002; Chen R, 2007, AM J REPROD IMMUNOL, V57, P93, DOI 10.1111/j.1600-0897.2006.00441.x; Compare D, 2010, EUR REV MED PHARMACO, V14, P302; Cui J, 2012, J MOL CELL BIOL, V4, P174, DOI 10.1093/jmcb/mjs017; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Gentner B, 2009, ANTICANCER RES, V29, P67; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang C, 2007, NUCLEIC ACIDS RES, V35, pD137, DOI 10.1093/nar/gkl1041; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Ke QD, 2006, MOL PHARMACOL, V70, P1469, DOI 10.1124/mol.106.027029; Liu X, 2011, CELL DEATH DIFFER, V18, P1561, DOI 10.1038/cdd.2011.13; Murtas D, 2013, BRIT J CANCER, V109, P76, DOI 10.1038/bjc.2013.335; Pawlus MR, 2013, ONCOGENE; Rius J, 2008, NATURE, V453, P807, DOI 10.1038/nature06905; Roukos DH, 2013, EXPERT REV MOL DIAGN, V13, P643, DOI 10.1586/14737159.2013.820540; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Silver-Morse L., 2013, JAK STAT, V2, DOI DOI 10.4161/JKST.26090; Solaini G, 2010, BBA-BIOENERGETICS, V1797, P1171, DOI 10.1016/j.bbabio.2010.02.011; Valibeigi B, 2013, PATHOL ONCOL RES; Xu CC, 2013, PATHOL RES PRACT, V209, P479, DOI 10.1016/j.prp.2013.04.017; Xu Q, 2013, GENE, V529, P104, DOI 10.1016/j.gene.2013.07.070; Zhang ZG, 2013, ASIAN PAC J CANCER P, V14, P4195, DOI 10.7314/APJCP.2013.14.7.4195; Zhang ZQ, 2006, INT J ONCOL, V29, P185; Zhang ZZ, 2009, CARCINOGENESIS, V30, P487, DOI 10.1093/carcin/bgp016; Zhou W, 2013, CANC LETT; Zhu CL, 2013, MOL BIOL REP, V40, P6055, DOI 10.1007/s11033-013-2715-z	32	26	29	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99835	10.1371/journal.pone.0099835	http://dx.doi.org/10.1371/journal.pone.0099835			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927122	Green Submitted, Green Published, gold			2022-12-27	WOS:000338278100084
J	Carson, JM; Okamura, K; Wakashin, H; McFann, K; Dobrinskikh, E; Kopp, JB; Blaine, J				Carson, John M.; Okamura, Kayo; Wakashin, Hidefumi; McFann, Kim; Dobrinskikh, Evgenia; Kopp, Jeffrey B.; Blaine, Judith			Podocytes Degrade Endocytosed Albumin Primarily in Lysosomes	PLOS ONE			English	Article							PROTEIN ACCUMULATION; GLOMERULAR PROTEIN; AUTOPHAGY; CELLS; REABSORPTION; DEFICIENCY; APOPTOSIS; SEGMENTS; REVEALS; NEPHRON	Albuminuria is a strong, independent predictor of chronic kidney disease progression. We hypothesize that podocyte processing of albumin via the lysosome may be an important determinant of podocyte injury and loss. A human urine derived podocyte-like epithelial cell (HUPEC) line was used for in vitro experiments. Albumin uptake was quantified by Western blot after loading HUPECs with fluorescein-labeled (FITC) albumin. Co-localization of albumin with lysosomes was determined by confocal microscopy. Albumin degradation was measured by quantifying FITC-albumin abundance in HUPEC lysates by Western blot. Degradation experiments were repeated using HUPECs treated with chloroquine, a lysosome inhibitor, or MG-132, a proteasome inhibitor. Lysosome activity was measured by fluorescence recovery after photo bleaching (FRAP). Cytokine production was measured by ELISA. Cell death was determined by trypan blue staining. In vivo, staining with lysosome-associated membrane protein-1 (LAMP-1) was performed on tissue from a Denys-Drash trangenic mouse model of nephrotic syndrome. HUPECs endocytosed albumin, which co-localized with lysosomes. Choloroquine, but not MG-132, inhibited albumin degradation, indicating that degradation occurs in lysosomes. Cathepsin B activity, measured by FRAP, significantly decreased in HUPECs exposed to albumin (12.5% of activity in controls) and chloroquine (12.8%), and declined further with exposure to albumin plus chloroquine (8.2%, p < 0.05). Cytokine production and cell death were significantly increased in HUPECs exposed to albumin and chloroquine alone, and these effects were potentiated by exposure to albumin plus chloroquine. Compared to wild-type mice, glomerular staining of LAMP-1 was significantly increased in Denys-Drash mice and appeared to be most prominent in podocytes. These data suggest lysosomes are involved in the processing of endocytosed albumin in podocytes, and lysosomal dysfunction may contribute to podocyte injury and glomerulosclerosis in albuminuric diseases. Modifiers of lysosomal activity may have therapeutic potential in slowing the progression of glomerulosclerosis by enhancing the ability of podocytes to process and degrade albumin.	[Carson, John M.; Okamura, Kayo; McFann, Kim; Dobrinskikh, Evgenia; Blaine, Judith] Univ Colorado, Hlth Sci Ctr, Aurora, CO 80045 USA; [Wakashin, Hidefumi; Kopp, Jeffrey B.] NIDDK, Kidney Dis Sect, NIH, Bethesda, MD USA	University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Carson, JM (corresponding author), Univ Colorado, Hlth Sci Ctr, Aurora, CO 80045 USA.	john.m.carson@ucdenver.edu	Kopp, Jeffrey B/O-2681-2015	Kopp, Jeffrey B/0000-0001-9052-186X	NIH [K08DK080989]; Intramural Research program, NIDDK, NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK080989] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural Research program, NIDDK, NIH; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This research was supported by NIH grant K08DK080989 to Judith Blaine and the Intramural Research program, NIDDK, NIH to Jeffrey B. Kopp. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbate M, 2008, J AM SOC NEPHROL, V19, P1158, DOI 10.1681/ASN.2007060686; Abbate M, 2006, J AM SOC NEPHROL, V17, P2974, DOI 10.1681/ASN.2006040377; Akilesh S, 2008, P NATL ACAD SCI USA, V105, P967, DOI 10.1073/pnas.0711515105; Alroy J, 2002, J AM SOC NEPHROL, V13, pS134, DOI 10.1097/01.ASN.0000016684.07368.75; APPELMANS F, 1955, BIOCHEM J, V59, P438, DOI 10.1042/bj0590438; Appelqvist H, 2013, J MOL CELL BIOL, V5, P214, DOI 10.1093/jmcb/mjt022; Bahr BA, 2012, REJUV RES, V15, P189, DOI 10.1089/rej.2011.1282; Bechtel W, 2013, J AM SOC NEPHROL, V24, P727, DOI 10.1681/ASN.2012070700; Bendiske J, 2003, J NEUROPATH EXP NEUR, V62, P451, DOI 10.1093/jnen/62.5.451; Boute N, 2000, NAT GENET, V24, P349, DOI 10.1038/74166; Bracamonte ER, 2006, AM J KIDNEY DIS, V48, P844, DOI 10.1053/j.ajkd.2006.05.034; Butler D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020501; Chatterjee PK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035361; Chen JC, 2013, J AM SOC NEPHROL, V24, P198, DOI 10.1681/ASN.2012010101; Cina DP, 2012, J AM SOC NEPHROL, V23, P412, DOI 10.1681/ASN.2011070690; DAVIES DJ, 1985, PATHOLOGY, V17, P412, DOI 10.3109/00313028509105494; Dobrinskikh E, 2014, AM J PHYSL RENAL PHY; Dupont N, 2011, EMBO J, V30, P4701, DOI 10.1038/emboj.2011.398; Eddy AA, 2000, KIDNEY INT, V58, P618, DOI 10.1046/j.1523-1755.2000.00208.x; Eyre J, 2007, AM J PHYSIOL-RENAL, V292, pF674, DOI 10.1152/ajprenal.00272.2006; FARQUHAR MG, 1961, J EXP MED, V113, P47, DOI 10.1084/jem.113.1.47; Gekle M, 2005, ANNU REV PHYSIOL, V67, P573, DOI 10.1146/annurev.physiol.67.031103.154845; Hartleben B, 2010, J CLIN INVEST, V120, P1084, DOI 10.1172/JCI39492; Haymann JP, 2000, J AM SOC NEPHROL, V11, P632, DOI 10.1681/ASN.V114632; He FF, 2011, CELL BIOL INT, V35, P827, DOI 10.1042/CBI20100411; He FF, 2011, GENE, V484, P18, DOI 10.1016/j.gene.2011.05.025; HORY B, 1994, CLIN NEPHROL, V42, P327; Karnovsky M J, 1972, Adv Nephrol Necker Hosp, V2, P35; Kestila M, 1998, MOL CELL, V1, P575, DOI 10.1016/S1097-2765(00)80057-X; Kobayashi N, 2002, AM J PHYSIOL-RENAL, V282, pF358, DOI 10.1152/ajprenal.0164.2001; Krysko DV, 2008, METHODS, V44, P205, DOI 10.1016/j.ymeth.2007.12.001; Liebau MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063506; Luzio JP, 2007, NAT REV MOL CELL BIO, V8, P622, DOI 10.1038/nrm2217; MAACK T, 1971, AM J PHYSIOL, V221, P1609, DOI 10.1152/ajplegacy.1971.221.6.1609; OHKUMA S, 1978, P NATL ACAD SCI USA, V75, P3327, DOI 10.1073/pnas.75.7.3327; Okamura K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054817; OLBRICHT CJ, 1986, AM J PHYSIOL, V250, P1055; Pryor PR, 2012, METHOD ENZYMOL, V505, P145, DOI 10.1016/B978-0-12-388448-0.00016-4; Ratelade J, 2010, HUM MOL GENET, V19, P1, DOI 10.1093/hmg/ddp462; Ruggenenti P, 1998, KIDNEY INT, V53, P1209, DOI 10.1046/j.1523-1755.1998.00874.x; Russo LM, 2007, KIDNEY INT, V71, P504, DOI 10.1038/sj.ki.5002041; Saito A, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/403272; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sakairi T, 2010, AM J PHYSIOL-RENAL, V298, pF557, DOI 10.1152/ajprenal.00509.2009; Sakamoto KM, 2002, MOL GENET METAB, V77, P44, DOI 10.1016/S1096-7192(02)00146-4; Schmieder RE, 2011, J AM SOC NEPHROL, V22, P1353, DOI 10.1681/ASN.2010091001; STRAUS W, 1957, J BIOPHYS BIOCHEM CY, V3, P933, DOI 10.1083/jcb.3.6.933; STRAUS W, 1964, J CELL BIOL, V21, P295, DOI 10.1083/jcb.21.3.295; TOJO A, 1992, AM J PHYSIOL, V263, pF601, DOI 10.1152/ajprenal.1992.263.4.F601; TROWBRIDGE IS, 1993, ANNU REV CELL BIOL, V9, P129, DOI 10.1146/annurev.cb.09.110193.001021; Tryggvason K, 2005, PHYSIOLOGY, V20, P96, DOI 10.1152/physiol.00045.2004; Turk B, 2009, J BIOL CHEM, V284, P21783, DOI 10.1074/jbc.R109.023820; van der Velde M, 2011, KIDNEY INT, V79, P1341, DOI 10.1038/ki.2010.536; Weide T, 2011, CELL TISSUE RES, V343, P467, DOI 10.1007/s00441-010-1115-0; Wiggins RC, 2007, KIDNEY INT, V71, P1205, DOI 10.1038/sj.ki.5002222; Yadav A, 2010, AM J PHYSIOL-CELL PH, V299, pC488, DOI 10.1152/ajpcell.00424.2009; Yang YP, 2013, ACTA PHARMACOL SIN, V34, P625, DOI 10.1038/aps.2013.5; Yoshida S, 2008, NEPHRON EXP NEPHROL, V108, pE57, DOI 10.1159/000124236; YOSHIKAWA N, 1986, ARCH PATHOL LAB MED, V110, P394	59	34	35	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99771	10.1371/journal.pone.0099771	http://dx.doi.org/10.1371/journal.pone.0099771			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924335	gold, Green Submitted, Green Published			2022-12-27	WOS:000338701300092
J	Choi, HY; Kim, SW; Kim, B; Lee, HN; Kim, SJ; Song, M; Kim, S; Kim, J; Kim, YB; Kim, JH; Cho, SG				Choi, Hye Yeon; Kim, Seung Woo; Kim, BongWoo; Lee, Hae Na; Kim, Su-Jeong; Song, Minjung; Kim, Sol; Kim, Jungho; Kim, Young Bong; Kim, Jin-Hoi; Cho, Ssang-Goo			Alpha-Fetoprotein, Identified as a Novel Marker for the Antioxidant Effect of Placental Extract, Exhibits Synergistic Antioxidant Activity in the Presence of Estradiol	PLOS ONE			English	Article							LOW-DENSITY-LIPOPROTEIN; OXIDATIVE STRESS; NITRIC-OXIDE; HYDROGEN-PEROXIDE; ESTROGEN-BINDING; FREE-RADICALS; DNA-DAMAGE; SKIN; FETAL; EXPRESSION	Placenta, as a reservoir of nutrients, has been widely used in medical and cosmetic materials. Here, we focused on the antioxidant properties of placental extract and attempted to isolate and identify the main antioxidant factors. Porcine placental extracts were prepared through homogenization or acid hydrolysis, and their antioxidant activity was investigated in the human keratinocyte HaCaT cell line. Treatment with homogenized placental extract (H-PE) increased the cell viability of H2O2-treated HaCaT cells more than two-fold. H-PE treatment suppressed H2O2-induced apoptotic and necrotic cell death and decreased intracellular ROS levels in H2O2-treated HaCaT cells. The antioxidant factors in H-PE were found to be thermounstable and were thus expected to include proteins. The candidate antioxidant proteins were fractionated with cation-exchange, anion-exchange, and size-exclusion chromatography, and the antioxidant properties of the chromatographic fractions were investigated. We obtained specific antioxidant fractions that suppressed ROS generation and ROS-induced DNA strand breaks. From silver staining and MALDI-TOF analyses, alpha-fetoprotein (AFP) precursor was identified as a main marker for the antioxidant effect of H-PE. Purified AFP or ectopically expressed AFP exhibited synergistic antioxidant activity in the presence of estradiol. Taken together, our data suggest that AFP, a serum glycoprotein produced at high levels during fetal development, is a novel marker protein for the antioxidant effect of the placenta that exhibits synergistic antioxidant activity in the presence of estradiol.	[Choi, Hye Yeon; Kim, Seung Woo; Kim, BongWoo; Lee, Hae Na; Kim, Su-Jeong; Song, Minjung; Kim, Young Bong; Kim, Jin-Hoi; Cho, Ssang-Goo] Konkuk Univ, Dept Anim Biotechnol, Anim Resources Res Ctr, Seoul, South Korea; [Choi, Hye Yeon; Kim, Seung Woo; Kim, BongWoo; Lee, Hae Na; Kim, Su-Jeong; Song, Minjung; Kim, Young Bong; Kim, Jin-Hoi; Cho, Ssang-Goo] Konkuk Univ, Incurable Dis Anim Model & Stem Cell Inst IDASI, Seoul, South Korea; [Kim, Sol; Kim, Jungho] Sogang Univ, Dept Life Sci, Seoul, South Korea	Konkuk University; Konkuk University; Sogang University	Cho, SG (corresponding author), Konkuk Univ, Dept Anim Biotechnol, Anim Resources Res Ctr, Seoul, South Korea.	ssangoo@konkuk.ac.kr	CHOI, HYEYEON/O-1234-2019	kim, jin-hoi/0000-0003-1232-5307; Cho, Ssang-Goo/0000-0002-0968-7932	National Research Foundation (NRF) - Korean government (MEST) [2010-0020348]; Bio-Industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs [312062-05];  [2013M3A9D3045880]	National Research Foundation (NRF) - Korean government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Bio-Industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs; 	This work was supported by grants from the National Research Foundation (NRF) funded by the Korean government (MEST) (No. 2010-0020348) (No. 2013M3A9D3045880) and by the Bio-Industry Technology Development Program, Ministry of Agriculture, Food and Rural Affairs (No. 312062-05). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDREWS GK, 1982, J BIOL CHEM, V257, P5148; Angelucci C, 1999, ANTICANCER RES, V19, P429; AVISSAR N, 1994, AM J PHYSIOL, V267, pE68, DOI 10.1152/ajpendo.1994.267.1.E68; Baker ME, 1998, P SOC EXP BIOL MED, V217, P317; Banerjee K K, 1992, Riv Eur Sci Med Farmacol, V14, P361; Barbouti A, 2002, FREE RADICAL BIO MED, V33, P691, DOI 10.1016/S0891-5849(02)00967-X; Bickers DR, 2006, J INVEST DERMATOL, V126, P2565, DOI 10.1038/sj.jid.5700340; Black HS, 2004, J INVEST DERMATOL, V122, pXIII, DOI 10.1111/j.0022-202X.2004.22625.x; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Briganti S, 2003, J EUR ACAD DERMATOL, V17, P663, DOI 10.1046/j.1468-3083.2003.00751.x; Chakraborty PD, 2006, INT IMMUNOPHARMACOL, V6, P100, DOI 10.1016/j.intimp.2005.07.018; Cianfarani F, 2006, AM J PATHOL, V169, P1167, DOI 10.2353/ajpath.2006.051314; CUCKLE HS, 1984, LANCET, V1, P926; De D, 2011, J CELL PHYSIOL, V226, P2033, DOI 10.1002/jcp.22535; DEUTSCH HF, 1991, ADV CANCER RES, V56, P253; Dodd S, 2008, EXPERT OPIN BIOL TH, V8, P1955, DOI 10.1517/14728220802517901 ; Gabant P, 2002, P NATL ACAD SCI USA, V99, P12865, DOI 10.1073/pnas.202215399; HALLIWELL B, 1990, METHOD ENZYMOL, V186, P1; Hedley SJ, 2002, PIGM CELL RES, V15, P49, DOI 10.1034/j.1600-0749.2002.00067.x; Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446; HISHIKAWA K, 1995, FEBS LETT, V360, P291, DOI 10.1016/0014-5793(95)00124-R; HOGG N, 1995, J LIPID RES, V36, P1756; HOGG N, 1993, FEBS LETT, V326, P199, DOI 10.1016/0014-5793(93)81790-7; Hong JW, 2010, ANN PLAS SURG, V65, P96, DOI 10.1097/SAP.0b013e3181b0bb67; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Jayaprakasha GK, 2004, BIOORGAN MED CHEM, V12, P5141, DOI 10.1016/j.bmc.2004.07.028; Jung TJ CH, 2006, METHOD MANUFACTURING; Kim SY, 2007, J NUTR BIOCHEM, V18, P31, DOI 10.1016/j.jnutbio.2006.02.006; Lappas M, 2005, ENDOCRINOLOGY, V146, P3334, DOI 10.1210/en.2005-0406; LEIGHTON PC, 1975, LANCET, V2, P1012; LENNON SV, 1991, CELL PROLIFERAT, V24, P203, DOI 10.1111/j.1365-2184.1991.tb01150.x; Liu KX, 1998, BIOL PHARM BULL, V21, P44; Mates JM, 2000, TOXICOLOGY, V153, P83, DOI 10.1016/S0300-483X(00)00306-1; Mizejewski GJ, 2001, EXP BIOL MED, V226, P377, DOI 10.1177/153537020122600503; MONTANO MM, 1995, BIOL REPROD, V53, P1198, DOI 10.1095/biolreprod53.5.1198; MOORADIAN AD, 1993, J STEROID BIOCHEM, V45, P509, DOI 10.1016/0960-0760(93)90166-T; NIKI E, 1990, METHOD ENZYMOL, V186, P330; NISHI S, 1991, P NATL ACAD SCI USA, V88, P3102, DOI 10.1073/pnas.88.8.3102; Parvez S, 2006, TOXICOLOGY, V225, P109, DOI 10.1016/j.tox.2006.05.009; Rahman K, 2007, CLIN INTERV AGING, V2, P219; Santanam N, 1998, J LIPID RES, V39, P2111; SIES H, 1993, EUR J BIOCHEM, V215, P213, DOI 10.1111/j.1432-1033.1993.tb18025.x; SUBBIAH MTR, 1993, J CLIN ENDOCR METAB, V77, P1095, DOI 10.1210/jc.77.4.1095; TAKEHARA Y, 1990, ACTA MED OKAYAMA, V44, P103; TILGHMAN SM, 1982, P NATL ACAD SCI-BIOL, V79, P5254, DOI 10.1073/pnas.79.17.5254; Togashi SI, 2002, PLACENTA, V23, P497, DOI 10.1053/plac.2002.0833; Trouba KJ, 2002, ANTIOXID REDOX SIGN, V4, P665, DOI 10.1089/15230860260220175; Wu CH, 2003, BRIT J DERMATOL, V148, P236, DOI 10.1046/j.1365-2133.2003.05164.x; Wu YT, 2008, AUTOPHAGY, V4, P457, DOI 10.4161/auto.5662; Yamashita H, 1999, J BIOL CHEM, V274, P29897, DOI 10.1074/jbc.274.42.29897; Zhou Q, 2009, FREE RADICAL BIO MED, V47, P891, DOI 10.1016/j.freeradbiomed.2009.06.033	51	14	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99421	10.1371/journal.pone.0099421	http://dx.doi.org/10.1371/journal.pone.0099421			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922551	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300060
J	Di Cesare, CS; Sarlegna, FR; Bourdin, C; Mestre, DR; Bringoux, L				Di Cesare, Cecile Scotto; Sarlegna, Fabrice R.; Bourdin, Christophe; Mestre, Daniel R.; Bringoux, Lionel			Combined Influence of Visual Scene and Body Tilt on Arm Pointing Movements: Gravity Matters!	PLOS ONE			English	Article							EYE-HAND COORDINATION; REFERENCE FRAMES; ORIENTATION; MICROGRAVITY; PERCEPTION; ENVIRONMENTS; ACCURACY; LEVEL; PITCH; HEAD	Performing accurate actions such as goal-directed arm movements requires taking into account visual and body orientation cues to localize the target in space and produce appropriate reaching motor commands. We experimentally tilted the body and/or the visual scene to investigate how visual and body orientation cues are combined for the control of unseen arm movements. Subjects were asked to point toward a visual target using an upward movement during slow body and/or visual scene tilts. When the scene was tilted, final pointing errors varied as a function of the direction of the scene tilt (forward or backward). Actual forward body tilt resulted in systematic target undershoots, suggesting that the brain may have overcompensated for the biomechanical movement facilitation arising from body tilt. Combined body and visual scene tilts also affected final pointing errors according to the orientation of the visual scene. The data were further analysed using either a body-centered or a gravity-centered reference frame to encode visual scene orientation with simple additive models (i.e., 'combined' tilts equal to the sum of 'single' tilts). We found that the body-centered model could account only for some of the data regarding kinematic parameters and final errors. In contrast, the gravity-centered modeling in which the body and visual scene orientations were referred to vertical could explain all of these data. Therefore, our findings suggest that the brain uses gravity, thanks to its invariant properties, as a reference for the combination of visual and non-visual cues.	[Di Cesare, Cecile Scotto; Sarlegna, Fabrice R.; Bourdin, Christophe; Mestre, Daniel R.; Bringoux, Lionel] Aix Marseille Univ, CNRS, ISM UMR 7287, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Di Cesare, CS (corresponding author), Univ Bielefeld, Dept Cognit Neurosci, D-33615 Bielefeld, Germany.	cecile.scotto@gmail.com	Mestre, Daniel R/J-9526-2015; Bourdin, Christophe/O-9395-2017	Mestre, Daniel R/0000-0002-0399-4747; Bourdin, Christophe/0000-0003-4149-1347; SARLEGNA, Fabrice/0000-0002-7718-7286; Scotto, Cecile/0000-0002-7139-2502				APPELLE S, 1972, PSYCHOL BULL, V78, P266, DOI 10.1037/h0033117; Ballinger CJ, 1988, THESIS NAVAL POSTGRA; Benson A. J., 1990, PERCEPTION CONTROL S, P145; Bockisch CJ, 2007, EXP BRAIN RES, V182, P387, DOI 10.1007/s00221-007-0997-x; Bourdin C, 2001, EXP BRAIN RES, V138, P62, DOI 10.1007/s002210000674; Bringoux L, 2012, J NEUROPHYSIOL, V107, P2541, DOI 10.1152/jn.00364.2011; Burns JK, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00221; Carriot J, 2004, AVIAT SPACE ENVIR MD, V75, P795; COHEN MM, 1995, PERCEPT PSYCHOPHYS, V57, P433, DOI 10.3758/BF03213069; Desmurget M, 2003, BRADFORD BOOKS, P289; Dichgans Johannes, 1978, PERCEPTION, P755, DOI DOI 10.1007/978-3-642-46354-9_25; DILORENZO JR, 1982, J EXP PSYCHOL HUMAN, V8, P536, DOI 10.1037/0096-1523.8.4.536; Duncker K, 1929, PSYCHOL FORSCH, V12, P180, DOI 10.1007/BF02409210; Ernst MO, 2002, NATURE, V415, P429, DOI 10.1038/415429a; Fouque F, 1999, ECOL PSYCHOL, V11, P1, DOI 10.1207/s15326969eco1101_1; Gaveau J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022045; Gentili R, 2007, NEUROSCIENCE, V145, P20, DOI 10.1016/j.neuroscience.2006.11.035; GOLDBERG JM, 1977, BRAIN RES, V122, P545, DOI 10.1016/0006-8993(77)90465-6; GOODENOUGH DR, 1981, PERCEPT PSYCHOPHYS, V29, P365, DOI 10.3758/BF03207346; Gueguen M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034380; Guerraz M, 1998, PERCEPT PSYCHOPHYS, V60, P287, DOI 10.3758/BF03206037; Guillaud E, 2011, NEUROPSYCHOLOGIA, V49, P2055, DOI 10.1016/j.neuropsychologia.2011.03.035; Howard I. P., 1982, HUMAN VISUAL ORIENTA; HOWARD IP, 1994, PERCEPTION, V23, P745, DOI 10.1068/p230745; Lackner JR, 1996, CURR OPIN NEUROBIOL, V6, P744, DOI 10.1016/S0959-4388(96)80023-7; Le Seac'h AB, 2007, NEUROSCI LETT, V423, P211, DOI 10.1016/j.neulet.2007.07.034; Li WX, 2005, VISION RES, V45, P2037, DOI 10.1016/j.visres.2005.01.014; Li WX, 2001, VISION RES, V41, P2873, DOI 10.1016/S0042-6989(01)00165-1; Lopez C, 2009, J VISION, V9, DOI 10.1167/9.5.1; Mars F, 2004, ERGONOMICS, V47, P1116, DOI 10.1080/00140130410001695933; MATIN L, 1995, J VESTIBUL RES-EQUIL, V5, P499, DOI 10.1016/0957-4271(95)02003-B; MATIN L, 1992, ANN NY ACAD SCI, V656, P242, DOI 10.1111/j.1749-6632.1992.tb25213.x; MATIN L, 1989, VISION RES, V29, P315, DOI 10.1016/0042-6989(89)90080-1; McIntyre J, 2001, NAT NEUROSCI, V4, P693, DOI 10.1038/89477; McIntyre J, 1998, BRAIN RES REV, V28, P143, DOI 10.1016/S0165-0173(98)00034-4; MITTELSTAEDT H, 1983, NATURWISSENSCHAFTEN, V70, P272, DOI 10.1007/BF00404833; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ooi TL, 2001, NATURE, V414, P197, DOI 10.1038/35102562; Papaxanthis C, 1998, ACTA ASTRONAUT, V43, P153, DOI 10.1016/S0094-5765(98)00151-9; Papaxanthis C, 2005, NEUROSCIENCE, V135, P371, DOI 10.1016/j.neuroscience.2005.06.063; Papaxanthis C, 1998, EXP BRAIN RES, V120, P496, DOI 10.1007/s002210050423; Poquin D, 1998, SPATIAL VISION, V11, P261, DOI 10.1163/156856898X00022; Pozzo T, 1998, BRAIN RES REV, V28, P92, DOI 10.1016/S0165-0173(98)00030-7; Prieur JM, 2006, J VESTIBUL RES-EQUIL, V16, P93; Sarlegna FR, 2007, EXP BRAIN RES, V176, P267, DOI 10.1007/s00221-006-0613-5; Sciutti A, 2012, J NEUROPHYSIOL, V107, P3433, DOI 10.1152/jn.00420.2011; Scott SH, 2004, NAT REV NEUROSCI, V5, P534, DOI 10.1038/nrn1427; Smetanin BN, 1997, EUR J NEUROSCI, V9, P7, DOI 10.1111/j.1460-9568.1997.tb01347.x; Stoper AE, 1999, EMORY S COG, P97; STOPER AE, 1989, PERCEPT PSYCHOPHYS, V46, P469, DOI 10.3758/BF03210862; Tagliabue M, 2013, NEUROSCIENCE, V248, P88, DOI 10.1016/j.neuroscience.2013.05.051; Tagliabue M, 2011, J NEUROSCI, V31, P1397, DOI 10.1523/JNEUROSCI.0623-10.2011; TEMPLETON WB, 1973, PERCEPT PSYCHOPHYS, V14, P451, DOI 10.3758/BF03211183; Welch RB, 1996, PERCEPT PSYCHOPHYS, V58, P383, DOI 10.3758/BF03206814	54	10	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99866	10.1371/journal.pone.0099866	http://dx.doi.org/10.1371/journal.pone.0099866			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925371	Green Published, gold			2022-12-27	WOS:000338701300102
J	Sadio, A; Gustafsson, JK; Pereira, B; Gomes, CP; Hansson, GC; David, L; Pego, AP; Almeida, R				Sadio, Ana; Gustafsson, Jenny K.; Pereira, Bruno; Gomes, Carla Pereira; Hansson, Gunnar C.; David, Leonor; Pego, Ana Paula; Almeida, Raquel			Modified-Chitosan/siRNA Nanoparticles Downregulate Cellular CDX2 Expression and Cross the Gastric Mucus Barrier	PLOS ONE			English	Article							TRIMETHYL CHITOSAN; IN-VITRO; POLYMERIC NANOPARTICLES; INTESTINAL METAPLASIA; RNA INTERFERENCE; CANCER-THERAPY; DRUG-DELIVERY; CELLS; VIVO; COLON	Development of effective non-viral vectors is of crucial importance in the implementation of RNA interference in clinical routine. The localized delivery of siRNAs to the gastrointestinal mucosa is highly desired but faces specific problems such as the stability in gastric acidity conditions and the presence of the mucus barrier. CDX2 is a transcription factor critical for intestinal differentiation being involved in the initiation and maintenance of gastrointestinal diseases. Specifically, it is the trigger of gastric intestinal metaplasia which is a precursor lesion of gastric cancer. Its expression is also altered in colorectal cancer, where it may constitute a lineage-survival oncogene. Our main objective was to develop a nanoparticle-delivery system of siRNA targeting CDX2 using modified chitosan as a vector. CDX2 expression was assessed in gastric carcinoma cell lines and nanoparticles behaviour in gastrointestinal mucus was tested in mouse explants. We show that imidazole-modified chitosan and trimethylchitosan/siRNA nanoparticles are able to downregulate CDX2 expression and overpass the gastric mucus layer but not colonic mucus. This system might constitute a potential therapeutic approach to treat CDX2-dependent gastric lesions.	[Sadio, Ana; Pereira, Bruno; David, Leonor; Almeida, Raquel] Univ Porto, IPATIMUP Inst Patol & Imunol Mol, P-4100 Oporto, Portugal; [Sadio, Ana; Gomes, Carla Pereira; Pego, Ana Paula] Univ Porto, INEB Inst Engn Biomed, P-4100 Oporto, Portugal; [Sadio, Ana] Unidade Local Saude Guarda, Dept Gastroenterol, Guarda, Portugal; [Sadio, Ana] Gulbenkian Programme Adv Med Educ, Lisbon, Portugal; [Sadio, Ana; David, Leonor; Almeida, Raquel] Univ Porto, Fac Med, P-4100 Oporto, Portugal; [Gustafsson, Jenny K.; Hansson, Gunnar C.] Univ Gothenburg, Dept Med Biochem, Gothenburg, Sweden; [Gomes, Carla Pereira; Pego, Ana Paula] Univ Porto, Fac Engn, P-4100 Oporto, Portugal; [Pego, Ana Paula] Univ Porto, ICBAS, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto; Universidade do Porto; University of Gothenburg; Universidade do Porto; Universidade do Porto	Almeida, R (corresponding author), Univ Porto, IPATIMUP Inst Patol & Imunol Mol, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	ralmeida@ipatimup.pt	Hansson, Gunnar C./AAF-7324-2019; David, Leonor/A-4829-2008; Pêgo, Ana Paula/C-6942-2012; Almeida, Raquel/B-9647-2012; Pereira, Bruno/H-5614-2019; Hansson, Gunnar C/A-1236-2009; Gomes, Carla/K-8690-2013	Hansson, Gunnar C./0000-0002-1900-1869; David, Leonor/0000-0003-4207-9258; Pêgo, Ana Paula/0000-0001-5169-328X; Almeida, Raquel/0000-0002-5622-1633; Hansson, Gunnar C/0000-0002-1900-1869; Gomes, Carla/0000-0002-1483-4079; Sadio, Ana/0000-0002-6575-4781; Pereira, Bruno/0000-0003-2460-6720	Sociedade Portuguesa de Gastrenterologia (SPG) [NORTE - 07-0124-FEDER-000024]; Programa Operacional Regional do Norte, under Quadro de Referencia Estrategico Nacional (QREN) [2 - O Novo Norte]; Fundo Europeu de Desenvolvimento Regional (FEDER); Swedish Research Council; Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation; Inga Britt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUA-ALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI095473] Funding Source: NIH RePORTER	Sociedade Portuguesa de Gastrenterologia (SPG); Programa Operacional Regional do Norte, under Quadro de Referencia Estrategico Nacional (QREN); Fundo Europeu de Desenvolvimento Regional (FEDER)(European Commission); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Foundation; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Inga Britt and Arne Lundberg Foundation; Sahlgren's University Hospital (LUA-ALF); Wilhelm and Martina Lundgren's Foundation; Torsten och Ragnar Soderbergs Stiftelser; Sahlgrenska Academy; Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Sociedade Portuguesa de Gastrenterologia (SPG), Project NORTE - 07-0124-FEDER-000024 co-financed by Programa Operacional Regional do Norte (ON. 2 - O Novo Norte), under Quadro de Referencia Estrategico Nacional (QREN) by Fundo Europeu de Desenvolvimento Regional (FEDER), the Swedish Research Council; The Swedish Cancer Foundation, The Knut and Alice Wallenberg Foundation, Inga Britt and Arne Lundberg Foundation, Sahlgren's University Hospital (LUA-ALF), Wilhelm and Martina Lundgren's Foundation, Torsten och Ragnar Soderbergs Stiftelser, The Sahlgrenska Academy, and The Swedish Foundation for Strategic Research - The Mucus-Bacteria-Colitis Center (MBC) of the Innate Immunity Program. IPATIMUP and INEB are Associated Laboratories of Ministerio da Educacao e Ciencia and are partially supported by Fundacao para a Ciencia e a Tecnologia (FCT). The Gulbenkian Programme for Advanced Medical Education is sponsored by Fundacao Calouste Gulbenkian, Fundacao Champalimaud, Ministerio da Saude and FCT. The authors would like to thank Vania Camilo (IPATIMUP) for all the support with cell experiments and Anna Ermund (Gothenburg) for the help with stomach dissection. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alameh M, 2010, INT J NANOMED, V5, P473; Atuma C, 2001, AM J PHYSIOL-GASTR L, V280, pG922, DOI 10.1152/ajpgi.2001.280.5.G922; Ballarin-Gonzalez B, 2013, MOL THER-NUCL ACIDS, V2, DOI 10.1038/mtna.2013.2; Barros R, 2012, TRENDS MOL MED, V18, P555, DOI 10.1016/j.molmed.2012.07.006; Barros R, 2011, GUT, V60, P290, DOI 10.1136/gut.2010.222323; Barros R, 2010, BIOCHEM SOC T, V38, P358, DOI 10.1042/BST0380358; Bonhomme C, 2003, GUT, V52, P1465, DOI 10.1136/gut.52.10.1465; Breunig M, 2007, P NATL ACAD SCI USA, V104, P14454, DOI 10.1073/pnas.0703882104; Caldara M, 2012, CURR BIOL, V22, P2325, DOI 10.1016/j.cub.2012.10.028; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; Ensign LM, 2012, ADV DRUG DELIVER REV, V64, P557, DOI 10.1016/j.addr.2011.12.009; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gartner F, 1996, VIRCHOWS ARCH, V428, P91; Gavrilov Kseniya, 2012, Yale Journal of Biology and Medicine, V85, P187; Gustafsson JK, 2012, AM J PHYSIOL-GASTR L, V302, pG430, DOI [10.1152/ajpgi.00405.2011, 10.1152/ajpgi.00405.2011.]; Howard KA, 2006, MOL THER, V14, P476, DOI 10.1016/j.ymthe.2006.04.010; Johansson MEV, 2013, NAT REV GASTRO HEPAT, V10, P352, DOI 10.1038/nrgastro.2013.35; Johansson MEV, 2008, P NATL ACAD SCI USA, V105, P15064, DOI 10.1073/pnas.0803124105; Kotze AF, 1997, PHARMACEUT RES, V14, P1197, DOI 10.1023/A:1012106907708; Lai SK, 2007, P NATL ACAD SCI USA, V104, P1482, DOI 10.1073/pnas.0608611104; Lai SK, 2009, ADV DRUG DELIVER REV, V61, P158, DOI 10.1016/j.addr.2008.11.002; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Mallo GV, 1998, J BIOL CHEM, V273, P14030, DOI 10.1074/jbc.273.22.14030; Mao SR, 2010, ADV DRUG DELIVER REV, V62, P12, DOI 10.1016/j.addr.2009.08.004; Miele E, 2012, INT J NANOMED, V7, P3637, DOI 10.2147/IJN.S23696; Mittnacht U, 2010, NANO LETT, V10, P3933, DOI 10.1021/nl1016909; Moreira C, 2009, ACTA BIOMATER, V5, P2995, DOI 10.1016/j.actbio.2009.04.021; Mourya VK, 2009, J MATER SCI-MATER M, V20, P1057, DOI 10.1007/s10856-008-3659-z; Salari K, 2012, P NATL ACAD SCI USA, V109, pE3196, DOI 10.1073/pnas.1206004109; Sandri G, 2010, AAPS PHARMSCITECH, V11, P362, DOI 10.1208/s12249-010-9390-3; Vias M, 2008, TRENDS MOL MED, V14, P486, DOI 10.1016/j.molmed.2008.09.002	31	19	19	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99449	10.1371/journal.pone.0099449	http://dx.doi.org/10.1371/journal.pone.0099449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925340	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300061
J	Beitzke, D; Nolz, R; Unterhumer, S; Plank, C; Weber, M; Schernthaner, R; Schopf, V; Wolf, F; Loewe, C				Beitzke, Dietrich; Nolz, Richard; Unterhumer, Sylvia; Plank, Christina; Weber, Michael; Schernthaner, Ruediger; Schoepf, Veronika; Wolf, Florian; Loewe, Christian			Low-Dose High-Pitch CT Angiography of the Supraaortic Arteries Using Sinogram-Affirmed Iterative Reconstruction	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY-ANGIOGRAPHY; DUAL-SOURCE CT; IMAGE-QUALITY; MULTIDETECTOR CT; TUBE VOLTAGE; SPIRAL CT; REDUCTION; SETTINGS; ARTIFACTS; PROTOCOLS	Objective: To prospectively evaluate image quality and radiation dose using a low-dose computed tomography angiography protocol and iterative image reconstruction for high-pitch dual-source CT-angiography (DSCTA) of the supraaortic arteries. Material and Methods: DSCTA was performed in 42 patients, using either 120 kVp tube voltage, 120 mAS tube current, 2.4 pitch and filtered back projection, or 100 kVp tube voltage, 100 mAs tube current, 3.2 pitch, and sinogram affirmed iterative reconstruction. Measurements of vessel attenuation, of the contrast-to-noise ratio (CNR) and the signal-to-noise ratio (SNR) were performed to objectively evaluate image quality. Two readers evaluated subjective image quality and image noise, using a four-point scale. Effective dose was used to compare the differences in radiation dose. Results: Low-dose protocol application showed significantly higher vessel opacification (p = 0.013), and non-significantly higher CNR and SNR values. There was no difference in the subjective image quality and image noise reading between the protocols. Effective dose was significantly lower using the low-dose protocol (1.29 +/- 0.21 mSv vs. 2.92 +/- 0.72 mSv; p<0.001). Conclusion: The combined use of reduced tube voltage, reduced tube current, and iterative reconstruction reduces radiation dose by 55.4% in high-pitch DSCTA of the supraaortic arteries without impairment of image quality.	[Beitzke, Dietrich; Nolz, Richard; Unterhumer, Sylvia; Plank, Christina; Weber, Michael; Schernthaner, Ruediger; Wolf, Florian; Loewe, Christian] Med Univ Vienna, Div Cardiovasc & Intervent Radiol, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria; [Schoepf, Veronika] Med Univ Vienna, Div Neuroradiol & Musculoskeletal Radiol, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Beitzke, D (corresponding author), Med Univ Vienna, Div Cardiovasc & Intervent Radiol, Dept Biomed Imaging & Image Guided Therapy, Vienna, Austria.	dietrich.beitzke@meduniwien.ac.at	Schernthaner, Rüdiger/AAG-4584-2021; Loewe, Christian/GSI-8660-2022; Weber, Michael/L-9836-2016	Weber, Michael/0000-0002-8507-2219; Schopf, Veronika/0000-0003-1937-4216; Loewe, Christian/0000-0003-2502-0676; /0000-0002-1194-1346; Nolz, Richard/0000-0002-7030-5972				Achenbach S, 2011, JACC-CARDIOVASC IMAG, V4, P328, DOI 10.1016/j.jcmg.2011.01.012; Achenbach S, 2010, EUR HEART J, V31, P340, DOI 10.1093/eurheartj/ehp470; Amacker NA, 2012, EUR J RADIOL, V81, pE392, DOI 10.1016/j.ejrad.2011.12.017; Anderson GB, 2000, STROKE, V31, P2168, DOI 10.1161/01.STR.31.9.2168; Beister M, 2012, PHYS MEDICA, V28, P94, DOI 10.1016/j.ejmp.2012.01.003; Beitzke D, 2011, EUR RADIOL, V21, P2434, DOI 10.1007/s00330-011-2188-1; Carpeggiani C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050168; Cho ES, 2012, INVEST RADIOL, V47, P142, DOI 10.1097/RLI.0b013e31823076a4; De Zordo T, 2012, EUR RADIOL, V22, P279, DOI 10.1007/s00330-011-2251-y; Deak PD, 2010, RADIOLOGY, V257, P158, DOI 10.1148/radiol.10100047; Ebersberger U, 2013, EUR RADIOL, V23, P125, DOI 10.1007/s00330-012-2580-5; Ertl-Wagner BB, 2004, RADIOLOGY, V231, P528, DOI 10.1148/radiol.2312030543; Flohr TG, 2009, MED PHYS, V36, P5641, DOI 10.1118/1.3259739; Fujikawa A, NEURORADIOLOGY, V52, P291; Gonzalez RG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030352; Hendee WR, 2012, RADIOLOGY, V264, P312, DOI 10.1148/radiol.12112678; Huda W, 2004, MED PHYS, V31, P588, DOI 10.1118/1.1646232; Kim JJ, 2010, AM J NEURORADIOL, V31, P91, DOI 10.3174/ajnr.A1768; Korn A, 2013, NEURORADIOLOGY, V55, P423, DOI 10.1007/s00234-012-1120-y; Korn A, 2012, NEURORADIOLOGY; Kulkarni NM, 2012, RADIOLOGY, V265, P158, DOI 10.1148/radiol.12112470; Lell MM, 2011, INVEST RADIOL, V46, P116, DOI 10.1097/RLI.0b013e3181f33b1d; Marin D, RADIOLOGY, V254, P145; May MS, 2011, INVEST RADIOL, V46, P465, DOI 10.1097/RLI.0b013e31821690a1; Mettler FA, 2009, RADIOLOGY, V253, P520, DOI 10.1148/radiol.2532082010; Mnyusiwalla A, 2009, NEURORADIOLOGY, V51, P635, DOI 10.1007/s00234-009-0543-6; Noel PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081141; Oda S, 2013, EUR J RADIOL, V82, P288, DOI 10.1016/j.ejrad.2012.11.003; Schulz B, 2012, J THORAC IMAG, V27, P382, DOI 10.1097/RTI.0b013e3182575729; Thai WE, 2012, CIRC-ARRHYTHMIA ELEC, V5, P521, DOI 10.1161/CIRCEP.111.968313; Tholen ATR, 2010, RADIOLOGY, V256, P585, DOI 10.1148/radiol.10091157; von Falck C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056875; Waaijer A, 2007, RADIOLOGY, V242, P832, DOI 10.1148/radiol.2423051191; Winklehner A, 2011, EUR RADIOL, V21, P2521, DOI 10.1007/s00330-011-2227-y; Wintermark M, 2008, ANN NEUROL, V64, P149, DOI 10.1002/ana.21424; Wintersperger B, 2005, EUR RADIOL, V15, P334, DOI 10.1007/s00330-004-2575-y	36	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99832	10.1371/journal.pone.0099832	http://dx.doi.org/10.1371/journal.pone.0099832			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919195	gold, Green Submitted, Green Published			2022-12-27	WOS:000338631000118
J	Healey, PGT; Purver, M; Howes, C				Healey, Patrick G. T.; Purver, Matthew; Howes, Christine			Divergence in Dialogue	PLOS ONE			English	Article							LANGUAGE PRODUCTION	One of the best known claims about human communication is that people's behaviour and language use converge during conversation. It has been proposed that these patterns can be explained by automatic, cross-person priming. A key test case is structural priming: does exposure to one syntactic structure, in production or comprehension, make reuse of that structure (by the same or another speaker) more likely? It has been claimed that syntactic repetition caused by structural priming is ubiquitous in conversation. However, previous work has not tested for general syntactic repetition effects in ordinary conversation independently of lexical repetition. Here we analyse patterns of syntactic repetition in two large corpora of unscripted everyday conversations. Our results show that when lexical repetition is taken into account there is no general tendency for people to repeat their own syntactic constructions. More importantly, people repeat each other's syntactic constructions less than would be expected by chance; i.e., people systematically diverge from one another in their use of syntactic constructions. We conclude that in ordinary conversation the structural priming effects described in the literature are overwhelmed by the need to actively engage with our conversational partners and respond productively to what they say.	[Healey, Patrick G. T.; Purver, Matthew; Howes, Christine] Queen Mary Univ London, Sch Elect Engn & Comp Sci, Cognit Sci Res Grp, London, England	University of London; Queen Mary University London	Healey, PGT (corresponding author), Queen Mary Univ London, Sch Elect Engn & Comp Sci, Cognit Sci Res Grp, London, England.	p.healey@qmul.ac.uk	Howes, Christine/AAP-6178-2020; Howes, Christine/AAE-2797-2019	Howes, Christine/0000-0002-2794-1586; Purver, Matthew/0000-0003-2297-1273; Healey, Patrick/0000-0003-3079-3374	Economic and Social Research Council (ESRC) through the DynDial project (Dynamics of Conversational Dialogue [RES-062-23-0962]; Engineering and Physical Sciences Research Council (EPSRC) through the RISER project (Robust Incremental Semantic Resources for Dialogue) [EP/J010383/1]; EPSRC [EP/D057426/1, EP/J010383/1, EP/K009559/1] Funding Source: UKRI; ESRC [ES/F027117/1] Funding Source: UKRI; Economic and Social Research Council [ES/F027117/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/K009559/1, EP/J010383/1, EP/D057426/1] Funding Source: researchfish	Economic and Social Research Council (ESRC) through the DynDial project (Dynamics of Conversational Dialogue; Engineering and Physical Sciences Research Council (EPSRC) through the RISER project (Robust Incremental Semantic Resources for Dialogue); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by the Economic and Social Research Council (ESRC; http://www.esrc.ac.uk/) through the DynDial project (Dynamics of Conversational Dialogue, RES-062-23-0962) and the Engineering and Physical Sciences Research Council (EPSRC; http://www.epsrc.ac.uk/) through the RISER project (Robust Incremental Semantic Resources for Dialogue, EP/J010383/1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aijmer K., 1996, CONVERSATIONAL ROUTI; Asher N., 2003, LOGICS CONVERSATION; BNC, 2007, BRIT NAT CORP VER 3; Branigan HP, 2007, COGNITION, V104, P163, DOI 10.1016/j.cognition.2006.05.006; Branigan HP, 2006, LANG COGNITIVE PROC, V21, P974, DOI 10.1080/016909600824609; Branigan HP, 2000, COGNITION, V75, pB13, DOI 10.1016/S0010-0277(99)00081-5; Chartrand T, 2013, ANN REV PSYCHOL, V64; Chartrand TL, 1999, J PERS SOC PSYCHOL, V76, P893, DOI 10.1037/0022-3514.76.6.893; Clark S, 2007, COMPUT LINGUIST, V33, P493, DOI 10.1162/coli.2007.33.4.493; Cleland AA, 2003, J MEM LANG, V49, P214, DOI 10.1016/S0749-596X(03)00060-3; DAVIES M, 2009, LANGUAGE, V85, P443; Doyen S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029081; Dubey Amit., 2005, P HUMAN LANGUAGE TEC, P827; Giles H., 1991, CONTEXTS ACCOMMODATI, DOI [10.1017/CBO9780511663673.001, DOI 10.1017/CBO9780511663673.001]; Ginzburg J., 2012, INTERACTIVE STANCE M; Gries ST, 2005, J PSYCHOLINGUIST RES, V34, P365, DOI 10.1007/s10936-005-6139-3; Howes C, 2010, COGNITION IN FLUX, P2004; Iacoboni M., 2005, PERSPECTIVES IMITATI, P77; Jaeger TF, 2010, COGNITIVE PSYCHOL, V61, P23, DOI 10.1016/j.cogpsych.2010.02.002; Jefferson Gail, 1983, STUDIUM LINGUISTIK, V14, P58; LEVELT WJM, 1982, COGNITIVE PSYCHOL, V14, P78, DOI 10.1016/0010-0285(82)90005-6; Menenti L, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00185; Oberman L, 2002, PSYCHOL BULL, V133, P310; Pickering M.J., 2006, RES LANGUAGE COMPUTA, V4, P203, DOI [10.1007/s11168-006-9004-0, DOI 10.1007/S11168-006-9004-0]; Pickering MJ, 2008, PSYCHOL BULL, V134, P427, DOI 10.1037/0033-2909.134.3.427; Pickering MJ, 2004, BEHAV BRAIN SCI, V27, P169; Pomerantz Anita M., 1984, STUDIES CONVERSATION, P57, DOI DOI 10.1017/CBO9780511665868.008; Quirk R., 1985, COMPREHENSIVE GRAMMA; Reitter D, 2011, COGNITIVE SCI, V35, P587, DOI 10.1111/j.1551-6709.2010.01165.x; Reitter David, 2006, COGSCI, P685; SCHEFLEN AE, 1964, PSYCHIATR, V27, P316; SCHENKEIN J, 1980, LANGUAGE PRODUCTION, V1, P21; Shanks DR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056515; Szmrecsanyi Benedikt, 2005, CORPUS LINGUIST LING, V1, P113; Tannen D., 2007, TALKING VOICES REPET, V26; WEINER EJ, 1983, J LINGUIST, V19, P29, DOI 10.1017/S0022226700007441	37	53	53	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98598	10.1371/journal.pone.0098598	http://dx.doi.org/10.1371/journal.pone.0098598			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24919186	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000022
J	Kim, YM; Lee, SW; Chun, SM; Kim, DY; Kim, JH; Kim, KR; Kim, YT; Nam, JH; van Hummelen, P; MacConaill, LE; Hahn, WC; Jang, SJ				Kim, Yong-Man; Lee, Shin-Wha; Chun, Sung-Min; Kim, Dae-Yeon; Kim, Jong-Hyeok; Kim, Kyu-Rae; Kim, Young-Tak; Nam, Joo-Hyun; van Hummelen, Paul; MacConaill, Laura E.; Hahn, William C.; Jang, Se Jin			Analysis and Comparison of Somatic Mutations in Paired Primary and Recurrent Epithelial Ovarian Cancer Samples	PLOS ONE			English	Article							FACTOR-RECEPTOR MUTATIONS; CELL LUNG-CANCER; COLORECTAL-CANCER; K-RAS; ADENOCARCINOMA; EXPRESSION; TUMORS; HETEROGENEITY; CARCINOMAS; GEFITINIB	The TP53 mutations have been proved to be predominated in ovarian cancer in a study from The Cancer Genome Atlas (TCGA). However, the molecular characteristics of recurrent ovarian cancers following initial treatment have been poorly estimated. This study was to investigate the pattern of somatic point mutations in matched paired samples of primary and recurrent epithelial ovarian cancers, using the OncoMap mutation detection protocol. We have adapted a high-throughput genotyping platform to determine the mutation status of a large panel of known cancer genes. OncoMap v. 4.4 was used to evaluate genomic DNA isolated from a set of 92 formalin-fixed, paraffin-embedded (FFPE) tumors, consisting of matched paired samples of initially diagnosed and recurrent tumors from 46 epithelial ovarian cancer (EOC) patients. Mutations were observed in 33.7% of the samples, with 29.3% of these samples having a single mutation and the remaining 4.3% having two or more mutations. Among the 41 genes analyzed, 35 mutations were found in four genes, namely, CDKN2A (2.2%), KRAS (6.5%), MLH1 (8.2%) and TP53 (20.7%). TP53 was the most frequently mutated gene, but there was no correlation between the presence of mutation in any gene and clinical prognosis. Furthermore, somatic mutations did not differ between primary and recurrent ovarian carcinomas. Every mutation present in recurrent samples was detected in the corresponding primary sample. In conclusion, these OncoMap data of Korean EOC samples provide that somatic mutations were found in CDKN2A, KRAS, MLH1, and TP53. No differences in mutational status between primary and recurrent samples were detected. To understand the biology of tumor recurrence in epithelial ovarian cancer, more studies are necessary, including epigenetic modifications or additional mutations in other genes.	[Kim, Yong-Man; Lee, Shin-Wha; Kim, Dae-Yeon; Kim, Jong-Hyeok; Kim, Young-Tak; Nam, Joo-Hyun] Univ Ulsan, ASAN Med Ctr, Dept Obstet & Gynecol, Seoul, South Korea; [Chun, Sung-Min; Kim, Kyu-Rae; Jang, Se Jin] Univ Ulsan, ASAN Med Ctr, Dept Pathol, Seoul, South Korea; [van Hummelen, Paul; MacConaill, Laura E.; Hahn, William C.] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [van Hummelen, Paul; MacConaill, Laura E.; Hahn, William C.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Kim, Yong-Man; Lee, Shin-Wha; Chun, Sung-Min; Jang, Se Jin] ASAN Med Ctr, ASAN Ctr Canc Genome Discovery, Seoul, South Korea	University of Ulsan; Asan Medical Center; University of Ulsan; Asan Medical Center; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Ulsan; Asan Medical Center	Jang, SJ (corresponding author), Univ Ulsan, ASAN Med Ctr, Dept Pathol, Seoul, South Korea.	jangsejin@amc.seoul.kr		Chun, Sung-Min/0000-0002-3357-1382; van hummelen, paul/0000-0002-4801-8600	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST) [2011-0030105]	Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology (MEST)	This study was supported by a grant of the Leading Foreign Research Institute Recruitment Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (MEST) (2011-0030105). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed AA, 2010, J PATHOL, V221, P49, DOI 10.1002/path.2696; Auner V, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-111; Bast RC, 2009, NAT REV CANCER, V9, P415, DOI 10.1038/nrc2644; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bookman MA, 2009, J CLIN ONCOL, V27, P1419, DOI 10.1200/JCO.2008.19.1684; BORING CC, 1991, CA-CANCER J CLIN, V41, P19, DOI 10.3322/canjclin.41.1.19; Choy E, 2012, CANCER-AM CANCER SOC, V118, P2905, DOI 10.1002/cncr.26617; Endo K, 2006, ONCOL REP, V16, P533; Goh AM, 2011, J PATHOL, V223, P116, DOI 10.1002/path.2784; Gow CH, 2009, ANN ONCOL, V20, P696, DOI 10.1093/annonc/mdn679; Hunter SM, 2012, CLIN CANCER RES, V18, P5267, DOI 10.1158/1078-0432.CCR-12-1103; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lee J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038892; LI ZH, 1994, AM J PATHOL, V144, P303; Liu J, 2010, ONCOLOGY-NY, V24, P721; MacConaill LE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007887; Maeng CH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041655; Matulonis UA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024433; Nakano H, 2008, LUNG CANCER, V60, P136, DOI 10.1016/j.lungcan.2007.08.021; Pal T, 2012, BRIT J CANCER, V107, P1783, DOI 10.1038/bjc.2012.452; Park S, 2009, J THORAC ONCOL, V4, P809, DOI 10.1097/JTO.0b013e3181a94af4; Penson RT, 2004, GYNECOL ONCOL, V93, P98, DOI 10.1016/j.ygyno.2003.11.053; Surowiak P, 2006, HISTOL HISTOPATHOL, V21, P713, DOI 10.14670/HH-21.713; Taniguchi K, 2008, CANCER SCI, V99, P929, DOI 10.1111/j.1349-7006.2008.00782.x; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Thompson AM, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2771; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Yatabe Y, 2011, J CLIN ONCOL, V29, P2972, DOI 10.1200/JCO.2010.33.3906; Zajchowski DA, 2012, MOL CANCER THER, V11, P492, DOI 10.1158/1535-7163.MCT-11-0746; Zhang J, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-146; Zhang R, 2012, COLORECTAL DIS, V14, pe80, DOI 10.1111/j.1463-1318.2011.02858.x	31	11	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99451	10.1371/journal.pone.0099451	http://dx.doi.org/10.1371/journal.pone.0099451			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936796	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400019
J	Suarez, JV; Banks, S; Thomas, PG; Day, A				Suarez, Julio V.; Banks, Stephen; Thomas, Paul G.; Day, Anil			A New F131V Mutation in Chlamydomonas Phytoene Desaturase Locates a Cluster of Norflurazon Resistance Mutations near the FAD-Binding Site in 3D Protein Models	PLOS ONE			English	Article							DOMINANT SELECTABLE MARKER; HERBICIDE NORFLURAZON; NUCLEAR TRANSFORMATION; CAROTENOID SYNTHESIS; GENE-EXPRESSION; PHOTOSYSTEM-II; ZETA-CAROTENE; REINHARDTII; EVOLUTION; SEQUENCE	The green alga Chlamydomonas reinhardtii provides a tractable genetic model to study herbicide mode of action using forward genetics. The herbicide norflurazon inhibits phytoene desaturase, which is required for carotenoid synthesis. Locating amino acid substitutions in mutant phytoene desaturases conferring norflurazon resistance provides a genetic approach to map the herbicide binding site. We isolated a UV-induced mutant able to grow in very high concentrations of norflurazon (150 mu M). The phytoene desaturase gene in the mutant strain contained the first resistance mutation to be localised to the dinucleotide-binding Rossmann-likedomain. A highly conserved phenylalanine amino acid at position 131 of the 564 amino acid precursor protein was changed to a valine in the mutant protein. F131, and two other amino acids whose substitution confers norflurazon resistance in homologous phytoene desaturase proteins, map to distant regions in the primary sequence of the C. reinhardtii protein (V472, L505) but in tertiary models these residues cluster together to a region close to the predicted FAD binding site. The mutant gene allowed direct 5 mM norflurazon based selection of transformants, which were tolerant to other bleaching herbicides including fluridone, flurtamone, and diflufenican but were more sensitive to beflubutamid than wild type cells. Norflurazon resistance and beflubutamid sensitivity allow either positive or negative selection against transformants expressing the mutant phytoene desaturase gene.	[Suarez, Julio V.; Banks, Stephen; Day, Anil] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Thomas, Paul G.] Syngenta, Bracknell, Berks, England	University of Manchester; Syngenta	Day, A (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	anil.day@manchester.ac.uk		Suarez, Julio/0000-0003-0557-4735; Day, Anil/0000-0001-7835-9572	CONACyT (Mexico) [209303]; BBSRC CASE [95/A2/P/00330]; Syngenta; Zeneca Agrochemicals	CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); BBSRC CASE(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Syngenta(Syngenta); Zeneca Agrochemicals	JVS was supported by CONACyT scholarship 209303 (Mexico), SB was the recipient of a BBSRC CASE studentship 95/A2/P/00330 with Syngenta (formerly Zeneca Agrochemicals). Zeneca Agrochemicals provided support in the form of salaries for author PGT and a stipend supplement to SB, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	ALTINGMEES MA, 1989, NUCLEIC ACIDS RES, V17, P9494, DOI 10.1093/nar/17.22.9494; ANDERSON IC, 1960, PLANT PHYSIOL, V35, P531, DOI 10.1104/pp.35.4.531; Arias RS, 2006, PLANT BIOTECHNOL J, V4, P263, DOI 10.1111/j.1467-7652.2006.00179.x; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; BARTELS PG, 1978, WEED SCI, V26, P198, DOI 10.1017/S0043174500049675; Bates PA, 2001, PROTEINS, P39; Berthold P, 2002, PROTIST, V153, P401, DOI 10.1078/14344610260450136; Binda C, 2004, J MED CHEM, V47, P1767, DOI 10.1021/jm031087c; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Buchan DWA, 2013, NUCLEIC ACIDS RES, V41, pW349, DOI 10.1093/nar/gkt381; Cao MQ, 2009, PROTOPLASMA, V235, P107, DOI 10.1007/s00709-009-0036-9; CHAMOVITZ D, 1991, PLANT MOL BIOL, V16, P967, DOI 10.1007/BF00016069; CHAMOVITZ D, 1993, J BIOL CHEM, V268, P17348; Contreras-Moreira B, 2002, BIOINFORMATICS, V18, P1141, DOI 10.1093/bioinformatics/18.8.1141; DAVIES DR, 1971, GENET RES, V17, P33, DOI 10.1017/S0016672300012015; DAY A, 1991, J MOL BIOL, V218, P273, DOI 10.1016/0022-2836(91)90712-F; DAY A, 1988, EMBO J, V7, P1917, DOI 10.1002/j.1460-2075.1988.tb03029.x; Day A, 2011, PLANT BIOTECHNOL J, V9, P540, DOI 10.1111/j.1467-7652.2011.00604.x; EBERSOLD WT, 1967, SCIENCE, V157, P447, DOI 10.1126/science.157.3787.447; ERICKSON JM, 1985, SCIENCE, V228, P204, DOI 10.1126/science.228.4696.204; ERICKSON JM, 1984, P NATL ACAD SCI-BIOL, V81, P3617, DOI 10.1073/pnas.81.12.3617; ERICKSON JM, 1989, PLANT CELL, V1, P361, DOI 10.1105/tpc.1.3.361; Erikson O, 2004, NAT BIOTECHNOL, V22, P455, DOI 10.1038/nbt946; Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543; FERRIS PJ, 1989, GENETICS, V122, P363; Fischer N, 2001, MOL GENET GENOMICS, V265, P888, DOI 10.1007/s004380100485; Fraser PD, 2004, PROG LIPID RES, V43, P228, DOI 10.1016/j.plipres.2003.10.002; GALLOWAY RE, 1984, PLANT PHYSIOL, V74, P469, DOI 10.1104/pp.74.3.469; Gisby MF, 2012, PLANT PHYSIOL, V160, P2219, DOI 10.1104/pp.112.204107; GOLDSCHMIDTCLERMONT M, 1986, J MOL BIOL, V191, P421, DOI 10.1016/0022-2836(86)90137-3; GROSS CH, 1988, CURR GENET, V13, P503, DOI 10.1007/BF02427756; Harris E. H., 1989, CHLAMYDOMONAS SOURCE; HUGUENEY P, 1992, EUR J BIOCHEM, V209, P399, DOI 10.1111/j.1432-1033.1992.tb17302.x; JOHANNINGMEIER U, 1987, FEBS LETT, V211, P221, DOI 10.1016/0014-5793(87)81440-0; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; KINDLE KL, 1990, P NATL ACAD SCI USA, V87, P1228, DOI 10.1073/pnas.87.3.1228; Kovar JL, 2002, PLANT J, V29, P109, DOI 10.1046/j.1365-313x.2002.01193.x; KRINSKY NI, 1979, PURE APPL CHEM, V51, P649, DOI 10.1351/pac197951030649; Liu J, 2013, PROCESS BIOCHEM, V48, P788, DOI 10.1016/j.procbio.2013.04.020; Liu J, 2010, PLANTA, V232, P61, DOI 10.1007/s00425-010-1132-y; Lumbreras V, 1998, PLANT J, V14, P441, DOI 10.1046/j.1365-313X.1998.00145.x; Madesis P, 2010, J BIOTECHNOL, V145, P377, DOI 10.1016/j.jbiotec.2009.12.001; Marchler-Bauer A, 2013, NUCLEIC ACIDS RES, V41, pD348, DOI 10.1093/nar/gks1243; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; MARTINEZFEREZ I, 1994, PESTIC BIOCHEM PHYS, V48, P185, DOI 10.1006/pest.1994.1019; MARTINEZFEREZ IM, 1992, PLANT MOL BIOL, V18, P981, DOI 10.1007/BF00019213; Maul JE, 2002, PLANT CELL, V14, P2659, DOI 10.1105/tpc.006155; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Michel A, 2004, MOL ECOL, V13, P3229, DOI 10.1111/j.1365-294X.2004.02280.x; Mijit G, 2003, Acta Genetica Sinica, V30, P646; NELSON JAE, 1994, MOL CELL BIOL, V14, P4011, DOI 10.1128/MCB.14.6.4011; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; OETTMEIER W, 1991, PESTIC SCI, V33, P399, DOI 10.1002/ps.2780330402; PECKER I, 1992, P NATL ACAD SCI USA, V89, P4962, DOI 10.1073/pnas.89.11.4962; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791; Randolph-Anderson BL, 1998, PLANT MOL BIOL, V38, P839, DOI 10.1023/A:1006085026294; ROSSMANN MG, 1974, NATURE, V250, P194, DOI 10.1038/250194a0; SANDMANN G, 1989, Z NATURFORSCH C, V44, P787; Schaub P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039550; Seetharaman J, CRYSTAL STRUCTURE OX; Sizova I, 2001, GENE, V277, P221, DOI 10.1016/S0378-1119(01)00616-3; Stevens DR, 1996, MOL GEN GENET, V251, P23; Tran PT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042196; Vallon O, 2000, PROTEINS, V38, P95, DOI 10.1002/(SICI)1097-0134(20000101)38:1<95::AID-PROT10>3.0.CO;2-A; Vartak V, 1997, WEED SCI, V45, P374, DOI 10.1017/S0043174500093000; Vila M, 2008, PROCESS BIOCHEM, V43, P1147, DOI 10.1016/j.procbio.2008.06.014; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; WIERENGA RK, 1986, J MOL BIOL, V187, P101, DOI 10.1016/0022-2836(86)90409-2; Zhang Z, CRYSTAL STRUCTURE OX	70	13	13	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99894	10.1371/journal.pone.0099894	http://dx.doi.org/10.1371/journal.pone.0099894			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936791	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400051
J	Merezhko, M; Muggalla, P; Nykanen, NP; Yan, X; Sakha, P; Huttunen, HJ				Merezhko, Maria; Muggalla, Pranuthi; Nykanen, Niko-Petteri; Yan, Xu; Sakha, Prasanna; Huttunen, Henri J.			Multiplex Assay for Live-Cell Monitoring of Cellular Fates of Amyloid-beta Precursor Protein (APP)	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; A-BETA; SECRETASE CLEAVAGE; TERMINAL FRAGMENTS; ENDOCYTOSIS; INHIBITION; IDENTIFICATION; TRAFFICKING; METABOLISM; GENERATION	Amyloid-beta precursor protein (APP) plays a central role in pathogenesis of Alzheimer's disease. APP has a short half-life and undergoes complex proteolytic processing that is highly responsive to various stimuli such as changes in cellular lipid or energy homeostasis. Cellular trafficking of APP is controlled by its large protein interactome, including dozens of cytosolic adaptor proteins, and also by interactions with lipids. Currently, cellular regulation of APP is mostly studied based on appearance of APP-derived proteolytic fragments to conditioned media and cellular extracts. Here, we have developed a novel live-cell assay system based on several indirect measures that reflect altered APP trafficking and processing in cells. Protein-fragment complementation assay technology for detection of APP-BACE1 protein-protein interaction forms the core of the new assay. In a multiplex form, the assay can measure four endpoints: total cellular APP level, total secreted sAPP level in media, APP-BACE1 interaction in cells and in exosomes released by the cells. Functional validation of the assay with pharmacological and genetic tools revealed distinct patterns of cellular fates of APP, with immediate mechanistic implications. This new technology will facilitate functional genomics studies of late-onset Alzheimer's disease, drug discovery efforts targeting APP and characterization of the physiological functions of APP and its proteolytic fragments.	[Merezhko, Maria; Muggalla, Pranuthi; Nykanen, Niko-Petteri; Yan, Xu; Sakha, Prasanna; Huttunen, Henri J.] Univ Helsinki, Ctr Neurosci, Helsinki, Finland	University of Helsinki	Huttunen, HJ (corresponding author), Univ Helsinki, Ctr Neurosci, Helsinki, Finland.	Henri.Huttunen@helsinki.fi		Huttunen, Henri/0000-0002-9867-4438	Academy of Finland [218081, 263762, 126889]; Sigrid Juselius Foundation; Biocentrum Helsinki; Finnish Cultural Foundation; European Union [206918]	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Biocentrum Helsinki; Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); European Union(European Commission)	This work was supported by grants from the Academy of Finland (grant numbers 218081, 263762 and 126889), Sigrid Juselius Foundation, Biocentrum Helsinki and Finnish Cultural Foundation. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2011) under grant agreement nu 206918. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2008, MOL CELL PROTEOMICS, V7, P15, DOI 10.1074/mcp.M700077-MCP200; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Bodovitz S, 1996, J BIOL CHEM, V271, P4436; BUXBAUM JD, 1994, P NATL ACAD SCI USA, V91, P4489, DOI 10.1073/pnas.91.10.4489; Carey RM, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-30; De Strooper B, 2000, J CELL SCI, V113, P1857; Domingues SCTS, 2007, ANN NY ACAD SCI, V1096, P184, DOI 10.1196/annals.1397.085; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Ehehalt R, 2003, J CELL BIOL, V160, P113, DOI 10.1083/jcb.200207113; GABUZDA D, 1994, J BIOL CHEM, V269, P13623; Gandy S, 2005, J CLIN INVEST, V115, P1121, DOI 10.1172/JCI200525100; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Grbovic OM, 2003, J BIOL CHEM, V278, P31261, DOI 10.1074/jbc.M304122200; HAASS C, 1994, J BIOL CHEM, V269, P17741; Hicks DA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00189; Hill TA, 2009, J MED CHEM, V52, P3762, DOI 10.1021/jm900036m; Huttunen HJ, 2009, FASEB J, V23, P3819, DOI 10.1096/fj.09-134999; Huttunen HJ, 2009, J MOL NEUROSCI, V37, P6, DOI 10.1007/s12031-008-9088-0; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kimberly WT, 2001, J BIOL CHEM, V276, P40288, DOI 10.1074/jbc.C100447200; Kinoshita A, 2003, J CELL SCI, V116, P3339, DOI 10.1242/jcs.00643; KNOPS J, 1995, J BIOL CHEM, V270, P2419, DOI 10.1074/jbc.270.6.2419; Kohli BM, 2012, J PROTEOME RES, V11, P4075, DOI 10.1021/pr300123g; Koo EH, 1996, J CELL SCI, V109, P991; KOO EH, 1994, J BIOL CHEM, V269, P17386; Kouchi Z, 1998, EUR J BIOCHEM, V258, P291, DOI 10.1046/j.1432-1327.1998.2580291.x; Kyriazis GA, 2008, J BIOL CHEM, V283, P25492, DOI 10.1074/jbc.M802072200; Lichtenthaler SF, 2003, J BIOL CHEM, V278, P48713, DOI 10.1074/jbc.M303861200; Lin XL, 2000, P NATL ACAD SCI USA, V97, P1456, DOI 10.1073/pnas.97.4.1456; Liu Q, 2007, NEURON, V56, P66, DOI 10.1016/j.neuron.2007.08.008; Milhas D, 2010, FEBS LETT, V584, P1887, DOI 10.1016/j.febslet.2009.10.058; Muller UC, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006288; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; NORDSTEDT C, 1993, J BIOL CHEM, V268, P608; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Perez-Gonzalez R, 2012, J BIOL CHEM, V287, P43108, DOI 10.1074/jbc.M112.404467; Perreau VM, 2010, PROTEOMICS, V10, P2377, DOI 10.1002/pmic.200900773; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Puglielli L, 2003, J BIOL CHEM, V278, P19777, DOI 10.1074/jbc.M300466200; Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979; Ring S, 2007, J NEUROSCI, V27, P7817, DOI 10.1523/JNEUROSCI.1026-07.2007; Savina A, 2003, J BIOL CHEM, V278, P20083, DOI 10.1074/jbc.M301642200; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; Sittampalam G.S., 2004, ASSAY GUIDANCE MANUA; Small SA, 2005, ANN NEUROL, V58, P909, DOI 10.1002/ana.20667; Small SA, 2006, NEURON, V52, P15, DOI 10.1016/j.neuron.2006.09.001; Sullivan CP, 2011, NEUROBIOL DIS, V43, P338, DOI 10.1016/j.nbd.2011.04.002; Tesco G, 2007, NEURON, V54, P721, DOI 10.1016/j.neuron.2007.05.012; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Thinakaran G, 2008, J BIOL CHEM, V283, P29615, DOI 10.1074/jbc.R800019200; Thomas AV, 2008, METHODS, V44, P299, DOI 10.1016/j.ymeth.2007.02.003; Trajkovic K, 2008, SCIENCE, V319, P1244, DOI 10.1126/science.1153124; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Vella LJ, 2012, FASEB J, V26, P2930, DOI 10.1096/fj.11-200295; Vetrivel KS, 2006, NEUROLOGY, V66, pS69, DOI 10.1212/01.wnl.0000192107.17175.39; von Arnim CAF, 2006, J NEUROSCI, V26, P9913, DOI 10.1523/JNEUROSCI.2290-06.2006; Walsh DM, 2002, NATURE, V416, P535, DOI 10.1038/416535a; Wang W, 2014, FASEB J, V28, P849, DOI 10.1096/fj.13-239301; WEIDEMANN A, 1989, CELL, V57, P115, DOI 10.1016/0092-8674(89)90177-3; Wen L, 2011, J CELL BIOL, V195, P765, DOI 10.1083/jcb.201105109; Yang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069824; Yuyama K, 2012, J BIOL CHEM, V287, P10977, DOI 10.1074/jbc.M111.324616	63	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98619	10.1371/journal.pone.0098619	http://dx.doi.org/10.1371/journal.pone.0098619			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932508	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600009
J	Wang, YC; Lin, YK				Wang, Yu-Chun; Lin, Yu-Kai			Association between Temperature and Emergency Room Visits for Cardiorespiratory Diseases, Metabolic Syndrome-Related Diseases, and Accidents in Metropolitan Taipei	PLOS ONE			English	Article							HOSPITAL ADMISSIONS; HEAT WAVES; AMBIENT-TEMPERATURE; SEASONAL-VARIATION; AIR-POLLUTION; RENAL-DISEASE; WIND-CHILL; MORTALITY; IMPACT; RISK	Objective: This study evaluated risks of the emergency room visits (ERV) for cerebrovascular diseases, heart diseases, ischemic heart disease, hypertensive diseases, chronic renal failure (CRF), diabetes mellitus (DM), asthma, chronic airway obstruction not elsewhere classified (CAO), and accidents associated with the ambient temperature from 2000 to 2009 in metropolitan Taipei. Methods: The distributed lag non-linear model was used to estimate the cumulative relative risk (RR) and confidence interval (CI) of cause-specific ERV associated with daily temperature from lag 0 to lag 3 after controlling for potential confounders. Results: This study identified that temperatures related to the lowest risk of ERV was 26 degrees C for cerebrovascular diseases, 18 degrees C for CRF, DM, and accidents, and 30 degrees C for hypertensive diseases, asthma, and CAO. These temperatures were used as the reference temperatures to measure RR for the corresponding diseases. A low temperature (14 degrees C) increased the ERV risk for cerebrovascular diseases, hypertensive diseases, and asthma, with respective cumulative 4-day RRs of 1.56 (95% CI: 1.23, 1.97), 1.78 (95% CI: 1.37, 2.34), and 2.93 (95% CI: 1.26, 6.79). The effects were greater on, or after, lag one. At 32 degrees C, the cumulative 4-day RR for ERV was significant for CRF (RR = 2.36; 95% CI: 1.33, 4.19) and accidents (RR = 1.23; 95% CI: 1.14, 1.33) and the highest RR was seen on lag 0 for CRF (RR = 1.69; 95% CI: 1.01, 3.58), DM (RR = 1.69; 95% CI: 1.09, 2.61), and accidents (RR = 1.19; 95% CI: 1.11, 1.27). Conclusions: Higher temperatures are associated with the increased ERV risks for CRF, DM, and accidents and lower temperatures with the increased ERV risks for cerebrovascular diseases, hypertensive diseases, and asthma in the subtropical metropolitan.	[Wang, Yu-Chun] Chung Yuan Christian Univ, Dept Bioenvironm Engn, Coll Engn, Jungli City, Taiwan; [Wang, Yu-Chun] Chung Yuan Christian Univ, Res Ctr Environm Risk Management, Jungli City, Taiwan; [Lin, Yu-Kai] Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Environm & Occupat Med & Epidemiol Program, Boston, MA 02115 USA; [Lin, Yu-Kai] Natl Taiwan Univ, Inst Environm Hlth, Coll Publ Hlth, Taipei 10764, Taiwan	Chung Yuan Christian University; Chung Yuan Christian University; Harvard University; Harvard T.H. Chan School of Public Health; National Taiwan University	Lin, YK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Environm Hlth, Environm & Occupat Med & Epidemiol Program, Boston, MA 02115 USA.	yul620@mail.harvard.edu	王, 玉純/AAP-9936-2021; Wang, Yu-Chun/AAP-8150-2021; Lin, Yu-Kai/AAQ-4642-2020	王, 玉純/0000-0002-4797-7447; 	Taiwan National Science Council [NSC 99-2221-E-033-052, NSC 100-2621-M-039-001, NSC 102-2621-M-033-001]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan)	The present study was supported by the Taiwan National Science Council (grants NSC 99-2221-E-033-052, NSC 100-2621-M-039-001 and NSC 102-2621-M-033-001). All the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2008, EMERG MED J, V25, P769, DOI 10.1136/emj.2007.056960; Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Andersen ZJ, 2012, THORAX, V67, P6, DOI 10.1136/thoraxjnl-2011-200711; Anderson BG, 2009, EPIDEMIOLOGY, V20, P205, DOI 10.1097/EDE.0b013e318190ee08; Andrade H, 2011, INT J BIOMETEOROL, V55, P665, DOI 10.1007/s00484-010-0379-0; Astrand PO, 2003, TXB WORK PHYSL PHYSL, V4th; Astrom DO, 2011, MATURITAS, V69, P99, DOI 10.1016/j.maturitas.2011.03.008; Basu R, 2012, EPIDEMIOLOGY, V23, P813, DOI 10.1097/EDE.0b013e31826b7f97; BINDER C, 1984, DIABETES CARE, V7, P188, DOI 10.2337/diacare.7.2.188; Bureau of National Health Insurance, 2001, NAT HLTH INS PROF; Carder M, 2005, OCCUP ENVIRON MED, V62, P702, DOI 10.1136/oem.2004.016394; Centers for Disease Control and Prevention (CDC), 2004, MMWR Morb Mortal Wkly Rep, V53, P172; Cheng MF, 2009, INHAL TOXICOL, V21, P1092, DOI 10.3109/08958370902744855; Curriero FC, 2002, AM J EPIDEMIOL, V155, P80, DOI 10.1093/aje/155.1.80; D'Ippoliti D, 2010, ENVIRON HEALTH-GLOB, V9, DOI 10.1186/1476-069X-9-37; Garcia-Donaire JA, 2010, CURR HYPERTENS REP, V12, P307, DOI 10.1007/s11906-010-0129-z; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2011, EPIDEMIOLOGY, V22, P68, DOI 10.1097/EDE.0b013e3181fdcd99; GILL JS, 1988, J CLIN EPIDEMIOL, V41, P225, DOI 10.1016/0895-4356(88)90125-4; Goldberg MS, 2011, ENVIRON RES, V111, P853, DOI 10.1016/j.envres.2011.05.022; Green RS, 2010, INT J PUBLIC HEALTH, V55, P113, DOI 10.1007/s00038-009-0076-0; Grineski SE, 2011, ENVIRON RES, V111, P1148, DOI 10.1016/j.envres.2011.06.007; Hajat S, 2006, EPIDEMIOLOGY, V17, P632, DOI 10.1097/01.ede.0000239688.70829.63; Hansen AL, 2008, INT J EPIDEMIOL, V37, P1359, DOI 10.1093/ije/dyn165; Honda Yasushi, 2007, Environmental Health and Preventive Medicine, V12, P209, DOI 10.1265/ehpm.12.209; Hong YC, 2012, SCI TOTAL ENVIRON, V435, P74, DOI 10.1016/j.scitotenv.2012.02.070; IPCC (Intergovernmental Panel on Climate Change), 2013, CLIMATE CHANGE 2013; Keatinge W R, 1995, Arctic Med Res, V54 Suppl 2, P16; Knowlton K, 2009, ENVIRON HEALTH PERSP, V117, P61, DOI 10.1289/ehp.11594; Kovats RS, 2004, OCCUP ENVIRON MED, V61, P893, DOI 10.1136/oem.2003.012047; KUNST AE, 1993, AM J EPIDEMIOL, V137, P331, DOI 10.1093/oxfordjournals.aje.a116680; Kuo HW, 2007, AM J KIDNEY DIS, V49, P46, DOI 10.1053/j.ajkd.2006.10.007; Lavigne E, 2014, ENVIRON HEALTH-GLOB, V13, DOI 10.1186/1476-069X-13-5; Lin S, 2009, EPIDEMIOLOGY, V20, P738, DOI 10.1097/EDE.0b013e3181ad5522; Lin YK, 2013, SCI TOTAL ENVIRON, V443, P812, DOI 10.1016/j.scitotenv.2012.10.108; Lin YK, 2013, ENVIRON RES, V120, P109, DOI 10.1016/j.envres.2012.09.002; Lin YK, 2011, ENVIRON RES, V111, P1156, DOI 10.1016/j.envres.2011.06.008; Linares C, 2008, EUR J PUBLIC HEALTH, V18, P317, DOI 10.1093/eurpub/ckm108; Mastrangelo G, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-200; Michelozzi P, 2009, AM J RESP CRIT CARE, V179, P383, DOI 10.1164/rccm.200802-217OC; Ministry of Health and Welfare, 2008, 2008 STAT CAUS DEATH; Murphy T., 2006, Morbidity and Mortality Weekly Report, V55, P282; National health insurance research database Taiwan, 2014, LONG HLTH INS DAT; Ockene IS, 2004, ARCH INTERN MED, V164, P863, DOI 10.1001/archinte.164.8.863; Ostro B, 2010, AM J EPIDEMIOL, V172, P1053, DOI 10.1093/aje/kwq231; Peel JL, 2005, EPIDEMIOLOGY, V16, P164, DOI 10.1097/01.ede.0000152905.42113.db; Pudpong N, 2011, SCI TOTAL ENVIRON, V409, P5260, DOI 10.1016/j.scitotenv.2011.09.005; Rocklov J, 2009, GLOB HLTH ACTION, V2; Semenza JC, 1999, AM J PREV MED, V16, P269, DOI 10.1016/S0749-3797(99)00025-2; Siple Paul A., 1945, PROC AMER PHIL SOC, V89, P177; Spencer-Hwang R, 2011, AM J KIDNEY DIS, V58, P608, DOI 10.1053/j.ajkd.2011.05.017; Taiwan Central Weather Bureau, 2014, CENTR WEATH BUR ONL; Taiwan Environmental Protection Administration, 2014, TAIW AIR QUAL MON NE; Theoharatos G, 2010, ENVIRON RES, V110, P152, DOI 10.1016/j.envres.2009.12.002; Tong SL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012155; Wang XY, 2012, OCCUP ENVIRON MED, V69, P163, DOI 10.1136/oem.2010.062141; Wang YC, 2012, SCI TOTAL ENVIRON, V416, P97, DOI 10.1016/j.scitotenv.2011.11.073; Yamada S, 2010, INTERNAL MED, V49, P171, DOI 10.2169/internalmedicine.49.2661; Yang WC, 2008, NEPHROL DIAL TRANSPL, V23, P3977, DOI 10.1093/ndt/gfn406	59	36	36	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99599	10.1371/journal.pone.0099599	http://dx.doi.org/10.1371/journal.pone.0099599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932702	Green Published, gold			2022-12-27	WOS:000337738600045
J	Das, S; Ghosal, S; Sen, R; Chakrabarti, J				Das, Shaoli; Ghosal, Suman; Sen, Rituparno; Chakrabarti, Jayprokas			InCeDB: Database of Human Long Noncoding RNA Acting as Competing Endogenous RNA	PLOS ONE			English	Article							TUMOR-SUPPRESSOR; CLIP-SEQ; EVOLUTION; CERNA; DIFFERENTIATION; CONSERVATION; EXPRESSION; NETWORKS; POLYCOMB; STARBASE	Long noncoding RNA (lncRNA) influences post-transcriptional regulation by interfering with the microRNA (miRNA) pathways, acting as competing endogenous RNA (ceRNA). These lncRNAs have miRNA responsive elements (MRE) in them, and control endogenous miRNAs available for binding with their target mRNAs, thus reducing the repression of these mRNAs. lnCeDB provides a database of human lncRNAs (from GENCODE 19 version) that can potentially act as ceRNAs. The putative mRNA targets of human miRNAs and the targets mapped to AGO clipped regions are collected from TargetScan and StarBase respectively. The lncRNA targets of human miRNAs (up to GENCODE 11) are downloaded from miRCode database. miRNA targets on the rest of the GENCODE 19 lncRNAs are predicted by our algorithm for finding seed-matched target sites. These putative miRNA-lncRNA interactions are mapped to the Ago interacting regions within lncRNAs. To find out the likelihood of an lncRNA-mRNA pair for actually being ceRNA we take recourse to two methods. First, a ceRNA score is calculated from the ratio of the number of shared MREs between the pair with the total number of MREs of the individual candidate gene. Second, the P-value for each ceRNA pair is determined by hypergeometric test using the number of shared miRNAs between the ceRNA pair against the number of miRNAs interacting with the individual RNAs. Typically, in a pair of RNAs being targeted by common miRNA(s), there should be a correlation of expression so that the increase in level of one ceRNA results in the increased level of the other ceRNA. Near-equimolar concentration of the competing RNAs is associated with more profound ceRNA effect. In lnCeDB one can not only browse for lncRNA-mRNA pairs having common targeting miRNAs, but also compare the expression of the pair in 22 human tissues to estimate the chances of the pair for actually being ceRNAs. Availability: Downloadable freely from http://gyanxet-beta. com/ lncedb/.	[Das, Shaoli; Ghosal, Suman; Chakrabarti, Jayprokas] Indian Assoc Cultivat Sci, Computat Biol Grp, Kolkata, W Bengal, India; [Sen, Rituparno; Chakrabarti, Jayprokas] Gyanxet, Kolkata, W Bengal, India	Department of Science & Technology (India); Indian Association for the Cultivation of Science (IACS) - Jadavpur	Chakrabarti, J (corresponding author), Indian Assoc Cultivat Sci, Computat Biol Grp, Kolkata, W Bengal, India.	j.chakrabarti@gyanxet.com	Das, Shaoli/AAE-6879-2020; Sen, Rituparno/AAX-9937-2021; Ghosal, Suman/AAW-9012-2020	Das, Shaoli/0000-0002-3428-1862; Sen, Rituparno/0000-0001-5980-5565; Ghosal, Suman/0000-0002-3772-2336	intramural funds of their host institutes; Indian Association for the Cultivation of Science; Gyanxet	intramural funds of their host institutes; Indian Association for the Cultivation of Science(Department of Science & Technology (India)Indian Association for the Cultivation of Science (IACS) - Jadavpur); Gyanxet	The authors received financial support from the intramural funds of their host institutes. SD, SG and JC received financial support from the Indian Association for the Cultivation of Science. RS was hosted by Gyanxet, an independent non-profit body. Funds for the website were contributed by Gyanxet. The fund giving organizations, namely, the Indian Association for the Cultivation of Science and Gyanxet, had no role in the design, data collection and analysis, the decision to publish, or in the preparation of the manuscript.	Aguilo F, 2011, CANCER RES, V71, P5365, DOI 10.1158/0008-5472.CAN-10-4379; Ala U, 2013, P NATL ACAD SCI USA, V110, P7154, DOI 10.1073/pnas.1222509110; Amaral PP, 2008, MAMM GENOME, V19, P454, DOI 10.1007/s00335-008-9136-7; Bhartiya D, 2013, DATABASE-OXFORD, DOI 10.1093/database/bat034; Braconi C, 2011, ONCOGENE, V30, P4750, DOI 10.1038/onc.2011.193; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Enright AJ, 2004, GENOME BIOL, V5; Fan M, 2013, EXP THER MED, V5, P1143, DOI 10.3892/etm.2013.933; Ghosal Suman, 2013, Frontiers in Genetics, V4, P283, DOI 10.3389/fgene.2013.00283; Ghosal S, 2013, STEM CELLS DEV, V22, P2240, DOI 10.1089/scd.2013.0014; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hansen TB, 2013, CANCER RES, V73, P5609, DOI 10.1158/0008-5472.CAN-13-1568; Hawkins PG, 2010, TRANSCR-AUSTIN, V1, P165, DOI 10.4161/trns.1.3.13332; Jalali S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053823; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Karolchik D., 2012, CURR PROTOC BIOINFOR, V40; Karreth FA, 2011, CELL, V147, P382, DOI 10.1016/j.cell.2011.09.032; Lam LT, 2010, MOL CANCER THER, V9, P2943, DOI 10.1158/1535-7163.MCT-10-0427; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Lv XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063516; Marques AC, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-11-r124; Menigatti M, 2013, ONCOGENESIS, V2, DOI 10.1038/oncsis.2013.21; Meola N, 2012, RNA, V18, P111, DOI 10.1261/rna.029454.111; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Mestdagh P, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr646; Ng SY, 2012, EMBO J, V31, P522, DOI 10.1038/emboj.2011.459; Pang KC, 2006, TRENDS GENET, V22, P1, DOI 10.1016/j.tig.2005.10.003; Paralkar VR, 2011, GENE DEV, V25, P2555, DOI 10.1101/gad.183020.111; Paraskevopoulou MD, 2013, NUCLEIC ACIDS RES, V41, pD239, DOI 10.1093/nar/gks1246; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Sarver AL, 2012, BIOINFORMATION, V8, P731, DOI 10.6026/97320630008731; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tay Y, 2014, NATURE, V505, P344, DOI 10.1038/nature12986; Tay Y, 2011, CELL, V147, P344, DOI 10.1016/j.cell.2011.09.029; Tripathi V, 2010, MOL CELL, V39, P925, DOI 10.1016/j.molcel.2010.08.011; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Yang JH, 2011, NUCLEIC ACIDS RES, V39, pD202, DOI 10.1093/nar/gkq1056; Zhao J, 2008, SCIENCE, V322, P750, DOI 10.1126/science.1163045	44	126	129	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98965	10.1371/journal.pone.0098965	http://dx.doi.org/10.1371/journal.pone.0098965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926662	gold, Green Submitted, Green Published			2022-12-27	WOS:000338278100024
J	Qin, YB; Xin, ZB; Yu, XX; Xiao, YL				Qin, Yunbin; Xin, Zhongbao; Yu, Xinxiao; Xiao, Yuling			Influence of Vegetation Restoration on Topsoil Organic Carbon in a Small Catchment of the Loess Hilly Region, China	PLOS ONE			English	Article							LAND-USE CHANGE; SOIL PROPERTIES; AGRICULTURAL SOILS; PLATEAU; EROSION; STOCKS; SEQUESTRATION; AFFORESTATION; DYNAMICS; NITROGEN	Understanding effects of land-use changes driven by the implementation of the "Grain for Green'' project and the corresponding changes in soil organic carbon (SOC) storage is important in evaluating the environmental benefits of this ecological restoration project. The goals of this study were to quantify the current soil organic carbon density (SOCD) in different land-use types [cultivated land, abandoned land (cessation of farming), woodland, wild grassland and orchards] in a catchment of the loess hilly and gully region of China to evaluate the benefits of SOC sequestration achieved by vegetation restoration in the past 10 years as well as to discuss uncertain factors affecting future SOC sequestration. Based on soil surveys (N = 83) and laboratory analyses, the results show that the topsoil (0-20 cm) SOCD was 20.44 Mg/ha in this catchment. Using the SOCD in cultivated lands (19.08 Mg/ha) as a reference, the SOCD in woodlands and abandoned lands was significantly higher by 33.81% and 8.49%, respectively, whereas in orchards, it was lower by 10.80%. The correlation analysis showed that SOC and total nitrogen (TN) were strongly correlated (R-2 = 0.98) and that the average C:N (SOC:TN) ratio was 9.69. With increasing years since planting, the SOCD in woodlands showed a tendency to increase; however, no obvious difference was observed in orchards. A high positive correlation was found between SOCD and elevation (R-2 = 0.395), but a low positive correlation was found between slope and SOCD (R-2 = 0.170, P = 0.127). In the past 10 years of restoration, SOC storage did not increase significantly (2.74% or 3706.46 t) in the catchment where the conversion of cultivated land to orchards was the primary restoration pattern. However, the potential contribution of vegetation restoration to SOC sequestration in the next several decades would be massive if the woodland converted from the cropland is well managed and maintained.	[Qin, Yunbin; Xin, Zhongbao; Yu, Xinxiao; Xiao, Yuling] Beijing Forestry Univ, Inst Soil & Water Conservat, Beijing, Peoples R China	Beijing Forestry University; Chinese Academy of Sciences; Institute of Soil & Water Conservation (ISWC), CAS	Xin, ZB (corresponding author), Beijing Forestry Univ, Inst Soil & Water Conservat, Beijing, Peoples R China.	xinzhongbao@126.com	Xin, Zhongbao/G-5404-2010	XIN, zhongbao/0000-0002-1653-8679	Fundamental Research Funds for the Central Universities [NoTD2011-2]; Open Foundation of Key Laboratory of Soil and Water Loss Process and Control on the Loess Plateau of Ministry of Water Resources [201301]; National Natural Science Foundation of China [41001362]; Beijing Forest University [201210022013]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Open Foundation of Key Laboratory of Soil and Water Loss Process and Control on the Loess Plateau of Ministry of Water Resources; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Forest University	This study was supported by the Fundamental Research Funds for the Central Universities (NoTD2011-2), the Open Foundation of Key Laboratory of Soil and Water Loss Process and Control on the Loess Plateau of Ministry of Water Resources (201301), the National Natural Science Foundation of China (No. 41001362) and the College Student Scientific Research Training Project of Beijing Forest University (No. 201210022013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Batterman SA, 2013, NATURE, V502, P224, DOI 10.1038/nature12525; Cao SX, 2009, LAND USE POLICY, V26, P1182, DOI 10.1016/j.landusepol.2009.02.006; Chang RY, 2011, ENVIRON MANAGE, V48, P1158, DOI 10.1007/s00267-011-9682-8; Chartier MP, 2013, J ARID ENVIRON, V88, P43, DOI 10.1016/j.jaridenv.2012.08.011; Chen HS, 2008, GEODERMA, V143, P91, DOI 10.1016/j.geoderma.2007.10.013; Chen LD, 2007, ECOL RES, V22, P641, DOI 10.1007/s11284-006-0065-1; DeGryze S, 2004, GLOBAL CHANGE BIOL, V10, P1120, DOI 10.1111/j.1529-8817.2003.00786.x; Deng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071923; Don A, 2011, GLOBAL CHANGE BIOL, V17, P1658, DOI 10.1111/j.1365-2486.2010.02336.x; Duan FL, 2007, RURAL EC, P16; Feng XM, 2010, GEOMORPHOLOGY, V118, P239, DOI 10.1016/j.geomorph.2010.01.004; Fu B.J., 2002, LAND USE STRUCTURE E, P1; FU BJ, 1989, SOIL USE MANAGE, V5, P76, DOI 10.1111/j.1475-2743.1989.tb00765.x; Fu XL, 2010, GEODERMA, V155, P31, DOI 10.1016/j.geoderma.2009.11.020; Gong J, 2006, LAND DEGRAD DEV, V17, P453, DOI 10.1002/ldr.701; Gregorich EG, 1998, SOIL TILL RES, V47, P291, DOI 10.1016/S0167-1987(98)00117-2; Guimaraes DV, 2013, SOIL TILL RES, V126, P177, DOI 10.1016/j.still.2012.07.010; Guo Guangfen, 2006, Shengtaixue Zazhi, V25, P435; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Houghton RA, 1999, TELLUS B, V51, P298, DOI 10.1034/j.1600-0889.1999.00013.x; Huang C., 2000, SOIL SCI; Institute of Soil Science Chinese Academy of Sciences (ISSCAS), 1978, PHYS CHEM AN METH SO, P7; *INT PAN CLIM CHAN, 2007, CLIM CHANG 2007 SCI; Laganiere J, 2010, GLOBAL CHANGE BIOL, V16, P439, DOI 10.1111/j.1365-2486.2009.01930.x; Lal R, 2005, FOREST ECOL MANAG, V220, P242, DOI 10.1016/j.foreco.2005.08.015; Lal R, 2004, NUTR CYCL AGROECOSYS, V70, P103, DOI 10.1023/B:FRES.0000048480.24274.0f; Lal R, 2003, ENVIRON INT, V29, P437, DOI 10.1016/S0160-4120(02)00192-7; Lal R, 2009, EUR J SOIL SCI, V60, P158, DOI 10.1111/j.1365-2389.2008.01114.x; Leifeld J, 2005, AGR ECOSYST ENVIRON, V105, P255, DOI 10.1016/j.agee.2004.03.006; Li DJ, 2012, NEW PHYTOL, V195, P172, DOI 10.1111/j.1469-8137.2012.04150.x; [李裕元 LI YuYuan], 2007, [生态学报, Acta Ecologica Sinica], V27, P2279; Li YuYuan, 2006, Acta Prataculturae Sinica, V15, P85; Lu N, 2013, BIOGEOSCIENCES DISCU, V10, P11181, DOI DOI 10.5194/BGD-10-11181-2013; Lu YH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031782; Luo YQ, 2006, ECOLOGY, V87, P53, DOI 10.1890/04-1724; Morris SJ, 2007, GLOBAL CHANGE BIOL, V13, P1145, DOI 10.1111/j.1365-2486.2007.01359.x; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; [牛俊杰 NIU Junjie], 2007, [地理研究, Geographical Research], V26, P773; Novara A, 2013, GEODERMA, V193, P213, DOI 10.1016/j.geoderma.2012.08.036; Pan ZB, 2012, RES SOIL WATER CONSE, V19, P298; [潘占兵 Pan Zhanbing], 2012, [水土保持研究, Research of Soil and Water Conservation], V19, P287; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Powlson D, 2005, NATURE, V433, P204, DOI 10.1038/433204a; Raiesi F, 2012, PLANT SOIL, V351, P161, DOI 10.1007/s11104-011-0941-5; Sauer TJ, 2012, PLANT SOIL, V360, P375, DOI 10.1007/s11104-012-1258-8; Schlesinger WH, 1999, SCIENCE, V284, P2095, DOI 10.1126/science.284.5423.2095; Shi H, 2000, J ARID ENVIRON, V45, P9, DOI 10.1006/jare.1999.0618; Smith P, 2008, PHILOS T R SOC B, V363, P789, DOI 10.1098/rstb.2007.2184; Umali BP, 2012, CATENA, V93, P38, DOI 10.1016/j.catena.2012.01.010; Wang BQ, 1999, SOIL EROSION SOIL WA, V5, P18; Wang Li, 2004, World Forestry Research, V17, P57; Wang QX, 2012, GLOBAL PLANET CHANGE, V92-93, P138, DOI 10.1016/j.gloplacha.2012.05.010; Wang YF, 2011, CATENA, V85, P58, DOI 10.1016/j.catena.2010.12.003; Wang Z, 2012, CATENA, V99, P26, DOI 10.1016/j.catena.2012.07.003; Wei J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040123; Xin ZB, 2011, REG ENVIRON CHANGE, V11, P149, DOI 10.1007/s10113-010-0127-3; Xue Sha, 2011, Scientia Agricultura Sinica, V44, P3154; Yang YuLin, 2008, Plant Nutrition and Fertilizer Science, V14, P685; [余新晓 Yu Xinxiao], 2009, [农业工程学报, Transactions of the Chinese Society of Agricultural Engineering], V25, P219; Zhao Yang, 2013, Journal of Beijing Forestry University, V35, P39; Zheng FL, 2006, PEDOSPHERE, V16, P420, DOI 10.1016/S1002-0160(06)60071-4; Zhou Yan, 2008, Shengtaixue Zazhi, V27, P1901; ZOU HY, 1998, RES SOIL WATER CONSE, V5, P126	63	16	17	3	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e94489	10.1371/journal.pone.0094489	http://dx.doi.org/10.1371/journal.pone.0094489			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926873	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100002
J	Singhal, V; Lawson, EA; Ackerman, KE; Fazeli, PK; Clarke, H; Lee, H; Eddy, K; Marengi, DA; Derrico, NP; Bouxsein, ML; Misra, M				Singhal, Vibha; Lawson, Elizabeth A.; Ackerman, Kathryn E.; Fazeli, Pouneh K.; Clarke, Hannah; Lee, Hang; Eddy, Kamryn; Marengi, Dean A.; Derrico, Nicholas P.; Bouxsein, Mary L.; Misra, Madhusmita			Irisin Levels Are Lower in Young Amenorrheic Athletes Compared with Eumenorrheic Athletes and Non-Athletes and Are Associated with Bone Density and Strength Estimates	PLOS ONE			English	Article							GROWTH-FACTOR 21; BROWN ADIPOSE-TISSUE; ANOREXIA-NERVOSA; MINERAL DENSITY; EXERCISE; OBESITY; SERUM; WOMEN; FGF21; MICROARCHITECTURE	Irisin and FGF21 are novel hormones implicated in the "browning'' of white fat, thermogenesis, and energy homeostasis. However, there are no data regarding these hormones in amenorrheic athletes (AA) (a chronic energy deficit state) compared with eumenorrheic athletes (EA) and non-athletes. We hypothesized that irisin and FGF21 would be low in AA, an adaptive response to low energy stores. Furthermore, because (i) brown fat has positive effects on bone, and (ii) irisin and FGF21 may directly impact bone, we hypothesized that bone density, structure and strength would be positively associated with these hormones in athletes and non-athletes. To test our hypotheses, we studied 85 females, 14-21 years [38 AA, 24 EA and 23 non-athletes (NA)]. Fasting serum irisin and FGF21 were measured. Body composition and bone density were assessed using dual energy X-ray absorptiometry, bone microarchitecture using high resolution peripheral quantitative CT, strength estimates using finite element analysis, resting energy expenditure (REE) using indirect calorimetry and time spent exercising/week by history. Subjects did not differ for pubertal stage. Fat mass was lowest in AA. AA had lower irisin and FGF21 than EA and NA, even after controlling for fat and lean mass. Across subjects, irisin was positively associated with REE and bone density Z-scores, volumetric bone mineral density (total and trabecular), stiffness and failure load. FGF21 was negatively associated with hours/week of exercise and cortical porosity, and positively with fat mass and cortical volumetric bone density. Associations of irisin (but not FGF21) with bone parameters persisted after controlling for potential confounders. In conclusion, irisin and FGF21 are low in AA, and irisin (but not FGF21) is independently associated with bone density and strength in athletes.	[Singhal, Vibha; Lawson, Elizabeth A.; Ackerman, Kathryn E.; Fazeli, Pouneh K.; Clarke, Hannah; Eddy, Kamryn; Marengi, Dean A.; Misra, Madhusmita] Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA; [Singhal, Vibha; Lawson, Elizabeth A.; Ackerman, Kathryn E.; Fazeli, Pouneh K.; Clarke, Hannah; Lee, Hang; Eddy, Kamryn; Marengi, Dean A.; Derrico, Nicholas P.; Bouxsein, Mary L.; Misra, Madhusmita] Harvard Univ, Sch Med, Boston, MA USA; [Singhal, Vibha; Misra, Madhusmita] Massachusetts Gen Hosp Children, Pediat Endocrine Unit, Boston, MA USA; [Ackerman, Kathryn E.] Boston Childrens Hosp, Div Sports Med, Boston, MA USA; [Lee, Hang] Massachusetts Gen Hosp, Dept Biostat, Boston, MA 02114 USA; [Eddy, Kamryn] Massachusetts Gen Hosp, Harris Ctr, Boston, MA 02114 USA; [Derrico, Nicholas P.; Bouxsein, Mary L.] Massachusetts Gen Hosp, Div Endocrine, Boston, MA 02114 USA; [Bouxsein, Mary L.] Beth Israel Deaconess Med Ctr, Dept Orthoped Surg, Boston, MA 02215 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center	Misra, M (corresponding author), Massachusetts Gen Hosp, Neuroendocrine Unit, Boston, MA 02114 USA.	mmisra@partners.org	Singhal, Vibha/AAN-1432-2021; Singhal, Vibha/AAP-3792-2020; Misra, Madhusmita/X-8807-2018	Misra, Madhusmita/0000-0002-9405-2981; Lawson, Elizabeth/0000-0001-8619-3349	NIH [UL1 RR025758, R01 HD060827, K23 MH092560, K24HD071843]; Massachusetts General Hospital Claflin Distinguished Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD071843, R01HD060827] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K23DK094820, P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH092560] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Massachusetts General Hospital Claflin Distinguished Scholar Award; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was funded by NIH Grants UL1 RR025758, R01 HD060827, K23 MH092560; K24HD071843; and Massachusetts General Hospital Claflin Distinguished Scholar Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN K, 2012, BONE IN PRESS; Ackerman KE, 2011, J CLIN ENDOCR METAB, V96, P3123, DOI 10.1210/jc.2011-1614; Anastasilakis AD, 2014, OSTEOPOROSIS INT, V25, P1633, DOI 10.1007/s00198-014-2673-x; BLUHER S, 2014, OBESITY SILVER SPRIN; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Bredella MA, 2012, J CLIN ENDOCR METAB, V97, pE584, DOI 10.1210/jc.2011-2246; Colaianni G, 2014, INT J ENDOCRINOL, V2014, DOI 10.1155/2014/902186; Cuevas-Ramos D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038022; Cuevas-Ramos D, 2010, EUR J ENDOCRINOL, V163, P469, DOI 10.1530/EJE-10-0454; Dostalova I, 2008, J CLIN ENDOCR METAB, V93, P3627, DOI 10.1210/jc.2008-0746; Fazeli PK, 2013, OSTEOPOROSIS INT, V24, P2433, DOI 10.1007/s00198-013-2353-2; FISHER FM, GENES DEV, V26, P271; Fletcher JA, 2012, APPL PHYSIOL NUTR ME, V37, P1054, DOI [10.1139/H2012-091, 10.1139/h2012-091]; Gorar S, 2010, GYNECOL ENDOCRINOL, V26, P819, DOI 10.3109/09513590.2010.487587; Harris JA, 1918, P NATL ACAD SCI USA, V4, P370, DOI 10.1073/pnas.4.12.370; Hecksteden A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-235; Hofmann T, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2013.00202; Huh JY, 2012, METABOLISM, V61, P1725, DOI 10.1016/j.metabol.2012.09.002; Ishida K, 2013, BIOCHEM BIOPH RES CO, V432, P677, DOI 10.1016/j.bbrc.2013.02.019; Kim KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063517; Kurdiova T, 2014, J PHYSIOL-LONDON, V592, P1091, DOI 10.1113/jphysiol.2013.264655; Lawson EA, 2013, EUR J ENDOCRINOL, V168, P457, DOI 10.1530/EJE-12-0869; Lee P, 2013, OSTEOPOROSIS INT, V24, P1513, DOI 10.1007/s00198-012-2110-y; LEE P, 2013, OSTEOPOROS INT; LEE P, J CLIN ENDOCRINOL ME, V98, pE98; Lee P, 2014, CELL METAB, V19, P302, DOI 10.1016/j.cmet.2013.12.017; Moreno-Navarrete JM, 2013, J CLIN ENDOCR METAB, V98, pE769, DOI 10.1210/jc.2012-2749; Miller KK, 2004, J CLIN ENDOCR METAB, V89, P525, DOI 10.1210/jc.2003-030680; Norheim F, 2014, FEBS J, V281, P739, DOI 10.1111/febs.12619; Park KH, 2013, J CLIN ENDOCR METAB, V98, P4899, DOI 10.1210/jc.2013-2373; Peter PR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094463; Ponrartana S, 2012, J CLIN ENDOCR METAB, V97, P2693, DOI 10.1210/jc.2012-1589; REINEHR T, J CLIN ENDOCRINOL ME, V97, P2143; SAHIN SB, 2014, SCAND J CLIN LAB INV; Shen Y, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-124; Stengel A, 2013, PEPTIDES, V39, P125, DOI 10.1016/j.peptides.2012.11.014; Wei W, 2012, P NATL ACAD SCI USA, V109, P3143, DOI 10.1073/pnas.1200797109; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; Yang SJ, 2011, CLIN ENDOCRINOL, V75, P464, DOI 10.1111/j.1365-2265.2011.04078.x; ZHANG J, 2013, ASBMR 2013; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476	41	73	75	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100218	10.1371/journal.pone.0100218	http://dx.doi.org/10.1371/journal.pone.0100218			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926783	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100121
J	Stamellou, E; Fontana, J; Wedel, J; Ntasis, E; Sticht, C; Becker, A; Pallavi, P; Wolf, K; Kramer, BK; Hafner, M; van Son, WJ; Yard, BA				Stamellou, Eleni; Fontana, Johann; Wedel, Johannes; Ntasis, Emmanouil; Sticht, Carsten; Becker, Anja; Pallavi, Prama; Wolf, Kerstin; Kraemer, Bernhard K.; Hafner, Mathias; van Son, Willem J.; Yard, Benito A.			N-Octanoyl Dopamine Treatment of Endothelial Cells Induces the Unfolded Protein Response and Results in Hypometabolism and Tolerance to Hypothermia	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; ER-STRESS; IN-VITRO; MOLECULAR CHAPERONES; PHENOLIC-COMPOUNDS; KINASE; ATF6; ADAPTATION; APOPTOSIS; INJURY	Aim: N-acyl dopamines (NADD) are gaining attention in the field of inflammatory and neurological disorders. Due to their hydrophobicity, NADD may have access to the endoplasmic reticulum (ER). We therefore investigated if NADD induce the unfolded protein response (UPR) and if this in turn influences cell behaviour. Methods: Genome wide gene expression profiling, confirmatory qPCR and reporter assays were employed on human umbilical vein endothelial cells (HUVEC) to validate induction of UPR target genes and UPR sensor activation by N-octanoyl dopamine (NOD). Intracellular ATP, apoptosis and induction of thermotolerance were used as functional parameters to assess adaptation of HUVEC. Results: NOD, but not dopamine dose dependently induces the UPR. This was also found for other synthetic NADD. Induction of the UPR was dependent on the redox activity of NADD and was not caused by selective activation of a particular UPR sensor. UPR induction did not result in cell apoptosis, yet NOD strongly impaired cell proliferation by attenuation of cells in the S-G2/M phase. Long-term treatment of HUVEC with low NOD concentration showed decreased intracellular ATP concentration paralleled with activation of AMPK. These cells were significantly more resistant to cold inflicted injury. Conclusions: We provide for the first time evidence that NADD induce the UPR in vitro. It remains to be assessed if UPR induction is causally associated with hypometabolism and thermotolerance. Further pharmacokinetic studies are warranted to address if the NADD concentrations used in vitro can be obtained in vivo and if this in turn shows therapeutic efficacy.	[Stamellou, Eleni; Wedel, Johannes; Ntasis, Emmanouil; Pallavi, Prama; Kraemer, Bernhard K.; Yard, Benito A.] Heidelberg Univ, Med Fac Mannheim, Med Dept 5, Mannheim, Germany; [Fontana, Johann] Ruhr Univ Bochum, Dept Neurosurg, Bochum, Germany; [Sticht, Carsten] Heidelberg Univ, Med Fac Mannheim, Med Res Ctr ZMF, Mannheim, Germany; [Becker, Anja; Wolf, Kerstin; Hafner, Mathias] Mannheim Univ Appl Sci, Inst Mol & Cellular Biol, Mannheim, Germany; [van Son, Willem J.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands	Ruprecht Karls University Heidelberg; Ruhr University Bochum; Ruprecht Karls University Heidelberg; University of Groningen	Stamellou, E (corresponding author), Heidelberg Univ, Med Fac Mannheim, Med Dept 5, Mannheim, Germany.	stamellou.eleni@googlemail.com		Stamellou, Eleni/0000-0001-7472-4907; Wedel, Johannes/0000-0002-3490-8477	Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wuerttemberg ("Innovative Projekte'')	Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wuerttemberg ("Innovative Projekte'')	The work was partially supported by a grant from the Ministerium fur Wissenschaft, Forschung und Kunst Baden-Wuerttemberg ("Innovative Projekte'') to M.H. and B.Y. No additional funding sources for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abubakar MB, 2012, INT J MOL SCI, V13, P15054, DOI 10.3390/ijms131115054; Achard CS, 2012, ENDOCRINOLOGY, V153, P2164, DOI 10.1210/en.2011-1881; Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011; Ait-Hsiko L, 2013, PLATELETS, V24, P428, DOI 10.3109/09537104.2012.715217; Almasi R, 2008, LIFE SCI, V82, P644, DOI 10.1016/j.lfs.2007.12.022; Anrather J, 1999, J BIOL CHEM, V274, P13594, DOI 10.1074/jbc.274.19.13594; Bisogno T, 2000, BIOCHEM J, V351, P817, DOI 10.1042/0264-6021:3510817; Bouma HR, 2010, TRANSPLANTATION, V90, P353, DOI 10.1097/TP.0b013e3181e7a3aa; Cojocari D, 2013, RADIOTHER ONCOL, V108, P541, DOI 10.1016/j.radonc.2013.06.005; Connor M, 2010, BRIT J PHARMACOL, V160, P1857, DOI 10.1111/j.1476-5381.2010.00862.x; Cybulsky AV, 2005, J BIOL CHEM, V280, P24396, DOI 10.1074/jbc.M500729200; Graf PCF, 2002, CELL MOL LIFE SCI, V59, P1624, DOI 10.1007/PL00012489; Harding HP, 2000, MOL CELL, V6, P1099, DOI 10.1016/S1097-2765(00)00108-8; Harding HP, 2003, MOL CELL, V11, P619, DOI 10.1016/S1097-2765(03)00105-9; Hottenrott MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073122; Janicke B, 2011, NUTR CANCER, V63, P611, DOI 10.1080/01635581.2011.538486; Kawabata T, 1996, BIOCHEM PHARMACOL, V51, P1569, DOI 10.1016/0006-2952(96)00101-3; Kohno K, 2010, J BIOCHEM, V147, P27, DOI 10.1093/jb/mvp196; Losel RM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009713; Mamady H, 2008, ARCH BIOCHEM BIOPHYS, V477, P77, DOI 10.1016/j.abb.2008.05.006; Martindale JJ, 2006, CIRC RES, V98, P1186, DOI 10.1161/01.RES.0000220643.65941.8d; Mori K, 2009, J BIOCHEM, V146, P743, DOI 10.1093/jb/mvp166; Ni M, 2007, FEBS LETT, V581, P3641, DOI 10.1016/j.febslet.2007.04.045; Okada T, 2002, BIOCHEM J, V366, P585, DOI 10.1042/BJ20020391; Papp E, 2003, BIOFACTORS, V17, P249, DOI 10.1002/biof.5520170124; Peralta C, 2001, HEPATOLOGY, V34, P1164, DOI 10.1053/jhep.2001.29197; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Rubio C, 2011, J CELL BIOL, V193, P171, DOI 10.1083/jcb.201007077; Rutkowski DT, 2007, TRENDS BIOCHEM SCI, V32, P469, DOI 10.1016/j.tibs.2007.09.003; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Samali A, 2010, INT J CELL BIOL, V2010, DOI [10.1155/2010/830307, DOI 10.1155/2010/830307]; Scheuner D, 2006, J BIOL CHEM, V281, P21458, DOI 10.1074/jbc.M603784200; Schindler AJ, 2009, P NATL ACAD SCI USA, V106, P17775, DOI 10.1073/pnas.0910342106; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Siveen KS, 2011, J ENVIRON PATHOL TOX, V30, P301, DOI 10.1615/JEnvironPatholToxicolOncol.v30.i4.30; Suh DH, 2012, ANN NY ACAD SCI, V1271, P20, DOI 10.1111/j.1749-6632.2012.06739.x; Tabata K, 2012, ANTICANCER RES, V32, P4781; Tadimalla A, 2008, CIRC RES, V103, P1249, DOI 10.1161/CIRCRESAHA.108.180679; TAKAHASHI K, 1995, BIOL PHARM BULL, V18, P1401; Tsagogiorgas C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043525; Tsang KY, 2010, J CELL SCI, V123, P2145, DOI 10.1242/jcs.068833; TSENG CF, 1992, CHEM PHARM BULL, V40, P396, DOI 10.1248/cpb.40.396; Vettel C, 2013, J PHARM EXP THER; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Wang SY, 2012, J CELL BIOL, V197, P857, DOI 10.1083/jcb.201110131; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0	46	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99298	10.1371/journal.pone.0099298	http://dx.doi.org/10.1371/journal.pone.0099298			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926788	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100033
J	Yang, M; Zhong, JL; Zhao, M; Wang, J; Gu, YY; Yuan, XH; Sang, JL; Huang, CZ				Yang, Mei; Zhong, Jialing; Zhao, Mei; Wang, Jia; Gu, Yuyu; Yuan, Xinghua; Sang, Jianli; Huang, Changzhi			Overexpression of Nuclear Apoptosis-Inducing Factor 1 Altered the Proteomic Profile of Human Gastric Cancer Cell MKN45 and Induced Cell Cycle Arrest at G1/S Phase	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; 26S PROTEASOME; TUMOR-METASTASIS; 14-3-3 PROTEINS; COMPLEX-I; EXPRESSION; GENES; THIOREDOXIN; IDENTIFICATION; SURVIVAL	Nuclear apoptosis-inducing factor 1 (NAIF1) was previously reported to induce apoptosis. Moreover, the expression of NAIF1 was significantly down-regulated in human gastric cancer tissues compared to adjacent normal tissues. However, the mechanism by which the NAIF1 gene induces apoptosis is not fully understood. Our results show that NAIF1 was minimally expressed in all the tested gastric cancer cell lines. Our data also demonstrates that NAIF1 is localized in the nuclei of cells as detected by monitoring the green fluorescence of NAIF1-GFP fusion protein using fluorescent confocal microscopy. Next, a comparative proteomic approach was used to identify the differential expression of proteins between gastric cancer cell lines MKN45/NAIF1 (-) and MKN45/NAIF1 (+). We found five proteins (proteasome 26S subunit 2, proteasome 26S subunit 13, NADH dehydrogenase Fe-S protein 1, chaperonin containing TCP1 subunit 3 and thioredoxin reductase 1) that were up-regulated and three proteins (ribonuclease inhibitor 1, 14-3-3 protein epsilon isoform and apolipoprotein A-I binding protein) that were down-regulated in the MKN45 cells overexpressing NAIF1. We also discovered that NAIF1 could induce cell cycle arrest at G1/S phase by altering the expression of cell cycle proteins cyclinD1, cdc2 and p21. The differentially expressed proteins identified here are related to various cellular programs involving cell cycle, apoptosis, and signal transduction regulation and suggest that NAIF1 may be a tumor suppressor in gastric cancer. Our research provides evidence that elucidates the role of how NAIF1 functions in gastric cancer.	[Yang, Mei; Zhong, Jialing; Zhao, Mei; Wang, Jia; Gu, Yuyu; Huang, Changzhi] Chinese Acad Med Sci, Dept Etiol & Carcinogenesis, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Yang, Mei; Zhong, Jialing; Zhao, Mei; Wang, Jia; Gu, Yuyu; Huang, Changzhi] Chinese Acad Med Sci, State Key Lab Mol Oncol, Canc Inst & Hosp, Beijing 100730, Peoples R China; [Yang, Mei; Zhong, Jialing; Zhao, Mei; Wang, Jia; Gu, Yuyu; Yuan, Xinghua; Huang, Changzhi] Peking Union Med Coll, Beijing 100021, Peoples R China; [Yuan, Xinghua] Chinese Acad Med Sci, Canc Inst & Hosp, Dept Abdomen Surg, Beijing 100730, Peoples R China; [Sang, Jianli] Beijing Normal Univ, Coll Life Sci, Inst Cell Biol, Beijing 100875, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Cancer Institute & Hospital - CAMS; Beijing Normal University	Huang, CZ (corresponding author), Chinese Acad Med Sci, Dept Etiol & Carcinogenesis, Canc Inst & Hosp, Beijing 100730, Peoples R China.	huangpumc@163.com			National Key Basic Research Program of China [2007CB914700]	National Key Basic Research Program of China(National Basic Research Program of China)	This research was supported by the National Key Basic Research Program of China (2007CB914700). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker A, 1997, CANCER RES, V57, P5162; Carlson BA, 2012, CARCINOGENESIS, V33, P1806, DOI 10.1093/carcin/bgs230; Carroll J, 2003, MOL CELL PROTEOMICS, V2, P117, DOI 10.1074/mcp.M300014-MCP200; Chile T, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-451; Dickson KA, 2005, PROG NUCLEIC ACID RE, V80, P349, DOI 10.1016/S0079-6603(05)80009-1; Frankland-Searby S, 2012, BBA-REV CANCER, V1825, P64, DOI 10.1016/j.bbcan.2011.10.003; Guggenheim DE, 2013, J SURG ONCOL, V107, P230, DOI 10.1002/jso.23262; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hofman ER, 1998, MOL CELL BIOL, V18, P6493, DOI 10.1128/MCB.18.11.6493; Iuso A, 2006, J BIOL CHEM, V281, P10374, DOI 10.1074/jbc.M513387200; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kim YJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028308; Ko BS, 2011, HISTOPATHOLOGY, V58, P705, DOI 10.1111/j.1365-2559.2011.03789.x; Leal MF, 2012, WORLD J GASTROENTERO, V18, P1531, DOI 10.3748/wjg.v18.i13.1531; Lechner S, 2003, LAB INVEST, V83, P1321, DOI 10.1097/01.LAB.0000085189.47968.F8; Li DQ, 2006, PROTEOMICS, V6, P3352, DOI 10.1002/pmic.200500617; Liou JY, 2007, CANCER RES, V67, P3185, DOI 10.1158/0008-5472.CAN-06-3431; Liou JY, 2006, ARTERIOSCL THROM VAS, V26, P1481, DOI 10.1161/01.ATV.0000223875.14120.93; Liu TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057968; Luo Q, 2011, ONCOL REP, V25, P1117, DOI 10.3892/or.2011.1171; Lv BF, 2006, INT J BIOCHEM CELL B, V38, P671, DOI 10.1016/j.biocel.2005.11.007; Ma YM, 2010, J CELL BIOCHEM, V110, P1512, DOI 10.1002/jcb.22726; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Midorikawa Y, 2002, JPN J CANCER RES, V93, P636, DOI 10.1111/j.1349-7006.2002.tb01301.x; Pal P, 2013, MOL CELL BIOCHEM, V376, P81, DOI 10.1007/s11010-012-1551-0; Pandey A, 2000, NATURE, V405, P837, DOI 10.1038/35015709; Piva R, 2006, ANTIOXID REDOX SIGN, V8, P478, DOI 10.1089/ars.2006.8.478; Qi WQ, 2005, INT J CANCER, V113, P359, DOI 10.1002/ijc.20492; Ricci JE, 2004, CELL, V117, P773, DOI 10.1016/j.cell.2004.05.008; Ritter M, 2002, GENOMICS, V79, P693, DOI 10.1006/geno.2002.6761; Schrader EK, 2009, NAT CHEM BIOL, V5, P815, DOI 10.1038/nchembio.250; Shah SA, 2001, J CELL BIOCHEM, V82, P110, DOI 10.1002/jcb.1150; Sinzelle L, 2008, P NATL ACAD SCI USA, V105, P4715, DOI 10.1073/pnas.0707746105; Sokolowska I, 2012, PROTEOME SCI, V10, DOI 10.1186/1477-5956-10-47; Sun Y, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-8; Tan YL, 2006, J BURN CARE RES, V27, P226, DOI 10.1097/01.BCR.0000203378.85736.38; van Horssen R, 2006, ONCOLOGIST, V11, P397, DOI 10.1634/theoncologist.11-4-397; Wang DG, 2013, MOL CELL BIOCH; Wang ZH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024843; Wilker E, 2004, J MOL CELL CARDIOL, V37, P633, DOI 10.1016/j.yjmcc.2004.04.015; Witort E, 2013, J CHEMOTHERAPY, V25, P292, DOI 10.1179/1973947813Y.0000000087; Wong N, 2003, J HEPATOL, V38, P298, DOI 10.1016/S0168-8278(02)00412-9; Yoon MK, 2012, BIOCHEM SOC T, V40, P981, DOI 10.1042/BST20120092; Zhu DX, 2013, J CELL BIOCHEM, V114, P448, DOI 10.1002/jcb.24384; Zhu Y, 2013, ONCOGENE	45	8	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100216	10.1371/journal.pone.0100216	http://dx.doi.org/10.1371/journal.pone.0100216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926661	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100120
J	Hema, R; Vemanna, RS; Sreeramulu, S; Reddy, CP; Senthil-Kumar, M; Udayakumar, M				Hema, Ramanna; Vemanna, Ramu S.; Sreeramulu, Shivakumar; Reddy, Chandrasekhara P.; Senthil-Kumar, Muthappa; Udayakumar, Makarla			Stable Expression of mtlD Gene Imparts Multiple Stress Tolerance in Finger Millet	PLOS ONE			English	Article							ELEUSINE-CORACANA-GAERTN; TRANSGENIC INDICA RICE; WATER-USE EFFICIENCY; SALT-TOLERANCE; FUNCTIONAL VALIDATION; OSMOLYTE ACCUMULATION; MANNITOL; L.; DROUGHT; SALINITY	Finger millet is susceptible to abiotic stresses, especially drought and salinity stress, in the field during seed germination and early stages of seedling development. Therefore developing stress tolerant finger millet plants combating drought, salinity and associated oxidative stress in these two growth stages is important. Cellular protection through osmotic adjustment and efficient free radical scavenging ability during abiotic stress are important components of stress tolerance mechanisms in plants. Mannitol, an osmolyte, is known to scavenge hydroxyl radicals generated during various abiotic stresses and thereby minimize stress damage in several plant species. In this study transgenic finger millet plants expressing the mannitol biosynthetic pathway gene from bacteria, mannitol-1-phosphate dehydrogenase (mtlD), were developed through Agrobacterium tumefaciens-mediated genetic transformation. mtlD gene integration in the putative transgenic plants was confirmed by Southern blot. Further, performance of transgenic finger millet under drought, salinity and oxidative stress was studied at plant level in T-1 generation and in T-1 and T-2 generation seedlings. Results from these experiments showed that transgenic finger millet had better growth under drought and salinity stress compared to wild-type. At plant level, transgenic plants showed better osmotic adjustment and chlorophyll retention under drought stress compared to the wildtype. However, the overall increase in stress tolerance of transgenics for the three stresses, especially for oxidative stress, was only marginal compared to other mtlD gene expressing plant species reported in the literature. Moreover, the Agrobacterium-mediated genetic transformation protocol developed for finger millet in this study can be used to introduce diverse traits of agronomic importance in finger millet.	[Hema, Ramanna; Vemanna, Ramu S.; Sreeramulu, Shivakumar; Reddy, Chandrasekhara P.; Senthil-Kumar, Muthappa; Udayakumar, Makarla] Univ Agr Sci, GKVK, Dept Crop Physiol, Bangalore, Karnataka, India; [Senthil-Kumar, Muthappa] Natl Inst Plant Genome Res, New Delhi, India	University of Agricultural Sciences Bangalore; Department of Biotechnology (DBT) India; National Institute of Plant Genome Research (NIPGR)	Senthil-Kumar, M (corresponding author), Univ Agr Sci, GKVK, Dept Crop Physiol, Bangalore, Karnataka, India.	skmuthappa@nipgr.ac.in	Senthil-Kumar, Muthappa/A-6699-2009; Mysore, Kirankumar/AAG-7112-2020	Senthil-Kumar, Muthappa/0000-0003-1502-1659; Mysore, Kirankumar/0000-0002-9805-5741; Vemanna, Ramu/0000-0002-9729-8768	Indian council of agricultural research, New Delhi; department of crop physiology; council of scientific and industrial research, New Delhi [9/271(86)/2004/EMR-1]; international foundation for science (IFS), Sweden [C/4066-1/Ac/17341R]	Indian council of agricultural research, New Delhi(Indian Council of Agricultural Research (ICAR)); department of crop physiology; council of scientific and industrial research, New Delhi(Council of Scientific & Industrial Research (CSIR) - India); international foundation for science (IFS), Sweden(International Foundation for Science)	This work was supported by grants from Indian council of agricultural research, New Delhi. HR acknowledges the financial assistance from department of crop physiology towards her PhD research. MS-K thanks the council of scientific and industrial research, New Delhi for the senior research fellowship award (No. 9/271(86)/2004/EMR-1) for his PhD research and also international foundation for science (IFS), Sweden (C/4066-1/Ac/17341R). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aarati P, 2003, PLANT SCI, V164, P25, DOI 10.1016/S0168-9452(02)00321-7; Abebe T, 2003, PLANT PHYSIOL, V131, P1748, DOI 10.1104/pp.102.003616; Adhikari R. K., 2012, Journal of Development and Agricultural Economics, V4, P151; Anjaneyulu E., 2011, World Applied Sciences Journal, V12, P919; Bhatt D, 2013, MOL BIOL REP, V40, P1155, DOI 10.1007/s11033-012-2157-z; Bhatt Deepesh, 2011, Physiology and Molecular Biology of Plants, V17, P347, DOI 10.1007/s12298-011-0084-4; Borges AA, 2003, PLANT PATHOL, V52, P429, DOI 10.1046/j.1365-3059.2003.00877.x; Ceasar SA, 2011, PLANT CELL REP, V30, P1759, DOI 10.1007/s00299-011-1084-0; Chan ZL, 2011, J EXP BOT, V62, P4787, DOI 10.1093/jxb/err130; Chandrashekar A, 2010, ADV FOOD NUTR RES, V59, P215, DOI 10.1016/S1043-4526(10)59006-5; Chiang YJ, 2005, J AM SOC HORTIC SCI, V130, P605, DOI 10.21273/JASHS.130.4.605; Conde A, 2011, PLANT CELL PHYSIOL, V52, P1766, DOI 10.1093/pcp/pcr121; CORCORAN AC, 1947, J BIOL CHEM, V170, P165; Dinesh-Kumar S P, 1987, PLANT CELL ENVIRON, V10, P661; DODGE AD, 1970, BIOCHEM J, V118, pP43, DOI 10.1042/bj1180043P; EAPEN S, 1989, PLANT SCI, V61, P127, DOI 10.1016/0168-9452(89)90126-X; Gelvin SB, 2006, METH MOL B, V343, P77; Gopalakrishna R, 2001, BIOCHEM BIOPH RES CO, V284, P574, DOI 10.1006/bbrc.2001.4992; Govind G, 2009, MOL GENET GENOMICS, V281, P591, DOI 10.1007/s00438-009-0432-z; Gowda BTS, 2000, CURR SCI INDIA, V79, P366; Gupta P., 2001, PLANT BIOTECHNOL, V18, P275, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.18.275; Hamza NB, 2009, PROGR PROSPECTS MILL, P260; Hare PD, 1998, PLANT CELL ENVIRON, V21, P535, DOI 10.1046/j.1365-3040.1998.00309.x; Hayat S, 2012, PLANT SIGNAL BEHAV, V7, P1456, DOI 10.4161/psb.21949; Hebbar S. Shankar, 1992, Crop Research (Hisar), V5, P92; Hema R, 2007, PLANTA, V226, P655, DOI 10.1007/s00425-007-0514-2; Hema R, 2001, THESIS U AGR SCI BAN; Hema R, 2006, RELEVANCE MANNITAL D; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Hu L, 2005, TREE PHYSIOL, V25, P1273, DOI 10.1093/treephys/25.10.1273; Ignacimuthu S, 2012, J BIOSCIENCES, V37, P135, DOI 10.1007/s12038-011-9178-y; Jagga-Chugh S, 2012, PLANT CELL TISS ORG, V109, P401, DOI 10.1007/s11240-011-0104-7; James VA, 2002, THEOR APPL GENET, V104, P553, DOI 10.1007/s001220100745; Jayaprakash T. L., 1992, Plant Physiology & Biochemistry (New Delhi), V19, P49; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kalarani M. K., 2001, Madras Agricultural Journal, V88, P509; Kalarani M. K., 2001, Indian Journal of Plant Physiology, V6, P435; KANDPAL RP, 1985, BIOCHEM INT, V11, P365; KANDPAL RP, 1985, PLANT SCI, V40, P73, DOI 10.1016/0168-9452(85)90044-5; Karaba A, 2007, P NATL ACAD SCI USA, V104, P15270, DOI 10.1073/pnas.0707294104; Kathuria H, 2009, PLANT BIOTECHNOL J, V7, P512, DOI 10.1111/j.1467-7652.2009.00420.x; Khare N, 2010, PLANT CELL TISS ORG, V103, P267, DOI 10.1007/s11240-010-9776-7; Kumar S, 2001, CURR SCI INDIA, V81, P1482; Latha AM, 2005, PLANT SCI, V169, P657, DOI 10.1016/j.plantsci.2005.05.009; Liu J, 1995, Chin J Biotechnol, V11, P275; Macaluso L, 2007, J HORTIC SCI BIOTECH, V82, P979, DOI 10.1080/14620316.2007.11512336; Mahalakshmi S, 2006, PLANTA, V224, P347, DOI 10.1007/s00425-005-0218-4; Maheswari M, 2010, BIOL PLANTARUM, V54, P647, DOI 10.1007/s10535-010-0115-y; Mbithi-Mwikya S, 2002, J AGR FOOD CHEM, V50, P3030, DOI 10.1021/jf011008a; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nagaraja A., 2008, Journal of Mycopathological Research, V46, P109; Nandini B., 2010, International Journal of Plant Sciences (Muzaffarnagar), V5, P602; Oghbaei M, 2012, J SCI FOOD AGR, V92, P2281, DOI 10.1002/jsfa.5622; Oltmanns H, 2010, PLANT PHYSIOL, V152, P1158, DOI 10.1104/pp.109.148585; Prabhavathi V, 2007, PLANT SCI, V173, P50, DOI 10.1016/j.plantsci.2007.04.004; Prabhavathi V, 2002, MOL BREEDING, V9, P137, DOI 10.1023/A:1026765026493; PRASAD SV, 1980, P INDIAN AS-PLANT SC, V89, P481; Pujni D, 2007, J PLANT BIOCHEM BIOT, V16, P1; Radchuk V, 2012, J EXP BOT, V63, P5497, DOI 10.1093/jxb/ers200; Rahnama H, 2011, ACTA PHYSIOL PLANT, V33, P1521, DOI 10.1007/s11738-010-0690-8; Rai Srubha, 2009, Indian Journal of Plant Physiology, V14, P82; Ramegowda V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040397; Rathinasabapathi B, 2000, ANN BOT-LONDON, V86, P709, DOI 10.1006/anbo.2000.1254; REDDY V C, 1983, Mysore Journal of Agricultural Sciences, V17, P325; SASHIDHAR VR, 1986, FIELD CROP RES, V13, P133, DOI 10.1016/0378-4290(86)90016-X; Schopfer P, 2001, PLANT PHYSIOL, V125, P1591, DOI 10.1104/pp.125.4.1591; Seckin B, 2009, J PLANT GROWTH REGUL, V28, P12, DOI 10.1007/s00344-008-9068-1; Senthil-Kumar M, 2003, J EXP BOT, V54, P2569, DOI 10.1093/jxb/erg278; Serraj R, 2002, PLANT CELL ENVIRON, V25, P333, DOI 10.1046/j.1365-3040.2002.00754.x; Shailaja HB, 2007, INDIAN J AGR SCI, V77, P672; Sharma M, 2011, PLANT CELL TISS ORG, V105, P93, DOI 10.1007/s11240-010-9846-x; Shen B, 1997, PLANT PHYSIOL, V115, P527, DOI 10.1104/pp.115.2.527; Shet RM, 2009, ENV ECOLOGY, V27, P1013; Sheveleva EV, 2000, J EXP BOT, V51, P115, DOI 10.1093/jexbot/51.342.115; SHI MM, 1994, J BIOL CHEM, V269, P26512; Shivakumar S, 2006, OVEREXPRESSION P5CS; Shivkumar B. G., 1996, Indian Journal of Agricultural Research, V30, P173; SIVADAS P, 1990, PLANT CELL REP, V9, P93, DOI 10.1007/BF00231557; SMIRNOFF N, 1989, PHYTOCHEMISTRY, V28, P1057, DOI 10.1016/0031-9422(89)80182-7; TARCZYNSKI MC, 1992, P NATL ACAD SCI USA, V89, P2600, DOI 10.1073/pnas.89.7.2600; THOMAS JC, 1995, PLANT CELL ENVIRON, V18, P801, DOI 10.1111/j.1365-3040.1995.tb00584.x; TOWILL LE, 1975, CAN J BOT, V53, P1097, DOI 10.1139/b75-129; UMA S, 1995, ANN BOT-LONDON, V76, P43, DOI 10.1006/anbo.1995.1076; Vasantha KM, 2013, TARGETING GENES ION; Vijayalakshmi D., 2012, Journal of Dairying, Foods and Home Sciences, V31, P223; Yadav D. S., 1999, Journal of Potassium Research, V15, P131; Yamada M, 2009, PLANT CELL PHYSIOL, V50, P1736, DOI 10.1093/pcp/pcp116; Yamunarani BR, 2009, MOL CHARACTERIZATION; Zhifang G, 2003, PLANT CELL ENVIRON, V26, P275, DOI 10.1046/j.1365-3040.2003.00958.x	89	46	49	3	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99110	10.1371/journal.pone.0099110	http://dx.doi.org/10.1371/journal.pone.0099110			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922513	Green Submitted, Green Published, gold			2022-12-27	WOS:000338701300030
J	Lang, LW; Liu, XY; Li, Y; Zhou, Q; Xie, P; Yan, CH; Chen, XG				Lang, Liwei; Liu, Xiaoyu; Li, Yan; Zhou, Qing; Xie, Ping; Yan, Chunhong; Chen, Xiaoguang			A Synthetic Manassantin A Derivative Inhibits Hypoxia-Inducible Factor 1 and Tumor Growth	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITORS; SAURURUS-CHINENSIS; ACTIVATION; RESISTANCE; ARYLATION; LIGNANS; ALPHA	The dineolignan manassantin A from Saururaceae was recently identified as a hypoxia-inducible factor 1 (HIF-1) inhibitor, but its in-vivo anti-tumor effect has not been explored. We synthesized a series of manassantin A derivatives, and found that replacing the central tetrahydrofuran moiety with a cyclopentane ring yielded a compound (LXY6006) with increased HIF-1-inhibitory activity yet decreased stereochemically complexity amenable to a simplified synthesis scheme. LXY6006 inhibited HIF-1 alpha nuclear accumulation induced by hypoxia, and inhibited cancer cell growth as a consequence of G2/M arrest. Oral administration of LXY6006 significantly inhibited growth of breast, lung, and pancreatic tumors implanted in nude mice. These results indicate that LXY6006 represents a novel class of agents targeting a broad range of human cancers.	[Lang, Liwei; Li, Yan; Zhou, Qing; Chen, Xiaoguang] Chinese Acad Med Sci, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Dept Pharmacol, Beijing 100050, Peoples R China; [Lang, Liwei; Liu, Xiaoyu; Li, Yan; Zhou, Qing; Xie, Ping; Chen, Xiaoguang] Peking Union Med Coll, Beijing 100021, Peoples R China; [Liu, Xiaoyu; Xie, Ping] Chinese Acad Med Sci, Inst Mat Med, Dept Synthet Med Chem, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China; [Lang, Liwei; Yan, Chunhong] Georgia Regents Univ, GRU Canc Ctr, Dept Biochem & Mol Biol, Med Coll Georgia, Augusta, GA 30901 USA	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Materia Medica - CAMS; University System of Georgia; Augusta University	Yan, CH (corresponding author), Georgia Regents Univ, GRU Canc Ctr, Dept Biochem & Mol Biol, Med Coll Georgia, Augusta, GA 30901 USA.	cyan@gru.edu; chxg@imm.ac.cn	Lang, Liwei/I-7744-2019	Yan, Chunhong/0000-0002-3974-7991; Lang, Liwei/0000-0002-2374-645X	Beijing Natural Science Foundation [7121010]; National Science and Technology Major Project [2012ZX09301002-006]; NIH/NCI [R01CA164006]; NATIONAL CANCER INSTITUTE [R01CA164006] Funding Source: NIH RePORTER	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Science and Technology Major Project; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported in part by the grants from Beijing Natural Science Foundation (7121010) and National Science and Technology Major Project (2012ZX09301002-006) to XC, and a NIH/NCI grant R01CA164006 to CY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang JS, 2011, J PHARMACOL SCI, V115, P84, DOI 10.1254/jphs.10239SC; Chou TC, 2005, CANCER CHEMOTH PHARM, V56, P379, DOI 10.1007/s00280-005-1019-y; Hahm JC, 2005, PLANTA MED, V71, P464, DOI 10.1055/s-2005-864143; Hanessian S, 2006, ORG LETT, V8, P5477, DOI 10.1021/ol0621710; Hossain CF, 2005, BIOCHEM BIOPH RES CO, V333, P1026, DOI 10.1016/j.bbrc.2005.05.191; Hu YZ, 2013, J CELL BIOCHEM, V114, P498, DOI 10.1002/jcb.24390; Hwang BY, 2003, PHYTOCHEMISTRY, V64, P765, DOI 10.1016/S0031-9422(03)00391-1; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; JEFFERY T, 1984, J CHEM SOC CHEM COMM, P1287, DOI 10.1039/c39840001287; Kasper AC, 2009, BIOORG MED CHEM LETT, V19, P3783, DOI 10.1016/j.bmcl.2009.04.071; Kim JY, 2009, J PHARMACOL SCI, V109, P583, DOI 10.1254/jphs.08299FP; Kim SJ, 2011, BIOL PHARM BULL, V34, P1769, DOI 10.1248/bpb.34.1769; Kwon OE, 2005, ARCH PHARM RES, V28, P55, DOI 10.1007/BF02975136; LAROCK RC, 1988, TETRAHEDRON LETT, V29, P905, DOI 10.1016/S0040-4039(00)82478-8; Lee HD, 2011, EXP DERMATOL, V20, P761, DOI 10.1111/j.1600-0625.2011.01296.x; Liu Wei, 2012, Int J Biochem Mol Biol, V3, P165; Lu CW, 2013, BIOCHEM PHARMACOL, V85, P1246, DOI 10.1016/j.bcp.2013.02.003; Oladipupo S, 2011, P NATL ACAD SCI USA, V108, P13264, DOI 10.1073/pnas.1101321108; PRASHAD M, 1989, TETRAHEDRON LETT, V30, P2877, DOI 10.1016/S0040-4039(00)99147-0; Rapisarda A, 2002, CANCER RES, V62, P4316; Rho MC, 2003, PLANTA MED, V69, P1147, DOI 10.1055/s-2003-818007; Rohwer N, 2013, ONCOGENE, V32, P3569, DOI 10.1038/onc.2012.510; Semenza GL, 2013, J CLIN INVEST, V123, P3664, DOI 10.1172/JCI67230; Wilson WR, 2011, NAT REV CANCER, V11, P393, DOI 10.1038/nrc3064; Zhou Q, 2012, BIOL PHARM BULL, V35, P2170, DOI 10.1248/bpb.b12-00513	25	20	20	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99584	10.1371/journal.pone.0099584	http://dx.doi.org/10.1371/journal.pone.0099584			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925080	gold, Green Published, Green Submitted			2022-12-27	WOS:000338701300079
J	Olchanheski, LR; Dourado, MN; Beltrame, FL; Zielinski, AAF; Demiate, IM; Pileggi, SAV; Azevedo, RA; Sadowsky, MJ; Pileggi, M				Olchanheski, Luiz R.; Dourado, Manuella N.; Beltrame, Flavio L.; Zielinski, Acacio A. F.; Demiate, Ivo M.; Pileggi, Sonia A. V.; Azevedo, Ricardo A.; Sadowsky, Michael J.; Pileggi, Marcos			Mechanisms of Tolerance and High Degradation Capacity of the Herbicide Mesotrione by Escherichia coli Strain DH5-alpha	PLOS ONE			English	Article							GLUTATHIONE-S-TRANSFERASE; ETHYL DIPROPYLTHIOCARBAMATE; ANTIOXIDANT ENZYMES; DEGRADING BACTERIA; DEFICIENT MUTANT; SOIL; MICROORGANISMS; METABOLISM; PARAQUAT; ATRAZINE	The intensive use of agrochemicals has played an important role in increasing agricultural production. One of the impacts of agrochemical use has been changes in population structure of soil microbiota. The aim of this work was to analyze the adaptive strategies that bacteria use to overcome oxidative stress caused by mesotrione, which inhibits 4-hydroxyphenylpyruvate dioxygenase. We also examined antioxidative stress systems, saturation changes of lipid membranes, and the capacity of bacteria to degrade mesotrione. Escherichia coli DH5-a was chosen as a non-environmental strain, which is already a model bacterium for studying metabolism and adaptation. The results showed that this bacterium was able to tolerate high doses of the herbicide (10 x field rate), and completely degraded mesotrione after 3 h of exposure, as determined by a High Performance Liquid Chromatography. Growth rates in the presence of mesotrione were lower than in the control, prior to the period of degradation, showing toxic effects of this herbicide on bacterial cells. Changes in the saturation of the membrane lipids reduced the damage caused by reactive oxygen species and possibly hindered the entry of xenobiotics in the cell, while activating glutathione-S-transferase enzyme in the antioxidant system and in the metabolizing process of the herbicide. Considering that E. coli DH5-alpha is a non-environmental strain and it had no previous contact with mesotrione, the defense system found in this strain could be considered non-specific. This bacterium system response may be a general adaptation mechanism by which bacterial strains resist to damage from the presence of herbicides in agricultural soils.	[Olchanheski, Luiz R.; Pileggi, Sonia A. V.; Pileggi, Marcos] Univ Estadual Ponta Grossa, Dept Biol Estrutural Mol & Genet, Ponta Grossa, PR, Brazil; [Dourado, Manuella N.; Azevedo, Ricardo A.] Univ Sao Paulo, ESALQ, Escola Super Agr Luiz de Queiroz, Piracicaba, SP, Brazil; [Beltrame, Flavio L.] Univ Estadual Ponta Grossa, Dept Ciencias Farmaceut, Ponta Grossa, PR, Brazil; [Zielinski, Acacio A. F.] Univ Fed Parana, Programa Posgrad Engn & Alimentos, BR-80060000 Curitiba, Parana, Brazil; [Demiate, Ivo M.] Univ Estadual Ponta Grossa, Dept Engn Alimentos, Ponta Grossa, PR, Brazil; [Sadowsky, Michael J.] Univ Minnesota, Dept Soil Water & Climate, St Paul, MN 55108 USA; [Sadowsky, Michael J.] Univ Minnesota, Inst Biotechnol, St Paul, MN 55108 USA	Universidade Estadual de Ponta Grossa; Universidade de Sao Paulo; Universidade Estadual de Ponta Grossa; Universidade Federal do Parana; Universidade Estadual de Ponta Grossa; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Pileggi, M (corresponding author), Univ Estadual Ponta Grossa, Dept Biol Estrutural Mol & Genet, Ponta Grossa, PR, Brazil.	marcos.pileggi@pq.cnpq.br	Pileggi, Marcos/H-2695-2017; Dourado, Manuella N/P-2337-2018; Zielinski, Acácio AF/L-5868-2016; Beltrame, Flavio Luis/H-8505-2015; Sadowsky, Michael/J-2507-2016; Zielinski, Acácio AF/N-4432-2013; Pileggi, Marcos/B-8651-2012; Azevedo, Ricardo Antunes/F-8863-2011; Demiate, Ivo M/C-3859-2008	Pileggi, Marcos/0000-0003-1633-8295; Dourado, Manuella N/0000-0002-2152-0246; Zielinski, Acácio AF/0000-0002-6184-9628; Beltrame, Flavio Luis/0000-0001-7067-5802; Sadowsky, Michael/0000-0001-8779-2781; Zielinski, Acácio AF/0000-0002-6184-9628; Pileggi, Marcos/0000-0003-1633-8295; Azevedo, Ricardo Antunes/0000-0001-7316-125X; Demiate, Ivo M/0000-0002-5609-0186	National Council of Technological and Scientific Development [221/2007, 473438/2010-0]; Foundation for Research Support of the State of Sao Paulo [2009/54676-6]; Foundation for Research Support of the State of Parana [21724]	National Council of Technological and Scientific Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Foundation for Research Support of the State of Sao Paulo; Foundation for Research Support of the State of Parana	The authors would like to thank the Brazilian funding agencies Coordination for the Improvement of Higher Level Personnel (www.capes.gov.br), Grant no. 221/2007, National Council of Technological and Scientific Development (www.cnpq.br), Grant no. 473438/2010-0, Foundation for Research Support of the State of Sao Paulo (www.fapesp.br), Grant no. 2009/54676-6, and Foundation for Research Support of the State of Parana (www.fundacaoaraucaria.org.br), Grant no. 21724, for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alferness P, 2002, J AGR FOOD CHEM, V50, P3926, DOI 10.1021/jf011696y; Allocati N, 2003, BIOCHEM J, V373, P305, DOI 10.1042/BJ20030184; Allocati N, 2009, FEBS J, V276, P58, DOI 10.1111/j.1742-4658.2008.06743.x; Araujo ASF, 2003, CHEMOSPHERE, V52, P799, DOI 10.1016/S0045-6535(03)00266-2; Armas Eduardo Dutra de, 2007, Quím. Nova, V30, P1119, DOI 10.1590/S0100-40422007000500013; Azevedo RA, 1998, PHYSIOL PLANTARUM, V104, P280, DOI 10.1034/j.1399-3054.1998.1040217.x; Balague C, 2001, ENVIRON TOXICOL, V16, P43, DOI 10.1002/1522-7278(2001)16:1<43::AID-TOX50>3.0.CO;2-R; Barrett Michael, 1995, Drug Metabolism and Drug Interactions, V12, P299; Batisson I, 2009, ENVIRON POLLUT, V157, P1195, DOI 10.1016/j.envpol.2008.12.009; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boger P, 2000, PEST MANAG SCI, V56, P497; Bonnet JL, 2008, ARCH ENVIRON CON TOX, V55, P576, DOI 10.1007/s00244-008-9145-2; Botelho RG, 2012, BRAZ J BIOL, V72, P141, DOI 10.1590/S1519-69842012000100016; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BUS JS, 1984, ENVIRON HEALTH PERSP, V55, P37, DOI 10.2307/3429690; Cia MC, 2012, ANN APPL BIOL, V161, P313, DOI 10.1111/j.1744-7348.2012.00575.x; Crouzet O, 2010, SOIL BIOL BIOCHEM, V42, P193, DOI 10.1016/j.soilbio.2009.10.016; Cummins I, 2011, DRUG METAB REV, V43, P266, DOI 10.3109/03602532.2011.552910; Cycon M, 2013, APPL SOIL ECOL, V72, P242, DOI 10.1016/j.apsoil.2013.07.015; Dayan FE, 2009, BIOORGAN MED CHEM, V17, P4022, DOI 10.1016/j.bmc.2009.01.046; DESOUZA ML, 1995, APPL ENVIRON MICROB, V61, P3373, DOI 10.1128/AEM.61.9.3373-3378.1995; Durand S, 2006, LETT APPL MICROBIOL, V43, P222, DOI 10.1111/j.1472-765X.2006.01923.x; Durand S, 2010, CHEMOSPHERE, V81, P372, DOI 10.1016/j.chemosphere.2010.07.017; Fournier J, 1997, SOIL ECOTOXICOLOGY, P85; Garcia JS, 2006, J AGR FOOD CHEM, V54, P8623, DOI 10.1021/jf061593l; GAUDU P, 1994, EUR J BIOCHEM, V226, P459, DOI 10.1111/j.1432-1033.1994.tb20070.x; Ghelfi A, 2011, ANN APPL BIOL, V159, P267, DOI 10.1111/j.1744-7348.2011.00491.x; Gratao PL, 2008, ANN APPL BIOL, V153, P321, DOI 10.1111/j.1744-7348.2008.00299.x; Gratao PL, 2005, FUNCT PLANT BIOL, V32, P481, DOI 10.1071/FP05016; GREENBERG JT, 1990, P NATL ACAD SCI USA, V87, P6181, DOI 10.1073/pnas.87.16.6181; Hatzios KK, 2004, WEED SCI, V52, P454, DOI 10.1614/P2002-168C; HEATH RL, 1968, ARCH BIOCHEM BIOPHYS, V125, P189, DOI 10.1016/0003-9861(68)90654-1; Hernandez M, 2011, FEMS MICROBIOL ECOL, V78, P511, DOI 10.1111/j.1574-6941.2011.01180.x; IIZUKA M, 1989, J BACTERIOL, V171, P6039, DOI 10.1128/jb.171.11.6039-6042.1989; Isarankura-Na-Ayudhya P, 2010, EXCLI J, V9, P108; Jiang L, 2008, J AGR FOOD CHEM, V56, P11933, DOI 10.1021/jf8023134; Jung IL, 2003, BIOCHEM BIOPH RES CO, V301, P915, DOI 10.1016/S0006-291X(03)00064-0; Kiely T, 2004, PESTICIDES IND SALES, P1; KRAUS TE, 1995, J PLANT PHYSIOL, V145, P570, DOI 10.1016/S0176-1617(11)81790-6; Lima E.S., 2001, BRAZ J PHARM SCI, V37, P293; Lopez-Perez GC, 2006, J AGR FOOD CHEM, V54, P1797, DOI 10.1021/jf0525737; Ma XX, 2009, EMBO REP, V10, P1320, DOI 10.1038/embor.2009.216; Martins PF, 2011, PROCESS BIOCHEM, V46, P1186, DOI 10.1016/j.procbio.2011.02.014; Martins PF, 2007, BRAZ ARCH BIOL TECHN, V50, P153, DOI 10.1590/S1516-89132007000100019; McGuinness MC, 2007, ENG LIFE SCI, V7, P611, DOI 10.1002/elsc.200720218; Medici LO, 2004, FUNCT PLANT BIOL, V31, P1, DOI 10.1071/FP03130; Mitchell G, 2001, PEST MANAG SCI, V57, P120, DOI 10.1002/1526-4998(200102)57:2<120::AID-PS254>3.0.CO;2-E; Monteiro CC, 2011, ENVIRON EXP BOT, V71, P306, DOI 10.1016/j.envexpbot.2010.12.020; NAGY I, 1995, APPL ENVIRON MICROB, V61, P2056, DOI 10.1128/AEM.61.5.2056-2060.1995; Nordby JN, 2008, WEED SCI, V56, P376, DOI 10.1614/WS-07-145.1; Norris SR, 1995, PLANT CELL, V7, P2139, DOI 10.1105/tpc.7.12.2139; Oakley A, 2011, DRUG METAB REV, V43, P138, DOI 10.3109/03602532.2011.558093; Penna TCV, 2004, AFR J BIOTECHNOL, V3, P105; PICKETT CB, 1989, ANNU REV BIOCHEM, V58, P743, DOI 10.1146/annurev.bi.58.070189.003523; Pileggi M, 2012, CHEMOSPHERE, V86, P1127, DOI 10.1016/j.chemosphere.2011.12.041; Sanchez M, 2005, APPL MICROBIOL BIOT, V66, P589, DOI 10.1007/s00253-004-1735-y; Sands DC, 2009, PLANT SCI, V177, P377, DOI 10.1016/j.plantsci.2009.07.011; SHAO ZQ, 1995, APPL ENVIRON MICROB, V61, P2061, DOI 10.1128/AEM.61.5.2061-2065.1995; Sharma D, 2010, TALANTA, V82, P1077, DOI 10.1016/j.talanta.2010.06.043; Silva TM, 2007, BRAZ J MICROBIOL, V38, P522, DOI 10.1590/S1517-83822007000300026; Skopelitou K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034263; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Van Eerd LL, 2003, WEED SCI, V51, P472, DOI 10.1614/0043-1745(2003)051[0472:PMIPAM]2.0.CO;2; Williams JA, 2009, BIOTECHNOL ADV, V27, P353, DOI 10.1016/j.biotechadv.2009.02.003; ZABLOTOWICZ RM, 1995, APPL ENVIRON MICROB, V61, P1054, DOI 10.1128/AEM.61.3.1054-1060.1995; Zhang Y, 2012, J HAZARD MATER, V229, P434, DOI 10.1016/j.jhazmat.2012.05.054	67	23	23	4	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99960	10.1371/journal.pone.0099960	http://dx.doi.org/10.1371/journal.pone.0099960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924203	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300110
J	Sun, P; Guo, JF; Guo, SC; Chen, JY; He, L; Fu, SM				Sun, Pei; Guo, Jianfei; Guo, Shichun; Chen, Jingyi; He, Le; Fu, Shimin			BOLD Signal Change and Contrast Reversing Frequency: An Event-Related fMRI Study in Human Primary Visual Cortex	PLOS ONE			English	Article							LATERAL GENICULATE-NUCLEUS; CEREBRAL-BLOOD-FLOW; TEMPORAL-FREQUENCY; SPATIOTEMPORAL FREQUENCY; STIMULUS FREQUENCY; CORTICAL RESPONSE; RATE DEPENDENCE; BRAIN ACTIVITY; STRIATE; NEURONS	It is believed that human primary visual cortex (V1) increases activity with increasing temporal frequency of a visual stimulus. Two kinds of visual stimulus were used in the previous studies, one is patterned-flash stimulus with a fixed onset period and an increasing average luminance with the increase of temporal frequency, the other is contrast reversing flickering checkerboard or grating with a constant average luminance across different temporal frequencies. That hemodynamic responses change as a function of reversal frequency of contrast reversing checkerboard is at odds with neurophysiological studies in animals and neuroimaging studies in humans. In the present study, we addressed the relationship between reversal frequency of contrast reversing checkerboard and hemodynamic response in human V1 using an event-related experimental paradigm and found that the transient characteristics of blood oxygenation level dependent response in human V1 depended very little on the reversal frequency of a contrast reversing checkerboard.	[Sun, Pei; Guo, Jianfei; Guo, Shichun; Fu, Shimin] Tsinghua Univ, Dept Psychol, Sch Social Sci, Beijing 100084, Peoples R China; [Sun, Pei] RIKEN Brain Sci Inst, Lab Cognit Brain Mapping, Wako, Saitama, Japan; [Guo, Shichun] Tsinghua Univ, Dept Comp Sci, Beijing 100084, Peoples R China; [Chen, Jingyi] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [He, Le] Tsinghua Univ, Ctr Biomed Imaging Res, Beijing 100084, Peoples R China	Tsinghua University; RIKEN; Tsinghua University; Tsinghua University; Tsinghua University	Sun, P (corresponding author), Tsinghua Univ, Dept Psychol, Sch Social Sci, Beijing 100084, Peoples R China.	peisun@tsinghua.edu.cn	Fu, Shimin/A-6438-2008; Fu, Shimin/ABD-7806-2021		Natural Science Foundation of China [31371142]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China(Scientific Research Foundation for the Returned Overseas Chinese ScholarsMinistry of Education, China)	The project supported by the Natural Science Foundation of China (31371142) and sponsored by the Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry, China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alitto HJ, 2004, J NEUROPHYSIOL, V91, P2797, DOI 10.1152/jn.00943.2003; Bouvier SE, 2011, NEUROIMAGE, V57, P1177, DOI 10.1016/j.neuroimage.2011.04.012; BRUDER H, 1992, MAGNET RESON MED, V23, P311, DOI 10.1002/mrm.1910230211; D'Souza DV, 2011, J VISION, V11, DOI 10.1167/11.8.8; Emir UE, 2008, NEUROSCI LETT, V436, P185, DOI 10.1016/j.neulet.2008.03.021; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Fawcett IP, 2004, NEUROIMAGE, V21, P1542, DOI 10.1016/j.neuroimage.2003.10.045; FOSTER KH, 1985, J PHYSIOL-LONDON, V365, P331, DOI 10.1113/jphysiol.1985.sp015776; FOX PT, 1984, J NEUROPHYSIOL, V51, P1109, DOI 10.1152/jn.1984.51.5.1109; FOX PT, 1985, ANN NEUROL, V17, P303, DOI 10.1002/ana.410170315; Hagenbeek RE, 2002, HUM BRAIN MAPP, V17, P244, DOI 10.1002/hbm.10067; Hawken MJ, 1996, VISUAL NEUROSCI, V13, P477, DOI 10.1017/S0952523800008154; HU XP, 1995, MAGNET RESON MED, V34, P201, DOI 10.1002/mrm.1910340211; IKEDA H, 1975, EXP BRAIN RES, V22, P363; Issa NP, 2008, J NEUROPHYSIOL, V99, P2745, DOI 10.1152/jn.90211.2008; Kastner S, 2004, J NEUROPHYSIOL, V91, P438, DOI 10.1152/jn.00553.2003; Kaufmann C, 2001, HUM BRAIN MAPP, V14, P28, DOI 10.1002/hbm.1039; Kim SG, 1996, MAGNET RESON MED, V35, P895, DOI 10.1002/mrm.1910350618; KWONG KK, 1992, P NATL ACAD SCI USA, V89, P5675, DOI 10.1073/pnas.89.12.5675; Law I, 2001, J CEREBR BLOOD F MET, V21, P1003, DOI 10.1097/00004647-200108000-00013; Lin AL, 2010, P NATL ACAD SCI USA, V107, P8446, DOI 10.1073/pnas.0909711107; Maas LC, 1997, MAGNET RESON MED, V37, P131, DOI 10.1002/mrm.1910370119; Mentis MJ, 1997, NEUROIMAGE, V5, P116, DOI 10.1006/nimg.1997.0256; Mirzajani A, 2007, PHYSIOL MEAS, V28, P547, DOI 10.1088/0967-3334/28/5/008; Moore Iv BD, 2005, J NEUROPHYSIOL; Moradi F, 2003, NEUROIMAGE, V18, P595, DOI 10.1016/S1053-8119(02)00053-8; MOVSHON JA, 1978, J PHYSIOL-LONDON, V283, P101, DOI 10.1113/jphysiol.1978.sp012490; Mullen KT, 2010, J VISION, V10, DOI 10.1167/10.13.13; Muthukumaraswamy SD, 2008, NEUROIMAGE, V40, P1552, DOI 10.1016/j.neuroimage.2008.01.052; Norcia AM, 2005, J VISION, V5, P34, DOI 10.1167/5.1.4; Ozus B, 2001, MAGN RESON IMAGING, V19, P21, DOI 10.1016/S0730-725X(01)00219-3; Parkes LM, 2004, NEUROIMAGE, V21, P236, DOI 10.1016/j.neuroimage.2003.08.025; Pastor MA, 2003, J NEUROSCI, V23, P11621; REID RC, 1992, VISUAL NEUROSCI, V9, P39, DOI 10.1017/S0952523800006350; SAUL AB, 1992, VISUAL NEUROSCI, V8, P365, DOI 10.1017/S0952523800005101; Shoham D, 1997, NATURE, V385, P529, DOI 10.1038/385529a0; Singh KD, 2000, NEUROIMAGE, V12, P550, DOI 10.1006/nimg.2000.0642; Singh M, 2003, MAGNET RESON MED, V49, P108, DOI 10.1002/mrm.10335; Sirotin YB, 2009, NATURE, V457, P475, DOI 10.1038/nature07664; Srinivasan R, 2007, EXP BRAIN RES, V180, P677, DOI 10.1007/s00221-007-0886-3; Sun P, 2007, NAT NEUROSCI, V10, P1404, DOI 10.1038/nn1983; Thomas CG, 1998, MAGNET RESON MED, V40, P203, DOI 10.1002/mrm.1910400206; To L, 2013, VISION RES, V90, P15, DOI 10.1016/j.visres.2013.04.011; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Toronov VY, 2006, NEUROIMAGE; Yen CCC, 2011, NEUROIMAGE, V58, P82, DOI 10.1016/j.neuroimage.2011.06.022; Zhu XH, 1998, MAGN RESON MED, V40, P703, DOI 10.1002/mrm.1910400510	47	0	0	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99547	10.1371/journal.pone.0099547	http://dx.doi.org/10.1371/journal.pone.0099547			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924221	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300072
J	Wosnitzer, MS; Mielnik, A; Dabaja, A; Robinson, B; Schlegel, PN; Paduch, DA				Wosnitzer, Matthew S.; Mielnik, Anna; Dabaja, Ali; Robinson, Brian; Schlegel, Peter N.; Paduch, Darius A.			Ubiquitin Specific Protease 26 (USP26) Expression Analysis in Human Testicular and Extragonadal Tissues Indicates Diverse Action of USP26 in Cell Differentiation and Tumorigenesis	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; CARCINOMA-IN-SITU; RAT LEYDIG-CELLS; ANDROGEN-RECEPTOR; GENE-EXPRESSION; PROSTATE-CANCER; HUMAN SPERM; GERM-CELLS; TESTIS; LOCALIZATION	Ubiquitin specific protease 26 (USP26), a deubiquitinating enzyme, is highly expressed early during murine spermatogenesis, in round spermatids, and at the blood-testis barrier. USP26 has also been recognized as a regulator of androgen receptor (AR) hormone-induced action involved in spermatogenesis and steroid production in in vitro studies. Prior mutation screening of USP26 demonstrated an association with human male infertility and low testosterone production, but protein localization and expression in the human testis has not been characterized previously. USP26 expression analysis of mRNA and protein was completed using murine and human testis tissue and human tissue arrays. USP26 and AR mRNA levels in human testis were quantitated using multiplex qRT-PCR. Immunofluorescence colocalization studies were performed with formalin-fixed/paraffin-embedded and frozen tissues using primary and secondary antibodies to detect USP26 and AR protein expression. Human microarray dot blots were used to identify protein expression in extra-gonadal tissues. For the first time, expression of USP26 and colocalization of USP26 with androgen receptor in human testis has been confirmed predominantly in Leydig cell nuclei, with less in Leydig cell cytoplasm, spermatogonia, primary spermatocytes, round spermatids, and Sertoli cells. USP26 likely affects regulatory proteins of early spermatogenesis, including androgen receptor with additional activity in round spermatids. This X-linked gene is not testis-specific, with USP26 mRNA and protein expression identified in multiple other human organ tissues (benign and malignant) including androgen-dependent tissues such as breast (myoepithelial cells and secretory luminal cells) and thyroid tissue (follicular cells). USP26/AR expression and interaction in spermatogenesis and androgen-dependent cancer warrants additional study and may prove useful in diagnosis and management of male infertility.	[Wosnitzer, Matthew S.; Mielnik, Anna; Dabaja, Ali; Schlegel, Peter N.; Paduch, Darius A.] Weill Cornell Med Coll, Dept Urol, New York, NY 10065 USA; [Robinson, Brian] Weill Cornell Med Coll, Dept Pathol, New York, NY USA	Cornell University; Cornell University	Wosnitzer, MS (corresponding author), Weill Cornell Med Coll, Dept Urol, New York, NY 10065 USA.	maw7011@med.cornell.edu	Wosnitzer, Matthew/O-4398-2019; Wosnitzer, Matthew/ABA-2308-2021; Paduch, Darius/AAD-9734-2020	Wosnitzer, Matthew/0000-0001-5379-9678; Paduch, Darius/0000-0003-1105-3493	Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust; New York Academy of Medicine - Ferdinand C. Valentine Fellowship in Urology; Society for the Study of Male Reproduction (SSMR) Research Grant	Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust; New York Academy of Medicine - Ferdinand C. Valentine Fellowship in Urology; Society for the Study of Male Reproduction (SSMR) Research Grant	This work was supported by The Frederick J. and Theresa Dow Wallace Fund of the New York Community Trust (http://issuu.com/nyct/docs/nyct_ar12_final_5.22/52), the New York Academy of Medicine - Ferdinand C. Valentine Fellowship in Urology 2013-2014 (http://www.nyam.org/grants/valentine.html) ,and the Society for the Study of Male Reproduction (SSMR) Research Grant (http://ssmr.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGELL N, 1988, BIOCHEM J, V250, P883, DOI 10.1042/bj2500883; Akimoto C, 2010, P NATL ACAD SCI USA, V107, P19891, DOI 10.1073/pnas.1010307107; Andersson AM, 2004, J CLIN ENDOCR METAB, V89, P3161, DOI 10.1210/jc.2003-031786; Aquila S, 2007, HUM REPROD, V22, P2594, DOI 10.1093/humrep/dem243; Aston KI, 2010, HUM REPROD, V25, P1383, DOI 10.1093/humrep/deq081; Baarends WM, 2000, J ENDOCRINOL INVEST, V23, P597, DOI 10.1007/BF03343782; Black BE, 2004, MOL ENDOCRINOL, V18, P834, DOI 10.1210/me.2003-0145; BREMNER WJ, 1994, ENDOCRINOLOGY, V135, P1227, DOI 10.1210/en.135.3.1227; BRYAN RM, 1984, CANCER, V54, P2436, DOI 10.1002/1097-0142(19841201)54:11<2436::AID-CNCR2820541121>3.0.CO;2-H; Cardozo CP, 2003, ARCH BIOCHEM BIOPHYS, V410, P134, DOI 10.1016/S0003-9861(02)00680-X; CIECHANOVER A, 1984, CELL, V37, P57, DOI 10.1016/0092-8674(84)90300-3; Davis-Dao CA, 2011, CARCINOGENESIS, V32, P1238, DOI 10.1093/carcin/bgr104; De Gendt K, 2004, P NATL ACAD SCI USA, V101, P1327, DOI 10.1073/pnas.0308114100; de Vries M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031485; DEMEYTS ER, 1992, J ENDOCRINOL, V135, pR1, DOI 10.1677/joe.0.135R001; Dirac AMG, 2010, MOL CANCER RES, V8, P844, DOI 10.1158/1541-7786.MCR-09-0424; Finley Daniel, 2004, Cell, VS116, pS29, DOI 10.1016/S0092-8674(03)00971-1; Ge RS, 2005, BIOL REPROD, V72, P1405, DOI 10.1095/biolreprod.104.037499; Heinlein CA, 2002, ENDOCR REV, V23, P175, DOI 10.1210/er.23.2.175; Hochstrasser M, 1996, ANNU REV GENET, V30, P405, DOI 10.1146/annurev.genet.30.1.405; Hochstrasser M, 2004, NAT CELL BIOL, V6, P571, DOI 10.1038/ncb0704-571; HOCHSTRASSER M, 1995, CURR OPIN CELL BIOL, V7, P215, DOI 10.1016/0955-0674(95)80031-X; Jacobsen R, 2000, BMJ-BRIT MED J, V321, P789, DOI 10.1136/bmj.321.7264.789; JANSSEN PJ, 1994, J HISTOCHEM CYTOCHEM, V42, P1169, DOI 10.1177/42.8.8027537; Joensen UN, 2007, NAT CLIN PRACT UROL, V4, P402, DOI 10.1038/ncpuro0859; Johnson L, 2001, HUM REPROD, V16, P1575, DOI 10.1093/humrep/16.8.1575; Kawate H, 2005, J CLIN ENDOCR METAB, V90, P6162, DOI 10.1210/jc.2005-0179; Lee IW, 2008, ASIAN J ANDROL, V10, P896, DOI 10.1111/j.1745-7262.2008.00439.x; Lin YW, 2011, INT J ANDROL, V34, pE368, DOI 10.1111/j.1365-2605.2010.01130.x; Lisowski P, 2008, J APPL GENET, V49, P367, DOI 10.1007/BF03195635; Mancini M, 2007, HUM REPROD, V22, P1042, DOI 10.1093/humrep/del500; Merlet J, 2007, P NATL ACAD SCI USA, V104, P3615, DOI 10.1073/pnas.0611421104; Miyajima N, 2008, CANCER RES, V68, P3486, DOI 10.1158/0008-5472.CAN-07-6059; ORTEGO LS, 1994, BIOTECH HISTOCHEM, V69, P317, DOI 10.3109/10520299409106312; Paduch DA, 2005, REPROD BIOMED ONLINE, V10, P747; Pelletier G, 2000, J ENDOCRINOL, V165, P359, DOI 10.1677/joe.0.1650359; Petersen PM, 1999, J CLIN ONCOL, V17, P173, DOI 10.1200/JCO.1999.17.1.173; Sciarra A, 2013, EUR UROL, V64, P722, DOI 10.1016/j.eururo.2013.04.020; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Solakidi S, 2005, HUM REPROD, V20, P3481, DOI 10.1093/humrep/dei267; Stanleya JA, 2010, STEROIDS, V75, P1058, DOI 10.1016/j.steroids.2010.06.009; Steger K, 1998, MOL HUM REPROD, V4, P227, DOI 10.1093/molehr/4.3.227; Stouffs K, 2005, EUR J HUM GENET, V13, P336, DOI 10.1038/sj.ejhg.5201335; Suarez-Quian CA, 1999, J CLIN ENDOCR METAB, V84, P350, DOI 10.1210/jc.84.1.350; TOBIAS JW, 1991, J BIOL CHEM, V266, P12021; van den Driesche S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030111; Varshavsky A, 1997, TRENDS BIOCHEM SCI, V22, P383, DOI 10.1016/S0968-0004(97)01122-5; Varshavsky A, 2000, METHOD ENZYMOL, V327, P578, DOI 10.1016/S0076-6879(00)27303-5; Wang PJ, 2005, HUM MOL GENET, V14, P2911, DOI 10.1093/hmg/ddi322; Wang PJ, 2001, NAT GENET, V27, P422, DOI 10.1038/86927; Weissman BA, 2005, J ANDROL, V26, P369, DOI 10.2164/jandrol.04178; Wilkinson KD, 2000, SEMIN CELL DEV BIOL, V11, P141, DOI 10.1006/scdb.2000.0164; Wilkinson KD, 1997, FASEB J, V11, P1245, DOI 10.1096/fasebj.11.14.9409543; Wong YC, 2001, MARC MALPIG SYMP SER, V7, P111; Wrobel KH, 2000, ANAT EMBRYOL, V202, P209, DOI 10.1007/s004290000111; Zhang J, 2007, ASIAN J ANDROL, V9, P809, DOI 10.1111/j.1745-7262.2007.00305.x; Zhang J, 2009, ASIAN J ANDROL, V11, P478, DOI 10.1038/aja.2009.31; Zhou Q, 2002, J ANDROL, V23, P870	58	18	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98638	10.1371/journal.pone.0098638	http://dx.doi.org/10.1371/journal.pone.0098638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922532	Green Submitted, Green Published, gold			2022-12-27	WOS:000338701300010
J	Zhao, DB; Ning, NN; Lei, Z; Sun, H; Wei, CF; Chen, DW; Li, JX				Zhao, Dongbo; Ning, Nannan; Lei, Zhen; Sun, Hua; Wei, Chuanfei; Chen, Dawei; Li, Jingxin			Identification of a Novel Protein Complex Containing ASIC1a and GABA(A) Receptors and Their Interregulation	PLOS ONE			English	Article							PROTON MODULATION; CONTRIBUTES; EXPRESSION; CHANNELS; CALCIUM	Acid-sensing ion channels (ASICs) belong to the family of the epithelial sodium channel/degenerin (ENaC/DEG) and are activated by extracellular protons. They are widely distributed within both the central and peripheral nervous systems. ASICs were modified by the activation of gamma-aminobutyric acid receptors (GABA(A)), a ligand-gated chloride channels, in hippocampal neurons. In contrast, the activity of GABA(A) receptors were also modulated by extracellular pH. However so far, the mechanisms underlying this intermodulation remain obscure. We hypothesized that these two receptors-GABA(A) receptors and ASICs channels might form a novel protein complex and functionally interact with each other. In the study reported here, we found that ASICs were modified by the activation of GABA(A) receptors either in HEK293 cells following transient co-transfection of GABA(A) and ASIC1a or in primary cultured dorsal root ganglia (DRG) neurons. Conversely, activation of ASIC1a also modifies the GABA(A) receptor-channel kinetics. Immunoassays showed that both GABA(A) and ASIC1a proteins were co-immunoprecipitated mutually either in HEK293 cells co-transfected with GABA(A) and ASIC1a or in primary cultured DRG neurons. Our results indicate that putative GABA(A) and ASIC1a channels functionally interact with each other, possibly via an inter-molecular association by forming a novel protein complex.	[Zhao, Dongbo; Sun, Hua] Shandong Canc Hosp & Inst, Dept Thorac Surg, Jinan, Peoples R China; [Ning, Nannan; Wei, Chuanfei; Chen, Dawei; Li, Jingxin] Shandong Univ, Dept Physiol, Sch Med, Jinan 250100, Peoples R China; [Lei, Zhen] Shandong Univ, Dept Anesthesiol, Qilu Hosp, Jinan 250100, Peoples R China	Shandong First Medical University & Shandong Academy of Medical Sciences; Shandong University; Shandong University	Li, JX (corresponding author), Shandong Univ, Dept Physiol, Sch Med, Jinan 250100, Peoples R China.	ljingxin@sdu.edu.cn		Chen, Dawei/0000-0002-2541-4512	Promotive Research Fund for Excellent Young and Middle-Aged Scientists of Shandong Province [BS2010SW029]; National Natural Science Foundation of China [31171108]	Promotive Research Fund for Excellent Young and Middle-Aged Scientists of Shandong Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from the Promotive Research Fund for Excellent Young and Middle-Aged Scientists of Shandong Province (No. BS2010SW029) and the National Natural Science Foundation of China (No. 31171108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askwith CC, 2004, J BIOL CHEM, V279, P18296, DOI 10.1074/jbc.M312145200; Chen CC, 2002, P NATL ACAD SCI USA, V99, P8992, DOI 10.1073/pnas.122245999; Chen X, PLOS ONE, V6; Chen XM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021970; de la Rosa DA, 2003, J PHYSIOL-LONDON, V546, P77, DOI 10.1113/jphysiol.2002.030692; Dietrich CJ, 2010, J NEUROSCI, V30, P16044, DOI 10.1523/JNEUROSCI.6364-09.2010; Escoubas P, 2000, J BIOL CHEM, V275, P25116, DOI 10.1074/jbc.M003643200; GarciaAnoveros J, 1997, P NATL ACAD SCI USA, V94, P1459, DOI 10.1073/pnas.94.4.1459; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Huang RQ, 2004, J NEUROPHYSIOL, V92, P883, DOI 10.1152/jn.01040.2003; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; KRISHTAL OA, 1981, NEUROSCIENCE, V6, P2599, DOI 10.1016/0306-4522(81)90105-6; Mamet J, 2002, J NEUROSCI, V22, P10662; ROBELLO M, 1994, NEUROSCIENCE, V61, P833, DOI 10.1016/0306-4522(94)90406-5; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Wemmie JA, 2002, NEURON, V34, P463, DOI 10.1016/S0896-6273(02)00661-X; Wemmie JA, 2003, J NEUROSCI, V23, P5496; Weng JY, 2010, J NEUROSCI, V30, P6548, DOI 10.1523/JNEUROSCI.0582-10.2010; Wilkins ME, 2005, J PHYSIOL-LONDON, V567, P365, DOI 10.1113/jphysiol.2005.088823; Wilkins ME, 2002, J NEUROSCI, V22, P5328; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yermolaieva O, 2004, P NATL ACAD SCI USA, V101, P6752, DOI 10.1073/pnas.0308636100; Zhou CY, 2007, BRAIN RES, V1145, P213, DOI 10.1016/j.brainres.2007.01.121; Ziemann AE, 2008, NAT NEUROSCI, V11, P816, DOI 10.1038/nn.2132	24	4	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99735	10.1371/journal.pone.0099735	http://dx.doi.org/10.1371/journal.pone.0099735			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923912	Green Submitted, gold, Green Published			2022-12-27	WOS:000338701300090
J	Yu, ZY; Tan, JC; McMahon, AC; Iismaa, SE; Xiao, XH; Kesteven, SH; Reichelt, ME; Mohl, MC; Smith, NJ; Fatkin, D; Allen, D; Head, SI; Graham, RM; Feneley, MP				Yu, Ze-Yan; Tan, Ju-Chiat; McMahon, Aisling C.; Iismaa, Siiri E.; Xiao, Xiao-Hui; Kesteven, Scott H.; Reichelt, Melissa E.; Mohl, Marion C.; Smith, Nicola J.; Fatkin, Diane; Allen, David; Head, Stewart I.; Graham, Robert M.; Feneley, Michael P.			RhoA/ROCK Signaling and Pleiotropic alpha(1A)-Adrenergic Receptor Regulation of Cardiac Contractility	PLOS ONE			English	Article							RHO-KINASE; HEART-FAILURE; ACTIVATION; MICE; OVEREXPRESSION; DYSFUNCTION; INHIBITION; PHOSPHORYLATION; HYPERTROPHY; PROTEINS	Aims: To determine the mechanisms by which the alpha(1A)-adrenergic receptor (AR) regulates cardiac contractility. Background: We reported previously that transgenic mice with cardiac-restricted alpha(1A)-AR overexpression (alpha(1A)-TG) exhibit enhanced contractility but not hypertrophy, despite evidence implicating this G alpha(q/11)-coupled receptor in hypertrophy. Methods: Contractility, calcium (Ca2+) kinetics and sensitivity, and contractile proteins were examined in cardiomyocytes, isolated hearts and skinned fibers from alpha(1A)-TG mice (170-fold overexpression) and their non-TG littermates (NTL) before and after alpha(1A)-AR agonist stimulation and blockade, angiotensin II (AngII), and Rho kinase (ROCK) inhibition. Results: Hypercontractility without hypertrophy with alpha(1A)-AR overexpression is shown to result from increased intracellular Ca2+ release in response to agonist, augmenting the systolic amplitude of the intracellular Ca2+ concentration [Ca2+](i) transient without changing resting [Ca2+](i). In the absence of agonist, however, alpha(1A)-AR overexpression reduced contractility despite unchanged [Ca2+](i). This hypocontractility is not due to heterologous desensitization: the contractile response to AngII, acting via its G alpha(q/11)-coupled receptor, was unaltered. Rather, the hypocontractility is a pleiotropic signaling effect of the alpha(1A)-AR in the absence of agonist, inhibiting RhoA/ROCK activity, resulting in hypophosphorylation of both myosin phosphatase targeting subunit 1 (MYPT1) and cardiac myosin light chain 2 (cMLC2), reducing the Ca2+ sensitivity of the contractile machinery: all these effects were rapidly reversed by selective alpha(1A)-AR blockade. Critically, ROCK inhibition in normal hearts of NTLs without alpha(1A)-AR overexpression caused hypophosphorylation of both MYPT1 and cMLC2, and rapidly reduced basal contractility. Conclusions: We report for the first time pleiotropic alpha(1A)-AR signaling and the physiological role of RhoA/ROCK signaling in maintaining contractility in the normal heart.	[Yu, Ze-Yan; Tan, Ju-Chiat; McMahon, Aisling C.; Iismaa, Siiri E.; Xiao, Xiao-Hui; Kesteven, Scott H.; Reichelt, Melissa E.; Mohl, Marion C.; Smith, Nicola J.; Fatkin, Diane; Graham, Robert M.; Feneley, Michael P.] Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia; [Yu, Ze-Yan; McMahon, Aisling C.; Fatkin, Diane; Graham, Robert M.; Feneley, Michael P.] St Vincents Hosp, Dept Cardiol, Darlinghurst, NSW 2010, Australia; [Yu, Ze-Yan; Iismaa, Siiri E.; Smith, Nicola J.; Fatkin, Diane; Graham, Robert M.; Feneley, Michael P.] Univ New S Wales, Fac Med, Sydney, NSW, Australia; [Allen, David] Univ Sydney, Dept Physiol, Sydney, NSW 2006, Australia; [Head, Stewart I.] Univ New S Wales, Dept Physiol, Sydney, NSW, Australia	Victor Chang Cardiac Research Institute; St Vincents Hospital Sydney; University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney	Feneley, MP (corresponding author), Victor Chang Cardiac Res Inst, Darlinghurst, NSW, Australia.	mfeneley@stvincents.com.au	Reichelt, Melissa E/C-9579-2014; Head, Stewart/O-7016-2019; Iismaa, Siiri/C-9300-2013	Reichelt, Melissa E/0000-0002-5059-2046; Head, Stewart/0000-0002-6891-7590; Smith, Nicola J/0000-0002-7247-9562; Iismaa, Siiri/0000-0003-2409-7356	National Health and Medical Research Council of Australia Program [354400, 573732, 526622]	National Health and Medical Research Council of Australia Program(National Health and Medical Research Council (NHMRC) of Australia)	National Health and Medical Research Council of Australia Program Grants #354400, 573732, 526622. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braz JC, 2004, NAT MED, V10, P248, DOI 10.1038/nm1000; Chaulet H, 2006, J MOL CELL CARDIOL, V40, P540, DOI 10.1016/j.yjmcc.2006.01.015; Chu L, 2005, N-S ARCH PHARMACOL, V371, P185, DOI 10.1007/s00210-005-1032-z; DAngelo DD, 1997, P NATL ACAD SCI USA, V94, P8121, DOI 10.1073/pnas.94.15.8121; DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001; Du XJ, 2006, CARDIOVASC RES, V71, P735, DOI 10.1016/j.cardiores.2006.06.015; Du XJ, 2004, J MOL CELL CARDIOL, V37, P979, DOI 10.1016/j.yjmcc.2004.07.010; Hamid SA, 2007, AM J PHYSIOL-HEART C, V292, pH2598, DOI 10.1152/ajpheart.01393.2006; Hattori T, 2004, CIRCULATION, V109, P2234, DOI 10.1161/01.CIR.0000127939.16111.58; HEAD SI, 1990, J PHYSIOL-LONDON, V422, P351, DOI 10.1113/jphysiol.1990.sp017988; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; KNOWLTON KU, 1993, J BIOL CHEM, V268, P15374; Kobayashi N, 2002, CARDIOVASC RES, V55, P757, DOI 10.1016/S0008-6363(02)00457-1; Lin G, 2001, CIRC RES, V89, P343, DOI 10.1161/hh1601.095912; Lin GR, 2007, CARDIOVASC RES, V75, P51, DOI 10.1016/j.cardiores.2007.03.009; MILANO CA, 1994, SCIENCE, V264, P582, DOI 10.1126/science.8160017; Mohl MC, 2011, CARDIOVASC RES, V91, P310, DOI 10.1093/cvr/cvr081; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Perez DM, 1996, MOL PHARMACOL, V49, P112; Satoh N, 2000, CIRCULATION, V102, P2249; Smith NJ, 2011, HYPERTENSION, V57, P973, DOI 10.1161/HYPERTENSIONAHA.110.166710; Solaro RJ, 2008, CARDIOVASC RES, V77, P616, DOI 10.1093/cvr/cvn004; van der Velden J, 2003, CARDIOVASC RES, V57, P37, DOI 10.1016/S0008-6363(02)00606-5; Warren SA, 2012, CIRCULATION, V126, P2575, DOI 10.1161/CIRCULATIONAHA.112.116202; Zhao X, 2012, AM J PHYSIOL-HEART C, V302, pH1614, DOI 10.1152/ajpheart.01072.2011	25	11	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99024	10.1371/journal.pone.0099024	http://dx.doi.org/10.1371/journal.pone.0099024			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919197	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000040
J	Bethlehem, RAI; Dumoulin, SO; Dalmaijer, ES; Smit, M; Berendschot, TTJM; Nijboer, TCW; Van der Stigchel, S				Bethlehem, Richard A. I.; Dumoulin, Serge O.; Dalmaijer, Edwin S.; Smit, Miranda; Berendschot, Tos T. J. M.; Nijboer, Tanja C. W.; Van der Stigchel, Stefan			Decreased Fixation Stability of the Preferred Retinal Location in Juvenile Macular Degeneration	PLOS ONE			English	Article							EYE-MOVEMENTS; ECCENTRIC FIXATION; CENTRAL SCOTOMAS; LOCUS; REORGANIZATION; PATTERNS; DISEASE; BEHAVIOR; HUMANS; GAZE	Macular degeneration is the main cause for diminished visual acuity in the elderly. The juvenile form of macular degeneration has equally detrimental consequences on foveal vision. To compensate for loss of foveal vision most patients with macular degeneration adopt an eccentric preferred retinal location that takes over tasks normally performed by the healthy fovea. It is unclear however, whether the preferred retinal locus also develops properties typical for foveal vision. Here, we investigated whether the fixation characteristics of the preferred retinal locus resemble those of the healthy fovea. For this purpose, we used the fixation-offset paradigm and tracked eye-position using a high spatial and temporal resolution infrared eye-tracker. The fixation-offset paradigm measures release from fixation under different fixation conditions and has been shown useful to distinguish between foveal and non-foveal fixation. We measured eye-movements in nine healthy age-matched controls and five patients with juvenile macular degeneration. In addition, we performed a simulation with the same task in a group of five healthy controls. Our results show that the preferred retinal locus does not adopt a foveal type of fixation but instead drifts further away from its original fixation and has overall increased fixation instability. Furthermore, the fixation instability is most pronounced in low frequency eye-movements representing a slow drift from fixation. We argue that the increased fixation instability cannot be attributed to fixation under an unnatural angle. Instead, diminished visual acuity in the periphery causes reduced oculomotor control and results in increased fixation instability.	[Bethlehem, Richard A. I.; Dumoulin, Serge O.; Dalmaijer, Edwin S.; Smit, Miranda; Nijboer, Tanja C. W.; Van der Stigchel, Stefan] Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands; [Smit, Miranda; Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands; [Smit, Miranda; Nijboer, Tanja C. W.] Univ Med Ctr Utrecht, Ctr Excellence Rehabil Med, Utrecht, Netherlands; [Smit, Miranda; Nijboer, Tanja C. W.] Rehabil Ctr De Hoogstraat, Utrecht, Netherlands; [Berendschot, Tos T. J. M.] Univ Eye Clin Maastricht, Maastricht, Netherlands; [Bethlehem, Richard A. I.] Univ Cambridge, Dept Psychiat, Autism Res Ctr, Cambridge, England	Utrecht University; Utrecht University; Utrecht University Medical Center; Utrecht University; Utrecht University Medical Center; Maastricht University; Maastricht University Medical Centre (MUMC); University of Cambridge	Bethlehem, RAI (corresponding author), Univ Utrecht, Helmholtz Inst, Utrecht, Netherlands.	rb643@cam.ac.uk	Berendschot, Tos TJM/M-8509-2016; Dumoulin, Serge O/A-3603-2012; Dalmaijer, Edwin/I-4279-2019	Berendschot, Tos TJM/0000-0002-8101-939X; Dumoulin, Serge O/0000-0001-7474-7711; Dalmaijer, Edwin/0000-0003-3241-0760; van der Stigchel, Stefan/0000-0002-5918-3521; Bethlehem, Richard A.I./0000-0002-0714-0685; Nijboer, Tanja/0000-0001-6683-0267	Dutch MD-foundation	Dutch MD-foundation	This research was funded by a grant from the Dutch MD-foundation to authors SD, TN, and SvS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allikmets R, 1997, NAT GENET, V17, P122, DOI 10.1038/ng0997-122b; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Baker CI, 2008, VISION RES, V48, P1910, DOI 10.1016/j.visres.2008.05.020; Baker CI, 2005, J NEUROSCI, V25, P614, DOI 10.1523/JNEUROSCI.3476-04.2005; Baseler HA, 2011, NAT NEUROSCI, V14, P649, DOI 10.1038/nn.2793; Bither PP, 1985, J AM OPTOMOL ASS, V59, P106; Cacho I, 2007, OPTOMETRY VISION SCI, V84, P487, DOI 10.1097/OPX.0b013e318073c2f2; Crossland MD, 2004, OPHTHAL PHYSL OPT, V24, P327, DOI 10.1111/j.1475-1313.2004.00213.x; Crossland MD, 2002, OPTOMETRY VISION SCI, V79, P735, DOI 10.1097/00006324-200211000-00011; Crossland MD, 2005, OPHTHALMOLOGY, V112, P1579, DOI 10.1016/j.ophtha.2005.03.027; Crossland MD, 2011, RETINA-J RET VIT DIS, V31, P2109, DOI 10.1097/IAE.0b013e31820d3fba; Crossland MD, 2011, INVEST OPHTH VIS SCI, V52, P411, DOI 10.1167/iovs.10-5473; Dalmaijer ES, 2013, BEHAV RES METHODS; Deruaz A, 2004, BRIT J OPHTHALMOL, V88, P461, DOI 10.1136/bjo.2003.025601; Dilks DD, 2009, J NEUROSCI, V29, P2768, DOI 10.1523/JNEUROSCI.5258-08.2009; EIZENMAN M, 1985, VISION RES, V25, P1635, DOI 10.1016/0042-6989(85)90134-8; Fendrich R, 1999, VISION RES, V39, P833, DOI 10.1016/S0042-6989(98)00164-3; Macedo A, 2007, OPTOMETRY VISION SCI, V84, P852, DOI 10.1097/OPX.0b013e3181559beb; FINDLAY JM, 1971, KYBERNETIK, V8, P207, DOI 10.1007/BF00288749; Gonzalez EG, 2011, INVEST OPHTH VIS SCI, V52, P4208, DOI 10.1167/iovs.10-7026; Greenstein VC, 2008, RETINA-J RET VIT DIS, V28, P1234, DOI 10.1097/IAE.0b013e31817c1b47; Kabanarou SA, 2006, OPHTHALMOLOGY, V113, P2251, DOI 10.1016/j.ophtha.2006.06.028; Koenekoop Robert K, 2003, Ophthalmic Genet, V24, P75, DOI 10.1076/opge.24.2.75.13996; Leibowitz H M, 1980, Surv Ophthalmol, V24, P335; Lingnau A, 2010, J VISION, V10, DOI 10.1167/10.11.13; Lingnau A, 2008, J VISION, V8, DOI 10.1167/8.5.6; Macedo AF, 2011, INVEST OPHTH VIS SCI, V52, P1275, DOI 10.1167/iovs.09-4334; Machado L, 2000, PERCEPT PSYCHOPHYS, V62, P1236; Martinez-Conde S, 2004, NAT REV NEUROSCI, V5, P229, DOI 10.1038/nrn1348; Masuda Y, 2008, CEREB CORTEX, V18, P2483, DOI 10.1093/cercor/bhm256; MORGAN MJ, 1989, NATURE, V340, P385, DOI 10.1038/340385a0; Murakami I, 2010, JPN PSYCHOL RES, V52, P54, DOI 10.1111/j.1468-5884.2010.00424.x; Ossewaarde-Van Norel J, 2002, J BIOMED OPT, V7, P190, DOI 10.1117/1.1462034; PORAC C, 1976, PSYCHOL BULL, V83, P880, DOI 10.1037/0033-2909.83.5.880; Rayner K, 1998, PSYCHOL BULL, V124, P372, DOI 10.1037/0033-2909.124.3.372; Reinhard J, 2007, VISION RES, V47, P2076, DOI 10.1016/j.visres.2007.04.012; Sivaprasad S, 2011, EYE, V25, P1612, DOI 10.1038/eye.2011.223; STEINMAN RM, 1967, SCIENCE, V155, P1577, DOI 10.1126/science.155.3769.1577; STEINMAN RM, 1965, J OPT SOC AM, V55, P1158, DOI 10.1364/JOSA.55.001158; STEINMAN RM, 1973, SCIENCE, V181, P810, DOI 10.1126/science.181.4102.810; Sunness JS, 2005, AM J OPHTHALMOL, V140, P1085, DOI 10.1016/j.ajo.2005.07.040; Sunness JS, 1996, OPHTHALMOLOGY, V103, P1458, DOI 10.1016/S0161-6420(96)30483-1; Tarita-Nistor L, 2006, CAN J OPHTHALMOL, V41, P327, DOI 10.1139/I06-029; Tarita-Nistor L, 2008, RETINA-J RET VIT DIS, V28, P125, DOI 10.1097/IAE.0b013e3180ed4571; Tarita-Nistor L, 2012, OPTOMETRY VISION SCI, V89, P277, DOI 10.1097/OPX.0b013e318244e8b1; Tarita-Nistor L, 2011, INVEST OPHTH VIS SCI, V52, P1887, DOI 10.1167/iovs.10-6059; Tarita-Nistor L, 2009, VISUAL NEUROSCI, V26, P487, DOI 10.1017/S0952523809990265; Timberlake GT, 2005, OPTOMETRY VISION SCI, V82, P177, DOI 10.1097/01.OPX.0000156311.49058.C8; TIMBERLAKE GT, 1986, INVEST OPHTH VIS SCI, V27, P1137; Van der Stigchel S, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00579; VANNORREN D, 1989, VISION RES, V29, P1825, DOI 10.1016/0042-6989(89)90163-6; WHITE JM, 1990, INVEST OPHTH VIS SCI, V31, P1149; WHITTAKER SG, 1988, INVEST OPHTH VIS SCI, V29, P268	53	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100171	10.1371/journal.pone.0100171	http://dx.doi.org/10.1371/journal.pone.0100171			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937090	Green Published, gold			2022-12-27	WOS:000338503400085
J	Cheng, L; Li, J; Ju, P; Peng, JJ; Wang, YD				Cheng, Liang; Li, Jie; Ju, Peng; Peng, Jiajie; Wang, Yadong			SemFunSim: A New Method for Measuring Disease Similarity by Integrating Semantic and Gene Functional Association	PLOS ONE			English	Article							PROTEIN-INTERACTION NETWORKS; POLYMYALGIA-RHEUMATICA; ONTOLOGY; PRIORITIZATION; INTERACTOME; IDENTIFICATION; DISCOVERY; MEDICINE; PHENOME	Background: Measuring similarity between diseases plays an important role in disease-related molecular function research. Functional associations between disease-related genes and semantic associations between diseases are often used to identify pairs of similar diseases from different perspectives. Currently, it is still a challenge to exploit both of them to calculate disease similarity. Therefore, a new method (SemFunSim) that integrates semantic and functional association is proposed to address the issue. Methods: SemFunSim is designed as follows. First of all, FunSim (Functional similarity) is proposed to calculate disease similarity using disease-related gene sets in a weighted network of human gene function. Next, SemSim (Semantic Similarity) is devised to calculate disease similarity using the relationship between two diseases from Disease Ontology. Finally, FunSim and SemSim are integrated to measure disease similarity. Results: The high average AUC (area under the receiver operating characteristic curve) (96.37%) shows that SemFunSim achieves a high true positive rate and a low false positive rate. 79 of the top 100 pairs of similar diseases identified by SemFunSim are annotated in the Comparative Toxicogenomics Database (CTD) as being targeted by the same therapeutic compounds, while other methods we compared could identify 35 or less such pairs among the top 100. Moreover, when using our method on diseases without annotated compounds in CTD, we could confirm many of our predicted candidate compounds from literature. This indicates that SemFunSim is an effective method for drug repositioning.	[Cheng, Liang; Li, Jie; Peng, Jiajie; Wang, Yadong] Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Bioinformat, Harbin 150006, Heilongjiang, Peoples R China; [Ju, Peng] Nanyang Technol Univ, Sch Elect & Elect Engn, Singapore 639798, Singapore	Harbin Institute of Technology; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Wang, YD (corresponding author), Harbin Inst Technol, Sch Comp Sci & Technol, Ctr Bioinformat, Harbin 150006, Heilongjiang, Peoples R China.	ydwang@hit.edu.cn	Peng, Jiajie/C-7776-2016; Peng, Jiajie/Y-5601-2019; Cheng, Liang/ABY-7421-2022	Peng, Jiajie/0000-0002-3857-7927; Cheng, Liang/0000-0002-6665-6710	China National 863 High-Tech Program [2012AA02A602, 2012AA020404]; postdoctoral science research developmental foundation of heilongjiang province [lbh-q13084]; National natural science foundation of China [61173085]	China National 863 High-Tech Program(National High Technology Research and Development Program of China); postdoctoral science research developmental foundation of heilongjiang province; National natural science foundation of China(National Natural Science Foundation of China (NSFC))	This work is partially supported by the China National 863 High-Tech Program (2012AA02A602, 2012AA020404), postdoctoral science research developmental foundation of heilongjiang province no. lbh-q13084 and National natural science foundation of China (61173085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amberger J, 2011, HUM MUTAT, V32, P564, DOI 10.1002/humu.21466; [Anonymous], 1997, CMPLG9709008 ARXIV; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Baudot A, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-6-221; Becker KG, 2004, NAT GENET, V36, P431, DOI 10.1038/ng0504-431; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Caporali R, 2004, ANN INTERN MED, V141, P493, DOI 10.7326/0003-4819-141-7-200410050-00005; Chan SY, 2012, CIRC RES, V111, P359, DOI 10.1161/CIRCRESAHA.111.258541; Chen J, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-392; Cheng L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075504; Dakshanamurthy S, 2012, J MED CHEM, V55, P6832, DOI 10.1021/jm300576q; DASGUPTA B, 1991, ANN RHEUM DIS, V50, P942, DOI 10.1136/ard.50.12.942; Davis AP, 2013, NUCLEIC ACIDS RES, V41, pD1104, DOI 10.1093/nar/gks994; DEVECCHI A, 1983, CLIN NEPHROL, V19, P221; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Gottlieb A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.26; Gray KA, 2013, NUCLEIC ACIDS RES, V41, pD545, DOI 10.1093/nar/gks1066; Guo X, 2006, BIOINFORMATICS, V22, P967, DOI 10.1093/bioinformatics/btl042; Heagerty PJ, 2005, BIOMETRICS, V61, P92, DOI 10.1111/j.0006-341X.2005.030814.x; Hu GH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006536; Kann MG, 2007, BRIEF BIOINFORM, V8, P333, DOI 10.1093/bib/bbm031; Kianifar HR, 2012, WORLD J GASTROENTERO, V18, P4912, DOI 10.3748/wjg.v18.i35.4912; KROGSGAARD MR, 1995, J RHEUMATOL, V22, P1660; Kurtoglu S, 2012, J CLIN RES PEDIATR E, V4, P111, DOI 10.4274/jcrpe.553; Lage K, 2007, NAT BIOTECHNOL, V25, P309, DOI 10.1038/nbt1295; Leacock C, 1998, LANG SPEECH & COMMUN, P265; Lee DS, 2008, P NATL ACAD SCI USA, V105, P9880, DOI 10.1073/pnas.0802208105; Lee I, 2011, GENOME RES, V21, P1109, DOI 10.1101/gr.118992.110; Li J, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-266; Li Jiao, 2012, Proceedings (IEEE Int Conf Bioinformatics Biomed), V2012, P1; Li Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004346; Lin D., 1998, Machine Learning. Proceedings of the Fifteenth International Conference (ICML'98), P296; Linghu B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r91; LOWE HJ, 1994, JAMA-J AM MED ASSOC, V271, P1103, DOI 10.1001/jama.271.14.1103; Mathur S, 2012, J BIOMED INFORM, V45, P363, DOI 10.1016/j.jbi.2011.11.017; Mathur Sachin, 2010, Summit Transl Bioinform, V2010, P12; Mitchell Joyce A, 2003, AMIA Annu Symp Proc, P460; Navlakha S, 2010, BIOINFORMATICS, V26, P1057, DOI 10.1093/bioinformatics/btq076; Ortutay C, 2009, NUCLEIC ACIDS RES, V37, P622, DOI 10.1093/nar/gkn982; Pakhomov S, 2010, SEMANTIC SIMILARITY, P572; Peng JJ, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-S2-S15; Pesquita C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000443; Piro RM, 2012, HUM GENET, V131, P1811, DOI 10.1007/s00439-012-1206-y; Reinhardt U, 1989, Z Arztl Fortbild (Jena), V83, P489; Resnik P, 1995, INT JOINT CONF ARTIF, P448; Robinson PN, 2010, CLIN GENET, V77, P525, DOI 10.1111/j.1399-0004.2010.01436.x; Schadt EE, 2009, NATURE, V461, P218, DOI 10.1038/nature08454; Schlicker A, 2010, BIOINFORMATICS, V26, pi561, DOI 10.1093/bioinformatics/btq384; Schriml LM, 2012, NUCLEIC ACIDS RES, V40, pD940, DOI 10.1093/nar/gkr972; Stuart JM, 2003, SCIENCE, V302, P249, DOI 10.1126/science.1087447; Suthram S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000662; Takata T, 1999, AM J MED SCI, V318, P353, DOI 10.1097/00000441-199911000-00013; van Driel MA, 2006, EUR J HUM GENET, V14, P535, DOI 10.1038/sj.ejhg.5201585; Vercelino R, 2008, BASIC CLIN PHARMACOL, V102, P370, DOI 10.1111/j.1742-7843.2007.00181.x; Vidal M, 2011, CELL, V144, P986, DOI 10.1016/j.cell.2011.02.016; Wang D, 2010, BIOINFORMATICS, V26, P1644, DOI 10.1093/bioinformatics/btq241; Wang JZ, 2007, BIOINFORMATICS, V23, P1274, DOI 10.1093/bioinformatics/btm087; Wang J, 2012, NUCLEIC ACIDS RES, V40, pD1055, DOI 10.1093/nar/gkr1171; Wu XB, 2009, BIOINFORMATICS, V25, P98, DOI 10.1093/bioinformatics/btn593; Xu W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049686; Zhang XH, 2011, EUR J HUM GENET, V19, P783, DOI 10.1038/ejhg.2011.30; Ziora D, 1997, Pneumonol Alergol Pol, V65, P635	62	94	94	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99415	10.1371/journal.pone.0099415	http://dx.doi.org/10.1371/journal.pone.0099415			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932637	gold, Green Published			2022-12-27	WOS:000337738600034
J	Guo, P; Zhang, Q; Zhu, ZL; Huang, ZL; Li, K				Guo, Pi; Zhang, Qin; Zhu, Zhenli; Huang, Zhengliang; Li, Ke			Mining Gene Expression Data of Multiple Sclerosis	PLOS ONE			English	Article							INTERFERON-BETA TREATMENT; MICROARRAY ANALYSIS; STRUCTURAL BASIS; MOLECULAR-MODEL; LIGAND TRAIL; HUMAN CDK2; APOPTOSIS; IDENTIFICATION; INHIBITION; UROPEPSIN	Objectives: Microarray produces a large amount of gene expression data, containing various biological implications. The challenge is to detect a panel of discriminative genes associated with disease. This study proposed a robust classification model for gene selection using gene expression data, and performed an analysis to identify disease-related genes using multiple sclerosis as an example. Materials and methods: Gene expression profiles based on the transcriptome of peripheral blood mononuclear cells from a total of 44 samples from 26 multiple sclerosis patients and 18 individuals with other neurological diseases (control) were analyzed. Feature selection algorithms including Support Vector Machine based on Recursive Feature Elimination, Receiver Operating Characteristic Curve, and Boruta algorithms were jointly performed to select candidate genes associating with multiple sclerosis. Multiple classification models categorized samples into two different groups based on the identified genes. Models' performance was evaluated using cross-validation methods, and an optimal classifier for gene selection was determined. Results: An overlapping feature set was identified consisting of 8 genes that were differentially expressed between the two phenotype groups. The genes were significantly associated with the pathways of apoptosis and cytokine-cytokine receptor interaction. TNFSF10 was significantly associated with multiple sclerosis. A Support Vector Machine model was established based on the featured genes and gave a practical accuracy of similar to 86%. This binary classification model also outperformed the other models in terms of Sensitivity, Specificity and F1 score. Conclusions: The combined analytical framework integrating feature ranking algorithms and Support Vector Machine model could be used for selecting genes for other diseases.	[Guo, Pi; Zhu, Zhenli; Li, Ke] Shantou Univ, Coll Med, Dept Publ Hlth, Shantou City, Guangdong, Peoples R China; [Zhang, Qin] Shantou Univ, Coll Med, Good Clin Practice Off, Canc Hosp, Shantou City, Guangdong, Peoples R China; [Huang, Zhengliang] Shantou Univ, Coll Med, Lab Cell Senescence, Shantou City, Guangdong, Peoples R China	Shantou University; Shantou University; Shantou University	Li, K (corresponding author), Shantou Univ, Coll Med, Dept Publ Hlth, Shantou City, Guangdong, Peoples R China.	littlesas@live.cn						Aktas O, 2005, NEURON, V46, P421, DOI 10.1016/j.neuron.2005.03.018; Altmann D, 2005, ARCH NEUROL-CHICAGO, V62, P688, DOI 10.1001/archneur.62.4.688-a; Azevedo LS, 2012, CURR BIOINFORM, V7, P352; Bomprezzi R, 2003, HUM MOL GENET, V12, P2191, DOI 10.1093/hmg/ddg221; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brynedal B, 2010, NEUROBIOL DIS, V37, P613, DOI 10.1016/j.nbd.2009.11.014; Buttmann M, 2007, J NEUROIMMUNOL, V190, P170, DOI 10.1016/j.jneuroim.2007.08.009; Canduri F, 2001, ACTA CRYSTALLOGR D, V57, P1560, DOI 10.1107/S0907444901013865; Chang GTG, 2002, APOPTOSIS, V7, P13, DOI 10.1023/A:1013504710343; Chang JT, 2006, BIOINFORMATICS, V22, P2926, DOI 10.1093/bioinformatics/btl483; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; De Azevedo WF, 2010, CURR DRUG TARGETS, V11, P327, DOI 10.2174/138945010790711941; De Azevedo WF, 2010, CURR DRUG TARGETS, V11, P261, DOI 10.2174/138945010790711969; de Azevedo WF, 2002, BIOCHEM BIOPH RES CO, V293, P566; de Azevedo WF, 2002, BIOCHEM BIOPH RES CO, V297, P1154, DOI 10.1016/S0006-291X(02)02352-5; de Azevedo WF, 2001, BIOCHEM BIOPH RES CO, V287, P277, DOI 10.1006/bbrc.2001.5555; DeAzevedo WF, 1997, EUR J BIOCHEM, V243, P518, DOI 10.1111/j.1432-1033.1997.0518a.x; deAzevedo WF, 1996, P NATL ACAD SCI USA, V93, P2735, DOI 10.1073/pnas.93.7.2735; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Guyon I, 2002, MACH LEARN, V46, P389, DOI 10.1023/A:1012487302797; Heberle G, 2011, CURR MED CHEM, V18, P1339, DOI 10.2174/092986711795029573; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kikuchi S, 2005, J NEUROIMMUNOL, V167, P170, DOI 10.1016/j.jneuroim.2005.06.021; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Lindberg RLP, 2004, J NEUROIMMUNOL, V152, P154, DOI 10.1016/j.jneuroim.2004.03.011; Lopez-Gomez C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021766; McLachlan GJ., 2005, ANAL MICROARRAY GENE; Pepe MS, 2003, BIOMETRICS, V59, P133, DOI 10.1111/1541-0420.00016; R Core Team, 2021, R LANGUAGE ENV STAT; Satoh J, 2005, NEUROBIOL DIS, V18, P537, DOI 10.1016/j.nbd.2004.10.007; Slonim DK, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000543; Sokolova M, 2006, LECT NOTES COMPUT SC, V4304, P1015; Spain BH, 1996, MOL CELL BIOL, V16, P6698; Wan YW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012222; Wandinger KP, 2003, LANCET, V361, P2036, DOI 10.1016/S0140-6736(03)13641-0; Weber A, 2004, J NEUROIMMUNOL, V149, P195, DOI 10.1016/j.jneuroim.2003.12.014; Weinstock-Guttman B, 2006, MULT SCLER J, V12, P541, DOI 10.1177/1352458506070605; Whitney LW, 1999, ANN NEUROL, V46, P425; Wiley SR, 1995, IMMUNITY, V3, P673, DOI 10.1016/1074-7613(95)90057-8; Xi ZQ, 2007, SYNAPSE, V61, P741, DOI 10.1002/syn.20417; Zhou XH, 2012, STAT MED, V31, P643, DOI 10.1002/sim.4382; Zipp F, 1999, IMMUNOL TODAY, V20, P550, DOI 10.1016/S0167-5699(99)01545-5	42	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100052	10.1371/journal.pone.0100052	http://dx.doi.org/10.1371/journal.pone.0100052			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932510	Green Published, gold			2022-12-27	WOS:000337738600087
J	Jackson, C; Mangtani, P; Fine, P; Vynnycky, E				Jackson, Charlotte; Mangtani, Punam; Fine, Paul; Vynnycky, Emilia			The Effects of School Holidays on Transmission of Varicella Zoster Virus, England and Wales, 1967-2008	PLOS ONE			English	Article							SOCIAL MIXING PATTERNS; CHICKENPOX; EPIDEMIOLOGY; MEASLES; IMPACT; SEROPREVALENCE; VACCINATION; INFECTIONS; DISEASES; CLOSURE	Background: Changes in children's contact patterns between termtime and school holidays affect the transmission of several respiratory-spread infections. Transmission of varicella zoster virus (VZV), the causative agent of chickenpox, has also been linked to the school calendar in several settings, but temporal changes in the proportion of young children attending childcare centres may have influenced this relationship. Methods: We used two modelling methods (a simple difference equations model and a Time series Susceptible Infectious Recovered (TSIR) model) to estimate fortnightly values of a contact parameter (the per capita rate of effective contact between two specific individuals), using GP consultation data for chickenpox in England and Wales from 1967-2008. Results: The estimated contact parameters were 22-31% lower during the summer holiday than during termtime. The relationship between the contact parameter and the school calendar did not change markedly over the years analysed. Conclusions: In England and Wales, reductions in contact between children during the school summer holiday lead to a reduction in the transmission of VZV. These estimates are relevant for predicting how closing schools and nurseries may affect an outbreak of an emerging respiratory-spread pathogen.	[Jackson, Charlotte; Mangtani, Punam; Fine, Paul; Vynnycky, Emilia] London Sch Hyg & Trop Med, Dept Infect Dis Epidemiol, London WC1, England; [Jackson, Charlotte; Vynnycky, Emilia] Publ Hlth England, Stat Modelling & Econ Dept, London, England	University of London; London School of Hygiene & Tropical Medicine; Public Health England	Jackson, C (corresponding author), UCL, Res Dept Infect & Populat Hlth, London, England.	c.r.jackson@ucl.ac.uk		Jackson, Charlotte/0000-0001-8544-7685; Mangtani, Punam/0000-0001-7074-2999	National Institute for Health Research; National Institute for Health Research [RTF/01/038] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR))	CJ was supported by a Research Training Fellowship from the National Institute for Health Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABBEY HELEN, 1952, HUMAN BIOL, V24, P201; ANDERSON R M, 1991; Brisson M., 2003, Journal of Medical Virology, V70, pS9, DOI 10.1002/jmv.10313; Brisson M, 2001, EPIDEMIOL INFECT, V127, P305, DOI 10.1017/S0950268801005921; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Carpenter J, 2000, STAT MED, V19, P1141, DOI 10.1002/(SICI)1097-0258(20000515)19:9<1141::AID-SIM479>3.0.CO;2-F; Cauchemez S, 2008, NATURE, V452, P750, DOI 10.1038/nature06732; Cauchemez S, 2009, LANCET INFECT DIS, V9, P473, DOI 10.1016/S1473-3099(09)70176-8; Deguen S, 2000, STAT MED, V19, P1207, DOI 10.1002/(SICI)1097-0258(20000515)19:9&lt;1207::AID-SIM423&gt;3.0.CO;2-L; Department of Education and Science, 1989, ED INN LOND ED AUTH; Eames KTD, 2011, EPIDEMICS-NETH, V3, P103, DOI 10.1016/j.epidem.2011.03.003; Fairley CK, 1996, J INFECT DIS, V174, pS314, DOI 10.1093/infdis/174.Supplement_3.S314; Ferguson NM, 1996, P NATL ACAD SCI USA, V93, P7231, DOI 10.1073/pnas.93.14.7231; Ferrari MJ, 2010, P ROY SOC B-BIOL SCI, V277, P2775, DOI 10.1098/rspb.2010.0536; Fine PEM, 2003, AM J EPIDEMIOL, V158, P1039, DOI 10.1093/aje/kwg251; FINE PEM, 1986, INT J EPIDEMIOL, V15, P237, DOI 10.1093/ije/15.2.237; FINE PEM, 1982, INT J EPIDEMIOL, V11, P5, DOI 10.1093/ije/11.1.5; Finkenstadt BF, 2000, J R STAT SOC C-APPL, V49, P187, DOI 10.1111/1467-9876.00187; Glass K, 2003, J THEOR BIOL, V223, P19, DOI 10.1016/S0022-5193(03)00031-6; GORDON JE, 1962, AM J MED SCI, V244, P362, DOI 10.1097/00000441-196209000-00013; Heininger U, 2006, VACCINE, V24, P3258, DOI 10.1016/j.vaccine.2006.01.026; Hens N, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-5; JOSEPH CA, 1988, BMJ-BRIT MED J, V296, P673, DOI 10.1136/bmj.296.6623.673; Kirkbride JB, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-001998; Kudesia G, 2002, J CLIN PATHOL, V55, P154, DOI 10.1136/jcp.55.2.154; LONDON WP, 1973, AM J EPIDEMIOL, V98, P453, DOI 10.1093/oxfordjournals.aje.a121575; Metcalf CJE, 2009, P ROY SOC B-BIOL SCI, V276, P4111, DOI 10.1098/rspb.2009.1058; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Nardone A, 2007, VACCINE, V25, P7866, DOI 10.1016/j.vaccine.2007.07.036; Office for National Statistics, 2011, REG FORM GOVT OFF RE; Office for National Statistics, 2009, EARL YEARS ED NUMB 3; Office for National Statistics, 2011, BIRTH STAT ENGL WAL; Office for National Statistics, 1981, ONS WEBS KEY POP VIT; Office for National Statistics, 2009, COUNT NONM DISTR UR; Office for National Statistics, 2008, NAM COD ADM GEOGR; Office of Population Censuses and Surveys, 1974, KEY POP VIT STAT; Richardson M, 2001, PEDIATR INFECT DIS J, V20, P380, DOI 10.1097/00006454-200104000-00004; Ross A M, 2000, Commun Dis Public Health, V3, P213; Royal College of General Practitioners, 2009, WEEKL RET SERV ANN R; Schenzle D, 1984, IMA J Math Appl Med Biol, V1, P169; Sengupta N, 2009, CURR PEDIATR REV, V5, P207, DOI 10.2174/157339609791317315; Whitaker HJ, 2004, BIOMETRICS, V60, P615, DOI 10.1111/j.0006-341X.2004.00210.x	42	11	15	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99762	10.1371/journal.pone.0099762	http://dx.doi.org/10.1371/journal.pone.0099762			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932994	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000337738600061
J	Mehta, A; Sidhu, C; Pinnaka, AK; Choudhury, AR				Mehta, Ananya; Sidhu, Chandni; Pinnaka, Anil Kumar; Choudhury, Anirban Roy			Extracellular Polysaccharide Production by a Novel Osmotolerant Marine Strain of Alteromonas macleodii and Its Application towards Biomineralization of Silver	PLOS ONE			English	Article							BACTERIAL EXOPOLYSACCHARIDES; ANTIMICROBIAL ACTIVITY; GEN. NOV.; NANOPARTICLES; GOLD	The present study demonstrates exopolysaccharide production by an osmotolerant marine isolate and also describes further application of the purified polysaccharide for production of colloidal suspension of silver nanoparticles with narrow size distribution. Phylogenetic analysis based on 16S r RNA gene sequencing revealed close affinity of the isolate to Alteromonas macleodii. Unlike earlier reports, where glucose was used as the carbon source, lactose was found to be the most suitable substrate for polysaccharide production. The strain was capable of producing 23.4 gl(-1) exopolysaccharide with a productivity of 7.8 gl(-1) day(-1) when 15% (w/v) lactose was used as carbon source. Furthermore, the purified polysaccharide was able to produce spherical shaped silver nanoparticles of around 70 nm size as characterized by Uv-vis spectroscopy, Dynamic light scattering and Transmission electron microscopy. These observations suggested possible commercial potential of the isolated strain for production of a polysaccharide which has the capability of synthesizing biocompatible metal nanoparticle.	[Mehta, Ananya; Sidhu, Chandni; Pinnaka, Anil Kumar; Choudhury, Anirban Roy] CSIR, Inst Microbial Technol, Chandigarh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH)	Choudhury, AR (corresponding author), CSIR, Inst Microbial Technol, Chandigarh, India.	anirban@imtech.res.in	Pinnaka, Anil Kumar/G-5063-2011	Sidhu, Chandni/0000-0003-1386-1881	CSIR, India	CSIR, India(Council of Scientific & Industrial Research (CSIR) - India)	The authors acknowledge CSIR, India, for the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bankura KP, 2012, CARBOHYD POLYM, V89, P1159, DOI 10.1016/j.carbpol.2012.03.089; Chi Z, 2007, BIORESOURCE TECHNOL, V98, P1329, DOI 10.1016/j.biortech.2006.05.001; Choudhury AR, 2011, CARBOHYD POLYM, V83, P1547, DOI 10.1016/j.carbpol.2010.10.003; Chun J, 2007, INT J SYST EVOL MICR, V57, P2259, DOI 10.1099/ijs.0.64915-0; Cia J, 2009, BIOMACROMOLECULES, V10, P87; DALBOW DG, 1975, BIOCHEM J, V150, P1; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Huang HZ, 2004, CARBOHYD RES, V339, P2627, DOI 10.1016/j.carres.2004.08.005; Kaler A, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/872940; Kanmani P, 2013, PROCESS BIOCHEM, V48, P1099, DOI 10.1016/j.procbio.2013.05.011; Kanmani P, 2013, CARBOHYD POLYM, V97, P421, DOI 10.1016/j.carbpol.2013.04.048; Kemp MM, 2009, BIOMACROMOLECULES, V10, P589, DOI 10.1021/bm801266t; Kim SJ, 2007, J MICROBIOL, V45, P510; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Ko SH., 2000, BIOTECHNOL BIOPROC E, V5, P181, DOI DOI 10.1007/BF02936591; Kumar PA, 2010, INT J SYST EVOL MICR, V60, P721, DOI 10.1099/ijs.0.014076; Laurienzo P, 2010, MAR DRUGS, V8, P2435, DOI 10.3390/md8092435; Le Costaouec T, 2012, CARBOHYD POLYM, V90, P49, DOI 10.1016/j.carbpol.2012.04.059; Mandal AK, 2013, J BIOSCI BIOENG, V115, P76, DOI 10.1016/j.jbiosc.2012.08.006; Mittal AK, 2013, BIOTECHNOL ADV, V31, P346, DOI 10.1016/j.biotechadv.2013.01.003; Narayanan KB, 2010, ADV COLLOID INTERFAC, V156, P1, DOI 10.1016/j.cis.2010.02.001; Nichols CAM, 2005, MAR BIOTECHNOL, V7, P253, DOI 10.1007/s10126-004-5118-2; Poli A, 2010, MAR DRUGS, V8, P1779, DOI 10.3390/md8061779; Raguenes G, 1996, APPL ENVIRON MICROB, V62, P67, DOI 10.1128/AEM.62.1.67-73.1996; Raveendran P, 2003, J AM CHEM SOC, V125, P13940, DOI 10.1021/ja029267j; Saha S, 2010, LANGMUIR, V26, P2885, DOI 10.1021/la902950x; Sharma N, 2012, MICROB CELL FACT, V11, DOI 10.1186/1475-2859-11-86; Srinivas TNR, 2011, INT J SYST EVOL MICR, V61, P1521, DOI 10.1099/ijs.0.025429-0; Suresh AK, 2011, ACTA BIOMATER, V7, P2148, DOI 10.1016/j.actbio.2011.01.023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Wei DW, 2009, CARBOHYD RES, V344, P2375, DOI 10.1016/j.carres.2009.09.001; [No title captured]	33	26	27	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98798	10.1371/journal.pone.0098798	http://dx.doi.org/10.1371/journal.pone.0098798			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932690	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600013
J	Cartier, F; Marcq, I; Douam, F; Ossart, C; Regnier, A; Debuysscher, V; Lavillette, D; Bouhlal, H				Cartier, Flora; Marcq, Ingrid; Douam, Florian; Ossart, Christele; Regnier, Aline; Debuysscher, Veronique; Lavillette, Dimitri; Bouhlal, Hicham			The Expression of the Hepatocyte SLAMF3 (CD229) Receptor Enhances the Hepatitis C Virus Infection	PLOS ONE			English	Article							CELL ENTRY; IDENTIFICATION; BINDING; CD81; CHOLESTEROL; REQUIRES; STEP; SAP	Hepatitis C virus (HCV) is a leading cause of cirrhosis and liver cancer worldwide. We recently characterized for the first time the expression of Signaling Lymphocyte Activating Molecule 3 (SLAMF3) in human hepatocytes and here, we report that SLAMF3 interacts with the HCV viral protein E2 and is implicated in HCV entry process. We found a strong correlation between SLAMF3 expression level and hepatocyte susceptibility to HCV infection. The use of specific siRNAs to down-modulate SLAMF3 expression and SLAMF3-blocking antibodies both decreased the hepatocytes susceptibility to HCV infection. Moreover, SLAMF3 over-expression significantly increased susceptibility to HCV infection. Interestingly, experiments with peptides derived from each SLAMF3 domain showed that the first N-terminal extracellular domain is essential for interaction with HCV particles. Finally, we showed that recombinant HCV envelop protein E2 can bind SLAMF3 and that anti-SLAMF3 antibodies inhibited specifically this interaction. Overall, our results revealed that SLAMF3 plays a role during HCV entry, likely by enhancing entry of viral particle within hepatocytes.	[Cartier, Flora; Marcq, Ingrid; Ossart, Christele; Regnier, Aline; Debuysscher, Veronique; Bouhlal, Hicham] Univ Picardie, CAP Sante FED 4231, EA 4666, UFR Med, Amiens, France; [Cartier, Flora] Univ Bordeaux Segalen, Lab Physiol Canc Foie, INSERM, U1053, Bordeaux, France; [Douam, Florian; Lavillette, Dimitri] Univ Lyon 1, UMR CNRS Ecol Microbienne 5557, F-69622 Villeurbanne, France; [Ossart, Christele; Regnier, Aline; Bouhlal, Hicham] CHU Amiens Sud, Lab Therapie Cellulaire, Amiens, France	Picardie Universites; Universite de Picardie Jules Verne (UPJV); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens	Bouhlal, H (corresponding author), Univ Picardie, CAP Sante FED 4231, EA 4666, UFR Med, Amiens, France.	hicham.bouhlal@u-picardie.fr		Lavillette, Dimitri/0000-0002-4706-1519	Conseil Regional de Picardie [Imm-HCV]; Amiens University Medical Center CHU Amiens; CHU Amiens; French Ministry of Research	Conseil Regional de Picardie(Region Hauts-de-France); Amiens University Medical Center CHU Amiens; CHU Amiens; French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was supported by the Conseil Regional de Picardie (project reference: Imm-HCV) and the Amiens University Medical Center CHU Amiens. FC received a doctoral fellowship from CHU Amiens. FD received a fellowship from the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Bartosch B, 2003, J BIOL CHEM, V278, P41624, DOI 10.1074/jbc.M305289200; Bartosch B, 2003, J EXP MED, V197, P633, DOI 10.1084/jem.20021756; Castelain S, 2004, J CLIN VIROL, V31, P227, DOI 10.1016/j.jcv.2004.03.009; Del Valle JM, 2003, J BIOL CHEM, V278, P17430, DOI 10.1074/jbc.M301569200; Douam F, 2013, CRITICAL INTERACTION, DOI [10.1002/hep.26733, DOI 10.1002/HEP.26733]; Engel P, 2003, NAT REV IMMUNOL, V3, P813, DOI 10.1038/nri1202; Evans MJ, 2007, NATURE, V446, P801, DOI 10.1038/nature05654; Flint Mike, 2009, V510, P265, DOI 10.1007/978-1-59745-394-3_20; Grove J, 2007, J VIROL, V81, P3162, DOI 10.1128/JVI.02356-06; Kapadia SB, 2007, J VIROL, V81, P374, DOI 10.1128/JVI.01134-06; Koutsoudakis G, 2006, J VIROL, V80, P5308, DOI 10.1128/JVI.02460-05; Lavillette D, 2005, HEPATOLOGY, V41, P265, DOI 10.1002/hep.20542; Lindenbach BD, 2005, SCIENCE, V309, P623, DOI 10.1126/science.1114016; Lupberger J, 2011, NAT MED, V17, P589, DOI 10.1038/nm.2341; Marcq I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082918; Martin DN, 2013, P NATL ACAD SCI USA, V110, P10777, DOI 10.1073/pnas.1301764110; Martin M, 2005, J IMMUNOL, V174, P5977, DOI 10.4049/jimmunol.174.10.5977; Meertens L, 2006, J VIROL, V80, P11571, DOI 10.1128/JVI.01717-06; Pileri P, 1998, SCIENCE, V282, P938, DOI 10.1126/science.282.5390.938; Ploss A, 2012, CURR OPIN VIROL, V2, P14, DOI 10.1016/j.coviro.2011.12.007; Ploss A, 2009, NATURE, V457, P882, DOI 10.1038/nature07684; Romero X, 2005, J IMMUNOL, V174, P7033, DOI 10.4049/jimmunol.174.11.7033; Sainz B, 2012, NAT MED, V18, P281, DOI 10.1038/nm.2581; Sandrin MS, 1996, IMMUNOGENETICS, V43, P13; Tatsuo H, 2000, NATURE, V406, P893, DOI 10.1038/35022579; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Zhang J, 2004, J VIROL, V78, P1448, DOI 10.1128/JVI.78.3.1448-1455.2004	28	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99601	10.1371/journal.pone.0099601	http://dx.doi.org/10.1371/journal.pone.0099601			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927415	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100054
J	Nielsen, RO; Ronnow, L; Rasmussen, S; Lind, M				Nielsen, Rasmus Oestergaard; Ronnow, Lotte; Rasmussen, Sten; Lind, Martin			A Prospective Study on Time to Recovery in 254 Injured Novice Runners	PLOS ONE			English	Article							LOWER-EXTREMITY INJURIES; OVERUSE INJURIES; RISK-FACTORS; FOOT	Objectives: Describe the diagnoses and the time to recovery of running-related injuries in novice runners. Design: Prospective cohort study on injured runners. Method: This paper is a secondary data analysis of a 933-person cohort study (DANO-RUN) aimed at characterizing risk factors for injury in novice runners. Among those sustaining running-related injuries, the types of injuries and time to recovery is described in the present paper. All injured runners were diagnosed after a thorough clinical examination and then followed prospectively during their recovery. If they recovered completely from injury, time to recovery of each injury was registered. Results: A total of 254 runners were injured. The proportion of runners diagnosed with medial tibial stress syndrome was 15%, 10% for patellofemoral pain, 9% for medial meniscal injury, 7% for Achilles tendinopathy and 5% for plantar fasciitis. Among the 220 runners (87%) recovering from their injury, the median time to recovery was 71 days (minimum = 9 days, maximum = 617 days). Conclusions: Medial tibial stress syndrome was the most common injury followed by patellofemoral pain, medial meniscal injury and Achilles tendinopathy. Half of the injured runners were unable to run 26500 meters without pain after 10 weeks. Almost 5% of the injured runners received surgical treatment.	[Nielsen, Rasmus Oestergaard] Aarhus Univ, Dept Publ Hlth, Sect Sports Sci, Aarhus, Denmark; [Nielsen, Rasmus Oestergaard; Rasmussen, Sten] Aalborg Univ Hosp, Sci & Innovat Ctr, Orthopaed Surg Res Unit, Aalborg, Denmark; [Ronnow, Lotte; Lind, Martin] Aarhus Univ Hosp, Dept Orthopaed, DK-8000 Aarhus, Denmark	Aarhus University; Aalborg University; Aalborg University Hospital; Aarhus University	Nielsen, RO (corresponding author), Aarhus Univ, Dept Publ Hlth, Sect Sports Sci, Aarhus, Denmark.	roen@sport.au.dk	Rasmussen, Sten/N-3916-2013; Nielsen, Rasmus Oestergaard/O-1288-2013	Rasmussen, Sten/0000-0002-8664-352X; Nielsen, Rasmus Oestergaard/0000-0001-5757-1806				Bertelsen ML, 2013, GAIT POSTURE, V38, P354, DOI 10.1016/j.gaitpost.2012.11.022; Buist I, 2010, BRIT J SPORT MED, V44, P598, DOI 10.1136/bjsm.2007.044677; Buist I, 2008, AM J SPORT MED, V36, P35, DOI 10.1177/0363546507307505; Buist I, 2010, AM J SPORT MED, V38, P273, DOI 10.1177/0363546509347985; Khan KM, 1998, CLIN J SPORT MED, V8, P1, DOI 10.1097/00042752-199801000-00001; Knobloch K, 2008, FOOT ANKLE INT, V29, P671, DOI 10.3113/FAI.2008.0671; KOPLAN JP, 1995, MED SCI SPORT EXER, V27, P1180; Lopes AD, 2012, SPORTS MED, V42, P891, DOI [10.2165/11631170-000000000-00000, 10.1007/BF03262301]; McKean KA, 2006, CLIN J SPORT MED, V16, P149, DOI 10.1097/00042752-200603000-00011; Moen MH, 2012, SCAND J MED SCI SPOR, V22, P34, DOI 10.1111/j.1600-0838.2010.01144.x; Nielsen RO, 2012, INT J SPORTS PHYS TH, V7, P58; Nielsen RO, 2014, BRIT J SPORT MED, V48, P440, DOI 10.1136/bjsports-2013-092202; Nielsen RO, 2011, BRIT J SPORT MED, V45, P365; Rasmussen CH, 2013, INT J SPORTS PHYS TH, V8, P111; Schneiders AG, 2012, J ORTHOP SPORT PHYS, V42, P760, DOI 10.2519/jospt.2012.4000; Taunton JE, 2003, BRIT J SPORT MED, V37, P239, DOI 10.1136/bjsm.37.3.239; Taunton JE, 2002, BRIT J SPORT MED, V36, P95, DOI 10.1136/bjsm.36.2.95; Teh J, 2011, SEMIN MUSCULOSKEL R, V15, P101, DOI 10.1055/s-0031-1271962; Van Middelkoop M, 2008, SCAND J MED SCI SPOR, V18, P691, DOI 10.1111/j.1600-0838.2007.00768.x; van Middelkoop M, 2007, CLIN J SPORT MED, V17, P25, DOI 10.1097/JSM.0b013e3180305e4d; Wen Dennis Y, 2007, Curr Sports Med Rep, V6, P307	22	51	52	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99877	10.1371/journal.pone.0099877	http://dx.doi.org/10.1371/journal.pone.0099877			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923269	gold, Green Published			2022-12-27	WOS:000338701300103
J	Toftager, M; Christiansen, LB; Ersboll, AK; Kristensen, PL; Due, P; Troelsen, J				Toftager, Mette; Christiansen, Lars B.; Ersboll, Annette K.; Kristensen, Peter L.; Due, Pernille; Troelsen, Jens			Intervention Effects on Adolescent Physical Activity in the Multicomponent SPACE Study: A Cluster Randomized Controlled Trial	PLOS ONE			English	Article							CHILDREN; PATTERNS; FITNESS; DESIGN	Background: Multicomponent school-based interventions have the potential to reduce the age-related decline in adolescents' physical activity (PA), yet there is not consistent evidence to guide non-curricular and school environment interventions. The aim of this study was to assess the effectiveness of a multicomponent environmental school-based intervention, designed to reduce the age-related decline in PA among adolescents. Methods: A cluster randomized controlled trial was conducted with 7 intervention and 7 control schools. Baseline measurements were carried out in spring 2010 with 2 years of follow-up. A total of 1,348 students (11-13 years, in grade 5 and 6) enrolled in the study at baseline. The 14 schools included in the study were located in the Region of Southern Denmark. The intervention consisted of organizational and physical changes in the school environment with a total of 11 intervention components. The primary outcome measure was overall PA (cpm, counts per minute) and was supported by analyses of time spent in MVPA, and time spent sedentary. Furthermore, a secondary outcome measure was PA in school time and during recess. PA was measured using accelerometer (Actigraph GT3X). Results: A total of 797 students completed the trial and had valid accelerometer data. No significant difference was found for overall PA with an adjusted difference of -19.1 cpm (95% CI: -93, 53) or for school time activity with an adjusted difference of 6 cpm (95% CI: -73, 85). A sensitivity analysis revealed a positive significant intervention effect of PA in recess with an adjusted difference of 95 cpm. Conclusions: No evidence was found of the overall effect of a non-curricular multicomponent school-based intervention on PA among Danish adolescents. The intervention was positively associated with PA during school time and recess, however, with small estimates. Lack of effect on overall PA could be due to both program theory and different degrees of implementation.	[Toftager, Mette; Christiansen, Lars B.; Kristensen, Peter L.; Troelsen, Jens] Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark; [Toftager, Mette; Christiansen, Lars B.; Ersboll, Annette K.; Due, Pernille; Troelsen, Jens] Univ Southern Denmark, Natl Inst Publ Hlth, Ctr Intervent Res Hlth Promot & Dis Prevent, Copenhagen, Denmark	University of Southern Denmark; University of Southern Denmark	Toftager, M (corresponding author), Univ Southern Denmark, Inst Sports Sci & Clin Biomech, Odense, Denmark.	mtoftager@health.sdu.dk		Ersboll, Annette Kjaer/0000-0002-9407-3387; Troelsen, Jens/0000-0001-8105-0349; Kristensen, Peter Lund/0000-0002-5666-9614; Christiansen, Lars Breum/0000-0002-5142-3623	Centre for Intervention Research in Health Promotion and Disease prevention	Centre for Intervention Research in Health Promotion and Disease prevention	Trygfonden supported the SPACE study. The SPACE study is part of the Centre for Intervention Research in Health Promotion and Disease prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraha I, 2010, BMJ, V340; Baadsgaard M, 2011, SCAND J PUBLIC HEALT, V39, P103, DOI 10.1177/1403494811405098; Bland JM, 1996, BMJ-BRIT MED J, V312, P1153; Cain KL, 2012, ACCELEROMETER DATA C; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; DIEHR P, 1995, STAT MED, V14, P1491, DOI 10.1002/sim.4780141309; Dobbins M, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007651.pub2; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Giles-Corti B, 2005, EXERC SPORT SCI REV, V33, P175, DOI 10.1097/00003677-200510000-00005; Grydeland M, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-17; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; HAGENAARS AJM, 1985, REV INCOME WEALTH, P139; Harold III WK, 2013, ED STUDENT BODY TAKI; Kahn JA, 2008, J ADOLESCENT HEALTH, V42, P369, DOI 10.1016/j.jadohealth.2007.11.143; King AC, 2002, AM J PREVENTIVE MED, V23; Kriemler S, 2011, BRIT J SPORT MED, V45, P923, DOI 10.1136/bjsports-2011-090186; Kriemler S, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c785; Metcalf B, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5888; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Pate RR, 2007, AM J PREV MED, V33, P276, DOI 10.1016/j.amepre.2007.06.005; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Riddoch CJ, 2004, MED SCI SPORT EXER, V36, P86, DOI 10.1249/01.MSS.0000106174.43932.92; Ridgers ND, 2012, AM J PREV MED, V43, P320, DOI 10.1016/j.amepre.2012.05.019; Sallis JE, 2006, ANNU REV PUBL HEALTH, V27, P297, DOI 10.1146/annurev.publhealth.27.021405.102100; Sallis JF, 2008, ECOLOGICAL MODELS HL; Santelli John S, 2003, J Adolesc Health, V33, P396; Sherar LB, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-485; Toftager M, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-777; Troelsen J, 2013, SPACE RUM FYSISK AKT; Trost SG, 2007, AM J LIFESTYLE MED, V1, P299, DOI 10.1177/1559827607301686; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; White IR, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d40	35	38	38	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99369	10.1371/journal.pone.0099369	http://dx.doi.org/10.1371/journal.pone.0099369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24921948	Green Published, gold			2022-12-27	WOS:000338701300055
J	de Boer, BA; van Duijvenboden, K; van den Boogaard, M; Christoffels, VM; Barnett, P; Ruijter, JM				de Boer, Bouke A.; van Duijvenboden, Karel; van den Boogaard, Malou; Christoffels, Vincent M.; Barnett, Phil; Ruijter, Jan M.			OccuPeak: ChIP-Seq Peak Calling Based on Internal Background Modelling	PLOS ONE			English	Article							PROTEIN-DNA INTERACTIONS; GENOME-WIDE ASSOCIATION; FACTOR-BINDING SITES; GENETIC-VARIATION; SYSTEMATIC EVALUATION; NONCODING SEQUENCES; TRANSCRIPTION; ENHANCERS; BIAS; CONDUCTION	ChIP-seq has become a major tool for the genome-wide identification of transcription factor binding or histone modification sites. Most peak-calling algorithms require input control datasets to model the occurrence of background reads to account for local sequencing and GC bias. However, the GC-content of reads in Input-seq datasets deviates significantly from that in ChIP-seq datasets. Moreover, we observed that a commonly used peak calling program performed equally well when the use of a simulated uniform background set was compared to an Input-seq dataset. This contradicts the assumption that input control datasets are necessary to fatefully reflect the background read distribution. Because the GC-content of the abundant single reads in ChIP-seq datasets is similar to those of randomly sampled regions we designed a peak-calling algorithm with a background model based on overlapping single reads. The application, OccuPeak, uses the abundant low frequency tags present in each ChIP-seq dataset to model the background, thereby avoiding the need for additional datasets. Analysis of the performance of OccuPeak showed robust model parameters. Its measure of peak significance, the excess ratio, is only dependent on the tag density of a peak and the global noise levels. Compared to the commonly used peak-calling applications MACS and CisGenome, OccuPeak had the highest sensitivity in an enhancer identification benchmark test, and performed similar in an overlap tests of transcription factor occupation with DNase I hypersensitive sites and H3K27ac sites. Moreover, peaks called by OccuPeak were significantly enriched with cardiac disease-associated SNPs. OccuPeak runs as a standalone application and does not require extensive tweaking of parameters, making its use straightforward and user friendly. Availability: http://occupeak.hfrc.nl	[de Boer, Bouke A.; van Duijvenboden, Karel; van den Boogaard, Malou; Christoffels, Vincent M.; Barnett, Phil; Ruijter, Jan M.] Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, NL-1105 AZ Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam	Barnett, P (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Anat Embryol & Physiol, Meibergdreef 9, NL-1105 AZ Amsterdam, Netherlands.	p.barnett@amc.uva.nl; j.m.ruijter@amc.uva.nl		Barnett, Phil/0000-0001-7420-6106; van den Boogaard, Malou/0000-0002-1954-7060	CHeartED [Health-F2-2008-223040]; Academic Medical Centre, Amsterdam	CHeartED; Academic Medical Centre, Amsterdam	BdB was supported by CHeartED (Health-F2-2008-223040); KvD is supported by a fellowship of the Academic Medical Centre, Amsterdam. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aird D, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-2-r18; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Benjamini Y, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks001; Blahnik KR, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1012; Blankenberg D, 2010, BIOINFORMATICS, V26, P1783, DOI 10.1093/bioinformatics/btq281; Chambers JC, 2010, NAT GENET, V42, P149, DOI 10.1038/ng.516; Chen YW, 2012, NAT METHODS, V9, P609, DOI [10.1038/NMETH.1985, 10.1038/nmeth.1985]; Cheung MS, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr425; Cock PJA, 2010, NUCLEIC ACIDS RES, V38, P1767, DOI 10.1093/nar/gkp1137; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Dixon JR, 2012, NATURE, V485, P376, DOI 10.1038/nature11082; Dubchak I, 2000, GENOME RES, V10, P1304, DOI 10.1101/gr.142200; Feng JX, 2012, NAT PROTOC, V7, P1728, DOI 10.1038/nprot.2012.101; Hard T, 1996, BIOPHYS CHEM, V62, P121, DOI 10.1016/S0301-4622(96)02197-7; He AB, 2011, P NATL ACAD SCI USA, V108, P5632, DOI 10.1073/pnas.1016959108; Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106; Hoang Stephen A, 2011, BMC Res Notes, V4, P288, DOI 10.1186/1756-0500-4-288; Holm H, 2010, NAT GENET, V42, P117, DOI 10.1038/ng.511; Hoogaars WMH, 2007, GENE DEV, V21, P1098, DOI 10.1101/gad.416007; Horsthuis T, 2009, CIRC RES, V105, P61, DOI 10.1161/CIRCRESAHA.108.192443; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Johnson DS, 2008, GENOME RES, V18, P393, DOI 10.1101/gr.7080508; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kidder BL, 2011, NAT IMMUNOL, V12, P918, DOI 10.1038/ni.2117; Laajala TD, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-618; Landt SG, 2012, GENOME RES, V22, P1813, DOI 10.1101/gr.136184.111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Maurano MT, 2012, SCIENCE, V337, P1190, DOI 10.1126/science.1222794; Montavon T, 2011, CELL, V147, P1132, DOI 10.1016/j.cell.2011.10.023; Nix DA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-523; Nobrega MA, 2003, SCIENCE, V302, P413, DOI 10.1126/science.1088328; Pennacchio LA, 2006, NATURE, V444, P499, DOI 10.1038/nature05295; Pfeufer A, 2010, NAT GENET, V42, P153, DOI 10.1038/ng.517; Phillips-Cremins JE, 2013, CELL, V153, P1281, DOI 10.1016/j.cell.2013.04.053; Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068; Rozowsky J, 2009, NAT BIOTECHNOL, V27, P66, DOI 10.1038/nbt.1518; Ruijter JM, 2002, PHYSIOL GENOMICS, V11, P37, DOI 10.1152/physiolgenomics.00042.2002; Rye MB, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkq1187; Schweikert C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-S8-S12; Shen Y, 2012, NATURE, V488, P116, DOI 10.1038/nature11243; Sherry ST, 2001, NUCLEIC ACIDS RES, V29, P308, DOI 10.1093/nar/29.1.308; Smith JG, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001304; Sotoodehnia N, 2010, NAT GENET, V42, P1068, DOI 10.1038/ng.716; Stamatoyannopoulos JA, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-418; Szalkowski AM, 2011, BRIEF BIOINFORM, V12, P626, DOI 10.1093/bib/bbq068; Teytelman L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006700; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; van den Boogaard M, 2012, J CLIN INVEST, V122, P2519, DOI 10.1172/JCI62613; Visel A, 2008, NAT GENET, V40, P158, DOI 10.1038/ng.2007.55; Wilbanks EG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011471; Zhang Yanfeng, 2012, Zoological Research, V33, pE121, DOI [10.3724/SP.J.1141.2012.E120-06E121, 10.3724/SP.J.1141.2012.E05-06E121]; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhu LC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-47	54	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99844	10.1371/journal.pone.0099844	http://dx.doi.org/10.1371/journal.pone.0099844			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936875	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400043
J	Smith, C; Skelly, C; Kung, N; Roberts, B; Field, H				Smith, Craig; Skelly, Chris; Kung, Nina; Roberts, Billie; Field, Hume			Flying-Fox Species Density - A Spatial Risk Factor for Hendra Virus Infection in Horses in Eastern Australia	PLOS ONE			English	Article							PTEROPID BATS; DISEASE; MORBILLIVIRUS; HENIPAVIRUSES; CORONAVIRUSES; PREVALENCE; RESERVOIR	Hendra virus causes sporadic but typically fatal infection in horses and humans in eastern Australia. Fruit-bats of the genus Pteropus (commonly known as flying-foxes) are the natural host of the virus, and the putative source of infection in horses; infected horses are the source of human infection. Effective treatment is lacking in both horses and humans, and notwithstanding the recent availability of a vaccine for horses, exposure risk mitigation remains an important infection control strategy. This study sought to inform risk mitigation by identifying spatial and environmental risk factors for equine infection using multiple analytical approaches to investigate the relationship between plausible variables and reported Hendra virus infection in horses. Spatial autocorrelation (Global Moran's I) showed significant clustering of equine cases at a distance of 40 km, a distance consistent with the foraging 'footprint' of a flying-fox roost, suggesting the latter as a biologically plausible basis for the clustering. Getis-Ord Gi* analysis identified multiple equine infection hot spots along the eastern Australia coast from far north Queensland to central New South Wales, with the largest extending for nearly 300 km from southern Queensland to northern New South Wales. Geographically weighted regression (GWR) showed the density of P. alecto and P. conspicillatus to have the strongest positive correlation with equine case locations, suggesting these species are more likely a source of infection of Hendra virus for horses than P. poliocephalus or P. scapulatus. The density of horses, climate variables and vegetation variables were not found to be a significant risk factors, but the residuals from the GWR suggest that additional unidentified risk factors exist at the property level. Further investigations and comparisons between case and control properties are needed to identify these local risk factors.	[Smith, Craig; Kung, Nina; Field, Hume] Dept Agr Fisheries & Forestry, Queensland Ctr Emerging Infect Dis, Brisbane, Qld, Australia; [Skelly, Chris] Dept Agr Fisheries & Forestry, Biosecur Intelligence Unit, Brisbane, Qld, Australia; [Roberts, Billie] Griffith Univ, Griffith Sch Environm, Brisbane, Qld 4111, Australia; [Field, Hume] EcoHlth Alliance, New York, NY USA; [Skelly, Chris] GIS People Pty Ltd, Brisbane, Qld, Australia	Queensland Department of Agriculture & Fisheries; Queensland Department of Agriculture & Fisheries; Griffith University; EcoHealth Alliance	Smith, C (corresponding author), Dept Agr Fisheries & Forestry, Queensland Ctr Emerging Infect Dis, Brisbane, Qld, Australia.	craig.smith@daff.qld.gov.au	Kung, Nina Y/H-1260-2012		State of Queensland, through the Queensland Centre for Emerging Infectious Diseases; State of New South Wales; Commonwealth of Australia under the National Hendra Virus Research Program; State of Queensland	State of Queensland, through the Queensland Centre for Emerging Infectious Diseases; State of New South Wales; Commonwealth of Australia under the National Hendra Virus Research Program; State of Queensland	The State of Queensland, through the Queensland Centre for Emerging Infectious Diseases, provided funding and logistical support for the project. Additional support was provided the by the State of Queensland, the State of New South Wales and the Commonwealth of Australia under the National Hendra Virus Research Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Almeida FC, 2014, MOL PHYLOGENET EVOL; [Anonymous], 2004, ECOLOGY HENDRA VIRUS; Baldock F. C., 1996, Singapore Veterinary Journal, V20, P57; BioMedware, 2012, METH DAT STAND; Breed A, 2011, PLOS ONE, V6; Brownstein JS, 2002, VECTOR-BORNE ZOONOT, V2, P157, DOI 10.1089/15303660260613729; Bureau of Meteorology, MAPS AV COND; Bureau of Meteorology, PER US CLIM MAPS STA; Chu DKW, 2006, J GEN VIROL, V87, P2461, DOI 10.1099/vir.0.82203-0; Department of Environment & Heritage Protection, WILDNET; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Field HE, 2007, AUST VET J, V85, P268, DOI 10.1111/j.1751-0813.2007.00170.x; Field H, 2012, CURR TOP MICROBIOL, V359, P11, DOI 10.1007/82_2012_214; Field H, 2011, CURR OPIN VIROL, V1, P658, DOI 10.1016/j.coviro.2011.10.025; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Field H, 2010, EMERG INFECT DIS, V16, P338, DOI 10.3201/eid1602.090780; Firestone SM, 2012, PREV VET MED, V106, P123, DOI 10.1016/j.prevetmed.2012.01.020; Firestone SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035284; Fogarty R, 2008, VIRUS RES, V132, P140, DOI 10.1016/j.virusres.2007.11.010; Fox S, 2011, BIOLOGY AND CONSERVATION OF AUSTRALASIAN BATS, P136; Geoscience Australia, 1988, VEG POST EUR SETTL; Getis A, 1992, GEOGRAPHICAL ANAL, V24; Gloza-Rausch F, 2008, EMERG INFECT DIS, V14, P626, DOI 10.3201/eid1404.071439; Halpin K., 1996, Communicable Diseases Intelligence, V20, P476; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Kitron U, 1997, AM J EPIDEMIOL, V145, P558, DOI 10.1093/oxfordjournals.aje.a009145; Li HF, 2007, GEOGR ANAL, V39, P357, DOI 10.1111/j.1538-4632.2007.00708.x; Markus N, 2004, WILDLIFE RES, V31, P345, DOI 10.1071/WR01117; Martin V, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001308; McFarlane R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028374; Middleton D, 2014, EMERG INFECT DIS, V20, P372, DOI 10.3201/eid2003.131159; MURRAY K, 1995, SCIENCE, V268, P94, DOI 10.1126/science.7701348; MURRAY K, 1995, EMERG INFECT DIS, V1, P31, DOI 10.3201/eid0101.950107; Nadin-Davis SA, 2001, VIRUS RES, V74, P139, DOI 10.1016/S0168-1702(00)00259-8; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; Plowright RK, 2008, P ROY SOC B-BIOL SCI, V275, P861, DOI 10.1098/rspb.2007.1260; Plowright RK, 2011, P ROY SOC B-BIOL SCI, V278, P3703, DOI 10.1098/rspb.2011.0522; Roberts BJ, 2012, AUSTRAL ECOL, V37, P12, DOI 10.1111/j.1442-9993.2011.02243.x; Scanlan JC, 2015, ECOHEALTH, V12, P121, DOI 10.1007/s10393-014-0920-4; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Wacharapluesadee S, 2010, VECTOR-BORNE ZOONOT, V10, P183, DOI 10.1089/vbz.2008.0105; Young PL, 1996, EMERG INFECT DIS, V2, P239, DOI 10.3201/eid0203.960315	44	25	25	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99965	10.1371/journal.pone.0099965	http://dx.doi.org/10.1371/journal.pone.0099965			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936789	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000338503400059
J	Qiu, YQ; Tang, YX; Chan, RCK; Sun, XY; He, J				Qiu, Yao-qin; Tang, Yun-xiang; Chan, Raymond C. K.; Sun, Xin-yang; He, Jia			P300 Aberration in First-Episode Schizophrenia Patients: A Meta-Analysis	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; PHONETIC ODDBALL TASKS; DRUG-NAIVE; SUSTAINED ATTENTION; BIPOLAR DISORDER; AUDITORY P300; RECENT-ONSET; HIGH-RISK; AMPLITUDE; STATE	Background: Decreased P300 amplitude is one of the most consistent findings in patients with schizophrenia. However, whether prolonged P300 latency occurs in patients with schizophrenia, especially first-episode schizophrenia (FES) patients, remains controversial. Methods: A meta-analyses of P300 aberration in FES patients and healthy control(HC) group was conducted. The meta-regression analysis was performed using a random effects model. The pooled standardized effect size (PSES) was calculated as the division of the difference between the means of the two groups by the common standard deviation. Results: A total of 569 FES patients and 747 HCs were included in this meta-analysis. P300 amplitude was significantly reduced (PSES = 20.83, 95% CI: 21.02-0.65, P = 0.00001) and P300 latency was delayed significantly in FES patients (PSES = 20.48, 95% CI: 0.14-0.81, P = 0.005). The meta-regression analysis showed that task difficulty was a source of heterogeneity. Conclusions: The meta-analysis confirms that disrupted information processing is found in FES patients, which is manifested by smaller P300 amplitude and delayed P300 latency.	[Qiu, Yao-qin] Second Mil Med Univ, Sch Nursing, Shanghai, Peoples R China; [Tang, Yun-xiang] Second Mil Med Univ, Fac Psychol & Mental Hlth, Dept Med Psychol, Shanghai, Peoples R China; [Chan, Raymond C. K.; Sun, Xin-yang] Chinese Acad Sci, Inst Psychol, Key Lab Mental Hlth, Neuropsychol & Appl Cognit Neurosci Lab, Beijing 100101, Peoples R China; [Qiu, Yao-qin; He, Jia] Second Mil Med Univ, Fac Med Serv, Dept Stat, Shanghai, Peoples R China	Naval Medical University; Naval Medical University; Chinese Academy of Sciences; Institute of Psychology, CAS; Naval Medical University	He, J (corresponding author), Second Mil Med Univ, Fac Med Serv, Dept Stat, Shanghai, Peoples R China.	hejia63@yahoo.com	Chan, Raymond CK/B-6717-2009	Chan, Raymond CK/0000-0002-3414-450X; He, Jia/0000-0002-2338-9501	Ministry of Science and Technology of China [2008ZX10002-007, 2008ZX10002-018, 2008ZX10002-025]; Leading Talents of Science in Shanghai [022]; Key Discipline Construction of Evidence-Based Public Health in Shanghai [12GWZX0602]; National Science Foundation of China [81373105, 81088001, 81372122]; Knowledge Innovation Project of the Chinese Academy of Sciences [KSCX2-EW-J-8]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Leading Talents of Science in Shanghai; Key Discipline Construction of Evidence-Based Public Health in Shanghai; National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Project of the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	The Ministry of Science and Technology of China (2008ZX10002-007, 2008ZX10002-018, 2008ZX10002-025), The Leading Talents of Science in Shanghai 2010 (022), The Key Discipline Construction of Evidence-Based Public Health in Shanghai (12GWZX0602), The National Science Foundation of China (81373105, 81088001,81372122), The Knowledge Innovation Project of the Chinese Academy of Sciences (KSCX2-EW-J-8). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alain C, 2001, SCHIZOPHR RES, V49, P179, DOI 10.1016/S0920-9964(00)00138-9; Bestelmeyer PEG, 2012, PSYCHIAT RES, V197, P140, DOI 10.1016/j.psychres.2011.09.030; Bonala B, 2008, PSYCHOPHYSIOLOGY, V45, P93, DOI 10.1111/j.1469-8986.2007.00613.x; Bozikas VP, 2005, SCHIZOPHR RES, V78, P225, DOI 10.1016/j.schres.2005.05.014; Bramon E, 2005, NEUROIMAGE, V27, P960, DOI 10.1016/j.neuroimage.2005.05.022; Bramon E, 2004, SCHIZOPHR RES, V70, P315, DOI 10.1016/j.schres.2004.01.004; Bramon E, 2008, SCHIZOPHR RES, V103, P178, DOI 10.1016/j.schres.2008.03.025; Brebion G, 1996, SCHIZOPHR RES, V22, P173, DOI 10.1016/S0920-9964(96)00054-0; Brown KJ, 2002, CLIN NEUROPHYSIOL, V113, P1754, DOI 10.1016/S1388-2457(02)00290-0; Bruder G, 1999, ARCH GEN PSYCHIAT, V56, P267, DOI 10.1001/archpsyc.56.3.267; Bruder GE, 2001, BIOL PSYCHIAT, V50, P447, DOI 10.1016/S0006-3223(01)01168-4; Chen B, 2010, SHAN XI YIKE DAXUE X, V41, P253; Chen XS, 2007, CHINESE MED J-PEKING, V120, P339, DOI 10.1097/00029330-200702020-00016; Coburn KL, 1998, BIOL PSYCHIAT, V44, P466, DOI 10.1016/S0006-3223(97)00402-2; de Miranda EC, 2012, BRAZ J OTORHINOLAR, V78, P83, DOI 10.5935/1808-8694.20120013; Demiralp T, 2002, PSYCHIAT RES, V111, P167, DOI 10.1016/S0165-1781(02)00133-6; Devrim-Ucok M, 2006, PROG NEURO-PSYCHOPH, V30, P1426, DOI 10.1016/j.pnpbp.2006.05.019; Fleck DE, 2001, SCHIZOPHR RES, V52, P251, DOI 10.1016/S0920-9964(01)00170-0; Ford JM, 1999, BIOL PSYCHIAT, V46, P94, DOI 10.1016/S0006-3223(98)00290-X; Higashima M, 2003, SCHIZOPHR RES, V59, P147, DOI 10.1016/S0920-9964(01)00397-8; Higuchi Y, 2008, SCHIZOPHR RES, V101, P320, DOI 10.1016/j.schres.2008.01.020; Hirayasu Y, 1998, BIOL PSYCHIAT, V43, P244, DOI 10.1016/S0006-3223(97)00275-8; Jeon YW, 2003, PSYCHOPHYSIOLOGY, V40, P684, DOI 10.1111/1469-8986.00070; Jung EK, 2013, NEUROIMAGE, V78, P305, DOI 10.1016/j.neuroimage.2013.04.027; Kayser J, 2001, BIOL PSYCHIAT, V49, P832, DOI 10.1016/S0006-3223(00)01090-8; Kayser J, 2010, CLIN EEG NEUROSCI, V41, P184, DOI 10.1177/155005941004100405; Korostenskaja M, 2006, ACTA NEUROBIOL EXP, V66, P139; Lee SY, 2010, NEUROSCI LETT, V486, P156, DOI 10.1016/j.neulet.2010.09.035; Lindin M, 2005, BIOL PSYCHOL, V69, P375, DOI 10.1016/j.biopsycho.2004.08.001; Liu L, 2007, DI SAN JUNYI DAXUE X, V29, P2286; Liu S, 2010, GENET TEST MOL BIOMA, V16, P1382; Mathalon DH, 2000, BIOL PSYCHIAT, V47, P413, DOI 10.1016/S0006-3223(99)00151-1; Mathalon DH, 2000, BIOL PSYCHIAT, V47, P434, DOI 10.1016/S0006-3223(99)00277-2; Moser C, 2006, COGN BEHAV NEUROL, V19, P150; Mori K, 2012, PSYCHIAT CLIN NEUROS, V66, P261, DOI 10.1111/j.1440-1819.2012.02345.x; Naatanen R, 2009, INT J NEUROPSYCHOPH, V12, P125, DOI 10.1017/S1461145708009322; Nehra Ritu, 2012, Indian J Psychol Med, V34, P376, DOI 10.4103/0253-7176.108225; O'Grada C, 2009, SCHIZOPHR RES, V107, P319, DOI 10.1016/j.schres.2008.07.013; Ozgurdal S, 2008, SCHIZOPHR RES, V105, P272, DOI 10.1016/j.schres.2008.05.017; Park EJ, 2010, PROG NEURO-PSYCHOPH, V34, P674, DOI 10.1016/j.pnpbp.2010.03.011; Pentaraki A, 2010, ANN GEN PSYCHIATR, V9, pS123, DOI DOI 10.1186/1744-859X-9-S1-S123; Polich J, 2000, INT J PSYCHOPHYSIOL, V38, P3, DOI 10.1016/S0167-8760(00)00127-6; Sabeti M, 2011, ADV EXP MED BIOL, V696, P589, DOI 10.1007/978-1-4419-7046-6_60; Salisbury DF, 1998, ARCH GEN PSYCHIAT, V55, P173, DOI 10.1001/archpsyc.55.2.173; Shin YW, 2010, SCHIZOPHR RES, V124, P110, DOI 10.1016/j.schres.2010.08.008; Tanriverdi F, 2009, GROWTH HORM IGF RES, V19, P24, DOI 10.1016/j.ghir.2008.05.002; Telles S, 2013, BIOPSYCHOSOC MED, V7, DOI 10.1186/1751-0759-7-11; Thonnessen H, 2008, BIOL PSYCHOL, V77, P205, DOI 10.1016/j.biopsycho.2007.10.009; Turetsky BI, 2007, SCHIZOPHRENIA BULL, V33, P69, DOI 10.1093/schbul/sbl060; Umbricht DSG, 2006, BIOL PSYCHIAT, V59, P762, DOI 10.1016/j.biopsych.2005.08.030; van der Stelt O, 2005, SCHIZOPHR RES, V77, P309, DOI 10.1016/j.schres.2005.04.024; van Tricht MJ, 2010, BIOL PSYCHIAT, V68, P642, DOI 10.1016/j.biopsych.2010.04.022; Wang CH, 2009, ZHONGGUO SHENJING JI, V35, P481; Wang JJ, 2010, INT J PSYCHOPHYSIOL, V75, P249, DOI 10.1016/j.ijpsycho.2009.12.005; Wang JJ, 2003, CLIN NEUROPHYSIOL, V114, P2029, DOI 10.1016/S1388-2457(03)00207-4; Wang Q, 2004, ZHONGGUO SHENJING JI, V30, P229; Winterer G, 2003, BIOL PSYCHIAT, V54, P1181, DOI 10.1016/S0006-3223(03)00532-8; Zaytseva Y, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/819587; Zhou YF, 2000, SICHUAN MENTAL HLTH, V13, P217	59	33	38	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e97794	10.1371/journal.pone.0097794	http://dx.doi.org/10.1371/journal.pone.0097794			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933577	gold, Green Published, Green Submitted			2022-12-27	WOS:000337738600005
J	Lee, MHH; Chen, SJ; Tsao, CM; Wu, CC				Lee, Michelle Hui-Hsin; Chen, Shiu-Jen; Tsao, Cheng-Ming; Wu, Chin-Chen			Perivascular Adipose Tissue Inhibits Endothelial Function of Rat Aortas via Caveolin-1	PLOS ONE			English	Article							NITRIC-OXIDE; VASCULAR FUNCTION; MUSCLE; FAT; ATHEROSCLEROSIS; INFLAMMATION; DYSFUNCTION; ENDOCRINE; ARTERIES; ALPHA	Perivascular adipose tissue (PVAT)-derived factors have been proposed to play an important role in the pathogenesis of atherosclerosis. Caveolin-1 (Cav-1), occupying the calcium/calmodulin binding site of endothelial NO synthase (eNOS) and then inhibiting nitric oxide (NO) production, is also involved in the development of atherosclerosis. Thus, we investigated whether PVAT regulated vascular tone via Cav-1 and/or endothelial NO pathways. Isometric tension studies were carried out in isolated thoracic aortas from Wistar rats in the presence and absence of PVAT. Concentration-response curves of phenylephrine, acetylcholine, and sodium nitroprusside were illustrated to examine the vascular reactivity and endothelial function. The protein expressions of eNOS and Cav-1 were also examined in aortic homogenates. Our results demonstrated that PVAT significantly enhanced vasoconstriction and inhibited vasodilatation via endothelium-dependent mechanism. The aortic NO production was diminished after PVAT treatment, whereas protein expression and activity of eNOS were not significantly affected. In addition, Cav-1 protein expression was significantly increased in aortas with PVAT transfer. Furthermore, a caveolae depleter methyl-beta-cyclodextrin abolished the effect of PVAT on the enhancement of vasoconstriction, and reversed the impairment of aortic NO production. In conclusion, unknown factor(s) released from PVAT may inhibit endothelial NO production and induce vasocontraction via an increase of Cav-1 protein expression.	[Lee, Michelle Hui-Hsin] Natl Def Med Ctr, Grad Inst Life Sci, Taipei, Taiwan; [Chen, Shiu-Jen] Natl Def Med Ctr, Dept Physiol, Taipei, Taiwan; [Tsao, Cheng-Ming] Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan; [Wu, Chin-Chen] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Chen, Shiu-Jen] Kang Ning Jr Coll Med Care & Management, Dept Nursing, Taipei, Taiwan; [Tsao, Cheng-Ming] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Tsao, Cheng-Ming] Natl Yang Ming Univ, Taipei 112, Taiwan; [Wu, Chin-Chen] Taipei Med Univ, Dept Pharmacol, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; National Defense Medical Center; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Taipei Medical University	Tsao, CM (corresponding author), Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan.	cm.cmtsao@gmail.com; ccwu@office365.ndmctsgh.edu.tw			National Science Council, Taiwan, ROC [NSC 101-2314-B-075-004, NSC 101-2320-B-345-001, NSC 101-2320-B-016-014]; Taipei Veterans General Hospital, Taiwan [VGH-V120C-143]	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan); Taipei Veterans General Hospital, Taiwan(Taipei Veterans General Hospital)	This study was supported by the Grants of NSC 101-2314-B-075-004 (CMT), NSC 101-2320-B-345-001 (SJC), and NSC 101-2320-B-016-014 (CCW) from the National Science Council, Taiwan, ROC, and by the Grant of VGH-V120C-143 (CMT) from Taipei Veterans General Hospital, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brasier AR, 1996, HYPERTENSION, V27, P1009, DOI 10.1161/01.HYP.27.4.1009; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Chen Z, 2009, CIRC RES, V104, P496, DOI 10.1161/CIRCRESAHA.108.187567; Cohen AW, 2004, PHYSIOL REV, V84, P1341, DOI 10.1152/physrev.00046.2003; Dubrovska G, 2004, AM J PHYSIOL-HEART C, V286, pH1107, DOI 10.1152/ajpheart.00656.2003; Fang LP, 2009, J HYPERTENS, V27, P2174, DOI 10.1097/HJH.0b013e328330a900; Fruhbeck G, 1999, DIABETES, V48, P903, DOI 10.2337/diabetes.48.4.903; Gao YJ, 2007, BRIT J PHARMACOL, V151, P323, DOI 10.1038/sj.bjp.0707228; Gao YJ, 2005, J THORAC CARDIOV SUR, V130, P1130, DOI 10.1016/j.jtcvs.2005.05.028; Gao YJ, 2006, CARDIOVASC RES, V71, P363, DOI 10.1016/j.cardiores.2006.03.013; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Iacobellis G, 2008, CURR DIABETES REP, V8, P20, DOI 10.1007/s11892-008-0005-2; KRAUSE BR, 1984, J LIPID RES, V25, P97; Lee YC, 2011, CIRCULATION, V124, P1160, DOI 10.1161/CIRCULATIONAHA.111.027375; Li R, 2013, EUR J PHARMACOL, V698, P310, DOI 10.1016/j.ejphar.2012.09.026; Lohn M, 2002, FASEB J, V16, P1057, DOI 10.1096/fj.02-0024com; Maenhaut N, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-25; Marchesi C, 2009, HYPERTENSION, V54, P1384, DOI 10.1161/HYPERTENSIONAHA.109.138305; Mariman ECM, 2010, CELL MOL LIFE SCI, V67, P1277, DOI 10.1007/s00018-010-0263-4; Meijer RI, 2013, DIABETES, V62, P590, DOI 10.2337/db11-1603; Mohamed-Ali V, 1998, INT J OBESITY, V22, P1145, DOI 10.1038/sj.ijo.0800770; Mount PF, 2007, J MOL CELL CARDIOL, V42, P271, DOI 10.1016/j.yjmcc.2006.05.023; MULVANY MJ, 1976, NATURE, V260, P617, DOI 10.1038/260617a0; Owen MK, 2013, CIRCULATION, V128, P9, DOI 10.1161/CIRCULATIONAHA.112.001238; Pavlides S, 2012, ADV EXP MED BIOL, V729, P127, DOI 10.1007/978-1-4614-1222-9_9; Payne GA, 2008, MICROCIRCULATION, V15, P417, DOI 10.1080/10739680701858447; Payne GA, 2009, AM J PHYSIOL-HEART C, V297, pH460, DOI 10.1152/ajpheart.00116.2009; Razani B, 2002, PHARMACOL REV, V54, P431, DOI 10.1124/pr.54.3.431; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Scotland RS, 2001, HYPERTENSION, V38, P833, DOI 10.1161/hy1001.092651; Shimokawa H, 1996, J CARDIOVASC PHARM, V28, P703, DOI 10.1097/00005344-199611000-00014; SOLTIS EE, 1991, CLIN EXP HYPERTENS A, V13, P277, DOI 10.3109/10641969109042063; Taguchi R, 2001, ATHEROSCLEROSIS, V157, P203, DOI 10.1016/S0021-9150(00)00709-7; Trayhurn P, 2004, BRIT J NUTR, V92, P347, DOI 10.1079/BJN20041213; Vanhoutte PM, 1997, EUR HEART J, V18, pE19, DOI 10.1016/S0195-668X(97)90005-1; Verhagen SN, 2011, ATHEROSCLEROSIS, V214, P3, DOI 10.1016/j.atherosclerosis.2010.05.034; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Wort SJ, 2009, J BIOL CHEM, V284, P24297, DOI 10.1074/jbc.M109.032524; Wozniak SE, 2009, DIGEST DIS SCI, V54, P1847, DOI 10.1007/s10620-008-0585-3; Zavaritskaya O, 2013, HYPERTENSION, V61, P151, DOI 10.1161/HYPERTENSIONAHA.112.197566; Zhang DX, 2002, AM J PHYSIOL-HEART C, V283, pH1785, DOI 10.1152/ajpheart.00318.2002	42	26	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99947	10.1371/journal.pone.0099947	http://dx.doi.org/10.1371/journal.pone.0099947			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926683	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100096
J	Liao, T; Yuan, DY; Zou, F; Gao, C; Yang, Y; Zhang, L; Tan, XF				Liao, Ting; Yuan, De-Yi; Zou, Feng; Gao, Chao; Yang, Ya; Zhang, Lin; Tan, Xiao-Feng			Self-Sterility in Camellia oleifera May Be Due to the Prezygotic Late-Acting Self-Incompatibility	PLOS ONE			English	Article							POLLEN-TUBE GROWTH; IPOMOPSIS-AGGREGATA POLEMONIACEAE; INBREEDING DEPRESSION; POSTPOLLINATION EVENTS; REPRODUCTIVE-BIOLOGY; CROSS-POLLINATION; BIGNONIACEAE; VIABILITY; PAPILIONOIDEAE; LEGUMINOSAE	In this report, self-sterility in Camellia oleifera was explored by comparing structural and statistical characteristics following self-pollination (SP) and cross-pollination (CP). Although slightly delayed pollen germination and pollen tube growth in selfed ovaries compared to crossed ovaries was observed, there was no significant difference in the percentages of pollen that germinated and pollen tubes that grew to the base of the style. There was also no difference in morphological structure after the two pollination treatments. However, the proportions of ovule penetration and double fertilization in selfed ovules were significantly lower than in crossed ovules, indicating that a prezygotic late-acting self-incompatible mechanism may exist in C. oleifera. Callose deposition was observed in selfed abortive ovules, but not in normal. Ovules did not show differences in anatomic structure during embryonic development, whereas significant differences were observed in the final fruit and seed set. In addition, aborted ovules in selfed ovaries occurred within 35 days after SP and prior to zygote division. However, this process did not occur continuously throughout the life cycle, and no zygotes were observed in the selfed abortive ovules. These results indicated that the self-sterility in C. oleifera may be caused by prezygotic late-acting self-incompatibility (LSI).	[Liao, Ting; Yuan, De-Yi; Zou, Feng; Gao, Chao; Yang, Ya; Zhang, Lin; Tan, Xiao-Feng] Cent South Univ Forestry & Technol, Key Lab Cultivat & Protect Nonwood Forest Trees, Minist Educ, Key Lab Nonwood Forest Prod,Forestry Minist, Changsha, Hunan, Peoples R China	Central South University of Forestry & Technology	Yuan, DY (corresponding author), Cent South Univ Forestry & Technol, Key Lab Cultivat & Protect Nonwood Forest Trees, Minist Educ, Key Lab Nonwood Forest Prod,Forestry Minist, Changsha, Hunan, Peoples R China.	yuan-deyi@163.com	tan, xiao/GZL-0264-2022; Zou, Feng/AAB-5985-2020	, Ting/0000-0003-1434-478X; Zou, Feng/0000-0001-5179-2261	National Natural Science Foundation of China [31170639]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (No. 31170639). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACKERMAN WILLIAM L., 1961, PROC AMER SOC HORT SCI, V77, P265; Asikainen E, 2005, AM J BOT, V92, P487, DOI 10.3732/ajb.92.3.487; Bittencourt NS, 2005, INT J PLANT SCI, V166, P493, DOI 10.1086/428758; Bittencourt NS, 2003, ANN BOT-LONDON, V91, P827, DOI 10.1093/aob/mcg088; BROYLES SB, 1993, AM J BOT, V80, P41, DOI 10.2307/2445118; Bryndum K., 1969, Silvae Genetica, V18, P77; Cao HJ, 1965, ACTA BOT SIN, V13, P44; Chai LJ, 2011, PLANT CELL TISS ORG, V104, P1, DOI 10.1007/s11240-010-9793-6; Chen X, 2012, BIOLOGIA, V67, P347, DOI 10.2478/s11756-012-0018-9; Chung Jeng-Der, 2005, Taiwan Journal of Forest Science, V20, P315; COPE FW, 1962, HEREDITY, V17, P157, DOI 10.1038/hdy.1962.14; de Nettancourt D., 1977, INCOMPATIBILITY ANGI; deNettancourt D, 1997, SEX PLANT REPROD, V10, P185, DOI 10.1007/s004970050087; Deng YY, 2009, THESIS CENTRAL S U F; DUMAS C, 1983, THEOR APPL GENET, V67, P1, DOI 10.1007/BF00303914; Franklin-Tong VE, 2003, PHILOS T R SOC B, V358, P1025, DOI 10.1098/rstb.2003.1287; Gibbs PE, 1999, ANN BOT-LONDON, V84, P449, DOI 10.1006/anbo.1999.0933; GIBBS PE, 1993, BOT ACTA, V106, P64, DOI 10.1111/j.1438-8677.1993.tb00339.x; He C.Y, 2009, THESIS CENTRAL S U F; HERRERO M, 1987, ANN BOT-LONDON, V60, P287, DOI 10.1093/oxfordjournals.aob.a087446; HERRERO M, 1989, AM J BOT, V76, P1441, DOI 10.2307/2444430; HIRATSUKA S, 1987, PLANT CELL PHYSIOL, V28, P293; Hiscock SJ, 2003, TRENDS PLANT SCI, V8, P606, DOI 10.1016/j.tplants.2003.10.007; Hsu Hsin-Wu, 2002, Taiwan Journal of Forest Science, V17, P241; HUSBAND BC, 1995, HEREDITY, V75, P206, DOI 10.1038/hdy.1995.125; HWANG YJ, 1992, J JPN SOC HORTIC SCI, V60, P955, DOI 10.2503/jjshs.60.955; Jiang CJ, 1987, J TEA SCI, V7, P23; KENRICK J, 1986, PLANTA, V169, P245, DOI 10.1007/BF00392321; Koehl V., 2002, THESIS U TORONTO TOR; Lewis G, 1999, PLANT SYST EVOL, V217, P43, DOI 10.1007/BF00984921; [李春林 LI Chunlin], 2011, [中国油料作物学报, Chinese Journal of Oil Crop Sciences], V33, P242; [廖婷 Liao Ting], 2012, [中南林业科技大学学报, Journal of Central South University of Forestry & Technology], V32, P34; Liu ZS, 1987, J TEA SCI, V7, P19; Luo Xiao-ying, 2011, Shengtaixue Zazhi, V30, P552; Mahy G, 1999, ANN BOT-LONDON, V83, P697, DOI 10.1006/anbo.1999.0874; MARTIN FW, 1959, STAIN TECHNOL, V34, P125, DOI 10.3109/10520295909114663; Nettancourt, 2001, INCOMPATIBILITY INCO; Obeso JR, 2002, NEW PHYTOL, V155, P321, DOI 10.1046/j.1469-8137.2002.00477.x; ONeill SD, 1997, ANNU REV PLANT PHYS, V48, P547, DOI 10.1146/annurev.arplant.48.1.547; PIMIENTA E, 1982, AM J BOT, V69, P913, DOI 10.2307/2442888; PIMIENTA E, 1983, ANN BOT, V71, P469; Pontieri V, 1999, ANN BOT-LONDON, V84, P507, DOI 10.1006/anbo.1999.0947; Pound LM, 2003, SEX PLANT REPROD, V16, P59, DOI 10.1007/s00497-003-0175-7; Pound LM, 2002, ANN BOT-LONDON, V89, P613, DOI 10.1093/aob/mcf089; Rodriguez-Riano T, 1999, CAN J BOT, V77, P809, DOI 10.1139/cjb-77-6-809; Sage TL, 2006, AM J BOT, V93, P254, DOI 10.3732/ajb.93.2.254; Sage TL, 1999, AM J BOT, V86, P855, DOI 10.2307/2656706; Sage TL, 2003, ANN BOT-LONDON, V91, P807, DOI 10.1093/aob/mcg085; SEAVEY SR, 1994, AM J BOT, V81, P331, DOI 10.2307/2445460; SEAVEY SR, 1986, BOT REV, V52, P195, DOI 10.1007/BF02861001; SEKHAR KNC, 1995, SEX PLANT REPROD, V8, P369; SETHI S. BALA, 1965, PROC NAT INST SCI INDIA PART B [BIOL SCI], V31, P24; Silva NF, 2001, CELL MOL LIFE SCI, V58, P1988, DOI 10.1007/PL00000832; STEPHENSON AG, 1981, ANNU REV ECOL SYST, V12, P253, DOI 10.1146/annurev.es.12.110181.001345; Stephenson AG, 2000, ANN BOT-LONDON, V85, P211, DOI 10.1006/anbo.1999.1033; Tan XiaoFeng, 2010, Journal of Zhejiang Forestry College, V27, P941; Tangmitcharoen S, 1997, ANN BOT-LONDON, V80, P401, DOI 10.1006/anbo.1996.0440; Valtuena FJ, 2010, AM J BOT, V97, P123, DOI 10.3732/ajb.0800332; Vaughton G, 2010, ANN BOT-LONDON, V106, P547, DOI 10.1093/aob/mcq149; Vishnyakova M. A., 1991, Phytomorphology, V41, P245; Wachira FN, 2005, J HORTIC SCI BIOTECH, V80, P716, DOI 10.1080/14620316.2005.11512004; Wang XiangNan, 2008, Scientia Silvae Sinicae, V44, P173; Wang Yu, 2008, Journal of Tea Science, V28, P429; WASER NM, 1986, OECOLOGIA, V70, P573, DOI 10.1007/BF00379906; WASER NM, 1991, AM J BOT, V78, P1036, DOI 10.2307/2444892; Yang MZ, 2000, CHINESE HORTICULTURE, V46, P83; Yuan D.Y, 2011, J CENTRAL S U FOR TE, V31, P15; Yuan DeYi, 2010, Journal of Fujian Agriculture and Forestry University (Natural Science Edition), V39, P471; ZAPATA TR, 1978, BIOTROPICA, V10, P221, DOI 10.2307/2387907; Zhou QY, 2012, PLANT SYST EVOL, V298, P457, DOI 10.1007/s00606-011-0558-4; Zhuang R.L, 2008, CAMELLIA OLEIFERA, V2nd ed.	71	36	42	4	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99639	10.1371/journal.pone.0099639	http://dx.doi.org/10.1371/journal.pone.0099639			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926879	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100058
J	Vidal-Castineira, JR; Lopez-Vazquez, A; Martinez-Borra, J; Martinez-Camblor, P; Prieto, J; Lopez-Rodriguez, R; Sanz-Cameno, P; de la Vega, J; Rodrigo, L; Perez-Lopez, R; Perez-Alvarez, R; Lopez-Larrea, C				Ramon Vidal-Castineira, Jose; Lopez-Vazquez, Antonio; Martinez-Borra, Jesus; Martinez-Camblor, Pablo; Prieto, Jesus; Lopez-Rodriguez, Rosario; Sanz-Cameno, Paloma; de la Vega, Juan; Rodrigo, Luis; Perez-Lopez, Rosa; Perez-Alvarez, Ramon; Lopez-Larrea, Carlos			Diversity of Killer Cell Immunoglobulin-Like Receptor (KIR) Genotypes and KIR2DL2/3 Variants in HCV Treatment Outcome	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; MHC CLASS-I; HLA-C; GENE DIVERSITY; HAPLOTYPES CONTAIN; ASSOCIATION; EXPRESSION; CLEARANCE; ALLELES; IL28B	The aim of this study was to analyse the distribution of KIR haplotypes and the KIR2DL2/3 alleles in chronic HCV-infected patients in order to establish the influence on the response to pegylated interferon plus ribavirin classical treatment. The alleles study of previously associated KIR2DL2/3 showed that KIR2DL2*001 was more frequent in non-SVR (NSVR) (42.2% vs. 27.5%, p<0.05) and KIR2DL3*001 was associated with sustained viral response (SVR) (41.6% vs. 61.2%, p<0.005). The KIR2DL3*001-HLA-C1 association was also significant (24.5% vs. 45.7%, p<0.001). From the frequencies of KIR obtained, 35 genotypes were assigned on the basis of previous studies. The centromeric A/A genotype was more frequent in SVR (44.1% vs. 34.5%, p<0.005) and the centromeric B/B genotype was found to be significantly more frequent in NSVR (20.9% vs. 11.2%, p<0.001). The logic regression model showed the importance of KIR genes in predicting the response to combined treatment, since the positive predictive value (PPV) was improved (from 55.9% to 75.3%) when the analysis of KIR was included in addition to the IFNL3 rs12979860 polymorphism. The study of KIR receptors may be a powerful tool for predicting the combined treatment response in patients with chronic HCV infection in association with the determination of IFNL3 polymorphism.	[Ramon Vidal-Castineira, Jose; Lopez-Vazquez, Antonio; Martinez-Borra, Jesus; Lopez-Larrea, Carlos] Hosp Univ Cent Asturias, Serv Immunol, Oviedo, Spain; [Martinez-Camblor, Pablo] OIB, Oviedo, Spain; [Prieto, Jesus] Univ Navarra, Univ Navarra Clin, Liver Unit, E-31080 Pamplona, Spain; [Prieto, Jesus] Univ Navarra, Univ Navarra Clin, Div Hepatol & Gene Therapy, E-31080 Pamplona, Spain; [Lopez-Rodriguez, Rosario; Sanz-Cameno, Paloma] Univ Autonoma Madrid, Inst Invest Sanitaria Princesa IIS IP, Hosp Univ Princesa, Liver Unit,Gastroenterol Serv, Madrid, Spain; [Lopez-Rodriguez, Rosario; Sanz-Cameno, Paloma] Inst Salud Carlos III, CIBERehd, Madrid, Spain; [de la Vega, Juan] Hosp San Agustin, Gastroenterol Serv, Aviles, Spain; [Rodrigo, Luis; Perez-Lopez, Rosa; Perez-Alvarez, Ramon] Hosp Univ Cent Asturias, Gastroenterol Serv, Oviedo, Spain; [Lopez-Larrea, Carlos] Fdn Renal Inigo Alvarez Toledo, Madrid, Spain	Central University Hospital Asturias; University of Navarra; University of Navarra; Autonomous University of Madrid; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Salud Carlos III; Hospital San Agustin; Central University Hospital Asturias	Lopez-Larrea, C (corresponding author), Hosp Univ Cent Asturias, Serv Immunol, Oviedo, Spain.	inmuno@hca.es	Rodrigo, Luis/A-6278-2010; Sanz, Paloma/C-7799-2014; Camblor, Pablo Martinez/Z-4834-2019; Lopez-Rodriguez, Rosario/M-3381-2014; Martinez-Camblor, Pablo/Q-1715-2015; López-Rodríguez, Rosario/AAB-2290-2022; RG, SMABSS/N-3322-2018	Rodrigo, Luis/0000-0003-1717-9345; Camblor, Pablo Martinez/0000-0001-7845-3905; Lopez-Rodriguez, Rosario/0000-0002-4713-0633; López-Rodríguez, Rosario/0000-0002-4713-0633; Vidal-Castineira, Jose Ramon/0000-0003-4877-3566; RG, SMABSS/0000-0001-9944-3861; Lopez-Larrea, Carlos/0000-0001-9988-1730; Prieto, Jesus/0000-0002-1091-9593; Research Group, SMIRE+CoDiRE/0000-0002-8871-4942	Spanish grant from the Instituto de Salud Carlos III [PI12-02587]; RETICS REDiNREN from the Instituto de Salud Carlos III [RD12/0021/0021]; European Union "Fondos FEDER''	Spanish grant from the Instituto de Salud Carlos III(Instituto de Salud Carlos III); RETICS REDiNREN from the Instituto de Salud Carlos III(Instituto de Salud Carlos III); European Union "Fondos FEDER''	Supported by Spanish grant PI12-02587 from the Instituto de Salud Carlos III, RETICS REDiNREN (RD12/0021/0021) from the Instituto de Salud Carlos III and by European Union "Fondos FEDER''. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Askar M, 2009, LIVER TRANSPLANT, V15, P1557, DOI 10.1002/lt.21878; Bjorkstrom NK, 2012, BLOOD, V120, P3455, DOI 10.1182/blood-2012-03-416867; Bryceson YT, 2011, J INNATE IMMUN, V3, P216, DOI 10.1159/000325265; Chazara O, 2011, J LEUKOCYTE BIOL, V90, P703, DOI 10.1189/jlb.0511227; Chen LM, 2005, GASTROENTEROLOGY, V128, P1437, DOI 10.1053/j.gastro.2005.01.059; Clausen J, 2012, BONE MARROW TRANSPL, V47, P791, DOI 10.1038/bmt.2011.187; Deng L, 2006, SEMIN IMMUNOL, V18, P159, DOI 10.1016/j.smim.2006.03.004; Diaz-Pena R, 2010, ARTHRITIS RHEUM-US, V62, P1000, DOI 10.1002/art.27332; Dring MM, 2011, P NATL ACAD SCI USA, V108, P5736, DOI 10.1073/pnas.1016358108; Fadda L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002805; Farnik H, 2010, CLIN GASTROENTEROL H, V8, P884, DOI 10.1016/j.cgh.2010.06.019; Faure M, 2002, J IMMUNOL, V168, P6208, DOI 10.4049/jimmunol.168.12.6208; Gallez-Hawkins GM, 2011, BIOL BLOOD MARROW TR, V17, P1662, DOI 10.1016/j.bbmt.2011.04.008; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Gomez-Lozano N, 2002, TISSUE ANTIGENS, V59, P184, DOI 10.1034/j.1399-0039.2002.590302.x; Gomez-Lozano N, 2002, IMMUNOGENETICS, V54, P314, DOI 10.1007/s00251-002-0476-2; Gonzalez A, 2008, TISSUE ANTIGENS, V72, P11, DOI 10.1111/j.1399-0039.2008.01050.x; Gonzalez-Galarza FF, 2011, NUCLEIC ACIDS RES, V39, pD913, DOI 10.1093/nar/gkq1128; Hirayasu K, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002565; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Hsu KC, 2002, IMMUNOL REV, V190, P40, DOI 10.1034/j.1600-065X.2002.19004.x; Jiang W, 2012, GENOME RES, V22, P1845, DOI 10.1101/gr.137976.112; Jobim M, 2010, INT J IMMUNOGENET, V37, P83, DOI 10.1111/j.1744-313X.2009.00894.x; Jost S, 2013, ANNU REV IMMUNOL, V31, P163, DOI 10.1146/annurev-immunol-032712-100001; Keaney L, 2004, TISSUE ANTIGENS, V64, P188, DOI 10.1111/j.1399-0039.2004.00263.x; Kikuchi-Maki A, 2005, J IMMUNOL, V174, P3859, DOI 10.4049/jimmunol.174.7.3859; Knapp S, 2010, HEPATOLOGY, V51, P1168, DOI 10.1002/hep.23477; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Lopez-Rodriguez R, 2011, CLIN PHARMACOL THER, V90, P712, DOI 10.1038/clpt.2011.189; Lopez-Vazquez A, 2005, J INFECT DIS, V192, P162, DOI 10.1086/430351; Lu ZM, 2008, CELL MOL IMMUNOL, V5, P457, DOI 10.1038/cmi.2008.57; Martinez-Camblor P, 2012, J STAT PLAN INFER, V142, P589, DOI 10.1016/j.jspi.2011.09.003; McKiernan SM, 2004, HEPATOLOGY, V40, P108, DOI 10.1002/hep.20261; Middleton D, 2007, HUM IMMUNOL, V68, P128, DOI 10.1016/j.humimm.2006.12.007; Middleton D, 2010, IMMUNOLOGY, V129, P8, DOI 10.1111/j.1365-2567.2009.03208.x; Moesta AK, 2008, J IMMUNOL, V180, P3969, DOI 10.4049/jimmunol.180.6.3969; Nozawa Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083381; Parham P, 2005, NAT REV IMMUNOL, V5, P201, DOI 10.1038/nri1570; Passweg JR, 2007, TRENDS IMMUNOL, V28, P437, DOI 10.1016/j.it.2007.07.008; Piasecki BA, 2004, HEPATOLOGY, V40, P892, DOI [10.1002/hep.20384, 10.1002/hep.1840400419]; Pyo CW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015115; Rajagopalan S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00258; Rajalingam R, 2008, IMMUNOGENETICS, V60, P207, DOI 10.1007/s00251-008-0286-2; Vidal-Castineira JR, 2012, J HEPATOL, V56, P1230, DOI 10.1016/j.jhep.2012.01.011; Ruczinski I, 2003, J COMPUT GRAPH STAT, V12, P475, DOI 10.1198/1061860032238; Suppiah V, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001092; Thomas DL, 2009, NATURE, V461, P798, DOI 10.1038/nature08463; Thompson AJ, 2010, GASTROENTEROLOGY, V139, P120, DOI 10.1053/j.gastro.2010.04.013; Tseng KC, 2013, HUM IMMUNOL, V74, P978, DOI 10.1016/j.humimm.2013.04.023; Uhrberg M, 2002, IMMUNOGENETICS, V54, P221, DOI 10.1007/s00251-002-0463-7; van Bergen J, 2011, AM J TRANSPLANT, V11, P1959, DOI 10.1111/j.1600-6143.2011.03621.x; Vidal-Castineira JR, 2010, J VIROL, V84, P475, DOI 10.1128/JVI.01285-09; Vierra-Green C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047491; Winter CC, 1998, J IMMUNOL, V161, P571	56	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99426	10.1371/journal.pone.0099426	http://dx.doi.org/10.1371/journal.pone.0099426			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927414	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100039
J	Chiang, CF; Albarino, CG; Lo, MK; Spiropoulou, CF				Chiang, Cheng-Feng; Albarino, Cesar G.; Lo, Michael K.; Spiropoulou, Christina F.			Small Interfering RNA Inhibition of Andes Virus Replication	PLOS ONE			English	Article							HANTAVIRUS CARDIOPULMONARY SYNDROME; PULMONARY SYNDROME; NUCLEOCAPSID PROTEIN; ANTIVIRAL IMMUNITY; MOSQUITO CELLS; DOUBLE-BLIND; TRANSMISSION; INFECTIONS; RESISTANCE; RIBAVIRIN	Andes virus (ANDV) is the most common causative agent of hantavirus pulmonary syndrome (HPS) in the Americas, and is the only hantavirus associated with human-to-human transmission. Case fatality rates of ANDV-induced HPS are approximately 40%. There are currently no effective vaccines or antivirals against ANDV. Since HPS severity correlates with viral load, we tested small interfering RNA (siRNA) directed against ANDV genes as a potential antiviral strategy. We designed pools of 4 siRNAs targeting each of the ANDV genome segments (S, M, and L), and tested their efficacy in reducing viral replication in vitro. The siRNA pool targeting the S segment reduced viral transcription and replication in Vero-E6 cells more efficiently than those targeting the M and L segments. In contrast, siRNAs targeting the S, M, or L segment were similar in their ability to reduce viral replication in human lung microvascular endothelial cells. Importantly, these siRNAs inhibit ANDV replication even if given after infection. Taken together, our findings indicate that siRNAs targeting the ANDV genome efficiently inhibit ANDV replication, and show promise as a strategy for developing therapeutics against ANDV infection.	[Chiang, Cheng-Feng; Albarino, Cesar G.; Lo, Michael K.; Spiropoulou, Christina F.] Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA	Centers for Disease Control & Prevention - USA	Spiropoulou, CF (corresponding author), Ctr Dis Control & Prevent, Viral Special Pathogens Branch, Div High Consequence Pathogens & Pathol, Atlanta, GA 30333 USA.	cspiropoulou@cdc.gov		Lo, Michael/0000-0002-0409-7896; Chiang, Cheng-Feng/0000-0002-3617-9124	Centers for Disease Control and Prevention (CDC)	Centers for Disease Control and Prevention (CDC)(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	This work was funded by Centers for Disease Control and Prevention (CDC) core funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljofan M, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-187; Alminaite A, 2006, J VIROL, V80, P9073, DOI 10.1128/JVI.00515-06; Billecocq A, 2000, J GEN VIROL, V81, P2161, DOI 10.1099/0022-1317-81-9-2161; Borges AA, 2006, MICROBES INFECT, V8, P2324, DOI 10.1016/j.micinf.2006.04.019; Chaparro J, 1998, J HOSP INFECT, V40, P281, DOI 10.1016/S0195-6701(98)90304-8; DeVincenzo J, 2010, P NATL ACAD SCI USA, V107, P8800, DOI 10.1073/pnas.0912186107; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Doyle TJ, 1998, INFECT DIS CLIN N AM, V12, P95, DOI 10.1016/S0891-5520(05)70411-6; Dykxhoorn DM, 2006, PLOS MED, V3, P1000, DOI 10.1371/journal.pmed.0030242; Enria DA, 2001, CURR TOP MICROBIOL, V256, P117; Ferres M, 2007, J INFECT DIS, V195, P1563, DOI 10.1086/516786; Flusin O, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-249; Geisbert TW, 2010, LANCET, V375, P1896, DOI 10.1016/S0140-6736(10)60357-1; Gitlin L, 2002, NATURE, V418, P430, DOI 10.1038/nature00873; Hutchinson KL, 1996, VIROLOGY, V224, P139, DOI 10.1006/viro.1996.0515; Jeang KT, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-58; Jonsson CB, 2008, ANTIVIR RES, V78, P162, DOI 10.1016/j.antiviral.2007.10.012; Kariwa H, 2003, ARCH VIROL, V148, P1671, DOI 10.1007/s00705-003-0141-6; Levin A, 2006, VIRUS RES, V120, P121, DOI 10.1016/j.virusres.2006.02.009; McNulty S, 2013, J VIROL, V87, P912, DOI 10.1128/JVI.02415-12; Mertz GJ, 2004, CLIN INFECT DIS, V39, P1307, DOI 10.1086/425007; Mir MA, 2004, J VIROL, V78, P8281, DOI 10.1128/jvi.78.15.8281-8288.2004; Mir MA, 2008, EMBO J, V27, P3129, DOI 10.1038/emboj.2008.228; Muller S, 2007, ANTIMICROB AGENTS CH, V51, P2215, DOI 10.1128/AAC.01368-06; Novina CD, 2002, NAT MED, V8, P681, DOI 10.1038/nm725; Powers AM, 1996, P NATL ACAD SCI USA, V93, P4187, DOI 10.1073/pnas.93.9.4187; Schmaljohn C.S., 2007, FIELDS VIROLOGY, P1741; SCHMALJOHN CS, 2001, HANTAVIRUSES; Severson WE, 2001, J VIROL, V75, P2646, DOI 10.1128/JVI.75.6.2646-2652.2001; Soldan SS, 2005, J VIROL, V79, P234, DOI 10.1128/JVI.79.1.234-244.2005; Spiropoulou CF, 2003, VIROLOGY, V308, P48, DOI 10.1016/S0042-6822(02)00092-2; Spiropoulou CF, 2007, J VIROL, V81, P2769, DOI 10.1128/JVI.02402-06; Terajima M, 1999, J INFECT DIS, V180, P2030, DOI 10.1086/315153; Umbach JL, 2009, GENE DEV, V23, P1151, DOI 10.1101/gad.1793309; Wells RM, 1997, EMERG INFECT DIS, V3, P361, DOI 10.3201/eid0303.970314; Xiao RB, 2006, J INFECT DIS, V194, P1403, DOI 10.1086/508494; Zhou JH, 2011, METHODS MOL BIOL, V721, P67, DOI 10.1007/978-1-61779-037-9_4	37	6	6	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99764	10.1371/journal.pone.0099764	http://dx.doi.org/10.1371/journal.pone.0099764			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924189	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300091
J	Deng, JJ; Dong, Y; Li, C; Zuo, WW; Meng, G; Xu, CP; Li, JJ				Deng, Junjiang; Dong, Yan; Li, Chong; Zuo, Wenwei; Meng, Gang; Xu, Chengping; Li, Jianjun			Decreased Expression of C10orf10 and Its Prognostic Significance in Human Breast Cancer	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; GENES; MARKERS; CELLS; PROGESTERONE; DEPP	Breast cancer is a common malignant tumor, which severely threatens the health of women with an increasing incidence in many countries. Here, we identified C10orf10 as a novel differentially expression gene using expression microarray screening. The expression analysis indicated that C10orf10 was frequently decreased in human breast cancers compared to noncancerous breast tissues (81/95, P = 0.0063). Kaplan-Meier analysis indicated that patients with low C10orf10 expression showed a poorer prognosis both in mRNA (n = 1115, P = 0.0013) and protein (n = 100, P = 0.003) levels. Univariate and multivariate analysis showed that the C10orf10 expression was an independent prognostic factor for overall survival of breast cancer patients. Further analysis revealed that low expression of C10orf10 was an unfavorable factor for the prognosis of the patients who were luminal A, luminal B, Her2+ subtypes, at histological grade 2, lymph node negative and ER positive. Our data provided the first evidence that C10orf10 expression was frequently decreased in breast cancer tissues, and low expression of C10orf10 may be an important prognostic factor for poorer survival time of breast cancer patients.	[Deng, Junjiang; Dong, Yan; Li, Chong; Zuo, Wenwei; Li, Jianjun] Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China; [Deng, Junjiang] Third Mil Med Univ, Chongqing, Peoples R China; [Meng, Gang; Xu, Chengping] Third Mil Med Univ, Southwest Hosp, Dept Pathol, Chongqing, Peoples R China	Army Medical University; Army Medical University; Army Medical University	Li, JJ (corresponding author), Third Mil Med Univ, Southwest Hosp, Dept Oncol, Chongqing, Peoples R China.	jianjunli@tmmu.edu.cn			National Natural Science Foundation of China [81172114]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (No. 81172114). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben T, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2904; Chen SM, 2011, FEBS LETT, V585, P1796, DOI 10.1016/j.febslet.2011.04.024; Cho WCS, 2012, EXPERT REV MOL DIAGN, V12, P315, DOI [10.1586/ERM.12.21, 10.1586/erm.12.21]; ELLEDGE RM, 1992, SEMIN ONCOL, V19, P244; Forouzanfar MH, 2011, LANCET, V378, P1461, DOI 10.1016/S0140-6736(11)61351-2; GALEA MH, 1992, BREAST CANCER RES TR, V22, P207, DOI 10.1007/BF01840834; Gao Q, 2007, J CLIN ONCOL, V25, P2586, DOI 10.1200/JCO.2006.09.4565; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; HAYES DF, 1993, ANN ONCOL, V4, P807, DOI 10.1093/oxfordjournals.annonc.a058385; Huang YB, 2013, CELL BIOSCI, V3, DOI 10.1186/2045-3701-3-16; Jiang L, 2013, EUR J RADIOL, V82, P1404, DOI 10.1016/j.ejrad.2013.03.006; Jung SP, 2013, J BREAST CANCER, V16, P16, DOI 10.4048/jbc.2013.16.1.16; Kuroda Y, 2010, HORM METAB RES, V42, P173, DOI 10.1055/s-0029-1241841; Pereira CBL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060576; Liu WB, 2010, MOL CARCINOGEN, V49, P556, DOI 10.1002/mc.20621; Metzger O, 2011, CRIT REV ONCOL HEMAT, V77, P21, DOI 10.1016/j.critrevonc.2010.01.011; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Peduzzi P, 1995, J CLIN EPIDEMIOL, V48, P1503, DOI 10.1016/0895-4356(95)00048-8; Ragel BT, 2007, NEUROSURG REV, V30, P181, DOI 10.1007/s10143-007-0070-z; Ramaswamy S, 2002, CANCER CELL, V2, P81, DOI 10.1016/S1535-6108(02)00086-7; Reyal F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055901; Shin DH, 2005, DEV DYNAM, V233, P1589, DOI 10.1002/dvdy.20479; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Taghipour S, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-299; THOMAS F, 1988, RADIOTHER ONCOL, V13, P267, DOI 10.1016/0167-8140(88)90222-8; VISSCHER DW, 1990, PATHOL ANNU, V25, P171; Watanabe H, 2005, MOL HUM REPROD, V11, P471, DOI 10.1093/molehr/gah186; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zhou L, 2013, HUM PATHOL, V44, P1421, DOI 10.1016/j.humpath.2012.10.027	29	3	4	3	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99730	10.1371/journal.pone.0099730	http://dx.doi.org/10.1371/journal.pone.0099730			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936657	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400034
J	Ip, IB; Bridge, H; Parker, AJ				Ip, Ifan Betina; Bridge, Holly; Parker, Andrew J.			Effects of Spatial and Feature Attention on Disparity-Rendered Structure-From-Motion Stimuli in the Human Visual Cortex	PLOS ONE			English	Article							3-DIMENSIONAL STRUCTURE; AREA MT; QUANTITATIVE-ANALYSIS; PERCEPTUAL LOAD; STEREOPSIS; DEPTH; ORGANIZATION; INTEGRATION; ROBUST; FMRI	that enhances the response to similar features or objects across the visual field. Here we test whether this non-spatial component can co-select individual features that are perceptually bound into a coherent object. We combined human psychophysics and functional magnetic resonance imaging (fMRI) to demonstrate the ability to co-select individual features from perceptually coherent objects. Our study used binocular disparity and visual motion to define disparity structure-from-motion (dSFM) stimuli. Although the spatial attention system induced strong modulations of the fMRI response in visual regions, the non-spatial system's ability to co-select features of the dSFM stimulus was less pronounced and variable across subjects. Our results demonstrate that feature and global feature attention effects are variable across participants, suggesting that the feature attention system may be limited in its ability to automatically select features within the attended object. Careful comparison of the task design suggests that even minor differences in the perceptual task may be critical in revealing the presence of global feature attention.	[Ip, Ifan Betina; Bridge, Holly; Parker, Andrew J.] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Ip, Ifan Betina; Bridge, Holly] Univ Oxford, Nuffield Dept Clin Neurosci, Oxford Ctr Funct Magnet Resonance Imaging Brain, Oxford, England	University of Oxford; University of Oxford	Ip, IB (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Oxford, England.	ifanbetinaip@gmail.com	Ip, Ifan Betina/HIA-0309-2022; Parker, Andrew J/I-7867-2013	Ip, Ifan Betina/0000-0003-3544-0711; Parker, Andrew J/0000-0001-5800-0407; Bridge, Holly/0000-0002-8089-6198	James S. McDonnell Foundation; Medical Research Council (United Kingdom); Royal Society Wolfson Research Merit Award; Medical Research Council [G0400132, MR/K014382/1, G0802171, G0700399] Funding Source: researchfish; MRC [G0700399, MR/K014382/1, G0802171, G0400132] Funding Source: UKRI	James S. McDonnell Foundation; Medical Research Council (United Kingdom)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Royal Society Wolfson Research Merit Award(Royal Society of London); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the James S. McDonnell Foundation and the Medical Research Council (United Kingdom). Andrew J. Parker held a Royal Society Wolfson Research Merit Award. Holly Bridge is a Royal Society University Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Arman AC, 2006, VISION RES, V46, P2968, DOI 10.1016/j.visres.2006.03.003; Ban H, 2012, NAT NEUROSCI, V15, P636, DOI 10.1038/nn.3046; Bichot NP, 2005, SCIENCE, V308, P529, DOI 10.1126/science.1109676; Bradley DC, 1998, NATURE, V392, P714, DOI 10.1038/33688; Brefczynski JA, 1999, NAT NEUROSCI, V2, P370, DOI 10.1038/7280; Bridge H, 2007, J VIS, V7; Brouwer GJ, 2007, J NEUROSCI, V27, P1015, DOI 10.1523/JNEUROSCI.4593-06.2007; Chandrasekaran C, 2007, J NEUROPHYSIOL, V97, P1553, DOI 10.1152/jn.01074.2006; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; DeAngelis GC, 1999, J NEUROSCI, V19, P1398; DEYOE EA, 1994, J NEUROSCI METH, V54, P171, DOI 10.1016/0165-0270(94)90191-0; Dodd JV, 2001, J NEUROSCI, V21, P4809, DOI 10.1523/JNEUROSCI.21-13-04809.2001; DOSHER BA, 1986, VISION RES, V26, P973, DOI 10.1016/0042-6989(86)90154-9; Dumoulin SO, 2000, CEREB CORTEX, V10, P454, DOI 10.1093/cercor/10.5.454; ENGEL SA, 1994, NATURE, V369, P525, DOI 10.1038/369525a0; Engel SA, 1997, CEREB CORTEX, V7, P181, DOI 10.1093/cercor/7.2.181; Gandhi SP, 1999, P NATL ACAD SCI USA, V96, P3314, DOI 10.1073/pnas.96.6.3314; HE ZJ, 1995, P NATL ACAD SCI USA, V92, P11155, DOI 10.1073/pnas.92.24.11155; HUBEL DH, 1987, J NEUROSCI, V7, P3378; Huk AC, 2002, J NEUROSCI, V22, P7195; Jehee JFM, 2011, J NEUROSCI, V31, P8210, DOI 10.1523/JNEUROSCI.6153-09.2011; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; JOHNSTON EB, 1993, VISION RES, V33, P813, DOI 10.1016/0042-6989(93)90200-G; Kamitani Y, 2005, NAT NEUROSCI, V8, P679, DOI 10.1038/nn1444; Kamitani Y, 2006, CURR BIOL, V16, P1096, DOI 10.1016/j.cub.2006.04.003; Kastner S, 1999, NEURON, V22, P751, DOI 10.1016/S0896-6273(00)80734-5; Katzner S, 2009, FRONT SYST NEUROSCI, V3, DOI 10.3389/neuro.06.012.2009; LANDY MS, 1995, VISION RES, V35, P389, DOI 10.1016/0042-6989(94)00176-M; Larsson J, 2001, IMAGING VISION FUNCT; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Martinez-Trujillo JC, 2004, CURR BIOL, V14, P744, DOI 10.1016/j.cub.2004.04.028; Maunsell JHR, 2006, TRENDS NEUROSCI, V29, P317, DOI 10.1016/j.tins.2006.04.001; Melcher D, 2005, NEURON, V46, P723, DOI 10.1016/j.neuron.2005.04.023; Mitchell JF, 2004, NATURE, V429, P410, DOI 10.1038/nature02584; Moradi F, 2004, VISION RES, V44, P2885, DOI 10.1016/j.visres.2004.06.021; NAWROT M, 1991, PERCEPT PSYCHOPHYS, V49, P230, DOI 10.3758/BF03214308; NAWROT M, 1989, SCIENCE, V244, P716, DOI 10.1126/science.2717948; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; PETERHANS E, 1993, EUR J NEUROSCI, V5, P509, DOI 10.1111/j.1460-9568.1993.tb00517.x; Preston TJ, 2008, J NEUROSCI, V28, P11315, DOI 10.1523/JNEUROSCI.2728-08.2008; Preston TJ, 2009, J NEUROSCI, V29, P1688, DOI 10.1523/JNEUROSCI.5021-08.2009; Prince SJD, 2002, J NEUROPHYSIOL, V87, P191, DOI 10.1152/jn.00465.2000; Ress D, 2000, NAT NEUROSCI, V3, P940, DOI 10.1038/78856; ROE AW, 1995, J NEUROSCI, V15, P3689; ROGERS B, 1982, VISION RES, V22, P261, DOI 10.1016/0042-6989(82)90126-2; Rokers B, 2009, NAT NEUROSCI, V12, P1050, DOI 10.1038/nn.2343; Saenz M, 2002, NAT NEUROSCI, V5, P631, DOI 10.1038/nn876; Saenz M, 2003, VISION RES, V43, P629, DOI 10.1016/S0042-6989(02)00595-3; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; SERENO MI, 1995, SCIENCE, V268, P889, DOI 10.1126/science.7754376; SIEGEL RM, 1988, NATURE, V331, P259, DOI 10.1038/331259a0; Silver MA, 2007, J NEUROPHYSIOL, V97, P229, DOI 10.1152/jn.00677.2006; Smith SM, 2002, NEUROIMAGE, V17, P479, DOI 10.1006/nimg.2002.1040; Tootell RBH, 1998, NEURON, V21, P1409, DOI 10.1016/S0896-6273(00)80659-5; Tootell RBH, 1998, P NATL ACAD SCI USA, V95, P811, DOI 10.1073/pnas.95.3.811; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Treue S, 1999, NATURE, V399, P575, DOI 10.1038/21176; TREUE S, 1995, VISION RES, V35, P139, DOI 10.1016/0042-6989(94)E0069-W; TREUE S, 1991, VISION RES, V31, P59, DOI 10.1016/0042-6989(91)90074-F; Treue S, 2007, NEURON, V55, P174, DOI 10.1016/j.neuron.2007.07.005; ULLMAN S, 1979, PROC R SOC SER B-BIO, V203, P405, DOI 10.1098/rspb.1979.0006; WALLACH H, 1953, J EXP PSYCHOL, V45, P205, DOI 10.1037/h0056880; Wannig A, 2007, NEURON, V54, P639, DOI 10.1016/j.neuron.2007.05.001; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; WORSLEY KJ, 1992, J CEREBR BLOOD F MET, V12, P900, DOI 10.1038/jcbfm.1992.127	68	0	0	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100074	10.1371/journal.pone.0100074	http://dx.doi.org/10.1371/journal.pone.0100074			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936974	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400069
J	Lee, W; Watters, KE; Troupis, AT; Reinen, NM; Suchy, FP; Moyer, KL; Frederick, RO; Tonelli, M; Aceti, DJ; Palmenberg, AC; Markley, JL				Lee, Woonghee; Watters, Kelly E.; Troupis, Andrew T.; Reinen, Nichole M.; Suchy, Fabian P.; Moyer, Kylie L.; Frederick, Ronnie O.; Tonelli, Marco; Aceti, David J.; Palmenberg, Ann C.; Markley, John L.			Solution Structure of the 2A Protease from a Common Cold Agent, Human Rhinovirus C2, Strain W12	PLOS ONE			English	Article							NMR-SPECTROSCOPY; CLEAVAGE SITE; PROTEINASE; SPECIFICITY; INHIBITION; RESIDUES; ELECTROSTATICS; COXSACKIEVIRUS; AUTOINDUCTION; TRANSCRIPTION	Human rhinovirus strains differ greatly in their virulence, and this has been correlated with the differing substrate specificity of the respective 2A protease (2A(pro)). Rhinoviruses use their 2A(pro) to cleave a spectrum of cellular proteins important to virus replication and anti-host activities. These enzymes share a chymotrypsin-like fold stabilized by a tetra-coordinated zinc ion. The catalytic triad consists of conserved Cys (C105), His (H34), and Asp (D18) residues. We used a semi-automated NMR protocol developed at NMRFAM to determine the solution structure of 2A(pro) (C(105)A variant) from an isolate of the clinically important rhinovirus C species (RV-C). The backbone of C2 2Apro superimposed closely (1.41-1.81 angstrom rmsd) with those of orthologs from RV-A2, coxsackie B4 (CB4), and enterovirus 71 (EV71) having sequence identities between 40% and 60%. Comparison of the structures suggest that the differential functional properties of C2 2A(pro) stem from its unique surface charge, high proportion of surface aromatics, and sequence surrounding the di-tyrosine flap.	[Lee, Woonghee; Tonelli, Marco; Markley, John L.] Univ Wisconsin, Dept Biochem, Natl Magnet Resonance Facil Madison, Madison, WI 53705 USA; [Troupis, Andrew T.; Reinen, Nichole M.; Suchy, Fabian P.; Moyer, Kylie L.; Frederick, Ronnie O.; Aceti, David J.; Markley, John L.] Univ Wisconsin, Dept Biochem, Ctr Eukaryot Struct Genom, Madison, WI 53705 USA; [Watters, Kelly E.; Palmenberg, Ann C.] Univ Wisconsin, Inst Mol Virol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Markley, JL (corresponding author), 171A DeLuca Biochem Labs, Madison, WI 53706 USA.	markley@nmrfam.wisc.edu			National Institutes of Health [U19 AI104317, T32 AI078985, U01 GM094622, P41GM103399]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI078985, U19AI104317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094622, P41GM103399] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health grant U19 AI104317 to ACP, NIH training grant T32 AI078985 to KW and NIH grants U01 GM094622, and P41GM103399 to JLM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahrami A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000307; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Baxter NJ, 2006, J VIROL, V80, P1451, DOI 10.1128/JVI.80.3.1451-1462.2006; BAZAN JF, 1988, P NATL ACAD SCI USA, V85, P7872, DOI 10.1073/pnas.85.21.7872; Bhattacharya A, 2007, PROTEINS, V66, P778, DOI 10.1002/prot.21165; Blommel PG, 2007, BIOTECHNOL PROGR, V23, P585, DOI 10.1021/bp070011x; Bochkov YA, 2011, NAT MED, V17, P627, DOI 10.1038/nm.2358; Cai QX, 2013, J VIROL, V87, P7348, DOI 10.1128/JVI.03541-12; Castello A, 2009, J CELL SCI, V122, P3799, DOI 10.1242/jcs.055988; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; CLARK ME, 1991, EMBO J, V10, P2941, DOI 10.1002/j.1460-2075.1991.tb07844.x; Cox JD, 2000, BIOCHEMISTRY-US, V39, P13687, DOI 10.1021/bi001649j; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; DeLano WL, 2005, ABSTR PAP AM CHEM S, V230, pU1371; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dominguez SR, 2008, J CLIN VIROL, V43, P219, DOI 10.1016/j.jcv.2008.06.007; EISENHABER F, 1993, J COMPUT CHEM, V14, P1272, DOI 10.1002/jcc.540141103; Foeger N, 2003, J BIOL CHEM, V278, P33200, DOI 10.1074/jbc.M304007200; Frederick Ronnie O., 2007, Journal of Structural and Functional Genomics, V8, P153, DOI 10.1007/s10969-007-9032-5; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Goddard D., 2008, SPARKY 3; Guntert Peter, 2004, Methods Mol Biol, V278, P353; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Klock Heath E., 2009, V498, P91, DOI 10.1007/978-1-59745-196-3_6; Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4; LAMPHEAR BJ, 1993, J BIOL CHEM, V268, P19200; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Lee WM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000966; Lee W, 2011, BIOINFORMATICS, V27, P1727, DOI 10.1093/bioinformatics/btr200; Lee W, 2009, BIOINFORMATICS, V25, P2085, DOI 10.1093/bioinformatics/btp345; Liebig HD, 2002, FEBS LETT, V523, P53, DOI 10.1016/S0014-5793(02)02933-2; McIntyre CL, 2010, J VIROL, V84, P10297, DOI 10.1128/JVI.00962-10; Mu ZX, 2013, J MOL BIOL, V425, P4530, DOI 10.1016/j.jmb.2013.08.016; Neubauer D, 2013, J GEN VIROL, V94, P1535, DOI 10.1099/vir.0.051201-0; Palmenberg AC, 2010, J ALLERGY CLIN IMMUN, V125, P1190, DOI 10.1016/j.jaci.2010.04.010; Petersen JFW, 1999, EMBO J, V18, P5463, DOI 10.1093/emboj/18.20.5463; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shin J, 2008, EXPERT REV PROTEOMIC, V5, P589, DOI 10.1586/14789450.5.4.589; SKERN T, 1991, VIROLOGY, V181, P46, DOI 10.1016/0042-6822(91)90468-Q; SOMMERGRUBER W, 1992, J BIOL CHEM, V267, P22639; Sousa C, 2006, FEBS LETT, V580, P5713, DOI 10.1016/j.febslet.2006.09.023; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Wang QM, 1998, ARCH BIOCHEM BIOPHYS, V356, P12, DOI 10.1006/abbi.1998.0746; Watters K, 2011, J VIROL, V85, P10874, DOI 10.1128/JVI.00718-11; Yalamanchili P, 1997, J VIROL, V71, P1220, DOI 10.1128/JVI.71.2.1220-1226.1997	46	8	8	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e97198	10.1371/journal.pone.0097198	http://dx.doi.org/10.1371/journal.pone.0097198			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937088	gold, Green Published, Green Submitted			2022-12-27	WOS:000338503400005
J	Deng, XJ; Zhang, HQ; Wang, Y; He, F; Liu, JL; Xiao, X; Shu, ZF; Li, W; Wang, GH; Wang, GL				Deng, Xiao-juan; Zhang, Hai-qing; Wang, Yue; He, Feng; Liu, Jin-ling; Xiao, Xiao; Shu, Zhi-feng; Li, Wei; Wang, Guo-huai; Wang, Guo-liang			Mapped Clone and Functional Analysis of Leaf-Color Gene Ygl7 in a Rice Hybrid (Oryza sativa L. ssp indica)	PLOS ONE			English	Article							PENTATRICOPEPTIDE REPEAT PROTEIN; CHLOROPHYLL-DEFICIENT MUTANT; MG-CHELATASE; MAGNESIUM-CHELATASE; DIVINYL REDUCTASE; H-SUBUNIT; IDENTIFICATION; BIOSYNTHESIS; CHLOROPLASTS; DISRUPTION	Leaf-color is an effective marker to identify the hybridization of rice. Leaf-color related genes function in chloroplast development and the photosynthetic pigment biosynthesis of higher plants. The ygl7 (yellow-green leaf 7) is a mutant with spontaneous yellow-green leaf phenotype across the whole lifespan but with no change to its yield traits. We cloned gene Ygl7 (Os03g59640) which encodes a magnesium-chelatase ChlD protein. Expression of ygl7 turns green-leaves to yellow, whereas RNAi-mediated silence of Ygl7 causes a lethal phenotype of the transgenic plants. This indicates the importance of the gene for rice plant. On the other hand, it corroborates that ygl7 is a non-null mutants. The content of photosynthetic pigment is lower in Ygl7 than the wild type, but its light efficiency was comparatively high. All these results indicated that the mutational YGL7 protein does not cause a complete loss of original function but instead acts as a new protein performing a new function. This new function partially includes its preceding function and possesses an additional feature to promote photosynthesis. Chl1, Ygl98, and Ygl3 are three alleles of the OsChlD gene that have been documented previously. However, mutational sites of OsChlD mutant gene and their encoded protein products were different in the three mutants. The three mutants have suppressed grain output. In our experiment, plant materials of three mutants (ygl7, chl1, and ygl98) all exhibited mutational leaf-color during the whole growth period. This result was somewhat different from previous studies. We used ygl7 as female crossed with chl1 and ygl98, respectively. Both the F-1 and F-2 generation display yellow-green leaf phenotype with their chlorophyll and carotenoid content falling between the values of their parents. Moreover, we noted an important phenomenon: ygl7-NIL's leaf-color is yellow, not yellowy-green, and this is also true of all back-crossed offspring with ygl7.	[Deng, Xiao-juan; Zhang, Hai-qing; Wang, Yue; He, Feng; Liu, Jin-ling; Xiao, Xiao; Shu, Zhi-feng; Wang, Guo-huai; Wang, Guo-liang] Hunan Agr Univ, Coll Agron, Changsha, Hunan, Peoples R China; [Deng, Xiao-juan; Wang, Yue; Wang, Guo-liang] Hunan Agr Univ, Hunan Prov Key Lab Crop Germplasm Innovat & Utili, Changsha, Hunan, Peoples R China; [Zhang, Hai-qing] State Key Lab Hybrid Rice, Wuhan, Hunan, Peoples R China; [He, Feng; Wang, Guo-liang] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China; [Li, Wei] Hunan Agr Univ, Coll Plant Preservat, Changsha, Hunan, Peoples R China; [Wang, Guo-liang] Ohio State Univ, Dept Plant Pathol, Columbus, OH 43210 USA	Hunan Agricultural University; Hunan Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS; Hunan Agricultural University; University System of Ohio; Ohio State University	Zhang, HQ (corresponding author), Hunan Agr Univ, Coll Agron, Changsha, Hunan, Peoples R China.	hunanhongli@aliyun.com		Wang, Guo-Liang/0000-0001-8877-3064	National Natural Science Foundation [30971839]; Hunan Natural Science Foundation [C110203]; Hunan Postgraduate Innovation project [CX2012B276]; Program for Innovative Research Team in University [IRT1239]; Rice Genomics Laboratory of Hunan Agricultural University	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Hunan Natural Science Foundation(Natural Science Foundation of Hunan Province); Hunan Postgraduate Innovation project; Program for Innovative Research Team in University; Rice Genomics Laboratory of Hunan Agricultural University	This study was supported by the National Natural Science Foundation (30971839), the Hunan Natural Science Foundation (C110203), the Hunan Postgraduate Innovation project (CX2012B276), the Program for Innovative Research Team in University (IRT1239), and the Rice Genomics Laboratory of Hunan Agricultural University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apchelimov AA, 2007, PLANTA, V225, P935, DOI 10.1007/s00425-006-0390-1; Axelsson E, 2006, PLANT CELL, V18, P3606, DOI 10.1105/tpc.106.042374; BOLLIVAR DW, 1994, J MOL BIOL, V237, P622, DOI 10.1006/jmbi.1994.1260; Chai CL, 2011, PLANT MOL BIOL, V75, P211, DOI 10.1007/s11103-010-9719-z; Chen XZ, 2009, ACTA AGR JIANGXI, V9, P008, DOI DOI 10.1371/J0URNAL.P0NE.0072811; [邓晓娟 Deng Xiaojuan], 2012, [杂交水稻, Hybrid Rice], V27, P9; Deng XJ, 2010, CROP RES, V24, P46; Dong H, 2013, PLANT PHYSIOL, V162, P1867, DOI 10.1104/pp.113.217604; Fang J, 2008, PLANT J, V54, P177, DOI 10.1111/j.1365-313X.2008.03411.x; Gong XD, 2013, G3-GENES GENOM GENET, V3, P1769, DOI 10.1534/g3.113.007856; Gothandam KM, 2005, PLANT MOL BIOL, V58, P421, DOI 10.1007/s11103-005-5702-5; Guo RB, 1998, PLANT PHYSIOL, V116, P605, DOI 10.1104/pp.116.2.605; Han SH, 2012, MOL CELLS, V33, P87, DOI 10.1007/s10059-012-2218-0; Hibara K, 2009, DEV BIOL, V334, P345, DOI 10.1016/j.ydbio.2009.07.042; Hu F, 2012, PLANT SCI, V195, P125, DOI 10.1016/j.plantsci.2012.06.006; Huang JL, 2013, PLANT SCI, V210, P241, DOI 10.1016/j.plantsci.2013.06.003; Huang XQ, 2008, RICE SCI, V15, P7, DOI 10.1016/S1672-6308(08)60013-X; Jiang HW, 2007, PLANT J, V52, P197, DOI 10.1111/j.1365-313X.2007.03221.x; Jung KH, 2003, PLANT CELL PHYSIOL, V44, P463, DOI 10.1093/pcp/pcg064; Li JQ, 2013, J PLANT BIOL, V56, P326, DOI 10.1007/s12374-013-0180-9; Li YH, 2003, PLANT CELL, V15, P2020, DOI 10.1105/tpc.011775; Liu Sheng, 2013, Zhongguo Shuidao Kexue, V27, P231, DOI 10.3969/j.issn.1001-7216.2013.03.002; Liu WZ, 2007, PLANTA, V226, P785, DOI 10.1007/s00425-007-0525-z; Masuda T, 2008, PHOTOCH PHOTOBIO SCI, V7, P1131, DOI 10.1039/b807210h; Mochizuki N, 2001, P NATL ACAD SCI USA, V98, P2053, DOI 10.1073/pnas.98.4.2053; Mochizuki N, 2008, P NATL ACAD SCI USA, V105, P15184, DOI 10.1073/pnas.0803245105; Nott A, 2006, ANNU REV PLANT BIOL, V57, P739, DOI 10.1146/annurev.arplant.57.032905.105310; Osanai T, 2009, P NATL ACAD SCI USA, V106, P6860, DOI 10.1073/pnas.0810040106; Park SY, 2007, PLANT CELL, V19, P1649, DOI 10.1105/tpc.106.044891; Peng Y, 2012, J GENET GENOMICS, V39, P385, DOI 10.1016/j.jgg.2012.05.001; PERRY KL, 1992, J GEN VIROL, V73, P2105, DOI 10.1099/0022-1317-73-8-2105; Rodermel S, 2003, BIOESSAYS, V25, P631, DOI 10.1002/bies.10308; Rogers S.O., 1989, EXTRACTION DNA PLANT, P73, DOI [10.1007/978-94-009-0951-9_6, DOI 10.1007/978-94-009-0951-9_6]; Sakuraba Y, 2013, PLANT J, V74, P122, DOI 10.1111/tpj.12110; Shu Q., 1996, ACTA AGRIC NUCL SIN, V10, P6; [宋克堡 SONG Kebao], 2007, [杂交水稻, Hybrid Rice], V22, P71; Stenbaek A, 2010, PHYTOCHEMISTRY, V71, P853, DOI 10.1016/j.phytochem.2010.03.022; Su N, 2012, PLANT PHYSIOL, V159, P227, DOI 10.1104/pp.112.195081; Sun XiaoQiu, 2011, Acta Agronomica Sinica, V37, P991, DOI 10.3724/SP.J.1006.2011.00991; Takai T, 2013, SCI REP-UK, V3, DOI 10.1038/srep02149; Tang YanLin, 2004, Rice Science, V11, P274; Tian XQ, 2013, GENES GENOM, V35, P87, DOI 10.1007/s13258-013-0069-5; Tsuzuki T, 2011, J PLANT RES, V124, P527, DOI 10.1007/s10265-011-0426-x; Wang CT, 2008, CHINA SEED IND, V8, P24; Wang Jing-Fing, 2007, Hunan Shifan Daxue Ziran Kexue Xuebao, V30, P89; [王平荣 Wang Pingrong], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P1305; [王平荣 Wang Pingrong], 2013, [中国农业科学, Scientia Agricultura Sinica], V46, P225; Wang PR, 2010, PLANT PHYSIOL, V153, P994, DOI 10.1104/pp.110.158477; Wang ZK, 2013, GENES GENOM, V35, P491, DOI 10.1007/s13258-013-0094-4; Willows RD, 2004, J STRUCT BIOL, V146, P227, DOI 10.1016/j.jsb.2003.11.019; Yang QS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020015; Zhang FT, 2013, RICE, V6, DOI 10.1186/1939-8433-6-7; Zhang HT, 2006, PLANT MOL BIOL, V62, P325, DOI 10.1007/s11103-006-9024-z; [张向前 Zhang Xiangqian], 2010, [科学通报, Chinese Science Bulletin], V55, P2296, DOI 10.1360/972010-396; Zhou KN, 2013, PLANTA, V237, P279, DOI 10.1007/s00425-012-1756-1; Zhou Y, 2013, J OPTIMIZ THEORY APP, V156, P1, DOI 10.1007/s10957-013-0271-2	56	61	82	10	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99564	10.1371/journal.pone.0099564	http://dx.doi.org/10.1371/journal.pone.0099564			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932524	gold, Green Published, Green Submitted			2022-12-27	WOS:000337738600042
J	Kling, RC; Tschammer, N; Lanig, H; Clark, T; Gmeiner, P				Kling, Ralf C.; Tschammer, Nuska; Lanig, Harald; Clark, Timothy; Gmeiner, Peter			Active-State Model of a Dopamine D-2 Receptor - G alpha(i) Complex Stabilized by Aripiprazole-Type Partial Agonists	PLOS ONE			English	Article							G-PROTEIN ACTIVATION; BETA(2)-ADRENERGIC RECEPTOR; STRUCTURAL BASIS; DRY MOTIF; EFFICACY; BINDING; CONFORMATIONS; FLEXIBILITY; MUTATIONS; EFFICIENT	Partial agonists exhibit a submaximal capacity to enhance the coupling of one receptor to an intracellular binding partner. Although a multitude of studies have reported different ligand-specific conformations for a given receptor, little is known about the mechanism by which different receptor conformations are connected to the capacity to activate the coupling to G-proteins. We have now performed molecular-dynamics simulations employing our recently described active-state homology model of the dopamine D-2 receptor-G alpha(i) protein-complex coupled to the partial agonists aripiprazole and FAUC350, in order to understand the structural determinants of partial agonism better. We have compared our findings with our model of the D2R-G alpha(i)-complex in the presence of the full agonist dopamine. The two partial agonists are capable of inducing different conformations of important structural motifs, including the extracellular loop regions, the binding pocket and, in particular, intracellular G-protein-binding domains. As G-protein-coupling to certain intracellular epitopes of the receptor is considered the key step of allosterically triggered nucleotide-exchange, it is tempting to assume that impaired coupling between the receptor and the G-protein caused by distinct ligand-specific conformations is a major determinant of partial agonist efficacy.	[Kling, Ralf C.; Tschammer, Nuska; Gmeiner, Peter] Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany; [Kling, Ralf C.; Lanig, Harald; Clark, Timothy] Univ Erlangen Nurnberg, Comp Chem Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany; [Lanig, Harald] Univ Erlangen Nurnberg, Cent Inst Sci Comp, D-91054 Erlangen, Germany; [Clark, Timothy] Univ Portsmouth, Ctr Mol Design, Portsmouth, Hants, England	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Portsmouth	Gmeiner, P (corresponding author), Univ Erlangen Nurnberg, Emil Fischer Ctr, Dept Chem & Pharm, D-91054 Erlangen, Germany.	peter.gmeiner@fau.de	Tschammer, Nuska/A-7359-2008; Gmeiner, Peter/N-5275-2015	Tschammer, Nuska/0000-0003-2433-3355; Clark, Timothy/0000-0001-7931-4659; Gmeiner, Peter/0000-0002-4127-197X; Lanig, Harald/0000-0003-1593-5557				Babin V., 2008, AMBER; BAYLY CI, 1993, J PHYS CHEM-US, V97, P10269, DOI 10.1021/j100142a004; BERENDSEN HJC, 1987, J PHYS CHEM-US, V91, P6269, DOI 10.1021/j100308a038; Bokoch MP, 2010, NATURE, V463, P108, DOI 10.1038/nature08650; Chien EYT, 2010, SCIENCE, V330, P1091, DOI 10.1126/science.1197410; CHO W, 1995, J NEUROCHEM, V65, P2105, DOI 10.1046/j.1471-4159.1995.65052105.x; Chung KY, 2011, NATURE, V477, P611, DOI 10.1038/nature10488; Coley C, 2000, J NEUROCHEM, V74, P358, DOI 10.1046/j.1471-4159.2000.0740358.x; Daeffler KNM, 2012, J AM CHEM SOC, V134, P14890, DOI 10.1021/ja304560x; DeLeon A, 2004, CLIN THER, V26, P649, DOI 10.1016/S0149-2918(04)90066-5; Deupi X, 2012, P NATL ACAD SCI USA, V109, P119, DOI 10.1073/pnas.1114089108; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Ehrlich K, 2009, J MED CHEM, V52, P4923, DOI 10.1021/jm900690y; Elgeti M, 2011, J AM CHEM SOC, V133, P7159, DOI 10.1021/ja200545n; Fowler JC, 2012, MOL PHARMACOL, V81, P820, DOI 10.1124/mol.111.075457; Freedman R, 2003, NEW ENGL J MED, V349, P1738, DOI 10.1056/NEJMra035458; Frisch G. W., 2013, GAUSSIAN 09; Galandrin S, 2007, TRENDS PHARMACOL SCI, V28, P423, DOI 10.1016/j.tips.2007.06.005; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Goetz A, 2011, J MOL BIOL; Goncalves JA, 2010, P NATL ACAD SCI USA, V107, P19861, DOI 10.1073/pnas.1009405107; Haberl F, 2009, PROTEINS, V77, P857, DOI 10.1002/prot.22505; Hess B, 2008, J CHEM THEORY COMPUT, V4, P435, DOI 10.1021/ct700301q; HOGGER P, 1995, J BIOL CHEM, V270, P7405; Holst B, 2010, J BIOL CHEM, V285, P3973, DOI 10.1074/jbc.M109.064725; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jantschak F, 2013, J PHARMACOL EXP THER, V347, P57, DOI 10.1124/jpet.113.205997; Katritch V, 2013, ANNU REV PHARMACOL, V53, P531, DOI 10.1146/annurev-pharmtox-032112-135923; Kaye RG, 2011, MOL PHARMACOL, V79, P701, DOI 10.1124/mol.110.070177; Kenakin T, 2002, NAT REV DRUG DISCOV, V1, P103, DOI 10.1038/nrd722; Kiss B, 2010, J PHARMACOL EXP THER, V333, P328, DOI 10.1124/jpet.109.160432; Kling RC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067244; KOBILKA BK, 1988, SCIENCE, V240, P1310, DOI 10.1126/science.2836950; Kobilka B, 2013, ANGEW CHEM INT EDIT, V52, P6380, DOI 10.1002/anie.201302116; Kofuku Y, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2046; Liu JJ, 2012, SCIENCE, V335, P1106, DOI 10.1126/science.1215802; Lober S, 2011, TRENDS PHARMACOL SCI, V32, P148, DOI 10.1016/j.tips.2010.12.003; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; Miao YL, 2013, P NATL ACAD SCI USA, V110, P10982, DOI 10.1073/pnas.1309755110; Miller BR, 2012, J CHEM THEORY COMPUT, V8, P3314, DOI 10.1021/ct300418h; MORO O, 1993, J BIOL CHEM, V268, P22273; Nanoff C, 2006, MOL PHARMACOL, V69, P397, DOI 10.1124/mol.105.016725; Niesen MJM, 2011, J AM CHEM SOC, V133, P13197, DOI 10.1021/ja205313h; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; Preininger AM, 2013, J MOL BIOL, V425, P2288, DOI 10.1016/j.jmb.2013.04.011; Rasmussen SGF, 2011, NATURE, V477, P549, DOI 10.1038/nature10361; Rasmussen SGF, 2011, NATURE, V469, P175, DOI 10.1038/nature09648; Ring AM, 2013, NATURE, V502, P575, DOI 10.1038/nature12572; Rosenbaum DM, 2011, NATURE, V469, P236, DOI 10.1038/nature09665; Rovati GE, 2007, MOL PHARMACOL, V71, P959, DOI 10.1124/mol.106.029470; Schneider EH, 2010, J PHARMACOL EXP THER, V333, P382, DOI 10.1124/jpet.109.163220; Schrodinger L., 2020, PYMOL; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; Seifert R, 2001, J PHARMACOL EXP THER, V297, P1218; Shan JF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002473; Shi L, 2002, J BIOL CHEM, V277, P14777, DOI 10.1074/jbc.M108967200; Siu SWI, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2897760; Tadori Y, 2005, EUR J PHARMACOL, V515, P10, DOI 10.1016/j.ejphar.2005.02.051; Trott O, 2010, J COMPUT CHEM, V31, P455, DOI 10.1002/jcc.21334; Tschammer N, 2011, MOL PHARMACOL, V79, P575, DOI 10.1124/mol.110.068106; Tschammer N, 2010, ACS CHEM NEUROSCI, V1, P25, DOI 10.1021/cn900001b; Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291; VOSS T, 1993, J BIOL CHEM, V268, P4637; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Warne T, 2011, NATURE, V469, P241, DOI 10.1038/nature09746; West GM, 2011, STRUCTURE, V19, P1424, DOI 10.1016/j.str.2011.08.001; Westfield GH, 2011, P NATL ACAD SCI USA, V108, P16086, DOI 10.1073/pnas.1113645108; Wheatley M, 2012, BRIT J PHARMACOL, V165, P1688, DOI 10.1111/j.1476-5381.2011.01629.x; Woodward R, 1996, J NEUROCHEM, V66, P394, DOI 10.1046/j.1471-4159.1996.66010394.x; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; Zurn A, 2009, MOL PHARMACOL, V75, P534, DOI 10.1124/mol.108.052399	73	33	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100069	10.1371/journal.pone.0100069	http://dx.doi.org/10.1371/journal.pone.0100069			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932547	gold, Green Submitted, Green Published			2022-12-27	WOS:000337738600088
J	Liu, CL; Wang, JJ; Zhang, XB				Liu, Cuilian; Wang, Jiajia; Zhang, Xiaobo			The Involvement of MiR-1-Clathrin Pathway in the Regulation of Phagocytosis	PLOS ONE			English	Article							MICRORNA TARGET PREDICTIONS; MURINE MACROPHAGES; PROTEINS; SHRIMP; ACTIVATION; EXPRESSION; EVOLUTION; JAPONICUS; RECEPTOR; GTPASE	Phagocytosis, one of the most powerful immune responses, is a complicated process regulated by many factors. However the regulation of phagocytosis mediated by microRNAs has not been extensively investigated. To address this issue, the regulation of phagocytosis by miR-1 was characterized in this study. The results showed that miR-1 played an important role in the phagocytosis regulation in shrimp in vivo. The sequence analysis indicated that miR-1 was highly conserved from invertebrates to mammals, suggesting that miR-1 might share the similar or same functions in phagocytosis of shrimp hemocytes and mammalian macrophages. The data presented that miR-1 was significantly downregulated in cancerous macrophage RAW264.7 cells compared with those in the isolated murine macrophage and in the immortalized macrophage ANA-1. The findings showed that miR-1 had a great effect on the regulation of phagocytosis in cancerous macrophage by the inhibition of clathrin heavy chain 1 (CLTC1) gene. Therefore our study presented a novel miR-1-mediated regulation of phagocytosis both in invertebrate and in vertebrate.	[Zhang, Xiaobo] Zhejiang Univ, Minist Agr, Key Lab Anim Virol, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Coll Life Sci, Hangzhou 310003, Zhejiang, Peoples R China	Ministry of Agriculture & Rural Affairs; Zhejiang University; Zhejiang University	Zhang, XB (corresponding author), Zhejiang Univ, Minist Agr, Key Lab Anim Virol, Hangzhou 310003, Zhejiang, Peoples R China.	zxb0812@zju.edu.cn		Zhang, Xiaobo/0000-0003-4606-212X	China Ocean Mineral Resources R D Association [DY125-15-E-01]; National Basic Research Program of China [2012CB114403]; Hi-Tech Research and Development Program of China (863 program of China) [2012AA092205-2]	China Ocean Mineral Resources R D Association; National Basic Research Program of China(National Basic Research Program of China); Hi-Tech Research and Development Program of China (863 program of China)(National High Technology Research and Development Program of China)	This work was financially supported by China Ocean Mineral Resources R & D Association (DY125-15-E-01), the National Basic Research Program of China (2012CB114403) and Hi-Tech Research and Development Program of China (863 program of China) (2012AA092205-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593; BLASI E, 1985, NATURE, V318, P667, DOI 10.1038/318667a0; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Creighton CJ, 2008, RNA, V14, P2290, DOI 10.1261/rna.1188208; D'Souza-Schorey C, 2006, NAT REV MOL CELL BIO, V7, P347, DOI 10.1038/nrm1910; Doran J, 2007, DNA CELL BIOL, V26, P353, DOI 10.1089/dna.2006.0546; Gresham HD, 2000, J EXP MED, V191, P515, DOI 10.1084/jem.191.3.515; Haworth R, 1998, METHOD MICROBIOL, V25, P287; Hayashi A, 2004, J BIOL CHEM, V279, P29450, DOI 10.1074/jbc.M400950200; Heasman SJ, 2003, J ENDOCRINOL, V178, P29, DOI 10.1677/joe.0.1780029; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Kirchhausen T, 2000, NAT REV MOL CELL BIO, V1, P187, DOI 10.1038/35043117; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Liu WF, 2009, J PROTEOME RES, V8, P1198, DOI 10.1021/pr800840x; Mansfield PJ, 2000, BLOOD, V95, P2407, DOI 10.1182/blood.V95.7.2407.007k02_2407_2412; Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575; Niedergang F, 2005, CURR TOP MICROBIOL, V291, P43; Niwa R, 2007, CURR OPIN GENET DEV, V17, P145, DOI 10.1016/j.gde.2007.02.004; ODIN JA, 1991, SCIENCE, V254, P1785, DOI 10.1126/science.1837175; Perry DG, 1999, J IMMUNOL, V162, P380; RALPH P, 1977, J IMMUNOL, V119, P950; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Rotshenker S, 2003, J MOL NEUROSCI, V21, P65, DOI 10.1385/JMN:21:1:65; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Underhill DM, 2002, ANNU REV IMMUNOL, V20, P825, DOI 10.1146/annurev.immunol.20.103001.114744; Wu WL, 2008, J PROTEOME RES, V7, P424, DOI 10.1021/pr700639t; Yang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039015; Zong RR, 2008, FISH SHELLFISH IMMUN, V25, P258, DOI 10.1016/j.fsi.2008.05.006	30	7	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98747	10.1371/journal.pone.0098747	http://dx.doi.org/10.1371/journal.pone.0098747			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932654	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600012
J	Liu, L; Su, QJ; Li, LX; Lin, XH; Gan, Y; Chen, SD				Liu, Li; Su, Qinji; Li, Lixia; Lin, Xiaohui; Gan, Yu; Chen, Sidong			The Common Variant rs4444235 near BMP4 Confers Genetic Susceptibility of Colorectal Cancer: An Updated Meta-Analysis Based on a Comprehensive Statistical Strategy	PLOS ONE			English	Article							ASSOCIATION; RISK; LOCI; POLYMORPHISM; PHENOTYPE	Objective: We performed an updated meta-analysis, using a comprehensive strategy of a logistic regression and a model-free approach, to evaluate more precisely the role of the rs4444235 variant near the Bone morphogenetic protein-4 (BMP4) gene in susceptibility to colorectal cancer (CRC). Methods: A total of 19 studies with 28770 cases and 28234 controls were included. Metagen system with logistic regression was applied to choose the most plausible genetic model for rs4444235. Generalized odds ratio (ORG) metric was used to provide a global test of relationship between rs4444235 and CRC risk. Results: Metagen analysis suggested the rs4444235 fitted best to an additive model. In assessment of the additive model, heterogeneity was observed (P = 0.059, I-2 = 36.1), and pooled per-allele OR was 1.08 (95% CI = 1.05-1.11). Based on the model-free approach, pooled ORG was 1.09 (95% CI = 1.05-1.14) under a random-effect model. Stratified analyses suggested heterogeneity could be in part explained by population ethnicity, study design, sources of controls, and sample size. Sensitivity analysis further supported the robust stability of the current results, by showing similar pooled estimates before and after sequential removal of each study. Conclusions: This meta-analysis provides a robust estimate of the positive association between the rs4444235 and CRC risk and further emphasizes the importance of the rs4444235 in CRC risk prediction.	[Liu, Li; Li, Lixia; Lin, Xiaohui; Gan, Yu; Chen, Sidong] Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China; [Liu, Li; Li, Lixia; Lin, Xiaohui; Gan, Yu; Chen, Sidong] Guangdong Pharmaceut Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Guangzhou, Guangdong, Peoples R China; [Su, Qinji] Guangxi Med Univ, Affiliated Hosp 1, Mental Hlth Ctr, Nanning, Guangxi, Peoples R China	Guangdong Pharmaceutical University; Guangdong Pharmaceutical University; Guangxi Medical University	Liu, L (corresponding author), Guangdong Pharmaceut Univ, Sch Publ Hlth, Guangdong Key Lab Mol Epidemiol, Guangzhou, Guangdong, Peoples R China.	pupuliu919@gmail.com			Program for Guangdong Medical Research Foundation [B2012176]; Foundation for Distinguished Young Talents in Higher Education of Guangdong [2012LYM_0082]; National Natural Science Foundation of China [81302493]	Program for Guangdong Medical Research Foundation; Foundation for Distinguished Young Talents in Higher Education of Guangdong; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Program for Guangdong Medical Research Foundation (Grant No. B2012176; http://www.gdwst.gov.cn/lixiang/), Foundation for Distinguished Young Talents in Higher Education of Guangdong (Grant No. 2012LYM_0082; http://www.gdhed.edu.cn/main/index.html) and National Natural Science Foundation of China (Grant No. 81302493; http://isisn.nsfc.gov.cn/egrantweb/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sohaily S, 2012, J GASTROEN HEPATOL, V27, P1423, DOI 10.1111/j.1440-1746.2012.07200.x; Bagos PG, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1281; Fernandez-Rozadilla C, 2013, CARCINOGENESIS, V34, P314, DOI 10.1093/carcin/bgs357; Fernandez-Rozadilla C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012673; Hardwick JC, 2008, NAT REV CANCER, V8, P806, DOI 10.1038/nrc2467; He J, 2011, CANCER EPIDEM BIOMAR, V20, P70, DOI 10.1158/1055-9965.EPI-10-0892; Ho JW, 2011, BRIT J CANCER, V104, P369, DOI 10.1038/sj.bjc.6605977; Houlston RS, 2008, NAT GENET, V40, P1426, DOI 10.1038/ng.262; Hughes MR, 2011, SEMIN COLON RECTAL S, V22, P65, DOI 10.1053/j.scrs.2010.12.002; Hutter CM, 2012, CANCER RES, V72, P2036, DOI 10.1158/0008-5472.CAN-11-4067; Ioannidis JPA, 2005, PLOS MED, V2, P696, DOI 10.1371/journal.pmed.0020124; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kupfer SS, 2010, GASTROENTEROLOGY, V139, P1677, DOI 10.1053/j.gastro.2010.07.038; Li FX, 2012, CHINESE J CANCER RES, V24, P29, DOI 10.1007/s11670-012-0029-7; Li J, 2012, MOL BIOL REP, V39, P5239, DOI 10.1007/s11033-011-1322-0; Lubbe SJ, 2012, ONCOGENE, V31, P3777, DOI 10.1038/onc.2011.564; Lubbe SJ, 2012, CARCINOGENESIS, V33, P108, DOI 10.1093/carcin/bgr243; Lubbe SJ, 2012, AM J EPIDEMIOL, V175, P1, DOI 10.1093/aje/kwr285; Mates IN, 2010, CHIRURGIA-BUCHAREST, V105, P749; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Niittymaki I, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-23; Niittymaki I, 2010, CANCER EPIDEM BIOMAR, V19, P1478, DOI 10.1158/1055-9965.EPI-09-1320; Peters U, 2013, GASTROENTEROLOGY, V144, P799, DOI 10.1053/j.gastro.2012.12.020; Thean LF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042407; Theodoratou E, 2012, JNCI-J NATL CANCER I, V104, P1433, DOI 10.1093/jnci/djs369; Tomlinson IPM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002105; von Holst S, 2010, BRIT J CANCER, V103, P575, DOI 10.1038/sj.bjc.6605774; Win AK, 2013, EUR J CANCER, V49, P1578, DOI 10.1016/j.ejca.2013.01.029; Xiong F, 2010, CANCER EPIDEM BIOMAR, V19, P1855, DOI 10.1158/1055-9965.EPI-10-0210; Zhong H, 2010, GENET EPIDEMIOL, V34, P78, DOI 10.1002/gepi.20437; Zhong R, 2013, CARCINOGENESIS, V34, P936, DOI 10.1093/carcin/bgs395; Zintzaras E, 2010, STAT APPL GENET MOL, V9, DOI 10.2202/1544-6115.1542	33	1	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100133	10.1371/journal.pone.0100133	http://dx.doi.org/10.1371/journal.pone.0100133			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932582	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600097
J	Hayashi, H; Terao, A; Kunimatsu, R; Kawata, T				Hayashi, Hidetaka; Terao, Akiko; Kunimatsu, Ryo; Kawata, Toshitsugu			Effects of a Low Level Laser on Periodontal Tissue in Hypofunctional Teeth	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; OCCLUSAL STIMULI; ROOT RESORPTION; THERAPY; IRRADIATION; FIBROBLASTS; PROLIFERATION; GINGIVECTOMY; LIGAMENT	Malocclusions, such as an open bite and high canines, are often encountered in orthodontic practice. Teeth without occlusal stimuli are known as hypofunctional teeth, and numerous atrophic changes have been reported in the periodontal tissue, including reductions in blood vessels in the periodontal ligament (PDL), heavy root resorption, and reduced bone mineral density (BMD) in the alveolar bone. Low Level Laser (LLL) has been shown to have a positive effect on bone formation and the vasculature. Although the recovery of hypofunctional teeth remains unclear, LLL is expected to have a positive influence on periodontal tissue in occlusal hypofunction. The aim of the present study was to elucidate the relationship between LLL and periodontal tissue in occlusal hypofunction. Twenty-four male rats aged 5 weeks were randomly divided into control and hypofunctional groups. An anterior metal cap and bite plate were attached to the maxillary and mandibular incisors in the hypofunctional group to simulate occlusal hypofunction in the molars. LLL irradiation was applied to the maxillary first molar through the gingival sulcus in half of the rats. Rats were divided into four groups; control, control+LLL, hypofunctional, and hypofunctional+LLL. Exposure to LLL irradiation was performed for 3 minutes every other day for 2 weeks. Animals were examined by Micro-CT at 5 and 7 weeks and were subsequently sacrificed. Heads were resected and examined histologically and immunohistologically. The hypofunctional group had obvious stricture of the PDL. However, no significant differences were observed in the PDL and alveolar bone between the hypofunctional+LLL and the control groups. In addition, the expression of basic fibroblast growth factor (bFGF) and vascular endothelial growth factor (VEGF)positive cells were higher in the hypofunctional + LLL group than in the hypofunctional group. These results indicated that LLL enhanced the production of bFGF and VEGF in the periodontal tissue of hypofunctional teeth.	[Hayashi, Hidetaka] Hiroshima Shuccho Dent Clin, Hiroshima, Japan; [Terao, Akiko; Kunimatsu, Ryo] Hiroshima Univ, Dept Orthodont & Craniofacial Dev Biol, Grad Sch Biomed Sci, Hiroshima, Japan; [Kawata, Toshitsugu] Kanagawa Dent Univ, Dept Orthodont, Yokosuka, Kanagawa, Japan	Hiroshima University; Kanagawa Dental College	Hayashi, H (corresponding author), Hiroshima Shuccho Dent Clin, Hiroshima, Japan.	hidetaka423@yahoo.co.jp			ministry of Education, Culture, Sports, Science and Technology of Japan [24890141]	ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by a Grant-in-Aid for Scientific Research from the ministry of Education, Culture, Sports, Science and Technology of Japan (24890141). Hidetaka Hayashi provided support in the form of salaries for author HH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Ministry of Education, Culture, Sports, Science and Technology of Japan had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aldridge SE, 2005, BIOCHEM BIOPH RES CO, V335, P793, DOI 10.1016/j.bbrc.2005.07.145; Barolet D, 2008, SEMIN CUTAN MED SURG, V27, P227, DOI 10.1016/j.sder.2008.08.003; Boonpratham Supatchai, 2007, Journal of Medical and Dental Sciences, V54, P71; Faitova J, 2004, Cesk Fysiol, V53, P92; Amorim JCF, 2006, PHOTOMED LASER SURG, V24, P588; GOSPODAROWICZ D, 1990, CLIN ORTHOP RELAT R, P231; HARRIS EF, 1992, AM J ORTHOD DENTOFAC, V101, P112, DOI 10.1016/0889-5406(92)70002-R; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Khadra M, 2005, J BIOMED MATER RES A, V73A, P55, DOI 10.1002/jbm.a.30270; Kilkenny C, 2012, OSTEOARTHR CARTILAGE, V20, P256, DOI 10.1016/j.joca.2012.02.010; Kreisler M, 2003, J CLIN PERIODONTOL, V30, P353, DOI 10.1034/j.1600-051X.2003.00001.x; Kronfeld R, 1931, J AM DENT ASSOC, V18, P1242; LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986; Motokawa M, 2013, ANGLE ORTHOD, V83, P597, DOI 10.2319/081812-661.1; Niida S, 1999, J EXP MED, V190, P293, DOI 10.1084/jem.190.2.293; Ozcelik O, 2008, J CLIN PERIODONTOL, V35, P250, DOI 10.1111/j.1600-051X.2007.01194.x; Saygun I, 2008, LASER MED SCI, V23, P211, DOI 10.1007/s10103-007-0477-3; Seifi M, 2010, LASER MED SCI, V25, P61, DOI 10.1007/s10103-009-0651-x; SENGER DR, 1983, SCIENCE, V219, P983, DOI 10.1126/science.6823562; Shakouri SK, 2010, LASER MED SCI, V25, P73, DOI 10.1007/s10103-009-0670-7; Shimomoto Y, 2007, J DENT RES, V86, P47, DOI 10.1177/154405910708600107; Sringkarnboriboon S, 2003, J DENT RES, V82, P486, DOI 10.1177/154405910308200616; Tajali SB, 2010, J ORTHOP SURG RES, V5, DOI 10.1186/1749-799X-5-1; Tanaka A, 1998, ORTHOD WAVES, V57, P180; Tuby H, 2006, LASER SURG MED, V38, P682, DOI 10.1002/lsm.20377	25	6	8	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100066	10.1371/journal.pone.0100066	http://dx.doi.org/10.1371/journal.pone.0100066			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927024	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100115
J	Hulzebos, CV; Dijk, PH; van Imhoff, DE; Bos, AF; Lopriore, E; Offringa, M; Ruiter, SAJ; van Braeckel, KNJA; Krabbe, PFM; Quik, EH; van Toledo-Eppinga, L; Nuytemans, DHGM; van Wassenaer-Leemhuis, AG; Benders, MJN; Korbeeck-van Hof, KKM; van Lingen, RA; Jebbink, LJMG; Liem, D; Mansvelt, P; Buijs, J; Govaert, P; van Vliet, I; Mulder, TLM; Wolfs, C; Fetter, WPF; Laarman, C				Hulzebos, Christian V.; Dijk, Peter H.; van Imhoff, Deirdre E.; Bos, Arend F.; Lopriore, Enrico; Offringa, Martin; Ruiter, Selma A. J.; van Braeckel, Koen N. J. A.; Krabbe, Paul F. M.; Quik, Elise H.; van Toledo-Eppinga, Letty; Nuytemans, Debbie H. G. M.; van Wassenaer-Leemhuis, Aleid G.; Benders, Manon J. N.; Korbeeck-van Hof, Karen K. M.; van Lingen, Richard A.; Jebbink, Liesbeth J. M. Groot; Liem, Djien; Mansvelt, Petri; Buijs, Jan; Govaert, Paul; van Vliet, Ineke; Mulder, Twan L. M.; Wolfs, Cecile; Fetter, Willem P. F.; Laarman, Celeste		BARTrial Study Grp	The Bilirubin Albumin Ratio in the Management of Hyperbilirubinemia in Preterm Infants to Improve Neurodevelopmental Outcome: A Randomized Controlled Trial - BARTrial	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; JAUNDICED NEWBORNS; PREMATURE-INFANTS; SERUM BILIRUBIN; KERNICTERUS; PHOTOTHERAPY; NEUROTOXICITY; ASSOCIATION	Background and Objective: High bilirubin/albumin (B/A) ratios increase the risk of bilirubin neurotoxicity. The B/A ratio may be a valuable measure, in addition to the total serum bilirubin (TSB), in the management of hyperbilirubinemia. We aimed to assess whether the additional use of B/A ratios in the management of hyperbilirubinemia in preterm infants improved neurodevelopmental outcome. Methods: In a prospective, randomized controlled trial, 615 preterm infants of 32 weeks' gestation or less were randomly assigned to treatment based on either B/A ratio and TSB thresholds (consensus-based), whichever threshold was crossed first, or on the TSB thresholds only. The primary outcome was neurodevelopment at 18 to 24 months' corrected age as assessed with the Bayley Scales of Infant Development III by investigators unaware of treatment allocation. Secondary outcomes included complications of preterm birth and death. Results: Composite motor (100 +/- 13 vs. 101 +/- 12) and cognitive (101 +/- 12 vs. 101 +/- 11) scores did not differ between the B/A ratio and TSB groups. Demographic characteristics, maximal TSB levels, B/A ratios, and other secondary outcomes were similar. The rates of death and/or severe neurodevelopmental impairment for the B/A ratio versus TSB groups were 15.4% versus 15.5% (P = 1.0) and 2.8% versus 1.4% (P = 0.62) for birth weights <= 1000 g and 1.8% versus 5.8% (P = 0.03) and 4.1% versus 2.0% (P = 0.26) for birth weights of > 1000 g. Conclusions: The additional use of B/A ratio in the management of hyperbilirubinemia in preterm infants did not improve their neurodevelopmental outcome.	[Hulzebos, Christian V.; Dijk, Peter H.; van Imhoff, Deirdre E.; Bos, Arend F.; van Braeckel, Koen N. J. A.] Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Neonatol, NL-9713 AV Groningen, Netherlands; [Lopriore, Enrico] Leiden Univ, Div Neonatol, Dept Pediat, Med Ctr, Leiden, Netherlands; [Offringa, Martin] Univ Toronto, Hosp Sick Children, Res Inst, Toronto, ON M5G 1X8, Canada; [Ruiter, Selma A. J.] Univ Groningen, Dept Orthopedag, Groningen, Netherlands; [Krabbe, Paul F. M.; Quik, Elise H.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Toledo-Eppinga, Letty; Nuytemans, Debbie H. G. M.; van Wassenaer-Leemhuis, Aleid G.] Emma Childrens Hosp, Acad Med Ctr, Dept Neonatol, Amsterdam, Netherlands; [Benders, Manon J. N.; Korbeeck-van Hof, Karen K. M.] Wilhelmina Childrens Hosp, Univ Med Ctr Utrecht, Dept Neonatol, Utrecht, Netherlands; [van Lingen, Richard A.; Jebbink, Liesbeth J. M. Groot] Princess Amalia Dept Pediat, Dept Neonatol, Isala, Zwolle, Netherlands; [Liem, Djien; Mansvelt, Petri] Radboud Univ Nijmegen Med Ctr, Dept Pediat, Div Neonatol, Nijmegen, Netherlands; [Buijs, Jan] Maxima Med Ctr, Dept Pediat, Veldhoven, Netherlands; [Govaert, Paul; van Vliet, Ineke] Sophia Childrens Univ Hosp, Erasmus MC, Rotterdam, Netherlands; [Mulder, Twan L. M.; Wolfs, Cecile] Maastricht Univ, Med Ctr, Dept Pediat, GROW Sch Oncol & Dev Biol, Maastricht, Netherlands; [Fetter, Willem P. F.; Laarman, Celeste] Vrije Univ Amsterdam Med Ctr, Dept Pediat, Amsterdam, Netherlands	University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Groningen; University of Groningen; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Radboud University Nijmegen; Maxima Medical Center; Erasmus University Rotterdam; Erasmus MC; Erasmus MC - Sophia Children's Hospital; Maastricht University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Dijk, PH (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Beatrix Childrens Hosp, Dept Neonatol, NL-9713 AV Groningen, Netherlands.	p.h.dijk@umcg.nl	Lopriore, Enrico/ABE-3576-2021; Krabbe, Paul/AAO-6590-2020; Liem, K.D./L-4489-2015; Hulzebos, Christian Victor/AAY-6803-2021; Mulder, Antonius/AAJ-5935-2021; Krabbe, Paul/B-2563-2013	Lopriore, Enrico/0000-0002-3513-5066; Krabbe, Paul/0000-0001-6042-1243; Hulzebos, Christian Victor/0000-0002-8159-7501; Mulder, Antonius/0000-0001-8625-4359; Krabbe, Paul/0000-0001-6042-1243; Offringa, Martin/0000-0002-4402-5299	Netherlands Organisation for Health Research and Development (ZonMw) [94507407]	Netherlands Organisation for Health Research and Development (ZonMw)(Netherlands Organization for Health Research and Development)	This study had been funded by the Netherlands Organisation for Health Research and Development (ZonMw), program cost-effectiveness number: 94507407. website: www.zonmw.nl. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlfors CE, 2004, SEMIN PERINATOL, V28, P334, DOI 10.1053/j.semperi.2004.09.002; AHLFORS CE, 1994, PEDIATRICS, V93, P488; Ahlfors CE, 2010, CURR OPIN PEDIATR, V22, P129, DOI 10.1097/MOP.0b013e328336eb28; Cans C, 2000, DEV MED CHILD NEUROL, V42, P816, DOI 10.1111/j.1469-8749.2000.tb00695.x; GARTNER LM, 1970, PEDIATRICS, V45, P906; Govaert P, 2003, PEDIATRICS, V112, P1256, DOI 10.1542/peds.112.6.1256; Hulzebos CV, 2008, ARCH DIS CHILD-FETAL, V93, pF384, DOI 10.1136/adc.2007.134056; LIPSITZ PJ, 1985, PEDIATRICS, V75, P422; Mazeiras G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030900; McDonagh AF, 2006, PEDIATRICS, V117, P523, DOI 10.1542/peds.2005-2073; Moll M, 2011, NEONATOLOGY, V99, P90, DOI 10.1159/000302719; Morris BH, 2008, NEW ENGL J MED, V359, P1885, DOI 10.1056/NEJMoa0803024; National Institude of Child and Human Development, 1985, PEDIATRICS, V75, P385; Oh W, 2003, PEDIATRICS, V112, P773, DOI 10.1542/peds.112.4.773; Oh W, 2010, ACTA PAEDIATR, V99, P673, DOI 10.1111/j.1651-2227.2010.01688.x; van Imhoff DE, 2011, EUR J PEDIATR, V170, P977, DOI 10.1007/s00431-010-1383-4; van Imhoff DE, 2011, EARLY HUM DEV, V87, P521, DOI 10.1016/j.earlhumdev.2011.04.004; Watchko JF, 2013, NEW ENGL J MED, V369, P2021, DOI 10.1056/NEJMra1308124; Wennberg RP, 2006, PEDIATRICS, V117, P474, DOI 10.1542/peds.2005-0395	19	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99466	10.1371/journal.pone.0099466	http://dx.doi.org/10.1371/journal.pone.0099466			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927259	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100045
J	Locke, B; Forsgren, E; de Miranda, JR				Locke, Barbara; Forsgren, Eva; de Miranda, Joachim R.			Increased Tolerance and Resistance to Virus Infections: A Possible Factor in the Survival of Varroa destructor-Resistant Honey Bees (Apis mellifera)	PLOS ONE			English	Article							DEFORMED-WING VIRUS; SACBROOD VIRUS; VERTICAL-TRANSMISSION; COLONIES; MITES; INFESTATION; POPULATION; PREVALENCE; JACOBSONI; PATHOGENS	The honey bee ectoparasitic mite, Varroa destructor, has a world-wide distribution and inflicts more damage than all other known apicultural diseases. However, Varroa-induced colony mortality is more accurately a result of secondary virus infections vectored by the mite. This means that honey bee resistance to Varroa may include resistance or tolerance to virus infections. The aim of this study was to see if this is the case for a unique population of mite-resistant (MR) European honey bees on the island of Gotland, Sweden. This population has survived uncontrolled mite infestation for over a decade, developing specific mite-related resistance traits to do so. Using RT-qPCR techniques, we monitored late season virus infections, Varroa mite infestation and honey bee colony population dynamics in the Gotland MR population and compared this to mite-susceptible (MS) colonies in a close by apiary. From summer to autumn the deformed wing virus (DWV) titres increased similarly between the MR and MS populations, while the black queen cell virus (BQCV) and sacbrood virus (SBV) titres decreased substantially in the MR population compared to the MS population by several orders of magnitude. The MR colonies all survived the following winter with high mite infestation, high DWV infection, small colony size and low proportions of autumn brood, while the MS colonies all perished. Possible explanations for these changes in virus titres and their relevance to Varroa resistance and colony winter survival are discussed.	[Locke, Barbara; Forsgren, Eva; de Miranda, Joachim R.] Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden	Swedish University of Agricultural Sciences	Locke, B (corresponding author), Swedish Univ Agr Sci, Dept Ecol, Uppsala, Sweden.	Barbara.locke@slu.se	locke, barbara/X-1857-2019	locke, barbara/0000-0001-6083-9981; Rodrigues de Miranda, Joachim/0000-0002-0335-0386; Forsgren, Eva/0000-0002-8244-7265	Swedish Research Council Formas [2012-1060]; EU-funded 7th Framework project BEE DOC [244956]; EC - National Program through the Swedish Board of Agriculture	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); EU-funded 7th Framework project BEE DOC; EC - National Program through the Swedish Board of Agriculture	This work was financially supported both by The Swedish Research Council Formas (grant diarienr. 2012-1060) and by the EU-funded 7th Framework project BEE DOC (grant agreement 244956). Financial support for maintaining the Gotland population was obtained from the EC funded National Program through the Swedish Board of Agriculture. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson D., 1993, Australasian Beekeeper, V94, P292; ANDERSON DL, 1992, J ECON ENTOMOL, V85, P47, DOI 10.1093/jee/85.1.47; BAILEY L, 1972, ANN APPL BIOL, V72, P27, DOI 10.1111/j.1744-7348.1972.tb01268.x; Bailey L., 1991, HONEY BEE PATHOLOGY; Boecking O, 2008, J VERBRAUCH LEBENSM, V3, P221, DOI 10.1007/s00003-008-0331-y; Bowen-Walker PL, 1999, J INVERTEBR PATHOL, V73, P101, DOI 10.1006/jipa.1998.4807; Dainat B, 2012, APPL ENVIRON MICROB, V78, P981, DOI 10.1128/AEM.06537-11; de Miranda JR, 2008, J INVERTEBR PATHOL, V98, P184, DOI 10.1016/j.jip.2008.02.004; de Miranda J. R., 2013, J APICULTURAL RES, V52; de Miranda JR, 2010, J INVERTEBR PATHOL, V103, pS48, DOI 10.1016/j.jip.2009.06.012; DEJONG D, 1982, J APICULT RES, V21, P165, DOI 10.1080/00218839.1982.11100535; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; Evans JD, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.4.11; Freiberg M, 2012, GENET MOL RES, V11, P3310, DOI 10.4238/2012.September.12.14; Fries I, 2003, APIDOLOGIE, V34, P389, DOI 10.1051/apido:2003032; FRIES I, 1991, EXP APPL ACAROL, V10, P279, DOI 10.1007/BF01198656; Fries I, 2006, APIDOLOGIE, V37, P564, DOI 10.1051/apido:2006031; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genersch E, 2010, VET RES, V41, DOI 10.1051/vetres/2010027; Gisder S, 2009, J GEN VIROL, V90, P463, DOI 10.1099/vir.0.005579-0; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Imdorf A., 1990, Schweizerische Bienen-Zeitung, V113, P378; Kralj J, 2007, J COMP PHYSIOL A, V193, P363, DOI 10.1007/s00359-006-0192-8; Laidlaw Jr H. H., 1979, CONT QUEEN REARING; Le Conte Y, 2007, APIDOLOGIE, V38, P566, DOI 10.1051/apido:2007040; Le Conte Y, 2010, APIDOLOGIE, V41, P353, DOI 10.1051/apido/2010017; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Locke B, 2012, ECOL EVOL, V2, P1144, DOI 10.1002/ece3.248; Locke B, 2012, APPL ENVIRON MICROB, V78, P2073, DOI 10.1128/AEM.00086-12; Locke B, 2011, APIDOLOGIE, V42, P533, DOI 10.1007/s13592-011-0029-5; Lourenco AP, 2008, APIDOLOGIE, V39, P372, DOI 10.1051/apido:2008015; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Medina LM, 2002, EXP APPL ACAROL, V27, P79, DOI 10.1023/A:1021579113907; Mockel N, 2011, J GEN VIROL, V92, P370, DOI 10.1099/vir.0.025940-0; Nielsen SL, 2008, APIDOLOGIE, V39, P310, DOI 10.1051/apido:2008007; Ribiere M., 2008, VIROLOGY HONEY BEE, P15, DOI DOI 10.1016/J.JVIROMET.2019.04.020; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Seeley TD, 2007, APIDOLOGIE, V38, P19, DOI 10.1051/apido:2006055; Shen MQ, 2005, VIROLOGY, V342, P141, DOI 10.1016/j.virol.2005.07.012; Strauss U, 2013, J INVERTEBR PATHOL, V114, P45, DOI 10.1016/j.jip.2013.05.003; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; Teixeira EW, 2008, J INVERTEBR PATHOL, V99, P117, DOI 10.1016/j.jip.2008.03.014; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Topolska G, 2008, THESIS WARSAW U LIFE; Winston M.L., 1991, BIOL HONEY BEE; Yang XL, 2005, P NATL ACAD SCI USA, V102, P7470, DOI 10.1073/pnas.0501860102; Yue C, 2005, J GEN VIROL, V86, P3419, DOI 10.1099/vir.0.81401-0; Yue C, 2007, J GEN VIROL, V88, P2329, DOI 10.1099/vir.0.83101-0	48	64	66	1	110	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99998	10.1371/journal.pone.0099998	http://dx.doi.org/10.1371/journal.pone.0099998			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926792	Green Accepted, gold, Green Published			2022-12-27	WOS:000338278100105
J	Santolini, M; Mora, T; Hakim, V				Santolini, Marc; Mora, Thierry; Hakim, Vincent			A General Pairwise Interaction Model Provides an Accurate Description of In Vivo Transcription Factor Binding Sites	PLOS ONE			English	Article							IDENTIFICATION; NETWORK; STATISTICS; PATTERNS; CONTACTS; ELEMENTS; MODULES	The identification of transcription factor binding sites (TFBSs) on genomic DNA is of crucial importance for understanding and predicting regulatory elements in gene networks. TFBS motifs are commonly described by Position Weight Matrices (PWMs), in which each DNA base pair contributes independently to the transcription factor (TF) binding. However, this description ignores correlations between nucleotides at different positions, and is generally inaccurate: analysing fly and mouse in vivo ChIPseq data, we show that in most cases the PWM model fails to reproduce the observed statistics of TFBSs. To overcome this issue, we introduce the pairwise interaction model (PIM), a generalization of the PWM model. The model is based on the principle of maximum entropy and explicitly describes pairwise correlations between nucleotides at different positions, while being otherwise as unconstrained as possible. It is mathematically equivalent to considering a TF-DNA binding energy that depends additively on each nucleotide identity at all positions in the TFBS, like the PWM model, but also additively on pairs of nucleotides. We find that the PIM significantly improves over the PWM model, and even provides an optimal description of TFBS statistics within statistical noise. The PIM generalizes previous approaches to interdependent positions: it accounts for co-variation of two or more base pairs, and predicts secondary motifs, while outperforming multiple-motif models consisting of mixtures of PWMs. We analyse the structure of pairwise interactions between nucleotides, and find that they are sparse and dominantly located between consecutive base pairs in the flanking region of TFBS. Nonetheless, interactions between pairs of non-consecutive nucleotides are found to play a significant role in the obtained accurate description of TFBS statistics. The PIM is computationally tractable, and provides a general framework that should be useful for describing and predicting TFBSs beyond PWMs.	[Santolini, Marc; Mora, Thierry; Hakim, Vincent] Univ D Diderot, Univ Paris 06, CNRS, Ecole Normale Super,Lab Phys Stat, Paris, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; PSL Research University Paris; Ecole Normale Superieure (ENS); Sorbonne Universite; Universite Paris Cite	Hakim, V (corresponding author), Univ D Diderot, Univ Paris 06, CNRS, Ecole Normale Super,Lab Phys Stat, Paris, France.	hakim@lps.ens.fr	Santolini, Marc/N-7530-2018	Santolini, Marc/0000-0003-1491-0120; hakim, vincent/0000-0001-7505-8192	CNRS institutional funds	CNRS institutional funds	This study was funded by CNRS institutional funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Bao ZR, 2002, GENOME RES, V12, P1269, DOI 10.1101/gr.88502; BARASH Y, 2003, P 7 ANN INT C RES CO, P28; Benos PV, 2002, NUCLEIC ACIDS RES, V30, P4442, DOI 10.1093/nar/gkf578; BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8; Bialek W, 2013, SOCIAL INTERACTIONS; Bialek W, 2012, P NATL ACAD SCI USA, V109, P4786, DOI 10.1073/pnas.1118633109; Bishop C. M, 2006, PATTERN RECOGNITION; Bulyk ML, 2002, NUCLEIC ACIDS RES, V30, P1255, DOI 10.1093/nar/30.5.1255; Cao Y, 2010, DEV CELL, V18, P662, DOI 10.1016/j.devcel.2010.02.014; Cavagna A., 2013, DYNAMICAL MAXIMUM EN; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cocco S, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.051123; Cocco S, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003176; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Djordjevic M, 2003, GENOME RES, V13, P2381, DOI 10.1101/gr.1271603; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; HOPFIELD JJ, 1982, P NATL ACAD SCI-BIOL, V79, P2554, DOI 10.1073/pnas.79.8.2554; Hu M, 2010, NUCLEIC ACIDS RES, V38, P2154, DOI 10.1093/nar/gkp1180; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; JAYNES ET, 1957, PHYS REV, V108, P171, DOI 10.1103/PhysRev.108.171; Jolma A, 2013, CELL, V152, P327, DOI 10.1016/j.cell.2012.12.009; Lassig M, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S7; Man TK, 2001, NUCLEIC ACIDS RES, V29, P2471, DOI 10.1093/nar/29.12.2471; Mathelier A, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003214; Mezard M., 1987, WORLD SCI LECT NOT P, V9; Mora T, 2010, P NATL ACAD SCI USA, V107, P5405, DOI 10.1073/pnas.1001705107; Morcos F, 2011, P NATL ACAD SCI USA, V108, pE1293, DOI 10.1073/pnas.1111471108; Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98; Portales-Casamar E, 2010, NUCLEIC ACIDS RES, V38, pD105, DOI 10.1093/nar/gkp950; Rivoire O, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.178102; Rouault H, 2010, P NATL ACAD SCI USA, V107, P14615, DOI 10.1073/pnas.1002876107; Roxin A, 2008, J NEUROSCI, V28, P10734, DOI 10.1523/JNEUROSCI.1016-08.2008; Schneidman E, 2006, NATURE, V440, P1007, DOI 10.1038/nature04701; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sharon E, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000154; Shlens J, 2006, J NEUROSCI, V26, P8254, DOI 10.1523/JNEUROSCI.1282-06.2006; Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067; Siddharthan R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009722; Spitz F, 2012, NAT REV GENET, V13, P613, DOI 10.1038/nrg3207; Stamatoyannopoulos JA, 2012, GENOME RES, V22, P1602, DOI 10.1101/gr.146506.112; Stormo GD, 1998, TRENDS BIOCHEM SCI, V23, P109, DOI 10.1016/S0968-0004(98)01187-6; Thomas MC, 2006, ELEMENTS INFORM THEO; Tkacik G, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003408; Wasserman WW, 2004, NAT REV GENET, V5, P276, DOI 10.1038/nrg1315; Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106; Wingender E, 2008, BRIEF BIOINFORM, V9, P326, DOI 10.1093/bib/bbn016; Zhao Y, 2012, GENETICS, V191, P781, DOI 10.1534/genetics.112.138685; Zhou Q, 2004, BIOINFORMATICS, V20, P909, DOI 10.1093/bioinformatics/bth006; Zinzen RP, 2009, NATURE, V462, P65, DOI 10.1038/nature08531	51	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99015	10.1371/journal.pone.0099015	http://dx.doi.org/10.1371/journal.pone.0099015			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926895	Green Submitted, Green Published, gold			2022-12-27	WOS:000338278100026
J	Park, JD; Kang, HJ; Kim, YA; Jo, M; Lee, ES; Shin, HY; Yun, YH				Park, June Dong; Kang, Hyoung Jin; Kim, Young Ae; Jo, MinKyoung; Lee, Eun Sook; Shin, Hee Young; Yun, Young Ho			Trends in the Aggressiveness of End-of-Life Care for Korean Pediatric Cancer Patients Who Died in 2007-2010	PLOS ONE			English	Article							CHILDREN; QUALITY; PERSPECTIVES; INDICATORS; SYMPTOMS	Background: In light of the Korean Supreme Court's 2009 ruling favoring a patient's right to die with dignity, we evaluated trends in aggressive care in a cohort of pediatric cancer patients. Methods We conducted a population-based retrospective study that used administrative data for patients who died in 2007-2010 among the 5,203 pediatric cancer patients registered at the Korean Cancer Central Registry (KCCR) during 2007-2009. Results: In the time period covered, 696 patients died. The proportion who had received chemotherapy in the last 30 days of life decreased from 58.1% to 28.9% (P<0.001), those who received new chemotherapy in the same time period decreased from 55.2% to 15.1% (P<0.001), and those who received treatment in the last 2 weeks of life decreased from 51.4% to 21.7% (P<0.001). In the last 30 days of life, the proportion of patients whose hospital admission period was over 14 days increased from 70.5% to 82.5% (P = 0.03), the proportion who received cardiopulmonary resuscitation decreased from 28.6% to 9.6% (P<0.001), and we found no statistically significant trends in the proportion of emergency department visits, intensive care unit admissions, or mechanical ventilation. Conclusions: In this study, in contrast with earlier ones, the aggressiveness of end-of-life care of Korean pediatric cancer patients decreased dramatically.	[Park, June Dong; Kang, Hyoung Jin; Shin, Hee Young] Seoul Natl Univ, Coll Med, Dept Pediat, Seoul, South Korea; [Kang, Hyoung Jin; Shin, Hee Young; Yun, Young Ho] Seoul Natl Univ, Coll Med, Inst Canc, Seoul, South Korea; [Kim, Young Ae; Jo, MinKyoung; Lee, Eun Sook] Natl Canc Ctr, Hosp & Res Inst, Goyang, South Korea; [Yun, Young Ho] Seoul Natl Univ Hosp, Dept Biomed Sci, Seoul 110744, South Korea; [Yun, Young Ho] Coll Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC); Seoul National University (SNU); Seoul National University Hospital	Yun, YH (corresponding author), Seoul Natl Univ, Coll Med, Inst Canc, Seoul, South Korea.	lawyun@snu.ac.kr		Park, June Dong/0000-0001-8113-1384	National Cancer Center [1010081];  [1310250-1]	National Cancer Center; 	This study was supported by National Cancer Center 1010081 grants and 1310250-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beretta S, 2010, PEDIATR BLOOD CANCER, V54, P88, DOI 10.1002/pbc.22284; Bradshaw Glenna, 2005, J Palliat Med, V8, P86, DOI 10.1089/jpm.2005.8.86; Earle CC, 2005, INT J QUAL HEALTH C, V17, P505, DOI 10.1093/intqhc/mzi061; Earle CC, 2003, J CLIN ONCOL, V21, P1133, DOI 10.1200/JCO.2003.03.059; Earle CC, 2004, J CLIN ONCOL, V22, P315, DOI 10.1200/JCO.2004.08.136; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; Fujii Y, 2003, PEDIATR INT, V45, P54, DOI 10.1046/j.1442-200X.2003.01664.x; Ho TH, 2011, J CLIN ONCOL, V29, P1587, DOI 10.1200/JCO.2010.31.9897; Mack JW, 2005, J CLIN ONCOL, V23, P9155, DOI 10.1200/JCO.2005.04.010; Meert KL, 2009, PEDIATR CRIT CARE ME, V10, P544, DOI 10.1097/PCC.0b013e3181a7045c; Pui CH, 2011, NAT REV CLIN ONCOL, V8, P540, DOI 10.1038/nrclinonc.2011.95; Sato K, 2008, SUPPORT CARE CANCER, V16, P113, DOI 10.1007/s00520-007-0332-x; Ser MJ, 2009, JOONGANG DAILY  0522; Shin Hai-Rim, 2005, Cancer Res Treat, V37, P325, DOI 10.4143/crt.2005.37.6.325; Tang ST, 2011, J CLIN ONCOL, V29, P890, DOI 10.1200/JCO.2010.32.5639; Tang ST, 2009, J CLIN ONCOL, V27, P4613, DOI 10.1200/JCO.2008.20.5096; von Lutzau P, 2012, J PALLIAT CARE, V28, P274, DOI 10.1177/082585971202800406; Wolfe J, 2000, NEW ENGL J MED, V342, P326, DOI 10.1056/NEJM200002033420506; Wolfe J, 2008, J CLIN ONCOL, V26, P1717, DOI 10.1200/JCO.2007.14.0277; Yun YH, 2007, ONCOLOGY-BASEL, V72, P164, DOI 10.1159/000112802; Yun YH, 2011, CAN MED ASSOC J, V183, pE673, DOI 10.1503/cmaj.110020	21	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99888	10.1371/journal.pone.0099888	http://dx.doi.org/10.1371/journal.pone.0099888			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923320	Green Submitted, gold, Green Published			2022-12-27	WOS:000338701300104
J	Wang, J; Qu, XF; Qi, YF; Li, JH; Song, XL; Li, L; Yin, DH; Xu, K; Li, J				Wang, Juan; Qu, Xiaofeng; Qi, Yanfei; Li, Jinhua; Song, Xiuling; Li, Li; Yin, Dehui; Xu, Kun; Li, Juan			Pharmacokinetics of Anti-HBV Polyoxometalate in Rats	PLOS ONE			English	Article							HEPATITIS-B-VIRUS; BIOLOGICAL-ACTIVITY; IN-VITRO; INFECTION; TITANIUM; TYPE-1	Polyoxometalates are non-nucleoside analogs that have been proven to exhibit broad-spectrum antiviral activity. In particular, Cs2K4Na[SiW9Nb3O40].H2O 1 shows low toxicity and high activity against HBV. The preclinical pharmacokinetics of Compound 1 in rats were characterized by establishing and applying inductively coupled plasma-mass spectrometry method to determine the concentration of W in plasma, urine, feces, bile and organ samples. The quantitative ICP-MS method demonstrated good sensitivity and application in the pharmacokinetics study of polyoxometalates. The pharmacokinetic behavior of Compound 1 after intravenous or oral administration fit a two-compartment model. T-max ranges from 0.1 h to 3 h and the T-1/2 of Compound 1 is between 20 h and 30 h. The absolute bioavailability of Compound 1 at 45, 180 and 720 mg/kg groups were 23.68%, 14.67% and 11.93%, respectively. The rates of plasma protein binding of Compound 1 at 9, 18 and 36 mg/ml of Compound 1 are 62.13 +/- 69.41%, 71.20 +/- 624.98% and 49.00 +/- 625.59%, respectively. Compound 1 was widely distributed throughout the body, and high levels of compound 1 were found in the kidney and liver. The level of Compound 1 in excretion was lower: 30% for urine, 0.28% for feces and 0.42% for bile, respectively. For elaborate pharmacokinetic characteristics to be fully understood, the metabolism of Compound 1 needs to be studied further.	[Wang, Juan; Qu, Xiaofeng; Qi, Yanfei; Li, Jinhua; Song, Xiuling; Li, Li; Yin, Dehui; Xu, Kun; Li, Juan] Jilin Univ, Sch Publ Hlth, Changchun 130023, Jilin, Peoples R China	Jilin University	Xu, K (corresponding author), Jilin Univ, Sch Publ Hlth, Changchun 130023, Jilin, Peoples R China.	xukun@jlu.edu.cn; li_juan@jlu.edu.cn		Li, Li/0000-0002-6789-2328	National S & T Major Project of China [2009ZX09103-105]; National Natural Science Foundation of China [81072337]; Talents Ph.D. Project of Bethune College of Medicine in Jilin University	National S & T Major Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Talents Ph.D. Project of Bethune College of Medicine in Jilin University	This work was financially supported by the National S & T Major Project of China (2009ZX09103-105) and the National Natural Science Foundation of China (Nos. 81072337). The authors acknowledge support from The Talents Ph.D. Project of Bethune College of Medicine in Jilin University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck J, 2007, WORLD J GASTROENTERO, V13, P48, DOI 10.3748/wjg.v13.i1.48; BOUDINOT FD, 1984, J PHARM SCI, V73, P774, DOI 10.1002/jps.2600730617; De Clercq E, 1999, INT J ANTIMICROB AG, V12, P81, DOI 10.1016/S0924-8579(99)00060-6; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; IKEDA S, 1993, J MED VIROL, V41, P191, DOI 10.1002/jmv.1890410304; Judd DA, 2001, J AM CHEM SOC, V123, P886, DOI 10.1021/ja001809e; JUDD DA, 1994, ANTIVIR CHEM CHEMOTH, V5, P410, DOI 10.1177/095632029400500609; Keita B, 2007, J MOL CATAL A-CHEM, V262, P190, DOI 10.1016/j.molcata.2006.08.066; KIM GS, 1994, J MED CHEM, V37, P816, DOI 10.1021/jm00032a016; Kogerler P, 2010, DALTON T, V39, P21, DOI 10.1039/b910716a; Liu J, 2000, ANTIVIR CHEM CHEMOTH, V11, P367, DOI 10.1177/095632020001100603; Long DL, 2007, CHEM SOC REV, V36, P105, DOI 10.1039/b502666k; Nguyen MH, 2009, J VIRAL HEPATITIS, V16, P149, DOI 10.1111/j.1365-2893.2009.01078.x; NI L, 1995, EUR J DRUG METAB PH, V20, P209, DOI 10.1007/BF03189672; NI L, 1994, ANTIMICROB AGENTS CH, V38, P504, DOI 10.1128/AAC.38.3.504; Pramoolsinsup C, 2002, J GASTROEN HEPATOL, V17, pS125, DOI 10.1046/j.1440-1746.17.s1.3.x; Qi YF, 2012, ANTIVIR RES, V93, P118, DOI 10.1016/j.antiviral.2011.11.003; Rhule JT, 1998, CHEM REV, V98, P327, DOI 10.1021/cr960396q; Shepard CW, 2006, EPIDEMIOL REV, V28, P112, DOI 10.1093/epirev/mxj009; Shigeta S, 2003, ANTIVIR RES, V58, P265, DOI 10.1016/S0166-3542(03)00009-3; Shigeta S, 1997, ANTIMICROB AGENTS CH, V41, P1423, DOI 10.1128/AAC.41.7.1423; Shigeta S, 2006, BIOMED PHARMACOTHER, V60, P211, DOI 10.1016/j.biopha.2006.03.009; TAKE Y, 1991, ANTIVIR RES, V15, P113, DOI 10.1016/0166-3542(91)90029-Q; Witvrouw M, 2000, J MED CHEM, V43, P778, DOI 10.1021/jm980263s; Yamase T, 2005, J MATER CHEM, V15, P4773, DOI 10.1039/b504585a; [原野 Yuan Ye], 2012, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V38, P28; Zhang H, 2012, BIOORG MED CHEM LETT, V22, P1664, DOI 10.1016/j.bmcl.2011.12.115; Zou L, 2010, J THEOR BIOL, V262, P330, DOI 10.1016/j.jtbi.2009.09.035	28	3	3	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98292	10.1371/journal.pone.0098292	http://dx.doi.org/10.1371/journal.pone.0098292			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921932	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300006
J	Dugan, VG; Emrich, SJ; Giraldo-Calderon, GI; Harb, OS; Newman, RM; Pickett, BE; Schriml, LM; Stockwell, TB; Stoeckert, CJ; Sullivan, DE; Singh, I; Ward, DV; Yao, A; Zheng, J; Barrett, T; Birren, B; Brinkac, L; Bruno, VM; Caler, E; Chapman, S; Collins, FH; Cuomo, CA; Di Francesco, V; Durkin, S; Eppinger, M; Feldgarden, M; Fraser, C; Fricke, WF; Giovanni, M; Henn, MR; Hine, E; Hotopp, JD; Karsch-Mizrachi, I; Kissinger, JC; Lee, EM; Mathur, P; Mongodin, EF; Murphy, CI; Myers, G; Neafsey, DE; Nelson, KE; Nierman, WC; Puzak, J; Rasko, D; Roos, DS; Sadzewicz, L; Silva, JC; Sobral, B; Squires, RB; Stevens, RL; Tallon, L; Tettelin, H; Wentworth, D; White, O; Will, R; Wortman, J; Zhang, Y; Scheuermann, RH				Dugan, Vivien G.; Emrich, Scott J.; Giraldo-Calderon, Gloria I.; Harb, Omar S.; Newman, Ruchi M.; Pickett, Brett E.; Schriml, Lynn M.; Stockwell, Timothy B.; Stoeckert, Christian J., Jr.; Sullivan, Dan E.; Singh, Indresh; Ward, Doyle V.; Yao, Alison; Zheng, Jie; Barrett, Tanya; Birren, Bruce; Brinkac, Lauren; Bruno, Vincent M.; Caler, Elizabet; Chapman, Sinead; Collins, Frank H.; Cuomo, Christina A.; Di Francesco, Valentina; Durkin, Scott; Eppinger, Mark; Feldgarden, Michael; Fraser, Claire; Fricke, W. Florian; Giovanni, Maria; Henn, Matthew R.; Hine, Erin; Hotopp, Julie Dunning; Karsch-Mizrachi, Ilene; Kissinger, Jessica C.; Lee, Eun Mi; Mathur, Punam; Mongodin, Emmanuel F.; Murphy, Cheryl I.; Myers, Garry; Neafsey, Daniel E.; Nelson, Karen E.; Nierman, William C.; Puzak, Julia; Rasko, David; Roos, David S.; Sadzewicz, Lisa; Silva, Joana C.; Sobral, Bruno; Squires, R. Burke; Stevens, Rick L.; Tallon, Luke; Tettelin, Herve; Wentworth, David; White, Owen; Will, Rebecca; Wortman, Jennifer; Zhang, Yun; Scheuermann, Richard H.			Standardized Metadata for Human Pathogen/Vector Genomic Sequences	PLOS ONE			English	Article							BIOINFORMATICS RESOURCE; METAGENOMIC PROJECTS; MINIMUM INFORMATION; DATABASE GOLD; ONTOLOGIES	High throughput sequencing has accelerated the determination of genome sequences for thousands of human infectious disease pathogens and dozens of their vectors. The scale and scope of these data are enabling genotype-phenotype association studies to identify genetic determinants of pathogen virulence and drug/insecticide resistance, and phylogenetic studies to track the origin and spread of disease outbreaks. To maximize the utility of genomic sequences for these purposes, it is essential that metadata about the pathogen/vector isolate characteristics be collected and made available in organized, clear, and consistent formats. Here we report the development of the GSCID/BRC Project and Sample Application Standard, developed by representatives of the Genome Sequencing Centers for Infectious Diseases (GSCIDs), the Bioinformatics Resource Centers (BRCs) for Infectious Diseases, and the U. S. National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), informed by interactions with numerous collaborating scientists. It includes mapping to terms from other data standards initiatives, including the Genomic Standards Consortium's minimal information (MIxS) and NCBI's BioSample/BioProjects checklists and the Ontology for Biomedical Investigations (OBI). The standard includes data fields about characteristics of the organism or environmental source of the specimen, spatial-temporal information about the specimen isolation event, phenotypic characteristics of the pathogen/vector isolated, and project leadership and support. By modeling metadata fields into an ontology-based semantic framework and reusing existing ontologies and minimum information checklists, the application standard can be extended to support additional project-specific data fields and integrated with other data represented with comparable standards. The use of this metadata standard by all ongoing and future GSCID sequencing projects will provide a consistent representation of these data in the BRC resources and other repositories that leverage these data, allowing investigators to identify relevant genomic sequences and perform comparative genomics analyses that are both statistically meaningful and biologically relevant.	[Dugan, Vivien G.; Pickett, Brett E.; Stockwell, Timothy B.; Singh, Indresh; Brinkac, Lauren; Caler, Elizabet; Durkin, Scott; Nelson, Karen E.; Nierman, William C.; Wentworth, David; Zhang, Yun; Scheuermann, Richard H.] J Craig Venter Inst, Rockville, MD 20850 USA; [Dugan, Vivien G.; Pickett, Brett E.; Stockwell, Timothy B.; Singh, Indresh; Brinkac, Lauren; Caler, Elizabet; Durkin, Scott; Nelson, Karen E.; Nierman, William C.; Wentworth, David; Zhang, Yun; Scheuermann, Richard H.] J Craig Venter Inst, La Jolla, CA USA; [Dugan, Vivien G.; Yao, Alison; Di Francesco, Valentina; Giovanni, Maria; Lee, Eun Mi; Mathur, Punam; Squires, R. Burke] NIAID, Rockville, MD USA; [Emrich, Scott J.; Giraldo-Calderon, Gloria I.; Collins, Frank H.] Univ Notre Dame, Notre Dame, IN 46556 USA; [Harb, Omar S.; Stoeckert, Christian J., Jr.; Zheng, Jie; Roos, David S.] Univ Penn, Philadelphia, PA 19104 USA; [Newman, Ruchi M.; Ward, Doyle V.; Birren, Bruce; Chapman, Sinead; Cuomo, Christina A.; Feldgarden, Michael; Henn, Matthew R.; Murphy, Cheryl I.; Neafsey, Daniel E.; Wortman, Jennifer] Broad Inst, Cambridge, MA USA; [Schriml, Lynn M.; Bruno, Vincent M.; Eppinger, Mark; Fraser, Claire; Fricke, W. Florian; Hine, Erin; Hotopp, Julie Dunning; Mongodin, Emmanuel F.; Myers, Garry; Rasko, David; Sadzewicz, Lisa; Silva, Joana C.; Tallon, Luke; Tettelin, Herve; White, Owen] Univ Maryland, Sch Med, Inst Genome Sci, Baltimore, MD 21201 USA; [Sullivan, Dan E.; Sobral, Bruno; Will, Rebecca] Virginia Bioinformat Inst, Cyberinfrastruct Div, Blacksburg, VA USA; [Barrett, Tanya; Karsch-Mizrachi, Ilene] Natl Lib Med, Natl Ctr Biotechnol Informat, Bethesda, MD 20894 USA; [Kissinger, Jessica C.] Univ Georgia, Athens, GA 30602 USA; [Puzak, Julia] Kelly Govt Solut, Rockville, MD USA; [Stevens, Rick L.] Argonne Natl Lab, Lemont, IL USA; [Scheuermann, Richard H.] Univ Calif San Diego, Dept Pathol, San Diego, CA 92103 USA	J. Craig Venter Institute; J. Craig Venter Institute; National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University of Notre Dame; University of Pennsylvania; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University System of Maryland; University of Maryland Baltimore; National Institutes of Health (NIH) - USA; NIH National Library of Medicine (NLM); University System of Georgia; University of Georgia; United States Department of Energy (DOE); Argonne National Laboratory; University of California System; University of California San Diego	Scheuermann, RH (corresponding author), J Craig Venter Inst, Rockville, MD 20850 USA.	rscheuermann@jcvi.org	Silva, Joana/GYQ-9526-2022; Pickett, Brett/AAE-3582-2020; Kissinger, Jessica C/E-9610-2010; Squires, R Burke/A-7163-2008; Mongodin, Emmanuel/AAF-1850-2020; Silva, Joana/GVT-6441-2022; Schriml, Lynn/AFO-9472-2022; Kissinger, Jessica/M-9920-2019; Zheng, Jie/M-1191-2015; Cuomo, Christina/L-2222-2019; Sobral, Bruno/GVU-7637-2022; Myers, Garry/E-7708-2011	Pickett, Brett/0000-0001-7930-8160; Kissinger, Jessica C/0000-0002-6413-1101; Squires, R Burke/0000-0001-9666-6285; Mongodin, Emmanuel/0000-0003-3833-7437; Kissinger, Jessica/0000-0002-6413-1101; Zheng, Jie/0000-0002-2999-0103; Cuomo, Christina/0000-0002-5778-960X; Sobral, Bruno/0000-0003-3908-577X; Harb, Omar/0000-0003-4446-6200; Myers, Garry/0000-0002-4756-4810; Stockwell, Timothy/0000-0002-3595-4539; Zhang, Yun/0000-0002-1180-275X; Wentworth, David/0000-0002-5190-980X; Fraser, Claire/0000-0003-1462-2428; Karsch Mizrachi, Ilene/0000-0002-0289-7101; Murphy, Cheryl/0000-0003-2285-8107; Roos, David Siker/0000-0001-6725-4089; Giraldo-Calderon, Gloria I./0000-0003-0598-0143; Schriml, Lynn/0000-0001-8910-9851; David, Rasko/0000-0002-7337-7154; Wortman, Jennifer/0000-0002-8713-1227; Fricke, W. Florian/0000-0003-1586-0962	U.S. National Institute of Allergy and Infectious Diseases [HHSN272200900018C, HHSN272200900009C, HHSN272200900007C]; Institute for Genome Sciences Genome at the University of Maryland; J. Craig Venter Institute; Bioinformatics Resource Centers [HHSN272200900038C, HHSN266200400041C, HHSN272200900040C, HHSN272200900039C, HHSN272200900041C]; EuPathDB; IRD; PATRIC; VectorBase; ViPR; NIH, National Library of Medicine;  [R01GM093132]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI110820, U19AI110818] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093132] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINE [ZIHLM200888] Funding Source: NIH RePORTER	U.S. National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Institute for Genome Sciences Genome at the University of Maryland; J. Craig Venter Institute; Bioinformatics Resource Centers; EuPathDB; IRD; PATRIC; VectorBase; ViPR; NIH, National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	This work was made possible by the generous financial and philosophical support from the U.S. National Institute of Allergy and Infectious Diseases to the Genome Sequencing Centers for Infectious Diseases located at the Broad Institute of MIT and Harvard, the Institute for Genome Sciences Genome at the University of Maryland, and the J. Craig Venter Institute (Contract Numbers HHSN272200900018C, HHSN272200900009C, and HHSN272200900007C, respectively), and the Bioinformatics Resource Centers, including EuPathDB, IRD, PATRIC, VectorBase, and ViPR (Contract Numbers HHSN272200900038C, HHSN266200400041C, HHSN272200900040C, HHSN272200900039C, and HHSN272200900041C, respectively). This work was also supported in part by R01GM093132 and the Intramural Research Program of the NIH, National Library of Medicine. Although the funders were involved in manuscript editing and coordination, they had no direct role in study design, data collection and analysis, or the decision to publish.	Aurrecoechea C, 2013, NUCLEIC ACIDS RES, V41, pD684, DOI 10.1093/nar/gks1113; Barrett T, 2012, NUCLEIC ACIDS RES, V40, pD57, DOI 10.1093/nar/gkr1163; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Brinkman Ryan R, 2010, J Biomed Semantics, V1 Suppl 1, pS7, DOI 10.1186/2041-1480-1-S1-S7; Cote RG, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-97; Drancourt M, 2012, CLIN MICROBIOL INFEC, V18, P224, DOI 10.1111/j.1469-0691.2012.03774.x; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Field D, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001088; Greene JM, 2007, INFECT IMMUN, V75, P3212, DOI 10.1128/IAI.00105-07; Grenon P, 2004, SPAT COGN COMPUT, V4, P69, DOI [10.1207/s15427633scc0401_5, DOI 10.1207/S15427633SCC0401_5]; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Liolios K, 2010, NUCLEIC ACIDS RES, V38, pD346, DOI 10.1093/nar/gkp848; Maguire E, 2013, BIOINFORMATICS, V29, P525, DOI 10.1093/bioinformatics/bts718; Megy K, 2012, NUCLEIC ACIDS RES, V40, pD729, DOI 10.1093/nar/gkr1089; Meyer JM, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001478; Noy NF, 2009, NUCLEIC ACIDS RES, V37, pW170, DOI 10.1093/nar/gkp440; Pagani I, 2012, NUCLEIC ACIDS RES, V40, pD571, DOI 10.1093/nar/gkr1100; Pickett BE, 2012, NUCLEIC ACIDS RES, V40, pD593, DOI 10.1093/nar/gkr859; Rocca-Serra P, 2010, BIOINFORMATICS, V26, P2354, DOI 10.1093/bioinformatics/btq415; Severson DW, 2012, ANNU REV ENTOMOL, V57, P143, DOI 10.1146/annurev-ento-120710-100651; Smith B, 2007, NAT BIOTECHNOL, V25, P1251, DOI 10.1038/nbt1346; Squires RB, 2012, INFLUENZA OTHER RESP, V6, P404, DOI 10.1111/j.1750-2659.2011.00331.x; Svensson JP, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-157; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Taylor CF, 2008, NAT BIOTECHNOL, V26, P889, DOI 10.1038/nbt.1411; van Opijnen T, 2012, GENOME RES, V22, P2541, DOI 10.1101/gr.137430.112; Wattam AR, 2014, NUCLEIC ACIDS RES, V42, pD581, DOI 10.1093/nar/gkt1099; Whetzel PL, 2011, NUCLEIC ACIDS RES, V39, pW541, DOI 10.1093/nar/gkr469; Yilmaz P, 2011, NAT BIOTECHNOL, V29, P415, DOI 10.1038/nbt.1823	29	26	26	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99979	10.1371/journal.pone.0099979	http://dx.doi.org/10.1371/journal.pone.0099979			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936976	Green Submitted, gold, Green Published			2022-12-27	WOS:000338503400061
J	Tome-Garcia, J; Li, D; Ghazaryan, S; Shu, LM; Wu, LZ				Tome-Garcia, Jessica; Li, Dan; Ghazaryan, Seda; Shu, Limin; Wu, Lizhao			ERBB2 Increases Metastatic Potentials Specifically in Androgen-Insensitive Prostate Cancer Cells	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; ACTIVATED PROTEIN-KINASE; HER-2/NEU ONCOPROTEIN; PROGNOSTIC VALUE; NEU ONCOGENE; GENE ENCODES; EXPRESSION; C-ERBB-2; PATHWAY; MYC	Despite all the blood-based biomarkers used to monitor prostate cancer patients, prostate cancer remains as the second common cause of cancer mortality in men in the United States. This is largely due to a lack of understanding of the molecular pathways that are responsible for the aggressive forms of prostate cancers, the castrate-resistant prostate cancer and the metastatic prostate cancer. Cell signaling pathways activated by the ERBB2 oncogene or the RAS oncogene are frequently found to be altered in metastatic prostate cancers. To evaluate and define the role of the ERBB2/RAS pathway in prostate cancer metastasis, we have evaluated the impact of ERBB2- or RAS-overexpression on the metastatic potentials for four prostate cancer cell lines derived from tumors with different androgen sensitivities. To do so, we transfected the human DU145, LnCaP, and PC3 prostate cancer cells and the murine Myc-CaP prostate cancer cells with the activated form of ERBB2 or H-RAS and assessed their metastatic potentials by three complementary assays, a wound healing assay, a transwell motility assay, and a transwell invasion assay. We showed that while overexpression of ERBB2 increased the metastatic potential of the androgen-insensitive prostate cancer cells (i.e. PC3 and DU145), it did not affect metastatic potentials of the androgen-sensitive prostate cancer cells (i.e. LnCaP and Myc-CaP). In contrast, overexpression of H-RAS only increased the cell motility of Myc-CaP cells, which overexpress the human c-MYC oncogene. Our data suggest that ERBB2 collaborates with androgen signaling to promote prostate cancer metastasis, and that although RAS is one of the critical downstream effectors of ERBB2, it does not phenocopy ERBB2 for its impact on the metastatic potentials of prostate cancer cell lines.	[Tome-Garcia, Jessica; Li, Dan; Ghazaryan, Seda; Shu, Limin; Wu, Lizhao] Rutgers New Jersey Med Sch Canc Ctr, Newark, NJ 07101 USA; [Wu, Lizhao] Rutgers New Jersey Med Sch, Dept Microbiol & Mol Genet, Newark, NJ USA	Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University New Brunswick; Rutgers State University Medical Center	Wu, LZ (corresponding author), Rutgers New Jersey Med Sch Canc Ctr, Newark, NJ 07101 USA.	wuli@njms.rutgers.edu	, 丹丹/I-2223-2019	TOME GARCIA, JESSICA/0000-0003-0554-8676	Rutgers New Jersey Medical School	Rutgers New Jersey Medical School	Start-up funds from Rutgers New Jersey Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2012, CURR MED CHEM, V19, P3748; Bakin RE, 2003, CANCER RES, V63, P1981; BARGMANN CI, 1986, CELL, V45, P649, DOI 10.1016/0092-8674(86)90779-8; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Bonaccorsi L, 2004, J CANCER RES CLIN, V130, P604, DOI 10.1007/s00432-004-0581-8; BOYDEN S, 1962, J EXP MED, V115, P453, DOI 10.1084/jem.115.3.453; Chen Hong-Chen, 2004, V294, P15; D'Cruz CM, 2001, NAT MED, V7, P235, DOI 10.1038/84691; Denker SP, 2002, J CELL BIOL, V159, P1087, DOI 10.1083/jcb.200208050; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Erlich S, 2006, BIOCHEM PHARMACOL, V72, P427, DOI 10.1016/j.bcp.2006.05.007; FOX SB, 1994, BRIT J UROL, V74, P214, DOI 10.1111/j.1464-410X.1994.tb16589.x; GIRI DK, 1993, PROSTATE, V23, P329, DOI 10.1002/pros.2990230406; Grant S, 2002, FRONT BIOSCI-LANDMRK, V7, pD376, DOI 10.2741/grant; GUY CT, 1992, P NATL ACAD SCI USA, V89, P10578, DOI 10.1073/pnas.89.22.10578; Horoszewicz J S, 1980, Prog Clin Biol Res, V37, P115; HUJANEN ES, 1985, CANCER RES, V45, P3517; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Ilic D, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004720.pub3; Itahana Koji, 2007, Methods Mol Biol, V371, P21; KAIGHN ME, 1979, INVEST UROL, V17, P16; KATOH M, 1993, BIOCHEM BIOPH RES CO, V192, P1189, DOI 10.1006/bbrc.1993.1542; KUHN EJ, 1993, J UROLOGY, V150, P1427, DOI 10.1016/S0022-5347(17)35799-3; Lau KS, 2009, MOL CELLS, V28, P315, DOI 10.1007/s10059-009-0143-7; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Lyne JC, 1997, CANCER J SCI AM, V3, P21; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Morote J, 1999, INT J CANCER, V84, P421, DOI 10.1002/(SICI)1097-0215(19990820)84:4<421::AID-IJC16>3.0.CO;2-9; Mydlo JH, 1998, EUR UROL, V34, P426, DOI 10.1159/000019777; MYERS RB, 1994, J NATL CANCER I, V86, P1140, DOI 10.1093/jnci/86.15.1140; Nemeth JA, 1999, CANCER RES, V59, P1987; Osman I, 2005, J UROLOGY, V174, P2174, DOI 10.1097/01.ju.0000181205.23233.65; PAIK S, 1990, J CLIN ONCOL, V8, P103, DOI 10.1200/JCO.1990.8.1.103; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PLOWMAN GD, 1993, P NATL ACAD SCI USA, V90, P1746, DOI 10.1073/pnas.90.5.1746; Reddy KB, 2003, CANCER METAST REV, V22, P395, DOI 10.1023/A:1023781114568; Rosello C, 2004, ACTA BIOTHEOR, V52, P343, DOI 10.1023/B:ACBI.0000046602.58202.5e; SADASIVAN R, 1993, J UROLOGY, V150, P126, DOI 10.1016/S0022-5347(17)35413-7; Sarkisian CJ, 2007, NAT CELL BIOL, V9, P493, DOI 10.1038/ncb1567; Scaltriti M, 2006, CLIN CANCER RES, V12, P5268, DOI 10.1158/1078-0432.CCR-05-1554; Schmitt Fernando, 2009, Adv Ther, V26 Suppl 1, pS1, DOI 10.1007/s12325-009-0046-1; Schwartz S, 1998, INT J CANCER, V76, P464, DOI 10.1002/(SICI)1097-0215(19980518)76:4<464::AID-IJC3>3.0.CO;2-P; Sears R, 2000, GENE DEV, V14, P2501, DOI 10.1101/gad.836800; Semenas J, 2012, CURR DRUG TARGETS, V13, P1308, DOI 10.2174/138945012802429615; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shulkla S, 2007, INT J CANCER, V121, P1424, DOI 10.1002/ijc.22862; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Signoretti S, 2000, JNCI-J NATL CANCER I, V92, P1918, DOI 10.1093/jnci/92.23.1918; SIKES RA, 1992, CANCER RES, V52, P3174; SLAMON DJ, 1987, SCIENCE, V235, P177, DOI 10.1126/science.3798106; STONE KR, 1978, INT J CANCER, V21, P274, DOI 10.1002/ijc.2910210305; TILLEY WD, 1990, CANCER RES, V50, P5382; TOYOSHIMA K, 1986, COLD SPRING HARB SYM, V51, P977, DOI 10.1101/SQB.1986.051.01.111; Tran PT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002125; Traynor P, 2008, DIS MARKERS, V24, P157, DOI 10.1155/2008/918087; USHIRO H, 1980, J BIOL CHEM, V255, P8363; VISAKORPI T, 1992, MODERN PATHOL, V5, P643; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yin JJ, 2007, MOL CELL BIOL, V27, P7538, DOI 10.1128/MCB.00955-07; ZHAU HE, 1994, J CELL BIOCHEM, P208; Zhau HYE, 1996, PROSTATE, V28, P73	62	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99525	10.1371/journal.pone.0099525	http://dx.doi.org/10.1371/journal.pone.0099525			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937171	gold, Green Submitted, Green Published			2022-12-27	WOS:000338503400022
J	Brock, SE; Rendon, BE; Xin, D; Yaddanapudi, K; Mitchell, RA				Brock, Stephanie E.; Rendon, Beatriz E.; Xin, Dan; Yaddanapudi, Kavitha; Mitchell, Robert A.			MIF Family Members Cooperatively Inhibit p53 Expression and Activity	PLOS ONE			English	Article							OXIDATIVE DNA-DAMAGE; CELL LUNG-CANCER; MIGRATION; ACTIVATION; PROMOTES; DEFICIENT; HOMOLOG; PATHWAY; CLONING; CDNA	The tumor suppressor p53 is induced by genotoxic stress in both normal and transformed cells and serves to transcriptionally coordinate cell cycle checkpoint control and programmed cell death responses. Macrophage migration inhibitory factor (MIF) is an autocrine and paracrine acting cytokine/growth factor that promotes lung adenocarcinoma cell motility, anchorage-independence and neo-angiogenic potential. Several recent studies indicate that the only known homolog of MIF, D-dopachrome tautomerase (D-DT - also referred to as MIF-2), has functionally redundant activities with MIF and cooperatively promotes MIF-dependent pro-tumorigenic phenotypes. We now report that MIF and D-DT synergistically inhibit steady state p53 phosphorylation, stabilization and transcriptional activity in human lung adenocarcinoma cell lines. The combined loss of MIF and D-DT by siRNA leads to dramatically reduced cell cycle progression, anchorage independence, focus formation and increased programmed cell death when compared to individual loss of MIF or D-DT. Importantly, p53 mutant and p53 null lung adenocarcinoma cell lines were only nominally rescued from the cell growth effects of MIF/D-DT combined deficiency suggesting only a minor role for p53 in these transformed cell growth phenotypes. Finally, increased p53 activation was found to be independent of aberrantly activated AMP-activated protein kinase (AMPK) that occurs in response to MIF/D-DT-deficiency but is dependent on reactive oxygen species (ROS) that mediate aberrant AMPK activation in these cells. Combined, these findings suggest that both p53 wildtype and mutant human lung adenocarcinoma tumors rely on MIF family members for maximal cell growth and survival.	[Brock, Stephanie E.; Rendon, Beatriz E.; Xin, Dan; Yaddanapudi, Kavitha; Mitchell, Robert A.] Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40292 USA	University of Louisville	Mitchell, RA (corresponding author), Univ Louisville, James Graham Brown Canc Ctr, Mol Targets Program, Louisville, KY 40292 USA.	robert.mitchell@louisville.edu			National Institutes of Health National Cancer Institute [CA102285]; Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE [R01CA102285] Funding Source: NIH RePORTER	National Institutes of Health National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kentucky Lung Cancer Research Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health National Cancer Institute - CA102285 (RAM), and Kentucky Lung Cancer Research Program (RAM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe R, 2001, J IMMUNOL, V166, P747, DOI 10.4049/jimmunol.166.2.747; Achanta G, 2004, CANCER RES, V64, P6233, DOI 10.1158/0008-5472.CAN-04-0494; Agarwal ML, 1998, P NATL ACAD SCI USA, V95, P14775, DOI 10.1073/pnas.95.25.14775; Ahrendt SA, 2003, J NATL CANCER I, V95, P961, DOI 10.1093/jnci/95.13.961; Brock SE, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378299; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chene P, 2003, NAT REV CANCER, V3, P102, DOI 10.1038/nrc991; Coleman AM, 2008, J IMMUNOL, V181, P2330, DOI 10.4049/jimmunol.181.4.2330; Cooke MS, 2003, FASEB J, V17, P1195, DOI 10.1096/fj.02-0752rev; Dessein AF, 2010, CANCER RES, V70, P4644, DOI 10.1158/0008-5472.CAN-09-3828; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Jung H, 2008, J BIOL CHEM, V283, P32669, DOI 10.1074/jbc.M806225200; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Maillet A, 2012, ANTIOXID REDOX SIGN, V16, P1285, DOI 10.1089/ars.2011.4434; Martin JL, 2008, FASEB J, V22; McClelland M, 2009, AM J PATHOL, V174, P638, DOI 10.2353/ajpath.2009.080463; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Nemajerova A, 2007, EMBO J, V26, P987, DOI 10.1038/sj.emboj.7601564; Nishihira J, 1998, BIOCHEM BIOPH RES CO, V243, P538, DOI 10.1006/bbrc.1998.8123; Panduri V, 2006, AM J RESP CELL MOL, V34, P443, DOI 10.1165/rcmb.2005-0352OC; Pasupuleti V, 2014, J BIOL CHEM, V289, P3713, DOI 10.1074/jbc.M113.500694; Ren Y, 2004, ONCOGENE, V23, P4146, DOI 10.1038/sj.onc.1207490; Rendon BE, 2007, J BIOL CHEM, V282, P29910, DOI 10.1074/jbc.M704898200; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Robles AI, 2002, ONCOGENE, V21, P6898, DOI 10.1038/sj.onc.1205563; Rosengren E, 1996, MOL MED, V2, P143, DOI 10.1007/BF03402210; RUSSELL KJ, 1995, CANCER RES, V55, P1639; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; Swope M, 1998, EMBO J, V17, P3534, DOI 10.1093/emboj/17.13.3534; Thiele M, 2005, ANTIOXID REDOX SIGN, V7, P1234, DOI 10.1089/ars.2005.7.1234; Vousden KH, 2002, NAT REV CANCER, V2, P594, DOI 10.1038/nrc864; Welford SM, 2006, GENE DEV, V20, P3366, DOI 10.1101/gad.1471106; White ES, 2001, J IMMUNOL, V166, P7549, DOI 10.4049/jimmunol.166.12.7549; Wilson JM, 2005, GASTROENTEROLOGY, V129, P1485, DOI 10.1053/j.gastro.2005.07.061; Winner M, 2008, CANCER RES, V68, P7253, DOI 10.1158/0008-5472.CAN-07-6227; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Xin D, 2010, MOL CANCER RES, V8, P1601, DOI 10.1158/1541-7786.MCR-10-0101; Yaddanapudi K, 2013, J IMMUNOL, V190, P2984, DOI 10.4049/jimmunol.1201650; ZHANG M, 1995, FEBS LETT, V373, P203, DOI 10.1016/0014-5793(95)01041-C; Zhu WG, 2004, J BIOL CHEM, V279, P15161, DOI 10.1074/jbc.M311703200	45	32	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99795	10.1371/journal.pone.0099795	http://dx.doi.org/10.1371/journal.pone.0099795			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932684	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600066
J	Kim, MH; Lee, SY; Lee, SE; Yang, MS; Jung, JW; Park, CM; Lee, W; Cho, SH; Kang, HR				Kim, Min-Hye; Lee, Suh-Young; Lee, Seung-Eun; Yang, Min-Suk; Jung, Jae-Woo; Park, Chang Min; Lee, Whal; Cho, Sang-Heon; Kang, Hye-Ryun			Anaphylaxis to Iodinated Contrast Media: Clinical Characteristics Related with Development of Anaphylactic Shock	PLOS ONE			English	Article							HYPERSENSITIVITY REACTIONS; SKIN-TESTS; ADVERSE-REACTIONS; RISK-FACTORS; PREVENTION; MANAGEMENT; PATHOPHYSIOLOGY	Objective: Anaphylaxis is the most severe form of radiocontrast media (RCM) induced hypersensitivity and can be life-threatening if profound hypotension is combined. With increased use of iodine based RCM, related hypersensitivity is rapidly growing. However, the clinical characteristics and risk factors of RCM induced anaphylaxis accompanied by hypotension (anaphylactic shock) are not clearly defined. This study was performed to investigate the risk factors of RCM induced anaphylactic shock and the clinical value of RCM skin testing to identify causative agents in affected patients. Methods: We analyzed the data of RCM induced anaphylaxis monitored by an inhospital pharmacovigilance center at a tertiary teaching hospital from January 2005 to December 2012 and compared the clinical features and skin test results according to the accompanying hypotension. Results: Among total of 104 cases of RCM induced anaphylaxis, 34.6% of patients, developed anaphylaxis on their first exposure to RCM. Anaphylactic patients presenting with shock were older (57.4 vs. 50.1 years, p = 0.026) and had a history of more frequently exposure to RCM (5.1 +/- 7.8 vs. 1.9 +/- 3.3, p = 0.004) compared to those without hypotension. Among RCMs, hypotension was more frequent in anaphylaxis related to iopromide compared to other agents (85.0% vs. 61.4%, p = 0.011). Skin tests were performed in 51 patients after development of RCM induced anaphylaxis. Overall skin test positivity to RCM was 64.7% and 81.8% in patients with anaphylactic shock. Conclusion: RCM induced anaphylactic shock is related to multiple exposures to RCM and most patients showed skin test positivity to RCM.	[Kim, Min-Hye; Lee, Suh-Young; Lee, Seung-Eun; Yang, Min-Suk; Cho, Sang-Heon; Kang, Hye-Ryun] Seoul Natl Univ Hosp, Div Allergy & Clin Immunol, Dept Internal Med, Seoul 110744, South Korea; [Kim, Min-Hye; Lee, Suh-Young; Lee, Seung-Eun; Yang, Min-Suk; Jung, Jae-Woo; Cho, Sang-Heon; Kang, Hye-Ryun] Seoul Natl Univ, Med Res Ctr, Inst Allergy & Clin Immunol, Seoul, South Korea; [Kim, Min-Hye; Cho, Sang-Heon; Kang, Hye-Ryun] Seoul Natl Univ Hosp, Reg Pharmacovigilance Ctr, Seoul 110744, South Korea; [Kim, Min-Hye] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Yang, Min-Suk] SMG SNU Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Jung, Jae-Woo] Chung Ang Univ, Coll Med, Dept Internal Med, Seoul 156756, South Korea; [Park, Chang Min; Lee, Whal] Seoul Natl Univ, Coll Med, Dept Radiol, Seoul, South Korea; [Park, Chang Min; Lee, Whal] Seoul Natl Univ, Coll Med, Inst Radiat Med, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Ewha Womans University; Seoul National University (SNU); Seoul National University Hospital; Chung Ang University; Chung Ang University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Kang, HR (corresponding author), Seoul Natl Univ Hosp, Div Allergy & Clin Immunol, Dept Internal Med, Seoul 110744, South Korea.	helenmed@snu.ac.kr	Lee, Seung Eun/ABG-1607-2021	Lee, Seung Eun/0000-0002-4266-7722	Ministry of Food and Drug Safety	Ministry of Food and Drug Safety(Ministry of Food & Drug Safety (MFDS), Republic of Korea)	This research was supported by a grant from Ministry of Food and Drug Safety to operation of the regional pharmacovigilance center in 2014. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brockow K, 2009, ALLERGY, V64, P234, DOI 10.1111/j.1398-9995.2008.01832.x; Brockow K, 2011, CURR OPIN ALLERGY CL, V11, P326, DOI 10.1097/ACI.0b013e32834877c3; Brockow K, 2010, CHEM IMMUNOL ALLERGY, V95, P157, DOI 10.1159/000315949; Caimmi S, 2010, CLIN EXP ALLERGY, V40, P805, DOI 10.1111/j.1365-2222.2010.03493.x; CASHMAN JD, 1991, MED J AUSTRALIA, V155, P618, DOI 10.5694/j.1326-5377.1991.tb93931.x; Davenport MS, 2009, RADIOLOGY, V253, P372, DOI 10.1148/radiol.2532090465; Dewachter P, 2011, EUR J RADIOL, V77, P495, DOI 10.1016/j.ejrad.2009.09.019; Goksel O, 2011, INT ARCH ALLERGY IMM, V155, P297, DOI 10.1159/000320760; Greenberger PA, 2007, ANN ALLERG ASTHMA IM, V98, P252, DOI 10.1016/S1081-1206(10)60714-4; KATAYAMA H, 1990, INVEST RADIOL, V25, pS16, DOI 10.1097/00004424-199009001-00007; Khan BQ, 2011, CURR OPIN ALLERGY CL, V11, P319, DOI 10.1097/ACI.0b013e3283481ab6; Kim MH, 2012, ANN ALLERG ASTHMA IM, V108, P167, DOI 10.1016/j.anai.2012.01.012; Kim SH, 2013, ANN ALLERG ASTHMA IM, V110, P258, DOI 10.1016/j.anai.2013.01.004; Lee JK, 2011, CLIN EXP ALLERGY, V41, P923, DOI 10.1111/j.1365-2222.2011.03779.x; Maddox TG, 2002, AM FAM PHYSICIAN, V66, P1229; Morcos SK, 2005, BRIT J RADIOL, V78, P686, DOI 10.1259/bjr/26301414; Morcos SK, 2001, EUR RADIOL, V11, P1720, DOI 10.1007/s003300000778; Muraro A, 2007, ALLERGY, V62, P857, DOI 10.1111/j.1398-9995.2007.01421.x; Sampson Hugh A, 2006, J Allergy Clin Immunol, V117, P391, DOI 10.1016/j.jaci.2005.12.1303; Thomsen HS, 1998, DRUG SAFETY, V19, P313, DOI 10.2165/00002018-199819040-00006; Trcka J, 2008, AM J ROENTGENOL, V190, P666, DOI 10.2214/AJR.07.2872; Williams AN, 2007, ANN ALLERG ASTHMA IM, V99, P467, DOI 10.1016/S1081-1206(10)60574-1; Wysowski DK, 2006, AM J ROENTGENOL, V186, P613, DOI 10.2214/AJR.04.1790; Yang MS, 2008, ANN ALLERG ASTHMA IM, V100, P31, DOI 10.1016/S1081-1206(10)60401-2	24	54	56	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100154	10.1371/journal.pone.0100154	http://dx.doi.org/10.1371/journal.pone.0100154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932635	gold, Green Submitted, Green Published			2022-12-27	WOS:000337738600098
J	Lim, SL; Ricciardelli, C; Oehler, MK; Tan, IMDD; Russell, D; Grutzner, F				Lim, Shu Ly; Ricciardelli, Carmela; Oehler, Martin K.; Tan, Izza M. D. De Arao; Russell, Darryl; Gruetzner, Frank			Overexpression of piRNA Pathway Genes in Epithelial Ovarian Cancer	PLOS ONE			English	Article							NOVO DNA METHYLATION; HIWI GENE; RETROTRANSPOSABLE ELEMENTS; HUMAN COLON; EXPRESSION; PIWI; LINE-1; HYPOMETHYLATION; MAELSTROM; PROTEIN	The importance of the Piwi-interacting RNA (piRNA) pathway for germ cell maintenance, genome integrity, DNA methylation and retrotransposon control raises possible roles of this pathway in cancer. Indeed aberrant expression of human PIWI orthologs and Maelstrom has been observed in various cancers. In this study we explored the expression and function of piRNA pathway genes in human ovarian cancer, based on our recent work, which showed widespread expression of piRNA pathway genes in the mammalian. Our work shows that PIWIL1 and MAEL expression is significantly increased in malignant EOC (n = 25) compared to benign tumor tissues (n = 19) and normal ovarian tissue (n = 8). The expression of PIWIL3 is lower in malignant and benign tissues when compared to normal ovary. Sequencing of PIWIL1 transcript revealed that in many tumors deletion of exon 17 leads to the introduction of a premature stop codon in the PIWI domain, likely due to a splicing error. In situ hybridization on tumor sections revealed that L1, PIWIL1, 2 and MAEL are specifically expressed in epithelial cells (cancerous cells) of EOC. Furthermore, PIWIL2 and MAEL are co-expressed in the stromal cells adjacent to tumor cells. Since PIWIL1 and MAEL are up regulated in malignant EOC and expressed in the epithelial cells, we investigated if these two genes affect invasiveness of ovarian cancer cell lines that do not normally express these genes. PIWIL1 and MAEL were transiently over expressed in the ovarian cancer cell line SKOV3, followed by real-time measurements of cell invasiveness. Surprisingly both PIWIL1 and MAEL over expression decreased the invasiveness of SKOV3 cells. Our findings support a growing body of evidence that shows that genes in this pathway are upregulated in cancer. In ovarian cancer we show for the first time that Piwil1 transcript may often be abnormal result in non functional product. In contrast to what has been observed in other cell types, we found that PIWIL1 and MAEL have a repressive effect on cell invasiveness.	[Lim, Shu Ly; Gruetzner, Frank] Univ Adelaide, Sch Mol & Biomed Sci, Robinson Res Inst, Adelaide, SA, Australia; [Ricciardelli, Carmela; Oehler, Martin K.; Tan, Izza M. D. De Arao; Russell, Darryl] Univ Adelaide, Robinson Res Inst, Discipline Obstet & Gynaecol, Adelaide, SA, Australia	Robinson Research Institute; University of Adelaide; Robinson Research Institute; University of Adelaide	Grutzner, F (corresponding author), Univ Adelaide, Sch Mol & Biomed Sci, Robinson Res Inst, Adelaide, SA, Australia.	frank.grutzner@adelaide.edu.au	Ricciardelli, Carmela/U-1814-2019; Grutzner, Frank/ABB-2820-2021; Grutzner, Frank/AAD-5834-2020; Ricciardelli, Carmela/K-2212-2015; Russell, Darryl L/I-6654-2012	Ricciardelli, Carmela/0000-0001-7415-1854; Grutzner, Frank/0000-0002-3088-7314; Ricciardelli, Carmela/0000-0001-7415-1854; Russell, Darryl L/0000-0002-4930-7658	University of Adelaide; ARC (Australian Research Council)	University of Adelaide; ARC (Australian Research Council)(Australian Research Council)	This study was funded by the University of Adelaide. F. G. is supported by an ARC (Australian Research Council) fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves G, 1996, GENE, V176, P39, DOI 10.1016/0378-1119(96)00205-3; Anttonen M, 2003, BIOL REPROD, V68, P1333, DOI 10.1095/biolreprod.102.008599; Aravin AA, 2008, GENE DEV, V22, P970, DOI 10.1101/gad.1669408; Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612; Asch HL, 1996, ONCOL RES, V8, P239; Bass BL, 2002, ANNU REV BIOCHEM, V71, P817, DOI 10.1146/annurev.biochem.71.110601.135501; Berasain C, 2010, WORLD J GASTROENTERO, V16, P3091, DOI 10.3748/wjg.v16.i25.3091; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Chen C, 2013, CANCER BIOMARK, V13, P315, DOI 10.3233/CBM-130360; Cirri P, 2011, AM J CANCER RES, V1, P482; Cordaux R, 2009, NAT REV GENET, V10, P691, DOI 10.1038/nrg2640; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Deng W, 2002, DEV CELL, V2, P819, DOI 10.1016/S1534-5807(02)00165-X; Eisenberg MC, 2011, P NATL ACAD SCI US; FEINBERG AP, 1983, NATURE, V301, P89, DOI 10.1038/301089a0; Foster R, 2013, CANCER LETT, V338, P147, DOI 10.1016/j.canlet.2012.10.023; Gilles C, 1996, INT J CANCER, V65, P209; Grochola LF, 2008, BRIT J CANCER, V99, P1083, DOI 10.1038/sj.bjc.6604653; Gualtieri A, 2013, ONCOTARGET, V4, P1882, DOI 10.18632/oncotarget.1188; Iramaneerat K, 2011, INT J GYNECOL CANCER, V21, P51, DOI 10.1097/IGC.0b013e3182021c1a; Janic A, 2010, SCIENCE, V330, P1824, DOI 10.1126/science.1195481; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lee JH, 2006, MOL REPROD DEV, V73, P173, DOI 10.1002/mrd.20391; Li L, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-38; Liang D, 2013, ASIAN PAC J CANCER P, V14, P1067, DOI 10.7314/APJCP.2013.14.2.1067; Lim SL, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.111211; Liu JJ, 2010, INT J CLIN EXP PATHO, V3, P328; Liu LL, 2014, HEPATOLOGY, V59, P531, DOI 10.1002/hep.26677; Liu XY, 2006, INT J CANCER, V118, P1922, DOI 10.1002/ijc.21575; Lu ZY, 2012, ONCOL REP, V27, P1587, DOI 10.3892/or.2012.1685; OKADA A, 1995, P NATL ACAD SCI USA, V92, P2730, DOI 10.1073/pnas.92.7.2730; Pek JW, 2009, DEV CELL, V17, P417, DOI 10.1016/j.devcel.2009.07.017; Piskareva O, 2011, CURR MOL MED, V11, P286, DOI 10.2174/156652411795677954; Qiao D, 2002, ONCOGENE, V21, P3988, DOI 10.1038/sj.onc.1205505; Ricciardelli C, 2009, MATURITAS, V62, P270, DOI 10.1016/j.maturitas.2009.01.001; Roman-Gomez J, 2005, ONCOGENE, V24, P7213, DOI 10.1038/sj.onc.1208866; Sarot E, 2004, GENETICS, V166, P1313, DOI 10.1534/genetics.166.3.1313; Shahali M, 2013, CELL J, V15, P250; Sharma A, 2012, ULTRASOUND OBST GYN, V40, P338, DOI 10.1002/uog.12270; Sharma AK, 2001, BLOOD, V97, P426, DOI 10.1182/blood.V97.2.426; Shuangshoti S, 2007, ASIAN PAC J CANCER P, V8, P307; Siomi MC, 2011, NAT REV MOL CELL BIO, V12, P246, DOI 10.1038/nrm3089; Smallwood SA, 2012, TRENDS GENET, V28, P33, DOI 10.1016/j.tig.2011.09.004; Soper SFC, 2008, DEV CELL, V15, P285, DOI 10.1016/j.devcel.2008.05.015; Stahtea XN, 2007, INT J CANCER, V121, P2808, DOI 10.1002/ijc.23029; Sun GA, 2011, BRAIN RES, V1373, P183, DOI 10.1016/j.brainres.2010.11.097; Taubert H, 2007, ONCOGENE, V26, P1098, DOI 10.1038/sj.onc.1209880; WOLF CR, 1987, INT J CANCER, V39, P695, DOI 10.1002/ijc.2910390607; Xi Biao, 2008, Biotechnology Journal, V3, P484, DOI 10.1002/biot.200800020; Xiao L, 2010, MOL BIOL REP, V37, P2355, DOI 10.1007/s11033-009-9741-x; Zhang DP, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-48	53	42	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99687	10.1371/journal.pone.0099687	http://dx.doi.org/10.1371/journal.pone.0099687			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932571	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600055
J	Turer, AT; Lewis, GD; O'Sullivan, JF; Elmariah, S; Mega, JL; Addo, TA; Sabatine, MS; de Lemos, JA; Gerszten, RE				Turer, Aslan T.; Lewis, Gregory D.; O'Sullivan, John F.; Elmariah, Sammy; Mega, Jessica L.; Addo, Tayo A.; Sabatine, Marc S.; de Lemos, James A.; Gerszten, Robert E.			Increases in Myocardial Workload Induced by Rapid Atrial Pacing Trigger Alterations in Global Metabolism	PLOS ONE			English	Article							BILE-ACIDS; ISCHEMIA; ADENOSINE; HUMANS; BLOOD; FAT	Objective: To determine whether increases in cardiac work lead to alterations in the plasma metabolome and whether such changes arise from the heart or peripheral organs. Background: There is growing evidence that the heart influences systemic metabolism through endocrine effects and affecting pathways involved in energy homeostasis. Methods: Nineteen patients referred for cardiac catheterization were enrolled. Peripheral and selective coronary sinus (CS) blood sampling was performed at serial timepoints following the initiation of pacing, and metabolite profiling was performed by liquid chromatography-mass spectrometry (LC-MS). Results: Pacing-stress resulted in a 225% increase in the median rate? pressure product from baseline. Increased myocardial work induced significant changes in the peripheral concentration of 43 of 125 metabolites assayed, including large changes in purine [ adenosine (+99%, p = 0.006), ADP (+42%, p = 0.01), AMP (+79%, p = 0.004), GDP (+69%, p = 0.003), GMP (+58%, p = 0.01), IMP (+50%, p = 0.03), xanthine (+61%, p = 0.0006)], and several bile acid metabolites. The CS changes in metabolites qualitatively mirrored those in the peripheral blood in both timing and magnitude, suggesting the heart was not the major source of the metabolite release. Conclusions: Isolated increases in myocardial work can induce changes in the plasma metabolome, but these changes do not appear to be directly cardiac in origin. A number of these dynamic metabolites have known signaling functions. Our study provides additional evidence to a growing body of literature on metabolic 'cross-talk' between the heart and other organs.	[Turer, Aslan T.; de Lemos, James A.] Univ Texas SW Med Ctr Dallas, Dept Med, Div Cardiol, Dallas, TX 75390 USA; [Lewis, Gregory D.; O'Sullivan, John F.; Elmariah, Sammy; Addo, Tayo A.; Gerszten, Robert E.] Massachusetts Gen Hosp, Dept Internal Med, Div Cardiol, Boston, MA 02114 USA; [Mega, Jessica L.; Sabatine, Marc S.] Brigham & Womens Hosp, Boston, MA 02115 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital	Turer, AT (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Med, Div Cardiol, Dallas, TX 75390 USA.	aslan.turer@utsouthwestern.edu	Sabatine, Marc/AAJ-6751-2020; de Lemos, James/ABD-6669-2021; Elmariah, Sammy/AAG-8752-2021	Sabatine, Marc/0000-0002-0691-3359; Elmariah, Sammy/0000-0002-8013-8733; O'Sullivan, John/0000-0001-8016-5128	Abbott Laboratories; Ortho-Clinical Diagnostics; Roche Diagnostics; Singulex; National Institutes of Health [K23 HL 091106, R01HL098280, R01DK081572, HHSN268201000033C]; American Heart Association Established Investigator Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL098280, K23HL091106] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081572] Funding Source: NIH RePORTER	Abbott Laboratories(Abbott Laboratories); Ortho-Clinical Diagnostics; Roche Diagnostics; Singulex; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association Established Investigator Award(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Dr. Sabatine: Abbott Laboratories, Ortho-Clinical Diagnostics, Roche Diagnostics, Singulex; Dr. de Lemos: Abbott Diagnostics, Roche Diagnostics; Dr Lewis: National Institutes of Health Grant: #K23 HL 091106; Dr Gerszten: National Institutes of Health Grants #R01HL098280 and #R01DK081572, National Institutes of Health contract #HHSN268201000033C, and American Heart Association Established Investigator Award; the other authors have no relevant disclosures. No companies had any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bodi V, 2012, J AM COLL CARDIOL, V59, P1629, DOI 10.1016/j.jacc.2011.09.083; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Boudina S, 2007, CIRCULATION, V115, P3213, DOI 10.1161/CIRCULATIONAHA.106.679597; Brunner MP, 2011, CIRC-CARDIOVASC GENE, V4, P695, DOI 10.1161/CIRCGENETICS.111.960575; Cao RS, 2010, J LIPID RES, V51, P2234, DOI 10.1194/jlr.M004929; ELY SW, 1992, CIRCULATION, V85, P893, DOI 10.1161/01.CIR.85.3.893; Grueter CE, 2012, CELL, V149, P671, DOI 10.1016/j.cell.2012.03.029; Hylemon PB, 2009, J LIPID RES, V50, P1509, DOI 10.1194/jlr.R900007-JLR200; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Lewis GD, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001006; MARKHAM RV, 1983, AM J CARDIOL, V51, P1589, DOI 10.1016/0002-9149(83)90192-3; Paganelli F, 2000, EUR J CLIN INVEST, V30, P105; Rhee EP, 2013, J AM SOC NEPHROL, V24, P1330, DOI 10.1681/ASN.2012101006; Sabatine MS, 2005, CIRCULATION, V112, P3868, DOI 10.1161/CIRCULATIONAHA.105.569137; Turer AT, 2011, J AM COLL CARDIOL, V57, P2398, DOI 10.1016/j.jacc.2010.11.066; Turer AT, 2009, CIRCULATION, V119, P1736, DOI 10.1161/CIRCULATIONAHA.108.816116; Wang TJ, 2012, NEW ENGL J MED, V367, P377, DOI 10.1056/NEJMcibr1204796	17	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99058	10.1371/journal.pone.0099058	http://dx.doi.org/10.1371/journal.pone.0099058			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932507	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600020
J	Drujont, L; Carretero-Iglesia, L; Bouchet-Delbos, L; Beriou, G; Merieau, E; Hill, M; Delneste, Y; Cuturi, MC; Louvet, C				Drujont, Lucile; Carretero-Iglesia, Laura; Bouchet-Delbos, Laurence; Beriou, Gaelle; Merieau, Emmanuel; Hill, Marcelo; Delneste, Yves; Cuturi, Maria Cristina; Louvet, Cedric			Evaluation of the Therapeutic Potential of Bone Marrow-Derived Myeloid Suppressor Cell (MDSC) Adoptive Transfer in Mouse Models of Autoimmunity and Allograft Rejection	PLOS ONE			English	Article							REGULATORY T-CELLS; DENDRITIC CELLS; DIFFERENTIATION; ACCUMULATE; TOLERANCE; MONOCYTES; RESPONSES; SURVIVAL; DISEASE; PGE(2)	Therapeutic use of immunoregulatory cells represents a promising approach for the treatment of uncontrolled immunity. During the last decade, myeloid-derived suppressor cells (MDSC) have emerged as novel key regulatory players in the context of tumor growth, inflammation, transplantation or autoimmunity. Recently, MDSC have been successfully generated in vitro from naive mouse bone marrow cells or healthy human PBMCs using minimal cytokine combinations. In this study, we aimed to evaluate the potential of adoptive transfer of such cells to control auto-and allo-immunity in the mouse. Culture of bone marrow cells with GM-CSF and IL-6 consistently yielded a majority of CD11b(+) Gr1(hi/lo) cells exhibiting strong inhibition of CD8(+) T cell proliferation in vitro. However, adoptive transfer of these cells failed to alter antigen-specific CD8(+) T cell proliferation and cytotoxicity in vivo. Furthermore, MDSC could not prevent the development of autoimmunity in a stringent model of type 1 diabetes. Rather, loading the cells prior to injection with a pancreatic neo-antigen peptide accelerated the development of the disease. Contrastingly, in a model of skin transplantation, repeated injection of MDSC or single injection of LPS-activated MDSC resulted in a significant prolongation of allograft survival. The beneficial effect of MDSC infusions on skin graft survival was paradoxically not explained by a decrease of donor-specific T cell response but associated with a systemic over-activation of T cells and antigen presenting cells, prominently in the spleen. Taken together, our results indicate that in vitro generated MDSC bear therapeutic potential but will require additional in vitro factors or adjunct immunosuppressive treatments to achieve safe and more robust immunomodulation upon adoptive transfer.	[Drujont, Lucile; Carretero-Iglesia, Laura; Bouchet-Delbos, Laurence; Beriou, Gaelle; Merieau, Emmanuel; Hill, Marcelo; Cuturi, Maria Cristina; Louvet, Cedric] INSERM, UMR S 1064, ITUN, Ctr Res Transplantat & Immunol, Nantes, France; [Delneste, Yves] Univ Angers, CHU Angers, INSERM, UMR 892,CNRS 6299,Lab Immunol & Allergol, Angers, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite d'Angers; Centre Hospitalier Universitaire d'Angers	Louvet, C (corresponding author), INSERM, UMR S 1064, ITUN, Ctr Res Transplantat & Immunol, Nantes, France.	cedric.louvet@univ-nantes.fr	Delneste, Yves/O-3956-2016; DELNESTE, Yves/K-7367-2015	DELNESTE, Yves/0000-0002-2142-596X; Hill, Marcelo/0000-0002-1589-0320	Labex IGO project - "Investissements d'Avenir" French Government program; IHU-Cesti, region Pays de la Loire et Nantes Metropole; Inserm-Region Pays de la Loire fellowship; Inserm "young researcher'' CDD;  [ANR-11-LABX-0016-01];  [ANR-10-IBHU-005]	Labex IGO project - "Investissements d'Avenir" French Government program(French National Research Agency (ANR)); IHU-Cesti, region Pays de la Loire et Nantes Metropole(Region Pays de la Loire); Inserm-Region Pays de la Loire fellowship(Region Pays de la Loire); Inserm "young researcher'' CDD; ; 	This work has been carried out thanks to the support of the Labex IGO project (no ANR-11-LABX-0016-01) funded by the "Investissements d'Avenir" French Government program, managed by the French National Research Agency (ANR). This work was also supported by funds from IHU-Cesti (Investissement d'Avenir ANR-10-IBHU-005, region Pays de la Loire et Nantes Metropole). LD was supported by an Inserm-Region Pays de la Loire fellowship. CL was supported by an Inserm "young researcher'' CDD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeegbe D, 2011, CELL TRANSPLANT, V20, P941, DOI 10.3727/096368910X540621; Brennan TV, 2011, J SURG RES, V169, pE69, DOI 10.1016/j.jss.2011.03.021; Centuori SM, 2012, J LEUKOCYTE BIOL, V92, P987, DOI 10.1189/jlb.0911465; CHOU HS, 2011, TRANSPLANTATION; Colonna L, 2011, J IMMUNOL, V187, P1516, DOI 10.4049/jimmunol.1190038; Cripps JG, 2011, INT IMMUNOPHARMACOL, V11, P789, DOI 10.1016/j.intimp.2011.01.026; De Wilde V, 2009, AM J TRANSPLANT, V9, P2034, DOI 10.1111/j.1600-6143.2009.02757.x; Dilek N, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00208; Dilek N, 2012, J IMMUNOL, V188, P4209, DOI 10.4049/jimmunol.1101512; Dugast AS, 2008, J IMMUNOL, V180, P7898, DOI 10.4049/jimmunol.180.12.7898; Eruslanov E, 2010, J LEUKOCYTE BIOL, V88, P839, DOI 10.1189/jlb.1209821; Fujii W, 2013, J IMMUNOL, V191, P1073, DOI 10.4049/jimmunol.1203535; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Guan QD, 2013, J LEUKOCYTE BIOL, V94, P803, DOI 10.1189/jlb.0113050; Haile LA, 2008, GASTROENTEROLOGY, V135, P871, DOI 10.1053/j.gastro.2008.06.032; Harbers SO, 2007, J CLIN INVEST, V117, P1361, DOI 10.1172/JCI29470; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Hu CY, 2012, J IMMUNOL, V188, P294, DOI 10.4049/jimmunol.1101590; Ioannou M, 2012, J IMMUNOL, V188, P1136, DOI 10.4049/jimmunol.1101816; Kurts C, 1996, J EXP MED, V184, P923, DOI 10.1084/jem.184.3.923; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Leslie M, 2011, SCIENCE, V332, P1020, DOI 10.1126/science.332.6033.1020; Luan Y, 2013, AM J TRANSPLANT, V13, P3123, DOI 10.1111/ajt.12461; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Nagaraj S, 2013, J IMMUNOL, V191, P17, DOI 10.4049/jimmunol.1300654; Nefedova Y, 2004, J IMMUNOL, V172, P464, DOI 10.4049/jimmunol.172.1.464; Obermajer N, 2011, BLOOD, V118, P5498, DOI 10.1182/blood-2011-07-365825; Ochando JC, 2012, IMMUNOL RES, V54, P275, DOI 10.1007/s12026-012-8335-1; Pan PY, 2010, CANCER RES, V70, P99, DOI 10.1158/0008-5472.CAN-09-1882; Peranzoni E, 2010, CURR OPIN IMMUNOL, V22, P238, DOI 10.1016/j.coi.2010.01.021; Ribechini E, 2010, MED MICROBIOL IMMUN, V199, P273, DOI 10.1007/s00430-010-0151-4; Garcia MR, 2010, J CLIN INVEST, V120, P2486, DOI 10.1172/JCI41628; Rossner S, 2005, EUR J IMMUNOL, V35, P3533, DOI 10.1002/eji.200526172; Sade-Feldman M, 2013, IMMUNITY, V38, P541, DOI 10.1016/j.immuni.2013.02.007; Schmidt K, 2013, BLOOD, V121, P1740, DOI 10.1182/blood-2012-06-436568; Singh V, 2011, EUR J IMMUNOL, V41, P2871, DOI 10.1002/eji.201141696; Tang QZ, 2012, J MOL CELL BIOL, V4, P11, DOI 10.1093/jmcb/mjr047; Tomihara K, 2010, J IMMUNOL, V184, P6151, DOI 10.4049/jimmunol.0903519; Turnquist HR, 2011, J IMMUNOL, V187, P4598, DOI 10.4049/jimmunol.1100519; Valaperti A, 2008, J IMMUNOL, V180, P2686, DOI 10.4049/jimmunol.180.4.2686; Wu TT, 2012, J IMMUNOL, V189, P4989, DOI 10.4049/jimmunol.1200068; Yi HF, 2012, J IMMUNOL, V189, P4295, DOI 10.4049/jimmunol.1200086; Yin BJ, 2010, J IMMUNOL, V185, P5828, DOI 10.4049/jimmunol.0903636; Zehntner SP, 2005, J IMMUNOL, V174, P5124, DOI 10.4049/jimmunol.174.8.5124; Zhang W, 2008, TRANSPLANTATION, V86, P1125, DOI 10.1097/TP.0b013e318186fccd; Zhou ZP, 2010, STEM CELLS, V28, P620, DOI 10.1002/stem.301; Zhu B, 2007, J IMMUNOL, V179, P5228, DOI 10.4049/jimmunol.179.8.5228	49	43	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100013	10.1371/journal.pone.0100013	http://dx.doi.org/10.1371/journal.pone.0100013			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927018	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100107
J	Kittaka, H; Akimoto, H; Takeshita, H; Funaoka, H; Hazui, H; Okamoto, M; Kobata, H; Ohishi, Y				Kittaka, Hirotada; Akimoto, Hiroshi; Takeshita, Hitoshi; Funaoka, Hiroyuki; Hazui, Hiroshi; Okamoto, Masao; Kobata, Hitoshi; Ohishi, Yasuo			Usefulness of Intestinal Fatty Acid-Binding Protein in Predicting Strangulated Small Bowel Obstruction	PLOS ONE			English	Article							CREATINE-PHOSPHOKINASE; DIAGNOSTIC-ACCURACY; ISCHEMIA; SERUM; CT; LACTATE; MARKER; TRANSLOCATION; CRITERIA; SYSTEM	Background: The level of intestinal fatty acid-binding protein (I-FABP) is considered to be useful diagnostic markers of small bowel ischemia. The purpose of this retrospective study was to investigate whether the serum I-FABP level is a predictive marker of strangulation in patients with small bowel obstruction (SBO). Methods: A total of 37 patients diagnosed with SBO were included in this study. The serum I-FABP levels were retrospectively compared between the patients with strangulation and those with simple obstruction, and cut-off values for the diagnosis of strangulation were calculated using a receiver operating characteristic curve. In addition, the sensitivity, specificity, positive predictive value (PPV) and negative predictive value (NPV) were calculated. Results: Twenty-one patients were diagnosed with strangulated SBO. The serum I-FABP levels were significantly higher in the patients with strangulation compared with those observed in the patients with simple obstruction (18.5 vs. 1.6 ng/ml p<0.001). Using a cut-off value of 6.5 ng/ml, the sensitivity, specificity, PPV and NPV were 71.4%, 93.8%, 93.8% and 71.4%, respectively. An I-FABP level greater than 6.5 ng/ml was found to be the only independent significant factor for a higher likelihood of strangulated SBO (P = 0.02; odds ratio: 19.826; 95% confidence interval: 2.1560 - 488.300). Conclusions: The I-FABP level is a useful marker for discriminating between strangulated SBO and simple SBO in patients with SBO.	[Kittaka, Hirotada; Akimoto, Hiroshi; Hazui, Hiroshi; Okamoto, Masao; Kobata, Hitoshi; Ohishi, Yasuo] Osaka Mishima Emergency Crit Care Ctr, Dept Emergency, Takatsuki, Osaka, Japan; [Takeshita, Hitoshi] Osaka Mishima Emergency Crit Care Ctr, Dept Inspect, Takatsuki, Osaka, Japan; [Funaoka, Hiroyuki] DS Pharma Biomed CO Ltd, Suita, Osaka, Japan		Kittaka, H (corresponding author), Osaka Mishima Emergency Crit Care Ctr, Dept Emergency, Takatsuki, Osaka, Japan.	kittaka142@osaka-mishima.jp	Takeshita, Hitoshi/AAC-4593-2019	Takeshita, Hitoshi/0000-0002-8444-2193				Akimoto Teruyuki, 2006, Int J Biomed Sci, V2, P160; ALPERS DH, 1984, P NATL ACAD SCI-BIOL, V81, P313, DOI 10.1073/pnas.81.2.313; Balthazar EJ, 1997, RADIOLOGY, V205, P519, DOI 10.1148/radiology.205.2.9356638; Bass K N, 1997, Adv Surg, V31, P1; Biondo S, 2003, BRIT J SURG, V90, P542, DOI 10.1002/bjs.4150; BIZER LS, 1981, SURGERY, V89, P407; Bossuyt PM, 2003, CLIN CHEM, V49, P7, DOI 10.1373/49.1.7; Cronk Daniel R, 2006, Curr Surg, V63, P322, DOI 10.1016/j.cursur.2006.05.006; DEITCH EA, 1989, ARCH SURG-CHICAGO, V124, P699; DELAURIER GA, 1989, AM J SURG, V158, P32, DOI 10.1016/0002-9610(89)90311-5; Di Saverio S, 2008, WORLD J SURG, V32, P2293, DOI 10.1007/s00268-008-9694-6; Evennett NJ, 2009, WORLD J SURG, V33, P1374, DOI 10.1007/s00268-009-0074-7; Fall Pamela J, 2005, J Intensive Care Med, V20, P255, DOI 10.1177/0885066605278644; Firoozmand E, 2001, AM SURGEON, V67, P1145; Fuller BM, 2012, CURR OPIN CRIT CARE, V18, P267, DOI 10.1097/MCC.0b013e3283532b8a; Funaoka H, 2010, IMMUNOL INVEST, V39, P54, DOI 10.3109/08820130903428283; GOLLIN G, 1993, SURGERY, V113, P545; GRAEBER GM, 1983, ARCH SURG-CHICAGO, V118, P837; GRAEBER GM, 1981, ANN SURG, V193, P499; Ha HK, 1997, RADIOLOGY, V204, P507, DOI 10.1148/radiology.204.2.9240545; Hayakawa K, 2013, EMERG RADIOL, V20, P3, DOI 10.1007/s10140-012-1070-z; KANDA T, 1992, DIGEST DIS SCI, V37, P1362, DOI 10.1007/BF01296004; Kanda T, 1996, GASTROENTEROLOGY, V110, P339, DOI 10.1053/gast.1996.v110.pm8566578; Kanda T, 2011, J GASTROENTEROL, V46, P492, DOI 10.1007/s00535-011-0373-2; Kim JH, 2004, WORLD J SURG, V28, P63, DOI 10.1007/s00268-003-6899-6; LAWS HL, 1976, SOUTHERN MED J, V69, P733, DOI 10.1097/00007611-197606000-00021; LEFFALL LD, 1965, ARCH SURG-CHICAGO, V91, P592; Lieberman JM, 1997, SURGERY, V121, P335, DOI 10.1016/S0039-6060(97)90363-9; Markogiannakis H, 2011, SURGERY, V149, P394, DOI 10.1016/j.surg.2010.08.007; Mihara M, 2012, CLIN SCI, V122, P143, DOI 10.1042/CS20110340; Miller G, 2000, AM J SURG, V180, P33, DOI 10.1016/S0002-9610(00)00407-4; MURRAY MJ, 1994, AM J SURG, V167, P575, DOI 10.1016/0002-9610(94)90101-5; OCKNER RK, 1974, J CLIN INVEST, V54, P326, DOI 10.1172/JCI107768; Okorie ON, 2011, CRIT CARE CLIN, V27, P299, DOI 10.1016/j.ccc.2010.12.013; Pelsers MMAL, 2003, CLIN BIOCHEM, V36, P529, DOI 10.1016/S0009-9120(03)00096-1; SAGAR PM, 1995, DIS COLON RECTUM, V38, P640, DOI 10.1007/BF02054126; SHATILA AH, 1976, AM J SURG, V132, P299, DOI 10.1016/0002-9610(76)90379-2; Sheedy SP, 2006, RADIOLOGY, V241, P729, DOI 10.1148/radiol.2413050965; SHIELDS HM, 1986, J LIPID RES, V27, P549; SILEN W, 1962, ARCH SURG-CHICAGO, V85, P121; SNYDER EN, 1966, AM J SURG, V111, P398, DOI 10.1016/S0002-9610(66)80018-1; Tanaka K, 2012, AM SURGEON, V78, P86; Thuijls G, 2011, ANN SURG, V253, P303, DOI 10.1097/SLA.0b013e318207a767; van Wijck K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022366; Yamamoto T, 2005, DIS COLON RECTUM, V48, P1451, DOI 10.1007/s10350-005-0019-7; Zalcman M, 2000, AM J ROENTGENOL, V175, P1601, DOI 10.2214/ajr.175.6.1751601; ZOLLINGER R M, 1964, Am Surg, V30, P1	47	24	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99915	10.1371/journal.pone.0099915	http://dx.doi.org/10.1371/journal.pone.0099915			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926782	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100089
J	Mackenzie, CL; Lynch, SA; Culloty, SC; Malham, SK				Mackenzie, Clara L.; Lynch, Sharon A.; Culloty, Sarah C.; Malham, Shelagh K.			Future Oceanic Warming and Acidification Alter Immune Response and Disease Status in a Commercial Shellfish Species, Mytilus edulis L.	PLOS ONE			English	Article							ACID-BASE-BALANCE; HALIOTIS-DIVERSICOLOR-SUPERTEXTA; CLIMATE-CHANGE; SEAWATER ACIDIFICATION; WATER TEMPERATURE; PERKINSUS-MARINUS; CARBONIC-ACID; MUSSEL; HEMOCYTES; PARASITE	Increases in atmospheric carbon dioxide are leading to physical changes in marine environments including parallel decreases in ocean pH and increases in seawater temperature. This study examined the impacts of a six month exposure to combined decreased pH and increased temperature on the immune response and disease status in the blue mussel, Mytilus edulis L. Results provide the first confirmation that exposure to future acidification and warming conditions via aquarium-based simulation may have parallel implications for bivalve health. Collectively, the data suggests that temperature more than pH may be the key driver affecting immune response in M. edulis. Data also suggests that both increases in temperature and/or lowered pH conditions may lead to changes in parasite abundance and diversity, pathological conditions, and bacterial incidence in M. edulis. These results have implications for future management of shellfish under a predicted climate change scenario and future sustainability of shellfisheries. Examination of the combined effects of two stressors over an extended exposure period provides key preliminary data and thus, this work represents a unique and vital contribution to current research efforts towards a collective understanding of expected near-future impacts of climate change on marine environments.	[Mackenzie, Clara L.] Heriot Watt Univ, Ctr Marine Biodivers & Biotechnol, Sch Life Sci, Edinburgh, Midlothian, Scotland; [Lynch, Sharon A.; Culloty, Sarah C.] Natl Univ Ireland Univ Coll Cork, Sch Biol Earth & Environm Sci, Aquaculture & Fisheries Dev Ctr, Cork, Ireland; [Malham, Shelagh K.] Bangor Univ, Ctr Appl Marine Sci, Menai Bridge, Anglesey, Wales	Heriot Watt University; University College Cork; Bangor University	Mackenzie, CL (corresponding author), Heriot Watt Univ, Ctr Marine Biodivers & Biotechnol, Sch Life Sci, Edinburgh, Midlothian, Scotland.	clm32@hw.ac.uk	Malham, Shelagh K/O-9054-2014	Mackenzie, Clara/0000-0002-5797-6106	Shellfish Productivity in the Irish Sea (SUSFISH); European Regional Development Fund (ERDF) through the Ireland Wales Territorial Co-operation (INTERREG 4A) Programme	Shellfish Productivity in the Irish Sea (SUSFISH); European Regional Development Fund (ERDF) through the Ireland Wales Territorial Co-operation (INTERREG 4A) Programme	This work was funded by the project entitled: Shellfish Productivity in the Irish Sea (SUSFISH). SUSFISH is partially funded by the European Regional Development Fund (ERDF) through the Ireland Wales Territorial Co-operation (INTERREG 4A) Programme 2007-2013. INTERREG 4A is managed in Ireland by the Southern and Eastern Regional Assembly on behalf of the Irish Government, the Welsh Government and the European Commission (http://www.irelandwales.ie). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AlKurashi M, 2011, VET PARASITOL, V177, P267, DOI 10.1016/j.vetpar.2010.11.053; Amaral V, 2011, ESTUAR COAST SHELF S, V93, P460, DOI 10.1016/j.ecss.2011.05.024; [Anonymous], NATURE; Berge JA, 2006, CHEMOSPHERE, V62, P681, DOI 10.1016/j.chemosphere.2005.04.111; Bibby R, 2008, AQUAT BIOL, V2, P67, DOI 10.3354/ab00037; Bindoff N, 2007, CLIM CHANG 2007; Bussell JA, 2008, J EXP MAR BIOL ECOL, V358, P78, DOI 10.1016/j.jembe.2008.01.018; Callaway R, 2012, AQUAT CONSERV, V22, P389, DOI 10.1002/aqc.2247; Cao A, 2007, AQUACULTURE, V263, P310, DOI 10.1016/j.aquaculture.2006.11.004; Carballal MJ, 1998, J INVERTEBR PATHOL, V72, P304, DOI 10.1006/jipa.1998.4779; Cheng W, 2004, FISH SHELLFISH IMMUN, V17, P235, DOI 10.1016/j.fsi.2004.03.007; Cheng W, 2000, FISH SHELLFISH IMMUN, V10, P387, DOI 10.1006/fsim.2000.0264; Cheng W, 2004, AQUACULTURE, V232, P103, DOI 10.1016/S0044-8486(03)00488-5; Chubb J.C., 1979, Advances in Parasitology, V17, P141, DOI 10.1016/S0065-308X(08)60551-5; Colwell RR, 1996, SCIENCE, V274, P2025, DOI 10.1126/science.274.5295.2025; Cook T, 1998, ESTUAR COAST SHELF S, V46, P587, DOI 10.1006/ecss.1997.0283; DICKSON AG, 1987, DEEP-SEA RES, V34, P1733, DOI 10.1016/0198-0149(87)90021-5; Discovering statistics using R, 2012, CHOICE REV ONLINE, V50, DOI [10.5860/choice.50-2114, DOI 10.5860/CHOICE.50-2114]; Ellis RP, 2011, FISH SHELLFISH IMMUN, V30, P1209, DOI 10.1016/j.fsi.2011.03.017; Ellis RP, 2013, THESIS U PLYMOUTH UK; Epstein PR, 1998, B AM METEOROL SOC, V79, P409, DOI 10.1175/1520-0477(1998)079<0409:BAPSOC>2.0.CO;2; FISHER WS, 1987, AQUACULTURE, V67, P179, DOI 10.1016/0044-8486(87)90024-X; Ford SE, 1996, J SHELLFISH RES, V15, P45; Gazeau F, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2006GL028554; Gooding RA, 2009, P NATL ACAD SCI USA, V106, P9316, DOI 10.1073/pnas.0811143106; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Harvell CD, 2002, SCIENCE, V296, P2158, DOI 10.1126/science.1063699; Harvell D, 2004, FRONT ECOL ENVIRON, V2, P375, DOI 10.1890/1540-9295(2004)002[0375:TRTOOD]2.0.CO;2; Harvell D, 2001, HYDROBIOLOGIA, V460, P97, DOI 10.1023/A:1013169331913; Hay SI, 2002, TRENDS PARASITOL, V18, P530, DOI 10.1016/S1471-4922(02)02374-7; Holmes JC, 1996, BIODIVERS CONSERV, V5, P975, DOI 10.1007/BF00054415; Hooper C, 2007, FISH SHELLFISH IMMUN, V22, P363, DOI 10.1016/j.fsi.2006.06.009; Houghton JT, 2001, CONTRIBUTION WORKING; Inoue K, 1995, BIOL BULL, V189, P370, DOI 10.2307/1542155; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; Jung T, 2010, METHODS MOL BIOL, V594, P173, DOI 10.1007/978-1-60761-411-1_13; Katz ML, 2002, ARCH GERONTOL GERIAT, V34, P169, DOI 10.1016/S0167-4943(02)00005-5; Kawai M, 2002, APPL ENVIRON MICROB, V68, P699, DOI 10.1128/AEM.68.2.699-704.2002; Kim K, 2000, MAR BIOL, V136, P259, DOI 10.1007/s002270050684; Kroeker KJ, 2010, ECOL LETT, V13, P1419, DOI 10.1111/j.1461-0248.2010.01518.x; Lacoste A, 2002, DEV COMP IMMUNOL, V26, P1, DOI 10.1016/S0145-305X(01)00067-2; Lafferty KD, 2004, ANNU REV ECOL EVOL S, V35, P31, DOI 10.1146/annurev.ecolsys.35.021103.105704; Lafferty KD, 2009, ECOLOGY, V90, P888, DOI 10.1890/08-0079.1; Lafferty Kevin D., 1997, P316; Le Roux F, 2001, J EUKARYOT MICROBIOL, V48, P449, DOI 10.1111/j.1550-7408.2001.tb00178.x; Lengeler J., 2009, BIOL PROKARYOTES; Lewis E., 1998, PROGRAM DEV CO2 SYST; Lynch SA, 2008, AQUACULTURE, V281, P17, DOI 10.1016/j.aquaculture.2008.06.005; Mackenzie CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086764; MacLeod CD, 2012, TRENDS PARASITOL, V28, P365, DOI 10.1016/j.pt.2012.06.007; Malagoli D, 2007, FISH SHELLFISH IMMUN, V23, P171, DOI 10.1016/j.fsi.2006.10.004; Malham SK, 2009, AQUACULTURE, V287, P128, DOI 10.1016/j.aquaculture.2008.10.006; Malham SK, 2003, J EXP ZOOL PART A, V295A, P136, DOI 10.1002/jez.a.10222; Matozzo V, 2011, ISJ-INVERT SURVIV J, V8, P70; Mayrand E, 2005, AQUAC RES, V36, P962, DOI 10.1111/j.1365-2109.2005.01302.x; McDonald MR, 2009, MAR ECOL PROG SER, V385, P179, DOI 10.3354/meps08099; MEHRBACH C, 1973, LIMNOL OCEANOGR, V18, P897, DOI 10.4319/lo.1973.18.6.0897; Michaelidis B, 2005, MAR ECOL PROG SER, V293, P109, DOI 10.3354/meps293109; Miles H, 2007, MAR POLLUT BULL, V54, P89, DOI 10.1016/j.marpolbul.2006.09.021; Molloy DP, 2012, PARASITOLOGY, V139, P463, DOI 10.1017/S0031182011002101; Monari M, 2007, FISH SHELLFISH IMMUN, V22, P98, DOI 10.1016/j.fsi.2006.03.016; Mortensen SH, 1996, FISH SHELLFISH IMMUN, V6, P111, DOI 10.1006/fsim.1996.0012; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Paillard C, 2004, DIS AQUAT ORGAN, V59, P249, DOI 10.3354/dao059249; Palumbi SR, 2001, SCIENCE, V293, P1786, DOI 10.1126/science.293.5536.1786; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parry HE, 2004, AQUAT TOXICOL, V69, P311, DOI 10.1016/j.aquatox.2004.06.003; Pascual M, 2000, SCIENCE, V289, P1766, DOI 10.1126/science.289.5485.1766; Patz JA, 2005, NATURE, V438, P310, DOI 10.1038/nature04188; Pietrock M, 2003, TRENDS PARASITOL, V19, P293, DOI 10.1016/S1471-4922(03)00117-X; Pilling P, 2011, 53 FAO CGRFA, P28; PIPE RK, 1992, DEV COMP IMMUNOL, V16, P111, DOI 10.1016/0145-305X(92)90012-2; PIPE RK, 1995, FISH SHELLFISH IMMUN, V5, P581, DOI 10.1016/S1050-4648(95)80043-3; Pipe RK, 1997, CELL TISSUE RES, V289, P537, DOI 10.1007/s004410050899; POJMANSKA T, 1980, Acta Parasitologica Polonica, V27, P319; Porter JW, 2001, HYDROBIOLOGIA, V460, P1, DOI 10.1023/A:1013177617800; Portner HO, 2004, J OCEANOGR, V60, P705, DOI 10.1007/s10872-004-5763-0; Renault T, 2000, DIS AQUAT ORGAN, V42, P207, DOI 10.3354/dao042207; Renwrantz L, 2013, COMP BIOCHEM PHYS A, V164, P629, DOI 10.1016/j.cbpa.2013.01.021; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; ROBLEDO JAF, 1994, AQUACULTURE, V127, P287, DOI 10.1016/0044-8486(94)90232-1; Rogers DJ, 2006, ADV PARASIT, V62, P345, DOI 10.1016/S0065-308X(05)62010-6; Rohr JR, 2008, NATURE, V455, P1235, DOI 10.1038/nature07281; Rohr JR, 2011, J APPL ECOL, V48, P174, DOI 10.1111/j.1365-2664.2010.01891.x; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; SCOTT M E, 1988, Conservation Biology, V2, P40, DOI 10.1111/j.1523-1739.1988.tb00334.x; SHAW BARBARA L., 1957, CANADIAN JOUR ZOOL, V35, P325, DOI 10.1139/z57-026; Shi SR, 2002, J HISTOCHEM CYTOCHEM, V50, P1005, DOI 10.1177/002215540205000802; Shumway S. E., 2012, WORLD AQUACULT, V34, P15, DOI DOI 10.1097/TA.0b013e318270160d; Smith V.J., 1992, Fish & Shellfish Immunology, V2, P1, DOI 10.1016/S1050-4648(06)80024-0; Sokolova IM, 2012, MAR ENVIRON RES, V79, P1, DOI 10.1016/j.marenvres.2012.04.003; Spicer JI, 2007, MAR BIOL, V151, P1117, DOI 10.1007/s00227-006-0551-6; Stevens Alan, 1996, P243; WALSH PS, 1991, BIOTECHNIQUES, V10, P506, DOI 10.2144/000114018; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Ward JR, 2004, PLOS BIOL, V2, P542, DOI 10.1371/journal.pbio.0020120; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Whiteley NM, 2011, MAR ECOL PROG SER, V430, P257, DOI 10.3354/meps09185; WONG P. P, 2007, CLIMATE CHANGE, P315, DOI DOI 10.1017/CB09781107415379; Wood HL, 2008, P ROY SOC B-BIOL SCI, V275, P1767, DOI 10.1098/rspb.2008.0343; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P249, DOI 10.1016/S1050-4648(02)00164-X; Wootton EC, 2003, FISH SHELLFISH IMMUN, V15, P195, DOI 10.1016/S1050-4648(02)00161-4; Zhang H, 2005, J PHYCOL, V41, P411, DOI 10.1111/j.1529-8817.2005.04168.x	103	69	70	3	162	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99712	10.1371/journal.pone.0099712	http://dx.doi.org/10.1371/journal.pone.0099712			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927423	gold, Green Submitted, Green Published			2022-12-27	WOS:000338278100071
J	Tiansawat, P; Davis, AS; Berhow, MA; Zalamea, PC; Dalling, JW				Tiansawat, Pimonrat; Davis, Adam S.; Berhow, Mark A.; Zalamea, Paul-Camilo; Dalling, James W.			Investment in Seed Physical Defence Is Associated with Species' Light Requirement for Regeneration and Seed Persistence: Evidence from Macaranga Species in Borneo	PLOS ONE			English	Article							CHEMICAL DEFENSE; MECHANICAL DEFENSE; TROPICAL FOREST; SOIL; PREDATION; TREE; RESISTANCE; DISPERSAL; PATTERNS; PLANTS	The seed stage is often critical in determining the regeneration success of plants. Seeds must survive an array of seed predators and pathogens and germinate under conditions favourable for seedling establishment. To maximise recruitment success plants protect seeds using a diverse set of chemical and physical defences. However, the relationship between these defence classes, and their association with other life history traits, is not well understood. Data on seed coat thickness and fracture resistance, and the abundance and diversity of potential defensive compounds were collected for 10 tree species of Macaranga from Borneo. The data were used to test whether there is a trade-off in physical versus chemical defence investment, and to determine how investment varies with seed mass, and light requirement for regeneration. Across species there was no correlation between seed coat thickness and abundance of potential defensive compounds, indicating the absence of a direct trade-off between defence classes. While chemical defences were not correlated to other traits, physical defences were positively correlated with light requirement for regeneration. For a subset of five Macaranga species we evaluated the relative investment in chemical and physical defence to seed persistence in the soil, measured as the time to half initial seed viability (seed half-life). Half-life was negatively related to the ratio of potential defensive compound abundance to seed coat thickness, suggesting that species with long persistence invested in physical defence more than stored chemical defences. These results indicate that investment in seed defences are associated with species' light requirements for regeneration, rather than scaling positively with seed mass. Furthermore, chemical defences, although highly variable among species, do not appear to be critical to long term persistence of Macaranga seeds, and may be important in defending seeds from natural enemies distinct from those found in the soil.	[Tiansawat, Pimonrat; Dalling, James W.] Univ Illinois, Dept Plant Biol, Urbana, IL 61801 USA; [Davis, Adam S.] ARS, Global Change & Photosynthesis Res Unit, United Dept Agr, Urbana, IL USA; [Berhow, Mark A.] ARS, Natl Ctr Agr Utilizat Res, United Dept Agr, Peoria, IL USA; [Zalamea, Paul-Camilo; Dalling, James W.] Smithsonian Trop Res Inst, Ancon, Panama	University of Illinois System; University of Illinois Urbana-Champaign; Smithsonian Institution; Smithsonian Tropical Research Institute	Tiansawat, P (corresponding author), Chiang Mai Univ, Dept Biol, Chiang Mai 50000, Thailand.	tiansawat@yahoo.co.th	Tiansawat, Pimonrat/AAJ-7033-2020	Tiansawat, Pimonrat/0000-0003-1354-1247; Zalamea, Paul-Camilo/0000-0002-0987-4164; Dalling, James/0000-0002-6488-9895; Berhow, Mark/0000-0002-1278-4071; Davis, Adam/0000-0002-7196-1197	Center of Tropical Forest Science; Royal Thai Government; National Science Foundation [1120205]; Direct For Biological Sciences [1120205] Funding Source: National Science Foundation	Center of Tropical Forest Science; Royal Thai Government; National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The funding for this work was provided by the Center of Tropical Forest Science (2010 Research Grant) to PT, the Royal Thai Government to PT and The National Science Foundation Grant 1120205 to JWD and ASD. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Monaim MF, 2011, AFR J BIOTECHNOL, V10, P10842; [Anonymous], 1995, SEED DEV GERMINATION, DOI DOI 10.1201/9780203740071-1; AUGSPURGER CK, 1984, OECOLOGIA, V61, P211, DOI 10.1007/BF00396763; Barthlott W., 1981, Nordic Journal of Botany, V1, P345, DOI 10.1111/j.1756-1051.1981.tb00704.x; BODMER RE, 1991, BIOTROPICA, V23, P255, DOI 10.2307/2388202; BRYANT JP, 1983, OIKOS, V40, P357, DOI 10.2307/3544308; Cardinal-Aucoin M, 2009, ANN ENTOMOL SOC AM, V102, P717, DOI 10.1603/008.102.0417; Cazetta E, 2008, OECOLOGIA, V155, P277, DOI 10.1007/s00442-007-0917-6; Chen X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032890; COLEY PD, 1983, ECOL MONOGR, V53, P209, DOI 10.2307/1942495; Conn JS, 2006, WEED SCI, V54, P464, DOI 10.1614/WS-05-161R.1; Dalling JW, 2011, J ECOL, V99, P89, DOI 10.1111/j.1365-2745.2010.01739.x; Dalling JW, 1998, ECOLOGY, V79, P564, DOI 10.1890/0012-9658(1998)079[0564:DPASBD]2.0.CO;2; Davies SJ, 1998, J ECOL, V86, P662, DOI 10.1046/j.1365-2745.1998.00299.x; Davies SJ, 1999, AM J BOT, V86, P1786, DOI 10.2307/2656675; Davies Stuart J., 2001, Harvard Papers in Botany, V6, P371; Davis AS, 2008, WEED SCI, V56, P676, DOI 10.1614/WS-07-196.1; Daws MI, 2005, FUNCT ECOL, V19, P874, DOI 10.1111/j.1365-2435.2005.01034.x; Ding H, 2000, J CHEM ECOL, V26, P969, DOI 10.1023/A:1005412309735; Fenner M., 2005, ECOLOGY SEEDS; Fine PVA, 2011, BIOTROPICA, V43, P265, DOI 10.1111/j.1744-7429.2011.00778.x; Fine PVA, 2004, SCIENCE, V305, P663, DOI 10.1126/science.1098982; GALEN C, 1986, AM J BOT, V73, P346, DOI 10.2307/2444077; Gallery RE, 2010, J ECOL, V98, P147, DOI 10.1111/j.1365-2745.2009.01589.x; Gallery RE, 2007, THESIS U ILLINOIS UR; Gardarin A, 2010, SEED SCI RES, V20, P243, DOI 10.1017/S0960258510000255; GARWOOD NC, 1983, ECOL MONOGR, V53, P159, DOI 10.2307/1942493; Goodale UM, 2012, FOREST ECOL MANAG, V277, P54, DOI 10.1016/j.foreco.2012.04.020; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Gower J.C., 2005, ENCY BIOSTATISTICS, DOI 10.1002/0470011815.b2a13070; Grubb PJ, 1998, OIKOS, V82, P467, DOI 10.2307/3546368; Hanley ME, 2002, FUNCT ECOL, V16, P216, DOI 10.1046/j.1365-2435.2002.00612.x; Heil M, 2002, OIKOS, V99, P457, DOI 10.1034/j.1600-0706.2002.11954.x; HENDRY GAF, 1994, FUNCT ECOL, V8, P658, DOI 10.2307/2389929; Janzen D. H., 1971, A Rev Ecol Syst, V2, P465, DOI 10.1146/annurev.es.02.110171.002341; JOHNSON HB, 1975, BOT REV, V41, P233, DOI 10.1007/BF02860838; Kestring D, 2009, J PLANT BIOL, V52, P569, DOI 10.1007/s12374-009-9073-3; Koizumi M, 2008, ANN BOT-LONDON, V102, P343, DOI 10.1093/aob/mcn095; Kumagai T, 2005, AGR FOREST METEOROL, V128, P81, DOI 10.1016/j.agrformet.2004.08.006; Kumagai T, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007307; Kuprewicz EK, 2010, J TROP ECOL, V26, P263, DOI 10.1017/S0266467410000039; Metzing D, 2001, BOT J LINN SOC, V137, P65, DOI 10.1111/j.1095-8339.2001.tb01105.x; MOHAMEDYASSEEN Y, 1994, BOT REV, V60, P426, DOI 10.1007/BF02857926; Moles AT, 2013, NEW PHYTOL, V198, P252, DOI 10.1111/nph.12116; Moles AT, 2003, ECOLOGY, V84, P3148, DOI 10.1890/02-0662; O'Hanlon-Manners DL, 2004, OECOLOGIA, V140, P650, DOI 10.1007/s00442-004-1625-0; Phommart S, 2005, J NAT PROD, V68, P927, DOI 10.1021/np0500272; R Core Team, 2016, R FDN STAT COMP; Read J, 2009, ANN BOT-LONDON, V103, P757, DOI 10.1093/aob/mcn246; Rodgerson L, 1998, ECOLOGY, V79, P1669, DOI 10.1890/0012-9658(1998)079[1669:MDISAF]2.0.CO;2; Roitto M, 2003, J CHEM ECOL, V29, P1905, DOI 10.1023/A:1024858413437; Schafer M, 2004, PLANT ECOL, V175, P19, DOI 10.1023/B:VEGE.0000048096.00772.23; Singh A, 1996, BIOL AGRIC HORTIC, V13, P205, DOI 10.1080/01448765.1996.9754782; Souza AJ, 2011, CROP PROT, V30, P651, DOI 10.1016/j.cropro.2010.12.014; STOCK WD, 1991, NEW PHYTOL, V117, P109, DOI 10.1111/j.1469-8137.1991.tb00950.x; Strauss SY, 2002, TRENDS ECOL EVOL, V17, P278, DOI 10.1016/S0169-5347(02)02483-7; Tiansawat P., 2013, THESIS U ILLINOIS UR; Twigg LE, 1996, OECOLOGIA, V108, P21, DOI 10.1007/BF00333210; Veldman JW, 2007, BIOTROPICA, V39, P87, DOI 10.1111/j.1744-7429.2006.00232.x; VENABLE DL, 1992, AM NAT, V140, P287, DOI 10.1086/285413; Whitmore T.C, 2008, GENUS MACARANGA PROD; Xu Y, 2007, ANAL CHEM, V79, P5633, DOI 10.1021/ac070134w; Yoder B J, 2005, THESIS VIRGINIA POLY; ZHANG J., 1997, TECHNICAL B INSECT P	64	14	14	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99691	10.1371/journal.pone.0099691	http://dx.doi.org/10.1371/journal.pone.0099691			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927025	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100067
J	Boon, MR; Bakker, LEH; van der Linden, RAD; Arias-Bouda, LP; Smit, F; Verberne, HJ; Lichtenbelt, WDV; Jazet, IM; Rensen, PCN				Boon, Mariette R.; Bakker, Leontine E. H.; van der Linden, Rianne A. D.; Arias-Bouda, Lenka Pereira; Smit, Frits; Verberne, Hein J.; Lichtenbelt, Wouter D. van Marken; Jazet, Ingrid M.; Rensen, Patrick C. N.			Supraclavicular Skin Temperature as a Measure of F-18-FDG Uptake by BAT in Human Subjects	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; NONSHIVERING THERMOGENESIS; ENERGY-EXPENDITURE; BLOOD-FLOW; COLD; MICE; INSULIN; MEN	Background: Brown adipose tissue (BAT) has emerged as a novel player in energy homeostasis in humans and is considered a potential new target for combating obesity and related diseases. The current 'gold standard' for quantification of BAT volume and activity is cold-induced F-18-FDG uptake in BAT. However, use of this technique is limited by cost and radiation exposure. Given the fact that BAT is a thermogenic tissue, mainly located in the supraclavicular region, the aim of the current study was to investigate whether cold-induced supraclavicular skin temperature and core body temperature may be alternative markers of BAT activation in humans. Subjects/Methods: BAT volume and activity were measured in 24 healthy lean adolescent males (mean age 24.1 +/- 0.8 years), using cold-induced F-18-FDG uptake with PET-CT. Core body temperature was measured continuously in the small intestine with use of an ingestible telemetric capsule and skin temperature was measured by eighteen wireless iButtons attached to the skin following ISO-defined locations. Results: Proximal and distal (hand/feet) skin temperatures markedly decreased upon cold exposure, while supraclavicular skin temperature significantly increased (35.2 +/- 0.1 vs. 35.5 +/- 0.1 degrees C, p = 0.001). Furthermore, cold-induced supraclavicular skin temperature positively correlated with both total (R-2 = 0.28, P = 0.010) and clavicular BAT volume (R-2 = 0.20, P = 0.030) and clavicular SUVmax (R-2 = 0.27, P = 0.010), while core body temperature did not. Conclusions: Supraclavicular skin temperature as measured by iButtons may have predictive value for BAT detection in adult humans. This is highly desirable considering the increasing interest in pharmacological interventions to stimulate BAT in human subjects.	[Boon, Mariette R.; Bakker, Leontine E. H.; van der Linden, Rianne A. D.; Jazet, Ingrid M.; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands; [Boon, Mariette R.; Bakker, Leontine E. H.; Jazet, Ingrid M.; Rensen, Patrick C. N.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Arias-Bouda, Lenka Pereira; Smit, Frits] Leiden Univ, Med Ctr, Dept Nucl Med, Leiden, Netherlands; [Arias-Bouda, Lenka Pereira; Smit, Frits] Rijnland Hosp, Dept Nucl Med, Leiderdorp, Netherlands; [Verberne, Hein J.] Univ Amsterdam, Acad Med Ctr, Dept Nucl Med, NL-1105 AZ Amsterdam, Netherlands; [Lichtenbelt, Wouter D. van Marken] Maastricht Univ, Med Ctr, Dept Human Biol, NUTRIM Sch Nutr Toxicol & Metab, Maastricht, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Rijnland Hospital; University of Amsterdam; Academic Medical Center Amsterdam; Maastricht University; Maastricht University Medical Centre (MUMC)	Boon, MR (corresponding author), Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, Leiden, Netherlands.	m.r.boon@lumc.nl	Rensen, Patrick C.N./D-7176-2018; Boon, Mariëtte/O-3660-2016	Rensen, Patrick C.N./0000-0002-8455-4988; Pereira Arias - Bouda, Lenka M./0000-0002-6879-5554	Dutch Diabetes Research Foundation [2012.11.1500]; Established Investigator of the Netherlands Heart Foundation [2009T038]	Dutch Diabetes Research Foundation; Established Investigator of the Netherlands Heart Foundation	This work was financed by the Dutch Diabetes Research Foundation (grant 2012.11.1500 to P.C.N.R. and M.R.B.). M.R.B. is supported by the Board of Directors of the Leiden University Medical Center (LUMC) and P.C.N.R. is Established Investigator of the Netherlands Heart Foundation (grant 2009T038). The authors also thank Roba Metals B. V. IJsselstein (Utrecht, The Netherlands) for financial support. The Blanketrol (R) III cooling device was kindly provided by FMH Medical (Veenendaal, The Netherlands). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All funders, including Roba Metals B.V. IJsselstein and FHM Medical, do not have competing interests that interfere with, or could be perceived as interfering with, the complete and objective presentation, peer review, editorial decision-making, or publication of a manuscript. Furthermore, the financial support of these funders does not alter the authors' adherence to PLOS ONE policies on sharing data and materials.	Bajzer M, 2011, DIABETOLOGIA, V54, P3121, DOI 10.1007/s00125-011-2302-6; Bakker LEH, 2013, LANCET DIAB IN PRESS; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Carter EA, 2011, J NUCL MED, V52, P1616, DOI 10.2967/jnumed.111.090175; Charkoudian N, 2003, MAYO CLIN PROC, V78, P603, DOI 10.4065/78.5.603; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; FOSTER DO, 1978, CAN J PHYSIOL PHARM, V56, P110, DOI 10.1139/y78-015; Geerling JJ, 2014, DIABETES IN PRESS; Golozoubova V, 2004, MOL ENDOCRINOL, V18, P384, DOI 10.1210/me.2003-0267; HARDY JD, 1948, SCIENCE, V107, P461; Kang HW, 2009, J LIPID RES, V50, P2212, DOI 10.1194/jlr.M900013-JLR200; Krauchi K, 1997, AM J PHYSIOL-REG I, V272, pR1178, DOI 10.1152/ajpregu.1997.272.4.R1178; Lichtenbelt WDV, 2011, AM J PHYSIOL-REG I, V301, pR285, DOI 10.1152/ajpregu.00652.2010; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Murano I, 2009, J ANAT, V214, P171, DOI 10.1111/j.1469-7580.2008.01001.x; Orava J, 2011, CELL METAB, V14, P272, DOI 10.1016/j.cmet.2011.06.012; Ouellet V, 2012, J CLIN INVEST, V122, P545, DOI 10.1172/JCI60433; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Symonds ME, 2012, J PEDIATR-US, V161, P892, DOI 10.1016/j.jpeds.2012.04.056; Lichtenbelt WDV, 2006, PHYSIOL BEHAV, V88, P489, DOI 10.1016/j.physbeh.2006.04.026; Vijgen GHEJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017247; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Vosselman MJ, 2013, AM J CLIN NUTR, V98, P57, DOI 10.3945/ajcn.113.059022; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105	27	65	65	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98822	10.1371/journal.pone.0098822	http://dx.doi.org/10.1371/journal.pone.0098822			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922545	gold, Green Published, Green Submitted			2022-12-27	WOS:000338701300017
J	Gomes, GM; Dalmolin, GD; Bar, J; Karpova, A; Mello, CF; Kreutz, MR; Rubin, MA				Gomes, Guilherme Monteiro; Dalmolin, Gerusa Duarte; Baer, Julia; Karpova, Anna; Mello, Carlos Fernando; Kreutz, Michael R.; Rubin, Maribel Antonello			Inhibition of the Polyamine System Counteracts beta-Amyloid Peptide-Induced Memory Impairment in Mice: Involvement of Extrasynaptic NMDA Receptors	PLOS ONE			English	Article							ALZHEIMERS-DISEASE; ORNITHINE-DECARBOXYLASE; NEURONAL DYSFUNCTION; DENDRITIC SPINES; MOLECULAR-BASIS; SYNAPSE LOSS; MEMANTINE; GLUTAMATE; OLIGOMERS; BRAIN	In Alzheimer's disease (AD), the beta-amyloid peptide (A beta) has been causally linked to synaptic dysfunction and cognitive impairment. Several studies have shown that N-Methyl-D-Aspartate receptors (NMDAR) activation is involved in the detrimental actions of A beta. Polyamines, like spermidine and spermine, are positive modulators of NMDAR function and it has been shown that their levels are regulated by A beta. In this study we show here that interruption of NMDAR modulation by polyamines through blockade of its binding site at NMDAR by arcaine (0.02 nmol/site), or inhibition of polyamine synthesis by DFMO (2.7 nmol/site), reverses A beta(25-35)-induced memory impairment in mice in a novel object recognition task. Incubation of hippocampal cell cultures with A beta(25-35) (10 mu M) significantly increased the nuclear accumulation of Jacob, which is a hallmark of NMDAR activation. The A beta-induced nuclear translocation of Jacob was blocked upon application of traxoprodil (4 nM), arcaine (4 mu M) or DFMO (5 mu M), suggesting that activation of the polyamine binding site at NMDAR located probably at extrasynaptic sites might underlie the cognitive deficits of A beta(25-35)-treated mice. Extrasynaptic NMDAR activation in primary neurons results in a stripping of synaptic contacts and simplification of neuronal cytoarchitecture. A beta(25-35) application in hippocampal primary cell cultures reduced dendritic spine density and induced alterations on spine morphology. Application of traxoprodil (4 nM), arcaine (4 mu M) or DFMO (5 mu M) reversed these effects of A beta(25-35). Taken together these data provide evidence that polyamine modulation of extrasynaptic NMDAR signaling might be involved in A beta pathology.	[Gomes, Guilherme Monteiro; Dalmolin, Gerusa Duarte; Rubin, Maribel Antonello] Univ Fed Santa Maria, Nat & Exact Sci Ctr, Biochem & Mol Biol Dept, BR-97119900 Santa Maria, RS, Brazil; [Gomes, Guilherme Monteiro; Baer, Julia; Karpova, Anna; Kreutz, Michael R.] Leibniz Inst Neurobiol, Res Grp Neuroplast, Magdeburg, Germany; [Mello, Carlos Fernando] Univ Fed Santa Maria, Dept Physiol & Pharmacol, BR-97119900 Santa Maria, RS, Brazil	Universidade Federal de Santa Maria (UFSM); Leibniz Institut fur Neurobiologie (LIN); Universidade Federal de Santa Maria (UFSM)	Rubin, MA (corresponding author), Univ Fed Santa Maria, Nat & Exact Sci Ctr, Biochem & Mol Biol Dept, BR-97119900 Santa Maria, RS, Brazil.	maribel.rubin@gmail.com	Mello, Carlos/C-7188-2013	Mello, Carlos/0000-0002-1326-1045; rubin, maribel/0000-0002-2763-9619	CNPq [306164/2010-8, 481664/2010-6, 476551/2009-9]; CNPq fellowships; DAAD/CAPES cooperation program fellowship; DFG [SFB 779]; DIP grant; German Center for Neurodegenerative Diseases (DZNE), Location Magdeburg, Germany; federal state of Saxony-Anhalt; Vorhaben: Center for Behavioral Brain Sciences (CBBS)	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CNPq fellowships(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); DAAD/CAPES cooperation program fellowship; DFG(German Research Foundation (DFG)); DIP grant; German Center for Neurodegenerative Diseases (DZNE), Location Magdeburg, Germany; federal state of Saxony-Anhalt; Vorhaben: Center for Behavioral Brain Sciences (CBBS)	This study was supported by CNPq (306164/2010-8, 481664/2010-6, 476551/2009-9). C.F. Mello and M.A. Rubin are recipients of CNPq fellowships. G.M. Gomes is recipient of DAAD/CAPES cooperation program fellowship. M.R. Kreutz is supported by the DFG (SFB 779 TP B8), DIP grant, and the German Center for Neurodegenerative Diseases (DZNE), Location Magdeburg, Germany. A. Karpova is supported by the federal state of Saxony-Anhalt, Vorhaben: Center for Behavioral Brain Sciences (CBBS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172; Behnisch T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017276; BERNSTEIN HG, 1995, NEUROSCI LETT, V186, P123, DOI 10.1016/0304-3940(95)11301-C; Buisson B, 1998, MOL PHARMACOL, V53, P555, DOI 10.1124/mol.53.3.555; Coffino P, 2001, NAT REV MOL CELL BIO, V2, P188, DOI 10.1038/35056508; Dalmolin GD, 2011, PAIN, V152, P2224, DOI 10.1016/j.pain.2011.04.015; Danysz W, 2012, BRIT J PHARMACOL, V167, P324, DOI 10.1111/j.1476-5381.2012.02057.x; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dickerson BC, 2010, NEUROPSYCHOPHARMACOL, V35, P86, DOI 10.1038/npp.2009.126; Dieterich DC, 2008, PLOS BIOL, V6, P286, DOI 10.1371/journal.pbio.0060034; Dunaevsky A, 1999, P NATL ACAD SCI USA, V96, P13438, DOI 10.1073/pnas.96.23.13438; Fischer M, 1998, NEURON, V20, P847, DOI 10.1016/S0896-6273(00)80467-5; Gomes GM, 2010, NEUROBIOL LEARN MEM, V93, P589, DOI 10.1016/j.nlm.2010.02.007; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Inoue K, 2013, SCI REP-UK, V3, DOI 10.1038/srep02364; Kamenetz F, 2003, NEURON, V37, P925, DOI 10.1016/S0896-6273(03)00124-7; Kaminsky YG, 2010, EXP NEUROL, V221, P26, DOI 10.1016/j.expneurol.2009.09.005; Karpova A, 2013, CELL, V152, P1119, DOI 10.1016/j.cell.2013.02.002; Kasai H, 2010, TRENDS NEUROSCI, V33, P121, DOI 10.1016/j.tins.2010.01.001; Kew JNC, 1998, J PHYSIOL-LONDON, V512, P17, DOI 10.1111/j.1469-7793.1998.017bf.x; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1113/expphysiol.2010.053793, 10.1111/j.1476-5381.2010.00872.x, 10.1113/jphysiol.2010.192278]; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Lison H, 2014, NEUROBIOL DIS, V63, P62, DOI 10.1016/j.nbd.2013.11.014; Lo D, 2011, EXPERT REV NEUROTHER, V11, P1359, DOI [10.1586/ern.11.132, 10.1586/ERN.11.132]; Makitie LT, 2010, BRAIN PATHOL, V20, P571, DOI 10.1111/j.1750-3639.2009.00334.x; Maurice T, 1996, BRAIN RES, V706, P181, DOI 10.1016/0006-8993(95)01032-7; Mony L, 2011, EMBO J, V30, P3134, DOI 10.1038/emboj.2011.203; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; MORRISON LD, 1995, NEUROSCI LETT, V197, P5, DOI 10.1016/0304-3940(95)11881-V; Morrison LD, 1998, J NEUROCHEM, V71, P288; Mota SI, 2014, NEUROPHARMACOLOGY, V76, P16, DOI 10.1016/j.neuropharm.2013.08.013; Palop JJ, 2010, NAT NEUROSCI, V13, P812, DOI 10.1038/nn.2583; Paoletti P, 2013, NAT REV NEUROSCI, V14, P383, DOI 10.1038/nrn3504; Perfecto K, 2013, J PSYCHOSOC NURS MEN, V51, P17, DOI 10.3928/02793695-20130731-01; Price M, 2009, WORLD ALZHEIMERS REP; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Ronicke R, 2011, NEUROBIOL AGING, V32, P2219, DOI 10.1016/j.neurobiolaging.2010.01.011; Rubin MA, 2004, J NEUROSCI, V24, P2328, DOI 10.1523/JNEUROSCI.1622-03.2004; Schneider LS, 2011, ARCH NEUROL-CHICAGO, V68, P991, DOI 10.1001/archneurol.2011.69; Shankar GM, 2007, J NEUROSCI, V27, P2866, DOI 10.1523/JNEUROSCI.4970-06.2007; Silva MA, 2011, BIOCHEM PHARMACOL, V82, P269, DOI 10.1016/j.bcp.2011.04.015; Small DH, 2008, TRENDS MOL MED, V14, P103, DOI 10.1016/j.molmed.2007.12.006; Talantova M, 2013, P NATL ACAD SCI USA, V110, pE2518, DOI 10.1073/pnas.1306832110; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wang DY, 2007, NEUROPSYCHOPHARMACOL, V32, P1261, DOI 10.1038/sj.npp.1301256; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Yatin SM, 2001, J NEUROSCI RES, V63, P395, DOI 10.1002/1097-4547(20010301)63:5<395::AID-JNR1034>3.0.CO;2-Q; Yatin SM, 1997, E NEUROSCI LETT, V263, P17	50	34	35	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99184	10.1371/journal.pone.0099184	http://dx.doi.org/10.1371/journal.pone.0099184			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921942	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300041
J	Gustafsson, PE; San Sebastian, M				Gustafsson, Per E.; San Sebastian, Miguel			When Does Hardship Matter for Health? Neighborhood and Individual Disadvantages and Functional Somatic Symptoms from Adolescence to Mid-Life in the Northern Swedish Cohort	PLOS ONE			English	Article							GEOGRAPHIC LIFE ENVIRONMENTS; MULTILEVEL ANALYSIS; ALLOSTATIC LOAD; HEART-DISEASE; RISK-FACTORS; DEPRESSION; RESIDENCE; ADULTHOOD; COMMUNITY; EPIDEMIOLOGY	A large body of research has shown that health is influenced by disadvantaged living conditions, including both personal and neighborhood conditions. Little is however known to what degree the health impact of different forms of disadvantage differ along the life course. The present study aims to examine when, during the life course, neighborhood and individual disadvantages relate to functional somatic symptoms. Participants (n = 992) came from The Northern Swedish Cohort and followed from age 16, 21, 30 until 42 years. Functional somatic symptoms, socioeconomic disadvantage, and social and material adversity were measured through questionnaires and linked to register data on neighborhood disadvantage. Data was analyzed with longitudinal and cross-sectional multilevel models. Results showed that neighborhood disadvantage, social and material adversity and gender all contributed independently to overall levels of symptoms across the life course. Cross-sectional analyses also suggested that the impact of disadvantage differed between life course periods; neighborhood disadvantage was most important in young adulthood, and the relative importance of material versus social adversity increased as participants grew older. In summary, the study suggests that disadvantages from different contextual sources may affect functional somatic health across the life course, but also through life course specific patterns.	[Gustafsson, Per E.; San Sebastian, Miguel] Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden	Umea University	Gustafsson, PE (corresponding author), Umea Univ, Dept Publ Hlth & Clin Med, Umea, Sweden.	Per.E.Gustafsson@umu.se	Gustafsson, Per/AAY-5068-2021	San Sebastian, Miguel/0000-0001-7234-3510	The Swedish Research Council Formas [259-2012-37]; Umea University [223-514-09]; The County Council of Vasterbotten [355661]	The Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Umea University; The County Council of Vasterbotten	The study was supported by The Swedish Research Council Formas (www.formas.se, grant# 259-2012-37) and by Umea University (www.umu.se, Young Researcher Award, grant# 223-514-09) and by The County Council of Vasterbotten (www.vll.se, grant# 355661). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bell Bethany A., 2008, JSM P SECTION SURVEY, P1122; Bohman H, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-90; Boyle MH, 2002, J CONSULT CLIN PSYCH, V70, P378, DOI 10.1037//0022-006X.70.2.378; Browne WJ, 2004, MCMC ESTIMATION MLWI; Campo JV, 2012, J CHILD PSYCHOL PSYC, V53, P575, DOI 10.1111/j.1469-7610.2012.02535.x; Chaix B, 2009, ANNU REV PUBL HEALTH, V30, P81, DOI 10.1146/annurev.publhealth.031308.100158; Clarke P, 2008, J EPIDEMIOL COMMUN H, V62, P752, DOI 10.1136/jech.2007.060798; CONGER RD, 1992, CHILD DEV, V63, P526, DOI 10.1111/j.1467-8624.1992.tb01644.x; CONGER RD, 1993, DEV PSYCHOL, V29, P206, DOI 10.1037/0012-1649.29.2.206; Creed FH, 2012, J PSYCHOSOM RES, V72, P311, DOI 10.1016/j.jpsychores.2012.01.009; Gustafsson PE, 2014, AM J PUBLIC HEALTH, V104, P904, DOI 10.2105/AJPH.2013.301707; Gustafsson PE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080241; Gustafsson PE, 2012, ANN BEHAV MED, V43, P117, DOI 10.1007/s12160-011-9309-6; Gustafsson PE, 2011, J EPIDEMIOL COMMUN H, V65, P986, DOI 10.1136/jech.2010.108332; Hammarstrom A, 1986, THESIS KAROLINSKA I; Hammarstrom A, 2012, INT J EPIDEMIOL, V41, P1545, DOI 10.1093/ije/dyr118; Janssens KAM, 2010, J CHILD PSYCHOL PSYC, V51, P304, DOI 10.1111/j.1469-7610.2009.02174.x; Jencks C., 1990, INNER CITY POVERTY U; Kim D, 2008, EPIDEMIOL REV, V30, P101, DOI 10.1093/epirev/mxn009; Leal C, 2011, OBES REV, V12, P217, DOI 10.1111/j.1467-789X.2010.00726.x; Leckie G, 2013, J STAT SOFTW, V52, P1; Leventhal T, 2000, PSYCHOL BULL, V126, P309, DOI 10.1037/0033-2909.126.2.309; Mair C, 2008, J EPIDEMIOL COMMUN H, V62, P940, DOI 10.1136/jech.2007.066605; Matheson FI, 2010, J EPIDEMIOL COMMUN H, V64, P705, DOI 10.1136/jech.2008.083303; Merlo J, 2009, J EPIDEMIOL COMMUN H, V63, P1043, DOI 10.1136/jech.2009.088310; Merlo J, 2003, J EPIDEMIOL COMMUN H, V57, P550, DOI 10.1136/jech.57.8.550; Merlo J, 2010, PSYCHOSOC INTERV, V20, P109; Merlo J, 2013, SOC SCI MED, V76, P39, DOI 10.1016/j.socscimed.2012.08.034; Merlo J, 2012, SOC SCI MED, V75, P1477, DOI 10.1016/j.socscimed.2012.06.004; Metcalfe A, 2011, PAEDIATR PERINAT EP, V25, P236, DOI 10.1111/j.1365-3016.2011.01192.x; Naess O, 2010, SCAND J PUBLIC HEALT, V38, P119, DOI 10.1177/1403494810384646; Oakes JM, 2004, SOC SCI MED, V58, P1929, DOI 10.1016/j.socscimed.2003.08.004; OECD, 2011, DIV WE STAND WHY IN; Ohlsson H, 2011, SOC SCI MED, V73, P1145, DOI 10.1016/j.socscimed.2011.08.005; Paczkowski MM, 2010, CURR OPIN PSYCHIATR, V23, P337, DOI 10.1097/YCO.0b013e32833ad70b; Pickett KE, 2001, J EPIDEMIOL COMMUN H, V55, P111, DOI 10.1136/jech.55.2.111; Raphael D, 2013, SCANDINAVIAN J PUBLI; Roux AVD, 2010, ANN NY ACAD SCI, V1186, P125, DOI 10.1111/j.1749-6632.2009.05333.x; Roux AVD, 2001, NEW ENGL J MED, V345, P99, DOI 10.1056/NEJM200107123450205; Sampson RJ, 2002, ANNU REV SOCIOL, V28, P443, DOI 10.1146/annurev.soc.28.110601.141114; Sellstrom E, 2006, SCAND J PUBLIC HEALT, V34, P544, DOI 10.1080/14034940600551251; Statistics Sweden, 1984, REPORTS STAT ORDINAT; Steinhausen HC, 2007, J CHILD PSYCHOL PSYC, V48, P508, DOI 10.1111/j.1469-7610.2006.01721.x; SWARTZ M, 1989, PSYCHOSOMATICS, V30, P44, DOI 10.1016/S0033-3182(89)72316-1; Theall KP, 2011, J EPIDEMIOL COMMUN H, V65, P688, DOI 10.1136/jech.2009.097956; West P, 1997, SOC SCI MED, V44, P833, DOI 10.1016/S0277-9536(96)00188-8; Yen IH, 2009, AM J PREV MED, V37, P455, DOI 10.1016/j.amepre.2009.06.022; Zijlema WL, 2013, J PSYCHOSOM RES, V74, P459, DOI 10.1016/j.jpsychores.2013.03.093	48	8	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99558	10.1371/journal.pone.0099558	http://dx.doi.org/10.1371/journal.pone.0099558			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24924384	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300073
J	Huynen, L; Gill, BJ; Doyle, A; Millar, CD; Lambert, DM				Huynen, Leon; Gill, Brian J.; Doyle, Anthony; Millar, Craig D.; Lambert, David M.			Identification, Classification, and Growth of Moa Chicks (Aves: Dinornithiformes) from the Genus Euryapteryx	PLOS ONE			English	Article							ANCIENT DNA; NEW-ZEALAND; CLIMATE; DIET	Background: The analysis of growth in extinct organisms is difficult. The general lack of skeletal material from a range of developmental states precludes determination of growth characteristics. For New Zealand's extinct moa we have available to us a selection of rare femora at different developmental stages that have allowed a preliminary determination of the early growth of this giant flightless bird. We use a combination of femora morphometrics, ancient DNA, and isotope analysis to provide information on the identification, classification, and growth of extinct moa from the genus Euryapteryx. Results: Using ancient DNA, we identify a number of moa chick bones for the species Euryapteryx curtus, Dinornis novaezealandiae, and Anomalopteryx didiformis, and the first chick bone for Pachyornis geranoides. Isotope analysis shows that partial derivative N-15 levels vary between the two known size classes of Euryapteryx, with the larger size class having reduced levels of partial derivative N-15. A growth series for femora of the two size classes of Euryapteryx shows that early femora growth characteristics for both classes are almost identical. Morphometric, isotopic, and radiographic analysis of the smallest Euryapteryx bones suggests that one of these femora is from a freshly hatched moa at a very early stage of development. Conclusion: Using morphometric, isotopic, and ancient DNA analyses have allowed the determination of a number of characteristics of rare moa chick femora. For Euryapteryx the analyses suggest that the smaller sized class II Euryapteryx is identical in size and growth to the extant Darwin's rhea.	[Huynen, Leon; Lambert, David M.] Griffith Univ, Environm Futures Ctr, Nathan, Qld 4111, Australia; [Gill, Brian J.] Auckland War Mem Museum, Auckland, New Zealand; [Doyle, Anthony] Univ Auckland, Fac Hlth & Med Sci, Auckland 1, New Zealand; [Millar, Craig D.] Univ Auckland, Sch Biol Sci, Allan Wilson Ctr Mol Ecol & Evolut, Auckland 1, New Zealand	Griffith University; University of Auckland; Massey University; University of Auckland	Lambert, DM (corresponding author), Griffith Univ, Environm Futures Ctr, Nathan, Qld 4111, Australia.	d.lambert@griffith.edu.au	Gill, Brian/I-9553-2019	Gill, Brian/0000-0003-4026-2905; Lambert, David/0000-0002-5821-3637	Australian Research Council [DP110101364]	Australian Research Council(Australian Research Council)	The authors thank the Australian Research Council for support (Grant number DP110101364; The molecular evolution of wings in ratites). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMBROSE SH, 1991, J ARCHAEOL SCI, V18, P293, DOI 10.1016/0305-4403(91)90067-Y; Applegate TJ, 2002, POULTRY SCI, V81, P1289, DOI 10.1093/ps/81.9.1289; BRUNING D, 1970, WILSON BULL, V82, P219; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Cooper A, 2000, SCIENCE, V289, P1139; Davies S., 2003, GRZIMEKS ANIMAL LIFE; Dickison MJ., 2007, THESIS DUKE U; Gill BJ, 2010, REC AUST MUS, V62, P115, DOI 10.3853/j.0067-1975.62.2010.1535; Hassan SM, 2004, POULTRY SCI, V83, P495, DOI 10.1093/ps/83.3.495; Hector J., 1872, T P NZ I, V4, P110; Holdaway Richard N., 2011, Notornis, V58, P1; Huynen L, 2010, P NATL ACAD SCI USA, V107, P16201, DOI 10.1073/pnas.0914096107; McCallum J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0050732; McMeans BC, 2009, J FISH BIOL, V75, P2464, DOI 10.1111/j.1095-8649.2009.02402.x; PRANGE HD, 1979, AM NAT, V113, P103, DOI 10.1086/283367; Rawlence NJ, 2012, QUATERNARY SCI REV, V50, P141, DOI 10.1016/j.quascirev.2012.07.004; REECE RL, 1984, AUST VET J, V61, P403, DOI 10.1111/j.1751-0813.1984.tb07174.x; Rogers KM, 2009, J AGR FOOD CHEM, V57, P4236, DOI 10.1021/jf803760s; Roots C., 2006, FLIGHTLESS BIRDS; STEADMAN D W, 1980, Contributions in Science (Los Angeles), P131; Turvey ST, 2005, J MORPHOL, V265, P70, DOI 10.1002/jmor.10341; Turvey ST, 2005, NATURE, V435, P940, DOI 10.1038/nature03635; Tykot RH, 2004, P INT SCH PHYS E FER; Wood Jamie R., 2007, Records of the Canterbury Museum, V21, P27; WORTHY T H, 1987, National Museum of New Zealand Records, V3, P59; Worthy TH, 2012, NEW ZEAL J ZOOL, V39, P87, DOI 10.1080/03014223.2012.665060; Worthy T. H., 2002, LOST WORLD MOA PREHI; Worthy TH, 1988, NATL MUSEUM NZ MISC, V17, P3	28	4	4	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99929	10.1371/journal.pone.0099929	http://dx.doi.org/10.1371/journal.pone.0099929			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923666	Green Published, gold			2022-12-27	WOS:000338701300107
J	Jhaveri, DJ; Nanavaty, I; Prosper, BW; Marathe, S; Husain, BFA; Kernie, SG; Bartlett, PF; Vaidya, VA				Jhaveri, Dhanisha J.; Nanavaty, Ishira; Prosper, Boris W.; Marathe, Swanand; Husain, Basma F. A.; Kernie, Steven G.; Bartlett, Perry F.; Vaidya, Vidita A.			Opposing Effects of alpha 2-and beta-Adrenergic Receptor Stimulation on Quiescent Neural Precursor Cell Activity and Adult Hippocampal Neurogenesis	PLOS ONE			English	Article							ELEMENT-BINDING PROTEIN; CHRONIC ANTIDEPRESSANT TREATMENT; RAT HIPPOCAMPUS; DENTATE GYRUS; 5-HYDROXYTRYPTAMINE RELEASE; NORADRENERGIC SYSTEM; NEUROTROPHIC FACTOR; BRAIN; ALPHA(2)-ADRENOCEPTORS; NOREPINEPHRINE	Norepinephrine regulates latent neural stem cell activity and adult hippocampal neurogenesis, and has an important role in modulating hippocampal functions such as learning, memory and mood. Adult hippocampal neurogenesis is a multi-stage process, spanning from the activation and proliferation of hippocampal stem cells, to their differentiation into neurons. However, the stage-specific effects of noradrenergic receptors in regulating adult hippocampal neurogenesis remain poorly understood. In this study, we used transgenic Nestin-GFP mice and neurosphere assays to show that modulation of alpha 2-and beta-adrenergic receptor activity directly affects Nestin-GFP/GFAP-positive precursor cell population albeit in an opposing fashion. While selective stimulation of alpha 2-adrenergic receptors decreases precursor cell activation, proliferation and immature neuron number, stimulation of beta-adrenergic receptors activates the quiescent precursor pool and enhances their proliferation in the adult hippocampus. Furthermore, our data indicate no major role for alpha 1-adrenergic receptors, as we did not observe any change in either the activation and proliferation of hippocampal precursors following selective stimulation or blockade of alpha 1-adrenergic receptors. Taken together, our data suggest that under physiological as well as under conditions that lead to enhanced norepinephrine release, the balance between alpha 2-and beta-adrenergic receptor activity regulates precursor cell activity and hippocampal neurogenesis.	[Jhaveri, Dhanisha J.; Prosper, Boris W.; Bartlett, Perry F.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia; [Nanavaty, Ishira; Marathe, Swanand; Husain, Basma F. A.; Vaidya, Vidita A.] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India; [Kernie, Steven G.] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Kernie, Steven G.] Columbia Univ Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA	University of Queensland; Tata Institute of Fundamental Research (TIFR); Columbia University; Columbia University	Bartlett, PF (corresponding author), Univ Queensland, Queensland Brain Inst, Brisbane, Qld, Australia.	p.bartlett@uq.edu.au; vvaidya@tifr.res.in	Kernie, Steven/AAT-9912-2020; Jhaveri, Dhanisha/D-2640-2009; Bartlett, Perry/F-3813-2012	Jhaveri, Dhanisha/0000-0002-5615-3546; Kernie, Steven/0000-0003-1371-0549; Vaidya, Vidita/0000-0002-3907-8580; Marathe, Swananda/0000-0002-2539-366X	Queensland Government; Estate of Dr. Clem Jones AO; Department of Biotechnology, Government of India; TIFR intramural funds	Queensland Government; Estate of Dr. Clem Jones AO; Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); TIFR intramural funds	This work was supported by an Indo-Queensland Biotechnology Project Fund Award from the Queensland Government and the Estate of Dr. Clem Jones AO to PFB and the Department of Biotechnology, Government of India to VAV and by TIFR intramural funds (VAV). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Bortolozzi A, 2003, NEUROPSYCHOPHARMACOL, V28, P421, DOI 10.1038/sj.npp.1300061; Brunello N, 2003, INT CLIN PSYCHOPHARM, V18, P191, DOI 10.1097/00004850-200307000-00001; Doze VA, 2011, MOL PHARMACOL, V80, P747, DOI 10.1124/mol.111.073734; DURSUN SM, 1993, BRIT J PHARMACOL, V109, P1046, DOI 10.1111/j.1476-5381.1993.tb13727.x; Dworkin S, 2009, STEM CELLS, V27, P1347, DOI 10.1002/stem.56; Esteban S, 1999, N-S ARCH PHARMACOL, V360, P135, DOI 10.1007/s002109900045; Flugge G, 2003, EUR J NEUROSCI, V17, P917, DOI 10.1046/j.1460-9568.2003.02510.x; Garcia-Vallejo P, 1998, BRAIN RES, V801, P72, DOI 10.1016/S0006-8993(98)00547-2; GLAVIN GB, 1985, LIFE SCI, V37, P461, DOI 10.1016/0024-3205(85)90408-4; Gobert A, 2003, J PHARMACOL EXP THER, V305, P338, DOI 10.1124/jpet.102.046383; Gupta MK, 2009, MOL PHARMACOL, V76, P314, DOI 10.1124/mol.109.057307; Harley CW, 2007, PROG BRAIN RES, V163, P299, DOI 10.1016/S0079-6123(07)63018-0; HEIN L, 1995, NEUROPHARMACOLOGY, V34, P357, DOI 10.1016/0028-3908(95)00018-2; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; Jhaveri DJ, 2012, DEV NEUROBIOL, V72, P1044, DOI 10.1002/dneu.22027; Jhaveri DJ, 2010, J NEUROSCI, V30, P2795, DOI 10.1523/JNEUROSCI.3780-09.2010; Kulkarni VA, 2002, EUR J NEUROSCI, V16, P2008, DOI 10.1046/j.1460-9568.2002.02268.x; LOY R, 1980, SCIENCE, V208, P1282, DOI 10.1126/science.7375941; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; Mantamadiotis T, 2012, BIOESSAYS, V34, P293, DOI 10.1002/bies.201100133; Marien MR, 2004, BRAIN RES REV, V45, P38, DOI 10.1016/j.brainresrev.2004.02.002; Masuda T, 2012, PROG NEURO-PSYCHOPH, V36, P44, DOI 10.1016/j.pnpbp.2011.08.019; Merz K, 2011, EUR J NEUROSCI, V33, P1078, DOI 10.1111/j.1460-9568.2011.07606.x; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Nair A, 2007, NEUROPSYCHOPHARMACOL, V32, P1504, DOI 10.1038/sj.npp.1301276; Nakagawa S, 2002, J NEUROSCI, V22, P9868; Nakagawa S, 2002, J NEUROSCI, V22, P3673; Nicholas AP, 1996, TRENDS PHARMACOL SCI, V17, P245, DOI 10.1016/S0165-6147(96)10022-5; O'Malley SS, 1998, EUR J PHARMACOL, V348, P287, DOI 10.1016/S0014-2999(98)00149-6; Peltier J, 2007, DEV NEUROBIOL, V67, P1348, DOI 10.1002/dneu.20506; Philipp M, 2004, PHARMACOL THERAPEUT, V101, P65, DOI 10.1016/j.pharmthera.2003.10.004; Ribas C, 2001, BRIT J PHARMACOL, V132, P1467, DOI 10.1038/sj.bjp.0703963; Sahay A, 2007, NAT NEUROSCI, V10, P1110, DOI 10.1038/nn1969; Sairanen M, 2005, J NEUROSCI, V25, P1089, DOI 10.1523/JNEUROSCI.3741-04.2005; Sanacora G, 2004, NEUROPSYCHOPHARMACOL, V29, P1166, DOI 10.1038/sj.npp.1300418; Subhash MN, 2003, NEUROCHEM INT, V43, P603, DOI 10.1016/S0197-0186(03)00097-4; Vaidya Vidita A, 2007, Expert Rev Neurother, V7, P853, DOI 10.1586/14737175.7.7.853; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008; Yanpallewar SU, 2010, J NEUROSCI, V30, P1096, DOI 10.1523/JNEUROSCI.2309-09.2010; Yoshioka M, 1995, EUR J PHARMACOL, V294, P565, DOI 10.1016/0014-2999(95)00582-X; Yu TS, 2005, GENESIS, V41, P147, DOI 10.1002/gene.20110	42	25	27	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98736	10.1371/journal.pone.0098736	http://dx.doi.org/10.1371/journal.pone.0098736			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922313	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300015
J	Rowehl, RA; Burke, S; Bialkowska, AB; Pettet, DW; Rowehl, L; Li, E; Antoniou, E; Zhang, YH; Bergamaschi, R; Shroyer, KR; Ojima, I; Botchkina, GI				Rowehl, Rebecca A.; Burke, Stephanie; Bialkowska, Agnieszka B.; Pettet, Donald W., III; Rowehl, Leahana; Li, Ellen; Antoniou, Eric; Zhang, Yuanhao; Bergamaschi, Roberto; Shroyer, Kenneth R.; Ojima, Iwao; Botchkina, Galina I.			Establishment of Highly Tumorigenic Human Colorectal Cancer Cell Line (CR4) with Properties of Putative Cancer Stem Cells	PLOS ONE			English	Article							Y-CHROMOSOME; CD133(+)CD44(+) POPULATION; INITIATING CELLS; SIDE POPULATION; POOR-PROGNOSIS; TUMOR-GROWTH; CD133; CD44; RESISTANCE; EXPRESSION	Background: Colorectal cancer (CRC) has the third highest mortality rates among the US population. According to the most recent concept of carcinogenesis, human tumors are organized hierarchically, and the top of it is occupied by malignant stem cells (cancer stem cells, CSCs, or cancer-initiating cells, CICs), which possess unlimited self-renewal and tumor-initiating capacities and high resistance to conventional therapies. To reflect the complexity and diversity of human tumors and to provide clinically and physiologically relevant cancer models, large banks of characterized patient-derived low-passage cell lines, and especially CIC-enriched cell lines, are urgently needed. Principal Findings: Here we report the establishment of a novel CIC-enriched, highly tumorigenic and clonogenic colon cancer cell line, CR4, derived from liver metastasis. This stable cell line was established by combining 3D culturing and 2D culturing in stem cell media, subcloning of cells with particular morphology, co-culture with carcinoma associated fibroblasts (CAFs) and serial transplantation to NOD/SCID mice. Using RNA-Seq complete transcriptome profiling of the tumorigenic fraction of the CR4 cells in comparison to the bulk tumor cells, we have identified about 360 differentially expressed transcripts, many of which represent stemness, pluripotency and resistance to treatment. Majority of the established CR4 cells express common markers of stemness, including CD133, CD44, CD166, EpCAM, CD24 and Lgr5. Using immunocytochemical, FACS and western blot analyses, we have shown that a significant ratio of the CR4 cells express key markers of pluripotency markers, including Sox-2, Oct3/4 and c-Myc. Constitutive overactivation of ABC transporters and NFkB and absence of tumor suppressors p53 and p21 may partially explain exceptional drug resistance of the CR4 cells. Conclusions: The highly tumorigenic and clonogenic CIC-enriched CR4 cell line may provide an important new tool to support the discovery of novel diagnostic and/or prognostic biomarkers as well as the development of more effective therapeutic strategies.	[Rowehl, Rebecca A.; Burke, Stephanie; Shroyer, Kenneth R.; Botchkina, Galina I.] SUNY Stony Brook, Dept Pathol, Med Ctr, Stony Brook, NY 11794 USA; [Bialkowska, Agnieszka B.; Pettet, Donald W., III; Rowehl, Leahana; Li, Ellen] SUNY Stony Brook, Dept Med, Med Ctr, Stony Brook, NY 11794 USA; [Antoniou, Eric] Cold Spring Harbor Lab, Genome Res Ctr, Cold Spring Harbor, NY 11724 USA; [Zhang, Yuanhao] SUNY Stony Brook, CEWIT, Stony Brook, NY 11794 USA; [Bergamaschi, Roberto] SUNY Stony Brook, Med Ctr, Dept Surg Surg Oncol, Stony Brook, NY 11794 USA; [Ojima, Iwao; Botchkina, Galina I.] SUNY Stony Brook, Inst Chem Biol & Drug Discovery, Stony Brook, NY 11794 USA; [Ojima, Iwao] SUNY Stony Brook, Dept Chem, Stony Brook, NY 11794 USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cold Spring Harbor Laboratory; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook	Botchkina, GI (corresponding author), SUNY Stony Brook, Dept Pathol, Med Ctr, Stony Brook, NY 11794 USA.	gbotchkina@stonybrookmedicine.edu		Ojima, Iwao/0000-0002-3628-1161	Fusion TRO grant [1104347-5-37298]; SBU Cancer Center; SBU Vice President for Research (RSR) [1111963-3-63845]; Department of Pathology; Institute of Chemical Biology & Drug Discovery (ICBDD); Simons Foundation	Fusion TRO grant; SBU Cancer Center; SBU Vice President for Research (RSR); Department of Pathology; Institute of Chemical Biology & Drug Discovery (ICBDD); Simons Foundation	This study was supported by Fusion TRO grant (P.I. Dr. Botchkina; 1104347-5-37298), SBU Cancer Center, and SBU Vice President for Research (RSR 1111963-3-63845). According to the Fusion TRO conditions, the Department of Pathology, the Institute of Chemical Biology & Drug Discovery (ICB&DD) and the Simons Foundation have also partially contributed to this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alhamdani MSS, 2012, J PROTEOMICS, V75, P3747, DOI 10.1016/j.jprot.2012.04.042; Amsterdam A, 2013, ACTA HISTOCHEM, V115, P320, DOI 10.1016/j.acthis.2012.09.003; Antoniou E, 2012, METHODS MOL BIOL, V825, P237, DOI 10.1007/978-1-61779-436-0_18; Attard G, 2009, PROSTATE, V69, P1507, DOI 10.1002/pros.20997; Bao SD, 2006, CANCER RES, V66, P7843, DOI 10.1158/0008-5472.CAN-06-1010; Becker L, 2008, THESCIENTIFICWORLDJO, V8, P1168, DOI 10.1100/tsw.2008.148; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Botchkina GI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069884; Botchkina Inna L., 2009, Cancer Genomics & Proteomics, V6, P19; Clarke MF, 2006, CELL, V124, P1111, DOI 10.1016/j.cell.2006.03.011; Cojoc Monica, 2013, Onco Targets Ther, V6, P1347, DOI 10.2147/OTT.S36109; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; Dirks PB, 2006, NATURE, V444, P687, DOI 10.1038/444687a; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Failli A, 2009, TUMORI J, V95, P343; Fredebohm J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048503; Friedrich J, 2009, NAT PROTOC, V4, P309, DOI 10.1038/nprot.2008.226; Gaiser T, 2011, AM J PATHOL, V178, P1478, DOI 10.1016/j.ajpath.2010.12.036; Gillet JP, 2011, P NATL ACAD SCI USA, V108, P18708, DOI 10.1073/pnas.1111840108; Gordon DJ, 2012, NAT REV GENET, V13, P189, DOI 10.1038/nrg3123; Guo CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034219; Haraguchi N, 2008, ANN SURG ONCOL, V15, P2927, DOI 10.1245/s10434-008-0074-0; Hermann PC, 2007, CELL STEM CELL, V1, P313, DOI 10.1016/j.stem.2007.06.002; Hermeking H, 2012, NAT REV CANCER, V12, P613, DOI 10.1038/nrc3318; Horst D, 2009, CANCER INVEST, V27, P844, DOI 10.1080/07357900902744502; Huang EH, 2009, CANCER RES, V69, P3382, DOI 10.1158/0008-5472.CAN-08-4418; Hutchinson L, 2011, NAT REV CLIN ONCOL, V8, P189, DOI [10.1038/nrclinonc.2010.204, 10.1038/nrclinonc.2011.34]; Jiang XH, 2002, ONCOGENE, V21, P6113, DOI 10.1038/sj.onc.1205778; Kirkland SC, 2009, BRIT J CANCER, V101, P320, DOI 10.1038/sj.bjc.6605143; Klarmann GJ, 2009, CLIN EXP METASTAS, V26, P433, DOI 10.1007/s10585-009-9242-2; Kobayashi S, 2012, STEM CELLS, V30, P2631, DOI 10.1002/stem.1257; Luo Jian-Hua, 2003, Expert Rev Mol Med, V5, P1, DOI 10.1017/S1462399403006057; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsuda Y, 2011, CANCER BIOL THER, V11, P512, DOI 10.4161/cbt.11.5.14673; Miki J, 2007, CANCER RES, V67, P3153, DOI 10.1158/0008-5472.CAN-06-4429; Mimeault M, 2010, HISTOL HISTOPATHOL, V25, P1057, DOI 10.14670/HH-25.1057; Muraro MG, 2012, STEM CELL TRANSL MED, V1, P592, DOI 10.5966/sctm.2012-0003; Nielander I, 2008, HAEMATOLOGICA, V93, P949, DOI 10.3324/haematol.12656; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Ohata H, 2012, CANCER RES, V72, P5101, DOI 10.1158/0008-5472.CAN-11-3812; Park JG, 1996, J CELL BIOCHEM, P131; Patrawala L, 2005, CANCER RES, V65, P6207, DOI 10.1158/0008-5472.CAN-05-0592; Peehl DM, 2004, J CELL BIOCHEM, V91, P185, DOI 10.1002/jcb.10691; Perez-Escuredo J, 2011, CELL ONCOL, V34, P23, DOI 10.1007/s13402-010-0002-8; Perinchery G, 2000, J UROLOGY, V163, P1339, DOI 10.1016/S0022-5347(05)67774-9; Puglisi MA, 2009, EUR REV MED PHARMACO, V13, P55; Rao GH, 2013, ACTA PHARMACOL SIN, V34, P793, DOI 10.1038/aps.2013.56; Ray S, 2012, J CANCER, V3, P196, DOI 10.7150/jca.4484; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Rowehl Rebecca A., 2008, Cancer Genomics & Proteomics, V5, P301; Shmelkov SV, 2008, J CLIN INVEST, V118, P2111, DOI 10.1172/JCI34401; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Streppel MM, 2013, ONCOGENE, V2013, P1; Takeda K, 2011, ANTICANCER RES, V31, P263; Taylor BS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003179; Todaro M, 2007, CELL STEM CELL, V1, P389, DOI 10.1016/j.stem.2007.08.001; Tortoreto M, 2009, P NATL ACAD SCI USA, V106; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vermeulen L, 2010, NAT CELL BIOL, V12, P468, DOI 10.1038/ncb2048; Vijayakumar S, 2005, GENE CHROMOSOME CANC, V44, P365, DOI 10.1002/gcc.20250; Vinci M, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-29; Wang CX, 2012, ONCOL REP, V28, P1301, DOI 10.3892/or.2012.1951; Wong BCY, 2003, ONCOGENE, V22, P1189, DOI 10.1038/sj.onc.1206234; Woodward WA, 2007, P NATL ACAD SCI USA, V104, P618, DOI 10.1073/pnas.0606599104; Wu YG, 2010, CLIN DEV IMMUNOL, DOI 10.1155/2010/537531; Yu Q, 1999, GENE DEV, V13, P35, DOI 10.1101/gad.13.1.35; Yu YJ, 2009, TRANSL ONCOL, V2, P321, DOI 10.1593/tlo.09193; Zhang NH, 2012, EXP THER MED, V3, P973, DOI 10.3892/etm.2012.527; Zhang SS, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-85; Zhang WH, 2011, CANCER-AM CANCER SOC, V117, P4092, DOI 10.1002/cncr.26021; Zheng XS, 2011, ONCOL RES, V19, P555, DOI 10.3727/096504012X13340632812631; Zhu LQ, 2009, NATURE, V457, P603, DOI 10.1038/nature07589; Zhu Z, 2010, INT J CANCER, V126, P2067, DOI 10.1002/ijc.24868; Zoller M, 2011, NAT REV CANCER, V11, P254, DOI 10.1038/nrc3023	78	23	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99091	10.1371/journal.pone.0099091	http://dx.doi.org/10.1371/journal.pone.0099091			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921652	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000338701300026
J	Su, WR; Li, ZH; Jia, Y; Zhuo, YH				Su, Wenru; Li, Zuohong; Jia, Yu; Zhuo, Yehong			Rapamycin Is Neuroprotective in a Rat Chronic Hypertensive Glaucoma Model	PLOS ONE			English	Article							GANGLION-CELL DEATH; MOUSE MODEL; TRANSCRIPTION FACTOR; AUTOPHAGY PATHWAY; PROTEIN-KINASE; IN-VITRO; KAPPA-B; ACTIVATION; MICROGLIA; SURVIVAL	Glaucoma is a leading cause of irreversible blindness. Injury of retinal ganglion cells (RGCs) accounts for visual impairment of glaucoma. Here, we report rapamycin protects RGCs from death in experimental glaucoma model and the underlying mechanisms. Our results showed that treatment with rapamycin dramatically promote RGCs survival in a rat chronic ocular hypertension model. This protective action appears to be attributable to inhibition of neurotoxic mediators release and/or direct suppression of RGC apoptosis. In support of this mechanism, in vitro, rapamycin significantly inhibits the production of NO, TNF-alpha in BV2 microglials by modulating NF-kappa B signaling. In experimental animals, treatment with rapamycin also dramatically inhibited the activation of microglials. In primary RGCs, rapamycin was capable of direct suppression the apoptosis of primary RGCs induced by glutamate. Mechanistically, rapamycin-mediated suppression of RGCs apoptosis is by sparing phosphorylation of Akt at a site critical for maintenance of its survival-promoting activity in cell and animal model. These results demonstrate that rapamycin is neuroprotective in experimental glaucoma, possibly via decreasing neurotoxic releasing and suppressing directly apoptosis of RGCs.	[Su, Wenru; Li, Zuohong; Jia, Yu; Zhuo, Yehong] Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhuo, YH (corresponding author), Sun Yat Sen Univ, Zhongshan Ophthalm Ctr, State Key Lab Ophthalmol, Guangzhou 510275, Guangdong, Peoples R China.	zhuoyh@mail.sysu.edu.cn		Su, Wenru/0000-0002-0506-6362	Natural Science Foundation of China [81270992, 81300740]; Natural Science Foundation of Guangdong Province [10251008901000028]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province)	This study was funded by Natural Science Foundation of China (81270992), Natural Science Foundation of Guangdong Province (10251008901000028) and Natural Science Foundation of China (81300740). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Almasieh M, 2012, PROG RETIN EYE RES, V31, P152, DOI 10.1016/j.preteyeres.2011.11.002; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P6639, DOI 10.1167/iovs.10-5431; Bai YJ, 2010, INVEST OPHTH VIS SCI, V51, P4722, DOI 10.1167/iovs.09-5032; Barnes PJ, 1997, NEW ENGL J MED, V336, P1066, DOI 10.1056/NEJM199704103361506; Berg A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059647; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; Bosco A, 2008, INVEST OPHTH VIS SCI, V49, P1437, DOI 10.1167/iovs.07-1337; Bosco A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043602; Caccamo A, 2009, J BIOL CHEM, V284, P27416, DOI 10.1074/jbc.M109.031278; Crews L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009313; Deng SF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077100; DiDonato JA, 1997, NATURE, V388, P548, DOI 10.1038/41493; Dudek H, 1997, SCIENCE, V275, P661, DOI 10.1126/science.275.5300.661; Ehninger D, 2008, NAT MED, V14, P843, DOI 10.1038/nm1788; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fox JH, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-26; Franke TF, 1997, CELL, V88, P435, DOI 10.1016/S0092-8674(00)81883-8; Greenstein RJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002496; Grisham MB, 1996, METHOD ENZYMOL, V268, P237; Han HE, 2013, BIOMOL THER, V21, P21, DOI 10.4062/biomolther.2012.089; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Jung WK, 2010, BRIT J PHARMACOL, V159, P1274, DOI 10.1111/j.1476-5381.2009.00615.x; Kaur C, 2013, J PINEAL RES, V54, P190, DOI 10.1111/jpi.12016; Kim B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034693; Kim HS, 2005, BRAIN RES, V1057, P17, DOI 10.1016/j.brainres.2005.07.005; Kitaoka Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.391; Knoferle J, 2010, P NATL ACAD SCI USA, V107, P6064, DOI 10.1073/pnas.0909794107; Lebrun-Julien F, 2009, MOL CELL NEUROSCI, V40, P410, DOI 10.1016/j.mcn.2008.12.005; Levkovitch-Verbin H, 2007, EXP EYE RES, V85, P250, DOI 10.1016/j.exer.2007.04.011; Malagelada C, 2010, J NEUROSCI, V30, P1166, DOI 10.1523/JNEUROSCI.3944-09.2010; Muller YD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010352; Nakazawa T, 2006, J NEUROSCI, V26, P12633, DOI 10.1523/JNEUROSCI.2801-06.2006; Naskar R, 2002, INVEST OPHTH VIS SCI, V43, P2962; Neufeld AH, 1999, ARCH OPHTHALMOL-CHIC, V117, P1050; Pan TH, 2008, NEUROBIOL DIS, V32, P16, DOI 10.1016/j.nbd.2008.06.003; Park HYL, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.26; Piras A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022514; Prevel N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074450; Quigley HA, 2011, LANCET, V377, P1367, DOI 10.1016/S0140-6736(10)61423-7; Ratai EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010523; Rodriguez-Muela N, 2012, CELL DEATH DIFFER, V19, P162, DOI 10.1038/cdd.2011.88; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Shi ZH, 2008, J BIOL CHEM, V283, P29156, DOI 10.1074/jbc.M802365200; Shi Z, 2007, DEV NEUROBIOL, V67, P884, DOI 10.1002/dneu.20360; Sirohi K, 2013, AUTOPHAGY, V9, P510, DOI 10.4161/auto.23458; Sivakumar V, 2011, J PATHOL, V224, P245, DOI 10.1002/path.2858; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Su WR, 2013, INVEST OPHTH VIS SCI, V54, P783, DOI 10.1167/iovs.12-10323; Yuan LY, 2001, J NEUROSCI RES, V64, P523, DOI 10.1002/jnr.1104; Zhu CS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035125; Zhu JL, 1999, GASTROENTEROLOGY, V117, P1198, DOI 10.1016/S0016-5085(99)70406-3	54	64	69	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99719	10.1371/journal.pone.0099719	http://dx.doi.org/10.1371/journal.pone.0099719			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923557	Green Submitted, Green Published, gold			2022-12-27	WOS:000338701300087
J	Gallant, AL; Euliss, NH; Browning, Z				Gallant, Alisa L.; Euliss, Ned H., Jr.; Browning, Zac			Mapping Large-Area Landscape Suitability for Honey Bees to Assess the Influence of Land-Use Change on Sustainability of National Pollination Services	PLOS ONE			English	Article							THEMATIC ACCURACY; CONSERVATION PROGRAMS; ECOSYSTEM SERVICES; COLONY LOSSES; UNITED-STATES; HABITAT LOSS; COVER DATA; WETLANDS; PLAINS	Pollination is a critical ecosystem service affected by various drivers of land-use change, such as policies and programs aimed at land resources, market values for crop commodities, local land-management decisions, and shifts in climate. The United States is the world's most active market for pollination services by honey bees, and the Northern Great Plains provide the majority of bee colonies used to meet the Nation's annual pollination needs. Legislation requiring increased production of biofuel crops, increasing commodity prices for crops of little nutritional value for bees in the Northern Great Plains, and reductions in government programs aimed at promoting land conservation are converging to alter the regional landscape in ways that challenge beekeepers to provide adequate numbers of hives for national pollination services. We developed a spatially explicit model that identifies sites with the potential to support large apiaries based on local-scale land-cover requirements for honey bees. We produced maps of potential apiary locations for North Dakota, a leading producer of honey, based on land-cover maps representing (1) an annual time series compiled from existing operational products and (2) a realistic scenario of land change. We found that existing land-cover products lack sufficient local accuracy to monitor actual changes in landscape suitability for honey bees, but our model proved informative for evaluating effects on suitability under scenarios of land change. The scenario we implemented was aligned with current drivers of land-use change in the Northern Great Plains and highlighted the importance of conservation lands in landscapes intensively and extensively managed for crops.	[Gallant, Alisa L.] US Geol Survey, Earth Resources Observat & Sci Ctr, Sioux Falls, SD 57198 USA; [Euliss, Ned H., Jr.] US Geol Survey, Northern Prairie Wildlife Res Ctr, Jamestown, ND USA; [Browning, Zac] Brownings Honey Co Inc, Jamestown, ND USA	United States Department of the Interior; United States Geological Survey; United States Department of the Interior; United States Geological Survey	Gallant, AL (corresponding author), US Geol Survey, Earth Resources Observat & Sci Ctr, Sioux Falls, SD 57198 USA.	gallant@usgs.gov	BITOUN, RACHEL Elisabeth/AAC-9538-2021	BITOUN, RACHEL Elisabeth/0000-0002-3614-9910	United States Geological Survey; United States Department of Agriculture, Farm Service Agency; United States Department of Agriculture, Natural Resources Conservation Service, Conservation Effects Assessment Project-Wetlands	United States Geological Survey(United States Geological Survey); United States Department of Agriculture, Farm Service Agency; United States Department of Agriculture, Natural Resources Conservation Service, Conservation Effects Assessment Project-Wetlands	The United States Geological Survey; the United States Department of Agriculture, Farm Service Agency; and the United States Department of Agriculture, Natural Resources Conservation Service, Conservation Effects Assessment Project-Wetlands jointly supported this project. Other than policy review by the United States Geological Survey and a general editorial review the authors solicited from a colleague at the United States Department of Agriculture's Farm Service Agency, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizen MA, 2009, CURR BIOL, V19, P915, DOI 10.1016/j.cub.2009.03.071; Alaux Cedric, 2010, Biol Lett, V6, P562, DOI 10.1098/rsbl.2009.0986; [Anonymous], 1986, CRP ENR RENT PAYM CO; Auch R.F., 2012, REMOTE SENSING LAND, P351; Auch Roger F., 2011, Great Plains Research, V21, P231; Balas CJ, 2012, WETLANDS, V32, P333, DOI 10.1007/s13157-012-0269-9; Batt B.D.J., 1989, P204; Beekman M, 2000, FUNCT ECOL, V14, P490, DOI 10.1046/j.1365-2435.2000.00443.x; Boryan C, 2011, GEOCARTO INT, V26, P341, DOI 10.1080/10106049.2011.562309; Broome FR, 2003, PHOTOGRAMM ENG REM S, V69, P1119, DOI 10.14358/PERS.69.10.1119; Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Calderone NW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037235; Claassen R., 2011, ERR120 USDA EC RES S; Cowan T, 2010, 75700 C RES SERV; Dadant MG, 1946, HIVE HONEYBEE NEW BO, P290; Di Pasquale G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072016; Euliss NH, 2008, WETLANDS, V28, P553, DOI 10.1672/07-154.1; Euliss NH, 2006, SCI TOTAL ENVIRON, V361, P179, DOI 10.1016/j.scitotenv.2005.06.007; Euliss NH, 2011, ECOL APPL, V21, pS128, DOI 10.1890/09-0285.1; Euliss NH, 2010, ENVIRON SCI TECHNOL, V44, P7761, DOI 10.1021/es102761c; Farm Service Agency, 2008, CONS RES PROGR CRP B; Fernandez-Cornejo J, 2012, EC INFORM B, V98, P18; Gallant AL, 2007, COPEIA, P967, DOI 10.1643/0045-8511(2007)7[967:GROHLA]2.0.CO;2; Gallant AL, 2009, J WILDLIFE MANAGE, V73, P796, DOI 10.2193/2007-509; Gleason RA, 2008, 1745 US GEOL SURV; Gutmann MP, 2005, POPULATION LAND USE, P84; Hagler J, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.14301; Hartman MD, 2011, ECOL APPL, V21, P1105, DOI 10.1890/10-0036.1; Haufler J.B., 2005, FISH WILDLIFE BENEFI; Hellerstein D., 2011, Economic Research Report - Economic Research Service, USDA; Johnson, 2013, R43191 C RES SERV; Johnson R, 2007, RL33938 C RES SERV; Manuel J, 2007, ENVIRON HEALTH PERSP, V115, pA92, DOI 10.1289/ehp.115-a92; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SY; Multi-Resolution Land Characteristics Consortium (MRLC), NAT LAND COV DAT FRE; National Agricultural Statistics Service, 2012, HON REP; National Agricultural Statistics Service, QUICK STATS; National Agricultural Statistics Service, 2011, AGR PRIC; National Agricultural Statistics Service, 2009, GEOGR AR SER 51, V1; National Research Council, 2007, STAT POLL N AM; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Pettis JS, 2010, APIDOLOGIE, V41, P256, DOI 10.1051/apido/2010013; Pettorelli N, 2005, TRENDS ECOL EVOL, V20, P503, DOI 10.1016/j.tree.2005.05.011; Roy DP, 2010, REMOTE SENS ENVIRON, V114, P35, DOI 10.1016/j.rse.2009.08.011; Rucker RR, 2012, AM J AGR ECON, V94, P956, DOI 10.1093/ajae/aas031; Schnepf R, 2010, 75700 C RES SERV; Skokstad E, 2007, SCIENCE, V316, P970; Smith A. J., 1964, WATERFOWL TOMORROW, P39; Sohl TL, 2012, AGR ECOSYST ENVIRON, V153, P1, DOI 10.1016/j.agee.2012.02.019; Sohl TL, 2004, PHOTOGRAMM ENG REM S, V70, P439, DOI 10.14358/PERS.70.4.439; Spivak M, 2011, ENVIRON SCI TECHNOL, V45, P34, DOI 10.1021/es101468w; Steffan-Dewenter I, 2003, P ROY SOC B-BIOL SCI, V270, P569, DOI 10.1098/rspb.2002.2292; Stehman SV, 2003, REMOTE SENS ENVIRON, V86, P500, DOI 10.1016/S0034-4257(03)00128-7; Stewart LO., 1935, PUBLIC LAND SURVEYS; Strong LL, 2005, GAP ANAL N DAKOTA FI; Stubbs M, 2009, AGR CONS ISS 111 C; Stubbs M, 2007, C RES SERV C; Sylvester KM, 2013, AGR ECOSYST ENVIRON, V168, P7, DOI 10.1016/j.agee.2013.01.014; Thogmartin WE, 2004, WILDLIFE SOC B, V32, P970, DOI 10.2193/0091-7648(2004)032[0970:CACTRU]2.0.CO;2; Thompson W, 2010, BIOMASS BIOENERG, V34, P883, DOI 10.1016/j.biombioe.2010.01.033; Tuvendal M, 2011, ECOL SOC, V16, DOI 10.5751/ES-04456-160421; U.S. Department of Agriculture, 1980, AGR HDB, V335; U.S. Department of Agriculture Census of Agriculture, 2007, 2007 CENS AG ATL MAP; U.S. Department of Agriculture Farm Service Agency, CONS PROGR; U.S. Department of Agriculture National Agricultural Statistics Service, 2005, 2002 AGR ATL US 1, V2; U.S. Department of Agriculture National Agricultural Statistics Service, 2009, 2006 N DAK CROPL DAT; U.S. Department of Agriculture National Agricultural Statistics Service, 2009, HON REP 2009; U.S. Department of Agriculture National Agricultural Statistics Service, 2013, HON REP 2013; U.S. Department of Agriculture National Agricultural Statistics Service, 2012, HON REP 2012; U.S. Department of Agriculture National Agricultural Statistics Service, 2002, ACR REP; U.S. Department of Agriculture National Agricultural Statistics Service, 2011, HON REP 2011; U.S. Department of Agriculture National Agricultural Statistics Service, STAT B; U.S. Department of Agriculture National Agricultural Statistics Service, 2010, HON REP 2010; U.S. Department of Agriculture National Agricultural Statistics Service, STAT B; U.S. Department of Agriculture National Agricultural Statistics Service, STAT B; U.S. Department of Agriculture National Agricultural Statistics Service, STAT B; U.S. Department of Agriculture National Agricultural Statistics Service, GROPL DAT LAYER MET; U.S. Department of Agriculture National Agricultural Statistics Service, 1992, 1992 CENS AGR AGR AT; U.S. Department of Commerce Bureau of the Census, 1990, 1987 CENS AGR 1, V2; U.S. Department of Commerce Bureau of the Census, 1985, 1982 CENS AGR, V2; U.S. Geological Survey, 2008, IM EV US GEOL SURV T; U.S. Geological Survey, WELD WEB EN LANDS DA; Undersander D, 2004, N CENTRAL REGION EXT; United States Department of Agriculture National Agricultural Statistics Service (NASS), 2012, ACR REP; US Governmental Accountability Office, 2009, GAO09446; USDA, CROPSCAPE CROPL DAT; Vanengelsdorp D, 2012, J APICULT RES, V51, P115, DOI 10.3896/IBRA.1.51.1.14; vanEngelsdorp D, 2010, J APICULT RES, V49, P7, DOI 10.3896/IBRA.1.49.1.03; Watts RD, 2007, SCIENCE, V316, P736, DOI 10.1126/science.1138141; Watts RD, 2005, DISTANCE NEAREST ROA; Wickham JD, 2010, REMOTE SENS ENVIRON, V114, P1286, DOI 10.1016/j.rse.2010.01.018; Wickham JD, 2004, REMOTE SENS ENVIRON, V91, P452, DOI 10.1016/j.rse.2004.04.002; WILEN BO, 1995, VEGETATIO, V118, P153, DOI 10.1007/BF00045197; Wu JJ, 2010, LAND ECON, V86, P1, DOI 10.1007/s10980-009-9444-7; Zhu Z, 2014, REMOTE SENS ENVIRON, V144, P152, DOI 10.1016/j.rse.2014.01.011; Zhu Z, 2012, REMOTE SENS ENVIRON, V122, P75, DOI 10.1016/j.rse.2011.10.030	97	52	52	1	117	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99268	10.1371/journal.pone.0099268	http://dx.doi.org/10.1371/journal.pone.0099268			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919181	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000070
J	Alvim, RD; Mourao, CA; de Oliveira, CM; Krieger, JE; Mill, JG; Pereira, AC				Alvim, Rafael de Oliveira; Mourao-Junior, Carlos Alberto; de Oliveira, Camila Maciel; Krieger, Jose E.; Mill, Jose G.; Pereira, Alexandre C.			Body Mass Index, Waist Circumference, Body Adiposity Index, and Risk for Type 2 Diabetes in Two Populations in Brazil: General and Amerindian	PLOS ONE			English	Article							HEALTH; RATIO; BMI	Objective: The use of the anthropometric indices of adiposity, especially body mass index and waist circumference in the prediction of diabetes mellitus has been widely explored. Recently, a new body composition index, the body adiposity index was proposed. The aim of this study was to compare the effectiveness of body mass index, waist circumference, and body adiposity index in the risk assessment for type 2 diabetes mellitus. Design and methods: A total of 1,572 individuals from the general population of Vitoria City, Brazil and 620 Amerindians from the Aracruz Indian Reserve, Brazil were randomly selected. BMI, waist circumference, and BAI were determined according to a standard protocol. Type 2 diabetes mellitus was diagnosed by the presence of fasting glucose >= 126 mg/dL or by the use of antidiabetic drugs. Results: The area under the curve was similar for all anthropometric indices tested in the Amerindian population, but with very different sensitivities or specificities. In women from the general population, the area under the curve of waist circumference was significantly higher than that of the body adiposity index. Regarding risk assessment for type 2 diabetes mellitus, the body adiposity index was a better risk predictor than body mass index and waist circumference in the Amerindian population and was the index with highest odds ratio for type 2 diabetes mellitus in men from the general population, while in women from the general population waist circumference was the best risk predictor. Conclusion: Body adiposity index was the best risk predictor for type 2 diabetes mellitus in the Amerindian population and men from the general population. Our data suggest that the body adiposity index is a useful tool for the risk assessment of type 2 diabetes mellitus in admixture populations.	[Alvim, Rafael de Oliveira; Krieger, Jose E.; Pereira, Alexandre C.] Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil; [Mourao-Junior, Carlos Alberto; de Oliveira, Camila Maciel] Univ Fed Juiz de Fora, Dept Physiol, Juiz De Fora, MG, Brazil; [Mill, Jose G.] Univ Fed Espirito Santo, Dept Physiol, Vitoria, ES, Brazil	Universidade de Sao Paulo; Universidade Federal de Juiz de Fora; Universidade Federal do Espirito Santo	Pereira, AC (corresponding author), Univ Sao Paulo, Sch Med, Heart Inst InCor, Lab Genet & Mol Cardiol, Sao Paulo, Brazil.	alexandre.pereira@incor.usp.br	Alvim, Rafael/ABA-7823-2021; Pereira, Alexandre/HHN-1038-2022; Mourao-Junior, Carlos Alberto/GLT-3294-2022	Alvim, Rafael/0000-0003-3150-4239; Mourao-Junior, Carlos Alberto/0000-0001-7199-5365; Krieger, Jose E/0000-0001-5464-1792	State of Sao Paulo Research Foundation - FAPESP	State of Sao Paulo Research Foundation - FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work is supported by State of Sao Paulo Research Foundation - FAPESP. However, the funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1988, J CLIN EPIDEMIOL, V41, P105, DOI 10.1016/0895-4356(88)90084-4; Armitage P., 2002, STAT METHODS MED RES; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Field AE, 2001, ARCH INTERN MED, V161, P1581, DOI 10.1001/archinte.161.13.1581; Freedman DZ, 2012, SUPERGRAVITY, P1, DOI 10.1017/CBO9781139026833; Freedman DS, 2013, OBESITY, V21, pE64, DOI 10.1002/oby.20054; Garduno-Diaz SD, 2012, DIABETES-METAB RES, V28, P6, DOI 10.1002/dmrr.1219; KAIRISTO V, 1995, SCAND J CLIN LAB INV, V55, P43, DOI 10.3109/00365519509088450; Li S, 2011, DIABETOLOGIA, V54, P776, DOI 10.1007/s00125-011-2044-5; Melmer A, 2013, OBESITY, V21, P775, DOI 10.1002/oby.20289; Molarius A, 1998, INT J OBESITY, V22, P719, DOI 10.1038/sj.ijo.0800660; Pereira AC, 2006, ATHEROSCLEROSIS, V184, P193, DOI 10.1016/j.atherosclerosis.2005.03.035; Pradhan AD, 2014, CLIN CHEM, V60, P44, DOI 10.1373/clinchem.2013.202549; Schulze MB, 2012, DIABETOLOGIA, V55, P1660, DOI 10.1007/s00125-012-2499-z; Stevens J, 2001, OBES RES, V9, P696, DOI 10.1038/oby.2001.94; Suchanek P, 2012, NEUROENDOCRINOL LETT, V33, P78; Talaei M, 2013, Diabetes Metab, V39, P424, DOI 10.1016/j.diabet.2013.04.001; Tulloch-Reid MK, 2003, DIABETES CARE, V26, P2556, DOI 10.2337/diacare.26.9.2556; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583; Vazquez G, 2007, EPIDEMIOL REV, V29, P115, DOI 10.1093/epirev/mxm008; Wei M, 1997, OBES RES, V5, P16, DOI 10.1002/j.1550-8528.1997.tb00278.x; World Health Organization, 1985, DIAB MELL REP WHO ST	22	29	32	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100223	10.1371/journal.pone.0100223	http://dx.doi.org/10.1371/journal.pone.0100223			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937307	Green Submitted, gold, Green Published			2022-12-27	WOS:000338503400095
J	Datta, K; Sahoo, G; Krishnan, S; Ganguly, M; Datta, SK				Datta, Karabi; Sahoo, Gayetri; Krishnan, Sellappan; Ganguly, Moumita; Datta, Swapan K.			Genetic Stability Developed for beta-Carotene Synthesis in BR29 Rice Line Using Dihaploid Homozygosity	PLOS ONE			English	Article							GOLDEN INDICA RICE; PHYTOENE SYNTHASE; TRANSGENIC RICE; BIOSYNTHETIC-PATHWAY; EMBRYOGENESIS; RESISTANCE; PROVITAMIN; EXPRESSION; ENDOSPERM; CULTIVARS	Obtaining transgenic crop lines with stable levels of carotenoids is highly desirable. We addressed this issue by employing the anther culture technique to develop dihaploid lines containing genes involved in beta-carotene metabolism. First, we used Agrobacterium- mediated transformation to develop primary transgenic plants containing the beta-carotene biosynthetic genes, phytoene synthase (psy) and phytoene desaturase (crtI), which were engineered for expression and accumulation in the endosperm. Transgenic plants were recovered by selecting for the expression of the phosphomannose isomerase (pmi) gene. Dihaploid plants in addition to haploid and tetraploid plant were generated from anther cultures of these primary transgenic plants. In addition to anatomical features of stomata, pollen of different ploidy-plants, molecular analyses confirmed the stable integration of the genes in the anther culture-derived dihaploid plants, and the yellow color of the polished seeds indicated the accumulation of carotenoids in the endosperm. High performance liquid chromatography (HPLC) analysis of the carotenoid extract further confirmed the levels of beta-carotene accumulation in the endosperms of the transgenic dihaploid rice seeds.	[Datta, Karabi; Ganguly, Moumita; Datta, Swapan K.] Univ Calcutta, Dept Bot, Plant Mol Biol & Biotechnol Lab, Kolkata, India; [Sahoo, Gayetri] Cent Rice Res Inst, Cuttack 753006, Odisha, India; [Krishnan, Sellappan] Goa Univ, Dept Bot, Bambolim, Goa, India; [Datta, Swapan K.] Indian Council Agr Res ICAR, Div Crop Sci, New Delhi, India	University of Calcutta; Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute; Goa University; Indian Council of Agricultural Research (ICAR); ICAR - Indian Agricultural Research Institute	Datta, K (corresponding author), Univ Calcutta, Dept Bot, Plant Mol Biol & Biotechnol Lab, Kolkata, India.	krbdatta@yahoo.com			Department of Biotechnology, Govt. of India	Department of Biotechnology, Govt. of India(Department of Biotechnology (DBT) India)	Department of Biotechnology, Govt. of India has provided the financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAISAKH N, 2001, RICE GENET NEWSL, V18, P91; Buckner B., 1993, Maize Genetics Cooperation Newsletter, P65; Burkhardt PK, 1997, PLANT J, V11, P1071, DOI 10.1046/j.1365-313X.1997.11051071.x; Datta K, 2003, PLANT BIOTECHNOL J, V1, P81, DOI 10.1046/j.1467-7652.2003.00015.x; Datta K, 1998, THEOR APPL GENET, V97, P20, DOI 10.1007/s001220050862; Datta K, 2006, CURR SCI INDIA, V91, P935; Datta SK, 2005, CURR SCI INDIA, V89, P1870; DATTA SK, 1990, BIO-TECHNOL, V8, P736, DOI 10.1038/nbt0890-736; DATTA SK, 1987, PLANT SCI, V48, P49, DOI 10.1016/0168-9452(87)90069-0; DATTA SK, 1990, PLANT SCI, V67, P83, DOI 10.1016/0168-9452(90)90053-Q; DAYANANDAN P, 1983, AM J BOT, V70, P1079, DOI 10.2307/2442818; Ducreux LJM, 2002, J EXPT BOT, V56, P81; Fraser PD, 2002, P NATL ACAD SCI USA, V99, P1092, DOI 10.1073/pnas.241374598; HAUPTMANN R, 1997, Patent No. 5618988; MISAWA N, 1993, PLANT J, V4, P833, DOI 10.1046/j.1365-313X.1993.04050833.x; MISAWA N, 1990, J BACTERIOL, V172, P6704, DOI 10.1128/jb.172.12.6704-6712.1990; Scolnik PA, 1996, PLANT MOL BIOL REP, V14, P305, DOI 10.1007/BF02673363; Shewmaker CK, 1999, PLANT J, V20, P401, DOI 10.1046/j.1365-313x.1999.00611.x; Tan J, 2005, INT J FOOD SCI TECH, V40, P563, DOI 10.1111/j.1365-2621.2005.00971.x; Vasconcelos M, 2003, PLANT SCI, V164, P371, DOI 10.1016/S0168-9452(02)00421-1; Ye XD, 2000, SCIENCE, V287, P303, DOI 10.1126/science.287.5451.303	21	9	10	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100212	10.1371/journal.pone.0100212	http://dx.doi.org/10.1371/journal.pone.0100212			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937154	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400094
J	Duan, YQ; Gu, HJ; Chen, R; Zhao, ZP; Zhang, LY; Xing, L; Lai, CC; Zhang, PR; Li, ZW; Zhang, KM; Wang, ZH; Zhang, SG; Wang, XL; Yang, PH				Duan, Yueqiang; Gu, Hongjing; Chen, Rui; Zhao, Zhongpeng; Zhang, Liangyan; Xing, Li; Lai, Chengcai; Zhang, Peirui; Li, Zhiwei; Zhang, Keming; Wang, Zhouhai; Zhang, Shaogeng; Wang, Xiliang; Yang, Penghui			Response of Mice and Ferrets to a Monovalent Influenza A (H7N9) Split Vaccine	PLOS ONE			English	Article							REVERSE GENETICS SYSTEM; HUMAN INFECTION; HEMAGGLUTININ CONTENT; VIRUS; ORIGIN; TECHNOLOGIES; GENERATION; H5N1	In early spring 2013, the emergence of the influenza A (H7N9) virus in humans in Eastern China raised concerns of a new influenza pandemic. Development of a safe and effective H7N9 influenza vaccine is urgently needed. To this end, we first synthesized the hemagglutinin (HA) and neuraminidase (NA) genes of the influenza A (H7N9) virus A/AnHui/1/2013. Using reverse genetics, we rescued a reassortant virus (H7N9/PR8) that contained the HA and NA genes from wild-type H7N9 and six genes encoding internal proteins from the A/Puerto Rico/8/34 (PR8) virus. Next, the pathogenicity of the reassortant virus was evaluated both in vivo and in vitro. We found that the virus was non-pathogenic in mice and was stable after serial passaging in eggs. Furthermore, we found that a monovalent influenza A (H7N9) split vaccine prepared from the virus was immunogenic in mice and ferrets. When given intramuscularly, the vaccine (two doses of at least 15-mu g) completely protected mice from normally lethal wild-type H7N9 virus challenge. In summary, our H7N9 vaccine, developed over a short time, is a potential candidate for further clinical evaluation and human use.	[Duan, Yueqiang; Gu, Hongjing; Chen, Rui; Zhao, Zhongpeng; Zhang, Liangyan; Xing, Li; Lai, Chengcai; Wang, Xiliang; Yang, Penghui] Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China; [Chen, Rui] Ningxia Med Univ, Sch Basic Med Sci, Dept Pathogen Biol & Med Immunol, Yinchuan, Peoples R China; [Zhang, Peirui; Li, Zhiwei; Zhang, Keming; Wang, Zhouhai; Zhang, Shaogeng; Yang, Penghui] 302 Mil Hosp, Beijing, Peoples R China	Beijing Institute of Microbiology & Epidemiology; Ningxia Medical University; Fifth Medical Center of Chinese PLA General Hospital	Wang, XL (corresponding author), Beijing Inst Microbiol & Epidemiol, State Key Lab Pathogen & Biosecur, Beijing, Peoples R China.	xiliangw@126.com; ypenghuiamms@hotmail.com		zhongpeng, zhao/0000-0002-9147-6252	Ministry of Science and Technology of China [2012CB518905, 2013ZX10004003, SS2012AA020905]; Beijing Nova Program of Science and Technology [Z141107001814054]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Beijing Nova Program of Science and Technology	This work was part-funded by the Ministry of Science and Technology of China (grant nos. 2012CB518905, 2013ZX10004003, and SS2012AA020905). P.H.Y. was supported by Beijing Nova Program of Science and Technology (No. Z141107001814054). No author has any financial or commercial conflict of interest. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang FY, 2013, NEW ENGL J MED, V369, P879, DOI 10.1056/NEJMc1308255; Chen Y, 2013, LANCET, V381, P1916, DOI 10.1016/S0140-6736(13)60903-4; De Groot AS, 2013, HUM VACC IMMUNOTHER, V9, P950, DOI 10.4161/hv.24939; Dormitzer PR, 2012, HUM VACC IMMUNOTHER, V8, P45, DOI 10.4161/hv.8.1.18859; Fries LF, 2013, NEW ENGLAND J MED; Gao HN, 2013, NEW ENGL J MED, V368, P2277, DOI 10.1056/NEJMoa1305584; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Greenberg ME, 2009, NEW ENGL J MED, V361, P2405, DOI 10.1056/NEJMoa0907413; Harvey R, 2008, VACCINE, V26, P6550, DOI 10.1016/j.vaccine.2008.09.050; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Jing XH, 2012, VACCINE, V30, P4144, DOI 10.1016/j.vaccine.2012.04.073; Krammer F, 2013, J VIROL; Li Q, 2013, NEW ENGLAND J MED; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Neumann G, 2005, P NATL ACAD SCI USA, V102, P16825, DOI 10.1073/pnas.0505587102; Osterholm MT, 2013, JAMA-J AM MED ASSOC, V309, P2557, DOI 10.1001/jama.2013.6589; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; Shaw A, 2012, VACCINE, V30, P4927, DOI 10.1016/j.vaccine.2012.04.095; Smith GE, 2013, VACCINE, V31, P4305, DOI 10.1016/j.vaccine.2013.07.043; Subbarao K, 2003, VIROLOGY, V305, P192, DOI 10.1006/viro.2002.1742; Wanitchang A, 2010, VIRUS RES, V147, P145, DOI 10.1016/j.virusres.2009.10.010; Webby RJ, 2004, LANCET, V363, P1099, DOI 10.1016/S0140-6736(04)15892-3; Xu L, 2013, J INFECT DIS; Yang PH, 2011, VACCINE, V29, P698, DOI 10.1016/j.vaccine.2010.11.026; Zhou JF, 2013, NATURE, V499, P500, DOI 10.1038/nature12379; Zhu H, 2013, SCIENCE, V341, P183, DOI 10.1126/science.1239844	26	15	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99322	10.1371/journal.pone.0099322	http://dx.doi.org/10.1371/journal.pone.0099322			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937303	Green Submitted, gold, Green Published			2022-12-27	WOS:000338503400015
J	Ekers, D; Webster, L; Van Straten, A; Cuijpers, P; Richards, D; Gilbody, S				Ekers, David; Webster, Lisa; Van Straten, Annemieke; Cuijpers, Pim; Richards, David; Gilbody, Simon			Behavioural Activation for Depression; An Update of Meta-Analysis of Effectiveness and Sub Group Analysis	PLOS ONE			English	Article							SELF-CONTROL THERAPY; COGNITIVE THERAPY; ANTIDEPRESSANT MEDICATION; COMPARATIVE EFFICACY; RANDOMIZED-TRIAL; PROGRAM; DISORDER; ADULTS; INTERVENTION; RELAPSE	Background: Depression is a common, disabling condition for which psychological treatments are recommended. Behavioural activation has attracted increased interest in recent years. It has been over 5 years since our meta-analyses summarised the evidence supporting and this systematic review updates those findings and examines moderators of treatment effect. Method: Randomised trials of behavioural activation for depression versus controls or anti-depressant medication were identified using electronic database searches, previous reviews and reference lists. Data on symptom level and study level moderators were extracted and analysed using meta-analysis, sub-group analysis and meta-regression respectively. Results: Twenty six randomised controlled trials including 1524 subjects were included in this meta-analysis. A random effects meta-analysis of symptom level post treatment showed behavioural activation to be superior to controls (SMD - 0.74 CI -0.91 to -0.56, k = 25, N = 1088) and medication (SMD -0.42 CI -0.83 to-0.00, k = 4, N = 283). Study quality was low in the majority of studies and follow- up time periods short. There was no indication of publication bias and subgroup analysis showed limited association between moderators and effect size. Conclusions: The results in this meta-analysis support and strengthen the evidence base indicating Behavioural Activation is an effective treatment for depression. Further high quality research with longer term follow-up is needed to strengthen the evidence base.	[Ekers, David] Univ Durham, Dept Med Pharm & Hlth, Tees Esk & Wear Valleys NHS Fdn Trust, Stockton On Tees, England; [Webster, Lisa] Univ Durham, Dept Med Pharm & Hlth, Stockton On Tees, England; [Van Straten, Annemieke; Cuijpers, Pim] Vrije Univ Amsterdam, Dept Clin Psychol, Amsterdam, Netherlands; [Richards, David] Univ Exeter, Sch Med, Exeter, Devon, England; [Gilbody, Simon] Univ York, Hull York Med Sch, York YO10 5DD, N Yorkshire, England; [Gilbody, Simon] Univ York, Dept Hlth Sci, York YO10 5DD, N Yorkshire, England	Durham University; Durham University; Vrije Universiteit Amsterdam; University of Exeter; University of Hull; University of York - UK; University of York - UK	Ekers, D (corresponding author), Univ Durham, Dept Med Pharm & Hlth, Tees Esk & Wear Valleys NHS Fdn Trust, Stockton On Tees, England.	David.Ekers@durham.ac.uk	Cuijpers, Pim/G-1703-2013; Gilbody, Simon/AAY-3720-2021; Webster, Lisa Amalia Denza/ABD-1308-2020; van Straten, Annemieke/P-8495-2019; Richards, David/B-4807-2009	Gilbody, Simon/0000-0002-8236-6983; Webster, Lisa Amalia Denza/0000-0002-2269-4942; van Straten, Annemieke/0000-0001-6875-2215; Richards, David/0000-0002-8821-5027; Ekers, David/0000-0003-3898-3340; Cuijpers, Pim/0000-0001-5497-2743	Mental Health Research Centre (Durham University); Mental Health Research Centre (Tees, Esk & Wear Valleys Foundation Trust); National Institute for Health Research [NF-SI-0611-10203] Funding Source: researchfish	Mental Health Research Centre (Durham University); Mental Health Research Centre (Tees, Esk & Wear Valleys Foundation Trust); National Institute for Health Research(National Institute for Health Research (NIHR))	Support for this research was provided by the Mental Health Research Centre (Durham University & Tees, Esk & Wear Valleys Foundation Trust) (https://www.dur.ac.uk/school.health/mhrc/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armento MEA, 2012, PSYCHOL RELIG SPIRIT, V4, P206, DOI 10.1037/a0026405; Barlow JP, 1986, DISS ABSTR INT, V46, p4389B; BARRERA M, 1979, J CONSULT CLIN PSYCH, V47, P413, DOI 10.1037/0022-006X.47.2.413; Barrera M, 1977, DISS ABSTR INT, V38, p2842B; Barth J, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001454; Besyner JK, 1978, DISS ABSTR INT, V39, p4568B; Borenstein M, 2009, INTRO META ANAL; Brugha T, 2009, ADULT PSYCHIAT MORBI; Carlbring P, 2013, J AFFECT DISORDERS, V148, P331, DOI 10.1016/j.jad.2012.12.020; Carpenter KM, 2008, AM J DRUG ALCOHOL AB, V34, P642, DOI 10.1080/00952990802308171; CATANESE RA, 1979, COGNITIVE THER RES, V3, P299, DOI 10.1007/BF01185970; Cole MA, 1983, DISS ABSTR INT, V45, p1009B; COMASDIAZ L, 1981, J CONSULT CLIN PSYCH, V49, P627, DOI 10.1037/0022-006X.49.5.627; Cuijpers P, 2007, CLIN PSYCHOL REV, V27, P318, DOI 10.1016/j.cpr.2006.11.001; Cuijpers P, 2011, NORD J PSYCHIAT, V65, P354, DOI 10.3109/08039488.2011.596570; Cuijpers P, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-36; Cullen J, 2006, BEHAV ANAL TODAY, V7, P151, DOI DOI 10.1037/H0100150; Cullen JM, 2002, DISS ABSTR INT, V64, p412B; Daughters SB, 2008, J CLIN PSYCHIAT, V69, P122, DOI 10.4088/JCP.v69n0116; Deeks J, 2009, COCHRANE HDB SYSTEMA; DEJONG R, 1986, COGNITIVE THER RES, V10, P645, DOI 10.1007/BF01173752; Dimidjian S, 2006, J CONSULT CLIN PSYCH, V74, P658, DOI 10.1037/0022-006X.74.4.658; Dobson KS, 2008, J CONSULT CLIN PSYCH, V76, P468, DOI 10.1037/0022-006X.76.3.468; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ekers D, 2008, PSYCHOL MED, V38, P611, DOI 10.1017/S0033291707001614; Ekers DM, 2013, J PSYCHIATR MENT HLT, V20, P186, DOI 10.1111/j.1365-2850.2012.01906.x; Ekers D, 2011, BRIT J PSYCHIAT, V198, P66, DOI 10.1192/bjp.bp.110.079111; EmanuelsZuurveen L, 1996, BRIT J PSYCHIAT, V169, P181, DOI 10.1192/bjp.169.2.181; FUCHS CZ, 1977, J CONSULT CLIN PSYCH, V45, P206, DOI 10.1037/0022-006X.45.2.206; Furukawa TA, 2006, J CLIN EPIDEMIOL, V59, P7, DOI 10.1016/j.jclinepi.2005.06.006; Gallagher D, 1981, BEHAV GROUP THERAPY, P187; GALLAGHER DE, 1982, PSYCHOTHER-THEOR RES, V19, P482, DOI 10.1037/h0088461; Gallagher-Thompson D., 2000, J CLIN GEROPSYCHOLOG, V6, P91, DOI [DOI 10.1023/A:1009584427018, 10.1023/A:1009584427018]; GASTON L, 1988, J CONSULT CLIN PSYCH, V56, P483, DOI 10.1037/0022-006X.56.4.483; Gawrysiak M, 2009, J COUNS PSYCHOL, V56, P468, DOI 10.1037/a0016383; Gortner ET, 1998, J CONSULT CLIN PSYCH, V66, P377, DOI 10.1037/0022-006X.66.2.377; Graf MG, 1977, DISS ABSTR INT, V38, p1400B; Gros DF, 2011, PRIM CARE COMPANION, V13; HAMMEN C L, 1975, Journal of Abnormal Psychology, V84, P718; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins JPT., 2008, COCHRANE HDB SYSTEMA, V1 edn; Hopko DR, 2011, J CONSULT CLIN PSYCH, V79, P834, DOI 10.1037/a0025450; Hopko DR, 2003, CLIN PSYCHOL REV, V23, P699, DOI 10.1016/S0272-7358(03)00070-9; Jacobson NS, 1996, J CONSULT CLIN PSYCH, V64, P295, DOI 10.1037/0022-006X.64.2.295; Kanter J, 2013, RANDOMIZED HYB UNPUB; Kanter JW, 2010, BEHAV MODIF, V34, P120, DOI 10.1177/0145445509359682; KORNBLITH SJ, 1983, COGNITIVE THER RES, V7, P499, DOI 10.1007/BF01172888; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; LIPSEY MW, 1993, AM PSYCHOL, V48, P1181, DOI 10.1037/0003-066X.48.12.1181; LOVETT S, 1988, BEHAV THER, V19, P321, DOI 10.1016/S0005-7894(88)80005-4; Lynch TR, 2007, INT J GERIATR PSYCH, V22, P131, DOI 10.1002/gps.1703; Maldonado Lopez A, 1982, REV PSICOLOGIA GEN A, V37, P31; Maldonado Lopez A, 1984, REV PSICOLOGIA GEN A, V39, P517; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Mazzucchelli T, 2009, CLIN PSYCHOL-SCI PR, V16, P383, DOI 10.1111/j.1468-2850.2009.01178.x; McKendree-Smith N, 1998, DISS ABSTR INT, V60, p5783B; MCLEAN PD, 1979, J CONSULT CLIN PSYCH, V47, P818, DOI 10.1037/0022-006X.47.5.818; MCNAMARA K, 1986, J COUNS PSYCHOL, V33, P23, DOI 10.1037/0022-0167.33.1.23; Mitchell PH, 2009, STROKE, V40, P3073, DOI 10.1161/STROKEAHA.109.549808; Moradveisi L, 2013, BRIT J PSYCHIAT, V202, P204, DOI 10.1192/bjp.bp.112.113696; National Institute of Clinical Excellence, 2009, MAN DEPR PRIM SEC CA; O'Mahen HA, 2013, J AFFECT DISORDERS, V150, P814, DOI 10.1016/j.jad.2013.03.005; OMahen HA, 2013, PSYCHOL MED, V23, P1, DOI DOI 10.1017/S0033291713002092]; Pace F, 1977, DISS ABSTR INT, V39, p992B; PADFIELD M, 1976, J COUNS PSYCHOL, V23, P209, DOI 10.1037/0022-0167.23.3.209; REHM LP, 1987, J CONSULT CLIN PSYCH, V55, P60, DOI 10.1037/0022-006X.55.1.60; REHM LP, 1981, BEHAV MODIF, V5, P459, DOI 10.1177/014544558154002; REHM LP, 1979, BEHAV THER, V10, P429, DOI 10.1016/S0005-7894(79)80048-9; Reynolds EK, 2011, J COUNS PSYCHOL, V58, P555, DOI 10.1037/a0024634; Rhodes S, 2014, RANDOMISED CONTROLLE; Rokke PD, 1999, PSYCHOL AGING, V14, P155, DOI 10.1037/0882-7974.14.1.155; Rothstein H, 2005, COMPREHENSIVE META A, P104; SCOGIN F, 1989, J CONSULT CLIN PSYCH, V57, P403, DOI 10.1037/0022-006X.57.3.403; SHAW BF, 1977, J CONSULT CLIN PSYCH, V45, P543, DOI 10.1037/0022-006X.45.4.543; Shinohara K, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008696.pub2; Skinner DA, 1984, DISS ABSTR INT, V45, p1031B; Snarski M, 2011, BEHAV THER, V42, P100, DOI 10.1016/j.beth.2010.05.001; Sutton A, 1998, HLTH TECHNOLOGY ASSE, V2, P19; Taylor F. G., 1977, COGNITIVE THERAPY RE, V1, P59, DOI DOI 10.1007/BF01173505; Teri L, 1997, J GERONTOL B-PSYCHOL, V52, pP159, DOI 10.1093/geronb/52B.4.P159; THOMPSON LW, 1987, J CONSULT CLIN PSYCH, V55, P385, DOI 10.1037/0022-006X.55.3.385; THOMPSON LW, 1984, ADV BEHAV RES THER, V6, P127, DOI 10.1016/0146-6402(84)90007-9; TURNER RW, 1979, J CLIN PSYCHOL, V35, P166, DOI 10.1002/1097-4679(197901)35:1<166::AID-JCLP2270350127>3.0.CO;2-1; VANDENHOUT JHC, 1995, ACTA PSYCHIAT SCAND, V92, P25; Wagner AW, 2007, COGN BEHAV PRACT, V14, P341, DOI 10.1016/j.cbpra.2006.05.002; Watkins ER, 2009, J ABNORM PSYCHOL, V118, P55, DOI 10.1037/a0013642; Weinstock LM, 2011, BEHAV MODIF, V35, P403, DOI 10.1177/0145445511405646; WILSON PH, 1983, COGNITIVE THER RES, V7, P111, DOI 10.1007/BF01190064; WILSON PH, 1982, BEHAV RES THER, V20, P173, DOI 10.1016/0005-7967(82)90116-4; ZEISS AM, 1979, J CONSULT CLIN PSYCH, V47, P427, DOI 10.1037/0022-006X.47.3.427	90	285	287	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100100	10.1371/journal.pone.0100100	http://dx.doi.org/10.1371/journal.pone.0100100			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK5YM	24936656	Green Accepted, gold, Green Submitted, Green Published			2022-12-27	WOS:000338503400074
J	Jin, J; Hu, C; Yu, MX; Chen, FF; Ye, L; Yin, XF; Zhuang, ZP; Tong, HY				Jin, Jie; Hu, Chao; Yu, Mengxia; Chen, Feifei; Ye, Li; Yin, Xiufeng; Zhuang, Zhengping; Tong, Hongyan			Prognostic Value of Isocitrate Dehydrogenase Mutations in Myelodysplastic Syndromes: A Retrospective Cohort Study and Meta-Analysis	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; WORLD-HEALTH-ORGANIZATION; SCORING SYSTEM; IDH2 MUTATIONS; CLASSIFICATION; GENES; TET2; 2-HYDROXYGLUTARATE; PATHOGENESIS; CANCER	Background: Recent genomic sequencing efforts have identified a number of recurrent mutations in myelodysplastic syndromes (MDS) that may contribute to disease progression and overall survival, including mutations in isocitrate dehydrogenases 1 and 2 (IDH1 and IDH2). Methods: Pretreatment bone marrow (BM) samples were acquired from mononuclear cells in 146 adult patients with de novo MDS from January 2006 to June 2013. Polymerase chain reaction (PCR) and direct sequencing were performed on exon 4 of IDH1/2 genes and mutation status was correlated with overall survival (OS) and leukemia-free survival (LFS). We then performed a meta-analysis combining previously published and current studies to explore the effect of IDH mutations on OS and LFS in MDS. Results: In our study, somatic mutations of either IDH gene were discovered in 11 MDS patients (7.53%) and were significantly correlated with poorer OS (P = 0.007). IDH mutations were specifically associated with a poorer OS in the intermediate-1 risk group by the International Prognostic Scoring System (IPSS) (P = 0.039). In addition, we discovered decitabine achieved a better therapeutic effect compared to other treatments in IDH mutation-positive patients (P = 0.023). We identified six previous studies of IDH mutations in MDS. A meta-analysis of these studies included 111 MDS patients IDH mutations and 1671 MDS patients with wild-type IDH1/2. The hazard ratios (HRs) of OS and LFS for patients with IDH mutations were 1.62 (95% CI, 1.27-2.09) and 2.21 (95% CI, 1.48-3.30), respectively. Conclusion: The results from our study and the meta-analysis provide firm evidence that IDH mutations are significantly associated with poorer clinical outcomes in MDS. Identification of IDH mutations may be pivotal for better risk stratification in MDS patients and improving IPSS score. Additionally, hypomethylating agents may be an effective treatment option for MDS patients with IDH mutations.	[Jin, Jie; Hu, Chao; Yu, Mengxia; Chen, Feifei; Ye, Li; Yin, Xiufeng; Tong, Hongyan] Zhejiang Univ, Dept Hematol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China; [Jin, Jie; Hu, Chao; Yu, Mengxia; Chen, Feifei; Ye, Li; Yin, Xiufeng; Tong, Hongyan] Zhejiang Univ, Sch Med, Inst Hematol, Hangzhou 310003, Zhejiang, Peoples R China; [Zhuang, Zhengping] NINDS, Surg Neurol Branch, NIH, Bethesda, MD 20892 USA	Zhejiang University; Zhejiang University; National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Tong, HY (corresponding author), Zhejiang Univ, Dept Hematol, Affiliated Hosp 1, Hangzhou 310003, Zhejiang, Peoples R China.	zjuhongyantong@163.com			Zhejiang Province Fund for Distinguished Young Scholars [LR12H08001]; Foundation of Key Innovation Team of Zhejiang Province [2011R50015]; National Public Health Grand Research Foundation [201202017]; Science Technology Department of Zhejiang Province [2013c03043-2]; National Natural Science Foundation of China [30870914, 81270582]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [ZIANS003052] Funding Source: NIH RePORTER	Zhejiang Province Fund for Distinguished Young Scholars; Foundation of Key Innovation Team of Zhejiang Province; National Public Health Grand Research Foundation; Science Technology Department of Zhejiang Province; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by grants from Zhejiang Province Fund for Distinguished Young Scholars (LR12H08001), the Foundation of Key Innovation Team of Zhejiang Province (2011R50015), National Public Health Grand Research Foundation (201202017), major program of Science Technology Department of Zhejiang Province fund (2013c03043-2) and the National Natural Science Foundation of China (No. 30870914, No. 81270582). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas S, 2010, BLOOD, V116, P2122, DOI 10.1182/blood-2009-11-250878; Abdel-Wahab O, 2012, CANCER CELL, V22, P180, DOI 10.1016/j.ccr.2012.06.032; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bejar R, 2011, NEW ENGL J MED, V364, P2496, DOI 10.1056/NEJMoa1013343; Bejar R, 2011, J CLIN ONCOL, V29, P504, DOI 10.1200/JCO.2010.31.1175; Bennett JM, 2000, INT J HEMATOL, V72, P131; BENNETT JM, 1982, BRIT J HAEMATOL, V51, P189, DOI 10.1111/j.1365-2141.1982.tb08475.x; Caramazza D, 2010, LEUKEMIA, V24, P2120, DOI 10.1038/leu.2010.213; Chou WC, 2011, LEUKEMIA, V25, P246, DOI 10.1038/leu.2010.267; Chou WC, 2010, BLOOD, V115, P2749, DOI 10.1182/blood-2009-11-253070; Chung YR, 2012, INT J HEMATOL, V96, P413, DOI 10.1007/s12185-012-1181-z; Corey SJ, 2007, NAT REV CANCER, V7, P118, DOI 10.1038/nrc2047; Dang L, 2009, NATURE, V462, P739, DOI 10.1038/nature08617; DiNardo CD, 2013, BLOOD, V121, P4917, DOI 10.1182/blood-2013-03-493197; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Fathi AT, 2012, BLOOD, V120, P4649, DOI 10.1182/blood-2012-06-438267; Figueroa ME, 2010, CANCER CELL, V18, P553, DOI 10.1016/j.ccr.2010.11.015; Garcia-Manero G, 2008, LEUKEMIA, V22, P538, DOI 10.1038/sj.leu.2405070; Greenberg P, 1997, BLOOD, V89, P2079, DOI 10.1182/blood.V89.6.2079; Greenberg PL, 2012, BLOOD, V120, P2454, DOI 10.1182/blood-2012-03-420489; Grimes DA, 2002, LANCET, V359, P341, DOI 10.1016/S0140-6736(02)07500-1; Head DR, 2011, BONE MARROW RES, DOI 10.1155/2011/950934; Jin GL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016812; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Khan H, 2013, SEMIN HEMATOL, V50, P16, DOI 10.1053/j.seminhematol.2013.01.001; Kosmider O, 2010, LEUKEMIA, V24, P1094, DOI 10.1038/leu.2010.52; Krell D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019868; Lin CC, 2013, AM J HEMATOL; Lin J, 2012, ANN HEMATOL, V91, P519, DOI 10.1007/s00277-011-1352-7; Lin TL, 2013, HAEMATOLOGICA; Malcovati L, 2007, J CLIN ONCOL, V25, P3503, DOI 10.1200/JCO.2006.08.5696; Muto T, 2013, J EXP MED, V210, P2627, DOI 10.1084/jem.20131144; Nimer SD, 2008, BLOOD, V111, P4841, DOI 10.1182/blood-2007-08-078139; Pardanani A, 2010, LEUKEMIA, V24, P1146, DOI 10.1038/leu.2010.77; Patnaik MM, 2012, LEUKEMIA, V26, P101, DOI 10.1038/leu.2011.298; Reitman ZJ, 2010, JNCI-J NATL CANCER I, V102, P932, DOI 10.1093/jnci/djq187; Rocquain J, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-401; Shih AH, 2011, SEMIN ONCOL, V38, P613, DOI 10.1053/j.seminoncol.2011.04.013; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Steensma DP, 2006, LEUKEMIA RES, V30, P1227, DOI 10.1016/j.leukres.2005.12.001; Tefferi A, 2012, LEUKEMIA, V26, P475, DOI 10.1038/leu.2011.253; Thol F, 2010, HAEMATOL-HEMATOL J, V95, P1668, DOI 10.3324/haematol.2010.025494; Tierney JF, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-16; Tong HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067537; Tong HY, 2012, LEUKEMIA LYMPHOMA, V53, P2412, DOI 10.3109/10428194.2012.696637; Tothova Z, 2013, CLIN CANCER RES, V19, P1637, DOI 10.1158/1078-0432.CCR-12-1251; Vardiman JW, 2002, BLOOD, V100, P2292, DOI 10.1182/blood-2002-04-1199; Ward PS, 2010, CANCER CELL, V17, P225, DOI 10.1016/j.ccr.2010.01.020; Yoshida K, 2011, LEUKEMIA, V25, P184, DOI 10.1038/leu.2010.241; Zhao SM, 2009, SCIENCE, V324, P261, DOI 10.1126/science.1170944	50	73	76	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100206	10.1371/journal.pone.0100206	http://dx.doi.org/10.1371/journal.pone.0100206			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936872	gold, Green Submitted, Green Published			2022-12-27	WOS:000338503400092
J	Shi, HJ; Shi, L				Shi, Haijia; Shi, Lei			Identifying Emerging Motif in Growing Networks	PLOS ONE			English	Article							EVOLUTIONARY CONSERVATION; CONVERGENT EVOLUTION; BUILDING-BLOCKS; ROBUST; CONTRIBUTE; STABILITY; TOPOLOGY; MODULES	As function units, network motifs have been detected to reveal evolutionary mechanisms of complex systems, such as biological networks, food webs, engineering networks and social networks. However, emergence of motifs in growing networks may be problematic due to large fluctuation of subgraph frequency in the initial stage. This paper contributes to present a method which can identify the emergence of motif in growing networks. Based on the Erdos-Renyi(E-R) random null model, the variation rate of expected frequency of subgraph at adjacent time points was used to define the suitable detection range for motif identification. Upper and lower boundaries of the range were obtained in analytical form according to a chosen risk level. Then, the statistical metric Z-score was extended to a new one, Z(continuous), which effectively reveals the statistical significance of subgraph in a continuous period of time. In this paper, a novel research framework of motif identification was proposed, defining critical boundaries for the evolutionary process of networks and a significance metric of time scale. Finally, an industrial ecosystem at Kalundborg was adopted as a case study to illustrate the effectiveness and convenience of the proposed methodology.	[Shi, Haijia; Shi, Lei] Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China	Tsinghua University	Shi, L (corresponding author), Tsinghua Univ, Sch Environm, State Key Joint Lab Environm Simulat & Pollut Con, Beijing 100084, Peoples R China.	slone@tsinghua.edu.cn			National Natural Science Foundation of China [41071352]; Tsinghua University Initiative Scientific Research Program [20121088096]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tsinghua University Initiative Scientific Research Program	The research was conducted with financial support from the National Natural Science Foundation of China (No. 41071352) and the Tsinghua University Initiative Scientific Research Program (No. 20121088096). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2008, THEOR ECOL-NETH, V1, P55, DOI 10.1007/s12080-007-0007-8; Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Artzy-Randrup Yael, 2004, Science, V305, P1107; Babu MM, 2004, CURR OPIN STRUC BIOL, V14, P283, DOI 10.1016/j.sbi.2004.05.004; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Bajardi P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019869; Baskerville K, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.051903; Bellafiore S, 2005, NATURE, V433, P892, DOI 10.1038/nature03286; Bender E. A., 1974, Discrete Mathematics, V10, P217, DOI 10.1016/0012-365X(74)90118-6; BENDER EA, 1978, J COMB THEORY A, V24, P296, DOI 10.1016/0097-3165(78)90059-6; Camacho J, 2007, J THEOR BIOL, V246, P260, DOI 10.1016/j.jtbi.2006.12.036; Camas FM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003657; Chung F., 2006, CBMS REGIONAL C SERI; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Conant GC, 2003, NAT GENET, V34, P264, DOI 10.1038/ng1181; Doyle J, 2005, PLOS BIOL, V3, P1868, DOI 10.1371/journal.pbio.0030392; Elena A, 2008, CISIS 2008: THE SECOND INTERNATIONAL CONFERENCE ON COMPLEX, INTELLIGENT AND SOFTWARE INTENSIVE SYSTEMS, PROCEEDINGS, P682, DOI 10.1109/CISIS.2008.31; Fretter C, 2012, PHYS REV E, V85; Hales D, 2008, NETW HETEROG MEDIA, V3, P239, DOI 10.3934/nhm.2008.3.239; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Hua H, 2013, ACTA PHYS SINICA, V62, P9; Huang CY, 2007, ARTIF INTELL MED, V41, P117, DOI 10.1016/j.artmed.2007.07.006; Itzkovitz S, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.026127; Itzkovitz S, 2005, PHYS REV E, P71; Jin YC, 2011, BIOSYSTEMS, V103, P38, DOI 10.1016/j.biosystems.2010.09.009; Juszczyszyn K, 2008, LECT NOTES ARTIF INT, V5178, P97, DOI 10.1007/978-3-540-85565-1_13; Kaluza P, 2007, EPL-EUROPHYS LETT, V79, DOI 10.1209/0295-5075/79/48001; Kaluza P, 2008, CHAOS, V18, DOI 10.1063/1.2945228; Kashtan N, 2005, P NATL ACAD SCI USA, V102, P13773, DOI 10.1073/pnas.0503610102; Kim H, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023012; Kinjo AR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031437; Knabe JF, 2008, BIOSYSTEMS, V94, P68, DOI 10.1016/j.biosystems.2008.05.012; Lee WP, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-89; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Luo JX, 2011, COMPLEXITY, V16, P53, DOI 10.1002/cplx.20368; Ma'ayan A, 2008, P NATL ACAD SCI USA, V105, P19235, DOI 10.1073/pnas.0805344105; Maslov S, 2002, SCIENCE, V296, P910, DOI 10.1126/science.1065103; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Milo R., 2003, UNIFORM GENERATION R; Mirzasoleiman B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020512; Mones E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033799; Newman MEJ, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.026118; Newman MEJ, 2004, PHYS REV E, V70, DOI [10.1103/PhysRevE.70.056131, 10.1103/PhysRevE.69.026113]; Ohnishi T, 2010, J ECON INTERACT COOR, V5, P171, DOI 10.1007/s11403-010-0066-6; Poyatos JF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-11-r93; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Rao AR., 1996, INDIAN J STAT, V58, P225; Reichardt J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021282; Reigl M, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-25; Ribeiro PMP, 2011, EFFICIENT SCALABLE A, P206; Rice JJ, 2005, P NATL ACAD SCI USA, V102, P3173, DOI 10.1073/pnas.0500130102; Squartini T, 2012, TRIADIC MOTIFS DYADI, P24; Stouffer DB, 2007, P ROY SOC B-BIOL SCI, V274, P1931, DOI 10.1098/rspb.2007.0571; Stouffer DB, 2010, ECOL LETT, V13, P154, DOI 10.1111/j.1461-0248.2009.01407.x; Valverde S, 2005, PHYS REV E, V72, DOI 10.1103/PhysRevE.72.026107; Ward JJ, 2007, PLOS COMPUT BIOL, V3, P1993, DOI 10.1371/journal.pcbi.0030198; Waters JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040337; Wernicke S, 2006, IEEE ACM T COMPUT BI, V3, P347, DOI 10.1109/TCBB.2006.51; Wong E, 2012, BRIEF BIOINFORM, V13, P202, DOI 10.1093/bib/bbr033; Wuchty S, 2003, NAT GENET, V35, P176, DOI 10.1038/ng1242; Yu HY, 2003, TRENDS GENET, V19, P422, DOI 10.1016/S0168-9525(03)00175-6	61	7	7	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99634	10.1371/journal.pone.0099634	http://dx.doi.org/10.1371/journal.pone.0099634			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936978	gold, Green Published, Green Submitted			2022-12-27	WOS:000338503400029
J	Yang, HB; Wang, QL; Bai, CJ; Li, XX; Liu, GD				Yang, Hubiao; Wang, Qinglong; Bai, Changjun; Li, Xiaoxia; Liu, Guodao			Carex diaoluoshanica (Carex sect. Lageniformes, Cyperaceae), a New Species from Hainan, China	PLOS ONE			English	Article							ZHEJIANG; RHOMBOIDALES	Carex diaoluoshanica, a new species of Carex sect. Lageniformes from Hainan, China, is described and illustrated. The new species is similar to C. breviscapa but differs in having wider leaves with the leaf base gradually narrowed, 5-10 cm long and petiolelike, culms subfiliform, with only two spikes, the lateral female spikes from near the culm base.	[Yang, Hubiao; Wang, Qinglong; Bai, Changjun; Liu, Guodao] Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Danzhou, Hainan, Peoples R China; [Li, Xiaoxia] Chinese Acad Trop Agr Sci, Environm & Plant Protect Inst, Haikou, Hainan, Peoples R China	Chinese Academy of Tropical Agricultural Sciences; Chinese Academy of Tropical Agricultural Sciences	Yang, HB (corresponding author), Chinese Acad Trop Agr Sci, Trop Crops Genet Resources Inst, Danzhou, Hainan, Peoples R China.	yanghubiao@163.com; liuguodao2008@163.com			Tropical Crops Genetic Resources Institute [1630032014030]; earmarked fund for China Agriculture Research System [CARS-35-03]; Genetic Resource Conservation of Ministry of Agriculture [12RZZY-09]	Tropical Crops Genetic Resources Institute; earmarked fund for China Agriculture Research System; Genetic Resource Conservation of Ministry of Agriculture	This research is supported by the basic scientific research fund of Tropical Crops Genetic Resources Institute (1630032014030); the earmarked fund for China Agriculture Research System (CARS-35-03) and Genetic Resource Conservation of Ministry of Agriculture (12RZZY-09). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blaser HW, 1944, AM J BOT, V31, P53, DOI 10.2307/2437667; Dai L.K., 2010, FLORA CHINA, V23, P285; Frodin DG, 2004, TAXON, V53, P753, DOI 10.2307/4135449; Jin SH, 2012, BRITTONIA, V64, P325, DOI 10.1007/s12228-012-9236-2; Jin XF, 2004, ACTA PHYTOTAXON SIN, V42, P541; Jin XF, 2012, SYST BOT, V37, P929, DOI 10.1600/036364412X656617; Jin XF, 2011, NORD J BOT, V29, P63, DOI 10.1111/j.1756-1051.2010.00977.x; Jin XF, 2010, NORD J BOT, V28, P709, DOI 10.1111/j.1756-1051.2010.00817.x; KOYAMA TETSUO, 1962, JOUR FAC SCI UNIV TOKYO SECT HI BOT, V8, P149; Kukenthal G., 1909, PFLANZENREICH 4; Li PC., 2000, FLORA REIPUBLICAE PO, V12, P56; [李森 Li Sen], 2005, [地理学报, Acta Geographica Sinica], V60, P433; LIAO WB, 2001, ADV PLANT SCI, V4, P57; Liu G.D., 2012, CYPERACEAE HAINAN; NELMES E., 1951, REINWARDTIA, V1, P221; Ohwi J., 1936, MEM COLL SCI KYOTO B, V11, P229; REZNICEK AA, 1990, CAN J BOT, V68, P1409, DOI 10.1139/b90-180; Shimizu Takahiro, 2008, APG Acta Phytotaxonomica et Geobotanica, V59, P67; Wang QL, 2012, PHYTOTAXA, V75, P65; Waterway Marcia J., 2007, Aliso, V23, P165; Waterway MJ, 2009, BOT REV, V75, P138, DOI 10.1007/s12229-008-9024-6; Yu LiYing, 2012, Journal of Tropical and Subtropical Botany, V20, P403	22	7	8	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e97658	10.1371/journal.pone.0097658	http://dx.doi.org/10.1371/journal.pone.0097658			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937208	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400006
J	Zhu, SY; Bing, YT; Wang, XB; Yu, Q; Wang, YP; Xu, SF; Song, L; Wang, XT; Xia, B; Zhu, YQ; Zhou, R				Zhu, Siying; Bing, Yuntao; Wang, Xiaobing; Yu, Qiao; Wang, Yipeng; Xu, Shufang; Song, Lu; Wang, Xintao; Xia, Bing; Zhu, Youqing; Zhou, Rui			CCL25/CCR9 Interactions Regulate the Function of iNKT Cells in Oxazolone-Induced Colitis in Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; THYMUS-EXPRESSED CHEMOKINE; NK-T-CELLS; ULCERATIVE-COLITIS; CROHNS-DISEASE; LAMINA PROPRIA; TUMOR-IMMUNITY; MURINE MODEL; LYMPHOCYTES; RECEPTOR	Background: Natural killer T (NKT) cells share phenotypic and functional properties with both conventional natural killer cells and T cells. These cells might have an important role in the pathogenesis of ulcerative colitis (UC). The interaction of chemokine ligand 25 (CCL25) with chemokine receptor 9 (CCR9) is involved in gut-specific migration of leukocytes and induces regulatory T cells (Tregs) to migrate to the intestine in chronic ileitis. Methodology/Findings: In UC patients, NKT receptor CD161, CCL25, and CCR9 expression levels were evaluated by qRT-PCR. A murine model of oxazolone-induced colitis was induced in BALB/c mice. The mRNA levels of NK1.1, CCL25 and CCR9, and pro-inflammatory cytokines in mice were evaluated. The CCR9 expression on Type I or invariant NKT (iNKT) cells, and the iNKT cells chemotaxis are observed according to flow cytometry. NKT receptor CD161, CCL25 and CCR9 expression levels were significantly increased in UC patients. And, the mRNA expression levels of NK1.1, CCL25 and CCR9 were increased in oxazolone-induced colitis in mice. The production of pro-inflammatory cytokines was significantly increased, especially interleukin 4 (IL-4), IL-10 and IL-13. We observed significantly increased CCR9 expression on iNKT cells. Furthermore, we found an increased iNKT population and enhanced chemotaxis during oxazolone-induced colitis. Conclusions/Significance: Our study suggests that CCL25/CCR9 interactions may promote the induction and function of iNKT cells during oxazolone-induced colitis. These findings may have important implications for UC treatment and suggest a role for CCR9 inhibitors.	[Zhu, Siying; Wang, Xiaobing; Wang, Yipeng; Xu, Shufang; Song, Lu; Wang, Xintao; Xia, Bing; Zhu, Youqing; Zhou, Rui] Wuhan Univ, Zhongnan Hosp, Dept Gastroenterol Hepatol, Wuhan 430072, Hubei, Peoples R China; [Zhu, Siying; Bing, Yuntao; Wang, Xiaobing; Yu, Qiao; Xu, Shufang; Song, Lu; Wang, Xintao; Xia, Bing; Zhu, Youqing; Zhou, Rui] Hubei Clin Ctr, Wuhan, Hubei, Peoples R China; [Zhu, Siying; Bing, Yuntao; Wang, Xiaobing; Yu, Qiao; Xu, Shufang; Song, Lu; Wang, Xintao; Xia, Bing; Zhu, Youqing; Zhou, Rui] Key Lab Intestinal & Colorectal Dis, Wuhan, Hubei, Peoples R China	Wuhan University	Zhu, YQ (corresponding author), Wuhan Univ, Zhongnan Hosp, Dept Gastroenterol Hepatol, Wuhan 430072, Hubei, Peoples R China.	uqing_zhu@sina.com; zhourui8310@126.com		Bing, Yuntao/0000-0002-0187-133X; Wang, Xiaobing/0000-0002-3134-0556	National Natural Science Foundation of China [81100266]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (No. 81100266). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akbari O, 2003, NAT MED, V9, P582, DOI 10.1038/nm851; Autschbach F, 2002, VIRCHOWS ARCH, V441, P500, DOI 10.1007/s00428-002-0684-z; Badr G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023741; Boirivant M, 1998, J EXP MED, V188, P1929, DOI 10.1084/jem.188.10.1929; Boirivant M, 2005, INFLAMM BOWEL DIS, V11, P48, DOI 10.1097/00054725-200501000-00007; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; Eksteen B, 2004, J EXP MED, V200, P1511, DOI 10.1084/jem.20041035; Fuss IJ, 2004, J CLIN INVEST, V113, P1490, DOI 10.1172/JCI200419836; Galitovskiy V, 2011, J IMMUNOL, V187, P2677, DOI 10.4049/jimmunol.1002711; Godfrey DI, 2004, NAT REV IMMUNOL, V4, P231, DOI 10.1038/nri1309; Godfrey DI, 2004, J CLIN INVEST, V114, P1379, DOI 10.1172/JCI200423594; Heller F, 2002, IMMUNITY, V17, P629, DOI 10.1016/S1074-7613(02)00453-3; Hunter MM, 2007, GASTROENTEROLOGY, V132, P1320, DOI 10.1053/j.gastro.2007.01.038; Hunter MM, 2005, J IMMUNOL, V174, P7368, DOI 10.4049/jimmunol.174.11.7368; Juno JA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002838; Kihara N, 2003, GUT, V52, P713, DOI 10.1136/gut.52.5.713; LENNARDJONES JE, 1989, SCAND J GASTROENTERO, V24, P2, DOI 10.3109/00365528909091339; Liao CM, 2013, INFLAMM BOWEL DIS, V19, P1330, DOI 10.1097/MIB.0b013e318280b1e3; Mantovani A, 1999, IMMUNOL TODAY, V20, P254, DOI 10.1016/S0167-5699(99)01469-3; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Montbarbon M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062208; Nieuwenhuis EES, 2002, NAT MED, V8, P588, DOI 10.1038/nm0602-588; Olaussen RW, 2007, GASTROENTEROLOGY, V132, P2371, DOI 10.1053/j.gastro.2007.04.023; Olszak T, 2012, SCIENCE, V336, P489, DOI 10.1126/science.1219328; Papadakis KA, 2000, J IMMUNOL, V165, P5069, DOI 10.4049/jimmunol.165.9.5069; Papadakis KA, 2001, GASTROENTEROLOGY, V121, P246, DOI 10.1053/gast.2001.27154; Podolsky DK, 2002, NEW ENGL J MED, V347, P417, DOI 10.1056/NEJMra0804647; Sallusto F, 1997, SCIENCE, V277, P2005, DOI 10.1126/science.277.5334.2005; Smyth MJ, 2000, NAT IMMUNOL, V1, P459, DOI 10.1038/82698; Stenstad H, 2006, BLOOD, V107, P3447, DOI 10.1182/blood-2005-07-2860; Terabe M, 2008, ADV CANCER RES, V101, P277, DOI 10.1016/S0065-230X(08)00408-9; TRUELOVE SC, 1955, BRIT MED J, V2, P1041, DOI 10.1136/bmj.2.4947.1041; Walters MJ, 2010, J PHARMACOL EXP THER, V335, P61, DOI 10.1124/jpet.110.169714; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Wermers JD, 2011, GASTROENTEROLOGY, V140, P1526, DOI 10.1053/j.gastro.2011.01.044; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wurbel MA, 2007, J IMMUNOL, V178, P7598, DOI 10.4049/jimmunol.178.12.7598; Wurbel MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016442; Yang J, 2009, J BIOMECH, V42, P811, DOI 10.1016/j.jbiomech.2009.01.028; Zlotnik A, 2000, IMMUNITY, V12, P121, DOI 10.1016/S1074-7613(00)80165-X	40	13	14	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100167	10.1371/journal.pone.0100167	http://dx.doi.org/10.1371/journal.pone.0100167			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936795	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400083
J	Hanusova, K; Ekrt, L; Vit, P; Kolar, F; Urfus, T				Hanusova, Kristyna; Ekrt, Libor; Vit, Petr; Kolar, Filip; Urfus, Tomas			Continuous Morphological Variation Correlated with Genome Size Indicates Frequent Introgressive Hybridization among Diphasiastrum Species (Lycopodiaceae) in Central Europe	PLOS ONE			English	Article							NUCLEAR-DNA CONTENT; PARTIAL LEAST-SQUARES; FLOW-CYTOMETRY; OVATUS COMPOSITAE; EVOLUTION; COMPLEX; HYPOTHESIS; SPECIATION; ASTERACEAE; ECOLOGY	Introgressive hybridization is an important evolutionary process frequently contributing to diversification and speciation of angiosperms. Its extent in other groups of land plants has only rarely been studied, however. We therefore examined the levels of introgression in the genus Diphasiastrum, a taxonomically challenging group of Lycopodiophytes, using flow cytometry and numerical and geometric morphometric analyses. Patterns of morphological and cytological variation were evaluated in an extensive dataset of 561 individuals from 57 populations of six taxa from Central Europe, the region with the largest known taxonomic complexity. In addition, genome size values of 63 individuals from Northern Europe were acquired for comparative purposes. Within Central European populations, we detected a continuous pattern in both morphological variation and genome size (strongly correlated together) suggesting extensive levels of interspecific gene flow within this region, including several large hybrid swarm populations. The secondary character of habitats of Central European hybrid swarm populations suggests that man-made landscape changes might have enhanced unnatural contact of species, resulting in extensive hybridization within this area. On the contrary, a distinct pattern of genome size variation among individuals from other parts of Europe indicates that pure populations prevail outside Central Europe. All in all, introgressive hybridization among Diphasiastrum species in Central Europe represents a unique case of extensive interspecific gene flow among spore producing vascular plants that cause serious complications of taxa delimitation.	[Hanusova, Kristyna; Vit, Petr; Kolar, Filip; Urfus, Tomas] Charles Univ Prague, Dept Bot, Prague, Czech Republic; [Ekrt, Libor] Univ South Bohemia, Dept Bot, Ceske Budejovice, Czech Republic; [Vit, Petr; Kolar, Filip; Urfus, Tomas] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic	Charles University Prague; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Urfus, T (corresponding author), Charles Univ Prague, Dept Bot, Prague, Czech Republic.	tomas.urfus@natur.cuni.cz	Ekrt, Libor/AAL-8458-2020; Hanusova, Kristyna/T-3687-2017; Urfus, Tomas/ABC-1854-2020; Urfus, Tomáš/H-1633-2014; Vit, Petr/J-3278-2014; kolar, filip/E-3826-2012	Hanusova, Kristyna/0000-0002-3581-6013; Urfus, Tomas/0000-0001-6878-6503; Urfus, Tomáš/0000-0001-6878-6503; Vit, Petr/0000-0003-3997-928X; kolar, filip/0000-0002-8793-7992	Grant Agency of Charles University [GAUK 90809]; Academy of Science of the Czech Republic [RVO 67985939]; Czech Science Foundation (Centre of Excellence PLADIAS) [14-36079G]	Grant Agency of Charles University; Academy of Science of the Czech Republic(Czech Academy of Sciences); Czech Science Foundation (Centre of Excellence PLADIAS)	This project was financially supported by the Grant Agency of Charles University (GAUK 90809), and additional support was provided by the Academy of Science of the Czech Republic (long-term research development project No. RVO 67985939) and institutional resources of the Ministry of Education, Youth and Sports of the Czech Republic for the support of science and research. It was also funded by the Czech Science Foundation (project no. 14-36079G, Centre of Excellence PLADIAS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aagaard SMD, 2009, THESIS UPPSALA U UPP; Aagaard SMD, 2009, TAXON, V58, P835, DOI 10.1002/tax.583012; Arnold M. L., 1997, NATURAL HYBRIDIZATIO; ARNOLD ML, 1990, HEREDITY, V65, P297, DOI 10.1038/hdy.1990.99; ARNOLD ML, 1993, AM J BOT, V80, P577, DOI 10.2307/2445375; BARANYI M, 1995, PLANT SYST EVOL, V194, P231, DOI 10.1007/BF00982857; Baranyi M, 1996, THEOR APPL GENET, V92, P297, DOI 10.1007/BF00223672; Bennert HW, 2011, ANN BOT-LONDON, V108, P867, DOI 10.1093/aob/mcr208; Bennert HW, 1999, BFN SCHRIFTENVERTRIE; Bennett MD, 2000, ANN BOT-LONDON, V85, P351, DOI 10.1006/anbo.1999.1071; BENNETT MD, 1987, NEW PHYTOL, V106, P177, DOI 10.1111/j.1469-8137.1987.tb04689.x; Boeuf R, 2001, B SOC BOT CTR OUEST, V32, P79; Bookstein F L, 1997, Med Image Anal, V1, P225; Bures P, 2004, ANN BOT-LONDON, V94, P353, DOI 10.1093/aob/mch151; Castroviejo S, 1986, FLORA IBERICA, VI, P7; Chrtek J, 2009, ANN BOT-LONDON, V104, P161, DOI 10.1093/aob/mcp107; CONANT DS, 1980, AM J BOT, V67, P1269, DOI 10.2307/2442130; Damboldt J, 1962, BER BAYER BOT GES, V35, P20; Dolezel J, 2005, ANN BOT-LONDON, V95, P99, DOI 10.1093/aob/mci005; Dolezel J, 1998, ANN BOT-LONDON, V82, P17, DOI 10.1006/anbo.1998.0730; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Dostal J., 1984, ILLUSTRIERTE FLORA M, VI, P28; Duskova E, 2010, PRESLIA, V82, P127; Dvorakova K, 2012, THESIS PRF UK PRAHA; Dvorakova K, 2009, THESIS PRF UK PRAHA; Dyer RJ, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-219; Ekrt L, 2008, SILVA GABRETA, V15, P173; Ekrt L, 2010, AM J BOT, V97, P1208, DOI 10.3732/ajb.0900206; Ennos RA, 2005, TRENDS ECOL EVOL, V20, P164, DOI 10.1016/j.tree.2005.01.012; Fischer M. A., 2005, EXKURSIONSFLORA OSTE; Futak J, 1966, FLORA SLOVENSKA, V2; GILMAN AV, 1994, RHODORA, V96, P287; Grant V., 1981, PLANT SPECIATION; Greilhuber J, 2005, ANN BOT-LONDON, V95, P91, DOI 10.1093/aob/mci004; Greilhuber J, 2005, ANN BOT-LONDON, V95, P255, DOI 10.1093/aob/mci019; Greilhuber J, 1997, HEREDITY, V78, P547, DOI 10.1038/hdy.1997.85; Haeupler H, 2007, BILDATLAS FARN BLUTE, P20; Haufler C.H., 1996, PTERIDOLOGY PERSPECT, P291; Haufler CH, 2008, BIOLOGY AND EVOLUTION OF FERNS AND LYCOPHYTES, P303, DOI 10.1017/CBO9780511541827.013; HOLUB J, 1975, Preslia (Prague), V47, P97; Horn K, 2002, DIPHASIASTRUM OELLGA; Jager E, 2005, KRITISCHER, V4; Jermy AC, 1993, FLORA EUROPAEA, P5; Jiggins CD, 2008, PHILOS T R SOC B, V363, P3047, DOI 10.1098/rstb.2008.0065; Jonsell B., 2010, FLORA NORDICA; Kentner EK, 2000, AM J BOT, V87, P1168, DOI 10.2307/2656653; Knight CA, 2005, ANN BOT-LONDON, V95, P177, DOI 10.1093/aob/mci011; Knight CA, 2002, ECOL LETT, V5, P66, DOI 10.1046/j.1461-0248.2002.00283.x; Krahulcova A, 1996, FOLIA GEOBOT PHYTOTX, V31, P219, DOI 10.1007/BF02812066; Kron P, 2007, ANNU REV ECOL EVOL S, V38, P847, DOI 10.1146/annurev.ecolsys.38.091206.095504; Krzanowski WJ., 1990, PRINCIPLES MULTIVARI; Kubat K, 1997, LYCOPODIACEAE; Kubat K., 2002, KLIC KE KVETENE CESK; Kubat K, 1988, DIPHASIASTRUM; KUKKONEN I, 1994, ANN BOT FENN, V31, P197; Lauber K., 1996, FLORA HELVETICA; LAWALREE ANDRE, 1957, BULL SOC ROY BOT BELGIQUE, V90, P109; Leong-Skornickova J, 2007, ANN BOT-LONDON, V100, P505, DOI 10.1093/aob/mcm144; Loureiro J, 2010, PRESLIA, V82, P3; Love A, 1961, BOT NOTISER, V114, P34; Lysak MA, 2000, ANN BOT-LONDON, V86, P399, DOI 10.1006/anbo.2000.1200; McGuire JL, 2010, QUATERN INT, V212, P198, DOI 10.1016/j.quaint.2009.09.004; Morgan-Richards M, 2009, J ROY SOC NEW ZEAL, V39, P15, DOI 10.1080/03014220909510561; Moscone EA, 2003, ANN BOT-LONDON, V92, P21, DOI 10.1093/aob/mcg105; Mullenniex A, 1998, SYST BOT, V23, P421, DOI 10.2307/2419374; Muller Serge, 2003, Biodiversity and Conservation, V12, P321, DOI 10.1023/A:1022419030577; Obermayer R, 1999, ANN BOT-LONDON, V84, P259, DOI 10.1006/anbo.1999.0907; Oberprieler C, 2011, PLANT SYST EVOL, V293, P177, DOI 10.1007/s00606-011-0431-5; Ollgaard B., 1987, OPERA BOT, V92, P153; Otto F, 1990, Methods Cell Biol, V33, P105; Pignatti S., 1982, FLORA DITALIA, VVolume I; Preston C, 2002, NEW ATLAS BRIT IRISH; Price HJ, 2000, ANN BOT-LONDON, V86, P929, DOI 10.1006/anbo.2000.1255; Prochazka F, 1998, ZPR CES BOT SPOLEC P, V1997, P123; Prochazka Frantisek, 1999, Preslia (Prague), V71, P193; Prochazka Frantisek, 1997, Preslia (Prague), V69, P169; Quintanilla LG, 2006, ANN BOT-LONDON, V98, P609, DOI 10.1093/aob/mcl137; Raudnitschka D, 2007, SYST BIODIVERS, V5, P333, DOI 10.1017/S1477200007002435; Repplinger M, 2007, PLANT SYST EVOL, V268, P75, DOI 10.1007/s00606-007-0547-9; RIESEBERG LH, 1993, HYBRID ZONES AND THE EVOLUTIONARY PROCESS, P70; Rohlf F.J., 2006, TPS SERIES DEP ECOLO; Rohlf FJ, 2000, SYST BIOL, V49, P740, DOI 10.1080/106351500750049806; Rohlf FJ, 2010, TPS DIG DIGITALIZE L; SAMPSON PD, 1989, NEUROTOXICOL TERATOL, V11, P477, DOI 10.1016/0892-0362(89)90025-1; Schierenbeck KA, 2009, BIOL INVASIONS, V11, P1093, DOI 10.1007/s10530-008-9388-x; SHEETS HD, 2002, IMP INTEGRATED MORPH; Simova I, 2011, P R SOC B, V279, P867; Slovak M, 2009, J BIOGEOGR, V36, P372, DOI 10.1111/j.1365-2699.2008.02005.x; Smarda P, 2006, ANN BOT-LONDON, V98, P665, DOI 10.1093/aob/mcl150; SOLTIS PS, 1988, AM J BOT, V75, P248, DOI 10.2307/2443891; Stebbins G. L., 1959, Proceedings of the American Philosophical Society, V103, P231; Stenberg L., 1992, NORDISKA FLORAN; Stoor A. M., 1996, Feddes Repertorium, V107, P149; Storchova H, 2001, ZPRAVY CES BOT SPOL, V36, P77; Suda J, 2007, ANN BOT-LONDON, V100, P1323, DOI 10.1093/aob/mcm218; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; THOMPSON K, 1990, EVOL TREND PLANT, V4, P113; VANDENWOLLENBERG AL, 1977, PSYCHOMETRIKA, V42, P207, DOI 10.1007/BF02294050; Vogel J. C., 1999, Feddes Repertorium, V110, P439; WAGNER FS, 1992, ANN MO BOT GARD, V79, P718, DOI 10.2307/2399761; WAGNER WH, 1985, P ROY SOC EDINB B, V86, P273, DOI 10.1017/S026972700000823X; WHITTIER DP, 1977, CAN J BOT, V55, P563, DOI 10.1139/b77-067; Wilce J.H., 1965, BEIH NOVA HEDWIGIA, V19, P1; Wilce JH, 1961, NOVA HEDWIGIA, V3, P93; Wissemann V, 2007, PLANT SYST EVOL, V263, P181, DOI 10.1007/s00606-006-0480-3; WOJCICKI JJ, 1991, VER GEOBOT, V106, P266; Zaveska E, 2011, BOT J LINN SOC, V165, P388, DOI 10.1111/j.1095-8339.2011.01122.x; Zelditch M. L., 2004, GEOMETRIC MORPHOMETR	108	29	33	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99552	10.1371/journal.pone.0099552	http://dx.doi.org/10.1371/journal.pone.0099552			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932509	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600041
J	Kleine, M; Worbs, T; Schrem, H; Vondran, FWR; Kaltenborn, A; Klempnauer, J; Forster, R; Josenhans, C; Suerbaum, S; Bektas, H				Kleine, Moritz; Worbs, Tim; Schrem, Harald; Vondran, Florian W. R.; Kaltenborn, Alexander; Klempnauer, Juergen; Foerster, Reinhold; Josenhans, Christine; Suerbaum, Sebastian; Bektas, Hueseyin			Helicobacter hepaticus Induces an Inflammatory Response in Primary Human Hepatocytes	PLOS ONE			English	Article							LIVER-INJURY; PORCINE HEPATOCYTES; LEUKOCYTE ADHESION; INNATE IMMUNITY; CYCLOOXYGENASE-2; EXPRESSION; MODEL; MICE; CELL; ASSOCIATION	Helicobacter hepaticus can lead to chronic hepatitis and hepatocellular carcinoma in certain strains of mice. Until now the pathogenic role of Helicobacter species on human liver tissue is still not clarified though Helicobacter species identification in human liver cancer was successful in case controlled studies. Therefore we established an in vitro model to investigate the interaction of primary human hepatocytes (PHH) with Helicobacter hepaticus. Successful co-culturing of PHH with Helicobacter hepaticus was confirmed by visualization of motile bacteria by two-photon-microscopy. Isolated human monocytes were stimulated with PHH conditioned media. Changes in mRNA expression of acute phase cytokines and proteins in PHH and stimulated monocytes were determined by Real-time PCR. Furthermore, cytokines and proteins were analyzed in PHH culture supernatants by ELISA. Co-cultivation with Helicobacter hepaticus induced mRNA expression of Interleukin-1 beta (IL-1 beta), Tumor necrosis factor-alpha, Interleukin-8 (IL-8) and Monocyte chemotactic protein-1 (MCP-1) in PHH (p<0.05) resulting in a corresponding increase of IL-8 and MCP-1 concentrations in PHH supernatants (p<0.05). IL-8 and IL-1 beta mRNA expression was induced in monocytes stimulated with Helicobacter hepaticus infected PHH conditioned media (p<0.05). An increase of Cyclooxygenase-2 mRNA expression was observed, with a concomitant increase of prostaglandin E2 concentration in PHH supernatants at 24 and 48 h (p<0.05). In contrast, at day 7 of co-culture, no persistent elevation of cytokine mRNA could be detected. High expression of intercellular adhesion molecule-1 on PHH cell membranes after co-culture was shown by two-photon-microscopy and confirmed by flow-cytomety. Finally, expression of Cytochrome P450 3A4 and albumin mRNA were downregulated, indicating an impairment of hepatocyte synthesis function by Helicobacter hepaticus presence. This is the first in vitro model demonstrating a pathogenic effect of a Helicobacter spp. on human liver cells, resulting in an inflammatory response with increased synthesis of inflammatory mediators and consecutive monocyte activation.	[Kleine, Moritz; Schrem, Harald; Vondran, Florian W. R.; Kaltenborn, Alexander; Klempnauer, Juergen; Bektas, Hueseyin] Hannover Med Sch, Dept Gen Visceral & Transplant Surg, Hannover, Germany; [Worbs, Tim; Foerster, Reinhold] Hannover Med Sch, Inst Immunol, Hannover, Germany; [Josenhans, Christine; Suerbaum, Sebastian] Hannover Med Sch, Inst Med Microbiol & Hosp Epidemiol, Hannover, Germany; [Kaltenborn, Alexander] Fed Armed Forces Med Ctr, Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School	Kleine, M (corresponding author), Hannover Med Sch, Dept Gen Visceral & Transplant Surg, Hannover, Germany.	kleine.moritz@mh-hannover.de		Forster, Reinhold/0000-0001-6190-7923; Worbs, Tim/0000-0001-9945-3103	Bayer Health Care, Germany; "Verein zur Forderung der Forschung und Lehre in der Allgemein Chirurgie", Germany; German Research Foundation [DFG SFB 621/B8, SFB 900/B6, DFG SFB 900-B1]	Bayer Health Care, Germany(Bayer AGBayer Healthcare Pharmaceuticals); "Verein zur Forderung der Forschung und Lehre in der Allgemein Chirurgie", Germany; German Research Foundation(German Research Foundation (DFG))	Supported by Bayer Health Care, Germany (to M. Kleine and H. Bektas), the "Verein zur Forderung der Forschung und Lehre in der Allgemein Chirurgie" (to M. Kleine), Germany, and grants DFG SFB 621/B8 (to S. Suerbaum), SFB 900/B6 (to C. Josenhans) and DFG SFB 900-B1 (to R. Forster) from the German Research Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams DH, 2010, TOXICOL SCI, V115, P307, DOI 10.1093/toxsci/kfq009; Avenaud P, 2003, INFECT IMMUN, V71, P3667, DOI 10.1128/IAI.71.6.3667-3672.2003; Bajt ML, 2001, AM J PHYSIOL-GASTR L, V281, pG1188, DOI 10.1152/ajpgi.2001.281.5.G1188; Bartonickova L, 2013, CELL MICROBIOL, V15, P992, DOI 10.1111/cmi.12094; Casado M, 2001, FASEB J, V15, P2016, DOI 10.1096/fj.01-0158fje; Colletti LM, 1996, HEPATOLOGY, V23, P506; Dewhirst FE, 2000, INT J SYST EVOL MICR, V50, P2231, DOI [10.1099/00207713-50-3-1399, 10.1099/00207713-50-3-1401]; ESSANI NA, 1995, HEPATOLOGY, V21, P1632, DOI 10.1002/hep.1840210623; Faouzi S, 2001, J BIOL CHEM, V276, P49077, DOI 10.1074/jbc.M109791200; Fox JG, 1996, INFECT IMMUN, V64, P1548, DOI 10.1128/IAI.64.5.1548-1558.1996; Garcia A, 2011, CANCER RES, V71, P2529, DOI 10.1158/0008-5472.CAN-10-1975; Ge ZM, 2007, CELL MICROBIOL, V9, P2070, DOI 10.1111/j.1462-5822.2007.00939.x; Jaeschke H, 1997, AM J PHYSIOL-GASTR L, V273, pG1169; Jaeschke H, 2008, HEPATOLOGY, V48, P699, DOI 10.1002/hep.22556; Jaeschke H, 2006, AM J PHYSIOL-GASTR L, V290, pG1083, DOI 10.1152/ajpgi.00568.2005; Jeschke MG, 2008, MOL MED, V14, P11, DOI 10.2119/2007-00062.Jeschke; Kleine M, 2008, XENOTRANSPLANTATION, V15, P208, DOI 10.1111/j.1399-3089.2008.00478.x; Koga H, 1999, HEPATOLOGY, V29, P688, DOI 10.1002/hep.510290355; Kuziel WA, 1997, P NATL ACAD SCI USA, V94, P12053, DOI 10.1073/pnas.94.22.12053; LASKIN DL, 1995, HEPATOLOGY, V21, P1045, DOI 10.1002/hep.1840210424; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mandell L, 2004, INFECT IMMUN, V72, P6446, DOI 10.1128/IAI.72.11.6446-6454.2004; Nagendra AR, 1997, AM J PHYSIOL-GASTR L, V272, pG408, DOI 10.1152/ajpgi.1997.272.3.G408; Nakagawa H, 2012, WORLD J GASTROENTERO, V18, P4071, DOI 10.3748/wjg.v18.i31.4071; Nilsson HO, 2001, GASTROENTEROLOGY, V120, P323, DOI 10.1053/gast.2001.21382; Nilsson HO, 2000, J CLIN MICROBIOL, V38, P1072, DOI 10.1128/JCM.38.3.1072-1076.2000; Parker GA, 2005, TOXICOL PATHOL, V33, P52, DOI 10.1080/01926230590522365; Pellicano R, 2008, LANCET INFECT DIS, V8, P254, DOI 10.1016/S1473-3099(08)70066-5; Queiroz DMD, 2001, GASTROENTEROLOGY, V121, P1023, DOI [10.1053/gast.2001.28574, 10.1016/S0016-5085(01)96000-7]; Roberts RA, 2007, TOXICOL SCI, V96, P2, DOI 10.1093/toxsci/kfl173; Rocha M, 2005, GUT, V54, P396, DOI 10.1136/gut.2004.042168; Schrem H, 2006, LIVER TRANSPLANT, V12, P1832, DOI 10.1002/lt.20918; Sterzenbach T, 2007, INFECT IMMUN, V75, P2717, DOI 10.1128/IAI.01935-06; Suerbaum S, 2003, P NATL ACAD SCI USA, V100, P7901, DOI 10.1073/pnas.1332093100; WARD JM, 1994, JNCI-J NATL CANCER I, V86, P1222, DOI 10.1093/jnci/86.16.1222; Yin H, 2007, HEPATOLOGY, V45, P159, DOI 10.1002/hep.21493; Zimmermann HW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00056; Zimmermann HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021381	38	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99713	10.1371/journal.pone.0099713	http://dx.doi.org/10.1371/journal.pone.0099713			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932686	gold, Green Published, Green Submitted			2022-12-27	WOS:000337738600057
J	Weir-McCall, JR; Khan, F; Lambert, MA; Adamson, CL; Gardner, M; Gandy, SJ; Ramkumar, PG; Belch, JJF; Struthers, AD; Rauchhaus, P; Morris, AD; Houston, JG				Weir-McCall, Jonathan R.; Khan, Faisel; Lambert, Matthew A.; Adamson, Carly L.; Gardner, Michael; Gandy, Stephen J.; Ramkumar, Prasad Guntur; Belch, Jill J. F.; Struthers, Allan D.; Rauchhaus, Petra; Morris, Andrew D.; Houston, J. Graeme			Common Carotid Intima Media Thickness and Ankle-Brachial Pressure Index Correlate with Local but Not Global Atheroma Burden: A Cross Sectional Study Using Whole Body Magnetic Resonance Angiography	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; CARDIOVASCULAR RISK PREDICTION; MR-ANGIOGRAPHY; SUBCLINICAL ATHEROSCLEROSIS; ENDOTHELIAL FUNCTION; EVENTS; PROGRESSION; ULTRASOUND; PLAQUE; SCORE	Background: Common carotid intima media thickness (CIMT) and ankle brachial pressure index (ABPI) are used as surrogate marker of atherosclerosis, and have been shown to correlate with arterial stiffness, however their correlation with global atherosclerotic burden has not been previously assessed. We compare CIMT and ABPI with atheroma burden as measured by whole body magnetic resonance angiography (WB-MRA). Methods: 50 patients with symptomatic peripheral arterial disease were recruited. CIMT was measured using ultrasound while rest and exercise ABPI were performed. WB-MRA was performed in a 1.5T MRI scanner using 4 volume acquisitions with a divided dose of intravenous gadolinium gadoterate meglumine (Dotarem, Guerbet, FR). The WB-MRA data was divided into 31 anatomical arterial segments with each scored according to degree of luminal narrowing: 0 = normal, 1 =, 50%, 2 = 50-70%, 3 = 70-99%, 4 = vessel occlusion. The segment scores were summed and from this a standardized atheroma score was calculated. Results: The atherosclerotic burden was high with a standardised atheroma score of 39.5611. Common CIMT showed a positive correlation with the whole body atheroma score (beta 0.32, p = 0.045), however this was due to its strong correlation with the neck and thoracic segments (beta 0.42 p = 0.01) with no correlation with the rest of the body. ABPI correlated with the whole body atheroma score (beta -0.39, p = 0.012), which was due to a strong correlation with the ilio-femoral vessels with no correlation with the thoracic or neck vessels. On multiple linear regression, no correlation between CIMT and global atheroma burden was present (beta 0.13 p = 0.45), while the correlation between ABPI and atheroma burden persisted (beta -0.45 p = 0.005). Conclusion: ABPI but not CIMT correlates with global atheroma burden as measured by whole body contrast enhanced magnetic resonance angiography in a population with symptomatic peripheral arterial disease. However this is primarily due to a strong correlation with ilio-femoral atheroma burden.	[Weir-McCall, Jonathan R.; Lambert, Matthew A.; Belch, Jill J. F.; Struthers, Allan D.; Morris, Andrew D.; Houston, J. Graeme] Univ Dundee, Med Res Inst, Div Cardiovasc & Diabet Med, Dundee, Scotland; [Weir-McCall, Jonathan R.; Ramkumar, Prasad Guntur; Houston, J. Graeme] Ninewells Hosp, NHS Tayside Clin Radiol, Dundee DD1 9SY, Scotland; [Khan, Faisel] Univ Dundee, Med Res Inst, Vasc & Inflammatory Dis Res Unit, Dundee, Scotland; [Adamson, Carly L.; Gardner, Michael] Univ Dundee, Ninewells Hosp & Med Sch, Dundee DD1 9SY, Scotland; [Gandy, Stephen J.] Ninewells Hosp, NHS Tayside Med Phys, Dundee DD1 9SY, Scotland; [Rauchhaus, Petra] Univ Dundee, Dundee Epidemiol & Biostat Unit, Dundee, Scotland	University of Dundee; University of Dundee; University of Dundee; University of Dundee; University of Dundee; University of Dundee	Weir-McCall, JR (corresponding author), Univ Dundee, Med Res Inst, Div Cardiovasc & Diabet Med, Dundee, Scotland.	j.weirmccall@dundee.ac.uk	Belch, Jill/AAE-9189-2019	Belch, Jill/0000-0001-8280-6689; Houston, Graeme/0000-0002-9786-7975; Khan, Faisel/0000-0002-9889-0229	Wyeth TMRC; Wellcome Trust through Scottish Translational Medicine and Therapeutics Initiative [WT 085664]	Wyeth TMRC; Wellcome Trust through Scottish Translational Medicine and Therapeutics Initiative	Funding for the study was provided by Wyeth TMRC. JRWM is supported by the Wellcome Trust through the Scottish Translational Medicine and Therapeutics Initiative (Grant no. WT 085664) in the form of a Clinical Research Fellowship. The authors have declared that no competing interests exist. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aboyans V, 2012, CIRCULATION, V126, P2890, DOI 10.1161/CIR.0b013e318276fbcb; Bamberg F, 2013, RADIOLOGY, V269, P730, DOI 10.1148/radiol.13130371; Bots ML, 2003, STROKE, V34, P2985, DOI 10.1161/01.STR.0000102044.27905.B5; Brevetti G, 2003, CIRCULATION, V108, P2093, DOI 10.1161/01.CIR.0000095273.92468.D9; Coskun U, 2009, CARDIOVASC ULTRASOUN, V7, DOI 10.1186/1476-7120-7-59; Costanzo P, 2010, J AM COLL CARDIOL, V56, P2006, DOI 10.1016/j.jacc.2010.05.059; Crouse JR, 2007, JAMA-J AM MED ASSOC, V297, P1344, DOI 10.1001/jama.297.12.1344; de Simone G, 2001, J HYPERTENS, V19, P1893, DOI 10.1097/00004872-200110000-00026; Den Ruijter HM, 2012, JAMA-J AM MED ASSOC, V308, P796, DOI 10.1001/jama.2012.9630; Engelen L, 2013, EUR HEART J, V34, P2368, DOI 10.1093/eurheartj/ehs380; Espeland MA, 2005, CURR CONTR TRIALS C, V6, DOI 10.1186/1468-6708-6-3; Espinola-Klein C, 2008, CIRCULATION, V118, P961, DOI 10.1161/CIRCULATIONAHA.107.763227; Fenchel M, 2006, RADIOLOGY, V238, P280, DOI 10.1148/radiol.2381041532; Fitch KV, 2011, ATHEROSCLEROSIS, V217, P437, DOI 10.1016/j.atherosclerosis.2011.04.009; Folsom AR, 2008, ARCH INTERN MED, V168, P1333, DOI 10.1001/archinte.168.12.1333; Fowkes FGR, 2008, JAMA-J AM MED ASSOC, V300, P197, DOI 10.1001/jama.300.2.197; Goehde SC, 2005, AM J ROENTGENOL, V184, P598, DOI 10.2214/ajr.184.2.01840598; Hansen T, 2008, EUR RADIOL, V18, P1174, DOI 10.1007/s00330-008-0864-6; Helfand M, 2009, ANN INTERN MED, V151, P496, DOI 10.7326/0003-4819-151-7-200910060-00010; Inaba Y, 2012, ATHEROSCLEROSIS, V220, P128, DOI 10.1016/j.atherosclerosis.2011.06.044; Kastelein JJP, 2008, NEW ENGL J MED, V358, P1431, DOI 10.1056/NEJMoa0800742; Kwon Taek-Geun, 2009, Korean Circ J, V39, P317, DOI 10.4070/kcj.2009.39.8.317; Lehrke S, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-36; Lerman A, 2005, CIRCULATION, V111, P363, DOI 10.1161/01.CIR.0000153339.27064.14; Lind L, 2009, CLIN PHYSIOL FUNCT I, V29, P321, DOI 10.1111/j.1475-097X.2009.00871.x; Lorenz MW, 2007, CIRCULATION, V115, P459, DOI 10.1161/CIRCULATIONAHA.106.628875; Lorenz MW, 2010, EUR HEART J, V31, P2041, DOI 10.1093/eurheartj/ehq189; Lundberg C, 2013, ATHEROSCLEROSIS, V228, P148, DOI 10.1016/j.atherosclerosis.2013.02.015; Matsumae T, 2007, HYPERTENS RES, V30, P377, DOI 10.1291/hypres.30.377; Migrino RQ, 2011, J CARDIOVASC MAGN R, V13, DOI 10.1186/1532-429X-13-37; Nead KT, 2013, J AM COLL CARDIOL, V62, P553, DOI 10.1016/j.jacc.2013.04.061; Nozue T, 2012, AM HEART J, V163, P191, DOI 10.1016/j.ahj.2011.11.004; Papamichael CM, 2000, AM J CARDIOL, V86, P615, DOI 10.1016/S0002-9149(00)01038-9; Peters SAE, 2011, EUR J CARDIOV PREV R, V18, P167, DOI 10.1177/1741826710389400; Polak JF, 2011, NEW ENGL J MED, V365, P213, DOI 10.1056/NEJMoa1012592; Ruehm SG, 2004, INT J CARDIOVAS IMAG, V20, P587, DOI 10.1007/s10554-004-7033-z; Sadeghi M, 2011, ARYA ATHEROSCLER, V7, P68; Sakuma H, 2011, RADIOLOGY, V258, P340, DOI 10.1148/radiol.10100116; van der Meer IM, 2004, CIRCULATION, V109, P1089, DOI 10.1161/01.CIR.0000120708.59903.1B; Waugh SA, 2009, J MAGN RESON IMAGING, V30, P1059, DOI 10.1002/jmri.21930; Wikstrom J, 2009, J VASC SURG, V50, P330, DOI 10.1016/j.jvs.2009.03.008; Yeboah J, 2008, ATHEROSCLEROSIS, V197, P840, DOI 10.1016/j.atherosclerosis.2007.07.032	42	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99190	10.1371/journal.pone.0099190	http://dx.doi.org/10.1371/journal.pone.0099190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933122	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600028
J	Baharia, RK; Tandon, R; Sahasrabuddhe, AA; Sundar, S; Dube, A				Baharia, Rajendra K.; Tandon, Rati; Sahasrabuddhe, Amogh A.; Sundar, Shyam; Dube, Anuradha			Nucleosomal Histone Proteins of L. donovani: A Combination of Recombinant H2A, H2B, H3 and H4 Proteins Were Highly Immunogenic and Offered Optimum Prophylactic Efficacy against Leishmania Challenge in Hamsters	PLOS ONE			English	Article							EXPERIMENTAL VISCERAL LEISHMANIASIS; MURINE CUTANEOUS LEISHMANIASIS; NECROSIS-FACTOR-ALPHA; T-CELL; IMMUNE-RESPONSES; INTERFERON-GAMMA; MAJOR INFECTION; NITRIC-OXIDE; REACTIVE NITROGEN; DNA VACCINES	The present study includes cloning and expression of recombinant Leishmania donovani histone proteins (rLdH2B, rLdH3, rLdH2A and rLdH4), assessment of their immunogenicity in Leishmania infected cured patients/endemic contacts as well as in cured hamsters and finally evaluation of their prophylactic efficacy in hamsters against L. donovani challenge. All recombinant proteins were expressed and purified from the heterologous bacterial host system. Leishmania infected cured patients/endemic contacts as well as cured hamsters exhibited significantly higher proliferative responses to individual recombinant histones and their pooled combination (rLdH2B+rLdH3+rLdH2A+rLdH4) than those of L. donovani infected hosts. The L.donovani soluble antigens (SLD) stimulated PBMCs of cured/exposed and Leishmania patients to produce a mixed Th1/Th2-type cytokine profile, whereas rLdH2B, rLdH3, rLdH2A, rLdH4 and pooled combination (rLdH2-4) stimulated the production of Th1 cytokines IFN-gamma, IL-12 and TNF-alpha but not Th2 cytokines IL-4 or IL-10. The immunogenicity of these histone proteins along with their combination was also checked in cured hamsters where they stimulated higher lymphoproliferation and Nitric oxide production in lymphocytes of cured hamsters than that of infected controls. Moreover, significantly increased IgG2 response, an indicative of cell mediated immunity, was observed in cured hamsters against these individual proteins and their combination as compared to infected hamsters. Further, it was demonstrated that rLdH2B, rLdH3, rLdH2A and rLdH4 and pooled combination were able to provide considerable protection for hamsters against L. donovani challenge. The efficacy was supported by the increased inducible Nitric Oxide Synthase (iNOS) mRNA transcripts and Th1-type cytokines - IFN-gamma, IL-12 and TNF-alpha and down-regulation of IL-4, IL-10 and TGF-beta. Hence, it is inferred that pooled rLdH2-4 elicits Th1-type of immune responses exclusively and confer considerable protection against experimental Visceral Leishmaniasis.	[Baharia, Rajendra K.; Tandon, Rati; Dube, Anuradha] Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India; [Sahasrabuddhe, Amogh A.] Cent Drug Res Inst, Div Mol & Struct Biol, Lucknow 226001, Uttar Pradesh, India; [Sundar, Shyam] Banaras Hindu Univ, Inst Med Sci, Dept Med, Varanasi 221005, Uttar Pradesh, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Drug Research Institute (CDRI); Banaras Hindu University (BHU)	Dube, A (corresponding author), Cent Drug Res Inst, Div Parasitol, Lucknow, Uttar Pradesh, India.	anuradha_dube@hotmail.com		Dube, Anuradha/0000-0002-5122-400X	Indian Council for Medical Research (ICMR), New Delhi, India	Indian Council for Medical Research (ICMR), New Delhi, India(Indian Council of Medical Research (ICMR))	Financial support for this work was given by Indian Council for Medical Research (ICMR), New Delhi, India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASSREUY J, 1994, EUR J IMMUNOL, V24, P672, DOI 10.1002/eji.1830240328; BELOSEVIC M, 1989, J IMMUNOL, V143, P266; Bhowmick S, 2007, VACCINE, V25, P6544, DOI 10.1016/j.vaccine.2007.05.042; BOGDAN C, 1990, EUR J IMMUNOL, V20, P1131, DOI 10.1002/eji.1830200528; Bosque F, 2000, SCAND J IMMUNOL, V51, P533; BURNS JM, 1991, J IMMUNOL, V146, P742; Carrion J, 2008, VACCINE, V26, P1155, DOI 10.1016/j.vaccine.2007.12.051; Carrion J, 2011, COMP IMMUNOL MICROB, V34, P381, DOI 10.1016/j.cimid.2011.06.002; Chenik M, 2006, VACCINE, V24, P2521, DOI 10.1016/j.vaccine.2005.12.027; CHOMARAT P, 1993, J EXP MED, V177, P523, DOI 10.1084/jem.177.2.523; Coler RN, 2002, INFECT IMMUN, V70, P4215, DOI 10.1128/IAI.70.8.4215-4225.2002; Costa SR, 1999, MEM I OSWALDO CRUZ, V94, P367, DOI 10.1590/S0074-02761999000300015; Cruz I, 2006, INDIAN J MED RES, V123, P357; Desjeux P, 2003, ANN TROP MED PARASIT, V97, P3, DOI 10.1179/000349803225002499; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DING AH, 1988, J IMMUNOL, V141, P2407; Dube A, 2005, PARASITOL RES, V96, P216, DOI 10.1007/s00436-005-1339-1; Galanti N, 1998, PARASITOL TODAY, V14, P64, DOI 10.1016/S0169-4758(97)01162-9; Garg R, 2005, CLIN EXP IMMUNOL, V140, P149, DOI 10.1111/j.1365-2249.2005.02745.x; Guerin PJ, 2002, LANCET INFECT DIS, V2, P494, DOI 10.1016/S1473-3099(02)00347-X; Gupta SK, 2007, PROTEOMICS, V7, P816, DOI 10.1002/pmic.200600725; Handman E, 2001, CLIN MICROBIOL REV, V14, P229, DOI 10.1128/CMR.14.2.229-243.2001; Herwaldt BL, 1999, LANCET, V354, P1191, DOI 10.1016/S0140-6736(98)10178-2; HOLADAY BJ, 1991, J IMMUNOL, V147, P1653; Iborra S, 2004, VACCINE, V22, P3865, DOI 10.1016/j.vaccine.2004.04.015; KEMP M, 1993, INFECT IMMUN, V61, P1069, DOI 10.1128/IAI.61.3.1069-1073.1993; KOBAYASHI M, 1989, J EXP MED, V170, P827, DOI 10.1084/jem.170.3.827; Kumari S, 2008, VACCINE, V26, P4813, DOI 10.1016/j.vaccine.2008.06.102; LIEW FY, 1989, EUR J IMMUNOL, V19, P1227, DOI 10.1002/eji.1830190712; LIEW FY, 1991, EUR J IMMUNOL, V21, P3009, DOI 10.1002/eji.1830211216; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; Melby PC, 1998, INFECT IMMUN, V66, P2135, DOI 10.1128/IAI.66.5.2135-2142.1998; Murray HW, 1999, J EXP MED, V189, P741, DOI 10.1084/jem.189.4.741; PIRMEZ C, 1993, J CLIN INVEST, V91, P1390, DOI 10.1172/JCI116341; REED SG, 1993, CURR OPIN IMMUNOL, V5, P524, DOI 10.1016/0952-7915(93)90033-O; RUSSO DM, 1991, J IMMUNOL, V147, P3575; Samant M, 2009, J IMMUNOL, V183, P470, DOI 10.4049/jimmunol.0900265; SCOTT P, 1993, SCIENCE, V260, P496, DOI 10.1126/science.8097337; Singh SP, 2006, TROP MED INT HEALTH, V11, P899, DOI 10.1111/j.1365-3156.2006.01647.x; Singh VP, 2010, AM J TROP MED HYG, V82, P9, DOI 10.4269/ajtmh.2010.09-0235; Soto M, 1999, CLIN EXP IMMUNOL, V115, P342, DOI 10.1046/j.1365-2249.1999.00796.x; TITUS RG, 1989, J EXP MED, V170, P2097, DOI 10.1084/jem.170.6.2097; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TRINCHIERI G, 1993, IMMUNOL TODAY, V14, P335, DOI 10.1016/0167-5699(93)90230-I; WANIDWORANUN C, 1993, J IMMUNOL, V151, P6853; WHITE AC, 1992, AM J TROP MED HYG, V46, P123, DOI 10.4269/ajtmh.1992.46.123	47	19	19	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e97911	10.1371/journal.pone.0097911	http://dx.doi.org/10.1371/journal.pone.0097911			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926878	Green Submitted, Green Published, gold			2022-12-27	WOS:000338278100010
J	Forn-Cuni, G; Reis, ES; Dios, S; Posada, D; Lambris, JD; Figueras, A; Novoa, B				Forn-Cuni, Gabriel; Reis, Edimara S.; Dios, Sonia; Posada, David; Lambris, John D.; Figueras, Antonio; Novoa, Beatriz			The Evolution and Appearance of C3 Duplications in Fish Originate an Exclusive Teleost c3 Gene Form with Anti-Inflammatory Activity	PLOS ONE			English	Article							COMPLEMENT COMPONENT C3; CARP CYPRINUS-CARPIO; MOLECULAR-CLONING; ZEBRAFISH MODEL; PROTEIN; EXPRESSION; ONTOGENY; TREE; IMPROVEMENT; PHYLOGENY	The complement system acts as a first line of defense and promotes organism homeostasis by modulating the fates of diverse physiological processes. Multiple copies of component genes have been previously identified in fish, suggesting a key role for this system in aquatic organisms. Herein, we confirm the presence of three different previously reported complement c3 genes (c3.1, c3.2, c3.3) and identify five additional c3 genes (c3.4, c3.5, c3.6, c3.7, c3.8) in the zebrafish genome. Additionally, we evaluate the mRNA expression levels of the different c3 genes during ontogeny and in different tissues under steady-state and inflammatory conditions. Furthermore, while reconciling the phylogenetic tree with the fish species tree, we uncovered an event of c3 duplication common to all teleost fishes that gave rise to an exclusive c3 paralog (c3.7 and c3.8). These paralogs showed a distinct ability to regulate neutrophil migration in response to injury compared with the other c3 genes and may play a role in maintaining the balance between inflammatory and homeostatic processes in zebrafish.	[Forn-Cuni, Gabriel; Dios, Sonia; Figueras, Antonio; Novoa, Beatriz] CSIC, Inst Marine Res, Vigo, Spain; [Reis, Edimara S.; Lambris, John D.] Univ Penn, Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Posada, David] Univ Vigo, Dept Biochem Genet & Immunol, Vigo 36310, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); University of Pennsylvania; Universidade de Vigo	Novoa, B (corresponding author), CSIC, Inst Marine Res, Vigo, Spain.	beatriznovoa@iim.csic.es	Posada, David/C-4502-2008; Dios, Sonia/M-4201-2018; Figueras, Antonio/B-5133-2015; Forn-Cuní, Gabriel/M-8498-2016; Figueras, Antonio/AAB-8921-2019; Novoa, Beatriz/K-3785-2014; Lambris, John/Q-5633-2018	Posada, David/0000-0003-1407-3406; Dios, Sonia/0000-0002-2126-991X; Figueras, Antonio/0000-0002-0617-0030; Forn-Cuní, Gabriel/0000-0001-5976-4759; Figueras, Antonio/0000-0002-0617-0030; Lambris, John/0000-0002-9370-5776; Novoa, Beatriz/0000-0003-4888-8419	Spanish Ministerio de Ciencia e Innovacion [CSD2007-00002]; "FISHFORPHARMA'' (EU) [ITN 289209]; Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC) [201230E057]	Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); "FISHFORPHARMA'' (EU); Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC)	This work has been funded by the project CSD2007-00002 "Aquagenomics'' from the Spanish Ministerio de Ciencia e Innovacion, the ITN 289209 "FISHFORPHARMA'' (EU) and project 201230E057 from the Agencia Estatal Consejo Superior de Investigaciones Cientificas (CSIC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Campanella JJ, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-29; Carmona-Fontaine C, 2011, DEV CELL, V21, P1026, DOI 10.1016/j.devcel.2011.10.012; Chondrou M, 2008, DEV COMP IMMUNOL, V32, P1454, DOI 10.1016/j.dci.2008.06.010; Darriba D, 2011, BIOINFORMATICS, V27, P1164, DOI 10.1093/bioinformatics/btr088; Del Rio-Tsonis K, 1998, J IMMUNOL, V161, P6819; Durand D, 2006, J COMPUT BIOL, V13, P320, DOI 10.1089/cmb.2006.13.320; Ellingsen T, 2005, FISH SHELLFISH IMMUN, V18, P351, DOI 10.1016/j.fsi.2004.09.002; Encinas P, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-518; Flicek P, 2012, NUCLEIC ACIDS RES, V40, pD84, DOI 10.1093/nar/gkr991; Gabaldon T, 2013, NAT REV GENET, V14, P360, DOI 10.1038/nrg3456; Gongora R, 1998, SCAND J IMMUNOL, V48, P651; Haynes T, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3312; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Janssen BJC, 2005, NATURE, V437, P505, DOI 10.1038/nature04005; Kato Y, 2003, IMMUNOGENETICS, V54, P807, DOI 10.1007/s00251-002-0528-7; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kimura A, 2009, DEV COMP IMMUNOL, V33, P77, DOI 10.1016/j.dci.2008.07.005; Kuroda N, 2000, IMMUNOGENETICS, V51, P117, DOI 10.1007/s002510050020; Lange SR, 2004, FISH SHELLFISH IMMUN, V16, P359, DOI 10.1016/j.fsi.2003.06.001; Lovoll M, 2007, FISH SHELLFISH IMMUN, V23, P542, DOI 10.1016/j.fsi.2007.01.002; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Marchler-Bauer A, 2011, NUCLEIC ACIDS RES, V39, pD225, DOI 10.1093/nar/gkq1189; Meijer AH, 2005, MOL IMMUNOL, V42, P1185, DOI 10.1016/j.molimm.2004.11.014; Mishra J, 2009, INDIAN J EXP BIOL, V47, P672; Muffato M, 2010, BIOINFORMATICS, V26, P1119, DOI 10.1093/bioinformatics/btq079; Nakao M, 2000, EUR J IMMUNOL, V30, P858, DOI 10.1002/1521-4141(200003)30:3&lt;858::AID-IMMU858&gt;3.0.CO;2-M; Negrisolo E, 2010, MOL BIOL EVOL, V27, P2757, DOI 10.1093/molbev/msq165; Nonaka M, 2006, IMMUNOGENETICS, V58, P701, DOI 10.1007/s00251-006-0142-1; Novoa B, 2012, ADV EXP MED BIOL, V946, P253, DOI 10.1007/978-1-4614-0106-3_15; Nusslein-Volhard C, 2002, ZEBRAFISH; Page RDM, 1997, MOL PHYLOGENET EVOL, V7, P231, DOI 10.1006/mpev.1996.0390; Papanastasiou AD, 2005, IMMUNOGENETICS, V57, P703, DOI 10.1007/s00251-005-0028-7; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinto MR, 2007, ADV EXP MED BIOL, V598, P372; Renshaw SA, 2006, BLOOD, V108, P3976, DOI 10.1182/blood-2006-05-024075; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Rombout JHWM, 2005, FISH SHELLFISH IMMUN, V19, P441, DOI 10.1016/j.fsi.2005.03.007; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozen S, 2000, Methods Mol Biol, V132, P365; Sahu A, 2001, IMMUNOL REV, V180, P35, DOI 10.1034/j.1600-065X.2001.1800103.x; Saxena S, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.014118; Sennblad B, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-148; Sjostrand J, 2012, BIOINFORMATICS, V28, P2994, DOI 10.1093/bioinformatics/bts548; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Tam VK, 2009, J FAC AGR KYUSHU U, V54, P389; Thisse B, 2004, ZFIN DIRECT DATA SUB; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vernot B, 2008, J COMPUT BIOL, V15, P981, DOI 10.1089/cmb.2008.0092; Wang ZP, 2008, FISH SHELLFISH IMMUN, V25, P264, DOI 10.1016/j.fsi.2008.05.010; Westerfield M, 2000, ZEBRAFISH BOOK GUIDE; Zarkadis IK, 2001, DEV COMP IMMUNOL, V25, P11, DOI 10.1016/S0145-305X(00)00039-2	55	35	35	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99673	10.1371/journal.pone.0099673	http://dx.doi.org/10.1371/journal.pone.0099673			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926798	gold, Green Submitted, Green Published			2022-12-27	WOS:000338278100065
J	Hu, DF; Wang, CS; Tao, F; Cui, Q; Xu, XM; Shang, WJ; Hu, XP				Hu, Dongfang; Wang, Chunsheng; Tao, Fei; Cui, Qian; Xu, Xiangming; Shang, Wenjing; Hu, Xiaoping			Whole Genome Wide Expression Profiles on Germination of Verticillium dahliae Microsclerotia	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; RNA-SEQ DATA; GENE-EXPRESSION; CONIDIAL GERMINATION; ASPERGILLUS-NIGER; HYDROPHOBIN GENE; ESTERASE; SEQUENCE; GPR1; VDH1	Verticillium dahliae is a fungal pathogen causing Verticillium wilt on a range of economically important crops. Microsclerotia are its main survival and dormancy structures and serve as the primary inoculum on many hosts. Studies were conducted to determine the effect of temperature (5 to 50 degrees C), pH (2 to 12) and nutrient regimes on microsclerotia germination. The optimal condition for microsclerotium germination was 20 degrees C with pH 8.0 whereas nutrient regimes had no significant effect on its germination. The whole genome wide expression profiles during microsclerotium germination were characterized using the Illumina sequencing technology. Approximately 7.4 million of 21-nt cDNA tags were sequenced in the cDNA libraries derived from germinated and non-germinated microsclerotia. About 3.9% and 2.3% of the unique tags were up-regulated and down-regulated at least five-fold, respectively, in the germinated microsclerotia compared with the non-germinated microsclerotia. A total of 1654 genes showing differential expression were identified. Genes that are likely to have played important roles in microsclerotium germination include those encoding G-protein coupled receptor, lipase/esterase, cyclopentanone 1,2-monooxygenase, H(+)/hexose cotransporter 1, fungal Zn(2)-Cys(6) binuclear cluster domain, thymus-specific serine protease, glucan 1,3-beta-glucosidase, and alcohol dehydrogenase. These genes were mainly up-regulated or down-regulated only in germinated microsclerotia, compared with non-germinated microsclerotia. The differential expression of genes was confirmed by qRT-PCR analysis of 20 randomly selected genes from the 40 most differentially expressed genes.	[Hu, Dongfang; Wang, Chunsheng; Tao, Fei; Cui, Qian; Xu, Xiangming; Shang, Wenjing; Hu, Xiaoping] Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China; [Xu, Xiangming] East Malling Res, East Malling, Kent, England	Northwest A&F University - China	Shang, WJ (corresponding author), Northwest A&F Univ, Coll Plant Protect, State Key Lab Crop Stress Biol Arid Areas, Yangling, Peoples R China.	shangwj@nwsuaf.edu.cn; xphu@nwsuaf.edu.cn	Xu, Xiangming/I-3050-2014	Xu, Xiangming/0000-0002-4567-7117	National Natural Science Foundation of China [31371888]; 111 project from Education Ministry of China [B07049]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 111 project from Education Ministry of China(Ministry of Education, China - 111 Project)	The study was financially supported by National Natural Science Foundation of China (No. 31371888) and the 111 project from Education Ministry of China (No. B07049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auer PL, 2010, GENETICS, V185, P405, DOI 10.1534/genetics.110.114983; BENYEPHET Y, 1977, PHYTOPARASITICA, V5, P159, DOI 10.1007/BF02980349; Bloom JS, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-221; Chung KS, 2001, J BIOL CHEM, V276, P40190, DOI 10.1074/jbc.M100341200; DEVAY JE, 1974, PHYTOPATHOLOGY, V64, P22, DOI 10.1094/Phyto-64-22; Duressa D, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-607; Garcia-Conesa MT, 1999, EUR J BIOCHEM, V266, P644, DOI 10.1046/j.1432-1327.1999.00910.x; Garrett S. D., 1970, PATHOGENIC ROOT INFE; GOTTLIEB D, 1950, BOT REV, V16, P229, DOI 10.1007/BF02873609; HANNAN PJ, 1959, APPL MICROBIOL, V7, P115, DOI 10.1128/AEM.7.2.115-117.1959; HEALE JB, 1965, BR MYCOL SOC TRANS, V48, P39; Hu XP, 2013, EUR J PLANT PATHOL, V136, P225, DOI 10.1007/s10658-013-0170-2; Iwaki H, 2002, APPL ENVIRON MICROB, V68, P5671, DOI 10.1128/AEM.68.11.5671-5684.2002; Klimes A, 2006, FUNGAL GENET BIOL, V43, P283, DOI 10.1016/j.fgb.2005.12.006; Klimes A, 2008, FUNGAL GENET BIOL, V45, P1525, DOI 10.1016/j.fgb.2008.09.014; Klosterman SJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002137; Krishnan A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029817; Kulkarni RD, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-r24; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; LOO M, 1976, DEV BIOL, V54, P201, DOI 10.1016/0012-1606(76)90299-2; Lorenz MC, 2000, GENETICS, V154, P609; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; NELSON PE, 1958, PHYTOPATHOLOGY, V48, P613; Neumann MJ, 2003, FUNGAL GENET BIOL, V38, P54, DOI 10.1016/S1087-1845(02)00507-8; Osherov N, 2000, GENETICS, V155, P647; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Romualdi C, 2003, PHYSIOL GENOMICS, V12, P159, DOI 10.1152/physiolgenomics.00096.2002; Schnathorst WC, 1981, FUNGAL WILT DIS PLAN, P81, DOI DOI 10.1016/B978-0-12-464450-2.50009-7; Staubmann R, 1999, J BIOTECHNOL, V75, P117, DOI 10.1016/S0168-1656(99)00151-0; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wagner GP, 2012, THEOR BIOSCI, V131, P281, DOI 10.1007/s12064-012-0162-3; Wang LK, 2010, BIOINFORMATICS, V26, P136, DOI 10.1093/bioinformatics/btp612; Wu JA, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-234; Xue CY, 2008, FEMS MICROBIOL REV, V32, P1010, DOI 10.1111/j.1574-6976.2008.00131.x; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996	39	24	26	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100046	10.1371/journal.pone.0100046	http://dx.doi.org/10.1371/journal.pone.0100046			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927478	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100111
J	Jahn, SC; Law, ME; Corsino, PE; Davis, BJ; Harrison, JK; Law, BK				Jahn, Stephan C.; Law, Mary E.; Corsino, Patrick E.; Davis, Bradley J.; Harrison, Jeffrey K.; Law, Brian K.			Signaling Mechanisms that Suppress the Cytostatic Actions of Rapamycin	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; MAMMARY-TUMORS; TYROSINE KINASES; PROTEIN-KINASE; BREAST-CANCER; ACTIVATION; AKT; MODEL; PHOSPHORYLATION; INACTIVATION	While rapamycin and the "rapalogs'' Everolimus and Temsirolimus have been approved for clinical use in the treatment of a number of forms of cancer, they have not met overarching success. Some tumors are largely refractory to rapamycin treatment, with some even undergoing an increase in growth rates. However the mechanisms by which this occurs are largely unknown. The results presented here reveal novel cell-signaling mechanisms that may lead to this resistance. The absence of TGF beta signaling results in resistance to rapamycin. Additionally, we observed that treatment of some cancer cell lines with rapamycin and its analogs not only potentiates mitogenic signaling and proliferation induced by HGF, but also stimulates the pro-survival kinase Akt. Together, the data show that the effectiveness of rapamycin treatment can be influenced by a number of factors and bring to light potential biomarkers for the prediction of responsiveness to treatment, and suggest combination therapies to optimize rapalog anticancer efficacy.	[Jahn, Stephan C.; Law, Mary E.; Corsino, Patrick E.; Davis, Bradley J.; Harrison, Jeffrey K.; Law, Brian K.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA; [Jahn, Stephan C.; Law, Mary E.; Corsino, Patrick E.; Davis, Bradley J.; Harrison, Jeffrey K.; Law, Brian K.] Univ Florida, Hlth Canc Ctr, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Law, BK (corresponding author), Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32611 USA.	bklaw@pharmacology.ufl.edu	Law, Brian/L-6043-2019		Susan G. Komen for the Cure [KG080510]; Bankhead-Coley [4BF03]	Susan G. Komen for the Cure(Susan G. Komen Breast Cancer Foundation); Bankhead-Coley	This work was supported in part by Susan G. Komen for the Cure (KG080510) and Bankhead-Coley (4BF03) grants to B.L. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Araki K, 2003, ONCOGENE, V22, P7632, DOI 10.1038/sj.onc.1206840; Arencibia JM, 2013, BBA-PROTEINS PROTEOM, V1834, P1302, DOI 10.1016/j.bbapap.2013.03.010; Argyriou Pinelopi, 2012, Adv Hematol, V2012, P435342, DOI 10.1155/2012/435342; BARNARD JA, 1988, AM J MED SCI, V296, P159, DOI 10.1097/00000441-198809000-00003; Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020; Brennan P, 1999, MOL CELL BIOL, V19, P4729; Chavez-MacGregor M, 2012, EXPERT OPIN INV DRUG, V21, P1835, DOI 10.1517/13543784.2012.726218; Chytil A, 2002, GENESIS, V32, P73, DOI 10.1002/gene.10046; Corsino P, 2007, CANCER RES, V67, P3135, DOI 10.1158/0008-5472.CAN-06-3815; Corsino P, 2009, J BIOL CHEM, V284, P29945, DOI 10.1074/jbc.M109.055251; Corsino PE, 2008, NEOPLASIA, V10, P1240, DOI 10.1593/neo.08710; Dieterle AM, 2013, ONCOGENE; Feng JH, 2004, J BIOL CHEM, V279, P41189, DOI 10.1074/jbc.M406731200; Forrester E, 2005, CANCER RES, V65, P2296, DOI 10.1158/0008-5472.CAN-04-3272; GONZATTIHACES M, 1988, P NATL ACAD SCI USA, V85, P21, DOI 10.1073/pnas.85.1.21; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Haagensen EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081763; Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200; Jahn SC, 2012, CANCER LETT, V326, P183, DOI 10.1016/j.canlet.2012.08.013; Law BK, 2002, MOL CELL BIOL, V22, P8184, DOI 10.1128/MCB.22.23.8184-8198.2002; Law M, 2006, CANCER RES, V66, P1070, DOI 10.1158/0008-5472.CAN-05-1672; Law ME, 2013, ONCOGENE, V32, P1316, DOI 10.1038/onc.2012.138; Liu P, 2014, NATURE; Liu PD, 2013, NAT CELL BIOL, V15, P1340, DOI 10.1038/ncb2860; Lu X, 2004, NEOPLASIA, V6, P603, DOI 10.1593/neo.04241; Mahajan K, 2012, J CELL PHYSIOL, V227, P3178, DOI 10.1002/jcp.24065; Marzec M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024849; Meric F, 2002, CLIN CANCER RES, V8, P361; Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9; Muraoka RS, 2002, J CLIN INVEST, V109, P1551, DOI 10.1172/JCI200215234; Muraoka-Cook RS, 2004, CANCER RES, V64, P9002, DOI 10.1158/0008-5472.CAN-04-2111; Najafov A, 2011, BIOCHEM J, V433, P357, DOI 10.1042/BJ20101732; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Pool SE, 2013, CANCER RES, V73, P12, DOI 10.1158/0008-5472.CAN-11-2089; Romero-Gallo J, 2005, ONCOGENE, V24, P3028, DOI 10.1038/sj.onc.1208475; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Smith AL, 2012, CLIN CANCER RES, V18, P4514, DOI 10.1158/1078-0432.CCR-11-3224; Sun SY, 2013, CANCER LETT, V340, P1, DOI 10.1016/j.canlet.2013.06.017; Wan X, 2007, ONCOGENE, V26, P1932, DOI 10.1038/sj.onc.1209990	40	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99927	10.1371/journal.pone.0099927	http://dx.doi.org/10.1371/journal.pone.0099927			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927123	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100092
J	King, T; Kocharunchitt, C; Gobius, K; Bowman, JP; Ross, T				King, Thea; Kocharunchitt, Chawalit; Gobius, Kari; Bowman, John P.; Ross, Tom			Global Genome Response of Escherichia coli O157:H7 Sakai during Dynamic Changes in Growth Kinetics Induced by an Abrupt Temperature Downshift	PLOS ONE			English	Article							LAG PHASE DURATION; GENE-EXPRESSION; STRESS-RESPONSE; SIGMA(S)-DEPENDENT GENES; TRANSCRIPTIONAL ANALYSIS; MICROARRAY ANALYSIS; PROTEOMIC ANALYSES; STATISTICAL-MODEL; STATIONARY-PHASE; GLYCINE BETAINE	Escherichia coli O157:H7 is a mesophilic food-borne pathogen. We investigated the growth kinetics of E. coli O157: H7 Sakai during an abrupt temperature downshift from 35 degrees C to either 20 degrees C, 17 degrees C, 14 degrees C or 10 degrees C; as well as the molecular mechanisms enabling growth after cold stress upon an abrupt downshift from 35 degrees C to 14 degrees C in an integrated transcriptomic and proteomic analysis. All downshifts caused a lag period of growth before growth resumed at a rate typical of the post-shift temperature. Lag and generation time increased with the magnitude of the shift or with the final temperature, while relative lag time displayed little variation across the test range. Analysis of time-dependent molecular changes revealed, in keeping with a decreased growth rate at lower temperature, repression of genes and proteins involved in DNA replication, protein synthesis and carbohydrate catabolism. Consistent with cold-induced remodelling of the bacterial cell envelope, alterations occurred in the expression of genes and proteins involved in transport and binding. The RpoS regulon exhibited sustained induction confirming its importance in adaptation and growth at 14 degrees C. The RpoE regulon was transiently induced, indicating a potential role for this extracytoplasmic stress response system in the early phase of low temperature adaptation during lag phase. Interestingly, genes previously reported to be amongst the most highly up-regulated under oxidative stress were consistently down-regulated. This comprehensive analysis provides insight into the molecular mechanisms operating during adaptation of E. coli to growth at low temperature and is relevant to its physiological state during chilling in foods, such as carcasses.	[King, Thea] Commonwealth Sci & Ind Res Org, Anim Food & Hlth Sci, N Ryde, NSW, Australia; [Kocharunchitt, Chawalit; Bowman, John P.; Ross, Tom] Univ Tasmania, Food Safety Ctr, Tasmanian Inst Agr, Hobart, Tas, Australia; [Gobius, Kari] Commonwealth Sci & Ind Res Org, Anim Food & Hlth Sci, Werribee, Vic, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); University of Tasmania; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	King, T (corresponding author), Commonwealth Sci & Ind Res Org, Anim Food & Hlth Sci, N Ryde, NSW, Australia.	Thea.King@csiro.au	Gobius, Kari/I-4700-2013; Bowman, John P./ABF-5108-2020; Bowman, John P/C-2414-2014	Gobius, Kari/0000-0002-3653-2581; Bowman, John P./0000-0002-4528-9333; Bowman, John P/0000-0002-4528-9333; Kocharunchitt, Chawalit/0000-0003-3919-2401; Ross, Tom/0000-0001-9916-7772	Meat and Livestock Australia; CSIRO; Food Safety Centre	Meat and Livestock Australia(Meat and Livestock Australia); CSIRO(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Food Safety Centre	This study was funded by Meat and Livestock Australia (http://www.mla.com.au), the CSIRO and the Food Safety Centre. The funder Meat and Livestock Australia had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The funders CSIRO and the Food Safety Centre were involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript.	Allen KJ, 2008, FOODBORNE PATHOG DIS, V5, P437, DOI 10.1089/fpd.2008.0100; Angelidis AS, 2003, APPL ENVIRON MICROB, V69, P7492, DOI 10.1128/AEM.69.12.7492-7498.2003; Beckering CL, 2002, J BACTERIOL, V184, P6395, DOI 10.1128/JB.184.22.6395-6402.2002; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boorsma A, 2005, NUCLEIC ACIDS RES, V33, pW592, DOI 10.1093/nar/gki484; Budde I, 2006, MICROBIOL-SGM, V152, P831, DOI 10.1099/mic.0.28530-0; Cagney C, 2004, FOOD MICROBIOL, V21, P203, DOI 10.1016/S0740-0020(03)00052-2; Cairrao F, 2003, MOL MICROBIOL, V50, P1349, DOI 10.1046/j.1365-2958.2003.03766.x; Carty SM, 1999, J BIOL CHEM, V274, P9677, DOI 10.1074/jbc.274.14.9677; Chen GA, 2002, MOL CELL PROTEOMICS, V1, P304, DOI 10.1074/mcp.M200008-MCP200; Choi H, 2008, J PROTEOME RES, V7, P47, DOI 10.1021/pr700747q; CLARK DP, 1983, BIOCHEMISTRY-US, V22, P5897, DOI 10.1021/bi00294a032; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; Dong T, 2009, MOL GENET GENOMICS, V281, P19, DOI 10.1007/s00438-008-0389-3; Durfee T, 2008, J BACTERIOL, V190, P1084, DOI 10.1128/JB.01092-07; Elder RO, 2000, P NATL ACAD SCI USA, V97, P2999, DOI 10.1073/pnas.060024897; Etchegaray JP, 1996, GENES CELLS, V1, P171, DOI 10.1046/j.1365-2443.1996.d01-231.x; Figueroa-Bossi N, 2006, MOL MICROBIOL, V62, P838, DOI 10.1111/j.1365-2958.2006.05413.x; Free A, 1997, J BACTERIOL, V179, P909, DOI 10.1128/jb.179.3.909-918.1997; Gadgil M, 2005, BIOTECHNOL PROGR, V21, P689, DOI 10.1021/bp049630l; Giuliodori AM, 2007, ANN NY ACAD SCI, V1113, P95, DOI 10.1196/annals.1391.008; Golovlev EL, 2003, MICROBIOLOGY+, V72, P1, DOI 10.1023/A:1022276318653; Griffin TJ, 2002, MOL CELL PROTEOMICS, V1, P323, DOI 10.1074/mcp.M200001-MCP200; Gustavsson N, 2002, MOL MICROBIOL, V43, P107, DOI 10.1046/j.1365-2958.2002.02720.x; Hagiwara D, 2003, J BACTERIOL, V185, P5735, DOI 10.1128/JB.185.19.5735-5746.2003; Hayashi T, 2001, DNA RES, V8, P11, DOI 10.1093/dnares/8.1.11; Horinouchi T, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-579; Hughes TR, 2000, NAT GENET, V25, P333, DOI 10.1038/77116; Ichikawa JK, 2000, P NATL ACAD SCI USA, V97, P9659, DOI 10.1073/pnas.160140297; Ideker T, 2001, SCIENCE, V292, P929, DOI 10.1126/science.292.5518.929; Ingraham J. L., 1996, ESCHERICHIA COLI SAL, V2, P1570; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jonas K, 2008, MOL MICROBIOL, V70, P236, DOI 10.1111/j.1365-2958.2008.06411.x; Jones PG, 1996, P NATL ACAD SCI USA, V93, P76, DOI 10.1073/pnas.93.1.76; Jozefczuk S, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.18; Kandror O, 2002, P NATL ACAD SCI USA, V99, P9727, DOI 10.1073/pnas.142314099; KATO M, 1992, EUR J BIOCHEM, V210, P1007, DOI 10.1111/j.1432-1033.1992.tb17506.x; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; King T, 2010, APPL ENVIRON MICROB, V76, P6514, DOI 10.1128/AEM.02392-09; Ko R, 1999, APPL ENVIRON MICROB, V65, P4040; Kobayashi A, 2006, J BACTERIOL, V188, P5693, DOI 10.1128/JB.00217-06; Kocharunchitt C, 2014, GLOBAL GENOME RESPON, VO157, pH7; Kocharunchitt C, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.009019; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; Li BG, 2003, MICROBIOL-SGM, V149, P1323, DOI 10.1099/mic.0.26213-0; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; MACKEY BM, 1986, J APPL BACTERIOL, V60, P501, DOI 10.1111/j.1365-2672.1986.tb01089.x; McClure P, 2000, WORLD J MICROB BIOT, V16, P749, DOI 10.1023/A:1008997310966; Mellefont LA, 2003, INT J FOOD MICROBIOL, V83, P281, DOI 10.1016/S0168-1605(02)00377-X; Mellefont LA, 2003, INT J FOOD MICROBIOL, V83, P295, DOI 10.1016/S0168-1605(02)00378-1; Moen B, 2009, CAN J MICROBIOL, V55, P714, DOI [10.1139/W09-016, 10.1139/w09-016]; Nachin L, 2005, J BACTERIOL, V187, P6265, DOI 10.1128/JB.187.18.6265-6272.2005; Nakashima K, 1996, J BACTERIOL, V178, P2994, DOI 10.1128/jb.178.10.2994-2997.1996; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Overgaard M, 2009, MOL MICROBIOL, V74, P1289, DOI 10.1111/j.1365-2958.2009.06943.x; Ozcan N, 2005, J BACTERIOL, V187, P4752, DOI 10.1128/JB.187.14.4752-4759.2005; Patten CL, 2004, MOL GENET GENOMICS, V272, P580, DOI 10.1007/s00438-004-1089-2; Phadtare S, 2004, J BACTERIOL, V186, P7007, DOI 10.1128/JB.186.20.7007-7014.2004; Phadtare S, 2004, CURR ISSUES MOL BIOL, V6, P125; Pham TV, 2010, BIOINFORMATICS, V26, P363, DOI 10.1093/bioinformatics/btp677; Polissi A, 2003, RES MICROBIOL, V154, P573, DOI 10.1016/S0923-2508(03)00167-0; Price NL, 2009, J BACTERIOL, V191, P1798, DOI 10.1128/JB.00798-08; Raivio TL, 1999, CURR OPIN MICROBIOL, V2, P159, DOI 10.1016/S1369-5274(99)80028-9; Rangel JM, 2005, EMERG INFECT DIS, V11, P603, DOI 10.3201/eid1104.040739; Rauch A, 2006, J PROTEOME RES, V5, P112, DOI 10.1021/pr0503533; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Robinson TP, 1998, INT J FOOD MICROBIOL, V44, P83, DOI 10.1016/S0168-1605(98)00120-2; Rock CO, 1996, J BACTERIOL, V178, P5382, DOI 10.1128/jb.178.18.5382-5387.1996; Rodrigues DF, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-547; Ross T, 2003, INT J FOOD MICROBIOL, V82, P33, DOI 10.1016/S0168-1605(02)00252-0; Rozen S, 2000, Methods Mol Biol, V132, P365; Russell NJ, 2002, INT J FOOD MICROBIOL, V79, P27, DOI 10.1016/S0168-1605(02)00176-9; Rustici G, 2013, NUCLEIC ACIDS RES, V41, pD987, DOI 10.1093/nar/gks1174; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Strocchi M, 2006, PROTEOMICS, V6, P193, DOI 10.1002/pmic.200500031; Thieringer HA, 1998, BIOESSAYS, V20, P49; Tian Q, 2004, MOL CELL PROTEOMICS, V3, P960, DOI 10.1074/mcp.M400055-MCP200; Tsui HCT, 1997, J BACTERIOL, V179, P7476, DOI 10.1128/jb.179.23.7476-7487.1997; Vizcaino JA, 2013, NUCLEIC ACIDS RES, V41, pD1063, DOI 10.1093/nar/gks1262; Watanabe H, 1996, LANCET, V348, P831, DOI 10.1016/S0140-6736(05)65257-9; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Weber Michael H. W., 2003, Science Progress, V86, P9, DOI 10.3184/003685003783238707; White-Ziegler CA, 2008, MICROBIOL-SGM, V154, P148, DOI 10.1099/mic.0.2007/012021-0; Liu XX, 2008, J BACTERIOL, V190, P972, DOI 10.1128/JB.01590-07; Yamanaka K, 1998, MOL MICROBIOL, V27, P247, DOI 10.1046/j.1365-2958.1998.00683.x; Yamanaka Kunitoshi, 1999, Journal of Molecular Microbiology and Biotechnology, V1, P193; Yang L, 2009, FEMS MICROBIOL LETT, V291, P50, DOI 10.1111/j.1574-6968.2008.01434.x; Yohannes E, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-59; Zheng JM, 2007, MOL MICROBIOL, V63, P1360, DOI 10.1111/j.1365-2958.2007.05611.x; Zheng M, 2001, J BACTERIOL, V183, P4562, DOI 10.1128/JB.183.15.4562-4570.2001; Zybailov B, 2006, J PROTEOME RES, V5, P2339, DOI 10.1021/pr060161n	93	12	12	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99627	10.1371/journal.pone.0099627	http://dx.doi.org/10.1371/journal.pone.0099627			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926786	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100057
J	Lu, X; Wang, YL; Meng, HY; Chen, PS; Huang, YQ; Wang, ZM; Zhou, NT; Li, CJ; Wang, LS; Jia, EZ; Yang, ZJ				Lu, Xin; Wang, Yunle; Meng, Haoyu; Chen, Pengsheng; Huang, Yaqing; Wang, Zemu; Zhou, Ningtian; Li, Chunjian; Wang, Liansheng; Jia, Enzhi; Yang, Zhijian			Association of Admission Serum Calcium Levels and In-Hospital Mortality in Patients with Acute ST-Elevated Myocardial Infarction: An Eight-Year, Single-Center Study in China	PLOS ONE			English	Article							CORONARY INTERVENTION; INTRACELLULAR CALCIUM; IONIZED HYPOCALCEMIA; CRITICALLY-ILL; RISK-FACTORS; TASK-FORCE; INFLAMMATION; GUIDELINES; PREDICTOR	Objective: The relationship between admission serum calcium levels and in-hospital mortality in patients with acute ST-segment elevation myocardial infarction (STEMI) has not been well definitively explored. The objective was to assess the predictive value of serum calcium levels on in-hospital mortality in STEMI patients. Methods: From 2003 to 2010, 1431 consecutive STEMI patients admitted to the First Affiliated Hospital of Nanjing Medical University were enrolled in the present study. Patients were stratified according to quartiles of serum calcium from the blood samples collected in the emergency room after admission. Between the aforementioned groups, the baseline characteristics, in-hospital management, and in-hospital mortality were analyzed. The association of serum calcium level with in-hospital mortality was calculated by a multivariable Cox regression analysis. Results: Among 1431 included patients, 79% were male and the median age was 65 years (range, 55-74). Patients in the lower quartiles of serum calcium, as compared to the upper quartiles of serum calcium, were older, had more cardiovascular risk factors, lower rate of emergency revascularization and higher in-hospital mortality. According to univariate Cox proportional analysis, patients with lower serum calcium level (hazard ratio 0.267, 95% confidence interval 0.164-0.433, p<0.001) was associated with higher in-hospital mortality. The result of multivariable Cox proportional hazard regression analyses showed that the Killip's class >= 3 (HR = 2.192, p = 0.026), aspartate aminotransferase (HR = 1.001, p<0.001), neutrophil count (HR = 1.123, p<0.001), serum calcium level (HR = 0.255, p = 0.001), and emergency revascularization (HR = 0.122, p<0.001) were significantly and independently associated with in-hospital mortality in STEMI patients. Conclusions: Serum calcium was an independent predictor for in-hospital mortality in patients with STEMI. This widely available serum biochemical index may be incorporated into the current established risk stratification model of STEMI patients. Further studies are required to determine the actual mechanism and whether patients with hypocalcaemia could benefit from calcium supplement.	[Lu, Xin; Wang, Yunle; Meng, Haoyu; Chen, Pengsheng; Wang, Zemu; Zhou, Ningtian; Li, Chunjian; Wang, Liansheng; Jia, Enzhi; Yang, Zhijian] Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China; [Huang, Yaqing] Nanjing Med Univ, Drum Tower Hosp, Dept Gastroenterol, Nanjing, Jiangsu, Peoples R China; [Yang, Zhijian] Nanjing Med Univ, Affiliated Hosp 1, Dept Geriatr, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing University; Nanjing Medical University	Yang, ZJ (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Cardiol, Nanjing, Jiangsu, Peoples R China.	zhijianyangnj@njmu.edu.cn	Jia, Enzhi/AGX-9137-2022; Wang, Ze-Mu/F-8243-2010	Wang, Ze-Mu/0000-0003-2517-7382	National Natural Science Foundation of China [81170102/H0203]; Priority Academic Program Development of Jiangsu Higher Education Institutions [BL2012011]; Chinese Medical Association of the Sunlight Foundation [SCRFCMDA201217]; Fourth Period Progect "333'' of Jiangsu Province [BRA2012207]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions; Chinese Medical Association of the Sunlight Foundation; Fourth Period Progect "333'' of Jiangsu Province	Project supported by the National Natural Science Foundation of China (No. 81170102/H0203), the Priority Academic Program Development of Jiangsu Higher Education Institutions (BL2012011), the Chinese Medical Association of the Sunlight Foundation (SCRFCMDA201217), the Fourth Period Progect "333'' of Jiangsu Province (BRA2012207). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baxter GF, 2002, BASIC RES CARDIOL, V97, P268, DOI 10.1007/s00395-002-0366-7; Boya P, 2001, EMBO J, V20, P4325, DOI 10.1093/emboj/20.16.4325; Campillo-Soto A, 2009, CIR ESPAN, V86, P391, DOI 10.1016/j.ciresp.2009.03.029; Cherry RA, 2006, J TRAUMA, V61, P774, DOI 10.1097/01.ta.0000239516.49799.63; Choi YC, 2008, J KOREAN MED SCI, V23, P700, DOI 10.3346/jkms.2008.23.4.700; CHULKOVA TM, 1989, VOP MED KHIM, V35, P2; Clunn GF, 1997, BRIT J PHARMACOL, V121, P1789, DOI 10.1038/sj.bjp.0701299; Cross KML, 2000, IN VITRO CELL DEV-AN, V36, P50; Eisner D, 2013, J MOL CELL CARDIOL, V58, P110, DOI 10.1016/j.yjmcc.2012.11.017; Frick TW, 2012, SURGERY, V152, pS157, DOI 10.1016/j.surg.2012.05.013; HADJIS T, 1993, CLIN NEPHROL, V39, P22; Hastbacka J, 2003, ACTA ANAESTH SCAND, V47, P1264, DOI 10.1046/j.1399-6576.2003.00236.x; HOVIS JG, 1993, ENDOCRINOLOGY, V132, P1931, DOI 10.1210/en.132.5.1931; Jorde R, 1999, HYPERTENSION, V34, P484, DOI 10.1161/01.HYP.34.3.484; Kaya MG, 2013, INT J CARDIOL, V168, P1154, DOI 10.1016/j.ijcard.2012.11.074; Kushner FG, 2009, CATHETER CARDIO INTE, V74, pE25, DOI [10.1016/j.jacc.2009.10.015, 10.1002/ccd.22351]; Lazzeri C, 2010, MED SCI MONITOR, V16, pCR567; Libby P, 2010, CIRC J, V74, P213, DOI 10.1253/circj.CJ-09-0706; Lind L, 1997, J CLIN EPIDEMIOL, V50, P967, DOI 10.1016/S0895-4356(97)00104-2; LIND L, 1988, BMJ-BRIT MED J, V297, P960, DOI 10.1136/bmj.297.6654.960; Lundgren E, 2001, SURGERY, V130, P978, DOI 10.1067/msy.2001.118377; Meissner J, 2011, AM J MED, V124, P534, DOI 10.1016/j.amjmed.2010.10.023; Morrow DA, 2000, CIRCULATION, V102, P2031, DOI 10.1161/01.CIR.102.17.2031; Muller B, 2000, EUR J CLIN INVEST, V30, P823; Pettit EJ, 1998, PHYSIOL REV, V78, P949, DOI 10.1152/physrev.1998.78.4.949; Silber S, 2005, EUR HEART J, V26, P804, DOI 10.1093/eurheartj/ehi138; SZYFELBEIN SK, 1981, CRIT CARE MED, V9, P454, DOI 10.1097/00003246-198106000-00004; Tantry US, 2010, PLATELETS, V21, P360, DOI 10.3109/09537100903548903; Thygesen K, 2007, CIRCULATION, V116, P2634, DOI 10.1161/CIRCULATIONAHA.107.187397; Van Hemelrijck M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061037; Varga-Szabo D, 2009, J THROMB HAEMOST, V7, P1057, DOI 10.1111/j.1538-7836.2009.03455.x; VINCENT JL, 1995, INTENS CARE MED, V21, P838, DOI 10.1007/BF01700968; WALKER BE, 1979, J CLIN PATHOL, V32, P488, DOI 10.1136/jcp.32.5.488	33	27	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99895	10.1371/journal.pone.0099895	http://dx.doi.org/10.1371/journal.pone.0099895			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926660	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100088
J	Romo, PA; Zeater, N; Wang, C; Dreher, B				Romo, Phillip A.; Zeater, Natalie; Wang, Chun; Dreher, Bogdan			Binocular Neurons in Parastriate Cortex: Interocular 'Matching' of Receptive Field Properties, Eye Dominance and Strength of Silent Suppression	PLOS ONE			English	Article							CAT STRIATE CORTEX; LATERAL GENICULATE-NUCLEUS; PRIMARY VISUAL-CORTEX; SPATIAL-FREQUENCY SELECTIVITY; OPTIC-NERVE FIBERS; OCULAR-DOMINANCE; ORIENTATION SELECTIVITY; DEPTH DISCRIMINATION; COMPLEX CELLS; SINGLE UNITS	Spike-responses of single binocular neurons were recorded from a distinct part of primary visual cortex, the parastriate cortex (cytoarchitectonic area 18) of anaesthetized and immobilized domestic cats. Functional identification of neurons was based on the ratios of phase-variant (F1) component to the mean firing rate (F0) of their spike-responses to optimized (orientation, direction, spatial and temporal frequencies and size) sine-wave-luminance-modulated drifting grating patches presented separately via each eye. In over 95% of neurons, the interocular differences in the phase-sensitivities (differences in F1F0 spike-response ratios) were small (<= 0.3) and in over 80% of neurons, the interocular differences in preferred orientations were <= 10 degrees. The interocular correlations of the direction selectivity indices and optimal spatial frequencies, like those of the phase sensitivies and optimal orientations, were also strong (coefficients of correlation r >= 0.7005). By contrast, the interocular correlations of the optimal temporal frequencies, the diameters of summation areas of the excitatory responses and suppression indices were weak (coefficients of correlation r <= 0.4585). In cells with high eye dominance indices (HEDI cells), the mean magnitudes of suppressions evoked by stimulation of silent, extra-classical receptive fields via the non-dominant eyes, were significantly greater than those when the stimuli were presented via the dominant eyes. We argue that the well documented 'eye-origin specific' segregation of the lateral geniculate inputs underpinning distinct eye dominance columns in primary visual cortices of mammals with frontally positioned eyes (distinct eye dominance columns), combined with significant interocular differences in the strength of silent suppressive fields, putatively contribute to binocular stereoscopic vision.	[Dreher, Bogdan] Univ Sydney, Discipline Anat & Histol, Sch Med Sci, Sydney, NSW 2006, Australia; Univ Sydney, Bosch Inst, Sydney, NSW 2006, Australia	University of Sydney; University of Sydney	Dreher, B (corresponding author), Univ Sydney, Discipline Anat & Histol, Sch Med Sci, Sydney, NSW 2006, Australia.	bogdand@anatomy.usyd.edu.au		Zeater, Natalie/0000-0001-8555-6574	National Health and Medical Research Council; Australian Research Council	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Australian Research Council(Australian Research Council)	This work has been supported by the grants from the National Health and Medical Research Council and the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON PA, 1988, J NEUROSCI, V8, P2183; Anzai A, 1999, J NEUROPHYSIOL, V82, P891, DOI 10.1152/jn.1999.82.2.891; Anzai A, 1999, J NEUROPHYSIOL, V82, P909, DOI 10.1152/jn.1999.82.2.909; Bardy C, 2006, J PHYSIOL-LONDON, V574, P731, DOI 10.1113/jphysiol.2006.110320; BARLOW HB, 1967, J PHYSIOL-LONDON, V193, P327, DOI 10.1113/jphysiol.1967.sp008360; BAUMAN LA, 1991, VISION RES, V31, P933, DOI 10.1016/0042-6989(91)90201-F; BERMAN N, 1982, J NEUROPHYSIOL, V48, P1362, DOI 10.1152/jn.1982.48.6.1362; BISHOP PO, 1962, J PHYSIOL-LONDON, V163, P466, DOI 10.1113/jphysiol.1962.sp006990; BISHOP PO, 1971, J PHYSIOL-LONDON, V216, P39, DOI 10.1113/jphysiol.1971.sp009508; BISTI S, 1985, J PHYSIOL-LONDON, V359, P259, DOI 10.1113/jphysiol.1985.sp015584; BLAKE R, 1991, TRENDS NEUROSCI, V14, P445, DOI 10.1016/0166-2236(91)90043-T; BLAKEMORE C, 1972, J PHYSIOL-LONDON, V226, P725, DOI 10.1113/jphysiol.1972.sp010006; BLAKEMORE C, 1975, J PHYSIOL-LONDON, V248, P663, DOI 10.1113/jphysiol.1975.sp010995; BLAKEMORE C, 1972, EXP BRAIN RES, V15, P439; BLAKEMORE C, 1974, J PHYSIOL-LONDON, V237, P195, DOI 10.1113/jphysiol.1974.sp010478; BLAKEMORE C, 1970, VISION RES, V10, P1181, DOI 10.1016/0042-6989(70)90036-2; BONDS AB, 1989, VISUAL NEUROSCI, V2, P41, DOI 10.1017/S0952523800004314; Bridge H, 2001, J NEUROSCI, V21, P7293, DOI 10.1523/JNEUROSCI.21-18-07293.2001; BRUCE CJ, 1981, J NEUROPHYSIOL, V46, P215, DOI 10.1152/jn.1981.46.2.215; BURKE W, 1992, VISUAL NEUROSCI, V9, P47, DOI 10.1017/S0952523800006362; CASANOVA C, 1992, VISUAL NEUROSCI, V9, P581, DOI 10.1017/S0952523800001826; Crair MC, 1998, SCIENCE, V279, P566, DOI 10.1126/science.279.5350.566; CREWTHER SG, 1980, J NEUROPHYSIOL, V44, P97, DOI 10.1152/jn.1980.44.1.97; Cumming BG, 2001, ANNU REV NEUROSCI, V24, P203, DOI 10.1146/annurev.neuro.24.1.203; CYNADER M, 1978, J PHYSIOL-LONDON, V274, P549, DOI 10.1113/jphysiol.1978.sp012166; CYNADER M, 1973, P NATL ACAD SCI USA, V70, P1353, DOI 10.1073/pnas.70.5.1353; CYNADER M, 1982, VISION RES, V22, P967, DOI 10.1016/0042-6989(82)90033-5; DEANGELIS GC, 1995, PERCEPTION, V24, P3, DOI 10.1068/p240003; DEANGELIS GC, 1991, NATURE, V352, P156, DOI 10.1038/352156a0; DERRINGTON AM, 1979, J PHYSIOL-LONDON, V293, P347, DOI 10.1113/jphysiol.1979.sp012893; DEVALOIS KK, 1983, J PHYSIOL-LONDON, V336, P359, DOI 10.1113/jphysiol.1983.sp014586; DiCarlo JJ, 1996, J NEUROSCI METH, V64, P75, DOI 10.1016/0165-0270(95)00113-1; DREHER B, 1980, J NEUROPHYSIOL, V44, P804, DOI 10.1152/jn.1980.44.4.804; DREHER B, 1992, VISUAL NEUROSCI, V9, P65, DOI 10.1017/S0952523800006374; DREHER B, 1975, J NEUROPHYSIOL, V38, P735, DOI 10.1152/jn.1975.38.4.735; Dreher B., 1986, VISUAL NEUROSCI, P290; ERULKAR SD, 1960, J PHYSIOL-LONDON, V154, P206, DOI 10.1113/jphysiol.1960.sp006574; Erwin E, 1998, J NEUROSCI, V18, P9870; Feldman DE, 2012, NEURON, V75, P556, DOI 10.1016/j.neuron.2012.08.001; Ferster D, 2000, ANNU REV NEUROSCI, V23, P441, DOI 10.1146/annurev.neuro.23.1.441; FERSTER D, 1981, J PHYSIOL-LONDON, V311, P623, DOI 10.1113/jphysiol.1981.sp013608; FREGNAC Y, 1984, PHYSIOL REV, V64, P325, DOI 10.1152/physrev.1984.64.1.325; FREUND TF, 1985, J COMP NEUROL, V242, P263, DOI 10.1002/cne.902420208; GALLI L, 1988, EXP BRAIN RES, V71, P1; GARDNER JC, 1986, EXP BRAIN RES, V64, P505, DOI 10.1007/BF00340488; GARDNER JC, 1985, BRAIN RES, V328, P154, DOI 10.1016/0006-8993(85)91335-6; Gardner JL, 1999, VISUAL NEUROSCI, V16, P1115, DOI 10.1017/S0952523899166112; Godecke I, 1996, NATURE, V379, P251, DOI 10.1038/379251a0; HAMMOND P, 1991, EXP BRAIN RES, V85, P631; Hammond P, 1996, J NEUROPHYSIOL, V75, P1163, DOI 10.1152/jn.1996.75.3.1163; HATA Y, 1988, NATURE, V335, P815, DOI 10.1038/335815a0; HEGGELUND P, 1986, J PHYSIOL-LONDON, V373, P277, DOI 10.1113/jphysiol.1986.sp016047; HIRSCH HVB, 1971, EXP BRAIN RES, V12, P509; Horton JC, 2005, PHILOS T R SOC B, V360, P837, DOI 10.1098/rstb.2005.1623; HUBEL DH, 1968, J PHYSIOL-LONDON, V195, P215, DOI 10.1113/jphysiol.1968.sp008455; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; HUMPHREY AL, 1985, J COMP NEUROL, V233, P190, DOI 10.1002/cne.902330204; JOSHUA DE, 1970, EXP BRAIN RES, V10, P389, DOI 10.1007/BF02324766; Kara P, 2009, NATURE, V458, P627, DOI 10.1038/nature07721; KATO H, 1981, J NEUROPHYSIOL, V46, P932, DOI 10.1152/jn.1981.46.5.932; Kimura A, 2013, EUR J NEUROSCI, V37, P1270, DOI 10.1111/ejn.12149; Kuhlmann L, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00081; LEHMKUHLE S, 1980, J NEUROPHYSIOL, V43, P520, DOI 10.1152/jn.1980.43.2.520; LEVAY S, 1988, VISUAL NEUROSCI, V1, P395, DOI 10.1017/S0952523800004168; LEVAY S, 1975, J COMP NEUROL, V159, P559, DOI 10.1002/cne.901590408; LEVAY S, 1977, J COMP NEUROL, V172, P563, DOI 10.1002/cne.901720402; LEVAY S, 1980, J COMP NEUROL, V191, P1, DOI 10.1002/cne.901910102; Ma WP, 2013, J NEUROSCI, V33, P11276, DOI 10.1523/JNEUROSCI.5598-12.2013; MACY A, 1982, EXP BRAIN RES, V48, P401; MASKE R, 1984, VISION RES, V24, P1921, DOI 10.1016/0042-6989(84)90026-9; MORRONE MC, 1982, PROC R SOC SER B-BIO, V216, P335, DOI 10.1098/rspb.1982.0078; MOVSHON JA, 1976, J PHYSIOL-LONDON, V261, P125, DOI 10.1113/jphysiol.1976.sp011551; NELSON JI, 1977, J NEUROPHYSIOL, V40, P260, DOI 10.1152/jn.1977.40.2.260; NIKARA T, 1968, EXP BRAIN RES, V6, P353; Ninomiya T, 2012, J NEUROPHYSIOL, V107, P2220, DOI 10.1152/jn.00832.2010; OHZAWA I, 1988, J NEUROSCI, V8, P2507; OHZAWA I, 1986, J NEUROPHYSIOL, V56, P243, DOI 10.1152/jn.1986.56.1.243; OHZAWA I, 1990, SCIENCE, V249, P1037, DOI 10.1126/science.2396096; Payne BR, 2002, CAT PRIMARY VISUAL C, P1, DOI [10.1016/b978-012552104-8/50002-x, DOI 10.1016/B978-012552104-8/50002-X]; PETTIGRE.JD, 1973, NATURE-NEW BIOL, V241, P123, DOI 10.1038/newbio241123a0; PETTIGREW JD, 1987, PROC R SOC SER B-BIO, V232, P297, DOI 10.1098/rspb.1987.0076; PETTIGREW JD, 1968, EXP BRAIN RES, V6, P391; PETTIGREW JD, 1979, INVEST OPHTH VIS SCI, V18, P490; RAMOA AS, 1986, NATURE, V321, P237, DOI 10.1038/321237a0; RAUSCHECKER JP, 1991, PHYSIOL REV, V71, P587, DOI 10.1152/physrev.1991.71.2.587; Read JCA, 2003, J NEUROPHYSIOL, V90, P2795, DOI 10.1152/jn.01110.2002; REGAN D, 1979, PROC R SOC SER B-BIO, V204, P485, DOI 10.1098/rspb.1979.0042; Regan D, 1991, VISION VISUAL DYSFUN, P137; Ringach DL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000251; Ringach DL, 2004, J NEUROPHYSIOL, V92, P468, DOI 10.1152/jn.01202.2003; Ringach DL, 2002, J NEUROPHYSIOL, V87, P1018, DOI 10.1152/jn.00614.2001; RODIECK RW, 1979, EXP BRAIN RES, V35, P465; RODIECK RW, 1967, VISION RES, V7, P107, DOI 10.1016/0042-6989(67)90031-4; Romo PA, 2011, J NEUROPHYSIOL, V106, P1688, DOI 10.1152/jn.00894.2010; Rosenquist AC., 1985, CEREB CORTEX, P81; Sanada TM, 2006, J NEUROPHYSIOL, V95, P2768, DOI 10.1152/jn.00955.2005; SANDERSON KJ, 1969, VISION RES, V9, P1297, DOI 10.1016/0042-6989(69)90117-5; SANDERSON KJ, 1971, J NEUROPHYSIOL, V34, P453, DOI 10.1152/jn.1971.34.3.453; Sarnaik R, 2013, CEREB CORTEX, P1, DOI 101093/cercor/bht027; Scholl B, 2013, J NEUROPHYSIOL, V109, P3013, DOI 10.1152/jn.01021.2012; Sengpiel F, 1998, NEUROPHARMACOLOGY, V37, P607, DOI 10.1016/S0028-3908(98)00034-3; SENGPIEL F, 1995, VISION RES, V35, P179, DOI 10.1016/0042-6989(94)00125-6; SHATZ CJ, 1977, BRAIN RES, V131, P103, DOI 10.1016/0006-8993(77)90031-2; SHERK H, 1978, J NEUROPHYSIOL, V41, P204, DOI 10.1152/jn.1978.41.1.204; SHINKMAN PG, 1983, J NEUROPHYSIOL, V49, P717, DOI 10.1152/jn.1983.49.3.717; SIEGEL S., 1956, NONPARAMETRIC STAT B; SILLITO AM, 1979, J PHYSIOL-LONDON, V289, P33, DOI 10.1113/jphysiol.1979.sp012723; SILLITO AM, 1980, EXP BRAIN RES, V41, P1; SINGER W, 1970, BRAIN RES, V18, P165, DOI 10.1016/0006-8993(70)90463-4; SKOTTUN BC, 1984, EXP BRAIN RES, V56, P206; SKOTTUN BC, 1991, VISION RES, V31, P1079, DOI 10.1016/0042-6989(91)90033-2; SPILEERS W, 1990, J NEUROPHYSIOL, V63, P936, DOI 10.1152/jn.1990.63.4.936; STONE J, 1973, J NEUROPHYSIOL, V36, P551, DOI 10.1152/jn.1973.36.3.551; STONE J, 1979, BRAIN RES REV, V1, P345, DOI 10.1016/0165-0173(79)90010-9; STRYKER MP, 1978, J NEUROPHYSIOL, V41, P896, DOI 10.1152/jn.1978.41.4.896; TIEMAN SB, 1983, BRAIN RES, V267, P35, DOI 10.1016/0006-8993(83)91037-5; Vidyasagar TR, 1996, TRENDS NEUROSCI, V19, P272, DOI 10.1016/S0166-2236(96)20027-X; Wang BS, 2010, NEURON, V65, P246, DOI 10.1016/j.neuron.2010.01.002; WANG C, 1994, EXP BRAIN RES, V97, P451; Wheatstone C., 1838, PHILOS T ROY SOC LON, P371, DOI DOI 10.1098/RSTL.1838.0019; WIESEL TN, 1974, BRAIN RES, V79, P273, DOI 10.1016/0006-8993(74)90416-8; WILSON HR, 1976, VISION RES, V16, P983, DOI 10.1016/0042-6989(76)90230-3; Yao HS, 2004, P NATL ACAD SCI USA, V101, P5081, DOI 10.1073/pnas.0302510101	124	1	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99600	10.1371/journal.pone.0099600	http://dx.doi.org/10.1371/journal.pone.0099600			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927276	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100053
J	De Angelis, M; Montemurno, E; Piccolo, M; Vannini, L; Lauriero, G; Maranzano, V; Gozzi, G; Serrazanetti, D; Dalfino, G; Gobbetti, M; Gesualdo, L				De Angelis, Maria; Montemurno, Eustacchio; Piccolo, Maria; Vannini, Lucia; Lauriero, Gabriella; Maranzano, Valentina; Gozzi, Giorgia; Serrazanetti, Diana; Dalfino, Giuseppe; Gobbetti, Marco; Gesualdo, Loreto			Microbiota and Metabolome Associated with Immunoglobulin A Nephropathy (IgAN)	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TERM-FOLLOW-UP; HIGH-FAT DIET; GUT MICROBIOTA; FECAL MICROBIOTA; GASTROINTESTINAL MICROBIOTA; INTESTINAL MICROBIOTA; CHILDREN; INFLAMMATION; PATHOGENESIS	This study aimed at investigating the fecal microbiota, and the fecal and urinary metabolome of non progressor (NP) and progressor (P) patients with immunoglobulin A nephropathy (IgAN). Three groups of volunteers were included in the study: (i) sixteen IgAN NP patients; (ii) sixteen IgAN P patients; and (iii) sixteen healthy control (HC) subjects, without known diseases. Selective media were used to determine the main cultivable bacterial groups. Bacterial tag-encoded FLX-titanium amplicon pyrosequencing of the 16S rDNA and 16S rRNA was carried out to determine total and metabolically active bacteria, respectively. Biochrom 30 series amino acid analyzer and gas-chromatography mass spectrometry/solid-phase microextraction (GC-MS/SPME) analyses were mainly carried out for metabolomic analyses. As estimated by rarefaction, Chao and Shannon diversity index, the lowest microbial diversity was found in P patients. Firmicutes increased in the fecal samples of NP and, especially, P patients due to the higher percentages of some genera/species of Ruminococcaceae, Lachnospiraceae, Eubacteriaceae and Streptococcaeae. With a few exceptions, species of Clostridium, Enterococcus and Lactobacillus genera were found at the highest levels in HC. Bacteroidaceae, Porphyromonadaceae, Prevotellaceae and Rikenellaceae families differed among NP, P and HC subjects. Sutterellaceae and Enterobacteriaceae species were almost the highest in the fecal samples of NP and/or P patients. Compared to HC subjects, Bifidobacterium species decreased in the fecal samples of NP and P. As shown by multivariate statistical analyses, the levels of metabolites (free amino acids and organic volatile compounds) from fecal and urinary samples markedly differentiated NP and, especially, P patients.	[De Angelis, Maria; Piccolo, Maria; Gobbetti, Marco] Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy; [Montemurno, Eustacchio; Lauriero, Gabriella; Maranzano, Valentina; Dalfino, Giuseppe; Gesualdo, Loreto] Univ Bari Aldo Moro, Dept Emergency & Organ Transplantat, Nephrol Unit, Bari, Italy; [Vannini, Lucia; Gozzi, Giorgia] Univ Bologna, Dept Agr & Food Sci, Bologna, Italy; [Serrazanetti, Diana] Univ Cesena, Interdept Ctr Ind Agri Food Res, Cesena, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Bologna	De Angelis, M (corresponding author), Univ Bari Aldo Moro, Dept Soil Plant & Food Sci, Bari, Italy.	maria.deangelis@uniba.it	De Angelis, Maria/AAA-9909-2019; Dalfino, Giuseppe G/I-8125-2018; Serrazanetti, Diana Isabella/K-2606-2016; Gesualdo, Loreto/K-7751-2016; Gobbetti, Marco/K-4138-2014	Dalfino, Giuseppe G/0000-0002-6381-6985; Serrazanetti, Diana Isabella/0000-0002-6796-4053; Gesualdo, Loreto/0000-0002-4861-0911; GOZZI, Giorgia/0000-0001-6015-6144; Vannini, Lucia/0000-0002-9417-8410; Gobbetti, Marco/0000-0003-0869-2737; De Angelis, Maria/0000-0002-2010-884X	University of Bari Aldo Moro; University of Bologna	University of Bari Aldo Moro; University of Bologna	This work was founded by the University of Bari Aldo Moro and the University of Bologna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALAMARTINE E, 1991, AM J KIDNEY DIS, V18, P12, DOI 10.1016/S0272-6386(12)80284-8; Anders HJ, 2013, KIDNEY INT, V83, P1010, DOI 10.1038/ki.2012.440; Bajaj JS, 2012, AM J GASTROENTEROL S, V1, P9, DOI DOI 10.1038/ajgsup.2012.3; Bammens B, 2003, KIDNEY INT, V64, P2196, DOI 10.1046/j.1523-1755.2003.00314.x; Berger J, 1968, J Urol Nephrol (Paris), V74, P694; Boyd JK, 2010, KIDNEY INT, V78, P1211, DOI 10.1038/ki.2010.365; Brandt LJ, 2012, AM J GASTROENTEROL, V107, P1079, DOI 10.1038/ajg.2012.60; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Chang JH, 2009, NEPHROL DIAL TRANSPL, V24, P2406, DOI 10.1093/ndt/gfp091; Chao A, 2002, BIOMETRICS, V58, P531, DOI 10.1111/j.0006-341X.2002.00531.x; Cho SB, 2013, BRIT J DERMATOL, V168, P977, DOI 10.1111/bjd.12128; Chow J, 2011, CURR OPIN IMMUNOL, V23, P473, DOI 10.1016/j.coi.2011.07.010; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DAMICO G, 1985, MEDICINE, V64, P49, DOI 10.1097/00005792-198501000-00004; De Angelis M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076993; Di Cagno R, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-219; Di Cagno R, 2009, APPL ENVIRON MICROB, V75, P3963, DOI 10.1128/AEM.02793-08; Di Mauro A, 2013, ITAL J PEDIATR, V39, DOI 10.1186/1824-7288-39-15; Dowd SE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003326; Dowd SE, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-93; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elgaali H, 2002, J BASIC MICROB, V42, P373, DOI 10.1002/1521-4028(200212)42:6<373::AID-JOBM373>3.0.CO;2-4; Finegold SM, 2010, ANAEROBE, V16, P444, DOI 10.1016/j.anaerobe.2010.06.008; Fox-Orenstein A. E, 2012, AM J GASTROENTEROL S, V1, P41, DOI DOI 10.1038/AJGSUP.2012.8; Francavilla R, 2012, PEDIAT ALLERG IMM-UK, V23, P420, DOI 10.1111/j.1399-3038.2012.01286.x; Fukuuchi F., 2002, CLIN EXP NEPHROL, V6, P99, DOI [10.1007/s101570200016, DOI 10.1007/S101570200016]; Glassock RJ, 2009, TREATMENT PRIMARY GL, P313; Gondalia SV, 2012, AUTISM RES, V5, P419, DOI 10.1002/aur.1253; Gontcharova Viktoria, 2010, Open Microbiol J, V4, P47, DOI 10.2174/1874285801004010047; Gowen CM, 2010, BIOTECHNOL J, V5, P759, DOI 10.1002/biot.201000084; Hansen J, 2010, CURR OPIN GASTROEN, V26, P564, DOI 10.1097/MOG.0b013e32833f1195; Hooper LV, 2012, SCIENCE, V336, P1268, DOI 10.1126/science.1223490; JOHNSTON PA, 1992, Q J MED, V84, P619; KATAFUCHI R, 1994, CLIN NEPHROL, V41, P191; Kiryluk K, 2013, ANNU REV MED, V64, P339, DOI 10.1146/annurev-med-041811-142014; Macfarlane GT, 2012, J AOAC INT, V95, P50, DOI 10.5740/jaoacint.SGE_Macfarlane; Manno C, 2007, AM J KIDNEY DIS, V49, P763, DOI 10.1053/j.ajkd.2007.03.013; Manno C, 2009, NEPHROL DIAL TRANSPL, V24, P3694, DOI 10.1093/ndt/gfp356; McCarthy DD, 2011, J CLIN INVEST, V121, P3991, DOI 10.1172/JCI45563; Medina M, 2008, J INFLAMM-LOND, V5, DOI 10.1186/1476-9255-5-19; Meijers BKI, 2011, NEPHROL DIAL TRANSPL, V26, P759, DOI 10.1093/ndt/gfq818; Meng H, 2012, J CLIN EXP HEMATOP, V52, P161, DOI 10.3960/jslrt.52.161; Ndagijimana M, 2009, INT J FOOD MICROBIOL, V134, P147, DOI 10.1016/j.ijfoodmicro.2009.04.016; Nicholson JK, 2012, SCIENCE, V336, P1262, DOI 10.1126/science.1223813; Otani M, 2012, J AM SOC NEPHROL, V23, P438, DOI 10.1681/ASN.2011070701; Prakash S, 2011, BIOL-TARGETS THER, V5, P71, DOI 10.2147/BTT.S19099; Ranganathan N, 2009, CURR MED RES OPIN, V25, P1919, DOI 10.1185/03007990903069249; Ringel Y, 2012, AM J GASTROENTEROL S, V1, P34, DOI DOI 10.1038/AJGSUP.2012.7; Rocchetti MT, 2008, PROTEOMICS, V8, P206, DOI 10.1002/pmic.200700492; Rocchetti MT, 2013, CLIN J AM SOC NEPHRO, V8, P1115, DOI 10.2215/CJN.05950612; Salazar N, 2008, APPL ENVIRON MICROB, V74, P4737, DOI 10.1128/AEM.00325-08; Scanlan PD, 2008, ENVIRON MICROBIOL, V10, P789, DOI 10.1111/j.1462-2920.2007.01503.x; Schmitt R, 2010, AM J PATHOL, V176, P608, DOI 10.2353/ajpath.2010.090428; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Serino M, 2012, GUT, V61, P543, DOI 10.1136/gutjnl-2011-301012; Serrazanetti DI, 2011, APPL ENVIRON MICROB, V77, P2656, DOI 10.1128/AEM.01826-10; Shannon CE, 1949, AT&T TECH J, V27, P359; Smith AC, 2006, J AM SOC NEPHROL, V17, P1192, DOI 10.1681/ASN.2005101115; Soylu A, 2007, PEDIATR NEPHROL, V22, P1040, DOI 10.1007/s00467-007-0433-2; Stachowicz N, 2013, POSTEP HIG MED DOSW, V67, P288, DOI 10.5604/17322693.1044746; Suchodolski JS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039333; Sui WG, 2012, CLINICS, V67, P363, DOI 10.6061/clinics/2012(04)10; Vaziri ND, 2013, KIDNEY INT, V83, P308, DOI 10.1038/ki.2012.345; Vaziri ND, 2012, CURR OPIN NEPHROL HY, V21, P587, DOI 10.1097/MNH.0b013e328358c8d5; Vitali B, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-4; Wang FQ, 2012, NEPHROLOGY, V17, P733, DOI 10.1111/j.1440-1797.2012.01647.x; Wang YW, 2009, ISME J, V3, P944, DOI 10.1038/ismej.2009.37; Zhang ZG, 2013, AM J GASTROENTEROL, V108, P1601, DOI 10.1038/ajg.2013.221; Zhao YY, 2013, CLIN CHIM ACTA, V422, P59, DOI 10.1016/j.cca.2013.03.033	69	134	139	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99006	10.1371/journal.pone.0099006	http://dx.doi.org/10.1371/journal.pone.0099006			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922509	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300023
J	Guo, BP; Cen, H; Tan, XH; Liu, WJ; Ke, Q				Guo, Baoping; Cen, Hong; Tan, Xiaohong; Liu, Wenjian; Ke, Qing			Prognostic Value of MET Gene Copy Number and Protein Expression in Patients with Surgically Resected Non-Small Cell Lung Cancer: A Meta-Analysis of Published Literatures	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; C-MET; FACTOR RECEPTOR; SURVIVAL; ACTIVATION; PATHWAY	Background: The prognostic value of the copy number (GCN) and protein expression of the mesenchymal-epithelial transition (MET) gene for survival of patients with non-small cell lung cancer NSCLC) remains controversial. This study aims to comprehensively and quantitatively asses the suitability of MET GCN and protein expression to predict patients' survival. Methods: PubMed, Embase, Web of Science and Google Scholar were searched for articles comparing overall survival in patients with high MET GCN or protein expression with those with low level. Pooled hazard ratio (HR) and 95% confidence intervals (CIs) were calculated using the random and the fixed-effects models. Subgroup and sensitivity analyses were also performed. Results: Eighteen eligible studies enrolling 5,516 patients were identified. Pooled analyses revealed that high MET GCN or protein expression was associated with poor overall survival (OS) (GCN: HR = 1.90, 95% CI 1.35-2.68, p, 0.001; protein expression: HR = 1.52, 95% CI 1.08-2.15, p = 0.017). In Asian populations (GCN: HR = 2.22, 95% CI 1.46-3.38, p, 0.001; protein expression: HR = 1.89, 95% CI 1.34-2.68, p, 0.001), but not in the non-Asian subset. For adenocarcinoma, high MET GCN or protein expression indicated decreased OS (GCN: HR = 1.49, 95% CI 1.05-2.10, p = 0.025; protein expression: HR = 1.69, 95% CI 1.31-2.19, p, 0.001). Results were similar for multivariate analysis (GCN: HR = 1.61, 95% CI 1.15-2.25, p = 0.005; protein expression: HR = 2.18, 95% CI 1.60-2.97, p, 0.001). The results of the sensitivity analysis were not materially altered and did not draw different conclusions. Conclusions: Increased MET GCN or protein expression was significantly associated with poorer survival in patients with surgically resected NSCLC; this information could potentially further stratify patients in clinical treatment.	[Guo, Baoping; Cen, Hong; Tan, Xiaohong; Liu, Wenjian; Ke, Qing] Guangxi Med Univ, Affiliated Tumor Hosp, Dept Chemotherapy, Nanning, Peoples R China	Guangxi Medical University	Cen, H (corresponding author), Guangxi Med Univ, Affiliated Tumor Hosp, Dept Chemotherapy, Nanning, Peoples R China.	cenhong01@163.com						Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; Bonine-Summers AR, 2007, CANCER BIOL THER, V6, P561, DOI 10.4161/cbt.6.4.3851; BOTTARO DP, 1991, SCIENCE, V251, P802, DOI 10.1126/science.1846706; Cappuzzo F, 2009, J CLIN ONCOL, V27, P1667, DOI 10.1200/JCO.2008.19.1635; Chen YT, 2011, J THORAC ONCOL, V6, P2027, DOI 10.1097/JTO.0b013e3182307e92; Cipriani NA, 2009, LUNG CANCER, V63, P169, DOI 10.1016/j.lungcan.2008.06.011; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dziadziuszko R, 2012, J THORAC ONCOL, V7, P340, DOI 10.1097/JTO.0b013e318240ca0d; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Go H, 2010, J THORAC ONCOL, V5, P305, DOI 10.1097/JTO.0b013e3181ce3d1d; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Hu Xingsheng, 2012, Zhongguo Fei Ai Za Zhi, V15, P399, DOI 10.3779/j.issn.1009-3419.2012.07.02; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; [刘宏侠 Liu Hongxia], 2010, [细胞与分子免疫学杂志, Chinese Journal of Cellular and Molecular Immunology], V26, P1027; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; Masuya D, 2004, BRIT J CANCER, V90, P1555, DOI 10.1038/sj.bjc.6601718; Miller CT, 2006, ONCOGENE, V25, P409, DOI 10.1038/sj.onc.1209057; Nakamura Y, 2007, CANCER SCI, V98, P1006, DOI 10.1111/j.1349-7006.2007.00493.x; Okuda K, 2008, CANCER SCI, V99, P2280, DOI 10.1111/j.1349-7006.2008.00916.x; Onitsuka T, 2010, J THORAC ONCOL, V5, P591, DOI 10.1097/JTO.0b013e3181d0a4db; PAESMANS M, 1995, J CLIN ONCOL, V13, P1221, DOI 10.1200/JCO.1995.13.5.1221; Park S, 2012, HISTOL HISTOPATHOL, V27, P197, DOI 10.14670/HH-27.197; Parmar MKB, 1998, STAT MED, V17, P2815, DOI 10.1002/(SICI)1097-0258(19981230)17:24<2815::AID-SIM110>3.0.CO;2-8; Ruiz MIG, 2009, BRIT J CANCER, V100, P145, DOI 10.1038/sj.bjc.6604781; Sun WZ, 2013, J BIOMED RES, V27, P220, DOI 10.7555/JBR.27.20130004; Tachibana K, 2012, LUNG CANCER, V75, P181, DOI 10.1016/j.lungcan.2011.07.008; Takanami I, 1996, ONCOLOGY, V53, P392; Tanaka A, 2012, LUNG CANCER, V75, P89, DOI 10.1016/j.lungcan.2011.06.004; Tokunou M, 2001, AM J PATHOL, V158, P1451, DOI 10.1016/S0002-9440(10)64096-5; Trusolino L, 2002, NAT REV CANCER, V2, P289, DOI 10.1038/nrc779; Tsuta K, 2012, J THORAC ONCOL, V7, P331, DOI 10.1097/JTO.0b013e318241655f; Wells G., 2014, NEWCASTLE OTTAWA SCA; Wistuba II, 2011, NAT REV CLIN ONCOL, V8, P135, DOI 10.1038/nrclinonc.2011.2; YUSUF S, 1985, PROG CARDIOVASC DIS, V27, P335, DOI 10.1016/S0033-0620(85)80003-7	34	57	59	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99399	10.1371/journal.pone.0099399	http://dx.doi.org/10.1371/journal.pone.0099399			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922520	Green Submitted, gold, Green Published			2022-12-27	WOS:000338701300058
J	Huguet, A; Hatton, A; Villot, R; Quenault, H; Blanchard, Y; Fessard, V				Huguet, Antoine; Hatton, Aurelie; Villot, Romain; Quenault, Helene; Blanchard, Yannick; Fessard, Valerie			Modulation of Chromatin Remodelling Induced by the Freshwater Cyanotoxin Cylindrospermopsin in Human Intestinal Caco-2 Cells	PLOS ONE			English	Article							CYANOBACTERIAL TOXIN CYLINDROSPERMOPSIN; PROTEIN-SYNTHESIS INHIBITION; CULTURED RAT HEPATOCYTES; OXIDATIVE STRESS; DNA-DAMAGE; ALKALOID CYLINDROSPERMOPSIN; HEPG2 CELLS; IN-VITRO; RACIBORSKII; TOXICITY	Cylindrospermopsin (CYN) is a cyanotoxin that has been recognised as an emerging potential public health risk. Although CYN toxicity has been demonstrated, the mechanisms involved have not been fully characterised. To identify some key pathways related to this toxicity, we studied the transcriptomic profile of human intestinal Caco-2 cells exposed to a sub-toxic concentration of CYN (1.6 mu M for 24hrs) using a non-targeted approach. CYN was shown to modulate different biological functions which were related to growth arrest (with down-regulation of cdkn1a and uhrf1 genes), and DNA recombination and repair (with up-regulation of aptx and pms2 genes). Our main results reported an increased expression of some histone-modifying enzymes (histone acetyl and methyltransferases MYST1, KAT5 and EHMT2) involved in chromatin remodelling, which is essential for initiating transcription. We also detected greater levels of acetylated histone H2A (Lys5) and dimethylated histone H3 (Lys4), two products of these enzymes. In conclusion, CYN overexpressed proteins involved in DNA damage repair and transcription, including modifications of nucleosomal histones. Our results highlighted some new cell processes induced by CYN.	[Huguet, Antoine; Hatton, Aurelie; Villot, Romain; Fessard, Valerie] Anses, Fougeres Lab, Contaminant Toxicol Unit, Fougeres, France; [Quenault, Helene; Blanchard, Yannick] Anses, Ploufragan Plouzane Lab, Viral Genet & Biosecur Unit, Ploufragan, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Fougeres; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES)	Huguet, A (corresponding author), Anses, Fougeres Lab, Contaminant Toxicol Unit, Fougeres, France.	antoine.huguet@anses.fr		Huguet, Antoine/0000-0001-5399-0907; Fessard, Valerie/0000-0001-9046-9117	AFSSET [EST 2009/1/58]	AFSSET	Financial support was provided by the AFSSET EST 2009/1/58 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achour M, 2009, BIOCHEM BIOPH RES CO, V390, P523, DOI 10.1016/j.bbrc.2009.09.131; Bain P, 2007, J TOXICOL ENV HEAL A, V70, P1687, DOI 10.1080/15287390701434877; Baken KA, 2007, TOXICOLOGY, V237, P35, DOI 10.1016/j.tox.2007.04.018; Barrero MJ, 2006, MOL CELL, V24, P233, DOI 10.1016/j.molcel.2006.09.020; Bazin E, 2012, ENVIRON TOXICOL, V27, P277, DOI 10.1002/tox.20640; Bazin E, 2010, ENVIRON MOL MUTAGEN, V51, P251, DOI 10.1002/em.20539; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chai XR, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003778; Chiswell RK, 1999, ENVIRON TOXICOL, V14, P155, DOI 10.1002/(SICI)1522-7278(199902)14:1<155::AID-TOX20>3.0.CO;2-Z; Chong MWK, 2002, TOXICON, V40, P205, DOI 10.1016/S0041-0101(01)00228-8; Chorus I, 2012, CURRENT APPROACHES C; Dmitriev RI, 2008, BIOCHEMISTRY-MOSCOW+, V73, P839, DOI 10.1134/S0006297908080014; Falconer IR, 2006, ENVIRON TOXICOL, V21, P299, DOI 10.1002/tox.20194; Falconer IR, 2001, ENVIRON TOXICOL, V16, P192, DOI 10.1002/tox.1024; Fang R, 2010, MOL CELL, V39, P222, DOI 10.1016/j.molcel.2010.07.008; Froscio SM, 2008, TOXICON, V51, P191, DOI 10.1016/j.toxicon.2007.09.001; Froscio SM, 2009, TOXICON, V54, P862, DOI 10.1016/j.toxicon.2009.06.019; Froscio SM, 2003, ENVIRON TOXICOL, V18, P243, DOI 10.1002/tox.10121; Froscio SM, 2001, ENVIRON TOXICOL, V16, P408, DOI 10.1002/tox.1050; Froscio SM, 2009, J TOXICOL ENV HEAL A, V72, P345, DOI 10.1080/15287390802529906; Fuller-Pace FV, 2007, BIOCHEM SOC T, V35, P1427, DOI 10.1042/BST0351427; Funari E, 2008, CRIT REV TOXICOL, V38, P97, DOI 10.1080/10408440701749454; Griffiths DJ, 2003, ENVIRON TOXICOL, V18, P78, DOI 10.1002/tox.10103; Gutierrez-Praena D, 2012, WATER RES, V46, P1566, DOI 10.1016/j.watres.2011.12.044; Gutierrez-Praena D, 2011, ECOTOX ENVIRON SAFE, V74, P1567, DOI 10.1016/j.ecoenv.2011.04.030; HAWKINS PR, 1985, APPL ENVIRON MICROB, V50, P1292, DOI 10.1128/AEM.50.5.1292-1295.1985; Humpage AR, 2005, J TOXICOL ENV HEAL A, V68, P739, DOI 10.1080/15287390590925465; Humpage AR, 2000, MUTAT RES-GEN TOX EN, V472, P155, DOI 10.1016/S1383-5718(00)00144-3; Kinnear S, 2010, MAR DRUGS, V8, P542, DOI 10.3390/md8030542; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lariviere L, 2012, NATURE, V492, P448, DOI 10.1038/nature11670; Li XZ, 2010, MOL CELL BIOL, V30, P5335, DOI 10.1128/MCB.00350-10; Lopez-Alonso H, 2013, CHEM RES TOXICOL, V26, P203, DOI 10.1021/tx3003438; Merel S, 2010, SCI TOTAL ENVIRON, V408, P3433, DOI 10.1016/j.scitotenv.2010.04.033; Miyamoto N, 2008, J BIOL CHEM, V283, P18218, DOI 10.1074/jbc.M802332200; OHTANI I, 1992, J AM CHEM SOC, V114, P7941, DOI 10.1021/ja00046a067; Rucker J, 2007, TOXICON, V50, P800, DOI 10.1016/j.toxicon.2007.06.019; RUNNEGAR MT, 1995, BIOCHEM PHARMACOL, V49, P219, DOI 10.1016/S0006-2952(94)00466-8; RUNNEGAR MT, 1994, BIOCHEM BIOPH RES CO, V201, P235, DOI 10.1006/bbrc.1994.1694; Sambuy Y, 2005, CELL BIOL TOXICOL, V21, P1, DOI 10.1007/s10565-005-0085-6; Shaw GR, 2000, THER DRUG MONIT, V22, P89, DOI 10.1097/00007691-200002000-00019; Shen XY, 2002, TOXICON, V40, P1499, DOI 10.1016/S0041-0101(02)00151-4; Sparfel L, 2010, TOXICOL SCI, V114, P247, DOI 10.1093/toxsci/kfq007; Straser A, 2013, TOXICOL IN VITRO; Straser A, 2013, MAR DRUGS, V11, P3077, DOI 10.3390/md11083077; Straser A, 2013, CHEMOSPHERE, V92, P24, DOI 10.1016/j.chemosphere.2013.03.023; Straser A, 2011, ARCH TOXICOL, V85, P1617, DOI 10.1007/s00204-011-0716-z; TERAO K, 1994, TOXICON, V32, P833, DOI 10.1016/0041-0101(94)90008-6; van Apeldoorn ME, 2007, MOL NUTR FOOD RES, V51, P7, DOI 10.1002/mnfr.200600185; Venneti S, 2013, J NEUROPATH EXP NEUR, V72, P298, DOI 10.1097/NEN.0b013e3182898113; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Young FM, 2012, TOXICOL IN VITRO, V26, P656, DOI 10.1016/j.tiv.2012.03.001; Zegura B, 2011, TOXICON, V58, P471, DOI 10.1016/j.toxicon.2011.08.005	53	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99121	10.1371/journal.pone.0099121	http://dx.doi.org/10.1371/journal.pone.0099121			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921660	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300033
J	Eckroth, JR; Aas-Hansen, O; Sneddon, LU; Bichao, H; Doving, KB				Eckroth, Jared R.; Aas-Hansen, Oyvind; Sneddon, Lynne U.; Bichao, Helena; Doving, Kjell B.			Physiological and Behavioural Responses to Noxious Stimuli in the Atlantic Cod (Gadus morhua)	PLOS ONE			English	Article							RAINBOW-TROUT; COPING STYLES; TELEOST FISH; PAIN; CAPSAICIN; STRESS; NOCICEPTION; ANESTHESIA; MORPHINE; GOLDFISH	In the present study, our aim was to compare physiological and behavioural responses to different noxious stimuli to those of a standardized innocuous stimulus, to possibly identify aversive responses indicative of injury detection in a commercially important marine teleost fish, the Atlantic cod. Individual fish were administered with a noxious stimulus to the lip under short-term general anaesthesia (MS-222). The noxious treatments included injection of 0.1% or 2% acetic acid, 0.005% or 0.1% capsaicin, or piercing the lip with a commercial fishing hook. Counts of opercular beat rate (OBR) at 10, 30, 60, 90 and 120 min and observations of behaviour at 30 and 90 min post-treatment were compared with pre-treatment values and with control fish injected with physiological saline, an innocuous stimulus. Circulatory levels of physiological stress indicators were determined in all fish at 120 minutes post-treatment. All treatments evoked temporarily increased OBR that returned to pre-treatment levels at 60 minutes (saline, 0.005% capsaicin, hook), 90 minutes (0.1% acetic acid, 0.1% capsaicin), or 120 minutes (2% acetic acid), but with no significant differences from the control group at any time point. Fish treated with 0.1% and 2% acetic acid and 0.1% capsaicin displayed increased hovering close to the bottom of the aquaria and fish given 2% acetic acid and 0.1% capsaicin also displayed a reduced use of shelter. The only effect seen in hooked fish was brief episodes of lateral head shaking which were not seen pre-treatment or in the other groups, possibly reflecting a resiliency to tissue damage in the mouth area related to the tough nature of the Atlantic cod diet. There were no differences between groups in circulatory stress indicators two hours after treatment. This study provides novel data on behavioural indicators that could be used to assess potentially aversive events in Atlantic cod.	[Eckroth, Jared R.; Doving, Kjell B.] Univ Oslo, Dept Mol Biosci, Oslo, Norway; [Aas-Hansen, Oyvind; Bichao, Helena] Nofima, Norwegian Inst Food Fisheries & Aquaculture Res, Tromso, Norway; [Sneddon, Lynne U.] Univ Liverpool, Inst Integrat Biol, Liverpool L69 3BX, Merseyside, England	University of Oslo; Nofima; University of Liverpool	Aas-Hansen, O (corresponding author), Nofima, Norwegian Inst Food Fisheries & Aquaculture Res, Tromso, Norway.	oyvind.aas-hansen@nofima.no		Higgs, Dennis/0000-0002-0771-4642; Sneddon, Lynne/0000-0001-9787-3948	Norwegian Research Council, NRC [18745/E40]; National Centre for the Replacement [NC/K000888/1] Funding Source: researchfish	Norwegian Research Council, NRC(Research Council of Norway); National Centre for the Replacement	This study was funded by the Norwegian Research Council (http://www.forskningsradet.no/) through the project "Nociception and potential pain perception in the Atlantic cod (Gadus morhua)", NRC project number 18745/E40. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlinghaus R, 2007, REV FISH SCI, V15, P75, DOI 10.1080/10641260601149432; Artigas ML, 2005, J FISH BIOL, V67, P384, DOI 10.1111/j.0022-1112.2005.00745.x; Ashley PJ, 2007, BRAIN RES, V1166, P47, DOI 10.1016/j.brainres.2007.07.011; Ashley PJ, 2009, ANIM BEHAV, V77, P403, DOI 10.1016/j.anbehav.2008.10.015; BEUKEMA J J, 1970, Netherlands Journal of Zoology, V20, P81; BEUKEMA JJ, 1970, J FISH BIOL, V2, P155, DOI 10.1111/j.1095-8649.1970.tb03268.x; Bonga SEW, 1997, PHYSIOL REV, V77, P591, DOI 10.1152/physrev.1997.77.3.591; Bossus M, 2011, COMP BIOCHEM PHYS A, V160, P43, DOI 10.1016/j.cbpa.2011.04.014; Braithwaite VA, 2004, ANIM WELFARE, V13, pS87; Brown JA, 2008, AQUACULTURE, V285, P135, DOI 10.1016/j.aquaculture.2008.08.027; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chandroo KP, 2004, APPL ANIM BEHAV SCI, V86, P225, DOI 10.1016/j.applanim.2004.02.004; Chervova L.S., 1997, J ICHTHYOL+, V37, P98; Chung G, 2010, PHARM PAIN, P327; COSEWIC, 2003, ASS UPD REP GAD MORH; Council of the European Union, 1998, EUR CONV PROT VERT A; FERNO A, 1983, FISH RES, V2, P19, DOI 10.1016/0165-7836(83)90100-5; Foss A, 2006, AQUACULTURE, V256, P255, DOI 10.1016/j.aquaculture.2006.02.032; Gallagher AJ, 2010, J AQUAT ANIM HEALTH, V22, P229, DOI 10.1577/H10-012.1; Herbert NA, 2005, MAR BIOL, V147, P1403, DOI 10.1007/s00227-005-0003-8; HOLZER P, 1991, PHARMACOL REV, V43, P143; Huntingford FA, 2006, J FISH BIOL, V68, P332, DOI 10.1111/j.0022-1112.2006.001046.x; IASP, 2011, IASP TAX INT ASS STU; Johansen JL, 2006, J FISH BIOL, V68, P1918, DOI 10.1111/j.1095-8649.2006.01080.x; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Karlsson A, 2011, FISH PHYSIOL BIOCHEM, p1 ; KAVALIERS M, 1988, BRAIN RES BULL, V21, P923, DOI 10.1016/0361-9230(88)90030-5; Koolhaas JM, 1999, NEUROSCI BIOBEHAV R, V23, P925, DOI 10.1016/S0149-7634(99)00026-3; Le Bars D, 2001, PHARMACOL REV, V53, P597; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Loeser J, 2008, KYOTO PROTOCOL IASP, V137, P5; Magerl W, 2001, BRAIN, V124, P1754, DOI 10.1093/brain/124.9.1754; Mangos S, 2007, GENE EXPR PATTERNS, V7, P480, DOI 10.1016/j.modgep.2006.10.011; McMahon SB, 2006, INFLAMMATORY MEDIATO, P49; Melzack R, 2006, WALL MELZACKS TXB PA, P291; Mettam JJ, 2011, APPL ANIM BEHAV SCI, V133, P265, DOI 10.1016/j.applanim.2011.06.009; Meyer RA, 2006, WALL MELZACKS TXB PA, V5, P3; Molony V, 1997, J ANIM SCI, V75, P266; Newby NC, 2009, CAN J ZOOL, V87, P388, DOI 10.1139/Z09-023; Newby NC, 2008, APPL ANIM BEHAV SCI, V114, P260, DOI 10.1016/j.applanim.2007.12.006; Nilsson J, 2008, ANIM COGN, V11, P215, DOI 10.1007/s10071-007-0103-6; Nordgreen J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092116; Nordgreen J, 2009, APPL ANIM BEHAV SCI, V119, P101, DOI 10.1016/j.applanim.2009.03.015; Olsen RE, 2010, NORWEGIAN SCI COMMIT, V09, P1; Overli O, 2007, NEUROSCI BIOBEHAV R, V31, P396, DOI 10.1016/j.neubiorev.2006.10.006; PARK KM, 1995, PAIN, V63, P163, DOI 10.1016/0304-3959(95)00029-R; Reilly SC, 2008, APPL ANIM BEHAV SCI, V114, P248, DOI 10.1016/j.applanim.2008.01.016; Roques JAC, 2010, PHYSIOL BEHAV, V101, P533, DOI 10.1016/j.physbeh.2010.08.001; Rose JD, 2007, DIS AQUAT ORGAN, V75, P139, DOI 10.3354/dao075139; Rose JD, 2002, REV FISH SCI, V10, P1, DOI 10.1080/20026491051668; Rose JD, 2012, FISH FISH, P1; Ross LG, 2008, ANAESTHETIC AND SEDATIVE TECHNIQUES FOR AQUATIC ANIMALS, 3RD EDITION, P1, DOI 10.1002/9781444302264; Schjolden J, 2007, BRAIN BEHAV EVOLUT, V70, P227, DOI 10.1159/000105486; Schmelz M, 2000, BRAIN, V123, P560, DOI 10.1093/brain/123.3.560; SCHULZ R, 1985, STEROIDS, V46, P717, DOI 10.1016/0039-128X(85)90051-0; Sherrington CS, 1903, J PHYSIOL-LONDON, V30, P39; SIMONE DA, 1989, PAIN, V38, P99, DOI 10.1016/0304-3959(89)90079-1; Sneddon LU, 2003, J PAIN, V4, P431, DOI 10.1067/S1526-5900(03)00717-X; Sneddon LU, 2003, APPL ANIM BEHAV SCI, V83, P153, DOI 10.1016/S0168-1591(03)00113-8; Sneddon LU, 2003, P ROY SOC B-BIOL SCI, V270, P1115, DOI 10.1098/rspb.2003.2349; Sneddon LU, 2003, BRAIN RES, V972, P44, DOI 10.1016/S0006-8993(03)02483-1; Sneddon LU, 2002, NEUROSCI LETT, V319, P167, DOI 10.1016/S0304-3940(01)02584-8; Sneddon LU, 2012, J EXOT PET MED, V21, P32, DOI 10.1053/j.jepm.2011.11.009; Sneddon LU, 2011, J CONSCIOUSNESS STUD, V18, P209; Tveiten H, 2010, J FISH BIOL, V76, P2318, DOI 10.1111/j.1095-8649.2010.02636.x; Zahl IH, 2010, FISH PHYSIOL BIOCHEM, V36, P719, DOI 10.1007/s10695-009-9346-2; Zahl IH, 2009, AQUACULTURE, V295, P52, DOI 10.1016/j.aquaculture.2009.06.019; Zimov S, 2004, J NEUROCYTOL, V33, P441, DOI 10.1007/s11068-004-4209-3	69	13	13	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100150	10.1371/journal.pone.0100150	http://dx.doi.org/10.1371/journal.pone.0100150			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936652	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400082
J	Jagielski, T; Ignatowska, H; Bakula, Z; Dziewit, L; Napiorkowska, A; Augustynowicz-Kopec, E; Zwolska, Z; Bielecki, J				Jagielski, Tomasz; Ignatowska, Helena; Bakula, Zofia; Dziewit, Lukasz; Napiorkowska, Agnieszka; Augustynowicz-Kopec, Ewa; Zwolska, Zofia; Bielecki, Jacek			Screening for Streptomycin Resistance-Conferring Mutations in Mycobacterium tuberculosis Clinical Isolates from Poland	PLOS ONE			English	Article							DRUG-RESISTANCE; MULTIDRUG-RESISTANT; MOLECULAR CHARACTERIZATION; RRS MUTATIONS; NORTH-INDIA; STRAINS; RPSL; LEVEL; IDENTIFICATION; MECHANISMS	Currently, mutations in three genes, namely rrs, rpsL, and gidB, encoding 16S rRNA, ribosomal protein S12, and 16S rRNA-specific methyltransferase, respectively, are considered to be involved in conferring resistance to streptomycin (STR) in Mycobacterium tuberculosis. The aim of this study was to investigate the spectrum and frequency of these mutations in M. tuberculosis clinical isolates, both resistant and susceptible to STR. Sixty-four M. tuberculosis isolates recovered from as many TB patients from Poland in 2004 were included in the study. Within the sample were 50 multidrug-resistant (32 STR-resistant and 18 STR-susceptible) and 14 pan-susceptible isolates. Preliminary testing for STR resistance was performed with the 1% proportion method. The MICs of STR were determined by the Etest method. Mutation profiling was carried out by amplifying and sequencing the entire rrs, rpsL, and gidB genes. Non-synonymous mutations in either rrs or rpsL gene were detected in 23 (71.9%) of the STR-resistant and none of the STR-susceptible isolates. Mutations in the gidB gene were distributed among 12 (37.5%) STR-resistant and 13 (40.6%) STR-susceptible isolates. Four (12.5%) STR-resistant isolates were wild-type at all three loci examined. None of the rrs, rpsL or gidB mutations could be linked to low, intermediate or high level of STR resistance. In accordance with previous findings, the gidB 47T -> G (L16R) mutation was associated with the Latin American-Mediterranean genotype family, whereas 276A -> C (E92D) and 615A -> G (A205A) mutations of the gidB gene were associated with the Beijing lineage. The study underlines the usefulness of rrs and rpsL mutations as molecular markers for STR resistance yet not indicative of its level. The gidB polymorphisms can serve as phylogenetic markers.	[Jagielski, Tomasz; Ignatowska, Helena; Bakula, Zofia; Bielecki, Jacek] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Appl Microbiol, Warsaw, Poland; [Dziewit, Lukasz] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland; [Napiorkowska, Agnieszka; Augustynowicz-Kopec, Ewa; Zwolska, Zofia] Natl TB & Lung Dis Res Inst, Dept Microbiol, Warsaw, Poland	University of Warsaw; University of Warsaw	Jagielski, T (corresponding author), Univ Warsaw, Fac Biol, Inst Microbiol, Dept Appl Microbiol, Warsaw, Poland.	t.jagielski@biol.uw.edu.pl	Jagielski, Tomasz/AAB-9099-2021; Augustynowicz-Kopeć, Ewa/AAL-1757-2020; Dziewit, Lukasz/L-1131-2016	Augustynowicz-Kopeć, Ewa/0000-0001-6162-8748; Dziewit, Lukasz/0000-0002-5057-2811; Jagielski, Tomasz/0000-0001-9553-5742; Bakula, Zofia/0000-0001-7560-2100; Zwolska, Zofia/0000-0003-3836-0776; Bielecki, Jacek/0000-0001-6533-2282	Iuventus Plus grant from the Polish Ministry of Science and Higher Education [IP2011018771]; Faculty of Biology, University of Warsaw intramural grant DSM [104934]	Iuventus Plus grant from the Polish Ministry of Science and Higher Education; Faculty of Biology, University of Warsaw intramural grant DSM	This work was supported by the "Iuventus Plus grant from the Polish Ministry of Science and Higher Education (IP2011018771; http://www.nauka.gov.pl/en/) and the Faculty of Biology, University of Warsaw intramural grant DSM (104934; http://www.biol.uw.edu.pl/en/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abadia E, 2010, INFECT GENET EVOL, V10, P1066, DOI 10.1016/j.meegid.2010.07.006; Abbadi SH, 2009, INT J INFECT DIS, V13, P673, DOI 10.1016/j.ijid.2008.10.006; Augustynowicz-Kopec E, 2003, INT J TUBERC LUNG D, V7, P645; Ballif M, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-191; Brzostek A, 2004, INT J TUBERC LUNG D, V8, P1032; Cooksey RC, 1996, ANTIMICROB AGENTS CH, V40, P1186, DOI 10.1128/AAC.40.5.1186; Cuevas-Cordoba B, 2013, J MICROBIOL IMMUNOL, V46, P30, DOI 10.1016/j.jmii.2012.08.020; Dobner P, 1997, MOL CELL PROBE, V11, P123, DOI 10.1006/mcpr.1996.0086; Feuerriegel S, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-90; Hazon MH, 2000, J CLIN MICROBIOL, V38, P4599; Homolka S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039855; Homolka S, 2009, J CLIN MICROBIOL, V47, P223, DOI 10.1128/JCM.01237-08; Ignatova A, 2006, J MED MICROBIOL, V55, P1413, DOI 10.1099/jmm.0.46575-0; Jagielski T, 2010, J CLIN MICROBIOL, V48, P3899, DOI 10.1128/JCM.00572-10; Jnawali HN, 2013, DIAGN MICR INFEC DIS, V76, P187, DOI 10.1016/j.diagmicrobio.2013.02.035; Jnawali HN, 2013, WORLD J MICROB BIOT, V29, P975, DOI 10.1007/s11274-013-1256-x; Joloba ML, 2000, J CLIN MICROBIOL, V38, P3834, DOI 10.1128/JCM.38.10.3834-3836.2000; Katsukawa E, 1997, J APPL MICROBIOL, V83, P634, DOI 10.1046/j.1365-2672.1997.00279.x; Meier A, 1996, ANTIMICROB AGENTS CH, V40, P2452, DOI 10.1128/AAC.40.11.2452; MUSSER JM, 1995, CLIN MICROBIOL REV, V8, P496, DOI 10.1128/CMR.8.4.496; Nhu NTQ, 2012, INT J TUBERC LUNG D, V16, P527, DOI 10.5588/ijtld.11.0202; Okamoto S, 2007, MOL MICROBIOL, V63, P1096, DOI 10.1111/j.1365-2958.2006.05585.x; Pardini M, 2009, TUBERCULOSIS, V89, P317, DOI 10.1016/j.tube.2009.04.002; Perdigao J, 2008, MICROB DRUG RESIST, V14, P133, DOI 10.1089/mdr.2008.0798; Ramaswamy SV, 2004, J MED MICROBIOL, V53, P107, DOI 10.1099/jmm.0.05343-0; Shi RR, 2007, MICROBES INFECT, V9, P1538, DOI 10.1016/j.micinf.2007.08.009; Siddiqi N, 2002, ANTIMICROB AGENTS CH, V46, P443, DOI 10.1128/AAC.46.2.443-450.2002; Spies FS, 2008, ANTIMICROB AGENTS CH, V52, P2947, DOI 10.1128/AAC.01570-07; Spies FS, 2013, TUBERCULOSIS, V93, P150, DOI 10.1016/j.tube.2012.11.004; Spies FS, 2011, J CLIN MICROBIOL, V49, P2625, DOI 10.1128/JCM.00168-11; Sreevatsan S, 1996, ANTIMICROB AGENTS CH, V40, P1024, DOI 10.1128/AAC.40.4.1024; Sun YJ, 2010, CLIN MICROBIOL INFEC, V16, P287, DOI 10.1111/j.1469-0691.2009.02800.x; Tudo G, 2010, J ANTIMICROB CHEMOTH, V65, P2341, DOI 10.1093/jac/dkq322; Van Rie A, 2001, J CLIN MICROBIOL, V39, P636, DOI 10.1128/JCM.39.2.636-641.2001; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Vitol I, 2006, INFECT GENET EVOL, V6, P491, DOI 10.1016/j.meegid.2006.03.003; *WHO, 2003, WHOTB2003320; Wong SY, 2011, ANTIMICROB AGENTS CH, V55, P2515, DOI 10.1128/AAC.01814-10; World Health Organization (WHO), 2010, GUIDELINES TREATMENT, V2nd; Yadav R, 2013, INT J TUBERC LUNG D, V17, P251, DOI 10.5588/ijtld.12.0319	40	47	51	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100078	10.1371/journal.pone.0100078	http://dx.doi.org/10.1371/journal.pone.0100078			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937123	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400070
J	Lund, SH; Gudbjartsson, DF; Rafnar, T; Sigurdsson, A; Gudjonsson, SA; Gudmundsson, J; Stefansson, K; Stefansson, G				Lund, Sigrun Helga; Gudbjartsson, Daniel Fannar; Rafnar, Thorunn; Sigurdsson, Asgeir; Gudjonsson, Sigurjon Axel; Gudmundsson, Julius; Stefansson, Kari; Stefansson, Gunnar			A Method for Detecting Long Non-Coding RNAs with Tiled RNA Expression Microarrays	PLOS ONE			English	Article							TILING ARRAY DATA; GENE-EXPRESSION; PROSTATE-CANCER; GENOME; REPRODUCIBILITY; ASSOCIATION; BIOMARKERS; SEARCH; ISSUES; LINKS	Long non-coding ribonucleic acids (lncRNAs) have been proposed as biomarkers in prostate cancer. This paper proposes a selection method which uses data from tiled microarrays to identify relatively long regions of moderate expression independent of the microarray platform and probe design. The method is used to search for candidate long non-coding ribonucleic acids (lncRNAs) at locus 8q24 and is run on three independent experiments which all use samples from prostate cancer patients. The robustness of the method is tested by utilizing repeated copies of tiled probes. The method shows high consistency between experiments that used the same samples, but different probe layout. There also is statistically significant consistency when comparing experiments with different samples. The method selected the long non-coding ribonucleic acid PCNCR1 in all three experiments.	[Lund, Sigrun Helga; Stefansson, Gunnar] Univ Iceland, Fac Phys Sci, Reykjavik, Iceland; [Gudbjartsson, Daniel Fannar; Rafnar, Thorunn; Sigurdsson, Asgeir; Gudjonsson, Sigurjon Axel; Gudmundsson, Julius; Stefansson, Kari] deCODE Genet, Reykjavik, Iceland	University of Iceland	Lund, SH (corresponding author), Univ Iceland, Fac Phys Sci, Reykjavik, Iceland.	sigrunhl@hi.is	Stefansson, Gunnar/A-2209-2008; Lund, Sigrun Helga/K-9144-2015; Stefansson, Gunnar/AAV-9432-2020; Stefansson, Kari/AAE-7187-2019; Lund, Sigrún Helga/AAG-6042-2019	Stefansson, Gunnar/0000-0002-2693-9142; Lund, Sigrun Helga/0000-0002-3806-2296; Stefansson, Gunnar/0000-0002-2693-9142; Lund, Sigrún Helga/0000-0002-3806-2296; Gudjonsson, Sigurjon A./0000-0001-9314-7412	National Cancer Institute (NCI) [5R01CA129991-02]; FS-Grant from the Icelandic Centre for Research (RANNIS); NATIONAL CANCER INSTITUTE [R01CA129991] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); FS-Grant from the Icelandic Centre for Research (RANNIS); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research project was funded in part by grant 5R01CA129991-02 from the National Cancer Institute (NCI) and by an FS-Grant from the Icelandic Centre for Research (RANNIS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-383; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Amaral PP, 2011, NUCLEIC ACIDS RES, V39, pD146, DOI 10.1093/nar/gkq1138; Amundadottir LT, 2006, NAT GENET, V38, P652, DOI 10.1038/ng1808; Baker M, 2011, NAT METHODS, V8, P379, DOI 10.1038/nmeth0511-379; Bu DC, 2012, NUCLEIC ACIDS RES, V40, pD210, DOI 10.1093/nar/gkr1175; BUTTYAN R, 1987, PROSTATE, V11, P327, DOI 10.1002/pros.2990110405; Carramusa L, 2007, J CELL PHYSIOL, V213, P511, DOI 10.1002/jcp.21133; Chen JJ, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-412; Chung SY, 2011, CANCER SCI, V102, P245, DOI 10.1111/j.1349-7006.2010.01737.x; Churchill GA, 2002, NAT GENET, V32, P490, DOI 10.1038/ng1031; Dhanasekaran SM, 2001, NATURE, V412, P822, DOI 10.1038/35090585; Dinger ME, 2009, NUCLEIC ACIDS RES, V37, pD122, DOI 10.1093/nar/gkn617; Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Ellatif S, 2012, REGULATORY RNAS, P197; Gibb EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025915; Gibb EA, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-38; Gudmundsson J, 2007, NAT GENET, V39, P631, DOI 10.1038/ng1999; Haiman CA, 2007, NAT GENET, V39, P638, DOI 10.1038/ng2015; Huarte M, 2010, HUM MOL GENET, V19, pR152, DOI 10.1093/hmg/ddq353; Huppi Konrad, 2012, Frontiers in Genetics, V3, P69, DOI 10.3389/fgene.2012.00069; Johnson JM, 2005, TRENDS GENET, V21, P93, DOI 10.1016/j.tig.2004.12.009; Kapranov P, 2012, FRONTIERS GENETICS, V3; Karpikov A, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-57; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Lund SH, 2014, ESTIMATING ROBUSTNES; Lund SH, 2009, JSM P, P4628; Mitra Sheetal A., 2012, Frontiers in Genetics, V3, P17, DOI 10.3389/fgene.2012.00017; Mockler TC, 2005, GENOMICS, V85, P1, DOI 10.1016/j.ygeno.2004.10.005; Otto C, 2012, BIOINFORMATICS, V28, P1471, DOI 10.1093/bioinformatics/bts142; Pozhitkov Alex E., 2007, Briefings in Functional Genomics & Proteomics, V6, P141, DOI 10.1093/bfgp/elm014; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reis E, 2012, FRONTIERS GENETICS, V3; Risueno A, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-221; Royce TE, 2005, TRENDS GENET, V21, P466, DOI 10.1016/j.tig.2005.06.007; Schmitt AM, 2013, NATURE, V500, P536, DOI 10.1038/nature12548; Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239; Shore AN, 2012, J MAMMARY GLAND BIOL, V17, P43, DOI 10.1007/s10911-012-9247-3; Spizzo R, 2012, ONCOGENE, V31, P4577, DOI 10.1038/onc.2011.621; Tahira AC, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-141; Tsai MC, 2011, CANCER RES, V71, P3, DOI 10.1158/0008-5472.CAN-10-2483; Vergara Ismael A., 2012, Frontiers in Genetics, V3, P23, DOI 10.3389/fgene.2012.00023; Wang XT, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a003756; Washietl S, 2005, NAT BIOTECHNOL, V23, P1383, DOI 10.1038/nbt1144; Weile C, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-244; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Willard SS, 2012, AM J CANCER RES, V2, P620; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Yeager M, 2007, NAT GENET, V39, P645, DOI 10.1038/ng2022	51	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99899	10.1371/journal.pone.0099899	http://dx.doi.org/10.1371/journal.pone.0099899			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937006	Green Submitted, gold, Green Published			2022-12-27	WOS:000338503400053
J	Na, KS; Park, YG; Han, K; Mok, JW; Joo, CK				Na, Kyung-Sun; Park, Yong-Gyu; Han, Kyungdo; Mok, Jee Won; Joo, Choun-Ki			Prevalence of and Risk Factors for Age-Related and Anterior Polar Cataracts in a Korean Population	PLOS ONE			English	Article							POSTERIOR SUBCAPSULAR CATARACTS; LENS OPACITIES; NUCLEAR; EPIDEMIOLOGY; DISEASE; EYE	Objective: To investigate the potential risk factors associated with nuclear, cortical, posterior subcapsular, and anterior polar cataracts (APC) in the Korean population. Research Design and Methods: This was a population-based, cross-sectional study of 7992 adults (over 40 years of age) from the data of the fourth annual Korea National Health and Nutrition Examination Survey, performed from 2007 to 2009. The presence of lens opacity was examined by slit-lamp biomicroscopy and evaluated according to LOCS II standard photographs. The subtype of cataract present, including nuclear, cortical, posterior subcapsular, and anterior polar cataracts, was noted. Multivariable adjusted logistic regression analysis was conducted to examine the odds ratio (OR) and 95% confidence interval (CI) for association of each specific type of cataract with age, sex, health examination, and medical history. Results: The prevalence of nuclear, cortical, and posterior subcapsular cataract increased gradually with increasing age. However, the prevalence of APC peaked in the 50-to 59-year-old subjects. All types of cataract except for APCs were more prevalent in women. Oral steroid use was associated with a lower risk of APC. Conclusions: These findings showed the unique characteristics of APC in the Korean population.	[Na, Kyung-Sun; Joo, Choun-Ki] Catholic Univ Korea, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea; [Park, Yong-Gyu; Han, Kyungdo] Catholic Univ Korea, Dept Biostat, Seoul, South Korea; [Na, Kyung-Sun; Mok, Jee Won] Catholic Univ Korea, Catholic Inst Visual Sci, Seoul, South Korea; [Na, Kyung-Sun] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Hlth Promot Ctr, Seoul, South Korea	Catholic University of Korea; Seoul St. Mary's Hospital; Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Joo, CK (corresponding author), Catholic Univ Korea, Seoul St Marys Hosp, Dept Ophthalmol & Visual Sci, Coll Med, Seoul, South Korea.	ckjoo@catholic.ac.kr		Park, Yong Gyu/0000-0002-8721-3230	National Research of Korea, Seoul, Korea [2011-0027157]	National Research of Korea, Seoul, Korea	This study was funded by the National Research of Korea (2011-0027157), Seoul, Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang JR, 2011, OPHTHALMOLOGY, V118, P2113, DOI 10.1016/j.ophtha.2011.03.032; CHYLACK LT, 1989, ARCH OPHTHALMOL-CHIC, V107, P991, DOI 10.1001/archopht.1989.01070020053028; Delcourt C, 2000, AM J EPIDEMIOL, V151, P497; Foster PJ, 2003, BRIT J OPHTHALMOL, V87, P1112, DOI 10.1136/bjo.87.9.1112; Graw J, 2011, INVEST OPHTH VIS SCI, V52, P7778, DOI 10.1167/iovs.10-7113; HIRVELA H, 1995, OPHTHALMOLOGY, V102, P108; Joo CK, 1999, J CATARACT REFR SURG, V25, P652, DOI 10.1016/S0886-3350(99)00009-7; Kim Hyojin, 2008, Korean J Ophthalmol, V22, P77, DOI 10.3341/kjo.2008.22.2.77; Landers J, 2010, CLIN EXP OPHTHALMOL, V38, P387, DOI 10.1111/j.1442-9071.2010.02257.x; Leske MC, 1997, ARCH OPHTHALMOL-CHIC, V115, P105, DOI 10.1001/archopht.1997.01100150107018; Lindblad BE, 2010, OPHTHALMOLOGY, V117, P424, DOI 10.1016/j.ophtha.2009.07.046; Maraini G, 2008, OPHTHALMOLOGY, V115, P599, DOI 10.1016/j.ophtha.2008.01.005; Mares JA, 2010, ARCH OPHTHALMOL-CHIC, V128, P738, DOI 10.1001/archophthalmol.2010.84; McCarty CA, 1999, AM J OPHTHALMOL, V128, P446, DOI 10.1016/S0002-9394(99)00218-4; Nirmalan PK, 2004, BRIT J OPHTHALMOL, V88, P989, DOI 10.1136/bjo.2003.038380; Richter GM, 2012, OPHTHALMOLOGY, V119, P547, DOI 10.1016/j.ophtha.2011.09.005; Sperduto RD, 2001, OPHTHALMOLOGY, V108, P1400; Tan JSL, 2008, OPHTHAL EPIDEMIOL, V15, P317, DOI 10.1080/09286580802105806; Taylor HR, 1999, EYE, V13, P445, DOI 10.1038/eye.1999.119; Vashist P, 2011, OPHTHALMOLOGY, V118, P272, DOI 10.1016/j.ophtha.2010.05.020; WEST SK, 1995, SURV OPHTHALMOL, V39, P323; Wu RY, 2010, ARCH OPHTHALMOL-CHIC, V128, P1029, DOI 10.1001/archophthalmol.2010.147; Zhang JS, 2011, OPHTHALMOLOGY, V118, P711, DOI 10.1016/j.ophtha.2010.08.021	23	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e96461	10.1371/journal.pone.0096461	http://dx.doi.org/10.1371/journal.pone.0096461			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936893	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400004
J	Aurin, TH; Munshi, SK; Kamal, SMM; Rahman, MM; Hossain, MS; Marma, T; Rahman, F; Noor, R				Aurin, Tafsina Haque; Munshi, Saurab Kishore; Kamal, S. M. Mostofa; Rahman, Md. Mostafizur; Hossain, Md. Shamim; Marma, Thaythayhla; Rahman, Farjana; Noor, Rashed			Molecular Approaches for Detection of the Multi-Drug Resistant Tuberculosis (MDR-TB) in Bangladesh	PLOS ONE			English	Article							GENOTYPE MTBDR ASSAY; XPERT MTB/RIF ASSAY; LINE PROBE ASSAY; MYCOBACTERIUM-TUBERCULOSIS; DRUG-RESISTANCE; PULMONARY TUBERCULOSIS; RIFAMPICIN-RESISTANCE; ISONIAZID RESISTANCE; SOUTH-AFRICA; DIAGNOSIS	The principal obstacles in the treatment of tuberculosis (TB) are delayed and inaccurate diagnosis which often leads to the onset of the drug resistant TB cases. To avail the appropriate treatment of the patients and to hinder the transmission of drug-resistant TB, accurate and rapid detection of resistant isolates is critical. Present study was designed to demonstrate the efficacy of molecular techniques inclusive of line probe assay (LPA) and GeneXpert MTB/RIF methods for the detection of multi-drug resistant (MDR) TB. Sputum samples from 300 different categories of treated and new TB cases were tested for the detection of possible mutation in the resistance specific genes (rpoB, inhA and katG) through Genotype MTBDRplus assay or LPA and GeneXpert MTB/RIF tests. Culture based conventional drug susceptibility test (DST) was also carried out to measure the efficacy of the molecular methods employed. Among 300 samples, 191 (63.7%) and 193 (64.3%) cases were found to be resistant against rifampicin in LPA and GeneXpert methods, respectively; while 189 (63%) cases of rifampicin resistance were detected by conventional DST methods. On the other hand, 196 (65.3%) and 191 (63.7%) isolates showed isoniazid resistance as detected by LPA and conventional drug susceptibility test (DST), respectively. Among the drug resistant isolates (collectively 198 in LPA and 193 in conventional DST), 189 (95.6%) and 187 (96.9%) were considered to be MDR as examined by LPA and conventional DST, respectively. Category-II and -IV patients encountered higher frequency of drug resistance compared to those from category-I and new cases. Considering the higher sensitivity, specificity and accuracy along with the required time to results significantly shorter, our study supports the adoption of LPA and GeneXpert assay as efficient tools in detecting drug resistant TB in Bangladesh.	[Aurin, Tafsina Haque; Munshi, Saurab Kishore; Rahman, Farjana; Noor, Rashed] Stamford Univ Bangladesh, Dept Microbiol, Dhaka, Bangladesh; [Kamal, S. M. Mostofa; Hossain, Md. Shamim; Marma, Thaythayhla] NIDCH, NTRL, Dhaka, Bangladesh; [Rahman, Md. Mostafizur] Univ Res Co LLC URC, Dhaka, Bangladesh	Stamford University Bangladesh	Noor, R (corresponding author), Stamford Univ Bangladesh, Dept Microbiol, Dhaka, Bangladesh.	noor.rashed@yahoo.com	Munshi, Saurab Kishore/Q-2705-2018; Noor, Rashed/GVU-1664-2022; Noor, Rashed/Q-7687-2019	Munshi, Saurab Kishore/0000-0003-3950-7741; Noor, Rashed/0000-0003-4837-221X; 				Armand S, 2011, J CLIN MICROBIOL, V49, P1772, DOI 10.1128/JCM.02157-10; Baker LV, 2005, ANTIMICROB AGENTS CH, V49, P1455, DOI 10.1128/AAC.49.4.1455-1464.2005; Bang H, 2011, J MED MICROBIOL, V60, P1447, DOI 10.1099/jmm.0.032292-0; Barnard M, 2012, J CLIN MICROBIOL, V50, P3712, DOI 10.1128/JCM.01958-12; Barnard M, 2010, LAB MANUAL MOL DETEC; Barnard M., 2012, MOL DETECTION DRUG R; Barnard M, 2007, INT J TUBERC LUNG D, V11, pS229; Barnard M, 2008, AM J RESP CRIT CARE, V177, P787, DOI 10.1164/rccm.200709-1436OC; Bengisun JS, 2000, SCAND J INFECT DIS, V32, P507, DOI 10.1080/003655400458785; Bwanga F, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-67; Cavusoglu C, 2002, J CLIN MICROBIOL, V40, P4435, DOI 10.1128/JCM.40.12.4435-4438.2002; Davies GR, 2010, TUBERCULOSIS, V90, P171, DOI 10.1016/j.tube.2010.03.007; Helb D, 2010, J CLIN MICROBIOL, V48, P229, DOI 10.1128/JCM.01463-09; Hillemann D, 2006, INT J TUBERC LUNG D, V10, P1057; Hillemann D, 2007, J CLIN MICROBIOL, V45, P2635, DOI 10.1128/JCM.00521-07; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Iqbal R, 2008, PAK J MED RES, V47, P26; Islam S, 2012, BANGLADESH J MED SCI, V11, P322, DOI 10.3329/bjms.v11i4.12605; Jou R, 2005, J CLIN MICROBIOL, V43, P1390, DOI 10.1128/JCM.43.3.1390-1394.2005; Kiepiela P, 2000, TUBERCLE LUNG DIS, V80, P47, DOI 10.1054/tuld.1999.0231; Kim BJ, 1999, J CLIN MICROBIOL, V37, P1714, DOI 10.1128/JCM.37.6.1714-1720.1999; Kumar V., 2007, ROBBINS BASIC PATHOL, P516; Lutfor AB, 2009, J MED MICROBIOL, V3, P1; Mahadev B, 2010, IND J TUB, V48, P129; Mahmud AM, 2008, RESPIROLOGY, V13, P106; Makinen J, 2006, J CLIN MICROBIOL, V44, P350, DOI 10.1128/JCM.44.2.350-352.2006; McAdam AJ, 2004, ROBBINS COTRAN PATHO, P381; Miotto P, 2006, J CLIN MICROBIOL, V44, P2485, DOI 10.1128/JCM.00083-06; Mokrousov I, 2002, ANTIMICROB AGENTS CH, V46, P1417, DOI 10.1128/AAC.46.5.1417-1424.2002; Munshi SK, 2012, INT J MYCOBACT, V1, P190, DOI 10.1016/j.ijmyco.2012.10.004; Noor R, 2013, J INFECT CHEMOTHER, V19, P818, DOI 10.1007/s10156-013-0566-0; Noor R, 2013, J INFECT CHEMOTHER, V19, P243, DOI [10.1007/s10156-012-0490-8, 10.1007/]; Piatek AS, 2000, ANTIMICROB AGENTS CH, V44, P103, DOI 10.1128/AAC.44.1.103-110.2000; Rahman A.M., 1970, STAMFORD J MICROBIOL, V1, P46, DOI [10.3329/sjm.v1i1.9133, DOI 10.3329/SJM.V1I1.9133, DOI 10.3329/sjm.v1i1.9133]; Richter Elvira, 2009, Expert Rev Respir Med, V3, P497, DOI 10.1586/ers.09.45; Sabouni R, 2008, ANN MICROBIOL, V58, P749, DOI 10.1007/BF03175585; Salim AH, 2006, INT J TUBERC LUNG D, V10, P1248; Shiferaw G, 2007, J CLIN MICROBIOL, V45, P1093, DOI 10.1128/JCM.01949-06; Somoskovi A, 2006, J CLIN MICROBIOL, V44, P4459, DOI 10.1128/JCM.01506-06; Sreeramareddy CT, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-91; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Telenti A, 1997, J CLIN MICROBIOL, V35, P719, DOI 10.1128/JCM.35.3.719-723.1997; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Van Rie A, 2001, J CLIN MICROBIOL, V39, P636, DOI 10.1128/JCM.39.2.636-641.2001; Van Rie A, 2012, INT J TUBERC LUNG D, V16, P206, DOI 10.5588/ijtld.11.0395; Warren RM, 2009, TUBERCULOSIS, V89, P199, DOI 10.1016/j.tube.2009.03.001; WHO, 2009, GLOB TUB CONTR 2009; WHO, 2010, GLOB TUB CONTR 2010; Wilson ML, 2011, MED MICROBIOL, V52, P1352; World Health Organization, 2008, MOL LIN PROB ASS RAP; World Health Organization, 2011, RAP IMPL XPERT MTB R; World Health Organization, 2011, DRUG RES TUB S E AS; Zaman K, 2005, SCAND J INFECT DIS, V37, P21, DOI 10.1080/00365540410026095	53	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99810	10.1371/journal.pone.0099810	http://dx.doi.org/10.1371/journal.pone.0099810			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932706	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600067
J	Burgess, GH; Bruce, BD; Cailliet, GM; Goldman, KJ; Grubbs, RD; Lowe, CG; MacNeil, MA; Mollet, HF; Weng, KC; O'Sullivan, JB				Burgess, George H.; Bruce, Barry D.; Cailliet, Gregor M.; Goldman, Kenneth J.; Grubbs, R. Dean; Lowe, Christopher G.; MacNeil, M. Aaron; Mollet, Henry F.; Weng, Kevin C.; O'Sullivan, John B.			A Re-Evaluation of the Size of the White Shark (Carcharodon carcharias) Population off California, USA	PLOS ONE			English	Article							BEHAVIOR; MOVEMENTS; CONSEQUENCES; DEMOGRAPHY; MIGRATION; ABUNDANCE; COLLAPSE; ISLANDS; HABITAT; BIOLOGY	White sharks are highly migratory and segregate by sex, age and size. Unlike marine mammals, they neither surface to breathe nor frequent haul-out sites, hindering generation of abundance data required to estimate population size. A recent tag-recapture study used photographic identifications of white sharks at two aggregation sites to estimate abundance in "central California'' at 219 mature and sub-adult individuals. They concluded this represented approximately one-half of the total abundance of mature and sub-adult sharks in the entire eastern North Pacific Ocean (ENP). This low estimate generated great concern within the conservation community, prompting petitions for governmental endangered species designations. We critically examine that study and find violations of model assumptions that, when considered in total, lead to population underestimates. We also use a Bayesian mixture model to demonstrate that the inclusion of transient sharks, characteristic of white shark aggregation sites, would substantially increase abundance estimates for the adults and sub-adults in the surveyed sub-population. Using a dataset obtained from the same sampling locations and widely accepted demographic methodology, our analysis indicates a minimum all-life stages population size of >2000 individuals in the California subpopulation is required to account for the number and size range of individual sharks observed at the two sampled sites. Even accounting for methodological and conceptual biases, an extrapolation of these data to estimate the white shark population size throughout the ENP is inappropriate. The true ENP white shark population size is likely several-fold greater as both our study and the original published estimate exclude non-aggregating sharks and those that independently aggregate at other important ENP sites. Accurately estimating the central California and ENP white shark population size requires methodologies that account for biases introduced by sampling a limited number of sites and that account for all life history stages across the species' range of habitats.	[Burgess, George H.] Univ Florida, Florida Museum Nat Hist, Florida Program Shark Res, Gainesville, FL 32611 USA; [Bruce, Barry D.] Commonwealth Sci & Ind Res Org Wealth Oceans Flag, Hobart, Tas, Australia; [Cailliet, Gregor M.; Mollet, Henry F.] Moss Landing Marine Lab, Moss Landing, CA USA; [Goldman, Kenneth J.] Alaska Dept Fish & Game, Homer, AK USA; [Grubbs, R. Dean] Florida State Univ, Coastal & Marine Lab, St Teresa, FL USA; [Lowe, Christopher G.] Calif State Univ Long Beach, Dept Biol Sci, Long Beach, CA 90840 USA; [MacNeil, M. Aaron] Australian Inst Marine Sci, Townsville, Qld 4810, Australia; [Weng, Kevin C.] Univ Hawaii Manoa, Dept Oceanog, Pelag Fisheries Res Program, Honolulu, HI 96822 USA; [Mollet, Henry F.; O'Sullivan, John B.] Monterey Bay Aquarium, Monterey, CA USA	State University System of Florida; University of Florida; Commonwealth Scientific & Industrial Research Organisation (CSIRO); Moss Landing Marine Laboratories; Alaska Department of Fish & Game; State University System of Florida; Florida State University; California State University System; California State University Long Beach; Australian Institute of Marine Science; University of Hawaii System; University of Hawaii Manoa; Monterey Bay Aquarium Research Institute	Burgess, GH (corresponding author), Univ Florida, Florida Museum Nat Hist, Florida Program Shark Res, Gainesville, FL 32611 USA.	gburgess@flmnh.ufl.edu	MacNeil, Aaron/E-8196-2017; MacNeil, M. Aaron/ABD-6444-2021; Weng, Kevin Chi-Ming/C-4709-2013	MacNeil, Aaron/0000-0001-8406-325X; MacNeil, M. Aaron/0000-0001-8406-325X; Weng, Kevin Chi-Ming/0000-0002-7069-7152	Australian Government's National Environmental Research Program, Marine Biodiversity Hub; Joint Institute for Marine and Atmospheric Research	Australian Government's National Environmental Research Program, Marine Biodiversity Hub(Australian Government); Joint Institute for Marine and Atmospheric Research	We are grateful for thoughts shared by numerous colleagues during informal discussions. We thank Malcolm Francis, Colin Simpfendorfer, Scott Meyer and two anonymous reviewers for their valuable comments on this manuscript, which helped to greatly improve it. Time on this paper for BDB was supported by the Australian Government's National Environmental Research Program, Marine Biodiversity Hub and for KCW by the Joint Institute for Marine and Atmospheric Research.	Aires-da-Silva AM, 2008, FISH RES, V92, P41, DOI 10.1016/j.fishres.2007.12.019; Anderson SD, 2008, CALIF FISH GAME, V94, P33; Anderson SD, 2011, MAR BIOL, V158, P1233, DOI 10.1007/s00227-011-1643-5; Anderson SD, 2003, CALIF FISH GAME, V89, P96; Anderson SD, 1996, CALIF FISH GAME, V82, P182; [Anonymous], 2004, MARINE FISHERIES REV; Barrett-Lennard LG, 2001, 2001065 DEP FISH OC; Baum JK, 2003, SCIENCE, V299, P389, DOI 10.1126/science.1079777; Blower DC, 2012, MAR ECOL PROG SER, V455, P229, DOI 10.3354/meps09659; Boustany AM, 2002, NATURE, V415, P35, DOI 10.1038/415035b; Bruce BD, 2006, MAR BIOL, V150, P161, DOI 10.1007/s00227-006-0325-1; Bruce BD, 2013, MAR BIOL, V160, P889, DOI 10.1007/s00227-012-2142-z; Bruce Barry D., 2012, P225; BRUCE BD, 1992, AUST J MAR FRESH RES, V43, P1; Burgess GH, 2005, FISHERIES, V30, P19, DOI 10.1577/1548-8446(2005)30[19:ITCOSP]2.0.CO;2; Cailliet G.M., 1985, Memoirs of the Southern California Academy of Sciences, V9, P49; CAILLIET GM, 1992, AUST J MAR FRESH RES, V43, P1313; Cailliet GM, 1996, GREAT WHITE SHARKS, P415, DOI 10.1016/B978-012415031-7/50039-2; Campana S, 2001, 2001067 CAN STOCK AS; CAREY FG, 1982, COPEIA, P254; Carlisle AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030492; CHAO A, 1987, BIOMETRICS, V43, P783, DOI 10.2307/2531532; Chapple TK, 2011, BIOL LETTERS, V7, P581, DOI 10.1098/rsbl.2011.0124; Chapple TK, 2010, THESIS U CALIFORNIA; Cliff G, 1996, GREAT WHITE SHARKS, P393, DOI 10.1016/B978-012415031-7/50037-9; Cortes E, 2007, MAR FRESHWATER RES, V58, P4, DOI 10.1071/MF06191; Daly-Engel TS, 2010, MAR ECOL PROG SER, V403, P255, DOI 10.3354/meps08417; Dawson S, 2008, MAMMAL REV, V38, P19, DOI 10.1111/j.1365-2907.2008.00119.x; Delaney DG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034753; Dewar H, 2004, ENVIRON BIOL FISH, V70, P133, DOI 10.1023/B:EBFI.0000029343.54027.6a; Dewar H., 2013, STATUS REV NE PACIFI; Domeier M. L., 2013, Animal Biotelemetry, V1, P1; Domeier Michael L., 2012, P133; Duffy Clinton A.J., 2012, P301; Estes JA, 2011, SCIENCE, V333, P301, DOI 10.1126/science.1205106; Fearnbach H, 2012, ECOL APPL, V22, P1689; Fergusson IK, 1996, GREAT WHITE SHARKS, P321, DOI 10.1016/B978-012415031-7/50031-8; Fergusson IK, 2000, ENVIRON BIOL FISH, V58, P447, DOI 10.1023/A:1007639324360; Ferretti F, 2010, ECOL LETT, V13, P1055, DOI 10.1111/j.1461-0248.2010.01489.x; Francis MP, 1996, GREAT WHITE SHARKS, P157, DOI 10.1016/B978-012415031-7/50016-1; Francis MP, 1997, IUCN SHARK SPECIALIS, V9, P8; GalvuYn-Magaua F., 2010, MAR BIODIV REC, V3, P1; Goldman KJ, 1999, ENVIRON BIOL FISH, V56, P351, DOI 10.1023/A:1007520931105; Gubili C, 2009, MAR BIOL, V156, P2199, DOI 10.1007/s00227-009-1233-y; Hamady LL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084006; Heithaus MR, 2008, TRENDS ECOL EVOL, V23, P202, DOI 10.1016/j.tree.2008.01.003; Heithaus MR, 2010, CRC MAR BIOL SER, P611; Hussey NE, 2012, GLOBAL PERSPECTIVES, P225; Jorgensen Salvador J., 2012, P159; Jorgensen SJ, 2010, P ROY SOC B-BIOL SCI, V277, P679, DOI 10.1098/rspb.2009.1155; Kendall WL, 1999, ECOLOGY, V80, P2517, DOI 10.1890/0012-9658(1999)080[2517:ROCCRM]2.0.CO;2; Kerr LA, 2006, ENVIRON BIOL FISH, V77, P337, DOI 10.1007/s10641-006-9125-1; Kim SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0030501, 10.1371/journal.pone.0045068]; KLIMLEY AP, 1994, AM SCI, V82, P122; Kock A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055048; Krebs C., 1985, Q REV BIOL, DOI DOI 10.1086/407551; Laroche RK, 2007, MAR ECOL PROG SER, V338, P199, DOI 10.3354/meps338199; Le Boeuf Burney J., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P89; Lowe Christopher G., 2012, P169; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; Malcolm H, 2001, REP ENV AUST MAR SPE; Marshall AD, 2012, J FISH BIOL, V80, P1361, DOI 10.1111/j.1095-8649.2012.03244.x; McDonald TL, 2003, WILDLIFE SOC B, V31, P814; Mollet HF, 2000, FISH B-NOAA, V98, P299; Mollet HF, 2002, MAR FRESHWATER RES, V53, P503, DOI 10.1071/MF01083; Nasby-Lucas Nicole, 2012, P381; OTIS DL, 1978, WILDLIFE MONOGR, P1; Pardini AT, 2001, NATURE, V412, P139, DOI 10.1038/35084125; Pyle P, 1996, GREAT WHITE SHARKS, P375, DOI 10.1016/B978-012415031-7/50035-5; Robbins R, 2012, MAR FRESHWATER RES, V63, P1215, DOI 10.1071/MF12208; Robbins Rachel L., 2012, P287; Robbins W, 2012, IND INVESTMENT NSW F, V132, P1; Santana-Morales Omar, 2012, P187; Sosa-Nishizaki Oscar, 2012, P393; Sperone E, 2010, MAR BIOL RES, V6, P408, DOI 10.1080/17451000903078648; Strong WR, 1996, GREAT WHITE SHARKS, P401, DOI 10.1016/B978-012415031-7/50038-0; Towner AV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066035; TRICAS T C, 1984, Proceedings of the California Academy of Sciences, V43, P221; WENG K, 2013, J MAR BIOL, V2013, pNIL1, DOI DOI 10.1155/2013/598745; Weng KC, 2007, MAR BIOL, V152, P877, DOI 10.1007/s00227-007-0739-4; Weng KC, 2007, MAR ECOL PROG SER, V338, P211, DOI 10.3354/meps338211; Williams TM, 2004, ECOLOGY, V85, P3373, DOI 10.1890/03-0696; Wilson E. O., 1971, PRIMER POPULATION BI; Wintner SP, 1999, FISH B-NOAA, V97, P153; Wirsing AJ, 2008, MAR MAMMAL SCI, V24, P1, DOI 10.1111/j.1748-7692.2007.00167.x; Worm B, 2013, MAR POLICY, V40, P194, DOI 10.1016/j.marpol.2012.12.034	86	39	39	5	160	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98078	10.1371/journal.pone.0098078	http://dx.doi.org/10.1371/journal.pone.0098078			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932483	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600007
J	Maksimovic, M; Vekovischeva, OY; Aitta-aho, T; Korpi, ER				Maksimovic, Milica; Vekovischeva, Olga Y.; Aitta-aho, Teemu; Korpi, Esa R.			Chronic Treatment with Mood-Stabilizers Attenuates Abnormal Hyperlocomotion of GluA1-Subunit Deficient Mice	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; MEDIAL TEMPORAL-LOBE; C-FOS EXPRESSION; BIPOLAR DISORDER; GLUTAMATE RECEPTORS; ENVIRONMENTAL ENRICHMENT; MESSENGER-RNAS; ANIMAL-MODELS; LONG-TERM; WILD-TYPE	Abnormal excitatory glutamate neurotransmission and plasticity have been implicated in schizophrenia and affective disorders. Gria1-/- mice lacking GluA1 subunit (encoded by Gria1 gene) of AMPA-type glutamate receptor show robust novelty-induced hyperactivity, social deficits and heightened approach features, suggesting that they could be used to test for anti-manic activity of drugs. Here, we tested the efficacy of chronic treatment with established anti-manic drugs on behavioural properties of the Gria1-/- mice. The mice received standard mood stabilizers (lithium and valproate) and novel ones (topiramate and lamotrigine, used more as anticonvulsants) as supplements in rodent chow for at least 4 weeks. All drugs attenuated novelty-induced locomotor hyperactivity of the Gria1-/- mice, especially by promoting the habituation, while none of them attenuated 2-mg/kg amphetamine-induced hyperactivity as compared to control diet. Treatment with lithium and valproate reversed the elevated exploratory activity of Gria1-/- mice. Valproate treatment also reduced struggling behaviour in tail suspension test and restored reciprocally-initiated social contacts of Gria12/2 mice to the level shown by the wild-type Gria1+/+ mice. Gria1-/- mice consumed slightly more sucrose during intermittent sucrose exposure than the wild-types, but ran similar distances on running wheels. These behaviours were not consistently affected by lithium and valproate in the Gria1-/- mice. The efficacy of various anti-manic drug treatments on novelty-induced hyperactivity suggests that the Gria1-/- mouse line can be utilized in screening for new therapeutics.	[Maksimovic, Milica; Vekovischeva, Olga Y.; Aitta-aho, Teemu; Korpi, Esa R.] Univ Helsinki, Inst Biomed, Helsinki, Finland; [Korpi, Esa R.] Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore, Singapore; [Korpi, Esa R.] Natl Univ Singapore, Inst Life Sci, Neurobiol & Ageing Programme, Singapore 117548, Singapore; [Korpi, Esa R.] SINAPSE, Singapore Inst Neurotechnol, Singapore, Singapore	University of Helsinki; National University of Singapore; National University of Singapore	Korpi, ER (corresponding author), Univ Helsinki, Inst Biomed, Helsinki, Finland.	esa.korpi@helsinki.fi		Korpi, Esa R./0000-0003-0683-4009; Aitta-aho, Teemu/0000-0001-9332-3340	Academy of Finland; Sigrid Juselius Foundation; Orion research foundation; Jane and Aatos Erkko Foundation; FinPharma Doctoral Program Drug Discovery section	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Orion research foundation; Jane and Aatos Erkko Foundation; FinPharma Doctoral Program Drug Discovery section	The study was supported by the Academy of Finland, the Sigrid Juselius Foundation, the Orion research foundation and the Jane and Aatos Erkko Foundation (ERK). The support of the FinPharma Doctoral Program Drug Discovery section (MM) is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitta-Aho T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038325; Anand A, 2000, ARCH GEN PSYCHIAT, V57, P270, DOI 10.1001/archpsyc.57.3.270; Bannerman DM, 2004, BEHAV NEUROSCI, V118, P643, DOI 10.1037/0735-7044.118.3.643; Barkus C, 2012, NEUROPHARMACOLOGY, V62, P1263, DOI 10.1016/j.neuropharm.2011.06.005; Basselin M, 2006, NEUROPSYCHOPHARMACOL, V31, P1659, DOI 10.1038/sj.npp.1300920; BERGGREN U, 1985, J NEURAL TRANSM, V64, P239, DOI 10.1007/BF01256470; Bramon E, 2001, Curr Psychiatry Rep, V3, P332; Bureau I, 1999, J NEUROSCI, V19, P653; CHAPOTEAU E, 1992, CLIN CHEM, V38, P1654; Collingridge GL, 2009, NEUROPHARMACOLOGY, V56, P2, DOI 10.1016/j.neuropharm.2008.06.063; Coyle JT, 2003, NEURON, V38, P157, DOI 10.1016/S0896-6273(03)00195-8; Dubreucq S, 2013, BIOL PSYCHIAT, V73, P895, DOI 10.1016/j.biopsych.2012.10.025; EASTWOOD SL, 1995, MOL BRAIN RES, V29, P211, DOI 10.1016/0169-328X(94)00247-C; Eastwood SL, 1997, BIOL PSYCHIAT, V41, P636, DOI 10.1016/S0006-3223(96)00220-X; Fisahn A, 2004, J NEUROSCI, V24, P9658, DOI 10.1523/JNEUROSCI.2973-04.2004; Fitzgerald PJ, 2010, NEUROBIOL DIS, V40, P608, DOI 10.1016/j.nbd.2010.08.005; Flaisher-Grinberg Shlomit, 2009, Journal of Pharmacological and Toxicological Methods, V59, P141, DOI 10.1016/j.vascn.2009.03.003; Flaisher-Grinberg S, 2009, J NEUROSCI METH, V177, P44, DOI 10.1016/j.jneumeth.2008.09.018; Ghasemi M, 2011, TRENDS PHARMACOL SCI, V32, P420, DOI 10.1016/j.tips.2011.03.006; Ghasemi M, 2010, EPILEPSY BEHAV, V18, P171, DOI 10.1016/j.yebeh.2010.04.002; Gibbs JW, 2000, EPILEPSIA, V41, pS10; Gigante AD, 2012, BIPOLAR DISORD, V14, P478, DOI 10.1111/j.1399-5618.2012.01033.x; Ginsberg SD, 2012, PHARMACOL BIOCHEM BE, V100, P705, DOI 10.1016/j.pbb.2011.09.015; Guilmatre A, 2014, DEV NEUROBIOL, V74, P113, DOI 10.1002/dneu.22128; Hall FS, 1997, PHYSIOL BEHAV, V62, P291, DOI 10.1016/S0031-9384(97)00116-9; Han K, 2013, NATURE, V503, P72, DOI 10.1038/nature12630; HARRISON PJ, 1991, LANCET, V337, P450, DOI 10.1016/0140-6736(91)93392-M; Hashimoto R, 2002, J NEUROCHEM, V80, P589, DOI 10.1046/j.0022-3042.2001.00728.x; Henry BL, 2013, J AFFECT DISORDERS, V150, P948, DOI 10.1016/j.jad.2013.05.020; Ibrahim HM, 2000, AM J PSYCHIAT, V157, P1811, DOI 10.1176/appi.ajp.157.11.1811; Inta D, 2013, HIPPOCAMPUS; Inta D, 2010, NEUROSCI BIOBEHAV R, V34, P285, DOI 10.1016/j.neubiorev.2009.07.010; Kato T, 2007, NEUROSCI BIOBEHAV R, V31, P832, DOI 10.1016/j.neubiorev.2007.03.003; Kelley AE, 2002, J NEUROSCI, V22, P3306; Kerner B, 2009, AM J MED GENET B, V150B, P24, DOI 10.1002/ajmg.b.30780; Krystal JH, 1999, NEUROPSYCHOPHARMACOL, V21, pS143, DOI 10.1016/S0893-133X(99)00102-5; Kubova H, 2010, EPILEPSIA, V51, P469, DOI 10.1111/j.1528-1167.2009.02305.x; Lan MJ, 2008, J MOL NEUROSCI, V35, P225, DOI 10.1007/s12031-008-9056-8; LEACH MJ, 1991, EPILEPSIA, V32, pS4, DOI 10.1111/j.1528-1157.1991.tb05882.x; Li XH, 2012, NEUROPSYCHOPHARMACOL, V37, P77, DOI 10.1038/npp.2011.198; Lin CY, 2012, NEUROBIOL DIS, V45, P48, DOI 10.1016/j.nbd.2011.08.025; Linden AM, 2006, J PHARMACOL EXP THER, V317, P615, DOI 10.1124/jpet.105.098525; Maeng Sungho, 2007, Curr Psychiatry Rep, V9, P467, DOI 10.1007/s11920-007-0063-1; Meador-Woodruff JH, 2001, BRAIN RES BULL, V55, P631, DOI 10.1016/S0361-9230(01)00523-8; Minassian A, 2010, J AFFECT DISORDERS, V120, P200, DOI 10.1016/j.jad.2009.04.018; Moghaddam B, 1998, SCIENCE, V281, P1349, DOI 10.1126/science.281.5381.1349; Newcomer JW, 1999, NEUROPSYCHOPHARMACOL, V20, P106, DOI 10.1016/S0893-133X(98)00067-0; NIESINK RJM, 1982, PHYSIOL BEHAV, V29, P819, DOI 10.1016/0031-9384(82)90331-6; O'Donnell KC, 2007, NEUROSCI BIOBEHAV R, V31, P932, DOI 10.1016/j.neubiorev.2007.04.002; Perry W, 2010, PSYCHIAT RES, V178, P84, DOI 10.1016/j.psychres.2010.04.032; Perry W, 2009, ARCH GEN PSYCHIAT, V66, P1072, DOI 10.1001/archgenpsychiatry.2009.58; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Procaccini C, 2013, NEUROSCIENCE, V250, P189, DOI 10.1016/j.neuroscience.2013.07.010; Procaccini C, 2011, EUR J NEUROSCI, V33, P161, DOI 10.1111/j.1460-9568.2010.07485.x; Rada P, 2005, NEUROSCIENCE, V134, P737, DOI 10.1016/j.neuroscience.2005.04.043; Ramos A, 2008, TRENDS PHARMACOL SCI, V29, P493, DOI 10.1016/j.tips.2008.07.005; Rao JS, 2010, MOL PSYCHIATR, V15, P384, DOI 10.1038/mp.2009.47; Saal D, 2003, NEURON, V38, P359, DOI 10.1016/S0896-6273(03)00208-3; Sanderson DJ, 2009, LEARN MEMORY, V16, P379, DOI 10.1101/lm.1339109; Shaldubina A, 2002, J NEURAL TRANSM, V109, P433, DOI 10.1007/s007020200035; Shaltiel G, 2008, MOL PSYCHIATR, V13, P858, DOI 10.1038/mp.2008.20; Shibata R, 2009, PHYSIOL BEHAV, V96, P667, DOI 10.1016/j.physbeh.2009.01.002; Simms JA, 2008, ALCOHOL CLIN EXP RES, V32, P1816, DOI 10.1111/j.1530-0277.2008.00753.x; Sokolov BP, 1998, J NEUROCHEM, V71, P2454; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Takao K, 2007, NEUROSCI RES, V58, P124, DOI 10.1016/j.neures.2007.02.009; Valdes JJ, 2009, BRAIN RES, V1268, P1, DOI 10.1016/j.brainres.2009.02.066; Van Loo PLP, 2004, LAB ANIM-UK, V38, P178, DOI 10.1258/002367704322968867; VandeWeerd HA, 1997, LAB ANIM, V31, P133, DOI 10.1258/002367797780600152; Varlinskaya EI, 1999, PHYSIOL BEHAV, V67, P475, DOI 10.1016/S0031-9384(98)00285-6; Vashchinkina E, 2012, J NEUROSCI, V32, P5310, DOI 10.1523/JNEUROSCI.4697-11.2012; Vekovischeva OY, 2013, BRIT J NUTR, V110, P1336, DOI 10.1017/S0007114513000238; Vekovischeva OY, 2004, GENES BRAIN BEHAV, V3, P253, DOI 10.1111/j.1601-1848.2004.00075.x; Vekovischeva OY, 2001, J NEUROSCI, V21, P4451, DOI 10.1523/JNEUROSCI.21-12-04451.2001; Voikar V, 2004, GENES BRAIN BEHAV, V3, P27, DOI 10.1046/j.1601-183X.2003.0044.x; Voikar V, 2005, GENES BRAIN BEHAV, V4, P240, DOI 10.1111/j.1601-183X.2004.00103.x; Wiedholz LM, 2008, MOL PSYCHIATR, V13, P631, DOI 10.1038/sj.mp.4002056; YAMASHITA S, 1995, J CHROMATOGR B, V670, P354, DOI 10.1016/0378-4347(95)00170-0; Zamanillo D, 1999, SCIENCE, V284, P1805, DOI 10.1126/science.284.5421.1805; Zarate CA, 2006, BIOL PSYCHIAT, V59, P1006, DOI 10.1016/j.biopsych.2005.10.021	80	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100188	10.1371/journal.pone.0100188	http://dx.doi.org/10.1371/journal.pone.0100188			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932798	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600101
J	Navarro, O; Cumplido, R; Villasenor-Pineda, L; Feregrino-Uribe, C; Carrasco-Ochoa, JA				Navarro, Osvaldo; Cumplido, Rene; Villasenor-Pineda, Luis; Feregrino-Uribe, Claudia; Ariel Carrasco-Ochoa, Jesus			A Node Linkage Approach for Sequential Pattern Mining	PLOS ONE			English	Article							FINDING FREQUENT; ALGORITHM	Sequential Pattern Mining is a widely addressed problem in data mining, with applications such as analyzing Web usage, examining purchase behavior, and text mining, among others. Nevertheless, with the dramatic increase in data volume, the current approaches prove inefficient when dealing with large input datasets, a large number of different symbols and low minimum supports. In this paper, we propose a new sequential pattern mining algorithm, which follows a pattern-growth scheme to discover sequential patterns. Unlike most pattern growth algorithms, our approach does not build a data structure to represent the input dataset, but instead accesses the required sequences through pseudo-projection databases, achieving better runtime and reducing memory requirements. Our algorithm traverses the search space in a depth-first fashion and only preserves in memory a pattern node linkage and the pseudo-projections required for the branch being explored at the time. Experimental results show that our new approach, the Node Linkage Depth-First Traversal algorithm (NLDFT), has better performance and scalability in comparison with state of the art algorithms.	[Navarro, Osvaldo; Cumplido, Rene; Villasenor-Pineda, Luis; Feregrino-Uribe, Claudia; Ariel Carrasco-Ochoa, Jesus] Inst Nacl Astrofis Opt & Electr, Dept Ciencias Computac, Puebla, Mexico	Instituto Nacional de Astrofisica, Optica y Electronica	Cumplido, R (corresponding author), Inst Nacl Astrofis Opt & Electr, Dept Ciencias Computac, Puebla, Mexico.	rcumplido@inaoep.mx	Feregrino, Claudia/AAW-2607-2021; Carrasco-Ochoa, Jesús Ariel/AAU-8484-2020; Villasenor-Pineda, Luis/A-2932-2009	Carrasco-Ochoa, Jesús Ariel/0000-0002-9982-7758; Villasenor-Pineda, Luis/0000-0003-1294-9128	CONACyT [106013, 106443, 158135, 51443]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was done under partial support of CONACyT (Project grants 106013, 106443 and 158135). The first author was funded by CONACyT (grant 51443) (www.conacyt.mx). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal R, 1995, DAT ENG 1995 P; Ahonen-Myka H., 2002, Pattern Detection and Discovery. ESF Exploratory Workshop Proceedings (Lecture Notes in Artificial Intelligence Vol. 2447), P180; Antunes C, 2003, LECT NOTES ARTIF INT, V2734, P239; Anwar F, 2012, EXPERT SYST APPL, V39, P4511, DOI 10.1016/j.eswa.2011.09.134; Cafaro M, 2011, CONCURR COMP-PRACT E, V23, P1774, DOI 10.1002/cpe.1761; Chen J, 2009, IEEE T KNOWL DATA EN, V22, P913; Coyotl-Morales RM, 2006, LECT NOTES COMPUT SC, V4225, P844; Denicia-Carral C, 2006, LECT NOTES ARTIF INT, V4139, P76; Ea Peterson, 2008, P 46 ANN SE REG C 20, V46, P34; Ezeife C, 2009, P 2009 INT DAT ENG A, P234, DOI [10.1145/ 1620432.1620457, DOI 10.1145/1620432.1620457]; Ezeife CI, 2005, DATA MIN KNOWL DISC, V10, P5, DOI 10.1007/s10618-005-0248-3; Garcia Blasco S, CEUR WORKSHOP P 2011; Garcia-Pedrajas N, 2011, PROGR ARTIFICIAL INT, V1, P71; Gouda K, 2010, J COMPUT SYST SCI, V76, P88, DOI 10.1016/j.jcss.2009.05.008; Hernandez-Reyes E, 2006, LECT NOTES ARTIF INT, V4139, P257; Karp RM, 2003, ACM T DATABASE SYST, V28, P51, DOI 10.1145/762471.762473; Kitsuregawa M, 2005, ICDE WORKSH, P1222; Li Chun, 2008, P SIAM INT C DAT MIN, P313; Mabroukeh NR, 2010, ACM COMPUT SURV, V43, DOI 10.1145/1824795.1824798; Masseglia F, 2009, EXPERT SYST APPL, V36, P2677, DOI 10.1016/j.eswa.2008.01.021; Pei J, 2000, DISCOVERY DATA MININ; Peiyi Tang, 2007, 16th International Conference on Software Engineering and Data Engineering, P247; Peiyi Tang, 2007, Proceedings of the 45th ACM Southeast Conference. ACMSE 07, P226, DOI 10.1145/1233341.1233382; Pitman A, 2011, WEBSITE HOSTING MARK; Shim B, 2012, EXPERT SYST APPL, V39, P7736, DOI 10.1016/j.eswa.2012.01.080; Spiliopoulou M, 1999, LECT NOTES COMPUT SC, V1590, P184; Tan H, 2006, WIT TRANS INFO COMM, V37, P315, DOI 10.2495/DATA060321; Tsai CY, 2012, EXPERT SYST APPL, V39, P3593, DOI 10.1016/j.eswa.2011.09.049; Zaki MJ, 2001, MACH LEARN, V42, P31, DOI 10.1023/A:1007652502315	29	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e95418	10.1371/journal.pone.0095418	http://dx.doi.org/10.1371/journal.pone.0095418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933123	Green Published, gold			2022-12-27	WOS:000337738600001
J	Boyko-Fabian, M; Niehr, F; Distel, L; Budach, V; Tinhofer, I				Boyko-Fabian, Mariya; Niehr, Franziska; Distel, Luitpold; Budach, Volker; Tinhofer, Ingeborg			Increased Growth-Inhibitory and Cytotoxic Activity of Arsenic Trioxide in Head and Neck Carcinoma Cells with Functional p53 Deficiency and Resistance to EGFR Blockade	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; INDUCED APOPTOSIS; TP53 MUTATIONS; FACTOR RECEPTOR; ORAL-CAVITY; TUMOR; RADIATION; LINES; ACTIVATION; CISPLATIN	Background and Purpose: Mutations in the p53 gene are frequently observed in squamous cell carcinoma of the head and neck region (SCCHN) and have been associated with drug resistance. The potential of arsenic trioxide (ATO) for treatment of p53-deficient tumor cells and those with acquired resistance to cisplatin and cetuximab was determined. Material and Methods: In a panel of 10 SCCHN cell lines expressing either wildtype p53, mutated p53 or which lacked p53 by deletion the interference of p53 deficiency with the growth-inhibitory and radiosensitizing potential of ATO was determined. The causal relationship between p53 deficiency and ATO sensitivity was evaluated by reconstitution of wildtype p53 in p53-deficient SCCHN cells. Interference of ATO treatment with cell cycle, DNA repair and apoptosis and its efficacy in cells with acquired resistance to cisplatin and cetuximab was evaluated. Results: Functional rather than structural defects in the p53 gene predisposed tumor cells to increased sensitivity to ATO. Reconstitution of wt p53 in p53-deficient SCCHN cells rendered them less sensitive to ATO treatment. Combination of ATO with irradiation inhibited clonogenic growth in an additive manner. The inhibitory effect of ATO in p53-deficient tumor cells was mainly associated with DNA damage, G2/M arrest, upregulation of TRAIL (tumor necrosis factor-related apoptosis-inducing ligand) receptors and apoptosis. Increased activity of ATO was observed in cetuximab-resistant SCCHN cells whereas cisplatin resistance was associated with cross-resistance to ATO. Conclusions: Addition of ATO to treatment regimens for p53-deficient SCCHN and tumor recurrence after cetuximab-containing regimens might represent an attractive strategy in SCCHN.	[Boyko-Fabian, Mariya; Niehr, Franziska; Budach, Volker; Tinhofer, Ingeborg] Charite, Translat Radiooncol Lab, Dept Radiooncol & Radiotherapy, Berlin, Germany; [Distel, Luitpold] Univ Erlangen Nurnberg, Dept Radiat Oncol, D-91054 Erlangen, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Erlangen Nuremberg	Tinhofer, I (corresponding author), Charite, Translat Radiooncol Lab, Dept Radiooncol & Radiotherapy, Berlin, Germany.	ingeborg.tinhofer@charite.de	Distel, Luitpold/ABD-9880-2020	Distel, Luitpold/0000-0002-8040-3226; Tinhofer, Ingeborg/0000-0002-0512-549X; Budach, Volker/0000-0002-2191-9871	German Cancer Aid [108791]	German Cancer Aid(Deutsche Krebshilfe)	The study was supported by a grant from the German Cancer Aid (grant no. 108791). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal N, 2011, SCIENCE, V333, P1154, DOI 10.1126/science.1206923; Akay C, 2003, CELL CYCLE, V2, P358, DOI 10.4161/cc.2.4.417; Ballo H, 1999, ANTICANCER RES, V19, P3827; Bode AM, 2002, CRIT REV ONCOL HEMAT, V42, P5, DOI 10.1016/S1040-8428(01)00215-3; Bornkamm GW, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni137; Brenner JC, 2010, HEAD NECK-J SCI SPEC, V32, P417, DOI 10.1002/hed.21198; Griffin RJ, 2005, INT J RADIAT ONCOL, V61, P1516, DOI 10.1016/j.ijrobp.2004.12.058; Haraf DJ, 1996, CLIN CANCER RES, V2, P755; Kato S, 2003, P NATL ACAD SCI USA, V100, P8424, DOI 10.1073/pnas.1431692100; Kim EH, 2008, CANCER RES, V68, P266, DOI 10.1158/0008-5472.CAN-07-2444; Kodigepalli KM, 2013, FEBS LETT, V587, P5, DOI 10.1016/j.febslet.2012.11.003; Kryeziu K, 2013, MOL CANCER THER, V12, P1073, DOI 10.1158/1535-7163.MCT-13-0065; Kumar P, 2008, MOL CANCER THER, V7, P2060, DOI 10.1158/1535-7163.MCT-08-0287; LANSFORD CD, 1999, HUMAN CELL CULTURE, V2, P185; Lee PC, 2010, NEOPLASIA, V12, P376, DOI 10.1593/neo.10110; Lew YS, 2002, CANCER RES, V62, P4202; Lin CJ, 2007, HEAD NECK-J SCI SPEC, V29, P163, DOI 10.1002/hed.20478; Lindenbergh-van der Plas M, 2011, CLIN CANCER RES, V17, P3733, DOI 10.1158/1078-0432.CCR-11-0183; Liu Q, 2003, BLOOD, V101, P4078, DOI 10.1182/blood-2002-10-3231; Liu ZM, 2011, BIOCHEM J, V438, P349, DOI 10.1042/BJ20101653; Ning SC, 2004, INT J RADIAT ONCOL, V60, P197, DOI 10.1016/j.ijrobp.2004.02.013; Ning SC, 2006, INT J RADIAT ONCOL, V65, P493, DOI 10.1016/j.ijrobp.2005.12.015; Perrone F, 2010, J CLIN ONCOL, V28, P761, DOI 10.1200/JCO.2009.22.4170; Poeta ML, 2007, NEW ENGL J MED, V357, P2552, DOI 10.1056/NEJMoa073770; Poeta ML, 2009, CLIN CANCER RES, V15, P7658, DOI 10.1158/1078-0432.CCR-09-1433; Raffoux E, 2003, J CLIN ONCOL, V21, P2326, DOI 10.1200/JCO.2003.01.149; RHEINWALD JG, 1981, CANCER RES, V41, P1657; Sertel S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035584; Shen ZX, 1997, BLOOD, V89, P3354, DOI 10.1182/blood.V89.9.3354; Simeonova PP, 2002, J BIOL CHEM, V277, P2945, DOI 10.1074/jbc.M109136200; Skinner HD, 2012, CLIN CANCER RES, V18, P290, DOI 10.1158/1078-0432.CCR-11-2260; Soignet SL, 1998, NEW ENGL J MED, V339, P1341, DOI 10.1056/NEJM199811053391901; SPITZ DR, 1993, J CELL PHYSIOL, V156, P72, DOI 10.1002/jcp.1041560111; Stransky N, 2011, SCIENCE, V333, P1157, DOI 10.1126/science.1208130; Tabor MP, 2003, J PATHOL, V199, P354, DOI 10.1002/path.1285; Tanaka-Kagawa T, 2003, BRIT J DERMATOL, V149, P1116, DOI 10.1111/j.1365-2133.2003.05704.x; Tandon S, 2010, CANCER EPIDEM BIOMAR, V19, P574, DOI 10.1158/1055-9965.EPI-09-0981; Taylor BF, 2006, J PHARMACOL EXP THER, V318, P142, DOI 10.1124/jpet.106.103077; VANKUPPEVELD FJM, 1994, APPL ENVIRON MICROB, V60, P149, DOI 10.1128/AEM.60.1.149-152.1994; Wahl AF, 1996, NAT MED, V2, P72, DOI 10.1038/nm0196-72; Waridel F, 1997, ONCOGENE, V14, P163, DOI 10.1038/sj.onc.1200812; Wei LH, 2005, ONCOGENE, V24, P390, DOI 10.1038/sj.onc.1208192; Westra WH, 2008, CLIN CANCER RES, V14, P366, DOI 10.1158/1078-0432.CCR-07-1402; YOKOMIZO A, 1995, CANCER RES, V55, P4293; Zhang LB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046255; Zhu J, 2002, NAT REV CANCER, V2, P705, DOI 10.1038/nrc887	46	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98867	10.1371/journal.pone.0098867	http://dx.doi.org/10.1371/journal.pone.0098867			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927258	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100021
J	Chen, RJ; Siao, SH; Hsu, CH; Chang, CY; Chang, LW; Wu, CH; Lin, PP; Wang, YJ				Chen, Rong-Jane; Siao, Shih-He; Hsu, Chung-Huei; Chang, Chu-Yung; Chang, Louis W.; Wu, Chih-Hsiung; Lin, Pinpin; Wang, Ying-Jan			TCDD Promotes Lung Tumors via Attenuation of Apoptosis through Activation of the Akt and ERK1/2 Signaling Pathways	PLOS ONE			English	Article							AROMATIC-HYDROCARBON RECEPTOR; EPITHELIAL-CELL LINE; ARYL-HYDROCARBON; 2,3,7,8-TETRACHLORODIBENZO-P-DIOXIN TCDD; STRESS-RESPONSE; CANCER; DIOXIN; EXPOSURE; EXPRESSION; INDUCTION	2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a multiple-site, multiple-species carcinogen that induces cancer in multiple organs. The molecular mechanisms underlying TCDD-induced lung tumorigenesis remain unclear. In the present study, a two-stage lung tumorigenesis model was established by administrating a single low dose of 4-(methylnitrosamino)-1-(3-pyridyl)- 1-butanone (NNK) combined with TCDD to female A/J mice. The results indicated that TCDD combined with low-dose NNK has a significant tumor-promoting effect compared with TCDD or low-dose NNK alone. Resistance to apoptosis is a hallmark of cancer and is thought to be one of the tumor-promoting mechanisms regulated by TCDD. We performed an additional series of experiments in the normal human bronchial epithelial cell line Beas2B cells, in which TCDD was combined with the apoptosis inducer staurosporine. Our in vitro results confirmed that TCDD could rescue cells from apoptosis induced by staurosporine. The inhibition of apoptosis is likely mediated by the activation of the Akt and ERK1/2 pathways, as determined by the effectiveness of pathway-specific inhibitors in abrogating the anti-apoptotic activity of TCDD. In conclusion, we demonstrated that TCDD promoted NNK-induced lung tumorigenesis and revealed that TCDD inhibits staurosporine-induced apoptosis, at least in part, through the Akt and ERK1/2 signaling pathways.	[Chen, Rong-Jane; Siao, Shih-He; Chang, Chu-Yung; Wang, Ying-Jan] Natl Cheng Kung Univ, Coll Med, Dept Environm & Occupat Hlth, Tainan 70101, Taiwan; [Chen, Rong-Jane] Taipei Med Univ, Grad Inst Clin Med, Taipei, Taiwan; [Hsu, Chung-Huei] Taipei Med Univ Hosp, Dept Nucl Med, Taipei, Taiwan; [Chang, Louis W.; Lin, Pinpin] Natl Hlth Res Inst, Natl Environm Hlth Res Ctr, Zhunan Town, Taiwan; [Wu, Chih-Hsiung] Taipei Med Univ, Shuang Ho Hosp, Sch Med, Dept Surg, Taipei, Taiwan; [Wu, Chih-Hsiung] Taipei Med Univ, Ctr Excellence Canc Res, Taipei, Taiwan; [Lin, Pinpin] Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan Town, Taiwan; [Wang, Ying-Jan] Asia Univ, Dept Biomed Informat, Taichung, Taiwan	National Cheng Kung University; Taipei Medical University; Taipei Medical University; Taipei Medical University Hospital; National Health Research Institutes - Taiwan; Taipei Medical University; Shuang Ho Hospital; Taipei Medical University; National Health Research Institutes - Taiwan; Asia University Taiwan	Lin, PP (corresponding author), Natl Hlth Res Inst, Div Environm Hlth & Occupat Med, Zhunan Town, Taiwan.	pplin@nhri.org.tw; yjwang@mail.ncku.edu.tw	Lin, PinPin/A-2006-2019; Lin, Pinpin/B-2668-2010	Lin, PinPin/0000-0001-5459-907X; Lin, Pinpin/0000-0001-5459-907X	National Science Council [NSC 102-2314-B-006-034]; Division of Environmental Health and Occupation Medicine (DEHOM), National Health Research Institutes (NHRI), Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Division of Environmental Health and Occupation Medicine (DEHOM), National Health Research Institutes (NHRI), Taiwan	This work is supported by the National Science Council (NSC 102-2314-B-006-034), and by the Division of Environmental Health and Occupation Medicine (DEHOM), National Health Research Institutes (NHRI), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BEEBE LE, 1995, CARCINOGENESIS, V16, P1345, DOI 10.1093/carcin/16.6.1345; Bertazzi PA, 2001, AM J EPIDEMIOL, V153, P1031, DOI 10.1093/aje/153.11.1031; Besteman EG, 2007, TOXICOL PATHOL, V35, P786, DOI 10.1080/01926230701584155; Biswas G, 2008, P NATL ACAD SCI USA, V105, P186, DOI 10.1073/pnas.0706183104; Bock KW, 2005, BIOCHEM PHARMACOL, V69, P1403, DOI 10.1016/j.bcp.2005.02.004; Bodner KM, 2003, OCCUP ENVIRON MED, V60, P672, DOI 10.1136/oem.60.9.672; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Chang F, 2003, LEUKEMIA, V17, P590, DOI 10.1038/sj.leu.2402824; Chen HM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089483; Chen RJ, 2012, J AGR FOOD CHEM, V60, P11533, DOI 10.1021/jf302778a; Chen RJ, 2011, J ONCOL, V2011, DOI 10.1155/2011/654931; Choi SS, 2006, TOXICOL SCI, V94, P163, DOI 10.1093/toxsci/kfl090; Chopra M, 2011, CRIT REV TOXICOL, V41, P292, DOI 10.3109/10408444.2010.524635; Chopra M, 2010, CELL BIOL TOXICOL, V26, P391, DOI 10.1007/s10565-010-9151-9; Cole P, 2003, REGUL TOXICOL PHARM, V38, P378, DOI 10.1016/j.yrtph.2003.08.002; Davis JW, 2003, TOXICOL APPL PHARM, V188, P42, DOI 10.1016/S0041-008X(03)00012-7; Davis JW, 2000, CARCINOGENESIS, V21, P881, DOI 10.1093/carcin/21.5.881; Davis JW, 2001, CANCER RES, V61, P3314; De Waard WJ, 2008, FOOD ADDIT CONTAM A, V25, P779, DOI 10.1080/02652030701798880; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Hattis D, 2009, CRIT REV TOXICOL, V39, P97, DOI 10.1080/10408440802307467 ; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Kasai A, 2006, CANCER RES, V66, P7143, DOI 10.1158/0008-5472.CAN-05-4541; Knerr S, 2006, MOL NUTR FOOD RES, V50, P897, DOI 10.1002/mnfr.200600006; Kogevinas M, 2000, FOOD ADDIT CONTAM, V17, P317, DOI 10.1080/026520300283388; Lee YC, 2011, AM J RESP CELL MOL, V45, P270, DOI 10.1165/rcmb.2010-0313OC; Li MY, 2010, J MOL MED, V88, P1265, DOI 10.1007/s00109-010-0676-4; Loh AHP, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00093; McGregor DB, 1998, ENVIRON HEALTH PERSP, V106, P755, DOI 10.2307/3433830; Nebert DW, 2000, BIOCHEM PHARMACOL, V59, P65, DOI 10.1016/S0006-2952(99)00310-X; Paajarvi G, 2005, CARCINOGENESIS, V26, P201, DOI 10.1093/carcin/bgh289; Papadimitrakopoulou V, 2012, J THORAC ONCOL, V7, P1315, DOI 10.1097/JTO.0b013e31825493eb; Park S, 2006, TOXICOLOGY, V217, P139, DOI 10.1016/j.tox.2005.09.002; Parzefall W, 2002, FOOD CHEM TOXICOL, V40, P1185, DOI 10.1016/S0278-6915(02)00059-5; Phin S, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00240; Pierre S, 2011, BIOCHEM PHARMACOL, V81, P304, DOI 10.1016/j.bcp.2010.10.003; Puga A, 2000, J BIOL CHEM, V275, P2943, DOI 10.1074/jbc.275.4.2943; Raimondi C, 2011, CURR MED CHEM, V18, P2763, DOI 10.2174/092986711796011238; Reyes-Hernandez OD, 2010, BIOCHEM PHARMACOL, V80, P932, DOI 10.1016/j.bcp.2010.05.007; Schecter A, 2001, J TOXICOL ENV HEAL A, V63, P1, DOI 10.1080/152873901750128326; Shimba S, 2002, J BIOCHEM, V132, P795, DOI 10.1093/oxfordjournals.jbchem.a003289; Tan ZQ, 2002, BIOCHEM PHARMACOL, V64, P771, DOI 10.1016/S0006-2952(02)01138-3; Tritscher AM, 2000, TOXICOL PATHOL, V28, P761, DOI 10.1177/019262330002800601; Wang YJ, 2011, J HAZARD MATER, V186, P869, DOI 10.1016/j.jhazmat.2010.11.082; Wu CH, 2004, FOOD CHEM TOXICOL, V42, P1217, DOI 10.1016/j.fct.2004.02.022; Xie GF, 2012, AM J PHYSIOL-GASTR L, V302, pG1006, DOI 10.1152/ajpgi.00427.2011	46	11	12	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99586	10.1371/journal.pone.0099586	http://dx.doi.org/10.1371/journal.pone.0099586			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927102	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100051
J	de Busserolles, F; Fitzpatrick, JL; Marshall, NJ; Collin, SP				de Busserolles, Fanny; Fitzpatrick, John L.; Marshall, N. Justin; Collin, Shaun P.			The Influence of Photoreceptor Size and Distribution on Optical Sensitivity in the Eyes of Lanternfishes (Myctophidae)	PLOS ONE			English	Article							DEEP-SEA FISH; GANGLION-CELL LAYER; VISUAL PIGMENTS; FAMILY MYCTOPHIDAE; FEEDING ECOLOGY; RETINAL SPECIALIZATIONS; OMMASTREPHES-BARTRAMII; FUNCTIONAL-MORPHOLOGY; TYRANT FLYCATCHERS; VERTICAL MIGRATION	The mesopelagic zone of the deep-sea (200-1000 m) is characterised by exponentially diminishing levels of downwelling sunlight and by the predominance of bioluminescence emissions. The ability of mesopelagic organisms to detect and behaviourally react to downwelling sunlight and/or bioluminescence will depend on the visual task and ultimately on the eyes and their capacity for detecting low levels of illumination and intermittent point sources of bioluminescent light. In this study, we investigate the diversity of the visual system of the lanternfish (Myctophidae). We focus specifically on the photoreceptor cells by examining their size, arrangement, topographic distribution and contribution to optical sensitivity in 53 different species from 18 genera. We also examine the influence(s) of both phylogeny and ecology on these photoreceptor variables using phylogenetic comparative analyses in order to understand the constraints placed on the visual systems of this large group of mesopelagic fishes at the first stage of retinal processing. We report great diversity in the visual system of the Myctophidae at the level of the photoreceptors. Photoreceptor distribution reveals clear interspecific differences in visual specialisations (areas of high rod photoreceptor density), indicating potential interspecific differences in interactions with prey, predators and/or mates. A great diversity in photoreceptor design (length and diameter) and density is also present. Overall, the myctophid eye is very sensitive compared to other teleosts and each species seems to be specialised for the detection of a specific signal (downwelling light or bioluminescence), potentially reflecting different visual demands for survival. Phylogenetic comparative analyses highlight several relationships between photoreceptor characteristics and the ecological variables tested (depth distribution and luminous tissue patterns). Depth distribution at night was a significant factor in most of the models tested, indicating that vision at night is of great importance for lanternfishes and may drive the evolution of their photoreceptor design.	[de Busserolles, Fanny; Collin, Shaun P.] Univ Western Australia, Sch Anim Biol, Crawley, Australia; [de Busserolles, Fanny; Collin, Shaun P.] Univ Western Australia, UWA Oceans Inst, Crawley, Australia; [de Busserolles, Fanny] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Fitzpatrick, John L.] Univ Western Australia, Sch Anim Biol, Ctr Evolutionary Biol, Crawley, Australia; [Fitzpatrick, John L.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Marshall, N. Justin] Univ Queensland, Queensland Brain Inst, Sensory Neurobiol Grp, Brisbane, Qld, Australia	University of Western Australia; University of Western Australia; King Abdullah University of Science & Technology; University of Western Australia; University of Manchester; University of Queensland	de Busserolles, F (corresponding author), Univ Western Australia, Sch Anim Biol, Crawley, Australia.	fanny.debusserolles@kaust.edu.sa	Collin, Shaun/K-8827-2012; de Busserolles, Fanny/A-1769-2013; Fitzpatrick, John/E-8766-2011	Collin, Shaun/0000-0001-6236-0771; de Busserolles, Fanny/0000-0002-4602-9840; Fitzpatrick, John/0000-0002-2834-4409; Marshall, Justin/0000-0001-9006-6713	Australian Research Council; West Australian State Government; Scholarship for International Research Fees (SIRF); University International Stipend (UIS) at the University of Western Australia	Australian Research Council(Australian Research Council); West Australian State Government; Scholarship for International Research Fees (SIRF); University International Stipend (UIS) at the University of Western Australia	This work was funded by the Australian Research Council (Discovery grant to SPC, the Deep-Australia Linkage Grant to NJM and SPC, and a Postdoctoral Fellowship to JLF) and the West Australian State Government (SPC). FdB was supported by a Scholarship for International Research Fees (SIRF) and a University International Stipend (UIS) at the University of Western Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1977, VISUAL SYSTEM VERTEB, DOI [DOI 10.1007/978-3-642-66468-7, 10.1007/978-3-642-66468-7_11, DOI 10.1007/978-3-642-66468-7_11]; ARNOTT HJ, 1970, SCIENCE, V169, P478, DOI 10.1126/science.169.3944.478; Baddeley A, 2005, J STAT SOFTW, V12, P1, DOI 10.18637/jss.v012.i06; BARNES AT, 1974, J EXP MAR BIOL ECOL, V15, P203, DOI 10.1016/0022-0981(74)90046-X; BASSI CJ, 1990, INVEST OPHTH VIS SCI, V31, P2320; CAREY PW, 1992, NEW ZEAL J ECOL, V16, P41; CASE JF, 1977, NATURE, V265, P179, DOI 10.1038/265179a0; Claes JM, 2010, J EXP MAR BIOL ECOL, V388, P28, DOI 10.1016/j.jembe.2010.03.009; CLARKE GL, 1956, DEEP-SEA RES, V3, P189, DOI 10.1016/0146-6313(56)90003-X; Coimbra JP, 2006, BRAIN BEHAV EVOLUT, V68, P15, DOI 10.1159/000092310; Coimbra JP, 2012, BRAIN BEHAV EVOLUT, V80, P254, DOI 10.1159/000341901; Collin S. P., 1997, Society for Neuroscience Abstracts, V23, P729; Collin SP, 2008, CLIN EXP OPTOM, V91, P85, DOI 10.1111/j.1444-0938.2007.00228.x; Collin SP, 1998, BRAIN BEHAV EVOLUT, V51, P291; COLLIN SP, 1988, BRAIN BEHAV EVOLUT, V31, P269, DOI 10.1159/000116594; COLLIN SP, 1988, BRAIN BEHAV EVOLUT, V31, P283, DOI 10.1159/000116595; Collin SP, 1997, ACTA PHYSIOL SCAND, V161, P5; CRESCITELLI F, 1990, J EXP ZOOL, P66; CURCIO CA, 1987, VISION RES, V27, P9, DOI 10.1016/0042-6989(87)90137-4; de Busserolles F, 2014, J COMP NEUROL, V522, P1618, DOI 10.1002/cne.23495; de Busserolles F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058519; DENTON EJ, 1990, LIGHT AND LIFE IN THE SEA, P127; DENTON EJ, 1989, J MAR BIOL ASSOC UK, V69, P409, DOI 10.1017/S0025315400029507; Douglas RH, 1997, J FISH BIOL, V50, P68; Douglas RH, 1998, PROG RETIN EYE RES, V17, P597, DOI 10.1016/S1350-9462(98)00002-0; EDWARDS AS, 1977, MAR BIOL, V41, P59, DOI 10.1007/BF00390582; Esposito V, 2009, SCI MAR, V73, P369, DOI 10.3989/scimar.2009.73n2369; FERNALD RD, 1990, J EXP ZOOL, P167; FITE KV, 1973, VISION RES, V13, P219, DOI 10.1016/0042-6989(73)90101-6; Frank TM, 1997, J PLANKTON RES, V19, P1975, DOI 10.1093/plankt/19.12.1975; Freckleton RP, 2002, AM NAT, V160, P712, DOI 10.1086/343873; Fritsches KA, 2003, MAR FRESHWATER RES, V54, P333, DOI 10.1071/MF02126; Garza-Gisholt E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093485; Glaser EM, 1998, J MICROSC-OXFORD, V192, P163, DOI 10.1046/j.1365-2818.1998.00417.x; Goldsworthy SD, 2002, MAR FRESHWATER RES, V53, P49, DOI 10.1071/MF00075; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; GREEN K, 1991, ANTARCT SCI, V3, P359, DOI 10.1017/S0954102091000457; Green K., 1998, Marine Ornithology, V26, P27; Haddock SHD, 2010, ANNU REV MAR SCI, V2, P443, DOI 10.1146/annurev-marine-120308-081028; Harmon LJ, 2008, BIOINFORMATICS, V24, P129, DOI 10.1093/bioinformatics/btm538; Harvey P.H., 1991, COMP METHOD EVOLUTIO; Hasegawa EI, 2008, J FISH BIOL, V72, P937, DOI 10.1111/j.1095-8649.2007.01772.x; HAYGOOD MG, 1994, J EXP ZOOL, V270, P225, DOI 10.1002/jez.1402700212; Herring P.J., 1985, Symposia of the Society for Experimental Biology, P323; Herring PJ, 2007, J MAR BIOL ASSOC UK, V87, P829, DOI 10.1017/S0025315407056433; Herring PJ, 2002, BIOL DEEP SEA; Hoang QV, 2002, VISUAL NEUROSCI, V19, P395, DOI 10.1017/S0952523802194028; Hulley P.A., 1984, FISHES NE ATLANTIC M, V1, P429, DOI DOI 10.1017/CBO9781107415324.004; HULLEY PA, 1981, ARCH FISCHEREIWISS, V31, P1; HULLEY PA, LIVING MARI IN PRESS; Ishihara S, 1997, NIPPON SUISAN GAKK, V63, P522; JACKSON S, 1988, CONDOR, V90, P20, DOI 10.2307/1368428; Karnella C, 1987, BIOL MIDWATER FISHES, V452, P51; Kozlov A.N., 1995, CCAMLR Science, V2, P71; Land M.F., 1981, HDB SENSORY PHYSL, P471, DOI DOI 10.1007/978-3-642-66907-14; Land MF, 2002, ANIMALS EYES; LAWRY JV, 1974, NATURE, V247, P155, DOI 10.1038/247155a0; Litherland L, 2008, VISUAL NEUROSCI, V25, P549, DOI 10.1017/S0952523808080693; Locket N. A., 1977, HDB SENSORY PHYSL  5, P67; LOCKET NA, 1971, J MAR BIOL ASSOC UK, V51, P79, DOI 10.1017/S0025315400006470; LOCKET NA, 1970, EXP EYE RES, V9, P22, DOI 10.1016/S0014-4835(70)80054-9; Madison W., 2011, MESQUITE MODULAR SYS; Marshall N. B., 1954, ASPECTS DEEP SEA BIO; Martin G, 2004, NATURWISSENSCHAFTEN, V91, P26, DOI 10.1007/s00114-003-0495-3; MATTHIESSEN L, 1882, PFLUG ARCH GES PHYS, V38, P521; Matthiessen L., 1882, ARCH GESAMTE PHYSIOL, V27, P510, DOI DOI 10.1007/BF01802978; Munk O., 1974, Videnskabelige Meddr dansk naturh Foren, V137, P65; MUNK OLE, 1966, DANA REP CARLSBERG FOUND, V70, P5; NICOL JAC, 1989, EYES FISHES; Nilsson DE, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0038; ODAY WT, 1976, MAR BIOL, V37, P187, DOI 10.1007/BF00389128; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; PANKHURST NW, 1987, ENVIRON BIOL FISH, V19, P269, DOI 10.1007/BF00003228; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Parry M, 2006, MAR ECOL PROG SER, V318, P229, DOI 10.3354/meps318229; PARTRIDGE JC, 1989, J COMP PHYSIOL A, V164, P513, DOI 10.1007/BF00610445; PARTRIDGE JC, 1992, J MAR BIOL ASSOC UK, V72, P113, DOI 10.1017/S0025315400048827; Coimbra JP, 2009, J COMP NEUROL, V514, P66, DOI 10.1002/cne.21992; Paxton J.R., 1984, American Society of Ichthyologists and Herpetologists Special Publication, P239; Podrazhanskaya S.G., 1993, Northwest Atlantic Fisheries Organization Scientific Council Studies, V19, P79; Poulsen JY, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-111; Pusch C, 2004, ARCH FISH MAR RES, V51, P251; Schieber NL, 2012, J MORPHOL, V273, P423, DOI 10.1002/jmor.11033; Shreeve RS, 2009, MAR ECOL PROG SER, V386, P221, DOI 10.3354/meps08064; Slomianka L, 2005, NEUROSCIENCE, V136, P757, DOI 10.1016/j.neuroscience.2005.06.086; SOMIYA H, 1980, MAR ECOL PROG SER, V2, P9, DOI 10.3354/meps002009; STEINBERG RH, 1973, J COMP NEUROL, V148, P229, DOI 10.1002/cne.901480209; Stone J, 1981, WHOLE MOUNT HDB GUID; TSUJI FI, 1971, NATURE, V233, P623, DOI 10.1038/233623a0; Turner JR, 2009, DEEP-SEA RES PT I, V56, P1003, DOI 10.1016/j.dsr.2009.01.007; TYLER HR, 1975, MAR BIOL, V32, P7, DOI 10.1007/BF00395156; Ullmann JFP, 2012, BRAIN BEHAV EVOLUT, V79, P26, DOI 10.1159/000332802; VILTER V, 1951, CR SOC BIOL, V145, P52; Wagner HJ, 1998, PROG RETIN EYE RES, V17, P637, DOI 10.1016/S1350-9462(98)00003-2; Wagner HJ, 2001, BRAIN BEHAV EVOLUT, V57, P117, DOI 10.1159/000047231; Warrant E, 2004, J COMP PHYSIOL A, V190, P765, DOI 10.1007/s00359-004-0546-z; Warrant E, 2000, PHILOS T ROY SOC B, V355, P1155, DOI 10.1098/rstb.2000.0658; Warrant EJ, 2004, BIOL REV, V79, P671, DOI 10.1017/S1464793103006420; Warrant EJ, 1998, VISION RES, V38, P195, DOI 10.1016/S0042-6989(97)00151-X; Warrant EJ, 1999, VISION RES, V39, P1611, DOI 10.1016/S0042-6989(98)00262-4; Watanabe H, 1999, FISH OCEANOGR, V8, P115, DOI 10.1046/j.1365-2419.1999.00103.x; Watanabe H, 2008, J MAR BIOL ASSOC UK, V88, P381, DOI 10.1017/S0025315408000635; WEST MJ, 1991, ANAT RECORD, V231, P482, DOI 10.1002/ar.1092310411; Widder EA, 2010, SCIENCE, V328, P704, DOI 10.1126/science.1174269; YOUNG JW, 1986, MAR BIOL, V93, P147, DOI 10.1007/BF00428663; YOUNG RE, 1979, MAR BIOL, V51, P371, DOI 10.1007/BF00389215	106	26	26	1	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99957	10.1371/journal.pone.0099957	http://dx.doi.org/10.1371/journal.pone.0099957			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927016	Green Published, gold			2022-12-27	WOS:000338278100099
J	Dhami, MK; Kumarasinghe, L				Dhami, Manpreet K.; Kumarasinghe, Lalith			A HRM Real-Time PCR Assay for Rapid and Specific Identification of the Emerging Pest Spotted-Wing Drosophila (Drosophila suzukii)	PLOS ONE			English	Article							SYBR GREEN; DIPTERA DROSOPHILIDAE; DNA; INFORMATION; SEQUENCES; SELECTION; INVASION; EVAGREEN; TAQMAN; FIELD	Spotted wing drosophila (Drosophila suzukii) is an emerging pest that began spreading in 2008 and its distribution now includes 13 countries across two continents. Countries where it is established have reported significant economic losses of fresh produce, such as cherries due to this species of fly. At larval stages, it is impossible to identify due to its striking similarities with other cosmopolitan and harmless drosophilids. Molecular methods allow identification but the current technique of DNA barcoding is time consuming. We developed and validated a rapid, highly sensitive and specific assay based on real-time PCR and high resolution melt (HRM) analysis using EvaGreen DNA intercalating dye chemistry. Performance characteristics of this qualitative assay, validation and applicability in a New Zealand quarantine framework are discussed. Application of this robust and independently validated assay across the spectrum of key food production and border protection industries will allow us to reduce the further spread of this damaging species worldwide.	[Dhami, Manpreet K.; Kumarasinghe, Lalith] Minist Primary Ind, Plant Hlth & Environm Lab, Auckland, New Zealand		Dhami, MK (corresponding author), Minist Primary Ind, Plant Hlth & Environm Lab, Auckland, New Zealand.	manpreetkdhami@gmail.com		Dhami, Manpreet K./0000-0002-8956-0674	Ministry for Primary Industries Operational Research Programme	Ministry for Primary Industries Operational Research Programme	The work was funded by the Ministry for Primary Industries Operational Research Programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armstrong KF, 2005, PHILOS T R SOC B, V360, P1813, DOI 10.1098/rstb.2005.1713; Armstrong KF, 1997, PROCEEDINGS OF THE FIFTIETH NEW ZEALAND PLANT PROTECTION CONFERENCE, P316, DOI 10.30843/nzpp.1997.50.11323; Benson Dennis A, 2005, Nucleic Acids Res, V33, pD34; Berry J. A., 2012, PEST RISK ASSESSMENT; Bilodeau GJ, 2007, PHYTOPATHOLOGY, V97, P632, DOI 10.1094/PHYTO-97-5-0632; Bolda M.P., 2010, AGR RESOUR EC UPDATE, V13, P5, DOI DOI 10.1016/J.JFF.2015.04.027; Bonants P., 2013, Bulletin OEPP, V43, P211, DOI 10.1111/epp.12030; Burrack HJ, 2013, PEST MANAG SCI, V69, P1173, DOI 10.1002/ps.3489; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Calabria G, 2012, J APPL ENTOMOL, V136, P139, DOI 10.1111/j.1439-0418.2010.01583.x; Cini A, 2012, B INSECTOL, V65, P149; DAFF, 2013, FIN PEST RISK ANAL R; Dalton DT, 2011, PEST MANAG SCI, V67, P1368, DOI 10.1002/ps.2280; Damus M, 2009, CFIA PLANT HLTH RISK, V2, P15; EPPO, 2012, DROSOPHILA SUZUKII; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Hauser M, 2011, PEST MANAG SCI, V67, P1352, DOI 10.1002/ps.2265; Heid CA, 1996, GENOME RES, V6, P986, DOI 10.1101/gr.6.10.986; Heim A, 2003, J MED VIROL, V70, P228, DOI 10.1002/jmv.10382; Jones JT, 2013, MOL PLANT PATHOL, V14, P946, DOI 10.1111/mpp.12057; Kacsoh BZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034721; Kadirvel P, 2013, J ECON ENTOMOL, V106, P408, DOI 10.1603/EC12119; Kaneshiro KY, 1983, P HAWAII ENTOMOL SOC, V24, P179; Kanzawa T, 1939, DROSOPHILA SUZUKII M, P49; Lee JC, 2011, PEST MANAG SCI, V67, P1349, DOI 10.1002/ps.2271; Lewis RL, 2005, MOL PHYLOGENET EVOL, V37, P15, DOI 10.1016/j.ympev.2005.02.018; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Maeda H, 2003, FEMS IMMUNOL MED MIC, V39, P81, DOI 10.1016/S0928-8244(03)00224-4; Mao F, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-76; Monti M, 2013, MOL CELL PROBE, V27, P129, DOI 10.1016/j.mcp.2013.02.001; Osman F, 2007, J VIROL METHODS, V141, P22, DOI 10.1016/j.jviromet.2006.11.035; R Core Team, 2021, R LANGUAGE ENV STAT; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Reed GH, 2007, PHARMACOGENOMICS, V8, P597, DOI 10.2217/14622416.8.6.597; Ritz C, 2008, BIOINFORMATICS, V24, P1549, DOI 10.1093/bioinformatics/btn227; Rouzes R, 2012, J INT SCI VIGNE VIN, V46, P145; Rozen S, 2000, Methods Mol Biol, V132, P365; Takamori H, 2006, ENTOMOL SCI, V9, P121, DOI 10.1111/j.1479-8298.2006.00159.x; Walsh DB, 2010, JIPM, V2, P1; Walsh K, 2005, J APPL ENTOMOL, V129, P272, DOI 10.1111/j.1439-0418.2005.00960.x; Yu DJ, 2004, J APPL ENTOMOL, V128, P670, DOI 10.1111/j.1439-0418.2004.00907.x; Zhang SD, 2011, MOL PHYLOGENET EVOL, V60, P21, DOI [10.1016/j.ympev.2011.04.008, 10.1016/j.ympev.2011.09.018]; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	44	24	24	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98934	10.1371/journal.pone.0098934	http://dx.doi.org/10.1371/journal.pone.0098934			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927410	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100022
J	Hassanali, N; De Silva, NMG; Robertson, N; Rayner, NW; Barrett, A; Bennett, AJ; Groves, CJ; Matthews, DR; Katulanda, P; Frayling, TM; McCarthy, MI				Hassanali, Neelam; De Silva, N. Maneka G.; Robertson, Neil; Rayner, N. William; Barrett, Amy; Bennett, Amanda J.; Groves, Christopher J.; Matthews, David R.; Katulanda, Prasad; Frayling, Timothy M.; McCarthy, Mark I.			Evaluation of Common Type 2 Diabetes Risk Variants in a South Asian Population of Sri Lankan Descent	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; SUSCEPTIBILITY LOCI; GENETIC ARCHITECTURE; METAANALYSIS; PREVALENCE; TCF7L2; IMPACT; CLASSIFICATION; REPLICATION; PRO12ALA	Introduction: Most studies seeking common variant associations with type 2 diabetes (T2D) have focused on individuals of European ancestry. These discoveries need to be evaluated in other major ancestral groups, to understand ethnic differences in predisposition, and establish whether these contribute to variation in T2D prevalence and presentation. This study aims to establish whether common variants conferring T2D-risk in Europeans contribute to T2D-susceptibility in the South Asian population of Sri Lanka. Methodology: Lead single nucleotide polymorphism (SNPs) at 37 T2D-risk loci attaining genome-wide significance in Europeans were genotyped in 878 T2D cases and 1523 normoglycaemic controls from Sri Lanka. Association testing was performed by logistic regression adjusting for age and sex and by the Cochran-Mantel-Haenszel test after stratifying according to self-identified ethnolinguistic subgroup. A weighted genetic risk score was generated to examine the combined effect of these SNPs on T2D-risk in the Sri Lankan population. Results: Of the 36 SNPs passing quality control, sixteen showed nominal (p<0.05) association in Sri Lankan samples, fifteen of those directionally-consistent with the original signal. Overall, these association findings were robust to analyses that accounted for membership of ethnolinguistic subgroups. Overall, the odds ratios for 31 of the 36 SNPs were directionally-consistent with those observed in Europeans (p = 3.2x10(-6)). Allelic odds ratios and risk allele frequencies in Sri Lankan subjects were not systematically different to those reported in Europeans. Genetic risk score and risk of T2D were strongly related in Sri Lankans (per allele OR 1.10 [95%CI 1.08-1.13], p = 1.2x10(-17)). Conclusion: Our data indicate that most T2D-risk variants identified in Europeans have similar effects in South Asians from Sri Lanka, and that systematic difference in common variant associations are unlikely to explain inter-ethnic differences in prevalence or presentation of T2D.	[Hassanali, Neelam; Robertson, Neil; Rayner, N. William; Barrett, Amy; Bennett, Amanda J.; Groves, Christopher J.; Matthews, David R.; Katulanda, Prasad; McCarthy, Mark I.] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England; [De Silva, N. Maneka G.; Frayling, Timothy M.] Univ Exeter, Sch Med, Exeter, Devon, England; [Robertson, Neil; Rayner, N. William; McCarthy, Mark I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford, England; [Matthews, David R.] Univ Oxford, Harris Manchester Coll, Oxford, England; [Katulanda, Prasad] Univ Colombo, Dept Clin Med, Fac Med, Colombo, Sri Lanka; [McCarthy, Mark I.] Churchill Hosp, Oxford Natl Inst Hlth Res Biomed Res Ctr, Oxford OX3 7LJ, England	University of Oxford; University of Exeter; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; University of Colombo; University of Oxford	McCarthy, MI (corresponding author), Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford, England.	mark.mccarthy@drl.ox.ac.uk	McCarthy, Mark/M-3763-2015	McCarthy, Mark/0000-0002-4393-0510; Katulanda, Prasad/0000-0003-4313-7528; bennett, amanda/0000-0003-2140-8710	Diabetes UK [09/0003943]; European Commission [ENGAGE: HEALTH-F4-2007-201413]; Diabetes UK PhD studentship award; National Science Foundation of Sri Lanka, the NIHR Biomedical Research Centre and the Sri Lanka Young Diabetes study group; National Institute for Health Research [NF-SI-0611-10099] Funding Source: researchfish	Diabetes UK(Diabetes UK); European Commission(European CommissionEuropean Commission Joint Research Centre); Diabetes UK PhD studentship award; National Science Foundation of Sri Lanka, the NIHR Biomedical Research Centre and the Sri Lanka Young Diabetes study group; National Institute for Health Research(National Institute for Health Research (NIHR))	The authors acknowledge the support provided by Diabetes UK (09/0003943) and by the European Commission (ENGAGE: HEALTH-F4-2007-201413). NH is funded by a Diabetes UK PhD studentship award. Collection of the SLYDS and SLDCS cohorts were supported by (The National Science Foundation of Sri Lanka, the NIHR Biomedical Research Centre and the Sri Lanka Young Diabetes study group). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Altshuler D, 2000, NAT GENET, V26, P76, DOI 10.1038/79216; Chauhan G, 2010, DIABETES, V59, P2068, DOI 10.2337/db09-1386; Chidambaram M, 2010, METABOLISM, V59, P1760, DOI 10.1016/j.metabol.2010.04.024; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gloyn AL, 2004, J CLIN ENDOCR METAB, V89, P3932, DOI 10.1210/jc.2004-0568; Grant SFA, 2006, NAT GENET, V38, P320, DOI 10.1038/ng1732; Gujral UP, 2013, ANN NY ACAD SCI, V1281, P51, DOI 10.1111/j.1749-6632.2012.06838.x; Jayawardena R, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-380; Johansen CT, 2010, NAT GENET, V42, P684, DOI 10.1038/ng.628; Katulanda P, 2008, DIABETIC MED, V25, P1062, DOI 10.1111/j.1464-5491.2008.02523.x; Katulanda P, 2008, DIABETOLOGIA, V51, P1368, DOI 10.1007/s00125-008-1052-6; Kooner JS, 2011, NAT GENET, V43, P984, DOI 10.1038/ng.921; Lin X, 2009, DIABETOLOGIA, V52, P600, DOI 10.1007/s00125-008-1254-y; Lyssenko V, 2009, NAT GENET, V41, P82, DOI 10.1038/ng.288; Mahajan A, 2014, NAT GENET, V46, P234, DOI 10.1038/ng.2897; Maller JB, 2012, NAT GENET, V44, P1294, DOI 10.1038/ng.2435; McCarthy MI, 2010, NEW ENGL J MED, V363, P2339, DOI 10.1056/NEJMra0906948; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Palmer ND, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029202; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rees SD, 2011, DIABETOLOGIA, V54, P1368, DOI 10.1007/s00125-011-2063-2; Sandhu MS, 2007, NAT GENET, V39, P951, DOI 10.1038/ng2067; Sanghera DK, 2008, BMC MED GENET, V9, DOI 10.1186/1471-2350-9-59; Saxena R, 2013, DIABETES, V62, P1746, DOI 10.2337/db12-1077; Saxena R, 2012, AM J HUM GENET, V90, P410, DOI 10.1016/j.ajhg.2011.12.022; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Steinthorsdottir V, 2007, NAT GENET, V39, P770, DOI 10.1038/ng2043; Tabassum R, 2013, DIABETES, V62, P977, DOI 10.2337/db12-0406; Voight BF, 2010, NAT GENET, V42, P579, DOI 10.1038/ng.609; Waters KM, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001078; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	36	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98608	10.1371/journal.pone.0098608	http://dx.doi.org/10.1371/journal.pone.0098608			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926958	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100018
J	Oh, CM; Park, S; Lee, JY; Won, YJ; Shin, A; Kong, HJ; Choi, KS; Lee, YJ; Chung, KW; Jung, KW				Oh, Chang-Mo; Park, Sohee; Lee, Joo Young; Won, Young-Joo; Shin, Aesun; Kong, Hyun-Joo; Choi, Kui-Sun; Lee, You Jin; Chung, Ki-Wook; Jung, Kyu-Won			Increased Prevalence of Chronic Lymphocytic Thyroiditis in Korean Patients with Papillary Thyroid Cancer	PLOS ONE			English	Article							LYMPH-NODE METASTASIS; HASHIMOTOS-THYROIDITIS; UNITED-STATES; IODINE INTAKE; CARCINOMA; TRENDS; RISK; TIME; MICROCARCINOMA; EPIDEMIOLOGY	Background: In recent years, some reports have suggested that papillary thyroid cancers are more frequently associated with lymphocytic thyroiditis or Hashimoto's thyroiditis. This study investigated a potential increase in the prevalence of chronic lymphocytic thyroiditis among papillary thyroid cancer patients. Materials and Methods: We used national epidemiological survey data on thyroid cancer patients diagnosed in 1999, 2005, and 2008. A retrospective medical record survey was conducted by representative sampling of a national cancer incidence database. The analysis included 5,378 papillary thyroid cancer patients aged 20-79 years. We calculated the age-standardized prevalence and age-adjusted prevalence ratios using a binomial regression model with a log link for the prevalence of chronic lymphocytic thyroiditis among papillary thyroid cancer patients by sex for each year. Results: The prevalence of chronic lymphocytic thyroiditis among papillary thyroid cancer patients was 4.0% and 12.8% for men and women in 1999, 6.5% and 24.6% in 2005, and 10.7% and 27.6% in 2008, respectively. Between 1999 and 2008, the age-standardized prevalence of chronic lymphocytic thyroiditis increased 4.1-fold in male patients and 2.0-fold in female patients with papillary thyroid cancer. The prevalence of other thyroid diseases, however, did not increase in either gender. Conclusions: Among Korean papillary thyroid cancer patients, the prevalence of chronic lymphocytic thyroiditis increased between 1999 and 2008, whereas the prevalence of other thyroid disorders did not change.	[Oh, Chang-Mo; Won, Young-Joo; Kong, Hyun-Joo; Choi, Kui-Sun; Jung, Kyu-Won] Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea; [Park, Sohee] Yonsei Univ, Grad Sch Publ Hlth, Dept Epidemiol & Hlth Promot, Seoul 120749, South Korea; [Lee, Joo Young] Natl Med Ctr, Natl Emergency Med Ctr, Seoul, South Korea; [Shin, Aesun] Seoul Natl Univ, Dept Prevent Med, Coll Med, Seoul, South Korea; [Lee, You Jin] Natl Canc Ctr, Ctr Thyroid Canc, Goyang, South Korea; [Chung, Ki-Wook] Asan Med Ctr, Dept Surg, Div Endocrine Surg, Seoul, South Korea	National Cancer Center - Korea (NCC); Yonsei University; Yonsei University Health System; National Medical Center - Korea; Seoul National University (SNU); National Cancer Center - Korea (NCC); University of Ulsan; Asan Medical Center	Jung, KW (corresponding author), Natl Canc Ctr, Natl Canc Control Inst, Goyang, South Korea.	ara@ncc.re.kr	Shin, Aesun/E-9145-2014	Shin, Aesun/0000-0002-6426-1969	National Cancer Center Grant [NCC-1310220]	National Cancer Center Grant	This work was supported by a National Cancer Center Grant (NCC-1310220). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benvenga S, 2008, THYROID, V18, P429, DOI 10.1089/thy.2007.0234; Blomberg M, 2012, INT J CANCER, V131, P2360, DOI 10.1002/ijc.27497; Caturegli P, 2013, THYROID, V23, P142, DOI 10.1089/thy.2012.0554; Cho BY, 2013, THYROID, V23, P797, DOI 10.1089/thy.2012.0329; Chow SM, 2003, CANCER-AM CANCER SOC, V98, P31, DOI 10.1002/cncr.11442; Cibas ES, 2009, THYROID, V19, P1159, DOI 10.1089/thy.2009.0274; Cunha LL, 2011, J THROID RES, V2011, DOI 10.4061/2011/387062; Curado MP, 2007, IARC SCI PUBLICATION, VIX; Dong WW, 2013, MED SCI MONITOR, V19, P49, DOI 10.12659/MSM.883736; Elisei R, 2010, J CLIN ENDOCR METAB, V95, P1516, DOI 10.1210/jc.2009-1536; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P784, DOI 10.1158/1055-9965.EPI-08-0960; Feldt-Rasmussen U, 2010, HORM-INT J ENDOCRINO, V9, P109, DOI 10.14310/horm.2002.1261; Ferlay JSI, 2013, GLOBOCAN 2012 V1 0 C; Greene FL, 2002, AJCC CANC STAGING MA, DOI DOI 10.1007/978-1-4757-3656-4; Grodski S, 2008, SURGERY, V144, P1038, DOI 10.1016/j.surg.2008.08.023; Harach HR, 2002, ENDOCR PATHOL, V13, P175, DOI 10.1385/EP:13:3:175; Jung KW, 2013, CANCER RES TREAT, V45, P15, DOI 10.4143/crt.2013.45.1.15; Kilfoy BA, 2009, CANCER CAUSE CONTROL, V20, P525, DOI 10.1007/s10552-008-9260-4; Kim JY, 1998, YONSEI MED J, V39, P355, DOI 10.3349/ymj.1998.39.4.355; Kim YS, 2013, J KOREAN SURG SOC, V85, P20, DOI 10.4174/jkss.2013.85.1.20; Konturek A, 2014, LANGENBECK ARCH SURG, V399, P229, DOI 10.1007/s00423-013-1158-2; Korea Centers for Disease Control and Prevention, 2012, KOR NAT HLTH NUTR EX; Kwak JY, 2008, THYROID, V18, P609, DOI 10.1089/thy.2007.0345; Lee JH, 2013, EUR J ENDOCRINOL, V168, P343, DOI 10.1530/EJE-12-0903; Leese GP, 2008, CLIN ENDOCRINOL, V68, P311, DOI 10.1111/j.1365-2265.2007.03051.x; Li N, 2013, THYROID, V23, P103, DOI 10.1089/thy.2012.0392; Loh KC, 1999, J CLIN ENDOCR METAB, V84, P458, DOI 10.1210/jc.84.2.458; Michikawa T, 2012, EUR J CANCER PREV, V21, P254, DOI 10.1097/CEJ.0b013e32834a8042; Morris LGT, 2013, THYROID, V23, P886, DOI 10.1089/thy.2013.0045; Morris LGT, 2010, AM J SURG, V200, P454, DOI 10.1016/j.amjsurg.2009.11.008; Oh CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072012; Pagano L, 2012, ENDOCRINE, V42, P382, DOI 10.1007/s12020-012-9612-4; Peterson E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029177; Rego-Iraeta A, 2009, THYROID, V19, P333, DOI 10.1089/thy.2008.0210; Repplinger D, 2008, J SURG RES, V150, P49, DOI 10.1016/j.jss.2007.09.020; Teng WP, 2006, NEW ENGL J MED, V354, P2783, DOI 10.1056/NEJMoa054022; The Korea Central Cancer Registry NCC, 2012, ANN REP CANC STAT KO; Thompson ML, 1998, OCCUP ENVIRON MED, V55, P272, DOI 10.1136/oem.55.4.272; Zhumadilov Z, 2000, J RADIAT RES, V41, P35, DOI 10.1269/jrr.41.35	39	14	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99054	10.1371/journal.pone.0099054	http://dx.doi.org/10.1371/journal.pone.0099054			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927027	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100027
J	Arvidsson, E; Viereckel, T; Mikulovic, S; Wallen-Mackenzie, A				Arvidsson, Emma; Viereckel, Thomas; Mikulovic, Sanja; Wallen-Mackenzie, Asa			Age- and Sex-Dependence of Dopamine Release and Capacity for Recovery Identified in the Dorsal Striatum of C57/BI6J Mice	PLOS ONE			English	Article							FAST CYCLIC VOLTAMMETRY; PARKINSONS-DISEASE; GENDER-DIFFERENCES; BASAL GANGLIA; TRANSPORTER; RAT; BRAIN; NEURONS	The dorsal striatum is the main input structure of the basal ganglia and the major target area of dopaminergic projections originating in the substantia nigra pars compacta. Heavily involved in the regulation of voluntary movement and habit formation, this structure is of strong importance in Parkinson's disease, obsessive-compulsive disorder, Tourette's syndrome and addiction. The C57/Bl6J mouse strain, the most commonly used strain in preclinical research today, is frequently used as a model organism for analysis of dopaminergic parameters implicated in human pathophysiology. Several components of the dopamine system have been shown to vary with age and sex, however knowledge of the contribution of these factors for dopamine release kinetics in the C57/Bl6J mouse strain is lacking. In the present study, we used an intracranial KCl-stimulation challenge paradigm to provoke release from dopaminergic terminals in the dorsal striatum of anaesthetized C57/Bl6J mice. By high-speed in vivo chronoamperometric recordings, we analyzed DA release parameters in male and female mice of two different ages. Our experiments demonstrate elevated DA amplitudes in adult compared to young mice of both sexes and higher DA amplitudes in females compared to males at both ages. Adult mice exhibited higher recovery capabilities after repeated stimulation than did young mice and also showed a lower variability in the kinetic parameters t(rise) and t(80) between stimulations. These results identified age- and sex-dimorphisms in DA release parameters and point to the importance of taking these dimorphisms into account when utilizing the C57/Bl6J mouse strain as model for neurological and neuropsychiatric disorders.	[Arvidsson, Emma; Viereckel, Thomas; Wallen-Mackenzie, Asa] Uppsala Univ, Unit Funct Neurobiol, Dept Neurosci, Uppsala, Sweden; [Mikulovic, Sanja] Uppsala Univ, Unit Dev Genet, Dept Neurosci, Uppsala, Sweden	Uppsala University; Uppsala University	Wallen-Mackenzie, A (corresponding author), Uppsala Univ, Unit Funct Neurobiol, Dept Neurosci, Uppsala, Sweden.	asa.mackenzie@neuro.uu.se	Wallén-Mackenzie, Åsa/B-9105-2017	Wallén-Mackenzie, Åsa/0000-0002-8713-070X; Viereckel, Thomas/0000-0001-9039-7707	Swedish Medical Research Council (SMRC) [2007-5742, 2011-4747]; Uppsala University; Parkinsonfonden; Swedish Brain Foundation; foundations of Bertil Hallsten, Major Gosta Lind, Ahlen; Ake Wiberg	Swedish Medical Research Council (SMRC)(Swedish Medical Research Council (SMRC)); Uppsala University; Parkinsonfonden; Swedish Brain Foundation; foundations of Bertil Hallsten, Major Gosta Lind, Ahlen; Ake Wiberg	The work was supported by grants from the Swedish Medical Research Council (SMRC 2007-5742, 2011-4747), Uppsala University, the Swedish Brain Foundation, Parkinsonfonden, and the foundations of Bertil Hallsten, Major Gosta Lind, Ahlen and Ake Wiberg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsio J, 2011, J NEUROSCI, V31, P12593, DOI 10.1523/JNEUROSCI.2397-11.2011; ANDEN NE, 1964, LIFE SCI, V3, P523, DOI 10.1016/0024-3205(64)90161-4; Bruun RD, 1997, NEUROL CLIN, V15, P291, DOI 10.1016/S0733-8619(05)70313-3; CILIAX BJ, 1995, J NEUROSCI, V15, P1714, DOI 10.1523/JNEUROSCI.15-03-01714.1995; Cosgrove KP, 2007, BIOL PSYCHIAT, V62, P847, DOI 10.1016/j.biopsych.2007.03.001; Dluzen DE, 2008, ANN NY ACAD SCI, V1139, P140, DOI 10.1196/annals.1432.010; Elsworth JD, 1997, EXP NEUROL, V144, P4, DOI 10.1006/exnr.1996.6379; FRIEDEMANN MN, 1992, NEUROBIOL AGING, V13, P325, DOI 10.1016/0197-4580(92)90046-Z; GERHARDT GA, 1986, J NEUROCHEM, V46, P842, DOI 10.1111/j.1471-4159.1986.tb13048.x; GERHARDT GA, 1984, BRAIN RES, V290, P390, DOI 10.1016/0006-8993(84)90963-6; Hafner H, 2003, PSYCHONEUROENDOCRINO, V28, P17, DOI 10.1016/S0306-4530(02)00125-7; Ji J, 2007, J NEUROENDOCRINOL, V19, P725, DOI 10.1111/j.1365-2826.2007.01581.x; Karayiorgou M, 1997, P NATL ACAD SCI USA, V94, P4572, DOI 10.1073/pnas.94.9.4572; Kumar V, 2013, SCIENCE, V342, P1508, DOI 10.1126/science.1245503; Laakso A, 2002, BIOL PSYCHIAT, V52, P759, DOI 10.1016/S0006-3223(02)01369-0; Lavalaye J, 2000, EUR J NUCL MED, V27, P867, DOI 10.1007/s002590000279; MICHAEL AC, 1987, BRAIN RES, V421, P325, DOI 10.1016/0006-8993(87)91302-3; Michael AC, 2007, FRONT NEUROENG, V1, P1; Nakano M, 1995, GERONTOLOGY, V41, P69; Obeso JA, 2008, MOVEMENT DISORD, V23, pS548, DOI 10.1002/mds.22062; Paxinos G, 2004, MOUSE BRAIN STEREOTA; PETER D, 1995, J NEUROSCI, V15, P6179; Ramsey LCB, 2011, NEUROSCIENCE, V180, P222, DOI 10.1016/j.neuroscience.2011.01.041; Reith MEA, 1997, EUR J PHARMACOL, V324, P1, DOI 10.1016/S0014-2999(97)00065-4; Riccardi P, 2006, NEUROPSYCHOPHARMACOL, V31, P1016, DOI 10.1038/sj.npp.1300916; Shulman LM, 2007, GENDER MED, V4, P8, DOI 10.1016/S1550-8579(07)80003-9; STAMFORD JA, 1989, J NEUROCHEM, V52, P1582, DOI 10.1111/j.1471-4159.1989.tb09212.x; Walker QD, 2000, NEUROSCIENCE, V95, P1061; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; Yin HH, 2006, NAT REV NEUROSCI, V7, P464, DOI 10.1038/nrn1919	30	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99592	10.1371/journal.pone.0099592	http://dx.doi.org/10.1371/journal.pone.0099592			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925086	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300080
J	Campbell, JE; Meledeo, MA; Cap, AP				Campbell, James E.; Meledeo, Michael Adam; Cap, Andrew P.			Comparative Response of Platelet fV and Plasma fV to Activated Protein C and Relevance to a Model of Acute Traumatic Coagulopathy	PLOS ONE			English	Article							TISSUE FACTOR PATHWAY; FACTOR VA INACTIVATION; IN-VITRO; THROMBIN GENERATION; BLOOD-COAGULATION; RECEPTOR; MECHANISMS; INHIBITOR; EXPRESSION; COFACTOR	Background: Acute traumatic coagulopathy (ATC) has been linked to an increase in activated protein C (aPC) from 40 pM in healthy individuals to 175 pM. aPC exerts its activity primarily through cleavage of active coagulation factor Va (fVa). Platelets reportedly possess fVa which is more resistant to aPC cleavage than plasma fVa; this work examines the hypothesis that normal platelets are sufficient to maintain coagulation in the presence of elevated aPC. Methods: Coagulation responses of normal plasma, fV deficient plasma (fVdp), and isolated normal platelets in fVdp were conducted: prothrombin (PT) tests, turbidimetry, and thromboelastography (TEG), including the dose response of aPC on the samples. Results: PT and turbidimetric assays demonstrate that normal plasma is resistant to aPC at doses much higher than those found in ATC. Additionally, an average physiological number of washed normal platelets (200,000 platelets/mm(3)) was sufficient to eliminate the anti-coagulant effects of aPC up to 10 nM, nearly two orders of magnitude above the ATC concentration and even the steady-state pharmacological concentration of human recombinant aPC, as measured by TEG. aPC also demonstrated no significant effect on clot lysis in normal plasma samples with or without platelets. Conclusions: Although platelet fVa shows slightly superior resistance to aPC's effects compared to plasma fVa in static models, neither fVa is sufficiently cleaved in simulations of ATC or pharmacologically-delivered aPC to diminish coagulation parameters. aPC is likely a correlative indicator of ATC or may play a cooperative role with other activity altering products generated in ATC.	[Campbell, James E.; Meledeo, Michael Adam; Cap, Andrew P.] JBSA FT Sam Houston, Coagulat & Blood Res Program, US Army Inst Surg Res, Houston, TX 78234 USA	United States Department of Defense; United States Army	Meledeo, MA (corresponding author), JBSA FT Sam Houston, Coagulat & Blood Res Program, US Army Inst Surg Res, Houston, TX 78234 USA.	michael.a.meledeo.vol@mail.mil		Meledeo, Michael/0000-0001-9958-9115	Combat Casualty Care Research Program of the United States Army Medical Research and Materiel Command [B_040_011]	Combat Casualty Care Research Program of the United States Army Medical Research and Materiel Command	Funding for this project was provided by the Combat Casualty Care Research Program of the United States Army Medical Research and Materiel Command, proposal designation B_040_011. https://ccc.amedd.army.mil/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bajzar L, 1996, BLOOD, V88, P2093, DOI 10.1182/blood.V88.6.2093.bloodjournal8862093; Berckmans RJ, 2001, THROMB HAEMOSTASIS, V85, P639; Bouillon B, 2010, J TRAUMA, V68, P225, DOI 10.1097/TA.0b013e3181c42815; Bravo MC, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-45; Brohi K, 2003, J TRAUMA, V54, P1127, DOI 10.1097/01.TA.0000069184.82147.06; Brohi K, 2008, J TRAUMA, V64, P1211, DOI 10.1097/TA.0b013e318169cd3c; Brohi K, 2007, CURR OPIN CRIT CARE, V13, P680, DOI 10.1097/MCC.0b013e3282f1e78f; Brohi K, 2007, ANN SURG, V245, P812, DOI 10.1097/01.sla.0000256862.79374.31; Butenas S, 2001, THROMB HAEMOSTASIS, V86, P660, DOI 10.1055/s-0037-1616110; CAMIRE RM, 1995, J BIOL CHEM, V270, P20794, DOI 10.1074/jbc.270.35.20794; Camire RM, 1998, BLOOD, V91, P2818, DOI 10.1182/blood.V91.8.2818.2818_2818_2829; Campbell JE, 2010, BLOOD, V116, P6082, DOI 10.1182/blood-2010-01-266395; Cap AP, 2012, J TRAUMA ACUTE CARE, V73, pS89, DOI 10.1097/TA.0b013e318260625a; CAREY JS, 1973, ANN SURG, V178, P87, DOI 10.1097/00000658-197307000-00018; Chesebro BB, 2009, SHOCK, V32, P659, DOI 10.1097/SHK.0b013e3181a5a632; Cohen MJ, 2009, J TRAUMA, V67, P1176, DOI 10.1097/TA.0b013e3181c1c1bc; Cohen MJ, 2012, ANN SURG, V255, P379, DOI 10.1097/SLA.0b013e318235d9e6; Cornet AD, 2013, J THROMB HAEMOST, V11, P894, DOI 10.1111/jth.12179; Cramer TJ, 2009, PATHOPHYSIOL HAEMO T, V37, P17, DOI 10.1159/000315141; Cui JS, 1996, NATURE, V384, P66, DOI 10.1038/384066a0; Cushman M, 2003, BRIT J HAEMATOL, V120, P109, DOI 10.1046/j.1365-2141.2003.03976.x; DANGELO A, 1987, BLOOD, V69, P231; Dhainaut JFO, 2003, THROMB HAEMOSTASIS, V90, P642, DOI 10.1160/TH02-11-0270; Duckers C, 2008, BLOOD, V112, P3615, DOI 10.1182/blood-2008-06-162453; Duckers C, 2010, BLOOD, V115, P879, DOI 10.1182/blood-2009-08-237719; ESPANA F, 1991, BLOOD, V77, P1754; Foley JH, 2012, ANAL BIOCHEM, V422, P46, DOI 10.1016/j.ab.2011.12.036; Gale AJ, 2008, J BIOL CHEM, V283, P16355, DOI 10.1074/jbc.M708985200; Gando S, 2013, J THROMB HAEMOST, V11, P826, DOI 10.1111/jth.12190; Gould WR, 2004, J BIOL CHEM, V279, P2383, DOI 10.1074/jbc.M308600200; Griffin JH, 2007, J THROMB HAEMOST, V5, P73, DOI 10.1111/j.1538-7836.2007.02491.x; GRUBER A, 1991, CIRCULATION, V84, P2454, DOI 10.1161/01.CIR.84.6.2454; GRUBER A, 1989, BLOOD, V73, P639; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Hockin MF, 1997, ARTERIOSCL THROM VAS, V17, P2765, DOI 10.1161/01.ATV.17.11.2765; Holcomb JB, 2008, ANN SURG, V248, P447, DOI 10.1097/SLA.0b013e318185a9ad; Isbister JP, 1997, TRANSFUS SCI, V18, P409, DOI 10.1016/S0955-3886(97)00040-4; Joyce DE, 2001, J BIOL CHEM, V276, P11199, DOI 10.1074/jbc.C100017200; Kaiser B, 1997, THROMB RES, V87, P197, DOI 10.1016/S0049-3848(97)00119-9; Kim PY, 2010, THROMB HAEMOSTASIS, V104, P61, DOI 10.1160/TH09-09-0650; Koestenberger M, 2005, THROMB HAEMOSTASIS, V94, P69; Komissarov AA, 2008, THROMB RES, V122, P397, DOI 10.1016/j.thromres.2007.10.012; Kurosawa S, 1998, BLOOD, V91, P725, DOI 10.1182/blood.V91.2.725; Lenting PJ, 2007, J THROMB HAEMOST, V5, P1353, DOI 10.1111/j.1538-7836.2007.02572.x; Lenting PJ, 1998, BLOOD, V92, P3983, DOI 10.1182/blood.V92.11.3983.423k51_3983_3996; Liaw PCY, 2000, J BIOL CHEM, V275, P5447, DOI 10.1074/jbc.275.8.5447; Lozano M, 1996, BRIT J HAEMATOL, V95, P179, DOI 10.1046/j.1365-2141.1996.d01-1870.x; Macias WL, 2002, CLIN PHARMACOL THER, V72, P391, DOI 10.1067/mcp.2002.128148; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Mosnier LO, 2011, J BIOL CHEM, V286, P502, DOI 10.1074/jbc.M110.147959; Mosnier LO, 2009, BLOOD, V113, P5970, DOI 10.1182/blood-2008-10-183327; MUSTARD JF, 1972, BRIT J HAEMATOL, V22, P193, DOI 10.1111/j.1365-2141.1972.tb08800.x; Panteleev MA, 2006, BIOPHYS J, V90, P1489, DOI 10.1529/biophysj.105.069062; Perez-Casal M, 2005, BLOOD, V105, P1515, DOI 10.1182/blood-2004-05-1896; Perez-Casal M, 2011, CRIT CARE, V15, DOI 10.1186/cc10356; Pidcoke HF, 2012, J TRAUMA ACUTE CARE, V73, pS445, DOI 10.1097/TA.0b013e3182754796; PRIST R, 1994, SHOCK, V1, P188, DOI 10.1097/00024382-199403000-00006; ROSING J, 1980, J BIOL CHEM, V255, P274; Schuepbach RA, 2008, BLOOD, V111, P2667, DOI 10.1182/blood-2007-09-113076; Schuerholz T, 2007, PLATELETS, V18, P373, DOI 10.1080/09537100601100788; SOLYMOSS S, 1993, THROMB HAEMOSTASIS, V69, P124; StearnsKurosawa DJ, 1996, P NATL ACAD SCI USA, V93, P10212, DOI 10.1073/pnas.93.19.10212; TAYLOR FB, 1985, THROMB RES, V37, P155, DOI 10.1016/0049-3848(85)90042-8; Taylor FB, 2001, BLOOD, V97, P1685, DOI 10.1182/blood.V97.6.1685; TAYLOR FB, 1985, THROMB RES, V37, P639, DOI 10.1016/0049-3848(85)90193-8; TRACY PB, 1982, BLOOD, V60, P59; Urano T, 2003, J THROMB HAEMOST, V1, P2615, DOI 10.1046/j.1538-7836.2003.00443.x; vantVeer C, 1997, J BIOL CHEM, V272, P7983, DOI 10.1074/jbc.272.12.7983; Wolberg AS, 2002, BLOOD COAGUL FIBRIN, V13, P533, DOI 10.1097/00001721-200209000-00008; Zivelin A, 1999, BLOOD, V94, P895, DOI 10.1182/blood.V94.3.895.415k01_895_901	70	28	30	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99181	10.1371/journal.pone.0099181	http://dx.doi.org/10.1371/journal.pone.0099181			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921658	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300040
J	Gilani, SZ; Rooney, K; Shafait, F; Walters, M; Mian, A				Gilani, Syed Zulqarnain; Rooney, Kathleen; Shafait, Faisal; Walters, Mark; Mian, Ajmal			Geometric Facial Gender Scoring: Objectivity of Perception	PLOS ONE			English	Article							SEXUAL-DIMORPHISM; HUMAN FACES; ATTRACTIVENESS; MASCULINITY; MEN; CLASSIFICATION; DIFFERENCE; TESTOSTERONE; PREFERENCES; SYMMETRY	Gender score is the cognitive judgement of the degree of masculinity or femininity of a face which is considered to be a continuum. Gender scores have long been used in psychological studies to understand the complex psychosocial relationships between people. Perceptual scores for gender and attractiveness have been employed for quality assessment and planning of cosmetic facial surgery. Various neurological disorders have been linked to the facial structure in general and the facial gender perception in particular. While, subjective gender scoring by human raters has been a tool of choice for psychological studies for many years, the process is both time and resource consuming. In this study, we investigate the geometric features used by the human cognitive system in perceiving the degree of masculinity/femininity of a 3D face. We then propose a mathematical model that can mimic the human gender perception. For our experiments, we obtained 3D face scans of 64 subjects using the 3dMDface scanner. The textureless 3D face scans of the subjects were then observed in different poses and assigned a gender score by 75 raters of a similar background. Our results suggest that the human cognitive system employs a combination of Euclidean and geodesic distances between biologically significant landmarks of the face for gender scoring. We propose a mathematical model that is able to automatically assign an objective gender score to a 3D face with a correlation of up to 0.895 with the human subjective scores.	[Gilani, Syed Zulqarnain; Shafait, Faisal; Mian, Ajmal] Univ Western Australia, Sch Comp Sci & Software Engn, Perth, WA 6009, Australia; [Rooney, Kathleen] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia; [Walters, Mark] Princess Margaret Hosp Children, CraniomaxilloFacial Unit, Perth, WA, Australia	University of Western Australia; University of Western Australia; University of Western Australia	Gilani, SZ (corresponding author), Univ Western Australia, Sch Comp Sci & Software Engn, Perth, WA 6009, Australia.	zulqarnain.gilani@uwa.edu.au	Gilani, Syed Zulqarnain/AAJ-8482-2021	Gilani, Syed Zulqarnain/0000-0002-7448-2327; Mian, Ajmal/0000-0002-5206-3842	Australian Research Council [DP110102399, LP110201008]; UWA Faculty of Engineering, Computing and Mathematics Development Grant; International Postgraduate Research Scholarship	Australian Research Council(Australian Research Council); UWA Faculty of Engineering, Computing and Mathematics Development Grant; International Postgraduate Research Scholarship(Australian Government)	This research was partly supported by Australian Research Council Discovery Grant DP110102399 and UWA Faculty of Engineering, Computing and Mathematics Development Grant. Syed Zulqarnain Gilani is supported by International Postgraduate Research Scholarship, and Faisal Shafait was supported by Australian Research Council grant LP110201008. The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABDI H, 1995, PERCEPTION, V24, P539, DOI 10.1068/p240539; Aldridge K, 2011, MOL AUTISM, V2, DOI 10.1186/2040-2392-2-15; Armann R, 2012, VISION RES, V63, P69, DOI 10.1016/j.visres.2012.05.005; BARDIN CW, 1981, SCIENCE, V211, P1285, DOI 10.1126/science.7010603; Bejerot S, 2012, BRIT J PSYCHIAT, V201, P116, DOI 10.1192/bjp.bp.111.097899; Ben Hamza A, 2006, IEEE T IMAGE PROCESS, V15, P2249, DOI 10.1109/TIP.2006.875250; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Blanz V, 2003, IEEE T PATTERN ANAL, V25, P1063, DOI 10.1109/TPAMI.2003.1227983; Boothroyd LG, 2008, EVOL HUM BEHAV, V29, P211, DOI 10.1016/j.evolhumbehav.2007.12.009; Bracaglia R, 2005, AESTHET PLAST SURG, V29, P230, DOI 10.1007/s00266-005-0034-z; Bronstein AM, 2005, INT J COMPUT VISION, V64, P5, DOI 10.1007/s11263-005-1085-y; BRUCE V, 1993, PERCEPTION, V22, P131, DOI 10.1068/p220131; BRUCE V, 1986, BRIT J PSYCHOL, V77, P305, DOI 10.1111/j.2044-8295.1986.tb02199.x; BURTON AM, 1993, PERCEPTION, V22, P153, DOI 10.1068/p220153; Chung EH, 2013, INT J PEDIAT OTORHIN; DeBruine LM, 2006, P ROY SOC B-BIOL SCI, V273, P1355, DOI 10.1098/rspb.2005.3445; DErico J., 2008, SURFACE FITTING USIN; Dey JK, 2013, LARYNGOSCOPE; Duda R.O., 2006, PATTERN CLASSIFICATI; Farkas Leslie G., 1994, P71; FARKAS LG, 1987, CLIN PLAST SURG, V14, P599; Gao JL, 2002, IEEE SYS MAN CYBERN, P2016; Graf ABA, 2006, NEURAL COMPUT, V18, P143, DOI 10.1162/089976606774841611; Gupta S, 2010, INT J COMPUT VISION, V90, P331, DOI 10.1007/s11263-010-0360-8; Hoss RA, 2005, PERCEPTION, V34, P1459, DOI 10.1068/p5154; Jones BC, 2013, BEHAV ECOL, V24, P373, DOI 10.1093/beheco/ars173; Koehler N, 2004, P ROY SOC B-BIOL SCI, V271, pS233, DOI 10.1098/rsbl.2003.0146; Kohavi R, 1997, ARTIF INTELL, V97, P273, DOI 10.1016/S0004-3702(97)00043-X; Lee AJ, 2013, BEHAV ECOL, V24, P779, DOI 10.1093/beheco/ars199; Leopold DA, 2010, J COMP PSYCHOL, V124, P233, DOI 10.1037/a0019460; Little AC, 2002, BRIT J PSYCHOL, V93, P451, DOI 10.1348/000712602761381349; Little AC, 2011, PHILOS T R SOC B, V366, P1634, DOI 10.1098/rstb.2010.0386; OToole AJ, 1997, PERCEPTION, V26, P75, DOI 10.1068/p260075; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Penton-Voak IS, 2001, P ROY SOC B-BIOL SCI, V268, P1617, DOI 10.1098/rspb.2001.1703; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Peters M, 2008, J EVOLUTION BIOL, V21, P572, DOI 10.1111/j.1420-9101.2007.01477.x; Pound N, 2009, P ROY SOC B-BIOL SCI, V276, P153, DOI 10.1098/rspb.2008.0990; Rhodes G, 2005, EVOL HUM BEHAV, V26, P186, DOI 10.1016/j.evolhumbehav.2004.08.014; Rhodes G, 2003, P ROY SOC B-BIOL SCI, V270, pS93, DOI 10.1098/rsbl.2003.0023; Rhodes G, 2000, BRIT J PSYCHOL, V91, P125, DOI 10.1348/000712600161718; Rieger G, 2010, ARCH SEX BEHAV, V39, P124, DOI 10.1007/s10508-008-9405-2; Scheib JE, 1999, P ROY SOC B-BIOL SCI, V266, P1913, DOI 10.1098/rspb.1999.0866; Scott IML, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013585; Stephen ID, 2012, EVOL HUM BEHAV, V33, P260, DOI 10.1016/j.evolhumbehav.2011.10.003; Thornhill R, 2006, EVOL HUM BEHAV, V27, P131, DOI 10.1016/j.evolhumbehav.2005.06.001; Weinberg SM, 2006, J CRANIOFAC SURG, V17, P477, DOI 10.1097/00001665-200605000-00015	48	18	20	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99483	10.1371/journal.pone.0099483	http://dx.doi.org/10.1371/journal.pone.0099483			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24923319	Green Published, gold			2022-12-27	WOS:000338701300065
J	Lu, F; Guan, HJ; Gong, B; Liu, XQ; Zhu, RR; Wang, Y; Qian, JJ; Zhou, TQ; Lan, XY; Wang, P; Lin, Y; Ma, S; Lin, H; Zhu, X; Chen, R; Zhu, XJ; Shi, Y; Yang, ZL				Lu, Fang; Guan, Huaijin; Gong, Bo; Liu, Xiaoqi; Zhu, Rongrong; Wang, Yong; Qian, Jingjing; Zhou, Tianqiu; Lan, Xiaoyan; Wang, Pu; Lin, Ying; Ma, Shi; Lin, He; Zhu, Xiong; Chen, Rong; Zhu, Xianjun; Shi, Yi; Yang, Zhenglin			Genetic Variants in PVRL2-TOMM40-APOE Region Are Associated with Human Longevity in a Han Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; APOLIPOPROTEIN-E; COGNITIVE DECLINE; SURVIVAL; APOE; HERITABILITY; FOXO3A; GENOTYPES; HOMOLOG; PROTEIN	Purpose: Human longevity results from a number of factors, including genetic background, favorable environmental, social factors and chance. In this study, we aimed to elucidate the association of human longevity with genetic variations in several major candidate genes in a Han Chinese population. Methods: A case-control association study of 1015 long-lived individuals (aged 90 years or older) and 1725 younger controls (30-70 years old) was undertaken. Rs2075650 in TOMM40 was firstly genotyped using the ABI SNaPshot method in an initial cohort consisted of 597 unrelated long-lived individuals and 1275 younger controls enrolled from Sichuan. Secondly, eighteen tag single-nucleotide polymorphisms (SNPs) in the PVRL2-TOMM40-APOE locus were genotyped for extensive study in the same cohort. Finally, 5 associated SNPs were genotyped in a replication cohort including 418 older individuals and 450 younger controls. The genotype and allele frequencies were evaluated using the chi(2) tests. The linkage disequilibrium (LD) block structure was examined using the program Haploview. Results: The case-control study of rs2075650 in TOMM40 showed significant difference in allele frequencies between cases and controls (P = 0.006) in an initial study. Of the 18 SNPs genotyped, rs405509 in APOE and another three SNPs (rs12978931, rs519825 and rs395908) in the PVRL2 gene also showed significant association with human longevity in extensive study in the same cohort. Rs2075650 in TOMM40, rs405509 in APOE and rs519825 in PVRL2 showed a significant association with human longevity in a replication cohort. Conclusion: These results suggested that PVRL2, TOMM40 and APOE might be associated with human longevity. However, further research is needed to identify the causal variants and determine which of these genes are involved in the progress of human longevity.	[Lu, Fang; Gong, Bo; Liu, Xiaoqi; Lan, Xiaoyan; Wang, Pu; Lin, Ying; Ma, Shi; Lin, He; Zhu, Xiong; Chen, Rong; Zhu, Xianjun; Shi, Yi; Yang, Zhenglin] Sichuan Acad Med Sci, Sichuan Key Lab Dis Gene Study, Chengdu, Sichuan, Peoples R China; [Lu, Fang; Gong, Bo; Liu, Xiaoqi; Lan, Xiaoyan; Wang, Pu; Lin, Ying; Ma, Shi; Lin, He; Zhu, Xiong; Chen, Rong; Zhu, Xianjun; Shi, Yi; Yang, Zhenglin] Sichuan Prov Peoples Hosp, Chengdu, Sichuan, Peoples R China; [Guan, Huaijin; Zhu, Rongrong; Wang, Yong; Qian, Jingjing; Zhou, Tianqiu] Nantong Univ, Inst Eye, Affiliated Hosp, Nantong, Jiangsu, Peoples R China; [Lu, Fang; Gong, Bo; Liu, Xiaoqi; Lan, Xiaoyan; Wang, Pu; Lin, Ying; Ma, Shi; Lin, He; Zhu, Xiong; Chen, Rong; Zhu, Xianjun; Shi, Yi; Yang, Zhenglin] Chinese Acad Sci, Sichuan Translat Med Res Hosp, Chengdu, Sichuan, Peoples R China; [Lu, Fang; Gong, Bo; Liu, Xiaoqi; Lan, Xiaoyan; Wang, Pu; Lin, Ying; Ma, Shi; Lin, He; Zhu, Xiong; Chen, Rong; Zhu, Xianjun; Shi, Yi; Yang, Zhenglin] Univ Elect Sci & Technol China, Sch Med, Chengdu 610054, Sichuan, Peoples R China	Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital; Nantong University; Chinese Academy of Sciences; University of Electronic Science & Technology of China	Shi, Y (corresponding author), Sichuan Acad Med Sci, Sichuan Key Lab Dis Gene Study, Chengdu, Sichuan, Peoples R China.	shiyi197911@gmail.com; zliny@yahoo.com		Zhu, Xianjun/0000-0002-2531-7552	natural Science Foundation of China [81371048, 81241001, 81070761, 81070718]; Department of Science and Technology of Sichuan Province [2011JTD0020, 2012JQ0023]; Medical key foundation of Jiangsu Province [XK200724]; Department of Sichuan Provincial Health [130167, 130193]	natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Department of Science and Technology of Sichuan Province; Medical key foundation of Jiangsu Province; Department of Sichuan Provincial Health	This study was supported by grants from the natural Science Foundation of China (81371048 to B. G., 81241001 and 81070761 to F. L.); the Department of Science and Technology of Sichuan Province (2011JTD0020 to Z.Y. and 2012JQ0023 to Y.S.); the Natural Science Foundation of China (81070718 to H. G.); the Medical key foundation of Jiangsu Province (XK200724 to H. G.); and the Department of Sichuan Provincial Health (130167 to B. G., 130193 to X. L.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen SL, 2012, J GERONTOL A-BIOL, V67, P395, DOI 10.1093/gerona/glr223; Asada T, 1996, NEUROLOGY, V47, P603, DOI 10.1212/WNL.47.2.603; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bathum L, 2006, J AM GERIATR SOC, V54, P654, DOI 10.1111/j.1532-5415.2005.53554.x; Christensen K, 2008, P NATL ACAD SCI USA, V105, P13274, DOI 10.1073/pnas.0804931105; Christensen K, 2006, NAT REV GENET, V7, P436, DOI 10.1038/nrg1871; de Magalhaes JP, 2010, AGEING RES REV, V9, P315, DOI 10.1016/j.arr.2009.10.006; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; EBERLE F, 1995, GENE, V159, P267, DOI 10.1016/0378-1119(95)00180-E; Flachsbart F, 2009, P NATL ACAD SCI USA, V106, P2700, DOI 10.1073/pnas.0809594106; Fossel M, 2000, J PEDIATR ENDOCR MET, V13, P1477; Gerdes LU, 2000, GENET EPIDEMIOL, V19, P202, DOI 10.1002/1098-2272(200010)19:3<202::AID-GEPI2>3.0.CO;2-Q; Gogele M, 2011, J GERONTOL A-BIOL, V66, P26, DOI 10.1093/gerona/glq163; Gudmundsson H, 2000, EUR J HUM GENET, V8, P743, DOI 10.1038/sj.ejhg.5200527; Herskind AM, 1996, HUM GENET, V97, P319, DOI 10.1007/s004390050042; Hjelmborg JV, 2006, HUM GENET, V119, P312, DOI 10.1007/s00439-006-0144-y; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; KERVINEN K, 1994, ATHEROSCLEROSIS, V105, P89, DOI 10.1016/0021-9150(94)90011-6; Li Y, 2009, HUM MOL GENET, V18, P4897, DOI 10.1093/hmg/ddp459; MCGUE M, 1993, J GERONTOL, V48, pB237, DOI 10.1093/geronj/48.6.B237; McKay GJ, 2011, AM J EPIDEMIOL, V173, P1357, DOI 10.1093/aje/kwr015; Nebel A, 2011, MECH AGEING DEV, V132, P324, DOI 10.1016/j.mad.2011.06.008; Oeppen J, 2002, SCIENCE, V296, P1029, DOI 10.1126/science.1069675; Pawlikowska L, 2009, AGING CELL, V8, P460, DOI 10.1111/j.1474-9726.2009.00493.x; Perls T, 2000, J AM GERIATR SOC, V48, P1483, DOI 10.1111/jgs.2000.48.11.1483; Perls T, 2002, J MOL NEUROSCI, V19, P233, DOI 10.1007/s12031-002-0039-x; Reed T, 2003, TWIN RES, V6, P227, DOI 10.1375/136905203765693889; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; Schoenmaker M, 2006, EUR J HUM GENET, V14, P79, DOI 10.1038/sj.ejhg.5201508; Schupf N, 2012, NEUROBIOL AGING; Sebastiani Paola, 2013, Front Public Health, V1, P38, DOI 10.3389/fpubh.2013.00038; Sebastiani P, 2013, AGING-US, V5, P653, DOI 10.18632/aging.100594; Sebastiani P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029848; Shukla D, 1999, J VIROL, V73, P4493, DOI 10.1128/JVI.73.5.4493-4497.1999; Skytthe A, 2003, TWIN RES, V6, P448, DOI 10.1375/twin.6.5.448; Soerensen M, 2012, AGE DORDR; Soerensen M, 2010, AGING CELL, V9, P1010, DOI 10.1111/j.1474-9726.2010.00627.x; Terry DF, 2008, ARCH INTERN MED, V168, P277, DOI 10.1001/archinternmed.2007.75; Tindale LC, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.09.010; Warner MS, 1998, VIROLOGY, V246, P179, DOI 10.1006/viro.1998.9218; Wilicox BJ, 2008, P NATL ACAD SCI USA, V105, P13987, DOI 10.1073/pnas.0801030105; Yu CE, 2007, GENOMICS, V89, P655, DOI 10.1016/j.ygeno.2007.02.002; Zhao L, 2012, AGING CELL, V11, P1094, DOI 10.1111/acel.12011	43	23	23	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99580	10.1371/journal.pone.0099580	http://dx.doi.org/10.1371/journal.pone.0099580			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924924	gold, Green Submitted, Green Published			2022-12-27	WOS:000338701300078
J	Buxton, JL; Das, S; Rodriguez, A; Kaakinen, M; Alves, AC; Sebert, S; Millwood, IY; Laitinen, J; O'Reilly, PF; Jarvelin, MR; Blakemore, AIF				Buxton, Jessica L.; Das, Shikta; Rodriguez, Alina; Kaakinen, Marika; Alves, Alexessander Couto; Sebert, Sylvain; Millwood, Iona Y.; Laitinen, Jaana; O'Reilly, Paul F.; Jarvelin, Marjo-Riitta; Blakemore, Alexandra I. F.			Multiple Measures of Adiposity Are Associated with Mean Leukocyte Telomere Length in the Northern Finland Birth Cohort 1966	PLOS ONE			English	Article							BODY-MASS INDEX; EARLY-LIFE; OBESITY; ADULTHOOD; MORTALITY; DISEASE; GENDER; HEART; AGE	Studies of leukocyte telomere length (LTL) and adiposity have produced conflicting results, and the relationship between body mass index (BMI) and telomere length throughout life remains unclear. We therefore tested association of adult LTL measured in 5,598 participants with: i) childhood growth measures (BMI and age at adiposity rebound (AR)); ii) change in BMI from childhood to adulthood and iii) adult BMI, waist-to-hip ratio (WHR), body adiposity index (BAI). Childhood BMI at AR was positively associated with LTL at 31 years in women (P = 0.041). Adult BMI and WHR in both men (P = 0.025 and P = 0.049, respectively) and women (P = 0.029 and P = 0.008, respectively), and BAI in women (P = 0.021) were inversely associated with LTL at 31 years. An increase in standardised BMI between early childhood and adulthood was associated with shorter adult LTL in women (P = 0.008). We show that LTL is inversely associated with multiple measures of adiposity in both men and women. Additionally, BMI increase in women from childhood to adulthood is associated with shorter telomeres at age 31, potentially indicating accelerated biological ageing.	[Buxton, Jessica L.; Blakemore, Alexandra I. F.] Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Investigat Med, London, England; [Das, Shikta; Rodriguez, Alina; Kaakinen, Marika; Alves, Alexessander Couto; Millwood, Iona Y.; O'Reilly, Paul F.; Jarvelin, Marjo-Riitta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Ctr Environm & Hlth, MRC,Publ Hlth England,Dept Epidemiol & Biostat, London, England; [Das, Shikta] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Primary Care & Publ Hlth, London, England; [Rodriguez, Alina] Mid Sweden Univ, Dept Psychol, Ostersund, Sweden; [Kaakinen, Marika; Sebert, Sylvain; Jarvelin, Marjo-Riitta] Univ Oulu, Inst Hlth Sci, Oulu, Finland; [Kaakinen, Marika; Jarvelin, Marjo-Riitta] Univ Oulu, Bioctr Oulu, Oulu, Finland; [Millwood, Iona Y.] Univ Oxford, Clin Trial Serv Unit, Oxford, England; [Millwood, Iona Y.] Univ Oxford, Epidemiol Studies Unit CTSU, Oxford, England; [Laitinen, Jaana] Finnish Inst Occupat Hlth, Helsinki, Finland; [O'Reilly, Paul F.] Kings Coll London, Inst Psychiat, MRC, Social Genet & Dev Psychiat Ctr, London, England; [Jarvelin, Marjo-Riitta] Natl Inst Hlth & Welf, Dept Children & Young People & Families, Oulu, Finland; [Jarvelin, Marjo-Riitta] Univ Oulu, Unit Primary Care, Oulu, Finland	Imperial College London; Imperial College London; Public Health England; Imperial College London; Mid-Sweden University; University of Oulu; University of Oulu; University of Oxford; University of Oxford; Finnish Institute of Occupational Health; University of London; King's College London; Finland National Institute for Health & Welfare; University of Oulu	Buxton, JL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Med, Sect Investigat Med, London, England.	j.buxton@imperial.ac.uk	Buxton, Jessica/L-9849-2019; Rodriguez, Alina/B-3541-2015	Rodriguez, Alina/0000-0003-1209-8802; Couto Alves, Alex/0000-0001-8519-7356; Sebert, Sylvain/0000-0001-6681-6983; O'Reilly, Paul/0000-0001-7515-0845; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Kaakinen, Marika/0000-0002-9228-0462	Wellcome Trust Fellowship [WT088431MA]; Medical Research Council (MRC) UK [G0500539]; National Institute for Health Research (NIHR); Imperial College Health Care NHS Trust, Biomedical Research Centre; Academy of Finland (Center of Excellence in Complex Disease Genetics and SALVE) [104781, 120315, 129269, 1114194]; University Hospital Oulu, Biocenter, University of Oulu, Finland [75617]; European Commission (EURO-BLCS) [QLG1-CT-2000-01643]; NHLBI through the STAMPEED program [5R01HL087679-02, 1RL1MH083268-01]; NIH/NIMH [5R01MH63706:02]; Medical Research Council, UK [G0500539, G0600705]; Wellcome Trust, UK [GR069224]; ENGAGE project; Academy of Finland and Biocentrum Helsinki;  [HEALTH-F4-2007-201413]; MRC [MR/K014536/1, G0600705] Funding Source: UKRI; Medical Research Council [G0600705, MR/K014536/1] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268] Funding Source: NIH RePORTER	Wellcome Trust Fellowship(Wellcome Trust); Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); Imperial College Health Care NHS Trust, Biomedical Research Centre; Academy of Finland (Center of Excellence in Complex Disease Genetics and SALVE); University Hospital Oulu, Biocenter, University of Oulu, Finland; European Commission (EURO-BLCS)(European CommissionEuropean Commission Joint Research Centre); NHLBI through the STAMPEED program; NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Medical Research Council, UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust, UK(Wellcome Trust); ENGAGE project(General Electric); Academy of Finland and Biocentrum Helsinki(Academy of Finland); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	JLB was supported by Wellcome Trust (http://www.wellcome.ac.uk/) Fellowship Grant WT088431MA; SD was supported by the Medical Research Council (MRC) UK (http://www.mrc.ac.uk/), (G0500539) and PFO was supported by the National Institute for Health Research (NIHR) (http://www.nihr.ac.uk/), Imperial College Health Care NHS Trust, Biomedical Research Centre. Financial support for the Northern Finland Birth Cohort 1966 (NFBC1966) was received from the Academy of Finland (project grants 104781, 120315, 129269, 1114194, Center of Excellence in Complex Disease Genetics and SALVE), University Hospital Oulu, Biocenter, University of Oulu, Finland (75617), the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), NIH/NIMH (5R01MH63706:02), the Medical Research Council, UK (G0500539, G0600705, PrevMetSyn/SALVE) and the Wellcome Trust (project grant GR069224), UK., ENGAGE project and grant agreement HEALTH-F4-2007-201413. The DNA extractions, sample quality controls, biobank upkeep and aliquotting were performed in the National Public Health Institute, Biomedicum Helsinki, Finland and supported financially by the Academy of Finland and Biocentrum Helsinki. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the	Adaikalakoteswari A, 2005, DIABETIC MED, V22, P1151, DOI 10.1111/j.1464-5491.2005.01574.x; Ahima RS, 2009, NAT MED, V15, P996, DOI 10.1038/nm0909-996; Aviv A, 2006, J CLIN ENDOCR METAB, V91, P635, DOI 10.1210/jc.2005-1814; Aviv A, 2009, INT J EPIDEMIOL, V38, P1735, DOI 10.1093/ije/dyp298; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergman RN, 2011, OBESITY, V19, P1083, DOI 10.1038/oby.2011.38; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; Buxton JL, 2011, J CLIN ENDOCR METAB, V96, P1500, DOI 10.1210/jc.2010-2924; Cawthon RM, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkn1027; Codd V, 2013, NAT GENET, V45, P422, DOI 10.1038/ng.2528; Cui Y, 2013, OBESITY, V21, P2582, DOI 10.1002/oby.20321; Drury S S, 2012, Mol Psychiatry, V17, P719, DOI 10.1038/mp.2011.53; Epel ES, 2004, P NATL ACAD SCI USA, V101, P17312, DOI 10.1073/pnas.0407162101; Farzaneh-Far R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008612; Flegal KM, 2013, JAMA-J AM MED ASSOC, V309, P71, DOI 10.1001/jama.2012.113905; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Garcia-Calzon S, 2014, INT J OBESITY, V38, P177, DOI 10.1038/ijo.2013.68; Garcia-Calzon S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089828; Gardner M, 2014, EXP GERONTOL, V51, P15, DOI 10.1016/j.exger.2013.12.004; Jarvelin MR, 2004, HYPERTENSION, V44, P838, DOI 10.1161/01.HYP.0000148304.33869.ee; Kim SM, 2009, CANCER EPIDEM BIOMAR, V18, P816, DOI 10.1158/1055-9965.EPI-08-0935; Kimura M, 2008, AM J EPIDEMIOL, V167, P799, DOI 10.1093/aje/kwm380; Kurz DJ, 2004, J CELL SCI, V117, P2417, DOI 10.1242/jcs.01097; Lee M, 2011, AM J HUM BIOL, V23, P100, DOI 10.1002/ajhb.21109; Ludlow Andrew T, 2011, J Aging Res, V2011, P790378, DOI 10.4061/2011/790378; Mather KA, 2011, J GERONTOL A-BIOL, V66, P202, DOI 10.1093/gerona/glq180; Muezzinler A, 2014, OBES REV, V15, P192, DOI 10.1111/obr.12126; Nordfjall K, 2008, OBESITY, V16, P2682, DOI 10.1038/oby.2008.413; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Oeseburg Hisko, 2010, Pflugers Arch, V459, P259, DOI 10.1007/s00424-009-0728-1; Rantakallio P, 1988, Paediatr Perinat Epidemiol, V2, P59, DOI 10.1111/j.1365-3016.1988.tb00180.x; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Rolland-Cachera MF, 2005, ADV EXP MED BIOL, V569, P35; ROLLANDCACHERA MF, 1984, AM J CLIN NUTR, V39, P129, DOI 10.1093/ajcn/39.1.129; Salpea KD, 2010, ATHEROSCLEROSIS, V209, P42, DOI 10.1016/j.atherosclerosis.2009.09.070; Schulze MB, 2012, DIABETOLOGIA, V55, P1660, DOI 10.1007/s00125-012-2499-z; Shalev I, 2013, MOL PSYCHIATR, V18, P576, DOI 10.1038/mp.2012.32; Sovio U, 2014, INT J OBESITY, V38, P53, DOI 10.1038/ijo.2013.165; Tzanetakou IP, 2012, AGEING RES REV, V11, P220, DOI 10.1016/j.arr.2011.12.003; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; von Zglinicki T, 2002, TRENDS BIOCHEM SCI, V27, P339, DOI 10.1016/S0968-0004(02)02110-2; Wentzensen IM, 2011, CANCER EPIDEM BIOMAR, V20, P1238, DOI 10.1158/1055-9965.EPI-11-0005; World Health Organisation, 1995, PHYS STAT USE INT AN	43	19	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99133	10.1371/journal.pone.0099133	http://dx.doi.org/10.1371/journal.pone.0099133			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919187	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000338631000052
J	Limoncin, E; Galli, D; Ciocca, G; Gravina, GL; Carosa, E; Mollaioli, D; Lenzi, A; Jannini, EA				Limoncin, Erika; Galli, Debora; Ciocca, Giacomo; Gravina, Giovanni Luca; Carosa, Eleonora; Mollaioli, Daniele; Lenzi, Andrea; Jannini, Emmanuele A.			The Psychosexual Profile of Sexual Assistants: An Internet-Based Explorative Study	PLOS ONE			English	Article							INTELLECTUAL DISABILITIES; PREVALENCE; PEOPLE; ADULTS	Introduction: Sexual assistance may have some aspects that resemble prostitution and others that might lead one to think of sexual assistants as similar to a group of subjects whose sexual object is disability (devotees). In this study, we investigate whether a rigorous selection and training process on the part of specialised organisations may reduce the risk of training subjects with an atypical sexual interest and behaviours resembling prostitution. Materials and Methods: The study population consisted of 152 subjects defining themselves as sexual assistants. Subjects were initially contacted on websites specifically dedicated to sexual assistants and prostitutes. One hundred and twenty subjects were selected, by propensity score analysis, and studied by means of a modified version of a semi-structured questionnaire previously developed to investigate a population of subjects attracted by disability. Results: The study group was composed of 80 trained and 40 untrained sexual assistants, with mean ages of 41.5 (SD +/-12.58) and 44.5 (SD +/-11.62), respectively. A significant number of untrained subjects affirmed that their motivation in carrying out sexual assistance was of a remunerative nature, while this number was lower among the trained assistants (p = 0.001). Nearly all untrained subjects claimed to do one or more of the following activities during sexual assistance: sexual intercourse, oral sex, and masturbation. Among the trained subjects, however, only 47.5% claimed to do one or more of these activities, which means that there is a significant gap between trained and untrained assistants (p<0.0001). The existence of an atypical sexual interest was more evident between untrained rather than between trained subjects (p<0.0001). Conclusions: Sexual assistance represents a way through which people affected by disabilities may attain the right to explore their sexuality in a safe setting. This can be guaranteed only if sexual assistants are trained and carefully selected by specialised organisations.	[Limoncin, Erika; Galli, Debora; Ciocca, Giacomo; Gravina, Giovanni Luca; Carosa, Eleonora; Mollaioli, Daniele; Jannini, Emmanuele A.] Univ Aquila, Sch Sexol, Dept Clin & Appl Sci & Biotechnol, I-67100 Laquila, Italy; [Lenzi, Andrea] Univ Roma La Sapienza, Dept Endocrinol, I-00185 Rome, Italy; [Jannini, Emmanuele A.] Univ Roma Tor Vergata, Dept Syst Med, Rome, Italy	University of L'Aquila; Sapienza University Rome; University of Rome Tor Vergata	Jannini, EA (corresponding author), Univ Aquila, Sch Sexol, Dept Clin & Appl Sci & Biotechnol, I-67100 Laquila, Italy.	eajannini@gmail.com	Mollaioli, Daniele/AAR-1039-2020; Lenzi, Andrea/I-7711-2015	Mollaioli, Daniele/0000-0001-5947-3310; Lenzi, Andrea/0000-0002-7711-0465; Gravina, Giovanni Luca/0000-0002-6797-8324; CAROSA, Eleonora/0000-0002-6593-6833; Jannini, Emmanuele A./0000-0002-5874-039X				Arneson CL, 2009, DISABIL HEALTH J, V2, P45, DOI 10.1016/j.dhjo.2008.08.001; Bigby C, 2008, J INTELLECT DEV DIS, V33, P148, DOI 10.1080/13668250802094141; Blackburn CM, 2010, BMC PEDIATR, V10, DOI 10.1186/1471-2431-10-21; Blissbomb L, 2010, DEMYSTIFYING SEX WOR, V8, P292; Di Nucci E, 2011, J MED ETHICS, V37, P158, DOI 10.1136/jme.2010.036723; Fedoroff JP, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0363-6; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Hall E, 2010, J INTELL DISABIL RES, V54, P48, DOI 10.1111/j.1365-2788.2009.01237.x; Harcourt C, 2005, SEX TRANSM INFECT, V81, P201, DOI 10.1136/sti.2004.012468; Jannini EA, 2012, J SEX MED, V9, P2994, DOI 10.1111/jsm.12018; Kiani R, 2013, J INTELL DISABIL RES, V57, P119, DOI 10.1111/j.1365-2788.2011.01523.x; Kinsey A, 1948, SEXUAL BEHAV HUMAN M, DOI 10.1037/t17515-000; Kuosmanen J, 2011, J SOC WORK DISABIL R, V10, P129, DOI 10.1080/1536710X.2011.596424; Limoncin E, 2013, INT J IMPOT RES, DOI 10.1038ijir.2013.34; Lockhart K, 2009, J POLICY PRACT INTEL, V6, P293, DOI 10.1111/j.1741-1130.2009.00235.x; Patton M. Q., 1990, QUALITATIVE EVALUATI; Reiter S, 2007, J INTELLECT DISABILI, V11, P371, DOI 10.1177/1744629507084602; Rembis MA, 2010, SEX DISABIL, V28, P51, DOI 10.1007/s11195-009-9133-0; Scorolli C, 2007, INT J IMPOT RES, V19, P432, DOI 10.1038/sj.ijir.3901547; Vazire S, 2004, J PERS SOC PSYCHOL, V87, P123, DOI 10.1037/0022-3514.87.1.123	20	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98413	10.1371/journal.pone.0098413	http://dx.doi.org/10.1371/journal.pone.0098413			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK7TQ	24919176	Green Published, gold			2022-12-27	WOS:000338631000016
J	Hu, FL; Li, YN; Zheng, L; Shi, LJ; Liu, HJ; Zhang, XW; Zhu, HU; Tang, SM; Zhu, L; Xu, LL; Yang, YQ; Li, ZG				Hu, Fanlei; Li, Yingni; Zheng, Li; Shi, Lianjie; Liu, Hongjiang; Zhang, Xuewu; Zhu, Huaqun; Tang, Sumei; Zhu, Lei; Xu, Liling; Yang, Yuqin; Li, Zhanguo			Toll-Like Receptors Expressed by Synovial Fibroblasts Perpetuate Th1 and Th17 Cell Responses in Rheumatoid Arthritis	PLOS ONE			English	Article							TISSUE; SYNOVIOCYTES; BLOCKADE; DISEASES; HYPOXIA; ALPHA; FLUID; VIVO; DNA	Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovial fibroblast hyperplasia and bone and cartilage erosion. Synovial fibroblast- and T cell-mediated inflammation plays crucial roles in the pathogenesis of RA. However how this inflammation is initiated, propagated, and maintained remains controversial. Here, we systemically examined the contribution of toll-like receptors (TLRs) to the inflammatory mediator production as well as Th1 and Th17 cell hyperactivity in RA. Our results show that rheumatoid arthritis synovial fibroblasts (RASF) express a series of TLRs, including TLR2, TLR3, TLR4, and TLR9, with the predominant expression of TLR3. Moreover, the expression levels of these TLRs were higher than those in osteoarthritis synovial fibroblasts (OASF). Ligation of TLR3, as well as TLR2 and TLR4, resulted in vigorous production of inflammatory cytokines, matrix metalloproteinases (MMPs), and vascular endothelial growth factor (VEGF) in RASF, with activation of the NF-kappa B, MAPK, and IRF3 pathways. More important, activation of these TLRs expressed by RASF exacerbated inflammatory Th1 and Th17 cell expansion both in cell-cell contact-dependent and inflammatory cytokine-dependent manners, which induced more IFN-gamma and IL-17 accumulation. Targeting TLRs may modulate the inflammation in RA and provide new therapeutic strategies for overcoming this persistent disease.	[Hu, Fanlei; Li, Yingni; Zheng, Li; Shi, Lianjie; Liu, Hongjiang; Zhang, Xuewu; Zhu, Huaqun; Tang, Sumei; Zhu, Lei; Xu, Liling; Yang, Yuqin; Li, Zhanguo] Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China	Peking University	Li, ZG (corresponding author), Peking Univ, Peoples Hosp, Dept Rheumatol & Immunol, Beijing 100871, Peoples R China.	li99@bjmu.edu.cn	zhang, xuan/GQO-8953-2022; zhang, xuan/AAN-9914-2020; zhang, xu/GYE-3558-2022; Zhang, xiaoyu/GXA-3206-2022; zhang, xian/GYA-0290-2022; zhang, xu/GRX-9733-2022	zhang, xuan/0000-0001-8775-1699; zhang, xuan/0000-0001-8775-1699; 	Natural Science Foundation of China [81302554, 81030057]; 973 program of China [2010CB529100]; Peking University People's Hospital [RDB2012-04, RDB2013-04]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); 973 program of China(National Basic Research Program of China); Peking University People's Hospital	This work was supported by grants from the Natural Science Foundation of China (81302554 and 81030057) and the 973 program of China (2010CB529100), as well as by Peking University People's Hospital Research and Development Funds (RDB2012-04 and RDB2013-04). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn JK, 2008, RHEUMATOLOGY, V47, P834, DOI 10.1093/rheumatology/ken086; Akira S, 2003, IMMUNOL LETT, V85, P85, DOI 10.1016/S0165-2478(02)00228-6; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Brennan FM, 2008, J CLIN INVEST, V118, P3537, DOI 10.1172/JCI36389; Brentano F, 2005, CELL IMMUNOL, V233, P90, DOI 10.1016/j.cellimm.2005.04.018; Brentano F, 2005, ARTHRITIS RHEUM-US, V52, P2656, DOI 10.1002/art.21273; Carrion M, 2011, ARTHRITIS RHEUM-US, V63, P1626, DOI 10.1002/art.30294; Chiang EY, 2009, NAT MED, V15, P766, DOI 10.1038/nm.1984; Choe JY, 2003, J EXP MED, V197, P537, DOI 10.1084/jem.20021850; Gabriel SE, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2669; Genovese MC, 2010, ARTHRITIS RHEUM-US, V62, P929, DOI 10.1002/art.27334; Han ZN, 2001, J CLIN INVEST, V108, P73, DOI 10.1172/JCI12466; Hu F, 2013, ANN RHEUM DIS; Hu FL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072650; Hu FL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051423; Karpus ON, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035606; Meng LS, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3034; Miossec P, 2009, NEW ENGL J MED, V361, P888, DOI 10.1056/NEJMra0707449; Ng CT, 2010, ANN RHEUM DIS, V69, P1389, DOI 10.1136/ard.2009.119776; Ospelt C, 2008, ARTHRITIS RHEUM-US, V58, P3684, DOI 10.1002/art.24140; Patel DD, 2001, CURR DIRECT AUTOIMMU, V3, P133; Samson M, 2012, ARTHRITIS RHEUM; Sokka T, 2003, CLIN EXP RHEUMATOL, V21, pS71; Stahl HD, 2000, ANN RHEUM DIS, V59, P342, DOI 10.1136/ard.59.5.342; Taylor PC, 2010, CURR OPIN PHARMACOL, V10, P308, DOI 10.1016/j.coph.2010.01.005; Trinchieri G, 2007, NAT REV IMMUNOL, V7, P179, DOI 10.1038/nri2038; Ultaigh SNA, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3261; van der Heijden IM, 2000, ARTHRITIS RHEUM-US, V43, P593, DOI 10.1002/1529-0131(200003)43:3<593::AID-ANR16>3.0.CO;2-1; van Oosterhout M, 2005, ANN RHEUM DIS, V64, P537, DOI 10.1136/ard.2004.024927	29	49	54	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100266	10.1371/journal.pone.0100266	http://dx.doi.org/10.1371/journal.pone.0100266			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936783	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400099
J	Liu, YW; Liao, TW; Chen, YH; Chiang, YC; Tsai, YC				Liu, Yen-Wenn; Liao, Tan-Wei; Chen, Yu-Han; Chiang, Yi-Chin; Tsai, Ying-Chieh			Oral Administration of Heat-Inactivated Lactobacillus plantarum K37 Modulated Airway Hyperresponsiveness in Ovalbumin-Sensitized BALB/c Mice	PLOS ONE			English	Article							ALLERGIC RHINITIS; IMMUNOGLOBULIN-E; CYTOKINE PRODUCTION; ATOPIC-DERMATITIS; DENDRITIC CELLS; MURINE MODEL; NC/NGA MICE; ASTHMA; INFLAMMATION; RESPONSES	This study aimed to investigate the anti-allergic effects of Lactobacillus plantarum K37 (K37) on airway hyperresponsiveness (AHR) and systemic allergic responses in ovalbumin (OVA)-sensitized and -challenged BALB/c mice. Heat-inactivated K37 (10(5), 10(7), and 10(9) CFU/mouse, day) were orally administered to OVA-sensitized BALB/c mice to investigate their effects on AHR, immunoglobulin (Ig) and cytokine production. The results showed that K37 dose-dependently lowered the serum levels of IgE, OVA-specific IgE and OVA-specific IgG1, ameliorated AHR induced by methacholine and suppressed eosinophil infiltration in bronchoalveolar lavage fluid (BALF). The cytokine production in spleen cells culture and BALF showed that K37 drove the immune responses toward T-helper cell type 1 (Th1) responses, elevated levels of IL-2 and IFN-gamma, and reduced of IL-4, IL-5 and IL-13. K37 also improved cell infiltration in lung sections. Our results demonstrated that oral administration of K37 alleviated effectively the allergic responses in vivo. Thus, K37 can be a good source material and a promising candidate for prophylactic and therapeutic treatments of allergic diseases, like asthma.	[Liu, Yen-Wenn; Liao, Tan-Wei; Chen, Yu-Han; Chiang, Yi-Chin; Tsai, Ying-Chieh] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan	National Yang Ming Chiao Tung University	Tsai, YC (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	tsaiyc@ym.edu.tw			Asian Probiotics and Prebiotics Ltd.; Kei Sei Ken Biotechnology Ltd.	Asian Probiotics and Prebiotics Ltd.; Kei Sei Ken Biotechnology Ltd.	This work was supported by the Asian Probiotics and Prebiotics Ltd. and Kei Sei Ken Biotechnology Ltd. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams CA, 2010, NUTR RES REV, V23, P37, DOI 10.1017/S0954422410000090; Besnard AG, 2012, J MOL CELL BIOL, V4, P3, DOI 10.1093/jmcb/mjr042; Chanez P, 2007, J ALLERGY CLIN IMMUN, V119, P1337, DOI 10.1016/j.jaci.2006.11.702; Chao SH, 2009, INT J FOOD MICROBIOL, V135, P203, DOI 10.1016/j.ijfoodmicro.2009.07.032; Chen C. C., 2011, BRIT J NUTR, V30, P1; Chiang DJ, 2003, AM J RESP CRIT CARE, V168, P575, DOI 10.1164/rccm.2205005; DJUKANOVIC R, 1990, AM REV RESPIR DIS, V142, P434, DOI 10.1164/ajrccm/142.2.434; Eder W, 2006, NEW ENGL J MED, V355, P2226, DOI 10.1056/NEJMra054308; Enomoto M, 2009, BIOSCI BIOTECH BIOCH, V73, P457, DOI 10.1271/bbb.80438; Ezendam J, 2008, CLIN EXP IMMUNOL, V154, P424, DOI 10.1111/j.1365-2249.2008.03788.x; Fujiwara D, 2004, INT ARCH ALLERGY IMM, V135, P205, DOI 10.1159/000081305; Gonzalo JA, 1996, J CLIN INVEST, V98, P2332, DOI 10.1172/JCI119045; Hong HJ, 2010, J CLIN IMMUNOL, V30, P449, DOI 10.1007/s10875-010-9375-8; Hong WS, 2011, J AGR FOOD CHEM, V59, P9022, DOI 10.1021/jf201913x; Hougee S, 2010, INT ARCH ALLERGY IMM, V151, P107, DOI 10.1159/000236000; Hsu CY, 2010, J GENE MED, V12, P11, DOI 10.1002/jgm.1408; Hu WX, 2014, MOL IMMUNOL, V58, P139, DOI 10.1016/j.molimm.2013.11.006; Humbert M, 1997, J ALLERGY CLIN IMMUN, V99, P657, DOI 10.1016/S0091-6749(97)70028-9; Inamine A, 2012, CLIN IMMUNOL, V143, P170, DOI 10.1016/j.clim.2012.01.008; Kawakami H, 2012, CLIN EXP ALLERGY, V42, P946, DOI 10.1111/j.1365-2222.2012.04006.x; Kim DS, 2012, EVID-BASED COMPL ALT, V2012, DOI 10.1155/2012/769508; Lee MY, 2012, INT IMMUNOPHARMACOL, V12, P117, DOI 10.1016/j.intimp.2011.10.021; Lee YT, 2013, CYTOKINE, V61, P237, DOI 10.1016/j.cyto.2012.09.024; Liu YW, 2011, INT IMMUNOPHARMACOL, V11, P2159, DOI 10.1016/j.intimp.2011.09.013; Magalhaes JG, 2011, P NATL ACAD SCI USA, V108, P14896, DOI 10.1073/pnas.1015063108; Mei HC, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/287803; Morisset M, 2011, EUR J CLIN NUTR, V65, P175, DOI 10.1038/ejcn.2010.250; Morokata T, 1999, IMMUNOLOGY, V98, P345, DOI 10.1046/j.1365-2567.1999.00890.x; Nonaka Y, 2008, INT ARCH ALLERGY IMM, V145, P249, DOI 10.1159/000109294; Platts-Mills TAE, 2001, AM J RESP CRIT CARE, V164, pS1, DOI 10.1164/ajrccm.164.supplement_1.2103024; Rothenberg ME, 1998, NEW ENGL J MED, V338, P1592, DOI 10.1056/NEJM199805283382206; Segawa S, 2008, INT J FOOD MICROBIOL, V121, P1, DOI 10.1016/j.ijfoodmicro.2007.10.004; Shida K, 2006, J DAIRY SCI, V89, P3306, DOI 10.3168/jds.S0022-0302(06)72367-0; Shida K, 1998, INT ARCH ALLERGY IMM, V115, P278, DOI 10.1159/000069458; Shida K, 2002, CLIN EXP ALLERGY, V32, P563, DOI 10.1046/j.0954-7894.2002.01354.x; Simon D, 2004, ALLERGY, V59, P561, DOI 10.1111/j.1398-9995.2004.00476.x; Sunada Y, 2007, BIOL PHARM BULL, V30, P2163, DOI 10.1248/bpb.30.2163; Tamura M, 2007, INT ARCH ALLERGY IMM, V143, P75, DOI 10.1159/000098318; Umland SP, 2000, J LEUKOCYTE BIOL, V67, P441, DOI 10.1002/jlb.67.3.441; Wassenberg J, 2011, CLIN EXP ALLERGY, V41, P565, DOI 10.1111/j.1365-2222.2011.03695.x; Wills-Karp M, 1998, SCIENCE, V282, P2258, DOI 10.1126/science.282.5397.2258; Won TJ, 2011, J APPL MICROBIOL, V110, P1195, DOI 10.1111/j.1365-2672.2011.04981.x; Won TJ, 2012, CELL IMMUNOL, V277, P49, DOI 10.1016/j.cellimm.2012.05.013; Yang GY, 2004, CYTOKINE, V28, P224, DOI 10.1016/j.cyto.2004.08.007; Yasui H, 2004, CLIN DIAGN LAB IMMUN, V11, P675, DOI 10.1128/CDLI.11.4.675-679.2004; Yoshida T, 2013, INT ARCH ALLERGY IMM, V162, P283, DOI 10.1159/000354924	46	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100105	10.1371/journal.pone.0100105	http://dx.doi.org/10.1371/journal.pone.0100105			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936861	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400076
J	Tseng, CW; Chen, CY; Chang, TT; Tzeng, SJ; Hsieh, YH; Hung, TH; Lee, CC; Wu, SF; Tseng, KC				Tseng, Chih-Wei; Chen, Chi-Yi; Chang, Ting-Tsung; Tzeng, Shinn-Jia; Hsieh, Yu-Hsi; Hung, Tsung-Hsing; Lee, Ching-Chih; Wu, Shu-Fen; Tseng, Kuo-Chih			Peginterferon Alfa-2a Is Associated with Elevations in Alanine Aminotransferase at the End of Treatment in Chronic Hepatitis C Patients with Sustained Virologic Response	PLOS ONE			English	Article							PEGYLATED-INTERFERON; PLUS RIBAVIRIN; VIRUS-RNA; MANAGEMENT	Background: The purpose of this study was to investigate the incidence and demographic/clinical factors of alanine aminotransferase (ALT) abnormalities at the end of treatment (EOT) in chronic hepatitis C (CHC) patients with sustained virologic response (SVR). Methods and Findings: Seven hundred naive CHC patients who underwent combination treatment between January 2003 and December 2010 were included in the study. The patients with SVR and serum ALT>upper limit of normal (ULN) at the EOT were further analyzed. The effects of clinical characteristics, treatment regimen, and virologic variables were evaluated by logistic regression. Of the 700 included patients, 488 (69.7%) achieved an SVR after treatment, and 235 (33.6%) had serum ALT levels>ULN at the EOT. Of those 488 patients, 137 (28.1%) had abnormal ALT values at the EOT. A multivariate analysis showed that the occurrence of ALT abnormalities at the EOT was significantly associated with pegylated interferon (PEG-IFN) alfa-2a (odds ratio [OR], 2.24; 95% confidence interval [CI], 1.45-3.45; P<0.001), baseline fatty liver (OR, 1.76; 95% CI, 1.16-2.76; P = 0.007), and baseline liver cirrhosis (OR, 2.35; 95% CI, 1.35-4.09; P = 0.002). Conclusions: Use of PEG-IFN-alfa-2a, fatty liver, and cirrhosis are important factors associated with EOT-ALT abnormality in CHC patients receiving combination therapy that achieve an SVR. PEG-IFN-alfa-2a-related EOT-ALT elevation will become normal at the end of follow-up, but fatty liver and cirrhosis-related ALT elevation will not be resolved.	[Tseng, Chih-Wei; Hsieh, Yu-Hsi; Hung, Tsung-Hsing; Tseng, Kuo-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Chiayi, Taiwan; [Tseng, Chih-Wei] Taipei Vet Gen Hosp, Dept Med, Div Gastroenterol, Taipei, Taiwan; [Tseng, Chih-Wei] Natl Yang Ming Univ, Sch Med, Taipei 112, Taiwan; [Tseng, Chih-Wei; Hsieh, Yu-Hsi; Hung, Tsung-Hsing; Tseng, Kuo-Chih] Tzuchi Univ, Sch Med, Hualien, Taiwan; [Chen, Chi-Yi] Chia Yi Christian Hosp, Dept Internal Med, Chiayi, Taiwan; [Chang, Ting-Tsung] Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan 70428, Taiwan; [Chang, Ting-Tsung] Natl Cheng Kung Univ, Coll Med, Tainan 70101, Taiwan; [Tzeng, Shinn-Jia] Natl Chiayi Univ, Dept Agron, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Ctr Clin Epidemiol & Biostat, Chiayi, Taiwan; [Lee, Ching-Chih] Buddhist Dalin Tzu Chi Gen Hosp, Dept Otolaryngol, Chiayi, Taiwan; [Wu, Shu-Fen] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi, Taiwan	Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; Tzu Chi University; National Cheng Kung University; National Cheng Kung University Hospital; National Cheng Kung University; National Chiayi University; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Dalin Tzu Chi Hospital; National Chung Cheng University	Tseng, KC (corresponding author), Buddhist Dalin Tzu Chi Gen Hosp, Dept Internal Med, Chiayi, Taiwan.	tsengkuochih@gmail.com	Tseng, Chih-Wei/AAP-8291-2020	Tseng, Chih-Wei/0000-0002-6951-4646	Dalin Tzuchi General Hospital [DTCRD99(2)-E-13]	Dalin Tzuchi General Hospital	The study was funded by Dalin Tzuchi General Hospital (DTCRD99(2)-E-13). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoki Y, 2011, HEPATOL RES, V41, P118, DOI 10.1111/j.1872-034X.2010.00749.x; Awad T, 2010, HEPATOLOGY, V51, P1176, DOI 10.1002/hep.23504; Basso M, 2009, HEPATOLOGY, V49, P1442, DOI 10.1002/hep.22810; Bullock GC, 2002, CLIN CHEM, V48, P2147; Calvaruso V, 2012, LIVER INT, V32, P2, DOI 10.1111/j.1478-3231.2011.02703.x; Cervoni JP, 1997, J HEPATOL, V27, P1113, DOI 10.1016/S0168-8278(97)80157-2; Chen CH, 2013, HEPATOL INT, V7, P162, DOI 10.1007/s12072-012-9388-x; Chuang WL, 2005, INTERVIROLOGY, V49, P99, DOI 10.1159/000087271; Ferenci P, 2005, J HEPATOL, V43, P425, DOI 10.1016/j.jhep.2005.04.009; Flori N, 2013, DRUGS, V73, P263, DOI 10.1007/s40265-013-0027-1; Foser S, 2003, PROTEIN EXPRES PURIF, V30, P78, DOI 10.1016/S1046-5928(03)00055-X; Foster GR, 2010, DRUGS, V70, P147, DOI 10.2165/11531990-000000000-00000; George PM, 2012, PHARMACOL THERAPEUT, V135, P44, DOI 10.1016/j.pharmthera.2012.03.006; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ghany MG, 2009, HEPATOLOGY, V49, P1335, DOI 10.1002/hep.22759; Grace M, 2001, J INTERF CYTOK RES, V21, P1103, DOI 10.1089/107999001317205240; Hung CH, 2002, J GASTROEN HEPATOL, V17, P1307, DOI 10.1046/j.1440-1746.2002.02874.x; Kim Tae Yeob, 2012, Korean J Hepatol, V18, P29, DOI 10.3350/kjhep.2012.18.1.29; Kim Yun Jung, 2012, Korean J Hepatol, V18, P41, DOI 10.3350/kjhep.2012.18.1.41; Kraus I, 2001, CAN J GASTROENTEROL, V15, P333, DOI 10.1155/2001/510742; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lee SD, 2005, J VIRAL HEPATITIS, V12, P283, DOI 10.1111/j.1365-2893.2005.00590.x; Nagashima M, 2008, INTERVIROLOGY, V51, P76, DOI 10.1159/000122604; Nakamura M, 2013, INT J MED SCI, V10, P1015, DOI 10.7150/ijms.6402; Omata M, 2012, HEPATOL INT, V6, P409, DOI 10.1007/s12072-012-9342-y; Ratge D, 2000, CLIN CHEM, V46, P1987; Ribeiro RM, 2003, HEPATOLOGY, V38, P509, DOI 10.1053/jhep.2003.50344; Romero-Gomez M, 2013, ALIMENT PHARM THER, V37, P1065, DOI 10.1111/apt.12314; SILVA MO, 1991, GASTROENTEROLOGY, V101, P840, DOI 10.1016/0016-5085(91)90547-X; Singal AK, 2010, HEPAT MON, V10, P165; Su WP, 2009, HEPATO-GASTROENTEROL, V56, P798; Thurairajah PH, 2007, ALIMENT PHARM THER, V25, P1293, DOI 10.1111/j.1365-2036.2007.03322.x; Webster R, 2007, DRUG METAB DISPOS, V35, P9, DOI 10.1124/dmd.106.012419; Yang ZG, 2013, GASTROENT RES PRACT, V2013, DOI 10.1155/2013/739029; Yu ML, 2009, J GASTROEN HEPATOL, V24, P336, DOI 10.1111/j.1440-1746.2009.05789.x; Zeuzem S, 2000, NEW ENGL J MED, V343, P1666, DOI 10.1056/NEJM200012073432301; Zeuzem S, 2003, SEMIN LIVER DIS, V23, P23	37	2	2	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100207	10.1371/journal.pone.0100207	http://dx.doi.org/10.1371/journal.pone.0100207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937007	Green Submitted, gold, Green Published			2022-12-27	WOS:000338503400093
J	Zhang, XH; Zhang, ZC; Zhao, H; Wang, Q; Zhu, J				Zhang, Xiaohang; Zhang, Zecong; Zhao, Han; Wang, Qi; Zhu, Ji			Extracting the Globally and Locally Adaptive Backbone of Complex Networks	PLOS ONE			English	Article							COMMUNITY STRUCTURE; SKELETON	A complex network is a useful tool for representing and analyzing complex systems, such as the world-wide web and transportation systems. However, the growing size of complex networks is becoming an obstacle to the understanding of the topological structure and their characteristics. In this study, a globally and locally adaptive network backbone (GLANB) extraction method is proposed. The GLANB method uses the involvement of links in shortest paths and a statistical hypothesis to evaluate the statistical importance of the links; then it extracts the backbone, based on the statistical importance, from the network by filtering the less important links and preserving the more important links; the result is an extracted subnetwork with fewer links and nodes. The GLANB determines the importance of the links by synthetically considering the topological structure, the weights of the links and the degrees of the nodes. The links that have a small weight but are important from the view of topological structure are not belittled. The GLANB method can be applied to all types of networks regardless of whether they are weighted or unweighted and regardless of whether they are directed or undirected. The experiments on four real networks show that the link importance distribution given by the GLANB method has a bimodal shape, which gives a robust classification of the links; moreover, the GLANB method tends to put the nodes that are identified as the core of the network by the k-shell algorithm into the backbone. This method can help us to understand the structure of the networks better, to determine what links are important for transferring information, and to express the network by a backbone easily.	[Zhang, Xiaohang; Zhang, Zecong; Zhao, Han; Wang, Qi] Beijing Univ Posts & Telecommun, Sch Econ & Management, Beijing 100088, Peoples R China; [Zhu, Ji] Univ Michigan, Dept Stat, Ann Arbor, MI 48109 USA	Beijing University of Posts & Telecommunications; University of Michigan System; University of Michigan	Zhang, XH (corresponding author), Beijing Univ Posts & Telecommun, Sch Econ & Management, Beijing 100088, Peoples R China.	zhangxiaohang@bupt.edu.cn		Zhang, Xiaohang/0000-0002-5315-8712	NSFC [71371034, 71372194]; National Basic Research Program of China [2012CB315805]; Program for NCET [NCET-13-0687]; Youth Research and Innovation Program in Beijing University of Posts and Telecommunications [2012RC1006]	NSFC(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Program for NCET(Program for New Century Excellent Talents in University (NCET)); Youth Research and Innovation Program in Beijing University of Posts and Telecommunications	This work was partially supported by NSFC (Grant Nos: 71371034 and 71372194; www.nsfc.gov.cn), the National Basic Research Program of China (Grant No: 2012CB315805; www.973.gov.cn), the Program for NCET (Grant No: NCET-13-0687; www.1000plan.org/qrjh/channel/159), and the Youth Research and Innovation Program in Beijing University of Posts and Telecommunications (Grant No: 2012RC1006; www.bupt.edu.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allesina S, 2006, ECOL MODEL, V194, P150, DOI 10.1016/j.ecolmodel.2005.10.016; Barabasi AL, 1999, SCIENCE, V286, P509, DOI 10.1126/science.286.5439.509; Barrat A, 2004, P NATL ACAD SCI USA, V101, P3747, DOI 10.1073/pnas.0400087101; Barthelemy M, 2003, PHYSICA A, V319, P633, DOI 10.1016/S0378-4371(02)01382-1; Brandes U, 2001, J MATH SOCIOL, V25, P163, DOI 10.1080/0022250X.2001.9990249; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Carmi S, 2007, P NATL ACAD SCI USA, V104, P11150, DOI 10.1073/pnas.0701175104; Eguiluz VM, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.018102; Foti NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016431; Girvan M, 2002, P NATL ACAD SCI USA, V99, P7821, DOI 10.1073/pnas.122653799; Goh KI, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.018701; Grady D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1847; Guimera R, 2005, P NATL ACAD SCI USA, V102, P7794, DOI 10.1073/pnas.0407994102; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Newman MEJ, 2001, P NATL ACAD SCI USA, V98, P404, DOI 10.1073/pnas.021544898; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Ruimera R, 2003, PHYS REV E, V68; Serrano MA, 2009, P NATL ACAD SCI USA, V106, P6483, DOI 10.1073/pnas.0808904106; Song CM, 2005, NATURE, V433, P392, DOI 10.1038/nature03248; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Zhang X, 2013, PHYSICA A, V392, P1547, DOI 10.1016/j.physa.2012.12.001	22	18	18	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100428	10.1371/journal.pone.0100428	http://dx.doi.org/10.1371/journal.pone.0100428			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936975	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400109
J	Lo, WT; Yu, SF; Hsieh, HY				Lo, Wen-Tseng; Yu, Shwu-Feng; Hsieh, Hung-Yen			Hydrographic Processes Driven by Seasonal Monsoon System Affect Siphonophore Assemblages in Tropical-Subtropical Waters (Western North Pacific Ocean)	PLOS ONE			English	Article							SOUTH CHINA SEA; GULF-OF-MEXICO; GELATINOUS ZOOPLANKTON; JELLYFISH BLOOMS; EPIPELAGIC SIPHONOPHORES; VERTICAL-DISTRIBUTION; TAIWAN STRAIT; CHEMICAL HYDROGRAPHY; COMMUNITY STRUCTURE; PELAGIC CNIDARIANS	This work is a part of the Taiwan Cooperative Oceanic Fisheries Investigation, the first large scale hydrographic and plankton survey around Taiwan (21-26 degrees N, 119-123 degrees E). The present study examined the influence of hydrodynamic and biological variables driven by monsoon system on the siphonophore assemblages through an annual cycle in 2004. Calycophorans, namely Chelophyes appendiculata, Diphyes chamissonis, Lensia subtiloides, Bassia bassensis, and Muggiaea atlantica, were the most dominant siphonophore species. Maximum abundance of these dominant species generally occurred during the warm period (May and August), while M. atlantica had a significantly peak abundance in February. Although no apparently temporal difference in siphonophore abundance was observed in the study, siphonophore assemblage was more diverse in August than in other sampling times. Result of a cluster analysis indicated that assemblage structure of siphonophores in the waters around Taiwan varied at temporal and spatial scales during the sampling period. The intrusions of the Kuroshio Branch Current and China Coastal Current to the study area play an important role on the transportation of siphonophores. Also, the distribution of siphonophore assemblage was closely related to the hydrographic characteristics, with temperature, chlorophyll a concentration, and zooplankton abundance being the major environmental factors affecting the spatio-temporal variability of siphonophores. This study contributes substantially to the new knowledge of the siphonophore assemblage in the tropical-temperate waters of Taiwan.	[Lo, Wen-Tseng; Yu, Shwu-Feng] Natl Sun Yat Sen Univ, Inst Marine Biotechnol & Resources, Kaohsiung 80424, Taiwan; [Hsieh, Hung-Yen] Natl Dong Hwa Univ, Inst Marine Biodivers & Evolutionary Biol, Checheng, Pingtung, Taiwan; [Hsieh, Hung-Yen] Natl Museum Marine Biol & Aquarium, Checheng, Pingtung, Taiwan	National Sun Yat Sen University; National Dong Hwa University; National Museum of Marine Biology & Aquarium	Hsieh, HY (corresponding author), Natl Dong Hwa Univ, Inst Marine Biodivers & Evolutionary Biol, Checheng, Pingtung, Taiwan.	hyhsieh@mail.ndhu.edu.tw			National Science Council [NSC98-2611-M 110-002]; Ministry of Education (Kuroshio Project), Taiwan [97C030200]	National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Education (Kuroshio Project), Taiwan	The study is supported by the National Science Council (NSC98-2611-M 110-002) and the Ministry of Education (Kuroshio Project, 97C030200), Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alldredge AL, 1984, FLOWS ENERGY MAT MAR, P407; ALVARINO A, 1967, PAC SCI, V21, P474; Alvarino A., 1990, Antarctic Research Series, V49, P1; Arai Mary Needler, 1992, Scientia Marina, V56, P99; Ashjian CJ, 2005, DEEP-SEA RES PT II, V52, P1363, DOI 10.1016/j.dsr2.2005.05.001; Batistic M, 2013, MAR ECOL-EVOL PERSP, V34, P3, DOI 10.1111/maec.12021; Boero F, 2008, MAR ECOL PROG SER, V356, P299, DOI 10.3354/meps07368; BRAY J. ROGER, 1957, ECOL MONOGR, V27, P325, DOI 10.2307/1942268; Brodeur RD, 1999, FISH OCEANOGR, V8, P296, DOI 10.1046/j.1365-2419.1999.00115.x; Buecher E, 1999, J SEA RES, V41, P295, DOI 10.1016/S1385-1101(99)00005-2; CARRE C, 1991, PHILOS T ROY SOC B, V334, P27, DOI 10.1098/rstb.1991.0095; Chern C.-S., 1990, TERR ATMOS OCEAN SCI, V1, P297, DOI [10.3319/TAO.1990.1.3.297(O), DOI 10.3319/TAO.1990.1.3.297(O)]; CHERN CS, 1990, J GEOPHYS RES-OCEANS, V95, P16017, DOI 10.1029/JC095iC09p16017; Chuang W.-S., 1993, J OCEANOGR, V49, P581, DOI DOI 10.1007/BF02237464; Chung SW, 2001, J OCEANOGR, V57, P47; CLARKE KR, 1993, MAR ECOL PROG SER, V92, P205, DOI 10.3354/meps092205; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Clarke KR., 2001, CHANGE MARINE COMMUN, V2; Delizo L, 2007, J PLANKTON RES, V29, P655, DOI 10.1093/plankt/fbm047; Dunn O. J., 1974, Applied statistics: analysis of variance and regression; Fang KL, 1982, ACTA OCEANOGRAPHICA, V13, P140; Frank KT, 2005, SCIENCE, V308, P1621, DOI 10.1126/science.1113075; Gasca R, 1999, B MAR SCI, V65, P75; Gibbons MJ, 2009, HYDROBIOLOGIA, V616, P51, DOI 10.1007/s10750-008-9593-8; Gibbons MJ, 2002, J MAR BIOL ASSOC UK, V82, P801, DOI 10.1017/S0025315402006161; Gong G.C., 1992, ACTA OCEANOGRAPHICA, V28, P118; Graham WM, 2001, HYDROBIOLOGIA, V451, P199, DOI 10.1023/A:1011876004427; Grossmann MM, 2013, J OCEANOGR, V69, P395, DOI 10.1007/s10872-013-0181-9; Hamner WM, 2009, HYDROBIOLOGIA, V616, P161, DOI 10.1007/s10750-008-9620-9; Hosia A, 2008, J PLANKTON RES, V30, P951, DOI 10.1093/plankt/fbn045; Hsieh HY, 2013, MAR FRESHWATER RES, V64, P348, DOI 10.1071/MF12151; Jan S, 2002, J MARINE SYST, V35, P249, DOI 10.1016/S0924-7963(02)00130-6; Jan S, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2006JC003656; Kirkpatrick PA, 1984, SYNOPSES BRIT FAUNA; Kitamura Minoru, 2003, Plankton Biology and Ecology, V50, P43; Kruskal J. B., 1978, SAGE U PAPER SERIES; Li KZ, 2012, J PLANKTON RES, V34, P636, DOI 10.1093/plankt/fbs035; Li KZ, 2013, CHIN J OCEANOL LIMN, V31, P312, DOI 10.1007/s00343-013-2058-6; Licandro P, 2012, PROG OCEANOGR, V97, P152, DOI 10.1016/j.pocean.2011.11.004; Lin Mao, 2011, Biodiversity Science, V19, P646; LIU KK, 1992, J GEOPHYS RES-OCEANS, V97, P12511, DOI 10.1029/92JC01179; Liu KK, 2000, CONT SHELF RES, V20, P493, DOI 10.1016/S0278-4343(99)00083-7; Lo WT, 2012, ZOOL STUD, V51, P1354; Lo WT, 1996, J PLANKTON RES, V18, P923, DOI 10.1093/plankt/18.6.923; Lopez-Lopez L, 2013, J PLANKTON RES, V35, P677, DOI 10.1093/plankt/fbt005; Lucic D, 2005, J MAR BIOL ASSOC UK, V85, P495, DOI 10.1017/S0025315405011422; Ma XP, 2005, MAR BIOL, V147, P225, DOI 10.1007/s00227-004-1539-8; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Mapstone G.M., 2009, SIPHONOPHORA CNIDARI; Mapstone GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087737; Maravelias CD, 1997, MAR ECOL PROG SER, V147, P1, DOI 10.3354/meps147001; MILLS CE, 1984, BIOL BULL, V166, P206, DOI 10.2307/1541442; Mills CE, 2001, HYDROBIOLOGIA, V451, P55, DOI 10.1023/A:1011888006302; MUNK P, 1995, MAR ECOL PROG SER, V125, P21, DOI 10.3354/meps125021; Pages F, 2001, MAR ECOL PROG SER, V210, P13, DOI 10.3354/meps210013; PAGES F, 1991, MAR ECOL PROG SER, V75, P205, DOI 10.3354/meps075205; Palma GS, 1999, INVEST MAR, V27, P19; Palma S, 2006, J PLANKTON RES, V28, P1143, DOI 10.1093/plankt/fbl044; Palma S, 2011, CONT SHELF RES, V31, P260, DOI 10.1016/j.csr.2010.04.007; Pestoric B, 2012, ACTA ADRIAT, V53, P291; PIELOU E. C., 1984, INTERPRETATION ECOLO; PIELOU EC, 1966, J THEOR BIOL, V13, P131, DOI 10.1016/0022-5193(66)90013-0; Polovina JJ, 2008, PROG OCEANOGR, V77, P217, DOI 10.1016/j.pocean.2008.03.011; Primo AL, 2012, MAR ENVIRON RES, V79, P152, DOI 10.1016/j.marenvres.2012.06.009; PUGH PR, 1984, PROG OCEANOGR, V13, P461, DOI 10.1016/0079-6611(84)90016-8; PUGH PR, 1974, J MAR BIOL ASSOC UK, V54, P25, DOI 10.1017/S0025315400022086; PURCELL JE, 1982, J EXP MAR BIOL ECOL, V62, P39, DOI 10.1016/0022-0981(82)90215-5; PURCELL JE, 1984, MAR ECOL PROG SER, V19, P189, DOI 10.3354/meps019189; PURCELL JE, 1981, MAR BIOL, V65, P83, DOI 10.1007/BF00397071; Purcell JE, 1997, ANN I OCEANOGR PARIS, V73, P125; Purcell JE, 2007, MAR ECOL PROG SER, V350, P153, DOI 10.3354/meps07093; Riemann L, 2011, MAR ECOL PROG SER, V426, P57, DOI 10.3354/meps09001; Sabates A, 2010, HYDROBIOLOGIA, V645, P153, DOI 10.1007/s10750-010-0221-z; Sanvicente-Anorve L, 2007, HYDROBIOLOGIA, V586, P69, DOI 10.1007/s10750-006-0492-6; Sanvicente-Anorve L, 2009, AQUAT ECOL, V43, P423, DOI 10.1007/s10452-008-9172-0; Shannon C.E., 1963, MATH THEORY COMMUNIC; Thibault-Botha D, 2004, J PLANKTON RES, V26, P1115, DOI 10.1093/plankt/fbh104; Totton A. K., 1954, Discovery Reports, V27, P1; Totton AK, 1965, SYNOPSIS SIPHONOPHOR; WANG J, 1988, PROG OCEANOGR, V21, P469; WONG GTF, 1991, ESTUAR COAST SHELF S, V33, P105, DOI 10.1016/0272-7714(91)90001-R; Xian WW, 2005, SCIENCE, V307, P41; Xu Z, 2006, BIODIVERSITY SCI, Vv14, P508, DOI DOI 10.1360/BIODIV.060066; Yu Cun-Gen, 2011, Acta Hydrobiologica Sinica, V35, P183; Zhang Jin-biao, 2001, Journal of Oceanography in Taiwan Strait, V20, P1; Zhang Jin-biao, 2005, Journal of Tropical Oceanography, V24, P41	86	12	12	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100085	10.1371/journal.pone.0100085	http://dx.doi.org/10.1371/journal.pone.0100085			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932727	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600091
J	Personnic, S; Boudouresque, CF; Astruch, P; Ballesteros, E; Blouet, S; Bellan-Santini, D; Bonhomme, P; Thibault-Botha, D; Feunteun, E; Harmelin-Vivien, M; Pergent, G; Pergent-Martini, C; Pastor, J; Poggiale, JC; Renaud, F; Thibaut, T; Ruitton, S				Personnic, Sebastien; Boudouresque, Charles F.; Astruch, Patrick; Ballesteros, Enric; Blouet, Sylvain; Bellan-Santini, Denise; Bonhomme, Patrick; Thibault-Botha, Delphine; Feunteun, Eric; Harmelin-Vivien, Mireille; Pergent, Gerard; Pergent-Martini, Christine; Pastor, Jeremy; Poggiale, Jean-Christophe; Renaud, Florent; Thibaut, Thierry; Ruitton, Sandrine			An Ecosystem-Based Approach to Assess the Status of a Mediterranean Ecosystem, the Posidonia oceanica Seagrass Meadow	PLOS ONE			English	Article							ECOLOGICAL STATUS; QUALITY ASSESSMENT; ORGANIC DEPOSITS; COASTAL WATERS; ASSEMBLAGES; BAY; DYNAMICS; GROWTH; SEA; POPULATIONS	Biotic indices, which reflect the quality of the environment, are widely used in the marine realm. Sometimes, key species or ecosystem engineers are selected for this purpose. This is the case of the Mediterranean seagrass Posidonia oceanica, widely used as a biological quality element in the context of the European Union Water Framework Directive (WFD). The good quality of a water body and the apparent health of a species, whether or not an ecosystem engineer such as P. oceanica, is not always indicative of the good structure and functioning of the whole ecosystem. A key point of the recent Marine Strategy Framework Directive (MSFD) is the ecosystem-based approach. Here, on the basis of a simplified conceptual model of the P. oceanica ecosystem, we have proposed an ecosystem-based index of the quality of its functioning, compliant with the MSFD requirements. This index (EBQI) is based upon a set of representative functional compartments, the weighting of these compartments and the assessment of the quality of each compartment by comparison of a supposed baseline. The index well discriminated 17 sites in the north-western Mediterranean (French Riviera, Provence, Corsica, Catalonia and Balearic Islands) covering a wide range of human pressure levels. The strong points of the EBQI are that it is easy to implement, non-destructive, relatively robust, according to the selection of the compartments and to their weighting, and associated with confidence indices that indicate possible weakness and biases and therefore the need for further field data acquisition.	[Personnic, Sebastien; Boudouresque, Charles F.; Thibault-Botha, Delphine; Harmelin-Vivien, Mireille; Poggiale, Jean-Christophe; Thibaut, Thierry; Ruitton, Sandrine] Aix Marseille Univ, MIO, Univ Toulon, CNRS,INSU,IRD,UM 110, Marseille, France; [Astruch, Patrick; Bonhomme, Patrick] Aix Marseille Univ, Pytheas Inst, GIS Posidonie, Marseille, France; [Ballesteros, Enric] CSIC, Ctr Estudis Avancats Blanes, Blanes, Spain; [Blouet, Sylvain] Aire Marine Protegee Cote Agathoise, Agde, France; [Bellan-Santini, Denise; Renaud, Florent] Aix Marseille Univ, IMBE, UMR 7263, Stn Marine Endoume, Marseille, France; [Feunteun, Eric] Museum Natl Hist Nat, UMR 7208, Stn Marine Dinard, Paris, France; [Pergent, Gerard; Pergent-Martini, Christine] Univ Corsica, Equipe Ecosyst Littoraux, FRES 3041, Corte, France; [Pastor, Jeremy] Univ Perpignan, Ctr Format & Rech Environm Mediterraneens, UMR 5110, F-66025 Perpignan, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Institut de Recherche pour le Developpement (IRD); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centre d'Estudis Avancats de Blanes (CEAB); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Earth Sciences & Astronomy (INSU); Universite Perpignan Via Domitia	Personnic, S (corresponding author), Aix Marseille Univ, MIO, Univ Toulon, CNRS,INSU,IRD,UM 110, Marseille, France.	sebastien.personnic@univ-amu.fr	Thibault, Delphine/AAR-4300-2020; Ruitton, Sandrine/AAT-4752-2021; Feunteun, Eric/GXV-5964-2022; THIBAUT, Thierry/S-4354-2019; Poggiale, Jean-Christophe/I-4582-2019	Ruitton, Sandrine/0000-0003-4485-9979; Feunteun, Eric/0000-0001-6344-6809; THIBAUT, Thierry/0000-0001-8530-9266; Poggiale, Jean-Christophe/0000-0002-3888-0096; Thibault, Delphine/0000-0002-0528-1062; Pergent-Martini, Christine/0000-0002-9098-6867	French Centre National de la Recherche Scientifique (CNRS); French Reseau des Stations et Observatoires Marins (RESOMAR); Museum National d'Histoire Naturelle (MNHN, Paris); French Agence de l'eau Rhone Mediterranee Corse through the French part of the European MSFD project (in French: Directive Cadre Strategie pour le Milieu Marin, DCSMM)	French Centre National de la Recherche Scientifique (CNRS)(Centre National de la Recherche Scientifique (CNRS)); French Reseau des Stations et Observatoires Marins (RESOMAR); Museum National d'Histoire Naturelle (MNHN, Paris); French Agence de l'eau Rhone Mediterranee Corse through the French part of the European MSFD project (in French: Directive Cadre Strategie pour le Milieu Marin, DCSMM)	This study has been funded by the French Centre National de la Recherche Scientifique (CNRS), the French Reseau des Stations et Observatoires Marins (RESOMAR), the Museum National d'Histoire Naturelle (MNHN, Paris), the French Agence de l'eau Rhone Mediterranee Corse through the French part of the European MSFD project (in French: Directive Cadre Strategie pour le Milieu Marin, DCSMM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcoverro T, 2001, MAR ECOL PROG SER, V211, P105, DOI 10.3354/meps211105; [Anonymous], 1979, B MUSEUM HIST NATURE; [Anonymous], 2000, BIOL MAR MEDITERR; Astruch P., 2012, SCI REP PORT CROS NA, V26, P45; Ballesteros E, 2007, MAR POLLUT BULL, V55, P172, DOI 10.1016/j.marpolbul.2006.08.038; BAY D, 1984, AQUAT BOT, V20, P43, DOI 10.1016/0304-3770(84)90026-3; Bazin N, 2012, CORMORAN HUPPE MEDIE; BELL J D, 1982, Tethys, V10, P337; Bellan-Santini D., 1984, P423; Bianchi C.N., 1989, INT WORKSH POS OC BE, P257; Bond W, 2001, SCIENCE, V292, P63, DOI 10.1126/science.1060793; Boudouresque C., 1982, CAHIERS 4 L 8O; Boudouresque C., 2006, BIOL MAR MEDITERR, V13, P109; Boudouresque C.-F., 2012, PROTECTION CONSERVAT; Boudouresque C.F., 1983, J RECH OCEANOGR, V8, P99; Boudouresque CF, 1984, INT WORKSHOP POSIDON, P185; Boudouresque CF, 1983, RAPP PV REUN COMM IN, V28, P111; Boudouresque CF, 2007, DEV AQUAC FISH SCI, V37, P243; Boudouresque CF, 2013, DEV AQUAC FISH SCI, V38, P297, DOI 10.1016/B978-0-12-396491-5.00021-6; Boudouresque CF, 2009, BOT MAR, V52, P395, DOI 10.1515/BOT.2009.057; Christensen V, 2011, ECOSYSTEM APPROACH F; Coles R, 2013, SEAGRASS WATCH, V47, P2; DALKEY N, 1963, MANAGE SCI, V9, P458, DOI 10.1287/mnsc.9.3.458; Di Maida G, 2013, MAR ENVIRON RES, V87-88, P96, DOI [10.1016/j.marenvres.2013.04.001, 10.1016/j.marenvres2013.04.001]; Diaz RJ, 2004, J ENVIRON MANAGE, V73, P165, DOI 10.1016/j.jenvman.2004.06.004; Fernandez-Torquemada Y, 2008, ICES J MAR SCI, V65, P1492, DOI 10.1093/icesjms/fsn146; Ferrari B, 2008, AQUAT BOT, V88, P295, DOI 10.1016/j.aquabot.2007.12.002; Fourqurean JW, 2012, NAT GEOSCI, V5, P505, DOI 10.1038/ngeo1477; Francour P, 1996, BIRD STUDY, V43, P129, DOI 10.1080/00063659609461004; FRANCOUR P, 1995, HYDROBIOLOGIA, V300, P345, DOI 10.1007/BF00024475; Francour P, 1997, MAR ECOL-P S Z N I, V18, P157, DOI 10.1111/j.1439-0485.1997.tb00434.x; Francour Patrice, 1995, Travaux Scientifiques du Parc Naturel Regional et des Reserves Naturelles de Corse, V53, P11; Gacia E, 1999, AQUAT BOT, V65, P255, DOI 10.1016/S0304-3770(99)00044-3; Garcia-March JR, 2007, MAR BIOL, V150, P861, DOI 10.1007/s00227-006-0386-1; Garcia-March JR, 2011, ACT C 2011 SOC ZOOL, P80; Garcia-Marin P, 2013, MAR POLLUT BULL, V68, P46, DOI 10.1016/j.marpolbul.2012.12.025; Giovannetti E, 2010, MAR POLLUT BULL, V60, P1031, DOI 10.1016/j.marpolbul.2010.01.024; Giovannetti E, 2008, CHEM ECOL, V24, P145; Gobert S, 2009, MAR POLLUT BULL, V58, P1727, DOI 10.1016/j.marpolbul.2009.06.012; Guinda X, 2008, ECOL INDIC, V8, P743, DOI 10.1016/j.ecolind.2008.01.004; Guyot I, 1990, TRAV SCI PARC NAT RE, V28, P1; Harmelin-Vivien M.L., 1982, Travaux Scientifiques du Parc National de Port-Cros, V8, P69; HARMELINVIVIEN ML, 1992, MAR ECOL-P S Z N I, V13, P41, DOI 10.1111/j.1439-0485.1992.tb00338.x; HARMELINVIVIEN ML, 1995, HYDROBIOLOGIA, V300, P309, DOI 10.1007/BF00024471; Hoare JM, 2013, ECOL INDIC, V25, P23, DOI 10.1016/j.ecolind.2012.09.007; Infantes E, 2012, MAR ECOL PROG SER, V456, P63, DOI 10.3354/meps09754; Jimenez S., 1996, P375; JONES CG, 1994, OIKOS, V69, P373, DOI 10.2307/3545850; KARR JR, 1981, FISHERIES, V6, P21, DOI 10.1577/1548-8446(1981)006<0021:AOBIUF>2.0.CO;2; Kenchington E, 2003, ICES J MAR SCI, V60, P1172, DOI 10.1016/S1054-3139(03)00136-X; LAWTON JH, 1994, OIKOS, V71, P367, DOI 10.2307/3545824; Le Direach L, 2007, SCI REP PORT GROS NA, V22, P17; Leriche A, 2006, AQUAT BOT, V84, P287, DOI 10.1016/j.aquabot.2005.10.001; Royo CLY, 2011, ECOL INDIC, V11, P557, DOI 10.1016/j.ecolind.2010.07.012; Royo CLY, 2010, ECOL INDIC, V10, P380, DOI 10.1016/j.ecolind.2009.07.005; Lopez-Saez JA, 2009, PALAEOGEOGR PALAEOCL, V271, P215, DOI 10.1016/j.palaeo.2008.10.020; Mabrouk L, 2013, AQUAT BOT, V108, P33, DOI 10.1016/j.aquabot.2013.03.002; Macquart-Moulin C, 1968, REC TRAV ST MAR END, V43, P311; Marba N, 2013, HYDROBIOLOGIA, V704, P265, DOI 10.1007/s10750-012-1403-7; Martin MA, 1994, TRABAJOS CAMPO RESER, P25; Martinez-Crego B, 2008, MAR ECOL PROG SER, V361, P93, DOI 10.3354/meps07358; Martinez-Crego B, 2010, J ENVIRON MONITOR, V12, P1013, DOI 10.1039/b920937a; Mascaro O, 2013, HYDROBIOLOGIA, V704, P279, DOI 10.1007/s10750-012-1426-0; Mateo MA, 1997, MAR ECOL PROG SER, V151, P43, DOI 10.3354/meps151043; Mateo MA, 2003, ESTUAR COAST SHELF S, V56, P85, DOI 10.1016/S0272-7714(02)00123-3; Mateo MA, 1997, ESTUAR COAST SHELF S, V44, P103, DOI 10.1006/ecss.1996.0116; Mazzuca S, 2013, FRONT PLANT SCI, V4, DOI 10.3389/fpls.2013.00038; MEINESZ A, 1991, MAR POLLUT BULL, V23, P343, DOI 10.1016/0025-326X(91)90698-R; Mezali K., 2003, Bulletin de la Societe Zoologique de France, V128, P49; Molinier R., 1952, ANN I OCEANOGR PARIS, V27, P157; Montefalcone M, 2007, MAR POLLUT BULL, V54, P206, DOI 10.1016/j.marpolbul.2006.10.005; Montefalcone M, 2009, ECOL INDIC, V9, P595, DOI 10.1016/j.ecolind.2008.09.013; Morat F, 2011, VIE MILIEU, V61, P77; Morat F, 2007, REGIME ALIMENTAIRE P; Morena D, 2001, BIOL CONSERV, V102, P325, DOI 10.1016/S0006-3207(01)00080-5; Naranjo SA, 1996, MAR ECOL PROG SER, V144, P119, DOI 10.3354/meps144119; Oliva S, 2012, ESTUAR COAST SHELF S, V114, P7, DOI 10.1016/j.ecss.2011.08.022; Orfanidis S, 2011, MEDITERR MAR SCI, V12, P199, DOI 10.12681/mms.60; Orfanidis S., 2003, ECOL INDIC, V3, P27, DOI DOI 10.1016/S1470-160X(03)00008-6; Orfanidis S., 2001, MEDITERRANEAN MARINE, V2, P45, DOI [DOI 10.12681/MMS.266, 10.12681/mms.266]; PANAYOTIDIS P, 1981, BOT MAR, V24, P115, DOI 10.1515/botm.1981.24.3.115; Panayotidis P, 1999, ESTUAR COAST SHELF S, V48, P205, DOI 10.1006/ecss.1998.0411; Parravicini V, 2012, ECOL INDIC, V19, P253, DOI 10.1016/j.ecolind.2011.07.027; Peirano A, 2001, SCI MAR, V65, P367, DOI 10.3989/scimar.2001.65n4367; Peres J. M., 1964, Recueil des Travaux de la Station Marine de l'Endoume, VNo. 47, P3; Pergent G, 1997, AQUAT BOT, V59, P307, DOI 10.1016/S0304-3770(97)00052-1; PERGENT G, 1991, AQUAT BOT, V42, P49, DOI 10.1016/0304-3770(91)90105-E; PERGENT G, 1994, MAR ECOL PROG SER, V106, P139, DOI 10.3354/meps106139; PERGENT G, 1989, MAR ECOL-P S Z N I, V10, P221, DOI 10.1111/j.1439-0485.1989.tb00474.x; Pergent G., 2012, MEDITERRANEAN SEAGRA; Pergent G., 1995, M SOG E MARSEILLE, V54, P3; Pergent-Martini C, 2005, ECOL INDIC, V5, P213, DOI 10.1016/j.ecolind.2005.02.004; Pergent-Martini C, 2006, ENVIRON MANAGE, V38, P889, DOI 10.1007/s00267-005-0056-y; PERGENTMARTINI C, 1994, MAR BIOL, V120, P9; PERGENTMARTINI C, 1994, OCEANOL ACTA, V17, P673; Pikitch EK, 2004, SCIENCE, V305, P346, DOI 10.1126/science.1098222; Prado P, 2007, MAR ECOL PROG SER, V340, P63, DOI 10.3354/meps340063; Rice JC, 2005, MAR ECOL PROG SER, V300, P265; ROMERO J, 1992, MAR ECOL-P S Z N I, V13, P69, DOI 10.1111/j.1439-0485.1992.tb00341.x; Romero J, 2012, FONS MARI ILLES MEDE, P81; Romero J, 2007, MAR POLLUT BULL, V55, P196, DOI 10.1016/j.marpolbul.2006.08.032; Rosenberg AA, 2005, MAR ECOL PROG SER, V300, P270; Rouanet E, 2012, SUIVI HERBIER POSIDO; Ruiz JM, 2009, BOT MAR, V52, P369, DOI 10.1515/BOT.2009.058; Sala E, 2004, ECOSYSTEMS, V7, P333, DOI 10.1007/s10021-003-0241-x; Sanchez-Gonzalez JF, 2011, J HYDRAUL RES, V49, P503, DOI 10.1080/00221686.2011.552464; Sartoretto S, 2011, DCSMMEIEEMO224C MIN; Short F.T., 2002, SEAGRASSNET MANUAL S; Thelin I, 1985, RAPP COMM INT MER ME, V29, P247; Thibault J.C., 2001, BALBUZARD PECHEUR CO; Tudela S, 2005, MAR ECOL PROG SER, V300, P282; Turrell B., 2004, EUROGOOS PUBL, V21, P1; UNEP-MAP-RAC/SPA, 2011, 10 M FOC POINTS SPAS; UNEP-MAP-RAC/SPA, 2011, 3599 UNEPDEPIMED WG; Urra J, 2013, ESTUAR COAST SHELF S, V117, P136, DOI 10.1016/j.ecss.2012.11.005; van der Ben D, 1971, MEM I R SCI NAT BELG, V168; Van Hoey G, 2010, MAR POLLUT BULL, V60, P2187, DOI 10.1016/j.marpolbul.2010.09.015; Verlaque M., 1981, Rapports et Proces-Verbaux des Reunions Commission Internationale pour l'Exploration Scientifique de la Mer Mediterranee Monaco, V27, P201; Vicente N, 1993, QUALITE MILIEU MARIN, P141; Ward T. J., 2003, MARINE PROTECTED ARE; White J, 2003, AQUAT CONSERV, V13, P331, DOI 10.1002/aqc.586	121	67	68	2	79	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98994	10.1371/journal.pone.0098994	http://dx.doi.org/10.1371/journal.pone.0098994			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933020	Green Published, gold			2022-12-27	WOS:000337738600017
J	Xie, HY; Ash, JE; Linde, CC; Cunningham, S; Nicotra, A				Xie, Hongyan; Ash, Julian E.; Linde, Celeste C.; Cunningham, Saul; Nicotra, Adrienne			Himalayan-Tibetan Plateau Uplift Drives Divergence of Polyploid Poppies: Meconopsis Viguier (Papaveraceae)	PLOS ONE			English	Article							EVOLUTION; HISTORY; DIVERSIFICATION; CLIMATE; ORIGINS; MIOCENE; COLONIZATION; CONSEQUENCES; POPULATIONS; VEGETATION	Meconopsis Viguier (Papaveraceae) is an iconic genus of alpine forbs that includes medicinal and ornamental species. This study extends previous phylogenetic analyses of Meconopsis, using ITS sequences representing all the major Meconopsis clades. Phenotypic traits are also analysed for all described species. Our results show that Meconopsis evolved as a >= octaploid clade, with considerable interior structure reflecting further changes in ploidy levels as well as phenotypic differentiation. We support the exclusion of a few species as Cathcartia or Papaver, making Meconopsis a Tibetan region clade. Based on average rates of nucleotide substitution in angiosperm herbs we estimate that the Meconopsis clade diverged from the Meconella clade of Papaver approximately 16.6 Ma. This is soon after the 'hard' collision of the Indian continent with Asia caused uplift of the Himalaya and Hengduan ranges, greatly extended the Tibetan plateau, and initiated monsoonal climates. Eight major clades within Meconopsis are well supported and these correspond closely to previously recognised subgenus groups. However, the relationship among the clades is poorly resolved, probably because they diverged rapidly similar to 15-11 Ma. Two of these clades are, dodecaploid but appear to have originated independently. The eight clades have distinct distributions, variously associated with the Himalaya, the eastern Plateau and Hengduan ranges. Some Meconopsis species were not monophyletic, suggesting that a combination of multilocus molecular and phenotypic traits is required when defining and revising species.	[Xie, Hongyan; Ash, Julian E.; Linde, Celeste C.; Nicotra, Adrienne] Australian Natl Univ, Div Evolut Ecol & Genet, Res Sch Biol, Canberra, ACT, Australia; [Xie, Hongyan] Chinese Acad Sci, Kunming Inst Bot, Kunming, Yunnan, Peoples R China; [Cunningham, Saul] Commonwealth Sci & Ind Res Org, Ecosyst Sci, Canberra, ACT, Australia	Australian National University; Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Xie, HY (corresponding author), Australian Natl Univ, Div Evolut Ecol & Genet, Res Sch Biol, Canberra, ACT, Australia.	hongyan.xie@anu.edu.au	Linde, Celeste/T-9449-2019; Nicotra, Adrienne B/C-1361-2009; Linde, Celeste/C-9306-2009; Cunningham, Saul A/B-9947-2009	Linde, Celeste/0000-0002-8207-1202; Nicotra, Adrienne B/0000-0001-6578-369X; Linde, Celeste/0000-0002-8207-1202; Cunningham, Saul A/0000-0003-0703-6893	Australian National University	Australian National University(Australian National University)	A PhD scholarship and Vice-Chancellor's Travel Grant to HYX from the Australian National University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2003, MOL ECOL, V12, P299, DOI 10.1046/j.1365-294X.2003.01731.x; Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Albertin W, 2012, P ROY SOC B-BIOL SCI, V279, P2497, DOI 10.1098/rspb.2012.0434; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; An LZ, 2009, NOVON, V19, P286, DOI 10.3417/2005012; Anderson CL, 2005, AM J BOT, V92, P1737, DOI 10.3732/ajb.92.10.1737; [Anonymous], 2009, PERSPECT PLANT ECOL, DOI DOI 10.1016/j.ppees.2009.01.001; Asparoukhov OK, 2001, COMPUT STAT DATA AN, V38, P139, DOI 10.1016/S0167-9473(01)00032-9; BILLINGS WD, 1968, BIOL REV, V43, P481, DOI 10.1111/j.1469-185X.1968.tb00968.x; Blewitt ME, 2008, NAT GENET, V40, P663, DOI 10.1038/ng.142; Bookhagen B., 2006, GEOPHYS RES LETT, V33; Bretagnolle F, 1998, BOT HELV, V108, P5; Burbank DW, 2003, NATURE, V426, P652, DOI 10.1038/nature02187; BURROUGH PA, 1981, NATURE, V294, P240, DOI 10.1038/294240a0; Carolan JC, 2006, ANN BOT-LONDON, V98, P141, DOI 10.1093/aob/mcl079; CHUANG H, 1981, Acta Botanica Yunnanica, V3, P139; Cobb JLS, 2012, MECONOPSIS WORLD VIS; CORBETT AL, 1992, CAN J BOT, V70, P200, DOI 10.1139/b92-027; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; [崔治家 Cui Zhijia], 2005, [广西植物, Guihaia], V25, P106; Ding ZL, 2002, PALEOCEANOGRAPHY, V17, DOI 10.1029/2001PA000725; Doyle JA, 2012, ANNU REV EARTH PL SC, V40, P301, DOI 10.1146/annurev-earth-042711-105313; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ., 2011, GENEIOUS PRO 5 4; Egan PA, 2011, PHYTOTAXA, V20, P47, DOI 10.11646/phytotaxa.20.1.4; Flynn JJ, 2000, MOL PHYLOGENET EVOL, V17, P190, DOI 10.1006/mpev.2000.0819; Givnish TJ, 2010, TAXON, V59, P1326, DOI 10.1002/tax.595003; Grey-Wilson C., 1996, New Plantsman, V3, P22; Grey-Wilson C, 2001, POPPIES GUIDE POPPY; Grey-Wilson C, 2006, ALPINE GARDNER, V74, P22; Grey-Wilson Christopher, 2006, Curtis's Botanical Magazine, V23, P176, DOI 10.1111/j.1355-4905.2006.00528.x; Gupta AK, 2008, HIMALAYAN J SCI, V5; Hughes C, 2006, P NATL ACAD SCI USA, V103, P10334, DOI 10.1073/pnas.0601928103; Husband BC, 2008, INT J PLANT SCI, V169, P195, DOI 10.1086/523367; JANIS CM, 1993, ANNU REV ECOL SYST, V24, P467, DOI 10.1146/annurev.es.24.110193.002343; Kadereit Joachim W., 2011, New Journal of Botany, V1, P80, DOI 10.1179/204234811X13194453002742; KADEREIT JW, 1991, PLANT SYST EVOL, V175, P93, DOI 10.1007/BF00942148; Kadereit JW, 1997, PLANT SYST EVOL, V204, P75, DOI 10.1007/BF00982533; Kawakita A, 2004, MOL PHYLOGENET EVOL, V32, P422, DOI 10.1016/j.ympev.2004.04.001; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; Kessell M, 2011, MECONOPSIS GROUP 199; Klimesova J, 2011, PLANT ECOL DIVERS, V4, P373, DOI 10.1080/17550874.2011.586734; Korner C, 1999, ALPINE PLANT LIFE FU; Kumar S, 2013, PROTOPLASMA, V250, P307, DOI 10.1007/s00709-012-0413-7; Kurup S, 1998, SEX PLANT REPROD, V11, P192, DOI 10.1007/s004970050141; Lavania UC, 1999, CURR SCI INDIA, V77, P429; Leonard JA, 2005, MOL ECOL, V14, P9, DOI 10.1111/j.1365-294X.2004.02389.x; LEVIN DA, 1983, AM NAT, V122, P1, DOI 10.1086/284115; Liu S, 1996, MECONOPSIS VIG FLORA, P387; Lu MaoZhen, 2006, Bulletin of Botanical Research, V26, P8; Lumaret R, 1997, BIODIVERS CONSERV, V6, P591, DOI 10.1023/A:1018389413659; Mable BK, 2004, NEW PHYTOL, V162, P803, DOI 10.1111/j.1469-8137.2004.01055.x; Maddison WPaDRM, 2009, MESQUITE MODULAR SYS; MANDELBROT BB, 1975, P NATL ACAD SCI USA, V72, P3825, DOI 10.1073/pnas.72.10.3825; Meng LH, 2007, MOL ECOL, V16, P4128, DOI 10.1111/j.1365-294X.2007.03459.x; Miller JS, 2000, SCIENCE, V289, P2335, DOI 10.1126/science.289.5488.2335; Ming QZ, 2006, INT GEOSCI REMOTE SE, P1587, DOI 10.1109/IGARSS.2006.409; Mueggler Erik, 2011, PAPER ROAD ARCH EXPE; NOAA, 2009, WORLD DAT CTR PAL; NORTON CR, 1986, J HORTIC SCI, V61, P257, DOI 10.1080/14620316.1986.11515699; Ohba H., 2009, Journal of Japanese Botany, V84, P294; OJALA A, 1990, HEREDITAS, V112, P221, DOI 10.1111/j.1601-5223.1990.tb00061.x; Opgenoorth L, 2010, NEW PHYTOL, V185, P332, DOI 10.1111/j.1469-8137.2009.03007.x; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; PALMER MW, 1992, AM NAT, V139, P375, DOI 10.1086/285332; Peng ZG, 2006, MOL PHYLOGENET EVOL, V39, P568, DOI 10.1016/j.ympev.2005.10.016; Petit JR, 1999, NATURE, V399, P429, DOI 10.1038/20859; Pollard D, 2009, NATURE, V458, P329, DOI 10.1038/nature07809; Prain D, 1906, ANN BOT-LONDON, V20, P323, DOI 10.1093/oxfordjournals.aob.a089107; Qu YH, 2005, MOL ECOL, V14, P1767, DOI 10.1111/j.1365-294X.2005.02528.x; R Core Team, 2021, R LANGUAGE ENV STAT; Rambaut A., 2009, FIGTREE 1 3 1; Reid AJ, 2005, J STRUCT GEOL, V27, P119, DOI 10.1016/j.jsg.2004.06.011; Ripley B. D., 1996, PATTERN RECOGNITION; Roberts JL, 2007, J BIOGEOGR, V34, P417, DOI 10.1111/j.1365-2699.2006.01621.x; Rowley DB, 2006, NATURE, V439, P677, DOI 10.1038/nature04506; Salick J., 2012, KHAWA KARPO TIBETAN; Saylor JE, 2009, AM J SCI, V309, P1, DOI 10.2475/01.2009.01; Schoenbohm LM, 2006, GEOLOGY, V34, P813, DOI 10.1130/G22679.1; Segraves KA, 1999, MOL ECOL, V8, P253, DOI 10.1046/j.1365-294X.1999.00562.x; Singhal VK, 2008, J BIOSCIENCES, V33, P371, DOI 10.1007/s12038-008-0057-0; Solstad H, 2003, BOT J LINN SOC, V143, P255, DOI 10.1046/j.1095-8339.2003.00211.x; Soltis DE, 2004, NEW PHYTOL, V161, P173, DOI 10.1046/j.1469-8137.2003.00948.x; SOLTIS DE, 1993, CRIT REV PLANT SCI, V12, P243, DOI 10.1080/713608048; Stamatakis A, 2008, SYST BIOL, V57, P758, DOI 10.1080/10635150802429642; Sun JM, 2010, GEOLOGY, V38, P515, DOI 10.1130/G30776.1; TAYLOR G, 1934, ACCOUNT GENUS MECONO; Thompson JN, 2008, ECOLOGY, V89, P2197, DOI 10.1890/07-1432.1; Trenberth K.E., 2007, CLIMATE CHANGE 2007, P235, DOI DOI 10.5194/CP-6-379-2010; Tseng ZJ, 2014, P ROYAL SOC B, V281; van Hinsbergen DJJ, 2012, P NATL ACAD SCI USA, V109, P7659, DOI 10.1073/pnas.1117262109; Wallace LE, 2003, INT J PLANT SCI, V164, P907, DOI 10.1086/378658; Wang BS, 2011, MOL ECOL, V20, P3796, DOI 10.1111/j.1365-294X.2011.05157.x; Wang CS, 2008, P NATL ACAD SCI USA, V105, P4987, DOI 10.1073/pnas.0703595105; Wang H, 2010, MOL ECOL, V19, P2964, DOI 10.1111/j.1365-294X.2010.04729.x; Wang LY, 2009, MOL ECOL, V18, P709, DOI 10.1111/j.1365-294X.2008.04055.x; Weir JT, 2008, MOL ECOL, V17, P2321, DOI 10.1111/j.1365-294X.2008.03742.x; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Winkworth RC, 2005, ORG DIVERS EVOL, V5, P237, DOI 10.1016/j.ode.2004.12.001; WU C-Y, 1980, Acta Botanica Yunnanica, V2, P371; Wu CY, 1999, PAPAVERACEAE FLORA C, P7; Wu LL, 2010, MOL ECOL, V19, P1691, DOI 10.1111/j.1365-294X.2010.04613.x; Xie HY, 1999, ETHNOBOTANICAL STUDY; Yang FS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037196; Yang FS, 2008, MOL ECOL, V17, P5135, DOI 10.1111/j.1365-294X.2008.03976.x; Yao HJ, 2008, GEOPHYS J INT, V173, P205, DOI 10.1111/j.1365-246X.2007.03696.x; Ying M, 2006, CARYOLOGIA, V59, P1; Yoshida T, 2011, PLANT DIVERSITY RESO, V33; Yoshida T, 2012, PLANT DIVERSITY RESO, V34; Yoshida T, 2007, ACTA BOT YUNNANICA, V29; Yoshida Toshio, 2010, Acta Botanica Yunnanica, V32, P503, DOI 10.3724/SP.J.1143.2010.10105; Yuan Chang-Chun, 2004, Yi Chuan Xue Bao, V31, P901; Zhang M, 2008, FLORA CHINA, P262; Zhang PZ, 2004, GEOLOGY, V32, P809, DOI 10.1130/G20554.1	114	17	18	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99177	10.1371/journal.pone.0099177	http://dx.doi.org/10.1371/journal.pone.0099177			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933008	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600027
J	Zhang, ZY; Xu, J; Ren, Y; Li, KKW; Ng, HK; Mao, Y; Zhong, P; Yao, Y; Zhou, LF				Zhang, Zhen-Yu; Xu, Jian; Ren, Yong; Li, Kay Ka-Wai; Ng, Ho-Keung; Mao, Ying; Zhong, Ping; Yao, Yu; Zhou, Liang-Fu			Medulloblastoma in China: Clinicopathologic Analyses of SHH, WNT, and Non-SHH/WNT Molecular Subgroups Reveal Different Therapeutic Responses to Adjuvant Chemotherapy	PLOS ONE			English	Article							PROGNOSTIC-FACTORS; ADULT MEDULLOBLASTOMA; CHILDREN; RADIATION; SERIES; TUMORS	Medulloblastoma (MB) is one of the most common primary central nervous system tumors in children. Data is lacking of a large cohort of medulloblastoma patients in China. Also, our knowledge on the sensitivity of different molecular subgroups of MB to adjuvant radiation therapy (RT) or chemotherapy (CHT) is still limited. The authors performed a retrospective study of 173 medulloblastoma patients treated at two institutions from 2002 to 2011. Formalin-fixed paraffin embedded (FFPE) tissues were available in all the cases and sections were stained to classify histological and molecular subgroups. Univariate and multivariate analyses were used to investigate prognostic factors. Of 173 patients, there were 118 children and 55 adults, 112 males and 61 females. Estimated 5-year overall survival (OS) rates for all patients, children and adults were 52%, 48% and 63%, respectively. After multivariate analysis, postoperative primary radiation therapy (RT) and chemotherapy (CHT) were revealed as favorable prognostic factors influencing OS and EFS. Postoperative primary chemotherapy (CHT) was found significantly improving the survival of children (p<0.001) while it was not a significant prognostic factor for adult patients. Moreover, patients in WNT subtype had better OS (p=0.028) than others (SHH and Non-SHH/WNT subtypes) given postoperative adjuvant therapies. Postoperative primary RT was found to be a strong prognostic factor influencing the survival in all histological and molecular subgroups (p<0.001). Postoperative primary CHT was found significantly to influence the survival of classic medulloblastoma (CMB) (OS p<0.001, EFS p<0.001), SHH subgroup (OS p=0.020, EFS p=0.049) and WNT subgroup (OS p=0.003, EFS p=0.016) but not in desmoplastic/nodular medulloblastoma (DMB) (OS p=0.361, EFS p=0.834) and Non-SHH/WNT subgroup (OS p=0.127, EFS p=0.055). Our study showed postoperative primary CHT significantly influence the survival of CMB, SHH subgroup and WNT subgroup but not in DMB and Non-SHH/WNT subgroup of MB.	[Zhang, Zhen-Yu; Xu, Jian; Mao, Ying; Zhong, Ping; Yao, Yu; Zhou, Liang-Fu] Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China; [Ren, Yong] Wuhan Gen Hosp Guangzhou Command, Dept Pathol, Peoples Liberat Army, Wuhan, Peoples R China; [Li, Kay Ka-Wai; Ng, Ho-Keung] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Anat & Cellular Pathol, Hong Kong, Peoples R China	Fudan University; Chinese University of Hong Kong; Prince of Wales Hospital	Zhong, P; Yao, Y (corresponding author), Fudan Univ, Huashan Hosp, Dept Neurosurg, Shanghai 200433, Peoples R China.	zhp2288991@126.com; yu_yao03@126.com	Ng, Ho Keung/I-3952-2015	Mao, Ying/0000-0001-8055-115X	Shanghai Talents Development Funds [2011063]	Shanghai Talents Development Funds	This study was supported by Shanghai Talents Development Funds (No. 2011063 to YY). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albright AL, 1996, NEUROSURGERY, V38, P265, DOI 10.1097/00006123-199602000-00007; Brandes AA, 2007, CANCER-AM CANCER SOC, V110, P2035, DOI 10.1002/cncr.23003; CARRIE C, 1994, CANCER-AM CANCER SOC, V74, P2352, DOI 10.1002/1097-0142(19941015)74:8<2352::AID-CNCR2820740821>3.0.CO;2-H; Chan AW, 2000, NEUROSURGERY, V47, P623, DOI 10.1097/00006123-200009000-00018; Choux M, 1983, Clin Neurosurg, V30, P246; Curran EK, 2009, J NEURO-ONCOL, V95, P81, DOI 10.1007/s11060-009-9894-4; del Charco JO, 1998, INT J RADIAT ONCOL, V42, P147, DOI 10.1016/S0360-3016(98)00197-7; Ellison DW, 2011, ACTA NEUROPATHOL, V121, P381, DOI 10.1007/s00401-011-0800-8; FROST PJ, 1995, INT J RADIAT ONCOL, V32, P951, DOI 10.1016/0360-3016(94)00612-O; Gajjar A, 2006, LANCET ONCOL, V7, P813, DOI 10.1016/S1470-2045(06)70867-1; Herrlinger U, 2005, J NEUROL, V252, P291, DOI 10.1007/s00415-005-0560-2; Johnston DL, 2009, J NEURO-ONCOL, V94, P51, DOI 10.1007/s11060-009-9799-2; Johnstone PAS, 2002, CURR PROB CANCER, V26, P317, DOI 10.1067/mcn.2002.130267; Kool M, 2012, ACTA NEUROPATHOL, V123, P473, DOI 10.1007/s00401-012-0958-8; Liu YP, 2005, JPN J CLIN ONCOL, V35, P111, DOI 10.1093/jjco/hyi038; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Malheiros SMF, 2002, J NEURO-ONCOL, V60, P247, DOI 10.1023/A:1021178518361; Menon G, 2008, J CLIN NEUROSCI, V15, P122, DOI 10.1016/j.jocn.2007.06.007; Northcott PA, 2011, J CLIN ONCOL, V29, P1408, DOI 10.1200/JCO.2009.27.4324; Packer R J, 1999, Neuro Oncol, V1, P232, DOI 10.1093/neuonc/1.3.232; PACKER RJ, 1994, J NEUROSURG, V81, P690, DOI 10.3171/jns.1994.81.5.0690; PACKER RJ, 1991, J NEUROSURG, V74, P433, DOI 10.3171/jns.1991.74.3.0433; Packer RJ, 2008, ARCH NEUROL-CHICAGO, V65, P1419, DOI 10.1001/archneur.65.11.1419; Padovani L, 2007, INT J RADIAT ONCOL, V68, P433, DOI 10.1016/j.ijrobp.2006.12.030; Rieken S, 2011, INT J RADIAT ONCOL, V81, pE7, DOI 10.1016/j.ijrobp.2010.12.042; Rieken S, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-450; Riffaud L, 2009, J NEUROSURG, V111, P478, DOI 10.3171/2009.1.JNS081004; Roldan G, 2008, CAN J NEUROL SCI, V35, P210, DOI 10.1017/S0317167100008659; Sarkar C, 2002, J NEURO-ONCOL, V59, P49, DOI 10.1023/A:1016357731363; Sun LM, 2002, J NEURO-ONCOL, V58, P77, DOI 10.1023/A:1015865614640; Taylor MD, 2012, ACTA NEUROPATHOL, V123, P465, DOI 10.1007/s00401-011-0922-z; von Hoff K, 2009, EUR J CANCER, V45, P1209, DOI 10.1016/j.ejca.2009.01.015; Weil MD, 1998, JAMA-J AM MED ASSOC, V279, P1474, DOI 10.1001/jama.279.18.1474; Whelan HT, 1998, PEDIATR NEUROL, V18, P103, DOI 10.1016/S0887-8994(97)00221-X; Wolff JEA, 1998, KLIN PADIATR, V210, P234, DOI 10.1055/s-2008-1043884; Wrensch M, 2002, NEURO-ONCOLOGY, V4, P278, DOI 10.1093/neuonc/4.4.278; Zeltzer PM, 1999, J CLIN ONCOL, V17, P832, DOI 10.1200/JCO.1999.17.3.832	37	15	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99490	10.1371/journal.pone.0099490	http://dx.doi.org/10.1371/journal.pone.0099490			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932704	gold, Green Published			2022-12-27	WOS:000337738600036
J	Brancato, A; Plescia, F; Marino, RAM; Maniaci, G; Navarra, M; Cannizzaro, C				Brancato, Anna; Plescia, Fulvio; Marino, Rosa Anna Maria; Maniaci, Giuseppe; Navarra, Michele; Cannizzaro, Carla			Involvement of Dopamine D2 Receptors in Addictive-Like Behaviour for Acetaldehyde	PLOS ONE			English	Article							VENTRAL TEGMENTAL AREA; NUCLEUS-ACCUMBENS; DRUG-ADDICTION; NEGATIVE REINFORCEMENT; ETHANOL OXIDATION; ALCOHOL ADDICTION; NEURONAL-ACTIVITY; IN-VIVO; RAT; BRAIN	Acetaldehyde, the first metabolite of ethanol, is active in the central nervous system, where it exerts motivational properties. Acetaldehyde is able to induce drinking behaviour in operant-conflict paradigms that resemble the core features of the addictive phenotype: drug-intake acquisition and maintenance, drug-seeking, relapse and drug use despite negative consequences. Since acetaldehyde directly stimulates dopamine neuronal firing in the mesolimbic system, the aim of this study was the investigation of dopamine D2-receptors' role in the onset of the operant drinking behaviour for acetaldehyde in different functional stages, by the administration of two different D2-receptor agonists, quinpirole and ropinirole. Our results show that acetaldehyde was able to induce and maintain a drug-taking behaviour, displaying an escalation during training, and a reinstatement behaviour after 1-week forced abstinence. Acetaldehyde operant drinking behaviour involved D2-receptor signalling: in particular, quinpirole administration at 0.03 mg/kg, induced a significant decrease in the number of lever presses both in extinction and in relapse. Ropinirole, administered at 0.03 mg/kg during extinction, did not produce any modification but, when administered during abstinence, induced a strong decrease in acetaldehyde intake in the following relapse session. Taken together, our data suggest that acetaldehyde exerts its own motivational properties, involving the dopaminergic transmission: indeed, activation of pre-synaptic D2-receptors by quinpirole, during extinction and relapse, negatively affects operant behaviour for acetaldehyde, likely decreasing acetaldehyde-induced dopamine release. The activation of post-synaptic D2-receptors by ropinirole, during abstinence, decreases the motivation to the consecutive reinstatement of acetaldehyde drinking behaviour, likely counteracting the reduction in the dopaminergic tone typical of withdrawal. These data further strengthen the evidence that acetaldehyde may play a crucial role as mediator of ethanol's central effects.	[Brancato, Anna; Plescia, Fulvio; Marino, Rosa Anna Maria; Maniaci, Giuseppe; Cannizzaro, Carla] Univ Palermo, Dept Sci Hlth Promot & Mother & Child Care G DAle, Palermo, Italy; [Navarra, Michele] Univ Messina, Dept Drug Sci & Prod Hlth, Messina, Italy	University of Palermo; University of Messina	Cannizzaro, C (corresponding author), Univ Palermo, Dept Sci Hlth Promot & Mother & Child Care G DAle, Palermo, Italy.	carla.cannizzaro@unipa.it	Plescia, Fulvio/AAZ-2591-2020; Brancato, Anna/P-7418-2017	Brancato, Anna/0000-0002-8635-4146; MANIACI, Giuseppe/0000-0001-7484-7704; PLESCIA, Fulvio/0000-0002-4786-8435; CANNIZZARO, Carla/0000-0002-7351-1712; Navarra, Michele/0000-0002-6492-7820	Department of Drug Sciences and Products for Health - University of Messina, Italy	Department of Drug Sciences and Products for Health - University of Messina, Italy	The research was supported by a grant from the Department of Drug Sciences and Products for Health - University of Messina, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahao KP, 2012, NEUROPHARMACOLOGY, V62, P882, DOI 10.1016/j.neuropharm.2011.09.017; Ahmed SH, 2005, PSYCHOPHARMACOLOGY, V180, P473, DOI 10.1007/s00213-005-2180-z; Alen F, 2008, EUR J NEUROSCI, V27, P3292, DOI 10.1111/j.1460-9568.2008.06302.x; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Berridge KC, 2007, PSYCHOPHARMACOLOGY, V191, P391, DOI 10.1007/s00213-006-0578-x; Blum K, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-24; Broadbent J, 2005, ALCOHOL, V35, P137, DOI 10.1016/j.alcohol.2005.03.006; Brooks DJ, 1998, CLIN NEUROPHARMACOL, V21, P101; BROWN ZW, 1979, PSYCHOPHARMACOLOGY, V64, P271, DOI 10.1007/BF00427509; BROWN ZW, 1983, ALCOHOL CLIN EXP RES, V7, P276, DOI 10.1111/j.1530-0277.1983.tb05459.x; Cacace S, 2012, ALCOHOL CLIN EXP RES, V36, P1278, DOI 10.1111/j.1530-0277.2011.01725.x; Cannizzaro C., 2011, Malta Medical Journal, V23, P27; Cannizzaro C, 2010, ALCOHOL CLIN EXP RES, V34, P588, DOI 10.1111/j.1530-0277.2009.01127.x; Cohen C, 1998, PSYCHOPHARMACOLOGY, V140, P478, DOI 10.1007/s002130050792; Colombo G, 1998, ALCOHOL ALCOHOLISM, V33, P126; Correa M, 2012, NEUROSCI BIOBEHAV R, V36, P404, DOI 10.1016/j.neubiorev.2011.07.009; De Mei C, 2009, CURR OPIN PHARMACOL, V9, P53, DOI 10.1016/j.coph.2008.12.002; Deehan GA, 2013, ALCOHOL CLIN EXP RES, V37, P722, DOI 10.1111/acer.12034; Deehan GA, 2013, CURR TOP BEHAV NEURO, V13, P163, DOI 10.1007/7854_2011_198; Di Chiara G, 2004, NEUROPHARMACOLOGY, V47, P227, DOI 10.1016/j.neuropharm.2004.06.032; Diana M, 1998, P NATL ACAD SCI USA, V95, P10269, DOI 10.1073/pnas.95.17.10269; DIANA M, 1993, P NATL ACAD SCI USA, V90, P7966, DOI 10.1073/pnas.90.17.7966; DIANA M, 1995, J PHARMACOL EXP THER, V272, P781; Diana Marco, 2011, Front Psychiatry, V2, P64, DOI 10.3389/fpsyt.2011.00064; Edwards S, 2013, BEHAV PHARMACOL, V24, P356, DOI 10.1097/FBP.0b013e3283644d15; Emilien G, 1999, PHARMACOL THERAPEUT, V84, P133, DOI 10.1016/S0163-7258(99)00029-7; Enrico P, 2009, DRUG ALCOHOL DEPEN, V100, P265, DOI 10.1016/j.drugalcdep.2008.10.010; Epping-Jordan MP, 1998, NATURE, V393, P76, DOI 10.1038/30001; Escrig MA, 2012, PHARMACOL BIOCHEM BE, V100, P404, DOI 10.1016/j.pbb.2011.10.002; Foddai M, 2004, NEUROPSYCHOPHARMACOL, V29, P530, DOI 10.1038/sj.npp.1300326; Franklin KM, 2009, ALCOHOL CLIN EXP RES, V33, P1721, DOI 10.1111/j.1530-0277.2009.01009.x; FURMIDGE L, 1991, J NEURAL TRANSM-GEN, V86, P61, DOI 10.1007/BF01250376; GINGRICH JA, 1993, ANNU REV NEUROSCI, V16, P299, DOI 10.1146/annurev.ne.16.030193.001503; GRACE AA, 1985, BRAIN RES, V333, P285, DOI 10.1016/0006-8993(85)91582-3; Heinz A, 2005, AM J PSYCHIAT, V162, P1515, DOI 10.1176/appi.ajp.162.8.1515; HIETALA J, 1994, PSYCHOPHARMACOLOGY, V116, P285, DOI 10.1007/BF02245330; Hoefer ME, 2006, PHARMACOL BIOCHEM BE, V83, P403, DOI 10.1016/j.pbb.2006.02.023; HOOVER DJ, 1981, CAN J PHYSIOL PHARM, V59, P65, DOI 10.1139/y81-011; Hunt WA, 1996, ALCOHOL, V13, P147, DOI 10.1016/0741-8329(95)02026-8; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; June HL, 2010, CURRENT PROTOCOLS NE, P1; Karahanian E, 2015, ADDICT BIOL, V20, P336, DOI 10.1111/adb.12130; Karahanian E, 2011, ALCOHOL CLIN EXP RES, V35, P606, DOI 10.1111/j.1530-0277.2011.01439.x; Katz JL, 2003, PSYCHOPHARMACOLOGY, V168, P21, DOI 10.1007/s00213-003-1441-y; Koob George F, 2013, Front Psychiatry, V4, P72, DOI 10.3389/fpsyt.2013.00072; Koob GF, 2013, CURR OPIN NEUROBIOL, V23, P559, DOI 10.1016/j.conb.2013.03.011; Koob GF, 2013, CURR TOP BEHAV NEURO, V13, P3, DOI 10.1007/7854_2011_129; LACEY MG, 1987, J PHYSIOL-LONDON, V392, P397, DOI 10.1113/jphysiol.1987.sp016787; Lieber CS, 1999, ALCOHOL CLIN EXP RES, V23, P991, DOI 10.1111/j.1530-0277.1999.tb04217.x; LIEBER CS, 1968, SCIENCE, V162, P917, DOI 10.1126/science.162.3856.917; Maremmani Angelo Giovanni Icro, 2011, Front Psychiatry, V2, P50, DOI 10.3389/fpsyt.2011.00050; Martinez D, 2005, BIOL PSYCHIAT, V58, P779, DOI 10.1016/j.biopsych.2005.04.044; McBride WJ, 2002, ALCOHOL CLIN EXP RES, V26, P114, DOI 10.1097/00000374-200201000-00016; Meini M, 2011, CURR PHARM DESIGN, V17, P1376, DOI 10.2174/138161211796150783; Melis M, 2007, EUR J NEUROSCI, V26, P2824, DOI 10.1111/j.1460-9568.2007.05887.x; Melis M, 2005, INT REV NEUROBIOL, V63, P101, DOI 10.1016/S0074-7742(05)63005-X; Muggironi G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00087; MYERS WD, 1982, PHARMACOL BIOCHEM BE, V17, P807, DOI 10.1016/0091-3057(82)90364-1; NUUTINEN H, 1983, ALCOHOL CLIN EXP RES, V7, P163, DOI 10.1111/j.1530-0277.1983.tb05432.x; Panin F, 2012, J PHARMACOL TOX MET, V65, P83, DOI 10.1016/j.vascn.2012.01.003; Peana AT, 2011, ALCOHOL, V45, P773, DOI 10.1016/j.alcohol.2011.06.003; Peana Alessandra T, 2010, Front Psychiatry, V1, P23, DOI 10.3389/fpsyt.2010.00023; Perra S, 2011, NEUROPSYCHOPHARMACOL, V36, P993, DOI 10.1038/npp.2010.237; Picetti R, 1997, CRIT REV NEUROBIOL, V11, P121, DOI 10.1615/CritRevNeurobiol.v11.i2-3.20; Plescia F, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00064; Quertemont E, 2005, ALCOHOL CLIN EXP RES, V29, P221, DOI 10.1097/01.ALC.0000156185.39073.D2; Quertemont E, 2004, MOL PSYCHIATR, V9, P570, DOI 10.1038/sj.mp.4001497; Quertemont E, 2001, PHARMACOL BIOCHEM BE, V68, P449, DOI 10.1016/S0091-3057(00)00486-X; Reichel Carmela M, 2009, Curr Drug Abuse Rev, V2, P184; Richtand NM, 2001, J ADDICT DIS, V20, P19, DOI 10.1300/J069v20n03_03; Rodd ZA, 2005, NEUROPSYCHOPHARMACOL, V30, P330, DOI 10.1038/sj.npp.1300561; Rodd-Henricks ZA, 2002, PHARMACOL BIOCHEM BE, V72, P55, DOI 10.1016/S0091-3057(01)00733-X; ROSSETTI ZL, 1992, ALCOHOL CLIN EXP RES, V16, P529, DOI 10.1111/j.1530-0277.1992.tb01411.x; Salamone JD, 1997, NEUROSCI BIOBEHAV R, V21, P341, DOI 10.1016/S0149-7634(96)00017-6; Samson HH, 1998, ALCOHOL CLIN EXP RES, V22, P1783, DOI 10.1097/00000374-199811000-00023; Sanchis-Segura C, 2006, ADDICT BIOL, V11, P2, DOI 10.1111/j.1369-1600.2006.00012.x; Segovia KN, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00048; SESACK SR, 1994, J NEUROSCI, V14, P88; Shaham Y, 2003, PSYCHOPHARMACOLOGY, V168, P1, DOI 10.1007/s00213-003-1469-z; SMITH B R, 1984, Alcohol, V1, P193, DOI 10.1016/0741-8329(84)90097-1; Soderpalm B, 2013, CURR TOP BEHAV NEURO, V13, P127, DOI 10.1007/7854_2011_170; Spanagel R, 2000, ALCOHOL RES HEALTH, V24, P124; TAKAHASHI T, 1993, HEPATOLOGY, V17, P236, DOI 10.1016/0270-9139(93)90083-Y; Thanos PK, 2008, SYNAPSE, V62, P481, DOI 10.1002/syn.20523; Thielen RJ, 2004, J PHARMACOL EXP THER, V309, P216, DOI 10.1124/jpet.103.059790; Usiello A, 2000, NATURE, V408, P199, DOI 10.1038/35041572; Vengeliene V, 2008, BRIT J PHARMACOL, V154, P299, DOI 10.1038/bjp.2008.30; Vezina P, 2004, NEUROSCI BIOBEHAV R, V27, P827, DOI 10.1016/j.neubiorev.2003.11.001; VIDAILHET MJ, 1990, LANCET, V336, P316, DOI 10.1016/0140-6736(90)91855-5; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 2002, PSYCHIAT RES-NEUROIM, V116, P163, DOI 10.1016/S0925-4927(02)00087-2; Ward RJ, 1997, NEUROPHARMACOLOGY, V36, P225, DOI 10.1016/S0028-3908(97)00007-5; Weiss F, 1996, J NEUROSCI, V16, P3474; WESTCOTT JY, 1980, BIOCHEM PHARMACOL, V29, P411, DOI 10.1016/0006-2952(80)90521-3; Westerlund M, 2007, FEBS J, V274, P1212, DOI 10.1111/j.1742-4658.2007.05665.x; WIDZOWSKI DV, 1993, J PHARMACOL EXP THER, V266, P526; WISE RA, 1987, PSYCHOL REV, V94, P469, DOI 10.1037/0033-295X.94.4.469; ZIMATKIN SM, 1991, J NEUROCHEM, V56, P1, DOI 10.1111/j.1471-4159.1991.tb02555.x	98	26	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99454	10.1371/journal.pone.0099454	http://dx.doi.org/10.1371/journal.pone.0099454			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926837	gold, Green Published			2022-12-27	WOS:000338278100041
J	Brossi, MJDL; Mendes, LW; Germano, MG; Lima, AB; Tsai, SM				de Lima Brossi, Maria Julia; Mendes, Lucas William; Germano, Mariana Gomes; Lima, Amanda Barbosa; Tsai, Siu Mui			Assessment of Bacterial bph Gene in Amazonian Dark Earth and Their Adjacent Soils	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MICROBIAL COMMUNITIES; DIOXYGENASE GENES; HYDROCARBON DEGRADATION; SUSTAINABLE AGRICULTURE; FUNCTIONAL DIVERSITY; TERRA-PRETA; ANTHROSOLS; CLASSIFICATION; IDENTIFICATION	Amazonian Anthrosols are known to harbour distinct and highly diverse microbial communities. As most of the current assessments of these communities are based on taxonomic profiles, the functional gene structure of these communities, such as those responsible for key steps in the carbon cycle, mostly remain elusive. To gain insights into the diversity of catabolic genes involved in the degradation of hydrocarbons in anthropogenic horizons, we analysed the bacterial bph gene community structure, composition and abundance using T-RFLP, 454-pyrosequencing and quantitative PCR essays, respectively. Soil samples were collected in two Brazilian Amazon Dark Earth (ADE) sites and at their corresponding non-anthropogenic adjacent soils (ADJ), under two different land use systems, secondary forest (SF) and manioc cultivation (M). Redundancy analysis of T-RFLP data revealed differences in bph gene structure according to both soil type and land use. Chemical properties of ADE soils, such as high organic carbon and organic matter, as well as effective cation exchange capacity and pH, were significantly correlated with the structure of bph communities. Also, the taxonomic affiliation of bph gene sequences revealed the segregation of community composition according to the soil type. Sequences at ADE sites were mostly affiliated to aromatic hydrocarbon degraders belonging to the genera Streptomyces, Sphingomonas, Rhodococcus, Mycobacterium, Conexibacter and Burkholderia. In both land use sites, shannon's diversity indices based on the bph gene data were higher in ADE than ADJ soils. Collectively, our findings provide evidence that specific properties in ADE soils shape the structure and composition of bph communities. These results provide a basis for further investigations focusing on the bio-exploration of novel enzymes with potential use in the biotechnology/biodegradation industry.	[de Lima Brossi, Maria Julia; Mendes, Lucas William; Lima, Amanda Barbosa; Tsai, Siu Mui] Univ Sao Paulo, Ctr Nucl Energy Agr, Cellular & Mol Biol Lab, Piracicaba, SP, Brazil; [Germano, Mariana Gomes] Embrapa Soybean, Brazilian Agr Res Corp, Londrina, PR, Brazil	Universidade de Sao Paulo; Empresa Brasileira de Pesquisa Agropecuaria (EMBRAPA)	Brossi, MJDL (corresponding author), Univ Sao Paulo, Ctr Nucl Energy Agr, Cellular & Mol Biol Lab, Piracicaba, SP, Brazil.	majubrossi@gmail.com	Fapesp, Biota/F-8655-2017; Tsai, Siu Mui/C-2793-2012; Mendes, Lucas William/E-5719-2011	Fapesp, Biota/0000-0002-9887-8449; Tsai, Siu Mui/0000-0002-3733-6312; Mendes, Lucas William/0000-0003-0980-7006	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico de Amparo a Pesquisa do Estado de Sao Paulo [FAPESP/Biota 2011/50914-3]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico de Amparo a Pesquisa do Estado de Sao Paulo	Funding provided by 'Conselho Nacional de Desenvolvimento Cientifico e Tecnologico de Amparo a Pesquisa do Estado de Sao Paulo' (FAPESP/Biota 2011/50914-3). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMANN RI, 1995, MICROBIOL REV, V59, P143, DOI 10.1128/MMBR.59.1.143-169.1995; Anderson CR, 2011, PEDOBIOLOGIA, V54, P309, DOI 10.1016/j.pedobi.2011.07.005; Arthur E, 2012, GEODERMA, V173, P50, DOI 10.1016/j.geoderma.2012.01.007; Bernhard AE, 2005, FEMS MICROBIOL ECOL, V52, P115, DOI 10.1016/j.femsec.2004.10.016; Bissett A, 2013, ECOL LETT, V16, P128, DOI 10.1111/ele.12109; Buckley DH, 2003, ENVIRON MICROBIOL, V5, P441, DOI 10.1046/j.1462-2920.2003.00404.x; Buckley DH, 2001, MICROB ECOL, V42, P11, DOI 10.1007/s002480000108; Bunemann EK, 2008, BIOL FERT SOILS, V44, P717, DOI 10.1007/s00374-007-0254-2; Butler CS, 1997, ADV MICROB PHYSIOL, V38, P47; Cannavan FS, 2012, ESTRUTURA COMPOSICAI; Claessen MEC, 1997, ANAL QUINICAS AVALIA; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Culman SW, 2008, J MICROBIOL METH, V75, P55, DOI 10.1016/j.mimet.2008.04.011; Cunha TJF, 2009, TERRAS PRETAS INDIO, P264; Demaneche S, 2004, APPL ENVIRON MICROB, V70, P6714, DOI 10.1128/AEM.70.11.6714-6725.2004; Ding GC, 2010, APPL ENVIRON MICROB, V76, P4765, DOI 10.1128/AEM.00047-10; Falcao N., 2009, TERRAS PRETAS INDIO, P189; Fierer N, 2006, P NATL ACAD SCI USA, V103, P626, DOI 10.1073/pnas.0507535103; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fitter AH, 2005, FUNCT ECOL, V19, P369, DOI 10.1111/j.0269-8463.2005.00969.x; Flocco CG, 2009, ENVIRON MICROBIOL, V11, P700, DOI 10.1111/j.1462-2920.2008.01858.x; Germano MG, 2012, PESQUI AGROPECU BRAS, V47, P654, DOI 10.1590/S0100-204X2012000500004; Gibson DT, 2000, CURR OPIN BIOTECH, V11, P236, DOI 10.1016/S0958-1669(00)00090-2; Glaser B, 2001, NATURWISSENSCHAFTEN, V88, P37, DOI 10.1007/s001140000193; Glaser B, 2007, PHILOS T R SOC B, V362, P187, DOI 10.1098/rstb.2006.1978; GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344; Goris J, 2004, INT J SYST EVOL MICR, V54, P1677, DOI 10.1099/ijs.0.63101-0; Gregory AS, 2007, EUR J SOIL SCI, V58, P1221, DOI 10.1111/j.1365-2389.2007.00956.x; Grossman JM, 2010, MICROB ECOL, V60, P192, DOI 10.1007/s00248-010-9689-3; Hayaishi O, 1962, OXYGENASES, P1; Heuer H, 1997, APPL ENVIRON MICROB, V63, P3233, DOI 10.1128/AEM.63.8.3233-3241.1997; Horner-Devine MC, 2004, P ROY SOC B-BIOL SCI, V271, P113, DOI 10.1098/rspb.2003.2549; Iwai S, 2010, ISME J, V4, P279, DOI 10.1038/ismej.2009.104; Jesus ED, 2009, ISME J, V3, P1004, DOI 10.1038/ismej.2009.47; Khan AA, 2001, APPL ENVIRON MICROB, V67, P3577, DOI 10.1128/AEM.67.8.3577-3585.2001; Kim JS, 2007, SOIL BIOL BIOCHEM, V39, P684, DOI 10.1016/j.soilbio.2006.08.010; Krivobok S, 2003, J BACTERIOL, V185, P3828, DOI 10.1128/JB.185.13.3828-3841.2003; Kweon Ohgew, 2008, BMC Biochemistry, V9, P11, DOI 10.1186/1471-2091-9-11; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; Lehmann J, 2003, PLANT SOIL, V249, P343, DOI 10.1023/A:1022833116184; Leigh MB, 2007, ISME J, V1, P134, DOI 10.1038/ismej.2007.26; Leys NMEJ, 2004, APPL ENVIRON MICROB, V70, P1944, DOI 10.1128/AEM.70.4.1944-1955.2004; Liang BQ, 2010, ORG GEOCHEM, V41, P206, DOI 10.1016/j.orggeochem.2009.09.007; Lima AB, 2012, INFLUENCIA COBERTURA; Luz AP, 2004, CAN J MICROBIOL, V50, P323, DOI 10.1139/W04-008; MASON JR, 1992, ANNU REV MICROBIOL, V46, P277, DOI 10.1146/annurev.mi.46.100192.001425; Miller CD, 2004, MICROB ECOL, V48, P230, DOI 10.1007/s00248-003-1044-5; Murphy DV, 2011, SOIL RES, V49, P582, DOI 10.1071/SR11203; Navarrete A. A., 2010, Diversity, V2, P787; Nicol GW, 2006, ENVIRON MICROBIOL, V8, P1382, DOI 10.1111/j.1462-2920.2006.01031.x; Nielsen UN, 2010, J BIOGEOGR, V37, P1317, DOI 10.1111/j.1365-2699.2010.02281.x; O'Neill B, 2009, MICROB ECOL, V58, P23, DOI 10.1007/s00248-009-9515-y; Ricklefs RE., 1999, ECOLOGY; Rodrigues JLM, 2013, P NATL ACAD SCI USA, V110, P988, DOI 10.1073/pnas.1220608110; Schjonning P, 2004, MANAGING SOIL QUALITY: CHALLENGES IN MODERN AGRICULTURE, P1, DOI 10.1079/9780851996714.0001; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Taketani RG, 2013, ANTON LEEUW INT J G, V104, P233, DOI 10.1007/s10482-013-9942-0; Taketani RG, 2010, MICROB ECOL, V59, P734, DOI 10.1007/s00248-010-9638-1; Tancsics A, 2010, SYST APPL MICROBIOL, V33, P398, DOI 10.1016/j.syapm.2010.08.005; Teixeira WG, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P271, DOI 10.1007/1-4020-2597-1_15; Thies J, 2004, AMAZONIAN DARK EARTHS: ORIGIN, PROPERTIES, MANAGEMENT, P287, DOI 10.1007/1-4020-2597-1_16; Vogel TM, 2009, NAT REV MICROBIOL, V7, P252, DOI 10.1038/nrmicro2119; Wackett LP, 2004, J BIOL CHEM, V279, P41259, DOI 10.1074/jbc.R400014200; Wawrik B, 2005, APPL ENVIRON MICROB, V71, P6776, DOI 10.1128/AEM.71.11.6776-6783.2005; Wessen E, 2010, SOIL BIOL BIOCHEM, V42, P1759, DOI 10.1016/j.soilbio.2010.06.013; Zhou HW, 2006, FEMS MICROBIOL LETT, V262, P148, DOI 10.1111/j.1574-6968.2006.00379.x; Zhou JZ, 2002, APPL ENVIRON MICROB, V68, P326, DOI 10.1128/AEM.68.1.326-334.2002	67	19	21	2	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99597	10.1371/journal.pone.0099597	http://dx.doi.org/10.1371/journal.pone.0099597			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927167	Green Submitted, Green Published, gold			2022-12-27	WOS:000338278100052
J	Matos, DA; Cole, BJ; Whitney, IP; MacKinnon, KJM; Kay, SA; Hazen, SP				Matos, Dominick A.; Cole, Benjamin J.; Whitney, Ian P.; MacKinnon, Kirk J. -M.; Kay, Steve A.; Hazen, Samuel P.			Daily Changes in Temperature, Not the Circadian Clock, Regulate Growth Rate in Brachypodium distachyon	PLOS ONE			English	Article							LEAF GROWTH; ARABIDOPSIS-THALIANA; DIURNAL-VARIATION; STEM ELONGATION; NATURAL VARIATION; WATER DEFICIT; TOMATO PLANTS; ROOT-GROWTH; MAIZE; LEAVES	Plant growth is commonly regulated by external cues such as light, temperature, water availability, and internal cues generated by the circadian clock. Changes in the rate of growth within the course of a day have been observed in the leaves, stems, and roots of numerous species. However, the relative impact of the circadian clock on the growth of grasses has not been thoroughly characterized. We examined the influence of diurnal temperature and light changes, and that of the circadian clock on leaf length growth patterns in Brachypodium distachyon using high-resolution time-lapse imaging. Pronounced changes in growth rate were observed under combined photocyles and thermocycles or with thermocycles alone. A considerably more rapid growth rate was observed at 28 degrees C than 12 degrees C, irrespective of the presence or absence of light. In spite of clear circadian clock regulated gene expression, plants exhibited no change in growth rate under conditions of constant light and temperature, and little or no effect under photocycles alone. Therefore, temperature appears to be the primary cue influencing observed oscillations in growth rate and not the circadian clock or photoreceptor activity. Furthermore, the size of the leaf meristem and final cell length did not change in response to changes in temperature. Therefore, the nearly five-fold difference in growth rate observed across thermocycles can be attributed to proportionate changes in the rate of cell division and expansion. A better understanding of the growth cues in B. distachyon will further our ability to model metabolism and biomass accumulation in grasses.	[Matos, Dominick A.; Whitney, Ian P.; MacKinnon, Kirk J. -M.; Hazen, Samuel P.] Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA; [Matos, Dominick A.; Whitney, Ian P.] Univ Massachusetts, Mol & Cellular Biol Grad Program, Amherst, MA 01003 USA; [Cole, Benjamin J.; Kay, Steve A.] Univ So Calif, Mol & Computat Biol Sect, Los Angeles, CA USA	University of Massachusetts System; University of Massachusetts Amherst; University of Massachusetts System; University of Massachusetts Amherst; University of Southern California	Hazen, SP (corresponding author), Univ Massachusetts, Dept Biol, Amherst, MA 01003 USA.	hazen@bio.umass.edu	Kay, Steve A/F-6025-2011	Kay, Steve A/0000-0002-0402-2878; Cole, Benjamin/0000-0001-9652-624X; Hazen, Samuel/0000-0001-9131-8994; MacKinnon, Kirk/0000-0001-9698-3985	Office of Science, Biological and Environmental Research, Department of Energy [DE-FG02-08ER64700DE, DE-SC0006621]	Office of Science, Biological and Environmental Research, Department of Energy(United States Department of Energy (DOE))	This work was supported by Office of Science, Biological and Environmental Research, Department of Energy [DE-FG02-08ER64700DE and DE-SC0006621 to S.P.H. and S.A.K.]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; ACEVEDO E, 1979, PLANT PHYSIOL, V64, P476, DOI 10.1104/pp.64.3.476; Ainsworth EA, 2005, J PLANT RES, V118, P343, DOI 10.1007/s10265-005-0227-1; BENHAJSALAH H, 1995, PLANT PHYSIOL, V109, P861, DOI 10.1104/pp.109.3.861; BERTRAM L, 1994, SCI HORTIC-AMSTERDAM, V58, P139, DOI 10.1016/0304-4238(94)90134-1; Bertram L, 1997, PHOTOCHEM PHOTOBIOL, V66, P396, DOI 10.1111/j.1751-1097.1997.tb03164.x; Brkljacic J, 2011, PLANT PHYSIOL, V157, P3, DOI 10.1104/pp.111.179531; BUSSO CA, 1992, PLANT CELL ENVIRON, V15, P855, DOI 10.1111/j.1365-3040.1992.tb02154.x; Campoli C, 2013, NEW PHYTOL, V199, P1045, DOI 10.1111/nph.12346; Campoli C, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-97; Cole B, 2011, PLANT J, V65, P991, DOI 10.1111/j.1365-313X.2010.04476.x; CUTLER JM, 1980, PLANT PHYSIOL, V66, P147, DOI 10.1104/pp.66.1.147; DAVIES WJ, 1983, J EXP BOT, V34, P987, DOI 10.1093/jxb/34.8.987; Devlin PF, 2001, ANNU REV PHYSIOL, V63, P677, DOI 10.1146/annurev.physiol.63.1.677; Dhugga KS, 2007, CROP SCI, V47, P2211, DOI 10.2135/cropsci2007.05.0299; Dohleman FG, 2009, PLANT PHYSIOL, V150, P2104, DOI 10.1104/pp.109.139162; Dowson-Day MJ, 1999, PLANT J, V17, P63, DOI 10.1046/j.1365-313X.1999.00353.x; DURAND JL, 1995, J EXP BOT, V46, P1147, DOI 10.1093/jxb/46.9.1147; Farre EM, 2012, PLANT BIOLOGY, V14, P401, DOI 10.1111/j.1438-8677.2011.00548.x; Faure S, 2012, P NATL ACAD SCI USA, V109, P8328, DOI 10.1073/pnas.1120496109; GALLAGHER JN, 1978, J AGR SCI-CAMBRIDGE, V91, P47, DOI 10.1017/S0021859600056616; Granier C, 2006, NEW PHYTOL, V169, P623, DOI 10.1111/j.1469-8137.2005.01609.x; Harmer SL, 2009, ANNU REV PLANT BIOL, V60, P357, DOI 10.1146/annurev.arplant.043008.092054; Hong SY, 2010, PLANT MOL BIOL, V72, P485, DOI 10.1007/s11103-009-9586-7; Hong SY, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-112; Iijima M, 2011, J PLANT PHYSIOL, V168, P2072, DOI 10.1016/j.jplph.2011.06.005; Imaizumi T, 2010, CURR OPIN PLANT BIOL, V13, P83, DOI 10.1016/j.pbi.2009.09.007; Izawa T, 2011, PLANT CELL, V23, P1741, DOI 10.1105/tpc.111.083238; Jansen M, 2009, FUNCT PLANT BIOL, V36, P902, DOI 10.1071/FP09095; JOHNSON WC, 1967, AGRON J, V59, P41, DOI 10.2134/agronj1967.00021962005900010012x; KEMP DR, 1980, J EXP BOT, V31, P821, DOI 10.1093/jxb/31.3.821; LANCASHIRE PD, 1991, ANN APPL BIOL, V119, P561, DOI 10.1111/j.1744-7348.1991.tb04895.x; Matsubara K, 2012, PLANT CELL PHYSIOL, V53, P709, DOI 10.1093/pcp/pcs028; MCDONALD AJS, 1992, TREE PHYSIOL, V11, P123, DOI 10.1093/treephys/11.2.123; MEIJER G, 1968, ACTA BOT NEERL, V17, P9, DOI 10.1111/j.1438-8677.1968.tb00060.x; Michael TP, 2008, PLOS BIOL, V6, P1887, DOI 10.1371/journal.pbio.0060225; Miller ND, 2007, PLANT J, V52, P374, DOI 10.1111/j.1365-313X.2007.03237.x; Murakami M, 2003, PLANT CELL PHYSIOL, V44, P1229, DOI 10.1093/pcp/pcg135; Murphy RL, 2011, P NATL ACAD SCI USA, V108, P16469, DOI 10.1073/pnas.1106212108; Nelissen H, 2012, CURR BIOL, V22, P1183, DOI 10.1016/j.cub.2012.04.065; Nozue K, 2007, NATURE, V448, P358, DOI 10.1038/nature05946; Nusinow DA, 2011, NATURE, V475, P398, DOI 10.1038/nature10182; Parent B, 2010, J EXP BOT, V61, P2057, DOI 10.1093/jxb/erq003; Poire R, 2010, J EXP BOT, V61, P1751, DOI 10.1093/jxb/erq049; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; Rymen B, 2007, PLANT PHYSIOL, V143, P1429, DOI 10.1104/pp.106.093948; Sadok W, 2007, PLANT CELL ENVIRON, V30, P135, DOI 10.1111/j.1365-3040.2006.01611.x; Schmer MR, 2008, P NATL ACAD SCI USA, V105, P464, DOI 10.1073/pnas.0704767105; Schmundt D, 1998, PLANT J, V16, P505, DOI 10.1046/j.1365-313x.1998.00314.x; SHACKEL KA, 1987, PLANT PHYSIOL, V84, P1166, DOI 10.1104/pp.84.4.1166; Song YH, 2010, CURR OPIN PLANT BIOL, V13, P594, DOI 10.1016/j.pbi.2010.05.004; TAYLOR G, 1986, NEW PHYTOL, V104, P347, DOI 10.1111/j.1469-8137.1986.tb02902.x; Tilman D, 2006, SCIENCE, V314, P1598, DOI 10.1126/science.1133306; Trabucco GM, 2013, BMC BIOTECHNOL, V13, DOI 10.1186/1472-6750-13-61; Turner A, 2005, SCIENCE, V310, P1031, DOI 10.1126/science.1117619; TUTTY JR, 1994, J AM SOC HORTIC SCI, V119, P138, DOI 10.21273/JASHS.119.2.138; Vogel JP, 2010, NATURE, V463, P763, DOI 10.1038/nature08747; Walter A, 2005, GLOBAL CHANGE BIOL, V11, P1207, DOI 10.1111/j.1365-2486.2005.00990.x; Walter A, 2005, ANN BOT-LONDON, V95, P891, DOI 10.1093/aob/mci103; Walter A, 2012, ANN BOT; Walter A, 2009, ANNU REV PLANT BIOL, V60, P279, DOI 10.1146/annurev.arplant.59.032607.092819; WATTS WR, 1971, NATURE, V229, P46, DOI 10.1038/229046a0; Wiese A, 2007, NEW PHYTOL, V174, P752, DOI 10.1111/j.1469-8137.2007.02053.x; Yang Y, 2013, MOL PLANT, V6, P202, DOI 10.1093/mp/sss062; Zakhrabekova S, 2012, P NATL ACAD SCI USA, V109, P4326, DOI 10.1073/pnas.1113009109; Zhao XY, 2005, PLANT MOL BIOL, V58, P53, DOI 10.1007/s11103-005-4162-2	66	26	26	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100072	10.1371/journal.pone.0100072	http://dx.doi.org/10.1371/journal.pone.0100072			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927130	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100116
J	Chen, ZY; Li, YQ; Liu, R; Gao, D; Chen, QH; Hu, ZA; Guo, JJ				Chen, Zongyong; Li, Yuqian; Liu, Rong; Gao, Dong; Chen, Quanhui; Hu, Zhian; Guo, Jiajun			Effects of Interface Pressure Distribution on Human Sleep Quality	PLOS ONE			English	Article							BACK-PAIN; MEMORY; RESTRICTION; DEPRIVATION; INFORMATION; PERFORMANCE; MATTRESS	High sleep quality promotes efficient performance in the following day. Sleep quality is influenced by environmental factors, such as temperature, light, sound and smell. Here, we investigated whether differences in the interface pressure distribution on healthy individuals during sleep influenced sleep quality. We defined four types of pressure models by differences in the area distribution and the subjective feelings that occurred when participants slept on the mattresses. One type of model was showed "over-concentrated'' distribution of pressure; one was displayed "over-evenly'' distributed interface pressure while the other two models were displayed intermediate distribution of pressure. A polysomnography analysis demonstrated an increase in duration and proportion of non-rapid-eye-movement sleep stages 3 and 4, as well as decreased number of micro-arousals, in subjects sleeping on models with pressure intermediately distributed compared to models with over-concentrated or over-even distribution of pressure. Similarly, higher scores of self-reported sleep quality were obtained in subjects sleeping on the two models with intermediate pressure distribution. Thus, pressure distribution, at least to some degree, influences sleep quality and self-reported feelings of sleep-related events, though the underlying mechanisms remain unknown. The regulation of pressure models imposed by external sleep environment may be a new direction for improving sleep quality. Only an appropriate interface pressure distribution is beneficial for improving sleep quality, over-concentrated or -even distribution of pressure do not help for good sleep.	[Chen, Zongyong; Li, Yuqian; Liu, Rong; Guo, Jiajun] DaZiRan Sci & Technol Ltd, Sleep Res Ctr, Guiyang, Guizhou, Peoples R China; [Chen, Quanhui; Hu, Zhian; Guo, Jiajun] Third Mil Med Univ, Dept Physiol, Chongqing, Peoples R China; [Gao, Dong] Third Mil Med Univ, Inst Surg Res, Daping Hosp, Dept Sleep & Psychol, Chongqing, Peoples R China	Army Medical University; Army Medical University	Hu, ZA (corresponding author), Third Mil Med Univ, Dept Physiol, Chongqing, Peoples R China.	zhianhu@aliyun.com; junjiaguo@yeah.net			Natural Science Foundation of China [81071074]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Natural Science Foundation of China (Grant number: 81071074). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arzi A, 2012, NAT NEUROSCI, V15, P1460, DOI 10.1038/nn.3193; Bader GG, 2000, APPL ERGON, V31, P487, DOI 10.1016/S0003-6870(00)00013-2; Bannerman DM, 2001, EXP BRAIN RES, V141, P281; Bonnet MH, 2003, SLEEP MED REV, V7, P297, DOI 10.1053/smrv.2001.0245; Buckle P, 1998, APPL ERGON, V29, P35, DOI 10.1016/S0003-6870(97)00023-9; Curcio G, 2006, SLEEP MED REV, V10, P323, DOI 10.1016/j.smrv.2005.11.001; Defloor T, 2000, APPL NURS RES, V13, P2, DOI 10.1016/S0897-1897(00)80013-0; DeVocht JW, 2006, APPL ERGON, V37, P297, DOI 10.1016/j.apergo.2005.07.002; Diekelmann S, 2010, NAT REV NEUROSCI, V11, P114, DOI 10.1038/nrn2762; Drummond SPA, 2013, SLEEP, V36, P1307, DOI 10.5665/sleep.2952; Faraut B, 2012, SLEEP MED REV, V16, P137, DOI 10.1016/j.smrv.2011.05.001; Goetz Lance L, 2002, J Spinal Cord Med, V25, P167; Hubbard J, 2013, SLEEP MED REV; Jacobson BH, 2008, APPL ERGON, V39, P247, DOI 10.1016/j.apergo.2007.04.002; Jacobson BH, 2010, APPL ERGON, V42, P91, DOI 10.1016/j.apergo.2010.05.004; Jacobson BH, 2006, J CHIROPR MED, V5, P128, DOI 10.1016/S0899-3467(07)60145-1; Killgore WDS, 2010, PROG BRAIN RES, V185, P105, DOI 10.1016/B978-0-444-53702-7.00007-5; Lee H, 2006, INT J IND ERGONOM, V36, P943, DOI 10.1016/j.ergon.2006.07.007; Levy Patrick, 2012, Front Biosci (Elite Ed), V4, P2007; Li Y, 2011, HIPPOCAMPUS, V21, P265, DOI 10.1002/hipo.20745; Moody Parivash, 2004, Dermatol Nurs, V16, P507; Ngo HVV, 2013, NEURON, V78, P545, DOI 10.1016/j.neuron.2013.03.006; Plihal W, 1997, J COGNITIVE NEUROSCI, V9, P534, DOI 10.1162/jocn.1997.9.4.534; Rasch B, 2007, SCIENCE, V315, P1426, DOI 10.1126/science.1138581; SALETU B, 1981, NEUROPSYCHOBIOLOGY, V7, P302, DOI 10.1159/000117865; Shelton F, 1998, APPL ERGON, V29, P491, DOI 10.1016/S0003-6870(97)00069-0; Siwek ME, 2014, SLEEP, V37, P881, DOI 10.5665/sleep.3652; St-Onge MP, 2013, J CLIN SLEEP MED, V9, P73, DOI 10.5664/jcsm.2348; Steffenach HA, 2005, NEURON, V45, P301, DOI 10.1016/j.neuron.2004.12.044; Tamminen J, 2013, J NEUROSCI, V33, P15376, DOI 10.1523/JNEUROSCI.5093-12.2013; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Tsai LL, 2008, APPL ERGON, V39, P261, DOI 10.1016/j.apergo.2007.03.003; Valham F, 2012, SLEEP, V35, P513, DOI 10.5665/sleep.1736; Watson CJ, 2012, SLEEP MED CLIN, V7, P469, DOI 10.1016/j.jsmc.2012.06.010; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Yan J, 2011, BRAIN RES, V1401, P52, DOI 10.1016/j.brainres.2011.05.032; Yang SR, 2012, SLEEP, V35, P849, DOI 10.5665/sleep.1888	37	8	9	4	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99969	10.1371/journal.pone.0099969	http://dx.doi.org/10.1371/journal.pone.0099969			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24924427	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300112
J	Mesti, T; Savarin, P; Triba, MN; Le Moyec, L; Ocvirk, J; Banissi, C; Carpentier, AF				Mesti, Tanja; Savarin, Philippe; Triba, Mohamed N.; Le Moyec, Laurence; Ocvirk, Janja; Banissi, Claire; Carpentier, Antoine F.			Metabolic Impact of Anti-Angiogenic Agents on U87 Glioma Cells	PLOS ONE			English	Article							MAGNETIC-RESONANCE-SPECTROSCOPY; GROWTH-FACTOR VEGF; IN-VIVO; H-1-NMR SPECTROSCOPY; MELANOMA-CELLS; GLIOBLASTOMA; THERAPY; BEVACIZUMAB; AUTOCRINE; INVASION	Background: Glioma cells not only secrete high levels of vascular endothelial growth factor (VEGF) but also express VEGF receptors (VEGFR), supporting the existence of an autocrine loop. The direct impact on glioma cells metabolism of drugs targeting the VEGF pathway, such as Bevacizumab (Bev) or VEGFR Tyrosine Kinase Inhibitor (TKI), is poorly known. Material and Methods: U87 cells were treated with Bev or SU1498, a selective VEGFR2 TKI. VEGFR expression was checked with FACS flow cytometry and Quantitative Real-Time PCR. VEGF secretion into the medium was assessed with an ELISA kit. Metabolomic studies on cells were performed using High Resolution Magic Angle Spinning Spectroscopy (HR-MAS). Results: U87 cells secreted VEGF and expressed low level of VEGFR2, but no detectable VEGFR1. Exposure to SU1498, but not Bev, significantly impacted cell proliferation and apoptosis. Metabolomic studies with HR MAS showed that Bev had no significant effect on cell metabolism, while SU1498 induced a marked increase in lipids and a decrease in glycerophosphocholine. Accordingly, accumulation of lipid droplets was seen in the cytoplasm of SU1498-treated U87 cells. Conclusion: Although both drugs target the VEGF pathway, only SU1498 showed a clear impact on cell proliferation, cell morphology and metabolism. Bevacizumab is thus less likely to modify glioma cells phenotype due to a direct therapeutic pressure on the VEGF autocrine loop. In patients treated with VEGFR TKI, monitoring lipids with magnetic resonance spectroscopic (MRS) might be a valuable marker to assess drug cytotoxicity.	[Mesti, Tanja; Banissi, Claire] Univ Paris 05, Hop Europeen Georges Pompidou, Lab Rech Biochirurg, Paris, France; [Savarin, Philippe; Triba, Mohamed N.] Univ Paris 13, CNRS, UMR 7244, Bobigny, France; [Le Moyec, Laurence] Univ Evry, INSERM, U902, Unite Biol Integrat Adaptat Exercice, Evry, France; [Ocvirk, Janja] Inst Oncol Ljubljana, Div Med Oncol, Ljubljana, Slovenia; [Carpentier, Antoine F.] Univ Paris 13, Unite Format & Rech Sante Med & Biol Humaine, Bobigny, France; [Carpentier, Antoine F.] Hop Avicenne, AP HP, F-93009 Bobigny, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Universite Paris 13; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institute of Oncology - Slovenia; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Avicenne - APHP; Universite Paris 13	Carpentier, AF (corresponding author), Univ Paris 13, Unite Format & Rech Sante Med & Biol Humaine, Bobigny, France.	antoine.carpentier@avc.aphp.fr		Carpentier, Antoine/0000-0003-2926-0060	European Association for Neuro Oncology (EANO) fellowship; Association Oligocyte; EANO; Association pour le Developpement des Neurosciences a Avicenne (ADNA)	European Association for Neuro Oncology (EANO) fellowship; Association Oligocyte; EANO; Association pour le Developpement des Neurosciences a Avicenne (ADNA)	TM was the recipient of the 2012 European Association for Neuro Oncology (EANO) fellowship. The study was supported by the Association Oligocyte (assoligocyte.wordpress.com), the EANO (wwww.eano.eu), and the Association pour le Developpement des Neurosciences a Avicenne (ADNA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adamcic U, 2012, NEOPLASIA, V14, P612, DOI 10.1593/neo.11948; Batchelor TT, 2013, J CLIN ONCOL, V31, P3212, DOI 10.1200/JCO.2012.47.2464; Batchelor TT, 2010, J CLIN ONCOL, V28, P2817, DOI 10.1200/JCO.2009.26.3988; Beckonert O, 2007, NAT PROTOC, V2, P2692, DOI 10.1038/nprot.2007.376; Chahal M, 2010, NEURO-ONCOLOGY, V12, P822, DOI 10.1093/neuonc/noq017; Chamberlain MC, 2011, J NEURO-ONCOL, V101, P319, DOI 10.1007/s11060-010-0251-4; Cloughesy T, 2010, LANCET ONCOL, V11, P1120, DOI 10.1016/S1470-2045(10)70269-2; Cuperlovic-Culf M, 2010, DRUG DISCOV TODAY, V15, P610, DOI 10.1016/j.drudis.2010.06.012; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Delikatny EJ, 2002, CANCER RES, V62, P1394; Francescone R, 2012, J BIOL CHEM, V287, P24821, DOI 10.1074/jbc.M111.334540; Friedman HS, 2009, J CLIN ONCOL, V27, P4733, DOI 10.1200/JCO.2008.19.8721; Grau S, 2011, J NEURO-ONCOL, V104, P103, DOI 10.1007/s11060-010-0480-6; Griffin JL, 2006, ANAL CHEM, V78, P1546, DOI 10.1021/ac051418o; Griffin JL, 2003, CANCER RES, V63, P3195; Hamerlik P, 2012, J EXP MED, V209, P507, DOI 10.1084/jem.20111424; Henriksson R, 2013, J CLIN ONCOL S; Huang HG, 2005, NEUROL RES, V27, P371, DOI 10.1179/016164105X39833; Jeon JY, 2012, AM J NEURORADIOL, V33, P2095, DOI 10.3174/ajnr.A3091; Kaur B, 2005, NEURO-ONCOLOGY, V7, P134, DOI 10.1215/S1152851704001115; Keunen O, 2011, P NATL ACAD SCI USA, V108, P3749, DOI 10.1073/pnas.1014480108; Kim H, 2011, CANCER RES, V71, P3745, DOI 10.1158/0008-5472.CAN-10-2991; Knizetova P, 2008, CELL CYCLE, V7, P2553, DOI 10.4161/cc.7.16.6442; Kronthaler J, 2012, OMICS, V16, P90, DOI 10.1089/omi.2011.0048; Kunkel P, 2001, CANCER RES, V61, P6624; Law M, 2003, AM J NEURORADIOL, V24, P1989; Lehtimaki KK, 2003, J BIOL CHEM, V278, P45915, DOI 10.1074/jbc.M306209200; Lucio-Eterovic AK, 2009, CLIN CANCER RES, V15, P4589, DOI 10.1158/1078-0432.CCR-09-0575; Martinho O, 2013, TRANSL ONCOL, V6, P187, DOI 10.1593/tlo.12400; Mentlein R, 2004, J NEURO-ONCOL, V67, P9, DOI 10.1023/B:NEON.0000021737.89357.cc; Mirbahai L, 2012, NMR BIOMED, V25, P1253, DOI 10.1002/nbm.2796; Morvan D, 2003, MAGN RESON MED, V49, P241, DOI 10.1002/mrm.10368; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Paez-Ribes M, 2009, CANCER CELL, V15, P220, DOI 10.1016/j.ccr.2009.01.027; Pan XY, 2013, METABOLOMICS, V9, P722, DOI 10.1007/s11306-012-0483-8; Ratai EM, 2013, NEURO-ONCOLOGY, V15, P936, DOI 10.1093/neuonc/not044; Reardon DA, 2011, J NATL COMPR CANC NE, V9, P414, DOI 10.6004/jnccn.2011.0038; Robinson CJ, 2001, J CELL SCI, V114, P853; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Triba MN, 2010, NMR BIOMED, V23, P1009, DOI 10.1002/nbm.1516; Trygg J, 2002, J CHEMOMETR, V16, P119, DOI 10.1002/cem.695; Vink H, 2000, AM J PHYSIOL-HEART C, V278, pH285, DOI 10.1152/ajpheart.2000.278.1.H285; von Baumgarten L, 2011, CLIN CANCER RES, V17, P6192, DOI 10.1158/1078-0432.CCR-10-1868; Wen PY, 2010, J CLIN ONCOL, V28, P1963, DOI 10.1200/JCO.2009.26.3541; Wick A, 2011, ANN NEUROL, V69, P586, DOI 10.1002/ana.22336; Xu CS, 2013, SCI WORLD J, DOI 10.1155/2013/417413	47	29	29	2	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99198	10.1371/journal.pone.0099198	http://dx.doi.org/10.1371/journal.pone.0099198			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922514	Green Published, gold			2022-12-27	WOS:000338701300044
J	Neogi, U; Haggblom, A; Santacatterina, M; Bratt, G; Gisslen, M; Albert, J; Sonnerborg, A				Neogi, Ujjwal; Haggblom, Amanda; Santacatterina, Michele; Bratt, Goran; Gisslen, Magnus; Albert, Jan; Sonnerborg, Anders			Temporal Trends in the Swedish HIV-1 Epidemic: Increase in Non-B Subtypes and Recombinant Forms over Three Decades	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; INFECTION; EUROPE; TYPE-1; TRANSMISSION; DYNAMICS; BRAZIL	Background: HIV-1 subtype B (HIV-1B) still dominates in resource-rich countries but increased migration contributes to changes in the global subtype distribution. Also, spread of non-B subtypes within such countries occurs. The trend of the subtype distribution from the beginning of the epidemic in the country has earlier not been reported in detail. Thus the primary objective of this study is to describe the temporal trend of the subtype distribution from the beginning of the HIV-1 epidemic in Sweden over three decades. Methods: HIV-1 pol sequences from patients (n = 3967) diagnosed in Sweden 1983-2012, corresponding to >40% of patients ever diagnosed, were re-subtyped using several automated bioinformatics tools. The temporal trends of subtypes and recombinants during three decades were described by a multinomial logistic regression model. Results: All eleven group M HIV-1 subtypes and sub-subtypes (78%), 17 circulating recombinant forms (CRFs) (19%) and 32 unique recombinants forms (URF) (3%) were identified. When all patients were analysed, there was an increase of newly diagnosed HIV-1C (RR, 95% CI: 1.10, 1.06-1.14), recombinants (1.20, 1.17-1.24) and other pure subtypes (1.11, 1.07-1.16) over time compared to HIV-1B. The same pattern was found when all patients infected in Sweden (n = 1165) were analysed. Also, for MSM patients infected in Sweden (n = 921), recombinant forms and other pure subtypes increased. Significance: Sweden exhibits one of the most diverse subtype epidemics outside Africa. The increase of non-B subtypes is due to migration and to a spread among heterosexually infected patients and MSM within the country. This viral heterogeneity may become a hotspot for development of more diverse and complex recombinant forms if the epidemics converge.	[Neogi, Ujjwal; Sonnerborg, Anders] Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden; [Haggblom, Amanda; Sonnerborg, Anders] Karolinska Inst, Dept Med Huddinge, Infect Dis Unit, Stockholm, Sweden; [Haggblom, Amanda] Cty Council Gavleborg, Dept Infect Dis, Gavle, Sweden; [Santacatterina, Michele] Karolinska Inst, Inst Environm Med, Unit Biostat, S-10401 Stockholm, Sweden; [Bratt, Goran] Stockholm South Gen Hosp, Dept Clin Sci & Educ, Venhalsan, Stockholm, Sweden; [Gisslen, Magnus] Univ Gothenburg, Dept Infect Dis, Gothenburg, Sweden; [Albert, Jan] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; University of Gothenburg; Karolinska Institutet	Neogi, U (corresponding author), Karolinska Inst, Dept Lab Med, Div Clin Microbiol, Stockholm, Sweden.	ujjwal.neogi@ki.se	Neogi, Ujjwal/E-4274-2012; Santacatterina, Michele/AAL-5050-2020; Sönnerborg, Anders/W-2011-2019; Neogi, Ujjwal/ABF-1172-2021; Gisslen, Magnus/D-7454-2015	Santacatterina, Michele/0000-0003-0599-3876; Sönnerborg, Anders/0000-0001-8928-3374; Neogi, Ujjwal/0000-0002-0844-3338; Gisslen, Magnus/0000-0002-2357-1020	Swedish International Developing Agency; CHAIN FP7 EU; Swedish Civil Contingencies Agency [SWE-2009-151]; Swedish Research Council [521-2012-3476, 2007-7092]	Swedish International Developing Agency; CHAIN FP7 EU; Swedish Civil Contingencies Agency; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Funding provided by Swedish International Developing Agency, CHAIN FP7 EU, the Swedish Civil Contingencies Agency [SWE-2009-151], and the Swedish Research Council [521-2012-3476 and 2007-7092]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis AB, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-7; Alcantara KC, 2013, J MED VIROL, V85, P396, DOI 10.1002/jmv.23474; Almeida SEM, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-306; [Anonymous], INFECT GENET EVOL; Bontell I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059337; Cohen MS, 2016, NEW ENGL J MED, V375, P830, DOI [10.1056/NEJMoa1600693, 10.1056/NEJMoa1105243]; Delatorre EO, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041904; Foster GM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083337; Fox J, 2010, AIDS, V24, P2397, DOI 10.1097/QAD.0b013e32833cbb5b; Frange P, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-69; Frentz D, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-36; Helleberg M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072257; Hemelaar J, 2011, AIDS, V25, P679, DOI 10.1097/QAD.0b013e328342ff93; Karlsson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033484; Kassu A, 2007, AIDS RES HUM RETROV, V23, P564, DOI 10.1089/aid.2006.0270; Lee K, 2013, J BIOPHARM STAT, V23, P681, DOI 10.1080/10543406.2012.756500; Lihana RW, 2012, AIDS REV, V14, P83; Lole KS, 1999, J VIROL, V73, P152, DOI 10.1128/JVI.73.1.152-160.1999; Neogi U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039819; Palma AC, 2007, INFECT GENET EVOL, V7, P391, DOI 10.1016/j.meegid.2007.01.009; Paraskevis D, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-49; Pyne MT, 2013, J CLIN MICROBIOL; Rice BD, 2012, AIDS, V26, P1961, DOI 10.1097/QAD.0b013e3283578b80; Sandstrom E, 2003, SCAND J INFECT DIS, V35, P155, DOI 10.1080/00365540310006395; Sonnerborg A, 1997, AIDS RES HUM RETROV, V13, P343, DOI 10.1089/aid.1997.13.343; Vangroenweghe D, 2001, PHILOS T ROY SOC B, V356, P923, DOI 10.1098/rstb.2001.0876; von Wyl V, 2011, J INFECT DIS, V204, P1095, DOI 10.1093/infdis/jir491; VONKROGH G, 1987, SCAND J INFECT DIS, V19, P285, DOI 10.3109/00365548709018471	28	36	36	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99390	10.1371/journal.pone.0099390	http://dx.doi.org/10.1371/journal.pone.0099390			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922326	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300057
J	Sava, SL; de Pasqua, V; Magis, D; Schoenen, J				Sava, Simona L.; de Pasqua, Victor; Magis, Delphine; Schoenen, Jean			Effects of Visual Cortex Activation on the Nociceptive Blink Reflex in Healthy Subjects	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; SPREADING DEPRESSION; AUTONOMIC RESPONSES; EVOKED POTENTIALS; INDUCED ANALGESIA; PAIN PERCEPTION; MACAQUE MONKEY; MOTOR CORTEX; MIGRAINE; PHOTOPHOBIA	Bright light can cause excessive visual discomfort, referred to as photophobia. The precise mechanisms linking luminance to the trigeminal nociceptive system supposed to mediate this discomfort are not known. To address this issue in healthy human subjects we modulated differentially visual cortex activity by repetitive transcranial magnetic stimulation (rTMS) or flash light stimulation, and studied the effect on supraorbital pain thresholds and the nociceptive-specific blink reflex (nBR). Low frequency rTMS that inhibits the underlying cortex, significantly decreased pain thresholds, increased the 1st nBR block ipsi- and contralaterally and potentiated habituation contralaterally. After high frequency or sham rTMS over the visual cortex, and rMS over the right greater occipital nerve we found no significant change. By contrast, excitatory flash light stimulation increased pain thresholds, decreased the 1st nBR block of ipsi- and contralaterally and increased habituation contralaterally. Our data demonstrate in healthy subjects a functional relation between the visual cortex and the trigeminal nociceptive system, as assessed by the nociceptive blink reflex. The results argue in favour of a top-down inhibitory pathway from the visual areas to trigemino-cervical nociceptors. We postulate that in normal conditions this visuo-trigeminal inhibitory pathway may avoid disturbance of vision by too frequent blinking and that hypoactivity of the visual cortex for pathological reasons may promote headache and photophobia.	[Sava, Simona L.; de Pasqua, Victor; Magis, Delphine; Schoenen, Jean] Univ Liege, Univ Dept Neurol, Headache Res Unit, Liege, Belgium	University of Liege	Schoenen, J (corresponding author), Univ Liege, Univ Dept Neurol, Headache Res Unit, Liege, Belgium.	jschoenen@ulg.ac.be		Magis, Delphine/0000-0002-4392-9413	National Fund for Scientific Research-Belgium [3.4.650.09]	National Fund for Scientific Research-Belgium(Fonds de la Recherche Scientifique - FNRS)	This work was supported by the research convention 3.4.650.09 of the National Fund for Scientific Research-Belgium to JS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS RW, 1988, ELECTROEN CLIN NEURO, V69, P45, DOI 10.1016/0013-4694(88)90034-X; ADAMS RW, 1989, CEPHALALGIA, V9, P107, DOI 10.1046/j.1468-2982.1989.0902107.x; Aramideh M, 2002, MUSCLE NERVE, V26, P14, DOI 10.1002/mus.10120; Bingel U, 2007, NEURON, V55, P157, DOI 10.1016/j.neuron.2007.05.032; Bohotin V, 2002, BRAIN, V125, P912, DOI 10.1093/brain/awf081; Boulloche N, 2010, J NEUROL NEUROSUR PS, V81, P978, DOI 10.1136/jnnp.2009.190223; CHAPMAN B, 1991, J NEUROSCI, V11, P1347; Chauvel V, 2012, EXP NEUROL, V236, P207, DOI 10.1016/j.expneurol.2012.05.002; Chen R, 1997, ELECTROMYOGR MOTOR C, V105, P415, DOI 10.1016/S0924-980X(97)00036-2; Chen R, 1997, NEUROLOGY, V48, P1398, DOI 10.1212/WNL.48.5.1398; Coppola G, 2010, J PAIN, V11, P291, DOI 10.1016/j.jpain.2009.08.012; Coppola G, 2009, NEUROBIOL LEARN MEM, V92, P249, DOI 10.1016/j.nlm.2008.07.006; de Tommaso M, 2011, CLIN NEUROPHYSIOL, V122, P2482, DOI 10.1016/j.clinph.2011.05.006; Di Clemente L, 2007, BRAIN, V130, P765, DOI 10.1093/brain/awl351; Di Clemente L, 2005, HEADACHE, V45, P1388, DOI 10.1111/j.1526-4610.2005.00271.x; Drummond PD, 1997, BRAIN, V120, P1857, DOI 10.1093/brain/120.10.1857; DRUMMOND PD, 1986, HEADACHE, V26, P465, DOI 10.1111/j.1526-4610.1986.hed2609465.x; DRUMMOND PD, 1993, CEPHALALGIA, V13, P321, DOI 10.1046/j.1468-2982.1993.1305321.x; Ellrich J, 1998, BRAIN RES, V803, P161, DOI 10.1016/S0006-8993(98)00646-5; Fumal A, 2003, EXP BRAIN RES, V150, P332, DOI 10.1007/s00221-003-1423-7; Fumal A, 2002, ACTA NEUROL BELG, V102, P171; GUTRECHT JA, 1994, J NEURO-OPHTHALMOL, V14, P122; Haggard P, 2013, CURR BIOL, V23, pR164, DOI 10.1016/j.cub.2013.01.047; Hallett M, 2008, NEUROLOGY, V71, P1275, DOI 10.1212/01.wnl.0000327601.46315.85; HUBEL DH, 1990, J NEUROSCI, V10, P2223, DOI 10.1523/jneurosci.10-07-02223.1990; ITOH K, 1979, J COMP NEUROL, V187, P349, DOI 10.1002/cne.901870206; Judit A, 2000, CEPHALALGIA, V20, P714, DOI 10.1111/j.1468-2982.2000.00122.x; Katnani HA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051843; Katsarava Z, 2002, CLIN NEUROPHYSIOL, V113, P1932, DOI 10.1016/S1388-2457(02)00307-3; Kaube H, 2000, CLIN NEUROPHYSIOL, V111, P413, DOI 10.1016/S1388-2457(99)00295-3; Kawasaki A, 2002, J NEURO-OPHTHALMOL, V22, P3, DOI 10.1097/00041327-200203000-00002; Klein E, 1999, BIOL PSYCHIAT, V46, P1451, DOI 10.1016/S0006-3223(99)00182-1; Koh CW, 2006, CLIN NEUROPHYSIOL, V117, P851, DOI 10.1016/j.clinph.2005.12.004; Kowacs PA, 2001, CEPHALALGIA, V21, P184, DOI 10.1046/j.1468-2982.2001.00178.x; Lambert G, 2008, CEPHALALGIA, V28, P640, DOI 10.1111/j.1468-2982.2008.01572.x; LEBENSOHN JE, 1951, AM J OPHTHALMOL, V34, P1294, DOI 10.1016/0002-9394(51)91866-1; Longo MR, 2012, J NEUROSCI, V32, P2601, DOI 10.1523/JNEUROSCI.4031-11.2012; Longo MR, 2009, J NEUROSCI, V29, P12125, DOI 10.1523/JNEUROSCI.3072-09.2009; Lui F, 1995, J COMP NEUROL, V363, P439, DOI 10.1002/cne.903630308; Maleki N, 2012, HUM BRAIN MAPP, V33, P75, DOI 10.1002/hbm.21194; MOSKOWITZ MA, 1993, J NEUROSCI, V13, P1167, DOI 10.1523/jneurosci.13-03-01167.1993; Moulton EA, 2009, PAIN, V145, P358, DOI 10.1016/j.pain.2009.07.018; Mouraux A, 2010, PAIN, V150, P199, DOI 10.1016/j.pain.2010.04.026; NEWMAN DB, 1989, BRAIN BEHAV EVOLUT, V34, P223, DOI 10.1159/000116508; Noseda R, 2011, J NEUROSCI, V31, P14204, DOI 10.1523/JNEUROSCI.3285-11.2011; Noseda R, 2010, NAT NEUROSCI, V13, P239, DOI 10.1038/nn.2475; Okamoto K, 2009, NEUROSCIENCE, V160, P858, DOI 10.1016/j.neuroscience.2009.03.003; Okamoto K, 2010, PAIN, V149, P235, DOI 10.1016/j.pain.2010.02.004; PASCUALLEONE A, 1994, BRAIN, V117, P847, DOI 10.1093/brain/117.4.847; Sandrini G, 2002, EUR J PHARMACOL, V450, P259, DOI 10.1016/S0014-2999(02)02188-X; Schoenen J, 2011, PAIN, V152, P239, DOI 10.1016/j.pain.2010.12.002; SHOOK BL, 1988, EXP BRAIN RES, V73, P215, DOI 10.1007/BF00279675; Smit AE, 2006, NEUROSCI RES, V56, P363, DOI 10.1016/j.neures.2006.08.005; Vanagaite J, 1997, CEPHALALGIA, V17, P733, DOI 10.1046/j.1468-2982.1997.1707733.x; Warner CE, 2012, J NEUROSCI, V32, P17073, DOI 10.1523/JNEUROSCI.3269-12.2012; Williams AE, 2009, INT J PSYCHOPHYSIOL, V71, P242, DOI 10.1016/j.ijpsycho.2008.10.004; Wu T, 2000, NEUROSCI LETT, V287, P37, DOI 10.1016/S0304-3940(00)01132-0	57	21	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100198	10.1371/journal.pone.0100198	http://dx.doi.org/10.1371/journal.pone.0100198			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936654	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400090
J	Du, Y; Su, T; Zhao, LJ; Tan, XJ; Chang, WJ; Zhang, HW; Cao, GW				Du, Yan; Su, Tong; Zhao, Lijun; Tan, Xiaojie; Chang, Wenjun; Zhang, Hongwei; Cao, Guangwen			Associations of Polymorphisms in DNA Repair Genes and MDR1 Gene with Chemotherapy Response and Survival of Non-Small Cell Lung Cancer	PLOS ONE			English	Article							SINGLE-NUCLEOTIDE POLYMORPHISMS; MESSENGER-RNA EXPRESSION; FUNCTIONAL POLYMORPHISMS; BRCA1; ERCC1; PLATINUM; PATHWAY; RISK; CHEMORESISTANCE; RESISTANCE	Objectives: We aimed to determine the associations of genetic polymorphisms of excision repair cross-complementation group 1 (ERCC1) rs11615, xeroderma pigmentosum group D (XPD/ERCC2) rs13181, X-ray repair cross complementing group 1 (XRCC1) rs25487, XRCC3 rs1799794, and breast cancer susceptibility gene 1 (BRCA1) rs1799966 from the DNA repair pathway and multiple drug resistance 1 (MDR1/ABCB1) rs1045642 with response to chemotherapy and survival of non-small cell lung cancer (NSCLC) in a Chinese population. Materials and Methods: A total of 352 NSCLC patients were enrolled to evaluate the associations of the six SNPs with response to chemotherapy and overall survival. Logistic regressions were applied to test the associations of genetic polymorphisms with response to chemotherapy in 161 advanced NSCLC patients. Overall survival was analyzed in 161 advanced and 156 early stage NSCLC patients using the Kaplan-Meier method with log-rank test, respectively. Multivariate Cox proportional hazards model was performed to determine the factors independently associated with NSCLC prognosis. Results: BRCA1 rs1799966 minor allele C (TC+CC vs. TT, OR = 0.402, 95% CI = 0.204-0.794, p = 0.008) and MDR1/ABCB1 rs1045642 minor allele A (GA + AA vs. GG, OR = 0.478, 95% CI = 0.244-0.934, p = 0.030) were associated with a better response to chemotherapy in advanced NSCLC patients. Survival analyses indicated that BRCA1 rs1799966 TC+CC genotypes were associated with a decreased risk of death (HR = 0.617, 95% CI = 0.402-0.948, p = 0.028) in advanced NSCLC patients, and the association was still significant after the adjustment for covariates. Multivariate Cox regression analysis showed that ERCC1 rs11615 AA genotype (P = 0.020) and smoking (p = 0.037) were associated with increased risks of death in early stage NSCLC patients after surgery. Conclusions: Polymorphisms of genes in DNA repair pathway and MDR1 could contribute to chemotherapy response and survival of patients with NSCLC.	[Du, Yan; Su, Tong; Tan, Xiaojie; Chang, Wenjun; Zhang, Hongwei; Cao, Guangwen] Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China; [Zhao, Lijun] Second Mil Med Univ, Changhai Hosp, Dept Pulm Med, Shanghai, Peoples R China	Naval Medical University; Naval Medical University	Cao, GW (corresponding author), Second Mil Med Univ, Dept Epidemiol, Shanghai, Peoples R China.	gcao@smmu.edu.cn	Du, Yan/AAD-5510-2020; tan, xiao/GZL-0264-2022	Du, Yan/0000-0001-5413-7836; Cao, Guangwen/0000-0002-8094-1278; chang, wenjun/0000-0002-8476-4731	Shanghai Science and Technology Committee [06DZ19503]; National Natural Science Foundation of China [81025015]	Shanghai Science and Technology Committee(Shanghai Science & Technology Committee); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Key Project of Shanghai Science and Technology Committee grant (06DZ19503 to G. Cao) and National Natural Science Foundation of China (81025015 to G. Cao). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albino AP, 2009, MUTAT RES-GEN TOX EN, V678, P43, DOI 10.1016/j.mrgentox.2009.06.009; Campa D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032784; Chang JS, 2008, CANCER EPIDEM BIOMAR, V17, P1368, DOI 10.1158/1055-9965.EPI-07-2830; Cobo M, 2007, J CLIN ONCOL, V25, P2747, DOI 10.1200/JCO.2006.09.7915; Dong J, 2012, MOL CARCINOGEN, V51, P546, DOI 10.1002/mc.20819; Hao BT, 2004, CANCER RES, V64, P4378, DOI 10.1158/0008-5472.CAN-04-0372; He J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049308; Hoffmeyer S, 2000, P NATL ACAD SCI USA, V97, P3473, DOI 10.1073/pnas.050585397; Hubner RA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025164; Isla D, 2004, ANN ONCOL, V15, P1194, DOI 10.1093/annonc/mdh319; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Joerger M, 2011, CANCER; Kim HT, 2008, J CLIN ONCOL, V26, P5972, DOI 10.1200/JCO.2008.16.6496; Kim M, 2010, CANCER SCI, V101, P2436, DOI 10.1111/j.1349-7006.2010.01699.x; Lafarge S, 2001, ONCOGENE, V20, P6597, DOI 10.1038/sj.onc.1204812; Le Chevalier T, 2004, NEW ENGL J MED, V350, P351, DOI 10.1056/nejmoa031644; Lee KM, 2007, GENETICS, V175, P1585, DOI 10.1534/genetics.106.067801; Lord RVN, 2002, CLIN CANCER RES, V8, P2286; Olaussen KA, 2006, NEW ENGL J MED, V355, P983, DOI 10.1056/NEJMoa060570; Park J, 2009, CLIN CANCER RES, V15, P1794, DOI 10.1158/1078-0432.CCR-08-1770; Quinn JE, 2003, CANCER RES, V63, P6221; Rosell R, 2002, LUNG CANCER, V38, P217, DOI 10.1016/S0169-5002(02)00224-6; Rosell R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001129; Sekine I, 2008, BRIT J CANCER, V99, P1757, DOI 10.1038/sj.bjc.6604721; Shiraishi K, 2010, J CLIN ONCOL, V28, P4945, DOI 10.1200/JCO.2010.30.5334; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Takenaka T, 2010, LUNG CANCER, V67, P101, DOI 10.1016/j.lungcan.2009.03.007; Tanaka Y, 2010, CANCER-AM CANCER SOC, V116, P896, DOI 10.1002/cncr.24850; Taron M, 2004, HUM MOL GENET, V13, P2443, DOI 10.1093/hmg/ddh260; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tibaldi C, 2008, CLIN CANCER RES, V14, P1797, DOI 10.1158/1078-0432.CCR-07-1364; Vinolas N, 2011, LUNG CANCER, V71, P191, DOI 10.1016/j.lungcan.2010.05.005; Wei HB, 2011, ARCH MED RES, V42, P412, DOI 10.1016/j.arcmed.2011.07.008; Wei QY, 2000, JNCI-J NATL CANCER I, V92, P440, DOI 10.1093/jnci/92.6.440; Wolfe KJ, 2007, PHARMACOGENET GENOM, V17, P897, DOI 10.1097/FPC.0b013e3280115e63; Wu LL, 2010, CLIN CANCER RES, V16, P3760, DOI 10.1158/1078-0432.CCR-10-0193; Yang YL, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-15; Yarden RI, 2006, MOL CANCER THER, V5, P1396, DOI 10.1158/1535-7163.MCT-05-0471; Yin JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038150; Yoo SS, 2009, J CLIN ONCOL, V27, P5823, DOI 10.1200/JCO.2009.23.1738; Yu JJ, 2000, INT J ONCOL, V16, P555; Zhang XM, 2005, CANCER RES, V65, P722; Zheng B, 2013, ANN ONCOL, V24, P1130, DOI [10.1093/annonc/mdt038, 10.1093/annonc/mdt063]; Zienolddiny S, 2006, CARCINOGENESIS, V27, P560, DOI 10.1093/carcin/bgi232	44	35	36	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99843	10.1371/journal.pone.0099843	http://dx.doi.org/10.1371/journal.pone.0099843			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933103	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600071
J	Gong, JB; Yuan, JJ; Wang, SH; Shi, LJ; Cui, XL; Luo, XR				Gong, Jingbo; Yuan, Jiajin; Wang, Suhong; Shi, Lijuan; Cui, Xilong; Luo, Xuerong			Feedback-Related Negativity in Children with Two Subtypes of Attention Deficit Hyperactivity Disorder	PLOS ONE			English	Article							ALTERED REINFORCEMENT MECHANISMS; DEFICIT/HYPERACTIVITY DISORDER; ELECTROPHYSIOLOGICAL EVIDENCE; ELECTROCORTICAL RESPONSE; AUTOMATIC VIGILANCE; UNPLEASANT PICTURES; SOCIAL INFORMATION; AROUSING PICTURES; VALENCE STRENGTH; GRABBING POWER	Objective: The current model of ADHD suggests abnormal reward and punishment sensitivity, although differences in ADHD subgroups are unclear. This study aimed to investigate the effect of feedback valence (reward or punishment) and punishment magnitude (small or large) on Feedback-Related Negativity (FRN) and Late Positive Potential (LPP) in two subtypes of ADHD (ADHD-C and ADHD-I) compared to typically developing children (TD) during a children's gambling task. Methods: Children with ADHD-C (n = 16), children with ADHD-I (n = 15) and typically developing children (n = 15) performed a children's gambling task under three feedback conditions: large losses, small losses and gains. FRN and LPP components in brain potentials were recorded and analyzed. Results: In TD children and children with ADHD-C, large loss feedback evoked more negative FRN amplitudes than small loss feedback, suggesting that brain sensitivity to the punishment and its magnitude is not impaired in children with ADHD-C. In contrast to these two groups, the FRN effect was absent in children with ADHD-I. The LPP amplitudes were larger in children with ADHD-C in comparison with those with ADHD-I, regardless of feedback valence and magnitude. Conclusion: Children with ADHD-C exhibit intact brain sensitivity to punishment similar to TD children. In contrast, children with ADHD-I are significantly impaired in neural sensitivity to the feedback stimuli and in particular, to punishment, compared to TD and ADHD-C children. Thus, FRN, rather than LPP, is a reliable index of the difference in reward and punishment sensitivity across different ADHD-subcategories.	[Gong, Jingbo; Wang, Suhong; Shi, Lijuan; Cui, Xilong; Luo, Xuerong] Cent S Univ, Mental Hlth Inst, Xiangya Hosp 2, Natl Technol Inst Psychiat,Key Lab Psychiat & Men, Changsha, Hunan, Peoples R China; [Gong, Jingbo] Tradit Chinese Med Univ Hunan, Changsha, Hunan, Peoples R China; [Yuan, Jiajin] Southwest Univ, Sch Psychol, Chongqing, Peoples R China; [Wang, Suhong] Soochow Univ, Affiliated Hosp 3, Dept Neurosci, Changzhou, Peoples R China	Central South University; Hunan University of Chinese Medicine; Southwest University - China; Soochow University - China	Luo, XR (corresponding author), Cent S Univ, Mental Hlth Inst, Xiangya Hosp 2, Natl Technol Inst Psychiat,Key Lab Psychiat & Men, Changsha, Hunan, Peoples R China.	luoxr@vip.sina.com	Cui, Xilong/HHM-6692-2022		Hunan Provincial Natural Science Foundation of China [12JJ5066]; National Natural Science of Foundation of China (NSFC) [81101018, 31371042]; Changzhou Science and Technology Application Project [CJ20112009, CJ20130026]	Hunan Provincial Natural Science Foundation of China(Natural Science Foundation of Hunan Province); National Natural Science of Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Changzhou Science and Technology Application Project	This work was supported by grants from the Hunan Provincial Natural Science Foundation of China (No. 12JJ5066), the National Natural Science of Foundation of China (NSFC, No. 81101018; 31371042), and Changzhou Science and Technology Application Project (Nos. CJ20112009, CJ20130026). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achenbach T., 1991, INTEGRATIVE GUIDE 19; Achenbach TM, 2003, J CLIN CHILD ADOLESC, V32, P328, DOI 10.1207/S15374424JCCP3203_02; Althaus M, 2010, BIOL PSYCHOL, V85, P19, DOI 10.1016/j.biopsycho.2010.04.007; American Psychiatric Association, 2000, DIAGN STAT MAN MENT; AUGUST GJ, 1987, J ABNORM CHILD PSYCH, V15, P429, DOI 10.1007/BF00916459; Barber MA, 1996, J CLIN CHILD PSYCHOL, V25, P66, DOI 10.1207/s15374424jccp2501_8; Barkley RA, 2002, J CLIN PSYCHIAT, V63, P36; BORCHERDING B, 1988, J ABNORM CHILD PSYCH, V16, P333, DOI 10.1007/BF00913804; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Carlson CL, 2002, J LEARN DISABIL-US, V35, P104, DOI 10.1177/002221940203500202; Carlson CL, 2000, COGNITIVE THER RES, V24, P87, DOI 10.1023/A:1005455009154; Carlson CL, 2000, J CONSULT CLIN PSYCH, V68, P73, DOI 10.1037/0022-006X.68.1.73; Centers for Disease Control National Center for Prevention Services (US) Division of Tuberculosis Elimination National Center for HIV, 2001, REP TUB US; Conzelmann A, 2009, BIOL PSYCHIAT, V65, P578, DOI 10.1016/j.biopsych.2008.10.038; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Delplanque S, 2005, BIOL PSYCHOL, V68, P107, DOI 10.1016/j.biopsycho.2004.04.006; Delplanque S, 2004, NEUROSCI LETT, V356, P1, DOI 10.1016/j.neulet.2003.10.014; DOUGLAS VI, 1994, J ABNORM CHILD PSYCH, V22, P281, DOI 10.1007/BF02168075; Edel MA, 2013, J PSYCHIATR RES, V47, P350, DOI 10.1016/j.jpsychires.2012.09.026; Foti D, 2008, J COGNITIVE NEUROSCI, V20, P977, DOI 10.1162/jocn.2008.20066; Frank MJ, 2007, NEUROPSYCHOPHARMACOL, V32, P1583, DOI 10.1038/sj.npp.1301278; Gau SSF, 2005, AM J PSYCHIAT, V162, P1344, DOI 10.1176/appi.ajp.162.7.1344; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; Groen Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059240; Groen Y, 2008, CLIN NEUROPHYSIOL, V119, P2476, DOI 10.1016/j.clinph.2008.08.004; HAENLEIN M, 1987, J AM ACAD CHILD PSY, V26, P356, DOI 10.1097/00004583-198705000-00014; Hajcak G, 2006, COGN AFFECT BEHAV NE, V6, P291, DOI 10.3758/CABN.6.4.291; Hajcak G, 2006, EMOTION, V6, P517, DOI 10.1037/1528-3542.6.3.517; HANSEN CH, 1988, J PERS SOC PSYCHOL, V54, P917, DOI 10.1037/0022-3514.54.6.917; Huang YX, 2006, NEUROSCI LETT, V398, P91, DOI 10.1016/j.neulet.2005.12.074; Hupp SDA, 2002, BEHAV MODIF, V26, P148, DOI 10.1177/0145445502026002002; Kelly ML, 1995, BEHAV MODIF, V19, P76; Krompinger JW, 2008, EMOTION, V8, P132, DOI 10.1037/1528-3542.8.1.132; Lahey BB, 1997, DSM 4 SOURCEBOOK, V3, P163; Luman M, 2005, CLIN PSYCHOL REV, V25, P183, DOI 10.1016/j.cpr.2004.11.001; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Nigg JT, 2005, DEV PSYCHOPATHOL, V17, P785, DOI 10.1017/S0954579405050376; PATTERSON CM, 1993, PSYCHOL REV, V100, P716, DOI 10.1037/0033-295X.100.4.716; Pelham PA, 1993, J CONSULT CLIN PSYCH, V61, P506; Polanczyk G, 2007, AM J PSYCHIAT, V164, P942, DOI 10.1176/appi.ajp.164.6.942; Power TJ, 2004, J ABNORM CHILD PSYCH, V32, P27, DOI 10.1023/B:JACP.0000007578.30863.93; PRATTO F, 1991, J PERS SOC PSYCHOL, V61, P380, DOI 10.1037/0022-3514.61.3.380; Quay H. C., 1988, ATTENTION DEFICIT DI, P117; QUAY HC, 1988, J AM ACAD CHILD PSY, V27, P262, DOI 10.1097/00004583-198803000-00030; Quay HC, 1988, ATTENTION DEFICIT DI, V3, P176; Sagvolden T, 1998, BEHAV BRAIN RES, V94, P61, DOI 10.1016/S0166-4328(97)00170-8; Sagvolden T, 2005, BEHAV BRAIN SCI, V28, P397, DOI 10.1017/S0140525X05000075; Scheres A, 2007, BIOL PSYCHIAT, V61, P720, DOI 10.1016/j.biopsych.2006.04.042; Schupp HT, 2000, PSYCHOPHYSIOLOGY, V37, P257, DOI 10.1017/S0048577200001530; Sergeant J, 2000, NEUROSCI BIOBEHAV R, V24, P7, DOI 10.1016/S0149-7634(99)00060-3; Sonuga-Barke EJS, 2003, NEUROSCI BIOBEHAV R, V27, P593, DOI 10.1016/j.neubiorev.2003.08.005; Swanson JM, 2001, J AM ACAD CHILD PSY, V40, P168, DOI 10.1097/00004583-200102000-00011; Tripp G, 2008, J CHILD PSYCHOL PSYC, V49, P691, DOI 10.1111/j.1469-7610.2007.01851.x; van Meel CS, 2011, J CHILD PSYCHOL PSYC, V52, P942, DOI 10.1111/j.1469-7610.2010.02352.x; van Meel CS, 2005, NEUROPSYCHOLOGIA, V43, P1946, DOI 10.1016/j.neuropsychologia.2005.03.018; VANDERMEERE J, 1995, J CHILD PSYCHOL PSYC, V36, P697, DOI 10.1111/j.1469-7610.1995.tb02323.x; Wentura D, 2000, J PERS SOC PSYCHOL, V78, P1024, DOI 10.1037//0022-3514.78.6.1024; Woo BSC, 2005, AUST NZ J PSYCHIAT, V39, P344, DOI 10.1080/j.1440-1614.2005.01580.x; Yuan JJ, 2008, NEUROSCIENCE, V157, P524, DOI 10.1016/j.neuroscience.2008.09.023; Yuan JJ, 2007, NEUROPSYCHOLOGIA, V45, P2764, DOI 10.1016/j.neuropsychologia.2007.04.018; Yuan JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089844; Yuan JJ, 2012, BIOL PSYCHOL, V89, P240, DOI 10.1016/j.biopsycho.2011.10.015; Yuan JJ, 2011, BRAIN RES, V1415, P84, DOI 10.1016/j.brainres.2011.07.053	63	14	16	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99570	10.1371/journal.pone.0099570	http://dx.doi.org/10.1371/journal.pone.0099570			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ5PV	24932610	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600043
J	Schnell, A; Chappuis, S; Schmutz, I; Brai, E; Ripperger, JA; Schaad, O; Welzl, H; Descombes, P; Alberi, L; Albrecht, U				Schnell, Anna; Chappuis, Sylvie; Schmutz, Isabelle; Brai, Emanuele; Ripperger, Juergen A.; Schaad, Olivier; Welzl, Hans; Descombes, Patrick; Alberi, Lavinia; Albrecht, Urs			The Nuclear Receptor REV-ERB alpha Regulates Fabp7 and Modulates Adult Hippocampal Neurogenesis	PLOS ONE			English	Article							FORCED SWIMMING TEST; NEURAL STEM-CELLS; DENTATE GYRUS; MICE LACKING; CIRCADIAN BEHAVIOR; GENE-EXPRESSION; BINDING; CLOCK; PROTEIN; BRAIN	The function of the nuclear receptor Rev-erb alpha (Nr1d1) in the brain is, apart from its role in the circadian clock mechanism, unknown. Therefore, we compared gene expression profiles in the brain between wild-type and Rev-erb alpha knock-out (KO) animals. We identified fatty acid binding protein 7 (Fabp7, Blbp) as a direct target of repression by REV-ERB alpha. Loss of Rev-erb alpha manifested in memory and mood related behavioral phenotypes and led to overexpression of Fabp7 in various brain areas including the subgranular zone (SGZ) of the hippocampus, where neuronal progenitor cells (NPCs) can initiate adult neurogenesis. We found increased proliferation of hippocampal neurons and loss of its diurnal pattern in Rev-erb alpha KO mice. In vitro, proliferation and migration of glioblastoma cells were affected by manipulating either Fabp7 expression or REV-ERB alpha activity. These results suggest an important role of Rev-erb alpha and Fabp7 in adult neurogenesis, which may open new avenues for treatment of gliomas as well as neurological diseases such as depression and Alzheimer.	[Schnell, Anna; Chappuis, Sylvie; Schmutz, Isabelle; Ripperger, Juergen A.; Albrecht, Urs] Univ Fribourg, Dept Biol, Biochem Unit, CH-1700 Fribourg, Switzerland; [Brai, Emanuele; Alberi, Lavinia] Univ Fribourg, Unit Anat, Dept Med, CH-1700 Fribourg, Switzerland; [Schaad, Olivier; Descombes, Patrick] Univ Geneva, NCCR Frontiers Genet, Geneva, Switzerland; [Welzl, Hans] Univ Zurich, Dept Anat, Zurich, Switzerland	University of Fribourg; University of Fribourg; University of Geneva; University of Zurich	Albrecht, U (corresponding author), Univ Fribourg, Dept Biol, Biochem Unit, CH-1700 Fribourg, Switzerland.	urs.albrecht@unifr.ch	Albrecht, Urs/A-9831-2011	Albrecht, Urs/0000-0002-0663-8676; Schnell, Anna/0000-0002-3943-598X	Swiss National Science Foundation; Velux Foundation; State of Fribourg	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Velux Foundation(Velux Fonden); State of Fribourg	Funding by the Swiss National Science Foundation, the Velux Foundation and the State of Fribourg is gratefully acknowledged. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akers KG, 2014, SCIENCE, V344, P598, DOI 10.1126/science.1248903; Albrecht U, 1997, CELL, V91, P1055, DOI 10.1016/S0092-8674(00)80495-X; Basak O, 2012, J NEUROSCI, V32, P5654, DOI 10.1523/JNEUROSCI.0455-12.2012; Bizon JL, 2001, EUR J NEUROSCI, V14, P1739, DOI 10.1046/j.0953-816x.2001.01781.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Borgs L, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-30; Bracko O, 2012, J NEUROSCI, V32, P3376, DOI 10.1523/JNEUROSCI.4248-11.2012; BRAFF DL, 1990, ARCH GEN PSYCHIAT, V47, P181; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chomez P, 2000, DEVELOPMENT, V127, P1489; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; De Rosa A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052113; Encinas JM, 2011, CELL STEM CELL, V8, P566, DOI 10.1016/j.stem.2011.03.010; FENG L, 1994, NEURON, V12, P895, DOI 10.1016/0896-6273(94)90341-7; Gerstner JR, 2012, J NEUROSCI, V32, P1383, DOI 10.1523/JNEUROSCI.3228-11.2012; Gerstner JR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001631; Giachino C, 2014, STEM CELLS, V32, P70, DOI 10.1002/stem.1520; Gibson EM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015267; Gilhooley MJ, 2011, NEUROSCI LETT, V489, P177, DOI 10.1016/j.neulet.2010.12.011; Goergen EM, 2002, J NEUROBIOL, V53, P90, DOI 10.1002/neu.10095; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; Gould E, 1997, DEV BRAIN RES, V103, P91, DOI 10.1016/S0165-3806(97)00079-5; Gould E, 1997, J NEUROSCI, V17, P2492; Gu Yan, 2013, Curr Top Behav Neurosci, V15, P31, DOI 10.1007/7854_2012_217; Guzman-Marin R, 2003, J PHYSIOL-LONDON, V549, P563, DOI 10.1113/jphysiol.2003.041665; Hampp G, 2008, CURR BIOL, V18, P678, DOI 10.1016/j.cub.2008.04.012; Hamprecht B, 1977, Int Rev Cytol, V49, P99; Jager J, 2014, MOL ENDOCRINOL, V28, P490, DOI 10.1210/me.2013-1351; Janich P, 2013, CELL STEM CELL, V13, P745, DOI 10.1016/j.stem.2013.09.004; Janich P, 2011, NATURE, V480, P209, DOI 10.1038/nature10649; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kimiwada T, 2009, NEUROCHEM INT, V54, P277, DOI 10.1016/j.neuint.2008.12.005; Kochman LJ, 2006, NEUROSCI LETT, V406, P256, DOI 10.1016/j.neulet.2006.07.058; Kojetin D, 2011, ACS CHEM BIOL, V6, P131, DOI 10.1021/cb1002575; Kott J, 2012, NEUROSCI LETT, V515, P177, DOI 10.1016/j.neulet.2012.03.048; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Lalonde R, 2002, NEUROSCI BIOBEHAV R, V26, P91, DOI 10.1016/S0149-7634(01)00041-0; Langmesser S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-41; Lee SY, 2012, BRAIN RES, V1478, P48, DOI 10.1016/j.brainres.2012.08.035; Li AH, 2013, FEBS LETT, V587, P2455, DOI 10.1016/j.febslet.2013.06.018; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Llaguno SRA, 2009, CLIN CANCER RES, V15, P7124, DOI 10.1158/1078-0432.CCR-09-0433; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Madden MH, 2014, CANCER CAUSE CONTROL, V25, P25, DOI 10.1007/s10552-013-0305-y; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Owada Y, 2006, EUR J NEUROSCI, V24, P175, DOI 10.1111/j.1460-9568.2006.04855.x; Petit-Demouliere B, 2005, PSYCHOPHARMACOLOGY, V177, P245, DOI 10.1007/s00213-004-2048-7; PONTEN J, 1978, MED BIOL, V56, P184; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Renard CE, 2003, FUND CLIN PHARMACOL, V17, P449, DOI 10.1046/j.1472-8206.2003.00160.x; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; Ripperger JRA, 2006, NAT GENET, V38, P369, DOI 10.1038/ng1738; Samuels BA, 2011, EUR J NEUROSCI, V33, P1152, DOI 10.1111/j.1460-9568.2011.07614.x; Schmutz I, 2010, GENE DEV, V24, P345, DOI 10.1101/gad.564110; Singh SK, 2003, CANCER RES, V63, P5821; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Stratmann M, 2010, GENE DEV, V24, P1317, DOI 10.1101/gad.578810; Tamai SI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003835; van Praag H, 1999, NAT NEUROSCI, V2, P266, DOI 10.1038/6368; Watanabe A, 2007, PLOS BIOL, V5, P2469, DOI 10.1371/journal.pbio.0050297; Wimmer ME, 2012, NEUROBIOL AGING, V33, P2220, DOI 10.1016/j.neurobiolaging.2011.07.007; Young JK, 2013, HIPPOCAMPUS, V23, P1476, DOI 10.1002/hipo.22200; Yun SW, 2012, P NATL ACAD SCI USA, V109, P10214, DOI 10.1073/pnas.1200817109; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033	68	65	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99883	10.1371/journal.pone.0099883	http://dx.doi.org/10.1371/journal.pone.0099883			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932636	gold, Green Accepted, Green Published			2022-12-27	WOS:000337738600076
J	Winston, ME; Hampton-Marcell, J; Zarraonaindia, I; Owens, SM; Moreau, CS; Gilbert, JA; Hartsel, J; Kennedy, SJ; Gibbons, SM				Winston, Max E.; Hampton-Marcell, Jarrad; Zarraonaindia, Iratxe; Owens, Sarah M.; Moreau, Corrie S.; Gilbert, Jack A.; Hartsel, Josh; Kennedy, Suzanne J.; Gibbons, S. M.			Understanding Cultivar-Specificity and Soil Determinants of the Cannabis Microbiome	PLOS ONE			English	Article							BACTERIAL COMMUNITIES; RHIZOSPHERE BACTERIA; ENDOPHYTIC BACTERIA; PLANT; GROWTH; TUBEROSUM; PHYTOREMEDIATION; COLONIZATION; DIVERSITY; VOLATILE	Understanding microbial partnerships with the medicinally and economically important crop Cannabis has the potential to affect agricultural practice by improving plant fitness and production yield. Furthermore, Cannabis presents an interesting model to explore plant-microbiome interactions as it produces numerous secondary metabolic compounds. Here we present the first description of the endorhiza-, rhizosphere-, and bulk soil-associated microbiome of five distinct Cannabis cultivars. Bacterial communities of the endorhiza showed significant cultivar-specificity. When controlling cultivar and soil type the microbial community structure was significantly different between plant cultivars, soil types, and between the endorhiza, rhizosphere and soil. The influence of soil type, plant cultivar and sample type differentiation on the microbial community structure provides support for a previously published two-tier selection model, whereby community composition across sample types is determined mainly by soil type, while community structure within endorhiza samples is determined mainly by host cultivar.	[Winston, Max E.; Moreau, Corrie S.] Field Museum, Dept Sci & Educ, Chicago, IL 60605 USA; [Winston, Max E.] Univ Chicago, Comm Evolutionary Biol, Chicago, IL 60637 USA; [Hampton-Marcell, Jarrad; Zarraonaindia, Iratxe; Owens, Sarah M.; Gilbert, Jack A.; Gibbons, S. M.] Inst Genom & Syst Biol, Argonne Natl Lab, Lemont, IL USA; [Hampton-Marcell, Jarrad; Gilbert, Jack A.] Univ Chicago, Dept Ecol & Evolut, Chicago, IL 60637 USA; [Zarraonaindia, Iratxe] Basque Country Govt, Bilbao, Spain; [Owens, Sarah M.] Univ Chicago, Computat Inst, Chicago, IL 60637 USA; [Hartsel, Josh] Cannavest, San Diego, CA USA; [Kennedy, Suzanne J.] MO BIO Labs, Carlsbad, CA USA; [Gibbons, S. M.] Univ Chicago, Grad Program Biophys Sci, Chicago, IL 60637 USA	Field Museum of Natural History (Chicago); University of Chicago; United States Department of Energy (DOE); Argonne National Laboratory; University of Chicago; Basque Government; University of Chicago; University of Chicago	Winston, ME (corresponding author), Field Museum, Dept Sci & Educ, Chicago, IL 60605 USA.	mewinsto@gmail.com	Zarraonaindia, Iratxe/ABF-4618-2020; Gilbert, Jack/AAF-3270-2019; Gibbons, Sean M./ABH-2562-2020	Zarraonaindia, Iratxe/0000-0002-0615-0187; Gibbons, Sean M./0000-0002-8724-7916; Moreau, Corrie/0000-0003-1139-5792	U.S. Dept. of Energy [DE-AC02-06CH11357]; U.S. Department of Education GAANN grant; U.S. Environmental Protection Agency STAR Graduate Fellowship; Amazon Web Services education grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER	U.S. Dept. of Energy(United States Department of Energy (DOE)); U.S. Department of Education GAANN grant; U.S. Environmental Protection Agency STAR Graduate Fellowship(United States Environmental Protection Agency); Amazon Web Services education grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	This work was supported in part by the U.S. Dept. of Energy under Contract DE-AC02-06CH11357. MEW was supported by a U.S. Department of Education GAANN grant. Funding for SMG was provided U.S. Environmental Protection Agency STAR Graduate Fellowship. Computational resources were funded by a Amazon Web Services education grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreote FD, 2009, APPL ENVIRON MICROB, V75, P3396, DOI 10.1128/AEM.00491-09; Bakker P., 2011, MULTITROPHIC INTERAC, V71, P169; Barac T, 2004, NAT BIOTECHNOL, V22, P583, DOI 10.1038/nbt960; Beattie GA, 2006, PLANT-ASSOCIATED BACTERIA, P1; Berendsen R.L., 2012, TRENDS PLANT SCI, P1; BERG B, 1972, J APPL BACTERIOL, V35, P201, DOI 10.1111/j.1365-2672.1972.tb03691.x; Berg G, 2009, FEMS MICROBIOL ECOL, V68, P1, DOI 10.1111/j.1574-6941.2009.00654.x; Bezemer TM, 2006, J ECOL, V94, P893, DOI 10.1111/j.1365-2745.2006.01158.x; Bokulich NA, 2014, P NATL ACAD SCI USA, V111, pE139, DOI 10.1073/pnas.1317377110; Bonanomi G, 2005, PLANT ECOL, V181, P269, DOI 10.1007/s11258-005-7221-5; Bonfante P, 2009, ANNU REV MICROBIOL, V63, P363, DOI 10.1146/annurev.micro.091208.073504; Bulgarelli D, 2013, ANNU REV PLANT BIOL, V64, P807, DOI 10.1146/annurev-arplant-050312-120106; Bulgarelli D, 2012, NATURE, V488, P91, DOI 10.1038/nature11336; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chiarini L, 1998, APPL SOIL ECOL, V8, P11, DOI 10.1016/S0929-1393(97)00071-1; Citterio S, 2005, CHEMOSPHERE, V59, P21, DOI 10.1016/j.chemosphere.2004.10.009; da Rocha UN, 2009, FEMS MICROBIOL ECOL, V69, P313, DOI 10.1111/j.1574-6941.2009.00702.x; Diaz CL, 1989, NATURE, V4, P338; Duineveld BM, 1998, APPL ENVIRON MICROB, V64, P4950; FROMMEL MI, 1991, PLANT PHYSIOL, V96, P928, DOI 10.1104/pp.96.3.928; Garbeva P, 2004, ANNU REV PHYTOPATHOL, V42, P243, DOI 10.1146/annurev.phyto.42.012604.135455; Gilbert JA, 2014, P NATL ACAD SCI USA, V111, P5, DOI 10.1073/pnas.1320471110; Glick BR, 1998, J THEOR BIOL, V190, P63, DOI 10.1006/jtbi.1997.0532; Gottel NR, 2011, APPL ENVIRON MICROB, V77, P5934, DOI 10.1128/AEM.05255-11; Jesus ED, 2010, BIOENERG RES, V3, P20, DOI 10.1007/s12155-009-9073-7; Jossi M, 2006, FEMS MICROBIOL ECOL, V55, P339, DOI 10.1111/j.1574-6941.2005.00040.x; Krivtsov V, 2007, ANIM BIOL, V57, P467, DOI 10.1163/157075607782232189; LAMBERT B, 1989, TRENDS BIOTECHNOL, V7, P215, DOI 10.1016/0167-7799(89)90107-8; Lekberg Y, 2013, ISME J, V7, P1424, DOI 10.1038/ismej.2013.41; Liste HH, 2006, CHEMOSPHERE, V62, P1411, DOI 10.1016/j.chemosphere.2005.05.018; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Mahaffee WF, 1997, MICROB ECOL, V34, P210, DOI 10.1007/s002489900050; Marschner P, 2001, SOIL BIOL BIOCHEM, V33, P1437, DOI 10.1016/S0038-0717(01)00052-9; Marschner P, 2004, PLANT SOIL, V261, P199, DOI 10.1023/B:PLSO.0000035569.80747.c5; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; Mendes R, 2011, SCIENCE, V332, P1097, DOI 10.1126/science.1203980; Milling A, 2004, PLANT SOIL, V266, P23; Nelson DR, 2006, AUST J SOIL RES, V44, P319, DOI 10.1071/SR06022; Oksanen J, 2013, COMMUNITY ECOLOGY PA, V2, P1; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Smalla K, 2001, APPL ENVIRON MICROB, V67, P4742, DOI 10.1128/AEM.67.10.4742-4751.2001; Swift MJ, 2004, AGR ECOSYST ENVIRON, V104, P113, DOI 10.1016/j.agee.2004.01.013; Taghavi S, 2005, APPL ENVIRON MICROB, V71, P8500, DOI 10.1128/AEM.71.12.8500-8505.2005; Turpault MP, 2007, GEODERMA, V137, P490, DOI 10.1016/j.geoderma.2006.10.005; van der Lelie D, 2009, CRIT REV PLANT SCI, V28, P346, DOI 10.1080/07352680903241204; van Overbeek L, 2008, FEMS MICROBIOL ECOL, V64, P283, DOI 10.1111/j.1574-6941.2008.00469.x; Verginer M, 2010, J AGR FOOD CHEM, V58, P8344, DOI 10.1021/jf100393w; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Whipps JM, 2001, J EXP BOT, V52, P487, DOI 10.1093/jexbot/52.suppl_1.487; Winston M, 2014, FIGSHARE	51	37	40	1	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99641	10.1371/journal.pone.0099641	http://dx.doi.org/10.1371/journal.pone.0099641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932479	gold, Green Published, Green Submitted			2022-12-27	WOS:000337738600051
J	Lu, YX; Zhang, Q; Xu, WH				Lu, Yu-Xuan; Zhang, Qi; Xu, Wei-Hua			Global Metabolomic Analyses of the Hemolymph and Brain during the Initiation, Maintenance, and Termination of Pupal Diapause in the Cotton Bollworm, Helicoverpa armigera	PLOS ONE			English	Article							AMINO-ACID POOLS; RICE STEM BORER; BOMBYX-MORI; SHONAI ECOTYPE; COLD-HARDINESS; FAT-BODY; SILKWORM; GLYCEROL; SORBITOL; EGGS	A strategy known as diapause (developmental arrest) has evolved in insects to increase their survival rate under harsh environmental conditions. Diapause causes a dramatic reduction in the metabolic rate and drastically extends lifespan. However, little is known about the mechanisms underlying the metabolic changes involved. Using gas chromatography-mass spectrometry, we compared the changes in the metabolite levels in the brain and hemolymph of nondiapause- and diapause-destined cotton bollworm, Helicoverpa armigera, during the initiation, maintenance, and termination of pupal diapause. A total of 55 metabolites in the hemolymph and 52 metabolites in the brain were detected. Of these metabolites, 21 and 12 metabolite levels were altered in the diapause pupal hemolymph and brain, respectively. During diapause initiation and maintenance, the number of metabolites with increased levels in the hemolymph of the diapausing pupae is far greater than the number in the nondiapause pupae. These increased metabolites function as an energy source, metabolic intermediates, and cryoprotectants. The number of metabolites with decreased levels in the brain of diapausing pupae is far greater than the number in the nondiapause pupae. Low metabolite levels are likely to directly or indirectly repress the brain metabolic activity. During diapause termination, most of the metabolite levels in the hemolymph of the diapausing pupae rapidly decrease because they function as energy and metabolic sources that promote pupa-adult development. In conclusion, the metabolites with altered levels in the hemolymph and brain serve as energy and metabolic resources and help to maintain a low brain metabolic activity during diapause.	[Lu, Yu-Xuan; Zhang, Qi; Xu, Wei-Hua] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Xu, WH (corresponding author), Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China.	xuweihua@mail.sysu.edu.cn	Lu, Yu-Xuan/GYU-8582-2022; Lu, Yu-Xuan/AHE-5003-2022; Xu, Weihua/GYJ-6124-2022	Lu, Yu-Xuan/0000-0001-6751-5250; Xu, wei-hua/0000-0003-1696-3330	Natural Scientific Foundation of China [31230066]; National Basic Research Program of China, Ministry of Science and Technology [2012CB114101]	Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China, Ministry of Science and Technology	This study was supported by a Grant-in-Aid from the Natural Scientific Foundation of China (31230066) and the National Basic Research Program of China, Ministry of Science and Technology (2012CB114101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bemani M, 2012, J INSECT PHYSIOL, V58, P897, DOI 10.1016/j.jinsphys.2012.04.003; CHINO H, 1958, J INSECT PHYSIOL, V2, P1, DOI 10.1016/0022-1910(58)90024-6; Colinet H, 2013, METABOLOMICS, V9, P608, DOI 10.1007/s11306-012-0471-z; Davis DJ, 2001, ARCH INSECT BIOCHEM, V48, P199, DOI 10.1002/arch.1072; Denlinger D.L., 2005, P615; Denlinger DL, 2002, ANNU REV ENTOMOL, V47, P93, DOI 10.1146/annurev.ento.47.091201.145137; Goto M, 2001, J INSECT PHYSIOL, V47, P709, DOI 10.1016/S0022-1910(00)00164-5; Goto Michiyo, 1998, Journal of Insect Physiology, V44, P87, DOI 10.1016/S0022-1910(97)00098-X; Hayward SAL, 2005, J INSECT PHYSIOL, V51, P631, DOI 10.1016/j.jinsphys.2004.11.009; Hirai MY, 2005, J BIOL CHEM, V280, P25590, DOI 10.1074/jbc.M502332200; Hollywood K, 2006, PROTEOMICS, V6, P4716, DOI 10.1002/pmic.200600106; Horie Y, 2000, J INSECT PHYSIOL, V46, P1009, DOI 10.1016/S0022-1910(99)00212-7; Kostal V, 2007, J INSECT PHYSIOL, V53, P580, DOI 10.1016/j.jinsphys.2007.02.009; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; Kostal V, 2011, P NATL ACAD SCI USA, V108, P13041, DOI 10.1073/pnas.1107060108; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Li YP, 2002, J INSECT PHYSIOL, V48, P303, DOI 10.1016/S0022-1910(01)00177-9; Li YP, 2002, ARCH INSECT BIOCHEM, V50, P53, DOI 10.1002/arch.10024; Lu YX, 2010, J PROTEOME RES, V9, P5053, DOI 10.1021/pr100356t; Michaud MR, 2007, J COMP PHYSIOL B, V177, P753, DOI 10.1007/s00360-007-0172-5; Nelson CJ, 2010, COMP BIOCHEM PHYS D, V5, P265, DOI 10.1016/j.cbd.2010.07.002; Nelson D.L., 2008, PRINCIPLES BIOCH; OSANAI M, 1986, INSECT BIOCHEM, V16, P373, DOI 10.1016/0020-1790(86)90050-8; SUZUKI K, 1984, INSECT BIOCHEM, V14, P557, DOI 10.1016/0020-1790(84)90012-X; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Xu J, 2009, GLYCOBIOLOGY, V19, P250, DOI 10.1093/glycob/cwn127; Xu WH, 2012, P NATL ACAD SCI USA, V109, P14687, DOI 10.1073/pnas.1212879109; YAGINUMA T, 1978, J INSECT PHYSIOL, V24, P347, DOI 10.1016/0022-1910(78)90074-4; Yaginuma T, 1999, J INSECT PHYSIOL, V45, P621, DOI 10.1016/S0022-1910(98)00150-4; Yang J, 2010, J INSECT PHYSIOL, V56, P1992, DOI 10.1016/j.jinsphys.2010.08.023; Zhang Q, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-751; Zhang Q, 2012, J PROTEOME RES, V11, P1042, DOI 10.1021/pr200796a	32	20	24	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99948	10.1371/journal.pone.0099948	http://dx.doi.org/10.1371/journal.pone.0099948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926789	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100097
J	Radszuweit, M; Engel, H; Bar, M				Radszuweit, Markus; Engel, Harald; Baer, Markus			An Active Poroelastic Model for Mechanochemical Patterns in Protoplasmic Droplets of Physarum polycephalum	PLOS ONE			English	Article							TRUE SLIME-MOLD; PLASMODIAL STRAND; FLOW MODELS; CYTOPLASM; CELL; OSCILLATIONS; DYNAMICS; CONTRACTION; ELASTICITY; MORPHOLOGY	Motivated by recent experimental studies, we derive and analyze a two-dimensional model for the contraction patterns observed in protoplasmic droplets of Physarum polycephalum. The model couples a description of an active poroelastic two-phase medium with equations describing the spatiotemporal dynamics of the intracellular free calcium concentration. The poroelastic medium is assumed to consist of an active viscoelastic solid representing the cytoskeleton and a viscous fluid describing the cytosol. The equations for the poroelastic medium are obtained from continuum force balance and include the relevant mechanical fields and an incompressibility condition for the two-phase medium. The reaction-diffusion equations for the calcium dynamics in the protoplasm of Physarum are extended by advective transport due to the flow of the cytosol generated by mechanical stress. Moreover, we assume that the active tension in the solid cytoskeleton is regulated by the calcium concentration in the fluid phase at the same location, which introduces a mechanochemical coupling. A linear stability analysis of the homogeneous state without deformation and cytosolic flows exhibits an oscillatory Turing instability for a large enough mechanochemical coupling strength. Numerical simulations of the model equations reproduce a large variety of wave patterns, including traveling and standing waves, turbulent patterns, rotating spirals and antiphase oscillations in line with experimental observations of contraction patterns in the protoplasmic droplets.	[Radszuweit, Markus] Leibniz Inst Forschungsverbund Berlin eV, Weierstr Inst Angew Anal & Stochast, Berlin, Germany; [Radszuweit, Markus; Engel, Harald] Tech Univ Berlin, Inst Theoret Phys, Berlin, Germany; [Radszuweit, Markus; Baer, Markus] Phys Tech Bundesanstalt, Berlin, Germany	Weierstrass Institute for Applied Analysis & Stochastics; Technical University of Berlin; Physikalisch-Technische Bundesanstalt (PTB)	Radszuweit, M (corresponding author), Leibniz Inst Forschungsverbund Berlin eV, Weierstr Inst Angew Anal & Stochast, Berlin, Germany.	Markus.Radszuweit@wias-berlin.de	Engel, Harald/ABD-2272-2020; Bär, Markus/B-8396-2011	Bär, Markus/0000-0002-6935-7759	German Science Foundation (DFG) [GRK 1558]	German Science Foundation (DFG)(German Research Foundation (DFG))	Funding was granted by the German Science Foundation (DFG) within the research training group: "Nonequilibrium Collective Dynamics in Condensed Matter and Biological Systems" (GRK 1558) (URL: http://www.dfg.de/en/index.jsp). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alt W, 1999, MATH BIOSCI, V156, P207, DOI 10.1016/S0025-5564(98)10067-6; Banerjee S, 2011, SOFT MATTER, V7, P463, DOI 10.1039/c0sm00494d; Banks HT, 2011, ADV APPL MATH MECH, V3, P1, DOI 10.4208/aamm.10-m1030; Baumgarten W, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/2/026003; Baumgarten W, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.046113; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; Borene ML, 2004, ANN BIOMED ENG, V32, P274, DOI 10.1023/B:ABME.0000012747.97620.3a; BRINKMAN HC, 1947, APPL SCI RES, V1, P27; BRIX K, 1987, PROTOPLASMA, V137, P156, DOI 10.1007/BF01281151; Bykov AV, 2009, J BIOPHOTONICS, V2, P540, DOI 10.1002/jbio.200910057; Callan-Jones AC, 2011, NEW J PHYS, V13, DOI 10.1088/1367-2630/13/9/093027; Charras GT, 2009, J CELL SCI, V122, P3233, DOI 10.1242/jcs.049262; Cogan NG, 2010, HFSP J, V4, P11, DOI 10.2976/1.3291142; DEMBO M, 1986, BIOPHYS J, V50, P109, DOI 10.1016/S0006-3495(86)83444-0; DONAHUE BS, 1987, CELL CALCIUM, V8, P437, DOI 10.1016/0143-4160(87)90027-3; Fessel A, 2012, PHYS REV LETT, V109, DOI 10.1103/PhysRevLett.109.078103; Guy RD, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.016310; Howard J, 2011, NAT REV MOL CELL BIO, V12, P392, DOI 10.1038/nrm3120; Joanny JF, 2009, HFSP J, V3, P94, DOI 10.2976/1.3054712; KAMIYA N, 1981, ANNU REV PLANT PHYS, V32, P205, DOI 10.1146/annurev.pp.32.060181.001225; KESSLER D, 1976, J CELL BIOL, V69, P393, DOI 10.1083/jcb.69.2.393; Kopf MH, 2013, PHYSICA D, V259, P48; Mitchison TJ, 2008, SEMIN CELL DEV BIOL, V19, P215, DOI 10.1016/j.semcdb.2008.01.008; Moulding DA, 2013, NAT MATER, V12, P253; NAGAI R, 1978, J CELL SCI, V33, P205; NAGAI R, 1975, PROTOPLASMA, V86, P141, DOI 10.1007/BF01275628; Nakagaki T, 1999, J THEOR BIOL, V197, P497, DOI 10.1006/jtbi.1998.0890; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Nakagaki T, 2004, P ROY SOC B-BIOL SCI, V271, P2305, DOI 10.1098/rspb.2004.2856; Nakagaki T, 2008, SOFT MATTER, V4, P57, DOI 10.1039/b706317m; Nakagaki T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.068104; Norris CH, 1940, J CELL COMPAR PHYSL, V16, P313, DOI 10.1002/jcp.1030160307; OSTER GF, 1984, CELL MOTIL CYTOSKEL, V4, P469, DOI 10.1002/cm.970040606; Panfilov AV, 2007, P NATL ACAD SCI USA, V104, P7922, DOI 10.1073/pnas.0701895104; Pelletier V, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.188303; Radszuweit M, 2010, EUR PHYS J-SPEC TOP, V191, P159, DOI 10.1140/epjst/e2010-01348-2; Radszuweit M, 2013, THESIS; Radszuweit M, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.138102; Romanovsky YM, 1995, PHYS USPEKHI, V38, P512; SATO M, 1983, J CELL BIOL, V97, P1089, DOI 10.1083/jcb.97.4.1089; Shewchuk JR, 1996, APPL COMPUTATIONAL G, P203, DOI DOI 10.1007/BFB0014497; SMITH DA, 1992, BIOPHYS J, V61, P368, DOI 10.1016/S0006-3495(92)81843-X; Takagi S, 2008, PHYSICA D, V237, P420, DOI 10.1016/j.physd.2007.09.012; Takagi S, 2010, PHYSICA D, V239, P873, DOI 10.1016/j.physd.2009.06.011; TEPLOV VA, 1991, BIOSYSTEMS, V24, P269, DOI 10.1016/0303-2647(91)90046-N; Tero A, 2005, PHYSICA D, V205, P125, DOI 10.1016/j.physd.2005.01.010; Tero A, 2010, SCIENCE, V327, P439, DOI 10.1126/science.1177894; Tsuda S, 2011, BIOSYSTEMS, V103, P331, DOI 10.1016/j.biosystems.2010.11.001; TURING AM, 1952, PHILOS T ROY SOC B, V237, P37, DOI 10.1098/rstb.1952.0012; Ueda K, 2011, PHYS REV E, V83, DOI 10.1103/PhysRevE.83.021916; Ueda T, 2005, NETWORKS INTERACTING, P221; WOHLFARTHBOTTERMANN KE, 1977, J EXP BIOL, V67, P49; Yamada H, 2007, J MATH BIOL, V54, P745, DOI 10.1007/s00285-006-0067-1; YOSHIMOTO Y, 1982, PROTOPLASMA, V110, P63, DOI 10.1007/BF01314683; YOSHIMOTO Y, 1981, CELL MOTIL CYTOSKEL, V1, P433, DOI 10.1002/cm.970010404	55	33	33	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99220	10.1371/journal.pone.0099220	http://dx.doi.org/10.1371/journal.pone.0099220			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927427	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100031
J	Sarr, O; Thompson, JA; Zhao, L; Lee, TY; Regnault, TRH				Sarr, Ousseynou; Thompson, Jennifer A.; Zhao, Lin; Lee, Ting-Yim; Regnault, Timothy R. H.			Low Birth Weight Male Guinea Pig Offspring Display Increased Visceral Adiposity in Early Adulthood	PLOS ONE			English	Article							HORMONE-SENSITIVE LIPASE; PPAR-GAMMA; GENE-EXPRESSION; IN-VIVO; TRIGLYCERIDE LIPASE; FAT-CELLS; TISSUE; ADIPOCYTE; INSULIN; OBESITY	Uteroplacental insufficiency (UPI)-induced intrauterine growth restriction (IUGR) predisposes individuals to adult visceral obesity. We postulated that low birth weight (LBW) offspring, from UPI-induced IUGR pregnancies, would display a visceral adipose lipogenic molecular signature involving altered gene expression, phosphorylation status of proteins of the lipid synthesis pathway and microRNA (miR) expression profile, occurring in association with increased visceral adiposity. Normal birth weight (NBW) and LBW (obtained by uterine artery ablation) male guinea pig pups were fed a control diet from weaning to 145 days and sacrificed. Despite being lighter at birth, LBW pups displayed body weights similar to NBW offspring at 145 days. At this age, which represents young adulthood, the relative weights of LBW epididymal white adipose tissue (EWAT) and lipid content were increased; which was consistent with adipocyte hypertrophy in the LBW offspring. Additionally, the mRNA expression of lipid synthesis-related genes including acetyl-CoA carboxylase 1 (ACC1), diglyceride acyltransferase 2 (DGAT2) and peroxisome proliferator-activated receptor gamma 1 (PPAR gamma 1), was increased in LBW EWAT. Further, LBW EWAT displayed decreased phospho-ACC (Ser79) and phospho-PPAR gamma (Ser273) proteins. Moreover, the mRNA expression of hormone-sensitive lipase (HSL) and fatty acid binding protein 4 (FABP4), both involved in promoting adipose lipid storage, was increased in LBW EWAT. Finally, miR-24 and miR-103-2, miRs related to adipocyte development, were both increased in LBW EWAT. These findings indicate that, following an adverse in utero environment, lipid synthesis-related genes and miR expression, along with phosphorylation status of key regulators of lipid synthesis, appear to be chronically altered and occur in association with increased visceral adiposity in young adult IUGR male offspring.	[Sarr, Ousseynou; Zhao, Lin; Regnault, Timothy R. H.] Univ Western Ontario, Childrens Hlth Res Inst, Dept Obstet & Gynecol, Lawson Hlth Res Inst, London, ON, Canada; [Thompson, Jennifer A.] Georgia Regents Univ, Dept Physiol, Augusta, GA USA; [Lee, Ting-Yim] Univ Western Ontario, Dept Med Imaging, London, ON, Canada; [Lee, Ting-Yim] Univ Western Ontario, Dept Med Biophys, London, ON, Canada; [Lee, Ting-Yim] Univ Western Ontario, Dept Oncol, London, ON, Canada; [Lee, Ting-Yim] Lawson Hlth Res Inst, London, ON, Canada; [Lee, Ting-Yim] Robarts Res Inst, London, ON N6A 5C1, Canada; [Regnault, Timothy R. H.] Univ Western Ontario, Dept Physiol & Pharmacol, London, ON, Canada	Western University (University of Western Ontario); University System of Georgia; Augusta University; Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Sarr, O (corresponding author), Univ Western Ontario, Childrens Hlth Res Inst, Dept Obstet & Gynecol, Lawson Hlth Res Inst, London, ON, Canada.	osarr@uwo.ca	Regnault, Timothy RH/AAE-3168-2021; Regnault, Timothy/J-8902-2014; Regnault, Timothy RH/GVS-9382-2022; Lee, Ting-Yim/M-1721-2013	Regnault, Timothy/0000-0003-1930-8358; Regnault, Timothy RH/0000-0003-1930-8358; Thompson, Jennifer/0000-0003-0421-3719	Canadian Institutes of Health Research [MOP-209113]; Whaley Postdoctoral Fellowship	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Whaley Postdoctoral Fellowship	This work was supported by the Canadian Institutes of Health Research (Operating Grant #MOP-209113). Ousseynou Sarr was supported by the Whaley Postdoctoral Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNER P, 1988, DIABETES METAB REV, V4, P507; Baschat AA, 2004, SEMIN PERINATOL, V28, P67, DOI 10.1053/j.semperi.2003.10.014; BJORNTORP P, 1972, EUR J CLIN INVEST, V2, P78, DOI 10.1111/j.1365-2362.1972.tb00573.x; BJORNTORP P, 1991, DIABETES CARE, V14, P1132, DOI 10.2337/diacare.14.12.1132; CARTER AM, 1990, J DEV PHYSIOL, V13, P261; Castaneda-Gutierrez E, 2011, AM J CLIN NUTR, V94, p1838S, DOI 10.3945/ajcn.110.000794; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; Darimont C, 1997, ENDOCRINOLOGY, V138, P1092, DOI 10.1210/en.138.3.1092; Desai M, 2008, REPROD SCI, V15, P785, DOI 10.1177/1933719108318597; Emanuela F, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/476380; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gathercole LL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026223; Gerin I, 2010, AM J PHYSIOL-ENDOC M, V299, pE198, DOI 10.1152/ajpendo.00179.2010; Gomez-Pinilla PJ, 2007, J UROLOGY, V177, P1558, DOI 10.1016/j.juro.2006.11.071; Granton PV, 2010, J APPL PHYSIOL, V109, P1162, DOI 10.1152/japplphysiol.00016.2010; Gruffat D, 1996, REPROD NUTR DEV, V36, P375, DOI 10.1051/rnd:19960404; Hardie DG, 2008, INT J OBESITY, V32, pS7, DOI 10.1038/ijo.2008.116; HORUK R, 1983, J BIOL CHEM, V258, P7425; Ibrahimi A, 2002, CURR OPIN CLIN NUTR, V5, P139, DOI 10.1097/00075197-200203000-00004; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Joss-Moore LA, 2010, EARLY HUM DEV, V86, P179, DOI 10.1016/j.earlhumdev.2010.02.006; Kalderon B, 2000, AM J PHYSIOL-ENDOC M, V279, pE221, DOI 10.1152/ajpendo.2000.279.1.E221; Kang M, 2013, GENET MOL RES, V12, P5267, DOI 10.4238/2013.November.7.1; Karbiener M, 2009, BIOCHEM BIOPH RES CO, V390, P247, DOI 10.1016/j.bbrc.2009.09.098; Kershaw EE, 2007, AM J PHYSIOL-ENDOC M, V293, pE1736, DOI 10.1152/ajpendo.00122.2007; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Kim JB, 1998, P NATL ACAD SCI USA, V95, P4333, DOI 10.1073/pnas.95.8.4333; Kim SY, 2010, BIOCHEM BIOPH RES CO, V392, P323, DOI 10.1016/j.bbrc.2010.01.012; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Kulshreshtha R, 2007, MOL CELL BIOL, V27, P1859, DOI 10.1128/MCB.01395-06; Large V, 1999, J LIPID RES, V40, P2059; Le Lay S, 2002, J BIOL CHEM, V277, P35625, DOI 10.1074/jbc.M203913200; Li PP, 2011, CELL, V147, P815, DOI 10.1016/j.cell.2011.09.050; Lie S, 2013, J DEV ORIG HLTH DIS, V4, P421, DOI 10.1017/S2040174413000202; Lim KI, 2010, CLIN ENDOCRINOL, V73, P588, DOI 10.1111/j.1365-2265.2010.03841.x; Lin XZ, 2013, GENE EXPRESSION, V16, P1, DOI 10.3727/105221613X13776146743262; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lowell BB, 1999, CELL, V99, P239, DOI 10.1016/S0092-8674(00)81654-2; Luconi M, 2010, STEROIDS, V75, P585, DOI 10.1016/j.steroids.2009.10.012; Lukaszewski MA, 2011, AM J PHYSIOL-ENDOC M, V301, pE548, DOI 10.1152/ajpendo.00011.2011; Luu YK, 2009, MED ENG PHYS, V31, P34, DOI 10.1016/j.medengphy.2008.03.006; MacLaren RE, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-3; Mandard S., 2006, Nutritional genomics: impact on health and disease, P208, DOI 10.1002/3527608109.ch12; Merkel M, 2002, J LIPID RES, V43, P1997, DOI 10.1194/jlr.R200015-JLR200; Nguyen LT, 2010, PLACENTA, V31, P902, DOI 10.1016/j.placenta.2010.07.014; Nuesken KD, 2008, ENDOCRINOLOGY, V149, P1056, DOI 10.1210/en.2007-0891; Rasmussen EL, 2005, DIABETES CARE, V28, P151, DOI 10.2337/diacare.28.1.151; RAVELLI GP, 1976, NEW ENGL J MED, V295, P349, DOI 10.1056/NEJM197608122950701; SAGGERSON ED, 1974, BIOCHEM J, V140, P211, DOI 10.1042/bj1400211; Schweiger M, 2006, J BIOL CHEM, V281, P40236, DOI 10.1074/jbc.M608048200; Storch J, 2000, BBA-MOL CELL BIOL L, V1486, P28, DOI 10.1016/S1388-1981(00)00046-9; Sun FY, 2009, BIOCHEM BIOPH RES CO, V380, P660, DOI 10.1016/j.bbrc.2009.01.161; Takekoshi K, 2006, METABOLISM, V55, P1122, DOI 10.1016/j.metabol.2006.04.007; Tong L, 2005, CELL MOL LIFE SCI, V62, P1784, DOI 10.1007/s00018-005-5121-4; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Tse MCL, 2013, MOL CELL BIOL, V33, P1797, DOI 10.1128/MCB.01410-12; Turner AJ, 2009, PLACENTA, V30, P236, DOI 10.1016/j.placenta.2008.11.023; Wakil SJ, 2009, J LIPID RES, V50, pS138, DOI 10.1194/jlr.R800079-JLR200; Xie HM, 2009, EXPERT OPIN THER TAR, V13, P1227, DOI 10.1517/14728220903190707; Xie HM, 2009, DIABETES, V58, P1050, DOI 10.2337/db08-1299; Yajima H, 2007, BIOCHEM BIOPH RES CO, V352, P526, DOI 10.1016/j.bbrc.2006.11.054; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yen CLE, 2008, J LIPID RES, V49, P2283, DOI 10.1194/jlr.R800018-JLR200; Zimmermann R, 2004, SCIENCE, V306, P1383, DOI 10.1126/science.1100747	64	23	24	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98433	10.1371/journal.pone.0098433	http://dx.doi.org/10.1371/journal.pone.0098433			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926663	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100016
J	Teerawattananon, K; Myint, CY; Wongkittirux, K; Teerawattananon, Y; Chinkulkitnivat, B; Orprayoon, S; Kusakul, S; Tengtrisorn, S; Jenchitr, W				Teerawattananon, Kanlaya; Myint, Chaw-Yin; Wongkittirux, Kwanjai; Teerawattananon, Yot; Chinkulkitnivat, Bunyong; Orprayoon, Surapong; Kusakul, Suwat; Tengtrisorn, Supaporn; Jenchitr, Watanee			Assessing the Accuracy and Feasibility of a Refractive Error Screening Program Conducted by School Teachers in Pre-Primary and Primary Schools in Thailand	PLOS ONE			English	Article							VISUAL IMPAIRMENT; CHILDREN; PREVALENCE; SCHOOLCHILDREN; PROGRESSION; BLINDNESS; MALAYSIA; IMPROVE; URBAN; AREA	Introduction: As part of the development of a system for the screening of refractive error in Thai children, this study describes the accuracy and feasibility of establishing a program conducted by teachers. Objective: To assess the accuracy and feasibility of screening by teachers. Methods: A cross-sectional descriptive and analytical study was conducted in 17 schools in four provinces representing four geographic regions in Thailand. A two-staged cluster sampling was employed to compare the detection rate of refractive error among eligible students between trained teachers and health professionals. Serial focus group discussions were held for teachers and parents in order to understand their attitude towards refractive error screening at schools and the potential success factors and barriers. Results: The detection rate of refractive error screening by teachers among pre-primary school children is relatively low (21%) for mild visual impairment but higher for moderate visual impairment (44%). The detection rate for primary school children is high for both levels of visual impairment (52% for mild and 74% for moderate). The focus group discussions reveal that both teachers and parents would benefit from further education regarding refractive errors and that the vast majority of teachers are willing to conduct a school-based screening program. Conclusion: Refractive error screening by health professionals in pre-primary and primary school children is not currently implemented in Thailand due to resource limitations. However, evidence suggests that a refractive error screening program conducted in schools by teachers in the country is reasonable and feasible because the detection and treatment of refractive error in very young generations is important and the screening program can be implemented and conducted with relatively low costs.	[Teerawattananon, Kanlaya; Myint, Chaw-Yin; Teerawattananon, Yot] HITAP, Nonthaburi, Thailand; [Teerawattananon, Kanlaya] Samut Prakan Hosp, Dept Ophthalmol, Samut Prakan, Thailand; [Wongkittirux, Kwanjai] Queen Sirikit Natl Inst Child Hlth, Dept Pediat Ophthalmol, Bangkok, Thailand; [Chinkulkitnivat, Bunyong] Surat Thani Hosp, Dept Ophthalmol, Surat Thani, Thailand; [Orprayoon, Surapong] Lamphun Hosp, Dept Ophthalmol, Lamphun, Thailand; [Kusakul, Suwat] Nakhon Phanom Hosp, Dept Ophthalmol, Nakhon Phanom, Thailand; [Tengtrisorn, Supaporn] Prince Songkla Univ, Dept Ophthalmol, Hat Yai, Thailand; [Jenchitr, Watanee] Rangsit Univ, Fac Optometry, Bangkok, Thailand	Prince of Songkla University; Rangsit University	Myint, CY (corresponding author), HITAP, Nonthaburi, Thailand.	chaw_yin.m@hitap.net; yot.t@hitap.net		Teerawattananon, Yot/0000-0003-2217-2930	Thailand Research Fund [RTA5580010]; Health Systems Research Institute, the National Health Security Office; Bureau of Health Policy and Strategy, Ministry of Public Health; National Health Security Office	Thailand Research Fund(Thailand Research Fund (TRF)); Health Systems Research Institute, the National Health Security Office; Bureau of Health Policy and Strategy, Ministry of Public Health; National Health Security Office	The Health Intervention and Technology Assessment Program is funded by the Thailand Research Fund under the Senior Research Scholar on Health Technology Assessment (RTA5580010), the Health Systems Research Institute, the National Health Security Office, and the Bureau of Health Policy and Strategy, Ministry of Public Health. This study was specifically funded by the National Health Security Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, THINK TANK BEN PACK; Baltussen R, 2009, HEALTH POLICY, V89, P201, DOI 10.1016/j.healthpol.2008.06.003; Dandona L, 2001, INVEST OPHTH VIS SCI, V42, P908; Dandona R, 2001, B WORLD HEALTH ORGAN, V79, P237; Ethan D, 2010, J SCHOOL HEALTH, V80, P340, DOI 10.1111/j.1746-1561.2010.00511.x; Fan DSP, 2004, INVEST OPHTH VIS SCI, V45, P1071, DOI 10.1167/iovs.03-1151; Gao Z, 2012, OPHTHAL EPIDEMIOL, V19, P16, DOI 10.3109/09286586.2011.632703; Goh PP, 2005, OPHTHALMOLOGY, V112, P678, DOI 10.1016/j.ophtha.2004.10.048; Hashim SE, 2008, ANN ACAD MED SINGAP, V37, P940; He MG, 2004, INVEST OPHTH VIS SCI, V45, P793, DOI 10.1167/iovs.03-1051; Ho CSD, 2006, BRIT J OPHTHALMOL, V90, P202, DOI 10.1136/bjo.2005.079343; Nepal BP, 2003, BRIT J OPHTHALMOL, V87, P531, DOI 10.1136/bjo.87.5.531; OstadiMoghaddam H, 2012, OPHTHAL EPIDEMIOL, V19, P166, DOI 10.3109/09286586.2011.602503; Resnikoff S, 2008, B WORLD HEALTH ORGAN, V86, P63, DOI 10.2471/BLT.07.041210; Sharma A, 2008, ARCH OPHTHALMOL-CHIC, V126, P1434, DOI 10.1001/archopht.126.10.1434; Sharma A, 2012, SURV OPHTHALMOL, V57, P272, DOI 10.1016/j.survophthal.2011.11.002; Shrestha GS., 2011, J OPTOM, V4, P49, DOI [10.1016/S1888-4296(11)70041-3, DOI 10.1016/S1888-4296(11)70041-3]; Smith TST, 2009, B WORLD HEALTH ORGAN, V87, P431, DOI 10.2471/BLT.08.055673; The International Agency for the Prevention of Blindness, 2010, INT AG PREV BLINDN 2; Tong L, 2004, INVEST OPHTH VIS SCI, V45, P3914, DOI 10.1167/iovs.04-0492; UNESCO Bangkok, 2011, BASIC ED; UNESCO Bangkok, 2011, EARL CHILDH CAR ED U; Watanee T, 2007, THAI J PUBLIC HLTH O, V21, P11; Wedner SH, 2000, BRIT J OPHTHALMOL, V84, P1291, DOI 10.1136/bjo.84.11.1291; World Health Organization, 2006, SIGHT TEST GLASS COU; Yingyong Penpimol, 2010, Journal of the Medical Association of Thailand, V93, P1205	26	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e96684	10.1371/journal.pone.0096684	http://dx.doi.org/10.1371/journal.pone.0096684			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926993	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100003
J	Yu, S; Klaus, A; Yang, HD; Plenz, D				Yu, Shan; Klaus, Andreas; Yang, Hongdian; Plenz, Dietmar			Scale-Invariant Neuronal Avalanche Dynamics and the Cut-Off in Size Distributions	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; PROPAGATING WAVES; CORTICAL NETWORKS; POWER LAWS; RANGE; POPULATION; CORTEX; MONKEY; PHASE	Identification of cortical dynamics strongly benefits from the simultaneous recording of as many neurons as possible. Yet current technologies provide only incomplete access to the mammalian cortex from which adequate conclusions about dynamics need to be derived. Here, we identify constraints introduced by sub-sampling with a limited number of electrodes, i.e. spatial 'windowing', for well-characterized critical dynamics_neuronal avalanches. The local field potential (LFP) was recorded from premotor and prefrontal cortices in two awake macaque monkeys during rest using chronically implanted 96-microelectrode arrays. Negative deflections in the LFP (nLFP) were identified on the full as well as compact sub-regions of the array quantified by the number of electrodes N (10-95), i.e., the window size. Spatiotemporal nLFP clusters organized as neuronal avalanches, i.e., the probability in cluster size, p(s), invariably followed a power law with exponent -1.5 up to N, beyond which p(s) declined more steeply producing a 'cut-off' that varied with N and the LFP filter parameters. Clusters of size s <= N consisted mainly of nLFPs from unique, non-repeated cortical sites, emerged from local propagation between nearby sites, and carried spatial information about cluster organization. In contrast, clusters of size s>N were dominated by repeated site activations and carried little spatial information, reflecting greatly distorted sampling conditions. Our findings were confirmed in a neuron-electrode network model. Thus, avalanche analysis needs to be constrained to the size of the observation window to reveal the underlying scale-invariant organization produced by locally unfolding, predominantly feed-forward neuronal cascades.	[Yu, Shan; Klaus, Andreas; Yang, Hongdian; Plenz, Dietmar] NIMH, Sect Crit Brain Dynam, Bethesda, MD 20892 USA; [Klaus, Andreas] Karolinska Inst, Nobel Inst Neurophysiol, Dept Neurosci, S-10401 Stockholm, Sweden	National Institutes of Health (NIH) - USA; NIH National Institute of Mental Health (NIMH); Karolinska Institutet	Yu, S (corresponding author), NIMH, Sect Crit Brain Dynam, Bethesda, MD 20892 USA.	yushan.mail@gmail.com	Yu, Shan/S-3123-2017; Yang, Hongdian/D-1450-2015	yu, shan/0000-0002-4385-6306; Klaus, Andreas/0000-0002-4133-351X	Intramural Research Program of the National Institute of Mental Health; National Institutes of Health/Karolinska Institutet Doctoral Program; NATIONAL INSTITUTE OF MENTAL HEALTH [ZIAMH002797] Funding Source: NIH RePORTER	Intramural Research Program of the National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); National Institutes of Health/Karolinska Institutet Doctoral Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This study was supported by the Intramural Research Program of the National Institute of Mental Health (http://intramural.nimh.nih.gov/). A.K. was in addition supported by the National Institutes of Health/Karolinska Institutet Doctoral Program (http://intramural.nimh.nih.gov/ ki-nih/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Beggs JM, 2003, J NEUROSCI, V23, P11167; Benayoun M, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000846; Burroughs SM, 2001, PURE APPL GEOPHYS, V158, P741, DOI 10.1007/PL00001202; Churchland MM, 2012, NATURE, V487, P51, DOI 10.1038/nature11129; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; de Arcangelis L, 2010, P NATL ACAD SCI USA, V107, P3977, DOI 10.1073/pnas.0912289107; Dehghani N, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00302; Deluca A, 2013, ACTA GEOPHYS, V61, P1351, DOI 10.2478/s11600-013-0154-9; Freeman WJ, 2000, J NEUROPHYSIOL, V84, P1266, DOI 10.1152/jn.2000.84.3.1266; Goard M, 2009, NAT NEUROSCI, V12, P1444, DOI 10.1038/nn.2402; Goldman MS, 2009, NEURON, V61, P621, DOI 10.1016/j.neuron.2008.12.012; Hahn G, 2010, J NEUROPHYSIOL, V104, P3312, DOI 10.1152/jn.00953.2009; Harris T. E., 1963, GRUNDLEHREN MATH WIS; Ikegaya Y, 2004, SCIENCE, V304, P559, DOI 10.1126/science.1093173; Kinouchi O, 2006, NAT PHYS, V2, P348, DOI 10.1038/nphys289; Klaus A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019779; Langlois D, 2014, PHYS REV E, V89, DOI 10.1103/PhysRevE.89.012709; Larremore DB, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.066131; Larremore DB, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.058101; Lauritsen KB, 1996, PHYS REV E, V54, P2483, DOI 10.1103/PhysRevE.54.2483; Levina A, 2007, NAT PHYS, V3, P857, DOI 10.1038/nphys758; Millman D, 2010, NAT PHYS, V6, P801, DOI 10.1038/NPHYS1757; Murphy BK, 2009, NEURON, V61, P635, DOI 10.1016/j.neuron.2009.02.005; Naselaris T, 2005, J NEUROPHYSIOL, V93, P2318, DOI 10.1152/jn.00581.2004; Nauhaus I, 2009, NAT NEUROSCI, V12, P70, DOI 10.1038/nn.2232; Newman MEJ, 2005, CONTEMP PHYS, V46, P323, DOI 10.1080/00107510500052444; Pajevic S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000271; Palva JM, 2013, P NATL ACAD SCI USA, V110, P3585, DOI 10.1073/pnas.1216855110; Pasquale V, 2008, NEUROSCIENCE, V153, P1354, DOI 10.1016/j.neuroscience.2008.03.050; Petermann T, 2009, P NATL ACAD SCI USA, V106, P15921, DOI 10.1073/pnas.0904089106; Plenz D, 2012, EUR PHYS J-SPEC TOP, V205, P259, DOI 10.1140/epjst/e2012-01575-5; Reimer A, 2011, CEREB CORTEX, V21, P166, DOI 10.1093/cercor/bhq073; Ribeiro TL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014129; Rubino D, 2006, NAT NEUROSCI, V9, P1549, DOI 10.1038/nn1802; Sato TK, 2012, NEURON, V75, P218, DOI 10.1016/j.neuron.2012.06.029; Shew WL, 2013, NEUROSCIENTIST, V19, P88, DOI 10.1177/1073858412445487; Shew WL, 2011, J NEUROSCI, V31, P55, DOI 10.1523/JNEUROSCI.4637-10.2011; Shew WL, 2009, J NEUROSCI, V29, P15595, DOI 10.1523/JNEUROSCI.3864-09.2009; Shriki O, 2013, J NEUROSCI, V33, P7079, DOI 10.1523/JNEUROSCI.4286-12.2013; Stanley HE, 1999, REV MOD PHYS, V71, pS358, DOI 10.1103/RevModPhys.71.S358; Tagliazucchi E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00015; Thiagarajan TC, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000278; Truccolo W, 2010, NAT NEUROSCI, V13, P105, DOI 10.1038/nn.2455; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Velliste M, 2008, NATURE, V453, P1098, DOI 10.1038/nature06996; Vincent K, 2012, FRONT COMPUT NEUROSC, V6, DOI 10.3389/fncom.2012.00086; Wessberg J, 2000, NATURE, V408, P361, DOI 10.1038/35042582; Wu JY, 2008, NEUROSCIENTIST, V14, P487, DOI 10.1177/1073858408317066; Xu WF, 2007, NEURON, V55, P119, DOI 10.1016/j.neuron.2007.06.016; Yang HD, 2012, J NEUROSCI, V32, P1061, DOI 10.1523/JNEUROSCI.2771-11.2012; Yu S, 2008, CEREB CORTEX, V18, P2891, DOI 10.1093/cercor/bhn047; Yu S, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00042; Yu S, 2011, J NEUROSCI, V31, P17514, DOI 10.1523/JNEUROSCI.3127-11.2011	54	32	32	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99761	10.1371/journal.pone.0099761	http://dx.doi.org/10.1371/journal.pone.0099761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927158	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100076
J	Gimenes, F; Medina, FS; de Abreu, ALP; Irie, MMT; Esquicati, IB; Malagutti, N; Vasconcellos, VRB; Discacciati, MG; Bonini, MG; Maria-Engler, SS; Consolaro, MEL				Gimenes, Fabricia; Medina, Fabiana Soares; Pimenta de Abreu, Andre Luelsdorf; Taguti Irie, Mary Mayumi; Esquicati, Isis Baroni; Malagutti, Natalia; Bulla Vasconcellos, Vinicius Rodrigo; Discacciati, Michele Garcia; Bonini, Marcelo Gialluisi; Maria-Engler, Silvya Stuchi; Lopes Consolaro, Marcia Edilaine			Sensitive Simultaneous Detection of Seven Sexually Transmitted Agents in Semen by Multiplex-PCR and of HPV by Single PCR	PLOS ONE			English	Article							CHLAMYDIA-TRACHOMATIS INFECTION; MALE GENITAL-TRACT; MYCOPLASMA-GENITALIUM; UREAPLASMA-UREALYTICUM; TRICHOMONAS-VAGINALIS; RAPID DETECTION; MEN; DISEASE; IMPACT; URETHRITIS	Sexually transmitted diseases (STDs) may impair sperm parameters and functions thereby promoting male infertility. To date limited molecular studies were conducted to evaluate the frequency and type of such infections in semen Thus, we aimed at conceiving and validating a multiplex PCR (M-PCR) assay for the simultaneous detection of the following STD pathogens in semen: Chlamydia trachomatis, Neisseria gonorrhoeae, Mycoplasma genitalium, Trichomonas vaginalis, Herpes virus simplex (HSV) -1 and -2, and Treponema pallidum; We also investigated the potential usefulness of this M-PCR assay in screening programs for semen pathogens. In addition, we aimed: to detect human Papillomavirus (HPV) and genotypes by single PCR (sPCR) in the same semen samples; to determine the prevalence of the seven STDs, HPV and co-infections; to assess the possibility that these infections affect semen parameters and thus fertility. The overall validation parameters of M-PCR were extremely high including agreement (99.2%), sensitivity (100.00%), specificity (99.70%), positive (96.40%) and negative predictive values (100.00%) and accuracy (99.80%). The prevalence of STDs was very high (55.3%). Furthermore, associations were observed between STDs and changes in semen parameters, highlighting the importance of STD detection in semen. Thus, this M-PCR assay has great potential for application in semen screening programs for pathogens in infertility and STD clinics and in sperm banks.	[Gimenes, Fabricia; Medina, Fabiana Soares; Pimenta de Abreu, Andre Luelsdorf; Taguti Irie, Mary Mayumi; Esquicati, Isis Baroni; Malagutti, Natalia; Bulla Vasconcellos, Vinicius Rodrigo; Lopes Consolaro, Marcia Edilaine] Univ Estadual Maringa, Sect Clin Cytol, Dept Clin Anal & Biomed, Maringa, Parana, Brazil; [Discacciati, Michele Garcia; Maria-Engler, Silvya Stuchi] Univ Sao Paulo, Clin Chem & Toxicol Dept, Sch Pharmaceut Sci, Sao Paulo, Brazil; [Bonini, Marcelo Gialluisi] Univ Illinois, Coll Med, Dept Pharmacol, Chicago, IL USA	Universidade Estadual de Maringa; Universidade de Sao Paulo; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Consolaro, MEL (corresponding author), Univ Estadual Maringa, Sect Clin Cytol, Dept Clin Anal & Biomed, Maringa, Parana, Brazil.	melconsolaro@gmail.com	Consolaro, Marcia EL/I-4932-2014; Engler, Silvya Stuchi Maria/K-5936-2016; Maria-Engler, Silvya/ABC-2016-2020; Discacciati, Michelle Garcia/B-4608-2014	Consolaro, Marcia EL/0000-0001-9102-4865; Engler, Silvya Stuchi Maria/0000-0003-4771-6041; Maria-Engler, Silvya/0000-0003-4771-6041; Discacciati, Michelle Garcia/0000-0003-3660-3826	Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), Brazilian Government [AUX-PE-PRODOC 2571/2010]	Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), Brazilian Government(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This work was supported by grants from Coordenacao de Aperfeicoamento de Pessoal de Nivel superior (CAPES), AUX-PE-PRODOC 2571/2010, Brazilian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Daghistani HI, 2010, MIDDLE EAST FERTIL S, V15, P29, DOI 10.1016/j.mefs.2010.03.003; Bezold G, 2007, FERTIL STERIL, V87, P1087, DOI 10.1016/j.fertnstert.2006.08.109; BOLAN G, 1999, SEXUALLY TRANSMITTED, P117; Brookings C, 2013, KOREAN J UROL, V54, P149, DOI 10.4111/kju.2013.54.3.149; Chen LH, 2013, J MED VIROL, V85, P1229, DOI 10.1002/jmv.23582; Cheng L, 2002, ESSENTIALS ANATOMIC; Cunningham KA, 2008, BIOL REPROD, V79, P180, DOI 10.1095/biolreprod.108.067835; Edwards JL, 2004, CLIN MICROBIOL REV, V17, P965, DOI 10.1128/CMR.17.4.965-981.2004; Elder K, 2005, INFECTIONS, INFERTILITY, AND ASSISTED REPRODUCTION, P1; Eley A, 2005, LANCET INFECT DIS, V5, P53, DOI 10.1016/S1473-3099(04)01254-X; Foresta C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015036; Foresta C, 2010, FERTIL STERIL, V94, P1723, DOI 10.1016/j.fertnstert.2009.11.012; Furuya R, 2004, J UROLOGY, V171, P1550, DOI 10.1097/01.ju.0000116288.59223.e9; Garolla A, 2013, J REPROD IMMUNOL, V100, P20, DOI 10.1016/j.jri.2013.03.004; Gdoura R, 2008, ANDROLOGIA, V40, P209, DOI 10.1111/j.1439-0272.2008.00845.x; Gonzales GF, 2004, ANDROLOGIA, V36, P1, DOI 10.1046/j.0303-4569.2003.00594.x; Gore-Felton C, 2003, INT J STD AIDS, V14, P539, DOI 10.1258/095646203767869156; Hobbs MM, 2006, J CLIN MICROBIOL, V44, P3994, DOI 10.1128/JCM.00952-06; Hobbs MM, 1999, SEX TRANSM DIS, V26, P381, DOI 10.1097/00007435-199908000-00003; Hook E. W., 1999, SEXU LLY TRANSMITTED, P451; Jensen JS, 2004, J EUR ACAD DERMATOL, V18, P1, DOI 10.1111/j.1468-3083.2004.00923.x; Kalwij S, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-802; Kaspersen MD, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-226; Kaspersen MD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018095; Kotronias D, 1998, IN VIVO, V12, P391; Krieger JN, 2002, INT J ANTIMICROB AG, V19, P475, DOI 10.1016/S0924-8579(02)00086-9; LaMontagne DS, 2004, SEX TRANSM INFECT, V80, P335, DOI 10.1136/sti.2004.012856; Lee JS, 2013, UROLOGY, V81, P1219, DOI 10.1016/j.urology.2013.02.044; MANOS MM, 1994, J INFECT DIS, V170, P1096, DOI 10.1093/infdis/170.5.1096; McIver CJ, 2009, J CLIN MICROBIOL, V47, P1358, DOI 10.1128/JCM.01873-08; McKechnie ML, 2009, J CLIN MICROBIOL, V47, P1871, DOI 10.1128/JCM.00120-09; Monavari SH, 2013, J BIOMED RES, V27, P56, DOI 10.7555/JBR.27.20110139; Muller, 1990, SEXUALLY TRANSMITTED, P481; Muvunyi CM, 2011, DIAGN MICR INFEC DIS, V71, P29, DOI 10.1016/j.diagmicrobio.2011.06.005; Nadala Elpidio-Cesar, 2009, BMJ, V339, pb2655, DOI 10.1136/bmj.b2655; Neofytou E, 2009, FERTIL STERIL, V91, P2487, DOI 10.1016/j.fertnstert.2008.03.074; Ochsendorf FR, 2008, ANDROLOGIA, V40, P72, DOI 10.1111/j.1439-0272.2007.00825.x; Olatunbosun O A, 1998, West Afr J Med, V17, P19; Mackern-Oberti JP, 2013, J REPROD IMMUNOL, V100, P37, DOI 10.1016/j.jri.2013.05.002; Peeling Rw, 2005, Can J Infect Dis Med Microbiol, V16, P73; Pellati D, 2008, EUR J OBSTET GYN R B, V140, P3, DOI 10.1016/j.ejogrb.2008.03.009; Rowe PJ., 1993, WHO MANUAL STANDARDI, V83; Rusz A, 2012, WORLD J UROL, V30, P23, DOI 10.1007/s00345-011-0726-8; Sankuntaw N, 2011, MOL CELL PROBE, V25, P114, DOI 10.1016/j.mcp.2011.03.004; Santiago E, 2006, J CLIN VIROL, V37, P38, DOI 10.1016/j.jcv.2006.06.001; Simms I, 2003, SEX TRANSM INFECT, V79, P491, DOI 10.1136/sti.79.6.491; Sleha R, 2013, EPIDEMIOL MIKROBI IM, V62, P26; Souza RP, 2013, AM J TROP MED HYG, V89, P1199, DOI 10.4269/ajtmh.13-0315; Svenstrup HF, 2003, HUM REPROD, V18, P2103, DOI 10.1093/humrep/deg392; Uuskula A, 2002, INT J STD AIDS, V13, P79, DOI 10.1258/0956462021924695; Van Der Pol B, 2008, J INFECT DIS, V197, P548, DOI 10.1086/526496; Wang Y, 2006, ASIAN J ANDROL, V8, P562, DOI 10.1111/j.1745-7262.2006.00190.x; Wikstrom A, 2006, SEX TRANSM INFECT, V82, P276, DOI 10.1136/sti.2005.018598; World Health Organization, 2007, GLOB STRAT PREV CONT; World Health Organization (WHO), 2021, WHO LAB MAN EX PROC, V6th, DOI DOI 10.HTTP://WHQLIBD0C.WH0.INT/PUBLICATI0NS/2010/9789241547789_; Wu Kun-He, 2007, Zhonghua Nan Ke Xue, V13, P1075; Yoshida T, 2003, J CLIN MICROBIOL, V41, P1850, DOI 10.1128/JCM.41.5.1850-1855.2003; Zuckerman RA, 2009, AIDS, V23, P479, DOI 10.1097/QAD.0b013e328326ca62	58	38	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98862	10.1371/journal.pone.0098862	http://dx.doi.org/10.1371/journal.pone.0098862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921247	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300018
J	Kuznetsova, AA; Kuznetsov, NA; Vorobjev, YN; Barthes, NPF; Michel, BY; Burger, A; Fedorova, OS				Kuznetsova, Alexandra A.; Kuznetsov, Nikita A.; Vorobjev, Yuri N.; Barthes, Nicolas P. F.; Michel, Benoit Y.; Burger, Alain; Fedorova, Olga S.			New Environment-Sensitive Multichannel DNA Fluorescent Label for Investigation of the Protein-DNA Interactions	PLOS ONE			English	Article							COLI ENDONUCLEASE-VIII; CONFORMATIONAL DYNAMICS; ANALOGS TC; RECOGNITION; NUCLEOSIDE; MECHANISM; REPAIR; GLYCOSYLASE; COMPLEXES; KINETICS	Here, we report the study of a new multichannel DNA fluorescent base analogue 3-hydroxychromone (3HC) to evaluate its suitability as a fluorescent reporter probe of structural transitions during protein-DNA interactions and its comparison with the current commercially available 2-aminopurine (aPu), pyrrolocytosine (C-py) and 1,3-diaza-2-oxophenoxazine (tC(O)). For this purpose, fluorescent base analogues were incorporated into DNA helix on the opposite or on the 5'-side of the damaged nucleoside 5,6-dihydrouridine (DHU), which is specifically recognized and removed by Endonuclease VIII. These fluorophores demonstrated different sensitivities to the DNA helix conformational changes. The highest sensitivity and the most detailed information about the conformational changes of DNA induced by protein binding and processing were obtained using the 3HC probe. The application of this new artificial fluorescent DNA base is a very useful tool for the studies of complex mechanisms of protein-DNA interactions. Using 3HC biosensor, the kinetic mechanism of Endonuclease VIII action was specified.	[Kuznetsova, Alexandra A.; Kuznetsov, Nikita A.; Vorobjev, Yuri N.; Fedorova, Olga S.] Russian Acad Sci, Inst Chem Biol & Fundamental Med, Siberian Branch, Novosibirsk, Russia; [Kuznetsova, Alexandra A.; Kuznetsov, Nikita A.; Vorobjev, Yuri N.; Fedorova, Olga S.] Novosibirsk State Univ, Dept Nat Sci, Novosibirsk 630090, Russia; [Barthes, Nicolas P. F.; Michel, Benoit Y.; Burger, Alain] Univ Nice Sophia Antipolis, CNRS, UMR 7272, Inst Chim Nice, F-06189 Nice, France	Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences; Novosibirsk State University; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite Cote d'Azur	Burger, A (corresponding author), Univ Nice Sophia Antipolis, CNRS, UMR 7272, Inst Chim Nice, F-06189 Nice, France.	burger@unice.fr; fedorova@niboch.nsc.ru	Kuznetsov, Nikita/AFU-9897-2022; Kuznetsov, Nikita A/F-3245-2011; Kuznetsova, Aleksandra A/G-5119-2013; Fedorova, Olga/ABE-6637-2020; Burger, Alain F/B-9586-2009; Kuznetsov, Nikita/CAA-3889-2022; Fedorova, Olga S./E-1291-2013; BARTHES, Nicolas P F/C-7948-2016	Kuznetsov, Nikita/0000-0002-4016-198X; Kuznetsov, Nikita A/0000-0002-4016-198X; Fedorova, Olga/0000-0002-4001-7187; Kuznetsov, Nikita/0000-0002-4016-198X; Fedorova, Olga S./0000-0002-4001-7187; Kuznetsova, Aleksandra/0000-0002-9805-7050; BARTHES, Nicolas P F/0000-0002-5102-3056	Russian Academy of Sciences "Molecular & Cell Biology" [6.11]; Russian Foundation for Basic Research [12-04-00135, 14-04-00531, 13-04-00013, 14-04-31174]; Russian Ministry of Education and Science [SS-1205.2014.4, SP-4012.2013.4]; Russian Scientific Foundation [14-14-00063]; ANR [ANR-12-BS08-0003-02]; FRM [DCM20111223038]; Russian Science Foundation [14-14-00063] Funding Source: Russian Science Foundation	Russian Academy of Sciences "Molecular & Cell Biology"; Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Russian Ministry of Education and Science(Ministry of Education and Science, Russian Federation); Russian Scientific Foundation(Russian Science Foundation (RSF)); ANR(French National Research Agency (ANR)); FRM(Fondation pour la Recherche Medicale); Russian Science Foundation(Russian Science Foundation (RSF))	The study was supported by the Program of the Russian Academy of Sciences '' Molecular & Cell Biology '' (No 6.11), the Grants from Russian Foundation for Basic Research (12-04-00135, 14-04-00531, 13-04-00013 and 14-04-31174) and Russian Ministry of Education and Science (SS-1205.2014.4 and SP-4012.2013.4), the Grant from Russian Scientific Foundation (14-14-00063). The ANR (ANR-12-BS08-0003-02) and the FRM (DCM20111223038) are thanked for financial support and grant for N.P.F.B. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burgess S, 2002, J BIOL CHEM, V277, P2938, DOI 10.1074/jbc.M110499200; Das R, 2009, PHOTOCH PHOTOBIO SCI, V8, P1583, DOI 10.1039/b906710h; Demchenko AP, 2006, FEBS LETT, V580, P2951, DOI 10.1016/j.febslet.2006.03.091; Dunlap CA, 2002, BIOCHEMISTRY-US, V41, P11226, DOI 10.1021/bi025837g; Dziuba D, 2012, J AM CHEM SOC, V134, P10209, DOI 10.1021/ja3030388; Golan G, 2005, NUCLEIC ACIDS RES, V33, P5006, DOI 10.1093/nar/gki796; Jiang DY, 1997, J BIOL CHEM, V272, P32230, DOI 10.1074/jbc.272.51.32230; Kanazhevskaya LY, 2012, BIOCHEMISTRY-US, V51, P1306, DOI 10.1021/bi201444m; Kim KT, 2013, ORG BIOMOL CHEM, V11, P5605, DOI 10.1039/c3ob41222a; Koval VV, 2010, MUTAT RES-FUND MOL M, V685, P3, DOI 10.1016/j.mrfmmm.2009.08.018; Koval VV, 2004, NUCLEIC ACIDS RES, V32, P926, DOI 10.1093/nar/gkh237; Kropachev KY, 2006, BIOCHEMISTRY-US, V45, P12039, DOI 10.1021/bi060663e; Kuznetsov NA, 2005, NUCLEIC ACIDS RES, V33, P3919, DOI 10.1093/nar/gki694; Kuznetsov NA, 2007, J BIOL CHEM, V282, P1029, DOI 10.1074/jbc.M605788200; Kuznetsov NA, 2007, BIOCHEMISTRY-US, V46, P424, DOI 10.1021/bi060787r; Kuznetsov NA, 2012, DNA REPAIR, V11, P884, DOI 10.1016/j.dnarep.2012.08.004; Kuznetsov NA, 2012, NUCLEIC ACIDS RES, V40, P7384, DOI 10.1093/nar/gks423; Kuznetsov NA, 2009, BIOCHEMISTRY-US, V48, P11335, DOI 10.1021/bi901100b; Kuznetsova AA, 2014, BBA-GEN SUBJECTS, V1840, P387, DOI 10.1016/j.bbagen.2013.09.035; Lakowicz J.R., 2006, PRINCIPLES FLUORESCE, V3rd, DOI DOI 10.1007/978-0-387-46312-4; Liu W, 2013, ACS CHEM BIOL, V8, P2017, DOI 10.1021/cb400256h; MELAMEDE RJ, 1994, BIOCHEMISTRY-US, V33, P1255, DOI 10.1021/bi00171a028; Ono T, 2012, ANGEW CHEM INT EDIT, V51, P1689, DOI 10.1002/anie.201108135; Pawar MG, 2013, J PHYS CHEM B, V117, P14273, DOI 10.1021/jp4071168; Pawar MG, 2013, BIOCONJUG CHEM; Popov A V, 2010, Mol Biol (Mosk), V44, P735; Reddy CK, 2001, J MOL BIOL, V314, P619, DOI 10.1006/jmbi.2001.5154; Rodgers BJ, 2014, CHEM-EUR J, V20, P2010, DOI 10.1002/chem.201303410; Sandin P, 2009, NUCLEIC ACIDS RES, V37, P3924, DOI 10.1093/nar/gkp266; Segal M, 2013, J MED CHEM, V56, P4860, DOI 10.1021/jm301838y; Shynkar VV, 2007, J AM CHEM SOC, V129, P2187, DOI 10.1021/ja068008h; Sinkeldam RW, 2010, CHEM REV, V110, P2579, DOI 10.1021/cr900301e; Sowers LC, 2000, BIOCHEMISTRY-US, V39, P7613, DOI 10.1021/bi992388k; Spadafora M, 2009, TETRAHEDRON, V65, P7809, DOI 10.1016/j.tet.2009.07.021; Stengel G, 2009, ANAL CHEM, V81, P9079, DOI 10.1021/ac9017555; Stengel G, 2009, BIOCHEMISTRY-US, V48, P7547, DOI 10.1021/bi9006995; Stivers JT, 1999, BIOCHEMISTRY-US, V38, P952, DOI 10.1021/bi9818669; Suzuki A, 2013, BIOORG MED CHEM LETT, V23, P886, DOI 10.1016/j.bmcl.2012.11.029; Wilhelmsson LM, 2010, Q REV BIOPHYS, V43, P159, DOI 10.1017/S0033583510000090; Yang KS, 2008, PHOTOCHEM PHOTOBIOL, V84, P741, DOI 10.1111/j.1751-1097.2007.00251.x; Zang Z, 2005, J BIOL CHEM, V280, P30873, DOI 10.1074/jbc.M505283200; Zharkov DO, 2002, EMBO J, V21, P789, DOI 10.1093/emboj/21.4.789	42	37	37	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e100007	10.1371/journal.pone.0100007	http://dx.doi.org/10.1371/journal.pone.0100007			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925085	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300118
J	Eftestol, E; Alver, TN; Gundersen, K; Bruusgaard, JC				Eftestol, Einar; Alver, Tine Norman; Gundersen, Kristian; Bruusgaard, Jo C.			Overexpression of SMPX in Adult Skeletal Muscle Does not Change Skeletal Muscle Fiber Type or Size	PLOS ONE			English	Article							ANABOLIC-STEROIDS; TRAPEZIUS MUSCLE; GENE SMPX; PROTEIN; IDENTIFICATION; HYPERTROPHY; COSTAMERES; MUTATIONS; PATHWAY	Mechanical factors such as stretch are thought to be important in the regulation of muscle phenotype. Small muscle protein X-linked (SMPX) is upregulated by stretch in skeletal muscle and has been suggested to serve both as a transcription factor and a mechanosensor, possibly giving rise to changes in both fiber size and fiber type. We have used in vivo confocal imaging to study the subcellular localization of SMPX in skeletal muscle fibers of adult rats using a SMPX-EGFP fusion protein. The fusion protein was localized predominantly in repetitive double stripes flanking the Z-disc, and was excluded from all nuclei. This localization would be consistent with SMPX being a mechanoreceptor, but not with SMPX playing a role as a transcription factor. In vivo overexpression of ectopic SMPX in skeletal muscle of adult mice gave no significant changes in fiber type distribution or cross sectional area, thus a role of SMPX in regulating muscle phenotype remains unclear.	[Eftestol, Einar; Alver, Tine Norman; Gundersen, Kristian; Bruusgaard, Jo C.] Univ Oslo, Dept Biosci, Oslo, Norway; [Bruusgaard, Jo C.] Atlantis Med Univ Coll, Oslo, Norway	University of Oslo	Bruusgaard, JC (corresponding author), Univ Oslo, Dept Biosci, Oslo, Norway.	bruusgaard@gmail.com	Eftestøl, Einar/AAC-3221-2021	Eftestøl, Einar/0000-0003-3791-3287; Bruusgaard, Jo Christiansen/0000-0001-8163-5849; Norman Alver, Tine/0000-0002-3681-4511				Abbott KL, 1998, MOL BIOL CELL, V9, P2905, DOI 10.1091/mbc.9.10.2905; Bruusgaard JC, 2010, P NATL ACAD SCI USA, V107, P15111, DOI 10.1073/pnas.0913935107; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Egner IM, 2013, J PHYSIOL-LONDON, V591, P6221, DOI 10.1113/jphysiol.2013.264457; Eriksson A, 2005, HISTOCHEM CELL BIOL, V124, P167, DOI 10.1007/s00418-005-0029-5; Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200; Gundersen K, 1998, ACTA PHYSIOL SCAND, V162, P333, DOI 10.1046/j.1365-201X.1998.0336e.x; Gundersen K, 2011, BIOL REV, V86, P564, DOI 10.1111/j.1469-185X.2010.00161.x; Huebner AK, 2011, AM J HUM GENET, V88, P621, DOI 10.1016/j.ajhg.2011.04.007; Kadi F, 2000, HISTOCHEM CELL BIOL, V113, P99, DOI 10.1007/s004180050012; Kadi F, 1999, HISTOCHEM CELL BIOL, V111, P189, DOI 10.1007/s004180050348; Kemp TJ, 2001, GENOMICS, V72, P260, DOI 10.1006/geno.2000.6461; Lunde IG, 2011, J PHYSIOL-LONDON, V589, P1443, DOI 10.1113/jphysiol.2010.202762; Palmer S, 2001, J CELL BIOL, V153, P985, DOI 10.1083/jcb.153.5.985; PARDO JV, 1983, P NATL ACAD SCI-BIOL, V80, P1008, DOI 10.1073/pnas.80.4.1008; Patzak D, 1999, HUM GENET, V105, P506, DOI 10.1007/s004390051138; Rana ZA, 2004, ACTA PHYSIOL SCAND, V181, P233, DOI 10.1111/j.1365-201X.2004.01282.x; Rana ZA, 2008, P NATL ACAD SCI USA, V105, P5921, DOI 10.1073/pnas.0801330105; Schiaffino S, 1996, PHYSIOL REV, V76, P371, DOI 10.1152/physrev.1996.76.2.371; Schindeler A, 2005, EXP CELL RES, V307, P367, DOI 10.1016/j.yexcr.2005.04.006; Schraders M, 2011, AM J HUM GENET, V88, P628, DOI 10.1016/j.ajhg.2011.04.012; Tzima E, 2006, CIRC RES, V98, P176, DOI 10.1161/01.RES.0000200162.94463.d7; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wu MZ, 2011, AGEING RES REV, V10, P1, DOI 10.1016/j.arr.2009.11.002	24	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99232	10.1371/journal.pone.0099232	http://dx.doi.org/10.1371/journal.pone.0099232			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936977	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400013
J	Jung, Y; Kim, M; Soh, H; Lee, S; Kim, J; Park, S; Song, K; Lee, I				Jung, Yusun; Kim, Minsung; Soh, Hyunsu; Lee, Soyoung; Kim, Jungtae; Park, Surim; Song, Kyuyoung; Lee, Inchul			TC1(C8orf4) Regulates Hematopoietic Stem/Progenitor Cells and Hematopoiesis	PLOS ONE			English	Article							STEM-CELLS; TC1 C8ORF4; DISTRIBUTION WIDTH; THYROID-CANCER; DIFFERENTIATION; METAANALYSIS; CONSORTIUM; CYTOKINES; PATHWAYS; SHOCK	Hematopoiesis is a complex process requiring multiple regulators for hematopoietic stem/progenitor cells (HSPC) and differentiation to multi-lineage blood cells. TC1(C8orf4) is implicated in cancers, hematological malignancies and inflammatory activation. Here, we report that Tc1 regulates hematopoiesis in mice. Myeloid and lymphoid cells are increased markedly in peripheral blood of Tc1-deleted mice compared to wild type controls. Red blood cells are small-sized but increased in number. The bone marrow of Tc1(-/-) mice is normocellular histologically. However, Lin(-)Sca-1(+)c-Kit(+) (LSK) cells are expanded in Tc1(-/-) mice compared to wild type controls. The expanded population mostly consists of CD150(-)CD48(+) cells, suggesting the expansion of lineage-restricted hematopoietic progenitor cells. Colony forming units (CFU) are increased in Tc1(-/-) mice bone marrow cells compared to controls. In wild type mice bone marrow, Tc1 is expressed in a limited population of HSPC but not in differentiated cells. Major myeloid transcriptional regulators such as Pu.1 and Cebp alpha are not up-regulated in Tc1(-/-) mice bone marrow. Our findings indicate that TC1 is a novel hematopoietic regulator. The mechanisms of TC1-dependent HSPC regulation and lineage determination are unknown.	[Jung, Yusun; Kim, Minsung; Soh, Hyunsu; Lee, Soyoung; Kim, Jungtae; Park, Surim] Univ Ulsan, Coll Med, Asan Inst Life Sci, Asan Med Ctr, Seoul, South Korea; [Song, Kyuyoung] Univ Ulsan, Coll Med, Dept Biochem & Mol Biol, Asan Med Ctr, Seoul, South Korea; [Lee, Inchul] Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul, South Korea	University of Ulsan; University of Ulsan; University of Ulsan	Lee, I (corresponding author), Univ Ulsan, Coll Med, Dept Pathol, Asan Med Ctr, Seoul, South Korea.	iclee@amc.seoul.kr	Park, Surim/AAD-4973-2019		National Research Foundation - Korean Ministry of Science, ICT, and Future Planning [2009-79398]	National Research Foundation - Korean Ministry of Science, ICT, and Future Planning	This work was supported by the Mid-career Research Program (2009-79398) through National Research Foundation grant funded by the Korean Ministry of Science, ICT, and Future Planning. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beutler E, 2005, BLOOD, V106, P740, DOI 10.1182/blood-2005-02-0713; Biermann H, 1999, J LEUKOCYTE BIOL, V65, P217, DOI 10.1002/jlb.65.2.217; Bouchon A, 2001, NATURE, V410, P1103, DOI 10.1038/35074114; Chua EL, 2000, GENOMICS, V69, P342, DOI 10.1006/geno.2000.6348; Chung SJ, 2012, PARKINSONISM RELAT D, V18, P881, DOI 10.1016/j.parkreldis.2012.04.025; Clements WK, 2013, NAT REV IMMUNOL, V13, P336, DOI 10.1038/nri3443; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Doulatov S, 2012, CELL STEM CELL, V10, P120, DOI 10.1016/j.stem.2012.01.006; Friedman JB, 2004, INT J CANCER, V111, P72, DOI 10.1002/ijc.20235; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Jung YS, 2006, CANCER RES, V66, P723, DOI 10.1158/0008-5472.CAN-05-3124; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kim B, 2006, CLIN CANCER RES, V12, P3541, DOI 10.1158/1078-0432.CCR-05-2440; Kim J, 2009, J IMMUNOL, V183, P3996, DOI 10.4049/jimmunol.0900956; Kim Y, 2006, FEBS LETT, V580, P3519, DOI 10.1016/j.febslet.2006.05.036; Lento W, 2013, COLD SPRING HARB PER, V5; Luc S, 2008, SEMIN IMMUNOL, V20, P213, DOI 10.1016/j.smim.2008.07.005; Mercer EM, 2011, SEMIN IMMUNOL, V23, P317, DOI 10.1016/j.smim.2011.08.004; Metcalf D, 2008, BLOOD, V111, P485, DOI 10.1182/blood-2007-03-079681; Montagnana M, 2012, CLIN CHEM LAB MED, V50, P635, DOI [10.1515/CCLM.2011.831, 10.1515/cclm.2011.831]; Mossadegh-Keller N, 2013, NATURE, V497, P239, DOI 10.1038/nature12026; Oguro H, 2013, CELL STEM CELL, V13, P102, DOI 10.1016/j.stem.2013.05.014; Park J, 2007, BIOCHEM BIOPH RES CO, V360, P447, DOI 10.1016/j.bbrc.2007.06.077; Patel KV, 2010, J GERONTOL A-BIOL, V65, P258, DOI 10.1093/gerona/glp163; Rieger MA, 2009, SCIENCE, V325, P217, DOI 10.1126/science.1171461; Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024; Rossi L, 2012, CELL STEM CELL, V11, P302, DOI 10.1016/j.stem.2012.08.006; Ruiz G, 2004, COMP BIOCHEM PHYS A, V139, P405, DOI 10.1016/j.cbpb.2004.03.003; Seita J, 2010, WIRES SYST BIOL MED, V2, P640, DOI 10.1002/wsbm.86; Soranzo N, 2009, NAT GENET, V41, P1182, DOI 10.1038/ng.467; Sunde M, 2004, CANCER RES, V64, P2766, DOI 10.1158/0008-5472.CAN-03-2093; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Walter MJ, 2009, P NATL ACAD SCI USA, V106, P12950, DOI 10.1073/pnas.0903091106; Wilson NK, 2010, CELL STEM CELL, V7, P532, DOI 10.1016/j.stem.2010.07.016; Yang ZQ, 2006, CANCER RES, V66, P11632, DOI 10.1158/0008-5472.CAN-06-2946; Zhang JH, 2011, MED ONCOL, V28, pS647, DOI 10.1007/s12032-010-9698-6	36	8	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100311	10.1371/journal.pone.0100311	http://dx.doi.org/10.1371/journal.pone.0100311			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937306	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400103
J	Bard, D; Kihal, W; Schillinger, C; Fermanian, C; Segala, C; Glorion, S; Arveiler, D; Weber, C				Bard, Denis; Kihal, Wahida; Schillinger, Charles; Fermanian, Christophe; Segala, Claire; Glorion, Sophie; Arveiler, Dominique; Weber, Christiane			Traffic-Related Air Pollution and the Onset of Myocardial Infarction: Disclosing Benzene as a Trigger? A Small-Area Case-Crossover Study	PLOS ONE			English	Article							PARTICULATE MATTER; HOSPITAL ADMISSIONS; HEART-DISEASE; EXPOSURE; MORTALITY; RISK; POLLUTANTS; EMISSIONS; GASOLINE	Background and Objectives: Exposure to traffic is an established risk factor for the triggering of myocardial infarction (MI). Particulate matter, mainly emitted by diesel vehicles, appears to be the most important stressor. However, the possible influence of benzene from gasoline-fueled cars has not been explored so far. Methods and Results: We conducted a case-crossover study from 2,134 MI cases recorded by the local Coronary Heart Disease Registry (2000-2007) in the Strasbourg Metropolitan Area (France). Available individual data were age, gender, previous history of ischemic heart disease and address of residence at the time of the event. Nitrogen dioxide, particles of median aerodynamic diameter,10 mm (PM10), ozone, carbon monoxide and benzene air concentrations were modeled on an hourly basis at the census block level over the study period using the deterministic ADMS-Urban air dispersion model. Model input data were emissions inventories, background pollution measurements, and meteorological data. We have found a positive, statistically significant association between concentrations of benzene and the onset of MI: per cent increase in risk for a 1 mu g/m(3) increase in benzene concentration in the previous 0, 0-1 and 1 day was 10.4 (95% confidence interval 3-18.2), 10.7 (2.7-19.2) and 7.2 (0.3-14.5), respectively. The associations between the other pollutants and outcome were much lower and in accordance with the literature. Conclusion: We have observed that benzene in ambient air is strongly associated with the triggering of MI. This novel finding needs confirmation. If so, this would mean that not only diesel vehicles, the main particulate matter emitters, but also gasoline-fueled cars-main benzene emitters-, should be taken into account for public health action.	[Bard, Denis; Kihal, Wahida; Fermanian, Christophe; Glorion, Sophie] Ecole Hautes Etud Sante Publ, Dept Epidemiol & Biostat, Rennes, France; [Bard, Denis; Kihal, Wahida; Fermanian, Christophe; Glorion, Sophie] Sorbonne Paris Cite, Paris, France; [Schillinger, Charles] Assoc Surveillance Qual Air Alsace ASPA, Schiltigheim, France; [Segala, Claire] SEPIA Sante, Baud, France; [Arveiler, Dominique] Univ Strasbourg, Dept Epidemiol & Publ Hlth, EA3430, Strasbourg, France; [Weber, Christiane] Univ Strasbourg, CNRS, Fac Geog & Amenagement, LIVE,UMR7362, Strasbourg, France	UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Bard, D (corresponding author), Ecole Hautes Etud Sante Publ, Dept Epidemiol & Biostat, Rennes, France.	denis.bard@ehesp.fr	bard, denis/O-4189-2019		French Agency for Food, Environmental and Occupational Health Safety (ANSES); Institute for Public Health Research (IRESP); Fondation Coeur et Arteres; French Environment and Energy Management Agency (ADEME); SITA Corporation	French Agency for Food, Environmental and Occupational Health Safety (ANSES); Institute for Public Health Research (IRESP); Fondation Coeur et Arteres; French Environment and Energy Management Agency (ADEME); SITA Corporation	This work was supported by French Agency for Food, Environmental and Occupational Health & Safety (ANSES); Institute for Public Health Research (IRESP); Fondation Coeur et Arteres; French Environment and Energy Management Agency (ADEME); and SITA Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baccarelli A, 2011, LANCET, V377, P694, DOI 10.1016/S0140-6736(10)62348-3; Bhaskaran K, 2009, HEART, V95, P1746, DOI 10.1136/hrt.2009.175018; Bhaskaran K, 2012, BRIT MED J, V345, DOI 10.1136/bmj.e8050; Bhatnagar A, 2006, CIRC RES, V99, P692, DOI 10.1161/01.RES.0000243586.99701.cf; Billionnet C, 2012, ANN EPIDEMIOL, V22, P126, DOI 10.1016/j.annepidem.2011.11.004; Bollati V, 2007, CANCER RES, V67, P876, DOI 10.1158/0008-5472.CAN-06-2995; Brook RD, 2010, CIRCULATION, V121, P2331, DOI 10.1161/CIR.0b013e3181dbece1; Carruthers D, 1998, INT J ENVIRON POLLUT, V14, P2000; Delfino RJ, 2003, ENVIRON HEALTH PERSP, V111, P647, DOI 10.1289/ehp.5992; European Environment Agency, 2012, AIR QUAL EUR 2012 RE; Farron O, 2008, TOXICOL IND HEALTH, V24, P261, DOI 10.1177/0748233708098504; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Fusco D, 2001, EUR RESPIR J, V17, P1143, DOI 10.1183/09031936.01.00005501; Havard S, 2009, EPIDEMIOLOGY, V20, P223, DOI 10.1097/EDE.0b013e31819464e1; Huang C, 2013, ATMOS ENVIRON, V77, P703, DOI 10.1016/j.atmosenv.2013.05.059; Janes H, 2005, EPIDEMIOLOGY, V16, P717, DOI 10.1097/01.ede.0000181315.18836.9d; Keenan JJ, 2010, CHEM-BIOL INTERACT, V184, P293, DOI 10.1016/j.cbi.2010.01.016; Kotseva K, 1998, INT ARCH OCC ENV HEA, V71, pS87; KURPPA K, 1984, SCAND J WORK ENV HEA, V10, P381, DOI 10.5271/sjweh.2316; Maclure M, 2000, ANNU REV PUBL HEALTH, V21, P193, DOI 10.1146/annurev.publhealth.21.1.193; Marcazzan GM, 2001, ATMOS ENVIRON, V35, P4639, DOI 10.1016/S1352-2310(01)00124-8; McHale CM, 2012, CARCINOGENESIS, V33, P240, DOI 10.1093/carcin/bgr297; Murugesan K, 2013, PROTEOMICS, V13, P3211, DOI 10.1002/pmic.201300126; Mustafic H, 2012, JAMA-J AM MED ASSOC, V307, P713, DOI 10.1001/jama.2012.126; Nawrot TS, 2011, LANCET, V377, P732, DOI 10.1016/S0140-6736(10)62296-9; Pant P, 2013, ATMOS ENVIRON, V77, P78, DOI 10.1016/j.atmosenv.2013.04.028; Peters A, 2004, NEW ENGL J MED, V351, P1721, DOI 10.1056/NEJMoa040203; Peters A, 2002, LANCET, V360, P1184, DOI 10.1016/S0140-6736(02)11289-X; Peters A, 2001, CIRCULATION, V103, P2810; Sacks JD, 2012, AM J EPIDEMIOL, V176, P622, DOI 10.1093/aje/kws135; Schwartz J, 1999, EPIDEMIOLOGY, V10, P17, DOI 10.1097/00001648-199901000-00005; Tsai DH, 2010, SCI TOTAL ENVIRON, V408, P1818, DOI 10.1016/j.scitotenv.2010.01.044; TUNSTALLPEDOE H, 1994, CIRCULATION, V90, P583, DOI 10.1161/01.CIR.90.1.583	33	24	24	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100307	10.1371/journal.pone.0100307	http://dx.doi.org/10.1371/journal.pone.0100307			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932584	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600108
J	Iqbal, SA; Hayton, MJ; Watson, JS; Szczypa, P; Bayat, A				Iqbal, Syed Amir; Hayton, Michael John; Watson, James Stewart; Szczypa, Piotr; Bayat, Ardeshir			First Identification of Resident and Circulating Fibrocytes in Dupuytren's Disease Shown to Be Inhibited by Serum Amyloid P and Xiapex	PLOS ONE			English	Article							PERIPHERAL-BLOOD FIBROCYTES; MESENCHYMAL STEM-CELLS; CLOSTRIDIUM-HISTOLYTICUM; POTENTIAL SOURCE; TISSUE-REPAIR; FIBROBLASTS; FIBROSIS; MYOFIBROBLASTS; EXPRESSION; DIFFERENTIATION	Dupuytren's disease (DD) is a common progressive fibroproliferative disorder causing permanent digital contracture. Proliferative myofibroblasts are thought to be the cells responsible for DD initiation and recurrence, although their source remains unknown. DD tissue has also been shown to harbor mesenchymal and hematopoietic stem cells. Fibrocytes are circulating cells that show characteristics of fibroblasts and they express surface markers for both hematopoietic and mesenchymal stromal cells. Fibrocytes differentiate from peripheral CD14(+) mononuclear cells, which can be inhibited by serum amyloid P (SAP). In this study we have demonstrated the presence of fibrocytes in DD blood and tissue, moreover we have evaluated the effects of SAP and Xiapex (Collagenase Clostridium histolyticum) on fibrocytes derived from DD. H&E staining showed typical Spindle shaped morphology of fibrocytes. FACS analysis based on a unique combination of 3 markers, revealed the increased presence of fibrocytes in blood and tissue of DD patients. Additionally, immunohistology of DD nodule and cord tissue showed the presence of collagen 1(+)/CD34(+) cells. No difference in plasma SAP levels was observed between DD and control. Higher concentrations of SAP significantly inhibited fibrocytes differentiated from DD derived monocytes compared to control. DD fascia derived fibrocytes showed resistance to growth inhibition by SAP, particularly nodule derived fibrocytes showed robust growth even at higher SAP concentrations compared to control. DD derived fibrocytes were positive for typical fibrocyte dual markers, i.e. Collagen 1/LSP-1 and collagen 1/CD34. Xiapex was more effective in inhibiting the growth of nodule derived cells compared to commercially available collagenase A. Our results show for the first time the increased presence of fibrocytes in DD patient's blood and disease tissue compared to control tissue. Additionally, we evaluate the response of these fibrocytes to SAP and Xiapex therapy.	[Iqbal, Syed Amir; Bayat, Ardeshir] Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England; [Hayton, Michael John] Wrightington Hosp, Dept Hand & Upper Limb Surg, Wrightington, England; [Watson, James Stewart; Bayat, Ardeshir] Wythenshawe Hosp, Dept Plast & Reconstruct Surg, Univ Hosp South Manchester NHS Fdn Trust, Manchester M23 9LT, Lancs, England; [Szczypa, Piotr] Med Affairs Pfizer Ltd, Tadworth, Surrey, England	University of Manchester; Wythenshawe Hospital NHS Foundation Trust; Wythenshawe Hospital; Pfizer	Bayat, A (corresponding author), Univ Manchester, Manchester Inst Biotechnol, Manchester, Lancs, England.	ardeshir.Bayat@manchester.ac.uk		BAYAT, ARDESHIR/0000-0002-4116-6491	Pfizer Pvt. Ltd. UK	Pfizer Pvt. Ltd. UK	The author(s) received funding from Pfizer Pvt. Ltd. UK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AZZARONE B, 1983, J CELL PHYSIOL, V117, P353, DOI 10.1002/jcp.1041170310; Bayat A, 2006, ANN ROY COLL SURG, V88, P3, DOI 10.1308/003588406X83104; Bayat A, 2007, BRIT J HOSP MED, V68, P604, DOI 10.12968/hmed.2007.68.11.27683; Bayat A, 2010, NAT REV RHEUMATOL, V6, P7, DOI 10.1038/nrrheum.2009.255; Bisson MA, 2003, J HAND SURG-BRIT EUR, V28B, P351, DOI 10.1016/S0266-7681(03)00135-9; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; BURKHARDT K, 1995, TRANSPLANT P, V27, P890; Chesney J, 1997, BIOCHEM SOC T, V25, P520, DOI 10.1042/bst0250520; Chesney J, 2000, Curr Rheumatol Rep, V2, P501, DOI 10.1007/s11926-000-0027-5; Chesney J, 1998, J IMMUNOL, V160, P419; Curnow SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009730; Dibenedetti Dana Britt, 2011, Hand (N Y), V6, P149, DOI 10.1007/s11552-010-9306-4; Grieb G, 2011, INT REV CEL MOL BIO, V291, P1, DOI 10.1016/B978-0-12-386035-4.00001-X; Herzog EL, 2010, EXP HEMATOL, V38, P548, DOI 10.1016/j.exphem.2010.03.004; Hindocha Sandip, 2009, Hand (N Y), V4, P256, DOI 10.1007/s11552-008-9160-9; Holland AJA, 2008, J BURN CARE RES, V29, P619, DOI 10.1097/BCR.0b013e31817db90a; HUESTON J, 1985, ANN ROY COLL SURG, V67, P372; Iqbal SA, 2012, ARCH DERMATOL RES, V304, P665, DOI 10.1007/s00403-012-1225-5; Iqbal SA, 2012, STEM CELLS DEV, V21, P609, DOI 10.1089/scd.2011.0140; Keeley EC, 2010, INT J BIOCHEM CELL B, V42, P535, DOI 10.1016/j.biocel.2009.10.014; Lugering N, 1998, ITAL J GASTROENTEROL, V30, P338; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; MCCANN BG, 1993, J HAND SURG-BRIT EUR, V18B, P656, DOI 10.1016/0266-7681(93)90029-F; Oh SJ, 1998, HISTOCHEM CELL BIOL, V109, P349, DOI 10.1007/s004180050235; PEPYS MB, 1978, CLIN EXP IMMUNOL, V32, P119; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Quan Timothy E, 2006, Curr Rheumatol Rep, V8, P145, DOI 10.1007/s11926-006-0055-x; RABINOWITZ JL, 1983, LIPIDS, V18, P371, DOI 10.1007/BF02537234; Ratajczak-Wielgomas K, 2012, CONNECT TISSUE RES, V53, P469, DOI 10.3109/03008207.2012.686542; Reilkoff RA, 2011, NAT REV IMMUNOL, V11, P427, DOI 10.1038/nri2990; Shih B, 2010, NAT REV RHEUMATOL, V6, P715, DOI 10.1038/nrrheum.2010.180; Starkweather KD, 1996, J HAND SURG-AM, V21A, P490, DOI 10.1016/S0363-5023(96)80368-6; Strieter RM, 2009, J LEUKOCYTE BIOL, V86, P1111, DOI 10.1189/jlb.0309132; Sun L, 2011, AM J PHYSIOL-LUNG C, V300, pL341, DOI 10.1152/ajplung.00122.2010; Syed F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031430; Thomas A, 2010, THER CLIN RISK MANAG, V6, P557, DOI 10.2147/TCRM.S8591; Vakil V, 2009, J MAGN RESON IMAGING, V30, P1284, DOI 10.1002/jmri.21800; Verjee LS, 2009, J HAND SURG-AM, V34A, P1785, DOI 10.1016/j.jhsa.2009.08.005; Wada T, 2007, KIDNEY INT, V72, P269, DOI 10.1038/sj.ki.5002325; Wang JF, 2007, WOUND REPAIR REGEN, V15, P113, DOI 10.1111/j.1524-475X.2006.00192.x; Wang JF, 2007, J LEUKOCYTE BIOL, V82, P1554, DOI 10.1189/0507306; Yang LJ, 2005, WOUND REPAIR REGEN, V13, P398, DOI 10.1111/j.1067-1927.2005.130407.x; Zeisberg M, 2004, J MOL MED, V82, P175, DOI 10.1007/s00109-003-0517-9	45	3	4	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99967	10.1371/journal.pone.0099967	http://dx.doi.org/10.1371/journal.pone.0099967			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933153	gold, Green Submitted, Green Published			2022-12-27	WOS:000337738600082
J	Lukasik, A; Zielenkiewicz, P				Lukasik, Anna; Zielenkiewicz, Piotr			In Silico Identification of Plant miRNAs in Mammalian Breast Milk Exosomes - A Small Step Forward?	PLOS ONE			English	Article							SITE ACCESSIBILITY; ACCESSORY PROTEIN; MICRORNAS; PREDICTION; RECEPTOR; TARGETS; BINDING; MICROBIOME; EXPRESSION; DIAGNOSIS	MicroRNAs (miRNAs) are a class of small RNA molecules that regulate gene expression by inhibiting the protein translation or targeting the mRNA cleavage. They play many important roles in living organism cells; however, the knowledge on miRNAs functions has become more extensive upon their identification in biological fluids and recent reports on plant-origin miRNAs abundance in human plasma and serum. Considering these findings, we performed a rigorous bioinformatics analysis of publicly available, raw data from high-throughput sequencing studies on miRNAs composition in human and porcine breast milk exosomes to identify the fraction of food-derived miRNAs. Several processing and filtering steps were applied to increase the accuracy, and to avoid false positives. Through aforementioned analysis, 35 and 17 miRNA species, belonging to 25 and 11 MIR families, were identified, respectively. In the human samples the highest abundance levels yielded the ath-miR166a, pab-miR951, ptc-miR472a and bdi-miR168, while in the porcine breast milk exosomes, the zma-miR168a, zma-miR156a and ath-miR166a have been identified in the largest amounts. The consensus prediction and annotation of potential human targets for select plant miRNAs suggest that the aforementioned molecules may interact with mRNAs coding several transcription factors, protein receptors, transporters and immune-related proteins, thus potentially influencing human organism. Taken together, the presented analysis shows proof of abundant plant miRNAs in mammal breast milk exosomes, pointing at the same time to the new possibilities arising from this discovery.	[Lukasik, Anna; Zielenkiewicz, Piotr] Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland; [Zielenkiewicz, Piotr] Univ Warsaw, Dept Plant Mol Biol, Inst Expt Plant Biol & Biotechnol, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; University of Warsaw	Zielenkiewicz, P (corresponding author), Polish Acad Sci, Inst Biochem & Biophys, Warsaw, Poland.	piotr@ibb.waw.pl		Zielenkiewicz, Piotr/0000-0001-8151-6874	Institute of Biochemistry and Biophysics, Polish Academy of Sciences (IBB PAS)	Institute of Biochemistry and Biophysics, Polish Academy of Sciences (IBB PAS)	This work was supported by the Institute of Biochemistry and Biophysics, Polish Academy of Sciences (IBB PAS). The IBB PAS had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexiou P, 2009, BIOINFORMATICS, V25, P3049, DOI 10.1093/bioinformatics/btp565; Augustin R, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-35; Broderick JA, 2011, GENE THER, V18, P1104, DOI 10.1038/gt.2011.50; Chackerian AA, 2007, J IMMUNOL, V179, P2551, DOI 10.4049/jimmunol.179.4.2551; Cheung H, 2005, J IMMUNOL, V174, P5351, DOI 10.4049/jimmunol.174.9.5351; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; De Guire V, 2013, CLIN BIOCHEM, V46, P846, DOI 10.1016/j.clinbiochem.2013.03.015; Debets R, 2000, J IMMUNOL, V165, P4950, DOI 10.4049/jimmunol.165.9.4950; DelValle J, 1997, AM J PHYSIOL-GASTR L, V273, pG987, DOI 10.1152/ajpgi.1997.273.5.G987; Dickinson B, 2013, NAT BIOTECHNOL, V31, P965, DOI 10.1038/nbt.2737; Dugas DV, 2004, CURR OPIN PLANT BIOL, V7, P512, DOI 10.1016/j.pbi.2004.07.011; Enright AJ, 2004, GENOME BIOL, V5; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fahlgren N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000219; Gu YR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043691; Hogg M, 2011, ADV GENET, V73, P87, DOI 10.1016/B978-0-12-380860-8.00003-3; Hu WQ, 2012, CELL RES, V22, P1322, DOI 10.1038/cr.2012.80; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Indrio F, 2009, ITAL J PEDIATR, V35, DOI 10.1186/1824-7288-35-39; Jones-Rhoades MW, 2012, PLANT MOL BIOL, V80, P3, DOI 10.1007/s11103-011-9829-2; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kawamata T, 2010, TRENDS BIOCHEM SCI, V35, P368, DOI 10.1016/j.tibs.2010.03.009; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Korkmaz G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082556; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Kruszka K, 2012, J PLANT PHYSIOL, V169, P1664, DOI 10.1016/j.jplph.2012.03.009; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu B., 2012, BRIEF BIOINFORM; Liu N, 2008, CELL RES, V18, P985, DOI 10.1038/cr.2008.278; Lukasik A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-801; Luzi E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039767; Ma YJ, 2012, J CELL MOL MED, V16, P2539, DOI 10.1111/j.1582-4934.2012.01572.x; Mack GS, 2007, NAT BIOTECHNOL, V25, P631, DOI 10.1038/nbt0607-631; Matsumoto S, 2013, CIRC RES, V113, P322, DOI 10.1161/CIRCRESAHA.113.301209; Motameny S, 2010, GENES-BASEL, V1, P70, DOI 10.3390/genes1010070; Muhlebach MD, 2011, NATURE, V480, P530, DOI 10.1038/nature10639; Munafo DB, 2010, RNA, V16, P2537, DOI 10.1261/rna.2242610; Noyce RS, 2012, TRENDS MICROBIOL, V20, P429, DOI 10.1016/j.tim.2012.05.006; Oboki Keisuke, 2010, Allergology International, V59, P143, DOI 10.2332/allergolint.10-RAI-0186; Pandey P, 2011, BMC SYST BIOL, V5, DOI 10.1186/1752-0509-5-56; Park SM, 2008, GENE DEV, V22, P894, DOI 10.1101/gad.1640608; Pattichis Katerina, 1995, Drug Metabolism and Drug Interactions, V12, P1; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Peterson SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00023; Pruitt KD, 2009, GENOME RES, V19, P1316, DOI 10.1101/gr.080531.108; Quackenbush JF, 2014, METHODS MOL BIOL, V1102, P641, DOI 10.1007/978-1-62703-727-3_34; Ramaswami G, 2013, NAT METHODS, V10, P128, DOI [10.1038/nmeth.2330, 10.1038/NMETH.2330]; Ramaswami G, 2012, NAT METHODS, V9, P579, DOI [10.1038/NMETH.1982, 10.1038/nmeth.1982]; Reczko Martin, 2012, Frontiers in Genetics, V2, P103, DOI 10.3389/fgene.2011.00103; Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604; Rekker K, 2014, CLIN BIOCHEM, V47, P135, DOI 10.1016/j.clinbiochem.2013.10.020; Reymond N, 2001, J BIOL CHEM, V276, P43205, DOI 10.1074/jbc.M103810200; Roberts T, 2014, NY TIMES BK REV, V119, P5; SAEKI K, 1975, J PHARMACOL EXP THER, V193, P910; Sethupathy P, 2006, NAT METHODS, V3, P881, DOI 10.1038/NMETH954; Sun LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043760; Sunkar R, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-37; Taylor DD, 2011, METHODS MOL BIOL, V728, P235, DOI 10.1007/978-1-61779-068-3_15; Vandenplas Y, 2000, J GASTROEN HEPATOL, V15, P593, DOI 10.1046/j.1440-1746.2000.02169.x; Wang K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051009; Weber JA, 2010, CLIN CHEM, V56, P1733, DOI 10.1373/clinchem.2010.147405; Wienholds E, 2005, FEBS LETT, V579, P5911, DOI 10.1016/j.febslet.2005.07.070; WILLIAMS TM, 1991, SCIENCE, V254, P1791, DOI 10.1126/science.1840704; Xie FL, 2011, GENE, V473, P8, DOI 10.1016/j.gene.2010.09.007; Yan X, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-92; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474; Ying SY, 2008, MOL BIOTECHNOL, V38, P257, DOI 10.1007/s12033-007-9013-8; Zhang BH, 2007, J CELL PHYSIOL, V210, P279, DOI 10.1002/jcp.20869; Zhang L, 2012, CELL RES, V22, P107, DOI 10.1038/cr.2011.158; Zhang Y, 2010, J INTEGR BIOINFORMAT, V7, DOI 10.2390/biecoll-jib-2010-127; Zhang YJ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-381; Zhang ZH, 2010, NUCLEIC ACIDS RES, V38, pD806, DOI 10.1093/nar/gkp818; Zhou Q, 2012, INT J BIOL SCI, V8, P118, DOI 10.7150/ijbs.8.118; Zhu BL, 2010, PROTEIN CELL, V1, P718, DOI 10.1007/s13238-010-0093-z	75	56	56	3	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99963	10.1371/journal.pone.0099963	http://dx.doi.org/10.1371/journal.pone.0099963			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933019	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600081
J	Ma, L; Shen, CJ; Cohen, EA; Xiong, SD; Wang, JH				Ma, Li; Shen, Chan-Juan; Cohen, Eric A.; Xiong, Si-Dong; Wang, Jian-Hua			miRNA-1236 Inhibits HIV-1 Infection of Monocytes by Repressing Translation of Cellular Factor VprBP	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; REPEAT LTR TRANSACTIVATION; E3 UBIQUITIN LIGASE; MICRORNA REGULATION; BLOOD MONOCYTES; HLA-C; REPLICATION; RESTRICTION; COMPLEX; PROTEIN	Primary monocytes are refractory to HIV-1 infection and become permissive upon differentiation into monocyte-derived dendritic cells (MDDCs) or macrophages. Multiple mechanisms have been proposed to interpret HIV-1 restriction in monocytes. Human cellular miRNAs can modulate HIV-1 infection by targeting either conserved regions of the HIV-1 genome or host gene transcripts. We have recently reported that the translation of host protein pur-alpha is repressed by abundant cellular miRNAs to inhibit HIV-1 infection in monocytes. Here, we report that the transcript of another cellular factor, VprBP [Vpr (HIV-1)-binding protein], was repressed by cellular miRNA-1236, which contributes to HIV-1 restriction in monocytes. Transfection of miR-1236 inhibitors enhanced translation of VprBP in monocytes and significantly promoted viral infection; exogenous input of synthesized miR-1236 mimics into MDDCs suppressed translation of VprBP, and, accordingly, significantly impaired viral infection. Our data emphasize the role of miRNA in modulating differentiation-dependent susceptibility of the host cell to HIV-1 infection. Understanding the modulation of HIV-1 infection by cellular miRNAs may provide key small RNAs or the identification of new important protein targets regulated by miRNAs for the development of antiviral strategies.	[Ma, Li; Xiong, Si-Dong] Soochow Univ, Inst Biol & Med Sci, Jiangsu Key Lab Infect & Immun, Suzhou, Peoples R China; [Ma, Li; Shen, Chan-Juan; Wang, Jian-Hua] Chinese Acad Sci, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China; [Cohen, Eric A.] Inst Rech Clin Montreal, Lab Human Retrovirol, Montreal, PQ H2W 1R7, Canada	Soochow University - China; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Institut de Recherche Clinique de Montreal (IRCM); Universite de Montreal	Wang, JH (corresponding author), Chinese Acad Sci, Key Lab Mol Virol & Immunol, Inst Pasteur Shanghai, Shanghai, Peoples R China.	Jh_wang@sibs.ac.cn			Chinese Academy of Sciences; Natural Science Foundation of China [81171567]; National Basic Research Program of China (973 Program) [2012CB519004]; Sanofi-Aventis-SIBS Scholarship Program	Chinese Academy of Sciences(Chinese Academy of Sciences); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Sanofi-Aventis-SIBS Scholarship Program	This work was supported by grants to J.H.W. from the Interdisciplinary and Collaboration team of Chinese Academy of Sciences; the Natural Science Foundation of China (No. 81171567), and the National Basic Research Program of China (973 Program) (2012CB519004). J.H.W. gratefully acknowledges the support of the Sanofi-Aventis-SIBS Scholarship Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahluwalia JK, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-117; Ahn J, 2012, J BIOL CHEM, V287, P12550, DOI 10.1074/jbc.M112.340711; Ahn J, 2010, J BIOL CHEM, V285, P37333, DOI 10.1074/jbc.M110.133181; Arfi V, 2008, J VIROL, V82, P6557, DOI 10.1128/JVI.02321-07; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Belzile JP, 2010, J VIROL, V84, P3320, DOI 10.1128/JVI.02590-09; Bergamaschi A, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-31; Berger A, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002425; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Chiang K, 2013, VIROLOGY, V438, P1, DOI 10.1016/j.virol.2012.12.016; Collini P, 2010, CURR MOL MED, V10, P727, DOI 10.2174/156652410793384141; Detsika MG, 2012, AIDS REV, V14, P188; Dong CS, 2009, J VIROL, V83, P3518, DOI 10.1128/JVI.02665-08; Duan M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060170; Duskova K, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-250; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; Fowler L, 2013, AIDS REV, V15, P3; Gaulke CA, 2014, J VIROL; Gerard FCA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089195; Hariharan M, 2005, BIOCHEM BIOPH RES CO, V337, P1214, DOI 10.1016/j.bbrc.2005.09.183; He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Hrecka K, 2011, NATURE, V474, P658, DOI 10.1038/nature10195; Huang JL, 2007, NAT MED, V13, P1241, DOI 10.1038/nm1639; Klase Z, 2012, J BIOL CHEM, V287, P40884, DOI 10.1074/jbc.R112.415448; Kogan M, 2013, J CELL PHYSIOL, V228, P781, DOI 10.1002/jcp.24226; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Kulkarni S, 2013, P NATL ACAD SCI USA, V110, P20705, DOI 10.1073/pnas.1312237110; Kulkarni S, 2011, NATURE, V472, P495, DOI 10.1038/nature09914; Laguette N, 2014, CELL, V156, P134, DOI 10.1016/j.cell.2013.12.011; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Lahouassa H, 2012, NAT IMMUNOL, V13, P223, DOI 10.1038/ni.2236; Mraz M, 2009, LEUKEMIA LYMPHOMA, V50, P506, DOI 10.1080/10428190902763517; Nathans R, 2009, MOL CELL, V34, P696, DOI 10.1016/j.molcel.2009.06.003; Neil S, 2001, J VIROL, V75, P5448, DOI 10.1128/JVI.75.12.5448-5456.2001; Qin Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027609; Seddiki N, 2013, EUR J IMMUNOL, V43, P510, DOI 10.1002/eji.201242695; Shen CJ, 2012, FASEB J, V26, P4755, DOI 10.1096/fj.12-209023; Sisk JM, 2012, VIRUSES-BASEL, V4, P1844, DOI 10.3390/v4101844; Sonza S, 1996, J VIROL, V70, P3863, DOI 10.1128/JVI.70.6.3863-3869.1996; Sun GH, 2012, NUCLEIC ACIDS RES, V40, P2181, DOI 10.1093/nar/gkr961; Sung TL, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000263; Swaminathan G, 2014, J MOL BIOL, V426, P1178, DOI 10.1016/j.jmb.2013.12.017; Swaminathan S, 2012, AIDS; Thapa DR, 2014, J ACQUIR IMMUNE DEFI; Triques K, 2004, J VIROL, V78, P5523, DOI 10.1128/JVI.78.10.5523-5527.2004; Van Lint C, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-67; Wang X, 2013, J BIOL CHEM, V288, P15474, DOI 10.1074/jbc.M112.416735; Zhang HS, 2012, FEBS LETT, V586, P4203, DOI 10.1016/j.febslet.2012.10.023; Zhang HS, 2012, BBA-MOL CELL RES, V1823, P1017, DOI 10.1016/j.bbamcr.2012.02.014; Zhang YJ, 2014, RETROVIROLOGY, V11, DOI 10.1186/1742-4690-11-23; Zhang ZN, 2013, CLIN CHEM, V59, P1175, DOI 10.1373/clinchem.2012.197335; Zhou HL, 2008, CELL HOST MICROBE, V4, P495, DOI 10.1016/j.chom.2008.10.004	54	25	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99535	10.1371/journal.pone.0099535	http://dx.doi.org/10.1371/journal.pone.0099535			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932481	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600040
J	Sepp, M; Sokolova, N; Jugai, S; Mandel, M; Peterson, P; Vendelin, M				Sepp, Mervi; Sokolova, Niina; Jugai, Svetlana; Mandel, Merle; Peterson, Pearu; Vendelin, Marko			Tight Coupling of Na+/K+-ATPase with Glycolysis Demonstrated in Permeabilized Rat Cardiomyocytes	PLOS ONE			English	Article							MUSCLE PYRUVATE-KINASE; MITOCHONDRIAL RESPIRATION; OXIDATIVE-PHOSPHORYLATION; SARCOPLASMIC-RETICULUM; FUNCTIONAL COMPLEXES; POTASSIUM-TRANSPORT; AEROBIC GLYCOLYSIS; SKELETAL-MUSCLE; CREATINE-KINASE; ADP DIFFUSION	The effective integrated organization of processes in cardiac cells is achieved, in part, by the functional compartmentation of energy transfer processes. Earlier, using permeabilized cardiomyocytes, we demonstrated the existence of tight coupling between some of cardiomyocyte ATPases and glycolysis in rat. In this work, we studied contribution of two membrane ATPases and whether they are coupled to glycolysis - sarcoplasmic reticulum Ca2+ ATPase (SERCA) and plasmalemma Na+/K+-ATPase (NKA). While SERCA activity was minor in this preparation in the absence of calcium, major role of NKA was revealed accounting to similar to 30% of the total ATPase activity which demonstrates that permeabilized cell preparation can be used to study this pump. To elucidate the contribution of NKA in the pool of ATPases, a series of kinetic measurements was performed in cells where NKA had been inhibited by 2 mM ouabain. In these cells, we recorded: ADP- and ATP-kinetics of respiration, competition for ADP between mitochondria and pyruvate kinase (PK), ADP-kinetics of endogenous PK, and ATP-kinetics of total ATPases. The experimental data was analyzed using a series of mathematical models with varying compartmentation levels. The results show that NKA is tightly coupled to glycolysis with undetectable flux of ATP between mitochondria and NKA. Such tight coupling of NKA to PK is in line with its increased importance in the pathological states of the heart when the substrate preference shifts to glucose.	[Sepp, Mervi; Sokolova, Niina; Jugai, Svetlana; Mandel, Merle; Peterson, Pearu; Vendelin, Marko] Tallinn Univ Technol, Inst Cybernet, Lab Syst Biol, EE-19086 Tallinn, Estonia	Tallinn University of Technology	Vendelin, M (corresponding author), Tallinn Univ Technol, Inst Cybernet, Lab Syst Biol, EE-19086 Tallinn, Estonia.	markov@sysbio.ioc.ee	Karro, Niina/AAF-8185-2020; Vendelin, Marko/AAE-7137-2020; Karro, Niina/AAF-9037-2020	Vendelin, Marko/0000-0002-6459-0391; Karro, Niina/0000-0002-3231-0789; Peterson, Pearu/0000-0001-7328-4305	The Wellcome Trust [WT081755MA]; European Union through European Regional Development Fund; Estonian Science Foundation [ETF8041]	The Wellcome Trust(Wellcome TrustEuropean Commission); European Union through European Regional Development Fund; Estonian Science Foundation	This research was funded by The Wellcome Trust (Fellowship no. WT081755MA, http://www.wellcome.ac.uk/), European Union through the European Regional Development Fund, the Estonian Science Foundation (grant no. ETF8041, Ph.D. stipend for NS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrienko T, 2003, J EXP BIOL, V206, P2059, DOI 10.1242/jeb.00242; Bers DM, 2006, ANN NY ACAD SCI, V1080, P165, DOI 10.1196/annals.1380.015; Boudina S, 2002, AM J PHYSIOL-HEART C, V282, pH821, DOI 10.1152/ajpheart.00471.2001; Branovets J, 2013, AM J PHYSIOL-HEART C, V305, pH506, DOI 10.1152/ajpheart.00919.2012; BRICKNELL OL, 1978, CIRC RES, V43, P102, DOI 10.1161/01.RES.43.1.102; CAMPBELL JD, 1992, J PHYSIOL-LONDON, V447, P67, DOI 10.1113/jphysiol.1992.sp018991; Crowther GJ, 2002, AM J PHYSIOL-ENDOC M, V282, pE74, DOI 10.1152/ajpendo.2002.282.1.E74; Dizon J, 1998, AM J PHYSIOL-HEART C, V274, pH1082, DOI 10.1152/ajpheart.1998.274.4.H1082; Dos Santos P, 2004, MOL CELL BIOCHEM, V256, P157, DOI 10.1023/B:MCBI.0000009866.75225.e2; Duicu O, 2013, MOL CELL BIOCHEM, V379, P229, DOI 10.1007/s11010-013-1644-4; ERECINSKA M, 1991, J NEUROSCI, V11, P2410; GIBBS CL, 1982, PHARMACOL THERAPEUT, V18, P133, DOI 10.1016/0163-7258(82)90065-1; Harjot K, 2007, AM J PHYSIOL-HEART C, V293, P169; Illaste A, 2012, BIOPHYS J, V102, P739, DOI 10.1016/j.bpj.2012.01.012; James JH, 1996, J CLIN INVEST, V98, P2388, DOI 10.1172/JCI119052; Jepihhina N, 2011, BIOPHYS J, V101, P2112, DOI 10.1016/j.bpj.2011.09.025; JOHNSON GS, 1970, J BIOL CHEM, V245, P238; Kaasik A, 2001, CIRC RES, V89, P153, DOI 10.1161/hh1401.093440; KACHMAR JF, 1953, J BIOL CHEM, V200, P669; Kay L, 2000, J BIOL CHEM, V275, P6937, DOI 10.1074/jbc.275.10.6937; Kay L, 1997, BBA-BIOENERGETICS, V1322, P41, DOI 10.1016/S0005-2728(97)00071-6; KEMP RG, 1973, J BIOL CHEM, V248, P3963; Kongas O, 2002, AM J PHYSIOL-CELL PH, V283, pC743, DOI 10.1152/ajpcell.00101.2002; KUMMEL L, 1988, CARDIOVASC RES, V22, P359, DOI 10.1093/cvr/22.5.359; Li LR, 2012, BIOPHYS J, V102, P2039, DOI 10.1016/j.bpj.2012.03.045; MANSIER P, 1982, NATURE, V300, P535, DOI 10.1038/300535a0; Mattevi A, 1996, FEBS LETT, V389, P15, DOI 10.1016/0014-5793(96)00462-0; MERCER RW, 1981, J GEN PHYSIOL, V78, P547, DOI 10.1085/jgp.78.5.547; MILDVAN AS, 1965, J BIOL CHEM, V240, P238; Munoz ME, 2003, COMP BIOCHEM PHYS B, V135, P197, DOI 10.1016/S1096-4959(03)00081-2; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Okamoto K, 2001, AM J PHYSIOL-ENDOC M, V281, pE479, DOI 10.1152/ajpendo.2001.281.3.E479; PARKER JC, 1967, J GEN PHYSIOL, V50, P893, DOI 10.1085/jgp.50.4.893; PAUL RJ, 1983, AM J PHYSIOL, V244, pC399, DOI 10.1152/ajpcell.1983.244.5.C399; PAUL RJ, 1979, SCIENCE, V206, P1414, DOI 10.1126/science.505014; PEUHKURINEN KJ, 1983, BIOCHEM J, V210, P193, DOI 10.1042/bj2100193; Ramay HR, 2009, BIOPHYS J, V97, P443, DOI 10.1016/j.bpj.2009.04.062; Rogers TB, 1995, BIOSCIENCE REP, V15, P341, DOI 10.1007/BF01788366; Ruiz-Meana M, 2007, BASIC RES CARDIOL, V102, P542, DOI 10.1007/s00395-007-0675-y; Saks V, 2003, BIOPHYS J, V84, P3436, DOI 10.1016/S0006-3495(03)70065-4; SAKS VA, 1993, BIOCHIM BIOPHYS ACTA, V1144, P134, DOI 10.1016/0005-2728(93)90166-D; SCHRIER SL, 1966, AM J PHYSIOL, V210, P139, DOI 10.1152/ajplegacy.1966.210.1.139; Sepp M, 2010, BIOPHYS J, V98, P2785, DOI 10.1016/j.bpj.2010.03.025; Seppet EK, 2001, BBA-BIOENERGETICS, V1504, P379, DOI 10.1016/S0005-2728(00)00269-3; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Takaki M, 2004, JPN J PHYSIOL, V54, P175, DOI 10.2170/jjphysiol.54.175; UYEDA K, 1965, J BIOL CHEM, V240, P4689; VEKSLER VI, 1987, BIOCHIM BIOPHYS ACTA, V892, P191, DOI 10.1016/0005-2728(87)90174-5; Vendelin M, 2004, MOL CELL BIOCHEM, V256, P229, DOI 10.1023/B:MCBI.0000009871.04141.64; Vendelin M, 2008, AM J PHYSIOL-CELL PH, V295, pC1302, DOI 10.1152/ajpcell.00313.2008; WEISS J, 1985, J CLIN INVEST, V75, P436, DOI 10.1172/JCI111718; Weiss JN, 2001, CIRC RES, V89, P108, DOI 10.1161/res.89.2.108	52	22	22	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99413	10.1371/journal.pone.0099413	http://dx.doi.org/10.1371/journal.pone.0099413			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932585	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600033
J	Huguet-Tapia, JC; Bignell, DRD; Loria, R				Huguet-Tapia, Jose C.; Bignell, Dawn R. D.; Loria, Rosemary			Characterization of the Integration and Modular Excision of the Integrative Conjugative Element PAISt in Streptomyces turgidiscabies Car8	PLOS ONE			English	Article							PLANT PATHOGENICITY; GENUS STREPTOMYCES; BACTERIAL GENOMES; ESCHERICHIA-COLI; SP-NOV; EVOLUTION; SITE; DATABASE; POSSESSES; INTEGRONS	PAISt is a large genomic island located in the chromosome of the plant pathogen Streptomyces turgidiscabies Car8. The island carries clustered virulence genes, transfers to other Streptomyces species, and integrates by site-specific recombination at the 8 bp palindrome TTCATGAA. The palindrome is located at the 3' end of the bacitracin resistance gene (bacA). We demonstrate that PAISt is able to excise in modules by recombination of one internal and two flanking palindromic direct repeats. The gene intSt located at the 3(end of PAISt encodes a tyrosine recombinase. Site-specific recombination activity of intSt was tested and confirmed by heterologous expression in Streptomyces coelicolor. Comparative analysis of PAISt homologues in Streptomyces scabies 87-22 and Streptomyces acidiscabies 84-104 indicates that these islands have been fixed by sequence erosion of intSt and the recombination sites.	[Huguet-Tapia, Jose C.; Loria, Rosemary] Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA; [Bignell, Dawn R. D.] Mem Univ Newfoundland, Dept Biol, St John, NF, Canada	State University System of Florida; University of Florida; Memorial University Newfoundland	Loria, R (corresponding author), Univ Florida, Dept Plant Pathol, Gainesville, FL 32611 USA.	rloria@ufl.edu		Bignell, Dawn/0000-0003-1731-5669	United States Department of Agriculture's National Institute of Food and Agriculture [2012-04027]; University of Florida, Institute of Food and Agricultural Sciences	United States Department of Agriculture's National Institute of Food and Agriculture; University of Florida, Institute of Food and Agricultural Sciences(University of Florida)	United States Department of Agriculture's National Institute of Food and Agriculture (http://www.csrees.usda.gov) grant No. 2012-04027. University of Florida, Institute of Food and Agricultural Sciences (http://ifas.ufl.edu) internal funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; BIBB MJ, 1985, GENE, V38, P215, DOI 10.1016/0378-1119(85)90220-3; Bukhalid RA, 1998, MOL PLANT MICROBE IN, V11, P960, DOI 10.1094/MPMI.1998.11.10.960; Burrus V, 2004, RES MICROBIOL, V155, P376, DOI 10.1016/j.resmic.2004.01.012; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Du L, 2012, INT J MOL SCI, V13, P4797, DOI 10.3390/ijms13044797; Esposito D, 1997, NUCLEIC ACIDS RES, V25, P3605, DOI 10.1093/nar/25.18.3605; Ghinet MG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027846; Gregory MA, 2003, J BACTERIOL, V185, P5320, DOI 10.1128/JB.185.17.5320-5323.2003; Grohmann E, 2003, MICROBIOL MOL BIOL R, V67, P277, DOI 10.1128/MMBR.67.2.277-301.2003; Groth AC, 2004, J MOL BIOL, V335, P667, DOI 10.1016/j.jmb.2003.09.082; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Hall RM, 2012, ANN NY ACAD SCI, V1267, P71, DOI 10.1111/j.1749-6632.2012.06588.x; Hochhut B, 2001, J BACTERIOL, V183, P1124, DOI 10.1128/JB.183.4.1124-1132.2001; Huguet-Tapia JC, 2011, PLASMID, V65, P118, DOI 10.1016/j.plasmid.2010.11.002; Joshi MV, 2007, MOL PLANT MICROBE IN, V20, P751, DOI 10.1094/MPMI-20-7-0751; Kers JA, 2005, MOL MICROBIOL, V55, P1025, DOI 10.1111/j.1365-2958.2004.04461.x; Lambert C, 2002, BIOINFORMATICS, V18, P1250, DOI 10.1093/bioinformatics/18.9.1250; LAMBERT DH, 1989, INT J SYST BACTERIOL, V39, P387, DOI 10.1099/00207713-39-4-387; LAMBERT DH, 1989, INT J SYST BACTERIOL, V39, P393, DOI 10.1099/00207713-39-4-393; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee CA, 2007, MOL MICROBIOL, V66, P1356, DOI 10.1111/j.1365-2958.2007.06000.x; Loria R, 1997, PLANT DIS, V81, P836, DOI 10.1094/PDIS.1997.81.8.836; Loria R, 2008, ANTON LEEUW INT J G, V94, P3, DOI 10.1007/s10482-008-9240-4; Loria R, 2006, ANNU REV PHYTOPATHOL, V44, P469, DOI 10.1146/annurev.phyto.44.032905.091147; Marra D, 1999, MOL MICROBIOL, V31, P609, DOI 10.1046/j.1365-2958.1999.01201.x; Mazel D, 2006, NAT REV MICROBIOL, V4, P608, DOI 10.1038/nrmicro1462; Miyajima K, 1998, INT J SYST BACTERIOL, V48, P495, DOI 10.1099/00207713-48-2-495; Pavlovic G, 2004, MICROBIOL-SGM, V150, P759, DOI 10.1099/mic.0.26883-0; Poele EMT, 2008, ANTON LEEUW INT J G, V94, P127, DOI 10.1007/s10482-008-9255-x; Quiroz TS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026031; Schubert S, 2004, MOL MICROBIOL, V51, P837, DOI 10.1046/j.1365-2958.2003.03870.x; Seipke RF, 2008, J BACTERIOL, V190, P7684, DOI 10.1128/JB.01010-08; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Wozniak RAF, 2010, NAT REV MICROBIOL, V8, P552, DOI 10.1038/nrmicro2382	35	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99345	10.1371/journal.pone.0099345	http://dx.doi.org/10.1371/journal.pone.0099345			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927117	gold, Green Submitted, Green Published			2022-12-27	WOS:000338278100036
J	Martens, L; Goode, G; Wold, JFH; Beck, L; Martin, G; Perings, C; Stolt, P; Baggerman, L				Martens, Leon; Goode, Grahame; Wold, Johan F. H.; Beck, Lionel; Martin, Georgina; Perings, Christian; Stolt, Pelle; Baggerman, Lucas			Structured Syncope Care Pathways Based on Lean Six Sigma Methodology Optimises Resource Use with Shorter Time to Diagnosis and Increased Diagnostic Yield	PLOS ONE			English	Article							PATIENT SATISFACTION; EMERGENCY-DEPARTMENT; MANAGEMENT	Aim: To conduct a pilot study on the potential to optimise care pathways in syncope/Transient Loss of Consciousness management by using Lean Six Sigma methodology while maintaining compliance with ESC and/or NICE guidelines. Methods: Five hospitals in four European countries took part. The Lean Six Sigma methodology consisted of 3 phases: 1) Assessment phase, in which baseline performance was mapped in each centre, processes were evaluated and a new operational model was developed with an improvement plan that included best practices and change management; 2) Improvement phase, in which optimisation pathways and standardised best practice tools and forms were developed and implemented. Staff were trained on new processes and change-management support provided; 3) Sustaining phase, which included support, refinement of tools and metrics. The impact of the implementation of new pathways was evaluated on number of tests performed, diagnostic yield, time to diagnosis and compliance with guidelines. One hospital with focus on geriatric populations was analysed separately from the other four. Results: With the new pathways, there was a 59% reduction in the average time to diagnosis (p = 0.048) and a 75% increase in diagnostic yield (p = 0.007). There was a marked reduction in repetitions of diagnostic tests and improved prioritisation of indicated tests. Conclusions: Applying a structured Lean Six Sigma based methodology to pathways for syncope management has the potential to improve time to diagnosis and diagnostic yield.	[Martens, Leon; Baggerman, Lucas] Medtron Hosp Solut, Heerlen, Netherlands; [Goode, Grahame] Blackpool Victoria Hosp, Blackpool, England; [Wold, Johan F. H.] Med Ctr Alkmaar, Alkmaar, Netherlands; [Beck, Lionel] Ctr Hosp Univ Caremeau, Nimes, France; [Martin, Georgina] Northern Gen Royal Hallamshire Hosp, Sheffield, S Yorkshire, England; [Perings, Christian] St Marien Hosp, Lunen, Germany; [Stolt, Pelle] MagliaRotta, Basel, Switzerland	Medical Center Of Alkmaar; Universite de Montpellier; CHU de Nimes; St. Marien Hospital	Stolt, P (corresponding author), MagliaRotta, Basel, Switzerland.	pelle.stolt@magliarotta.com		Stolt, Pelle/0000-0001-6270-3332				Baron-Esquivias G, 2010, EUROPACE, V12, P869, DOI 10.1093/europace/euq018; Brignole M, 2006, EUROPACE, V8, P644, DOI 10.1093/europace/eul071; Brignole M, 2010, EUROPACE, V12, P109, DOI 10.1093/europace/eup370; Camacho Fabian, 2006, N C Med J, V67, P409; CAMPBELL JL, 1994, FAM PRACT, V11, P438, DOI 10.1093/fampra/11.4.438; De Bleser Leentje, 2006, J Nurs Manag, V14, P553, DOI 10.1111/j.1365-2934.2006.00702.x; Disertori M, 2003, EUROPACE, V5, P283, DOI 10.1016/S1099-5129(03)00049-7; Edvardsson NG, 2012, ECE 2012 MUN GERM P; Edvardsson N, 2011, EUROPACE, V13, P262, DOI 10.1093/europace/euq418; Farwell DJ, 2004, HEART, V90, P52, DOI 10.1136/heart.90.1.52; Guldner S, 2012, DTSCH ARZTEBL INT, V109, P58, DOI 10.3238/arztebl.2012.0058; Kong MC, 2007, HEALTH QUAL LIFE OUT, V5, DOI 10.1186/1477-7525-5-62; McCarthy F, 2010, IRISH J MED SCI, V179, P551, DOI 10.1007/s11845-010-0497-z; Moya A, 2009, EUR HEART J, V30, P2631, DOI 10.1093/eurheartj/ehp298; NICE, CG 109 TRANS LOSS CO; Niedzwiecki D, 2012, UCLA HLTH SYSTEM; Sanders NA, 2013, PACE, V36, P152, DOI 10.1111/pace.12033; Shen WK, 2004, CIRCULATION, V110, P3636, DOI 10.1161/01.CIR.0000149236.92822.07; Shirazi SAA, 2013, INT J CARE PATHW, V16, P160; Soteriades ES, 2002, NEW ENGL J MED, V347, P878, DOI 10.1056/NEJMoa012407; Womack JamesP., 1990, MACHINE CHANGED WORL	21	17	18	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100208	10.1371/journal.pone.0100208	http://dx.doi.org/10.1371/journal.pone.0100208			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927475	Green Submitted, Green Published, gold			2022-12-27	WOS:000338278100119
J	Ni, XJ; Liu, SN; Lu, FC; Shi, XG; Guo, XF				Ni, Xiaojia; Liu, Shaonan; Lu, Fuchang; Shi, Xiaogeng; Guo, Xinfeng			Efficacy and Safety of Tai Chi for Parkinson's Disease: A Systematic Review and Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Review							QUALITY-OF-LIFE; CHALLENGES INHERENT; RISK-FACTORS; EXERCISE; INTERVENTION; FALLS	Background and Objective: In Parkinson's disease (PD), wearing off and side effects of long-term medication and complications pose challenges for neurologists. Although Tai Chi is beneficial for many illnesses, its efficacy for PD remains uncertain. The purpose of this review was to evaluate the efficacy and safety of Tai Chi for PD. Methods: Randomized controlled trials (RCTs) of Tai Chi for PD were electronically searched by the end of December 2013 and identified by two independent reviewers. The tool from the Cochrane Handbook 5.1 was used to assess the risk of bias. A standard meta-analysis was performed using RevMan 5.2 software. Results: Ten trials with PD of mild-to-moderate severity were included in the review, and nine trials (n = 409) were included in the meta-analysis. The risk of bias was generally high in the blinding of participants and personnel. Improvements in the Unified Parkinson's Disease Rating Scale Part III (mean difference (MD) -4.34, 95% confidence interval (CI) -6.67 - -2.01), Berg Balance Scale (MD: 4.25, 95% CI: 2.83-5.66), functional reach test (MD: 3.89, 95% CI: 1.73-6.04), Timed Up and Go test (MD: -0.75, 95% CI: -1.30 - -0.21), stride length (standardized MD: 0.56, 95% CI: 0.03-1.09), health-related quality of life (standardized MD: -1.10, 95% CI: -1.81- -0.39) and reduction of falls were greater after interventions with Tai Chi plus medication. Satisfaction and safety were high. Intervention with Tai Chi alone was more effective for only a few balance and mobility outcomes. Conclusions: Tai Chi performed with medication resulted in promising gains in mobility and balance, and it was safe and popular among PD patients at an early stage of the disease. This provides a new evidence for PD management. More RCTs with larger sample size that carefully address blinding and prudently select outcomes are needed.	[Ni, Xiaojia] Guangdong Prov Hosp Chinese Med, Res & Dev Dept New Drugs, Guangzhou, Guangdong, Peoples R China; [Ni, Xiaojia; Lu, Fuchang] Guangzhou Univ Chinese Med, Coll Clin Med 2, Guangzhou, Guangdong, Peoples R China; [Liu, Shaonan; Guo, Xinfeng] Guangdong Prov Hosp Chinese Med, Key Unit Methodol Clin Res, Guangzhou, Guangdong, Peoples R China; [Shi, Xiaogeng] Guangdong Prov Hosp Chinese Med, Dept Neurol, Guangzhou, Guangdong, Peoples R China	Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine; Guangzhou University of Chinese Medicine	Guo, XF (corresponding author), Guangdong Prov Hosp Chinese Med, Key Unit Methodol Clin Res, Guangzhou, Guangdong, Peoples R China.	drguoxinfeng@163.com	Ni, Xiaojia/C-1378-2014; Northcote, Matthew/B-8209-2019; Guo, Xinfeng/AAG-6818-2019; Northcote, Matthew/L-1135-2019; Liu, Shaonan/K-4946-2019; GUO, Xinfeng/AAM-6850-2021	Ni, Xiaojia/0000-0001-6624-5244; Guo, Xinfeng/0000-0003-2699-9740; Liu, Shaonan/0000-0003-4618-5779; Liu, Shaonan/0000-0001-7981-7977	Joint Special Project of Guangdong Provincial Department of Science and Technology-Guangdong Provincial Academy of Chinese Medical Sciences: Construction and Application of Evidence-Based Knowledge Management System for Traditional Chinese Medicine, China [2012A032500009]	Joint Special Project of Guangdong Provincial Department of Science and Technology-Guangdong Provincial Academy of Chinese Medical Sciences: Construction and Application of Evidence-Based Knowledge Management System for Traditional Chinese Medicine, China	This study was supported by Joint Special Project of Guangdong Provincial Department of Science and Technology-Guangdong Provincial Academy of Chinese Medical Sciences: Construction and Application of Evidence-Based Knowledge Management System for Traditional Chinese Medicine (No. 2012A032500009), China. http://pro.gdstc.gov.cn/stms/main.jsp The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amano S, 2013, PARKINSONISM RELAT D, V19, P955, DOI 10.1016/j.parkreldis.2013.06.007; ANTMAN EM, 1992, JAMA-J AM MED ASSOC, V268, P240, DOI 10.1001/jama.268.2.240; Antonini A, 2009, EXPERT REV NEUROTHER, V9, P859, DOI [10.1586/ern.09.48, 10.1586/ERN.09.48]; Caminiti G, 2011, REHABIL RES PRACT, V2011, DOI 10.1155/2011/761958; Chang Jason Y, 2011, Medsurg Nurs, V20, P63; Choi Hye-Jung, 2013, ISRN Neurol, V2013, P548240, DOI 10.1155/2013/548240; Ding M, 2012, AM J PHYS MED REHAB, V91, P1091, DOI 10.1097/PHM.0b013e31826edd21; Gladfelter BA, 2011, EFFECT TAI CHI EXERC; Goetz CG, 2003, MOVEMENT DISORD, V18, P738, DOI 10.1002/mds.10473; Hackney ME, 2008, GAIT POSTURE, V28, P456, DOI 10.1016/j.gaitpost.2008.02.005; Hackney ME, 2009, PARKINSONISM RELAT D, V15, P644, DOI 10.1016/j.parkreldis.2009.03.003; Hall AM, 2009, BMC MUSCULOSKEL DIS, V10, DOI 10.1186/1471-2474-10-55; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Higginson IJ, 2010, PLOS ONE, V7; Irwin MR, 2008, SLEEP, V31, P1001; Kenny RAM, 2011, J AM GERIATR SOC, V59, P148, DOI 10.1111/j.1532-5415.2010.03234.x; Kerr GK, 2010, NEUROLOGY, V75, P116, DOI 10.1212/WNL.0b013e3181e7b688; Lan C, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/502131; Lee MS, 2008, PARKINSONISM RELAT D, V14, P589, DOI 10.1016/j.parkreldis.2008.02.003; Li FZ, 2008, AM J PUBLIC HEALTH, V98, P1195, DOI 10.2105/AJPH.2007.120402; Li FZ, 2014, MOVEMENT DISORD, V29, P539, DOI 10.1002/mds.25787; Li FZ, 2012, NEW ENGL J MED, V366, P511, DOI 10.1056/NEJMoa1107911; Li JX, 2011, MOTION CONTROL EFFEC; Macdonald Geraldine, 2012, Cochrane Database Syst Rev, pCD001930, DOI 10.1002/14651858.CD001930.pub3; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; National Center for Complementary and Alternative Medicine, 2006, TAI CHI HLTH PURP; National Collaborating Centre for Chronic Conditions (UK), 2006, PARK DIS NAT CLIN GU; Nocera Joe R, 2013, J Yoga Phys Ther, V3, DOI 10.4172/2157-7595.1000137; Okun MS, 2010, EXPERT REV NEUROTHER, V10, P1847, DOI 10.1586/ERN.10.156; Ossig C, 2013, J NEURAL TRANSM, V120, P523, DOI 10.1007/s00702-013-1008-y; OXMAN AD, 1993, ANN NY ACAD SCI, V703, P125, DOI 10.1111/j.1749-6632.1993.tb26342.x; Pahwa R, 2009, CURR MED RES OPIN, V25, P841, DOI [10.1185/03007990902779319, 10.1185/03007990902779319 ]; Pedrosa DJ, 2013, NEUROPSYCH DIS TREAT, V9, P321, DOI [10.2147/NDT.S32302, 10.2147/NDT.532302]; Rudzinska M, 2013, NEUROL NEUROCHIR POL, V47, P431, DOI 10.5114/ninp.2013.38223; Schrag A, 2006, MOVEMENT DISORD, V21, P1200, DOI 10.1002/mds.20914; Shulman LM, 2010, ARCH NEUROL-CHICAGO, V67, P64, DOI 10.1001/archneurol.2009.295; Soh SE, 2012, PHYSIOTHER CAN, V64, P338, DOI 10.3138/ptc.2011-26; Tang JL, 2010, FUNDAMENTALS EVIDENC; Tanner CM, 2014, MOV DISORD; Toh SFM, 2013, HONG KONG J OCCUP TH, V23, P69, DOI 10.1016/j.hkjot.2013.11.001; Tomlinson CL, 2012, BMJ-BRIT MED J, V345, DOI 10.1136/bmj.e5004; Wang Chenchen, 2010, BMC Complement Altern Med, V10, P23, DOI 10.1186/1472-6882-10-23; Wang CC, 2011, RHEUM DIS CLIN N AM, V37, P19, DOI 10.1016/j.rdc.2010.11.002; Wang CC, 2010, NEW ENGL J MED, V363, P743, DOI 10.1056/NEJMoa0912611; Wang J, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/215254; Wayne PM, 2008, J ALTERN COMPLEM MED, V14, P191, DOI 10.1089/acm.2007.7170B; Wayne PM, 2008, J ALTERN COMPLEM MED, V14, P95, DOI 10.1089/acm.2007.7170A; Wayne PM, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-7; Wood L, 2008, BMJ-BRIT MED J, V336, P601, DOI 10.1136/bmj.39465.451748.AD; World Health Organization, 2006, NEUR DIS PUBL HLTH C; Yeh GY, 2010, RESP CARE, V55, P1475; Zhang ZX, 2005, LANCET, V365, P595, DOI 10.1016/S0140-6736(05)70801-1; [朱毅 Zhu Yi], 2011, [中国康复理论与实践, Chinese Journal of Rehabilitation Theory and Practice], V17, P355	53	66	69	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99377	10.1371/journal.pone.0099377	http://dx.doi.org/10.1371/journal.pone.0099377			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927169	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100037
J	Saito, PK; Yamakawa, RH; Aparecida, EP; da Silva, WV; Borelli, SD				Saito, Patricia Keiko; Yamakawa, Roger Haruki; Aparecida, Erica Pereira; da Silva Junior, Waldir Verissimo; Borelli, Sueli Donizete			Evaluation of the Humoral Immune Response to Human Leukocyte Antigens in Brazilian Renal Transplant Candidates	PLOS ONE			English	Article							KIDNEY GRAFT FAILURE; HLA-DP ANTIBODIES; CLASS-I; HYPERACUTE REJECTION; MEDIATED REJECTION; VOLUNTEER DONORS; POPULATION; POLYMORPHISM; IMPACT; ALLOANTIBODIES	Pre-transplant sensitization to human leukocyte antigens (HLA) is a risk factor for graft failure. Studies of the immunological profile related to anti-HLA antibodies in Brazilian renal transplant candidates are few. In this study, we evaluated the humoral immune response to HLA antigens in 269 renal transplant candidates, in Parana State, Brazil. The HLA typing was performed by the polymerase chain reaction sequence-specific oligonucleotide method (PCR-SSO) combined with Luminex technology, using an SSO-LABType commercial kit (One Lambda, Inc., Canoga Park, CA, USA). The percentages of panel-reactive antibodies (PRA) and the specificity of anti-HLA antibodies were determined using the LS1PRA and LS2PRA commercial kits (One Lambda, Inc.). The PRA-positive group consisted of 182 (67.7%) patients, and the PRA-negative group of 87 (32.3%) patients. The two groups differed significantly only with respect to gender. Females were the most sensitized. Among the 182 patients with PRA-positive, 62 (34.1%) were positive for class I and negative for class II, 39 (21.4%) were negative for class I and positive for class II, and 81 (44.5%) were positive for both classes I and II. The HLA-A*02, A*24, A*01, B*44, B*35, B*15, DRB1*11, DRB1*04 and DRB1*03 allele groups were the most frequent. The specificities of anti-HLA antibodies were more frequent: A34, B57, Cw15, Cw16, DR51, DQ8 and DP14. This study documented the profile of anti-HLA antibodies in patients with chronic renal failure who were on waiting lists for an organ in Parana, and found high sensitization to HLA antigens in the samples.	[Saito, Patricia Keiko; Yamakawa, Roger Haruki; Borelli, Sueli Donizete] Univ Estadual Maringa, Dept Basic Hlth Sci, Maringa, Parana, Brazil; [Aparecida, Erica Pereira] Histogene Lab Histocompatibil & Genet, Maringa, Parana, Brazil; [da Silva Junior, Waldir Verissimo] Univ Estadual Maringa, Dept Stat, Maringa, Parana, Brazil	Universidade Estadual de Maringa; Universidade Estadual de Maringa	Borelli, SD (corresponding author), Univ Estadual Maringa, Dept Basic Hlth Sci, Maringa, Parana, Brazil.	sueliborelli@gmail.com			National Council for Scientific and Technological Development [830008/2003-9]; Coordination for Enhancement of Higher Education Personnel - CAPES	National Council for Scientific and Technological Development(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordination for Enhancement of Higher Education Personnel - CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	This study was supported by National Council for Scientific and Technological Development (grant number 830008/2003-9) and Coordination for Enhancement of Higher Education Personnel - CAPES. The funders' websites are http://www.capes.gov.br/ for CAPES, and http://www.cnpq.br/ for CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe M, 1997, TRANSPLANTATION, V63, P1616, DOI 10.1097/00007890-199706150-00014; Assane AAA, 2010, HUM IMMUNOL, V71, P1027, DOI 10.1016/j.humimm.2010.06.017; Bachelet T, 2011, AM J TRANSPLANT, V11, P1543, DOI 10.1111/j.1600-6143.2011.03584.x; Barama A, 2000, CLIN TRANSPLANT, V14, P212, DOI 10.1034/j.1399-0012.2000.140306.x; Bardi Marlene Silva, 2012, Rev. Bras. Hematol. Hemoter., V34, P25, DOI 10.5581/1516-8484.20120010; Bortolotto AS, 2012, HUM IMMUNOL, V73, P180, DOI 10.1016/j.humimm.2011.11.009; CARVALHO AS, 1983, TISSUE ANTIGENS, V21, P39; CHAPMAN JR, 1986, TRANSPLANTATION, V42, P91; Silva Silvia Fernandes Ribeiro da, 2013, Rev. Bras. Hematol. Hemoter., V35, P185, DOI 10.5581/1516-8484.20130043; Dausset Jean, 1954, VOX SANG BASEL, V4, P190; Duquesnoy RJ, 2011, TRANSPL IMMUNOL, V24, P164, DOI 10.1016/j.trim.2010.12.003; Egfjord M, 2003, SCAND J IMMUNOL, V57, P362, DOI 10.1046/j.1365-3083.2003.01203.x; Frohn C, 2001, NEPHROL DIAL TRANSPL, V16, P355, DOI 10.1093/ndt/16.2.355; Fu Q, 2012, TRANSPL P, V44, P217, DOI 10.1016/j.transproceed.2011.12.041; Gilbert M, 2011, TRANSPL P, V43, P3412, DOI 10.1016/j.transproceed.2011.09.023; GOODNOUGH LT, 1994, CLIN NEPHROL, V41, P303; Goral S, 2008, NEPHROL DIAL TRANSPL, V23, P390, DOI 10.1093/ndt/gfm703; HALLORAN PF, 1990, TRANSPLANTATION, V49, P85, DOI 10.1097/00007890-199001000-00019; Heise E, 2001, CLIN TRANSPLANT, V15, P22, DOI 10.1034/j.1399-0012.2001.00004.x; Idica Adam, 2006, Clin Transpl, P139; Karahan GE, 2009, TRANSPL P, V41, P3651, DOI 10.1016/j.transproceed.2009.04.007; KISSMEYE F, 1966, LANCET, V2, P662, DOI 10.1016/S0140-6736(66)92829-7; Kliger AS, 2012, CLIN J AM SOC NEPHRO, V7, P354, DOI 10.2215/CJN.11961111; Krishnan N S, 2012, Indian J Nephrol, V22, P409, DOI 10.4103/0971-4065.106029; Ling M, 2012, HUM IMMUNOL, V73, P879, DOI 10.1016/j.humimm.2012.07.320; Matas AJ, 2000, CLIN TRANSPLANT, V14, P90, DOI 10.1034/j.1399-0012.2000.140117.x; Mota Mariza Aparecida, 2013, Rev. Bras. Hematol. Hemoter., V35, P160, DOI 10.5581/1516-8484.20130046; Nigam P, 2004, TISSUE ANTIGENS, V64, P204, DOI 10.1111/j.1399-0039.2004.00264.x; Ozdemir FN, 2004, TRANSPL IMMUNOL, V12, P185, DOI 10.1016/j.trim.2003.11.003; Parra FC, 2003, P NATL ACAD SCI USA, V100, P177, DOI 10.1073/pnas.0126614100; PATEL R, 1969, NEW ENGL J MED, V280, P735, DOI 10.1056/NEJM196904032801401; Paximadis M, 2012, HUM IMMUNOL, V73, P80, DOI 10.1016/j.humimm.2011.10.013; PAYNE R, 1958, J CLIN INVEST, V37, P1756, DOI 10.1172/JCI103768; Phelan PJ, 2012, CLIN TRANSPLANT, V26, P544, DOI 10.1111/j.1399-0012.2011.01581.x; Piazza A, 1989, Gene Geogr, V3, P141; Probst CM, 2000, HUM BIOL, V72, P597; Qiu JX, 2005, TRANSPLANTATION, V80, P1511, DOI 10.1097/01.tp.0000181384.49832.3a; Ribas F, 2008, TISSUE ANTIGENS, V72, P532, DOI 10.1111/j.1399-0039.2008.01142.x; Ruiz TM, 2005, TRANSPL P, V37, P2293, DOI 10.1016/j.transproceed.2005.03.036; Singh P, 2010, TRANSPLANTATION, V90, P220, DOI 10.1097/TP.0b013e3181e1177d; Susal C, 2002, TRANSPLANTATION, V73, P1269; Tanhehco YC, 2012, SEMIN DIALYSIS, V25, P539, DOI 10.1111/j.1525-139X.2012.01089.x; Thaunat O, 2009, TRANSPL IMMUNOL, V20, P209, DOI 10.1016/j.trim.2008.12.006; THICK M, 1984, TRANSPLANTATION, V37, P525, DOI 10.1097/00007890-198405000-00023; Tran TH, 2011, TRANSPLANTATION, V92, P419, DOI 10.1097/TP.0b013e318224c14e; VANROOD JJ, 1958, NATURE, V181, P1735, DOI 10.1038/1811735a0; Vongwiwatana A, 2003, IMMUNOL REV, V196, P197, DOI 10.1046/j.1600-065X.2003.00093.x	47	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100270	10.1371/journal.pone.0100270	http://dx.doi.org/10.1371/journal.pone.0100270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927116	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100124
J	Uddin, MJ; Khan, WA; Amin, NS				Uddin, Mohammed J.; Khan, Waqar A.; Amin, Norsarahaida S.			g-Jitter Mixed Convective Slip Flow of Nanofluid past a Permeable Stretching Sheet Embedded in a Darcian Porous Media with Variable Viscosity	PLOS ONE			English	Article							BOUNDARY-LAYER-FLOW; STAGNATION-POINT FLOW; HEAT-TRANSFER; NATURAL-CONVECTION; MASS-TRANSFER; SURFACE; PLATE	The unsteady two-dimensional laminar g-Jitter mixed convective boundary layer flow of Cu-water and Al2O3-water nanofluids past a permeable stretching sheet in a Darcian porous is studied by using an implicit finite difference numerical method with quasi-linearization technique. It is assumed that the plate is subjected to velocity and thermal slip boundary conditions. We have considered temperature dependent viscosity. The governing boundary layer equations are converted into non-similar equations using suitable transformations, before being solved numerically. The transport equations have been shown to be controlled by a number of parameters including viscosity parameter, Darcy number, nanoparticle volume fraction, Prandtl number, velocity slip, thermal slip, suction/injection and mixed convection parameters. The dimensionless velocity and temperature profiles as well as friction factor and heat transfer rates are presented graphically and discussed. It is found that the velocity reduces with velocity slip parameter for both nanofluids for fluid with both constant and variable properties. It is further found that the skin friction decreases with both Darcy number and momentum slip parameter while it increases with viscosity variation parameter. The surface temperature increases as the dimensionless time increases for both nanofluids. Nusselt numbers increase with mixed convection parameter and Darcy numbers and decreases with the momentum slip. Excellent agreement is found between the numerical results of the present paper with published results.	[Uddin, Mohammed J.] Amer Int Univ Bangladesh, Dept Math, Dhaka, Bangladesh; [Khan, Waqar A.] Natl Univ Sci & Technol, Dept Engn Sci, PN Engn Coll, Karachi, Pakistan; [Amin, Norsarahaida S.] Univ Teknol Malaysia, Fac Sci, Dept Math Sci, Johor Baharu, Malaysia	American International University Bangladesh (AIUB); National University of Sciences & Technology - Pakistan; Universiti Teknologi Malaysia	Khan, WA (corresponding author), Natl Univ Sci & Technol, Dept Engn Sci, PN Engn Coll, Karachi, Pakistan.	wkhan_2000@yahoo.com	Khan, Waqar/H-3886-2013	Khan, Waqar/0000-0002-8328-850X; Uddin, Dr. Md. Jashim/0000-0002-3243-3455	Universiti Teknologi Malaysia [03H34]	Universiti Teknologi Malaysia	Part of the work is supported through Research University Grant Scheme Vot No 03H34 Universiti Teknologi Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beg O. Anwar, 2011, 12 UK NAT HEAT TRANS; Beg TA, 2012, INT J MICRO IN PRESS; Bhattacharyya K, 2013, AIN SHAMS ENG J, V4, P299, DOI 10.1016/j.asej.2012.09.003; Bocquet L, 2007, SOFT MATTER, V3, P685, DOI 10.1039/b616490k; Buongiorno J, 2006, J HEAT TRANS-T ASME, V128, P240, DOI 10.1115/1.2150834; Chamkha AJ, 2012, INT J NUMER METHOD H, V22, P1073, DOI 10.1108/09615531211271871; Chamkha A, 2011, TRANSPORT POROUS MED, V86, P13, DOI 10.1007/s11242-010-9601-0; CHEN H, 1994, J CRYST GROWTH, V142, P362, DOI 10.1016/0022-0248(94)90347-6; Chen WY, 1999, J FLUID MECH, V395, P327, DOI 10.1017/S0022112099006011; Cimpean DS, 2012, INT J HEAT MASS TRAN, V55, P907, DOI 10.1016/j.ijheatmasstransfer.2011.10.018; Das K, 2012, COMPUT MATH APPL, V63, P255, DOI 10.1016/j.camwa.2011.11.018; Gorla RSR, 2011, NANOSCALE RES LETT, V6, DOI 10.1186/1556-276X-6-207; Gorla RSR, 2011, J NANOSCALE MICROSCA, V15, P81094; GRUBKA LJ, 1985, J HEAT TRANS-T ASME, V107, P248, DOI 10.1115/1.3247387; Hamad MAA, 2012, NUCL ENG DES, V242, P194, DOI 10.1016/j.nucengdes.2011.09.005; Ibrahim W, 2013, COMPUT FLUIDS, V86, P433, DOI 10.1016/j.compfluid.2013.07.029; Kameswaran PK, 2013, INT J HEAT MASS TRAN, V57, P465, DOI 10.1016/j.ijheatmasstransfer.2012.10.047; Karniadakis G, 2005, MICROFLOWS NANOFLOWS; Khan WA, 2011, INT J THERM SCI, V50, P2154, DOI 10.1016/j.ijthermalsci.2011.05.022; Kleinstreuer C, 2008, INT J HEAT MASS TRAN, V51, P5590, DOI 10.1016/j.ijheatmasstransfer.2008.04.043; Krajnik P., 2011, ADV SUSTAINABLE MANU, P107; Kuznetsov AV, 2012, J POROUS MEDIA, V15, P233, DOI 10.1615/JPorMedia.v15.i3.30; Kuznetsov AV, 2010, INT J THERM SCI, V49, P243, DOI 10.1016/j.ijthermalsci.2009.07.015; Lehoczky S, 1994, GROWTH SOLID SOLUTIO; Li BQ, 1996, INT J HEAT MASS TRAN, V39, P2853, DOI 10.1016/0017-9310(95)00389-4; Matthews MT, 2007, J MATH ANAL APPL, V333, P381, DOI 10.1016/j.jmaa.2006.08.047; Mukhopadhyay S, 2012, MECCANICA, V47, P863, DOI 10.1007/s11012-011-9457-6; Murthy PVSN, 2013, INT COMMUN HEAT MASS, V47, P41, DOI 10.1016/j.icheatmasstransfer.2013.06.001; Nield DA, 2009, INT J HEAT MASS TRAN, V52, P5792, DOI 10.1016/j.ijheatmasstransfer.2009.07.024; Nkurikiyimfura I, 2013, RENEW SUST ENERG REV, V21, P548, DOI 10.1016/j.rser.2012.12.039; Noghrehabadi A, 2013, HEAT MASS TRANSFER, V49, P1357, DOI 10.1007/s00231-013-1179-y; Oztop HF, 2008, INT J HEAT FLUID FL, V29, P1326, DOI 10.1016/j.ijheatfluidflow.2008.04.009; Pal D, 2013, NUCL ENG DES, V256, P350, DOI 10.1016/j.nucengdes.2012.08.015; Prasad KV, 2010, INT J THERM SCI, V49, P603, DOI 10.1016/j.ijthermalsci.2009.08.005; Rees DAS, 2001, INT J HEAT MASS TRAN, V44, P877, DOI 10.1016/S0017-9310(00)00120-4; Rees DAS, 2001, HEAT MASS TRANSFER, V37, P403, DOI 10.1007/s002310000178; Said Z, 2013, INT COMMUN HEAT MASS, V46, P74, DOI 10.1016/j.icheatmasstransfer.2013.05.013; Shafie S, 2007, MECH RES COMMUN, V34, P115, DOI 10.1016/j.mechrescom.2006.05.004; Tiwari RK, 2007, INT J HEAT MASS TRAN, V50, P2002, DOI 10.1016/j.ijheatmasstransfer.2006.09.034; Uddin MJ, 2014, MATH PROBL ENG, V2014, DOI 10.1155/2014/179172; Vajravelu K, 2011, INT J THERM SCI, V50, P843, DOI 10.1016/j.ijthermalsci.2011.01.008; Vajravelu K, 2013, J HYDRODYN, V25, P1, DOI 10.1016/S1001-6058(13)60332-7; Van Gorder RA, 2010, COMMUN NONLINEAR SCI, V15, P1494, DOI 10.1016/j.cnsns.2009.06.004; Wang CY, 2009, NONLINEAR ANAL-REAL, V10, P375, DOI 10.1016/j.nonrwa.2007.09.013; Wasu S, 2011, MATHEMATICS IN SCIENCE AND TECHNOLOGY: MATHEMATICAL METHODS, MODELS AND ALGORITHMS IN SCIENCE AND TECHNOLOGY, P510; WONG KV, 2010, ADV MECH ENG, V2010, P1, DOI DOI 10.1155/2010/519659; Wu L, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3052923; Yasin MH, 2012, ADV SCI LETT, V13, P833, DOI DOI 10.1166/ASL.2012.3863; Zheng LC, 2012, NONLINEAR ANAL-REAL, V13, P513, DOI 10.1016/j.nonrwa.2011.02.016	49	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99384	10.1371/journal.pone.0099384	http://dx.doi.org/10.1371/journal.pone.0099384			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927277	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100038
J	Zhao, B; Fei, J; Chen, Y; Ying, YL; Ma, L; Song, XQ; Wang, L; Chen, EZ; Mao, EQ				Zhao, Bing; Fei, Jian; Chen, Ying; Ying, Yi-Lin; Ma, Li; Song, Xiao-Qin; Wang, Lu; Chen, Er-Zhen; Mao, En-Qiang			Pharmacological Preconditioning with Vitamin C Attenuates Intestinal Injury via the Induction of Heme Oxygenase-1 after Hemorrhagic Shock in Rats	PLOS ONE			English	Article							ASCORBIC-ACID; TISSUE-INJURY; UP-REGULATION; EXPRESSION; PROTEIN; RESUSCITATION; PROTECTION; CELLS; HEME-OXYGENASE-1; PROOXIDANT	Pre-induction of heme oxygenase (HO)-1, which is regarded as an effective method of "organ preconditioning'', exerts beneficial effects during hemorrhagic shock (HS). However, the available HO-1 inducers exhibit disadvantages such as toxicity or complex technical requirements. Therefore, a safe and convenient HO-1 inducer would be promising and could be exploited in the treatment of foreseeable hemorrhaging, such as prior to major surgery. Here we investigated the effect of vitamin C (VitC), a common antioxidant, on intestinal HO-1 expression and examined whether VitC pretreatment prevented HS related intestinal tissue injuries after HO-1 induction. First, we conducted an in vitro study and found that HO-1 expression in rat intestinal epithelial cells (IEC-6) was induced by non-toxic VitC in a time and concentration dependent manner, and the mechanism was related to the activation of extracellular signal-regulated kinase 1/2 (ERK1/2). Next, we conducted an in vivo study and found that VitC induced intestinal HO-1 protein expression (mainly observed in the intestinal epithelial cells) and HO-1 activity in normal SD rats, and that these HO-1 levels were further enhanced by VitC in a rat model of HS. The HS related intestinal injuries, including histological damage, pro-inflammatory cytokine levels (tumor necrosis factor and interleukin-6), neutrophil infiltration and apoptosis decreased after VitC pretreatment, and this alleviating of organ injuries was abrogated after the inhibition of HO-1 activity by zinc protoporphyrin-IX. It was of note that VitC did little histological damage to the intestine of the sham rats. These data suggested that VitC might be applied as a safe inducer of intestinal HO-1 and that VitC pretreatment attenuated HS related intestinal injuries via the induction of HO-1.	[Zhao, Bing; Chen, Ying; Ying, Yi-Lin; Song, Xiao-Qin; Wang, Lu; Chen, Er-Zhen; Mao, En-Qiang] Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Emergency Intens Care Unit, Shanghai 200030, Peoples R China; [Fei, Jian] Shanghai Jiao Tong Univ, Sch Med, Dept Surg, Ruijin Hosp, Shanghai 200030, Peoples R China; [Ma, Li] Shanghai Jiao Tong Univ, Sch Med, Dept Emergency Intens Care Unit, Peoples Hosp 3, Shanghai 200030, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University	Chen, EZ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, Dept Emergency Intens Care Unit, Shanghai 200030, Peoples R China.	chenerzhen@hotmail.com; maoeq@yeah.net			National Natural Science Foundation of China [81171789]; Science and Technology Commission of Shanghai Municipality [124119a4600]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	This work is supported by National Natural Science Foundation of China projects 81171789 (to En-Qiang Mao) and the Science and Technology Commission of Shanghai Municipality 124119a4600 (to Jian Fei). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; [Anonymous], CANC LETT, V246, P54; Anwar AA, 2005, FREE RADICAL BIO MED, V39, P227, DOI 10.1016/j.freeradbiomed.2005.03.012; Chao XDD, 2013, EXP NEUROL, V239, P163, DOI 10.1016/j.expneurol.2012.09.020; Chen Q, 2008, P NATL ACAD SCI USA, V105, P11105, DOI 10.1073/pnas.0804226105; Coimbra R, 2006, J TRAUMA, V60, P41, DOI 10.1097/01.ta.0000197417.03460.0a; Cooney RN, 2011, J TRAUMA, V71, P24; Cristante AF, 2009, SPINAL CORD, V47, P458, DOI 10.1038/sc.2008.155; Elbirt KK, 1998, J BIOL CHEM, V273, P8922, DOI 10.1074/jbc.273.15.8922; Filomeni G, 2012, BIOCHEM PHARMACOL, V83, P1349, DOI 10.1016/j.bcp.2012.02.003; Food U Administration D, 2002, GUIDANCE INDUSTRY RE; Gozzelino R, 2010, ANNU REV PHARMACOL, V50, P323, DOI 10.1146/annurev.pharmtox.010909.105600; Hassoun HT, 2001, SHOCK, V15, P1, DOI 10.1097/00024382-200115010-00001; Hu GY, 2011, GUT, V60, P820, DOI 10.1136/gut.2010.215178; Huang J, 2013, STROKE, V44, P190, DOI 10.1161/STROKEAHA.112.670299; Huang YN, 2012, TOXICOL APPL PHARM, V265, P241, DOI 10.1016/j.taap.2012.08.036; Inoue K, 2008, SHOCK, V29, P252, DOI 10.1097/shk.0b013e3180cab913; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kim JH, 2014, STEM CELLS DEV; Kim JY, 2004, LIFE SCI, V75, P2015, DOI 10.1016/j.lfs.2004.06.002; Kubulus D, 2008, SHOCK, V29, P583, DOI 10.1097/SHK.0b013e318157e526; Lee TS, 2002, NAT MED, V8, P240, DOI 10.1038/nm0302-240; Leung PS, 2009, ANTIOXID REDOX SIGN, V11, P135, DOI 10.1089/ars.2008.2109; Liu SX, 2012, INT J CARDIOL, V160, P95, DOI 10.1016/j.ijcard.2011.03.033; Maier M, 2003, SHOCK, V19, P457, DOI 10.1097/01.shk.0000056961.48384.f2; Mallick IH, 2010, AM J SURG, V199, P223, DOI 10.1016/j.amjsurg.2009.01.011; Moretti M, 2014, J PSYCHIATR RES, V48, P16, DOI 10.1016/j.jpsychires.2013.10.014; Morin MJ, 1998, CRIT CARE MED, V26, P1258, DOI 10.1097/00003246-199807000-00031; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Raddatz A, 2006, AM J RESP CRIT CARE, V174, P198, DOI 10.1164/rccm.200508-1221OC; Raeburn CD, 2001, ARCH SURG-CHICAGO, V136, P1263, DOI 10.1001/archsurg.136.11.1263; Ryter SW, 2006, PHYSIOL REV, V86, P583, DOI 10.1152/physrev.00011.2005; Sakamoto N, 2005, INT J HYPERTHER, V21, P603, DOI 10.1080/02656730500188599; Schipper HM, 1999, NEUROTOX RES, V1, P57, DOI 10.1007/BF03033339; Sonnier DI, 2010, J GASTROINTEST SURG, V14, P1592, DOI 10.1007/s11605-010-1321-9; Tsai MS, 2011, INTENS CARE MED, V37, P2033, DOI 10.1007/s00134-011-2362-6; Umeda K, 2009, SHOCK, V31, P40, DOI 10.1097/SHK.0b013e318177823a; Van PY, 2011, J TRAUMA, V71, P20, DOI 10.1097/TA.0b013e3182214f44; Vilcheze C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2898; Yan Y, 2013, PROTEIN CELL, V4, P620, DOI 10.1007/s13238-013-3030-0; Yasuda H, 2005, BRAIN RES, V1032, P176, DOI 10.1016/j.brainres.2004.11.009; Yu HP, 2011, SHOCK, V35, P517, DOI 10.1097/SHK.0b013e318209e931; Zhang HY, 2012, SURGERY, V151, P594, DOI 10.1016/j.surg.2011.10.001	45	10	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99134	10.1371/journal.pone.0099134	http://dx.doi.org/10.1371/journal.pone.0099134			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927128	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100028
J	Ames, RM; Money, D; Lovell, SC				Ames, Ryan M.; Money, Daniel; Lovell, Simon C.			Inferring Gene Family Histories in Yeast Identifies Lineage Specific Expansions	PLOS ONE			English	Article							OXIDATIVE STRESS-RESPONSE; TREE RECONCILIATION; SACCHAROMYCES-CEREVISIAE; EVOLUTIONARY ANALYSIS; DUPLICATION; DEATH; SCALE; PHYLOGENIES; DIVERGENCE; TREHALOSE	The complement of genes found in the genome is a balance between gene gain and gene loss. Knowledge of the specific genes that are gained and lost over evolutionary time allows an understanding of the evolution of biological functions. Here we use new evolutionary models to infer gene family histories across complete yeast genomes; these models allow us to estimate the relative genome-wide rates of gene birth, death, innovation and extinction (loss of an entire family) for the first time. We show that the rates of gene family evolution vary both between gene families and between species. We are also able to identify those families that have experienced rapid lineage specific expansion/contraction and show that these families are enriched for specific functions. Moreover, we find that families with specific functions are repeatedly expanded in multiple species, suggesting the presence of common adaptations and that these family expansions/contractions are not random. Additionally, we identify potential specialisations, unique to specific species, in the functions of lineage specific expanded families. These results suggest that an important mechanism in the evolution of genome content is the presence of lineage-specific gene family changes.	[Ames, Ryan M.; Lovell, Simon C.] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Money, Daniel] Univ Kansas, Dept Ecol & Evolutionary Biol, Lawrence, KS 66045 USA	University of Manchester; University of Kansas	Ames, RM (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	ryan.ames@manchester.ac.uk	Money, Daniel/W-3401-2019	Money, Daniel/0000-0001-5151-3648; Ames, Ryan/0000-0002-1432-5629; Lovell, Simon/0000-0002-4092-8458	BBSRC [BB/I020489/1]; Biotechnology and Biological Sciences Research Council [BB/I020489/1] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work is funded by BBSRC grant BB/I020489/1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerborg O, 2009, P NATL ACAD SCI USA, V106, P5714, DOI 10.1073/pnas.0806251106; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Alvarez-Peral FJ, 2002, MICROBIOL-SGM, V148, P2599, DOI 10.1099/00221287-148-8-2599; Ames RM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062670; Ames RM, 2012, BIOINFORMATICS, V28, P48, DOI 10.1093/bioinformatics/btr592; Ames RM, 2010, GENOME BIOL EVOL, V2, P591, DOI 10.1093/gbe/evq043; Arvestad L, 2003, BIOINFORMATICS, V19, pi7, DOI 10.1093/bioinformatics/btg1000; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Ashby SF, 1926, ANN BOT-LONDON, V40, P69, DOI 10.1093/oxfordjournals.aob.a090018; Balzer M, 2005, VIS SOFTW UND AN 200, P1; Balzer M., 2005, P 2005 ACM S SOFTW V, P165, DOI DOI 10.1145/1056018.1056041; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brown C, 1998, MULTIPLE DUPLICATION; Brown CA, 2010, CURR BIOL, V20, P895, DOI 10.1016/j.cub.2010.04.027; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Cai J, 2008, GENETICS, V179, P487, DOI 10.1534/genetics.107.084491; Carvunis AR, 2012, NATURE IN PRESS; Chen K, 2000, J COMPUT BIOL, V7, P429, DOI 10.1089/106652700750050871; COHEN G, 1985, MOL GEN GENET, V200, P74, DOI 10.1007/BF00383315; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Csuros M, 2010, BIOINFORMATICS, V26, P1910, DOI 10.1093/bioinformatics/btq315; DAMORE T, 1991, J IND MICROBIOL, V7, P191, DOI 10.1007/BF01575882; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Demuth JP, 2009, BIOESSAYS, V31, P29, DOI 10.1002/bies.080085; Despons L, 2006, TRENDS GENET, V22, P10, DOI 10.1016/j.tig.2005.10.001; Dujon B, 2010, NAT REV GENET, V11, P512, DOI 10.1038/nrg2811; DUNLOP PC, 1978, J BIOL CHEM, V253, P1297; Durand D, 2006, RES COMP MOL BIOL 9; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; FELSENSTEIN J, 1992, EVOLUTION, V46, P159, DOI [10.2307/2409811, 10.1111/j.1558-5646.1992.tb01991.x]; FLEET GH, 1990, J APPL BACTERIOL, V68, P199, DOI 10.1111/j.1365-2672.1990.tb02566.x; Gordon JL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000485; Gorecki P, 2004, P 8 ANN INT C RES CO, P316; Hahn MW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r141; Hahn MW, 2007, PLOS GENET, V3, P2135, DOI 10.1371/journal.pgen.0030197; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Hakes L, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r209; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Han MV, 2013, MOL BIOL EV IN PRESS; Howe K, 2002, BIOINFORMATICS, V18, P1546, DOI 10.1093/bioinformatics/18.11.1546; Karev GP, 2002, BMC EVOL BIOL, V2, DOI 10.1186/1471-2148-2-18; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Kunin V, 2003, GENETRACE RECONSTRUC; Kwon HB, 2003, FEMS YEAST RES, V3, P433, DOI 10.1016/S1567-1356(03)00035-7; LAGUNAS R, 1993, FEMS MICROBIOL LETT, V104, P229, DOI 10.1016/0378-1097(93)90598-V; Larget BR, 2010, BIOINFORMATICS, V26, P2910, DOI 10.1093/bioinformatics/btq539; Lee J, 1999, J BIOL CHEM, V274, P16040, DOI 10.1074/jbc.274.23.16040; Librado P, 2012, BIOINFORMATICS, V28, P279, DOI 10.1093/bioinformatics/btr623; Lin ZG, 2011, MOL BIOL EVOL, V28, P131, DOI 10.1093/molbev/msq184; Long M, 2003, NAT REV GENET, V4, P865, DOI 10.1038/nrg1204; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Lynch M, 2000, GENETICS, V154, P459; Mirkin BG, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-2; Nikolski M, 2007, BIOINFORMATICS, V23, pE71, DOI 10.1093/bioinformatics/btl314; Nobre A, 1999, APPL ENVIRON MICROB, V65, P3594; Novozhilov AS, 2006, BRIEF BIOINFORM, V7, P70, DOI 10.1093/bib/bbk006; Ohno S., 1970, EVOLUTION GENE DUPLI; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; ONISHI H, 1960, B AGR CHEM SOC JAPAN, V24, P126; Ozcan S, 1999, MICROBIOL MOL BIOL R, V63, P554; Page RDM, 1998, BIOINFORMATICS, V14, P819, DOI 10.1093/bioinformatics/14.9.819; Rasmussen MD, 2011, MOL BIOL EVOL, V28, P273, DOI 10.1093/molbev/msq189; Scannell DR, 2006, NATURE, V440, P341, DOI 10.1038/nature04562; Sherman DJ, 2009, NUCLEIC ACIDS RES, V37, pD550, DOI 10.1093/nar/gkn859; SINCLAIR K, 1994, GENE, V144, P37, DOI 10.1016/0378-1119(94)90200-3; Smits GJ, 2005, CURR OPIN BIOTECH, V16, P225, DOI 10.1016/j.copbio.2005.02.005; Vernot B, 2008, J COMPUT BIOL, V15, P981, DOI 10.1089/cmb.2008.0092; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Wehe A, 2008, BIOINFORMATICS, V24, P1540, DOI 10.1093/bioinformatics/btn230; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zhou Q, 2008, GENOME RES, V18, P1446, DOI 10.1101/gr.076588.108	75	6	6	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99480	10.1371/journal.pone.0099480	http://dx.doi.org/10.1371/journal.pone.0099480			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921666	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300064
J	Lood, C; Tyden, H; Gullstrand, B; Sturfelt, G; Jonsen, A; Truedsson, L; Bengtsson, AA				Lood, Christian; Tyden, Helena; Gullstrand, Birgitta; Sturfelt, Gunnar; Jonsen, Andreas; Truedsson, Lennart; Bengtsson, Anders A.			Platelet Activation and Anti-Phospholipid Antibodies Collaborate in the Activation of the Complement System onle Platelets in Systemic Lupus Erythematosus	PLOS ONE			English	Article							RABBIT ANTICARDIOLIPIN ANTIBODIES; RISK-FACTORS; THROMBOSIS; AGGREGATION; DISEASE; MANIFESTATIONS; INFARCTION; COLLAGEN; BINDING; DAMAGE	Anti-phospholipid (aPL) antibodies are important contributors to development of thrombosis in patients with the autoimmune rheumatic disease systemic lupus erythematosus (SLE). The underlying mechanism of aPL antibody-mediated thrombosis is not fully understood but existing data suggest that platelets and the complement system are key components. Complement activation on platelets is seen in SLE patients, especially in patients with aPL antibodies, and has been related to venous thrombosis and stroke. The aim of this study was to investigate if aPL antibodies could support classical pathway activation on platelets in vitro as well as in SLE patients. Furthermore, we investigated if complement deposition on platelets was associated with vascular events, either arterial or venous, when the data had been adjusted for traditional cardiovascular risk factors. Finally, we analyzed if platelet complement deposition, both C1q and C4d, was specific for SLE. We found that aPL antibodies supported C4d deposition on platelets in vitro as well as in SLE patients (p = 0.001 and p<0.05, respectively). Complement deposition on platelets was increased in SLE patients when compared with healthy individuals (p<0.0001). However, high levels of C4d deposition and a pronounced C1q deposition were also seen in patients with rheumatoid arthritis and systemic sclerosis. In SLE, C4d deposition on platelets was associated with platelet activation, complement consumption, disease activity and venous (OR = 5.3, p = 0.02), but not arterial, thrombosis, observations which were independent of traditional cardiovascular risk factors. In conclusion, several mechanisms operate in SLE to amplify platelet complement deposition, of which aPL antibodies and platelet activation were identified as important contributors in this investigation. Complement deposition on platelets was identified as a marker of venous, but not arterial thrombosis, in SLE patients independently of traditional risk factors and aPL antibodies. Further studies are needed to elucidate the role of complement deposition on platelets in development of venous thrombosis.	[Lood, Christian; Tyden, Helena; Sturfelt, Gunnar; Jonsen, Andreas; Bengtsson, Anders A.] Lund Univ, Dept Clin Sci Lund, Rheumatol Sect, Lund, Sweden; [Lood, Christian; Tyden, Helena; Sturfelt, Gunnar; Jonsen, Andreas; Bengtsson, Anders A.] Skane Univ Hosp, Lund, Sweden; [Gullstrand, Birgitta; Truedsson, Lennart] Lund Univ, Sect Microbiol Immunol & Glycobiol, Dept Lab Med Lund, Lund, Sweden	Lund University; Lund University; Skane University Hospital; Lund University	Lood, C (corresponding author), Lund Univ, Dept Clin Sci Lund, Rheumatol Sect, Lund, Sweden.	Christian.Lood@med.lu.se	Lood, Christian/H-5670-2019	Lood, Christian/0000-0002-6171-1952	Medical Faculty at Lund University; Crafoord Foundation; Swedish Combine Projects; Greta and Johan Kock's Foundation; King Gustaf V's 80th Birthday Foundation; Lund University Hospital; Swedish Rheumatism Association; Swedish Society of Medicine; Foundation of the National Board of Health and Welfare and Osterlund's Foundation	Medical Faculty at Lund University; Crafoord Foundation; Swedish Combine Projects; Greta and Johan Kock's Foundation; King Gustaf V's 80th Birthday Foundation; Lund University Hospital; Swedish Rheumatism Association; Swedish Society of Medicine; Foundation of the National Board of Health and Welfare and Osterlund's Foundation	This work was supported by grants from the Medical Faculty at Lund University; The Crafoord Foundation; Swedish Combine Projects; Greta and Johan Kock's Foundation; King Gustaf V's 80th Birthday Foundation; Lund University Hospital; the Swedish Rheumatism Association; Swedish Society of Medicine; and the Foundation of the National Board of Health and Welfare and Osterlund's Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Homood Ibrahim A, 2012, ISRN Rheumatol, V2012, P428269, DOI 10.5402/2012/428269; ANDERSON GP, 1991, BRIT J HAEMATOL, V79, P75, DOI 10.1111/j.1365-2141.1991.tb08010.x; Betts NA, 2013, PATHOLOGY, V45, P155, DOI 10.1097/PAT.0b013e32835cc277; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Carrera-Marin AL, 2012, LUPUS, V21, P1497, DOI 10.1177/0961203312458839; Crispin JC, 2010, TRENDS MOL MED, V16, P47, DOI 10.1016/j.molmed.2009.12.005; Esdaile JM, 2001, ARTHRITIS RHEUM, V44, P2331, DOI 10.1002/1529-0131(200110)44:10<2331::AID-ART395>3.0.CO;2-I; Girardi G, 2003, J CLIN INVEST, V112, P1644, DOI 10.1172/JCI200318817; Gladman D, 1996, ARTHRITIS RHEUM, V39, P363, DOI 10.1002/art.1780390303; Gladman DD, 2002, J RHEUMATOL, V29, P288; Hamad OA, 2008, J THROMB HAEMOST, V6, P1413, DOI 10.1111/j.1538-7836.2008.03034.x; Holers VM, 2002, J EXP MED, V195, P211, DOI 10.1084/jem.200116116; Hughes G, 2007, CLIN REV ALLERG IMMU, V32, P3, DOI 10.1007/BF02686077; HUGHES GRV, 1994, J ROY COLL PHYS LOND, V28, P301; Jonsson G, 2007, RHEUMATOLOGY, V46, P1133, DOI 10.1093/rheumatology/kem023; JONSSON H, 1989, MEDICINE, V68, P141, DOI 10.1097/00005792-198905000-00002; Kao AH, 2013, TRANSL STROKE RES; Koskenmies S, 2004, SCAND J RHEUMATOL, V33, P246, DOI 10.1080/03009740410005386; LARSSON A, 1994, PLATELETS, V5, P149, DOI 10.3109/09537109409005528; LIN YL, 1992, BLOOD, V80, P3135; Lood C, 2012, LUPUS, V21, P1423, DOI 10.1177/0961203312457210; Lood C, 2010, BLOOD, V116, P1951, DOI 10.1182/blood-2010-03-274605; Manzi S, 1997, AM J EPIDEMIOL, V145, P408; Mehta N, 2008, STROKE, V39, P3236, DOI 10.1161/STROKEAHA.108.514687; Navratil JS, 2006, ARTHRITIS RHEUM-US, V54, P670, DOI 10.1002/art.21627; Nojima J, 2004, THROMB HAEMOSTASIS, V91, P967, DOI 10.1160/TH03-10-0608; Peerschke EIB, 2009, LUPUS, V18, P530, DOI 10.1177/0961203308099974; Pierangeli SS, 2005, ANN NY ACAD SCI, V1051, P413, DOI 10.1196/annals.1361.083; RUBIN LA, 1985, Q J MED, V55, P87; Sallai KK, 2007, SCAND J RHEUMATOL, V36, P198, DOI 10.1080/03009740601089283; Salmon JE, 2008, LUPUS, V17, P405, DOI 10.1177/0961203308090025; Shanmugavelayudam SK, 2011, PLATELETS; Shinzato M, 2005, LUPUS, V14, P953, DOI 10.1191/0961203305lu2252oa; Svenungsson E, 2001, CIRCULATION, V104, P1887, DOI 10.1161/hc4101.097518; TAN EM, 1982, ARTHRITIS RHEUM, V25, P1271, DOI 10.1002/art.1780251101; TESTI R, 1990, J EXP MED, V172, P701, DOI 10.1084/jem.172.3.701; TESTI R, 1992, J IMMUNOL, V148, P2867; TSUBAKIO T, 1986, BRIT J HAEMATOL, V63, P293; Vega-Ostertag M, 2004, ARTHRITIS RHEUM-US, V50, P2911, DOI 10.1002/art.20434; Vikerfors A, 2013, RHEUMATOLOGY, V52, P501, DOI 10.1093/rheumatology/kes252; Wang L, 2002, BRIT J HAEMATOL, V118, P1152, DOI 10.1046/j.1365-2141.2002.03739.x; WIENER HM, 1991, VOX SANG, V61, P111, DOI 10.1111/j.1423-0410.1991.tb00256.x; Wraith KS, 2013, BLOOD, V122, P580, DOI 10.1182/blood-2013-04-491688; Ziakas PD, 2006, CLIN EXP IMMUNOL, V145, P71, DOI 10.1111/j.1365-2249.2006.03122.x	44	45	48	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99386	10.1371/journal.pone.0099386	http://dx.doi.org/10.1371/journal.pone.0099386			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922069	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300056
J	Luo, JN; Lushchak, OV; Goergen, P; Williams, MJ; Nassel, DR				Luo, Jiangnan; Lushchak, Oleh V.; Goergen, Philip; Williams, Michael J.; Nassel, Dick R.			Drosophila Insulin-Producing Cells Are Differentially Modulated by Serotonin and Octopamine Receptors and Affect Social Behavior	PLOS ONE			English	Article							SHORT NEUROPEPTIDE-F; LIFE-SPAN; GENETIC-ANALYSIS; GROWTH; METABOLISM; EXPRESSION; FOOD; PEPTIDES; NEURONS; SLEEP	A set of 14 insulin-producing cells (IPCs) in the Drosophila brain produces three insulin-like peptides (DILP2, 3 and 5). Activity in IPCs and release of DILPs is nutrient dependent and controlled by multiple factors such as fat body-derived proteins, neurotransmitters, and neuropeptides. Two monoamine receptors, the octopamine receptor OAMB and the serotonin receptor 5-HT1A, are expressed by the IPCs. These receptors may act antagonistically on adenylate cyclase. Here we investigate the action of the two receptors on activity in and output from the IPCs. Knockdown of OAMB by targeted RNAi led to elevated Dilp3 transcript levels in the brain, whereas 5-HT1A knockdown resulted in increases of Dilp2 and 5. OAMB-RNAi in IPCs leads to extended survival of starved flies and increased food intake, whereas 5-HT1A-RNAi produces the opposite phenotypes. However, knockdown of either OAMB or 5-HT1A in IPCs both lead to increased resistance to oxidative stress. In assays of carbohydrate levels we found that 5-HT1A knockdown in IPCs resulted in elevated hemolymph glucose, body glycogen and body trehalose levels, while no effects were seen after OAMB knockdown. We also found that manipulations of the two receptors in IPCs affected male aggressive behavior in different ways and 5-HT1A-RNAi reduced courtship latency. Our observations suggest that activation of 5-HT1A and OAMB signaling in IPCs generates differential effects on Dilp transcription, fly physiology, metabolism and social interactions. However the findings do not support an antagonistic action of the two monoamines and their receptors in this particular system.	[Luo, Jiangnan; Lushchak, Oleh V.; Nassel, Dick R.] Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden; [Goergen, Philip; Williams, Michael J.] Uppsala Univ, Dept Neurosci, Uppsala, Sweden	Stockholm University; Uppsala University	Nassel, DR (corresponding author), Stockholm Univ, Dept Zool, S-10691 Stockholm, Sweden.	dnassel@zoologi.su.se	Lushchak, Oleh V./ABE-4061-2020	Lushchak, Oleh V./0000-0002-4627-1987	Swedish Research Council; Carl Trygger Foundation; Stiftelsen Olle Engkvist Byggmastare and Stiftelsen Lars Hiertas Minne	Swedish Research Council(Swedish Research CouncilEuropean Commission); Carl Trygger Foundation; Stiftelsen Olle Engkvist Byggmastare and Stiftelsen Lars Hiertas Minne	The study was supported by: The Swedish Research Council (D.R.N) and The Carl Trygger Foundation ( D.R.N., M.J.W.), Stiftelsen Olle Engkvist Byggmastare and Stiftelsen Lars Hiertas Minne (both to M.J.W.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseyenko OV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010806; Bai H, 2012, AGING CELL, V11, P978, DOI 10.1111/acel.12000; Baier A, 2002, J EXP BIOL, V205, P1233; Becnel J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020800; Birse RT, 2011, J EXP BIOL; Blenau W, 2011, ARTHROPOD STRUCT DEV, V40, P381, DOI 10.1016/j.asd.2011.01.004; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brembs B, 2007, J NEUROSCI, V27, P11122, DOI 10.1523/JNEUROSCI.2704-07.2007; Brogiolo W, 2001, CURR BIOL, V11, P213, DOI 10.1016/S0960-9822(01)00068-9; Broughton SJ, 2005, P NATL ACAD SCI USA, V102, P3105, DOI 10.1073/pnas.0405775102; Broughton SJ, 2010, AGING CELL, V9, P336, DOI 10.1111/j.1474-9726.2010.00558.x; Cao C, 2001, CELL TISSUE RES, V304, P317, DOI 10.1007/s004410100367; Certel SJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013248; Chen S, 2002, P NATL ACAD SCI USA, V99, P5664, DOI 10.1073/pnas.082102599; Cognigni P, 2011, CELL METAB, V13, P92, DOI 10.1016/j.cmet.2010.12.010; Cole SH, 2005, J BIOL CHEM, V280, P14948, DOI 10.1074/jbc.M414197200; Colombani J, 2012, SCIENCE, V336, P582, DOI 10.1126/science.1216689; Crocker A, 2008, J NEUROSCI, V28, P9377, DOI 10.1523/JNEUROSCI.3072-08a.2008; Crocker A, 2010, NEURON, V65, P670, DOI 10.1016/j.neuron.2010.01.032; Dacks AM, 2009, J NEUROGENET, V23, P366, DOI 10.3109/01677060903085722; Davis SM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4177; Enell LE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015780; Erion R, 2012, J BIOL CHEM, V287, P32406, DOI 10.1074/jbc.M112.360875; FERNANDEZ R, 1995, EMBO J, V14, P3373, DOI 10.1002/j.1460-2075.1995.tb07343.x; Garelli A, 2012, SCIENCE, V336, P579, DOI 10.1126/science.1216735; Garofalo RS, 2002, TRENDS ENDOCRIN MET, V13, P156, DOI 10.1016/S1043-2760(01)00548-3; Geminard C, 2006, DIABETES, V55, pS5, DOI 10.2337/db06-S001; Gronke S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000857; Han KA, 1998, J NEUROSCI, V18, P3650; Hansen M, 2013, CELL METAB, V17, P10, DOI 10.1016/j.cmet.2012.12.003; Ikeya T, 2002, CURR BIOL, V12, P1293, DOI 10.1016/S0960-9822(02)01043-6; Ja WW, 2007, P NATL ACAD SCI USA, V104, P8253, DOI 10.1073/pnas.0702726104; Johnson O, 2009, NEUROSCIENCE, V158, P1292, DOI 10.1016/j.neuroscience.2008.10.055; Kaletsky R, 2010, DIS MODEL MECH, V3, P415, DOI 10.1242/dmm.001040; Kapan N, 2012, CELL MOL LIFE SCI, V69, P4051, DOI 10.1007/s00018-012-1097-z; Kenyon CJ, 2010, NATURE, V464, P504, DOI 10.1038/nature08980; Kim YC, 2003, GENE EXPR PATTERNS, V3, P237, DOI 10.1016/S1567-133X(02)00098-4; Kim YC, 2013, J NEUROSCI, V33, P1672, DOI 10.1523/JNEUROSCI.3042-12.2013; Kuo TH, 2012, PLOS GENET, V8, P640, DOI 10.1371/journal.pgen.1002684; Lee G, 2001, J NEUROBIOL, V47, P121, DOI 10.1002/neu.1021; Lee KS, 2004, J BIOL CHEM, V279, P50781, DOI 10.1074/jbc.M407842200; Lee KS, 2008, NAT CELL BIOL, V10, P468, DOI 10.1038/ncb1710; Lindblom J, 2006, EUR J NEUROSCI, V23, P180, DOI 10.1111/j.1460-9568.2005.04531.x; Luo JN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1004052; Luo JN, 2012, CELL MOL LIFE SCI, V69, P471, DOI 10.1007/s00018-011-0789-0; Mattaliano MD, 2007, MOL CELL NEUROSCI, V36, P211, DOI 10.1016/j.mcn.2007.06.008; Neckameyer WS, 2007, GENES BRAIN BEHAV, V6, P756, DOI 10.1111/j.1601-183X.2007.00307.x; Nichols DE, 2008, CHEM REV, V108, P1614, DOI 10.1021/cr078224o; Nilsen SP, 2004, P NATL ACAD SCI USA, V101, P12342, DOI 10.1073/pnas.0404693101; Park D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001896; Polter AM, 2010, CELL SIGNAL, V22, P1406, DOI 10.1016/j.cellsig.2010.03.019; Rajan A, 2012, CELL, V151, P123, DOI 10.1016/j.cell.2012.08.019; Root CM, 2011, CELL, V145, P133, DOI 10.1016/j.cell.2011.02.008; Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058; Sakai T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088175; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Sitaraman D, 2012, J NEUROGENET, V26, P238, DOI 10.3109/01677063.2012.666298; Soderberg Jeannette A E, 2012, Front Endocrinol (Lausanne), V3, P109, DOI 10.3389/fendo.2012.00109; Taguchi A, 2008, ANNU REV PHYSIOL, V70, P191, DOI 10.1146/annurev.physiol.70.113006.100533; Teleman AA, 2010, BIOCHEM J, V425, P13, DOI 10.1042/BJ20091181; Williams MJ, 2014, GENETICS, V196, P349, DOI 10.1534/genetics.113.158402; Wu Q, 2005, NAT NEUROSCI, V8, P1350, DOI 10.1038/nn1540; Wu Q, 2005, P NATL ACAD SCI USA, V102, P13289, DOI 10.1073/pnas.0501914102; Yuan Q, 2005, NEURON, V47, P115, DOI 10.1016/j.neuron.2005.05.027; Yuan Q, 2006, CURR BIOL, V16, P1051, DOI 10.1016/j.cub.2006.04.032; Zhang T, 2013, P NATL ACAD SCI USA, V110, P15431, DOI 10.1073/pnas.1308816110; Zhou C, 2012, J NEUROSCI, V32, P14281, DOI 10.1523/JNEUROSCI.0517-12.2012; Zumstein N, 2004, J EXP BIOL, V207, P3515, DOI 10.1242/jeb.01181	68	49	54	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99732	10.1371/journal.pone.0099732	http://dx.doi.org/10.1371/journal.pone.0099732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923784	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300089
J	Schaefer, RJ; Briskine, R; Springer, NM; Myers, CL				Schaefer, Robert J.; Briskine, Roman; Springer, Nathan M.; Myers, Chad L.			Discovering Functional Modules across Diverse Maize Transcriptomes Using COB, the Co-Expression Browser	PLOS ONE			English	Article							GENETIC-ANALYSIS; NETWORK; EXPRESSION; ASSOCIATION; INFORMATION; CYTOSCAPE; DATABASE; KNOTTED1; OMICS	Tools that provide improved ability to relate genotype to phenotype have the potential to accelerate breeding for desired traits and to improve our understanding of the molecular variants that underlie phenotypes. The availability of large-scale gene expression profiles in maize provides an opportunity to advance our understanding of complex traits in this agronomically important species. We built co-expression networks based on genome-wide expression data from a variety of maize accessions as well as an atlas of different tissues and developmental stages. We demonstrate that these networks reveal clusters of genes that are enriched for known biological function and contain extensive structure which has yet to be characterized. Furthermore, we found that co-expression networks derived from developmental or tissue atlases as compared to expression variation across diverse accessions capture unique functions. To provide convenient access to these networks, we developed a public, web-based Co-expression Browser (COB), which enables interactive queries of the genome-wide networks. We illustrate the utility of this system through two specific use cases: one in which gene-centric queries are used to provide functional context for previously characterized metabolic pathways, and a second where lists of genes produced by mapping studies are further resolved and validated using co-expression networks.	[Schaefer, Robert J.; Myers, Chad L.] Univ Minnesota Rochester, Biomed Informat & Computat Biol Grad Program, Rochester, MN 55904 USA; [Briskine, Roman; Myers, Chad L.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN USA; [Springer, Nathan M.] Univ Minnesota, Dept Plant Biol, Microbial & Plant Genom Inst, St Paul, MN USA	University of Minnesota System; University of Minnesota Rochester; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Myers, CL (corresponding author), Univ Minnesota Rochester, Biomed Informat & Computat Biol Grad Program, Rochester, MN 55904 USA.	cmyers@cs.umn.edu		Briskine, Roman/0000-0002-6831-3914	Biomedical Informatics and Computational Biology (BICB) Fellowship; National Science Foundation [DBI-1237931, IOS 1126950, DBI 0953881]; US Department of Agriculture Hatch funds; CIFAR Genetic Networks Program; Direct For Biological Sciences [1126950] Funding Source: National Science Foundation	Biomedical Informatics and Computational Biology (BICB) Fellowship; National Science Foundation(National Science Foundation (NSF)); US Department of Agriculture Hatch funds(United States Department of Agriculture (USDA)); CIFAR Genetic Networks Program; Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	R.S. was partially supported by a Biomedical Informatics and Computational Biology (BICB) Fellowship. This work was supported by a grant from the National Science Foundation to N.M.S. (DBI-1237931) and by US Department of Agriculture Hatch funds to N.M.S. and C.L.M.R.S., R.B. and C.L.M. were partially supported by grants from the National Science Foundation (IOS 1126950 and DBI 0953881). C.L.M. is supported by the CIFAR Genetic Networks Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alstott J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085777; Aoki K, 2007, PLANT CELL PHYSIOL, V48, P381, DOI 10.1093/pcp/pcm013; Baxter I, 2007, PLANT PHYSIOL, V143, P600, DOI 10.1104/pp.106.092528; BECRAFT PW, 1994, GENETICS, V136, P295; Bolduc N, 2012, GENE DEV, V26, P1685, DOI 10.1101/gad.193433.112; DAVID FN, 1949, BIOMETRIKA, V36, P394, DOI 10.1093/biomet/36.3-4.394; de Sousa SM, 2008, PLANT MOL BIOL, V68, P203, DOI 10.1007/s11103-008-9362-0; Deshpande R, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001028; Downs GS, 2013, PLANT PHYSIOL, V161, P1830, DOI 10.1104/pp.112.213231; Fan LJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007612; Ficklin SP, 2011, PLANT PHYSIOL, V156, P1244, DOI 10.1104/pp.111.173047; Ficklin SP, 2010, PLANT PHYSIOL, V154, P13, DOI 10.1104/pp.110.159459; Foster T, 1999, PLANT CELL, V11, P1239, DOI 10.1105/tpc.11.7.1239; Fowler JE, 1996, DEV GENET, V18, P198, DOI 10.1002/(SICI)1520-6408(1996)18:3&lt;198::AID-DVG2&gt;3.0.CO;2-4; Fukushima A, 2012, PLANT PHYSIOL, V158, P1487, DOI 10.1104/pp.111.188367; Ghazalpour A, 2006, PLOS GENET, V2, P1182, DOI 10.1371/journal.pgen.0020130; GIROUX MJ, 1994, PLANT PHYSIOL, V106, P713, DOI 10.1104/pp.106.2.713; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Huttenhower C, 2008, BIOINFORMATICS, V24, P1559, DOI 10.1093/bioinformatics/btn237; Huttenhower C, 2006, BIOINFORMATICS, V22, P2890, DOI 10.1093/bioinformatics/btl492; Ideker Trey, 2002, Bioinformatics, V18 Suppl 1, pS233; Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067; Kim CY, 2008, NEW PHYTOL, V180, P57, DOI 10.1111/j.1469-8137.2008.02557.x; Lawrence CJ, 2004, NUCLEIC ACIDS RES, V32, pD393, DOI 10.1093/nar/gkh011; Lopes CT, 2010, BIOINFORMATICS, V26, P2347, DOI 10.1093/bioinformatics/btq430; Mochida K, 2011, PLANT CELL PHYSIOL, V52, P785, DOI 10.1093/pcp/pcr035; Moreno-Risueno MA, 2010, CURR OPIN PLANT BIOL, V13, P126, DOI 10.1016/j.pbi.2009.11.005; Morrell PL, 2012, NAT REV GENET, V13, P85, DOI 10.1038/nrg3097; Myers AM, 2000, PLANT PHYSIOL, V122, P989, DOI 10.1104/pp.122.4.989; Myers CL, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-r114; Orlando DA, 2009, METHODS MOL BIOL, V553, P57, DOI 10.1007/978-1-60327-563-7_4; Ramirez J, 2009, PLANT PHYSIOL, V151, P1878, DOI 10.1104/pp.109.145920; Schmid M, 2005, NAT GENET, V37, P501, DOI 10.1038/ng1543; Sekhon RS, 2011, PLANT J, V66, P553, DOI 10.1111/j.1365-313X.2011.04527.x; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Swanson-Wagner R, 2012, P NATL ACAD SCI USA, V109, P11878, DOI 10.1073/pnas.1201961109; Swanson-Wagner RA, 2010, GENOME RES, V20, P1689, DOI 10.1101/gr.109165.110; Tian F, 2011, NAT GENET, V43, P159, DOI 10.1038/ng.746; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1633, DOI 10.1111/j.1365-3040.2009.02040.x; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; VanDongen S.M., 2001, THESIS U UTRECHT; Wei HR, 2006, PLANT PHYSIOL, V142, P762, DOI 10.1104/pp.106.080358; Zhu T, 2003, PLANT BIOTECHNOL J, V1, P59, DOI 10.1046/j.1467-7652.2003.00006.x	43	17	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99193	10.1371/journal.pone.0099193	http://dx.doi.org/10.1371/journal.pone.0099193			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922320	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300043
J	Xia, XY; Ge, M; Hsi, JH; He, X; Ruan, YH; Wang, ZX; Shao, YM; Pan, XM				Xia, Xia-Yu; Ge, Meng; Hsi, Jenny H.; He, Xiang; Ruan, Yu-Hua; Wang, Zhi-Xin; Shao, Yi-Ming; Pan, Xian-Ming			High-Accuracy Identification of Incident HIV-1 Infections Using a Sequence Clustering Based Diversity Measure	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SEROCONVERSION; MARKER; ASSAY	Accurate estimates of HIV-1 incidence are essential for monitoring epidemic trends and evaluating intervention efforts. However, the long asymptomatic stage of HIV-1 infection makes it difficult to effectively distinguish incident infections from chronic ones. Current incidence assays based on serology or viral sequence diversity are both still lacking in accuracy. In the present work, a sequence clustering based diversity (SCBD) assay was devised by utilizing the fact that viral sequences derived from each transmitted/founder (T/F) strain tend to cluster together at early stage, and that only the intra-cluster diversity is correlated with the time since HIV-1 infection. The dot-matrix pairwise alignment was used to eliminate the disproportional impact of insertion/deletions (indels) and recombination events, and so was the proportion of clusterable sequences (P-c) as an index to identify late chronic infections with declined viral genetic diversity. Tested on a dataset containing 398 incident and 163 chronic infection cases collected from the Los Alamos HIV database (last modified 2/8/2012), our SCBD method achieved 99.5% sensitivity and 98.8% specificity, with an overall accuracy of 99.3%. Further analysis and evaluation also suggested its performance was not affected by host factors such as the viral subtypes and transmission routes. The SCBD method demonstrated the potential of sequencing based techniques to become useful for identifying incident infections. Its use may be most advantageous for settings with low to moderate incidence relative to available resources.	[Xia, Xia-Yu; Ge, Meng; Wang, Zhi-Xin; Pan, Xian-Ming] Tsinghua Univ, Sch Life Sci, Key Lab Bioinformat, Minist Educ, Beijing 100084, Peoples R China; [Hsi, Jenny H.; He, Xiang; Ruan, Yu-Hua; Shao, Yi-Ming] Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China	Tsinghua University; Chinese Center for Disease Control & Prevention; National Center for AIDS/STD Control & Prevention, Chinese Center for Disease Control & Prevention	Shao, YM (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Ctr AIDS STD Control & Prevent, State Key Lab Infect Dis Prevent & Control, Beijing, Peoples R China.	yshao08@gmail.com; pan-xm@mail.tsinghua.edu.cn	wang, zhixin/GZH-2500-2022; He, Xiang/E-7082-2013	He, Xiang/0000-0003-2428-5349	Ministry of Science and Technology of China [2009CB918801]; Ministry of Health of China [2012ZX10001001-015]; International Development Research Center, Ottawa, Canada [104519-010]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); Ministry of Health of China; International Development Research Center, Ottawa, Canada	This work was supported in part by grant 2009CB918801 from the Ministry of Science and Technology of China, 2012ZX10001001-015 from the Ministry of Health of China, and 104519-010 from the International Development Research Center, Ottawa, Canada. The funding organizations did not have any role in the design and conduct of the study, in the collection, management, analysis, and interpretation of the data, or in the preparation, review, or approval of the manuscript.	Allam O, 2011, AIDS, V25, P2047, DOI 10.1097/QAD.0b013e32834bac66; [Anonymous], 2006, Wkly Epidemiol Rec, V81, P40; Atun R, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001045; Baldi P, 2000, BIOINFORMATICS, V16, P412, DOI 10.1093/bioinformatics/16.5.412; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Chawla A, 2007, J CLIN MICROBIOL, V45, P415, DOI 10.1128/JCM.01879-06; China MOH UNAIDS WHO, 2011, EST HIV AIDS EP CHIN; Fiebig EW, 2003, AIDS, V17, P1871, DOI 10.1097/00002030-200309050-00005; Guy R, 2009, LANCET INFECT DIS, V9, P747, DOI 10.1016/S1473-3099(09)70300-7; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Hayashida T, 2008, AIDS RES HUM RETROV, V24, P495, DOI 10.1089/aid.2007.0150; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; Justman J, 2010, SCIENCE, V329, P120, DOI 10.1126/science.1193218; Karita E, 2007, AIDS, V21, P403, DOI 10.1097/QAD.0b013e32801481b7; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kouyos RD, 2011, CLIN INFECT DIS, V52, P532, DOI 10.1093/cid/ciq164; Lee HY, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000240; Li H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000890; Loytynoja A, 2008, SCIENCE, V320, P1632, DOI 10.1126/science.1158395; MANSKY LM, 1995, J VIROL, V69, P5087, DOI 10.1128/JVI.69.8.5087-5094.1995; Murphy G, 2008, EUROSURVEILLANCE, V1, P13; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; Park SY, 2011, AIDS, V25, pF13, DOI 10.1097/QAD.0b013e328349f089; Ragonnet-Cronin M, 2012, J INFECT DIS, V206, P756, DOI 10.1093/infdis/jis411; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Tey J, 1996, ANN ACAD MED SINGAP, V41, P194; Yang J, 2012, SCI CHINA LIFE SCI, V55, P328, DOI 10.1007/s11427-012-4312-0	27	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e100081	10.1371/journal.pone.0100081	http://dx.doi.org/10.1371/journal.pone.0100081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925130	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300119
J	Manel, S; Couvreur, TLP; Munoz, F; Couteron, P; Hardy, OJ; Sonke, B				Manel, Stephanie; Couvreur, Thomas L. P.; Munoz, Francois; Couteron, Pierre; Hardy, Olivier J.; Sonke, Bonaventure			Characterizing the Phylogenetic Tree Community Structure of a Protected Tropical Rain Forest Area in Cameroon	PLOS ONE			English	Article							BETA-DIVERSITY; DNA-SEQUENCES; MOLECULAR PHYLOGENETICS; FUNCTIONAL TRAITS; SPACER SEQUENCES; INTERACTIVE TREE; APOCYNACEAE S.L.; PLASTID RBCL; TRNL INTRON; FAMILY	Tropical rain forests, the richest terrestrial ecosystems in biodiversity on Earth are highly threatened by global changes. This paper aims to infer the mechanisms governing species tree assemblages by characterizing the phylogenetic structure of a tropical rain forest in a protected area of the Congo Basin, the Dja Faunal Reserve (Cameroon). We re-analyzed a dataset of 11538 individuals belonging to 372 taxa found along nine transects spanning five habitat types. We generated a dated phylogenetic tree including all sampled taxa to partition the phylogenetic diversity of the nine transects into alpha and beta components at the level of the transects and of the habitat types. The variation in phylogenetic composition among transects did not deviate from a random pattern at the scale of the Dja Faunal Reserve, probably due to a common history and weak environmental variation across the park. This lack of phylogenetic structure combined with an isolation-by-distance pattern of taxonomic diversity suggests that neutral dispersal limitation is a major driver of community assembly in the Dja. To assess any lack of sensitivity to the variation in habitat types, we restricted the analyses of transects to the terra firme primary forest and found results consistent with those of the whole dataset at the level of the transects. Additionally to previous analyses, we detected a weak but significant phylogenetic turnover among habitat types, suggesting that species sort in varying environments, even though it is not predominating on the overall phylogenetic structure. Finer analyses of clades indicated a signal of clustering for species from the Annonaceae family, while species from the Apocynaceae family indicated overdispersion. These results can contribute to the conservation of the park by improving our understanding of the processes dictating community assembly in these hyperdiverse but threatened regions of the world.	[Manel, Stephanie] Aix Marseille Univ, IRD, LPED, UMR 151, Marseille, France; [Manel, Stephanie] Ctr Cooperat Int Rech Agron Dev, UMR AMAP, Montpellier, France; [Couvreur, Thomas L. P.] Inst Rech Dev, UMR DIADE, Montpellier, France; [Couvreur, Thomas L. P.; Sonke, Bonaventure] Univ Yaounde I, Ecole Normale Super, Lab Bot Systemat & Ecol, Dept Sci Biol, Yaounde, Cameroon; [Munoz, Francois] Univ Montpellier 2, UMR AMAP, Montpellier, France; [Couteron, Pierre] Inst Rech Dev, UMR AMAP, Montpellier, France; [Hardy, Olivier J.] Univ Libre Bruxelles, Fac Sci Evolutionary Biol & Ecol Brussels, Brussels, Belgium	UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; University of Yaounde I; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Universite Libre de Bruxelles	Manel, S (corresponding author), Aix Marseille Univ, IRD, LPED, UMR 151, Marseille, France.	stephanie.manel@univ-amu.fr	Couvreur, Thomas LP/D-8172-2011; Munoz, Francois/C-4239-2015	Couvreur, Thomas LP/0000-0002-8509-6587; Munoz, Francois/0000-0001-8776-4705	PEERS ISMOBIAC - Agence inter-etablissements de recherche pour le developpement - Programme Doctorant du Sud (AIRD-DPF)	PEERS ISMOBIAC - Agence inter-etablissements de recherche pour le developpement - Programme Doctorant du Sud (AIRD-DPF)	PC and BS are partly funded by "PEERS ISMOBIAC" through support provided by the Agence inter-etablissements de recherche pour le developpement - Programme Doctorant du Sud (AIRD-DPF). The funders had no role in study design, data collection and analysis, decision to publish or preparation manuscript.	Alverson WS, 1999, AM J BOT, V86, P1474, DOI 10.2307/2656928; Baraloto C, 2012, J ECOL, V100, P690, DOI 10.1111/j.1365-2745.2012.01966.x; Bele MY, 2011, J HORTICULTURE FORES, V10, P307; Bremer B, 2009, INT J PLANT SCI, V170, P766, DOI 10.1086/599077; Bruneau A, 2001, SYST BOT, V26, P487; Buerki S, 2009, MOL PHYLOGENET EVOL, V51, P238, DOI 10.1016/j.ympev.2009.01.012; Burgess N, 2005, BIODIVERS CONSERV, V14, P1877, DOI 10.1007/s10531-004-1299-2; Chatrou LW, 2012, BOT J LINN SOC, V169, P5, DOI 10.1111/j.1095-8339.2012.01235.x; Chave J, 2002, ENVIRON MODEL ASSESS, V7, P115, DOI 10.1023/A:1015601800181; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Couvreur TLP, 2011, J BIOGEOGR, V38, P664, DOI 10.1111/j.1365-2699.2010.02434.x; Davies TJ, 2004, P NATL ACAD SCI USA, V101, P1904, DOI 10.1073/pnas.0308127100; Diniz-Filho JAF, 2013, DARWINIAN SHORTFALLS; Eastman JM, 2011, BIOINFORMATICS, V27, P2437, DOI 10.1093/bioinformatics/btr403; FAITH DP, 1992, BIOL CONSERV, V61, P1, DOI 10.1016/0006-3207(92)91201-3; Fine PVA, 2011, ECOGRAPHY, V34, P552, DOI 10.1111/j.1600-0587.2010.06548.x; G TAP, 2009, BOT J LINN SOC, V161, P105; GENTRY AH, 1988, P NATL ACAD SCI USA, V85, P156, DOI 10.1073/pnas.85.1.156; Gibson L, 2011, NATURE, V478, P378, DOI 10.1038/nature10425; Givnish TJ, 1999, J ECOL, V87, P193, DOI 10.1046/j.1365-2745.1999.00333.x; Groppo M, 2008, AM J BOT, V95, P985, DOI 10.3732/ajb.2007313; Gustafsson MHG, 2002, INT J PLANT SCI, V163, P1045, DOI 10.1086/342521; Hardy O.J., 2010, SPACODI 0 10 PROGRAM; Hardy OJ, 2004, FOREST ECOL MANAG, V197, P191, DOI 10.1016/j.foreco.2004.05.014; Hardy OJ, 2008, J ECOL, V96, P914, DOI 10.1111/j.1365-2745.2008.01421.x; Hardy OJ, 2008, J ECOL, V96, P849, DOI 10.1111/j.1365-2745.2008.01423.x; Hardy OJ, 2007, J ECOL, V95, P493, DOI 10.1111/j.1365-2745.2007.01222.x; Hardy OJ, 2012, GLOBAL ECOL BIOGEOGR, V21, P1007, DOI 10.1111/j.1466-8238.2011.00742.x; Hubbell Stephen P., 2001, V32, pi; Jenkins CN, 2009, BIOL CONSERV, V142, P2166, DOI 10.1016/j.biocon.2009.04.016; Koleff P, 2003, GLOBAL ECOL BIOGEOGR, V12, P483, DOI 10.1046/j.1466-822X.2003.00056.x; Kraft NJB, 2011, SCIENCE, V333, P1755, DOI 10.1126/science.1208584; Kress WJ, 2010, PLOS ONE, V5; Lahaye R, 2005, AM J BOT, V92, P1381, DOI 10.3732/ajb.92.8.1381; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lebrun J, 1954, CLASSIFICATION ECCOL, V63, P9; Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Lewis SL, 2006, PHILOS T R SOC B, V361, P195, DOI 10.1098/rstb.2005.1711; Maddison WP, 2019, MESQUITE MODULAR SYS; Malecot V, 2008, SYST BOT, V33, P97, DOI 10.1600/036364408783887384; Mayfield MM, 2010, ECOL LETT, V13, P1085, DOI 10.1111/j.1461-0248.2010.01509.x; McGill BJ, 2006, TRENDS ECOL EVOL, V21, P178, DOI 10.1016/j.tree.2006.02.002; McGinley M, 2008, ENCY EARTH; Mouquet N, 2012, BIOL REV, V87, P769, DOI 10.1111/j.1469-185X.2012.00224.x; Muellner AN, 2010, AM J BOT, V97, P511, DOI 10.3732/ajb.0900229; Muellner AN, 2003, AM J BOT, V90, P471, DOI 10.3732/ajb.90.3.471; Munoz F, 2008, AM NAT, V172, P116, DOI 10.1086/587842; Olmstead RG, 2009, AM J BOT, V96, P1731, DOI 10.3732/ajb.0900004; Parmentier I, 2007, J ECOL, V95, P1058, DOI 10.1111/j.1365-2745.2007.01273.x; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Potgieter K, 2001, ANN MO BOT GARD, V88, P523, DOI 10.2307/3298632; Rolland J, 2012, BIOL LETTERS, V8, P692, DOI 10.1098/rsbl.2011.1024; Sauquet H, 2003, BOT J LINN SOC, V142, P125, DOI 10.1046/j.1095-8339.2003.00171.x; Sonke B, 2004, SCRIPTA BOT BELGICA, V32, P1; Sonke B, 1998, THESIS U LIBRE DEBRU, P129; Sonke Bonaventure, 2014, Biodivers Data J, pe1049, DOI 10.3897/BDJ.2.e1049; Swenson NG, 2013, ECOGRAPHY, V36, P264, DOI 10.1111/j.1600-0587.2012.00121.x; Swenson NG, 2012, ECOLOGY, V93, pS112, DOI 10.1890/11-0402.1; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Swenson NG, 2011, P ROY SOC B-BIOL SCI, V278, P877, DOI 10.1098/rspb.2010.1369; Tan FX, 2002, J PLANT RES, V115, P475, DOI 10.1007/s10265-002-0059-1; Team RC, 2012, R LANG ENV STAT COMP; Webb CO, 2008, BIOINFORMATICS, V24, P2098, DOI 10.1093/bioinformatics/btn358; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Webb CO, 2002, ANNU REV ECOL SYST, V33, P475, DOI 10.1146/annurev.ecolsys.33.010802.150448; WHITE F, 1983, DESCRIPTIVE MEMOIR A; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wilson PG, 2005, PLANT SYST EVOL, V251, P3, DOI 10.1007/s00606-004-0162-y; Winter M, 2013, TRENDS ECOL EVOL, V28, P199, DOI 10.1016/j.tree.2012.10.015; Wurdack KJ, 2005, AM J BOT, V92, P1397, DOI 10.3732/ajb.92.8.1397; Wurdack KJ, 2004, AM J BOT, V91, P1882, DOI 10.3732/ajb.91.11.1882; Yakandawala D, 2010, ANN MO BOT GARD, V97, P259, DOI 10.3417/2007175	73	7	7	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e98920	10.1371/journal.pone.0098920	http://dx.doi.org/10.1371/journal.pone.0098920			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936786	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400011
J	Yang, FY; Lin, YL; Chou, FI; Lin, YC; Liu, YWH; Chang, LW; Hsieh, YL				Yang, Feng-Yi; Lin, Yi-Li; Chou, Fong-In; Lin, Yu-Chuan; Liu, Yen-Wan Hsueh; Chang, Lun-Wei; Hsieh, Yu-Ling			Pharmacokinetics of BPA in Gliomas with Ultrasound Induced Blood-Brain Barrier Disruption as Measured by Microdialysis	PLOS ONE			English	Article							NEUTRON-CAPTURE THERAPY; NEWLY-DIAGNOSED GLIOBLASTOMA; FOCUSED ULTRASOUND; ENHANCED SURVIVAL; DRUG-DELIVERY; INTRACAROTID INJECTION; LIPOSOMAL DOXORUBICIN; SODIUM BOROCAPTATE; TUMORS; BORONOPHENYLALANINE	The blood-brain barrier (BBB) can be transiently disrupted by focused ultrasound (FUS) in the presence of microbubbles for targeted drug delivery. Previous studies have illustrated the pharmacokinetics of drug delivery across the BBB after sonication using indirect visualization techniques. In this study, we investigated the in vivo extracellular kinetics of boronophenylalanine-fructose (BPA-f) in glioma-bearing rats with FUS-induced BBB disruption by microdialysis. After simultaneous intravenous administration of BPA and FUS exposure, the boron concentration in the treated brains was quantified by inductively coupled plasma mass spectroscopy. With FUS, the mean peak concentration of BPA-f in the glioma dialysate was 3.6 times greater than without FUS, and the area under the concentration-time curve was 2.1 times greater. This study demonstrates that intracerebral microdialysis can be used to assess local BBB transport profiles of drugs in a sonicated site. Applying microdialysis to the study of metabolism and pharmacokinetics is useful for obtaining selective information within a specific brain site after FUS-induced BBB disruption.	[Yang, Feng-Yi; Lin, Yi-Li; Chang, Lun-Wei; Hsieh, Yu-Ling] Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan; [Yang, Feng-Yi] Natl Yang Ming Univ, Biophoton & Mol Imaging Res Ctr, Taipei 112, Taiwan; [Chou, Fong-In] Natl Tsing Hua Univ, Nucl Sci & Technol Dev Ctr, Hsinchu, Taiwan; [Chou, Fong-In; Lin, Yu-Chuan; Liu, Yen-Wan Hsueh] Natl Tsing Hua Univ, Inst Nucl Engn & Sci, Hsinchu, Taiwan	National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Tsing Hua University; National Tsing Hua University	Yang, FY (corresponding author), Natl Yang Ming Univ, Dept Biomed Imaging & Radiol Sci, Taipei 112, Taiwan.	fyyang@ym.edu.tw			National Science Council of Taiwan [NSC 102-2221-E-010-005-MY3, NSC 101-2320-B-010-036-MY3]; Cheng Hsin General Hospital Foundation [102F218C11, 103F003C17]; Biophotonics & Molecular Imaging Research Center; Ministry of Education, Aim for the Top University Plan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Cheng Hsin General Hospital Foundation; Biophotonics & Molecular Imaging Research Center; Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	This study was supported by grants from the National Science Council of Taiwan (no. NSC 102-2221-E-010-005-MY3 and NSC 101-2320-B-010-036-MY3), Cheng Hsin General Hospital Foundation (no. 102F218C11 and 103F003C17), Biophotonics & Molecular Imaging Research Center, and the Ministry of Education, Aim for the Top University Plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkins RD, 2013, NEURO-ONCOLOGY, V15, P1225, DOI 10.1093/neuonc/not052; Barth RF, 2000, INT J RADIAT ONCOL, V47, P209, DOI 10.1016/S0360-3016(00)00421-1; Barth RF, 1996, CANCER INVEST, V14, P534, DOI 10.3109/07357909609076899; Barth RF, 2005, CLIN CANCER RES, V11, P3987, DOI 10.1158/1078-0432.CCR-05-0035; Barth RF, 1998, J NEURO-ONCOL, V36, P91, DOI 10.1023/A:1005805203044; Barth RF, 2002, INT J RADIAT ONCOL, V52, P858, DOI 10.1016/S0360-3016(01)02734-1; Barth RF, 1997, CANCER RES, V57, P1129; BENVENISTE H, 1990, PROG NEUROBIOL, V35, P195, DOI 10.1016/0301-0082(90)90027-E; Bergenheim AT, 2005, J NEURO-ONCOL, V71, P287, DOI 10.1007/s11060-004-1724-0; Evrard PA, 1996, PHARMACEUT RES, V13, P12, DOI 10.1023/A:1016056628685; Hynynen K, 2001, RADIOLOGY, V220, P640, DOI 10.1148/radiol.2202001804; Johansen MJ, 1997, PHARMACOTHERAPY, V17, P464; Kabalka GW, 2003, J NEURO-ONCOL, V62, P187, DOI 10.1007/BF02699944; Kawabata S, 2009, J RADIAT RES, V50, P51, DOI 10.1269/jrr.08043; KEHR J, 1993, J NEUROSCI METH, V48, P251, DOI 10.1016/0165-0270(93)90096-A; Kroll RA, 1998, NEUROSURGERY, V42, P1083, DOI 10.1097/00006123-199805000-00082; Miyatake SI, 2009, J NEURO-ONCOL, V91, P199, DOI 10.1007/s11060-008-9699-x; Park J, 2012, J CONTROL RELEASE, V162, P134, DOI 10.1016/j.jconrel.2012.06.012; Rubin LL, 1999, ANNU REV NEUROSCI, V22, P11, DOI 10.1146/annurev.neuro.22.1.11; Skold K, 2010, BRIT J RADIOL, V83, P596, DOI 10.1259/bjr/56953620; Smith DR, 2001, CANCER RES, V61, P8179; Vlachos F, 2010, PHYS MED BIOL, V55, P5451, DOI 10.1088/0031-9155/55/18/012; Vlachos F, 2011, MAGN RESON MED, V66, P821, DOI 10.1002/mrm.22848; Wang HE, 2004, J NUCL MED, V45, P302; WESTERINK BHC, 1987, LIFE SCI, V41, P1763, DOI 10.1016/0024-3205(87)90695-3; Yang FY, 2012, FUTURE ONCOL, V8, P1361, DOI [10.2217/fon.12.118, 10.2217/FON.12.118]; Yang FY, 2012, J CONTROL RELEASE, V160, P652, DOI 10.1016/j.jconrel.2012.02.023; Yang FY, 2012, INT J NANOMED, V7, P965, DOI 10.2147/IJN.S29229; Yang FY, 2011, J NUCL MED, V52, P478, DOI 10.2967/jnumed.110.083071; Yang FY, 2011, J CONTROL RELEASE, V150, P111, DOI 10.1016/j.jconrel.2010.10.038; YOSHINO K, 1989, STRAHLENTHER ONKOL, V165, P127	31	13	13	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100104	10.1371/journal.pone.0100104	http://dx.doi.org/10.1371/journal.pone.0100104			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936788	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400075
J	Grundy, A; Cotterchio, M; Kirsh, VA; Kreiger, N				Grundy, Anne; Cotterchio, Michelle; Kirsh, Victoria A.; Kreiger, Nancy			Associations between Anxiety, Depression, Antidepressant Medication, Obesity and Weight Gain among Canadian Women	PLOS ONE			English	Article							NATIONAL EPIDEMIOLOGIC SURVEY; PSYCHIATRIC-DISORDERS; BODY-WEIGHT; PUTATIVE CONTRIBUTORS; ADOLESCENT DEPRESSION; GENDER-DIFFERENCES; MAJOR DEPRESSION; EARLY ADULTHOOD; SYMPTOMS; HEALTH	Purpose: Some mental illnesses have been suggested to be associated with obesity, although results are somewhat inconsistent and research has focused mainly on depression. Methods: Associations between anxiety, depression, medications for these illnesses, and obesity were investigated cross-sectionally among women aged 25-74 (n = 3004) who participated as population controls in a cancer case-control study. Participants self-reported information on anxiety, depression, height, current weight and weight at age 25. Results: No association was observed between either anxiety or depression and either current overweight or obesity status. However, depressed women taking antidepressants were more likely to be obese [OR = 1.71 (95% CI = 1.16-2.52) daily antidepressant use; OR = 1.89 (95% CI = 1.21-2.96) ever tricyclic antidepressant use]. In the full study sample consistent positive associations between anxiety, depression and obesity among women with a history of antidepressant use, and generally negative associations among women without, were suggested. Finally, weight gain was associated with history of anxiety [5-19 kg OR = 1.29 (95% CI = 1.06-1.57); >= 20 kg OR = 1.43 (95% CI = 1.08-1.88)] and depression [>= 20 kg OR = 1.28 (95% CI = 0.99-1.65)]. Conclusions: These results suggest depression and anxiety may be associated with weight gain and antidepressant use may be associated with obesity.	[Grundy, Anne; Cotterchio, Michelle; Kirsh, Victoria A.; Kreiger, Nancy] Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada; [Cotterchio, Michelle; Kirsh, Victoria A.; Kreiger, Nancy] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Kreiger, Nancy] Univ Toronto, Dept Nutr Sci, Toronto, ON, Canada	Cancer Care Ontario; University of Toronto; University of Toronto	Grundy, A (corresponding author), Canc Care Ontario, Prevent & Canc Control, Toronto, ON, Canada.	anne.l.grundy@gmail.com		Cotterchio, Michelle/0000-0003-2862-7895	Canadian Breast Cancer Research Alliance [007235]; Cancer Care Ontario	Canadian Breast Cancer Research Alliance; Cancer Care Ontario	Funding for the Women's Health Study was provided by the Canadian Breast Cancer Research Alliance (Grant No. 007235). Anne Grundy was supported by a postdoctoral fellowship from Cancer Care Ontario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlberg AC, 2002, PSYCHIAT RES, V112, P101, DOI 10.1016/S0165-1781(02)00192-0; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Andreyeva T, 2007, PUBLIC HEALTH, V121, P497, DOI 10.1016/j.puhe.2006.11.016; Aronne LJ, 2003, J CLIN PSYCHIAT, V64, P22; Bardone AM, 1998, J AM ACAD CHILD PSY, V37, P594, DOI 10.1097/00004583-199806000-00009; Barefoot JC, 1998, INT J OBESITY, V22, P688, DOI 10.1038/sj.ijo.0800647; Barry D, 2008, ANN EPIDEMIOL, V18, P458, DOI 10.1016/j.annepidem.2007.12.009; CASEY VA, 1991, AM J CLIN NUTR, V53, P1493, DOI 10.1093/ajcn/53.6.1493; Chiriboga DE, 2008, OBESITY, V16, P137, DOI 10.1038/oby.2007.38; Cotterchio M, 2001, CANCER EPIDEM BIOMAR, V10, P1213; CRISP AH, 1976, BRIT MED J, V1, P7, DOI 10.1136/bmj.1.6000.7; Faith MS, 2011, OBES REV, V12, pe438, DOI 10.1111/j.1467-789X.2010.00843.x; Fava M, 2000, J CLIN PSYCHIAT, V61, P37; First M.B., 1990, USERS GUIDE STRUCTUR; Franko DL, 2005, PSYCHOL MED, V35, P1505, DOI 10.1017/S0033291705005386; Frise S, 2002, CAN J PSYCHIAT, V47, P849, DOI 10.1177/070674370204700906; Goodman E, 2002, PEDIATRICS, V110, P497, DOI 10.1542/peds.110.3.497; Goodwin RD, 2009, PSYCHOL MED, V39, P301, DOI 10.1017/S0033291708003504; Hasler G, 2005, MOL PSYCHIATR, V10, P842, DOI 10.1038/sj.mp.4001671; Heo M, 2006, INT J OBESITY, V30, P513, DOI 10.1038/sj.ijo.0803122; Keith SW, 2006, INT J OBESITY, V30, P1585, DOI 10.1038/sj.ijo.0803326; Kovalchik S, 2009, PUBLIC HEALTH NUTR, V12, P1072, DOI 10.1017/S1368980008003728; Lee RSC, 2012, J AFFECT DISORDERS, V140, P113, DOI 10.1016/j.jad.2011.10.023; Luppino FS, 2010, ARCH GEN PSYCHIAT, V67, P220, DOI 10.1001/archgenpsychiatry.2010.2; Mather AA, 2009, J PSYCHOSOM RES, V66, P277, DOI 10.1016/j.jpsychores.2008.09.008; McAllister EJ, 2009, CRIT REV FOOD SCI, V49, P868, DOI 10.1080/10408390903372599; Must A, 1999, JAMA-J AM MED ASSOC, V282, P1523, DOI 10.1001/jama.282.16.1523; Nyholm M, 2007, OBESITY, V15, P197, DOI 10.1038/oby.2007.536; Ohayon MM, 2007, J PSYCHIAT RES, V41, P207, DOI 10.1016/j.jpsychires.2006.10.006; Palinkas LA, 1996, J PSYCHOSOM RES, V40, P59, DOI 10.1016/0022-3999(95)00542-0; Papakostas GI, 2014, J CLIN PSYCHIAT, V75, P8, DOI 10.4088/JCP.13r08710; Patten SB, 2011, J AFFECT DISORDERS, V134, P288, DOI 10.1016/j.jad.2011.06.027; Patten SB, 2009, PSYCHOTHER PSYCHOSOM, V78, P182, DOI 10.1159/000209349; PERRY GS, 1995, EPIDEMIOLOGY, V6, P61, DOI 10.1097/00001648-199501000-00012; Petry NM, 2008, PSYCHOSOM MED, V70, P288, DOI 10.1097/PSY.0b013e3181651651; Pine DS, 2001, PEDIATRICS, V107, P1049, DOI 10.1542/peds.107.5.1049; Pine DS, 1997, AM J PUBLIC HEALTH, V87, P1303, DOI 10.2105/AJPH.87.8.1303; Rhew IC, 2008, GEN HOSP PSYCHIAT, V30, P458, DOI 10.1016/j.genhosppsych.2008.06.008; Richardson LP, 2003, ARCH PEDIAT ADOL MED, V157, P739, DOI 10.1001/archpedi.157.8.739; Roberts RE, 2003, INT J OBESITY, V27, P514, DOI 10.1038/sj.ijo.0802204; ROBINS LN, 1981, ARCH GEN PSYCHIAT, V38, P381; Rohde P, 2008, CHILD ABUSE NEGLECT, V32, P878, DOI 10.1016/j.chiabu.2007.11.004; Rosmond R, 1998, OBES RES, V6, P338, DOI 10.1002/j.1550-8528.1998.tb00361.x; Rothman K., 1998, MODERN EPIDEMIOLOGY, P253; Schwartz T L, 2004, Obes Rev, V5, P115, DOI 10.1111/j.1467-789X.2004.00139.x; Scott KA, 2008, J PSYCHOSOM RES, V64, P97, DOI 10.1016/j.jpsychores.2007.09.006; Shields Margot, 2008, Health Rep, V19, P61; Simon GE, 2008, GEN HOSP PSYCHIAT, V30, P32, DOI 10.1016/j.genhosppsych.2007.09.001; Simon GE, 2006, ARCH GEN PSYCHIAT, V63, P824, DOI 10.1001/archpsyc.63.7.824; Steingart A, 2003, INT J EPIDEMIOL, V32, P961, DOI 10.1093/ije/dyg155; STEVENS J, 1990, AM J EPIDEMIOL, V132, P1156, DOI 10.1093/oxfordjournals.aje.a115758; Stice E, 2005, J CONSULT CLIN PSYCH, V73, P195, DOI 10.1037/0022-006X.73.2.195; Tremblay A, 2008, APPL PHYSIOL NUTR ME, V33, P791, DOI 10.1139/H08-038; Vogelzangs N, 2008, ARCH GEN PSYCHIAT, V65, P1386, DOI 10.1001/archpsyc.65.12.1386; Zimmermann U, 2003, J PSYCHIATR RES, V37, P193, DOI 10.1016/S0022-3956(03)00018-9	55	46	48	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99780	10.1371/journal.pone.0099780	http://dx.doi.org/10.1371/journal.pone.0099780			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ5PV	24932472	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600062
J	Jacquier, M; Crauste, F; Soulage, CO; Soula, HA				Jacquier, Marine; Crauste, Fabien; Soulage, Christophe O.; Soula, Hedi A.			A Predictive Model of the Dynamics of Body Weight and Food Intake in Rats Submitted to Caloric Restrictions	PLOS ONE			English	Article							NERVOUS-SYSTEM CONTROL; FAT-FREE MASS; ADAPTIVE THERMOGENESIS; MATHEMATICAL-MODEL; ENERGY-EXPENDITURE; GHRELIN; OBESITY; METABOLISM; APPETITE; LEPTIN	Dynamics of body weight and food intake can be studied by temporally perturbing food availability. This perturbation can be obtained by modifying the amount of available food over time while keeping the overall food quantity constant. To describe food intake dynamics, we developed a mathematical model that describes body weight, fat mass, fat-free mass, energy expenditure and food intake dynamics in rats. In addition, the model considers regulation of food intake by leptin, ghrelin and glucose. We tested our model on rats experiencing temporally variable food availability. Our model is able to predict body weight and food intake variations by taking into account energy expenditure dynamics based on a memory of the previous food intake. This model allowed us to estimate this memory lag to approximately 8 days. It also explains how important variations in food availability during periods longer than these 8 days can induce body weight gains.	[Jacquier, Marine; Crauste, Fabien] Univ Lyon 1, CNRS, Inst Camille Jordan, UMR 5208, F-69622 Villeurbanne, France; [Jacquier, Marine; Crauste, Fabien] Inria Ctr Grenoble Rhone Alpes, Inria Team Dracula, Grenoble Rhone Alpes, France; [Soulage, Christophe O.; Soula, Hedi A.] Univ Lyon 1, CarMeN, INSERM, INSA Lyon,U1060, F-69622 Villeurbanne, France; [Soula, Hedi A.] Inria Ctr Grenoble Rhone Alpes, Project Team Beagle, Grenoble Rhone Alpes, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Mathematical Sciences (INSMI); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ecole Centrale de Lyon; Institut National des Sciences Appliquees de Lyon - INSA Lyon; Universite Jean Monnet; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1	Jacquier, M (corresponding author), Univ Lyon 1, CNRS, Inst Camille Jordan, UMR 5208, F-69622 Villeurbanne, France.	marine.jacquier@inria.fr	Carmen, Team1/Y-7382-2019; SOULAGE, Christophe O/J-2759-2014; Carmen, Team3/Y-7384-2019	Carmen, Team1/0000-0003-4234-1746; SOULAGE, Christophe O/0000-0002-8800-2144; Carmen, Team3/0000-0002-3614-0924; Crauste, Fabien/0000-0002-9979-9638; Lab, Carmen/0000-0002-5935-3236	INSA Lyon, University Lyon 1; Inria; Inserm	INSA Lyon, University Lyon 1; Inria; Inserm(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	This work was funded by the authors' institutions: INSA Lyon, University Lyon 1, Inria and Inserm. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams P, 2011, CURR OPIN ENDOCRINOL, V18, P23, DOI 10.1097/MED.0b013e3283424b37; Barsh GS, 2000, NATURE, V404, P644, DOI 10.1038/35007519; Beck B, 2002, BIOCHEM BIOPH RES CO, V292, P1031, DOI 10.1006/bbrc.2002.6737; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; CAMPFIELD LA, 1990, INT J OBESITY, V14, P15; Chow CC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000045; COBELLI C, 1984, MATH BIOSCI, V72, P291, DOI 10.1016/0025-5564(84)90114-7; Covasa M, 2010, AM J PHYSIOL-REG I, V299, pR1423, DOI 10.1152/ajpregu.00126.2010; Cummings DE, 2006, PHYSIOL BEHAV, V89, P71, DOI 10.1016/j.physbeh.2006.05.022; Cummings DE, 2003, ARCH SURG-CHICAGO, V138, P389, DOI 10.1001/archsurg.138.4.389; de Graaf AA, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000554; Duca FA, 2012, BRIT J NUTR, V108, P778, DOI 10.1017/S0007114512000529; Duca FA, 2013, HORM BEHAV, V64, P812, DOI 10.1016/j.yhbeh.2013.09.004; Evans SA, 2005, J APPL PHYSIOL, V99, P1336, DOI 10.1152/japplphysiol.01380.2004; Flier JS, 2004, CELL, V116, P337, DOI 10.1016/S0092-8674(03)01081-X; Friedman JM, 2000, NATURE, V404, P632, DOI 10.1038/35007504; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; GARROW JS, 1987, AM J CLIN NUTR, V45, P1114, DOI 10.1093/ajcn/45.5.1114; Greenberg JA, 2000, MECH AGEING DEV, V113, P37, DOI 10.1016/S0047-6374(99)00094-9; Guo JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015961; Guo J, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000511; Hall KD, 2007, BRIT J NUTR, V97, P1059, DOI 10.1017/S0007114507691946; Hall KD, 2006, AM J PHYSIOL-ENDOC M, V291, pE23, DOI 10.1152/ajpendo.00523.2005; Hall KD, 2011, LANCET, V378, P826, DOI 10.1016/S0140-6736(11)60812-X; Hall KD, 2010, BRIT J NUTR, V104, P4, DOI 10.1017/S0007114510000206; Hall KD, 2010, AM J PHYSIOL-ENDOC M, V298, pE449, DOI 10.1152/ajpendo.00559.2009; Higgins SC, 2007, ANN MED, V39, P116, DOI 10.1080/07853890601149179; Horgan GW, 2011, J THEOR BIOL, V270, P1, DOI 10.1016/j.jtbi.2010.11.001; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; MCCARTER RJ, 1992, AM J PHYSIOL, V263, pE448, DOI 10.1152/ajpendo.1992.263.3.E448; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; NELSON KM, 1992, AM J CLIN NUTR, V56, P848, DOI 10.1093/ajcn/56.5.848; NEWBY FD, 1990, AM J PHYSIOL, V259, pR1117, DOI 10.1152/ajpregu.1990.259.6.R1117; Periwal V, 2006, AM J PHYSIOL-ENDOC M, V291, pE929, DOI 10.1152/ajpendo.00122.2006; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Crespo CS, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00058; STEPHENS TW, 1995, NATURE, V377, P530, DOI 10.1038/377530a0; Tam J, 2009, CELL METAB, V9, P52, DOI 10.1016/j.cmet.2008.11.005; Tremblay A, 2013, INT J OBESITY, V37, P759, DOI 10.1038/ijo.2012.124; van Leeuwen IMM, 2002, BIOGERONTOLOGY, V3, P373, DOI 10.1023/A:1021336321551; Vestergaard ET, 2007, AM J PHYSIOL-ENDOC M, V292, pE1829, DOI 10.1152/ajpendo.00682.2006; Wijers SLJ, 2009, OBES REV, V10, P218, DOI 10.1111/j.1467-789X.2008.00538.x; Woods SC, 2000, ANNU REV PSYCHOL, V51, P255, DOI 10.1146/annurev.psych.51.1.255; Woods SC, 1998, SCIENCE, V280, P1378, DOI 10.1126/science.280.5368.1378; Wren AM, 2001, J CLIN ENDOCR METAB, V86, P5992, DOI 10.1210/jc.86.12.5992; Zeng JB, 1997, AM J PHYSIOL-ENDOC M, V273, pE1102, DOI 10.1152/ajpendo.1997.273.6.E1102	48	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100073	10.1371/journal.pone.0100073	http://dx.doi.org/10.1371/journal.pone.0100073			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932616	Green Published, gold			2022-12-27	WOS:000337738600089
J	Lenda, M; Skorka, P; Knops, JMH; Moron, D; Sutherland, WJ; Kuszewska, K; Woyciechowski, M				Lenda, Magdalena; Skorka, Piotr; Knops, Johannes M. H.; Moron, Dawid; Sutherland, William J.; Kuszewska, Karolina; Woyciechowski, Michal			Effect of the Internet Commerce on Dispersal Modes of Invasive Alien Species	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; BIOLOGICAL INVASIONS; PROPAGULE PRESSURE; PLANT INVASIONS; TRADE; ESTABLISHMENT; ECOSYSTEMS; MANAGEMENT; ECOLOGY; ORIGIN	The spread of invasive alien plants has considerable environmental and economic consequences, and is one of the most challenging ecological problems. The spread of invasive alien plant species depends largely on long-distance dispersal, which is typically linked with human activity. The increasing domination of the internet will have impacts upon almost all components of our lives, including potential consequences for the spread of invasive species. To determine whether the rise of Internet commerce has any consequences for the spread of invasive alien plant species, we studied the sale of thirteen of some of the most harmful Europe invasive alien plant species sold as decorative plants from twenty-eight large, well known gardening shops in Poland that sold both via the Internet and through traditional customer sales. We also analyzed temporal changes in the number of invasive plants sold in the largest Polish internet auction portal. When sold through the Internet invasive alien plant species were transported considerably longer distances than for traditional sales. For internet sales, seeds of invasive alien plant species were transported further than were live plants saplings; this was not the case for traditional sales. Also, with e-commerce the shape of distance distribution were flattened with low skewness comparing with traditional sale where the distributions were peaked and right-skewed. Thus, e-commerce created novel modes of long-distance dispersal, while traditional sale resembled more natural dispersal modes. Moreover, analysis of sale in the biggest Polish internet auction portal showed that the number of alien specimens sold via the internet has increased markedly over recent years. Therefore internet commerce is likely to increase the rate at which ecological communities become homogenized and increase spread of invasive species by increasing the rate of long distance dispersal.	[Lenda, Magdalena; Kuszewska, Karolina; Woyciechowski, Michal] Jagiellonian Univ, Inst Environm Sci, Krakow, Poland; [Skorka, Piotr] Poznan Univ Life Sci, Inst Zool, Poznan, Poland; [Knops, Johannes M. H.] Univ Nebraska, Sch Biol Sci, Lincoln, NE USA; [Moron, Dawid] Polish Acad Sci, Inst Systemat & Evolut Anim, Krakow, Poland; [Sutherland, William J.] Univ Cambridge, Dept Zool, Conservat Sci Grp, Cambridge, England	Jagiellonian University; Poznan University of Life Sciences; University of Nebraska System; University of Nebraska Lincoln; Polish Academy of Sciences; Institute of Systematics & Evolution of Animals of the Polish Academy of Sciences; University of Cambridge	Lenda, M (corresponding author), Jagiellonian Univ, Inst Environm Sci, Krakow, Poland.	lenda.m@vp.pl	Skórka, Piotr/B-7218-2009; Knops, Johannes/AAA-8546-2020; Moroń, Dawid/A-8595-2010	Skórka, Piotr/0000-0002-3221-296X; Moroń, Dawid/0000-0003-3692-7855; Skorka, Piotr/0000-0002-7486-2928; Sutherland, William/0000-0002-6498-0437; kuszewska, Karolina/0000-0001-8104-8740; Lenda, Magdalena/0000-0001-7824-7220	Jagiellonian University [DS/BiNoZ/INoS/756]; Polish National Science Centre [UMO-2011/01/N/NZ8/03211]; Arcadia; Foundation for Polish Science	Jagiellonian University; Polish National Science Centre; Arcadia; Foundation for Polish Science(Foundation for Polish ScienceEuropean Commission)	Funding for this project was partially provided by the Jagiellonian University, DS/BiNoZ/INoS/756, and Polish National Science Centre UMO-2011/01/N/NZ8/03211. WJS is funded by Arcadia. ML and KK were beneficiaries of the Grant for Young Scientists "Start" of the Foundation for Polish Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2009, BIOL INVASIONS, V11, P1145, DOI 10.1007/s10530-008-9382-3; Barton KA, 2012, P ROY SOC B-BIOL SCI, V279, P1194, DOI 10.1098/rspb.2011.1254; Bauer C., 2002, Electronic Markets, V12, P130, DOI 10.1080/10196780252844571; Bouse Derek, 2003, VISUAL STUD, V18, P123, DOI DOI 10.1080/14725860310001631994; Bullock JM, 2000, OECOLOGIA, V124, P506, DOI 10.1007/PL00008876; Cassey P, 2004, J BIOGEOGR, V31, P277, DOI 10.1046/j.0305-0270.2003.00979.x; Chittka L, 2001, NATURE, V411, P653, DOI 10.1038/35079676; Crooks JA, 2005, ECOSCIENCE, V12, P316, DOI 10.2980/i1195-6860-12-3-316.1; Czarnecka J, 2012, CENT EUR J BIOL, V7, P895, DOI 10.2478/s11535-012-0081-9; DAISIE, 2009, HDB ALIEN SPECIES EU, DOI [10.1007/978-1-4020-8280-1, DOI 10.1007/978-1-4020-8280-1]; Davis M. A., 2009, INVASION BIOL; Dehnen-Schmutz K, 2007, CONSERV BIOL, V21, P224, DOI 10.1111/j.1523-1739.2006.00538.x; Derraik JGB, 2010, BIOL INVASIONS, V12, P1477, DOI 10.1007/s10530-009-9595-0; Dlugosch KM, 2008, MOL ECOL, V17, P431, DOI 10.1111/j.1365-294X.2007.03538.x; Drake JM, 2004, P ROY SOC B-BIOL SCI, V271, P575, DOI 10.1098/rspb.2003.2629; Elton C. S., 1958, ECOLOGY INVASIONS AN; Essl F, 2012, BIOL INVASIONS, V14, P1331, DOI 10.1007/s10530-011-0156-y; Essl F, 2011, P NATL ACAD SCI USA, V108, P203, DOI 10.1073/pnas.1011728108; Forman Richard T.T., 2002, ROAD ECOLOGY SCI SOL; Frankel SJ, 2008, AUSTRALAS PLANT PATH, V37, P19, DOI 10.1071/AP07088; Freund CL, 2004, J INT ECON, V62, P171, DOI 10.1016/S0022-1996(03)00059-X; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Hobbs RJ, 2009, TRENDS ECOL EVOL, V24, P599, DOI 10.1016/j.tree.2009.05.012; Hulme PE, 2009, J APPL ECOL, V46, P10, DOI 10.1111/j.1365-2664.2008.01600.x; Kikillus KH, 2012, BIOL INVASIONS, V14, P2657, DOI 10.1007/s10530-012-0262-5; Lenda M, 2012, P ROY SOC B-BIOL SCI, V279, P1491, DOI 10.1098/rspb.2011.2153; Lewis T, 2008, SMART LIVING LIFESTY, V15; Lines J, 2007, BRIT MED J, V335, P576, DOI 10.1136/bmj.39342.563310.80; Lipinska AM, 2009, NAT CONSERV, V65, P79; Lockwood JL, 2005, TRENDS ECOL EVOL, V20, P223, DOI 10.1016/j.tree.2005.02.004; Longley P.A., 2010, GEOGRAPHICAL INFORM; Margolis M, 2005, ECOL ECON, V52, P305, DOI 10.1016/j.ecolecon.2004.07.017; McCullough DG, 2006, BIOL INVASIONS, V8, P611, DOI 10.1007/s10530-005-1798-4; Moron D, 2009, BIOL CONSERV, V142, P1322, DOI 10.1016/j.biocon.2008.12.036; Nathan R, 2008, TRENDS ECOL EVOL, V23, P638, DOI 10.1016/j.tree.2008.08.003; Nathan R, 2006, SCIENCE, V313, P786, DOI 10.1126/science.1124975; Pautasso M, 2013, BIOL CONSERV, V158, P37, DOI 10.1016/j.biocon.2012.08.026; Pysek P., 1994, Ecology and management of invasive riverside plants., P19; Pysek P, 2012, GLOBAL CHANGE BIOL, V18, P1725, DOI 10.1111/j.1365-2486.2011.02636.x; Quinn GP, 2003, EXPT DESIGN DATA ANA; Richardson DM, 2008, DIVERS DISTRIB, V14, P161, DOI 10.1111/j.1472-4642.2007.00464.x; Richardson DM, 2000, BIOL REV, V75, P65, DOI 10.1017/S0006323199005435; Rieseberg LH, 2007, GENETICA, V129, P149, DOI 10.1007/s10709-006-9011-y; Rixon CAM, 2005, BIODIVERS CONSERV, V14, P1365, DOI 10.1007/s10531-004-9663-9; Saura-Mas S, 2005, ACTA OECOL, V27, P129, DOI 10.1016/j.actao.2004.12.001; Simberloff D, 2009, ANNU REV ECOL EVOL S, V40, P81, DOI 10.1146/annurev.ecolsys.110308.120304; Snaddon JL, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002579; Tatem AJ, 2009, ECOGRAPHY, V32, P94, DOI 10.1111/j.1600-0587.2008.05588.x; Von der Lippe M, 2007, CONSERV BIOL, V21, P986, DOI 10.1111/j.1523-1739.2007.00722.x; Ward DF, 2006, DIVERS DISTRIB, V12, P601, DOI 10.1111/j.1366-9516.2006.00270.x; White PCL, 2008, WILDLIFE RES, V35, P171, DOI 10.1071/WR08058; Zmihorski M, 2013, OIKOS, V122, P183, DOI 10.1111/j.1600-0706.2012.20486.x	52	41	41	0	83	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99786	10.1371/journal.pone.0099786	http://dx.doi.org/10.1371/journal.pone.0099786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932498	Green Published, gold			2022-12-27	WOS:000337738600063
J	Skardelly, M; Hempel, E; Hirrlinger, J; Wegner, F; Meixensberger, J; Milosevic, J				Skardelly, Marco; Hempel, Eileen; Hirrlinger, Johannes; Wegner, Florian; Meixensberger, Juergen; Milosevic, Javorina			Fluorescent Protein-Expressing Neural Progenitor Cells as a Tool for Transplantation Studies	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; STEM-CELLS; TRANSGENIC MICE; BRAIN; PRECURSORS; NEUROGENESIS; ASTROCYTES; MIGRATION; DELIVERY; NEURONS	The purpose of this study was to generate quadruple fluorescent protein (QFP) transgenic mice as a source for QFP-expressing neural stem and progenitor cells (NSCs/NPCs) that could be utilized as a tool for transplantation research. When undifferentiated, these NSCs only express cyan fluorescent protein (CFP); however, upon neuronal differentiation, the cells express yellow fluorescent protein (YFP). During astrocytic differentiation, the cells express green fluorescent protein (GFP), and during oligodendrocytic differentiation, the cells express red fluorescent protein (DsRed). Using immunocytochemistry, immunoblotting, flow cytometry and electrophysiology, quadruple transgenic NPCs (Q-NPCs) and GFP-sorted NPCs were comprehensively characterized in vitro. Overall, the various transgenes did not significantly affect proliferation and differentiation of transgenic NPCs in comparison to wild-type NPCs. In contrast to a strong CFP and GFP expression in vitro, NPCs did not express YFP and dsRed either during proliferation or after differentiation in vitro. GFP-positive sorted NPCs, expressing GFP under the control of the human GFAP promoter, demonstrated a significant improvement in astroglial differentiation in comparison to GFP-negative sorted NPCs. In contrast to non-sorted and GFP-positive sorted NPCs, GFP-negative sorted NPCs demonstrated a high proportion of neuronal differentiation and proved to be functional in vitro. At 6 weeks after the intracerebroventricular transplantation of Q-NPCs into neonatal wild-type mice, CFP/DCX (doublecortin) double-positive transplanted cells were observed. The Q-NPCs did not express any other fluorescent proteins and did not mature into neuronal or glial cells. Although this model failed to visualize NPC differentiation in vivo, we determined that activation of the NPC glial fibrillary acid protein (GFAP) promoter, as indicated by GFP expression, can be used to separate neuronal and glial progenitors as a valuable tool for transplantation studies.	[Skardelly, Marco; Milosevic, Javorina] Univ Leipzig, Translat Ctr Regenerat Med, D-04109 Leipzig, Germany; [Skardelly, Marco; Hempel, Eileen; Meixensberger, Juergen] Univ Hosp, Dept Neurosurg, Leipzig, Germany; [Hirrlinger, Johannes] Univ Leipzig, Fac Med, Carl Ludwig Inst Physiol, D-04109 Leipzig, Germany; [Wegner, Florian] Hannover Med Sch, Dept Neurol, Hannover, Germany	Leipzig University; Leipzig University; Leipzig University; Hannover Medical School	Skardelly, M (corresponding author), Univ Tubingen Hosp, Dept Neurosurg, Tubingen, Germany.	marco.skardelly@med.uni-tuebingen.de	Skardelly, Marco/AAF-8680-2021; Hirrlinger, Johannes/F-5984-2010		German Federal Ministry of Education and Research (BMBF) [PtJ-Bio 0315883]; Deutsche Forschungsgemeinschaft; Tuebingen University	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Tuebingen University	This work was supported by the German Federal Ministry of Education and Research (BMBF, PtJ-Bio 0315883). The authors acknowledge support from Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann N, 2001, PHYSIOL REV, V81, P871, DOI 10.1152/physrev.2001.81.2.871; Bidlingmaier S, 2008, J MOL MED, V86, P1025, DOI 10.1007/s00109-008-0357-8; Bordey A, 2006, CELL CYCLE, V5, P722, DOI 10.4161/cc.5.7.2614; BRENNER M, 1994, J NEUROSCI, V14, P1030, DOI 10.1523/JNEUROSCI.14-03-01030.1994; Brustle O, 1998, NAT BIOTECHNOL, V16, P1040, DOI 10.1038/3481; Capone C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000373; Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5; Carpenter MK, 2001, EXP NEUROL, V172, P383, DOI 10.1006/exnr.2001.7832; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chazal G, 2000, J NEUROSCI, V20, P1446; Coskun V, 2008, P NATL ACAD SCI USA, V105, P1026, DOI 10.1073/pnas.0710000105; Delaunay D, 2008, J NEUROSCI, V28, P2551, DOI 10.1523/JNEUROSCI.5497-07.2008; Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9; Elkouris M, 2011, STEM CELLS, V29, P89, DOI 10.1002/stem.554; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Goldman S, 2005, NAT BIOTECHNOL, V23, P862, DOI 10.1038/nbt1119; Guzman R, 2007, P NATL ACAD SCI USA, V104, P10211, DOI 10.1073/pnas.0608519104; Hirrlinger PG, 2005, MOL CELL NEUROSCI, V30, P291, DOI 10.1016/j.mcn.2005.08.011; Hu HY, 1996, NEURON, V16, P735, DOI 10.1016/S0896-6273(00)80094-X; Kim DE, 2004, STROKE, V35, P952, DOI 10.1161/01.STR.0000120308.21946.5D; Kordower JH, 1997, J COMP NEUROL, V387, P96, DOI 10.1002/(SICI)1096-9861(19971013)387:1<96::AID-CNE8>3.0.CO;2-I; Mason JL, 2002, MOL CELL NEUROSCI, V20, P30, DOI 10.1006/mcne.2002.1114; Milosevic J, 2007, J NEUROSCI, V27, P412, DOI 10.1523/JNEUROSCI.2482-06.2007; Milosevic J, 2009, NEUROTOX RES, V15, P367, DOI 10.1007/s12640-009-9043-z; Nieoullon V, 2005, MOL CELL NEUROSCI, V28, P462, DOI 10.1016/j.mcn.2004.10.007; Nolte C, 2001, GLIA, V33, P72; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Pruszak J, 2009, STEM CELLS, V27, P2928, DOI 10.1002/stem.211; Schepers GE, 2002, DEV CELL, V3, P167, DOI 10.1016/S1534-5807(02)00223-X; SCHMID I, 1994, J IMMUNOL METHODS, V170, P145, DOI 10.1016/0022-1759(94)90390-5; Shen JF, 2008, J CEREBR BLOOD F MET, V28, P1460, DOI 10.1038/jcbfm.2008.37; Thaci B, 2012, CANCER GENE THER, V19, P431, DOI 10.1038/cgt.2012.21; Thu MS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007218; Uchida N, 2000, P NATL ACAD SCI USA, V97, P14720, DOI 10.1073/pnas.97.26.14720; Wang C, 2012, CANCER GENE THER, V19, P796, DOI 10.1038/cgt.2012.63; Wegner F, 2009, J NEUROCHEM, V111, P204, DOI 10.1111/j.1471-4159.2009.06315.x; WIGHT PA, 1993, J CELL BIOL, V123, P443, DOI 10.1083/jcb.123.2.443; XUE GP, 1990, DEVELOPMENT, V109, P851; Yuan SH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017540; Zhuo L, 2001, GENESIS, V31, P85, DOI 10.1002/gene.10008	41	1	1	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99819	10.1371/journal.pone.0099819	http://dx.doi.org/10.1371/journal.pone.0099819			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932758	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600068
J	Korhonen, T; Loukola, A; Wedenoja, J; Nyman, E; Latvala, A; Broms, U; Happola, A; Paunio, T; Schrage, AJ; Vink, JM; Mbarek, H; Boomsma, DI; Penninx, BWJH; Pergadia, ML; Madden, PAF; Kaprio, J				Korhonen, Tellervo; Loukola, Anu; Wedenoja, Juho; Nyman, Emma; Latvala, Antti; Broms, Ulla; Happola, Anja; Paunio, Tiina; Schrage, Andrew J.; Vink, Jaqueline M.; Mbarek, Hamdi; Boomsma, Dorret I.; Penninx, Brenda W. J. H.; Pergadia, Michele L.; Madden, Pamela A. F.; Kaprio, Jaakko			Role of Nicotine Dependence in the Association between the Dopamine Receptor Gene DRD3 and Major Depressive Disorder	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; LUNG-CANCER; LINKAGE DISEQUILIBRIUM; SUSCEPTIBILITY LOCUS; QUANTITATIVE TRAITS; D-3 RECEPTOR; POLYMORPHISM; ABUSE; NESDA; TWINS	Background: The aims of this study were to analyze associations of dopamine receptor genes (DRD1-5) with Major Depressive Disorder (MDD) and nicotine dependence (ND), and to investigate whether ND moderates genetic influences on MDD. Methods: The sample was ascertained from the Finnish Twin Cohort. Twin pairs concordant for smoking history were recruited along with their family members, as part of the multisite Nicotine Addiction Genetics consortium. Genetic association analyses were based on 1428 adults. Total of 70 tagging single nucleotide polymorphisms within the dopamine receptor genes were genotyped and analyzed for association with MDD, ND, and MD-ND co-morbidity. Individual level logistic regression analyses were based on 1296 adults with data on ND and MDD diagnoses, as well as on dopamine receptor genotypes adjusted for sex, age, and alcohol use. Four independent samples, such as population-based and casecontrol samples, were used for replication. Results: Rs2399496, located 1.5 kb downstream of DRD3, showed suggestive association for MDD (p = 0.00076) and significant association for MDD-ND co-morbidity (p = 0.000079). Suggestive gene-(rs2399496) by-ND-interaction justified analyses by genetic risk variant and ND status. Individuals with ND and two minor alleles (AA) of rs2399496 had almost sixfold risk for MDD (OR 5.74, 95% CI 3.12-10.5, p = 9.010e-09) compared to individuals without ND and with two major alleles (TT). Conclusions: Significant association between a variant downstream of DRD3 and a co-morbid MDD-ND phenotype was detected. Our results further suggest that nicotine dependence may potentiate the influence of the DRD3 genetic variant on MDD.	[Korhonen, Tellervo; Loukola, Anu; Wedenoja, Juho; Latvala, Antti; Broms, Ulla; Happola, Anja; Kaprio, Jaakko] Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland; [Korhonen, Tellervo; Loukola, Anu; Nyman, Emma; Latvala, Antti; Broms, Ulla; Paunio, Tiina; Kaprio, Jaakko] Natl Inst Hlth & Welf, Dept Mental Hlth, Helsinki, Finland; [Korhonen, Tellervo; Loukola, Anu; Nyman, Emma; Latvala, Antti; Broms, Ulla; Paunio, Tiina; Kaprio, Jaakko] Natl Inst Hlth & Welf, Subst Abuse Serv, Helsinki, Finland; [Korhonen, Tellervo] Univ Eastern Finland, Inst Publ Hlth & Clin Nutr, Kuopio, Finland; [Nyman, Emma; Paunio, Tiina; Kaprio, Jaakko] Univ Helsinki, Inst Mol Med Finland FIMM, Helsinki, Finland; [Paunio, Tiina] Univ Helsinki, Dept Psychiat, Cent Hosp, SF-00180 Helsinki, Finland; [Schrage, Andrew J.; Pergadia, Michele L.; Madden, Pamela A. F.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Vink, Jaqueline M.; Mbarek, Hamdi; Boomsma, Dorret I.] Vrije Univ Amsterdam, Dept Biol Psychol, Netherlands Twin Register, Amsterdam, Netherlands; [Penninx, Brenda W. J. H.] Vrije Univ Amsterdam, Med Ctr, GGZ, Dept Psychiat, Amsterdam, Netherlands	University of Helsinki; Finland National Institute for Health & Welfare; Finland National Institute for Health & Welfare; University of Eastern Finland; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Washington University (WUSTL); Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Korhonen, T (corresponding author), Univ Helsinki, Dept Publ Hlth, Hjelt Inst, Helsinki, Finland.	tellervo.korhonen@helsinki.fi	Kaprio, Jaakko/A-1820-2008; Boomsma, Dorret I/AAX-4470-2020; Latvala, Antti/AFK-1462-2022; Penninx, Brenda WJH/S-7627-2017; Wedenoja, Juho/AAX-7008-2020	Kaprio, Jaakko/0000-0002-3716-2455; Penninx, Brenda WJH/0000-0001-7779-9672; Wedenoja, Juho/0000-0002-6155-0378; Latvala, Antti/0000-0001-5695-117X; Korhonen, Tellervo/0000-0003-2838-3085; Loukola, Anu-Maria/0000-0003-0542-5967; Mbarek, Hamdi/0000-0002-1108-0371	Academy of Finland; NIH [DA12854, DA019951]; Doctoral Programs of Public Health; Yrjo Jahnsson Foundation; Juho Vainio Foundation for Post-Doctoral research; Academy of Finland Post-Doctoral Fellowship; Finnish Cultural Foundation; Finnish Medical Foundation; Helsinki Biomedical Graduate School; Global Research Awards for Nicotine Dependence (GRAND) - Pfizer Inc.; Biocentrum Helsinki Foundation; Sigrid Juselius Foundation; University of Helsinki Research Foundation; Orion-Farmos Research Foundation grant; Academy of Finland Center of Excellence in Complex Disease Genetics; ERC [284167]; Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health; Netherlands Organization for Scientific Research (NWO) [Addiction-31160008, 40-0056-98-9032, 985-10-002, 904-61-193]; SPI [56-464-14192]; universities and mental health care institutes involved in NESDA (GGZ InGeest, Rivierduinen, UMC Groningen, GGZ Lentis, GGZ Friesland, GGZ Drenthe) [10-000-1002]; CMSB: Centre for Medical Systems Biology (NWO Genomics); NBIC/BioAssist/RK/024; Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); BBMRI [NL-184.021.007]; European Science Council [284167, 230374]; Rutgers University Cell and DNA Repository cooperative agreement [NIMH U24 MH068457-06]; NATIONAL INSTITUTE OF MENTAL HEALTH [U24MH068457] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA012854, R01DA018673, K08DA019951, R56DA012854] Funding Source: NIH RePORTER	Academy of Finland(Academy of Finland); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doctoral Programs of Public Health; Yrjo Jahnsson Foundation; Juho Vainio Foundation for Post-Doctoral research; Academy of Finland Post-Doctoral Fellowship(Academy of Finland); Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Finnish Medical Foundation; Helsinki Biomedical Graduate School; Global Research Awards for Nicotine Dependence (GRAND) - Pfizer Inc.; Biocentrum Helsinki Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); University of Helsinki Research Foundation; Orion-Farmos Research Foundation grant; Academy of Finland Center of Excellence in Complex Disease Genetics(Academy of Finland); ERC(European Research Council (ERC)European Commission); Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); SPI; universities and mental health care institutes involved in NESDA (GGZ InGeest, Rivierduinen, UMC Groningen, GGZ Lentis, GGZ Friesland, GGZ Drenthe); CMSB: Centre for Medical Systems Biology (NWO Genomics); NBIC/BioAssist/RK/024; Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); BBMRI; European Science Council; Rutgers University Cell and DNA Repository cooperative agreement; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported for data collection by Academy of Finland grants to JK and a NIH grant (grant numbers DA12854 to PAFM, DA019951 to MLP). This work was supported by Doctoral Programs of Public Health (UB), the Yrjo Jahnsson Foundation (UB), the Juho Vainio Foundation for Post-Doctoral research (UB), Academy of Finland Post-Doctoral Fellowship (AL), Finnish Cultural Foundation (TK, JW), Finnish Medical Foundation (JW), Helsinki Biomedical Graduate School (JW), a NIH grant (DA019951 to MLP), a Global Research Awards for Nicotine Dependence (GRAND) funded by Pfizer Inc. (to JK), the Biocentrum Helsinki Foundation (EN), the Sigrid Juselius Foundation (EN), the University of Helsinki Research Foundation grant for young researchers (to EN), the Orion-Farmos Research Foundation grant (to EN), and by the Academy of Finland Center of Excellence in Complex Disease Genetics. JV was supported by the ERC starting grant 284167. Finally, the authors would like to thank the NTR and the NESDA studies in the NL for data they used for replication. The work was supported by: Genetic Association Information Network (GAIN) of the Foundation for the US National Institutes of Health; Netherlands Organization for Scientific Research (NWO: MagW/ZonMW) Addiction-31160008; 40-0056-98-9032; 985-10-002; 904-61-193; SPI 56-464-14192; Geestkracht (10-000-1002) and matching funds from universities and mental health care institutes involved in NESDA (GGZ InGeest, Rivierduinen, UMC Groningen, GGZ Lentis, GGZ Friesland, GGZ Drenthe); CMSB: Centre for Medical Systems Biology (NWO Genomics); NBIC/BioAssist/RK/2008.024; Institute for Health and Care Research (EMGO+); Neuroscience Campus Amsterdam (NCA); BBMRI NL-184.021.007; European Science Council 230374, 284167; Rutgers University Cell and DNA Repository cooperative agreement (NIMH U24 MH068457-06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2000, AM J HUM GENET, V66, P279, DOI 10.1086/302698; Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Audrain-McGovern J, 2004, AM J PSYCHIAT, V161, P1224, DOI 10.1176/appi.ajp.161.7.1224; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bevilacqua L, 2010, NATURE, V468, P1061, DOI 10.1038/nature09629; Bierut LJ, 2010, TRENDS PHARMACOL SCI, V31, P46, DOI 10.1016/j.tips.2009.10.004; Boomsma DI, 2008, EUR J HUM GENET, V16, P335, DOI 10.1038/sj.ejhg.5201979; Boomsma DI, 2006, TWIN RES HUM GENET, V9, P849, DOI 10.1375/183242706779462426; Broms U, 2007, DRUG ALCOHOL DEPEN, V89, P42, DOI 10.1016/j.drugalcdep.2006.11.017; Broms U, 2012, NICOTINE TOB RES, V14, P720, DOI 10.1093/ntr/ntr283; BUCHOLZ KK, 1994, J STUD ALCOHOL, V55, P149, DOI 10.15288/jsa.1994.55.149; COTTLER LB, 1991, BRIT J PSYCHIAT, V159, P653, DOI 10.1192/bjp.159.5.653; Czermak C, 2004, NICOTINE TOB RES, V6, P49, DOI 10.1080/14622200310001656858; Dani JA, 2005, NAT NEUROSCI, V8, P1465, DOI 10.1038/nn1580; Dannlowski U, 2013, INT J NEUROPSYCHOPH, V16, P1443, DOI 10.1017/S1461145711001659; Dome P, 2010, NEUROSCI BIOBEHAV R, V34, P295, DOI 10.1016/j.neubiorev.2009.07.013; Gelernter J, 2006, HUM MOL GENET, V15, P3498, DOI 10.1093/hmg/ddl426; Goldberg D, 2006, PSYCHOL MED, V36, P1341, DOI 10.1017/S0033291706007665; Goring HHH, 2000, AM J HUM GENET, V66, P1310, DOI 10.1086/302845; Haddock C K, 1999, Nicotine Tob Res, V1, P59, DOI 10.1080/14622299050011161; Heistaro S, 2008, METHODOLOGY REPORT H, P26; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Huang WH, 2008, AM J MED GENET B, V147B, P1109, DOI 10.1002/ajmg.b.30731; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Knaapila A, 2011, BEHAV GENET, V41, P512, DOI 10.1007/s10519-010-9403-8; LANDER ES, 1989, GENETICS, V121, P185; Le Foll B, 2005, NEUROPHARMACOLOGY, V49, P525, DOI 10.1016/j.neuropharm.2005.04.022; Lerman C, 1998, HEALTH PSYCHOL, V17, P56, DOI 10.1037/0278-6133.17.1.56; Li J, 2005, HEREDITY, V95, P221, DOI 10.1038/sj.hdy.6800717; Lopez LS, 2005, BIOL PSYCHIAT, V57, P999, DOI 10.1016/j.biopsych.2005.01.030; Loukola A, 2008, PHARMACOGENOMICS J, V8, P209, DOI 10.1038/sj.tpj.6500464; Nolen-Hoeksema S, 2007, ABNORMAL PSYCHOL, P99; Nyholt DR, 2004, AM J HUM GENET, V74, P765, DOI 10.1086/383251; Nyman ES, 2011, BMJ OPEN, V1, DOI 10.1136/bmjopen-2011-000087; Peltonen L, 2000, NAT REV GENET, V1, P182, DOI 10.1038/35042049; Penninx BWJH, 2008, INT J METH PSYCH RES, V17, P121, DOI 10.1002/mpr.256; Ptacek R, 2011, MED SCI MONITOR, V17, pRA215, DOI 10.12659/MSM.881925; Purcell S, 2002, TWIN RES, V5, P554, DOI 10.1375/136905202762342026; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rose RJ, 2010, HANDBOOK OF BEHAVIOR GENETICS, P411, DOI 10.1007/978-0-387-76727-7_28; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Service S, 2006, NAT GENET, V38, P556, DOI 10.1038/ng1770; Stapleton JA, 2011, PHARMACOGENET GENOM, V21, P447, DOI 10.1097/FPC.0b013e328347473a; StataCorp, 2021, STATA STAT SOFTWARE; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thornton T, 2007, AM J HUM GENET, V81, P321, DOI 10.1086/519497; Vandenbergh DJ, 2007, ADDICT BIOL, V12, P106, DOI 10.1111/j.1369-1600.2007.00054.x; Verde Z, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026668; Vink JM, 2009, AM J HUM GENET, V84, P367, DOI 10.1016/j.ajhg.2009.02.001; Williams RL, 2000, BIOMETRICS, V56, P645, DOI 10.1111/j.0006-341X.2000.00645.x; World Health Organization, 2004, NEUR PSYCH SUBST US	53	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98199	10.1371/journal.pone.0098199	http://dx.doi.org/10.1371/journal.pone.0098199			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927283	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100014
J	Brodland, GW; Veldhuis, JH; Kim, S; Perrone, M; Mashburn, D; Hutson, MS				Brodland, G. Wayne; Veldhuis, Jim H.; Kim, Steven; Perrone, Matthew; Mashburn, David; Hutson, M. Shane			CellFIT: A Cellular Force-Inference Toolkit Using Curvilinear Cell Boundaries	PLOS ONE			English	Article							LASER MICROSURGERY; FINITE-ELEMENT; DORSAL CLOSURE; MECHANICS; MORPHOGENESIS; ADHESION; INVAGINATION; INSIGHTS; REVEALS; TENSION	Mechanical forces play a key role in a wide range of biological processes, from embryogenesis to cancer metastasis, and there is considerable interest in the intuitive question, "Can cellular forces be inferred from cell shapes?'' Although several groups have posited affirmative answers to this stimulating question, nagging issues remained regarding equation structure, solution uniqueness and noise sensitivity. Here we show that the mechanical and mathematical factors behind these issues can be resolved by using curved cell edges rather than straight ones. We present a new package of force-inference equations and assessment tools and denote this new package CellFIT, the Cellular Force Inference Toolkit. In this approach, cells in an image are segmented and equilibrium equations are constructed for each triple junction based solely on edge tensions and the limiting angles at which edges approach each junction. The resulting system of tension equations is generally overdetermined. As a result, solutions can be obtained even when a modest number of edges need to be removed from the analysis due to short length, poor definition, image clarity or other factors. Solving these equations yields a set of relative edge tensions whose scaling must be determined from data external to the image. In cases where intracellular pressures are also of interest, Laplace equations are constructed to relate the edge tensions, curvatures and cellular pressure differences. That system is also generally overdetermined and its solution yields a set of pressures whose offset requires reference to the surrounding medium, an open wound, or information external to the image. We show that condition numbers, residual analyses and standard errors can provide confidence information about the inferred forces and pressures. Application of CellFIT to several live and fixed biological tissues reveals considerable force variability within a cell population, significant differences between populations and elevated tensions along heterotypic boundaries.	[Brodland, G. Wayne; Veldhuis, Jim H.; Kim, Steven; Perrone, Matthew] Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada; [Mashburn, David; Hutson, M. Shane] Vanderbilt Univ, Dept Phys & Astron, Nashville, TN 37235 USA; [Hutson, M. Shane] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA; [Hutson, M. Shane] Vanderbilt Univ, Vanderbilt Inst Integrat Biosyst Res & Educ, Nashville, TN 37235 USA	University of Waterloo; Vanderbilt University; Vanderbilt University; Vanderbilt University	Brodland, GW (corresponding author), Univ Waterloo, Dept Civil & Environm Engn, Waterloo, ON N2L 3G1, Canada.	brodland@uwaterloo.ca		Perrone, Matthew/0000-0002-3720-212X	National Institutes of Health [1R01-GM099107]; Natural Sciences and Engineering Research Council of Canada (NSERC); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099107] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by the National Institutes of Health (1R01-GM099107), http://www.nih.gov/, and Natural Sciences and Engineering Research Council of Canada (NSERC), http://www.nserc-crsng.gc.ca/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anon E, 2012, P NATL ACAD SCI USA, V109, P10891, DOI 10.1073/pnas.1117814109; Benko R, 2007, ANN BIOMED ENG, V35, P672, DOI 10.1007/s10439-006-9250-1; Beucher S., 1992, MATH MORPHOLOGY IMAG, V34, P433; Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007; Borghi N, 2012, P NATL ACAD SCI USA, V109, P12568, DOI 10.1073/pnas.1204390109; Brodland G. W., 2004, Applied Mechanics Review, V57, P47, DOI 10.1115/1.1583758; Brodland G. Wayne, 2003, Computer Methods in Biomechanics and Biomedical Engineering, V6, P89; Brodland GW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044281; Brodland GW, 2010, P NATL ACAD SCI USA, V107, P22111, DOI 10.1073/pnas.1006591107; Brodland GW, 2010, HFSP J, V4, P142, DOI 10.2976/1.3338713; BRODLAND GW, 1994, J BIOMECH ENG-T ASME, V116, P146, DOI 10.1115/1.2895713; Brodland GW, 2000, J BIOMECH ENG-T ASME, V122, P402, DOI 10.1115/1.1288205; Campas O, 2014, NAT METHODS, V11, P183, DOI [10.1038/NMETH.2761, 10.1038/nmeth.2761]; Capitanio M, 2013, BIOPHYS J, V105, P1293, DOI 10.1016/j.bpj.2013.08.007; Chen HH, 2000, J BIOMECH ENG-T ASME, V122, P394, DOI 10.1115/1.1286563; Chen XG, 2009, J MECH BEHAV BIOMED, V2, P494, DOI 10.1016/j.jmbbm.2008.12.004; Chen XG, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/015003; Cheney E, 1994, NUMERICAL MATH COMPU, V3rd; Chiou KK, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002512; Coelho L. P., 2013, J OPEN RES SOFTWARE, V1; Conte V, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034473, 10.1371/journal.pone.0037062]; Conte V, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016010; Cook RD, 1999, ADV MECH MAT; Cranston PG, 2010, ANN BIOMED ENG; Dahmann C, 2011, NAT REV GENET, V12, P43, DOI 10.1038/nrg2902; Davidson LA, 2008, CURR TOP DEV BIOL, V81, P113, DOI 10.1016/S0070-2153(07)81003-9; Fernandez-Gonzalez R, 2009, DEV CELL, V17, P736, DOI 10.1016/j.devcel.2009.09.003; Hayashi Fumio, 2000, ECONOMETRICS; Hibbeler R.C., 2005, MECH MAT, V6th ed.; Hibbeler R. C., 2011, STATICS MECH MAT; Hutson MS, 2009, BIOPHYS J, V97, P3075, DOI 10.1016/j.bpj.2009.09.034; Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552; Ishihara S, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13045-8; Ishihara S, 2012, J THEOR BIOL, V313, P201, DOI 10.1016/j.jtbi.2012.08.017; Kasza KE, 2011, COLD SPRING HARB PRO, V2011; Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471; Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4; Kwiesielewicz M, 1996, EUR J OPER RES, V93, P611, DOI 10.1016/0377-2217(95)00079-8; Lecuit T, 2011, ANNU REV CELL DEV BI, V27, P157, DOI 10.1146/annurev-cellbio-100109-104027; Legant WR, 2010, NAT METHODS, V7, P969, DOI 10.1038/NMETH.1531; Ma XY, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/3/036004; Maitre JL, 2012, SCIENCE, V338, P253, DOI 10.1126/science.1225399; Martin AC, 2010, DEV BIOL, V341, P114, DOI 10.1016/j.ydbio.2009.10.031; Mashburn DN, 2012, CYTOM PART A, V81A, P409, DOI 10.1002/cyto.a.22034; Miller CJ, 2013, NAT REV GENET, V14, P733, DOI 10.1038/nrg3513; Morimatsu M, 2013, NANO LETT, V13, P3985, DOI 10.1021/nl4005145; Oda H, 2001, J CELL SCI, V114, P493; Ohnishi Y, 2014, NAT CELL BIOL, V16, P27, DOI 10.1038/ncb2881; Peralta XG, 2007, BIOPHYS J, V92, P2583, DOI 10.1529/biophysj.106.094110; Puech PH, 2005, J CELL SCI, V118, P4199, DOI 10.1242/jcs.02547; RAPPAPORT R, 1977, J EXP ZOOL, V201, P375, DOI 10.1002/jez.1402010304; Schock F, 2003, GENE DEV, V17, P597, DOI 10.1101/gad.1068403; Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050; STEIN MB, 1982, J THEOR BIOL, V97, P625, DOI 10.1016/0022-5193(82)90363-0; Tambe DT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055172; Thomas G, 2013, JOVE-J VIS EXP, DOI 10.3791/50497; Thompson D. W., 1917, GROWTH FORM; Varner VD, 2010, DEVELOPMENT, V137, P3801, DOI 10.1242/dev.054387; Wong VW, 2011, J INVEST DERMATOL, V131, P2186, DOI 10.1038/jid.2011.212; Yim EKF, 2012, STEM CELL RES THER, V3, DOI 10.1186/scrt132	60	74	74	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99116	10.1371/journal.pone.0099116	http://dx.doi.org/10.1371/journal.pone.0099116			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921257	Green Submitted, Green Published, gold			2022-12-27	WOS:000338701300032
J	Drusco, A; Nuovo, GJ; Zanesi, N; Di Leva, G; Pichiorri, F; Volinia, S; Fernandez, C; Antenucci, A; Costinean, S; Bottoni, A; Rosito, IA; Liu, CG; Burch, A; Acunzo, M; Pekarsky, Y; Alder, H; Ciardi, A; Croce, CM				Drusco, Alessandra; Nuovo, Gerard J.; Zanesi, Nicola; Di Leva, Gianpiero; Pichiorri, Flavia; Volinia, Stefano; Fernandez, Cecilia; Antenucci, Anna; Costinean, Stefan; Bottoni, Arianna; Rosito, Immacolata A.; Liu, Chang-Gong; Burch, Aaron; Acunzo, Mario; Pekarsky, Yuri; Alder, Hansjuerg; Ciardi, Antonio; Croce, Carlo M.			MicroRNA Profiles Discriminate among Colon Cancer Metastasis	PLOS ONE			English	Article							EXPRESSION PROFILES; HEPATOCELLULAR-CARCINOMA; COLORECTAL-CANCER; BREAST-CANCER; LYMPH-NODES; SURVIVAL; MIR-21; MELANOMA; INVASION; STAGE	MicroRNAs are being exploited for diagnosis, prognosis and monitoring of cancer and other diseases. Their high tissue specificity and critical role in oncogenesis provide new biomarkers for the diagnosis and classification of cancer as well as predicting patients' outcomes. MicroRNAs signatures have been identified for many human tumors, including colorectal cancer (CRC). In most cases, metastatic disease is difficult to predict and to prevent with adequate therapies. The aim of our study was to identify a microRNA signature for metastatic CRC that could predict and differentiate metastatic target organ localization. Normal and cancer tissues of three different groups of CRC patients were analyzed. RNA microarray and TaqMan Array analysis were performed on 66 Italian patients with or without lymph nodes and/or liver recurrences. Data obtained with the two assays were analyzed separately and then intersected to identify a primary CRC metastatic signature. Five differentially expressed microRNAs (hsa-miR-21, -103, -93, -31 and -566) were validated by qRT-PCR on a second group of 16 American metastatic patients. In situ hybridization was performed on the 16 American patients as well as on three distinct commercial tissues microarray (TMA) containing normal adjacent colon, the primary adenocarcinoma, normal and metastatic lymph nodes and liver. Hsa-miRNA-21, -93, and -103 upregulation together with hsa-miR-566 downregulation defined the CRC metastatic signature, while in situ hybridization data identified a lymphonodal invasion profile. We provided the first microRNAs signature that could discriminate between colorectal recurrences to lymph nodes and liver and between colorectal liver metastasis and primary hepatic tumor.	[Drusco, Alessandra; Nuovo, Gerard J.; Zanesi, Nicola; Di Leva, Gianpiero; Pichiorri, Flavia; Volinia, Stefano; Fernandez, Cecilia; Costinean, Stefan; Bottoni, Arianna; Burch, Aaron; Acunzo, Mario; Pekarsky, Yuri; Alder, Hansjuerg; Croce, Carlo M.] Ohio State Univ, MVIMG, Columbus, OH 43210 USA; [Volinia, Stefano] Univ Ferrara, Dept Morphol Surg & Expt Med, I-44100 Ferrara, Italy; [Antenucci, Anna; Rosito, Immacolata A.] Regina Elena Inst Canc Res, UOSD Clin Pathol, Rome, Italy; [Liu, Chang-Gong] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut Unit 1950, Houston, TX 77030 USA; [Ciardi, Antonio] Univ Roma La Sapienza, Dept Radiol & Oncol Sci & Pathol, I-00185 Rome, Italy	University System of Ohio; Ohio State University; University of Ferrara; IRCCS Istituti Fisioterapici Ospitalieri (IFO); IRCCS Regina Elena; University of Texas System; UTMD Anderson Cancer Center; Sapienza University Rome	Croce, CM (corresponding author), Ohio State Univ, MVIMG, Columbus, OH 43210 USA.	carlo.croce@osumc.edu	Volinia, Stefano/A-3029-2010; Young, Richard A/F-6495-2012; Acunzo, Mario/ABE-1739-2020; Volinia, Stefano/AAA-9264-2019	Volinia, Stefano/0000-0003-0910-3893; Young, Richard A/0000-0001-8855-8647; Volinia, Stefano/0000-0003-0910-3893; Acunzo, Mario/0000-0002-3942-9061; Di Leva, Gianpiero/0000-0001-6759-8682; Ciardi, Antonio/0000-0001-8480-6236	NIH [U01 CA152785]; NATIONAL CANCER INSTITUTE [R21CA152785, P30CA016058] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was funded by NIH Grant U01 CA152785 microRNAs/UCRs: biomarkers for cancer risk, tumor detection, progression and treatment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asangani IA, 2008, ONCOGENE, V27, P2128, DOI 10.1038/sj.onc.1210856; Barshack I, 2010, INT J BIOCHEM CELL B, V42, P1355, DOI 10.1016/j.biocel.2009.02.021; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chan JA, 2005, CANCER RES, V65, P6029, DOI 10.1158/0008-5472.CAN-05-0137; Chang SS, 2008, INT J CANCER, V123, P2791, DOI 10.1002/ijc.23831; Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605; Chen RF, 2010, CLIN EXP ALLERGY, V40, P1482, DOI 10.1111/j.1365-2222.2010.03592.x; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-60; Choi HK, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-267; Cottonham CL, 2010, J BIOL CHEM, V285, P35293, DOI 10.1074/jbc.M110.160069; Creighton CJ, 2010, CANCER RES, V70, P1906, DOI 10.1158/0008-5472.CAN-09-3875; Donnem T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029671; EDMONSON H, 1987, NEOPLASMS LIVER, P1109; Eggermont AMM, 2000, RECENT RESULTS CANC, V157, P178; Fang L, 2011, ONCOGENE, V30, P806, DOI 10.1038/onc.2010.465; Gao W, 2012, BIOMED PHARMACOTHER, V66, P21, DOI 10.1016/j.biopha.2011.09.004; Garden OJ, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.098053; Gottardo F, 2007, UROL ONCOL-SEMIN ORI, V25, P387, DOI 10.1016/j.urolonc.2007.01.019; Grunder E, 2011, EUR J CANCER, V47, P2479, DOI 10.1016/j.ejca.2011.06.041; Guo Y, 2008, CANCER RES, V68, P26, DOI 10.1158/0008-5472.CAN-06-4418; Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001; Hayashi T, 2011, DEV BIOL, V352, P299, DOI 10.1016/j.ydbio.2011.01.030; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Jiang J, 2008, CLIN CANCER RES, V14, P419, DOI 10.1158/1078-0432.CCR-07-0523; Karakatsanis A, 2013, MOL CARCINOGEN, V52, P297, DOI 10.1002/mc.21864; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Lee EJ, 2007, INT J CANCER, V120, P1046, DOI 10.1002/ijc.22394; Leite KR, 2011, UROL ONCOL; Li Y, 2009, CANCER SCI, V100, P1234, DOI 10.1111/j.1349-7006.2009.01164.x; Liu CG, 2004, P NATL ACAD SCI USA, V101, P9740, DOI 10.1073/pnas.0403293101; Liu CG, 2008, NAT PROTOC, V3, P563, DOI 10.1038/nprot.2008.14; Liu CJ, 2010, CANCER RES, V70, P1635, DOI 10.1158/0008-5472.CAN-09-2291; Liu LZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019139; Liu X, 2010, J CLIN INVEST, V120, P1298, DOI 10.1172/JCI39566; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lu TX, 2009, J IMMUNOL, V182, P4994, DOI 10.4049/jimmunol.0803560; Lui WO, 2007, CANCER RES, V67, P6031, DOI 10.1158/0008-5472.CAN-06-0561; Ma XJ, 2006, ARCH PATHOL LAB MED, V130, P465; MacKie RM, 2003, NEW ENGL J MED, V348, P567, DOI 10.1056/NEJM200302063480620; Manfredi S, 2006, ANN SURG, V244, P254, DOI 10.1097/01.sla.0000217629.94941.cf; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; Medina PP, 2010, NATURE, V467, P86, DOI 10.1038/nature09284; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Neely LA, 2010, UROL ONCOL-SEMIN ORI, V28, P39, DOI 10.1016/j.urolonc.2008.06.006; Nuovo GJ, 2008, METHODS, V44, P39, DOI 10.1016/j.ymeth.2007.10.008; O'Connell JB, 2004, JNCI-J NATL CANCER I, V96, P1420, DOI 10.1093/jnci/djh275; Pantel K, 2009, NAT REV CLIN ONCOL, V6, P339, DOI 10.1038/nrclinonc.2009.44; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pavlidis N, 2003, EUR J CANCER, V39, P1990, DOI 10.1016/S0959-8049(03)00547-1; Pedrioli DML, 2010, MOL CELL BIOL, V30, P3620, DOI 10.1128/MCB.00185-10; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Poritz LS, 2011, SURGERY, V150, P649, DOI 10.1016/j.surg.2011.07.049; Ramachandra RK, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-41; Ramaswamy S, 2001, P NATL ACAD SCI USA, V98, P15149, DOI 10.1073/pnas.211566398; Riethmuller G, 2001, SEMIN CANCER BIOL, V11, P307, DOI 10.1006/scbi.2001.0386; Roldo C, 2006, J CLIN ONCOL, V24, P4677, DOI 10.1200/JCO.2005.05.5194; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Salhab M, 2011, SURG ONCOL, V20, pE195, DOI 10.1016/j.suronc.2011.06.006; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Schetter AJ, 2008, JAMA-J AM MED ASSOC, V299, P425, DOI 10.1001/jama.299.4.425; Schetter AJ, 2010, CARCINOGENESIS, V31, P37, DOI 10.1093/carcin/bgp272; Schetter AJ, 2009, CLIN CANCER RES, V15, P5878, DOI 10.1158/1078-0432.CCR-09-0627; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Simmonds PC, 2006, BRIT J CANCER, V94, P982, DOI 10.1038/sj.bjc.6603033; Simon R, 2007, CANCER INFORM, V3, P11; Singh SK, 2008, NATURE, V453, P223, DOI 10.1038/nature06863; Smith AL, 2012, ONCOGENE, V31, P5162, DOI 10.1038/onc.2012.11; Storli KE, 2011, INT J COLORECTAL DIS, V26, P1299, DOI 10.1007/s00384-011-1244-2; Suarez Y, 2010, J IMMUNOL, V184, P21, DOI 10.4049/jimmunol.0902369; Tchemitsa O, 2010, J PATHOL, V222, P310, DOI 10.1002/path.2759; Triantafilou M, 2002, TRENDS IMMUNOL, V23, P301, DOI 10.1016/S1471-4906(02)02233-0; Ulmer A, 2005, CLIN CANCER RES, V11, P5425, DOI 10.1158/1078-0432.CCR-04-1995; Valastyan S, 2009, CELL, V137, P1032, DOI 10.1016/j.cell.2009.03.047; van der Fits L, 2011, J INVEST DERMATOL, V131, P762, DOI 10.1038/jid.2010.349; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang CJ, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-616; Wang CJ, 2009, DIS MARKERS, V26, P27, DOI [10.3233/DMA-2009-0601, 10.1155/2009/921907]; Weiser MR, 2008, J CLIN ONCOL, V26, P380, DOI 10.1200/JCO.2007.14.1291; Weiser MR, 2011, J CLIN ONCOL, V29, P4796, DOI 10.1200/JCO.2011.36.5080; Wong QWL, 2008, GASTROENTEROLOGY, V135, P257, DOI 10.1053/j.gastro.2008.04.003; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wright GW, 2003, BIOINFORMATICS, V19, P2448, DOI 10.1093/bioinformatics/btg345; Wszolek MF, 2011, UROL ONCOL-SEMIN ORI, V29, P794, DOI 10.1016/j.urolonc.2009.08.024; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xi YG, 2006, BIOMARK INSIGHTS, V1, P113; Yang CH, 2011, J BIOL CHEM, V286, P39172, DOI 10.1074/jbc.M111.285098; Yantiss RK, 2009, AM J SURG PATHOL, V33, P572, DOI 10.1097/PAS.0b013e31818afd6b; Zhang YY, 2010, MED ONCOL, V27, P685, DOI 10.1007/s12032-009-9269-x; Zhang ZY, 2008, LAB INVEST, V88, P1358, DOI 10.1038/labinvest.2008.94; Zhu L, 2011, AM J CANCER RES, V1, P574; Zhu SM, 2008, CELL RES, V18, P350, DOI 10.1038/cr.2008.24	94	90	93	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e96670	10.1371/journal.pone.0096670	http://dx.doi.org/10.1371/journal.pone.0096670			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921248	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300004
J	Ferreira, AJS; Siam, R; Setubal, JC; Moustafa, A; Sayed, A; Chambergo, FS; Dawe, AS; Ghazy, MA; Sharaf, H; Ouf, A; Alam, I; Abdel-Haleem, AM; Lehvaslaiho, H; Ramadan, E; Antunes, A; Stingl, U; Archer, JAC; Jankovic, BR; Sogin, M; Bajic, VB; El-Dorry, H				Ferreira, Ari J. S.; Siam, Rania; Setubal, Joao C.; Moustafa, Ahmed; Sayed, Ahmed; Chambergo, Felipe S.; Dawe, Adam S.; Ghazy, Mohamed A.; Sharaf, Hazem; Ouf, Amged; Alam, Intikhab; Abdel-Haleem, Alyaa M.; Lehvaslaiho, Heikki; Ramadan, Eman; Antunes, Andre; Stingl, Ulrich; Archer, John A. C.; Jankovic, Boris R.; Sogin, Mitchell; Bajic, Vladimir B.; El-Dorry, Hamza			Core Microbial Functional Activities in Ocean Environments Revealed by Global Metagenomic Profiling Analyses	PLOS ONE			English	Article							OXYGEN MINIMUM ZONES; HORIZONTAL GENE-TRANSFER; MARINE ECOSYSTEMS; SEA; EVOLUTION; OCEANOGRAPHY; DEEP; COMMUNITIES; PROKARYOTES; INNOVATION	Metagenomics-based functional profiling analysis is an effective means of gaining deeper insight into the composition of marine microbial populations and developing a better understanding of the interplay between the functional genome content of microbial communities and abiotic factors. Here we present a comprehensive analysis of 24 datasets covering surface and depth-related environments at 11 sites around the world's oceans. The complete datasets comprises approximately 12 million sequences, totaling 5,358 Mb. Based on profiling patterns of Clusters of Orthologous Groups (COGs) of proteins, a core set of reference photic and aphotic depth-related COGs, and a collection of COGs that are associated with extreme oxygen limitation were defined. Their inferred functions were utilized as indicators to characterize the distribution of light-and oxygen-related biological activities in marine environments. The results reveal that, while light level in the water column is a major determinant of phenotypic adaptation in marine microorganisms, oxygen concentration in the aphotic zone has a significant impact only in extremely hypoxic waters. Phylogenetic profiling of the reference photic/aphotic gene sets revealed a greater variety of source organisms in the aphotic zone, although the majority of individual photic and aphotic depth-related COGs are assigned to the same taxa across the different sites. This increase in phylogenetic and functional diversity of the core aphotic related COGs most probably reflects selection for the utilization of a broad range of alternate energy sources in the absence of light.	[Ferreira, Ari J. S.; Siam, Rania; Moustafa, Ahmed; Sayed, Ahmed; Ghazy, Mohamed A.; Sharaf, Hazem; Ouf, Amged; Abdel-Haleem, Alyaa M.; Ramadan, Eman; El-Dorry, Hamza] Amer Univ Cairo, Dept Biol, Sch Sci & Engn, Cairo, New Cairo, Egypt; [Ferreira, Ari J. S.; Siam, Rania; Moustafa, Ahmed; Sayed, Ahmed; Ghazy, Mohamed A.; Sharaf, Hazem; Ouf, Amged; Abdel-Haleem, Alyaa M.; Ramadan, Eman; El-Dorry, Hamza] Amer Univ Cairo, Sci & Technol Res Ctr, Sch Sci & Engn, Cairo, New Cairo, Egypt; [Setubal, Joao C.] Univ Sao Paulo, Inst Quim, Dept Bioquim, BR-01498 Sao Paulo, Brazil; [Chambergo, Felipe S.] Univ Sao Paulo, Escola Artes Ciencias & Humanidades, Sao Paulo, Brazil; [Dawe, Adam S.; Alam, Intikhab; Lehvaslaiho, Heikki; Archer, John A. C.; Jankovic, Boris R.; Bajic, Vladimir B.] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Thuwal, Saudi Arabia; [Antunes, Andre] Univ Minho, Inst Biotechnol & Bioengn, Ctr Biol Engn, P-4719 Braga, Portugal; [Stingl, Ulrich] King Abdullah Univ Sci & Technol, Red Sea Res Ctr, Thuwal, Saudi Arabia; [Sogin, Mitchell] Marine Biol Lab, Josephine Bay Paul Ctr, Woods Hole, MA 02543 USA	Egyptian Knowledge Bank (EKB); American University Cairo; Egyptian Knowledge Bank (EKB); American University Cairo; Universidade de Sao Paulo; Universidade de Sao Paulo; King Abdullah University of Science & Technology; Universidade do Minho; King Abdullah University of Science & Technology; Marine Biological Laboratory - Woods Hole	El-Dorry, H (corresponding author), Amer Univ Cairo, Dept Biol, Sch Sci & Engn, Cairo, New Cairo, Egypt.	dorry@aucegypt.edu	Ferreira, Ari J S/C-2266-2015; Chambergo, Felipe S/B-8599-2012; Sharaf, Hazem/ABG-5995-2021; Antunes, André/A-8711-2012; Moustafa, Ahmed/C-5234-2009; Ghazy, Mohamed/ABD-6832-2020; Archer, John/AAW-1990-2021; Moustafa, Ahmed/AAZ-3991-2020; Setubal, Joao Carlos/C-7305-2012; Sogin, Mitchell/AAE-7186-2019; Stingl, Uli/H-1191-2014; Bajic, Vladimir/D-2810-2009	Ferreira, Ari J S/0000-0002-7526-5543; Chambergo, Felipe S/0000-0001-7567-0656; Sharaf, Hazem/0000-0002-6728-1631; Antunes, André/0000-0001-7668-9842; Moustafa, Ahmed/0000-0002-0111-3555; Archer, John/0000-0002-3302-3933; Moustafa, Ahmed/0000-0002-0111-3555; Setubal, Joao Carlos/0000-0001-9174-2816; Alam, Intikhab/0000-0001-5306-847X; Jankovic, Boris/0000-0003-1868-6007; Abdel-haleem, Alyaa/0000-0002-3114-1100; Stingl, Uli/0000-0002-0684-2597; Bajic, Vladimir/0000-0001-5435-4750; Ramadan, Eman/0000-0002-5483-9536	King Abdullah University for Science and Technology Global Collaborative Partners (GCR) program	King Abdullah University for Science and Technology Global Collaborative Partners (GCR) program	This work was supported by King Abdullah University for Science and Technology Global Collaborative Partners (GCR) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arrigo KR, 2005, NATURE, V437, P349, DOI 10.1038/nature04159; Azam F, 2007, NAT REV MICROBIOL, V5, P782, DOI 10.1038/nrmicro1747; Balaji S, 2007, J MOL BIOL, V372, P1108, DOI 10.1016/j.jmb.2007.06.084; Baumbach J, 2010, NUCLEIC ACIDS RES, V38, P7877, DOI 10.1093/nar/gkq699; BESIKTEPE ST, 1994, PROG OCEANOGR, V34, P285, DOI 10.1016/0079-6611(94)90018-3; Bryant JA, 2012, ECOLOGY, V93, P1659, DOI 10.1890/11-1204.1; Crombach A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000112; Daneri G, 2000, MAR ECOL PROG SER, V197, P41, DOI 10.3354/meps197041; DeLong EF, 2005, NATURE, V437, P336, DOI 10.1038/nature04157; DeLong EF, 2006, SCIENCE, V311, P496, DOI 10.1126/science.1120250; Diaz RJ, 2008, SCIENCE, V321, P926, DOI 10.1126/science.1156401; Eloe EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020388; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Ghai R, 2010, ISME J, V4, P1154, DOI 10.1038/ismej.2010.44; Giovannoni SJ, 2012, SCIENCE, V335, P671, DOI 10.1126/science.1198078; Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204; Gregoracci GB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031408; Jorgensen BB, 2007, NAT REV MICROBIOL, V5, P770, DOI 10.1038/nrmicro1745; Karl DM, 2007, NAT REV MICROBIOL, V5, P759, DOI 10.1038/nrmicro1749; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Konstantinidis KT, 2009, APPL ENVIRON MICROB, V75, P5345, DOI 10.1128/AEM.00473-09; Kroger S, 2005, TRENDS BIOTECHNOL, V23, P250, DOI 10.1016/j.tibtech.2005.03.004; Lam P, 2011, ANNU REV MAR SCI, V3, P317, DOI 10.1146/annurev-marine-120709-142814; Lipson DA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064659; Lutz RA, 2012, SCIENCE, V336, P301, DOI 10.1126/science.1222641; Martinez A, 2010, ENVIRON MICROBIOL, V12, P222, DOI 10.1111/j.1462-2920.2009.02062.x; Maslov S, 2009, P NATL ACAD SCI USA, V106, P9743, DOI 10.1073/pnas.0903206106; Muller J, 2010, NUCLEIC ACIDS RES, V38, pD190, DOI 10.1093/nar/gkp951; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Osburne MS, 2010, ENVIRON MICROBIOL, V12, P1978, DOI 10.1111/j.1462-2920.2010.02203.x; Quaiser A, 2011, ISME J, V5, P285, DOI 10.1038/ismej.2010.113; Revsbech NP, 2009, LIMNOL OCEANOGR-METH, V7, P371, DOI 10.4319/lom.2009.7.371; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rusch DB, 2007, PLOS BIOL, V5, P398, DOI 10.1371/journal.pbio.0050077; Schafer H, 2010, J EXP BOT, V61, P315, DOI 10.1093/jxb/erp355; Sobecky Patricia A., 2009, V532, P435, DOI 10.1007/978-1-60327-853-9_25; Steinberg DK, 2001, DEEP-SEA RES PT II, V48, P1405, DOI 10.1016/S0967-0645(00)00148-X; Stewart FJ, 2012, ENVIRON MICROBIOL, V14, P23, DOI 10.1111/j.1462-2920.2010.02400.x; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Ulloa O, 2012, P NATL ACAD SCI USA, V109, P15996, DOI 10.1073/pnas.1205009109; Varin T, 2012, APPL ENVIRON MICROB, V78, P549, DOI 10.1128/AEM.06354-11; Venter JC, 2004, SCIENCE, V304, P66, DOI 10.1126/science.1093857; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578; Yooseph S, 2010, NATURE, V468, P60, DOI 10.1038/nature09530	45	21	21	3	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e97338	10.1371/journal.pone.0097338	http://dx.doi.org/10.1371/journal.pone.0097338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921648	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300005
J	Lee, S; Kim, JY; Hwang, J; Kim, S; Lee, JH; Han, DH				Lee, Soohyung; Kim, Ji-Young; Hwang, Jihye; Kim, Sanguk; Lee, Jae-Hoon; Han, Dong-Hoo			Investigation of Pathogenic Genes in Peri-Implantitis from Implant Clustering Failure Patients: A Whole-Exome Sequencing Pilot Study	PLOS ONE			English	Article							CHRONIC PERIODONTITIS; EUROPEAN WORKSHOP; ASSOCIATION; SURVIVAL; DISEASES; RATES; CONSENSUS; SAMPLES; COHORT; SALIVA	Peri-implantitis is a frequently occurring gum disease linked to multi-factorial traits with various environmental and genetic causalities and no known concrete pathogenesis. The varying severity of peri-implantitis among patients with relatively similar environments suggests a genetic aspect which needs to be investigated to understand and regulate the pathogenesis of the disease. Six unrelated individuals with multiple clusterization implant failure due to severe peri-implantitis were chosen for this study. These six individuals had relatively healthy lifestyles, with minimal environmental causalities affecting peri-implantitis. Research was undertaken to investigate pathogenic genes in peri-implantitis albeit with a small number of subjects and incomplete elimination of environmental causalities. Whole-exome sequencing was performed on collected saliva samples via self DNA collection kit. Common variants with minor allele frequencies (MAF) > = 0.05 from all control datasets were eliminated and variants having high and moderate impact and loss of function were used for comparison. Gene set enrichment analysis was performed to reveal functional groups associated with the genetic variants. 2,022 genes were left after filtering against dbSNP, the 1000 Genomes East Asian population, and healthy Korean randomized subsample data (GSK project). 175 (p-value <0.05) out of 927 gene sets were obtained via GSEA (DAVID). The top 10 was chosen (p-value <0.05) from cluster enrichment showing significance of cytoskeleton, cell adhesion, and metal ion binding. Network analysis was applied to find relationships between functional clusters. Among the functional groups, ion metal binding was located in the center of all clusters, indicating dysfunction of regulation in metal ion concentration might affect cell morphology or cell adhesion, resulting in implant failure. This result may demonstrate the feasibility of and provide pilot data for a larger research project aimed at discovering biomarkers for early diagnosis of peri-implantitis.	[Lee, Soohyung; Kim, Ji-Young; Lee, Jae-Hoon; Han, Dong-Hoo] Yonsei Univ, Coll Dent, Dept Prosthodont, Oral Sci Res Ctr, Seoul 120749, South Korea; [Hwang, Jihye; Kim, Sanguk] Pohang Univ Sci & Technol, Dept IT Convergence & Engn, Pohang, South Korea	Yonsei University; Yonsei University Health System; Pohang University of Science & Technology (POSTECH)	Lee, JH (corresponding author), Yonsei Univ, Coll Dent, Dept Prosthodont, Oral Sci Res Ctr, Seoul 120749, South Korea.	jaehoon115@yuhs.ac; donghoohan@yuhs.ac		Lee, Jae Hoon/0000-0003-2281-8885; Kim, Sanguk/0000-0002-3449-3814	Oral Science Research Center and School of Dentistry Intramural Research [6-2012-0207]; Basic Science Research Program through the National research Foundation of Korea (NRF) - Ministy of Science, ICT and Future Planning [2011-0014268]; National Research Foundation of Korea (NRF) [2013018606]	Oral Science Research Center and School of Dentistry Intramural Research; Basic Science Research Program through the National research Foundation of Korea (NRF) - Ministy of Science, ICT and Future Planning; National Research Foundation of Korea (NRF)(National Research Foundation of Korea)	This work is supported by research funding provided by Oral Science Research Center and School of Dentistry Intramural Research (6-2012-0207). This research was supported by Basic Science Research Program through the National research Foundation of Korea (NRF) funded by the Ministy of Science, ICT and Future Planning (2011-0014268). This research was also supported by funding provided by National Research Foundation of Korea (NRF) (2013018606). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham JE, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-19; ADELL R, 1990, International Journal of Oral and Maxillofacial Implants, V5, P347; Alissa R, 2012, J ORAL IMPLANTOL, V38, P51, DOI 10.1563/AAID-JOI-D-10-00086; BECKER W, 1990, International Journal of Oral and Maxillofacial Implants, V5, P31; Buser D, 1997, CLIN ORAL IMPLAN RES, V8, P161, DOI 10.1034/j.1600-0501.1997.080302.x; Buser D, 2012, CLIN IMPLANT DENT R, V14, P839, DOI 10.1111/j.1708-8208.2012.00456.x; Chuang SK, 2005, J DENT RES, V84, P54, DOI 10.1177/154405910508400109; Consolaro Alberto, 2010, Dental Press J. Orthod., V15, P19; De Smet E, 2001, INT J PERIODONT REST, V21, P381; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Dereka X, 2012, CLIN ORAL IMPLAN RES, V23, P775, DOI 10.1111/j.1600-0501.2011.02329.x; Esposito M, 1999, INT J ORAL MAX IMPL, V14, P473; Hall J, 2011, EUR J ORAL IMPLANTOL, V4, P371; Hansen TVO, 2007, CANCER EPIDEM BIOMAR, V16, P2072, DOI 10.1158/1055-9965.EPI-07-0611; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang K, 2014, OBESITY, V22, P984, DOI 10.1002/oby.20647; Hutton J E, 1995, Int J Oral Maxillofac Implants, V10, P33; Kadkhodazadeh Mahdi, 2013, Journal of Basic and Clinical Physiology and Pharmacology, V24, P131, DOI 10.1515/jbcpp-2012-0055; Karoussis IK, 2003, CLIN ORAL IMPLAN RES, V14, P329, DOI 10.1034/j.1600-0501.000.00934.x; Lang NP, 2011, J CLIN PERIODONTOL, V38, P178, DOI 10.1111/j.1600-051X.2010.01674.x; LeDuc CA, 2014, JIMD REP, V12, P121, DOI 10.1007/8904_2013_254; Lee CS JJ, 2004, J PERIODONTAL IMPLAN, V2, P2093; Li BS, 2008, AM J HUM GENET, V83, P311, DOI 10.1016/j.ajhg.2008.06.024; Lindhe J, 2008, J CLIN PERIODONTOL, V35, P282, DOI 10.1111/j.1600-051X.2008.01283.x; Madsen BE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000384; Michalowicz BS, 2000, J PERIODONTOL, V71, P1699, DOI 10.1902/jop.2000.71.11.1699; Mombelli A, 2002, PERIODONTOL 2000, V28, P177, DOI 10.1034/j.1600-0757.2002.280107.x; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Nishizaka T, 2000, P NATL ACAD SCI USA, V97, P692, DOI 10.1073/pnas.97.2.692; Petkovic-Curcin A, 2011, VOJNOSANIT PREGL, V68, P435, DOI 10.2298/VSP1105435P; Pjetursson BE, 2004, CLIN ORAL IMPLAN RES, V15, P625, DOI 10.1111/j.1600-0501.2004.01117.x; Polizzi G, 2013, INT J PROSTHODONT, V26, P350, DOI 10.11607/ijp.3386; Prathapachandran Jayachandran, 2012, Dent Res J (Isfahan), V9, P516; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Quirynen M, 2002, CLIN ORAL IMPLAN RES, V13, P1, DOI 10.1034/j.1600-0501.2002.130101.x; Rabbani B, 2012, J HUM GENET, V57, P621, DOI 10.1038/jhg.2012.91; Raszek MM, 2001, APPL EXOME SEQUENCIN; Sanchez- Garces MA, 2004, MED ORAL PATOL ORAL, V9, P63; Sanchez-Garces Maria Angeles, 2004, Med Oral Patol Oral Cir Bucal, V9 Suppl, P69; Santos MCLG, 2002, BRAZ J ORAL SCI, V1, P103, DOI DOI 10.20396/BJOS.V1I3.8641045; Shekaran A, 2011, J BIOMED MATER RES A, V96A, P261, DOI 10.1002/jbm.a.32979; Smoot ME, 2011, BIOINFORMATICS, V27, P431, DOI 10.1093/bioinformatics/btq675; Stadlinger B, 2007, J BIOMED MATER RES B, V83B, P222, DOI 10.1002/jbm.b.30787; Teles RP HA, 2008, PERIIMPLANT INFECT C; Verrier S, 2002, BIOMATERIALS, V23, P585, DOI 10.1016/S0142-9612(01)00145-4; WEYANT RJ, 1993, J DENT RES, V72, P2, DOI 10.1177/00220345930720010201; Wu MC, 2011, AM J HUM GENET, V89, P82, DOI 10.1016/j.ajhg.2011.05.029; Zhang K, 2012, CELL ADHES MIGR, V6, P20, DOI 10.4161/cam.18702; Zhou HF, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S2-S2; Zhou HF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-S3-S20	51	11	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99360	10.1371/journal.pone.0099360	http://dx.doi.org/10.1371/journal.pone.0099360			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921256	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300053
J	Xiu, YL; Zhao, Y; Gou, WF; Chen, S; Takano, Y; Zheng, HC				Xiu, Yin-Ling; Zhao, Yang; Gou, Wen-Feng; Chen, Shuo; Takano, Yasuo; Zheng, Hua-Chuan			Anacardic Acid Enhances the Proliferation of Human Ovarian Cancer Cells	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HISTONE ACETYLTRANSFERASE; INHIBITION; APOPTOSIS; PHOSPHORYLATION; PROGRESSION; PRODUCTS; SURVIVAL; RECEPTOR; MARKER	Background: Anacardic acid (AA) is a mixture of 2-hydroxy-6-alkylbenzoic acid homologs. Certain antitumor activities of AA have been reported in a variety of cancers. However, the function of AA in ovarian cancer, to date, has remained unknown. Methods: Ovarian cancer cell lines were exposed to AA, after which cell proliferation, apoptosis, invasion and migration assays were performed. Phalloidin staining was used to observe lamellipodia formation. Reverse transcription polymerase chain reaction (RT-PCR) and western blotting were used to assess the mRNA and protein expression levels of Phosphatidylinositol 3-kinase (PI3K), vascular endothelial growth factor (VEGF) and caspase 3. Results: Our results showed that AA promotes ovarian cancer cell proliferation, inhibits late apoptosis, and induces cell migration and invasion, as well as lamellipodia formation. AA exposure significantly up-regulated PI3K and VEGF mRNA and protein expression, while, in contrast, it down-regulated caspase 3 mRNA and protein expression in comparison to untreated control cells. Conclusion: Taken together, our results demonstrate for the first time that AA may potentiate the proliferation, invasion, metastasis and lamellipodia formation in ovarian cancer cell lines via PI3K, VEGF and caspase 3 pathways.	[Xiu, Yin-Ling; Zhao, Yang; Chen, Shuo] China Med Univ, Affiliated Hosp 1, Dept Gynecol, Shenyang, Peoples R China; [Gou, Wen-Feng; Zheng, Hua-Chuan] China Med Univ, Inst Pathol & Pathophysiol, Dept Biochem & Mol Biol, Coll Basic Med, Shenyang, Peoples R China; [Takano, Yasuo] Kanagawa Canc Ctr, Clin Canc Inst, Yokohama, Kanagawa 2410815, Japan	China Medical University; China Medical University; Kanagawa Prefectural Cancer Center	Zheng, HC (corresponding author), China Med Univ, Inst Pathol & Pathophysiol, Dept Biochem & Mol Biol, Coll Basic Med, Shenyang, Peoples R China.	zheng_huachuan@hotmail.com		Gou, Wenfeng/0000-0002-4828-4298	Shenyang Outstanding Talent Foundation of China; Shenyang Science and Technology Grant [F11-264-1-10, F12-277-1-01]; Project Supported by Scientific Research Fund of Liaoning Provincial Education Department [L2010633]; Liaoning Science and Technology Grant [2009225008-11, 2013021077]; Natural Scientific Foundation of China [81172371, 81202049]	Shenyang Outstanding Talent Foundation of China; Shenyang Science and Technology Grant; Project Supported by Scientific Research Fund of Liaoning Provincial Education Department; Liaoning Science and Technology Grant; Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by Shenyang Outstanding Talent Foundation of China; Shenyang Science and Technology Grant (F11-264-1-10; F12-277-1-01); the Project Supported by Scientific Research Fund of Liaoning Provincial Education Department (L2010633); Liaoning Science and Technology Grant (2009225008-11; 2013021077); and the Natural Scientific Foundation of China (81172371; 81202049). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altomare DA, 2004, ONCOGENE, V23, P5853, DOI 10.1038/sj.onc.1207721; Begum P, 2002, Z NATURFORSCH C, V57, P874; Cassady JM, 1981, INT RES C MED PLANT, P93; Cejka D, 2009, BRIT J CANCER, V100, P1739, DOI 10.1038/sj.bjc.6605076; Chattopadhyaya MK, 1969, INDIAN J PHARM, V31, P104; Bizzo SMD, 2010, INT J GYNECOL OBSTET, V109, P113, DOI 10.1016/j.ijgo.2009.11.021; Dobbin ZC, 2013, INT J MOL SCI, V14, P8213, DOI 10.3390/ijms14048213; Eisenkop SM, 1998, GYNECOL ONCOL, V69, P103, DOI 10.1006/gyno.1998.4955; Gurunathan S, 2013, INT J NANOMED, V8, P4399, DOI 10.2147/IJN.S51881; Hefler LA, 2006, GYNECOL ONCOL, V103, P512, DOI 10.1016/j.ygyno.2006.03.058; Ji K, 2013, INT J MOL MED, V32, P747, DOI 10.3892/ijmm.2013.1472; Kajdaniuk D, 2011, ENDOKRYNOL POL, V62, P444; Kusio-Kobialka M, 2013, ANTI-CANCER AGENT ME, V13, P762; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Lin MY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/207279; Mantia-Smaldone Gina M, 2011, Cancer Manag Res, V3, P25, DOI 10.2147/CMR.S8759; Mazzoletti M, 2010, CURR MED CHEM, V17, P4433, DOI 10.2174/092986710794182999; Rea AI, 2003, FITOTERAPIA, V74, P732, DOI 10.1016/j.fitote.2003.08.007; Schultz DJ, 2010, MOL CANCER THER, V9, P594, DOI 10.1158/1535-7163.MCT-09-0978; Seong YA, 2013, CELL BIOCH BIOPHYS; Seong YA, 2013, INT J ONCOL, V42, P1045, DOI 10.3892/ijo.2013.1763; SHOBHA SV, 1994, J NAT PRODUCTS, V57, P1755, DOI 10.1021/np50114a025; Sowmyalakshmi S, 2005, PLANTA, V220, P910, DOI 10.1007/s00425-004-1405-4; Sukumari-Ramesh S, 2011, J NEUROSURG, V114, P1681, DOI 10.3171/2010.12.JNS10588; Sun YL, 2006, FEBS LETT, V580, P4353, DOI 10.1016/j.febslet.2006.06.092; Sung B, 2008, BLOOD, V111, P4880, DOI 10.1182/blood-2007-10-117994; Tan J, 2012, CHINESE J CANCER RES, V24, P275, DOI [10.3978/j.issn.1000-9604.2012.10.07, 10.1007/s11670-012-0264-y]; Toyomizu M, 1999, LIFE SCI, V66, P229; Toyomizu Masaaki, 2003, Animal Science Journal, V74, P499, DOI 10.1046/j.1344-3941.2003.00144.x; Trevisan MTS, 2006, FOOD CHEM TOXICOL, V44, P188, DOI 10.1016/j.fct.2005.06.012; Wu YY, 2011, J PHARMACOL EXP THER, V339, P403, DOI 10.1124/jpet.111.181891; Yu B, 2014, ONCOL REP, V31, P849, DOI 10.3892/or.2013.2869; Zhao Y, 2013, GYNECOL ONCOL, V130, P570, DOI 10.1016/j.ygyno.2013.06.004	33	11	11	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99361	10.1371/journal.pone.0099361	http://dx.doi.org/10.1371/journal.pone.0099361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921663	Green Submitted, gold, Green Published			2022-12-27	WOS:000338701300054
J	Cecchelli, R; Aday, S; Sevin, E; Almeida, C; Culot, M; Dehouck, L; Coisne, C; Engelhardt, B; Dehouck, MP; Ferreira, L				Cecchelli, Romeo; Aday, Sezin; Sevin, Emmanuel; Almeida, Catarina; Culot, Maxime; Dehouck, Lucie; Coisne, Caroline; Engelhardt, Britta; Dehouck, Marie-Pierre; Ferreira, Lino			A Stable and Reproducible Human Blood-Brain Barrier Model Derived from Hematopoietic Stem Cells	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; PERICYTES; CNS; INTEGRITY	The human blood brain barrier (BBB) is a selective barrier formed by human brain endothelial cells (hBECs), which is important to ensure adequate neuronal function and protect the central nervous system (CNS) from disease. The development of human in vitro BBB models is thus of utmost importance for drug discovery programs related to CNS diseases. Here, we describe a method to generate a human BBB model using cord blood-derived hematopoietic stem cells. The cells were initially differentiated into ECs followed by the induction of BBB properties by co-culture with pericytes. The brain-like endothelial cells (BLECs) express tight junctions and transporters typically observed in brain endothelium and maintain expression of most in vivo BBB properties for at least 20 days. The model is very reproducible since it can be generated from stem cells isolated from different donors and in different laboratories, and could be used to predict CNS distribution of compounds in human. Finally, we provide evidence that Wnt/beta-catenin signaling pathway mediates in part the BBB inductive properties of pericytes.	[Cecchelli, Romeo; Sevin, Emmanuel; Culot, Maxime; Dehouck, Lucie; Dehouck, Marie-Pierre] Univ Artois, Blood Brain Barrier Lab, Lens, France; [Aday, Sezin; Almeida, Catarina; Ferreira, Lino] Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal; [Aday, Sezin; Almeida, Catarina; Ferreira, Lino] Biocant Ctr Innovat Biotechnol, Biomat & Stem Cell Based Therapeut Lab, Cantanhede, Portugal; [Almeida, Catarina] Univ Coimbra IIIUC, Inst Interdisciplinary Res, Coimbra, Portugal; [Coisne, Caroline; Engelhardt, Britta] Univ Bern, Theodor Kocher Inst, Bern, Switzerland	Universite d'Artois; Universidade de Coimbra; Universidade de Coimbra; University of Bern	Ferreira, L (corresponding author), Univ Coimbra, CNC Ctr Neurosci & Cell Biol, Coimbra, Portugal.	lino@biocant.pt	Engelhardt, Britta/K-7267-2014; Aday, Sezin/I-5901-2019	Engelhardt, Britta/0000-0003-3059-9846; Aday, Sezin/0000-0003-4396-7812; Praca, Catarina/0000-0003-1669-0125; CULOT, Maxime/0000-0001-7452-0867; ferreira, lino/0000-0001-8985-9302	Marie Curie-Reintegration Grant [230929]; funds of FEDER through the "Programa Operacional Factores de Competitividade-Compete"; Portuguese funds through FCT-Science and Technology Foundation [PTDC/CTM/099659/2008, PEst-C/SAU/LA0001/2013-2014, SFRH/BD/42871/2008]; COMPETE [201024, 202213]; PRIM	Marie Curie-Reintegration Grant(European Commission); funds of FEDER through the "Programa Operacional Factores de Competitividade-Compete"; Portuguese funds through FCT-Science and Technology Foundation; COMPETE; PRIM(European Commission)	This work was supported by a Marie Curie-Reintegration Grant (FP7-People-2007-4-3-IRG; contract no 230929), funds of FEDER through the "Programa Operacional Factores de Competitividade-Compete" and Portuguese funds through FCT-Science and Technology Foundation (PTDC/CTM/099659/2008, PEst-C/SAU/LA0001/2013-2014; and SFRH/BD/42871/2008, a fellowship to S. A.), COMPETE funding (Project "Stem cell based platforms for Regenerative and Therapeutic Medicine'', Centro-07-ST24-FEDER-002008), FP7 (contracts 201024 and 202213 (European Stroke Network)) and PRIM (from the region Nord-Pas de Calais (France)). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez JI, 2011, SCIENCE, V334, P1727, DOI 10.1126/science.1206936; Armulik A, 2010, NATURE, V468, P557, DOI 10.1038/nature09522; Bo L, 1996, J NEUROPATH EXP NEUR, V55, P1060, DOI 10.1097/00005072-199655100-00006; Cecchelli R, 2007, NAT REV DRUG DISCOV, V6, P650, DOI 10.1038/nrd2368; COLLINS T, 1995, FASEB J, V9, P899, DOI 10.1096/fasebj.9.10.7542214; Culot M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080634; Daneman R, 2010, NATURE, V468, P562, DOI 10.1038/nature09513; Daneman R, 2009, P NATL ACAD SCI USA, V106, P641, DOI 10.1073/pnas.0805165106; Deli MA, 2005, CELL MOL NEUROBIOL, V25, P59, DOI 10.1007/s10571-004-1377-8; Dohgu S, 2005, BRAIN RES, V1038, P208, DOI 10.1016/j.brainres.2005.01.027; Friden M, 2007, DRUG METAB DISPOS, V35, P1711, DOI 10.1124/dmd.107.015222; Friden M, 2009, J MED CHEM, V52, P6233, DOI 10.1021/jm901036q; Gulati R, 2003, CIRCULATION, V108, P1520, DOI 10.1161/01.CIR.0000089084.48655.49; He TR, 2004, STROKE, V35, P2378, DOI 10.1161/01.STR.0000141893.33677.5d; Hori S, 2004, J NEUROCHEM, V89, P503, DOI 10.1111/j.1471-4159.2004.02343.x; Liebner S, 2008, J CELL BIOL, V183, P409, DOI 10.1083/jcb.200806024; Lippmann ES, 2012, NAT BIOTECHNOL; Lippmann ES, 2014, SCI REP-UK, V4, DOI 10.1038/srep04160; Okita K, 2011, PHILOS T R SOC B, V366, P2198, DOI 10.1098/rstb.2011.0016; Pedroso DCS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016114; PONIO J, 2014, PLOS ONE, V0009; Prieto P, 2004, ATLA-ALTERN LAB ANIM, V32, P37, DOI 10.1177/026119290403200107; Saeed AI, 2006, METHOD ENZYMOL, V411, P134, DOI 10.1016/S0076-6879(06)11009-5; Sano Y, 2010, J CELL PHYSIOL, V225, P519, DOI 10.1002/jcp.22232; Shimomura Y, 2010, NATURE, V464, P1043, DOI 10.1038/nature08875; SIFLINGERBIRNBOIM A, 1987, J CELL PHYSIOL, V132, P111, DOI 10.1002/jcp.1041320115; Simon R, 2007, CANCER INFORM, V3, P11; Stenman JM, 2008, SCIENCE, V322, P1247, DOI 10.1126/science.1164594; TATSUTA T, 1992, J BIOL CHEM, V267, P20383; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Zhang ZG, 2002, CIRC RES, V90, P284, DOI 10.1161/hh0302.104460	32	186	190	2	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99733	10.1371/journal.pone.0099733	http://dx.doi.org/10.1371/journal.pone.0099733			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936790	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400035
J	Keleg, S; Titov, A; Heller, A; Giese, T; Tjaden, C; Ahmad, SS; Gaida, MM; Bauer, AS; Werner, J; Giese, NA				Keleg, Shereen; Titov, Alexandr; Heller, Anette; Giese, Thomas; Tjaden, Christine; Ahmad, Sufian S.; Gaida, Matthias M.; Bauer, Andrea S.; Werner, Jens; Giese, Nathalia A.			Chondroitin Sulfate Proteoglycan CSPG4 as a Novel Hypoxia-Sensitive Marker in Pancreatic Tumors	PLOS ONE			English	Article							VON-HIPPEL-LINDAU; PAPILLARY-MUCINOUS NEOPLASMS; IN-VITRO; DUCTAL ADENOCARCINOMA; STEM-CELLS; NG2 PROTEOGLYCAN; UVEAL MELANOMA; CANCER; MOUSE; GENE	CSPG4 marks pericytes, undifferentiated precursors and tumor cells. We assessed whether the shed ectodomain of CSPG4 (sCSPG4) might circulate and reflect potential changes in CSPG4 tissue expression (pCSPG4) due to desmoplastic and malignant aberrations occurring in pancreatic tumors. Serum sCSPG4 was measured using ELISA in test (n = 83) and validation (n = 221) cohorts comprising donors (n = 11+ 26) and patients with chronic pancreatitis (n = 11+ 20) or neoplasms: benign (serous cystadenoma SCA, n = 13+20), premalignant (intraductal dysplastic IPMNs, n = 9+55), and malignant (IPMN-associated invasive carcinomas, n = 4+14; ductal adenocarcinomas, n = 35+86). Pancreatic pCSPG4 expression was evaluated using qRT-PCR (n = 139), western blot analysis and immunohistochemistry. sCSPG4 was found in circulation, but its level was significantly lower in pancreatic patients than in donors. Selective maintenance was observed in advanced IPMNs and PDACs and showed a nodal association while lacking prognostic relevance. Pancreatic pCSPG4 expression was preserved or elevated, whereby neoplastic cells lacked pCSPG4 or tended to overexpress without shedding. Extreme pancreatic overexpression, membranous exposure and tissue(high)/sera(low)-discordance highlighted stroma-poor benign cystic neoplasm. SCA is known to display hypoxic markers and coincide with von-Hippel-Lindau and Peutz-Jeghers syndromes, in which pVHL and LBK1 mutations affect hypoxic signaling pathways. In vitro testing confined pCSPG4 overexpression to normal mesenchymal but not epithelial cells, and a third of tested carcinoma cell lines; however, only the latter showed pCSPG4-responsiveness to chronic hypoxia. siRNA-based knockdowns failed to reduce the malignant potential of either normoxic or hypoxic cells. Thus, overexpression of the newly established conditional hypoxic indicator, CSPG4, is apparently nonpathogenic in pancreatic malignancies but might mark distinct epithelial lineage and contribute to cell polarity disorders. Surficial retention on tumor cells renders CSPG4 an attractive therapeutic target. Systemic 'drop and restoration' alterations accompanying IPMN and PDAC progression indicate that the interference of pancreatic diseases with local and remote shedding/release of sCSPG4 into circulation deserves broad diagnostic exploration.	[Keleg, Shereen; Titov, Alexandr; Heller, Anette; Tjaden, Christine; Ahmad, Sufian S.; Werner, Jens; Giese, Nathalia A.] Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, European Pancreas Ctr, Heidelberg, Germany; [Giese, Thomas] Univ Heidelberg Hosp, Inst Immunol, Heidelberg, Germany; [Bauer, Andrea S.] German Canc Res Ctr, Dept Funct Genom, Heidelberg, Germany; [Gaida, Matthias M.] Univ Heidelberg Hosp, Inst Pathol, Heidelberg, Germany	Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Giese, NA (corresponding author), Univ Heidelberg Hosp, Dept Gen Visceral & Transplantat Surg, European Pancreas Ctr, Heidelberg, Germany.	nathalia.giese@med.uni-heidelberg.de	Ahmad, Sufian S/H-3881-2014	Ahmad, Sufian S/0000-0001-9763-092X	Dietmar Hopp Stiftung; BMBF [NGFN-01GS08114]	Dietmar Hopp Stiftung; BMBF(Federal Ministry of Education & Research (BMBF))	The work was supported by grants from the Dietmar Hopp Stiftung (http://www.dietmar-hopp-stiftung.de/) to N.A. Giese and from the BMBF to N.A. Giese and A. Bauer (NGFN-01GS08114; http://www.bmbf.de). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aichler M, 2012, J PATHOL, V226, P723, DOI 10.1002/path.3017; Amato E, 2014, J PATHOL; Arafat H, 2011, SURGERY, V150, P306, DOI 10.1016/j.surg.2011.05.011; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Bachem MG, 1998, GASTROENTEROLOGY, V115, P421, DOI 10.1016/S0016-5085(98)70209-4; Bartel M, 2008, J PATHOL, V215, P195, DOI 10.1002/path.2348; Carlotti F, 2010, ISLETS, V2, P164, DOI 10.4161/isl.2.3.11449; Ceyhan GO, 2009, GASTROENTEROLOGY, V136, P177, DOI 10.1053/j.gastro.2008.09.029; Chekenya M, 2008, ONCOGENE, V27, P5182, DOI 10.1038/onc.2008.157; Collisson EA, 2011, NAT MED, V17, P500, DOI 10.1038/nm.2344; Davies JA, 1996, ACTA ANAT, V156, P187; Erkan M, 2008, CLIN GASTROENTEROL H, V6, P1155, DOI 10.1016/j.cgh.2008.05.006; Erkan M, 2007, GASTROENTEROLOGY, V132, P1447, DOI 10.1053/j.gastro.2007.01.031; Esposito I, 2007, PANCREAS, V35, P212, DOI 10.1097/mpa.0b013e31805d0190; Faubert B, 2014, P NATL ACAD SCI USA, V111, P2554, DOI 10.1073/pnas.1312570111; Furukawa T, 1996, AM J PATHOL, V148, P1763; Geldres C, 2014, CLIN CANCER RES, V20, P962, DOI 10.1158/1078-0432.CCR-13-2218; Girolamo F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084883; Habbe N, 2008, P NATL ACAD SCI USA, V105, P18913, DOI 10.1073/pnas.0810097105; Hartwig W, 2011, ANN SURG, V254, P311, DOI 10.1097/SLA.0b013e31821fd334; Hezel AF, 2008, MOL CELL BIOL, V28, P2414, DOI 10.1128/MCB.01621-07; Higuchi Y, 2011, CONGENIT ANOM, V51, P21, DOI 10.1111/j.1741-4520.2010.00307.x; Ideno N, 2013, ANN SURG, V258, P141, DOI 10.1097/SLA.0b013e31828cd008; Ju PJ, 2012, CYTOTHERAPY, V14, P608, DOI 10.3109/14653249.2011.651528; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; Kim SG, 2003, MODERN PATHOL, V16, P1086, DOI 10.1097/01.MP.0000094088.37888.A6; Koh MY, 2012, TRENDS BIOCHEM SCI, V37, P364, DOI 10.1016/j.tibs.2012.06.004; Kong B, 2011, NAT REV GASTRO HEPAT, V8, P467, DOI 10.1038/nrgastro.2011.114; Koninger J, 2004, CLIN CANCER RES, V10, P4776, DOI 10.1158/1078-0432.CCR-1190-03; Konstantinou F, 2013, J PANCREAS, V14, P141, DOI 10.6092/1590-8577/1467; Kraman M, 2010, SCIENCE, V330, P827, DOI 10.1126/science.1195300; Landsman L, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001143; Legg J, 2003, DEVELOPMENT, V130, P6049, DOI 10.1242/dev.00837; Levine JM, 1996, PERSPECT DEV NEUROBI, V3, P245; Li Y, 2005, INVEST OPHTH VIS SCI, V46, P4365, DOI 10.1167/iovs.05-0559; Liu H, 2012, CURR PHARM DESIGN, V18, P2395, DOI 10.2174/13816128112092395; Lonser RR, 2003, LANCET, V361, P2059, DOI 10.1016/S0140-6736(03)13643-4; Mazumdar J, 2010, P NATL ACAD SCI USA, V107, P14182, DOI 10.1073/pnas.1001296107; Mino-Kenudson M, 2011, GUT, V60, P1712, DOI 10.1136/gut.2010.232272; Mohr VH, 2000, AM J PATHOL, V157, P1615, DOI 10.1016/S0002-9440(10)64799-2; Mohri D, 2012, J GASTROENTEROL, V47, P203, DOI 10.1007/s00535-011-0482-y; Monti P, 2004, VIRCHOWS ARCH, V445, P236, DOI 10.1007/s00428-004-1053-x; Moore PS, 2001, AM J PATHOL, V158, P317, DOI 10.1016/S0002-9440(10)63971-5; Murtaugh LC, 2007, CANCER CELL, V11, P211, DOI 10.1016/j.ccr.2007.02.020; Neesse A, 2011, GUT, V60, P861, DOI 10.1136/gut.2010.226092; NEUMANN HPH, 1991, GASTROENTEROLOGY, V101, P465, DOI 10.1016/0016-5085(91)90026-H; NISHIYAMA A, 1995, MOL BIOL CELL, V6, P1819, DOI 10.1091/mbc.6.12.1819; Ozerdem U, 2006, OPHTHAL RES, V38, P251, DOI 10.1159/000094833; Pankova D, 2012, EUR J CELL BIOL; Perez-Mancera PA, 2012, GASTROENTEROLOGY, V142, P1079, DOI 10.1053/j.gastro.2012.03.002; Poli A, 2013, ONCOTARGET, V4, P1527, DOI 10.18632/oncotarget.1291; Rovira M, 2010, P NATL ACAD SCI USA, V107, P75, DOI 10.1073/pnas.0912589107; Sahin F, 2003, MODERN PATHOL, V16, P686, DOI 10.1097/01.MP.0000075645.97329.86; Sato N, 2001, AM J PATHOL, V159, P2017, DOI 10.1016/S0002-9440(10)63053-2; Shackelford DB, 2009, P NATL ACAD SCI USA, V106, P11137, DOI 10.1073/pnas.0900465106; Smith FO, 1996, BLOOD, V87, P1123, DOI 10.1182/blood.V87.3.1123.bloodjournal8731123; Stallcup WB, 2002, J NEUROCYTOL, V31, P423, DOI 10.1023/A:1025731428581; Stanger BZ, 2005, CANCER CELL, V8, P185, DOI 10.1016/j.ccr.2005.07.015; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Strobel O, 2007, GASTROENTEROLOGY, V133, P1999, DOI 10.1053/j.gastro.2007.09.009; Svendsen A, 2011, ACTA NEUROPATHOL, V122, P495, DOI 10.1007/s00401-011-0867-2; Tanaka M, 2012, PANCREATOLOGY, V12, P183, DOI 10.1016/j.pan.2012.04.004; Wang J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023062; Wiesener MS, 2009, J MOL MED-JMM, V87, P871, DOI 10.1007/s00109-009-0504-x	64	16	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100178	10.1371/journal.pone.0100178	http://dx.doi.org/10.1371/journal.pone.0100178			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932730	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600100
J	Poznanski, J; Poznanska, A; Shugar, D				Poznanski, Jaroslaw; Poznanska, Anna; Shugar, David			A Protein Data Bank Survey Reveals Shortening of Intermolecular Hydrogen Bonds in Ligand-Protein Complexes When a Halogenated Ligand Is an H-Bond Donor	PLOS ONE			English	Article							RANDOM COIL TRANSITIONS; MEDICINAL CHEMISTRY; C-H...O; DNA; RECOGNITION; COMPETITION; SUBSTITUENT; PARALLEL; ACCEPTOR; BINDING	Halogen bonding in ligand-protein complexes is currently widely exploited, e. g. in drug design or supramolecular chemistry. But little attention has been directed to other effects that may result from replacement of a hydrogen by a strongly electronegative halogen. Analysis of almost 30000 hydrogen bonds between protein and ligand demonstrates that the length of a hydrogen bond depends on the type of donor-acceptor pair. Interestingly, lengths of hydrogen bonds between a protein and a halogenated ligand are visibly shorter than those estimated for the same family of proteins in complexes with non-halogenated ligands. Taking into account the effect of halogenation on hydrogen bonding is thus important when evaluating structural and/or energetic parameters of ligand-protein complexes. All these observations are consistent with the concept that halogenation increases the acidity of the proximal amino/imino/hydroxyl groups and thus makes them better, i.e. stronger, H-bond donors.	[Poznanski, Jaroslaw] Inst Biochem & Biophys PAS, Dept Biophys, Warsaw, Poland; [Poznanska, Anna] Natl Inst Hyg, Ctr Monitoring & Anal Populat Hlth Status, Natl Inst Publ Hlth, PL-00791 Warsaw, Poland; [Shugar, David] Inst Biochem & Biophys PAS, Warsaw, Poland	Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; National Institute of Hygiene (NIH); National Institute of Public Health (NIPH); Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences	Poznanski, J (corresponding author), Inst Biochem & Biophys PAS, Dept Biophys, Warsaw, Poland.	jarek@ibb.waw.pl; gwalesshugar@gmail.com	Poznanski, Jaroslaw/F-7705-2014	Poznanski, Jaroslaw/0000-0003-2684-1775; Poznanska, Anna/0000-0002-2026-7293	National Science Centre, Poland [2012/07/B/ST4/01334]	National Science Centre, Poland(National Science Centre, Poland)	This work was supported by National Science Centre, Poland (http://ncn.gov.pl/); Grant number 2012/07/B/ST4/01334. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aakeroy CB, 2013, CRYSTENGCOMM, V15, P3125, DOI 10.1039/c2ce26747k; AAKEROY CB, 1993, CHEM SOC REV, V22, P397, DOI 10.1039/cs9932200397; Aakeroy CB, 2010, CRYSTENGCOMM, V12, P22, DOI 10.1039/b919819a; An XL, 2013, J MOL MODEL, V19, P4529, DOI 10.1007/s00894-013-1969-7; ANDERSON TW, 1952, ANN MATH STAT, V23, P193, DOI 10.1214/aoms/1177729437; [Anonymous], 2011, STAT DAT AN SOFTW SY; ATWOOD JL, 1991, NATURE, V349, P683, DOI 10.1038/349683a0; Auffinger P, 2004, P NATL ACAD SCI USA, V101, P16789, DOI 10.1073/pnas.0407607101; Baldrighi M, 2013, MOL PHARMACEUT, V10, P1760, DOI 10.1021/mp300574j; BENT HA, 1968, CHEM REV, V68, P587, DOI 10.1021/cr60255a003; Carter M, 2011, CRYST GROWTH DES, V11, P5087, DOI 10.1021/cg200991v; CULLEN BR, 1976, NUCLEIC ACIDS RES, V3, P49, DOI 10.1093/nar/3.1.49; DESIRAJU GR, 1991, ACCOUNTS CHEM RES, V24, P290, DOI 10.1021/ar00010a002; DESIRAJU GR, 1995, ANGEW CHEM INT EDIT, V34, P2311, DOI 10.1002/anie.199523111; Freidlin B, 2000, AM STAT, V54, P161, DOI 10.2307/2685584; Guerra CF, 2005, STRUCT CHEM, V16, P211, DOI 10.1007/s11224-005-4453-x; Hardegger LA, 2011, ANGEW CHEM INT EDIT, V50, P314, DOI 10.1002/anie.201006781; HASSEL O, 1954, ACTA CHEM SCAND, V8, P873, DOI 10.3891/acta.chem.scand.08-0873; Hauchecorne D, 2010, CHEM PHYS, V374, P30, DOI 10.1016/j.chemphys.2010.06.004; Hernandes MZ, 2010, CURR DRUG TARGETS, V11, P303, DOI 10.2174/138945010790711996; Heshmati E, 2009, BIOORG MED CHEM LETT, V19, P5256, DOI 10.1016/j.bmcl.2009.06.105; INMAN RB, 1962, J MOL BIOL, V5, P185, DOI 10.1016/S0022-2836(62)80083-7; INMAN RB, 1964, J MOL BIOL, V8, P452, DOI 10.1016/S0022-2836(64)80003-6; INMAN RB, 1962, J MOL BIOL, V5, P172, DOI 10.1016/S0022-2836(62)80082-5; Jeffrey GA, 1994, HYDROGEN BONDING BIO; KOSHLAND DE, 1994, ANGEW CHEM INT EDIT, V33, P2375; Krieger E, 2009, PROTEINS, V77, P114, DOI 10.1002/prot.22570; KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441; Kuhn B, 2010, J MED CHEM, V53, P2601, DOI 10.1021/jm100087s; KUOPIO R, 1976, ACTA CHEM SCAND A, V30, P1, DOI 10.3891/acta.chem.scand.30a-0001; Li QZ, 2010, PHYS CHEM CHEM PHYS, V12, P6837, DOI 10.1039/b926355a; Liu XF, 2013, SPECTROCHIM ACTA A, V101, P172, DOI 10.1016/j.saa.2012.09.043; Lozinski T, 2001, ACTA BIOCHIM POL, V48, P495; Lu YX, 2012, EXPERT OPIN DRUG DIS, V7, P375, DOI 10.1517/17460441.2012.678829; MANN HB, 1947, ANN MATH STAT, V18, P50, DOI 10.1214/aoms/1177730491; Metrangolo P, 2001, CHEM-EUR J, V7, P2511, DOI 10.1002/1521-3765(20010618)7:12<2511::AID-CHEM25110>3.0.CO;2-T; Metrangolo P, 2005, ACCOUNTS CHEM RES, V38, P386, DOI 10.1021/ar0400995; Metrangolo P, 2008, ANGEW CHEM INT EDIT, V47, P6114, DOI 10.1002/anie.200800128; Metrangolo P, 2011, CRYST GROWTH DES, V11, P4238, DOI 10.1021/cg200888n; Mooibroek TJ, 2013, CRYSTENGCOMM, V15, P4565, DOI 10.1039/c3ce40285a; Mooibroek TJ, 2013, CRYSTENGCOMM, V15, P1802, DOI 10.1039/c2ce26853a; Parisini E, 2011, CHEM SOC REV, V40, P2267, DOI 10.1039/c0cs00177e; Pauletti PM, 2010, MAR DRUGS, V8, P1526, DOI 10.3390/md8051526; Politzer P, 2007, J MOL MODEL, V13, P305, DOI 10.1007/s00894-006-0154-7; Politzer P, 2010, PHYS CHEM CHEM PHYS, V12, P7748, DOI 10.1039/c004189k; Poznanski J, 2013, BBA-PROTEINS PROTEOM, V1834, P1381, DOI 10.1016/j.bbapap.2013.01.026; Raatikainen K, 2010, BEILSTEIN J ORG CHEM, V6, DOI 10.3762/bjoc.6.4; Rendine S, 2011, PHYS CHEM CHEM PHYS, V13, P19508, DOI 10.1039/c1cp22436k; Riley KE, 2013, J MOL MODEL, V19, P2879, DOI 10.1007/s00894-012-1727-2; Rissanen K, 2008, CRYSTENGCOMM, V10, P1107, DOI 10.1039/b803329n; Sarwar MG, 2010, J AM CHEM SOC, V132, P1646, DOI 10.1021/ja9086352; Scholfield MR, 2013, PROTEIN SCI, V22, P139, DOI 10.1002/pro.2201; Seela F, 2005, J AM CHEM SOC, V127, P7739, DOI 10.1021/ja0425785; SIMPSON RT, 1974, BIOCHEMISTRY-US, V13, P4609, DOI 10.1021/bi00719a022; Steiner T, 2001, J MOL BIOL, V305, P535, DOI 10.1006/jmbi.2000.4301; Stryer L., 1995, BIOCHEMISTRY-US, V4th ed.; TAYLOR R, 1982, J AM CHEM SOC, V104, P5063, DOI 10.1021/ja00383a012; Voth AR, 2007, CURR TOP MED CHEM, V7, P1336; Voth AR, 2007, P NATL ACAD SCI USA, V104, P6188, DOI 10.1073/pnas.0610531104; Voth AR, 2009, NAT CHEM, V1, P74, DOI [10.1038/NCHEM.112, 10.1038/nchem.112]; Vulpetti A, 2012, DRUG DISCOV TODAY, V17, P890, DOI 10.1016/j.drudis.2012.03.014; Wang W, 2005, J NAT PROD, V68, P620, DOI 10.1021/np040199j; Wasik R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048898; Wasik R, 2012, J PHYS CHEM B, V116, P7259, DOI 10.1021/jp301561x; Wasik R, 2010, J PHYS CHEM B, V114, P10601, DOI 10.1021/jp102848y; Wilcken R, 2013, J MED CHEM, V56, P1363, DOI 10.1021/jm3012068; Xu ZJ, 2011, J MED CHEM, V54, P5607, DOI 10.1021/jm200644r; Zhou P, 2010, MINI-REV MED CHEM, V10, P309, DOI 10.2174/138955710791331016	68	11	11	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99984	10.1371/journal.pone.0099984	http://dx.doi.org/10.1371/journal.pone.0099984			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933273	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600083
J	Rajpathak, SN; Vellarikkal, SK; Patowary, A; Scaria, V; Sivasubbu, S; Deobagkar, DD				Rajpathak, Shriram N.; Vellarikkal, Shamsudheen Karuthedath; Patowary, Ashok; Scaria, Vinod; Sivasubbu, Sridhar; Deobagkar, Deepti D.			Human 45,X Fibroblast Transcriptome Reveals Distinct Differentially Expressed Genes Including Long Noncoding RNAs Potentially Associated with the Pathophysiology of Turner Syndrome	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; PLACENTAL GROWTH-FACTOR; FRIZZLED-RELATED PROTEIN-1; OSTEOGENIC DIFFERENTIATION; LUTEINIZING-HORMONE; X-INACTIVATION; SHORT STATURE; Y-CHROMOSOME; STEM-CELLS; SNORNA U50	Turner syndrome is a chromosomal abnormality characterized by the absence of whole or part of the X chromosome in females. This X aneuploidy condition is associated with a diverse set of clinical phenotypes such as gonadal dysfunction, short stature, osteoporosis and Type II diabetes mellitus, among others. These phenotypes differ in their severity and penetrance among the affected individuals. Haploinsufficiency for a few X linked genes has been associated with some of these disease phenotypes. RNA sequencing can provide valuable insights to understand molecular mechanism of disease process. In the current study, we have analysed the transcriptome profiles of human untransformed 45, X and 46,XX fibroblast cells and identified differential expression of genes in these two karyotypes. Functional analysis revealed that these differentially expressing genes are associated with bone differentiation, glucose metabolism and gonadal development pathways. We also report differential expression of lincRNAs in X monosomic cells. Our observations provide a basis for evaluation of cellular and molecular mechanism(s) in the establishment of Turner syndrome phenotypes.	[Rajpathak, Shriram N.; Deobagkar, Deepti D.] Univ Pune, Dept Zool, Ctr Adv Studies, Pune, Maharashtra, India; [Vellarikkal, Shamsudheen Karuthedath; Sivasubbu, Sridhar] CSIR Inst Genom & Integrat Biol, Delhi, India; [Patowary, Ashok; Scaria, Vinod] CSIR Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India; [Scaria, Vinod; Sivasubbu, Sridhar] Anusandhan Bhawan, Acad Sci & Innovat Res AcSIR, New Delhi, India	Savitribai Phule Pune University; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Genomics & Integrative Biology (IGIB); Academy of Scientific & Innovative Research (AcSIR)	Scaria, V (corresponding author), CSIR Inst Genom & Integrat Biol, GN Ramachandran Knowledge Ctr Genome Informat, Delhi, India.	vinods@igib.in; s.sivasubbu@igib.res.in; deepti.deobagkar@gmail.com	Scaria, Vinod/AAS-3151-2021; Patowary, Ashok/AAT-5305-2020; Karuthedath Vellarikkal, Shamsudheen/AAC-4142-2022	Patowary, Ashok/0000-0001-7507-3907; Karuthedath Vellarikkal, Shamsudheen/0000-0002-6384-2948; Scaria, Vinod/0000-0001-7644-7181	University Grants Commission, Government of India; Council of Scientific and Industrial Research, India [BSC0122]	University Grants Commission, Government of India(University Grants Commission, India); Council of Scientific and Industrial Research, India(Council of Scientific & Industrial Research (CSIR) - India)	SR is thankful to University Grants Commission, Government of India, for senior research fellowship. SS and VS acknowledge funding from Council of Scientific and Industrial Research, India, through grant BSC0122 (CARDIOMED) for the sequencing. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agretti P, 2007, J ENDOCRINOL INVEST, V30, P279, DOI 10.1007/BF03346294; Aksglaede L, 2008, J CLIN ENDOCR METAB, V93, P169, DOI 10.1210/jc.2007-1426; Arthold S, 2011, HUM GENET, V130, P295, DOI 10.1007/s00439-011-1002-0; Bakalov VK, 2009, J CLIN ENDOCR METAB, V94, P3289, DOI 10.1210/jc.2009-0384; Bandyopadhyay A, 2006, PLOS GENET, V2, P2116, DOI 10.1371/journal.pgen.0020216; Beckmann JS, 2007, NAT REV GENET, V8, P639, DOI 10.1038/nrg2149; Berger AH, 2011, J PATHOL, V223, P137, DOI 10.1002/path.2800; Bhartiya D, 2012, EXPERT OPIN DRUG DIS, V7, P503, DOI 10.1517/17460441.2012.682055; Bione S, 1998, AM J HUM GENET, V62, P533, DOI 10.1086/301761; Birchler JA, 2012, P NATL ACAD SCI USA, V109, P14746, DOI 10.1073/pnas.1207726109; Bodine PVN, 2004, MOL ENDOCRINOL, V18, P1222, DOI 10.1210/me.2003-0498; Bottcher Y, 2006, J CLIN ENDOCR METAB, V91, P4948, DOI 10.1210/jc.2006-0540; BURGOYNE PS, 1989, NATURE, V342, P860, DOI 10.1038/342860a0; Carmona-Mora P, 2010, CURR GENOMICS, V11, P607, DOI 10.2174/138920210793360952; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chao W, 2008, CYTOKINE GROWTH F R, V19, P111, DOI 10.1016/j.cytogfr.2008.01.005; Chen LA, 2010, J BONE MINER RES, V25, P2447, DOI 10.1002/jbmr.133; Cheng HW, 2003, J BONE JOINT SURG AM, V85A, P1544, DOI 10.2106/00004623-200308000-00017; Christiansen J, 2009, J MOL ENDOCRINOL, V43, P187, DOI 10.1677/JME-09-0016; Clement-Jones M, 2000, HUM MOL GENET, V9, P695, DOI 10.1093/hmg/9.5.695; Cox MP, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-485; DENNY P, 1992, EMBO J, V11, P3705, DOI 10.1002/j.1460-2075.1992.tb05455.x; Di Cunto F, 2013, MOL PATHWAYS SYNDROM; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Du KY, 2003, SCIENCE, V300, P1574, DOI 10.1126/science.1079817; Edelman EA, 2007, CLIN GENET, V71, P540, DOI 10.1111/j.1399-0004.2007.00815.x; Ellison JW, 1997, HUM MOL GENET, V6, P1341, DOI 10.1093/hmg/6.8.1341; EWART AK, 1993, NAT GENET, V5, P11, DOI 10.1038/ng0993-11; Farooque A, 2012, PEDIAT BLOOD CANC; Feuk L, 2006, NAT REV GENET, V7, P85, DOI 10.1038/nrg1767; FISHER EMC, 1990, CELL, V63, P1205, DOI 10.1016/0092-8674(90)90416-C; Gaur T, 2006, J CELL PHYSIOL, V208, P87, DOI 10.1002/jcp.20637; Gerstenfeld Louis C, 2004, Expert Opin Drug Saf, V3, P131, DOI 10.1517/14740338.3.2.131; Goldacre MJ, 2014, ARCH DIS CHILD, V99, P71, DOI 10.1136/archdischild-2013-304617; Gravholt CH, 1999, CLIN ENDOCRINOL, V50, P791; Gravholt CH, 2001, AM J PHYSIOL-ENDOC M, V280, pE308, DOI 10.1152/ajpendo.2001.280.2.E308; Groeneveld EHJ, 2000, EUR J ENDOCRINOL, V142, P9, DOI 10.1530/eje.0.1420009; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kaushik K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083616; Kelkar A, 2010, EPIGENETICS-US, V5, P612, DOI 10.4161/epi.5.7.12797; Lefebvre W, 2002, J BONE MINER METAB, V20, P121, DOI 10.1007/s007740200017; Li CM, 2006, BMC MED GENET, V7, DOI 10.1186/1471-2350-7-24; Li W, 2012, HUM MOL GENET, V21, P32, DOI 10.1093/hmg/ddr435; Liu ZY, 2011, ASIAN PAC J CANCER P, V12, P2819; Lleo A, 2012, AUTOIMMUN REV, V11, pA538, DOI 10.1016/j.autrev.2011.11.015; Lockstone HE, 2007, GENOMICS, V90, P647, DOI 10.1016/j.ygeno.2007.08.005; Lohse M, 2012, NUCLEIC ACIDS RES, V40, pW622, DOI 10.1093/nar/gks540; Luo CW, 2005, ENDOCRINOLOGY, V146, P469, DOI 10.1210/en.2004-1197; Luo CW, 2004, MOL ENDOCRINOL, V18, P2085, DOI 10.1210/me.2004-0066; Maes C, 2006, J CLIN INVEST, V116, P1230, DOI 10.1172/JCI26772; Marrony S, 2003, BONE, V33, P426, DOI 10.1016/S8756-3282(03)00195-9; McCoy RJ, 2013, STEM CELLS, V31, P2420, DOI 10.1002/stem.1482; Meyre D, 2005, NAT GENET, V37, P863, DOI 10.1038/ng1604; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Myers LK, 2006, BONE, V39, P1048, DOI 10.1016/j.bone.2006.05.015; Obermann-Borst SA, 2011, EUR J CLIN INVEST, V41, P143, DOI 10.1111/j.1365-2362.2010.02388.x; Ogata T, 2001, J MED GENET, V38, P1, DOI 10.1136/jmg.38.1.1; Pacilli A, 2013, INT J MOL SCI, V14, P14923, DOI 10.3390/ijms140714923; Pan JA, 2010, ONCOL REP, V24, P105, DOI 10.3892/or_00000834; Rajpathak SN, 2013, CURR PHARM DES; Rodriguez S, 2006, EUR J HUM GENET, V14, P109, DOI 10.1038/sj.ejhg.5201505; Rovet J, 2004, LEARNING DISABILITIE, V19, P133, DOI DOI 10.1111/J.1540-5826.2004.00097.X; Samur MK, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-672; Schoemaker MJ, 2008, LANCET ONCOL, V9, P239, DOI 10.1016/S1470-2045(08)70033-0; Simms D., 1993, FOCUS, V15, P532, DOI DOI 10.1016/0003-267061)80041-X; Sybert VP, 2004, NEW ENGL J MED, V351, P1227, DOI 10.1056/NEJMra030360; Tanaka R, 2000, GENES CELLS, V5, P277, DOI 10.1046/j.1365-2443.2000.00325.x; Tang Y, 2004, ANN NEUROL, V56, P808, DOI 10.1002/ana.20291; Temple CM, 1996, DEV NEUROPSYCHOL, V12, P343, DOI 10.1080/87565649609540657; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Urbach A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004175; Valtorta E, 2013, INT J CANC; Vawter MP, 2007, AM J MED GENET B, V144B, P728, DOI 10.1002/ajmg.b.30454; Visser JA, 2013, HUM REPROD, V28, P1899, DOI 10.1093/humrep/det089; Xu MF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080374; Zhang R, 2013, BMC GENOMICS, V14, P1; Zinn AR, 1998, CURR OPIN GENET DEV, V8, P322, DOI 10.1016/S0959-437X(98)80089-0	80	34	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100076	10.1371/journal.pone.0100076	http://dx.doi.org/10.1371/journal.pone.0100076			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932682	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600090
J	Roger, M; Biaso, F; Castelle, CJ; Bauzan, M; Chaspoul, F; Lojou, E; Sciara, G; Caffarri, S; Giudici-Orticoni, MT; Ilbert, M				Roger, Magali; Biaso, Frederic; Castelle, Cindy J.; Bauzan, Marielle; Chaspoul, Florence; Lojou, Elisabeth; Sciara, Giuliano; Caffarri, Stefano; Giudici-Orticoni, Marie-Therese; Ilbert, Marianne			Spectroscopic Characterization of a Green Copper Site in a Single-Domain Cupredoxin	PLOS ONE			English	Article							CONTAINING NITRITE REDUCTASE; EXTREME ACIDIC CONDITIONS; CYTOCHROME-C-OXIDASE; THIOBACILLUS-FERROOXIDANS; ACIDITHIOBACILLUS-FERROOXIDANS; SUPRAMOLECULAR ORGANIZATION; ACHROMOBACTER-CYCLOCLASTES; NITROSOMONAS-EUROPAEA; ELECTRONIC-STRUCTURE; CRYSTAL-STRUCTURES	Cupredoxins are widespread copper-binding proteins, mainly involved in electron transfer pathways. They display a typical rigid greek key motif consisting of an eight stranded beta-sandwich. A fascinating feature of cupredoxins is the natural diversity of their copper center geometry. These geometry variations give rise to drastic changes in their color, such as blue, green, red or purple. Based on several spectroscopic and structural analyses, a connection between the geometry of their copper-binding site and their color has been proposed. However, little is known about the relationship between such diversity of copper center geometry in cupredoxins and possible implications for function. This has been difficult to assess, as only a few naturally occurring green and red copper sites have been described so far. We report herein the spectrocopic characterization of a novel kind of single domain cupredoxin of green color, involved in a respiratory pathway of the acidophilic organism Acidithiobacillus ferrooxidans. Biochemical and spectroscopic characterization coupled to bioinformatics analysis reveal the existence of some unusual features for this novel member of the green cupredoxin sub-family. This protein has the highest redox potential reported to date for a green-type cupredoxin. It has a constrained green copper site insensitive to pH or temperature variations. It is a green-type cupredoxin found for the first time in a respiratory pathway. These unique properties might be explained by a region of unknown function never found in other cupredoxins, and by an unusual length of the loop between the second and the fourth copper ligands. These discoveries will impact our knowledge on non-engineered green copper sites, whose involvement in respiratory chains seems more widespread than initially thought.	[Roger, Magali; Biaso, Frederic; Lojou, Elisabeth; Sciara, Giuliano; Giudici-Orticoni, Marie-Therese; Ilbert, Marianne] Aix Marseille Univ, Inst Microbiol Mediterranee, Unite Bioenerget & Ingn Prot, CNRS,UMR7281, Marseille, France; [Castelle, Cindy J.] Univ Calif Berkeley, Dept Earth & Planetary Sci, Berkeley, CA 94720 USA; [Bauzan, Marielle] Aix Marseille Univ, Inst Microbiol Mediterranee, Unite Fermentat, CNRS,FR 3479, Marseille, France; [Chaspoul, Florence] Aix Marseille Univ, Fac Pharm, Unite Chim Phys Prevent Risques & Nuisances Techn, CNRS,UMR 7263, Marseille, France; [Caffarri, Stefano] Aix Marseille Univ, CEA, Unite Biol Vegetale & Microbiol Environm, CNRS,UMR 7265, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; University of California System; University of California Berkeley; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite; Institut de Recherche pour le Developpement (IRD); CEA; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Aix-Marseille Universite	Ilbert, M (corresponding author), Aix Marseille Univ, Inst Microbiol Mediterranee, Unite Bioenerget & Ingn Prot, CNRS,UMR7281, Marseille, France.	milbert@imm.cnrs.fr	Caffarri, Stefano/AAX-8913-2021; Ilbert, marianne/ABG-5015-2021; sciara, giuliano/AAL-4478-2020	Caffarri, Stefano/0000-0002-4729-7679; Roger, Magali/0000-0001-9696-2762; Castelle, Cindy/0000-0002-0751-9804; ilbert, marianne/0000-0002-9070-2334	National French Network for EPR equipments ("Tres Grands Equipements pour la Resonance Paramagnetique Electronique''); Agence Nationale de la Recherche, Bioenergie, Centre Nationale de la Recherche Scientifique - Aix-Marseille Universitee; French Ministry of Research (Ministere de l'Enseignement Superieur et de la Recherche)	National French Network for EPR equipments ("Tres Grands Equipements pour la Resonance Paramagnetique Electronique''); Agence Nationale de la Recherche, Bioenergie, Centre Nationale de la Recherche Scientifique - Aix-Marseille Universitee(French National Research Agency (ANR)); French Ministry of Research (Ministere de l'Enseignement Superieur et de la Recherche)(Ministry of Research, France)	Financial support from the National French Network for EPR equipments ("Tres Grands Equipements pour la Resonance Paramagnetique Electronique'') for conducting the research is gratefully acknowledged. Additional funding was provided by Agence Nationale de la Recherche, Bioenergie, Centre Nationale de la Recherche Scientifique - Aix-Marseille Universitee. Magali Roger has a fellowship of the French Ministry of Research (Ministere de l'Enseignement Superieur et de la Recherche). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADMAN ET, 1995, J BIOL CHEM, V270, P27458, DOI 10.1074/jbc.270.46.27458; ADMAN ET, 1991, ADV PROTEIN CHEM, V42, P145; Alcaraz LA, 2007, BIOINORG CHEM APPL, V2007, DOI 10.1155/2007/54232; Arciero DM, 2002, BIOCHEMISTRY-US, V41, P1703, DOI 10.1021/bi015908w; Arnesano F, 2003, P NATL ACAD SCI USA, V100, P3814, DOI 10.1073/pnas.0636904100; Arnesano F, 2002, STRUCTURE, V10, P1337, DOI 10.1016/S0969-2126(02)00858-4; Basumallick L, 2005, J AM CHEM SOC, V127, P3531, DOI 10.1021/ja044412+; Berry SM, 2010, J INORG BIOCHEM, V104, P1071, DOI 10.1016/j.jinorgbio.2010.06.004; Bertini I, 2010, COORDIN CHEM REV, V254, P506, DOI 10.1016/j.ccr.2009.07.024; Botuyan MV, 1996, J MOL BIOL, V263, P752, DOI 10.1006/jmbi.1996.0613; Carrell CJ, 2007, BIOCHEMISTRY-US, V46, P1900, DOI 10.1021/bi0619674; Castelle C, 2008, J BIOL CHEM, V283, P25803, DOI 10.1074/jbc.M802496200; Castelle C, 2010, J BIOL CHEM, V285, P21519, DOI 10.1074/jbc.M110.131359; Li C, 2006, P NATL ACAD SCI USA, V103, P7258, DOI 10.1073/pnas.0600774103; Choi M, 2011, METALLOMICS, V3, P140, DOI 10.1039/c0mt00061b; Clark KM, 2010, J AM CHEM SOC, V132, P10093, DOI 10.1021/ja102632p; Deligeer, 2002, J INORG BIOCHEM, V91, P132, DOI 10.1016/S0162-0134(02)00442-7; Dennison C, 2005, COORDIN CHEM REV, V249, P3025, DOI 10.1016/j.ccr.2005.04.021; Dennison C, 2005, DALTON T, P3436, DOI 10.1039/b507440c; Donaire A, 2002, J AM CHEM SOC, V124, P13698, DOI 10.1021/ja0267019; Farver O, 2011, COORDIN CHEM REV, V255, P757, DOI 10.1016/j.ccr.2010.08.005; Fu Y, 2013, NAT CHEM BIOL, V9, P177, DOI [10.1038/NCHEMBIO.1168, 10.1038/nchembio.1168]; Ghosh S, 2009, P NATL ACAD SCI USA, V106, P4969, DOI 10.1073/pnas.0900995106; Gough J, 2004, STRUCTURE, V12, P917, DOI 10.1016/j.str.2004.03.029; GROSSMANN JG, 1995, BIOCHEMISTRY-US, V34, P8406, DOI 10.1021/bi00026a023; Hay M, 1996, P NATL ACAD SCI USA, V93, P461, DOI 10.1073/pnas.93.1.461; Ilbert M, 2013, BBA-BIOENERGETICS, V1827, P161, DOI 10.1016/j.bbabio.2012.10.001; INGLEDEW WJ, 1982, BIOCHIM BIOPHYS ACTA, V683, P89, DOI 10.1016/0304-4173(82)90007-6; Jimenez B, 2003, BIOCHEMISTRY-US, V42, P10396, DOI 10.1021/bi034692q; Jones LH, 2003, J BIOL CHEM, V278, P47269, DOI 10.1074/jbc.M308863200; Kanbi LD, 2002, J MOL BIOL, V320, P263, DOI 10.1016/S0022-2836(02)00443-6; Kataoka K, 2003, BIOCHEM BIOPH RES CO, V303, P519, DOI 10.1016/S0006-291X(03)00381-4; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; King JD, 2013, BIOCHEMISTRY-US, V52, P8267, DOI 10.1021/bi401163g; Kosman DJ, 2010, J BIOL INORG CHEM, V15, P15, DOI 10.1007/s00775-009-0590-9; Kroes SJ, 1996, EUR J BIOCHEM, V240, P342, DOI 10.1111/j.1432-1033.1996.0342h.x; LaCroix LB, 1996, J AM CHEM SOC, V118, P7755, DOI 10.1021/ja961217p; Li H, 2004, J AM CHEM SOC, V126, P8010, DOI 10.1021/ja049345y; Libeu CAP, 1997, BIOCHEMISTRY-US, V36, P13160, DOI 10.1021/bi9704111; Lieberman RL, 2001, BIOCHEMISTRY-US, V40, P5674, DOI 10.1021/bi0102611; Machonkin TE, 1998, BIOCHEMISTRY-US, V37, P9570, DOI 10.1021/bi980434v; Malarte G, 2005, BIOCHEMISTRY-US, V44, P6471, DOI 10.1021/bi048425b; Marshall NM, 2009, NATURE, V462, P113, DOI 10.1038/nature08551; Nersissian AM, 1998, PROTEIN SCI, V7, P1915, DOI 10.1002/pro.5560070907; NUNZI F, 1994, BIOCHEM BIOPH RES CO, V203, P1655, DOI 10.1006/bbrc.1994.2376; Olesen K, 1998, BIOCHEMISTRY-US, V37, P6086, DOI 10.1021/bi971603z; PEISACH J, 1974, ARCH BIOCHEM BIOPHYS, V165, P691, DOI 10.1016/0003-9861(74)90298-7; Pereira MM, 2001, BBA-BIOENERGETICS, V1505, P185, DOI 10.1016/S0005-2728(01)00169-4; Pierloot K, 1998, J AM CHEM SOC, V120, P13156, DOI 10.1021/ja982385f; Roger M, 2014, ANAL BIOANAL CHEM, V406, P1011, DOI 10.1007/s00216-013-7465-1; Roger M, 2012, BIOCHEM SOC T, V40, P1324, DOI 10.1042/BST20120141; Ryde U, 1996, J MOL BIOL, V261, P586, DOI 10.1006/jmbi.1996.0484; RYDEN LG, 1993, J MOL EVOL, V36, P41, DOI 10.1007/BF02407305; Sato K, 2009, P NATL ACAD SCI USA, V106, P5616, DOI 10.1073/pnas.0811324106; Solomon EI, 2006, INORG CHEM, V45, P8012, DOI 10.1021/ic060450d; Solomon EI, 2011, COORDIN CHEM REV, V255, P774, DOI 10.1016/j.ccr.2010.12.008; Solomon EI, 2004, CHEM REV, V104, P419, DOI 10.1021/cr0206317; Stoll S, 2006, J MAGN RESON, V178, P42, DOI 10.1016/j.jmr.2005.08.013; Suzuki S, 1999, J BIOL INORG CHEM, V4, P749, DOI 10.1007/s007750050347; Vila AJ, 2001, HANDBOOK ON METALLOPROTEINS, P813; Worrall JAR, 2006, J AM CHEM SOC, V128, P14579, DOI 10.1021/ja064112n; Xie XJ, 2009, J INORG BIOCHEM, V103, P1307, DOI 10.1016/j.jinorgbio.2009.04.012; Yamaguchi K, 2004, BIOCHEMISTRY-US, V43, P14180, DOI 10.1021/bi0492657; Zhang L, 2006, J AM CHEM SOC, V128, P5834, DOI 10.1021/ja058528x	64	23	23	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98941	10.1371/journal.pone.0098941	http://dx.doi.org/10.1371/journal.pone.0098941			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932914	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600016
J	Smelt, AFH; Louter, MA; Kies, DA; Blom, JW; Terwindt, GM; van der Heijden, GJMG; De Gucht, V; Ferrari, MD; Assendelft, WJJ				Smelt, Antonia F. H.; Louter, Mark A.; Kies, Dennis A.; Blom, Jeanet W.; Terwindt, Gisela M.; van der Heijden, Geert J. M. G.; De Gucht, Veronique; Ferrari, Michel D.; Assendelft, Willem J. J.			What Do Patients Consider to Be the Most Important Outcomes for Effectiveness Studies on Migraine Treatment? Results of a Delphi Study	PLOS ONE			English	Article							QUESTIONNAIRE; GUIDELINES	Background: The outcome measures most frequently used in studies on the effectiveness of migraine treatment are whether the patient is free of pain, nausea, and free of photophobia/phonophobia within two hours. However, no patient-centred outcome measures are available. Therefore, we performed an online Delphi procedure to compile a list of outcome measures deemed most important to migraine patients. Methods: From a large database of migraine patients, we randomly selected 150 males and 150 females patients. We asked the open-ended question: 'If a new medicine was developed for migraine attacks, what would you wish the effect of this medication to be?' In the second and third rounds, we presented the answers of the first round and asked the patients to rate the importance of each item. Results: The initial response rate was 56% (n = 169). In the subsequent rounds the response rates were 90% (n = 152), and 97% (n = 147), respectively. Patients wanted their attack medication to treat the headache within 30 min, to prevent the attack from getting worse, to ensure they could function properly within 1 h, and prevent the recurrence of symptoms during the same day. Conclusions: The currently used outcome measures in migraine research do not sufficiently reflect the wishes of patients. Patients want the medication to work faster, to take away pain at an earlier stage, to make them able to function properly quickly, and to prevent recurrence. These aspects should be considered in future evaluation of new attack medication for migraine.	[Smelt, Antonia F. H.; Blom, Jeanet W.; Assendelft, Willem J. J.] Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands; [Louter, Mark A.; Kies, Dennis A.; Terwindt, Gisela M.; Ferrari, Michel D.] Leiden Univ, Med Ctr, Dept Neurol, Leiden, Netherlands; [Louter, Mark A.] Leiden Univ, Med Ctr, Dept Psychiat, Leiden, Netherlands; [van der Heijden, Geert J. M. G.] VU Amsterdam Univ, Acad Ctr Dent Amsterdam, Dept Social Dent, Amsterdam, Netherlands; [van der Heijden, Geert J. M. G.] Univ Amsterdam, Amsterdam, Netherlands; [De Gucht, Veronique] Leiden Univ, Dept Psychol, Leiden, Netherlands; [Assendelft, Willem J. J.] Radboud Univ Nijmegen, Med Ctr, Dept Primary & Community Care, NL-6525 ED Nijmegen, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Academic Center for Dentistry Amsterdam; Vrije Universiteit Amsterdam; University of Amsterdam; Leiden University; Leiden University - Excl LUMC; Radboud University Nijmegen	Smelt, AFH (corresponding author), Leiden Univ, Med Ctr, Dept Publ Hlth & Primary Care, Leiden, Netherlands.	a.f.h.smelt@lumc.nl	Assendelft, W.J.J./H-8008-2014; Louter, Mark/N-6855-2017; assendelft, willem/AAW-1854-2021; Ferrari, Michel D./ABE-3758-2021; van der Heijden, Geert/M-3733-2013	Assendelft, W.J.J./0000-0002-2966-3778; assendelft, willem/0000-0002-2966-3778; Ferrari, Michel D./0000-0001-9691-9449; van der Heijden, Geert/0000-0003-4979-2099; De Gucht, Veronique/0000-0001-5155-0983				Bes A, 2013, CEPHALALGIA, V33, P629, DOI 10.1177/0333102413485658; Bigal M, 2007, HEADACHE, V47, P475, DOI 10.1111/j.1526-4610.2007.00752.x; Coon CD, 2012, HEADACHE, V52, P550, DOI 10.1111/j.1526-4610.2012.02099.x; Hamelsky SW, 2005, CEPHALALGIA, V25, P87, DOI 10.1111/j.1468-2982.2005.00797.x; Hasson F, 2000, J ADV NURS, V32, P1008, DOI 10.1046/j.1365-2648.2000.01567.x; JONES J, 1995, BRIT MED J, V311, P376, DOI 10.1136/bmj.311.7001.376; Kirwan JR, 2007, J RHEUMATOL, V34, P1174; Lipton RB, 2002, HEADACHE, V42, pS3, DOI 10.1046/j.1526-4610.2002.0420s1003.x; Lipton RB., 1999, HEADACHE, V39, pS20, DOI [10.1111/j.1526-4610.1999.00006.x, DOI 10.1111/J.1526-4610.1999.00006.X]; Selby JV, 2012, JAMA-J AM MED ASSOC, V307, P1583, DOI 10.1001/jama.2012.500; Tfelt-Hansen P, 2012, CEPHALALGIA, V32, P6, DOI 10.1177/0333102411417901; van der Heijden GJMG, 2000, J CLIN EPIDEMIOL, V53, P29, DOI 10.1016/S0895-4356(99)00078-5; van Oosterhout WPJ, 2011, CEPHALALGIA, V31, P1359, DOI 10.1177/0333102411418846	13	39	40	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98933	10.1371/journal.pone.0098933	http://dx.doi.org/10.1371/journal.pone.0098933			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932784	Green Published, gold			2022-12-27	WOS:000337738600015
J	Daniels, J; Komarek, A; Makusha, T; Van Heerden, A; Gray, G; Chingono, A; Mbwambo, JKK; Coates, T; Richter, L				Daniels, Joseph; Komarek, Arnost; Makusha, Tawanda; Van Heerden, Alastair; Gray, Glenda; Chingono, Alfred; Mbwambo, Jessie K. K.; Coates, Thomas; Richter, Linda			Effects of a Community Intervention on HIV Prevention Behaviors among Men Who Experienced Childhood Sexual or Physical Abuse in Four African Settings: Findings from NIMH Project Accept (HPTN 043)	PLOS ONE			English	Article							SUB-SAHARAN AFRICA; RISK BEHAVIOR; POSITIVE ADULTS; HISTORY; PEOPLE; METAANALYSIS; HIV/AIDS; VIOLENCE	Background: There is increased focus on HIV prevention with African men who report experiencing childhood sexual (CSA) or physical abuse (CPA). Objective: To better understand the effects of a community-based intervention (Project Accept HPTN 043) on HIV prevention behaviors among men who report CSA or CPA experiences. Methods: Project Accept compared a community-based voluntary mobile counseling and testing (CBVCT) intervention with standard VCT. The intervention employed individual HIV risk reduction planning with motivational interviewing in 34 African communities (16 communities at 2 sites in South Africa, 10 in Tanzania, and 8 in Zimbabwe). Communities were randomized unblinded in matched pairs to CBVCT or SVCT, delivered over 36 months. The post-intervention assessment was conducted using a single, cross-sectional random survey of 18-32 year-old community members (total N = 43,292). We analyzed the effect of the intervention on men with reported CSA or CPA across the African sites. Men were identified with a survey question asking about having experienced CSA or CPA across the lifespan. The effect of intervention on considered outcomes of the preventive behavior was statistically evaluated using the logistic regression models. Results: Across the sites, the rates of CSA or CPA among men indicated that African men reflected the global prevalence (20%) with a range of 13-24%. The statistically significant effect of the intervention among these men was seen in their increased effort to receive their HIV test results (OR 2.71; CI: (1.08, 6.82); P: 0.034). The intervention effect on the other designated HIV prevention behaviors was less pronounced. Conclusion: The effect of the intervention on these men showed increased motivation to receive their HIV test results. However, more research is needed to understand the effects of community-based interventions on this group, and such interventions need to integrate other keys predictors of HIV including trauma, coping strategies, and intimate partner violence.	[Daniels, Joseph; Coates, Thomas] Univ Calif Los Angeles, UCLA Ctr World Hlth, Los Angeles, CA 90095 USA; [Komarek, Arnost] Charles Univ Prague, Fac Math & Phys, Prague, Czech Republic; [Makusha, Tawanda; Van Heerden, Alastair; Richter, Linda] Human Sci Res Council, Durban, South Africa; [Gray, Glenda] Univ Witwatersrand, Chris Hani Baragwanath Hosp, Fac Hlth Sci, Perinatal HIV Res Unit, Soweto, South Africa; [Chingono, Alfred] Univ Zimbabwe, Coll Hlth Sci, Harare, Zimbabwe; [Mbwambo, Jessie K. K.] Muhimbili Univ, Teaching Hosp, Muhimbili Univ Hlth & Allied Sci, Dar Es Salaam, Tanzania; [Richter, Linda] Univ Witwatersrand, Dev Pathways Hlth Res Unit, Johannesburg, South Africa	University of California System; University of California Los Angeles; Charles University Prague; Human Sciences Research Council-South Africa; University of Witwatersrand; University of Zimbabwe; Muhimbili University of Health & Allied Sciences; University of Witwatersrand	Daniels, J (corresponding author), Univ Calif Los Angeles, UCLA Ctr World Hlth, Los Angeles, CA 90095 USA.	jdaniels@mednet.ucla.edu	Komarek, Arnost/A-5534-2012; Van Heerden, Alastair/AAY-6262-2020; Makusha, Tawanda/AAE-5356-2022	Komarek, Arnost/0000-0001-8778-3762; Van Heerden, Alastair/0000-0003-2530-6885; Makusha, Tawanda/0000-0003-2120-8989	U.S. National Institute of Mental Health through (Johns Hopkins University - David Celentano, PI) [U01MH066687]; Medical University of South Carolina - Michael Sweat, PI [U01MH066688]; University of California Los Angeles - Thomas J. Coates, PI [U01MH066701]; University of California San Francisco - Stephen F. Morin, PI [U01MH066702]; HPTN Protocol 043 through HPTN Network Laboratory - Susan Eshleman, PI [U01AI068613/UM1AI068613]; SCHARP - Deborah Donnell, PI [U01AI068617/UM1AI068617]; Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases [U01AI068619/UM1AI068619]; Office of AIDS Research of the U. S. National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069453, U01AI068617, U01AI068613, U01AI068619, UM1AI069453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [U01MH066688, U01MH066687, U01MH066701, U01MH066702] Funding Source: NIH RePORTER	U.S. National Institute of Mental Health through (Johns Hopkins University - David Celentano, PI); Medical University of South Carolina - Michael Sweat, PI; University of California Los Angeles - Thomas J. Coates, PI; University of California San Francisco - Stephen F. Morin, PI; HPTN Protocol 043 through HPTN Network Laboratory - Susan Eshleman, PI; SCHARP - Deborah Donnell, PI; Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Office of AIDS Research of the U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was sponsored by the U.S. National Institute of Mental Health as a cooperative agreement, through contracts U01MH066687 (Johns Hopkins University - David Celentano, PI); U01MH066688 (Medical University of South Carolina - Michael Sweat, PI); U01MH066701 (University of California Los Angeles - Thomas J. Coates, PI); and U01MH066702 (University of California San Francisco - Stephen F. Morin, PI). In addition, this work was supported as HPTN Protocol 043 through contracts U01AI068613/UM1AI068613 (HPTN Network Laboratory - Susan Eshleman, PI); U01AI068617/UM1AI068617 (SCHARP - Deborah Donnell, PI); and U01AI068619/UM1AI068619 (HIV Prevention Trials Network - Sten Vermund/Wafaa El-Sadr, PIs) of the Division of AIDS of the U.S. National Institute of Allergy and Infectious Diseases; and by the Office of AIDS Research of the U. S. National Institutes of Health. Views expressed are those of the authors, and not necessarily those of sponsoring agencies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arriola KRJ, 2005, CHILD ABUSE NEGLECT, V29, P725, DOI 10.1016/j.chiabu.2004.10.014; Coates TJ, 2014, LANCET GLOB HEALTH, V2, pE267, DOI 10.1016/S2214-109X(14)70032-4; Core Team, 2013, R LANG ENV STAT COMP; Dunkle KL, 2006, AIDS, V20, P2107, DOI 10.1097/01.aids.0000247582.00826.52; Genberg BL, 2008, JAIDS-J ACQ IMM DEF, V49, P309, DOI 10.1097/QAI.0b013e3181893ed0; Hunter M, 2010, HEALTH PLACE, V16, P25, DOI 10.1016/j.healthplace.2009.08.003; Jewkes R., 2009, UNDERSTANDING MENS H; Jones DJ, 2010, J CLIN CHILD ADOLESC, V39, P667, DOI 10.1080/15374416.2010.501286; Khumalo-Sakutukwa G, 2008, JAIDS-J ACQ IMM DEF, V49, P422, DOI 10.1097/QAI.0b013e31818a6cb5; Laeyendecker O, 2013, PLOS ONE, V8; O'Donnell L, 2009, AIDS EDUC PREV, V21, P299, DOI 10.1521/aeap.2009.21.4.299; Parillo KM, 2001, CHILD ABUSE NEGLECT, V25, P335, DOI 10.1016/S0145-2134(00)00253-2; Persons E, 2010, AIDS PATIENT CARE ST, V24, P571, DOI 10.1089/apc.2009.0209; Posel D, 2013, AFRICAN STUDIES REV; Posel D, 2013, APPL ECON, V45, P663, DOI 10.1080/00036846.2011.610749; Richter L, 2014, AIDS BEHAV, V18, P381, DOI 10.1007/s10461-013-0439-7; Sikkema KJ, 2013, J CONSULT CLIN PSYCH, V81, P274, DOI 10.1037/a0030144; Sikkema KJ, 2009, ARCH SEX BEHAV, V38, P121, DOI 10.1007/s10508-007-9238-4; Stoltenborgh M, 2011, CHILD MALTREATMENT, V16, P79, DOI 10.1177/1077559511403920; Sweat M, 2011, LANCET INFECT DIS, V11, P525, DOI 10.1016/S1473-3099(11)70060-3; Sweet T, 2012, JAIDS-J ACQ IMM DEF, V59, P400, DOI 10.1097/QAI.0b013e3182400e75; van Rooyen H, 2013, AIDS BEHAV, V17, P2946, DOI 10.1007/s10461-012-0368-x; Williams JK, 2013, AM J PUBLIC HEALTH, V103, P1476, DOI 10.2105/AJPH.2012.301121	23	4	4	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99643	10.1371/journal.pone.0099643	http://dx.doi.org/10.1371/journal.pone.0099643			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2VQ	24926999	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100059
J	Krell, J; Frampton, AE; Mirnezami, R; Harding, V; De Giorgio, A; Alonso, LR; Cohen, P; Ottaviani, S; Colombo, T; Jacob, J; Pellegrino, L; Buchanan, G; Stebbing, J; Castellano, L				Krell, Jonathan; Frampton, Adam E.; Mirnezami, Reza; Harding, Victoria; De Giorgio, Alex; Alonso, Laura Roca; Cohen, Patrizia; Ottaviani, Silvia; Colombo, Teresa; Jacob, Jimmy; Pellegrino, Loredana; Buchanan, Gordon; Stebbing, Justin; Castellano, Leandro			Growth Arrest-Specific Transcript 5 Associated snoRNA Levels Are Related to p53 Expression and DNA Damage in Colorectal Cancer	PLOS ONE			English	Article							SMALL-NUCLEOLAR RNAS; HOST GENES; CELL-LINES; PROGNOSTIC-FACTOR; PROSTATE-CANCER; NONCODING RNAS; BREAST-CANCER; GROWTH-ARREST; GAS5; BIOGENESIS	Background: The growth arrest-specific transcript 5 gene (GAS5) encodes a long noncoding RNA (lncRNA) and hosts a number of small nucleolar RNAs (snoRNAs) that have recently been implicated in multiple cellular processes and cancer. Here, we investigate the relationship between DNA damage, p53, and the GAS5 snoRNAs to gain further insight into the potential role of this locus in cell survival and oncogenesis both in vivo and in vitro. Methods: We used quantitative techniques to analyse the effect of DNA damage on GAS5 snoRNA expression and to assess the relationship between p53 and the GAS5 snoRNAs in cancer cell lines and in normal, pre-malignant, and malignant human colorectal tissue and used biological techniques to suggest potential roles for these snoRNAs in the DNA damage response. Results: GAS5-derived snoRNA expression was induced by DNA damage in a p53-dependent manner in colorectal cancer cell lines and their levels were not affected by DICER. Furthermore, p53 levels strongly correlated with GAS5-derived snoRNA expression in colorectal tissue. Conclusions: In aggregate, these data suggest that the GAS5-derived snoRNAs are under control of p53 and that they have an important role in mediating the p53 response to DNA damage, which may not relate to their function in the ribosome. We suggest that these snoRNAs are not processed by DICER to form smaller snoRNA-derived RNAs with microRNA (miRNA)-like functions, but their precise role requires further evaluation. Furthermore, since GAS5 host snoRNAs are often used as endogenous controls in qPCR quantifications we show that their use as housekeeping genes in DNA damage experiments can lead to inaccurate results.	[Krell, Jonathan; Harding, Victoria; De Giorgio, Alex; Alonso, Laura Roca; Ottaviani, Silvia; Jacob, Jimmy; Pellegrino, Loredana; Castellano, Leandro] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Div Canc, Hammersmith Hosp, London, England; [Frampton, Adam E.] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, HPB Surg Unit, Hammersmith Hosp, London, England; [Mirnezami, Reza] Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, St Marys Hosp Campus, London, England; [Cohen, Patrizia] Hammersmith Hosp, Dept Histopathol, London W12 0HS, England; [Colombo, Teresa] CNR, Inst Comp Applicat Mauro Picone, Rome, Italy; [Buchanan, Gordon] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Colorectal Surg Unit, London, England; [Stebbing, Justin] Imperial Coll Healthcare NHS Trust, Charing Cross Hosp, Dept Oncol, London, England	Imperial College London; Imperial College London; Imperial College London; Imperial College London; Consiglio Nazionale delle Ricerche (CNR); Istituto per le Applicazioni del Calcolo "Mauro Picone" (IAC-CNR); Imperial College London; Imperial College London	Krell, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Surg & Canc, Div Canc, Hammersmith Hosp, London, England.	j.krell@imperial.ac.uk	Colombo, Teresa/P-2959-2018; Castellano, Leandro/AAE-1366-2021	Colombo, Teresa/0000-0003-2415-7507; Ottaviani, Silvia/0000-0002-8830-9947; Stebbing, Justin/0000-0002-1117-6947; Castellano, Leandro/0000-0002-3059-4829	Searle Memorial Charitable trust; Cancer Research UK [14549] Funding Source: researchfish; Medical Research Council [MR/L000172/1, G1100425] Funding Source: researchfish; National Institute for Health Research [NIHR-RP-011-053, CL-2013-21-012] Funding Source: researchfish; MRC [G1100425, MR/L000172/1] Funding Source: UKRI	Searle Memorial Charitable trust; Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors would like to thank The Searle Memorial (2005) Charitable trust, Michael and Lottie Hunter, Peter and Marilyn Cooper, Steve Mobbs and Pauline Thomas, and Denise and Edward Pincheson for their generous support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adrover E, 1999, BRIT J CANCER, V81, P122, DOI 10.1038/sj.bjc.6690660; Brameier M, 2011, NUCLEIC ACIDS RES, V39, P675, DOI 10.1093/nar/gkq776; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Castellano L, 2009, P NATL ACAD SCI USA, V106, P15732, DOI 10.1073/pnas.0906947106; Chang LS, 2002, BIOCHEM BIOPH RES CO, V299, P196, DOI 10.1016/S0006-291X(02)02623-2; Cummins JM, 2006, P NATL ACAD SCI USA, V103, P3687, DOI 10.1073/pnas.0511155103; Deisenroth Chad, 2011, Genes Cancer, V2, P392, DOI 10.1177/1947601911409737; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Dong XY, 2008, HUM MOL GENET, V17, P1031, DOI 10.1093/hmg/ddm375; Dong XY, 2009, J GENET GENOMICS, V36, P447, DOI 10.1016/S1673-8527(08)60134-4; Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017; Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4; Gee HE, 2011, BRIT J CANCER, V104, P1168, DOI 10.1038/sj.bjc.6606076; Henras AK, 2004, CURR OPIN STRUC BIOL, V14, P335, DOI 10.1016/j.sbi.2004.05.006; Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943; Kino T, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000568; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2; Kressner U, 1999, J CLIN ONCOL, V17, P593, DOI 10.1200/JCO.1999.17.2.593; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liao JP, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-198; Liu Y, 2006, P NATL ACAD SCI USA, V103, P976, DOI 10.1073/pnas.0510146103; Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124; Mei YP, 2012, ONCOGENE, V31, P2794, DOI 10.1038/onc.2011.449; Mourtada-Maarabouni M, 2009, ONCOGENE, V28, P195, DOI 10.1038/onc.2008.373; Mourtada-Maarabouni M, 2008, J CELL SCI, V121, P939, DOI 10.1242/jcs.024646; Muller AJ, 1998, MAMM GENOME, V9, P773, DOI 10.1007/s003359900862; Nikulenkov F, 2012, CELL DEATH DIFFER, V19, P1992, DOI 10.1038/cdd.2012.89; Pestov DG, 2001, MOL CELL BIOL, V21, P4246, DOI 10.1128/MCB.21.13.4246-4255.2001; Pickard MR, 2013, BBA-MOL BASIS DIS, V1832, P1613, DOI 10.1016/j.bbadis.2013.05.005; RODRIGUES NR, 1990, P NATL ACAD SCI USA, V87, P7555, DOI 10.1073/pnas.87.19.7555; Sarasqueta AF, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-277; Scott MS, 2011, BIOCHIMIE, V93, P1987, DOI 10.1016/j.biochi.2011.05.026; Scott MS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000507; Smith CM, 1998, MOL CELL BIOL, V18, P6897, DOI 10.1128/MCB.18.12.6897; Taft RJ, 2009, RNA, V15, P1233, DOI 10.1261/rna.1528909; Tycowski KT, 1996, NATURE, V379, P464, DOI 10.1038/379464a0; Tycowski KT, 2001, EUR J CELL BIOL, V80, P119, DOI 10.1078/0171-9335-00150; Williams GT, 2012, NAT REV CANCER, V12, P84, DOI 10.1038/nrc3195	39	63	69	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98561	10.1371/journal.pone.0098561	http://dx.doi.org/10.1371/journal.pone.0098561			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926850	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000338278100017
J	Chen, SW; Chao, SC				Chen, Szi-Wen; Chao, Shih-Chieh			A Reweighted l(1)-Minimization Based Compressed Sensing for the Spectral Estimation of Heart Rate Variability Using the Unevenly Sampled Data	PLOS ONE			English	Article							EFFICIENT ALGORITHM; RECONSTRUCTION; SIGNALS; MODEL	In this paper, a reweighted l(1)-minimization based Compressed Sensing (CS) algorithm incorporating the Integral Pulse Frequency Modulation (IPFM) model for spectral estimation of HRV is introduced. Knowing as a novel sensing/sampling paradigm, the theory of CS asserts certain signals that are considered sparse or compressible can be possibly reconstructed from substantially fewer measurements than those required by traditional methods. Our study aims to employ a novel reweighted l(1)-minimization CS method for deriving the spectrum of the modulating signal of IPFM model from incomplete RR measurements for HRV assessments. To evaluate the performance of HRV spectral estimation, a quantitative measure, referred to as the Percent Error Power (PEP) that measures the percentage of difference between the true spectrum and the spectrum derived from the incomplete RR dataset, was used. We studied the performance of spectral reconstruction from incomplete simulated and real HRV signals by experimentally truncating a number of RR data accordingly in the top portion, in the bottom portion, and in a random order from the original RR column vector. As a result, for up to 20% data truncation/loss the proposed reweighted l(1)-minimization CS method produced, on average, 2.34%, 2.27%, and 4.55% PEP in the top, bottom, and random data-truncation cases, respectively, on Autoregressive (AR) model derived simulated HRV signals. Similarly, for up to 20% data loss the proposed method produced 5.15%, 4.33%, and 0.39% PEP in the top, bottom, and random data-truncation cases, respectively, on a real HRV database drawn from PhysioNet. Moreover, results generated by a number of intensive numerical experiments all indicated that the reweighted l(1)-minimization CS method always achieved the most accurate and high-fidelity HRV spectral estimates in every aspect, compared with the,l(1)-minimization based method and Lomb's method used for estimating the spectrum of HRV from unevenly sampled RR data.	[Chen, Szi-Wen; Chao, Shih-Chieh] Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan; [Chen, Szi-Wen] Chang Gung Univ, HARC, Taoyuan, Taiwan	Chang Gung University; Chang Gung University	Chen, SW (corresponding author), Chang Gung Univ, Dept Elect Engn, Taoyuan, Taiwan.	chensw@mail.cgu.edu.tw		Chen, Szi-Wen/0000-0001-6171-0493	Taiwan National Science Council (NSC) [NSC 102-2221-E-182-023]	Taiwan National Science Council (NSC)(Ministry of Science and Technology, Taiwan)	This work was supported by the Taiwan National Science Council (NSC) under the Grant NSC 102-2221-E-182-023. The URL of Taiwan NSC is http://www.nsc.gov.tw. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AKSELROD S, 1981, SCIENCE, V213, P220, DOI 10.1126/science.6166045; Baraniuk RG, 2008, IEEE SIGNAL PROC MAG, V25, P12, DOI 10.1109/MSP.2008.915557; Baron D., 2005, P 43 ALL C COMM CONT; BERGER RD, 1986, IEEE T BIO-MED ENG, V33, P900, DOI 10.1109/TBME.1986.325789; Camm AJ, 1996, CIRCULATION, V93, P1043; Candes EJ, 2005, IEEE T INFORM THEORY, V51, P4203, DOI 10.1109/TIT.2005.858979; Candes EJ, 2008, IEEE SIGNAL PROC MAG, V25, P21, DOI 10.1109/MSP.2007.914731; Candes EJ, 2008, J FOURIER ANAL APPL, V14, P877, DOI 10.1007/s00041-008-9045-x; Chen F, 2005, P ANN INT IEEE EMBS, P936, DOI 10.1109/IEMBS.2005.1616569; Chen S-W, 2007, Journal of Medical Engineering & Technology, V31, P210, DOI 10.1080/03091900600747617; Chen SW, 2002, IEEE T BIO-MED ENG, V49, P736, DOI 10.1109/TBME.2002.1010859; Chen SW, 2006, COMPUT METH PROG BIO, V82, P187, DOI 10.1016/j.cmpb.2005.11.012; Chen SW, 2014, IEEE J BIOMED HEALTH, V18, P1081, DOI 10.1109/JBHI.2013.2282307; Chiu HW, 2001, IEEE ENG MED BIOL, V20, P69, DOI 10.1109/51.917726; Choi K, 2010, MED PHYS, V37, P5113, DOI 10.1118/1.3481510; DEBOER RW, 1985, MED BIOL ENG COMPUT, V23, P138, DOI 10.1007/BF02456750; Figueiredo MAT, 2007, IEEE J-STSP, V1, P586, DOI 10.1109/JSTSP.2007.910281; Goldberger AL, 2000, CIRCULATION, V101, pE215, DOI 10.1161/01.CIR.101.23.e215; Laguna P, 1998, IEEE T BIO-MED ENG, V45, P698, DOI 10.1109/10.678605; LOMB NR, 1976, ASTROPHYS SPACE SCI, V39, P447, DOI 10.1007/BF00648343; Lustig M, 2008, IEEE SIGNAL PROC MAG, V25, P72, DOI 10.1109/MSP.2007.914728; MALLIANI A, 1991, CIRCULATION, V84, P482, DOI 10.1161/01.CIR.84.2.482; Mateo J, 2003, IEEE T BIO-MED ENG, V50, P334, DOI 10.1109/TBME.2003.808831; Mateo J, 2000, IEEE T BIO-MED ENG, V47, P985, DOI 10.1109/10.855925; Mitov IP, 2001, MED BIOL ENG COMPUT, V39, P348, DOI 10.1007/BF02345290; MOODY GB, 1993, COMPUT CARDIOL, P715; Orini M, 2012, BIOMED SIGNAL PROCES, V7, P141, DOI 10.1016/j.bspc.2011.05.003; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; ROMPELMAN O, 1977, MED BIOL ENG COMPUT, V15, P233, DOI 10.1007/BF02441043; Solem K, 2006, IEEE T BIO-MED ENG, V53, P13, DOI 10.1109/TBME.2005.859780; Takhar D. etal, 2006, P COMP IM 4 SPIE EL; TENVOORDE BJ, 1994, MED BIOL ENG COMPUT, V32, P63, DOI 10.1007/BF02512480	32	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99098	10.1371/journal.pone.0099098	http://dx.doi.org/10.1371/journal.pone.0099098			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922059	Green Submitted, Green Published, gold			2022-12-27	WOS:000338701300028
J	Kaczmarek, J; Homsi, Y; van Uum, J; Metzger, C; Knolle, PA; Kolanus, W; Lang, T; Diehl, L				Kaczmarek, Julita; Homsi, Yahya; van Ueuem, Jan; Metzger, Christina; Knolle, Percy A.; Kolanus, Waldemar; Lang, Thorsten; Diehl, Linda			Liver Sinusoidal Endothelial Cell-Mediated CD8 T Cell Priming Depends on Co-Inhibitory Signal Integration over Time	PLOS ONE			English	Article							IMMUNOLOGICAL SYNAPSE; ACTIVATION; TOLERANCE; ANTIGEN; PHOSPHORYLATION; MICROCLUSTERS; IL-2	The initiation of adaptive immunity requires cell-to-cell contact between T cells and antigen-presenting cells. Together with immediate TCR signal transduction, the formation of an immune synapse (IS) is one of the earliest events detected during T cell activation. Here, we show that interaction of liver sinusoidal endothelial cells (LSEC) with naive CD8 T cells, which induces CD8 T cells without immediate effector function, is characterized by a multi-focal type IS. The co-inhibitory molecule B7H1, which is pivotal for the development of non-responsive LSEC-primed T cells, did not alter IS structure or TCR beta/CD11a cluster size or density, indicating that IS form does not determine the outcome of LSEC-mediated T cell activation. Instead, PD-1 signaling during CD8 T cell priming by LSEC repressed IL-2 production as well as sustained CD25 expression. When acting during the first 24 h of LSEC/CD8 T cell interaction, CD28 co-stimulation inhibited the induction of non-responsive LSEC-primed T cells. However, after more than 36 h of PD-1 signaling, CD28 co-stimulation failed to rescue effector function in LSEC-primed T cells. Together, these data show that during LSEC-mediated T cell priming, integration of co-inhibitory PD1 signaling over time turns on a program for CD8 T cell development, that cannot be overturned by co-stimulatory signals.	[Kaczmarek, Julita; Metzger, Christina; Diehl, Linda] Univ Bonn, LIMES Inst, Inst Mol Med, Bonn, Germany; [Homsi, Yahya; van Ueuem, Jan; Lang, Thorsten] Univ Bonn, LIMES Inst, Dept Membrane Biochem, Bonn, Germany; [Kolanus, Waldemar] Univ Bonn, LIMES Inst, Dept Mol Immunol, Bonn, Germany; [Knolle, Percy A.] Tech Univ Munich, Inst Mol Immunol, D-80290 Munich, Germany	University of Bonn; University of Bonn; University of Bonn; Technical University of Munich	Diehl, L (corresponding author), Univ Bonn, LIMES Inst, Inst Mol Med, Bonn, Germany.	linda.diehl@ukb.uni-bonn.de		Knolle, Percy A./0000-0003-2983-0414	grant of the german research council [CRC704]	grant of the german research council	This study was financially supported by a grant of the german research council (CRC704) to LD and TL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bottcher JP, 2013, CELL REPORTS, P1; Carter LL, 2002, EUR J IMMUNOL, V32, P634, DOI 10.1002/1521-4141(200203)32:3<634::AID-IMMU634>3.0.CO;2-9; Diehl L, 2008, HEPATOLOGY, V47, P296, DOI 10.1002/hep.21965; Dustin ML, 2009, COLD SPRING HARBOR P, V1; Feau S, 2011, NAT IMMUNOL, V12, P908, DOI 10.1038/ni.2079; Fisher PJ, 2008, BLOOD, V112, P5037, DOI 10.1182/blood-2008-04-149526; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Hailman E, 2002, IMMUNITY, V16, P839, DOI 10.1016/S1074-7613(02)00326-6; Kern M, 2010, GASTROENTEROLOGY, V138, P336, DOI 10.1053/j.gastro.2009.08.057; Knolle PA, 1999, YGAST, V116, P1428; Kruse N, 2009, HEPATOLOGY, V50, P1904, DOI 10.1002/hep.23191; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Macintyre AN, 2011, IMMUNITY, P1; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Okkenhaug K, 2003, NAT REV IMMUNOL, V3, P317, DOI 10.1038/nri1056; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Pentcheva-Hoang T, 2007, P NATL ACAD SCI USA, V104, P17765, DOI 10.1073/pnas.0708767104; Quast T, 2011, BLOOD, V118, P1818, DOI 10.1182/blood-2010-12-326595; Schurich A, 2010, J IMMUNOL, V184, P4107, DOI 10.4049/jimmunol.0902580; Sheppard KA, 2004, FEBS LETT, V574, P37, DOI 10.1016/j.febslet.2004.07.083; Stinchcombe JC, 2001, IMMUNITY, V15, P751, DOI 10.1016/S1074-7613(01)00234-5; Thauland TJ, 2010, IMMUNOLOGY, V131, P466, DOI 10.1111/j.1365-2567.2010.03366.x; Thomson AW, 2010, NAT REV IMMUNOL, V10, P753, DOI 10.1038/nri2858; van Stipdonk MJB, 2003, NAT IMMUNOL, V4, P361, DOI 10.1038/ni912; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; von Oppen N, 2009, HEPATOLOGY, V49, P1664, DOI 10.1002/hep.22795; Yokosuka T, 2005, NAT IMMUNOL, V6, P1253, DOI 10.1038/ni1272	27	7	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99574	10.1371/journal.pone.0099574	http://dx.doi.org/10.1371/journal.pone.0099574			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924593	Green Submitted, Green Published, gold			2022-12-27	WOS:000338701300076
J	Marics, I; Malapert, P; Reynders, A; Gaillard, S; Moqrich, A				Marics, Irene; Malapert, Pascale; Reynders, Ana; Gaillard, Stephane; Moqrich, Aziz			Acute Heat- Evoked Temperature Sensation Is Impaired but Not Abolished in Mice Lacking TRPV1 and TRPV3 Channels	PLOS ONE			English	Article							RECEPTOR POTENTIAL VANILLOID-1; CAPSAICIN-RECEPTOR; ION CHANNELS; THERMAL HYPERALGESIA; KERATINOCYTES; KNOCKOUT; SKIN; THERMOSENSATION; NOCICEPTION; EXPRESSION	The discovery of heat-sensitive Transient Receptor Potential Vanilloid ion channels (ThermoTRPVs) greatly advanced our molecular understanding of acute and injury-evoked heat temperature sensation. ThermoTRPV channels are activated by partially overlapping temperatures ranging from warm to supra-threshold noxious heat. TRPV1 is activated by noxious heat temperature whereas TRPV3 can be activated by warm as well as noxious heat temperatures. Loss-of-function studies in single TRPV1 and TRPV3 knock-out mice have shown that heat temperature sensation is not completely abolished suggesting functional redundancies among these two channels and highlighting the need of a detailed analysis of TRPV1::TRPV3 double knock-out mice (V1V3dKO) which is hampered by the close proximity of the loci expressing the two channels. Here we describe the generation of a novel mouse model in which trpv1 and trpv3 genes have been inactivated using bacterial artificial chromosome (BAC)-based homologous recombination in embryonic stem cells. In these mice, using classical thermosensory tests such hot plate, tail flick and the thermotaxis gradient paradigms, we confirm that TRPV1 is the master channel for sensing noxious heat temperatures and identify a cooperative role of TRPV1 and TRPV3 for sensing a well-defined window of acute moderate heat temperature. Using the dynamic hot plate assay, we unravel an intriguing and unexpected pronounced escape behavior in TRPV1 knock-out mice that was attenuated in the V1V3dKO. Together, and in agreement with the temperature activation overlap between TRPV1 and TRPV3 channels, our data provide in vivo evidence of a cooperative role between skin-derived TRPV3 and primary sensory neurons-enriched TRPV1 in modulation of moderate and noxious heat temperature sensation and suggest that other mechanisms are required for heat temperature sensation.	[Marics, Irene; Malapert, Pascale; Reynders, Ana; Gaillard, Stephane; Moqrich, Aziz] Aix Marseille Univ, CNRS, Inst Biol Dev Marseille, UMR 7288, Marseille, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Aix-Marseille Universite	Moqrich, A (corresponding author), Aix Marseille Univ, CNRS, Inst Biol Dev Marseille, UMR 7288, Marseille, France.	aziz.moqrich@univ-amu.fr		moqrich, aziz/0000-0002-1937-1675; Gaillard, Stephane/0000-0001-9326-5363	CNRS	CNRS(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the CNRS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Cavanaugh DJ, 2011, J NEUROSCI, V31, P10119, DOI 10.1523/JNEUROSCI.1299-11.2011; Cavanaugh DJ, 2011, J NEUROSCI, V31, P5067, DOI 10.1523/JNEUROSCI.6451-10.2011; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Christoph T, 2008, MOL CELL NEUROSCI, V37, P579, DOI 10.1016/j.mcn.2007.12.006; Chung MK, 2004, J BIOL CHEM, V279, P21569, DOI 10.1074/jbc.M401872200; Chung MK, 2003, J BIOL CHEM, V278, P32037, DOI 10.1074/jbc.M303251200; Davis JB, 2000, NATURE, V405, P183, DOI 10.1038/35012076; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Garami A, 2011, J NEUROSCI, V31, P1721, DOI 10.1523/JNEUROSCI.4671-10.2011; Gavva NR, 2008, PAIN, V136, P202, DOI 10.1016/j.pain.2008.01.024; Gavva NR, 2007, J NEUROSCI, V27, P3366, DOI 10.1523/JNEUROSCI.4833-06.2007; Huang SM, 2011, MOL PAIN, V7, DOI 10.1186/1744-8069-7-37; Huang SM, 2008, J NEUROSCI, V28, P13727, DOI 10.1523/JNEUROSCI.5741-07.2008; Iida T, 2005, NEUROSCI LETT, V378, P28, DOI 10.1016/j.neulet.2004.12.007; Kunkler PE, 2011, PAIN, V152, P38, DOI 10.1016/j.pain.2010.08.021; Lee HS, 2005, J NEUROSCI, V25, P1304, DOI 10.1523/JNEUROSCI.4745.04.2005; Marsch R, 2007, J NEUROSCI, V27, P832, DOI 10.1523/JNEUROSCI.3303-06.2007; Miyamoto T, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1371; Miyamoto T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007596; Moqrich A, 2005, SCIENCE, V307, P1468, DOI 10.1126/science.1108609; Nilius B, 2007, PHYSIOL REV, V87, P165, DOI 10.1152/physrev.00021.2006; Park U, 2011, J NEUROSCI, V31, P11425, DOI 10.1523/JNEUROSCI.1384-09.2011; Patapoutian A, 2005, CHEM SENSES, V30, pI193, DOI 10.1093/chemse/bjh180; Patapoutian A, 2003, NAT REV NEUROSCI, V4, P529, DOI 10.1038/nrn1141; Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140; Romanovsky AA, 2009, PHARMACOL REV, V61, P228, DOI 10.1124/pr.109.001263; Schicho R, 2004, EUR J NEUROSCI, V19, P1811, DOI 10.1111/j.1460-9568.2004.03290.x; Smith GD, 2002, NATURE, V418, P186, DOI 10.1038/nature00894; Steiner AA, 2007, J NEUROSCI, V27, P7459, DOI 10.1523/JNEUROSCI.1483-07.2007; Szallasi A, 1995, BRAIN RES, V703, P175, DOI 10.1016/0006-8993(95)01094-7; Szelenyi Z, 2004, EUR J NEUROSCI, V19, P1421, DOI 10.1111/j.1460-9568.2004.03221.x; Tamayo N, 2008, J MED CHEM, V51, P2744, DOI 10.1021/jm7014638; Todaka H, 2004, J BIOL CHEM, V279, P35133, DOI 10.1074/jbc.M406260200; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Toth DM, 2011, CELL MOL LIFE SCI, V68, P2589, DOI 10.1007/s00018-010-0569-2; Xu HX, 2002, NATURE, V418, P181, DOI 10.1038/nature00882; Yalcin I, 2009, J PAIN, V10, P767, DOI 10.1016/j.jpain.2009.01.325	40	33	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99828	10.1371/journal.pone.0099828	http://dx.doi.org/10.1371/journal.pone.0099828			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925072	gold, Green Published, Green Submitted			2022-12-27	WOS:000338701300098
J	Obirikorang, C; Osakunor, DNM; Ntaadu, B; Adarkwa, OK				Obirikorang, Christian; Osakunor, Derick Nii Mensah; Ntaadu, Benedict; Adarkwa, Opei Kwafo			Renal Function in Ghanaian HIV-Infected Patients on Highly Active Antiretroviral Therapy: A Case-Control Study	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; DISEASE; KIDNEY; PREVALENCE; MORTALITY; HEALTH; WOMEN; RISK; MEN	Background: HAART is anticipated to result in an increase in long-term survival, but may present with the development of associated complications. The aim of this study was to assess the renal function of HIV-infected patients on antiretroviral therapy. Methods: A case-control study (January to May 2013) conducted at the Suntreso Government Hospital, Kumasi, Ghana. A total of 163 HIV-infected patients (mean age 39.9 +/- 10.22) were studied, of which 111 were on HAART (HIV-HAART) and 52 were not (HIV-Controls). Serum urea, creatinine, potassium, sodium, chloride and CD4 counts were measured with the determination of eGFR (CKD-EPI and MDRD). Data was analysed using GraphPad Prism. The Chi-square, t-test, one-way ANOVA and Spearman's correlation were used. P values <0.05 were considered significant. Results: Mean CD4 count of HIV-Controls was higher than that of HIV-HAART but was not significant (p = 0.304). But for sodium levels which were higher in HIV-Controls (p = 0.0284), urea (p = 0.1209), creatinine (p = 0.7155), potassium (p = 0.454) and chloride (p = 0.6282) levels did not differ significantly between both groups. All serum biochemical parameters did not differ significantly, irrespective of duration on therapy and CD4 counts. Based on regimen, sodium, chloride, urea and creatinine did not differ significantly between TDF, EVF and NVP-based therapies. Prevalence of CKD (eGFR <60 ml/min/1.73 m(2)) in the total population was 9.9% and 3.7% with the MDRD and EPI-CKD equations respectively. Conclusions: Renal insufficiency remains prevalent in HIV patients. Changes in renal function occur in HIV infection and over the course of HAART but the difference at either stage is not significant. This suggests the role of HIV infection, HAART and the presence of traditional risk factors but not HAART in itself, in renal dysfunction. We however recommend a close monitoring of patients before and during HAART, to aid in evaluating drug combinations and implement dose modifications when necessary.	[Obirikorang, Christian; Osakunor, Derick Nii Mensah] KNUST, Coll Hlth Sci, Sch Med Sci, Dept Mol Med, Kumasi, Ghana; [Ntaadu, Benedict] KNUST, Coll Hlth Sci, Fac Allied Hlth Sci, Dept Med Lab Technol, Kumasi, Ghana; [Adarkwa, Opei Kwafo] KATH, Dept Obstet & Gynaecol, Kumasi, Ghana	Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Osakunor, DNM (corresponding author), KNUST, Coll Hlth Sci, Sch Med Sci, Dept Mol Med, Kumasi, Ghana.	osakunor@gmail.com	Obirikorang, Christian/F-5843-2011	Obirikorang, Christian/0000-0002-6128-1358; Osakunor, Derick Nii Mensah/0000-0002-4853-5384				Abbassi-Ghanavati M, 2009, OBSTET GYNECOL, V114, P1326, DOI 10.1097/AOG.0b013e3181c2bde8; Agaba E I, 2003, Niger J Med, V12, P120; ANDIA I, 2005, 3 IAS C HIV PATH TRE; [Anonymous], 2002, HRSA Careaction, P5; [Anonymous], BMJ, V304, P809; Bailes E, 2003, SCIENCE, V300, P1713, DOI 10.1126/science.1080657; Berns JS, 2006, CLIN J AM SOC NEPHRO, V1, P117, DOI 10.2215/CJN.00370705; Chen M., 2001, SUPPORTING WORKERS I; Chi YC, 2007, NEPHROL DIALYSIS TRA, V10; Essien EJ, 2007, MIL MED, V172, P1177, DOI 10.7205/MILMED.172.11.1177; Estrella MM, 2010, JAIDS-J ACQ IMM DEF, V55, P217, DOI 10.1097/QAI.0b013e3181e674f4; Finney H, 2000, ANN CLIN BIOCHEM, V37, P49, DOI 10.1258/0004563001901524; Franceschini N, 2005, KIDNEY INT, V67, P1526, DOI 10.1111/j.1523-1755.2005.00232.x; Gallant JE, 2009, AIDS, V23, P1971, DOI 10.1097/QAD.0b013e32832c96e9; Gerard L, 2007, ANTIVIR THER, V12, P31; Glynn JR, 2001, AIDS, V15, pS51, DOI 10.1097/00002030-200108004-00006; Gumodoka B, 1997, B WORLD HEALTH ORGAN, V75, P133; Gupta SK, 2004, CLIN NEPHROL, V61, P1; Haagsma JA, 2012, OCCUP ENVIRON MED, V69, P140, DOI 10.1136/oemed-2011-100068; Hunt K, 2011, J HEALTH SERV RES PO, V16, P108, DOI 10.1258/jhsrp.2010.009131; Kirunga C T, 1997, Health Transit Rev, V7 Suppl, P175; Obirikorang C, 2013, ISRN AIDS, V2013, P1; Okuonghae PO, 2011, ADV LAB MED INT, V1, P25; Onodugo Obinna D, 2013, J Int Assoc Provid AIDS Care; Owiredu WKBA, 2013, AFR HEALTH SCI, V13, P101, DOI 10.4314/ahs.v13i1.14; PADIAN NS, 1991, JAMA-J AM MED ASSOC, V266, P1664; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Peters E, 2010, PSYCHOL SCI, V21, P1369, DOI 10.1177/0956797610381506; RAO TKS, 1984, NEW ENGL J MED, V310, P669, DOI 10.1056/NEJM198403153101101; Roling J, 2006, CLIN INFECT DIS, V42, P1488, DOI 10.1086/503566; Smith CJ, 2004, J INFECT DIS, V190, P1860, DOI 10.1086/425075; Smith William C., 2012, INT PERSPECTIVES ED, V18, P79, DOI DOI 10.1108/IPES; Susman E, 2005, 12 C RETR OPP INF CR; Ugwuja E, 2006, INTERNET J LAB MED, V2; *UNAIDS, 2007, AIDS EP UPD; Wools-Kaloustian K, 2007, NEPHROL DIAL TRANSPL, V22, P2208, DOI 10.1093/ndt/gfm223	36	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99469	10.1371/journal.pone.0099469	http://dx.doi.org/10.1371/journal.pone.0099469			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921259	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300062
J	Zhao, N; Watson, N; Xu, ZG; Chen, YJ; Waterman, J; Sankar, J; Zhu, DH				Zhao, Nan; Watson, Nevija; Xu, Zhigang; Chen, Yongjun; Waterman, Jenora; Sankar, Jagannathan; Zhu, Donghui			In Vitro Biocompatibility and Endothelialization of Novel Magnesium-Rare Earth Alloys for Improved Stent Applications	PLOS ONE			English	Article							DRUG-ELUTING STENTS; MECHANICAL-PROPERTIES; CORONARY STENTS; DEFORMATION-BEHAVIOR; CARDIOVASCULAR STENT; CORROSION BEHAVIOR; VASCULAR GRAFTS; MOLECULAR-BASIS; CELL-ADHESION; ZR ALLOYS	Magnesium (Mg) based alloys are the most advanced cardiovascular stent materials. This new generation of stent scaffold is currently under clinical evaluation with encouraging outcomes. All these Mg alloys contain a certain amount of rare earth (RE) elements though the exact composition is not yet disclosed. RE alloying can usually enhance the mechanical strength of different metal alloys but their toxicity might be an issue for medical applications. It is still unclear how RE elements will affect the magnesium (Mg) alloys intended for stent materials as a whole. In this study, we evaluated MgZnCaY-1RE, MgZnCaY-2RE, MgYZr-1RE, and MgZnYZr-1RE alloys for cardiovascular stents applications regarding their mechanical strength, corrosion resistance, hemolysis, platelet adhesion/activation, and endothelial biocompatibility. The mechanical properties of all alloys were significantly improved. Potentiodynamic polarization showed that the corrosion resistance of four alloys was at least 3-10 times higher than that of pure Mg control. Hemolysis test revealed that all the materials were non-hemolytic while little to moderate platelet adhesion was found on all materials surface. No significant cytotoxicity was observed in human aorta endothelial cells cultured with magnesium alloy extract solution for up to seven days. Direct endothelialization test showed that all the alloys possess significantly better capability to sustain endothelial cell attachment and growth. The results demonstrated the promising potential of these alloys for stent material applications in the future.					Zhao, Nan/GMX-1019-2022; Xu, Zhigang/AAC-7839-2019; Zhu, Donghui/H-9058-2017	Zhu, Donghui/0000-0002-3057-1889; Waterman, Jenora/0000-0002-6643-2768; XU, ZHIGANG/0000-0003-4477-7391	National Institute of Health [SC2NS082475]; NSF Engineering Research Center-Revolutionizing Metallic Biomaterials (ERC-RMB) at North Carolina A&T State University [NSF-0812348]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC2NS082475] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF Engineering Research Center-Revolutionizing Metallic Biomaterials (ERC-RMB) at North Carolina A&T State University; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors acknowledge funding from the National Institute of Health (SC2NS082475) and support from NSF Engineering Research Center-Revolutionizing Metallic Biomaterials (ERC-RMB) (NSF-0812348) at North Carolina A&T State University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson JM, 2001, ANNU REV MATER RES, V31, P81, DOI 10.1146/annurev.matsci.31.1.81; [Anonymous], 10993122008 ISOE; Asl KM, 2010, MAT SCI ENG A-STRUCT, V527, P2027, DOI 10.1016/j.msea.2009.11.061; Ben-Hamu G, 2007, J ALLOY COMPD, V431, P269, DOI 10.1016/j.jallcom.2006.05.075; Bornapour M, 2013, ACTA BIOMATER, V9, P5319, DOI 10.1016/j.actbio.2012.07.045; Cha PR, 2013, SCI REP-UK, V3, DOI 10.1038/srep02367; Costa MA, 2005, CIRCULATION, V111, P2257, DOI 10.1161/01.CIR.0000163587.36485.A7; De Visscher G, 2012, ACTA BIOMATER, V8, P1330, DOI 10.1016/j.actbio.2011.09.016; Drynda A, 2009, J BIOMED MATER RES A, V91A, P360, DOI 10.1002/jbm.a.32235; Fan J, 2013, MAT SCI ENG C-MATER, V33, P2345, DOI 10.1016/j.msec.2013.01.063; Geis-Gerstorfer J, 2011, MATER SCI ENG B-ADV, V176, P1761, DOI 10.1016/j.mseb.2011.06.006; GOODMAN SL, 1989, J BIOMED MATER RES, V23, P105, DOI 10.1002/jbm.820230109; Gu XN, 2010, BIOMATERIALS, V31, P1093, DOI 10.1016/j.biomaterials.2009.11.015; Gu XN, 2009, BIOMATERIALS, V30, P484, DOI 10.1016/j.biomaterials.2008.10.021; HANELT M, 1994, MYCOPATHOLOGIA, V128, P167, DOI 10.1007/BF01138479; Hiltunen MO, 2000, CIRCULATION, V102, P2262; Hou SS, 2013, J CHEM TECHNOL BIOT, V88, P2062, DOI 10.1002/jctb.4069; HWANG DL, 1992, AM J HYPERTENS, V5, P700, DOI 10.1093/ajh/5.10.700; Inoue T, 2009, CIRC J, V73, P615, DOI 10.1253/circj.CJ-09-0059; Ji DW, 2013, MATER SCI TECH-LOND, V29, P480, DOI 10.1179/1743284712Y.0000000165; Kverneland A, 2011, MAT SCI ENG A-STRUCT, V528, P880, DOI 10.1016/j.msea.2010.10.001; Laser T, 2008, ACTA MATER, V56, P2791, DOI 10.1016/j.actamat.2008.02.010; Li WP, 2009, J ALLOY COMPD, V475, P227, DOI 10.1016/j.jallcom.2008.07.128; Li ZJ, 2008, BIOMATERIALS, V29, P1329, DOI 10.1016/j.biomaterials.2007.12.021; Mani G, 2007, BIOMATERIALS, V28, P1689, DOI 10.1016/j.biomaterials.2006.11.042; Mao L, 2012, MATER LETT, V88, P1, DOI 10.1016/j.matlet.2012.08.012; MARKS DC, 1992, LEUKEMIA RES, V16, P1165, DOI 10.1016/0145-2126(92)90114-M; MCEVER RP, 1984, J BIOL CHEM, V259, P9799; Mirza FA, 2013, MATER DESIGN, V46, P411, DOI 10.1016/j.matdes.2012.10.040; Murai T, 2003, J MATER PROCESS TECH, V141, P207, DOI 10.1016/S0924-0136(02)01106-8; Nam SW, 2013, MET MATER INT, V19, P205, DOI 10.1007/s12540-013-2010-5; Ouyang LZ, 2013, INT J HYDROGEN ENERG, V38, P2973, DOI 10.1016/j.ijhydene.2012.12.092; de Prado AP, 2013, CURR VASC PHARMACOL, V11, P74; Persaud-Sharma Dharam, 2012, J Biomim Biomater Tissue Eng, V12, P25, DOI 10.4028/www.scientific.net/JBBTE.12.25; Peuster M, 2006, BIOMATERIALS, V27, P4955, DOI 10.1016/j.biomaterials.2006.05.029; Seitz JM, 2012, ACTA BIOMATER, V8, P3852, DOI 10.1016/j.actbio.2012.05.024; SERRUYS PW, 1991, NEW ENGL J MED, V324, P13, DOI 10.1056/NEJM199101033240103; Shahryari A, 2010, ACTA BIOMATER, V6, P695, DOI 10.1016/j.actbio.2009.07.007; Standard A.C, 2006, ANN BOOK ASTM STAND; Stanford N, 2013, MAT SCI ENG A-STRUCT, V565, P469, DOI 10.1016/j.msea.2012.10.084; Stanford N, 2013, MAT SCI ENG A-STRUCT, V565, P459, DOI 10.1016/j.msea.2012.12.023; Tian X, 2008, J ALLOY COMPD, V465, P412, DOI 10.1016/j.jallcom.2007.10.100; Varga-Szabo D, 2008, ARTERIOSCL THROM VAS, V28, P403, DOI 10.1161/ATVBAHA.107.150474; Verma A, 2006, BIO-MED MATER ENG, V16, P381; Wang B, 2011, MATER SCI ENG B-ADV, V176, P1673, DOI 10.1016/j.mseb.2011.03.015; Wang HX, 2010, ACTA BIOMATER, V6, P1743, DOI 10.1016/j.actbio.2009.12.009; Waterhouse A, 2010, BIOMATERIALS, V31, P8332, DOI 10.1016/j.biomaterials.2010.07.062; Witte F, 2010, ACTA BIOMATER, V6, P1792, DOI 10.1016/j.actbio.2009.10.012; Xiao X, 2013, J BIONIC ENG, V10, P156, DOI 10.1016/S1672-6529(13)60210-3; Xu SW, 2011, SCRIPTA MATER, V65, P269, DOI 10.1016/j.scriptamat.2011.04.026; Xu ZG, 2011, MATER SCI ENG B-ADV, V176, P1660, DOI 10.1016/j.mseb.2011.06.008; Ye CH, 2013, T NONFERR METAL SOC, V23, P996, DOI 10.1016/S1003-6326(13)62558-3; Zhang J, 2009, MATER SCI FORUM, V610-613, P810, DOI 10.4028/www.scientific.net/MSF.610-613.810; Zhang SX, 2010, ACTA BIOMATER, V6, P626, DOI 10.1016/j.actbio.2009.06.028; Zhang SX, 2009, MAT SCI ENG C-MATER, V29, P1907, DOI 10.1016/j.msec.2009.03.001; Zhang XB, 2013, MATER TECHNOL, V28, P155, DOI 10.1179/1753555712Y.0000000048; Zhang YJ, 2013, MED DEVICES-EVID RES, V6, P37, DOI 10.2147/MDER.S22547; Zhao MC, 2008, CORROS SCI, V50, P1939, DOI 10.1016/j.corsci.2008.04.010; Zheng WT, 2012, BIOMATERIALS, V33, P2880, DOI 10.1016/j.biomaterials.2011.12.047; Zhou M, 2012, J BIOMED MATER RES B, V100B, P111, DOI 10.1002/jbm.b.31928; Zhou WR, 2013, ACTA BIOMATER, V4	61	26	27	2	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98674	10.1371/journal.pone.0098674	http://dx.doi.org/10.1371/journal.pone.0098674			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921251	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300011
J	Skaik, Y; Vahlsing, S; Goudeva, L; Eiz-Vesper, B; Battermann, A; Blasczyk, R; Figueiredo, C				Skaik, Younis; Vahlsing, Stefanie; Goudeva, Lilia; Eiz-Vesper, Britta; Battermann, Anja; Blasczyk, Rainer; Figueiredo, Constanca			Secreted beta(3)-Integrin Enhances Natural Killer Cell Activity against Acute Myeloid Leukemia Cells	PLOS ONE			English	Article							ALLOGENEIC HEMATOPOIETIC TRANSPLANTATION; IFN-GAMMA; NK CELLS; T-CELL; INTEGRIN; IMMUNOTHERAPY; CYTOTOXICITY; EXPRESSION; CANCER; ACTIVATION	Integrins are a large family of heterodimeric proteins that are involved in cell adhesion, migration, and proliferation. Integrin diversity and function is regulated by alternative splicing. Membrane-bound and truncated beta(3)-integrins were shown to be key players in cancer metastasis. However, the immunomodulatory functions of the soluble (s) beta(3)-integrin have not been investigated yet. In this study, we described a novel form of s beta(3)-integrin in acute myeloid leukaemia (AML) patients. Furthermore, we assessed the role of the s beta(3)-integrin in the modulation of natural killer (NK)-cell activity. Levels of s beta(3)-integrin were analysed in plasma samples of 23 AML patients and 26 healthy donors by ELISA. The capacity of s beta(3)-integrin to regulate NK cell activity was investigated using proliferation, cytokine secretion, and cytotoxicity assays. Circulating s beta(3)-integrin was detected in the plasma of 8 AML patients. NK cells showed significantly higher proliferation rates after stimulation with s beta(3)-integrin and IL-2, IL-15 (73%). Significant increases in the NK cells' secreted levels of TNF-alpha, IFN-gamma were measured in presence of s beta(3)-integrin. In addition, s beta(3)-integrin caused the upregulation of Granzyme B transcripts levels as well as FasL expression levels in NK cells. Most importantly, significantly higher K562 or AML blast target cell lysis rates were observed when NK cells were exposed to s beta(3)-integrin. This study reports the identification of a novel s beta(3)-integrin in AML patients and provides novel insights into its role in the immunomodulation of NK cell activity.	[Skaik, Younis; Vahlsing, Stefanie; Goudeva, Lilia; Eiz-Vesper, Britta; Battermann, Anja; Blasczyk, Rainer; Figueiredo, Constanca] Hannover Med Sch, Inst Transfus Med, Hannover, Germany	Hannover Medical School	Figueiredo, C (corresponding author), Hannover Med Sch, Inst Transfus Med, Hannover, Germany.	figueiredo.constanca@mh-hannover.de		Blasczyk, Rainer/0000-0003-3875-3190	Deutscher Akademischer Austauschdienst -DAAD; Excellence Cluster for Regenerative Medicine and Reconstructive Therapies - REBIRTH	Deutscher Akademischer Austauschdienst -DAAD(Deutscher Akademischer Austausch Dienst (DAAD)); Excellence Cluster for Regenerative Medicine and Reconstructive Therapies - REBIRTH	YS is supported by a scholarship of the "Deutscher Akademischer Austauschdienst -DAAD''. This study was financed in part by the Excellence Cluster for Regenerative Medicine and Reconstructive Therapies - REBIRTH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen DL, 2012, J IMMUNOL METHODS, V375, P166, DOI 10.1016/j.jim.2011.10.008; Barrett AJ, 2010, CLIN EXP IMMUNOL, V161, P223, DOI 10.1111/j.1365-2249.2010.04197.x; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Brakebusch C, 2002, J CLIN INVEST, V109, P999, DOI 10.1172/JCI200215468; Cho D, 2009, KOREAN J LAB MED, V29, P89, DOI 10.3343/kjlm.2009.29.2.89; DJAFFAR I, 1994, BIOCHEM J, V300, P69, DOI 10.1042/bj3000069; Eisele G, 2013, ANTICANCER RES, V33, P3563; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fauriat C, 2007, BLOOD, V109, P323, DOI 10.1182/blood-2005-08-027979; Geller MA, 2013, CYTOTHERAPY, V15, P1297, DOI 10.1016/j.jcyt.2013.05.022; Guilloton F, 2007, CELL SIGNAL, V19, P1132, DOI 10.1016/j.cellsig.2006.12.005; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Jaimes Y, 2010, TRANSFUSION, V50, P1988, DOI 10.1111/j.1537-2995.2010.02677.x; Jin RX, 2007, CANCER BIOL THER, V6, P1559, DOI 10.4161/cbt.6.10.4710; Kim HW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070194; Koehl U, 2004, BLOOD CELL MOL DIS, V33, P261, DOI 10.1016/j.bcmd.2004.08.013; Kon S, 2011, EXP CELL RES, V317, P1774, DOI 10.1016/j.yexcr.2011.04.005; Leong JW, 2011, BLOOD, V117, P2297, DOI 10.1182/blood-2011-01-327247; Lion E, 2012, LEUKEMIA, V26, P2019, DOI 10.1038/leu.2012.87; Lonsdorf AS, 2012, J BIOL CHEM, V287, P2168, DOI 10.1074/jbc.M111.269811; Orleans-Lindsay JK, 2001, CLIN EXP IMMUNOL, V126, P403, DOI 10.1046/j.1365-2249.2001.01692.x; Pardo J, 2002, EUR J IMMUNOL, V32, P2881, DOI 10.1002/1521-4141(2002010)32:10<2881::AID-IMMU2881>3.0.CO;2-K; Pieper C, 2014, BRAIN RES; Ruggeri L, 2007, CURR OPIN ONCOL, V19, P142, DOI 10.1097/CCO.0b013e3280148a1a; Ruggeri L, 2006, IMMUNOL REV, V214, P202, DOI 10.1111/j.1600-065X.2006.00455.x; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; Siena L, 2014, IMMUNOLOGY, V141, P242, DOI 10.1111/imm.12190; Skaik Y, 2013, J IMMUNOL METHODS, V391, P72, DOI 10.1016/j.jim.2013.02.011; Smits ELJ, 2011, CANCER IMMUNOL IMMUN, V60, P757, DOI 10.1007/s00262-011-1022-6; Smyth MJ, 2005, MOL IMMUNOL, V42, P501, DOI 10.1016/j.molimm.2004.07.034; Soiffer RJ, 2008, BEST PRACT RES CL HA, V21, P455, DOI 10.1016/j.beha.2008.07.009; Szczepanski MJ, 2010, CANCER IMMUNOL IMMUN, V59, P73, DOI 10.1007/s00262-009-0724-5; Takada Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-215; Tarone G, 2000, INT J DEV BIOL, V44, P725; Verheyden S, 2008, LEUKEMIA, V22, P249, DOI 10.1038/sj.leu.2405040; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vrbanus L, 2010, COLLEGIUM ANTROPOL, V34, P705; Wang RP, 2012, J LEUKOCYTE BIOL, V91, P299, DOI 10.1189/jlb.0611308; WANG Z, 2013, TUMOUR BIOL; Whiteway A, 2003, BRIT J HAEMATOL, V120, P442, DOI 10.1046/j.1365-2141.2003.04085.x; Xu GW, 2008, BIOCHEM BIOPH RES CO, V375, P666, DOI 10.1016/j.bbrc.2008.08.077	41	6	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e98936	10.1371/journal.pone.0098936	http://dx.doi.org/10.1371/journal.pone.0098936			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919191	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000034
J	O'Brien, KR; Kober, T; Hagmann, P; Maeder, P; Marques, J; Lazeyras, F; Krueger, G; Roche, A				O'Brien, Kieran R.; Kober, Tobias; Hagmann, Patric; Maeder, Philippe; Marques, Jose; Lazeyras, Francois; Krueger, Gunnar; Roche, Alexis			Robust T1-Weighted Structural Brain Imaging and Morphometry at 7T Using MP2RAGE	PLOS ONE			English	Article							MRI; SEGMENTATION	Purpose: To suppress the noise, by sacrificing some of the signal homogeneity for numerical stability, in uniform T1 weighted (T1w) images obtained with the magnetization prepared 2 rapid gradient echoes sequence (MP2RAGE) and to compare the clinical utility of these robust T1w images against the uniform T1w images. Materials and Methods: 8 healthy subjects (29.0 +/- 4.1 years; 6 Male), who provided written consent, underwent two scan sessions within a 24 hour period on a 7T head-only scanner. The uniform and robust T1w image volumes were calculated inline on the scanner. Two experienced radiologists qualitatively rated the images for: general image quality; 7T specific artefacts; and, local structure definition. Voxel-based and volume-based morphometry packages were used to compare the segmentation quality between the uniform and robust images. Statistical differences were evaluated by using a positive sided Wilcoxon rank test. Results: The robust image suppresses background noise inside and outside the skull. The inhomogeneity introduced was ranked as mild. The robust image was significantly ranked higher than the uniform image for both observers (observer 1/2, p-value = 0.0006/0.0004). In particular, an improved delineation of the pituitary gland, cerebellar lobes was observed in the robust versus uniform T1w image. The reproducibility of the segmentation results between repeat scans improved (p-value = 0.0004) from an average volumetric difference across structures of approximate to 6.6% to approximate to 2.4% for the uniform image and robust T1w image respectively. Conclusions: The robust T1w image enables MP2RAGE to produce, clinically familiar T1w images, in addition to T1 maps, which can be readily used in uniform morphometry packages.	[O'Brien, Kieran R.; Lazeyras, Francois] Univ Geneva, Dept Radiol, Hop Univ Geneve, Ctr Imagerie BioMed, Geneva, Switzerland; [O'Brien, Kieran R.; Kober, Tobias; Krueger, Gunnar; Roche, Alexis] Ctr Imagerie BioMed Siemens, Adv Clin Imaging Technogoly, Lausanne, Switzerland; [Kober, Tobias; Krueger, Gunnar; Roche, Alexis] Siemens Schweiz AG, Siemens Healthcare, Rennes, Switzerland; [Hagmann, Patric; Maeder, Philippe; Roche, Alexis] CHU Vaudois, Dept Radiol, Lausanne, Switzerland; [Marques, Jose] Univ Lausanne, Dept Radiol, Ctr Imagerie BioMed Anim & Imaging Technol Core, Lausanne, Switzerland	University of Geneva; Siemens AG; Siemens AG; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne	O'Brien, KR (corresponding author), Univ Geneva, Dept Radiol, Hop Univ Geneve, Ctr Imagerie BioMed, Geneva, Switzerland.	kieran.obrien@gmail.com	O'Brien, Kieran/B-7276-2016; Marques, José Pedro/R-3616-2018; Marques, Jose/B-4922-2015	O'Brien, Kieran/0000-0003-1996-3563; Marques, José Pedro/0000-0001-8157-8864; Marques, Jose/0000-0001-8157-8864; Roche, Alexis/0000-0002-4821-6893	Centre d'Imagerie BioMedicale (CIBM) of the UNIL; Centre d'Imagerie BioMedicale (CIBM) of the UNIGE; Centre d'Imagerie BioMedicale (CIBM) of the HUG; Centre d'Imagerie BioMedicale (CIBM) of the CHUV; Centre d'Imagerie BioMedicale (CIBM) of the EPFL; Leenaards foundation; Louis-Jeantet foundation	Centre d'Imagerie BioMedicale (CIBM) of the UNIL; Centre d'Imagerie BioMedicale (CIBM) of the UNIGE; Centre d'Imagerie BioMedicale (CIBM) of the HUG; Centre d'Imagerie BioMedicale (CIBM) of the CHUV; Centre d'Imagerie BioMedicale (CIBM) of the EPFL; Leenaards foundation; Louis-Jeantet foundation	This work was supported by the Centre d'Imagerie BioMedicale (CIBM) of the UNIL, UNIGE, HUG, CHUV and EPFL, and the Leenaards and Louis-Jeantet foundations. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACIT, 2013, BRAINMORPH AUT BRAIN; Bazin PL, 2014, NEUROIMAGE, V93, P201, DOI 10.1016/j.neuroimage.2013.03.077; FIL ([Wellcome Trust Centre for Neuroimaging UCL], 1991, SPM STAT PAR MAPP; GUDBJARTSSON H, 1995, MAGNET RESON MED, V34, P910, DOI 10.1002/mrm.1910340618; Jack CR, 2008, J MAGN RESON IMAGING, V27, P685, DOI 10.1002/jmri.21049; Marques JP, 2010, NEUROIMAGE, V49, P1271, DOI 10.1016/j.neuroimage.2009.10.002; Max Planck Institute for Human Cognitive and Brain Sciences, 2013, CBS HIGH RES BRAIN P; Mueller Susanne G, 2005, Alzheimers Dement, V1, P55, DOI 10.1016/j.jalz.2005.06.003; MUGLER JP, 1991, JMRI-J MAGN RESON IM, V1, P561, DOI 10.1002/jmri.1880010509; MUGLER JP, 1990, MAGNET RESON MED, V15, P152, DOI 10.1002/mrm.1910150117; O'Brien K, 2013, SIMPLE METHOD DENOIS, P269; O'Brien KR, 2014, J MAGNETIC RESONANCE; Roche A, 2011, MED IMAGE ANAL, V15, P830, DOI 10.1016/j.media.2011.05.002; Solomon C.J., 2010, FUNDAMENTALS DIGITAL, Vist; Van De Moortele PF, 2005, MAGN RESON MED, V54, P1503, DOI 10.1002/mrm.20708; Van de Moortele PF, 2009, NEUROIMAGE, V46, P432, DOI 10.1016/j.neuroimage.2009.02.009; Vaughan JT, 2001, MAGN RESON MED, V46, P24, DOI 10.1002/mrm.1156	18	73	73	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99676	10.1371/journal.pone.0099676	http://dx.doi.org/10.1371/journal.pone.0099676			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932514	Green Submitted, gold, Green Published			2022-12-27	WOS:000337738600054
J	Yu, K; AI-Nashash, H; Thakor, N; Li, XP				Yu, Ke; AI-Nashash, Hasan; Thakor, Nitish; Li, Xiaoping			The Analytic Bilinear Discrimination of Single-Trial EEG Signals in Rapid Image Triage	PLOS ONE			English	Article							SPATIAL FILTERS; PHASE; P300; FREQUENCY; ODDBALL	The linear discriminant analysis (LDA) method is a classical and commonly utilized technique for dimensionality reduction and classification in brain-computer interface (BCI) systems. Being a first-order discriminator, LDA is usually preceded by the feature extraction of electroencephalogram (EEG) signals, as multi-density EEG data are of second order. In this study, an analytic bilinear classification method which inherits and extends LDA is proposed. This method considers 2-dimentional EEG signals as the feature input and performs classification using the optimized complex-valued bilinear projections. Without being transformed into frequency domain, the complex-valued bilinear projections essentially spatially and temporally modulate the phases and magnitudes of slow event-related potentials (ERPs) elicited by distinct brain states in the sense that they become more separable. The results show that the proposed method has demonstrated its discriminating capability in the development of a rapid image triage (RIT) system, which is a challenging variant of BCIs due to the fast presentation speed and consequently overlapping of ERPs.	[Yu, Ke; AI-Nashash, Hasan; Thakor, Nitish] Natl Univ Singapore, Singapore Inst Neurotechnol, Singapore 117548, Singapore; [AI-Nashash, Hasan] Amer Univ Sharjah, Dept Elect Engn, Sharjah, U Arab Emirates; [Thakor, Nitish] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD USA; [Li, Xiaoping] Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore	National University of Singapore; American University of Sharjah; Johns Hopkins University; National University of Singapore	Li, XP (corresponding author), Natl Univ Singapore, Dept Mech Engn, Singapore 117548, Singapore.	mpelixp@nus.edu.sg	AL-Nashash, Hasan/AEW-9979-2022; Thakor, Nitish/G-9110-2015; Thakor, Nitish V/A-5878-2008	Thakor, Nitish/0000-0002-9981-9395; Al-Nashash, Hasan/0000-0002-9685-4937				Bernat E, 2001, CLIN NEUROPHYSIOL, V112, P159, DOI 10.1016/S1388-2457(00)00445-4; Blankertz B, 2008, IEEE SIGNAL PROC MAG, V25, P41, DOI 10.1109/MSP.2008.4408441; DaSalla CS, 2009, NEURAL NETWORKS, V22, P1334, DOI 10.1016/j.neunet.2009.05.008; Dornhege G, 2006, IEEE T BIO-MED ENG, V53, P2274, DOI 10.1109/TBME.2006.883649; Duda RO, 2001, PATTERN CLASSIFICATI, V2nd, P20; Falzon O, 2012, IEEE T BIO-MED ENG, V59, P2486, DOI 10.1109/TBME.2012.2205246; Falzon O, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/045009; Falzon O, 2010, IEEE ENG MED BIO, P4707, DOI 10.1109/IEMBS.2010.5626381; Finke A, 2009, NEURAL NETWORKS, V22, P1329, DOI 10.1016/j.neunet.2009.07.003; Gerson AD, 2006, IEEE T NEUR SYS REH, V14, P174, DOI 10.1109/TNSRE.2006.875550; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Huang YH, 2011, NEUROCOMPUTING, V74, P2041, DOI 10.1016/j.neucom.2010.12.025; Hughes G, 2012, NEUROIMAGE; Jia CA, 2011, IEEE T BIO-MED ENG, V58, P200, DOI 10.1109/TBME.2010.2068571; Kruglikov SY, 2003, J NEUROSCI, V23, P10122; Lagerlund TD, 1997, J CLIN NEUROPHYSIOL, V14, P73, DOI 10.1097/00004691-199701000-00007; Lemm S, 2005, IEEE T BIO-MED ENG, V52, P1541, DOI 10.1109/TBME.2005.851521; Leuthardt EC, 2006, NEUROSURGERY, V59, P1, DOI 10.1227/01.NEU.0000221506.06947.AC; Leuthardt EC, 2004, J NEURAL ENG, V1, P63, DOI 10.1088/1741-2560/1/2/001; Li J, 2009, IEEE T NEUR SYS REH, V17, P107, DOI 10.1109/TNSRE.2008.2008394; Li M, 2005, PATTERN RECOGN LETT, V26, P527, DOI 10.1016/j.patrec.2004.09.007; Lu HP, 2011, PATTERN RECOGN, V44, P1540, DOI 10.1016/j.patcog.2011.01.004; Makeig S, 1996, ADV NEUR IN, V8, P145; McCleery JP, 2011, J NEUROSCI, V31, P12849, DOI 10.1523/JNEUROSCI.1392-11.2011; Mertens R, 1997, EVOKED POTENTIAL, V104, P488, DOI 10.1016/S0168-5597(97)00041-5; Miwakeichi F, 2004, NEUROIMAGE, V22, P1035, DOI 10.1016/j.neuroimage.2004.03.039; Pohlmeyer EA, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036025; Polich J, 1997, INT J PSYCHOPHYSIOL, V25, P169, DOI 10.1016/S0167-8760(96)00742-8; Polich J, 2006, INT J PSYCHOPHYSIOL, V60, P172, DOI 10.1016/j.ijpsycho.2005.12.012; Ramoser H, 2000, IEEE T REHABIL ENG, V8, P441, DOI 10.1109/86.895946; Sajda P, 2010, P IEEE, V98, P462, DOI 10.1109/JPROC.2009.2038406; Samek W, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/2/026013; Tomioka R, 2006, SPECTRALLY WEIGHTED; VanRullen R, 2011, FRONTIERS PSYCHOL, V2; Visani M, 2005, NORMALIZED RADIAL BA, P342; Xu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014634; Ye J., 2004, P ADV NEUR INF PROC, P1569; Yu K, 2012, J NEURAL ENG, V9, DOI 10.1088/1741-2560/9/4/046013; Yu K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076923; Yu K, 2012, J NEUROSCI METH, V204, P288, DOI 10.1016/j.jneumeth.2011.11.023; Yu K, 2011, IEEE T BIO-MED ENG, V58, P2513, DOI 10.1109/TBME.2011.2158542; Zhang R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074433	42	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100097	10.1371/journal.pone.0100097	http://dx.doi.org/10.1371/journal.pone.0100097			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933017	gold, Green Submitted, Green Published			2022-12-27	WOS:000337738600094
J	Liljavirta, J; Niku, M; Pessa-Morikawa, T; Ekman, A; Iivanainen, A				Liljavirta, Jenni; Niku, Mikael; Pessa-Morikawa, Tiina; Ekman, Anna; Iivanainen, Antti			Expansion of the Preimmune Antibody Repertoire by Junctional Diversity in Bos taurus	PLOS ONE			English	Article							TERMINAL DEOXYNUCLEOTIDYL TRANSFERASE; EXCEPTIONALLY LONG CDR3H; B-CELL DIFFERENTIATION; ACUTE MYELOID-LEUKEMIA; H GENE FAMILY; N-REGIONS; BONE-MARROW; NUCLEOTIDE ADDITION; V(D)J RECOMBINATION; MOLECULAR-BIOLOGY	Cattle have a limited range of immunoglobulin genes which are further diversified by antigen independent somatic hypermutation in fetuses. Junctional diversity generated during somatic recombination contributes to antibody diversity but its relative significance has not been comprehensively studied. We have investigated the importance of terminal deoxynucleotidyl transferase (TdT) -mediated junctional diversity to the bovine immunoglobulin repertoire. We also searched for new bovine heavy chain diversity (IGHD) genes as the information of the germline sequences is essential to define the junctional boundaries between gene segments. New heavy chain variable genes (IGHV) were explored to address the gene usage in the fetal recombinations. Our bioinformatics search revealed five new IGHD genes, which included the longest IGHD reported so far, 154 bp. By genomic sequencing we found 26 new IGHV sequences that represent potentially new IGHV genes or allelic variants. Sequence analysis of immunoglobulin heavy chain cDNA libraries of fetal bone marrow, ileum and spleen showed 0 to 36 nontemplated N-nucleotide additions between variable, diversity and joining genes. A maximum of 8 N nucleotides were also identified in the light chains. The junctional base profile was biased towards A and T nucleotide additions (64% in heavy chain VD, 52% in heavy chain DJ and 61% in light chain VJ junctions) in contrast to the high G/C content which is usually observed in mice. Sequence analysis also revealed extensive exonuclease activity, providing additional diversity. B-lymphocyte specific TdT expression was detected in bovine fetal bone marrow by reverse transcription-qPCR and immunofluorescence. These results suggest that TdT-mediated junctional diversity and exonuclease activity contribute significantly to the size of the cattle preimmune antibody repertoire already in the fetal period.	[Liljavirta, Jenni; Niku, Mikael; Pessa-Morikawa, Tiina; Ekman, Anna; Iivanainen, Antti] Univ Helsinki, Dept Vet Biosci, Helsinki, Finland	University of Helsinki	Iivanainen, A (corresponding author), Univ Helsinki, Dept Vet Biosci, Helsinki, Finland.	antti.iivanainen@helsinki.fi	Niku, Mikael/F-8490-2011	Niku, Mikael/0000-0003-1087-9859	Academy of Finland; Orion-Farmos Research Foundation; Finnish Veterinary Foundation; Finnish Foundation of Veterinary Research	Academy of Finland(Academy of Finland); Orion-Farmos Research Foundation; Finnish Veterinary Foundation; Finnish Foundation of Veterinary Research	This study was supported by The Academy of Finland, Finnish Veterinary Foundation, Finnish Foundation of Veterinary Research, and Orion-Farmos Research Foundation. JL is a student at the Viikki Graduate School in Molecular Biosciences. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALT FW, 1982, P NATL ACAD SCI-BIOL, V79, P4118, DOI 10.1073/pnas.79.13.4118; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; BASU M, 1983, BIOCHEM BIOPH RES CO, V111, P1105, DOI 10.1016/0006-291X(83)91413-4; Benedict CL, 2001, J EXP MED, V193, P89, DOI 10.1084/jem.193.1.89; Benedict CL, 2000, IMMUNOL REV, V175, P150, DOI 10.1034/j.1600-065X.2000.017518.x; Bentolila LA, 1997, J IMMUNOL, V158, P715; BENTOLILA LA, 1995, EMBO J, V14, P4221, DOI 10.1002/j.1460-2075.1995.tb00096.x; Berens SJ, 1997, INT IMMUNOL, V9, P189, DOI 10.1093/intimm/9.1.189; Bertocci B, 2003, IMMUNITY, V19, P203, DOI 10.1016/S1074-7613(03)00203-6; Bertocci B, 2006, IMMUNITY, V25, P31, DOI 10.1016/j.immuni.2006.04.013; Butler JE, 2004, J IMMUNOL, V173, P6794, DOI 10.4049/jimmunol.173.11.6794; Butler JE, 2000, J IMMUNOL, V165, P6999, DOI 10.4049/jimmunol.165.12.6999; CHANG LMS, 1986, CRC CR REV BIOCH MOL, V21, P27, DOI 10.3109/10409238609113608; DEIBEL MR, 1983, J IMMUNOL, V131, P195; DESIDERIO SV, 1984, NATURE, V311, P752, DOI 10.1038/311752a0; DREXLER HG, 1993, LEUKEMIA, V7, P1142; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ekman A, 2012, DEV COMP IMMUNOL, V37, P39, DOI 10.1016/j.dci.2011.12.009; Ekman A, 2010, DEV COMP IMMUNOL, V34, P896, DOI 10.1016/j.dci.2010.03.012; Ekman A, 2009, BMC IMMUNOL, V10, DOI 10.1186/1471-2172-10-22; FEENEY AJ, 1990, J EXP MED, V172, P1377, DOI 10.1084/jem.172.5.1377; Galler GR, 2004, J EXP MED, V199, P1523, DOI 10.1084/jem.20031523; Gauss GH, 1996, MOL CELL BIOL, V16, P258; Gilfillan S, 1995, IMMUNOL REV, V148, P201, DOI 10.1111/j.1600-065X.1995.tb00099.x; Gontier E, 2005, VET IMMUNOL IMMUNOP, V103, P31, DOI 10.1016/j.vetimm.2004.08.013; GORE SD, 1991, BLOOD, V77, P1681; Gozalbo-Lopez B, 2009, MOL CELL BIOL, V29, P1266, DOI 10.1128/MCB.01518-08; GREENBERG JM, 1987, BLOOD, V69, P356; GREGOIRE KE, 1979, J IMMUNOL, V123, P1347; Hollander M., 2014, NONPARAMETRIC STAT M, V3rd ed.; Hosseini A, 2004, INT IMMUNOL, V16, P843, DOI 10.1093/intimm/dxh085; Jenne CN, 2003, J IMMUNOL, V170, P3739, DOI 10.4049/jimmunol.170.7.3739; Jeong Y, 2001, IMMUNOLOGY, V103, P26, DOI 10.1046/j.1365-2567.2001.01227.x; Kaushik AK, 2009, VET IMMUNOL IMMUNOP, V127, P106, DOI 10.1016/j.vetimm.2008.09.024; KOMORI T, 1993, SCIENCE, V261, P1171, DOI 10.1126/science.8356451; Koti M, 2008, DEV BIOLOGICALS, V132, P307, DOI 10.1159/000317176; Koti M, 2010, MOL IMMUNOL, V47, P2119, DOI 10.1016/j.molimm.2010.02.014; LEFLER CF, 1969, J BIOL CHEM, V244, P594; Lefranc MP, 2001, CURR PROTOC IMMUNOL, DOI [10.1002/0471142735.ima01ps40, DOI 10.1002/0471142735.IM-A01PS40]; LI YS, 1993, J EXP MED, V178, P951, DOI 10.1084/jem.178.3.951; Liljavirta J, 2013, MUCOSAL IMMUNOL, V6, P942, DOI 10.1038/mi.2012.132; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mickelsen S, 1999, J IMMUNOL, V163, P834; Murphy K., 2011, JANEWAYS IMMUNOBIOLO, V8th ed.; Niku M, 2012, DEV COMP IMMUNOL, V37, P457, DOI 10.1016/j.dci.2012.02.006; Pages H, 2014, BIOSTRINGS STRING OB; Patel KP, 2013, MODERN PATHOL, V26, P195, DOI 10.1038/modpathol.2012.142; Pramanik S, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-78; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RILEY LK, 1988, P NATL ACAD SCI USA, V85, P2489, DOI 10.1073/pnas.85.8.2489; Saini SS, 1997, MOL IMMUNOL, V34, P641, DOI 10.1016/S0161-5890(97)00055-2; Saini SS, 1999, EUR J IMMUNOL, V29, P2420, DOI 10.1002/(SICI)1521-4141(199908)29:08&lt;2420::AID-IMMU2420&gt;3.0.CO;2-A; Sandor Z, 2004, NUCLEIC ACIDS RES, V32, P1866, DOI 10.1093/nar/gkh502; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schroeder HW, 1995, ANN NY ACAD SCI, V764, P242; Sinclair MC, 1997, J IMMUNOL, V159, P3883; Sinkora M, 2003, J IMMUNOL, V170, P1781, DOI 10.4049/jimmunol.170.4.1781; TAKAHARA K, 1994, BIOSCI BIOTECH BIOCH, V58, P786, DOI 10.1271/bbb.58.786; Thai TH, 2004, J IMMUNOL, V173, P4009, DOI 10.4049/jimmunol.173.6.4009; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Uchiyama Y, 2009, BIOCHIMIE, V91, P165, DOI 10.1016/j.biochi.2008.07.005; Verma S, 2012, VET IMMUNOL IMMUNOP, V145, P14, DOI 10.1016/j.vetimm.2011.10.001; Wang F, 2013, CELL, V153, P1379, DOI 10.1016/j.cell.2013.04.049; Weill JC, 1998, DEV COMP IMMUNOL, V22, P379, DOI 10.1016/S0145-305X(98)00014-7; Wertz N, 2013, MOL IMMUNOL, V55, P319, DOI 10.1016/j.molimm.2013.03.012; Zhao YF, 2006, DEV COMP IMMUNOL, V30, P175, DOI 10.1016/j.dci.2005.06.012; Zhao YF, 2003, J BIOL CHEM, V278, P35024, DOI 10.1074/jbc.M301337200	68	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99808	10.1371/journal.pone.0099808	http://dx.doi.org/10.1371/journal.pone.0099808			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926997	gold, Green Submitted, Green Published			2022-12-27	WOS:000338278100083
J	Puig-Oliveras, A; Ramayo-Caldas, Y; Corominas, J; Estelle, J; Perez-Montarelo, D; Hudson, NJ; Casellas, J; Folch, JM; Ballester, M				Puig-Oliveras, Anna; Ramayo-Caldas, Yuliaxis; Corominas, Jordi; Estelle, Jordi; Perez-Montarelo, Dafne; Hudson, Nicholas J.; Casellas, Joaquim; Folch, Josep M.; Ballester, Maria			Differences in Muscle Transcriptome among Pigs Phenotypically Extreme for Fatty Acid Composition	PLOS ONE			English	Article							EXPRESSION ANALYSIS; ADIPOSE-TISSUE; SKELETAL-MUSCLE; GENE-EXPRESSION; LONGISSIMUS-DORSI; MEAT QUALITY; METABOLISM; DEPOSITION; PHOSPHOLIPIDS; ASSOCIATIONS	Backgroud: Besides having an impact on human health, the porcine muscle fatty acid profile determines meat quality and taste. The RNA-Seq technologies allowed us to explore the pig muscle transcriptome with an unprecedented detail. The aim of this study was to identify differentially-expressed genes between two groups of 6 sows belonging to an Iberian 6 Landrace backcross with extreme phenotypes according to FA profile. Results: We sequenced the muscle transcriptome acquiring 787.5 M of 75 bp paired-end reads. About 85.1% of reads were mapped to the reference genome. Of the total reads, 79.1% were located in exons, 6.0% in introns and 14.9% in intergenic regions, indicating expressed regions not annotated in the reference genome. We identified a 34.5% of the intergenic regions as interspersed repetitive regions. We predicted a total of 2,372 putative proteins. Pathway analysis with 131 differentially-expressed genes revealed that the most statistically-significant metabolic pathways were related with lipid metabolism. Moreover, 18 of the differentially-expressed genes were located in genomic regions associated with IMF composition in an independent GWAS study in the same genetic background. Thus, our results indicate that the lipid metabolism of FAs is differently modulated when the FA composition in muscle differs. For instance, a high content of PUFA may reduce FA and glucose uptake resulting in an inhibition of the lipogenesis. These results are consistent with previous studies of our group analysing the liver and the adipose tissue transcriptomes providing a view of each of the main organs involved in lipid metabolism. Conclusions: The results obtained in the muscle transcriptome analysis increase the knowledge of the gene regulation of IMF deposition, FA profile and meat quality, in terms of taste and nutritional value. Besides, our results may be important in terms of human health.	[Puig-Oliveras, Anna; Corominas, Jordi; Folch, Josep M.; Ballester, Maria] Ctr Recerca Agrigen CRAG, Dept Genet Anim, Bellaterra, Spain; [Puig-Oliveras, Anna; Corominas, Jordi; Casellas, Joaquim; Folch, Josep M.; Ballester, Maria] UAB, Dept Ciencia Anim & Aliments, Bellaterra, Spain; [Ramayo-Caldas, Yuliaxis; Estelle, Jordi] INRA, Genet Anim & Biol Integrat GABI UMR1313, Jouy En Josas, France; [Estelle, Jordi] AgroParisTech, Genet Anim & Biol Integrat GABI UMR1313, Jouy En Josas, France; [Estelle, Jordi] Commissariat Energie Atom & Energies Alternat CEA, LREG, Jouy En Josas, France; [Perez-Montarelo, Dafne] Inst Nacl Invest Tecnol Agr & Alimentaria INIA, Dept Genet Anim, Madrid, Spain; [Hudson, Nicholas J.] Commonwealth Sci & Ind Res Org CSIRO, Food & Hlth SciencesQLD, Brisbane, Qld, Australia; [Casellas, Joaquim] IRTA, Dept Genet & Millora Anim, Lleida, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Centre de Recerca en Agrigenomica (CRAG); Autonomous University of Barcelona; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; AgroParisTech; UDICE-French Research Universities; Universite Paris Saclay; CEA; UDICE-French Research Universities; Universite Paris Cite; Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Commonwealth Scientific & Industrial Research Organisation (CSIRO); IRTA	Puig-Oliveras, A (corresponding author), Ctr Recerca Agrigen CRAG, Dept Genet Anim, Bellaterra, Spain.	anna.puig@cragenomica.es	Corominas Galbany, Jordi/B-6356-2018; Hudson, Nick/C-1201-2008; Ballester, Maria/E-7201-2016; Puig Oliveras, Anna/M-5551-2015; Estellé, Jordi/A-7976-2008; Folch, Josep M/I-4738-2015; Devis, Maria Ballester/AAV-2467-2020; Caldas, Yuliaxis Ramayo/B-6337-2014; Hudson, Nick/AAF-5644-2020; Hudson, Nicholas J/D-1606-2011	Corominas Galbany, Jordi/0000-0003-1736-1278; Ballester, Maria/0000-0002-5413-4640; Puig Oliveras, Anna/0000-0003-2551-9012; Estellé, Jordi/0000-0002-6241-1732; Folch, Josep M/0000-0003-3689-1303; Devis, Maria Ballester/0000-0002-5413-4640; Caldas, Yuliaxis Ramayo/0000-0002-8142-0159; Hudson, Nick/0000-0002-3549-9396; Hudson, Nicholas J/0000-0002-3549-9396; Casellas, Joaquim/0000-0002-4982-3556	MICINN (Ministerio de Economia y Competitividad) [AGL2011-29821-C02]; Innovation Consolider-Ingenio Program [CSD2007-00036]; Personal Investigador en Formacion (PIF) PhD grant from the Universitat Autonoma de Barcelona [458-01-1/2011]; Formacion de Personal Investigador (FPI) PhD grant from Spanish Ministerio de Educacion [BES-2009018223]; Formacion del Profesorado Universitario (FPU) PhD grant [AP2008-01450]	MICINN (Ministerio de Economia y Competitividad); Innovation Consolider-Ingenio Program; Personal Investigador en Formacion (PIF) PhD grant from the Universitat Autonoma de Barcelona; Formacion de Personal Investigador (FPI) PhD grant from Spanish Ministerio de Educacion; Formacion del Profesorado Universitario (FPU) PhD grant(German Research Foundation (DFG))	This work has been funded by MICINN project AGL2011-29821-C02 (Ministerio de Economia y Competitividad) and by the Innovation Consolider-Ingenio 2010 Program (CSD2007-00036). A. Puig-Oliveras was funded by a Personal Investigador en Formacion (PIF) PhD grant from the Universitat Autonoma de Barcelona (458-01-1/2011). J. Corominas was funded by a Formacion de Personal Investigador (FPI) PhD grant from Spanish Ministerio de Educacion (BES-2009018223), Y. Ramayo by a Formacion del Profesorado Universitario (FPU) PhD grant (AP2008-01450). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Basco D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058712; Bayorh MA, 2005, CLIN EXP HYPERTENS, V27, P355, DOI 10.1081/CEH-200057423; Benhamed F, 2012, J CLIN INVEST, V122, P2176, DOI 10.1172/JCI41636; Bosma M, 2013, BBA-MOL CELL BIOL L, V1831, P844, DOI 10.1016/j.bbalip.2013.01.007; Cao HM, 2008, CELL, V134, P933, DOI 10.1016/j.cell.2008.07.048; Chegary M, 2009, BBA-MOL CELL BIOL L, V1791, P806, DOI 10.1016/j.bbalip.2009.05.006; Chen CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-448; Chen JX, 2008, DIABETES, V57, P3335, DOI 10.2337/db08-0503; Cohen P, 2002, SCIENCE, V297, P240, DOI 10.1126/science.1071527; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corominas J, 2013, ANAL PORCINE ADIPOSE; Dai ZL, 2013, BIOFACTORS, V39, P383, DOI 10.1002/biof.1099; Dalen KT, 2007, BBA-MOL CELL BIOL L, V1771, P210, DOI 10.1016/j.bbalip.2006.11.011; Damon M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033763; Estany J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086177; Esteve-Codina A, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-552; Estevez M, 2003, MEAT SCI, V64, P499, DOI 10.1016/S0309-1740(02)00228-0; FAO, 2008, REPORT EXPERT CONSUL, VVolume 91, P180; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Garcia-Alcalde F, 2012, BIOINFORMATICS, V28, P2678, DOI 10.1093/bioinformatics/bts503; Hamill RM, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-453; He M, 2007, AM J HUM GENET, V81, P87, DOI 10.1086/519219; Herman MA, 2012, NATURE, V484, P333, DOI 10.1038/nature10986; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jiang ZH, 2008, INT J BIOL SCI, V4, P345, DOI 10.7150/ijbs.4.345; Jung WY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042198; Kubota T, 2013, REV ENDOCR METAB DIS, V14, P207, DOI 10.1007/s11154-013-9242-z; Lagace TA, 2013, BBA-MOL CELL RES, V1833, P2499, DOI 10.1016/j.bbamcr.2013.05.018; Leonardini A, 2009, PPAR RES, V2009, DOI 10.1155/2009/818945; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Lunney JK, 2007, INT J BIOL SCI, V3, P179, DOI 10.7150/ijbs.3.179; Luo J, 2006, CELL METAB, V3, P355, DOI 10.1016/j.cmet.2006.04.003; Madeira MS, 2013, BRIT J NUTR, V110, P216, DOI 10.1017/S0007114512004916; Maharani D, 2013, MOL BIOL REP, V40, P73, DOI 10.1007/s11033-012-2014-0; Martinez-Botas J, 2000, NAT GENET, V26, P474, DOI 10.1038/82630; Medina I, 2010, NUCLEIC ACIDS RES, V38, pW210, DOI 10.1093/nar/gkq388; Merlot E, 2012, ANIMAL, V6, P1290, DOI 10.1017/S1751731112000080; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Munoz M, 2013, GENOME WIDE ANAL POR; Novgorodtseva TP, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-18; Oubaha M, 2009, BLOOD, V114, P3343, DOI 10.1182/blood-2008-12-196584; Pena RN, 2013, ANIM GENET, V44, P648, DOI 10.1111/age.12066; Perez-Enciso M, 2000, J ANIM SCI, V78, P2525; PUTNEY JW, 1993, ENDOCR REV, V14, P610, DOI 10.1210/er.14.5.610; Quesneville H, 2005, PLOS COMPUT BIOL, V1, P166, DOI 10.1371/journal.pcbi.0010022; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Ramayo-Caldas Y, 2012, J ANIM SCI, V90, P2883, DOI 10.2527/jas.2011-4900; Ramayo-Caldas Y, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-547; Reiter SS, 2007, COMP BIOCHEM PHYS D, V2, P200, DOI 10.1016/j.cbd.2007.04.008; Renaville B, 2013, MEAT SCI, V93, P495, DOI 10.1016/j.meatsci.2012.11.019; Revilla M., 2014, Genetics, Selection, Evolution, V46; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Rodriguez A, 2011, J CLIN ENDOCR METAB, V96, pE586, DOI 10.1210/jc.2010-1408; Serra X, 1998, LIVEST PROD SCI, V56, P215, DOI 10.1016/S0301-6226(98)00151-1; Soneson C, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-91; Stanke M, 2008, BIOINFORMATICS, V24, P637, DOI 10.1093/bioinformatics/btn013; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Sung HK, 2009, AM J PHYSIOL-ENDOC M, V297, pE402, DOI 10.1152/ajpendo.00122.2009; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Webb EC, 2008, MEAT SCI, V80, P28, DOI 10.1016/j.meatsci.2008.05.029; Wilcox Gisela, 2005, Clin Biochem Rev, V26, P19; Wilkinson S, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003453; Wood JD, 2008, MEAT SCI, V78, P343, DOI 10.1016/j.meatsci.2007.07.019; Xi Q, 2008, CIRC RES, V102, P1118, DOI 10.1161/CIRCRESAHA.108.173948; Yendrek Craig R, 2012, BMC Res Notes, V5, P506, DOI 10.1186/1756-0500-5-506; Yu KF, 2013, INT J BIOL SCI, V9, P108, DOI 10.7150/ijbs.5306; Zhang S, 2009, J ANIM BREED GENET, V126, P259, DOI 10.1111/j.1439-0388.2008.00782.x; Zhang WA, 2010, MEAT SCI, V86, P15, DOI 10.1016/j.meatsci.2010.04.018; Zhao X, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0019774, 10.1371/journal.pone.0021739]	76	46	47	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99720	10.1371/journal.pone.0099720	http://dx.doi.org/10.1371/journal.pone.0099720			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926690	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100072
J	Yadav, S; Verma, PJ; Panda, D				Yadav, Saroj; Verma, Paul J.; Panda, Dulal			C-Terminal Region of MAP7 Domain Containing Protein 3 (MAP7D3) Promotes Microtubule Polymerization by Binding at the C-Terminal Tail of Tubulin	PLOS ONE			English	Article							TAU-PROTEIN; DNA-SEQUENCE; IN-VITRO; ENSCONSIN; IDENTIFICATION; E-MAP-115; STABILIZATION; LOCALIZATION; PURIFICATION; SUBTILISIN	MAP7 domain containing protein 3 (MAP7D3), a newly identified microtubule associated protein, has been shown to promote microtubule assembly and stability. Its microtubule binding region has been reported to consist of two coiled coil motifs located at the N-terminus. It possesses a MAP7 domain near the C-terminus and belongs to the microtubule associated protein 7 (MAP7) family. The MAP7 domain of MAP7 protein has been shown to bind to kinesin-1; however, the role of MAP7 domain in MAP7D3 remains unknown. Based on the bioinformatics analysis of MAP7D3, we hypothesized that the MAP7 domain of MAP7D3 may have microtubule binding activity. Indeed, we found that MAP7 domain of MAP7D3 bound to microtubules as well as enhanced the assembly of microtubules in vitro. Interestingly, a longer fragment MDCT that contained the MAP7 domain (MD) with the C-terminal tail (CT) of the protein promoted microtubule polymerization to a greater extent than MD and CT individually. MDCT stabilized microtubules against dilution induced disassembly. MDCT bound to reconstituted microtubules with an apparent dissociation constant of 3.0 +/- 0.5 mu M. An immunostaining experiment showed that MDCT localized along the length of the preassembled microtubules. Competition experiments with tau indicated that MDCT shares its binding site on microtubules with tau. Further, we present evidence indicating that MDCT binds to the C-terminal tail of tubulin. In addition, MDCT could bind to tubulin in HeLa cell extract. Here, we report a microtubule binding region in the C-terminal region of MAP7D3 that may have a role in regulating microtubule assembly dynamics.	[Yadav, Saroj] Indian Inst Technol, IITB Monash Res Acad, Mumbai 400076, Maharashtra, India; [Verma, Paul J.] Monash Univ, Monash Inst Med Res, Ctr Reprod & Dev, Clayton, Vic, Australia; [Panda, Dulal] Indian Inst Technol, Dept Biosci & Bioengn, Mumbai 400076, Maharashtra, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay; Monash University; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Bombay	Panda, D (corresponding author), Indian Inst Technol, Dept Biosci & Bioengn, Mumbai 400076, Maharashtra, India.	panda@iitb.ac.in	Verma, Paul/AAQ-4657-2021		Department of Biotechnology, Government of India; IITB-Monash Research Academy; IIT-B Monash Research Academy	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); IITB-Monash Research Academy; IIT-B Monash Research Academy	This work was supported by a grant from Department of Biotechnology, Government of India to DP and partly by IITB-Monash Research Academy. SY is supported by fellowship from IIT-B Monash Research Academy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Akhmanova A, 2010, J CELL SCI, V123, P3415, DOI 10.1242/jcs.062414; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Asthana J, 2012, J BIOL CHEM, V287, P40793, DOI 10.1074/jbc.M112.394353; Banerjee A, 2010, ANAL BIOCHEM, V402, P194, DOI 10.1016/j.ab.2010.03.035; Barlan K, 2013, CURR BIOL, V23, P317, DOI 10.1016/j.cub.2013.01.008; Bhattacharya S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076286; BOHM G, 1992, PROTEIN ENG, V5, P191, DOI 10.1093/protein/5.3.191; Bosc C, 2003, BIOCHEMISTRY-US, V42, P12125, DOI 10.1021/bi0352163; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BULINSKI JC, 1979, P NATL ACAD SCI USA, V76, P293, DOI 10.1073/pnas.76.1.293; BULINSKI JC, 1994, J CELL SCI, V107, P2839; BUTNER KA, 1991, J CELL BIOL, V115, P717, DOI 10.1083/jcb.115.3.717; COFFEY RL, 1995, J BIOL CHEM, V270, P1035, DOI 10.1074/jbc.270.3.1035; Dehmelt L, 2005, GENOME BIOL, V6; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Fabre-Jonca N, 1998, DIFFERENTIATION, V63, P169, DOI 10.1111/j.1432-0436.1998.00169.x; Faire K, 1999, J CELL SCI, V112, P4243; Goode BL, 1997, MOL BIOL CELL, V8, P353, DOI 10.1091/mbc.8.2.353; GUSTKE N, 1994, BIOCHEMISTRY-US, V33, P9511, DOI 10.1021/bi00198a017; HAMEL E, 1981, ARCH BIOCHEM BIOPHYS, V209, P29, DOI 10.1016/0003-9861(81)90253-8; HERNANDEZ MA, 1986, EUR J BIOCHEM, V154, P41, DOI 10.1111/j.1432-1033.1986.tb09356.x; HUBER G, 1990, J CELL SCI, V95, P237; Letunic I, 2012, NUCLEIC ACIDS RES, V40, pD302, DOI 10.1093/nar/gkr931; LICHTENBERGKRAAG B, 1992, P NATL ACAD SCI USA, V89, P5384, DOI 10.1073/pnas.89.12.5384; Ludin B, 1996, J CELL SCI, V109, P91; MACCIONI RB, 1995, PHYSIOL REV, V75, P835, DOI 10.1152/physrev.1995.75.4.835; MASSON D, 1993, J CELL BIOL, V123, P357, DOI 10.1083/jcb.123.2.357; Metzger T, 2012, NATURE, V484, P120, DOI 10.1038/nature10914; Mollinari C, 2002, J CELL BIOL, V157, P1175, DOI 10.1083/jcb.200111052; Mungall AJ, 2003, NATURE, V425, P805, DOI 10.1038/nature02055; OOKATA K, 1995, J CELL BIOL, V128, P849, DOI 10.1083/jcb.128.5.849; Ota T, 2004, NAT GENET, V36, P40, DOI 10.1038/ng1285; PANDA D, 1995, BIOCHEMISTRY-US, V34, P11117, DOI 10.1021/bi00035a017; Patel K, 2012, CYTOSKELETON, V69, P155, DOI 10.1002/cm.21005; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; RIEDERER B, 1986, J NEUROCYTOL, V15, P763, DOI 10.1007/BF01625193; RODIONOV VI, 1990, J BIOL CHEM, V265, P5702; Ross MT, 2005, NATURE, V434, P325, DOI 10.1038/nature03440; Samora CP, 2011, NAT CELL BIOL, V13, P1040, DOI 10.1038/ncb2297; SAOUDI Y, 1995, J CELL SCI, V108, P357; Sato Y, 2013, J CELL SCI, V126, P4671, DOI 10.1242/jcs.127845; Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; SCHWEERS O, 1994, J BIOL CHEM, V269, P24290; SCOTT CW, 1992, J NEUROSCI RES, V33, P19, DOI 10.1002/jnr.490330104; SERRANO L, 1985, EUR J BIOCHEM, V153, P595, DOI 10.1111/j.1432-1033.1985.tb09342.x; SERRANO L, 1984, BIOCHEMISTRY-US, V23, P4675, DOI 10.1021/bi00315a024; Slep KC, 2007, MOL CELL, V27, P976, DOI 10.1016/j.molcel.2007.07.023; Slep KC, 2010, CURR OPIN CELL BIOL, V22, P88, DOI 10.1016/j.ceb.2009.10.009; Sun XO, 2011, CELL CYCLE, V10, P3929, DOI 10.4161/cc.10.22.18106; Sung HH, 2008, DEV CELL, V15, P866, DOI 10.1016/j.devcel.2008.10.006; Tokuraku K, 2003, J BIOL CHEM, V278, P29609, DOI 10.1074/jbc.M302186200; Tortosa E, 2011, J BIOL CHEM, V286, P40638, DOI 10.1074/jbc.M111.271320; VALLEE RB, 1982, J CELL BIOL, V92, P435, DOI 10.1083/jcb.92.2.435; van der Vaart B, 2009, BIOCHEM SOC T, V37, P1007, DOI 10.1042/BST0371007	58	19	20	3	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99539	10.1371/journal.pone.0099539	http://dx.doi.org/10.1371/journal.pone.0099539			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927501	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100047
J	Heerah, K; Hindell, M; Guinet, C; Charrassin, JB				Heerah, Karine; Hindell, Mark; Guinet, Christophe; Charrassin, Jean-Benoit			A New Method to Quantify within Dive Foraging Behaviour in Marine Predators	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEALS; AREA-RESTRICTED SEARCH; WEDDELL SEALS; FINE-SCALE; DIVING BEHAVIOR; PREY INTERACTIONS; MIROUNGA-LEONINA; STABLE-ISOTOPES; MOVEMENTS; DEPTH	Studies on diving behaviour classically divide a dive into three phases: the descent, bottom and ascent phases, with foraging assumed to occur during the bottom phase. The greater complexity of dive revealed through modern, high resolution data highlights the need to re-assess this approach and to consider a larger number of phases within individual dives. Two southern elephant seals (SES) were fitted with a head mounted Time Depth Recorder (TDR) and an accelerometer from which prey capture attempts were estimated. A Weddell seal was also fitted with a TDR. TDRs for both species recorded depth once per second. We quantified the within dive behaviour using an automated broken stick algorithm identifying the optimal number of segments within each dive. The vertical sinuosity of the segments was used to infer two types of behaviours, with highly sinuous segments indicating "hunting" and less sinuous segments indicating "transiting". Using the broken stick method the seals alternated between "hunting" and "transit" modes with an average of 6 +/- 2 and 7 +/- 0.02 behavioural phases within each dive for the Weddell seal and SES, respectively. In SES, 77% of prey capture attempts (identified from the acceleration data) occurred in highly sinuous phases ("hunting'') as defined by our new approach. SES spent more time in transit mode within a dive, and hunting mostly occurred during the bottom phase. Conversely the Weddell seal spent more time in hunting mode which also occurred during bottom phase but occurred mostly at shallower depths. Such differences probably reflect different foraging tactics and habitat use. For both species, hunting time differs significantly from bottom time previously used as a proxy for the time spent foraging in a dive. The hunting time defined by our method therefore provides a more accurate fine-scale description of the seals' foraging behaviour.	[Heerah, Karine; Charrassin, Jean-Benoit] MNHN, IRD, CNRS, Lab Oceanog & Climat Experimentat & Approches Num, Paris, France; [Heerah, Karine; Hindell, Mark] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia; [Hindell, Mark] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Guinet, Christophe] Ctr Etud Biol Chize, Villiers En Bois, France	Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite; University of Tasmania; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania	Heerah, K (corresponding author), MNHN, IRD, CNRS, Lab Oceanog & Climat Experimentat & Approches Num, Paris, France.	karine.heerah@hotmail.fr	Guinet, Christophe/AAR-8457-2020	Hindell, Mark/0000-0002-7823-7185	Australian Antarctic Science grant (AAS) [2794]; Terre-Ocean-Surface Continentale-Atmosphere from Centre National d'Etudes Spatiales (TOSCA-CNES)	Australian Antarctic Science grant (AAS); Terre-Ocean-Surface Continentale-Atmosphere from Centre National d'Etudes Spatiales (TOSCA-CNES)	This study was supported by an Australian Antarctic Science grant (AAS project 2794), and program Terre-Ocean-Surface Continentale-Atmosphere from Centre National d'Etudes Spatiales (TOSCA-CNES). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews-Goff Virginia, 2010, Endangered Species Research, V10, P83, DOI 10.3354/esr00257; Bailleul F, 2008, J ANIM ECOL, V77, P948, DOI 10.1111/j.1365-2656.2008.01407.x; Bailleul F, 2007, DEEP-SEA RES PT II, V54, P343, DOI 10.1016/j.dsr2.2006.11.005; Bailleul F, 2010, ECOGRAPHY, V33, P709, DOI 10.1111/j.1600-0587.2009.06034.x; Biuw M, 2007, P NATL ACAD SCI USA, V104, P13705, DOI 10.1073/pnas.0701121104; Block BA, 2011, NATURE, V475, P86, DOI 10.1038/nature10082; Bost CA, 2007, DEEP-SEA RES PT II, V54, P248, DOI 10.1016/j.dsr2.2006.11.007; Burns JM, 1998, POLAR BIOL, V19, P272, DOI 10.1007/s003000050245; CASTELLINI MA, 1992, J EXP BIOL, V165, P181; CHARNOV EL, 1976, THEOR POPUL BIOL, V9, P129, DOI 10.1016/0040-5809(76)90040-X; Cherel Y, 2008, MAR ECOL PROG SER, V370, P239, DOI 10.3354/meps07673; CORNET A, 1980, MAMMALIA, V44, P497, DOI 10.1515/mamm.1980.44.4.497; Davis RW, 2003, MAR ECOL PROG SER, V264, P109, DOI 10.3354/meps264109; Davis RW, 2012, DEEP SEA RES 2; Dragon A. C., 2011, MODELISATION STRATEG; Dragon AC, 2012, MAR ECOL PROG SER, V452, P253, DOI 10.3354/meps09618; Dragon AC, 2012, MAR ECOL PROG SER, V447, P243, DOI 10.3354/meps09498; Evans K, 2012, DEEP SEA RES 2; Fauchald P, 2003, ECOLOGY, V84, P282, DOI 10.1890/0012-9658(2003)084[0282:UFPTIT]2.0.CO;2; Fauchald P, 2002, MAR ECOL PROG SER, V231, P279, DOI 10.3354/meps231279; Fauchald P, 2000, ECOLOGY, V81, P773, DOI 10.1890/0012-9658(2000)081[0773:SDPPIT]2.0.CO;2; Fedak MA, 2001, MAR MAMMAL SCI, V17, P94, DOI 10.1111/j.1748-7692.2001.tb00982.x; Field IC, 2002, VET REC, V151, P235, DOI 10.1136/vr.151.8.235; Fuiman LA, 2002, MAR BIOL, V140, P815, DOI 10.1007/s00227-001-0752-y; Fuiman LA, 2007, DEEP-SEA RES PT II, V54, P270, DOI 10.1016/j.dsr2.2006.11.011; Gallon S, 2012, DEEP SEA RES 2; GREEN K, 1987, AUST WILDLIFE RES, V14, P475; Guinet C, 2014, MAR ECOL PROG SER, V499, P285, DOI 10.3354/meps10660; Hanuise N, 2010, J EXP BIOL, V213, P3874, DOI 10.1242/jeb.044057; Harcourt RG, 2000, POLAR BIOL, V23, P479, DOI 10.1007/s003000000109; Heerah K, 2013, DEEP SEA RES 2; Hindell MA, 2002, MAR ECOL PROG SER, V242, P275, DOI 10.3354/meps242275; HINDELL MA, 1991, AUST J ZOOL, V39, P595, DOI 10.1071/ZO9910595; Hindell MA, 2010, FORAGING BEHAV MARIN, P241; Hocking DP, 2013, POLAR BIOL, V36, P211, DOI 10.1007/s00300-012-1253-9; Horsburgh JM, 2008, MAR MAMMAL SCI, V24, P207, DOI 10.1111/j.1748-7692.2007.00156.x; Jonsen ID, 2007, MAR ECOL PROG SER, V337, P255, DOI 10.3354/meps337255; KAREIVA P, 1987, AM NAT, V130, P233, DOI 10.1086/284707; Kooyman GL, 1968, ANTARCT RES SER, V3, P227; Lake S, 2003, MAR ECOL PROG SER, V254, P293, DOI 10.3354/meps254293; LEBOEUF BJ, 1988, CAN J ZOOL, V66, P446, DOI 10.1139/z88-064; MACARTHUR RH, 1966, AM NAT, V100, P603, DOI 10.1086/282454; Marshall CD, 2008, J EXP BIOL, V211, P699, DOI 10.1242/jeb.009852; Mcintyre T, 2012, ANTARCT SCI, V24, P561, DOI 10.1017/S0954102012000570; Millot G.., 2011, COMPRENDRE R ALISER, V2; Mitani Y, 2004, MAR ECOL PROG SER, V281, P275, DOI 10.3354/meps281275; Mitani Y, 2003, POLAR BIOL, V26, P311, DOI 10.1007/s00300-003-0487-y; Moline MA, 2008, ANN NY ACAD SCI, V1134, P267, DOI 10.1196/annals.1439.010; Naito Y, 2010, POLAR SCI, V4, P309, DOI 10.1016/j.polar.2010.05.009; Naito Y, 2013, FUNCT ECOL, V27, P710, DOI 10.1111/1365-2435.12083; Plotz J, 2001, POLAR BIOL, V24, P901, DOI 10.1007/s003000100297; R Core Team, 2018, R LANG ENV STAT COMP; Ropert-Coudert Y, 2006, MAR BIOL, V149, P139, DOI 10.1007/s00227-005-0188-x; Sato K, 2008, J EXP BIOL, V211, P58, DOI 10.1242/jeb.009811; Scheffer A, 2012, MAR ECOL PROG SER, V465, P281, DOI 10.3354/meps09884; Schreer JF, 1996, MAR MAMMAL SCI, V12, P227, DOI 10.1111/j.1748-7692.1996.tb00573.x; Schreer JF, 2001, ECOL MONOGR, V71, P137, DOI 10.1890/0012-9615(2001)071[0137:CDPOPA]2.0.CO;2; Simeone A, 2003, MAR BIOL, V143, P825, DOI 10.1007/s00227-003-1114-8; Simpkins MA, 2001, MAR MAMMAL SCI, V17, P909, DOI 10.1111/j.1748-7692.2001.tb01305.x; Suzuki I, 2009, POLAR BIOL, V32, P667, DOI 10.1007/s00300-009-0596-3; TESTA JW, 1994, CAN J ZOOL, V72, P1700, DOI 10.1139/z94-229; Thums M, 2013, J ANIM ECOL, V82, P72, DOI 10.1111/j.1365-2656.2012.02021.x; Viviant M, 2010, POLAR BIOL, V33, P713, DOI 10.1007/s00300-009-0750-y; Watanabe Y, 2003, MAR ECOL PROG SER, V252, P283, DOI 10.3354/meps252283; Watanabe YY, 2013, P NATL ACAD SCI USA, V110, P2199, DOI 10.1073/pnas.1216244110; Weimerskirch H, 2007, AM NAT, V170, P734, DOI 10.1086/522059; Wheatley Kathryn E, 2006, BMC Vet Res, V2, P8, DOI 10.1186/1746-6148-2-8; Zimmer I, 2010, AQUAT BIOL, V8, P269, DOI 10.3354/ab00213	68	30	30	1	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99329	10.1371/journal.pone.0099329	http://dx.doi.org/10.1371/journal.pone.0099329			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922323	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300050
J	Jensen, HA; Bunaciu, RP; Ibabao, CN; Myers, R; Varner, JD; Yen, A				Jensen, Holly A.; Bunaciu, Rodica P.; Ibabao, Christopher N.; Myers, Rebecca; Varner, Jeffrey D.; Yen, Andrew			Retinoic Acid Therapy Resistance Progresses from Unilineage to Bilineage in HL-60 Leukemic Blasts	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; LIGAND-BINDING DOMAIN; CELL-DIFFERENTIATION; MONOCYTIC DIFFERENTIATION; RAR-ALPHA; MYELOID DIFFERENTIATION; INCREASED SENSITIVITY; VITAMIN-D-3 ANALOGS; EXPRESSION; ACTIVATION	Emergent resistance can be progressive and driven by global signaling aberrations. All-trans retinoic acid (RA) is the standard therapeutic agent for acute promyelocytic leukemia, but 10-20% of patients are not responsive, and initially responsive patients relapse and develop retinoic acid resistance. The patient-derived, lineage-bipotent acute myeloblastic leukemia (FAB M2) HL-60 cell line is a potent tool for characterizing differentiation-induction therapy responsiveness and resistance in t(15; 17)-negative cells. Wild-type (WT) HL-60 cells undergo RA-induced granulocytic differentiation, or monocytic differentiation in response to 1,25-dihydroxyvitamin D3 (D3). Two sequentially emergent RA-resistant HL-60 cell lines, R38+ and R38-, distinguishable by RA-inducible CD38 expression, do not arrest in G1/G0 and fail to upregulate CD11b and the myeloid-associated signaling factors Vav1, c-Cbl, Lyn, Fgr, and c-Raf after RA treatment. Here, we show that the R38+ and R38- HL-60 cell lines display a progressive reduced response to D3-induced differentiation therapy. Exploiting the biphasic dynamic of induced HL-60 differentiation, we examined if resistance-related defects occurred during the first 24 h (the early or "precommitment'' phase) or subsequently (the late or "lineage-commitment'' phase). HL-60 were treated with RA or D3 for 24 h, washed and retreated with either the same, different, or no differentiation agent. Using flow cytometry, D3 was able to induce CD38, CD11b and CD14 expression, and G1/G0 arrest when present during the lineage-commitment stage in R38+ cells, and to a lesser degree in R38- cells. Clustering analysis of cytometry and quantified Western blot data indicated that WT, R38+ and R38- HL-60 cells exhibited decreasing correlation between phenotypic markers and signaling factor expression. Thus differentiation induction therapy resistance can develop in stages, with initial partial RA resistance and moderate vitamin D3 responsiveness (unilineage maturation block), followed by bilineage maturation block and progressive signaling defects, notably the reduced expression of Vav1, Fgr, and c-Raf.	[Jensen, Holly A.; Varner, Jeffrey D.] Cornell Univ, Sch Chem & Biomol Engn, Ithaca, NY USA; [Bunaciu, Rodica P.; Yen, Andrew] Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA; [Ibabao, Christopher N.] Cornell Univ, Dept Biol, Ithaca, NY USA; [Myers, Rebecca] Rutgers State Univ, Dept Biol, New Brunswick, NJ 08903 USA	Cornell University; Cornell University; Cornell University; Rutgers State University New Brunswick	Yen, A (corresponding author), Cornell Univ, Dept Biomed Sci, Ithaca, NY 14850 USA.	ay13@cornell.edu		Bunaciu, Rodica/0000-0002-3101-0928	NIH [R01 CA033505, R01 CA152870]; NIH/PS-OC; NYSTEM NY Dept. Health; Cornell Vertebrate Genomics (VERGE); NSF [CBET-0846876]; Directorate For Engineering [0846876] Funding Source: National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA033505, R01CA152870] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH/PS-OC; NYSTEM NY Dept. Health; Cornell Vertebrate Genomics (VERGE); NSF(National Science Foundation (NSF)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants R01 CA033505 and R01 CA152870 from NIH (A.Y.) and NIH/PS-OC (Shuler/A.Y./R.P.B.), NYSTEM NY Dept. Health (A.Y.), Cornell Vertebrate Genomics (VERGE) (R. P. B.), and CBET-0846876 from NSF (J.D.V./H.A.J.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINS KB, 1995, BLOOD, V86, P2475; Battle TE, 2000, EXP CELL RES, V254, P287, DOI 10.1006/excr.1999.4766; Battle TE, 2001, EUR J CELL BIOL, V80, P59, DOI 10.1078/0171-9335-00141; Bertagnolo V, 2012, CELL SIGNAL, V24, P612, DOI 10.1016/j.cellsig.2011.11.017; Bertagnolo V, 2011, CELL TISSUE RES, V345, P163, DOI 10.1007/s00441-011-1195-5; Brooks SC, 1996, BLOOD, V87, P227; Bunaciu RP, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-39; Bunaciu RP, 2011, CANCER RES, V71, P2371, DOI 10.1158/0008-5472.CAN-10-2299; Bushue N, 2010, ADV DRUG DELIVER REV, V62, P1285, DOI 10.1016/j.addr.2010.07.003; Cheung FSG, 2012, EXPERT REV ANTICANC, V12, P811, DOI [10.1586/era.12.53, 10.1586/ERA.12.53]; Congleton J, 2012, LEUKEMIA, V26, P1180, DOI 10.1038/leu.2011.390; Dore BT, 1996, LEUKEMIA RES, V20, P761, DOI 10.1016/0145-2126(96)00043-4; DORE BT, 1994, LEUKEMIA, V8, P2179; DORE BT, 1993, LEUKEMIA RES, V17, P749, DOI 10.1016/0145-2126(93)90108-W; Dos Santos C, 2008, BLOOD, V111, P2269, DOI 10.1182/blood-2007-04-082099; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Gallagher RE, 2002, LEUKEMIA, V16, P1940, DOI 10.1038/sj.leu.2402719; Harrison J.S., 2012, LEUK RES TREAT, V2012, DOI DOI 10.1155/2012/125814; HAZIOT A, 1988, J IMMUNOL, V141, P547; Hong HY, 2001, DIFFERENTIATION, V68, P55, DOI 10.1046/j.1432-0436.2001.068001055.x; Hu LJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013305; Jensen HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058621; KATAGIRI K, 1991, J IMMUNOL, V146, P701; Koshizuka K, 1999, BREAST CANCER RES TR, V53, P113, DOI 10.1023/A:1006123819675; Kropf PL, 2010, LEUKEMIA, V24, P663, DOI 10.1038/leu.2009.267; Lamkin TJ, 2006, J CELL BIOCHEM, V97, P1328, DOI 10.1002/jcb.20745; MAZZONE A, 1995, HAEMATOLOGICA, V80, P161; Mori J, 1999, JPN J CANCER RES, V90, P660, DOI 10.1111/j.1349-7006.1999.tb00798.x; Muto A, 1999, BLOOD, V93, P2225, DOI 10.1182/blood.V93.7.2225.407a05_2225_2233; NILSSON B, 1984, BRIT J HAEMATOL, V57, P365, DOI 10.1111/j.1365-2141.1984.tb02910.x; NORMAN AW, 1990, CANCER RES, V50, P6857; Oeth P, 1998, BLOOD, V91, P2857, DOI 10.1182/blood.V91.8.2857.2857_2857_2865; PRATT MAC, 1990, MOL CELL BIOL, V10, P6445, DOI 10.1128/MCB.10.12.6445; REBEL VI, 1992, LEUKEMIA RES, V16, P443, DOI 10.1016/0145-2126(92)90169-8; Rego EM, 2001, SEMIN HEMATOL, V38, P54, DOI 10.1053/shem.2001.20865; Reiterer G, 2007, CANCER RES, V67, P7765, DOI 10.1158/0008-5472.CAN-07-0014; Reiterer G, 2006, CANCER RES, V66, P9083, DOI 10.1158/0008-5472.CAN-06-0972; ROBERTSON KA, 1992, BLOOD, V80, P1885; Shao WL, 1997, BLOOD, V89, P4282, DOI 10.1182/blood.V89.12.4282; Shen M, 2011, LEUK LYMPHOMA; Shen MQ, 2009, J BIOL CHEM, V284, P25664, DOI 10.1074/jbc.M109.014241; SKOWRONSKI RJ, 1995, ENDOCRINOLOGY, V136, P20, DOI 10.1210/en.136.1.20; Smith J, 2009, EXP CELL RES, V315, P2241, DOI 10.1016/j.yexcr.2009.03.004; Tang XH, 2011, ANNU REV PATHOL-MECH, V6, P345, DOI 10.1146/annurev-pathol-011110-130303; Wang JR, 2008, J BIOL CHEM, V283, P4375, DOI 10.1074/jbc.M708471200; Wang XN, 2001, J CELL BIOCHEM, V80, P471, DOI 10.1002/1097-4644(20010315)80:4<471::AID-JCB1001>3.0.CO;2-J; WARRELL RP, 1993, BLOOD, V82, P1949, DOI 10.1182/blood.V82.7.1949.bloodjournal8271949; Welch H, 1997, ONCOGENE, V15, P2021, DOI 10.1038/sj.onc.1201356; YEN A, 1984, J CELL PHYSIOL, V118, P277, DOI 10.1002/jcp.1041180310; Yen A, 2000, IN VITRO CELL DEV-AN, V36, P249; YEN A, 1987, CANCER RES, V47, P129; YEN A, 1994, EUR J CELL BIOL, V65, P103; YEN A, 1990, CANCER RES, V50, P1411; YEN A, 1987, EXP CELL RES, V173, P80, DOI 10.1016/0014-4827(87)90333-8; YEN A, 1995, J CELL PHYSIOL, V163, P502, DOI 10.1002/jcp.1041630310; Yen A, 1999, IN VITRO CELL DEV-AN, V35, P527; Yen A, 1998, CANCER RES, V58, P3163; ZHOU JY, 1991, BLOOD, V78, P75; ZINZAR S, 1989, LEUKEMIA RES, V13, P23, DOI 10.1016/0145-2126(89)90027-1	60	10	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98929	10.1371/journal.pone.0098929	http://dx.doi.org/10.1371/journal.pone.0098929			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922062	Green Submitted, gold, Green Published			2022-12-27	WOS:000338701300021
J	Daw, MA; Shabash, A; El-Bouzedi, A; Dau, AA				Daw, Mohamed A.; Shabash, Amira; El-Bouzedi, Abdallah; Dau, Aghnya A.		Libyan Study Grp Hepatitis HIV	Seroprevalence of HBV, HCV & HIV Co-Infection and Risk Factors Analysis in Tripoli-Libya	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; SUB-SAHARAN AFRICA; B-VIRUS; BLOOD-DONORS; MIDDLE-EAST; DRUG-USERS; INFECTION; PREVALENCE; EPIDEMIOLOGY; POPULATION	Background: In 1998 Libya experienced a major outbreak of multiple blood borne viral hepatitis and HIV infections. Since then, no studies have been done on the epidemic features and risk factors of HBV, HCV, HIV and co-infection among the general population. Methods: A prospective study was carried out using a multi-centre clustering method to collect samples from the general population. The participants were interviewed, and relevant information was collected, including socio-demographic, ethnic, and geographic variables. This information was correlated with the risk factors involved in the transmission of HBV, HCV and HIV. Blood samples were collected and the sera were tested for HBsAg, anti-HCV and anti-HIV using enzyme immunoassay. Results: A total of 9,170 participants from the nine districts of Tripoli were enrolled. The average prevalence of HBsAg was 3.7%, anti-HCV 0.9%, anti-HIV 0.15% and co-infection 0.02%. The prevalence varied from one district to another. HBV was more prevalent among those aged over 50 years and was associated with family history. Anti-HCV and anti-HIV were more prevalent among those aged 20-40 years. Intravenous drug use and blood transfusion were the main risk factors for HCV and HIV infection. Conclusion: HBV, HCV, HIV and co-infection are relatively common in Libya. High prevalence was associated with geographic, ethnic and socioeconomic variability within the community. HCV and HIV infections among the younger age groups are becoming an alarming issue. Regulations and health care education need to be implemented and longer term follow-up should be planned.	[Daw, Mohamed A.; Shabash, Amira] Fac Med, Dept Med Microbiol, Tripoli, Libya; [El-Bouzedi, Abdallah] Fac Biotechnol, Dept Lab Med, Tripoli, Libya; [Daw, Mohamed A.; Dau, Aghnya A.] Tripoli Med Ctr, Dept Surg, Fac Med, Tripoli, Libya		Daw, MA (corresponding author), Fac Med, Dept Med Microbiol, Tripoli, Libya.	mohamedadaw@gmail.com						Abu-Raddad LJ, 2010, AIDS, V24, pS5, DOI 10.1097/01.aids.0000386729.56683.33; Bagasra Omar, 2007, Libyan J Med, V2, P57, DOI 10.4176/070221; Baha W, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-50; Barth RE, 2010, INT J INFECT DIS, V14, pE1024, DOI 10.1016/j.ijid.2010.06.013; Ben Halima S, 2010, N AFRICA VIROL J, V15, P7; Breban R, 2013, J VIRAL HEPATITIS, V20, P294, DOI 10.1111/j.1365-2893.2012.01650.x; Cacoub P, 2000, GASTROEN CLIN BIOL, V24, P169; Dau AA, 2013, E MEDITERR HEALTH J, V19, P4; Daw MA, 2008, LIBYAN J MED, V3, P1, DOI 10.4176/071208; Daw MA, 2002, SAUDI MED J, V23, P1356; Daw MA, 2001, ANN SAUDI MED, V21, P130, DOI 10.5144/0256-4947.2001.130a; Daw MA, 2000, SAUDI MED J, V21, P1157; Daw MA, 2013, VIROLOGY DISCOVERY, V1, P3; Daw MA, 2014, MENTAL DISORDER; Daw MA, 2013, TRACING MODELLING HI, P2874; Daw MA, 2012, SCI WORLD J, V2012; Daw MA, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-17; Daw MA, 2012, SCI WORLD J, DOI 10.1100/2012/719494; de Oliveira T, 2006, NATURE, V444, P836, DOI 10.1038/444836a; El-Sherif A, 2009, J GASTROENTEROL, V44, P359, DOI 10.1007/s00535-009-0020-3; Elasifer HA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-317; Ezzikouri S, 2013, J MED VIROL, V85, P1542, DOI 10.1002/jmv.23643; Ezzikouri S, 2013, LIVER INT, V33, P811, DOI 10.1111/liv.12135; Feuth T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059302; Garcia-Calleja JM, 2006, SEX TRANSM INFECT, V82, pIII64, DOI 10.1136/sti.2006.019901; Hatzakis A, 2013, J VIRAL HEPATITIS, V20, P1, DOI 10.1111/jvh.12120; Hoffmann CJ, 2007, LANCET INFECT DIS, V7, P402, DOI 10.1016/S1473-3099(07)70135-4; Jobarteh M, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-230; Karatapanis S, 2012, EUR J GASTROEN HEPAT, V24, P878, DOI 10.1097/MEG.0b013e328354834f; Karoney MJ, 2013, PAN AFR MED J, V14, DOI 10.11604/pamj.2013.14.44.2199; MA Daw, 2014, HEPATITIS C VIRUS MO; Maaref F, 2011, PATHOL BIOL, V59, P213, DOI 10.1016/j.patbio.2009.10.004; Mejri S, 2005, J MED VIROL, V76, P185, DOI 10.1002/jmv.20342; Modi AA, 2007, AIDS REV, V9, P25; Mohamoud YA, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-288; Muehlberger N, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-34; Mumtaz G, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000444; Perrin Luc, 2007, Libyan J Med, V2, P55, DOI 10.4176/070219; Quan VM, 2009, AIDS CARE, V21, P7, DOI 10.1080/09540120802017610; Rebbani K, 2013, CLIN MICROBIOL INFEC, V19, pE454, DOI 10.1111/1469-0691.12252; Romano L, 2013, BLOOD TRANSFUS-ITALY, V11, P281, DOI 10.2450/2012.0160-12; Rouabhia S, 2013, WORLD J HEPATOL, V5, P393, DOI 10.4254/wjh.v5.i7.393; Rouabhia S, 2010, WORLD J GASTROENTERO, V16, P3427, DOI 10.3748/wjg.v16.i27.3427; ROUDIFAHIMI F, 2007, TIME INTERVENE PREVE; Rusine J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063303; Schreuder I, 2010, HARM REDUCT J, V7, DOI 10.1186/1477-7517-7-25; Shawky S, 2009, JAIDS-J ACQ IMM DEF, V51, pS83, DOI 10.1097/QAI.0b013e3181aafd3f; Singal AK, 2009, WORLD J GASTROENTERO, V15, P3713, DOI 10.3748/wjg.15.3713	48	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e98793	10.1371/journal.pone.0098793	http://dx.doi.org/10.1371/journal.pone.0098793			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936655	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400010
J	Determan, C; Anderson, R; Becker, A; Witowski, N; Lusczek, E; Mulier, K; Beilman, GJ				Determan, Charles, Jr.; Anderson, Rebecca; Becker, Aaron; Witowski, Nancy; Lusczek, Elizabeth; Mulier, Kristine; Beilman, Greg J.			Fed State Prior to Hemorrhagic Shock and Polytrauma in a Porcine Model Results in Altered Liver Transcriptomic Response	PLOS ONE			English	Article							CELL-VOLUME REGULATION; NO-REFLOW PHENOMENON; ISCHEMIA-REPERFUSION INJURY; COMBAT CASUALTY CARE; HYPERTONIC SALINE; MYOCARDIAL-ISCHEMIA; GENE-EXPRESSION; HYDRATION STATE; TISSUE-DAMAGE; RESUSCITATION	Hemorrhagic shock is a leading cause of trauma-related mortality in both civilian and military settings. Resuscitation often results in reperfusion injury and survivors are susceptible to developing multiple organ failure (MOF). The impact of fed state on the overall response to shock and resuscitation has been explored in some murine models but few clinically relevant large animal models. We have previously used metabolomics to establish that the fed state results in a different metabolic response in the porcine liver following hemorrhagic shock and resuscitation. In this study, we used our clinically relevant model of hemorrhagic shock and polytrauma and the Illumina HiSeq platform to determine if the liver transcriptomic response is also altered with respect to fed state. Functional analysis of the response to shock and resuscitation confirmed several typical responses including carbohydrate metabolism, cytokine inflammation, decreased cholesterol synthesis, and apoptosis. Our findings also suggest that the fasting state, relative to a carbohydrate prefed state, displays decreased carbohydrate metabolism, increased cytoskeleton reorganization and decreased inflammation in response to hemorrhagic shock and reperfusion. Evidence suggests that this is a consequence of a shrunken, catabolic state of the liver cells which provides an anti-inflammatory condition that partially mitigates hepatocellar damage.	[Determan, Charles, Jr.; Anderson, Rebecca; Becker, Aaron; Witowski, Nancy; Lusczek, Elizabeth; Mulier, Kristine; Beilman, Greg J.] Univ Minnesota, Dept Surg, Div Crit Care & Acute Care Surg, Minneapolis, MN 55455 USA	University of Minnesota System; University of Minnesota Twin Cities	Determan, C (corresponding author), Univ Minnesota, Dept Surg, Div Crit Care & Acute Care Surg, Box 242 UMHC, Minneapolis, MN 55455 USA.	deter088@umn.edu		Lusczek, Elizabeth/0000-0003-4680-965X; Beilman, Gregory/0000-0001-5036-3027	University of Minnesota Department of Surgery Grant; Office of Naval Research [N00014-09-1-0323 P00005]	University of Minnesota Department of Surgery Grant; Office of Naval Research(Office of Naval Research)	This work was funding by the University of Minnesota Department of Surgery Grant and the Office of Naval Research (N00014-09-1-0323 P00005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angele MK, 2008, CRIT CARE, V12, DOI 10.1186/cc6919; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bahrami S, 2006, SHOCK, V25, P283, DOI 10.1097/01.shk.0000208808.03148.ea; Benkhart EM, 2000, J IMMUNOL, V165, P1612, DOI 10.4049/jimmunol.165.3.1612; Benkoel L, 2001, DIGEST DIS SCI, V46, P1663, DOI 10.1023/A:1010693218680; Cinel I, 2009, CRIT CARE MED, V37, P291, DOI 10.1097/CCM.0b013e31819267fb; Coimbra R, 1997, J TRAUMA, V42, P602, DOI 10.1097/00005373-199704000-00004; Determan CE, 2014, METABOLOMICS, V10, P950, DOI 10.1007/s11306-014-0621-6; Dubick Michael A, 2011, US Army Med Dep J, P18; Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525; Eastridge BJ, 2012, J TRAUMA ACUTE CARE, V73, pS431, DOI 10.1097/TA.0b013e3182755dcc; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; FLORES J, 1972, J MEMBRANE BIOL, V10, P331, DOI 10.1007/BF01867864; Gatsios P, 1998, J BIOL CHEM, V273, P22962, DOI 10.1074/jbc.273.36.22962; GAUSSIN V, 1992, BIOCHEM J, V287, P17, DOI 10.1042/bj2870017; GAVIN JB, 1983, VIRCHOWS ARCH A, V399, P325, DOI 10.1007/BF00612950; HAUSSINGER D, 1994, AM J PHYSIOL, V267, pE343, DOI 10.1152/ajpendo.1994.267.3.E343; HAUSSINGER D, 1993, LANCET, V341, P1330, DOI 10.1016/0140-6736(93)90828-5; Haussinger D, 1996, BIOCHEM J, V313, P697; Hoffmann EK, 2009, PHYSIOL REV, V89, P193, DOI 10.1152/physrev.00037.2007; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; Holcomb JB, 1999, J TRAUMA, V46, P49, DOI 10.1097/00005373-199901000-00009; Holcomb John, 2007, US Army Med Dep J, P24; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Iyegha UP, 2012, J AM COLL SURGEONS, V215, pS52, DOI 10.1016/j.jamcollsurg.2012.06.152; Ke QH, 2006, DIGEST DIS SCI, V51, P2257, DOI 10.1007/s10620-006-9135-6; Kol A, 2000, J IMMUNOL, V164, P13, DOI 10.4049/jimmunol.164.1.13; LEAF A, 1973, CIRCULATION, V48, P455, DOI 10.1161/01.CIR.48.3.455; Lexcen DR, 2012, J TRAUMA ACUTE CARE, V73, pS147, DOI 10.1097/TA.0b013e3182609821; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Lusczek ER, 2013, METABOLOMICS, V9, P223, DOI 10.1007/s11306-012-0441-5; MANCIET LH, 1994, AM J PHYSIOL, V266, pH1541, DOI 10.1152/ajpheart.1994.266.4.H1541; Molitoris BA, 1997, AM J PHYSIOL-RENAL, V272, pF430, DOI 10.1152/ajprenal.1997.272.4.F430; Murao Y, 2003, SHOCK, V20, P23, DOI 10.1097/01.shk.0000078832.57685.6c; Oreopoulos GD, 2004, HEPATOLOGY, V40, P211, DOI 10.1002/hep.20281; Oshlack A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-12-220; Pedersen SF, 2001, COMP BIOCHEM PHYS A, V130, P385, DOI 10.1016/S1095-6433(01)00429-9; Peitzman A B, 1995, Curr Probl Surg, V32, P925, DOI 10.1016/S0011-3840(05)80008-5; Rezkalla SH, 2002, CIRCULATION, V105, P656, DOI 10.1161/hc0502.102867; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Scribner DM, 2010, J SURG RES, V164, pE131, DOI 10.1016/j.jss.2010.07.046; Smedley D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-22; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; THEODOROPOULOS PA, 1992, FEBS LETT, V311, P241, DOI 10.1016/0014-5793(92)81111-X; TRANUMJENSEN J, 1981, CIRC RES, V49, P364, DOI 10.1161/01.RES.49.2.364; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsan MF, 2004, AM J PHYSIOL-CELL PH, V286, pC739, DOI 10.1152/ajpcell.00364.2003; Yoshidome H, 1999, HEPATOLOGY, V30, P203, DOI 10.1002/hep.510300120	50	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100088	10.1371/journal.pone.0100088	http://dx.doi.org/10.1371/journal.pone.0100088			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937255	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400071
J	Dutta, B; Gitaitis, R; Smith, S; Langston, D				Dutta, Bhabesh; Gitaitis, Ronald; Smith, Samuel; Langston, David, Jr.			Interactions of Seedborne Bacterial Pathogens with Host and Non-Host Plants in Relation to Seed Infestation and Seedling Transmission	PLOS ONE			English	Article							AVENAE SUBSP CITRULLI; CAMPESTRIS PV VESICATORIA; ACIDOVORAX-AVENAE; XANTHOMONAS-CAMPESTRIS; TOMATO; COLONIZATION; WATERMELON; SURVIVAL; ASSOCIATION; DISEASE	The ability of seed-borne bacterial pathogens (Acidovorax citrulli, Clavibacter michiganensis subsp. michiganensis, Pseudomonas syringae pv. tomato, Xanthomonas euvesicatoria, and Pseudomonas syringae pv. glycinea) to infest seeds of host and non-host plants (watermelon, tomato, pepper, and soybean) and subsequent pathogen transmission to seedlings was investigated. A non-pathogenic, pigmented strain of Serratia marcescens was also included to assess a null-interacting situation with the same plant species. Flowers of host and non-host plants were inoculated with 1x10(6) colony forming units (CFUs)/flower for each bacterial species and allowed to develop into fruits or umbels (in case of onion). Seeds harvested from each host/non-host bacterial species combination were assayed for respective bacteria by plating on semi-selective media. Additionally, seedlots for each host/non-host bacterial species combination were also assayed for pathogen transmission by seedling grow-out (SGO) assays under greenhouse conditions. The mean percentage of seedlots infested with compatible and incompatible pathogens was 31.7 and 30.9% (by plating), respectively and they were not significantly different (P = 0.67). The percentage of seedlots infested with null-interacting bacterial species was 16.8% (by plating) and it was significantly lower than the infested lots generated with compatible and incompatible bacterial pathogens (P = 0.03). None of the seedlots with incompatible/null-interacting bacteria developed symptoms on seedlings; however, when seedlings were assayed for epiphytic bacterial presence, 19.5 and 9.4% of the lots were positive, respectively. These results indicate that the seeds of non-host plants can become infested with incompatible and null-interacting bacterial species through flower colonization and they can be transmitted via epiphytic colonization of seedlings. In addition, it was also observed that flowers and seeds of non-host plants can be colonized by compatible/incompatible/null-interacting bacteria to higher populations; however, the level of colonization differed significantly depending on the type of bacterial species used.	[Dutta, Bhabesh; Gitaitis, Ronald; Smith, Samuel; Langston, David, Jr.] Univ Georgia, Coastal Plain Expt Stn, Dept Plant Pathol, Tifton, GA 31793 USA	University System of Georgia; University of Georgia	Dutta, B (corresponding author), Univ Georgia, Coastal Plain Expt Stn, Dept Plant Pathol, Tifton, GA 31793 USA.	bhabesh@uga.edu		Dutta, Bhabesh/0000-0001-9841-257X	Georgia Agricultural Commodity Commission for Vegetables [2631RE682316]; Vidalia Onion Commission [2521RF332621]	Georgia Agricultural Commodity Commission for Vegetables; Vidalia Onion Commission	This work was supported in part by Georgia Agricultural Commodity Commission for Vegetables (Grant# 2631RE682316). The additional funding for this project came from Vidalia Onion Commission (Grant#2521RF332621). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNAUDSANTANA E, 1991, PLANT DIS, V75, P952, DOI 10.1094/PD-75-0952; Assouline I, 1997, PHYTOPARASITICA, V25, P117, DOI 10.1007/BF02981192; Bach HJ, 2003, J MICROBIOL METH, V52, P85, DOI 10.1016/S0167-7012(02)00152-5; Burdman S, 2012, MOL PLANT PATHOL, V13, P805, DOI 10.1111/j.1364-3703.2012.00810.x; COOK AA, 1952, PHYTOPATHOLOGY, V42, P316; Cook KA, 2005, J ECON ENTOMOL, V98, P673, DOI 10.1603/0022-0493-98.3.673; Darrasse A, 2010, APPL ENVIRON MICROB, V76, P6787, DOI 10.1128/AEM.01098-10; Darsonval A, 2008, APPL ENVIRON MICROB, V74, P2669, DOI 10.1128/AEM.02906-07; Dutta B, 2014, PHYTOPATHOLOGY, V104, P232, DOI 10.1094/PHYTO-05-13-0138-R; Dutta B, 2013, SEED SCI TECHNOL, V41, P383, DOI 10.15258/sst.2013.41.3.06; Dutta B, 2012, PHYTOPATHOLOGY, V102, P461, DOI 10.1094/PHYTO-10-11-0286-R; Fessehaie A, 2005, PHYTOPATHOLOGY, V95, P413, DOI 10.1094/PHYTO-95-0413; FETT WF, 1979, PLANT DIS REP, V63, P79; GIBSON S, 1978, J CLIN MICROBIOL, V7, P279; Gilbertson R. L., 1992, Plant diseases of international importance. Volume II. Diseases of vegetables and oil seed crops.., P18; GITAITIS R, 1992, PLANT DIS, V76, P651, DOI 10.1094/PD-76-0651; Gitaitis R, 1998, PLANT DIS, V82, P935, DOI 10.1094/PDIS.1998.82.8.935; GITAITIS RD, 1978, PHYTOPATHOLOGY, V68, P227, DOI 10.1094/Phyto-68-227; GITAITIS RD, 1991, PLANT DIS, V75, P834, DOI 10.1094/PD-75-0834; Gitaitis R, 2007, ANNU REV PHYTOPATHOL, V45, P371, DOI 10.1146/annurev.phyto.45.062806.094321; GLEASON ML, 1993, PLANT DIS, V77, P1069, DOI 10.1094/PD-77-1069; Ha Y, 2009, PHYTOPATHOLOGY, V99, P666, DOI 10.1094/PHYTO-99-6-0666; Hopkins DL, 2002, HORTSCIENCE, V37, P924, DOI 10.21273/HORTSCI.37.6.924; Johnson KL, 2011, PLANT DIS, V95, P697, DOI 10.1094/PDIS-09-10-0660; Jones JB, 2000, INT J SYST EVOL MICR, V50, P1211, DOI 10.1099/00207713-50-3-1211; Jones JB, 2004, SYST APPL MICROBIOL, V27, P755, DOI 10.1078/0723202042369884; JONES JB, 1986, PHYTOPATHOLOGY, V76, P430, DOI 10.1094/Phyto-76-430; KAUFFMAN PH, 1974, PHYTOPATHOLOGY, V64, P329, DOI 10.1094/Phyto-64-329; LAMKA GL, 1991, PHYTOPATHOLOGY, V81, P839, DOI 10.1094/Phyto-81-839; MCCARTER SM, 1983, PHYTOPATHOLOGY, V73, P1393, DOI 10.1094/Phyto-73-1393; Nelson EB, 2004, ANNU REV PHYTOPATHOL, V42, P271, DOI 10.1146/annurev.phyto.42.121603.131041; RANE KK, 1992, PLANT DIS, V76, P509, DOI 10.1094/PD-76-0509; ROBERTS DP, 1994, PLANT SCI, V101, P83, DOI 10.1016/0168-9452(94)90167-8; Schaad NW, 2008, SYST APPL MICROBIOL, V31, P434, DOI 10.1016/j.syapm.2008.09.003; SCHAAD NW, 1981, PHYTOPATHOLOGY, V71, P1215, DOI 10.1094/Phyto-71-1215; SCHAAD NW, 1978, INT J SYST BACTERIOL, V28, P117, DOI 10.1099/00207713-28-1-117; SCHAAD NW, 2001, LAB GUIDE IDENTIFICA, P75; SHARON E, 1982, J APPL BACTERIOL, V53, P371, DOI 10.1111/j.1365-2672.1982.tb01285.x; SIJAM K, 1991, PHYTOPATHOLOGY, V81, P831, DOI 10.1094/Phyto-81-831; Spinelli F, 2005, EUR J PLANT PATHOL, V113, P395, DOI 10.1007/s10658-005-4511-7; STALL RE, 1994, INT J SYST BACTERIOL, V44, P47, DOI 10.1099/00207713-44-1-47; Strider D.L., 1969, NC AGR EXP STN TECH, V193, P1; Thri-Murty V.S, 1981, ORYZA, V18, P59; van der Wolf JM, 2010, J PHYTOPATHOL, V158, P726, DOI 10.1111/j.1439-0434.2010.01690.x; Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25; Walcott RR, 2003, PHYTOPATHOLOGY, V93, P528, DOI 10.1094/PHYTO.2003.93.5.528; Walcott RR, 2000, PHYTOPATHOLOGY, V90, P191, DOI 10.1094/PHYTO.2000.90.2.191; Walcott RR, 2000, PLANT DIS, V84, P470, DOI 10.1094/PDIS.2000.84.4.470; Webb R. E., 1965, PLANT DIS REP, V49, P818; Wells ML, 2002, ANN ENTOMOL SOC AM, V95, P719, DOI 10.1603/0013-8746(2002)095[0719:AOTTFF]2.0.CO;2; Zaccardelli M, 2005, EUR J PLANT PATHOL, V111, P85, DOI 10.1007/s10658-004-2734-7; Zhang Q, 2005, APPL ENVIRON MICROB, V71, P7716, DOI 10.1128/AEM.71.12.7716-7723.2005	52	30	33	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99215	10.1371/journal.pone.0099215	http://dx.doi.org/10.1371/journal.pone.0099215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936863	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400012
J	Luo, XQ; Suzuki, M; Ghandhi, SA; Amundson, SA; Boothman, DA				Luo, Xiuquan; Suzuki, Masatoshi; Ghandhi, Shanaz A.; Amundson, Sally A.; Boothman, David A.			ATM Regulates Insulin-Like Growth Factor 1-Secretory Clusterin (IGF-1-sCLU) Expression that Protects Cells against Senescence	PLOS ONE			English	Article							HUMAN-DIPLOID FIBROBLASTS; INDUCED PREMATURE SENESCENCE; DNA-DAMAGE RESPONSE; CELLULAR SENESCENCE; CLUSTERIN/APOLIPOPROTEIN-J; CANCER-CELLS; TRIGGERS SENESCENCE; OXIDATIVE STRESS; APOPTOSIS; SECRETION	Downstream factors that regulate the decision between senescence and cell death have not been elucidated. Cells undergo senescence through three pathways, replicative senescence (RS), stress-induced premature senescence (SIPS) and oncogene-induced senescence. Recent studies suggest that the ataxia telangiectasia mutant (ATM) kinase is not only a key protein mediating cellular responses to DNA damage, but also regulates cellular senescence induced by telomere end exposure (in RS) or persistent DNA damage (in SIPS). Here, we show that expression of secretory clusterin (sCLU), a known pro-survival extracellular chaperone, is transcriptionally up-regulated during both RS and SIPS, but not in oncogene-induced senescence, consistent with a DNA damage-inducible mechanism. We demonstrate that ATM plays an important role in insulin-like growth factor 1 (IGF-1) expression, that in turn, regulates downstream sCLU induction during senescence. Loss of ATM activity, either by genomic mutation (ATM-deficient fibroblasts from an ataxia telangiectasia patient) or by administration of a chemical inhibitor (AAI, an inhibitor of ATM and ATR), blocks IGF-1-sCLU expression in senescent cells. Downstream, sCLU induction during senescence is mediated by IGF-1R/MAPK/Egr-1 signaling, identical to its induction after DNA damage. In contrast, administration of an IGF-1 inhibitor caused apoptosis of senescent cells. Thus, IGF-1 signaling is required for survival, whereas sCLU appears to protect cells from premature senescence, as IMR-90 cells with sCLU knockdown undergo senescence faster than control cells. Thus, the ATM-IGF-1-sCLU pathway protects cells from lethality and suspends senescence.	[Luo, Xiuquan; Suzuki, Masatoshi; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Program Cell Stress & Canc Nanomed, Dept Pharmacol,Lab Mol Cell Stress Responses, Dallas, TX 75390 USA; [Luo, Xiuquan; Suzuki, Masatoshi; Boothman, David A.] Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Program Cell Stress & Canc Nanomed, Dept Radiat Oncol,Lab Mol Cell Stress Responses, Dallas, TX 75390 USA; [Ghandhi, Shanaz A.; Amundson, Sally A.] Columbia Univ, Ctr Radiol Res, Med Ctr, New York, NY 10032 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Columbia University	Boothman, DA (corresponding author), Univ Texas SW Med Ctr Dallas, Simmons Canc Ctr, Program Cell Stress & Canc Nanomed, Dept Pharmacol,Lab Mol Cell Stress Responses, Dallas, TX 75390 USA.	David.Boothman@UTSouthwestern.edu	Ghandhi, Shanaz/C-5930-2016; Boothman, David/Q-7776-2019		DOD [X81XWH-091-0168]; Department of Energy (DOE) [DE-FG-022179-18-21]; NIH [R01 CA139217, U19 AI067773, CA-49062]; NATIONAL CANCER INSTITUTE [R01CA139217, P30CA142543, P01CA049062, R01CA102792] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067773] Funding Source: NIH RePORTER	DOD(United States Department of Defense); Department of Energy (DOE)(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by DOD postdoctoral fellowship, X81XWH-091-0168, to XL, and grants DE-FG-022179-18-21 from the Department of Energy (DOE) and R01 CA139217 from the NIH to DAB, and NIH grants U19 AI067773 and CA-49062 to SAA and SAG. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barascu A, EMBO J, V31, P1080; Bhatti S, 2011, CELL MOL LIFE SCI, V68, P2977, DOI 10.1007/s00018-011-0683-9; Calderwood SK, 2009, GERONTOLOGY, V55, P550, DOI 10.1159/000225957; Campisi J, 2005, CELL, V120, P513, DOI 10.1016/j.cell.2005.02.003; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; CHEN Q, 1995, P NATL ACAD SCI USA, V92, P4337, DOI 10.1073/pnas.92.10.4337; Chen QM, 2001, EXP CELL RES, V265, P294, DOI 10.1006/excr.2001.5182; Criswell T, 2005, J BIOL CHEM, V280, P14212, DOI 10.1074/jbc.M412569200; Denchi EL, 2007, NATURE, V448, P1068, DOI 10.1038/nature06065; Di Micco R, NAT CELL BIOL, V13, P292; Frippiat C, 2002, FREE RADICAL BIO MED, V33, P1334, DOI 10.1016/S0891-5849(02)01044-4; Frippiat C, 2001, J BIOL CHEM, V276, P2531, DOI 10.1074/jbc.M006809200; Gabai VL, 2009, MOL CELL BIOL, V29, P559, DOI 10.1128/MCB.01041-08; Goetz EM, 2011, ONCOGENE, V30, P3745, DOI 10.1038/onc.2011.92; Herbig U, 2004, MOL CELL, V14, P501, DOI 10.1016/S1097-2765(04)00256-4; Kitagawa R, 2005, COLD SH Q B, V70, P99, DOI 10.1101/sqb.2005.70.002; Klock G, 1998, J CELL PHYSIOL, V177, P593, DOI 10.1002/(SICI)1097-4652(199812)177:4<593::AID-JCP10>3.3.CO;2-6; Krtolica A, 2001, P NATL ACAD SCI USA, V98, P12072, DOI 10.1073/pnas.211053698; Ksiazek K, 2007, BIOCHEM BIOPH RES CO, V362, P707, DOI 10.1016/j.bbrc.2007.08.047; Lau SH, 2006, ONCOGENE, V25, P1242, DOI 10.1038/sj.onc.1209141; Liu D, 2007, CANCER RES, V67, P3117, DOI 10.1158/0008-5472.CAN-06-3452; MacLaren A, 2004, MOL CELL BIOL, V24, P9006, DOI 10.1128/MCB.24.20.9006-9018.2004; Miura Y, 2011, EXP GERONTOL, V46, P81, DOI 10.1016/j.exger.2010.10.002; Naka K, 2004, J BIOL CHEM, V279, P2030, DOI 10.1074/jbc.M309457200; O'Callaghan-Sunol C, 2007, CANCER RES, V67, P11779, DOI 10.1158/0008-5472.CAN-07-2441; Ogrunc M, 2011, EUR J CANCER, V47, P1616, DOI 10.1016/j.ejca.2011.04.003; Petropoulou C, 2001, FEBS LETT, V509, P287, DOI 10.1016/S0014-5793(01)03150-7; Rai P, 2009, P NATL ACAD SCI USA, V106, P169, DOI 10.1073/pnas.0809834106; Restall IJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011076; Rodier F, 2009, NAT CELL BIOL, V11, P973, DOI 10.1038/ncb1909; Shannan B, 2006, CELL DEATH DIFFER, V13, P12, DOI 10.1038/sj.cdd.4401779; Shiloh Y, 2003, NAT REV CANCER, V3, P155, DOI 10.1038/nrc1011; Suzuki M, 2008, J RADIAT RES, V49, P105, DOI 10.1269/jrr.07081; Trougakos IP, 2002, INT J BIOCHEM CELL B, V34, P1430, DOI 10.1016/S1357-2725(02)00041-9; Trougakos IP, 2004, CANCER RES, V64, P1834, DOI 10.1158/0008-5472.CAN-03-2664; Volonte D, 2009, AGING-US, V1, P831, DOI 10.18632/aging.100079; Volonte D, 2009, J BIOL CHEM, V284, P5462, DOI 10.1074/jbc.C800225200; von Zglinicki T, 2005, MECH AGEING DEV, V126, P111, DOI 10.1016/j.mad.2004.09.034; Yaglom JA, 2007, CANCER RES, V67, P2373, DOI 10.1158/0008-5472.CAN-06-3796; Zhan H, 2010, J BIOL CHEM, V285, P29662, DOI 10.1074/jbc.M110.125138; Zhang HL, 2005, NAT CELL BIOL, V7, P909, DOI 10.1038/ncb1291	41	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99983	10.1371/journal.pone.0099983	http://dx.doi.org/10.1371/journal.pone.0099983			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937130	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400062
J	Pousada, G; Baloira, A; Vilarino, C; Cifrian, JM; Valverde, D				Pousada, Guillermo; Baloira, Adolfo; Vilarino, Carlos; Manuel Cifrian, Jose; Valverde, Diana			Novel Mutations in BMPR2, ACVRL1 and KCNA5 Genes and Hemodynamic Parameters in Patients with Pulmonary Arterial Hypertension	PLOS ONE			English	Article							RECEPTOR-LIKE KINASE-1; ATRIAL-FIBRILLATION; HEART-DISEASE; II RECEPTOR; K+ CHANNELS; VARIANTS; CHILDREN; DOMAIN; CELLS; ALK-1	Background: Pulmonary arterial hypertension (PAH) is a rare and progressive vascular disorder characterized by increased pulmonary vascular resistance and right heart failure. The aim of this study was to analyze the Bone Morphogenetic Protein Receptor 2 (BMPR2), Activin A type II receptor like kinase 1 (ALK1/ACVRL1) and potassium voltage-gated channel, shakerrelated subfamily, member 5 (KCNA5) genes in patients with idiopathic and associated PAH. Correlation among pathogenic mutations and clinical and functional parameters was further analyzed. Methods and Results: Forty one patients and fifty controls were included in this study. Analysis of BMPR2, ACVRL1 and KCNA5 genes was performed by polymerase chain reaction (PCR) and direct sequencing. Fifty one nucleotide changes were detected in these genes in 40 of the 41 patients; only 22 of these changes, which were classified as pathogenic, have been detected in 21 patients (51.2%). Ten patients (62.5%) with idiopathic PAH and 10 (40%) with associated PAH showed pathogenic mutations in some of the three genes. Several clinical and hemodynamics parameters showed significant differences between carriers and non-carriers of mutations, being more severe in carriers: mean pulmonary artery pressure (p = 0.043), pulmonary vascular resistence (p = 0.043), cardiac index (p = 0.04) and 6 minute walking test (p = 0.02). This differences remained unchanged after adjusting for PAH type (idiopathic vs non idiopathic). Conclusions: Pathogenic mutations in BMPR2 gene are frequent in patients with idiopathic and associated PAH group I. Mutations in ACVRL1 and KCNA5 are less frequent. The presence of these mutations seems to increase the severity of the disease.	[Pousada, Guillermo; Valverde, Diana] Univ Vigo, Fac Biol, Dept Biochem Genet & Immunol, Inst Invest Biomed Vigo IBIV, Vigo 36310, Spain; [Baloira, Adolfo] Complejo Hosp Univ Pontevedra, Div Resp, Pontevedra, Spain; [Vilarino, Carlos] Complejo Hosp Univ Vigo, Div Resp, Vigo, Spain; [Manuel Cifrian, Jose] Hosp Univ Marques de Valdecilla, Div Resp, Santander, Spain	Universidade de Vigo; Complexo Hospitalario Universitario de Pontevedra; Complexo Hospitalario Universitario de Vigo; Hospital Universitario Marques de Valdecilla (HUMV)	Valverde, D (corresponding author), Univ Vigo, Fac Biol, Dept Biochem Genet & Immunol, Inst Invest Biomed Vigo IBIV, Vigo 36310, Spain.	dianaval@uvigo.es	Valverde, Diana/Y-1101-2019; Pousada, Guillermo/M-5017-2016; Diana, Valverde/I-2409-2012	Valverde, Diana/0000-0002-7024-1657; Pousada, Guillermo/0000-0002-2466-8094; Diana, Valverde/0000-0002-7024-1657; Cifrian, Jose Manuel/0000-0003-3682-0142	SOGAPAR [IN-202-05]; Actelion Pharmaceuticals [CO-0085-10]; INBIOMED Xunta de Galicia [2009-063]	SOGAPAR; Actelion Pharmaceuticals; INBIOMED Xunta de Galicia	This study was supported by the grants IN-202-05 from SOGAPAR, CO-0085-10 from Actelion Pharmaceuticals and INBIOMED 2009-063 Xunta de Galicia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdalla SA, 2003, EUR J HUM GENET, V11, P279, DOI 10.1038/sj.ejhg.5200919; Adzhubei Ivan, 2013, Curr Protoc Hum Genet, VChapter 7, DOI 10.1002/0471142905.hg0720s76; Austin ED, 2009, RESP RES, V10, DOI 10.1186/1465-9921-10-87; Berg JN, 1997, AM J HUM GENET, V61, P60, DOI 10.1086/513903; Burg ED, 2008, BRIT J PHARMACOL, V153, pS99, DOI 10.1038/sj.bjp.0707635; Burg ED, 2010, AM J PHYSIOL-CELL PH, V298, pC496, DOI 10.1152/ajpcell.00464.2009; Chida A, 2012, CIRC J, V76, P1804, DOI 10.1253/circj.CJ-66-0047; Christophersen IE, 2013, EUR HEART J, V34, P1517, DOI 10.1093/eurheartj/ehs442; Czech A, 2010, MOL BIOSYST, V6, P1767, DOI 10.1039/c004796c; Davies RJ, 2008, CHEST, V134, P1271, DOI 10.1378/chest.08-1341; Deng ZM, 2000, AM J HUM GENET, V67, P737, DOI 10.1086/303059; Elliott CG, 2006, CIRCULATION, V113, P2509, DOI 10.1161/CIRCULATIONAHA.105.601930; Ferrer-Costa C, 2004, PROTEINS, V57, P811, DOI 10.1002/prot.20252; Fessel Joshua P, 2011, Pulm Circ, V1, P305, DOI 10.4103/2045-8932.87293; Fujiwara M, 2008, CIRC J, V72, P127, DOI 10.1253/circj.72.127; Galie N, 2009, EUR HEART J, V30, P2493, DOI 10.1093/eurheartj/ehp297; Garrido-Martin EM, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-51; Girerd B, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-73; Girerd B, 2010, AM J RESP CRIT CARE, V181, P851, DOI 10.1164/rccm.200908-1284OC; Hamid R, 2009, HUM MUTAT, V30, P649, DOI 10.1002/humu.20922; Johnson JA, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-58; Kumar P, 2009, NAT PROTOC, V4, P1073, DOI 10.1038/nprot.2009.86; Kurata HT, 2002, J BIOL CHEM, V277, P29045, DOI 10.1074/jbc.M111470200; Liu D, 2012, CIRC-CARDIOVASC GENE, V5, P511, DOI 10.1161/CIRCGENETICS.111.962209; Machado RD, 2009, J AM COLL CARDIOL, V54, pS32, DOI 10.1016/j.jacc.2009.04.015; Machado RD, 2006, HUM MUTAT, V27, P121, DOI 10.1002/humu.20285; Majka S, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-84; Morrell NW, 2010, F1000 BIOL REP, V2, P22; Park Won Sun, 2010, Journal of Smooth Muscle Research, V46, P89; Peacock AJ, 2007, EUR RESPIR J, V30, P104, DOI 10.1183/09031936.00092306; Pfarr N, 2013, RESP RES, V14, DOI 10.1186/1465-9921-14-3; Pfarr N, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-99; Portillo K, 2010, ARCH BRONCONEUMOL, V46, P129, DOI 10.1016/j.arbres.2009.11.005; Remillard CV, 2007, AM J PHYSIOL-CELL PH, V292, pC1837, DOI 10.1152/ajpcell.00405.2006; Sanchez O, 2010, Rev Mal Respir, V27, pe79, DOI 10.1016/j.rmr.2009.12.001; Santos C, 2014, J MOL DIAGN, V16, P324, DOI 10.1016/j.jmoldx.2014.01.005; Schulte Claudia, 2005, Hum Mutat, V25, P595, DOI 10.1002/humu.9345; Selva-O'Callaghan A, 2007, CLIN RHEUMATOL, V26, P947, DOI 10.1007/s10067-006-0388-x; Ulrich S, 2010, RESPIRATION, V79, P279, DOI 10.1159/000250322; Upton PD, 2009, J BIOL CHEM, V284, P15794, DOI 10.1074/jbc.M109.002881; Wipff J, 2010, ARTHRITIS RHEUM-US, V62, P3093, DOI 10.1002/art.27607; Yang T, 2010, HEART RHYTHM, V7, P1246, DOI 10.1016/j.hrthm.2010.05.032	42	29	30	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100261	10.1371/journal.pone.0100261	http://dx.doi.org/10.1371/journal.pone.0100261			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936649	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400098
J	Albers, DJ; Elhadad, N; Tabak, E; Perotte, A; Hripcsak, G				Albers, D. J.; Elhadad, Noemie; Tabak, E.; Perotte, A.; Hripcsak, George			Dynamical Phenotyping: Using Temporal Analysis of Clinically Collected Physiologic Data to Stratify Populations	PLOS ONE			English	Article							CONTROL-ORIENTED MODEL; GLUCOSE DYNAMICS; INSULIN	Using glucose time series data from a well measured population drawn from an electronic health record (EHR) repository, the variation in predictability of glucose values quantified by the time-delayed mutual information (TDMI) was explained using a mechanistic endocrine model and manual and automated review of written patient records. The results suggest that predictability of glucose varies with health state where the relationship (e. g., linear or inverse) depends on the source of the acuity. It was found that on a fine scale in parameter variation, the less insulin required to process glucose, a condition that correlates with good health, the more predictable glucose values were. Nevertheless, the most powerful effect on predictability in the EHR subpopulation was the presence or absence of variation in health state, specifically, in-and out-of-control glucose versus in-control glucose. Both of these results are clinically and scientifically relevant because the magnitude of glucose is the most commonly used indicator of health as opposed to glucose dynamics, thus providing for a connection between a mechanistic endocrine model and direct insight to human health via clinically collected data.	[Albers, D. J.; Elhadad, Noemie; Perotte, A.; Hripcsak, George] Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA; [Tabak, E.] NYU, Courant Inst Math Sci, Dept Math, New York, NY USA	Columbia University; New York University	Albers, DJ (corresponding author), Columbia Univ, Dept Biomed Informat, New York, NY 10027 USA.	dja2119@cumc.columbia.edu		Perotte, Adler/0000-0002-6695-0282	NIH-NLM [RO1 LM06910]; NATIONAL LIBRARY OF MEDICINE [R01LM006910] Funding Source: NIH RePORTER	NIH-NLM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NATIONAL LIBRARY OF MEDICINE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM))	DA and GH acknowledge the financial support provided by NIH-NLM Grant No. RO1 LM06910. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnelli JP, 2010, SIAM MMS; Albers D, 2013, TIME SERIES AN UNPUB; Albers DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048058; Albers DJ, 2012, CHAOS, V22, DOI 10.1063/1.3675621; [Anonymous], 2011, PRECISION MED BUILDI; Astrom K. J., 2008, FEEDBACK SYSTEMS INT; Bishop C. M., 2006, J ELECT IMAG, V16, P140; Bodenreider O, 2003, J BIOMED INFORM, V36, P414, DOI 10.1016/j.jbi.2003.11.002; Brunetti P, 2003, ARTIF CELL BLOOD SUB, V31, P127, DOI 10.1081/BIO-120020169; Christopher D.M., 2008, MANNING PRABHAKAR RA; Demner-Fushman D, 2009, J BIOMED INFORM, V42, P760, DOI 10.1016/j.jbi.2009.08.007; Fabietti PG, 2007, DIABETES TECHNOL THE, V9, P327, DOI 10.1089/dia.2006.0030; Fabietti PG, 2006, MED BIOL ENG COMPUT, V44, P69, DOI 10.1007/s11517-005-0012-2; Friedman C, 2013, BIOMEDICAL INFORM CO; Gray AG, 2003, OINT STAT M; Hagar Y, 2014, STAT ANAL D IN PRESS; Hirata Y, 2010, CHAOS, V20, DOI DOI 10.1063/1.3526968; Hripcsak G, 2012, J AM MED INFORM ASSN, V10, P1, DOI DOI 10.1136/AMIAJN1-2012-001145; Hripcsak G., 2013, J AM MED INFORM ASSN, P1; Hripcsak G, 2011, J AM MED INFORM ASSN, V18, pI109, DOI 10.1136/amiajnl-2011-000463; Hripcsak G, 2009, J AM MED INFORM ASSN, V16, P220, DOI 10.1197/jamia.M3007; Kantz H., 2003, NONLINEAR TIME SERIE; Keener J, 2008, MATH PHYSL; Kirk D, 1988, OPTIMAL CONTROL THEO; Kjaer M, 1998, ADV EXP MED BIOL, V441, P117; Kovatchev Boris P, 2009, J Diabetes Sci Technol, V3, P44; Lai Albert M, 2008, AMIA Annu Symp Proc, P374; Liao TW, 2005, PATTERN RECOGN, V38, P1857, DOI 10.1016/j.patcog.2005.01.025; LINDBERG DAB, 1993, METHOD INFORM MED, V32, P281, DOI 10.1055/s-0038-1634945; Lorenc A, 1988, Q J ROY METEOR SOC, V112, P1177; Pivovarov R, 2014, J BIOMEDICA IN PRESS; ROWLANDS G, 1992, PHYSICA D, V58, P251, DOI 10.1016/0167-2789(92)90113-2; SCHIFF S. J., 2011, NEURAL CONTROL ENG E; Sedigh-Sarvestan M, 2012, 34 ANN INT IEEE EMBS; SHAW CT, 1992, PHYSICA D, V58, P288, DOI 10.1016/0167-2789(92)90117-6; Sprott JC, 2003, CHAOS TIME SERIES AN; Stengel R. F., 1994, OPTIMAL CONTROL ESTI; STURIS J, 1991, AM J PHYSIOL, V260, pE801, DOI 10.1152/ajpendo.1991.260.5.E801	38	25	25	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e96443	10.1371/journal.pone.0096443	http://dx.doi.org/10.1371/journal.pone.0096443			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933368	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600003
J	Godinho, RMD; Matassoli, FL; Lucas, CGD; Rigato, PO; Goncalves, JLS; Sato, MN; Maciel, M; Pecanha, LMT; August, JT; Marques, ETA; de Arruda, LB				da Costa Godinho, Rodrigo Maciel; Matassoli, Flavio Lemos; de Oliveira Lucas, Carolina Goncalves; Rigato, Paula Ordonhez; Santos Goncalves, Jorge Luiz; Sato, Maria Notomi; Maciel, Milton, Jr.; Torres Pecanha, Ligia Maria; Thomas August, J.; de Azevedo Marques, Ernesto Torres, Jr.; de Arruda, Luciana Barros			Regulation of HIV-Gag Expression and Targeting to the Endolysosomal/Secretory Pathway by the Luminal Domain of Lysosomal-Associated Membrane Protein (LAMP-1) Enhance Gag-Specific Immune Response	PLOS ONE			English	Article							T-CELL RESPONSES; VIRUS TYPE-1 GAG; CLASS-II COMPARTMENT; MHC CLASS-I; DNA VACCINATION; LYMPHOCYTE RESPONSES; ANTIGEN PRESENTATION; CODON USAGE; LONGITUDINAL ANALYSIS; ELITE CONTROLLERS	We have previously demonstrated that a DNA vaccine encoding HIV-p55gag in association with the lysosomal associated membrane protein-1 (LAMP-1) elicited a greater Gag-specific immune response, in comparison to a DNA encoding the native gag. In vitro studies have also demonstrated that LAMP/Gag was highly expressed and was present in MHCII containing compartments in transfected cells. In this study, the mechanisms involved in these processes and the relative contributions of the increased expression and altered traffic for the enhanced immune response were addressed. Cells transfected with plasmid DNA constructs containing p55gag attached to truncated sequences of LAMP-1 showed that the increased expression of gag mRNA required p55gag in frame with at least 741 bp of the LAMP-1 luminal domain. LAMP luminal domain also showed to be essential for Gag traffic through lysosomes and, in this case, the whole sequence was required. Further analysis of the trafficking pathway of the intact LAMP/Gag chimera demonstrated that it was secreted, at least in part, associated with exosome-like vesicles. Immunization of mice with LAMP/gag chimeric plasmids demonstrated that high expression level alone can induce a substantial transient antibody response, but targeting of the antigen to the endolysosomal/secretory pathways was required for establishment of cellular and memory response. The intact LAMP/gag construct induced polyfunctional CD4(+) T cell response, which presence at the time of immunization was required for CD8(+) T cell priming. LAMP-mediated targeting to endolysosomal/secretory pathway is an important new mechanistic element in LAMP-mediated enhanced immunity with applications to the development of novel anti-HIV vaccines and to general vaccinology field.	[da Costa Godinho, Rodrigo Maciel; Matassoli, Flavio Lemos; de Oliveira Lucas, Carolina Goncalves; de Arruda, Luciana Barros] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil; [Rigato, Paula Ordonhez; Sato, Maria Notomi] Univ Sao Paulo, Fac Med, Dept Dermatol, Lab Dermatol Imunodeficiencias,LIM 56, Sao Paulo, Brazil; [Santos Goncalves, Jorge Luiz; Torres Pecanha, Ligia Maria] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Imunol, Rio De Janeiro, Brazil; [Maciel, Milton, Jr.] Naval Med Res Ctr, Infect Dis Directorate, Enter Dis Dept, Silver Spring, MD USA; [Maciel, Milton, Jr.; Thomas August, J.; de Azevedo Marques, Ernesto Torres, Jr.] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD USA; [de Azevedo Marques, Ernesto Torres, Jr.] Ctr Vaccine Res, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [de Azevedo Marques, Ernesto Torres, Jr.] Fiocruz Pernambuco, Dept Virol, Recife, PE, Brazil	Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; Universidade Federal do Rio de Janeiro; Naval Medical Research Center (NMRC); Johns Hopkins University; Johns Hopkins Medicine; Fundacao Oswaldo Cruz	de Arruda, LB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Virol, Rio De Janeiro, Brazil.	arruda@micro.ufrj.br	Ordonhez Rigato, Paula/J-3618-2012; Marques, Ernesto T. A/L-4967-2013; iMed.ULisboa, M2B/B-5277-2014; Sato, Maria N/C-1196-2012; Arruda, Luciana B/N-9086-2013; Sato, Maria N/C-2853-2012; Godinho, Rodrigo/G-5135-2015	Marques, Ernesto T. A/0000-0003-3826-9358; iMed.ULisboa, M2B/0000-0002-1245-3715; Sato, Maria N/0000-0002-7911-1824; RIGATO, PAULA ORDONHEZ/0000-0002-4416-3544; Lucas, Carolina/0000-0003-4590-2756	National Institute of Allergy and Infectious Diseases, National Institutes of Health [R37-AI41908, R21-AI44317]; Brazilian Ministry of Health; CAPES; CNPq; FAPERJ; FINEP; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI044317] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Brazilian Ministry of Health; CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPERJ(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); FINEP(Financiadora de Inovacao e Pesquisa (Finep)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by Grants R37-AI41908 and R21-AI44317 from the National Institute of Allergy and Infectious Diseases, National Institutes of Health; and by Brazilian Ministry of Health, CAPES, CNPq, FAPERJ, and FINEP. R. M. C. Godinho and F. L. Matassoli were the recipients of a CNPq fellowship; C.G.O. Lucas was the recipient of a FAPERJ fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], MOL IMMUNOL, V47, P1507; Arruda LB, 2006, J IMMUNOL, V177, P2265, DOI 10.4049/jimmunol.177.4.2265; Bazhan SI, 2010, MOL IMMUNOL, V47, P1507, DOI 10.1016/j.molimm.2010.01.020; Bertoletti A, 1998, J VIROL, V72, P2439, DOI 10.1128/JVI.72.3.2439-2448.1998; Bivas-Benita M, 2013, MUCOSAL IMMUNOL, V6, P156, DOI 10.1038/mi.2012.59; Bockl K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034723; Bojak A, 2002, INTERVIROLOGY, V45, P275, DOI 10.1159/000067919; BORROW P, 1994, J VIROL, V68, P6103, DOI 10.1128/JVI.68.9.6103-6110.1994; CHANG DD, 1989, CELL, V59, P789, DOI 10.1016/0092-8674(89)90602-8; Chikhlikar P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000135; Clayton A, 2005, J CELL SCI, V118, P3631, DOI 10.1242/jcs.02494; COCHRANE AW, 1991, J VIROL, V65, P5305, DOI 10.1128/JVI.65.10.5305-5313.1991; De Arruda LB, 2004, IMMUNOLOGY, V112, P126, DOI 10.1111/j.1365-2567.2004.01823.x; Delcayre A, 2005, BLOOD CELL MOL DIS, V35, P158, DOI 10.1016/j.bcmd.2005.07.003; Deml L, 2001, J VIROL, V75, P10991, DOI 10.1128/JVI.75.22.10991-11001.2001; Denzer K, 2000, J CELL SCI, V113, P3365; DUBEY C, 1995, J IMMUNOL, V155, P45; Durali D, 1998, J VIROL, V72, P3547, DOI 10.1128/JVI.72.5.3547-3553.1998; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; FELBER BK, 1989, P NATL ACAD SCI USA, V86, P1495, DOI 10.1073/pnas.86.5.1495; Ferre AL, 2010, J VIROL, V84, P11020, DOI 10.1128/JVI.00980-10; Ferre AL, 2010, J VIROL, V84, P10354, DOI 10.1128/JVI.00803-10; Ferre AL, 2009, BLOOD, V113, P3978, DOI 10.1182/blood-2008-10-182709; Fu TM, 1997, MOL MED, V3, P362, DOI 10.1007/BF03401683; Fuller DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033715; Graf M, 2000, J VIROL, V74, P10822, DOI 10.1128/JVI.74.22.10822-10826.2000; Hartman ZC, 2011, VACCINE, V29, P9361, DOI 10.1016/j.vaccine.2011.09.133; Kaur M, 2009, VACCINE, V27, P2128, DOI 10.1016/j.vaccine.2009.01.128; Kessler PD, 1996, P NATL ACAD SCI USA, V93, P14082, DOI 10.1073/pnas.93.24.14082; KLEIN MR, 1995, J EXP MED, V181, P1365, DOI 10.1084/jem.181.4.1365; Kotsopoulou E, 2000, J VIROL, V74, P4839, DOI 10.1128/JVI.74.10.4839-4852.2000; KOUP RA, 1994, J VIROL, V68, P4650, DOI 10.1128/JVI.68.7.4650-4655.1994; Langlade-Demoyen P, 2003, EUR J IMMUNOL, V33, P720, DOI 10.1002/eji.200323287; Letvin NL, 2006, SCIENCE, V312, P1530, DOI 10.1126/science.1124226; Lu Y, 2003, VACCINE, V21, P2178, DOI 10.1016/S0264-410X(03)00009-4; Maecker HT, 1998, J IMMUNOL, V161, P6532; Marques ETA, 2003, J BIOL CHEM, V278, P37926, DOI 10.1074/jbc.M303336200; McAdam S, 1998, AIDS, V12, P571, DOI 10.1097/00002030-199806000-00005; Midha S, 2009, EUR J IMMUNOL, V39, P159, DOI 10.1002/eji.200838058; Nanjundappa RH, 2012, VACCINE, V30, P3519, DOI 10.1016/j.vaccine.2012.03.075; Nanjundappa RH, 2011, VACCINE, V29, P3538, DOI 10.1016/j.vaccine.2011.02.095; Ngumbela KC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002356; Nguyen DG, 2003, J BIOL CHEM, V278, P52347, DOI 10.1074/jbc.M309009200; Owen RE, 2010, AIDS, V24, P1095, DOI 10.1097/QAD.0b013e3283377a1e; Pissani F, 2012, VACCINE, V30, P5519, DOI 10.1016/j.vaccine.2012.06.042; Pollard VW, 1998, ANNU REV MICROBIOL, V52, P491, DOI 10.1146/annurev.micro.52.1.491; Pontesilli O, 1998, J INFECT DIS, V178, P1008, DOI 10.1086/515659; Porgador A, 1998, J EXP MED, V188, P1075, DOI 10.1084/jem.188.6.1075; Qiu JT, 2000, J VIROL, V74, P5997, DOI 10.1128/JVI.74.13.5997-6005.2000; Qiu JT, 1999, J VIROL, V73, P9145, DOI 10.1128/JVI.73.11.9145-9152.1999; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Rosenberg ES, 1997, SCIENCE, V278, P1447, DOI 10.1126/science.278.5342.1447; Schliehe C, 2012, J VIROL, V86, P9782, DOI 10.1128/JVI.00694-12; Schneider R, 1997, J VIROL, V71, P4892, DOI 10.1128/JVI.71.7.4892-4903.1997; SCHWARTZ S, 1992, J VIROL, V66, P7176, DOI 10.1128/JVI.66.12.7176-7182.1992; Shedlock DJ, 2000, J LEUKOCYTE BIOL, V68, P793; Stober D, 2002, EUR J IMMUNOL, V32, P1099, DOI 10.1002/1521-4141(200204)32:4<1099::AID-IMMU1099>3.3.CO;2-#; Sui YJ, 2010, P NATL ACAD SCI USA, V107, P9843, DOI 10.1073/pnas.0911932107; Thakur A, 2012, VACCINE, V30, P4907, DOI 10.1016/j.vaccine.2012.05.049; Thery C, 2001, J IMMUNOL, V166, P7309, DOI 10.4049/jimmunol.166.12.7309; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Vaccari M, 2005, J IMMUNOL, V175, P3502, DOI 10.4049/jimmunol.175.6.3502; Vargas-Inchaustegui DA, 2012, J IMMUNOL, V189, P1878, DOI 10.4049/jimmunol.1201026; Wang QM, 2012, DNA CELL BIOL, V31, P489, DOI 10.1089/dna.2011.1309; Wolfers J, 2001, NAT MED, V7, P297, DOI 10.1038/85438; Zhang HF, 2011, CELL MOL IMMUNOL, V8, P23, DOI 10.1038/cmi.2010.59; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	67	9	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99887	10.1371/journal.pone.0099887	http://dx.doi.org/10.1371/journal.pone.0099887			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932692	Green Submitted, gold, Green Published			2022-12-27	WOS:000337738600077
J	Mori, M; Saito, K; Ohta, Y				Mori, Mamiko; Saito, Koji; Ohta, Yasutaka			ARHGAP22 Localizes at Endosomes and Regulates Actin Cytoskeleton	PLOS ONE			English	Article							GTPASE-ACTIVATING PROTEIN; CELL-MIGRATION; RHO GTPASES; FILAMIN-A; RAC; FILGAP; MORPHOLOGY; MOVEMENT; MOTILITY; POLARITY	Rho small GTPases control cell morphology and motility through the rearrangement of actin cytoskeleton. We have previously shown that FilGAP, a Rac-specific GAP, binds to the actin-cross-linking protein Filamin A (FLNa) and suppresses Rac-dependent lamellae formation and cell spreading. ARHGAP22 is a member of FilGAP family, and implicated in the regulation of tumor cell motility. However, little is known concerning the cellular localization and mechanism of regulation at the molecular level. Whereas FilGAP binds to FLNa and localizes to lamellae, we found that ARHGAP22 did not bind to FLNa. Forced expression of ARHGAP22 induced enlarged vesicular structures containing the endocytic markers EEA1, Rab5, and Rab11. Moreover, endogenous ARHGAP22 is co-localized with EEA1-and Rab11-positive endosomes but not with trans-Golgi marker TNG46. When constitutively activated Rac Q61L mutant was expressed, ARHGAP22 is co-localized with Rac Q61L at membrane ruffles, suggesting that ARHGAP22 is translocated from endosomes to membrane ruffles to inactivate Rac. Forced expression of ARHGAP22 suppressed lamellae formation and cell spreading. Conversely, knockdown of endogenous ARHGAP22 stimulated cell spreading. Thus, our findings suggest that ARHGAP22 controls cell morphology by inactivating Rac but its localization is not mediated by its interaction with FLNa.	[Mori, Mamiko; Saito, Koji; Ohta, Yasutaka] Kitasato Univ, Sch Sci, Dept Biosci, Div Cell Biol, Sagamihara, Kanagawa, Japan	Kitasato University	Ohta, Y (corresponding author), Kitasato Univ, Sch Sci, Dept Biosci, Div Cell Biol, Sagamihara, Kanagawa, Japan.	yohta@kitasato-u.ac.jp			Japan Society for the Promotion of Science; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Kitasato University	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Kitasato University	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science and the Ministry of Education, Culture, Sports, Science, and Technology of Japan, Grant for All Kitasato Project Study, and Kitasato University Research Grant for Young Researchers. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitsebaomo J, 2004, J BIOL CHEM, V279, P17963, DOI 10.1074/jbc.M311721200; Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; Bos JL, 2007, CELL, V129, P865, DOI 10.1016/j.cell.2007.05.018; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Ceresa BP, 2001, J BIOL CHEM, V276, P9649, DOI 10.1074/jbc.M010387200; Croft DR, 2008, CANCER CELL, V14, P349, DOI 10.1016/j.ccr.2008.10.009; Dinneen JL, 2004, TRAFFIC, V5, P606, DOI 10.1111/j.1398-9219.2004.00204.x; Friedl P, 2008, NAT IMMUNOL, V9, P960, DOI 10.1038/ni.f.212; Guilluy C, 2011, TRENDS CELL BIOL, V21, P718, DOI 10.1016/j.tcb.2011.08.002; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hu SH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041731; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Jones MC, 2006, CURR OPIN CELL BIOL, V18, P549, DOI 10.1016/j.ceb.2006.08.003; Ladhani O, 2011, NEOPLASIA, V13, P633, DOI 10.1593/neo.11446; Lavelin I, 2005, J BIOL CHEM, V280, P7178, DOI 10.1074/jbc.M411990200; Magadan JG, 2006, MOL CELL BIOL, V26, P2595, DOI 10.1128/MCB.26.7.2595-2614.2006; Nakamura F, 2013, BIOCHEM J, V453, P17, DOI 10.1042/BJ20130290; Nakamura F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004928; Ohta Y, 2006, NAT CELL BIOL, V8, P803, DOI 10.1038/ncb1437; Osmani N, 2010, J CELL BIOL, V191, P1261, DOI 10.1083/jcb.201003091; Palamidessi A, 2008, CELL, V134, P135, DOI 10.1016/j.cell.2008.05.034; Parsons JT, 2010, NAT REV MOL CELL BIO, V11, P633, DOI 10.1038/nrm2957; Price LS, 1998, MOL BIOL CELL, V9, P1863, DOI 10.1091/mbc.9.7.1863; Rowland AF, 2011, MOL CELL BIOL, V31, P4789, DOI 10.1128/MCB.05583-11; Saito K, 2012, MOL BIOL CELL, V23, P4739, DOI 10.1091/mbc.E12-04-0310; Sanz-Moreno V, 2008, CELL, V135, P510, DOI 10.1016/j.cell.2008.09.043; Sanz-Moreno V, 2010, CURR OPIN CELL BIOL, V22, P690, DOI 10.1016/j.ceb.2010.08.020; Schiefermeier N, 2011, CURR OPIN CELL BIOL, V23, P615, DOI 10.1016/j.ceb.2011.04.001; STENMARK H, 1994, EMBO J, V13, P1287, DOI 10.1002/j.1460-2075.1994.tb06381.x; Torres VA, 2011, CURR PROTEIN PEPT SC, V12, P43; Valnegri P, 2011, HUM MOL GENET, V20, P4797, DOI 10.1093/hmg/ddr418; Wegner CS, 2010, HISTOCHEM CELL BIOL, V133, P41, DOI 10.1007/s00418-009-0643-8; Winter JF, 2012, NAT CELL BIOL, V14, P666, DOI 10.1038/ncb2508	33	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100271	10.1371/journal.pone.0100271	http://dx.doi.org/10.1371/journal.pone.0100271			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933155	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600104
J	Jiang, YN; Lou, JJ; Wang, SQ; Zhao, Y; Wang, C; Wang, DH				Jiang, Yanni; Lou, Jianjuan; Wang, Siqi; zhao, Yi; Wang, Cong; Wang, Dehang			Evaluation of the Role of Dynamic Contrast-Enhanced MR Imaging for Patients with BI-RADS 3-4 Microcalcifications	PLOS ONE			English	Article							ASSISTED BREAST BIOPSY; MAMMOGRAPHIC FEATURES; DATA SYSTEM; CANCER; LESIONS; MULTICENTER; MALIGNANCY; EXPERIENCE; RESOLUTION; ACCURACY	Objective: The purpose of study was to prospectively evaluate the diagnostic performance of dynamic contrast-enhanced MR imaging in the differentiation of malignant lesions from benign ones in patients with BI-RADS 3-4 microcalcifications detected by mammography. Materials and Methods: 93 women with 100 microcalcifications had undergone breast MRI from June 2010 to July 2013. Subsequently, 91 received open biopsy and 2 received stereotactic vacuum-assisted biopsy. All results were compared with histological findings. The PPV, NPV and area under curve (AUC) of the mammography and breast MRI were calculated. Results: There were 31 (31.0%) BI-RADS 3 microcalcifications and 69 (69.0%) BI-RADS 4. The PPV and NPV of mammography is 65.2% (45/69) and 90.3% (28/31). The PPV and NPV of breast MRI was 90.2% (46/51) and 95.9% (47/49). Among 31 BI-RADS 3 microcalcifications, the PPV and NPV of breast MRI was 100% (3/3) and 100% (28/28). Among 69 BI-RADS 4 microcalcifications, the PPV and NPV of breast MRI was 89.6% (43/48) and 90.5% (19/21). The AUC of mammography and breast MRI assessment were 0.738 (95% CI, 0.639-0.837) and 0.931 (95% CI, 0.874-0.988) (p<0.05). Conclusion: Dynamic contrast-enhanced MR imaging of breast is able to be applied to predict the risk of malignance before follow-up for BI-RADS 3 microcalcifications and biopsy for BI-RADS 4 microcalcifications.	[Jiang, Yanni; Lou, Jianjuan; Wang, Siqi; Wang, Dehang] Nanjing Med Univ, Affiliated Hosp 1, Div Radiol, Nanjing, Jiangsu, Peoples R China; [zhao, Yi] Nanjing Med Univ, Affiliated Hosp 1, Div Breast Surg, Nanjing, Jiangsu, Peoples R China; [Wang, Cong] Nanjing Med Univ, Affiliated Hosp 1, Div Pathol, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University; Nanjing Medical University	Wang, DH (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Div Radiol, Nanjing, Jiangsu, Peoples R China.	wangdehang@hotmail.com						American College of Radiology, 2003, BREAST IM REP DAT SY; Atuegwu NC, 2014, MED PHYS, V41, DOI 10.1118/1.4870966; Baltzer PAT, 2010, AM J ROENTGENOL, V194, P1658, DOI 10.2214/AJR.09.3486; Bazzocchi M, 2006, AM J ROENTGENOL, V186, P1723, DOI 10.2214/AJR.04.1898; Berg WA, 2004, RADIOLOGY, V233, P830, DOI 10.1148/radiol.2333031484; El Khouli RH, 2008, SEMIN ROENTGENOL, V43, P265, DOI 10.1053/j.ro.2008.07.002; Gilles R, 1996, J COMPUT ASSIST TOMO, V20, P9, DOI 10.1097/00004728-199601000-00003; Houssami N, 2008, J CLIN ONCOL, V26, P3248, DOI 10.1200/JCO.2007.15.2108; Houssami N, 2009, CA-CANCER J CLIN, V59, P290, DOI 10.3322/caac.20028; Huang W, 2004, RADIOLOGY, V232, P585, DOI 10.1148/radiol.2322030547; Kettritz U, 2004, CANCER-AM CANCER SOC, V100, P245, DOI 10.1002/cncr.11887; Kneeshaw PJ, 2006, BREAST, V15, P29, DOI 10.1016/j.breast.2005.05.002; Koolen BB, 2013, Q J NUCL MED MOL IM, V57, P92; Koolen BB, 2014, NUCL MED COMMUN, V35, P446, DOI 10.1097/MNM.0000000000000072; Kuhl CK, 2007, RADIOLOGY, V244, P672, DOI 10.1148/radiol.2443051661; Kuhl CK, 1997, RADIOLOGY, V203, P137, DOI 10.1148/radiology.203.1.9122382; Kuhl CK, 2005, RADIOLOGY, V236, P789, DOI 10.1148/radiol.2363040811; Liberman L, 1998, AM J ROENTGENOL, V171, P35, DOI 10.2214/ajr.171.1.9648759; Liberman L, 2003, CANCER-AM CANCER SOC, V98, P377, DOI 10.1002/cncr.11491; Mendez A, 2004, ANN ONCOL, V15, P450, DOI 10.1093/annonc/mdh088; Mendez A, 2004, CANCER-AM CANCER SOC, V100, P710, DOI 10.1002/cncr.20017; Nakahara H, 2001, Breast Cancer, V8, P116, DOI 10.1007/BF02967490; Orel SG, 2001, RADIOLOGY, V220, P13, DOI 10.1148/radiology.220.1.r01jl3113; Orel SG, 1999, RADIOLOGY, V211, P845, DOI 10.1148/radiology.211.3.r99jn31845; Pages EB, 2012, RADIOLOGY, V264, P40, DOI 10.1148/radiol.12111917; Schnall MD, 2006, RADIOLOGY, V238, P42, DOI 10.1148/radiol.2381042117; Shimauchi A, 2010, AM J ROENTGENOL, V194, P1674, DOI 10.2214/AJR.09.3568; Tozaki M, 2006, AM J ROENTGENOL, V187, P330, DOI 10.2214/AJR.05.0998; Uematsu T, 2007, BREAST CANCER RES TR, V103, P269, DOI 10.1007/s10549-006-9373-y; Westerhof JP, 1998, RADIOLOGY, V207, P675, DOI 10.1148/radiology.207.3.9609890	30	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99669	10.1371/journal.pone.0099669	http://dx.doi.org/10.1371/journal.pone.0099669			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927476	gold, Green Submitted, Green Published			2022-12-27	WOS:000338278100063
J	Olias, P; Adam, I; Meyer, A; Scharff, C; Gruber, AD				Olias, Philipp; Adam, Iris; Meyer, Anne; Scharff, Constance; Gruber, Achim D.			Reference Genes for Quantitative Gene Expression Studies in Multiple Avian Species	PLOS ONE			English	Article							POLYMERASE CHAIN-REACTION; TRANSCRIPTION-PCR DATA; REAL-TIME PCR; HOUSEKEEPING GENES; JAPANESE-QUAIL; NORMALIZATION; SELECTION; VALIDATION; GENOME; MODEL	Quantitative real-time PCR (qPCR) rapidly and reliably quantifies gene expression levels across different experimental conditions. Selection of suitable reference genes is essential for meaningful normalization and thus correct interpretation of data. In recent years, an increasing number of avian species other than the chicken has been investigated molecularly, highlighting the need for an experimentally validated pan-avian primer set for reference genes. Here we report testing a set for 14 candidate reference genes (18S, ABL, GAPDH, GUSB, HMBS, HPRT, PGK1, RPL13, RPL19, RPS7, SDHA, TFRC, VIM, YWHAZ) on different tissues of the mallard (Anas platyrhynchos), domestic chicken (Gallus gallus domesticus), common crane (Grus grus), white-tailed eagle (Haliaeetus albicilla), domestic turkey (Meleagris gallopavo f. domestica), cockatiel (Nymphicus hollandicus), Humboldt penguin (Sphenicus humboldti), ostrich (Struthio camelus) and zebra finch (Taeniopygia guttata), spanning a broad range of the phylogenetic tree of birds. Primer pairs for six to 11 genes were successfully established for each of the nine species. As a proof of principle, we analyzed expression levels of 10 candidate reference genes as well as FOXP2 and the immediate early genes, EGR1 and CFOS, known to be rapidly induced by singing in the avian basal ganglia. We extracted RNA from microbiopsies of the striatal song nucleus Area X of adult male zebra finches after they had sang or remained silent. Using three different statistical algorithms, we identified five genes (18S, PGK1, RPS7, TFRC, YWHAZ) that were stably expressed within each group and also between the singing and silent conditions, establishing them as suitable reference genes. In conclusion, the newly developed pan-avian primer set allows accurate normalization and quantification of gene expression levels in multiple avian species.	[Olias, Philipp; Meyer, Anne; Gruber, Achim D.] Free Univ Berlin, Inst Vet Pathol, Berlin, Germany; [Adam, Iris; Scharff, Constance] Free Univ Berlin, Inst Biol, Dept Anim Behav, Berlin, Germany	Free University of Berlin; Free University of Berlin	Olias, P (corresponding author), Free Univ Berlin, Inst Vet Pathol, Berlin, Germany.	olias@borcim.wustl.edu; iris.adam@fu-berlin.de	Scharff, Constance/HHN-0673-2022; Gruber, Achim D./ABA-4514-2021	Adam, Iris/0000-0001-7561-7636; Olias, Philipp/0000-0002-7200-2414				Abruzzo LV, 2005, BIOTECHNIQUES, V38, P785, DOI 10.2144/05385MT01; Ahi EP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066389; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; Arsenijevic T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037517; Ball GF, 2010, ILAR J, V51, P310, DOI 10.1093/ilar.51.4.310; Banerjee SB, 2012, P ROY SOC B-BIOL SCI, V279, P759, DOI 10.1098/rspb.2011.1265; Barber MRW, 2010, P NATL ACAD SCI USA, V107, P5913, DOI 10.1073/pnas.1001755107; Bateson M, 2010, ILAR J, V51, P394, DOI 10.1093/ilar.51.4.394; Bustin SA, 2000, J MOL ENDOCRINOL, V25, P169, DOI 10.1677/jme.0.0250169; Bustin Stephen A., 2009, P111; Castoe TA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030953; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chechi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032265; Dalloul RA, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000475; De Boever S, 2008, VET IMMUNOL IMMUNOP, V122, P312, DOI 10.1016/j.vetimm.2007.12.002; De Winter P, 2008, BRIT POULTRY SCI, V49, P566, DOI 10.1080/00071660802294558; Dheda K, 2005, ANAL BIOCHEM, V344, P141, DOI 10.1016/j.ab.2005.05.022; Ding ST, 2007, POULTRY SCI, V86, P1206, DOI 10.1093/ps/86.6.1206; Dridi S, 2005, DOMEST ANIM ENDOCRIN, V29, P646, DOI 10.1016/j.domaniend.2005.05.002; Dugas-Ford J, 2012, P NATL ACAD SCI USA, V109, P16974, DOI 10.1073/pnas.1204773109; Ellegren H, 2012, NATURE, V491, P756, DOI 10.1038/nature11584; Goossens K, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-27; Haesler S, 2007, PLOS BIOL, V5, P2885, DOI 10.1371/journal.pbio.0050321; Hibbeler S, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-18; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Holmes DJ, 2003, EXP GERONTOL, V38, P1365, DOI 10.1016/j.exger.2003.10.018; Huang YH, 2013, NAT GENET, V45, P776, DOI 10.1038/ng.2657; Jarvis ED, 1998, NEURON, V21, P775, DOI 10.1016/S0896-6273(00)80594-2; Khurshid N, 2009, J CHEM NEUROANAT, V37, P158, DOI 10.1016/j.jchemneu.2008.12.001; Kimpo RR, 1997, NEURON, V18, P315, DOI 10.1016/S0896-6273(00)80271-8; Koshiba-Takeuchi K, 2009, NATURE, V461, P95, DOI 10.1038/nature08324; Kuchipudi SV, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-230; Latham GJ, 2010, METHODS MOL BIOL, V667, P19, DOI 10.1007/978-1-60761-811-9_2; Maroufi A, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-15; Mukai M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008182; Naurin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046854; Nerren JR, 2010, VET IMMUNOL IMMUNOP, V136, P151, DOI 10.1016/j.vetimm.2010.02.017; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Nygard AB, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-67; O'Connell LA, 2012, SCIENCE, V336, P1154, DOI 10.1126/science.1218889; Olias P, 2013, VET RES, V44, DOI 10.1186/1297-9716-44-10; Perfito N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034997; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Radonic A, 2004, BIOCHEM BIOPH RES CO, V313, P856, DOI 10.1016/j.bbrc.2003.11.177; Rubie C, 2005, MOL CELL PROBE, V19, P101, DOI 10.1016/j.mcp.2004.10.001; Scharff C, 2013, CURR OPIN NEUROBIOL, V23, P29, DOI 10.1016/j.conb.2012.10.001; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Teramitsu I, 2006, J NEUROSCI, V26, P7390, DOI 10.1523/JNEUROSCI.1662-06.2006; Thompson CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035119; Tomaszycki ML, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-24; Tricarico C, 2002, ANAL BIOCHEM, V309, P293, DOI 10.1016/S0003-2697(02)00311-1; Van Bers NEM, 2012, MOL ECOL RESOUR, V12, P753, DOI 10.1111/j.1755-0998.2012.03141.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Veazey KJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027592; Wada K, 2006, P NATL ACAD SCI USA, V103, P15212, DOI 10.1073/pnas.0607098103; Warren WC, 2010, NATURE, V464, P757, DOI 10.1038/nature08819; Wolf JBW, 2010, MOL ECOL, V19, P162, DOI 10.1111/j.1365-294X.2009.04471.x; Yin RF, 2011, BIOCHEM BIOPH RES CO, V413, P537, DOI 10.1016/j.bbrc.2011.08.131; Yue Hua, 2010, Virologica Sinica, V25, P425, DOI 10.1007/s12250-010-3114-4	60	71	75	2	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99678	10.1371/journal.pone.0099678	http://dx.doi.org/10.1371/journal.pone.0099678			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926893	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100066
J	Ibarbalz, FM; Perez, MV; Figuerola, ELM; Erijman, L				Ibarbalz, Federico M.; Victoria Perez, Maria; Figuerola, Eva L. M.; Erijman, Leonardo			The Bias Associated with Amplicon Sequencing Does Not Affect the Quantitative Assessment of Bacterial Community Dynamics	PLOS ONE			English	Article							SPECIES RICHNESS; WASTE-WATER; DIVERSITY; PRIMERS; UNIQUE; LENGTH; TOOLS; TAXA	The performance of two sets of primers targeting variable regions of the 16S rRNA gene V1-V3 and V4 was compared in their ability to describe changes of bacterial diversity and temporal turnover in full-scale activated sludge. Duplicate sets of high-throughput amplicon sequencing data of the two 16S rRNA regions shared a collection of core taxa that were observed across a series of twelve monthly samples, although the relative abundance of each taxon was substantially different between regions. A case in point was the changes in the relative abundance of filamentous bacteria Thiothrix, which caused a large effect on diversity indices, but only in the V1-V3 data set. Yet the relative abundance of Thiothrix in the amplicon sequencing data from both regions correlated with the estimation of its abundance determined using fluorescence in situ hybridization. In nonmetric multidimensional analysis samples were distributed along the first ordination axis according to the sequenced region rather than according to sample identities. The dynamics of microbial communities indicated that V1-V3 and the V4 regions of the 16S rRNA gene yielded comparable patterns of: 1) the changes occurring within the communities along fixed time intervals, 2) the slow turnover of activated sludge communities and 3) the rate of species replacement calculated from the taxa-time relationships. The temperature was the only operational variable that showed significant correlation with the composition of bacterial communities over time for the sets of data obtained with both pairs of primers. In conclusion, we show that despite the bias introduced by amplicon sequencing, the variable regions V1-V3 and V4 can be confidently used for the quantitative assessment of bacterial community dynamics, and provide a proper qualitative account of general taxa in the community, especially when the data are obtained over a convenient time window rather than at a single time point.	[Ibarbalz, Federico M.; Victoria Perez, Maria; Figuerola, Eva L. M.; Erijman, Leonardo] Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol INGEBI, RA-1033 Buenos Aires, DF, Argentina; [Victoria Perez, Maria] Agua & Saneamientos Argentinos SA AySA, Buenos Aires, DF, Argentina; [Erijman, Leonardo] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol Biol Mol & Celular, Buenos Aires, DF, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); University of Buenos Aires	Erijman, L (corresponding author), Consejo Nacl Invest Cient & Tecn, Inst Invest Ingn Genet & Biol Mol INGEBI, RA-1033 Buenos Aires, DF, Argentina.	erijman@dna.uba.ar	Erijman, Leonardo/AAI-1359-2020; Core, UNC Microbiome/AAB-3304-2022	Erijman, Leonardo/0000-0001-7525-2112; Figuerola, Eva Lucia Margarita/0000-0002-7784-1452	FONCyT [1877]; UBACYT; AYSA-CONICET [3816/11]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK034987] Funding Source: NIH RePORTER	FONCyT(FONCyT); UBACYT; AYSA-CONICET; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was partly funded by FONCyT (PICT 2012 No. 1877), UBACYT, and by a cooperative agreement AYSA-CONICET (Res. 3816/11). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2005, ECOLOGY, V86, P2032, DOI 10.1890/05-0067; Anderson MJ, 2003, ECOLOGY, V84, P511, DOI 10.1890/0012-9658(2003)084[0511:CAOPCA]2.0.CO;2; Ayarza JM, 2011, MICROB ECOL, V61, P486, DOI 10.1007/s00248-010-9762-y; Ayarza JM, 2010, MICROB ECOL, V59, P436, DOI 10.1007/s00248-009-9581-1; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Cai L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053649; Claesson MJ, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq873; Claesson MJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006669; Cole JR, 2014, NUCLEIC ACIDS RES, V42, pD633, DOI 10.1093/nar/gkt1244; Daims H, 2009, COLD SPRING HARB PRO, V2009; Eichner CA, 1999, APPL ENVIRON MICROB, V65, P102; Engelbrektson A, 2010, ISME J, V4, P642, DOI 10.1038/ismej.2009.153; Falk MW, 2009, WATER RES, V43, P842, DOI 10.1016/j.watres.2008.11.021; Fernandez A, 1999, APPL ENVIRON MICROB, V65, P3697; Forney LJ, 2004, CURR OPIN MICROBIOL, V7, P210, DOI 10.1016/j.mib.2004.04.015; Fuhrman JA, 2006, P NATL ACAD SCI USA, V103, P13104, DOI 10.1073/pnas.0602399103; Gonzalez A, 2012, CURR OPIN BIOTECH, V23, P431, DOI 10.1016/j.copbio.2011.11.017; Guo F, 2013, APPL MICROBIOL BIOT, V97, P4607, DOI 10.1007/s00253-012-4244-4; Heinrich F, 2013, AQUAT MICROB ECOL, V70, P33, DOI 10.3354/ame01637; Hong SH, 2009, ISME J, V3, P1365, DOI 10.1038/ismej.2009.89; Ibarbalz FM, 2013, WATER RES, V47, P3854, DOI 10.1016/j.watres.2013.04.010; Jenkins D, 2004, MANUAL CAUSES ACTIVA; Ju F, 2014, ENVIRON MICROBIOL, V16, P2421, DOI 10.1111/1462-2920.12355; Kaewpipat K, 2002, WATER SCI TECHNOL, V46, P19, DOI 10.2166/wst.2002.0450; Kanagawa T, 2000, APPL ENVIRON MICROB, V66, P5043, DOI 10.1128/AEM.66.11.5043-5052.2000; Kim TS, 2013, APPL MICROBIOL BIOT, V97, P1755, DOI 10.1007/s00253-012-4002-7; Klindworth A, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks808; Kumar PS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020956; LaPara TM, 2002, WATER RES, V36, P638, DOI 10.1016/S0043-1354(01)00277-9; Lee CK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044224; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Magurran AE, 2010, PHILOS T R SOC B, V365, P3611, DOI 10.1098/rstb.2010.0285; Mao DP, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-66; Marzorati M, 2008, ENVIRON MICROBIOL, V10, P1571, DOI 10.1111/j.1462-2920.2008.01572.x; Oliver A, 2012, MICROBIAL ECOLOGICAL THEORY: CURRENT PERSPECTIVES, P71; Peiffer JA, 2013, P NATL ACAD SCI USA, V110, P6548, DOI 10.1073/pnas.1302837110; Pinto AJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043093; Polz MF, 1998, APPL ENVIRON MICROB, V64, P3724; Quince C, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-38; REYSENBACH AL, 1992, APPL ENVIRON MICROB, V58, P3417, DOI 10.1128/AEM.58.10.3417-3418.1992; Scheiner SM, 2011, ECOL MONOGR, V81, P195, DOI 10.1890/10-1426.1; Schloss PD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027310; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shade A., 2010, MICROB ECOL, V59, P546, DOI [10.1007/s00248-009-9589-6, DOI 10.1007/s00248-009-9589-6]; Shade A, 2013, ISME J, V7, P1493, DOI 10.1038/ismej.2013.54; Sipos R, 2007, FEMS MICROBIOL ECOL, V60, P341, DOI 10.1111/j.1574-6941.2007.00283.x; Smith S, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf110; Suchankova P, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0076431, 10.1371/journal.pone.0071284]; Suzuki M, 1998, APPL ENVIRON MICROB, V64, P4522; van der Gast CJ, 2008, ENVIRON MICROBIOL, V10, P1411, DOI 10.1111/j.1462-2920.2007.01550.x; Vasileiadis S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042671; von Wintzingerode F, 1997, FEMS MICROBIOL REV, V21, P213; WALLNER G, 1993, CYTOMETRY, V14, P136, DOI 10.1002/cyto.990140205; Wang X, 2010, J APPL MICROBIOL, V109, P1218, DOI 10.1111/j.1365-2672.2010.04742.x; Wells GF, 2011, WATER RES, V45, P5476, DOI 10.1016/j.watres.2011.08.006; Wells GF, 2009, ENVIRON MICROBIOL, V11, P2310, DOI 10.1111/j.1462-2920.2009.01958.x; Werker AG, 2006, WATER SCI TECHNOL, V54, P11, DOI 10.2166/wst.2006.366; Werner JJ, 2011, P NATL ACAD SCI USA, V108, P4158, DOI 10.1073/pnas.1015676108; Youssef N, 2009, APPL ENVIRON MICROB, V75, P5227, DOI 10.1128/AEM.00592-09; Zhang W, 2014, BIORESOURCE TECHNOL, V151, P397, DOI 10.1016/j.biortech.2013.10.004	60	38	38	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99722	10.1371/journal.pone.0099722	http://dx.doi.org/10.1371/journal.pone.0099722			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923665	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300088
J	Maranon, E; Cermeno, P; Huete-Ortega, M; Lopez-Sandoval, DC; Mourino-Carballido, B; Rodriguez-Ramos, T				Maranon, Emilio; Cermeno, Pedro; Huete-Ortega, Maria; Lopez-Sandoval, Daffne C.; Mourino-Carballido, Beatriz; Rodriguez-Ramos, Tamara			Resource Supply Overrides Temperature as a Controlling Factor of Marine Phytoplankton Growth	PLOS ONE			English	Article							NUTRIENT LIMITATION; COMMUNITY STRUCTURE; METABOLIC BALANCE; ECOSYSTEM RIA; OCEAN; RATES; RESPIRATION; DEPENDENCE; CARBON; PHOTOSYNTHESIS	The universal temperature dependence of metabolic rates has been used to predict how ocean biology will respond to ocean warming. Determining the temperature sensitivity of phytoplankton metabolism and growth is of special importance because this group of organisms is responsible for nearly half of global primary production, sustains most marine food webs, and contributes to regulate the exchange of CO2 between the ocean and the atmosphere. Phytoplankton growth rates increase with temperature under optimal growth conditions in the laboratory, but it is unclear whether the same degree of temperature dependence exists in nature, where resources are often limiting. Here we use concurrent measurements of phytoplankton biomass and carbon fixation rates in polar, temperate and tropical regions to determine the role of temperature and resource supply in controlling the large-scale variability of in situ metabolic rates. We identify a biogeographic pattern in phytoplankton metabolic rates, which increase from the oligotrophic subtropical gyres to temperate regions and then coastal waters. Variability in phytoplankton growth is driven by changes in resource supply and appears to be independent of seawater temperature. The lack of temperature sensitivity of realized phytoplankton growth is consistent with the limited applicability of Arrhenius enzymatic kinetics when substrate concentrations are low. Our results suggest that, due to widespread resource limitation in the ocean, the direct effect of sea surface warming upon phytoplankton growth and productivity may be smaller than anticipated.	[Maranon, Emilio; Mourino-Carballido, Beatriz; Rodriguez-Ramos, Tamara] Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain; [Cermeno, Pedro; Lopez-Sandoval, Daffne C.] CSIC, Inst Ciencias Mar, Barcelona, Spain; [Huete-Ortega, Maria] Univ Sheffield, Dept Chem & Biol Engn, Sheffield, S Yorkshire, England	Universidade de Vigo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Mediterraneo de Investigaciones Marinas y Ambientales (CMIMA); CSIC - Instituto de Ciencias del Mar (ICM); University of Sheffield	Maranon, E (corresponding author), Univ Vigo, Dept Ecol & Biol Anim, Vigo 36310, Spain.	em@uvigo.es	C, López-Sandoval D./O-8516-2018; Mourino, Beatriz/E-8635-2016; Marañón, Emilio/Q-5817-2019; Marañón, Emilio/F-3013-2013; Huete-Ortega, Maria/K-4530-2014; Ramos, Tamara Rodríguez/P-6883-2017	C, López-Sandoval D./0000-0002-4605-0113; Marañón, Emilio/0000-0003-1572-2121; Marañón, Emilio/0000-0003-1572-2121; Huete-Ortega, Maria/0000-0002-8746-5518; Ramos, Tamara Rodríguez/0000-0002-8766-9991; Mourino-Carballido, Beatriz/0000-0001-7961-1477; Cermeno, Pedro/0000-0002-3902-3475	Spanish Ministry of Science and Innovation through research projects 'Macroecological patterns in marine phytoplankton' [CTM2008-03699]; MALASPINA [CSD2008-00077]; Role of turbulence and nutrient supply dynamics on the structure of marine phytoplankton communities [CTM2012-30680]; Ramon y Cajal-MEC	Spanish Ministry of Science and Innovation through research projects 'Macroecological patterns in marine phytoplankton'(Ministry of Science and Innovation, Spain (MICINN)); MALASPINA; Role of turbulence and nutrient supply dynamics on the structure of marine phytoplankton communities; Ramon y Cajal-MEC(Spanish Government)	This research was funded by the Spanish Ministry of Science and Innovation through research projects 'Macroecological patterns in marine phytoplankton' (CTM2008-03699), 'MALASPINA 2010' (CSD2008-00077) and 'Role of turbulence and nutrient supply dynamics on the structure of marine phytoplankton communities (CTM2012-30680). PC and BMC were supported by a Ramon y Cajal-MEC contract. This is contribution 250 of the AMT programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen AP, 2009, ECOL LETT, V12, P369, DOI 10.1111/j.1461-0248.2009.01302.x; Atkin OK, 2003, TRENDS PLANT SCI, V8, P343, DOI 10.1016/S1360-1385(03)00136-5; BANSE K, 1991, LIMNOL OCEANOGR, V36, P1886, DOI 10.4319/lo.1991.36.8.1886; BANSE K, 1995, ICES J MAR SCI, V52, P265, DOI 10.1016/1054-3139(95)80043-3; Behrenfeld MJ, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002299; Berry J. A., 1981, PHYSL PLANT ECOLOGY, P277, DOI [10.1007/978-3-642-68090-8-11, DOI 10.1007/978-3-642-68090-8_11, DOI 10.1007/978-3-642-68090-8]; Bissinger JE, 2008, LIMNOL OCEANOGR, V53, P487, DOI 10.4319/lo.2008.53.2.0487; Boyd PW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063091; Boyd PW, 2010, LIMNOL OCEANOGR, V55, P1353, DOI 10.4319/lo.2010.55.3.1353; Boyd PW, 2000, NATURE, V407, P695, DOI 10.1038/35037500; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cermeno P, 2006, ESTUAR COAST SHELF S, V67, P251, DOI 10.1016/j.ecss.2005.11.027; CULLEN JJ, 1992, ENVIR SCI R, V43, P69; Davey M, 2008, LIMNOL OCEANOGR, V53, P1722, DOI 10.4319/lo.2008.53.5.1722; Davidson EA, 2006, NATURE, V440, P165, DOI 10.1038/nature04514; Davidson EA, 2006, GLOBAL CHANGE BIOL, V12, P154, DOI 10.1111/j.1365-2486.2005.01065.x; Degerman R, 2013, AQUAT MICROB ECOL, V68, P131, DOI 10.3354/ame01609; Doney SC, 1996, DEEP-SEA RES PT II, V43, P591, DOI 10.1016/0967-0645(95)00104-2; EPPLEY RW, 1972, FISH B-NOAA, V70, P1063; Falkowski P, 2012, NATURE, V483, pS17, DOI 10.1038/483S17a; Falkowski PG, 1998, SCIENCE, V281, P200, DOI 10.1126/science.281.5374.200; FENCHEL T, 1974, OECOLOGIA, V14, P317, DOI 10.1007/BF00384576; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; Flombaum P, 2013, P NATL ACAD SCI USA, V110, P9824, DOI 10.1073/pnas.1307701110; Frew R, 2001, DEEP-SEA RES PT II, V48, P2467, DOI 10.1016/S0967-0645(01)00004-2; FURNAS MJ, 1990, J PLANKTON RES, V12, P1117, DOI 10.1093/plankt/12.6.1117; Gall MP, 2001, DEEP-SEA RES PT II, V48, P2571, DOI 10.1016/S0967-0645(01)00009-1; Gall MP, 2001, DEEP-SEA RES PT II, V48, P2551, DOI 10.1016/S0967-0645(01)00008-X; GEIDER RJ, 1987, NEW PHYTOL, V106, P1, DOI 10.1111/j.1469-8137.1987.tb04788.x; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; GOLDMAN JC, 1974, LIMNOL OCEANOGR, V19, P756, DOI 10.4319/lo.1974.19.5.0756; GOLDMAN JC, 1979, NATURE, V279, P210, DOI 10.1038/279210a0; Griffith SM, 2001, ANN BOT-LONDON, V87, P599, DOI 10.1006/anbo.2001.1380; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Kirchman DL, 2002, MAR ECOL PROG SER, V233, P303, DOI 10.3354/meps233303; Laws EA, 2013, ANNU REV MAR SCI, V5, P247, DOI 10.1146/annurev-marine-121211-172258; LI WKW, 1985, DEEP-SEA RES, V32, P1381, DOI 10.1016/0198-0149(85)90054-8; Litchman E, 2012, MAR ECOL PROG SER, V470, P235, DOI 10.3354/meps09912; Lopez-Urrutia A, 2006, P NATL ACAD SCI USA, V103, P8739, DOI 10.1073/pnas.0601137103; Maranon E, 2005, LIMNOL OCEANOGR, V50, P299, DOI 10.4319/lo.2005.50.1.0299; Maranon E, 2000, DEEP-SEA RES PT I, V47, P825, DOI 10.1016/S0967-0637(99)00087-4; Maranon E, 2013, ECOL LETT, V16, P371, DOI 10.1111/ele.12052; Marinov I, 2010, BIOGEOSCIENCES, V7, P3941, DOI 10.5194/bg-7-3941-2010; Moisan JR, 2002, ECOL MODEL, V153, P197, DOI 10.1016/S0304-3800(02)00008-X; Montagnes DJS, 2001, LIMNOL OCEANOGR, V46, P2008, DOI 10.4319/lo.2001.46.8.2008; Moore CM, 2013, NAT GEOSCI, V6, P701, DOI [10.1038/ngeo1765, 10.1038/NGEO1765]; Moore CM, 2008, LIMNOL OCEANOGR, V53, P291, DOI 10.4319/lo.2008.53.1.0291; Nogueira E, 1997, ESTUAR COAST SHELF S, V44, P285, DOI 10.1006/ecss.1996.0119; O'Connor MI, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000178; RAVEN JA, 1988, NEW PHYTOL, V110, P441, DOI 10.1111/j.1469-8137.1988.tb00282.x; Reay DS, 2001, MAR ECOL PROG SER, V219, P51, DOI 10.3354/meps219051; Regaudie-De-Gioux A, 2012, GLOBAL BIOGEOCHEM CY, V26, DOI 10.1029/2010GB003907; RHEE GY, 1981, LIMNOL OCEANOGR, V26, P635, DOI 10.4319/lo.1981.26.4.0635; Schmittner A, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002283; Solomon S., 2007, PHYS SCI BASIS WORKI; SOMERO GN, 1995, ANNU REV PHYSIOL, V57, P43, DOI 10.1146/annurev.ph.57.030195.000355; Staehr PA, 2006, FRESHWATER BIOL, V51, P249, DOI 10.1111/j.1365-2427.2005.01490.x; Staehr PA, 2006, PHYCOLOGIA, V45, P648, DOI 10.2216/06-04.1; Tadonleke RD, 2010, LIMNOL OCEANOGR, V55, P973, DOI 10.4319/lo.2010.55.3.0973; Taucher J, 2011, GEOPHYS RES LETT, V38, DOI 10.1029/2010GL045934; Thomas MK, 2012, SCIENCE, V338, P1085, DOI 10.1126/science.1224836; Toseland A, 2013, NAT CLIM CHANGE, V3, P979, DOI 10.1038/NCLIMATE1989; Veldhuis MJW, 2004, DEEP-SEA RES PT I, V51, P507, DOI 10.1016/j.dsr.2003.12.002; Wohlers-Zollner J, 2011, LIMNOL OCEANOGR, V56, P599, DOI 10.4319/lo.2011.56.2.0599; Yvon-Durocher G, 2010, PHILOS T R SOC B, V365, P2117, DOI 10.1098/rstb.2010.0038	65	70	70	2	81	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99312	10.1371/journal.pone.0099312	http://dx.doi.org/10.1371/journal.pone.0099312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921945	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000338701300048
J	Stanoev, A; Trpevski, D; Kocarev, L				Stanoev, Angel; Trpevski, Daniel; Kocarev, Ljupco			Modeling the Spread of Multiple Concurrent Contagions on Networks	PLOS ONE			English	Article							POPULATION-DYNAMICS; COEXISTENCE; DISEASES; PATTERNS	Many contagions spread over various types of communication networks and their spreading dynamics have been extensively studied in the literature. Here we propose a general model for the concurrent spread of an arbitrary number of contagions in complex networks. The model is stochastic and runs in discrete time, and includes two widely used mechanisms by which a node can change its state. The first, termed the spontaneous state change mechanism, describes spontaneous transition to another state, while the second, termed the contact-induced state change mechanism, describes acquiring other contagions due to contact with the neighbors. We consider reactive discrete-time spreading processes of multiple concurrent contagions where time steps are of finite size without neglecting the possibility of multiple infecting events in a single time step. An essential element for making the model numerically tractable is the use of an approximation for the probability that a node transits to a specific state given any set of neighboring states. Different transmission probabilities may be present between each pair of states. We also derive corresponding continuous-time equations that are simple and intuitive. The model includes many well-known epidemic and rumor spreading models as a special case and it naturally captures spreading processes in multiplex networks.	[Stanoev, Angel; Trpevski, Daniel; Kocarev, Ljupco] Macedonian Acad Sci & Arts, Skopje, North Macedonia		Kocarev, L (corresponding author), Macedonian Acad Sci & Arts, Skopje, North Macedonia.	lkocarev@manu.edu.mk	Kocarev, Ljupco/AAS-3002-2020	Stanoev, Angel/0000-0001-6478-7496; Trpevski, Daniel/0000-0001-9068-6744	Macedonian Academy of Sciences and Arts	Macedonian Academy of Sciences and Arts	This work was partially supported by the Macedonian Academy of Sciences and Arts. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	ANDERSON R M, 1991; Andersson H., 2000, STOCHASTIC EPIDEMIC, V4; Bornholdt S, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.058701; Brauer F., 2012, MATH MODELS POPULATI; Chakrabarti D, 2008, ACM T INFORM SYST SE, V10, DOI 10.1145/1284680.1284681; Cozzo E, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.050801; Daley D., 1965, IMA J APPL MATH, V1, P42, DOI [DOI 10.1093/IMAMAT/1.1.42, 10.1093/imamat/1.1.42]; Daley D. J., 2001, EPIDEMIC MODELLING I, V15; DALEY DJ, 1964, NATURE, V204, P1118, DOI 10.1038/2041118a0; Faloutsos C., 2012, P 18 ACM SIGKDD INT, P426; Gomez S, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.028701; Gomez S, 2010, EPL-EUROPHYS LETT, V89, DOI 10.1209/0295-5075/89/38009; Gomez S, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036105; Gomez-Gardenes J, 2008, P NATL ACAD SCI USA, V105, P1399, DOI 10.1073/pnas.0707332105; Granell C, 2013, ARXIV13064136; Guerra B, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.035101; Jolles AE, 2008, ECOLOGY, V89, P2239, DOI 10.1890/07-0995.1; Karrer B, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.036106; Kermack WO, 1932, P R SOC LOND A-CONTA, V138, P55, DOI 10.1098/rspa.1932.0171; Kosmidis K, 2005, PHYSICA A, V353, P595, DOI 10.1016/j.physa.2005.02.038; Lipsitch M, 2009, EPIDEMICS-NETH, V1, P2, DOI 10.1016/j.epidem.2008.07.001; Maki D.P., 1973, MATH MODELS APPL EMP; Nekovee M, 2007, PHYSICA A, V374, P457, DOI 10.1016/j.physa.2006.07.017; Newman MEJ, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.108701; Oli MK, 2006, ECOL MODEL, V198, P183, DOI 10.1016/j.ecolmodel.2006.04.007; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Prakash BA, 2012, KNOWL INF SYST, V33, P549, DOI 10.1007/s10115-012-0520-y; Prakash BA, 2012, P 21 INT C WORLD WID, P1037, DOI [10.1145/2187836.2187975, DOI 10.1145/2187836.2187975]; Roche B, 2010, EPIDEMICS-NETH, V2, P92, DOI 10.1016/j.epidem.2010.03.002; Smilkov D, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.016114; Sneppen K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013326; Stauffer D, 2005, PHYS LIFE REV, V2, P89, DOI 10.1016/j.plrev.2005.03.001; Trpevski D, 2010, PHYS REV E, V81, DOI 10.1103/PhysRevE.81.056102; Uekermann F, 2012, PHYS REV E, V86, DOI 10.1103/PhysRevE.86.036108; Wang Y, 2003, SYM REL DIST SYST, P25; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Wei XT, 2012, ACM SIGCOMM COMP COM, V42, P5, DOI 10.1145/2378956.2378958; Wolfowitz J., 1963, P AM MATH SOC, V14, P733, DOI [DOI 10.1090/S0002-9939-1963-0154756-3, 10.1090/S0002-9939-1963-0154756-3]	38	19	19	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e95669	10.1371/journal.pone.0095669	http://dx.doi.org/10.1371/journal.pone.0095669			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922541	Green Submitted, Green Published, gold			2022-12-27	WOS:000338701300003
J	Tebruegge, M; Ritz, N; Koetz, K; Noguera-Julian, A; Seddon, JA; Welch, SB; Tsolia, M; Kampmann, B				Tebruegge, Marc; Ritz, Nicole; Koetz, Karsten; Noguera-Julian, Antoni; Seddon, James A.; Welch, Steven B.; Tsolia, Maria; Kampmann, Beate		Paediat TB Network European	Availability and Use of Molecular Microbiological and Immunological Tests for the Diagnosis of Tuberculosis in Europe	PLOS ONE			English	Article							GAMMA RELEASE ASSAYS; LINE-PROBE ASSAY; XPERT MTB/RIF; PULMONARY TUBERCULOSIS; RESPIRATORY SPECIMENS; RAPID DIAGNOSIS; COMPLEX; RESISTANCE; RIFAMPIN; FEASIBILITY	Introduction: Currently only limited data exist regarding the availability and clinical use of molecular and immunological tests for tuberculosis (TB) in the European setting. Methods: Web-based survey of Paediatric-Tuberculosis-Network-European-Trialsgroup (ptbnet) and Tuberculosis-Network-European-Trialsgroup (TBnet) members conducted June to December 2013. Both networks comprise clinicians, microbiologists, epidemiologists and researchers predominately based in Europe. Results: 191 healthcare professionals from 31 European countries participated. Overall, 26.8% of respondents did not have access to the Xpert MTB/RIF assay; only 44.6% had access to the assay in-house. However, a substantial proportion had access to other commercial and/or non-commercial PCR-based assays for TB (68.8% and 31.8%, respectively). Only 6.4% did not have access to any PCR-based assays for TB. A large proportion of participants with access to the Xpert MTB/RIF assay had used it for the analysis of non-respiratory samples [pleural fluid: 36.5%, gastric aspirates: 34.7%, cerebrospinal fluid: 34.7%, stool samples: 4.3%, blood/serum: 2.6%, 'other samples' (which included biopsy/tissue samples, lymph node aspirates, joint aspirates and urine samples): 16.5%]. Regarding interferon-gamma release assays, a greater proportion of respondents had access to the QuantiFERON-TB Gold assay (84.7%) than to the T-SPOT.TB assay (52.2%). Conclusions: Both immunological and molecular TB tests are widely available across Europe. The QuantiFERON-TB Gold assay is more widely used than the T-SPOT.TB assay, which may reflect the difficulties of integrating an ELISPOT assay into the routine laboratory setting. Although Xpert MTB/RIF assays are optimised and solely licensed for the analysis of sputum samples, in clinical practice they are commonly used for non-respiratory samples. Further research is needed to establish how current molecular TB tests impact on patient care and outcome in the routine clinical setting.	[Tebruegge, Marc] Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England; [Tebruegge, Marc] Univ Hosp Southampton NHS Fdn Trust, Dept Paediat Infect Dis & Immunol, Southampton, Hants, England; [Tebruegge, Marc] Univ Southampton, Inst Life Sci, Southampton, Hants, England; [Tebruegge, Marc; Ritz, Nicole] Univ Melbourne, Dept Paediat, Parkville, Vic 3052, Australia; [Ritz, Nicole] Univ Childrens Hosp Basel, Infect Dis Unit, Basel, Switzerland; [Koetz, Karsten] Sahlgrens Univ Hosp, Dept Paediat, Gothenburg, Sweden; [Noguera-Julian, Antoni] Univ Barcelona, Hosp St Joan de Deu, Dept Paediat, Barcelona, Spain; [Seddon, James A.; Kampmann, Beate] Univ London Imperial Coll Sci Technol & Med, Fac Med, Acad Dept Paediat, London, England; [Welch, Steven B.] Heart England NHS Fdn Trust, Birmingham Chest Clin, Southampton, Hants, England; [Tsolia, Maria] Univ Athens, Sch Med, P&A Kyriakou Childrens Hosp, Univ Dept Pediat 2, Athens 11528, Greece; [Kampmann, Beate] Med Res Council MRC Unit Gambia, Banjul, Gambia	University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; University of Southampton; University of Melbourne; University of Basel; Sahlgrenska University Hospital; University of Barcelona; Imperial College London; Heart of England NHS Foundation Trust; Athens Medical School; National & Kapodistrian University of Athens; University of London; London School of Hygiene & Tropical Medicine	Tebruegge, M (corresponding author), Univ Southampton, Fac Med, Acad Unit Clin & Expt Sci, Southampton SO9 5NH, Hants, England.	m.tebruegge@soton.ac.uk	Ritz, Nicole/G-2924-2015; Ritz, Nicole/L-1452-2019; Seddon, James/HHC-2093-2022	Ritz, Nicole/0000-0002-1498-1685; Ritz, Nicole/0000-0002-1498-1685; Seddon, James/0000-0002-2296-2302	UK National Institute for Health Research (NIHR); NIHR Southampton Respiratory Biomedical Research Unit; UK Technology Strategy Board (TSB); University of Basel; NIHR Senior Research Fellowship; MRC Program grant; Rozalia Foundation; Academy of Medical Sciences (AMS) [AMS-SGCL11-Seddon] Funding Source: researchfish; Medical Research Council [MC_UP_A900_1115, MC_UP_A900_1122] Funding Source: researchfish; National Institute for Health Research [CL-2011-26-004, CL-2012-21-006, SRF-2009-02-07] Funding Source: researchfish; MRC [MC_UP_A900_1122, MC_UP_A900_1115] Funding Source: UKRI	UK National Institute for Health Research (NIHR)(National Institute for Health Research (NIHR)); NIHR Southampton Respiratory Biomedical Research Unit; UK Technology Strategy Board (TSB); University of Basel; NIHR Senior Research Fellowship; MRC Program grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Rozalia Foundation; Academy of Medical Sciences (AMS)(Academy of Medical Sciences (AMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	No funding specifically related to this study was received. MT is supported by a Clinical Lectureship provided by the UK National Institute for Health Research (NIHR), the NIHR Southampton Respiratory Biomedical Research Unit, and a research grant provided by the UK Technology Strategy Board (TSB). NR is supported by a career advancement grant from the University of Basel and a grant from the Rozalia Foundation. BK is supported by an NIHR Senior Research Fellowship and an MRC Program grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ablanedo-Terrazas Y, 2014, LARYNGOSCOPE, V124, P1382, DOI 10.1002/lary.24478; Andersen P, 2000, LANCET, V356, P1099, DOI 10.1016/S0140-6736(00)02742-2; Barnard M, 2012, AM J RESP CRIT CARE, V186, P1298, DOI 10.1164/rccm.201205-0960OC; Boehme CC, 2011, LANCET, V377, P1495, DOI 10.1016/S0140-6736(11)60438-8; Boehme CC, 2010, NEW ENGL J MED, V363, P1005, DOI 10.1056/NEJMoa0907847; DAMATO RF, 1995, J CLIN MICROBIOL, V33, P1832, DOI 10.1128/JCM.33.7.1832-1834.1995; Dheda K, 2009, CURR OPIN PULM MED, V15, P188, DOI 10.1097/MCP.0b013e32832a0adc; Eisenhut M, 2012, NEW ENGL J MED, V367, P1568, DOI 10.1056/NEJMc1210173; European Centre for Disease Prevention and Control/WHO Regional Office for Europe, 2013, TUB SURV MON EUR 201; Heifets L, 2000, J CLIN MICROBIOL, V38, P1227, DOI 10.1128/JCM.38.3.1227-1230.2000; Herrera V, 2011, CLIN INFECT DIS, V52, P1031, DOI 10.1093/cid/cir068; Hillemann D, 2011, J CLIN MICROBIOL, V49, P1202, DOI 10.1128/JCM.02268-10; Lacoma A, 2008, J CLIN MICROBIOL, V46, P3660, DOI 10.1128/JCM.00618-08; Lawn SD, 2013, LANCET INFECT DIS, V13, P349, DOI 10.1016/S1473-3099(13)70008-2; Lawn SD, 2012, INT J TUBERC LUNG D, V16, P701, DOI 10.5588/ijtld.12.0131; Lawn SD, 2011, FUTURE MICROBIOL, V6, P1067, DOI [10.2217/FMB.11.84, 10.2217/fmb.11.84]; Ligthelm LJ, 2011, J CLIN MICROBIOL, V49, P3967, DOI 10.1128/JCM.01310-11; Moure R, 2012, J CLIN MICROBIOL, V50, P513, DOI 10.1128/JCM.06467-11; Nhu NTQ, 2014, J CLIN MICROBIOL, V52, P226, DOI 10.1128/JCM.01834-13; Nicol MP, 2013, CLIN INFECT DIS, V57, pE18, DOI 10.1093/cid/cit230; Nulty DD, 2008, ASSESS EVAL HIGH EDU, V33, P301, DOI 10.1080/02602930701293231; Pai M, 2007, LANCET INFECT DIS, V7, P428, DOI 10.1016/S1473-3099(07)70086-5; Patel VB, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001536; Pfyffer GE, 1999, J CLIN MICROBIOL, V37, P137, DOI 10.1128/JCM.37.1.137-140.1999; Porcel JM, 2013, INT J TUBERC LUNG D, V17, P1217, DOI 10.5588/ijtld.13.0178; Tebruegge M, 2010, EUR RESPIR J, V36, P214, DOI 10.1183/09031936.00025510; Tebruegge M, 2013, THORAX, V68, P588, DOI 10.1136/thoraxjnl-2012-202824; Theron G, 2014, LANCET, V383, P424, DOI 10.1016/S0140-6736(13)62073-5; Tortoli E, 2012, EUR RESPIR J, V40, P442, DOI 10.1183/09031936.00176311; U.S. Food and Drug Administration, 2013, XPERT MTB RIF ASS DE; US Food and Drug Administration, 2001, DEV APPR CLEAR QUANT; Viveiros M, 2005, J CLIN MICROBIOL, V43, P4880, DOI 10.1128/JCM.43.9.4880-4884.2005; VUORINEN P, 1995, J CLIN MICROBIOL, V33, P1856, DOI 10.1128/JCM.33.7.1856-1859.1995; WHO, 2012, GLOBAL TUBERCULOSIS REPORT 2012, P1; World Health Organization, 2014, WHO MON XPERT MTB RI; World Health Organization, 2013, XPERT MTBRIF ASSAY D	36	28	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99129	10.1371/journal.pone.0099129	http://dx.doi.org/10.1371/journal.pone.0099129			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922084	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300035
J	Fanghanel, S; Wadhwani, P; Strandberg, E; Verdurmen, WPR; Burck, J; Ehni, S; Mykhailiuk, PK; Afonin, S; Gerthsen, D; Komarov, IV; Brock, R; Ulrich, AS				Fanghaenel, Susanne; Wadhwani, Parvesh; Strandberg, Erik; Verdurmen, Wouter P. R.; Buerck, Jochen; Ehni, Sebastian; Mykhailiuk, Pavel K.; Afonin, Sergii; Gerthsen, Dagmar; Komarov, Igor V.; Brock, Roland; Ulrich, Anne S.			Structure Analysis and Conformational Transitions of the Cell Penetrating Peptide Transportan 10 in the Membrane-Bound State	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; CIRCULAR-DICHROISM SPECTRA; BETA-SHEET TRANSITION; AMINO-ACID; NMR ANALYSIS; ALPHA-SYNUCLEIN; LIPID-BILAYERS; DRUG-DELIVERY; SDS MICELLES; PGLA	Structure analysis of the cell-penetrating peptide transportan 10 (TP10) revealed an exemplary range of different conformations in the membrane-bound state. The bipartite peptide (derived N-terminally from galanin and C-terminally from mastoparan) was found to exhibit prominent characteristics of (i) amphiphilic alpha-helices, (ii) intrinsically disordered peptides, as well as (iii) beta-pleated amyloid fibrils, and these conformational states become interconverted as a function of concentration. We used a complementary approach of solid-state F-19-NMR and circular dichroism in oriented membrane samples to characterize the structural and dynamical behaviour of TP10 in its monomeric and aggregated forms. Nine different positions in the peptide were selectively substituted with either the L-or D-enantiomer of 3-(trifluoromethyl)-bicyclopent-[1.1.1]-1-ylglycine (CF3-Bpg) as a reporter group for F-19-NMR. Using the L-epimeric analogs, a comprehensive three-dimensional structure analysis was carried out in lipid bilayers at low peptide concentration, where TP10 is monomeric. While the N-terminal region is flexible and intrinsically unstructured within the plane of the lipid bilayer, the C-terminal alpha-helix is embedded in the membrane with an oblique tilt angle of similar to 55 degrees and in accordance with its amphiphilic profile. Incorporation of the sterically obstructive D-CF3-Bpg reporter group into the helical region leads to a local unfolding of the membrane-bound peptide. At high concentration, these helix-destabilizing C-terminal substitutions promote aggregation into immobile beta-sheets, which resemble amyloid fibrils. On the other hand, the obstructive D-CF3-Bpg substitutions can be accommodated in the flexible N-terminus of TP10 where they do not promote aggregation at high concentration. The cross-talk between the two regions of TP10 thus exerts a delicate balance on its conformational switch, as the presence of the alpha-helix counteracts the tendency of the unfolded N-terminus to self-assemble into beta-pleated fibrils.	[Fanghaenel, Susanne; Ehni, Sebastian; Ulrich, Anne S.] Karlsruhe Inst Technol KIT, Inst Organ Chem, Karlsruhe, Germany; [Fanghaenel, Susanne; Ehni, Sebastian; Ulrich, Anne S.] Karlsruhe Inst Technol KIT, DFG Ctr Funct Nanostruct CFN, Karlsruhe, Germany; [Wadhwani, Parvesh; Strandberg, Erik; Buerck, Jochen; Afonin, Sergii; Ulrich, Anne S.] KIT, Inst Biol Interfaces IBG2, Karlsruhe, Germany; [Verdurmen, Wouter P. R.; Brock, Roland] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Biochem, NL-6525 ED Nijmegen, Netherlands; [Mykhailiuk, Pavel K.] Taras Shevchenko Natl Univ Kyiv, Dept Chem, Kiev, Ukraine; [Mykhailiuk, Pavel K.] Enamine Ltd, Kiev, Ukraine; [Gerthsen, Dagmar] KIT, Lab Electron Microscopy, Karlsruhe, Germany; [Komarov, Igor V.] Taras Shevchenko Natl Univ Kyiv, Inst High Technol, Kiev, Ukraine	Helmholtz Association; Karlsruhe Institute of Technology; German Research Foundation (DFG); Helmholtz Association; Karlsruhe Institute of Technology; Helmholtz Association; Karlsruhe Institute of Technology; Radboud University Nijmegen; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev; Enamine Ltd; Helmholtz Association; Karlsruhe Institute of Technology; Ministry of Education & Science of Ukraine; Taras Shevchenko National University Kiev	Ulrich, AS (corresponding author), Karlsruhe Inst Technol KIT, Inst Organ Chem, Karlsruhe, Germany.	anne.ulrich@kit.edu	Mykhailiuk, Pavel/K-8262-2012; Gerthsen, Dagmar/I-4448-2012; Gerthsen, Dagmar/N-6245-2019; Verdurmen, Wouter/H-7457-2016; Komarov, Igor V./C-5467-2015; Brock, Roland/K-2590-2012; Afonin, Sergii/T-2737-2019; Brock, Roland/O-9411-2019; Ulrich, Anne S./H-5519-2013	Mykhailiuk, Pavel/0000-0003-1821-9011; Verdurmen, Wouter/0000-0002-2463-277X; Komarov, Igor V./0000-0002-7908-9145; Brock, Roland/0000-0003-1395-6127; Afonin, Sergii/0000-0002-2356-4226; Ulrich, Anne S./0000-0001-5571-9483; Strandberg, Erik/0000-0002-2401-7478; Wadhwani, Parvesh/0000-0002-7290-5154	DFG-Center for Functional Nanostructures [TP E1.2]; Radboud University Medical Centre, Nijmegen	DFG-Center for Functional Nanostructures(German Research Foundation (DFG)); Radboud University Medical Centre, Nijmegen	We acknowledge the DFG-Center for Functional Nanostructures for financial support (TP E1.2, and Z-project). Wouter Verdurmen was supported by funds from the Radboud University Medical Centre, Nijmegen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afonin S, 2007, J PEPT SCI, V13, P614, DOI 10.1002/psc.854; Afonin S, 2006, CHEMPHYSCHEM, V7, P2134, DOI 10.1002/cphc.200600306; Afonin S, 2008, J AM CHEM SOC, V130, P16512, DOI 10.1021/ja803156d; Aisenbrey C, 2008, EUR BIOPHYS J BIOPHY, V37, P247, DOI 10.1007/s00249-007-0237-0; Almeida PF, 2009, BIOCHEMISTRY-US, V48, P8083, DOI 10.1021/bi900914g; Alves ID, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024096; Ambroggio EE, 2005, BIOPHYS J, V88, P2706, DOI 10.1529/biophysj.104.055582; Barany-Wallje E, 2004, FEBS LETT, V567, P265, DOI 10.1016/j.febslet.2004.04.079; Barany-Wallje E, 2007, FEBS LETT, V581, P2389, DOI 10.1016/j.febslet.2007.04.046; Bartels T, 2010, BIOPHYS J, V99, P2116, DOI 10.1016/j.bpj.2010.06.035; BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372; Bond PJ, 2010, PROTEIN PEPTIDE LETT, V17, P1313; Burck J, 2008, BIOPHYS J, V95, P3872, DOI 10.1529/biophysj.108.136085; Clark KS, 2011, BIOCHEMISTRY-US, V50, P7919, DOI 10.1021/bi200873u; Comellas G, 2012, J AM CHEM SOC, V134, P5090, DOI 10.1021/ja209019s; CORNELL BA, 1988, BIOPHYS J, V53, P67, DOI 10.1016/S0006-3495(88)83066-2; Doran TM, 2012, J MOL BIOL, V421, P315, DOI 10.1016/j.jmb.2012.01.055; Dunkin CM, 2011, J PHYS CHEM B, V115, P1188, DOI 10.1021/jp107763b; Dupont E, 2011, METHODS MOL BIOL, V683, P21, DOI 10.1007/978-1-60761-919-2_2; Eggenberger K, 2011, CHEMBIOCHEM, V12, P132, DOI 10.1002/cbic.201000402; Eisenberg D, 2006, ACCOUNTS CHEM RES, V39, P568, DOI 10.1021/ar0500618; FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x; Fischer R, 2005, CHEMBIOCHEM, V6, P2126, DOI 10.1002/cbic.200500044; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Glaser RW, 2005, BIOPHYS J, V88, P3392, DOI 10.1529/biophysj.104.056424; Glaser RW, 2004, J MAGN RESON, V168, P153, DOI 10.1016/j.jmr.2004.02.008; Glaser RW, 2003, J MAGN RESON, V164, P104, DOI 10.1016/S1090-7807(03)00207-6; Gorbenko GP, 2006, CHEM PHYS LIPIDS, V141, P72, DOI 10.1016/j.chemphyslip.2006.02.006; Grage S, 2005, NMR SPECTROSCOPY BIO, P215; Grage SL, 2004, CHEM PHYS LIPIDS, V132, P65, DOI 10.1016/j.chemphyslip.2004.09.006; Grasnick D, 2011, EUR BIOPHYS J BIOPHY, V40, P529, DOI 10.1007/s00249-011-0676-5; Hebda JA, 2009, ANNU REV BIOPHYS, V38, P125, DOI 10.1146/annurev.biophys.050708.133622; Henriques ST, 2006, BIOCHEM J, V399, P1, DOI 10.1042/BJ20061100; HIGASHIJIMA T, 1988, J BIOL CHEM, V263, P6491; Huang R, 2012, J MOL BIOL, V416, P108, DOI 10.1016/j.jmb.2011.12.023; Ieronimo M, 2010, J AM CHEM SOC, V132, P8822, DOI 10.1021/ja101608z; Janek K, 2001, BIOCHEMISTRY-US, V40, P5457, DOI 10.1021/bi002005e; Johnson WC, 1999, PROTEINS, V35, P307, DOI 10.1002/(SICI)1097-0134(19990515)35:3<307::AID-PROT4>3.0.CO;2-3; Jones SW, 2005, BRIT J PHARMACOL, V145, P1093, DOI 10.1038/sj.bjp.0706279; Kerth A, 2004, BIOPHYS J, V86, P3750, DOI 10.1529/biophysj.103.035964; Khafagy ES, 2012, ADV DRUG DELIVER REV, V64, P531, DOI 10.1016/j.addr.2011.12.014; Khemtemourian L, 2011, J AM CHEM SOC, V133, P15598, DOI 10.1021/ja205007j; Khurana R, 2005, J STRUCT BIOL, V151, P229, DOI 10.1016/j.jsb.2005.06.006; Kilk K, 2005, J CONTROL RELEASE, V103, P511, DOI 10.1016/j.jconrel.2004.12.006; Koren E, 2011, DRUG DELIV, V18, P377, DOI 10.3109/10717544.2011.567310; Kubyshkin VS, 2011, FLUORINE PHARM MEDIN, P91; Langel U., 2002, CELL PENETRATING PEP, V1st ed; Langel U, 2007, HDB CELL PENETRATING; Lindberg M, 2001, BIOCHEMISTRY-US, V40, P3141, DOI 10.1021/bi0008985; Lindberg M, 2001, FEBS LETT, V497, P39, DOI 10.1016/S0014-5793(01)02433-4; Lobley A, 2002, BIOINFORMATICS, V18, P211, DOI 10.1093/bioinformatics/18.1.211; Magzoub M, 2001, BBA-BIOMEMBRANES, V1512, P77, DOI 10.1016/S0005-2736(01)00304-2; McKeown AN, 2011, BIOCHEMISTRY-US, V50, P654, DOI 10.1021/bi1013358; Meier M, 2008, J AM CHEM SOC, V130, P1017, DOI 10.1021/ja077231r; Meier M, 2007, J MOL BIOL, V369, P277, DOI 10.1016/j.jmb.2007.02.082; Mikhailiuk PK, 2006, ANGEW CHEM INT EDIT, V45, P5659, DOI 10.1002/anie.200600346; Mueller J, 2008, BIOCONJUGATE CHEM, V19, P2363, DOI 10.1021/bc800194e; Mykhailiuk PK, 2010, J FLUORINE CHEM, V131, P217, DOI 10.1016/j.jfluchem.2009.10.004; Naito A, 2007, BBA-BIOMEMBRANES, V1768, P1900, DOI 10.1016/j.bbamem.2007.03.025; Nakase I, 2012, ACCOUNTS CHEM RES, V45, P1132, DOI 10.1021/ar200256e; Nelson R, 2006, CURR OPIN STRUC BIOL, V16, P260, DOI 10.1016/j.sbi.2006.03.007; Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680; Nelson R, 2006, ADV PROTEIN CHEM, V73, P235, DOI 10.1016/S0065-3233(06)73008-X; OHMAN A, 1995, BBA-BIOMEMBRANES, V1236, P259, DOI 10.1016/0005-2736(95)00056-9; Orcellet ML, 2011, CURR PROTEIN PEPT SC, V12, P188; Padari K, 2005, BIOCONJUGATE CHEM, V16, P1399, DOI 10.1021/bc050125z; Pooga M, 1998, FASEB J, V12, P67, DOI 10.1096/fasebj.12.1.67; PROVENCHER SW, 1981, BIOCHEMISTRY-US, V20, P33, DOI 10.1021/bi00504a006; Pujals S, 2006, BBA-BIOMEMBRANES, V1758, P264, DOI 10.1016/j.bbamem.2006.01.006; RANCE M, 1983, J MAGN RESON, V52, P221, DOI 10.1016/0022-2364(83)90190-7; Saalik P, 2004, BIOCONJUGATE CHEM, V15, P1246, DOI 10.1021/bc049938y; Saalik P, 2011, J CONTROL RELEASE, V153, P117, DOI 10.1016/j.jconrel.2011.03.011; Saar K, 2005, ANAL BIOCHEM, V345, P55, DOI 10.1016/j.ab.2005.07.033; Salwiczek M, 2010, AMINO ACIDS, V39, P1589, DOI 10.1007/s00726-010-0581-8; Sciarretta KL, 2006, METHOD ENZYMOL, V413, P273, DOI 10.1016/S0076-6879(06)13015-3; Soomets U, 2000, BBA-BIOMEMBRANES, V1467, P165, DOI 10.1016/S0005-2736(00)00216-9; Splith K, 2011, EUR BIOPHYS J BIOPHY, V40, P387, DOI 10.1007/s00249-011-0682-7; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; SREERAMA N, 1993, ANAL BIOCHEM, V209, P32, DOI 10.1006/abio.1993.1079; Sreerama N, 1999, PROTEINS, V36, P400, DOI 10.1002/(SICI)1097-0134(19990901)36:4<400::AID-PROT3>3.0.CO;2-B; Strandberg E, 2006, BIOPHYS J, V90, P1676, DOI 10.1529/biophysj.105.073858; Strandberg E, 2008, BIOCHEMISTRY-US, V47, P2601, DOI 10.1021/bi701944r; Strandberg E, 2009, BIOPHYS J, V96, P3223, DOI 10.1016/j.bpj.2009.02.040; Strandberg E, 2009, BBA-BIOMEMBRANES, V1788, P1667, DOI 10.1016/j.bbamem.2008.12.018; TATEMOTO K, 1983, FEBS LETT, V164, P124, DOI 10.1016/0014-5793(83)80033-7; Tremouilhac P, 2006, J BIOL CHEM, V281, P32089, DOI 10.1074/jbc.M604759200; Ulrich AS, 2005, PROG NUCL MAG RES SP, V46, P1, DOI 10.1016/j.pnmrs.2004.11.001; Ulrich AS, 1999, BIOPHYS J, V77, P829, DOI 10.1016/S0006-3495(99)76935-3; VANSTOKKUM IHM, 1990, ANAL BIOCHEM, V191, P110, DOI 10.1016/0003-2697(90)90396-Q; Wadhwani P, 2014, BBA-BIOMEMBRANES, V1838, P940, DOI 10.1016/j.bbamem.2013.11.001; Wadhwani P, 2013, PHYS CHEM CHEM PHYS, V15, P8962, DOI 10.1039/c3cp50896j; Wadhwani P, 2012, J AM CHEM SOC, V134, P6512, DOI 10.1021/ja301328f; Wadhwani P, 2012, EUR BIOPHYS J BIOPHY, V41, P177, DOI 10.1007/s00249-011-0771-7; Wadhwani P, 2008, J AM CHEM SOC, V130, P16515, DOI 10.1021/ja804928q; Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371; Yandek LE, 2008, BIOCHEMISTRY-US, V47, P3051, DOI 10.1021/bi702205r; Yandek LE, 2007, BIOPHYS J, V92, P2434, DOI 10.1529/biophysj.106.100198; Zhang M, 2013, P NATL ACAD SCI USA, V110, P4828, DOI 10.1073/pnas.1220253110; ZHANG S, 1990, CHEM PHYS LETT, V173, P481, DOI 10.1016/0009-2614(90)87239-N	99	36	36	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99653	10.1371/journal.pone.0099653	http://dx.doi.org/10.1371/journal.pone.0099653			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937132	Green Published, gold			2022-12-27	WOS:000338503400030
J	Fling, BW; Cohen, RG; Mancini, M; Carpenter, SD; Fair, DA; Nutt, JG; Horak, FB				Fling, Brett W.; Cohen, Rajal G.; Mancini, Martina; Carpenter, Samuel D.; Fair, Damien A.; Nutt, John G.; Horak, Fay B.			Functional Reorganization of the Locomotor Network in Parkinson Patients with Freezing of Gait	PLOS ONE			English	Article							HUMAN BASAL GANGLIA; CONNECTIVITY; DISEASE; MOTOR; MOVEMENT; CORTEX; PEDUNCULOPONTINE; NEUROPHYSIOLOGY; INHIBITION; POSTURE	Freezing of gait (FoG) is a transient inability to initiate or maintain stepping that often accompanies advanced Parkinson's disease (PD) and significantly impairs mobility. The current study uses a multimodal neuroimaging approach to assess differences in the functional and structural locomotor neural network in PD patients with and without FoG and relates these findings to measures of FoG severity. Twenty-six PD patients and fifteen age-matched controls underwent resting-state functional magnetic resonance imaging and diffusion tensor imaging along with self-reported and clinical assessments of FoG. After stringent movement correction, fifteen PD patients and fourteen control participants were available for analysis. We assessed functional connectivity strength between the supplementary motor area (SMA) and the following locomotor hubs: 1) subthalamic nucleus (STN), 2) mesencephalic and 3) cerebellar locomotor region (MLR and CLR, respectively) within each hemisphere. Additionally, we quantified structural connectivity strength between locomotor hubs and assessed relationships with metrics of FoG. FoG+ patients showed greater functional connectivity between the SMA and bilateral MLR and between the SMA and left CLR compared to both FoG- and controls. Importantly, greater functional connectivity between the SMA and MLR was positively correlated with i) clinical, ii) self-reported and iii) objective ratings of freezing severity in FoG+, potentially reflecting a maladaptive neural compensation. The current findings demonstrate a reorganization of functional communication within the locomotor network in FoG+ patients whereby the higher-order motor cortex (SMA) responsible for gait initiation communicates with the MLR and CLR to a greater extent than in FoG- patients and controls. The observed pattern of altered connectivity in FoG+ may indicate a failed attempt by the CNS to compensate for the loss of connectivity between the STN and SMA and may reflect a loss of lower-order, automatic control of gait by the basal ganglia.	[Fling, Brett W.; Mancini, Martina; Nutt, John G.; Horak, Fay B.] Oregon Hlth & Sci Univ, Dept Neurol, Sch Med, Portland, OR 97201 USA; [Carpenter, Samuel D.; Fair, Damien A.] Oregon Hlth & Sci Univ, Sch Med, Dept Behav Neurosci, Portland, OR 97201 USA; [Fair, Damien A.] Oregon Hlth & Sci Univ, Sch Med, Dept Psychiat, Portland, OR 97201 USA; [Cohen, Rajal G.] Univ Idaho, Dept Psychol & Commun Studies, Moscow, ID 83843 USA; [Horak, Fay B.] Portland VA Med Ctr, Portland, OR USA	Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Idaho; University of Idaho; US Department of Veterans Affairs; Veterans Health Administration (VHA); Portland VA Medical Center	Fling, BW (corresponding author), Oregon Hlth & Sci Univ, Dept Neurol, Sch Med, Portland, OR 97201 USA.	fling@ohsu.edu		Fling, Brett/0000-0003-1815-3681; Mancini, Martina/0000-0002-4532-3984; Cohen, Rajal/0000-0001-6691-2561	Pacific Northwest Udall Center (PANUC); National Institute on Aging [R37 AG006457]; National Multiple Sclerosis Society [MB0011]; Oregon Clinical and Translational Research Institute (OCTRI) from the National Center for Research Resources (NCRR) a component of the National Institutes of Health (NIH) [UL1 RR024140]; NIH Roadmap for Medical Research; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024140] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG006457, R01AG006457] Funding Source: NIH RePORTER; Veterans Affairs [I01RX001075] Funding Source: NIH RePORTER	Pacific Northwest Udall Center (PANUC); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Multiple Sclerosis Society(National Multiple Sclerosis Society); Oregon Clinical and Translational Research Institute (OCTRI) from the National Center for Research Resources (NCRR) a component of the National Institutes of Health (NIH); NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by pilot awards from the Pacific Northwest Udall Center (PANUC; RC), a MERIT award from the National Institute on Aging (FH: R37 AG006457), and a postdoctoral Mentored Research Award from the National Multiple Sclerosis Society (Horak #MB0011). Additional support was provided from the Oregon Clinical and Translational Research Institute (OCTRI), grant number UL1 RR024140 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG DM, 1988, J PHYSIOL-LONDON, V400, P425, DOI 10.1113/jphysiol.1988.sp017130; Aron AR, 2007, NEUROSCIENTIST, V13, P214, DOI 10.1177/1073858407299288; Baudrexel S, 2011, NEUROIMAGE, V55, P1728, DOI 10.1016/j.neuroimage.2011.01.017; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Boulinguez P, 2009, CLIN NEUROPHYSIOL, V120, P730, DOI 10.1016/j.clinph.2009.02.167; Braak H, 2002, J NEUROL, V249, DOI [1007/s00415-002-1301-4, 10.1007/s00415-002-1301-4, DOI 10.1007/S00415-002-1301-4]; Brown P, 2003, MOVEMENT DISORD, V18, P357, DOI 10.1002/mds.10358; Coxon JP, 2012, J NEUROSCI, V32, P8401, DOI 10.1523/JNEUROSCI.6360-11.2012; Dejean C, 2008, J NEUROPHYSIOL, V100, P385, DOI 10.1152/jn.90466.2008; Eickhoff SB, 2010, J NEUROSCI, V30, P6409, DOI 10.1523/JNEUROSCI.5664-09.2010; Fair DA, 2013, FRONT SYST NEUROSCI, V6, DOI 10.3389/fnsys.2012.00080; Fling BW, 2013, BRAIN, V136, P2405, DOI 10.1093/brain/awt172; Fogelson N, 2006, CEREB CORTEX, V16, P64, DOI 10.1093/cercor/bhi084; Forstmann BU, 2010, P NATL ACAD SCI USA, V107, P15916, DOI 10.1073/pnas.1004932107; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Giladi N, 2001, J NEURAL TRANSM, V108, P53, DOI 10.1007/s007020170096; Hanakawa T, 1999, BRAIN, V122, P1271, DOI 10.1093/brain/122.7.1271; Huang CR, 2007, BRAIN, V130, P1834, DOI 10.1093/brain/awm086; Iansek R, 1995, ADV PSYCHOL, V111, P37; Jacobs JV, 2009, NEUROSCIENCE, V164, P877, DOI 10.1016/j.neuroscience.2009.08.002; Jacobs JV, 2009, EXP NEUROL, V215, P334, DOI 10.1016/j.expneurol.2008.10.019; Jahn K, 2008, NEUROIMAGE, V39, P786, DOI 10.1016/j.neuroimage.2007.09.047; Jahn K, 2008, PROG BRAIN RES, V171, P353, DOI 10.1016/S0079-6123(08)00652-3; Ko JH, 2013, J NEUROSCI, V33, P4540, DOI 10.1523/JNEUROSCI.5024-12.2013; Lalo E, 2008, J NEUROSCI, V28, P3008, DOI 10.1523/JNEUROSCI.5295-07.2008; Lancaster JL, 2007, HUM BRAIN MAPP, V28, P1194, DOI 10.1002/hbm.20345; Lancaster JL, 1995, HUM BRAIN MAPP, V3, P209, DOI 10.1002/hbm.460030305; Mancini M, 2012, IEEE ENG MED BIO, P1198, DOI 10.1109/EMBC.2012.6346151; MASSION J, 1992, PROG NEUROBIOL, V38, P35, DOI 10.1016/0301-0082(92)90034-C; Mayka MA, 2006, NEUROIMAGE, V31, P1453, DOI 10.1016/j.neuroimage.2006.02.004; MESULAM MM, 1989, J COMP NEUROL, V283, P611, DOI 10.1002/cne.902830414; Miezin FM, 2000, NEUROIMAGE, V11, P735, DOI 10.1006/nimg.2000.0568; Moore ST, 2008, J NEUROSCI METH, V167, P340, DOI 10.1016/j.jneumeth.2007.08.023; Mori S, 2001, ADV NEUROL, V87, P25; Nieuwboer A, 2008, Br J Neurosurg, V22 Suppl 1, pS16, DOI 10.1080/02688690802448376; Nutt JG, 2011, LANCET NEUROL, V10, P734, DOI 10.1016/S1474-4422(11)70143-0; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Prodoehl J, 2008, NEUROIMAGE, V39, P956, DOI 10.1016/j.neuroimage.2007.09.027; Saitou K, 1996, ELECTROEN CLIN NEURO, V98, P449, DOI 10.1016/0013-4694(96)95004-X; Seidler RD, 2010, NEUROSCI BIOBEHAV R, V34, P721, DOI 10.1016/j.neubiorev.2009.10.005; SHIK ML, 1976, PHYSIOL REV, V56, P465, DOI 10.1152/physrev.1976.56.3.465; Shine JM, 2012, PARKINSONISM RELAT D, V18, P25, DOI 10.1016/j.parkreldis.2011.08.002; Shine JM, 2013, BRAIN, V136, P3671, DOI 10.1093/brain/awt272; Shine JM, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00061; Shine JM, 2013, BRAIN, V136, P1204, DOI 10.1093/brain/awt049; Smith BA, 2012, EXP BRAIN RES, V222, P455, DOI 10.1007/s00221-012-3232-3; Snijders AH, 2012, PARKINSONISM RELAT D, V18, P149, DOI 10.1016/j.parkreldis.2011.09.006; Snijders AH, 2011, BRAIN, V134, P59, DOI 10.1093/brain/awq324; Takakusaki K, 2013, MOVEMENT DISORD, V28, P1483, DOI 10.1002/mds.25669; Talairach J., 1988, COPLANAR STEREOTAXIC; Tessitore A, 2012, PARKINSONISM RELAT D, V18, P781, DOI 10.1016/j.parkreldis.2012.03.018; Thevathasan W, 2012, BRAIN, V135, P1446, DOI 10.1093/brain/aws039; Vercruysse S, 2013, CEREB CORTEX; VIALLET F, 1992, EXP BRAIN RES, V88, P674; VIDAILHET M, 1993, NEUROLOGY, V43, P1784, DOI 10.1212/WNL.43.9.1784; Walton CC, 2014, RESTOR NEUROL NEUROS; WIESENDANGER M, 1987, CIBA F SYMP, V132, P40	58	148	151	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100291	10.1371/journal.pone.0100291	http://dx.doi.org/10.1371/journal.pone.0100291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937008	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400101
J	Golden, M; Muhire, BM; Semegni, Y; Martin, DP				Golden, Michael; Muhire, Brejnev M.; Semegni, Yves; Martin, Darren P.			Patterns of Recombination in HIV-1M Are Influenced by Selection Disfavouring the Survival of Recombinants with Disrupted Genomic RNA and Protein Structures	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; INTERSUBTYPE RECOMBINATION; REVERSE-TRANSCRIPTASE; TYPE-1 RECOMBINATION; ACCEPTOR RNA; HOT-SPOTS; IN-VIVO; ARCHITECTURE; MECHANISM; GP120	Genetic recombination is a major contributor to the ongoing diversification of HIV. It is clearly apparent that across the HIV-genome there are defined recombination hot and cold spots which tend to co-localise both with genomic secondary structures and with either inter-gene boundaries or intra-gene domain boundaries. There is also good evidence that most recombination breakpoints that are detectable within the genes of natural HIV recombinants are likely to be minimally disruptive of intra-protein amino acid contacts and that these breakpoints should therefore have little impact on protein folding. Here we further investigate the impact on patterns of genetic recombination in HIV of selection favouring the maintenance of functional RNA and protein structures. We confirm that chimaeric Gag p24, reverse transcriptase, integrase, gp120 and Nef proteins that are expressed by natural HIV-1 recombinants have significantly lower degrees of predicted folding disruption than randomly generated recombinants. Similarly, we use a novel single-stranded RNA folding disruption test to show that there is significant, albeit weak, evidence that natural HIV recombinants tend to have genomic secondary structures that more closely resemble parental structures than do randomly generated recombinants. These results are consistent with the hypothesis that natural selection has acted both in the short term to purge recombinants with disrupted RNA and protein folds, and in the longer term to modify the genome architecture of HIV to ensure that recombination prone sites correspond with those where recombination will be minimally deleterious.	[Golden, Michael] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Muhire, Brejnev M.; Martin, Darren P.] Univ Cape Town, Computat Biol Grp, Inst Infect Dis & Mol Med, ZA-7925 Cape Town, South Africa; [Semegni, Yves] Cape Peninsula Univ Technol, Dept Math & Phys, Cape Town, South Africa	University of Oxford; University of Cape Town; Cape Peninsula University of Technology	Golden, M (corresponding author), Univ Oxford, Dept Stat, Oxford OX1 3TG, England.	golden@stats.ox.ac.uk	Golden, Michael/Q-3600-2019; Martin, Darren P/C-4599-2008; Martin, Darren/ABE-3614-2021	Golden, Michael/0000-0002-3653-8019; 	National Research Foundation innovation grant [NBIG UID 86935]; University of Cape Town	National Research Foundation innovation grant; University of Cape Town	This study was supported by a National Research Foundation innovation grant (NBIG UID 86935). BM was funded on a University of Cape Town bursary. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agniswamy J, 2012, BIOCHEMISTRY-US, V51, P1041, DOI 10.1021/bi201809s; Archer J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000178; Baird HA, 2006, NUCLEIC ACIDS RES, V34, P5203, DOI 10.1093/nar/gkl669; BERNSTEIN FC, 1977, EUR J BIOCHEM, V80, P319, DOI 10.1111/j.1432-1033.1977.tb11885.x; Drummond DA, 2005, P NATL ACAD SCI USA, V102, P5380, DOI 10.1073/pnas.0500729102; Escriu F, 2007, PLOS PATHOG, V3, P67, DOI 10.1371/journal.ppat.0030008; Fan J, 2007, INFECT GENET EVOL, V7, P717, DOI 10.1016/j.meegid.2007.07.012; FELSENSTEIN J, 1974, GENETICS, V78, P737; Galetto R, 2004, J BIOL CHEM, V279, P36625, DOI 10.1074/jbc.M405476200; Galli A, 2010, J VIROL, V84, P7651, DOI 10.1128/JVI.00276-10; Hanson MN, 2005, J MOL BIOL, V353, P772, DOI 10.1016/j.jmb.2005.08.065; Jetzt AE, 2000, J VIROL, V74, P1234, DOI 10.1128/JVI.74.3.1234-1240.2000; Lefeuvre P, 2007, PLOS PATHOG, V3, P1782, DOI 10.1371/journal.ppat.0030181; Magiorkinis G, 2003, J GEN VIROL, V84, P2715, DOI 10.1099/vir.0.19180-0; Markham Nicholas R., 2008, V453, P3, DOI 10.1007/978-1-60327-429-6_1; Martin DP, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002203; Martin DP, 2010, BIOINFORMATICS, V26, P2462, DOI 10.1093/bioinformatics/btq467; Martin DP, 2005, PLOS GENET, V1, P475, DOI 10.1371/journal.pgen.0010051; Minin VN, 2007, GENETICS, V175, P1773, DOI 10.1534/genetics.106.066258; Moumen A, 2003, J BIOL CHEM, V278, P15973, DOI 10.1074/jbc.M212306200; MULLER HJ, 1964, MUTAT RES, V1, P2, DOI 10.1016/0027-5107(64)90047-8; Onafuwa A, 2003, J VIROL, V77, P4577, DOI 10.1128/JVI.77.8.4577-4587.2003; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Pornillos O, 2009, CELL, V137, P1282, DOI 10.1016/j.cell.2009.04.063; Rizk G, 2009, COMPUT SCI, V2009, P1; Rokyta DR, 2009, MOL BIOL EVOL, V26, P2831, DOI 10.1093/molbev/msp199; Shen W, 2009, J BIOL CHEM, V284, P33883, DOI 10.1074/jbc.M109.055368; Simon-Loriere E, 2011, NAT REV MICROBIOL, V9, P617, DOI 10.1038/nrmicro2614; Simon-Loriere E, 2010, J VIROL, V84, P12675, DOI 10.1128/JVI.01302-10; Simon-Loriere E, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000418; Su HP, 2010, J VIROL, V84, P7625, DOI 10.1128/JVI.00353-10; Tan KM, 1997, P NATL ACAD SCI USA, V94, P12303, DOI 10.1073/pnas.94.23.12303; Tu XY, 2010, NAT STRUCT MOL BIOL, V17, P1202, DOI 10.1038/nsmb.1908; Voigt CA, 2002, NAT STRUCT BIOL, V9, P553, DOI 10.1038/nsb805; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Watts JM, 2009, NATURE, V460, P711, DOI 10.1038/nature08237; Woo J, 2014, VIROLOGY IN PRESS; Zhang JY, 2000, J VIROL, V74, P2313, DOI 10.1128/JVI.74.5.2313-2322.2000; Zhuang JL, 2002, J VIROL, V76, P11273, DOI 10.1128/JVI.76.22.11273-11282.2002	39	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100400	10.1371/journal.pone.0100400	http://dx.doi.org/10.1371/journal.pone.0100400			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936864	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400108
J	Maidhof, R; Jacobsen, T; Papatheodorou, A; Chahine, NO				Maidhof, Robert; Jacobsen, Timothy; Papatheodorou, Angelos; Chahine, Nadeen O.			Inflammation Induces Irreversible Biophysical Changes in Isolated Nucleus Pulposus Cells	PLOS ONE			English	Article							INTERVERTEBRAL DISC CELLS; AQUAPORIN 1 AQP1; TNF-ALPHA; GENE-EXPRESSION; ARTICULAR CHONDROCYTES; TISSUE DEGENERATION; WATER CHANNEL; IN-VITRO; MIGRATION; MATRIX	Intervertebral disc degeneration is accompanied by elevated levels of inflammatory cytokines that have been implicated in disease etiology and matrix degradation. While the effects of inflammatory stimulation on disc cell metabolism have been well-studied, their effects on cell biophysical properties have not been investigated. The hypothesis of this study is that inflammatory stimulation alters the biomechanical properties of isolated disc cells and volume responses to step osmotic loading. Cells from the nucleus pulposus (NP) of bovine discs were isolated and treated with either lipopolysaccharide (LPS), an inflammatory ligand, or with the recombinant cytokine TNF-alpha for 24 hours. We measured cellular volume regulation responses to osmotic loading either immediately after stimulation or after a 1 week recovery period from the inflammatory stimuli. Cells from each group were tested under step osmotic loading and the transient volume-response was captured via time-lapse microscopy. Volume-responses were analyzed using mixture theory framework to investigate two biomechanical properties of the cell, the intracellular water content and the hydraulic permeability. Intracellular water content did not vary between treatment groups, but hydraulic permeability increased significantly with inflammatory treatment. In the 1 week recovery group, hydraulic permeability remained elevated relative to the untreated recovery control. Cell radius was also significantly increased both after 24 hours of treatment and after 1 week recovery. A significant linear correlation was observed between hydraulic permeability and cell radius in untreated cells at 24 hours and at 1-week recovery, though not in the inflammatory stimulated groups at either time point. This loss of correlation between cell size and hydraulic permeability suggests that regulation of volume change is disrupted irreversibly due to inflammatory stimulation. Inflammatory treated cells exhibited altered F-actin cytoskeleton expression relative to untreated cells. We also found a significant decrease in the expression of aquaporin-1, the predominant water channel in disc NP cells, with inflammatory stimulation. To our knowledge, this is the first study providing evidence that inflammatory stimulation directly alters the mechanobiology of NP cells. The cellular biophysical changes observed in this study are coincident with documented changes in the extracellular matrix induced by inflammation, and may be important in disease etiology.	[Maidhof, Robert; Jacobsen, Timothy; Papatheodorou, Angelos; Chahine, Nadeen O.] North Shore LIJ Hlth Syst, Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA; [Chahine, Nadeen O.] Hofstra North Shore LIJ Sch Med, Hempstead, NY USA	Northwell Health; Hofstra University; Northwell Health	Chahine, NO (corresponding author), North Shore LIJ Hlth Syst, Feinstein Inst Med Res, Ctr Autoimmune & Musculoskeletal Dis, Manhasset, NY 11030 USA.	nchahine@nshs.edu	Chahine, Nadeen/AAF-9975-2019; Chahine, Nadeen/O-5496-2015	Chahine, Nadeen/0000-0002-0478-6042; 	National Science Foundation [1151605]; Feinstein Institute for Medical Research	National Science Foundation(National Science Foundation (NSF)); Feinstein Institute for Medical Research	This work was funded in part by National Science Foundation (www.nsf.gov) CAREER Award 1151605 (NOC) and The Feinstein Institute for Medical Research (www.feinsteininstitute.org). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn SH, 2002, SPINE, V27, P911, DOI 10.1097/00007632-200205010-00005; Albro MB, 2007, J BIOMECH ENG-T ASME, V129, P503, DOI 10.1115/1.2746371; Albro MB, 2009, BIOPHYS J, V97, P2886, DOI 10.1016/j.bpj.2009.09.011; Alexopoulos LG, 2002, J MICROSC-OXFORD, V205, P125, DOI 10.1046/j.0022-2720.2001.00976.x; Antoniou J, 1996, J CLIN INVEST, V98, P996, DOI 10.1172/JCI118884; Ateshian GA, 2006, J BIOMECH, V39, P464, DOI 10.1016/j.jbiomech.2004.12.013; Bachmeier BE, 2007, ANN NY ACAD SCI, V1096, P44, DOI 10.1196/annals.1397.069; Burke JG, 2003, SPINE, V28, P2685, DOI 10.1097/01.BRS.0000103341.45133.F3; Burke JG, 2002, J BONE JOINT SURG BR, V84B, P196, DOI 10.1302/0301-620X.84B2.12511; Bush PG, 2001, J ORTHOP RES, V19, P768, DOI 10.1016/S0736-0266(01)00013-4; Cao L, 2011, BIOMECH MODEL MECHAN, V10, P1, DOI 10.1007/s10237-010-0214-x; Chao PG, 2005, J BIOMECH, V38, P1273, DOI 10.1016/j.jbiomech.2004.06.016; Demoor-Fossard M, 1999, MOL CELL BIOCHEM, V199, P69, DOI 10.1023/A:1006947015094; Frenkel SR, 1996, ARTHRITIS RHEUM, V39, P1905, DOI 10.1002/art.1780391118; Gov NS, 2005, BIOPHYS J, V88, P1859, DOI 10.1529/biophysj.104.045328; GRONOWICZ G, 1992, J PERIODONTAL RES, V27, P562, DOI 10.1111/j.1600-0765.1992.tb01737.x; Guilak F, 1999, SPINE, V24, P2475, DOI 10.1097/00007632-199912010-00009; Horner HA, 2002, SPINE, V27, P1018, DOI 10.1097/00007632-200205150-00004; Hu J, 2006, FASEB J, V20, P1892, DOI 10.1096/fj.06-5930fje; HUMZAH MD, 1988, ANAT RECORD, V220, P337, DOI 10.1002/ar.1092200402; KWANT W O, 1970, Journal of General Physiology, V55, P208, DOI 10.1085/jgp.55.2.208; Le Maitre CL, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2275; Le Maitre CL, 2005, ARTHRITIS RES THER, V7, pR732, DOI 10.1186/ar1732; Liang HT, 2008, CLIN EXP PHARMACOL P, V35, P7, DOI 10.1111/j.1440-1681.2007.04808.x; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Massey CJ, 2012, J ORTHOP RES, V30, P122, DOI 10.1002/jor.21475; Mavrogonatou E, 2012, J CELL PHYSIOL, V227, P1179, DOI 10.1002/jcp.22840; Mobasheri A, 2010, ANN ANAT, V192, P116, DOI 10.1016/j.aanat.2010.01.001; Monzani E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006167; Musumeci G, 2013, TISSUE CELL, V45, P145, DOI 10.1016/j.tice.2012.10.004; Neidlinger-Wilke C, 2006, EUR SPINE J, V15, pS372, DOI 10.1007/s00586-006-0112-1; Neidlinger-Wilke C, 2012, J ORTHOP RES, V30, P112, DOI 10.1002/jor.21481; PEARCE RH, 1987, J ORTHOP RES, V5, P198, DOI 10.1002/jor.1100050206; Pritchard S, 2002, BIOPHYS J, V83, P2502, DOI 10.1016/S0006-3495(02)75261-2; Rajan N., 2012, SPINE PHILA PA 1976; Richardson SM, 2008, J MOL HISTOL, V39, P303, DOI 10.1007/s10735-008-9166-1; Roughley PJ, 2002, BIOCHEM SOC T, V30, P869, DOI 10.1042/BST0300869; Seguin CA, 2008, SPINE, V33, P356, DOI 10.1097/BRS.0b013e3181642a5e; Seguin CA, 2006, MATRIX BIOL, V25, P409, DOI 10.1016/j.matbio.2006.07.002; Setton LA, 2006, J BONE JOINT SURG AM, V88A, P52, DOI 10.2106/JBJS.F.00001; Sivan S, 2006, BIORHEOLOGY, V43, P283; Su X, 2004, RESP PHYSIOL NEUROBI, V142, P1, DOI 10.1016/j.resp.2004.05.001; URBAN JPG, 1988, SPINE, V13, P179, DOI 10.1097/00007632-198802000-00009; Urban JPG, 2002, BIOCHEM SOC T, V30, P858, DOI 10.1042/bst0300858; Urban JPG, 2000, AM ZOOL, V40, P53, DOI 10.1668/0003-1569(2000)040[0053:TNOTID]2.0.CO;2; Wuertz K, 2007, J ORTHOP RES, V25, P1513, DOI 10.1002/jor.20436	46	36	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99621	10.1371/journal.pone.0099621	http://dx.doi.org/10.1371/journal.pone.0099621			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936787	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400027
J	Kung, KS; Greco, K; Sobolevsky, S; Ratti, C				Kung, Kevin S.; Greco, Kael; Sobolevsky, Stanislav; Ratti, Carlo			Exploring Universal Patterns in Human Home-Work Commuting from Mobile Phone Data	PLOS ONE			English	Article							TRAVEL-TIME; CONGESTION; MODEL	Home-work commuting has always attracted significant research attention because of its impact on human mobility. One of the key assumptions in this domain of study is the universal uniformity of commute times. However, a true comparison of commute patterns has often been hindered by the intrinsic differences in data collection methods, which make observation from different countries potentially biased and unreliable. In the present work, we approach this problem through the use of mobile phone call detail records (CDRs), which offers a consistent method for investigating mobility patterns in wholly different parts of the world. We apply our analysis to a broad range of datasets, at both the country (Portugal, Ivory Coast, and Saudi Arabia), and city (Boston) scale. Additionally, we compare these results with those obtained from vehicle GPS traces in Milan. While different regions have some unique commute time characteristics, we show that the home-work time distributions and average values within a single region are indeed largely independent of commute distance or country (Portugal, Ivory Coast, and Boston)-despite substantial spatial and infrastructural differences. Furthermore, our comparative analysis demonstrates that such distance-independence holds true only if we consider multimodal commute behaviors-as consistent with previous studies. In car-only (Milan GPS traces) and car-heavy (Saudi Arabia) commute datasets, we see that commute time is indeed influenced by commute distance. Finally, we put forth a testable hypothesis and suggest ways for future work to make more accurate and generalizable statements about human commute behaviors.	[Kung, Kevin S.; Greco, Kael; Sobolevsky, Stanislav; Ratti, Carlo] MIT, Senseable City Lab, Cambridge, MA 02139 USA; [Kung, Kevin S.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Greco, Kael; Ratti, Carlo] MIT, Dept Urban Studies & Planning, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Kung, KS (corresponding author), MIT, Senseable City Lab, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	kkung@mit.edu	Sobolevsky, Stanislav/ABH-7108-2020	Sobolevsky, Stanislav/0000-0001-6281-0656; /0000-0001-7080-9196; Kung, Kevin/0000-0003-1539-771X	Audi; Volkswagen; BBVA; Coca Cola Company; Ericsson; Ferrovial; GE	Audi(Volkswagen); Volkswagen(Volkswagen); BBVA(BBVA Foundation); Coca Cola Company; Ericsson(Ericsson); Ferrovial; GE	Audi, Volkswagen, BBVA, The Coca Cola Company, Ericsson, Ferrovial, GE provided funding for this study. There are no patents, products in development or marketed products to declare. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan A., 2001, WORLD TRANSPORT POL, V7, P44; American Community Survey, 2010, COMM JOURN WORK; Amini A, 2014, IMPACT SOCIAL SEGREG; Amini A, 2013, P 3 INT C AN MOB PHO; Becker RA, 2011, IEEE PERVAS COMPUT, V10, P18, DOI 10.1109/MPRV.2011.44; Boyd, 2011, S DYN INT SOC, DOI 10.2139/ssrn.1926431; Brockmann D, 2006, NATURE, V439, P462, DOI 10.1038/nature04292; Calabrese F, 2013, TRANSPORT RES C-EMER, V26, P301, DOI 10.1016/j.trc.2012.09.009; Cervero R, 1998, URBAN STUD, V35, P1059, DOI 10.1080/0042098984484; Chalasani V.S., 2005, J TRANSP STAT, V8, P1; GOLOB TF, 1981, TRANSPORT RES B-METH, V15, P375, DOI 10.1016/0191-2615(81)90022-9; GOLOB TF, 1990, TRANSPORT RES A-POL, V24, P443, DOI 10.1016/0191-2607(90)90035-5; Gonzalez MC, 2008, NATURE, V453, P779, DOI 10.1038/nature06958; Goodwin P, 1981, TRANSPORT RES A-POL, V15A, P106; GORDON P, 1991, J AM PLANN ASSOC, V57, P416, DOI 10.1080/01944369108975516; GORDON P, 1989, INT REGIONAL SCI REV, V12, P45, DOI 10.1177/016001768901200103; HAMED MM, 1993, TRANSPORT SCI, V27, P381, DOI 10.1287/trsc.27.4.381; Hawelka B, 2013, ARXIV13110680; Hubert JP, 2003, GIS BASED ENRICHMENT; HUPKES G, 1982, FUTURES, V14, P38, DOI 10.1016/0016-3287(82)90070-2; Issacman S, 2010, P HOTMOBILE 10, P10; Jia T, 2012, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2012/11/P11024; Kang C., 2013, P ACM SIGKDD INT C K, P1, DOI [10.1145/2505821.2505826, DOI 10.1145/2505821.2505826]; Kenworthy JR, 1999, TRANSPORT RES A-POL, V33, P691, DOI 10.1016/S0965-8564(99)00006-3; Levinson D, 2005, TRANSPORTATION, V32, P187, DOI 10.1007/s11116-004-5507-4; Levinson DM, 1997, GROWTH CHANGE, V28, P147, DOI 10.1111/1468-2257.00054; Liang X, 2012, PHYSICA A, V391, P2135, DOI 10.1016/j.physa.2011.11.035; Mahdi W, 2012, BLOOMBERG NEWS; Mokhtarian PL, 2004, TRANSPORT RES A-POL, V38, P643, DOI 10.1016/j.tra.2003.12.004; Noulas A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037027; Nunes da Silva F, 2013, IMPACTS SUMITS CONVE; OECD, 2013, HOWS LIF MEAS WELL B; Ranjan G, 2012, MOB COMPUT COMMUN RE, V16, P33, DOI 10.1145/2412096.2412101; Rhee I, 2011, IEEE ACM T NETWORK, V19, P630, DOI 10.1109/TNET.2011.2120618; Robinson J., 1999, TIME LIFE SURPRISING, V2nd; Santi P, 2013, ARXIV3102963; Schafer A, 2000, TRANSPORT RES A-POL, V34, P171, DOI 10.1016/S0965-8564(98)00071-8; Schneider CM, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0246; Schwanen T, 2002, TRANSPORT RES A-POL, V36, P573, DOI 10.1016/S0965-8564(01)00023-4; Simini F, 2012, NATURE, V484, P96, DOI 10.1038/nature10856; Taylor B.D., 2002, ACCESS, P8; van Wee B, 2006, J TRANSP GEOGR, V14, P109, DOI 10.1016/j.jtrangeo.2005.06.003; Vazquez-Prokopec GM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058802; VICKREY WS, 1969, AM ECON REV, V59, P251; Vilhelmson B., 1999, GEOJOURNAL, V48, P177, DOI DOI 10.1023/A:1007075524340; Willumsen LG, 2011, MOD TRANSP 4 ED; Yang M, 2010, TRAFFIC TRANSPORTATI, V383, P557; Zahavi Y., P 59 ANN M TRANSP RE	50	164	166	6	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e96180	10.1371/journal.pone.0096180	http://dx.doi.org/10.1371/journal.pone.0096180			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ5PV	24933264	gold, Green Published, Green Submitted			2022-12-27	WOS:000337738600002
J	Li, JQ; Wu, B; Xu, J; Liu, C				Li, Jianqin; Wu, Bin; Xu, Jiang; Liu, Chang			Genome-Wide Identification and Characterization of Long Intergenic Non-Coding RNAs in Ganoderma lucidum	PLOS ONE			English	Article							TRANSCRIPTION INITIATION; GENE; EXPRESSION; CHROMATIN; ARABIDOPSIS; EVOLUTION; SEQUENCE; REVEALS; COMPLEXITY; ASSOCIATE	Ganoderma lucidum is a white-rot fungus best-known for its medicinal activities. We have previously sequenced its genome and annotated the protein coding genes. However, long non-coding RNAs in G. lucidum genome have not been analyzed. In this study, we have identified and characterized long intergenic non-coding RNAs (lincRNA) in G. lucidum systematically. We developed a computational pipeline, which was used to analyze RNA-Seq data derived from G. lucidum samples collected from three developmental stages. A total of 402 lincRNA candidates were identified, with an average length of 609 bp. Analysis of their adjacent protein-coding genes (apcGenes) revealed that 46 apcGenes belong to the pathways of triterpenoid biosynthesis and lignin degradation, or families of cytochrome P450, mating type B genes, and carbohydrate-active enzymes. To determine if lincRNAs and these apcGenes have any interactions, the corresponding pairs of lincRNAs and apcGenes were analyzed in detail. We developed a modified 39 RACE method to analyze the transcriptional direction of a transcript. Among the 46 lincRNAs, 37 were found unidirectionally transcribed, and 9 were found bidirectionally transcribed. The expression profiles of 16 of these 37 lincRNAs were found to be highly correlated with those of the apcGenes across the three developmental stages. Among them, 11 are positively correlated (r>0.8) and 5 are negatively correlated (r<-0.8). The co-localization and co-expression of lincRNAs and those apcGenes playing important functions is consistent with the notion that lincRNAs might be important regulators for cellular processes. In summary, this represents the very first study to identify and characterize lincRNAs in the genomes of basidiomycetes. The results obtained here have laid the foundation for study of potential lincRNA-mediated expression regulation of genes in G. lucidum.	[Liu, Chang] Chinese Acad Med Sci, Inst Med Plant Dev, Ctr Bioinformat, Beijing 100730, Peoples R China; Peking Union Med Coll, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Medicinal Plant Development - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Liu, C (corresponding author), Chinese Acad Med Sci, Inst Med Plant Dev, Ctr Bioinformat, Beijing 100730, Peoples R China.	cliu6688@yahoo.com	Liu, Chang/A-1148-2014		National Science Foundation of China [81373912, 81274015]; Chinese Academy of Medical Science [431118]; Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives [YZ-12-04]; research grant for returned Overseas Chinese Scholars, and Ministry of Human Resources [431207]; Program for Changjiang Scholars and Innovative Research Team in the University from Ministry of Education of China [IRT1150]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Medical Science; Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives; research grant for returned Overseas Chinese Scholars, and Ministry of Human Resources(Scientific Research Foundation for the Returned Overseas Chinese Scholars); Program for Changjiang Scholars and Innovative Research Team in the University from Ministry of Education of China	This study was supported by the National Science Foundation of China granted to C. Liu (Grant No. 81373912), a start fund from the Chinese Academy of Medical Science (Grant No. 431118), the Basic Scientific Research Operation Grants for State-Level Public Welfare Scientific Research Initiatives (Grant No. YZ-12-04), a research grant for returned Overseas Chinese Scholars, and Ministry of Human Resources (Grant No. 431207). This study was also supported by the National Science Foundation of China (Grant No. 81274015) granted to B. Wu and the Program for Changjiang Scholars and Innovative Research Team in the University from Ministry of Education of China (Grant No. IRT1150). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ben Amor B, 2009, GENOME RES, V19, P57, DOI 10.1101/gr.080275.108; Bertani S, 2011, MOL CELL, V43, P1040, DOI 10.1016/j.molcel.2011.08.019; Boh B, 2007, BIOTECHNOL ANN REV, V13, P265, DOI 10.1016/S1387-2656(07)13010-6; Bumgarner SL, 2009, P NATL ACAD SCI USA, V106, P18321, DOI 10.1073/pnas.0909641106; Burleigh SH, 1999, PLANT PHYSIOL, V119, P241, DOI 10.1104/pp.119.1.241; Burleigh SH, 1997, PLANT MOL BIOL, V34, P199, DOI 10.1023/A:1005841119665; Chen SL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1923; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Costa FF, 2010, BIOESSAYS, V32, P599, DOI 10.1002/bies.200900112; CRESPI MD, 1994, EMBO J, V13, P5099, DOI 10.1002/j.1460-2075.1994.tb06839.x; De Santa F, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000384; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176; Djebali S, 2008, NAT METHODS, V5, P629, DOI 10.1038/nmeth.1216; Feng JC, 2006, GENE DEV, V20, P1470, DOI 10.1101/gad.1416106; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hainer SJ, 2011, GENE DEV, V25, P29, DOI 10.1101/gad.1975011; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Heard E, 2005, CURR OPIN GENET DEV, V15, P482, DOI 10.1016/j.gde.2005.08.009; Heo JB, 2011, SCIENCE, V331, P76, DOI 10.1126/science.1197349; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; Hirsch J, 2006, PLANT PHYSIOL, V140, P1192, DOI 10.1104/pp.105.073817; Houseley J, 2008, MOL CELL, V32, P685, DOI 10.1016/j.molcel.2008.09.027; Hutchinson JN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-39; Jiang N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052734; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Kapranov P, 2007, SCIENCE, V316, P1484, DOI 10.1126/science.1138341; Kaushik K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083616; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kim TK, 2010, NATURE, V465, P182, DOI 10.1038/nature09033; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Kurihara Y, 2009, P NATL ACAD SCI USA, V106, P2453, DOI 10.1073/pnas.0808902106; Lai F, 2013, NATURE, V494, P497, DOI 10.1038/nature11884; Li WB, 2013, NATURE, V498, P516, DOI 10.1038/nature12210; Liu CM, 1997, PLANT MOL BIOL, V33, P867, DOI 10.1023/A:1005729309569; Liu J, 2012, PLANT CELL, V24, P4333, DOI 10.1105/tpc.112.102855; MacIntosh GC, 2001, PLANT PHYSIOL, V127, P765, DOI 10.1104/pp.010501; Maenner S, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000276; Martens JA, 2004, NATURE, V429, P571, DOI 10.1038/nature02538; Martin AC, 2000, PLANT J, V24, P559, DOI 10.1046/j.1365-313x.2000.00893.x; Natoli G, 2012, ANNU REV GENET, V46, P1, DOI 10.1146/annurev-genet-110711-155459; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Park J, 2008, BIOINFORMATICS, V24, P1024, DOI 10.1093/bioinformatics/btn058; Pinskaya M, 2009, EMBO J, V28, P1697, DOI 10.1038/emboj.2009.108; Pollier J, 2013, NATURE, V504, P148, DOI 10.1038/nature12685; Ponjavic J, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000617; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Prasanth KV, 2007, GENE DEV, V21, P11, DOI 10.1101/gad.1484207; Rymarquis LA, 2008, TRENDS PLANT SCI, V13, P329, DOI 10.1016/j.tplants.2008.02.009; Sanodiya BS, 2009, CURR PHARM BIOTECHNO, V10, P717, DOI 10.2174/138920109789978757; Shin H, 2006, PLANT J, V45, P712, DOI 10.1111/j.1365-313X.2005.02629.x; Sugiyama R, 2003, DNA RES, V10, P213, DOI 10.1093/dnares/10.5.213; Sun J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075750; Swiezewski S, 2009, NATURE, V462, P799, DOI 10.1038/nature08618; Szell M, 2008, SEMIN CANCER BIOL, V18, P141, DOI 10.1016/j.semcancer.2008.01.007; Teramoto H, 1996, PLANT MOL BIOL, V32, P797, DOI 10.1007/BF00020478; Thiebaut M, 2008, MOL CELL, V31, P671, DOI 10.1016/j.molcel.2008.08.010; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang D, 2011, NATURE, V474, P390, DOI 10.1038/nature10006; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang XT, 2008, NATURE, V454, P126, DOI 10.1038/nature06992; Wen Jiayu, 2007, In Silico Biology, V7, P485; Wilusz JE, 2009, GENE DEV, V23, P1494, DOI 10.1101/gad.1800909; Wu B, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-15; Xin MM, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-61; Young RS, 2012, GENOME BIOL EVOL, V4, P427, DOI 10.1093/gbe/evs020	71	11	12	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99442	10.1371/journal.pone.0099442	http://dx.doi.org/10.1371/journal.pone.0099442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932683	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600035
J	Rosato, RR; Fernandez, R; Paz, LI; Singh, CR; Rosato, AE				Rosato, Roberto R.; Fernandez, Regina; Paz, Liliana I.; Singh, Christopher R.; Rosato, Adriana E.			TCA Cycle-Mediated Generation of ROS Is a Key Mediator for HeR-MRSA Survival under beta-Lactam Antibiotic Exposure	PLOS ONE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; BACTERICIDAL ANTIBIOTICS; METHICILLIN RESISTANCE; ESCHERICHIA-COLI; CLINICAL STRAINS; CELL-DEATH; PHENOTYPIC-EXPRESSION; SUPEROXIDE-DISMUTASE; INDUCED MUTAGENESIS; HYDROGEN-PEROXIDE	Methicillin-resistant Staphylococcus aureus (MRSA) is a major multidrug resistant pathogen responsible for several difficult-to-treat infections in humans. Clinical Hetero-resistant (HeR) MRSA strains, mostly associated with persistent infections, are composed of mixed cell populations that contain organisms with low levels of resistance (hetero-resistant HeR) and those that display high levels of drug resistance (homo-resistant HoR). However, the full understanding of beta-lactam-mediated HeR/HoR selection remains to be completed. In previous studies we demonstrated that acquisition of the HoR phenotype during exposure to beta-lactam antibiotics depended on two key elements: (1) activation of the SOS response, a conserved regulatory network in bacteria that is induced in response to DNA damage, resulting in increased mutation rates, and (2) adaptive metabolic changes redirecting HeR-MRSA metabolism to the tricarboxylic acid (TCA) cycle in order to increase the energy supply for cell-wall synthesis. In the present work, we identified that both main mechanistic components are associated through TCA cycle-mediated reactive oxygen species (ROS) production, which temporally affects DNA integrity and triggers activation of the SOS response resulting in enhanced mutagenesis. The present work brings new insights into a role of ROS generation on the development of resistance to beta-lactam antibiotics in a model of natural occurrence, emphasizing the cytoprotective role in HeR-MRSA survival mechanism.	[Rosato, Roberto R.; Fernandez, Regina; Paz, Liliana I.; Singh, Christopher R.; Rosato, Adriana E.] Houston Methodist Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA; [Rosato, Adriana E.] Houston Methodist Hosp, Dept Pathol & Genom Med, Houston, TX USA	The Methodist Hospital System; The Methodist Hospital - Houston; The Methodist Hospital System; The Methodist Hospital - Houston	Rosato, AE (corresponding author), Houston Methodist Res Inst, Ctr Mol & Translat Human Infect Dis Res, Houston, TX 77030 USA.	aerosato@HoustonMethodist.org		Rosato, Adriana E./0000-0001-6115-6955	National Institutes of Health [5R01AI080688-03]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI080688] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by National Institutes of Health grant 5R01AI080688-03 to A. E. Rosato (principal investigator). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba Y, 2013, ANTIMICROB AGENTS CH, V57, P4861, DOI 10.1128/AAC.00720-13; Baharoglu Z, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003421; Ballal A, 2009, J BACTERIOL, V191, P3301, DOI 10.1128/JB.01496-08; Chambers HF, 2009, NAT REV MICROBIOL, V7, P629, DOI 10.1038/nrmicro2200; Chambers HF, 2001, EMERG INFECT DIS, V7, P178, DOI 10.3201/eid0702.010204; CHAMBERS HF, 1990, J INFECT DIS, V161, P1170, DOI 10.1093/infdis/161.6.1170; Chittezham TV, 2013, MBIO, V4, DOI [10.1128/mBio.00437-13, DOI 10.1128/MBIO.00437-13]; Chung M, 2008, ANTIMICROB AGENTS CH, V52, P2709, DOI 10.1128/AAC.00266-08; Corrigan RM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002217; Cuirolo A, 2009, J ANTIMICROB CHEMOTH, V64, P37, DOI 10.1093/jac/dkp164; Davies J, 2006, CURR OPIN MICROBIOL, V9, P445, DOI 10.1016/j.mib.2006.08.006; Dengler V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073512; Dwyer DJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100135; Dwyer DJ, 2009, CURR OPIN MICROBIOL, V12, P482, DOI 10.1016/j.mib.2009.06.018; Ender M, 2008, INT J MED MICROBIOL, V298, P607, DOI 10.1016/j.ijmm.2008.01.015; Fernandez JL, 2008, APPL ENVIRON MICROB, V74, P5925, DOI 10.1128/AEM.00318-08; FIGUEIREDO AMS, 1991, J INFECT DIS, V164, P883, DOI 10.1093/infdis/164.5.883; Finan JE, 2002, ANTIMICROB AGENTS CH, V46, P24, DOI 10.1128/AAC.46.1.24-30.2002; Forbes BA, 2008, DIAGN MICR INFEC DIS, V61, P387, DOI 10.1016/j.diagmicrobio.2008.04.003; Foti JJ, 2012, SCIENCE, V336, P315, DOI 10.1126/science.1219192; Goldstein F, 2007, ANTIMICROB AGENTS CH, V51, P2514, DOI 10.1128/AAC.00040-07; Gutierrez A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2607; HACKBARTH CJ, 1994, ANTIMICROB AGENTS CH, V38, P2568, DOI 10.1128/AAC.38.11.2568; HARTMAN BJ, 1984, J BACTERIOL, V158, P513, DOI 10.1128/JB.158.2.513-516.1984; HARTMAN BJ, 1986, ANTIMICROB AGENTS CH, V29, P85, DOI 10.1128/AAC.29.1.85; Herold BC, 1998, JAMA-J AM MED ASSOC, V279, P593, DOI 10.1001/jama.279.8.593; Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181; IMLAY JA, 1988, SCIENCE, V240, P640, DOI 10.1126/science.2834821; Keaton MA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071025; Keren I, 2013, SCIENCE, V339, P1213, DOI 10.1126/science.1232688; Kim C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082814; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kohanski MA, 2010, NAT REV MICROBIOL, V8, P423, DOI 10.1038/nrmicro2333; Kohanski MA, 2010, MOL CELL, V37, P311, DOI 10.1016/j.molcel.2010.01.003; Ledala N, 2014, J BACTERIOL, V196, P2178, DOI 10.1128/JB.01475-14; Liu YL, 2012, ANTIMICROB AGENTS CH, V56, P6048, DOI 10.1128/AAC.00754-12; Liu YY, 2013, SCIENCE, V339, P1210, DOI 10.1126/science.1232751; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mosel M, 2013, ANTIMICROB AGENTS CH, V57, P5755, DOI 10.1128/AAC.00754-13; MURAKAMI K, 1989, J BACTERIOL, V171, P874, DOI 10.1128/jb.171.2.874-879.1989; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; NEWTON GL, 1993, J BACTERIOL, V175, P2734, DOI 10.1128/JB.175.9.2734-2742.1993; NOVOGRODSKY A, 1982, P NATL ACAD SCI-BIOL, V79, P1171, DOI 10.1073/pnas.79.4.1171; Plata KB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061083; Plata KB, 2011, ANTIMICROB AGENTS CH, V55, P3176, DOI 10.1128/AAC.01119-09; REPINE JE, 1981, J BIOL CHEM, V256, P7094; Rohrer S, 2003, J MED MICROBIOL, V52, P605, DOI 10.1099/jmm.0.05176-0; TOMASZ A, 1991, ANTIMICROB AGENTS CH, V35, P124, DOI 10.1128/AAC.35.1.124; TOUATI D, 1995, J BACTERIOL, V177, P2305, DOI 10.1128/jb.177.9.2305-2314.1995; Wang XH, 2009, ANTIMICROB AGENTS CH, V53, P1395, DOI 10.1128/AAC.01087-08; Werth BJ, 2013, ANTIMICROB AGENTS CH, V57, P2664, DOI 10.1128/AAC.02308-12; Wilhelm J, 2009, MOL CELL BIOCHEM, V328, P167, DOI 10.1007/s11010-009-0086-5; Yeom J, 2010, J BIOL CHEM, V285, P22689, DOI 10.1074/jbc.M110.127456	53	35	35	3	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99605	10.1371/journal.pone.0099605	http://dx.doi.org/10.1371/journal.pone.0099605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932751	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600046
J	Xu, B; Li, Z; Yue, J; Jin, L; Li, YF; Ai, JH; Zhang, HW; Zhu, GJ				Xu, Bei; Li, Zhou; Yue, Jing; Jin, Lei; Li, Yufeng; Ai, Jihui; Zhang, Hanwang; Zhu, Guijin			Effect of Dehydroepiandrosterone Administration in Patients with Poor Ovarian Response According to the Bologna Criteria	PLOS ONE			English	Article							IN-VITRO FERTILIZATION; GROWTH-FACTOR-I; ANDROGEN SUPPLEMENTATION; WOMEN; DHEA; STIMULATION; IVF; EXPRESSION; IMPROVES; HORMONE	Background: Dehydroepiandrosterone (DHEA) is now widely used as an adjuvant to IVF treatment protocols in poor responders. However, clinical evidence for DHEA on improvement of ovarian response and IVF outcome is still limited, the validity of the results of the earlier studies, especially the varied inclusion criteria, is a subject of debate. Recently, the ESHRE Working Group developed a new definition, the Bologna criteria. The aim of the current study was to investigate the potential effect of DHEA treatment on in vitro fertilization (IVF) outcome of poor ovarian responders that fulfill the Bologna criteria. Methods: This study investigated 386 poor ovarian responders that fulfill the Bologna criteria. Patients underwent IVF-ET treatment with the GnRH antagonist protocol. The study group contained 189 patients, who received 75 mg of DHEA daily (25 mg three times daily) before the IVF cycle. The control group was composed of 197 patients who received infertility treatment, but did not receive DHEA. The IVF outcome parameters in each group were compared. Results: The study and control groups did not show statistically significant differences in terms of patient demographics characteristics, mean numbers of oocytes retrieved, mature oocytes, fertilization rate, cleavage rate, or embryo availability. While the DHEA group demonstrated significantly higher implantation rates (18.7% vs. 10.1%; P<0.01) and ongoing PRs (26.7% vs. 15.8%; P<0.05) as compared with the control. Conclusions: DHEA pre-treatment does not significantly increase oocyte yield. However, the ongoing PRs in this subgroup of women are significantly higher after DHEA administration, suggesting that DHEA may increase IVF results by improving oocyte and embryo quality.	[Xu, Bei; Li, Zhou; Yue, Jing; Jin, Lei; Li, Yufeng; Ai, Jihui; Zhang, Hanwang; Zhu, Guijin] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Reprod Med Ctr, Wuhan 430074, Peoples R China	Huazhong University of Science & Technology	Zhu, GJ (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Reprod Med Ctr, Wuhan 430074, Peoples R China.	zhu_guijin@sina.com		Li, Yufeng/0000-0003-3906-8144	National Natural Sciences Foundation of China [30901601, 81170619]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by research grants from the National Natural Sciences Foundation of China (30901601, 81170619). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersen CY, 2008, FERTIL STERIL, V89, P1760, DOI 10.1016/j.fertnstert.2007.05.003; Barad D, 2005, FERTIL STERIL, V84, P374, DOI 10.1016/j.fertnstert.2005.01.132; Barad D, 2007, J ASSIST REPROD GEN, V24, P629, DOI 10.1007/s10815-007-9178-x; Barad D, 2006, HUM REPROD, V21, P2845, DOI 10.1093/humrep/del254; Bosdou JK, 2012, HUM REPROD UPDATE, V18, P127, DOI 10.1093/humupd/dmr051; Casson PR, 1998, FERTIL STERIL, V70, P107, DOI 10.1016/S0015-0282(98)00121-6; Feigenberg T, 2009, REPROD BIOMED ONLINE, V19, P888, DOI 10.1016/j.rbmo.2009.09.012; Ferraretti AP, 2011, HUM REPROD, V26, P1616, DOI 10.1093/humrep/der092; Gleicher N, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-140; Gleicher N, 2010, REPROD BIOMED ONLINE, V21, P440, DOI 10.1016/j.rbmo.2010.06.042; Gleicher N, 2010, REPROD BIOMED ONLINE, V21, P360, DOI 10.1016/j.rbmo.2010.04.006; Gleicher N, 2009, REPROD BIOL ENDOCRIN, V7, DOI 10.1186/1477-7827-7-108; Harper AJ, 1999, SEMIN REPROD ENDOCR, V17, P327; HILLIER SG, 1994, MOL CELL ENDOCRINOL, V100, P51, DOI 10.1016/0303-7207(94)90278-X; IVF Worldwide Survey, POOR RESP DEF DIAGN; Kara M, 2014, EUR J OBSTET GYN R B, V173, P63, DOI 10.1016/j.ejogrb.2013.11.008; Keay SD, 1997, BRIT J OBSTET GYNAEC, V104, P521, DOI 10.1111/j.1471-0528.1997.tb11525.x; Kolibianakis EM, 2011, HUM REPROD, V26, P730, DOI 10.1093/humrep/deq397; Loutradis D, 2008, CURR OPIN OBSTET GYN, V20, P374, DOI 10.1097/GCO.0b013e328305b9b8; Mamas L, 2009, FERTIL STERIL, V91, P644, DOI 10.1016/j.fertnstert.2007.11.055; Menezo Y, 2010, ZYGOTE, V18, P357, DOI 10.1017/S0967199410000286; Narkwichean A, 2014, HUM REPROD, V29, P146, DOI 10.1093/humrep/det408; Narkwichean A, 2013, REPROD BIOL ENDOCRIN, V11, DOI 10.1186/1477-7827-11-44; Nielsen ME, 2011, MOL HUM REPROD, V17, P63, DOI 10.1093/molehr/gaq073; Pandian Z, 2010, COCHRANE DB SYST REV, V1; Pitteloud N, 2005, DIABETES CARE, V28, P1636, DOI 10.2337/diacare.28.7.1636; Polyzos NP, 2011, FERTIL STERIL, V96, P1058, DOI 10.1016/j.fertnstert.2011.09.048; Sen A, 2010, MOL ENDOCRINOL, V24, P1393, DOI 10.1210/me.2010-0006; Sonmezer M, 2009, REPROD BIOMED ONLINE, V19, P508; Sunkara SK, 2012, HUM REPROD, V27, P637, DOI 10.1093/humrep/der464; Sunkara SK, 2011, REPROD BIOMED ONLINE, V22, P545, DOI 10.1016/j.rbmo.2011.01.015; Tarlatzis BC, 2003, HUM REPROD UPDATE, V9, P61, DOI 10.1093/humupd/dmg007; Vendola K, 1999, BIOL REPROD, V61, P353, DOI 10.1095/biolreprod61.2.353; Vendola KA, 1998, J CLIN INVEST, V101, P2622, DOI 10.1172/JCI2081; Weil S, 1999, J CLIN ENDOCR METAB, V84, P2951, DOI 10.1210/jc.84.8.2951; Weil SJ, 1998, J CLIN ENDOCR METAB, V83, P2479, DOI 10.1210/jc.83.7.2479; Wiser A, 2010, HUM REPROD, V25, P2496, DOI 10.1093/humrep/deq220; Younis JS, 2012, HUM REPROD, V27, P1874, DOI 10.1093/humrep/des118	38	32	34	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99858	10.1371/journal.pone.0099858	http://dx.doi.org/10.1371/journal.pone.0099858			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932478	gold, Green Published, Green Submitted			2022-12-27	WOS:000337738600073
J	Chen, JQ; Wang, JZ; Huang, Y; Lai, XS; Tang, CZ; Yang, JJ; Wu, JX; Zeng, TJ; Qu, SS				Chen, Junqi; Wang, Jizhou; Huang, Yong; Lai, Xinsheng; Tang, Chunzhi; Yang, Junjun; Wu, Junxian; Zeng, Tongjun; Qu, Shanshan			Modulatory Effect of Acupuncture at Waiguan (TE5) on the Functional Connectivity of the Central Nervous System of Patients with Ischemic Stroke in the Left Basal Ganglia	PLOS ONE			English	Article							SHAM ACUPUNCTURE; CONTROLLED-TRIAL; BRAIN NETWORKS; MOTOR FUNCTION; DEFAULT MODE; FMRI; HAND; REORGANIZATION; STIMULATION; IMPAIRMENT	Objective: To study the influence of acupuncture at Waiguan (TE5) on the functional connectivity of the central nervous system of patients with ischemic stroke. Methods: Twenty-four patients with ischemic stroke in the left basal ganglia were randomized based on gender to receive TE5 acupuncture (n = 12) or nonacupoint acupuncture (n = 12). Each group underwent sham acupuncture and then verum acupuncture while being scanned with functional magnetic resonance imaging. Six regions of interest (ROI) were defined, including bilateral motor, somatosensory, and bilateral basal ganglia areas. The functional connectivity between these ROIs and all voxels of the brain was analyzed in Analysis of Functional NeuroImages(AFNI) to explore the differences between verum acupuncture and sham acupuncture at TE5 and between TE5 acupuncture and nonacupoint acupuncture. The participants were blinded to the allocation. Result: The effect of acupuncture on six seed-associated networks was explored. The result demonstrated that acupuncture at Waiguan (TE5) can regulate the sensorimotor network of the ipsilesional hemisphere, stimulate the contralesional sensorimotor network, increase cooperation of bilateral sensorimotor networks, and change the synchronization between the cerebellum and cerebrum. Furthermore, a lot of differences of effect existed between verum acupuncture and sham acupuncture at TE5, but there was little difference between TE5 acupuncture and nonacupoint acupuncture. Conclusion: The modulation of synchronizations between different regions within different brain networks might be the mechanism of acupuncture at Waiguan (TE5). Stimulation of the contralesional sensorimotor network and increase of cooperation of bilateral hemispheres imply a compensatory effect of the intact hemisphere, whereas changes in synchronization might influence the sensorimotor function of the affected side of the body.	[Chen, Junqi] Southern Med Univ, Dept Rehabil, Affiliated Hosp 3, Guangzhou, Guangdong, Peoples R China; [Wang, Jizhou] Southern Med Univ, Med Clin Sch 1, Guangzhou, Guangdong, Peoples R China; [Huang, Yong; Qu, Shanshan] Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China; [Lai, Xinsheng; Tang, Chunzhi; Yang, Junjun] Guangzhou Univ Tradit Chinese Med, Sch Acupuncture & Rehabil, Guangzhou, Guangdong, Peoples R China; [Wu, Junxian] Shantou Cent Hosp, Dept Acupuncture & Moxibust, Shantou, Peoples R China; [Zeng, Tongjun] First Peoples Hosp Shunde, Foshan, Peoples R China	Southern Medical University - China; Southern Medical University - China; Southern Medical University - China; Guangzhou University of Chinese Medicine	Huang, Y (corresponding author), Southern Med Univ, Sch Tradit Chinese Med, Guangzhou, Guangdong, Peoples R China.	nfhy@fimmu.com; lai1023@163.com		chen, jun-qi/0000-0001-6847-0891	National 973 Program of China [2006CB504505, 2012CB518504]; Third Key Subject of the '211 Project' of Guangdong Province	National 973 Program of China(National Basic Research Program of China); Third Key Subject of the '211 Project' of Guangdong Province	This study was supported by National 973 Program of China (no.: 2006CB504505), National 973 Program of China (no.: 2012CB518504) and Third Key Subject of the '211 Project' of Guangdong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Askim T, 2009, NEUROREHAB NEURAL RE, V23, P295, DOI 10.1177/1545968308322840; Breakspear M, 2003, NETWORK-COMP NEURAL, V14, P703, DOI 10.1088/0954-898X/14/4/305; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Cheng XN, 2000, CHINESE ACUPUNCTURE; Claunch JD, 2012, AM J CHINESE MED, V40, P695, DOI 10.1142/S0192415X12500528; Dhond RP, 2008, PAIN, V136, P407, DOI 10.1016/j.pain.2008.01.011; Dinomais M, 2012, HUM BRAIN MAPP, V33, P628, DOI 10.1002/hbm.21227; Fang JL, 2009, HUM BRAIN MAPP, V30, P1196, DOI 10.1002/hbm.20583; Feng YY, 2012, MAGN RESON IMAGING, V30, P672, DOI 10.1016/j.mri.2012.01.003; Fink MG, 2000, Z RHEUMATOL, V59, P191, DOI 10.1007/s003930070080; Gao JH, 1996, SCIENCE, V272, P545, DOI 10.1126/science.272.5261.545; Grefkes C, 2008, ANN NEUROL, V63, P236, DOI 10.1002/ana.21228; Grefkes C, 2011, BRAIN, V134, P1264, DOI 10.1093/brain/awr033; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; He BJ, 2007, NEURON, V53, P905, DOI 10.1016/j.neuron.2007.02.013; Hsu SF, 2011, AM J CHINESE MED, V39, P673, DOI 10.1142/S0192415X11009111; Huang WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032960; Huang Y, 2013, ACUPUNCT MED; Hui KKS, 2009, BRAIN RES, V1287, P84, DOI 10.1016/j.brainres.2009.06.061; Hui KK, 2010, J VIS EXP; Hummel F, 2005, BRAIN, V128, P490, DOI 10.1093/brain/awh369; Johansen-Berg H, 2002, BRAIN, V125, P2731, DOI 10.1093/brain/awf282; Johansen-Berg H, 2002, P NATL ACAD SCI USA, V99, P14518, DOI 10.1073/pnas.222536799; Leibing E, 2002, PAIN, V96, P189, DOI 10.1016/S0304-3959(01)00444-4; Li Y, 2009, HEADACHE, V49, P805, DOI 10.1111/j.1526-4610.2009.01424.x; Liu Bo, 2009, Zhongguo Zhen Jiu, V29, P981; Liu JX, 2011, J MAGN RESON IMAGING, V33, P33, DOI 10.1002/jmri.22393; Liu P, 2009, J MAGN RESON IMAGING, V30, P41, DOI 10.1002/jmri.21805; Liu P, 2009, NEUROSCI LETT, V462, P183, DOI 10.1016/j.neulet.2009.07.015; Maciocia G, 1994, PRACTICE CHINESE MED; Moffet HH, 2009, J ALTERN COMPLEM MED, V15, P213, DOI 10.1089/acm.2008.0356; Molsberger AF, 2012, EUR J PAIN, V16, P1264, DOI 10.1002/j.1532-2149.2012.00145.x; Murase N, 2004, ANN NEUROL, V55, P400, DOI 10.1002/ana.10848; Nomura EM, 2010, P NATL ACAD SCI USA, V107, P12017, DOI 10.1073/pnas.1002431107; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Qin W, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-55; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; Schaechter JD, 2007, J ALTERN COMPLEM MED, V13, P527, DOI 10.1089/acm.2007.6316; Small SL, 2002, BRAIN, V125, P1544, DOI 10.1093/brain/awf148; Sporns O, 2004, TRENDS COGN SCI, V8, P418, DOI 10.1016/j.tics.2004.07.008; Wang Jing-Jing, 2009, Zhongguo Zhen Jiu, V29, P315; Wang L, 2010, BRAIN, V133, P1224, DOI 10.1093/brain/awq043; Zhang Y, 2009, NEUROSCI LETT, V458, P6, DOI 10.1016/j.neulet.2009.04.027; Zhong CG, 2012, J MAGN RESON IMAGING, V35, P572, DOI 10.1002/jmri.22887	44	29	35	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e96777	10.1371/journal.pone.0096777	http://dx.doi.org/10.1371/journal.pone.0096777			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927275	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100006
J	Dorweiler, JE; Ni, T; Zhu, J; Munroe, SH; Anderson, JT				Dorweiler, Jane E.; Ni, Ting; Zhu, Jun; Munroe, Stephen H.; Anderson, James T.			Certain Adenylated Non-Coding RNAs, Including 5' Leader Sequences of Primary MicroRNA Transcripts, Accumulate in Mouse Cells following Depletion of the RNA Helicase MTR4	PLOS ONE			English	Article							RIBOSOMAL-RNA; QUALITY-CONTROL; NUCLEAR-RNA; SACCHAROMYCES-CEREVISIAE; MESSENGER-RNA; POLY(A) POLYMERASE; U3B RNA; EXOSOME; YEAST; POLYADENYLATION	RNA surveillance plays an important role in posttranscriptional regulation. Seminal work in this field has largely focused on yeast as a model system, whereas exploration of RNA surveillance in mammals is only recently begun. The increased transcriptional complexity of mammalian systems provides a wider array of targets for RNA surveillance, and, while many questions remain unanswered, emerging data suggest the nuclear RNA surveillance machinery exhibits increased complexity as well. We have used a small interfering RNA in mouse N2A cells to target the homolog of a yeast protein that functions in RNA surveillance (Mtr4p). We used high-throughput sequencing of polyadenylated RNAs (PA-seq) to quantify the effects of the mMtr4 knockdown (KD) on RNA surveillance. We demonstrate that overall abundance of polyadenylated protein coding mRNAs is not affected, but several targets of RNA surveillance predicted from work in yeast accumulate as adenylated RNAs in the mMtr4KD. microRNAs are an added layer of transcriptional complexity not found in yeast. After Drosha cleavage separates the pre-miRNA from the microRNA's primary transcript, the byproducts of that transcript are generally thought to be degraded. We have identified the 59 leading segments of pri-miRNAs as novel targets of mMtr4 dependent RNA surveillance.	[Dorweiler, Jane E.; Munroe, Stephen H.; Anderson, James T.] Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA; [Ni, Ting; Zhu, Jun] NHLBI, DNA Sequencing & Genom Core, Genet & Dev Biol Ctr, NIH, Bethesda, MD 20892 USA	Marquette University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI)	Munroe, SH (corresponding author), Marquette Univ, Dept Biol Sci, Milwaukee, WI 53233 USA.	Stephen.munroe@marquette.edu; james.anderson@marquette.edu	Dorweiler, Jane/K-3116-2019		Marquette University Way Klingler College of Arts and Sciences; Marquette University Department of Biological Sciences; National Heart Lung Blood Institute, National Institutes of Health; National Institutes of Health [1R15GM100445-01A1]; open access charge: Marquette University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZICHL006058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R15GM100445] Funding Source: NIH RePORTER	Marquette University Way Klingler College of Arts and Sciences; Marquette University Department of Biological Sciences; National Heart Lung Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); open access charge: Marquette University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Marquette University Way Klingler College of Arts and Sciences to J.T.A.; by Marquette University Department of Biological Sciences to J.T.A. and S.H.M.; and by intramural research program at National Heart Lung Blood Institute, National Institutes of Health to J.Z.; and by National Institutes of Health grant number 1R15GM100445-01A1 to J.T.A. Funding for open access charge: Marquette University and National Institutes of Health grant number 1R15GM100445-01A1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HW, 2010, MOL HUM REPROD, V16, P463, DOI 10.1093/molehr/gaq017; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Anderson JT, 2009, CRIT REV BIOCHEM MOL, V44, P16, DOI [10.1080/10409230802640218 , 10.1080/10409230802640218]; Assenholt J, 2008, RNA, V14, P2305, DOI 10.1261/rna.1108008; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Bassuk AG, 2007, NEUROGENETICS, V8, P45, DOI 10.1007/s10048-006-0067-8; Beaulieu YB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003078; Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; Blencowe BJ, 2009, GENE DEV, V23, P1379, DOI 10.1101/gad.1788009; Boyle AP, 2008, BIOINFORMATICS, V24, P2537, DOI 10.1093/bioinformatics/btn480; Bremer J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012450; Bresson SM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003893; Brockdorff N, 2013, RNA, V19, P429, DOI 10.1261/rna.037598.112; Bruserud O, 2007, CURR PHARM BIOTECHNO, V8, P318, DOI 10.2174/138920107783018408; Chiang HR, 2010, GENE DEV, V24, P992, DOI 10.1101/gad.1884710; CRAIG N, 1987, P NATL ACAD SCI USA, V84, P629, DOI 10.1073/pnas.84.3.629; CRAIG N, 1991, MOL CELL BIOL, V11, P458, DOI 10.1128/MCB.11.1.458; Cristodero M, 2007, NUCLEIC ACIDS RES, V35, P7023, DOI 10.1093/nar/gkm736; DARNELL JE, 1968, BACTERIOL REV, V32, P262, DOI 10.1128/MMBR.32.3.262-290.1968; David CJ, 2010, GENE DEV, V24, P2343, DOI 10.1101/gad.1973010; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Derti A, 2012, GENOME RES, V22, P1173, DOI 10.1101/gr.132563.111; Di Giammartino DC, 2011, MOL CELL, V43, P853, DOI 10.1016/j.molcel.2011.08.017; Dichtl B, 1997, EMBO J, V16, P7184, DOI 10.1093/emboj/16.23.7184; Dieci G, 2013, BBA-GENE REGUL MECH, V1829, P296, DOI 10.1016/j.bbagrm.2012.09.010; Dogini DB, 2008, J MOL NEUROSCI, V35, P331, DOI 10.1007/s12031-008-9068-4; Dugas JC, 2010, NEURON, V65, P597, DOI 10.1016/j.neuron.2010.01.027; Eda A, 2011, GENE, V485, P46, DOI 10.1016/j.gene.2011.05.034; Eda A, 2009, BIOCHEM BIOPH RES CO, V388, P648, DOI 10.1016/j.bbrc.2009.08.040; Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206; Etheridge RD, 2009, MOL BIOCHEM PARASIT, V164, P66, DOI 10.1016/j.molbiopara.2008.11.004; Fasken MB, 2011, J BIOL CHEM, V286, P37429, DOI 10.1074/jbc.M111.271494; Fogel BL, 2006, NEUROLOGY, V67, P2083, DOI 10.1212/01.wnl.0000247661.19601.28; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; GILHAM PT, 1970, ANNU REV BIOCHEM, V39, P227, DOI 10.1146/annurev.bi.39.070170.001303; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Griffiths-Jones S, 2004, NUCLEIC ACIDS RES, V32, pD109, DOI 10.1093/nar/gkh023; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Haracska L, 2005, MOL CELL BIOL, V25, P10183, DOI 10.1128/MCB.25.22.10183-10189.2005; Hessle V, 2009, MOL BIOL CELL, V20, P3459, DOI 10.1091/mbc.E09-01-0079; Holub P, 2012, NUCLEIC ACIDS RES, V40, P5679, DOI 10.1093/nar/gks223; Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008; Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921; Inoue K, 2000, J BIOL CHEM, V275, P32793, DOI 10.1074/jbc.M004560200; Jia HJ, 2011, CELL, V145, P890, DOI 10.1016/j.cell.2011.05.010; Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406; Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804; Kawahara H, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00030; Kent T, 2009, RNA, V15, P14, DOI 10.1261/rna.1384709; Kim MY, 2009, BMB REP, V42, P125, DOI 10.5483/BMBRep.2009.42.3.125; Kim T, 2013, INT J MOL SCI, V14, P4934, DOI 10.3390/ijms14034934; KLEBE RJ, 1969, J CELL BIOL, V43, pA69; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lebreton A, 2008, BBA-GENE REGUL MECH, V1779, P558, DOI 10.1016/j.bbagrm.2008.02.003; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang S, 1996, MOL CELL BIOL, V16, P5139; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lubas M, 2011, MOL CELL, V43, P624, DOI 10.1016/j.molcel.2011.06.028; MATTAJ IW, 1993, FASEB J, V7, P47, DOI 10.1096/fasebj.7.1.8422974; MAZAN S, 1990, GENE, V94, P263, DOI 10.1016/0378-1119(90)90397-A; MAZAN S, 1991, CYTOGENET CELL GENET, V56, P18, DOI 10.1159/000133037; MAZAN S, 1988, J BIOL CHEM, V263, P19461; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; Moreira MC, 2004, NAT GENET, V36, P225, DOI 10.1038/ng1303; MURAMATSU M, 1966, BIOCHIM BIOPHYS ACTA, V123, P116, DOI 10.1016/0005-2787(66)90164-X; Nabavi S, 2008, CURR GENET, V54, P175, DOI 10.1007/s00294-008-0210-1; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P461, DOI 10.1097/01.jnen.0000240474.27791.f3; Ni T, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-615; Ni T, 2010, NAT METHODS, V7, P521, DOI [10.1038/nmeth.1464, 10.1038/NMETH.1464]; OLMSTED JB, 1970, P NATL ACAD SCI USA, V65, P129, DOI 10.1073/pnas.65.1.129; Parker R, 2012, GENETICS, V191, P671, DOI 10.1534/genetics.111.137265; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Pendrak ML, 2011, RNA, V17, P2235, DOI 10.1261/rna.028050.111; Perumal K, 2002, GENE EXPRESSION, V10, P59; Petfalski E, 1998, MOL CELL BIOL, V18, P1181, DOI 10.1128/MCB.18.3.1181; PRESTAYKO A W, 1970, Journal of Molecular Biology, V47, P505, DOI 10.1016/0022-2836(70)90318-9; Rammelt C, 2011, RNA, V17, P1737, DOI 10.1261/rna.2787011; Saba Reuben, 2008, P73, DOI 10.1007/978-1-4020-8533-8_5; Scherrer K, 2003, TRENDS BIOCHEM SCI, V28, P566, DOI 10.1016/j.tibs.2003.08.004; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Schonrock N, 2012, CIRC RES, V111, P1349, DOI 10.1161/CIRCRESAHA.112.268953; Schonrock N, 2012, CELL MOL LIFE SCI, V69, P3543, DOI 10.1007/s00018-012-1125-z; Schonrock N, 2012, EXP NEUROL, V235, P447, DOI 10.1016/j.expneurol.2011.11.013; Shcherbik N, 2010, EMBO REP, V11, P106, DOI 10.1038/embor.2009.271; Sloan KE, 2012, BIOCHEM SOC T, V40, P850, DOI 10.1042/BST20120061; Smirnova L, 2005, EUR J NEUROSCI, V21, P1469, DOI 10.1111/j.1460-9568.2005.03978.x; Starega-Roslan J, 2011, CELL MOL LIFE SCI, V68, P2859, DOI 10.1007/s00018-011-0726-2; Tan L, 2013, MOL NEUROBIOL, V47, P382, DOI 10.1007/s12035-012-8359-5; Thompson DM, 2007, MOL CELL BIOL, V27, P92, DOI 10.1128/MCB.01023-06; Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000; Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189; Wang XY, 2008, RNA, V14, P107, DOI 10.1261/rna.808608; WEINBERG RA, 1968, J MOL BIOL, V38, P289, DOI 10.1016/0022-2836(68)90387-2; West S, 2006, MOL CELL, V21, P437, DOI 10.1016/j.molcel.2005.12.008; West S, 2004, NATURE, V432, P522, DOI 10.1038/nature03035; Will S, 2013, GENOME RES; Wolin SL, 2012, TRENDS GENET, V28, P306, DOI 10.1016/j.tig.2012.03.005; Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030	103	5	5	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99430	10.1371/journal.pone.0099430	http://dx.doi.org/10.1371/journal.pone.0099430			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926684	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100040
J	Ikuo, M; Nagano, G; Saito, Y; Mao, H; Sekimizu, K; Kaito, C				Ikuo, Mariko; Nagano, Gentaro; Saito, Yuki; Mao, Han; Sekimizu, Kazuhisa; Kaito, Chikara			Inhibition of Exotoxin Production by Mobile Genetic Element SCCmec-Encoded psm-mec RNA Is Conserved in Staphylococcal Species	PLOS ONE			English	Article							AGR LOCUS; EPIDERMIDIS; VIRULENCE; AUREUS; BACTEREMIA; RESISTANCE; INFECTION; EVOLUTION; PEPTIDES; CAPACITY	Staphylococcal species acquire antibiotic resistance by incorporating the mobile-genetic element SCCmec. We previously found that SCCmec-encoded psm-mec RNA suppresses exotoxin production as a regulatory RNA, and the psm-mec translation product increases biofilm formation in Staphylococcus aureus. Here, we examined whether the regulatory role of psm-mec on host bacterial virulence properties is conserved among other staphylococcal species, S. epidermidis and S. haemolyticus, both of which are important causes of nosocomial infections. In S. epidermidis, introduction of psm-mec decreased the production of cytolytic toxins called phenol-soluble modulins (PSMs) and increased biofilm formation. Introduction of psm-mec with a stop-codon mutation that did not express PSM-mec protein but did express psm-mec RNA also decreased PSM production, but did not increase biofilm formation. Thus, the psm-mec RNA inhibits PSM production, whereas the PSM-mec protein increases biofilm formation in S. epidermidis. In S. haemolyticus, introduction of psm-mec decreased PSM production, but did not affect biofilm formation. The mutated psm-mec with a stop-codon also caused the same effect. Thus, the psm-mec RNA also inhibits PSM production in S. haemolyticus. These findings suggest that the inhibitory role of psm-mec RNA on exotoxin production is conserved among staphylococcal species, although the stimulating effect of the psm-mec gene on biofilm formation is not conserved.	[Ikuo, Mariko; Nagano, Gentaro; Saito, Yuki; Mao, Han; Sekimizu, Kazuhisa; Kaito, Chikara] Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo, Japan	University of Tokyo	Kaito, C (corresponding author), Univ Tokyo, Grad Sch Pharmaceut Sci, Microbiol Lab, Bunkyo Ku, Tokyo, Japan.	kaito@mol.f.u-tokyo.ac.jp	Kaito, Chikara/G-1248-2017; Kaito, Chikara/W-1815-2019	Kaito, Chikara/0000-0002-2895-3386; Kaito, Chikara/0000-0002-2895-3386	Genome Pharmaceutical Institute;  [23249009];  [24590519];  [25117507]	Genome Pharmaceutical Institute; ; ; 	This study was supported by Grants-in-Aid for Scientific Research (23249009, 24590519, 25117507). This study was supported in part by the Genome Pharmaceutical Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brzychczy-Wloch M, 2013, ANN CLIN MICROB ANTI, V12, DOI 10.1186/1476-0711-12-41; Chabelskaya S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000927; Chatterjee SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028781; Cheung GYC, 2014, FEMS MICROBIOL REV, V38, P698, DOI 10.1111/1574-6976.12057; Cheung GYC, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001133; Cheung GYC, 2010, CURR OPIN INFECT DIS, V23, P208, DOI 10.1097/QCO.0b013e328337fecb; Davies BW, 2012, CELL, V149, P358, DOI 10.1016/j.cell.2012.01.053; Dufour P, 2002, J BACTERIOL, V184, P1180, DOI 10.1128/jb.184.4.1180-1186.2002; Fischetti VA, 2006, GRAM POSITIVE PATHOG, Vxiii; Fowler VG, 2004, J INFECT DIS, V190, P1140, DOI 10.1086/423145; Kaito C, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003269; Kaito C, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001267; Kaito C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003921; Kiedrowski MR, 2011, ANN NY ACAD SCI, V1241, P104, DOI 10.1111/j.1749-6632.2011.06281.x; Kretschmer D, 2012, J INNATE IMMUN, V4, P201, DOI 10.1159/000332142; Lindsay JA, 2010, INT J MED MICROBIOL, V300, P98, DOI 10.1016/j.ijmm.2009.08.013; McNamara PJ, 1998, J BACTERIOL, V180, P2609, DOI 10.1128/JB.180.10.2609-2615.1998; Monecke S, 2012, MOL CELL PROBE, V26, P99, DOI 10.1016/j.mcp.2012.01.001; Novick RP, 2010, NAT REV MICROBIOL, V8, P541, DOI 10.1038/nrmicro2393; Novick RP, 2003, MOL MICROBIOL, V48, P1429, DOI 10.1046/j.1365-2958.2003.03526.x; Otto M, 2009, NAT REV MICROBIOL, V7, P555, DOI 10.1038/nrmicro2182; Paulander W, 2012, MBIO, V3, DOI 10.1128/mBio.00459-12; Peschel A, 2013, NAT REV MICROBIOL, V11, P667, DOI 10.1038/nrmicro3110; Pfeiffer V, 2007, MOL MICROBIOL, V66, P1174, DOI 10.1111/j.1365-2958.2007.05991.x; Queck SY, 2008, MOL CELL, V32, P150, DOI 10.1016/j.molcel.2008.08.005; Queck SY, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000533; Raimundo O, 2002, J HOSP INFECT, V51, P33, DOI 10.1053/jhin.2002.1203; Sakoulas G, 2002, ANTIMICROB AGENTS CH, V46, P1492, DOI 10.1128/AAC.46.5.1492-1502.2002; SCHENK S, 1992, FEMS MICROBIOL LETT, V94, P133; SCHLEIFER KH, 1975, INT J SYST BACTERIOL, V25, P50, DOI 10.1099/00207713-25-1-50; Schmidt H, 2004, CLIN MICROBIOL REV, V17, P14, DOI 10.1128/CMR.17.1.14-56.2004; SCHWALBE RS, 1987, NEW ENGL J MED, V316, P927, DOI 10.1056/NEJM198704093161507; Somerville GA, 2002, J BACTERIOL, V184, P1430, DOI 10.1128/JB.184.5.1430-1437.2002; Traber K, 2006, MOL MICROBIOL, V59, P1519, DOI 10.1111/j.1365-2958.2006.04986.x; Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0; Vuong C, 2004, CELL MICROBIOL, V6, P753, DOI 10.1111/j.1462-5822.2004.00401.x; Wang R, 2007, NAT MED, V13, P1510, DOI 10.1038/nm1656; Wang R, 2011, J CLIN INVEST, V121, P238, DOI 10.1172/JCI42520; Zhang YQ, 2003, MOL MICROBIOL, V49, P1577, DOI 10.1046/j.1365-2958.2003.03671.x	39	9	10	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100260	10.1371/journal.pone.0100260	http://dx.doi.org/10.1371/journal.pone.0100260			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926994	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100123
J	Siebold, A; Donk, M				Siebold, Alisha; Donk, Mieke			On the Importance of Relative Salience: Comparing Overt Selection Behavior of Single versus Simultaneously Presented Stimuli	PLOS ONE			English	Article							SACCADIC TARGET SELECTION; VISUAL-SEARCH; OCULOMOTOR SELECTION; ATTENTIONAL CAPTURE; TIME; GOAL; TOP; COMPONENT; DRIVEN; SHIFTS	The goal of the current study was to investigate time-dependent effects of the number of targets presented and its interaction with stimulus salience on oculomotor selection performance. To this end, observers were asked to make a speeded eye movement to a target orientation singleton embedded in a homogeneous background of vertically oriented lines. In Experiment 1, either one or two physically identical targets were presented, whereas in Experiment 2 an additional orientation-based salience manipulation was performed. The results showed that the probability of a singleton being available for selection is reduced in the presence of an identical singleton (Experiment 1) and that this effect is modulated by the salience of the other singleton (Experiment 2). While the absolute orientation contrast of a target relative to the background contributed to the probability that it is available for selection, the crucial factor affecting selection was the relative salience between singletons. These findings are incompatible with a processing speed account, which highlights the importance of visibility and claims that a certain singleton identity has a unique speed with which it can be processed. In contrast, the finding that the number of targets presented affected a target's availability suggests an important role of the broader display context in determining oculomotor selection performance.	[Siebold, Alisha; Donk, Mieke] Free Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands	Vrije Universiteit Amsterdam	Siebold, A (corresponding author), Free Univ Amsterdam, Dept Cognit Psychol, Amsterdam, Netherlands.	a.siebold@vu.nl		Donk, Mieke/0000-0001-9310-8210				Ahissar M, 2004, TRENDS COGN SCI, V8, P457, DOI 10.1016/j.tics.2004.08.011; ALBRECHT DG, 1995, VISUAL NEUROSCI, V12, P1191, DOI 10.1017/S0952523800006817; de Vries JP, 2011, PSYCHOL SCI, V22, P916, DOI 10.1177/0956797611410572; Dombrowe IC, 2010, FRONT PSYCHOL, V1, DOI 10.3389/fpsyg.2010.00189; Donk M, 2008, PSYCHOL SCI, V19, P733, DOI 10.1111/j.1467-9280.2008.02149.x; Donk M, 2011, VISION RES, V51, P2156, DOI 10.1016/j.visres.2011.08.013; Donk M, 2011, PERCEPTION, V40, P63, DOI 10.1068/p6718; Donk M, 2010, J EXP PSYCHOL HUMAN, V36, P286, DOI 10.1037/a0017605; Egeth HE, 2010, ACTA PSYCHOL, V135, P130, DOI 10.1016/j.actpsy.2010.05.012; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Henderson JM, 2009, PSYCHON B REV, V16, P850, DOI 10.3758/PBR.16.5.850; Hochstein S, 2002, NEURON, V36, P791, DOI 10.1016/S0896-6273(02)01091-7; Hunt AR, 2007, J EXP PSYCHOL HUMAN, V33, P271, DOI 10.1037/0096-1523.33.2.271; Itti L, 2001, NAT REV NEUROSCI, V2, P194, DOI 10.1038/35058500; Itti L, 2000, VISION RES, V40, P1489, DOI 10.1016/S0042-6989(99)00163-7; Kiss M, 2008, PSYCHOPHYSIOLOGY, V45, P1013, DOI 10.1111/j.1469-8986.2008.00700.x; KOCH C, 1985, HUM NEUROBIOL, V4, P219; Lamme VAF, 2000, TRENDS NEUROSCI, V23, P571, DOI 10.1016/S0166-2236(00)01657-X; Leber AB, 2006, PSYCHON B REV, V13, P132, DOI 10.3758/BF03193824; Mazer JA, 2002, P NATL ACAD SCI USA, V99, P1645, DOI 10.1073/pnas.022638499; MULLER HJ, 1995, PERCEPT PSYCHOPHYS, V57, P1, DOI 10.3758/BF03211845; Navalpakkam V, 2005, VISION RES, V45, P205, DOI 10.1016/j.visres.2004.07.042; Pomplun M, 2006, VISION RES, V46, P1886, DOI 10.1016/j.visres.2005.12.003; Rao RPN, 2002, VISION RES, V42, P1447, DOI 10.1016/S0042-6989(02)00040-8; Rutishauser U, 2007, J VISION, V7, DOI 10.1167/7.6.5; Siebold A, ATTEN PERCE IN PRESS; Siebold A, 2013, J EXP PSYCHOL HUMAN, V39, P1516, DOI 10.1037/a0032182; Siebold A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023552; Tatler BW, 2005, VISION RES, V45, P643, DOI 10.1016/j.visres.2004.09.017; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; THEEUWES J, 1992, PERCEPT PSYCHOPHYS, V51, P599, DOI 10.3758/BF03211656; Theeuwes J, 2010, ACTA PSYCHOL, V135, P77, DOI 10.1016/j.actpsy.2010.02.006; Tollner T, 2009, J COGNITIVE NEUROSCI, V21, P1653, DOI 10.1162/jocn.2009.21108; Tollner T, 2012, PNAS PLUS P NATL ACA, V109, P1990; Van Zoest W, 2006, SPATIAL VISION, V19, P61, DOI 10.1163/156856806775009205; van Zoest W, 2005, VIS COGN, V12, P353, DOI 10.1080/13506280444000229; van Zoest W, 2004, J EXP PSYCHOL HUMAN, V30, P746, DOI 10.1037/0096-1523.30.4.749; van Zoest W, 2008, Q J EXP PSYCHOL, V61, P1553, DOI 10.1080/17470210701595555; van Zoest W, 2010, CONSCIOUS COGN, V19, P861, DOI 10.1016/j.concog.2010.04.001; WOLFE JM, 1994, PSYCHON B REV, V1, P202, DOI 10.3758/BF03200774; Zhang LY, 2008, J VISION, V8, DOI 10.1167/8.7.32	41	2	2	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99707	10.1371/journal.pone.0099707	http://dx.doi.org/10.1371/journal.pone.0099707			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2VQ	24927282	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100070
J	Steen, V; Skagen, SK; Noon, BR				Steen, Valerie; Skagen, Susan K.; Noon, Barry R.			Vulnerability of Breeding Waterbirds to Climate Change in the Prairie Pothole Region, USA	PLOS ONE			English	Article							SPECIES DISTRIBUTION; NORTH-DAKOTA; WETLANDS; WATERFOWL; DISTRIBUTIONS; PREDICTION; FUTURE; SHIFTS	The Prairie Pothole Region (PPR) of the north-central U.S. and south-central Canada contains millions of small prairie wetlands that provide critical habitat to many migrating and breeding waterbirds. Due to their small size and the relatively dry climate of the region, these wetlands are considered at high risk for negative climate change effects as temperatures increase. To estimate the potential impacts of climate change on breeding waterbirds, we predicted current and future distributions of species common in the PPR using species distribution models (SDMs). We created regional-scale SDMs for the U.S. PPR using Breeding Bird Survey occurrence records for 1971-2011 and wetland, upland, and climate variables. For each species, we predicted current distribution based on climate records for 1981-2000 and projected future distributions to climate scenarios for 2040-2049. Species were projected to, on average, lose almost half their current habitat (-46%). However, individual species projections varied widely, from +8% (Upland Sandpiper) to -100% (Wilson's Snipe). Variable importance ranks indicated that land cover (wetland and upland) variables were generally more important than climate variables in predicting species distributions. However, climate variables were relatively more important during a drought period. Projected distributions of species responses to climate change contracted within current areas of distribution rather than shifting. Given the large variation in species-level impacts, we suggest that climate change mitigation efforts focus on species projected to be the most vulnerable by enacting targeted wetland management, easement acquisition, and restoration efforts.	[Steen, Valerie; Skagen, Susan K.] US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA; [Steen, Valerie; Noon, Barry R.] Colorado State Univ, Dept Fish Wildlife & Conservat Biol, Ft Collins, CO USA; [Steen, Valerie; Noon, Barry R.] Colorado State Univ, Grad Degree Program Ecol, Ft Collins, CO USA	United States Department of the Interior; United States Geological Survey; Colorado State University; Colorado State University	Steen, V (corresponding author), US Geol Survey, Ft Collins Sci Ctr, Ft Collins, CO 80526 USA.	valerie.steen@gmail.com	Steen, Valerie/P-9913-2016	Steen, Valerie/0000-0002-1417-8139	U.S. Geological Survey; National Climate Change and Wildlife Science Center (NCCWSC); Plains and Prairie Pothole Landscape Cooperative (PPPLCC)	U.S. Geological Survey(United States Geological Survey); National Climate Change and Wildlife Science Center (NCCWSC); Plains and Prairie Pothole Landscape Cooperative (PPPLCC)	We thank the U.S. Geological Survey, National Climate Change and Wildlife Science Center (NCCWSC) and the Plains and Prairie Pothole Landscape Cooperative (PPPLCC) for research funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, WETLAND ECOLOGY PRIN; Beale CM, 2012, PHILOS T R SOC B, V367, P247, DOI 10.1098/rstb.2011.0178; Beaumont LJ, 2005, ECOL MODEL, V186, P250, DOI 10.1016/j.ecolmodel.2005.01.030; Beyersbergen G. W., 2004, NO PRAIRIE PARKLAND; Braunisch V, 2013, ECOGRAPHY, V36, P971, DOI 10.1111/j.1600-0587.2013.00138.x; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chen C., 2004, USING RANDOM FOREST, V110, P24; Cook Benjamin I., 2014, Climate Dynamics, V43, P2607, DOI 10.1007/s00382-014-2075-y; Coulson DP, 2009, CLIMATE SCENARIOS CO; Coulson DP, 2010, HIST CLIMATE 1940 20; Cowardin L. M., 1995, 2 US DEP INT NAT BIO; Cowardin L.M., 1979, CLASSIFICATION WETLA; Dahl T.E., 1990, WETLANDS LOSSES US 1, P13; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Elith J, 2009, ECOGRAPHY, V32, P66, DOI 10.1111/j.1600-0587.2008.05505.x; Field C.B., 2014, SPEC REP GLOB WARM 1, DOI 10.1017/cbo9780511976988.002; GIORGI F, 1991, REV GEOPHYS, V29, P191, DOI 10.1029/90RG02636; Gleason RA, 2011, ECOL APPL, V21, pS65, DOI 10.1890/09-0216.1; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hosmer DavidW., 2000, APPL LOGISTIC REGRES; JOHNSON DH, 1988, WILDLIFE MONOGR, P1; Johnson R., 1997, WETLAND RESOURCES E; Johnson RR, 2008, J SOIL WATER CONSERV, V63, p84A, DOI 10.2489/63.3.84A; Johnson WC, 2010, BIOSCIENCE, V60, P128, DOI 10.1525/bio.2010.60.2.7; Kantrud H. A., 1989, PRAIRIE BASIN WETLAN; KANTRUD HA, 1977, J WILDLIFE MANAGE, V41, P243, DOI 10.2307/3800601; Kundzewicz ZW, 2007, CONTRIBUTION WORKING, P173; LARSON DL, 1995, CLIMATIC CHANGE, V30, P169, DOI 10.1007/BF01091840; Lawler JJ, 2006, GLOBAL CHANGE BIOL, V12, P1568, DOI 10.1111/j.1365-2486.2006.01191.x; Liu CR, 2005, ECOGRAPHY, V28, P385, DOI 10.1111/j.0906-7590.2005.03957.x; MARTIN AH, 2012, NY TIMES BK REV 0415, P22; Matthews SN, 2011, ECOGRAPHY, V34, P933, DOI 10.1111/j.1600-0587.2011.06803.x; National Center Atmospheric Research Staff, 2014, CLIM DAT GUID REGR O; Niemuth ND, 2003, WATERBIRDS, V26, P233, DOI 10.1675/1524-4695(2003)026[0233:ROWTNO]2.0.CO;2; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; POIANI KA, 1991, BIOSCIENCE, V41, P611, DOI 10.2307/1311698; Prasad AM, 2006, ECOSYSTEMS, V9, P181, DOI 10.1007/s10021-005-0054-1; R Core Team, 2021, R LANGUAGE ENV STAT; SAUER JR, 2007, N AM BREEDING BIRD S; Schroeder Boris, 2000, Zeitschrift fuer Oekologie und Naturschutz, V8, P195; Skamarock W C, 2008, DESCRIPTION ADV RES, P1, DOI [DOI 10.5065/D68S4MVH, 10.5065/D68S4MVH]; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorenson LG, 1998, CLIMATIC CHANGE, V40, P343, DOI 10.1023/A:1005441608819; Stewart R.E., 1971, RES PUBLICATION, V92; Tingley MW, 2012, GLOBAL CHANGE BIOL, V18, P3279, DOI 10.1111/j.1365-2486.2012.02784.x; Weller M.W., 1965, 43 IOW STAT U AM US; Winter TC, 1998, CLIMATIC CHANGE, V40, P189, DOI 10.1023/A:1005448416571	48	27	28	1	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e96747	10.1371/journal.pone.0096747	http://dx.doi.org/10.1371/journal.pone.0096747			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927165	gold, Green Submitted, Green Published			2022-12-27	WOS:000338278100005
J	Bonardi, D; Papini, N; Pasini, M; Dileo, L; Orizio, F; Monti, E; Caimi, L; Venerando, B; Bresciani, R				Bonardi, Dario; Papini, Nadia; Pasini, Mario; Dileo, Loredana; Orizio, Flavia; Monti, Eugenio; Caimi, Luigi; Venerando, Bruno; Bresciani, Roberto			Sialidase NEU3 Dynamically Associates to Different Membrane Domains Specifically Modifying Their Ganglioside Pattern and Triggering Akt Phosphorylation	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; LIPID RAFTS; GM3 BINDING; EXPRESSION; CELLS; MICRODOMAINS; ROLES; IDENTIFICATION; CAVEOLIN; PROTEIN	Lipid rafts are known to regulate several membrane functions such as signaling, trafficking and cellular adhesion. The local enrichment in sphingolipids and cholesterol together with the low protein content allows their separation by density gradient flotation after extraction with non-ionic detergent at low temperature. These structures are also referred to as detergent resistant membranes (DRM). Among sphingolipids, gangliosides play important roles in different biological events, including signal transduction and tumorigenesis. Sialidase NEU3 shows high enzymatic specificity toward gangliosides. Moreover, the enzyme is present both at the cell surface and in endosomal structures and cofractionates with caveolin. Although changes in the expression level of NEU3 have been correlated to different tumors, little is known about the precise distribution of the protein and its ability in modifying the ganglioside composition of DRM and non-DRM, thus regulating intracellular events. By means of inducible expression cell system we found that i) newly synthesized NEU3 is initially associated to non-DRM; ii) at steady state the protein is equally distributed between the two membrane subcompartments, i. e., DRM and non-DRM; iii) NEU3 is degraded via the proteasomal pathway; iv) the enzyme specifically modifies the ganglioside composition of the membrane areas where it resides; and v) NEU3 triggers phosphorylation of Akt, even in absence of exogenously administered EGF. Taken together our data demonstrate that NEU3 regulates the DRM ganglioside content and it can be considered as a modulator of Akt phosphorylation, further supporting the role of this enzyme in cancer and tumorigenesis.	[Bonardi, Dario; Pasini, Mario; Orizio, Flavia; Monti, Eugenio; Caimi, Luigi; Bresciani, Roberto] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Papini, Nadia; Dileo, Loredana; Venerando, Bruno] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy	University of Brescia; University of Milan	Bresciani, R (corresponding author), Univ Brescia, Dept Mol & Translat Med, Brescia, Italy.	brescian@med.unibs.it	papini, nadia/M-2425-2017; Bresciani, Roberto/AAA-9728-2020	papini, nadia/0000-0003-4066-4955; Bresciani, Roberto/0000-0002-7881-7550; MONTI, Eugenio/0000-0002-4742-7445; Caimi, Luigi/0000-0002-7163-9405	"Ministero dell'Istruzione, dell'Universita e della Ricerca" (MIUR); Regione Lombardia; Network Enable Drug Discovery (NEDD) grant; Fondazione Cariplo [2010-0700]; AIRC [IG-13131]	"Ministero dell'Istruzione, dell'Universita e della Ricerca" (MIUR)(Ministry of Education, Universities and Research (MIUR)); Regione Lombardia(Regione Lombardia); Network Enable Drug Discovery (NEDD) grant; Fondazione Cariplo(Fondazione Cariplo); AIRC(Fondazione AIRC per la ricerca sul cancro)	This work was supported by "Ministero dell'Istruzione, dell'Universita e della Ricerca" (MIUR) to EM, BV, LC and RB; Regione Lombardia (http://www.regione.lombardia.it) and Network Enable Drug Discovery (NEDD) grant to EM; Fondazione Cariplo (2010-0700) and AIRC (IG-13131) to BV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Broquet AH, 2003, J BIOL CHEM, V278, P21601, DOI 10.1074/jbc.M302326200; BROWN DA, 1992, CELL, V68, P533, DOI 10.1016/0092-8674(92)90189-J; Chakrabarti O, 2011, MOL BIOL CELL, V22, P1625, DOI 10.1091/mbc.E10-07-0638; Coskun U, 2011, P NATL ACAD SCI USA, V108, P9044, DOI 10.1073/pnas.1105666108; DAMKE H, 1995, J CELL BIOL, V131, P69, DOI 10.1083/jcb.131.1.69; GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547; HANADA K, 1995, J BIOL CHEM, V270, P6254, DOI 10.1074/jbc.270.11.6254; Hanzal-Bayer MF, 2007, FEBS LETT, V581, P2098, DOI 10.1016/j.febslet.2007.03.019; Hasegawa T, 2000, J BIOL CHEM, V275, P14778; Ilangumaran S, 1998, BIOCHEM J, V335, P433, DOI 10.1042/bj3350433; Kawashima N, 2009, J BIOL CHEM, V284, P6147, DOI 10.1074/jbc.M808171200; Kurzchalia TV, 1999, CURR OPIN CELL BIOL, V11, P424, DOI 10.1016/S0955-0674(99)80061-1; Lichtenberg D, 2005, TRENDS BIOCHEM SCI, V30, P430, DOI 10.1016/j.tibs.2005.06.004; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Miyagi T, 1999, J BIOL CHEM, V274, P5004, DOI 10.1074/jbc.274.8.5004; Miyagi T, 2008, PROTEOMICS, V8, P3303, DOI 10.1002/pmic.200800248; Miyagi T, 2008, BBA-GEN SUBJECTS, V1780, P532, DOI 10.1016/j.bbagen.2007.09.016; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 2000, BIOCHEM J, V349, P343, DOI 10.1042/0264-6021:3490343; Monti E, 2010, ADV CARBOHYD CHEM BI, V64, P403, DOI 10.1016/S0065-2318(10)64007-3; Papini N, 2004, J BIOL CHEM, V279, P16989, DOI 10.1074/jbc.M400881200; Parton RG, 2006, J CELL SCI, V119, P787, DOI 10.1242/jcs.02853; Pike LJ, 2005, J BIOL CHEM, V280, P26796, DOI 10.1074/jbc.M503805200; Pilecka I, 2011, EXP CELL RES, V317, P1093, DOI 10.1016/j.yexcr.2011.02.002; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Sonnino S, 2013, CURR MED CHEM, V20, P4; Staubach S, 2011, EXPERT REV PROTEOMIC, V8, P263, DOI [10.1586/EPR.11.2, 10.1586/epr.11.2]; Wada T, 2007, ONCOGENE, V26, P2483, DOI 10.1038/sj.onc.1210341; Wada T, 1999, BIOCHEM BIOPH RES CO, V261, P21, DOI 10.1006/bbrc.1999.0973; Wang XQ, 2001, GLYCOBIOLOGY, V11, P515, DOI 10.1093/glycob/11.7.515; Wang Y, 2002, J BIOL CHEM, V277, P26252, DOI 10.1074/jbc.M110515200; Wang Y, 2001, EUR J BIOCHEM, V268, P2201, DOI 10.1046/j.1432-1327.2001.02069.x; Wickstrom SA, 2003, J BIOL CHEM, V278, P37895, DOI 10.1074/jbc.M303569200; Zanchetti G, 2007, BIOCHEM J, V408, P211, DOI 10.1042/BJ20070503	35	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99405	10.1371/journal.pone.0099405	http://dx.doi.org/10.1371/journal.pone.0099405			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925219	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300059
J	Putko, BN; Wang, ZC; Lo, J; Anderson, T; Becher, H; Dyck, JRB; Kassiri, Z; Oudit, GY				Putko, Brendan N.; Wang, Zuocheng; Lo, Jennifer; Anderson, Todd; Becher, Harald; Dyck, Jason R. B.; Kassiri, Zamaneh; Oudit, Gavin Y.		Alberta HEART Investigators	Circulating Levels of Tumor Necrosis Factor-Alpha Receptor 2 Are Increased in Heart Failure with Preserved Ejection Fraction Relative to Heart Failure with Reduced Ejection Fraction: Evidence for a Divergence in Pathophysiology	PLOS ONE			English	Article							NATRIURETIC PEPTIDE; DIASTOLIC FUNCTION; MORTALITY; ANGIOTENSIN-CONVERTING-ENZYME-2; COMORBIDITIES; DYSFUNCTION; POPULATION; PREVALENCE; BIOMARKERS; PROGNOSIS	Background: Various pathways have been implicated in the pathogenesis of heart failure (HF) with preserved ejection fraction (HFPEF). Inflammation in response to comorbid conditions, such as hypertension and diabetes, may play a proportionally larger role in HFPEF as compared to HF with reduced ejection fraction (HFREF). Methods and Results: This study investigated inflammation mediated by the tumor necrosis factor-alpha (TNF alpha) axis in community-based cohorts of HFPEF patients (n = 100), HFREF patients (n = 100) and healthy controls (n = 50). Enzyme-linked immunosorbent assays were used to investigate levels of TNF alpha, its two receptors (TNFR1 and TNFR2), and a non-TNF alpha cytokine, interleukin-6 (IL-6), in plasma derived from peripheral blood samples. Plasma levels of TNF alpha and TNFR1 were significantly elevated in HFPEF relative to controls, while levels of TNFR2 were significantly higher in HFPEF than both controls and HFREF. TNF alpha, TNFR1 and TNFR2 were each significantly associated with at least two of the following: age, estimated glomerular filtration rate, hypertension, diabetes, smoking, peripheral vascular disease or history of atrial fibrillation. TNFR2 levels were also significantly associated with increasing grade of diastolic dysfunction and severity of symptoms in HFPEF. Conclusions: Inflammation mediated through TNF alpha and its receptors, TNFR1 and TNFR2, may represent an important component of a comorbidity-induced inflammatory response that partially drives the pathophysiology of HFPEF.	[Putko, Brendan N.; Wang, Zuocheng; Lo, Jennifer; Becher, Harald; Oudit, Gavin Y.] Univ Alberta, Dept Med, Div Cardiol, Edmonton, AB, Canada; [Putko, Brendan N.; Wang, Zuocheng; Lo, Jennifer; Becher, Harald; Dyck, Jason R. B.; Kassiri, Zamaneh; Oudit, Gavin Y.] Univ Alberta, Mazankowski Alberta Heart Inst, Edmonton, AB, Canada; [Anderson, Todd] Univ Calgary, Libin Cardiovasc Inst, Calgary, AB, Canada; [Dyck, Jason R. B.] Univ Alberta, Dept Pediat, Edmonton, AB, Canada; [Kassiri, Zamaneh] Univ Alberta, Dept Physiol, Edmonton, AB, Canada	University of Alberta; University of Alberta; Libin Cardiovascular Institute Of Alberta; University of Calgary; University of Alberta; University of Alberta	Oudit, GY (corresponding author), Univ Alberta, Dept Med, Div Cardiol, Edmonton, AB, Canada.	gavin.oudit@ualberta.ca	Thompson, Richard B/E-9821-2011	Dyck, Jason/0000-0002-7045-2884	Canadian Institutes of Health Research [MOP-86602]; Alberta Innovates [201200819] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Innovates	This work was funded by the Canadian Institutes of Health Research, MOP-86602, http://www.cihr-irsc.gc.ca/e/193.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	'Alessio AD, 2012, J CELL MOL MED, V16, P627, DOI 10.1111/j.1582-4934.2011.01353.x; Ather S, 2012, J AM COLL CARDIOL, V59, P998, DOI 10.1016/j.jacc.2011.11.040; Bell JH, 2007, J LEUKOCYTE BIOL, V82, P173, DOI 10.1189/jlb.0307193; Berry C, 2012, EUR HEART J, V33, P1750, DOI 10.1093/eurheartj/ehr254; Bhatia RS, 2006, NEW ENGL J MED, V355, P260, DOI 10.1056/NEJMoa051530; Bionda C, 2006, ANN CLIN LAB SCI, V36, P299; Bursi F, 2006, JAMA-J AM MED ASSOC, V296, P2209, DOI 10.1001/jama.296.18.2209; Cesari M, 2003, CIRCULATION, V108, P2317, DOI 10.1161/01.CIR.0000097109.90783.FC; Cheng JM, 2013, EUR J HEART FAIL, V15, P1350, DOI 10.1093/eurjhf/hft106; Chung ES, 2003, CIRCULATION, V107, P3133, DOI 10.1161/01.CIR.0000077913.60364.D2; Defer N, 2007, J BIOL CHEM, V282, P35564, DOI 10.1074/jbc.M704003200; Dunlay SM, 2008, CIRCULATION, V118, P625, DOI 10.1161/CIRCULATIONAHA.107.759191; Epelman S, 2008, J AM COLL CARDIOL, V52, P750, DOI 10.1016/j.jacc.2008.02.088; Epelman S, 2009, J CARD FAIL, V15, P565, DOI 10.1016/j.cardfail.2009.01.014; Feldman AM, 2013, CIRC-HEART FAIL, V6, P461, DOI 10.1161/CIRCHEARTFAILURE.112.000185; Hamid T, 2009, CIRCULATION, V119, P1386, DOI 10.1161/CIRCULATIONAHA.108.802918; Haslam DW, 2005, LANCET, V366, P1197, DOI 10.1016/S0140-6736(05)67483-1; Haykowsky MJ, 2012, J AM COLL CARDIOL, V60, P120, DOI 10.1016/j.jacc.2012.02.055; Ho JE, 2012, J AM COLL CARDIOL, V60, P1249, DOI 10.1016/j.jacc.2012.04.053; Lambert DW, 2005, J BIOL CHEM, V280, P30113, DOI 10.1074/jbc.M505111200; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Lovren F, 2008, AM J PHYSIOL-HEART C, V295, pH1377, DOI 10.1152/ajpheart.00331.2008; Luo Y, 2010, ARTERIOSCL THROM VAS, V30, P1307, DOI 10.1161/ATVBAHA.110.204222; Marti CN, 2014, CIRC-HEART FAIL, V7, P5, DOI 10.1161/CIRCHEARTFAILURE.113.000344; Nagueh SF, 2009, J AM SOC ECHOCARDIOG, V22, P107, DOI 10.1016/j.echo.2008.11.023; Niethammer M, 2008, INT J CARDIOL, V129, P111, DOI 10.1016/j.ijcard.2007.05.061; Oh JK, 2011, CIRC-CARDIOVASC IMAG, V4, P444, DOI 10.1161/CIRCIMAGING.110.961623; Owan TE, 2006, NEW ENGL J MED, V355, P251, DOI 10.1056/NEJMoa052256; Patel VB, 2014, J MOL CELL CARDIOL, V66, P167, DOI 10.1016/j.yjmcc.2013.11.017; Paulus WJ, 2007, EUR HEART J, V28, P2539, DOI 10.1093/eurheartj/ehm037; Paulus WJ, 2013, J AM COLL CARDIOL, V62, P263, DOI 10.1016/j.jacc.2013.02.092; Putko BN, 2014, CAN J CARDIOL, V30, P264, DOI 10.1016/j.cjca.2013.12.021; RICKHAM PP, 1964, BRIT MED J, V2, P173; Romanatto T, 2009, J BIOL CHEM, V284, P36213, DOI 10.1074/jbc.M109.030874; Santhanakrishnan R, 2012, EUR J HEART FAIL, V14, P1338, DOI 10.1093/eurjhf/hfs130; Valgimigli M, 2005, CIRCULATION, V111, P863, DOI 10.1161/01.CIR.0000155614.35441.69; van Veldhuisen DJ, 2013, J AM COLL CARDIOL, V61, P1498, DOI 10.1016/j.jacc.2012.12.044; Wu CK, 2011, CRIT CARE MED, V39, P984, DOI 10.1097/CCM.0b013e31820a91b9; Yancy CW, 2013, J AM COLL CARDIOL, V62, pE147, DOI 10.1016/j.jacc.2013.05.019; Zhong JC, 2010, CIRCULATION, V122, P717, DOI 10.1161/CIRCULATIONAHA.110.955369; Zile MR, 2011, CIRCULATION, V124, P2491, DOI 10.1161/CIRCULATIONAHA.110.011031; Zile MR, 2011, CIRC-HEART FAIL, V4, P246, DOI 10.1161/CIRCHEARTFAILURE.110.958199	42	80	83	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99495	10.1371/journal.pone.0099495	http://dx.doi.org/10.1371/journal.pone.0099495			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923671	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300069
J	Samuni-Blank, M; Izhaki, I; Laviad, S; Bar-Massada, A; Gerchman, Y; Halpern, M				Samuni-Blank, Michal; Izhaki, Ido; Laviad, Sivan; Bar-Massada, Avi; Gerchman, Yoram; Halpern, Malka			The Role of Abiotic Environmental Conditions and Herbivory in Shaping Bacterial Community Composition in Floral Nectar	PLOS ONE			English	Article							MICROBIAL BIOGEOGRAPHY; REPRODUCTIVE-BIOLOGY; BETA DIVERSITY; POLLINATION; NICHES; MAINTENANCE; RICHNESS; PATTERNS; ECOLOGY	Identifying the processes that drive community assembly has long been a central theme in ecology. For microorganisms, a traditional prevailing hypothesis states that "everything is everywhere, but the environment selects". Although the bacterial community in floral nectar may be affected by both atmosphere (air-borne bacteria) and animals as dispersal vectors, the environmental and geographic factors that shape microbial communities in floral nectar are unknown. We studied culturable bacterial communities in Asphodelus aestivus floral nectar and in its typical herbivorous bug Capsodes infuscatus, along an aridity gradient. Bacteria were sampled from floral nectar and bugs at four sites, spanning a geographical range of 200 km from Mediterranean to semi-arid conditions, under open and bagged flower treatments. In agreement with the niche assembly hypothesis, the differences in bacterial community compositions were explained by differences in abiotic environmental conditions. These results suggest that microbial model systems are useful for addressing macro-ecological questions. In addition, similar bacterial communities were found in the nectar and on the surface of the bugs that were documented visiting the flowers. These similarities imply that floral nectar bacteria dispersal is shaped not only by air borne bacteria and nectar consumers as previously reported, but also by visiting vectors like the mirid bugs.	[Samuni-Blank, Michal; Izhaki, Ido; Laviad, Sivan; Halpern, Malka] Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel; [Bar-Massada, Avi; Gerchman, Yoram; Halpern, Malka] Univ Haifa, Dept Biol & Environm, Oranim, Tivon, Israel	University of Haifa; University of Haifa	Halpern, M (corresponding author), Univ Haifa, Fac Nat Sci, Dept Evolutionary & Environm Biol, IL-31999 Haifa, Israel.	mhalpern@research.haifa.ac.il	Izhaki, Ido/I-9712-2019; Gerchman, Yoram/H-4698-2019; Gerchman, Yoram/F-5226-2015; Halpern, Malka/AAH-1498-2019	Izhaki, Ido/0000-0002-4525-4683; Gerchman, Yoram/0000-0002-8637-9589; Halpern, Malka/0000-0002-3407-2198; Laviad-Shitrit, Sivan/0000-0002-0911-3453	Israel Science Foundation (ISF) [189/08, 1094/12]	Israel Science Foundation (ISF)(Israel Science Foundation)	This study was supported by grants from the Israel Science Foundation (ISF, grants no. 189/08 and 1094/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler LS, 2000, OIKOS, V91, P409, DOI 10.1034/j.1600-0706.2000.910301.x; Aizenberg-Gershtein Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067556; Alvarez-Perez S, 2013, FEMS MICROBIOL ECOL, V83, P685, DOI 10.1111/1574-6941.12027; Alvarez-Perez S, 2012, FEMS MICROBIOL ECOL, V80, P591, DOI 10.1111/j.1574-6941.2012.01329.x; AYAL Y, 1993, OECOLOGIA, V93, P518, DOI 10.1007/BF00328960; AYAL Y, 1994, ECOL ENTOMOL, V19, P207, DOI 10.1111/j.1365-2311.1994.tb00411.x; Baas-Becking L.G.M., 1934, GEOBIOLOGIE INLEIDIN, P263; BERNARDELLO L, 1994, BOT J LINN SOC, V114, P293, DOI 10.1006/bojl.1994.1019; Chanbusarakum L, 2008, J INVERTEBR PATHOL, V99, P318, DOI 10.1016/j.jip.2008.09.001; Chase JM, 2011, PHILOS T R SOC B, V366, P2351, DOI 10.1098/rstb.2011.0063; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clements F.E., 1916, PLANT SUCCESSION ANA; Colwell RK, 2004, ESTIMATES STAT ESTIM; de Vega C, 2009, S AFR J BOT, V75, P798, DOI 10.1016/j.sajb.2009.07.016; Emerson BC, 2008, TRENDS ECOL EVOL, V23, P619, DOI 10.1016/j.tree.2008.07.005; Ferrier S, 2007, DIVERS DISTRIB, V13, P252, DOI 10.1111/j.1472-4642.2007.00341.x; Forcone A, 1997, BIOCHEM SYST ECOL, V25, P395, DOI 10.1016/S0305-1978(97)00030-6; Fridman S, 2012, ENV MICROBIOL REP, V4, P97, DOI 10.1111/j.1758-2229.2011.00309.x; Fuhrman JA, 2009, NATURE, V459, P193, DOI 10.1038/nature08058; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Gomes NCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014065; Gonzalez-Teuber M, 2009, PLANT SIGNAL BEHAV, V4, P809, DOI 10.4161/psb.4.9.9393; Gotelli N, 2013, ENCY BIODIVERSITY, V5; Green JL, 2008, SCIENCE, V320, P1039, DOI 10.1126/science.1153475; Halpern M, 2013, INT J SYST EVOL MICR, V63, P4259, DOI 10.1099/ijs.0.052217-0; Hantsis-Zacharov E, 2007, APPL ENVIRON MICROB, V73, P7162, DOI 10.1128/AEM.00866-07; Heil M, 2011, TRENDS PLANT SCI, V16, P191, DOI 10.1016/j.tplants.2011.01.003; Herrera CM, 2010, P ROY SOC B-BIOL SCI, V277, P747, DOI 10.1098/rspb.2009.1485; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1991, B MATH BIOL, V53, P193, DOI 10.1007/BF02464429; Jacquemyn H, 2013, MICROBIOLOGYOPEN, V2, P644, DOI 10.1002/mbo3.103; Jacquemyn H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056917; Jessup CM, 2004, TRENDS ECOL EVOL, V19, P189, DOI 10.1016/j.tree.2004.01.008; Kim OS, 2012, INT J SYST EVOL MICR, V62, P716, DOI 10.1099/ijs.0.038075-0; Laliberte E, 2009, OECOLOGIA, V159, P377, DOI 10.1007/s00442-008-1214-8; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Levine JM, 2009, NATURE, V461, P254, DOI 10.1038/nature08251; Lifante ZD, 1996, PLANT SYST EVOL, V200, P177, DOI 10.1007/BF00984934; Logue Jurg Brendan, 2008, Freshwater Reviews, V1, P99, DOI 10.1608/FRJ-1.1.9; MAC ARTHUR ROBERT H., 1967; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Miambi E, 2003, INT J FOOD MICROBIOL, V82, P111, DOI 10.1016/S0168-1605(02)00256-8; Mitchell RJ, 2004, ECOLOGY, V85, P1527, DOI 10.1890/03-0388; Moran NA, 2006, CURR BIOL, V16, pR866, DOI 10.1016/j.cub.2006.09.019; Ollerton J., 2012, Journal of Pollination Ecology, V9, P85; Pozo MI, 2011, MICROB ECOL, V61, P82, DOI 10.1007/s00248-010-9682-x; Samocha Y, 2010, ARTHROPOD-PLANT INTE, V4, P153, DOI 10.1007/s11829-010-9091-6; SANDHU DK, 1985, MICROB ECOL, V11, P51, DOI 10.1007/BF02015108; SCHUSTER A, 1993, NEW PHYTOL, V123, P165; Senderovich Y, 2008, ISME J, V2, P276, DOI 10.1038/ismej.2007.114; Senderovich Y, 2013, ISME J, V7, P2147, DOI 10.1038/ismej.2013.100; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Team R, 2012, R LANG ENV STAT COMP; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Vamosi SM, 2009, MOL ECOL, V18, P572, DOI 10.1111/j.1365-294X.2008.04001.x; Vannette RL, 2013, P ROYAL SOC B, V280; Waser NM., 2006, PLANT POLLINATOR INT; Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578	59	32	33	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99107	10.1371/journal.pone.0099107	http://dx.doi.org/10.1371/journal.pone.0099107			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922317	Green Submitted, Green Published, gold			2022-12-27	WOS:000338701300029
J	Boning, D; Littschwager, A; Hutler, M; Beneke, R; Staab, D				Boening, Dieter; Littschwager, Angela; Huetler, Matthias; Beneke, Ralph; Staab, Doris			Hemoglobin Oxygen Affinity in Patients with Cystic Fibrosis	PLOS ONE			English	Article							HIGH-ALTITUDE HYPOXIA; RED-BLOOD-CELLS; DISSOCIATION CURVE; NITRIC-OXIDE; IN-VIVO; UNTRAINED SUBJECTS; LUNG-DISEASE; TRANSPORT; BOHR; GLUTATHIONE	In patients with cystic fibrosis lung damages cause arterial hypoxia. As a typical compensatory reaction one might expect changes in oxygen affinity of hemoglobin. Therefore position (standard half saturation pressure P(50)st) and slope (Hill's n) of the O-2 dissociation curve as well as the Bohr coefficients (BC) for CO2 and lactic acid were determined in blood of 14 adult patients (8 males, 6 females) and 14 healthy controls (6 males, 8 females). While Hill's n amounted to approximately 2.6 in all subjects, P50st was slightly increased by 1mmHg in both patient groups (controls male 26.7 +/- 0.2, controls female 27.0 +/- 0.1, patients male 27.7 +/- 0.5, patients female 28.0 +/- 0.3 mmHg; mean and standard error, overall p<0.01). Main cause was a rise of 1-2 mu mol/g hemoglobin in erythrocytic 2,3-biphosphoglycerate concentration. One patient only, clearly identified as an outlier and with the mutation G551D, showed a reduction of both P(50)st (24.5 mmHg) and [2,3-biphosphoglycerate] (9.8 mu mol/g hemoglobin). There were no differences in BCCO2, but small sex differences in the BC for lactic acid in the controls which were not detectable in the patients. Causes for the right shift of the O-2 dissociation curve might be hypoxic stimulation of erythrocytic glycolysis and an increased red cell turnover both causing increased [2,3-biphosphoglycerate]. However, for situations with additional hypercapnia as observed in exercising patients a left shift seems to be a more favourable adaptation in cystic fibrosis. Additionally when in vivo PO2 values were corrected to the standard conditions they mostly lay left of the in vitro O-2 dissociation curve in both patients and controls. This hints to unknown fugitive factors influencing oxygen affinity.	[Boening, Dieter; Littschwager, Angela; Huetler, Matthias; Beneke, Ralph] Charite, Inst Sportmed, D-13353 Berlin, Germany; [Staab, Doris] Charite, Klin Padiat Pneumol & Immunol, D-13353 Berlin, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Boning, D (corresponding author), Charite, Inst Sportmed, D-13353 Berlin, Germany.	dieter.boening@charite.de	Böning, Dieter/AAM-7720-2020	Boning, Dieter/0000-0001-7090-592X	Christiane Herzog Stiftung fur Mukoviszidose-Kranke	Christiane Herzog Stiftung fur Mukoviszidose-Kranke	Funding provided by the following Foundation: Christiane Herzog Stiftung fur Mukoviszidose-Kranke, http://www.christianeherzogstiftung.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTURSON G, 1971, ACTA ANAESTH SCAND, P39; Balaban DY, 2013, RESP PHYSIOL NEUROBI, V186, P45, DOI 10.1016/j.resp.2012.12.011; Barrett PM, 2012, HUM MOL GENET, V21, pR66, DOI 10.1093/hmg/dds345; Baumann R, 1987, COMPR PHYSIOL, P147; Beall CM, 2002, P NATL ACAD SCI USA, V99, P17215, DOI 10.1073/pnas.252649199; Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Ben Rayana MC, 2008, CLIN CHEM LAB MED, V46, P21, DOI 10.1515/CCLM.2008.001; BERGHOUT AGRV, 1984, PEDIATR RES, V18, P1017; Boning D, 2008, EUR J APPL PHYSIOL, V103, P127, DOI 10.1007/s00421-008-0675-0; Boning D, 2007, EUR J APPL PHYSIOL, V99, P163, DOI 10.1007/s00421-006-0328-0; Boning D, 2013, RESP PHYSIOL NEUROBI, V188, P79, DOI 10.1016/j.resp.2013.05.008; BONING D, 1978, RESP PHYSIOL, V34, P195, DOI 10.1016/0034-5687(78)90028-2; BONING D, 1975, EUR J APPL PHYSIOL O, V34, P1, DOI 10.1007/BF00999910; BONING D, 1987, BLUT, V54, P361, DOI 10.1007/BF00626019; BONING D, 1976, EUR J APPL PHYSIOL O, V35, P243, DOI 10.1007/BF00423283; Boning D, 2001, INT J SPORTS MED, V22, P572, DOI 10.1055/s-2001-18530; BONING D, 1993, J APPL PHYSIOL, V74, P710, DOI 10.1152/jappl.1993.74.2.710; BRAUMANN KM, 1979, EUR J APPL PHYSIOL, V42, P51, DOI 10.1007/BF00421104; BRAUMANN KM, 1982, J APPL PHYSIOL, V52, P1524, DOI 10.1152/jappl.1982.52.6.1524; Campbell KL, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-214; CHRISTIANSEN TF, 1981, P IFCC EXP PAN PH BL, P77; Christoforou Elena, 2005, J Cyst Fibros, V4, P151, DOI 10.1016/j.jcf.2005.05.013; Cohen TS, 2012, NAT MED, V18, P509, DOI 10.1038/nm.2715; CRAESCU CT, 1986, J BIOL CHEM, V261, P4710; Cristancho E, 2007, HIGH ALT MED BIOL, V8, P296, DOI 10.1089/ham.2007.8406; Derichs N, 2013, EUR RESPIR REV, V22, P58, DOI 10.1183/09059180.00008412; Diem K, 1969, WISSENSCHAFTLICHE TA; Duranton C, 2012, AM J PATHOL, V181, P1367, DOI 10.1016/j.ajpath.2012.06.017; Erzurum SC, 2007, P NATL ACAD SCI USA, V104, P17593, DOI 10.1073/pnas.0707462104; Fischer R, 2007, PEDIATR PULM, V42, P1193, DOI 10.1002/ppul.20717; GARBY L, 1972, ACTA PHYSIOL SCAND, V84, P482, DOI 10.1111/j.1748-1716.1972.tb05198.x; Gladwin MT, 1999, J CLIN INVEST, V104, P937, DOI 10.1172/JCI7637; Head CA, 1997, J CLIN INVEST, V100, P1193, DOI 10.1172/JCI119631; Hrinczenko BW, 2000, BRIT J HAEMATOL, V110, P412, DOI 10.1046/j.1365-2141.2000.02203.x; HUCKAUF H, 1976, B EUR PHYSIOPATH RES, V12, P129; Hudson VM, 2001, FREE RADICAL BIO MED, V30, P1440, DOI 10.1016/S0891-5849(01)00530-5; Hughes JMB, 1996, EUR RESPIR J, V9, P184, DOI 10.1183/09031936.96.09020184; HUMPELER E, 1977, PFLUG ARCH EUR J PHY, V372, P287, DOI 10.1007/BF01063866; HUMPELER E, 1973, PFLUG ARCH EUR J PHY, V343, P151, DOI 10.1007/BF00585710; Hutler M, 2000, CLIN CHIM ACTA, V301, P213, DOI 10.1016/S0009-8981(00)00349-1; JURGENS KD, 1988, J COMP PHYSIOL B, V158, P469, DOI 10.1007/BF00691144; Mairbaurl H, 2012, COMPR PHYSIOL, V2, P1463, DOI 10.1002/cphy.c080113; Makhro A, 2013, AM J PHYSIOL-CELL PH, V305, pC1123, DOI 10.1152/ajpcell.00031.2013; MEIER U, 1974, PFLUG ARCH EUR J PHY, V349, P203, DOI 10.1007/BF00592448; Morgan T J, 1999, Crit Care Resusc, V1, P93; MORPURGO G, 1976, P NATL ACAD SCI USA, V73, P747, DOI 10.1073/pnas.73.3.747; MORPURGO G, 1970, NATURE, V227, P387, DOI 10.1038/227387a0; MORSE M, 1950, J CLIN INVEST, V29, P1091, DOI 10.1172/JCI102341; O'connor T M, 2002, J Cyst Fibros, V1, P31, DOI 10.1016/S1569-1993(01)00004-2; ORZALESI MM, 1973, AM REV RESPIR DIS, V107, P928; QUANJER PH, 1993, EUR RESPIR J, V6, P85, DOI 10.1183/09041950.085s1693; RASMUSSEN B, 1975, J APPL PHYSIOL, V38, P250, DOI 10.1152/jappl.1975.38.2.250; ROLLEMA HS, 1975, J BIOL CHEM, V250, P1333; ROSENTHAL A, 1977, PEDIATRICS, V59, P588; ROSENTHAL A, 1977, PEDIATRICS, V59, P919; Samaja M, 2003, EUR J APPL PHYSIOL, V90, P351, DOI 10.1007/s00421-003-0954-8; Schillers H, 2008, PFLUG ARCH EUR J PHY, V456, P163, DOI 10.1007/s00424-007-0399-8; SCHMIDT W, 1990, INT J SPORTS MED, V11, P15, DOI 10.1055/s-2007-1024755; SCHMIDT W, 1987, RESP PHYSIOL, V68, P215, DOI 10.1016/S0034-5687(87)80007-5; SMITH JE, 1976, AM J VET RES, V37, P1135; SPROULE BJ, 1960, J CLIN INVEST, V39, P378, DOI 10.1172/JCI104048; Storz JF, 2008, HIGH ALT MED BIOL, V9, P148, DOI 10.1089/ham.2007.1079; Uhle MJ, 2004, THESIS UNIVERSITATSM; VICHINSKY EP, 1984, J PEDIATR-US, V105, P15, DOI 10.1016/S0022-3476(84)80349-2; von Pickardt B, 2003, THESIS FREIE U BERLI; WAGENER JS, 1983, AM J PEDIAT HEMATOL, V5, P153; Watts KD, 2011, PEDIATR PULM, V46, P683, DOI 10.1002/ppul.21428; Weber RE, 2007, RESP PHYSIOL NEUROBI, V158, P132, DOI 10.1016/j.resp.2007.05.001; West JB., 2007, HIGH ALTITUDE MED PH; Winslow RM, 2007, RESP PHYSIOL NEUROBI, V158, P121, DOI 10.1016/j.resp.2007.03.011; Zielenski J, 2000, RESPIRATION, V67, P117, DOI 10.1159/000029497	71	10	10	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e97932	10.1371/journal.pone.0097932	http://dx.doi.org/10.1371/journal.pone.0097932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919182	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000010
J	Chen, P; Hu, H; Chen, Z; Cai, XX; Zhang, Z; Yang, Y; Yu, N; Zhang, J; Xia, L; Ge, J; Yu, KM; Zhuang, J				Chen, Pei; Hu, Huan; Chen, Zhao; Cai, Xiaoxiao; Zhang, Zhang; Yang, Ying; Yu, Na; Zhang, Jing; Xia, Lei; Ge, Jian; Yu, Keming; Zhuang, Jing			BRCA1 Silencing Is Associated with Failure of DNA Repairing in Retinal Neurocytes	PLOS ONE			English	Article							BASE EXCISION-REPAIR; DOUBLE-STRAND BREAKS; END-JOINING ACTIVITY; NEURAL STEM-CELLS; DAMAGE RESPONSE; GENOMIC STABILITY; RGC-5 CELLS; RAT-BRAIN; MAINTENANCE; DEFICIENCY	Retinal post-mitotic neurocytes display genomic instability after damage induced by physiological or pathological factors. The involvement of BRCA1, an important factor in development and DNA repair in mature retinal neurocytes remains unclear. Thus, we investigated the developmental expression profile of BRCA1 in the retina and defined the role of BRCA1 in DNA repair in retinal neurocytes. Our data show the expression of BRCA1 is developmentally down-regulated in the retinas of mice after birth. Similarly, BRCA1 is down-regulated after differentiation induced by TSA in retinal precursor cells. An end-joining activity assay and DNA fragmentation analysis indicated that the DNA repair capacity is significantly reduced. Moreover, DNA damage in differentiated cells or cells in which BRCA1 is silenced by siRNA interference is more extensive than that in precursor cells subjected to ionizing radiation. To further investigate non-homologous end joining (NHEJ), the major repair pathway in non-divided neurons, we utilized an NHEJ substrate (pEPI-NHEJ) in which double strand breaks are generated by I-SceI. Our data showed that differentiation and the down-regulation of BRCA1 respectively result in a 2.39-fold and 1.68-fold reduction in the total NHEJ frequency compared with that in cells with normal BRCA1. Furthermore, the analysis of NHEJ repair junctions of the plasmid substrate indicated that BRCA1 is involved in the fidelity of NHEJ. In addition, as expected, the down-regulation of BRCA1 significantly inhibits the viability of retina precursor cells. Therefore, our data suggest that BRCA1 plays a critical role in retinal development and repairs DNA damage of mature retina neurocytes.	[Chen, Pei; Hu, Huan; Chen, Zhao; Cai, Xiaoxiao; Zhang, Zhang; Yang, Ying; Yu, Na; Zhang, Jing; Xia, Lei; Ge, Jian; Yu, Keming; Zhuang, Jing] Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Zhuang, J (corresponding author), Sun Yat Sen Univ, State Key Lab Ophthalmol, Zhongshan Ophthalm Ctr, Guangzhou 510275, Guangdong, Peoples R China.	zhuangj@mail.sysu.edu.cn			National Natural Science Foundation [30970923, 81170850]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC))	All the studies were funded by the grants from the National Natural Science Foundation (Project: 30970923, 81170850). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barzilai A, 2008, DNA REPAIR, V7, P1010, DOI 10.1016/j.dnarep.2008.03.005; Bromberg KD, 2008, SCIENCE, V320, P903, DOI 10.1126/science.1152662; dit Huart LM, 2004, MOL CELL NEUROSCI, V26, P441, DOI 10.1016/j.mcn.2004.04.002; Evans Teresa A, 2007, Int J Med Sci, V4, P140; Gowen LC, 1996, NAT GENET, V12, P191, DOI 10.1038/ng0296-191; Gudmundsdottir K, 2006, ONCOGENE, V25, P5864, DOI 10.1038/sj.onc.1209874; Jenke ACW, 2004, P NATL ACAD SCI USA, V101, P11322, DOI 10.1073/pnas.0401355101; Jeppesen DK, 2011, PROG NEUROBIOL, V94, P166, DOI 10.1016/j.pneurobio.2011.04.013; Jiang GC, 2013, J BIOL CHEM, V288, P8966, DOI 10.1074/jbc.M112.412650; Kondo T, 2004, GENE DEV, V18, P2963, DOI 10.1101/gad.309404; Korhonen L, 2003, J NEUROSCI RES, V71, P769, DOI 10.1002/jnr.10546; Li J, 2011, BIOCHEM BIOPH RES CO, V410, P40, DOI 10.1016/j.bbrc.2011.05.101; Lundin C, 2002, MOL CELL BIOL, V22, P5869, DOI 10.1128/MCB.22.16.5869-5878.2002; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Meulle A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003345; Moynahan ME, 1999, MOL CELL, V4, P511, DOI 10.1016/S1097-2765(00)80202-6; Oka A, 2000, NEUROSCI LETT, V292, P167, DOI 10.1016/S0304-3940(00)01462-2; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Ren KQ, 2002, J NEUROCHEM, V80, P949, DOI 10.1046/j.0022-3042.2002.00776.x; Saha T, 2010, J BIOL CHEM, V285, P19092, DOI 10.1074/jbc.M110.104430; Schneider L, 2012, CELL DEATH DIFFER, V19, P582, DOI 10.1038/cdd.2011.129; Schulte-Uentrop L, 2008, NUCLEIC ACIDS RES, V36, P2561, DOI 10.1093/nar/gkn094; Scully R, 1997, CELL, V88, P265, DOI 10.1016/S0092-8674(00)81847-4; Sharma S, 2007, BRAIN RES BULL, V73, P48, DOI 10.1016/j.brainresbull.2007.02.001; Swain U, 2011, MECH AGEING DEV, V132, P374, DOI 10.1016/j.mad.2011.04.012; Szaflik JP, 2009, MUTAT RES-FUND MOL M, V669, P169, DOI 10.1016/j.mrfmmm.2009.06.008; Tilgner K, 2013, CELL DEATH DIFFER, V20, P1089, DOI 10.1038/cdd.2013.44; Van Bergen NJ, 2009, INVEST OPHTH VIS SCI, V50, P4267, DOI 10.1167/iovs.09-3484; Wang SP, 2008, STROKE, V39, P2587, DOI 10.1161/STROKEAHA.107.509158; Wang SW, 2001, GENE DEV, V15, P24, DOI 10.1101/gad.855301; Wang Y, 2000, GENE DEV, V14, P927; West SC, 2003, NAT REV MOL CELL BIO, V4, P435, DOI 10.1038/nrm1127; Weterings E, 2004, DNA REPAIR, V3, P1425, DOI 10.1016/j.dnarep.2004.06.003; Willers H, 2006, RADIAT RES, V166, P567, DOI 10.1667/RR0524.1; Wood JPM, 2010, INVEST OPHTH VIS SCI, V51, P3774, DOI 10.1167/iovs.09-4305; Xu B, 2001, MOL CELL BIOL, V21, P3445, DOI 10.1128/MCB.21.10.3445-3450.2001; Xu G, 2008, MECH AGEING DEV, V129, P366, DOI 10.1016/j.mad.2008.03.001; Yoshida K, 2004, CANCER SCI, V95, P866, DOI 10.1111/j.1349-7006.2004.tb02195.x; YOUNG RW, 1985, DEV BRAIN RES, V21, P229, DOI 10.1016/0165-3806(85)90211-1; Zhong Q, 2002, CANCER RES, V62, P3966; Zhong Q, 1999, SCIENCE, V285, P747, DOI 10.1126/science.285.5428.747; Zhuang J, 2006, CANCER RES, V66, P1401, DOI 10.1158/0008-5472.CAN-05-3278; Zhuang J, 2010, NEUROREPORT, V21, P282, DOI 10.1097/WNR.0b013e328336ee7e; Zhuang J, 2009, J BIOL CHEM, V284, P30565, DOI 10.1074/jbc.M109.059444; Zhuang J, 2009, BIOCHEM BIOPH RES CO, V380, P650, DOI 10.1016/j.bbrc.2009.01.162	47	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99371	10.1371/journal.pone.0099371	http://dx.doi.org/10.1371/journal.pone.0099371			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919198	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000082
J	Abraham, V; Ouskova, V; Kunes, P				Abraham, Vojtech; Ouskova, Veronika; Kunes, Petr			Present-Day Vegetation Helps Quantifying Past Land Cover in Selected Regions of the Czech Republic	PLOS ONE			English	Article							RELEVANT SOURCE AREA; POLLEN PRODUCTIVITY; QUANTITATIVE RECONSTRUCTION; HOLOCENE VEGETATION; CULTURAL LANDSCAPE; PLANT ABUNDANCE; CENTRAL-EUROPE; REVEALS-MODEL; KOTLINA BASIN; FOREST	The REVEALS model is a tool for recalculating pollen data into vegetation abundances on a regional scale. We explored the general effect of selected parameters by performing simulations and ascertained the best model setting for the Czech Republic using the shallowest samples from 120 fossil sites and data on actual regional vegetation (60 km radius). Vegetation proportions of 17 taxa were obtained by combining the CORINE Land Cover map with forest inventories, agricultural statistics and habitat mapping data. Our simulation shows that changing the site radius for all taxa substantially affects REVEALS estimates of taxa with heavy or light pollen grains. Decreasing the site radius has a similar effect as increasing the wind speed parameter. However, adjusting the site radius to 1 m for local taxa only (even taxa with light pollen) yields lower, more correct estimates despite their high pollen signal. Increasing the background radius does not affect the estimates significantly. Our comparison of estimates with actual vegetation in seven regions shows that the most accurate relative pollen productivity estimates (PPEs) come from Central Europe and Southern Sweden. The initial simulation and pollen data yielded unrealistic estimates for Abies under the default setting of the wind speed parameter (3 m/s). We therefore propose the setting of 4 m/s, which corresponds to the spring average in most regions of the Czech Republic studied. Ad hoc adjustment of PPEs with this setting improves the match 3-4-fold. We consider these values (apart from four exceptions) to be appropriate, because they are within the ranges of standard errors, so they are related to original PPEs. Setting a 1 m radius for local taxa (Alnus, Salix, Poaceae) significantly improves the match between estimates and actual vegetation. However, further adjustments to PPEs exceed the ranges of original values, so their relevance is uncertain.	[Abraham, Vojtech; Kunes, Petr] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Abraham, Vojtech] Univ South Bohemia, Fac Sci, Dept Bot, Ceske Budejovice, Czech Republic; [Ouskova, Veronika] Nat Conservat Agcy Czech Republ, Prague, Czech Republic; [Kunes, Petr] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic	Charles University Prague; University of South Bohemia Ceske Budejovice; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences	Abraham, V (corresponding author), Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic.	vojtech.abraham@gmail.com	Abraham, Vojtěch/E-6784-2016; Kuneš, Petr/C-7099-2008	Abraham, Vojtěch/0000-0001-6738-0392; Kuneš, Petr/0000-0001-9605-8204	Czech Science Foundation (GACR) [P504/12/0649, 13-11193S]; European Research Council under the European Union [278065]	Czech Science Foundation (GACR)(Grant Agency of the Czech Republic); European Research Council under the European Union(European Research Council (ERC))	The work was supported by projects No. P504/12/0649 and 13-11193S from Czech Science Foundation (GACR) http://www.gacr.cz/ and by institutional resources of MSMT. PK has received funding from the European Research Council under the European Union's Seventh Framework Programme (FP7/2007-2013)/ERC Grant agreement No. 278065 http://erc.europa.eu/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham V, 2006, PRIROZENA VEGETACE J; Abraham V, 2008, BIOARCHEOLOGIE CESKE, P443; Abraham V, 2012, REV PALAEOBOT PALYNO, V179, P1, DOI 10.1016/j.revpalbo.2012.04.004; ANDERSEN S T, 1974, Grana, V14, P57, DOI 10.1080/00173137409429894; Behre K.E., 1981, POLLEN SPORES, V23, P225; Boublik Karel, 2007, Tuexenia, P73; Brizova E, 1999, ACTA PALAEOBOT S, V2, P549; Brizova E, 2009, B GEOSCI, V84, P637, DOI 10.3140/bull.geosci.1140; Brostrom A, 2004, HOLOCENE, V14, P368, DOI 10.1191/0959683604hl713rp; Brostrom A, 2008, VEG HIST ARCHAEOBOT, V17, P461, DOI 10.1007/s00334-008-0148-8; Chaloupkova K, 1995, PYLOVA ANAL ADRSPASS; Chytry M, 2001, KATALOG BIOTOPU; Chytry M., 2007, VEGETACE CESKE REPUB; Chytry M., 2009, VEGETACE CESKE REPUB; Chytry M., 2013, VEGETACE CESKE REPUB; Chytry M, 2012, PRESLIA, V84, P427; Czech Hydrometeorological Institute, 2005, CLIMATE ATLAS CZECHI; DreslerovuY D., 2004, ANCIENT LANDSCAPE SE, P121; Engel Z, 2010, QUATERNARY SCI REV, V29, P913, DOI 10.1016/j.quascirev.2009.12.008; European Enviromental Agency, 2012, CORINE LAND COVER 20; Feranec J., 2000, INT J APPL EARTH OBS, V2, P129, DOI DOI 10.1016/S0303-2434(00)85006-0; Filippov P, 2008, PRIRUCKA HODNOCENI B; Forest management institute, 2007, AGG INF FORST INV SL; Fredh D, 2013, BIOGEOSCIENCES, V10, P3159, DOI 10.5194/bg-10-3159-2013; Fyfe RM, 2013, QUATERNARY SCI REV, V73, P132, DOI 10.1016/j.quascirev.2013.05.014; Gaillard MJ, 2010, CLIM PAST, V6, P483, DOI 10.5194/cp-6-483-2010; Hartel H, 2008, MAPOVANI BIOTOPU CES; Hellman S, 2008, J QUATERNARY SCI, V23, P21, DOI 10.1002/jqs.1126; Hellman SEV, 2008, VEG HIST ARCHAEOBOT, V17, P445, DOI 10.1007/s00334-008-0149-7; Hjelle KL, 2012, HOLOCENE, V22, P313, DOI 10.1177/0959683611423690; JACOBSON GL, 1981, QUATERNARY RES, V16, P80, DOI 10.1016/0033-5894(81)90129-0; JANKOVSKA V, 1987, FOLIA GEOBOT PHYTOTX, V22, P199, DOI 10.1007/BF02853194; JANKOVSKA V, 1990, FOLIA GEOBOT PHYTOTX, V25, P1; JANKOVSKA V, 1992, FOLIA GEOBOT PHYTOTX, V27, P137, DOI 10.1007/BF02856245; Jankovska V, 1980, PALAOGEOBOTANISHE RE; Jankovska V, 1996, FLOODPLAIN ECOLOGY M, P53; Jankovska V, 1971, FOLIA GEOBOT PHYTOTX, V6, P281, DOI 10.1007/BF02851832; Kozakova R, 2014, VEG HIST ARCHAEOBOTA; Kunes P., 2000, GEOLINES, V11, P112; Kunes P, 2011, J BIOGEOGR, V38, P2150, DOI 10.1111/j.1365-2699.2011.02557.x; Kunes P, 2009, PRESLIA, V81, P209; Marquer L, 2014, QUATERNARY SCI REV, V90, P199, DOI 10.1016/j.quascirev.2014.02.013; Matthias I, 2012, VEG HIST ARCHAEOBOT, V21, P471, DOI 10.1007/s00334-012-0373-z; Mazier F, 2012, REV PALAEOBOT PALYNO, V187, P38, DOI 10.1016/j.revpalbo.2012.07.017; Mazier F, 2008, VEG HIST ARCHAEOBOT, V17, P479, DOI 10.1007/s00334-008-0143-0; Nielsen AB, 2004, J BIOGEOGR, V31, P1693, DOI 10.1111/j.1365-2699.2004.01080.x; Nielsen AB, 2012, QUATERNARY SCI REV, V47, P131, DOI 10.1016/j.quascirev.2012.05.011; Overballe-Petersen MV, 2013, J VEG SCI, V24, P755, DOI 10.1111/jvs.12007; PARSONS RW, 1981, REV PALAEOBOT PALYNO, V32, P127, DOI 10.1016/0034-6667(81)90001-4; Peichlova M, 1979, HIST VEGETACE BROUMO; Pesa V, 2012, SPUREN GERMANEN, P128; Petr L, 2013, FOLIA GEOBOT; Petr L, 2008, BIOARCHEOLOGIE CESKE, P73; Pokorny P., 2005, FERRANTIA, V44, P101; Pokorny P, 2009, GRANA, V48, P77, DOI 10.1080/00173130902759816; Poska A, 2011, REV PALAEOBOT PALYNO, V167, P30, DOI 10.1016/j.revpalbo.2011.07.001; Poska A, 2010, VEG HIST ARCHAEOBOT, V19, P91, DOI 10.1007/s00334-009-0230-x; Prentice C., 1988, VEGETATION HIST, P17, DOI [10.1007/978-94-009-3081-0_2, DOI 10.1007/978-94-009-3081-0_2]; PRENTICE IC, 1983, BIOMETRICS, V39, P1051, DOI 10.2307/2531338; PRENTICE IC, 1985, QUATERNARY RES, V23, P76, DOI 10.1016/0033-5894(85)90073-0; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Reitalu T, 2013, J BIOGEOGR, V40, P1524, DOI 10.1111/jbi.12092; RYBNICEK K, 1968, Folia Geobotanica and Phytotaxonomica, V3, P117; RYBNICEK K, 1983, HYDROBIOLOGIA, V103, P247; Rybnicek K, 2008, VEG HIST ARCHAEOBOT, V17, P701, DOI 10.1007/s00334-008-0160-z; RYBNICKOVA E, 1985, FOLIA GEOBOT PHYTOTX, V20, P419, DOI 10.1007/BF02853288; RYBNICKOVA E, 1975, Folia Geobotanica and Phytotaxonomica, V10, P157; RYBNICKOVA E, 1988, FOLIA GEOBOT PHYTOTX, V23, P285, DOI 10.1007/BF02854824; Rybnickova E, 1975, PFAFFENSCHLAG, P183; RybnuikovuY E., 1974, ENTWICKLUNG VEGETATI; Skrzypek G, 2009, REV PALAEOBOT PALYNO, V156, P507, DOI 10.1016/j.revpalbo.2009.04.014; Soepboer W, 2007, HOLOCENE, V17, P65, DOI 10.1177/0959683607073279; Soepboer W, 2010, QUATERNARY SCI REV, V29, P472, DOI 10.1016/j.quascirev.2009.09.027; Speranza A, 2000, HOLOCENE, V10, P575, DOI 10.1191/095968300668946885; Speranza A, 2000, QUATERNARY SCI REV, V19, P1589, DOI 10.1016/S0277-3791(99)00108-0; Speranza A, 2000, SOLAR ANTHR FORCING; Stalling H, 1987, UNTERSUNCHUNGEN SPAT; Strandberg G, 2013, CLIM PAST DISCUSS, V9, P5785, DOI [10.5194/cpd-9-5785-2013, DOI 10.5194/CPD-9-5785-2013]; Sugita S, 1999, HOLOCENE, V9, P409, DOI 10.1191/095968399666429937; SUGITA S, 1994, J ECOL, V82, P881, DOI 10.2307/2261452; Sugita S, 2007, HOLOCENE, V17, P229, DOI 10.1177/0959683607075837; Sugita S, 2007, HOLOCENE, V17, P243, DOI 10.1177/0959683607075838; Sugita S, 2010, QUATERNARY RES, V74, P289, DOI 10.1016/j.yqres.2010.07.008; Svobodova H, 2002, QUATERN INT, V91, P123, DOI 10.1016/S1040-6182(01)00106-9; Svobodova H., 1997, Verhandlungen der Zoologisch-Botanischen Gesellschaft in Osterreich, V134, P317; Svobodova H, 2001, VEG HIST ARCHAEOBOT, V10, P185, DOI 10.1007/PL00006930; Svobodova H, 1991, VYVOJ VEGETACE JIZNI; Svobodova H, 2004, OPERA CORCONTICA, V41, P124; Svobodova H, 2002, OPERA CORCONTICA, V39, P5; Svobodova H, 1989, PAMATKY ARCHEOL, V80, P188	90	24	24	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100117	10.1371/journal.pone.0100117	http://dx.doi.org/10.1371/journal.pone.0100117			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936973	Green Submitted, gold, Green Published			2022-12-27	WOS:000338503400077
J	Tsubokura, M; Kato, S; Nomura, S; Gilmour, S; Nihei, M; Sakuma, Y; Oikawa, T; Kanazawa, Y; Kami, M; Hayano, R				Tsubokura, Masaharu; Kato, Shigeaki; Nomura, Shuhei; Gilmour, Stuart; Nihei, Masahiko; Sakuma, Yu; Oikawa, Tomoyoshi; Kanazawa, Yukio; Kami, Masahiro; Hayano, Ryugo			Reduction of High Levels of Internal Radio-Contamination by Dietary Intervention in Residents of Areas Affected by the Fukushima Daiichi Nuclear Plant Disaster: A Case Series	PLOS ONE			English	Article							CHERNOBYL ACCIDENT; EXPOSURE; CS-137; RADIOCESIUM; INGESTION; CHILDREN; UKRAINE; ADULTS; OBLAST	Maintaining low levels of chronic internal contamination among residents in radiation-contaminated areas after a nuclear disaster is a great public health concern. However, the efficacy of reduction measures for individual internal contamination remains unknown. To reduce high levels of internal radiation exposure in a group of individuals exposed through environmental sources, we performed careful dietary intervention with identification of suspected contaminated foods, as part of mass voluntary radiation contamination screenings and counseling program in Minamisoma Municipal General Hospital and Hirata Central Hospital. From a total of 30,622 study participants, only 9 residents displayed internal cesium-137 (Cs-137) levels of more than 50 Bq/kg. The median level of internal Cs-137 contamination in these residents at the initial screening was 4,830 Bq/body (range: 2,130-15,918 Bq/body) and 69.6 Bq/kg (range: 50.7-216.3 Bq/kg). All these residents with high levels of internal contamination consumed homegrown produce without radiation inspection, and often collected mushrooms in the wild or cultivated them on bed-logs in their homes. They were advised to consume distributed food mainly and to refrain from consuming potentially contaminated foods without radiation inspection and local produces under shipment restrictions such as mushrooms, mountain vegetables, and meat of wild life. A few months after the intervention, re-examination of Cs levels revealed remarkable reduction of internal contamination in all residents. Although the levels of internal radiation exposure appear to be minimal amongst most residents in Fukushima, a subset of the population, who unknowingly consumed highly contaminated foodstuffs, experienced high levels of internal contamination. There seem to be similarities in dietary preferences amongst residents with high internal contamination levels, and intervention based on pre-and post-test counseling and dietary advice from medical care providers about risky food intake appears to be a feasible option for changing residents' dietary practices, subsequently resulting in a reduction in Cs internal contamination levels.	[Tsubokura, Masaharu; Kami, Masahiro] Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, Tokyo, Japan; [Kato, Shigeaki] Soma Cent Hosp, Dept Radiat Protect, Soma, Fukushima, Japan; [Nomura, Shuhei] Univ London Imperial Coll Sci Technol & Med, Sch Publ Hlth, Dept Epidemiol & Biostat, London, England; [Gilmour, Stuart] Univ Tokyo, Grad Sch Med, Dept Global Hlth Policy, Bunkyo Ku, Tokyo, Japan; [Nihei, Masahiko; Sakuma, Yu] Hirata Cent Hosp, Hirata Radioact Inspect Ctr, Hirata, Fukushima, Japan; [Oikawa, Tomoyoshi; Kanazawa, Yukio] Minamisoma Municipal Gen Hosp, Dept Radiat Protect, Fukushima, Japan; [Hayano, Ryugo] Univ Tokyo, Dept Phys, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; Imperial College London; University of Tokyo; University of Tokyo	Tsubokura, M (corresponding author), Univ Tokyo, Inst Med Sci, Div Social Commun Syst Adv Clin Res, Minato Ku, Tokyo, Japan.	tsubokura-tky@umin.ac.jp	Nomura, Shuhei/HCH-5356-2022; Tsubokura, Masaharu/AAV-4364-2021; Hayano, Ryugo/F-7889-2012; Tsubokura, Masaharu/D-7300-2017	Tsubokura, Masaharu/0000-0001-8027-202X; Hayano, Ryugo/0000-0002-1214-7806; Tsubokura, Masaharu/0000-0001-8027-202X; Nomura, Shuhei/0000-0002-2963-7297				Balonov MI, 2007, RADIAT PROT DOSIM, V127, P491, DOI 10.1093/rpd/ncm301; Fukushima prefecture, 2013, RES INTERNAL RAD EXP; Hamada N, 2012, J RADIAT RES, V53, P641, DOI 10.1093/jrr/rrs032; Hayano RS, 2013, P JPN ACAD B-PHYS, V89, P157, DOI 10.2183/pjab.89.157; Hoshi M, 2000, HEALTH PHYS, V79, P182, DOI 10.1097/00004032-200008000-00011; International Commission on Radiological Protection, 2009, ICRP PUBL, V110 39; Ishikawa K, 2012, J AM GERIATR SOC, V60, P2357, DOI 10.1111/jgs.12012; Kramer GH, 2005, HEALTH PHYS, V88, P350, DOI 10.1097/01.HP.0000152106.93202.05; Likhtarev IA, 1996, HEALTH PHYS, V70, P297, DOI 10.1097/00004032-199603000-00001; Likhtarev IA, 2000, HEALTH PHYS, V79, P341, DOI 10.1097/00004032-200010000-00002; Ministry of Agriculture Forestry and Fisheries, 2012, QUEST ANSW RIC MEAT; Nagataki S, 2013, RAD RES; Nomura S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060192; Preston DL, 2007, RADIAT RES, V168, P1, DOI 10.1667/RR0763.1; Ruhm W, 1999, HEALTH PHYS, V77, P373, DOI 10.1097/00004032-199910000-00004; Sato O, 2013, J RADIOL PROT, V33, P823, DOI 10.1088/0952-4746/33/4/823; Sugimoto A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065331; Tonnessen A, 2002, J TRAUMA STRESS, V15, P453, DOI 10.1023/A:1020961604434; Tsubokura M, 2013, JAMA PEDIAT; Tsubokura M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081909; Tsubokura M, 2012, JAMA-J AM MED ASSOC, V308, P669, DOI 10.1001/jama.2012.9839; Yasutaka T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075308	22	42	44	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100302	10.1371/journal.pone.0100302	http://dx.doi.org/10.1371/journal.pone.0100302			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932486	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600107
J	Zhang, YH; Shao, L; Xu, YX; Cui, YG; Liu, JY; Chian, RC				Zhang, Yihui; Shao, Li; Xu, Yixin; Cui, Yigui; Liu, Jiayin; Chian, Ri-Cheng			Effect of Anti-Mullerian Hormone in Culture Medium on Quality of Mouse Oocytes Matured In Vitro	PLOS ONE			English	Article							RIBONUCLEIC-ACID EXPRESSION; INHIBITING SUBSTANCE; FOLLICULAR-FLUID; OVARIAN-FOLLICLES; SECRETED FACTORS; RAT OVARY; MATURATION; RECEPTOR; GROWTH; PREDICTORS	Anti-mullerian hormone (AMH) is thought to reflect the growth of follicles and the ovarian function. However, the role of AMH in culture medium during in vitro maturation (IVM) on oocyte quality and subsequent development potential is unclear. The objective of this study is to investigate the effect of recombinant human AMH (rh-AMH) supplemented into IVM medium on oocyte quality. Cumulus-oocyte complexes (COCs) were obtained from ICR mice and cultured in vitro with the different concentrations (0-1,000 ng/ml) of rh-AMH. Following 16-18 h of culture, quantitative PCR and ELISA were performed to analyze GDF9 and BMP15 mRNA expression and protein production from the oocytes. Subsequently, in vitro fertilization (IVF) and early embryonic development were employed to further evaluate the quality of in vitro matured oocytes. The results showed that AMH was only expressed in cumulus cells but not in the oocytes. However, AMH most specific receptor, AMHR-II, was expressed in both oocytes and cumulus cells. The levels of GDF9 and BMP15 expression and blastocyst formation rate were significantly increased (p<0.05) when the IVM medium was supplemented with 100 ng/ml of rh-AMH. With AdH1-SiRNA/AMH for knocking down of AMH expression during IVM significantly reduced (p<0.05) the levels of GDF9 and BMP15 expression and blastocysts formation rate. These results suggest that AHM improves oocytes quality by up-regulating GDF9 and BMP15 expressions during IVM.	[Zhang, Yihui; Shao, Li; Xu, Yixin; Cui, Yigui; Liu, Jiayin; Chian, Ri-Cheng] Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China; [Chian, Ri-Cheng] McGill Univ, Dept Obstet & Gynecol, Div Res, Montreal, PQ H3A 2T5, Canada	Nanjing Medical University; McGill University	Liu, JY (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China.	jyliu_nj@126.com; ri-cheng.chian@mcgill.ca			Natural Sciences Foundation of China [NSFC81270746]	Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by a grant from Natural Sciences Foundation of China, No. NSFC81270746 to Ri-Cheng Chian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckaert E, 2013, HUM REPROD UPDATE, V19, P52, DOI 10.1093/humupd/dms042; Andersen CY, 2006, J CLIN ENDOCR METAB, V91, P4064, DOI 10.1210/jc.2006-1066; BAARENDS WM, 1995, ENDOCRINOLOGY, V136, P4951, DOI 10.1210/en.136.11.4951; BEZARD J, 1987, J REPROD FERTIL, V80, P509, DOI 10.1530/jrf.0.0800509; Carlsson IB, 2006, HUM REPROD, V21, P2223, DOI 10.1093/humrep/del165; Chian RC, 2013, FERTIL STERIL, V99, P1173, DOI 10.1016/j.fertnstert.2013.01.141; Das M, 2008, HUM REPROD, V23, P2122, DOI 10.1093/humrep/den185; di Clemente N, 2010, MOL ENDOCRINOL, V24, P2193, DOI 10.1210/me.2010-0273; DICLEMENTE N, 1994, MOL ENDOCRINOL, V8, P1006, DOI 10.1210/me.8.8.1006; Dunning KR, 2012, BIOL REPROD, V87, DOI 10.1095/biolreprod.111.096271; Durlinger ALL, 2002, ENDOCRINOLOGY, V143, P1076, DOI 10.1210/en.143.3.1076; Durlinger ALL, 1999, ENDOCRINOLOGY, V140, P5789, DOI 10.1210/en.140.12.5789; Durlinger ALL, 2002, REPRODUCTION, V124, P601, DOI 10.1530/reprod/124.5.601; Fanchin R, 2007, J CLIN ENDOCR METAB, V92, P1796, DOI 10.1210/jc.2006-1053; Ficicioglu C, 2006, FERTIL STERIL, V85, P592, DOI 10.1016/j.fertnstert.2005.09.019; Fortune JE, 2003, ANIM REPROD SCI, V78, P135, DOI 10.1016/S0378-4320(03)00088-5; Gilchrist RB, 2008, HUM REPROD UPDATE, V14, P159, DOI 10.1093/humupd/dmm040; Gilchrist RB, 2011, REPROD FERT DEVELOP, V23, P23, DOI 10.1071/RD10225; Hattori Y, 2013, EUR J OBSTET GYN R B, V169, P252, DOI 10.1016/j.ejogrb.2013.03.021; He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509; HIROBE S, 1992, ENDOCRINOLOGY, V131, P854, DOI 10.1210/en.131.2.854; HIROBE S, 1994, BIOL REPROD, V50, P1238, DOI 10.1095/biolreprod50.6.1238; Hussein TS, 2006, DEV BIOL, V296, P514, DOI 10.1016/j.ydbio.2006.06.026; Hutt KJ, 2007, REPROD BIOMED ONLINE, V14, P758, DOI 10.1016/S1472-6483(10)60679-7; Josso Nathalie, 2006, Pediatr Endocrinol Rev, V3, P347; Juengel JL, 2004, ANIM REPROD SCI, V82-3, P447, DOI 10.1016/j.anireprosci.2004.04.021; Juengel JL, 2005, HUM REPROD UPDATE, V11, P144, DOI 10.1093/humupd/dmh061; Kevenaar ME, 2006, ENDOCRINOLOGY, V147, P3228, DOI 10.1210/en.2005-1588; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; La Marca A, 2010, HUM REPROD UPDATE, V16, P113, DOI 10.1093/humupd/dmp036; Li HWR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061095; MacLaughlin DT, 2002, ADV EXP MED BIOL, V511, P25; Mehta Bindu N, 2013, J Hum Reprod Sci, V6, P99, DOI 10.4103/0974-1208.117168; Nelson SM, 2007, HUM REPROD, V22, P2414, DOI 10.1093/humrep/dem204; Nilsson E, 2007, REPRODUCTION, V134, P209, DOI 10.1530/REP-07-0119; Nilsson EE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020087; Park JH, 2011, REPROD SCI, V18, P334, DOI 10.1177/1933719110388294; Patrelli TS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044571; Qiao J, 2011, HUM REPROD UPDATE, V17, P17, DOI 10.1093/humupd/dmq032; Sedes L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081551; Shen CX, 2003, FEBS LETT, V539, P111, DOI 10.1016/S0014-5793(03)00209-6; Silberstein T, 2006, HUM REPROD, V21, P159, DOI 10.1093/humrep/dei270; Smitz JEJ, 2011, SEMIN REPROD MED, V29, P24, DOI 10.1055/s-0030-1268701; Takahashi C, 2008, FERTIL STERIL, V89, P586, DOI 10.1016/j.fertnstert.2007.03.080; TAKAHASHI M, 1986, MOL CELL ENDOCRINOL, V47, P225, DOI 10.1016/0303-7207(86)90116-4; Trounson A, 2001, REPRODUCTION, V121, P51, DOI 10.1530/rep.0.1210051; TSAFRIRI A, 1988, BIOL REPROD, V38, P481, DOI 10.1095/biolreprod38.2.481; UENO S, 1989, ENDOCRINOLOGY, V125, P1060, DOI 10.1210/endo-125-2-1060; UENO S, 1989, ENDOCRINOLOGY, V124, P1000, DOI 10.1210/endo-124-2-1000; Veiga-Lopez A, 2012, FERTIL STERIL, V97, P748, DOI 10.1016/j.fertnstert.2011.12.028; Visser JA, 2006, REPRODUCTION, V131, P1, DOI 10.1530/rep.1.00529; Visser JA, 2005, MOL CELL ENDOCRINOL, V234, P81, DOI 10.1016/j.mce.2004.09.008; Wilson T, 2001, BIOL REPROD, V64, P1225, DOI 10.1095/biolreprod64.4.1225; Wunder DM, 2008, FERTIL STERIL, V90, P2203, DOI 10.1016/j.fertnstert.2007.10.078; Yan CN, 2001, MOL ENDOCRINOL, V15, P854, DOI 10.1210/me.15.6.854	55	17	20	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99393	10.1371/journal.pone.0099393	http://dx.doi.org/10.1371/journal.pone.0099393			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932501	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600031
J	Arts, MR; Baron, M; Chokr, N; Fritzler, MJ; Servant, MJ				Arts, Monique R.; Baron, Murray; Chokr, Nidaa; Fritzler, Marvin J.; Servant, Marc J.		CSRG	Systemic Sclerosis Immunoglobulin Induces Growth and a Pro-Fibrotic State in Vascular Smooth Muscle Cells through the Epidermal Growth Factor Receptor	PLOS ONE			English	Article							PULMONARY ARTERIAL-HYPERTENSION; RNA-POLYMERASE-III; ANGIOTENSIN-II; STIMULATORY AUTOANTIBODIES; PDGF RECEPTOR; FACTOR-BETA; ACTIVATION; PHOSPHORYLATION; TRANSACTIVATION; EXPRESSION	Objective: It has been suggested that autoantibodies in systemic sclerosis (SSc) may induce the differentiation of cultured fibroblasts into myofibroblasts through platelet-derived growth factor receptor (PDGFR) activation. The present study aims to characterize the effects of SSc IgG on vascular smooth muscle cells (VSMCs) and to determine if stimulatory autoantibodies directed to the PDGFR can be detected, and whether they induce a profibrotic response in primary cultured VSMCs. Methods: Cultured VSMCs were exposed to IgG fractions purified from SSc-patient or control sera. VSMC responses were then analyzed for ERK1/2 and Akt phosphorylation, PDGFR immunoprecipitation, cellular proliferation, protein synthesis, and pro-fibrotic changes in mRNA expression. Results: Stimulatory activity in IgG fractions was more prevalent and intense in the SSc samples. SSc IgG immunoprecipitated the PDGFR with greater avidity than control IgG. Interestingly, activation of downstream signaling events (e.g. Akt, ERK1/2) was independent of PDGFR activity, but required functional EGFR. We also detected increased protein synthesis in response to SSc IgG (p<0.001) and pro-fibrotic changes in gene expression (Tgfb1 + 200%; Tgfb2-23%; p<0.001)) in VSMCs treated with SSc IgG. Conclusion: When compared to control IgG, SSc IgG have a higher stimulation index in VSMCs. Although SSc IgG interact with the PDGFR, the observed remodeling signaling events occur through the EGFR in VSMC. Our data thus favour a model of transactivation of the EGFR by SSc-derived PDGFR autoantibodies and suggest the use of EGFR inhibitors in future target identification studies in the field of SSc.	[Arts, Monique R.; Chokr, Nidaa; Servant, Marc J.] Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada; [Arts, Monique R.; Baron, Murray] McGill Univ, Jewish Gen Hosp, Montreal, PQ H3T 1E2, Canada; [Fritzler, Marvin J.] Univ Calgary, Dept Med, Calgary, AB, Canada	Universite de Montreal; McGill University; University of Calgary	Servant, MJ (corresponding author), Univ Montreal, Fac Pharm, Montreal, PQ H3C 3J7, Canada.	marc.servant@umontreal.ca	Pope, Janet/G-3342-2011; Baron, Murray/AAF-9486-2019	Pope, Janet/0000-0003-1479-5302; 	Canadian Institutes of Health Research (CIHR) [MOP 53282]; Canada Research Chair in Signaling Networks in Inflammation; CIHR Strategic Training Initiative in Health Research grant [SKI 83345]; Arthritis Society Research Chair; CIHR [FRN 83518]; Scleroderma Society of Canada; Scleroderma Society of Ontario; Sclerodermie Quebec; Cure Scleroderma Foundation; INOVA Diagnostics Inc (San Diego, CA); Dr. Fooke Laboratorien GmbH (Neuss, Germany); Euroimmun (Lubeck, Germany); Mikrogen GmbH; Fonds de la recherche en sante du Quebec (FRSQ); Canadian Arthritis Network (CAN); Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC; Pfizer; Actelion pharmaceuticals	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Canada Research Chair in Signaling Networks in Inflammation; CIHR Strategic Training Initiative in Health Research grant(Canadian Institutes of Health Research (CIHR)); Arthritis Society Research Chair; CIHR(Canadian Institutes of Health Research (CIHR)); Scleroderma Society of Canada; Scleroderma Society of Ontario; Sclerodermie Quebec; Cure Scleroderma Foundation; INOVA Diagnostics Inc (San Diego, CA); Dr. Fooke Laboratorien GmbH (Neuss, Germany); Euroimmun (Lubeck, Germany); Mikrogen GmbH; Fonds de la recherche en sante du Quebec (FRSQ)(Fonds de la Recherche en Sante du Quebec); Canadian Arthritis Network (CAN); Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC; Pfizer(Pfizer); Actelion pharmaceuticals	MJS holds Canadian Institutes of Health Research (CIHR) Grant MOP 53282 and a Canada Research Chair in Signaling Networks in Inflammation. MRA and NC received Canadian Scleroderma Research Group (CSRG) Studentship awards, which are funded by a CIHR Strategic Training Initiative in Health Research grant (SKI 83345). MJF holds the Arthritis Society Research Chair. The CSRG is funded by the CIHR (FRN 83518), the Scleroderma Society of Canada and its provincial Chapters, Scleroderma Society of Ontario, Sclerodermie Quebec, Cure Scleroderma Foundation, INOVA Diagnostics Inc. (San Diego, CA), Dr. Fooke Laboratorien GmbH (Neuss, Germany), Euroimmun (Lubeck, Germany), Mikrogen GmbH (Neuried, Cover Letter 2 Germany), Fonds de la recherche en sante du Quebec (FRSQ), the Canadian Arthritis Network (CAN), and the Lady Davis Institute of Medical Research of the Jewish General Hospital, Montreal, QC. The CSRG has also received eductional grants from Pfizer and Actelion pharmaceuticals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1980, ARTHRITIS RHEUM, V23, P581, DOI 10.1002/art.1780230510; Balada E, 2008, ANN RHEUM DIS, V67, P1027, DOI 10.1136/ard.2007.085480; Baroni SS, 2006, NEW ENGL J MED, V354, P2667; Black PC, 2011, J UROLOGY, V185, P693, DOI 10.1016/j.juro.2010.09.082; Bokemeyer D, 2000, KIDNEY INT, V58, P549, DOI 10.1046/j.1523-1755.2000.t01-1-00201.x; BORDER WA, 1994, NEW ENGL J MED, V331, P1286; Bussone G, 2012, ANN RHEUM DIS, V71, P596, DOI 10.1136/annrheumdis-2011-200195; Chan SY, 2008, J MOL CELL CARDIOL, V44, P14, DOI 10.1016/j.yjmcc.2007.09.006; Classen JF, 2009, ARTHRITIS RHEUM-US, V60, P1137, DOI 10.1002/art.24381; COUNTAWAY JL, 1989, J BIOL CHEM, V264, P13642; Daoussis D, 2011, INT J RHEUMATOL, V2011, DOI 10.1155/2011/214013; DECKER SJ, 1989, J BIOL CHEM, V264, P9204; Demoulin J-B, 2014, CYTOKINE GROWTH FACT; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; Douillette A, 2006, J BIOL CHEM, V281, P13275, DOI 10.1074/jbc.M512815200; Doyon P, 2010, J BIOL CHEM, V285, P30708, DOI 10.1074/jbc.M110.126433; Duprez DA, 2006, J HYPERTENS, V24, P983, DOI 10.1097/01.hjh.0000226182.60321.69; Eguchi S, 1998, J BIOL CHEM, V273, P8890, DOI 10.1074/jbc.273.15.8890; Furst DE, 1998, J RHEUMATOL, V25, P84; Gingras AC, 1998, GENE DEV, V12, P502, DOI 10.1101/gad.12.4.502; Graves Lee M, 2002, Mol Interv, V2, P208, DOI 10.1124/mi.2.4.208; Gschwind A, 2001, ONCOGENE, V20, P1594, DOI 10.1038/sj.onc.1204192; Hsu VM, 2008, J RHEUMATOL, V35, P458; Khimdas S, 2011, ARTHRIT CARE RES, V63, P142, DOI 10.1002/acr.20336; KOVALENKO M, 1994, CANCER RES, V54, P6106; Kurasawa K, 2010, MOD RHEUMATOL, V20, P458, DOI 10.1007/s10165-010-0310-x; Kuwana M, 2005, ARTHRITIS RHEUM-US, V52, P2425, DOI 10.1002/art.21232; Lambova S, 2010, AUTOIMMUN REV, V9, P761, DOI 10.1016/j.autrev.2010.06.006; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loizos N, 2009, ARTHRITIS RHEUM-US, V60, P1145, DOI 10.1002/art.24365; Lurje G, 2009, ONCOLOGY-BASEL, V77, P400, DOI 10.1159/000279388; Matchkov VV, 2012, BASIC CLIN PHARMACOL, V110, P42, DOI 10.1111/j.1742-7843.2011.00818.x; Medsger TA, 2003, CLIN EXP RHEUMATOL, V21, pS42; Moinzadeh P, 2013, J EXPT PHARM, V2013, P15; Mouthon L, 2012, NAT REV RHEUMATOL, V8, P72, DOI 10.1038/nrrheum.2011.203; Mukerjee D, 2004, RHEUMATOLOGY, V43, P461, DOI 10.1093/rheumatology/keh067; Overbeek MJ, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3315; Pardanani A, 2004, BLOOD, V104, P1931, DOI 10.1182/blood-2004-01-0246; Planque S, 2003, FASEB J, V17, P136, DOI 10.1096/fj.01-0847com; Pope J, 2011, ARTHRITIS RHEUM-US, V63, P3547, DOI 10.1002/art.30549; Prelog M, 2005, ARTHRITIS RHEUM-US, V52, P1804, DOI 10.1002/art.21109; Prey S, 2012, BRIT J DERMATOL, V167, P1138, DOI 10.1111/j.1365-2133.2012.11186.x; Riemekasten G, 2011, ANN RHEUM DIS, V70, P530, DOI 10.1136/ard.2010.135772; Saito Y, 2001, MOL CELL BIOL, V21, P6387, DOI 10.1128/MCB.21.19.6387-6394.2001; Saito Y, 2001, J MOL CELL CARDIOL, V33, P3, DOI 10.1006/jmcc.2000.1272; Santiago M, 2007, J RHEUMATOL, V34, P1528; Servant MJ, 2000, J CELL BIOL, V148, P543, DOI 10.1083/jcb.148.3.543; Shiojima I, 2002, CIRC RES, V90, P1243, DOI 10.1161/01.RES.0000022200.71892.9F; Skhirtladze C, 2008, ARTHRITIS RHEUM, V58, P1475, DOI 10.1002/art.23436; Svegliati S, 2007, BLOOD, V110, P237, DOI 10.1182/blood-2007-01-071043; Tinhofer I, 1996, J BIOL CHEM, V271, P30505, DOI 10.1074/jbc.271.48.30505; Tse KF, 2001, LEUKEMIA, V15, P1001, DOI 10.1038/sj.leu.2402199; Ushio-Fukai M, 1999, J BIOL CHEM, V274, P22699, DOI 10.1074/jbc.274.32.22699; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; WALKER F, 1991, J BIOL CHEM, V266, P2746; Zhan YM, 2003, ARTERIOSCL THROM VAS, V23, P795, DOI 10.1161/01.ATV.0000066132.32063.F2	57	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100035	10.1371/journal.pone.0100035	http://dx.doi.org/10.1371/journal.pone.0100035			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927197	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100109
J	Reyes-Hernandez, OD; Vega, L; Jimenez-Rios, MA; Martinez-Cervera, PF; Lugo-Garcia, JA; Hernandez-Cadena, L; Ostrosky-Wegman, P; Orozco, L; Elizondo, G				Reyes-Hernandez, Octavio D.; Vega, Libia; Jimenez-Rios, Miguel A.; Martinez-Cervera, Pedro F.; Lugo-Garcia, Juan A.; Hernandez-Cadena, Leticia; Ostrosky-Wegman, Patricia; Orozco, Lorena; Elizondo, Guillermo			The PXR rs7643645 Polymorphism Is Associated with the Risk of Higher Prostate-Specific Antigen Levels in Prostate Cancer Patients	PLOS ONE			English	Article							PREGNANE-X-RECEPTOR; GENETIC VARIANT; CLINICAL PRESENTATION; XENOBIOTIC RECEPTOR; ACID-PHOSPHATASE; PROMOTER VARIANT; AFRICAN-AMERICAN; CYP3A4; EXPRESSION; CYTOCHROME-P-450	Levels of enzymes that determine testosterone catabolism such as CYP3A4 have been associated with prostate cancer (PCa) risk. Although some studies have related CYP3A4*1B allele, a gene polymorphism that modifies CYP3A4 expression level, with PCa risk, others have failed, suggesting that additional genetic variants may be involved. Expression of CYP3A4 is largely due to the activation of Pregnane X Receptor (PXR). Particularly, rs2472677 and rs7643645 PXR polymorphisms modify CYP3A4 expression levels. To evaluate whether PXR-HNF3 beta/T (rs2472677), PXR-HNF4/G (rs7643645), and CYP3A4*1B (rs2740574) polymorphisms are associated with PCa a case control-study was performed. The multiple testing analysis showed that the PXR-HNF4/G polymorphism was associated with higher levels of prostate-specific antigen (PSA) in patients with PCa (OR = 3.99, p = 0.03). This association was stronger in patients diagnosed at the age of 65 years or older (OR = 10.8, p = 0.006). Although the CYP3A4*1B/*1B genotype was overrepresented in PCa patients, no differences were observed in the frequency of this and PXR-HNF3 beta/T alleles between controls and cases. Moreover, no significant association was found between these polymorphisms and PSA, Gleason grade, or tumor lymph node metastasis.	[Reyes-Hernandez, Octavio D.; Lugo-Garcia, Juan A.] Hosp Juarez Mexico, Lab Genet & Diagnost Mol, Mexico City, DF, Mexico; [Vega, Libia] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Toxicol, Mexico City, DF, Mexico; [Jimenez-Rios, Miguel A.; Martinez-Cervera, Pedro F.] Inst Nacl Cancerol, Dept Urol, Mexico City, DF, Mexico; [Hernandez-Cadena, Leticia] Inst Nacl Salud Publ, Dept Salud Ambiental, Mexico City, DF, Mexico; [Ostrosky-Wegman, Patricia] Univ Nacl Autonoma Mexico, Inst Invest Biomed, Mexico City 04510, DF, Mexico; [Orozco, Lorena] Inst Nacl Med Genom, Lab Inmunogenom & Enfermedades Metab, Mexico City, DF, Mexico; [Elizondo, Guillermo] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Mexico City, DF, Mexico	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico; Instituto Nacional de Cancerologia (INCAN); Instituto Nacional de Salud Publica; Universidad Nacional Autonoma de Mexico; Instituto Nacional de Medicina Genomica; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Instituto Politecnico Nacional - Mexico	Elizondo, G (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Mexico City, DF, Mexico.	gazuela@cinvestav.mx		Vega, Libia/0000-0002-4993-5267; Orozco, Lorena/0000-0002-5801-9180; ostrosky-wegman, patricia/0000-0002-8564-3472; Hernandez Cadena, Leticia/0000-0003-3807-2758	CONACyT [13756]	CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This work was supported by CONACyT (www.conacyt.gob.mx) grant number 13756. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amirimani B, 2003, ENVIRON MOL MUTAGEN, V42, P299, DOI 10.1002/em.10199; Balk Steven P, 2008, Nucl Recept Signal, V6, pe001, DOI 10.1621/nrs.06001; Ball SE, 1999, CLIN PHARMACOL THER, V66, P288, DOI 10.1016/S0009-9236(99)70037-8; Bostwick DG, 2004, CANCER-AM CANCER SOC, V101, P2371, DOI 10.1002/cncr.20408; BRIAN WR, 1990, BIOCHEMISTRY-US, V29, P11280, DOI 10.1021/bi00503a018; Fujimura T, 2012, CANCER SCI, V103, P176, DOI 10.1111/j.1349-7006.2011.02143.x; Fujimura T, 2009, UROLOGY, V74, P391, DOI 10.1016/j.urology.2009.02.033; Gray MA, 2013, J STEROID BIOCHEM, V133, P110, DOI 10.1016/j.jsbmb.2012.09.025; Hsing AW, 2008, CANCER EPIDEM BIOMAR, V17, P2525, DOI 10.1158/1055-9965.EPI-08-0448; Hsing AW, 2006, FRONT BIOSCI-LANDMRK, V11, P1388, DOI 10.2741/1891; Hsing AW, 1996, J NATL CANCER I, V88, P1093, DOI 10.1093/jnci/88.16.1093; Hustert E, 2001, DRUG METAB DISPOS, V29, P1454; Johnson JL, 2005, BIOCHEM J, V391, P699, DOI 10.1042/BJ20050380; Kittles RA, 2002, HUM GENET, V110, P553, DOI 10.1007/s00439-002-0731-5; Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9; Konno Y, 2009, MOL PHARMACOL, V75, P265, DOI 10.1124/mol.108.051904; Kraft P, 2009, NAT REV GENET, V10, P264, DOI 10.1038/nrg2516; Kuehl P, 2001, NAT GENET, V27, P383, DOI 10.1038/86882; Lamba J, 2008, DRUG METAB DISPOS, V36, P169, DOI 10.1124/dmd.107.016600; Lamba JK, 2002, PHARMACOGENETICS, V12, P121, DOI 10.1097/00008571-200203000-00006; LIN MF, 1993, ARCH BIOCHEM BIOPHYS, V300, P384, DOI 10.1006/abbi.1993.1052; Ozdemir V, 2000, PHARMACOGENETICS, V10, P373, DOI 10.1097/00008571-200007000-00001; Paris PL, 1999, CANCER EPIDEM BIOMAR, V8, P901; Rebbeck TR, 1998, J NATL CANCER I, V90, P1225, DOI 10.1093/jnci/90.16.1225; SCHRODER FH, 1992, PROSTATE, P129; SHIMADA T, 1994, J PHARMACOL EXP THER, V270, P414; Spurdle AB, 2002, PHARMACOGENETICS, V12, P355, DOI 10.1097/00008571-200207000-00003; SUNDIN M, 1987, J BIOL CHEM, V262, P12293; Taioli E, 2013, PROSTATE, V73, P668, DOI 10.1002/pros.22612; Tayeb MT, 2002, ONCOL REP, V9, P653; THUMMEL KE, 1994, J PHARMACOL EXP THER, V271, P557; Wandel C, 2000, CLIN PHARMACOL THER, V68, P82, DOI 10.1067/mcp.2000.108506; WAXMAN DJ, 1988, ARCH BIOCHEM BIOPHYS, V263, P424, DOI 10.1016/0003-9861(88)90655-8; Webber MM, 1995, CLIN CANCER RES, V1, P1089; YOUNG CYF, 1991, CANCER RES, V51, P3748; Zanger UM, 2013, PHARMACOL THERAPEUT, V138, P103, DOI 10.1016/j.pharmthera.2012.12.007; Zeigler-Johnson CM, 2002, HUM HERED, V54, P13, DOI 10.1159/000066695	37	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99974	10.1371/journal.pone.0099974	http://dx.doi.org/10.1371/journal.pone.0099974			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924803	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300115
J	Rostami, SM; Benet, T; Spears, J; Reynolds, A; Satyaraj, E; Sprenger, N; Austin, S				Rostami, Shirin Macias; Benet, Thierry; Spears, Julie; Reynolds, Arleigh; Satyaraj, Ebenezer; Sprenger, Norbert; Austin, Sean			Milk Oligosaccharides over Time of Lactation from Different Dog Breeds	PLOS ONE			English	Article							SIALIC-ACID UTILIZATION; CHEMICAL-CHARACTERIZATION; HUMAN COLOSTRUM; LACTOSE; BEAR; NUTRIENT; GLYCANS	The partnership of humans and dogs goes back to over 10'000 years, yet relatively little is known about a dog's first extrauterine nutrition particularly when it comes to milk oligosaccharides. We set out to identify and quantify milk oligosaccharides over the course of lactation from different dog breeds (Labrador retriever, Schnauzer and 3 Alaskan husky crossbreeds). To this end, 2 different chromatographic methods with fluorescence and mass spectrometry detection were developed and one was validated for quantification. Besides lactose and lactose-sulphate, we identified 2 different trisaccharides composed of 3 hexose units, 3'sialyllactose (3'SL), 6'sialyllactose (6'SL), 2'fucosyllactose (2'FL), and a tetrasaccharide composed of 2 hexoses, an N-acetylhexosamine and a deoxyhexose. 3'SL was present at the highest levels in milk of all dog breeds starting at around 7.5 g/L and dropping to about 1.5 g/L in the first 10 days of lactation. 6'SL was about 10 times less abundant and 2'FL and the tetrasaccharide had rather varying levels in the milk of the different breeds with the tetrasaccharide only detectable in the Alaskan husky crossbreeds. The longitudinal and quantitative data of milk oligosaccharides from different dog breeds are an important basis to further our understanding on their specific biological roles and also on the specific nutritional requirements of lactating puppies.	[Rostami, Shirin Macias; Benet, Thierry; Sprenger, Norbert; Austin, Sean] Nestec Ltd, Nestle Res Ctr, Lausanne, Switzerland; [Spears, Julie; Reynolds, Arleigh; Satyaraj, Ebenezer] Nestec Ltd, Nestle Purina Res, St Louis, MO USA	Nestle SA; Nestle SA	Sprenger, N (corresponding author), Nestec Ltd, Nestle Res Ctr, Lausanne, Switzerland.	Norbert.Sprenger@rdls.nestle.com; Sean.Austin@rdls.nestle.com			Nestec S.A.	Nestec S.A.	The study was financed by Nestec S.A. and all authors were employees of Nestec S. A., when the study was conducted. The funder/employer had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adkins Y, 2001, AM J VET RES, V62, P1266, DOI 10.2460/ajvr.2001.62.1266; Albrecht S, 2011, CARBOHYD RES, V346, P2173, DOI 10.1016/j.carres.2011.06.034; Asakuma S, 2008, EUR J CLIN NUTR, V62, P488, DOI 10.1038/sj.ejcn.1602738; Asakuma S, 2007, BIOSCI BIOTECH BIOCH, V71, P1447, DOI 10.1271/bbb.60529; Austin S, 2014, INT J ANAL CHEM, V2014, DOI 10.1155/2014/768406; Benet T, 2011, ANAL BIOCHEM, V414, P166, DOI 10.1016/j.ab.2011.03.002; BIGGE JC, 1995, ANAL BIOCHEM, V230, P229, DOI 10.1006/abio.1995.1468; Bubb WA, 1999, CARBOHYD RES, V318, P123, DOI 10.1016/S0008-6215(99)00102-0; Duncan PI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008241; Fuhrer A, 2010, J EXP MED, V207, P2843, DOI 10.1084/jem.20101098; GROLLMAN AP, 1965, J BIOL CHEM, V240, P975; Jantscher-Krenn E, 2012, MINERVA PEDIATR, V64, P83; JOURDIAN GW, 1963, ANN NY ACAD SCI, V106, P202; Kobata A, 2010, P JPN ACAD B-PHYS, V86, P731, DOI 10.2183/pjab.86.731; KUHN NJ, 1972, BIOCHEM J, V130, P177, DOI 10.1042/bj1300177; Kunz C, 2000, ANNU REV NUTR, V20, P699, DOI 10.1146/annurev.nutr.20.1.699; Kurakevich E, 2013, P NATL ACAD SCI USA, V110, P17444, DOI 10.1073/pnas.1306322110; Lemay DG, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r43; Newburg DS, 2009, J ANIM SCI, V87, P26, DOI 10.2527/jas.2008-1347; PRIETO PA, 1995, J BIOL CHEM, V270, P29515, DOI 10.1074/jbc.270.49.29515; Ruiz-Palacios GM, 2003, J BIOL CHEM, V278, P14112, DOI 10.1074/jbc.M207744200; Sela DA, 2010, TRENDS MICROBIOL, V18, P298, DOI 10.1016/j.tim.2010.03.008; Senda A, 2010, ANIM SCI J, V81, P687, DOI 10.1111/j.1740-0929.2010.00787.x; Sprenger N, 2012, ADV NUTR, V3, p392S, DOI 10.3945/an.111.001479; Tao N, 2009, J DAIRY SCI, V92, P2991, DOI 10.3168/jds.2008-1642; Taufik E, 2013, ANIM SCI J, V84, P569, DOI 10.1111/asj.12040; Urashima T, 1997, BBA-GEN SUBJECTS, V1334, P247, DOI 10.1016/S0304-4165(96)00101-8; Urashima T, 2003, COMP BIOCHEM PHYS B, V136, P887, DOI 10.1016/j.cbpc.2003.09.001; Urashima T, 2002, COMP BIOCHEM PHYS B, V132, P611, DOI 10.1016/S1096-4959(02)00083-0; Urashima T, 2001, GLYCOCONJUGATE J, V18, P357, DOI 10.1023/A:1014881913541; Urashima T, 2012, ANIMAL, V6, P369, DOI 10.1017/S1751731111001248; Urashima T, 2003, COMP BIOCHEM PHYS A, V135, P549, DOI 10.1016/S1095-6433(03)00130-2; Urashima T, 1997, COMP BIOCHEM PHYS B, V116, P311, DOI 10.1016/S0305-0491(96)00209-X; Urashima T, 1999, BBA-GEN SUBJECTS, V1472, P290, DOI 10.1016/S0304-4165(99)00134-8; Urashima T., 2011, ENCY DAIRY SCI, V3, P241, DOI DOI 10.1016/B978-0-12-374407-4.00279-X; Urashima T, 2013, BIOSCI BIOTECH BIOCH, V77, P455, DOI 10.1271/bbb.120810; Wang B, 2003, EUR J CLIN NUTR, V57, P1351, DOI 10.1038/sj.ejcn.1601704; Wang B, 2012, ADV NUTR, V3, p465S, DOI 10.3945/an.112.001875	38	11	11	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99824	10.1371/journal.pone.0099824	http://dx.doi.org/10.1371/journal.pone.0099824			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924915	Green Submitted, Green Published, gold			2022-12-27	WOS:000338701300097
J	Walters, P; Barley, EA; Mann, A; Phillips, R; Tylee, A				Walters, Paul; Barley, Elizabeth A.; Mann, Anthony; Phillips, Rachel; Tylee, Andre			Depression in Primary Care Patients with Coronary Heart Disease: Baseline Findings from the UPBEAT UK Study	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; MAJOR DEPRESSION; GENERAL-PRACTITIONERS; MANAGING DEPRESSION; RISK-FACTOR; PREVALENCE; MORTALITY; ANXIETY	Background: An association between depression and coronary heart disease is now accepted but there has been little primary care research on this topic. The UPBEAT-UK studies are centred on a cohort of primary patients with coronary heart disease assessed every six months for up to four years. The aim of this research was to determine the prevalence and associations of depression in this cohort at baseline. Method: Participants with coronary heart disease were recruited from general practice registers and assessed for cardiac symptoms, depression, quality of life and social problems. Results: 803 people participated. 42% had a documented history of myocardial infarction, 54% a diagnosis of ischaemic heart disease or angina. 44% still experienced chest pain. 7% had an ICD-10 defined depressive disorder. Factors independently associated with this diagnosis were problems living alone (OR 5.49, 95% CI 2.11-13.30), problems carrying out usual activities (OR 3.71, 95% CI 1.93-7.14), experiencing chest pain (OR 3.27, 95% CI 1.58-6.76), other pains or discomfort (OR 3.39, 95% CI 1.42-8.10), younger age (OR 0.95 per year 95% CI 0.92-0.98). Conclusion: Problems living alone, chest pain and disability are important predictors of depression in this population.	[Walters, Paul] Univ NHS Fdn Trust, Univ Dept Mental Hlth, Dorset HealthCare, Bournemouth, Dorset, England; [Walters, Paul] Bournemouth Univ, Bournemouth, Dorset, England; [Barley, Elizabeth A.] Kings Coll London, Florence Nightingale Sch Nursing & Midwifery, London WC2R 2LS, England; [Mann, Anthony; Phillips, Rachel; Tylee, Andre] Kings Coll London, Sect Primary Care Mental Hlth, Hlth Serv, London WC2R 2LS, England; [Mann, Anthony; Phillips, Rachel; Tylee, Andre] Kings Coll London, Sect Primary Care Mental Hlth, Populat Res Dept, London WC2R 2LS, England	Bournemouth University; University of London; King's College London; University of London; King's College London; University of London; King's College London	Walters, P (corresponding author), Univ NHS Fdn Trust, Univ Dept Mental Hlth, Dorset HealthCare, Bournemouth, Dorset, England.	Paul.Walters@dhuft.nhs.uk	Barley, Elizabeth/M-6663-2019	Phillips, Rachel/0000-0002-3634-7845; Barley, Elizabeth/0000-0001-9955-0384	NIHR Mental Health BRC at the Institute of Psychiatry; Kings College London; South London and Maudsley Foundation Trust; National Institute for Health Research [MET-08-08-101, RP-PG-0606-1048] Funding Source: researchfish	NIHR Mental Health BRC at the Institute of Psychiatry; Kings College London(General Electric); South London and Maudsley Foundation Trust; National Institute for Health Research(National Institute for Health Research (NIHR))	AT is partly funded by the NIHR Mental Health BRC at the Institute of Psychiatry, Kings College London and South London and Maudsley Foundation Trust. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barley EA, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-1; Barley EA, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-47; Barth J, 2004, PSYCHOSOM MED, V66, P802, DOI 10.1097/01.psy.0000146332.53619.b2; Brown G., 1978, SOCIAL ORIGINS DEPRE; Carroll K, 2003, J PUBLIC HEALTH MED, V25, P29, DOI 10.1093/pubmed/fdg007; CORNEY RH, 1985, PSYCHOL MED, V15, P637, DOI 10.1017/S0033291700031494; Davidson KW, 2006, PSYCHOSOM MED, V68, P645, DOI 10.1097/01.psy.0000233233.48738.22; Dickens C, 2008, PSYCHOSOM MED, V70, P450, DOI 10.1097/PSY.0b013e31816a74de; Egede LE, 2007, GEN HOSP PSYCHIAT, V29, P409, DOI 10.1016/j.genhosppsych.2007.06.002; Goldberg DP., 1992, COMMON MENTAL DISORD; Gulliksson Mats, 2007, BMC Cardiovasc Disord, V7, P36, DOI 10.1186/1471-2261-7-36; Herbst S, 2007, PSYCHOSOM MED, V69, P729, DOI 10.1097/PSY.0b013e3181574977; Kendrick T, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13220; Lett HS, 2004, PSYCHOSOM MED, V66, P305, DOI 10.1097/01.psy.0000126207.43307.c0; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; MARKS JN, 1979, PSYCHOL MED, V9, P337, DOI 10.1017/S0033291700030853; Pajak P, 2012, EUROPEAN J PREVANTIV, V20, P331; Rabin R, 2001, ANN MED, V33, P337, DOI 10.3109/07853890109002087; Rimington LD, 2001, THORAX, V56, P266, DOI 10.1136/thorax.56.4.266; ROSE GA, 1962, B WORLD HEALTH ORGAN, V27, P645; Salokangas RKR, 1998, J AFFECT DISORDERS, V48, P171, DOI 10.1016/S0165-0327(97)00171-7; Singleton N., 2001, PSYCHIAT MORBIDITY A; The Information Centre for Health and Social Care, QUAL OUTC FRAM 2010; Tylee A, 2012, BMC PSYCHIATRY, V12, DOI 10.1186/1471-244X-12-58; Tylee A, 2011, BMC FAM PRACT, V12, DOI 10.1186/1471-2296-12-38; USTUN TB, 1995, MENTAL ILLNESS GEN H; Wilhelm K, 2003, J AFFECT DISORDERS, V75, P155, DOI 10.1016/S0165-0327(02)00040-X; World Health Organization, 1992, ICD 10 CLASSIFICATIO; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	29	24	24	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98342	10.1371/journal.pone.0098342	http://dx.doi.org/10.1371/journal.pone.0098342			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24922312	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000338701300008
J	Brown, GP; Shine, R				Brown, Gregory P.; Shine, Richard			Immune Response Varies with Rate of Dispersal in Invasive Cane Toads (Rhinella marina)	PLOS ONE			English	Article							LONG-DISTANCE DISPERSAL; CHAUNUS BUFO MARINUS; ECOLOGICAL IMMUNOLOGY; TRADE-OFFS; PARASITES; STRESS; HOST; RESISTANCE; DEFENSE; SYSTEM	What level of immunocompetence should an animal maintain while undertaking long-distance dispersal? Immune function (surveillance and response) might be down-regulated during prolonged physical exertion due to energy depletion, and/or to avoid autoimmune reactions arising from damaged tissue. On the other hand, heightened immune vigilance might be favored if the organism encounters novel pathogens as it enters novel environments. We assessed the links between immune defense and long-distance movement in a population of invasive cane toads (Rhinella marina) in Australia. Toads were radio-tracked for seven days to measure their activity levels and were then captured and subjected to a suite of immune assays. Toads that moved further showed decreased bacteria-killing ability in their plasma and decreased phagocytic activity in their whole blood, but a heightened skin-swelling response to phytohemagglutinin. Baseline and post-stress corticosterone levels were unrelated to distance moved. Thus, long-distance movement in cane toads is associated with a dampened response in some systems and enhanced response in another. This pattern suggests that sustained activity is accompanied by trade-offs among immune components rather than an overall down or up-regulation. The finding that high mobility is accompanied by modification of the immune system has important implications for animal invasions.	[Brown, Gregory P.; Shine, Richard] Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia	University of Sydney	Shine, R (corresponding author), Univ Sydney, Sch Biol Sci, Sydney, NSW 2006, Australia.	rick.shine@sydney.edu.au	Brown, Gregory P./F-9897-2011	Brown, Gregory P./0000-0002-2924-9040	Australian Research Council [FF0561365]	Australian Research Council(Australian Research Council)	Funded by Australian Research Council (www.arc.gov.au) grant FF0561365 to R. Shine. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alford RA, 2009, WILDLIFE RES, V36, P23, DOI 10.1071/WR08021; Allen LC, 2009, J COMP PHYSIOL B, V179, P315, DOI 10.1007/s00360-008-0315-3; Altizer S, 2011, SCIENCE, V331, P296, DOI 10.1126/science.1194694; Barton DP, 1997, AUST J ECOL, V22, P316, DOI 10.1111/j.1442-9993.1997.tb00677.x; Baucom RS, 2011, FUNCT ECOL, V25, P18, DOI 10.1111/j.1365-2435.2010.01742.x; Bonneaud C, 2003, AM NAT, V161, P367, DOI 10.1086/346134; Brown GP, 2007, P NATL ACAD SCI USA, V104, P17698, DOI 10.1073/pnas.0705057104; Brown GP, 2006, BIOL CONSERV, V133, P88, DOI 10.1016/j.biocon.2006.05.020; Brown GP, 2011, FUNCT ECOL, V25, P1339, DOI 10.1111/j.1365-2435.2011.01888.x; Brown GP, 2011, METHODS ECOL EVOL, V2, P341, DOI 10.1111/j.2041-210X.2011.00090.x; Buehler DM, 2010, INTEGR COMP BIOL, V50, P346, DOI 10.1093/icb/icq055; Dubey S, 2008, MOL ECOL, V17, P4418, DOI 10.1111/j.1365-294X.2008.03922.x; Dunn AM, 2012, FUNCT ECOL, V26, P1234, DOI 10.1111/1365-2435.12022; Dunn AM, 2009, ADV PARASIT, V68, P161, DOI 10.1016/S0065-308X(08)00607-6; Fellous S, 2011, BIOL LETTERS, V7, P327, DOI 10.1098/rsbl.2010.0862; Freidenreich DJ, 2012, EXERC IMMUNOL REV, V18, P8; Hartigan A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018871; Hasselquist D, 2007, J EXP BIOL, V210, P1123, DOI 10.1242/jeb.02712; Hilker FM, 2005, BIOL INVASIONS, V7, P817, DOI 10.1007/s10530-005-5215-9; Jessop TS, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1444; Kelehear C, 2012, PARASITOLOGY, V139, P1596, DOI 10.1017/S0031182012000832; Koch AJ, 2010, AM J LIFESTYLE MED, V4, P244, DOI 10.1177/1559827609360190; Kurtz J, 2002, EVOL ECOL RES, V4, P431; Lee KA, 2005, OECOLOGIA, V145, P244, DOI 10.1007/s00442-005-0113-5; Lee KA, 2004, TRENDS ECOL EVOL, V19, P523, DOI 10.1016/j.tree.2004.07.012; LEVER C., 2001, CANE TOAD HIST ECOLO; Lindstrom T, 2013, P NATL ACAD SCI USA, V110, P13452, DOI 10.1073/pnas.1303157110; Llewellyn D, 2011, PHYSIOL BIOCHEM ZOOL, V84, P77, DOI 10.1086/657609; Llewellyn D, 2012, BIOL INVASIONS, V14, P999, DOI 10.1007/s10530-011-0135-3; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Lowe WH, 2009, ECOLOGY, V90, P1456, DOI 10.1890/08-1903.1; Martin LB, 2012, J EXP BIOL, V215, P4097, DOI 10.1242/jeb.073049; Martin LB, 2010, OECOLOGIA, V164, P339, DOI 10.1007/s00442-010-1654-9; Matson KD, 2006, PHYSIOL BIOCHEM ZOOL, V79, P556, DOI 10.1086/501057; Moller AP, 2004, J ANIM ECOL, V73, P1035, DOI 10.1111/j.0021-8790.2004.00879.x; Moller AP, 2004, J EVOLUTION BIOL, V17, P603, DOI 10.1111/j.1420-9101.2004.00694.x; Moller AP, 2001, ECOL LETT, V4, P484, DOI 10.1046/j.1461-0248.2001.00259.x; O'Neal Dawn M., 2011, P7; Owen JC, 2008, J ETHOL, V26, P383, DOI 10.1007/s10164-008-0092-1; Pedersen BK, 2000, PHYSIOL REV, V80, P1055, DOI 10.1152/physrev.2000.80.3.1055; Perez-Tris J, 2005, ECOL LETT, V8, P838, DOI 10.1111/j.1461-0248.2005.00788.x; Phillips BL, 2010, J EVOLUTION BIOL, V23, P2595, DOI 10.1111/j.1420-9101.2010.02118.x; Phillips BL, 2010, ECOLOGY, V91, P872, DOI 10.1890/09-0530.1; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Pizzatto L, 2012, J WILDLIFE DIS, V48, P951, DOI 10.7589/2012-02-050; Prenter J, 2004, TRENDS ECOL EVOL, V19, P385, DOI 10.1016/j.tree.2004.05.002; Raberg L, 1998, P ROY SOC B-BIOL SCI, V265, P1637, DOI 10.1098/rspb.1998.0482; Sears BF, 2011, TRENDS PARASITOL, V27, P382, DOI 10.1016/j.pt.2011.05.004; Segerstrom SC, 2007, CURR DIR PSYCHOL SCI, V16, P326, DOI 10.1111/j.1467-8721.2007.00522.x; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shilton CM, 2008, VET PATHOL, V45, P85, DOI 10.1354/vp.45-1-85; Shine R, 2008, PHILOS T R SOC B, V363, P363, DOI 10.1098/rstb.2007.2144; Shine R, 2011, P NATL ACAD SCI USA, V108, P5708, DOI 10.1073/pnas.1018989108; Smith MA, 2006, ECOGRAPHY, V29, P649, DOI 10.1111/j.2006.0906-7590.04584.x; Smith MA, 2005, ECOGRAPHY, V28, P110; Snoeijs T, 2004, P ROY SOC B-BIOL SCI, V271, pS199, DOI 10.1098/rsbl.2003.0148; SPEARE R, 1990, AUST WILDLIFE RES, V17, P387; Suhonen J, 2010, OECOLOGIA, V162, P541, DOI 10.1007/s00442-009-1470-2; Urban MC, 2007, P ROY SOC B-BIOL SCI, V274, P1413, DOI 10.1098/rspb.2007.0114; Viney ME, 2005, TRENDS ECOL EVOL, V20, P665, DOI 10.1016/j.tree.2005.10.003; Wang Y, 2011, ECOL APPL, V21, P729, DOI 10.1890/09-2406.1; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; White TA, 2012, FUNCT ECOL, V26, P1313, DOI 10.1111/1365-2435.12012; Wright K. M., 2001, Amphibian medicine and captive husbandry, P129; Zou JW, 2008, ECOGRAPHY, V31, P663, DOI 10.1111/j.0906-7590.2008.05540.x	66	41	41	3	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99734	10.1371/journal.pone.0099734	http://dx.doi.org/10.1371/journal.pone.0099734			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936876	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400036
J	Kang, M; Jeong, CW; Choi, WS; Park, YH; Cho, SY; Lee, S; Lee, SB; Ku, JH; Hong, SK; Byun, SS; Jeong, H; Kwak, C; Kim, HH; Lee, E; Lee, SE				Kang, Minyong; Jeong, Chang Wook; Choi, Woo Suk; Park, Yong Hyun; Cho, Sung Yong; Lee, Sangchul; Lee, Seung Bae; Ku, Ja Hyeon; Hong, Sung Kyu; Byun, Seok-Soo; Jeong, Hyeon; Kwak, Cheol; Kim, Hyeon Hoe; Lee, Eunsik; Lee, Sang Eun		Seoul Natl Univ	Pre- and Post-Operative Nomograms to Predict Recurrence-Free Probability in Korean Men with Clinically Localized Prostate Cancer	PLOS ONE			English	Article							RADICAL PROSTATECTOMY; PATHOLOGICAL STAGE; PREOPERATIVE NOMOGRAM; BIOCHEMICAL RECURRENCE; ANTIGEN RECURRENCE; DISEASE RECURRENCE; MANAGEMENT; OUTCOMES	Objectives: Although the incidence of prostate cancer (PCa) is rapidly increasing in Korea, there are few suitable prediction models for disease recurrence after radical prostatectomy (RP). We established pre- and post-operative nomograms estimating biochemical recurrence (BCR)-free probability after RP in Korean men with clinically localized PCa. Patients and Methods: Our sampling frame included 3,034 consecutive men with clinically localized PCa who underwent RP at our tertiary centers from June 2004 through July 2011. After inappropriate data exclusion, we evaluated 2,867 patients for the development of nomograms. The Cox proportional hazards regression model was used to develop pre- and postoperative nomograms that predict BCR-free probability. Finally, we resampled from our study cohort 200 times to determine the accuracy of our nomograms on internal validation, which were designated with concordance index (c-index) and further represented by calibration plots. Results: Over a median of 47 months of follow-up, the estimated BCR-free rate was 87.8% (1 year), 83.8% (2 year), and 72.5% (5 year). In the pre-operative model, Prostate-Specific Antigen (PSA), the proportion of positive biopsy cores, clinical T3a and biopsy Gleason score (GS) were independent predictive factors for BCR, while all relevant predictive factors (PSA, extra-prostatic extension, seminal vesicle invasion, lymph node metastasis, surgical margin, and pathologic GS) were associated with BCR in the post-operative model. The c-index representing predictive accuracy was 0.792 (pre-) and 0.821 (post-operative), showing good fit in the calibration plots. Conclusions: In summary, we developed pre- and post-operative nomograms predicting BCR-free probability after RP in a large Korean cohort with clinically localized PCa. These nomograms will be provided as the mobile application-based SNUH Prostate Cancer Calculator. Our nomograms can determine patients at high risk of disease recurrence after RP who will benefit from adjuvant therapy.	[Kang, Minyong; Jeong, Chang Wook; Choi, Woo Suk; Ku, Ja Hyeon; Kwak, Cheol; Kim, Hyeon Hoe; Lee, Eunsik] Seoul Natl Univ Hosp, Dept Urol, Seoul 110744, South Korea; [Park, Yong Hyun; Lee, Sangchul; Hong, Sung Kyu; Byun, Seok-Soo; Lee, Sang Eun] Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea; [Cho, Sung Yong; Lee, Seung Bae; Jeong, Hyeon] Seoul Natl Univ, Boramae Hosp, Dept Urol, Seoul, South Korea	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital	Lee, SE (corresponding author), Seoul Natl Univ, Bundang Hosp, Dept Urol, Songnam, South Korea.	selee@snubh.org	Kang, Minyong/AAO-6484-2020; Ku, Ja Hyeon/E-6682-2016					Byun SS, 2012, YONSEI MED J, V53, P543, DOI 10.3349/ymj.2012.53.3.543; Center MM, 2012, EUR UROL, V61, P1079, DOI 10.1016/j.eururo.2012.02.054; Chatterjee S, 1998, STAT PROBABIL LETT, V40, P307, DOI 10.1016/S0167-7152(98)00116-3; Cho YM, 2014, WORLD J UROL, V32, P399, DOI 10.1007/s00345-013-1111-6; Chung JS, 2011, YONSEI MED J, V52, P74, DOI 10.3349/ymj.2011.52.1.74; Chung JS, 2010, J KOREAN MED SCI, V25, P1443, DOI 10.3346/jkms.2010.25.10.1443; Fichtner J, 2000, BJU INT, V86, P181, DOI 10.1046/j.1464-410x.2000.00701.x; Freedland SJ, 2007, J UROLOGY, V177, P1985, DOI 10.1016/j.juro.2007.01.137; Haas GP, 2008, CAN J UROL, V15, P3866; Iasonos A, 2008, J CLIN ONCOL, V26, P1364, DOI 10.1200/JCO.2007.12.9791; Iremashvili V, 2012, INT J UROL, V19, P853, DOI 10.1111/j.1442-2042.2012.03058.x; Jeong CW, 2012, INT J UROL, V19, P846, DOI 10.1111/j.1442-2042.2012.03040.x; Jeong CW, 2013, KOREAN J UROL, V11, P133; Kattan MW, 1997, CANCER-AM CANCER SOC, V79, P528, DOI 10.1002/(SICI)1097-0142(19970201)79:3<528::AID-CNCR15>3.3.CO;2-D; Kattan MW, 1999, J CLIN ONCOL, V17, P1499, DOI 10.1200/JCO.1999.17.5.1499; Kattan MW, 1998, JNCI-J NATL CANCER I, V90, P766, DOI 10.1093/jnci/90.10.766; Kim KH, 2014, BJU INT, V113, P598, DOI 10.1111/bju.12280; Kotb AF, 2011, PROSTATE CANCER, V2011, DOI 10.1155/2011/485189; Li XG, 2012, CHINESE MED J-PEKING, V125, P1529, DOI 10.3760/cma.j.issn.0366-6999.2012.09.002; Naito S, 2005, JPN J CLIN ONCOL, V35, P365, DOI 10.1093/jjco/hyi113; Sengupta S, 2006, J UROLOGY, V175, P1684, DOI 10.1016/S0022-5347(05)00978-X; Shariat SF, 2008, CANCER-AM CANCER SOC, V113, P3075, DOI 10.1002/cncr.23908; Shariat SF, 2008, CLIN CANCER RES, V14, P4400, DOI 10.1158/1078-0432.CCR-07-4713; Shariat SF, 2008, J CLIN ONCOL, V26, P1526, DOI 10.1200/JCO.2007.12.4669; Shariat SF, 2009, FUTURE ONCOL, V5, P1555, DOI [10.2217/fon.09.121, 10.2217/FON.09.121]; Song C, 2005, J KOREAN MED SCI, V20, P262, DOI 10.3346/jkms.2005.20.2.262; Song C, 2006, UROLOGY, V68, P820, DOI 10.1016/j.urology.2006.04.029; Stephenson AJ, 2006, J CLIN ONCOL, V24, P3973, DOI 10.1200/JCO.2005.04.0756; Stephenson AJ, 2006, JNCI-J NATL CANCER I, V98, P715, DOI 10.1093/jnci/djj190; Stephenson AJ, 2006, BJU INT, V98, P39, DOI 10.1111/j.1464-410X.2006.06173.x; Swanson GP, 2011, J CANCER, V2, P1, DOI 10.7150/jca.2.1; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Yan Y, 2000, CANCER, V88, P1122, DOI 10.1002/(SICI)1097-0142(20000301)88:5<1122::AID-CNCR24>3.0.CO;2-Q	33	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100053	10.1371/journal.pone.0100053	http://dx.doi.org/10.1371/journal.pone.0100053			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936784	Green Submitted, gold, Green Published			2022-12-27	WOS:000338503400067
J	Yang, GD; Chen, JJ; Xu, F; Bao, Z; Yao, YK; Zhou, JY				Yang, Guangdie; Chen, Junjun; Xu, Fei; Bao, Zhang; Yao, Yake; Zhou, Jianying			Association between Tumor Necrosis Factor-alpha rs1800629 Polymorphism and Risk of Asthma: A Meta-Analysis	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; CYTOKINE GENE POLYMORPHISMS; TNF-ALPHA; ATOPIC ASTHMA; PROMOTER POLYMORPHISM; MOLECULAR ASSOCIATION; CHILDHOOD ASTHMA; BRONCHIAL-ASTHMA; ADULT ASTHMA; POPULATION	Objective: The purpose of this study was to explore the association between the TNF-alpha rs1800629 (also refers as - 308G/A) polymorphism and asthma susceptibility. Methods: We searched the Pubmed, Embase, Cochrane Central Register of Controlled Trials (CENTRAL) and Wanfang databases. Odds ratios (ORs) with 95% confidence intervals (CIs) were used to calculate the strength of association. Results: A total of 34 studies involving 5477 asthma patients and 5962 controls were included in present study. The results indicated that TNF-alpha rs1800629 polymorphism was significantly associated with asthma risk in a recessive genetic model (OR = 1.46, 95% CI 1.21-1.76, P<0.0001). Subgroup analyses found that the TNF-alpha rs1800629 polymorphism was significantly associated with asthma risk in West Asians and South Asians (OR = 2.47, 95% CI = 1.48-4.12, P = 0.0005; OR = 1.83, 95% CI = 1.42-2.36, P<0.00001), but not East Asians and Caucasians. Furthermore, significant association also was observed in allergic asthma (OR = 1.51, 95% CI = 1.24-1.83, P<0.0001), adults and children (OR = 1.43, 95 CI% = 1.07-1.91, P = 0.02; OR = 1.57, 95% CI = 1.19-2.06, P = 0.001). Conclusions: This meta-analysis suggested that the rs1800629 polymorphism in TNF-alpha was a risk factor for asthma.	[Yang, Guangdie; Chen, Junjun; Xu, Fei; Bao, Zhang; Yao, Yake; Zhou, Jianying] Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Dis, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University	Zhou, JY (corresponding author), Zhejiang Univ, Coll Med, Affiliated Hosp 1, Dept Resp Dis, Hangzhou 310003, Zhejiang, Peoples R China.	zjyhz@zju.edu.cn	Bao, Zhang/F-2989-2010	Bao, Zhang/0000-0002-3057-1109	National Natural Science Foundation of China [81170038, 81300009]; Natural Science Foundation for the Youth of Zhejiang Province, China [Q13H010001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation for the Youth of Zhejiang Province, China	This research was funded by grants from the National Natural Science Foundation of China (No.81170038&No.81300009) and by grant from the Natural Science Foundation for the Youth of Zhejiang Province, China (No.Q13H010001). The funder (No. 81170038) had a role in our study design, the funder (No. 81300009) had a role in data collection and analysis, while the funder (No.Q13H010001) had a role in preparation of our manuscript.	[Anonymous], SHANDONG MED J; [Anonymous], J JIANGXI MED COLL; [Anonymous], ACTA ACAD MED WEIFAN; Aoki Takeshi, 2006, J Hum Genet, V51, P677, DOI 10.1007/s10038-006-0007-3; Attia J, 2003, J CLIN EPIDEMIOL, V56, P297, DOI 10.1016/S0895-4356(03)00011-8; Aytekin C, 2009, TUBERK TORAK, V57, P62; Barton A, 2008, HUM MOL GENET, V17, P2274, DOI 10.1093/hmg/ddn128; Beghe B, 2004, ALLERGY, V59, P61, DOI 10.1046/j.1398-9995.2003.00352.x; Bilolikar H, 2005, EUR RESPIR J, V26, P637, DOI 10.1183/09031936.05.00071104; Buckova D, 2002, J INVEST ALLERG CLIN, V12, P192; CARROLL MC, 1987, P NATL ACAD SCI USA, V84, P8535, DOI 10.1073/pnas.84.23.8535; Chen XJ, 2011, J HUAZHONG U SCI-MED, V31, P137, DOI 10.1007/s11596-011-0165-1; Cohn L, 2004, ANNU REV IMMUNOL, V22, P789, DOI 10.1146/annurev.immunol.22.012703.104716; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Cui LY, 2010, ACTA ACAD MED NEIMON, V32, P354; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dhaouadi T, 2011, REV FR ALLERGOL, V51, P659, DOI 10.1016/j.reval.2011.05.003; Egger M, 1997, BMJ-BRIT MED J, V315, P1533, DOI 10.1136/bmj.315.7121.1533; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ferreira MAR, 2011, LANCET, V378, P1006, DOI 10.1016/S0140-6736(11)60874-X; Ferreira MAR, 2011, EUR J HUM GENET, V19, P458, DOI 10.1038/ejhg.2010.191; Gao J, 2006, THORAX, V61, P466, DOI 10.1136/thx.2005.051284; Gao Jinming, 2003, Chinese Medical Sciences Journal, V18, P248; Gupta V, 2005, J ASTHMA, V42, P839, DOI 10.1080/02770900500370924; Hancock DB, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000623; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Himes BE, 2009, AM J HUM GENET, V84, P581, DOI 10.1016/j.ajhg.2009.04.006; Hirota T, 2011, NAT GENET, V43, P893, DOI 10.1038/ng.887; Jiffri EH, 2011, GENET TEST MOL BIOMA, V15, P293, DOI 10.1089/gtmb.2010.0157; Kamali-Sarvestani E, 2007, J INVEST ALLERG CLIN, V17, P361; Kim HB, 2008, CLIN EXP ALLERGY, V38, P774, DOI 10.1111/j.1365-2222.2008.02965.x; Koppelman GH, 2011, CURR OPIN ALLERGY CL, V11, P414, DOI 10.1097/ACI.0b013e32834a9573; Kroeger KM, 1997, MOL IMMUNOL, V34, P391, DOI 10.1016/S0161-5890(97)00052-7; Kumar Ajay, 2008, Indian J Med Sci, V62, P323; Li XN, 2010, J ALLERGY CLIN IMMUN, V125, P328, DOI 10.1016/j.jaci.2009.11.018; Li Y, 2013, INT J RESP, V33, P165; Li YF, 2008, RESP MED, V102, P984, DOI 10.1016/j.rmed.2008.02.008; [刘东方 Liu Dongfang], 2004, [华中科技大学学报. 医学版, Journal of Huazhong University of Science and Technology], V33, P196; Louis E, 1998, CLIN EXP IMMUNOL, V113, P401; Louis R, 2000, EUR RESPIR J, V16, P604, DOI 10.1034/j.1399-3003.2000.16d06.x; Mahdaviani SA, 2009, J CLIN IMMUNOL, V29, P57, DOI 10.1007/s10875-008-9232-1; Mak JCW, 2007, INT ARCH ALLERGY IMM, V144, P114, DOI 10.1159/000103222; Mathias RA, 2010, J ALLERGY CLIN IMMUN, V125, P336, DOI 10.1016/j.jaci.2009.08.031; Michel S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013894; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Murk W, 2011, HUM HERED, V71, P97, DOI 10.1159/000319536; Nakae S, 2007, J ALLERGY CLIN IMMUN, V120, P48, DOI 10.1016/j.jaci.2007.02.046; Nicolae D, 2005, AM J HUM GENET, V76, P349, DOI 10.1086/427763; Obase Y, 2001, ANN ALLERG ASTHMA IM, V86, P304, DOI 10.1016/S1081-1206(10)63303-0; Shaker OG, 2013, HUM IMMUNOL, V74, P796, DOI 10.1016/j.humimm.2013.01.004; Sharma S, 2006, AM J RESP CELL MOL, V35, P488, DOI 10.1165/rcmb.2006-0084OC; Shin HD, 2004, HUM MOL GENET, V13, P397, DOI 10.1093/hmg/ddh036; Sleiman PMA, 2010, NEW ENGL J MED, V362, P36, DOI 10.1056/NEJMoa0901867; Thakkinstian A, 2005, AM J EPIDEMIOL, V162, P201, DOI 10.1093/aje/kwi184; Thakkinstian A, 2005, STAT MED, V24, P1291, DOI 10.1002/sim.2010; Thomas PS, 1996, CLIN EXP ALLERGY, V26, P710, DOI 10.1111/j.1365-2222.1996.tb00598.x; Tolgyesi G, 2006, PEDIATR RES, V60, P543, DOI 10.1203/01.pdr.0000242298.24089.52; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Trajkov D, 2008, IRAN J ALLERGY ASTHM, V7, P143, DOI 07.03/ijaai.143156; Wang JY, 2009, J CLIN IMMUNOL, V29, P205, DOI 10.1007/s10875-008-9256-6; Wang TN, 2004, CLIN EXP ALLERGY, V34, P184, DOI 10.1111/j.1365-2222.2004.01867.x; Winchester EC, 2000, HUM GENET, V107, P591, DOI 10.1007/s004390000410; Witte JS, 2002, EUR J HUM GENET, V10, P82, DOI 10.1038/sj.ejhg.5200746; Wjst M, 1999, GENOMICS, V58, P1, DOI 10.1006/geno.1999.5806; Zhang YG, 2011, J CLIN IMMUNOL, V31, P174, DOI 10.1007/s10875-010-9477-3; [赵海军 Zhao Haijun], 2005, [吉林大学学报. 医学版, Journal of Jilin Univeristy. Medicine edition], V31, P449; Zheng BQ, 2012, STUDY GENETIC SUSCEP	68	19	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99962	10.1371/journal.pone.0099962	http://dx.doi.org/10.1371/journal.pone.0099962			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936650	gold, Green Published, Green Submitted			2022-12-27	WOS:000338503400058
J	Gargon, E; Gurung, B; Medley, N; Altman, DG; Blazeby, JM; Clarke, M; Williamson, PR				Gargon, Elizabeth; Gurung, Binu; Medley, Nancy; Altman, Doug G.; Blazeby, Jane M.; Clarke, Mike; Williamson, Paula R.			Choosing Important Health Outcomes for Comparative Effectiveness Research: A Systematic Review	PLOS ONE			English	Review							CLINICAL-TRIALS; QUALITY	Background: A core outcome set (COS) is a standardised set of outcomes which should be measured and reported, as a minimum, in all effectiveness trials for a specific health area. This will allow results of studies to be compared, contrasted and combined as appropriate, as well as ensuring that all trials contribute usable information. The COMET (Core Outcome Measures for Effectiveness Trials) Initiative aims to support the development, reporting and adoption of COS. Central to this is a publically accessible online resource, populated with all available COS. The aim of the review we report here was to identify studies that sought to determine which outcomes or domains to measure in all clinical trials in a specific condition and to describe the methodological techniques used in these studies. Methods: We developed a multi-faceted search strategy for electronic databases (MEDLINE, SCOPUS, and Cochrane Methodology Register). We included studies that sought to determine which outcomes/domains to measure in all clinical trials in a specific condition. Results: A total of 250 reports relating to 198 studies were judged eligible for inclusion in the review. Studies covered various areas of health, most commonly cancer, rheumatology, neurology, heart and circulation, and dentistry and oral health. A variety of methods have been used to develop COS, including semi-structured discussion, unstructured group discussion, the Delphi Technique, Consensus Development Conference, surveys and Nominal Group Technique. The most common groups involved were clinical experts and non-clinical research experts. Thirty-one (16%) studies reported that the public had been involved in the process. The geographic locations of participants were predominantly North America (n = 164; 83%) and Europe (n = 150; 76%). Conclusions: This systematic review identified many health areas where a COS has been developed, but also highlights important gaps. It is a further step towards a comprehensive, up-to-date database of COS. In addition, it shows the need for methodological guidance, including how to engage key stakeholder groups, particularly members of the public.	[Gargon, Elizabeth; Gurung, Binu; Medley, Nancy; Williamson, Paula R.] Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England; [Altman, Doug G.] Univ Oxford, Ctr Stat Med, Botnar Res Ctr, Oxford, England; [Blazeby, Jane M.] Univ Bristol, Sch Social & Community Med, Bristol, Avon, England; [Clarke, Mike] Queens Univ Belfast, Inst Clin Sci, Royal Hosp, Belfast, Antrim, North Ireland	University of Liverpool; University of Oxford; University of Bristol; Queens University Belfast	Gargon, E (corresponding author), Univ Liverpool, Dept Biostat, Liverpool L69 3BX, Merseyside, England.	e.gargon@liv.ac.uk	Williamson, Paula R/B-6425-2016	Williamson, Paula R/0000-0001-9802-6636	MRC MRP (Medical Research Council Methodology Research Panel) [MR/J004847/1]; European Union [305081]; Cancer Research UK [16895] Funding Source: researchfish; Medical Research Council [MR/J004847/1, G0800800, G0901530] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10025] Funding Source: researchfish; MRC [G0901530, G0800800, MR/J004847/1] Funding Source: UKRI	MRC MRP (Medical Research Council Methodology Research Panel)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the MRC MRP (Medical Research Council Methodology Research Panel), grant number MR/J004847/1; and European Union Seventh Framework Programme ([FP7/2007-2013] [FP7/2007-2011]) under grant agreement no 305081. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chalmers I, 2009, LANCET, V374, P86, DOI 10.1016/S0140-6736(09)60329-9; Chan AW, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.e7586; Dwan K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003081; Hirsch BR, 2013, JAMA INTERN MED, V173, P972, DOI 10.1001/jamainternmed.2013.627; Hopewell S, 2007, COCHRANE DB SYST REV, DOI [10.1002/14651858.MR000001.pub2, 10.1002/14651858.MR000011.pub2]; INVOLVE, 2012, BRIEF NOT RES INV PU; Kirkham JJ, 2013, TRIALS, V14, DOI 10.1186/1745-6215-14-21; Kostanjsek N, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S4-S3; Miyar J, 2013, SCHIZOPHRENIA BULL, V39, P226, DOI 10.1093/schbul/sbr140; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Sinha I, 2008, PLOS MED, V5, P569, DOI 10.1371/journal.pmed.0050096; Williamson PR, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-132	13	212	221	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99111	10.1371/journal.pone.0099111	http://dx.doi.org/10.1371/journal.pone.0099111			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932522	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600021
J	Guo, ZQ; Doll, K; Dastjerdi, R; Karlovsky, P; Dehne, HW; Altincicek, B				Guo, Zhiqing; Doell, Katharina; Dastjerdi, Raana; Karlovsky, Petr; Dehne, Heinz-Wilhelm; Altincicek, Boran			Effect of Fungal Colonization of Wheat Grains with Fusarium spp. on Food Choice, Weight Gain and Mortality of Meal Beetle Larvae (Tenebrio molitor)	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; ENTOMOPATHOGENIC FUNGUS; BEAUVERIA-BASSIANA; ARTEMIA-SALINA; F-GRAMINEARUM; ANIMAL HEALTH; TOXICITY; MYCOTOXINS; METABOLITES; FUMONISINS	Species of Fusarium have significant agro-economical and human health-related impact by infecting diverse crop plants and synthesizing diverse mycotoxins. Here, we investigated interactions of grain-feeding Tenebrio molitor larvae with four grain-colonizing Fusarium species on wheat kernels. Since numerous metabolites produced by Fusarium spp. are toxic to insects, we tested the hypothesis that the insect senses and avoids Fusarium-colonized grains. We found that only kernels colonized with F. avenaceum or Beauveria bassiana (an insect-pathogenic fungal control) were avoided by the larvae as expected. Kernels colonized with F. proliferatum, F. poae or F. culmorum attracted T. molitor larvae significantly more than control kernels. The avoidance/preference correlated with larval feeding behaviors and weight gain. Interestingly, larvae that had consumed F. proliferatum- or F. poae-colonized kernels had similar survival rates as control. Larvae fed on F. culmorum-, F. avenaceum-or B. bassiana-colonized kernels had elevated mortality rates. HPLC analyses confirmed the following mycotoxins produced by the fungal strains on the kernels: fumonisins, enniatins and beauvericin by F. proliferatum, enniatins and beauvericin by F. poae, enniatins by F. avenaceum, and deoxynivalenol and zearalenone by F. culmorum. Our results indicate that T. molitor larvae have the ability to sense potential survival threats of kernels colonized with F. avenaceum or B. bassiana, but not with F. culmorum. Volatiles potentially along with gustatory cues produced by these fungi may represent survival threat signals for the larvae resulting in their avoidance. Although F. proliferatum or F. poae produced fumonisins, enniatins and beauvericin during kernel colonization, the larvae were able to use those kernels as diet without exhibiting increased mortality. Consumption of F. avenaceum-colonized kernels, however, increased larval mortality; these kernels had higher enniatin levels than F. proliferatum or F. poae-colonized ones suggesting that T. molitor can tolerate or metabolize those toxins.	[Guo, Zhiqing; Dehne, Heinz-Wilhelm; Altincicek, Boran] Univ Bonn, Inst Crop Sci & Resource Conservat INRES Phytomed, Bonn, Germany; [Doell, Katharina; Dastjerdi, Raana; Karlovsky, Petr] Univ Gottingen, D-37073 Gottingen, Germany	University of Bonn; University of Gottingen	Altincicek, B (corresponding author), Univ Bonn, Inst Crop Sci & Resource Conservat INRES Phytomed, Bonn, Germany.	boran.altincicek@uni-bonn.de	dastjerdi, raana/J-5398-2017	Karlovsky, Petr/0000-0002-6532-5856; Altincicek, Boran/0000-0003-2019-452X	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG) [AL902/4-1]; PLANTFOODSEC project from the European Union [261752]; Chinese Scholarship Council	German Research Foundation (Deutsche Forschungsgemeinschaft, DFG)(German Research Foundation (DFG)); PLANTFOODSEC project from the European Union; Chinese Scholarship Council(China Scholarship Council)	The authors greatly appreciate financial support by the German Research Foundation (Deutsche Forschungsgemeinschaft, DFG, AL902/4-1 to B. A.), the PLANTFOODSEC project from the European Union Seventh Framework Programme (FP7/2007-2013) under Grant Agreement number 261752 and the Chinese Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adejumo TO, 2007, FOOD ADDIT CONTAM, V24, P993, DOI 10.1080/02652030701317285; Adejumo TO, 2007, INT J FOOD MICROBIOL, V116, P350, DOI 10.1016/j.ijfoodmicro.2007.02.009; Altincicek B, 2013, PLOS ONE, V8, DOI DOI 10.1371/journal.pone.0052004; [Anonymous], 2006, BLACKWELL PUB PROF; Brandfass C, 2008, INT J MOL SCI, V9, P2306, DOI 10.3390/ijms9112306; CONOVER WJ, 1981, TECHNOMETRICS, V23, P351, DOI 10.2307/1268225; D'Mello JPF, 1999, ANIM FEED SCI TECH, V80, P183, DOI 10.1016/S0377-8401(99)00059-0; DESJARDINS AE, 2006, FUSARIUM MYCOTOXINS; Doll K, 2013, P ROYAL SOC B, P280; DOWD PF, 1989, MYCOLOGIA, V81, P646, DOI 10.2307/3760143; Fornelli F, 2004, J INVERTEBR PATHOL, V85, P74, DOI 10.1016/j.jip.2004.01.002; GAUMANN E, 1947, EXPERIENTIA, V3, P202, DOI 10.1007/BF02163993; Geiser DM, 2004, EUR J PLANT PATHOL, V110, P473, DOI 10.1023/B:EJPP.0000032386.75915.a0; Glenn AE, 2007, ANIM FEED SCI TECH, V137, P213, DOI 10.1016/j.anifeedsci.2007.06.003; Gortz A, 2009, AUFTRETEN FUSARIUM K; GROVE JF, 1980, MYCOPATHOLOGIA, V70, P103, DOI 10.1007/BF00443075; GUPTA S, 1991, MYCOPATHOLOGIA, V115, P185, DOI 10.1007/BF00462223; Hamill R. L, 1969, TETRAHEDRON LETT, V49, P4255; Hegedus DD, 1996, J INVERTEBR PATHOL, V67, P21, DOI 10.1006/jipa.1996.0004; Jurado M, 2006, SYST APPL MICROBIOL, V29, P681, DOI 10.1016/j.syapm.2006.01.014; Knorr E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004751; Mburu DM, 2013, J CHEM ECOL, V39, P101, DOI 10.1007/s10886-012-0207-6; McCormick SP, 2011, TOXINS, V3, P802, DOI 10.3390/toxins3070802; Meyling NV, 2006, ECOL ENTOMOL, V31, P162, DOI 10.1111/j.0307-6946.2006.00781.x; MOORE KC, 1983, J INVERTEBR PATHOL, V42, P413, DOI 10.1016/0022-2011(83)90187-8; Morales-Ramos JA, 2011, ENVIRON ENTOMOL, V40, P1285, DOI 10.1603/EN10239; Moretti A, 2007, INT J FOOD MICROBIOL, V118, P158, DOI 10.1016/j.ijfoodmicro.2007.07.004; NELSON PE, 1993, ANNU REV PHYTOPATHOL, V31, P233, DOI 10.1146/annurev.py.31.090193.001313; Cambuim IIF, 2007, BRAZ J MICROBIOL, V38, P285, DOI 10.1590/S1517-83822007000200018; Nucci M, 2007, CLIN MICROBIOL REV, V20, P695, DOI 10.1128/CMR.00014-07; Nutz S, 2011, ANAL BIOANAL CHEM, V401, P717, DOI 10.1007/s00216-011-5089-x; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; Ormond EL, 2011, FEMS MICROBIOL ECOL, V77, P229, DOI 10.1111/j.1574-6941.2011.01100.x; Parry DW, 1996, PLANT PATHOL, V45, P383, DOI 10.1046/j.1365-3059.1996.d01-133.x; PARRY DW, 1995, PLANT PATHOL, V44, P207, DOI 10.1111/j.1365-3059.1995.tb02773.x; Pestka JJ, 2007, ANIM FEED SCI TECH, V137, P283, DOI 10.1016/j.anifeedsci.2007.06.006; Placinta CM, 1999, ANIM FEED SCI TECH, V78, P21, DOI 10.1016/S0377-8401(98)00278-8; Proctor RH, 1995, MOL PLANT MICROBE IN, V8, P1995; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Rohlfs M, 2011, FUNGAL GENET BIOL, V48, P23, DOI 10.1016/j.fgb.2010.08.008; Rohlfs Marko, 2009, Mycotoxin Res, V25, P103, DOI 10.1007/s12550-009-0015-1; Schilling AG, 1996, PHYTOPATHOLOGY, V86, P515, DOI 10.1094/Phyto-86-515; Staaden S, 2010, SOIL BIOL BIOCHEM, V42, P1766, DOI 10.1016/j.soilbio.2010.06.014; STRONGMAN DB, 1988, J CHEM ECOL, V14, P753, DOI 10.1007/BF01018770; Summerell BA, 2010, FUNGAL DIVERS, V44, P3, DOI 10.1007/s13225-010-0060-2; TEETORBARSCH GH, 1983, MYCOPATHOLOGIA, V84, P3, DOI 10.1007/BF00436991; Trienens M, 2012, FUNGAL ECOL, V5, P191, DOI 10.1016/j.funeco.2011.07.009; Utermark J, 2007, APPL ENVIRON MICROB, V73, P637, DOI 10.1128/AEM.01440-06; Voss KA, 2007, ANIM FEED SCI TECH, V137, P299, DOI 10.1016/j.anifeedsci.2007.06.007; Waalwijk C, 2004, EUR J PLANT PATHOL, V110, P481, DOI 10.1023/B:EJPP.0000032387.52385.13; Wang QG, 2012, MOLECULES, V17, P2367, DOI 10.3390/molecules17032367; Waskiewicz A, 2010, FOOD ADDIT CONTAM A, V27, P608, DOI 10.1080/19440040903551947	53	13	14	0	73	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100112	10.1371/journal.pone.0100112	http://dx.doi.org/10.1371/journal.pone.0100112			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932485	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600096
J	Koumura, T; Urakubo, H; Ohashi, K; Fujii, M; Kuroda, S				Koumura, Takuya; Urakubo, Hidetoshi; Ohashi, Kaoru; Fujii, Masashi; Kuroda, Shinya			Stochasticity in Ca2+ Increase in Spines Enables Robust and Sensitive Information Coding	PLOS ONE			English	Article							CEREBELLAR PURKINJE-CELLS; SMALL SUBCELLULAR VOLUMES; LONG-TERM DEPRESSION; DENDRITIC SPINES; REWARD PROBABILITY; CLIMBING FIBER; MOTOR CONTROL; DYNAMICS; PLASTICITY; INDUCTION	A dendritic spine is a very small structure (similar to 0.1 mu m(3)) of a neuron that processes input timing information. Why are spines so small? Here, we provide functional reasons; the size of spines is optimal for information coding. Spines code input timing information by the probability of Ca2+ increases, which makes robust and sensitive information coding possible. We created a stochastic simulation model of input timing-dependent Ca2+ increases in a cerebellar Purkinje cell's spine. Spines used probability coding of Ca2+ increases rather than amplitude coding for input timing detection via stochastic facilitation by utilizing the small number of molecules in a spine volume, where information per volume appeared optimal. Probability coding of Ca2+ increases in a spine volume was more robust against input fluctuation and more sensitive to input numbers than amplitude coding of Ca2+ increases in a cell volume. Thus, stochasticity is a strategy by which neurons robustly and sensitively code information.	[Koumura, Takuya; Kuroda, Shinya] Univ Tokyo, Undergrad Dept Bioinformat & Syst Biol, Bunkyo Ku, Tokyo, Japan; [Urakubo, Hidetoshi; Ohashi, Kaoru; Fujii, Masashi; Kuroda, Shinya] Univ Tokyo, Grad Sch Sci, Dept Biophys & Biochem, Bunkyo Ku, Tokyo 113, Japan	University of Tokyo; University of Tokyo	Kuroda, S (corresponding author), Univ Tokyo, Undergrad Dept Bioinformat & Syst Biol, Bunkyo Ku, Tokyo, Japan.	skuroda@bs.s.u-tokyo.ac.jp	Koumura, Takuya/GYQ-5737-2022; Fujii, Masashi/S-1516-2019	Fujii, Masashi/0000-0002-1586-6435; Koumura, Takuya/0000-0002-8380-9598; Urakubo, Hidetoshi/0000-0002-1816-0040	Ministry of Education, Culture, Sports, Science, and Technology of Japan; CREST from the Japan Science and Technology; Human Frontier Science Project [RGP0061/2011]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CREST from the Japan Science and Technology; Human Frontier Science Project(Human Frontier Science Program)	This work was supported by the National Project "Next Generation Integrated Living Matter Simulation" and "Bioinformatics for Brain Sciences" of the Ministry of Education, Culture, Sports, Science, and Technology of Japan (www.jsps.go.jp), the Creation of Fundamental Technologies for Understanding and Control of Biosystem Dynamics, CREST, from the Japan Science and Technology (www.jst.go.jp), and by a Human Frontier Science Project (www.hfsp.org) grant (RGP0061/2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antunes G, 2012, J NEUROSCI, V32, P9288, DOI 10.1523/JNEUROSCI.5976-11.2012; BARBOUR B, 1993, NEURON, V11, P759, DOI 10.1016/0896-6273(93)90085-6; Berridge MJ, 1998, NEURON, V21, P13, DOI 10.1016/S0896-6273(00)80510-3; Bhalla US, 2004, BIOPHYS J, V87, P733, DOI 10.1529/biophysj.104.040469; Bhalla US, 2004, BIOPHYS J, V87, P745, DOI 10.1529/biophysj.104.040501; Bogacki P., 1989, APPL MATH LETT, V2, P321, DOI [10.1016/0893-9659(89)90079-7, DOI 10.1016/0893-9659(89)90079-7]; Cao Y, 2006, J CHEM PHYS, V124, DOI 10.1063/1.2159468; De Schutter E, 2012, NEURAL NETW; Doi T, 2005, J NEUROSCI, V25, P950, DOI 10.1523/JNEUROSCI.2727-04.2005; EILERS J, 1995, P NATL ACAD SCI USA, V92, P10272, DOI 10.1073/pnas.92.22.10272; Enoki R, 2009, NEURON, V62, P242, DOI 10.1016/j.neuron.2009.02.026; Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541; HARRIS KM, 1988, J NEUROSCI, V8, P4455; Inoue T, 1998, J NEUROSCI, V18, P5366, DOI 10.1523/JNEUROSCI.18-14-05366.1998; Ito M, 2002, NAT REV NEUROSCI, V3, P896, DOI 10.1038/nrn962; ITO M, 1970, INT J NEUROL, V7, P162; Kawato M, 1999, CURR OPIN NEUROBIOL, V9, P718, DOI 10.1016/S0959-4388(99)00028-8; Kawato M, 2011, CURR OPIN NEUROBIOL, V21, P791, DOI 10.1016/j.conb.2011.05.014; Kitamura K, 2011, J NEUROSCI, V31, P10847, DOI 10.1523/JNEUROSCI.2525-10.2011; Komorowski M, 2011, P NATL ACAD SCI USA, V108, P8645, DOI 10.1073/pnas.1015814108; Kuroda S, 2001, J NEUROSCI, V21, P5693, DOI 10.1523/JNEUROSCI.21-15-05693.2001; Mauk MD, 1998, NEURON, V20, P359, DOI 10.1016/S0896-6273(00)80978-2; McDonnell MD, 2011, NAT REV NEUROSCI, V12, P415, DOI 10.1038/nrn3061; MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178, DOI 10.1152/jn.1992.68.4.1178; NAPPER RMA, 1988, J COMP NEUROL, V274, P168, DOI 10.1002/cne.902740204; O'Connor DH, 2005, P NATL ACAD SCI USA, V102, P9679, DOI 10.1073/pnas.0502332102; Petersen CCH, 1998, P NATL ACAD SCI USA, V95, P4732, DOI 10.1073/pnas.95.8.4732; RAPP M, 1994, J PHYSIOL-LONDON, V474, P101, DOI 10.1113/jphysiol.1994.sp020006; Skupin A, 2008, BIOPHYS J, V94, P2404, DOI 10.1529/biophysj.107.119495; Skupin A, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000870; STEINMETZ JE, 1990, BEHAV BRAIN RES, V38, P97, DOI 10.1016/0166-4328(90)90008-3; Stuart G., 1999, DENDRITES; TAKACS J, 1994, J NEUROSCI RES, V38, P515, DOI 10.1002/jnr.490380505; Tanaka K, 2008, NEURON, V59, P608, DOI 10.1016/j.neuron.2008.06.026; Thomas AP, 1996, FASEB J, V10, P1505, DOI 10.1096/fasebj.10.13.8940296; Thomas J, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00214; Thurley K, 2011, BIOPHYS J, V101, P2638, DOI 10.1016/j.bpj.2011.10.030; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; van Duuren E, 2009, J NEUROSCI, V29, P8965, DOI 10.1523/JNEUROSCI.0005-09.2009; Wang SSH, 2000, NAT NEUROSCI, V3, P1266, DOI 10.1038/81792	40	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99040	10.1371/journal.pone.0099040	http://dx.doi.org/10.1371/journal.pone.0099040			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932482	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600018
J	Lebel, A; Kestens, Y; Clary, C; Bisset, S; Subramanian, SV				Lebel, Alexandre; Kestens, Yan; Clary, Christelle; Bisset, Sherri; Subramanian, S. V.			Geographic Variability in the Association between Socioeconomic Status and BMI in the USA and Canada	PLOS ONE			English	Article							BODY-MASS INDEX; POPULATION INTERVENTIONS; UNITED-STATES; OBESITY; HEALTH; INEQUALITIES; PREVALENCE; WEIGHT; TRENDS; PLACE	Objective: Reported associations between socioeconomic status (SES) and obesity are inconsistent depending on gender and geographic location. Globally, these inconsistent observations may hide a variation in the contextual effect on individuals' risk of obesity for subgroups of the population. This study explored the regional variability in the association between SES and BMI in the USA and in Canada, and describes the geographical variance patterns by SES category. Methods: The 2009-2010 samples of the Behavioral Risk Factor Surveillance System (BRFSS) and the Canadian Community Health Survey (CCHS) were used for this comparison study. Three-level random intercept and differential variance multilevel models were built separately for women and men to assess region-specific BMI by SES category and their variance bounds. Results: Associations between individual SES and BMI differed importantly by gender and countries. At the regional-level, the mean BMI variation was significantly different between SES categories in the USA, but not in Canada. In the USA, whereas the county-specific mean BMI of higher SES individuals remained close to the mean, its variation grown as SES decreased. At the county level, variation of mean BMI around the regional mean was 5 kg/m(2) in the high SES group, and reached 8.8 kg/m(2) in the low SES group. Conclusions: This study underlines how BMI varies by country, region, gender and SES. Lower socioeconomic groups within some regions show a much higher variation in BMI than in other regions. Above the BMI regional mean, important variation patterns of BMI by SES and place of residence were found in the USA. No such pattern was found in Canada. This study suggests that a change in the mean does not necessarily reflect the change in the variance. Analyzing the variance by SES may be a good way to detect subtle influences of social forces underlying social inequalities.	[Lebel, Alexandre; Bisset, Sherri] Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ, Canada; [Lebel, Alexandre; Subramanian, S. V.] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Lebel, Alexandre] Univ Laval, Grad Sch Land Management & Reg Planning, Quebec City, PQ, Canada; [Kestens, Yan; Clary, Christelle] CHUM Res Ctr, Montreal, PQ, Canada; [Kestens, Yan; Clary, Christelle] Univ Montreal, Dept Social & Prevent Med, Montreal, PQ, Canada; [Bisset, Sherri] Univ Laval, Fac Nursing Sci, Quebec City, PQ, Canada	Laval University; Quebec Heart & Lung Institute; Harvard University; Harvard T.H. Chan School of Public Health; Laval University; Universite de Montreal; Universite de Montreal; Laval University	Lebel, A (corresponding author), Univ Laval, Quebec Heart & Lung Inst, Quebec City, PQ, Canada.	alebel@criucpq.ulaval.ca	Kestens, Yan/D-1631-2012	Kestens, Yan/0000-0003-2619-5750; Lebel, Alexandre/0000-0001-6774-7633	Quebec's Funds for Health research (FRQS) [20757]	Quebec's Funds for Health research (FRQS)	The study was funded by the the Quebec's Funds for Health research (FRQS,20757). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bird CE, 2008, GENDER AND HEALTH: THE EFFECTS OF CONSTRAINED CHOICES AND SOCIAL POLICIES, P1, DOI 10.1017/CBO9780511807305; Center for Disease Control and Prevention, 2006, NCHS URB RUR CLASS S; Centers for Disease Control and Prevention, 2012, BEH RISK FACT SURV S; Chaix B, 2010, EPIDEMIOLOGY, V21, P124, DOI 10.1097/EDE.0b013e3181c04e70; Cummins S, 2007, SOC SCI MED, V65, P1825, DOI 10.1016/j.socscimed.2007.05.036; Curtis S., 2004, HLTH INEQUALITY GEOG; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Ford ES, 2008, J CLIN ENDOCR METAB, V93, pS1, DOI 10.1210/jc.2008-1356; Freedman DS, 2011, OBESITY US 1988 2008; Giskes K, 2010, OBES REV, V11, P413, DOI 10.1111/j.1467-789X.2009.00658.x; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Gorber SC, 2010, OBESITY, V18, P354, DOI 10.1038/oby.2009.206; Grabner M, 2012, OBESITY FACTS, V5, P112, DOI 10.1159/000337018; Huang TT, 2009, PREV CHRONIC DIS, V6; Kawachi I., 2003, NEIGHBORHOODS HLTH; King D, 2011, LANCET, V378, P743, DOI 10.1016/S0140-6736(11)61261-0; Liu SY, 2012, EPIDEMIOLOGY, V23, P657, DOI 10.1097/EDE.0b013e318261c7cc; Ljungvall A, 2012, SOCIAL SCI MED; Marmot M., 2009, SOCIAL DETERMINANTS; Matheson FI, 2008, SOC SCI MED, V66, P675, DOI 10.1016/j.socscimed.2007.10.008; McGrail KM, 2009, AM J PUBLIC HEALTH, V99, P1856, DOI 10.2105/AJPH.2007.129361; McKeown-Eyssen G, 2006, EPIDEMIOLOGY, V17, P134, DOI 10.1097/01.ede.0000199256.61707.b3; McLaren L., 2011, OXFORD HDB SOCIAL SC, P276; McLaren L, 2007, EPIDEMIOL REV, V29, P29, DOI 10.1093/epirev/mxm001; Michimi A, 2010, AM J PREV MED, V39, pE1, DOI 10.1016/j.amepre.2010.04.008; Monteiro CA, 2004, B WORLD HEALTH ORGAN, V82, P940; Ogden C.L., 2010, OBESITY SOCIOECONOMI; Openshaw S., 1983, MODIFIABLE AREAL UNI; Pampel FC, 2012, SOC SCI MED, V74, P1073, DOI 10.1016/j.socscimed.2011.12.028; PHAC/CIHI, 2011, OB CAN; Prus SG, 2011, SOC SCI MED, V73, P50, DOI 10.1016/j.socscimed.2011.04.010; Roux AVD, 2002, J EPIDEMIOL COMMUN H, V56, P588, DOI 10.1136/jech.56.8.588; Shields M, 2011, ADULT OBESITY PREVAL; SOBAL J, 1989, PSYCHOL BULL, V105, P260, DOI 10.1037/0033-2909.105.2.260; Stamatakis KA, 2012, J PUBLIC HEALTH MAN, V18, P402, DOI 10.1097/PHH.0b013e318221718c; Statistics Canada, 2012, CAN COMM HLTH SURV; Subramanian SV, 2011, AM J CLIN NUTR, V93, P413, DOI 10.3945/ajcn.110.004820; Subramanian SV, 2004, EPIDEMIOL REV, V26, P78, DOI 10.1093/epirev/mxh003; Tjepkema M, 2006, ADULT OBESITY, P9; Veerman JL, 2010, EPIDEMIOLOGY, V21, P274, DOI 10.1097/EDE.0b013e3181cc9dee; Walls HL, 2010, EPIDEMIOLOGY, V21, P275, DOI 10.1097/EDE.0b013e3181cc93be	43	22	22	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99158	10.1371/journal.pone.0099158	http://dx.doi.org/10.1371/journal.pone.0099158			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ5PV	24932774	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600025
J	Zhang, CL; Hu, JJ; Liu, XY; Yan, JQ				Zhang, Chengliang; Hu, Jiajia; Liu, Xinyao; Yan, Jianqin			Effects of Intravenous Dexmedetomidine on Emergence Agitation in Children under Sevoflurane Anesthesia: A Meta-Analysis of Randomized Controlled Trials	PLOS ONE			English	Article							POSTOPERATIVE RECOVERY; INTRANASAL FENTANYL; REDUCES AGITATION; GREATER INCIDENCE; CLINICAL-USES; HALOTHANE; DESFLURANE; SURGERY; DELIRIUM; MORPHINE	Objective: Emergence agitation (EA) is a common complication in children under sevoflurane anesthesia. The aim of this meta-analysis was to evaluate the effects of intravenous dexmedetomidine on EA in children under sevoflurane anesthesia. Methods: A comprehensive literature search was conducted to identify clinical trials that evaluated the effects of intravenous dexmedetomidine and placebo on EA in children under sevoflurane anesthesia. The search collected trials from MEDLINE, Cochrane Central Register of Controlled Trials (CENTRAL), Embase, and Web of Science. Analysis was conducted using STATA version 12.0. Data from each trial were pooled using relative ratio (RR) for dichotomous data or weighted mean difference (WMD) for continuous data and corresponding 95% confidence interval (95% CI). Heterogeneity assessment, sensitivity analysis, and publication bias were performed. Results: Twelve trials, in which 459 patients received dexmedetomidine and 353 patients received placebo, were included in this analysis. We found that intravenous dexmedetomidine decreased the incidences of EA (RR = 0.346, 95% CI 0.263 to 0.453, P<0.001), and postoperative pain (RR = 0.405, 95% CI 0.253 to 0.649, P<0.001). Intravenous dexmedetomidine also prolonged extubation time (WMD = 0.617, 95% CI 0.276 to 958, P<0.001), and emergence time (WMD = 0.997, 95% CI 0.392 to 1.561, P = 0.001). Further evidences are required to evaluate the incidence of postoperative nausea and vomiting (PONV). Sensitivity analysis strengthened evidences for lower incidences of EA, pain, and prolonged extubation time, and emergence time. Funnel plots did not detect any significant publication bias. Conclusion: Meta-analysis demonstrated that dexmedetomidine decreased the incidence of EA in children under sevoflurane anesthesia.	[Zhang, Chengliang; Hu, Jiajia; Yan, Jianqin] Cent South Univ, Xiangya Hosp, Dept Anesthesiol, Changsha, Hunan, Peoples R China; [Liu, Xinyao] Cent South Univ, Xiangya Hosp 3, Dept Cardiol, Changsha, Hunan, Peoples R China	Central South University; Central South University	Yan, JQ (corresponding author), Cent South Univ, Xiangya Hosp, Dept Anesthesiol, Changsha, Hunan, Peoples R China.	jqyan480@gmail.com						Ali Monaz Abdulrahman, 2013, Saudi J Anaesth, V7, P296, DOI 10.4103/1658-354X.115363; Aono J, 1997, ANESTHESIOLOGY, V87, P1298, DOI 10.1097/00000542-199712000-00006; Aono J, 1999, ACTA ANAESTH SCAND, V43, P542, DOI 10.1034/j.1399-6576.1999.430509.x; Aouad MT, 2005, CURR OPIN ANESTHESIO, V18, P614, DOI 10.1097/01.aco.0000188420.84763.35; Arain SR, 2004, ANESTH ANALG, V98, P153, DOI 10.1213/01.ANE.0000093225.39866.75; Bhana N, 2000, DRUGS, V59, P263, DOI 10.2165/00003495-200059020-00012; Blaudszun G, 2012, ANESTHESIOLOGY, V116, P1312, DOI 10.1097/ALN.0b013e31825681cb; Bortone L, 2006, PEDIATR ANESTH, V16, P1138, DOI 10.1111/j.1460-9592.2006.01954.x; Chen JY, 2013, CAN J ANESTH, V60, P385, DOI 10.1007/s12630-013-9886-x; Cohen IT, 2002, ANESTH ANALG, V94, P1178, DOI 10.1097/00000539-200205000-00023; Cohen IT, 2001, ANESTH ANALG, V93, P88; Cohen IT, 2003, PAEDIATR ANAESTH, V13, P63, DOI 10.1046/j.1460-9592.2003.00948.x; Dahmani S, 2010, BRIT J ANAESTH, V104, P216, DOI 10.1093/bja/aep376; Ebert TJ, 2000, ANESTHESIOLOGY, V93, P382, DOI 10.1097/00000542-200008000-00016; Eger EI, 2004, AM J HEALTH-SYST PH, V61, pS3, DOI 10.1093/ajhp/61.suppl_4.S3; Erdil F, 2009, ANAESTH INTENS CARE, V37, P571, DOI 10.1177/0310057X0903700405; Finkel JC, 2001, ANESTH ANALG, V92, P1164; Galinkin JL, 2000, ANESTHESIOLOGY, V93, P1378, DOI 10.1097/00000542-200012000-00006; Guler G, 2005, PEDIATR ANESTH, V15, P762, DOI 10.1111/j.1460-9592.2004.01541.x; Gupta N, 2013, J NEUROSURG ANESTH, V25, P271, DOI 10.1097/ANA.0b013e31828cb6c0; He L, 2013, ANAESTH INTENS CARE, V41, P328, DOI 10.1177/0310057X1304100309; Higgins J.P., 2011, COCHRANE HDB SYSTEMA, V4, DOI [10.1002/9780470712184, DOI 10.1002/9780470712184]; Higgins JP, 2008, COCHRANE HDB SYSTEMA, P412; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Ibacache ME, 2004, ANESTH ANALG, V98, P60, DOI 10.1213/01.ANE.0000094947.20838.8E; Isik B, 2006, PEDIATR ANESTH, V16, P748, DOI 10.1111/j.1460-9592.2006.01845.x; KALLIO A, 1989, CLIN PHARMACOL THER, V46, P33, DOI 10.1038/clpt.1989.103; Kamibayashi T, 2000, ANESTHESIOLOGY, V93, P1345, DOI 10.1097/00000542-200011000-00030; Kanaya A, 2013, J ANESTH; Kuratani N, 2008, ANESTHESIOLOGY, V109, P225, DOI 10.1097/ALN.0b013e31817f5c18; Liberati A, 2009, PLOS MED, V6, DOI [10.1371/journal.pmed.1000100, 10.1136/bmj.b2700, 10.7326/0003-4819-151-4-200908180-00136]; Lin TF, 2009, BRIT J ANAESTH, V102, P117, DOI 10.1093/bja/aen320; Mason KP, 2011, ANESTH ANALG, V113, P1129, DOI 10.1213/ANE.0b013e31822b8629; Meng QT, 2012, INT J PEDIATR OTORHI, V76, P1036, DOI 10.1016/j.ijporl.2012.03.028; Miyasaka K, 2003, PAEDIATR ANAESTH, V13, P641, DOI 10.1046/j.1460-9592.2003.00986_2.x; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Moore JK, 2003, BRIT J ANAESTH, V90, P461, DOI 10.1093/bja/aeg098; Przybylo HJ, 2003, PAEDIATR ANAESTH, V13, P609, DOI 10.1046/j.1460-9592.2003.01099.x; Reardon DP, 2013, AM J HEALTH-SYST PH, V70, P767, DOI 10.2146/ajhp120211; Sato M, 2010, J ANESTH, V24, P675, DOI 10.1007/s00540-010-0976-4; Shukry M, 2005, PEDIATR ANESTH, V15, P1098, DOI 10.1111/j.1460-9592.2005.01660.x; Su F, 2011, EXPERT OPIN DRUG SAF, V10, P55, DOI 10.1517/14740338.2010.512609; Tobias JD, 2007, PEDIATR CRIT CARE ME, V8, P115, DOI 10.1097/01.PCC.0000257100.31779.41; Unlugenc H, 2005, EUR J ANAESTH, V22, P386, DOI 10.1017/S0265021505000669; Venn RM, 2002, BRIT J ANAESTH, V88, P669, DOI 10.1093/bja/88.5.669; Vlajkovic GP, 2007, ANESTH ANALG, V104, P84, DOI 10.1213/01.ane.0000250914.91881.a8; Welborn LG, 1996, ANESTH ANALG, V83, P917, DOI 10.1097/00000539-199611000-00005; Xu LL, 2012, J ANESTH, V26, P556, DOI 10.1007/s00540-012-1354-1	48	23	26	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99718	10.1371/journal.pone.0099718	http://dx.doi.org/10.1371/journal.pone.0099718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932765	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600059
J	Zhang, YF; Shi, WW; Gao, HF; Zhou, L; Hou, AJ; Zhou, YH				Zhang, Yu-Fei; Shi, Wei-Wu; Gao, Hong-Fang; Zhou, Li; Hou, An-Ji; Zhou, Yu-Hao			Folate Intake and the Risk of Breast Cancer: A Dose-Response Meta-Analysis of Prospective Studies	PLOS ONE			English	Article							FOLIC-ACID; POSTMENOPAUSAL WOMEN; TREND ESTIMATION; ALCOHOL; VITAMIN-B-12; METHIONINE; CONSUMPTION; PROSTATE; DIET	Background: Previous observational studies regarding the existence of an association between folate intake and the risk of breast cancer have been inconsistent. This study aimed to summarize the evidence regarding this relationship using a dose-response meta-analytic approach. Methodology and Principal Findings: We performed electronic searches of the PubMed, EmBase, and Cochrane Library databases to identify studies published through June 2013. Only prospective observational studies that reported breast cancer effect estimates with 95% confidence intervals (CIs) for more than 2 folate intake categories were included. We excluded traditional case-control studies because of possible bias from various confounding factors. Overall, we included 14 prospective studies that reported data on 677,858 individuals. Folate intake had little effect on the breast cancer risk (relative risk (RR) for highest versus lowest category = 0.97; 95% CI, 0.90-1.05; P = 0.451). Dose-response meta-analysis also suggested that a 100 mg/day increase in folate intake had no significant effect on the risk of breast cancer (RR = 0.99; 95% CI, 0.98-1.01; P = 0.361). Furthermore, we used restricted cubic splines to evaluate the nonlinear relationship between folate intake and the risk of breast cancer, and discovered a potential J-shaped correlation between folate intake and breast cancer risk (P = 0.007) and revealed that a daily folate intake of 200-320 mg was associated with a lower breast cancer risk; however, the breast cancer risk increased significantly with a daily folate intake >400 mg. Conclusion/Significance: Our study revealed that folate intake had little or no effect on the risk of breast cancer; moreover, a dose-response meta-analysis suggested a J-shaped association between folate intake and breast cancer.	[Zhang, Yu-Fei; Gao, Hong-Fang; Zhou, Li; Hou, An-Ji] Shanghai Seventh Peoples Hosp, Dept Oncol, Shanghai, Peoples R China; [Shi, Wei-Wu] Taizhou Hosp Zhejiang Prov, Wenzhou Med Coll, Med Res Ctr, Linhai, Zhejiang, Peoples R China; [Zhou, Yu-Hao] Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China	Wenzhou Medical University	Zhou, YH (corresponding author), Shanghai Seventh Peoples Hosp, Dept Rehabil Inst, Shanghai, Peoples R China.	zhou_ly@126.com	Zhang, yufei/HHC-7375-2022		academic pacemaker programming in health systems, Pudong New Area, Shanghai [PWRD2012-12]; Fund being innovative of science and technology development fund, Pudong New Area, Shanghai [PKJ2012-Y04]; medicant project of Shuguang foundation of Chinese medical development office in Shanghai [2012JJHM012]	academic pacemaker programming in health systems, Pudong New Area, Shanghai; Fund being innovative of science and technology development fund, Pudong New Area, Shanghai; medicant project of Shuguang foundation of Chinese medical development office in Shanghai	This study was funded by the academic pacemaker programming in health systems, Pudong New Area, Shanghai (PWRD2012-12), Fund being innovative of science and technology development fund, Pudong New Area, Shanghai (PKJ2012-Y04) and the medicant project of Shuguang foundation of Chinese medical development office in Shanghai (2012JJHM012). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ades AE, 2005, MED DECIS MAKING, V25, P646, DOI 10.1177/0272989X05282643; Baglietto L, 2005, BMJ-BRIT MED J, V331, P807, DOI 10.1136/bmj.38551.446470.06; Bassett JK, 2013, CANCER CAUSE CONTROL, V24, P1555, DOI 10.1007/s10552-013-0232-y; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Cho EY, 2003, CANCER EPIDEM BIOMAR, V12, P713; Choi SW, 2002, J NUTR, V132, p2413S, DOI 10.1093/jn/132.8.2413S; Collin SM, 2010, CANCER EPIDEM BIOMAR, V19, P1632, DOI 10.1158/1055-9965.EPI-10-0180; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Duffy CM, 2009, BREAST CANCER RES TR, V116, P551, DOI 10.1007/s10549-008-0167-2; Ebbing M, 2009, JAMA-J AM MED ASSOC, V302, P2119, DOI 10.1001/jama.2009.1622; Egger M, 1997, BMJ-BRIT MED J, V315, P629, DOI 10.1136/bmj.315.7109.629; Ericson U, 2007, AM J CLIN NUTR, V86, P434, DOI 10.1093/ajcn/86.2.434; Feigelson HS, 2003, CANCER EPIDEM BIOMAR, V12, P161; GREENLAND S, 1992, AM J EPIDEMIOL, V135, P1301, DOI 10.1093/oxfordjournals.aje.a116237; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Jefferson T, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000975.pub2; Kennedy DA, 2011, CANCER EPIDEMIOL, V35, P2, DOI 10.1016/j.canep.2010.11.004; Lajous M, 2006, CANCER CAUSE CONTROL, V17, P1209, DOI 10.1007/s10552-006-0053-3; Larsson SC, 2007, JNCI-J NATL CANCER I, V99, P64, DOI 10.1093/jnci/djk006; Larsson SC, 2006, GASTROENTEROLOGY, V131, P1271, DOI 10.1053/j.gastro.2006.08.010; Larsson SC, 2008, CANCER EPIDEM BIOMAR, V17, P3444, DOI 10.1158/1055-9965.EPI-08-0692; Lin J, 2008, AM J CLIN NUTR, V87, P734, DOI 10.1093/ajcn/87.3.734; Maruti SS, 2009, AM J CLIN NUTR, V89, P624, DOI 10.3945/ajcn.2008.26568; Mason J B, 1996, Oncology (Williston Park), V10, P1727; Mason JB, 2007, CANCER EPIDEM BIOMAR, V16, P1325, DOI 10.1158/1055-9965.EPI-07-0329; Moher D, 2009, PLOS MED, V6, DOI [10.1136/bmj.b4037, 10.1371/journal.pmed.1000097]; Orsini N, 2006, STATA J, V6, P40, DOI 10.1177/1536867X0600600103; Rohan TE, 2000, J NATL CANCER I, V92, P266, DOI 10.1093/jnci/92.3.266; Roswall N, 2010, EUR J CANCER PREV, V19, P360, DOI 10.1097/CEJ.0b013e32833ade68; Sellers TA, 2004, CANCER CAUSE CONTROL, V15, P113, DOI 10.1023/B:CACO.0000019471.97208.c6; Sellers TA, 2001, EPIDEMIOLOGY, V12, P420, DOI 10.1097/00001648-200107000-00012; Shrubsole MJ, 2011, AM J EPIDEMIOL, V173, P1171, DOI 10.1093/aje/kwq491; Stevens VL, 2010, AM J CLIN NUTR, V91, P1708, DOI 10.3945/ajcn.2009.28553; Stolzenberg-Solomon RZ, 2006, AM J CLIN NUTR, V83, P895, DOI 10.1093/ajcn/83.4.895; Tjonneland A, 2006, EUR J CLIN NUTR, V60, P280, DOI 10.1038/sj.ejcn.1602313; Vollset SE, 2013, LANCET, V381, P1029, DOI 10.1016/S0140-6736(12)62001-7; Wells G.A., 2000, VIS COMMUN Q; Zhang SMM, 2008, JAMA-J AM MED ASSOC, V300, P2012, DOI 10.1001/jama.2008.555; Zhang SM, 1999, JAMA-J AM MED ASSOC, V281, P1632, DOI 10.1001/jama.281.17.1632	40	29	29	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100044	10.1371/journal.pone.0100044	http://dx.doi.org/10.1371/journal.pone.0100044			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932496	Green Submitted, gold, Green Published			2022-12-27	WOS:000337738600086
J	Aichele, SR; Mulder, MB; James, S; Grimm, K				Aichele, Stephen R.; Mulder, Monique Borgerhoff; James, Susan; Grimm, Kevin			Attitudinal and Behavioral Characteristics Predict High Risk Sexual Activity in Rural Tanzanian Youth	PLOS ONE			English	Article							YOUNG-PEOPLE; HIV PREVENTION; SOUTH-AFRICA; HEALTH; ADOLESCENCE; PREVALENCE	The incidence of HIV infection in rural African youth remains high despite widespread knowledge of the disease within the region and increasing funds allocated to programs aimed at its prevention and treatment. This suggests that program efficacy requires a more nuanced understanding of the profiles of the most at-risk individuals. To evaluate the explanatory power of novel psychographic variables in relation to high-risk sexual behaviors, we conducted a survey to assess the effects of psychographic factors, both behavioral and attitudinal, controlling for standard predictors in 546 youth (12-26 years of age) across 8 villages in northern Tanzania. Indicators of high-risk sexual behavior included HIV testing, sexual history (i.e., virgin/non-virgin), age of first sexual activity, condom use, and number of lifetime sexual partners. Predictors in the statistical models included standard demographic variables, patterns of media consumption, HIV awareness, and six new psychographic features identified via factor analyses: personal vanity, family-building values, ambition for higher education, town recreation, perceived parental strictness, and spending preferences. In a series of hierarchical regression analyses, we find that models including psychographic factors contribute significant additional explanatory information when compared to models including only demographic and other conventional predictors. We propose that the psychographic approach used here, in so far as it identifies individual characteristics, aspirations, aspects of personal life style and spending preferences, can be used to target appropriate communities of youth within villages for leading and receiving outreach, and to build communities of like-minded youth who support new patterns of sexual behavior.	[Aichele, Stephen R.; Grimm, Kevin] Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA; [Aichele, Stephen R.] Univ Geneva, Dept Psychol, Geneva, Switzerland; [Mulder, Monique Borgerhoff] Univ Calif Davis, Dept Anthropol, Davis, CA 95616 USA; [Mulder, Monique Borgerhoff; James, Susan] Savannas Forever, Arusha, Tanzania; [Mulder, Monique Borgerhoff] Wissensch Kolleg Berlin, Berlin, Germany; [Mulder, Monique Borgerhoff; James, Susan] Univ Minnesota, Whole Village Project, Minneapolis, MN USA	University of California System; University of California Davis; University of Geneva; University of California System; University of California Davis; University of Minnesota System; University of Minnesota Twin Cities	Aichele, SR (corresponding author), Univ Calif Davis, Dept Psychol, Davis, CA 95616 USA.	stephen.aichele@unige.ch		Aichele, Stephen/0000-0002-3397-7921	USAID; African Wildlife Foundation; Institute on the Environment (University of Minnesota)	USAID(United States Agency for International Development (USAID)); African Wildlife Foundation; Institute on the Environment (University of Minnesota)(University of Minnesota System)	The following organizations provided funding for this study: USAID (US President's Emergency Plan for AIDS Relief, PEPFAR, http://www.pepfar.gov/); The African Wildlife Foundation (http://www.awf.org/); and the Institute on the Environment (University of Minnesota, http://environment.umn.edu/). The sponsors had no role in the design of the study, nor in the collection, analysis and interpretation of the data, nor in the preparation of this material for publication.	Aaro LE, 2006, SCAND J PUBLIC HEALT, V34, P150, DOI 10.1080/14034940510032356; Bankole Akinrinola, 2007, Afr J Reprod Health, V11, P28, DOI 10.2307/25549730; Battles HB, 2002, J ADOLESCENT HEALTH, V30, P161, DOI 10.1016/S1054-139X(01)00341-X; Beguy D, 2009, J ADOLESCENT HEALTH, V45, P595, DOI 10.1016/j.jadohealth.2009.03.014; Brehney P, 2013, VISUALIZATION REGRES; Brown LK, 2000, J AM ACAD PEDIAT, V106, P22; Cowan F, 2009, CURR OPIN HIV AIDS, V4, P288, DOI 10.1097/COH.0b013e32832c7d10; Diamond C, 2000, AM J PUBLIC HEALTH, V90, P115, DOI 10.2105/AJPH.90.1.115; Gallant M, 2004, SOC SCI MED, V58, P1337, DOI 10.1016/S0277-9536(03)00331-9; Hallett TB, 2010, AIDS, V24, P147, DOI 10.1097/QAD.0b013e32833062dc; Hargreaves JR, 2010, AIDS, V24, P754, DOI 10.1097/QAD.0b013e328336672e; Hays RB, 1997, AIDS, V11, P1495, DOI 10.1097/00002030-199712000-00014; Hurley AE, 1997, J ORGAN BEHAV, V18, P667, DOI 10.1002/(SICI)1099-1379(199711)18:6<667::AID-JOB874>3.0.CO;2-T; James S, 2004, ACTA PAEDIATR, V93, P264, DOI 10.1080/08035250310007925; Kwesigabo G, 2012, J PUBLIC HEALTH POL, V33, pS23, DOI 10.1057/jphp.2012.47; Lindstrom DP, 2010, STUD FAMILY PLANN, V41, P251, DOI 10.1111/j.1728-4465.2010.00251.x; Macintyre K, 2004, AIDS BEHAV, V8, P237, DOI 10.1023/B:AIBE.0000044072.71361.b3; Mackie G, 1996, AM SOCIOL REV, V61, P999, DOI 10.2307/2096305; Mackie G., 2000, FEMALE CIRCUMCISION, P253; Mathews C, 2012, INT HEALTH, V4, P111, DOI 10.1016/j.inhe.2012.02.001; Mhalu A, 2013, J INT AIDS SOC, V16, DOI 10.7448/IAS.16.1.17342; Michielsen K, 2010, AIDS, V24, P1193, DOI 10.1097/QAD.0b013e3283384791; Ministry of Health, 1999, 13 MIN HLTH NACP EP; Moyo W, 2008, AIDS BEHAV, V12, P431, DOI 10.1007/s10461-007-9343-3; Mulder MB, 2009, HUM NATURE-INT BIOS, V20, P130, DOI 10.1007/s12110-009-9060-x; Peters LWH, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-182; Plummer ML, 2011, YOUNG PEOPLES LIVES; Range N, 2001, INT J TUBERC LUNG D, V5, P405; Rotheram-Borus MJ, 1997, AIDS BEHAV, V112, P43; Swidler A, 2007, STUD FAMILY PLANN, V38, P147, DOI 10.1111/j.1728-4465.2007.00127.x; TACAIDS, 2012, TANZ HIV AIDS MAL IN; TACAIDS, HIST TRENDS PREV EFF; TACAIDS/Tanzania ZAC/Tanzania NBS/Tanzania OCGS/Tanzania and Macro International, 2008, TANZ HIV AIDS MAL IN; UNAIDS, UNAIDS REP GLOB AIDS	34	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99987	10.1371/journal.pone.0099987	http://dx.doi.org/10.1371/journal.pone.0099987			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK2VQ	24927421	Green Published, gold			2022-12-27	WOS:000338278100103
J	Bu, ZQ; Zhao, FF; Wang, KY; Guo, YH; Su, YC; Zhai, J; Sun, YP				Bu, Zhiqin; Zhao, Feifei; Wang, Keyan; Guo, Yihong; Su, Yingchun; Zhai, Jun; Sun, Yingpu			Serum Progesterone Elevation Adversely Affects Cumulative Live Birth Rate in Different Ovarian Responders during In Vitro Fertilization and Embryo Transfer: A Large Retrospective Study	PLOS ONE			English	Article							ONGOING PREGNANCY RATES; ENDOMETRIAL RECEPTIVITY; PREMATURE LUTEINIZATION; BLASTOCYST TRANSFER; HORMONE ANTAGONIST; CYCLES; IVF; METAANALYSIS; STIMULATION; MORPHOLOGY	In order to explore the relationship between serum progesterone (P) level on the day of human chorionic gonadotrophin (HCG) administration and cumulative live birth rate in patients with different ovarian response during in vitro fertilization (IVF), we carried out this retrospective cohort study including a total of 4,651 patients undergoing their first IVF cycles from January 2011 to December 2012. All patients with a final live birth outcome (4,332 patients) were divided into three groups according to ovarian response: poor ovarian responder (<= 5 oocytes, 785 patients), intermediate ovarian responder (6-19 oocytes, 3065 patients) and high ovarian responder (>= 20 oocytes, 482 patients). The thresholds for serum P elevation were 1.60 ng/ml, 2.24 ng/ml, and 2.50 ng/ml for poor, intermediate, and high ovarian responders, respectively. Cumulative live birth rate per oocyte retrieval cycle was calculated in each group. The relationship between serum P level and cumulative live birth rate was evaluated by both univariate and multivariate logistic regression analysis. Cumulative live birth rate per oocyte retrieval cycle was inversely associated with serum P level in patients with different ovarian response. For all responders, patients with elevated P level had significantly higher number of oocytes retrieved, but lower high quality embryo rate, and lower cumulative live birth rate compared with patients with normal serum P level. In addition, serum P level adversely affected cumulative live birth rate by both univariate and multivariate logistic regression analysis, independent of ovarian response. Serum P elevation on the day of HCG administration adversely affects cumulative live birth rate per oocyte retrieval cycle in patients with different ovarian response.	[Bu, Zhiqin; Zhao, Feifei; Guo, Yihong; Su, Yingchun; Zhai, Jun; Sun, Yingpu] Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou, Henan, Peoples R China; [Wang, Keyan] Zhengzhou Univ, Sch Publ Hlth, Zhengzhou, Henan, Peoples R China	Zhengzhou University; Zhengzhou University	Sun, YP (corresponding author), Zhengzhou Univ, Affiliated Hosp 1, Reprod Med Ctr, Zhengzhou, Henan, Peoples R China.	syp2008@vip.sina.com			National Natural Science Foundation of China [31271605, U1304315]; Youth Foundation of The First Affiliated Hospital of Zhengzhou University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Foundation of The First Affiliated Hospital of Zhengzhou University	This work was supported by the National Natural Science Foundation of China (Grant NO. 31271605 and U1304315) and Youth Foundation of The First Affiliated Hospital of Zhengzhou University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balaban B, 2001, HUM REPROD, V16, P2357, DOI 10.1093/humrep/16.11.2357; Bosch E, 2010, HUM REPROD, V25, P2092, DOI 10.1093/humrep/deq125; Doldi N, 1999, HUM REPROD, V14, P601, DOI 10.1093/humrep/14.3.601; Forman EJ, 2012, HUM REPROD, V27, P1217, DOI 10.1093/humrep/des020; Garcia-Velasco JA, 2011, FERTIL STERIL, V96, P590, DOI 10.1016/j.fertnstert.2011.06.022; Garrido N, 2011, FERTIL STERIL, V96, P40, DOI 10.1016/j.fertnstert.2011.05.008; Griesinger G, 2013, FERTIL STERIL, V100, P1622, DOI 10.1016/j.fertnstert.2013.08.045; Huang CC, 2012, HUM REPROD, V27, P2036, DOI 10.1093/humrep/des141; Kotze DJ, 2010, J ASSIST REPROD GEN, V27, P309, DOI 10.1007/s10815-010-9403-x; Labarta E, 2011, HUM REPROD, V26, P1813, DOI 10.1093/humrep/der126; Li HWR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061095; Li R, 2008, REPROD BIOMED ONLINE, V16, P627, DOI 10.1016/S1472-6483(10)60475-0; Melo MAB, 2006, HUM REPROD, V21, P1503, DOI 10.1093/humrep/dei474; Papanikolaou EG, 2009, FERTIL STERIL, V91, P949, DOI 10.1016/j.fertnstert.2006.12.064; Roque M, 2013, FERTIL STERIL, V99, P156, DOI 10.1016/j.fertnstert.2012.09.003; Segal S, 2009, FERTIL STERIL, V91, P1755, DOI 10.1016/j.fertnstert.2008.02.009; Shapiro BS, 2011, FERTIL STERIL, V96, P516, DOI 10.1016/j.fertnstert.2011.02.059; SILVERBERG KM, 1994, FERTIL STERIL, V61, P508; Valbuena D, 2001, FERTIL STERIL, V76, P962, DOI 10.1016/S0015-0282(01)02018-0; Venetis CA, 2013, HUM REPROD UPDATE, V19, P433, DOI 10.1093/humupd/dmt014; Xu B, 2012, FERTIL STERIL, V97, P1321, DOI 10.1016/j.fertnstert.2012.03.014; Zhang HJ, 2012, CHINESE MED J-PEKING, V125, P2837, DOI 10.3760/cma.j.issn.0366-6999.2012.16.007; Zhang YL, 2013, SYST BIOL REPROD MED, V59, P34, DOI 10.3109/19396368.2012.731470	23	44	48	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100011	10.1371/journal.pone.0100011	http://dx.doi.org/10.1371/journal.pone.0100011			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926883	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100106
J	de Abreu, LA; Vaz, ID; Moreira, LA; da Fonseca, RN; Logullo, C				de Abreu, Leonardo Araujo; Vaz, Itabajara da Silva, Jr.; Moreira, Luciano A.; da Fonseca, Rodrigo Nunes; Logullo, Carlos			The Modulation of the Symbiont/Host Interaction between Wolbachia pipientis and Aedes fluviatilis Embryos by Glycogen Metabolism	PLOS ONE			English	Article							SYNTHASE KINASE-3; AEGYPTI; DROSOPHILA; DENGUE; GENE; EGG; EMBRYOGENESIS; INHIBITION; MOSQUITOS; BACTERIA	Wolbachia pipientis, a maternally transmitted bacterium that colonizes arthropods, may affect the general aspects of insect physiology, particularly reproduction. Wolbachia is a natural endosymbiont of Aedes fluviatilis, whose effects in embryogenesis and reproduction have not been addressed so far. In this context, we investigated the correlation between glucose metabolism and morphological alterations during A. fluviatilis embryo development in Wolbachia-positive (W+) and Wolbachia-negative (W-) mosquito strains. While both strains do not display significant morphological and larval hatching differences, larger differences were observed in hexokinase activity and glycogen contents during early and mid-stages of embryogenesis, respectively. To investigate if glycogen would be required for parasite-host interaction, we reduced Glycogen Synthase Kinase-3 (GSK-3) levels in adult females and their eggs by RNAi. GSK-3 knock-down leads to embryonic lethality, lower levels of glycogen and total protein and Wolbachia reduction. Therefore, our results suggest that the relationship between A. fluviatilis and Wolbachia may be modulated by glycogen metabolism.	[de Abreu, Leonardo Araujo; Logullo, Carlos] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Lab Sanidade Anim, Lab Quim & Funcao Prot & Peptideos, Campos Goytacazes, Rio De Janeiro, Brazil; [de Abreu, Leonardo Araujo; Logullo, Carlos] Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Unidade Expt Anim RJ, Campos Goytacazes, Rio De Janeiro, Brazil; [Moreira, Luciano A.] Fiocruz MS, Lab Malaria, Ctr Pesquisas Rene Rachou, Belo Horizonte, MG, Brazil; [de Abreu, Leonardo Araujo; da Fonseca, Rodrigo Nunes] Univ Fed Rio de Janeiro UFRJ Macae, LIBHM, Nucleo Pesquisas Ecol & Socioambientais Macae NUP, Rio De Janeiro, Brazil; [Vaz, Itabajara da Silva, Jr.] Univ Fed Rio Grande do Sul, Ctr Biotecnol, BR-90046900 Porto Alegre, RS, Brazil	Universidade Estadual do Norte Fluminense; Universidade Estadual do Norte Fluminense; Fundacao Oswaldo Cruz; Universidade Federal do Rio Grande do Sul	Logullo, C (corresponding author), Univ Estadual Norte Fluminense Darcy Ribeiro UENF, Lab Sanidade Anim, Lab Quim & Funcao Prot & Peptideos, Campos Goytacazes, Rio De Janeiro, Brazil.	carloslogullo@yahoo.com.br	vaz, itabajara/F-5244-2014; Costa, Evenilton Pessoa/F-9692-2012; da Fonseca, Rodrigo Nunes/S-3964-2018; Costa, Evenilton Pessoa/X-2273-2019; Nunes-da-Fonseca, Rodrigo/ABI-1404-2022; Silva Vaz Jr., Itabajara/A-5943-2009	vaz, itabajara/0000-0003-0309-9328; Costa, Evenilton Pessoa/0000-0003-3316-2834; da Fonseca, Rodrigo Nunes/0000-0001-9576-2849; Costa, Evenilton Pessoa/0000-0003-3316-2834; Nunes-da-Fonseca, Rodrigo/0000-0001-9576-2849; Silva Vaz Jr., Itabajara/0000-0003-0309-9328; ARAUJO DE ABREU, LEONARDO/0000-0003-0659-8931	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior (CAPES); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ))	This work was supported by grants from Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, INCT de Entomologia Molecular), Fundacao de Coordenacao de Aperfeicoamento do Pessoal de nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa de Estado do Rio de Janeiro (FAPERJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Baton LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059619; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bricker DK, 2012, SCIENCE, V337, P96, DOI 10.1126/science.1218099; Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Clevers H, 2009, CELL, V139, P227, DOI 10.1016/j.cell.2009.09.027; Consoli R. A. G B., 1976, THESIS U FEDERAL MIN; CONSOLI RAGB, 1978, B ENTOMOL RES, V68, P123, DOI 10.1017/S0007485300007203; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Darby AC, 2012, GENOME RES, V22, P2467, DOI 10.1101/gr.138420.112; DAVIS Nelson C., 1931, American Journal of Tropical Medicine, V11, P21; Dedeine F, 2001, P NATL ACAD SCI USA, V98, P6247, DOI 10.1073/pnas.101304298; Emily-Fenouil F, 1998, DEVELOPMENT, V125, P2489; Fabres A, 2010, PARASITOLOGY, V137, P1537, DOI 10.1017/S0031182010000284; Ferkey DM, 2000, DEV BIOL, V225, P471, DOI 10.1006/dbio.2000.9816; Forattini O P, 2002, CULICIDOLOGICA MED; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; Fraga A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065125; Frame S, 2001, BIOCHEM J, V359, P1, DOI 10.1042/0264-6021:3590001; Galina A, 2000, PHYTOCHEMISTRY, V53, P29, DOI 10.1016/S0031-9422(99)00456-2; Gentile C, 2005, MEM I OSWALDO CRUZ, V100, P645; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Henschel A, 2004, NUCLEIC ACIDS RES, V32, pW113, DOI 10.1093/nar/gkh408; Horn T, 2010, NUCLEIC ACIDS RES, V38, pW332, DOI 10.1093/nar/gkq317; Ikeya T, 2009, P ROY SOC B-BIOL SCI, V276, P3799, DOI 10.1098/rspb.2009.0778; Iturbe-Ormaetxe I, 2011, EMBO REP, V12, P508, DOI 10.1038/embor.2011.84; Jope RS, 2004, TRENDS BIOCHEM SCI, V29, P95, DOI 10.1016/j.tibs.2003.12.004; KOSE H, 1995, MECH DEVELOP, V51, P275, DOI 10.1016/0925-4773(95)00372-X; McMeniman CJ, 2011, J MED ENTOMOL, V48, P76, DOI 10.1603/ME09188; Melnikow E, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002151; Monnerat AT, 2002, MEM I OSWALDO CRUZ, V97, P589, DOI 10.1590/S0074-02762002000400026; Moraes J, 2007, COMP BIOCHEM PHYS A, V146, P528, DOI 10.1016/j.cbpa.2006.05.009; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Naito Y, 2005, NUCLEIC ACIDS RES, V33, pW589, DOI 10.1093/nar/gki419; Shepard DS, 2013, PLOS NEGLECT TROP D, V7, DOI [10.1371/journal.pntd.0002055, 10.1371/journal.pntd.0002056]; Sinkins SP, 2000, INSECT TRANSGENESIS, P271; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TRPIS M, 1973, B WORLD HEALTH ORGAN, V48, P447; Verheyen EM, 2010, DEV DYNAM, V239, P34, DOI 10.1002/dvdy.22019; Vital W, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-25; Walker T, 2011, NATURE, V476, P450, DOI 10.1038/nature10355; Werren John H, 2008, Nat Rev Microbiol, V6, P741, DOI 10.1038/nrmicro1969; Worthington CC, 1988, WORTH ENZ MAN ENZ RE; Yamazaki H, 2003, BIOCHEM BIOPH RES CO, V304, P229, DOI 10.1016/S0006-291X(03)00582-5; Zientz E, 2004, MICROBIOL MOL BIOL R, V68, P745, DOI 10.1128/MMBR.68.4.745-770.2004; Zug R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038544	47	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98966	10.1371/journal.pone.0098966	http://dx.doi.org/10.1371/journal.pone.0098966			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926801	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100025
J	Liu, WX; Maurer, HP; Li, GL; Tucker, MR; Gowda, M; Weissmann, EA; Hahn, V; Wurschum, T				Liu, Wenxin; Maurer, Hans Peter; Li, Guoliang; Tucker, Matthew R.; Gowda, Manje; Weissmann, Elmar A.; Hahn, Volker; Wuerschum, Tobias			Genetic Architecture of Winter Hardiness and Frost Tolerance in Triticale	PLOS ONE			English	Article							LOW-TEMPERATURE TOLERANCE; QUANTITATIVE TRAIT LOCI; CROSS-VALIDATION; CANDIDATE GENES; PLANT HEIGHT; AESTIVUM L.; VERNALIZATION; RESISTANCE; QTL; EPISTASIS	Abiotic stress experienced by autumn-sown crops during winter is of great economic importance as it can have a severe negative impact on yield. In this study, we investigated the genetic architecture of winter hardiness and frost tolerance in triticale. To this end, we used a large mapping population of 647 DH lines phenotyped for both traits in combination with genome-wide marker data. Employing multiple-line cross QTL mapping, we identified nine main effect QTL for winter hardiness and frost tolerance of which six were overlapping between both traits. Three major QTL were identified on chromosomes 5A, 1B and 5R. In addition, an epistasis scan revealed the contribution of epistasis to the genetic architecture of winter hardiness and frost tolerance in triticale. Taken together, our results show that winter hardiness and frost tolerance are complex traits that can be improved by phenotypic selection, but also that genomic approaches hold potential for a knowledge-based improvement of these important traits in elite triticale germplasm.	[Liu, Wenxin; Li, Guoliang] China Agr Univ, Crop Genet & Breeding Dept, Beijing 100094, Peoples R China; [Maurer, Hans Peter; Gowda, Manje; Hahn, Volker; Wuerschum, Tobias] Univ Hohenheim, State Plant Breeding Inst, Stuttgart, Germany; [Tucker, Matthew R.] Univ Adelaide, ARC Ctr Excellence Plant Cell Walls, Urrbrae, Australia; [Weissmann, Elmar A.] Saatzucht Dr Hege GbR Domane Hohebuch, Waldenburg, Germany	China Agricultural University; University Hohenheim; University of Adelaide; KWS Saat AG	Wurschum, T (corresponding author), Univ Hohenheim, State Plant Breeding Inst, Stuttgart, Germany.	tobias.wuerschum@uni-hohenheim.de	Gowda, Manje/AAH-4207-2019; Gowda, Manje/AAG-2251-2019; Tucker, Matthew R/C-6207-2008; Liu, Wenxin/AAI-3539-2020	Gowda, Manje/0000-0003-4434-6364; Tucker, Matthew R/0000-0003-4661-6700; Li, Guoliang/0000-0002-1190-9725; Wurschum, Tobias/0000-0002-7397-7731	German Federal Ministry of Education and Research (BMBF) [0315414]	German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF))	This research was funded by the German Federal Ministry of Education and Research (BMBF) under the promotional reference 0315414. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alheit KV, 2014, THEOR APPL GENET, V127, P251, DOI 10.1007/s00122-013-2214-6; Alheit KV, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-235; Alheit KV, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-380; [Anonymous], 2010, R LANG ENV STAT COMP; Baga M, 2007, FUNCT INTEGR GENOMIC, V7, P53, DOI 10.1007/s10142-006-0030-7; Blanc G, 2006, THEOR APPL GENET, V113, P206, DOI 10.1007/s00122-006-0287-1; Buckler ES, 2009, SCIENCE, V325, P714, DOI 10.1126/science.1174276; Busemeyer L, 2013, SCI REP-UK, V3, DOI 10.1038/srep02442; Campoli C, 2009, MOL GENET GENOMICS, V282, P141, DOI 10.1007/s00438-009-0451-9; Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407; Dhillon T, 2013, THEOR APPL GENET, V126, P2777, DOI 10.1007/s00122-013-2171-0; Dhillon T, 2010, PLANT PHYSIOL, V153, P1846, DOI 10.1104/pp.110.159079; Doerge RW, 1996, GENETICS, V142, P285; Fowler DB, 2008, CROP SCI, V48, P1147, DOI 10.2135/cropsci2007.10.0581; Galiba G, 2009, PLANT SCI, V176, P12, DOI 10.1016/j.plantsci.2008.09.016; Gilmour AR, 2009, ASREML USER GUIDE RE; Holland JB, 2002, THEOR APPL GENET, V105, P113, DOI 10.1007/s00122-001-0845-5; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; LANDER ES, 1989, GENETICS, V121, P185; Li YL, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-146; Limin AE, 2002, ANN BOT-LONDON, V89, P579, DOI 10.1093/aob/mcf102; LIMIN AE, 1985, CAN J PLANT SCI, V65, P487, DOI 10.4141/cjps85-070; Limin AE, 2006, PLANTA, V224, P360, DOI 10.1007/s00425-006-0219-y; Liu W, 2013, HEREDITY, V110, P71, DOI 10.1038/hdy.2012.63; Liu WX, 2012, THEOR APPL GENET, V125, P987, DOI 10.1007/s00122-012-1889-4; Mahfoozi S, 2001, ANN BOT-LONDON, V87, P751, DOI 10.1006/anbo.2001.1403; Miller AK, 2006, MOL GENET GENOMICS, V275, P193, DOI 10.1007/s00438-005-0076-6; Pearce S, 2013, THEOR APPL GENET, V126, P2683, DOI 10.1007/s00122-013-2165-y; PLASCHKE J, 1993, THEOR APPL GENET, V85, P1049, DOI 10.1007/BF00215046; Reif JC, 2011, THEOR APPL GENET, V123, P283, DOI 10.1007/s00122-011-1583-y; SAS Institute, 2008, SAS STAT 9 2 US GUID; Sieber AN, 2014, PLANT BREEDING, V133, P465, DOI 10.1111/pbr.12181; Snape JW, 1997, ACTA AGRON HUNG, V45, P268; Steinhoff J, 2012, THEOR APPL GENET, V125, P1539, DOI 10.1007/s00122-012-1933-4; Steinhoff J, 2011, CROP SCI, V51, P2505, DOI 10.2135/cropsci2011.03.0181; SUTKA J, 1989, EUPHYTICA, V42, P41, DOI 10.1007/BF00042613; Sutka J, 2001, EUPHYTICA, V119, P167, DOI 10.1023/A:1017520720183; Toth B, 2003, THEOR APPL GENET, V107, P509, DOI 10.1007/s00122-003-1275-3; Utz HF, 2000, GENETICS, V154, P1839; Vagujfalvi A, 2005, MOL GENET GENOMICS, V274, P506, DOI 10.1007/s00438-005-0047-y; Vagujfalvi A, 2003, MOL GENET GENOMICS, V269, P60, DOI 10.1007/s00438-003-0806-6; Vagujfalvi A, 2000, MOL GEN GENET, V263, P194, DOI 10.1007/s004380051160; Williams E, 2011, BIOMETRICAL J, V53, P19, DOI 10.1002/bimj.201000102; Wurschum T, 2014, HEREDITY, V112, P463, DOI 10.1038/hdy.2013.126; Wurschum T, 2012, HEREDITY, V108, P332, DOI 10.1038/hdy.2011.78; Wurschum T, 2014, IN VITRO CELL DEV-PL, V50, P143, DOI 10.1007/s11627-013-9539-3; Wurschum T, 2013, THEOR APPL GENET, V126, P435, DOI 10.1007/s00122-012-1991-7; Wurschum T, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-109; Wurschum T, 2012, THEOR APPL GENET, V125, P201, DOI 10.1007/s00122-012-1887-6; Yan L, 2003, P NATL ACAD SCI USA, V100, P6263, DOI 10.1073/pnas.0937399100; Zhao YS, 2013, J EXP BOT, V64, P4453, DOI 10.1093/jxb/ert259	51	9	11	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99848	10.1371/journal.pone.0099848	http://dx.doi.org/10.1371/journal.pone.0099848			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927281	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100086
J	Oliver, TR; Middlebrooks, CD; Tinker, SW; Allen, EG; Bean, LJH; Begum, F; Feingold, E; Chowdhury, R; Cheung, V; Sherman, SL				Oliver, Tiffany Renee; Middlebrooks, Candace D.; Tinker, Stuart W.; Allen, Emily Graves; Bean, Lora J. H.; Begum, Ferdouse; Feingold, Eleanor; Chowdhury, Reshmi; Cheung, Vivian; Sherman, Stephanie L.			An Examination of the Relationship between Hotspots and Recombination Associated with Chromosome 21 Nondisjunction	PLOS ONE			English	Article							DOWN-SYNDROME; HUMAN GENOME; CONFIGURATIONS; POPULATIONS; PRDM9; MAP	Trisomy 21, resulting in Down Syndrome (DS), is the most common autosomal trisomy among live-born infants and is caused mainly by nondisjunction of chromosome 21 within oocytes. Risk factors for nondisjunction depend on the parental origin and type of meiotic error. For errors in the oocyte, increased maternal age and altered patterns of recombination are highly associated with nondisjunction. Studies of normal meiotic events in humans have shown that recombination clusters in regions referred to as hotspots. In addition, GC content, CpG fraction, Poly(A)/Poly(T) fraction and gene density have been found to be significant predictors of the placement of sex-averaged recombination in the human genome. These observations led us to ask whether the altered patterns of recombination associated with maternal nondisjunction of chromosome 21 could be explained by differences in the relationship between recombination placement and recombination-related genomic features (i.e., GC content, CpG fraction, Poly(A)/Poly(T) fraction or gene density) on 21q or differential hot-spot usage along the nondisjoined chromosome 21. We found several significant associations between our genomic features of interest and recombination, interestingly, these results were not consistent among recombination types (single and double proximal or distal events). We also found statistically significant relationships between the frequency of hotspots and the distribution of recombination along nondisjoined chromosomes. Collectively, these findings suggest that factors that affect the accessibility of a specific chromosome region to recombination may be altered in at least a proportion of oocytes with MI and MII errors.	[Oliver, Tiffany Renee; Middlebrooks, Candace D.; Tinker, Stuart W.; Allen, Emily Graves; Bean, Lora J. H.; Sherman, Stephanie L.] Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA; [Oliver, Tiffany Renee] Spelman Coll, Dept Biol, Atlanta, GA 30314 USA; [Begum, Ferdouse; Feingold, Eleanor] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Biostat, Pittsburgh, PA 15261 USA; [Feingold, Eleanor; Chowdhury, Reshmi] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Cheung, Vivian] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA; [Cheung, Vivian] Univ Michigan, Dept Human Genet, Ann Arbor, MI 48109 USA	Emory University; Spelman College; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Oliver, TR (corresponding author), Emory Univ, Sch Med, Dept Human Genet, Atlanta, GA 30322 USA.	Toliver4@spelman.edu	Oliver, Tiffany R/H-8855-2016; Cheung, Vivian G./AAT-3115-2020	Oliver, Tiffany R/0000-0002-8212-3121; Feingold, Eleanor/0000-0003-2898-6484	 [R01 HD38979];  [R01 HL083300];  [UL1TR000454]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD038979] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083300] Funding Source: NIH RePORTER	; ; ; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by R01 HD38979, R01 HL083300 and UL1TR000454. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Berg IL, 2010, NAT GENET; Berg IL, 2011, P NATL ACAD SCI USA, V108, P12378, DOI 10.1073/pnas.1109531108; Chowdhury R, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000648; DAWBER TR, 1951, AM J PUBLIC HEALTH, V41, P279; Fledel-Alon A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020321; Freeman SB, 2007, PUBLIC HEALTH REP, V122, P62, DOI 10.1177/003335490712200109; Hinch AG, 2011, NATURE, V476, P170, DOI 10.1038/nature10336; Holmquist GP, 2006, CYTOGENET GENOME RES, V114, P96, DOI 10.1159/000093326; Kong A, 2002, NAT GENET, V31, P241, DOI 10.1038/ng917; Kong A, 2010, NATURE, V467, P1099, DOI 10.1038/nature09525; Lamb NE, 1996, NAT GENET, V14, P400, DOI 10.1038/ng1296-400; Lamb NE, 1997, HUM MOL GENET, V6, P1391, DOI 10.1093/hmg/6.9.1391; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Oliver TR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000033; Oliver TR, 2011, HUM GENET; Oliver TR, HUM GENET; Polk Deborah E, 2008, BMC Oral Health, V8, P18, DOI 10.1186/1472-6831-8-18; Sherman SL, 2007, MENT RETARD DEV D R, V13, P221, DOI 10.1002/mrdd.20157; WARREN AC, 1987, SCIENCE, V237, P652, DOI 10.1126/science.2955519; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974	21	16	16	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99560	10.1371/journal.pone.0099560	http://dx.doi.org/10.1371/journal.pone.0099560			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926858	Green Accepted, gold, Green Published			2022-12-27	WOS:000338278100049
J	Tixier, F; Groves, AM; Goh, V; Hatt, M; Ingrand, P; Le Rest, CC; Visvikis, D				Tixier, Florent; Groves, Ashley M.; Goh, Vicky; Hatt, Mathieu; Ingrand, Pierre; Le Rest, Catherine Cheze; Visvikis, Dimitris			Correlation of Intra-Tumor F-18-FDG Uptake Heterogeneity Indices with Perfusion CT Derived Parameters in Colorectal Cancer	PLOS ONE			English	Article							CELL LUNG-CANCER; POSITRON-EMISSION-TOMOGRAPHY; VASCULAR PARAMETERS; GLUCOSE-METABOLISM; TEXTURAL FEATURES; THERAPY RESPONSE; RECTAL-CANCER; FDG UPTAKE; HEAD; QUANTIFICATION	Application of textural features analysis to 18F-fluorodeoxyglucose (F-18-FDG) positron emission tomography (PET) images has been used to characterize intra-tumor uptake heterogeneity and has been shown to reflect disease outcome. A current hypothesis is that F-18-FDG uptake heterogeneity may reflect the physiological tracer uptake related to tumor perfusion. The purpose of our study was to investigate the correlations between intra-tumor uptake heterogeneity and vascular parameters derived from dynamic contrast enhanced (DCE) computed tomography (CT) obtained from an integrated F-18-FDG PET/perfusion CT examination. Methods: Thirty patients with proven colorectal cancer prospectively underwent integrated F-18-FDG PET/DCE-CT to assess the metabolic-flow phenotype. Both CT blood flow parametric maps and PET images were analyzed. Correlations between PET heterogeneity and perfusion CT were assessed by Spearman's rank correlation analysis. Results: Blood flow visualization provided by DCE-CT images was significantly correlated with F-18-FDG PET metabolically active tumor volume as well as with uptake heterogeneity for patients with stage III/IV tumors (|rho|:0.66 to 0.78; p-value < 0.02). Conclusion: The positive correlation found with tumor blood flow indicates that intra-tumor heterogeneity of F-18-FDG PET accumulation reflects to some extent tracer distribution and consequently indicates that F-18-FDG PET intra-tumor heterogeneity may be associated with physiological processes such as tumor vascularization.	[Tixier, Florent; Hatt, Mathieu; Visvikis, Dimitris] CHRU Morvan, UMR1101, LaTIM, INSERM, Brest, France; [Groves, Ashley M.] UCL, Inst Nucl Med, London, England; [Goh, Vicky] St Thomas Hosp, Kings Coll London, Div Imaging Sci & Biomed Engn, London, England; [Ingrand, Pierre] CHU La Miletrie, INSERM, CIC 1402, Poitiers, France; [Le Rest, Catherine Cheze] CHU La Miletrie, Dept Nucl Med, Poitiers, France	CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; University of London; University College London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; CHU Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; CHU Poitiers; Universite de Poitiers	Tixier, F (corresponding author), CHRU Morvan, UMR1101, LaTIM, INSERM, Brest, France.	florent.tixier@univ-brest.fr	Hatt, Mathieu/M-8917-2017; Tixier, Florent/AAE-2952-2019; Visvikis, Dimitris/AAM-7868-2021; Visvikis, Dimitris/AAM-7865-2021; VISVIKIS, Dimitris/H-4277-2014; Goh, Vicky/AAG-2708-2020	Hatt, Mathieu/0000-0002-8938-8667; VISVIKIS, Dimitris/0000-0003-0831-3637; Goh, Vicky/0000-0002-2321-8091	French Ministry of Education and Research	French Ministry of Education and Research	This study was supported by a fellowship from the French Ministry of Education and Research. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu S, 2011, EUR J NUCL MED MOL I, V38, P987, DOI 10.1007/s00259-011-1787-z; Bellomi M, 2007, RADIOLOGY, V244, P486, DOI 10.1148/radiol.2442061189; Bisdas S, 2008, AM J NEURORADIOL, V29, P1376, DOI 10.3174/ajnr.A1111; Chowdhury FU, 2010, POSTGRAD MED J, V86, P174, DOI 10.1136/pgmj.2009.079087; Cook GJR, 2013, J NUCL MED, V54, P19, DOI 10.2967/jnumed.112.107375; de Geus-Oei LF, 2009, J NUCL MED, V50, p43S, DOI 10.2967/jnumed.108.057224; Dimitrakopoulou-Strauss A, 2003, Q J NUCL MED, V47, P8; El Naqa I, 2009, PATTERN RECOGN, V42, P1162, DOI 10.1016/j.patcog.2008.08.011; Garcia-Figueiras R, 2013, AM J ROENTGENOL, V200, P8, DOI 10.2214/AJR.11.8476; Goh V, 2009, CLIN RADIOL, V64, P368, DOI 10.1016/j.crad.2008.08.018; Goh V, 2008, AM J ROENTGENOL, V191, pW288, DOI 10.2214/AJR.07.3985; Goh V, 2008, RADIOLOGY, V249, P510, DOI 10.1148/radiol.2492071365; Goh V, 2012, J NUCL MED, V53, P687, DOI 10.2967/jnumed.111.098525; Groves AM, 2011, EUR J NUCL MED MOL I, V36, P416; HARALICK RM, 1973, IEEE T SYST MAN CYB, VSMC3, P610, DOI 10.1109/TSMC.1973.4309314; Hatt M, 2013, EUR J NUCL MED MOL I, V40, P1662, DOI 10.1007/s00259-013-2486-8; Hatt M, 2009, IEEE T MED IMAGING, V28, P881, DOI 10.1109/TMI.2008.2012036; Hendlisz A, 2012, ANN ONCOL, V23, P1687, DOI 10.1093/annonc/mdr554; Henson JS, 1997, AJCC CANC STAGING MA; Herbertson RA, 2009, CLIN RADIOL, V64, P225, DOI 10.1016/j.crad.2008.08.008; Hirasawa S, 2007, ACAD RADIOL, V14, P312, DOI 10.1016/j.acra.2006.12.017; Janssen MHM, 2012, INT J RADIAT ONCOL, V82, P849, DOI 10.1016/j.ijrobp.2010.10.029; Kan ZX, 2005, RADIOLOGY, V237, P151, DOI 10.1148/radiol.2363041293; Kanda T, 2012, EUR J RADIOL, V81, P2075, DOI 10.1016/j.ejrad.2011.07.003; Kunkel M, 2003, CANCER, V97, P1015, DOI 10.1002/cncr.11159; Larson Steven M., 1999, Clin Positron Imaging, V2, P159, DOI 10.1016/S1095-0397(99)00016-3; Lazanyi KS, 2010, LUNG CANCER, V70, P280, DOI 10.1016/j.lungcan.2010.03.004; Liebig C, 2009, J CLIN ONCOL, V27, P5131, DOI 10.1200/JCO.2009.22.4949; Miles KA, 2006, EUR J NUCL MED MOL I, V33, P22, DOI 10.1007/s00259-005-1932-7; Pugachev A, 2005, INT J RADIAT ONCOL, V62, P545, DOI 10.1016/j.ijrobp.2005.02.009; Rajendran JG, 2006, CLIN CANCER RES, V12, P5435, DOI 10.1158/1078-0432.CCR-05-1773; Rajpopat M, 2012, DIAGNOSTIC IMAGING E, V1, P11; Tepper JE, 2002, J CLIN ONCOL, V20, P1744, DOI 10.1200/JCO.2002.07.132; Thibault G., 2009, PROC PATTERN RECOGNI, P140; Tixier F, 2012, J NUCL MED, V53, P693, DOI 10.2967/jnumed.111.099127; Tixier F, 2011, J NUCL MED, V52, P369, DOI 10.2967/jnumed.110.082404; Tsushima Y, 2002, ACAD RADIOL, V9, P922, DOI 10.1016/S1076-6332(03)80462-2; van Velden FHP, 2011, EUR J NUCL MED MOL I, V38, P1636, DOI 10.1007/s00259-011-1845-6; Vikram Raghu, 2008, Cancer Imaging, V8 Spec No A, pS46, DOI 10.1102/1470-7330.2008.9009; WEIDNER N, 1995, AM J PATHOL, V147, P9; Willaime JMY, 2013, PHYS MED BIOL, V58, P187, DOI 10.1088/0031-9155/58/2/187; Win T, 2013, CLIN CANCER RES, V19, P3591, DOI 10.1158/1078-0432.CCR-12-1307	42	29	30	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99567	10.1371/journal.pone.0099567	http://dx.doi.org/10.1371/journal.pone.0099567			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926986	Green Submitted, gold, Green Published			2022-12-27	WOS:000338278100050
J	Yeo, Y; Ma, SH; Hwang, Y; Horn-Ross, PL; Hsing, A; Lee, KE; Park, YJ; Park, DJ; Yoo, KY; Park, SK				Yeo, Yohwan; Ma, Seung-Hyun; Hwang, Yunji; Horn-Ross, Pamela L.; Hsing, Ann; Lee, Kyu-Eun; Park, Young Joo; Park, Do-Joon; Yoo, Keun-Young; Park, Sue K.			Diabetes Mellitus and Risk of Thyroid Cancer: A Meta-Analysis	PLOS ONE			English	Article							POPULATION-BASED COHORT; METABOLIC SYNDROME; PHYSICAL-ACTIVITY; POOLED ANALYSIS; HORMONE; OBESITY; MEN; MORTALITY; SURVIVAL; DISEASE	Introduction: Diabetes mellitus (DM) is an important risk factor for endocrine cancers; however, the association with thyroid cancer is not clear. We performed a systematic review and meta-analysis to clarify the association between thyroid cancer and DM. Methods: We searched MEDLINE, PUBMED and EMBASE databases through July 2012, using search terms related to diabetes mellitus, cancer, and thyroid cancer. We conducted a meta-analysis of the risk of incidence of thyroid cancer from pre-existing diabetes. Of 2,123 titles initially identified, sixteen articles met our inclusion criteria. An additional article was identified from a bibliography. Totally, 14 cohort and 3 case-control studies were selected for the meta-analysis. The risks were estimated using random-effects model and sensitivity test for the studies which reported risk estimates and used different definition of DM. Results: Compared with individuals without DM, the patients with DM were at 1.34-fold higher risk for thyroid cancer (95% CI 1.11-1.63). However, there was heterogeneity in the results (p<0.0001). Sensitivity tests and studies judged to be high quality did not show heterogeneity and DM was associated with higher risk for thyroid cancer in these sub-analyses (both of RRs = 1.18, 95% CIs 1.08-1.28). DM was associated with a 1.38-fold increased risk of thyroid cancer in women (95% CI 1.13-1.67) after sensitivity test. Risk of thyroid cancer in men did not remain significant (RR 1.11, 95% CI 0.80-1.53). Conclusions: Compared with their non-diabetic counterparts, women with pre-existing DM have an increased risk of thyroid cancer.	[Yeo, Yohwan; Ma, Seung-Hyun; Yoo, Keun-Young; Park, Sue K.] Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea; [Ma, Seung-Hyun; Hwang, Yunji; Park, Sue K.] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Hwang, Yunji; Park, Sue K.] Seoul Natl Univ, Grad Sch, Dept Biomed Sci, Seoul, South Korea; [Horn-Ross, Pamela L.; Hsing, Ann] Canc Prevent Inst Calif, Fremont, CA USA; [Park, Young Joo; Park, Do-Joon] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Lee, Kyu-Eun] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University (SNU); Cancer Prevention Institute of California; Seoul National University (SNU); Seoul National University (SNU)	Park, SK (corresponding author), Seoul Natl Univ, Coll Med, Dept Prevent Med, Seoul, South Korea.	suepark@snu.ac.kr	Park, Young Joo/J-4161-2012	Park, Young Joo/0000-0002-3671-6364	BRL (Basic Research Laboratory) program through the National Research Foundation of Korea - Ministry of Education, Science and Technology [2012-0000347]; Korean Foundation for Cancer Research [CB-2011-03-01]	BRL (Basic Research Laboratory) program through the National Research Foundation of Korea - Ministry of Education, Science and Technology; Korean Foundation for Cancer Research	This research was supported by BRL (Basic Research Laboratory) program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (2012-0000347) and by the Research Grant Number CB-2011-03-01 of the Korean Foundation for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMI HO, 1991, CANCER CAUSE CONTROL, V2, P307, DOI 10.1007/BF00051670; Almquist M, 2011, CANCER CAUSE CONTROL, V22, P743, DOI 10.1007/s10552-011-9747-2; Aschebrook-Kilfoy B, 2011, THYROID, V21, P957, DOI 10.1089/thy.2010.0396; Atchison EA, 2011, INT J CANCER, V128, P635, DOI 10.1002/ijc.25362; BACH LA, 1992, DIABETES METAB REV, V8, P229, DOI 10.1002/dmr.5610080304; Ben QW, 2011, EUR J CANCER, V47, P1928, DOI 10.1016/j.ejca.2011.03.003; Boelaert K, 2009, ENDOCR-RELAT CANCER, V16, P1065, DOI 10.1677/ERC-09-0150; Borena W, 2011, CANCER CAUSE CONTROL, V22, P291, DOI 10.1007/s10552-010-9697-0; Busco S, 2013, CANCER EPIDEMIOL, V37, P262, DOI 10.1016/j.canep.2013.02.007; Chodick G, 2010, CANCER CAUSE CONTROL, V21, P879, DOI 10.1007/s10552-010-9515-8; Cowey S, 2006, AM J PATHOL, V169, P1505, DOI 10.2353/ajpath.2006.051090; Dang CV, 1999, TRENDS BIOCH SCI, V24; Duran AO, 2013, INT J CLIN ONCOL, V18, P585, DOI 10.1007/s10147-012-0435-3; Ferlay J, 2013, IARC CANCERBASE; Fiore E, 2009, ENDOCR-RELAT CANCER, V16, P1251, DOI 10.1677/ERC-09-0036; Giovannucci E, 2007, GASTROENTEROLOGY, V132, P2008; Gursoy A, 2010, MED HYPOTHESES, V74, P35, DOI 10.1016/j.mehy.2009.08.021; Hankinson SE, 1998, LANCET, V351, P1393, DOI 10.1016/S0140-6736(97)10384-1; Hard GC, 1998, ENVIRON HEALTH PERSP, V106, P427, DOI 10.2307/3434174; Haymart MR, 2008, J CLIN ENDOCR METAB, V93, P809, DOI 10.1210/jc.2007-2215; Hemminki K, 2010, ONCOLOGIST, V15, P548, DOI 10.1634/theoncologist.2009-0300; Hirohata T, 1976, Semin Oncol, V3, P25; Hjartaker A, 2008, ADV EXP MED BIOL, V630, P72; Hsu IR, 2007, AM J CLIN NUTR, V86, p867S, DOI 10.1093/ajcn/86.3.867S; Inoue M, 2006, ARCH INTERN MED, V166, P1871, DOI 10.1001/archinte.166.17.1871; Johnson JA, 2011, DIABETOLOGIA, V54, P2263, DOI 10.1007/s00125-011-2242-1; Jung KW, 2010, J KOREAN MED SCI, V25, P1113, DOI 10.3346/jkms.2010.25.8.1113; Kabat GC, 2012, CANCER EPIDEMIOL, V36, P335, DOI 10.1016/j.canep.2012.03.013; Kabat GC, 2012, CANCER CAUSE CONTROL, V23, P421, DOI 10.1007/s10552-011-9890-9; Kilfoy BA, 2009, CANCER CAUSE CONTROL, V20, P525, DOI 10.1007/s10552-008-9260-4; Kilfoy BA, 2009, CANCER EPIDEM BIOMAR, V18, P1092, DOI 10.1158/1055-9965.EPI-08-0976; Kitahara CM, 2012, CANCER CAUSE CONTROL, V23, P463, DOI 10.1007/s10552-012-9896-y; Kitahara CM, 2011, CANCER EPIDEM BIOMAR, V20, P464, DOI 10.1158/1055-9965.EPI-10-1220; Kohrle J, 2007, BEST PRACT RES CL EN, V21, P173, DOI 10.1016/j.beem.2007.04.001; Kohrle J, 1999, MOL CELL ENDOCRINOL, V151, P103, DOI 10.1016/S0303-7207(99)00040-4; Korea centers for Disease Control & Prevention, 2007, IN DEPTH AN REP EX P; Korean National Cancer Information Center, 2011, CANC STAT KOR 2009; Kuriki K, 2007, EUR J CANCER PREV, V16, P83, DOI 10.1097/01.cej.0000228404.37858.40; LAVECCHIA C, 1994, BRIT J CANCER, V70, P950, DOI 10.1038/bjc.1994.427; Liu XD, 2012, CANCER-AM CANCER SOC, V118, P1353, DOI 10.1002/cncr.26420; Lo S-F, 2012, INT J CANCER; Ma J, 1999, J NATL CANCER I, V91, P620, DOI 10.1093/jnci/91.7.620; Meinhold CL, 2010, AM J EPIDEMIOL, V171, P242, DOI 10.1093/aje/kwp354; Paes JE, 2010, J CLIN ENDOCR METAB, V95, P4244, DOI 10.1210/jc.2010-0440; Potenza M, 2009, ENDOCR PRACT, V15, P254, DOI 10.4158/EP.15.3.254; Rapp K, 2006, DIABETOLOGIA, V49, P945, DOI 10.1007/s00125-006-0207-6; RON E, 1987, JNCI-J NATL CANCER I, V79, P1; Ron E, 2006, CANC EPIDEMIOLOGY PR; Ropero AB, 2008, STEROIDS, V73, P874, DOI 10.1016/j.steroids.2007.12.018; Saad F, 2009, J STEROID BIOCHEM, V114, P40, DOI 10.1016/j.jsbmb.2008.12.022; Sella T, 2011, CANCER CAUSE CONTROL, V22, P1513, DOI 10.1007/s10552-011-9825-5; Shih S-R, 2012, EXP DIABETES RES, V2012, P1; Shu X, 2010, DIABETIC MED, V27, P791, DOI 10.1111/j.1464-5491.2010.03011.x; SMITH GD, 1992, AM J EPIDEMIOL, V136, P1110, DOI 10.1093/oxfordjournals.aje.a116576; Stang A, 2010, EUR J EPIDEMIOL, V25, P603, DOI 10.1007/s10654-010-9491-z; Stocks T, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000201; Tamez-Perez HE, 2012, MED CLIN-BARCELONA, V138, P475, DOI 10.1016/j.medcli.2011.08.009; Tulinius H, 1997, CANCER EPIDEM BIOMAR, V6, P863; Udiong CEJ, 2007, INDIAN J CLIN BIOCHE, V22, P74, DOI 10.1007/BF02913318; Weiderpass E, 2001, J CLIN EPIDEMIOL, V54, P802, DOI 10.1016/S0895-4356(01)00342-0; Wideroff L, 1997, J NATL CANCER I, V89, P1360, DOI 10.1093/jnci/89.18.1360; Wild S, 2004, DIABETES CARE, V27, P1047, DOI 10.2337/diacare.27.5.1047; Wolin KY, 2010, ONCOLOGIST, V15, P556, DOI 10.1634/theoncologist.2009-0285; Xue F, 2007, AM J CLIN NUTR, V86, p823S, DOI 10.1093/ajcn/86.3.823S; Yang WS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027326; Zendehdel K, 2003, JNCI-J NATL CANCER I, V95, P1797, DOI 10.1093/jnci/djg105	66	56	57	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e98135	10.1371/journal.pone.0098135	http://dx.doi.org/10.1371/journal.pone.0098135			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927125	Green Submitted, gold, Green Published			2022-12-27	WOS:000338278100012
J	Casas, R; Sacanella, E; Urpi-Sarda, M; Chiva-Blanch, G; Ros, E; Martinez-Gonzalez, MA; Covas, MI; Lamuela-Raventos, RM; Salas-Salvado, J; Fiol, M; Aros, F; Estruch, R				Casas, Rosa; Sacanella, Emilio; Urpi-Sarda, Mireia; Chiva-Blanch, Gemma; Ros, Emilio; Martinez-Gonzalez, Miguel-Angel; Covas, Maria-Isabel; Ma Lamuela-Raventos, Rosa; Salas-Salvado, Jordi; Fiol, Miquel; Aros, Fernando; Estruch, Ramon			The Effects of the Mediterranean Diet on Biomarkers of Vascular Wall Inflammation and Plaque Vulnerability in Subjects with High Risk for Cardiovascular Disease. A Randomized Trial	PLOS ONE			English	Article							BLOOD-PRESSURE; PROFILE; ADULTS; NUTS	Background: Adherence to the Mediterranean diet (MD) is associated with reduced morbidity and mortality due to cardiovascular disease. However, how the MD exerts its effects is not fully known. Aim: To assess the 12-month effects of two enhanced MDs compared to a low-fat diet on inflammatory biomarkers related to atherosclerosis and plaque vulnerability in a subcohort of the PREDIMED (Prevencion con Dieta Mediterranea) study. Methods: A total of 164 participants at high risk for cardiovascular disease were randomized into three diet groups: MD supplemented with 50 mL/d of extra virgin olive oil (MD+EVOO) or 30 g/d of nuts (MD+Nuts) and a low-fat diet. Changes in classical cardiovascular risk factors, inflammatory biomarkers of atherosclerosis and plaque vulnerability were measured after 12 months of intervention. Results: Compared to participants in the low-fat diet group, those receiving MD+EVOO and MD+Nuts showed a higher decrease in systolic (6 mmHg)and diastolic (3 mmHg) blood pressure (P = 0.02; both), as well as a reduction of 10% and 8% in LDL-cholesterol (P = 0.04), respectively. Patients in the MD+Nuts group showed a significant reduction of 34% in CD40 expression on monocyte surface compared to low-fat diet patients (P = 0.03). In addition, inflammatory biomarkers related to plaque instability such as C-reactive protein and interleukin-6 were reduced by 45% and 35% and 95% and 90% in the MD+EVOO and MD+Nuts groups, respectively (P<0.05; all) compared to the low-fat diet group. Likewise, sICAM and Pselectin were also reduced by 50% and 27%, respectively in the MD+ EVOO group (P = 0.04) and P-selectin by 19% in MD+Nuts group (P = 0.04) compared to the low-fat diet group. Conclusions: Adherence to the MD is associated with an increase in serum markers of atheroma plaque stability which may explain, at least in part, the protective role of MD against ischemic heart disease.	[Casas, Rosa; Sacanella, Emilio; Urpi-Sarda, Mireia; Chiva-Blanch, Gemma; Estruch, Ramon] Univ Barcelona, IDIBAPS, Hosp Clin, Dept Internal Med, Barcelona, Spain; [Casas, Rosa; Sacanella, Emilio; Chiva-Blanch, Gemma; Ros, Emilio; Martinez-Gonzalez, Miguel-Angel; Covas, Maria-Isabel; Ma Lamuela-Raventos, Rosa; Salas-Salvado, Jordi; Fiol, Miquel; Aros, Fernando; Estruch, Ramon] Inst Salud Carlos III, CIBER Fisiopatol Obesidad & Nutr 06 03, Madrid, Spain; [Urpi-Sarda, Mireia; Ma Lamuela-Raventos, Rosa] Univ Barcelona, Fac Pharm, Nutr & Food Sci Dept, Barcelona, Spain; [Ros, Emilio] IDIBAPS, Hosp Clin, Lipid Clin, Serv Endocrinol & Nutr, Barcelona, Spain; [Martinez-Gonzalez, Miguel-Angel] Univ Navarra, Sch Med, Dept Prevent Med & Publ Hlth, E-31080 Pamplona, Spain; [Covas, Maria-Isabel] Municipal Inst Med Res IMIM, Cardiovasc Epidemiol Unit, Barcelona, Spain; [Salas-Salvado, Jordi] Univ Rovira & Virgili, IISPV, Hosp Univ Sant Joan de Reus, Human Nutr Unit, E-43201 Reus, Spain; [Fiol, Miquel] Univ Inst Hlth Sci Invest, Palma De Mallorca, Spain; [Aros, Fernando] Hosp Alava, Dept Cardiol, Vitoria, Spain	University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; Instituto de Salud Carlos III; University of Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; University of Navarra; Institut Hospital del Mar d'Investigacions Mediques (IMIM); Universitat Rovira i Virgili; Institut d'Investigacio Sanitaria Pere Virgili (IISPV)	Sacanella, E (corresponding author), Univ Barcelona, IDIBAPS, Hosp Clin, Dept Internal Med, Barcelona, Spain.	esacane@clinic.ub.es	Urpi-Sarda, Mireia/D-5937-2013; Martinez-Gonzalez, Miguel A./AAE-7669-2019; Salas-Salvado, Jordi/C-7229-2017; Casas, Rosa/ABD-1915-2020; Fiol, Miguel/F-6793-2016; Chiva-Blanch, Gemma/O-8072-2018; Estruch, Ramon/AAZ-3723-2020; Lamuela-Raventos, Rosa M/F-3986-2016	Urpi-Sarda, Mireia/0000-0002-4064-5175; Salas-Salvado, Jordi/0000-0003-2700-7459; Casas, Rosa/0000-0002-0211-9166; Fiol, Miguel/0000-0002-5370-1391; Chiva-Blanch, Gemma/0000-0001-6093-0160; Martinez-Gonzalez, Miguel A./0000-0002-3917-9808; Lamuela-Raventos, Rosa M/0000-0002-1287-4560; Ros, Emilio/0000-0002-2573-1294	CIBEROBN; RETICS [RD06/0045]; Spanish Ministry of Economy and Competitiveness (MEC) [AGL2009-13906-C02-02, AGL2010-22319-C03-02]; Instituto de Salud Carlos III [PI10/01407, G03/140]; European Union (FEDER)	CIBEROBN; RETICS; Spanish Ministry of Economy and Competitiveness (MEC)(Spanish Government); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); European Union (FEDER)(European Commission)	This work has been supported by grants from CIBEROBN, RETICS RD06/0045, Spanish Ministry of Economy and Competitiveness (MEC) (AGL2009-13906-C02-02 and AGL2010-22319-C03-02); Instituto de Salud Carlos III (PI10/01407, G03/140), CIBEROBN, and European Union (FEDER). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Martinez-Gonzalez MA, 2012, INT J EPIDEMIOL, V41, P377, DOI 10.1093/ije/dyq250; Babio N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058354; Barbaresko J, 2013, NUTR REV, V71, P511, DOI 10.1111/nure.12035; Bendinelli B, 2011, AM J CLIN NUTR, V93, P275, DOI 10.3945/ajcn.110.000521; Bjorck L, 2007, VASC HEALTH RISK MAN, V3, P1045; Castaner O, 2013, AM J CLIN NUTR, V98, P845, DOI 10.3945/ajcn.113.060582; Chiva-Blanch G, 2013, ALCOHOL ALCOHOLISM, V48, P270, DOI 10.1093/alcalc/agt007; Estruch R, 2013, NEW ENGL J MED, V368, P1279, DOI 10.1056/NEJMoa1200303; Estruch R, 2006, ANN INTERN MED, V145, P1, DOI 10.7326/0003-4819-145-1-200607040-00004; Finn AV, 2010, ARTERIOSCL THROM VAS, V30, P1282, DOI 10.1161/ATVBAHA.108.179739; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hansson J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016185; Hermus L, 2010, ATHEROSCLEROSIS, V213, P21, DOI 10.1016/j.atherosclerosis.2010.05.013; Hu EA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060166; Hu Y, 2009, DIABETES VASC DIS RE, V6, P262, DOI 10.1177/1479164109339966; Juanola-Falgarona M, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-7; Khan DA, 2011, J INTERF CYTOK RES, V31, P561, DOI 10.1089/jir.2010.0157; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Llorente-Cortes V, 2010, ATHEROSCLEROSIS, V208, P442, DOI 10.1016/j.atherosclerosis.2009.08.004; Lohse B, 2010, J NUTR, V140, P1322, DOI 10.3945/jn.109.120188; Lopez-Miranda J, 2010, NUTR METAB CARDIOVAS, V20, P284, DOI 10.1016/j.numecd.2009.12.007; Marin C, 2011, AM J CLIN NUTR, V93, P267, DOI 10.3945/ajcn.110.006866; Mena MP, 2009, AM J CLIN NUTR, V89, P248, DOI 10.3945/ajcn.2008.26094; Mente A, 2009, ARCH INTERN MED, V169, P659, DOI 10.1001/archinternmed.2009.38; Ros E, 2009, AM J CLIN NUTR, V89, pS1649, DOI 10.3945/ajcn.2009.26736R; Salas-Salvado J, 2011, DIABETES CARE, V34, P14, DOI 10.2337/dc10-1288; Sofi F, 2010, AM J CLIN NUTR, V92, P1189, DOI 10.3945/ajcn.2010.29673; Tanindi A, 2011, CORONARY ARTERY DIS, V22, P253, DOI 10.1097/MCA.0b013e328343fc18; Mitjavila MT, 2013, CLIN NUTR, V32, P172, DOI 10.1016/j.clnu.2012.08.002; Toledo E, 2009, BRIT J NUTR, V101, P59, DOI 10.1017/S0007114508981496; Troseid M, 2010, CARDIOVASC DIABETOL, V9, DOI 10.1186/1475-2840-9-11; Urpi-Sarda M, 2012, PHARMACOL RES, V65, P577, DOI 10.1016/j.phrs.2012.03.006	33	157	160	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e100084	10.1371/journal.pone.0100084	http://dx.doi.org/10.1371/journal.pone.0100084			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24925270	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300120
J	Escott-Price, V; Bellenguez, C; Wang, LS; Choi, SH; Harold, D; Jones, L; Holmans, P; Gerrish, A; Vedernikov, A; Richards, A; DeStefano, AL; Lambert, JC; Ibrahim-Verbaas, CA; Naj, AC; Sims, R; Jun, G; Bis, JC; Beecham, GW; Grenier-Boley, B; Russo, G; Thornton-Wells, TA; Denning, N; Smith, AV; Chouraki, V; Thomas, C; Ikram, MA; Zelenika, D; Vardarajan, BN; Kamatani, Y; Lin, CF; Schmidt, H; Kunkle, B; Dunstan, ML; Vronskaya, M; Johnson, AD; Ruiz, A; Bihoreau, MT; Reitz, C; Pasquier, F; Hollingworth, P; Hanon, O; Fitzpatrick, AL; Buxbaum, JD; Campion, D; Crane, PK; Baldwin, C; Becker, T; Gudnason, V; Cruchaga, C; Craig, D; Amin, N; Berr, C; Lopez, OL; De Jager, PL; Deramecourt, V; Johnston, JA; Evans, D; Lovestone, S; Letenneur, L; Hernandez, I; Rubinsztein, DC; Eiriksdottir, G; Sleegers, K; Goate, AM; Fievet, N; Huentelman, MJ; Gill, M; Brown, K; Kamboh, MI; Keller, L; Barberger-Gateau, P; McGuinness, B; Larson, EB; Myers, AJ; Dufouil, C; Todd, S; Wallon, D; Love, S; Rogaeva, E; Gallacher, J; St George-Hyslop, P; Clarimon, J; Lleo, A; Bayer, A; Tsuang, DW; Yu, L; Tsolaki, M; Bossu, P; Spalletta, G; Proitsi, P; Collinge, J; Sorbi, S; Garcia, FS; Fox, NC; Hardy, J; Naranjo, MCD; Bosco, P; Clarke, R; Brayne, C; Galimberti, D; Scarpini, E; Bonuccelli, U; Mancuso, M; Siciliano, G; Moebus, S; Mecocci, P; Del Zompo, M; Maier, W; Hampel, H; Pilotto, A; Frank-Garcia, A; Panza, F; Solfrizzi, V; Caffarra, P; Nacmias, B; Perry, W; Mayhaus, M; Lannfelt, L; Hakonarson, H; Pichler, S; Carrasquillo, MM; Ingelsson, M; Beekly, D; Alvarez, V; Zou, FG; Valladares, O; Younkin, SG; Coto, E; Hamilton-Nelson, KL; Gu, W; Razquin, C; Pastor, P; Mateo, I; Owen, MJ; Faber, KM; Jonsson, PV; Combarros, O; O'Donovan, MC; Cantwell, LB; Soininen, H; Blacker, D; Mead, S; Mosley, TH; Bennett, DA; Harris, TB; Fratiglioni, L; Holmes, C; de Bruijn, RFAG; Passmore, P; Montine, TJ; Bettens, K; Rotter, JI; Brice, A; Morgan, K; Foroud, TM; Kukull, WA; Hannequin, D; Powell, JF; Nalls, MA; Ritchie, K; Lunetta, KL; Kauwe, JSK; Boerwinkle, E; Riemenschneider, M; Boada, M; Hiltunen, M; Martin, ER; Schmidt, R; Rujescu, D; Dartigues, JF; Mayeux, R; Tzourio, C; Hofman, A; Nothen, MM; Graff, C; Psaty, BM; Haines, JL; Lathrop, M; Pericak-Vance, MA; Launer, LJ; Van Broeckhoven, C; Farrer, LA; van Duijn, CM; Ramirez, A; Seshadri, S; Schellenberg, GD; Amouyel, P; Williams, J				Escott-Price, Valentina; Bellenguez, Celine; Wang, Li-San; Choi, Seung-Hoan; Harold, Denise; Jones, Lesley; Holmans, Peter; Gerrish, Amy; Vedernikov, Alexey; Richards, Alexander; DeStefano, Anita L.; Lambert, Jean-Charles; Ibrahim-Verbaas, Carla A.; Naj, Adam C.; Sims, Rebecca; Jun, Gyungah; Bis, Joshua C.; Beecham, Gary W.; Grenier-Boley, Benjamin; Russo, Giancarlo; Thornton-Wells, Tricia A.; Denning, Nicola; Smith, Albert V.; Chouraki, Vincent; Thomas, Charlene; Ikram, M. Arfan; Zelenika, Diana; Vardarajan, Badri N.; Kamatani, Yoichiro; Lin, Chiao-Feng; Schmidt, Helena; Kunkle, Brian; Dunstan, Melanie L.; Vronskaya, Maria; Johnson, Andrew D.; Ruiz, Agustin; Bihoreau, Marie-Therese; Reitz, Christiane; Pasquier, Florence; Hollingworth, Paul; Hanon, Olivier; Fitzpatrick, Annette L.; Buxbaum, Joseph D.; Campion, Dominique; Crane, Paul K.; Baldwin, Clinton; Becker, Tim; Gudnason, Vilmundur; Cruchaga, Carlos; Craig, David; Amin, Najaf; Berr, Claudine; Lopez, Oscar L.; De Jager, Philip L.; Deramecourt, Vincent; Johnston, Janet A.; Evans, Denis; Lovestone, Simon; Letenneur, Luc; Hernandez, Isabel; Rubinsztein, David C.; Eiriksdottir, Gudny; Sleegers, Kristel; Goate, Alison M.; Fievet, Nathalie; Huentelman, Matthew J.; Gill, Michael; Brown, Kristelle; Kamboh, M. Ilyas; Keller, Lina; Barberger-Gateau, Pascale; McGuinness, Bernadette; Larson, Eric B.; Myers, Amanda J.; Dufouil, Carole; Todd, Stephen; Wallon, David; Love, Seth; Rogaeva, Ekaterina; Gallacher, John; St George-Hyslop, Peter; Clarimon, Jordi; Lleo, Alberto; Bayer, Anthony; Tsuang, Debby W.; Yu, Lei; Tsolaki, Magda; Bossu, Paola; Spalletta, Gianfranco; Proitsi, Petra; Collinge, John; Sorbi, Sandro; Garcia, Florentino Sanchez; Fox, Nick C.; Hardy, John; Deniz Naranjo, Maria Candida; Bosco, Paolo; Clarke, Robert; Brayne, Carol; Galimberti, Daniela; Scarpini, Elio; Bonuccelli, Ubaldo; Mancuso, Michelangelo; Siciliano, Gabriele; Moebus, Susanne; Mecocci, Patrizia; Del Zompo, Maria; Maier, Wolfgang; Hampel, Harald; Pilotto, Alberto; Frank-Garcia, Ana; Panza, Francesco; Solfrizzi, Vincenzo; Caffarra, Paolo; Nacmias, Benedetta; Perry, William; Mayhaus, Manuel; Lannfelt, Lars; Hakonarson, Hakon; Pichler, Sabrina; Carrasquillo, Minerva M.; Ingelsson, Martin; Beekly, Duane; Alvarez, Victoria; Zou, Fanggeng; Valladares, Otto; Younkin, Steven G.; Coto, Eliecer; Hamilton-Nelson, Kara L.; Gu, Wei; Razquin, Cristina; Pastor, Pau; Mateo, Ignacio; Owen, Michael J.; Faber, Kelley M.; Jonsson, Palmi V.; Combarros, Onofre; O'Donovan, Michael C.; Cantwell, Laura B.; Soininen, Hilkka; Blacker, Deborah; Mead, Simon; Mosley, Thomas H., Jr.; Bennett, David A.; Harris, Tamara B.; Fratiglioni, Laura; Holmes, Clive; de Bruijn, Renee F. A. G.; Passmore, Peter; Montine, Thomas J.; Bettens, Karolien; Rotter, Jerome I.; Brice, Alexis; Morgan, Kevin; Foroud, Tatiana M.; Kukull, Walter A.; Hannequin, Didier; Powell, John F.; Nalls, Michael A.; Ritchie, Karen; Lunetta, Kathryn L.; Kauwe, John S. K.; Boerwinkle, Eric; Riemenschneider, Matthias; Boada, Merce; Hiltunen, Mikko; Martin, Eden R.; Schmidt, Reinhold; Rujescu, Dan; Dartigues, Jean-Francois; Mayeux, Richard; Tzourio, Christophe; Hofman, Albert; Noethen, Markus M.; Graff, Caroline; Psaty, Bruce M.; Haines, Jonathan L.; Lathrop, Mark; Pericak-Vance, Margaret A.; Launer, Lenore J.; Van Broeckhoven, Christine; Farrer, Lindsay A.; van Duijn, Cornelia M.; Ramirez, Alfredo; Seshadri, Sudha; Schellenberg, Gerard D.; Amouyel, Philippe; Williams, Julie		United Kingdom Brain Expression	Gene-Wide Analysis Detects Two New Susceptibility Genes for Alzheimer's Disease	PLOS ONE			English	Article							GENOME SCAN METAANALYSIS; IDENTIFIES VARIANTS; BIPOLAR DISORDER; COMMON VARIANTS; ASSOCIATION; TP53INP1; LOCI; CLU; SCHIZOPHRENIA; TARGET	Background: Alzheimer's disease is a common debilitating dementia with known heritability, for which 20 late onset susceptibility loci have been identified, but more remain to be discovered. This study sought to identify new susceptibility genes, using an alternative gene-wide analytical approach which tests for patterns of association within genes, in the powerful genome-wide association dataset of the International Genomics of Alzheimer's Project Consortium, comprising over 7 m genotypes from 25,580 Alzheimer's cases and 48,466 controls. Principal Findings: In addition to earlier reported genes, we detected genome-wide significant loci on chromosomes 8 (TP53INP1, p = 1.4x10(-6)) and 14 (IGHV1-67 p = 7.9x10(-8)) which indexed novel susceptibility loci. Significance: The additional genes identified in this study, have an array of functions previously implicated in Alzheimer's disease, including aspects of energy metabolism, protein degradation and the immune system and add further weight to these pathways as potential therapeutic targets in Alzheimer's disease.	[Escott-Price, Valentina; Harold, Denise; Jones, Lesley; Holmans, Peter; Gerrish, Amy; Vedernikov, Alexey; Richards, Alexander; Sims, Rebecca; Denning, Nicola; Thomas, Charlene; Dunstan, Melanie L.; Vronskaya, Maria; Hollingworth, Paul; Owen, Michael J.; O'Donovan, Michael C.; Williams, Julie] Cardiff Univ, MRC Ctr Neuropsychiat Genet & Genom, Inst Psychol Med & Clin Neurosci, Cardiff CF10 3AX, S Glam, Wales; [Bellenguez, Celine; Lambert, Jean-Charles; Grenier-Boley, Benjamin; Chouraki, Vincent; Fievet, Nathalie; Amouyel, Philippe] INSERM, U744, F-59045 Lille, France; [Bellenguez, Celine; Lambert, Jean-Charles; Grenier-Boley, Benjamin; Chouraki, Vincent; Pasquier, Florence; Deramecourt, Vincent; Amouyel, Philippe] Univ Lille 2, Lille, France; [Bellenguez, Celine; Lambert, Jean-Charles; Grenier-Boley, Benjamin; Chouraki, Vincent; Fievet, Nathalie; Amouyel, Philippe] Inst Pasteur, F-59019 Lille, France; [Wang, Li-San; Lin, Chiao-Feng; Valladares, Otto; Cantwell, Laura B.; Schellenberg, Gerard D.] Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Choi, Seung-Hoan; DeStefano, Anita L.; Jun, Gyungah; Lunetta, Kathryn L.; Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Biostat, Boston, MA USA; [Ibrahim-Verbaas, Carla A.] Erasmus MC Univ Med Ctr, Dept Epidemiol & Neurol, Rotterdam, Netherlands; [Naj, Adam C.] Univ Penn, Perelman Sch Med, Dept Biostat & Epidemiol, Philadelphia, PA 19104 USA; [Naj, Adam C.] Univ Penn, Perelman Sch Med, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Jun, Gyungah; Vardarajan, Badri N.; Baldwin, Clinton; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med Biomed Genet, Boston, MA 02118 USA; [Jun, Gyungah; Lathrop, Mark; Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, Boston, MA 02118 USA; [Bis, Joshua C.; Fitzpatrick, Annette L.; Psaty, Bruce M.] Univ Washington, Dept Med, Cardiovasc Hlth Res Unit, Seattle, WA USA; [Beecham, Gary W.; Kunkle, Brian; Perry, William; Hamilton-Nelson, Kara L.; Pericak-Vance, Margaret A.] Univ Miami, John P Hussman Inst Human Genom, Miami, FL USA; [Beecham, Gary W.; Perry, William; Pericak-Vance, Margaret A.] Univ Miami, Dr John T Macdonald Fdn, Dept Human Genet, Miami, FL USA; [Russo, Giancarlo] ETH Univ Zurich, Funct Genom Ctr Zurich, Zurich, Switzerland; [Thornton-Wells, Tricia A.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA; [Smith, Albert V.; Gudnason, Vilmundur; Jonsson, Palmi V.] Univ Iceland, Fac Med, Reykjavik, Iceland; [Smith, Albert V.; Gudnason, Vilmundur; Eiriksdottir, Gudny] Iceland Heart Assoc, Kopavogur, Iceland; [Chouraki, Vincent; Seshadri, Sudha] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Ikram, M. Arfan; Hofman, Albert] Erasmus MC Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Ikram, M. Arfan; Hofman, Albert] Erasmus MC Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands; [Ikram, M. Arfan; Hofman, Albert] Erasmus MC Univ Med Ctr, Dept Radiol, Rotterdam, Netherlands; [Ikram, M. Arfan; Hofman, Albert; van Duijn, Cornelia M.] Netherlands Consortium Hlth Aging, Leiden, Netherlands; [Zelenika, Diana; Bihoreau, Marie-Therese] CEA, Inst Genom, Ctr Natl Genotypage, Evry, France; [Kamatani, Yoichiro; Lathrop, Mark] Fdn Jean Dausset CEPH, Paris, France; [Schmidt, Helena] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Zelenika, Diana; United Kingdom Brain Expression] UCL Inst Neurol, Dept Mol Neurosci, Reta Lila Weston Res Labs, London, England; [Johnson, Andrew D.] NHLBI, Cardiovasc Epidemiol & Human Genom Branch, Framingham Heart Study, Framingham, MA USA; [Ruiz, Agustin; Hernandez, Isabel; Boada, Merce] Fundacio ACE, Memory Clin, Inst Catala Neurociencies Aplicades, Barcelona, Spain; [Vardarajan, Badri N.; Reitz, Christiane; Mayeux, Richard] Columbia Univ, Dept Neurol, Taub Inst Alzheimers Dis & Aging Brain, New York, NY USA; [Vardarajan, Badri N.; Reitz, Christiane; Mayeux, Richard] Columbia Univ, Dept Neurol, Gertrude H Sergievsky Ctr, New York, NY USA; [Pasquier, Florence; Deramecourt, Vincent; Amouyel, Philippe] CHRU Lille, CNR MAJ, F-59037 Lille, France; [Hanon, Olivier] Univ Paris 05, Sorbonne Paris 5, Broca Hosp, Dept Geriatr, Paris, France; [Fitzpatrick, Annette L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Fitzpatrick, Annette L.] Univ Washington, Dept Global Hlth, Seattle, WA 98195 USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Neurosci, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Psychiat, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genet, New York, NY USA; [Buxbaum, Joseph D.] Mt Sinai Sch Med, Dept Genom Sci, New York, NY USA; [Campion, Dominique; Wallon, David; Hannequin, Didier] Rouen Univ Hosp, CNR MAJ, INSERM, U1079, F-76031 Rouen, France; [Crane, Paul K.; Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA USA; [Becker, Tim] Univ Bonn, German Ctr Neurodegenerat Dis DZNE, Bonn, Germany; [Becker, Tim] Univ Bonn, Inst Med Biometry Informat & Epidemiol, Bonn, Germany; [Cruchaga, Carlos; Goate, Alison M.] Washington Univ, Sch Med, Dept Psychiat, St Louis, MO 63110 USA; [Cruchaga, Carlos; Goate, Alison M.] Washington Univ, Sch Med, Hope Ctr Program Prot Aggregat & Neurodegenerat, St Louis, MO USA; [Craig, David; Johnston, Janet A.; McGuinness, Bernadette; Todd, Stephen; Passmore, Peter] Queens Univ Belfast, Sch Med Dent & Biomed Sci, Ctr Publ Hlth, Ageing Grp, Belfast, Antrim, North Ireland; [Amin, Najaf; van Duijn, Cornelia M.] Erasmus MC Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Berr, Claudine; Ritchie, Karen] Hop Colombiere, Fac Med, INSERM, U1061, Montpellier, France; [Lopez, Oscar L.] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [De Jager, Philip L.] Brigham & Womens Hosp, Dept Neurol & Psychiat, Inst Neurosci, Program Translat NeuroPsychiat Genom, Boston, MA 02115 USA; [De Jager, Philip L.] Harvard Univ, Sch Med, Boston, MA USA; [De Jager, Philip L.] Broad Inst, Program Med & Populat Genet, Boston, MA USA; [Evans, Denis] Rush Univ, Med Ctr, Dept Internal Med, Rush Inst Hlth Aging, Chicago, IL 60612 USA; [Lovestone, Simon; Barberger-Gateau, Pascale; Proitsi, Petra; Powell, John F.] Kings Coll London, Inst Psychiat, Dept Neurosci, London WC2R 2LS, England; [Letenneur, Luc; Dufouil, Carole; Dartigues, Jean-Francois] Victor Segalen Univ, INSERM, U897, F-33076 Bordeaux, France; [Rubinsztein, David C.] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [Sleegers, Kristel; Bettens, Karolien; Van Broeckhoven, Christine] Univ Antwerp VIB, Dept Mol Genet, Neurodegenerat Brain Dis Grp, B-2610 Antwerp, Belgium; [Sleegers, Kristel; Bettens, Karolien; Van Broeckhoven, Christine] Univ Antwerp, Inst Born Bunge, Neurogenet Lab, B-2020 Antwerp, Belgium; [Huentelman, Matthew J.] Translat Genom Res Inst, Neurogen Div, Phoenix, AZ USA; [Gill, Michael] Univ Dublin Trinity Coll, Discipline Psychiat, Dublin 2, Ireland; [Brown, Kristelle; Morgan, Kevin] Univ Nottingham, Queens Med Ctr, Inst Genet, Nottingham NG7 2RD, England; [Kamboh, M. Ilyas] Univ Pittsburgh, Dept Human Genet, Pittsburgh, PA USA; [Kamboh, M. Ilyas] Univ Pittsburgh, Alzheimers Dis Res Ctr, Pittsburgh, PA USA; [Keller, Lina] Karolinska Inst, Dept Neurobiol, Care Sci & Soc, Aging Reasearch Ctr, Stockholm, Sweden; [Keller, Lina; Fratiglioni, Laura] Stockholm Univ, S-10691 Stockholm, Sweden; [Larson, Eric B.] Grp Hlth Res Inst, Grp Hlth, Seattle, WA USA; [Myers, Amanda J.] Univ Miami, Miller Sch Med, Dept Psychiat & Behav Sci, Miami, FL 33136 USA; [Love, Seth] Univ Bristol, Inst Clin Neurosci, Sch Clin Sci, Frenchay Hosp, Bristol, Avon, England; [Rogaeva, Ekaterina; St George-Hyslop, Peter] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON, Canada; [Gallacher, John; Bayer, Anthony] Cardiff Univ, Neuadd Meirionnydd, Univ Wales Hosp, Inst Primary Care & Publ Hlth, Cardiff CF10 3AX, S Glam, Wales; [St George-Hyslop, Peter] Univ Cambridge, Cambridge Inst Med Res, Cambridge, England; [St George-Hyslop, Peter] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Clarimon, Jordi; Lleo, Alberto] Univ Autonoma Barcelona, St Pau Hosp, IIB St Pau, Dept Neurol, E-08193 Barcelona, Spain; [Clarimon, Jordi; Lleo, Alberto] Ctr Networker Biomed Res Neurodegenerat Dis CIBER, Barcelona, Spain; [Tsuang, Debby W.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Yu, Lei; Bennett, David A.] Rush Univ, Med Ctr, Dept Neurol Sci, Chicago, IL 60612 USA; [Tsolaki, Magda] Aristotle Univ Thessaloniki, Dept Neurol 3, GR-54006 Thessaloniki, Greece; [Bossu, Paola; Spalletta, Gianfranco] Fdn Santa Lucia, Rome, Italy; [Collinge, John; Mead, Simon] UCL Inst Neurol, Dept Neurodegenerat Dis, MRC Prion Unit, London, England; [Sorbi, Sandro; Nacmias, Benedetta] Univ Florence, NEUROFARBA Dept Neurosci Psychol Drug Res & Child, Florence, Italy; [Sorbi, Sandro; Nacmias, Benedetta] Univ Florence, Ctr Ric Trasferimento & Alta Formaz DENOTHE, Florence, Italy; [Garcia, Florentino Sanchez; Deniz Naranjo, Maria Candida] Hosp Univ Dr Negrin, Dept Immunol, Las Palmas Gran Canaria, Spain; [Fox, Nick C.] UCL Inst Neurol, Dept Neurodegenerat Dis, Dementia Res Ctr, London, England; [Hardy, John] Inst Neurol, Dept Mol Neurosci, London WC1N 3BG, England; [Hardy, John] Inst Neurol, Reta Lilla Weston Labs, London WC1N 3BG, England; [Bosco, Paolo] IRCCS Assoc Oasi Maria SS, Troina, Italy; [Clarke, Robert] Univ Oxford, Clin Trial Serv Unit, OHAP, Oxford, England; [Brayne, Carol] Univ Cambridge, Inst Publ Hlth, CFAS, Cambridge, England; [Galimberti, Daniela; Scarpini, Elio] Univ Milan, Fdn Ca Granda, IRCCS Osped Policlin, Milan, Italy; [Bonuccelli, Ubaldo; Mancuso, Michelangelo; Siciliano, Gabriele] Univ Pisa, Neurol Clin, Pisa, Italy; [Moebus, Susanne] Univ Duisburg Essen, Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany; [Mecocci, Patrizia] Univ Perugia, Dept Clin & Expt Med, Sect Gerontol & Geriatr, I-06100 Perugia, Italy; [Del Zompo, Maria] Univ Cagliari, Dept Biomed Sci, Sect Neurosci & Clin Pharmacol, Cagliari, Italy; [Maier, Wolfgang] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [Maier, Wolfgang; Noethen, Markus M.] German Ctr Neurodegenerat Dis DZNE Bonn, Bonn, Germany; [Hampel, Harald] Goethe Univ Frankfurt, Dept Psychiat, D-60054 Frankfurt, Germany; [Hampel, Harald; Rujescu, Dan] Univ Munich, Dept Psychiat, D-80539 Munich, Germany; [Pilotto, Alberto] IRCCS Casa Sollievo Sofferenza, Gerontol & Geriatr Res Lab, San Giovanni Rotondo, Italy; [Frank-Garcia, Ana] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Frank-Garcia, Ana] Ctr Invest Biomed Red Enfermedades Neurodegenerat, Madrid, Spain; [Frank-Garcia, Ana] Hosp la Paz IdIPaz, Inst Invest Sanitaria, Madrid, Spain; [Panza, Francesco; Solfrizzi, Vincenzo] Univ Bari, Ctr Aging Brain, Dept Geriatr, Bari, Italy; [Caffarra, Paolo] Univ Parma, Dept Neurosci, I-43100 Parma, Italy; [Caffarra, Paolo] Ctr Cognit Disorders AUSL, Parma, Italy; [Mayhaus, Manuel; Pichler, Sabrina] Univ Hosp, Dept Psychiat, Saarland, Germany; [Lannfelt, Lars; Ingelsson, Martin] Uppsala Univ, Dept Publ Health Geriatr, Uppsala, Sweden; [Hakonarson, Hakon] Childrens Hosp Philadelphia, Ctr Appl Genom, Philadelphia, PA 19104 USA; [Carrasquillo, Minerva M.; Zou, Fanggeng; Younkin, Steven G.] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA; [Beekly, Duane] Univ Washington, Natl Alzheimers Coordinating Ctr, Seattle, WA 98195 USA; [Alvarez, Victoria; Coto, Eliecer] Genet Mol Huca Oviedo, Oviedo, Spain; [Gu, Wei; Riemenschneider, Matthias] Univ Hosp, Dept Psychiat, Saarland, Germany; [Razquin, Cristina; Pastor, Pau] Univ Navarra, Sch Med, Ctr Appl Med Res, Neurogenet Lab,Div Neurosci, E-31080 Pamplona, Spain; [Pastor, Pau] Inst Salud Carlos III, Ctr Invest Biome Red Enfermedades Neurodegenerat, CIBERNED, Madrid, Spain; [Mateo, Ignacio; Combarros, Onofre] Univ Cantabria, Marques de Valdecilla Univ Hosp, Neurol Serv, E-39005 Santander, Spain; [Mateo, Ignacio; Combarros, Onofre] Univ Cantabria, Marques de Valdecilla Univ Hosp, CIBERNED, E-39005 Santander, Spain; [Mateo, Ignacio; Combarros, Onofre] IFIMAV, Santander, Spain; [Faber, Kelley M.; Foroud, Tatiana M.] Indiana Univ, Dept Med & Mol Genet, Indianapolis, IN 46204 USA; [Jonsson, Palmi V.] Landspitali Univ Hosp, Reykjavik, Iceland; [Soininen, Hilkka; Hiltunen, Mikko] Univ Eastern Finland, Inst Clin Med Neurol, Kuopio, Finland; [Soininen, Hilkka; Hiltunen, Mikko] Kuopio Univ Hosp, Dept Neurol, SF-70210 Kuopio, Finland; [Blacker, Deborah] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA; [Blacker, Deborah] Harvard Univ, Sch Med, Dept Psychiat, Massachusetts Gen Hosp, Boston, MA 02115 USA; [Mosley, Thomas H., Jr.] Univ Mississippi, Med Ctr, Dept Geriatr Med, Jackson, MS 39216 USA; [Bennett, David A.] Rush Univ, Med Ctr, Rush Alzheimers Dis Ctr, Chicago, IL 60612 USA; [Harris, Tamara B.; Launer, Lenore J.] NIH, Lab Epidemiol Demog & Biometry, Bethesda, MD 20892 USA; [Fratiglioni, Laura] Karolinska Inst, Care Sci & Soc, Dept Neurobiol, Aging Res Ctr, Stockholm, Sweden; [Fratiglioni, Laura; Graff, Caroline] Karolinska Univ Hosp Huddinge, Genet Unit, Dept Geriatr Med, Stockholm, Sweden; [Holmes, Clive] Univ Southampton, Sch Med, Div Clin Neurosci, Southampton, Hants, England; [de Bruijn, Renee F. A. G.] Erasmus MC Univ Med Ctr, Dept Neurol, Rotterdam, Netherlands; [de Bruijn, Renee F. A. G.] Erasmus MC Univ Med Ctr, Dept Epidemiol, Rotterdam, Netherlands; [Montine, Thomas J.] Univ Washington, Dept Pathol, Seattle, WA 98195 USA; [Rotter, Jerome I.] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Inst Translat Genom & Populat Sci, Torrance, CA 90509 USA; [Brice, Alexis] Univ Paris 06, INSERM UMR S975 CNRS UMR 7225, Ctr Rech, Inst Cerveau & Moelle Epiniere CRICM,Hop Salpetri, Paris, France; [Brice, Alexis] Hop La Pitie Salpetriere, AP HP, Paris, France; [Kukull, Walter A.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Nalls, Michael A.] NIA, Neurogenet Lab, Intramural Res Program, Bethesda, MD 20892 USA; [Ritchie, Karen] Univ London Imperial Coll Sci Technol & Med, London, England; [Kauwe, John S. K.] Brigham Young Univ, Dept Biol, Provo, UT 84602 USA; [Boerwinkle, Eric] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Ctr Human Genet, Houston, TX 77030 USA; [Boerwinkle, Eric] Univ Texas Hlth Sci Ctr Houston, Div Epidemiol, Houston, TX 77030 USA; [Boada, Merce] Univ Autonoma Barcelona VHIR UAB, Inst Recerca, Hosp Univ Vall d Hebron, Barcelona, Spain; [Schmidt, Reinhold] Med Univ Graz, Dept Neurol, Graz, Austria; [Dartigues, Jean-Francois] CHU Bordeaux, Ctr Memoire Ressources & Rech Bordeaux, Bordeaux, France; [Tzourio, Christophe] Victor Segalen Univ, INSERM, U708, Bordeaux, France; [Noethen, Markus M.] Univ Bonn, Life & Brain Ctr, Dept Genom, Inst Human Genet, Bonn, Germany; [Graff, Caroline] Karolinska Inst, Dept Neurobiol, Care Sci & Soc, KIADRC, Stockholm, Sweden; [Psaty, Bruce M.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Haines, Jonathan L.] Vanderbilt Univ, Vanderbilt Ctr Human Genet Res, Nashville, TN 37235 USA; [Haines, Jonathan L.] Case Western Reserve Univ, Dept Epidemiol & Biostat, Cleveland, OH 44106 USA; [Lathrop, Mark] McGill Univ, Montreal, PQ, Canada; [Lathrop, Mark] Genome Quebec Innovat Ctr, Montreal, PQ, Canada; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [van Duijn, Cornelia M.] Ctr Med Syst Biol, Leiden, Netherlands; [Ramirez, Alfredo] Univ Bonn, Dept Psychiat & Psychotherapy, Bonn, Germany; [Ramirez, Alfredo] Univ Bonn, Inst Human Genet, Bonn, Germany; [Seshadri, Sudha] Framingham Heart Dis Epidemiol Study, Framingham, MA USA; [Amouyel, Philippe] CHRU Lille, F-59037 Lille, France	Cardiff University; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; University of Pennsylvania; Pennsylvania Medicine; Boston University; Erasmus University Rotterdam; Erasmus MC; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; Boston University; Boston University; University of Washington; University of Washington Seattle; University of Miami; University of Miami; Swiss Federal Institutes of Technology Domain; ETH Zurich; Vanderbilt University; University of Iceland; Icelandic Heart Association; Boston University; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; CEA; UDICE-French Research Universities; Universite Paris Saclay; Foundation Jean Dausset-CEPH; Medical University of Graz; University of London; University College London; Framingham Heart Study; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Columbia University; Columbia University; Universite de Lille - ISITE; CHU Lille; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Broca - APHP; UDICE-French Research Universities; Universite Paris Cite; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai; CHU de Rouen; Institut National de la Sante et de la Recherche Medicale (Inserm); University of Washington; University of Washington Seattle; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Bonn; University of Bonn; Washington University (WUSTL); Washington University (WUSTL); Queens University Belfast; Erasmus University Rotterdam; Erasmus MC; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; CHU de Montpellier; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rush University; University of London; King's College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Cambridge; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Antwerp; Translational Genomics Research Institute; Trinity College Dublin; University of Nottingham; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Karolinska Institutet; Stockholm University; University of Miami; University of Bristol; University of Toronto; Cardiff University; University of Cambridge; University of Cambridge; Autonomous University of Barcelona; University of Washington; University of Washington Seattle; Rush University; Aristotle University of Thessaloniki; IRCCS Santa Lucia; University of London; University College London; University of Florence; University of Florence; University of London; University College London; University of London; University College London; University of London; University College London; IRCCS Oasi Maria SS; University of Oxford; University of Cambridge; IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Pisa; University of Duisburg Essen; University of Perugia; University of Cagliari; University of Bonn; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); Goethe University Frankfurt; University of Munich; IRCCS Casa Sollievo Della Sofferenza; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM); CIBERNED; Universita degli Studi di Bari Aldo Moro; University of Parma; Uppsala University; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Mayo Clinic; University of Washington; University of Washington Seattle; Central University Hospital Asturias; University of Navarra; CIBERNED; Instituto de Salud Carlos III; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; CIBERNED; Hospital Universitario Marques de Valdecilla (HUMV); Universidad de Cantabria; Indiana University System; Indiana University-Purdue University Indianapolis; Landspitali National University Hospital; University of Eastern Finland; Kuopio University Hospital; University of Eastern Finland; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Mississippi; University of Mississippi Medical Center; Rush University; National Institutes of Health (NIH) - USA; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; University of Southampton; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; University of Washington; University of Washington Seattle; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; Lundquist Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Washington; University of Washington Seattle; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Imperial College London; Brigham Young University; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Medical University of Graz; CHU Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; University of Bonn; Karolinska Institutet; Group Health Cooperative; Vanderbilt University; Case Western Reserve University; McGill University; Boston University; Boston University; University of Bonn; University of Bonn; Framingham Heart Study; Universite de Lille - ISITE; CHU Lille	Schellenberg, GD (corresponding author), Univ Penn, Perelman Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA.	gerardsc@mail.med.upenn.edu; philippe.amouyel@pasteur-lille.fr; WilliamsJ@cf.ac.uk	Ruiz, Agustin/G-5677-2012; Russo, Giancarlo/GQY-5601-2022; Deramecourt, Vincent/G-5504-2018; Mancuso, Michelangelo/K-4170-2016; Belllenguez, Céline/Y-3183-2018; Brayne, Carol/AAA-4285-2020; Yu, Lei/AAT-3685-2020; Pasquier, Florence/F-1527-2017; graff, caroline/A-2545-2009; Ritchie, Karen/G-3571-2013; Buxbaum, Joseph D/G-6001-2010; Tsuang, Debby/L-7234-2016; Melief, Erica/M-6436-2019; Hanon, Olivier/GWR-0220-2022; lambert, jean-charles/F-8787-2013; Schmidt, Reinhold/E-1137-2014; Nacmias, Benedetta/J-5084-2018; Bayer, Antony/H-4376-2019; Reitz, Christiane/GNP-0257-2022; Van Broeckhoven, Christine/G-8362-2017; Ikram, M. Arfan/AAM-5225-2021; O'Donovan, Michael C/P-7005-2018; Rubinsztein, David C/C-3472-2011; Fox, Nick C/AAE-1849-2021; Caffarra, Paolo/K-6567-2016; Bonuccelli, Ubaldo/K-8681-2016; Spalletta, Gianfranco/K-3828-2018; Van Broeckhoven, Christine/M-7853-2019; Gudnason, Vilmundur/AAE-7126-2019; DARTIGUES, Jean François/T-4513-2019; Bossù, Paola/E-4832-2014; Haines, Jonathan/C-3374-2012; Gu, Wei/G-4003-2010; Bayer, Antony/H-4434-2019; Lleó, Alberto/K-5783-2019; Tzourio, christophe/B-4015-2009; brice, alexis/AAE-8275-2019; Cruchaga, Carlos/ABF-4065-2020; Dufouil, Carole/J-4968-2012; Kauwe, John/AAC-6646-2021; berr, Claudine/D-5238-2014; Kamatani, Yoichiro/N-5513-2015; Panza, Francesco/Y-2539-2019; Ramirez, Alfredo/S-5126-2019; Bellenguez, Céline/X-4004-2019; Fox, Nick C/B-1319-2009; LETENNEUR, Luc/T-4424-2019; McGuinness, Bernadette/AAH-2755-2021; Galimberti, Daniela/N-7209-2019; Razquin, Cristina/H-2366-2017; alvarez, victoria/ABC-7891-2021; , beccie/AAM-3770-2021; Alvarez, Maria/GZH-1345-2022; Tzourio, christophe/L-6344-2019; Johnson, Andrew D/G-6520-2013; Rotter, Jerome/AAY-6598-2021; Smith, Albert Vernon/K-5150-2015; solfrizzi, vincenzo/AAL-3222-2020; Wallon, David/AAI-1352-2020; Mecocci, Patrizia/W-2116-2019; Farrer, Lindsay/AAS-1035-2020; Hardy, John/C-2451-2009; Powell, John F/G-4412-2011; Brice, Alexis/A-2170-2009; Todd, Stephen/AAF-6729-2020; García, Ana Frank/I-5159-2015; Panza, Francesco/M-6804-2017; Gudnason, Vilmundur/K-6885-2015; Rujescu, Dan/GRS-3875-2022; Dufouil, Carole/F-5751-2014; alvarez, victoria/GXV-1088-2022; Holmans, Peter/F-4518-2015; Pastor, Pau/C-9834-2009; Lambert, jean-charles/A-9553-2014; Scarpini, Elio/K-6547-2016	Deramecourt, Vincent/0000-0001-9742-7833; Mancuso, Michelangelo/0000-0003-2738-8562; Belllenguez, Céline/0000-0002-1240-7874; Brayne, Carol/0000-0001-5307-663X; Pasquier, Florence/0000-0001-9880-9788; Ritchie, Karen/0000-0002-0688-8982; Tsuang, Debby/0000-0002-4716-1894; lambert, jean-charles/0000-0003-0829-7817; Nacmias, Benedetta/0000-0001-9338-9040; Van Broeckhoven, Christine/0000-0003-0183-7665; O'Donovan, Michael C/0000-0001-7073-2379; Fox, Nick C/0000-0002-6660-657X; Caffarra, Paolo/0000-0003-2246-5223; Bonuccelli, Ubaldo/0000-0001-6218-6312; Spalletta, Gianfranco/0000-0002-7432-4249; Van Broeckhoven, Christine/0000-0003-0183-7665; Gudnason, Vilmundur/0000-0001-5696-0084; Bossù, Paola/0000-0002-1432-0078; Haines, Jonathan/0000-0002-4351-4728; Gu, Wei/0000-0003-3951-6680; Bayer, Antony/0000-0002-7514-248X; Tzourio, christophe/0000-0002-6517-2984; brice, alexis/0000-0002-0941-3990; Cruchaga, Carlos/0000-0002-0276-2899; Kauwe, John/0000-0001-8641-2468; berr, Claudine/0000-0001-5254-7655; Panza, Francesco/0000-0002-7220-0656; Ramirez, Alfredo/0000-0003-4991-763X; Bellenguez, Céline/0000-0002-1240-7874; Fox, Nick C/0000-0002-6660-657X; LETENNEUR, Luc/0000-0002-3274-937X; McGuinness, Bernadette/0000-0002-7028-5633; Galimberti, Daniela/0000-0002-9284-5953; Razquin, Cristina/0000-0003-3480-2645; alvarez, victoria/0000-0002-1916-2523; , beccie/0000-0002-3885-1199; Tzourio, christophe/0000-0002-6517-2984; Johnson, Andrew D/0000-0001-6369-5178; Smith, Albert Vernon/0000-0003-1942-5845; solfrizzi, vincenzo/0000-0002-8524-0315; Mecocci, Patrizia/0000-0003-0729-5246; Hardy, John/0000-0002-3122-0423; Powell, John F/0000-0001-6124-439X; García, Ana Frank/0000-0003-3858-9116; Panza, Francesco/0000-0002-7220-0656; Gudnason, Vilmundur/0000-0001-5696-0084; Dufouil, Carole/0000-0003-2442-4476; alvarez, victoria/0000-0002-1916-2523; Holmans, Peter/0000-0003-0870-9412; Pastor, Pau/0000-0002-7493-8777; Lambert, jean-charles/0000-0003-0829-7817; Buxbaum, Joseph/0000-0001-8898-8313; Mead, Simon/0000-0002-4326-1468; Hanon, Olivier/0000-0002-4697-122X; Jun, Gyungah/0000-0002-3230-8697; Proitsi, Petroula/0000-0002-2553-6974; Morgan, Kevin/0000-0002-8217-2396; Escott-Price, Valentina/0000-0003-1784-5483; Nothen, Markus/0000-0002-8770-2464; Scarpini, Elio/0000-0002-6395-2119; Van Duijn, Cornelia/0000-0002-2374-9204; Love, Seth/0000-0001-8683-3625; Graff, Caroline/0000-0002-9949-2951; sorbi, sandro/0000-0002-0380-6670; Wallon, David/0000-0002-2634-7198; Seshadri, Sudha/0000-0001-6135-2622; Ruiz Laza, Agustin/0000-0003-2633-2495; Goate, Alison/0000-0002-0576-2472; Kamboh, M. Ilyas/0000-0002-3453-1438; Chouraki, Vincent/0000-0002-4698-1794; Williams, Julie/0000-0002-4069-0259; Holmes, Clive/0000-0003-1999-6912; Todd, Stephen/0000-0002-2312-9195; Tsolaki, Magda/0000-0002-2072-8010; Farrer, Lindsay/0000-0001-5533-4225; Lunetta, Kathryn/0000-0002-9268-810X; Crane, Paul/0000-0003-4278-7465; Kukull, Walter/0000-0001-8761-9014; Amin, Najaf/0000-0002-8944-1771; Harold, Denise/0000-0001-5195-0143; Gill, Michael/0000-0003-0206-5337; Clarimon, Jordi/0000-0002-6824-6942; Lin, Chiao-Feng/0000-0002-6177-8807; Gerrish, Amy/0000-0002-5982-1685; Hampel, Harald/0000-0003-0894-8982; St George-Hyslop, Peter/0000-0003-0796-7209; Denning, Nicola/0000-0001-8467-7382; Moebus, Susanne/0000-0002-0072-5410; Lovestone, Simon/0000-0003-0473-4565; Amouyel, Philippe/0000-0001-9088-234X	French National Foundation; Institut Pasteur de Lille, Inserm, FRC (fondation pour la recherche sur le cerveau) and Rotary; LABEX (laboratory of excellence program investment for the future) DISTALZ grant (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease); LABEX GENMED grant (Medical Genomics); IGAP; National Foundation for Alzheimer's disease and related disorders, the Institut Pasteur de Lille and the Centre National de Genotypage; The Fondation pour la Recherche Medicale; Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Agence Francaise, de Securite Sanitaire des Produits de Sante; ANR; Eisai; Belgian Science Policy Office Interuniversity Attraction Poles program; Foundation Alzheimer Research (SAO-FRA); Flemish Government initiated Methusalem Excellence Program; Research Foundation Flanders (FWO); University of Antwerp Research Fund, Belgium; Health Research Council of the Academy of Finland; Kuopio University Hospital [5772708]; Nordic Centre of Excellence in Neurodegeneration; Cassa di Risparmio di Pistoia e Pescia [2012]; Cassa di Risparmio di Firenze [2012]; Stichting MS Research; Brain Net Europe; Hersenstichting Nederland Breinbrekend Werk; International Parkinson Fonds, Internationale Stiching Alzheimer Onderzoek; Institut de Neuropatologia, Servei Anatomia Patologica, Universitat de Barcelona; ADNI; Abbott; AstraZeneca AB; Bayer Schering Pharma AG; Bristol-Myers Squibb; Eisai Global Clinical Development; Elan Corporation; Genentech; GE Healthcare; Glaxo-SmithKline; Innogenetics; Johnson and Johnson; Eli Lilly and Co; Medpace, Inc; Merck and Co., Inc.; Novartis AG; Pfizer Inc; F. Hoffman-La Roche; Schering-Plough; Synarc, Inc.; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Dana Foundation; National Institute of Biomedical Imaging and Bioengineering; NIA [U01 AG024904, RC2 AG036535, K01 AG030514]; ADNI (National Institutes of Health) [U01 AG024904]; National Institute on Aging; The Canadian Institutes of Health Research; NIH [K01 AG030514, P30 AG010129]; Alzheimer Association (LAF) [IIRG-08-89720]; Alzheimer Association (MP-V) [IIRG-05-14147]; United States Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program; Wellcome Trust; Howard Hughes Medical Institute; Canadian Institute of Health; LABEX; CNG; EADI; Aquitaine and Bourgogne Regional Councils, Agence Nationale de la Recherche;  [RF-2010-2319722]; MRC [MC_PC_14095, MC_U123192748, MC_U137686857, G0902227, MC_U123160651, MR/K013041/1] Funding Source: UKRI; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124, UL1TR001108] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL105756, R01HL080295, R01HL093029, ZIAHL006170, R01HL087652, R01HL038444, RC2HL102419, U01HL080295] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG006375] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK063491] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008151] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH060451] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P50NS039764] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG034504, U01AG024904, R01AG041797, R01AG037212, U24AG021886, P01AG003991, P30AG010129, R01AG019085, R01AG020098, P50AG008671, R01AG021547, R01AG030653, P30AG010161, U01AG049505, P50AG025688, P30AG013846, P50AG005681, P01AG010491, R01AG023629, R01AG041232, R56AG023629, U01AG016976, P50AG005136, R01AG041718, RC2AG036535, R01AG027058, R01AG008122, P30AG010124, P50AG005142, R01AG019757, N01AG012100, R01AG017917, U01AG006781, P50AG005133, R56AG020098, K01AG030514, R01AG015928, R01AG027944, R01AG033193, ZIAAG007270, RF1AG015819] Funding Source: NIH RePORTER; Alzheimers Research UK [ART-BIG2009-1, ARUK-PG2014-1, ARUK-PG2014-2, ARUK-NCG2014A-1] Funding Source: researchfish; Medical Research Council [MC_U123192748, MC_U123160651, MC_PC_14095, MR/K013041/1, G0902227, MC_U137686857, MR/L010305/1, MR/L501517/1] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084, NF-SI-0508-10123, NF-SI-0512-10053, NF-SI-0513-10134] Funding Source: researchfish; Alzheimer&quot;s Society [167, 164] Funding Source: researchfish	French National Foundation; Institut Pasteur de Lille, Inserm, FRC (fondation pour la recherche sur le cerveau) and Rotary; LABEX (laboratory of excellence program investment for the future) DISTALZ grant (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease); LABEX GENMED grant (Medical Genomics); IGAP; National Foundation for Alzheimer's disease and related disorders, the Institut Pasteur de Lille and the Centre National de Genotypage; The Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Agence Francaise, de Securite Sanitaire des Produits de Sante(General Electric); ANR(French National Research Agency (ANR)); Eisai(Eisai Co Ltd); Belgian Science Policy Office Interuniversity Attraction Poles program; Foundation Alzheimer Research (SAO-FRA); Flemish Government initiated Methusalem Excellence Program; Research Foundation Flanders (FWO)(FWO); University of Antwerp Research Fund, Belgium; Health Research Council of the Academy of Finland(Academy of Finland); Kuopio University Hospital; Nordic Centre of Excellence in Neurodegeneration; Cassa di Risparmio di Pistoia e Pescia; Cassa di Risparmio di Firenze(Fondazione Cassa Risparmio Firenze); Stichting MS Research; Brain Net Europe; Hersenstichting Nederland Breinbrekend Werk; International Parkinson Fonds, Internationale Stiching Alzheimer Onderzoek; Institut de Neuropatologia, Servei Anatomia Patologica, Universitat de Barcelona; ADNI; Abbott(Abbott Laboratories); AstraZeneca AB(AstraZeneca); Bayer Schering Pharma AG(Bayer AG); Bristol-Myers Squibb(Bristol-Myers Squibb); Eisai Global Clinical Development(Eisai Co Ltd); Elan Corporation; Genentech(Roche HoldingGenentech); GE Healthcare(General ElectricGE Healthcare); Glaxo-SmithKline(GlaxoSmithKline); Innogenetics; Johnson and Johnson(Johnson & JohnsonJohnson & Johnson USA); Eli Lilly and Co(Eli Lilly); Medpace, Inc; Merck and Co., Inc.(Merck & Company); Novartis AG; Pfizer Inc(Pfizer); F. Hoffman-La Roche; Schering-Plough(Merck & CompanySchering Plough Corporation); Synarc, Inc.; Alzheimer's Association(Alzheimer's Association); Alzheimer's Drug Discovery Foundation; Dana Foundation; National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); ADNI (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); The Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alzheimer Association (LAF); Alzheimer Association (MP-V); United States Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program; Wellcome Trust(Wellcome TrustEuropean Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Canadian Institute of Health(Canadian Institutes of Health Research (CIHR)); LABEX; CNG; EADI; Aquitaine and Bourgogne Regional Councils, Agence Nationale de la Recherche(French National Research Agency (ANR)); ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Alzheimers Research UK(Alzheimer&apos;s Research UK (ARUK)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); Alzheimer&quot;s Society	The i-Select chips was funded by the French National Foundation on Alzheimer's disease and related disorders. The French National Fondation on Alzheimer's disease and related disorders supported several I-GAP meetings and communications. Data management involved the Centre National de Genotypage, and was supported by the Institut Pasteur de Lille, Inserm, FRC (fondation pour la recherche sur le cerveau) and Rotary. This work has been developed and supported by the LABEX (laboratory of excellence program investment for the future) DISTALZ grant (Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease) and by the LABEX GENMED grant (Medical Genomics). The French National Foundation on Alzheimer's disease and related disorders and the Alzheimer's Association (Chicago, Illinois) grant supported IGAP in-person meetings, communication and the Alzheimer's Association (Chicago, Illinois) grant provided some funds to each consortium for analyses. EADI The authors thank Dr. Anne Boland (CNG) for her technical help in preparing the DNA samples for analyses. This work was supported by the National Foundation for Alzheimer's disease and related disorders, the Institut Pasteur de Lille and the Centre National de Genotypage. The Three-City Study was performed as part of a collaboration between the Institut National de la Sante et de la Recherche Medicale (Inserm), the Victor Segalen Bordeaux II University and Sanofi-Synthelabo. The Fondation pour la Recherche Medicale funded the preparation and initiation of the study. The 3C Study was also funded by the Caisse Nationale Maladie des Travailleurs Salaries, Direction Generale de la Sante, MGEN, Institut de la Longevite, Agence Francaise, de Securite Sanitaire des Produits de Sante, the Aquitaine and Bourgogne Regional Councils, Agence Nationale de la Recherche, ANR supported the COGINUT and COVADIS projects. Fondation de France and the joint French Ministry of Research/INSERM << Cohortes et collections de donnees biologiques >> programme. Lille Genopole received an unconditional grant from Eisai. The Three-city biological bank was developed and maintained by the laboratory for genomic analysis LAG-BRC - Institut Pasteur de Lille. Belgium sample collection: The patients were clinically and pathological characterized by the neurologists Sebastiaan Engelborghs, Rik Vandenberghe and Peter P. De Deyn, and in part genetically by Caroline Van Cauwenberghe, Karolien Bettens and Kristel Sleegers. Research at the Antwerp site is funded in part by the Belgian Science Policy Office Interuniversity Attraction Poles program, the Foundation Alzheimer Research (SAO-FRA), the Flemish Government initiated Methusalem Excellence Program, the Research Foundation Flanders (FWO) and the University of Antwerp Research Fund, Belgium. Karolien Bettens is a postdoctoral fellow of the FWO. The Antwerp site authors thank the personnel of the VIB Genetic Service Facility, the Biobank of the Institute Born-Bunge and the Departments of Neurology and Memory Clinics at the Hospital Network Antwerp and the University Hospitals Leuven. Finish sample collection: Financial support for this project was provided by the Health Research Council of the Academy of Finland, EVO grant 5772708 of Kuopio University Hospital, and the Nordic Centre of Excellence in Neurodegeneration. Italian sample collections: the Bologna site (FL) obtained funds from the Italian Ministry of research and University as well as Carimonte Foundation.; The Florence site was supported by grant RF-2010-2319722, grant from the the Cassa di Risparmio di Pistoia e Pescia (Grant 2012) and the Cassa di Risparmio di Firenze (Grant 2012). The Milan site was supported by a grant from the (funding via numerous sources including Stichting MS Research, Brain Net Europe, Hersenstichting Nederland Breinbrekend Werk, International Parkinson Fonds, Internationale Stiching Alzheimer Onderzoek), Institut de Neuropatologia, Servei Anatomia Patologica, Universitat de Barcelona. Marcelle Morrison-Bogorad, PhD., Tony Phelps, PhD and Walter Kukull PhD are thanked for helping to co-ordinate this collection. ADNI Funding for ADNI is through the Northern California Institute for Research and Education by grants from Abbott, AstraZeneca AB, Bayer Schering Pharma AG, Bristol-Myers Squibb, Eisai Global Clinical Development, Elan Corporation, Genentech, GE Healthcare, Glaxo-SmithKline, Innogenetics, Johnson and Johnson, Eli Lilly and Co., Medpace, Inc., Merck and Co., Inc., Novartis AG, Pfizer Inc, F. Hoffman-La Roche, Schering-Plough, Synarc, Inc., Alzheimer's Association, Alzheimer's Drug Discovery Foundation, the Dana Foundation, and by the National Institute of Biomedical Imaging and Bioengineering and NIA grants U01 AG024904, RC2 AG036535, K01 AG030514. Data collection and sharing for this project was funded by the ADNI (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Alzheimer's Association; Alzheimer's Drug Discovery Foundation; BioClinica, Inc.; Biogen Idec Inc.; Bristol-Myers Squibb Company; Eisai Inc.; Elan Pharmaceuticals, Inc.; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc.; GE Healthcare; Innogenetics, N.V.; IXICO Ltd.; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc.; Merck & Co., Inc.; Meso Scale Diagnostics, LLC.; NeuroRx Research; Novartis Pharmaceuticals Corporation; Pfizer Inc.; Piramal Imaging; Servier; Synarc Inc.; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation for the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for Neuro Imaging at the University of California, Los Angeles. This research was also supported by NIH grants P30 AG010129 and K01 AG030514. The authors thank Drs. D. Stephen Snyder and Marilyn Miller from NIA who are ex-o_cio ADGC members. Support was also from the Alzheimer's Association (LAF, IIRG-08-89720; MP-V, IIRG-05-14147) and the United States Department of Veterans Affairs Administration, Office of Research and Development, Biomedical Laboratory Research Program. Peter St George-Hyslop is supported by Wellcome Trust, Howard Hughes Medical Institute, and the Canadian Institute of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benit P, 2004, J MED GENET, V41, P14, DOI 10.1136/jmg.2003.014316; Bernhard F, 2013, DIABETOLOGIA, V56, P311, DOI 10.1007/s00125-012-2773-0; Bettens K, 2013, LANCET NEUROL, V12, P92, DOI 10.1016/S1474-4422(12)70259-4; Bettens K, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-3; BROWN MB, 1975, BIOMETRICS, V31, P987, DOI 10.2307/2529826; Chen Y, 2013, MOL CELL PROTEOMICS, V12, P2804, DOI 10.1074/mcp.M112.025882; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Dahl HHM, 1998, AM J HUM GENET, V63, P1594, DOI 10.1086/302169; Driver JA, 2012, BRIT MED J, V344, DOI 10.1136/bmj.e1442; Fall T, 2012, DIABETIC MED, V29, pE62, DOI 10.1111/j.1464-5491.2012.03665.x; Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168; Giusiano S, 2012, PROSTATE, V72, P1286, DOI 10.1002/pros.22477; Guerreiro RJ, 2011, BIOCHEM SOC T, V39, P910, DOI 10.1042/BST0390910; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Haupt A, 2010, OBESITY, V18, P1212, DOI 10.1038/oby.2009.413; Hollingworth P, 2011, NAT GENET, V43, P429, DOI 10.1038/ng.803; Howie BN, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000529; Ioannidis JPA, 2007, HUM HERED, V64, P203, DOI 10.1159/000103512; Johnson AD, 2008, BIOINFORMATICS, V24, P2938, DOI 10.1093/bioinformatics/btn564; Katz C, 2012, J BIOL CHEM, V287, P15016, DOI 10.1074/jbc.M111.328377; Kiezun A, 2012, NAT GENET, V44, P623, DOI 10.1038/ng.2303; Lambert JCea, 2013, EXTENDED METAANALYSI; Lambert JC, 2013, NAT GENET, V45, P1452, DOI 10.1038/ng.2802; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; Lewis CM, 2003, AM J HUM GENET, V73, P34, DOI 10.1086/376549; Li Y, 2010, GENET EPIDEMIOL, V34, P816, DOI 10.1002/gepi.20533; Moskvina V, 2007, HUM HERED, V64, P63, DOI 10.1159/000101424; Moskvina V, 2008, GENET EPIDEMIOL, V32, P567, DOI 10.1002/gepi.20331; Moskvina V, 2011, GENET EPIDEMIOL, V35, P861, DOI 10.1002/gepi.20636; Naj AC, 2011, NAT GENET, V43, P436, DOI 10.1038/ng.801; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Palmieri F, 2013, MOL ASPECTS MED, V34, P465, DOI 10.1016/j.mam.2012.05.005; RISCH N, 1990, AM J HUM GENET, V46, P222; Roe CM, 2010, NEUROLOGY, V74, P106, DOI 10.1212/WNL.0b013e3181c91873; Segurado R, 2003, AM J HUM GENET, V73, P49, DOI 10.1086/376547; Seillier M, 2012, CELL DEATH DIFFER, V19, P1525, DOI 10.1038/cdd.2012.30; Seshadri S, 2010, JAMA-J AM MED ASSOC, V303, P1832, DOI 10.1001/jama.2010.574; Seux M, 2011, ONCOGENE, V30, P3049, DOI 10.1038/onc.2011.25; Terwilliger JD, 2006, EUR J HUM GENET, V14, P426, DOI 10.1038/sj.ejhg.5201583; Trabzuni D, 2011, J NEUROCHEM, V119, P275, DOI 10.1111/j.1471-4159.2011.07432.x; Warnatz HJ, 2011, J BIOL CHEM, V286, P23521, DOI 10.1074/jbc.M111.220178; Watson CT, 2012, GENES IMMUN, V13, P363, DOI 10.1038/gene.2012.12; Webster JA, 2009, AM J HUM GENET, V84, P445, DOI 10.1016/j.ajhg.2009.03.011	43	81	83	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e94661	10.1371/journal.pone.0094661	http://dx.doi.org/10.1371/journal.pone.0094661			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922517	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000338701300002
J	Hutchens, MP; Kosaka, Y; Zhang, W; Fujiyoshi, T; Murphy, S; Alkayed, N; Anderson, S				Hutchens, Michael P.; Kosaka, Yasuharu; Zhang, Wenri; Fujiyoshi, Tetsuhiro; Murphy, Stephanie; Alkayed, Nabil; Anderson, Sharon			Estrogen-Mediated Renoprotection following Cardiac Arrest and Cardiopulmonary Resuscitation Is Robust to GPR30 Gene Deletion	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; ACUTE KIDNEY INJURY; PERFORMANCE LIQUID-CHROMATOGRAPHY; G-PROTEIN; IN-VIVO; EXPERIMENTAL STROKE; RECEPTOR; 17-BETA-ESTRADIOL; MICE; ISCHEMIA	Introduction: Acute kidney injury is a serious, sexually dimorphic perioperative complication, primarily attributed to hypoperfusion. We previously found that estradiol is renoprotective after cardiac arrest and cardiopulmonary resuscitation in ovariectomized female mice. Additionally, we found that neither estrogen receptor alpha nor beta mediated this effect. We hypothesized that the G protein estrogen receptor (GPR30) mediates the renoprotective effect of estrogen. Methods: Ovariectomized female and gonadally intact male wild-type and GPR30 gene-deleted mice were treated with either vehicle or 17 beta-estradiol for 7 days, then subjected to cardiac arrest and cardiopulmonary resuscitation. Twenty four hours later, serum creatinine and urea nitrogen were measured, and histologic renal injury was evaluated by unbiased stereology. Results: In both males and females, GPR30 gene deletion was associated with reduced serum creatinine regardless of treatment. Estrogen treatment of GPR30 gene-deleted males and females was associated with increased preprocedural weight. In ovariectomized female mice, estrogen treatment did not alter resuscitation, but was renoprotective regardless of GPR30 gene deletion. In males, estrogen reduced the time-to-resuscitate and epinephrine required. In wild-type male mice, serum creatinine was reduced, but neither serum urea nitrogen nor histologic outcomes were affected by estrogen treatment. In GPR30 gene-deleted males, estrogen did not alter renal outcomes. Similarly, renal injury was not affected by G1 therapy of ovariectomized female wild-type mice. Conclusion: Treatment with 17 beta-estradiol is renoprotective after whole-body ischemia-reperfusion in ovariectomized female mice irrespective of GPR30 gene deletion. Treatment with the GPR30 agonist G1 did not alter renal outcome in females. We conclude GPR30 does not mediate the renoprotective effect of estrogen in ovariectomized female mice. In males, estrogen therapy was not renoprotective. Estrogen treatment of GPR30 gene-deleted mice was associated with increased preprocedural weight in both sexes. Of significance to further investigation, GPR30 gene deletion was associated with reduced serum creatinine, regardless of treatment.	[Hutchens, Michael P.; Kosaka, Yasuharu; Zhang, Wenri; Fujiyoshi, Tetsuhiro; Murphy, Stephanie; Alkayed, Nabil] Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA; [Anderson, Sharon] Oregon Hlth & Sci Univ, Div Nephrol & Hypertens, Portland, OR 97201 USA	Oregon Health & Science University; Oregon Health & Science University	Hutchens, MP (corresponding author), Oregon Hlth & Sci Univ, Dept Anesthesiol & Perioperat Med, Portland, OR 97201 USA.	hutchenm@ohsu.edu		Hutchens, Michael/0000-0001-8583-1812	National Institute of Diabetes and Digestive and Kidney Disease [DK90754]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K08DK090754] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Funded by a grant from the National Institute of Diabetes and Digestive and Kidney Disease (http://www2.niddk.nih.gov), #DK90754 to MPH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aigouy B, 2013, NAT METHODS, V10, P1048, DOI 10.1038/nmeth.2692; Ardelt AA, 2005, STROKE, V36, P337, DOI 10.1161/01.STR.0000153795.38388.72; Bologa CG, 2006, NAT CHEM BIOL, V2, P207, DOI 10.1038/nchembio775; Bove T, 2004, J CARDIOTHOR VASC AN, V18, P442, DOI 10.1053/j.jvca.2004.05.021; Deschamps AM, 2009, AM J PHYSIOL-HEART C, V297, pH1806, DOI 10.1152/ajpheart.00283.2009; Dhandapani KM, 2002, BIOL REPROD, V67, P1379, DOI 10.1095/biolreprod.102.003848; Dietrich W, 2008, ANESTHESIOLOGY, V108, P189, DOI 10.1097/01.anes.0000299428.55062.67; Doddakula Kishore, 2007, Interact Cardiovasc Thorac Surg, V6, P314, DOI 10.1510/icvts.2006.148874; Duff GL, 1941, AM J MED SCI, V201, P429; Filardo EJ, 2002, MOL ENDOCRINOL, V16, P70, DOI 10.1210/me.16.1.70; Ford J, 2011, J BONE MINER RES, V26, P298, DOI 10.1002/jbmr.209; Foryst-Ludwig A, 2010, J STEROID BIOCHEM, V122, P74, DOI 10.1016/j.jsbmb.2010.06.012; Gruber CJ, 2002, NEW ENGL J MED, V346, P340, DOI 10.1056/NEJMra000471; Haas E, 2009, CIRC RES, V104, P288, DOI 10.1161/CIRCRESAHA.108.190892; Hofmeister MV, 2012, AM J PHYSIOL-RENAL, V302, pF358, DOI 10.1152/ajprenal.00343.2011; HOU SH, 1983, AM J MED, V74, P243, DOI 10.1016/0002-9343(83)90618-6; Hutchens MP, 2008, ANESTH ANALG, V107, P239, DOI 10.1213/ane.0b013e318178ca42; Hutchens MP, 2008, RESUSCITATION, V76, P89, DOI 10.1016/j.resuscitation.2007.06.031; Hutchens MP, 2012, AM J PHYSIOL-RENAL, V303, pF377, DOI 10.1152/ajprenal.00354.2011; Hutchens MP, 2010, ANESTHESIOLOGY, V112, P395, DOI 10.1097/ALN.0b013e3181c98da9; Keppler A, 2007, KIDNEY INT, V71, P74, DOI 10.1038/sj.ki.5001988; Kheterpal S, 2009, ANESTHESIOLOGY, V110, P505, DOI 10.1097/ALN.0b013e3181979440; Kim J, 2006, J BIOL CHEM, V281, P20349, DOI 10.1074/jbc.M512740200; Kosaka Y, 2012, TRANSL STROKE RES, V3, P500, DOI 10.1007/s12975-012-0211-8; Kowdley Gopal C, 2005, Curr Surg, V62, P64, DOI 10.1016/j.cursur.2004.06.007; Li X, 2012, AM J PHYSIOL-RENAL, V302, pF519, DOI 10.1152/ajprenal.00011.2011; Liang Y, 2001, BRAIN RES BULL, V54, P661, DOI 10.1016/S0361-9230(01)00483-X; Lindsey SH, 2011, HYPERTENSION, V58, P665, DOI 10.1161/HYPERTENSIONAHA.111.175174; Lindsey SH, 2011, J CARDIOVASC PHARM; Liu SB, 2013, BRAIN RES BULL, V93, P27, DOI 10.1016/j.brainresbull.2012.10.004; Meyer MR, 2010, PHARMACOLOGY, V86, P58, DOI 10.1159/000315497; MEYER MH, 1985, ANAL BIOCHEM, V144, P285, DOI 10.1016/0003-2697(85)90118-6; Micevych PE, 2012, NEUROENDOCRINOLOGY, V96, P103, DOI 10.1159/000338400; Muller V, 2002, KIDNEY INT, V62, P1364, DOI 10.1111/j.1523-1755.2002.kid590.x; Noppens RR, 2005, CRIT CARE MED, V33, P1595, DOI 10.1097/01.CCM.0000169884.81769.F7; Park KM, 2004, J BIOL CHEM, V279, P52282, DOI 10.1074/jbc.M407629200; Park KM, 2005, BIOCHEM BIOPH RES CO, V328, P312, DOI 10.1016/j.bbrc.2004.12.177; Perez E, 2005, BRAIN RES, V1038, P216, DOI 10.1016/j.brainres.2005.01.026; Qiu J, 2003, J NEUROSCI, V23, P9529; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Satake A, 2008, KIDNEY INT, V73, P308, DOI 10.1038/sj.ki.5002690; Sharma G., 2013, ENDOCRINOLOGY; Shibata Y, 2004, J CARDIOVASC PHARM, V44, pS459, DOI 10.1097/01.fjc.0000166315.38258.e1; Simpkins JW, 2012, NEUROENDOCRINOLOGY, V96, P119, DOI 10.1159/000338409; Song HK, 2008, ANN THORAC SURG, V85, P2040, DOI 10.1016/j.athoracsur.2008.02.082; Tanaka R, 2013, EUR J PHARMACOL, V714, P397, DOI 10.1016/j.ejphar.2013.07.008; Thakar CV, 2003, AM J KIDNEY DIS, V41, P742, DOI 10.1016/S0272-6386(03)00021-0; Thomas P, 2005, ENDOCRINOLOGY, V146, P624, DOI 10.1210/en.2004-1064; Toran-Allerand CD, 2005, ANN NY ACAD SCI, V1052, P136, DOI 10.1196/annals.1347.009; Wang C, 2008, MOL ENDOCRINOL, V22, P636, DOI 10.1210/me.2007-0359; Wang C, 2009, J IMMUNOL, V182, P3294, DOI 10.4049/jimmunol.0803205; Weil BR, 2010, SURGERY, V148, P436, DOI 10.1016/j.surg.2010.03.011; Yue W, 2010, INT J CANCER, V127, P1748, DOI 10.1002/ijc.25207; Zhang B, 2010, J IMMUNOL, V184, P4087, DOI 10.4049/jimmunol.0902339	55	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99910	10.1371/journal.pone.0099910	http://dx.doi.org/10.1371/journal.pone.0099910			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923556	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300106
J	Liu, J; Lee, GY; Lawitts, JA; Toner, M; Biggers, JD				Liu, Jie; Lee, Gloria Y.; Lawitts, Joel A.; Toner, Mehmet; Biggers, John D.			Live Pups from Evaporatively Dried Mouse Sperm Stored at Ambient Temperature for up to 2 Years	PLOS ONE			English	Article							ZYGOTIC TRANSITION; SPERMATOZOA; INJECTION; OOCYTES; STORAGE	The purpose of this study is to develop a mouse sperm preservation method based on evaporative drying. Mouse sperm were evaporatively dried and stored at 4 degrees C and ambient temperature for 3 months to 2 years. Upon rehydration, a single sperm was injected into a mature oocyte to develop into a blastocyst after culture or a live birth after embryo transfer to a recipient female. For the samples stored at 4 degrees C for 3, 6, 12, 18, and 24 months, the blastocyst formation rate was 61.5%, 49.1%, 31.5%, 32.2%, and 41.4%, respectively. The blastocyst rate for those stored at ambient temperature (similar to 22 degrees C) for 3, 6, 12, and 18 months was 57.8%, 36.2%, 33.6%, and 34.4%, respectively. Fifteen, eight and three live pups were produced from sperm stored at room temperature for 12, 18, and 24 months, respectively. This is the first report of live offspring produced from dried mouse sperm stored at ambient temperature for up to 2 years. Based on these results, we suggest that evaporative drying is a potentially useful method for the routine preservation of mouse sperm.	[Liu, Jie; Lee, Gloria Y.; Toner, Mehmet; Biggers, John D.] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02163 USA; [Liu, Jie; Lee, Gloria Y.; Toner, Mehmet; Biggers, John D.] Shriners Hosp Children, Boston, MA USA; [Lawitts, Joel A.] Beth Israel Deaconess Med Ctr, Boston, MA 02215 USA; [Biggers, John D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School	Liu, J (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Boston, MA 02163 USA.	jliu22@mgh.harvard.edu			National Institutes of Health and the National Center for Research Resources [R24 RR018934]; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR018934] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R24OD016985] Funding Source: NIH RePORTER	National Institutes of Health and the National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health and the National Center for Research Resources (grant number R24 RR018934). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhowmick S, 2003, BIOL REPROD, V68, P1779, DOI 10.1095/biolreprod.102.009407; Biggers JD, 2000, BIOL REPROD, V63, P281, DOI 10.1095/biolreprod63.1.281; BIGGERS JD, 1988, AM J PHYSIOL, V255, pC419, DOI 10.1152/ajpcell.1988.255.4.C419; Buitink J, 1998, PLANT PHYSIOL, V118, P531, DOI 10.1104/pp.118.2.531; Cui XS, 2007, MOL REPROD DEV, V74, P133, DOI 10.1002/mrd.20483; Fu XB, 2008, THESIS A M U COLL ST; Hamatani Toshio, 2006, Hum Cell, V19, P98; Hochi S, 2008, MOL REPROD DEV, V75, P890, DOI 10.1002/mrd.20825; Hochi S, 2011, J REPROD DEVELOP, V57, P557, DOI 10.1262/jrd.11-061O; Kaneko T, 2005, COMPARATIVE MED, V55, P140; Kaneko T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035043; Klooster KL, 2011, CRYOBIOLOGY, V62, P161, DOI 10.1016/j.cryobiol.2011.02.002; Kusakabe H, 2001, P NATL ACAD SCI USA, V98, P13501, DOI 10.1073/pnas.241517598; Lechene CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042267; Lee KB, 2006, BIOL REPROD, V74, P146, DOI 10.1095/biolreprod.105.044743; Li L, 2013, MOL ASPECTS MED, V34, P919, DOI 10.1016/j.mam.2013.01.003; Li MW, 2007, REPRODUCTION, V133, P919, DOI 10.1530/REP-06-0096; Liu J, 2012, J ANIM SCI, V90, P3739, DOI 10.2527/jas.2012-5136; Liu J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029924; McGinnis LK, 2005, BIOL REPROD, V73, P627, DOI 10.1095/biolreprod.105.042291; MERYMAN HT, 1960, ANN NY ACAD SCI, V85, P630, DOI 10.1111/j.1749-6632.1960.tb49987.x; Swann K, 2013, CELL CALCIUM, V53, P55, DOI 10.1016/j.ceca.2012.11.001; Tadros W, 2009, DEVELOPMENT, V136, P3033, DOI 10.1242/dev.033183; Xue ZG, 2013, NATURE, V500, P593, DOI 10.1038/nature12364	24	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99809	10.1371/journal.pone.0099809	http://dx.doi.org/10.1371/journal.pone.0099809			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924588	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300095
J	Toro, AR; Maymo, JL; Ibarbalz, FM; Perez, AP; Maskin, B; Faletti, AG; Margalet, VS; Varone, CL				Rayen Toro, Ayelen; Lorena Maymo, Julieta; Matias Ibarbalz, Federico; Perez Perez, Antonio; Maskin, Bernardo; Graciela Faletti, Alicia; Sanchez Margalet, Victor; Laura Varone, Cecilia			Leptin Is an Anti-Apoptotic Effector in Placental Cells Involving p53 Downregulation	PLOS ONE			English	Article							TROPHOBLAST APOPTOSIS; EXPRESSION; PROTEIN; BAX; DEATH; BCL-2; PROLIFERATION; ACTIVATION; PREGNANCY; EMBRYO	Leptin, a peripheral signal synthetized by the adipocyte to regulate energy metabolism, can also be produced by placenta, where it may work as an autocrine hormone. We have previously demonstrated that leptin promotes proliferation and survival of trophoblastic cells. In the present work, we aimed to study the molecular mechanisms that mediate the survival effect of leptin in placenta. We used the human placenta choriocarcinoma BeWo and first trimester Swan-71 cell lines, as well as human placental explants. We tested the late phase of apoptosis, triggered by serum deprivation, by studying the activation of Caspase-3 and DNA fragmentation. Recombinant human leptin added to BeWo cell line and human placental explants, showed a decrease on Caspase-3 activation. These effects were dose dependent. Maximal effect was achieved at 250 ng leptin/ml. Moreover, inhibition of endogenous leptin expression with 2 mu M of an antisense oligonucleotide, reversed Caspase-3 diminution. We also found that the cleavage of Poly [ADP-ribose] polymerase-1 (PARP-1) was diminished in the presence of leptin. We analyzed the presence of low DNA fragments, products from apoptotic DNA cleavage. Placental explants cultivated in the absence of serum in the culture media increased the apoptotic cleavage of DNA and this effect was prevented by the addition of 100 ng leptin/ml. Taken together these results reinforce the survival effect exerted by leptin on placental cells. To improve the understanding of leptin mechanism in regulating the process of apoptosis we determined the expression of different intermediaries in the apoptosis cascade. We found that under serum deprivation conditions, leptin increased the anti-apoptotic BCL-2 protein expression, while downregulated the pro-apoptotic BAX and BID proteins expression in Swan-71 cells and placental explants. In both models leptin augmented BCL-2/BAX ratio. Moreover we have demonstrated that p53, one of the key cell cycle-signaling proteins, is downregulated in the presence of leptin under serum deprivation. On the other hand, we determined that leptin reduced the phosphorylation of Ser-46 p53 that plays a pivotal role for apoptotic signaling by p53. Our data suggest that the observed anti-apoptotic effect of leptin in placenta is in part mediated by the p53 pathway. In conclusion, we provide evidence that demonstrates that leptin is a trophic factor for trophoblastic cells.	[Rayen Toro, Ayelen; Lorena Maymo, Julieta; Matias Ibarbalz, Federico; Laura Varone, Cecilia] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Inst Quim Biol, Buenos Aires, DF, Argentina; [Perez Perez, Antonio; Sanchez Margalet, Victor] Univ Seville, Fac Med, Hosp Univ Virgen Macarena, Dept Bioquim Med & Biol Mol, Seville, Spain; [Maskin, Bernardo] Hosp Nacl Prof Alejandro Posadas, Buenos Aires, DF, Argentina; [Graciela Faletti, Alicia] Univ Buenos Aires, Fac Med, Ctr Estudios Farmacol & Bot, Buenos Aires, DF, Argentina	University of Buenos Aires; Hospital Universitario Virgen Macarena; University of Sevilla; University of Buenos Aires	Varone, CL (corresponding author), Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Quim Biol, Inst Quim Biol, Buenos Aires, DF, Argentina.	cvarone@qb.fcen.uba.ar	Sánchez-Margalet, Victor/AAB-9986-2021; Maymo, Julieta/AAU-3777-2020	Sánchez-Margalet, Victor/0000-0001-8638-8680; Maymo, Julieta/0000-0003-1308-9887	CONICET fellowship; Instituto de Salud Carlos III [CM07/00025]; Universidad de Buenos Aires (UBACYT); ANPCyT [PICT 2008-0425]; CONICET [PIP 2010-247]; Fundacion Florencio Fiorini, Buenos Aires, Argentina; Instituto de Salud Carlos III, Spain [PS09/00119]	CONICET fellowship(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Universidad de Buenos Aires (UBACYT)(University of Buenos Aires); ANPCyT(ANPCyT); CONICET(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion Florencio Fiorini, Buenos Aires, Argentina; Instituto de Salud Carlos III, Spain(Instituto de Salud Carlos III)	Grant Support: ART and JLM are supported by a CONICET fellowship. APP is a research fellow supported by the Instituto de Salud Carlos III (CM07/00025). This project was supported by the Universidad de Buenos Aires (UBACYT), the ANPCyT (PICT 2008-0425), the CONICET (PIP 2010-247), the Fundacion Florencio Fiorini, Buenos Aires, Argentina and the Instituto de Salud Carlos III (PS09/00119), Spain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allaire AD, 2000, OBSTET GYNECOL, V96, P271, DOI 10.1016/S0029-7844(00)00895-4; Bajoria R, 2002, PLACENTA, V23, P103, DOI 10.1053/plac.2001.0769; Basanez G, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001399; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bruno A, 2005, J IMMUNOL, V174, P8090, DOI 10.4049/jimmunol.174.12.8090; Butte NF, 1997, J CLIN ENDOCR METAB, V82, P585, DOI 10.1210/jc.82.2.585; Caprio M, 2001, TRENDS ENDOCRIN MET, V12, P65, DOI 10.1016/S1043-2760(00)00352-0; Cervero A, 2005, REPROD BIOMED ONLINE, V10, P217, DOI 10.1016/S1472-6483(10)60943-1; Cockell AP, 1997, BRIT J OBSTET GYNAEC, V104, P235, DOI 10.1111/j.1471-0528.1997.tb11052.x; Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7; Dewson G, 2012, CELL DEATH DIFFER, V19, P661, DOI 10.1038/cdd.2011.138; Fujita Y, 2002, CLIN EXP IMMUNOL, V128, P21, DOI 10.1046/j.1365-2249.2002.01797.x; Gambino YP, 2012, PLACENTA; Gambino YP, 2010, BIOL REPROD; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Heazell AEP, 2008, PLACENTA, V29, P772, DOI 10.1016/j.placenta.2008.07.003; Heazell AEP, 2008, PLACENTA, V29, P175, DOI 10.1016/j.placenta.2007.11.002; Heazell AEP, 2011, APOPTOSIS, V16, P135, DOI 10.1007/s10495-010-0551-3; Henson MC, 2005, BIOL REPROD; Houseknecht KL, 1998, DOMEST ANIM ENDOCRIN, V15, P457, DOI 10.1016/S0739-7240(98)00035-6; Hromadnikova I, 2012, DNA CELL BIOL, V31, P1221, DOI 10.1089/dna.2011.1530; Huppertz B, 2005, PLACENTA, V26, pS46, DOI 10.1016/j.placenta.2005.02.002; Huppertz Berthold, 2005, Birth Defects Research, V75, P249, DOI 10.1002/bdrc.20056; Iwagaki S, 2004, GYNECOL ENDOCRINOL, V18, P263, DOI 10.1080/0951359042000196277; Kadyrov M, 2006, AM J OBSTET GYNECOL, V194, P557, DOI 10.1016/j.ajog.2005.07.035; Kaufmann T, 2012, CELL DEATH DIFFER, V19, P42, DOI 10.1038/cdd.2011.121; Lam QLK, 2010, P NATL ACAD SCI USA, V107, P13812, DOI 10.1073/pnas.1004185107; Leung DN, 2001, AM J OBSTET GYNECOL, V184, P1249, DOI 10.1067/mob.2001.112906; Levy R, 2000, PLACENTA, V21, P1, DOI 10.1053/plac.1999.0450; Li XX, 2005, J BIOL CHEM, V280, P24245, DOI 10.1074/jbc.M414637200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Magarinos MP, 2007, BIOL REPROD, V76, P203, DOI 10.1095/biolreprod.106.051391; Martin SJ, 2012, MOL CELL, V46, P387, DOI 10.1016/j.molcel.2012.04.026; Masuzaki H, 1997, NAT MED, V3, P1029, DOI 10.1038/nm0997-1029; Maymo JL, 2011, PLACENTA, V32, pS146, DOI 10.1016/j.placenta.2011.01.004; Maymo JL, 2010, ENDOCRINOLOGY, V151, P3738, DOI 10.1210/en.2010-0064; Maymo JL, 2009, ENDOCRINOLOGY, V150, P304, DOI 10.1210/en.2008-0522; Meek DW, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000950; MIYASHITA T, 1995, CELL, V80, P293; Oda K, 2000, CELL, V102, P849, DOI 10.1016/S0092-8674(00)00073-8; OLTVAI ZN, 1993, CELL, V74, P609, DOI 10.1016/0092-8674(93)90509-O; Perez-Perez A, 2008, ARCH BIOCHEM BIOPHYS, V477, P390, DOI 10.1016/j.abb.2008.06.015; Perez-Perez A, 2010, BIOCHEM BIOPH RES CO, V396, P956, DOI 10.1016/j.bbrc.2010.05.031; Perez-Perez A, 2009, BIOL REPROD, V81, P826, DOI 10.1095/biolreprod.109.076513; Prives C, 1998, CELL, V95, P5, DOI 10.1016/S0092-8674(00)81774-2; Prives C, 1999, J PATHOL, V187, P112; Ramhorst R, 2012, AM J REPROD IMMUNOL, V67, P17, DOI 10.1111/j.1600-0897.2011.01056.x; Reed JC, 2006, CELL DEATH DIFFER, V13, P1378, DOI 10.1038/sj.cdd.4401975; Reitman ML, 2001, BIOCHEM SOC T, V29, P68, DOI 10.1042/BST0290068; Renault TT, 2013, INT J BIOCHEM CELL B, V45, P64, DOI 10.1016/j.biocel.2012.09.022; Sagawa N, 2002, PLACENTA, V23, pS80, DOI 10.1053/plac.2002.0814; Saxena NK, 2004, FASEB J, V18, P1612, DOI 10.1096/fj.04-1847fje; Senaris R, 1997, ENDOCRINOLOGY, V138, P4501, DOI 10.1210/en.138.10.4501; Sharp AN, 2010, AM J REPROD IMMUNOL, V64, P159, DOI 10.1111/j.1600-0897.2010.00837.x; Standley PR, 2002, AM J HYPERTENS, V15, P565, DOI 10.1016/S0895-7061(02)02272-0; Straszewski-Chavez SL, 2009, PLACENTA, V30, P939, DOI 10.1016/j.placenta.2009.08.007; Tran VH, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.191; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2000, CELL, V103, P691, DOI 10.1016/S0092-8674(00)00171-9; Wade M, 2013, NAT REV CANCER, V13, P83, DOI 10.1038/nrc3430; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zinkel SS, 2013, ONCOGENE, V32, P3213, DOI 10.1038/onc.2012.454	62	30	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99187	10.1371/journal.pone.0099187	http://dx.doi.org/10.1371/journal.pone.0099187			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922063	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300042
J	Shieh, JM; Shen, CJ; Chang, WC; Cheng, HC; Chan, YY; Huang, WC; Chang, WC; Chen, BK				Shieh, Jiunn-Min; Shen, Chih-Jie; Chang, Wei-Chiao; Cheng, Hung-Chi; Chan, Ya-Yi; Huang, Wan-Chen; Chang, Wen-Chang; Chen, Ben-Kuen			An Increase in Reactive Oxygen Species by Deregulation of ARNT Enhances Chemotherapeutic Drug-Induced Cancer Cell Death	PLOS ONE			English	Article							RECEPTOR NUCLEAR TRANSLOCATOR; GENE-EXPRESSION; APOPTOSIS; STRESS; DOXORUBICIN; ACTIVATION; MDR1; AHR	Background: Unique characteristics of tumor microenvironments can be used as targets of cancer therapy. The aryl hydrocarbon receptor nuclear translocator (ARNT) is an important mediator of tumor progression. However, the functional role of ARNT in chemotherapeutic drug-treated cancer remains unclear. Methodology/Principal Findings: Here, we found that knockdown of ARNT in cancer cells reduced the proliferation rate and the transformation ability of those cells. Moreover, cisplatin-induced cell apoptosis was enhanced in ARNT-deficient cells. Expression of ARNT also decreased in the presence of cisplatin through proteasomal degradation pathway. However, ARNT level was maintained in cisplatin-treated drug-resistant cells, which prevented cell from apoptosis. Interestingly, reactive oxygen species (ROS) dramatically increased when ARNT was knocked down in cancer cells, enhancing cisplatin-induced apoptosis. ROS promoted cell death was inhibited in cells treated with the ROS scavenger, N-acetyl-cysteine (NAC). Conclusions/Significance: These results suggested that the anticancer activity of cisplatin is attributable to its induction of the production of ROS by ARNT degradation. Targeting ARNT could be a potential strategy to eliminate drug resistance in cancer cells.	[Shieh, Jiunn-Min] Chi Mei Med Ctr, Dept Internal Med, Tainan, Taiwan; [Shieh, Jiunn-Min] Chia Nan Univ Pharm & Sci, Ctr Gen Educ, Tainan, Taiwan; [Shen, Chih-Jie; Huang, Wan-Chen; Chen, Ben-Kuen] Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharmacol, Dept Clin Pharmacol, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Sch Pharmacol, Master Program Clin Pharmacogen & Pharmacoprote, Taipei, Taiwan; [Chang, Wei-Chiao] Taipei Med Univ, Wanfang Hosp, Dept Pharm, Taipei, Taiwan; [Cheng, Hung-Chi] Natl Cheng Kung Univ, Inst Biochem, Tainan 70101, Taiwan; [Chan, Ya-Yi; Chen, Ben-Kuen] Natl Cheng Kung Univ, Coll Med, Dept Pharmacol, Tainan 70101, Taiwan; [Chang, Wen-Chang; Chen, Ben-Kuen] Taipei Med Univ, Coll Med, Grad Inst Med Sci, Taipei, Taiwan	Chi Mei Hospital; Chia Nan University of Pharmacy & Science; National Cheng Kung University; Taipei Medical University; Taipei Medical University; Taipei Medical University; Taipei Municipal WanFang Hospital; National Cheng Kung University; National Cheng Kung University; Taipei Medical University	Chen, BK (corresponding author), Natl Cheng Kung Univ, Coll Biosci & Biotechnol, Inst Bioinformat & Biosignal Transduct, Tainan 70101, Taiwan.	bkchen58@mail.ncku.edu.tw	Huang, Wan-Chen/N-2472-2019	Huang, Wan-Chen/0000-0002-7341-4373; Chang, Wei-Chiao/0000-0002-8573-5924; SHEN, CHIH-JIE/0000-0001-7392-056X	National Science Council of the Republic of China [NSC 102-2628-B-006-011-MY3]; Headquarters of University Advancement at the National Cheng Kung University	National Science Council of the Republic of China(Ministry of Science and Technology, Taiwan); Headquarters of University Advancement at the National Cheng Kung University	This work was supported by grant NSC 102-2628-B-006-011-MY3 from the National Science Council of the Republic of China. This research was supported in part by the Headquarters of University Advancement at the National Cheng Kung University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Chan YY, 2013, MOL PHARMACOL, V84, P591, DOI 10.1124/mol.113.087197; Chang KY, 2011, CLIN CANCER RES, V17, P7116, DOI 10.1158/1078-0432.CCR-11-0796; Chang KY, 2009, J BIOL CHEM, V284, P9908, DOI 10.1074/jbc.M806210200; Choi H, 2006, MOL PHARMACOL, V70, P1664, DOI 10.1124/mol.106.025817; Dalton TP, 2002, CHEM-BIOL INTERACT, V141, P77, DOI 10.1016/S0009-2797(02)00067-4; De Nicola GM, 2011, NATURE, V475, P106, DOI 10.1038/nature10189; Dickinson BC, 2011, NAT CHEM BIOL, V7, P504, DOI [10.1038/NCHEMBIO.607, 10.1038/nchembio.607]; Giaccia A, 2003, NAT REV DRUG DISCOV, V2, P803, DOI 10.1038/nrd1199; GROS P, 1991, P NATL ACAD SCI USA, V88, P7289, DOI 10.1073/pnas.88.16.7289; Gu CH, 2013, LEUKEMIA RES, V37, P1750, DOI 10.1016/j.leukres.2013.10.010; Huang WC, 2010, CELL MOL LIFE SCI, V67, P3523, DOI 10.1007/s00018-010-0392-9; Irani K, 1997, SCIENCE, V275, P1649, DOI 10.1126/science.275.5306.1649; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Joo MS, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.427; Kallio PJ, 1997, P NATL ACAD SCI USA, V94, P5667, DOI 10.1073/pnas.94.11.5667; Kang HJ, 2006, J BIOL CHEM, V281, P14654, DOI 10.1074/jbc.M601613200; Ko SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055795; Kobayashi A, 1996, J BIOL CHEM, V271, P12310, DOI 10.1074/jbc.271.21.12310; Lebwohl D, 1998, EUR J CANCER, V34, P1522, DOI 10.1016/S0959-8049(98)00224-X; Maltepe E, 1997, NATURE, V386, P403, DOI 10.1038/386403a0; Mimura J, 2003, BBA-GEN SUBJECTS, V1619, P263, DOI 10.1016/S0304-4165(02)00485-3; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Oda Y, 2012, TOXICOL APPL PHARM, V260, P222, DOI 10.1016/j.taap.2012.02.012; Ohndorf UM, 1999, NATURE, V399, P708, DOI 10.1038/21460; Park SJ, 2004, J BIOL CHEM, V279, P51057, DOI 10.1074/jbc.M406543200; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schofield CJ, 2004, NAT REV MOL CELL BIO, V5, P343, DOI 10.1038/nrm1366; Sedletska Yuliya, 2005, Current Medicinal Chemistry - Anti-Cancer Agents, V5, P251, DOI 10.2174/1568011053765967; Suzuki H, 2001, ONCOGENE, V20, P5779, DOI 10.1038/sj.onc.1204742; Tian H, 1997, GENE DEV, V11, P72, DOI 10.1101/gad.11.1.72; UEDA K, 1987, P NATL ACAD SCI USA, V84, P3004, DOI 10.1073/pnas.84.9.3004; Wang QO, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-159; Wang SW, 2004, J BIOL CHEM, V279, P25535, DOI 10.1074/jbc.M400944200	34	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99242	10.1371/journal.pone.0099242	http://dx.doi.org/10.1371/journal.pone.0099242			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921657	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300047
J	Xie, JS; Wang, RM; Chang, S				Xie, Jiushu; Wang, Ruiming; Chang, Song			The Mechanism of Valence-Space Metaphors: ERP Evidence for Affective Word Processing	PLOS ONE			English	Article							SPATIAL ATTENTION; SELECTIVE ATTENTION; TIME; PERFORMANCE; EMBODIMENT; POTENTIALS; SHIFTS; N100; P50; BAD	Embodied cognition contends that the representation and processing of concepts involve perceptual, somatosensory, motoric, and other physical re-experiencing information. In this view, affective concepts are also grounded in physical information. For instance, people often say "feeling down'' or "cheer up'' in daily life. These phrases use spatial information to understand affective concepts. This process is referred to as valence-space metaphor. Valence-space metaphors refer to the employment of spatial information (lower/higher space) to elaborate affective concepts (negative/positive concepts). Previous studies have demonstrated that processing affective words affects performance on a spatial detection task. However, the mechanism(s) behind this effect remain unclear. In the current study, we hypothesized that processing affective words might produce spatial information. Consequently, spatial information would affect the following spatial cue detection/discrimination task. In Experiment 1, participants were asked to remember an affective word. Then, they completed a spatial cue detection task while event-related potentials were recorded. The results indicated that the top cues induced enhanced amplitude of P200 component while participants kept positive words relative to negative words in mind. On the contrary, the bottom cues induced enhanced P200 amplitudes while participants kept negative words relative to positive words in mind. In Experiment 2, we conducted a behavioral experiment that employed a similar paradigm to Experiment 1, but used arrows instead of dots to test the attentional nature of the valence-space metaphor. We found a similar facilitation effect as found in Experiment 1. Positive words facilitated the discrimination of upper arrows, whereas negative words facilitated the discrimination of lower arrows. In summary, affective words might activate spatial information and cause participants to allocate their attention to corresponding locations. Valence-space metaphors might be grounded in attention allocation.	[Xie, Jiushu; Wang, Ruiming; Chang, Song] S China Normal Univ, Sch Psychol, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China	South China Normal University	Wang, RM (corresponding author), S China Normal Univ, Sch Psychol, Ctr Studies Psychol Applicat, Guangzhou, Guangdong, Peoples R China.	wangrm@scnu.edu.cn			National Natural Science Foundation of China [31200785]; National Excellent Doctoral Dissertation Foundation of China [201204]; Humanities and Social Science Research Base Project from the Ministry of Education of China [13JJD190006]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Excellent Doctoral Dissertation Foundation of China; Humanities and Social Science Research Base Project from the Ministry of Education of China	This research was funded by National Natural Science Foundation of China (31200785), National Excellent Doctoral Dissertation Foundation of China (201204) and Humanities and Social Science Research Base Project from the Ministry of Education of China (13JJD190006). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansorge U, 2010, COGNITION, V116, P303, DOI 10.1016/j.cognition.2010.05.010; Barsalou LW, 2008, CURR DIR PSYCHOL SCI, V17, P91, DOI 10.1111/j.1467-8721.2008.00555.x; Barsalou LW, 2009, PHILOS T R SOC B, V364, P1281, DOI 10.1098/rstb.2008.0319; Barsalou LW, 1999, BEHAV BRAIN SCI, V22, P577, DOI 10.1017/S0140525X99532147; Barsalou LW, 2005, TRENDS COGN SCI, V9, P309, DOI 10.1016/j.tics.2005.05.003; Beteleva T. G., 2006, Human Physiology, V32, P509, DOI 10.1134/S0362119706050021; Boroditsky L, 2002, PSYCHOL SCI, V13, P185, DOI 10.1111/1467-9280.00434; Casasanto D, 2009, J EXP PSYCHOL GEN, V138, P351, DOI 10.1037/a0015854; de la Vega I, 2012, J EXP PSYCHOL HUMAN, V38, P375, DOI 10.1037/a0024979; Doallo S, 2007, NEUROSCI LETT, V418, P111, DOI 10.1016/j.neulet.2007.03.009; Eimer M, 2000, BIOL PSYCHOL, V52, P205, DOI 10.1016/S0301-0511(00)00028-4; Eimer M, 2003, COGNITIVE BRAIN RES, V15, P308, DOI 10.1016/S0926-6410(02)00203-3; Ferreira-Santos F, 2012, CLIN NEUROPHYSIOL, V123, P1300, DOI 10.1016/j.clinph.2011.11.036; Fischer MH, 2003, NAT NEUROSCI, V6, P555, DOI 10.1038/nn1066; Glenberg AM, 2002, PSYCHON B REV, V9, P558, DOI 10.3758/BF03196313; Gole M, 2012, NEUROSCI LETT, V507, P112, DOI 10.1016/j.neulet.2011.11.054; Gozli DG, 2013, VIS COGN, V21, P628, DOI 10.1080/13506285.2013.815680; Gozli DG, 2013, J EXP PSYCHOL GEN, V142, P1028, DOI 10.1037/a0030362; Hess U, 2013, SOC COGNITION, V31, P72, DOI 10.1521/soco.2013.31.1.72; Holmes A, 2003, COGNITIVE BRAIN RES, V16, P174, DOI 10.1016/S0926-6410(02)00268-9; JOHANNES S, 1995, COGNITIVE BRAIN RES, V2, P189, DOI 10.1016/0926-6410(95)90008-X; Joormann J, 2007, J ABNORM PSYCHOL, V116, P80, DOI 10.1037/0021-843X.116.1.80; JUNHONG H, 2013, PLOS ONE, V0008; Kranjec A, 2010, COGNITION, V114, P111, DOI 10.1016/j.cognition.2009.09.008; Lakens D, 2012, J EXP PSYCHOL GEN, V141, P584, DOI 10.1037/a0026468; Lakens D, 2012, J EXP PSYCHOL LEARN, V38, P726, DOI 10.1037/a0024955; Leppanen JM, 2004, PSYCHOL RES-PSYCH FO, V69, P22, DOI 10.1007/s00426-003-0157-2; Leppanen JM, 2007, BRAIN RES, V1166, P103, DOI 10.1016/j.brainres.2007.06.060; Lijffijt M, 2012, J PSYCHIATR RES, V46, P743, DOI 10.1016/j.jpsychires.2012.03.001; Lijffijt M, 2009, PSYCHOPHYSIOLOGY, V46, P1059, DOI 10.1111/j.1469-8986.2009.00845.x; Louwerse MM, 2010, COGNITION, V114, P96, DOI 10.1016/j.cognition.2009.09.002; LU CH, 1995, PSYCHON B REV, V2, P174, DOI 10.3758/BF03210959; LUCK SJ, 1994, PSYCHOPHYSIOLOGY, V31, P291, DOI 10.1111/j.1469-8986.1994.tb02218.x; LUCK SJ, 1995, INT J NEUROSCI, V80, P281, DOI 10.3109/00207459508986105; Ma QG, 2010, NEUROSCI LETT, V483, P206, DOI 10.1016/j.neulet.2010.08.009; Macaluso E, 2010, CORTEX, V46, P282, DOI 10.1016/j.cortex.2009.05.010; Meier BP, 2004, PSYCHOL SCI, V15, P243, DOI 10.1111/j.0956-7976.2004.00659.x; Merritt DJ, 2010, COGNITION, V117, P191, DOI 10.1016/j.cognition.2010.08.011; Murphy G. L., 2002, BIG BOOK CONCEPTS; Niedenthal PM, 2007, SCIENCE, V316, P1002, DOI 10.1126/science.1136930; Niedenthal PM, 2009, J PERS SOC PSYCHOL, V96, P1120, DOI 10.1037/a0015574; Oliveri M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007933; Ouellet M, 2010, J EXP PSYCHOL HUMAN, V36, P17, DOI 10.1037/a0017176; Potts GF, 2001, COGNITIVE BRAIN RES, V11, P147, DOI 10.1016/S0926-6410(00)00075-6; Rosch E., 1978, COGNITION CATEGORIZA, P27, DOI DOI 10.1037/0012-1649.16.5.391; Smith LB, 2005, COGNITIVE SCI, V29, P665, DOI 10.1207/s15516709cog0000_13; Torralbo A, 2006, COGNITIVE SCI, V30, P745, DOI 10.1207/s15516709cog0000_67; van Dantzig S, 2009, J EXP SOC PSYCHOL, V45, P345, DOI 10.1016/j.jesp.2008.11.001; Vermeulen N, 2007, COGNITIVE SCI, V31, P183, DOI 10.1080/03640210709336990; [王一牛 WANG Yi-Niu], 2008, [中国心理卫生杂志, Chinese Mental Health Journal], V22, P608; Weger UW, 2008, PSYCHON B REV, V15, P426, DOI 10.3758/PBR.15.2.426; Williams LE, 2008, SCIENCE, V322, P606, DOI 10.1126/science.1162548; Wiswede D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005754; Yun XY, 2011, NEUROSCI LETT, V498, P10, DOI 10.1016/j.neulet.2011.04.040; Zwaan RA, 2003, PSYCHON B REV, V10, P954, DOI 10.3758/BF03196557; Zwaan RA, 2003, COGNITION, V87, pB79, DOI 10.1016/S0010-0277(02)00235-4	56	14	14	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99479	10.1371/journal.pone.0099479	http://dx.doi.org/10.1371/journal.pone.0099479			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24923271	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300063
J	Yokoyama, Y; Tanito, M; Nitta, K; Katai, M; Kitaoka, Y; Omodaka, K; Tsuda, S; Nakagawa, T; Nakazawa, T				Yokoyama, Yu; Tanito, Masaki; Nitta, Koji; Katai, Maki; Kitaoka, Yasushi; Omodaka, Kazuko; Tsuda, Satoru; Nakagawa, Toshiaki; Nakazawa, Toru			Stereoscopic Analysis of Optic Nerve Head Parameters in Primary Open Angle Glaucoma: The Glaucoma Stereo Analysis Study	PLOS ONE			English	Article							HEIDELBERG RETINA TOMOGRAPH; OCULAR HYPERTENSION; NEURORETINAL RIM; REFRACTIVE ERROR; DISC TOPOGRAPHY; JAPANESE POPULATION; GENERAL-POPULATION; CHINESE POPULATION; RACIAL-DIFFERENCES; ADULT CHINESE	Purpose: The Glaucoma Stereo Analysis Study (GSAS), a cross sectional multicenter collaborative study, used a stereo fundus camera to assess various morphological parameters of the optic nerve head (ONH) in glaucoma patients and investigated the relationships between these parameters and patient characteristics. Subjects and Methods: The study included 187 eyes of 187 subjects with primary open angle glaucoma or normal tension glaucoma (male: female = 100: 87, age = 61 +/- 9 years). Stereo pairs of ONH photographs were made with a stereo fundus camera (nonmyd WX). ONH morphological parameters were calculated with prototype analysis software. In addition to 35 standard parameters, we defined three novel parameters: disc tilt angle, rim decentering, and the absolute value of rim decentering. The correlation between each parameter and patient characteristics was analyzed with Spearman's rank correlation coefficient. Results: Patient characteristics included refractive error of -3.38 +/- 3.75 diopters, intraocular pressure (IOP) of 13.6 +/- 2.6 mmHg, and visual field mean deviation (MD) of -4.71 +/- 3.26 dB. Representative ONH parameters included a horizontal disc width of 1.66 +/- 0.28 mm, vertical disc width of 1.86 +/- 0.23 mm, disc area of 2.42 +/- 0.63 mm(2), cup area of 1.45 +/- 0.57 mm(2), and cup volume of 0.31 +/- 0.22 mm(3). Correlation analysis revealed significant negative associations between vertical cup-to-disc ratio (0.82 +/- 0.08) and MD (r = -0.40, P<0.01) and between disc tilt angle (10.5 +/- 12.5 degrees) and refractive error (r = -0.36, P<0.01). Seventy-five percent of the eyes had a positive value for rim decentering (0.30 +/- 0.42), indicating that rim thinning manifested more often as an inferior lesion than a superior lesion. Conclusion: We used stereoscopic analysis to establish a database of ONH parameters, which may facilitate future studies of glaucomatous changes in ONH morphology.	[Yokoyama, Yu; Omodaka, Kazuko; Tsuda, Satoru; Nakazawa, Toru] Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan; [Tanito, Masaki] Shimane Univ, Fac Med, Dept Ophthalmol, Matsue, Shimane, Japan; [Nitta, Koji] Fukui Ken Saiseikai Hosp, Dept Ophthalmol, Fukui, Japan; [Katai, Maki] Sapporo Teishin Hosp, Dept Ophthalmol, Sapporo, Hokkaido, Japan; [Kitaoka, Yasushi] St Marianna Univ, Sch Med, Dept Ophthalmol, Kawasaki, Kanagawa, Japan; [Nakagawa, Toshiaki] Kowa Co Ltd, Nagoya, Aichi, Japan	Tohoku University; Shimane University; Saint Marianna University; Kowa Company, Ltd.	Nakazawa, T (corresponding author), Tohoku Univ, Grad Sch Med, Dept Ophthalmol, Sendai, Miyagi 980, Japan.	ntoru@oph.med.tohoku.ac.jp						Araie Makoto, 2012, Nippon Ganka Gakkai Zasshi, V116; Asakawa K, 2013, J GLAUCOMA, V22, P698, DOI 10.1097/IJG.0b013e318264be18; Bayer A, 2002, AM J OPHTHALMOL, V133, P758, DOI 10.1016/S0002-9394(02)01422-8; Bourne RRA, 2008, BRIT J OPHTHALMOL, V92, P303, DOI 10.1136/bjo.2007.123273; Crowston JG, 2004, BRIT J OPHTHALMOL, V88, P766, DOI 10.1136/bjo.2003.028548; Francis BA, 2011, INVEST OPHTH VIS SCI, V52, P6257, DOI 10.1167/iovs.09-5126; Garway-Heath DF, 1998, BRIT J OPHTHALMOL, V82, P352, DOI 10.1136/bjo.82.4.352; Girkin CA, 2003, INVEST OPHTH VIS SCI, V44, P3382, DOI 10.1167/iovs.02-0792; GLOSTER J, 1974, BRIT J OPHTHALMOL, V58, P850, DOI 10.1136/bjo.58.10.850; Grodum K, 2001, ACTA OPHTHALMOL SCAN, V79, P560, DOI 10.1034/j.1600-0420.2001.790603.x; Harper R, 2000, OPHTHAL PHYSL OPT, V20, P265, DOI 10.1016/S0275-5408(99)00092-7; Henderer JD, 2003, AM J OPHTHALMOL, V135, P44, DOI 10.1016/S0002-9394(02)01833-0; How ACS, 2009, ARCH OPHTHALMOL-CHIC, V127, P894, DOI 10.1001/archophthalmol.2009.134; Jayasundera T, 2005, CLIN EXP OPHTHALMOL, V33, P259, DOI 10.1111/j.1442-9071.2005.01000.x; JOHNSON CA, 1979, INVEST OPHTH VIS SCI, V18, P1252; JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P213, DOI 10.1007/BF02181183; JONAS JB, 1993, OPHTHALMOLOGY, V100, P63; JONAS JB, 1988, INVEST OPHTH VIS SCI, V29, P1151; Kass MA, 2002, ARCH OPHTHALMOL-CHIC, V120, P701; Lichter P R, 1976, Trans Am Ophthalmol Soc, V74, P532; Lloyd MJ, 2013, J GLAUCOMA, V22, P343, DOI 10.1097/IJG.0b013e31824c9251; Martus P, 2005, AM J OPHTHALMOL, V139, P999, DOI 10.1016/j.ajo.2004.12.056; Mitchell P, 1999, OPHTHALMOLOGY, V106, P2010, DOI 10.1016/S0161-6420(99)90416-5; Nakagawa T, 2008, J BIOMED OPT, V13, DOI 10.1117/1.3041711; Nakatsue T, 2004, J GLAUCOMA, V13, P291, DOI 10.1097/00061198-200408000-00006; Nakazawa T, 2012, J GLAUCOMA, V21, P426, DOI 10.1097/IJG.0b013e3182182897; Nicolela MT, 1996, OPHTHALMOLOGY, V103, P640, DOI 10.1016/S0161-6420(96)30640-4; OGDEN TE, 1988, EXP EYE RES, V46, P559, DOI 10.1016/S0014-4835(88)80012-5; Omodaka K, 2010, CLIN OPHTHALMOL, V4, P765; Park HYL, 2012, OPHTHALMOLOGY, V119, P1844, DOI 10.1016/j.ophtha.2012.03.006; Parkin B, 2001, BRIT J OPHTHALMOL, V85, P1347, DOI 10.1136/bjo.85.11.1347; Perera SA, 2010, ARCH OPHTHALMOL-CHIC, V128, P900, DOI 10.1001/archophthalmol.2010.125; QUIGLEY HA, 1990, ARCH OPHTHALMOL-CHIC, V108, P51, DOI 10.1001/archopht.1990.01070030057028; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Ramrattan RS, 1999, OPHTHALMOLOGY, V106, P1588, DOI 10.1016/S0161-6420(99)90457-8; Resnikoff S, 2004, B WORLD HEALTH ORGAN, V82, P844; ROBIN AL, 1979, AM J OPHTHALMOL, V88, P847, DOI 10.1016/0002-9394(79)90562-2; Sawada A, 2008, OPHTHALMOLOGY, V115, P363, DOI 10.1016/j.ophtha.2007.03.075; Suzuki Y, 2006, OPHTHALMOLOGY, V113, P1613, DOI 10.1016/j.ophtha.2006.03.059; Tanito M, 2013, JPN J OPHTHALMOL; Tay E, 2005, AM J OPHTHALMOL, V139, P247, DOI 10.1016/j.ajo.2004.08.076; Tezel G, 2001, ARCH OPHTHALMOL-CHIC, V119, P813; VARMA R, 1994, ARCH OPHTHALMOL-CHIC, V112, P1068, DOI 10.1001/archopht.1994.01090200074026; Wolfs RCW, 1999, OPHTHALMOLOGY, V106, P1597, DOI 10.1016/S0161-6420(99)90458-X; Xu L, 2007, BRIT J OPHTHALMOL, V91, P1616, DOI 10.1136/bjo.2007.121509; Xu LA, 2007, OPHTHALMOLOGY, V114, P216, DOI 10.1016/j.ophtha.2006.06.050; You QS, 2008, EYE, V22, P728, DOI 10.1038/eye.2008.87; Zangwill LM, 2004, ARCH OPHTHALMOL-CHIC, V122, P22, DOI 10.1001/archopht.122.1.22	48	16	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99138	10.1371/journal.pone.0099138	http://dx.doi.org/10.1371/journal.pone.0099138			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922327	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300036
J	Boudreau, JE; Le Luduec, JB; Hsu, KC				Boudreau, Jeanette E.; Le Luduec, Jean-Benoit; Hsu, Katharine C.			Development of a Novel Multiplex PCR Assay to Detect Functional Subtypes of KIR3DL1 Alleles	PLOS ONE			English	Article							NK CELL RECEPTORS; HLA-B; INHIBITORY RECEPTORS; CLASS-I; EXPRESSION; POLYMORPHISM; DIVERSITY; COMBINATION; REPERTOIRE; HAPLOTYPES	Among NK cell receptor-ligand partnerships, KIR3DL1 and HLA-Bw4 demonstrate the greatest diversity; permutations of their allelic combinations titrate NK reactivity. Balancing selection has maintained distinct subtypes of KIR3DL1 alleles in global populations, implying that each may provide unique fitness advantages and variably influence disease processes. Though approaches exist for determining HLA-B allotypes, practical methods for identifying KIR3DL1 alleles are lacking. We have developed a PCR-based approach that identifies functional subtypes of KIR3DL1 alleles; it is suitable for research and may have clinical application. Six allele subsets were identified based on expression characteristics of the eleven most common KIR3DL1 alleles represented in reported populations. The remaining 62 low-frequency alleles were distributed into these groups based on sequence homology to coding regions. Subtype-specific SNPs were found in exons 3, 4, and 7, and used as priming sites for five multiplex PCR reactions. Genomic DNA derived from 175 unrelated donors and 52 related individuals from 6 families demonstrated >99.5% concordance between sequence-based typing and our novel approach. Finally, PCR-based typing accurately predicted NK phenotypes obtained by flow cytometry after staining with DX9 and Z27 monoclonal antibodies. This novel approach facilitates high-throughput analysis of KIR3DL1 allotypes to enable a broader understanding of KIR3DL1 and HLA-Bw4 interaction in health and disease.	[Boudreau, Jeanette E.; Le Luduec, Jean-Benoit; Hsu, Katharine C.] Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Program Immunol, New York, NY 10021 USA; [Hsu, Katharine C.] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Hsu, Katharine C.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University	Hsu, KC (corresponding author), Mem Sloan Kettering Canc Ctr, Sloan Kettering Inst Canc Res, Program Immunol, 1275 York Ave, New York, NY 10021 USA.	hsuk@mskcc.org		Boudreau, Jeanette/0000-0003-0203-2180; LE LUDUEC, Jean-Benoit/0000-0002-1046-2941	National Institutes of Health U01 [AI069197]; National Institutes of Health R01 [HL088134]; Office of Naval Research [N00014-08-1207]; NATIONAL CANCER INSTITUTE [P30CA008748, P01CA023766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088134] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069197] Funding Source: NIH RePORTER	National Institutes of Health U01; National Institutes of Health R01(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Naval Research(Office of Naval Research); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	National Institutes of Health U01 (#AI069197) to KCH, National Institutes of Health R01 (#HL088134) to KCH (http://grants.nih.gov/grants/funding/ funding_program.htm). The NMDP reference KIR typing and samples were supported by funding from the Office of Naval Research grant N00014-08-1207. The funders had no role in study design, data collection and and analysis, decision to publish, or preparation of the manuscript.	Anfossi N, 2006, IMMUNITY, V25, P331, DOI 10.1016/j.immuni.2006.06.013; Bonaparte MI, 2004, BLOOD, V104, P2087, DOI 10.1182/blood-2004-02-0696; Brodin P, 2009, TRENDS IMMUNOL, V30, P143, DOI 10.1016/j.it.2009.01.006; Carr WH, 2005, J IMMUNOL, V175, P5222, DOI 10.4049/jimmunol.175.8.5222; Gagne K, 2013, EUR J IMMUNOL, V43, P1085, DOI 10.1002/eji.201243007; Gardiner CM, 2001, J IMMUNOL, V166, P2992, DOI 10.4049/jimmunol.166.5.2992; Halfpenny IA, 2004, HUM IMMUNOL, V65, P602, DOI 10.1016/j.humimm.2004.03.003; Hollenbach JA, 2009, IMMUNOGENETICS, V61, P663, DOI 10.1007/s00251-009-0396-5; Hsu KC, 2002, J IMMUNOL, V169, P5118, DOI 10.4049/jimmunol.169.9.5118; Jiang W, 2012, GENOME RES, V22, P1845, DOI 10.1101/gr.137976.112; KEATING PJ, 1995, BRIT J CANCER, V72, P405, DOI 10.1038/bjc.1995.346; Kim S, 2008, P NATL ACAD SCI USA, V105, P3053, DOI 10.1073/pnas.0712229105; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lebedeva TV, 2007, HUM IMMUNOL, V68, P789, DOI 10.1016/j.humimm.2007.07.002; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; Martin MP, 2003, J IMMUNOL, V171, P2192, DOI 10.4049/jimmunol.171.5.2192; Norman PJ, 2007, NAT GENET, V39, P1092, DOI 10.1038/ng2111; O'Connor GM, 2007, J IMMUNOL, V178, P235, DOI 10.4049/jimmunol.178.1.235; O'Connor GM, 2014, J IMMUNOL, V192, P2875, DOI 10.4049/jimmunol.1303142; O'Connor GM, 2013, CRIT REV IMMUNOL, V33, P203, DOI 10.1615/CritRevImmunol.2013007409; Pando MJ, 2003, J IMMUNOL, V171, P6640, DOI 10.4049/jimmunol.171.12.6640; Parham P, 2011, J IMMUNOL, V187, P11, DOI 10.4049/jimmunol.0902332; Pascal V, 2007, J IMMUNOL, V179, P1625, DOI 10.4049/jimmunol.179.3.1625; Ruggeri L, 2007, BLOOD, V110, P433, DOI 10.1182/blood-2006-07-038687; Sharma D, 2009, J IMMUNOL, V183, P4569, DOI 10.4049/jimmunol.0901734; Sun JY, 2008, TISSUE ANTIGENS, V72, P578, DOI 10.1111/j.1399-0039.2008.01141.x; Tarek N, 2012, J CLIN INVEST, V122, P3260, DOI 10.1172/JCI62749; Thomas R, 2008, J IMMUNOL, V180, P6743, DOI 10.4049/jimmunol.180.10.6743; Trundley A, 2007, EUR J IMMUNOL, V37, P780, DOI 10.1002/eji.200636773; Venstrom JM, 2012, NEW ENGL J MED, V367, P805, DOI 10.1056/NEJMoa1200503; Vierra-Green C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047491; Vilches C, 2007, TISSUE ANTIGENS, V70, P415, DOI 10.1111/j.1399-0039.2007.00923.x; Yawata M, 2006, J EXP MED, V203, P633, DOI 10.1084/jem.20051884; Yu J, 2007, J IMMUNOL, V179, P5977, DOI 10.4049/jimmunol.179.9.5977	34	29	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99543	10.1371/journal.pone.0099543	http://dx.doi.org/10.1371/journal.pone.0099543			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919192	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000094
J	Chen, CH; Cheng, CY; Chen, YC; Sue, YM; Liu, CT; Cheng, TH; Hsu, YH; Chen, TH				Chen, Cheng-Hsien; Cheng, Chung-Yi; Chen, Yen-Cheng; Sue, Yuh-Mou; Liu, Chung-Te; Cheng, Tzu-Hurng; Hsu, Yung-Ho; Chen, Tso-Hsiao			MicroRNA-328 Inhibits Renal Tubular Cell Epithelial-to-Mesenchymal Transition by Targeting the CD44 in Pressure-Induced Renal Fibrosis	PLOS ONE			English	Article							UNILATERAL URETERAL OBSTRUCTION; DIABETIC-NEPHROPATHY; CARDIAC FIBROSIS; IN-VIVO; EXPRESSION; OSTEOPONTIN; CANCER; FIBROGENESIS; HYALURONAN; GROWTH	Epithelial-mesenchymal transition (EMT) occurs in stressed tubular epithelial cells, contributing to renal fibrosis. Initial mechanisms promoting EMT are unknown. Pressure force is an important mechanism contributing to the induction and progression of renal fibrogenesis in ureteric obstruction. In our study of cultured rat renal tubular cells (NRK-52E) under 60 mmHg of pressure, we found that the epithelial marker E-cadherin decreased and mesenchymal markers, e.g., alpha-smooth muscle actin, fibronectin and Snail, increased. Pressure also induced the expression of connective tissue growth factor and transforming growth factor-beta. MicroRNA array assays showed that pressure reduced miR-328 at the initial stage of pressurization. We identified a potential target sequence of miR-328 in rat CD44 3'-untranslated regions. In contrast with the miR-328 expression, CD44 expression was up-regulated at the initial pressurization stage. We also found that miR-328 expression decreased and CD44 increased in ureteric obstruction kidneys in the animal study. CD44 siRNA transfection significantly increased E-cadherin expression and inhibited pressure-induced EMT. Both hyaluronan binding peptide pep-1 and osteopontin neutralizing antibody inhibited pressure-induced EMT. Our results suggest that miR-328-mediated CD44 transient upregulation is an important trigger of the pressure-induced EMT in renal fibrosis.	[Chen, Cheng-Hsien; Cheng, Chung-Yi; Chen, Yen-Cheng; Sue, Yuh-Mou; Liu, Chung-Te; Chen, Tso-Hsiao] Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan; [Chen, Cheng-Hsien; Hsu, Yung-Ho] Taipei Med Univ, Shuang Ho Hosp, Dept Internal Med, Div Nephrol, New Taipei City, Taiwan; [Cheng, Tzu-Hurng] China Med Univ, Dept Biol Sci & Technol, Coll Life Sci, Taichung, Taiwan	Taipei Medical University; Taipei Municipal WanFang Hospital; Taipei Medical University; China Medical University Taiwan	Chen, TH (corresponding author), Taipei Med Univ, Wan Fang Hosp, Dept Internal Med, Div Nephrol, Taipei, Taiwan.	tsohsiao@yahoo.com.tw			Taiwan National Science Council [NSC 101-2314-B-038-018]; Wan Fang Hospital [102swf06]	Taiwan National Science Council(Ministry of Science and Technology, Taiwan); Wan Fang Hospital	This work was supported by grants from the Taiwan National Science Council (grant number: NSC 101-2314-B-038-018), and Wan Fang Hospital (grant number: 102swf06). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Broadbelt NV, 2007, AM J PHYSIOL-RENAL, V293, pF1877, DOI 10.1152/ajprenal.00238.2007; Carew RM, 2012, CELL TISSUE RES, V347, P103, DOI 10.1007/s00441-011-1227-1; Chen CF, 2001, NEUROUROL URODYNAM, V20, P125, DOI 10.1002/1520-6777(2001)20:1<125::AID-NAU14>3.0.CO;2-Y; Chen CH, 2013, EUR J PHARMACOL, V700, P65, DOI 10.1016/j.ejphar.2012.12.017; Cicha I, 2009, BIOFACTORS, V35, P200, DOI 10.1002/biof.30; Eddy AA, 2005, PEDIATR NEPHROL, V20, P1369, DOI 10.1007/s00467-005-1995-5; Felsen D, 2003, J UROLOGY, V169, P373, DOI 10.1016/S0022-5347(05)64130-4; Garg Minal, 2013, World J Stem Cells, V5, P188, DOI 10.4252/wjsc.v5.i4.188; Graf K, 2004, HYPERTENSION, V44, P809, DOI 10.1161/01.HYP.0000148459.25908.49; Gregory PA, 2008, NAT CELL BIOL, V10, P593, DOI 10.1038/ncb1722; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kaimori A, 2007, J BIOL CHEM, V282, P22089, DOI 10.1074/jbc.M700998200; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kaneto H, 1999, KIDNEY INT, V56, P2137, DOI 10.1046/j.1523-1755.1999.00790.x; Kato M, 2007, P NATL ACAD SCI USA, V104, P3432, DOI 10.1073/pnas.0611192104; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim MK, 2013, INT J CLIN EXP PATHO, V6, P1747; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; Li L, 2010, AM J PATHOL, V176, P1767, DOI 10.2353/ajpath.2010.090345; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066356; Li YJ, 2011, J EXP MED, V208, P1459, DOI 10.1084/jem.20102510; Lin CH, 2013, INT J MOL SCI, V14, P13266, DOI 10.3390/ijms140713266; Loeffler I, 2014, NEPHROL DIAL TRANSPL, V29, pI37, DOI 10.1093/ndt/gft267; Marhaba R, 2004, J MOL HISTOL, V35, P211; Misseri Rosalia, 2005, Curr Urol Rep, V6, P140, DOI 10.1007/s11934-005-0083-5; Mummert ME, 2005, IMMUNOL RES, V31, P189, DOI 10.1385/IR:31:3:189; Mummert ME, 2000, J EXP MED, V192, P769, DOI 10.1084/jem.192.6.769; Naor D, 2002, CRIT REV CL LAB SCI, V39, P527, DOI 10.1080/10408360290795574; Naor D, 2007, ANN NY ACAD SCI, V1110, P233, DOI 10.1196/annals.1423.025; Nicholas SB, 2010, KIDNEY INT, V77, P588, DOI 10.1038/ki.2009.518; Pan YZ, 2009, MOL PHARMACOL, V75, P1374, DOI 10.1124/mol.108.054163; Phillips Aled, 2007, Chang Gung Med J, V30, P2; Vandewalle C, 2005, NUCLEIC ACIDS RES, V33, P6566, DOI 10.1093/nar/gki965; Vaughan E Darracott Jr, 2004, J Urol, V172, P2563, DOI 10.1097/01.ju.0000144286.53562.95; Vongwiwatana A, 2005, AM J TRANSPLANT, V5, P1367, DOI 10.1111/j.1600-6143.2005.00843.x; Wang B, 2011, DIABETES, V60, P280, DOI 10.2337/db10-0892; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Wang S, 2008, NEPHROL DIAL TRANSPL, V23, P2167, DOI 10.1093/ndt/gfn115; Winter J, 2009, NAT CELL BIOL, V11, P228, DOI 10.1038/ncb0309-228; Wu B, 2012, J UROLOGY, V188, P1033, DOI 10.1016/j.juro.2012.05.004; Wu ZF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047270; Xu CG, 2013, EXP THER MED, V6, P731, DOI 10.3892/etm.2013.1197; Xu D, 2013, TRANSPL P, V45, P659, DOI 10.1016/j.transproceed.2012.02.048; Xu XT, 2012, BRIT J CANCER, V106, P1320, DOI 10.1038/bjc.2012.88; Zahradka P, 2008, CIRC RES, V102, P270, DOI 10.1161/CIRCRESAHA.107.170555; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183	49	29	34	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99802	10.1371/journal.pone.0099802	http://dx.doi.org/10.1371/journal.pone.0099802			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919189	Green Published, gold, Green Submitted			2022-12-27	WOS:000338631000112
J	Kerckhof, FM; Courtens, ENP; Geirnaert, A; Hoefman, S; Ho, A; Vilchez-Vargas, R; Pieper, DH; Jauregui, R; Vlaeminck, SE; Van de Wiele, T; Vandamme, P; Heylen, K; Boon, N				Kerckhof, Frederiek-Maarten; Courtens, Emilie N. P.; Geirnaert, Annelies; Hoefman, Sven; Ho, Adrian; Vilchez-Vargas, Ramiro; Pieper, Dietmar H.; Jauregui, Ruy; Vlaeminck, Siegfried E.; Van de Wiele, Tom; Vandamme, Peter; Heylen, Kim; Boon, Nico			Optimized Cryopreservation of Mixed Microbial Communities for Conserved Functionality and Diversity	PLOS ONE			English	Article							HETEROTROPHIC GROUNDWATER COMMUNITY; ROTATING BIOLOGICAL CONTACTOR; LONG-TERM STORAGE; OXIDIZING BACTERIA; METHANOTROPHIC COMMUNITIES; FECAL MICROBIOTA; METHANE; IMPACT; RNA; PRESERVATION	The use of mixed microbial communities (microbiomes) for biotechnological applications has steadily increased over the past decades. However, these microbiomes are not readily available from public culture collections, hampering their potential for widespread use. The main reason for this lack of availability is the lack of an effective cryopreservation protocol. Due to this critical need, we evaluated the functionality as well as the community structure of three different types of microbiomes before and after cryopreservation with two cryoprotective agents (CPA). Microbiomes were selected based upon relevance towards applications: (1) a methanotrophic co-culture (MOB), with potential for mitigation of greenhouse gas emissions, environmental pollutants removal and bioplastics production; (2) an oxygen limited autotrophic nitrification/denitrification (OLAND) biofilm, with enhanced economic and ecological benefits for wastewater treatment, and (3) fecal material from a human donor, with potential applications for fecal transplants and pre/probiotics research. After three months of cryopreservation at -80 degrees C, we found that metabolic activity, in terms of the specific activity recovery of MOB, aerobic ammonium oxidizing bacteria (AerAOB) and anaerobic AOB (AnAOB, anammox) in the OLAND mixed culture, resumes sooner when one of our selected CPA [dimethyl sulfoxide (DMSO) and DMSO plus trehalose and tryptic soy broth (DMSO+TT)] was added. However, the activity of the fecal community was not influenced by the CPA addition, although the preservation of the community structure (as determined by 16S rRNA gene sequencing) was enhanced by addition of CPA. In summary, we have evaluated a cryopreservation protocol that succeeded in preserving both community structure and functionality of value-added microbiomes. This will allow individual laboratories and culture collections to boost the use of microbiomes in biotechnological applications.	[Kerckhof, Frederiek-Maarten; Courtens, Emilie N. P.; Geirnaert, Annelies; Ho, Adrian; Vilchez-Vargas, Ramiro; Vlaeminck, Siegfried E.; Van de Wiele, Tom; Boon, Nico] Univ Ghent, Fac Biosci Engn, Lab Microbial Ecol & Technol, B-9000 Ghent, Belgium; [Hoefman, Sven; Vandamme, Peter; Heylen, Kim] Univ Ghent, Fac Sci, Microbiol Lab, B-9000 Ghent, Belgium; [Pieper, Dietmar H.; Jauregui, Ruy] Helmholtz Ctr Infect Res, Microbial Interact & Proc Res Grp, Dept Med Microbiol, Braunschweig, Germany	Ghent University; Ghent University; Helmholtz Association; Helmholtz-Center for Infection Research	Boon, N (corresponding author), Univ Ghent, Fac Biosci Engn, Lab Microbial Ecol & Technol, B-9000 Ghent, Belgium.	nico.boon@ugent.be	Ho, Adrian/J-3586-2013; Van de Wiele, Tom/C-8638-2011; Vandamme, Peter AR/B-7967-2009; Kerckhof, Frederiek-Maarten/E-5059-2011; Vlaeminck, Siegfried E./B-4203-2014; Ho, Adrian/AAT-3848-2021; Boon, Nico/B-4083-2011; Vandamme, Peter/ABG-3431-2021; Heylen, Kim/G-4085-2011; Geirnaert, Annelies/E-3857-2019	Van de Wiele, Tom/0000-0001-6854-5689; Vandamme, Peter AR/0000-0002-5581-7937; Kerckhof, Frederiek-Maarten/0000-0002-4472-6810; Vlaeminck, Siegfried E./0000-0002-2596-8857; Boon, Nico/0000-0002-7734-3103; Vandamme, Peter/0000-0002-5581-7937; Geirnaert, Annelies/0000-0002-3390-6701; Jauregui, Ruy/0000-0002-3484-8937; Ho Kah Wye, Adrian/0000-0003-1082-2078; Vilchez-Vargas, Ramiro/0000-0001-6535-8212	Geconcerteerde Onderzoeksactie (GOA) of Ghent University [BOF09/GOA/005]; Research Foundation Flanders (FWO-Vlaanderen); "Strategisch Basisonderzoek - SBO" of the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen) [100016]	Geconcerteerde Onderzoeksactie (GOA) of Ghent University; Research Foundation Flanders (FWO-Vlaanderen)(FWO); "Strategisch Basisonderzoek - SBO" of the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	FMK, AH and NB were supported by research grants from the Geconcerteerde Onderzoeksactie (GOA) of Ghent University (BOF09/GOA/005). ENPC was supported as doctoral candidate (Aspirant) and SEV and KH as a postdoctoral fellow from the Research Foundation Flanders (FWO-Vlaanderen). AG was supported by a research grant of the "Strategisch Basisonderzoek - SBO" of the Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT-Vlaanderen, project nr. 100016). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agler MT, 2011, TRENDS BIOTECHNOL, V29, P70, DOI 10.1016/j.tibtech.2010.11.006; Anderson MJ, 2006, ECOL LETT, V9, P683, DOI 10.1111/j.1461-0248.2006.00926.x; Bell T, 2005, NATURE, V436, P1157, DOI 10.1038/nature03891; Bodrossy L, 2003, ENVIRON MICROBIOL, V5, P566, DOI 10.1046/j.1462-2920.2003.00450.x; Bohorquez LC, 2012, MICROB ECOL, V63, P103, DOI 10.1007/s00248-011-9943-3; Brenner K, 2008, TRENDS BIOTECHNOL, V26, P483, DOI 10.1016/j.tibtech.2008.05.004; Camarinha-Silva A, 2014, ENVIRON MICROBIOL, V16, P2939, DOI 10.1111/1462-2920.12362; Cayrou C, 2013, APMIS, V121, P1082, DOI 10.1111/apm.12087; Chiellini C, 2013, CURR MICROBIOL, V67, P77, DOI 10.1007/s00284-013-0333-6; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; De Clippeleir H, 2012, ENVIRON SCI TECHNOL, V46, P8826, DOI 10.1021/es301717b; De Weirdt R, 2010, FEMS MICROBIOL ECOL, V74, P601, DOI 10.1111/j.1574-6941.2010.00974.x; Dejonghe W, 2001, ENVIRON MICROBIOL, V3, P649, DOI 10.1046/j.1462-2920.2001.00236.x; Egli K, 2003, MICROB ECOL, V45, P419, DOI 10.1007/s00248-002-2037-5; Eller G, 2005, FEMS MICROBIOL ECOL, V51, P279, DOI 10.1016/j.femsec.2004.09.007; Emerson D, 2009, NAT REV MICROBIOL, V7, P758, DOI 10.1038/nrmicro2246; Fuller BJ, 2004, CRYOLETTERS, V25, P375; Greenberg A.E., 1984, P AWWA WAT QUAL TECH, P11; Griffiths RI, 2000, APPL ENVIRON MICROB, V66, P5488, DOI 10.1128/AEM.66.12.5488-5491.2000; Hamilton MJ, 2012, AM J GASTROENTEROL, V107, P761, DOI 10.1038/ajg.2011.482; Hanson RS, 1996, MICROBIOL REV, V60, P439, DOI 10.1128/MMBR.60.2.439-471.1996; Helm J, 2006, J APPL MICROBIOL, V101, P387, DOI 10.1111/j.1365-2672.2006.02960.x; Heylen K, 2012, APPL MICROBIOL BIOT, V94, P565, DOI 10.1007/s00253-011-3797-y; Heylen K, 2012, APPL ENVIRON MICROB, V78, P3010, DOI 10.1128/AEM.07501-11; Ho A, ISME J IN PRESS; Ho A, 2013, ENV MICROBIOL REP, V5, P335, DOI 10.1111/j.1758-2229.2012.00370.x; Ho A, 2013, APPL ENVIRON MICROB, V79, P2841, DOI 10.1128/AEM.03426-12; Ho A, 2011, ISME J, V5, P750, DOI 10.1038/ismej.2010.163; Hoefman S, 2013, RES MICROBIOL, V164, P288, DOI 10.1016/j.resmic.2013.01.007; Hoefman S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034196; Hollister EB, 2010, APPL MICROBIOL BIOT, V88, P389, DOI 10.1007/s00253-010-2789-7; Hrsak D, 1998, J APPL MICROBIOL, V85, P448, DOI 10.1046/j.1365-2672.1998.853505.x; Hrsak D, 2000, APPL ENVIRON MICROB, V66, P4433; Hubalek Z, 2003, CRYOBIOLOGY, V46, P205, DOI 10.1016/s0011-2240(03)00046-4; Iguchi H, 2011, APPL ENVIRON MICROB, V77, P8509, DOI 10.1128/AEM.05834-11; Jiang H, 2010, BIOCHEM ENG J, V49, P277, DOI 10.1016/j.bej.2010.01.003; Kleerebezem R, 2007, CURR OPIN BIOTECH, V18, P207, DOI 10.1016/j.copbio.2007.05.001; Konietschke F, 2009, SIMULTANE KONFIDEZIN; Konietschke F, 2012, ELECTRON J STAT, V6, P738, DOI 10.1214/12-EJS691; Krause S, 2012, ENV MICROBIOL REP, V4, P203, DOI 10.1111/j.1758-2229.2011.00322.x; Kuai LP, 1998, APPL ENVIRON MICROB, V64, P4500; Laurin V, 2006, WATER RES, V40, P1836, DOI 10.1016/j.watres.2006.03.002; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Marshall CW, 2013, CURR OPIN BIOTECH, V24, P391, DOI 10.1016/j.copbio.2013.03.016; Murase J, 2007, ENVIRON MICROBIOL, V9, P3025, DOI 10.1111/j.1462-2920.2007.01414.x; Ott M, 2010, 2007 ACM/IEEE SC07 CONFERENCE, P466; Pieja AJ, 2012, BIORESOURCE TECHNOL, V107, P385, DOI 10.1016/j.biortech.2011.12.044; Possemiers S, 2009, CURR PHARM DESIGN, V15, P2051, DOI 10.2174/138161209788489159; Prakash O, 2013, FEMS MICROBIOL LETT, V339, P1, DOI 10.1111/1574-6968.12034; Pynaert K, 2003, APPL ENVIRON MICROB, V69, P3626, DOI 10.1128/AEM.69.6.3626-3635.2003; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Read S, 2011, APPL MICROBIOL BIOT, V90, P861, DOI 10.1007/s00253-011-3223-5; Rechner AR, 2004, FREE RADICAL BIO MED, V36, P212, DOI 10.1016/j.freeradbiomed.2003.09.022; Rothrock MJ, 2011, APPL MICROBIOL BIOT, V92, P147, DOI 10.1007/s00253-011-3316-1; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Smith D, 2008, CRYOLETTERS, V29, P63; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stock M, 2013, RES MICROBIOL, V164, P1045, DOI 10.1016/j.resmic.2013.08.006; Su Y, 2014, APPL MICROBIOL BIOT, V98, P3121, DOI 10.1007/s00253-013-5297-8; Van den Abbeele P, 2013, MICROB BIOTECHNOL, V6, P335, DOI 10.1111/1751-7915.12049; Van den Abbeele P, 2012, MICROB BIOTECHNOL, V5, P106, DOI 10.1111/j.1751-7915.2011.00308.x; van der Ha D, 2013, ANTON LEEUW INT J G, V103, P527, DOI 10.1007/s10482-012-9835-7; van der Ha D, 2011, WATER RES, V45, P2845, DOI 10.1016/j.watres.2011.03.005; van der Ha D, 2010, APPL MICROBIOL BIOT, V87, P2355, DOI 10.1007/s00253-010-2702-4; Vekeman B, 2013, SYST APPL MICROBIOL, V36, P579, DOI 10.1016/j.syapm.2013.07.002; Vlaeminck SE, 2012, MICROB BIOTECHNOL, V5, P433, DOI 10.1111/j.1751-7915.2012.00341.x; Vlaeminck SE, 2007, APPL MICROBIOL BIOT, V74, P1376, DOI 10.1007/s00253-006-0770-2; Vlaeminck SE, 2010, APPL ENVIRON MICROB, V76, P900, DOI 10.1128/AEM.02337-09; Vogelsang C, 1999, WATER RES, V33, P164, DOI 10.1016/S0043-1354(98)00200-0; Waite DW, 2013, ZOO BIOL, V32, P620, DOI 10.1002/zoo.21098; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Werner JJ, 2012, ISME J, V6, P94, DOI 10.1038/ismej.2011.82; WHITTENB.R, 1970, J GEN MICROBIOL, V61, P205, DOI 10.1099/00221287-61-2-205; Wittebolle L, 2009, NATURE, V458, P623, DOI 10.1038/nature07840	74	50	53	4	98	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99517	10.1371/journal.pone.0099517	http://dx.doi.org/10.1371/journal.pone.0099517			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937032	Green Published, gold			2022-12-27	WOS:000338503400021
J	Silva, ART; Santos, ACF; Farfel, JM; Grinberg, LT; Ferretti, REL; Campos, AHJFM; Cunha, IW; Begnami, MD; Rocha, RM; Carraro, DM; Pereira, CAD; Jacob, W; Brentani, H				Silva, Aderbal R. T.; Feio Santos, Ana Cecilia; Farfel, Jose M.; Grinberg, Lea T.; Ferretti, Renata E. L.; Froes Marques Campos, Antonio Hugo Jose; Cunha, Isabela Werneck; Begnami, Maria Dirlei; Rocha, Rafael M.; Carraro, Dirce M.; de Braganca Pereira, Carlos Alberto; Jacob-Filho, Wilson; Brentani, Helena			Repair of Oxidative DNA Damage, Cell-Cycle Regulation and Neuronal Death May Influence the Clinical Manifestation of Alzheimer's Disease	PLOS ONE			English	Article							MILD COGNITIVE IMPAIRMENT; AMYLOID BETA-PEPTIDE; HUMAN BRAIN; MITOCHONDRIAL-DNA; INFORMANT QUESTIONNAIRE; NUCLEAR-LOCALIZATION; ALTERED DISTRIBUTION; ENTORHINAL CORTEX; TUMOR SUPPRESSION; POSTMORTEM DELAY	Alzheimer's disease (AD) is characterized by progressive cognitive decline associated with a featured neuropathology (neuritic plaques and neurofibrillary tangles). Several studies have implicated oxidative damage to DNA, DNA repair, and altered cell-cycle regulation in addition to cell death in AD post-mitotic neurons. However, there is a lack of studies that systematically assess those biological processes in patients with AD neuropathology but with no evidence of cognitive impairment. We evaluated markers of oxidative DNA damage (8-OHdG, H2AX), DNA repair (p53, BRCA1, PTEN), and cell-cycle (Cdk1, Cdk4, Cdk5, Cyclin B1, Cyclin D1, p(27Kip1), phospho-Rb and E2F1) through immunohistochemistry and cell death through TUNEL in autopsy hippocampal tissue samples arrayed in a tissue microarray (TMA) composed of three groups: I) "clinical-pathological AD" (CP-AD) - subjects with neuropathological AD (Braak >= IV and CERAD = B or C) and clinical dementia (CDR >= 2, IQCODE >= 3.8); II) "pathological AD" (P-AD) - subjects with neuropathological AD (Braak >= IV and CERAD = B or C) and without cognitive impairment (CDR 0, IQCODE < 3.2); and III) "normal aging" (N) - subjects without neuropathological AD (Braak <= II and CERAD 0 or A) and with normal cognitive function (CDR 0, IQCODE<3.2). Our results show that high levels of oxidative DNA damage are present in all groups. However, significant reductions in DNA repair and cell-cycle inhibition markers and increases in cell-cycle progression and cell death markers in subjects with CP-AD were detected when compared to both P-AD and N groups, whereas there were no significant differences in the studied markers between P-AD individuals and N subjects. This study indicates that, even in the setting of pathological AD, healthy cognition may be associated with a preserved repair to DNA damage, cell-cycle regulation, and cell death in post-mitotic neurons.	[Silva, Aderbal R. T.; Feio Santos, Ana Cecilia; Brentani, Helena] Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Lab Clin Pathol,Lab Med Invest 23, Sao Paulo, Brazil; [Farfel, Jose M.; Grinberg, Lea T.; Ferretti, Renata E. L.; Jacob-Filho, Wilson] Univ Sao Paulo, Sch Med, LIM 22, Brazilian Brain Bank,Aging Brain Study Grp, Sao Paulo, Brazil; [Farfel, Jose M.; Ferretti, Renata E. L.; Jacob-Filho, Wilson] Univ Sao Paulo, Sch Med, Div Geriatr, Sao Paulo, Brazil; [Grinberg, Lea T.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Froes Marques Campos, Antonio Hugo Jose; Cunha, Isabela Werneck; Begnami, Maria Dirlei] AC Camargo Canc Ctr, Dept Pathol, Sao Paulo, Brazil; [Rocha, Rafael M.; Carraro, Dirce M.] AC Camargo Canc Ctr, Res Ctr CIPE, Sao Paulo, Brazil; [de Braganca Pereira, Carlos Alberto] Univ Sao Paulo, Math & Stat Inst, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade de Sao Paulo; University of California System; University of California San Francisco; A.C.Camargo Cancer Center; A.C.Camargo Cancer Center; Universidade de Sao Paulo	Brentani, H (corresponding author), Univ Sao Paulo, Sch Med, Dept & Inst Psychiat, Lab Clin Pathol,Lab Med Invest 23, Sao Paulo, Brazil.	helena.brentani@gmail.com	de Lucena Ferretti-Rebustini, Renata Eloah/ABF-5144-2020; Jacob-Filho, Wilson WJF/H-5837-2012; Begnami, Maria/D-9663-2012; Cunha, Isabela/H-3013-2012; Farfel, Jose/C-8936-2012; Faria, Carolina Pereira de Morais/HHT-0142-2022; de Lucena Ferretti-Rebustini, Renata Eloah/C-8126-2012; carraro, dirce/C-9179-2009; Campos, Antonio Hugo/AAB-9287-2019; Brentani, Helena/G-6839-2011; Pereira, Carlos Alberto de Braganca/O-5022-2015; Ruy T. Silva, Aderbal/K-6503-2012	de Lucena Ferretti-Rebustini, Renata Eloah/0000-0002-6159-5787; Begnami, Maria/0000-0003-0848-7813; Cunha, Isabela/0000-0002-2029-5139; Farfel, Jose/0000-0003-2057-3669; de Lucena Ferretti-Rebustini, Renata Eloah/0000-0002-6159-5787; carraro, dirce/0000-0001-5667-1418; Campos, Antonio Hugo/0000-0001-5322-7549; Brentani, Helena/0000-0001-5192-4682; Pereira, Carlos Alberto de Braganca/0000-0001-6315-7484; grinberg, lea/0000-0002-6809-0618; Ruy T. Silva, Aderbal/0000-0003-1158-5617	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2011/01652-6, 2009/02030-9, 2009/01527-7]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This research is supported by Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP - www.fapesp.br) grants 2011/01652-6, 2009/02030-9, 2009/01527-7. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn KW, 2008, J NEUROSCI RES, V86, P2476, DOI 10.1002/jnr.21690; Aizenstein HJ, 2008, ARCH NEUROL-CHICAGO, V65, P1509, DOI 10.1001/archneur.65.11.1509; Anderson AJ, 1996, J NEUROSCI, V16, P1710, DOI 10.1523/jneurosci.16-05-01710.1996; Appert-Collin A, 2006, LIFE SCI, V79, P484, DOI 10.1016/j.lfs.2006.01.032; Arnold SE, 2013, NEUROBIOL AGING, V34, P157, DOI 10.1016/j.neurobiolaging.2012.03.004; Barreto PD, 2013, AM J ALZHEIMERS DIS, V28, P304, DOI 10.1177/1533317513488926; Bassi C, 2013, SCIENCE, V341, P395, DOI 10.1126/science.1236188; Bennett DA, 2006, NEUROEPIDEMIOLOGY, V27, P169, DOI 10.1159/000096129; Bennett S, 2009, J ALZHEIMERS DIS, V17, P245, DOI 10.3233/JAD-2009-1041; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Bucholtz N, 2013, DNA REPAIR AMST; Busser J, 1998, J NEUROSCI, V18, P2801; Chang CJ, 2008, MOL CELL BIOL, V28, P3281, DOI 10.1128/MCB.00310-08; Cotman CW, 1996, BRAIN PATHOL, V6, P493, DOI 10.1111/j.1750-3639.1996.tb00878.x; Culmsee C, 2001, J NEUROCHEM, V77, P220, DOI 10.1046/j.1471-4159.2001.00220.x; DRAGUNOW M, 1995, NEUROREPORT, V6, P1053, DOI 10.1097/00001756-199505090-00026; Evans Teresa A, 2007, Int J Med Sci, V4, P140; Fagan AM, 2007, ARCH NEUROL-CHICAGO, V64, P343, DOI 10.1001/archneur.64.3.noc60123; Fagan AM, 2009, ANN NEUROL, V65, P176, DOI 10.1002/ana.21559; Ferretti Renata Eloah de Lucena, 2010, Dement. neuropsychol., V4, P138, DOI 10.1590/S1980-57642010DN40200011; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fuller GN, 1997, HISTOLOGY PATHOLOGIS, P1200; Gabbita SP, 1998, J NEUROCHEM, V71, P2034, DOI 10.1046/j.1471-4159.1998.71052034.x; GALASKO D, 1994, ARCH NEUROL-CHICAGO, V51, P888, DOI 10.1001/archneur.1994.00540210060013; Gao C, 2012, REV NEUROSCIENCE, V23, P1, DOI [10.1515/RNS.2011.061, 10.1515/rns.2011.061]; GEARING M, 1995, NEUROLOGY, V45, P461, DOI 10.1212/WNL.45.3.461; Giovanni A, 2000, J BIOL CHEM, V275, P11553, DOI 10.1074/jbc.275.16.11553; Gowen LC, 1998, SCIENCE, V281, P1009, DOI 10.1126/science.281.5379.1009; Griffin RJ, 2005, J NEUROCHEM, V93, P105, DOI 10.1111/j.1471-4159.2004.02949.x; Grinberg Lea Tenenholz, 2007, Cell and Tissue Banking, V8, P151, DOI 10.1007/s10561-006-9022-z; Hernandez-Ortega K, 2007, J NEUROSCI RES, V85, P1744, DOI 10.1002/jnr.21301; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hoerndli FJ, 2007, EUR J NEUROSCI, V26, P60, DOI 10.1111/j.1460-9568.2007.05618.x; Iacono D, 2009, NEUROLOGY, V73, P665, DOI 10.1212/WNL.0b013e3181b01077; Isella V, 2006, J NEUROL NEUROSUR PS, V77, P166, DOI 10.1136/jnnp.2005.069765; Ittner LM, 2011, NAT REV NEUROSCI, V12, P67, DOI 10.1038/nrn2967; Jordan-Sciutto KL, 2002, J NEUROPATH EXP NEUR, V61, P358, DOI 10.1093/jnen/61.4.358; JORM AF, 1994, PSYCHOL MED, V24, P145, DOI 10.1017/S003329170002691X; Jorm AF, 1997, ALZ DIS ASSOC DIS, V11, P158, DOI 10.1097/00002093-199709000-00008; Katsel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068361; Kitamura Y, 1997, BIOCHEM BIOPH RES CO, V232, P418, DOI 10.1006/bbrc.1997.6301; KUKULL WA, 1990, NEUROLOGY, V40, P1364, DOI 10.1212/WNL.40.9.1364; Lovell MA, 2011, MECH AGEING DEV, V132, P443, DOI 10.1016/j.mad.2011.08.003; Lu PJ, 1999, NATURE, V399, P784; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; LUCASSEN PJ, 1995, J HISTOCHEM CYTOCHEM, V43, P1163, DOI 10.1177/43.11.7560899; Lucassen PJ, 1997, J NEUROPATH EXP NEUR, V56, P887, DOI 10.1097/00005072-199708000-00007; Lyras L, 1997, J NEUROCHEM, V68, P2061; Maehama T, 1998, J BIOL CHEM, V273, P13375, DOI 10.1074/jbc.273.22.13375; Majd S, 2008, BRAIN RES, V1218, P224, DOI 10.1016/j.brainres.2008.04.050; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; McShea A, 1997, AM J PATHOL, V150, P1933; MECOCCI P, 1993, ANN NEUROL, V34, P609, DOI 10.1002/ana.410340416; MECOCCI P, 1994, ANN NEUROL, V36, P747, DOI 10.1002/ana.410360510; MIRRA SS, 1991, NEUROLOGY, V41, P479, DOI 10.1212/WNL.41.4.479; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Mosch B, 2007, J NEUROSCI, V27, P6859, DOI 10.1523/JNEUROSCI.0379-07.2007; MULLAART E, 1990, NEUROBIOL AGING, V11, P169, DOI 10.1016/0197-4580(90)90542-8; Murray IVJ, 2011, EXP BIOL MED, V236, P772, DOI 10.1258/ebm.2011.010355; Myung NH, 2008, AGE, V30, P209, DOI 10.1007/s11357-008-9050-7; Nagy Z, 1997, ACTA NEUROPATHOL, V94, P6, DOI 10.1007/s004010050665; Nunomura A, 1999, J NEUROSCI, V19, P1959; O'Brien RJ, 2009, J ALZHEIMERS DIS, V18, P665, DOI 10.3233/JAD-2009-1179; Ogawa O, 2003, AGING CELL, V2, P105, DOI 10.1046/j.1474-9728.2003.00042.x; Pei JJ, 1998, BRAIN RES, V797, P267, DOI 10.1016/S0006-8993(98)00296-0; Pratico D, 2008, TRENDS PHARMACOL SCI, V29, P609, DOI 10.1016/j.tips.2008.09.001; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Price JL, 2001, ARCH NEUROL-CHICAGO, V58, P1395, DOI 10.1001/archneur.58.9.1395; Price JL, 2009, NEUROBIOL AGING, V30, P1026, DOI 10.1016/j.neurobiolaging.2009.04.002; Ramalho RM, 2004, J NEUROCHEM, V90, P567, DOI 10.1111/j.1471-4159.2004.02517.x; Rass U, 2007, CELL, V130, P991, DOI 10.1016/j.cell.2007.08.043; Reitz C, 2011, NAT REV NEUROL, V7, P137, DOI [10.1038/nrneurol.2011.2, 10.1101/cshperspect.a006239]; Riudavets MA, 2007, NEUROBIOL AGING, V28, P1484, DOI 10.1016/j.neurobiolaging.2007.05.005; Roe CM, 2008, ARCH NEUROL-CHICAGO, V65, P1467, DOI 10.1001/archneur.65.11.1467; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; Schmitt FA, 2000, NEUROLOGY, V55, P370, DOI 10.1212/WNL.55.3.370; Scully R, 1997, CELL, V90, P425, DOI 10.1016/S0092-8674(00)80503-6; Shao C, 2008, FREE RADICAL BIO MED, V45, P813, DOI 10.1016/j.freeradbiomed.2008.06.003; Shen WH, 2007, CELL, V128, P157, DOI 10.1016/j.cell.2006.11.042; Silva ART, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048751; Simpson JE, 2010, NEUROPATH APPL NEURO, V36, P25, DOI 10.1111/j.1365-2990.2009.01030.x; Sohur US, 2006, PHILOS T R SOC B, V361, P1477, DOI 10.1098/rstb.2006.1887; Sonoda Y, 2010, NEUROSCI LETT, V471, P20, DOI 10.1016/j.neulet.2009.12.078; Sperling R.A., 2011, DEFINING PRECLINICAL; Stern Y, 2006, ALZ DIS ASSOC DIS, V20, pS69, DOI 10.1097/00002093-200607001-00010; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Sultana R, 2007, NEUROCHEM RES, V32, P655, DOI 10.1007/s11064-006-9123-x; Tang YF, 2006, CANCER RES, V66, P736, DOI 10.1158/0008-5472.CAN-05-1557; Thakur A, 2008, INT J CLIN EXP PATHO, V1, P134; Townsend M, 2007, J BIOL CHEM, V282, P33305, DOI 10.1074/jbc.M610390200; Trotman LC, 2007, CELL, V128, P141, DOI 10.1016/j.cell.2006.11.040; Tyas SL, 2007, AM J EPIDEMIOL, V165, P1231, DOI 10.1093/aje/kwm085; VICTOROFF J, 1995, AM J PSYCHIAT, V152, P1476; Villemagne VL, 2008, NEUROPSYCHOLOGIA, V46, P1688, DOI 10.1016/j.neuropsychologia.2008.02.008; Vincent I, 1997, J NEUROSCI, V17, P3588; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Wang J, 2005, J NEUROCHEM, V93, P953, DOI 10.1111/j.1471-4159.2005.03053.x; Wang JQ, 2006, J NEUROCHEM, V96, P825, DOI 10.1111/j.1471-4159.2005.03615.x; Weiner Michael W, 2012, Alzheimers Dement, V8, pS1, DOI [10.1016/j.jalz.2013.05.1769, 10.1016/j.jalz.2011.09.172]; Weissman L, 2007, NUCLEIC ACIDS RES, V35, P5545, DOI 10.1093/nar/gkm605; West MJ, 2004, NEUROBIOL AGING, V25, P1205, DOI 10.1016/j.neurobiolaging.2003.12.005; White L, 2009, J ALZHEIMERS DIS, V18, P713, DOI 10.3233/JAD-2009-1178; Yang Y, 2003, J NEUROSCI, V23, P2557; Zhang J, 2008, CELL CYCLE, V7, P3487, DOI 10.4161/cc.7.22.7045; Zhang J, 2008, P NATL ACAD SCI USA, V105, P8772, DOI 10.1073/pnas.0711355105; Zhang J, 2012, J BIOL CHEM, V287, P25985, DOI 10.1074/jbc.M112.343152; Zhang J, 2010, J NEUROSCI, V30, P5219, DOI 10.1523/JNEUROSCI.5628-09.2010	109	61	62	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99897	10.1371/journal.pone.0099897	http://dx.doi.org/10.1371/journal.pone.0099897			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936870	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400052
J	Das, L; Vinayak, M				Das, Laxmidhar; Vinayak, Manjula			Long Term Effect of Curcumin in Regulation of Glycolytic Pathway and Angiogenesis via Modulation of Stress Activated Genes in Prevention of Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; INDUCIBLE FACTOR-I; KINASE-C-ALPHA; MATRIX METALLOPROTEINASES; SUPEROXIDE-DISMUTASE; ANTICARCINOGENIC ACTION; TUMOR-METASTASIS; NADPH OXIDASE; MOUSE MODEL; INHIBITION	Oxidative stress, an important factor in modulation of glycolytic pathway and induction of stress activated genes, is further augmented due to reduced antioxidant defense system, which promotes cancer progression via inducing angiogenesis. Curcumin, a naturally occurring chemopreventive phytochemical, is reported to inhibit carcinogenesis in various experimental animal models. However, the underlying mechanism involved in anticarcinogenic action of curcumin due to its long term effect is still to be reported because of its rapid metabolism, although metabolites are accumulated in tissues and remain for a longer time. Therefore, the long term effect of curcumin needs thorough investigation. The present study aimed to analyze the anticarcinogenic action of curcumin in liver, even after withdrawal of treatment in Dalton's lymphoma bearing mice. Oxidative stress observed during lymphoma progression reduced antioxidant enzyme activities, and induced angiogenesis as well as activation of early stress activated genes and glycolytic pathway. Curcumin treatment resulted in activation of antioxidant enzyme super oxide dismutase and down regulation of ROS level as well as activity of ROS producing enzyme NADPH: oxidase, expression of stress activated genes HIF-1 alpha, cMyc and LDH activity towards normal level. Further, it lead to significant inhibition of angiogenesis, observed via MMPs activity, PKC alpha and VEGF level, as well as by matrigel plug assay. Thus findings of this study conclude that the long term effect of curcumin shows anticarcinogenic potential via induction of antioxidant defense system and inhibition of angiogenesis via down regulation of stress activated genes and glycolytic pathway in liver of lymphoma bearing mice.	[Das, Laxmidhar; Vinayak, Manjula] Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Ctr Adv Study, Varanasi 221005, Uttar Pradesh, India	Banaras Hindu University (BHU)	Vinayak, M (corresponding author), Banaras Hindu Univ, Dept Zool, Biochem & Mol Biol Lab, Ctr Adv Study, Varanasi 221005, Uttar Pradesh, India.	manjulavinayak@rediffmail.com			Department of Science and Technology, Government of India [SR/S0/AS-97/2007]	Department of Science and Technology, Government of India(Department of Science & Technology (India))	The work was supported by grants from the Department of Science and Technology (Grant No.-SR/S0/AS-97/2007), Government of India to MV. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Behrend L, 2005, MOL CELL BIOL, V25, P7758, DOI 10.1128/MCB.25.17.7758-7769.2005; BRAVARD A, 1992, INT J CANCER, V51, P476, DOI 10.1002/ijc.2910510323; Chen JQ, 2012, BBA-REV CANCER, V1826, P370, DOI 10.1016/j.bbcan.2012.06.004; Das L, 2014, LEUKEMIA LYMPHOMA, V55, P2627, DOI 10.3109/10428194.2014.889824; Das L, 2014, INT IMMUNOPHARMACOL, V20, P141, DOI 10.1016/j.intimp.2014.02.024; Das L, 2012, BIOSCIENCE REP, V32, P161, DOI 10.1042/BSR20110043; Devi BJ, 2006, CANCER LETT, V238, P135, DOI 10.1016/j.canlet.2005.07.014; DIETZ AA, 1967, ANAL BIOCHEM, V20, P246, DOI 10.1016/0003-2697(67)90030-9; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Gao P, 2007, CANCER CELL, V12, P230, DOI 10.1016/j.ccr.2007.08.004; GOLDIE H, 1951, CANCER RES, V11, P73; Hashimoto G, 2002, J BIOL CHEM, V277, P36288, DOI 10.1074/jbc.M201674200; HIBBS MS, 1985, J BIOL CHEM, V260, P2493; Hwang JH, 2012, TOXICOLOGY, V294, P27, DOI 10.1016/j.tox.2012.01.013; Jacobs DR, 2009, AM J CLIN NUTR, V89, pS1543, DOI 10.3945/ajcn.2009.26736B; Jensen RL, 2006, J NEURO-ONCOL, V78, P233, DOI 10.1007/s11060-005-9103-z; Kessenbrock K, 2010, CELL, V141, P52, DOI 10.1016/j.cell.2010.03.015; Kim JW, 2007, MOL CELL BIOL, V27, P7381, DOI 10.1128/MCB.00440-07; Klein G, 2004, CRIT REV ONCOL HEMAT, V50, P87, DOI 10.1016/j.critevonc.2003.09.001; Kobayashi Y, 2008, CANCER SCI, V99, P1546, DOI 10.1111/j.1349-7006.2008.00856.x; Lee HB, 2004, KIDNEY INT, V65, P1170, DOI 10.1111/j.1523-1755.2004.00491.x; Mishra S, 2011, LEUKEMIA LYMPHOMA, V52, P2155, DOI 10.3109/10428194.2011.591014; Moon EJ, 2010, P NATL ACAD SCI USA, V107, P20477, DOI 10.1073/pnas.1006646107; Nagy MA, 2011, J CANC SCI THER, V3, P035; Nishikawa M, 2008, CANCER LETT, V266, P53, DOI 10.1016/j.canlet.2008.02.031; Nishikawa M, 2006, EXPERT OPIN DRUG DEL, V3, P355, DOI 10.1517/17425247.3.3.355; Pathak C, 2005, MOL BIOL REP, V32, P191, DOI 10.1007/s11033-004-6941-2; Pathak C, 2007, BIOFACTORS, V29, P159, DOI 10.1002/biof.5520290401; Podar K, 2010, CELL CYCLE, V9, P1722, DOI 10.4161/cc.9.9.11358; Rundhaug JE, 2005, J CELL MOL MED, V9, P267, DOI 10.1111/j.1582-4934.2005.tb00355.x; Sagi M, 2001, PLANT PHYSIOL, V126, P1281, DOI 10.1104/pp.126.3.1281; Schrader M, 2006, BBA-MOL CELL RES, V1763, P1755, DOI 10.1016/j.bbamcr.2006.09.006; Seth P, 2011, NEOPLASIA, V13, P60, DOI 10.1593/neo.101020; Sharma R, 2012, LEUKEMIA LYMPHOMA, V53, P1203, DOI 10.3109/10428194.2011.637213; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Shishodia S, 2007, CURR PROB CANCER, V31, P243, DOI 10.1016/j.currproblcancer.2007.04.001; SINHA AK, 1972, ANAL BIOCHEM, V47, P389, DOI 10.1016/0003-2697(72)90132-7; Sotgia F, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-62; Ushio-Fukai M, 2006, CARDIOVASC RES, V71, P226, DOI 10.1016/j.cardiores.2006.04.015; Van den Eynden GG, 2013, CANCER RES, V73, P2031, DOI 10.1158/0008-5472.CAN-12-3931; Vidal-Vanaclocha F, 2008, CANCER MICROENVIRON, V1, P113, DOI 10.1007/s12307-008-0011-6; Wagner H, 2011, FITOTERAPIA, V82, P34, DOI 10.1016/j.fitote.2010.11.016; WARREN RS, 1995, J CLIN INVEST, V95, P1789, DOI 10.1172/JCI117857; Wu WS, 2010, CANCER METAST BIOL T, V15, P103, DOI 10.1007/978-90-481-9522-0_6; Xia C, 2007, CANCER RES, V67, P10823, DOI 10.1158/0008-5472.CAN-07-0783; Xu H, 2008, CARDIOVASC RES, V78, P349, DOI 10.1093/cvr/cvm085; Yoon SO, 2003, J BIOCHEM MOL BIOL, V36, P128; Yoshiji H, 1999, CANCER RES, V59, P4413; Zhao YF, 2001, CANCER RES, V61, P6082	51	36	39	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99583	10.1371/journal.pone.0099583	http://dx.doi.org/10.1371/journal.pone.0099583			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932681	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600044
J	Lee, JH; Guo, Z; Myler, LR; Zheng, ST; Paull, TT				Lee, Ji-Hoon; Guo, Zhi; Myler, Logan R.; Zheng, Suting; Paull, Tanya T.			Direct Activation of ATM by Resveratrol under Oxidizing Conditions	PLOS ONE			English	Article							DOUBLE-STRAND BREAKS; PROTEIN-KINASE; DNA; APOPTOSIS; PATHWAYS; PHOSPHORYLATION; GENISTEIN; TARGETS; CELLS; P53	Resveratrol has been widely reported to reduce cancer progression in model systems and to selectively induce cell death in transformed cell lines. Many enzymes have been reported to respond to resveratrol in mammalian cells, including the Ataxia-Telangiectasia Mutated (ATM) protein kinase that acts in DNA damage recognition, signaling, and repair. Here we investigate the responses of ATM to resveratrol exposure in normal and transformed human cell lines and find that ATM autophosphorylation and substrate phosphorylation is stimulated by resveratrol in a manner that is promoted by reactive oxygen species (ROS). We observe direct stimulatory effects of resveratrol on purified ATM in vitro and find that the catalytic efficiency of the kinase on a model substrate is increased by resveratrol. In the purified system we also observe a requirement for oxidation, as the effect of resveratrol on ATM signaling is substantially reduced by agents that prevent disulfide bond formation in ATM. These results demonstrate that resveratrol effects on ATM are direct, and suggest a mechanism by which the oxidizing environment of transformed cells promotes ATM activity and blocks cell proliferation.	[Lee, Ji-Hoon; Myler, Logan R.; Zheng, Suting; Paull, Tanya T.] Univ Texas Austin, Howard Hughes Med Inst, Dept Mol Biosci, Austin, TX 78712 USA; [Lee, Ji-Hoon; Myler, Logan R.; Zheng, Suting; Paull, Tanya T.] Univ Texas Austin, Inst Cellular & Mol Biol, Austin, TX 78712 USA; [Guo, Zhi] Brigham & Womens Hosp, Dept Med, Div Genet, Boston, MA 02115 USA; [Guo, Zhi] Harvard Univ, Sch Med, Dept Genet, Boston, MA USA; [Guo, Zhi] Brigham & Womens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute	Paull, TT (corresponding author), Univ Texas Austin, Howard Hughes Med Inst, Dept Mol Biosci, Austin, TX 78712 USA.	tpaull@utexas.edu	Lee, Jihoon/AAK-3497-2021	Lee, Jihoon/0000-0001-7387-935X; Paull, Tanya/0000-0002-2991-651X	NIH [CA132813]; CPRIT [RP100670]; NATIONAL CANCER INSTITUTE [R01CA132813] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CPRIT; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	NIH CA132813 and CPRIT RP100670. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	de la Lastral CA, 2007, BIOCHEM SOC T, V35, P1156, DOI 10.1042/BST0351156; Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Bakkenist CJ, 2003, NATURE, V421, P499, DOI 10.1038/nature01368; Bandele OJ, 2007, BIOCHEMISTRY-US, V46, P6097, DOI 10.1021/bi7000664; Baur JA, 2012, NAT REV DRUG DISCOV, V11, P443, DOI 10.1038/nrd3738; Bensimon A, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2001034; Catalgol B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00141; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; Ditch S, 2012, TRENDS BIOCHEM SCI, V37, P15, DOI 10.1016/j.tibs.2011.10.002; Gatz SA, 2008, CARCINOGENESIS, V29, P519, DOI 10.1093/carcin/bgm283; Guo Z, 2010, CELL CYCLE, V9, P4805, DOI 10.4161/cc.9.24.14323; Guo Z, 2010, SCIENCE, V330, P517, DOI 10.1126/science.1192912; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Lee JH, 2007, ONCOGENE, V26, P7741, DOI 10.1038/sj.onc.1210872; Lee JH, 2004, SCIENCE, V304, P93, DOI 10.1126/science.1091496; Lee JH, 2005, SCIENCE, V308, P551, DOI 10.1126/science.1108297; Li YB, 2006, PHARMACOL RES, V53, P6, DOI 10.1016/j.phrs.2005.08.002; Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321; Piotrowska H, 2012, MUTAT RES-REV MUTAT, V750, P60, DOI 10.1016/j.mrrev.2011.11.001; Pirola L, 2008, IUBMB LIFE, V60, P323, DOI 10.1002/iub.47; Podhorecka M, 2011, ANN HEMATOL, V90, P173, DOI 10.1007/s00277-010-1045-7; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Shiloh Y, 2013, NAT REV MOL CELL BIO, V14, P197, DOI 10.1038/nrm3546; Shimizu T, 2006, BIOCHEM PHARMACOL, V71, P742, DOI 10.1016/j.bcp.2005.12.018; Tyagi A, 2005, CARCINOGENESIS, V26, P1978, DOI 10.1093/carcin/bgi165; Weng CJ, 2012, CANCER TREAT REV, V38, P76, DOI 10.1016/j.ctrv.2011.03.001; Yang Y, 2013, CURR MED CHEM, V20, P3677, DOI 10.2174/0929867311320999165; Ye RQ, 2004, DNA REPAIR, V3, P235, DOI 10.1016/j.dnarep.2003.10.014; Ye RQ, 2001, J BIOL CHEM, V276, P4828, DOI 10.1074/jbc.M004894200	31	24	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e97969	10.1371/journal.pone.0097969	http://dx.doi.org/10.1371/journal.pone.0097969			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933654	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600006
J	Mdzinarishvili, T; Sherman, S				Mdzinarishvili, Tengiz; Sherman, Simon			Heuristic Modeling of Carcinogenesis for the Population with Dichotomous Susceptibility to Cancer: A Pancreatic Cancer Example	PLOS ONE			English	Article							MULTISTAGE CARCINOGENESIS; AGE DISTRIBUTION	At present, carcinogenic models imply that all individuals in a population are susceptible to cancer. These models either ignore a fall of the cancer incidence rate at old ages, or use some poorly identifiable parameters for its accounting. In this work, a new heuristic model is proposed. The model assumes that, in a population, only a small fraction (pool) of individuals is susceptible to cancer and decomposes the problem of the carcinogenic modeling on two sequentially solvable problems: (i) determination of the age-specific hazard rate in individuals susceptible to cancer (individual hazard rate) from the observed hazard rate in the population (population hazard rate); and (ii) modelling of the individual hazard rate by a chosen "up'' of the theoretical hazard function describing cancer occurrence in individuals in time (age). The model considers carcinogenesis as a failure of individuals susceptible to cancer to resist cancer occurrence in aging and uses, as the theoretical hazard function, the three-parameter Weibull hazard function, often utilized in a failure analysis. The parameters of this function, providing the best fit of the modeled and observed individual hazard rates (determined from the population hazard rates), are the outcomes of the modeling. The model was applied to the pancreatic cancer data. It was shown that, in the populations stratified by gender, race and the geographic area of living, the modeled and observed population hazard rates of pancreatic cancer occurrence have similar turnovers at old ages. The sizes of the pools of individuals susceptible to this cancer: (i) depend on gender, race and the geographic area of living; (ii) proportionally influence the corresponding population hazard rates; and (iii) do not influence the individual hazard rates. The model should be further tested using data on other types of cancer and for the populations stratified by different categorical variables.	[Mdzinarishvili, Tengiz; Sherman, Simon] Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center	Sherman, S (corresponding author), Univ Nebraska Med Ctr, Eppley Inst Res Canc, Omaha, NE 68198 USA.	ssherm@unmc.edu			NIH [1 R01 CA140940-04]; NATIONAL CANCER INSTITUTE [P30CA036727, R01CA140940] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was partially supported by the 1 R01 CA140940-04 (NIH, SS the PI) grant. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aalen OO, 1999, CANCER CAUSE CONTROL, V10, P285, DOI 10.1023/A:1008916718152; Anfinsen KP, 2011, CANCER EPIDEM BIOMAR, V20, P1770, DOI 10.1158/1055-9965.EPI-11-0136; ARMITAGE P, 1954, BRIT J CANCER, V8, P1, DOI 10.1038/bjc.1954.1; Byrne HM, 2006, PHILOS T R SOC A, V364, P1563, DOI 10.1098/rsta.2006.1786; COOK PJ, 1969, INT J CANCER, V4, P93, DOI 10.1002/ijc.2910040113; Doll R, 2004, INT J EPIDEMIOL, V33, P1183, DOI 10.1093/ije/dyh359; Gordon RA, 2003, TOXICOL IND HEALTH, V19, P125, DOI 10.1191/0748233703th195oa; Gsteiger S, 2008, THEOR BIOL MED MODEL, V5, DOI 10.1186/1742-4682-5-13; Holford TR, 2005, ENCY BIOSTATISTICS, P17; Kleinbaum DG, 2012, STAT BIOL HEALTH, P1, DOI 10.1007/978-1-4419-6646-9; Luebeck EG, 2013, CANCER RES, V73, P1086, DOI 10.1158/0008-5472.CAN-12-2198; Luebeck EG, 2002, P NATL ACAD SCI USA, V99, P15095, DOI 10.1073/pnas.222118199; Manton K, 2009, CANC MORTALITY MORBI; MATLAB, 2010, VERS 7 10 0 R2010A; Mdzinarishvili T, 2013, CANCER INFORM, V12, P67, DOI 10.4137/CIN.S8063; Mdzinarishvili T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034362; Mdzinarishvili T, 2010, CANCER INFORM, V9, P179; Meza R, 2008, P NATL ACAD SCI USA, V105, P16284, DOI 10.1073/pnas.0801151105; Moger TA, 2004, BIOSTATISTICS, V5, P1, DOI 10.1093/biostatistics/5.1.1; Morgenthaler S, 2004, J MATH BIOL, V49, P455, DOI 10.1007/s00285-004-0271-9; Ries LAG, 2007, NIH PUB, V07-6215, P59; Schollnberger H, 2010, CANCER RES, V70, P6797, DOI 10.1158/0008-5472.CAN-09-4392; Selvin S, 2004, STAT ANAL EPIDEMIOLO, P263; Surveillance Epidemiology and End Results (SEER) Program, 2011, SEER STAT DAT INC SE; Weisstein EW, ERROR PROPAGATION	25	3	3	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100087	10.1371/journal.pone.0100087	http://dx.doi.org/10.1371/journal.pone.0100087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932779	Green Submitted, gold, Green Published			2022-12-27	WOS:000337738600092
J	Hu, N; Mora-Jensen, H; Theilgaard-Monch, K; Doornbos-van der Meer, B; Huitema, MG; Stegeman, CA; Heeringa, P; Kallenberg, CGM; Westra, J				Hu, Nan; Mora-Jensen, Helena; Theilgaard-Monch, Kim; Doornbos-van der Meer, Berber; Huitema, Minke G.; Stegeman, Coen A.; Heeringa, Peter; Kallenberg, Cees G. M.; Westra, Johanna			Differential Expression of Granulopoiesis Related Genes in Neutrophil Subsets Distinguished by Membrane Expression of CD177	PLOS ONE			English	Article							ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; WEGENERS-GRANULOMATOSIS; SURFACE EXPRESSION; PROTEINASE-3 PR3; UP-REGULATION; NB1 GP; VASCULITIS; ANTIGEN; MYELOPEROXIDASE; SPECIFICITY	Objective: Differential gene expression in CD177(+) and CD177(-) neutrophils was investigated, in order to detect possible differences in neutrophil function which could be related to the pathogenesis of ANCA-associated Vasculitides (AAV). Methods: Neutrophils were isolated from healthy controls (HC) with high, negative or bimodal CD177 expression, and sorted into CD177(+) and CD177(-) subpopulations. Total RNA was screened for expression of 24,000 probes with Illumina Ref8 Beadchips. Genes showing differential expression between CD177(+) and CD177(-) subsets in microarray analysis were reassessed using quantitative-PCR. CD177 expression on neutrophil precursors in bone marrow was analyzed using quantitative PCR and flowcytometry. Results: The proportion of CD177(+) cells increased during neutrophil maturation in bone marrow. Fold change analysis of gene expression profile of sorted CD177(+) and CD177(-) neutrophils resulted in 14 genes with fold change (fc) >3 difference in expression. Interestingly, 10 of these genes have been reported to change significantly in expression during neutrophil maturation, and most of these genes were granule protein (GP) coding genes. mRNA expression levels measured by RT-PCR of a number of these GP, and of PR3 and MPO were higher in the CD177(-) neutrophil subset in HC, however, particular granule protein amounts were comparable between CD177(+) and CD177(-) neutrophil subsets. AAV patients had higher amounts of CD177(+) neutrophils, but contrary to neutrophils from HC expression of GP-genes was increased, possibly due to activation. Conclusion: The neutrophil population can be distinguished by membrane expression of CD177 into subsets that are different in expression of GP mRNA but not in GP protein production. GP gene expression is also elevated in AAV patients, which is not explained by skewed distribution of CD177(+) and CD177(-) subsets but may be associated with neutrophil activation during on-going inflammation.	[Hu, Nan] Peking Univ, Hosp 1, Dept Med, Beijing 100871, Peoples R China; [Mora-Jensen, Helena] Univ Copenhagen, Rigshosp, Dept Hematol, Granulocyte Res Lab, DK-2100 Copenhagen, Denmark; [Theilgaard-Monch, Kim] Univ Copenhagen, Rigshosp, Finsen Lab, DK-2100 Copenhagen, Denmark; [Theilgaard-Monch, Kim] Univ Copenhagen, Biotech & Res Innovat Ctr, Copenhagen, Denmark; [Theilgaard-Monch, Kim] Lund Univ, Dept Hematol, Skane Univ Hosp, Lund, Sweden; [Doornbos-van der Meer, Berber; Huitema, Minke G.; Kallenberg, Cees G. M.; Westra, Johanna] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [Stegeman, Coen A.] Univ Groningen, Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands; [Heeringa, Peter] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Groningen, Netherlands	Peking University; Rigshospitalet; University of Copenhagen; Rigshospitalet; University of Copenhagen; University of Copenhagen; Lund University; Skane University Hospital; University of Groningen; University of Groningen; University of Groningen	Westra, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	johanna.westra@umcg.nl	Heeringa, Peter/A-6008-2009	Heeringa, Peter/0000-0001-8684-763X; Theilgaard-Monch, Kim/0000-0002-4239-4939; Stegeman, Coen/0000-0002-0224-0927	Novo Nordisk Fonden [NNF12OC1015986] Funding Source: researchfish; The Danish Cancer Society [R72-A4572] Funding Source: researchfish	Novo Nordisk Fonden(Novo Nordisk Foundation); The Danish Cancer Society(Danish Cancer Society)		Abdgawad M, 2010, CLIN EXP IMMUNOL, V161, P89, DOI 10.1111/j.1365-2249.2010.04154.x; Abdgawad M, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0032439, 10.1371/journal.pone.0046057]; Abdulahad WH, 2008, ARTHRITIS RHEUM-US, V58, P2196, DOI 10.1002/art.23557; Bauer S, 2007, J LEUKOCYTE BIOL, V81, P458, DOI 10.1189/jlb.0806514; Boomsma MM, 2000, ARTHRITIS RHEUM-US, V43, P2025, DOI 10.1002/1529-0131(200009)43:9<2025::AID-ANR13>3.0.CO;2-O; Chen M, 2010, NAT REV RHEUMATOL, V6, P653, DOI 10.1038/nrrheum.2010.158; Ciavatta DJ, 2010, J CLIN INVEST, V120, P3209, DOI 10.1172/JCI40034; FALK RJ, 1988, NEW ENGL J MED, V318, P1651, DOI 10.1056/NEJM198806233182504; Gohring K, 2004, BRIT J HAEMATOL, V126, P252, DOI 10.1111/j.1365-2141.2004.05027.x; GOLDSCHMEDING R, 1989, J CLIN INVEST, V84, P1577, DOI 10.1172/JCI114335; HALBWACHSMECARELLI L, 1995, FEBS LETT, V374, P29, DOI 10.1016/0014-5793(95)01073-N; Hu N, 2009, ARTHRITIS RHEUM-US, V60, P1548, DOI 10.1002/art.24442; Jelinek J, 2007, EXP HEMATOL, V35, P1677, DOI 10.1016/j.exphem.2007.09.008; Jennette JC, 2013, ARTHRITIS RHEUM-US, V65, P1, DOI 10.1002/art.37715; JENNETTE JC, 1990, BLOOD, V75, P2263; KALLENBERG CGM, 1994, KIDNEY INT, V46, P1, DOI 10.1038/ki.1994.239; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kissel K, 2002, BLOOD, V99, P4231, DOI 10.1182/blood.V99.11.4231; Matsuo K, 2000, TRANSFUSION, V40, P654, DOI 10.1046/j.1537-2995.2000.40060654.x; Meyerson HJ, 2013, AM J CLIN PATHOL, V140, P658, DOI 10.1309/AJCPDFBEBQZW1OI7; Mora-Jensen H, 2011, J LEUKOCYTE BIOL, V90, P629, DOI 10.1189/jlb.0311123; Moritz E, 2010, VOX SANG, V98, P160, DOI 10.1111/j.1423-0410.2009.01233.x; Nogales-Cadenas R, 2009, NUCLEIC ACIDS RES, V37, pW317, DOI 10.1093/nar/gkp416; Ohlsson S, 2004, MEDIAT INFLAMM, V13, P275, DOI 10.1080/09629350400003100; Pliyev BK, 2012, EUR J HAEMATOL, V89, P236, DOI 10.1111/j.1600-0609.2012.01817.x; Rarok AA, 2002, J AM SOC NEPHROL, V13, DOI 10.1097/01.ASN.0000028642.26222.00; Sachs UJH, 2007, J BIOL CHEM, V282, P23603, DOI 10.1074/jbc.M701120200; Schreiber A, 2003, J AM SOC NEPHROL, V14, P68, DOI 10.1097/01.ASN.0000040751.83734.D1; Stroncek DF, 1998, TRANSFUSION MED, V8, P119; STRONCEK DF, 1990, BLOOD, V75, P744; Theilgaard-Monch K, 2005, BLOOD, V105, P1785, DOI 10.1182/blood-2004-08-3346; van Rossum AP, 2007, ANN RHEUM DIS, V66, P1350, DOI 10.1136/ard.2006.063230; von Vietinghoff S, 2007, BLOOD, V109, P4487, DOI 10.1182/blood-2006-10-055327; Witko-Sarsat V, 1999, J AM SOC NEPHROL, V10, P1224; Wolff J, 2003, BLOOD, V102, P731, DOI 10.1182/blood-2002-09-2831; Wolff JC, 2006, TRANSFUSION, V46, P132, DOI 10.1111/j.1537-2995.2005.00676.x; Xiao H, 2002, J CLIN INVEST, V110, P955, DOI 10.1172/JCI200215918; Yang JJ, 2004, J AM SOC NEPHROL, V15, P2103, DOI 10.1097/01.ASN.0000135058.46193.72	38	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99671	10.1371/journal.pone.0099671	http://dx.doi.org/10.1371/journal.pone.0099671			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926686	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100064
J	Koppensteiner, R; Samartzis, EP; Noske, A; von Teichman, A; Dedes, I; Gwerder, M; Imesch, P; Ikenberg, K; Moch, H; Fink, D; Stucki, M; Dedes, KJ				Koppensteiner, Romana; Samartzis, Eleftherios P.; Noske, Aurelia; von Teichman, Adriana; Dedes, Ioannis; Gwerder, Myriam; Imesch, Patrick; Ikenberg, Kristian; Moch, Holger; Fink, Daniel; Stucki, Manuel; Dedes, Konstantin J.			Effect of MRE11 Loss on PARP-Inhibitor Sensitivity in Endometrial Cancer In Vitro	PLOS ONE			English	Article							STRAND BREAK REPAIR; MICROSATELLITE INSTABILITY; COLORECTAL-CANCER; REPLICATION FORKS; DNA-REPAIR; CELL-LINE; MUTATIONS; EXPRESSION; COMPLEX; CARCINOMA	Aim of the study: To evaluate the frequency of MRE11/RAD50/NBS1 (MRN)-complex loss of protein expression in endometrial cancers (EC) and to determine whether loss of MRE11 renders the cancer cells sensitive to Poly(ADP-ribose) polymerase (PARP)-inhibitory treatment. Methods: MRN expression was examined in 521 samples of endometrial carcinomas and in 10 cancer cell lines. A putative mutation hotspot in the form of an intronic poly(T) allele in MRE11 was sequenced in selected cases (n = 26). Sensitivity to the PARP-inhibitor, BMN673 was tested in colony formation assays before and after MRE11 silencing using siRNA. Homologous recombination (HR) DNA repair was evaluated by RAD51-foci formation assay upon irradiation and drug treatment. Results: Loss of MRE11 protein was found in 30.7% of EC tumours and significantly associated with loss of RAD50, NBS1 and mismatch repair protein expression. One endometrial cell line showed a markedly reduced MRE11 expression due to a homozygous poly(T) mutation of MRE11, thereby exhibiting an increased sensitivity to BMN673. MRE11 depletion sensitizes MRE11 expressing EC cell lines to the treatment with BMN673. The increased sensitivity to PARP-inhibition correlates with reduced RAD51 foci formation upon ionizing radiation in MRE11-depleted cells. Conclusion: Loss of the MRE11 protein predicts sensitivity to PARP-inhibitor sensitivity in vitro, defining it as an additional synthetic lethal gene with PARP. The high incidence of MRE11 loss in ECs can be potentially exploited for PARP-inhibitor therapy. Furthermore, MRE11 protein expression using immunohistochemistry could be investigated as a predictive biomarker for PARP-inhibitor treatment.	[Koppensteiner, Romana; Samartzis, Eleftherios P.; Dedes, Ioannis; Gwerder, Myriam; Imesch, Patrick; Fink, Daniel; Stucki, Manuel; Dedes, Konstantin J.] Univ Zurich Hosp, Div Gynaecol, CH-8091 Zurich, Switzerland; [Noske, Aurelia; von Teichman, Adriana; Ikenberg, Kristian; Moch, Holger] Univ Zurich Hosp, Inst Surg Pathol, CH-8091 Zurich, Switzerland	University of Zurich; University Zurich Hospital; University of Zurich; University Zurich Hospital	Dedes, KJ (corresponding author), Univ Zurich Hosp, Div Gynaecol, CH-8091 Zurich, Switzerland.	Konstantin.Dedes@usz.ch	Stucki, Manuel/H-4739-2017; Dedes, Konstantin/AAK-1281-2021; Samartzis, Eleftherios P./AAJ-5650-2020	Samartzis, Eleftherios P./0000-0002-8246-5842; Dedes, Ioannis/0000-0001-7265-4765	Julius Muller Foundation; Zurich Cancer League	Julius Muller Foundation; Zurich Cancer League	This study was partially funded by the Julius Muller Foundation and Zurich Cancer League. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams KE, 2006, ONCOGENE, V25, P3894, DOI 10.1038/sj.onc.1209426; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bilbao C, 2010, EUR J CANCER, V46, P2821, DOI 10.1016/j.ejca.2010.06.116; Brough R, 2011, CURR OPIN GENET DEV, V21, P34, DOI 10.1016/j.gde.2010.10.009; Choudhury A, 2010, CANCER RES, V70, P7017, DOI 10.1158/0008-5472.CAN-10-1202; Daemen A, 2012, BREAST CANCER RES TR, V135, P505, DOI 10.1007/s10549-012-2188-0; De Bono JS, 2013, J CLIN ONCOL, V31; Dedes KJ, 2011, NAT REV CLIN ONCOL, V8, P261, DOI 10.1038/nrclinonc.2010.216; Dedes KJ, 2011, CELL CYCLE, V10, P1192, DOI 10.4161/cc.10.8.15273; Dedes KJ, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3001538; Dellinger TH, 2009, EXPERT REV ANTICANC, V9, P905, DOI [10.1586/era.09.54, 10.1586/ERA.09.54]; Esteller M, 1998, ONCOGENE, V17, P2413, DOI 10.1038/sj.onc.1202178; Forster MD, 2011, NAT REV CLIN ONCOL, V8, P302, DOI 10.1038/nrclinonc.2011.42; Fraser M, 2012, CLIN CANCER RES, V18, P1015, DOI 10.1158/1078-0432.CCR-11-2189; Gao JF, 2008, HISTOL HISTOPATHOL, V23, P1495, DOI 10.14670/HH-23.1495; Gaymes TJ, 2013, HAEMATOLOGICA, V98, P1397, DOI 10.3324/haematol.2012.079251; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Giannini G, 2004, ONCOGENE, V23, P2640, DOI 10.1038/sj.onc.1207409; Giannini G, 2002, EMBO REP, V3, P248, DOI 10.1093/embo-reports/kvf044; Hecht JL, 2006, J CLIN ONCOL, V24, P4783, DOI 10.1200/JCO.2006.06.7173; Lamarche BJ, 2010, FEBS LETT, V584, P3682, DOI 10.1016/j.febslet.2010.07.029; McPherson LA, 2014, CANCER LETT, V343, P217, DOI 10.1016/j.canlet.2013.10.034; Miturski R, 2002, EXP BIOL MED, V227, P579, DOI 10.1177/153537020222700805; Miyasaka A, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-179; Mo B, 2006, BIOL REPROD, V75, P387, DOI 10.1095/biolreprod.106.051870; NOZAWA S, 1989, AM J OBSTET GYNECOL, V161, P1079, DOI 10.1016/0002-9378(89)90787-4; Oplustilova L, 2012, CELL CYCLE, V11, P3837, DOI 10.4161/cc.22026; Ottini L, 2004, CARCINOGENESIS, V25, P2337, DOI 10.1093/carcin/bgh257; Pichierri P, 2004, EMBO J, V23, P3154, DOI 10.1038/sj.emboj.7600277; Price JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063313; Santin AD, 1996, INT J CANCER, V65, P688; Stewart GS, 1999, CELL, V99, P577, DOI 10.1016/S0092-8674(00)81547-0; Stracker TH, 2011, NAT REV MOL CELL BIO, V12, P90, DOI 10.1038/nrm3047; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Unoki M, 2003, ONCOGENE, V22, P2172, DOI 10.1038/sj.onc.1206222; Vilar E, 2011, CANCER RES, V71, P2632, DOI 10.1158/0008-5472.CAN-10-1120; Walsh PS, 1996, NUCLEIC ACIDS RES, V24, P2807, DOI 10.1093/nar/24.14.2807; Wild PJ, 2012, EMBO MOL MED, V4, P808, DOI 10.1002/emmm.201101063; Xiao YH, 1997, NUCLEIC ACIDS RES, V25, P2985, DOI 10.1093/nar/25.15.2985; Ying SM, 2012, CANCER RES, V72, P2814, DOI 10.1158/0008-5472.CAN-11-3417; Yuan SSF, 2012, JNCI-J NATL CANCER I, V104, P1485, DOI 10.1093/jnci/djs355; Zhao SM, 2013, P NATL ACAD SCI USA, V110, P2916, DOI 10.1073/pnas.1222577110	42	56	58	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100041	10.1371/journal.pone.0100041	http://dx.doi.org/10.1371/journal.pone.0100041			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927325	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100110
J	Habig, C; Geffers, R; Distl, O				Habig, Christin; Geffers, Robert; Distl, Ottmar			A Replication Study for Genome-Wide Gene Expression Levels in Two Layer Lines Elucidates Differentially Expressed Genes of Pathways Involved in Bone Remodeling and Immune Responsiveness	PLOS ONE			English	Article							FEATHER PECKING BEHAVIOR; MANUAL RESTRAINT; STRESS; CHICKEN; MICROARRAY; POLYMORPHISM; RESPONSES; REDUCTASE; COMT	The current replication study confirmed significant differences in gene expression profiles of the cerebrum among the two commercial layer lines Lohmann Selected Leghorn (LSL) and Lohmann Brown (LB). Microarray analyses were performed for 30 LSL and another 30 LB laying hens kept in the small group housing system Eurovent German. A total of 14,103 microarray probe sets using customized Affymetrix ChiGene-1_0-st Arrays with 20,399 probe sets were differentially expressed among the two layer lines LSL and LB (FDR adjusted P-value <0.05). An at least 2-fold change in expression levels could be observed for 388 of these probe sets. In LSL, 214 of the 388 probe sets were down- and 174 were up-regulated and vice versa for the LB layer line. Among the 174 up-regulated probe sets in LSL, we identified 51 significantly enriched Gene ontology (GO) terms of the biological process category. A total of 63 enriched GO-terms could be identified for the 214 down-regulated probe sets of the layer line LSL. We identified nine genes significantly differentially expressed between the two layer lines in both microarray experiments. These genes play a crucial role in protection of neuronal cells from oxidative stress, bone mineral density and immune response among the two layer lines LSL and LB. Thus, the different regulation of these genes may significantly contribute to phenotypic trait differences among these layer lines. In conclusion, these novel findings provide a basis for further research to improve animal welfare in laying hens and these layer lines may be of general interest as an animal model.	[Habig, Christin; Distl, Ottmar] Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany; [Geffers, Robert] Helmholtz Ctr Infect Res, Dept Cell Biol, Braunschweig, Germany	University of Veterinary Medicine Hannover, Foundation; Helmholtz Association; Helmholtz-Center for Infection Research	Distl, O (corresponding author), Univ Vet Med Hannover, Inst Anim Breeding & Genet, Hannover, Germany.	ottmar.distl@tiho-hannover.de			Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Federal Office for Agriculture and Food (BLE), Bonn, Germany [PGI 06.01 28 1-36.004-07]	Federal Ministry of Food, Agriculture and Consumer Protection (BMELV), Federal Office for Agriculture and Food (BLE), Bonn, Germany	This project and CH have been supported by funds of the Federal Ministry of Food, Agriculture and Consumer Protection (BMELV) via the Federal Office for Agriculture and Food (BLE), Bonn, Germany, under the innovation support program (PGI 06.01 28 1-36.004-07). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berczi I, 1998, ANN NY ACAD SCI, V851, P3, DOI 10.1111/j.1749-6632.1998.tb08969.x; Bottje WG, 2012, POULTRY SCI, V91, P2576, DOI 10.3382/ps.2012-02204; Burt DW, 2007, POULTRY SCI, V86, P1460, DOI 10.1093/ps/86.7.1460; Chang MT, 2013, REPROD DOMEST ANIM, V48, P98, DOI 10.1111/j.1439-0531.2012.02038.x; Chen JS, 2004, AM J HUM GENET, V75, P807, DOI 10.1086/425589; Cogburn LA, 2007, POULTRY SCI, V86, P2059, DOI 10.1093/ps/86.10.2059; Dantzer R, 1997, ACTA PHYSIOL SCAND, V161, P43; DOHMS JE, 1991, VET IMMUNOL IMMUNOP, V30, P89, DOI 10.1016/0165-2427(91)90011-Z; Dwight SS, 2002, NUCLEIC ACIDS RES, V30, P69, DOI 10.1093/nar/30.1.69; Glaser R, 1998, ANN NY ACAD SCI, V840, P649, DOI 10.1111/j.1749-6632.1998.tb09603.x; Gross W. B., 1993, Livestock handling and transport., P21; GROSS WB, 1983, AVIAN DIS, V27, P972, DOI 10.2307/1590198; Habig C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046787; Hocking PM, 2011, ANIMAL WELFARE 2011, P270; Kaminski Stanislaw, 2002, Journal of Applied Genetics, V43, P123; Kjaer JB, 1997, BRIT POULTRY SCI, V38, P333, DOI 10.1080/00071669708417999; Kjaer JB, 2000, APPL ANIM BEHAV SCI, V65, P331, DOI 10.1016/S0168-1591(99)00064-7; Korte SM, 1997, PHYSIOL BEHAV, V62, P437, DOI 10.1016/S0031-9384(97)00149-2; Korte SM, 1999, PHYSIOL BEHAV, V65, P649; Labouriau R, 2009, POULTRY SCI, V88, P2052, DOI 10.3382/ps.2009-00113; Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007; Li CL, 2012, POULTRY SCI, V91, P3184, DOI 10.3382/ps.2012-02392; Li D, 2012, CHEM-BIOL INTERACT, V195, P25, DOI 10.1016/j.cbi.2011.09.007; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Lorentzon M, 2004, J BONE MINER RES, V19, P2005, DOI 10.1359/JBMR.040909; Magnusson U, 1998, AM J VET RES, V59, P421; MAXWELL MH, 1993, WORLD POULTRY SCI J, V49, P34, DOI 10.1079/WPS19930004; McCall MN, 2012, BRIEF BIOINFORM, V13, P536, DOI 10.1093/bib/bbr072; Nie HS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011990; NILES MJ, 1995, P NATL ACAD SCI USA, V92, P2884, DOI 10.1073/pnas.92.7.2884; Picklo MJ, 2001, BRAIN RES, V916, P229, DOI 10.1016/S0006-8993(01)02897-9; Rubin JB, 2002, DEVELOPMENT, V129, P2223; SCANLON PD, 1979, SCIENCE, V203, P63, DOI 10.1126/science.758679; Sheridan JF, 1998, ANN NY ACAD SCI, V840, P803, DOI 10.1111/j.1749-6632.1998.tb09618.x; Shum L, 2002, ARTHRITIS RES, V4, P94, DOI 10.1186/ar396; Stolk L, 2007, J CLIN ENDOCR METAB, V92, P3206, DOI 10.1210/jc.2006-2136; Takeda S, 2002, CELL, V111, P305, DOI 10.1016/S0092-8674(02)01049-8; Yao JB, 2004, PHYSIOL GENOMICS, V19, P84, DOI 10.1152/physiolgenomics.00123.2004; Zhu BT, 1998, CARCINOGENESIS, V19, P1, DOI 10.1093/carcin/19.1.1	39	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98350	10.1371/journal.pone.0098350	http://dx.doi.org/10.1371/journal.pone.0098350			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922511	Green Submitted, Green Published, gold			2022-12-27	WOS:000338701300009
J	Liang, Y; Zhou, YY; Zhang, JW; Rao, T; Zhou, LJ; Xing, R; Wang, Q; Fu, HX; Hao, K; Xie, L; Wang, GJ				Liang, Yan; Zhou, Yuanyuan; Zhang, Jingwei; Rao, Tai; Zhou, Lijun; Xing, Rong; Wang, Qian; Fu, Hanxu; Hao, Kun; Xie, Lin; Wang, Guangji			Pharmacokinetic Compatibility of Ginsenosides and Schisandra Lignans in Shengmai-san: From the Perspective of P-Glycoprotein	PLOS ONE			English	Article							TRADITIONAL CHINESE MEDICINE; INTESTINAL CACO-2 CELLS; IN-VITRO; CYCLOSPORINE-A; RATS; ABSORPTION; TRANSPORT; EXTRACT; EFFLUX; INJURY	Background: Phytochemical-mediated alterations in P-glycoprotein (P-gp) activity may result in herb-drug interactions by altering drug pharmacokinetics. Shengmai-san, a traditional Chinese herbal medicine composed by Panax Ginseng, Ophiopogon Japonicus, and Schisandra Chinensis, is routinely being used for treating various coronary heart diseases. In our previous studies, Schisandra Lignans Extract (SLE) was proved as a strong P-gp inhibitor, and herein, the compatibility of Shengmai-san was studied by investigating the influence of SLE on the pharmacokinetics of the ginsenosides from the perspective of P-gp. Methodology: Pharmacokinetic experiments were firstly performed based on in vitro uptake, efflux and transport experiments in Caco-2, LLC-PK1 wild-type and MDR1-overexpressing L-MDR1 cells. During the whole experiment, digoxin, a classical P-gp substrate, was used as a positive control drug to verify the cells used are the valid models. Meanwhile, the effects of SLE on the pharmacokinetics of ginsenosides were further investigated in rats after single-dose and multi-dose of SLE. Results and Conclusions: The efflux ratios of ginsenoside Rb2, Rc, Rg2, Rg3, Rd and Rb1 were found more than 3.5 in L-MDR1 cells and can be decreased significantly by verapamil (a classical P-gp inhibitor). Contrarily, the efflux ratios of other ginsenosides (Rh1, F1, Re, and Rg1) were lower than 2.0 and not affected by verapamil. Then, the effects of SLE on the uptake and transport of ginsenosides were investigated, and SLE was found can significantly enhance the uptake and inhibit the efflux ratio of ginsenoside Rb2, Rc, Rg2, Rg3, Rd and Rb1 in Caco-2 and L-MDR1 cells. Besides, In vivo experiments showed that single-dose and multi-dose of SLE at 500 mg/kg could increase the area under the plasma concentration time curve of Rb2, Rc and Rd significantly without affecting terminal elimination half-time. In conclusion, SLE could enhance the exposure of ginsenosides Rb2, Rc, Rg2, Rg3, Rd and Rb1 significantly.	[Liang, Yan; Zhou, Yuanyuan; Zhang, Jingwei; Rao, Tai; Zhou, Lijun; Xing, Rong; Wang, Qian; Fu, Hanxu; Hao, Kun; Xie, Lin; Wang, Guangji] China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University	Xie, L (corresponding author), China Pharmaceut Univ, Key Lab Drug Metab & Pharmacokinet, Nanjing, Jiangsu, Peoples R China.	jsxielin@sina.com.cn; guangjiwang@hotmail.com	Zhou, Li/GSE-4531-2022		National Nature Science Foundation [81102881, 81273589, 81374054]; Natural Science Foundation of Jiangsu Province [BK20131311]	National Nature Science Foundation(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province)	This study was supported by the National Nature Science Foundation (81102881, 81273589, 81374054), Natural Science Foundation of Jiangsu Province (Grants BK20131311). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angela PA, 2000, J NUTR, V130, P1329; Bao Hong, 2010, Chin J Cancer, V29, P937; Cao HJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081650; Chen CY, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/703815; Fan L, 2009, XENOBIOTICA, V39, P249, DOI 10.1080/00498250802687657; Feng Y, 2006, ARTIF INTELL MED, V38, P219, DOI 10.1016/j.artmed.2006.07.005; Gnoth MJ, 2011, J PHARMACOL EXP THER, V338, P372, DOI 10.1124/jpet.111.180240; Han M, 2006, PLANTA MED, V72, P398, DOI 10.1055/s-2005-916211; Hashiguchi Y, 2013, BIOCHEM BIOPH RES CO, V439, P221, DOI 10.1016/j.bbrc.2013.08.054; Hoenders H J R, 2006, Tijdschr Psychiatr, V48, P733; Kim SW, 2003, BIOCHEM PHARMACOL, V65, P75, DOI 10.1016/S0006-2952(02)01446-6; Li LH, 2013, CHIN J NAT MEDICINES, V11, P222, DOI [10.1016/S1875-5364(13)60020-5, 10.3724/SP.J.1009.2013.00222]; Lin TX, 2009, DTSCH Z AKUPUNKT, V52, P27, DOI 10.1016/J.DZA.2009.05.008; Liu HF, 2009, DRUG METAB DISPOS, V37, P2290, DOI 10.1124/dmd.109.029819; Meng Z, 2007, BIOMED CHROMATOGR, V21, P635, DOI 10.1002/bmc.799; Mills E, 2005, THER DRUG MONIT, V27, P549, DOI 10.1097/01.ftd.0000170880.95267.90; SCHINKEL AH, 1995, J CLIN INVEST, V96, P1698, DOI 10.1172/JCI118214; Seo TB, 2009, J PHARMACOL SCI, V110, P483, DOI 10.1254/jphs.09044FP; Wang J, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/896467; Wang L, 2008, P NATL ACAD SCI USA, V105, P4826, DOI 10.1073/pnas.0712365105; Wang SP, 2012, J ETHNOPHARMACOL, V143, P412, DOI 10.1016/j.jep.2012.07.033; Wang XJ, 2013, MOL CELL PROTEOMICS, V12, P1226, DOI 10.1074/mcp.M112.021683; Yang Z, 2012, DRUG METAB DISPOS, V40, P1538, DOI 10.1124/dmd.111.044008; Yao HT, 2008, J ETHNOPHARMACOL, V116, P49, DOI 10.1016/j.jep.2007.10.043; Yoo HH, 2007, PLANTA MED, V73, P444, DOI 10.1055/s-2007-967178; Yu CP, 2013, PHYTOMEDICINE, V20, P648, DOI 10.1016/j.phymed.2013.01.008; Zhang JM, 2013, J ETHNOPHARMACOL, V147, P128, DOI 10.1016/j.jep.2013.02.019; Zhang JW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035768; Zhang JZ, 2012, J ETHNOPHARMACOL, V144, P277, DOI 10.1016/j.jep.2012.09.009; Zhou SF, 2005, EUR J PHARM SCI, V24, P513, DOI 10.1016/j.ejps.2005.01.006	32	23	29	2	86	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98717	10.1371/journal.pone.0098717	http://dx.doi.org/10.1371/journal.pone.0098717			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922060	gold, Green Submitted, Green Published			2022-12-27	WOS:000338701300014
J	Miller, JA; Teel, DJ; Peterson, WT; Baptista, AM				Miller, Jessica A.; Teel, David J.; Peterson, William T.; Baptista, Antonio M.			Assessing the Relative Importance of Local and Regional Processes on the Survival of a Threatened Salmon Population	PLOS ONE			English	Article							SIZE-SELECTIVE MORTALITY; JUVENILE CHINOOK SALMON; COLUMBIA RIVER; ONCORHYNCHUS-TSHAWYTSCHA; LIFE-HISTORY; FRESH-WATER; OCEAN; FISH; RECRUITMENT; CLIMATE	Research on regulatory mechanisms in biological populations often focuses on environmental covariates. An integrated approach that combines environmental indices with organismal-level information can provide additional insight on regulatory mechanisms. Survival of spring/summer Snake River Chinook salmon (Oncorhynchus tshawytscha) is consistently low whereas some adjacent populations with similar life histories experience greater survival. It is not known if populations with differential survival respond similarly during early marine residence, a critical period in the life history. Ocean collections, genetic stock identification, and otolith analyses were combined to evaluate the growth-mortality and match-mismatch hypotheses during early marine residence of spring/summer Snake River Chinook salmon. Interannual variation in juvenile attributes, including size at marine entry and marine growth rate, was compared with estimates of survival and physical and biological metrics. Multiple linear regression and multi-model inference were used to evaluate the relative importance of biological and physical metrics in explaining interannual variation in survival. There was relatively weak support for the match-mismatch hypothesis and stronger evidence for the growth-mortality hypothesis. Marine growth and size at capture were strongly, positively related to survival, a finding similar to spring Chinook salmon from the Mid-Upper Columbia River. In hindcast models, basin-scale indices (Pacific Decadal Oscillation (PDO) and the North Pacific Gyre Oscillation (NPGO)) and biological indices (juvenile salmon catch-per-unit-effort (CPUE) and a copepod community index (CCI)) accounted for substantial and similar portions of variation in survival for juvenile emigration years 1998-2008 (R-2 > 0.70). However, in forecast models for emigration years 2009-2011, there was an increasing discrepancy between predictions based on the PDO (50-448% of observed value) compared with those based on the NPGO (68-212%) or biological indices (CPUE and CCI: 83-172%). Overall, the PDO index was remarkably informative in earlier years but other basin-scale and biological indices provided more accurate indications of survival in recent years.	[Miller, Jessica A.] Oregon State Univ, Coastal Oregon Marine Expt Stn, Dept Fisheries & Wildlife, Newport, OR 97365 USA; [Teel, David J.] NOAA Fisheries, NW Fisheries Sci Ctr, Manchester, WA USA; [Peterson, William T.] NOAA Fisheries, NW Fisheries Sci Ctr, Newport, OR USA; [Baptista, Antonio M.] Oregon Hlth & Sci Univ, NSF Sci & Technol Ctr Coastal Margin Observat & P, Beaverton, OR USA	Oregon State University; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA; National Science Foundation (NSF); Oregon Health & Science University	Miller, JA (corresponding author), Oregon State Univ, Coastal Oregon Marine Expt Stn, Dept Fisheries & Wildlife, Newport, OR 97365 USA.	jessica.miller@oregonstate.edu		Baptista, Antonio/0000-0002-7641-5937; Miller, Jessica/0000-0002-6491-4085	Bonneville Power Administration (BPA) [00053808, 00052946/00059479]; National Science Foundation (NSF) [OCE-0424602]; National Oceanic and Atmospheric Administration's Integrated Ocean Observing System program	Bonneville Power Administration (BPA); National Science Foundation (NSF)(National Science Foundation (NSF)); National Oceanic and Atmospheric Administration's Integrated Ocean Observing System program	This work was supported by the Bonneville Power Administration (BPA Contract No. 00053808 to Oregon State University and No. 00052946/00059479 to Oregon Health and Science University). The Virtual Columbia River is also partially supported by the National Science Foundation (NSF) (OCE-0424602) and the National Oceanic and Atmospheric Administration's Integrated Ocean Observing System program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achord S, 2011, MONITORING MIGRATION, P123; Achord Stephen, 1996, North American Journal of Fisheries Management, V16, P302, DOI 10.1577/1548-8675(1996)016<0302:UOPITP>2.3.CO;2; Anderson D. R., 2008, MODEL BASED INFERENC; ANDERSON J T, 1988, Journal of Northwest Atlantic Fishery Science, V8, P55; Anderson PJ, 1999, MAR ECOL PROG SER, V189, P117, DOI 10.3354/meps189117; Bailey KM, 2000, MAR ECOL PROG SER, V198, P215, DOI 10.3354/meps198215; Barnett-Johnson R, 2010, ENVIRON BIOL FISH, V89, P533, DOI 10.1007/s10641-010-9662-5; Beamish RJ, 2001, PROG OCEANOGR, V49, P423, DOI 10.1016/S0079-6611(01)00034-9; Botsford LW, 2001, ICES J MAR SCI, V58, P1081, DOI 10.1006/jmsc.2001.1085; Budy P, 2002, N AM J FISH MANAGE, V22, P35, DOI 10.1577/1548-8675(2002)022&lt;0035:ELDMOS&gt;2.0.CO;2; Burke BJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054134; Burla M, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2008JC004964; Checkley DM, 2009, PROG OCEANOGR, V83, P49, DOI 10.1016/j.pocean.2009.07.028; Checkley DMJ, 1988, SCIENCE, V335, P356; CURY P, 1989, CAN J FISH AQUAT SCI, V46, P670, DOI 10.1139/f89-086; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Cushing DH, 1975, MARINE ECOLOGY FISHE; DiLorenzo E, 2008, GEOPHYS RES LETT, V35, P6; Elsdon TS, 2003, MAR ECOL PROG SER, V260, P263, DOI 10.3354/meps260263; FOGARTY MJ, 1991, TRENDS ECOL EVOL, V6, P241, DOI 10.1016/0169-5347(91)90069-A; Haeseker SL, 2012, T AM FISH SOC, V141, P121, DOI 10.1080/00028487.2011.652009; Hare SR, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:IPR>2.0.CO;2; Hare SR, 2000, PROG OCEANOGR, V47, P103, DOI 10.1016/S0079-6611(00)00033-1; Healey M.C., 1991, PACIFIC SALMON LIFE, P313; Hickey B, 2005, CONT SHELF RES, V25, P1631, DOI 10.1016/j.csr.2005.04.010; Hooff RC, 2006, LIMNOL OCEANOGR, V51, P2607, DOI 10.4319/lo.2006.51.6.2607; Houde ED, 2008, J NW ATL FISH SCI, V41; Kalinowski S.T., 2007, ONCOR COMPUTER PROGR; Keister JE, 2011, GLOBAL CHANGE BIOL, V17, P2498, DOI 10.1111/j.1365-2486.2010.02383.x; Kent AJR, 2006, AM MINERAL, V91, P1401, DOI 10.2138/am.2006.2030; LASKER R, 1975, FISH B-NOAA, V73, P453; Lawson PW, 2004, CAN J FISH AQUAT SCI, V61, P360, DOI 10.1139/F04-003; Lehodey P, 2006, J CLIMATE, V19, P5009, DOI 10.1175/JCLI3898.1; Logerwell EA, 2003, FISH OCEANOGR, V12, P554, DOI 10.1046/j.1365-2419.2003.00238.x; Mantua NJ, 2002, J OCEANOGR, V58, P35, DOI 10.1023/A:1015820616384; Meekan MG, 2006, MAR ECOL PROG SER, V317, P237, DOI 10.3354/meps317237; Miller JA, 2011, J EXP MAR BIOL ECOL, V405, P42, DOI 10.1016/j.jembe.2011.05.017; Miller JA, 2009, J FISH BIOL, V75, P39, DOI 10.1111/j.1095-8649.2009.02262.x; Miller JA, 2013, CAN J FISH AQUAT SCI, V70, P617, DOI 10.1139/cjfas-2012-0354; Miller JA, 2011, CAN J FISH AQUAT SCI, V68, P603, DOI [10.1139/F11-002, 10.1139/f2011-002]; Miller JA, 2010, MAR ECOL PROG SER, V408, P227, DOI 10.3354/meps08613; Morgan CA, 2003, MAR ECOL PROG SER, V249, P223, DOI 10.3354/meps249223; Myers J, 1998, NOAA TECH MEMO, P443; NEILSON JD, 1982, CAN J FISH AQUAT SCI, V39, P1340, DOI 10.1139/f82-180; Pearcy W. G., 1992, OCEAN ECOLOGY PACIFI; PETERMAN RM, 1987, SCIENCE, V235, P354, DOI 10.1126/science.235.4786.354; PETERMAN RM, 1988, CAN J FISH AQUAT SCI, V45, P8, DOI 10.1139/f88-002; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Prentice E.F., 1990, American Fisheries Society Symposium, P317; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; Rechisky EL, 2013, P NATL ACAD SCI USA, V110, P6883, DOI 10.1073/pnas.1219910110; Rupp DE, 2012, FISH OCEANOGR, V21, P1, DOI 10.1111/j.1365-2419.2011.00605.x; Scheuerell MD, 2009, J APPL ECOL, V46, P983, DOI 10.1111/j.1365-2664.2009.01693.x; Seeb LW, 2007, FISHERIES, V32, P540, DOI 10.1577/1548-8446(2007)32[540:DOASDD]2.0.CO;2; Shanks A, 2010, CAL COOP OCEAN FISH, V51, P106; Sogard SM, 1997, B MAR SCI, V60, P1129; Teel DJ, 2009, T AM FISH SOC, V138, P211, DOI 10.1577/T08-084.1; Tomaro LM, 2012, MAR ECOL PROG SER, V452, P237, DOI 10.3354/meps09620; Tuomikoski J, 2013, COMP SURVIVAL STUDY; Woodson LE, 2013, MAR ECOL PROG SER, V487, P163, DOI 10.3354/meps10353; Zabel RW, 2004, ECOLOGY, V85, P795, DOI 10.1890/02-0719; Zhang YL, 2008, OCEAN MODEL, V21, P71, DOI 10.1016/j.ocemod.2007.11.005; Zhang YL, 2004, CONT SHELF RES, V24, P2187, DOI 10.1016/j.csr.2004.07.021	64	21	22	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99814	10.1371/journal.pone.0099814	http://dx.doi.org/10.1371/journal.pone.0099814			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924741	Green Published, gold			2022-12-27	WOS:000338701300096
J	Sanchez-Fresneda, R; Martinez-Esparza, M; Maicas, S; Arguelles, JC; Valentin, E				Sanchez-Fresneda, Ruth; Martinez-Esparza, Maria; Maicas, Sergi; Argueelles, Juan-Carlos; Valentin, Eulogio			In Candida parapsilosis the ATC1 Gene Encodes for an Acid Trehalase Involved in Trehalose Hydrolysis, Stress Resistance and Virulence	PLOS ONE			English	Article							GALLERIA-MELLONELLA; ATH1 GENE; PROTEIN; DISRUPTION; ALBICANS; EPIDEMIOLOGY; GROWTH; PHOSPHORYLASE; EVOLUTIONARY; PREDICTION	An ORF named CPAR2-208980 on contig 005809 was identified by screening a Candida parapsilosis genome data base. Its 67% identity with the acid trehalase sequence from C. albicans (ATC1) led us to designate it CpATC1. Homozygous mutants that lack acid trehalase activity were constructed by gene disruption at the two CpATC1 chromosomal alleles. Phenotypic characterization showed that atc1 Delta null cells were unable to grow on exogenous trehalose as carbon source, and also displayed higher resistance to environmental challenges, such as saline exposure (1.2 M NaCl), heat shock (42 degrees C) and both mild and severe oxidative stress (5 and 50 mM H2O2). Significant amounts of intracellular trehalose were specifically stored in response to the thermal upshift in both wild type and mutant strains. Analysis of their antioxidant activities revealed that catalase was only triggered in response to heat shock in atc1 Delta cells, whereas glutathione reductase was activated upon mild oxidative stress in wild type and reintegrant strains, and in response to the whole set of stress treatments in the homozygous mutant. Furthermore, yeast cells with double CpATC1 deletion were significantly attenuated in non-mammalian infection models, suggesting that CpATC1 is required for the pathobiology of the fungus. Our results demonstrate the involvement of CpAtc1 protein in the physiological hydrolysis of external trehalose in C. parapsilosis, where it also plays a major role in stress resistance and virulence.	[Sanchez-Fresneda, Ruth; Argueelles, Juan-Carlos] Univ Murcia, Fac Biol, Dept Genet & Microbiol, Murcia, Spain; [Sanchez-Fresneda, Ruth; Martinez-Esparza, Maria] Univ Murcia, Fac Med, Dept Bioquim Biol Mol & Inmunol B, Murcia, Spain; [Sanchez-Fresneda, Ruth; Martinez-Esparza, Maria] Univ Murcia, Murcia, Spain; [Sanchez-Fresneda, Ruth; Valentin, Eulogio] Univ Valencia, Fac Farm, Dept Microbiol & Ecol, E-46010 Valencia, Spain; [Maicas, Sergi] Univ Valencia, Fac Biol, Dept Microbiol & Ecol, Valencia, Spain	University of Murcia; University of Murcia; University of Murcia; University of Valencia; University of Valencia	Arguelles, JC (corresponding author), Univ Murcia, Fac Biol, Dept Genet & Microbiol, Campus Espinardo, Murcia, Spain.	arguelle@um.es	Sanchez-Fresneda, Ruth/ABF-7327-2020; Maicas, Sergi/L-7462-2014; Valentin, Eulogio/K-1436-2017; Martínez-Esparza, María/R-9646-2019; Maicas, Sergi/J-6563-2019	Maicas, Sergi/0000-0003-4360-611X; Valentin, Eulogio/0000-0002-7895-9460; Martínez-Esparza, María/0000-0001-5765-8231; 	Ministerio de Economia y Competitividad, ISCIII, Spain [PI12/01797]; Cespa Servicios Urbanos de Murcia, S.A	Ministerio de Economia y Competitividad, ISCIII, Spain; Cespa Servicios Urbanos de Murcia, S.A	The experimental work has been supported by grant PI12/01797 (Ministerio de Economia y Competitividad, ISCIII, Spain). The authors are also indebted to the financial contract provided by Cespa Servicios Urbanos de Murcia, S.A. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott DW, 2007, J MOL BIOL, V367, P1023, DOI 10.1016/j.jmb.2007.01.030; Al-Bader N, 2010, INFECT IMMUN, V78, P3007, DOI 10.1128/IAI.00813-09; ALESHIN AE, 1994, J MOL BIOL, V238, P575, DOI 10.1006/jmbi.1994.1316; Alizadeh P, 1996, FEBS LETT, V391, P273, DOI 10.1016/0014-5793(96)00751-X; Almirante B, 2006, J CLIN MICROBIOL, V44, P1681, DOI 10.1128/JCM.44.5.1681-1685.2006; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1996, BIOCH MOL BIOL BERLI; ARGUELLES JC, 1988, A VAN LEEUW J MICROB, V54, P555, DOI 10.1007/BF00588391; Arguelles JC, 2000, ARCH MICROBIOL, V174, P217, DOI 10.1007/s002030000192; Bates PA, 2001, PROTEINS, P39; Bolam DN, 1998, BIOCHEM J, V331, P775, DOI 10.1042/bj3310775; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brennan M, 2002, FEMS IMMUNOL MED MIC, V34, P153, DOI 10.1111/j.1574-695X.2002.tb00617.x; Burke D., 2000, METHODS YEAST GENETI; Castillo L, 2006, FUNGAL GENET BIOL, V43, P124, DOI 10.1016/j.fgb.2005.12.002; Mesa-Arango AC, 2013, MED MYCOL, V51, P461, DOI 10.3109/13693786.2012.737031; Cheema MS, 2011, MED MYCOL, V49, P202, DOI 10.3109/13693786.2010.512301; de Groot PWJ, 2012, FUNGAL GENET BIOL, V49, P173, DOI 10.1016/j.fgb.2011.12.009; dEnfert C, 1997, MOL MICROBIOL, V24, P203, DOI 10.1046/j.1365-2958.1997.3131693.x; Ding C, 2007, EUKARYOT CELL, V6, P1310, DOI 10.1128/EC.00136-07; Egloff MP, 2001, STRUCTURE, V9, P689, DOI 10.1016/S0969-2126(01)00626-8; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Estruch F, 2000, FEMS MICROBIOL REV, V24, P469, DOI 10.1016/S0168-6445(00)00035-8; Fallon AM, 2001, INSECT BIOCHEM MOLEC, V31, P263, DOI 10.1016/S0965-1748(00)00146-6; Fallon John, 2012, Methods Mol Biol, V845, P469, DOI 10.1007/978-1-61779-539-8_33; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; FUJIMURA HA, 1993, BIOTECHNIQUES, V14, P538; Garcia-Rodas R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024485; Gibson RP, 2007, ANGEW CHEM INT EDIT, V46, P4115, DOI 10.1002/anie.200604825; Gonzalez-Parraga P, 2003, YEAST, V20, P1161, DOI 10.1002/yea.1029; Gonzalez-Parraga P, 2011, BBA-GEN SUBJECTS, V1810, P777, DOI 10.1016/j.bbagen.2011.04.012; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; Hernandez J, 1999, NEW PHYTOL, V141, P241, DOI 10.1046/j.1469-8137.1999.00341.x; Hidaka M, 2004, STRUCTURE, V12, P937, DOI 10.1016/j.str.2004.03.027; Hoffmann JA, 1999, SCIENCE, V284, P1313, DOI 10.1126/science.284.5418.1313; Ishihara R, 1997, GENE, V202, P69, DOI 10.1016/S0378-1119(97)00455-1; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Kim J, 1996, APPL ENVIRON MICROB, V62, P1563, DOI 10.1128/AEM.62.5.1563-1569.1996; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Lobaina Rodriguez Tamara, 2010, Rev Cubana Med Trop, V62, P48; Lupetti A, 2002, J CLIN MICROBIOL, V40, P2363, DOI 10.1128/JCM.40.7.2363-2369.2002; Martinez-Esparza M, 2007, CLIN MICROBIOL INFEC, V13, P384, DOI 10.1111/j.1469-0691.2007.01663.x; Martinez-Esparza M, 2009, INT J MED MICROBIOL, V299, P453, DOI 10.1016/j.ijmm.2008.12.001; Nwaka S, 1996, FEBS LETT, V386, P235, DOI 10.1016/0014-5793(96)00450-4; Parrou JL, 2005, FEMS YEAST RES, V5, P503, DOI 10.1016/j.femsyr.2005.01.002; Pedreno Y, 2004, J BIOL CHEM, V279, P40852, DOI 10.1074/jbc.M400216200; Pedreno Y, 2007, MICROBIOL-SGM, V153, P1372, DOI 10.1099/mic.0.2006/003921-0; Pfaller MA, 2010, CRIT REV MICROBIOL, V36, P1, DOI 10.3109/10408410903241444; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; Romani L, 1999, CURR OPIN MICROBIOL, V2, P363, DOI 10.1016/S1369-5274(99)80064-2; Sakon J, 1997, NAT STRUCT BIOL, V4, P810, DOI 10.1038/nsb1097-810; Stam MR, 2005, CARBOHYD RES, V340, P2728, DOI 10.1016/j.carres.2005.09.018; Trofa D, 2008, CLIN MICROBIOL REV, V21, P606, DOI 10.1128/CMR.00013-08; van Asbeck EC, 2009, CRIT REV MICROBIOL, V35, P283, DOI 10.3109/10408410903213393; VONHEIJNE G, 1986, NUCLEIC ACIDS RES, V14, P4683, DOI 10.1093/nar/14.11.4683; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; WEEMS JJ, 1992, CLIN INFECT DIS, V14, P756, DOI 10.1093/clinids/14.3.756; Zaragoza O, 1998, J BACTERIOL, V180, P3809, DOI 10.1128/JB.180.15.3809-3815.1998; Zaragoza O, 2002, MICROBIOL-SGM, V148, P1281, DOI 10.1099/00221287-148-5-1281	61	27	28	0	113	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99113	10.1371/journal.pone.0099113	http://dx.doi.org/10.1371/journal.pone.0099113			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922533	gold, Green Published, Green Submitted			2022-12-27	WOS:000338701300031
J	Wang, RH; Xu, S; Liu, XY; Zhang, YY; Wang, JZ; Zhang, ZX				Wang, Ruohan; Xu, Sai; Liu, Xiangyu; Zhang, Yiyuan; Wang, Jianzhong; Zhang, Zhixiang			Thermogenesis, Flowering and the Association with Variation in Floral Odour Attractants in Magnolia sprengeri (Magnoliaceae)	PLOS ONE			English	Article							TEMPERATURE REGULATION; POLLINATION ECOLOGY; BEETLE POLLINATION; AFRICAN CYCAD; HEAT; BIOLOGY; CONES; RESPIRATION; PRECISION; RESPONSES	Magnolia sprengeri Pamp. is an ornamentally and ecologically important tree that blooms at cold temperatures in early spring. In this study, thermogenesis and variation in the chemical compounds of floral odours and insect visitation in relation to flowering cycles were studied to increase our understanding of the role of floral thermogenesis in the pollination biology of M. sprengeri. There were five distinct floral stages across the floral cycle of this species: pre-pistillate, pistillate, pre-staminate, staminate and post-staminate. Floral thermogenesis during anthesis and consisted of two distinct peaks: one at the pistillate stage and the other at the staminate stage. Insects of five families visited M. sprengeri during the floral cycle, and sap beetles (Epuraea sp., Nitidulidae) were determined to be the most effective pollinators, whereas bees (Apis cerana, Apidae) were considered to be occasional pollinators. A strong fragrance was released during thermogenesis, consisting of 18 chemical compounds. Although the relative proportions of these compounds varied at different floral stages across anthesis, linalool, 1-iodo-2-methylundecane and 2,2,6-trimethyl-6-vinyltetrahydro-2H-pyran-3-ol were dominant. Importantly, we found that the floral blends released during the pistillate and staminate stages were very similar, and coincided with flower visitation by sap beetles and the two thermogenic episodes. Based on these results, we propose that odour acts as a signal for a reward (pollen) and that an odour mimicry of staminate-stage flowers occurs during the pistillate stage.	[Wang, Ruohan; Xu, Sai; Zhang, Yiyuan; Wang, Jianzhong] Beijing Forestry Univ, Coll Biol Sci & Biotechnol, Key Lab Genet & Breeding Forest Trees & Ornamenta, Natl Engn Lab Tree Breeding,Minist Educ, Beijing, Peoples R China; [Liu, Xiangyu; Zhang, Zhixiang] Beijing Forestry Univ, Coll Nat Conservat, Lab Systemat Evolut & Biogeog Woody Plants, Beijing, Peoples R China; [Xu, Sai] Tsinghua Univ, Sch Environm, Beijing 100084, Peoples R China	Beijing Forestry University; Beijing Forestry University; Tsinghua University	Zhang, ZX (corresponding author), Beijing Forestry Univ, Coll Nat Conservat, Lab Systemat Evolut & Biogeog Woody Plants, Beijing, Peoples R China.	zxzhang@bjfu.edu.cn	Xu, Sai/L-9259-2016	Xu, Sai/0000-0002-5395-4903	Fundamental Research Funds for Central Universities [YX 2014-14]; National Science Fund of China [31100450, J1103516]	Fundamental Research Funds for Central Universities(Fundamental Research Funds for the Central Universities); National Science Fund of China(National Natural Science Foundation of China (NSFC))	This work was supported by the Fundamental Research Funds for Central Universities (No. YX 2014-14) and the National Science Fund of China (No. 31100450 & No. J1103516). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albre J, 2003, BOT J LINN SOC, V141, P205, DOI 10.1046/j.1095-8339.2003.00139.x; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; Azuma Hiroshi, 1997, Plant Species Biology, V12, P69, DOI 10.1111/j.1442-1984.1997.tb00159.x; Azuma Hiroshi, 1999, Plant Species Biology, V14, P121, DOI 10.1046/j.1442-1984.1999.00015.x; Dieringer G, 1999, INT J PLANT SCI, V160, P64, DOI 10.1086/314099; Endress P. K., 1994, DIVERSITY EVOLUTIONA; Endress PK, 2010, PHILOS T R SOC B, V365, P411, DOI 10.1098/rstb.2009.0228; Ervik Finn, 1999, Acta Botanica Venezuelica, V22, P195; Gottsberger G, 2012, FLORA, V207, P107, DOI 10.1016/j.flora.2011.11.003; Ishida Kiyoshi, 1996, Plant Species Biology, V11, P199, DOI 10.1111/j.1442-1984.1996.tb00146.x; Kang YX, 2011, PLANT BIOSYST, V145, P906, DOI 10.1080/11263504.2011.633352; KIKUZAWA K, 1990, Plant Species Biology, V5, P255, DOI 10.1111/j.1442-1984.1990.tb00185.x; KNUTSON RM, 1974, SCIENCE, V186, P746, DOI 10.1126/science.186.4165.746; Kuchmeister Heike, 1998, Acta Amazonica, V28, P217; Kumano-Nomura Y, 2009, J PLANT RES, V122, P183, DOI 10.1007/s10265-008-0204-6; Lamprecht I, 2002, THERMOCHIM ACTA, V391, P107, DOI 10.1016/S0040-6031(02)00168-5; Li JK, 2009, ANN BOT-LONDON, V103, P1159, DOI 10.1093/aob/mcp051; Meeuse B. J. D., 1988, Sexual Plant Reproduction, V1, P3, DOI 10.1007/BF00227016; NADEL H, 1994, ENVIRON ENTOMOL, V23, P878, DOI 10.1093/ee/23.4.878; Proches S, 2009, AM J BOT, V96, P1722, DOI 10.3732/ajb.0800377; R Development Core Team, 2012, R LANG ENV STAT COMP; Raguso RA, 2008, ANNU REV ECOL EVOL S, V39, P549, DOI 10.1146/annurev.ecolsys.38.091206.095601; Sapir Y, 2006, OECOLOGIA, V147, P53, DOI 10.1007/s00442-005-0246-6; Seymour RS, 2008, J EXP BOT, V59, P1353, DOI 10.1093/jxb/ern042; Seymour RS, 2010, FUNCT PLANT BIOL, V37, P870, DOI 10.1071/FP10039; Seymour RS, 2010, PLANTA, V231, P1291, DOI 10.1007/s00425-010-1128-7; Seymour RS, 2009, ANN BOT-LONDON, V104, P823, DOI 10.1093/aob/mcp168; Seymour RS, 2009, BIOL LETTERS, V5, P568, DOI 10.1098/rsbl.2009.0064; Seymour RS, 2000, AQUAT BOT, V67, P155, DOI 10.1016/S0304-3770(00)00087-5; Seymour RS, 2004, PLANT CELL ENVIRON, V27, P1014, DOI 10.1111/j.1365-3040.2004.01206.x; Seymour RS, 2003, NATURE, V426, P243, DOI 10.1038/426243a; Suinyuy TN, 2013, ANN BOT-LONDON, V112, P891, DOI 10.1093/aob/mct159; Takacs S, 2009, P ROY SOC B-BIOL SCI, V276, P649, DOI 10.1098/rspb.2008.0742; Terry I, 2007, SCIENCE, V318, P70, DOI 10.1126/science.1145147; THIEN LB, 1974, AM J BOT, V61, P1037, DOI 10.2307/2441921; Thien LB, 2000, INT J PLANT SCI, V161, pS225, DOI 10.1086/317575; Tomimatsu Hiroshi, 2003, Plant Species Biology, V18, P123, DOI 10.1111/j.1442-1984.2003.00090.doc.x; Wagner AM, 2008, BBA-BIOENERGETICS, V1777, P993, DOI 10.1016/j.bbabio.2008.04.001; Wang RH, 2013, TREES-STRUCT FUNCT, V27, P1755, DOI 10.1007/s00468-013-0921-x; Wang RH, 2010, FLORA, V205, P259, DOI 10.1016/j.flora.2009.04.003; Xia NH, 2008, FLORA CHINA, P48; Yasukawa S, 1992, PLANT SPEC BIOL, V7, P121	42	17	21	2	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99356	10.1371/journal.pone.0099356	http://dx.doi.org/10.1371/journal.pone.0099356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922537	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300052
J	Hayashi, K; Iwata, S; Ogose, A; Kawai, A; Ueda, T; Otsuka, T; Tsuchiya, H				Hayashi, Katsuhiro; Iwata, Shintaro; Ogose, Akira; Kawai, Akira; Ueda, Takafumi; Otsuka, Takanobu; Tsuchiya, Hiroyuki			Factors that Influence Functional Outcome after Total or Subtotal Scapulectomy: Japanese Musculoskeletal Oncology Group (JMOG) Study	PLOS ONE			English	Article							SHOULDER-GIRDLE; ALLOGRAFT RECONSTRUCTION; SURGICAL CLASSIFICATION; MALIGNANT-TUMORS; SCAPULAR TUMORS; RESECTION; PROSTHESIS; SARCOMA; SYSTEM; BONE	Background: Scapulectomy requires not only joint resection but also wide resection of the shoulder girdle muscles. Even the significance of reconstruction has not yet been determined because of the difficulties in comparing the different conditions. The purpose of this study was to investigate factors that influence functional outcomes after scapulectomy in a multicenter study. Methods: This retrospective study comprised 48 patients who underwent total or subtotal scapulectomy and were followed for at least one year after surgery. Patients were registered at the Japanese Musculoskeletal Oncology Group affiliated hospitals. Soft tissue reconstruction for joint stabilization was performed when there was enough remaining tissue for reconstruction of the rotator cuff and tendons. In 23 cases, humeral suspension was performed. The average follow-up period was 61.9 months. Multivariate analysis was performed using the patient's background to determine which factors influence the Enneking functional score or active range of motion. Results: The average functional score was 21.1 out of 30. Active shoulder range of motion was 42.7 degree in flexion, 39.7 degree in abduction, 49.6 degree of internal rotation and 16.8 degree of external rotation. The amount of remaining bone influenced functional outcome, which means that preserving the glenoid or the acromion lead to better function compared to total scapulectomy (p<0.01). Factors that influenced each functional measure include the amount of remaining bone, soft tissue reconstruction, the length of the resected humerus and nerve resection (p<0.05). Conclusion: Although shoulder function was almost eliminated following total or subtotal scapulectomy, minimal resection of bone, and soft tissue reconstruction should lead to better function.	[Hayashi, Katsuhiro; Tsuchiya, Hiroyuki] Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan; [Iwata, Shintaro] Chiba Canc Ctr, Div Orthoped Surg, Chiba 2608717, Japan; [Ogose, Akira] Niigata Univ, Grad Sch Med & Dent Sci, Div Orthoped Surg, Niigata, Japan; [Kawai, Akira] Natl Canc Ctr Hosp, Dept Orthopaed Surg, Kashiwa, Chiba, Japan; [Ueda, Takafumi] Osaka Natl Hosp, Dept Orthopaed Surg, Osaka, Japan; [Hayashi, Katsuhiro; Otsuka, Takanobu] Nagoya City Univ, Sch Med, Dept Orthopaed Surg, Nagoya, Aichi 467, Japan	Kanazawa University; Chiba Cancer Center; Niigata University; National Cancer Center - Japan; Osaka National Hospital; Nagoya City University	Hayashi, K (corresponding author), Kanazawa Univ, Grad Sch Med Sci, Dept Orthopaed Surg, Kanazawa, Ishikawa, Japan.	hayashikatsu830@aol.com	Hayashi, K/C-4685-2015	Hayashi, K/0000-0001-8665-2154	Grants-in-Aid for Scientific Research [26293333] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Cleeman E, 2013, J SHOULDER ELB SURG, V14, P460; COELLO AJ, 1947, BRIT J TUBERC DIS CH, V41, P75, DOI 10.1016/S0366-0869(47)80032-2; De Nancrede CBG, 1909, ANN SURG, V50, P1, DOI 10.1097/00000658-190907000-00001; ENNEKING WF, 1993, CLIN ORTHOP RELAT R, P241; Griffin AM, 2008, ANN SURG ONCOL, V15, P2250, DOI 10.1245/s10434-008-9975-1; Hayashi K, 2011, INT J CLIN ONCOL, V16, P568, DOI 10.1007/s10147-011-0229-z; Kiss J, J SHOULDER ELBOW SUR, V16, P273; Linberg BE, 1999, CLIN ORTHOP RELAT R, P3; MALAWER MM, 1991, CLIN ORTHOP RELAT R, P33; MALAWER MM, 1991, ORTHOP CLIN N AM, V22, P7; Masamed R, 2008, AM J ROENTGENOL, V191, P482, DOI 10.2214/AJR.07.3286; Mavrogenis AF, 2009, J SURG ONCOL, V100, P611, DOI 10.1002/jso.21340; Mnaymneh WA, 2002, CLIN ORTHOP RELAT R, P223, DOI 10.1097/01.blo.0000030510.43495.e6; Pritsch T, 2007, CLIN ORTHOP RELAT R, P188, DOI 10.1097/01.blo.0000238840.26423.b6; Syme J, 1864, EXCISION SCAPULA; Tang XD, 2011, J SHOULDER ELB SURG, V20, P1163, DOI 10.1016/j.jse.2010.12.014; Tanzawa Y, 2009, J ORTHOP SCI, V14, P761, DOI 10.1007/s00776-009-1392-1; Vahanan NM, 2007, INT ORTHOP, V31, P831, DOI 10.1007/s00264-006-0261-1; Villalobos CE, 2009, ANN SURG ONCOL, V16, P2321, DOI 10.1245/s10434-009-0522-5; Watanabe K, 2013, J ORTHOP SCI, V18, P101, DOI 10.1007/s00776-012-0327-4; Wittig JC, 2002, CLIN ORTHOP RELAT R, P143; Zhang KW, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-45	22	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100119	10.1371/journal.pone.0100119	http://dx.doi.org/10.1371/journal.pone.0100119			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937254	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400079
J	Yi, B; Hu, XF; Zhang, H; Huang, J; Liu, JS; Hu, J; Li, W; Huang, LH				Yi, Bin; Hu, Xiaofang; Zhang, Hao; Huang, Jing; Liu, Jishi; Hu, Jing; Li, Wei; Huang, Lihua			Nuclear NF-kappa B p65 in Peripheral Blood Mononuclear Cells Correlates with Urinary MCP-1, RANTES and the Severity of Type 2 Diabetic Nephropathy	PLOS ONE			English	Article							OXIDATIVE-STRESS; INFLAMMATION; ACTIVATION	Aims: To investigate if nuclear NF-kappa B p65 expression in ex vivo isolated peripheral blood mononuclear cells correlates with urinary MCP-1 or RANTES and the severity of type 2 diabetic nephropathy. Methods: According to their urinary albumin-to-creatinine ratio (uACR), 107 patients with type 2 diabetes (eGFR >60 ml/min) were divided into normal albuminuria group (DN0 group, 38 cases), microalbuminuria group (DN1 group, 38 cases), and macroalbuminuria group (DN2 group, 31 cases), compared with matched healthy normal control group (NC group, 30 cases). Nuclear NF-kappa B p65 protein expression levels in peripheral blood mononuclear cells were detected by western blotting. Real-time quantitative polymerase chain reaction was used to detect NF-kappa B p65 mRNA expression and ELISA assay was used to detect the levels of urinary MCP-1 and RANTES. Results: Nuclear NF-kappa B p65 protein and NF-kappa B p65 mRNA expression levels in peripheral blood mononuclear cells, urinary MCP-1/Cr and RANTES/Cr were all significantly higher in all diabetes groups as compared with NC group. In particular, the increase of nuclear NF-kappa B p65 protein and NF-kappa B p65 mRNA expressions, urinary MCP-1/Cr and RANTES/Cr all correlated with the severity of type 2 diabetic nephropathy as indicated by the increase in uACR. Pearson correlation analysis indicated that both urinary MCP-1/Cr and RANTES/Cr were positively correlated with nuclear NF-kappa B p65 protein or NF-kappa B p65 mRNA levels. Stepwise multiple regression analysis showed that nuclear NF-kappa B p65 protein or NF-kappa B p65 mRNA was an independent variable for urinary MCP-1/Cr, and MCP-1/Cr and RANTES/Cr were two independent variables for uACR. Conclusion: Our research demonstrates that nuclear NF-kappa B p65 protein and mRNA expressions in ex vivo isolated peripheral blood mononuclear cells well correlate with urinary MCP-1/Cr, RANTES/Cr and the severity of type 2 diabetic nephropathy.	[Yi, Bin; Hu, Xiaofang; Zhang, Hao; Huang, Jing; Liu, Jishi; Hu, Jing; Li, Wei] Cent S Univ, Xiangya Hosp 3, Dept Nephrol, Changsha, Hunan, Peoples R China; [Huang, Lihua] Cent S Univ, Xiangya Hosp 3, Ctr Med Expt, Changsha, Hunan, Peoples R China	Central South University; Central South University	Zhang, H (corresponding author), Cent S Univ, Xiangya Hosp 3, Dept Nephrol, Changsha, Hunan, Peoples R China.	zhanghaoliaoqing@163.com			National Natural Science Foundation of China [81100516]; Natural Science Foundation of Hunan Province [13JJ3033]; Scientific and Technological Project of Hunan Province [2011FJ3217]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hunan Province(Natural Science Foundation of Hunan Province); Scientific and Technological Project of Hunan Province	This study was supported by the National Natural Science Foundation of China (NO. 81100516), the Natural Science Foundation of Hunan Province (NO. 13JJ3033), and the Scientific and Technological Project of Hunan Province (NO. 2011FJ3217). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afkarian M, 2013, J AM SOC NEPHROL, V24, P302, DOI 10.1681/ASN.2012070718; Amann B, 2003, DIABETES CARE, V26, P2421, DOI 10.2337/diacare.26.8.2421; Bondar IA, 2008, TERAPEVT ARKH, V80, P52; Chen HM, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-69; Chen Pin, 2012, Zhonghua Nei Ke Za Zhi, V51, P460; Collins Allan J, 2012, Am J Kidney Dis, V59, pe1, DOI 10.1053/j.ajkd.2011.11.015; Dai CS, 2011, J BIOL CHEM, V286, P7052, DOI 10.1074/jbc.M110.174821; Hofmann MA, 1999, DIABETOLOGIA, V42, P222, DOI 10.1007/s001250051142; KIM J, 2013, NATL GEOGR, V224, P8; Levin A, 2007, AM J KIDNEY DIS, V49, pS10, DOI 10.1053/j.ajkd.2006.12.004; Luis-Rodriguez D, 2012, WORLD J DIABETES, V3, P7, DOI 10.4239/wjd.v3.i1.7; Mezzano S, 2004, NEPHROL DIAL TRANSPL, V19, P2505, DOI 10.1093/ndt/gfh207; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Qiu-Yue W, 2009, DIABETES RES CLIN PR, V83, P215, DOI 10.1016/j.diabres.2008.09.048; Ricardo SD, 2008, J CLIN INVEST, V118, P3522, DOI 10.1172/JCI36150; Ruster C, 2008, FRONT BIOSCI-LANDMRK, V13, P944, DOI 10.2741/2734; Takebayashi K, 2006, J CLIN ENDOCR METAB, V91, P2214, DOI 10.1210/jc.2005-1718; Tam FWK, 2009, CYTOKINE, V47, P37, DOI 10.1016/j.cyto.2009.04.001; Tan XY, 2008, J AM SOC NEPHROL, V19, P1741, DOI 10.1681/ASN.2007060666; Wu CC, 2010, CLIN CHIM ACTA, V411, P700, DOI 10.1016/j.cca.2010.01.036; Wu J, 2011, LAB INVEST, V91, P1459, DOI 10.1038/labinvest.2011.93; Zhang Z, 2007, KIDNEY INT, V72, P193, DOI 10.1038/sj.ki.5002296	22	34	42	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99633	10.1371/journal.pone.0099633	http://dx.doi.org/10.1371/journal.pone.0099633			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936866	Green Submitted, Green Published, gold			2022-12-27	WOS:000338503400028
J	Goode, G; Pratap, S; Eltom, SE				Goode, Gennifer; Pratap, Siddharth; Eltom, Sakina E.			Depletion of the Aryl Hydrocarbon Receptor in MDA-MB-231 Human Breast Cancer Cells Altered the Expression of Genes in Key Regulatory Pathways of Cancer	PLOS ONE			English	Article							MAMMARY EPITHELIAL-CELLS; ACTIVATION; OVEREXPRESSION; TRANSCRIPTION; ANGIOGENESIS; LIGAND; SIGNAL; ABCC3; CCL2; P53	The aryl hydrocarbon receptor (AhR), a transcription factor that is best known for its role in mediating the toxic responses elicited by poly aromatic hydrocarbons as well as many other environmental factors; is also involved in breast cancer progression. We previously reported that stable knockdown of AhR decreased the tumorigenic properties of the highly metastatic MDA-MB-231 breast cancer cell line; whereas ectopic overexpression of AhR was sufficient to transform immortalized human mammary epithelial cells to exhibit malignant phenotypes. In the present study we investigated the genes that are differentially regulated by AhR and are controlling cellular processes linked to breast cancer. We used Affymetrix Human GeneChip 1.0-ST whole transcriptome arrays to analyze alterations of gene expression resulting from stable AhR knockdown in the MDA-MB-231 breast cancer cell line. The expression of 144 genes was significantly altered with >= 2.0-fold change and a multiple test corrected p-value <= 0.05, as a result of AhR knockdown. We demonstrate that AhR knockdown alters the expression of several genes known to be linked to cancer. These genes include those involved in tryptophan metabolism (KYNU), cell growth (MUC1 and IL8), cell survival (BIRC3 and BCL3), cell migration and invasion (S100A4 and ABI3), multi-drug resistance (ABCC3) and angiogenesis (VEGFA and CCL2). The identification of the genes and pathways affected by AhR depletion provides new insight into possible molecular events that could explain the reported phenotypic changes. In conclusion AhR knockdown alters the expression of genes known to enhance or inhibit cancer progression; tipping the balance towards a state that counteracts tumor progression.	[Goode, Gennifer; Eltom, Sakina E.] Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA; [Pratap, Siddharth] Meharry Med Coll, Micorarray & Bioinformat Core, Nashville, TN 37208 USA	Meharry Medical College; Meharry Medical College	Eltom, SE (corresponding author), Meharry Med Coll, Dept Biochem & Canc Biol, Nashville, TN 37208 USA.	seltom@mmc.edu		Pratap, Siddharth/0000-0003-2200-0848	NIH [SC1-CA153326, G12-RR003032, G12-MD007586]; NATIONAL CANCER INSTITUTE [SC1CA153326] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [G12RR003032] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007586] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This research was supported by NIH grants SC1-CA153326 and G12-RR003032 (SEE) and G12-MD007586 (SP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson P, 2002, P NATL ACAD SCI USA, V99, P9990, DOI 10.1073/pnas.152706299; Brooks J, 2011, CURR CANCER DRUG TAR, V11, P654, DOI 10.2174/156800911795655967; Callero MA, 2011, INT J BREAST CANCER, V2011, DOI 10.4061/2011/923250; Cerutti JM, 2004, J CLIN INVEST, V113, P1234, DOI 10.1172/JCI200419617; Cogswell PC, 2000, ONCOGENE, V19, P1123, DOI 10.1038/sj.onc.1203412; Dai Y, 2003, MOL PHARMACOL, V64, P1402, DOI 10.1124/mol.64.6.1402; Dale YR, 2006, MOL PHARMACOL, V70, P1481, DOI 10.1124/mol.106.027474; Eguchi H, 1997, J BIOL CHEM, V272, P17640, DOI 10.1074/jbc.272.28.17640; Eltom SE, 2006, P AM ASS CAN RES, V47; Fondevila C, 2004, BRIT J CANCER, V90, P206, DOI 10.1038/sj.bjc.6601455; Gao J, 2009, BIOINFORMATICS, V25, P137, DOI 10.1093/bioinformatics/btn501; Goode GD, 2013, INT J CANCER, V133, P2769, DOI 10.1002/ijc.28297; Hattrup CL, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1515; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ismail TM, 2010, J BIOL CHEM, V285, P914, DOI 10.1074/jbc.M109.010892; Kanno Y, 2007, BIOCHEM BIOPH RES CO, V364, P1026, DOI 10.1016/j.bbrc.2007.10.140; Lee HJ, 2004, J NEUROCHEM, V88, P647, DOI 10.1111/j.1471-4159.2004.02191.x; Li ZH, 2003, BIOCHEMISTRY-US, V42, P14258, DOI 10.1021/bi0354379; Low-Marchelli JM, 2013, CANCER RES, V73, P662, DOI 10.1158/0008-5472.CAN-12-0653; Ma O, 2009, CANCER RES, V69, P2559, DOI 10.1158/0008-5472.CAN-08-2929; Miyazaki K, 2000, BBA-GENE STRUCT EXPR, V1493, P237, DOI 10.1016/S0167-4781(00)00158-5; Moennikes O, 2004, CANCER RES, V64, P4707, DOI 10.1158/0008-5472.CAN-03-0875; Nebert DW, 2004, J BIOL CHEM, V279, P23847, DOI 10.1074/jbc.R400004200; Ning Y, 2012, EXPERT OPIN THER TAR; O'Brien C, 2008, CANCER RES, V68, P5380, DOI 10.1158/0008-5472.CAN-08-0234; Opitz CA, 2011, NATURE, V478, P197, DOI 10.1038/nature10491; Partanen L, 2012, GENE CHROMOSOME CANC, V51, P832, DOI 10.1002/gcc.21967; POLAND A, 1982, ANNU REV PHARMACOL, V22, P517, DOI 10.1146/annurev.pa.22.040182.002505; Salcedo R, 2000, BLOOD, V96, P34, DOI 10.1182/blood.V96.1.34.013a49_34_40; Schlezinger JJ, 2006, BIOL CHEM, V387, P1175, DOI 10.1515/BC.2006.145; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; SWANSON HI, 1993, PHARMACOGENETICS, V3, P213, DOI 10.1097/00008571-199310000-00001; Wong PS, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-234; Xie KP, 2001, CYTOKINE GROWTH F R, V12, P375, DOI 10.1016/S1359-6101(01)00016-8; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	36	18	22	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100103	10.1371/journal.pone.0100103	http://dx.doi.org/10.1371/journal.pone.0100103			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932473	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600095
J	Hall, S; Bourke, P; Guo, K				Hall, Sophie; Bourke, Patrick; Guo, Kun			Low Level Constraints on Dynamic Contour Path Integration	PLOS ONE			English	Article							COLLINEAR FACILITATION; VISUAL SENSITIVITY; LONG-RANGE; COLOR; ORIENTATION; CONTRAST; BRAIN; CELLS; V1; CONFIGURATION	Contour integration is a fundamental visual process. The constraints on integrating discrete contour elements and the associated neural mechanisms have typically been investigated using static contour paths. However, in our dynamic natural environment objects and scenes vary over space and time. With the aim of investigating the parameters affecting spatiotemporal contour path integration, we measured human contrast detection performance of a briefly presented foveal target embedded in dynamic collinear stimulus sequences (comprising five short 'predictor' bars appearing consecutively towards the fovea, followed by the 'target' bar) in four experiments. The data showed that participants' target detection performance was relatively unchanged when individual contour elements were separated by up to 2 degrees spatial gap or 200 ms temporal gap. Randomising the luminance contrast or colour of the predictors, on the other hand, had similar detrimental effect on grouping dynamic contour path and subsequent target detection performance. Randomising the orientation of the predictors reduced target detection performance greater than introducing misalignment relative to the contour path. The results suggest that the visual system integrates dynamic path elements to bias target detection even when the continuity of path is disrupted in terms of spatial (2u), temporal (200 ms), colour (over 10 colours) and luminance (-25% to 25%) information. We discuss how the findings can be largely reconciled within the functioning of V1 horizontal connections.	[Hall, Sophie; Bourke, Patrick; Guo, Kun] Lincoln Univ, Sch Psychol, Lincoln, England	University of Lincoln	Hall, S (corresponding author), Lincoln Univ, Sch Psychol, Lincoln, England.	shall@lincoln.ac.uk	Bourke, Patrick/D-8550-2012	Bourke, Patrick/0000-0002-5957-1073; Hall, Sophie/0000-0002-9847-8269; Guo, Kun/0000-0001-6765-1957				Albright TD, 2002, ANNU REV NEUROSCI, V25, P339, DOI 10.1146/annurev.neuro.25.112701.142900; Altmann CF, 2003, CURR BIOL, V13, P342, DOI 10.1016/S0960-9822(03)00052-6; Angelucci A, 2002, J NEUROSCI, V22, P8633; Bar M, 2007, TRENDS COGN SCI, V11, P280, DOI 10.1016/j.tics.2007.05.005; Beaudot WHA, 2003, VISUAL NEUROSCI, V20, P51, DOI 10.1017/S0952523803201061; Beaudot WHA, 2001, PERCEPTION, V30, P833, DOI 10.1068/p3164; Bonneh Y, 1998, VISION RES, V38, P3541, DOI 10.1016/S0042-6989(98)00045-5; Bosking WH, 1997, J NEUROSCI, V17, P2112; Bours RJE, 2007, J VISION, V7, DOI 10.1167/7.11.8; Cass J, 2006, J VISION, V6, P915, DOI 10.1167/6.9.5; Caywood MS, 2004, J NEUROPHYSIOL, V91, P2859, DOI 10.1152/jn.00775.2003; Chavane F, 2000, J PHYSIOL-PARIS, V94, P333, DOI 10.1016/S0928-4257(00)01096-2; Chen C, 2008, OBES REV, V9, P1, DOI 10.1111/j.1467-789X.2007.00429.x; Dakin SC, 2009, J VISION, V9, DOI 10.1167/9.2.13; DONG DW, 1995, NETWORK-COMP NEURAL, V6, P345, DOI 10.1088/0954-898X/6/3/003; Dong DW, 2001, MOTION VISION, P371; Ellenbogen T, 2006, SPATIAL VISION, V19, P547, DOI 10.1163/156856806779194062; Ernst UA, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002520; FIELD DJ, 1993, VISION RES, V33, P173, DOI 10.1016/0042-6989(93)90156-Q; Friedman HS, 2003, J PHYSIOL-LONDON, V548, P593, DOI 10.1113/jphysiol.2002.033555; Friston KJ, 2005, PHILOS T R SOC B, V360, P815, DOI 10.1098/rstb.2005.1622; Gilad A, 2013, NEURON, V78, P389, DOI 10.1016/j.neuron.2013.02.013; GILBERT CD, 1989, J NEUROSCI, V9, P2432; Gilbert CD, 2007, NEURON, V54, P677, DOI 10.1016/j.neuron.2007.05.019; Guo K, 2004, VISION RES, V44, P2349, DOI 10.1016/j.visres.2004.04.014; Guo K, 2007, EUR J NEUROSCI, V26, P1045, DOI 10.1111/j.1460-9568.2007.05712.x; Hall S, 2010, VISION RES, V50, P2411, DOI 10.1016/j.visres.2010.09.011; Hall SS, 2013, NEUROSCI LETT, V556, P46, DOI 10.1016/j.neulet.2013.09.065; Hess R, 1999, TRENDS COGN SCI, V3, P480, DOI 10.1016/S1364-6613(99)01410-2; Hess RF, 2003, J PHYSIOL-PARIS, V97, P105, DOI 10.1016/j.jphysparis.2003.09.013; Hess RF, 2001, VISION RES, V41, P1023, DOI 10.1016/S0042-6989(01)00020-7; Huang PC, 2007, J VISION, V7, DOI 10.1167/7.11.6; Huang PC, 2008, VISION RES, V48, P2715, DOI 10.1016/j.visres.2008.09.013; Johnson EN, 2001, NAT NEUROSCI, V4, P409, DOI 10.1038/86061; KAPADIA MK, 1995, NEURON, V15, P843, DOI 10.1016/0896-6273(95)90175-2; Knill DC, 2004, TRENDS NEUROSCI, V27, P712, DOI 10.1016/j.tins.2004.10.007; Kovacs I, 1996, BEHAV BRAIN RES, V82, P1, DOI 10.1016/S0166-4328(97)81103-5; KOVACS I, 1993, P NATL ACAD SCI USA, V90, P7495, DOI 10.1073/pnas.90.16.7495; Krekelberg B, 2003, NATURE, V424, P674, DOI 10.1038/nature01852; Kuai S-G, 2010, J VIS, V10, P1164; LEVENTHAL AG, 1995, J NEUROSCI, V15, P1808, DOI 10.1523/JNEUROSCI.15-03-01808.1995; Li W, 2002, J NEUROPHYSIOL, V88, P2846, DOI 10.1152/jn.00289.2002; Li W, 2008, NEURON, V57, P442, DOI 10.1016/j.neuron.2007.12.011; Li W, 2006, NEURON, V50, P951, DOI 10.1016/j.neuron.2006.04.035; Li ZP, 1998, NEURAL COMPUT, V10, P903, DOI 10.1162/089976698300017557; Mullen KT, 2000, VISION RES, V40, P639, DOI 10.1016/S0042-6989(99)00204-7; NELSON JI, 1985, EXP BRAIN RES, V61, P54; Nobrel AC, 2007, CURR OPIN NEUROBIOL, V17, P465, DOI 10.1016/j.conb.2007.07.006; Norton TT, 2002, PSYCHOPHYSICAL MEASU; Paradis A-L, 2012, FRONT HUM NEUROSCI, V6, P1; Polat U, 2006, VISION RES, V46, P953, DOI 10.1016/j.visres.2005.09.031; POLAT U, 1993, VISION RES, V33, P993, DOI 10.1016/0042-6989(93)90081-7; POLAT U, 1994, VISION RES, V34, P73, DOI 10.1016/0042-6989(94)90258-5; Polat U, 1998, NATURE, V391, P580, DOI 10.1038/35372; Polat U, 2009, SPATIAL VISION, V22, P179, DOI 10.1163/156856809787465609; Pollux PMJ, 2011, NEUROSCIENCE, V190, P258, DOI 10.1016/j.neuroscience.2011.05.043; Pollux PMJ, 2009, NEUROREPORT, V20, P525, DOI 10.1097/WNR.0b013e32832770a5; Saarinen J, 2001, VISION RES, V41, P1785, DOI 10.1016/S0042-6989(01)00058-X; Schwartz O, 2007, NAT REV NEUROSCI, V8, P522, DOI 10.1038/nrn2155; Su YR, 2010, VISION RES, V50, P1833, DOI 10.1016/j.visres.2010.06.004; Summerfield C, 2008, NEURON, V59, P336, DOI 10.1016/j.neuron.2008.05.021; Tanaka Y, 1998, VISION RES, V38, P2591, DOI 10.1016/S0042-6989(97)00465-3; TSO DY, 1988, J NEUROSCI, V8, P1712; TSO DY, 1986, J NEUROSCI, V6, P1160; Usher M, 1998, NATURE, V394, P179, DOI 10.1038/28166; Verghese P, 2000, J OPT SOC AM A, V17, P1525, DOI 10.1364/JOSAA.17.001525; Verghese P, 2002, J VISION, V2, P413, DOI 10.1167/2.5.5; Watanabe M, 1996, NATURE, V382, P629, DOI 10.1038/382629a0; Westheimer G, 1997, J NEUROPHYSIOL, V77, P2677, DOI 10.1152/jn.1997.77.5.2677	69	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98268	10.1371/journal.pone.0098268	http://dx.doi.org/10.1371/journal.pone.0098268			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932494	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000337738600008
J	Ye, ZK; Li, C; Zhai, SD				Ye, Zhi-Kang; Li, Can; Zhai, Suo-Di			Guidelines for Therapeutic Drug Monitoring of Vancomycin: A Systematic Review	PLOS ONE			English	Review							SERUM CONCENTRATIONS; INFECTIONS; CONSENSUS; QUALITY; NEED	Background and Objective: Despite the availability of clinical practice guidelines (CPGs) for therapeutic drug monitoring (TDM) of vancomycin, vancomycin serum concentrations still do not reach therapeutic concentrations in many patients. Thus, we sought to systematically review the quality and consistency of recommendations for an international cohort of CPGs regarding vancomycin TDM. Methods: PubMed, Embase, guidelines' websites and Google were searched for CPGs for vancomycin TDM. Two independent assessors rated the quality of each CPG using the Appraisal of Guidelines for Research & Evaluation II (AGREEII) instrument and data were independently extracted. Results: Twelve guidelines were evaluated and the overall quality of guidelines for vancomycin TDM was moderate. The highest score was recorded in the domain of clarity of presentation, and the lowest score was recorded in the domain of rigor of development and stakeholder involvement. The specific recommendations for vancomycin TDM were moderately consistent and guidelines varied in trough concentration monitoring, frequency of TDM, and serum concentration targets. Conclusion: The overall guideline quality for vancomycin TDM was not optimal and effort is needed to improve guideline quality, especially in the domain of rigor of development and stakeholder involvement.	[Ye, Zhi-Kang; Li, Can; Zhai, Suo-Di] Peking Univ, Hosp 3, Dept Pharm, Beijing 100871, Peoples R China; [Ye, Zhi-Kang; Li, Can] Peking Univ, Hlth Sci Ctr, Sch Pharmaceut Sci, Dept Pharm Adm & Clin Pharm, Beijing 100871, Peoples R China	Peking University; Peking University	Zhai, SD (corresponding author), Peking Univ, Hosp 3, Dept Pharm, Beijing 100871, Peoples R China.	zhaisuodi@163.com						Acuna-Izcaray A, 2013, CHEST; Alberta Health Services, 2011, VANC MON DOS GUID; Calderdale and Huddersfield NHS Foundation Trust, 2009, PRESCR GUID INTR VAN; Campbell F, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-47; Cataldo MA, 2012, J ANTIMICROB CHEMOTH, V67, P17, DOI 10.1093/jac/dkr442; Cluzeau F, 1994, Qual Health Care, V3, P121, DOI 10.1136/qshc.3.3.121; Commandeur D, 2011, MED MALADIES INFECT, V41, P410, DOI 10.1016/j.medmal.2011.01.012; De Cock P, 2010, BASIC CLIN PHARM, V107, P250; De Haas E, 2007, J EUR ACAD DERMATOL, V21, P1193, DOI 10.1111/j.1468-3083.2007.02216.x; de Lemos J, 2011, VANCOMYCIN THERAPEUT; Delicourt A, 2012, MED MALADIES INFECT, V42, P167, DOI 10.1016/j.medmal.2012.02.001; Eiland LS, 2011, ANN PHARMACOTHER, V45, P582, DOI 10.1345/aph.1P588; Grilli R, 2000, LANCET, V355, P103, DOI 10.1016/S0140-6736(99)02171-6; Grimshaw J, 1995, Qual Health Care, V4, P55, DOI 10.1136/qshc.4.1.55; Guyatt GH, 2008, BRIT MED J, V336, P924, DOI 10.1136/bmj.39489.470347.AD; Hahn DL, 2009, ANN FAM MED, V7, P364, DOI 10.1370/afm.995; Hochart C, 2011, MED MALADIES INFECT, V41, P652, DOI 10.1016/j.medmal.2011.09.014; Holmer HK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058625; Institute of Medicine, 2011, CLIN PRACTICE GUIDEL; Kendall J, 2010, VANCOMYCIN PRESCRIPT; Khotaei Ghamar Taj, 2010, Acta Med Iran, V48, P91; Li J, 2012, INT J ANTIMICROB AG, V39, P69, DOI 10.1016/j.ijantimicag.2011.08.017; Marengo LL, 2010, BRAZ J INFECT DIS, V14, P203, DOI 10.1590/S1413-86702010000200019; Mariani-Kurkdjian P, 2008, ARCH PEDIATRIE, V15, P1625, DOI 10.1016/j.arcped.2008.08.016; Matsumoto K, 2013, J INFECT CHEMOTHER, V19, P365, DOI 10.1007/s10156-013-0599-4; Royal Devon and Exeter NHS, 2010, GUID INTR IV VANC DO; Royal United Hospitals Bath NHS, 2009, GUID DOS MON GENT VA; Rybak Michael, 2009, Am J Health Syst Pharm, V66, P82, DOI 10.2146/ajhp080434; Scottish Antimicrobial Prescribing Group, 2013, INTR VANC US AD INT; Swartling M, 2012, INT J CLIN PHARM-NET, V34, P282, DOI 10.1007/s11096-012-9614-6; The AGREE Next Steps Consortium, 2009, APPR GUID RES EV; VA Greater Los Angeles Healthcare System, 2013, VANC DOS MON SER VAN; Wilson FP, 2012, CLIN NEPHROL, V77, P329, DOI 10.5414/CN106993; Worcestershire Acute Hosptials NHS, 2008, GUID VANC DOS MON AD; Ye ZK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077169; Zhang ZW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053566	36	65	67	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99044	10.1371/journal.pone.0099044	http://dx.doi.org/10.1371/journal.pone.0099044			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932495	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600019
J	Zhang, YY; Chen, H; Sun, C; Wang, HZ; Liu, ML; Li, YY; Nie, XL; Du, MR; Li, DJ; Zhang, JP				Zhang, Yuan-yuan; Chen, Hui; Sun, Chan; Wang, Hua-zhao; Liu, Mei-lan; Li, Yi-yang; Nie, Xiao-lu; Du, Mei-rong; Li, Da-jin; Zhang, Jian-ping			Expression and Functional Characterization of NOD2 in Decidual Stromal Cells Isolated during the First Trimester of Pregnancy	PLOS ONE			English	Article							MATERNAL-FETAL INTERFACE; INTESTINAL EPITHELIAL-CELLS; TOLL-LIKE RECEPTORS; DENDRITIC CELLS; BACTERIAL PEPTIDOGLYCAN; OLIGOMERIZATION DOMAIN; TROPHOBLAST CELLS; HUMAN-ENDOMETRIUM; HUMAN MONOCYTES; TNF-ALPHA	NOD2, one of the cytosolic proteins that contain a nuclear oligomerization domain (NOD), is a pattern recognition receptor (PRR) involved in innate immune responses to intracellular pathogens. Little is known, however, about the effect of NOD2 expression on the maternal-fetal relationship. Our aim was to elucidate the functions of NOD2 in normal decidual stromal cells (DSCs) from the first trimester. Tissues and DSCs were isolated from 26 patients with normal pregnancies that required abortion. The expression of NOD2 in deciduas/decidual stromal cells (DSCs) was examined by real-time PCR, immunohistochemistry, and In-cell western. DSCs containing NOD2 were stimulated by its ligand, muramyl dipeptide (MDP). The secretion of various cytokines and chemokines were measured by ELISA and the apoptotic rate was determined by flow cytometry. Treatment with MDP significantly elevated the expression of both NOD2 mRNA and protein levels in DSCs. In addition, MDP activation of NOD2 significantly increased IL-1 beta and MCP-1 cytokine expression in a dose dependent manner but had no effect on IL-12 expression. IL-1 beta and TNF-alpha also significantly increased the expression of NOD2 in DSCs, suggesting a positive feedback loop mechanism. Moreover, MDP stimulation augmented DSC apoptosis. In summary, the results suggest that NOD2 expression in DSCs plays an important role in protecting the embryo and preventing infection in the maternal-fetal interface.	[Zhang, Yuan-yuan; Chen, Hui; Wang, Hua-zhao; Liu, Mei-lan; Nie, Xiao-lu; Zhang, Jian-ping] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Obstet & Gynecol, Guangzhou 510275, Guangdong, Peoples R China; [Zhang, Yuan-yuan; Chen, Hui; Wang, Hua-zhao; Liu, Mei-lan; Nie, Xiao-lu; Zhang, Jian-ping] Sun Yat Sen Univ, Key Lab Malignant Tumor Gene Regulat & Target The, Guangdong Higher Educ Inst, Guangzhou 510275, Guangdong, Peoples R China; [Sun, Chan; Du, Mei-rong; Li, Da-jin] Fudan Univ, Shanghai Med Coll, Lab Reprod Immunol Hosp, Shanghai 200433, Peoples R China; [Sun, Chan; Du, Mei-rong; Li, Da-jin] Fudan Univ, Shanghai Med Coll, Inst Obstet & Gynecol, Shanghai 200433, Peoples R China; [Li, Yi-yang] Jilin Univ, Hosp 1, Dept Obstet & Gynecol, Changchun 130023, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Fudan University; Fudan University; Jilin University	Li, DJ (corresponding author), Fudan Univ, Shanghai Med Coll, Lab Reprod Immunol Hosp, Shanghai 200433, Peoples R China.	djli@shmu.edu.cn; zjp2570@126.com			National Nature Science Foundation of China [81000259, 81170625, 81270754, 30973207, 81070746]; Guangdong Natural Science Foundation [S2013010014411, 10151008901000007, 10451008901004246]; Guangdong Province Science and technology plan project [2012B031800352, 2010A030400011-07]; Fundamental Research Funds for the Central Universities [09YKPY73, 12ykpy29]; Research Fund for the Doctoral Program of Higher Education of China [20090171120075]; Sun Yat - sen University 5010 project [2012006]; Sun Yat - sen Memorial Hospital of Sun Yat - sen University Sun Yat - sen talent program [YY002013001]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Guangdong Province Science and technology plan project; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Sun Yat - sen University 5010 project; Sun Yat - sen Memorial Hospital of Sun Yat - sen University Sun Yat - sen talent program	This study was supported partially by National Nature Science Foundation of China (Nos. 81000259, 81170625, 81270754, 30973207 and 81070746), Guangdong Natural Science Foundation (Nos. S2013010014411, 10151008901000007 and 10451008901004246), Guangdong Province Science and technology plan project (No. 2012B031800352, 2010A030400011-07), Fundamental Research Funds for the Central Universities (Youth Program 09YKPY73, 12ykpy29), Research Fund for the Doctoral Program of Higher Education of China (No. 20090171120075), Sun Yat - sen University 5010 project (No. 2012006) and Sun Yat - sen Memorial Hospital of Sun Yat - sen University Sun Yat - sen talent program (YY002013001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahams VM, 2008, IMMUNOL INVEST, V37, P427, DOI 10.1080/08820130802191599; BULMER JN, 1988, REPROD NUTR DEV, V28, P1599, DOI 10.1051/rnd:19881006; Carneiro LAM, 2008, J PATHOL, V214, P136, DOI 10.1002/path.2271; Chamaillard M, 2003, NAT IMMUNOL, V4, P702, DOI 10.1038/ni945; Chaouat G, 2002, J REPROD IMMUNOL, V53, P241, DOI 10.1016/S0165-0378(01)00119-X; Costello MJ, 2007, AM J REPROD IMMUNOL, V57, P67, DOI 10.1111/j.1600-0897.2006.00447.x; Daher S, 2004, J REPROD IMMUNOL, V62, P151, DOI 10.1016/j.jri.2003.10.004; Du MR, 2014, J IMMUNOL, V192, P1502, DOI 10.4049/jimmunol.1203425; Egorina EM, 2006, J THROMB HAEMOST, V4, P614, DOI 10.1111/j.1538-7836.2005.01781.x; Erlebacher A, 2013, ANNU REV IMMUNOL, V31, P387, DOI 10.1146/annurev-immunol-032712-100003; Fritz JH, 2005, EUR J IMMUNOL, V35, P2459, DOI 10.1002/eji.200526286; Gardner L, 2003, BIOL REPROD, V69, P1438, DOI 10.1095/biolreprod.103.017574; Girardin SE, 2003, J BIOL CHEM, V278, P8869, DOI 10.1074/jbc.C200651200; Girardin SE, 2003, SCIENCE, V300, P1584, DOI 10.1126/science.1084677; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Gurevich P, 2007, AM J REPROD IMMUNOL, V58, P460, DOI 10.1111/j.1600-0897.2007.00531.x; Gutierrez O, 2002, J BIOL CHEM, V277, P41701, DOI 10.1074/jbc.M206473200; He YY, 2012, CLIN IMMUNOL, V145, P161, DOI 10.1016/j.clim.2012.07.017; Hess AP, 2007, BIOL REPROD, V76, P102, DOI 10.1095/biolreprod.106.054791; Houser Brandy L., 2012, Yale Journal of Biology and Medicine, V85, P105; Hugot JP, 2001, NATURE, V411, P599, DOI 10.1038/35079107; Kabesch M, 2003, J ALLERGY CLIN IMMUN, V111, P813, DOI 10.1067/mai.2003.1336; KING A, 1989, HUM IMMUNOL, V24, P195, DOI 10.1016/0198-8859(89)90060-8; King AE, 2009, MOL HUM REPROD, V15, P311, DOI 10.1093/molehr/gap020; Krikun G, 2007, HISTOL HISTOPATHOL, V22, P847, DOI 10.14670/HH-22.847; Lamont RF, 2003, HOSP MED, V64, P644, DOI 10.12968/hosp.2003.64.11.2343; Lee KH, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.410027; Meresman GF, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-126; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mitchell JA, 2007, J ENDOCRINOL, V193, P323, DOI 10.1677/JOE-07-0067; Mulla MJ, 2009, AM J REPROD IMMUNOL, V61, P294, DOI 10.1111/j.1600-0897.2009.00694.x; Ogura Y, 2001, J BIOL CHEM, V276, P4812, DOI 10.1074/jbc.M008072200; Oh HM, 2005, CELL IMMUNOL, V237, P37, DOI 10.1016/j.cellimm.2005.09.006; Opitz B, 2005, CIRC RES, V96, P319, DOI 10.1161/01.RES.0000155721.83594.2c; Rosenstiel P, 2003, GASTROENTEROLOGY, V124, P1001, DOI 10.1053/gast.2003.50157; Rull K, 2013, PLACENTA, V34, P141, DOI 10.1016/j.placenta.2012.11.032; Saini V, 2011, CLIN CHIM ACTA, V412, P702, DOI 10.1016/j.cca.2011.01.002; Sanguansermsri D, 2008, ASIAN PAC J ALLERGY, V26, P171; Schatz F, 2012, AM J REPROD IMMUNOL, V68, P146, DOI 10.1111/j.1600-0897.2012.01148.x; Takahashi Y, 2006, J VET MED SCI, V68, P471, DOI 10.1292/jvms.68.471; Uehara A, 2007, J DENT RES, V86, P249, DOI 10.1177/154405910708600310; van Rijn BB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001865; von Dadelszen P, 2002, ACTA OBSTET GYN SCAN, V81, P642, DOI 10.1034/j.1600-0412.2002.810710.x; Wei DH, 2014, EXP THER MED, V7, P191, DOI 10.3892/etm.2013.1399	44	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99612	10.1371/journal.pone.0099612	http://dx.doi.org/10.1371/journal.pone.0099612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932916	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600048
J	Diao, YF; Oqani, RK; Li, XX; Lin, T; Kang, JW; Jin, DI				Diao, Yun Fei; Oqani, Reza K.; Li, Xiao Xia; Lin, Tao; Kang, Jung Won; Jin, Dong Il			Changes in Histone H3 Lysine 36 Methylation in Porcine Oocytes and Preimplantation Embryos	PLOS ONE			English	Article							RNA-POLYMERASE-II; CELL NUCLEAR TRANSFER; CLONED MOUSE EMBRYOS; GENOME-WIDE; TRANSCRIPTIONAL ELONGATION; CHROMATIN MODIFICATIONS; H3K36 METHYLATION; GENE-EXPRESSION; STEM-CELLS; IN-VITRO	Histone H3 lysine 36 (H3K36) methylation is known to be associated with transcriptionally active genes, and is considered a genomic marker of active loci. To investigate the changes in H3K36 methylation in pig, we determined the mono-, di-, and tri-methylations of H3K36 (H3K36me1, H3K36me2 and H3K36me3, respectively) in porcine fetal fibroblasts, oocytes and preimplantation embryos by immunocytochemistry using specific antibodies and confocal microscopy. These analyses revealed that only H3K36me3 in porcine fetal fibroblasts consistently colocalized with transcription sites identified as actively synthesizing RNA based on fluorouridine (FU) incorporation. Treatment of cells with flavopiridol, which blocks transcription elongation, completely abrogated both H3K36me3 signals and RNA synthesis. All three types of H3K36 methylation were present and did not significantly differ during oocyte maturation. In parthenogenetic embryos, H3K36me1 and -me2 were detected in 1-cell through blastocyst-stage embryos. In contrast, H3K36me3 was not detected in most 1-cell stage embryos. H3K36me3 signals became detectable in 2-cell stage embryos, peaked at the 4-cell stage, decreased at the 8-cell stage, and then became undetectable at blastocyst stages in both parthenogenetic and in vitro-fertilized (IVF) embryos. Unlike the case in IVF embryos, H3K36me3 could not be demethylated completely during the 1-cell stage in somatic cell nuclear transfer (SCNT) embryos. These results collectively indicate that H3K36me3, but not H3K36me1 or -me2, is associated with transcription elongation in porcine fetal fibroblasts. H3K36me3 is developmentally regulated and may be a histone mark of embryonic gene activation in pig. Aberrant H3K36 tri-methylation occurred during the nuclear reprogramming of SCNT embryos.	[Diao, Yun Fei; Oqani, Reza K.; Li, Xiao Xia; Lin, Tao; Kang, Jung Won; Jin, Dong Il] Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Res Ctr Transgen Cloned Pigs, Taejon, South Korea	Chungnam National University	Jin, DI (corresponding author), Chungnam Natl Univ, Dept Anim Sci & Biotechnol, Res Ctr Transgen Cloned Pigs, Taejon, South Korea.	dijin@cnu.ac.kr		Lin, Tao/0000-0001-9100-6042	BioGreen 21 Program of the Rural Development Administration [PJ009060]; Bio-industry Technology Development Program of the Ministry for Food and Agriculture, Republic of Korea [IPET312060-5]	BioGreen 21 Program of the Rural Development Administration(Rural Development Administration (RDA), Republic of Korea); Bio-industry Technology Development Program of the Ministry for Food and Agriculture, Republic of Korea	This work was supported by the BioGreen 21 Program of the Rural Development Administration (grant no. PJ009060) and the Bio-industry Technology Development Program (grant no. IPET312060-5) of the Ministry for Food and Agriculture, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARNES FL, 1991, MOL REPROD DEV, V29, P117, DOI 10.1002/mrd.1080290205; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bell O, 2007, EMBO J, V26, P4974, DOI 10.1038/sj.emboj.7601926; Bellier S, 1997, EMBO J, V16, P6250, DOI 10.1093/emboj/16.20.6250; Bjerregaard B, 2007, MOL REPROD DEV, V74, P35, DOI 10.1002/mrd.20594; Boskovic A, 2012, EPIGENETICS-US, V7, P747, DOI 10.4161/epi.20584; Breton A, 2010, J REPROD DEVELOP, V56, P379, DOI 10.1262/jrd.09-182A; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Diao YF, 2013, ANIM REPROD SCI, V141, P164, DOI 10.1016/j.anireprosci.2013.08.008; Dillon N, 2002, TRENDS GENET, V18, P252, DOI 10.1016/S0168-9525(02)02648-3; Edmunds JW, 2008, EMBO J, V27, P406, DOI 10.1038/sj.emboj.7601967; Gerber M, 2003, J BIOL CHEM, V278, P26303, DOI 10.1074/jbc.R300014200; Hamatani T, 2004, DEV CELL, V6, P117, DOI 10.1016/S1534-5807(03)00373-3; Hu M, 2010, P NATL ACAD SCI USA, V107, P2956, DOI 10.1073/pnas.0915033107; Hyttel P, 2000, BIOL REPROD, V63, P1848, DOI 10.1095/biolreprod63.6.1848; Joshi AA, 2005, MOL CELL, V20, P971, DOI 10.1016/j.molcel.2005.11.021; Kanka J, 2003, THERIOGENOLOGY, V59, P3, DOI 10.1016/S0093-691X(02)01267-0; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003; Latham KE, 2001, FRONT BIOSCI, V6, pD748, DOI 10.2741/Latham; Lee JS, 2007, MUTAT RES-FUND MOL M, V618, P130, DOI 10.1016/j.mrfmmm.2006.08.014; Li B, 2007, GENE DEV, V21, P1422, DOI 10.1101/gad.1539307; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Li F, 2013, CELL, V153, P590, DOI 10.1016/j.cell.2013.03.025; Li XX, 2013, THERIOGENOLOGY, V79, P291, DOI 10.1016/j.theriogenology.2012.08.019; Lin CQ, 2011, GENE DEV, V25, P1486, DOI 10.1101/gad.2059211; Luo L, 2009, J CELL SCI, V122, P3729, DOI 10.1242/jcs.052555; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Mason K, 2012, ANIM REPROD SCI, V134, P45, DOI 10.1016/j.anireprosci.2012.08.010; Miao F, 2005, MOL CELL BIOL, V25, P4650, DOI 10.1128/MCB.25.11.4650-4661.2005; Morris SA, 2005, EUKARYOT CELL, V4, P1446, DOI 10.1128/EC.4.8.1446-1454.2005; Ng HH, 2003, MOL CELL, V11, P709, DOI 10.1016/S1097-2765(03)00092-3; Pan GJ, 2007, CELL STEM CELL, V1, P299, DOI 10.1016/j.stem.2007.08.003; Pokholok DK, 2005, CELL, V122, P517, DOI 10.1016/j.cell.2005.06.026; Rao B, 2005, MOL CELL BIOL, V25, P9447, DOI 10.1128/MCB.25.21.9447-9459.2005; Santos F, 2005, DEV BIOL, V280, P225, DOI 10.1016/j.ydbio.2005.01.025; Schneider R, 2004, NAT CELL BIOL, V6, P73, DOI 10.1038/ncb1076; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; SCHULTZ RM, 1993, BIOESSAYS, V15, P531, DOI 10.1002/bies.950150806; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Sims RJ, 2003, TRENDS GENET, V19, P629, DOI 10.1016/j.tig.2003.09.007; Stabell M, 2007, BIOCHEM BIOPH RES CO, V359, P784, DOI 10.1016/j.bbrc.2007.05.189; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Vastenhouw NL, 2010, NATURE, V464, P922, DOI 10.1038/nature08866; Venkatesh S, 2013, WIRES DEV BIOL, V2, P685, DOI 10.1002/wdev.109; Venkatesh S, 2012, NATURE, V489, P452, DOI 10.1038/nature11326; Wang FC, 2007, BIOL REPROD, V77, P1007, DOI 10.1095/biolreprod.107.063149; Wang QT, 2004, DEV CELL, V6, P133, DOI 10.1016/S1534-5807(03)00404-0; Whetstine JR, 2006, CELL, V125, P467, DOI 10.1016/j.cell.2006.03.028; WORRAD DM, 1994, DEVELOPMENT, V120, P2347; Xie SQ, 2006, MOL BIOL CELL, V17, P1723, DOI 10.1091/mbc.E05-08-0726; Yuan W, 2009, J BIOL CHEM, V284, P15701, DOI 10.1074/jbc.M808431200; Zhang M, 2009, J BIOL CHEM, V284, P24981, DOI 10.1074/jbc.M109.011973; Zhang Y, 2001, GENE DEV, V15, P2343, DOI 10.1101/gad.927301; Zhao XD, 2007, CELL STEM CELL, V1, P286, DOI 10.1016/j.stem.2007.08.004	59	12	16	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100205	10.1371/journal.pone.0100205	http://dx.doi.org/10.1371/journal.pone.0100205			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927323	Green Published, Green Submitted, gold			2022-12-27	WOS:000338278100118
J	Carbonetto, B; Rascovan, N; Alvarez, R; Mentaberry, A; Vazquez, MP				Carbonetto, Belen; Rascovan, Nicolas; Alvarez, Roberto; Mentaberry, Alejandro; Vazquez, Martin P.			Structure, Composition and Metagenomic Profile of Soil Microbiomes Associated to Agricultural Land Use and Tillage Systems in Argentine Pampas	PLOS ONE			English	Article							ORGANIC-MATTER; RIBOSOMAL-RNA; NO-TILLAGE; NITROGEN-FERTILIZATION; BACTERIAL COMMUNITIES; REVEALS DIFFERENCES; CARBON; PATTERNS; SUSTAINABILITY; AGGREGATION	Agriculture is facing a major challenge nowadays: to increase crop production for food and energy while preserving ecosystem functioning and soil quality. Argentine Pampas is one of the main world producers of crops and one of the main adopters of conservation agriculture. Changes in soil chemical and physical properties of Pampas soils due to different tillage systems have been deeply studied. Still, not much evidence has been reported on the effects of agricultural practices on Pampas soil microbiomes. The aim of our study was to investigate the effects of agricultural land use on community structure, composition and metabolic profiles on soil microbiomes of Argentine Pampas. We also compared the effects associated to conventional practices with the effects of no-tillage systems. Our results confirmed the impact on microbiome structure and composition due to agricultural practices. The phyla Verrucomicrobia, Plactomycetes, Actinobacteria, and Chloroflexi were more abundant in non cultivated soils while Gemmatimonadetes, Nitrospirae and WS3 were more abundant in cultivated soils. Effects on metabolic metagenomic profiles were also observed. The relative abundance of genes assigned to transcription, protein modification, nucleotide transport and metabolism, wall and membrane biogenesis and intracellular trafficking and secretion were higher in cultivated fertilized soils than in non cultivated soils. We also observed significant differences in microbiome structure and taxonomic composition between soils under conventional and no-tillage systems. Overall, our results suggest that agronomical land use and the type of tillage system have induced microbiomes to shift their life-history strategies. Microbiomes of cultivated fertilized soils (i.e. higher nutrient amendment) presented tendencies to copiotrophy while microbiomes of non cultivated homogenous soils appeared to have a more oligotrophic life-style. Additionally, we propose that conventional tillage systems may promote copiotrophy more than no-tillage systems by decreasing soil organic matter stability and therefore increasing nutrient availability.	[Carbonetto, Belen; Rascovan, Nicolas; Vazquez, Martin P.] Predio CCT Rosario, Inst Agrobiotecnol Rosario INDEAR, Santa Fe, Argentina; [Alvarez, Roberto] Univ Buenos Aires, Fac Agron, Buenos Aires, DF, Argentina; [Mentaberry, Alejandro] Univ Buenos Aires, Fac Ciencias Exactas & Nat, Dept Fisiol & Biol Mol & Celular, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Carbonetto, B (corresponding author), Predio CCT Rosario, Inst Agrobiotecnol Rosario INDEAR, Santa Fe, Argentina.	belen.carbonetto@indear.com; martin.vazquez@indear.com	Rascovan, Nicolás/Q-4531-2018	Rascovan, Nicolás/0000-0002-2129-5878; Carbonetto, Maria Belen/0000-0002-2784-5324	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina [PAE 37164]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina(ANPCyT)	Funding for this work was provided by Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina-PAE 37164. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agaras B, 2012, APPL SOIL ECOL, V61, P305, DOI 10.1016/j.apsoil.2011.11.016; ALVAREZ R, 1995, SOIL TILL RES, V33, P17, DOI 10.1016/0167-1987(94)00432-E; Alvarez R, 2009, SOIL TILL RES, V104, P1, DOI 10.1016/j.still.2009.02.005; Alvarez R, 2001, SOIL USE MANAGE, V17, P62, DOI 10.1111/j.1475-2743.2001.tb00010.x; Aon MA, 2001, APPL SOIL ECOL, V18, P239, DOI 10.1016/S0929-1393(01)00153-6; Apple JK, 2007, ISME J, V1, P729, DOI 10.1038/ismej.2007.86; Attard E, 2010, ENVIRON MICROBIOL, V12, P315, DOI 10.1111/j.1462-2920.2009.02070.x; Balmford A, 2005, GLOBAL CHANGE BIOL, V11, P1594, DOI 10.1111/j.1365-2486.2005.001035.x; Barabote RD, 2009, GENOME RES, V19, P1033, DOI 10.1101/gr.084848.108; Bayer C, 2000, SOIL TILL RES, V54, P101, DOI 10.1016/S0167-1987(00)00090-8; Bennett EM, 2001, BIOSCIENCE, V51, P227, DOI 10.1641/0006-3568(2001)051[0227:HIOEPA]2.0.CO;2; Berhongaray G, 2013, GEODERMA, V192, P97, DOI 10.1016/j.geoderma.2012.07.016; Bernardos JN, 2001, AGR SYST, V69, P215, DOI 10.1016/S0308-521X(01)00027-0; Bongiovanni MD, 2006, GEODERMA, V136, P660, DOI 10.1016/j.geoderma.2006.05.002; Bremner JM., 1965, METHODS SOIL ANAL, V9, P1149; Cai L, 2011, COLD SH Q B, V76, P195, DOI 10.1101/sqb.2011.76.010769; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DeBruyn JM, 2011, APPL ENVIRON MICROB, V77, P6295, DOI 10.1128/AEM.05005-11; Delmont TO, 2012, ISME J, V6, P1677, DOI 10.1038/ismej.2011.197; Deng WD, 2008, MOL BIOL REP, V35, P265, DOI 10.1007/s11033-007-9079-1; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dion P., 2008, MICROBIOLOGY EXTREME; Dixon P, 2003, J VEG SCI, V14, P927, DOI 10.1111/j.1654-1103.2003.tb02228.x; Dong L, 2009, SOIL BIOL BIOCHEM, V41, P1612, DOI 10.1016/j.soilbio.2009.04.023; Doucette CD, 2011, NAT CHEM BIOL, V7, P894, DOI [10.1038/NCHEMBIO.685, 10.1038/nchembio.685]; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Edwards AL, 2010, RNA, V16, P2144, DOI 10.1261/rna.2341610; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Fierer N, 2007, ECOLOGY, V88, P1354, DOI 10.1890/05-1839; Fierer N, 2012, P NATL ACAD SCI USA, V109, P21390, DOI 10.1073/pnas.1215210110; Fierer N, 2013, SCIENCE, V342, P621, DOI 10.1126/science.1243768; Fierer N, 2012, ISME J, V6, P1007, DOI 10.1038/ismej.2011.159; Figuerola ELM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051075; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Foley JA, 2011, NATURE, V478, P337, DOI 10.1038/nature10452; Fortunato CS, 2012, ISME J, V6, P554, DOI 10.1038/ismej.2011.135; Galantini J, 2006, SOIL TILL RES, V87, P72, DOI 10.1016/j.still.2005.02.032; Gee G.W., 1986, METHODS SOIL ANAL PA, P383; Gomez E, 2000, APPL SOIL ECOL, V15, P273, DOI 10.1016/S0929-1393(00)00078-0; Hall A.J., 1992, P413; Hevia GG, 2003, GEODERMA, V116, P265, DOI 10.1016/S0016-7061(03)00104-6; Jiao Y, 2006, GEODERMA, V134, P24, DOI 10.1016/j.geoderma.2005.08.012; Kassam A, 2009, INT J AGR SUSTAIN, V7, P292, DOI 10.3763/ijas.2009.0477; Kim HJ, 2008, P NATL ACAD SCI USA, V105, P18188, DOI 10.1073/pnas.0807935105; Kindt R, 2005, TREE DIVERSITY ANAL; Kuo S., 1996, Methods of soil analysis. Part 3 - chemical methods., P869; LANGDALE GW, 1992, SOIL TECHNOL, V5, P81, DOI 10.1016/0933-3630(92)90009-P; Lauber CL, 2013, ISME J, V7, P1641, DOI 10.1038/ismej.2013.50; Lauro FM, 2009, P NATL ACAD SCI USA, V106, P15527, DOI 10.1073/pnas.0903507106; Lavado RS, 2008, MATERIA ORGANICA VAL, P1; Leonardi R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011107; Loenen WAM, 2006, BIOCHEM SOC T, V34, P330, DOI 10.1042/BST0340330; LOPEZ MF, 1984, CAN J MICROBIOL, V30, P746, DOI 10.1139/m84-114; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Maixner F, 2006, ENVIRON MICROBIOL, V8, P1487, DOI 10.1111/j.1462-2920.2006.01033.x; McInerney MJ, 2009, CURR OPIN BIOTECH, V20, P623, DOI 10.1016/j.copbio.2009.10.001; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Nelson D. W., 1982, Methods of soil analysis. Part 2. Chemical and microbiological properties, P539; Nemergut DR, 2008, ENVIRON MICROBIOL, V10, P3093, DOI 10.1111/j.1462-2920.2008.01735.x; Nievas F, 2012, APPL SOIL ECOL, V53, P74, DOI 10.1016/j.apsoil.2011.11.010; Nudler E, 2004, TRENDS BIOCHEM SCI, V29, P11, DOI 10.1016/j.tibs.2003.11.004; Plaza-Bonilla D, 2013, GEODERMA, V193, P76, DOI 10.1016/j.geoderma.2012.10.022; Power AG, 2010, PHILOS T R SOC B, V365, P2959, DOI 10.1098/rstb.2010.0143; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; Quiroga AR, 1996, SOIL SCI, V161, P104, DOI 10.1097/00010694-199602000-00004; Ramirez KS, 2012, GLOBAL CHANGE BIOL, V18, P1918, DOI 10.1111/j.1365-2486.2012.02639.x; Ramirez KS, 2010, ECOLOGY, V91, P3463, DOI 10.1890/10-0426.1; Rascovan N, 2013, MICROBIOME, V1, DOI 10.1186/2049-2618-1-21; Rhoades J. D., 1996, Methods of soil analysis. Part 3 - chemical methods., P417; Pontes DS, 2007, J IND MICROBIOL BIOT, V34, P463, DOI 10.1007/s10295-007-0219-3; Sanudo-Wilhelmy SA, 2012, P NATL ACAD SCI; Satorre E. H., 1999, Wheat: ecology and physiology of yield determination., P333; Scholes MC, 2013, SCIENCE, V342, P565, DOI 10.1126/science.1244579; Sieber JR, 2012, ANNU REV MICROBIOL, V66, P429, DOI 10.1146/annurev-micro-090110-102844; Slepetiene A, 2005, GEODERMA, V127, P207, DOI 10.1016/j.geoderma.2004.12.001; Sogin ML, 2006, P NATL ACAD SCI USA, V103, P12115, DOI 10.1073/pnas.0605127103; Souza RC, 2013, APPL SOIL ECOL, V72, P49, DOI 10.1016/j.apsoil.2013.05.021; Taylor PG, 2010, NATURE, V464, P1178, DOI 10.1038/nature08985; Tilman D, 2002, NATURE, V418, P671, DOI 10.1038/nature01014; Tilman D, 2011, P NATL ACAD SCI USA, V108, P20260, DOI 10.1073/pnas.1116437108; Tivet F, 2013, GEODERMA, V209, P214, DOI 10.1016/j.geoderma.2013.06.008; Tropis M, 2005, J BIOL CHEM, V280, P26573, DOI 10.1074/jbc.M502104200; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Winkler WC, 2005, ANNU REV MICROBIOL, V59, P487, DOI 10.1146/annurev.micro.59.030804.121336; Yan DL, 2007, P NATL ACAD SCI USA, V104, P9475, DOI 10.1073/pnas.0703360104; Zabaloy MC, 2008, APPL SOIL ECOL, V40, P1, DOI 10.1016/j.apsoil.2008.02.004; Zabaloy MC, 2012, APPL SOIL ECOL, V61, P333, DOI 10.1016/j.apsoil.2011.12.004; Zhang H, 2003, INT J SYST EVOL MICR, V53, P1155, DOI 10.1099/ijs.0.02520-0	90	118	124	5	101	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99949	10.1371/journal.pone.0099949	http://dx.doi.org/10.1371/journal.pone.0099949			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923965	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300109
J	Liu, B; Meng, D; Wei, TT; Zhang, SY; Hu, YX; Wang, M				Liu, Bo; Meng, Di; Wei, Tangting; Zhang, Siyi; Hu, Yanxin; Wang, Ming			Apoptosis and Pro-inflammatory Cytokine Response of Mast Cells Induced by Influenza A Viruses	PLOS ONE			English	Article							HUMAN MACROPHAGES; BCL-2 FAMILY; HOST IMMUNE; INFECTION; PROTEIN; ACTIVATION; CASPASE-1; INDUCTION; SURVIVAL; NECROSIS	The pathogenesis of the influenza A virus has been investigated heavily, and both the inflammatory response and apoptosis have been found to have a definitive role in this process. The results of studies performed by the present and other groups have indicated that mast cells may play a role in the severity of the disease. To further investigate cellular responses to influenza A virus infection, apoptosis and inflammatory response were studied in mouse mastocytoma cell line P815. This is the first study to demonstrate that H1N1 (A/WSN/33), H5N1 (A/Chicken/Henan/1/04), and H7N2 (A/Chicken/Hebei/2/02) influenza viruses can induce mast cell apoptosis. They were found to do this mainly through the mitochondria/cytochrome c-mediated intrinsic pathway, and the activation of caspase 8-mediated extrinsic pathway was here found to be weak. Two pro-apoptotic Bcl-2 homology domain 3 (BH3) -only molecules Bim and Puma appeared to be involved in the apoptotic pathways. When virus-induced apoptosis was inhibited in P815 cells using pan-caspase (Z-VAD-fmk) and caspase-9 (Z-LEHD-fmk) inhibitors, the replication of these three subtypes of viruses was suppressed and the secretions of pro-inflammatory cytokines and chemokines, including IL-6, IL-18, TNF-alpha, and MCP-1, decreased. The results of this study may further understanding of the role of mast cells in host defense and pathogenesis of influenza virus. They may also facilitate the development of novel therapeutic aids against influenza virus infection.	[Liu, Bo; Meng, Di; Wei, Tangting; Zhang, Siyi; Hu, Yanxin; Wang, Ming] China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Zoonosis, Beijing 100094, Peoples R China; [Wang, Ming] China Anim Husb Grp, Zhongmu Inst, Beijing, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Hu, YX (corresponding author), China Agr Univ, Coll Vet Med, Minist Agr, Key Lab Zoonosis, Beijing 100094, Peoples R China.	huyx@cau.edu.cn; vetdean@cau.edu.cn			National Natural Science Foundation of China [31272531]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the National Natural Science Foundation of China (Grant No. 31272531). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham SN, 2010, NAT REV IMMUNOL, V10, P440, DOI 10.1038/nri2782; Alfredsson J, 2005, CELL DEATH DIFFER, V12, P136, DOI 10.1038/sj.cdd.4401537; Balachandran S, 2000, J VIROL, V74, P1513, DOI 10.1128/JVI.74.3.1513-1523.2000; Brincks EL, 2008, HUM IMMUNOL, V69, P634, DOI 10.1016/j.humimm.2008.07.012; Brown MG, 2009, J LEUKOCYTE BIOL, V85, P71, DOI 10.1189/jlb.0308167; Brydon EWA, 2005, FEMS MICROBIOL REV, V29, P837, DOI 10.1016/j.femsre.2004.12.003; Brydon EWA, 2003, J GEN VIROL, V84, P2389, DOI 10.1099/vir.0.18913-0; Chen WS, 2001, NAT MED, V7, P1306, DOI 10.1038/nm1201-1306; Cheung CY, 2002, LANCET, V360, P1831, DOI 10.1016/S0140-6736(02)11772-7; Choi YK, 2006, EXP MOL MED, V38, P11, DOI 10.1038/emm.2006.2; Cilloniz C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000604; Cottey R, 2001, Curr Protoc Immunol, VChapter 19, DOI 10.1002/0471142735.im1911s42; de Jong MD, 2006, NAT MED, V12, P1203, DOI 10.1038/nm1477; Ekoff M, 2007, BLOOD, V110, P3209, DOI 10.1182/blood-2007-02-073957; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Fujimoto I, 1998, CELL DEATH DIFFER, V5, P426, DOI 10.1038/sj.cdd.4400362; Galonek HL, 2006, NAT CELL BIOL, V8, P1317, DOI 10.1038/ncb1206-1317; Graham AC, 2013, J IMMUNOL, V190, P4676, DOI 10.4049/jimmunol.1202096; Halder UC, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.75; Herold S, 2012, J LEUKOCYTE BIOL, V92, P75, DOI 10.1189/jlb.1011530; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hu YX, 2012, J VIROL, V86, P3347, DOI 10.1128/JVI.06053-11; Ito T, 2002, VIRUS RES, V84, P27, DOI 10.1016/S0168-1702(01)00414-2; Kash JC, 2006, NATURE, V443, P578, DOI 10.1038/nature05181; Kurokawa M, 1999, INT J MOL MED, V3, P527; Lam WY, 2008, J VIROL, V82, P2741, DOI 10.1128/JVI.01712-07; Marcet CW, 2013, IMMUNOL RES, V56, P32, DOI 10.1007/s12026-012-8377-4; Marshall JS, 2004, NAT REV IMMUNOL, V4, P787, DOI 10.1038/nri1460; MORI I, 1995, J GEN VIROL, V76, P2869, DOI 10.1099/0022-1317-76-11-2869; Ouyang L, 2012, CELL PROLIFERAT, V45, P487, DOI 10.1111/j.1365-2184.2012.00845.x; Pirhonen J, 2001, EUR J IMMUNOL, V31, P726, DOI 10.1002/1521-4141(200103)31:3<726::AID-IMMU726>3.0.CO;2-5; Pirhonen J, 1999, J IMMUNOL, V162, P7322; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Shelburne CP, 2011, ADV EXP MED BIOL, V716, P162, DOI 10.1007/978-1-4419-9533-9_10; SINKOVICS JG, 1991, ACTA MICROBIOL HUNG, V38, P321; Stasakova J, 2005, J GEN VIROL, V86, P185, DOI 10.1099/vir.0.80422-0; Stray SJ, 2001, VIRUS RES, V77, P3, DOI 10.1016/S0168-1702(01)00260-X; Szegezdi E, 2009, AM J PHYSIOL-CELL PH, V296, pC941, DOI 10.1152/ajpcell.00612.2008; TAKIZAWA T, 1995, VIROLOGY, V209, P288, DOI 10.1006/viro.1995.1260; Technau-Ihling K, 2001, ARCH VIROL, V146, P1655, DOI 10.1007/s007050170054; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; Tumpey TM, 2000, J VIROL, V74, P6105, DOI 10.1128/JVI.74.13.6105-6116.2000; Us D, 2008, MIKROBIYOL BUL, V42, P365; Wurzer WJ, 2003, EMBO J, V22, P2717, DOI 10.1093/emboj/cdg279; Xing Z, 2011, AM J RESP CELL MOL, V44, P24, DOI 10.1165/rcmb.2009-0120OC; Yamada H, 2004, FEBS LETT, V578, P331, DOI 10.1016/j.febslet.2004.11.017; Yang W, 2009, MOL CELL BIOCHEM, V332, P233, DOI 10.1007/s11010-009-0196-0; Yeung TK, 1999, BIOCHEM BIOPH RES CO, V263, P398, DOI 10.1006/bbrc.1999.1375	48	37	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e100109	10.1371/journal.pone.0100109	http://dx.doi.org/10.1371/journal.pone.0100109			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923273	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300122
J	Luchetti, M; Montebarocci, O; Rossi, N; Cutti, AG; Sutin, AR				Luchetti, Martina; Montebarocci, Ornella; Rossi, Nicolino; Cutti, Andrea G.; Sutin, Angelina R.			Autobiographical Memory and Psychological Distress in a Sample of Upper-Limb Amputees	PLOS ONE			English	Article							PSYCHOSOCIAL ADJUSTMENT; POSTTRAUMATIC-STRESS; BREAST-CANCER; TRAUMATIC UPPER; AMPUTATION; DISORDER; PHENOMENOLOGY; PEOPLE; SCALE	Amputation is a traumatic and life-changing event that can take years to adjust to. The present study (a) examines psychological adjustment in a specific trauma-exposed sample, (b) compares the phenomenology (e. g., vividness) of amputation-related memories to more recent memories, and (c) tests whether memory phenomenology is associated with psychological distress. A total of 24 upper-limb amputees recalled two autobiographical memories-an amputation-related memory and a recent memory-and rated the phenomenological qualities of each memory, including Vividness, Coherence, Emotional Intensity, Visual Perspective, and Distancing. Participants also completed self-rated measures of psychological distress and personality. The sample was generally well adjusted; participants showed no relevant symptoms of anxiety and depression, and personality scores were similar to the general population. There were no significant differences in phenomenology between the two types of memories recalled. Even though amputation-related memories were, on average, almost 20 years older than the recent memories, they retained their intense phenomenology. Despite the intensity of the memory, none of the phenomenological dimensions were associated with psychological distress. It is worth to further define which dimensions of phenomenology characterize memories of traumatic events, and their association with individuals' psychological reactions.	[Luchetti, Martina; Montebarocci, Ornella; Rossi, Nicolino] Univ Bologna, Dept Psychol, I-40126 Bologna, Italy; [Cutti, Andrea G.] INAIL, Prosthesis Ctr, Bologna, Italy; [Sutin, Angelina R.] Florida State Univ, Coll Med, Dept Behav Sci & Social Med, Tallahassee, FL 32306 USA	University of Bologna; State University System of Florida; Florida State University	Luchetti, M (corresponding author), Univ Bologna, Dept Psychol, I-40126 Bologna, Italy.	martina.luchetti3@unibo.it	Luchetti, Martina/A-4530-2017; Cutti, Andrea Giovanni/GZM-7387-2022	Luchetti, Martina/0000-0002-7370-8443; MONTEBAROCCI, ORNELLA/0000-0001-5429-1307; ROSSI, NICOLINO CESARE FRANCO/0000-0003-2060-6926				38Singer J. A., 2010, PRAGMATIC CASE STUDI, V6, P134, DOI DOI 10.14713/PCSP.V6I3.1041; Baumgartner RF, 2001, J REHABIL RES DEV, V38, pVII; Brewin CR, 2007, MEMORY, V15, P227, DOI 10.1080/09658210701256423; Cheung E, 2003, REHABIL PSYCHOL, V48, P109, DOI 10.1037/0090-5550.48.2.109; Coffey L, 2009, DIABETIC MED, V26, P1063, DOI 10.1111/j.1464-5491.2009.02802.x; Craft MA, 2013, J ADV NURS, V69, P305, DOI 10.1111/j.1365-2648.2012.06008.x; Crawford JR, 2001, BRIT J CLIN PSYCHOL, V40, P429, DOI 10.1348/014466501163904; Datta D, 2004, CLIN REHABIL, V18, P172, DOI 10.1191/0269215504cr716oa; Dekel S, 2013, PSYCHOL TRAUMA-US, V5, P26, DOI 10.1037/a0022750; Desmond DM, 2007, J PSYCHOSOM RES, V62, P15, DOI 10.1016/j.jpsychores.2006.07.027; Desmond DM, 2006, J PAIN SYMPTOM MANAG, V31, P362, DOI 10.1016/j.jpainsymman.2005.08.014; Fossati A, 2011, EUR J PSYCHOL ASSESS, V27, P50, DOI 10.1027/1015-5759/a000043; Hesse E., 2008, HDB ATTACHMENT THEOR, P552; Horgan O, 2004, DISABIL REHABIL, V26, P837, DOI 10.1080/09638280410001708869; HOROWITZ M, 1979, PSYCHOSOM MED, V41, P209, DOI 10.1097/00006842-197905000-00004; John O, 1991, BIG 5 INVENTORY VERS; Kangas M, 2005, J CONSULT CLIN PSYCH, V73, P293, DOI 10.1037/0022-006X.73.2.293; Murray C, 2010, AMPUTATION, PROSTHESIS USE, AND PHANTOM LIMB PAIN, P175, DOI 10.1007/978-0-387-87462-3_12; National Limb Loss Information Center, 2008, FACT SHEET STAT CAUS; Nilsson-Ihrfelt E, 2004, J PSYCHOSOM RES, V57, P363, DOI 10.1016/j.jpsychores.2004.01.009; Ostlie K, 2011, DISABIL REHABIL, V33, P1594, DOI 10.3109/09638288.2010.540293; Richards JM, 2000, J ABNORM PSYCHOL, V109, P156, DOI 10.1037/0021-843X.109.1.156; Rubin DC, 2008, J EXP PSYCHOL GEN, V137, P591, DOI 10.1037/a0013165; Rybarczyk B, 2004, DISABIL REHABIL, V26, P944, DOI 10.1080/09638280410001708986; Singer J. A, 1993, REMEMBERED SELF; Singer JA, 2011, INT J PSYCHOANAL, V92, P1183, DOI 10.1111/j.1745-8315.2011.00415.x; Sumner JA, 2012, CLIN PSYCHOL REV, V32, P34, DOI 10.1016/j.cpr.2011.10.003; Sutin AR, 2007, MEMORY, V15, P390, DOI 10.1080/09658210701256654; Sutin AR, 2009, J COUNS PSYCHOL, V56, P351, DOI 10.1037/a0014917; Thomsen DK, 2007, NARRAT INQ, V17, P349; Williams JMG, 2007, PSYCHOL BULL, V133, P122, DOI 10.1037/0033-2909.133.1.122; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	32	3	3	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99803	10.1371/journal.pone.0099803	http://dx.doi.org/10.1371/journal.pone.0099803			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24924483	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300094
J	Mirabella, F; Murison, A; Aronson, LI; Wardell, CP; Thompson, AJ; Hanrahan, SJ; Fok, JHL; Pawlyn, C; Kaiser, MF; Walker, BA; Davies, FE; Morgan, GJ				Mirabella, Fabio; Murison, Alexander; Aronson, Lauren I.; Wardell, Christopher P.; Thompson, Andrew J.; Hanrahan, Sarah J.; Fok, Jacqueline H. L.; Pawlyn, Charlotte; Kaiser, Martin F.; Walker, Brian A.; Davies, Faith E.; Morgan, Gareth J.			A Novel Functional Role for MMSET in RNA Processing Based on the Link Between the REIIBP Isoform and Its Interaction with the SMN Complex	PLOS ONE			English	Article							CELL-CYCLE PROGRESSION; MULTIPLE-MYELOMA; RIBONUCLEOPROTEIN BIOGENESIS; HISTONE METHYLTRANSFERASE; GENE-EXPRESSION; LYSINE 36; PROTEIN; T(4/14); PATHWAY; METHYLATION	The chromosomal translocation t(4; 14) deregulates MMSET (WHSC1/NSD2) expression and is a poor prognostic factor in multiple myeloma (MM). MMSET encodes two major protein isoforms. We have characterized the role of the shorter isoform (REIIBP) in myeloma cells and identified a clear and novel interaction of REIIBP with members of the SMN (survival of motor neuron) complex that directly affects the assembly of the spliceosomal ribonucleic particles. Using RNA-seq we show that REIIBP influences the RNA splicing pattern of the cell. This new discovery provides novel insights into the understanding of MM pathology, and potential new leads for therapeutic targeting.	[Mirabella, Fabio; Murison, Alexander; Aronson, Lauren I.; Wardell, Christopher P.; Fok, Jacqueline H. L.; Pawlyn, Charlotte; Kaiser, Martin F.; Walker, Brian A.; Davies, Faith E.; Morgan, Gareth J.] Inst Canc Res, Ctr Myeloma Res, Div Mol Pathol, Sutton, Surrey, England; [Thompson, Andrew J.; Hanrahan, Sarah J.] Inst Canc Res, Prote Core Facil, London SW3 6JB, England	University of London; Institute of Cancer Research - UK; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK	Morgan, GJ (corresponding author), Inst Canc Res, Ctr Myeloma Res, Div Mol Pathol, Sutton, Surrey, England.	gareth.morgan@icr.ac.uk	Thompson, Andrew/B-1463-2014; Wardell, Christopher/B-5053-2018; Mirabella, Fabio/GVU-1467-2022	Thompson, Andrew/0000-0003-2413-3281; Wardell, Christopher/0000-0002-9416-7818; Mirabella, Fabio/0000-0003-3785-6868; morgan, gareth/0000-0002-4271-6360; Aronson, Lauren/0000-0002-8479-5685; Fok, Jacqueline Hoi Lam/0000-0002-6563-3023; Kaiser, Martin/0000-0002-3677-4804; Pawlyn, Charlotte/0000-0002-7190-0028; Davies, Faith/0000-0002-3971-2393; Walker, Brian/0000-0002-8615-6254	programme grant from Myeloma UK [MUK005X]; NIHR Biomedical Research Centre at the Royal Marsden Hospital	programme grant from Myeloma UK; NIHR Biomedical Research Centre at the Royal Marsden Hospital	This work was supported by a programme grant from Myeloma UK [MUK005X] (http://www.myeloma.org.uk/) and funding from The NIHR Biomedical Research Centre at the Royal Marsden Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronson LI, 2013, LEUKEMIA, V27, P2397, DOI 10.1038/leu.2013.150; Battle DJ, 2007, J BIOL CHEM, V282, P27953, DOI 10.1074/jbc.M702317200; Battle DJ, 2006, MOL CELL, V23, P273, DOI 10.1016/j.molcel.2006.05.036; Berg MG, 2012, CELL, V150, P53, DOI 10.1016/j.cell.2012.05.029; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Boyd KD, 2012, LEUKEMIA, V26, P349, DOI 10.1038/leu.2011.204; Brameier M, 2007, BIOINFORMATICS, V23, P1159, DOI 10.1093/bioinformatics/btm066; Brito JLR, 2009, HAEMATOL-HEMATOL J, V94, P78, DOI 10.3324/haematol.13426; Cao XJ, 2013, EPIGENETICS-US, V8, P477, DOI 10.4161/epi.24547; Chu L, 2012, J CLIN INVEST, V122, P2793, DOI 10.1172/JCI63051; Corrionero A, 2011, GENE DEV, V25, P445, DOI 10.1101/gad.2014311; Davenport EL, 2007, BLOOD, V110, P2641, DOI 10.1182/blood-2006-11-053728; Dieci G, 2009, GENOMICS, V94, P83, DOI 10.1016/j.ygeno.2009.05.002; Fischer U, 1997, CELL, V90, P1023, DOI 10.1016/S0092-8674(00)80368-2; Fu Y, 2011, NUCLEIC ACIDS RES, V39, P4396, DOI 10.1093/nar/gkr026; Fuller HR, 2010, J PROTEOME RES, V9, P556, DOI 10.1021/pr900884g; Gabanella F, 2005, HUM MOL GENET, V14, P3629, DOI 10.1093/hmg/ddi390; Gabanella F, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000921; Hao LT, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-28; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang Z, 2013, CANCER RES, V73, P6277, DOI 10.1158/0008-5472.CAN-13-1000; Imielinski M, 2012, CELL, V150, P1107, DOI 10.1016/j.cell.2012.08.029; Isono K, 2005, GENE DEV, V19, P536, DOI 10.1101/gad.1284605; Kaida D, 2010, NATURE, V468, P664, DOI 10.1038/nature09479; Keats JJ, 2005, BLOOD, V105, P4060, DOI 10.1182/blood-2004-09-3704; Keats JJ, 2003, BLOOD, V101, P1520, DOI 10.1182/blood-2002-06-1675; Kim JY, 2008, MOL CELL BIOL, V28, P2023, DOI 10.1128/MCB.02130-07; Kuo AJ, 2011, MOL CELL, V44, P609, DOI 10.1016/j.molcel.2011.08.042; Lauring J, 2008, BLOOD, V111, P856, DOI 10.1182/blood-2007-05-088674; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Lotti F, 2012, CELL, V151, P440, DOI 10.1016/j.cell.2012.09.012; Lucio-Eterovic AK, 2011, TRANSCR-AUSTIN, V2, P158, DOI 10.4161/trns.2.4.16217; Marango J, 2008, BLOOD, V111, P3145, DOI 10.1182/blood-2007-06-092122; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Mirabella F, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.9; Nimura K, 2009, NATURE, V460, P287, DOI 10.1038/nature08086; Pacheco TR, 2006, MOL BIOL CELL, V17, P4187, DOI 10.1091/mbc.E06-01-0036; PADGETT RA, 1983, CELL, V35, P101, DOI 10.1016/0092-8674(83)90212-X; Patel SB, 2008, NUCLEIC ACIDS RES, V36, P6482, DOI 10.1093/nar/gkn658; Paushkin S, 2002, CURR OPIN CELL BIOL, V14, P305, DOI 10.1016/S0955-0674(02)00332-0; Pei HD, 2011, NATURE, V470, P124, DOI 10.1038/nature09658; Pellizzoni L, 2002, SCIENCE, V298, P1775, DOI 10.1126/science.1074962; Pellizzoni L, 2007, EMBO REP, V8, P340, DOI 10.1038/sj.embor.7400941; Puente XS, 2011, NATURE, V475, P101, DOI 10.1038/nature10113; Quesada V, 2012, NAT GENET, V44, P47, DOI 10.1038/ng.1032; Ronchetti D, 2012, BLOOD CANCER J, V2, DOI 10.1038/bcj.2012.41; Todoerti K, 2005, BRIT J HAEMATOL, V131, P214, DOI 10.1111/j.1365-2141.2005.05741.x; Walker BA, 2010, BLOOD, V116, pE56, DOI 10.1182/blood-2010-04-279596; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wong JJL, 2013, CELL, V154, P583, DOI 10.1016/j.cell.2013.06.052; Workman E, 2012, BRAIN RES, V1462, P93, DOI 10.1016/j.brainres.2012.02.051; Xiao R, 2012, MOL CELL, V45, P656, DOI 10.1016/j.molcel.2012.01.009; Yap K, 2012, GENE DEV, V26, P1209, DOI 10.1101/gad.188037.112; Yoshida K, 2011, NATURE, V478, P64, DOI 10.1038/nature10496; Zhang L, 2013, CANCER LETT, V339, P49, DOI 10.1016/j.canlet.2013.07.023; Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031; Zhang ZG, 2010, EMBO J, V29, P3733, DOI 10.1038/emboj.2010.247; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	58	5	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99493	10.1371/journal.pone.0099493	http://dx.doi.org/10.1371/journal.pone.0099493			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923560	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300068
J	Monnier, J; Zabel, BA				Monnier, Justin; Zabel, Brian A.			Anti-Asialo GM1 NK Cell Depleting Antibody Does Not Alter the Development of Bleomycin Induced Pulmonary Fibrosis	PLOS ONE			English	Article							NATURAL-KILLER-CELLS; LUNG INFLAMMATION; INTERFERON-GAMMA; INFECTION; MICE; SUSCEPTIBILITY; INHIBITION; INJURY; CD8(+)	Despite circumstantial evidence postulating a protective role for NK cells in many fibrotic conditions, their contribution to the development of pulmonary fibrosis has yet to be tested. Lung-migrating NK cells are thought to attenuate the development of bleomycin induced pulmonary fibrosis (BIPF) by providing anti-fibrotic mediators and cytokines, such as IFN-gamma. If true, we reasoned that depletion of NK cells during experimentally-induced fibrotic disease would lead to exacerbated fibrosis. To test this, we treated mice with NK cell-depleting antisera (anti-asialo GM1) and evaluated lung inflammation and fibrosis in the BIPF model. While NK cell infiltration into the airways was maximal at day 10 after bleomycin injection, NK cells represented a minor portion (1-3%) of the total leukocytes in BAL fluid. Anti-asialo GM1 significantly abrogated NK cell numbers over the course of the disease. Depletion of NK cells with anti-asialo GM1 before and throughout the BIPF model, or during just the fibrotic phase did not alter fibrosis development or affect the levels of any of the pro-inflammatory/pro-fibrotic cytokines measured (IL-1 beta, IL-17, IFN-gamma, TGF-beta and TNF-alpha). In addition, adoptively transferred NK cells, which were detectable systemically and in the airways throughout BIPF, failed to impact lung fibrosis. These findings indicate that NK cells likely do not play an essential protective role in controlling pulmonary fibrosis development.	[Monnier, Justin] Stanford Univ, Dept Pathol, Sch Med, Stanford, CA 94305 USA; [Monnier, Justin; Zabel, Brian A.] Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto Inst Res & Educ, Palo Alto, CA 94304 USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Zabel, BA (corresponding author), Dept Vet Affairs Palo Alto Hlth Care Syst, Palo Alto Inst Res & Educ, Palo Alto, CA 94304 USA.	bazabel@alum.mit.edu			Department of Defense [W81XWH-11-1-0512]; NIH [AI-079320]; NIH T-32 training [T32-AI07290-25, T32-AI07290-24]; American Cancer Society; FACS Core Facility of the Stanford Digestive Disease Center [P30 DK056339]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI079320, T32AI007290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056339] Funding Source: NIH RePORTER	Department of Defense(United States Department of Defense); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH T-32 training(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); FACS Core Facility of the Stanford Digestive Disease Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by Department of Defense grant W81XWH-11-1-0512 and NIH grant AI-079320 to BAZ; by fellowships to JM under NIH T-32 training grant T32-AI07290-25, T32-AI07290-24 and the American Cancer Society; and by the FACS Core Facility of the Stanford Digestive Disease Center under P30 DK056339. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Aono Y, 2012, AM J RESP CRIT CARE, V185, P525, DOI 10.1164/rccm.201103-0561OC; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; BITTERMAN PB, 1986, NEW ENGL J MED, V314, P1343, DOI 10.1056/NEJM198605223142103; Burdick MD, 2005, AM J RESP CRIT CARE, V171, P261, DOI 10.1164/rccm.200409-1164OC; Chen ES, 2001, AM J RESP CELL MOL, V24, P545, DOI 10.1165/ajrcmb.24.5.4064; Culley FJ, 2009, IMMUNOLOGY, V128, P151, DOI 10.1111/j.1365-2567.2009.03167.x; Eckelhart E, 2011, BLOOD, V117, P1565, DOI 10.1182/blood-2010-06-291633; Gao B, 2009, J LEUKOCYTE BIOL, V86, P513, DOI [10.1189/JLB.0309135, 10.1189/jlb.0309135]; Gao K, 2013, CANCER LETT, V335, P463, DOI 10.1016/j.canlet.2013.03.002; Horikawa M, 2006, AM J PATHOL, V169, P740, DOI 10.2353/ajpath.2006.060086; Hummel S, 2002, J LEUKOCYTE BIOL, V72, P898; Jessen B, 2011, BLOOD, V118, P4620, DOI 10.1182/blood-2011-05-356113; Jiang DH, 2004, J CLIN INVEST, V114, P291, DOI 10.1172/JCI200416861; Jiang DH, 2010, J CLIN INVEST, V120, P2049, DOI 10.1172/JCI38644; KASAI M, 1980, EUR J IMMUNOL, V10, P175, DOI 10.1002/eji.1830100304; Kataoka S, 2004, DNA CELL BIOL, V23, P549, DOI 10.1089/dna.2004.23.549; Kim JH, 2005, AM J PATHOL, V167, P1231, DOI 10.1016/S0002-9440(10)61211-4; King TE, 2009, LANCET, V374, P222, DOI 10.1016/S0140-6736(09)60551-1; Koyama K, 2002, PARASITE IMMUNOL, V24, P527, DOI 10.1046/j.1365-3024.2002.00497.x; Kumar P, 2013, MUCOSAL IMMUNOL, V6, P69, DOI 10.1038/mi.2012.49; Melhem A, 2006, J HEPATOL, V45, P60, DOI 10.1016/j.jhep.2005.12.025; Moore BB, 2008, AM J PHYSIOL-LUNG C, V294, pL152, DOI 10.1152/ajplung.00313.2007; Nishikado H, 2011, J IMMUNOL, V186, P5766, DOI 10.4049/jimmunol.1100370; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Segel MJ, 2003, AM J PHYSIOL-LUNG C, V285, pL1255, DOI 10.1152/ajplung.00303.2002; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Slifka MK, 2000, J IMMUNOL, V164, P2009, DOI 10.4049/jimmunol.164.4.2009; Small CL, 2010, J IMMUNOL, V184, P2048, DOI 10.4049/jimmunol.0902772; STEINSTREILEIN J, 1986, J IMMUNOL, V136, P1435; Tager AM, 2004, AM J RESP CELL MOL, V31, P395, DOI 10.1165/rcmb.2004-0175OC; Tian ZG, 2013, HEPATOLOGY, V57, P1654, DOI 10.1002/hep.26115; Tighe RM, 2011, AM J RESP CELL MOL, V45, P781, DOI 10.1165/rcmb.2010-0471OC; Trambley J, 1999, J CLIN INVEST, V104, P1715, DOI 10.1172/JCI8082; Waggoner SN, 2013, J VIROLOGY; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; WILTROUT RH, 1985, J LEUKOCYTE BIOL, V37, P597, DOI 10.1002/jlb.37.5.597; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Zaldivar MM, 2012, LAB INVEST, V92, P724, DOI 10.1038/labinvest.2012.48; Zhou G, 2013, EUR J IMMUNOL, V43, P929, DOI 10.1002/eji.201242620	40	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99350	10.1371/journal.pone.0099350	http://dx.doi.org/10.1371/journal.pone.0099350			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922516	gold, Green Published, Green Submitted			2022-12-27	WOS:000338701300051
J	Park, HJ; Kim, DH; Choi, JY; Kim, WJ; Kim, JY; Senejani, AG; Hwang, SS; Kim, LK; Tobiasova, Z; Lee, GR; Craft, J; Bothwell, ALM; Choi, JM				Park, Hong-Jai; Kim, Do-Hyun; Choi, Jin-Young; Kim, Won-Ju; Kim, Ji Yun; Senejani, Alireza G.; Hwang, Soo Seok; Kim, Lark Kyun; Tobiasova, Zuzana; Lee, Gap Ryol; Craft, Joseph; Bothwell, Alfred L. M.; Choi, Je-Min			PPAR gamma Negatively Regulates T Cell Activation to Prevent Follicular Helper T Cells and Germinal Center Formation	PLOS ONE			English	Article							CXC CHEMOKINE RECEPTOR-5; NUCLEAR RECEPTORS; AGONISTS; EXPRESSION; IMMUNOREGULATION; INFLAMMATION; MATURATION; PHENOTYPE; ICOS; MICE	Peroxisome proliferator-activated receptor gamma (PPAR gamma) is a transcription factor that regulates lipid and glucose metabolism. Although studies of PPAR gamma ligands have demonstrated its regulatory functions in inflammation and adaptive immunity, its intrinsic role in T cells and autoimmunity has yet to be fully elucidated. Here we used CD4-PPAR gamma(KO) mice to investigate PPAR gamma-deficient T cells, which were hyper-reactive to produce higher levels of cytokines and exhibited greater proliferation than wild type T cells with increased ERK and AKT phosphorylation. Diminished expression of I kappa B alpha, Sirt1, and Foxo1, which are inhibitors of NF-kappa B, was observed in PPAR gamma-deficient T cells that were prone to produce all the signature cytokines under Th1, Th2, Th17, and Th9 skewing condition. Interestingly, 1-year-old CD4-PPAR gamma(KO) mice spontaneously developed moderate autoimmune phenotype by increased activated T cells, follicular helper T cells (T-FH cells) and germinal center B cells with glomerular inflammation and enhanced autoantibody production. Sheep red blood cell immunization more induced T-FH cells and germinal centers in CD4-PPAR gamma(KO) mice and the T cells showed increased of Bcl-6 and IL-21 expression suggesting its regulatory role in germinal center reaction. Collectively, these results suggest that PPAR gamma has a regulatory role for T-FH cells and germinal center reaction to prevent autoimmunity.	[Park, Hong-Jai; Kim, Do-Hyun; Kim, Won-Ju; Kim, Ji Yun; Choi, Je-Min] Hanyang Univ, Res Inst Nat Sci, Dept Life Sci, Seoul 133791, South Korea; [Park, Hong-Jai; Kim, Do-Hyun; Kim, Won-Ju; Kim, Ji Yun; Choi, Je-Min] Hanyang Biomed Res Inst, Seoul, South Korea; [Choi, Jin-Young; Craft, Joseph] Yale Univ, Sch Med, Dept Internal Med Rheumatol, New Haven, CT USA; [Senejani, Alireza G.] Yale Univ, Sch Med, Dept Therapeut Radiol & Genet, New Haven, CT USA; [Hwang, Soo Seok; Lee, Gap Ryol] Sogang Univ, Dept Life Sci, Seoul, South Korea; [Kim, Lark Kyun; Tobiasova, Zuzana; Craft, Joseph; Bothwell, Alfred L. M.] Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA	Hanyang University; Yale University; Yale University; Sogang University; Yale University	Bothwell, ALM (corresponding author), Yale Univ, Sch Med, Dept Immunobiol, New Haven, CT 06520 USA.	alfred.bothwell@yale.edu; jeminchoi@hanyang.ac.kr	Hwang, Soo Seok/AAL-3292-2020	Hwang, Soo Seok/0000-0002-1635-4191; Kim, Wonju/0000-0002-1800-0485; Choi, Je-Min/0000-0002-9482-710X	Basic Science Research Program through National Research Foundation of Korea [NRF-2011-0012859, NRF-2013R1A1A2A10060048]; NIH [HL088258, AR40072]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000142] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088258] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R37AR040072, R01AR040072] Funding Source: NIH RePORTER	Basic Science Research Program through National Research Foundation of Korea(National Research Foundation of Korea); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the Basic Science Research Program through National Research Foundation of Korea grants (NRF-2011-0012859 and NRF-2013R1A1A2A10060048) to J.M. Choi. It also was supported by NIH grant HL088258 to A.L.M. Bothwell and AR40072 to J. Craft. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akiba H, 2005, J IMMUNOL, V175, P2340, DOI 10.4049/jimmunol.175.4.2340; Baratelli F, 2005, J IMMUNOL, V175, P1483, DOI 10.4049/jimmunol.175.3.1483; BEREK C, 1991, CELL, V67, P1121, DOI 10.1016/0092-8674(91)90289-B; Breitfeld D, 2000, J EXP MED, V192, P1545, DOI 10.1084/jem.192.11.1545; Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866; Choi JM, 2012, MOL CELLS, V33, P217, DOI 10.1007/s10059-012-2297-y; Choi YS, 2011, IMMUNITY, V34, P932, DOI 10.1016/j.immuni.2011.03.023; Cipolletta D, 2012, NATURE, V486, P549, DOI 10.1038/nature11132; Clark RB, 2000, J IMMUNOL, V164, P1364, DOI 10.4049/jimmunol.164.3.1364; Craft JE, 2012, NAT REV RHEUMATOL, V8, P337, DOI 10.1038/nrrheum.2012.58; Crotty S, 2011, ANNU REV IMMUNOL, V29, P621, DOI 10.1146/annurev-immunol-031210-101400; Desreumaux P, 2001, J EXP MED, V193, P827, DOI 10.1084/jem.193.7.827; Dowell P, 2003, J BIOL CHEM, V278, P45485, DOI 10.1074/jbc.M309069200; EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939; Fazilleau N, 2009, NAT IMMUNOL, V10, P375, DOI 10.1038/ni.1704; Gervois P, 2007, NAT CLIN PRACT ENDOC, V3, P145, DOI 10.1038/ncpendmet0397; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Hontecillas R, 2007, J IMMUNOL, V178, P2940, DOI 10.4049/jimmunol.178.5.2940; Hsueh WA, 2001, ARTERIOSCL THROM VAS, V21, P1891, DOI 10.1161/hq1201.100261; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Kerdiles YM, 2010, IMMUNITY, V33, P890, DOI 10.1016/j.immuni.2010.12.002; King C, 2008, ANNU REV IMMUNOL, V26, P741, DOI 10.1146/annurev.immunol.26.021607.090344; Klotz L, 2009, J EXP MED, V206, P2079, DOI 10.1084/jem.20082771; LANE P, 1994, J EXP MED, V179, P819, DOI 10.1084/jem.179.3.819; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Liu YJ, 1996, IMMUNITY, V4, P241, DOI 10.1016/S1074-7613(00)80432-X; MACLENNAN ICM, 1994, ANNU REV IMMUNOL, V12, P117, DOI 10.1146/annurev.iy.12.040194.001001; Nurieva RI, 2009, SCIENCE, V325, P1001, DOI 10.1126/science.1176676; Ouyang WM, 2009, IMMUNITY, V30, P358, DOI 10.1016/j.immuni.2009.02.003; Park Hong-Jai, 2014, Immune Netw, V14, P21, DOI 10.4110/in.2014.14.1.21; Poholek AC, 2010, J IMMUNOL, V185, P313, DOI 10.4049/jimmunol.0904023; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Schaerli P, 2000, J EXP MED, V192, P1553, DOI 10.1084/jem.192.11.1553; Simpson N, 2010, ARTHRITIS RHEUM-US, V62, P234, DOI 10.1002/art.25032; Su DM, 2009, DIABETES, V58, P2624, DOI 10.2337/db09-0232; Sweet RA, 2012, CURR OPIN IMMUNOL, V24, P658, DOI 10.1016/j.coi.2012.10.003; Tobiasova Z, 2011, CIRCULATION, V124, P196, DOI 10.1161/CIRCULATIONAHA.110.015396; Vogelzang A, 2008, IMMUNITY, V29, P127, DOI 10.1016/j.immuni.2008.06.001; Walker LSK, 1999, J EXP MED, V190, P1115, DOI 10.1084/jem.190.8.1115; Wohlfert EA, 2007, J IMMUNOL, V178, P4129, DOI 10.4049/jimmunol.178.7.4129; Xiong SQ, 2011, J BIOL CHEM, V286, P5289, DOI 10.1074/jbc.M110.163667; Xue HH, 2002, P NATL ACAD SCI USA, V99, P13759, DOI 10.1073/pnas.212214999; Yang XY, 2000, J BIOL CHEM, V275, P4541, DOI 10.1074/jbc.275.7.4541; Zhang JN, 2009, J CLIN INVEST, V119, P3048, DOI 10.1172/JCI38902	45	25	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99127	10.1371/journal.pone.0099127	http://dx.doi.org/10.1371/journal.pone.0099127			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921943	gold, Green Published, Green Submitted			2022-12-27	WOS:000338701300034
J	Seino, S; Shinkai, S; Fujiwara, Y; Obuchi, S; Yoshida, H; Hirano, H; Kim, HK; Ishizaki, T; Takahashi, R				Seino, Satoshi; Shinkai, Shoji; Fujiwara, Yoshinori; Obuchi, Shuichi; Yoshida, Hideyo; Hirano, Hirohiko; Kim, Hun Kyung; Ishizaki, Tatsuro; Takahashi, Ryutaro		TMIG-LISA Res Grp	Reference Values and Age and Sex Differences in Physical Performance Measures for Community-Dwelling Older Japanese: A Pooled Analysis of Six Cohort Studies	PLOS ONE			English	Article							WALKING SPEED; GAIT SPEED; HANDGRIP STRENGTH; MUSCLE STRENGTH; RURAL-COMMUNITY; TOTAL MORTALITY; GO TEST; ADULTS; DECLINE; PEOPLE	Objectives: To determine age- and sex-specific reference values for six physical performance measures, i.e. hand-grip strength, one-legged stance, and gait speed and step length at both usual and maximum paces, and to investigate age and sex differences in these measures among community-dwelling older Japanese adults. Methods: We conducted a pooled analysis of data from six cohort studies collected between 2002 and 2011 as part of the Tokyo Metropolitan Institute of Gerontology-Longitudinal Interdisciplinary Study on Aging. The pooled analysis included cross-sectional data from 4683 nondisabled, community-dwelling adults aged 65 years or older (2168 men, 2515 women; mean age: 74.0 years in men and 73.9 years in women). Results: Unweighted simple mean (standard deviation) hand-grip strength, one-legged stance, usual gait speed, usual gait step length, maximum gait speed, and maximum gait step length were 31.7 (6.7) kg, 39.3 (23.0) s, 1.29 (0.25) m/s, 67.7 (10.0) cm, 1.94 (0.38) m/s, and 82.3 (11.6) cm, respectively, in men and 20.4 (5.0) kg, 36.8 (23.4) s, 1.25 (0.27) m/s, 60.8 (10.0) cm, 1.73 (0.36) m/s, and 69.7 (10.8) cm, respectively, in women. All physical performance measures showed significant decreasing trends with advancing age in both sexes (all P<0.001 for trend). We also constructed age-and sex-specific appraisal standards according to quintiles. With increasing age, the sex difference in hand-grip strength decreased significantly (P<0.001 for age and sex interaction). In contrast, sex differences significantly increased in all other measures (all P<0.05 for interactions) except step length at maximum pace. Conclusion: Our pooled analysis yielded inclusive age-and sex-specific reference values and appraisal standards for major physical performance measures in nondisabled, community-dwelling, older Japanese adults. The characteristics of age-related decline in physical performance measures differed between sexes.	[Seino, Satoshi; Shinkai, Shoji; Fujiwara, Yoshinori; Obuchi, Shuichi; Yoshida, Hideyo; Hirano, Hirohiko; Kim, Hun Kyung; Ishizaki, Tatsuro; Takahashi, Ryutaro] Tokyo Metropolitan Inst Gerontol, Itabashi Ku, Tokyo, Japan; [Seino, Satoshi] Japan Soc Promot Sci, Chiyoda Ku, Tokyo, Japan	Tokyo Metropolitan Institute of Gerontology; Japan Society for the Promotion of Science	Shinkai, S (corresponding author), Tokyo Metropolitan Inst Gerontol, Itabashi Ku, 35-2 Sakae, Tokyo, Japan.	sshinkai@tmig.or.jp		Seino, Satoshi/0000-0002-3620-8730	Tokyo Metropolitan Government; Japan Arteriosclerosis Prevention Fund; Research Institute of Science and Technology for Society; Japan Science and Technology Agency; International Life Sciences Institute of Japan; Japan Society for the Promotion of Science [17659192]; Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan [H14-Chouju-006, H15-Ganyobo-065, H15-Seisaku-017, H16-Chouju-031, H23-Chouju-Ippan-001, H23-Chouju-Ippan-002];  [14370150];  [17390194];  [21390212]; Grants-in-Aid for Scientific Research [24792611, 24390173, 26282201, 26310111] Funding Source: KAKEN	Tokyo Metropolitan Government(Tokyo Metropolitan Government); Japan Arteriosclerosis Prevention Fund; Research Institute of Science and Technology for Society; Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); International Life Sciences Institute of Japan; Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Health Labour Sciences Research Grants from the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); ; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by grants from the Tokyo Metropolitan Government, the Japan Arteriosclerosis Prevention Fund (jals.gr.jp/en/index.html), the Research Institute of Science and Technology for Society, the Japan Science and Technology Agency (www.ristex.jp/EN/index.html), International Life Sciences Institute of Japan (www.ilsijapan.org/English/ILSIJapan/ILJ/IL.php), Grants-in-Aid for Scientific Research (B) (2) 14370150, (B) 17390194, (B) 21390212, and a Grant-in-Aid for Exploratory Research 17659192 from the Japan Society for the Promotion of Science, and Health Labour Sciences Research Grants H14-Chouju-006, H15-Ganyobo-065, H15-Seisaku-017, H16-Chouju-031, H23-Chouju-Ippan-001, and H23-Chouju-Ippan-002 from the Ministry of Health, Labour and Welfare of Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken L. S., 1991, MULTIPLE REGRESSION; Aoyagi K, 2001, BMC Geriatr, V1, P3, DOI 10.1186/1471-2318-1-3; Beauchet O, 2013, J NUTR HEALTH AGING, V17, P235, DOI 10.1007/s12603-012-0394-4; Bohannon Richard W, 2006, J Geriatr Phys Ther, V29, P64; Bohannon RW, 2006, PERCEPT MOTOR SKILL, V103, P215, DOI 10.2466/PMS.103.1.215-222; Bohannon RW, 2011, PHYSIOTHERAPY, V97, P182, DOI 10.1016/j.physio.2010.12.004; Bohannon Richard W, 2008, J Geriatr Phys Ther, V31, P3; Bohannon RW, 1997, ARCH PHYS MED REHAB, V78, P26, DOI 10.1016/S0003-9993(97)90005-8; Bohannon RW, 1997, AGE AGEING, V26, P15, DOI 10.1093/ageing/26.1.15; Cesari M, 2005, J AM GERIATR SOC, V53, P1675, DOI 10.1111/j.1532-5415.2005.53501.x; Cesari M, 2011, JAMA-J AM MED ASSOC, V305, P93, DOI 10.1001/jama.2010.1970; Chen LK, 2014, J AM MED DIR ASSOC, V15, P95, DOI 10.1016/j.jamda.2013.11.025; Coldham F, 2006, J HAND THER, V19, P318, DOI 10.1197/j.jht.2006.04.002; COOPER R, 2011, PLOS ONE, V0006; Cooper R, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c4467; Cooper R, 2011, AGE AGEING, V40, P14, DOI 10.1093/ageing/afq117; Fess EE., 1992, CLIN ASSESSMENT RECO, P41; Fitzpatrick AL, 2007, J GERONTOL A-BIOL, V62, P1244, DOI 10.1093/gerona/62.11.1244; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fujiwara Y, 2013, J GERIATR PSYCH NEUR, V26, P209, DOI 10.1177/0891988713497096; Goodpaster BH, 2006, J GERONTOL A-BIOL, V61, P1059, DOI 10.1093/gerona/61.10.1059; Graham JE, 2008, ARCH PHYS MED REHAB, V89, P865, DOI 10.1016/j.apmr.2007.11.029; Graham JE, 2008, J EVAL CLIN PRACT, V14, P552, DOI 10.1111/j.1365-2753.2007.00917.x; Hamilton A, 1994, J Hand Ther, V7, P163; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Hollman JH, 2011, GAIT POSTURE, V34, P111, DOI 10.1016/j.gaitpost.2011.03.024; Ishizaki T, 2000, J AM GERIATR SOC, V48, P1424, DOI 10.1111/j.1532-5415.2000.tb02632.x; Ishizaki T, 2011, J EPIDEMIOL, V21, P176, DOI 10.2188/jea.JE20100138; Ishizaki T, 2009, GERONTOLOGY, V55, P344, DOI 10.1159/000183749; Kamide N, 2011, GERIATR GERONTOL INT, V11, P445, DOI 10.1111/j.1447-0594.2011.00704.x; Kan Mari, 2006, Nihon Koshu Eisei Zasshi, V53, P688; Kenny RA, 2013, J AM GERIATR SOC, V61, pS279, DOI [10.1111/jgs.12195, 10.1111/jgs.12200]; KOYANO W, 1991, ARCH GERONTOL GERIAT, V13, P103, DOI 10.1016/0167-4943(91)90053-S; Lauretani F, 2003, J APPL PHYSIOL, V95, P1851, DOI 10.1152/japplphysiol.00246.2003; Lindemann U, 2008, GAIT POSTURE, V27, P91, DOI 10.1016/j.gaitpost.2007.02.005; Lindernann U, 2008, AGING CLIN EXP RES, V20, P394; Murayama H, 2012, J EPIDEMIOL, V22, P551, DOI 10.2188/jea.JE20120015; Neyeloff Jeruza L, 2012, BMC Res Notes, V5, P52, DOI 10.1186/1756-0500-5-52; Oh-Park M, 2010, J AM GERIATR SOC, V58, P1512, DOI 10.1111/j.1532-5415.2010.02962.x; Rantanen T, 2003, J AM GERIATR SOC, V51, P636, DOI 10.1034/j.1600-0579.2003.00207.x; Roberts HC, 2011, AGE AGEING, V40, P423, DOI 10.1093/ageing/afr051; Sallinen J, 2010, J AM GERIATR SOC, V58, P1721, DOI 10.1111/j.1532-5415.2010.03035.x; Sanada K, 2010, EUR J APPL PHYSIOL, V110, P57, DOI 10.1007/s00421-010-1473-z; Schoene D, 2013, J AM GERIATR SOC, V61, P202, DOI 10.1111/jgs.12106; Shinkai S, 2000, AGE AGEING, V29, P441, DOI 10.1093/ageing/29.5.441; Shinkai S, 2008, ARCH INTERN MED, V168, P200, DOI 10.1001/archinternmed.2007.64; Studenski S, 2011, JAMA-J AM MED ASSOC, V305, P50, DOI 10.1001/jama.2010.1923; Suzuki Takao, 2003, Nihon Koshu Eisei Zasshi, V50, P39; Taniguchi Y, 2012, J GERONTOL A-BIOL, V67, P796, DOI 10.1093/gerona/glr243; Tseng L.A., 2013, J GERONTOL A-BIOL, V69, P93; van Kan GA, 2009, J NUTR HEALTH AGING, V13, P881; Verghese J, 2013, J GERONTOL A-BIOL, V68, P412, DOI 10.1093/gerona/gls191; Vianna LC, 2007, J STRENGTH COND RES, V21, P1310; Volpato S, 2011, J GERONTOL A-BIOL, V66, P89, DOI 10.1093/gerona/glq167; Wang CY, 2012, PERCEPT MOTOR SKILL, V114, P469, DOI 10.2466/10.25.26.PMS.114.2.469-478; Woo J, 1999, J AM GERIATR SOC, V47, P1257, DOI 10.1111/j.1532-5415.1999.tb05209.x; Yoshida Yuko, 2008, Nihon Koshu Eisei Zasshi, V55, P221; Yukawa M, 2000, J AM GERIATR SOC, V48, P1527, DOI 10.1111/jgs.2000.48.11.1527	58	84	85	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99487	10.1371/journal.pone.0099487	http://dx.doi.org/10.1371/journal.pone.0099487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24923425	gold, Green Published, Green Submitted			2022-12-27	WOS:000338701300067
J	Wu, Y; Liu, HB; Shi, XF; Song, Y				Wu, Ying; Liu, Hong-Bing; Shi, Xue-Fei; Song, Yong			Conventional Hypoglycaemic Agents and the Risk of Lung Cancer in Patients with Diabetes: A Meta-Analysis	PLOS ONE			English	Article							ACTIVATED RECEPTOR-GAMMA; THIAZOLIDINEDIONE USE; METFORMIN; INSULIN; CELLS; APOPTOSIS; GLUCOSE; TUMORIGENESIS; PIOGLITAZONE; MALIGNANCIES	Background: Accumulating evidence suggests that hypoglycaemic agents influence lung cancer risk in patients with diabetes. It remains to be fully elucidated whether conventional hypoglycaemic agents (metformin, sulfonylureas, thiazolidinediones [TZDs] or insulin) affect lung cancer incidence in patients with diabetes. Methods: We performed a meta-analysis using EMBASE, MEDLINE and Web of Science to search randomised controlled trials (RCTs), cohort studies, and case-control studies published up to October 2013 that assessed the effects of metformin, sulfonylurea, TZDs or insulin on lung cancer risk in subjects with diabetes. Fixed and random effects meta-analysis models were used, and the effect size was expressed as a summary odds ratio (OR) with 95% confidence intervals (CI). The Grades of Research, Assessment, Development and Evaluation (GRADE) approach was applied to define the quality of the evidence. Results: Analysis of 15 studies (11 cohort studies, 2 case-control studies, and 2 RCTs) showed that metformin use was associated with a 15% reduction in risk of lung cancer (OR 0.85, 95% CI 0.77 to 0.92), but this finding was not supported by sub-analysis of smoking-adjusted studies (OR 0.84, 95% CI 0.61 to 1.06). Moreover, sulfonylurea or TZDs use was not associated with increased or decreased lung cancer risk, respectively (OR 1.10, 95% CI 0.93 to 1.26), (OR 0.86, 95% CI 0.70 to 1.02). Higher lung cancer risk was related to insulin (OR 1.23, 95% CI 1.10 to 1.35). However, all data from RCTs failed to demonstrate a statistically significant effect. Conclusions: This analysis demonstrated that metformin use may reduce lung cancer risk in patients with diabetes but not in a smoking-adjusted subgroup and that insulin use may be associated with an increased lung cancer risk in subjects with diabetes.	[Wu, Ying; Liu, Hong-Bing; Shi, Xue-Fei; Song, Yong] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University	Song, Y (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp Med, Nanjing 210008, Jiangsu, Peoples R China.	yong_song6310@yahoo.com						Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Bodmer M, 2012, LUNG CANCER, V78, P133, DOI 10.1016/j.lungcan.2012.08.010; Bosetti C, 2013, ONCOLOGIST, V18, P148, DOI 10.1634/theoncologist.2012-0302; Bren-Mattison Y, 2005, ONCOGENE, V24, P1412, DOI 10.1038/sj.onc.1208333; Chang CH, 2012, J CLIN ENDOCR METAB, V97, pE1170, DOI 10.1210/jc.2012-1162; Chang CH, 2012, HEPATOLOGY, V55, P1462, DOI 10.1002/hep.25509; Chang TH, 2000, CANCER RES, V60, P1129; Colmers IN, 2012, DIABETES METAB, V38, P485, DOI 10.1016/j.diabet.2012.08.011; Colmers IN, 2012, DIABETES METAB, V38, P475, DOI 10.1016/j.diabet.2012.06.003; Danaei G, 2011, LANCET, V378, P31, DOI 10.1016/S0140-6736(11)60679-X; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Egger M, 1998, BMJ-BRIT MED J, V316, P61, DOI 10.1136/bmj.316.7124.61; Ferrara A, 2011, DIABETES CARE, V34, P923, DOI 10.2337/dc10-1067; Golder S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1001026; Govindarajan R, 2007, J CLIN ONCOL, V25, P1476, DOI 10.1200/JCO.2006.07.2777; GREENLAND S, 1987, EPIDEMIOL REV, V9, P1; Gu YJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053411; Guyatt GH, 2011, J CLIN EPIDEMIOL, V64, P1311, DOI [10.1016/j.jclinepi.2011.03.017, 10.1016/j.jclinepi.2011.06.004]; Higgins JPT, 2002, STAT MED, V21, P1539, DOI 10.1002/sim.1186; Higgins J, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.ED000049; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Home PD, 2010, DIABETOLOGIA, V53, P1838, DOI 10.1007/s00125-010-1804-y; Hsieh MC, 2012, EXP DIABETES RES, DOI 10.1155/2012/413782; Inzucchi SE, 2005, ENDOCRIN METAB CLIN, V34, P199, DOI 10.1016/j.ecl.2004.11.008; Janghorbani M, 2012, HORM CANCER-US, V3, P137, DOI 10.1007/s12672-012-0112-z; Johnson JA, 2012, DIABETOLOGIA, V55, P1607, DOI 10.1007/s00125-012-2525-1; Lai SW, 2012, CLIN LUNG CANCER, V13, P143, DOI 10.1016/j.cllc.2011.10.002; Lee JY, 2013, EUR J CANCER, V49, P2411, DOI 10.1016/j.ejca.2013.02.025; Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175; Luo JH, 2012, DIABETES CARE, V35, P1485, DOI 10.2337/dc11-2108; MANTEL N, 1959, J NATL CANCER I, V22, P719; Mazzone PJ, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-410; Do MT, 2013, TOXICOL APPL PHARM, V271, P229, DOI 10.1016/j.taap.2013.05.010; Moher David, 2009, Ann Intern Med, V151, P264, DOI [10.1136/bmj.b2535, 10.1016/j.ijsu.2010.02.007]; Neumann A, 2012, DIABETOLOGIA, V55, P1953, DOI 10.1007/s00125-012-2538-9; Noto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033411; Pollak M, 2012, NAT REV CANCER, V12, P159, DOI 10.1038/nrc3215; Qian X, 2008, BIOCHEM PHARMACOL, V76, P1705, DOI 10.1016/j.bcp.2008.09.009; Quinn BJ, 2013, CANCER PREV RES, V6, P801, DOI 10.1158/1940-6207.CAPR-13-0058-T; Ruiter R, 2012, DIABETES CARE, V35, P119, DOI 10.2337/dc11-0857; Salani B, 2012, FASEB J, V26, P788, DOI 10.1096/fj.11-192088; Schiel R, 2005, EUR J MED RES, V10, P339; Sertznig P, 2007, J CELL PHYSIOL, V212, P1, DOI 10.1002/jcp.20998; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Shiau CW, 2005, CANCER RES, V65, P1561, DOI 10.1158/0008-5472.CAN-04-1677; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Smiechowski BB, 2013, DIABETES CARE, V36, P124, DOI 10.2337/dc12-0740; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Suzuki Y, 2012, INT J ONCOL, V41, P465, DOI 10.3892/ijo.2012.1483; Tang XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051814; Thakkar B, 2013, METABOLISM, V62, P922, DOI 10.1016/j.metabol.2013.01.014; Tsuta K, 2013, HUM PATHOL, V44, P975, DOI 10.1016/j.humpath.2012.09.002; Vallarino C, 2013, CLIN DRUG INVEST, V33, P621, DOI 10.1007/s40261-013-0106-9; Wells G, 2000, NEWCASTLE OTTAWA SCA; Wu N, 2011, NEOPLASMA, V58, P482, DOI 10.4149/neo_2011_06_482; Zhou J, 2009, INT J BIOCHEM CELL B, V41, P2334, DOI 10.1016/j.biocel.2009.06.007	56	14	14	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99577	10.1371/journal.pone.0099577	http://dx.doi.org/10.1371/journal.pone.0099577			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924771	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300077
J	Dietzel, S; Pircher, J; Nekolla, AK; Gull, M; Brandli, AW; Pohl, U; Rehberg, M				Dietzel, Steffen; Pircher, Joachim; Nekolla, A. Katharina; Gull, Mazhar; Braendli, Andre W.; Pohl, Ulrich; Rehberg, Markus			Label-Free Determination of Hemodynamic Parameters in the Microcirculaton with Third Harmonic Generation Microscopy	PLOS ONE			English	Article							ENDOTHELIAL SURFACE-LAYER; IN-VIVO; BLOOD-FLOW; 3RD-HARMONIC GENERATION; SHEAR RATE; GLYCOCALYX; VELOCITY; RESOLUTION; REVEALS; VESSELS	Determination of blood flow velocity and related hemodynamic parameters is an important aspect of physiological studies which in many settings requires fluorescent labeling. Here we show that Third Harmonic Generation (THG) microscopy is a suitable tool for label-free intravital investigations of the microcirculation in widely-used physiological model systems. THG microscopy is a non-fluorescent multi-photon scanning technique combining the advantages of label-free imaging with restriction of signal generation to a focal spot. Blood flow was visualized and its velocity was measured in adult mouse cremaster muscle vessels, non-invasively in mouse ear vessels and in Xenopus tadpoles. In arterioles, THG line scanning allowed determination of the flow pulse velocity curve and hence the heart rate. By relocating the scan line we obtained velocity profiles through vessel diameters, allowing shear rate calculations. The cell free layer containing the glycocalyx was also visualized. Comparison of the current microscopic resolution with theoretical, diffraction limited resolution let us conclude that an about sixty-fold THG signal intensity increase may be possible with future improved optics, optimized for 1200-1300 nm excitation. THG microscopy is compatible with simultaneous two-photon excited fluorescence detection. It thus also provides the opportunity to determine important hemodynamic parameters in parallel to common fluorescent observations without additional label.	[Dietzel, Steffen; Pircher, Joachim; Nekolla, A. Katharina; Gull, Mazhar; Braendli, Andre W.; Pohl, Ulrich; Rehberg, Markus] Univ Munich, Walter Brendel Zentrum Expt Med, Munich, Germany; [Pohl, Ulrich] SyNergy, Munich Cluster Syst Neurol, Munich, Germany; [Pohl, Ulrich] Deutsch Zentrum Herz Kreislaufforsch eV, Munich, Germany	University of Munich; German Centre for Cardiovascular Research	Dietzel, S (corresponding author), Univ Munich, Walter Brendel Zentrum Expt Med, Munich, Germany.	dietzel@lmu.de		Dietzel, Steffen/0000-0001-5725-3242; Rehberg, Markus/0000-0001-7314-6332	BioImaging Network of the Ludwig-Maximilians-Universitat Munchen; Excellence Initiative of the Deutsche Forschungsgemeinschaft; Bundesministerium fur Bildung und Forschung; European Commission (EU FP7 Program, EURenOmics Grant) [305608]; DFG [SFB1032]	BioImaging Network of the Ludwig-Maximilians-Universitat Munchen; Excellence Initiative of the Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF)); European Commission (EU FP7 Program, EURenOmics Grant); DFG(German Research Foundation (DFG))	This study was supported by the BioImaging Network of the Ludwig-Maximilians-Universitat Munchen (www.lmu.de) and the Excellence Initiative of the Deutsche Forschungsgemeinschaft (www.dfg.de) and the Bundesministerium fur Bildung und Forschung (www.bmbf.de). Further support was obtained by a grant from the European Commission (EU FP7 Program, EURenOmics Grant Agreement 305608 to AWB; http://cordis.europa.eu/fp7/home_en.html) and a grant from the DFG (SFB1032, Project B10 to MR). Funding institutions had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amos B, 2011, COMPREHENSIVE BIOPHYSICS, VOL 2: BIOPHYSICAL TECHNIQUES FOR CHARACTERIZATION OF CELLS, P3, DOI 10.1016/B978-0-12-374920-8.00203-4; Autio J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024056; BAEZ S, 1973, MICROVASC RES, V5, P384, DOI 10.1016/0026-2862(73)90054-X; Becker BF, 2010, BASIC RES CARDIOL, V105, P687, DOI 10.1007/s00395-010-0118-z; Bihari P, 2008, PART FIBRE TOXICOL, V5, DOI 10.1186/1743-8977-5-14; BLOCH EH, 1962, AM J ANAT, V110, P125, DOI 10.1002/aja.1001100204; Brandli AW, 2004, CHIMIA, V58, P694, DOI 10.2533/000942904777677443; Buerkle MA, 2004, CIRCULATION, V110, P2053, DOI 10.1161/01.CIR.0000143234.51796.A9; Campagnola PJ, 2008, HDB BIOMEDICAL NONLI, P377; Chaigneau E, 2003, P NATL ACAD SCI USA, V100, P13081, DOI 10.1073/pnas.2133652100; Chang CF, 2010, J BIOPHOTONICS, V3, P678, DOI 10.1002/jbio.201000045; Chen SY, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3269676; Cheng P-C, 2006, HDB BIOL CONFOCAL MI, P703, DOI DOI 10.1007/978-0-387-45524-2_40; Clay GO, 2006, J OPT SOC AM B, V23, P932, DOI 10.1364/JOSAB.23.000932; Cosgrove D, 2010, EUR J NUCL MED MOL I, V37, pS65, DOI 10.1007/s00259-010-1537-7; Cox G, 2004, MICROSC RES TECHNIQ, V63, P18, DOI 10.1002/jemt.10423; DAMON DN, 1979, MICROVASC RES, V17, P330, DOI 10.1016/S0026-2862(79)80008-4; De Backer D, 2012, J CLIN MONIT COMPUT, V26, P361, DOI 10.1007/s10877-012-9383-8; Fahraeus R, 1931, AM J PHYSIOL, V96, P562, DOI 10.1152/ajplegacy.1931.96.3.562; Farrar MJ, 2011, BIOPHYS J, V100, P1362, DOI 10.1016/j.bpj.2011.01.031; GOLDSMITH HL, 1986, MICROVASC RES, V31, P121, DOI 10.1016/0026-2862(86)90029-4; Helmchen F, 2008, METHOD ENZYMOL, V444, P231, DOI 10.1016/S0076-6879(08)02810-3; HOU PCL, 1995, AM J PHYSIOL-REG I, V269, pR1120, DOI 10.1152/ajpregu.1995.269.5.R1120; Jain Rakesh K, 2013, Cold Spring Harb Protoc, V2013, P354, DOI 10.1101/pdb.prot073916; Kalin RE, 2009, BLOOD, V114, P1110, DOI 10.1182/blood-2009-03-211771; Kamoun WS, 2010, NAT METHODS, V7, P655, DOI [10.1038/NMETH.1475, 10.1038/nmeth.1475]; Khandoga AG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004693; Kim S, 2007, AM J PHYSIOL-HEART C, V293, pH1526, DOI 10.1152/ajpheart.01090.2006; Kim TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038590; Kleinfeld D, 1998, P NATL ACAD SCI USA, V95, P15741, DOI 10.1073/pnas.95.26.15741; Krotz F, 2010, CARDIOVASC RES, V85, P542, DOI 10.1093/cvr/cvp301; Leahy M.J, 2012, MICROCIRCULATION IMA; Lee JH, 2009, J BIOMED OPT, V14, DOI 10.1117/1.3077182; Levick J.R., 2013, INTRO CARDIOVASCULAR; Millard AC, 1999, APPL OPTICS, V38, P7393, DOI 10.1364/AO.38.007393; Moffett Thomas, 1634, INSECTORUM SIVE MINI; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Oron D, 2004, J STRUCT BIOL, V147, P3, DOI 10.1016/S1047-8477(03)00125-4; Pfeffer CP, 2008, J STRUCT BIOL, V164, P140, DOI 10.1016/j.jsb.2008.07.002; Pircher J, 2012, ARTERIOSCL THROM VAS, V32, P2884, DOI 10.1161/ATVBAHA.112.300627; Poelma C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045247; Popel AS, 2005, ANNU REV FLUID MECH, V37, P43, DOI 10.1146/annurev.fluid.37.042604.133933; Pries AR, 1997, AM J PHYSIOL-HEART C, V273, pH2272, DOI 10.1152/ajpheart.1997.273.5.H2272; Rehberg M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028237; Rehberg M, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3374337; Reitsma S, 2007, PFLUG ARCH EUR J PHY, V454, P345, DOI 10.1007/s00424-007-0212-8; ROSENBLUM WI, 1969, CIRC RES, V24, P887, DOI 10.1161/01.RES.24.6.887; SARELIUS IH, 1982, AM J PHYSIOL, V243, pH1018, DOI 10.1152/ajpheart.1982.243.6.H1018; Schaller RD, 2000, ANAL CHEM, V72, P5361, DOI 10.1021/ac000699r; Schonfeld W, 1938, ARCH DERMATOL SYPH-G, V178, P201, DOI 10.1007/BF02061140; Schwerte T, 2003, COMP BIOCHEM PHYS A, V135, P131, DOI 10.1016/S1095-6433(03)00044-8; Smith ML, 2003, BIOPHYS J, V85, P637, DOI 10.1016/S0006-3495(03)74507-X; Sperandio M, 2013, BLOOD, V121, pE118, DOI 10.1182/blood-2012-07-447144; Sumen C, 2004, IMMUNITY, V21, P315, DOI 10.1016/S1074-7613(04)00237-7; TANGELDER GJ, 1988, AM J PHYSIOL, V254, pH1059, DOI 10.1152/ajpheart.1988.254.6.H1059; Thayil A, 2011, J BIOMED OPT, V16, DOI 10.1117/1.3569614; Tsai MR, 2011, BIOMED OPT EXPRESS, V2, P2317, DOI 10.1364/BOE.2.002317; Vink H, 2000, AM J PHYSIOL-HEART C, V278, pH285, DOI 10.1152/ajpheart.2000.278.1.H285; Vink H, 1996, CIRC RES, V79, P581, DOI 10.1161/01.RES.79.3.581; Weigelin Bettina, 2012, Intravital, V1, P32, DOI 10.4161/intv.21223; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Yu JH, 2013, NAT MATER, V12, P359, DOI [10.1038/NMAT3565, 10.1038/nmat3565]; Ziegler T, 2013, J CLIN INVEST, V123, P3436, DOI 10.1172/JCI66549	63	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99615	10.1371/journal.pone.0099615	http://dx.doi.org/10.1371/journal.pone.0099615			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933027	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600049
J	Jacques, J; Hotton, D; De la Dure-Molla, M; Petit, S; Asselin, A; Kulkarni, AB; Gibson, CW; Brookes, SJ; Berdal, A; Isaac, J				Jacques, Jaime; Hotton, Dominique; De la Dure-Molla, Muriel; Petit, Stephane; Asselin, Audrey; Kulkarni, Ashok B.; Gibson, Carolyn Winters; Brookes, Steven Joseph; Berdal, Ariane; Isaac, Juliane			Tracking Endogenous Amelogenin and Ameloblastin In Vivo	PLOS ONE			English	Article							PERIODONTAL-LIGAMENT CELLS; ENAMEL MATRIX PROTEINS; PRIMARY RNA TRANSCRIPT; RAT INCISOR; SUPRAMOLECULAR STRUCTURES; RECOMBINANT AMELOGENIN; PROGENITOR CELLS; BONE-FORMATION; ALVEOLAR BONE; STEM-CELLS	Research on enamel matrix proteins (EMPs) is centered on understanding their role in enamel biomineralization and their bioactivity for tissue engineering. While therapeutic application of EMPs has been widely documented, their expression and biological function in non-enamel tissues is unclear. Our first aim was to screen for amelogenin (AMELX) and ameloblastin (AMBN) gene expression in mandibular bones and soft tissues isolated from adult mice (15 weeks old). Using RT-PCR, we showed mRNA expression of AMELX and AMBN in mandibular alveolar and basal bones and, at low levels, in several soft tissues; eyes and ovaries were RNA-positive for AMELX and eyes, tongues and testicles for AMBN. Moreover, in mandibular tissues AMELX and AMBN mRNA levels varied according to two parameters: 1) ontogenic stage (decreasing with age), and 2) tissue-type (e. g. higher level in dental epithelial cells and alveolar bone when compared to basal bone and dental mesenchymal cells in 1 week old mice). In situ hybridization and immunohistodetection were performed in mandibular tissues using AMELX KO mice as controls. We identified AMELX-producing (RNA-positive) cells lining the adjacent alveolar bone and AMBN and AMELX proteins in the microenvironment surrounding EMPs-producing cells. Western blotting of proteins extracted by non-dissociative means revealed that AMELX and AMBN are not exclusive to mineralized matrix; they are present to some degree in a solubilized state in mandibular bone and presumably have some capacity to diffuse. Our data support the notion that AMELX and AMBN may function as growth factor-like molecules solubilized in the aqueous microenvironment. In jaws, they might play some role in bone physiology through autocrine/paracrine pathways, particularly during development and stress-induced remodeling.	[Jacques, Jaime; Hotton, Dominique; De la Dure-Molla, Muriel; Petit, Stephane; Asselin, Audrey; Berdal, Ariane; Isaac, Juliane] Univ Paris 05, Univ Paris 06, INSERM UMRS 1138, Lab Mol Oral Pathophysiol,Team Berdal,Cordeliers, Paris, France; [Jacques, Jaime; De la Dure-Molla, Muriel; Berdal, Ariane] Univ Paris 07, UFR Odontol, Paris, France; [Jacques, Jaime] Univ Talca, Dept Stomatol, Unit Periodontol, Talca, Chile; [De la Dure-Molla, Muriel; Berdal, Ariane] Hosp Rothschild, AP HP, Ctr Rare Malformat Face & Oral Cav MAFACE, Paris, France; [Kulkarni, Ashok B.] Natl Inst Dent & Craniofacial Res, Funct Genom Sect, Lab Cell & Dev Biol, NIH, Bethesda, MD USA; [Gibson, Carolyn Winters] Univ Penn, Sch Dent Med, Dept Anat & Cell Biol, Philadelphia, PA 19104 USA; [Brookes, Steven Joseph] Univ Leeds, Sch Dent, Dept Oral Biol, Leeds LS2 9JT, W Yorkshire, England; [Isaac, Juliane] CNRS URA 2578, Inst Pasteur, Dept Dev & Stem Cells Biol, Lab Morphogenesis Mol Genet, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Universidad de Talca; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Rothschild - APHP; UDICE-French Research Universities; Sorbonne Universite; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Pennsylvania; University of Leeds; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Isaac, J (corresponding author), Univ Paris 05, Univ Paris 06, INSERM UMRS 1138, Lab Mol Oral Pathophysiol,Team Berdal,Cordeliers, Paris, France.	isaacjuliane@yahoo.fr	Berdal, Ariane/AAC-8745-2022; Isaac, Juliane/G-4944-2017; Isaac, Juliane/AAV-5765-2021; Isaac, Juliane/AAD-8395-2022; de La Dure - Molla, Muriel/H-5068-2017	Berdal, Ariane/0000-0001-5833-5813; Isaac, Juliane/0000-0001-7898-022X; Isaac, Juliane/0000-0001-7898-022X; BROOKES, STEVEN/0000-0002-9097-7311; de La Dure - Molla, Muriel/0000-0003-3557-2845	French National Research Agency [ANR-12-BSV1-0018]; National Commission for Scientific and Technological Research of Chile CONICYT; IDEX Sorbonne Paris - Cite; The Wellcome Trust [093113]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000664] Funding Source: NIH RePORTER	French National Research Agency(French National Research Agency (ANR)); National Commission for Scientific and Technological Research of Chile CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); IDEX Sorbonne Paris - Cite; The Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This research was supported by the French National Research Agency (Osteodiversity project: ANR-12-BSV1-0018) and the National Commission for Scientific and Technological Research of Chile CONICYT grant. Financial support (Once upon a tooth) was obtained from IDEX Sorbonne Paris - Cite. S.J. Brookes was supported by The Wellcome Trust (grant no. 093113). The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Aioub M, 2007, BONE, V41, P851, DOI 10.1016/j.bone.2007.07.023; Alikhani M, 2012, J DENT RES, V91, P413, DOI 10.1177/0022034512438590; Amin HD, 2013, ACTA BIOMATER, V9, P4796, DOI 10.1016/j.actbio.2012.09.008; Amin HD, 2012, TISSUE ENG PT A, V18, P1193, DOI [10.1089/ten.TEA.2011.0375, 10.1089/ten.tea.2011.0375]; Athanassiou-Papaefthymiou M, EUR J ORAL SCI S1, V119, P35; Atsawasuwan P, 2013, J DENT RES, V92, P622, DOI 10.1177/0022034513487906; Atsawasuwan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052800; Bartlett JD, 2006, EUR J ORAL SCI, V114, P18, DOI 10.1111/j.1600-0722.2006.00292.x; Bartlett John D, 2013, ISRN Dent, V2013, P684607, DOI 10.1155/2013/684607; BERDAL A, 1993, DEV BIOL, V155, P172, DOI 10.1006/dbio.1993.1016; Beyeler M, 2010, EXP CELL RES, V316, P1202, DOI 10.1016/j.yexcr.2009.12.019; Bosshardt DD, 2008, J CLIN PERIODONTOL, V35, P87, DOI 10.1111/j.1600-051X.2008.01264.x; Brookes SJ, 2001, ARCH ORAL BIOL, V46, P201, DOI 10.1016/S0003-9969(00)00121-7; Coxon TL, 2012, CELLS TISSUES ORGANS, V196, P420, DOI 10.1159/000336440; Deutsch D, 2006, EUR J ORAL SCI, V114, P183, DOI 10.1111/j.1600-0722.2006.00301.x; FINCHAM AG, 1994, J STRUCT BIOL, V112, P103, DOI 10.1006/jsbi.1994.1011; Fukae M, 2006, EUR J ORAL SCI, V114, P212, DOI 10.1111/j.1600-0722.2006.00309.x; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; George A, 2008, CHEM REV, V108, P4670, DOI 10.1021/cr0782729; Gibson CW, 2001, J BIOL CHEM, V276, P31871, DOI 10.1074/jbc.M104624200; Grandin HM, 2012, TISSUE ENG PART B-RE, V18, P181, DOI [10.1089/ten.teb.2011.0365, 10.1089/ten.TEB.2011.0365]; Gruenbaum-Cohen Y, 2009, J EXP ZOOL PART B, V312B, P445, DOI 10.1002/jez.b.21255; Hatakeyama J, 2006, J DENT RES, V85, P144, DOI 10.1177/154405910608500206; Hatakeyama J, 2003, J BIOL CHEM, V278, P35743, DOI 10.1074/jbc.M306284200; Haze A, 2007, ANAT REC, V290, P455, DOI 10.1002/ar.20520; Haze A, 2009, J CELL MOL MED, V13, P1110, DOI 10.1111/j.1582-4934.2009.00700.x; Huang YC, 2010, CELL TISSUE RES, V342, P205, DOI 10.1007/s00441-010-1064-7; Iizuka S, 2011, MOL CELL BIOL, V31, P783, DOI 10.1128/MCB.00912-10; Iwata T, 2007, J DENT RES, V86, P153, DOI 10.1177/154405910708600209; Izumikawa M, 2012, SCI WORLD J, V2012; Jedeon K, 2013, AM J PATHOL, V183, P108, DOI 10.1016/j.ajpath.2013.04.004; Kakegawa A, 2010, J PERIODONTAL RES, V45, P643, DOI 10.1111/j.1600-0765.2010.01279.x; Kawasaki K, 2009, ANNU REV GENET, V43, P119, DOI 10.1146/annurev-genet-102108-134242; Kitagawa M, 2011, ARCH ORAL BIOL, V56, P374, DOI 10.1016/j.archoralbio.2010.10.012; Kunimatsu R, 2011, J PERIODONTOL, V82, P1632, DOI 10.1902/jop.2011.110031; Kuroda S, 2011, EUR CELLS MATER, V22, P56, DOI 10.22203/eCM.v022a05; Landin Maria A. dos Santos Silva, 2012, Frontiers in Genetics, V3, P139, DOI 10.3389/fgene.2012.00139; LAU EC, 1992, BIOCHEM BIOPH RES CO, V188, P1253, DOI 10.1016/0006-291X(92)91366-X; Li W, 1998, ARCH ORAL BIOL, V43, P497, DOI 10.1016/S0003-9969(98)00013-2; Li Y, 2006, EUR J ORAL SCI, V114, P190, DOI 10.1111/j.1600-0722.2006.00286.x; Limeback H, 1989, TOOTH ENAMEL, P269; Lu XY, 2013, BONE, V54, P157, DOI 10.1016/j.bone.2013.01.041; Lyngstadaas SP, 2009, ORTHOD CRANIOFAC RES, V12, P243, DOI 10.1111/j.1601-6343.2009.01459.x; Matsuzawa M, 2009, J PERIODONTAL RES, V44, P289, DOI 10.1111/j.1600-0765.2008.01091.x; Molla M, 2010, AM J PATHOL, V177, P2516, DOI 10.2353/ajpath.2010.091224; Nielsen BS, 2011, CLIN EXP METASTAS, V28, P27, DOI 10.1007/s10585-010-9355-7; Nunez J, 2010, J PERIODONTAL RES, V45, P809, DOI 10.1111/j.1600-0765.2010.01291.x; Papagerakis P, 2003, BONE, V32, P228, DOI 10.1016/S8756-3282(02)00978-X; Rached MT, 2010, J CLIN INVEST, V120, P357, DOI 10.1172/JCI39901; Saito K, 2008, BONE, V43, P371, DOI 10.1016/j.bone.2008.03.029; SIMMER JP, 1994, CALCIFIED TISSUE INT, V55, P302, DOI 10.1007/BF00310410; Smith CE, 2009, EUR J ORAL SCI, V117, P485, DOI 10.1111/j.1600-0722.2009.00666.x; Sodek J, 2000, PERIODONTOL 2000, V24, P99, DOI 10.1034/j.1600-0757.2000.2240106.x; Sonoda A, 2009, J BIOL CHEM, V284, P27176, DOI 10.1074/jbc.M109.033464; Spahr A, 2006, EUR J ORAL SCI, V114, P504, DOI 10.1111/j.1600-0722.2006.00403.x; Stahl J, 2013, MATRIX BIOL, V32, P432, DOI 10.1016/j.matbio.2013.05.004; Staines KA, 2012, J ENDOCRINOL, V214, P241, DOI 10.1530/JOE-12-0143; Tamburstuen MV, 2011, BONE, V48, P406, DOI 10.1016/j.bone.2010.09.007; Tamburstuen MV, 2010, EUR J ORAL SCI, V118, P451, DOI 10.1111/j.1600-0722.2010.00760.x; Uchida T, 1997, J HISTOCHEM CYTOCHEM, V45, P1329, DOI 10.1177/002215549704501002; Veis A, 2000, J BIOL CHEM, V275, P41263, DOI 10.1074/jbc.M002308200; Wald T, 2013, J BIOL CHEM, V288, P22333, DOI 10.1074/jbc.M113.456012; Wang HJ, 2005, J BONE MINER RES, V20, P1032, DOI 10.1359/JBMR.050111; Warotayanont R, 2008, BIOCHEM BIOPH RES CO, V367, P1, DOI 10.1016/j.bbrc.2007.12.048; Wazen RM, 2009, MATRIX BIOL, V28, P292, DOI 10.1016/j.matbio.2009.04.004; Wen X, 2011, BIOMATERIALS, V32, P6478, DOI 10.1016/j.biomaterials.2011.05.045; Zeichner-David M, 2006, EUR J ORAL SCI, V114, P244, DOI 10.1111/j.1600-0722.2006.00322.x; Zhang YB, 2011, EUR J ORAL SCI, V119, P280, DOI 10.1111/j.1600-0722.2011.00887.x; Zheng L, BONE, V55, P158; Zhou YL, 2000, J BIOL CHEM, V275, P12273, DOI 10.1074/jbc.275.16.12273	70	16	17	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99626	10.1371/journal.pone.0099626	http://dx.doi.org/10.1371/journal.pone.0099626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933156	Green Published, gold			2022-12-27	WOS:000337738600050
J	Jia, CL; Xiong, MQ; Wang, PW; Cui, JG; Du, XY; Yang, QB; Wang, WJ; Chen, Y; Zhang, T				Jia, Chenglin; Xiong, Minqi; Wang, Peiwei; Cui, Jingang; Du, Xiaoye; Yang, Qinbo; Wang, Wenjian; Chen, Yu; Zhang, Teng			Notoginsenoside R1 Attenuates Atherosclerotic Lesions in ApoE Deficient Mouse Model	PLOS ONE			English	Article							ISCHEMIA-REPERFUSION INJURY; MICRORNA EXPRESSION; ENDOTHELIAL-CELLS; PANAX-NOTOGINSENG; ACTIVATION; MICE; INFLAMMATION; DISEASE	Aims: Atherosclerosis is the primary cause of cardiovascular diseases and stroke. The current study evaluated the interventional effects of a naturally occurring compound Notoginsenoside R1 (NR1) on atherosclerosis in ApoE(-/-) mice. Methods and Results: The atherosclerotic lesion was significantly alleviated by NR1 treatment and this attenuation was marked by reduction in lipid deposition, fibrosis and oxidative stress. Increased serum levels of GSH and SOD and decreased level of MDH were observed in NR1-treated ApoE(-/-) mice. NR1 treatment also significantly decreased the levels of CHO, TG, ox-LDL and increased the level of HDL. Additionally, the levels of inflammatory cytokines including IL-2, IL-6, TNF-alpha and gamma-IFN were markedly reduced in NR1-treated ApoE(-/-) mice. Furthermore, significantly increased aortic expression of miR-26a, miR-21, miR-126a, miR-132, miR-146 and miR-155 and decreased expression of miR-20a and miR-92a were observed in the vehicle-treated ApoE(-/-) mice. While NR1 treatment led to a significant reduction in the expression of miR-21, miR-26a, miR-126 and increased expression of miR-20a. Conclusion: Collectively, our results demonstrated for the first time the anti-atherosclerotic effects of NR1, which could be in part mediated through its multiple targeting effects on inflammation, oxidative stress, lipid metabolism and microRNA expression. These results therefore justify further evaluation of NR1 as a therapeutic agent treating atherosclerosis.	[Jia, Chenglin; Xiong, Minqi; Wang, Peiwei; Cui, Jingang; Du, Xiaoye; Yang, Qinbo; Chen, Yu; Zhang, Teng] Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Shanghai, Peoples R China; [Wang, Peiwei; Cui, Jingang; Du, Xiaoye; Yang, Qinbo; Wang, Wenjian; Chen, Yu; Zhang, Teng] Shanghai Univ Tradit Chinese Med, Clin Res Inst Integrat Med, Shanghai, Peoples R China; [Wang, Wenjian] Fudan Univ, Inst Integrat Med, Shanghai 200433, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Fudan University	Chen, Y (corresponding author), Shanghai Univ Tradit Chinese Med, Yueyang Hosp, Shanghai, Peoples R China.	chenyu6639@gmail.com; zhangteng501@hotmail.com			Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Science and Technology Commission of Shanghai Municipality [11PJ1409000, 13PJ1407800]; Shu Guang Project; Shanghai Municipal Education Commission; Shanghai Education Development Foundation [13SG42]; National Natural Science Foundation of China [81273960]; Funding for Outstanding Junior Faculties at Shanghai Institutions of Higher Learning [ZZszy12048]; Three-year Projects to Promote Traditional Chinese Medicine, Shanghai [ZYSNXD-CC-ZDYJ050]; Key Disciplines of Clinical Integrative Medicine at the State Administration of Traditional Chinese Medicine of China	Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM)); Shu Guang Project(Chinese Academy of Sciences); Shanghai Municipal Education Commission(Shanghai Municipal Education Commission (SHMEC)); Shanghai Education Development Foundation; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Funding for Outstanding Junior Faculties at Shanghai Institutions of Higher Learning; Three-year Projects to Promote Traditional Chinese Medicine, Shanghai; Key Disciplines of Clinical Integrative Medicine at the State Administration of Traditional Chinese Medicine of China	This work was supported by the Program for Professor of Special Appointment (Eastern Scholar) at Shanghai Institutions of Higher Learning (YC and TZ), Program for Pu Jiang Scholar at Science and Technology Commission of Shanghai Municipality (11PJ1409000, 13PJ1407800, YC and TZ), Shu Guang Project supported by Shanghai Municipal Education Commission and Shanghai Education Development Foundation (13SG42, YZ), National Natural Science Foundation of China (81273960) (TZ), Funding for Outstanding Junior Faculties at Shanghai Institutions of Higher Learning (ZZszy12048) (PW), Three-year Projects to Promote Traditional Chinese Medicine, Shanghai (NO. ZYSNXD-CC-ZDYJ050), and Key Disciplines of Clinical Integrative Medicine at the State Administration of Traditional Chinese Medicine of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali KM, 2012, BRIT J PHARMACOL, V167, P1177, DOI 10.1111/j.1476-5381.2012.02081.x; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Chen T, 2009, CARDIOVASC RES, V83, P131, DOI 10.1093/cvr/cvp121; Dou L, 2012, CELL PHYSIOL BIOCHEM, V29, P875, DOI 10.1159/000315061; Fleissner F, 2010, CIRC RES, V107, P138, DOI 10.1161/CIRCRESAHA.110.216770; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Forrest ARR, 2010, LEUKEMIA, V24, P460, DOI 10.1038/leu.2009.246; Hansson GK, 2006, ANNU REV PATHOL-MECH, V1, P297, DOI 10.1146/annurev.pathol.1.110304.100100; HE L, 2004, NAT REV GENET, V5, P522; Hulsmans M, 2011, FASEB J, V25, P2515, DOI 10.1096/fj.11-181149; Ji RR, 2007, CIRC RES, V100, P1579, DOI 10.1161/CIRCRESAHA.106.141986; Ji W, 2007, J ETHNOPHARMACOL, V113, P318, DOI 10.1016/j.jep.2007.06.022; Kuehbacher A, 2007, CIRC RES, V101, P59, DOI 10.1161/CIRCRESAHA.107.153916; Leeper NJ, 2011, J CELL PHYSIOL, V226, P1035, DOI 10.1002/jcp.22422; Li C, 2014, AM J PHYSIOL-GASTR L, V306, pG111, DOI 10.1152/ajpgi.00123.2013; Ling SH, 2008, INT J CARDIOL, V128, P350, DOI 10.1016/j.ijcard.2007.05.111; Liu WJ, 2010, SHOCK, V34, P314, DOI 10.1097/SHK.0b013e3181ceede4; Lusis AJ, 2000, NATURE, V407, P233, DOI 10.1038/35025203; Madamanchi NR, 2005, ARTERIOSCL THROM VAS, V25, P950, DOI 10.1161/01.ATV.0000161050.77646.68; Manduteanu I, 2012, J CELL MOL MED, V16, P1978, DOI 10.1111/j.1582-4934.2012.01552.x; Meng X, 2014, FREE RADICAL RES, V48, P445, DOI 10.3109/10715762.2014.885117; Meng X, 2014, FREE RADICAL RES, V7, P7, DOI DOI 10.1111/1751-7915.12145; Nakamura Y, 2004, MOL CELL ENDOCRINOL, V219, P17, DOI 10.1016/j.mce.2004.02.013; O'Connell RM, 2012, ANNU REV IMMUNOL, V30, P295, DOI 10.1146/annurev-immunol-020711-075013; Post WS, 1999, CARDIOVASC RES, V43, P985, DOI 10.1016/S0008-6363(99)00153-4; ROSS R, 1993, NATURE, V362, P801, DOI 10.1038/362801a0; Sun B, 2013, BRIT J PHARMACOL, V168, P1758, DOI 10.1111/bph.12063; Tamminen M, 1999, ARTERIOSCL THROM VAS, V19, P847, DOI 10.1161/01.ATV.19.4.847; Toth Peter P, 2003, Curr Atheroscler Rep, V5, P386, DOI 10.1007/s11883-003-0010-5; Toth PP, 2004, CIRCULATION, V109, P1809, DOI 10.1161/01.CIR.0000126889.97626.B8; Wan JB, 2009, J AGR FOOD CHEM, V57, P6692, DOI 10.1021/jf900529w; Zampetaki A, 2013, FREE RADICAL BIO MED, V64, P69, DOI 10.1016/j.freeradbiomed.2013.06.025; Zhang WJ, 1997, ARTERIOSCL THROM VAS, V17, P465, DOI 10.1161/01.ATV.17.3.465; Zheng LA, 2010, BIOCHEM BIOPH RES CO, V400, P483, DOI 10.1016/j.bbrc.2010.08.067	35	46	55	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99849	10.1371/journal.pone.0099849	http://dx.doi.org/10.1371/journal.pone.0099849			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933211	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600072
J	Novak, P; Hribova, E; Neumann, P; Koblizkova, A; Dolezel, J; Macas, J				Novak, Petr; Hribova, Eva; Neumann, Pavel; Koblizkova, Andrea; Dolezel, Jaroslav; Macas, Jiri			Genome-Wide Analysis of Repeat Diversity across the Family Musaceae	PLOS ONE			English	Article							GENERATION SEQUENCING REVEALS; BANANA CULTIVARS; ACUMINATA GENOME; SIZE VARIATION; DNA; PHYLOGENY; EVOLUTION; ALIGNMENT; ELEMENTS; RETROTRANSPOSONS	Background: The banana family (Musaceae) includes genetically a diverse group of species and their diploid and polyploid hybrids that are widely cultivated in the tropics. In spite of their socio-economic importance, the knowledge of Musaceae genomes is basically limited to draft genome assemblies of two species, Musa acuminata and M. balbisiana. Here we aimed to complement this information by analyzing repetitive genome fractions of six species selected to represent various phylogenetic groups within the family. Results: Low-pass sequencing of M. acuminata, M. ornata, M. textilis, M. beccarii, M. balbisiana, and Ensete gilletii genomes was performed using a 454/Roche platform. Sequence reads were subjected to analysis of their overall intra-and interspecific similarities and, all major repeat families were quantified using graph-based clustering. Maximus/SIRE and Angela lineages of Ty1/copia long terminal repeat (LTR) retrotransposons and the chromovirus lineage of Ty3/gypsy elements were found to make up most of highly repetitive DNA in all species (14-34.5% of the genome). However, there were quantitative differences and sequence variations detected for classified repeat families as well as for the bulk of total repetitive DNA. These differences were most pronounced between species from different taxonomic sections of the Musaceae family, whereas pairs of closely related species (M. acuminata/M. ornata and M. beccarii/M. textilis) shared similar populations of repetitive elements. Conclusions: This study provided the first insight into the composition and sequence variation of repetitive parts of Musaceae genomes. It allowed identification of repetitive sequences specific for a single species or a group of species that can be utilized as molecular markers in breeding programs and generated computational resources that will be instrumental in repeat masking and annotation in future genome assembly projects.	[Novak, Petr; Neumann, Pavel; Koblizkova, Andrea; Macas, Jiri] Biol Ctr ASCR, Inst Plant Mol Biol, Ceske Budejovice, Czech Republic; [Hribova, Eva; Dolezel, Jaroslav] Ctr Reg Hana Biotechnol & Agr Res, Inst Expt Bot, Olomouc, Czech Republic	Czech Academy of Sciences; Biology Centre of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences	Novak, P (corresponding author), Biol Ctr ASCR, Inst Plant Mol Biol, Ceske Budejovice, Czech Republic.	petr@umbr.cas.cz	Macas, Jiri/G-8618-2014; Novak, Petr/A-3059-2013; Dolezel, Jaroslav/B-7716-2008; hribova, eva/F-7291-2014; Neumann, Pavel/H-7345-2013	Macas, Jiri/0000-0003-0829-1570; Novak, Petr/0000-0002-5068-9681; Dolezel, Jaroslav/0000-0002-6263-0492; Neumann, Pavel/0000-0001-6711-6639; Hribova, Eva/0000-0002-6868-4344	Ministry of Education, Youth, and Sports of the Czech Republic, INGO II [LG12021]; Bioversity International Bioversity International [LoA CfL 2012/43]; Ministry of Education, Youth, and Sports of the Czech Republic [LO1204]; Ministry of Education, Youth, and Sports of the Czech Republic KONTAKT II [LH11058]; Czech Science Foundation [GBP501/12/G090]; Academy of Sciences of the Czech Republic [RVO:60077344]	Ministry of Education, Youth, and Sports of the Czech Republic, INGO II; Bioversity International Bioversity International; Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Education, Youth, and Sports of the Czech Republic KONTAKT II; Czech Science Foundation(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	Funding was provided by the Ministry of Education, Youth, and Sports of the Czech Republic, INGO II No. LG12021, http://www.msmt.cz/ (JD); Bioversity International Bioversity International, LoA CfL 2012/43, www.bioversityinternational.org (JD), Ministry of Education, Youth, and Sports of the Czech Republic, LO1204, http://www.msmt.cz/ (JD); Ministry of Education, Youth, and Sports of the Czech Republic KONTAKT II LH11058, http://www.msmt.cz/ (JM); The Czech Science Foundation, GBP501/12/G090, www.gacr.cz (JM); and The Academy of Sciences of the Czech Republic, RVO:60077344, http://www.cas.cz/ (JM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bartos J, 2005, CYTOGENET GENOME RES, V109, P50, DOI 10.1159/000082381; Carreel F, 1994, ETUDE DIVERSITE BANA; CHEESMAN E. E., 1950, Kew Bulletin, P27, DOI 10.2307/4119816; Cheesman EE, 2008, CLASSIFICATION BANAN; Christelova P, 2011, AOB PLANTS, DOI 10.1093/aobpla/plr024; Christelova P, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-103; Cizkova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054808; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Davey MW, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-683; DOLEZEL J, 1994, BIOL PLANTARUM, V36, P351, DOI 10.1007/BF02920930; Ellis THN, 1998, MOL GEN GENET, V260, P9, DOI 10.1007/s004380050865; FRUCHTERMAN TMJ, 1991, SOFTWARE PRACT EXPER, V21, P1129, DOI 10.1002/spe.4380211102; Galtier N, 1996, COMPUT APPL BIOSCI, V12, P543; Gong ZY, 2012, PLANT CELL, V24, P3559, DOI 10.1105/tpc.112.100511; Hakkinen M, 2013, TAXON, V62, P809, DOI 10.12705/624.3; Hawkins JS, 2006, GENOME RES, V16, P1252, DOI 10.1101/gr.5282906; Heckmann S, 2013, PLANT J, V73, P555, DOI 10.1111/tpj.12054; Heslop-Harrison JS, 2007, ANN BOT-LONDON, V100, P1073, DOI 10.1093/aob/mcm191; Hribova E, 2007, CYTOGENET GENOME RES, V119, P268, DOI 10.1159/000112073; Hribova E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017863; Hribova E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-204; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; JARRET RL, 1992, THEOR APPL GENET, V84, P579, DOI 10.1007/BF00224155; Kalendar R, 1999, THEOR APPL GENET, V98, P704, DOI 10.1007/s001220051124; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; LANDER E S, 1988, Genomics, V2, P231; Li LF, 2010, MOL PHYLOGENET EVOL, V57, P1, DOI 10.1016/j.ympev.2010.06.021; Loh JP, 2000, MOL PHYLOGENET EVOL, V17, P360, DOI 10.1006/mpev.2000.0848; Macas J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027335; Martis MM, 2012, P NATL ACAD SCI USA, V109, P13343, DOI 10.1073/pnas.1204237109; Neumann P, 2006, GENETICS, V173, P1047, DOI 10.1534/genetics.106.056259; Neumann P, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002777; Neumann P, 2011, MOBILE DNA-UK, V2, DOI 10.1186/1759-8753-2-4; Novak P, 2013, BIOINFORMATICS, V29, P792, DOI 10.1093/bioinformatics/btt054; Novak P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-378; Pagan HJT, 2012, GENOME BIOL EVOL, V4, P575, DOI 10.1093/gbe/evs038; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Piednoel M, 2012, MOL BIOL EVOL, V29, P3601, DOI 10.1093/molbev/mss168; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; PURUGGANAN MD, 1995, MOL ECOL, V4, P265, DOI 10.1111/j.1365-294X.1995.tb00218.x; Renny-Byfield S, 2011, MOL BIOL EVOL, V28, P2843, DOI 10.1093/molbev/msr112; Risterucci AM, 2009, THEOR APPL GENET, V119, P1093, DOI 10.1007/s00122-009-1111-5; Ruangsuttapha S, 2007, GENET RESOUR CROP EV, V54, P1565, DOI 10.1007/s10722-006-9169-2; Safar J, 2004, PLANT J, V39, P960, DOI 10.1111/j.1365-313X.2004.02179.x; SIMMONDS N. W., 1956, Kew Bulletin, P463, DOI 10.2307/4109131; SIMMONDS N. W., 1955, JOUR LINNEAN SOC BOT, V55, P302; Smit A, 1996, REPEATMASKER OPEN 30; Staton SE, 2012, PLANT J, V72, P142, DOI 10.1111/j.1365-313X.2012.05072.x; Tenaillon MI, 2011, GENOME BIOL EVOL, V3, P219, DOI 10.1093/gbe/evr008; Velasco R, 2010, NAT GENET, V42, P833, DOI 10.1038/ng.654; Wang Y, 2013, PLANT J, V76, P557, DOI 10.1111/tpj.12313; Wong C, 2001, ANN BOT-LONDON, V88, P1017, DOI 10.1006/anbo.2001.1542; ZHANG HB, 1995, PLANT J, V7, P175, DOI 10.1046/j.1365-313X.1995.07010175.x; Zuccolo A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-152	55	48	49	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98918	10.1371/journal.pone.0098918	http://dx.doi.org/10.1371/journal.pone.0098918			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932725	gold, Green Submitted, Green Published			2022-12-27	WOS:000337738600014
J	Sanquetta, CR; Behling, A; Dalla Corte, AP; Netto, SP; Rodrigues, AL; Simon, AA				Sanquetta, Carlos Roberto; Behling, Alexandre; Dalla Corte, Ana Paula; Netto, Sylvio Pellico; Rodrigues, Aurelio Lourenco; Simon, Augusto Arlindo			A Model Based on Environmental Factors for Diameter Distribution in Black Wattle in Brazil	PLOS ONE			English	Article							PINUS-RADIATA; EUCALYPTUS-GRANDIS; WEIBULL FUNCTION; STAND STRUCTURE; GROWTH; WATER; DYNAMICS; YIELD; PRODUCTIVITY; EFFICIENCY	This article discusses the dynamics of a diameter distribution in stands of black wattle throughout its growth cycle using the Weibull probability density function. Moreover, the parameters of this distribution were related to environmental variables from meteorological data and surface soil horizon with the aim of finding a model for diameter distribution which their coefficients were related to the environmental variables. We found that the diameter distribution of the stand changes only slightly over time and that the estimators of the Weibull function are correlated with various environmental variables, with accumulated rainfall foremost among them. Thus, a model was obtained in which the estimators of the Weibull function are dependent on rainfall. Such a function can have important applications, such as in simulating growth potential in regions where historical growth data is lacking, as well as the behavior of the stand under different environmental conditions. The model can also be used to project growth in diameter, based on the rainfall affecting the forest over a certain time period.	[Sanquetta, Carlos Roberto; Behling, Alexandre; Dalla Corte, Ana Paula; Netto, Sylvio Pellico; Rodrigues, Aurelio Lourenco] Univ Fed Parana, Dept Forest Sci, BR-80060000 Curitiba, Parana, Brazil; [Simon, Augusto Arlindo] TANAC SA Forest Dept, Montenegro, RS, Brazil	Universidade Federal do Parana	Rodrigues, AL (corresponding author), Univ Fed Parana, Dept Forest Sci, BR-80060000 Curitiba, Parana, Brazil.	alourencorodrigues@gmail.com	Corte, Ana Paula Dalla/K-6833-2014	Corte, Ana Paula Dalla/0000-0001-8529-5554; Rodrigues, Aurelio/0000-0003-4070-8305	company TANAC SA; National Institute of Meteorology (INMET); CNPq	company TANAC SA; National Institute of Meteorology (INMET); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	The authors would like to thank the company TANAC SA and the National Institute of Meteorology (INMET) for supporting this research, and CNPq for the masters' level scholarship that co-author Alexandre Behling received.	Allen H. L., 1999, Bosque, V20, P3; [Anonymous], 2009, ANALISE MULTIVARIADA; Arce JE, 1999, MODELOS DINAMICOS DI, P21; Arce Julio Eduardo, 2004, Ciênc. Florest., V14, P149, DOI 10.5902/198050981790; BENSON ML, 1992, FOREST ECOL MANAG, V52, P117, DOI 10.1016/0378-1127(92)90498-X; Binkley D, 2004, FOREST ECOL MANAG, V193, P5, DOI 10.1016/j.foreco.2004.01.019; Blake T., 1992, ECOPHYSIOL SHORT ROT, P66; Binoti DHB, 2010, REV ARVORE, V34, P147, DOI 10.1590/S0100-67622010000100016; BURKHART HE, 1997, EMPIRICAL PROCESS BA, P53; Campos J. C. C., 1981, Revista Arvore, V5, P1; CAO QV, 1984, FOREST SCI, V30, P129; Cao QV, 2004, FOREST SCI, V50, P682; Catalunha MJ., 2002, REV BRAS AGROMETEORO, V10, P153; Clutter J. L., 1965, DIAMETER DISTRIBUTIO; Clutter JL, 1983, TIMBER MANAGEMENT QU; Clutter JL, 1974, GROWTH MODELS TREE S, P136; Dalla Corte AP, 2004, REV ACAD, V2, P33, DOI [DOI 10.7213/CIENCIAANIMAL.V2I3.15093, 10.7213/cienciaanimal.v2i3.15093]; Retslaff FAD, 2012, REV ARVORE, V36, P719, DOI 10.1590/S0100-67622012000400013; Draper NR, 1980, APPL REGRESSION ANAL; Figura MR, 2010, THESIS; Finger CAG, 1982, THESIS; HUNTER IR, 1984, NEW ZEAL J FOR SCI, V14, P53; Johnson N.L., 1995, CONTINUOUS UNIVARIAT, VVolumes 1 and 2; Kayahara G, 1998, FOREST ECOL MANAG, V74, P161; Landsberg J., 2003, FBMIS, V1, P49; Leite Helio Garcia, 2006, Rev. Árvore, V30, P89, DOI 10.1590/S0100-67622006000100011; LEVINS R, 1966, AM SCI, V54, P421; Loetsch F., 1973, FOREST INVENTORY; Machado S. A., 2000, Cerne, V6, P55; Machado SA, 2009, SCI AGRARIA, V10, P103, DOI DOI 10.5380/RSA.V10I2.13575; Machado Sebastião do Amaral, 2006, Rev. Árvore, V30, P759, DOI 10.1590/S0100-67622006000500009; MAESTRI R., 1992, THESIS U FED PARANA; Miguel EP, 2010, CERNE, V16, P94, DOI 10.1590/S0104-77602010000100011; NAUTIYAL JC, 1984, FOREST SCI, V30, P761; Nogueira Gilciano Saraiva, 2005, Rev. Árvore, V29, P579, DOI 10.1590/S0100-67622005000400010; Palahi M, 2007, EUR J FOREST RES, V126, P563, DOI 10.1007/s10342-007-0177-3; Pearson K, 1905, BIOMETRIKA, V4, P169, DOI 10.1093/biomet/4.1-2.169; Pearson K, 1894, PHILOS T R SOC A, V186, P343, DOI DOI 10.1098/RSTA.1895.0010; Pereira A. B., 2004, Acta Scientiarum - Agronomy, V26, P437; Robert A, 2003, ECOL MODEL, V167, P287, DOI 10.1016/S0304-3800(03)00200-X; Ryan MG, 2010, FOREST ECOL MANAG, V259, P1695, DOI 10.1016/j.foreco.2010.01.013; Samuelson LJ, 2004, FOREST ECOL MANAG, V192, P59, DOI 10.1016/j.foreco.2004.01.005; SANDS R, 1990, FOREST ECOL MANAG, V30, P91, DOI 10.1016/0378-1127(90)90129-Y; SAS Institute Inc, 1989, SAS QC SOFTW REF VER; SCOLFORO J. R. S., 1998, MANEJO FLORESTAL; Scolforo JR, 1990, THESIS; SNOWDON P, 1992, FOREST ECOL MANAG, V52, P87, DOI 10.1016/0378-1127(92)90497-W; Snowdon P, 1998, NEW FOREST, V16, P101, DOI 10.1023/A:1006524609459; Soares C., 2000, SCI FOR, V58, P41, DOI DOI 10.1016/J.FORECO.2018.08.051; Soares TS, 2011, REV ARVORE, V35, P1027, DOI 10.1590/S0100-67622011000600008; Stape J. L., 2002, THESIS; Stape JL, 2010, FOREST ECOL MANAG, V259, P1684, DOI 10.1016/j.foreco.2010.01.012; Steinmetz S., 1999, Agropecuaria Clima Temperado, V2, P77; Vianello R.F., 2000, METEOROLOGIA BASICA; Villa Nova NA, 2003, REV BRASILEIRA AGROM, V11, P63; WEIBULL W, 1951, J APPL MECH-T ASME, V18, P293; Williams TM, 2006, BIOMASS BIOENERG, V30, P370, DOI 10.1016/j.biombioe.2005.07.017	57	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100093	10.1371/journal.pone.0100093	http://dx.doi.org/10.1371/journal.pone.0100093			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932909	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600093
J	Chan, PL; Rose, RJ; Murad, AMA; Zainal, Z; Low, ETL; Ooi, LCL; Ooi, SE; Yahya, S; Singh, R				Chan, Pek-Lan; Rose, Ray J.; Murad, Abdul Munir Abdul; Zainal, Zamri; Low, Eng-Ti Leslie; Ooi, Leslie Cheng-Li; Ooi, Siew-Eng; Yahya, Suzaini; Singh, Rajinder			Evaluation of Reference Genes for Quantitative Real-Time PCR in Oil Palm Elite Planting Materials Propagated by Tissue Culture	PLOS ONE			English	Article							ELAEIS-GUINEENSIS JACQ.; EXPRESSED SEQUENCE TAGS; INTERNAL CONTROL GENES; SOMATIC EMBRYOGENESIS; RT-PCR; TRANSCRIPTOME ANALYSIS; GOSSYPIUM-HIRSUTUM; NORMALIZATION; VALIDATION; SELECTION	Background: The somatic embryogenesis tissue culture process has been utilized to propagate high yielding oil palm. Due to the low callogenesis and embryogenesis rates, molecular studies were initiated to identify genes regulating the process, and their expression levels are usually quantified using reverse transcription quantitative real-time PCR (RT-qPCR). With the recent release of oil palm genome sequences, it is crucial to establish a proper strategy for gene analysis using RT-qPCR. Selection of the most suitable reference genes should be performed for accurate quantification of gene expression levels. Results: In this study, eight candidate reference genes selected from cDNA microarray study and literature review were evaluated comprehensively across 26 tissue culture samples using RT-qPCR. These samples were collected from two tissue culture lines and media treatments, which consisted of leaf explants cultures, callus and embryoids from consecutive developmental stages. Three statistical algorithms (geNorm, NormFinder and BestKeeper) confirmed that the expression stability of novel reference genes (pOP-EA01332, PD00380 and PD00569) outperformed classical housekeeping genes (GAPDH, NAD5, TUBULIN, UBIQUITIN and ACTIN). PD00380 and PD00569 were identified as the most stably expressed genes in total samples, MA2 and MA8 tissue culture lines. Their applicability to validate the expression profiles of a putative ethylene-responsive transcription factor 3-like gene demonstrated the importance of using the geometric mean of two genes for normalization. Conclusions: Systematic selection of the most stably expressed reference genes for RT-qPCR was established in oil palm tissue culture samples. PD00380 and PD00569 were selected for accurate and reliable normalization of gene expression data from RT-qPCR. These data will be valuable to the research associated with the tissue culture process. Also, the method described here will facilitate the selection of appropriate reference genes in other oil palm tissues and in the expression profiling of genes relating to yield, biotic and abiotic stresses.	[Chan, Pek-Lan; Low, Eng-Ti Leslie; Ooi, Leslie Cheng-Li; Ooi, Siew-Eng; Singh, Rajinder] MPOB, Adv Biotechnol & Breeding Ctr, Kajang, Selangor, Malaysia; [Rose, Ray J.] Univ Newcastle, Sch Environm & Life Sci, Australian Res Council Ctr Excellence Integrat Le, Callaghan, NSW 2308, Australia; [Murad, Abdul Munir Abdul; Zainal, Zamri] Univ Kebangsaan Malaysia, Fac Sci & Technol, Sch Biosci & Biotechnol, Ukm Bangi, Selangor, Malaysia; [Yahya, Suzaini] Sime Darby Biotech Labs Sdn Bhd, Banting, Selangor, Malaysia	Malaysian Palm Oil Board; University of Newcastle; Universiti Kebangsaan Malaysia	Chan, PL (corresponding author), MPOB, Adv Biotechnol & Breeding Ctr, 6 Persiaran Inst, Kajang, Selangor, Malaysia.	chanpl@mpob.gov.my	Murad, Abdul/CAG-9324-2022; Singh, Rajinder/P-9179-2015; Low, Eng Ti Leslie/AHD-7011-2022; Munir, Abdul/L-8575-2017	Singh, Rajinder/0000-0001-9933-4884; Low, Eng Ti Leslie/0000-0003-3414-8401; Munir, Abdul/0000-0001-6402-7198; Ooi, Siew-Eng/0000-0002-6621-5456; Ooi, Leslie/0000-0002-6996-2801	Malaysian Palm Oil Board (MPOB) [R000999000-RB01-J]	Malaysian Palm Oil Board (MPOB)	The research work was supported by Malaysian Palm Oil Board (MPOB) through research grant R000999000-RB01-J. The funder had no role in study design, data collection and analysis, or preparation of the manuscript. The MPOB Director-General supported publication of the manuscript and did not influence the content.	Andersen CL, 2004, CANCER RES, V64, P5245, DOI 10.1158/0008-5472.CAN-04-0496; [Anonymous], 2013, PALM OIL FACTS FIGUR; Artico S, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-49; Baker WJ, 2011, ANN BOT-LONDON, V108, P1417, DOI 10.1093/aob/mcr020; Barsalobres-Cavallari CF, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-1; BOWLER C, 1989, EMBO J, V8, P31, DOI 10.1002/j.1460-2075.1989.tb03345.x; Brunner Amy M., 2004, BMC Plant Biology, V4, P14, DOI 10.1186/1471-2229-4-14; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chan PL, 2010, ELECTRON J BIOTECHN, V13, DOI 10.2225/vol13-issue1-fulltext-14; Chandna R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036918; Chang EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033278; Chi XY, 2012, MOL GENET GENOMICS, V287, P167, DOI 10.1007/s00438-011-0665-5; Choo YM, 2005, PALM OIL DEV, V42, P3; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Corley RHV, 2003, OIL PALM VEGETATIVE; de Vega-Bartol JJ, 2013, PLANT CELL REP, V32, P715, DOI 10.1007/s00299-013-1407-4; Dekkers BJW, 2012, PLANT CELL PHYSIOL, V53, P28, DOI 10.1093/pcp/pcr113; Dussert S, 2013, PLANT PHYSIOL, V162, P1337, DOI 10.1104/pp.113.220525; Exposito-Rodriguez M, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-131; Fan CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056573; Gantasala Nagavara Prasad, 2013, BMC Res Notes, V6, P312, DOI 10.1186/1756-0500-6-312; Han B, 2013, BIOMETALS, V26, P403, DOI 10.1007/s10534-013-9623-5; Han XJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043084; Ho CL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-381; Hu RB, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-93; Jouannic S, 2005, FEBS LETT, V579, P2709, DOI 10.1016/j.febslet.2005.03.093; Kushairi A., 2010, INT SEM ADV OIL PALM; Le DT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046487; Thuc LV, 2011, MOL BIOTECHNOL, V48, P156, DOI 10.1007/s12033-010-9356-4; Li Q, 2012, PLANT CELL REP, V31, P1789, DOI 10.1007/s00299-012-1282-4; Lin HC, 2009, PLANT MOL BIOL, V70, P173, DOI 10.1007/s11103-009-9464-3; Lin YL, 2010, PLANT SCI, V178, P359, DOI 10.1016/j.plantsci.2010.02.005; Low E. T. L., 2009, THESIS U PUTRA MALAY; Low ETL, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-62; Ma LM, 2013, MAR GENOM, V11, P67, DOI 10.1016/j.margen.2013.08.002; Mafra V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031263; Maksup S, 2013, CHINESE SCI BULL, V58, P1919, DOI 10.1007/s11434-013-5726-1; Mantiri FR, 2008, PLANT PHYSIOL, V146, P1622, DOI 10.1104/pp.107.110379; McCarty DR, 1986, MAIZE GEN COOP NEWSL, V60, P61; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Narsai R, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-56; Nicot N, 2005, J EXP BOT, V56, P2907, DOI 10.1093/jxb/eri285; Ooi SE, 2012, PLANT CELL TISS ORG, V110, P201, DOI 10.1007/s11240-012-0143-8; Pfaffl MW, 2004, BIOTECHNOL LETT, V26, P509, DOI 10.1023/B:BILE.0000019559.84305.47; Piyatrakul P, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-244; Podevin N, 2012, MOL BREEDING, V30, P1237, DOI 10.1007/s11032-012-9711-1; Roowi SH, 2010, MOL BIOTECHNOL, V46, P1, DOI 10.1007/s12033-010-9262-9; Rozen S, 2000, Methods Mol Biol, V132, P365; Shearman JR, 2013, GENOMICS, V101, P306, DOI 10.1016/j.ygeno.2013.02.012; Singh R, 2013, NATURE, V500, P335, DOI 10.1038/nature12309; Tranbarger TJ, 2011, PLANT PHYSIOL, V156, P564, DOI 10.1104/pp.111.175141; Udvardi MK, 2008, PLANT CELL, V20, P1736, DOI 10.1105/tpc.108.061143; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang LJ, 2013, PLANT PHYSIOL BIOCH, V70, P304, DOI 10.1016/j.plaphy.2013.05.038; Wang M, 2013, GENE, V530, P44, DOI 10.1016/j.gene.2013.07.084; Wheelan SJ, 2001, GENOME RES, V11, P1952, DOI 10.1101/gr.195301; Willis LB, 2008, J OIL PALM RES, P1; Wooi K. C., 1995, P 1993 ISOPB INT S R, P21; Xiao D, 2012, FUNCT PLANT BIOL, V39, P342, DOI 10.1071/FP11246; Yeap WC, 2014, PLANT CELL TISS ORG, V116, P55, DOI 10.1007/s11240-013-0382-3; Yeap WC, 2012, PLANT CELL REP, V31, P1829, DOI 10.1007/s00299-012-1297-x; Zamzuri I., 2007, OIL PALM B, V55, P26; Zhu XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044405	63	23	24	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99774	10.1371/journal.pone.0099774	http://dx.doi.org/10.1371/journal.pone.0099774			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927412	Green Published, gold			2022-12-27	WOS:000338278100078
J	Hectors, SJCG; Jacobs, I; Strijkers, GJ; Nicolay, K				Hectors, Stefanie J. C. G.; Jacobs, Igor; Strijkers, Gustav J.; Nicolay, Klaas			Multiparametric MRI Analysis for the Identification of High Intensity Focused Ultrasound-Treated Tumor Tissue	PLOS ONE			English	Article							PERCUTANEOUS RADIOFREQUENCY ABLATION; CONTRAST-ENHANCED MRI; IMAGING FOLLOW-UP; MAGNETIZATION-TRANSFER; UTERINE FIBROIDS; THERMAL DOSIMETRY; CELL CARCINOMA; BREAST-CANCER; LIVER-TUMORS; IN-VIVO	Purpose: In this study endogenous magnetic resonance imaging (MRI) biomarkers for accurate segmentation of High Intensity Focused Ultrasound (HIFU)-treated tumor tissue and residual or recurring non-treated tumor tissue were identified. Methods: Multiparametric MRI, consisting of quantitative T-1, T-2, Apparent Diffusion Coefficient (ADC) and Magnetization Transfer Ratio (MTR) mapping, was performed in tumor-bearing mice before (n = 14), 1 h after (n = 14) and 72 h (n = 7) after HIFU treatment. A non-treated control group was included (n = 7). Cluster analysis using the Iterative Self Organizing Data Analysis (ISODATA) technique was performed on subsets of MRI parameters (feature vectors). The clusters resulting from the ISODATA segmentation were divided into a viable and non-viable class based on the fraction of pixels assigned to the clusters at the different experimental time points. ISODATA-derived non-viable tumor fractions were quantitatively compared to histology-derived non-viable tumor volume fractions. Results: The highest agreement between the ISODATA-derived and histology-derived non-viable tumor fractions was observed for feature vector {T-1, T-2, ADC}. R-1 (1/T-1), R-2 (1/T-2), ADC and MTR each were significantly increased in the ISODATA-defined non-viable tumor tissue at 1 h after HIFU treatment compared to viable, non-treated tumor tissue. R1, ADC and MTR were also significantly increased at 72 h after HIFU. Conclusions: This study demonstrates that non-viable, HIFU-treated tumor tissue can be distinguished from viable, non-treated tumor tissue using multiparametric MRI analysis. Clinical application of the presented methodology may allow for automated, accurate and objective evaluation of HIFU treatment.	[Hectors, Stefanie J. C. G.; Jacobs, Igor; Strijkers, Gustav J.; Nicolay, Klaas] Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, NL-5600 MB Eindhoven, Netherlands; [Hectors, Stefanie J. C. G.; Jacobs, Igor; Strijkers, Gustav J.; Nicolay, Klaas] Ctr Imaging Res & Educ, Eindhoven, Netherlands; [Strijkers, Gustav J.] Univ Amsterdam, Acad Med Ctr, NL-1105 AZ Amsterdam, Netherlands	Eindhoven University of Technology; University of Amsterdam; Academic Medical Center Amsterdam	Hectors, SJCG (corresponding author), Eindhoven Univ Technol, Dept Biomed Engn, Biomed NMR, POB 513, NL-5600 MB Eindhoven, Netherlands.	s.j.c.g.hectors@tue.nl		Hectors, Stefanie/0000-0001-9457-6606; Nicolay, Klaas/0000-0002-4179-616X; Strijkers, Gustav/0000-0001-6700-5058	Center for Translational Molecular Medicine, project VOLTA [05T-201]	Center for Translational Molecular Medicine, project VOLTA	This work was supported by the Center for Translational Molecular Medicine (www.ctmm.nl), project VOLTA (grant 05T-201). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alic L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022835; Aulino P, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-363; Carano RAD, 2004, MAGNET RESON MED, V51, P542, DOI 10.1002/mrm.10731; Dewhirst MW, 2003, INT J HYPERTHER, V19, P267, DOI 10.1080/0265673031000119006; Dromain C, 2002, RADIOLOGY, V223, P255, DOI 10.1148/radiol.2231010780; Graham SJ, 1999, MAGNET RESON MED, V42, P1061, DOI 10.1002/(SICI)1522-2594(199912)42:6<1061::AID-MRM10>3.0.CO;2-T; Henkelman RM, 2001, NMR BIOMED, V14, P57, DOI 10.1002/nbm.683; Henning EC, 2007, MAGN RESON MED, V57, P501, DOI 10.1002/mrm.21161; Hesley GK, 2013, CARDIOVASC INTER RAD, V36, P5, DOI 10.1007/s00270-012-0367-3; Hijnen NM, 2013, J THER ULTRASOUND, V1, DOI 10.1186/2050-5736-1-8; Hijnen NM, 2012, INT J HYPERTHER, V28, P141, DOI 10.3109/02656736.2011.648137; Hundt W, 2009, TECHNOL CANCER RES T, V8, P85, DOI 10.1177/153303460900800201; Hynynen K, 2010, ULTRASONICS, V50, P221, DOI 10.1016/j.ultras.2009.08.015; Jacobs MA, 2000, JMRI-J MAGN RESON IM, V11, P425, DOI 10.1002/(SICI)1522-2586(200004)11:4<425::AID-JMRI11>3.0.CO;2-0; Jacobs MA, 2009, J MAGN RESON IMAGING, V29, P649, DOI 10.1002/jmri.21677; Karlsson M, 1999, MAGN RESON IMAGING, V17, P1481, DOI 10.1016/S0730-725X(99)00078-8; Kennedy JE, 2005, NAT REV CANCER, V5, P321, DOI 10.1038/nrc1591; Kirkham APS, 2008, RADIOLOGY, V246, P833, DOI 10.1148/radiol.2463062080; Leslie T, 2012, BRIT J RADIOL, V85, P1363, DOI 10.1259/bjr/56737365; Leslie TA, 2008, BRIT J RADIOL, V81, P564, DOI 10.1259/bjr/27118953; Levitt M, 1981, J MAGN RESON, V43, P56; McSheehy PMJ, 2010, CLIN CANCER RES, V16, P212, DOI 10.1158/1078-0432.CCR-09-0686; Merckel LG, 2013, CARDIOVASC INTER RAD, V36, P292, DOI 10.1007/s00270-012-0526-6; Merkle EM, 2005, RADIOLOGY, V235, P1065, DOI 10.1148/radiol.2353040871; Murat Francois-Joseph, 2007, Cancer Control, V14, P244; Ogawara K, 2008, INT J PHARMACEUT, V359, P234, DOI 10.1016/j.ijpharm.2008.03.025; Omran MGH, 2007, INTELL DATA ANAL, V11, P583, DOI 10.3233/IDA-2007-11602; Peng HH, 2009, J MAGN RESON IMAGING, V30, P596, DOI 10.1002/jmri.21860; Pilatou MC, 2009, J MAGN RESON IMAGING, V29, P404, DOI 10.1002/jmri.21688; Rieke V, 2008, J MAGN RESON IMAGING, V27, P376, DOI 10.1002/jmri.21265; Rouviere O, 2012, NAT REV CLIN ONCOL, V9, P721, DOI 10.1038/nrclinonc.2012.136; Rouviere O, 2010, EUR RADIOL, V20, P48, DOI 10.1007/s00330-009-1520-5; Schmitz AC, 2008, EUR RADIOL, V18, P1431, DOI 10.1007/s00330-008-0906-0; Seip R, 2010, IEEE T BIO-MED ENG, V57, P61, DOI 10.1109/TBME.2009.2028874; ter Haar G, 2007, PROG BIOPHYS MOL BIO, V93, P111, DOI 10.1016/j.pbiomolbio.2006.07.005; Voogt MJ, 2012, EUR RADIOL, V22, P411, DOI 10.1007/s00330-011-2262-8; Wijlemans JW, 2013, INVEST RADIOL, V48, P381, DOI 10.1097/RLI.0b013e3182820257; WOLFE DA, 1976, BIOMETRIKA, V63, P214, DOI 10.1093/biomet/63.1.214; WOLFF SD, 1994, RADIOLOGY, V192, P593, DOI 10.1148/radiology.192.3.8058919; Yarmolenko PS, 2011, INT J HYPERTHER, V27, P320, DOI 10.3109/02656736.2010.534527; Zhang YY, 2011, EUR J RADIOL, V79, P347, DOI 10.1016/j.ejrad.2010.06.039	41	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99936	10.1371/journal.pone.0099936	http://dx.doi.org/10.1371/journal.pone.0099936			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927280	Green Published, gold			2022-12-27	WOS:000338278100094
J	Lee, J; Lee, JP; Park, JI; Hwang, JH; Jang, HM; Choi, JY; Kim, YL; Yang, CW; Kang, SW; Kim, NH; Kim, YS; Lim, CS				Lee, Jeonghwan; Lee, Jung Pyo; Park, Ji In; Hwang, Jin Ho; Jang, Hye Min; Choi, Ji-Young; Kim, Yong-Lim; Yang, Chul Woo; Kang, Shin-Wook; Kim, Nam-Ho; Kim, Yon Su; Lim, Chun Soo		CRC ESRD Investigators	Early Nephrology Referral Reduces the Economic Costs among Patients Who Start Renal Replacement Therapy: A Prospective Cohort Study in Korea	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; HEMODIALYSIS-PATIENTS; DIALYSIS; OUTCOMES; IMPACT; CARE; MORTALITY; COMORBIDITY; ACCESS; HEALTH	Background: The nature of cost-saving effects of early referral to a nephrologist in patients with chronic kidney disease (CKD) is not fully evaluated. We evaluated the health care costs before and after dialysis according to the referral time. Methods: A total of 879 patients who were newly diagnosed as having end-stage renal disease from August 2008 to June 2011 were prospectively enrolled. The early referral (ER) group was defined as patients who were referred to a nephrologist more than a year before dialysis and had visited a nephrology clinic 2 or more times. Patients whose referral time was less than a year were considered the late referral (LR) group. Information about medical costs was acquired from the claim data of the Korea Health Insurance Review and Assessment Service. Results: The total medical costs during the first 12 months after the initiation of dialysis were not different between the 526 ER patients and the 353 LR patients. However, the costs of the ER patients during the first month were significantly lower than those of the LR patients (ER vs. LR: 3029 +/- 2219 vs. 3438 +/- 2821 US dollars [USD], P = 0.025). The total 12-month health care costs before the initiation of dialysis were significantly lower in the ER group (ER vs. LR: 6206 +/- 5873 vs. 8610 +/- 7820 USD, P<0.001). In the multivariate analysis, ER significantly lowered the health care costs during the 12 months before (2534.0 +/- 436.2 USD, P<0.001) and the first month (428.5 +/- 172.3 USD, P = 0.013) after the initiation of dialysis. Conclusions: The ER of patients with CKD to a nephrologist is associated with decreased medical costs during the pretreatment period of renal replacement therapy and the early period of dialysis initiation.	[Lee, Jeonghwan] Hallym Univ, Hangang Sacred Heart Hosp, Dept Internal Med, Seoul, South Korea; [Lee, Jeonghwan; Lee, Jung Pyo; Park, Ji In; Hwang, Jin Ho; Jang, Hye Min; Choi, Ji-Young; Kim, Yong-Lim; Yang, Chul Woo; Kang, Shin-Wook; Kim, Nam-Ho; Kim, Yon Su; Lim, Chun Soo; CRC ESRD Investigators] CRC ESRD, Taegu, South Korea; [Lee, Jung Pyo; Lim, Chun Soo] Seoul Natl Univ, Boramae Med Ctr, Dept Internal Med, Seoul, South Korea; [Park, Ji In; Kim, Yon Su; Lim, Chun Soo] Seoul Natl Univ, Coll Med, Dept Internal Med, Seoul 151, South Korea; [Hwang, Jin Ho] Chung Ang Univ Hosp, Dept Internal Med, Seoul, South Korea; [Jang, Hye Min] Kyungpook Natl Univ, Dept Stat, Taegu, South Korea; [Choi, Ji-Young; Kim, Yong-Lim] Kyungpook Natl Univ, Dept Internal Med, Sch Med, Taegu, South Korea; [Yang, Chul Woo] Catholic Univ Korea, Coll Med, Dept Internal Med, Seoul, South Korea; [Kang, Shin-Wook] Yonsei Univ, Coll Med, Dept Internal Med, Seoul, South Korea; [Kim, Nam-Ho] Chonnam Natl Univ, Dept Internal Med, Sch Med, Kwangju, South Korea	Hallym University; Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Chung Ang University; Chung Ang University Hospital; Kyungpook National University; Kyungpook National University; Catholic University of Korea; Yonsei University; Yonsei University Health System; Chonnam National University	Lim, CS (corresponding author), CRC ESRD, Taegu, South Korea.	cslimjy@snu.ac.kr	Lee, Jeonghwan/C-5214-2011; Hwang, Jin Ho/E-7203-2015	Lee, Jeonghwan/0000-0003-3199-635X; Park, Ji In/0000-0003-4662-3759; Hwang, Jin Ho/0000-0003-0829-0922	Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea [HI10C2020]	Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea	This study was supported by a grant of the Korea Healthcare technology R&D Project, Ministry of Health and Welfare, Republic of Korea. (HI10C2020). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arora P, 1999, J AM SOC NEPHROL, V10, P1281; Astor BC, 2001, AM J KIDNEY DIS, V38, P494, DOI 10.1053/ajkd.2001.26833; Avorn J, 2002, J CLIN EPIDEMIOL, V55, P711, DOI 10.1016/S0895-4356(02)00415-8; Avron J, 2002, ARCH INTERN MED, V162, P2002; Caskey FJ, 2003, NEPHROL DIAL TRANSPL, V18, P1330, DOI 10.1093/ndt/gfg156; Chae JW, 2011, NEPHRON CLIN PRACT, V117, pC379, DOI 10.1159/000321525; Chan MR, 2007, AM J MED, V120, P1063, DOI 10.1016/j.amjmed.2007.04.024; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Chen SC, 2010, AM J MED SCI, V339, P123, DOI 10.1097/MAJ.0b013e3181c0678a; Choi JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084257; Collins AJ, 2013, AM J KIDNEY DIS, V61, pE1, DOI 10.1053/j.ajkd.2012.11.031; Collins AJ, 2009, AM J KIDNEY DIS, V53, pS1, DOI 10.1053/j.ajkd.2008.10.005; DAVIES SJ, 1995, AM J KIDNEY DIS, V26, P353, DOI 10.1016/0272-6386(95)90657-6; Eadington DW, 1996, NEPHROL DIAL TRANSPL, V11, P2124, DOI 10.1093/oxfordjournals.ndt.a027123; Hommel K, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-108; Ifudu O, 1996, AM J KIDNEY DIS, V28, P841, DOI 10.1016/S0272-6386(96)90383-2; INNES A, 1992, NEPHROL DIAL TRANSPL, V7, P467; Ismail N, 1998, NEPHROL DIAL TRANSPL, V13, P246, DOI 10.1093/ndt/13.2.246; James MT, 2010, LANCET, V375, P1296, DOI 10.1016/S0140-6736(09)62004-3; Jin Dong Chan, 2011, Korean Journal of Internal Medicine, V26, P123, DOI 10.3904/kjim.2011.26.2.123; Jones C, 2006, NEPHROL DIAL TRANSPL, V21, P2133, DOI 10.1093/ndt/gfl198; JUNGERS P, 1993, KIDNEY INT, V43, pS170; JUNGERS P, 1993, NEPHROL DIAL TRANSPL, V8, P1089; Kazmi WH, 2004, NEPHROL DIAL TRANSPL, V19, P1808, DOI 10.1093/ndt/gfg573; Keith DS, 2004, ARCH INTERN MED, V164, P659, DOI 10.1001/archinte.164.6.659; Kessler M, 2003, AM J KIDNEY DIS, V42, P474, DOI 10.1016/S0272-6386(03)00805-9; Kim do H, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0055323, DOI 10.1371/J0URNAL.P0NE.0055323]; Kim S, 2009, J KOREAN MED SCI, V24, pS11, DOI 10.3346/jkms.2009.24.S1.S11; Kinchen KS, 2002, ANN INTERN MED, V137, P479, DOI 10.7326/0003-4819-137-6-200209170-00007; Ledoux F, 2001, REV MED INTERNE, V22, P245, DOI 10.1016/S0248-8663(00)00325-8; Levey AS, 2012, LANCET, V379, P165, DOI 10.1016/S0140-6736(11)60178-5; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levin A, 1997, AM J KIDNEY DIS, V29, P533, DOI 10.1016/S0272-6386(97)90334-6; Metcalfe W, 2000, KIDNEY INT, V57, P2539, DOI 10.1046/j.1523-1755.2000.00113.x; Obialo CI, 2005, AM J KIDNEY DIS, V46, P881, DOI 10.1053/j.ajkd.2005.08.003; Roderick P, 2002, NEPHROL DIAL TRANSPL, V17, P1252, DOI 10.1093/ndt/17.7.1252; Roderick P, 2002, QJM-INT J MED, V95, P363, DOI 10.1093/qjmed/95.6.363; Roubicek C, 2000, AM J KIDNEY DIS, V36, P35, DOI 10.1053/ajkd.2000.8241; Schmidt RJ, 1998, AM J KIDNEY DIS, V32, P278, DOI 10.1053/ajkd.1998.v32.pm9708613; Seok Su Jin, 2010, Korean Journal of Internal Medicine, V25, P188, DOI 10.3904/kjim.2010.25.2.188; Smart NA, 2011, AM J MED, V124, P1073, DOI 10.1016/j.amjmed.2011.04.026; Smith DH, 2004, J AM SOC NEPHROL, V15, P1300, DOI 10.1097/01.ASN.0000125670.64996.BB; Stack AG, 2003, AM J KIDNEY DIS, V41, P310, DOI 10.1053/ajkd.2003.50038; Stehman-Breen CO, 2000, KIDNEY INT, V57, P639, DOI 10.1046/j.1523-1755.2000.t01-1-00885.x; Winkelmayer WC, 2002, TRANSPLANTATION, V73, P1918, DOI 10.1097/00007890-200206270-00012; Winkelmayer WC, 2001, KIDNEY INT, V60, P1547, DOI 10.1046/j.1523-1755.2001.00958.x; Yokoyama Y, 2009, NEPHRON CLIN PRACT, V113, pC191, DOI 10.1159/000232601	47	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99460	10.1371/journal.pone.0099460	http://dx.doi.org/10.1371/journal.pone.0099460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927081	gold, Green Submitted, Green Published			2022-12-27	WOS:000338278100043
J	Liu, JL; Zhang, B; Song, SJ; Ma, M; Si, SY; Wang, YH; Xu, BX; Feng, K; Wu, JG; Guo, YC				Liu, JunLi; Zhang, Bing; Song, ShuJun; Ma, Ming; Si, ShaoYan; Wang, YiHu; Xu, BingXin; Feng, Kai; Wu, JiGong; Guo, YanChuan			Bovine Collagen Peptides Compounds Promote the Proliferation and Differentiation of MC3T3-E1 Pre-Osteoblasts	PLOS ONE			English	Article							ALKALINE-PHOSPHATASE; ANTIOXIDANT ACTIVITY; BONE; EXPRESSION; CELLS; HYDROLYSATE; DISEASE; RATS; MINERALIZATION; GELATIN	Objective: Collagen peptides (CP) compounds, as bone health supplements, are known to play a role in the treatment of osteoporosis. However, the molecular mechanisms of this process remain unclear. This study aimed to investigate the effects of bovine CP compounds on the proliferation and differentiation of MC3T3-E1 cells. Methods: Mouse pre-osteoblast cell line MC3T3-E1 subclone 4 cells were treated with bovine CP compounds. Cell proliferation was analyzed by MTT assays and the cell cycle was evaluated by flow cytometry scanning. Furthermore, MC3T3-E1 cell differentiation was analyzed at the RNA level by real-time PCR and at the protein level by western blot analysis for runt-related transcription factor 2 (Runx2), a colorimetric p-nitrophenyl phosphate assay for alkaline phosphatase (ALP), and ELISA for osteocalcin (OC). Finally, alizarin red staining for mineralization was measured using Image Software Pro Plus 6.0. Results: Cell proliferation was very efficient after treatment with different concentrations of bovine CP compounds, and the best concentration was 3 mg/mL. Bovine CP compounds significantly increased the percentage of MC3T3-E1 cells in G(2)/S phase. Runx2 expression, ALP activity, and OC production were significantly increased after treatment with bovine CP compounds for 7 or 14 days. Quantitative analyses with alizarin red staining showed significantly increased mineralization of MC3T3-E1 cells after treatment with bovine CP compounds for 14 or 21 days. Conclusions: Bovine CP compounds increased osteoblast proliferation, and played positive roles in osteoblast differentiation and mineralized bone matrix formation. Taking all the experiments together, our study indicates a molecular mechanism for the potential treatment of osteoarthritis and osteoporosis.	[Liu, JunLi; Song, ShuJun; Si, ShaoYan; Xu, BingXin; Feng, Kai; Wu, JiGong] 306 Hosp PLA, Dept Pathol & Expt Med, Beijing, Peoples R China; [Zhang, Bing; Ma, Ming; Wang, YiHu; Guo, YanChuan] Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Photochem Convers & Optoelect Mat, Beijing, Peoples R China	Chinese Academy of Sciences; Technical Institute of Physics & Chemistry, CAS	Guo, YC (corresponding author), Chinese Acad Sci, Tech Inst Phys & Chem, Key Lab Photochem Convers & Optoelect Mat, Beijing, Peoples R China.	guoyanchuan79@163.com			Technical institute of Physics and Chemistry, CAS [LHS-DBSW2013-01]	Technical institute of Physics and Chemistry, CAS(Chinese Academy of Sciences)	This work was supported by The cooperation project from Technical institute of Physics and Chemistry, CAS (Grant No. LHS-DBSW2013-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam M, 1996, Cas Lek Cesk, V135, P74; Aleman A, 2011, FOOD RES INT, V44, P1044, DOI 10.1016/j.foodres.2011.03.010; Aleman A, 2011, LWT-FOOD SCI TECHNOL, V44, P407, DOI 10.1016/j.lwt.2010.09.003; Banerjee P, 2014, CHEM-BIOL INTERACT, V211, P1, DOI 10.1016/j.cbi.2014.01.002; Bello AE, 2006, CURR MED RES OPIN, V22, P2221, DOI 10.1185/030079906X148373; BERESFORD JN, 1993, AM J MED GENET, V45, P163, DOI 10.1002/ajmg.1320450205; Clark KL, 2008, CURR MED RES OPIN, V24, P1485, DOI 10.1185/030079908X291967 ; Dennison E, 2006, RHEUM DIS CLIN N AM, V32, P617, DOI 10.1016/j.rdc.2006.08.003; FRANCESCHI RT, 1992, J BONE MINER RES, V7, P235; Jackix ED, 2010, J MED FOOD, V13, P1385, DOI 10.1089/jmf.2009.0256; Ji CH, 1998, J CELL BIOCHEM, V69, P353, DOI 10.1002/(SICI)1097-4644(19980601)69:3<353::AID-JCB12>3.3.CO;2-W; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kawaguchi T, 2012, BIOL PHARM BULL, V35, P422, DOI 10.1248/bpb.35.422; Kim HK, 2013, MOLECULES, V18, P15474, DOI 10.3390/molecules181215474; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Lai CF, 2001, J BIOL CHEM, V276, P14443, DOI 10.1074/jbc.M010021200; Lee KE, 2013, GENET MOL RES, V12, P4567, DOI 10.4238/2013.October.15.5; Li Yinqing, 2010, Zhongguo Zhong Yao Za Zhi, V35, P759; Moskowitz RW, 2000, SEMIN ARTHRITIS RHEU, V30, P87, DOI 10.1053/sarh.2000.9622; Nomura Y, 2005, NUTRITION, V21, P1120, DOI 10.1016/j.nut.2005.03.007; Orimo Hideo, 2010, Journal of Nippon Medical School, V77, P4; Patti A, 2013, INT J ENDOCRINOL, V2013, DOI 10.1155/2013/846480; Proksch E, 2014, SKIN PHARMACOL PHYS, V27, P113, DOI 10.1159/000355523; Schadow S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053955; STEIN GS, 1990, FASEB J, V4, P3111, DOI 10.1096/fasebj.4.13.2210157; SUDO H, 1983, J CELL BIOL, V96, P191, DOI 10.1083/jcb.96.1.191; Takeda S, 2013, J INT SOC SPORT NUTR, V10, DOI 10.1186/1550-2783-10-35; WEINREB M, 1990, J BONE MINER RES, V5, P831; Yamada S, 2013, DENT MATER J, V32, P88, DOI 10.4012/dmj.2012-220; Yamakawa K, 2003, J RHEUMATOL, V30, P1032; Zhang W, 2002, CELL RES, V12, P9, DOI 10.1038/sj.cr.7290105; Zheng ZH, 2009, J BIOMED MATER RES A, V89A, P453, DOI 10.1002/jbm.a.31979	32	47	53	3	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99920	10.1371/journal.pone.0099920	http://dx.doi.org/10.1371/journal.pone.0099920			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926875	gold, Green Submitted, Green Published			2022-12-27	WOS:000338278100090
J	Moffett, RC; Vasu, S; Thorens, B; Drucker, DJ; Flatt, PR				Moffett, R. Charlotte; Vasu, Srividya; Thorens, Bernard; Drucker, Daniel J.; Flatt, Peter R.			Incretin Receptor Null Mice Reveal Key Role of GLP-1 but Not GIP in Pancreatic Beta Cell Adaptation to Pregnancy	PLOS ONE			English	Article							GLUCAGON-LIKE PEPTIDE-1; ALPHA-CELLS; INSULIN-SECRETION; GLUCOSE-HOMEOSTASIS; ISLET; MASS; PROGLUCAGON; PHYSIOLOGY; EXPRESSION; PROLIFERATION	Islet adaptations to pregnancy were explored in C57BL6/J mice lacking functional receptors for glucagon-like peptide 1 (GLP-1) and gastric inhibitory polypeptide (GIP). Pregnant wild type mice and GIPRKO mice exhibited marked increases in islet and beta cell area, numbers of medium/large sized islets, with positive effects on Ki67/Tunel ratio favouring beta cell growth and enhanced pancreatic insulin content. Alpha cell area and glucagon content were unchanged but prohormone convertases PC2 and PC1/3 together with significant amounts of GLP-1 and GIP were detected in alpha cells. Knockout of GLP-1R abolished these islet adaptations and paradoxically decreased pancreatic insulin, GLP-1 and GIP. This was associated with abolition of normal pregnancy-induced increases in plasma GIP, L-cell numbers, and intestinal GIP and GLP-1 stores. These data indicate that GLP-1 but not GIP is a key mediator of beta cell mass expansion and related adaptations in pregnancy, triggered in part by generation of intra-islet GLP-1.	[Moffett, R. Charlotte; Vasu, Srividya; Flatt, Peter R.] Univ Ulster, SAAD Ctr Pharm & Diabet, Coleraine BT52 1SA, Londonderry, North Ireland; [Thorens, Bernard] Univ Lausanne, Ctr Integrat Genom, Lausanne, Switzerland; [Drucker, Daniel J.] Univ Toronto, Mt Sinai Hosp, Lunenfield Tanenbaum Res Inst, Toronto, ON M5G 1X5, Canada	Ulster University; University of Lausanne; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto	Vasu, S (corresponding author), Univ Ulster, SAAD Ctr Pharm & Diabet, Cromore Rd, Coleraine BT52 1SA, Londonderry, North Ireland.	s.vasu@ulster.ac.uk	Drucker, Daniel J/A-4092-2010	Flatt, Peter/0000-0001-8548-7943; Moffett, R Charlotte/0000-0002-7196-7863	EFSD/Boehringer Ingelheim Grant; Department of Education and Learning, Northern Ireland; Canada Research Chairs Program; BBDC-Novo Nordisk Chair in Incretin Biology; CIHR [82700]	EFSD/Boehringer Ingelheim Grant; Department of Education and Learning, Northern Ireland; Canada Research Chairs Program(Canada Research Chairs); BBDC-Novo Nordisk Chair in Incretin Biology; CIHR(Canadian Institutes of Health Research (CIHR))	The study was supported in part by an EFSD/Boehringer Ingelheim Grant and a research scholarship to RCM from Department of Education and Learning, Northern Ireland. DJD is supported by the Canada Research Chairs Program, a BBDC-Novo Nordisk Chair in Incretin Biology, and CIHR grant 82700. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahren B, 2010, VITAM HORM, V84, P203, DOI [10.1016/S0083-6729(10)84011-7, 10.1016/B978-0-12-381517-0.00007-2]; Anini Y, 2003, ENDOCRINOLOGY, V144, P3244, DOI 10.1210/en.2003-0143; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Barnett AH, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f4382; Butler AE, 2010, DIABETOLOGIA, V53, P2167, DOI 10.1007/s00125-010-1809-6; Campbell JE, 2013, CELL METAB, V17, P819, DOI 10.1016/j.cmet.2013.04.008; Campbell RK, 2011, CLIN THER, V33, P511, DOI 10.1016/j.clinthera.2011.04.015; Campbell RK, 2009, J AM PHARM ASSOC, V49, pS10, DOI 10.1331/JAPhA.2009.09076; Chen GF, 2011, ENDOCRINE, V39, P118, DOI 10.1007/s12020-010-9421-6; Combettes MMJ, 2006, CURR OPIN PHARMACOL, V6, P598, DOI 10.1016/j.coph.2006.08.003; Dalle Stephane, 2011, Curr Mol Pharmacol, V4, P187; Derosa G, 2012, CURR CLIN PHARMACOL, V7, P214, DOI 10.2174/157488412800958686; Devlieger R, 2008, ACTA OBSTET GYN SCAN, V87, P1266, DOI 10.1080/00016340802443863; Drucker DJ, 2006, CELL METAB, V3, P153, DOI 10.1016/j.cmet.2006.01.004; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; EISSELE R, 1992, EUR J CLIN INVEST, V22, P283, DOI 10.1111/j.1365-2362.1992.tb01464.x; Ellingsgaard H, 2011, NAT MED, V17, P1481, DOI 10.1038/nm.2513; FLATT PR, 1981, DIABETOLOGIA, V20, P573; Friedrichsen BN, 2006, J ENDOCRINOL, V188, P481, DOI 10.1677/joe.1.06160; Fujita Y, 2010, GASTROENTEROLOGY, V138, P1966, DOI 10.1053/j.gastro.2010.01.049; Fukami A, 2013, DIABETES, V62, P510, DOI 10.2337/db12-0294; Girard J, 2008, DIABETES METAB, V34, P550, DOI 10.1016/j.diabet.2008.09.001; GREENBAUM CJ, 1991, J CLIN INVEST, V88, P767, DOI 10.1172/JCI115375; Grigoryan M, 2012, ENDOCRINOLOGY, V153, P3076, DOI 10.1210/en.2012-1120; Hansen AMK, 2011, DIABETOLOGIA, V54, P1379, DOI 10.1007/s00125-011-2080-1; Hansotia T, 2005, REGUL PEPTIDES, V128, P125, DOI 10.1016/j.regpep.2004.07.019; Herbach N, 2005, REGUL PEPTIDES, V125, P103, DOI 10.1016/j.regpep.2004.08.021; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Huang C, 2009, ENDOCRINOLOGY, V150, P1618, DOI 10.1210/en.2008-1003; Irwin N, 2013, BIOCHEM PHARMACOL, V85, P81, DOI 10.1016/j.bcp.2012.10.008; Irwin N, 2010, EXPERT OPIN INV DRUG, V19, P1039, DOI 10.1517/13543784.2010.513381; Irwin N, 2009, BEST PRACT RES CL EN, V23, P499, DOI 10.1016/j.beem.2009.03.001; Jacovetti C, 2012, J CLIN INVEST, V122, P3541, DOI 10.1172/JCI64151; Karaca M, 2009, DIABETES METAB, V35, P77, DOI 10.1016/j.diabet.2008.09.007; Kawamori D, 2009, CELL METAB, V9, P350, DOI 10.1016/j.cmet.2009.02.007; Kilimnik G, 2010, ISLETS, V2, P149, DOI 10.4161/isl.2.3.11396; Kim H, 2010, NAT MED, V16, P804, DOI 10.1038/nm.2173; Larsen MO, 2009, DAN MED BULL, V56, P153; Ling Z, 2001, VIRCHOWS ARCH, V438, P382, DOI 10.1007/s004280000374; Marchetti P, 2012, DIABETOLOGIA, V55, P3262, DOI 10.1007/s00125-012-2716-9; McIntosh CHS, 2010, VITAM HORM, V84, P21, DOI [10.1016/S0083-6729(10)84016-6, 10.1016/B978-0-12-381517-0.00002-3]; Miyawaki K, 2002, NAT MED, V8, P738, DOI 10.1038/nm727; MOJSOV S, 1990, J BIOL CHEM, V265, P8001; Nadal A, 2009, J PHYSIOL-LONDON, V587, P5031, DOI 10.1113/jphysiol.2009.177188; Nauck MA, 2013, DIABETOLOGIA, V56, P1878, DOI 10.1007/s00125-013-2953-6; Nie Y, 2000, J CLIN INVEST, V105, P955, DOI 10.1172/JCI7456; PARSONS JA, 1995, ENDOCRINOLOGY, V136, P2013, DOI 10.1210/en.136.5.2013; Pederson RA, 1998, DIABETES, V47, P1046, DOI 10.2337/diabetes.47.7.1046; Preitner F, 2004, J CLIN INVEST, V113, P635, DOI 10.1172/JCI200420518; Rieck S, 2010, TRENDS ENDOCRIN MET, V21, P151, DOI 10.1016/j.tem.2009.11.001; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Schraenen A, 2010, DIABETOLOGIA, V53, P2589, DOI 10.1007/s00125-010-1913-7; Scrocchi LA, 1996, NAT MED, V2, P1254, DOI 10.1038/nm1196-1254; Sugiyama C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043745; Tolhurst G, 2009, J PHYSIOL-LONDON, V587, P27, DOI 10.1113/jphysiol.2008.164012; Whalley NM, 2011, J ENDOCRINOL, V211, P99, DOI 10.1530/JOE-11-0094; Wideman RD, 2007, DIABETES, V56, P2744, DOI 10.2337/db07-0563; Wu TZ, 2010, VITAM HORM, V84, P81, DOI [10.1016/S0083-6729(10)84015-4, 10.1016/B978-0-12-381517-0.00003-5]; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xu E, 2006, CELL METAB, V3, P47, DOI 10.1016/j.cmet.2005.11.015; Xue Y, 2010, ENDOCRINE, V37, P83, DOI 10.1007/s12020-009-9273-0	62	52	52	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e96863	10.1371/journal.pone.0096863	http://dx.doi.org/10.1371/journal.pone.0096863			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927416	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100007
J	Wolfram, D; Starzl, R; Hackl, H; Barclay, D; Hautz, T; Zelger, B; Brandacher, G; Lee, WPA; Eberhart, N; Vodovotz, Y; Pratschke, J; Pierer, G; Schneeberger, S				Wolfram, Dolores; Starzl, Ravi; Hackl, Hubert; Barclay, Derek; Hautz, Theresa; Zelger, Bettina; Brandacher, Gerald; Lee, W. P. Andrew; Eberhart, Nadine; Vodovotz, Yoram; Pratschke, Johann; Pierer, Gerhard; Schneeberger, Stefan			Insights from Computational Modeling in Inflammation and Acute Rejection in Limb Transplantation	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ALLOGRAFT-REJECTION; FACTOR-ALPHA; BINDING-PROTEIN; SKIN; CELLS; MECHANISMS; DISCOVERY; CYTOKINES; DISEASE	Acute skin rejection in vascularized composite allotransplantation (VCA) is the major obstacle for wider adoption in clinical practice. This study utilized computational modeling to identify biomarkers for diagnosis and targets for treatment of skin rejection. Protein levels of 14 inflammatory mediators in skin and muscle biopsies from syngeneic grafts [n = 10], allogeneic transplants without immunosuppression [n = 10] and allografts treated with tacrolimus [n = 10] were assessed by multiplexed analysis technology. Hierarchical Clustering Analysis, Principal Component Analysis, Random Forest Classification and Multinomial Logistic Regression models were used to segregate experimental groups. Based on Random Forest Classification, Multinomial Logistic Regression and Hierarchical Clustering Analysis models, IL-4, TNF-alpha and IL-12p70 were the best predictors of skin rejection and identified rejection well in advance of histopathological alterations. TNF-alpha and IL-12p70 were the best predictors of muscle rejection and also preceded histopathological alterations. Principal Component Analysis identified IL-1 alpha, IL-18, IL-1 beta, and IL-4 as principal drivers of transplant rejection. Thus, inflammatory patterns associated with rejection are specific for the individual tissue and may be superior for early detection and targeted treatment of rejection.	[Wolfram, Dolores; Eberhart, Nadine; Pierer, Gerhard] Med Univ Innsbruck, Dept Plast Reconstruct & Aesthet Surg, A-6020 Innsbruck, Austria; [Starzl, Ravi] Carnegie Mellon Univ, Language Technol Inst, Pittsburgh, PA 15213 USA; [Hackl, Hubert] Med Univ Innsbruck, Div Bioinformat, Bioctr, A-6020 Innsbruck, Austria; [Barclay, Derek; Vodovotz, Yoram] Univ Pittsburgh, Dept Immunol, Pittsburgh, PA USA; [Hautz, Theresa; Pratschke, Johann; Schneeberger, Stefan] Med Univ Innsbruck, Dept Visceral Transplant & Thorac Surg, A-6020 Innsbruck, Austria; [Zelger, Bettina] Med Univ Innsbruck, Dept Pathol, A-6020 Innsbruck, Austria; [Brandacher, Gerald; Lee, W. P. Andrew; Schneeberger, Stefan] Johns Hopkins Univ, Sch Med, Dept Plast & Reconstruct Surg, Baltimore, MD USA	Medical University of Innsbruck; Carnegie Mellon University; Medical University of Innsbruck; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Medical University of Innsbruck; Medical University of Innsbruck; Johns Hopkins University	Wolfram, D (corresponding author), Med Univ Innsbruck, Dept Plast Reconstruct & Aesthet Surg, A-6020 Innsbruck, Austria.	dolores.wolfram@i-med.ac.at	Hackl, Hubert/B-3168-2018; Brandacher, Gerald/L-7540-2016; Schneeberger, Stefan/S-9329-2019	Hackl, Hubert/0000-0003-4055-3841; Schneeberger, Stefan/0000-0002-2619-8639; Hautz, Theresa/0000-0003-0388-0202; Wolfram, Dolores/0000-0003-0920-7211; Brandacher, Gerald/0000-0001-7790-441X	Armed Forces Institute for Advanced Regenerative Medicine Program (TATRC, DOD) Program, Department of Defense [WX81XWH-07-1-0415]; Austrian Research Fund (Erwin Schrodinger Stipendium); Austrian Society of Plastic and Reconstructive Surgery; Pennsylvania Department of Health Commonwealth Universal Research Enhancement (CURE) program	Armed Forces Institute for Advanced Regenerative Medicine Program (TATRC, DOD) Program, Department of Defense; Austrian Research Fund (Erwin Schrodinger Stipendium); Austrian Society of Plastic and Reconstructive Surgery; Pennsylvania Department of Health Commonwealth Universal Research Enhancement (CURE) program	Funding for this work was provided by the Armed Forces Institute for Advanced Regenerative Medicine Program (TATRC, DOD) Program, Department of Defense grant WX81XWH-07-1-0415, the Austrian Research Fund (Erwin Schrodinger Stipendium), the Austrian Society of Plastic and Reconstructive Surgery and the and the Pennsylvania Department of Health Commonwealth Universal Research Enhancement (CURE) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azhar N, 2013, ANAL SERUM INFLAMMAT; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bohra R, 2013, TRANSPL INT, V26, P225, DOI 10.1111/tri.12003; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; BUBNOVA LN, 1992, TRANSPLANT P, V24, P2545; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Carmi Y, 2009, J IMMUNOL, V183, P4705, DOI 10.4049/jimmunol.0901511; Cendales LC, 2008, AM J TRANSPLANT, V8, P1396, DOI 10.1111/j.1600-6143.2008.02243.x; Chow CC, 2005, SHOCK, V24, P74, DOI 10.1097/01.shk.0000168526.97716.f3; Coin L, 2003, P NATL ACAD SCI USA, V100, P4516, DOI 10.1073/pnas.0737502100; Dey BR, 1998, BLOOD, V91, P3315, DOI 10.1182/blood.V91.9.3315.3315_3315_3322; Dinarello CA, 1999, J ALLERGY CLIN IMMUN, V103, P11, DOI 10.1016/S0091-6749(99)70518-X; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Goriely S, 2008, CURR OPIN ORGAN TRAN, V13, P4, DOI 10.1097/MOT.0b013e3282f406c4; Grenz A, 2000, CLIN CHEM LAB MED, V38, P1183, DOI 10.1515/CCLM.2000.184; GREWAL HP, 1993, TRANSPLANT P, V25, P132; Hautz T, 2010, AM J TRANSPLANT, V10, P1200, DOI 10.1111/j.1600-6143.2010.03075.x; Hautz T, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/757310; IMAGAWA DK, 1990, TRANSPLANTATION, V50, P219, DOI 10.1097/00007890-199008000-00009; Kanitakis J, 2000, TRANSPLANTATION, V69, P1380, DOI 10.1097/00007890-200004150-00029; Kanitakis J, 2008, J CUTAN PATHOL, V35, P738, DOI 10.1111/j.1600-0560.2007.00889.x; Mesarovic M. D., 2004, Systems Biology, V1, P19, DOI 10.1049/sb:20045010; Mi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019424; Namas RA, 2012, MOL MED, V18, P1366, DOI 10.2119/molmed.2012.00106; NATHAN C, 1991, J CELL BIOL, V113, P981, DOI 10.1083/jcb.113.5.981; Novick D, 1999, IMMUNITY, V10, P127, DOI 10.1016/S1074-7613(00)80013-8; Page EK, 2012, TRANSPL INT, V25, P707, DOI 10.1111/j.1432-2277.2012.01456.x; Piccotti JR, 1996, J IMMUNOL, V157, P1951; Rider P, 2011, J IMMUNOL, V187, P4835, DOI 10.4049/jimmunol.1102048; Robert C, 1999, NEW ENGL J MED, V341, P1817, DOI 10.1056/NEJM199912093412407; Sarwal MM, 2006, IMMUNOL REV, V210, P138, DOI 10.1111/j.0105-2896.2006.00359.x; Schneeberger S, 2008, AM J TRANSPLANT, V8, P688, DOI 10.1111/j.1600-6143.2007.02105.x; Schon MP, 2005, EXPERT OPIN THER TAR, V9, P225, DOI 10.1517/14728222.9.2.225; Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207; Tak PP, 2006, EUR J DRUG METAB PH, V31, P109; Tarca AL, 2007, PLOS COMPUT BIOL, V3, P953, DOI 10.1371/journal.pcbi.0030116; van de Veerdonk FL, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00167; Veenbergen S, 2010, ANN RHEUM DIS, V69, P276, DOI 10.1136/ard.2008.100867; Verma ND, 2006, TRANSPLANTATION, V82, P1324, DOI 10.1097/01.tp.0000239519.56358.c1; Vodovotz Y, 2006, IMMUNOL RES, V36, P237, DOI 10.1385/IR:36:1:237; WALSH LJ, 1991, P NATL ACAD SCI USA, V88, P4220, DOI 10.1073/pnas.88.10.4220; Warren HS, 2009, MOL MED, V15, P220, DOI 10.2119/molmed.2009.00027; Yuan J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060714	43	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99926	10.1371/journal.pone.0099926	http://dx.doi.org/10.1371/journal.pone.0099926			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926998	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100091
J	Kanamori, S; Kai, Y; Aida, J; Kondo, K; Kawachi, I; Hirai, H; Shirai, K; Ishikawa, Y; Suzuki, K				Kanamori, Satoru; Kai, Yuko; Aida, Jun; Kondo, Katsunori; Kawachi, Ichiro; Hirai, Hiroshi; Shirai, Kokoro; Ishikawa, Yoshiki; Suzuki, Kayo		JAGES Grp	Social Participation and the Prevention of Functional Disability in Older Japanese: The JAGES Cohort Study	PLOS ONE			English	Article							MORTALITY; COMMUNITY; DECLINE; HEALTH; ASSOCIATION; POPULATION	Background: We examined the relationship between incident functional disability and social participation from the perspective of number of types of organizations participated in and type of social participation in a prospective cohort study. Method: The study was based on the Aichi Gerontological Evaluation Study (AGES) Cohort Study data. We followed 13,310 individuals aged 65 years or older for 4 years. Analysis was carried out on 12,951 subjects, excluding 359 people whose information on age or sex was missing. Social participation was categorized into 8 types. Results: Compared to those that did not participate in any organizations, the hazard ratio (HR) was 0.83 (95% CI: 0.73-0.95) for participation in one, 0.72 (0.61-0.85) for participation in two, and 0.57 (0.46-0.70) for participation in three or more different types of organizations. In multivariable adjusted models, participation in the following types of organization was protective for incident disability: local community organizations (HR = 0.85, 95% CI: 0.76-0.96), hobby organizations (HR = 0.75, 95% CI: 0.64-0.87), and sports organizations (HR = 0.64, 95% CI: 0.54-0.81). Conclusion: Social participation may decrease the risk of incident functional disability in older people in Japan. This effect may be strengthened by participation in a variety of different types of organizations. Participating in a local community, hobby, or sports group or organization may be especially effective for decreasing the risk of disability.	[Kanamori, Satoru] Tokyo Med Univ, Dept Prevent Med & Publ Hlth, Tokyo 1608402, Japan; [Kanamori, Satoru] ITOCHU Technosolut Corp, Human Resource Management Dept, Tokyo, Japan; [Kai, Yuko] Meiji Yasuda Life Fdn Hlth & Welf, Phys Fitness Res Inst, Tokyo, Japan; [Aida, Jun] Tohoku Univ, Grad Sch Dent, Dept Int & Community Oral Hlth, Sendai, Miyagi 980, Japan; [Kondo, Katsunori] Chiba Univ, Ctr Prevent Med Sci, Chiba, Japan; [Kondo, Katsunori] Nihon Fukushi Univ, Ctr Well Being & Soc, Mihama, Aichi, Japan; [Kawachi, Ichiro] Harvard Univ, Sch Publ Hlth, Dept Social & Behav Sci, Boston, MA 02115 USA; [Hirai, Hiroshi] Iwate Univ, Dept Civil & Environm Engn, Fac Engn, Morioka, Iwate, Japan; [Shirai, Kokoro] Univ Ryukyus, Sch Law & Letters, Dept Human Sci, Nishihara, Okinawa 90301, Japan; [Ishikawa, Yoshiki] Univ Tokyo, Sch Publ Hlth, Dept Hlth & Social Behav, Tokyo, Japan; [Suzuki, Kayo] Aichi Gakuin Univ, Dept Social Policies, Nisshin, Aichi, Japan	Tokyo Medical University; Tohoku University; Chiba University; Harvard University; Harvard T.H. Chan School of Public Health; Iwate University; University of the Ryukyus; University of Tokyo; Aichi Gakuin University	Kanamori, S (corresponding author), Tokyo Med Univ, Dept Prevent Med & Publ Hlth, Tokyo 1608402, Japan.	satoru_kanamori@hotmail.com	Kondo, Katsunori/AAI-6373-2020; Fujino, Yoshihisa/F-3054-2010; Aida, Jun/S-9371-2019; Tsuboya, Toru/M-3847-2016	Fujino, Yoshihisa/0000-0002-9126-206X; Aida, Jun/0000-0002-8405-9872; Ashida, Toyo/0000-0002-0334-121X; Tsuboya, Toru/0000-0001-7741-0751; Misawa, Jimpei/0000-0003-3987-8251; Hanazato, Masamichi/0000-0002-0317-7616; Kai, Yuko/0000-0002-7176-0352	Health Labour Sciences Research Grant; Japanese Ministryof Health,Labour and Welfare [H25-Choju-Ippan-003]; Japan Society for the Promotion of Science [KAKENHI 23243070]	Health Labour Sciences Research Grant(Ministry of Health, Labour and Welfare, Japan); Japanese Ministryof Health,Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported in part by Health Labour Sciences Research Grant, Comprehensive Research on Aging and Health (H25-Choju-Ippan-003 2013- 2015 from the Japanese Ministryof Health,Labour and Welfare (http://www.mhlw.go.jp/seisakunitsuite/bunya/hokabunya/kenkyujigyou/hojokin-koubo-h25/gaiyo/16.html), and Grant-in-Aid for Scientific Research (KAKENHI 23243070) from the Japan Society for the Promotion of Science (http://kaken.nii.ac.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aida J, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-499; Ali SM, 2006, SOC SCI MED, V63, P2204, DOI 10.1016/j.socscimed.2006.04.007; Buchman AS, 2009, ARCH INTERN MED, V169, P1139, DOI 10.1001/archinternmed.2009.135; Chiao C, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-292; Cruwys T, 2013, SOC SCI MED, V98, P179, DOI 10.1016/j.socscimed.2013.09.013; Earhart H. B, 1974, JAPANESE RELIG UNITY, V1st; Glass TA, 1999, BRIT MED J, V319, P478, DOI 10.1136/bmj.319.7208.478; Glei DA, 2012, SOC SCI MED, V74, P1891, DOI 10.1016/j.socscimed.2012.02.020; Haslam C, 2008, NEUROPSYCHOL REHABIL, V18, P671, DOI 10.1080/09602010701643449; Hirai Hiroshi, 2009, Nihon Koshu Eisei Zasshi, V56, P501; Hsu HC, 2007, AGING MENT HEALTH, V11, P699, DOI 10.1080/13607860701366335; Ichida Y, 2013, SOC SCI MED, V94, P83, DOI 10.1016/j.socscimed.2013.05.006; Iwasaki M, 2002, INT J EPIDEMIOL, V31, P1208, DOI 10.1093/ije/31.6.1208; James BD, 2011, J INT NEUROPSYCH SOC, V17, P998, DOI 10.1017/S1355617711000531; James BD, 2011, J GERONTOL A-BIOL, V66, P467, DOI 10.1093/gerona/gly231; Julianne HL, 2010, PLOS MED, V7; Kanamori S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051061; Kondo K., 2010, HLTH INEQUALITIES JA; Koyano W, 1987, JPN J PUBLIC HLTH, V34, P109; McCullough ME, 2000, HEALTH PSYCHOL, V19, P211, DOI 10.1037//0278-6133.19.3.211; Nishi A, 2011, J EPIDEMIOL, V21, P151, DOI 10.2188/jea.JE20100135; Osaka university commerce JGSS Research Center, JGSS NO CHOUS GAIYOU; Paterson DH, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-38; ROOK KS, 1984, J PERS SOC PSYCHOL, V46, P1097, DOI 10.1037/0022-3514.46.5.1097; Rothman KJ, 2013, INT J EPIDEMIOL, V42, P1012, DOI 10.1093/ije/dys223; Sheikh JA, 1986, CLIN GERONTOLOGY GUI; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Takagi D, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-701; Takeda T, 2010, JAPANESE J PUBLIC HL, V57, P1054; Takeda T, 2009, J JAPANESE OCCUPATIO, V28, P178; Takeuchi K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061741; Tsutsui T, 2005, J AM GERIATR SOC, V53, P522, DOI 10.1111/j.1532-5415.2005.53175.x; Umberson D, 2010, J HEALTH SOC BEHAV, V51, pS54, DOI 10.1177/0022146510383501; Vaananen A, 2009, PREV MED, V49, P142, DOI 10.1016/j.ypmed.2009.06.026; who, ACT AG POL FRAM	35	163	165	14	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99638	10.1371/journal.pone.0099638	http://dx.doi.org/10.1371/journal.pone.0099638			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AK8TP	24923270	gold, Green Published, Green Submitted			2022-12-27	WOS:000338701300084
J	Kim, HS; Kim, M; Jeong, CW; Kwak, C; Kim, HH; Ku, JH				Kim, Hyung Suk; Kim, Myong; Jeong, Chang Wook; Kwak, Cheol; Kim, Hyeon Hoe; Ku, Ja Hyeon			Multifactorial, Site-Specific Recurrence Models after Radical Cystectomy for Urothelial Carcinoma: External Validation in a Cohort of Korean Patients	PLOS ONE			English	Article							BLADDER-CANCER; FOLLOW-UP; SURVIVAL; PREDICTION; PATTERNS; RISK	Purpose: The aim of this study was to evaluate the accuracy of site-specific recurrence models after radical cystectomy in the Korean population. Materials and Methods: We conducted a review of an electronic medical record of 572 patients who underwent radical cystectomy for urothelial carcinoma of the bladder. Primary end point was the site-specific recurrence after radical cystectomy. Results: The median follow-up in the validation cohort was 42.3 months (interquartile range: 23.0-89.3 months). During the follow-up period, there were 165 patients (28.8%), 85 (14.9%), 31 (5.4%), and 78 (13.6%) who recurred in abdomen/pelvis, thoracic region, upper urinary tract, and bone, respectively. The c-indices of abdomen/pelvis, thoracic region, upper urinary tract, and bone models 3 years after radical cystectomy were 0.69 (95% confidence interval [CI], 0.65-0.73), 0.69 (95% CI, 0.64-0.75), 0.61 (95% CI, 0.52-0.69), and 0.65 (95% CI, 0.59-0.71), respectively. Kaplan-Meier curves demonstrated that models discriminated well and log-rank test were all highly significant (all p < 0.001), except upper urinary tract model (p = 0.366). Decision curve analysis revealed that the use of prediction models for abdomen/pelvis, thoracic region, and bone recurrence was associated with net benefit gains relative to the treat-all strategy, but not the model for upper urinary tract recurrence. Conclusions: Abdomen/pelvis, thoracic region, and bone models demonstrate moderate discrimination, adequate calibration, and meaningful net benefit gains, whereas upper urinary tract model does not seem applicable to patients from Asia because it has suboptimal accuracy.	[Kim, Hyung Suk; Kim, Myong; Jeong, Chang Wook; Kwak, Cheol; Kim, Hyeon Hoe; Ku, Ja Hyeon] Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea	Seoul National University (SNU)	Ku, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Urol, Seoul, South Korea.	kuuro70@snu.ac.kr	Ku, Ja Hyeon/E-6682-2016	Kim, Hyung Suk/0000-0002-3661-275X; Kim, Myong/0000-0001-6995-6850				Bajorin DF, 1999, J CLIN ONCOL, V17, P3173, DOI 10.1200/JCO.1999.17.10.3173; Bochner BH, 2006, J CLIN ONCOL, V24, P3967, DOI 10.1200/JCO.2005.05.3884; Boorjian SA, 2011, J UROLOGY, V186, P1796, DOI 10.1016/j.juro.2011.07.005; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Giannarini G, 2010, EUR UROL, V58, P486, DOI 10.1016/j.eururo.2010.05.041; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Hassan JM, 2006, J UROLOGY, V175, P2054, DOI 10.1016/S0022-5347(06)00323-5; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Jung KW, 2013, CANCER RES TREAT, V45, P15, DOI 10.4143/crt.2013.45.1.15; Ku JH, 2013, UROL ONCOL-SEMIN ORI, V31, P1731, DOI 10.1016/j.urolonc.2012.06.012; Linder BJ, 2014, J UROLOGY, V191, P1256, DOI 10.1016/j.juro.2013.11.103; Mitra AP, 2012, BJU INT, V109, P846, DOI 10.1111/j.1464-410X.2011.10455.x; Nieuwenhuijzen JA, 2014, EUR J SURG ONCOL, DOI [10.1016/j.ejso.2013.12.017, DOI 10.1016/J.EJSO.2013.12.017.]; Shariat SF, 2008, CLIN CANCER RES, V14, P4400, DOI 10.1158/1078-0432.CCR-07-4713; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Umbreit EC, 2010, CANCER-AM CANCER SOC, V116, P3399, DOI 10.1002/cncr.25202; Vickers AJ, 2006, MED DECIS MAKING, V26, P565, DOI 10.1177/0272989X06295361; Visser O, 2005, J UROLOGY, V174, P97, DOI 10.1097/01.ju.0000162055.58405.96; Volkmer BG, 2009, J UROLOGY, V181, P1587, DOI 10.1016/j.juro.2008.11.112; Yafi FA, 2012, BJU INT, V110, P1317, DOI 10.1111/j.1464-410X.2012.11133.x	20	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e100491	10.1371/journal.pone.0100491	http://dx.doi.org/10.1371/journal.pone.0100491			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24937260	gold, Green Published, Green Submitted			2022-12-27	WOS:000338503400111
J	Tong, ZC; Zhang, LD; Ling, JQ; Jian, YT; Huang, LJ; Deng, DM				Tong, Zhongchun; Zhang, Luodan; Ling, Junqi; Jian, Yutao; Huang, Lijia; Deng, Dongmei			An In Vitro Study on the Effect of Free Amino Acids Alone or in Combination with Nisin on Biofilms as well as on Planktonic Bacteria of Streptococcus mutans	PLOS ONE			English	Article							CELL-WALL; LIPID-II; EXOPOLYSACCHARIDE; CHLORHEXIDINE; TRIGGER; MATRIX	Free D-amino acids (D-AAs) are one of the most striking features of the peptidoglycan composition in bacteria and play a key role in regulating and disassembling bacterial biofilms. Previous studies have indicated that the antimicrobial peptide nisin can inhibit the growth of the cariogenic bacteria Streptococcus mutans. The present study investigated the effect of free amino acids either alone or in combination with nisin on biofilm and on planktonic S. mutans bacteria. The results of the MIC and MBC analyses showed that D-cysteine (Cys), D- or L-aspartic acid (Asp), and D-or L-glutamic acid (Glu) significantly improve the antibacterial activity of nisin against S. mutans and that the mixture of D-Cys, D-Asp, and D-Glu (3D-AAs) and the mixture of L-Cys, L-Asp, and L-Glu (3L-AAs) at a concentration of 40 mM can prevent S. mutans growth. Crystal violet staining showed that the D- or L-enantiomers of Cys, Asp, and Glu at a concentration of 40 mM can inhibit the formation of S. mutans biofilms, and their mixture generated a stronger inhibition than the components alone. Furthermore, the mixture of the three D-AAs or L-AAs may improve the antibacterial activity of nisin against S. mutans biofilms. This study underscores the potential of free amino acids for the enhancement of the antibacterial activity of nisin and the inhibition of the cariogenic bacteria S. mutans and biofilms.	[Tong, Zhongchun; Zhang, Luodan; Ling, Junqi; Huang, Lijia] Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Operat Dent & Endodont, Guangzhou 510275, Guangdong, Peoples R China; [Tong, Zhongchun; Ling, Junqi; Jian, Yutao] Sun Yat Sen Univ, Guangdong Prov Key Lab Stomatol, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Dongmei] Univ Amsterdam, Acad Ctr Dent Amsterdam ACTA, Dept Cariol Endodontol Pedodontol, Amsterdam, Netherlands; [Deng, Dongmei] Vrije Univ Amsterdam, Amsterdam, Netherlands	Sun Yat Sen University; Sun Yat Sen University; Academic Center for Dentistry Amsterdam; University of Amsterdam; Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam	Ling, JQ (corresponding author), Sun Yat Sen Univ, Guanghua Sch Stomatol, Dept Operat Dent & Endodont, Guangzhou 510275, Guangdong, Peoples R China.	Junqi_Ling@hotmail.com	Deng, Dongmei/V-9230-2017		National Natural Science Foundation of China [81371132]; Bairenjihua Research Fund by Sun Yat-Sen University [985[2012]245]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Bairenjihua Research Fund by Sun Yat-Sen University	This work was supported by National Natural Science Foundation of China (No. 81371132) and the Bairenjihua Research Fund by Sun Yat-Sen University (No 985[2012]245). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abee T, 2011, CURR OPIN BIOTECH, V22, P172, DOI 10.1016/j.copbio.2010.10.016; Banas JA, 2004, FRONT BIOSCI-LANDMRK, V9, P1267, DOI 10.2741/1305; Bowen WH, 2011, CARIES RES, V45, P69, DOI 10.1159/000324598; Brandenburg KS, 2013, ANTIMICROB AGENTS CH, V57, P1921, DOI 10.1128/AAC.00007-13; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Cava F, 2011, EMBO J, V30, P3442, DOI 10.1038/emboj.2011.246; Cava F, 2011, CELL MOL LIFE SCI, V68, P817, DOI 10.1007/s00018-010-0571-8; Hall-Stoodley L, 2009, CELL MICROBIOL, V11, P1034, DOI 10.1111/j.1462-5822.2009.01323.x; Hasper HE, 2004, BIOCHEMISTRY-US, V43, P11567, DOI 10.1021/bi049476b; Hochbaum AI, 2011, J BACTERIOL, V193, P5616, DOI 10.1128/JB.05534-11; Kanisavaran ZM, 2008, INT DENT J, V58, P247, DOI 10.1922/IDJ_1910Mohamadi11; Kleinberg I, 2002, CRIT REV ORAL BIOL M, V13, P108, DOI 10.1177/154411130201300202; Kolodkin-Gal I, 2012, CELL, V149, P684, DOI 10.1016/j.cell.2012.02.055; Kolodkin-Gal I, 2010, SCIENCE, V328, P627, DOI 10.1126/science.1188628; Koo H, 2013, J DENT RES, V92, P1065, DOI 10.1177/0022034513504218; Lam H, 2009, SCIENCE, V325, P1552, DOI 10.1126/science.1178123; Leme AFP, 2006, J DENT RES, V85, P878, DOI 10.1177/154405910608501002; Lu TK, 2007, P NATL ACAD SCI USA, V104, P11197, DOI 10.1073/pnas.0704624104; Mohammadi Z, 2009, AUST ENDOD J, V35, P131, DOI 10.1111/j.1747-4477.2009.00164.x; Sanchez CJ, 2013, BIOMATERIALS, V34, P7533, DOI 10.1016/j.biomaterials.2013.06.026; Scheffers DJ, 2005, MICROBIOL MOL BIOL R, V69, P585, DOI 10.1128/MMBR.69.4.585-607.2005; Stewart PS, 2001, LANCET, V358, P135, DOI 10.1016/S0140-6736(01)05321-1; Takahashi N, 2011, J DENT RES, V90, P294, DOI 10.1177/0022034510379602; Tong ZC, 2011, PEPTIDES, V32, P2021, DOI 10.1016/j.peptides.2011.09.002; Tong ZC, 2010, PEPTIDES, V31, P2003, DOI 10.1016/j.peptides.2010.07.016; Vollmer W, 2008, FEMS MICROBIOL REV, V32, P149, DOI 10.1111/j.1574-6976.2007.00094.x; Vollmer W, 2010, TRENDS MICROBIOL, V18, P59, DOI 10.1016/j.tim.2009.12.004; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Zhou L, 2013, ORAL DIS, V19, P494, DOI 10.1111/odi.12031; Zhou L, 2010, ARCH ORAL BIOL, V55, P401, DOI 10.1016/j.archoralbio.2010.03.013	30	34	35	1	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99513	10.1371/journal.pone.0099513	http://dx.doi.org/10.1371/journal.pone.0099513			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936873	Green Published, Green Submitted, gold			2022-12-27	WOS:000338503400020
J	Del Rey, MJ; Fare, R; Izquierdo, E; Usategui, A; Rodriguez-Fernandez, JL; Suarez-Fueyo, A; Canete, JD; Pablos, JL				Del Rey, Manuel J.; Fare, Regina; Izquierdo, Elena; Usategui, Alicia; Rodriguez-Fernandez, Jose L.; Suarez-Fueyo, Abel; Canete, Juan D.; Pablos, Jose L.			Clinicopathological Correlations of Podoplanin (gp38) Expression in Rheumatoid Synovium and Its Potential Contribution to Fibroblast Platelet Crosstalk	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; LYMPHATIC ENDOTHELIAL-CELLS; FOLLICULAR DENDRITIC CELLS; LECTIN RECEPTOR CLEC-2; STROMAL CELLS; IN-VIVO; LYMPHOID-TISSUES; ARTHRITIS; INFLAMMATION; SYNOVIOCYTES	Introduction: Synovial fibroblasts (SF) undergo phenotypic changes in rheumatoid arthritis (RA) that contribute to inflammatory joint destruction. This study was undertaken to evaluate the clinical and functional significance of ectopic podoplanin (gp38) expression by RA SF. Methods: Expression of gp38 and its CLEC2 receptor was analyzed by immunohistochemistry in synovial arthroscopic biopsies from RA patients and normal and osteoarthritic controls. Correlation between gp38 expression and RA clinicopathological variables was analyzed. In patients rebiopsied after anti-TNF-alpha therapy, changes in gp38 expression were determined. Platelet-SF coculture and gp38 silencing in SF were used to analyze the functional contribution of gp38 to SF migratory and invasive properties, and to SF platelet crosstalk. Results: gp38 was abundantly but variably expressed in RA, and it was undetectable in normal synovial tissues. Among clinicopathologigal RA variables, significantly increased gp38 expression was only found in patients with lymphoid neogenesis (LN), and RF or ACPA autoantibodies. Cultured synovial but not dermal fibroblasts showed strong constitutive gp38 expression that was further induced by TNF-alpha. In RA patients, anti-TNF-alpha therapy significantly reduced synovial gp38 expression. In RA synovium, CLEC2 receptor expression was only observed in platelets. gp38 silencing in cultured SF did not modify their migratory and invasive properties but reduced the expression of IL-6 and IL-8 genes induced by SF-platelet interaction. Conclusions: In RA, synovial expression of gp38 is strongly associated to LN and it is reduced after anti-TNF-alpha therapy. Interaction between gp38 and CLEC2 platelet receptor is feasible in RA synovium in vivo and can specifically contribute to gene expression by SF.	[Del Rey, Manuel J.; Fare, Regina; Usategui, Alicia; Suarez-Fueyo, Abel; Pablos, Jose L.] Hosp 12 Octubre i 12, Serv Reumatol, Inst Invest, Madrid, Spain; [Izquierdo, Elena; Rodriguez-Fernandez, Jose L.] CSIC, Ctr Invest Biol, Madrid, Spain; [Canete, Juan D.] Hosp Clin Barcelona, Serv Reumatol, Unitat Artritis, Barcelona, Spain; [Canete, Juan D.] Inst Invest Biomed August Pi & Sunyer, Barcelona, Spain	Hospital Universitario 12 de Octubre; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Investigaciones Biologicas (CIB); University of Barcelona; Hospital Clinic de Barcelona; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Pablos, JL (corresponding author), Hosp 12 Octubre i 12, Serv Reumatol, Inst Invest, Madrid, Spain.	jlpablos@h12o.es	Del Rey, Manuel/O-6114-2014; Izquierdo, Elena/Z-1861-2019; crespillo, Juan D. cañete/M-4428-2017; Suarez Fueyo, Abel/E-5746-2017; Rodriguez-Fernandez, Jose Luis/Q-5021-2019; Usategui, Alicia/O-6476-2014; Cañete, Juan D/AAV-8910-2021; Suarez-Fueyo, Abel/D-1691-2013	Del Rey, Manuel/0000-0002-8180-1584; Izquierdo, Elena/0000-0002-3355-2798; crespillo, Juan D. cañete/0000-0003-2606-0573; Rodriguez-Fernandez, Jose Luis/0000-0001-8874-1425; Usategui, Alicia/0000-0001-8874-9523; Cañete, Juan D/0000-0003-2606-0573; Suarez-Fueyo, Abel/0000-0002-8696-0197; Pablos, Jose L./0000-0001-7229-6005	Instituto de Salud Carlos III [FIS 12/439, RETICS RD12/0009 RIER]; Instituto de Salud Carlos III (Rio Hortega program); Comunidad de Madrid [S2010/BMD2350]	Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); Instituto de Salud Carlos III (Rio Hortega program); Comunidad de Madrid(Comunidad de Madrid)	This study was supported by Instituto de Salud Carlos III (FIS 12/439, RETICS RD12/0009 RIER, and Rio Hortega program to R. F.), and Comunidad de Madrid (S2010/BMD2350, RAPHYME). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acton SE, 2012, IMMUNITY, V37, P276, DOI 10.1016/j.immuni.2012.05.022; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bajenoff M, 2006, IMMUNITY, V25, P989, DOI 10.1016/j.immuni.2006.10.011; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Benito-Miguel M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040620; Bertozzi CC, 2010, BLOOD, V116, P661, DOI 10.1182/blood-2010-02-270876; Boilard E, 2010, SCIENCE, V327, P580, DOI 10.1126/science.1181928; Boulaftali Y, 2013, J CLIN INVEST, V123, P908, DOI 10.1172/JCI65154; Bradfield PF, 2003, ARTHRITIS RHEUM, V48, P2472, DOI 10.1002/art.11219; Canete JD, 2009, ANN RHEUM DIS, V68, P751, DOI 10.1136/ard.2008.089284; Choi YS, 2013, J IMMUNOL, V190, P3049, DOI 10.4049/jimmunol.1203032; del Rey MJ, 2009, ARTHRITIS RHEUM-US, V60, P2926, DOI 10.1002/art.24844; Dulauroy S, 2012, NAT MED, V18, P1262, DOI 10.1038/nm.2848; Ekwall AKH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3274; FARR AG, 1992, J EXP MED, V176, P1477, DOI 10.1084/jem.176.5.1477; Genovese MC, 2013, J RHEUMATOL, V40, P768, DOI 10.3899/jrheum.120687; Hsu J, 2013, IMMUNOL LETT, V150, P97, DOI 10.1016/j.imlet.2012.12.007; Izquierdo E, 2011, ARTHRITIS RHEUM-US, V63, P2575, DOI 10.1002/art.30433; Kawase A, 2008, INT J CANCER, V123, P1053, DOI 10.1002/ijc.23611; Kopf M, 1998, J EXP MED, V188, P1895, DOI 10.1084/jem.188.10.1895; Lee A, 2013, ARTHRITIS RHEUM-US, V65, P928, DOI 10.1002/art.37853; Lindhout E, 1999, J IMMUNOL, V162, P5949; Link A, 2011, AM J PATHOL, V178, P1662, DOI 10.1016/j.ajpath.2010.12.039; Manzo A, 2005, EUR J IMMUNOL, V35, P1347, DOI 10.1002/eji.200425830; Martin-Villar E, 2006, J CELL SCI, V119, P4541, DOI 10.1242/jcs.03218; MullerLadner U, 1996, AM J PATHOL, V149, P1607; Navarro A, 2011, AM J PHYSIOL-LUNG C, V300, pL32, DOI 10.1152/ajplung.00171.2010; Naylor AJ, 2013, CLIN EXP IMMUNOL, V171, P30, DOI 10.1111/j.1365-2249.2012.04634.x; Neidhart M, 2003, ARTHRITIS RHEUM, V48, P1873, DOI 10.1002/art.11166; Neumann E, 2010, TRENDS MOL MED, V16, P458, DOI 10.1016/j.molmed.2010.07.004; Osada M, 2012, J BIOL CHEM, V287, P22241, DOI 10.1074/jbc.M111.329987; Peduto L, 2009, J IMMUNOL, V182, P5789, DOI 10.4049/jimmunol.0803974; Peters A, 2011, IMMUNITY, V35, P986, DOI 10.1016/j.immuni.2011.10.015; Pretzel D, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2618; Schacht V, 2005, AM J PATHOL, V166, P913, DOI 10.1016/S0002-9440(10)62311-5; Schacht V, 2003, EMBO J, V22, P3546, DOI 10.1093/emboj/cdg342; Suzuki-Inoue K, 2010, J BIOL CHEM, V285, P24494, DOI 10.1074/jbc.M110.130575; Timmer TCG, 2007, ARTHRITIS RHEUM-US, V56, P2492, DOI 10.1002/art.22748; Uhrin P, 2010, BLOOD, V115, P3997, DOI 10.1182/blood-2009-04-216069; vanGestel AM, 1996, ARTHRITIS RHEUM, V39, P34, DOI 10.1002/art.1780390105; Victoratos P, 2009, IMMUNITY, V30, P130, DOI 10.1016/j.immuni.2008.10.019; Wicki A, 2006, CANCER CELL, V9, P261, DOI 10.1016/j.ccr.2006.03.010; Zimmer G, 1999, BIOCHEM J, V341, P277, DOI 10.1042/0264-6021:3410277; Zufferey R, 1998, J VIROL, V72, P9873, DOI 10.1128/JVI.72.12.9873-9880.1998	44	36	37	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99607	10.1371/journal.pone.0099607	http://dx.doi.org/10.1371/journal.pone.0099607			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932813	gold, Green Published			2022-12-27	WOS:000337738600047
J	Hammerle, H; Amman, F; Vecerek, B; Stulke, J; Hofacker, I; Blasi, U				Haemmerle, Hermann; Amman, Fabian; Vecerek, Branislav; Stuelke, Joerg; Hofacker, Ivo; Blaesi, Udo			Impact of Hfq on the Bacillus subtilis Transcriptome	PLOS ONE			English	Article							STAPHYLOCOCCUS-AUREUS RNAIII; SMALL REGULATORY RNA; STREPTOCOCCUS-PNEUMONIAE; MESSENGER-RNA; STATIONARY-PHASE; NONCODING RNAS; IDENTIFICATION; PROTEIN; BINDING; SPORULATION	The RNA chaperone Hfq acts as a central player in post-transcriptional gene regulation in several Gram-negative Bacteria, whereas comparatively little is known about its role in Gram-positive Bacteria. Here, we studied the function of Hfq in Bacillus subtilis, and show that it confers a survival advantage. A comparative transcriptome analysis revealed mRNAs with a differential abundance that are governed by the ResD-ResE system required for aerobic and anaerobic respiration. Expression of resD was found to be up-regulated in the hfq(-) strain. Furthermore, several genes of the GerE and ComK regulons were de-regulated in the hfq(-) background. Surprisingly, only six out of >100 known and predicted small RNAs (sRNAs) showed altered abundance in the absence of Hfq. Moreover, Hfq positively affected the transcript abundance of genes encoding type I toxin-antitoxin systems. Taken the moderate effect on sRNA levels and mRNAs together, it seems rather unlikely that Hfq plays a central role in RNA transactions in Bacillus subtilis.	[Haemmerle, Hermann; Vecerek, Branislav; Blaesi, Udo] Univ Vienna, Ctr Mol Biol, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Vienna, Austria; [Amman, Fabian; Hofacker, Ivo] Univ Vienna, Inst Theoret Chem, Vienna, Austria; [Stuelke, Joerg] Univ Gottingen, Inst Microbiol & Genet, Dept Gen Microbiol, D-37073 Gottingen, Germany	Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL); University of Vienna; University of Gottingen	Blasi, U (corresponding author), Univ Vienna, Ctr Mol Biol, Max F Perutz Labs, Dept Microbiol Immunobiol & Genet, Vienna, Austria.	Udo.Blaesi@univie.ac.at	Vecerek, Branislav/H-2545-2014; Stülke, Jörg/AAD-1600-2021; Hofacker, Ivo L/A-2378-2013	Vecerek, Branislav/0000-0001-9520-6324; Hofacker, Ivo L/0000-0001-7132-0800; Stulke, Jorg/0000-0001-5881-5390; Amman, Fabian/0000-0002-8646-859X	Austrian Science Fund [RNA-REG F43, AF4311]; doctoral program RNA-Biology [W-1207]	Austrian Science Fund(Austrian Science Fund (FWF)); doctoral program RNA-Biology	The work was supported by the Austrian Science Fund (www.fwf.ac.at/en) through the Special Research Program RNA-REG F43, subproject AF4311 (UB), and the doctoral program RNA-Biology W-1207 (HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acebo P, 2012, RNA, V18, P530, DOI 10.1261/rna.027359.111; Afonyushkin T, 2005, NUCLEIC ACIDS RES, V33, P1678, DOI 10.1093/nar/gki313; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Beich-Frandsen M, 2011, NUCLEIC ACIDS RES, V39, P4900, DOI 10.1093/nar/gkq1346; Bernhart SH, 2006, BIOINFORMATICS, V22, P614, DOI 10.1093/bioinformatics/btk014; Boisset S, 2007, GENE DEV, V21, P1353, DOI 10.1101/gad.423507; Chevalier C, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000809; Christiansen JK, 2006, RNA, V12, P1383, DOI 10.1261/rna.49706; Christiansen JK, 2004, J BACTERIOL, V186, P3355, DOI 10.1128/JB.186.11.3355-3362.2004; Commichau FM, 2007, MOL MICROBIOL, V65, P642, DOI 10.1111/j.1365-2958.2007.05816.x; Cui MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071933; Dambach M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055156; Dunn AK, 1999, GENE, V226, P297, DOI 10.1016/S0378-1119(98)00544-7; Durand S, 2012, RNA BIOL, V9, P1491, DOI 10.4161/rna.22358; Eichenberger P, 2004, PLOS BIOL, V2, P1664, DOI 10.1371/journal.pbio.0020328; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; Geissmann T, 2009, NUCLEIC ACIDS RES, V37, P7239, DOI 10.1093/nar/gkp668; Geng H, 2007, J BACTERIOL, V189, P1745, DOI 10.1128/JB.01502-06; Gottesman S, 2006, COLD SPRING HARB SYM, V71, P1, DOI 10.1101/sqb.2006.71.016; Gyan S, 2006, J BACTERIOL, V188, P7062, DOI 10.1128/JB.00601-06; Hartig E, 2012, ADV MICROB PHYSIOL, V61, P195, DOI 10.1016/B978-0-12-394423-8.00005-6; Halfmann A, 2007, MOL MICROBIOL, V66, P110, DOI 10.1111/j.1365-2958.2007.05900.x; Hamoen LW, 2003, MICROBIOL-SGM, V149, P9, DOI 10.1099/mic.0.26003-0; Heidrich N, 2007, NUCLEIC ACIDS RES, V35, P4331, DOI 10.1093/nar/gkm439; Heidrich N, 2006, MOL MICROBIOL, V62, P520, DOI 10.1111/j.1365-2958.2006.05384.x; Hoffmann S, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000502; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Irnov I, 2010, NUCLEIC ACIDS RES, V38, P6637, DOI 10.1093/nar/gkq454; Jahn N, 2012, MOL MICROBIOL, V83, P579, DOI 10.1111/j.1365-2958.2011.07952.x; Jousselin A, 2009, TRENDS MICROBIOL, V17, P399, DOI 10.1016/j.tim.2009.06.003; Kumar R, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-350; KUNST F, 1995, J BACTERIOL, V177, P2403, DOI 10.1128/jb.177.9.2403-2407.1995; Larsson JT, 2005, MICROBIOL-SGM, V151, P3323, DOI 10.1099/mic.0.28124-0; Lehnik-Habrink M, 2010, MOL MICROBIOL, V77, P958, DOI 10.1111/j.1365-2958.2010.07264.x; Leisner M, 2008, CURR OPIN MICROBIOL, V11, P553, DOI 10.1016/j.mib.2008.09.020; Liu Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013069; Lopez D, 2009, FEMS MICROBIOL REV, V33, P152, DOI 10.1111/j.1574-6976.2008.00148.x; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Mann B, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002788; Masse E, 2003, GENE DEV, V17, P2374, DOI 10.1101/gad.1127103; Moll I, 2003, RNA, V9, P1308, DOI 10.1261/rna.5850703; Moller T, 2002, MOL CELL, V9, P23, DOI 10.1016/S1097-2765(01)00436-1; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Nakano MM, 1998, J BACTERIOL, V180, P5344, DOI 10.1128/JB.180.20.5344-5350.1998; Nakano MM, 1996, J BACTERIOL, V178, P3796, DOI 10.1128/jb.178.13.3796-3802.1996; Nakano MM, 1998, ANNU REV MICROBIOL, V52, P165, DOI 10.1146/annurev.micro.52.1.165; Nielsen JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019019; Nielsen JS, 2008, J BACTERIOL, V190, P6264, DOI 10.1128/JB.00740-08; Nielsen JS, 2010, NUCLEIC ACIDS RES, V38, P907, DOI 10.1093/nar/gkp1081; Oliver HF, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-641; Olsen AS, 2010, J MOL BIOL, V404, P173, DOI 10.1016/j.jmb.2010.09.038; Rasmussen S, 2009, MOL MICROBIOL, V73, P1043, DOI 10.1111/j.1365-2958.2009.06830.x; Robertson GT, 1999, MOL MICROBIOL, V34, P690, DOI 10.1046/j.1365-2958.1999.01629.x; Rochat T, 2012, BIOCHIMIE, V94, P1554, DOI 10.1016/j.biochi.2012.01.016; Schnorpfeil A, 2013, MOL MICROBIOL, V89, P334, DOI 10.1111/mmi.12277; Schultz D, 2009, P NATL ACAD SCI USA, V106, P21027, DOI 10.1073/pnas.0912185106; Silvaggi JM, 2006, J BACTERIOL, V188, P532, DOI 10.1128/JB.188.2.532-541.2006; Silvaggi JM, 2005, J BACTERIOL, V187, P6641, DOI 10.1128/JB.187.19.6641-6650.2005; Sittka A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000163; Sledjeski DD, 2001, J BACTERIOL, V183, P1997, DOI 10.1128/JB.183.6.1997-2005.2001; Smaidone GT, 2012, J BACTERIOL, V194, P2586, DOI 10.1128/JB.05567-11; Someya T, 2012, NUCLEIC ACIDS RES, V40, P1856, DOI 10.1093/nar/gkr892; Sonnleitner E, 2006, MOL MICROBIOL, V59, P1542, DOI 10.1111/j.1365-2958.2006.05032.x; Sun XG, 2002, NUCLEIC ACIDS RES, V30, P3662, DOI 10.1093/nar/gkf508; Tafer H, 2011, BIOINFORMATICS, V27, P1934, DOI 10.1093/bioinformatics/btr281; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Tsui HCT, 2010, J BACTERIOL, V192, P264, DOI 10.1128/JB.01204-09; Vecerek B, 2008, NUCLEIC ACIDS RES, V36, P133, DOI 10.1093/nar/gkm985; Vogel J, 2011, NAT REV MICROBIOL, V9, P578, DOI 10.1038/nrmicro2615; Wang E, 2008, MOL MICROBIOL, V69, P466, DOI 10.1111/j.1365-2958.2008.06295.x; Zhang AX, 2002, MOL CELL, V9, P11, DOI 10.1016/S1097-2765(01)00437-3	71	30	33	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98661	10.1371/journal.pone.0098661	http://dx.doi.org/10.1371/journal.pone.0098661			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932523	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600010
J	Han, HY; Dong, H; Zhu, SH; Zhao, QP; Jiang, LL; Wang, YG; Li, LJ; Wu, YL; Huang, B				Han, Hongyu; Dong, Hui; Zhu, Shunhai; Zhao, Qiping; Jiang, Lianlian; Wang, Yange; Li, Liujia; Wu, Youlin; Huang, Bing			Molecular Characterization and Analysis of a Novel Protein Disulfide Isomerase-Like Protein of Eimeria tenella	PLOS ONE			English	Article							SUBTRACTIVE HYBRIDIZATION; TOXOPLASMA-GONDII; APICAL ORGANELLES; IGA ANTIBODIES; HOST-CELL; GENE; IDENTIFICATION; THIOREDOXIN; EXPRESSION; LEISHMANIA	Protein disulfide isomerase (PDI) and PDI-like proteins are members of the thioredoxin superfamily. They contain thioredoxin-like domains and catalyze the physiological oxidation, reduction and isomerization of protein disulfide bonds, which are involved in cell function and development in prokaryotes and eukaryotes. In this study, EtPDIL, a novel PDI-like gene of Eimeria tenella, was cloned using rapid amplification of cDNA ends (RACE) according to the expressed sequence tag (EST). The EtPDIL cDNA contained 1129 nucleotides encoding 216 amino acids. The deduced EtPDIL protein belonged to thioredoxin-like superfamily and had a single predicted thioredoxin domain with a non-classical thioredoxin-like motif (SXXC). BLAST analysis showed that the EtPDIL protein was 55-59% identical to PDI-like proteins of other apicomplexan parasites. The transcript and protein levels of EtPDIL at different development stages were investigated by real-time quantitative PCR and western blot. The messenger RNA and protein levels of EtPDIL were higher in sporulated oocysts than in unsporulated oocysts, sporozoites or merozoites. Protein expression was barely detectable in unsporulated oocysts. Western blots showed that rabbit antiserum against recombinant EtPDIL recognized only a native 24 kDa protein from parasites. Immunolocalization with EtPDIL antibody showed that EtPDIL had a disperse distribution in the cytoplasm of whole sporozoites and merozoites. After sporozoites were incubated in complete medium, EtPDIL protein concentrated at the anterior of the sporozoites and appeared on the surface of parasites. Specific staining was more intense and mainly located on the parasite surface after merozoites released from mature schizonts invaded DF-1 cells. After development of parasites in DF-1 cells, staining intensified in trophozoites, immature schizonts and mature schizonts. Antibody inhibition of EtPDIL function reduced the ability of E. tenella to invade DF-1 cells. These results suggested that EtPDIL might be involved in sporulation in external environments and in host cell adhesion, invasion and development of E. tenella.	[Han, Hongyu; Dong, Hui; Zhu, Shunhai; Zhao, Qiping; Jiang, Lianlian; Wang, Yange; Li, Liujia; Wu, Youlin; Huang, Bing] Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Ministry of Agriculture & Rural Affairs	Huang, B (corresponding author), Chinese Acad Agr Sci, Shanghai Vet Res Inst, Key Lab Anim Parasitol, Minist Agr, Shanghai, Peoples R China.	hb@shvri.ac.cn			National Science Foundation of China [31201699]; Central Public Welfare Research Institutions; Basic Scientific Research Business Expenses [2014JB03]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central Public Welfare Research Institutions; Basic Scientific Research Business Expenses	This work was supported by grants from National Science Foundation of China (No. 31201699) and Central Public Welfare Research Institutions and Basic Scientific Research Business Expenses (No. 2014JB03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apperizeller-Herzog C, 2008, BBA-MOL CELL RES, V1783, P535, DOI 10.1016/j.bbamcr.2007.11.010; Ben Achour Y, 2002, INFECT IMMUN, V70, P3576, DOI 10.1128/IAI.70.7.3576-3585.2002; Ben Khalaf N, 2012, PARASITOL RES, V110, P1911, DOI 10.1007/s00436-011-2717-5; Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0; Blake DP, 2014, TRENDS PARASITOL, V30, P12, DOI 10.1016/j.pt.2013.10.003; Blunt DS, 1996, GENE, V181, P221, DOI 10.1016/S0378-1119(96)00460-X; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Chapman HD, 2013, ADV PARASIT, V83, P93, DOI 10.1016/B978-0-12-407705-8.00002-1; Clissold PM, 2003, BIOESSAYS, V25, P603, DOI 10.1002/bies.10287; d'Aloisio E, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-101; Dalloul RA, 2005, AVIAN DIS, V49, P1, DOI 10.1637/7306-11150R; Darby NJ, 1996, BIOCHEMISTRY-US, V35, P10517, DOI 10.1021/bi960763s; Davids BJ, 2004, MOL BIOCHEM PARASIT, V136, P173, DOI 10.1016/j.molbiopara.2004.03.011; Dong H, 2014, PARASITOL RES, V113, P735, DOI 10.1007/s00436-013-3703-x; Ebel T, 2002, MOL BIOCHEM PARASIT, V121, P265, DOI 10.1016/S0166-6851(02)00036-1; Galligan JJ, 2012, HUM GENOMICS, V6, DOI 10.1186/1479-7364-6-6; GILLIN FD, 1990, P NATL ACAD SCI USA, V87, P4463, DOI 10.1073/pnas.87.12.4463; Han HY, 2013, PARASITOLOGY, V140, P746, DOI 10.1017/S0031182012002107; Han HY, 2010, J PARASITOL, V96, P95, DOI 10.1645/GE-2221.1; HAWKINS HC, 1991, BIOCHEM J, V275, P349, DOI 10.1042/bj2750349; Hu Y, 2012, PARASITOL RES, V111, P983, DOI 10.1007/s00436-012-2922-x; Jahn D, 2009, PARASITOL RES, V105, P655, DOI 10.1007/s00436-009-1437-6; Jiang LL, 2012, PARASITOL RES, V110, P865, DOI 10.1007/s00436-011-2568-0; Jiang LL, 2013, PLOS ONE, V7; Kimura T, 2005, J BIOL CHEM, V280, P31438, DOI 10.1074/jbc.M503377200; Lal K, 2009, PROTEOMICS, V9, P1142, DOI 10.1002/pmic.200800404; Laurindo FRM, 2012, FREE RADICAL BIO MED, V52, P1954, DOI 10.1016/j.freeradbiomed.2012.02.037; Li LD, 2012, EXP PARASITOL, V132, P465, DOI 10.1016/j.exppara.2012.09.014; Liao M, 2007, INSECT BIOCHEM MOLEC, V37, P641, DOI 10.1016/j.ibmb.2007.03.015; Mahajan B, 2006, INT J PARASITOL, V36, P1037, DOI 10.1016/j.ijpara.2006.04.012; MANDEL R, 1993, P NATL ACAD SCI USA, V90, P4112, DOI 10.1073/pnas.90.9.4112; Meek B, 2002, FEBS LETT, V522, P104, DOI 10.1016/S0014-5793(02)02911-3; Meek B, 2002, INT IMMUNOL, V14, P1291, DOI 10.1093/intimm/dxf091; Miska KB, 2004, J PARASITOL, V90, P1245, DOI 10.1645/GE-309R; Mouray E, 2007, BIOCHIMIE, V89, P337, DOI 10.1016/j.biochi.2006.11.001; Naguleswaran A, 2005, INT J PARASITOL, V35, P1459, DOI 10.1016/j.ijpara.2005.06.006; Ng ST, 2002, EXP PARASITOL, V101, P168, DOI 10.1016/S0014-4894(02)00109-1; Norgaard P, 2001, BIOCHEM J, V358, P269, DOI 10.1042/0264-6021:3580269; Novo C, 2009, INT J BIOL MACROMOL, V45, P399, DOI 10.1016/j.ijbiomac.2009.07.001; Padilla A, 2003, J BIOL CHEM, V278, P1872, DOI 10.1074/jbc.M210322200; Peroval M, 2006, INT J PARASITOL, V36, P1205, DOI 10.1016/j.ijpara.2006.04.006; Podell S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-37; Rainey-Barger EK, 2007, MOL BIOL CELL, V18, P1253, DOI 10.1091/mbc.E06-11-1004; Riemer J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017037; Rietsch A, 1998, ANNU REV GENET, V32, P163, DOI 10.1146/annurev.genet.32.1.163; Rigobello MP, 2001, BIOCHEM J, V356, P567, DOI 10.1042/0264-6021:3560567; Rubotham J, 2005, J BIOL CHEM, V280, P10410, DOI 10.1074/jbc.M409375200; Shirley MW, 2007, VACCINE, V25, P5540, DOI 10.1016/j.vaccine.2006.12.030; Shirley MW, 2005, ADV PARASIT, V60, P285, DOI 10.1016/S0065-308X(05)60005-X; Stolf BS, 2011, THESCIENTIFICWORLDJO, V11, P1749, DOI 10.1100/2011/289182; TACHIKAWA H, 1995, FEBS LETT, V369, P212, DOI 10.1016/0014-5793(95)00750-4; Tomley F, 1997, METHODS, V13, P171, DOI 10.1006/meth.1997.0509; van Lith M, 2005, J BIOL CHEM, V280, P1376, DOI 10.1074/jbc.M408651200; Walker KW, 1996, BIOCHEMISTRY-US, V35, P1972, DOI 10.1021/bi952157n; Wang HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070884; Wang HM, 2000, CURR GENET, V37, P57, DOI 10.1007/s002940050009; Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017	58	8	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99914	10.1371/journal.pone.0099914	http://dx.doi.org/10.1371/journal.pone.0099914			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932912	gold, Green Published, Green Submitted			2022-12-27	WOS:000337738600080
J	Yang, B; Liang, G; Khojasteh, S; Wu, Z; Yang, WQ; Joseph, D; Wei, HF				Yang, Bin; Liang, Ge; Khojasteh, Soorena; Wu, Zhen; Yang, Wenqiong; Joseph, Donald; Wei, Huafeng			Comparison of Neurodegeneration and Cognitive Impairment in Neonatal Mice Exposed to Propofol or Isoflurane	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; RHESUS MACAQUE BRAIN; DEVELOPING RAT-BRAIN; NEURONAL APOPTOSIS; CELL-DEATH; INDUCED NEUROAPOPTOSIS; CALCIUM HOMEOSTASIS; ALZHEIMERS-DISEASE; MOUSE-BRAIN; ANESTHESIA	Background: While previous studies have demonstrated neuronal apoptosis and associated cognitive impairment after isoflurane or propofol exposure in neonatal rodents, the effects of these two anesthetics have not been directly compared. Here, we compare and contrast the effectiveness of isoflurane and propofol to cause neurodegeneration in the developing brain and associated cognitive dysfunction. Methods: Seven-day-old mice were used. Mice in the isoflurane treatment group received 6 h of 1.5% isoflurane, while mice in propofol treatment group received one peritoneal injection (150 mg/kg), which produced persistent anesthesia with loss of righting for at least 6 h. Mice in control groups received carrying gas or a peritoneal injection of vehicle (intralipid). At 6 h after anesthetic treatment, a subset of each group was sacrificed and examined for evidence of neurodegeneration, using plasma levels of S100 beta, and apoptosis using caspase-3 immunohistochemistry in the cerebral cortex and hippocampus and Western blot assays of the cortex. In addition, biomarkers for inflammation (interleukin-1, interleukin-6, and tumor necrosis factor alpha) were examined with Western blot analyses of the cortex. In another subset of mice, learning and memory were assessed 32 days after the anesthetic exposures using the Morris water maze. Results: Isoflurane significantly increased plasma S100 beta levels compared to controls and propofol. Both isoflurane and propofol significantly increased caspase-3 levels in the cortex and hippocampus, though isoflurane was significantly more potent than propofol. However, there were no significant differences in the inflammatory biomarkers in the cortex or in subsequent learning and memory between the experimental groups. Conclusion: Both isoflurane and propofol caused significant apoptosis in the mouse developing brain, with isoflurane being more potent. Isoflurane significantly increased levels of the plasma neurodegenerative biomarker, S100 beta. However, these neurodegenerative effects of isoflurane and propofol in the developing brain were not associated with effects on inflammation or with cognitive dysfunction in later life.	[Yang, Bin; Liang, Ge; Khojasteh, Soorena; Wu, Zhen; Yang, Wenqiong; Joseph, Donald; Wei, Huafeng] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA; [Yang, Bin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Peoples Hosp 1, Dept Anesthesiol, Shanghai 200030, Peoples R China; [Wu, Zhen] Huazhong Univ Sci & Technol, Dept Anesthesiol, Tongji Hosp, Tongji Med Coll, Wuhan 430074, Peoples R China; [Yang, Wenqiong] Hubei Univ Med, Dongfeng Gen Hosp, Dept Neurol, Shiyan, Hubei, Peoples R China	University of Pennsylvania; Pennsylvania Medicine; Shanghai Jiao Tong University; Huazhong University of Science & Technology; Hubei University of Medicine	Wei, HF (corresponding author), Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA.	weih@uphs.upenn.edu	Yang, Bin/AAO-4183-2021	Yang, Bin/0000-0002-6604-5565	National Institute of General Medical Science, National Institutes of Health, Baltimore, Maryland [1-K08-GM073224, 1-R01GM084979-01, 3R01GM084979-02S1]; March of Dimes Birth Defects Foundation Research Grant, White Plains, New York [12-FY05-62]; Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM084979, K08GM073224] Funding Source: NIH RePORTER	National Institute of General Medical Science, National Institutes of Health, Baltimore, Maryland; March of Dimes Birth Defects Foundation Research Grant, White Plains, New York(March of Dimes); Department of Anesthesiology and Critical Care, Perelman School of Medicine at the University of Pennsylvania; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institute of General Medical Science, National Institutes of Health, Baltimore, Maryland, K08 grant (1-K08-GM073224, to HW) and R01 grant (1-R01GM084979-01, 3R01GM084979-02S1 to HW); March of Dimes Birth Defects Foundation Research Grant (12-FY05-62, to HW), White Plains, New York; and Department of Anesthesiology and Critical Care research funds, Perelman School of Medicine at the University of Pennsylvania. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bloomfield SM, 2007, NEUROCRIT CARE, V6, P121, DOI 10.1007/s12028-007-0008-x; Brambrink AM, 2012, ANN NEUROL, V72, P525, DOI 10.1002/ana.23652; Brambrink AM, 2012, ANESTHESIOLOGY, V116, P372, DOI 10.1097/ALN.0b013e318242b2cd; Brambrink AM, 2010, ANESTHESIOLOGY, V112, P834, DOI 10.1097/ALN.0b013e3181d049cd; Cao L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051431; Cata JP, 2011, BRIT J ANAESTH, V107, P844, DOI 10.1093/bja/aer338; Cattano D, 2008, ANESTH ANALG, V106, P1712, DOI 10.1213/ane.0b013e318172ba0a; Creeley C, 2013, BRIT J ANAESTH, V110, P29, DOI 10.1093/bja/aet173; Feng XM, 2013, ANESTHESIOLOGY, V118, P1098, DOI 10.1097/ALN.0b013e318286d0c9; Flick RP, 2011, PEDIATRICS, V128, pE1053, DOI 10.1542/peds.2011-0351; Head BP, 2009, ANESTHESIOLOGY, V110, P813, DOI 10.1097/ALN.0b013e31819b602b; Ikonomidou C, 2001, BIOCHEM PHARMACOL, V62, P401, DOI 10.1016/S0006-2952(01)00696-7; Istaphanous GK, 2013, ANESTH ANALG, V116, P845, DOI 10.1213/ANE.0b013e318281e988; Istaphanous GK, 2011, ANESTHESIOLOGY, V114, P578, DOI 10.1097/ALN.0b013e3182084a70; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Kodama M, 2011, ANESTHESIOLOGY, V115, P979, DOI 10.1097/ALN.0b013e318234228b; Li YJ, 2007, NEUROPHARMACOLOGY, V53, P942, DOI 10.1016/j.neuropharm.2007.09.005; Liang G, 2008, ANESTH ANALG, V106, P492, DOI 10.1213/ane.0b013e3181605b71; Liang G, 2010, ANESTHESIOLOGY, V112, P1325, DOI 10.1097/ALN.0b013e3181d94da5; Lin DW, 2011, NEUROPHARMACOLOGY, V61, P1354, DOI 10.1016/j.neuropharm.2011.08.011; Liu YZ, 2013, AM J MED SCI, V345, P355, DOI 10.1097/MAJ.0b013e31825a674d; Loepke AW, 2010, PEDIATR CRIT CARE ME, V11, P217, DOI 10.1097/PCC.0b013e3181b80383; Lunardi N, 2010, NEUROTOX RES, V17, P179, DOI 10.1007/s12640-009-9088-z; Luo T, 2013, ANESTHESIOLOGY, V119, P1370, DOI 10.1097/ALN.0000000000000020; Ma DQ, 2007, ANESTHESIOLOGY, V106, P746, DOI 10.1097/01.anes.0000264762.48920.80; Paxinos G, 2007, ATLAS DEV MOUSE BRAI; Pearn ML, 2012, ANESTHESIOLOGY, V116, P352, DOI 10.1097/ALN.0b013e318242a48c; Peng Y, 2011, NEUR M PLANN SOC NEU; Sanchez V, 2011, ANESTHESIOLOGY, V115, P992, DOI 10.1097/ALN.0b013e3182303a63; Sanders RD, 2010, ACTA ANAESTH SCAND, V54, P710, DOI 10.1111/j.1399-6576.2009.02177.x; Shen X, 2013, ANESTHESIOLOGY, V118, P502, DOI 10.1097/ALN.0b013e3182834d77; Sinner B, 2011, ANESTH ANALG, V113, P1161, DOI 10.1213/ANE.0b013e31822747df; Slikker W, 2007, TOXICOL SCI, V98, P145, DOI 10.1093/toxsci/kfm084; Soriano SG, 2010, ANESTHESIOLOGY, V112, P1155, DOI 10.1097/ALN.0b013e3181d3e0c2; Stratmann G, 2009, ANESTHESIOLOGY, V110, P849, DOI 10.1097/ALN.0b013e31819c7140; Sun L, 2010, BRIT J ANAESTH, V105, pI61, DOI 10.1093/bja/aeq302; Tang JXX, 2013, ANN SURG, V257, P439, DOI 10.1097/SLA.0b013e318269d623; Tang JXX, 2011, CURR OPIN ANESTHESIO, V24, P389, DOI 10.1097/ACO.0b013e32834871c5; Terrando N, 2011, ANN NEUROL, V70, P986, DOI 10.1002/ana.22664; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Tu SF, 2011, BRAIN RES BULL, V86, P29, DOI 10.1016/j.brainresbull.2011.06.017; Valentim AM, 2010, ANESTHESIOLOGY, V113, P1099, DOI 10.1097/ALN.0b013e3181f79c7c; Wang QJ, 2011, TOXICOL APPL PHARM, V250, P291, DOI 10.1016/j.taap.2010.10.032; Wang SP, 2009, PEDIATR RES, V66, P435, DOI 10.1203/PDR.0b013e3181b3381b; Wei HF, 2008, ANESTHESIOLOGY, V108, P251, DOI 10.1097/01.anes.0000299435.59242.0e; Wei HF, 2011, ANESTH ANALG, V113, P972, DOI 10.1213/ANE.0b013e3182323261; Wei HF, 2009, CURR ALZHEIMER RES, V6, P30, DOI 10.2174/156720509787313934; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Xie ZC, 2008, ANN NEUROL, V64, P618, DOI 10.1002/ana.21548; Yang H, 2008, ANESTHESIOLOGY, V109, P243, DOI 10.1097/ALN.0b013e31817f5c47; Yon JH, 2006, NEUROBIOL DIS, V21, P522, DOI 10.1016/j.nbd.2005.08.011; Yu DS, 2013, NEUROSCI LETT, V534, P41, DOI 10.1016/j.neulet.2012.12.033; Yu GX, 2011, SURGERY, V150, P887, DOI 10.1016/j.surg.2011.04.002; Zhang GH, 2008, J NEUROSCI, V28, P4551, DOI 10.1523/JNEUROSCI.5694-07.2008; Zhang J, 2014, NEUROSCIENCE, V261, P1, DOI 10.1016/j.neuroscience.2013.12.034; Zhang YY, 2012, ANN NEUROL, V71, P687, DOI 10.1002/ana.23536; Zhao XL, 2013, ANESTHESIOLOGY, V118, P537, DOI 10.1097/ALN.0b013e3182833fae; Zhao YL, 2011, ANESTH ANALG, V113, P1152, DOI 10.1213/ANE.0b013e318230b3fd; Zhao YF, 2010, J PHARMACOL EXP THER, V333, P14, DOI 10.1124/jpet.109.161562; Zhou R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082729; Zou X, 2008, NEUROSCIENCE, V151, P1053, DOI 10.1016/j.neuroscience.2007.12.013; Zou XJ, 2011, NEUROTOXICOL TERATOL, V33, P592, DOI 10.1016/j.ntt.2011.06.003	62	44	49	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99171	10.1371/journal.pone.0099171	http://dx.doi.org/10.1371/journal.pone.0099171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932894	gold, Green Published, Green Submitted			2022-12-27	WOS:000337738600026
J	Li, P; Xu, XY; Cao, EH; Yu, B; Li, WC; Fan, M; Huang, M; Shi, LN; Zeng, R; Su, X; Shi, Y				Li, Pei; Xu, Xiaoyong; Cao, Ehong; Yu, Bo; Li, Wanchun; Fan, Ming; Huang, Mei; Shi, Lining; Zeng, Rong; Su, Xin; Shi, Yi			Vitamin D Deficiency Causes Defective Resistance to Aspergillus fumigatus in Mice via Aggravated and Sustained Inflammation	PLOS ONE			English	Article							INHIBITS NEUTROPHIL RECRUITMENT; PATTERN-RECOGNITION RECEPTORS; ACUTE LUNG INJURY; HOST-DEFENSE; INVASIVE ASPERGILLOSIS; INFECTIOUS-DISEASES; CYTOKINE PRODUCTION; FUNGAL-INFECTIONS; HAMSTER MODEL; TUBERCULOSIS	Background: Vitamin D plays an important role in pulmonary resistance and immunity, and its deficiency has been linked to various respiratory infections. Little is known about the effect of vitamin D deficiency on host pulmonary defense to Aspergillus fumigatus (A. fumigatus). Methods: Mice raised on vitamin D sufficient or deficient diets were infected intratracheally with A. fumigatus conidia. Mortality, fungal growth, weight loss and lung histology were monitored. Alveolar macrophages (AMs) were stimulated with A. fumigatus conidia in vitro. The kinetics of pro-inflammatory cytokines (TNF-alpha, IL-1 beta and IL-6), chemokines (CXCL1, CCL3), and pattern recognition receptors (Toll-like receptor [TLR] 2, TLR 4 and dectin-1) expression in the lungs and AMs were measured. Results: Upon A. fumigatus infection, vitamin D deficient mice showed higher mortality, greater fungal load, and more weight loss than its sufficient counterparts. Vitamin D deficient mice demonstrated aggravated and prolonged histological evidence of lung inflammation as well as enhanced BAL cell counts, dominated by neutrophils after A. fumigatus inoculation. Increased basal levels of pro-inflammatory cytokines in the lungs and AMs from naive vitamin D deficient mice were observed. Upon A. fumigatus exposure, vitamin D deficiency led to enhanced and sustained expression of TNF-alpha, IL-1 beta, IL-6, CXCL1 and CCL3 both in vivo and in vitro. Up-regulation of TLR2, TLR4 and dectin-1 was observed in the lungs and AMs from vitamin D deficient mice both at baseline and after A. fumigatus exposure. Conclusions: Vitamin D deficiency causes defective pulmonary resistance to A. fumigatus in mice, possibly by the enhanced basal expression of pattern recognition receptors and pro-inflammatory cytokines, which induced excessive inflammatory response in response to A. fumigatus challenge.	[Li, Pei; Xu, Xiaoyong; Cao, Ehong; Su, Xin; Shi, Yi] Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp & Crit Care Med, Nanjing 210008, Jiangsu, Peoples R China; [Yu, Bo; Li, Wanchun] Nanjing Univ, Sch Med, Jinling Hosp, Dept Pathol, Nanjing 210008, Jiangsu, Peoples R China; [Fan, Ming; Huang, Mei] Nanjing Univ, Sch Med, Jinling Hosp, Dept Clin Microbiol, Nanjing 210008, Jiangsu, Peoples R China; [Shi, Lining; Zeng, Rong] Nanjing Univ, Sch Med, Dept Clin Lab, Jinling Hosp, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University	Su, X (corresponding author), Nanjing Univ, Sch Med, Jinling Hosp, Dept Resp & Crit Care Med, Nanjing 210008, Jiangsu, Peoples R China.	suxinjs@hotmail.com; shiyi56@126.com	Su, Xin/X-2589-2018	su, Xin/0000-0002-3910-9156	National Natural Science Foundation of China (NSFC) [81270064]	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (NSFC 81270064). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JS, 1985, J EXP MED, V161, P755, DOI 10.1084/jem.161.4.755; Baeke F, 2010, CURR OPIN PHARMACOL, V10, P482, DOI 10.1016/j.coph.2010.04.001; Barnes PD, 2007, BRIT J HAEMATOL, V139, P519, DOI 10.1111/j.1365-2141.2007.06812.x; Bellocchio S, 2004, J IMMUNOL, V172, P3059, DOI 10.4049/jimmunol.172.5.3059; Bretz C, 2008, INFECT IMMUN, V76, P952, DOI 10.1128/IAI.00927-07; Campbell GR, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002689; Casadevall A, 2003, NAT REV MICROBIOL, V1, P17, DOI 10.1038/nrmicro732; CHEN SF, 1995, J STEROID BIOCHEM, V52, P67; Cheng XW, 2011, RESP PHYSIOL NEUROBI, V175, P185, DOI 10.1016/j.resp.2010.11.004; CIMOLAI N, 1992, MICROBIOL IMMUNOL, V36, P465, DOI 10.1111/j.1348-0421.1992.tb02045.x; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; Dini C, 2012, ANN I SUPER SANITA, V48, P319, DOI 10.4415/ANN_12_03_13; Gao JL, 1997, J EXP MED, V185, P1959, DOI 10.1084/jem.185.11.1959; Gombart AF, 2009, FUTURE MICROBIOL, V4, P1151, DOI 10.2217/FMB.09.87; Gonzalez-Juarrero M, 2003, J IMMUNOL, V171, P3128, DOI 10.4049/jimmunol.171.6.3128; Hansdottir S, 2008, J IMMUNOL, V181, P7090, DOI 10.4049/jimmunol.181.10.7090; Hansdottir S, 2011, VITAM HORM, V86, P217, DOI 10.1016/B978-0-12-386960-9.00009-5; Hansdottir S, 2010, J IMMUNOL, V184, P965, DOI 10.4049/jimmunol.0902840; Heaney RP, 2012, NEW ENGL J MED, V367, P77, DOI 10.1056/NEJMe1206858; Holick MF, 2008, AM J CLIN NUTR, V87, p1080S; Hughes DA, 2009, CLIN EXP IMMUNOL, V158, P20, DOI 10.1111/j.1365-2249.2009.04001.x; Khoo AL, 2011, CLIN EXP IMMUNOL, V164, P72, DOI 10.1111/j.1365-2249.2010.04315.x; Khoo AL, 2012, CRIT REV MICROBIOL, V38, P122, DOI 10.3109/1040841X.2011.622716; Khoo AL, 2011, CYTOKINE, V55, P294, DOI 10.1016/j.cyto.2011.04.016; Khoo AL, 2011, J INFECT DIS, V203, P122, DOI 10.1093/infdis/jiq008; Kreindler JL, 2010, J CLIN INVEST, V120, P3242, DOI 10.1172/JCI42388; Laaksi I, 2007, AM J CLIN NUTR, V86, P714, DOI 10.1093/ajcn/86.3.714; Lagishetty V, 2010, ENDOCRINOLOGY, V151, P2423, DOI 10.1210/en.2010-0089; Legrand F, 2008, CLIN INFECT DIS, V46, P696, DOI 10.1086/527390; Matsumoto K, 1995, Verh K Acad Geneeskd Belg, V57, P109; Mehrad B, 1999, J IMMUNOL, V162, P1633; Miceli MH, 2007, CANCER-AM CANCER SOC, V110, P112, DOI 10.1002/cncr.22738; Romani L, 2008, NATURE, V451, P211, DOI 10.1038/nature06471; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; Sadeghi K, 2006, EUR J IMMUNOL, V36, P361, DOI 10.1002/eji.200425995; Science M., 2013, CLIN INFECT DIS; Segal BH, 2007, ONCOLOGIST, V12, P7, DOI 10.1634/theoncologist.12-S2-7; Shreiner AB, 2012, INFECT IMMUN, V80, P388, DOI 10.1128/IAI.05530-11; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Takano Y, 2012, STEROIDS, V77, P1535, DOI 10.1016/j.steroids.2012.09.008; Takano Y, 2011, STEROIDS, V76, P1305, DOI 10.1016/j.steroids.2011.06.009; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Thacher TD, 2011, MAYO CLIN PROC, V86, P50, DOI 10.4065/mcp.2010.0567; Tighe RM, 2011, J IMMUNOL, V187, P4800, DOI 10.4049/jimmunol.1101312; Tisoncik JR, 2012, MICROBIOL MOL BIOL R, V76, P16, DOI 10.1128/MMBR.05015-11; van de Veerdonk FL, 2008, CURR OPIN MICROBIOL, V11, P305, DOI 10.1016/j.mib.2008.06.002; van Schoor NM, 2011, BEST PRACT RES CL EN, V25, P671, DOI 10.1016/j.beem.2011.06.007; Vieth R, 2006, PROG BIOPHYS MOL BIO, V92, P26, DOI 10.1016/j.pbiomolbio.2006.02.003; Wayse V, 2004, EUR J CLIN NUTR, V58, P563, DOI 10.1038/sj.ejcn.1601845; Werner JL, 2009, J IMMUNOL, V182, P4938, DOI 10.4049/jimmunol.0804250; White JH, 2010, J STEROID BIOCHEM, V121, P234, DOI 10.1016/j.jsbmb.2010.03.034; Wilkinson RJ, 2000, LANCET, V355, P618, DOI 10.1016/S0140-6736(99)02301-6; Xue ML, 2002, IMMUNOL CELL BIOL, V80, P340, DOI 10.1046/j.1440-1711.80.4august.1.x; ZARRABEITIA MT, 1992, BONE, V13, P185, DOI 10.1016/8756-3282(92)90010-T; Zhang Y, 2012, J IMMUNOL, V188, P2127, DOI 10.4049/jimmunol.1102412	55	28	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99805	10.1371/journal.pone.0099805	http://dx.doi.org/10.1371/journal.pone.0099805			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926881	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100082
J	Song, GX; Zhang, J; Wang, K				Song, Genxin; Zhang, Jing; Wang, Ke			Selection of Optimal Auxiliary Soil Nutrient Variables for Cokriging Interpolation	PLOS ONE			English	Article							REGRESSION; NITROGEN	In order to explore the selection of the best auxiliary variables (BAVs) when using the Cokriging method for soil attribute interpolation, this paper investigated the selection of BAVs from terrain parameters, soil trace elements, and soil nutrient attributes when applying Cokriging interpolation to soil nutrients (organic matter, total N, available P, and available K). In total, 670 soil samples were collected in Fuyang, and the nutrient and trace element attributes of the soil samples were determined. Based on the spatial autocorrelation of soil attributes, the Digital Elevation Model (DEM) data for Fuyang was combined to explore the coordinate relationship among terrain parameters, trace elements, and soil nutrient attributes. Variables with a high correlation to soil nutrient attributes were selected as BAVs for Cokriging interpolation of soil nutrients, and variables with poor correlation were selected as poor auxiliary variables (PAVs). The results of Cokriging interpolations using BAVs and PAVs were then compared. The results indicated that Cokriging interpolation with BAVs yielded more accurate results than Cokriging interpolation with PAVs (the mean absolute error of BAV interpolation results for organic matter, total N, available P, and available K were 0.020, 0.002, 7.616, and 12.4702, respectively, and the mean absolute error of PAV interpolation results were 0.052, 0.037, 15.619, and 0.037, respectively). The results indicated that Cokriging interpolation with BAVs can significantly improve the accuracy of Cokriging interpolation for soil nutrient attributes. This study provides meaningful guidance and reference for the selection of auxiliary parameters for the application of Cokriging interpolation to soil nutrient attributes.	[Wang, Ke] Zhejiang Univ, Inst Agr Remote Sensing & Informat Tech, Hangzhou 310003, Zhejiang, Peoples R China; Zhejiang Univ, Minist Educ, Key Lab Environm Remediat Ecol & Hlth, Hangzhou 310003, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wang, K (corresponding author), Zhejiang Univ, Inst Agr Remote Sensing & Informat Tech, Hangzhou 310003, Zhejiang, Peoples R China.	kwang@zju.edu.cn			National Natural Science Fund of China [31172023]	National Natural Science Fund of China(National Natural Science Foundation of China (NSFC))	The study was supported by the National Natural Science Fund of China (Grant No. 31172023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ATKINSON PM, 1994, REMOTE SENS ENVIRON, V50, P335, DOI 10.1016/0034-4257(94)90083-3; Behrens T, 2014, GEODERMA, V213, P578, DOI 10.1016/j.geoderma.2013.07.031; Bo L, 2013, J ENV PROT SCI, V39; Brimelow JC, 2010, AGR FOREST METEOROL, V150, P100, DOI 10.1016/j.agrformet.2009.09.006; Eldeiry AA, 2010, J IRRIG DRAIN ENG, V136, P355, DOI 10.1061/(ASCE)IR.1943-4774.0000208; Jiang Yong, 2006, Yingyong Shengtai Xuebao, V17, P97; Juan P, 2011, J GEOCHEM EXPLOR, V108, P62, DOI 10.1016/j.gexplo.2010.10.003; KE-LIN H., 2001, ADV WATER RESOURCE, V12, P460; Kunkel ML, 2011, GEODERMA, V165, P1, DOI 10.1016/j.geoderma.2011.06.011; Laurent L, 2013, COMPUT MECH, V51, P151, DOI 10.1007/s00466-012-0711-0; Lei F, 2010, T CSAE, V10, P39; [连纲 LIAN Gang], 2008, [地理科学, Scientia Geographica Sinica], V28, P554; Lin QH, 2013, FOREST ECOL MANAG, V308, P214, DOI 10.1016/j.foreco.2013.07.028; Lu Qiao, 2011, Proceedings of the 2011 International Conference on Remote Sensing, Environment and Transportation Engineering (RSETE 2011), P8124, DOI 10.1109/RSETE.2011.5964041; Mouazen AM, 2010, GEODERMA, V158, P23, DOI 10.1016/j.geoderma.2010.03.001; [邱扬 Qiu Yang], 2002, [地理学报, Acta Geographica Sinica], V57, P587; Shi WJ, 2012, J GEOGR SCI, V22, P752, DOI 10.1007/s11442-012-0960-z; SONG G., 2013, IEEE, P1; Tittonell P, 2010, EUR J AGRON, V32, P10, DOI 10.1016/j.eja.2009.05.008; Vachaud G., 1985, J HYDRUL ENG ASCE, V9, P10; Wang K, 2013, APPL GEOGR, V42, P73, DOI 10.1016/j.apgeog.2013.04.002; Willmott C.J., 1981, PHYS GEOGR, V2, P184, DOI [10.1080/02723646.1981.10642213, DOI 10.1080/02723646.1981.10642213]; XIAOQING Z., 2013, CHINESE AGR SCI, V29, P160; Xu HongWei, 2007, Transactions of the Chinese Society of Agricultural Engineering, V23, P13; Yan L, 2004, ACTA PEDOL SIN, V41, P434; Yao RJ, 2012, ENVIRON MONIT ASSESS, P1; Yao XL, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0056537, 10.1371/journal.pone.0054660]; Zeiner M, 2013, ENVIRON MONIT ASSESS, V185, P223, DOI 10.1007/s10661-012-2546-8; Zhang SW, 2012, GEODERMA, V171, P35, DOI 10.1016/j.geoderma.2011.07.012; Zhang W, 2004, SPAA STAT ANAL ADV T; Zhao ChunJiang, 2003, Transactions of the Chinese Society of Agricultural Engineering, V19, P7	31	5	6	4	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99695	10.1371/journal.pone.0099695	http://dx.doi.org/10.1371/journal.pone.0099695			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927129	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100068
J	van de Put, MAJ; Croonen, D; Nolte, IM; Japing, WJ; Hooymans, JM; Los, LI				van de Put, Mathijs A. J.; Croonen, Danna; Nolte, Ilja M.; Japing, Wouter J.; Hooymans, JohannaM. M.; Los, Leonoor I.			Postoperative Recovery of Visual Function after Macula-Off Rhegmatogenous Retinal Detachment	PLOS ONE			English	Article							CONTRAST SENSITIVITY; CENTRAL VISION; SURGERY; DURATION; FAILURE; HEIGHT; ACUITY	Purpose: To determine which factors affect the recovery of visual function in macula-off rhegmatogenous retinal detachment (RRD). Methods: In a prospective study of forty-five patients with a primary macula-off RRD of 24 hours to 6 weeks duration, the height of the macular detachment was determined by ultrasonography. At 12 months postoperatively, best corrected visual acuity (BCVA), contrast acuity, and color confusion indexes (CCI) were obtained. Results: Macular detachment was present for 2-32 (median 7) days before repair. A shorter duration of macular detachment was correlated with a better CCI sature (p = 0.0026) and lower LogMAR BCVA (better Snellen visual acuity)(p = 0.012). Also, a smaller height of macular detachment was correlated with a lower LogMAR BCVA (p = 0.0034). A younger age and lower pre-operative LogMAR BCVA at presentation were both correlated with better postoperative contrast acuity in the total group (age: p = 1.7 x 10(-4) and pre-operative LogMAR BCVA: p = 0.0034). Conclusion: Functional recovery after macula-off RRD is affected by the duration and the height of the macular detachment. Recovery of contrast acuity is also affected by age and BCVA at presentation.	[van de Put, Mathijs A. J.; Croonen, Danna; Japing, Wouter J.; Hooymans, JohannaM. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands; [Nolte, Ilja M.] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [Hooymans, JohannaM. M.; Los, Leonoor I.] Univ Groningen, Univ Med Ctr Groningen, Grad Sch Med Sci, WJ Kolff Inst, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen	van de Put, MAJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Ophthalmol, Groningen, Netherlands.	m.a.j.van.de.put@umcg.nl			Stichting Blindenhulp; Professor Mulder Stichting; Stichting Nederlands Oogheelkundig Onderzoek	Stichting Blindenhulp; Professor Mulder Stichting; Stichting Nederlands Oogheelkundig Onderzoek	This work was supported by Grant/financial supports: Stichting Blindenhulp, Professor Mulder Stichting, Stichting Nederlands Oogheelkundig Onderzoek. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON C, 1981, ACTA OPHTHALMOL, V59, P161; BOWMAN KJ, 1982, ACTA OPHTHALMOL, V60, P907; Burton T C, 1982, Trans Am Ophthalmol Soc, V80, P475; CHIGNELL AH, 1973, BRIT J OPHTHALMOL, V57, P525, DOI 10.1136/bjo.57.8.525; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; D'Amico DJ, 2008, NEW ENGL J MED, V359, P2346, DOI 10.1056/NEJMcp0804591; Davies E W, 1972, Trans Ophthalmol Soc U K, V92, P335; Diederen RMH, 2007, OPHTHALMOLOGY, V114, P705, DOI 10.1016/j.ophtha.2006.09.004; Doyle E, 2007, EYE, V21, P534, DOI 10.1038/sj.eye.6702260; GRIZZARD WS, 1994, GRAEF ARCH CLIN EXP, V232, P1, DOI 10.1007/BF00176431; GUNDRY MF, 1974, AM J OPHTHALMOL, V77, P310, DOI 10.1016/0002-9394(74)90735-1; Hassan TS, 2002, OPHTHALMOLOGY, V109, P146, DOI 10.1016/S0161-6420(01)00886-7; Jay B, 1965, Trans Ophthalmol Soc U K, V85, P101; Kreissig I, 1981, Dev Ophthalmol, V2, P77; Kreissig I, 1977, Mod Probl Ophthalmol, V18, P415; Lecleire-Collet A, 2005, RETINA-J RET VIT DIS, V25, P44, DOI 10.1097/00006982-200501000-00006; Lewis GP, 2004, AM J OPHTHALMOL, V137, P1085, DOI 10.1016/j.ajo.2004.01.045; LIEM ATA, 1994, OPHTHALMOLOGY, V101, P1945; MACHEMER R, 1968, AM J OPHTHALMOL, V66, P396, DOI 10.1016/0002-9394(68)91523-7; Mantyjarvi M, 2001, J CATARACT REFR SURG, V27, P261, DOI 10.1016/S0886-3350(00)00562-9; Mervin K, 1999, AM J OPHTHALMOL, V128, P155, DOI 10.1016/S0002-9394(99)00104-X; Minihan M, 2001, BRIT J OPHTHALMOL, V85, P546, DOI 10.1136/bjo.85.5.546; Mitry D, 2012, BR J OPHTHALMOL, P1; Mowatt L, 2010, EYE, V24, P323, DOI 10.1038/eye.2009.74; Pastor JC, 2008, BRIT J OPHTHALMOL, V92, P378, DOI 10.1136/bjo.2007.129437; Rachal WF, 1979, ARCH OPHTHALMOL-CHIC, V18, P415; Reese AB., 1937, AM J OPHTHALMOL, V20, P591, DOI [10.1016/S0002-9394(37)91116-4, DOI 10.1016/S0002-9394(37)91116-4]; Ross W, 2005, OPHTHALMOLOGY, V112, P1213, DOI 10.1016/j.ophtha.2005.01.040; Ross WH, 1998, OPHTHALMOLOGY, V105, P2149, DOI 10.1016/S0161-6420(98)91142-3; Rosser DA, 2003, INVEST OPHTH VIS SCI, V44, P3278, DOI 10.1167/iovs.02-1100; SHARMA T, 1994, RETINA-J RET VIT DIS, V14, P338, DOI 10.1097/00006982-199414040-00008; TANI P, 1981, AM J OPHTHALMOL, V92, P611, DOI 10.1016/S0002-9394(14)74651-3; van de Put MAJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062518; Van de Put MAJ, 2013, OPHTHALMOLOGY, V120, P616, DOI 10.1016/j.ophtha.2012.09.001; Wilkinson Charles Patton, 2009, Trans Am Ophthalmol Soc, V107, P55; zgur S, 2007, RETINA, V27, P359	36	15	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99787	10.1371/journal.pone.0099787	http://dx.doi.org/10.1371/journal.pone.0099787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927502	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100079
J	Yam, H; Rahim, AA; Mohamad, S; Mahadi, NM; Manaf, UA; Shu-Chien, AC; Najimudin, N				Yam, Hokchai; Rahim, Ainihayati Abdul; Mohamad, Suriani; Mahadi, Nor Muhammad; Manaf, Uyub Abdul; Shu-Chien, Alexander Chong; Najimudin, Nazalan			The Multiple Roles of Hypothetical Gene BPSS1356 in Burkholderia pseudomallei	PLOS ONE			English	Article							ARGININE DEIMINASE SYSTEM; RNA-POLYMERASE HOLOENZYME; CYSTIC-FIBROSIS LUNG; IN-VITRO; PSEUDOMONAS-AERUGINOSA; IDENTIFICATION; MELIOIDOSIS; GLYCEROL; PROTEIN; GROWTH	Burkholderia pseudomallei is an opportunistic pathogen and the causative agent of melioidosis. It is able to adapt to harsh environments and can live intracellularly in its infected hosts. In this study, identification of transcriptional factors that associate with the beta' subunit (RpoC) of RNA polymerase was performed. The N-terminal region of this subunit is known to trigger promoter melting when associated with a sigma factor. A pull-down assay using histidine-tagged B. pseudomallei RpoC N-terminal region as bait showed that a hypothetical protein BPSS1356 was one of the proteins bound. This hypothetical protein is conserved in all B. pseudomallei strains and present only in the Burkholderia genus. A BPSS1356 deletion mutant was generated to investigate its biological function. The mutant strain exhibited reduced biofilm formation and a lower cell density during the stationary phase of growth in LB medium. Electron microscopic analysis revealed that the Delta BPSS1356 mutant cells had a shrunken cytoplasm indicative of cell plasmolysis and a rougher surface when compared to the wild type. An RNA microarray result showed that a total of 63 genes were transcriptionally affected by the BPSS1356 deletion with fold change values of higher than 4. The expression of a group of genes encoding membrane located transporters was concurrently down-regulated in DBPSS1356 mutant. Amongst the affected genes, the putative ion transportation genes were the most severely suppressed. Deprivation of BPSS1356 also down-regulated the transcriptions of genes for the arginine deiminase system, glycerol metabolism, type III secretion system cluster 2, cytochrome bd oxidase and arsenic resistance. It is therefore obvious that BPSS1356 plays a multiple regulatory roles on many genes.	[Yam, Hokchai; Rahim, Ainihayati Abdul; Manaf, Uyub Abdul; Shu-Chien, Alexander Chong; Najimudin, Nazalan] Univ Sains Malaysia, Sch Biol Sci, Minden, Pulau Pinang, Malaysia; [Rahim, Ainihayati Abdul] Univ Malaysia Kelantan, Fac Agro Based Ind, Jeli, Kelantan, Malaysia; [Mohamad, Suriani] Univ Sains Malaysia, Sch Pharmaceut Sci, Minden, Pulau Pinang, Malaysia; [Mahadi, Nor Muhammad] Malaysia Genome Inst, Comparat Genom & Genet Res Ctr, Kajang, Selangor, Malaysia	Universiti Sains Malaysia; Universiti Malaysia Kelantan; Universiti Sains Malaysia	Najimudin, N (corresponding author), Univ Sains Malaysia, Sch Biol Sci, Minden, Pulau Pinang, Malaysia.	nazalan@usm.my	Yam, Hok Chai/AAJ-2029-2020; Najimudin, Nazalan/B-2952-2011; Shu-Chien, Alexander Chong/D-4041-2009	Shu-Chien, Alexander Chong/0000-0003-3014-442X; Abdul Rahim, Ainihayati/0000-0002-4847-5393	Malaysian Ministry of Science, Technology and Innovation (MOSTI); Universiti Sains Malaysia (USM) [07-05-MGI-GMB008]	Malaysian Ministry of Science, Technology and Innovation (MOSTI)(Ministry of Energy, Science, Technology, Environment and Climate Change (MESTECC), Malaysia); Universiti Sains Malaysia (USM)(Universiti Sains Malaysia)	The research is funded by the Malaysian Ministry of Science, Technology and Innovation (MOSTI) to the Malaysia Genome Institute (GENOMalaysia) and Universiti Sains Malaysia (USM) under the Genomics and Molecular Biology Initiatives Programme (Project No. 07-05-MGI-GMB008). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Accardi A, 2004, NATURE, V427, P803, DOI 10.1038/nature02314; Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Alvarez-Ortega C, 2007, MOL MICROBIOL, V65, P153, DOI 10.1111/j.1365-2958.2007.05772.x; Arifuzzaman M, 2006, GENOME RES, V16, P686, DOI 10.1101/gr.4527806; Borisov VB, 2011, BBA-BIOENERGETICS, V1807, P1398, DOI 10.1016/j.bbabio.2011.06.016; Brisson D, 2001, BIOESSAYS, V23, P534, DOI 10.1002/bies.1073; Burmann BM, 2010, SCIENCE, V328, P501, DOI 10.1126/science.1184953; Butland G, 2005, NATURE, V433, P531, DOI 10.1038/nature03239; CASIANOCOLON A, 1988, APPL ENVIRON MICROB, V54, P1318; Chantratita N, 2012, J PROTEOMICS, V75, P1031, DOI 10.1016/j.jprot.2011.10.015; Charalambous K, 2011, BIOCHEMISTRY-US, V50, P6742, DOI 10.1021/bi200942y; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; COLE ST, 1988, J BACTERIOL, V170, P2448, DOI 10.1128/jb.170.6.2448-2456.1988; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Coutinho CP, 2011, FRONT CELL INFECT MI, V1, DOI 10.3389/fcimb.2011.00012; CSONKA LN, 1989, MICROBIOL REV, V53, P121, DOI 10.1128/MMBR.53.1.121-147.1989; Darst SA, 2001, CURR OPIN STRUC BIOL, V11, P155; Degnan BA, 2000, INFECT IMMUN, V68, P2441, DOI 10.1128/IAI.68.5.2441-2448.2000; Dutzler R, 2003, SCIENCE, V300, P108, DOI 10.1126/science.1082708; Flemming HC, 2010, NAT REV MICROBIOL, V8, P623, DOI 10.1038/nrmicro2415; Fulde M, 2011, MICROBIOL-SGM, V157, P572, DOI 10.1099/mic.0.043067-0; Galyov EE, 2010, ANNU REV MICROBIOL, V64, P495, DOI 10.1146/annurev.micro.112408.134030; Gruening P, 2006, J BACTERIOL, V188, P361, DOI 10.1128/JB.188.2.361-369.2006; HAGENBUCH B, 1991, P NATL ACAD SCI USA, V88, P10629, DOI 10.1073/pnas.88.23.10629; HAGENBUCH B, 1994, J CLIN INVEST, V93, P1326, DOI 10.1172/JCI117091; Hall-Stoodley L, 2004, NAT REV MICROBIOL, V2, P95, DOI 10.1038/nrmicro821; Hames C, 2009, J BACTERIOL, V191, P747, DOI 10.1128/JB.01103-08; Hayden HS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036507; Hoboth C, 2009, J INFECT DIS, V200, P118, DOI 10.1086/599360; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Kabus A, 2007, APPL ENVIRON MICROB, V73, P861, DOI 10.1128/AEM.01818-06; Kanehisa M, 2012, NUCLEIC ACIDS RES, V40, pD109, DOI 10.1093/nar/gkr988; Kung C, 2004, MOL MICROBIOL, V53, P373, DOI 10.1111/j.1365-2958.2004.04180.x; Lee YH, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-28; Lenn T, 2008, MOL MICROBIOL, V70, P1397, DOI 10.1111/j.1365-2958.2008.06486.x; Loisel-Meyer S, 2005, INFECT IMMUN, V73, P7768, DOI 10.1128/IAI.73.11.7768-7771.2005; Matulef K, 2007, MOL MEMBR BIOL, V24, P342, DOI 10.1080/09687680701413874; Milton DL, 1996, J BACTERIOL, V178, P1310, DOI 10.1128/jb.178.5.1310-1319.1996; Munch R, 2005, BIOINFORMATICS, V21, P4187, DOI 10.1093/bioinformatics/bti635; Nielsen KK, 2005, APPL ENVIRON MICROB, V71, P2949, DOI 10.1128/AEM.71.6.2949-2954.2005; Pappas CJ, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002102; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Pumirat P, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-171; Rainbow L, 2002, J MED MICROBIOL, V51, P374, DOI 10.1099/0022-1317-51-5-374; Ren QH, 2007, NUCLEIC ACIDS RES, V35, pD274, DOI 10.1093/nar/gkl925; Rojas-Jimenez K, 2005, MOL PLANT MICROBE IN, V18, P1175, DOI 10.1094/MPMI-18-1175; Ryan S, 2009, ENVIRON MICROBIOL, V11, P432, DOI 10.1111/j.1462-2920.2008.01782.x; Saier MH, 1999, BBA-REV BIOMEMBRANES, V1422, P1, DOI 10.1016/S0304-4157(98)00023-9; Sanders OI, 1997, J BACTERIOL, V179, P3365, DOI 10.1128/jb.179.10.3365-3367.1997; Sawasdidoln C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009196; Schell MA, 2011, J PROTEOME RES, V10, P2417, DOI 10.1021/pr1012398; Schwarz H, 1995, MICROBIOL-UK, V141, P3161, DOI 10.1099/13500872-141-12-3161; Shi LB, 2005, P NATL ACAD SCI USA, V102, P15629, DOI 10.1073/pnas.0507850102; Silver S, 2005, APPL ENVIRON MICROB, V71, P599, DOI 10.1128/AEM.71.2.599-608.2005; Stroud RM, 2003, CURR OPIN STRUC BIOL, V13, P424, DOI 10.1016/S0959-440X(03)00114-3; Subsin B, 2003, J BACTERIOL, V185, P7008, DOI 10.1128/JB.185.23.7008-7014.2003; Sun GW, 2010, TRENDS MICROBIOL, V18, P561, DOI 10.1016/j.tim.2010.09.002; Taweechaisupapong S, 2005, MICROB PATHOGENESIS, V39, P77, DOI 10.1016/j.micpath.2005.06.001; Thomas F, 2011, J MICROBIOL METH, V84, P61, DOI 10.1016/j.mimet.2010.10.016; Trunck LA, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000519; Tunpiboonsak S, 2010, J MICROBIOL, V48, P63, DOI 10.1007/s12275-010-9138-5; VANDERWAUVEN C, 1988, ARCH MICROBIOL, V150, P400, DOI 10.1007/BF00408314; Vassylyev DG, 2002, NATURE, V417, P712, DOI 10.1038/nature752; Velapatino B, 2012, MICROBES INFECT, V14, P335, DOI 10.1016/j.micinf.2011.11.011; Warawa J, 2005, FEMS MICROBIOL LETT, V242, P101, DOI 10.1016/j.femsle.2004.10.045; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; WONG MH, 1995, J BIOL CHEM, V270, P27228, DOI 10.1074/jbc.270.45.27228; Yam H, 2012, PROTEIN J, V31, P246, DOI 10.1007/s10930-012-9398-5; Young BA, 2004, SCIENCE, V303, P1382, DOI 10.1126/science.1092462; Young BA, 2001, CELL, V105, P935, DOI 10.1016/S0092-8674(01)00398-1; Zuniga M, 2002, MOL PHYLOGENET EVOL, V25, P429, DOI 10.1016/S1055-7903(02)00277-4	71	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99218	10.1371/journal.pone.0099218	http://dx.doi.org/10.1371/journal.pone.0099218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927285	Green Published, gold, Green Submitted			2022-12-27	WOS:000338278100030
J	Costoya, X; deCastro, M; Gomez-Gesteira, M; Santos, F				Costoya, Xurxo; deCastro, Maite; Gomez-Gesteira, Moncho; Santos, Fran			Mixed Layer Depth Trends in the Bay of Biscay over the Period 1975-2010	PLOS ONE			English	Article							DATA ASSIMILATION ANALYSIS; SEA-SURFACE TEMPERATURE; UPPER OCEAN 1950-95; INTERANNUAL VARIABILITY; SOUTHERN BAY; CLIMATE	Wintertime trends in mixed layer depth (MLD) were calculated in the Bay of Biscay over the period 1975-2010 using the Simple Ocean Data Assimilation (SODA) package. The reliability of the SODA database was confirmed correlating its results with those obtained from the experimental Argo database over the period 2003-2010. An iso-thermal layer depth (TLD) and an iso-pycnal layer depth (PLD) were defined using the threshold difference method with Delta T = 0.5 degrees C and Delta sigma(theta) = 0.125 kg/m(3). Wintertime trends of the MLD were calculated using winter extended (December-March) anomalies and annual maxima. Trends calculated for the whole Bay of Biscay using both parameters (TLD and PLD) showed to be dependent on the area. Thus, MLD became deeper in the southeastern corner and shallower in the rest of the area. Air temperature was shown to play a key role in regulating the different spatial behavior of the MLD. Negative air temperature trends localized in the southeastern corner coincide with MLD deepening in this area, while, positive air temperature trends are associated to MLD shoaling in the rest of the bay. Additionally, the temperature trend calculated along the first 700 m of the water column is in good agreement with the different spatial behavior revealed for the MLD trend.	[Costoya, Xurxo; deCastro, Maite; Gomez-Gesteira, Moncho; Santos, Fran] Univ Vigo, Fac Ciencias, EPHYSLAB, Orense, Spain	Universidade de Vigo	Costoya, X (corresponding author), Univ Vigo, Fac Ciencias, EPHYSLAB, Orense, Spain.	xurxocostoya@uvigo.es	Gesteira, Moncho Gomez/R-9431-2019; deCastro, Maite/R-6739-2019	Gesteira, Moncho Gomez/0000-0002-0661-9731; deCastro, Maite/0000-0001-6443-3620; Santos, Fran/0000-0002-4576-3744; Costoya, Xurxo/0000-0001-8050-760X	Xunta de Galicia through the Plan Galego de Investigacion, Innovacion e Crecemento; Innovacion e Crecemento (Plan I2C) in collaboration with the International Campus do Mar	Xunta de Galicia through the Plan Galego de Investigacion, Innovacion e Crecemento; Innovacion e Crecemento (Plan I2C) in collaboration with the International Campus do Mar	X. Costoya is supported by the Xunta de Galicia through the Plan Galego de Investigacion, Innovacion e Crecemento 2011-2015 (Plan I2C) in collaboration with the International Campus do Mar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bates NR, 2001, DEEP-SEA RES PT II, V48, P1507, DOI 10.1016/S0967-0645(00)00151-X; BRAINERD KE, 1995, DEEP-SEA RES PT I, V42, P1521, DOI 10.1016/0967-0637(95)00068-H; Carton JA, 2000, J PHYS OCEANOGR, V30, P311, DOI [10.1175/1520-0485(2000)030<0311:ASODAA>2.0.CO;2, 10.1175/1520-0485(2000)030<0294:ASODAA>2.0.CO;2]; Carton JA, 2008, MON WEATHER REV, V136, P2999, DOI 10.1175/2007MWR1978.1; Carton JA, 2008, J CLIMATE, V21, P1029, DOI 10.1175/2007JCLI1798.1; de Boyer Montegut C, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2004JC002378; deCastro M, 2009, CONT SHELF RES, V29, P1053, DOI 10.1016/j.csr.2008.11.016; Dumousseaud C, 2010, BIOGEOSCIENCES, V7, P1481, DOI 10.5194/bg-7-1481-2010; Garcia-Soto C, 2002, J GEOPHYS RES-OCEANS, V107, DOI 10.1029/2001JC001012; Garcia-Soto C, 2009, CONT SHELF RES, V29, P1111, DOI 10.1016/j.csr.2008.12.012; Giese BS, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2010JC006695; Goikoetxea N, 2009, CONT SHELF RES, V29, P1060, DOI 10.1016/j.csr.2008.11.014; Gomez-Gesteira M, 2013, CONT SHELF RES, V65, P73, DOI 10.1016/j.csr.2013.06.014; Gomez-Gesteira M, 2011, CLIM RES, V48, P109, DOI 10.3354/cr00967; Gomez-Gesteira M, 2008, J GEOPHYS RES-OCEANS, V113, DOI 10.1029/2007JC004315; Gonzalez-Pola C, 2005, J GEOPHYS RES-OCEANS, V110, DOI 10.1029/2004JC002367; Gruber N, 2002, SCIENCE, V298, P2374, DOI 10.1126/science.1077077; Holte J, 2009, J ATMOS OCEAN TECH, V26, P1920, DOI 10.1175/2009JTECHO543.1; Hosoda S, 2010, J OCEANOGR, V66, P773, DOI 10.1007/s10872-010-0063-3; Kara AB, 2000, J GEOPHYS RES-OCEANS, V105, P16803, DOI 10.1029/2000JC900072; Kara AB, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2000JC000736; Koutsikopoulos C, 1998, OCEANOL ACTA, V21, P335, DOI 10.1016/S0399-1784(98)80020-0; Koutsikopoulos C, 1996, SCI MAR, V60, P9; Levitus S, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037155; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Levitus S, 1994, NESDIS ATLAS SERIES, V4; Liu HL, 2009, J CLIMATE, V22, P6104, DOI 10.1175/2009JCLI2974.1; Llope M, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002963; Lorbacher K, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2003JC002157; Michaels AF, 1996, DEEP-SEA RES PT II, V43, P157, DOI 10.1016/0967-0645(96)00004-5; Michel S, 2009, AQUAT LIVING RESOUR, V22, P447, DOI 10.1051/alr/2009054; Montegut CD, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC003953; Monterey G., 1997, NOAA ATLAS NESDIS; Nilsen JEO, 2006, PROG OCEANOGR, V70, P58, DOI 10.1016/j.pocean.2006.03.014; Pascual A, 2004, ELSEV OCEANOGR SERIE, V70, P53; Patti B, 2010, ESTUAR COAST SHELF S, V88, P45, DOI 10.1016/j.ecss.2010.03.004; Planque B., 2003, ICES J MAR SCI, V219, P61; PRICE JF, 1986, J GEOPHYS RES-OCEANS, V91, P8411, DOI 10.1029/JC091iC07p08411; REYNOLDS RW, 1994, J CLIMATE, V7, P929, DOI 10.1175/1520-0442(1994)007<0929:IGSSTA>2.0.CO;2; Roemmich D., 2001, OBSERVING OCEANS 21, P248; Santos F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050666; Saunders PM, 1982, J MAR RES, V40, P641; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Cabrillo RS, 2011, OCEAN DYNAM, V61, P1215, DOI 10.1007/s10236-011-0407-6; Somavilla R, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC004974; Sverdrup H.U., 1953, ICES J MAR SCI, V18, P287, DOI [10.1093/icesjms/18.3.287, DOI 10.1093/ICESJMS/18.3.287]; UNESCO, 1983, 44 UNESCO, V44; Wilks D. S, 1995, STAT METHODS ATMOSPH; Wong A., 2013, AGRO QUALITY CONTROL; Zheng YX, 2009, J GEOPHYS RES-OCEANS, V114, DOI 10.1029/2008JC005190	50	6	7	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99321	10.1371/journal.pone.0099321	http://dx.doi.org/10.1371/journal.pone.0099321			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922066	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300049
J	Elsenburg, LK; Corpeleijn, E; van Sluijs, EMF; Atkin, AJ				Elsenburg, Leonie K.; Corpeleijn, Eva; van Sluijs, Esther M. F.; Atkin, Andrew J.			Clustering and Correlates of Multiple Health Behaviours in 9-10 Year Old Children	PLOS ONE			English	Article							WEIGHT STATUS DEVELOPMENT; SCHOOL-AGED CHILDREN; SHORT-SLEEP DURATION; PHYSICAL-ACTIVITY; RISK-FACTORS; LIFE-STYLE; YOUNG-PEOPLE; LONGITUDINAL ASSOCIATION; 5-YEAR-OLD CHILDREN; SEDENTARY BEHAVIOR	Background: Sleep, physical activity, screen time and dietary behaviours influence health during childhood, but few studies have looked at all of these behaviours simultaneously and previous research has relied predominantly on self- or proxy-reports of physical activity and food frequency questionnaires for the assessment of diet. Purpose: To assess the prevalence and clustering of health behaviours and examine the socio-demographic characteristics of children that fail to meet multiple health behaviour guidelines. Methods: Data are from the Sport, Physical activity and Eating behaviour: Environmental Determinants in Young people (SPEEDY) study. Participants (n = 1472, 42.9% male) were dichotomized based on whether or not they met public health guidelines for accelerometer-assessed physical activity, diet-diary assessed fruit/vegetable intake and fat/non-milk extrinsic sugar (NMES) intake, and self-reported screen time and sleep duration. Behavioural clustering was assessed using an observed over expected ratio (O/E). Socio-demographic characteristics of participants that failed to meet multiple health behaviour guidelines were examined using ordinal logistic regression. Data were analysed in 2013. Results: 83.3% of children failed to meet guidelines for two or more health behaviours. The O/E ratio for two behavioural combinations significantly exceeded 1, both of which featured high screen time, insufficient fruit/vegetable consumption and excessive fat/NMES intake. Children who were older (Proportional odds ratio (95% confidence interval): 1.69 (1.21,2.37)) and those that attended a school with a physical activity or diet-related policy (1.28 (1.01,1.62)) were more likely to have a poor health behaviour profile. Girls (0.80 (0.64,0.99)), participants with siblings (0.76 (0.61,0.94)) and those with more highly educated parents (0.73 (0.56,0.94)) were less likely to have a poor health behaviour profile. Conclusions: A substantial proportion of children failed to meet guidelines for multiple health behaviours and there was evidence of clustering of screen viewing and unhealthy dietary behaviours. Sub-groups at greatest risk may be targeted for intervention.	[Elsenburg, Leonie K.; Corpeleijn, Eva] Univ Groningen, Univ Med Ctr Groningen, Dept Epidemiol, Groningen, Netherlands; [van Sluijs, Esther M. F.] Univ Cambridge, Sch Clin Med, MRC, Epidemiol Unit, Cambridge, England; [van Sluijs, Esther M. F.; Atkin, Andrew J.] Univ Cambridge, Sch Clin Med, UKCRC Ctr Diet & Act Res CEDAR, MRC,Epidemiol Unit, Cambridge, England	University of Groningen; University of Cambridge; University of Cambridge	Atkin, AJ (corresponding author), Univ Cambridge, Sch Clin Med, UKCRC Ctr Diet & Act Res CEDAR, MRC,Epidemiol Unit, Cambridge, England.	aa595@medschl.cam.ac.uk		van Sluijs, Esther/0000-0001-9141-9082; Corpeleijn, Eva/0000-0002-2974-3305	Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration Public Health Research Centre of Excellence [RES-590-28-0002]; British Heart Foundation; Economic and Social Research Council; Medical Research Council; National Institute for Health Research; Wellcome Trust; UK Clinical Research Collaboration; Medical Research Council [MC_UU_12015/7, MC_UU_12015/3, MC_UU_12015/4]; National Prevention Research Initiative; ESRC [ES/G007462/1] Funding Source: UKRI; MRC [MC_UU_12015/7, MC_UU_12015/4, G0501294, MR/K023187/1, MC_UP_1001/2, MC_UU_12015/3] Funding Source: UKRI; Economic and Social Research Council [ES/G007462/1] Funding Source: researchfish; Medical Research Council [MC_UP_1001/2, MR/K023187/1, G0501294] Funding Source: researchfish	Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration Public Health Research Centre of Excellence; British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research(National Institute for Health Research (NIHR)); Wellcome Trust(Wellcome Trust); UK Clinical Research Collaboration; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Prevention Research Initiative(Diabetes UK); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work of Andrew J. Atkin and Esther M. F. van Sluijs was supported, wholly or in part, by the Centre for Diet and Activity Research (CEDAR), a UK Clinical Research Collaboration Public Health Research Centre of Excellence (RES-590-28-0002). Funding from the British Heart Foundation, Economic and Social Research Council, Medical Research Council, the National Institute for Health Research, and the Wellcome Trust, under the auspices of the UK Clinical Research Collaboration, is gratefully acknowledged. The SPEEDY study was funded by the Medical Research Council (Unit Programme number MC_UU_12015/7, MC_UU_12015/3, MC_UU_12015/4) and the National Prevention Research Initiative, consisting of the following funding partners: British Heart Foundation; Cancer Research United Kingdom; Department of Health; Diabetes United Kingdom; Economic and Social Research Council; Medical Research Council; Health and Social Care Research and Development Office for Northern Ireland; Chief Scientist Office, Scottish Government Health Directorates; Welsh Assembly Government; and World Cancer Research Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alamian A, 2009, PREV MED, V48, P493, DOI 10.1016/j.ypmed.2009.02.015; Bibby P., 2004, DEV NEW CLASSIFICATI; Biddle SJH, 2011, BRIT J SPORT MED, V45, P886, DOI 10.1136/bjsports-2011-090185; Bingham S, 2008, INT J EPIDEMIOL, V37, P978, DOI 10.1093/ije/dyn111; Cappuccio FP, 2008, SLEEP, V31, P619, DOI 10.1093/sleep/31.5.619; Cole TJ, 2000, BMJ-BRIT MED J, V320, P1240, DOI 10.1136/bmj.320.7244.1240; Corder K, 2009, AM J CLIN NUTR, V89, P862, DOI 10.3945/ajcn.2008.26739; Council on Communications and Media, 2011, Pediatrics, V128, P201, DOI 10.1542/peds.2011-1066; Craig R, 2009, HLTH SURVEY ENGLAND; Craigie AM, 2011, MATURITAS, V70, P266, DOI 10.1016/j.maturitas.2011.08.005; CRAWFORD PB, 1994, J AM DIET ASSOC, V94, P626, DOI 10.1016/0002-8223(94)90158-9; Currie C., 2012, SOCIAL DETERMINANTS; Davies OH, 2008, J HUM NUTR DIET, V21, P46, DOI 10.1111/j.1365-277X.2007.00846.x; Department of Health, 2011, REP PHYS ACT HLTH 4; Dollman I, 2007, ACTA PAEDIATR, V96, P1011, DOI 10.1111/j.1651-2227.2007.00278.x; Dumith SC, 2012, PREV MED, V54, P393, DOI 10.1016/j.ypmed.2012.03.014; Eisenmann JC, 2006, ACTA PAEDIATR, V95, P956, DOI 10.1080/08035250600731965; Ekelund U, 2001, MED SCI SPORT EXER, V33, P275; Epstein LH, 2008, ARCH PEDIAT ADOL MED, V162, P239, DOI 10.1001/archpediatrics.2007.45; Gubbels JS, 2012, INT J BEHAV NUTR PHY, V9, DOI 10.1186/1479-5868-9-77; Gubbels JS, 2012, PUBLIC HEALTH NUTR, V15, P1402, DOI 10.1017/S1368980011003089; Hardy LL, 2012, J ADOLESCENT HEALTH, V51, P265, DOI 10.1016/j.jadohealth.2011.12.017; IGD, 2006, BEST PRACT GUID PRES; Janssen I, 2010, INT J BEHAV NUTR PHY, V7, DOI 10.1186/1479-5868-7-40; Khaw KT, 2008, PLOS MED, V5, P39, DOI 10.1371/journal.pmed.0050012; Lim SS, 2012, LANCET, V380, P2224, DOI 10.1016/S0140-6736(12)61766-8; Liu JH, 2012, J SPEC PEDIATR NURS, V17, P193, DOI 10.1111/j.1744-6155.2012.00332.x; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; McAloney K, 2013, PREV MED, V56, P365, DOI 10.1016/j.ypmed.2013.03.002; National Sleep Foundation (NSF), 2012, CHILDR SLEEP; NHS Choices, WHY 5 DAY; Olds T, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-43; Pearson N, 2011, AM J PREV MED, V41, P178, DOI 10.1016/j.amepre.2011.05.002; Pearson N, 2009, INT J BEHAV NUTR PHY, V6, DOI 10.1186/1479-5868-6-45; Rideout V.J., 2010, HENRY J KAIS FAM FOU; Ruiz JR, 2011, AM J EPIDEMIOL, V174, P173, DOI 10.1093/aje/kwr068; Sabbe D, 2008, HEALTH EDUC RES, V23, P753, DOI 10.1093/her/cyl135; Sanchez A, 2007, AM J PREV MED, V32, P124, DOI 10.1016/j.amepre.2006.10.012; School Food Trust, 2007, GUID INTR GOV NEW FO; Schuit AJ, 2002, PREV MED, V35, P219, DOI 10.1006/pmed.2002.1064; Seghers J, 2010, PUBLIC HEALTH NUTR, V13, P1838, DOI 10.1017/S1368980010000418; Shi ZM, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-609; Stringhini S, 2011, PLOS MED, V8, DOI 10.1371/journal.pmed.1000419; Telford A, 2004, PEDIATR EXERC SCI, V16, P64, DOI 10.1123/pes.16.1.64; Tremblay MS, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-98; Trost SG, 2011, MED SCI SPORT EXER, V43, P1360, DOI 10.1249/MSS.0b013e318206476e; Twisk JWR, 1997, AM J EPIDEMIOL, V145, P888, DOI 10.1093/oxfordjournals.aje.a009048; Tyrrell VJ, 2001, INT J OBESITY, V25, P273, DOI 10.1038/sj.ijo.0801531; U.S. Department of Agriculture U.S. Department of Health and Human Services, 2010, REP DIET GUID ADV CO; van Sluijs EMF, 2007, BMJ-BRIT MED J, V335, P703, DOI 10.1136/bmj.39320.843947.BE; van Sluijs EMF, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-388; Wissler RW, 1995, AM J MED SCI, V310, pS29, DOI 10.1097/00000441-199512000-00006; World Health Organisation, 2000, INF SER SCH HLTH LOC; Wrieden WL, 2008, BRIT J NUTR, V99, P1344, DOI 10.1017/S0007114507868516	54	11	10	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99498	10.1371/journal.pone.0099498	http://dx.doi.org/10.1371/journal.pone.0099498			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24923793	Green Accepted, Green Submitted, gold, Green Published			2022-12-27	WOS:000338701300070
J	McLeod, BA; Frasier, TR; Lucas, Z				McLeod, Brenna A.; Frasier, Timothy R.; Lucas, Zoe			Assessment of the Extirpated Maritimes Walrus Using Morphological and Ancient DNA Analysis	PLOS ONE			English	Article							ODOBENUS-ROSMARUS-ROSMARUS; ATLANTIC WALRUS; BOWHEAD WHALES; DIRECTIONAL ASYMMETRY; MITOCHONDRIAL-DNA; PORPOISE; CANADA; BONES; WEST	Species biogeography is a result of complex events and factors associated with climate change, ecological interactions, anthropogenic impacts, physical geography, and evolution. To understand the contemporary biogeography of a species, it is necessary to understand its history. Specimens from areas of localized extinction are important, as extirpation of species from these areas may represent the loss of unique adaptations and a distinctive evolutionary trajectory. The walrus (Odobenus rosmarus) has a discontinuous circumpolar distribution in the arctic and subarctic that once included the southeastern Canadian Maritimes region. However, exploitation of the Maritimes population during the 16th-18th centuries led to extirpation, and the species has not inhabited areas south of 55 degrees N for similar to 250 years. We examined genetic and morphological characteristics of specimens from the Maritimes, Atlantic (O. r. rosmarus) and Pacific (O. r. divergens) populations to test the hypothesis that the first group was distinctive. Analysis of Atlantic and Maritimes specimens indicated that most skull and mandibular measurements were significantly different between the Maritimes and Atlantic groups and discriminant analysis of principal components confirmed them as distinctive groups, with complete isolation of skull features. The Maritimes walrus appear to have been larger animals, with larger and more robust tusks, skulls and mandibles. The mtDNA control region haplotypes identified in Maritimes specimens were unique to the region and a greater average number of nucleotide differences were found between the regions (Atlantic and Maritimes) than within either group. Levels of diversity (h and p) were lower in the Maritimes, consistent with other studies of species at range margins. Our data suggest that the Maritimes walrus was a morphologically and genetically distinctive group that was on a different evolutionary path from other walrus found in the north Atlantic.	[McLeod, Brenna A.; Frasier, Timothy R.] St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada; [McLeod, Brenna A.; Lucas, Zoe] Nova Scotia Museum Nat Hist, Halifax, NS, Canada; [Lucas, Zoe] Friends Green Horse Soc, Halifax, NS, Canada	Saint Marys University - Canada	McLeod, BA (corresponding author), St Marys Univ, Dept Biol, Halifax, NS B3H 3C3, Canada.	bmysticetus@gmail.com		Frasier, Brenna/0000-0002-8535-1410	ExxonMobil; The Friends of the Green Horse Society; Nova Scotia Museum of Natural History	ExxonMobil(Exxon Mobil Corporation); The Friends of the Green Horse Society; Nova Scotia Museum of Natural History	The research was funded by ExxonMobil (www.exxonmobil.com), The Friends of the Green Horse Society (http://www.greenhorsesociety.com), and the Nova Scotia Museum of Natural History (http://naturalhistory.novascotia.ca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN GLOVER M., 1930, JOUR MAMMALOGY, V11, P139, DOI 10.2307/1374062; Allen J. A., 1876, American Naturalist, Vx, P708; Allen Joel Asaph, 1880, HIST N AM PINNIPEDS; AMANO M, 1992, MAR MAMMAL SCI, V8, P240, DOI 10.1111/j.1748-7692.1992.tb00407.x; Andersen LW, 1998, MOL ECOL, V7, P1323, DOI 10.1046/j.1365-294x.1998.00455.x; Andersen LW, 2000, CAN J ZOOL, V78, P1999, DOI 10.1139/cjz-78-11-1999; Auerbach BM, 2006, J HUM EVOL, V50, P203, DOI 10.1016/j.jhevol.2005.09.004; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Born EW, 2001, POLAR BIOL, V24, P713; BOUCHARD MA, 1993, CAN J EARTH SCI, V30, P1715, DOI 10.1139/e93-150; Chessel D., 2004, R NEWS, V4, P5; CLAPHAM PJ, 1995, ANIM BEHAV, V50, P73, DOI 10.1006/anbe.1995.0222; Coltman DW, 2003, NATURE, V426, P655, DOI 10.1038/nature02177; Department of Fisheries and Oceans, 2008, SPEC RISK ACT REC ST; Drummond A.J., MOL EVOLUTION PHYLOG; Dyke AS, 1999, ARCTIC, V52, P160; FAY F H, 1985, Mammalian Species, P1, DOI 10.2307/3503810; Fay FH, 1982, N AM FAUNA, DOI DOI 10.3996/NAFA.74.0001; Fay FH, 1981, HDB MARINE MAMMALS, V1, P1; Fisher KI, 1997, CAN J ZOOL, V75, P1166, DOI 10.1139/z97-139; Galatius A, 2005, MAR MAMMAL SCI, V21, P401, DOI 10.1111/j.1748-7692.2005.tb01240.x; Gjertz I, 1995, POPULATION ASSESSMEN; Harington C.R., 2003, ANNOTATED BIBLIO QUA; Harington C. Richard, 2004, Geographie Physique et Quaternaire, V57, P85; HARINGTON CR, 1993, GEOGR PHYS QUATERN, V47, P111, DOI 10.7202/032935ar; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; HOCHBERG Y, 1988, BIOMETRIKA, V75, P800, DOI 10.1093/biomet/75.4.800; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Irwin DL, 2003, BIOTECHNIQUES, V34, P932, DOI 10.2144/03345bm06; Jombart T, 2010, BMC GENET, V11, DOI [DOI 10.1186/1471-2156-11-94, 10.1186/1471-2156-11-94]; Kasuya T, 1970, Scient. Rep. Whales Res. Inst., Tokyo, VNo. 22, P39; Keane TM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-29; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Levermann Nette, 2003, BMC Ecology, V3, P1; Lindqvist C, 2009, ZOOL SCR, V38, P113, DOI 10.1111/j.1463-6409.2008.00364.x; Lowry L, 2009, IUCN RED LIST THREAT; Mansfield AW, 1958, FISH RES BOARD CAN M, V653; MANVILLE RICHARD H., 1960, JOUR MAMMAL, V41, P499, DOI 10.2307/1377539; Martijn CA, 2003, NLS, V19, P44; Mays SA, 2002, J ARCHAEOL SCI, V29, P435, DOI 10.1006/jasc.2002.0729; McLeod BA, 2008, ARCTIC, V61, P61; McLeod BA, 2012, MAR MAMMAL SCI, V28, pE426, DOI 10.1111/j.1748-7692.2011.00551.x; Miller R.F., 1990, Atlantic Geology, V26, P97; Miller RF, 1997, GEOGR PHYS QUATERN, V51, P107, DOI 10.7202/004852ar; MOWAT F, 1984, SEA SLAUGHTER; Naughton D., 2012, NATURAL HIST CANADIA, DOI 10.3138/9781442669574; O'Corry-Crowe G, 2008, ECOL APPL, V18, pS56, DOI 10.1890/06-0795.1; Outridge PM, 2003, ARCTIC, V56, P82, DOI 10.14430/arctic605; Perrin WF, 2009, ENCYCLOPEDIA OF MARINE MAMMALS, 2ND EDITION, P1; *R COR DEV TEAM, 2012, R LANG ENV STAT COMP; Rastogi T, 2004, CAN J ZOOL, V82, P1647, DOI 10.1139/Z04-146; Repenning C.A., 1979, PROCEEDINGS OF THE ANNUAL BIOLOGY COLLOQUIUM (OREGON STATE UNIVERSITY), P357; Richer S, 2003, GLOBE MAIL; Ross G.J.B., 1990, P101; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sariyar-Akbulut B, 2010, CHEM BIOCHEM ENG Q, V24, P119; SCHEFFER VB, 1967, J MAMMAL, V48, P459; Sexton JP, 2009, ANNU REV ECOL EVOL S, V40, P415, DOI 10.1146/annurev.ecolsys.110308.120317; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shaw J, 2002, QUATERNARY SCI REV, V21, P1861, DOI 10.1016/S0277-3791(02)00004-5; Sheffield G, 2009, MAR MAMMAL SCI, V25, P761, DOI 10.1111/j.1748-7692.2009.00316.x; Sobey DG, 2007, CAN FIELD NAT, V121, P384, DOI 10.22621/cfn.v121i4.510; STEELE J, 1995, INT J OSTEOARCHAEOL, V5, P39, DOI 10.1002/oa.1390050105; Stewart REA, 2008, ARCTIC, V61, P292; TERSHY BR, 1992, MAR MAMMAL SCI, V8, P315, DOI 10.1111/j.1748-7692.1992.tb00416.x; Venables WN., 2002, MODERN APPL STAT S 4; WELCH BL, 1951, BIOMETRIKA, V38, P330, DOI 10.2307/2332579; Wiig O, 1996, J ZOOL, V240, P495; Wiig O, 2007, POLAR BIOL, V31, P69, DOI 10.1007/s00300-007-0334-7; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; WRIGHT BRUCE S., 1951, CANADIAN FIELD NAT, V65, P61	71	13	14	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99569	10.1371/journal.pone.0099569	http://dx.doi.org/10.1371/journal.pone.0099569			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24924490	Green Published, gold			2022-12-27	WOS:000338701300075
J	Benod, C; Villagomez, R; Filgueira, CS; Hwang, PK; Leonard, PG; Poncet-Montange, G; Rajagopalan, S; Fletterick, RJ; Gustafsson, JA; Webb, P				Benod, Cindy; Villagomez, Rosa; Filgueira, Carly S.; Hwang, Peter K.; Leonard, Paul G.; Poncet-Montange, Guillaume; Rajagopalan, Senapathy; Fletterick, Robert J.; Gustafsson, Jan-Ake; Webb, Paul			The Human Orphan Nuclear Receptor Tailless (TLX, NR2E1) Is Druggable	PLOS ONE			English	Article							NEURAL STEM-CELLS; HISTONE DEMETHYLASE LSD1; BRAIN; TUMOR; PROLIFERATION; ASSOCIATION; PROGRESSION; EPENDYMOMA; SIGNATURES; LRH-1	Nuclear receptors (NRs) are an important group of ligand-dependent transcriptional factors. Presently, no natural or synthetic ligand has been identified for a large group of orphan NRs. Small molecules to target these orphan NRs will provide unique resources for uncovering regulatory systems that impact human health and to modulate these pathways with drugs. The orphan NR tailless (TLX, NR2E1), a transcriptional repressor, is a major player in neurogenesis and Neural Stem Cell (NSC) derived brain tumors. No chemical probes that modulate TLX activity are available, and it is not clear whether TLX is druggable. To assess TLX ligand binding capacity, we created homology models of the TLX ligand binding domain (LBD). Results suggest that TLX belongs to an emerging class of NRs that lack LBD helices alpha 1 and alpha 2 and that it has potential to form a large open ligand binding pocket (LBP). Using a medium throughput screening strategy, we investigated direct binding of 20,000 compounds to purified human TLX protein and verified interactions with a secondary (orthogonal) assay. We then assessed effects of verified binders on TLX activity using luciferase assays. As a result, we report identification of three compounds (ccrp1, ccrp2 and ccrp3) that bind to recombinant TLX protein with affinities in the high nanomolar to low micromolar range and enhance TLX transcriptional repressive activity. We conclude that TLX is druggable and propose that our lead compounds could serve as scaffolds to derive more potent ligands. While our ligands potentiate TLX repressive activity, the question of whether it is possible to develop ligands to de-repress TLX activity remains open.	[Benod, Cindy; Villagomez, Rosa; Filgueira, Carly S.; Rajagopalan, Senapathy; Webb, Paul] HMRI, Dept Genom Med, Houston, TX 77030 USA; [Hwang, Peter K.; Fletterick, Robert J.] Univ Calif San Francisco, Dept Biophys & Biochem, San Francisco, CA 94143 USA; [Leonard, Paul G.; Poncet-Montange, Guillaume] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Leonard, Paul G.] Univ Texas Houston, MD Anderson Canc Ctr, Ctr Biomol Struct & Funct, Houston, TX 77030 USA; [Gustafsson, Jan-Ake] Univ Houston Ctr Nucl Receptors & Cell Signaling, Houston, TX USA	University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Webb, P (corresponding author), HMRI, Dept Genom Med, Houston, TX 77030 USA.	PWebb@houstonmethodist.org	Filgueira, Carly/B-7077-2009	Filgueira, Carly/0000-0002-3246-303X; Poncet-Montange, Guillaume/0000-0002-9884-7378	ETF [300-9-1958]; National Institutes of Health (NIH) [UO1 GM094614-01, DK41482]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM094614] Funding Source: NIH RePORTER	ETF; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Research was supported by: 1) an ETF grant to P.W. and J.A.G.: TETF (Texas Emerging Technology Fund) Superiority grant 300-9-1958 (governor.state.tx.us/ecodev/etf/); 2) National Institutes of Health (NIH) grant UO1 GM094614-01 to P.W.; and 3) NIH grant DK41482 to P. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abad MC, 2008, J STEROID BIOCHEM, V108, P44, DOI 10.1016/j.jsbmb.2007.06.006; Achanta P, 2010, ANTI-CANCER AGENT ME, V10, P121, DOI 10.2174/187152010790909290; Baell JB, 2010, J MED CHEM, V53, P2719, DOI 10.1021/jm901137j; Benod C, 2013, J BIOL CHEM, V288, P19830, DOI 10.1074/jbc.M112.411686; Blumberg B, 1998, GENE DEV, V12, P3149, DOI 10.1101/gad.12.20.3149; Catherinot V, 2004, BIOINFORMATICS, V20, P3694, DOI 10.1093/bioinformatics/bth429; Chavali PL, 2011, J BIOL CHEM, V286, P9393, DOI 10.1074/jbc.M110.167445; Elmi M, 2010, MOL CELL NEUROSCI, V45, P121, DOI 10.1016/j.mcn.2010.06.003; Estruch SB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037963; Eswar N., 2006, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0506-15; Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2; Haffner CD, 2004, J MED CHEM, V47, P2010, DOI 10.1021/jm030565g; Kruse SW, 2008, PLOS BIOL, V6, P2002, DOI 10.1371/journal.pbio.0060227; Li GZ, 2009, PROTEOMICS, V9, P1696, DOI 10.1002/pmic.200800564; Li SX, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043324; Li WW, 2008, MOL ENDOCRINOL, V22, P56, DOI 10.1210/me.2007-0290; Liu HK, 2010, GENE DEV, V24, P683, DOI 10.1101/gad.560310; Modena P, 2006, J CLIN ONCOL, V24, P5223, DOI 10.1200/JCO.2006.06.3701; Moras D, 1998, CURR OPIN CELL BIOL, V10, P384, DOI 10.1016/S0955-0674(98)80015-X; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Park HJ, 2010, MOL CELLS, V30, P403, DOI 10.1007/s10059-010-0122-z; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Qu QH, 2010, NAT CELL BIOL, V12, P31, DOI 10.1038/ncb2001; Qu QH, 2009, J CELL PHYSIOL, V221, P5, DOI 10.1002/jcp.21862; Sablin EP, 2008, P NATL ACAD SCI USA, V105, P18390, DOI 10.1073/pnas.0808936105; Schuck P, 2003, ANAL BIOCHEM, V320, P104, DOI 10.1016/S0003-2697(03)00289-6; Sharma MK, 2007, CANCER RES, V67, P890, DOI 10.1158/0008-5472.CAN-06-0973; Shi YH, 2008, CRIT REV ONCOL HEMAT, V65, P43, DOI 10.1016/j.critrevonc.2007.06.004; Shi YH, 2004, NATURE, V427, P78, DOI 10.1038/nature02211; Silva JC, 2006, MOL CELL PROTEOMICS, V5, P144, DOI 10.1074/mcp.M500230-MCP200; Silva JC, 2005, ANAL CHEM, V77, P2187, DOI 10.1021/ac048455k; Sim FJ, 2006, J NEUROSCI, V26, P12544, DOI 10.1523/JNEUROSCI.0829-06.2006; Sladek FM, 2003, EXPERT OPIN THER TAR, V7, P679; Sun GQ, 2007, P NATL ACAD SCI USA, V104, P15282, DOI 10.1073/pnas.0704089104; Sun GQ, 2010, ADV DRUG DELIVER REV, V62, P1299, DOI 10.1016/j.addr.2010.08.003; Sun GQ, 2010, MOL CELL BIOL, V30, P1997, DOI 10.1128/MCB.01116-09; Tan MHE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074359; Taylor MD, 2005, CANCER CELL, V8, P323, DOI 10.1016/j.ccr.2005.09.001; Vistica J, 2004, ANAL BIOCHEM, V326, P234, DOI 10.1016/j.ab.2003.12.014; Wang ZL, 2003, NATURE, V423, P555, DOI 10.1038/nature01645; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhi XY, 2014, P NATL ACAD SCI USA, V111, P839, DOI 10.1073/pnas.1322827111	45	34	35	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 17	2014	9	6							e99440	10.1371/journal.pone.0099440	http://dx.doi.org/10.1371/journal.pone.0099440			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK5YM	24936658	Green Published, gold, Green Submitted			2022-12-27	WOS:000338503400018
J	Beigel, F; Deml, M; Schnitzler, F; Breiteneicher, S; Goke, B; Ochsenkuhn, T; Brand, S				Beigel, Florian; Deml, Matthias; Schnitzler, Fabian; Breiteneicher, Simone; Goeke, Burkhard; Ochsenkuehn, Thomas; Brand, Stephan			Rate and Predictors of Mucosal Healing in Patients with Inflammatory Bowel Disease Treated with Anti-TNF-Alpha Antibodies	PLOS ONE			English	Article							CROHNS-DISEASE; ULCERATIVE-COLITIS; INFLIXIMAB THERAPY; FECAL CALPROTECTIN; REMISSION; VALIDATION; MARKERS; SCORE	Objective: Mucosal healing (MH) is an important treatment goal in patients with inflammatory bowel disease (IBD), but factors predicting MH under medical therapy are largely unknown. In this study, we aimed to characterize predictive factors for MH in anti-TNF-alpha antibody-treated IBD patients. Methods: We retrospectively analyzed 248 IBD patients (61.3% CD, 38.7% UC) treated with anti-TNF-alpha antibodies (infliximab and/or adalimumab) for MH, defined as macroscopic absence of inflammatory lesions (Mayo endoscopy score 0 or SES-CD score 0) in colonoscopies which were analyzed before and after initiation of an anti-TNF-alpha antibody treatment. Results: In patients treated with only one anti-TNF-alpha antibody ("TNF1 group", n = 202), 56 patients (27.7%) achieved complete MH at follow-up colonoscopy (median overall follow-up time: 63 months). In a second cohort (n = 46), which comprised patients who were consecutively treated with two anti-TNF-alpha antibodies ("TNF2 group"), 13 patients (28.3%) achieved complete MH (median overall follow-up time: 64.5 months). Compared to patients without MH, CRP values at follow-up colonoscopy were significantly lower in patients with MH (TNF1 group: p = 8.35x10(-5); TNF2 group: p = 0.002). Multivariate analyses confirmed CRP at follow-up colonoscopy as predictor for MH in the TNF1 group (p = 0.012). Overall need for surgery was lower in patients with MH (TNF1 group: p = 0.01; TNF2 group: p = 0.03). Conclusions: We identified low serum CRP level at follow-up colonoscopy as predictor for MH, while MH was an excellent negative predictor for the need for surgery.	[Beigel, Florian; Deml, Matthias; Schnitzler, Fabian; Breiteneicher, Simone; Goeke, Burkhard; Brand, Stephan] Univ Munich, Dept Med 2, Univ Hosp Munich Grosshadern, Munich, Germany; [Ochsenkuehn, Thomas] Isarmed Zentrum, Munich, Germany	University of Munich	Beigel, F (corresponding author), Univ Munich, Dept Med 2, Univ Hosp Munich Grosshadern, Munich, Germany.	florian.beigel@med.uni-muenchen.de			Deutsche Forschungsgemeinschaft (DFG) [BE 4490/2-1, BR 1912/5-1]; Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium) [2010_EKES.32]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium)	F. Beigel is supported by grants from the Deutsche Forschungsgemeinschaft (DFG, BE 4490/2-1). S. Brand is supported by grants from the Deutsche Forschungsgemeinschaft (DFG, BR 1912/5-1), the Else Kroner-Fresenius-Stiftung (Else Kroner Exzellenzstipendium 2010; 2010_EKES.32). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	af Bjorkesten CG, 2012, SCAND J GASTROENTERO, V47, P528, DOI 10.3109/00365521.2012.660542; af Bjorkesten CG, 2011, INFLAMM BOWEL DIS, V17, P947, DOI 10.1002/ibd.21439; Baert F, 2009, GASTROENTEROLOGY, V138, pe410; Baert F, 2010, GASTROENTEROLOGY, V138, P463, DOI 10.1053/j.gastro.2009.09.056; Bessissow T, 2012, AM J GASTROENTEROL, V107, P1684, DOI 10.1038/ajg.2012.301; Colombel JF, 2011, GASTROENTEROLOGY, V141, P1194, DOI 10.1053/j.gastro.2011.06.054; Colombel JF, 2010, NEW ENGL J MED, V362, P1383, DOI 10.1056/NEJMoa0904492; Cosnes J, 2002, INFLAMM BOWEL DIS, V8, P244, DOI 10.1097/00054725-200207000-00002; Cosnes J, 2011, GASTROENTEROLOGY, V140, P1785, DOI 10.1053/j.gastro.2011.01.055; D'Haens G, 1999, GASTROENTEROLOGY, V116, P1029, DOI 10.1016/S0016-5085(99)70005-3; D'Haens G, 1999, GASTROINTEST ENDOSC, V50, P667, DOI 10.1016/S0016-5107(99)80017-0; D'Haens G, 2012, INFLAMM BOWEL DIS, V18, P2218, DOI 10.1002/ibd.22917; Daperno M, 2004, GASTROINTEST ENDOSC, V60, P505, DOI 10.1016/S0016-5107(04)01878-4; Dave Maneesh, 2012, Gastroenterol Hepatol (N Y), V8, P29; de Bruyn M, 2013, INFLAMM BOWEL DIS; de Chambrun GP, 2010, NAT REV GASTRO HEPAT, V7, P15, DOI 10.1038/nrgastro.2009.203; Gunther C, 2011, NATURE, V477, P335, DOI 10.1038/nature10400; Hanauer SB, 2002, LANCET, V359, P1541, DOI 10.1016/S0140-6736(02)08512-4; Ierardi E, 2011, J CLIN PATHOL, V64, P968, DOI 10.1136/jcp.2010.086892; Jurgens M, 2011, CLIN GASTROENTEROL H, V9, P421, DOI 10.1016/j.cgh.2011.02.008; Kiss LS, 2011, ALIMENT PHARM THER, V34, P911, DOI 10.1111/j.1365-2036.2011.04827.x; KOZAREK RA, 1989, ANN INTERN MED, V110, P353, DOI 10.7326/0003-4819-110-5-353; LICHTIGER S, 1994, NEW ENGL J MED, V330, P1841, DOI 10.1056/NEJM199406303302601; MARY JY, 1989, GUT, V30, P983, DOI 10.1136/gut.30.7.983; MATTS SG, 1961, Q J MED, V30, P393; OLAISON G, 1990, GUT, V31, P325, DOI 10.1136/gut.31.3.325; Ordas I, 2014, GASTROENTEROLOGY, V146, P374, DOI 10.1053/j.gastro.2013.10.055; Ordas I, 2011, GUT, V60, P1754, DOI 10.1136/gutjnl-2011-300934; Peyrin-Biroulet L, 2011, J CROHNS COLITIS, V5, P477, DOI 10.1016/j.crohns.2011.06.009; Rutgeerts P, 2012, GASTROENTEROLOGY; Rutgeerts P, 2012, GASTROENTEROLOGY, V142, P1102, DOI 10.1053/j.gastro.2012.01.035; Sandborn WJ, 2012, GASTROENTEROLOGY, V142, P257, DOI 10.1053/j.gastro.2011.10.032; Schnitzler F, 2009, INFLAMM BOWEL DIS, V15, P1295, DOI 10.1002/ibd.20927; SCHROEDER KW, 1987, NEW ENGL J MED, V317, P1625, DOI 10.1056/NEJM198712243172603; Sipponen T, 2008, ALIMENT PHARM THER, V28, P1221, DOI 10.1111/j.1365-2036.2008.03835.x; van Assche G, 2010, CURR DRUG TARGETS, V11, P227; Vos ACW, 2012, INFLAMM BOWEL DIS, V18, P401, DOI 10.1002/ibd.21818	37	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e99293	10.1371/journal.pone.0099293	http://dx.doi.org/10.1371/journal.pone.0099293			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24932476	Green Submitted, Green Published, gold			2022-12-27	WOS:000337738600029
J	Maripuu, M; Wikgren, M; Karling, P; Adolfsson, R; Norrback, KF				Maripuu, Martin; Wikgren, Mikael; Karling, Pontus; Adolfsson, Rolf; Norrback, Karl-Fredrik			Relative Hypo-and Hypercortisolism Are Both Associated with Depression and Lower Quality of Life in Bipolar Disorder: A Cross-Sectional Study	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; DEXAMETHASONE-SUPPRESSION TEST; WEEKLY SYMPTOMATIC STATUS; NATURAL-HISTORY; CORTISOL METABOLISM; PROSPECTIVE COHORT; MAJOR DEPRESSION; DOUBLE-BLIND; HORMONE TEST; STRESS	Background: Depression in unipolar and bipolar disorders is associated with hypothalamic-pituitary-adrenal-axis (HPA-axis) hyperactivity. Also, unipolar disorder has recently been shown to exhibit HPA-axis hypoactivity. We studied for the first time how HPA-axis hypo-and hyperactivity relate to depression and disease burden in bipolar disorder. We were interested in studying hypocortisolism; characterized by increased HPA-axis negative feedback sensitivity and lower basal cortisol levels together with the opposite HPA-axis regulatory pattern of hypercortisolism. Methods: This cross-sectional study includes 145 type 1 and 2 bipolar outpatients and 145 matched controls. A dexamethasone-suppression-test (DST) measures the negative feedback sensitivity and a weight-adjusted very-low-dose DST was employed, which is sensitive in identifying hypocortisolism and hypercortisolism. The 25th and 75th percentiles of control post-DST values were used as cut-offs identifying patients exhibiting relative hypo-, and hypercortisolism. Self-report questionnaires were employed: Beck-Depression-Inventory (BDI), Montgomery-Asberg-Depression-Rating-Scale (MADRS-S), World-Health-Organization-Quality-of-Life-Assessment-100 and Global-Assessment-of-Functioning. Results: Patients exhibiting relative hypocortisolism expectedly exhibited lowered basal cortisol levels (p = 0.046). Patients exhibiting relative hypercortisolism expectedly exhibited elevated basal levels (p<0.001). Patients exhibiting relative hypocortisolism showed 1.9-2.0 (BDI, p = 0.017, MADRS-S, p = 0.37) and 6.0 (p<0.001) times increased frequencies of depression and low overall life quality compared with patients exhibiting mid post-DST values (eucortisolism). Adjusted Odds Ratios (OR:s) for depression ranged from 3.8-4.1 (BDI, p = 0.006, MADRS-S, p = 0.011) and was 23.4 (p<0.001) for life quality. Patients exhibiting relative hypercortisolism showed 1.9-2.4 (BDI, p = 0.017, MADRS-S, p = 0.003) and 4.7 (p<0.001) times higher frequencies of depression and low overall life quality compared with patients exhibiting eucortisolism. Adjusted OR: s for depression ranged from 2.2-2.7 (BDI, p = 0.068, MADRS-S, p = 0.045) and was 6.3 (p = 0.008) for life quality. Limitations: The cross-sectional design and lack of pre-established reference values of the DST employed. Conclusions: Relative hypocortisolism and relative hypercortisolism were associated with depression and lower life quality, providing novel insights into the detrimental role of stress in bipolar disorder.	[Maripuu, Martin; Wikgren, Mikael; Adolfsson, Rolf; Norrback, Karl-Fredrik] Umea Univ, Dept Clin Sci, Div Psychiat, Umea, Sweden; [Karling, Pontus] Umea Univ, Dept Publ Hlth & Clin Med, Div Med, Umea, Sweden	Umea University; Umea University	Maripuu, M (corresponding author), Umea Univ, Dept Clin Sci, Div Psychiat, Umea, Sweden.	martin.maripuu@psychiat.umu.se		Adolfsson, Rolf/0000-0001-9785-8473	Swedish Research Council [2006-4472, 2009-5269]; Medical Faculty of Umea University; County Council of Jamtland, Sweden; County Council of Vasterbotten, Sweden; County Council of Norrbotten, Sweden	Swedish Research Council(Swedish Research CouncilEuropean Commission); Medical Faculty of Umea University; County Council of Jamtland, Sweden; County Council of Vasterbotten, Sweden; County Council of Norrbotten, Sweden	The research was funded by the Swedish Research Council (grants 2006-4472; 2009-5269), the Medical Faculty of Umea University and the County Councils of Jamtland, Vasterbotten and Norrbotten, Sweden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrogio AG, 2008, PITUITARY, V11, P219, DOI 10.1007/s11102-008-0114-6; Angst J, 2000, BIOL PSYCHIAT, V48, P445, DOI 10.1016/S0006-3223(00)00909-4; ARANA GW, 1995, AM J PSYCHIAT, V152, P265; ASBERG M, 1978, ACTA PSYCHIAT SCAND, P5; Association A.P., 1994, DIAGN STAT MAN MENT, V4th; BEALE MD, 1995, AM J PSYCHIAT, V152, P959; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Belmaker RH, 2004, NEW ENGL J MED, V351, P476, DOI 10.1056/NEJMra035354; BODLUND O, 1994, ACTA PSYCHIAT SCAND, V90, P342, DOI 10.1111/j.1600-0447.1994.tb01604.x; Bouwer C, 2000, DEPRESS ANXIETY, V12, P44, DOI 10.1002/1520-6394(2000)12:1<44::AID-DA6>3.0.CO;2-C; Bremmer MA, 2007, BIOL PSYCHIAT, V62, P479, DOI 10.1016/j.biopsych.2006.11.033; Brenner K, 2011, SCHIZOPHR RES, V128, P23, DOI 10.1016/j.schres.2011.01.016; Brown ES, 2009, ANN NY ACAD SCI, V1179, P41, DOI 10.1111/j.1749-6632.2009.04981.x; Bschor T, 2003, J PSYCHIATR RES, V37, P135, DOI 10.1016/S0022-3956(02)00088-2; Bschor T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027613; CARROLL BJ, 1982, BRIT J PSYCHIAT, V140, P292, DOI 10.1192/bjp.140.3.292; Chrousos GP, 2009, NAT REV ENDOCRINOL, V5, P374, DOI 10.1038/nrendo.2009.106; da Rocha NS, 2009, COMPR PSYCHIAT, V50, P549, DOI 10.1016/j.comppsych.2008.11.015; Daban C, 2005, PSYCHIAT CLIN N AM, V28, P469, DOI 10.1016/j.psc.2005.01.005; Dantzer R, 2012, BIOL PSYCHIAT, V71, P4, DOI 10.1016/j.biopsych.2011.10.025; DeBattista C, 2000, AM J PSYCHIAT, V157, P1334, DOI 10.1176/appi.ajp.157.8.1334; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Fountoulakis Konstantinos N, 2008, Ann Gen Psychiatry, V7, P22, DOI 10.1186/1744-859X-7-22; Fries E, 2005, PSYCHONEUROENDOCRINO, V30, P1010, DOI 10.1016/j.psyneuen.2005.04.006; Gustafsson PE, 2012, PSYCHONEUROENDOCRINO, V37, P789, DOI 10.1016/j.psyneuen.2011.09.011; Heim C, 2000, PSYCHONEUROENDOCRINO, V25, P1, DOI 10.1016/S0306-4530(99)00035-9; Hirschfeld RMA, 2004, EUR NEUROPSYCHOPHARM, V14, pS83, DOI 10.1016/j.euroneuro.2004.03.001; IsHak WW, 2012, BIPOLAR DISORD, V14, P6, DOI 10.1111/j.1399-5618.2011.00969.x; IsHak WW, 2011, HARVARD REV PSYCHIAT, V19, P229, DOI 10.3109/10673229.2011.614099; Judd Lewis L, 2003, Curr Psychiatry Rep, V5, P417, DOI 10.1007/s11920-003-0077-2; Judd LL, 2005, ARCH GEN PSYCHIAT, V62, P1322, DOI 10.1001/archpsyc.62.12.1322; Judd LL, 2002, ARCH GEN PSYCHIAT, V59, P530, DOI 10.1001/archpsyc.59.6.530; Judd LL, 2003, ARCH GEN PSYCHIAT, V60, P261, DOI 10.1001/archpsyc.60.3.261; Karling P, 2007, SCAND J GASTROENTERO, V42, P1294, DOI 10.1080/00365520701395945; Kaushik M L, 2003, Indian J Med Sci, V57, P249; Kenna HA, 2011, PSYCHIAT CLIN NEUROS, V65, P549, DOI 10.1111/j.1440-1819.2011.02260.x; Kupfer DJ, 2002, J CLIN PSYCHIAT, V63, P120, DOI 10.4088/JCP.v63n0206; Michalak EE, 2008, CNS DRUGS, V22, P389, DOI 10.2165/00023210-200822050-00003; Michalak Erin E, 2005, Health Qual Life Outcomes, V3, P72, DOI 10.1186/1477-7525-3-72; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Morrison MF, 2000, BIOL PSYCHIAT, V47, P144, DOI 10.1016/S0006-3223(99)00099-2; Nemeroff CB, 1996, MOL PSYCHIATR, V1, P336; Nilsson LG, 1997, AGING NEUROPSYCHOL C, V4, P1, DOI 10.1080/13825589708256633; Nilsson LG, 2004, AGING NEUROPSYCHOL C, V11, P134, DOI 10.1080/13825580490511026; Oldehinkel AJ, 2001, PSYCHIAT RES, V104, P39, DOI 10.1016/S0165-1781(01)00300-6; Patten SB, 2000, DRUG SAFETY, V22, P111, DOI 10.2165/00002018-200022020-00004; Penninx BWJH, 2007, AM J GERIAT PSYCHIAT, V15, P522, DOI 10.1097/JGP.0b013e318033ed80; Pfennig A, 2005, BIOL PSYCHIAT, V57, P336, DOI 10.1016/j.biopsych.2004.11.017; Plihal W, 1996, PSYCHONEUROENDOCRINO, V21, P515, DOI 10.1016/S0306-4530(96)00011-X; Power M, 1998, SOC SCI MED, V46, P1569, DOI 10.1016/s0277-9536(98)00009-4; Quiroz JA, 2004, MOL PSYCHIATR, V9, P756, DOI 10.1038/sj.mp.4001521; Rapaport MH, 2005, AM J PSYCHIAT, V162, P1171, DOI 10.1176/appi.ajp.162.6.1171; Rask E, 2001, J CLIN ENDOCR METAB, V86, P1418, DOI 10.1210/jc.86.3.1418; Rask E, 2002, J CLIN ENDOCR METAB, V87, P3330, DOI 10.1210/jc.87.7.3330; Rush AJ, 1996, J CLIN PSYCHIAT, V57, P470, DOI 10.4088/JCP.v57n1006; Rybakowski JK, 1999, J PSYCHIAT RES, V33, P363, DOI 10.1016/S0022-3956(99)00014-X; Schmider J, 1995, BIOL PSYCHIAT, V38, P797, DOI 10.1016/0006-3223(95)00064-X; Schmidt LA, 1999, PSYCHONEUROENDOCRINO, V24, P461, DOI 10.1016/S0306-4530(99)00007-4; Sonino N, 2001, CNS DRUGS, V15, P361, DOI 10.2165/00023210-200115050-00003; Sonino N, 1998, PSYCHOTHER PSYCHOSOM, V67, P140, DOI 10.1159/000012274; Sonino N, 2010, REV ENDOCR METAB DIS, V11, P95, DOI 10.1007/s11154-009-9123-7; Spijker AT, 2012, NEUROENDOCRINOLOGY, V95, P179, DOI 10.1159/000329846; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; SVANBORG P, 1994, ACTA PSYCHIAT SCAND, V89, P21, DOI 10.1111/j.1600-0447.1994.tb01480.x; TYRER P, 1984, J NEUROL NEUROSUR PS, V47, P970, DOI 10.1136/jnnp.47.9.970; van Aken MO, 2005, J CLIN ENDOCR METAB, V90, P3279, DOI 10.1210/jc.2004-1375; Watson S, 2004, BRIT J PSYCHIAT, V184, P496, DOI 10.1192/bjp.184.6.496; Wikgren M, 2012, BIOL PSYCHIAT, V71, P294, DOI 10.1016/j.biopsych.2011.09.015; Wittchen HU, 2003, INT J NEUROPSYCHOPH, V6, P145, DOI 10.1017/S146114570300333X; Yehuda R, 2009, ANN NY ACAD SCI, V1179, P56, DOI 10.1111/j.1749-6632.2009.04979.x	72	39	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e98682	10.1371/journal.pone.0098682	http://dx.doi.org/10.1371/journal.pone.0098682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	AJ5PV	24932586	Green Published, gold, Green Submitted			2022-12-27	WOS:000337738600011
J	Ohnishi, N; Tahara, Y; Kuriki, D; Haraguchi, A; Shibata, S				Ohnishi, Nobuaki; Tahara, Yu; Kuriki, Daisuke; Haraguchi, Atsushi; Shibata, Shigenobu			Warm Water Bath Stimulates Phase-Shifts of the Peripheral Circadian Clocks in PER2::LUCIFERASE Mouse	PLOS ONE			English	Article							AMBIENT-TEMPERATURE CYCLES; REV-ERB-ALPHA; BODY-TEMPERATURE; ACTIVITY RHYTHMS; LIVER CLOCK; ENTRAINMENT; OSCILLATIONS; PROTEIN; LOOP	Circadian clocks in the peripheral tissues of mice are known to be entrained by pulse stimuli such as restricted feeding, novel wheel running, and several other agents. However, there are no reports on high temperature pulse-mediated entrainment on the phase-shift of peripheral clocks in vivo. Here we show that temperature treatment of mice for two days at 41 degrees C, instead of 37 degrees C, for 1-2 h during the inactive period, using a temperature controlled water bath stimulated phase-advance of peripheral clocks in the kidney, liver, and submandibular gland of PER2::LUCIFERASE mice. On the other hand, treatment for 2 days at 35 degrees C ambient room temperature for 2 h did not cause a phase-advance. Maintenance of mice at 41 degrees C in a water bath, sustained the core body temperature at 40-41 degrees C. However, the use of 37 degrees C water bath or the 35 degrees C ambient room temperature elevated the core body temperature to 38.5 degrees C, suggesting that at least a core body temperature of 40-41 degrees C is necessary to cause phase-advance under light-dark cycle conditions. The temperature pulse stimulation at 41 degrees C, instead of 37 degrees C water bath for 2 h led to the elevated expression of Per1 and Hsp70 in the peripheral tissue of mice. In summary, the present study demonstrates that transient high temperature pulse using water bath during daytime causes phase-advance in mouse peripheral clocks in vivo. The present results suggest that hot water bath may affect the phase of peripheral clocks.	[Ohnishi, Nobuaki; Tahara, Yu; Kuriki, Daisuke; Haraguchi, Atsushi; Shibata, Shigenobu] Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Tokyo, Japan	Waseda University	Shibata, S (corresponding author), Waseda Univ, Sch Adv Sci & Engn, Lab Physiol & Pharmacol, Tokyo, Japan.	shibatas@waseda.jp	Haraguchi, Atsushi/ABC-6337-2020; Tahara, Yu/Q-4324-2018	Haraguchi, Atsushi/0000-0003-4162-2474; Tahara, Yu/0000-0002-3015-8883	Ministry of Education, Culture, Sports, Science and Technology of Japan [23300278]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was supported by a Grant-in-Aid for Scientific Research (B) (23300278) from the Ministry of Education, Culture, Sports, Science and Technology of Japan (S. S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Balsalobre A, 2000, SCIENCE, V289, P2344, DOI 10.1126/science.289.5488.2344; Brown SA, 2002, CURR BIOL, V12, P1574, DOI 10.1016/S0960-9822(02)01145-4; Buhr Ethan D, 2013, Handb Exp Pharmacol, P3, DOI 10.1007/978-3-642-25950-0_1; Buhr ED, 2010, SCIENCE, V330, P379, DOI 10.1126/science.1195262; Chappuis S, 2013, MOL METAB, V2, P184, DOI 10.1016/j.molmet.2013.05.002; FRANCIS AJP, 1988, PHYSIOL BEHAV, V43, P471, DOI 10.1016/0031-9384(88)90121-7; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gerhart-Hines Z, 2013, NATURE, V503, P410, DOI 10.1038/nature12642; Goldman BD, 1997, J BIOL RHYTHM, V12, P348, DOI 10.1177/074873049701200407; Griffin EA, 1999, SCIENCE, V286, P768, DOI 10.1126/science.286.5440.768; Hara R, 2001, GENES CELLS, V6, P269, DOI 10.1046/j.1365-2443.2001.00419.x; Hogenesch JB, 1998, P NATL ACAD SCI USA, V95, P5474, DOI 10.1073/pnas.95.10.5474; Itokawa M, 2013, NUTR RES, V33, P109, DOI 10.1016/j.nutres.2012.12.004; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; LINDBERG RG, 1974, CHRONOBIOLOGIA, V1, P356; Lowrey PL, 2011, ADV GENET, V74, P175, DOI 10.1016/B978-0-12-387690-4.00006-4; Marchant EG, 1996, PHYSIOL BEHAV, V60, P657, DOI 10.1016/S0031-9384(96)80045-X; Morf J, 2012, SCIENCE, V338, P379, DOI 10.1126/science.1217726; Pohl H, 1998, BIOL RHYTHM RES, V29, P311, DOI 10.1076/brhm.29.3.311.1436; Rajaratnam SMW, 1998, PHYSIOL BEHAV, V63, P271, DOI 10.1016/S0031-9384(97)00440-X; REEBS SG, 1989, J BIOL RHYTHM, V4, P39, DOI 10.1177/074873048900400103; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Refinetti R, 2010, J BIOL RHYTHM, V25, P247, DOI 10.1177/0748730410372074; Roenneberg T, 2010, J BIOL RHYTHM, V25, P329, DOI 10.1177/0748730410379082; Saini C, 2012, GENE DEV, V26, P567, DOI 10.1101/gad.183251.111; Sangoram AM, 1998, NEURON, V21, P1101, DOI 10.1016/S0896-6273(00)80627-3; Sato TK, 2006, NAT GENET, V38, P312, DOI 10.1038/ng1745; Sujino M, 2012, ENDOCRINOLOGY, V153, P2277, DOI 10.1210/en.2011-1794; Tahara Y, 2012, CURR BIOL, V22, P1029, DOI 10.1016/j.cub.2012.04.009; Tahara Y, 2011, J BIOL RHYTHM, V26, P230, DOI 10.1177/0748730411405958; Tamaru T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024521; Yoo SH, 2005, P NATL ACAD SCI USA, V102, P2608, DOI 10.1073/pnas.0409763102; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	33	14	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 16	2014	9	6							e100272	10.1371/journal.pone.0100272	http://dx.doi.org/10.1371/journal.pone.0100272			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AJ5PV	24933288	Green Published, Green Submitted, gold			2022-12-27	WOS:000337738600105
J	Boitano, S; Hoffman, J; Tillu, DV; Asiedu, MN; Zhang, ZY; Sherwood, CL; Wang, Y; Dong, XZ; Price, TJ; Vagner, J				Boitano, Scott; Hoffman, Justin; Tillu, Dipti V.; Asiedu, Marina N.; Zhang, Zhenyu; Sherwood, Cara L.; Wang, Yan; Dong, Xinzhong; Price, Theodore J.; Vagner, Josef			Development and Evaluation of Small Peptidomimetic Ligands to Protease-Activated Receptor-2 (PAR(2)) through the Use of Lipid Tethering	PLOS ONE			English	Article							AGONISTS; ANTAGONISTS; SENSITIZES; MECHANISMS; ALLODYNIA; RESPONSES; PEPTIDES; POTENT; GPCRS; PAR2	Protease-activated receptor-2 (PAR(2)) is a G-Protein Coupled Receptor (GPCR) activated by proteolytic cleavage to expose an attached, tethered ligand (SLIGRL). We evaluated the ability for lipid-tethered-peptidomimetics to activate PAR(2) with in vitro physiological and Ca2+ signaling assays to determine minimal components necessary for potent, specific and full PAR(2) activation. A known PAR(2) activating compound containing a hexadecyl (Hdc) lipid via three polyethylene glycol (PEG) linkers (2at-LIGRL-PEG(3)-Hdc) provided a potent agonist starting point (physiological EC50 = 1.4 nM; 95% CI: 1.2-2.3 nM). In a set of truncated analogs, 2at-LIGR-PEG(3)-Hdc retained potency (EC50 = 2.1 nM; 1.3-3.4 nM) with improved selectivity for PAR(2) over Mas1 related G-protein coupled receptor type C11, a GPCR that can be activated by the PAR(2) peptide agonist, SLIGRL-NH2. 2at-LIG-PEG(3)-Hdc was the smallest full PAR(2) agonist, albeit with a reduced EC50 (46 nM; 20-100 nM). 2at-LI-PEG(3)-Hdc retained specific activity for PAR(2) with reduced EC50 (310 nM; 260-360 nM) but displayed partial PAR(2) activation in both physiological and Ca2+ signaling assays. Further truncation (2at-L-PEG(3)-Hdc and 2at-PEG(3)-Hdc) eliminated in vitro activity. When used in vivo, full and partial PAR(2) in vitro agonists evoked mechanical hypersensitivity at a 15 pmole dose while 2at-L-PEG(3)-Hdc lacked efficacy. Minimum peptidomimetic PAR(2) agonists were developed with known heterocycle substitutes for Ser(1) (isoxazole or aminothiazoyl) and cyclohexylalanine (Cha) as a substitute for Leu(2). Both heterocycle-tetrapeptide and heterocycle-dipeptides displayed PAR(2) specificity, however, only the heterocycle-tetrapeptides displayed full PAR(2) agonism. Using the lipid-tethered-peptidomimetic approach we have developed novel structure activity relationships for PAR(2) that allows for selective probing of PAR(2) function across a broad range of physiological systems.	[Boitano, Scott; Hoffman, Justin; Sherwood, Cara L.] Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85721 USA; [Boitano, Scott; Hoffman, Justin; Sherwood, Cara L.] Univ Arizona, Dept Physiol, Tucson, AZ USA; [Boitano, Scott; Hoffman, Justin; Zhang, Zhenyu; Sherwood, Cara L.; Price, Theodore J.; Vagner, Josef] Univ Arizona, Collaborat Res Inst BIO5, Tucson, AZ USA; [Tillu, Dipti V.; Asiedu, Marina N.; Price, Theodore J.] Univ Arizona, Dept Pharmacol, Tucson, AZ USA; [Wang, Yan] Sichuan Univ, West China Hosp Stomatol, State Key Lab Oral Dis, Chengdu 610064, Peoples R China; [Dong, Xinzhong] Johns Hopkins Univ, Dept Neurosci, Baltimore, MD USA	University of Arizona; University of Arizona; University of Arizona; University of Arizona; Sichuan University; Johns Hopkins University	Boitano, S (corresponding author), Univ Arizona, Arizona Resp Ctr, Tucson, AZ 85721 USA.	sboitano@email.arizona.edu; tjp140130@utdallas.edu; vagner@email.arizona.edu	wang, yan/AAZ-4988-2021; Price, Theodore/M-3810-2018	Price, Theodore/0000-0002-6971-6221	National Institutes of Health (NIH)/NINDS [NS073664]; NIH/NIEHS Superfund Research [ES04940]; NIH/NINDS [NS065926, NS054791]; NIH/NIAID [AI083403]; NIH/NIGMS [GM087369]; Technology and Research Initiative Fund from Arizona State; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI083403, R56AI083403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004940, T32ES007091, P30ES006694] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM087369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073664, R01NS065926, R01NS054791] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIEHS Superfund Research; NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIH/NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIH/NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Technology and Research Initiative Fund from Arizona State; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This manuscript was developed through a multi-principal investigator collaboration between S.B., T.J.P. and J.V. This work was primarily supported by a multi-principal investigator grant from the National Institutes of Health (NIH)/NINDS, NS073664 (S.B., T.J.P., J.V.). This work was additionally supported by the following grants: NIH/NIEHS Superfund Research Grant ES04940 (S.B.; Raina Maier, P.I.); NIH/NINDS Grant NS065926 (T.J.P.); NIH/NIAID Grant AI083403 (S.B.; Michael O. Daines, P.I.); NIH/NIGMS Grant GM087369 (X.D.); NIH/NINDS Grant NS054791 (X.D.); and the Technology and Research Initiative Fund from Arizona State Proposition 301 (J.V.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MN, 2011, PHARMACOL THERAPEUT, V130, P248, DOI 10.1016/j.pharmthera.2011.01.003; Al-Ani B, 2004, MOL PHARMACOL, V65, P149, DOI 10.1124/mol.65.1.149; Amadesi S, 2004, J NEUROSCI, V24, P4300, DOI 10.1523/JNEUROSCI.5679-03.2004; Amadesi S, 2006, J PHYSIOL-LONDON, V575, P555, DOI 10.1113/jphysiol.2006.111534; Atienza JM, 2005, J BIOMOL SCREEN, V10, P795, DOI 10.1177/1087057105279635; Barry GD, 2006, CURR MED CHEM, V13, P243, DOI 10.2174/092986706775476070; Barry GD, 2010, J MED CHEM, V53, P7428, DOI 10.1021/jm100984y; Blackhart BD, 1996, J BIOL CHEM, V271, P16466, DOI 10.1074/jbc.271.28.16466; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Dai Y, 2004, J NEUROSCI, V24, P4293, DOI 10.1523/JNEUROSCI.0454-04.2004; Dai Y, 2007, J CLIN INVEST, V117, P1979, DOI 10.1172/JCI30951; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Flynn AN, 2013, FASEB J, V27, P1498, DOI 10.1096/fj.12-217323; Flynn AN, 2011, J BIOL CHEM, V286, P19076, DOI 10.1074/jbc.M110.185264; GRUENERT DC, 1995, AM J PHYSIOL-LUNG C, V268, pL347, DOI 10.1152/ajplung.1995.268.3.L347; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hollenberg MD, 2014, BRIT J PHARMACOL, V171, P1180, DOI 10.1111/bph.12544; Hollenberg MD, 1996, MOL PHARMACOL, V49, P229; Jalink K, 2010, BIOESSAYS, V32, P13, DOI 10.1002/bies.200900153; Kawabata A, 2006, BRIT J PHARMACOL, V148, P54, DOI 10.1038/sj.bjp.0706708; Kawabata A, 1999, J PHARMACOL EXP THER, V288, P358; Lam DK, 2010, PAIN, V149, P263, DOI 10.1016/j.pain.2010.02.010; LaMotte RH, 2014, NAT REV NEUROSCI, V15, P19, DOI 10.1038/nrn3641; Liu Q, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001925; Maryanoff BE, 2001, ARCH BIOCHEM BIOPHYS, V386, P195, DOI 10.1006/abbi.2000.2207; McGuire JJ, 2004, J PHARMACOL EXP THER, V309, P1124, DOI 10.1124/jpet.103.064584; Mishra SK, 2013, SCIENCE, V340, P968, DOI 10.1126/science.1233765; Nichols HL, 2012, P NATL ACAD SCI USA, V109, P16660, DOI 10.1073/pnas.1208881109; Rajagopal S, 2010, NAT REV DRUG DISCOV, V9, P373, DOI 10.1038/nrd3024; Ramachandran R, 2012, NAT REV DRUG DISCOV, V11, P69, DOI 10.1038/nrd3615; Ramachandran R, 2011, J BIOL CHEM, V286, P24638, DOI 10.1074/jbc.M110.201988; Ramachandran R, 2009, MOL PHARMACOL, V76, P791, DOI 10.1124/mol.109.055509; Soh UJK, 2010, BRIT J PHARMACOL, V160, P191, DOI 10.1111/j.1476-5381.2010.00705.x; Stallaert W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029420; Vergnolle N, 2001, NAT MED, V7, P821, DOI 10.1038/89945; Zhang L, 2012, CURR MED CHEM, V19, P1602; Zheng H, 2010, IUBMB LIFE, V62, P112, DOI 10.1002/iub.293	37	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99140	10.1371/journal.pone.0099140	http://dx.doi.org/10.1371/journal.pone.0099140			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927179	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100029
J	Garrido, MG; Beck, SC; Muhlfriedel, R; Julien, S; Schraermeyer, U; Seeliger, MW				Garrido, Marina Garcia; Beck, Susanne C.; Muehlfriedel, Regine; Julien, Sylvie; Schraermeyer, Ulrich; Seeliger, Mathias W.			Towards a Quantitative OCT Image Analysis	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; LEBER CONGENITAL AMAUROSIS; RETINAL DEGENERATION; GENE-THERAPY; MOUSE MODELS; HABITAT	Background: Optical coherence tomography (OCT) is an invaluable diagnostic tool for the detection and follow-up of retinal pathology in patients and experimental disease models. However, as morphological structures and layering in health as well as their alterations in disease are complex, segmentation procedures have not yet reached a satisfactory level of performance. Therefore, raw images and qualitative data are commonly used in clinical and scientific reports. Here, we assess the value of OCT reflectivity profiles as a basis for a quantitative characterization of the retinal status in a cross-species comparative study. Methods: Spectral-Domain Optical Coherence Tomography (OCT), confocal Scanning-La-ser Ophthalmoscopy (SLO), and Fluorescein Angiography (FA) were performed in mice (Mus musculus), gerbils (Gerbillus perpadillus), and cynomolgus monkeys (Macaca fascicularis) using the Heidelberg Engineering Spectralis system, and additional SLOs and FAs were obtained with the HRA I (same manufacturer). Reflectivity profiles were extracted from 8-bit greyscale OCT images using the ImageJ software package (http://rsb.info.nih.gov/ij/). Results: Reflectivity profiles obtained from OCT scans of all three animal species correlated well with ex vivo histomorphometric data. Each of the retinal layers showed a typical pattern that varied in relative size and degree of reflectivity across species. In general, plexiform layers showed a higher level of reflectivity than nuclear layers. A comparison of reflectivity profiles from specialized retinal regions (e.g. visual streak in gerbils, fovea in non-human primates) with respective regions of human retina revealed multiple similarities. In a model of Retinitis Pigmentosa (RP), the value of reflectivity profiles for the follow-up of therapeutic interventions was demonstrated. Conclusions: OCT reflectivity profiles provide a detailed, quantitative description of retinal layers and structures including specialized retinal regions. Our results highlight the potential of this approach in the long-term follow-up of therapeutic strategies.	[Garrido, Marina Garcia; Beck, Susanne C.; Muehlfriedel, Regine; Seeliger, Mathias W.] Ctr Ophthalmol, Inst Ophthalm Res, Div Ocular Neurodegenerat, Tubingen, Germany; [Julien, Sylvie; Schraermeyer, Ulrich] Ctr Ophthalmol, Sect Expt Vitreoretinal Surg, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Garrido, MG (corresponding author), Ctr Ophthalmol, Inst Ophthalm Res, Div Ocular Neurodegenerat, Tubingen, Germany.	marina.garcia-garrido@med.uni-tuebingen.de		Julien-Schraermeyer, Sylvie/0000-0002-2322-511X	European Union [HEALTH-F2-2008-200234, HEALTH-F2-2010-242013]; Deutsche Forschungsgemeinschaft (DFG) [Se837/5-2, Se837/6-1, Se837/6-2, Se837/7-1]; German Ministry of Education and Research (BMBF) [HOPE 2 01GM1108A]; Deutsche Forschungsgemeinschaft; Open Access Publishing Fund of Tuebingen University	European Union(European Commission); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); German Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Open Access Publishing Fund of Tuebingen University	This work was supported by the European Union(HEALTH-F2-2008-200234 and HEALTH-F2-2010-242013), Deutsche Forschungsgemeinschaft (DFG, grants Se837/5-2, Se837/6-1, Se837/6-2, Se837/7-1), and the German Ministry of Education and Research (BMBF, HOPE 2 01GM1108A). We acknowledge support by Deutsche Forschungsgemeinschaft and Open Access Publishing Fund of Tuebingen University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballantyne A J, 1940, Proc R Soc Med, V34, P19; Barthelmes D, 2006, INVEST OPHTH VIS SCI, V47, P1161, DOI 10.1167/iovs.05-0783; Barthelmes D, 2008, INVEST OPHTH VIS SCI, V49, P2156, DOI 10.1167/iovs.07-0478; Biel M, 2007, MOL NEUROBIOL, V35, P266, DOI 10.1007/s12035-007-0025-y; Boudard DL, 2010, NEUROSCIENCE, V169, P1815, DOI 10.1016/j.neuroscience.2010.06.037; Drexler W, 2003, ARCH OPHTHALMOL-CHIC, V121, P695, DOI 10.1001/archopht.121.5.695; Dubis AM, 2012, ARCH OPHTHALMOL-CHIC, V130, P1291, DOI 10.1001/archophthalmol.2012.2270; Fischer MD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007507; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; FUJIMOTO JG, 1995, NAT MED, V1, P970, DOI 10.1038/nm0995-970; Grewal DS, 2013, CURR OPIN OPHTHALMOL, V24, P150, DOI 10.1097/ICU.0b013e32835d9e27; Huber G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013403; Huber G, 2009, INVEST OPHTH VIS SCI, V50, P5888, DOI 10.1167/iovs.09-3724; Huttl S, 2005, J NEUROSCI, V25, P130, DOI 10.1523/JNEUROSCI.3764-04.2005; Jacobson SG, 2012, ARCH OPHTHALMOL-CHIC, V130, P9, DOI 10.1001/archophthalmol.2011.298; Jacobson SG, 2009, MOL VIS, V15, P1098; Jacobson SG, 2003, HUM MOL GENET, V12, P1073, DOI 10.1093/hmg/ddg117; Koch S, 2012, HUM MOL GENET, V21, P4486, DOI 10.1093/hmg/dds290; Masland RH, 2012, NEURON, V76, P266, DOI 10.1016/j.neuron.2012.10.002; Mataftsi A, 2007, INVEST OPHTH VIS SCI, V48, P5160, DOI 10.1167/iovs.06-1013; Narfstrom K, 2011, VET OPHTHALMOL, V14, P30, DOI 10.1111/j.1463-5224.2011.00915.x; OGDEN TE, 1983, VISION RES, V23, P581, DOI 10.1016/0042-6989(83)90063-9; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Samardzija M, 2006, FASEB J, V20, P2411, DOI 10.1096/fj.06-5895fje; Schiviz AN, 2008, J COMP NEUROL, V507, P1336, DOI 10.1002/cne.21626; Schraermeyer U, 2012, GRAEF ARCH CLIN EXP, V250, P1303, DOI 10.1007/s00417-012-2055-z; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; Spaide RF, 2011, RETINA-J RET VIT DIS, V31, P1609, DOI 10.1097/IAE.0b013e3182247535; van Velthoven MEJ, 2007, PROG RETIN EYE RES, V26, P57, DOI 10.1016/j.preteyeres.2006.10.002	30	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e100080	10.1371/journal.pone.0100080	http://dx.doi.org/10.1371/journal.pone.0100080			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927180	gold, Green Published, Green Submitted			2022-12-27	WOS:000338278100117
J	Ma, DL; He, HZ; Chan, DSH; Wong, CY; Leung, CH				Ma, Dik-Lung; He, Hong-Zhang; Chan, Daniel Shiu-Hin; Wong, Chun-Yuen; Leung, Chung-Hang			A Colorimetric and Luminescent Dual-Modal Assay for Cu(II) Ion Detection Using an Iridium(III) Complex	PLOS ONE			English	Article							SWITCH-ON PROBE; SELECTIVE ELECTROCHEMICAL SENSOR; LABEL-FREE; FLUORESCENT SENSOR; AQUEOUS-SOLUTION; LIVING CELLS; COPPER(II) ION; PHOSPHORESCENT; CU2+; CHEMOSENSOR	A novel iridium(III) complex-based chemosensor bearing the 5,6-bis(salicylideneimino)-1,10-phenanthroline ligand receptor was developed, which exhibited a highly sensitive and selective color change from colorless to yellow and a visible turn-off luminescence response upon the addition of Cu(II) ions. The interactions of this iridium(III) complex with Cu2+ ions and thirteen other cations have been investigated by UV-Vis absorption titration, emission titration, and H-1 NMR titration.	[Ma, Dik-Lung; He, Hong-Zhang; Chan, Daniel Shiu-Hin] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China; [Wong, Chun-Yuen] City Univ Hong Kong, Dept Biol & Chem, Kowloon, Hong Kong, Peoples R China; [Leung, Chung-Hang] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China	Hong Kong Baptist University; City University of Hong Kong; University of Macau	Ma, DL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.	edmondma@hkbu.edu.hk	Wong, Chun-Yuen/H-2272-2011	Wong, Chun-Yuen/0000-0003-4780-480X; Ma, Dik-Lung/0000-0002-9515-340X	Hong Kong Baptist University [FRG2/12-13/021, FRG2/13-14/008]; Centre for Cancer and Inflammation Research, the School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund [HMRF/13121482]; Research Grants Council [HKBU/201811, HKBU/204612, HKBU/201913]; French National Research Agency/Research Grants Council Joint Research Scheme [A-HKBU201/12]; Science and Technology Development Fund, Macao SAR [103/2012/A3]; University of Macau [MYRG091(Y3-L2)-ICMS12-LCH, MYRG121(Y3-L2)-ICMS12-LCH, MRG007/LCH/2014/ICMS, MRG023/LCH/2013/ICMS]	Hong Kong Baptist University; Centre for Cancer and Inflammation Research, the School of Chinese Medicine (CCIR-SCM, HKBU); Health and Medical Research Fund; Research Grants Council(Hong Kong Research Grants Council); French National Research Agency/Research Grants Council Joint Research Scheme(French National Research Agency (ANR)); Science and Technology Development Fund, Macao SAR; University of Macau	This work is supported by Hong Kong Baptist University (FRG2/12-13/021 and FRG2/13-14/008), the Centre for Cancer and Inflammation Research, the School of Chinese Medicine (CCIR-SCM, HKBU), the Health and Medical Research Fund (HMRF/13121482), the Research Grants Council (HKBU/201811, HKBU/204612, and HKBU/201913), the French National Research Agency/Research Grants Council Joint Research Scheme (A-HKBU201/12), the Science and Technology Development Fund, Macao SAR (103/2012/A3) and the University of Macau (MYRG091(Y3-L2)-ICMS12-LCH, MYRG121(Y3-L2)-ICMS12-LCH, MRG007/LCH/2014/ICMS and MRG023/LCH/2013/ICMS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araya JC, 2010, NEW J CHEM, V34, P21, DOI 10.1039/b9nj00515c; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Beija M, 2009, CHEM SOC REV, V38, P2410, DOI 10.1039/b901612k; BENESI HA, 1949, J AM CHEM SOC, V71, P2703, DOI 10.1021/ja01176a030; Brandel J, 2010, CHEM COMMUN, V46, P3958, DOI 10.1039/c002401e; Burdette SC, 2001, J AM CHEM SOC, V123, P7831, DOI 10.1021/ja010059l; Chan DSH, 2009, CHEM COMMUN, P7479, DOI 10.1039/b913995h; Charbonniere LJ, 2003, INORG CHEM, V42, P3466, DOI 10.1021/ic020671t; Chen XY, 2009, ORG LETT, V11, P4426, DOI 10.1021/ol901787w; Chen XQ, 2012, CHEM REV, V112, P1910, DOI 10.1021/cr200201z; Chen XQ, 2006, ANAL CHIM ACTA, V575, P217, DOI 10.1016/j.aca.2006.05.097; Chen XQ, 2009, ANAL CHIM ACTA, V632, P9, DOI 10.1016/j.aca.2007.08.025; Cheng PPH, 2006, J PHYS CHEM B, V110, P4637, DOI 10.1021/jp057028n; DEMAS JN, 1971, J PHYS CHEM-US, V75, P991, DOI 10.1021/j100678a001; Domaille DW, 2010, J AM CHEM SOC, V132, P1194, DOI 10.1021/ja907778b; Gill MR, 2009, NAT CHEM, V1, P662, DOI [10.1038/nchem.406, 10.1038/NCHEM.406]; Gray NF., 2008, DRINKING WATER QUALI; He HZ, 2014, CHEM COMMUN, V50, P5313, DOI 10.1039/c3cc47444e; He HZ, 2013, METHODS, V64, P218, DOI 10.1016/j.ymeth.2013.08.011; He HZ, 2013, METHODS, V64, P212, DOI 10.1016/j.ymeth.2013.07.021; He HZ, 2013, METHODS, V64, P205, DOI 10.1016/j.ymeth.2013.07.023; He HZ, 2013, BIOSENS BIOELECTRON, V41, P871, DOI 10.1016/j.bios.2012.08.060; He HZ, 2012, CHEM COMMUN, V48, P9462, DOI 10.1039/c2cc32253f; Hirayama T, 2012, P NATL ACAD SCI USA, V109, P2228, DOI 10.1073/pnas.1113729109; Ho ML, 2006, ORG BIOMOL CHEM, V4, P98, DOI 10.1039/b511943j; HORROCKS WD, 1981, ACCOUNTS CHEM RES, V14, P384, DOI 10.1021/ar00072a004; Huang WS, 2004, CHEM MATER, V16, P2480, DOI 10.1021/cm0498943; Jung JY, 2013, CHEM COMMUN, V49, P176, DOI 10.1039/c2cc36626f; Kaur N, 2007, CHEM COMMUN, P3069, DOI 10.1039/b703529b; Kim HB, 2013, B KOREAN CHEM SOC, V34, P653, DOI 10.5012/bkcs.2013.34.2.653; Kramer R, 1998, ANGEW CHEM INT EDIT, V37, P772, DOI 10.1002/(SICI)1521-3773(19980403)37:6<772::AID-ANIE772>3.0.CO;2-Z; Lamansky S, 2001, INORG CHEM, V40, P1704, DOI 10.1021/ic0008969; Leung KH, 2013, ACS APPL MATER INTER, V5, P12249, DOI 10.1021/am404314p; Leung KH, 2013, CHEM COMMUN, V49, P5630, DOI 10.1039/c3cc41129j; Leung KH, 2013, CHEM COMMUN, V49, P771, DOI 10.1039/c2cc37710a; Li CK, 2004, INORG CHEM, V43, P7421, DOI 10.1021/ic049094u; Li XH, 2014, CHEM REV, V114, P590, DOI 10.1021/cr300508p; Lin HW, 2010, DALTON T, V39, P5130, DOI 10.1039/c000449a; Liu Y, 2011, INORG CHEM, V50, P5969, DOI 10.1021/ic102481x; Lowry MS, 2006, CHEM-EUR J, V12, P7970, DOI 10.1002/chem.200600618; Ma BL, 2010, SENSOR ACTUAT B-CHEM, V145, P451, DOI 10.1016/j.snb.2009.12.054; Ma DL, 2014, NANOSCALE, V6, P8489, DOI 10.1039/c4nr00541d; Ma DL, 2013, CHEM SOC REV, V42, P3427, DOI 10.1039/c2cs35472a; Ma DL, 2012, COORDIN CHEM REV, V256, P3087, DOI 10.1016/j.ccr.2012.07.005; Ma DL, 2011, NUCLEIC ACIDS RES, V39, DOI 10.1093/nar/gkr106; Man BYW, 2011, CHEM SCI, V2, P917, DOI 10.1039/c0sc00636j; Man BYW, 2010, CHEM COMMUN, V46, P8534, DOI 10.1039/c0cc01201g; Miller EW, 2006, NAT PROTOC, V1, P824, DOI 10.1038/nprot.2006.140; NONOYAMA M, 1974, B CHEM SOC JPN, V47, P767, DOI 10.1246/bcsj.47.767; Pellegrin Y, 2005, CHEM-EUR J, V11, P3698, DOI 10.1002/chem.200401064; Quang D. T., 2010, CHEM REV, V110, P6280, DOI DOI 10.1021/CR100154P; Shi HF, 2010, CHEM-EUR J, V16, P12158, DOI 10.1002/chem.201000748; Singh AK, 2006, ANAL CHIM ACTA, V575, P25, DOI 10.1016/j.aca.2006.05.076; Singh LP, 2004, TALANTA, V64, P313, DOI 10.1016/j.talanta.2004.02.020; Sun Y, 2008, INORG CHEM, V47, P6427, DOI 10.1021/ic800560x; Tamayo AB, 2003, J AM CHEM SOC, V125, P7377, DOI 10.1021/ja034537z; Wang W, 2013, DALTON T, V42, P1827, DOI 10.1039/c2dt32279j; Xu ZC, 2010, J AM CHEM SOC, V132, P601, DOI 10.1021/ja907334j; Xue L, 2009, ORG LETT, V11, P1655, DOI 10.1021/ol900315r; Yang WR, 2001, ANALYST, V126, P1573, DOI 10.1039/b102898g; Yang YM, 2013, CHEM REV, V113, P192, DOI 10.1021/cr2004103; You Y, 2013, CURR OPIN CHEM BIOL, V17, P699, DOI 10.1016/j.cbpa.2013.05.023; You Y, 2011, J AM CHEM SOC, V133, P11488, DOI 10.1021/ja204997c; Zhao QA, 2010, CHEM SOC REV, V39, P3007, DOI 10.1039/b915340c; Zhou Y, 2009, ORG LETT, V11, P4442	65	28	28	1	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99930	10.1371/journal.pone.0099930	http://dx.doi.org/10.1371/journal.pone.0099930			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24927177	Green Submitted, Green Published, gold			2022-12-27	WOS:000338278100093
J	Mamo, H				Mamo, Hassen			Intestinal Parasitic Infections among Prison Inmates and Tobacco Farm Workers in Shewa Robit, North-Central Ethiopia	PLOS ONE			English	Article							TRANSMITTED HELMINTH INFECTIONS; SCHOOL-CHILDREN; PREVALENCE; GROWTH; HOOKWORM	Background: Intestinal parasitic infections (IPIs) particularly soil-transmitted helminthiasis (STH) and schistosomiasis are among neglected tropical diseases (NTDs) globally. Apart from being associated with anemia, malabsorption and retarded cognitive development these diseases are complicating the clinical picture of more serious infections like HIV, TB and malaria. Renewed and up-to-date information on the epidemiology of IPIs in more vulnerable groups such as irrigated-farm workers and prisoners would significantly contribute towards improving the health condition of such at-risk groups. Methods: A cross-sectional survey was conducted to determine the prevalence of IPIs among prison inmates and tobacco farm workers in Shewa-Robit, north-central Ethiopia in November 2008. A total of 236 fecal samples were examined microscopically to detect helminths and/or protozoa using direct-smear and formol-ether concentration methods. Results: Overall, 8 intestinal parasite species have been recovered singly or in combinations from 146 (61.8 %) samples. The prevalence in prison population (88/121 = 72.7%) was significantly higher than that in tobacco farm (58/115 = 50.4%). There were no significant differences in the prevalence of IPI by most socio-demographics. Except for hookworm there was no significant difference in parasite prevalence between different age-groups though the frequency of individual parasites slightly varied between the age-groups. Multivariate logistic regression analysis showed that inmates were more likely to acquire IPIs than tobacco-farm workers (Odds Ratio (OR) = 2.62, 95% confidence interval (CI) = 1.52-4.5). In addition, participants who did not report past treatment for IPIs were more likely to acquire IPIs than participants who self-reported treatment for IPIs in the past twelve months (OR = 3.25, 95% CI = 1.75-6.06). All other socio-demographics were not significantly associated with IPIs in univariate analysis. Entamoeba histolytica/dispar/moshkovskii was the most frequently encountered species in both study sites accounting for 48.8 and 51.7 percent of the positives in prison and tobacco farm population respectively. Other intestinal parasites detected, with slight variation in prevalence in the two study areas, were hookworm, Ascaris lumbricoides, Trichuris trichiura, Schistosoma mansoni, Strongyloides stercolaris, Hymenolepis nana and Taenia sp. 35.5 and 33.0 percent of the total positive cases were mixed infections in Shewa Robit prison and tobacco farm, respectively. Conclusion: The results show that IPIs are common health problems in the studied populations.	Univ Addis Ababa, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia	Addis Ababa University	Mamo, H (corresponding author), Univ Addis Ababa, Coll Nat Sci, Dept Microbial Cellular & Mol Biol, Addis Ababa, Ethiopia.	binmamo@yahoo.com	Mamo, Hassen/AAX-3481-2020	Mamo, Hassen/0000-0001-9541-8976	Addis Ababa University	Addis Ababa University	This study was funded by Addis Ababa University. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemu A, 2011, ASIAN PAC J TROP MED, V4, P661, DOI 10.1016/S1995-7645(11)60168-5; Alonso-Sanz M, 1995, ENFERM INFEC MICR CL, V13, P228; Amuga G, 2006, INT J NAT APPL SCI, V2, P7; [Anonymous], 1987, WHO TECH REP SER, P7; [Anonymous], 2012, ADDIS FORTUNE N 1106, V12; Birrie H., 1998, SCHISTOSOMIASIS ETHI, V2, P29; Brooker S, 2010, INT J PARASITOL, V40, P1137, DOI 10.1016/j.ijpara.2010.04.004; Colman S, 2013, AJMR, V1, P11, DOI DOI 10.15413/ajmr.2012.0103; Degarege Abraham, 2010, BMC Res Notes, V3, P143, DOI 10.1186/1756-0500-3-143; Dejenie T, 2009, ETHIOP J HEALTH DEV, V23, P48; Dickson R, 2000, BMJ-BRIT MED J, V320, P1697, DOI 10.1136/bmj.320.7251.1697; Fraser A, 2007, HLTH PRISONS WHO GUI, P21; Hotez P, 2008, ANN NY ACAD SCI, V1136, P38, DOI 10.1196/annals.1425.000; Jemaneh L, 2000, ETHIOPIAN MED J, V38, P105; Jemaneh L, 1998, ETHIOPIAN MED J, V36, P1; King CH, 2010, ACTA TROP, V113, P95, DOI 10.1016/j.actatropica.2009.11.012; King JD, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002223; Kloos H, 1993, ECOLOGY HLTH DIS ETH, P223; Knopp S, 2009, AM J TROP MED HYG, V81, P1071, DOI 10.4269/ajtmh.2009.09-0377; Koroma MM, 1996, J TROP PEDIATRICS, V42, P371, DOI 10.1093/tropej/42.6.371; KYRONSEPPA H, 1976, SCAND J INFECT DIS, V8, P199, DOI 10.3109/inf.1976.8.issue-3.15; Mahfouz AAR, 1997, J TROP PEDIATRICS, V43, P341, DOI 10.1093/tropej/43.6.341; Mamo H, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-51; McConnell E., 1976, Ethiopian Medical Journal, V14, P159; Mecroritch E, 1965, AM J TROP MED HYG, V4, P719; Munyekenye OG, 2005, EMERG INFECT DIS, V11, P1571, DOI 10.3201/eid1110.050106; Nasr NA, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-27; Okolie N, 2008, INT J PARASITIC DIS, V4; Ostan I, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-342; Pullan RL, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-37; Pullan RL, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-81; Rayan P, 2010, INDIAN J PATHOL MICR, V53, P498, DOI 10.4103/0377-4929.68292; Schmidt G.D., 2009, FDN PARASITOLOGY EDS, V8th; STEPHENSON LS, 1993, J NUTR, V123, P1036; Sugunan A. P., 1996, Journal of Communicable Diseases, V28, P253; Tedla S., 1989, Sinet, an Ethiopian Journal of Science, V12, P25; Wegayehu T, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-151; Weisbuch JC, 1992, PUBLIC HLTH PREVENTI, P1159; *WHO, 2006, NEGL TROP DIS HIDD S; Wokem GN, 2008, NIG J PARASIT, V29, P115; World Health Organization, 1991, BAS LAB METH MED PAR	41	25	25	2	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e99559	10.1371/journal.pone.0099559	http://dx.doi.org/10.1371/journal.pone.0099559			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926687	Green Submitted, Green Published, gold			2022-12-27	WOS:000338278100048
J	Campos-Martorell, M; Montero, MA; Hernandez-Guillamon, M; Rosell, A; Gomis, J; Salat, D; Garcia-Bonilla, L; Montaner, J				Campos-Martorell, Mireia; Angeles Montero, Ma; Hernandez-Guillamon, Mar; Rosell, Anna; Gomis, Javier; Salat, David; Garcia-Bonilla, Lidia; Montaner, Joan			Rat Middle Cerebral Artery Occlusion Is Not a Suitable Model for the Study of Stroke-Induced Spontaneous Infections	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; MEDICAL COMPLICATIONS; ISCHEMIC-STROKE; IMMUNODEPRESSION; ACTIVATION; INJURY; IMMUNODEFICIENCY; PNEUMONIA	Background: Infections related to stroke-induced immunodepression are an important complication causing a high rate of death in patients. Several experimental studies in mouse stroke models have described this process but it has never been tested in other species such as rats. Methods: Our study focused on the appearance of secondary systemic and pulmonary infections in ischemic rats, comparing with sham and naive animals. For that purpose, male Wistar rats were subjected to embolic middle cerebral artery occlusion (eMCAO) or to transient MCAO (tMCAO) inserting a nylon filament. Forty-eight hours after ischemia, blood and lung samples were evaluated. Results: In eMCAO set, ischemic rats showed a significant decrease in blood-peripheral lymphocytes (naive = 58.8 +/- 18.1%, ischemic = 22.9 +/- 16.4%) together with an increase in polymorphonuclears (PMNs) (naive = 29.2 +/- 14.7%, ischemic = 71.7 +/- 19.5%), while no change in monocytes was observed. The increase in PMNs counts was positively correlated with worse neurological outcome 48 hours after eMCAO (r = 0.55, p = 0.043). However, sham animals showed similar changes in peripheral leukocytes as those seen in ischemic rats (lymphocytes: 40.1 +/- 19.7%; PMNs: 51.7 +/- 19.2%). Analysis of bacteriological lung growth showed clear differences between naive (0 +/- 0 CFU/mL; log10) and both sham (3.9 +/- 2.5 CFU/mL; log10) and ischemic (4.3 +/- 2.9 CFU/mL; log10) groups. Additionally, naive animals presented non-pathological lung histology, while both sham and ischemic showed congestion, edema or hemorrhage. Concordant results were found in the second set of animals submitted to a tMCAO. Conclusions: Inflammatory and infection changes in Wistar rats subjected to MCAO models may be attributed not only to the brain ischemic injury but to the surgical aggression and/or anaesthetic stress. Consequently, we suggest that stroke-induced immunodepression in ischemic experimental models should be interpreted with caution in further experimental and translational studies, at least in rat stroke models that entail cervicotomy and cranial trepanation.	[Campos-Martorell, Mireia; Hernandez-Guillamon, Mar; Rosell, Anna; Garcia-Bonilla, Lidia; Montaner, Joan] Univ Autonoma Barcelona, Inst Recerca Vall dHebron, Neurovasc Res Lab, E-08193 Barcelona, Spain; [Angeles Montero, Ma] Hosp Valle De Hebron, Dept Anat Pathol, Barcelona, Spain; [Gomis, Javier] Univ Autonoma Barcelona, Inst Recerca Vall dHebron, Infect Dis Res Lab, E-08193 Barcelona, Spain; [Salat, David; Montaner, Joan] Univ Autonoma Barcelona, Hosp Vall dHebron, Dept Neurol, Neurovasc Unit, E-08193 Barcelona, Spain	Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Hospital Universitari Vall d'Hebron; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron	Montaner, J (corresponding author), Univ Autonoma Barcelona, Inst Recerca Vall dHebron, Neurovasc Res Lab, E-08193 Barcelona, Spain.	31862jmv@comb.cat	Montero, Angeles/AAQ-1696-2021; Montaner, Joan/D-3063-2015	Montero, Angeles/0000-0002-2381-6833; Montaner, Joan/0000-0003-4845-2279; Rosell Novel, Anna/0000-0003-1082-3599; Hernandez Guillamon, Maria Mar/0000-0001-8844-0091	FIS [FI 10/00508]; Spanish Ministry of Health; European Union's Seventh Framework Programme (European Stroke Network) [n degrees201024, n degrees202213]; Eurosalud Programme [EUS2008-03610]; Spanish stroke research network INVICTUS [RD12/0014/0005]	FIS(Instituto de Salud Carlos III); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); European Union's Seventh Framework Programme (European Stroke Network); Eurosalud Programme; Spanish stroke research network INVICTUS	MC is supported by a FIS grant (FI 10/00508) from the Spanish Ministry of Health, and MHG and AR are senior researchers of the Miguel Servet Programme (CP12/03259 and CP09/00265), all those from the Instituto de Salud Carlos III from the Spanish Ministry of Economy. The research leading to these results has received funding from the European Union's Seventh Framework Programme (FP7/2007-2013) under grant agreements n degrees 201024 and n degrees 202213 (European Stroke Network), Eurosalud Programme (EUS2008-03610) and the Spanish stroke research network INVICTUS (RD12/0014/0005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASADULLAH K, 1995, CRIT CARE MED, V23, P1976, DOI 10.1097/00003246-199512000-00006; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Brait VH, 2012, J CEREBR BLOOD F MET, V32, P598, DOI 10.1038/jcbfm.2012.6; Buck BH, 2008, STROKE, V39, P355, DOI 10.1161/STROKEAHA.107.490128; Campbell SJ, 2005, AM J PATHOL, V166, P1487, DOI 10.1016/S0002-9440(10)62365-6; Carmichael S Thomas, 2005, NeuroRx, V2, P396; CZLONKOWSKA A, 1979, J NEUROL SCI, V43, P455, DOI 10.1016/0022-510X(79)90024-8; Denes A, 2011, J CEREBR BLOOD F MET, V31, P1036, DOI 10.1038/jcbfm.2010.198; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Elneihoum AM, 1996, STROKE, V27, P1734, DOI 10.1161/01.STR.27.10.1734; Engel O, 2010, EXP TRANSL STROKE ME, V15; Garcia-Bonilla L, 2011, BRAIN RES, V1373, P211, DOI 10.1016/j.brainres.2010.12.005; Gu LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059602; HENON H, 1995, STROKE, V26, P392, DOI 10.1161/01.STR.26.3.392; Hernandez-Guillamon M, 2010, STROKE, V41, P1528, DOI 10.1161/STROKEAHA.110.584623; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Jin R, 2013, STROKE, V44, P1135, DOI 10.1161/STROKEAHA.111.000633; Johnston KC, 1998, STROKE, V29, P447, DOI 10.1161/01.STR.29.2.447; KALRA L, 1995, STROKE, V26, P990, DOI 10.1161/01.STR.26.6.990; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; KOSTIC V, 1988, EUR NEUROL, V28, P331, DOI 10.1159/000116296; Kurabayashi H, 1996, J MED, V27, P171; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Liesz A, 2009, STROKE, V40, P2849, DOI 10.1161/STROKEAHA.109.549618; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meisel C, 2004, STROKE, V35, P2, DOI 10.1161/01.STR.0000109041.89959.4C; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; Pfeilschifter Waltraud, 2011, Exp Transl Stroke Med, V3, P2, DOI 10.1186/2040-7378-3-2; Popovich P, 2009, NAT MED, V15, P736, DOI 10.1038/nm0709-736; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Prass K, 2006, STROKE, V37, P2607, DOI 10.1161/01.STR.0000240409.68739.2b; Schulte-Herbruggen O, 2006, NEUROIMMUNOMODULAT, V13, P13, DOI 10.1159/000092109; Urra X, 2009, NEUROSCIENCE, V158, P1174, DOI 10.1016/j.neuroscience.2008.06.014; Vermeij FH, 2009, CEREBROVASC DIS, V27, P465, DOI 10.1159/000210093; Vogelgesang A, 2008, STROKE, V39, P237, DOI 10.1161/STROKEAHA.107.493635; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Woiciechowsky C, 1998, NAT MED, V4, P808, DOI 10.1038/nm0798-808; Yan J, 2009, J NEUROIMMUNOL, V206, P112, DOI 10.1016/j.jneuroim.2008.11.001	38	2	2	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99169	10.1371/journal.pone.0099169	http://dx.doi.org/10.1371/journal.pone.0099169			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922549	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300038
J	Kadoya, T; Takenaka, A; Ishihama, F; Fujita, T; Ogawa, M; Katsuyama, T; Kadono, Y; Kawakubo, N; Serizawa, S; Takahashi, H; Takamiya, M; Fujii, S; Matsuda, H; Muneda, K; Yokota, M; Yonekura, K; Yahara, T				Kadoya, Taku; Takenaka, Akio; Ishihama, Fumiko; Fujita, Taku; Ogawa, Makoto; Katsuyama, Teruo; Kadono, Yasuro; Kawakubo, Nobumitsu; Serizawa, Shunsuke; Takahashi, Hideki; Takamiya, Masayuki; Fujii, Shinji; Matsuda, Hiroyuki; Muneda, Kazuo; Yokota, Masatsugu; Yonekura, Koji; Yahara, Tetsukazu			Crisis of Japanese Vascular Flora Shown By Quantifying Extinction Risks for 1618 Taxa	PLOS ONE			English	Article							BIODIVERSITY	Although many people have expressed alarm that we are witnessing a mass extinction, few projections have been quantified, owing to limited availability of time-series data on threatened organisms, especially plants. To quantify the risk of extinction, we need to monitor changes in population size over time for as many species as possible. Here, we present the world's first quantitative projection of plant species loss at a national level, with stochastic simulations based on the results of population censuses of 1618 threatened plant taxa in 3574 map cells of ca. 100 km(2). More than 500 lay botanists helped monitor those taxa in 1994-1995 and in 2003-2004. We projected that between 370 and 561 vascular plant taxa will go extinct in Japan during the next century if past trends of population decline continue. This extinction rate is approximately two to three times the global rate. Using time-series data, we show that existing national protected areas (PAs) covering ca. 7% of Japan will not adequately prevent population declines: even core PAs can protect at best <60% of local populations from decline. Thus, the Aichi Biodiversity Target to expand PAs to 17% of land (and inland water) areas, as committed to by many national governments, is not enough: only 29.2% of currently threatened species will become non-threatened under the assumption that probability of protection success by PAs is 0.5, which our assessment shows is realistic. In countries where volunteers can be organized to monitor threatened taxa, censuses using our method should be able to quantify how fast we are losing species and to assess how effective current conservation measures such as PAs are in preventing species extinction.	[Kadoya, Taku; Takenaka, Akio; Ishihama, Fumiko] Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan; [Fujita, Taku] Nat Conservat Soc Japan, Chuo Ku, Tokyo, Japan; [Ogawa, Makoto] Tokushima Prefectural Museum, Tokushima, Japan; [Katsuyama, Teruo] Kanagawa Prefectural Museum Nat Hist, Odawara, Kanagawa, Japan; [Kadono, Yasuro] Kobe Univ, Fac Sci, Kobe, Hyogo 657, Japan; [Kawakubo, Nobumitsu] Gifu Univ, Fac Appl Biol Sci, Gifu, Japan; [Serizawa, Shunsuke] Aichi Kyoiku Univ, Dept Biol, Kariya, Aichi, Japan; [Takahashi, Hideki] Hokkaido Univ Museum, Sapporo, Hokkaido, Japan; [Takamiya, Masayuki] Kumamoto Univ, Dept Environm Sci, Kumamoto, Japan; [Fujii, Shinji] Univ Human Environm, Div Human Environm, Okazaki, Aichi, Japan; [Matsuda, Hiroyuki; Muneda, Kazuo] Yokohama Natl Univ, Fac Nat Environm & Informat Sci, Hodogaya Ku, Yokohama, Kanagawa 240, Japan; [Yokota, Masatsugu] Univ Ryukyus, Fac Sci, Nakagami, Okinawa, Japan; [Yonekura, Koji] Tohoku Univ, Ctr Acad Resources & Arch, Bot Gardens, Aoba Ku, Sendai, Miyagi 980, Japan; [Yahara, Tetsukazu] Kyushu Univ, Dept Biol, Higashi Ku, Fukuoka 812, Japan	National Institute for Environmental Studies - Japan; Kobe University; Gifu University; Aichi University Education; Hokkaido University; Kumamoto University; Yokohama National University; University of the Ryukyus; Tohoku University; Kyushu University	Kadoya, T (corresponding author), Natl Inst Environm Studies, Ctr Environm Biol & Ecosyst Studies, Tsukuba, Ibaraki, Japan.	kadoya@nies.go.jp	Ogawa, Makoto/AAE-6161-2021; Ishihama, Fumiko/AAC-1461-2022	Yahara, Tetsukazu/0000-0001-5105-7152	Ministry of the Environment of Japan and the Japanese Society of Plant Taxonomists; Environment Research and Technology Development fund of the Ministry of the Environment, Japan [S9-1]; Grants-in-Aid for Scientific Research [25550102] Funding Source: KAKEN	Ministry of the Environment of Japan and the Japanese Society of Plant Taxonomists; Environment Research and Technology Development fund of the Ministry of the Environment, Japan(Ministry of the Environment, Japan); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. This work was supported by the Ministry of the Environment of Japan and the Japanese Society of Plant Taxonomists, and in part by the Environment Research and Technology Development fund (S9-1) of the Ministry of the Environment, Japan.	Butchart SHM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032529; IUCN, 2012, IUCN RED LIST THREAT; IUCN U.-W., 2012, WORLD DAT PROT AR WD; Kadoya T, 2009, BIOL CONSERV, V142, P1899, DOI 10.1016/j.biocon.2009.02.033; Kadoya T, 2009, BIOL CONSERV, V142, P1011, DOI 10.1016/j.biocon.2009.01.012; Laurance WF, 2012, NATURE, V489, P290, DOI 10.1038/nature11318; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Moilanen A., 2009, SPATIAL CONSERVATION; Moore JL, 2003, ECOGRAPHY, V26, P595, DOI 10.1034/j.1600-0587.2003.03467.x; Possingham HP, 2005, NATURE, V436, P919, DOI 10.1038/436919a; Possingham HP, 2002, TRENDS ECOL EVOL, V17, P503, DOI 10.1016/S0169-5347(02)02614-9; Rodrigues ASL, 2006, TRENDS ECOL EVOL, V21, P71, DOI 10.1016/j.tree.2005.10.010; SMITH FDM, 1993, NATURE, V364, P494, DOI 10.1038/364494b0; Yahara T, 1998, P JPN SOC PLANT TAXO, V13, P89	14	7	8	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98954	10.1371/journal.pone.0098954	http://dx.doi.org/10.1371/journal.pone.0098954			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922311	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300022
J	Kersten, P; White, PJ; Tennant, A				Kersten, Paula; White, Peter J.; Tennant, Alan			Is the Pain Visual Analogue Scale Linear and Responsive to Change? An Exploration Using Rasch Analysis	PLOS ONE			English	Article							SCORES; ACUPUNCTURE; RELIABILITY; VALIDATION; DIFFERENCE; VALIDITY; TESTS; WOMEN; VAS	Objectives: Pain visual analogue scales (VAS) are commonly used in clinical trials and are often treated as an interval level scale without evidence that this is appropriate. This paper examines the internal construct validity and responsiveness of the pain VAS using Rasch analysis. Methods: Patients (n = 221, mean age 67, 58% female) with chronic stable joint pain (hip 40% or knee 60%) of mechanical origin waiting for joint replacement were included. Pain was scored on seven daily VASs. Rasch analysis was used to examine fit to the Rasch model. Responsiveness (Standardized Response Means, SRM) was examined on the raw ordinal data and the interval data generated from the Rasch analysis. Results: Baseline pain VAS scores fitted the Rasch model, although 15 aberrant cases impacted on unidimensionality. There was some local dependency between items but this did not significantly affect the person estimates of pain. Daily pain (item difficulty) was stable, suggesting that single measures can be used. Overall, the SRMs derived from ordinal data overestimated the true responsiveness by 59%. Changes over time at the lower and higher end of the scale were represented by large jumps in interval equivalent data points; in the middle of the scale the reverse was seen. Conclusions: The pain VAS is a valid tool for measuring pain at one point in time. However, the pain VAS does not behave linearly and SRMs vary along the trait of pain. Consequently, Minimum Clinically Important Differences using raw data, or change scores in general, are invalid as these will either under-or overestimate true change; raw pain VAS data should not be used as a primary outcome measure or to inform parametric-based Randomised Controlled Trial power calculations in research studies; and Rasch analysis should be used to convert ordinal data to interval data prior to data interpretation.	[Kersten, Paula] Auckland Univ Technol, Sch Rehabil & Occupat Studies, Person Centred Res Ctr, Auckland, New Zealand; [White, Peter J.] Univ Southampton, Fac Hlth Sci, Southampton, Hants, England; [Tennant, Alan] Univ Leeds, Dept Rehabil Med, Leeds, W Yorkshire, England	Auckland University of Technology; University of Southampton; University of Leeds	Kersten, P (corresponding author), Auckland Univ Technol, Sch Rehabil & Occupat Studies, Person Centred Res Ctr, Auckland, New Zealand.	pkersten@aut.ac.nz		Tennant, Alan/0000-0002-0728-2130	Department of Health Post Doctoral Fellowship Award (NCC RCD) [CAMs 03/12]	Department of Health Post Doctoral Fellowship Award (NCC RCD)	This project was funded by a Department of Health Post Doctoral Fellowship Award (NCC RCD - CAMs 03/12). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDRICH D, 2003, RUMM 2020; Andrich D., 1988, SAGE PUBLICATIONS; Auffinger BM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067408; Bijur PE, 2001, ACAD EMERG MED, V8, P1153, DOI 10.1111/j.1553-2712.2001.tb01132.x; Bird SB, 2001, ANN EMERG MED, V38, P639, DOI 10.1067/mem.2001.118012; Bjordal JM, 2004, BMJ-BRIT MED J, V329, P1317, DOI 10.1136/bmj.38273.626655.63; BLAND JM, 1995, BRIT MED J, V310, P170, DOI 10.1136/bmj.310.6973.170; Brouwer RW, 2006, J BONE JOINT SURG BR, V88B, P1454, DOI 10.1302/0301-620X.88B11.17743; Cohen, 1988, STAT POWER BEHAV SCI; DeLoach LJ, 1998, ANESTH ANALG, V86, P102, DOI 10.1097/00000539-199801000-00020; Dones I, 2011, NEUROL SCI, V32, P731, DOI 10.1007/s10072-011-0570-z; Elden H, 2005, BMJ-BRIT MED J, V330, P761, DOI 10.1136/bmj.38397.507014.E0; Emshoff R, 2011, PAIN, V152, P2277, DOI 10.1016/j.pain.2011.06.003; Ender SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065119; Fisher G, 1995, RASCH MODELS FDN REC; Gallagher EJ, 2002, AM J EMERG MED, V20, P287, DOI 10.1053/ajem.2002.33778; Gallagher EJ, 2001, ANN EMERG MED, V38, P633, DOI 10.1067/mem.2001.118863; Grimby G, 1998, RASCH MEAS T, V12, P651; Hartrick Craig T, 2003, Pain Pract, V3, P310; Holland PW., 1993, DIFFERENTIAL ITEM FU, DOI DOI 10.4324/9780203357811; HUSKISSON EC, 1974, LANCET, V2, P1127, DOI 10.1016/S0140-6736(74)90884-8; Jackson D, 2006, CLIN MED, V6, P580, DOI 10.7861/clinmedicine.6-6-580; Jensen MP, 2003, J PAIN, V4, P407, DOI 10.1016/S1526-5900(03)00716-8; Kelly AM, 1998, ACAD EMERG MED, V5, P1086, DOI 10.1111/j.1553-2712.1998.tb02667.x; Kennedy S, 2008, COMPLEMENT THER MED, V16, P139, DOI 10.1016/j.ctim.2007.03.001; Kersten P, 2012, J REHABIL MED, V44, P609, DOI 10.2340/16501977-0999; Kersten P, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-80; Lee JS, 2003, ACAD EMERG MED, V10, P1128, DOI 10.1197/S1069-6563(03)00372-5; Lerdal A, 2013, PSYCHIAT RES, V205, P241, DOI 10.1016/j.psychres.2012.08.031; Linacre J., 1994, RASCH MEASUREMENT T, V7, P328; Linacre JM, 1998, RASCH MEASUREMENT T, V12, P639; LOEVINGER J, 1957, PSYCHOL REP, V3, P635, DOI 10.2466/PR0.3.7.635-694; Marais Ida, 2009, J Appl Meas, V10, P17; Marais Ida, 2008, J Appl Meas, V9, P105; Marais Ida, 2008, J Appl Meas, V9, P200; Munshi J, 1990, METHOD CONSTRUCTING; Myles PS, 1999, ANESTH ANALG, V89, P1517, DOI 10.1097/00000539-199912000-00038; Rasch G., 1960, PROBABILISTIC MODELS; Richmond SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071529; SCOTT J, 1979, ANN RHEUM DIS, V38, P558, DOI 10.1136/ard.38.6.558; Sengupta N, 2004, MED CARE, V42, P927, DOI 10.1097/01.mlr.0000135812.52570.42; Smith Everett V Jr, 2005, J Appl Meas, V6, P147; Smith Everett V Jr, 2002, J Appl Meas, V3, P205; Spss Inc, 2007, SPSS 15 0 WIND REL 1; STEVENS SS, 1946, SCIENCE, V103, P677, DOI 10.1126/science.103.2684.677; Straube D, 2003, J PHYS THER ED, V17, P33; Streiner DL, 2015, HLTH MEASUREMENT SCA, DOI [10.1891/1521-0987.17.3.150, DOI 10.1891/1521-0987.17.3.150]; Tennant A., 2006, RASCH MEAS T, V20, P1048; THOMEE R, 1995, SCAND J REHABIL MED, V27, P145; Todd KH, 1996, ANN EMERG MED, V27, P485, DOI 10.1016/S0196-0644(96)70238-X; Wright BD, 1996, RASCH MEASUREMENT T, V9, P468	51	112	118	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99485	10.1371/journal.pone.0099485	http://dx.doi.org/10.1371/journal.pone.0099485			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921952	gold, Green Published, Green Submitted			2022-12-27	WOS:000338701300066
J	Nourian, Z; Li, M; Leo, MD; Jaggar, JH; Braun, AP; Hill, MA				Nourian, Zahra; Li, Min; Leo, M. Dennis; Jaggar, Jonathan H.; Braun, Andrew P.; Hill, Michael A.			Large Conductance Ca2+-Activated K+ Channel (BKCa) alpha-Subunit Splice Variants in Resistance Arteries from Rat Cerebral and Skeletal Muscle Vasculature	PLOS ONE			English	Article							ACTIVATED POTASSIUM CHANNELS; SURFACE EXPRESSION; SMOOTH-MUSCLE; MEMBRANE TRAFFICKING; CALCIUM; VOLTAGE; SENSITIVITY; MODULATION; CLONING; BRAIN	Previous studies report functional differences in large conductance Ca2+ activated-K+ channels (BKCa) of smooth muscle cells (VSMC) from rat cerebral and cremaster muscle resistance arteries. The present studies aimed to determine if this complexity in BKCa activity may, in part, be due to splice variants in the pore-forming alpha-subunit. BKCa variants in the intracellular C terminus of the alpha-subunit, and their relative expression to total alpha-subunit, were examined by qPCR. Sequencing of RT-PCR products showed two alpha-subunit variants, ZERO and STREX, to be identical in cremaster and cerebral arteries. Levels of STREX mRNA expression were, however, significantly higher in cremaster VSMCs (28.9 +/- 4.2% of total alpha-BKCa) compared with cerebral vessels (16.5 +/- 0.9%). Further, a low level of BKCa SS4 alpha-subunit variant was seen in cerebral arteries, while undetectable in cremaster arteries. Protein biotinylation assays, in expression systems and arterial preparations, were used to determine whether differences in splice variant mRNA expression affect surface membrane/cytosolic location of the channel. In AD-293 and CHO-K1 cells, rat STREX was more likely to be located at the plasma membrane compared to ZERO, although the great majority of channel protein was in the membrane in both cases. Co-expression of beta 1-BKCa subunit with STREX or ZERO did not influence the dominant membrane expression of alpha-BKCa subunits, whereas in the absence of alpha-BKCa, a significant proportion of beta 1-subunit remained cytosolic. Biotinylation assays of cremaster and cerebral arteries showed that differences in STREX/ZERO expression do not alter membrane/cytosolic distribution of the channel under basal conditions. These data, however, revealed that the amount of alpha-BKCa in cerebral arteries is approximately 20X higher than in cremaster vessels. Thus, the data support the major functional differences in BKCa activity in cremaster, as compared to cerebral VSMCs, being related to total alpha-BKCa expression, regardless of differences in splice variant expression.	[Nourian, Zahra; Li, Min; Hill, Michael A.] Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA; [Hill, Michael A.] Univ Missouri, Dept Med Pharmacol & Physiol, Columbia, MO USA; [Leo, M. Dennis; Jaggar, Jonathan H.] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Braun, Andrew P.] Univ Calgary, Dept Physiol & Pharmacol, Calgary, AB, Canada	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Tennessee System; University of Tennessee Health Science Center; University of Calgary	Hill, MA (corresponding author), Univ Missouri, Dalton Cardiovasc Res Ctr, Columbia, MO 65211 USA.	hillmi@missouri.edu	Hill, Michael/AAV-5350-2020	Hill, Michael/0000-0002-4455-2072	National Institutes of Health [RO1 HL092241, P01 HL095486]; Natural Sciences and Engineering Research Council of Canada [RGPIN/312240]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092241, P01HL095486, R01HL110347, R01HL067061] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by the National Institutes of Health (RO1 HL092241: Michael A. Hill and P01 HL095486: Gerald Meininger, P.I.) and the Natural Sciences and Engineering Research Council of Canada (RGPIN/312240: Andrew P. Braun). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bannister JP, 2009, CIRC RES, V105, P948, DOI 10.1161/CIRCRESAHA.109.203620; Bao L, 2005, J GEN PHYSIOL, V126, P393, DOI 10.1085/jgp.200509346; Brenner R, 2000, J BIOL CHEM, V275, P6453, DOI 10.1074/jbc.275.9.6453; Chen L, 2010, J BIOL CHEM, V285, P23263, DOI 10.1074/jbc.M110.139758; Chen LN, 2005, J BIOL CHEM, V280, P21418, DOI 10.1074/jbc.M413955200; Chiu YH, 2010, MOL PHARMACOL, V77, P497, DOI 10.1124/mol.109.061929; CHUNG SK, 1991, SCIENCE, V253, P560, DOI 10.1126/science.1857986; Clifford PS, 2011, ARTERIOSCL THROM VAS, V31, P2889, DOI 10.1161/ATVBAHA.111.236570; Crnich R, 2010, AM J PHYSIOL-CELL PH, V299, pC682, DOI 10.1152/ajpcell.00101.2010; Ha TS, 2000, EUR J BIOCHEM, V267, P910, DOI 10.1046/j.1432-1327.2000.01076.x; Hill MA, 2010, FEBS LETT, V584, P2033, DOI 10.1016/j.febslet.2010.02.045; Jackson WF, 1998, AM J PHYSIOL-HEART C, V274, pH27, DOI 10.1152/ajpheart.1998.274.1.H27; Jan LY, 1997, ANNU REV NEUROSCI, V20, P91, DOI 10.1146/annurev.neuro.20.1.91; Kim EY, 2007, NEUROSCIENCE, V146, P1652, DOI 10.1016/j.neuroscience.2007.03.038; Kim EY, 2007, J NEUROPHYSIOL, V97, P3508, DOI 10.1152/jn.00009.2007; LATORRE R, 1989, ANNU REV PHYSIOL, V51, P385, DOI 10.1146/annurev.ph.51.030189.002125; Ledoux J, 2006, PHYSIOLOGY, V21, P69, DOI 10.1152/physiol.00040.2005; Lee US, 2010, TRENDS NEUROSCI, V33, P415, DOI 10.1016/j.tins.2010.06.004; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald SHF, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-37; Mahmoud SF, 2002, J NEUROSCI METH, V115, P189, DOI 10.1016/S0165-0270(02)00015-8; MARTY A, 1981, NATURE, V291, P497, DOI 10.1038/291497a0; MEININGER GA, 1991, AM J PHYSIOL, V261, pH950, DOI 10.1152/ajpheart.1991.261.3.H950; Poulsen AN, 2011, PFLUG ARCH EUR J PHY, V461, P65, DOI 10.1007/s00424-010-0887-0; Poulsen AN, 2009, BBA-BIOMEMBRANES, V1788, P380, DOI 10.1016/j.bbamem.2008.10.001; REINHART PH, 1991, J NEUROSCI, V11, P1627; Rosati B, 2004, CIRC RES, V94, P874, DOI 10.1161/01.RES.0000124921.81025.1F; Sandow SL, 2009, AM J PHYSIOL-HEART C, V297, pH1, DOI 10.1152/ajpheart.00042.2009; Schubert R, 2001, TRENDS PHARMACOL SCI, V22, P505, DOI 10.1016/S0165-6147(00)01775-2; Shipston MJ, 2013, BIOCHEM SOC T, V41, P67, DOI 10.1042/BST20120226; Shipston MJ, 2001, TRENDS CELL BIOL, V11, P353, DOI 10.1016/S0962-8924(01)02068-2; Shipston MJ, 1999, MOL ENDOCRINOL, V13, P1728, DOI 10.1210/me.13.10.1728; Tian L, 2004, P NATL ACAD SCI USA, V101, P11897, DOI 10.1073/pnas.0402590101; Tian LJ, 2008, P NATL ACAD SCI USA, V105, P21006, DOI 10.1073/pnas.0806700106; Tian LJ, 2001, J PHYSIOL-LONDON, V537, P57, DOI 10.1111/j.1469-7793.2001.0057k.x; Tian LJ, 2001, J BIOL CHEM, V276, P7717, DOI 10.1074/jbc.C000741200; Toro B, 2006, NEUROSCIENCE, V142, P661, DOI 10.1016/j.neuroscience.2006.06.061; TSENGCRANK J, 1994, NEURON, V13, P1315, DOI 10.1016/0896-6273(94)90418-9; Wallner M, 1995, RECEPTOR CHANNEL, V3, P185; Wu RS, 2010, KIDNEY INT, V78, P963, DOI 10.1038/ki.2010.325; Wulf H, 2008, CELL TISSUE RES, V334, P359, DOI 10.1007/s00441-008-0701-x; Xie JY, 1998, SCIENCE, V280, P443, DOI 10.1126/science.280.5362.443; Yan JS, 2010, NATURE, V466, P513, DOI 10.1038/nature09162; Yang Y, 2013, J PHYSIOL-LONDON, V591, P1277, DOI 10.1113/jphysiol.2012.241562; Yang Y, 2009, J PHYSIOL-LONDON, V587, P3025, DOI 10.1113/jphysiol.2009.169920; Zarei MM, 2004, P NATL ACAD SCI USA, V101, P10072, DOI 10.1073/pnas.0302919101; Zarei MM, 2001, J BIOL CHEM, V276, P16232, DOI 10.1074/jbc.M008852200	47	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e98863	10.1371/journal.pone.0098863	http://dx.doi.org/10.1371/journal.pone.0098863			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24921651	Green Published, Green Submitted, gold			2022-12-27	WOS:000338701300019
J	Skobo, T; Benato, F; Grumati, P; Meneghetti, G; Cianfanelli, V; Castagnaro, S; Chrisam, M; Di Bartolomeo, S; Bonaldo, P; Cecconi, F; Dalla Valle, L				Skobo, Tatjana; Benato, Francesca; Grumati, Paolo; Meneghetti, Giacomo; Cianfanelli, Valentina; Castagnaro, Silvia; Chrisam, Martina; Di Bartolomeo, Sabrina; Bonaldo, Paolo; Cecconi, Francesco; Dalla Valle, Luisa			Zebrafish ambra1a and ambra1b Knockdown Impairs Skeletal Muscle Development	PLOS ONE			English	Article							EMBRYONIC-DEVELOPMENT; AUTOPHAGY; CELLS; MYOPATHIES; SLOW; MYOD	The essential role of autophagy in muscle homeostasis has been clearly demonstrated by phenotype analysis of mice with muscle-specific inactivation of genes encoding autophagy-related proteins. Ambra1 is a key component of the Beclin 1 complex and, in zebrafish, it is encoded by two paralogous genes, ambra1a and ambra1b, both required for normal embryogenesis and larval development. In this study we focused on the function of Ambra1, a positive regulator of the autophagic process, during skeletal muscle development by means of morpholino (MO)-mediated knockdown and compared the phenotype of zebrafish Ambra1-depleted embryos with that of Ambra1(gt/gt) mouse embryos. Morphological analysis of zebrafish morphant embryos revealed that silencing of ambra1 impairs locomotor activity and muscle development, as well as myoD1 expression. Skeletal muscles in ATG-morphant embryos displayed severe histopathological changes and contained only small areas of organized myofibrils that were widely dispersed throughout the cell. Double knockdown of ambra1a and ambra1b resulted in a more severe phenotype whereas defects were much less evident in splice-morphants. The morphants phenotypes were effectively rescued by co-injection with human AMBRA1 mRNA. Together, these results indicate that ambra1a and ambra1b are required for the correct development and morphogenesis of skeletal muscle.	[Skobo, Tatjana; Benato, Francesca; Meneghetti, Giacomo; Dalla Valle, Luisa] Univ Padua, Dept Biol, Padua, Italy; [Grumati, Paolo; Castagnaro, Silvia; Chrisam, Martina; Bonaldo, Paolo] Univ Padua, Dept Mol Med, Padua, Italy; [Cianfanelli, Valentina; Di Bartolomeo, Sabrina; Cecconi, Francesco] Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy; [Cecconi, Francesco] Santa Lucia Fdn, IRCCS, Dept Neurosci, Rome, Italy; [Cecconi, Francesco] Danish Canc Soc, Res Ctr, Unit Cell Stress & Survival, Copenhagen, Denmark	University of Padua; University of Padua; University of Rome Tor Vergata; IRCCS Santa Lucia; Danish Cancer Society	Cecconi, F (corresponding author), Univ Roma Tor Vergata, Dept Biol, I-00173 Rome, Italy.	francesco.cecconi@uniroma2.it; luisa.dallavalle@unipd.it	Grumati, Paolo/AAA-5787-2019; Di+Bartolomeo, Sabrina/AAB-9791-2019; Cecconi, Francesco/K-3969-2016; Cianfanelli, Valentina/AAA-2682-2020; Dalla Valle, Luisa/G-6721-2011	Cecconi, Francesco/0000-0002-5614-4359; Cianfanelli, Valentina/0000-0002-3857-9463; Dalla Valle, Luisa/0000-0001-8097-6369; DI BARTOLOMEO, Sabrina/0000-0002-5748-1541; Castagnaro, Silvia/0000-0003-4753-0597; Chrisam, Martina/0000-0002-5328-1737; Bonaldo, Paolo/0000-0002-9571-8140; Skobo, Tatjana/0000-0002-4868-5606	Telethon-Italy [GGP10225]; University of Padova; AIRC; FISM; Italian Ministry of University and Research; Italian Ministry of Health (Ricerca Finalizzata and Ricerca Corrente); Lundbeck Foundation [R165-2013-15982] Funding Source: researchfish	Telethon-Italy(Fondazione Telethon); University of Padova; AIRC(Fondazione AIRC per la ricerca sul cancro); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health (Ricerca Finalizzata and Ricerca Corrente); Lundbeck Foundation(Lundbeckfonden)	This work was financially supported by Telethon-Italy (Grant GGP10225) and by University of Padova (RFO-ex 60%). FC is also supported by AIRC (IG2010), FISM (2009), the Italian Ministry of University and Research (PRIN 2009 and FIRB Accordi di Programma 2011), the Italian Ministry of Health (Ricerca Finalizzata and Ricerca Corrente). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benato F, 2013, AUTOPHAGY, V9, P476, DOI 10.4161/auto.23278; Berger J, 2010, NEUROMUSCULAR DISORD, V20, P826, DOI 10.1016/j.nmd.2010.08.004; Blagden CS, 1997, GENE DEV, V11, P2163, DOI 10.1101/gad.11.17.2163; Carmignac V, 2011, HUM MOL GENET, V20, P4891, DOI 10.1093/hmg/ddr427; Choi JC, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003875; Coutelle O, 2001, DEV BIOL, V236, P136, DOI 10.1006/dbio.2001.0193; Cullup T, 2013, NAT GENET, V45, P83, DOI 10.1038/ng.2497; De Palma C, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.159; Devoto SH, 1996, DEVELOPMENT, V122, P3371; Di Bartolomeo S, 2010, J CELL BIOL, V191, P155, DOI 10.1083/jcb.201002100; Dolez M, 2011, DEVELOPMENT, V138, P97, DOI 10.1242/dev.053975; Du SJ, 1997, J CELL BIOL, V139, P145, DOI 10.1083/jcb.139.1.145; Ellis K, 2013, J CELL BIOL, V200, P667, DOI 10.1083/jcb.201212095; Fimia GM, 2013, ONCOGENE, V32, P3311, DOI 10.1038/onc.2012.455; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Gibbs EM, 2013, FEBS J, V280, P4187, DOI 10.1111/febs.12412; Grumati P, 2010, NAT MED, V16, P1313, DOI 10.1038/nm.2247; He CC, 2009, AUTOPHAGY, V5, P520, DOI 10.4161/auto.5.4.7768; Jackson HE, 2013, MECH DEVELOP, V130, P447, DOI 10.1016/j.mod.2013.06.001; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Masiero E, 2009, CELL METAB, V10, P507, DOI 10.1016/j.cmet.2009.10.008; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Nord H, 2013, J CELL SCI, V126, P1868, DOI 10.1242/jcs.119917; Ochi H, 2007, DEV GROWTH DIFFER, V49, P1, DOI 10.1111/j.1440-169x.2007.00905.x; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Raben N, 2008, HUM MOL GENET, V17, P3897, DOI 10.1093/hmg/ddn292; Ramos FJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003802; Sandri M, 2013, J CELL SCI, V126, P5325, DOI 10.1242/jcs.114041; Seger C, 2011, DEV DYNAM, V240, P2440, DOI 10.1002/dvdy.22745; Thisse C, 2008, NAT PROTOC, V3, P59, DOI 10.1038/nprot.2007.514; Vainshtein A, 2014, J MOL MED, V92, P127, DOI 10.1007/s00109-013-1096-z; Weinberg ES, 1996, DEVELOPMENT, V122, P271; Westerfield M., 1995, ZEBRAFISH BOOK GUIDE; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5	35	30	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99210	10.1371/journal.pone.0099210	http://dx.doi.org/10.1371/journal.pone.0099210			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922546	Green Published, gold, Green Submitted			2022-12-27	WOS:000338701300045
J	Maurer, F; Arcos, MAN; Bauer, P				Maurer, Felix; Arcos, Maria Augusta Naranjo; Bauer, Petra			Responses of a Triple Mutant Defective in Three Iron Deficiency-Induced BASIC HELIX-LOOP-HELIX Genes of the Subgroup Ib(2) to Iron Deficiency and Salicylic Acid	PLOS ONE			English	Article							TRANSCRIPTION FACTOR FAMILY; FERRIC-CHELATE REDUCTASE; ARABIDOPSIS-THALIANA; METAL HOMEOSTASIS; CIRCADIAN CLOCK; GENOME-WIDE; FACTOR FIT; PROTEIN; EXPRESSION; NICOTIANAMINE	Plants are sessile organisms that adapt to external stress by inducing molecular and physiological responses that serve to better cope with the adverse growth condition. Upon low supply of the micronutrient iron, plants actively increase the acquisition of soil iron into the root and its mobilization from internal stores. The subgroup Ib(2) BHLH genes function as regulators in this response, however their concrete functions are not fully understood. Here, we analyzed a triple loss of function mutant of BHLH39, BHLH100 and BHLH101 (3xbhlh mutant). We found that this mutant did not have any iron uptake phenotype if iron was provided. However, under iron deficiency the mutant displayed a more severe leaf chlorosis than the wild type. Microarray-based transcriptome analysis revealed that this mutant phenotype resulted in the mis-regulation of 198 genes, out of which only 15% were associated with iron deficiency regulation itself. A detailed analysis revealed potential targets of the bHLH transcription factors as well as genes reflecting an exaggerated iron deficiency response phenotype. Since the BHLH genes of this subgroup have been brought into the context of the plant hormone salicylic acid, we investigated whether the 3xbhlh mutant might have been affected by this plant signaling molecule. Although a very high number of genes responded to SA, also in a differential manner between mutant and wild type, we did not find any indication for an association of the BHLH gene functions in SA responses upon iron deficiency. In summary, our study indicates that the bHLH subgroup Ib(2) transcription factors do not only act in iron acquisition into roots but in other aspects of the adaptation to iron deficiency in roots and leaves.	[Maurer, Felix; Arcos, Maria Augusta Naranjo; Bauer, Petra] Univ Saarland, Dept Biosci Plant Biol, D-66123 Saarbrucken, Germany; [Arcos, Maria Augusta Naranjo; Bauer, Petra] Univ Dusseldorf, Inst Bot, Dusseldorf, Germany; [Arcos, Maria Augusta Naranjo; Bauer, Petra] Univ Dusseldorf, Cluster Excellence Plant Sci CEPLAS, Dusseldorf, Germany	Saarland University; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; University of Cologne	Bauer, P (corresponding author), Univ Saarland, Dept Biosci Plant Biol, D-66123 Saarbrucken, Germany.	petra.bauer@hhu.de			University of Saarland; Heinrich Heine University Dusseldorf; Deutsche Forschungsgemeinschaft [DFG-Ba1610/5-1]	University of Saarland; Heinrich Heine University Dusseldorf; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work has been partly funded by the University of Saarland and the Heinrich Heine University Dusseldorf. Funding by the Deutsche Forschungsgemeinschaft grant No. DFG-Ba1610/5-1to PB is was provided. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bauer P, 2007, PLANT PHYSIOL BIOCH, V45, P260, DOI 10.1016/j.plaphy.2007.03.006; Bauer P, 2011, PLANT SIGNAL BEHAV, V6, P1669, DOI 10.4161/psb.6.11.17847; Baxter IR, 2008, P NATL ACAD SCI USA, V105, P12081, DOI 10.1073/pnas.0804175105; Brady SM, 2007, SCIENCE, V318, P801, DOI 10.1126/science.1146265; Buckhout TJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-147; Cao H, 1997, CELL, V88, P57, DOI 10.1016/S0092-8674(00)81858-9; Chen YY, 2013, PLANT PHYSIOL, V161, P1409, DOI 10.1104/pp.112.212068; Colangelo EP, 2004, PLANT CELL, V16, P3400, DOI 10.1105/tpc.104.024315; de Benoist B, 2008, WHO GLOBAL DATABASE; Dinneny JR, 2008, SCIENCE, V320, P942, DOI 10.1126/science.1153795; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI [10.1186/1471-2105-1110-1148, DOI 10.1186/1471-2105-1110-1148]; Eide D, 1996, P NATL ACAD SCI USA, V93, P5624, DOI 10.1073/pnas.93.11.5624; Ferrari S, 2003, PLANT J, V35, P193, DOI 10.1046/j.1365-313X.2003.01794.x; Garcia M, 2010, CINEASTE, V35, P61; Garcia MJ, 2011, PLANT PHYSIOL BIOCH, V49, P537, DOI 10.1016/j.plaphy.2011.01.019; Heim MA, 2003, MOL BIOL EVOL, V20, P735, DOI 10.1093/molbev/msg088; Hong S, 2013, PLANT PHYSIOL, V161, P893, DOI 10.1104/pp.112.208603; Ivanov R, 2012, MOL PLANT, V5, P27, DOI 10.1093/mp/ssr065; Jakoby M, 2004, FEBS LETT, V577, P528, DOI 10.1016/j.febslet.2004.10.062; Kang HG, 2003, PLANT J, V35, P362, DOI 10.1046/j.1365-313X.2003.01812.x; Klatte M, 2009, PLANT PHYSIOL, V150, P257, DOI 10.1104/pp.109.136374; Klatte Marco, 2009, V479, P61, DOI 10.1007/978-1-59745-289-2_4; Koen E, 2013, PLANT SCI, V209, P1, DOI 10.1016/j.plantsci.2013.04.006; Lanquar V, 2005, EMBO J, V24, P4041, DOI 10.1038/sj.emboj.7600864; Li XX, 2006, PLANT PHYSIOL, V141, P1167, DOI 10.1104/pp.106.080580; Lingam S, 2011, PLANT CELL, V23, P1815, DOI 10.1105/tpc.111.084715; Long TA, 2010, PLANT CELL, V22, P2219, DOI 10.1105/tpc.110.074096; Maurer F, 2011, PLANT PHYSIOL BIOCH, V49, P530, DOI 10.1016/j.plaphy.2011.01.025; Meiser J, 2011, PLANT PHYSIOL, V157, P2154, DOI 10.1104/pp.111.183285; Mukherjee I, 2006, PLANTA, V223, P1178, DOI 10.1007/s00425-005-0165-0; Obayashi T, 2007, NUCLEIC ACIDS RES, V35, pD863, DOI 10.1093/nar/gkl783; Palmer CM, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003953; Peiffer GA, 2012, PLANT PHYSIOL, V158, P1745, DOI 10.1104/pp.111.189860; Pires N, 2010, MOL BIOL EVOL, V27, P862, DOI 10.1093/molbev/msp288; Robinson NJ, 1999, NATURE, V397, P694, DOI 10.1038/17800; Salome PA, 2013, EMBO J, V32, P511, DOI 10.1038/emboj.2012.330; Schuler M, 2012, PLANT CELL, V24, P2380, DOI 10.1105/tpc.112.099077; Schuler M, 2011, BMC PLANT BIOL, V11, DOI 10.1186/1471-2229-11-87; Sivitz A, 2011, PLANT J, V66, P1044, DOI 10.1111/j.1365-313X.2011.04565.x; Sivitz AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044843; Stacey MG, 2008, PLANT PHYSIOL, V146, P589, DOI 10.1104/pp.107.108183; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Uauy C, 2006, SCIENCE, V314, P1298, DOI 10.1126/science.1133649; Vert G, 2002, PLANT CELL, V14, P1223, DOI 10.1105/tpc.001388; Vicente MRS, 2011, J EXP BOT, V62, P3321, DOI 10.1093/jxb/err031; Wang HY, 2007, PLANTA, V226, P773, DOI 10.1007/s00425-007-0524-0; Wang N, 2013, MOL PLANT, V6, P503, DOI 10.1093/mp/sss089; Yang TJW, 2010, PLANT PHYSIOL, V152, P2130, DOI 10.1104/pp.109.152728; Yuan YX, 2008, CELL RES, V18, P385, DOI 10.1038/cr.2008.26; Yuan YX, 2005, CELL RES, V15, P613, DOI 10.1038/sj.cr.7290331; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	51	31	31	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99234	10.1371/journal.pone.0099234	http://dx.doi.org/10.1371/journal.pone.0099234			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919188	gold, Green Published, Green Submitted			2022-12-27	WOS:000338631000064
J	Schyns, JF; Hoekstra, AY				Schyns, Joep F.; Hoekstra, Arjen Y.			The Added Value of Water Footprint Assessment for National Water Policy: A Case Study for Morocco	PLOS ONE			English	Article							CONSUMPTION	A Water Footprint Assessment is carried out for Morocco, mapping the water footprint of different activities at river basin and monthly scale, distinguishing between surface- and groundwater. The paper aims to demonstrate the added value of detailed analysis of the human water footprint within a country and thorough assessment of the virtual water flows leaving and entering a country for formulating national water policy. Green, blue and grey water footprint estimates and virtual water flows are mainly derived from a previous grid-based (5x5 arc minute) global study for the period 1996-2005. These estimates are placed in the context of monthly natural runoff and waste assimilation capacity per river basin derived from Moroccan data sources. The study finds that: (i) evaporation from storage reservoirs is the second largest form of blue water consumption in Morocco, after irrigated crop production; (ii) Morocco's water and land resources are mainly used to produce relatively low-value (in US$/m(3) and US$/ha) crops such as cereals, olives and almonds; (iii) most of the virtual water export from Morocco relates to the export of products with a relatively low economic water productivity (in US$/m(3)); (iv) blue water scarcity on a monthly scale is severe in all river basins and pressure on groundwater resources by abstractions and nitrate pollution is considerable in most basins; (v) the estimated potential water savings by partial relocation of crops to basins where they consume less water and by reducing water footprints of crops down to benchmark levels are significant compared to demand reducing and supply increasing measures considered in Morocco's national water strategy.	[Schyns, Joep F.; Hoekstra, Arjen Y.] Univ Twente, Twente Water Ctr, NL-7500 AE Enschede, Netherlands	University of Twente	Schyns, JF (corresponding author), Univ Twente, Twente Water Ctr, POB 217, NL-7500 AE Enschede, Netherlands.	j.f.schyns@utwente.nl	Schyns, Joep/N-3675-2019; Schyns, Joep F/H-8559-2014; Hoekstra, Arjen Y./B-4980-2008	Schyns, Joep/0000-0001-5058-353X; Schyns, Joep F/0000-0001-5058-353X; Hoekstra, Arjen Y./0000-0002-4769-5239	Deltares; Institute for Innovation and Governance Studies (IGS) of the University of Twente	Deltares; Institute for Innovation and Governance Studies (IGS) of the University of Twente	The research was funded by Deltares (http://www.deltares.nl/en). Karen Meijer (Deltares) had a role in study design. Wil van der Krogt (Deltares) had a role in data collection. The writing stage of the manuscript was funded by the Institute for Innovation and Governance Studies (IGS) of the University of Twente (http://www.utwente.nl/Igs/). The funders had no role in data analysis, decision to publish, or preparation of the manuscript.	Al-Taiee TM, 2012, IHP 7 SERIES GROUNDW, V4, P35; Aldaya M. M., 2010, WATER POLICY SPAIN, p[49, 59]; Aldaya MM, 2010, WATER RESOUR MANAG, V24, P941, DOI 10.1007/s11269-009-9480-8; [Anonymous], 2010, GREEN BLUE GREY WATE; Chahed J, 2011, VALUE WATER RES REPO, V54, P99; Chapagain A.K, 2008, GLOBALIZATION WATER; FAO, 2013, GLOB MAP MONTHL REF; FAO, 2013, AQUASTAT ONL DAT COU; FAO, 2013, FAOSTAT ONL DAT; FAO, 2013, AQUASTAT ONL DAT GEO; Finigue A., 2017, G OGRAPHIE; Hoekstra A., 2003, VALUE WATER RES REPO, V12; Hoekstra AY, 2007, WATER RESOUR MANAG, V21, P35, DOI 10.1007/s11269-006-9039-x; Hoekstra A.Y., 2011, WATER FOOTPRINT ASSE, DOI DOI 10.1080/0969160X.2011.593864; Hoekstra AY, 2007, ECOL ECON, V64, P143, DOI 10.1016/j.ecolecon.2007.02.023; Hoekstra AY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032688; Hoekstra AY, 2012, P NATL ACAD SCI USA, V109, P3232, DOI 10.1073/pnas.1109936109; Hoekstra AY., 2013, WATER FOOTPRINT MODE; Hoff H, 2010, J HYDROL, V384, P177, DOI 10.1016/j.jhydrol.2009.06.026; ITC, 2007, SITA VERS 1996 2005; Laouina A, 2001, INTERDEPENDENCY AGR, V2001, P17; Mekonnen MM, 2010, HYDROL EARTH SYST SC, V14, P1259, DOI 10.5194/hess-14-1259-2010; Mekonnen M. M., 2011, VALUE WATER RES REPO, V50; Ministry EMWE, 2012, EAUX SOUT; Ministry EMWE, 2011, STRAT NAT EAU; Riad S., 2003, THESIS; Rockstrom J, 2009, WATER RESOUR RES, V45, DOI 10.1029/2007WR006767; Schuol J, 2008, WATER RESOUR RES, V44, DOI 10.1029/2007WR006609; Tekken V, 2012, WATER-SUI, V4, P959, DOI 10.3390/w4040959; Weiland FCS, 2010, HYDROL EARTH SYST SC, V14, P1595, DOI 10.5194/hess-14-1595-2010	30	98	102	4	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 11	2014	9	6							e99705	10.1371/journal.pone.0099705	http://dx.doi.org/10.1371/journal.pone.0099705			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK7TQ	24919194	Green Published, Green Submitted, gold			2022-12-27	WOS:000338631000106
J	Zhou, YX; Yu, F; Duong, T				Zhou, Yongxia; Yu, Fang; Duong, Timothy			Multiparametric MRI Characterization and Prediction in Autism Spectrum Disorder Using Graph Theory and Machine Learning	PLOS ONE			English	Article							INFERIOR FRONTAL GYRUS; FUNCTIONAL CONNECTIVITY; CORTICAL THICKNESS; FEATURE-SELECTION; BRAIN; CHILDREN; CORTEX; PERFORMANCE; NETWORKS; MIND	This study employed graph theory and machine learning analysis of multiparametric MRI data to improve characterization and prediction in autism spectrum disorders (ASD). Data from 127 children with ASD (13.5 +/- 6.0 years) and 153 age- and gender-matched typically developing children (14.5 +/- 5.7 years) were selected from the multi-center Functional Connectome Project. Regional gray matter volume and cortical thickness increased, whereas white matter volume decreased in ASD compared to controls. Small-world network analysis of quantitative MRI data demonstrated decreased global efficiency based on gray matter cortical thickness but not with functional connectivity MRI (fcMRI) or volumetry. An integrative model of 22 quantitative imaging features was used for classification and prediction of phenotypic features that included the autism diagnostic observation schedule, the revised autism diagnostic interview, and intelligence quotient scores. Among the 22 imaging features, four (caudate volume, caudate-cortical functional connectivity and inferior frontal gyrus functional connectivity) were found to be highly informative, markedly improving classification and prediction accuracy when compared with the single imaging features. This approach could potentially serve as a biomarker in prognosis, diagnosis, and monitoring disease progression.	[Zhou, Yongxia] Univ Penn, Dept Radiol, Philadelphia, PA 19104 USA; [Yu, Fang; Duong, Timothy] Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, South Texas Vet Hlth Care Syst, Dept Vet Affairs,Dept Ophthalmol, San Antonio, TX 78229 USA	University of Pennsylvania; University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Duong, T (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Res Imaging Inst, South Texas Vet Hlth Care Syst, Dept Vet Affairs,Dept Ophthalmol, San Antonio, TX 78229 USA.	duongt@uthscsa.edu	Yu, Fang/AAO-9407-2020; Duong, Tim/AAL-8357-2021	Duong, Tim/0000-0001-6403-2827; Zhou, Yongxia (Sharon)/0000-0002-4931-2318; O'Neill, Christopher/0000-0003-4003-8727	NINDS NIH HHS [R01 NS039135] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS039135] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Anderson JS, 2011, CEREB CORTEX, V21, P1134, DOI 10.1093/cercor/bhq190; Assaf M, 2010, NEUROIMAGE, V53, P247, DOI 10.1016/j.neuroimage.2010.05.067; Bastiaansen JA, 2011, BIOL PSYCHIAT, V69, P832, DOI 10.1016/j.biopsych.2010.11.007; Buitelaar JK, 1999, J CHILD PSYCHOL PSYC, V40, P869, DOI 10.1111/1469-7610.00505; Dapretto M, 2006, NAT NEUROSCI, V9, P28, DOI 10.1038/nn1611; Di Martino A, 2014, Mol Psychiatry, V19, P659, DOI 10.1038/mp.2013.78; Di Martino A, 2011, BIOL PSYCHIAT, V69, P847, DOI 10.1016/j.biopsych.2010.10.029; Di Martino A, 2009, BIOL PSYCHIAT, V65, P63, DOI 10.1016/j.biopsych.2008.09.022; Duchesnay E, 2011, NEUROIMAGE, V57, P1003, DOI 10.1016/j.neuroimage.2011.05.011; Ebisch SJH, 2011, HUM BRAIN MAPP, V32, P1013, DOI 10.1002/hbm.21085; Ecker C, 2013, JAMA PSYCHIAT, V70, P59, DOI 10.1001/jamapsychiatry.2013.265; Ecker C, 2009, NEUROREPORT, V20, P1155, DOI 10.1097/WNR.0b013e32832ec181; Elliott MA, 1999, MAGN RESON MED, V41, P450, DOI 10.1002/(SICI)1522-2594(199903)41:3<450::AID-MRM4>3.0.CO;2-9; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fletcher PT, 2010, NEUROIMAGE, V51, P1117, DOI 10.1016/j.neuroimage.2010.01.083; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Frith U, 2001, NEURON, V32, P969, DOI 10.1016/S0896-6273(01)00552-9; Gagliardi F, 2011, ARTIF INTELL MED, V52, P123, DOI 10.1016/j.artmed.2011.04.002; Gallese V, 2013, DEV MED CHILD NEUROL, V55, P15, DOI 10.1111/j.1469-8749.2012.04398.x; Geva S, 2011, BRAIN, V134, P3071, DOI 10.1093/brain/awr232; Hamilton AFD, 2013, DEV COGN NEUROS-NETH, V3, P91, DOI 10.1016/j.dcn.2012.09.008; Hardan AY, 2006, AM J PSYCHIAT, V163, P1290, DOI 10.1176/appi.ajp.163.7.1290; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Hsieh L, 2001, BRAIN LANG, V76, P227, DOI 10.1006/brln.2000.2382; Huang Y Y, 1983, Sheng Li Ke Xue Jin Zhan, V14, P356; Hui W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045502; Jakab A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060982; Kang S, 2013, RES DEV DISABIL, V34, P739, DOI 10.1016/j.ridd.2012.10.007; Kennedy DP, 2006, P NATL ACAD SCI USA, V103, P8275, DOI 10.1073/pnas.0600674103; Khan S, 2013, P NATL ACAD SCI USA, V110, P3107, DOI 10.1073/pnas.1214533110; Lange N, 2010, AUTISM RES, V3, P350, DOI 10.1002/aur.162; Langen M, 2007, BIOL PSYCHIAT, V62, P262, DOI 10.1016/j.biopsych.2006.09.040; Langen M, 2009, BIOL PSYCHIAT, V66, P327, DOI 10.1016/j.biopsych.2009.03.017; Lee PS, 2009, CEREB CORTEX, V19, P1787, DOI 10.1093/cercor/bhn209; Nixon P, 2004, J COGNITIVE NEUROSCI, V16, P289, DOI 10.1162/089892904322984571; Peng HC, 2005, IEEE T PATTERN ANAL, V27, P1226, DOI 10.1109/TPAMI.2005.159; Peters JM, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-54; Rapin I, 2008, PEDIATR CLIN N AM, V55, P1129, DOI 10.1016/j.pcl.2008.07.005; Rizzolatti G, 2010, EXP BRAIN RES, V200, P223, DOI 10.1007/s00221-009-2002-3; Rudie JD, 2012, CEREB CORTEX, V22, P1025, DOI 10.1093/cercor/bhr171; Sahyoun CP, 2010, NEUROPSYCHOLOGIA, V48, P86, DOI 10.1016/j.neuropsychologia.2009.08.013; Sivaswamy L, 2010, J CHILD NEUROL, V25, P1223, DOI 10.1177/0883073809358765; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Stark DE, 2008, J NEUROSCI, V28, P13754, DOI 10.1523/JNEUROSCI.4544-08.2008; Travers BG, 2012, AUTISM RES, V5, P289, DOI 10.1002/aur.1243; Turner Katherine C, 2006, Behav Brain Funct, V2, P34, DOI 10.1186/1744-9081-2-34; Uddin Lucina Q, 2013, Front Hum Neurosci, V7, P458, DOI 10.3389/fnhum.2013.00458; van der Zande FHR, 2005, NEURORADIOLOGY, V47, P114, DOI 10.1007/s00234-004-1274-3; Villalobos ME, 2005, NEUROIMAGE, V25, P916, DOI 10.1016/j.neuroimage.2004.12.022; Vissers ME, 2012, NEUROSCI BIOBEHAV R, V36, P604, DOI 10.1016/j.neubiorev.2011.09.003; Walsh CA, 2008, CELL, V135, P396, DOI 10.1016/j.cell.2008.10.015; Zhou Y, 2013, AM J NEURORADIOL, V34, P1180, DOI 10.3174/ajnr.A3386; Zhou Yongxia, 2013, ISRN Geriatr, V2013; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310	56	78	78	1	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e90405	10.1371/journal.pone.0090405	http://dx.doi.org/10.1371/journal.pone.0090405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	25051234	gold, Green Published, Green Submitted			2022-12-27	WOS:000338701300001
J	Crichton, GE; Elias, MF; Davey, A; Alkerwi, A				Crichton, Georgina E.; Elias, Merrill F.; Davey, Adam; Alkerwi, Ala'a			Cardiovascular Health and Cognitive Function: The Maine-Syracuse Longitudinal Study	PLOS ONE			English	Article							BLOOD-PRESSURE; RISK SCORE; SERUM-CHOLESTEROL; PHYSICAL-ACTIVITY; SEDENTARY TIME; DEMENTIA RISK; HEART-DISEASE; DIET QUALITY; PERFORMANCE; MORTALITY	Background: Smoking, physical inactivity, and poor diet, along with obesity, fasting glucose and blood pressure have been independently associated with poorer cognitive performance. Few studies have related scales representing a combination of these variables to multiple domains of cognitive performance. The aim of this study was to investigate the association between overall cardiovascular health, incorporating seven components, and cognitive function. Methods: A cross-sectional analysis employing 972 participants, from the Maine-Syracuse Longitudinal Study was undertaken. Four health behaviors (body mass index, physical activity, diet, smoking) and three health factors (total cholesterol, blood pressure, and fasting plasma glucose) were measured. Each was categorized according to the American Heart Association definitions for ideal cardiovascular health, except diet, for which two food scores were calculated. A Cardiovascular Health Score was determined by summing the number of cardiovascular metrics at ideal levels. Cognitive function was assessed using a thorough neuropsychological test battery. Results: Cardiovascular Health Score was positively associated with seven out of eight measures of cognitive function, with adjustment for age, education, and gender. With further adjustment for cardiovascular and psychological variables, these associations remained significant for Visual-Spatial Memory, Working Memory, Scanning and Tracking, Executive Function and the Global Composite score (p<0.05 for all). Ideal levels of a number of health factors and behaviors were positively associated with global cognitive performance. Conclusion: Increasing cardiovascular health, indexed by a higher number of metrics at ideal levels, is associated with greater cognitive performance. Smoking, physical activity, and diet are important components of cardiovascular health that impact upon cognition.	[Crichton, Georgina E.] Univ S Australia, Nutr Physiol Res Ctr, Adelaide, SA 5001, Australia; [Crichton, Georgina E.; Alkerwi, Ala'a] Ctr Etud Sante, Ctr Rech Publ Sante, Strassen, Luxembourg; [Elias, Merrill F.] Univ Maine, Dept Psychol, Orono, ME 04469 USA; [Elias, Merrill F.] Univ Maine, Grad Sch Biomed Sci & Engn, Orono, ME USA; [Davey, Adam] Temple Univ, Dept Publ Hlth, Philadelphia, PA 19122 USA	University of South Australia; Luxembourg Institute of Health; University of Maine System; University of Maine Orono; University of Maine System; University of Maine Orono; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Crichton, GE (corresponding author), Univ S Australia, Nutr Physiol Res Ctr, Adelaide, SA 5001, Australia.	whige003@mymail.unisa.edu.au		Alkerwi, Ala'a/0000-0002-7448-3936	National Heart, Lung and Blood Institute, National Institutes of Health (USA) [R01HL067358, R01HL081290]; National Institute on Aging, National Institutes of Health (USA) [R01AG03055]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067358, R01HL081290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG003055] Funding Source: NIH RePORTER	National Heart, Lung and Blood Institute, National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging, National Institutes of Health (USA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Maine Syracuse Longitudinal Study was supported by grants R01HL067358, and R01HL081290 from the National Heart, Lung and Blood Institute, National Institutes of Health (USA), and research grant R01AG03055 from the National Institute on Aging, National Institutes of Health (USA). GC is a National Health and Medical Research Council (NHMRC) Sidney Sax Research Fellow (GNT1054567) (Australia). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AINSWORTH BE, 1993, MED SCI SPORT EXER, V25, P71, DOI 10.1249/00005768-199301000-00011; Ambrose JA, 2004, J AM COLL CARDIOL, V43, P1731, DOI 10.1016/j.jacc.2003.12.047; Appel LJ, 2012, CIRCULATION, V125, P973, DOI 10.1161/CIRCULATIONAHA.111.088542; Baik I, 2013, EUR J CLIN NUTR, V67, P25, DOI 10.1038/ejcn.2012.175; Bambs C, 2011, CIRCULATION, V123, P850, DOI 10.1161/CIRCULATIONAHA.110.980151; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Conroy RM, 2003, EUR HEART J, V24, P987, DOI 10.1016/S0195-668X(03)00114-3; Crawford AG, 2010, POPUL HEALTH MANAG, V13, P151, DOI 10.1089/pop.2009.0039; D'Agostino RB, 2008, CIRCULATION, V118, pE86, DOI 10.1161/CIRCULATIONAHA.108.190154; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Dore GA, 2008, ANN BEHAV MED, V35, P341, DOI 10.1007/s12160-008-9038-7; Edwardson CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034916; Elias MF, 2007, HYPERTENSION, V49, P439, DOI 10.1161/01.HYP.0000256361.68158.24; Elias Merrill F, 2005, Neurobiol Aging, V26 Suppl 1, P11, DOI 10.1016/j.neurobiolaging.2005.08.019; Elias MF, 2006, PSYCHOSOM MED, V68, P547, DOI 10.1097/01.psy.0000221380.92521.51; Elias MF, 2012, J ALZHEIMERS DIS, V30, pS113, DOI 10.3233/JAD-2011-111175; Elias MF, 2009, HYPERTENSION, V53, P668, DOI 10.1161/HYPERTENSIONAHA.108.126342; Elias MF, 2003, INT J OBESITY, V27, P260, DOI 10.1038/sj.ijo.802225; Elias MF, 2004, STROKE, V35, P404, DOI 10.1161/01.STR.0000103141.82869.77; Elias PK, 2005, PSYCHOSOM MED, V67, P24, DOI 10.1097/01.psy.0000151745.67285.c2; Elias PK, 1997, DIABETES CARE, V20, P1388, DOI 10.2337/diacare.20.9.1388; Folsom AR, 2011, J AM COLL CARDIOL, V57, P1690, DOI 10.1016/j.jacc.2010.11.041; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Ford ES, 2012, CIRCULATION, V125, P1955, DOI 10.1161/CIRCULATIONAHA.112.102327; Ford ES, 2012, CIRCULATION, V125, P987, DOI 10.1161/CIRCULATIONAHA.111.049122; Francis H, 2013, APPETITE, V63, P119, DOI 10.1016/j.appet.2012.12.018; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gunstad John, 2005, J Cardiopulm Rehabil, V25, P173, DOI 10.1097/00008483-200505000-00009; Healy GN, 2011, EUR HEART J, V32, P590, DOI 10.1093/eurheartj/ehq451; Hippisley-Cox J, 2007, BMJ-BRIT MED J, V335, P136, DOI 10.1136/bmj.39261.471806.55; Jaccard J, 2010, THEORY CONSTRUCTION; Kaffashian S, 2013, NEUROLOGY, V80, P1300, DOI 10.1212/WNL.0b013e31828ab370; Kaluza J, 2009, EUR J CLIN NUTR, V63, P451, DOI 10.1038/sj.ejcn.1602968; Kanoski SE, 2011, PHYSIOL BEHAV, V103, P59, DOI 10.1016/j.physbeh.2010.12.003; Kant AK, 2000, JAMA-J AM MED ASSOC, V283, P2109, DOI 10.1001/jama.283.16.2109; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Kroke A, 1999, AM J CLIN NUTR, V70, P439; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Lloyd-Jones DM, 2010, CIRCULATION, V121, P586, DOI 10.1161/CIRCULATIONAHA.109.192703; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Michels KB, 2002, INT J EPIDEMIOL, V31, P847, DOI 10.1093/ije/31.4.847; Middleton LE, 2009, ARCH NEUROL-CHICAGO, V66, P1210, DOI 10.1001/archneurol.2009.201; Muldoon MF, 1997, PSYCHOSOM MED, V59, P382, DOI 10.1097/00006842-199707000-00008; Muldoon MF, 2001, NEUROPSYCHOLOGY OF CARDIOVASCULAR DISEASE, P37; Office of the Surgeon General (US) Office on Smoking and Health (US), 2004, HLTH CONS SMOK REP S; Petretta M, 2012, EUR J NUCL MED MOL I, V39, P1959, DOI 10.1007/s00259-012-2254-1; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Reis JP, 2013, ANN NEUROL, V73, P170, DOI 10.1002/ana.23836; Robbins MA, 2005, PSYCHOSOM MED, V67, P707, DOI 10.1097/01.psy.0000171164.50990.80; Rovio S, 2005, LANCET NEUROL, V4, P705, DOI 10.1016/S1474-4422(05)70198-8; Sacco RL, 2011, CIRCULATION, V123, P2653, DOI 10.1161/CIR.0b013e318220dec1; SCHULTZ NR, 1979, J GERONTOL, V34, P246, DOI 10.1093/geronj/34.2.246; Singh-Manoux A, 2012, NEUROLOGY, V79, P755, DOI 10.1212/WNL.0b013e3182661f63; Tangney CC, 2011, AM J CLIN NUTR, V93, P601, DOI 10.3945/ajcn.110.007369; US Department of Agriculture & US Department of Health and Human Services, 2010, DIET GUID AM 2010; Waldstein S.R., 2001, NEUROPSYCHOLOGY CARD; WALDSTEIN SR, 1995, EXP AGING RES, V21, P321, DOI 10.1080/03610739508253989; Weiner H, 1976, PSYCHOL BULL, V2, P213; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Wilmot EG, 2012, DIABETOLOGIA, V55, P2895, DOI 10.1007/s00125-012-2677-z; WOLF AM, 1994, INT J EPIDEMIOL, V23, P991, DOI 10.1093/ije/23.5.991; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; World Health Organization and Alzheimers Disease International, 2012, DEM PUBL HLTH PRIOR; Wright CB, 2008, STROKE, V39, P800, DOI 10.1161/STROKEAHA.107.484147; Yaffe K, 2004, NEUROLOGY, V63, P658, DOI 10.1212/01.WNL.0000134666.64593.BA; Yang QH, 2012, JAMA-J AM MED ASSOC, V307, P1273, DOI 10.1001/jama.2012.339	67	70	71	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAR 3	2014	9	3							e89317	10.1371/journal.pone.0089317	http://dx.doi.org/10.1371/journal.pone.0089317			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AC4CT	24595096	gold, Green Accepted, Green Published, Green Submitted			2022-12-27	WOS:000332468900013
J	Zhao, YL; Wang, HM; Chen, W; Li, YH				Zhao, Yunlei; Wang, Hongmei; Chen, Wei; Li, Yunhai			Genetic Structure, Linkage Disequilibrium and Association Mapping of Verticillium Wilt Resistance in Elite Cotton (Gossypium hirsutum L.) Germplasm Population	PLOS ONE			English	Article							SIMPLE SEQUENCE REPEAT; QUANTITATIVE TRAIT LOCI; FIBER QUALITY; NUCLEOTIDE DIVERSITY; COMPUTER-PROGRAM; GENOME STRUCTURE; UPLAND COTTON; YIELD; QTL; SSR	Understanding the population structure and linkage disequilibrium in an association panel can effectively avoid spurious associations and improve the accuracy in association mapping. In this study, one hundred and fifty eight elite cotton (Gossypium hirsutum L.) germplasm from all over the world, which were genotyped with 212 whole genome-wide marker loci and phenotyped with an disease nursery and greenhouse screening method, were assayed for population structure, linkage disequilibrium, and association mapping of Verticillium wilt resistance. A total of 480 alleles ranging from 2 to 4 per locus were identified from all collections. Model-based analysis identified two groups (G1 and G2) and seven subgroups (G1a-c, G2a-d), and differentiation analysis showed that subgroup having a single origin or pedigree was apt to differentiate with those having a mixed origin. Only 8.12% linked marker pairs showed significant LD (P<0.001) in this association panel. The LD level for linked markers is significantly higher than that for unlinked markers, suggesting that physical linkage strongly influences LD in this panel, and LD level was elevated when the panel was classified into groups and subgroups. The LD decay analysis for several chromosomes showed that different chromosomes showed a notable change in LD decay distances for the same gene pool. Based on the disease nursery and greenhouse environment, 42 marker loci associated with Verticillium wilt resistance were identified through association mapping, which widely were distributed among 15 chromosomes. Among which 10 marker loci were found to be consistent with previously identified QTLs and 32 were new unreported marker loci, and QTL clusters for Verticillium wilt resistanc on Chr.16 were also proved in our study, which was consistent with the strong linkage in this chromosome. Our results would contribute to association mapping and supply the marker candidates for marker-assisted selection of Verticillium wilt resistance in cotton.	[Zhao, Yunlei; Wang, Hongmei; Chen, Wei; Li, Yunhai] Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS	Wang, HM (corresponding author), Chinese Acad Agr Sci, Inst Cotton Res, State Key Lab Cotton Biol, Anyang, Peoples R China.	wanghm@cricaas.com.cn		Liang, Peng/0000-0001-8485-1694; Liu, Jin/0000-0002-2026-2513	National Natural Science Foundation of China [31000733]; National Hi-Tech Research and Development Program of China [2012AA101108-02-02]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Hi-Tech Research and Development Program of China(National High Technology Research and Development Program of China)	This research was supported by the National Natural Science Foundation of China (Grant No. 31000733) and by the National Hi-Tech Research and Development Program of China (Grant No. 2012AA101108-02-02). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdurakhmonov IY, 2009, GENETICA, V136, P401, DOI 10.1007/s10709-008-9337-8; Abdurakhmonov IY, 2008, MOL DIVERSITY ASS MA; [Anonymous], GENOMICS, V92, P478; Bolek Y, 2005, PLANT SCI, V168, P1581, DOI 10.1016/j.plantsci.2005.02.008; Bradbury PJ, 2007, BIOINFORMATICS, V23, P2633, DOI 10.1093/bioinformatics/btm308; Caldwell KS, 2006, GENETICS, V172, P557, DOI 10.1534/genetics.104.038489; Chen Guang, 2006, Acta Genetica Sinica, V33, P733, DOI 10.1016/S0379-4172(06)60106-6; Chen ZJ, 2007, PLANT PHYSIOL, V145, P1303, DOI 10.1104/pp.107.107672; Bertini CHCD, 2006, GENET MOL BIOL, V29, P321, DOI 10.1590/S1415-47572006000200021; Ersoz E.S., 2007, GENOMICS ASSISTED CR, P97, DOI DOI 10.1007/978-1-4020-6295-7_5; Esbroeck G. van., 1998, Journal of Cotton Science, V2, P121; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Falush D, 2003, GENETICS, V164, P1567; Flint-Garcia SA, 2003, ANNU REV PLANT BIOL, V54, P357, DOI 10.1146/annurev.arplant.54.031902.134907; Guo WZ, 2007, GENETICS, V176, P527, DOI 10.1534/genetics.107.070375; Ha C, 2011, PLOS ONE, V6; Hardy OJ, 2002, MOL ECOL NOTES, V2, P618, DOI 10.1046/j.1471-8286.2002.00305.x; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; He DH, 2005, EUPHYTICA, V144, P141, DOI 10.1007/s10681-005-5297-6; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Iqbal MJ, 2001, THEOR APPL GENET, V103, P547, DOI 10.1007/PL00002908; Jiang F, 2009, SCI CHINA SER C, V52, P872, DOI 10.1007/s11427-009-0110-8; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Lacape JM, 2007, MOL BREEDING, V19, P45, DOI 10.1007/s11032-006-9042-1; Lacape JM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-132; Lacape JM, 2009, THEOR APPL GENET, V119, P281, DOI 10.1007/s00122-009-1037-y; Lam HM, 2010, NAT GENET, V42, P1053, DOI 10.1038/ng.715; Lijavetzky D, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-424; Liu AZ, 2006, GENETICS, V173, P321, DOI 10.1534/genetics.105.051110; Liu KJ, 2005, BIOINFORMATICS, V21, P2128, DOI 10.1093/bioinformatics/bti282; Liu S, 2000, CROP SCI, V40, P1459, DOI 10.2135/cropsci2000.4051459x; Ma XX, 2008, J INTEGR PLANT BIOL, V50, P491, DOI 10.1111/j.1744-7909.2008.00636.x; McNally KL, 2009, P NATL ACAD SCI USA, V106, P12273, DOI 10.1073/pnas.0900992106; Moiana L. D., 2012, African Journal of Biotechnology, V11, P11640; Morrell PL, 2005, P NATL ACAD SCI USA, V102, P2442, DOI 10.1073/pnas.0409804102; Nordborg M, 2002, NAT GENET, V30, P190, DOI 10.1038/ng813; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Pritchard JK, 2000, GENETICS, V155, P945; Qin HD, 2008, THEOR APPL GENET, V117, P883, DOI 10.1007/s00122-008-0828-x; Rungis D, 2005, AUST J AGR RES, V56, P301, DOI 10.1071/AR04190; Schneider S, 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Song BH, 2009, GENETICS, V181, P1021, DOI 10.1534/genetics.108.095364; Stich B, 2005, THEOR APPL GENET, V111, P723, DOI 10.1007/s00122-005-2057-x; Wang Baohua, 2007, Journal of Genetics and Genomics, V34, P35, DOI 10.1016/S1673-8527(07)60005-8; WANG HM, 2007, J INTE PL BIO, V50, P174; Wang HM, 2008, J INTEGR PLANT BIOL, V50, P174, DOI 10.1111/j.1744-7909.2007.00612.x; Whitt Sr, 2003, METH MOL B, V236, P123; Yan JB, 2010, NAT GENET, V42, P322, DOI 10.1038/ng.551; Yan JB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008451; Yang C, 2008, PLANT SCI, V174, P290, DOI 10.1016/j.plantsci.2007.11.016; Yu JW, 2007, J INTEGR PLANT BIOL, V49, P716, DOI 10.1111/j.1744-7909.2007.00459.x; Yu JW, 2013, THEOR APPL GENET, V126, P275, DOI 10.1007/s00122-012-1980-x; Yu JM, 2006, NAT GENET, V38, P203, DOI 10.1038/ng1702; Yu JZ, 2012, G3-GENES GENOM GENET, V2, P43, DOI 10.1534/g3.111.001552; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-15; Zhang J, 2007, WORLD COTT RES C 4 L, P1014; Zhang TZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057220; Zhang TZ, 2003, THEOR APPL GENET, V106, P262, DOI 10.1007/s00122-002-1101-3; Zhang XueYong, 2007, Agricultural Sciences in China, V6, P255, DOI 10.1016/S1671-2927(07)60043-1; Zhu CS, 2008, PLANT GENOME-US, V1, P5, DOI 10.3835/plantgenome2008.02.0089	61	101	119	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 23	2014	9	1							e86308	10.1371/journal.pone.0086308	http://dx.doi.org/10.1371/journal.pone.0086308			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	297XI	24466016	Green Submitted, Green Published, gold			2022-12-27	WOS:000330288000082
J	Zhang, XC; Zhu, XL; Wang, X; Zhu, XZ; Zhong, MT; Yi, JY; Rao, HY; Yao, SQ				Zhang, Xiaocui; Zhu, Xueling; Wang, Xiang; Zhu, Xiongzhao; Zhong, Mingtian; Yi, Jinyao; Rao, Hengyi; Yao, Shuqiao			First-Episode Medication-Naive Major Depressive Disorder Is Associated with Altered Resting Brain Function in the Affective Network	PLOS ONE			English	Article							VENTROMEDIAL PREFRONTAL CORTEX; POSITRON-EMISSION-TOMOGRAPHY; ORBITOFRONTAL CORTEX; SPONTANEOUS FLUCTUATIONS; TRYPTOPHAN DEPLETION; REGIONAL HOMOGENEITY; NEGATIVE AFFECT; DEFAULT MODE; STATE; CONNECTIVITY	Background: Major depressive disorder (MDD) has been associated with abnormal structure and function of the brain's affective network, including the amygdala and orbitofrontal cortex (OFC). However, it is unclear if alterations of resting-state function in this affective network are present at the initial onset of MDD. Aims: To examine resting-state function of the brain's affective network in first-episode, medication-naive patients with MDD compared to healthy controls (HCs). Methods: Resting-state functional magnetic resonance imaging (rs-fMRI) was performed on 32 first-episode, medication-naive young adult patients with MDD and 35 matched HCs. The amplitude of low-frequency fluctuations (ALFF) of the blood oxygen level-dependent (BOLD) signal and amygdala-seeded functional connectivity (FC) were investigated. Results: Compared to HC, MDD patients showed reduced ALFF in the bilateral OFC and increased ALFF in the bilateral temporal lobe extending to the insular and left fusiform cortices. Enhanced anti-correlation of activity between the left amygdala seed and the left OFC was found in MDD patients but not in HCs. Conclusions: Reduced ALFF in the OFC suggests hypo-functioning of emotion regulation in the affective network. Enhanced anti-correlation of activity between the amygdala and OFC may reflect dysfunction of the amygdala-OFC network and additionally represent a pathological process of MDD.	[Zhang, Xiaocui; Zhu, Xueling; Wang, Xiang; Zhu, Xiongzhao; Yi, Jinyao; Yao, Shuqiao] Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China; [Zhang, Xiaocui; Rao, Hengyi] Univ Penn, Ctr Funct Neuroimaging, Dept Neurol, Philadelphia, PA 19104 USA; [Zhong, Mingtian] S China Normal Univ, Sch Psychol, Guangzhou, Guangdong, Peoples R China; [Rao, Hengyi] Sun Yat Sen Univ, Dept Psychol, Guangzhou 510275, Guangdong, Peoples R China	Central South University; University of Pennsylvania; Pennsylvania Medicine; South China Normal University; Sun Yat Sen University	Yao, SQ (corresponding author), Cent S Univ, Xiangya Hosp 2, Inst Med Psychol, Changsha, Hunan, Peoples R China.	shuqiaoyao@163.com	Rao, Hengyi/K-5152-2019; Rao, Hengyi/AAQ-4919-2020; Rao, Hengyi/A-7064-2009; Zhong, Mingtian/AAA-3305-2022	Rao, Hengyi/0000-0003-2735-2500; Rao, Hengyi/0000-0003-2735-2500; 	National Natural Science Foundation of China [30670709, 81071104, 30700236, 81301211, 31070984]; China Scholarship Council	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Scholarship Council(China Scholarship Council)	This work was supported by the National Natural Science Foundation of China (Grant No. 30670709, 81071104 awarded to Shuqiao Yao, Grant No. 30700236 awarded to Xiang Wang, Grant No. 81301211 awarded to Xueling Zhu and Grant No. 31070984 awarded to Hengyi Rao). This work is partly supported by China Scholarship Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Psychiatric Association, 2000, DIAGN STAT MAN MENT; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; BIVER F, 1994, BIOL PSYCHIAT, V36, P381, DOI 10.1016/0006-3223(94)91213-0; Bremner JD, 2002, BIOL PSYCHIAT, V51, P273, DOI 10.1016/S0006-3223(01)01336-1; Bremner JD, 2003, JAMA-J AM MED ASSOC, V289, P3125, DOI 10.1001/jama.289.23.3125; Bremner JD, 1997, ARCH GEN PSYCHIAT, V54, P364; BROZOSKI TJ, 1979, SCIENCE, V205, P929, DOI 10.1126/science.112679; de Almeida JRC, 2009, BIOL PSYCHIAT, V66, P451, DOI 10.1016/j.biopsych.2009.03.024; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Dichter GS, 2009, SOC COGN AFFECT NEUR, V4, P59, DOI 10.1093/scan/nsn037; Dougherty DD, 2004, ARCH GEN PSYCHIAT, V61, P795, DOI 10.1001/archpsyc.61.8.795; DREVETS WC, 1992, J NEUROSCI, V12, P3628; DREVETS WC, 1995, J CEREB BLOOD FLOW M, V15, pS93; Fales CL, 2008, BIOL PSYCHIAT, V63, P377, DOI 10.1016/j.biopsych.2007.06.012; First M.B., 2016, STRUCTURED CLIN INTE; Fox MD, 2007, NAT REV NEUROSCI, V8, P700, DOI 10.1038/nrn2201; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; FRISTON KJ, 1993, J CEREBR BLOOD F MET, V13, P5, DOI 10.1038/jcbfm.1993.4; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; Galynker II, 1998, J NUCL MED, V39, P608; Gan ZY, 2011, J AFFECT DISORDERS, V134, P119, DOI 10.1016/j.jad.2011.05.054; Goncalves SI, 2006, NEUROIMAGE, V30, P203, DOI 10.1016/j.neuroimage.2005.09.062; Gottfried JA, 2003, SCIENCE, V301, P1104, DOI 10.1126/science.1087919; Grafman J, 1996, NEUROLOGY, V46, P1231, DOI 10.1212/WNL.46.5.1231; Guo WB, 2011, PROG NEURO-PSYCHOPH, V35, P1297, DOI 10.1016/j.pnpbp.2011.02.006; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Jiao Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025159; Johnstone T, 2007, J NEUROSCI, V27, P8877, DOI 10.1523/JNEUROSCI.2063-07.2007; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Lacerda ALT, 2004, BIOL PSYCHIAT, V55, P353, DOI 10.1016/j.biopsych.2003.08.021; Liu ZF, 2010, PSYCHIAT RES-NEUROIM, V182, P211, DOI 10.1016/j.pscychresns.2010.03.004; Lui S, 2010, ARCH GEN PSYCHIAT, V67, P783, DOI 10.1001/archgenpsychiatry.2010.84; Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1; Monkul ES, 2012, HUM BRAIN MAPP, V33, P272, DOI 10.1002/hbm.21212; Murray EA, 2007, ANN NY ACAD SCI, V1121, P273, DOI 10.1196/annals.1401.021; Nagafusa Y, 2012, J AFFECT DISORDERS, V140, P296, DOI 10.1016/j.jad.2012.03.026; Neumeister A, 2004, ARCH GEN PSYCHIAT, V61, P765, DOI 10.1001/archpsyc.61.8.765; Ochsner KN, 2004, NEUROIMAGE, V23, P483, DOI 10.1016/j.neuroimage.2004.06.030; Phan KL, 2005, BIOL PSYCHIAT, V57, P210, DOI 10.1016/j.biopsych.2004.10.030; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Price JL, 2007, ANN NY ACAD SCI, V1121, P54, DOI 10.1196/annals.1401.008; Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rajkowska G, 2000, BIOL PSYCHIAT, V48, P766, DOI 10.1016/S0006-3223(00)00950-1; Rajkowska G, 1999, BIOL PSYCHIAT, V45, P1085, DOI 10.1016/S0006-3223(99)00041-4; Rogers RD, 1999, NEUROPSYCHOPHARMACOL, V20, P322, DOI 10.1016/S0893-133X(98)00091-8; Rosenkranz JA, 2003, J NEUROSCI, V23, P11054; Salzman CD, 2010, ANNU REV NEUROSCI, V33, P173, DOI 10.1146/annurev.neuro.051508.135256; Scheuerecker J, 2010, J PSYCHIATR NEUROSCI, V35, P311, DOI 10.1503/jpn.090076; Shimamura AP, 2000, PSYCHOBIOLOGY, V28, P207; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Steingard RJ, 2000, BIOL PSYCHIAT, V48, P1053, DOI 10.1016/S0006-3223(00)00942-2; Tang Y, 2013, PSYCHOL MED, V43, P1921, DOI 10.1017/S0033291712002759; Tao H, 2013, MOL PSYCHIATR, V18, P101, DOI 10.1038/mp.2011.127; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Urry HL, 2006, J NEUROSCI, V26, P4415, DOI 10.1523/JNEUROSCI.3215-05.2006; Veer IM, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00041; Versace A, 2010, BIOL PSYCHIAT, V67, P422, DOI 10.1016/j.biopsych.2009.11.025; Victor TA, 2010, ARCH GEN PSYCHIAT, V67, P1128, DOI 10.1001/archgenpsychiatry.2010.144; Wang LH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039845, 10.1371/journal.pone.0051769, 10.1371/journal.pone.0045491, 10.1371/journal.pone.0044596]; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Wu QZ, 2011, HUM BRAIN MAPP, V32, P1290, DOI 10.1002/hbm.21108; Yang HJ, 2004, J AFFECT DISORDERS, V82, P419, DOI 10.1016/j.jad.2004.04.008; Zang YF, 2007, BRAIN DEV-JPN, V29, P83, DOI 10.1016/j.braindev.2006.07.002; Zeng LL, 2012, BRAIN, V135, P1498, DOI 10.1093/brain/aws059; Zhong MT, 2012, PSYCHIAT RES-NEUROIM, V201, P107, DOI 10.1016/j.pscychresns.2011.06.003; Zhu XL, 2012, BIOL PSYCHIAT, V71, P611, DOI 10.1016/j.biopsych.2011.10.035	69	206	219	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JAN 9	2014	9	1							e85241	10.1371/journal.pone.0085241	http://dx.doi.org/10.1371/journal.pone.0085241			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	291XP	24933024	Green Submitted, Green Published, gold			2022-12-27	WOS:000329866300057
J	Wu, CC; Tsai, TH; Chang, C; Lee, TT; Lin, C; Cheng, IHJ; Sun, MC; Chuang, YJ; Chen, BS				Wu, Chia-Chou; Tsai, Tsung-Han; Chang, Chieh; Lee, Tian-Thai; Lin, Che; Cheng, Irene Han-Juo; Sun, Mu-Chien; Chuang, Yung-Jen; Chen, Bor-Sen			On the Crucial Cerebellar Wound Healing-Related Pathways and Their Cross-Talks after Traumatic Brain Injury in Danio rerio	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ZEBRAFISH MODEL; CELL-MIGRATION; IMMUNE-SYSTEM; REGENERATION; NEUROTRANSMITTERS; NEUROGENESIS; CANNABINOIDS; PATHOGENESIS; MECHANISMS	Upon injury, the direct damage and the subsequent secondary injury in the brain often result in chronic neurological disorders. Due to multifactorial nature of secondary injury and subsequent complex cellular responses, much of the underlying mechanisms are unclear. This study used an adult zebrafish cerebellum injury model to investigate the phenotypes and the secondary injury responses for recovery mechanisms of injured brain. Using the time course microarray analysis, a candidate protein-protein interaction (PPI) network was refined as cerebellar wound healing PPI network by dynamic modeling and big data mining. Pathway enrichment and ontological analysis were incorporated into the refined network to highlight the main molecular scheme of cerebellar wound healing. Several significant pathways, including chemokine, Phosphatidylinositide 3-kinases, and axon guidance signaling pathway and their cross-talks through PI3K, PAK2, and PLXNA3 were identified to coordinate for neurogenesis and angiogenesis, which are essential for the restoration of the injured brain. Our finding provides an insight into the molecular restoration mechanisms after traumatic brain injury, and open up new opportunity to devise the treatment for traumatic brain injury in human.	[Wu, Chia-Chou; Tsai, Tsung-Han; Lin, Che; Chen, Bor-Sen] Natl Tsing Hua Univ, Deptartment Elect Engn, Hsinchu, Taiwan; [Chang, Chieh; Lee, Tian-Thai; Chuang, Yung-Jen] Natl Tsing Hua Univ, Deptartment Med Sci, Hsinchu, Taiwan; [Chang, Chieh; Lee, Tian-Thai; Chuang, Yung-Jen] Natl Tsing Hua Univ, Inst Bioinformat & Struct Biol, Hsinchu, Taiwan; [Cheng, Irene Han-Juo] Natl Yang Ming Univ, Inst Brain Sci, Taipei 112, Taiwan; [Sun, Mu-Chien] Changhua Christian Hosp, Stroke Ctr, Changhua, Taiwan; [Sun, Mu-Chien] Changhua Christian Hosp, Deptartment Neurol, Changhua, Taiwan	National Tsing Hua University; National Tsing Hua University; National Tsing Hua University; National Yang Ming Chiao Tung University; Changhua Christian Hospital; Changhua Christian Hospital	Chen, BS (corresponding author), Natl Tsing Hua Univ, Deptartment Elect Engn, Hsinchu, Taiwan.	bschen@ee.nthu.edu.tw	Wu, Chia-Chou/L-1058-2013; Chen, Bor-Sen/D-9114-2017; Hsu, Yuan-Man/K-7074-2015	Wu, Chia-Chou/0000-0002-4009-6858; Chang, Jia-Hao/0000-0001-7843-2688; Chang, Chiung-Hung/0000-0001-6917-4875; Hsu, Yuan-Man/0000-0002-4575-7475	National Science Council of Taiwan, R.O.C. [NSC 102-2745-E-007-001-ASP]	National Science Council of Taiwan, R.O.C.(Ministry of Science and Technology, Taiwan)	The work was supported by the National Science Council of Taiwan, R.O.C. [NSC 102-2745-E-007-001-ASP]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antos CL, 2010, ADV EXP MED BIOL, V695, P184, DOI 10.1007/978-1-4419-7037-4_13; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; Berg DA, 2013, DEVELOPMENT, V140, P2548, DOI 10.1242/dev.088005; BLALOCK JE, 1992, CHEM IMMUNOL, V52, P1; Bradford Y, 2011, NUCLEIC ACIDS RES, V39, pD822, DOI 10.1093/nar/gkq1077; Cameron DA, 2005, MOL VIS, V11, P775; Chen BS, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-46; Craig Sonya E L, 2008, J Ocul Biol Dis Infor, V1, P73, DOI 10.1007/s12177-008-9011-5; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Feala JD, 2013, J NEUROTRAUM, V30, P1101, DOI 10.1089/neu.2012.2631; Giancotti FG, 1999, SCIENCE, V285, P1028, DOI 10.1126/science.285.5430.1028; Guingab-Cagmat JD, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00061; Guo Y, 2011, NEUROSCIENCE, V172, P329, DOI 10.1016/j.neuroscience.2010.10.026; Horner PJ, 2000, NATURE, V407, P963, DOI 10.1038/35039559; Hui SP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084212; Jiang W, 2005, J CLIN INVEST, V115, P3104, DOI 10.1172/JCI25509; Kalueff AV, 2013, ZEBRAFISH, V10, P70, DOI 10.1089/zeb.2012.0861; Kishimoto N, 2012, DIS MODEL MECH, V5, P200, DOI 10.1242/dmm.007336; Kizil C, 2012, DEV NEUROBIOL, V72, P429, DOI 10.1002/dneu.20918; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Levin ED, 2009, FRONT NEUROSCI, P293; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Lukacs NW, 2001, NAT REV IMMUNOL, V1, P108, DOI 10.1038/35100503; Martins RAP, 2008, BRAIN RES, V1192, P37, DOI 10.1016/j.brainres.2007.04.076; McCurley AT, 2010, J EXP NEUROSCI, V4, P17; Mechoulam R, 2002, TRENDS MOL MED, V8, P58, DOI 10.1016/S1471-4914(02)02276-1; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Piomelli D, 2003, NAT REV NEUROSCI, V4, P873, DOI 10.1038/nrn1247; Poss KD, 2002, SCIENCE, V298, P2188, DOI 10.1126/science.1077857; Postlethwait J, 1999, METHOD CELL BIOL, V60, P149; Qin Z, 2009, P NATL ACAD SCI USA, V106, P9310, DOI 10.1073/pnas.0811186106; Qiu YH, 1996, ADV NEUROIMMUNOL, V6, P223, DOI 10.1016/S0960-5428(96)00018-6; Rajaram MVS, 2006, J IMMUNOL, V177, P6317, DOI 10.4049/jimmunol.177.9.6317; Ridley AJ, 2001, J CELL SCI, V114, P2713; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stadelmann WK, 1998, AM J SURG, V176, p39S, DOI 10.1016/S0002-9610(98)00184-6; Stark C, 2006, NUCLEIC ACIDS RES, V34, pD535, DOI 10.1093/nar/gkj109; Tanaka EM, 2009, NAT REV NEUROSCI, V10, P713, DOI 10.1038/nrn2707; Vicente-Manzanares M, 2002, INT REV CYTOL, V216, P233; Wang YC, 2010, BMC SYST BIOL, V4, DOI [10.1186/1752-0509-4-S2-S1, 10.1186/1752-0509-4-20]; Webster JI, 2002, ANNU REV IMMUNOL, V20, P125, DOI 10.1146/annurev.immunol.20.082401.104914; Yang SK, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-19	49	16	18	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e97902	10.1371/journal.pone.0097902	http://dx.doi.org/10.1371/journal.pone.0097902			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	24926785	gold, Green Submitted, Green Published			2022-12-27	WOS:000338278100009
J	Lin, Y; Qian, XN; Krischer, J; Vehik, K; Lee, HS; Huang, S				Lin, Ying; Qian, Xiaoning; Krischer, Jeffrey; Vehik, Kendra; Lee, Hye-Seung; Huang, Shuai			A Rule-Based Prognostic Model for Type 1 Diabetes by Identifying and Synthesizing Baseline Profile Patterns	PLOS ONE			English	Article							RISK; PROGRESSION; GLUCOSE; PERIOD; TRIAL; ONSET; AGE	Objective: To identify the risk-predictive baseline profile patterns of demographic, genetic, immunologic, and metabolic markers and synthesize these patterns for risk prediction. Research Design and Methods: RuleFit is used to identify the risk-predictive baseline profile patterns of demographic, immunologic, and metabolic markers, using 356 subjects who were randomized into the control arm of the prospective Diabetes Prevention Trial-Type 1 (DPT-1) study. A novel latent trait model is developed to synthesize these baseline profile patterns for disease risk prediction. The primary outcome was Type 1 Diabetes (T1D) onset. Results: We identified ten baseline profile patterns that were significantly predictive to the disease onset. Using these ten baseline profile patterns, a risk prediction model was built based on the latent trait model, which produced superior prediction performance over existing risk score models for T1D. Conclusion: Our results demonstrated that the underlying disease progression process of T1D can be detected through some risk-predictive patterns of demographic, immunologic, and metabolic markers. A synthesis of these patterns provided accurate prediction of disease onset, leading to more cost-effective design of prevention trials of T1D in the future.	[Lin, Ying; Huang, Shuai] Univ S Florida, Dept Ind & Management Syst Engn, Tampa, FL 33606 USA; [Qian, Xiaoning] Texas A&M Univ, Dept Elect & Comp Engn, College Stn, TX USA; [Krischer, Jeffrey; Vehik, Kendra; Lee, Hye-Seung] Univ S Florida, Coll Med, Dept Pediat, Tampa, FL 33612 USA	State University System of Florida; University of South Florida; Texas A&M University System; Texas A&M University College Station; State University System of Florida; University of South Florida	Huang, S (corresponding author), Univ S Florida, Dept Ind & Management Syst Engn, Tampa, FL 33606 USA.	shuaihuang@usf.edu	Lin, Ying/AAE-1879-2020; Lin, Zhenyue/O-1211-2019; Lin, Zhenyue/H-1569-2017	Lin, Zhenyue/0000-0002-6367-2459; Lin, Zhenyue/0000-0002-6367-2459; zhang, muqing/0000-0003-3138-3422	University of South Florida; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061010, U01DK085476, UC4DK097835, U01DK061058, T32DK007161, UC4DK117009, U01DK085461] Funding Source: NIH RePORTER	University of South Florida; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work has been supported by the University of South Florida. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baker F.B., 2004, ITEM RESPONSE THEORY; Bingley PJ, 1996, DIABETES, V45, P1720, DOI 10.2337/diabetes.45.12.1720; Bougneres P, 2008, J EXP MED, V205, P2953, DOI 10.1084/jem.20082622; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chase HP, 2001, J PEDIATR-US, V138, P244, DOI 10.1067/mpd.2001.111274; Diabetes Prevention Trial-Type 1 Diabetes Study Group, 2005, DIABETES CARE, V28, P1068; Frieman JH, 2008, ANN APPL STAT, V2, P916, DOI 10.1214/07-AOAS148; Gale EAM, 2004, LANCET, V363, P925, DOI 10.1016/S0140-6736(04)15786-3; Gimenez M, 2007, DIABETES CARE, V30, P1593, DOI 10.2337/dc06-2578; Lernmark A, 1998, NAT GENET, V19, P213, DOI 10.1038/881; Lunn D., 2012, BUGS BOOK PRACTICAL; Mrena S, 2006, DIABETES CARE, V29, P662, DOI 10.2337/diacare.29.03.06.dc05-0774; NELDER JA, 1972, J R STAT SOC SER A-G, V135, P370, DOI 10.2307/2344614; Skyler JS, 2002, NEW ENGL J MED, V346, P1685; Sosenko JM, 2008, DIABETES CARE, V31, P2188, DOI 10.2337/dc08-0935; Sosenko JM, 2008, DIABETES CARE, V31, P528, DOI 10.2337/dc07-1459; Sosenko JM, 2011, DIABETES CARE, V34, P1785, DOI 10.2337/dc11-0641; Sosenko JM, 2006, DIABETES CARE, V29, P643, DOI 10.2337/diacare.29.03.06.dc05-1006; SRIKANTA S, 1984, DIABETOLOGIA, V27, P146, DOI 10.1007/BF00275674; Stern SE, 2005, DIABETES, V54, P333, DOI 10.2337/diabetes.54.2.333; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vella A, 2011, CLIN DILEMMAS DIABET; Xu P, 2010, DIABETES CARE, V33, P2508, DOI 10.2337/dc10-0802; Ziegler AG, 2010, IMMUNITY, V32, P468, DOI 10.1016/j.immuni.2010.03.018	24	56	72	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 13	2014	9	6							e91095	10.1371/journal.pone.0091095	http://dx.doi.org/10.1371/journal.pone.0091095			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK2VQ	25141192	Green Published, gold			2022-12-27	WOS:000338278100001
J	Apitzsch, JC; Westphal, S; Penzkofer, T; Kuhl, CK; Knuchel, R; Mahnken, AH				Apitzsch, Jonas Christoph; Westphal, Saskia; Penzkofer, Tobias; Kuhl, Christiane Katharina; Knuechel, Ruth; Mahnken, Andreas H.			The Use of Contrast-Enhanced Post Mortem CT in the Detection of Cardiovascular Deaths	PLOS ONE			English	Article							DECLINING AUTOPSY RATE; POSTMORTEM ANGIOGRAPHY; VIRTOPSY; RATES	Objectives: To evaluate the diagnostic value of contrast enhanced post mortem computed tomography (PMCT) in comparison to non-enhanced post mortem CT in the detection of cardiovascular causes of death (COD). Background: As autopsy rates decline, new methods to determine CODs are necessary. So contrast enhanced PMCT shall be evaluated in comparison to established non-enhanced PMCT in order to further improve the method. Methods: In a prospective study, 20 corpses were examined using a 64-row multisclice CT (MSCT) before and after intraarterial perfusion with a newly developed, barium-bearing contrast agent and ventilation of the lungs. The cause of death was determined in enhanced and unenhanced scans and a level of confidence (LOC) was given by three experienced radiologists on a scale between 0 and 4. Results were compared to autopsy results as gold standard. Autopsy was performed blinded to PMCT-findings. Results: The method allowed visualization of different types of cause of death. There was a significant improvement in LOC in enhanced scans compared to unenhanced scans as well as an improvement in the detection of COD. The cause of death could be determined in 19 out of 20 patients. Conclusions: PMCT is feasible and appears to be robust for diagnosing cardiovascular causes of death. When compared with unenhanced post-mortem CT intraarterial perfusion and pulmonary ventilation significantly improve visualization and diagnostic accuracy. These promising results warrant further studies.	[Apitzsch, Jonas Christoph] Philipps Univ Hosp Marburg, Dept Diagnost & Intervent Radiol, Marburg, Germany; [Westphal, Saskia; Knuechel, Ruth] RWTH Aachen Univ Hosp, Dept Pathol, Aachen, Germany; [Penzkofer, Tobias] Rhein Westfal TH Aachen, Helmholtz Inst, Aachen, Germany; [Penzkofer, Tobias; Kuhl, Christiane Katharina; Mahnken, Andreas H.] RWTH Aachen Univ Hosp, Dept Diagnost & Intervent Radiol, Aachen, Germany	Philipps University Marburg; RWTH Aachen University; RWTH Aachen University Hospital; Helmholtz Association; RWTH Aachen University; RWTH Aachen University; RWTH Aachen University Hospital	Apitzsch, JC (corresponding author), Philipps Univ Hosp Marburg, Dept Diagnost & Intervent Radiol, Marburg, Germany.	apitzsch@med.uni-marburg.de	Penzkofer, Tobias/AAW-8839-2020; Penzkofer, Tobias/AFN-1192-2022; Kuhl, Christiane K/H-3301-2013	Penzkofer, Tobias/0000-0001-9591-8575; Kuhl, Christiane K/0000-0001-8696-2363; Malvick, Dean/0000-0002-0131-8411; von Stillfried, Saskia/0000-0002-5260-8494; Mahnken, Andreas H./0000-0001-8077-9306				Brinkmann B, 2002, DEUT MED WOCHENSCHR, V127, P791, DOI 10.1055/s-2002-25021; Chariot P, 2000, ARCH PATHOL LAB MED, V124, P739; Davies DJ, 2004, MED J AUSTRALIA, V180, P281, DOI 10.5694/j.1326-5377.2004.tb05926.x; Ebert LC, 2012, J FORENSIC LEG MED, V19, P126, DOI 10.1016/j.jflm.2011.12.007; Grabherr S, 2008, AM J ROENTGENOL, V190, P345, DOI 10.2214/AJR.07.2261; Grabherr Silke, 2006, AJR Am J Roentgenol, V187, pW515, DOI 10.2214/AJR.05.1394; Grabherr S, 2007, AM J ROENTGENOL, V188, P832, DOI 10.2214/AJR.06.0787; Grabherr S, 2011, INT J LEGAL MED, V125, P791, DOI 10.1007/s00414-010-0526-5; Harrington DE, 2010, SOC SCI MED, V70, P191, DOI 10.1016/j.socscimed.2009.09.018; Ishiko T, 1989, Gan To Kagaku Ryoho, V16, P1920; Jackowski C, 2005, J FORENSIC SCI, V50, P1175; Jackowski C, 2006, J FORENSIC SCI, V51, P1134, DOI 10.1111/j.1556-4029.2006.00207.x; Lindstrom P, 1997, J INTERN MED, V242, P157, DOI 10.1046/j.1365-2796.1997.00178.x; Lloyd-Jones D, 2010, CIRCULATION, V121, pE46, DOI 10.1161/CIRCULATIONAHA.109.192667; McNamara JJ, 1971, JAMA, V216, P1185; Michiue T, 2012, FORENSIC SCI INT, V220, P232, DOI 10.1016/j.forsciint.2012.03.007; Roberts ISD, 2012, LANCET, V379, P136, DOI 10.1016/S0140-6736(11)61483-9; Ross S, 2008, AM J ROENTGENOL, V190, P1380, DOI 10.2214/AJR.07.3082; Ross SG, 2012, RADIOLOGY, V264, P250, DOI 10.1148/radiol.12092415; Ruder TD, 2011, LEGAL MED, V13, P91, DOI 10.1016/j.legalmed.2010.11.005; Smith M, 1999, ARCH PATHOL LAB MED, V123, P885; START RD, 1993, J PATHOL, V171, P63, DOI 10.1002/path.1711710113; Thali MJ, 2005, J FORENSIC SCI, V50, P428; Westphal SE, 2012, VIRCHOWS ARCH; ZAPATA MG, 1989, Z RECHTSMED, V103, P27, DOI 10.1007/BF01255843	25	14	15	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 23	2014	9	4							e93101	10.1371/journal.pone.0093101	http://dx.doi.org/10.1371/journal.pone.0093101			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AG3EI	24759757	Green Published, Green Submitted, gold			2022-12-27	WOS:000335298200006
J	Yuan, JS; Chen, S; Qiao, SB; Duan, FJ; Zhang, JF; Wang, H				Yuan, Jiansong; Chen, Shi; Qiao, Shubin; Duan, Fujian; Zhang, Jiafen; Wang, Hao			Characteristics of Myocardial Postsystolic Shortening in Patients with Symptomatic Hypertrophic Obstructive Cardiomyopathy before and Half a Year after Alcohol Septal Ablation Assessed by Speckle Tracking Echocardiography	PLOS ONE			English	Article							CARDIOVASCULAR MAGNETIC-RESONANCE; VENTRICULAR DIASTOLIC FUNCTION; STRAIN-RATE; MICROVASCULAR FUNCTION; FOLLOW-UP; DYSFUNCTION; DOPPLER; FIBROSIS; FLOW	Objectives: Postsystolic shortening (PSS) has been proposed as a marker of myocardial dysfunction. Percutaneous transluminal septal myocardial ablation (PTSMA) is an alternative therapy for patients with hypertrophic obstructive cardiomyopathy (HOCM) that results in sustained improvements in atrial structure and function. We investigated the effects of PTSMA on PSS in HOCM patients using speckle tracking imaging. Methods: Conventional echocardiographic and PSS parameters were obtained in 18 healthy controls and 30 HOCM patients before and half a year after PTSMA. Results: Compared with the healthy controls, the number of segments having PSS and the average value of PSS were significantly increased in the HOCM patients. At 6 months after PTSMA, both the number of segments having PSS (10.5 +/- 2.8 vs. 13.2 +/- 2.6; P<0.001) and the average value of PSS (-1.24 +/- 0.57 vs. -1.55 +/- 0.56; P=0.009) were significantly reduced. Moreover, the reductions in the average value of PSS correlated well with the reductions in the E-to-Ea ratio (r = 0.705, P<0.001). Conclusions: Both the number of segments having PSS and the average value of PSS were significantly increased in the HOCM patients. PTSMA has a favourable effect on PSS, which may partly account for the persistent improvement in LV diastolic function in HOCM patients after PTSMA.	[Yuan, Jiansong; Qiao, Shubin] Peking Union Med Coll, Dept Cardiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China; [Yuan, Jiansong; Qiao, Shubin; Duan, Fujian; Zhang, Jiafen; Wang, Hao] Chinese Acad Med Sci, Beijing 100730, Peoples R China; [Chen, Shi] Sichuan Univ, Dept Cardiol, West China Hosp, Chengdu 610064, Sichuan, Peoples R China; [Duan, Fujian; Zhang, Jiafen; Wang, Hao] Peking Union Med Coll, Dept Echocardiog, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College; Chinese Academy of Medical Sciences - Peking Union Medical College; Sichuan University; Chinese Academy of Medical Sciences - Peking Union Medical College; Fu Wai Hospital - CAMS; Peking Union Medical College	Qiao, SB (corresponding author), Peking Union Med Coll, Dept Cardiol, State Key Lab Cardiovasc Dis, Fuwai Hosp,Natl Ctr Cardiovasc Dis, Beijing 100021, Peoples R China.	yuanjs100@sina.com			Immunonephrology Working Group ERA-EDTA	Immunonephrology Working Group ERA-EDTA	This study was partly supported by Immunonephrology Working Group ERA-EDTA. We thank Sonya Siragusa and Daniela Campanella (both of Department of Soil, Plant and Food Sciences, University of Bari Aldo Moro, Bari, Italy) for technical assistance.	BERTHA BG, 1986, CIRCULATION, V74, P901, DOI 10.1161/01.CIR.74.4.901; Biagini E, 2009, AM J CARDIOL, V104, P1727, DOI 10.1016/j.amjcard.2009.07.057; Bradham WS, 2002, J AM COLL CARDIOL, V40, P2165, DOI 10.1016/S0735-1097(02)02595-0; Carlhall C, 2003, AM J CARDIOL, V91, P1490, DOI 10.1016/S0002-9149(03)00407-7; Chen S, 2013, ECHOCARDIOGR-J CARD, V30, P564, DOI 10.1111/echo.12087; Dai ZH, 2012, J CARDIOL, V60, P416, DOI 10.1016/j.jjcc.2012.06.009; Ellims AH, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-76; Geske JB, 2007, CIRCULATION, V116, P2702, DOI 10.1161/CIRCULATIONAHA.107.698985; Green JJ, 2012, JACC-CARDIOVASC IMAG, V5, P370, DOI 10.1016/j.jcmg.2011.11.021; Huang L, 2013, CLIN RADIOL, V68, P676, DOI 10.1016/j.crad.2013.01.003; Ito T, 2006, J AM SOC ECHOCARDIOG, V19, P987, DOI 10.1016/j.echo.2006.03.019; Jassal DS, 2006, EUR HEART J, V27, P1805, DOI 10.1093/eurheartj/ehl106; Jensen MK, 2011, CIRC-CARDIOVASC INTE, V4, P256, DOI 10.1161/CIRCINTERVENTIONS.110.959718; Kukulski T, 2002, J AM SOC ECHOCARDIOG, V15, P1, DOI 10.1067/mje.2002.114844; Malek LA, 2008, EUR J HEART FAIL, V10, P1123, DOI 10.1016/j.ejheart.2008.09.005; Matsumura Y, 2002, HEART, V87, P247, DOI 10.1136/heart.87.3.247; Nagueh SF, 2001, CIRCULATION, V103, P1844; Nakai H, 2009, EUR J ECHOCARDIOGR, V10, P926, DOI 10.1093/ejechocard/jep097; Olivotto I, 2011, J AM COLL CARDIOL, V58, P839, DOI 10.1016/j.jacc.2011.05.018; Plaksej R, 2009, J HYPERTENS, V27, P2483, DOI 10.1097/HJH.0b013e3283316c4d; Prinz C, 2012, ACTA CARDIOL, V67, P187, DOI 10.1080/AC.67.2.2154209; Soliman OII, 2008, AM J CARDIOL, V101, P1321, DOI 10.1016/j.amjcard.2007.12.032; Stoylen A, 2003, ECHOCARDIOGR-J CARD, V20, P167, DOI 10.1046/j.1540-8175.2003.03013.x; Stroud RE, 2005, J CARD FAIL, V11, P124, DOI 10.1016/j.cardfail.2004.05.002; Timmer SAJ, 2011, AM J PHYSIOL-HEART C, V301, pH129, DOI 10.1152/ajpheart.00077.2011; Tsai WC, 2012, J HYPERTENS, V30, P787, DOI 10.1097/HJH.0b013e32834f6b2b; Voigt JU, 2003, CIRCULATION, V107, P2120, DOI 10.1161/01.CIR.0000065249.69988.AA; Voigt JV, 2003, J AM SOC ECHOCARDIOG, V16, P415, DOI 10.1016/S0894-7317(03)00111-1; Yang L, 2007, CHINESE MED J-PEKING, V120, P1894, DOI 10.1097/00029330-200711010-00008; Yuan JS, 2010, AM J CARDIOL, V106, P1487, DOI 10.1016/j.amjcard.2010.07.017	30	14	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 12	2014	9	6							e99014	10.1371/journal.pone.0099014	http://dx.doi.org/10.1371/journal.pone.0099014			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AK8TP	24922531	gold, Green Published, Green Submitted			2022-12-27	WOS:000338701300024
J	Lin, ZY; Xu, SQ; Que, YX; Wang, JH; Comstock, JC; Wei, JJ; McCord, PH; Chen, BS; Chen, RK; Zhang, MQ				Lin, Zhenyue; Xu, Shiqiang; Que, Youxiong; Wang, Jihua; Comstock, Jack C.; Wei, Jinjin; McCord, Per H.; Chen, Baoshan; Chen, Rukai; Zhang, Muqing			Species-Specific Detection and Identification of Fusarium Species Complex, the Causal Agent of Sugarcane Pokkah Boeng in China	PLOS ONE			English	Article							REAL-TIME PCR; QUANTIFICATION; SEQUENCES; DIAGNOSIS; DIVERSITY; FUJIKUROI; STRAINS; BANANA; PLANTS; SPP.	Background: Pokkah boeng disease caused by the Fusarium species complex results in significant yield losses in sugarcane. Thus, the rapid and accurate detection and identification of the pathogen is urgently required to manage and prevent the spreading of sugarcane pokkah boeng. Methods: A total of 101 isolates were recovered from the pokkah boeng samples collected from five major sugarcane production areas in China throughout 2012 and 2013. The causal pathogen was identified by morphological observation, pathogenicity test, and phylogenetic analysis based on the fungus-conserved rDNA-ITS. Species-specific TaqMan real-time PCR and conventional PCR methods were developed for rapid and accurate detection of the causal agent of sugarcane pokkah boeng. The specificity and sensitivity of PCR assay were also evaluated on a total of 84 isolates of Fusarium from China and several isolates from other fungal pathogens of Sporisorium scitamineum and Phoma sp. and sugarcane endophyte of Acremonium sp. Result: Two Fusarium species (F. verticillioides and F. proliferatum) that caused sugarcane pokahh boeng were identified by morphological observation, pathogenicity test, and phylogenetic analysis. Species-specific TaqMan PCR and conventional PCR were designed and optimized to target their rDNA-ITS regions. The sensitivity of the TaqMan PCR was approximately 10 pg of fungal DNA input, which was 1,000-fold over conventional PCR, and successfully detected pokkah boeng in the field-grown sugarcane. Conclusions/Significance: This study was the first to identify two species, F. verticillioides and F. proliferatum, that were causal pathogens of sugarcane pokkah boeng in China. It also described the development of a species-specific PCR assay to detect and confirm these pathogens in sugarcane plants from mainland China. This method will be very useful for a broad range of research endeavors as well as the regulatory response and management of sugarcane pokkah boeng.	[Lin, Zhenyue; Xu, Shiqiang; Wang, Jihua; Chen, Baoshan; Zhang, Muqing] Guangxi Univ, Nanning 530004, Guangxi, Peoples R China; [Lin, Zhenyue; Que, Youxiong; Wei, Jinjin; Chen, Rukai; Zhang, Muqing] Fujian Agr & Forestry Univ, Fuzhou, Peoples R China; [Comstock, Jack C.; McCord, Per H.] ARS, USDA, Sugarcane Field Stn, Canal Point, FL USA	Guangxi University; Fujian Agriculture & Forestry University; United States Department of Agriculture (USDA)	Zhang, MQ (corresponding author), Guangxi Univ, Nanning 530004, Guangxi, Peoples R China.	mqzhang@ufl.edu	Lin, Ying/AAE-1879-2020; Lin, Zhenyue/O-1211-2019; Lin, Zhenyue/H-1569-2017	Lin, Zhenyue/0000-0002-6367-2459; Lin, Zhenyue/0000-0002-6367-2459; zhang, muqing/0000-0003-3138-3422	Guangxi special funding for distinguished experts and Funds from State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources; Guangxi Natural Science Foundation [2014GXNSFFA118002]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK061010, U01DK085476, UC4DK097835, U01DK061058, T32DK007161, UC4DK117009, U01DK085461] Funding Source: NIH RePORTER	Guangxi special funding for distinguished experts and Funds from State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources; Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Financial support was provided by Guangxi special funding for distinguished experts and Funds from State Key Laboratory for Conservation and Utilization of Subtropical Agro-bioresources. This project is also supported by Guangxi Natural Science Foundation (2014GXNSFFA118002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amatulli MT, 2012, EUR J PLANT PATHOL, V134, P401, DOI 10.1007/s10658-012-9998-0; BACON CW, 1994, J FOOD PROTECT, V57, P514, DOI 10.4315/0362-028X-57.6.514; Blackburn F, 1984, SUGAR CANE, P414; Bower NI, 2005, PLANT SCI, V168, P761, DOI 10.1016/j.plantsci.2004.10.006; Diamond M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069542; Dita MA, 2010, PLANT PATHOL, V59, P348, DOI 10.1111/j.1365-3059.2009.02221.x; Gonzalez-Jaen MT, 2004, EUR J PLANT PATHOL, V110, P525, DOI 10.1023/B:EJPP.0000032392.20106.81; Goswami D, 2013, J BASIC MICROB, V00, P1; Govender P., 2010, Proceedings of the Annual Congress - South African Sugar Technologists' Association, P267; Irawan Whittle P, 2000, GUIDE SUGARCANE DIS, P136; Iskandar HM, 2004, PLANT MOL BIOL REP, V22, P325, DOI 10.1007/BF02772676; Khani KT., 2013, P IRNOP 2013 C JUNE, V28, P1; Kvas M, 2009, FUNGAL DIVERS, V34, P1; Leslie JF, 2006, FUSARIUM LAB MANUAL, P385; Li WB, 2008, PLANT DIS, V92, P854, DOI 10.1094/PDIS-92-6-0854; Lian S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063380; Lin ZY, 2014, PLANT DIS, V98, P850, DOI 10.1094/PDIS-10-13-1061-PDN; Martin J, 1989, DIS SUGARCANE MAJOR, P157; Martin JP, 1961, SUGARCANE DIS WORLD, V1; McFarlane S. A., 2005, Proceedings of the 79th Annual Congress of South African Sugar Technologists' Association, held at Kwa-Shukela, Mount Edgecombe, South Africa, 19-22 July 2005, P120; Mohammadi A, 2012, PLANT PROTECT SCI, V48, P80, DOI 10.17221/49/2011-PPS; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; O'Donnell Kerry, 2000, Mycoscience, V41, P61, DOI 10.1007/BF02464387; Sampietro DA, 2010, FUNGAL BIOL-UK, V114, P74, DOI 10.1016/j.mycres.2009.10.008; Sayler RJ, 2012, PLANT DIS, V96, P1757, DOI 10.1094/PDIS-12-11-1033-RE; Sheldon JL, 1904, AGR EXP STN NEBRASKA, V17, P23; Siddique S, 2007, THESIS U MALAYSIA MA; Siti Nordahliawate M. S., 2008, Pertanika Journal of Tropical Agricultural Science, V31, P279; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tan MK, 2003, MYCOL RES, V107, P811, DOI 10.1017/S0953756203008013; Thompson JD, 2002, CURR PROTOC BIOINFOR, V2, P23, DOI 10.1002/0471250953.bi0203s00; Vishwakarma S. K., 2013, Journal of Plant Pathology and Microbiology, V4, P170; Wang H, 2011, J CLIN MICROBIOL, V49, P1890, DOI 10.1128/JCM.02415-10; White TJ, 1990, AMPLIFICATION DIRECT, V18, P315; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Wulff EG, 2010, ENVIRON MICROBIOL, V12, P649, DOI 10.1111/j.1462-2920.2009.02105.x; Zeng XY, 2007, J CLIN MICROBIOL, V45, P2872, DOI 10.1128/JCM.00687-07; Zhu YJ, 2010, EUR J PLANT PATHOL, V127, P263, DOI 10.1007/s10658-010-9591-3	38	56	72	3	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 20	2014	9	8							e104195	10.1371/journal.pone.0104195	http://dx.doi.org/10.1371/journal.pone.0104195			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AQ3JB	25141192	Green Published, Green Submitted, gold			2022-12-27	WOS:000342687200015
J	Chen, LH; Li, CX; Sargolzaei, M; Schenkel, F				Chen, Liuhong; Li, Changxi; Sargolzaei, Mehdi; Schenkel, Flavio			Impact of Genotype Imputation on the Performance of GBLUP and Bayesian Methods for Genomic Prediction	PLOS ONE			English	Article							RELATIONSHIP MATRIX; ACCURACY; SELECTION; VALUES; RELIABILITY; NUCLEOTIDE; STRATEGIES; CATTLE; CHIPS	The aim of this study was to evaluate the impact of genotype imputation on the performance of the GBLUP and Bayesian methods for genomic prediction. A total of 10,309 Holstein bulls were genotyped on the BovineSNP50 BeadChip (50 k). Five low density single nucleotide polymorphism (SNP) panels, containing 6,177, 2,480, 1,536, 768 and 384 SNPs, were simulated from the 50 k panel. A fraction of 0%, 33% and 66% of the animals were randomly selected from the training sets to have low density genotypes which were then imputed into 50 k genotypes. A GBLUP and a Bayesian method were used to predict direct genomic values (DGV) for validation animals using imputed or their actual 50 k genotypes. Traits studied included milk yield, fat percentage, protein percentage and somatic cell score (SCS). Results showed that performance of both GBLUP and Bayesian methods was influenced by imputation errors. For traits affected by a few large QTL, the Bayesian method resulted in greater reductions of accuracy due to imputation errors than GBLUP. Including SNPs with largest effects in the low density panel substantially improved the accuracy of genomic prediction for the Bayesian method. Including genotypes imputed from the 6 k panel achieved almost the same accuracy of genomic prediction as that of using the 50 k panel even when 66% of the training population was genotyped on the 6 k panel. These results justified the application of the 6 k panel for genomic prediction. Imputations from lower density panels were more prone to errors and resulted in lower accuracy of genomic prediction. But for animals that have close relationship to the reference set, genotype imputation may still achieve a relatively high accuracy.	[Chen, Liuhong; Li, Changxi] Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada; [Li, Changxi] Agr & Agri Food Canada, Lacombe Res Ctr, Lacombe, AB, Canada; [Sargolzaei, Mehdi] Univ Guelph, Dept Anim & Poultry Sci, Guelph, ON N1G 2W1, Canada; [Schenkel, Flavio] LAlliance Boviteq Inc, Quebec City, PQ, Canada	University of Alberta; Agriculture & Agri Food Canada; University of Guelph	Chen, LH (corresponding author), Univ Alberta, Dept Agr Food & Nutr Sci, Edmonton, AB, Canada.	liuhong@ualberta.ca; schenkel@uoguelph.ca	Schenkel, Flavio/ABG-1842-2021	WU, KWAN-DUN/0000-0002-3339-1509; Schenkel, Flavio/0000-0001-8700-0633; CHEN, YUNG-MING/0000-0002-9241-1258	Natural Sciences and Engineering Research Council of Canada; L'Alliance Boviteq Inc., Quebec, Canada	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); L'Alliance Boviteq Inc., Quebec, Canada	This work was supported by the Natural Sciences and Engineering Research Council of Canada, and L'Alliance Boviteq Inc., Quebec, Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boichard D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034130; Calus M P L, 2008, Genetics, V178, P553, DOI 10.1534/genetics.107.080838; Calus MPL, 2010, ANIMAL, V4, P157, DOI 10.1017/S1751731109991352; Cleveland MA, 2013, J ANIM SCI, V91, P3583, DOI 10.2527/jas.2013-6270; Daetwyler HD, 2010, GENETICS, V185, P1021, DOI 10.1534/genetics.110.116855; Dassonneville R, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-40; Gianola D, 2009, GENETICS, V183, P347, DOI 10.1534/genetics.109.103952; Gilmour AR, 2009, ASREML USER GUIDE RE; Goddard ME, 2011, J ANIM BREED GENET, V128, P409, DOI 10.1111/j.1439-0388.2011.00964.x; Grisart B, 2004, P NATL ACAD SCI USA, V101, P2398, DOI 10.1073/pnas.0308518100; Habier D, 2007, GENETICS, V177, P2389, DOI 10.1534/genetics.107.081190; Habier D, 2009, GENETICS, V182, P343, DOI 10.1534/genetics.108.100289; Habier D, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-186; Hayes BJ, 2009, J DAIRY SCI, V92, P433, DOI 10.3168/jds.2008-1646; Huang YJ, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-25; Khatkar MS, 2012, BMC GENOMICS, V13, P1, DOI 10.1186/1471-2164-13-538; Legarra A, 2009, J DAIRY SCI, V92, P4656, DOI 10.3168/jds.2009-2061; Meuwissen THE, 2001, GENETICS, V157, P1819; Meuwissen THE, 2009, GENET SEL EVOL, V41, DOI 10.1186/1297-9686-41-35; Mulder HA, 2012, J DAIRY SCI, V95, P876, DOI 10.3168/jds.2011-4490; NejatiJavaremi A, 1997, J ANIM SCI, V75, P1738; Sargolzaei M, 2008, J DAIRY SCI, V91, P2106, DOI 10.3168/jds.2007-0553; Sargolzaei M, 2011, GEBV SOFTWARE; Stachowicz K, 2011, J DAIRY SCI, V94, P5160, DOI 10.3168/jds.2010-3308; Van Doormaal B, 2012, GENOTYPING LOW DENSI; VanRaden PM, 2008, J DAIRY SCI, V91, P4414, DOI 10.3168/jds.2007-0980; VanRaden PM, 2009, J DAIRY SCI, V92, P16, DOI 10.3168/jds.2008-1514; Verbyla KL, 2009, GENET RES, V91, P307, DOI 10.1017/S0016672309990243; Weigel KA, 2010, J DAIRY SCI, V93, P5423, DOI 10.3168/jds.2010-3149; Wiggans GR, 2013, J DAIRY SCI, V96, P1258, DOI 10.3168/jds.2012-6192; Wiggans GR, 2011, J DAIRY SCI, V94, P6188, DOI 10.3168/jds.2011-4481; Zhang Z, 2011, J DAIRY SCI, V94, P3642, DOI 10.3168/jds.2010-3917; Zhang Z, 2010, J DAIRY SCI, V93, P5487, DOI 10.3168/jds.2010-3501; Zhang Z, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012648	34	80	86	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 15	2014	9	7							e101544	10.1371/journal.pone.0101544	http://dx.doi.org/10.1371/journal.pone.0101544			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AM6RN	24551186	gold, Green Submitted, Green Published			2022-12-27	WOS:000339992400017
J	Chen, LX; Cai, Y; Zhou, GB; Shi, XJ; Su, JH; Chen, GW; Lin, K				Chen, Linxiang; Cai, Ying; Zhou, Guangbiao; Shi, Xiaojun; Su, Jianhui; Chen, Guanwu; Lin, Kun			Rapid Sanger Sequencing of the 16S rRNA Gene for Identification of Some Common Pathogens	PLOS ONE			English	Article							ESCHERICHIA-COLI STRAINS; BACTERIAL IDENTIFICATION; DNA; PCR; AMPLIFICATION; SHIGELLA; SYSTEM; MYCOBACTERIA; DATABASE; SAMPLES	Conventional Sanger sequencing remains time-consuming and laborious. In this study, we developed a rapid improved sequencing protocol of 16S rRNA for pathogens identification by using a new combination of SYBR Green I real-time PCR and Sanger sequencing with FTA (R) cards. To compare the sequencing quality of this method with conventional Sanger sequencing, 12 strains, including three kinds of strains (1 reference strain and 3 clinical strains, which were previously identified by biochemical tests), which have 4 Pseudomonas aeruginosa, 4 Staphyloccocus aureus and 4 Escherichia coli, were targeted. Additionally, to validate the sequencing results and bacteria identification, expanded specimens with 90 clinical strains, also comprised of the three kinds of strains which included 30 samples respectively, were performed as just described. The results showed that although statistical differences (P<0.05) were found in sequencing quality between the two methods, their identification results were all correct and consistent. The workload, the time consumption and the cost per batch were respectively light versus heavy, 8 h versus 11 h and $420 versus $400. In the 90 clinical strains, all of the Pseudomonas aeruginosa and Staphyloccocus aureus strains were correctly identified, but only 26.7% of the Escherichia coli strains were recognized as Escherichia coli, while 33.3% as Shigella sonnei and 40% as Shigella dysenteriae. The protocol described here is a rapid, reliable, stable and convenient method for 16S rRNA sequencing, and can be used for Pseudomonas aeruginosa and Staphyloccocus aureus identification, yet it is not completely suitable for discriminating Escherichia coli and Shigella strains.	[Chen, Linxiang; Shi, Xiaojun; Lin, Kun] Shantou Univ Med Coll, Dept Prevent Med, Shantou, Guangdong, Peoples R China; [Chen, Linxiang; Cai, Ying; Zhou, Guangbiao; Su, Jianhui; Chen, Guanwu] Shantou Entry Exit Inspect & Quarantine Bur, Mol Biol Lab, Shantou, Guangdong, Peoples R China		Lin, K (corresponding author), Shantou Univ Med Coll, Dept Prevent Med, Shantou, Guangdong, Peoples R China.	klin@stu.edu.cn	Schenkel, Flavio/ABG-1842-2021	WU, KWAN-DUN/0000-0002-3339-1509; Schenkel, Flavio/0000-0001-8700-0633; CHEN, YUNG-MING/0000-0002-9241-1258	Shantou Bureau of Science and Technology [[2009]387-126]; Guangdong Entry-Exit Inspection and Quarantine Bureau [2012 GDK45]; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology	Shantou Bureau of Science and Technology; Guangdong Entry-Exit Inspection and Quarantine Bureau; Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology	Shantou Bureau of Science and Technology (grant No. [2009]387-126), Guangdong Entry-Exit Inspection and Quarantine Bureau (grant No. 2012 GDK45) Guangdong Provincial Key Laboratory of Infectious Diseases and Molecular Immunopathology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aye KS, 2011, JPN J INFECT DIS, V64, P246; Becker K, 2004, J CLIN MICROBIOL, V42, P4988, DOI 10.1128/JCM.42.11.4988-4995.2004; Bhattacharya D, 2003, APPL ENVIRON MICROB, V69, P1435, DOI 10.1128/AEM.69.3.1435-1441.2003; Cloud JL, 2004, J CLIN MICROBIOL, V42, P578, DOI 10.1128/JCM.42.2.578-584.2004; Corless CE, 2000, J CLIN MICROBIOL, V38, P1747, DOI 10.1128/JCM.38.5.1747-1752.2000; Fukushima H, 2003, J CLIN MICROBIOL, V41, P5134, DOI 10.1128/JCM.41.11.5134-5146.2003; Fukushima M, 2002, J CLIN MICROBIOL, V40, P2779, DOI 10.1128/JCM.40.8.2779-2785.2002; Gustavsson I, 2009, J CLIN VIROL, V46, P112, DOI 10.1016/j.jcv.2009.06.021; Hall L, 2003, J CLIN MICROBIOL, V41, P1447, DOI 10.1128/JCM.41.4.1447-1453.2003; Han XY, 2002, AM J CLIN PATHOL, V118, P796, DOI 10.1309/HN44-XQYM-JMAQ-2EDL; Janda JM, 2007, J CLIN MICROBIOL, V45, P2761, DOI 10.1128/JCM.01228-07; Killgore G, 2008, J CLIN MICROBIOL, V46, P431, DOI 10.1128/JCM.01484-07; Lan R, 2001, TRENDS MICROBIOL, V9, P419, DOI 10.1016/S0966-842X(01)02133-3; Li YY, 2006, J CLIN MICROBIOL, V44, P4376, DOI 10.1128/JCM.01389-06; Menassa N, 2010, INVEST OPHTH VIS SCI, V51, P1905, DOI 10.1167/iovs.09-3737; Monnet C, 2006, APPL ENVIRON MICROB, V72, P6972, DOI 10.1128/AEM.01303-06; Mullen MP, 2009, IRISH J AGR FOOD RES, V48, P109; PEATTIE DA, 1979, P NATL ACAD SCI USA, V76, P1760, DOI 10.1073/pnas.76.4.1760; Petti CA, 2007, CLIN INFECT DIS, V44, P1108, DOI 10.1086/512818; Pupo GM, 2000, P NATL ACAD SCI USA, V97, P10567, DOI 10.1073/pnas.180094797; Schuurman T, 2004, J CLIN MICROBIOL, V42, P734, DOI 10.1128/JCM.42.2.734-740.2004; Smith L. M., 2004, BMC Ecology, V4, P4, DOI 10.1186/1472-6785-4-4; Tewari D, 2011, J VET DIAGN INVEST, V23, P1104, DOI 10.1177/1040638711425583; Vliegen I, 2006, J MICROBIOL METH, V66, P156, DOI 10.1016/j.mimet.2005.11.005; Willi B, 2009, J CLIN MICROBIOL, V47, P4049, DOI 10.1128/JCM.01478-09; Woo PCY, 2001, DIAGN MICR INFEC DIS, V39, P85, DOI 10.1016/S0732-8893(01)00206-1; Woo PCY, 2003, J CLIN MICROBIOL, V41, P1996, DOI 10.1128/JCM.41.5.1996-2001.2003	27	80	86	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	FEB 14	2014	9	2							e88886	10.1371/journal.pone.0088886	http://dx.doi.org/10.1371/journal.pone.0088886			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AA7IR	24551186	gold, Green Published, Green Submitted			2022-12-27	WOS:000331271500079
J	Li, X; Wu, LH; Liu, W; Jin, YC; Chen, Q; Wang, LL; Fan, XH; Li, Z; Cheng, YY				Li, Xiang; Wu, Leihong; Liu, Wei; Jin, Yecheng; Chen, Qian; Wang, Linli; Fan, Xiaohui; Li, Zheng; Cheng, Yiyu			A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-Compound, Multi-Target, Multi-Pathway Mode of Action	PLOS ONE			English	Article							PPAR-GAMMA AGONISTS; SIGNALING PATHWAYS; HEME OXYGENASE-1; RAW264.7; EXPRESSION; MECHANISMS; PROTEIN; LIPOPOLYSACCHARIDE; INFLAMMATION; THERAPEUTICS	Chinese medicine is a complex system guided by traditional Chinese medicine (TCM) theories, which has proven to be especially effective in treating chronic and complex diseases. However, the underlying modes of action (MOA) are not always systematically investigated. Herein, a systematic study was designed to elucidate the multi-compound, multi-target and multi-pathway MOA of a Chinese medicine, QiShenYiQi (QSYQ), on myocardial infarction. QSYQ is composed of Astragalus membranaceus (Huangqi), Salvia miltiorrhiza (Danshen), Panax notoginseng (Sanqi), and Dalbergia odorifera (Jiangxiang). Male Sprague Dawley rat model of myocardial infarction were administered QSYQ intragastrically for 7 days while the control group was not treated. The differentially expressed genes (DEGs) were identified from myocardial infarction rat model treated with QSYQ, followed by constructing a cardiovascular disease (CVD)-related multilevel compound-target-pathway network connecting main compounds to those DEGs supported by literature evidences and the pathways that are functionally enriched in ArrayTrack. 55 potential targets of QSYQ were identified, of which 14 were confirmed in CVD-related literatures with experimental supporting evidences. Furthermore, three sesquiterpene components of QSYQ, Trans-nerolidol, (3S, 6S, 7R)-3,7,11-trimethyl-3,6-epoxy-1,10-dodecadien-7-ol and (3S, 6R, 7R)-3,7,11-trimethyl- 3,6-epoxy-1,10-dodecadien-7-ol from Dalbergia odorifera T. Chen, were validated experimentally in this study. Their anti-inflammatory effects and potential targets including extracellular signal-regulated kinase-1/2, peroxisome proliferator-activated receptor-gamma and heme oxygenase-1 were identified. Finally, through a three-level compound-target-pathway network with experimental analysis, our study depicts a complex MOA of QSYQ on myocardial infarction.	[Li, Xiang; Wu, Leihong; Liu, Wei; Jin, Yecheng; Chen, Qian; Wang, Linli; Fan, Xiaohui; Cheng, Yiyu] Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China; [Li, Zheng] Tianjin Univ Tradit Chinese Med, State Key Lab Modern Chinese Med, Tianjin, Peoples R China	Zhejiang University; Tianjin University of Traditional Chinese Medicine	Fan, XH (corresponding author), Zhejiang Univ, Coll Pharmaceut Sci, Pharmaceut Informat Inst, Hangzhou 310003, Zhejiang, Peoples R China.	fanxh@zju.edu.cn; lizheng1@gmail.com	Wu, Leihong/AAM-9483-2020; FAN, Xiaohui/F-6458-2010; Bligh, S W Annie/AAI-9786-2020	Wu, Leihong/0000-0002-4093-3708; FAN, Xiaohui/0000-0002-6336-3007; Bligh, S W Annie/0000-0002-4757-2159; LI, Xiaojun/0000-0003-0336-8081	National Basic Research Program of China [2012CB518405]; National Natural Science Foundation of China [81373893]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the National Basic Research Program of China (no. 2012CB518405) and the National Natural Science Foundation of China (no. 81373893). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Microarray test was performed by National Engineering Center for Biochip at Shanghai by Dr. Huasheng Xiao's team.	Abraham NG, 2008, PHARMACOL REV, V60, P79, DOI 10.1124/pr.107.07104; Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Amara U, 2008, ADV EXP MED BIOL, V632, P71, DOI 10.1007/978-0-387-78952-1_6; Aramoto H, 2004, AM J PHYSIOL-HEART C, V287, pH1590, DOI 10.1152/ajpheart.00767.2003; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Barber GN, 2011, CURR OPIN IMMUNOL, V23, P10, DOI 10.1016/j.coi.2010.12.015; Berger SI, 2009, BIOINFORMATICS, V25, P2466, DOI 10.1093/bioinformatics/btp465; Burns KA, 2007, BBA-MOL CELL BIOL L, V1771, P952, DOI 10.1016/j.bbalip.2007.04.018; Campbell IW, 2005, CURR MOL MED, V5, P349, DOI 10.2174/1566524053766068; Chao W, 2009, AM J PHYSIOL-HEART C, V296, pH1, DOI 10.1152/ajpheart.00995.2008; Chen G, 2009, ANNU REV PATHOL-MECH, V4, P365, DOI 10.1146/annurev.pathol.4.110807.092239; Chen T, 2011, JIANGXI MED J, V46, P3; Cheung F, 2011, NATURE, V480, pS82, DOI 10.1038/480S82a; Cline MS, 2007, NAT PROTOC, V2, P2366, DOI 10.1038/nprot.2007.324; Crow MT, 2004, CIRC RES, V95, P957, DOI 10.1161/01.RES.0000148632.35500.d9; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Diez D, 2010, MOL BIOSYST, V6, P289, DOI 10.1039/b912078e; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Finck BN, 2007, CARDIOVASC RES, V73, P269, DOI 10.1016/j.cardiores.2006.08.023; Fritz JH, 2006, NAT IMMUNOL, V7, P1250, DOI 10.1038/ni1412; Gardner TS, 2003, SCIENCE, V301, P102, DOI 10.1126/science.1081900; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Hirota SA, 2009, RECENT PATENTS INFLA, V3, P1, DOI 10.2174/187221309787158434; Hong SeChul, 2012, Journal of Medicinal Plants Research, V6, P4494; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Hopkins AL, 2007, NAT BIOTECHNOL, V25, P1110, DOI 10.1038/nbt1007-1110; Humar R, 2002, FASEB J, V16, DOI 10.1096/fj.01-0658com; Jeong JB, 2013, FOOD CHEM TOXICOL, V55, P229, DOI 10.1016/j.fct.2012.12.062; Ji HY, 2010, INFLAMM RES, V59, P921, DOI 10.1007/s00011-010-0203-7; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Jiang WY, 2005, TRENDS PHARMACOL SCI, V26, P558, DOI 10.1016/j.tips.2005.09.006; Kaminska B, 2005, BBA-PROTEINS PROTEOM, V1754, P253, DOI 10.1016/j.bbapap.2005.08.017; Kim BC, 2006, J ETHNOPHARMACOL, V106, P364, DOI 10.1016/j.jep.2006.01.009; Kitano H, 2002, SCIENCE, V295, P1662, DOI 10.1126/science.1069492; Kronke G, 2007, ARTERIOSCL THROM VAS, V27, P1276, DOI 10.1161/ATVBAHA.107.142638; Laplante M, 2009, J CELL SCI, V122, P3589, DOI 10.1242/jcs.051011; Lee M, 2012, STRAD, V123, P7; Li YF, 2008, J PHARMACEUT BIOMED, V47, P407, DOI 10.1016/j.jpba.2007.12.037; Li YF, 2008, CHROMATOGRAPHIA, V67, P293, DOI 10.1365/s10337-007-0479-0; Lin HY, 2003, BIOCHEM PHARMACOL, V66, P1821, DOI 10.1016/S0006-2952(03)00422-2; Markiewski MM, 2007, TRENDS IMMUNOL, V28, P184, DOI 10.1016/j.it.2007.02.006; Martin H, 2009, MUTAT RES-FUND MOL M, V669, P1, DOI 10.1016/j.mrfmmm.2009.06.009; Miksa M, 2007, J IMMUNOL, V179, P6263, DOI 10.4049/jimmunol.179.9.6263; Murphy GJ, 2000, TRENDS PHARMACOL SCI, V21, P469, DOI 10.1016/S0165-6147(00)01559-5; NEEDLEMAN P, 1986, ANNU REV BIOCHEM, V55, P69, DOI 10.1146/annurev.biochem.55.1.69; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Palojoki E, 2001, AM J PHYSIOL-HEART C, V280, pH2726, DOI 10.1152/ajpheart.2001.280.6.H2726; Petit V, 2000, BIOL CELL, V92, P477, DOI 10.1016/S0248-4900(00)01101-1; PFEFFER MA, 1979, CIRC RES, V44, P503, DOI 10.1161/01.RES.44.4.503; Robinson ES, 2010, SEMIN NEPHROL, V30, P591, DOI 10.1016/j.semnephrol.2010.09.007; Sawle P, 2005, BRIT J PHARMACOL, V145, P800, DOI 10.1038/sj.bjp.0706241; Suefuji H, 1997, AM HEART J, V134, P253, DOI 10.1016/S0002-8703(97)70132-7; Suh SJ, 2006, ARCH BIOCHEM BIOPHYS, V447, P136, DOI 10.1016/j.abb.2006.01.016; Tang S, 2011, INFLAMMATION, V34, P111, DOI 10.1007/s10753-010-9214-3; Tao Y, 2010, FITOTERAPIA, V81, P393, DOI 10.1016/j.fitote.2009.11.012; Terzic A, 2011, CTS-CLIN TRANSL SCI, V4, P225, DOI 10.1111/j.1752-8062.2011.00295.x; Timmers L, 2008, CIRC RES, V102, P257, DOI 10.1161/CIRCRESAHA.107.158220; Tong WD, 2003, ENVIRON HEALTH PERSP, V111, P1819, DOI 10.1289/ehp.6497; von Knethen A, 2011, FREE RADICAL BIO MED, V51, P396, DOI 10.1016/j.freeradbiomed.2011.04.033; Wahli W, 2012, TRENDS ENDOCRIN MET, V23, P351, DOI 10.1016/j.tem.2012.05.001; Waldman SA, 2011, CLIN PHARMACOL THER, V90, P483, DOI 10.1038/clpt.2011.213; Wang Linli, 2013, Evid Based Complement Alternat Med, V2013, P652373, DOI 10.1155/2013/652373; [魏万林 WEI Wan-lin], 2009, [中国循环杂志, Chinese Circulation Journal], V24, P182; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Wu Leihong, 2013, Database (Oxford), V2013, pbat047, DOI 10.1093/database/bat047; Xing B, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-4; Yamaguchi F, 1997, J MOL CELL CARDIOL, V29, P753, DOI 10.1006/jmcc.1996.0319; Yamauchi T, 2002, NAT MED, V8, P1288, DOI 10.1038/nm788; Yan F. F., 2007, SHANGHAI J TRADITION, V41, P59; Yaoita H, 2000, CARDIOVASC RES, V45, P630, DOI 10.1016/S0008-6363(99)00349-1; Zaytseva YY, 2011, ANTICANCER RES, V31, P813; Zhang L, 2010, INT J CARDIOL, V143, P105, DOI 10.1016/j.ijcard.2008.11.210; Zhang YF, 2012, CURR DRUG METAB, V13, P510, DOI 10.2174/1389200211209050510; Zhao S, 2012, ANNU REV PHARMACOL, V52, P505, DOI 10.1146/annurev-pharmtox-010611-134520; Zheng XH, 2007, AM J CHINESE MED, V35, P831, DOI 10.1142/S0192415X07005302; Zimmermann GR, 2007, DRUG DISCOV TODAY, V12, P34, DOI 10.1016/j.drudis.2006.11.008; 朱明丹, 2013, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V24, P22; 刘梅, 2009, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V20, P829	80	220	235	12	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 9	2014	9	5							e95004	10.1371/journal.pone.0095004	http://dx.doi.org/10.1371/journal.pone.0095004			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	AI4LX	24587076	Green Published, Green Submitted, gold			2022-12-27	WOS:000336838000010
